<SEC-DOCUMENT>0001956827-25-000010.txt : 20250324
<SEC-HEADER>0001956827-25-000010.hdr.sgml : 20250324
<ACCEPTANCE-DATETIME>20250324170026
ACCESSION NUMBER:		0001956827-25-000010
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		193
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250324
DATE AS OF CHANGE:		20250324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Abivax S.A.
		CENTRAL INDEX KEY:			0001956827
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41842
		FILM NUMBER:		25764931

	BUSINESS ADDRESS:	
		STREET 1:		7 BD HAUSSMANN
		CITY:			PARIS
		STATE:			I0
		ZIP:			75009
		BUSINESS PHONE:		01 53 83 09 63

	MAIL ADDRESS:	
		STREET 1:		7 BD HAUSSMANN
		CITY:			PARIS
		STATE:			I0
		ZIP:			75009
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>abvx-20241231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5b13969f-ba48-4e71-920c-2a5c64899678,g:b21d6730-553e-45e9-b346-3f9a3ffd9584,d:a894b143b6fc4522a0483350194c625e-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:abvx="http://www.abivax.com/20241231" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/><title>abvx-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-39">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-40">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-41">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-42">0001956827</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="dei:NoTradingSymbolFlag" format="ixt:fixed-true" id="f-43">TRUE</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="abvx:NumberOfOperatingSegment" scale="0" id="f-714">1</ix:nonFraction><ix:nonNumeric contextRef="c-496" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1585">one year</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-497" decimals="6" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" scale="0" id="f-1586">0.020833</ix:nonFraction><ix:nonNumeric contextRef="c-622" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1587">one year</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-623" decimals="6" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" scale="0" id="f-1588">0.020833</ix:nonFraction><ix:nonNumeric contextRef="c-596" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1589">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-597" name="abvx:VestingRequirementsForShareBasedPaymentArrangementServicePeriod" format="ixt-sec:durwordsen" id="f-1590">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-624" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1591">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-625" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1592">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-626" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1593">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-601" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1594">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-603" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1595">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-627" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1596">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-916" name="abvx:ConvertibleLoansNotesPeriod" format="ixt-sec:durwordsen" id="f-1994">one year</ix:nonNumeric><ix:nonNumeric contextRef="c-86" name="abvx:ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" format="ixt-sec:durday" id="f-1995">5</ix:nonNumeric><ix:nonNumeric contextRef="c-978" name="abvx:ConversionPriceVolumeWeightedAveragePricePeriod" id="f-2097">P30D</ix:nonNumeric><ix:nonNumeric contextRef="c-1039" name="abvx:LeaseExtensionPeriod" id="f-2206">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-1330" name="abvx:OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" id="f-3291">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="c-1335" name="abvx:OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" id="f-3299">P5Y</ix:nonNumeric><ix:nonFraction unitRef="eur" contextRef="c-1353" decimals="0" name="abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" format="ixt:fixed-zero" scale="0" id="f-3331">immaterial</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="abvx-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="transaction"><xbrli:measure>abvx:transaction</xbrli:measure></xbrli:unit><xbrli:unit id="plan"><xbrli:measure>abvx:plan</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="criteria"><xbrli:measure>abvx:criteria</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>abvx:segment</xbrli:measure></xbrli:unit><xbrli:unit id="tranche"><xbrli:measure>abvx:tranche</xbrli:measure></xbrli:unit><xbrli:unit id="scenario"><xbrli:measure>abvx:scenario</xbrli:measure></xbrli:unit><xbrli:unit id="closing"><xbrli:measure>abvx:closing</xbrli:measure></xbrli:unit><xbrli:unit id="installment"><xbrli:measure>abvx:installment</xbrli:measure></xbrli:unit><xbrli:unit id="y"><xbrli:measure>utr:Y</xbrli:measure></xbrli:unit><xbrli:unit id="employee"><xbrli:measure>abvx:employee</xbrli:measure></xbrli:unit><xbrli:unit id="license"><xbrli:measure>abvx:license</xbrli:measure></xbrli:unit><xbrli:unit id="academic_institution"><xbrli:measure>abvx:academic_institution</xbrli:measure></xbrli:unit><xbrli:unit id="project"><xbrli:measure>abvx:project</xbrli:measure></xbrli:unit><xbrli:unit id="financial_institution"><xbrli:measure>abvx:financial_institution</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">abvx:AmericanDepositorySharesNASDAQGlobalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">abvx:OrdinarySharesNASDAQGlobalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:FinancialEffectOfChangesInAccountingPolicyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:FinancialEffectOfChangesInAccountingPolicyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-04</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:SaleOfStockAxis">abvx:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:SaleOfStockAxis">abvx:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-04</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorRevenueTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">abvx:ProsynergiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abvx:ProsynergiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAgreementWithUniversityHospitalCenterOfNiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAgreementWithUniversityHospitalCenterOfNiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAgreementWithUniversityHospitalCenterOfNiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-02</xbrli:startDate><xbrli:endDate>2022-09-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-02</xbrli:startDate><xbrli:endDate>2022-09-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-11</xbrli:startDate><xbrli:endDate>2022-10-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A130.0MillionCrossOverFinancingFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A130.0MillionCrossOverFinancingFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-22</xbrli:startDate><xbrli:endDate>2023-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A130.0MillionCrossOverFinancingFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-22</xbrli:startDate><xbrli:endDate>2023-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A150.0MillionFinancingAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A150.0MillionFinancingAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-22</xbrli:startDate><xbrli:endDate>2023-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingAndHeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-24</xbrli:startDate><xbrli:endDate>2023-10-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">abvx:AmericanDepositorySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-24</xbrli:startDate><xbrli:endDate>2023-10-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-24</xbrli:startDate><xbrli:endDate>2023-10-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">abvx:AmericanDepositorySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-11</xbrli:startDate><xbrli:endDate>2024-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBAndCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-01</xbrli:startDate><xbrli:endDate>2016-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:SaleOfStockAxis">abvx:AtTheMarketATMProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-19</xbrli:startDate><xbrli:endDate>2024-11-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20252Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:IndustrialMaterialsAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:IndustrialMaterialsAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:TechnicalFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:TechnicalFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:SplicosSASABX464Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:SplicosSASABX464Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:SplicosSASABX464Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-22</xbrli:startDate><xbrli:endDate>2024-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">abvx:DeferredFinancingCostsNettingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-22</xbrli:startDate><xbrli:endDate>2023-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:ConditionalAdvancesAndPGELoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:ConditionalAdvancesAndPGELoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:ConditionalAdvancesAndPGELoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-24</xbrli:startDate><xbrli:endDate>2021-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-07</xbrli:startDate><xbrli:endDate>2022-09-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-22</xbrli:startDate><xbrli:endDate>2023-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241AndBSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241AndBSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-07</xbrli:startDate><xbrli:endDate>2016-11-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-23</xbrli:startDate><xbrli:endDate>2017-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-20</xbrli:startDate><xbrli:endDate>2017-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-20</xbrli:startDate><xbrli:endDate>2017-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-20</xbrli:startDate><xbrli:endDate>2017-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-15</xbrli:startDate><xbrli:endDate>2018-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-14</xbrli:startDate><xbrli:endDate>2018-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-14</xbrli:startDate><xbrli:endDate>2018-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-14</xbrli:startDate><xbrli:endDate>2018-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-03-11</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCEExceptBCE20142Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-04</xbrli:startDate><xbrli:endDate>2015-12-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-04</xbrli:startDate><xbrli:endDate>2015-12-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-18</xbrli:startDate><xbrli:endDate>2017-09-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-22</xbrli:startDate><xbrli:endDate>2018-01-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-03-11</xbrli:startDate><xbrli:endDate>2014-03-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-03-11</xbrli:startDate><xbrli:endDate>2014-03-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-04</xbrli:startDate><xbrli:endDate>2024-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-04</xbrli:startDate><xbrli:endDate>2024-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-03-11</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-04</xbrli:startDate><xbrli:endDate>2024-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-04</xbrli:startDate><xbrli:endDate>2024-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-04</xbrli:startDate><xbrli:endDate>2024-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-04</xbrli:startDate><xbrli:endDate>2024-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-28</xbrli:startDate><xbrli:endDate>2023-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-28</xbrli:startDate><xbrli:endDate>2023-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-01</xbrli:startDate><xbrli:endDate>2023-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-02</xbrli:startDate><xbrli:endDate>2024-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20242Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20243Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-23</xbrli:startDate><xbrli:endDate>2024-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20243Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20243Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-11</xbrli:startDate><xbrli:endDate>2024-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20245Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-11</xbrli:startDate><xbrli:endDate>2024-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20245Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20245Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20247Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-05</xbrli:startDate><xbrli:endDate>2024-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20247Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20247Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TranchesOneToFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:VestingServiceConditionsAxis">abvx:VestingConditionsCompletedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:VestingServiceConditionsAxis">abvx:VestingConditionsNotCompletedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AndAGA20234Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-28</xbrli:startDate><xbrli:endDate>2023-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-28</xbrli:startDate><xbrli:endDate>2023-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-28</xbrli:startDate><xbrli:endDate>2023-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-28</xbrli:startDate><xbrli:endDate>2023-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-28</xbrli:startDate><xbrli:endDate>2023-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244AGA20245AndAGA20246Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-11</xbrli:startDate><xbrli:endDate>2024-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:EmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-02</xbrli:startDate><xbrli:endDate>2024-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:EmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-02</xbrli:startDate><xbrli:endDate>2024-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:EmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-02</xbrli:startDate><xbrli:endDate>2024-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-11</xbrli:startDate><xbrli:endDate>2023-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BorrowingsByNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BorrowingsByNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BorrowingsByNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConvertibleLoansNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConvertibleLoansNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConvertibleLoansNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-655"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-656"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-662"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-663"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-664"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OtherFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-666"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OtherFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OtherFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-671"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-675"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-21</xbrli:startDate><xbrli:endDate>2024-06-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-687"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-22</xbrli:startDate><xbrli:endDate>2023-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-689"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-691"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-696"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-700"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-732"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-733"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-734"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-737"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-738"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-739"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-740"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-742"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-743"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-745"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-748"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-749"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-751"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-28</xbrli:startDate><xbrli:endDate>2024-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-752"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-753"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-754"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-755"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-756"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-21</xbrli:startDate><xbrli:endDate>2024-06-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-758"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-21</xbrli:startDate><xbrli:endDate>2024-06-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-21</xbrli:startDate><xbrli:endDate>2024-06-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-760"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-21</xbrli:startDate><xbrli:endDate>2024-06-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-761"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-21</xbrli:startDate><xbrli:endDate>2024-06-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-762"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-764"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-766"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-767"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-768"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-769"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-771"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-772"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-773"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-774"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-775"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-776"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-777"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-778"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-779"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-780"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-781"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-782"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-784"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-785"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-787"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-788"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-790"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-791"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-792"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-796"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-799"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-800"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:DrawdownProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:DrawdownProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputExpiryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputTenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-832"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-834"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-835"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-837"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-838"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-839"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-841"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-843"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-845"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-846"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-853"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-854"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-855"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-856"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-857"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-859"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-861"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-863"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-865"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-866"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-869"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-870"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-871"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-872"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-873"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-874"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ConversionPricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ConversionPricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-876"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ConversionPricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-878"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-879"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-880"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-883"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:InitialPriceLimitMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-884"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:InitialPriceLimitMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:InitialPriceLimitMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-886"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:EarlyRedemptionAmountMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-887"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:EarlyRedemptionAmountMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-888"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:EarlyRedemptionAmountMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-889"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-890"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-891"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-892"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-893"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-894"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-895"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-897"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-898"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-899"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-900"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-907"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-913"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-20</xbrli:startDate><xbrli:endDate>2023-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1NonConvertibleBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-24</xbrli:startDate><xbrli:endDate>2018-07-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-24</xbrli:startDate><xbrli:endDate>2018-07-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-932"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-933"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-24</xbrli:startDate><xbrli:endDate>2018-07-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-934"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-21</xbrli:startDate><xbrli:endDate>2023-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-935"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-936"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-937"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-938"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-939"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-940"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-941"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-942"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-943"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-944"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-946"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-947"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-948"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-949"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-950"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-951"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-952"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-953"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-954"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-955"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-956"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-957"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-958"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-959"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-960"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-961"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-962"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-963"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-964"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-965"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-966"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-967"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-969"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-970"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-971"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-972"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2TrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-973"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2TrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-974"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-975"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-976"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-977"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-30</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-978"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-979"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After18MonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-980"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After24MonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-981"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After36MonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-982"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After18MonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-983"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After24MonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-984"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After36MonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-985"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-986"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-987"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-988"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-989"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-990"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-991"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-992"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-993"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-994"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-995"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-996"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-997"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-998"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-999"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1000"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-24</xbrli:startDate><xbrli:endDate>2023-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1005"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1006"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1017"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-16</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-01</xbrli:startDate><xbrli:endDate>2017-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-16</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-01</xbrli:startDate><xbrli:endDate>2013-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-09-01</xbrli:startDate><xbrli:endDate>2014-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-06-01</xbrli:startDate><xbrli:endDate>2016-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1032"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1033"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1034"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1035"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1036"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1037"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-02</xbrli:startDate><xbrli:endDate>2024-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1038"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesBostonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1039"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesBostonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1040"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesBostonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1041"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMontpellierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1042"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1043"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1044"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1045"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1046"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1047"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketCapitalizationMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1048"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketCapitalizationMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1049"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1050"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1051"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1052"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1053"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1054"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1055"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1056"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1058"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1059"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1060"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1061"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1062"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1063"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1064"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1065"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1066"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1067"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1068"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-02</xbrli:startDate><xbrli:endDate>2022-09-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1069"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-02</xbrli:startDate><xbrli:endDate>2022-09-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1070"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1071"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1072"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1074"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1075"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1076"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1077"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1078"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1079"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1080"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1081"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1082"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1083"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1084"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1085"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1086"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1087"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1088"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1089"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1090"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1091"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1092"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1093"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1095"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1096"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1097"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1098"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1099"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheABMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2021TaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2022TaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2023TaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2021TaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:SalesAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:SalesAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:SalesAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:RetirementBenefitObligationsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:RetirementBenefitObligationsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:RetirementBenefitObligationsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:LeasesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:LeasesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:LeasesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:SubsidiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:SubsidiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:SubsidiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">abvx:AbivaxLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">abvx:AbivaxLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:AdvisorToTheChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-18</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-12-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-11-11</xbrli:startDate><xbrli:endDate>2006-11-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvx:TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-16</xbrli:startDate><xbrli:endDate>2013-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-16</xbrli:startDate><xbrli:endDate>2013-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-16</xbrli:startDate><xbrli:endDate>2013-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-16</xbrli:startDate><xbrli:endDate>2016-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-16</xbrli:startDate><xbrli:endDate>2016-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-16</xbrli:startDate><xbrli:endDate>2016-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPILanguedocRoussillonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMontpellierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001956827</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-63 f-64 f-66 f-67 f-69 f-70 f-72 f-73 f-75 f-76 f-78 f-79 f-81 f-82 f-84 f-85 f-87 f-88 f-90 f-91 f-93 f-94 f-96 f-97 f-99 f-100 f-102 f-103 f-105 f-106 f-108 f-109 f-111 f-112 f-114 f-115 f-117 f-118 f-120 f-121 f-123 f-124 f-126 f-127 f-129 f-130 f-132 f-133 f-135 f-136 f-138 f-139 f-141 f-142 f-144 f-145 f-147 f-148 f-150 f-151 f-153 f-154 f-156 f-157 f-159 f-160 f-162 f-163 f-165 f-166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-439 f-440 f-441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"/></ix:resources></ix:header></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">1<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_1"></div><div style="line-height: 12pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 258.18pt; position: var(--position); text-decoration: none; white-space: pre;">UNITED STATES<span style="display: inline-block; height: 8.12pt;"></span><span id="if5cb76dda0e44c66bee7b98cc47e6863"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 86.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 176.9pt; position: var(--position); text-decoration: none; white-space: pre;">SECURITIES AND EXCHANGE COMMISSION<span style="display: inline-block; height: 8.12pt;"></span><span id="i9f6228f580a94e8eacf0171f6c653a35"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 100.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 232.19pt; position: var(--position); text-decoration: none; white-space: pre;">WASHINGTON, D.C. 20549<span style="display: inline-block; height: 8.12pt;"></span><span id="ib89e856ca643417b9a644f57de031854"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 129.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 274.52pt; position: var(--position); text-decoration: none; white-space: pre;">FORM <span style="display: inline-block; height: 8.12pt;"></span><span id="iacf830c5c6c340e8b5067df6686994e2"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 314.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">20-F</ix:nonNumeric><span style="display: inline-block; height: 8.12pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">(Mark One)<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 169.6pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="f-2">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 81.37pt; position: var(--position); white-space: pre;">&#160; &#160; &#160;  REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 183.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">EXCHANGE ACT OF 1934<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 298.5pt; position: var(--position); white-space: pre;">OR<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 205.44pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="f-3">&#9746;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 81.37pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">ACT OF 1934<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 211.65pt; position: var(--position); white-space: pre;">For the fiscal year ended <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 319.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-5"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>, 2024</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 298.5pt; position: var(--position); white-space: pre;">OR<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 263.68pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="f-6">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 81.37pt; position: var(--position); white-space: pre;">&#160; &#160; &#160;  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 277.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">EXCHANGE ACT OF 1934<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 298.5pt; position: var(--position); white-space: pre;">OR<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 310.72pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentShellCompanyReport" format="ixt-sec:boolballotbox" id="f-7">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 81.37pt; position: var(--position); white-space: pre;">&#160; &#160; &#160;  SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">EXCHANGE ACT OF 1934<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 200.95pt; position: var(--position); white-space: pre;">Date of event requiring this shell company report<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 368.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 228.95pt; position: var(--position); white-space: pre;">Commission file number: <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 339.71pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-8">001-41842</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 18pt; position: var(--position); top: 393.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 18pt; font-style: normal; font-weight: bold; left: 264.75pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-9">Abivax SA</ix:nonNumeric><span style="display: inline-block; height: 12.19pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.96pt; position: var(--position); white-space: pre;">(Exact name of Registrant as specified in its charter and translation of Registrant&#8217;s name into English)<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 436.82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 291.02pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-10">France</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448.02pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.15pt; position: var(--position); white-space: pre;">(Jurisdiction of incorporation or organization)<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 247.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-11">7-11 boulevard Haussmann</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 481.62pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">75009</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 288.68pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 291.18pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-13">Paris</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 313.37pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 318.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-14">France</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492.82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.65pt; position: var(--position); white-space: pre;">(Address of principal executive offices)<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 515.22pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 270.49pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelName" id="f-15">Marc de Garidel</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 255.79pt; position: var(--position); white-space: pre;">Chief Executive Officer<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 537.62pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 247.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-16">7-11 boulevard Haussmann</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548.82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-17">75009</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 288.68pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 291.18pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-18">Paris</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 313.37pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 318.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-19">France</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 560.02pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 252.48pt; position: var(--position); white-space: pre;">Tel: <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 272.17pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:CityAreaCode" id="f-20">+33</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 287.86pt; position: var(--position); white-space: pre;"> (0) <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 304.52pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:LocalPhoneNumber" id="f-21">1 53 83 09 63</ix:nonNumeric><span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 571.22pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 268.72pt; position: var(--position); white-space: pre;">info@abivax.com<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.73pt; position: var(--position); white-space: pre;">(Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person)<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604.82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Securities registered or to be registered pursuant to Section 12(b) of the Act.<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="position: var(--position); top: 616.02pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 465.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 191.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 179.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 191.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 3.22pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 61.78pt; position: var(--position); text-decoration: none; white-space: pre;">Title of each class<span style="display: inline-block; height: 6.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 0pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 3.22pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;">Trading Symbol(s)<span style="display: inline-block; height: 6.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 0pt; width: 179.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 3.22pt; width: 179.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.96pt; position: var(--position); text-decoration: none; white-space: pre;">Name of each exchange on which registered<span style="display: inline-block; height: 6.09pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12.75pt; width: 191.25pt;"><div><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-22"><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.1pt; position: var(--position); text-decoration: none; white-space: pre;">American Depositary Shares, each representing <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.71pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.57pt; position: var(--position); text-decoration: none; white-space: pre;">one ordinary share, nominal value &#8364;0.01 per share<span style="display: inline-block; height: 6.24pt;"></span></span></div></ix:nonNumeric></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 12.75pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.89pt; position: var(--position); white-space: pre;"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-23">ABVX</ix:nonNumeric><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 12.75pt; width: 179.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 179.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 40.55pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-24">The Nasdaq Global Market</ix:nonNumeric><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 191.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.63pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.2pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-4" name="dei:Security12bTitle" id="f-25">Ordinary shares, nominal value &#8364;0.01 per share</ix:nonNumeric><span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 178.54999999999998pt; position: var(--position); white-space: pre;">*<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 36pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 45.37pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 36pt; width: 179.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.63pt; width: 179.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 38.3pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-26">The Nasdaq Global Market</ix:nonNumeric><span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.45pt; position: var(--position); white-space: pre;">*<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 669.77pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 389.09pt;">*Not for trading, but only in connection with the registration of the American Depositary Shares.<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692.17pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.18pt; position: var(--position); white-space: pre;">Securities registered or to be registered pursuant to Section 12(g) of the Act. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 448.61pt; position: var(--position); white-space: pre;">None<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 703.37pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.69pt; position: var(--position); white-space: pre;">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 471.1pt; position: var(--position); white-space: pre;">None<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">2<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 83.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 94.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">of the period covered by the annual report.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Ordinary shares: <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 148.05pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-27">63,347,837</ix:nonFraction><span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 193.05pt; position: var(--position); white-space: pre;"> shares outstanding as of December 31, 2024<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 139.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Act. <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.42pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.23pt; position: var(--position); white-space: pre;"> Yes <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.77000000000001pt; position: var(--position); white-space: pre;">&#9746;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-28">No</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 173.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.19pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369pt; position: var(--position); white-space: pre;"> Yes <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.54pt; position: var(--position); white-space: pre;">&#9746;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.85pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-29">No</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 217.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.01pt; position: var(--position); white-space: pre;">&#9746;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 511.32pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-30">Yes</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.86pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.36pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.1700000000001pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">No<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 273.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">such shorter period that the registrant was required to submit such files). <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.63pt; position: var(--position); white-space: pre;">&#9746;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.94pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-31">Yes</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.98pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.79pt; position: var(--position); white-space: pre;"> No<span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 307.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 329.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">growth company&#8221; in Rule 12b-2 of the Exchange Act.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 352.3pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 469.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 117pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 117pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 130.5pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 117pt;"><div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 2.63pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre; width: 92.3pt;">Large accelerated filer <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.92999999999999pt; position: var(--position); white-space: pre; width: 7.81pt;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 2.63pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre; width: 66.8pt;"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-32">Accelerated filer</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.42999999999999pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.92999999999999pt; position: var(--position); white-space: pre; width: 7.81pt;">&#9746;<span style="display: inline-block; height: 7.28pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 222pt; position: var(--position); top: 0pt; width: 117pt;"><div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 2.63pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre; width: 87.06pt;">Non-accelerated filer <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.69pt; position: var(--position); white-space: pre; width: 7.81pt;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 0pt; width: 130.5pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 2.63pt; width: 130.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre; width: 111.85pt;">Emerging growth company <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre; width: 7.81pt;"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-33">&#9746;</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 371.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">check mark if the registrant has elected not to use the extended transition period for complying with any new or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 393.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act. <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.46pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-34">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 427.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Standards Board to its Accounting Standards Codification after April 5, 2012.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 449.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 461.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-35">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 505.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">statements of the registrant included in the filing reflect the correction of an error to previously issued financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 517.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">statements. <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.15pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-36">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 539.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 561.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">period pursuant to &#167;240.10D-1(b). <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.93pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 595.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">included in this filing:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">U.S. GAAP <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAccountingStandard" id="f-37">International Financial Reporting Standards</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.06pt; position: var(--position); white-space: pre;"> as issued by the International Accounting Standards Board <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.54pt; position: var(--position); white-space: pre;">&#9746;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.35pt; position: var(--position); white-space: pre;"> Other <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.1pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 651.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">item the registrant has elected to follow. <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.1pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.91pt; position: var(--position); white-space: pre;"> Item 17 <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.71000000000004pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.52pt; position: var(--position); white-space: pre;"> Item 18<span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 673.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 685.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">12b-2 of the Exchange Act). <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.81pt; position: var(--position); white-space: pre;"> Yes <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.35pt; position: var(--position); white-space: pre;">&#9746;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.16pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.66pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-38">No</ix:nonNumeric><span style="display: inline-block; height: 7.28pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">3<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_7"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 252.15pt; position: var(--position); text-decoration: none; white-space: pre;">TABLE OF CONTENTS<span style="display: inline-block; height: 6.77pt;"></span><span id="id02c3bd4892d4cf58dd16e27b3ebc92f"></span></span></div><div style="position: var(--position); top: 96pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 421.2pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 46.8pt;"/></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 0pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.87pt; position: var(--position); text-decoration: none; white-space: pre;">Page<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 13.21pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ic1d3b1792b2944548fcf9927f3a92928">INTRODUCTION</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 78.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 78.42pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 78.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.53999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">........................................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 13.21pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ic1d3b1792b2944548fcf9927f3a92928">4</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 26.42pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4e0d3ee6e28245428b0ecb200bfc1f73">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 302.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 303.01pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 303.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 303.45pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.46999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 26.42pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4e0d3ee6e28245428b0ecb200bfc1f73">4</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.63pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1b17195103564ebbbfec28ffbaeafbab">PART I</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 34pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 35.160000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 35.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 35.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 35.86pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 35.88pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 35.89pt; position: var(--position); text-decoration: none; white-space: pre;">.........................................................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 39.63pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1b17195103564ebbbfec28ffbaeafbab">7</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 52.84pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if345470e360349c1956ae16ba02fca41">Item 1.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if345470e360349c1956ae16ba02fca41"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if345470e360349c1956ae16ba02fca41">Identity of Directors, Senior Management and Advisers</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 296.9pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 298.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 298.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 298.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 298.40999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.42pt; position: var(--position); text-decoration: none; white-space: pre;">................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 52.84pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if345470e360349c1956ae16ba02fca41">7</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.05pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9ffbe1e6f2b94899a70693a46d1906cb">Item 2.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9ffbe1e6f2b94899a70693a46d1906cb"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9ffbe1e6f2b94899a70693a46d1906cb">Offer Statistics and Expected Timetable</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 234.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 235.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 235.82999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 235.91pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.92pt; position: var(--position); text-decoration: none; white-space: pre;">.........................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 66.05pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9ffbe1e6f2b94899a70693a46d1906cb">8</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.26pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i076b01dba0464724b98e10c4b7c9b90e">Item 3.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i076b01dba0464724b98e10c4b7c9b90e"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i076b01dba0464724b98e10c4b7c9b90e">Key Information</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 141.51pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 142.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 143.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 143.32999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 143.37pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.39pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 79.26pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i076b01dba0464724b98e10c4b7c9b90e">9</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.47pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5127f6dc71a24d80a1730fb78265c265">Item 4.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5127f6dc71a24d80a1730fb78265c265"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5127f6dc71a24d80a1730fb78265c265">Information on the Company.</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 193.42pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 193.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 193.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 193.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.57pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 92.47pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 34.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5127f6dc71a24d80a1730fb78265c265">60</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.68pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i32caf7541b704924ae356d7247aec86d">Item 4A. </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i32caf7541b704924ae356d7247aec86d">Unresolved Staff Comments.</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 190.91pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.06pt; position: var(--position); text-decoration: none; white-space: pre;">...........................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 105.68pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i32caf7541b704924ae356d7247aec86d">101</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.89pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e192020445745d0a526f53acc4e9e77">Item 5.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e192020445745d0a526f53acc4e9e77"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e192020445745d0a526f53acc4e9e77">Operating and Financial Review and Prospects</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 261.90999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 263.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 263.36pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 263.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.42pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 118.89pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e192020445745d0a526f53acc4e9e77">102</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132.1pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7652ff9c52cb43d1b49f8758a9c1b94f">Item 6.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7652ff9c52cb43d1b49f8758a9c1b94f"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7652ff9c52cb43d1b49f8758a9c1b94f">Directors, Senior Management and Employees</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 261.36pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 262.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 263.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 263.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 263.33pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 263.37pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.38pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 132.1pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7652ff9c52cb43d1b49f8758a9c1b94f">118</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 145.31pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if3eba5cf4ffa4d54bb14637296387901">Item 7.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if3eba5cf4ffa4d54bb14637296387901"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if3eba5cf4ffa4d54bb14637296387901">Major Shareholders and Related Party Transactions</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 280.77pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 280.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 281pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 281.04pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.06pt; position: var(--position); text-decoration: none; white-space: pre;">.......................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 145.31pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if3eba5cf4ffa4d54bb14637296387901">151</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 158.52pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4d9c6a82e9464ef0ac2cf9da51e48b9a">Item 8.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4d9c6a82e9464ef0ac2cf9da51e48b9a"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4d9c6a82e9464ef0ac2cf9da51e48b9a">Financial Information</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 162.01999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 163.18pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 163.32999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 163.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 163.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.44pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 158.52pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4d9c6a82e9464ef0ac2cf9da51e48b9a">155</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171.73pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6e0fa3c38e0f4dada2bfff4c2264f2de">Item 9.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6e0fa3c38e0f4dada2bfff4c2264f2de"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6e0fa3c38e0f4dada2bfff4c2264f2de">The Offer and Listing</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 162.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 163.19pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 163.34pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 163.42pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.44pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 171.73pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6e0fa3c38e0f4dada2bfff4c2264f2de">156</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 184.94pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie19058836d894dd498ae3ece1a3f07fc">Item 10.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie19058836d894dd498ae3ece1a3f07fc"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie19058836d894dd498ae3ece1a3f07fc">Additional Information.</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 170.09pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 170.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 170.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.98pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 184.94pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie19058836d894dd498ae3ece1a3f07fc">157</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.15pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie54cb3b294e144bcb495313e21e35170">Item 11.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie54cb3b294e144bcb495313e21e35170"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie54cb3b294e144bcb495313e21e35170">Quantitative and Qualitative Disclosures About Market Risk</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 316.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 317.71999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 318.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 318.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.39pt; position: var(--position); text-decoration: none; white-space: pre;">........................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 198.15pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie54cb3b294e144bcb495313e21e35170">172</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 211.36pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9beab7f30c164277953b192e0ae7b6dd">Item 12.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9beab7f30c164277953b192e0ae7b6dd"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9beab7f30c164277953b192e0ae7b6dd">Description of Securities Other than Equity Securities</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 289.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 290.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 290.79pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 290.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 290.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.96999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 211.36pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9beab7f30c164277953b192e0ae7b6dd">174</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 224.57pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i74eb700c00f24f4db398b8c6a584c2d7">PART II</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 37.330000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 37.910000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 38.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 38.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.470000000000006pt; position: var(--position); text-decoration: none; white-space: pre;">........................................................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 224.57pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i74eb700c00f24f4db398b8c6a584c2d7">177</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.78pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7feea7bb48364c06acccf8da29b446c3">Item 13.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7feea7bb48364c06acccf8da29b446c3"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7feea7bb48364c06acccf8da29b446c3">Defaults, Dividend Arrearages and Delinquencies</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 273.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.57pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 237.78pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7feea7bb48364c06acccf8da29b446c3">177</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 250.99pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0791810245f94442bc953c09756296ed">Item 14.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0791810245f94442bc953c09756296ed"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0791810245f94442bc953c09756296ed">Material Modifications to the Rights of Security Holders and Use of Proceeds</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 385.69pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 385.98pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 386.02pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.04pt; position: var(--position); text-decoration: none; white-space: pre;">.............<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 250.99pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0791810245f94442bc953c09756296ed">178</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 264.2pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib0f26dcd869d418d9f22f5f85cd85b71">Item 15.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib0f26dcd869d418d9f22f5f85cd85b71"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib0f26dcd869d418d9f22f5f85cd85b71">Controls and Procedures</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 172.88pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 173.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 173.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.51pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 264.2pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib0f26dcd869d418d9f22f5f85cd85b71">179</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 277.41pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6afb786a6f764c75a23cd2c306545822">Item 16.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6afb786a6f764c75a23cd2c306545822"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6afb786a6f764c75a23cd2c306545822">[Reserved]</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 118.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 118.53999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 118.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.57pt; position: var(--position); text-decoration: none; white-space: pre;">........................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 277.41pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6afb786a6f764c75a23cd2c306545822">181</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 290.62pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27bb8463fb01478b99f7ebcc6281a232">Item 16A.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27bb8463fb01478b99f7ebcc6281a232">Audit Committee Financial Expert</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 213.04999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 213.34pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 213.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.53pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 290.62pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27bb8463fb01478b99f7ebcc6281a232">181</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 303.83pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i24898a84d7cc41e3ac8f4994e4884ee0">Item 16B.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i24898a84d7cc41e3ac8f4994e4884ee0">Code of Ethics</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 134.01pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 135.17pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 135.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 135.82999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 135.87pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.89pt; position: var(--position); text-decoration: none; white-space: pre;">.................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 303.83pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i24898a84d7cc41e3ac8f4994e4884ee0">181</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.04pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie58f9ca2d81c4cd28372bce4e7192e06">Item 16C.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie58f9ca2d81c4cd28372bce4e7192e06">Principal Accountant Fees and Services</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 233.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 233.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 233.54999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 233.56pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 317.04pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie58f9ca2d81c4cd28372bce4e7192e06">181</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 330.25pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie6a1a5f190d84977b8434ce7a6c3ce88">Item 16D.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie6a1a5f190d84977b8434ce7a6c3ce88">Exemptions from the Listing Standards for Audit Committees</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 321.88pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 323.04pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 323.33pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 323.40999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.42pt; position: var(--position); text-decoration: none; white-space: pre;">......................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 330.25pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie6a1a5f190d84977b8434ce7a6c3ce88">182</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 343.46pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#id16374bc2ff249fba6c409dc12484ea5">Item 16E.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#id16374bc2ff249fba6c409dc12484ea5">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 354.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 355.21pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 355.79pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 355.87pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.89pt; position: var(--position); text-decoration: none; white-space: pre;">.........................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 343.46pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#id16374bc2ff249fba6c409dc12484ea5">182</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 356.67pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib1f44c1cbe7b4319af9f420cdd4f639f">Item 16F.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib1f44c1cbe7b4319af9f420cdd4f639f">Change in Registrant&#8217;s Certifying Accountant</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 258.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 258.45pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 258.53000000000003pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 258.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.56pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 356.67pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib1f44c1cbe7b4319af9f420cdd4f639f">182</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 369.88pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2171f402b22a4a42b0641e479ae89474">Item 16G.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2171f402b22a4a42b0641e479ae89474">Corporate Governance</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 165.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 165.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.01pt; position: var(--position); text-decoration: none; white-space: pre;">.....................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 369.88pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2171f402b22a4a42b0641e479ae89474">182</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 383.09pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifb8131a68fda4c36bb0b5e209db753e6">Item 16H.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifb8131a68fda4c36bb0b5e209db753e6">Mine Safety Disclosure</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 168.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 170.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 170.71pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 170.85999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.88pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 383.09pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifb8131a68fda4c36bb0b5e209db753e6">182</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 396.3pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9392e6cfe72e41ef9ecec0f92c72fee9">Item 16I.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9392e6cfe72e41ef9ecec0f92c72fee9">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 346.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 347.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 348.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 348.36pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 348.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.39pt; position: var(--position); text-decoration: none; white-space: pre;">............................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 396.3pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9392e6cfe72e41ef9ecec0f92c72fee9">183</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 409.51pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2643e649e989428092c845066d0d0eb1">Item 16J.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2643e649e989428092c845066d0d0eb1">Insider Trading Policies</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 170.63pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 170.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 171pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.04pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 409.51pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2643e649e989428092c845066d0d0eb1">183</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 422.72pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia720e12b1a2d4c82a1b486218f51ba70">Item 16K.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia720e12b1a2d4c82a1b486218f51ba70">Cybersecurity</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 130.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 130.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.04pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 422.72pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia720e12b1a2d4c82a1b486218f51ba70">183</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 435.93pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iffa568ce6ad74ab1a41a85ba4ca61966">PART III</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 40.660000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 40.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 41.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.04pt; position: var(--position); text-decoration: none; white-space: pre;">.......................................................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 435.93pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iffa568ce6ad74ab1a41a85ba4ca61966">185</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 449.14pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia148bf23629a45459756d04ceec8f419">Item 17.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia148bf23629a45459756d04ceec8f419"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia148bf23629a45459756d04ceec8f419">Financial Statements</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 158.10999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 158.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 158.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 158.51999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.54pt; position: var(--position); text-decoration: none; white-space: pre;">........................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 449.14pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia148bf23629a45459756d04ceec8f419">185</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 462.35pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i72eace45f5f544a1b5a3f440b993546e">Item 18.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i72eace45f5f544a1b5a3f440b993546e"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i72eace45f5f544a1b5a3f440b993546e">Financial Statements</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 158.10999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 158.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 158.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 158.51999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.54pt; position: var(--position); text-decoration: none; white-space: pre;">........................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 462.35pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i72eace45f5f544a1b5a3f440b993546e">186</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 475.56pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9d70ca845c2740bab0cd62f30cf4df83">Item 19.</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 38.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9d70ca845c2740bab0cd62f30cf4df83"></a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 74.63pt; position: var(--position);"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9d70ca845c2740bab0cd62f30cf4df83">Exhibits</a><span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 107.92999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">............................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 475.56pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9d70ca845c2740bab0cd62f30cf4df83">187</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 13.21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 488.77pt; width: 421.2pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 421.2pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i492b2a542c37444b90f19a3b924ab360">SIGNATURES</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 65.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 65.69pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 65.84pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 65.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 65.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.97pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 421.2pt; position: var(--position); top: 488.77pt; width: 46.8pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 46.8pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.17pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i492b2a542c37444b90f19a3b924ab360">190</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 602.98pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 422.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 422.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 422.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_259">INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.94pt; position: var(--position); text-decoration: none; white-space: pre;">.........................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 45.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.23pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_259">1</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">4<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_10"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 266.02pt; position: var(--position); text-decoration: none; white-space: pre;">INTRODUCTION<span style="display: inline-block; height: 6.77pt;"></span><span id="ic1d3b1792b2944548fcf9927f3a92928"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Unless otherwise indicated or the context otherwise requires, &#8220;Abivax,&#8221; &#8220;the company,&#8221; &#8220;our company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 107.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and &#8220;our&#8221; refer to Abivax SA and its consolidated subsidiary, taken as a whole. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 129.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">&#8220;Abivax&#8221; and the Abivax logo and other trademarks or service marks of Abivax SA appearing in this Annual Report <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">on Form 20-F are the property of Abivax SA. Solely for convenience, the trademarks, service marks and trade <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">names referred to in this annual report are listed without the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 313.64pt; position: var(--position); top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.34000000000003pt; position: var(--position); white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 336.77pt; position: var(--position); top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#8482;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.54pt; position: var(--position); white-space: pre;"> symbols, but such references should not be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 163.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">right thereto. All other trademarks, trade names and service marks appearing in this annual report are the property of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 185.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">their respective owners. We do not intend to use or display other companies&#8217; trademarks and trade names to imply <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">any relationship with, or endorsement or sponsorship of us by, any other companies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 221.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">This Annual Report on Form 20-F includes our audited financial statements as of and for the years ended December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 233pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">31, 2024, 2023 and 2022 prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;), as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">issued by the International Accounting Standards Board (&#8220;IASB&#8221;). None of our financial statements were prepared <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 255.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Our financial statements are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">presented in euros and, unless otherwise stated, all monetary amounts are in euros. All references in this annual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 277.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">report to &#8220;$&#8221;, &#8220;U.S. dollars&#8221; and &#8220;dollars&#8221; mean U.S. dollars, and all references to &#8220;&#8364;&#8221;, &#8220;EUR&#8221; and &#8220;euros&#8221; mean <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 289pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">European Monetary Union euros, unless otherwise noted. Throughout this annual report, references to &#8220;ADSs&#8221; mean <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">American Depositary Shares representing an ownership interest in our ordinary shares or ordinary shares represented <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 311.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">by such American Despositary Shares, as the case may be.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 322.6pt;" id="ia894b143b6fc4522a0483350194c625e_13"></div><div style="line-height: 10pt; position: var(--position); top: 322.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 147.48pt; position: var(--position); text-decoration: none; white-space: pre;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS<span style="display: inline-block; height: 6.77pt;"></span><span id="i4e0d3ee6e28245428b0ecb200bfc1f73"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">This Annual Report on Form 20-F, or annual report, contains forward-looking statements within the meaning of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">amended ("Exchange Act"), that are based on our management&#8217;s beliefs and assumptions and on information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">currently available to our management. All statements other than present and historical facts and conditions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">contained in this annual report, including statements regarding our future results of operations and financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">positions, business strategy, plans and our objectives for future operations, are forward-looking statements. When <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">used in this annual report, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">designed to,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;objective,&#8221; &#8220;should,&#8221; or the negative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">of these and similar expressions identify forward-looking statements. Forward-looking statements include, but are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">not limited to, statements about:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the prospects of attaining, maintaining and expanding marketing authorization for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 489.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the potential attributes and clinical advantages of our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 501pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the initiation, timing, progress and results of our preclinical and clinical trials (and those conducted by third <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">parties) and other research and development programs; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 523.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the timing of the availability of data from our clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the timing of and our ability to advance drug candidates through clinical development; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 545.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the timing or likelihood of regulatory meetings and filings; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the timing of and our ability to obtain and maintain regulatory approvals for any of our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">our ability to identify and develop new drug candidates from our preclinical studies; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 579.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">our ability to develop sales and marketing capabilities and transition into a commercial-stage company; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the effects of increased competition as well as innovations by new and existing competitors in our industry; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 601.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">our ability to enter into strategic relationships or partnerships; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 613pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">our ability to obtain, maintain, protect and enforce our intellectual property rights and propriety technologies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">and to operate our business without infringing the intellectual property rights and proprietary technology of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 635.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">third parties; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">our expectations regarding our cash requirements; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 657.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">our estimates regarding expenses, future revenues, capital requirements and the need for additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">financing; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">the impact of government laws and regulations;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 691.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">our competitive position;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">unfavorable conditions in our industry, the global economy or global supply chain, including financial and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 83.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">credit market fluctuations, international trade relations, political turmoil, natural catastrophes, warfare (such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 94.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">as the Russia-Ukraine war or the conflict in the Middle East), and terrorist attacks; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 105.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.5pt; position: var(--position); white-space: pre;">other risks and uncertainties, including those listed in this annual report under the caption &#8220;Risk Factors.&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">You should refer to the section of this annual report titled &#8220;Item 3.D-Risk Factors&#8221; for a discussion of important <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 139.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">statements. As a result of these factors, we cannot assure you that the forward-looking statements in this annual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 161.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">report will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">not regard these statements as a representation or warranty by us or any other person that we will achieve our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 195.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">objectives and plans in any specified time frame or at all. We undertake no obligation to publicly update any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">forward-looking statements, whether as a result of new information, future events or otherwise, except as required <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 217.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">by law.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">You should read this annual report and the documents that we reference in this annual report and have filed as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 251.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exhibits to this annual report completely and with the understanding that our actual future results may be materially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">This annual report contains market data and industry forecasts that were obtained from industry publications. These <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 307.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">estimates. We have not independently verified any third-party information. While we believe the market position, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">market opportunity and market size information included in this annual report is generally reliable, such information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 329.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">is inherently imprecise.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Summary Risk Factors<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 374.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">We are a clinical-stage company with a limited operating history and no approved products and no <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 387.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">historical product revenues, which makes it difficult to assess our future prospects and financial results. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 401.28pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">We have incurred considerable losses historically, which we anticipate will continue and may increase in <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414.72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">the future. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 428.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">There is substantial doubt about our ability to continue as a going concern. We will require substantial <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 441.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">additional funding, which may not be available on acceptable terms or at all, and failure to obtain this <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 455.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">necessary capital may force us to delay, limit or terminate our product development efforts or other <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">operations.&#160; <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 481.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">We have significant debt commitments, which require us to meet certain operating covenants, and if we fail <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">to comply with those covenants the bondholders would be able to accelerate our repayment obligations.<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Our principal tangible and intangible assets serve as collateral under the terms of debt agreements for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Kreos / Claret Financing. If we default on these debt obligations, the Secured Lenders could foreclose on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 531.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">those assets, and we would be unable to continue our business and operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Drug candidates under development must undergo costly, rigorous and highly regulated preclinical studies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 553.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">and clinical trials, whose time of completion, number and outcomes are uncertain. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">We are heavily dependent on the success of our drug candidates, in particular obefazimod, and we cannot <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">be certain that obefazimod or any of our other current or future drug candidates will receive regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">approval, and, without regulatory approval, we will not be able to market our drug candidates.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Clinical failure can occur at any stage of clinical development. The results of earlier clinical trials as well as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">data from any interim analysis of ongoing trials are not necessarily predictive of future results and any drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">candidate we advance through clinical trials may not have favorable results in later clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Our future may depend on our most advanced clinical development program, obefazimod, since our other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 643.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">drug candidates are in a less advanced stage of development. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">We expect to expand our organization, and as a result, we may encounter difficulties in managing our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 665.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">growth, which could disrupt our operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">We rely on a small number of third-party suppliers and manufacturers, and in certain cases a single-source <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">supplier, and we may be in a position of dependence with respect to these third parties. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 699.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Our future success depends on our ability to retain our key executives and to attract, retain and motivate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">qualified personnel. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">6<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">There are material weaknesses in our internal controls over financial reporting and if we are unable to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 83.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">maintain effective internal controls over financial reporting, the accuracy and timeliness of our financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 94.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">reporting may be adversely affected, which could adversely affect our business, investor confidence and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 105.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">market price of our securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 116.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Our ability to exclusively commercialize our drug candidates may decrease if we are unable to protect our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">intellectual property rights or if these rights are insufficient for our purposes.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 139.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Failure or perceived failure to comply with existing or future laws, regulations, contracts, self-regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">schemes, standards, and other obligations related to data privacy or security (including security incidents) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 161.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">could harm our business.&#160; Compliance or the actual or perceived failure to comply with such obligations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">could increase our costs, limit our ability to engage in our business, and otherwise negatively affect our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">operating results and business. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">7<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_16"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 289.2pt; position: var(--position); text-decoration: none; white-space: pre;">PART I<span style="display: inline-block; height: 6.77pt;"></span><span id="i1b17195103564ebbbfec28ffbaeafbab"></span></span></div><div style="position: absolute; top: 108pt;" id="ia894b143b6fc4522a0483350194c625e_19"></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 1.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Identity of Directors, Senior Management and Advisers<span style="display: inline-block; height: 6.77pt;"></span></span><span id="if345470e360349c1956ae16ba02fca41"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">8<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_22"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 2.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Offer Statistics and Expected Timetable<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i9ffbe1e6f2b94899a70693a46d1906cb"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.5pt; position: var(--position); white-space: pre;">9<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_25"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 3.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Key Information<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i076b01dba0464724b98e10c4b7c9b90e"></span></span></div><div style="position: absolute; top: 96pt;" id="ia894b143b6fc4522a0483350194c625e_28"></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="i68af35ae8b714eb0a0a069321f2da132"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">[Reserved]<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 144pt;" id="ia894b143b6fc4522a0483350194c625e_31"></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="i8fedf72033c44c82baf872f11a56599c"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Capitalization and Indebtedness<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 192pt;" id="ia894b143b6fc4522a0483350194c625e_34"></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span><span id="ifb7170b3a701423a8b2df16e5703c35b"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Reasons for the Offer and Use of Proceeds<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 240pt;" id="ia894b143b6fc4522a0483350194c625e_37"></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">D.<span style="display: inline-block; height: 6.77pt;"></span><span id="i17fbed5316d148d7a3f0a32a7bc7e282"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our business faces significant risks. You should carefully consider all of the information set forth in this <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">annual report and in our other filings with the United States Securities and Exchange Commission, or the SEC, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including the following risk factors which we face and which are faced by our industry. Our business, financial <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">condition or results of operations could be materially adversely affected by any of these risks. This report also <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contains forward-looking statements that involve risks and uncertainties. Our results could materially differ from <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">those anticipated in these forward-looking statements, as a result of certain factors including the risks described <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">below and elsewhere in this annual report and our other SEC filings. See &#8220;Special Note Regarding Forward-<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Looking Statements&#8221; above.<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risks Related to our Financial Position and Need for Additional Capital <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We are a clinical-stage company with a limited operating history and no approved products and no historical <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product revenues, which makes it difficult to assess our future prospects and financial results. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are a clinical-stage biopharmaceutical company with a limited operating history upon which you can <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evaluate our business and prospects. We were incorporated as a <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 328.64pt; position: var(--position); text-decoration: none; white-space: pre;">soci&#233;t&#233; anonyme<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.94pt; position: var(--position); text-decoration: none; white-space: pre;"> (limited liability company) on <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;4, 2013 and, to date, we have focused primarily on organizing and staffing our company, business <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">planning, raising capital, identifying, acquiring and&#160;in-licensing&#160;our drug candidates, establishing our intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">property portfolio, conducting research, preclinical studies and clinical trials, establishing arrangements with third <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">parties for the manufacture of our drug candidates and related raw materials and providing general and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">administrative support for these operations.&#160;Investment in product development in the healthcare industry, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of biopharmaceutical products, is highly speculative because it entails substantial upfront capital expenditures and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant risk that any potential drug candidate will fail to demonstrate adequate effect or an acceptable safety <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profile, gain regulatory approval or become commercially viable. As a result, our ability to reduce our losses and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reach consistent profitability from product sales is unproven, and we may never sustain profitability. We have no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products approved for commercial sale and have not generated any revenue from product sales to date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our ability to generate revenue from product sales and achieve and maintain profitability depends on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ability, alone or with any future collaborators, to successfully complete the development of, and obtain the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory approvals necessary to commercialize, our lead drug candidate, obefazimod. Our prospects, including our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ability to finance our operations and generate revenue from product sales, therefore will depend substantially on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development and commercialization of obefazimod, as other programs in our preclinical portfolio are still in earlier <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">stages of development. Since our inception in 2013, the majority of our operating income has been derived from our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reliance on research collaborations unrelated to obefazimod, and we do not anticipate generating revenue from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product sales for the next several years, if ever. Our ability to generate revenue from product sales depends heavily <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on our or any future collaborators&#8217; success in: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">timely and successful completion of clinical development of obefazimod, our lead drug candidate; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">obtaining and maintaining regulatory and marketing approval for obefazimod and any future drug <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">candidates for which we successfully complete clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">launching and commercializing any drug candidates for which we obtain regulatory and marketing <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">approval by establishing a sales force, marketing and distribution infrastructure or, alternatively, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">collaborating with a commercialization partner; <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">10<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">obtaining coverage and adequate reimbursement from government and third-party payors for our <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">current or any future drug candidates, if approved, both in the United States and internationally, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">reaching acceptable agreements with foreign government and third-party payors on pricing terms; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 106.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 107.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">developing, validating and maintaining a commercially viable, sustainable, scalable, reproducible and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 117.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">transferable manufacturing process for obefazimod or any future drug candidates that are compliant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 127.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">with current good manufacturing practices; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 143.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">establishing and maintaining supply and manufacturing relationships with third parties that can provide <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 153.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">an adequate amount and quality of drugs and services to support our planned clinical development, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 163.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">well as the market demand for obefazimod and any future drug candidates, if approved; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 179.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">obtaining market acceptance, if and when approved, of obefazimod or any future drug candidates as a <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 189.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">viable treatment option by physicians, patients, third-party payors and others in the medical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 199.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">community; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 215.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">effectively addressing any competing technological and market developments; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 231.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">implementing additional internal systems and infrastructure, as needed; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 247.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">negotiating favorable terms in any collaboration, licensing or other arrangements into which we may <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 257.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">enter, and performing our obligations pursuant to such arrangements; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 273.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 283.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">trade secrets and know-how; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 299.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">avoiding and defending against third-party interference or infringement claims; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 315.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">attracting, hiring and retaining qualified personnel. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 343.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We have incurred considerable losses historically, which we anticipate will continue and may increase in the <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 353.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">future. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 369.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since our inception, we have incurred net losses. For the years ended December&#160;31, 2024, 2023 and 2022, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reported net losses of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.69pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.54pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;147.7&#160;million, and &#8364;60.7 million, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.92pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> As of December 31, 2024, we </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 389.5pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">carried forward accumulated tax losse</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224pt; position: var(--position); text-decoration: none; white-space: pre;">s of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.72pt; position: var(--position); text-decoration: none; white-space: pre;"> &#8364;609.4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.07pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 411.5pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">We have devoted most of our financial resources to research and development, including our clinical and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 421.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical development activities. Even if we obtain regulatory approval to market a drug candidate, our future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 431.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">revenues will depend upon the size of any markets in which our drug candidates have received approval and our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 441.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ability to achieve sufficient market acceptance, reimbursement from third-party payors and adequate market share <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 451.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for our drug candidates in those markets. There can be no assurance that we will ever earn any revenues or revenues <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 461.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sufficient to offset past, current and future losses or achieve profitability, which would impair our ability to sustain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 471.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our operations. Moreover, even if we achieve profitability, such profitability may not be sustainable. Any inability to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 481.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generate sustained profits could have a material adverse effect on our business, prospects, financial condition, cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 491.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">flows and results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 513.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We expect to continue to incur significant expenses and operating losses for the foreseeable future. We do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 523.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">anticipate achieving profitability in the future unless we obtain the regulatory approvals necessary to commercialize <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 533.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and any additional drug candidates that we may pursue in the future. We anticipate that our expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 543.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will increase substantially if, and as, we: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 559.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">timely and successfully complete clinical development of obefazimod, our clinical-stage drug <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 569.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">candidate; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 585.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">seek and maintain regulatory and marketing approvals for obefazimod and any future drug candidates <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 595.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">for which we successfully complete clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 611.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">continue the preclinical and clinical development of our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 627.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">expand the scope of our current clinical trials for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 643pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">begin new clinical trials for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">develop, scale and validate our commercial manufacturing capabilities for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 675pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">establish a sales, marketing and distribution infrastructure to commercialize any drugs for which we <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 685pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">may obtain marketing approval for which we have not entered into a collaboration with a third-party; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 701pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">seek to discover, identify and validate additional drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">11<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">acquire or in-license other drug candidates and technologies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">make milestone, royalty or other payments under in-license or collaboration agreements; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">obtain, maintain, protect, enforce and expand our intellectual property portfolio; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">attract new and retain existing skilled personnel; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">continue our operations as a U.S. public company. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, following the issuance of royalty certificates in September 2022 and other royalties that may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">become payable under our royalty agreements, the payment of royalties in the event of commercialization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod will result in a decrease in cash flows generated by sales of the product, which could have an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unfavorable impact on our financial position, particularly at the beginning of the commercialization phase. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The net losses we incur may fluctuate significantly from quarter-to-quarter and year-to-year, such that a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">period-to-period comparison of our results of operations may not be a good indication of our future performance. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any particular period or periods, our operating results could be below the expectations of securities analysts or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">investors, which could cause the price of the ordinary shares (which may be in the form of ADSs) to decline. An <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increase in operational losses would have a material adverse effect on our business, financial position, income, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">growth and outlook. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">There is substantial doubt about our ability to continue as a going concern. We will require substantial additional <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">funding, which may not be available on acceptable terms or at all, and failure to obtain this necessary capital <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may force us to delay, limit or terminate our product development efforts or other operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our operations have consumed substantial amounts of cash since inception. We are currently advancing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod through clinical development and conducting preclinical studies with respect to other programs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Developing drug candidates is expensive, lengthy and risky, and we expect our research and development expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to increase substantially in connection with our ongoing activities, particularly as we seek to advance obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">toward commercialization, if our Phase 3 clinical trial results are positive. If our clinical trials are successful and we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtain regulatory approval for drug candidates that we develop, we will incur commercialization expenses before <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these drug candidates are marketed and sold. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Based on (a) our existing cash and cash equivalents of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;144.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.56pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.06pt; position: var(--position); text-decoration: none; white-space: pre;">as of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.25pt; position: var(--position); text-decoration: none; white-space: pre;"> and (b) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected reimbursement of the CIR from 2024 in the second half of 2025 amounting to &#8364;5.7 million, we expect to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">able to fund our forecasted cash flow requirements into the fourth quarter of 2025. Accordingly, there is substantial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">doubt about our ability to continue as a going concern for a period of 12 months from the date of issuance of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial statements included in this Annual Report on Form 20-F. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our forecasted cash flow requirements take into account our assumption that research and development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expenditure will be substantially increased in 2025 driven by the progression of the Phase 3 clinical trials of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod in ulcerative colitis ("UC") and the continuation of the Phase 2b trial for Crohn's disease ("CD"), which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we initiated in 2024. We have based this estimate on assumptions that may prove to be wrong, and we could utilize <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our available capital resources sooner than we expect. We anticipate that we will require additional capital as we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">seek regulatory approval of our drug candidates. We intend to assess and plan for any such funding requirements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and aim to regularly update the market on our financing need projections. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Until we can generate sufficient product or royalty revenue to finance our cash requirements, which we may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">never do, we may seek additional financing in the form of public or private equity or debt financings, sales of ADSs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">under our existing at-the-market program with an aggregate offering price of up to $150.0 million, government or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other third-party funding, marketing and distribution arrangements and collaborations, strategic alliances and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">licensing arrangements or a combination of these sources. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The amount and timing of our funding needs will depend on factors that are largely outside of our control, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such as: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">higher costs and slower-than-expected progress on our research and development programs and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">costs related to preparing, filing, enforcing and maintaining our patents and other intellectual property <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">rights; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the scope of the research required and time needed to sign licensing agreements with industrial <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">partners; <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">12<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the expenses needed to respond to technological and market developments; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">higher costs and longer-than-expected lead times obtaining regulatory authorizations, including time <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">for preparing application dossiers for the relevant authorities; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">new opportunities for developing new products or acquiring technologies, products or companies. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Any additional fundraising efforts may divert our management from their day-to-day activities, which may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adversely affect our ability to develop and, if approved, commercialize our drug candidates. In addition, we cannot <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">French law, our share capital may be increased only with shareholders&#8217; approval at an extraordinary general <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; meeting on the basis of a report from the board of directors. In addition, the French Commercial Code <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">imposes certain limitations on our ability to price certain offerings of our share capital without preferential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subscription rights (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 151.94pt; position: var(--position); text-decoration: none; white-space: pre;">droit pr&#233;f&#233;rentiel de souscription<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.28999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">), which limitation may prevent us from successfully <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completing any such offering. To the extent that we raise additional capital, the terms of any financing may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adversely affect the holdings or the rights of our shareholders and the issuance of additional securities, whether <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">equity or debt, by us, or the possibility of such issuance, may cause the market price of our ordinary shares (which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may be in the form of ADSs) to decline. The sale of additional equity or convertible securities will dilute our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders' ownership interest. The incurrence of indebtedness would result in increased fixed payment obligations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that could adversely impact our ability to conduct our business. To the extent that we raise additional funds through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">arrangements with research and development partners or otherwise, we may be required to relinquish some of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technologies, drug candidates or revenue streams, license our technologies or drug candidates on unfavorable terms, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or otherwise agree to terms unfavorable for us. If we are unable to obtain adequate financing, we may be required to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delay, reduce or eliminate the number or scope of our projects and drug candidates (including our preclinical studies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and clinical trial programs). In order to obtain financing, we may be required to relinquish rights to some of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technologies or drug candidates or otherwise agree to terms unfavorable to us. If we are unable to obtain funding on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development programs or the commercialization of any drug candidate or be unable to expand our operations or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">otherwise capitalize on our business opportunities, as desired, which could impair our prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The report of our independent registered public accounting firm for the years ended December 31, 2024, 2023 <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and 2022 contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concern.<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99pt; position: var(--position); text-decoration: none; white-space: pre;">Due to the uncertainty of our ability to meet our current operating and capital expenses, in its report on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">audited annual financial statements as of and for the years ended December 31, 2024, 2023 and 2022, our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">independent auditors included an explanatory paragraph regarding our ability to continue as going concern. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Substantial doubt about our ability to continue as a going concern may materially and adversely affect the price per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">share of our common stock and we may have a more difficult time obtaining financing. Further, the perception that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we may be unable to continue as a going concern may impede our ability to raise additional funds or operate our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business due to concerns regarding our ability to discharge our contractual obligations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">There are material weaknesses in our internal controls over financial reporting and if we are unable to maintain <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">effective internal controls over financial reporting, the accuracy and timeliness of our financial reporting may be <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adversely affected, which could adversely affect our business, investor confidence and the market price of our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">securities. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Internal control over financial reporting is a process designed by, or under the supervision of, the company's <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">principal executive and principal financial officers, or persons performing similar functions, and effected by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company's board of directors, management and other personnel, to provide reasonable assurance regarding the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reliability of financial reporting and the preparation of financial statements for external purposes in accordance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generally accepted accounting principles. Internal control over financial reporting includes those policies and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">procedures that pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company's transactions and dispositions of the company's assets; provide reasonable assurance that transactions are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recorded as necessary to permit preparation of financial statements in accordance with generally accepted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accounting principles, and that receipts and expenditures of the company are being made only in accordance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorizations of management and directors of the company; and provide reasonable assurance regarding prevention <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or timely detection of unauthorized acquisition, use or disposition of the company's assets that could have a material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">effect on the financial statements. Because of its inherent limitations, internal control over financial reporting is not <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">13<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intended to provide absolute assurance that a misstatement of our financial statements would be prevented or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">detected. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We must maintain effective internal controls over financial reporting in order to accurately and timely report <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our results of operations and financial condition. In addition, as a public company listed in the United States, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley Act requires, among other things, that we assess the effectiveness of our internal controls over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial reporting at the end of each fiscal year. However, our independent registered public accounting firm will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not be required to attest to the effectiveness of our internal controls over financial reporting for so long as we are an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;emerging growth company,&#8221; which may be up to five fiscal years following our initial public offering of our ADSs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the United States. An independent assessment of the effectiveness of our internal controls could detect problems <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that our management&#8217;s assessment might not. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our independent registered public accounting firm has not conducted an audit of our internal controls over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial reporting. As previously disclosed in our Form 20-F for the period ended December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">originally in our Form F-1, management identified material weaknesses in our internal controls over financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reporting. These material weaknesses continue to exist as of December 31, 2024. The material weaknesses related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a lack of risk assessment as well as formal, documented and implemented processes, controls and review <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">procedures, specifically due to a lack of a sufficient number of professionals with an appropriate level of internal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control knowledge, training and experience. The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.43pt; position: var(--position); text-decoration: none; white-space: pre;">material<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.13pt; position: var(--position); text-decoration: none; white-space: pre;"> weakness in 2024 related to some deficiencies in formal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">documented and implemented process, controls and review procedures in certain areas. These material weaknesses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">did not result in a material misstatement to our financial statements included herein, however these material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">weaknesses could result in material inaccuracies in our financial statements and impair our ability to comply with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable financial reporting requirements and related regulatory filings on a timely basis. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have developed a remediation plan to address these material weaknesses and strengthen our controls in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these areas. In this regard, we have reorganized our finance and accounting function by hiring additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">experienced employees to provide more review and oversight over our financial processes. While we are working to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remediate the material weaknesses as quickly and efficiently as possible, we cannot at this time provide the expected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">timeline in connection with implementing our remediation. As of December 31, 2024, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.56pt; position: var(--position); text-decoration: none; white-space: pre;">we had not fully completed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the remediation of these material weaknesses.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.06pt; position: var(--position); text-decoration: none; white-space: pre;"> These remediation measures may be time-consuming and costly and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">might place significant demands on our financial and operational resources. There is no assurance that the actions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we may take in the future will be sufficient to remediate the control deficiencies that led to these material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">weaknesses in our internal control over financial reporting or that they will prevent or avoid potential future material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">weaknesses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The rules governing the standards that will have to be met for our management to assess our internal controls <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">over financial reporting pursuant to Section&#160;404 of the Sarbanes-Oxley Act are complex and require significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">documentation, testing and possible remediation. These stringent standards require that our audit committee be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advised and regularly updated on management&#8217;s review of internal controls over financial reporting. Designing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">implementing, and testing internal controls over financial reporting required to comply with this obligation is time-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consuming, costly, and complicated. Our management may not be able to effectively and timely implement controls <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and procedures that adequately respond to the increased regulatory compliance and reporting requirements that are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable to us as a public company listed in the United States. If we fail to staff our accounting and finance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">function adequately or maintain internal controls over financial reporting adequate to meet the demands that are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">placed upon us as a public company listed in the United States, our business and reputation may be harmed and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price of our ordinary shares and ADSs may decline. In addition, undetected material weaknesses in our internal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">controls over financial reporting could lead to restatements of financial statements and require us to incur the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expense of remediation. Any of these developments could result in investor perceptions of us being adversely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">affected, which could cause a decline in the market price of our securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our management is responsible for establishing and maintaining adequate internal control over financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reporting. Our growth will place significant additional pressure on our system of internal control over financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reporting. Any failure to maintain an effective system of internal control over financial reporting could limit our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ability to report our financial results accurately and timely or to detect and prevent fraud. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 605.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Significant impairment of our goodwill could materially impact our financial position and results of our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We carry a goodwill balance, which is allocated to obefazimod and ABX196, on our balance sheet as a result <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of past business acquisitions, including with respect to obefazimod and ABX196. We are required to review our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">goodwill for impairment on an annual basis or more frequently if events or changes in circumstances indicate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evidence of impairment. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.86pt; position: var(--position); text-decoration: none; white-space: pre;">We did not record any goodwill impairment loss for the year ended December 31, 2024 or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 672.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2023.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"> For the year ended December 31, 2022, we recorded a goodwill impairment loss of &#8364;13.6 million. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">goodwill impairment loss was related to an impairment test conducted with respect to the ABX196 cash-generating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unit as a result of significant external changes in the hepatocellular carcinoma treatment landscape, which are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected to require a new, lengthy, heavy and risky internal development process (use of a combination of <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">14<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compounds). As such, due to the lack of progress made in the negotiation of a development partnership, we made <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the decision to freeze the development program for ABX196 in the treatment of hepatocellular cancer, which led to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">full impairment of ABX196 goodwill. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.87pt; position: var(--position); text-decoration: none; white-space: pre;">In July 2023, we decided to completely stop our ABX196 program, which has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">been reflected in our financial statements accompanying this annual report. After full impairment of the goodwill <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">allocated to ABX196, we continue to carry a goodwill balance allocated to obefazimod amounting to &#8364;18.4&#160;million <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the aggregate as of December 31, 2024. We have not currently identified reasons to impair the goodwill allocated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to obefazimod. However, there can be no assurance that, based on the results of our annual goodwill impairment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tests, we will not be required to identify further goodwill impairment losses, which could have a material adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">effect on our results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We have significant debt commitments, which require us to meet certain operating covenants, and if we fail to <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">comply with those covenants the bondholders would be able to accelerate our repayment obligations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On August 20, 2023, we entered into a framework subscription agreement (the "Framework Subscription <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Agreement") with entities affiliated with Kreos Capital ("Kreos") and entities affiliated with Claret European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Growth Capital ("Claret"), as the Secured Lenders (the "Kreos / Claret Financing"). Under this Framework <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription Agreement, we could draw up to &#8364;75 million in structured debt financing, in three tranches of &#8364;25 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million in aggregate principal amount each, which were all drawn in full as of the date of this Annual Report on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Form 20-F. The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exceptions), which include, among other things, restrictions on the incurrence of indebtedness, cross-default, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distribution of dividends and the grant of security interests. As security for the Kreos / Claret Financing, the Secured <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Lenders benefit from the grant of first-ranking collateral on our principal tangible and intangible assets, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pledges over our business (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 180.81pt; position: var(--position); text-decoration: none; white-space: pre;">fonds de commerce<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.95pt; position: var(--position); text-decoration: none; white-space: pre;">) as a going concern and intellectual property rights in our lead drug <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidate, as well as pledges over our bank accounts and receivables. Such securities apply to all tranches of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret Financing. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, on August 20, 2023, we entered into a subscription agreement with entities affiliated with Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Capital Management ("Heights", and such agreement, the "Heights Subscription Agreement"). Under the Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription Agreement, we could draw up to &#8364;75 million in amortizing senior convertible notes, in two tranches of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;35 million and &#8364;40&#160;million, respectively, as further described below (the "Heights Financing"). The first tranche in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">aggregate principal amount of &#8364;35 million was drawn on August 24, 2023, and the drawdown period for the second <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tranche expired on August 24, 2024. The terms and conditions of the Heights Convertible Notes include a negative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pledge providing that any security granted in favor of other borrowed debt or debt instruments should also be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">granted in favor of the Heights Convertible Notes on an equal basis (with the exception of the securities issued <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pursuant to the Kreos / Claret Financing). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2020, we obtained a non-dilutive financing in the form of a State-guaranteed loan of &#8364;5.0&#160;million. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">loan was structured with an initial maturity of 12 months at 0.25% and a five-year extension option. In March 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we exercised the five-year extension option with a one-year deferral of principal repayment, with the following <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conditions: (i)&#160;a revised interest rate of 0.58% <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 257.62pt; position: var(--position); text-decoration: none; white-space: pre;">per annum,<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> excluding insurance and State-guaranteed premium; and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(ii)&#160;a State-guaranteed premium of &#8364;0.1&#160;million to be paid by installments over the contract period starting in June <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2021. The loan includes certain customary covenants and prepayment provisions. The negative covenants include an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">undertaking not to dispose of all or part of our assets for more than 50% of the gross value of our fixed assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There is no guarantee that we will have sufficient cash to pay the bonds issued to the Secured Lenders or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Heights at maturity, which could have a negative impact on our business as security interests have been granted on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our principal tangible and intangible assets: in particular, on our goodwill and intellectual property rights relating to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our lead drug candidate, as well as a pledge of our bank accounts and claims. There is also no guarantee that we will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have sufficient cash to make the scheduled payments on the Kreos / Claret Financing, the Heights Financing or the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">State-guaranteed loan, which could have a material adverse effect on our business, financial position and results of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations. Any failure to make scheduled payments or trigger early repayment of the loan could have a material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse effect on our business, financial position, income, growth and outlook. If we breach our obligations under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any of these agreements, it could result in default and trigger an early repayment of the bonds or loan. There is no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">guarantee that we would have the necessary resources to fund an advance repayment of the bonds. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our principal tangible and intangible assets serve as collateral under the terms of debt agreements for the Kreos / <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Claret Financing. If we default on these debt obligations, the Secured Lenders could foreclose on those assets, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and we would be unable to continue our business and operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In August 2023, we entered into the Kreos / Claret Financing. In connection with the financing, we have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">granted the Secured Lenders first-ranking liens on our principal tangible and intangible assets, including pledges <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">over our business (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 147.79000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">fonds de commerce<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.93pt; position: var(--position); text-decoration: none; white-space: pre;">) as a going concern and intellectual property rights in our lead drug <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidate, as well as pledges over our bank accounts and receivables until our debt obligations thereunder are repaid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in full. There can be no assurance that we will not breach the covenants or other terms of, or that an event of default <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">15<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will not occur under, the debt agreements for the Kreos / Claret Financing. If a breach or event of default occurs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">there can be no assurance that we will be able to cure the breach within the time permitted. In the event of any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">failure to pay our obligations when due, any breach or default of our covenants or other obligations, or any other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">event that causes an acceleration of payment at a time when we do not have sufficient resources to meet these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations, the Secured Lenders could foreclose on the collateral. If the Secured Lenders were to be successful, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would lose our intellectual property rights in our lead drug candidate and be unable to commercialize our lead drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidate and conduct our business. Any of these consequences would have a material adverse effect on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business, financial condition and share price. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Current equity agreements and convertible debt instruments may dilute our equity resulting in dilution to our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since our incorporation, we have issued and granted founder&#8217;s share warrants (BCE) and share warrants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(BSA) and granted free shares (AGA) to persons linked to us and financing entities. We have also issued convertible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bonds. See "Item 5.B&#8212;Liquidity and Capital Resources.&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The theoretical exercise of all the founder&#8217;s share warrants (BCE) and share warrant (BSA) instruments giving <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">access to our capital issued and outstanding as of December&#160;31, 2024, excluding securities held by financing entities, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would allow for the subscription of 554,123 potential new ordinary shares, resulting in a hypothetical dilution equal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to 0.87% based on our existing share capital as of December&#160;31, 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Using the delegation granted by our general meeting held on June 6, 2023, we issued in August 2023 the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 301.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">following securities in connection with the Kreos / Claret Financing and the Heights Financing: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;&#160; &#160;  25,000,000 convertible bonds with warrants attached with an individual nominal value of &#8364;1.00 per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 323.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">convertible bond issued to Kreos and Claret, which allow for the subscription of up to 1,178,084 new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">ordinary shares at a conversion price of &#8364;21.22 per ordinary share; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;&#160; &#160; &#160; 214,198 share warrants (BSA) issued to Kreos and Claret, which allow for the subscription of up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">214,198 new ordinary shares at an exercise price of &#8364;18.67 per ordinary share; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;&#160; &#160;  350 convertible notes due in August 2027 with an individual nominal value of &#8364;100,000 issued to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 381.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">Heights, which allow for the subscription of up to 1,012,417 new shares, as of December 31, 2024, at a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">conver<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.19pt; position: var(--position); white-space: pre;">sion price of &#8364;23.77 per ordinary share. In case we opt to repay the principal and accrued <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 403.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">interest of such notes entirely in shares, we may issue up to 2,830,201 new ordinary shares in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">connection with such repayment. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 439.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Using the delegation granted by our general meeting held on June 6, 2023, we further issued in November <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">2023 405,831 share warrants (BSA) to Kreos and Claret, which allow for the subscription of up to 405,831 new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 461.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ordinary shares at an exercise price of &#8364;9.86 per ordinary share.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our general meeting of May 30, 2024 delegated authority to the board of directors (the &#8220;Board&#8221;) to carry out <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">one or more capital increases and/or issues of securities giving access to our capital subject to the following <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">limitations: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">a total maximum nominal amount of the capital increases set at &#8364;250,000 (or the equivalent value of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">that amount in the event of an issue in another currency) with a total maximum nominal amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">debt securities that may be issued set at &#8364;150,000,000 (or the equivalent value of that amount in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">event of an issue in another currency); and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the shares that may be issued or allotted in the context of equity incentive plans (share warrants (BSA), <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">share options and/or free shares (AGA)) may not exceed 10% of the share capital on a fully diluted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 598.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">basis recorded as of May 30, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our failure to maintain certain tax benefits applicable to French biopharmaceutical companies may adversely <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">affect our operations and finances. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As a French biopharmaceutical company, we have benefited from certain tax advantages, including, for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example, the Research and Development Tax Credit (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 286.7pt; position: var(--position); text-decoration: none; white-space: pre;">cr&#233;dit imp&#244;t recherche<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.68pt; position: var(--position); text-decoration: none; white-space: pre;">) (&#8220;CIR&#8221;), which is a French tax credit <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">aimed at stimulating research and development. CIR can be offset against French corporate income tax due and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">portion in excess, if any, may be refunded. CIR is calculated based on our claimed amount of eligible research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development expenditures in France and represents &#8364;5.7 million for 2024. The French tax authorities, with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assistance of the Higher Education and Research Ministry, may audit each research and development program in <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">16<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respect of which a CIR benefit has been claimed and assess whether such program qualifies in its view for the CIR <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">benefit. The French tax authorities may challenge our eligibility for, or our calculation of, certain tax reductions or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deductions in respect of our research and development activities and, should the French tax authorities be successful, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our credits may be reduced, which would have a negative impact on our results of operations and future cash flows. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Furthermore, the French Parliament may decide to eliminate, or to reduce the scope or the rate of, the CIR benefit, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">either of which it could decide to do at any time. If we fail to receive future CIR amounts, our business, prospects, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial condition, cash flows or results of operations could be adversely affected. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may be unable to carry forward existing tax losses. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, we carried forward accumulated tax losses of &#8364;609.4 million. In 2014, we acquired <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the companies Splicos, Wittycell and Zophis by means of a universal transfer of assets and liabilities. The tax losses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">carried forward of the three companies combined (Splicos, Wittycell and Zophis) amounted to &#8364;26.0&#160;million on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">date of the mergers and transfer of remaining assets. The transfer to us of these losses was subject to a post-merger <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approval by the French tax authorities, which approved the transfer of a total amount of &#8364;22.5 million of tax losses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">To the extent we have continued conducting the business that led to these losses for a minimum period of three <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">years, without making significant changes during this period, the transfer of such tax losses should be definitive. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.77pt; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">France, the maximum amount of carried forward tax losses that can be written off against the tax profits of a given <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial year is limited to &#8364;1&#160;million plus 50% of the amount of taxable profits for the financial year exceeding <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;million. The outstanding tax losses remain valid and can be carried forward to be written off against tax profits of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent financial years subject to the same limit, for an unlimited period of time (subject to any &#8220;significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">change of activity&#8221; at our level). <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.75pt; position: var(--position); text-decoration: none; white-space: pre;">It cannot be ruled out that regulatory or legislative changes in corporate taxation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may suppress or limit all or part of the ability to use carried forward tax losses, or limit how long they can be used, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to offset future profits. Changes in corporate taxation regarding the use of carried forward tax losses to offset future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tax profits could have a material adverse effect on our financial position and results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risks Related to Product Development, Regulatory Approval and Commercialization <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Drug candidates under development must undergo costly, rigorous and highly regulated preclinical studies and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials, whose time of completion, number and outcomes are uncertain. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The development of a drug candidate is a long and expensive process with an uncertain outcome, progressing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in several phases, where the objective is to demonstrate the therapeutic benefit provided by the drug candidate for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">one or more indications. Any failure during the various preclinical and clinical phases for a given indication could <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delay development, production and commercialization of the therapeutic product concerned or even lead to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discontinuing its development. Identifying and developing potential drug candidates is a time-consuming, expensive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and uncertain process that takes years to complete, and we may never generate the data or results required to obtain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval and achieve commercialization. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">During clinical trials, we may encounter difficulties determining and recruiting patients with the appropriate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profile as well as other enrollment issues, which could delay our clinical trials. This profile could also vary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">depending on the different phases of these clinical trials. Patients might then not be recruited according to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">timetable compatible with our financial resources which may result in a harm to our operating results. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">At each phase of clinical development, we must ask for authorization <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.59pt; position: var(--position); white-space: pre;">or absence of opposition <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.06pt; position: var(--position); text-decoration: none; white-space: pre;">from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 531.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relevant authorities of various countries, according to our development plan, to conduct clinical trials and then <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">present the results of the clinical trials to these authorities. The authorities may <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.33pt; position: var(--position); white-space: pre;">issue negative opinion, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 483.68pt; position: var(--position); text-decoration: none; white-space: pre;">refuse to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 553.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provide the authorizations necessary for clinical trials or have additional requirements (for example, relating to study <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protocols, patient characteristics, treatment durations, post-treatment follow-up, or certain differences in interpreting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results between local regulatory agencies), and in some cases may require additional studies. Any <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.29pt; position: var(--position); white-space: pre;">negative opinion, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">refusal or decision by health authorities to require additional trials or examinations would be likely to result in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discontinuation or delay of the development of the product candidates concerned. An absence of or delay in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapeutic response could also result in the delay or even discontinuation of the development of our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 641pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We cannot guarantee that the development of our drug candidates will ultimately be successful, especially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">within time frames compatible with our financial resources or market needs. Any failure or delay in the development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of these product candidates would have a material adverse effect on our business, income, financial position and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outlook. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are developing drug candidates for inflammatory diseases. To our knowledge, currently there are no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 704pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">similar immunological treatments with a mechanism of action based on enhanced expression of a single microRNA <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">17<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">miR-124 with marketing authorization granted by competent regulatory authorities. As a result, the outlook is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">uncertain for the development and profitability of obefazimod in the area of inflammatory diseases, its efficacy and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">acceptance by patients, doctors and paying agencies. Animal testing does not necessarily predict the results that will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be obtained in humans. Positive results for obefazimod during Phase 1, Phase 2b or Phase&#160;3 clinical trials or those <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for all the products in the portfolio during their research or preclinical phases might not be confirmed by subsequent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">phases. Such outcomes could have a material adverse impact on our business, income, financial position and growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We are heavily dependent on the success of our drug candidates, in particular obefazimod, and we cannot be <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certain that obefazimod or any of our other current or future drug candidates will receive regulatory approval, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and, without regulatory approval, we will not be able to market our drug candidates. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We currently have no drug candidates approved for marketing, and we cannot guarantee that we will ever have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 203.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketable drug candidates. Our ability to generate revenue related to sales, if any, will in the near future depend <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entirely on the successful development and regulatory approval of obefazimod. In Europe and the United States, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 225.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">well as in many other countries, access to the drug market is strictly controlled and marketing must be authorized by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a regulatory authority. Most of the time, this registration application is filed with a national or federal health <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authority. However, in the European Union, the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.15pt; position: var(--position); white-space: pre;">application for a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.11pt; position: var(--position); text-decoration: none; white-space: pre;">marketing authorization (&#8220;MA&#8221;) must be submitted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 259.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">at the EU-level to the European Medicines Agency (&#8220;EMA&#8221;) for categories of the most innovative medicinal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products, in order to obtain a centralized marketing authorization valid for all the European Union territory. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 293.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The research, testing, manufacturing, safety, efficacy, labeling, approval, sale, marketing and distribution of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 303.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates are, and will remain, subject to comprehensive and extensive regulation controlled by the EMA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 313.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and European Union Member States national authorities in the European Union, the Food and Drug Administration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 323.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;FDA&#8221;) in the United States, the Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) in Japan and other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 333.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory authorities in other countries, with regulations differing from country to country. Subject to limited <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 343.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exceptions, we are not permitted to market our drug candidates in the European Union, the United States or Japan <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 353.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">until we receive a MA from the European Commission following EMA&#8217;s opinion or (a) European Union Member <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 363.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">State(s) authority(ies) or a new drug application (&#8220;NDA&#8221;) from the FDA or the PMDA, respectively. Regulators of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 373.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">each jurisdiction have their own procedures for approval of drug candidates. We have not applied for any MA for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 383.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any of our drug candidates yet. Failure to obtain regulatory approval for our drug candidates in any jurisdiction will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 393.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prevent us from commercializing and marketing our drug candidates in such jurisdictions, and marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 403.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorizations may be granted for narrow indications which may significantly reduce the scope of market of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 413.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 435.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Obtaining and maintaining MA, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.21pt; position: var(--position); white-space: pre;">as the case may be <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.03999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">by country or by geographical area in the case of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">European Union, presupposes compliance with the mandatory standards imposed by the concerned regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities and submission to the authorities of a great deal of information about the drug candidate regarding its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 469.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">toxicity, dosage, quality, efficacy and safety all over its life cycle. The authorization process is long and expensive, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and the result of this process remains highly uncertain. We are therefore careful to continuously comply with good <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 491.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">practices in order not to jeopardize our chances of ultimately obtaining, directly or via our business partners, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing authorization for the products we are developing. Furthermore, obtaining marketing authorization for a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product in a given country or geographical area does not automatically ensure or immediately lead to obtaining <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing authorization in other countries for the same product. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In order to obtain MA for one of our drug candidates, we have to perform preclinical animal studies and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">complete human clinical trials in order to demonstrate the safety and efficacy of the drug candidates. MAs, NDAs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and similar authorizations must include extensive preclinical and clinical data and supporting information to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">establish the drug candidate&#8217;s safety and efficacy for each desired indication. In the event patients are exposed to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unforeseen and serious risks, we or the regulatory authorities may choose to suspend or early terminate these clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">NDAs, MAs and similar authorizations must also include significant information regarding the chemistry, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing and controls for the drug. Obtaining approval of a MA or a NDA and similar authorizations, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">collecting all required information, proof and data for this process, is a lengthy, expensive and uncertain process, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and we may not be successful in obtaining approval. This is further enhanced by the fact that each regulator has its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">own requirements and procedures for the scientific evaluation or approval of drug candidates. The EMA, European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Union Member States national authorities, FDA and PMDA review processes can therefore take years to complete <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and approval is never guaranteed.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">18<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, delays in approvals or rejections of marketing applications in the European Union, the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States or other countries may be based upon many factors, including regulatory requests for additional analyses, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reports, data, preclinical studies and clinical trials, regulatory questions regarding different interpretations of data <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and results, changes in regulatory policy during the period of drug development and the emergence of new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information regarding our drug candidates or other drug candidates. Even if a drug is approved, the FDA, the EMA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or the PMDA, as the case may be, may limit the indications for which the drug may be marketed, require extensive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warnings on the drug labeling or require expensive and time-consuming post-marketing clinical trials or reporting as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conditions of approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Even if we receive regulatory approval for any drug candidate, we will be subject to ongoing regulatory <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations and continued regulatory review, which may result in significant additional expense <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Even if we receive approval of any of our drug candidates, such regulatory approval may be withdrawn, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such approvals may be contingent on ongoing obligations and continued regulatory review, which may result in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant additional expense. As a general matter, any regulatory approvals that we may receive for our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advertising, promotion, import, export and recordkeeping for our drug candidates will be subject to extensive and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ongoing regulatory requirements. These requirements include submissions of safety, efficacy and other post-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing information and reports, registration, as well as ongoing compliance with current Good Manufacturing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Practice (&#8220;GMP&#8221;) and Good Clinical Practice requirements (&#8220;GCPs&#8221;) for any clinical trials that we may be required <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to conduct post-marketing. In addition, manufacturers of drug products and their facilities are subject to continual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">review and periodic, unannounced inspections by the FDA and other regulatory authorities for compliance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">GMP regulations and standards.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, our drug candidates, even if approved, may be subject to restrictions or prohibition on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advertising, include limitations related to prescriptions by specialists, use restrictions for specified age groups, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warnings, precautions or contraindications, and may include burdensome post-approval study or risk management <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">requirements. For example, the FDA may require a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) as a condition <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of approval of our drugs candidates, which could include requirements for a medication guide, physician training <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">registries and other risk minimization tools. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Obtaining and maintaining a Good Manufacturing Practice (&#8220;GMP&#8221;) certificate will be required in order to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">produce the immunotherapies that we are developing (for clinical trial purposes and during the commercialization <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">phase). We cannot guarantee that we will obtain or be able to maintain this certificate, nor that certain additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">constraints related to this certificate will not be imposed on us in the future. Any failure to follow and document <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adherence to such GMP regulations or other regulatory requirements may lead to significant delays in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">availability of products for commercial sale or clinical trials, may result in the termination of or a hold on a clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trial, or may delay or prevent filing or approval of marketing applications for our products. Failure to comply with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable regulations could also result in the FDA or other applicable regulatory authorities taking various actions, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">levying fines and other civil penalties; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">imposing consent decrees or injunctions; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">requiring us to suspend or put on hold one or more of our clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">suspending or withdrawing regulatory approvals; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delaying or refusing to approve pending applications or supplements to approved applications; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">requiring us or our third-party manufacturers to suspend manufacturing activities or product sales, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">imports or exports; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">requiring us to communicate with physicians and other customers about concerns related to actual or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">potential safety, efficacy and other issues involving our products; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">mandating product recalls or withdrawals or seizing products; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">imposing operating restrictions; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">seeking criminal prosecutions. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Failure to obtain or maintain authorization for our drug candidates in one or more jurisdictions, particularly in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respect of our lead drug candidate, obefazimod, would have a material adverse effect on our business, outlook, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial position, results and development. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">19<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our drug candidates may cause undesirable side effects or have other properties that could delay or prevent their <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval, or, if approval is received, require our drug candidates to be withdrawn from the market, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">require them to include safety warnings or otherwise limit their sales. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Undesirable side effects caused by our drug candidates could cause us or regulatory authorities to interrupt, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delay or halt clinical trials, or even discontinuation and could result in a more restrictive label or the delay or denial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of regulatory approval by the European Commission, FDA, PDMA or other comparable authorities in other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions. If severe side effects were to occur, or if one of our drug candidates is shown to have other unexpected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">characteristics, we may need to either restrict the use of such product to a smaller population or abandon <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development of such drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If one or more of our drug candidates received marketing approval, and we or others later identify undesirable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">side effects caused by such drugs or negative interactions with other products or treatments (including, for example, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as a result of interactions with other products once on the market), a number of potentially significant negative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consequences could result, including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">regulatory authorities may withdraw or reduce the scope of approvals of such product; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">regulatory authorities may require additional warnings on the product&#8217;s label; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">we may be required to create a medication guide outlining the risks of such side effects for distribution <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">to patients; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 282.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 283.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">we could be sued and held liable for harm caused to patients; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 299.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">physicians, healthcare payors, patients or the medical community in general may not recommend/use <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 309.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">our products; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 325.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">sales of the product may decrease significantly; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 341.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our reputation may suffer. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 363.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Any of these events could prevent us from achieving or maintaining market acceptance of the particular drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 373.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidate, if approved, and could have a material adverse effect on our business, prospects, financial condition, cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 383.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">flows or results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 411.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Clinical failure can occur at any stage of clinical development. The results of earlier clinical trials as well as data <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 421.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from any interim analysis of ongoing trials are not necessarily predictive of future results and any drug candidate <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 431.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we advance through clinical trials may not have favorable results in later clinical trials. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 447.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 457.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Clinical failure can occur at any stage of our clinical development. Success in preclinical studies and early clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 467.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials, as well as data from any interim analysis of ongoing trials do not ensure that subsequent clinical trials will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 477.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generate the same or similar results. A number of companies in the pharmaceuticals industry, including those with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 487.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">greater resources and experience than us, have suffered significant setbacks in the last development phase (Phase 3) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 497.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials, even after seeing promising results in earlier clinical trials, and we could face similar setbacks. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 507.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">some instances, there can be significant variation in safety or efficacy results between different clinical trials of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">same drug candidate due to numerous factors, including changes in trial procedures set forth in protocols, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">differences in the size and type of the patient populations, changes in and adherence to the dosing regimen and other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 537.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trial protocols and the rate of dropout among clinical trial participants. Any such delays or failures could <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">negatively impact our business, financial condition, results of operation and prospects. The positive results generated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in preclinical and clinical trials for obefazimod does not ensure that current or future trials will continue to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 567.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">demonstrate similar safety and/or efficacy results. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 589.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Drug candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 599.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">having progressed through preclinical studies and earlier clinical trials. In addition to the safety and efficacy traits of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any drug candidate, clinical trial failures may result from a multitude of factors including flaws in trial design, dose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 619.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">selection, placebo effect and patient enrollment criteria. Based upon negative or inconclusive results, we or our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 629.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">collaborators may decide, or regulators may require us, to conduct additional clinical trials or preclinical studies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 639.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Further, data obtained from trials and studies are susceptible to varying interpretation, and regulators may not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 649.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interpret our data as favorably as we do, which may delay, limit or prevent regulatory approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">20<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We cannot guarantee the commercial success or the pricing and reimbursement of the drug candidates that we <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">develop. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we or one or more of our commercial partners succeeds in obtaining marketing authorization, allowing us or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">them to market the therapeutic products developed by us, it may nevertheless take time to gain the support of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">medical community, health care providers and third-party payors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The level of market acceptance for each of our products will depend on several factors, notably on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">prescribers&#8217; perception of the product&#8217;s therapeutic benefit; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">healthcare policies established in each of the countries in which we are considering marketing our <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">products; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 206.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 207.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">possible occurrence of adverse reactions once marketing authorization has been obtained; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 223.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">ease of use of the product, especially relating to its mode of administration; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 239.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">cost of treatment; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 255.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">reimbursement policies of governments and other third parties; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 271.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">effectiveness of sales and marketing efforts; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 287.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">effective implementation of a scientific publication strategy; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 303.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">willingness of the target patient population to try new therapies and of physicians to prescribe these <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 313.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">therapies; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 329.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">prevalence and severity of any side effects; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 345.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">development of one or more competing products for the same indication; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 361.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">restrictions on the use of the product together with medications. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 383.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Although the products we are developing are intended to provide a therapeutic response to a need that is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 393.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">presently unmet, poor market penetration resulting from one or more of the factors described above would have a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 403.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">negative impact on their commercialization and on our ability to generate profits, which could have a material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 413.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse effect on our business, outlook, financial position, income and growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 435.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The level of market acceptance and sale of our drug candidates, if approved, will heavily depend on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">availability of coverage and adequate reimbursement from third-party payors. The conditions for setting the sales <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 457.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price and reimbursement rate for drugs are beyond the control of pharmaceutical companies. They are decided by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 469.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">competent public committees and bodies and by social security or private insurance companies and are dependent on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a number of factors. Pricing and reimbursement schemes vary widely from country to country. In the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 491.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Union, pricing and reimbursement are determined individually by European Union Member States. Some countries <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may approve a specific price for a product while others may instead allow companies to fix their own prices for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 513.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products but monitor and control company profits. Within the US, as a principle, drug companies set their own list <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prices, which may then be discounted through negotiations with payors. However, as a result of the Inflation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Reduction Act of 2022 (&#8220;IRA&#8221;), the Secretary of Health and Human Services is now authorized to negotiate prices <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with pharmaceutical companies for certain <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.79pt; position: var(--position); white-space: pre;">high-expenditure, single-source <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.82pt; position: var(--position); text-decoration: none; white-space: pre;">drugs <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.54pt; position: var(--position); white-space: pre;">that have been on the market for at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">least 7 years and are <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.49pt; position: var(--position); text-decoration: none; white-space: pre;">covered under Medicare <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.08pt; position: var(--position); white-space: pre;">Part B or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">Part D programs (i.e., prescription drugs for Americans aged <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 569.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">65 or older and Americans receiving social security disability) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.63pt; position: var(--position); white-space: pre;">and imposes rebates under Medicare Part B and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 581.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Medicare Part D to penalize price increases that outpace inflation. The IRA permits the U.S. Department of Health <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and Human Services (&#8220;HHS&#8221;) to implement many of these provisions through guidance, as opposed to regulation, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">for the initial years. HHS has and will continue to issue and update guidance as these programs are implemented, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">although the Medicare drug price negotiation program is currently subject to legal challenges. These provisions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 625.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">began to take effect progressively starting in fiscal year 2023.On August 15, 2024, HHS announced the agreed-upon <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 637.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">prices of the first ten drugs that were subject to price negotiations, which take effect in January 2026. HHS will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">select up to fifteen additional products covered under Part D for negotiation in 2025. Each year thereafter more Part <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">B and Part D products will become subject to the HHS price negotiation program.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.43pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Generally, the downward pressure on health care costs has become intense. As a result, increasingly high <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">barriers are being erected to the entry of new products. Delays in the price negotiation procedure may result in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant delay in marketing, our product may not obtain an appropriate level of reimbursement, or the accepted <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">21<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price level and reimbursement rate of the treatments we market may be changed. We are also unable to guarantee <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that we will succeed in maintaining, over time, the price level of our products or the accepted reimbursement rate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our future may depend on our most advanced clinical development program, obefazimod, since our other drug <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates are in a less advanced stage of development. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod is our most advanced drug candidate. Obefazimod has required, and may continue to require, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant investments of our time and financial resources, as well as the special attention of highly qualified staff. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, if we were unable to obtain conclusive results in ongoing maintenance trials, Phase 3 of obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in UC or Phase 2 of obefazimod in CD, it could have a material adverse effect on our business, outlook, financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">position, results and development. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We may experience setbacks that could delay or prevent regulatory approval of our drug candidates or our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ability to commercialize any products, including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">negative or inconclusive results from our preclinical studies or clinical trials or the clinical trials of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">others for drug candidates similar to ours, leading to a decision or requirement to conduct additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical testing or clinical trials or abandon a program; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">product-related side effects experienced by subjects in our clinical trials or by individuals using drugs <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">or therapeutics comparable to our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays in submitting investigational new drug applications in the United States or comparable foreign <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">applications or delays or failure in obtaining the necessary approvals from regulators or institutional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">review boards (&#8220;IRBs&#8221;) or ethics committees to commence a clinical trial, or a suspension or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">termination of a clinical trial once commenced; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">if the FDA or comparable foreign authorities do not accept the earlier preclinical and clinical trial <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">work, then we may need to conduct additional preclinical studies or clinical trials beyond that which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">we currently have planned and significant preclinical study or clinical trial delays also could shorten <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">any periods during which we may have the exclusive right to commercialize our drug candidates or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">allow our competitors to bring products to market before we do and impair our ability to successfully <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialize our drug candidates and may harm our business; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">conditions imposed by the FDA or comparable foreign authorities regarding the scope or design of our <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 426.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 427.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays in contracting with clinical sites or enrolling subjects in clinical trials, including due to any <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 437.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">health pandemic and/or other macroeconomic factors; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 453.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays or interruptions in the supply of materials necessary for the conduct of our clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 469.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">regulators or IRBs or ethics committees may not authorize us or our investigators to commence a <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 479.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trial or conduct a clinical trial at a prospective trial site; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 495.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the FDA or other comparable regulatory authorities may disagree with our clinical trial design, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 505.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">including with respect to dosing levels administered in our planned clinical trials, which may delay or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 515.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">prevent us from initiating our clinical trials with our originally intended trial design; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 531.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays in reaching, or failure to reach, agreement on acceptable terms with prospective trial sites, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 541.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">investigators and prospective contract research organizations (&#8220;CROs&#8221;) which can be subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 551.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">extensive negotiation and may vary significantly among different CROs and trial sites; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 567.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the number of subjects required for clinical trials of any drug candidates may be larger than we <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 577.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">anticipate or subjects may drop out of these clinical trials or fail to return for post-treatment follow-up <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">at a higher rate than we anticipate; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our CROs for preclinical studies or clinical trials may fail to comply with regulatory requirements or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 613.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">meet their contractual obligations to us in a timely manner, or at all, or may deviate from the clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 623.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">trial protocol or take actions that could cause clinical sites or clinical investigators to drop out of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 633.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">trial, which may require that we add new clinical trial sites or investigators; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 649.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">greater than anticipated clinical trial costs, including as a result of delays or interruptions that could <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">increase the overall costs to finish our clinical trials as our fixed costs are not substantially reduced <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">during delays; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 685.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">we may elect to, or regulators, IRBs or Data Safety Monitoring Boards (&#8220;DSMBs&#8221;) may require that <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 695.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">we or our investigators, suspend or terminate clinical research or trials for various reasons, including <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">22<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">noncompliance with regulatory requirements or a finding that the participants are being exposed to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">unacceptable health risks; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">we may not have the financial resources available to begin and complete the planned trials, or the cost <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of clinical trials of any drug candidates may be greater than we anticipate; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the supply or quality of our drug candidates or other materials necessary to conduct clinical trials of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates may be insufficient or inadequate to initiate or complete a given clinical trial; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the FDA or other comparable foreign regulatory authorities may require us to submit additional data <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">such as long term toxicology studies, or impose other requirements before permitting us to initiate a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trial, including because the FDA has not reviewed our preclinical or clinical data, to date, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">having been developed outside the United States; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">inability to compete with other therapies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">poor efficacy of our drug candidates during clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">unfavorable FDA or other regulatory agency inspection and review of clinical trial sites or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing facilities; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">unfavorable product labeling associated with any product approvals and any requirements for a Risk <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) that may be required by the FDA or comparable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">requirements in other jurisdictions to ensure the benefits of an individual product outweigh its risks; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">unfavorable acceptance of our clinical trial data by the patient or medical communities or third-party <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">payors; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 314.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 321.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays and changes in regulatory requirements, policy and guidelines, including the imposition of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 331.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">additional regulatory oversight around clinical testing generally or with respect to our technology in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 341.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">particular; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 357.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">varying interpretations of data by the FDA and similar foreign regulatory agencies. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 379.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We do not have complete control over many of these factors, including certain aspects of clinical development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 389.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and the regulatory submission process, potential threats to our intellectual property rights and our manufacturing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 399.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing, distribution and sales efforts or that of any future collaborator. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 427.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may find it difficult to enroll patients in our clinical trials. If we encounter difficulties enrolling patients in <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 437.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our clinical trials, our clinical development activities could be delayed or otherwise adversely affected. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 453.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Patient enrollment is a significant factor in the timing of clinical trials, including with respect to data read and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 463.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the timing of our clinical trials will depend, in part, on the speed at which we can recruit patients to participate in our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 473.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials, as well as completion of required follow-up periods. We may not be able to initiate or continue clinical trials <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 483.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for our drug candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 493.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these trials to such trial&#8217;s conclusion as required by applicable regulatory authorities. The eligibility criteria of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 503.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials, once established, may further limit the pool of available trial participants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Patient enrollment in clinical trials may be affected by other factors, including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 541.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">size and nature of the targeted patient population; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">severity of the disease or condition under investigation; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 573.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">availability and efficacy of approved therapies for the disease or condition under investigation; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 589.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">patient eligibility criteria for the trial in question as defined in the protocol; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 605.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">perceived risks and benefits of the drug candidate under study; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 621.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the drug candidate being studied <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 631.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">in relation to other available therapies, including any products that may be approved for, or any drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 641.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">candidates under investigation for, the indications we are investigating; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 657.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">efforts to facilitate timely enrollment in clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 673.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">patient referral practices of physicians; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 689.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the ability to monitor patients adequately during and after treatment; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 705.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">proximity and availability of clinical trial sites for prospective patients;<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">23<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">any instability in the geographic regions in which our clinical trial sites are located;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">continued enrollment of prospective patients by clinical trial sites; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the risk that patients enrolled in clinical trials will drop out of such trials before completion. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, other pharmaceutical companies targeting these same diseases are recruiting clinical trial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients from these patient populations, which may make it more difficult to fully enroll any clinical trials. We also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rely on, and will continue to rely on, CROs and clinical trial sites to ensure proper and timely conduct of our clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials and preclinical studies. Though we have entered into agreements governing their services, we will have limited <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">influence over their actual performance. Our inability to enroll a sufficient number of patients for our clinical trials <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would result in significant delays or may require us to abandon one or more clinical trials altogether. Enrollment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delays in our clinical trials may result in increased development costs for our drug candidates and jeopardize our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ability to obtain regulatory approval for the sale of our drug candidates. Furthermore, even if we are able to enroll a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sufficient number of patients for our clinical trials, we may have difficulty maintaining enrollment of such patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in our clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 253.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We are developing certain of our drug candidates in combination with other therapies, and safety or supply issues <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with combination use products may delay or prevent development and approval of our therapeutic candidates. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are developing certain of our drug candidates in combination with one or more approved or investigational <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies. Even if any drug candidate we develop were to receive marketing approval or be commercialized for use <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in combination with other existing therapies, we would continue to be subject to the risks that the FDA, European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Commission, PDMA or similar foreign regulatory authorities could revoke approval of the therapy used in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">combination with our product or that safety, efficacy, manufacturing or supply issues could arise with any of those <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">existing therapies. If the therapies we use in combination with our drug candidates are replaced as the standard of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">care for the indications we choose for any of our drug candidates, the EMA, FDA, PDMA or similar foreign <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory authorities outside may require us to conduct additional clinical trials. The occurrence of any of these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks could result in our own products, if approved, being removed from the market or being less successful <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercially. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We also may evaluate our drug candidates in combination with one or more therapies that have not yet been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved for marketing by the FDA, European Commission, PDMA or similar foreign regulatory authorities. We <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will not be able to market and sell any drug candidate we develop in combination with an unapproved therapy if that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unapproved therapy does not ultimately obtain marketing approval. In addition, unapproved therapies face the same <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks described with respect to our drug candidates currently in development, including the potential for serious <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse effects, delay in their clinical trials and lack of FDA, European Commission, or PDMA, or similar foreign <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory authorities or PDMA approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If the FDA, European Commission or similar foreign regulatory authorities do not approve these other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies or revoke their approval of, or if safety, efficacy, manufacturing or supply issues arise with, the therapies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we choose to evaluate in combination with our drug candidates, we may be unable to obtain approval of or market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any such drug candidate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may conduct clinical trials for our drug candidates outside of the U.S., and the FDA may not accept data <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from such trials, in which case our development plans may be delayed, which could materially harm our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have in the past conducted clinical trials or a portion of our clinical trials for our drug candidates outside <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the U.S. The acceptance of study data from clinical trials conducted outside the U.S. or another jurisdiction by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">FDA or comparable foreign regulatory authority may be subject to certain conditions or may not be accepted at all. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">In cases where data from foreign clinical trials are intended to serve as the sole basis for marketing approval in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S., for example, the FDA will generally not approve the application on the basis of foreign data alone unless (i) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the data are applicable to the U.S. population and U.S. medical practice; (ii) the trials were performed by clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">investigators of recognized competence and pursuant to GCP regulations; and (iii) the data may be considered valid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">without the need for an on-site inspection by the FDA, or if the FDA considers such inspection to be necessary, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">FDA is able to validate the data through an on-site inspection or other appropriate means. In addition, even where <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the foreign study data are not intended to serve as the sole basis for approval, the FDA will not accept the data as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">support for an application for marketing approval unless the study is well-designed and well-conducted in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with GCP requirements and the FDA is able to validate the data from the study through an onsite <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inspection if deemed necessary. Many foreign regulatory authorities have similar requirements for clinical data <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">gathered outside of their respective jurisdictions. In addition, such foreign trials would be subject to the applicable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 708.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">24<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">comparable foreign regulatory authority will accept data from trials conducted outside of the U.S. or the relevant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">jurisdiction. If the FDA or any comparable foreign regulatory authority does not accept such data, it may result in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the need for additional trials, which could be costly and time-consuming, and which may result in current or future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drug candidates that we may develop not receiving approval for commercialization in the applicable jurisdiction. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 125.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Interim, &#8220;top-line&#8221; and preliminary data from our clinical trials and preclinical studies that we announce or <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">publish from time to time may change as more patient data become available and are subject to audit and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">verification procedures that could result in material changes in the final data. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">From time to time, we may publicly disclose interim, top-line or preliminary data from our clinical trials and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical studies, which is based on a preliminary analysis of then-available data, and the results and related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">findings and conclusions are subject to change following a more comprehensive review of the data related to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interim, top-line or preliminary results that we report may differ from future results of the same studies or trials, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">different conclusions or considerations may qualify such results, once additional data have been received and fully <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evaluated. Top-line and preliminary data also remain subject to audit and verification procedures that may result in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the final data being materially different from the top-line or preliminary data we previously published. As a result, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">top-line and preliminary data should be viewed with caution until the final data are available. Moreover, caution <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">should be exercised in drawing any conclusions from a comparison of data that does not come from head-to-head <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">analysis.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Interim data from clinical trials that we may complete are further subject to the risk that one or more of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical outcomes may materially change as patient enrollment continues and more patient data become available. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Adverse differences between interim, top-line or preliminary data and final data could significantly harm our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business prospects. Further, disclosure of such data by us or by our competitors could result in volatility in the price <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of our securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">impact the value of the particular development program, the approvability or commercialization of the particular <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drug candidate or product and our company in general. In addition, the information we choose to publicly disclose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regarding a particular study or clinical trial is based on what is typically extensive information, and you or others <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may not agree with what we determine is material or otherwise appropriate information to include in our disclosure, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and any information we determine not to disclose may ultimately be deemed significant with respect to future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">decisions, conclusions, views, activities or otherwise regarding a particular drug candidate or our business. If the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interim, top-line or preliminary data that we report differ from actual results, or if others, including regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates may be harmed, which could harm our business, operating results, prospects or financial condition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could hinder their ability to hire, retain or deploy key leadership and other personnel, prevent new or modified <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products from being developed, reviewed, approved or commercialized in a timely manner or at all, which could <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">negatively impact our business. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The ability of the FDA and foreign regulatory authorities to review and approve new products can be affected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">by a variety of factors, including government budget and funding levels, statutory, regulatory and policy changes, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the FDA&#8217;s or foreign regulatory authorities&#8217; ability to hire and retain key personnel and accept the payment of user <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fees, and other events that may otherwise affect the FDA&#8217;s or foreign regulatory authorities&#8217; ability to perform <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">routine functions. Average review times at the FDA and foreign regulatory authorities have fluctuated in recent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">years as a result. In addition, government funding of other government agencies that fund research and development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other agencies may also slow the time necessary for new drugs or modifications to approved drugs and to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reviewed and/or approved by necessary government agencies, which would adversely affect our business. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example, over the last several years, the U.S. government has shut down several times and certain regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities. If a prolonged <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">government shutdown occurs, or if a public health crisis prevents the FDA or other regulatory authorities from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have a material adverse effect on our business. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">25<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">off-label uses. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FDA strictly regulates marketing, labeling, advertising and promotion of prescription drugs. These <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations include standards and restrictions for direct-to-consumer advertising, industry-sponsored scientific and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">educational activities, promotional activities involving the internet and off-label promotion. Any regulatory approval <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that the FDA grants is limited to those specific diseases and indications for which a product is deemed to be safe and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">effective by FDA. While physicians in the United States may choose, and are generally permitted, to prescribe drugs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for uses that are not described in the product&#8217;s labeling and for uses that differ from those tested in clinical trials and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved by the regulatory authorities, our ability to promote any products will be narrowly limited to those <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">indications that are specifically approved by the FDA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we are found to have promoted such off-label uses, we may become subject to significant liability. The U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">federal government has levied large civil and criminal fines against companies for alleged improper promotion of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">off-label use and has enjoined several companies from engaging in off-label promotion. The FDA has also requested <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">changed or curtailed. If we cannot successfully manage the promotion of any drug candidates, if approved, we could <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">become subject to significant liability, which would materially adversely affect our business and financial condition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may not be able to find industrial partners to pursue the clinical and commercial development of obefazimod. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We may enter into licensing and distribution partnerships with pharmaceutical companies in order to fund the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completion of the clinical development and marketing preparation of our lead drug candidate, obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, we should find partners with sufficient capacity to perform Phase 1, 2 and/or 3 clinical trials on a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">national or international scale and mass-produce, distribute and market immunotherapies and anti-inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatments such as obefazimod. If we were to enter into such partnerships, the commercialization of our products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would depend, in part, on the clinical, industrial, marketing and commercial development efforts of our business <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">partners and the ability of these partners to produce and sell obefazimod. Any failure on the part of our partners <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could have a material adverse effect on our growth and outlook. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">It is also possible that we may not be able to enter into partnerships under economically reasonable conditions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or at all. This could have a material adverse effect on our business, outlook, financial position, results and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may not be able to conduct, or contract others to conduct, animal testing in the future, which could harm our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">research and development activities. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Certain laws and regulations relating to drug development require us to test our drug candidates on animals <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">before initiating clinical trials involving humans. Animal testing activities have been the subject of controversy and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse publicity. Animal rights groups and other organizations and individuals have attempted to stop animal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">testing activities by pressing for legislation and regulation in these areas and by disrupting these activities through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protests and other means. To the extent the activities of these groups are successful, our research and development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">activities may be interrupted or delayed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risks Related to our Operations and Strategic Development <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We expect to expand our organization, and as a result, we may encounter difficulties in managing our growth, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which could disrupt our operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In order to manage our anticipated development and expansion, including the potential commercialization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates in Europe and the United States, we must continue to implement and improve our managerial, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operational and financial systems, expand our facilities and continue to recruit and train additional qualified <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personnel. Due to our limited financial resources and the limited experience of our management team in managing a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company with such expected growth, we may not be able to effectively manage the expansion of our operations or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may divert the attention of our management and business development resources away from day-to-day activities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and devote a substantial amount of time to managing internal or external growth. Our inability to manage growth or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unexpected difficulties encountered during expansion could have a material adverse effect on our business, income, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial position, growth and outlook. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">26<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our international operations subject us to various risks, and our failure to manage these risks could adversely <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">affect our results of operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We face significant operational risks as a result of doing business internationally, such as: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">fluctuations in foreign currency exchange rates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">differing payor reimbursement regimes, governmental payors or patient&#160;self-pay&#160;systems and price <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">controls; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">potential changes to the accounting standards, which may influence our financial situation and results; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">becoming subject to the different, complex and changing laws, regulations and court systems of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">multiple jurisdictions and compliance with a wide variety of foreign laws, treaties and regulations; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">reduced protection of, or significant difficulties in enforcing, intellectual property rights in certain <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">countries; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">difficulties in attracting and retaining qualified personnel; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">restrictions imposed by local labor practices and laws on our business and operations, including <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">unilateral cancellation or modification of contracts; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">rapid changes in global government, economic and political policies and conditions, political or civil <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">unrest or instability, terrorism or epidemics and other similar outbreaks or events, and potential failure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">in confidence of our suppliers or customers due to such changes or events; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">tariffs, trade protection measures, import or export licensing requirements, trade embargoes and other <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">trade barriers, including any governmental responses thereto. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The market opportunities for our drug candidates may be limited to patients who are ineligible for or have failed <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prior treatments and may be small or different from our estimates. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The current IBD treatment approach is influenced by multiple factors, including disease severity, previous <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">response to treatment, side effects and co-morbidities. The current standard of care for treatment of patients with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">mild IBD involves the use of conventional anti-inflammatory therapies. Conventional anti-inflammatory therapies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">include: aminosalicylates (e.g., 5-ASA), immunosuppressants or immunomodulators (e.g., 6-mercaptopurine (&#8220;6-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">MP&#8221;), methotrexate (&#8220;MTX&#8221;)) and corticosteroids that are usually prescribed for short-term treatment to manage <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">flare-ups. Despite these conventional therapies, patients suffering from mild IBD may evolve towards moderate and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">severe forms of IBD requiring the use of advanced therapies. However, available therapies often only have moderate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">efficacy that changes or may wane over time, as patients have the potential to stop responding or do not respond at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">all to these treatments and thus require new therapeutic management options. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">While we hope to position obefazimod as a potential first-line advanced therapy, there is no guarantee that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">even if approved, it would be approved for first-line advanced therapy. This could limit our potential market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">opportunity. In addition, we may have to conduct additional clinical trials prior to gaining approval for first-line <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advanced therapy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The estimates of market opportunity and forecasts of market growth included in this Annual Report on Form 20-<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">F may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business may not grow at similar rates, or at all. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Market opportunity estimates and growth forecasts included in this Annual Report on Form 20-F are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant uncertainty and are based on assumptions and estimates which may not prove to be accurate. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">estimates and forecasts included in this Annual Report on Form 20-F relating to size and expected growth of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">target market may prove to be inaccurate. Even if the markets in which we compete meet the size estimates and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">growth forecasts included in this Annual Report on Form 20-F, our business may not grow at similar rates, or at all. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our growth is subject to many factors, including our success in implementing our business strategy, which is subject <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to many risks and uncertainties. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Sales of our drug candidates, if approved, could be adversely impacted by the reluctance of physicians, healthcare <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payors, patients or the medical community in general to adopt them and by the availability of competing drugs. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Even if we obtain regulatory approval for one or more of our drug candidates, physicians, healthcare payors, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients or the medical community in general may be reluctant to try a new drug due to the high degree of risk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">associated with the application of new drugs in the field of human medicine, especially if the new drug differs from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the currently prevailing medication for a given complaint. We will need to expend significant sums of money to <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">27<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market our products to increase the public&#8217;s awareness within numerous limits set by the regulations concerning the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">promotion of drugs. If our products do not achieve an adequate level of acceptance, we may not generate enough <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">revenues to become profitable or the profitability may occur much later. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Competing drug candidates in the chronic inflammatory disease field are being manufactured and marketed by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other companies, including, but not limited to, AbbVie, Eli Lilly, Johnson&#160;&amp; Johnson, Pfizer and Takeda. Merck, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Roche, and Teva/Sanofi are all potential future competitors based on recent acquisitions of TL1A molecules. To <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compete with other drugs, particularly any that sell at lower prices, our drug candidates will have to provide <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">medically significant advantages or be more cost-effective. Even if we can overcome physician reluctance and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compete with products that are currently on the market, our competitors may succeed in developing new, safer, more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accurate or more cost-effective treatments or therapeutic indications that could render our drug candidates obsolete <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or non-competitive. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Global economic conditions could materially adversely impact demand for our drug candidates. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our operations and performance depend significantly on economic conditions. Global financial conditions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">continue to be subject to volatility arising from international geopolitical developments, such as the war in Ukraine <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and global economic phenomena, as well as general financial market turbulence, natural phenomena and any public <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">health crisis. Uncertainty about global economic conditions could result in: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">third-party suppliers being unable to produce components for our drug candidates in the same quantity <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">or on the same timeline or being unable to deliver such parts and components as quickly as before or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">subject to price fluctuations, which could have a material adverse effect on our production or the cost <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of such production; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 318.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 319.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">once our drug candidates are available for sale, customers postponing purchases of our drug candidates <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 329.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">in response to tighter credit, unemployment, negative financial news and/or declines in income or asset <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 339.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">values and other macroeconomic factors, which could have a material adverse effect on demand for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 349.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 371.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">either of which could, accordingly, have a material adverse effect on our business, results of operations or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 381.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial condition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 403.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Access to public financing and credit can be negatively affected by the effect of these events on European, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 413.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. and global credit markets. The health of the global financing and credit markets may affect our ability to obtain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 423.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">equity or debt financing in the future and the terms at which financing or credit is available to us. These instances of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 433.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">volatility and market turmoil could adversely affect our operations and the trading price of our ordinary shares. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 461.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Changes to trade policy, tariffs, and import/export regulations may have a material adverse effect on our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 471.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business, financial condition, and results of operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 487.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in laws and policies governing foreign trade could adversely affect our business. As a result of recent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 497.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and future policy changes, there may be greater restrictions and economic disincentives on international trade. Such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 507.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">changes have the potential to adversely impact the global and local economies, our industry and global demand for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates and, as a result, could have a material adverse effect on our business, financial condition and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 555.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Fluctuations in currency exchange rates may significantly impact our results of operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 571.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our business is located, and our operations are conducted, in Europe. As a result, we are exposed to an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 581.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exchange rate risk between the U.S. dollar and the Euro. The exchange rates between these currencies in recent years <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 591.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have fluctuated significantly and may continue to do so in the future. An appreciation of the Euro against the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 601.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S.&#160;dollar could increase the relative cost of our drug candidates outside of Europe, which could have a negative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 611.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">effect on sales. Conversely, to the extent that we are required to pay for goods or services in U.S.&#160;dollars, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 621.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">depreciation of the Euro against the U.S.&#160;dollar would increase the cost of such goods and services. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 643.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We do not hedge our currency exposure and, therefore, we incur currency transaction risk whenever we enter <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 653.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">into either a purchase or sale transaction using a currency other than the Euro. Given the volatility of exchange rates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 663.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we might not be able to effectively manage our currency transaction risks, and volatility in currency exchange rates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 673.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">might have a material adverse effect on our business, financial condition or results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">28<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We rely on a small number of third-party suppliers and manufacturers, and in certain cases a single-source <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supplier, and we may be in a position of dependence with respect to these third parties. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We do not own or operate manufacturing facilities and have no current plans to develop our own clinical or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercial-scale manufacturing capabilities. We currently rely, and expect to continue to rely, on a small number of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">third-party suppliers, and in certain cases a single-source supplier, for the supply of various raw materials and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">chemical products and clinical batches needed for our preclinical studies and clinical trials. In the case of certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufactured and clinical supplies, we rely on single-source suppliers. The supply of specific raw materials and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products required for conducting clinical trials and manufacturing our products cannot be guaranteed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are dependent on third parties for the supply of various materials, including chemical or biological <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products that are necessary to produce drug candidates for our clinical trials and, ultimately, commercial supply for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any of our drug candidates that may receive approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 209pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The facilities used by our third-party manufacturers must be approved for the manufacture of our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates by the FDA, the EMA and any comparable foreign regulatory authorities in other jurisdictions, pursuant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to inspections that will be conducted after we submit an NDA to the FDA, a marketing authorization application <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">("MAA") to the EMA, or submit a comparable marketing application to a comparable regulatory authority. We do <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not control the manufacturing process of, and are completely dependent on, third-party manufacturers for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compliance with GMP requirements for manufacture of our drug candidates. If these third-party manufacturers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of any applicable regulatory authority, they will not be able to secure and/or maintain regulatory approval for the use <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of their manufacturing facilities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we have no control over the ability of third-party manufacturers to maintain adequate quality <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control, quality assurance and qualified personnel. If any regulatory authority does not approve these facilities for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the manufacture our drug candidates, or if such authorities withdraw any such approval in the future, we may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">required to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval for or market our drug candidates, if approved. Our failure, or the failure of our third-party <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, seizures or recalls, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operating restrictions and criminal prosecutions, any of which could significantly and adversely affect our financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">position. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our or a third party&#8217;s failure to execute on our manufacturing requirements on commercially reasonable terms <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and in compliance with GMP or other regulatory requirements could adversely affect our business in a number of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ways, including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">an inability to initiate or complete clinical trials of our drug candidates in a timely manner; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delay in submitting regulatory applications, or receiving regulatory approvals, for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">subjecting third-party manufacturing facilities to additional inspections by regulatory authorities; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">requirements to cease development or to recall batches of our drug candidates; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">in the event of approval to market and commercialize any drug candidate, an inability to meet <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercial demands. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we do not have any long-term commitments or supply agreements with any third-party <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturers. We may be unable to establish any long-term supply agreements with third-party manufacturers or to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">do so on acceptable terms, which increases the risk of failing to timely obtain sufficient quantities of our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates or such quantities at an acceptable cost. Any performance failure on the part of our existing or future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturers or suppliers could delay clinical development or marketing approval, and any related remedial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">measures may be costly or time consuming to implement. We do not currently have second source for all required <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">raw materials used in the manufacture of our drug candidates. If our existing or future third-party manufacturers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cannot perform as agreed, we may be required to replace such manufacturers and we may be unable to replace them <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on a timely basis or at all, which would have a material adverse impact on our financial position. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We rely on third parties to conduct our preclinical studies and clinical trials. If these third parties do not <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approval for or commercialize our drug candidates and our business could be substantially harmed. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are dependent on third parties to conduct our clinical trials and preclinical studies. Specifically, we rely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on, and will continue to rely on, medical institutions, clinical investigators, CROs and consultants to conduct <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical studies and clinical trials, in each case in accordance with trial protocols and regulatory requirements. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">29<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">These CROs, investigators and other third parties play a significant role in the conduct and timing of these trials and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent collection and analysis of data. Though we expect to carefully manage our relationships with such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">CROs, investigators and other third parties, there can be no assurance that we will not encounter challenges or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delays in the future, or that these delays or challenges will not have a material adverse impact on our business, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial condition and prospects. Further, while we have and will have agreements governing the activities of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">third-party contractors, we have limited influence over their actual performance. Nevertheless, we are responsible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for ensuring that each of our clinical trials is conducted in accordance with the applicable protocol and legal, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory and scientific standards and requirements, and our reliance on our CROs and other third parties does not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relieve us of our regulatory responsibilities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we and our CROs are required to comply with stringent standards governing the conduct of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical studies and clinical trials, including Good Laboratory Practice (&#8220;GLP&#8221;) and GCP requirements, which are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities, for our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates in clinical development. Regulatory authorities enforce GCPs through periodic inspections of trial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sponsors, principal investigators and trial sites. If we or any of our CROs or trial sites fail to comply with applicable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">GLP, GCP or other requirements, the data generated in our clinical trials may be deemed unreliable, and the FDA or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing applications, if ever. Furthermore, our clinical trials must be conducted with materials manufactured in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with GMP regulations. Failure to comply with these regulations may require us to repeat clinical trials, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which would delay the regulatory approval process. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There is no guarantee that any of our CROs, investigators or other third parties will devote adequate time and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resources to such trials or studies or perform as contractually required. If any of these third parties fails to meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected deadlines, adhere to our clinical protocols or meet regulatory requirements, or otherwise perform in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">substandard manner, our clinical trials may be extended, delayed or terminated. In addition, many of the third parties <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with whom we contract may also have relationships with other commercial entities, including our competitors, for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">whom they may also be conducting clinical trials or other activities that could harm our competitive position. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition, principal investigators for our clinical trials may be asked to serve as scientific advisors or consultants to us <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from time to time and may receive cash or equity compensation in connection with such services. If these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relationships and any related compensation result in perceived or actual conflicts of interest, or the FDA concludes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that the financial relationship may have affected the interpretation of the study, the integrity of the data generated at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the applicable clinical trial site may be questioned and the utility of the clinical trial itself may be jeopardized, which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could result in the delay or rejection by the FDA of any NDA we submit. Any such delay or rejection could prevent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">us from commercializing our drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, our CROs have the right to terminate their agreements with us in the event of an uncured material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">breach and under other specified circumstances. If any of our relationships with these third parties terminate, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may not be able to enter into arrangements with alternative third parties on commercially reasonable terms or at all. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Switching or adding additional CROs, investigators and other third parties involves additional cost and requires our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management&#8217;s time and focus. In addition, there is a natural transition period when a new CRO commences work. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Though we work to carefully manage our relationships with our CROs, investigators and other third parties, there <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will not have a material adverse impact on our business, financial condition and prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If any of our relationships with these third parties terminate, we may not be able to enter into arrangements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with alternative third parties on commercially reasonable terms or at all. Switching or adding additional CROs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">investigators and other third parties involves additional cost and requires our management&#8217;s time and focus. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">materially impact our ability to meet our desired clinical development timelines. Though we work to carefully <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manage our relationships with our CROs, investigators and other third parties, there can be no assurance that we will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">impact on our business, financial condition and prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our future success depends on our ability to retain our key executives and to attract, retain and motivate <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">qualified personnel. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are highly dependent on our management, scientific and medical personnel whose services are critical to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our success. Our success depends greatly on the involvement and expertise of our senior executives and qualified <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">scientific staff. We do not maintain key person insurance. The temporary or permanent unavailability of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management and scientific staff could lead to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">loss of know-how and weakening of certain activities, especially in the case of transfer to the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">competition; and <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">30<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">deficiencies in terms of technical skills that could slow down activity and ultimately impair our ability <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">to reach our objectives. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Recruiting and retaining additional qualified management and scientific, clinical, manufacturing and sales and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing personnel will also be critical to our success, particularly as we expand in order to acquire additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">skills, such as manufacturing, quality assurance and regulatory and medical affairs. The loss of the services of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">senior management team or other key employees could impede the achievement of our research, development and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization objectives and seriously harm our ability to successfully implement our business strategy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">time because of the limited number of individuals in our industry with the breadth of skills and experience required <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to successfully develop, gain regulatory approval of and commercialize drug candidates. Competition to hire from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We also experience intense competition for the hiring of scientific and clinical personnel from other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">companies, universities and research institutions. We may not be able to attract or retain qualified management and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">scientific personnel in the future due to intense competition for a limited number of qualified personnel. Many of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">those that compete with us for qualified personnel have greater financial and other resources, different risk profiles <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and a longer history in the industry than we do. Our competitors may also provide more diverse opportunities and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">better chances for career advancement. An inability to attract and retain high quality personnel will have a material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse effect on our business, prospects, financial condition, cash flow or results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">formulating our research and development and commercialization strategy. Our consultants and advisors may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employed by employers other than us and may have commitments under consulting or advisory contracts with other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entities that may limit their availability to us. If we are unable to continue to attract and retain high quality <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personnel, the marketing and production of our drugs could be delayed or prevented, which could, in turn, have a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">material adverse effect on our business, prospects, financial condition, cash flows or results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our employees, principal investigators, consultants and commercial partners may engage in misconduct or other <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">improper activities, including noncompliance with regulatory standards and requirements and insider trading. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are exposed to the risk of fraud or other misconduct by our employees, principal investigators, consultants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and commercial partners. Misconduct by these parties could include intentional failures, reckless and/or negligent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conduct or unauthorized activity that violates (i)&#160;the laws and regulations of the European Economic Area (&#8220;EEA&#8221;) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">countries, the European Commission, FDA and other regulatory authorities, including those laws requiring the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reporting of true, complete and accurate information to such authorities, (ii)&#160;manufacturing standards, (iii)&#160;federal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and state data privacy, security, fraud and abuse and other healthcare laws and regulations in Europe, the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States and elsewhere and (iv)&#160;laws that require the true, complete and accurate reporting of financial information or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">data. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commission, customer incentive programs and other business arrangements. Such misconduct also could involve the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">improper use of individually identifiable information, including, without limitation, information obtained in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">course of clinical trials, creating fraudulent data in our preclinical studies or clinical trials or illegal misappropriation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of drug product, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">us from government investigations or other actions or lawsuits stemming from a failure to comply with these laws or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations. Additionally, we are subject to the risk that a person or government could allege such fraud or other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">misconduct, even if none occurred. If any such actions are instituted against us and we are not successful in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">defending ourselves or asserting our rights, those actions could result in significant civil, criminal and administrative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">penalties, damages, fines, disgorgement, imprisonment, exclusion from participating in government-funded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws, contractual damages, reputational harm and the curtailment or restructuring of our operations, any of which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could have a negative impact on our business, financial condition, results of operations and prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We have limited infrastructure in market access, sales, marketing and distribution. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We lack infrastructure and resources in the fields of sales, marketing and distribution. We need to develop our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">own marketing and sales capacity, either alone or with partners once marketing authorizations have been obtained. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As part of setting up our sales and marketing infrastructure, we will need to incur additional expenses, mobilize <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">31<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management resources, implement new skills and take the time necessary to set up the appropriate organization and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">structure to support the products in accordance with current legislation and, more generally, optimize <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization efforts. We compete with many companies that currently have extensive, experienced and well-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">funded market access, marketing and sales operations to recruit, hire, train and retain marketing and sales personnel, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and will have to compete with those companies to recruit, hire, train and retain any of our own market access, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing and sales personnel. If we are unable to expand our sales and marketing team, we may be unable to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compete successfully against these more established companies. Alternatively, if we choose to collaborate, either <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">globally or on a territory-by-territory basis, with third parties that have direct sales forces and established <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distribution systems, either to augment our own sales force and distribution systems or in lieu of our own sales force <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and distribution systems, we will be required to negotiate and enter into arrangements with such third parties relating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to the proposed collaboration. If we are unable to enter into such arrangements when needed, on acceptable terms, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">at all, we may not be able to successfully commercialize any of our drug candidates that receive regulatory approval <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or any such commercialization may experience delays or limitations. Factors that may inhibit our efforts to build a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sales, marketing and distribution organization: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our inability to recruit, train and retain adequate numbers of effective sales and marketing personnel; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the inability of sales personnel to obtain access to physicians, educate physicians about patients for <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">whom our drug candidates may be appropriate treatment options and attain adequate numbers of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">physicians to prescribe any drugs; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the inability of reimbursement professionals to negotiate arrangements for formulary access, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement and other acceptance by payors; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 294.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 295.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">restricted or closed distribution channels that make it difficult to distribute our products to segments of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 305.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the patient population; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 321.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the lack of complementary medicines to be offered by sales personnel, which may put us at a <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 331.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">competitive disadvantage relative to companies with more extensive product lines; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 347.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">unforeseen costs and expenses associated with creating an independent sales and marketing <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 357.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">organization. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 385.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">There are numerous competitors in the market for therapeutic treatments of inflammatory diseases. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 401.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The biotechnology and pharmaceutical industries are highly competitive and subject to significant and rapid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 411.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technological change as researchers learn more about diseases and develop new technologies and treatments. Many <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 421.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical companies, biotech companies, institutions, universities and other research organizations are actively <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 431.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">engaged in the research, discovery, development and commercialization of therapeutic responses for the treatment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 441.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the diseases targeted by us. Significant competitive factors in our industry include: (i)&#160;product efficacy and safety; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 451.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(ii)&#160;quality and breadth of an organization&#8217;s technology; (iii)&#160;skill of an organization&#8217;s employees and its ability to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 461.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recruit and retain key employees; (iv)&#160;timing and scope of regulatory approvals; (v)&#160;government reimbursement rates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 471.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for, and the average selling price of, pharmaceutical products; (vi)&#160;the availability of raw materials and qualified <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 481.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing capacity; (vii)&#160;manufacturing costs; (viii)&#160;intellectual property and patent rights and their protection; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 491.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and (ix)&#160;sales and marketing capabilities. Given the intense competition in our industry, we cannot assure you that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 501.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any of the products that we successfully develop will be clinically superior or scientifically preferable to products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 511.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">developed or introduced by our competitors. In addition, significant delays in the development of our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 521.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates could allow our competitors to succeed in obtaining European Commission, FDA, PMDA or other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 531.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory approvals for their drug candidates more rapidly than us, which could place us at a significant competitive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 541.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disadvantage or deny us marketing exclusivity rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 563.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our competitors in the chronic inflammatory disease field are primarily large pharmaceuticals companies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 573.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including, but not limited to AbbVie, Eli Lilly, Johnson&#160;&amp; Johnson, Pfizer and Takeda. Several lines of research are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 583.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">being developed to improve the treatment of IBD. Many companies are working to develop new, more effective and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 593.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">better tolerated treatments with more practical formulations, especially small molecules administered orally, better <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accepted than monoclonal antibodies that require administration by injection. See &#8220;Item 4.C. Business Overview&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 613.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Competition.&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 635.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Further, our competitors may be more effective at using their technologies to develop commercial products. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 645.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Many of the organizations competing with us have significantly greater financial resources and expertise in research <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 655.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and development, manufacturing, preclinical studies, conducting clinical trials, obtaining regulatory approvals and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 665.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 675.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 685.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">also prove to be significant competitors, particularly through partnership arrangements with large and established <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 695.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">companies. These companies also compete with us in recruiting and retaining qualified scientific and management <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">32<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technologies complementary to, or necessary for, our programs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The development potential in the markets in which we operate is such that the arrival of new competition is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">probable. New market entrants, increased competition in specific areas, or in general, would have a material adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">effect on our business, income, financial position and outlook for growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We depend on, and will continue to depend on, collaboration and strategic alliances with third partners. To the <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extent we are able to enter into collaborative arrangements or strategic alliances, we will be exposed to risks <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related to those collaborations and alliances. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">An important element of our strategy for developing, manufacturing and commercializing our drug candidates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is entering into partnerships and strategic alliances with other pharmaceutical companies or other industry <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">participants. The collaboration agreements that we have established, and any collaboration arrangements that we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may enter into in the future, may not be successful, which would have a negative impact on our business, results of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations, financial condition and growth prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Any partnerships or alliance we have or may have in the future may be terminated for reasons beyond our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control or we may not be able to negotiate future alliances on acceptable terms, if at all. These arrangements may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">result in us receiving less revenue than if we sold our products directly, may place the development, sales and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing of our products outside of our control, may require us to relinquish important rights or may otherwise be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on unfavorable terms. Collaborative arrangements or strategic alliances will also subject us to a number of risks, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including the risk that: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">we may not be able to control the amount and timing of resources that our strategic partner/<span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">collaborators may devote to the drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">strategic partner/collaborators may experience financial difficulties; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the failure to successfully collaborate with third parties may delay, prevent or otherwise impair the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">development or commercialization of our drug candidates or revenue expectations; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">products being developed by partners/collaborators may never reach commercial stage resulting in <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">reduced or even no milestone or royalty payments; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">business combinations or significant changes in a collaborator&#8217;s business strategy may also adversely <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">affect a collaborator&#8217;s willingness or ability to complete their obligations under any arrangement; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">a collaborator could independently move forward with a competing product developed either <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">independently or in collaboration with others, including our competitors; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">collaborative arrangements are often terminated or allowed to expire, which would delay the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">development and may increase the cost of developing drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our partnerships and licensing agreements relating to the technologies belonging to us may not be successful. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The various drug candidates developed by us arise from proprietary or licensed technologies with leading <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">academic partners, including Scripps Research Institute, University of Chicago, Brigham Young University, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Montpellier Institute of Molecular Genetics at the <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 273.11pt; position: var(--position); text-decoration: none; white-space: pre;">Centre National de la Recherche Scientifique<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.24pt; position: var(--position); text-decoration: none; white-space: pre;"> (&#8220;CNRS&#8221;) and the <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Institut Curie<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.55pt; position: var(--position); text-decoration: none; white-space: pre;">. If the clinical trials conducted by us were to reveal safety and/or therapeutic efficacy problems or if <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the use of one of the platforms were to violate an intellectual property right held by a third party, this could threaten <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the use and operation of some of our technology platforms and require additional research and development efforts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and additional time and expense to address these difficulties, with success not being guaranteed. The development of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a portion of our product portfolio would be affected, which would have a material adverse effect on our business, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outlook, growth, financial position and income. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The reimbursement of drugs and treatments is beyond our control. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">After achieving regulatory authorization and once marketing authorization is granted, the process of setting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the sales price of drugs and their reimbursement rates begins. The conditions for setting the sales price and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement rate for drugs are beyond the control of pharmaceutical companies. They are decided by competent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">public committees and bodies and by social security or private insurance companies. In this context, we or our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">partners could be asked to perform additional studies on our products. These studies could generate additional costs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for us or our partners and lead to delays in marketing the drug, which could have an impact on our financial position. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">33<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There is significant uncertainty related to the reimbursement of newly-approved drugs. The level of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement will impact market acceptance and sale of our drug candidates. Reimbursement by a third-party is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dependent on a number of factors, including, without limitation, the third-party payor&#8217;s determination that use of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product is: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">a covered benefit under its health plan; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">safe, effective and medically necessary; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">appropriate for the specific patient; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">cost-effective; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">neither experimental nor investigational. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The possibility that we could receive royalties from our industrial partner or partners on the sale of some of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our products and our ability to make sufficient profits on the marketing of our treatments or those for which we have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entered into distribution contracts will depend on these reimbursement conditions. If delays in the price negotiation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">procedure result in a significant delay in marketing, if our product does not obtain an appropriate level of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement, or if the accepted price level and reimbursement rate of the treatments we market are changed, our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profitability will be reduced. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are also unable to guarantee that we will succeed in maintaining, over time, the price level of our products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or those for which licenses have been granted, or the accepted reimbursement rate. Under these conditions, there <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could be a material adverse effect on our business, financial position and results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The pricing, insurance coverage and reimbursement status of newly-approved products is uncertain. Failure to <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtain or maintain adequate coverage and reimbursement for our drug candidates, if approved, could limit our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ability to market those products and decrease our ability to generate product revenue. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Successful sales of our drug candidates, if approved, depend on the availability of coverage and adequate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement from third-party payors including governmental healthcare programs, such as Medicare and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Medicaid in the United States, managed care organizations and commercial payors, among others. Significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">uncertainty exists as to the coverage and reimbursement status of any drug candidates for which we obtain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the United States, no uniform policy for coverage and reimbursement exists, and coverage and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement for drug products can differ significantly from payor to payor. Therefore, one payor&#8217;s determination <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to provide coverage for a drug product does not assure that other payors will also provide coverage for the drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product. Third-party payors often follow Medicare coverage policy and payment limitations in setting their own <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement rates, but also have their own methods and approval process apart from Medicare determinations. As <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a result, the coverage determination process is often a time-consuming and costly process that will require us to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provide scientific and clinical support for the use of our products to each payor separately, with no assurance that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Moreover, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">coverage policies and reimbursement rates may be implemented in the future. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Reimbursement may impact the demand for, and/or the price of, any product for which we obtain marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approval. Assuming we obtain coverage for a given product by a third-party payor, the resulting reimbursement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payment rates may not be adequate or may require co-payments that patients find unacceptably high. Patients who <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are prescribed medications for the treatment of their conditions, and their prescribing physicians, generally rely on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">third-party payors to reimburse all or part of the costs associated with their prescription drugs. Patients are unlikely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to use our products unless coverage is provided, and reimbursement is adequate to cover all or a significant portion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the cost of our products. Therefore, coverage and adequate reimbursement is critical to new product acceptance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 623pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, we or our collaborators may develop companion diagnostic tests for use with our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates. We or our collaborators will be required to obtain coverage and reimbursement for these tests separate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and apart from the coverage and reimbursement we seek for our drug candidates, once approved. Similar challenges <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">companion diagnostics. Our inability to promptly obtain coverage and adequate reimbursement from both third-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">party payors for the drug candidates and companion diagnostic tests that we or our collaborators develop and for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which we obtain regulatory approval could have a material and adverse effect on our business, financial condition, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results of operations and prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">34<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the EU, pricing and reimbursement schemes vary widely from country to country. Some countries provide <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that products may be marketed only after a reimbursement price has been agreed. Some countries may require the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completion of additional studies that compare the cost-effectiveness of a particular drug candidate to currently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">available therapies. EU member states may approve a specific price for a product or it may instead adopt a system of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">direct or indirect controls on the profitability of the company placing the product on the market. Other member <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">states allow companies to fix their own prices for products, but monitor and control company profits. The downward <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pressure on health care costs has become intense. As a result, increasingly high barriers are being erected to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">competitive pressure that may reduce pricing within a country. Any country that has price controls or reimbursement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">limitations may not allow favorable reimbursement and pricing arrangements, and prices are usually revised <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">periodically, such that any given price may decrease upon various occurrences. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, the containment of healthcare costs has become a priority of federal and state governments, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the prices of drugs have been a focus of this effort. The U.S. government, state legislatures and foreign governments <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have shown significant interest in implementing cost-containment programs, including price controls, restrictions on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could further limit our net revenue and results. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Price controls may be imposed in markets in which we operate, which may negatively affect our future <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profitability. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In some countries, particularly EU member states, Japan, Australia and Canada, the pricing of prescription <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drugs is subject to governmental control. In these countries, pricing negotiations with governmental authorities can <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">take considerable time after receipt of marketing approval for a product. In addition, there can be considerable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">containment measures. Political, economic and regulatory developments may further complicate pricing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">by various EU member states and parallel distribution, or arbitrage between low-priced and high-priced member <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">states, can further reduce prices. In some countries, we or our collaborators may be required to conduct a clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trial or other studies that compare the cost-effectiveness of our drug candidates to other available therapies in order <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to obtain or maintain reimbursement or pricing approval. Publication of discounts by third-party payors or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other countries. If reimbursement of our drug candidates is unavailable or limited in scope or amount, or if pricing is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">set at unsatisfactory levels, there could be a material adverse effect on our business, financial condition or results of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">If our <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 98.67pt; position: var(--position); text-decoration: none; white-space: pre;">information technology systems<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 229.11pt; position: var(--position); text-decoration: none; white-space: pre;"> or those of the third parties with whom we work, or our data are or were <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compromised, we could experience adverse consequences resulting from such compromise, including but not <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">limited to: regulatory investigations or actions; litigation; fines and penalties; disruptions of our business <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations; reputational harm; loss of revenue and profits; and other adverse consequences.<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the ordinary course of our business, we and the third parties with whom we work process personal data <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(including data we collect about trial participants in connection with clinical trials) and other sensitive information, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including proprietary and confidential business data, trade secrets, intellectual property, sensitive third-party data, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business plans, transactions, and financial information (collectively, sensitive data). We and the third parties with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">whom we work face a variety of evolving threats to information technology systems and data. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Cyber-attacks, malicious internet-based activity, online and offline fraud and other similar activities threaten <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the confidentiality, integrity and availability of our sensitive data and information technology systems, and those of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the third parties with whom we work. Such threats are prevalent and continue to rise, are increasingly difficult to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">detect, and come from a variety of sources, including traditional computer &#8220;hackers,&#8221; threat actors, &#8220;hacktivists,&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">organized criminal threat actors, personnel (such as through error, theft or misuse), sophisticated nation states and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">nation-state-supported actors. For geopolitical reasons and in conjunction with military conflicts and defense <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">activities, some actors have in the past and are expected to in the future engage in nefarious cybersecurity attacks. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">During times of war and other major conflicts, we and the third parties with whom we work are vulnerable to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations, supply chain and ability to produce, sell and distribute our services. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We and the third parties with whom we work are subject to and have experienced a variety of evolving threats, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">more difficult to identify as a fake, and phishing attacks), malicious code (such as viruses and worms), malware <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(including as a result of advanced persistent threat intrusions), denial-of-service attacks, credential stuffing attacks, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">credential harvesting, personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">35<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">telecommunications failures, earthquakes, fires, floods, other natural disasters, attacks enhanced or facilitated by AI, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and other similar threats. In particular, severe ransomware attacks are becoming increasingly prevalent and can lead <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to significant interruptions in our operations, ability to provide our services, loss of sensitive data and income, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations prohibiting such payments.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Remote work has increased risks to our information technology systems and data, as more of our personnel <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">utilize network connections, computers, and devices outside our premises or network, including working at home, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">while in transit and in public locations. Additionally, future or past business transactions (such as acquisitions or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">affected by vulnerabilities present in acquired or integrated entities&#8217; systems and technologies. Furthermore, we may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discover security issues that were not found during due diligence of such acquired or integrated entities, and it may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be difficult to integrate companies into our information technology environment and security program. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, our reliance on third-party service providers could introduce new cybersecurity risks and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">vulnerabilities, including supply-chain attacks, and other threats to our business operations. We rely on third-party <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">service providers and technologies to operate critical business systems to process sensitive data in a variety of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contexts, including, without limitation, cloud-based infrastructure, cybersecurity monitoring, data hosting, personnel <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">email, and other functions. We also rely on third-party service providers to provide other products, services, parts, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">otherwise to operate our business. Our ability to monitor these third parties&#8217; information security practices is limited, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and these third parties may not have adequate information security measures in place. Our third-party service <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">providers have in the past and may in the future experience a security incident or other interruption. While we may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. In addition, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">infrastructure in our supply chain or our third-party partners&#8217; supply chains have not been compromised. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">While we have implemented security measures designed to protect against security incidents, there can be no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assurance that these measures have been or will be effective. We take steps designed to detect, mitigate, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remediate vulnerabilities in our information systems (such as our hardware and/or software, including that of third <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">parties with whom we work). We may not, however, detect and remediate all such vulnerabilities including on a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">timely and effective basis. Further, we may experience delays in developing and deploying remedial measures and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patches designed to address identified vulnerabilities. These vulnerabilities could be exploited and result in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">security incident. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Any of the previously identified or similar threats have caused and could cause a security incident or other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interruption that could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">alteration, encryption, disclosure of, or access to or other compromise of our sensitive data or our information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technology systems, or those of the third parties upon whom we rely. A security incident or other interruption could <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disrupt our ability (and that of third parties with whom we work) to provide our services. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We may expend significant resources or modify our business activities (including our clinical trial activities) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to try to protect against security incidents. Additionally, certain data privacy and security obligations require us to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">implement and maintain specific security measures or industry-standard or reasonable security measures to protect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our information technology systems and sensitive data. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Applicable data privacy and security obligations may require us, or we may voluntarily choose, to notify <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relevant stakeholders, including affected individuals, regulators, investors and others, of security incidents, or to take <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other actions, such as providing credit monitoring and identity theft protection services. We have in the past notified <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relevant stakeholders of such security incidents. Such disclosures and related actions can be costly, and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disclosure or the failure to comply with such applicable requirements could lead to adverse consequences.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we (or a third party with whom we work) experience a security incident or are perceived to have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">experienced a security incident, we may experience adverse consequences. These consequences may include: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reporting requirements and/or oversight; restrictions on processing sensitive data (including personal data); litigation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">diversions; interruptions in our operations (including availability of data); financial loss; and other similar harms. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Security incidents and attendant consequences may cause relevant stakeholders to stop using our services, deter new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">stakeholders from using our services, and negatively impact our ability to grow and operate our business.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">36<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, sensitive information of the Company could be leaked, disclosed, or revealed as a result of or in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">connection with our personnel&#8217;s or vendors&#8217; use of generative AI technologies.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">An outbreak of communicable diseases around the world may cause disruption to our business. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Any public health crisis due to the outbreak of communicable diseases may cause any of the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays or difficulties in recruiting patients for our clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays or difficulties in launching clinical trial sites, including difficulties in recruiting investigators <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and clinical site staff; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 244.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 245.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">diversion of health care resources from the conduct of clinical trials, of hospital staff supporting the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 255.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">conduct of clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 277.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to the risks listed above, and as part of our clinical trials in countries in pandemic zones, we may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 287.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">also experience the following adverse effects: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 303.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">potential delays in the conduct of our research and preclinical studies, preventing research and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 313.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical studies from being conducted as planned; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 329.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays in obtaining authorizations from the administrative and regulatory authorities required to launch <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 339.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the planned preclinical studies and clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 355.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays in the receipt of supplies and equipment necessary for the completion of our research activities <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 365.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and our preclinical studies and clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 381.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">interruption or delays affecting the activity of contractors who provide research services to us; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 397.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">refusal of the competent regulatory authorities to accept data from clinical trials conducted in the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 407.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">geographical areas affected by the pandemic; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 423.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the interruption of global maritime trade could affect the transportation of research materials for <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 433.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical studies and clinical trials, such as experimental drugs and comparator drugs used in our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 443.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 459.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">delays in the necessary interactions with local authorities, ethics committees or other important and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 469.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">third-party co-contracting bodies due to limitations in human resources or forced leave of state <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 479.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">employees. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 501.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If one or more of the above risks were to materialize, the planned and ongoing clinical trials and, therefore, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 511.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">publication of the data and results of these studies and all subsequent steps leading to the commercialization of drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 521.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates being studied, could be significantly delayed. Such a situation could have a material adverse effect on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 531.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business, income, financial position and growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 553.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The extent to which the outbreak of communicable diseases around the world may impact our activity and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 563.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials will depend on future developments, which cannot be predicted with certainty, such as the emergence <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 573.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of diseases that may be resistant to the vaccines or treatments currently available, access to vaccines and treatments <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 583.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the various populations worldwide, the final geographical spread of the disease, its duration, travel restrictions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 593.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and social distancing measures in the European Union, the United States and other countries, business closures or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disruptions, and the effectiveness of measures taken in those countries to contain and treat the disease. There can be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 613.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">no assurance that the outbreak of communicable diseases around the world will not result in an adverse effect on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 623.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial markets, our share price and our ability to obtain finance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 651.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The war between Ukraine and Russia may affect our business, industry and the markets in which we operate. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 667.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The Russia-Ukraine war continues. The conflict has already had major implications for the global economy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 677.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and the rate of inflation, particularly in relation to the supply of energy, raw materials and food products. It has also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 687.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">caused intense volatility on the financial markets, something that is still ongoing at the reporting date and has pushed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 697.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">down stock market prices around the world. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">37<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Given these developments, we have decided not to include Russia and Belarus in our global Phase&#160;3 program <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for obefazimod in UC. However, the global scale of this conflict remains uncertain. We, therefore, cannot rule out <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an adverse impact of this conflict on our business, including in terms of access to raw materials, logistics, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">performance of clinical trials and in relation to any future financing we may seek. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our global Phase 3 clinical trials currently have clinical sites in Ukraine. None of these sites are located in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic, or the so-called Luhansk People&#8217;s Republic. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We continue to monitor developments in the region, but any instability as a result of the war may have material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse impacts on these clinical sites, which could negatively impact our Phase 3 clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 457.57pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risks Related to Intellectual Property <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our ability to exclusively commercialize our drug candidates may decrease if we are unable to protect our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property rights or if these rights are insufficient for our purposes. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our commercial success depends in part on our ability and the ability of our partners to obtain, maintain and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ensure, against third parties, the protection of our patents, trademarks and related applications and other intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">property rights or similar rights (such as trade secrets, business secrets and know-how) or those we are authorized to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">use in the course of our business in Europe, the United States, Asia and other key countries. We dedicate substantial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial and human resources to this and intend to continue our policy of protection through new patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applications as soon as we deem it appropriate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our technology is currently protected by patents and patent applications that we have filed or for which we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have an exclusive license. However, we or our partners might not be able to maintain the protection of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property rights and we could, thereby, lose our technological and competitive advantage in whole or in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">part. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Firstly, our intellectual property rights and those of our partners offer protection for a period that may vary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from one territory to another. The term of individual patents depends upon the legal term of the patents in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">countries in which they are obtained. In most countries in which we have obtained or are seeking patent protection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for our drug candidates, the patent term is 20 years from the earliest filing date of a non-provisional patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">application. In the United States, the term of a patent may be lengthened by a patent term adjustment, which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provides for term extension in the case of administrative delays at the United States Patent and Trademark Office <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;USPTO&#8221;) in granting a patent, or may be shortened if a patent is terminally disclaimed over another patent with an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">earlier expiration date. Furthermore, in the United States, the term of a patent covering an FDA approved drug may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be eligible for a patent term extension under the Hatch-Waxman Amendments as compensation for the loss of patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">term during the FDA regulatory review process. The period of extension may be up to five years beyond the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expiration of the patent but cannot extend the term of a patent beyond a total of 14 years from the date of product <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approval. Only one patent covering a single FDA-approved product among those eligible for an extension may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extended. In the future, if any of our drug candidates receives FDA approval, we expect to apply for a patent term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extension, if available, to extend the term of the patent covering such approved drug product. In France and the rest <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of Europe generally, the term of a patent is 20 years from the date the patent application is filed, with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">understanding that this period may be extended up to another five years if a supplementary protection certificate is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">filed and an additional six months if a pediatric investigation plan is applied. We expect to seek patent term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extensions in any jurisdictions where they are available, however, there is no guarantee that the applicable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities, including the FDA, will agree with our assessment of whether such an extension should be granted, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">even if granted, the length of such an extension. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Secondly, we and our partners could encounter difficulties in the filing or examination of some of our patent, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trademark or other intellectual property rights applications currently being examined/registered. During the patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">application process, we may receive Office Actions from the USPTO or from comparable agencies in foreign <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions rejecting the claims of the patent application. Although we would be given an opportunity to respond to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">those objections, we may be unable to overcome such rejections. At the time a patent application is filed, there may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be other patents that could constitute opposable prior art that may have not yet been published. Despite prior art <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">searches and monitoring, we cannot be certain that we are the first to conceive of an invention and file a patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">application relating thereto; in particular, it should be noted that in most countries, the publication of patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applications takes place 18 months after the earliest priority date of patent filing, or in some cases not at all, and that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discoveries are sometimes only the subject of publication or patent application months or even years later. Likewise, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">when filing one of our trademarks in a country where it is not covered, we could find that the trademark in question <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is not available in that country. A new trademark would then need to be sought for the country in question or an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreement negotiated with the prior holder of the trademark. We may not be able to prevent a disclosure of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information to third parties that could have an impact on our future intellectual property rights. Therefore, it is in no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">way certain that our current and future applications for patents, trademarks and other intellectual property rights will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">result in registrations. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">38<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Thirdly, the simple granting or registration of a patent, trademark or other intellectual property right does not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">guarantee validity or enforceability. Our competitors may at any time contest the validity or enforceability of our or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our partners&#8217; patents, trademarks or applications relating thereto before a court or in the context of other specific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">procedures which, depending on the outcome of such disputes, could reduce their scope, result in their invalidation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or allow them to be circumvented by competitors. In addition, developments, changes or divergences in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interpretation of the legal framework governing intellectual property in Europe, the United States or other countries <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could allow competitors to use our or our partners&#8217; inventions or intellectual property rights to develop or market our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products or technologies without financial compensation. Moreover, there are still certain countries that do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protect intellectual property rights in the same way as in Europe and the United States, and the effective procedures <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and rules necessary to ensure the defense of our rights may not exist in these countries. There is therefore no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certainty that our existing and future patents, trademarks and other intellectual property rights will not be disputed, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">invalidated or circumvented, or that they will provide effective protection against competition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, our rights to our owned or licensed patents, trademarks and related applications and other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property rights may not confer the protection expected against competition. We therefore cannot <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">guarantee with certainty that: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">we will be able to develop novel inventions for which a patent could be filed or issued; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">applications for patents and other property rights currently under review will actually result in the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">granting of patents, trademarks or other registered intellectual property rights; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">patents or other intellectual property rights granted to us or our partners will not be contested, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">invalidated or circumvented; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the scope of protection conferred by our or our partners&#8217; patents, trademarks and other intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">property rights is and will remain sufficient to protect us against competition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Were these eventualities to occur, they could have a material adverse effect on our business and growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, third parties (or even our employees) could use or attempt to use elements of our technologies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protected by an intellectual property right, which would create a detrimental situation for us. We may therefore be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compelled to bring legal or administrative proceedings against these third parties in order to enforce our intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">property rights (patents, trademarks, designs and models or domain names) in court. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Enforcing a claim that a party illegally infringed or misappropriated our intellectual property is difficult, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expensive and time-consuming, and the outcome is unpredictable. Any litigation or dispute, regardless of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outcome, could lead to substantial costs, affect our reputation, negatively influence our income and financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">position and possibly not lead to the desired protection or sanction. Some competitors with more substantial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resources than us may be able to bear the costs of litigation more easily. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 477.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">If we fail to comply with our obligations in any agreements under which we may license intellectual property <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rights from third parties or otherwise experience disruptions to our business relationships with our licensors, we <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could lose rights that are important to our business. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our ability to pursue the development of some of our drug-based candidates partially depends on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintenance in force of the licensing agreements entered into with various institutes. We have licenses granted by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the CNRS, the University of Montpellier and/or the Institut Curie for certain patent and patent applications co-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ownership rights resulting from cooperation with the CNRS, the University of Montpellier and the Institut Curie, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which allowed obefazimod to be developed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">These license contracts provide the possibility for the licensor to end an agreed exclusivity or terminate the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contracts in certain events, including the event of non-payment of fees, a dispute over the validity of the patents <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">licensed or a violation by us of our obligations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We may from time to time be party to license or collaboration agreements with third parties to advance our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">research or allow commercialization of current or future drug candidates. Such agreements may impose numerous <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations, such as development, diligence, payment, commercialization, funding, milestone, royalty, sublicensing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">insurance, patent prosecution, enforcement and other obligations on us and may require us to meet development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">timelines, or to exercise commercially reasonable efforts to develop and commercialize licensed products, in order to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintain the licenses. In spite of our best efforts, our licensors might conclude that we have materially breached our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">license agreements and might therefore terminate the license agreements, thereby removing or limiting our ability to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">develop and commercialize products and technologies covered by these license agreements. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">39<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Any termination of these licenses, or if the underlying licensed rights fail to provide the intended exclusivity, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could result in the loss of significant rights and could harm our ability to commercialize our current or future drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates, and competitors or other third parties would have the freedom to seek regulatory approval of, and to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market, products identical to ours and we may be required to cease our development and commercialization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certain of our current or future drug candidates. Any of the foregoing could have a material adverse effect on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">competitive position, business, financial conditions, results of operations, and prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Disputes may also arise between us and our licensors regarding intellectual property subject to a license <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreement, including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the scope of rights granted under the license agreement and other interpretation-related issues; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">whether and the extent to which our technology and processes infringe, misappropriate or otherwise <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">violate intellectual property rights of the licensor that is not subject to the licensing agreement; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our right to sublicense patent and other rights to third parties under collaborative development <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">relationships; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our diligence obligations with respect to the use of the licensed technology in relation to our <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">development and commercialization of our current or future drug candidates, and what activities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">satisfy those diligence obligations; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the priority of invention of any patented technology; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the ownership of inventions and&#160;know-how&#160;resulting from the joint creation or use of intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">property by our future licensors and us and our partners. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the agreements under which we may license intellectual property or technology from third parties <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are likely to be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The adverse resolution of any contract interpretation disagreement that may arise could narrow what we believe to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be the scope of our rights to the relevant intellectual property or technology or increase what we believe to be our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial or other obligations under the relevant agreement, either of which could have a material adverse effect on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that we have licensed or may license prevent or impair our ability to maintain future licensing arrangements on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">acceptable terms, we may be unable to successfully develop and commercialize the affected current or future drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates, which could have a material adverse effect on our business, financial conditions, results of operations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and prospects. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may be sued for infringing or misappropriating the intellectual property rights of third parties, and if we are, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such litigation could be costly and time consuming and could prevent or delay us from developing or <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercializing our drug candidates. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our commercial success will also depend on our ability to develop products and technologies that do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">infringe the patents or other rights of third parties. It is important for the success of our business that we are able to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">use our products and conduct research and development efforts leading to commercialization of our products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">without infringing patents or other third-party rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We continue to carry out, as we have done to date, the preliminary studies that we consider necessary in view <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the above risks, before investing in the development of our various products and technologies. With the help of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property consulting and law firms, we monitor our competitors&#8217; activity (particularly with respect to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patent filings). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We therefore cannot guarantee with certainty that: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">there are no prior patents or other intellectual property rights of third parties covering certain of our <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">products, methods, technologies, results or activities and that, consequently, third parties might bring <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">an action for infringement or violation of their rights against us with a view to obtaining damages and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">interest and/or the cessation of our activities in the manufacture and/or commercialization of products, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">methods and the like thus disputed; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">there are no trademark rights or other prior rights of third parties that could be the basis of an <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">infringement or liability action against us; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our domain names are not subject, on the part of third parties who have prior rights (for example <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">trademark rights), to a Uniform Domain-Name Dispute-Resolution Policy (&#8220;UDRP&#8221;) or similar policy, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">or an infringement action. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">40<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the event of intellectual property litigation, we may have to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">stop developing, making, selling, offering for sale or using the product or products that depended on <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the disputed intellectual property; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">obtain a license from the holder of the intellectual property rights, however, such a license may be <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">unobtainable or only be obtainable under unfavorable economic conditions for us; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">revise the design of some of our products/technologies or, in the case of trademark applications, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">rename our products to avoid infringing the intellectual property rights of third parties, which may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">prove impossible or time-consuming and expensive, and could impact our marketing efforts. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Litigation can also result in an order to pay damages (including treble damages) and being subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">injunctions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Patent terms may be inadequate to protect our competitive position on our drugs for an adequate amount of time, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and we may seek to rely, but may not be able to rely, on other forms of protection, such as regulatory exclusivity. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Given the amount of time required for the development, testing and regulatory review of new drug candidates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patents protecting such candidates might expire before or shortly after such candidates are commercialized. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example, the certain patents protecting obefazimod&#8217;s composition of matter expire in 2030 and the certain patents <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protecting obefazimod methods of use expire in 2035 which pose a risk to its successful commercialization. We <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expect to seek extensions of patent terms in the United States and, if available, in other countries where we are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prosecuting patents. In the United States, the Drug Price Competition and Patent Term Restoration Act of 1984 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">permits a patent term extension of up to five years beyond the normal expiration of the patent, which is limited to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved indication (or any additional indications approved during the period of extension). However, the applicable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities, including the FDA and the USPTO in the United States, and any equivalent regulatory authority in other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">countries, may not agree with our assessment of whether such extensions are available, and may refuse to grant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extensions to our patents, or may grant more limited extensions than we request. We may also seek to rely on other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">forms of protection, such as regulatory exclusivity, but there can be no assurance that such other forms of protection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will be available or sufficient. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We will not seek to protect our intellectual property rights in all jurisdictions throughout the world and we may <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not be able to adequately enforce our intellectual property rights even in the jurisdictions where we seek <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protection. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Filing, prosecuting and defending patents on our drug candidates in all countries and jurisdictions throughout <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States could be less extensive than those in the United States, assuming that rights are obtained in the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Competitors may use our technologies in jurisdictions where we do not pursue and obtain patent protection to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">develop their own products and further, may export otherwise infringing products to territories where we have patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protection, but enforcement is not as strong as that in the United States. These products may compete with our drugs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and our patents or other intellectual property rights may not be effective or sufficient to prevent them from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">competing. Even if we pursue and obtain issued patents in particular jurisdictions, our patent claims or other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property rights may not be effective or sufficient to prevent third parties from so competing. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the federal and state laws in the United States. Many companies have encountered significant problems in protecting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and defending intellectual property rights in certain foreign jurisdictions. The legal systems of some countries, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">particularly developing countries, do not favor the enforcement of patents and other intellectual property protection, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">especially those relating to biopharmaceuticals or biotechnologies. This could make it difficult for us to stop the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">infringement of our patents, if obtained, or the misappropriation of our other intellectual property rights. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example, many foreign countries have compulsory licensing laws under which a patent owner must grant licenses to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">third parties. In addition, many countries limit the enforceability of patents against third parties, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">government agencies or government contractors. In these countries, patents may provide limited or no benefit. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Patent protection must ultimately be sought on a country-by-country basis, which is an expensive and time-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">countries, and we will not have the benefit of patent protection in such countries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interpreted narrowly, could put our patent applications at risk of not being issued and could provoke third parties to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 704pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">awarded, if any, may not be commercially meaningful. In addition, changes in the law and legal decisions by courts <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">41<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the United States and foreign countries may affect our ability to obtain adequate protection for our technology and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the enforcement of our intellectual property. In addition, monitoring the unauthorized use of our products and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technology and the infringement of our intellectual property rights is challenging. We cannot guarantee with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certainty that we will be able to prevent, take legal action against and obtain compensation for infringement, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">misappropriation or unauthorized use of our products and technologies, particularly in foreign countries where our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rights are less well protected because of the territorial scope of intellectual property rights. Accordingly, our efforts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advantage from the intellectual property that we develop or license. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 161pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Further, in Europe, a new unitary patent system took effect June 1, 2023, which significantly impacts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">European patents, including those granted before the introduction of such a system. Under the unitary patent system, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">European applications have the option, upon grant of a patent, of becoming a Unitary Patent which will be subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the jurisdiction of the Unitary Patent Court, or the UPC. As the UPC is a new court system, there is currently little <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">precedent for the court, increasing the uncertainty of any litigation. Patents granted before the implementation of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UPC will have the option of opting out of the jurisdiction of the UPC and remaining as national patents in the UPC <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">countries. Patents that remain under the jurisdiction of the UPC will be potentially vulnerable to a single UPC-based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">revocation challenge that, if successful, could invalidate the patent in all countries who are signatories to the UPC. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We cannot predict with certainty the long-term effects of these changes. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, geo-political actions in the United States and in foreign countries could increase the uncertainties <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and costs surrounding the prosecution or maintenance of our patent applications and the maintenance, enforcement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or defense of our issued patents. For example, the United States and foreign government actions related to Russia&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">invasion of Ukraine may limit or prevent filing, prosecution, and maintenance of patent applications in Russia. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Government actions may also prevent maintenance of issued patents in Russia. These actions could result in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">abandonment or lapse of our patents or patent applications, resulting in partial or complete loss of patent rights in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Russia. If such an event were to occur, it could have a material adverse effect on our business. In addition, a decree <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">was adopted by the Russian government in March 2022, allowing Russian companies and individuals to exploit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inventions owned by patentees from the United States without consent or compensation. Consequently, we would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not be able to prevent third parties from practicing our inventions in Russia or from selling or importing products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">made using our inventions in and into Russia. Accordingly, our competitive position may be impaired, and our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business, financial condition, results of operations and prospects may be adversely affected. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">If our trademarks and trade names are not adequately protected by us or our partners that develop trademarks <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for our future products, then we may not be able to build name or brand recognition in our markets of interest, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and our business may be adversely affected. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our registered or unregistered trademarks and trade names and the registered or unregistered trademarks and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trade names that our partners will develop may be challenged, infringed, diluted, circumvented or declared generic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or determined to be infringing on other marks. We and our partners may not be able to protect our rights to these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trademarks and trade names, which we need to build name and brand recognition among potential partners or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">customers in our markets of interest. We expect to rely on our partners to protect the trade names and trademarks <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that they will develop, and they may not adequately protect such tradenames and trademarks, and we may have little <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or no recourse in respect thereof. At times, competitors may adopt trademarks and trade names similar to ours, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thereby impeding our ability to build brand identity and possibly leading to market confusion. During the trademark <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">registration process, we may receive Office Actions from the USPTO or from comparable agencies in foreign <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions objecting to the registration of our trademark. Although we would be given an opportunity to respond <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to those objections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applications and/or to seek the cancellation of registered trademarks. Opposition or cancellation proceedings may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">filed against our trademark applications or registrations, and our trademark applications or registrations may not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">survive such proceedings. In addition, there could be potential trademark infringement claims brought by owners of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Over the long term, if we are unable to establish name and brand recognition based on our trademarks, then we may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not be able to compete effectively and our business may be adversely affected. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Obtaining and maintaining patent protection depends on compliance with various procedural, document <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">submission, fee payment and other requirements imposed by governmental patent agencies, and our patent <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protection could be reduced or eliminated for non-compliance with these requirements. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applications are required to be paid to the USPTO and various governmental patent agencies outside of the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States in several stages over the lifetime of the patents and applications. The USPTO and various non-U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">42<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">similar provisions during the patent application process and after a patent has issued. There are situations in which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">complete loss of patent rights in the relevant jurisdiction. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">If we are unable to protect the confidentiality of our trade secrets and know-how, our business and competitive <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">position could be harmed. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to seeking patent protection for our drug candidates, we also rely on trade secrets, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unpatented know-how, technology and other proprietary information, to establish and maintain our competitive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">position. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">It is also important for us to protect against the unauthorized use and disclosure of our confidential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information, know-how and trade secrets. Unpatented and/or unpatentable technologies, processes, methods, know-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">how and data are considered trade secrets that we seek to protect, in part, by entering into non-disclosure and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">confidentiality agreements with parties who have access to them, such as our employees, collaborators, consultants, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advisors, university and/or institutional researchers and other third parties. We also have entered or seek to enter into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">confidentiality and invention or patent assignment agreements with our employees, advisors and consultants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the context of collaboration, partnership or research contracts, or other types of cooperation between us and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">researchers from academic institutions, and with other public or private entities, subcontractors, or any co-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contracting third parties, various information and/or products may be entrusted to them in order to conduct certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tests and clinical trials. In such cases, we require that confidentiality agreements be signed. Furthermore, as a general <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rule, we take care that the collaboration or research contracts that we are party to give us access to full ownership or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">co-ownership of results and/or inventions resulting from the collaboration, or to an exclusive license based on these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results and/or inventions resulting from the collaboration. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Despite these efforts, counterparties may breach our agreements and disclose our proprietary information, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Our trade secrets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may also be obtained by third parties by other means, such as breaches of our physical or computer security systems. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">willing or unwilling to protect trade secrets. Moreover, if any of our trade secrets were to be lawfully obtained or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">independently developed by a competitor, we would have no right to prevent them, or those to whom they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disclosed to, or independently developed by, a competitor, our competitive position would be harmed and our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business may be adversely affected. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There can be no assurance that the agreements put in place to protect our technology and trade secrets and/or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the know-how being used will provide the protection sought or will not be violated, that we will have appropriate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">solutions for such violations, or that our trade secrets will not be disclosed to or independently developed by our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">competitors. In the context of contracts that we enter into with third parties, we sometimes take the precaution of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">providing that they are not authorized to use third-party services or that they may only do so with our prior approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">However, it cannot be ruled out that some of these co-contractors may nevertheless use third parties. In this event, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we have no control over the conditions under which third parties with which we do not contract protect their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">confidential information, irrespective of whether we provide in our agreements with our co-contractors that they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">undertake to pass on confidentiality obligations to their own co-contractors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Such contracts therefore expose us to the risk of having the third parties concerned (i)&#160;claim the benefit of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property rights on our inventions or other intellectual property rights, (ii)&#160;fail to ensure the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">confidentiality of unpatented innovations or improvements of our confidential information and know-how, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(iii)&#160;disclose our trade secrets to our competitors or independently develop these trade secrets and/or (iv)&#160;violate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such agreements, without our having an appropriate solution for such violations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, our rights to our confidential information, trade secrets and know-how may not confer the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected protection against competition and we cannot guarantee with certainty that: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our knowledge and trade secrets will not be obtained, stolen, circumvented, transmitted or used <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">without our authorization; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our competitors have not already developed similar technologies or products, or ones similar in nature <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">or purpose to ours; <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">43<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">no co-contracting party will claim the benefit of all or part of the intellectual property rights relating to <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">inventions, knowledge or results that we hold in our own right or in co-ownership, or for which we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">would be entitled to a license; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our employees will not claim rights or payment of additional compensation or fair price for inventions <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">in the creation of which they participated. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The occurrence of one or more of these risks could have a material adverse effect on our business, outlook, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial position, income and growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Intellectual property rights do not address all potential threats to our competitive advantage. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">property rights have limitations, and may not adequately protect our business, or permit us to maintain our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">competitive advantage. The following examples are illustrative. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Competitors may be able to formulate compositions that are similar to ours but that are not covered by <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">our intellectual property rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Competitors may independently develop similar or alternative compositions or otherwise circumvent <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">any of our applications or registrations without infringing our intellectual property rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 280.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 281.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">We or any of our collaboration partners might not have been the first to conceive and reduce to <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 291.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">practice the inventions covered by the patents or patent applications that we own, license or will own <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 301.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">or license. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 317.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">We or any of our collaboration partners might not have been the first to file patent applications <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 327.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">covering certain of the patents or patent applications that we or they own or have licensed, or will own <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 337.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">or will have licensed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 353.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">It is possible that any pending patent applications that we have filed, or will file, will not lead to issued <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 363.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">patents. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 379.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Issued patents that we own may not provide us with any competitive advantage, or may be held invalid <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 389.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">or unenforceable, as a result of legal challenges by our competitors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 405.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Our competitors might conduct research and development activities in countries where we do not have <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 415.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">patent rights, or in countries where research and development safe harbor laws exist, and then use the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 425.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">information learned from such activities to develop competitive products for sale in our major <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 435.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercial markets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 451.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Ownership of our patents or patent applications may be challenged by third parties. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 467.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">We may infringe on the patents of third parties or pending or future applications of third parties, if <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 477.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">issued, and the patents of third parties or pending or future applications of third parties, if issued, may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 487.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">have an adverse effect on our business. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 515.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risks Related to Legal and Compliance <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 531.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our business is subject to a restrictive and changing regulatory framework. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">One of the major issues for a growing company like ours is to successfully develop, alone or with the help of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">partners, products incorporating our technologies in an increasingly restrictive regulatory environment. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 567.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical industry faces constant changes in its legal and regulatory environment and increased oversight by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 577.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the competent authorities, such as the National Agency for Medicines and Health Products Safety (&#8220;ANSM&#8221;) in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">France, the EMA in the European Union, the FDA in the United States or the PMDA in Japan, and other regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 597.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities in the rest of the world. At the same time, the public is demanding more guarantees and transparency <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 607.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regarding drug safety and efficacy. This may at any time lead to a more restrictive regulatory environment for our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 617.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drug candidates which may have a material adverse effect on business, financial position, income, growth and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 627.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outlook. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 649.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Health authorities oversee preclinical studies, clinical trials, pharmaceutical operations of companies, and drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing, commercialization and distribution. This increasing stringency of the legislative and regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">framework is common worldwide; however, requirements may vary from country to country. In particular, health <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 679.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities, especially the ANSM, EMA, FDA and PMDA, have imposed increasingly burdensome requirements in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 689.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terms of the volume and quality of data required to demonstrate the efficacy and safety of a product. These increased <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 699.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">requirements may have thus reduced the number of products authorized in comparison to the number of applications <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 709.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">filed. The risk/benefit ratio of products on the market is also subject to continuous monitoring and periodic review <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">44<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">after their authorization. The delayed discovery of problems not identified at the research and development or initial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assessment stage can lead at any time to marketing restrictions, suspension of the marketing or withdrawal of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products from the market, and to an increased risk of litigation. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Therefore, the authorization process is long and expensive; it can take many years and the result is not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">predictable and likely to continuously evolve. Insofar as new legal or regulatory provisions would result in an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increase in the requirements and associated costs for obtaining and maintaining product marketing authorizations or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would limit the targeted indications for a product that a product targets or the economic value of a new product to its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inventor, the growth prospects for the pharmaceutical industry, and us, could be reduced. If we experience delays <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completing, or if we terminate early, any of our clinical trials, or if we are required to conduct additional clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials, the commercial prospects for our drug candidates may be harmed and our ability to generate product revenue <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will be delayed. The occurrence of one or more of these risks could have a material adverse effect on our business, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outlook, financial position, income and growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 217.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We are subject to healthcare laws and regulations which may require substantial compliance efforts and could <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expose us to criminal sanctions, civil and administrative penalties, contractual damages, reputational harm and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">diminished profits and future earnings, among other penalties. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Healthcare providers, including physicians, and others will play a primary role in the recommendation and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prescription of our products, if approved. Our arrangements with such persons and third-party payors and our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">general business operations will expose us to broadly applicable fraud and abuse and other healthcare laws and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations that may constrain the business or financial arrangements and relationships through which we research, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market, sell and distribute our drugs, if we obtain marketing approval. Restrictions under applicable U.S. federal, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">state and foreign healthcare laws and regulations include, but are not limited to, the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">knowingly and willfully soliciting, offering, receiving or providing remuneration, including any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">kickback, bribe or rebate, directly or indirectly, in cash or in kind, to induce or reward, or in return for, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">either the referral of an individual for, or the purchase or lease, order or recommendation of, any item, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">good, facility or service, for which payment may be made under federal healthcare programs such as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">specific intent to violate it in order to have committed a violation; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. federal civil and criminal false claims laws and civil monetary penalties laws, including the civil <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">False Claims Act (&#8220;FCA&#8221;), which impose criminal and civil penalties, including those from civil <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">whistleblower or qui tam actions, against individuals or entities for, among other things, knowingly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">presenting, or causing to be presented, claims for payment that are false or fraudulent or making a false <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">statement to avoid, decrease, or conceal an obligation to pay money to the federal government. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">example, pharmaceutical companies have been prosecuted under the FCA in connection with their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">alleged off-label promotion of drugs, purportedly concealing price concessions in the pricing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">information submitted to the government for government price reporting purposes, and allegedly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">providing free product to customers with the expectation that the customers would bill federal health <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">care programs for the product. In addition, the government may assert that a claim including items and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">claim for purposes of the FCA; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the U.S. federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">created additional federal criminal statutes that impose criminal and civil liability for, among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">things, executing or attempting to execute a scheme to defraud any healthcare benefit program or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">knowingly and willingly falsifying, concealing or covering up a material fact or making false <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">statements relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">entity does not need to have actual knowledge of the healthcare fraud statute implemented under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">HIPAA or specific intent to violate it in order to have committed a violation; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;HITECH&#8221;) and its implementing regulations, which impose certain requirements on covered entities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and their business associates, as well as their covered subcontractors, including mandatory contractual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">terms, with respect to safeguarding the privacy, security and transmission of individually identifiable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">health information; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">federal and state consumer protection and unfair competition laws, which broadly regulate marketplace <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">activities and activities that potentially harm consumers; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. federal transparency requirements under the Physician Payments Sunshine Act, enacted as part of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the Affordable Care Act (&#8220;ACA&#8221;), that require applicable manufacturers of covered drugs, devices, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">biologics and medical supplies for which payment is available under Medicare, Medicaid or the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Children&#8217;s Health Insurance Program, with specific exceptions, to track and annually report to <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">45<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Concerned Member States (&#8220;CMS&#8221;) payments and other transfers of value provided to physicians, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">certain other healthcare providers (such as physicians assistants and nurse practitioners), and teaching <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">hospitals, and require certain manufacturers and group purchasing organizations to report annually <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">certain ownership and investment interests held by physicians or their immediate family members; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 116.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 117.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">analogous state or foreign laws and regulations, such as state anti-kickback and false claims laws, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 127.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">which may apply to items or services reimbursed by any third-party payor, including commercial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 137.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">insurers, state marketing and/or transparency laws applicable to manufacturers that may be broader in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 147.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">scope than the federal requirements, state laws that require biopharmaceutical companies to comply <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 157.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">with the biopharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 167.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">guidance promulgated by the federal government and state laws governing the privacy and security of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 177.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">health information in certain circumstances, many of which differ from each other in significant ways <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 187.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and may not have the same effect as HIPAA, thus complicating compliance efforts. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 209.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Ensuring that our business arrangements with third parties comply with applicable healthcare laws and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 219.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations will likely be costly. It cannot be excluded that governmental authorities will conclude that our business <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 229.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 239.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or other healthcare laws and regulations. If our operations were found to be in violation of any of these laws or any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 249.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other governmental regulations that may apply to us, we may be subject to significant civil, criminal and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 259.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">administrative penalties, damages, fines, disgorgement, imprisonment, possible exclusion from government funded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 269.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm, diminished profits <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 279.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and future earnings and curtailment of our operations, any of which could substantially disrupt our operations. If the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 289.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">physicians or other providers or entities with whom we expect to do business are found not to be in compliance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 299.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 309.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">government funded healthcare programs. We may incur significant costs achieving and maintaining compliance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 319.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable federal and state privacy, security, and fraud laws. Any action against us for violation of these laws, even <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 329.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 339.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">attention from the operation of our business. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 367.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Current and future health reform measures could adversely affect our business operations. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 383.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the United States and some foreign jurisdictions there have been, and we expect there will continue to be, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 393.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">several legislative and regulatory changes and proposed reforms of the healthcare system to contain costs, improve <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 403.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">quality, and expand access to care. For example, in March 2010, President Obama signed the ACA into law, which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 413.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">substantially changed the way healthcare is financed by both governmental and private insurers and continues to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 423.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significantly impact the United States pharmaceutical industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 445.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There have been judicial, congressional and executive branch challenges to certain aspects of the ACA. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 455.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example, on June&#160;17, 2021, the United States Supreme Court dismissed a challenge on procedural grounds that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 465.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">argued the ACA is unconstitutional in its entirety because the individual mandate was repealed by Congress. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 475.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Moreover, there have been a number of health reform initiatives that have impacted the ACA. For example, on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 485.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">August&#160;16, 2022, President Biden signed the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;), into law, which among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 495.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">things, extends enhanced subsidies for individuals purchasing health insurance coverage in ACA marketplaces <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 505.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">through plan year 2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 515.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2025 by significantly lowering the beneficiary maximum out-of-pocket cost through a newly-established <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturer discount program. It is unclear how other healthcare reform measures, if any, will impact our business. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For example, on August&#160;2, 2011, the Budget Control Act of 2011 was signed into law which among other things, led <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 567.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to aggregate reductions in Medicare payments to providers. These reductions went into effect on April&#160;1, 2013, and, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 577.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">due to subsequent legislative amendments, will remain in effect until 2032, unless additional Congressional action is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">taken. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to the IRA, there have been several recent U.S. presidential executive orders, congressional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 619.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inquiries and proposed and enacted legislation at the federal and state levels designed to, among other things, bring <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 629.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 639.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reduce the cost of drugs under Medicare, and reform government program reimbursement methodologies for drugs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 649.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For example, on March 11, 2023, the American Rescue Plan Act of 2021 was signed into law, which eliminated the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">statutory Medicaid drug rebate cap, previously set at 100% of a drug&#8217;s average manufacturer price, effective January <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024. Further, on December 7, 2023, the Biden administration announced an initiative to control the price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 679.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prescription drugs through the use of march-in rights under the Bayh-Dole Act. On December 8, 2023, the National <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 689.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Institute of Standards and Technology published for comment a Draft Interagency Guidance Framework for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 699.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Considering the Exercise of March-In Rights which for the first time includes the price of a product as one factor an <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">46<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agency can use when deciding to exercise march-in rights. While march-in rights have not previously been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exercised, it is uncertain if that will continue under the new framework.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">some cases, designed to encourage importation from other countries and bulk purchasing. For example, on January <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">5, 2024, the FDA approved Florida&#8217;s Section 804 Importation Program ("SIP") proposal to import certain drugs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from Canada for specific state healthcare programs. It is unclear how this program will be implemented, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which drugs will be chosen, and whether it will be subject to legal challenges in the United States or Canada. Other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">states have also submitted SIP proposals that are pending review by the FDA. Any such approved importation plans, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">when implemented, may result in lower drug prices for products covered by those programs. If healthcare policies or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reforms intended to curb healthcare costs are adopted, or if we experience negative publicity with respect to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pricing of our products or the pricing of pharmaceutical drugs generally, the prices that we charge for any approved <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products may be limited, our commercial opportunity may be limited and/or our revenues from sales of our products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may be negatively impacted. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We expect that other healthcare reform measures may be adopted in the future, particularly in light of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recent U.S. Presidential and Congressional elections, which may result in more rigorous coverage criteria and in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">additional downward pressure on the price that we receive for any approved product. Any reduction in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement from Medicare or other government programs may result in a similar reduction in payments from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">being able to generate revenue, attain profitability, or commercialize our drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We are subject to anti-corruption laws, as well as export control laws, customs laws, sanctions laws and other <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws governing our operations. If we fail to comply with these laws, we could be subject to civil or criminal <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">penalties, other remedial measures and legal expenses, which could adversely affect our business, results of <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations and financial condition. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are subject to other laws and regulations governing our international operations, including regulations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">administered by the governments of the United States, and authorities in the European Union and in Japan, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable export control regulations, economic sanctions on countries and persons, customs requirements and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">currency exchange regulations, collectively referred to as the trade control laws. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are also subject to anti-corruption laws, including the U.S. Foreign Corrupt Practices Act of 1977, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amended (&#8220;FCPA&#8221;), which prohibits any U.S. individual or business from paying, offering, or authorizing payment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or offering of anything of value, directly or indirectly, to any foreign official, political party, or candidate for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtaining or retaining business, and other state and national anti-bribery and anti-money laundering laws in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">countries in which we conduct activities, including the French anti-corruption laws: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Article 433-1 of the French Criminal Code (bribery of domestic public officials); <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 502.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 503.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Article 433-2 of the French Criminal Code (influence peddling involving domestic public officials); <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 519.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Article 434-9 of the French Criminal Code (bribery of domestic judicial staff); <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 535.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Article 434-9-1 of the French Criminal Code (influence peddling involving domestic judicial staff); <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 551.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Articles 435-1 and 435-3 of the French Criminal Code (bribery of foreign or international public <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 561.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">officials); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 577.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Articles 435-7 and 435-9 of the French Criminal Code (bribery of foreign or international judicial <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">staff); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Articles 435-2, 435-4, 435-8 and 435-10 of the French Criminal Code (active and passive influence <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 613.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">peddling involving foreign or international public officials and foreign or international judicial staff); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 629.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Articles 445-1 and 445-2 of the French Criminal Code (bribery of private individuals); and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 645.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">French Law No.&#160;2016-1691 of December&#160;9, 2016 on Transparency, the Fight Against Corruption and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 655.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the Modernization of the Economy (Sapin 2 Law), which provides for numerous new obligations for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 665.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">large companies such as the obligation to draw up and adopt a code of conduct defining and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 675.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">illustrating the different types of behavior to be proscribed as being likely to characterize acts of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 685.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">corruption or influence peddling, to set up an internal warning system designed to enable the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 695.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">collections of reports from employees relating to the existence of conduct or situations contrary to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 705.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s code of conduct, to set up accounting control procedures, whether internal or external, <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">47<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">designed to ensure that the books, registers and accounts are not used to conceal acts of corruption or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">influence peddling, to set up a disciplinary system for sanctioning company employees in the event of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">a breach of the company&#8217;s code of conduct or a system for monitoring and evaluating the measures <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">implemented. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FCPA also obligates companies whose securities are listed in the United States to comply with accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accounting controls for international operations. Activities that violate the FCPA, even if they occur wholly outside <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the United States, can result in criminal and civil fines, imprisonment, disgorgement, oversight, and debarment from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">government contracts. The scope and enforcement of these laws is uncertain and subject to rapid change. Further, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">enforcement bodies have increased their scrutiny of interactions between healthcare companies and healthcare <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">providers. This has resulted in an increase in the number of investigations, prosecutions, convictions and settlements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the healthcare industry. Responding to investigations can be both resource and time consuming and can divert <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management&#8217;s attention from the business. Any such investigation or settlement could increase our costs or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">otherwise have a material adverse effect on our business, outlook, financial position, income and growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FCPA and other anti-corruption laws are interpreted broadly and prohibit companies and their employees, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agents, contractors, and other collaborators from authorizing, promising, offering, or providing, directly or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">indirectly, improper payments or anything else of value to recipients in the public or private sector. We may engage <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">third parties to sell our products outside the United States, to conduct clinical trials and/or to obtain necessary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">permits, licenses, patent registrations, and other regulatory approvals. We have direct or indirect interactions with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">officials and employees of government agencies or government-affiliated hospitals, universities, and other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">organizations. We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There is no complete assurance that we will be effective in ensuring our compliance with all applicable anti-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corruption laws, including the FCPA, the French anti-corruption laws or other legal requirements, including trade <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control laws. If we are not in compliance with the FCPA, the French anti-corruption laws and other anti-corruption <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws or trade control laws, we may be subject to criminal and civil penalties, disgorgement and other sanctions and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remedial measures and legal expenses, which could have an adverse impact on our business, financial condition, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results of operations and liquidity. Likewise, any investigation of any potential violations of the FCPA, the French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">anti-corruption laws, other anti-corruption laws or trade control laws by U.S. or other authorities could also have an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse impact on our reputation, our business, results of operations and financial condition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, changes in our products and drug candidates or changes in applicable export or import laws and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations may create delays in the introduction or provision of our products and drug candidates in other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions, prevent others from using our products and drug candidates or, in some cases, prevent the export or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">import of our products and drug candidates to certain countries, governments or persons altogether. Any limitation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on our ability to export or provide our products and drug candidates could adversely affect our business, financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">condition and results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Product liability and other lawsuits could divert our resources, result in substantial liabilities and reduce the <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercial potential of our drug candidates. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The risk that we may be sued on product liability claims is inherent in the development and commercialization <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of our drug candidates. Side effects of, or manufacturing defects in, drugs that we develop could result in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deterioration of a patient&#8217;s condition, injury or even death. For example, our liability could be sought after by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients participating in the clinical trials of the drug candidates tested, who suffer from unexpected side effects <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resulting from the administration of these drugs. In addition, we could face liability due to undetected side-effects <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">caused by the interaction of our drugs with other drugs following release of the drug candidate to the market. Once a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product is approved for sale and commercialized, the likelihood of product liability lawsuits increases. Criminal or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">civil proceedings might also be filed against us by patients, regulatory authorities, biopharmaceutical companies and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any other third party using or marketing our drugs. Physicians and patients may not comply with any warnings that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">identify known potential adverse effects and patients who should not use our drug candidates. These actions could <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">include claims resulting from actions by our partners, licensees and subcontractors, over which we have little or no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control. These lawsuits may divert our management from pursuing our business strategy and may be costly to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">defend. In addition, if we are held liable in any of these lawsuits, we may incur substantial liabilities, may be forced <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to limit or forgo further commercialization of the affected products and may suffer damage to our reputation. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We maintain product liability insurance coverage for our clinical trials at levels which we believe are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">appropriate for our clinical trials. Nevertheless, we cannot guarantee that the insurance policy taken out or the <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">48<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">indemnification (that may be contractually limited) granted by our subcontractors will be sufficient to cover the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">claims that could be brought against us or losses we may suffer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If our liability, or that of our partners, licensees and subcontractors, was thereby activated, if we or our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">partners, licensees and subcontractors were unable to obtain and maintain appropriate insurance coverage at an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">acceptable cost or protect ourselves in any way against liability claims, this would seriously affect the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization of our products and, more generally, have a material adverse effect on our business, income, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial position and outlook for growth. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 167.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We and the third parties with whom we work are subject to stringent and evolving U.S. and foreign laws, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations, rules, contractual obligations, industry standards, policies and other obligations <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 454.56pt; position: var(--position); text-decoration: none; white-space: pre;">related to data <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">privacy and security<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 154.68pt; position: var(--position); text-decoration: none; white-space: pre;">. Our (or the third parties with whom we work) actual or perceived failure to comply with <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such obligations could lead to regulatory investigations or actions; litigation (including class claims) and mass <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">arbitration demands; fines and penalties; disruptions of our business operations; reputational harm; loss of <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">revenue or profits; and other adverse business consequences. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the ordinary course of business, we (and others on our behalf) collect, receive, store, process, generate, use, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">transfer, archive, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, process) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personal data and other sensitive information, including proprietary and confidential business data, trade secrets, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property, sensitive third-party data, personal data/personal information (including data we collected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">about trial participants in connection with clinical trials), business plans, transactions, and financial information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(collectively, sensitive data). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our data processing activities subjects us to numerous data privacy and security obligations, such as various <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws, regulations, guidance, industry standards, external and internal privacy and security policies, contractual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">requirements, and other obligations relating to data privacy and security. New data privacy and security laws may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proposed or enacted.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the United States, federal, state, and local governments have enacted numerous data privacy and security <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws, including data breach notification laws, personal data privacy laws, consumer protection laws (e.g., Section&#160;5 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the Federal Trade Commission Act), and other similar laws (e.g., wiretapping laws). For example, the California <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;) requires businesses to provide specific disclosures in privacy notices and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">honor requests of California residents to exercise certain privacy rights. The CCPA provides for civil penalties of up <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to $7,500 per intentional violation and allows private litigants affected by certain data breaches to recover significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">statutory damages.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Other states, such as Virginia, Colorado, Utah and Connecticut have also passed comprehensive privacy laws, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and similar laws are being considered in several other states, as well as at the federal and local levels. While the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">CCPA and other comprehensive U.S. state privacy laws exempt some data processed in the context of clinical trials, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these developments may further complicate compliance efforts and may increase legal risk and compliance costs for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">us and the third parties upon whom we rely. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Outside the United States, an increasing number of laws, regulations, and industry standards may govern data <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">privacy and security. For example, among other laws, the European Union&#8217;s Regulation (EU) 2016/679 of 27 April <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such data, as amended (&#8220;EU GDPR&#8221;), the United Kingdom&#8217;s GDPR (&#8220;UK GDPR&#8221;) (collectively, the EU GDPR and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the UK GDPR are the &#8220;GDPR&#8221;), Brazil&#8217;s General Data Protection Law (Lei Geral de Prote&#231;&#227;o de Dados Pessoais, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;LGPD&#8221;) (Law No.&#160;13,709/2018), Canada&#8217;s Personal Information Protection and Electronic Documents Act <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;PIPEDA&#8221;), and China&#8217;s Personal Information Protection Law (&#8220;PIPL&#8221;) impose strict requirements for processing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personal data. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The collection and use of personal health data in the European Union and the United Kingdom is governed by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the provisions of the GDPR. Under the GDPR, companies may face temporary or definitive bans on data processing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and other corrective actions; fines of up to &#8364;20&#160;million under the EU GDPR, 17.5 million pounds sterling under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UK GDPR or, in each case, 4% of annual global revenue, whichever is greater; or private litigation related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">processing of personal data brought by classes of data subjects or consumer protection organizations authorized at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 644.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">law to represent their interests. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.38pt; position: var(--position); text-decoration: none; white-space: pre;">We<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.24pt; position: var(--position); text-decoration: none; white-space: pre;"> also engage in clinical trial activities in other foreign jurisdictions.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we may be unable to transfer personal data from Europe and other jurisdictions to the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States or other third party countries in which local data privacy laws are less stringent due to limitations on cross-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">border data flows. Europe and other jurisdictions have enacted laws requiring data to be localized or limiting the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">transfer of personal data to other countries. In particular, the European Economic Area ("EEA") and the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kingdom (&#8220;UK&#8221;) have significantly restricted the transfer of personal data to countries whose privacy laws it <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">49<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">believes are inadequate. Other jurisdictions may adopt or have adopted similarly stringent data localization and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cross-border data transfer laws. Although there are currently various mechanisms that may be used to transfer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personal data from the EEA and UK to the United States in compliance with law, such as the EU-U.S. Trans-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Atlantic Data Privacy Framework, the UK&#8217;s International Data Transfer Agreement, or the EEA and UK&#8217;s standard <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contractual clauses, these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rely on these measures to lawfully transfer personal data to the United States or other third party countries. If there is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">no lawful manner for us to transfer personal data from the EEA, the UK, or other jurisdictions to the United States, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business or data processing activities to other jurisdictions at significant expense, increased exposure to regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">parties, and injunctions against our processing or transferring of personal data necessary to operate our business. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Some European regulators have prevented companies from transferring personal data out of Europe for allegedly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">violating the EU GDPR&#8217;s cross-border data transfer limitations. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.22pt; position: var(--position); text-decoration: none; white-space: pre;">Regulators in the United States are also increasingly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">scrutinizing certain personal data transfers and have proposed and enacted certain data transfer requirements or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prohibitions, for example, the Biden Administration&#8217;s executive order Preventing Access to Americans&#8217; Bulk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Sensitive Personal Data and United States Government-Related Data by Countries of Concern.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to data privacy and security laws, we are contractually subject to industry standards adopted by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">industry groups and may become subject to such obligations in the future. Depending upon the context, we may also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be bound by other contractual obligations related to data privacy and security, and our efforts to comply with such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations may not be successful. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We publish and may <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">publish privacy policies, marketing materials, and other statements<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.57pt; position: var(--position); text-decoration: none; white-space: pre;">, such as compliance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with certain certifications or self-regulatory principles, regarding data privacy and security. Regulators in the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States are increasingly scrutinizing these statements, and if these policies, materials or statements are found to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deficient, lacking in transparency, deceptive, unfair, misleading, or misrepresentative of our practices, we may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to investigation, enforcement actions by regulators, or other adverse consequences. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Obligations related to data privacy and security are quickly changing, becoming increasingly stringent, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">creating regulatory uncertainty. Additionally, these obligations may be subject to differing applications and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interpretations, which may be inconsistent or conflict among jurisdictions. Preparing for and complying with these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations requires us to devote significant resources and may necessitate changes to our services, information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technologies, systems, and practices and to those of any third parties that process personal data on our behalf. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We may at times fail (or be perceived to have failed) in our efforts to comply with our data privacy and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">security obligations. Moreover, despite our efforts, our personnel or third parties with whom we work may fail to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">comply with such obligations, which could negatively impact our business operations. If we or the third parties with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">whom we work fail, or are perceived to have failed, to address or comply with applicable data privacy or security <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations, we could face significant consequences, including but not limited to: government enforcement actions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(e.g., investigations, fines, penalties, audits, inspections, and similar); litigation (including class-action claims); and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">mass arbitration demands; additional reporting requirements and/or oversight; bans on processing personal data; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">orders to destroy or not use personal data. Any of these events could have a material adverse effect on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reputation, business, or financial condition, including but not limited to: loss of customers; inability to process <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personal data or to operate in certain jurisdictions; limited ability to develop or commercialize our products; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expenditure of time and resources to defend any claim or inquiry; adverse publicity; or substantial changes to our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business model or operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risks Related to Ownership of Our ADSs and Our Status as a Non-U.S. Company with Foreign Private <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Issuer Status <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">If we do not achieve our projected development and commercialization goals in the timeframes we announce and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expect, our business will be harmed, and the price of our securities could decline as a result. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We sometimes estimate for planning purposes the timing of the accomplishment of various scientific, clinical, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory and other product development objectives. These milestones may include our expectations regarding the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commencement or completion of scientific studies, clinical trials, the submission of regulatory filings, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization objectives. From time to time, we may publicly announce the expected timing of some of these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">milestones, such as the completion of an ongoing clinical trial, the initiation of other clinical programs, receipt of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing approval, or a commercial launch of a product. The achievement of many of these milestones may be <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">50<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outside of our control. All of these milestones are based on a variety of assumptions which may cause the timing of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achievement of the milestones to vary considerably from our estimates, including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our available capital resources or capital constraints we experience; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the rate of progress, costs and results of our clinical trials and research and development activities, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">including the extent of scheduling conflicts with participating clinicians and collaborators, and our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">ability to identify and enroll patients who meet clinical trial eligibility criteria; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our receipt of approvals by the European Commission, FDA and other regulatory agencies and the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">timing thereof; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">other actions, decisions or rules issued by regulators; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our ability to access sufficient, reliable and affordable supplies of compounds and raw materials used <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">in the manufacture of our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the efforts of our collaborators with respect to the commercialization of our products; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the securing of, costs related to, and timing issues associated with, product manufacturing as well as <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">sales and marketing activities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we fail to achieve announced milestones in the timeframes we expect, the commercialization of our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates may be delayed, our business and results of operations may be harmed, and the trading price of the ADSs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may decline as a result. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may be a &#8220;passive foreign investment company&#8221; for U.S. federal income tax purposes, which could result in <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse U.S. federal income tax consequences to U.S. investors. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Generally, if, for any taxable year, at least 75% of our gross income is passive income (&#8220;income test&#8221;), or at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">least 50% of the value of our assets (based on an average of the quarterly values of the assets during a taxable year) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is attributable to assets that produce passive income or are held for the production of passive income, including cash, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we would be characterized as a passive foreign investment company (&#8220;PFIC&#8221;) for U.S. federal income tax purposes. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For purposes of these tests, passive income includes, among other things, dividends, interest, and gains from the sale <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or exchange of investment property and rents or royalties other than rents or royalties which are received from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unrelated parties in connection with the active conduct of a trade or business. Cash and cash equivalents are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generally treated as passive assets. Goodwill is treated as an active asset to the extent associated with business <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">activities that produce active income. For purposes of the PFIC rules, a non-U.S. corporation that owns, directly or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">indirectly, at least 25% by value of the equity interests of another corporation or partnership is treated as if it held its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proportionate share of the assets of the other corporation or partnership, and received directly its proportionate share <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the income of the other corporation or partnership. Equity interests of less than 25% by value in any other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporation or partnership are treated as passive assets, regardless of the nature of the other corporation or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">partnership&#8217;s business. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we are a PFIC for any taxable year in which a U.S. Holder (as defined in Item 10.E. Taxation&#8212;Material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Federal Income Tax Considerations for U.S. Holders) holds an ADS, certain adverse U.S. federal income tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consequences could apply to such U.S. Holder including increased tax liability on disposition gains and certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;excess distributions&#8221; and additional reporting requirements. See Item 10.E. Taxation&#8212;Material U.S. Federal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Income Tax Considerations for U.S. Holders&#8212;Passive Foreign Investment Company Rules. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Based on our analysis of our financial statements, activities and relevant market and shareholder data, we do <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not believe that we were a PFIC for the taxable year ended December 31, 2024. The determination of whether we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are a PFIC is a fact-intensive determination made on an annual basis and the applicable law is subject to varying <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interpretation. Whether we are a PFIC for any taxable year will depend on the composition of our income and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composition, nature and value of our assets from time to time (including the value of our goodwill, which may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">determined by reference to the value of our ADSs, which could fluctuate considerably). We currently do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generate product revenues and therefore we may be a PFIC for any taxable year in which we do not generate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sufficient amounts of non-passive income to offset our passive income. As a result, there can be no assurance that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we will not be treated as a PFIC for the current or any future taxable year and our U.S. counsel expresses no opinion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with respect to our PFIC status for any prior, current or future taxable year. Even if we determine that we are not a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">PFIC for a taxable year, there can be no assurance that the Internal Revenue Service, or the IRS, will agree with our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conclusion and that the IRS would not successfully challenge our position. Each U.S. holder is strongly urged to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consult its tax advisor regarding these issues and any available elections to mitigate such tax consequences.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">51<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">If a United States person is treated as owning at least 10% of the value or voting power of our ADSs, such holder <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may be subject to adverse U.S. federal income tax consequences. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If a United States person is treated as owning (directly, indirectly, or constructively) at least 10% of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">aggregate value or voting power of our ADSs, such person may be treated as a &#8220;United States shareholder&#8221; with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respect to each &#8220;controlled foreign corporation&#8221; in our group (if any), which may subject such person to adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. federal income tax consequences. Our group currently includes one U.S. subsidiary corporation and, therefore, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">under current law our current non-U.S. subsidiary and any future newly formed or acquired non-U.S. subsidiaries <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that are treated as corporations for U.S. federal income tax purposes will be treated as controlled foreign <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporations, regardless of whether we are treated as a controlled foreign corporation. A United States shareholder <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of a controlled foreign corporation generally is required to report annually and include in its U.S. taxable income its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pro rata share of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income,&#8221; and investments in U.S. property by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">controlled foreign corporations, regardless of whether we make any distributions. An individual that is a United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States shareholder with respect to a controlled foreign corporation generally would not be allowed certain tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deductions or foreign tax credits that would be available to a United States shareholder that is a U.S. corporation. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Failure to comply with these reporting obligations may subject a United States shareholder to significant monetary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">penalties and may prevent the statute of limitations with respect to such shareholder&#8217;s U.S. federal income tax return <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the year for which reporting was due from starting. We cannot provide any assurances that we will assist <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">investors in determining whether we are treated as a controlled foreign corporation or whether any holder of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs is treated as a United States shareholder with respect to any such controlled foreign corporation or furnish to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any United States shareholders information that may be necessary to comply with the aforementioned reporting and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tax paying obligations. The United States Internal Revenue Service provided limited guidance on situations in which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">investors may rely on publicly available information to comply with their reporting and tax paying obligations with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respect to foreign-controlled CFCs. Each U.S. holder of our ADSs should consult its advisors regarding the potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">application of these rules to an investment in our ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The rights of shareholders in companies subject to French corporate law differ in material respects from the <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rights of shareholders of corporations incorporated in the United States. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are a French company with limited liability. Our corporate affairs are governed by our by-laws and by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws governing companies incorporated in France. The rights of shareholders and the responsibilities of members of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our Board are in many ways different from the rights and obligations of shareholders in companies governed by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws of U.S. jurisdictions. For example, in the performance of its duties, our Board is required by French law to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consider the interests of our company, its shareholders, its employees and other stakeholders, rather than solely our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders and/or creditors. It is possible that some of these parties will have interests that are different from, or in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition to, your interests as a shareholder or holder of ADSs.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">You may face difficulties protecting your interests, and your ability to protect your rights through the U.S.&#160;federal <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">courts may be limited because we are incorporated under the laws of France, all of our assets are in the <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">European Union and a majority of our directors and executive officers reside outside the United&#160;States. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are constituted under the laws of France. A majority of our officers and directors reside outside the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States. In addition, a substantial portion of their assets and our assets are located outside of the United&#160;States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As a result, you may have difficulty serving legal process within the United&#160;States upon us or any of these persons. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">You may also have difficulty enforcing, both in and outside of the United&#160;States, judgments you may obtain in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S.&#160;courts against us or these persons in any action, including actions based upon the civil liability provisions of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S.&#160;Federal or state securities laws. Furthermore, there is substantial doubt as to the enforceability in France against <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">us or against any of our directors and officers who are not residents of the United&#160;States, in original actions or in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">actions for enforcement of judgments of U.S.&#160;courts, of liabilities based solely upon the civil liability provisions of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the U.S.&#160;federal securities laws. In addition, shareholders in French corporations may not have standing to initiate a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shareholder derivative action in U.S.&#160;federal courts. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As a result, our public shareholders may have more difficulty in protecting their interests through actions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">against us, our management, our directors or our major shareholders than would shareholders of a corporation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">incorporated in a jurisdiction in the United&#160;States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The dual listing of our ordinary shares and the ADSs may adversely affect the liquidity and value of the ADSs. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our ordinary shares are listed on Euronext Paris and our ADSs are listed on the Nasdaq Stock Market. Trading <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the ADSs or ordinary shares in these markets will take place in different currencies (U.S. dollars on Nasdaq and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">euros on Euronext Paris), and at different times (resulting from different time zones, different trading days and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">different public holidays in the United States and France). The trading prices of our ordinary shares on these two <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">markets may differ due to these and other factors. Any decrease in the price of our ordinary shares on Euronext Paris <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">52<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could cause a decrease in the trading price of the ADSs on Nasdaq. Investors could seek to sell or buy our ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares to take advantage of any price differences between the markets through a practice referred to as arbitrage. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Any arbitrage activity could create unexpected volatility in both our share prices on one exchange, and the ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares available for trading on the other exchange. In addition, holders of ADSs will not be immediately able to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">surrender their ADSs and withdraw the underlying ordinary shares for trading on the other market without effecting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">necessary procedures with the depositary. This could result in time delays and additional cost for holders of ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We cannot predict the effect of this dual listing on the value of our ordinary shares and the ADSs. However, the dual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">listing of our ordinary shares and the ADSs may reduce the liquidity of these securities in one or both markets and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may adversely affect the development of an active trading market for the ADSs in the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our by-laws and French corporate law contain provisions that may delay or discourage a takeover attempt. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions contained in our by-laws and French corporate law could make it more difficult for a third party to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">acquire us, even if doing so might be beneficial to our shareholders. In addition, provisions of our by-laws impose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">various procedural and other requirements, which could make it more difficult for shareholders to effect certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporate actions. These provisions include the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">under French law, the owner of 90% of the share capital or voting rights of a public company listed on <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">a regulated market in a Member State of the European Union or in a state party to the EEA Agreement, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">including from the main French stock exchange, has the right to force out minority shareholders <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">following a tender offer made to all shareholders; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">under French law, a non-resident of France as well as any French entity controlled by non-residents of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">France may have to file a declaration for statistical purposes with the Bank of France (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 472.43pt; position: var(--position); text-decoration: none; white-space: pre;">Banque de <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">France<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.9pt; position: var(--position); text-decoration: none; white-space: pre;">) within 20 working days following the date of certain direct foreign investments in us, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">including any purchase of our ADSs. In particular, such filings are required in connection with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">investments exceeding &#8364;15&#160;million that lead to the acquisition of at least 10% of our share capital or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">voting rights or cross such 10% threshold. See &#8220;Limitations Affecting Shareholders of a French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Company&#8221;; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">under French law, certain foreign investments in companies incorporated under French laws are <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">subject to the prior authorization from the French Minister of Economy, where all or part of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">target&#8217;s business and activity relate to a strategic sector, such as energy, transportation, the protection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of public health, telecommunications, research and development in biotechnologies, etc.; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">a merger (i.e.,&#160;in a French law context, a share for share exchange following which our company <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">would be dissolved into the acquiring entity and our shareholders would become shareholders of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">acquiring entity) of our company into a company incorporated in the European Union would require <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the approval of our Board as well as a two-thirds majority of the votes held by the shareholders <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">present, represented by proxy or voting by mail at the relevant meeting; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">a merger of our company into a company incorporated outside of the European Union would require <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">100% of our shareholders to approve it; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">under French law, a cash merger is treated as a share purchase and would require the consent of each <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">participating shareholder; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our shareholders have granted and may grant in the future our Board broad authorizations to increase <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">our share capital or to issue additional ordinary shares or other securities, such as warrants, to our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders, the public or qualified investors, including as a possible defense following the launching <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of a tender offer for our shares; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.94pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our shareholders have preferential subscription rights on a <span style="display: inline-block; height: 6.94pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 361.8pt; position: var(--position); text-decoration: none; white-space: pre;">pro rata<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> basis on the issuance by us of any <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">additional securities for cash or a set-off of cash debts, which rights may only be waived by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">extraordinary general meeting by a two-thirds majority vote of our shareholders or on an individual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">basis by each shareholder; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our Board has the right to appoint directors to fill a vacancy created by the resignation or death of a <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">director, subject to the approval by the shareholders of such appointment at the next shareholders&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">meeting, which prevents shareholders from having the sole right to fill vacancies on our Board; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our Board can be convened by our chairman, including upon request from our Chief Executive Officer <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 130.38pt; position: var(--position); text-decoration: none; white-space: pre;">directeur g&#233;n&#233;ral<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.01pt; position: var(--position); text-decoration: none; white-space: pre;">), if the positions of Chief Executive Officer and Chairman of the Board are not held <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">by the same person, or, when no board meeting has been held for more than two consecutive months, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">from directors representing at least one-third of the total number of directors; <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">53<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our Board meetings can only be regularly held if at least half of the directors attend either physically or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">by way of videoconference or teleconference enabling the directors&#8217; identification and ensuring their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">effective participation in the Board&#8217;s decisions; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our shares are registered or bearer, if the legislation so permits, according to the shareholder&#8217;s choice; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 122.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 123.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">approval of at least a majority of the votes held by shareholders present, represented by a proxy, or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 133.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">voting by mail at the relevant ordinary shareholders&#8217; general meeting is required to remove directors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 143.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">with or without cause; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 159.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">advance notice is required for nominations to the Board or for proposing matters to be acted upon at a <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 169.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; meeting, except that a vote to remove and replace a director can be proposed at any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 179.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; meeting without notice; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 195.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">our by-laws can be changed in accordance with applicable French laws and regulations; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 211.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the crossing of certain thresholds must be disclosed and can impose certain obligations (including <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 221.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">filing a mandatory public tender offer); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 237.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">transfers of shares shall comply with applicable insider trading rules and regulations and, in particular, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 247.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">with the EU Market Abuse Directive and Regulation dated April&#160;16, 2014; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 263.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">pursuant to French law, the sections of our by-laws relating to the number of directors and election and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 273.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">removal of a director from office, may only be modified by a resolution adopted by two-thirds of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 283.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">votes of our shareholders present, represented by a proxy or voting by mail at the meeting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 311.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Existing and potential investors in our ordinary shares or ADSs may have to request the prior authorization from <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 321.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the French Ministry of Economy prior to acquiring an interest in our ordinary shares or ADSs. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 337.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Under French law, direct and indirect acquisition of control of all or part of a branch of activity, or, acting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 347.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">alone or in concert, of more than 25% (10% for investments made by non-EU/EEA investors in companies like ours <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 357.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">whose shares are admitted to trading on a French or EU regulated market) of voting rights of a French company <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 367.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deemed to be active in a strategic industry, by foreign investors is subject to prior authorization of the French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 377.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ministry of Economy pursuant to Articles L. 151-1 et seq. and R. 151-1 et seq. of the French Monetary and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 387.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Code. Industries essential to the protection of public health and research and development activities in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 397.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">biotechnologies are among the categories which fall within the scope of this regulation. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 419.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">If necessary to protect strategic assets, the ministry may oppose to the transaction or condition its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 431.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorization upon the commitment of the investor to certain structural and behavioral remedies that aim at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 443.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintaining strategic activities, knowledge, MAs and intellectual property in France. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 467.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If an investment requiring the prior authorization of the French Minister of Economy is completed without <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 477.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such authorization having been granted, the French Minister of Economy might order the relevant investor to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 487.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(i)&#160;submit a request for authorization, (ii)&#160;have the situation prior to the completion of the investment restored at its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 497.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">own expense or (iii)&#160;amend the investment. Non-compliance with the authorization requirement or breach to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 507.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conditions imposed may expose the relevant investor to a criminal fine which cannot exceed the greater of: (i)&#160;twice <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the amount of the relevant investment, (ii) 10% of the annual turnover before tax of the target company and (iii) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5&#160;million (for an entity) or &#8364;1&#160;million (for an individual). The French Minister of Economy may also adopt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 537.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">precautionary measures it deems necessary to protect strategic sovereign assets, including the suspension of voting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rights or the prohibition or limitation of the distribution of dividends and remuneration attached to shares whose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ownership by the investor should have been subject to prior authorization. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 579.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The non-EU/EEA investors in French companies whose shares are admitted to trading on a French or EU <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 589.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulated market reaching the 10% voting rights threshold benefit from a &#8220;fast-track procedure&#8221; pursuant to which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 599.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the investor is exempt from the authorization request sets forth in Article R. 151-5 of the Monetary and Financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Code, provided that the investment project has been the subject of a prior simplified notification to the French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 619.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Minister of Economy, and the French Minister of Economy did not oppose to the transaction or request to follow the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 629.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">standard authorization process, the transaction can proceed as from ten working days following notification. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 651.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Failure to comply with such measures could result in significant consequences in the concerned investment. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 661.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Such measures could also delay or discourage a takeover or more broadly a foreign investment attempt, and we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 671.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cannot predict whether these measures will result in a lower or more volatile market price of our ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72.25pt; position: var(--position); text-decoration: none; white-space: pre;">You may not be able to exercise your right to vote the ordinary shares underlying your ADSs. <span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">54<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Holders of ADSs may exercise voting rights with respect to the ordinary shares represented by the ADSs only <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in accordance with the provisions of the deposit agreement. The deposit agreement provides that, upon receipt of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">notice of any meeting of holders of our ordinary shares, the depositary will fix a record date for the determination of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADS holders who shall be entitled to give instructions for the exercise of voting rights. Upon timely receipt of notice <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from us, if we so request, the depositary shall distribute to the holders as of the record date (i)&#160;the notice of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">meeting or solicitation of consent or proxy sent by us and (ii)&#160;a statement as to the manner in which instructions may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be given by the holders. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Purchasers of ADSs may instruct the depositary of their ADSs to vote the ordinary shares underlying their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs. Otherwise, purchasers of ADSs will not be able to exercise voting rights unless they withdraw the ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares underlying the ADSs they hold. However, a holder of ADSs may not know about the meeting far enough in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advance to withdraw those ordinary shares. If we ask for a holder of ADSs&#8217; instructions, the depositary, upon timely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">notice from us, will notify him or her of the upcoming vote and arrange to deliver our voting materials to him or her. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We cannot guarantee to any holder of ADSs that he or she will receive the voting materials in time to ensure that he <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or she can instruct the depositary to vote his or her ordinary shares or to withdraw his or her ordinary shares so that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">he or she can vote them. If the depositary does not receive timely voting instructions from a holder of ADSs, it may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">give a proxy to a person designated by us to vote the ordinary shares underlying his or her ADSs. In addition, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">out voting instructions. This means that a holder of ADSs may not be able to exercise his or her right to vote, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">there may be nothing he or she can do if the ordinary shares underlying his or her ADSs are not voted as he or she <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">requested. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Purchasers of ADSs are not holders of our ordinary shares. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A holder of ADSs will not be treated as one of our shareholders and will not have direct shareholder rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">French law governs our shareholder rights. The depositary will be the holder of the ordinary shares underlying ADSs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">held by purchasers of ADSs. Purchasers of ADSs will have ADS holder rights. The deposit agreement among us, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">depositary and purchasers of ADSs, as ADS holders, and all other persons directly and indirectly holding ADSs, sets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">out ADS holder rights, as well as the rights and obligations of the depositary. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A double voting right is attached to each registered ordinary share (except treasury shares) that is held in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">name of the same shareholder for at least two years. However, the ordinary shares underlying our ADSs will not be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entitled to double voting rights as the depositary will hold the ordinary shares underlying our ADSs in bearer form. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The right as a holder of ADSs to participate in any future preferential subscription rights or to elect to receive <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dividends in shares may be limited, which may cause dilution to the holdings of purchasers of ADSs. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">According to French law, if we issue additional securities for cash, current shareholders will have preferential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subscription rights for these securities on a <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 245.43pt; position: var(--position); text-decoration: none; white-space: pre;">pro rata<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.48pt; position: var(--position); text-decoration: none; white-space: pre;"> basis unless they waive those rights at an extraordinary meeting <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of our shareholders by a two-thirds majority vote or individually by each shareholder. However, ADS holders will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not be entitled to exercise or sell such rights unless we register the rights and the securities to which the rights relate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">under the Securities Act or an exemption from the registration requirements is available. In addition, the deposit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreement provides that the depositary will not make rights available to purchasers of ADSs unless the distribution <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to ADS holders of both the rights and any related securities are either registered under the Securities Act or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exempted from registration under the Securities Act. Further, if we offer holders of our ordinary shares the option to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">receive dividends in either cash or shares, under the deposit agreement the depositary may require satisfactory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assurances from us that extending the offer to holders of ADSs does not require registration of any securities under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Securities Act before making the option available to holders of ADSs. We are under no obligation to file&#160;a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">registration statement with respect to any such rights or securities or to endeavor to cause such a registration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">statement to be declared effective. Moreover, we may not be able to establish an exemption from registration under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Securities Act. Accordingly, ADS holders may be unable to participate in our rights offerings or to elect to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">receive dividends in shares and may experience dilution in their holdings. In addition, if the depositary is unable to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sell rights that are not exercised or not distributed or if the sale is not lawful or reasonably practicable, it will allow <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the rights to lapse, in which case you will receive no value for these rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Purchasers of ADSs may be subject to limitations on the withdrawal of the underlying ordinary shares. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Temporary delays in the cancellation of ADSs and withdrawal of the underlying ordinary shares may arise <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">because the depositary has closed its transfer books or we have closed our transfer books, the transfer of ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares is blocked to permit voting at a shareholders&#8217; meeting or we are paying a dividend on our ordinary shares. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition, a holder of ADSs may not be able to cancel his or her ADSs and withdraw the underlying ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">when he or she owes money for fees, taxes and similar charges and when it is necessary to prohibit withdrawals in <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">55<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares or other deposited securities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADS holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could result in less favorable outcomes to the plaintiffs in any such action. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The deposit agreement governing the ADSs representing our ordinary shares provides that, to the fullest extent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">arising out of or relating to our shares, the ADSs or the deposit agreement, including any claim under the U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">federal securities laws. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable state <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with claims arising under the federal securities laws has not been finally adjudicated by the United States Supreme <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Court. However, we believe that a contractual pre-dispute jury trial waiver provision is generally enforceable, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including under the laws of the State of New York, which govern the deposit agreement, by a federal or state court <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the City of New York, which has non-exclusive jurisdiction over matters arising under the deposit agreement. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">determining whether to enforce a contractual pre-dispute jury trial waiver provision, courts will generally consider <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">whether a party knowingly, intelligently and voluntarily waived the right to a jury trial. We believe that this is the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">case with respect to the deposit agreement and the ADSs. It is advisable that you consult legal counsel regarding the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">jury waiver provision before entering into the deposit agreement. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If you or any other holders or beneficial owners of ADSs bring a claim against us or the depositary in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">connection with matters arising under the deposit agreement or the ADSs, including claims under federal securities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws, you or such other holder or beneficial owner may not be entitled to a jury trial with respect to such claims, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which may have the effect of limiting and discouraging lawsuits against us and the depositary. If a lawsuit is brought <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">against either or both of us and the depositary under the deposit agreement, it may be heard only by a judge or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">justice of the applicable trial court, which would be conducted according to different civil procedures and may result <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in different outcomes than a trial by jury would have, including results that could be less favorable to the plaintiffs in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any such action. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Nevertheless, if this jury trial waiver provision is not permitted by applicable law, an action could proceed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">under the terms of the deposit agreement with a jury trial. No condition, stipulation or provision of the deposit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreement or ADSs serves as a waiver by any holder or beneficial owner of ADSs or by us or the depositary of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compliance with U.S. federal securities laws and the rules and regulations promulgated thereunder. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As a foreign private issuer, we are exempt from a number of rules under the U.S. securities laws and are <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">permitted to file less information with the SEC than a U.S. public company. This may limit the information <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">available to holders of ADSs. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are a foreign private issuer, as defined in the SEC&#8217;s rules and regulations and, consequently, we are not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to all of the disclosure requirements applicable to public companies organized within the United States. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example, we are exempt from certain rules under the Exchange Act that regulate disclosure obligations and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">procedural requirements related to the solicitation of proxies, consents or authorizations applicable to a security <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">registered under the Exchange Act, including the U.S. proxy rules under Section&#160;14 of the Exchange Act. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition, our officers and directors are exempt from the reporting and &#8220;short-swing&#8221; profit recovery provisions of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Section&#160;16 of the Exchange Act and related rules with respect to their purchases and sales of our securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Moreover, while we make annual and semi-annual filings with respect to our listing on Euronext Paris, we are not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. public <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">companies and are not required to file quarterly reports on Form&#160;10-Q or current reports on Form&#160;8-K under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Exchange Act. Accordingly, there will be less publicly available information concerning our company than there <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would be if we were not a foreign private issuer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As a foreign private issuer, we are permitted, and we expect, to follow certain home country practices in relation <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to corporate governance matters that differ significantly from Nasdaq&#8217;s corporate governance standards. These <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">practices may afford less protection to shareholders than they would enjoy if we complied fully with the corporate <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">governance standards of the Nasdaq Global Market. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As a foreign private issuer listed on the Nasdaq Global Market, we are subject to Nasdaq&#8217;s corporate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">governance standards. However, Nasdaq rules provide that foreign private issuers are permitted to follow home <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">country corporate governance practices in lieu of Nasdaq&#8217;s corporate governance standards, with certain exceptions, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as long as notification is provided to Nasdaq of the intention to take advantage of such exemptions. We intend to <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">56<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rely on exemptions for foreign private issuers and follow French corporate governance practices in lieu of Nasdaq&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporate governance standards, to the extent possible. Certain corporate governance practices in France, which is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our home country, may differ significantly from Nasdaq corporate governance standards. For example, as a French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company, neither the corporate laws of France nor our by-laws require a majority of our directors to be independent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and we can include non-independent directors as members of our remuneration committee, and our independent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directors are not required to hold regularly scheduled meetings at which only independent directors are present. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are also exempt from provisions set forth in Nasdaq rules which require an issuer to provide in its by-laws <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">stock. Consistent with French law, our by-laws provide that a quorum requires the presence of shareholders having <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">at least (i)&#160;20% of the shares entitled to vote in the case of an ordinary shareholders&#8217; general meeting or at an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extraordinary shareholders&#8217; general meeting where shareholders are voting on a capital increase by capitalization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reserves, profits or share premium, or (ii)&#160;25% of the shares entitled to vote in the case of any other extraordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; general meeting. If a quorum is not present, the meeting is adjourned. There is no quorum requirement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">when an ordinary general meeting is reconvened, but the reconvened meeting may consider only questions which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">were on the agenda of the adjourned meeting. When an extraordinary general meeting is reconvened, the quorum <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">required is 20% of the shares entitled to vote, except where the reconvened meeting is considering capital increases <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">through capitalization of reserves, profits or share premium. For these matters, no quorum is required at the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reconvened meeting. If a quorum is not present at a reconvened meeting requiring a quorum, then the meeting may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be adjourned for a maximum of two months. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As a foreign private issuer, we are required to comply with Rule&#160;10A-3 of the Exchange Act, relating to audit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">committee composition and responsibilities. Under French law, the audit committee may only have an advisory role <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and appointment of our statutory auditors, in particular, must be decided by the shareholders at our annual meeting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Therefore, our shareholders may be afforded less protection than they otherwise would have under Nasdaq&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporate governance standards applicable to U.S. domestic issuers. For an overview of our corporate governance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">practices, see &#8220;Part II&#8212;Item 16G&#8212;Corporate Governance.&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We are an &#8220;emerging growth company&#8221; under the JOBS Act and will be able to avail ourselves of reduced <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disclosure requirements applicable to emerging growth companies, which could make our ADSs less attractive to <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">investors. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and we intend to take advantage of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certain exemptions from various reporting requirements that are applicable to other public companies that are not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;emerging growth companies&#8221;, including not being required to comply with the auditor attestation requirements of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Section&#160;404(b) of the Sarbanes-Oxley Act of 2002 (&#8220;Sarbanes-Oxley Act&#8221;), and exemptions from the requirements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payments not previously approved. In addition, Section&#160;107 of the JOBS Act also provides that an emerging growth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B) of the Securities Act, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for complying with new or revised accounting standards. We will not take advantage of the extended transition <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">period provided under Section&#160;7(a)(2)(B) of the Securities Act for complying with new or revised accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">standards. Since IFRS makes no distinction between public and private companies for purposes of compliance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">new or revised accounting standards, the requirements for our compliance as a private company and as a public <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company are the same. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We cannot predict if investors will find our ADSs less attractive because we may rely on these exemptions. If <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">some investors find our ADSs less attractive as a result, there may be a less active trading market for our ADSs and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the price of our ADSs may be more volatile. We may take advantage of these reporting exemptions until we are no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">longer an emerging growth company. We will remain an emerging growth company until the earliest of (1)&#160;the last <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">day of the fiscal year in which we have total annual gross revenue of $1.235&#160;billion or more; (2)&#160;the last day of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fiscal year following the fifth anniversary of the date of the completion of our U.S. initial public offering and listing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on Nasdaq; (3)&#160;the date on which we have issued more than $1.0&#160;billion in nonconvertible debt during the previous <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">three years; and (4)&#160;the date on which we are deemed to be a large accelerated filer under the rules of the SEC. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may lose our foreign private issuer status in the future, which could result in significant additional cost and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expense. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">While we currently qualify as a foreign private issuer, the determination of foreign private issuer status is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">made annually on the last business day of an issuer&#8217;s most recently completed second fiscal quarter and, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accordingly, the next determination will be made with respect to us on June&#160;30, 2025. In the future, we could lose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our foreign private issuer status if we fail to meet the requirements necessary to maintain our foreign private issuer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">status as of the relevant determination date. We will remain a foreign private issuer until such time that more than <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">57<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applies: (i)&#160;the majority of our executive officers or directors are U.S. citizens or residents; (ii)&#160;more than 50% of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assets are located in the United States; or (iii)&#160;our business is administered principally in the United States. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">additional information relating to our principal shareholders, see Item 7.A Major Shareholders. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significantly more than costs we incur as a foreign private issuer. If we are not a foreign private issuer, we will be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">required to file periodic reports and registration statements on U.S. domestic issuer forms with the SEC, which are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">more detailed and extensive in certain respects than the forms available to a foreign private issuer. We would be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">required under current SEC rules to prepare our financial statements in accordance with U.S.&#160;GAAP, rather than <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS, and modify certain of our policies to comply with corporate governance practices associated with U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">domestic issuers. Such conversion of our financial statements to U.S.&#160;GAAP would involve significant time and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cost. In addition, we may lose our ability to rely upon exemptions from certain corporate governance requirements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on U.S. stock exchanges that are available to foreign private issuers such as the ones described herein and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exemptions from procedural requirements related to the solicitation of proxies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">General Risk Factors <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may not be successful in obtaining or maintaining necessary rights to product components and processes for <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our development pipeline through acquisitions and&#160;in-licenses. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The growth of our business may depend in part on our ability to acquire,&#160;in-license&#160;or use third-party <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proprietary rights. For example, our drug candidates may require specific formulations to work effectively and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">efficiently, we may develop drug candidates containing our compounds and&#160;pre-existing&#160;pharmaceutical compounds, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or we may be required by the FDA or comparable foreign regulatory authorities to provide a companion diagnostic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">test or tests with our drug candidates, any of which could require us to obtain rights to use intellectual property held <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">by third parties. In addition, with respect to any patents we may&#160;co-own&#160;with third parties, we may require licenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to such&#160;co-owner&#8217;s&#160;interest to such patents. We may be unable to acquire or&#160;in-license&#160;any compositions, methods of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">use, processes or other third-party intellectual property rights from third parties that we identify as necessary or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">important to our business operations. In addition, we may fail to obtain any of these licenses at a reasonable cost or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on reasonable terms, if at all. Were that to happen, we may need to cease use of the compositions or methods <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">covered by those third-party intellectual property rights, and may need to seek to develop alternative approaches that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">do not infringe on those intellectual property rights, which may entail additional costs and development delays, even <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">if we were able to develop such alternatives, which may not be feasible. Even if we are able to obtain a license, it <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may be&#160;non-exclusive,&#160;which means that our competitors may also receive access to the same technologies licensed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to us. In that event, we may be required to expend significant time and resources to develop or license replacement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technology. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, we sometimes collaborate with academic institutions to accelerate our preclinical research or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development under written agreements with these institutions. In certain cases, these institutions provide us with an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Even if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we hold such an option, we may be unable to negotiate a license from the institution within the specified timeframe <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rights to others, potentially blocking our ability to pursue our program. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The licensing and acquisition of third-party intellectual property rights is a competitive area, and companies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that may be more established or have greater resources than we do may also be pursuing strategies to license or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates. More established companies may have a competitive advantage over us due to their size, cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resources and greater clinical development and commercialization capabilities. In addition, companies that perceive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">us to be a competitor may be unwilling to assign or license rights to us. There can be no assurance that we will be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">able to successfully complete these types of negotiations and ultimately acquire the rights to the intellectual property <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">surrounding the additional drug candidates that we may seek to develop or market. If we are unable to successfully <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have, we may have to abandon development of certain programs and our business financial condition, results of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations and prospects could suffer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The market price of our equity securities may be volatile, and purchasers of our ADSs could incur substantial <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">losses. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The market price for our ADSs may be volatile. The stock market in general and the market for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">biopharmaceutical companies in particular have experienced extreme volatility that has often been unrelated to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operating performance of particular companies. As a result of this volatility, investors may not be able to sell their <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">58<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs at or above the price originally paid for the security. The market price for our ADSs and ordinary shares may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be influenced by many factors, including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">actual or anticipated fluctuations in our financial condition and operating results; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">actual or anticipated changes in our growth rate relative to our competitors; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">competition from existing products or new products that may emerge; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">ventures, collaborations, or capital commitments; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">failure to meet or exceed financial estimates and projections of the investment community or that we <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">provide to the public; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">issuance of new or updated research or reports by securities analysts; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">fluctuations in the valuation of companies perceived by investors to be comparable to us; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">share price and volume fluctuations attributable to inconsistent trading volume levels of our shares; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">additions or departures of key management or scientific personnel; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">lawsuits threatened or filed against us, disputes or other developments related to proprietary rights, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">including patents, litigation matters, and our ability to obtain patent protection for our technologies; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">changes to coverage policies or reimbursement levels by commercial third-party payors and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">government payors and any announcements relating to coverage policies or reimbursement levels; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">announcement or expectation of additional debt or equity financing efforts; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">sales of our ordinary shares or ADSs by us, our insiders or our other shareholders; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">general economic and market conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">These and other market and industry factors may cause the market price and demand for our ADSs to fluctuate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">substantially, regardless of our actual operating performance, which may limit or prevent investors from readily <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">selling their ADSs and may otherwise negatively affect the liquidity of the trading market for our ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business, the price of our ADSs and their trading volume could decline. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The trading market for our ADSs depends in part on the research and reports that securities or industry <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">analysts publish about us or our business. If no or few securities or industry analysts cover our company, the trading <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price for our ADSs would be negatively impacted. If one or more of the analysts who covers us downgrades our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">equity securities or publishes incorrect or unfavorable research about our business, the price of our ADSs would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">likely decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regularly, or downgrades our securities, demand for our ADSs could decrease, which could cause the price of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs or their trading volume to decline. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The requirements of being a U.S. public company may strain our resources and divert management&#8217;s attention. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are required to comply with various corporate governance and financial reporting requirements under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley Act, the Exchange Act, Nasdaq listing rules, and the rules and regulations adopted by the SEC and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Public Company Accounting Oversight Board, in addition to operating as a dual-listed company in France. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Further, compliance with various regulatory reporting requires significant commitments of time from our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management and our directors, which reduces the time available for the performance of their other responsibilities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our failure to track and comply with the various rules may materially adversely affect our reputation, ability to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtain the necessary certifications to financial statements, lead to additional regulatory enforcement actions, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">could adversely affect the value of our ordinary shares or ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 639.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We may be at an increased risk of securities class action litigation. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Historically, securities class action litigation has often been brought against a company following a decline in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the market price of its securities. This risk is especially relevant for us because biotechnology and biopharmaceutical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">companies have experienced significant share price volatility in recent years. If we were to be sued, it could result in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">substantial costs, which could be insufficiently covered by insurance, and a diversion of management&#8217;s attention and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resources, which could harm our business. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">59<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We do not currently intend to pay dividends on our securities and, consequently, your ability to achieve a return <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on your investment will depend on appreciation in the price of the ordinary shares and our ADSs. In addition, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">French law may limit the amount of dividends we are able to distribute. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have never declared or paid any cash dividends on our ordinary shares and do not currently intend to do so <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the foreseeable future. We currently intend to invest our future earnings, if any, to fund our growth. Therefore, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">you are not likely to receive any dividends on your ADSs for the foreseeable future and the success of an investment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in ADSs will depend upon any future appreciation in its value. Consequently, investors may need to sell all or part <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of their holdings of ADSs after price appreciation, which may never occur, as the only way to realize any future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">gains on their investment. There is no guarantee that the ADSs will appreciate in value or even maintain the price at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which our shareholders have purchased them. Investors seeking cash dividends should not purchase our ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Furthermore, certain of our debt instruments restrict the payment of dividends or require consent to pay dividends. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">See &#8220;Item 8.A Consolidated Statements and Other Financial Information&#8212;Dividend Policy.&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Further, under French law, the determination of whether we have been sufficiently profitable to pay dividends <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is made on the basis of our statutory financial statements prepared and presented in accordance with accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">standards applicable in France. In addition, payment of dividends may subject us to additional taxes under French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">law. Therefore, we may be more restricted in our ability to declare dividends than companies not based in France. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, exchange rate fluctuations may affect the amount of euros that we are able to distribute, and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amount in U.S. dollars that our shareholders receive upon the payment of cash dividends or other distributions we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">declare and pay in euros, if any. These factors could harm the value of our ADSs, and, in turn, the U.S. dollar <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceeds that holders receive from the sale of our ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">60<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_40"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 4.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Information on the Company.<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i5127f6dc71a24d80a1730fb78265c265"></span></span></div><div style="position: absolute; top: 96pt;" id="ia894b143b6fc4522a0483350194c625e_43"></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="i36033099bece49e3acf656780e01d227"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">History and Development of the Company<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our legal and commercial name is Abivax SA. We were incorporated as a <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 395.01pt; position: var(--position); text-decoration: none; white-space: pre;">soci&#233;t&#233; anonyme<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.31pt; position: var(--position); text-decoration: none; white-space: pre;"> (limited liability <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company) under the laws of France on December&#160;4, 2013 for a period of 99 years until December 22, 2112, subject <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to extension or early dissolution and registered at the Paris Trade and Company Register on December&#160;27, 2013 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">under the number 799&#160;363&#160;718. Our principal executive offices are located at 7-11 boulevard Haussmann 75009 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Paris, France, and our telephone number is +33&#160;(0)&#160;1&#160;53&#160;83&#160;09&#160;63. We have one wholly owned subsidiary, Abivax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">LLC, a Delaware limited liability company, formed on March 20, 2023. Our agent for service of process in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">United States is CT Corporation System, 1015 15th Street N.W., Suite 1000, Washington, D.C. 20005. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">We have <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.22pt; position: var(--position); text-decoration: none; white-space: pre;">been<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.07999999999998pt; position: var(--position); white-space: pre;"> listed on Euronext Paris since June 2015. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">In October 2023, we completed the initial public <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">offering of our ordinary shares in the form of ADSs on the Nasdaq Global Market, raising approximately $235.8 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million in gross proceeds (equivalent to approximately &#8364;223.3 million based on the exchange rate then in effect), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inclusive of proceeds from our concurrent private placement of ordinary shares in certain jurisdictions outside of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">United States.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We did not incur any material capital expenditures for the years ended December 31, 2024, 2023 and 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The SEC maintains an Internet site that contains reports, proxy information statements and other information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regarding issuers that file electronically with the SEC. The address of that site is http://www.sec.gov. Our website <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">address is www.abivax.com. The reference to our website is an inactive textual reference only and information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contained in, or that can be accessed through, our website or any other website cited in this annual report is not part <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of this annual report.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 324pt;" id="ia894b143b6fc4522a0483350194c625e_46"></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="ie94f07b3593b445891596ecdd4869506"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Business Overview<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are a clinical-stage biotechnology company focused on developing therapeutics that harness the body&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. We <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are currently evaluating our lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with moderately to severely active ulcerative colitis (&#8220;UC&#8221;). We have also initiated a Phase 2b clinical trial of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod in patients with Crohn&#8217;s disease (&#8220;CD&#8221;), with our first patient enrolled in October 2024, and we are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evaluating other potential inflammatory indications. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We focus on indications where existing treatments have left patients with significant unmet needs, and where <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we believe our investigational agents have the potential to be meaningfully differentiated from currently available <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies. The indications we target have substantial populations and represent large commercial opportunities, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pending regulatory approvals and successful commercialization. Our initial focus is on inflammatory bowel diseases <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;IBD&#8221;), chronic conditions involving inflammation of the gastrointestinal (&#8220;GI&#8221;) tract, of which the two most <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">common forms are UC and CD.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> As of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.61pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.61pt; position: var(--position); text-decoration: none; white-space: pre;">, an aggregate of approximately 3.6&#160;million patients across the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States, EU4 (France, Germany, Italy and Spain), the United Kingdom and Japan suffered from IBD, with 1.4&#160;million <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of these patients in the United States alone. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">One of the primary goals of IBD therapy is to achieve durable&#160;clinical remission while simultaneously taking <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">into consideration a patient&#8217;s quality of life and concerns regarding potential side effects. Despite a number of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">different therapies approved for UC and CD, the vast majority of these therapies require chronic administration via <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">injections or intravenous infusions, and may come with serious and concerning warnings, including, but not limited <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to, risks of serious infections leading to hospitalizations or death and increased risks of various malignancies. A vast <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">majority of IBD patients do not achieve clinical remission with existing therapies, and a significant number of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients will lose response over time, especially those patients on TNF-alpha inhibitor therapy where anti-drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">antibodies are common. Further, despite the increased number of biosimilars, such as TNF-alpha inhibitor therapies, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">becoming available for the treatment of IBD, biosimilars unfortunately do not alleviate any of the potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">side&#160;effect concerns that often cause patients to delay, or avoid altogether, stepping up to more advanced therapies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, although a small number of oral therapies have more recently been approved for the treatment of IBD, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these therapies also come with concerning potential side effects and/or extensive pre-initiation exams, which can <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discourage patients from initiating treatment with advanced therapies. Therefore, there continues to be significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unmet need for novel oral therapies with durable efficacy, improved safety profiles and minimal preinitiation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">requirements for patients with moderately to severely active IBD. Moreover, we believe the IBD market has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant growth potential driven by growing diagnosis of these diseases and increased penetration of oral <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatments with improved benefit/risk profiles. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">61<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We believe our lead drug candidate, obefazimod, is differentiated from competing approaches for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatment of IBD via its novel mechanism of action. Obefazimod was demonstrated to specifically enhance the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expression of a single micro-RNA, miR-124, which plays a critical role in the regulation of the inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">response. In the context of inflammation, miR-124 is a natural regulator of the inflammatory response, controlling <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">progression of inflammation and stabilizing the immune system, without causing broader immunosuppression. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contrast to currently available advanced therapies, prescribed post-conventional therapies, some of which target only <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a single cytokine or pathway, miR-124 modulates the expression of several key cytokines and pathways. Modulating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">multiple inflammatory pathways simultaneously may lead to more durability of efficacy results over the long-term, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which is critical in lifelong conditions such as IBD, potentially differentiating obefazimod from currently available <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">IBD treatments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In our Phase 2 clinical trials for the treatment of moderately to severely active UC, consistent with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pharmacological effects observed in our preclinical studies, obefazimod demonstrated an onset of symptom relief by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">day 8 of dosing, with meaningful reductions in rectal bleeding and stool frequency scores. In our Phase 2b induction <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trial, which included 252 patients, obefazimod met the primary endpoint of a statistically significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reduction in Modified Mayo Score, a measure of disease activity relative to placebo. In addition, we observed high <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rates of sustained and newly achieved clinical remission in the subsequent open-label maintenance extension trial of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">up to two years of treatment, of which approximately 45% of patients were previously exposed to biologics or Janus <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">kinase (&#8220;JAK&#8221;) inhibitors. Greater than 90% of patients previously exposed to advanced therapy prior to enrollment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">were highly refractory, having failed two or more advanced therapies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In April 2023, we reported the results from the final analysis of our Phase 2b open-label maintenance trial, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including 217 patients of which 164 patients (76%) completed the second year of once-daily oral treatment with 50 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">mg obefazimod. At the conclusion of the second year of treatment, 114 of the 217 patients enrolled (53%) achieved <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical remission and 158 patients (73%) achieved clinical response. Among the 98 bio-refractory patients, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">66&#160;patients (67%) had a clinical response, 38 patients (39%) were in clinical remission, 46&#160;patients (47%) had <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopic improvement and 20&#160;patients (20%) had endoscopic remission at week&#160;96. Among the 124&#160;patients that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achieved clinical response at the end of the 8-week induction period of the double-blind study, 82 patients (66%) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achieved clinical remission at week 48, mimicking the re-randomization of responders approach typically utilized in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 maintenance trials. Of the 124 patients in clinical response at week 8, 74 patients (60%) achieved clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remission, 95 patients (77%) had clinical response, 79 patients (64%) achieved endoscopic improvement and 52 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients (42%) achieved endoscopic remission at week 96. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In October 2024, we announced the results of an interim efficacy and safety analysis of an open-label <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintenance ("OLM") trial that enrolled patients with UC at the conclusion of the Phase 2a and Phase 2b OLM <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials, where they had received obefazimod 50 mg once daily. The data demonstrated maintenance of clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remission and a safety profile consistent with prior trials of oral, once-daily obefazimod when administered at a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reduced dose of 25 mg for up to an additional two years. In this OLM trial, patients who had completed the four-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">year Phase 2a or two-year Phase 2b OLM trials, where they had received 50 mg of once-daily obefazimod, were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">given the opportunity to continue receiving obefazimod at a reduced dose of 25 mg daily for up to five additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">years (provided they met the eligibility criteria of Mayo Endoscopic Subscore of 0 or 1). A total of 130 patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entered the trial. As of September 11, 2024, the data cut-off date, 113 patients have been evaluated out to 48 weeks <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and 74 patients have undergone the full 96-week evaluation. At trial baseline, 89% (116/130) of patients were in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical remission. At weeks 48 and 96 of treatment, 84% (95/113) and 87% (64/74) of patients evaluated were in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical remission, respectively. Similarly, 92% (119/130) of patients were in symptomatic remission at trial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">baseline. At weeks 48 and 96, 91% (103/113) and 92% (68/74) of patients evaluated were in symptomatic remission, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respectively. Similar trends were observed with other efficacy analyses.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod&#8217;s tolerability profile indicates potentially important clinical differentiation. As of the data cutoff <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">date (of November 30, 2024), 1,300 patients have received obefazimod in all completed and ongoing clinical trials <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">across all indications, including 97 patients for longer than six months and 241 patients for longer than one year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, 765 patients have received only blinded obefazimod or placebo in the ABTECT program or Phase 2b <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trial in CD, of which 160 patients received treatment for longer than six months and 66 patients for longer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">than one year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We initiated our pivotal Phase 3 clinical trials of obefazimod for the treatment of moderately to severely active <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UC in October 2022, which consist of two induction trials (ABTECT-1 and ABTECT-2) and one ABTECT <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintenance trial. Top-line data from the ABTECT-1 and ABTECT-2 induction trials is expected to be announced <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.27pt; position: var(--position); text-decoration: none; white-space: pre;">the third quarter of 2025, and top-line data from the ABTECT maintenance trial is expected to be announced in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the second quarter of 2026<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.57pt; position: var(--position); text-decoration: none; white-space: pre;">. Our Investigational New Drug application (&#8220;IND&#8221;) for a Phase 2b clinical trial in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients with CD was cleared by the FDA in the fourth quarter of 2023, and we initiated enrollment in October of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024. We intend to announce Phase 2b induction trial top-line results in the second half of 2026 with the objective to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">demonstrate clinical response and tolerability profile consistent with that already observed in our clinical trials for <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">62<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">moderately to severely active UC. Based on the results from this Phase 2b clinical trial, if positive, we intend to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceed to a Phase 3 clinical trial. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 105.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 106.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our Pipeline <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our lead drug candidate, obefazimod, is in clinical development for the treatment of moderately to severely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">active UC. We are continuing to develop obefazimod for the treatment of CD and are evaluating additional potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory indications to pursue, subject to the availability of necessary resources and funding. In parallel, we are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the process of generating follow-on compounds based on the miR-124 platform. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The chart below sets forth detail<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.49pt; position: var(--position); text-decoration: none; white-space: pre;">s relating to the current stages of development o<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 417.48pt; position: var(--position); text-decoration: none; white-space: pre;">f our lead drug candid<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.73pt; position: var(--position); text-decoration: none; white-space: pre;">ate: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 220.5pt; width: 612pt;"><div style="left: 72pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g1.jpg" alt="ABTECT Trial Timeline.jpg" style="height: 171.87pt; width: 468pt;"/></div></div></div><div style="position: var(--position); top: 413.37pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 431.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 26.68pt;"></span></span><span style="left: 114.1pt; position: var(--position);">Decision subject to results of the Phase 3 monotherapy induction trials. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 457.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">IBD Overview and Limitations of Existing Treatments <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 473.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">IBD, such as UC and CD, is a chronic life-long immune-mediated inflammatory condition of the GI tract with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 483.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">many contributing factors, including genetic, environmental and immunologic. UC and CD are the two most <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 493.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">common forms of IBD and are characterized by dysregulation of lymphocytes contributing to inflammation. Both <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 503.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UC and CD are chronic, relapsing, remitting, inflammatory conditions of the GI tract that begin most commonly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 513.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">during adolescence and young adulthood. UC involves the innermost lining of the large intestine, and symptoms <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 523.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">include abdominal pain and diarrhea, frequently with blood and mucus. CD can affect the entire thickness of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 533.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bowel wall and all parts of the GI tract from mouth to anus. CD symptoms include abdominal pain, diarrhea and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 543.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other more systemic symptoms, such as weight loss, nutritional deficiencies and fever. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">IBD, as of 2024, affected approximately 1.4&#160;million patients in the United States alone. As of 2024, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prevalence of UC and CD in the United States were estimated at approximately 0.8&#160;million and 0.6&#160;million patients, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respectively. The prevalence of IBD in the EU4 and the United Kingdom is estimated at 2&#160;million with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 1.2&#160;million patients with UC and 0.8&#160;million patients with CD. As of 2024, an aggregate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 3.6&#160;million patients across the United States, EU4, the United Kingdom and Japan suffered from IBD. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 615.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">This figure is expected to grow to approximately 3.7 million patients by 2030. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 637.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">One of the primary goals of IBD therapy is to achieve durable&#160;clinical remission while simultaneously taking <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 647.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">into consideration a patient&#8217;s quality of life and concerns regarding potential side effects. Despite a number of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">different therapies approved for UC and CD, the vast majority of these therapies require chronic administration via <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">injections or intravenous infusions, and may come with serious and concerning warnings, including, but not limited <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to, risks of serious infections leading to hospitalizations or death and increased risks of various malignancies. A vast <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">majority of IBD patients do not achieve clinical remission with existing therapies, and a significant number of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients will lose response over time, especially those patients on TNF-alpha inhibitor therapy where anti-drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 707.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">antibodies are very common. Further, despite the increased number of biosimilars, such as TNF-alpha inhibitor <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">63<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies, becoming available for the treatment of IBD, biosimilars unfortunately do not alleviate any of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">potential side&#160;effect concerns that often cause patients to delay, or avoid altogether, stepping up to more advanced <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies. In addition, although a small number of oral therapies have more recently been approved for the treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of IBD, these therapies also come with concerning potential side effects, which can also discourage patients from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">initiating treatment with advanced therapies. Therefore, there continues to be significant unmet need for novel oral <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies with durable efficacy, improved safety profiles and minimal preinitiation requirements for patients with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">moderately to severely active IBD. Moreover, we believe the IBD market has significant growth potential driven by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">growing diagnosis of these diseases and increased penetration of oral treatments with improved benefit/risk profiles. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In 2024, pharmaceutical sales in IBD were $16.2&#160;billion in the United States and $7.6&#160;billion in the rest of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">world, totaling $23.7&#160;billion worldwide. In 2030, pharmaceutical sales in IBD are estimated to be $21.5&#160;billion and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">$30.8&#160;billion in the United States and worldwide, respectively. Worldwide sales in the UC market were $8.3&#160;billion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in 2024 and are estimated to be $12.7&#160;billion in 2030, while in the CD market worldwide sales reached $15.4&#160;billion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in 2024 and are estimated to be $18.1&#160;billion in 2030. We believe the IBD market has significant growth potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">driven by growing diagnosis of these diseases and increased penetration of oral treatments with improved benefit/<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk profiles. We believe the potential for oral agents to gain significant market share is supported by physician and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patient preference for the convenience of oral administration over injectable agents, increasing demand for therapies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with long-term efficacy profiles and the opportunity for potent and well-tolerated oral agents to expand the overall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">segment of the moderately to severely active UC population undergoing treatment. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Medical treatment of IBD is typically divided into two types of therapy: induction and maintenance. Induction <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapy is used to reduce inflammation quickly (in three months or less) and maintenance therapy is used to sustain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that reduction. Patients with IBD are classified by the activity of their disease as either mild to moderately active or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">moderately to severely active based on the level of symptoms experienced, inflammatory biomarkers and severity of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disease on endoscopy. The current standard of care for the treatment of patients with moderately to severely active <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">IBD is to reduce inflammation with anti-inflammatory agents. Patients with mild to moderately active IBD are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treated with so-called &#8220;conventional therapies&#8221; which are anti-inflammatory treatments that include: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">aminosalicylates (e.g., 5-ASAs), immunosuppressants or immunomodulators (e.g., 6-mercaptopurine, methotrexate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and azathioprine) and corticosteroids. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Despite the widespread use of conventional therapies to treat mild to moderately active IBD, due to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">progressive and lifelong nature of both UC and CD, for many patients the severity of their disease progresses in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">activity and are considered moderately to severely active. This requires patients and their physicians to consider <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">using more targeted therapies typically termed &#8220;advanced therapies.&#8221; The majority of advanced therapies require <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">chronic parenteral administration including TNF-alpha inhibitors (e.g., infliximab, adalimumab and golimumab), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Interleukin (&#8220;IL&#8221;)-12/23 inhibitor (ustekinumab), anti-integrin antibodies (vedolizumab) or IL-23 inhibitors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(mirikizumab, guselkumab, risankizumab). There are also two classes of oral treatments including JAK inhibitors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(e.g., tofacitinib, filgotinib and upadacitinib) and sphingosine-1-phosphate (&#8220;S1P&#8221;) receptor agonists (ozanimod). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Although these therapies have demonstrated efficacy in UC and/or CD, the majority of IBD patients do not achieve <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical remission, and a significant number of patients lose response over time, especially those treated with TNF-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">alpha inhibitor therapies where anti-drug antibodies are common. Due to mechanisms of action that are poorly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">understood, with each line of advanced therapy that is exhausted, patients become less likely to respond to the next <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advanced therapy utilized in the sequence of care. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Each of the advanced therapy classes are associated with notable side effect and safety tradeoffs that must be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">considered before initiating treatment. For instance: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: underline; white-space: pre;">TNF-alpha inhibitors<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.69pt; position: var(--position); text-decoration: none; white-space: pre;">: Boxed warnings for increased risk of serious infections leading to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">hospitalizations or death and various forms of malignancies are noted in the United States prescribing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">information with similar warnings in the European Medicines Agency (&#8220;EMA&#8221;) summary of product <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">characteristics (&#8220;SmPCs&#8221;). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: underline; white-space: pre;">IL-12/23 inhibitors<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.38pt; position: var(--position); text-decoration: none; white-space: pre;">: Warnings in label for serious infections, tuberculosis, malignancies and posterior <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">reversible encephalopathy syndrome (PRES). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 616.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 617.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: underline; white-space: pre;">Anti-integrin antibodies<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.76999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">: Warnings in label for potential risk of Progressive Multifocal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 627.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Leukoencephalopathy (&#8220;PML&#8221;), gut specificity of vedolizumab may be connected with exacerbating or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 637.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">causing extraintestinal manifestations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 653.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: underline; white-space: pre;">IL-23 inhibitors<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.61pt; position: var(--position); text-decoration: none; white-space: pre;">: Warnings in labels include serious allergic reactions and infections with mirikizumab <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 663.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and risankizumab having a hepatotoxicity warning as well.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 679.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: underline; white-space: pre;">JAK inhibitors<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.18pt; position: var(--position); text-decoration: none; white-space: pre;">: Boxed warnings for increased risk of serious infections leading to hospitalization or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 689.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">death, higher rates of all-cause mortality, malignancies, cardiovascular death, myocardial infarction, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 699.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">stroke and thrombosis appear in the United States prescribing information with similar warnings in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 709.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">EU. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">64<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: underline; white-space: pre;">S1P receptor agonists<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.64pt; position: var(--position); text-decoration: none; white-space: pre;">: Warnings in label for infections, bradyarrhythmia and atrioventricular <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">conduction delays, liver injury and macular edema. These warnings result in multiple preinitiation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">requirements prior to initiating therapy. Risk of PML also exists. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Patients and physicians must take into consideration the lifelong burden of chronic parenteral administration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for injectable agents and the potential safety warnings for all therapies when deciding which treatment, if any, to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">initiate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following chart depicts the current UC treatment landscape: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 178pt; width: 612pt;"><div style="left: 72pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g2.jpg" alt="UC Treatment Paradigm w Disease Progression.jpg" style="height: 212.42pt; width: 468pt;"/></div></div></div><div style="line-height: 10pt; position: var(--position); top: 407.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For patients who do not or no longer respond to treatment, or experience complications, surgical treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 417.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may be necessary. Approximately 50% to 80% of CD patients and 10% to 30% of UC patients require surgery over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 427.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their lifetime. In light of the above, we believe that there is significant unmet medical need in the UC treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 437.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">paradigm due to imperfect existing therapies with unfavorable clinical characteristics and limited efficacy that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 447.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">frequently wanes over time. A general patient preference for oral agents over injectables suggests a potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 457.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">untapped market opportunity available for efficacious, well-tolerated oral therapies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 485.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our Strategy <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 501.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our primary goal is to develop and commercialize obefazimod for the treatment of inflammatory diseases, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 511.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">starting with moderately to severely active UC and CD. We focus on indications with high unmet needs with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 521.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">substantial commercial potential. To achieve our goal, we are pursuing the following key elements of our strategy: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 537.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 127.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Advance obefazimod through pivotal clinical trials and establish obefazimod as a potential first-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">line advanced therapy for IBD.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.46pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 563.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">We believe that the strength of the data we have generated in our Phase 2 clinical trials, specifically <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 573.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the potential to demonstrate rapid onset of action and durability of safety and efficacy results (as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 583.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">evidenced by a clinical remission rate of 53%, clinical response rate of 73% and no new adverse safety <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 593.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">signals observed from our two-year Phase 2b open-label maintenance trial), if supported by the results <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of our Phase 3 clinical trials, uniquely positions obefazimod as a potential first-line advanced therapy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 613.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">choice for moderately to severely active UC, if approved. We believe our data, if supported by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 623.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">results of our Phase 3 clinical trials with an expected induction data-read out in the third quarter of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 633.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">2025, well-positions obefazimod as a potential first-line advanced therapy choice for moderately to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 643.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">severely active UC, if approved. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Based on the positive clinical data generated in our UC trials, preclinical studies in dextran sulfate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">sodium (&#8220;DSS&#8221;) mouse model which provide support for pursuing further development in CD, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 679.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">underlying biological and mechanistic rationale, we initiated a Phase 2b clinical trial in patients with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 689.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">CD in the fourth quarter of 2024, with a planned top-line data read-out in the second half of 2026, to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 699.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">potentially demonstrate outcomes consistent with those observed in our Phase 2 clinical trials for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 709.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">moderately to severely active UC. CD causes long-lasting inflammation and ulcers in the digestive <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">65<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">tract, with fibrosis and stricturing, playing a key role in disease progression. It differs from UC in that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">it affects the entire thickness of the bowel wall and all parts of the digestive tract from mouth to anus. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">However, CD shares many of the underlying pathophysiological processes and clinical manifestations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of UC, and, as a result, the current treatment paradigm of CD is similar to UC, as described further <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">below. In addition, we believe that obefazimod&#8217;s clinical profile observed to-date lends itself to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">potential combinations with existing or new therapies, which we are exploring. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 127.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Potential Combination Therapy in IBD with obefazimod.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.96999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Currently available therapies have limited efficacy and durability that wanes over time, have extensive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">pre-initiation requirements, carry significant safety and tolerability challenges (such as black box <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">safety warnings), and many of them are injectable biologics. We believe several of obefazimod&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">attributes make it a potentially attractive candidate to pair with other advanced treatments. First, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">oral route of administration is preferred by a majority of patients, potentially resulting in higher levels <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of medication adherence. Further, obefazimod&#8217;s proposed mechanism of action harnesses the body&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">diseases. The novel mechanism of action of obefazimod potentially lends itself as complementary to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">other oral or injectable agents with the potential of improving the induction and remission efficacy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">over monotherapy. We have initiated a formal process evaluating oral and injectable combination <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">therapy candidate with obefazimod in UC. In September 2024, we announced results of initial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">preclinical combination data of obefazimod combined with etrasimod in a mouse model of IBD. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">results showed that treatment with the combination improved the response on body weight protection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and Disease Activity Index, and a synergistic and statistically significant reduction of several cytokines <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">(TNFa, IL-17, IL-6, IFNg) in the blood compared to each drug alone. Additional preclinical data to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">support our decision-making on a combination agent is expected in 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 127.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Leverage library of miR-124 enhancers to expand our pipeline in chronic inflammatory diseases.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.66pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Based on the mechanistic concept of obefazimod, we have launched a research and development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">program to generate new potential drug candidates to strengthen our intellectual property portfolio on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the miR-124 platform and to identify additional drug candidates from our proprietary small molecule <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">library that includes additional miR-124 enhancers. We expect to announce an obefazimod follow-on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">candidate selection <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.8pt; position: var(--position); text-decoration: none; white-space: pre;">during <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.39999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.39999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 127.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Opportunistically evaluate strategic partnerships to maximize the value of obefazimod and our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">therapeutic pipeline.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.73000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">We have discovered and are developing obefazimod as an innovative medicinal product and we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">currently hold its worldwide rights. We intend to retain worldwide development and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization rights for obefazimod. For certain geographies, we may opportunistically enter into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">strategic partnerships to accelerate development activities in order to realize the commercial potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of obefazimod as well as other assets in our pipeline. In connection with any potential strategic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">partnership, we plan to pursue and receive upfront funding, milestone payments and future royalties <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">for these agreements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our Programs <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our lead drug candidate, obefazimod, is in clinical development for the treatment of moderately to severely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">active UC. We are continuing to develop obefazimod for the treatment of CD and are evaluating additional potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory indications to pursue, subject to the availability of necessary resources and funding. In parallel, we are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the process of generating follow-on compounds based on the miR-124 platform. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our Lead Drug Candidate for the Treatment of Inflammatory Diseases: Obefazimod <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod is an oral small molecule drug candidate in clinical development for the treatment of moderately <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to severely active UC. We believe that obefazimod is the only small molecule drug candidate in clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development with a mechanism of action that was demonstrated to specifically enhance the expression of a single <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">micro-RNA, miR-124, which plays a critical role in the regulation of the inflammatory response. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In our induction Phase 2b clinical trial, which included 252 patients, obefazimod met the primary endpoint of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a statistically significant reduction in Modified Mayo Score, a measure of disease activity relative to placebo. We <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have observed an onset of symptom relief by day 8 of dosing, with meaningful reductions in rectal bleeding and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">stool frequency scores, consistent with the pharmacological effects observed in our preclinical studies, and high <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rates of sustained and newly achieved clinical remission in the subsequent open-label maintenance extension trial of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">up to two years of treatment, of which approximately 45% of patients were previously exposed to biologics or JAK <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 708pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inhibitors. In April 2023, we reported the results from the final analysis of our Phase 2b open-label maintenance <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">66<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trial, including 217 patients of which 164 patients (76%) completed the second year of once-daily oral treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with 50 mg obefazimod. At the conclusion of the second year of treatment, 114 of the 217 patients enrolled (53%) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achieved clinical remission and 158 patients (73%) achieved clinical response. Among the 98 bio-refractory patients, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">66 patients (67%) had a clinical response, 38 patients (39%) were in clinical remission, 46 patients (47%) had <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopic improvement and 20 patients (20%) had endoscopic remission at week 96. Among the 124 patients that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achieved clinical response at the end of the 8-week induction period of the double-blind study, 82 patients (66%) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achieved clinical remission at week 48, mimicking the re-randomization of responders approach typically utilized in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 maintenance trials. Of the 124 patients in clinical response at week 8, 74 patients (60%) achieved clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remission, 95 patients (77%) had clinical response, 79 patients (64%) achieved endoscopic improvement and 52 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients (42%) achieved endoscopic remission at week 96. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In September 2023, we reported an interim analysis of step-down dosing from 50 mg to 25 mg for the third <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and fifth year of open-label maintenance treatment with obefazimod in UC patients. These patients were treated with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">50 mg of oral, once-daily obefazimod for approximately four years in the Phase 2a clinical trial and approximately <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">two years in the Phase 2b clinical trial. Patients were eligible to enroll in the trial if they had a Mayo endoscopic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subscore of 0 or 1. Eligible patients were switched to 25 mg, and an interim analysis was performed at week 48 with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a cut-off date of July 31, 2023. Of the 71 eligible patients, 63 completed their 48-week visit. Among these patients, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">53 out of 63 patients (84%) demonstrated disease control (stable or improved Modified Mayo Score). No new safety <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">signals were detected in UC patients treated up to five years with oral, once-daily obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Furthermore, obefazimod&#8217;s tolerability profile indicates potentially important clinical differentiation. As of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">data cutoff date (of November 30, 2024), 1,300 patients have received obefazimod in all completed and ongoing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials across all indications, including 97 patients for longer than six months and 241 patients for longer than <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">one year. Additionally, 765 patients have received only blinded obefazimod or placebo in the ABTECT program or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2b clinical trial in CD, of which 160 patients received treatment for longer than six months and 66 patients for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">longer than one year.<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 156.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.35pt; position: var(--position); text-decoration: none; white-space: pre;">The most common treatment emergent adverse event (&#8220;TEAE&#8221;) reported has been mild to <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">moderate headache, which has been transient and manageable with or without over-the-counter medications. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Furthermore, at present and based on data from all completed or non-blinded clinical trials with obefazimod, no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increased rate of opportunistic infections or malignancies have been observed.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In October 2024, we announced the results of an interim efficacy and safety analysis of an OLM trial that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">enrolled patients with UC at the conclusion of the Phase 2a and Phase 2b OLM trials, where they had received <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod 50 mg once daily. The data demonstrated maintenance of clinical remission and a safety profile <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consistent with prior trials of oral, once-daily obefazimod when administered at a reduced dose of 25 mg for up to an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">additional two years. In this OLM trial, patients who had completed the four-year Phase 2a or two-year Phase 2b <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">OLM trials, where they had received 50 mg of once-daily obefazimod, were given the opportunity to continue <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">receiving obefazimod at a reduced dose of 25 mg daily for up to five additional years (provided they met the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">eligibility criteria of Mayo Endoscopic Subscore of 0 or 1). A total of 130 patients entered the trial. As of September <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">11, 2024, the data cut-off date, 113 patients have been evaluated out to 48 weeks and 74 patients have undergone the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">full 96-week evaluation. At trial baseline, 89% (116/130) of patients were in clinical remission. At weeks 48 and 96 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of treatment, 84% (95/113) and 87% (64/74) of patients evaluated were in clinical remission, respectively. Similarly, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">92% (119/130) of patients were in symptomatic remission at trial baseline. At weeks 48 and 96, 91% (103/113) and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">92% (68/74) of patients evaluated were in symptomatic remission, respectively. Similar trends were observed with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other efficacy analyses.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We initiated our pivotal Phase 3 clinical trials of obefazimod for the treatment of moderately to severely active <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UC in consultation with international regulators, including the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">EMA, the Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) and the China Center for Drug Evaluation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;CDE&#8221;). These pivotal Phase 3 clinical trials consist of two induction trials (ABTECT-1 and ABTECT-2) and one <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ABTECT maintenance trial in doses of 25 mg and 50 mg across 36 countries in North America, Latin America, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Europe and Asia Pacific, involving 1,200 moderately to severely active UC patients in over 600 sites. Each of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials will be randomized, double-blind and placebo-controlled, using independent and central review of video-taped <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopies with the primary endpoint of clinical remission according to the Modified Mayo Score assessed at week <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">8 (induction) and at week 44 (maintenance), as recommended by the FDA. Enrollment of the first patient under this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">program occurred on October&#160;11, 2022. Top-line data from the ABTECT-1 and ABTECT-2 induction trials is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected to be announced in the third quarter of 2025, and top-line data from the ABTECT maintenance trial is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected to be announced in the second quarter of 2026. We currently expect to complete enrollment for our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">induction trials in the second quarter of 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Currently, the obefazimod safety database is supported by more than 1,000 subjects treated with obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">across different indications, including UC patients, some of whom are in their fifth year of continuous daily dosing. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">67<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Summary of Obefazimod&#8217;s Mechanism of Action <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We believe our lead drug candidate, obefazimod, is differentiated from competing approaches for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatment of IBD via its novel mechanism of action. Obefazimod was demonstrated to specifically enhance the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expression of a single micro-RNA, miR-124, which plays a critical role in the regulation of the inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">response. In the context of inflammation, miR-124 is a natural regulator of the inflammatory response, controlling <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">progression of inflammation and restoring homeostasis of the immune system, without causing broader <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immunosuppression. Once expressed, micro-RNA interact with specific mRNA targets and decrease their translation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">into proteins to regulate specific pathways. By binding to the cap binding complex, a complex playing a role in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cellular RNA biogenesis, obefazimod enhances the selective splicing of a single long non-coding RNA to generate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the anti-inflammatory micro-RNA, miR-124, in immune cells. Importantly, obefazimod does not impact the splicing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of cellular messenger RNA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">By targeting key inflammatory mRNA players such as STAT3 and MCP1, miR-124, a known anti-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory micro-RNA, regulates inflammation by decreasing macrophag recruitment and activation and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">decreasing levels of pro-inflammatory cytokines, such as TNF-alpha, IL-6, IL-1, IL-23, and IL-17, to control <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">overactive immune stimulation seen in chronic inflammatory diseases. This downregulation thereby regulates the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory process and suggests broad potential as a novel anti-inflammatory therapeutic agent. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following charts provide schematics of obefazimod&#8217;s mechanism of action at both a protein-level (direct <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">downregulation) and cellular-level (indirect downregulation): <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 295pt; width: 612pt;"><div style="left: 73.87pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g3.jpg" alt="Image_5.jpg" style="height: 157.25pt; width: 464.25pt;"/></div></div></div><div style="line-height: 12pt; position: var(--position); top: 457.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 469.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 470.25pt; width: 612pt;"><div style="left: 73.87pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g4.jpg" alt="Image_6.jpg" style="height: 243.65pt; width: 464.25pt;"/></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">68<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In a DSS mouse model, we observed that administration of DSS enhances the expression of pro-inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cytokines in colonic tissue and Th17 cells in lymph nodes and that the treatment of these mice with obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reduced the level of pro-inflammatory cytokines and Th17 cells back to their normal level. Interestingly, when we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treated healthy mice with obefazimod, we did not observe any effect on Th17 cells in the lymph node and on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cytokine levels in the colonic tissue, which we believe illustrates that regulation via enhanced expression of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">miR-124 has an effect only when these pathways are dysregulated, as shown below: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 145pt; width: 612pt;"><div style="left: 75.3pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g5.jpg" alt="Image_7.jpg" style="height: 197pt; width: 461.4pt;"/></div></div></div><div style="line-height: 10pt; position: var(--position); top: 359pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Laboratory analysis of the Phase 2b clinical trial at week 8 showed a highly statistically significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 369pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">enhancement of expression of miR-124 in rectal tissue in patients treated with obefazimod, compared to baseline. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 379pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The median increases were 13-fold for the 25 mg group, 25-fold for the 50 mg group and 25-fold for the 100 mg <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 389pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">group, while no enhanced expression was observed in the placebo group (1.02-fold increase), indicative of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 399pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">positive pharmacological effect of obefazimod. Downstream effects of enhancement of expression of miR-124 have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 409pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">been demonstrated by the reduction in IL-17 and Il-23 levels in the blood and rectal biopsies of patients treated with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.16pt; position: var(--position); text-decoration: none; white-space: pre;">The following charts depict those results: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 429pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 441pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 442pt; width: 612pt;"><div style="left: 76.47pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g6.jpg" alt="Image_8.jpg" style="height: 178.55pt; width: 459.05pt;"/></div></div></div><div style="line-height: 1pt; position: var(--position); top: 634.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">69<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 12pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 84pt; width: 612pt;"><div style="left: 72pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g7.jpg" alt="Image_9.jpg" style="height: 179.7pt; width: 459.65pt;"/></div></div></div><div style="line-height: 10pt; position: var(--position); top: 268.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In contrast to currently available advanced therapies, prescribed post-conventional therapies, some of which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 279.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">target only a single cytokine or pathway, miR-124 modulates the expression of several key cytokines and pathways. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 291.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Restoring multiple inflammatory pathways simultaneously to homeostatic level may lead to more durability of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">efficacy results over the long-term, which is critical in lifelong conditions such as IBD, potentially differentiating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 313.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod from currently available IBD treatments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod in UC <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UC Overview <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">UC, one of the most common forms of IBD, is a chronic inflammatory disease of the large intestine or colon, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that affects the lining of the colon and causes small sores or ulcers. UC is the result of several factors that are not yet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">well understood. Abnormal inflammatory response, genetics, microbiome and environmental factors all contribute to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UC. UC can occur at any age, though most people are diagnosed aged 20 to 30, and men and women are equally <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">likely to be affected. UC can affect people of any racial or ethnic group. UC symptoms can vary, depending on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">severity of inflammation and where it occurs. Signs and symptoms may include diarrhea, rectal bleeding, abdominal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pain and cramping, weight loss, fatigue and fever, substantially impacting the quality of life of patients with this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">debilitating disease. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.82pt; position: var(--position); text-decoration: none; white-space: pre;">There were an estimat<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.28pt; position: var(--position); text-decoration: none; white-space: pre;">ed <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.21pt; position: var(--position); text-decoration: none; white-space: pre;">4.4&#160;million prevalent cases of UC globally in 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.51pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">During the 12 months ended May 2023, we estimate that there were approximately 776,000 patients treated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for UC in the United States. Of those patients, approximately 594,000 patients received conventional therapies; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 285,000 patients were maintained on conventional therapy, approximately 193,000 patients received <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">steroids only and approximately 116,000 patients could not be controlled with conventional therapies. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remaining 182,000 patients received some form of advanced therapies, which we believe represented approximately <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">$5.3 billion of sales in the United States; approximately 43,000 patients were new to advanced therapy, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 51,000 patients received suboptimal results or recently switched from other forms of therapy and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 88,000 patients were maintained on advanced therapy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Existing Therapies and Their Limitations <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The current UC treatment approach is influenced by multiple factors, including disease severity, previous <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">response to treatment, side effects and co-morbidities. Both existing conventional therapies as well as advanced <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies, including approved products and drug candidates in development, face significant room for improvement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in efficacy, safety and tolerability, and convenience from dosing and route of administration standpoints as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discussed below. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 644.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 645.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conventional Therapies for UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 661.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Aminosalicylates (5-ASAs) are used as a first-line therapy in mildly to moderately active UC. Corticosteroids <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 671.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are used primarily during induction therapy and are effective for reducing symptoms, but do not address mucosal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 681.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">healing which limit their ability to modify and improve the underlying cause of disease. In addition, there are safety <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 691.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">considerations with extended corticosteroid use, including lowered quality of life, bone loss, weight gain and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 701.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cardiovascular complications. As a result, corticosteroids are used primarily as a bridge to manage symptoms until <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">70<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immunomodulators or biologic agents become effective and enable mucosal healing. Oral immunosuppressants (e.g. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">azathioprine, 6-mercatopurine and methotrexate) have not been effective as induction agents and are generally used <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for steroid-sparing or as an adjunctive therapy for reducing immunogenicity against biologic agents. Oral <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immunosuppressants are also associated with known toxicities such as drops in white blood cell counts and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increased risk for infection. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Given the above insufficiencies of these conventional therapies, patients suffering from mild UC may evolve <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">towards moderate and severe forms requiring the use of advanced therapies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Advanced Therapies for UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Advanced therapies for UC include biological agents as well as emerging oral molecules. Biological agents <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such as TNF-alpha inhibitors (including infliximab, adalimumab and golimumab), IL-12/23 inhibitors (such as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ustekinumab) or IL-23 inhibitors (mirikizumab, guselkumab, risankizumab), which specifically block certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory factors involved in UC. Biological agents also include gut-specific anti-integrin antibodies (such as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">vedolizumab and natalizumab). New oral molecules acting on certain pathways of the inflammation include JAK <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inhibitors (including tofacitinib and upadacitinib) &#8211; or, on the trafficking of inflammatory cells such as S1P receptor <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agonists (e.g., ozanimod). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">However, these therapies often only have moderate efficacy that may wane over time, as patients stop <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responding or do not respond at all to these treatments and thus require new therapeutic management options. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients who do not or no longer respond to treatment, or experience complications, surgical treatment may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">necessary. Approximately 10% to 30% of UC patients require surgery over their lifetime. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, while TNF-alpha inhibitors and JAK inhibitors and newer biological agents, including anti-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">integrin antibodies, IL-12/23 inhibitors and IL-23 inhibitors, have generally improved the care of moderate to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">severely active IBD, these are all anti-inflammatory agents with safety and tolerability concerns. These include <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increased risks for cancers, infections and blood clots due to their systemic impact and resulting effects on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immune system outside of the GI tract. In addition, prolonged treatment with biological therapies can lead to anti-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drug antibody development by patients&#8217; immune systems which may lead to gradual waning of therapeutic efficacy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and patients needing to switch to other biological agents. Furthermore, biological agents require injections or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intravenous infusions, resulting in patient inconvenience and burden, which often negatively impacts patient <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compliance. Injections can also lead to injection-related events such as sciatica, neuralgia, neuropathic pain and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">peripheral neuropathy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In September 2021, the FDA published strict warnings about increased risk of serious heart-related events, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cancer, blood clots and death for JAK inhibitors that treat certain chronic inflammatory conditions (including UC). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">In January 2023, the EMA stated recommendations to minimize the risk of serious side effects with JAK inhibitors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">used to treat several chronic inflammatory disorders, noting that these side effects include cardiovascular conditions, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">blood clots, cancer and serious infections which were adopted by the European Commission in March 2023. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Recently, there have been efforts to develop drug candidates targeting novel mechanisms, such as S1P <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">receptor agonists and TL1A inhibitors. S1P agonists, while offering convenient oral dosing, have not achieved <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">meaningful commercial adoption. Ozanimod and other S1P agonists work by blocking capacity of lymphocytes to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">egress from lymph nodes, thereby reducing the number of lymphocytes in peripheral blood, which can lead to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increased susceptibility to infections. Furthermore, Ozanimod, in its UC Study 1 which assessed efficacy during the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">induction period, achieved 18% clinical remission in all patients compared to 6% for placebo at week 10.&#160; For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients with prior exposure to TNF inhibitors, only 10% of patients achieved clinical remission compared to 5% for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">placebo. TL1A inhibitors have garnered interest from those seeking newer targets and agents with differentiated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical profile. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.5pt; position: var(--position); text-decoration: none; white-space: pre;">Merck-Prometheus and Pfizer-Roivant have generated promising early Phase 2 data in both <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">biologics-experienced and biologics-na&#239;ve patients, and have recently initiated Phase 3 clinical trials<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.09pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In summary, we believe that there is significant unmet medical need in the UC treatment paradigm due to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">imperfect existing therapies with unfavorable clinical characteristics and limited efficacy that frequently wanes over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">time. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod is being developed as a once-daily, oral medication which, combined with its observed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tolerability to date, would represent a meaningfully differentiated clinical profile from existing therapies. We believe <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">this may position obefazimod as a potential first-line advanced therapy choice for both prescribers and patients, if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">71<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our Market Opportunity: UC <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The estimated market opportunity for UC was approximately $8.3&#160;billion in worldwide sales in 2024 and is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected to reach $12.7&#160;billion in worldwide sales in 2030. In 2022, there were 4.3&#160;million prevalent cases of UC <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">worldwide. In the United States, EU4, the United Kingdom and Japan, there were 2.1&#160;million prevalent cases of UC, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of which 1.3&#160;million of these cases in G7 countries were treated with 5-ASAs or advanced therapies. In addition, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 76% of patients suffering from UC in the United States were covered by commercial insurance, with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 20% and 3% covered by Medicare and Medicaid, respectively. The UC market has significant growth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">potential driven by increasing incidence of the disease as well as the development of innovative oral therapeutics. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We believe the potential for oral agents to gain significant market share is supported by physician and patient <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preference for the convenience of oral administration over injectable agents, increasing demand for therapies with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">long-term efficacy profiles and the opportunity for potent and well-tolerated oral agents to expand the overall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">segment of the moderately to severely active UC population undergoing treatment. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Clinical Trial Results of Obefazimod in Moderately to Severely Active UC <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of November&#160;30, 2024 (the last safety data cut-off date), 1,300 subjects have received obefazimod, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">according to various administration schedules, in all completed and ongoing open-label clinical trials across all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">indications, including 97 subjects for longer than 6 months and 241 subjects for longer than one year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.69pt; position: var(--position); text-decoration: none; white-space: pre;">. The most <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">common TEAE reported has been mild to moderate headache, which has been transient and manageable with or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">without over-the-counter medications. Furthermore, at present and based on data from all completed or non-blinded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials with obefazimod, no increased rate of opportunistic infections or malignancies have been observed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We are conducting Phase 3 clinical trials in moderately to severely active UC in the United States, Europe, Asia <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Pacific and Latin America. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2a Clinical Trial with Obefazimod for the Treatment of Moderately to Severely Active UC <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The induction Phase 2a clinical trial was a randomized trial of an 8-week placebo-controlled, double-blind <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">induction phase followed by an open-label long term extension trial. It was completed in September 2018. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proof-of-concept trial enrolled 32 adult patients who had been diagnosed with moderately to severely active UC for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">at least 12 weeks and who failed or were intolerant to conventional treatments (50%) or biologics (50%). Patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">who completed the induction phase were eligible to continue in the open-label extension trial. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the induction phase, patients were randomized two-to-one to a once-daily orally-administered 50 mg dose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of obefazimod or placebo for eight weeks. In the long-term extension, all patients received a once-daily orally-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">administered 50 mg dose of obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">This double-blind, placebo-controlled trial follows a standard study design in this indication for which a dose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">response as well as placebo effect can be frequently observed. The 50 mg daily dose was selected on the basis of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">safety data accumulated for this dose. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 489pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">72<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The trial design of our Phase 2a clinical trial for obefazimod in patients with moderately to severely active UC <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is depicted below: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 104pt; width: 612pt;"><div style="left: 74.15pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g8.jpg" alt="Image_10.jpg" style="height: 198.7pt; width: 463.7pt;"/></div></div></div><div style="line-height: 10pt; position: var(--position); top: 325.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview of Primary Endpoints of Induction Phase 2a Clinical Trial with Obefazimod for the Treatment of UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 341.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The primary endpoint in the induction Phase 2a clinical trial was safety, assessed as the rate of TEAEs. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 351.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">primary endpoint in the induction phase, evaluation of safety and tolerability of obefazimod, was met. The most <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 361.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">frequently reported adverse events reported in the 50 mg group were GI disorders and headache. GI disorders were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 371.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">experienced by 35% of subjects in the obefazimod group and 22% of subjects in the placebo group. These included <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 381.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">abdominal pain, abdominal pain upper, anal fissure, anorectal discomfort, dyspepsia and nausea for the obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 391.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">group and abdominal pain and diarrhea for the placebo group. Headache was experienced by 17% of subjects in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 401.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod group and 0% in the placebo group. Headaches occurred early and were transient (lasting only a few <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 411.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">days), mainly mild or moderate (grade 1 or 2) and manageable with or without over-the-counter medications. No <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 421.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">serious adverse events related to treatment were observed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 443.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table provides an overall summary of TEAEs by treatment group: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 453.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 465.7pt; width: 612pt;"><div style="left: 76.47pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g9.jpg" alt="Image_11.jpg" style="height: 173.95pt; width: 459.05pt;"/></div></div></div><div style="line-height: 8pt; position: var(--position); top: 656.65pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">AE = adverse event; TEAE = treatment-emergent adverse event <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 678.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">73<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview of Secondary Endpoints of Induction Phase 2a Clinical Trial with Obefazimod for the Treatment of UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table depicts secondary efficacy endpoints of our Phase 2a clinical trial with obefazimod in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">moderately to severely active UC at week 8: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 120pt; width: 612pt;"><div style="left: 74.15pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g10.jpg" alt="Image_12.jpg" style="height: 121.55pt; width: 463.7pt;"/></div></div></div><div style="line-height: 8pt; position: var(--position); top: 258.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">1.<span style="display: inline-block; height: 5.54pt; width: 0.1pt;"></span></span><span style="left: 84.19999999999999pt; position: var(--position);">POC Study was not powered for efficacy <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 266.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ITT = Intent-to-treat; PP = Per Protocol <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The secondary endpoints in the induction Phase 2a clinical trial included the proportion of patients achieving <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical remission at week 8 as compared to placebo, change from baseline to week 8 in total Modified Mayo Score <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(which is based on stool frequency, rectal bleeding, physician global assessment and endoscopic subscore), rate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopic improvement, clinical response rate, as well as miR-124 expression in the rectal tissue of the patients. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview of Additional Follow-Up Data from Long Term Extension Portion of Phase 2a Clinical Trial with <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod for the Treatment of Moderately to Severely Active UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the long-term extension, the primary objective was long term safety of obefazimod. Additional efficacy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endpoints included clinical and endoscopic rates of response and remission. Overall, 32 patients were enrolled in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">induction phase, 23 patients were randomized to obefazimod, and nine patients were randomized to placebo. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Of the 29 patients who completed the induction phase (20 patients for obefazimod and nine patients for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">placebo), 22 patients continued their treatment into the long-term extension. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In October 2019, we announced the 12-month data from this Phase 2a proof-of-concept trial. This open-label <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintenance trial was conducted in 22 patients, of which 19 completed the first year of treatment. At 12&#160;months, an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopy was performed in 16 of the 19 patients to evaluate the rate of clinical remission, and 12 of the 16 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evaluable patients (75%) were observed to achieve clinical remission. Obefazimod was also observed to maintain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">enhanced expression of miR-124 throughout the 12 months of the trial. At month&#160;12, mean change in Mayo Score <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">was observed at -2.6 points compared to the maintenance baseline. Median fecal calprotectin decreased from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">153.1&#160;microg/g (baseline) to 27.9&#160;microg/g and 31.6&#160;microg/g at week&#160;52 and month&#160;24, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table depicts secondary efficacy endpoints of our Phase&#160;2a clinical trial with obefazimod in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">moderately to severely active UC at 24 and 48 months: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 546.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 558.55pt; width: 612pt;"><div style="left: 68.98pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g11.jpg" alt="Image_13.jpg" style="height: 92.75pt; width: 474.05pt;"/></div></div></div><div style="line-height: 1pt; position: var(--position); top: 669.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">74<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2b Clinical Trial with Obefazimod for the Treatment of UC <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview of Induction Phase 2b Clinical Trial with Obefazimod for the Treatment of UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The induction Phase 2b clinical trial for the treatment of moderately to severely active UC was conducted in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">252 patients enrolled at 130 trial sites across 15 European countries, Canada and the United States. It was completed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in April 2021. The trial was a randomized, double-blind and placebo-controlled 16-week induction trial with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">primary efficacy endpoint at week 8 involving four treatment groups (receiving an oral once-daily 25 mg, 50 mg or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">100 mg dose of obefazimod or placebo). Endoscopies were read centrally and blinded, by independent reviewers. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Electronic patient diaries were used to enhance the reliability of the collection of stool frequency, rectal bleedings, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and other patient reported outcomes-all efficacy endpoints were set according to FDA guidance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following chart depicts the design of our Phase 2b clinical trial with obefazimod in moderately to severely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">active UC: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 219pt; width: 612pt;"><div style="left: 73.57pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g12.jpg" alt="Image_14.jpg" style="height: 201.6pt; width: 464.85pt;"/></div></div></div><div style="line-height: 10pt; position: var(--position); top: 437.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Between August&#160;13, 2019 and April&#160;16, 2021, 252 patients were randomly allocated to obefazimod 100 mg <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 447.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(n=64), obefazimod 50 mg (n=63), obefazimod 25 mg (n=61) or placebo (n=64). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 469.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Baseline characteristics were well-balanced among the treatment groups, indicating a moderately to severely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 479.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">active UC population. At screening, 49% of patients had an inadequate response, loss of response, or intolerance to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 489.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">TNF-alpha inhibitors, vedolizumab, other biologics and/or JAK inhibitors treatments, while the other patients were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 499.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">refractory to conventional treatments only. Enrolled patients suffered from longstanding UC with an overall mean <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 509.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disease duration of 8.05 years and 71% of the patients had a severe disease profile (baseline Modified Mayo Score <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 519.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of 7 to 9 points). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 538.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 539.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table depicts the baseline characteristics of our Phase 2b clinical trial: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 549.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 561.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 562.6pt; width: 612pt;"><div style="left: 97.77pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g13.jpg" alt="Image_15.jpg" style="height: 139.4pt; width: 416.45pt;"/></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">75<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">*<span style="display: inline-block; height: 5.54pt; width: 2.1pt;"></span></span><span style="left: 84.19999999999999pt; position: var(--position);">Percentages based on number of patients with previous exposure to biologics/JAK inhibitors <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview of Primary Endpoints of Induction Phase 2b Clinical Trial with Obefazimod for the Treatment of UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: underline; white-space: pre;">Modified Mayo Score<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.76pt; position: var(--position); text-decoration: none; white-space: pre;">: In the full analysis set (&#8220;FAS&#8221;), corresponding to an ITT analysis, the primary endpoint <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">was met at week 8 (statistically significant reduction of Modified Mayo Score) with -2.9 (95% CI -3.4 to -2.5) for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the obefazimod 100 mg group, -3.2 (-3.7 to -2.7) for the obefazimod 50 mg group, -3.1 (-3.6 to -2.6) for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod 25 mg group, and -1.9 (-2.4 to -1.5) for placebo group. The magnitude of the difference in Modified <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mayo Score from baseline was significantly greater in all three obefazimod groups compared with placebo <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(p=0.0039 for obefazimod 100 mg vs placebo, p=0.0003 for obefazimod 50 mg vs placebo, and p=0.0010 for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod 25 mg vs placebo). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: underline; white-space: pre;">Clinical Response, Clinical Remission and Endoscopic Improvement<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.56pt; position: var(--position); text-decoration: none; white-space: pre;">: Furthermore, rates of clinical response <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and clinical remission at week 8 in the FAS were higher in the three obefazimod dosage groups than with placebo. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Although there is no apparent dose response in clinical remission, we observe <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.28pt; position: var(--position); text-decoration: none; white-space: pre;">that<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.25pt; position: var(--position); white-space: pre;"> there is a trend for the most <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">objective measure which is the endoscopic improvement score. In addition, we also see the same trend for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">bionaive population.<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.91pt; position: var(--position); text-decoration: none; white-space: pre;">The subgroup of patients who were refractory to one or more second line therapies showed <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results that were consistent with the overall analysis for clinical response and clinical remission at week 8. Rates of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopic improvement at week 8 were also higher in the obefazimod dosage groups than in the placebo group in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the FAS. Change in fecal calprotectin from baseline in the FAS was greater in all obefazimod groups than with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">placebo. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 289pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables depict the changes of the primary endpoint from baseline in Modified Mayo Score at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">week 8: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 322pt; width: 612pt;"><div style="left: 156.82pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g14.jpg" alt="Image_16.jpg" style="height: 241.35pt; width: 298.35pt;"/></div></div></div><div style="line-height: 1pt; position: var(--position); top: 568.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 569.35pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 587.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">ANCOVA model for change from baseline MMS at week 8 which includes baseline MMS as a covariate and treatment, previous exposure <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 595.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.35pt; position: var(--position); text-decoration: none; white-space: pre;">to biological drugs or JAK inhibitors as fixed effects and a random error term. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 603.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">p-values are based on nonparametric ANCOVA using ranked data. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 611.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">MMS is the sum of assessment scores (0-3) of mucosal appearance on endoscopy, stool frequency, and rectal bleeding. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 619.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">n = number of patients in the category with data available for baseline and week 8 visit. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">76<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables depict the secondary efficacy endpoint results at week 8: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 94pt; width: 612pt;"><div style="left: 72pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g15.jpg" alt="pg 76 endpoint results at week 8.jpg" style="height: 159.68pt; width: 468pt;"/></div></div></div><div style="position: var(--position); top: 258.68pt; width: 612pt;"><div style="font-size: 0pt; left: 30.38pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 276.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Clinical remission (per Modified Mayo Score) is defined as stool frequency subscore (SFS) &#8804;1, rectal bleeding subscore (RBS) of 0 and <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 284.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.35pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopic subscore &#8804;1. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 292.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Clinical response (per Adapted Mayo Score) is defined as a decrease from baseline in the Modified Mayo Score &#8805;2 points and &#8805;30&#160;percent <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 300.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.35pt; position: var(--position); text-decoration: none; white-space: pre;">from baseline, plus a decrease in RBS &#8805;1 or an absolute RBS &#8804;1. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 308.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Endoscopic improvement is defined as endoscopic subscore &#8804;1 without friability. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 316.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">n = number of patients that met the respective endpoint. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 324.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(5)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">N = number of patients in the relevant analysis set. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 332.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(6)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Delta = arithmetic difference rounded to nearest full percentage. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 349.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We also conducted sub-group analyses of biologics / JAK-na&#239;ve and biologics / JAK-experienced patients, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results of which are displayed below: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 24pt; position: var(--position); top: 370.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 24pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 16.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 394.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 395.43pt; width: 612pt;"><div style="left: 76.47pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g16.jpg" alt="Image_18.jpg" style="height: 241.35pt; width: 459.05pt;"/></div></div></div><div style="position: var(--position); top: 641.78pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 659.53pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">*<span style="display: inline-block; height: 5.54pt; width: 8.25pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Trial not powered for statistical significance for sub-group analysis. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 667.53pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">n = Number of patients in the category with data available for baseline and week 8 visit. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 675.53pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">MMS is the sum of assessment scores (0-3) of mucosal appearance on endoscopy, stool frequency, and rectal bleeding. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">77<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 24pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 24pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 16.64pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 97pt; width: 612pt;"><div style="left: 76.47pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g17.jpg" alt="Image_19.jpg" style="height: 239.05pt; width: 459.05pt;"/></div></div></div><div style="position: var(--position); top: 341.05pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 358.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">*<span style="display: inline-block; height: 5.54pt; width: 8.25pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Trial not powered for statistical significance for sub-group analysis. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 366.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Endoscopic improvement is defined as endoscopic subscore &#8804;1 without friability. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 374.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">n = number of patients that met the respective endpoint. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 382.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">N = number of patients in the relevant analysis set. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 390.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Delta = arithmetic difference rounded to nearest full percentage. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 407.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview of Maintenance Phase 2b Clinical Trial with Obefazimod for the Treatment of UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Of the 222 patients who completed the 16-week Phase 2b induction trial, 217 patients (98%) enrolled in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent open-label maintenance trial to evaluate the induction Phase 2b clinical trial long-term safety and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">efficacy profile of obefazimod for up to two years, irrespective of treatments or treatment outcome during the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">induction phase. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">At week 48, of those 217 patients who received a 50 mg once-daily oral dosing with obefazimod, 178 patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(82%) had clinical response, 119 patients (55%) were in clinical remission, 133 patients (61%) had endoscopic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">improvement and 72 patients (33%) had endoscopic remission. Moreover, 38 patients were in sustained clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remission and 107 patients showed sustained clinical response. A total of 71 patients exhibited de novo clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">response and 81 patients exhibited de novo clinical remission. Among the 98 bio-refractory patients, 66 patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(67%) had a clinical response, 38 patients (39%) were in clinical remission, 46 patients (47%) had endoscopic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">improvement and 20 patients (20%) had endoscopic remission at week 96. These results demonstrate the long-term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical response of obefazimod in patients who were refractory to conventional treatments, as well as patients who <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">were previously exposed to treatment with biologics and/or JAK inhibitors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">At week 96, of the 49 patients who were in clinical remission at the end of the induction phase, 33 patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(67%) remained in clinical remission. Of the 168 patients who were not in clinical remission at the end of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">induction phase, 81 patients (48%) exhibited de novo clinical remission. Furthermore, the clinical remission rate for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients who did not show at least a clinical response at the end of the 8-week induction phase was 43% <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(40&#160;patients). Of the patients included in the maintenance trial, 164 patients (75%) completed two years of once-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">daily oral dosing with 50 mg obefazimod. Thirty patients dropped out during the first year of treatment. Six&#160;patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">did not qualify for the second year due to non-response after the first year of treatment, and 17&#160;patients dropped out <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">during the second year. These patients were all considered as treatment failures in the intent-to-treat analysis. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Of all 217 patients who entered the Phase 2b open-label maintenance trial, regardless of their status at the end <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the 8-week induction period, 119 patients (55%) achieved clinical remission at week 48 and 114 patients (53%) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achieved clinical remission at week 96. Among the 124 patients who achieved clinical response at the end of the 8-<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">78<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">week induction period of the double-blind study, 82 patients (66%) achieved clinical remission at week 48, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">mimicking the re-randomization of responders approach typically utilized in Phase 3 maintenance trials, and 74 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients (60%) achieved clinical remission at week 96. This comparison is shown below: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 114pt; width: 612pt;"><div style="left: 76.47pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g18.jpg" alt="Image_21.jpg" style="height: 175.7pt; width: 459.05pt;"/></div></div></div><div style="position: var(--position); top: 294.7pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 312.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; 217/222 eligible patients enrolled into open label maintenance study. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 320.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">Irrespective of patient outcome at the end of the 8-week induction phase. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 328.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">n = Number of patients that met the respective endpoint. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 336.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">N = Number of patients in the relevant analysis set. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 344.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(5)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">124 patients achieved clinical response at end of 8-week induction phase. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 352.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(6)<span style="display: inline-block; height: 5.54pt; width: 2.93pt;"></span></span><span style="left: 90.35pt; position: var(--position);">From week 48 to week 96, 19 patients began experiencing symptoms of UC again (i.e., were not in clinical remission anymore), and <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 360.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.35pt; position: var(--position); text-decoration: none; white-space: pre;">14&#160;patients achieved clinical remission. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The below table depicts the types of adverse events observed from our Phase 2b clinical trial: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 390.45pt; width: 612pt;"><div style="left: 76.47pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g19.jpg" alt="Image_22.jpg" style="height: 144.6pt; width: 459.05pt;"/></div></div></div><div style="line-height: 1pt; position: var(--position); top: 549.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">During the induction and the maintenance treatments of the Phase 2b clinical trial, the safety and tolerability <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 560.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profile observed was consistent with previous findings and no new adverse safety signals were observed. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.82pt; position: var(--position); text-decoration: none; white-space: pre;">As of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 570.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">November&#160;30,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.18pt; position: var(--position); text-decoration: none; white-space: pre;"> 2024 (the last safety data cut-off date), 1,300 subjects have received obefazimod, according to various <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 580.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">administration schedules, in all completed and ongoing open-label clinical trials across all indications, including 97 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subjects for longer than 6 months and 241 subjects for longer than one year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.12pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">79<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview of Phase 2 Open-Label Trial to Evaluate Long-Term Safety and Efficacy of Obefazimod at 25 mg <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In September 2023, we reported an interim analysis of step-down dosing from 50 mg to 25 mg for the third <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and fifth year of open-label maintenance treatment with obefazimod in UC patients. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 126pt; width: 612pt;"><div style="left: 72pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g20.jpg" alt="Phase 2b LT Safety - 108.jpg" style="height: 181.61pt; width: 468pt;"/></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 334.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">These patients were treated with 50 mg of oral, once-daily obefazimod for approximately four years in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2a clinical trial and approximately two years in the Phase 2b clinical trial. Patients were eligible to enroll in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the trial if they had a Mayo endoscopic subscore of 0 or 1. Eligible patients were switched to 25 mg, and an interim <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">analysis was performed at week 48 with a cut-off date of July 31, 2023. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 386.61pt; width: 612pt;"><div style="left: 72pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g21.jpg" alt="Phase 2b LT Safety - 108 Timepoint Study.jpg" style="height: 172.83pt; width: 468pt;"/></div></div></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 576.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="position: var(--position); top: 577.44pt; width: 612pt;"><div style="font-size: 0pt; left: 30.38pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 595.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 26.68pt;"></span></span><span style="left: 114.1pt; position: var(--position);">ABX464-108 Interim Analysis Outputs as of July 31, 2023. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 603.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt; width: 26.68pt;"></span></span><span style="left: 114.1pt; position: var(--position);">n = Number of patients that met the respective endpoint. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 611.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 26.68pt;"></span></span><span style="left: 114.1pt; position: var(--position);">N = Number of patients in the relevant analysis set. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 628.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 629.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Of the 71 eligible patients, 63 completed their 48-week visit. Among these patients, 53 out of 63 patients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 639.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(84%) demonstrated disease control (stable or improved Modified Mayo Score). No new safety signals were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 649.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">detected in UC patients treated up to five years with oral, once-daily obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">80<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 Clinical Trials and Regulatory Pathway in UC <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are working with IQVIA, a global premier contract research organization, to conduct the Phase 3 clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials with obefazimod in moderately to severely active UC, following consultations with regulatory agencies, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including FDA, EMA, CDE and PMDA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">These pivotal Phase 3 clinical trials consist of two induction trials (ABTECT-1 and ABTECT-2) and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent ABTECT maintenance trial investigating obefazimod at doses of 25 mg and 50 mg across 36&#160;countries <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in North America, Latin America, Europe and Asia Pacific, involving 1,200 moderately to severely active UC <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients in over 600 sites. Each of the trials will be randomized, double-blind and placebo-controlled, using <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">independent and central review of the video-taped endoscopies with the primary endpoint of clinical remission <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">according to the Modified Mayo Score assessed at week 8 (induction) and at the end of the 44-week maintenance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trial (total 52 weeks), as recommended by the FDA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The Modified Mayo Score evaluates UC disease activity, based on three parameters: stool frequency, rectal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bleeding and endoscopic evaluation. Each parameter of the score ranges from zero (normal or inactive disease) to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">three (severe activity). The patient rates stool frequency score (&#8220;SFS&#8221;) and rectal bleeding score (&#8220;RBS&#8221;) daily. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopy subscore is evaluated by a central reader (who is blinded to any clinical information about the patient) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from an endoscopy that is performed at the trial site. The inclusion criteria based on FDA guidance for moderately to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">severely active UC is active disease defined by a Modified Mayo Score &#8805; 5 with (RBS) &#8805; 1 and endoscopy subscore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of 2 or 3 (confirmed by central reader). The primary endpoint for induction and maintenance is clinical remission <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">defined as SFS of 0 or 1 and not greater than baseline and RBS = 0 and endoscopy subscore of 0 or 1. At week 8, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">secondary endpoints include endoscopic improvement, clinical response, symptomatic remission and histologic-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopic mucosal improvement (&#8220;HEMI&#8221;). At week 44 of the maintenance trial, secondary endpoints include <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">endoscopic improvement, symptomatic remission, corticosteroid-free clinical remission, sustained clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remission, HEMI and endoscopic remission. After week 44, a long-term extension trial will follow for eligible and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">willing subjects for an additional for up to 4&#160; years, or until the commercialization of obefazimod, whichever occurs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">first.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following chart depicts the design of our Phase 3 clinical trial with obefazimod in moderately to severely <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">active UC: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 396pt; width: 612pt;"><div style="left: 70.92pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g22.jpg" alt="design.jpg" style="height: 164.83pt; width: 470.16pt;"/></div></div></div><div style="line-height: 10pt; position: var(--position); top: 577.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Enrollment of the first patient under this program in the United States occurred on October&#160;11, 2022. Top-line <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">data from the ABTECT-1 and ABTECT-2 induction trials is expected to be announced in the third quarter of 2025, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 597.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and top-line data from the ABTECT maintenance trial is expected to be announced in the second quarter of 2026. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 607.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Additional Clinical Trials Completed with Obefazimod <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, four Phase 1 clinical trials have recently been completed to assess the tolerability and safety <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profile of obefazimod: (i)&#160;a Phase 1 heart rhythm (QT interval) trial, for which we enrolled 120 healthy volunteers; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(ii)&#160;a Phase 1 clinical trial of drug-drug interactions, for the purposes of providing further information on any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">possible interactions of obefazimod with other drugs, for which we enrolled 60 healthy volunteers; (iii)&#160;a Phase 1 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">absorption, distribution, metabolism and excretion trial for the purposes of generating additional data to further <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evaluate the safety profile of obefazimod, for which we enrolled 12 healthy volunteers; and (iv)&#160;a Phase 1 clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trial conducted in Japanese subjects to further evaluate pharmacokinetics and tolerability of obefazimod in this <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">81<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">population, for which we enrolled 48 healthy volunteers. The results of these Phase 1 clinical trials provide <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supportive data for our further clinical development and New Drug Application (&#8220;NDA&#8221;) submission. Furthermore, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">additional Phase 1 clinical trials to support NDA submission are planned. While we have decided not to pursue <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">additional clinical work in RA at this point, we have completed a Phase 2a clinical trial in patients with RA, where <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we saw encouraging proof-of-concept data supporting obefazimod&#8217;s potential role in addressing inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conditions beyond IBD. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod in CD <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">CD Overview <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">CD is a chronic inflammatory condition that can affect the GI tract from mouth to anus but typically affects <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the colon and last section of the ileum (terminal ileum). Although considered in the same category of IBD as UC, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammation occurs across the bowel wall which leads to different complications including stricture and fistula <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">formation. CD affects about 3.2 per 1,000 people in Europe, North America&#160;and the United Kingdom. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.89pt; position: var(--position); text-decoration: none; white-space: pre;">Collectively, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we estimate there are approximately 1.5&#160;million CD patients in G7 countries. Of these patients, approximately 59%) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are estimated to be diagnosed with moderately to severely active CD.&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.62pt; position: var(--position); text-decoration: none; white-space: pre;">While this disease is diagnosed at any age, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">onset is more common among adolescents and young adults.&#160;Patients typically present with abdominal pain, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">diarrhea, fatigue and weight loss.&#160;In cases of bowel obstruction, patients will also experience bloating and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">vomiting.&#160;The likelihood of having surgery mostly due to bowel obstruction within the lifetime of a CD patient is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approximately 80%.&#160;Besides bowel complications, patients can experience extra-intestinal manifestations (&#8220;EIMs&#8221;), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which impact the skin, eye and joints primarily.&#160;The prevalence rate of EIMs is approximately 24% in all IBD <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients, 27% in UC patients, but as high as 35% in CD patients. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Existing Therapies and Their Limitations <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Similar to existing UC treatments, patients may receive oral immunosuppressants, such as azathioprine and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">methotrexate as well as short courses of corticosteroids.&#160;In cases of moderately to severely active CD, the options for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advanced therapy include very commonly prescribed TNF-alpha inhibitors, anti-integrin antibodies, IL-12/23 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inhibitors, IL-23 inhibitors and JAK inhibitors.&#160;Therapies such as TNF-alpha inhibitors, IL-12/23 inhibitors or IL-23 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inhibitors are injectable agents, representing a significant commercial disadvantage due to patients&#8217; and prescribers&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preference for the convenience of oral therapies.&#160;JAK inhibitors are accompanied by safety warnings due to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increased risk of adverse events such as infection, cancer or blood clots. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Induction remission rates for these existing therapies are less than 50% and maintenance remission rates often <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">decrease over time. There remains unmet needs for more effective and durable therapy, including those with more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convenient delivery methods (as there are no approved oral therapies for first-line use in the United&#160;States), durable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">efficacy, treatment of patients who have failed biologic agents, improved mucosal healing, improved treatment for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fistulizing CD and improved corticosteroid free remission. We believe obefazimod&#8217;s differentiated clinical profile, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including dosing as a once-daily, oral therapy as well as its demonstrated tolerability and durability to date, position <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">it favorably as a potential first-line advanced therapy option for patients and prescribers, if approved. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Our Market Opportunity: CD <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The estimated market opportunity for CD was approximately $15.4&#160;billion in worldwide sales in 2024 and is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected to reach $18.1&#160;billion in worldwide sales in 2030. In 2024, approximately $10.7&#160;billion of sales came from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the United States. Similar to the UC market, we believe oral agents represent a significant commercial opportunity, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">particularly if such therapeutics can provide long-term safety and efficacy profiles comparable to injectable agents. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod CD Development Program <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In February 2024, we announced that our obefazimod CD IND filed with the FDA in December 2023 was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cleared to proceed. In alignment with FDA feedback, we modified our CD trial design and are conducting a dose-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ranging Phase 2b clinical trial. Our first patient was enrolled in October 2024 and our 12 week induction readout is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected in the second half of 2026.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">82<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following chart depicts the design of our Phase 2b clinical trial with obefazimod in CD: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 94pt; width: 612pt;"><div style="left: 72pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g23.jpg" alt="pg 82 phase 2b CD design.jpg" style="height: 187.69pt; width: 468pt;"/></div></div></div><div style="line-height: 10pt; position: var(--position); top: 304.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Potential Combination Therapy for the Treatment of IBD with Obefazimod as the Cornerstone <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Despite the development of various advanced targeted therapies for IBD over the past 20 years, a single agent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with transformational efficacy remains elusive. Although cross-trial efficacy comparisons must be interpreted with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">caution, induction of clinical remission rates have currently reached a placebo-adjusted therapeutic ceiling up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">30%. Improved efficacy of combination therapy with thiopurines and TNF-alpha inhibitors has been well described <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(SONIC and UC-SUCCESS) but did not breach the aforementioned efficacy ceiling. Emerging data utilizing dual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advanced targeted therapy affecting complementary mechanisms of action indicate a potential path to higher <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">efficacy rates. The first trial utilizing this strategy (VEGA) randomized patients to three parallel treatment groups: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(1) dual combination therapy with guselkumab (IL-23 inhibitor) plus golimumab (TNF-alpha inhibitor); (2) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">guselkumab alone; or (3)&#160;golimumab alone. At the end of the 12-week induction period, a greater proportion of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients randomized to dual combination therapy achieved clinical remission (approximately 47%) compared to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">either monotherapy treatment arms (guselkumab at approximately 25%; golimumab at approximately 24%). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Importantly, adverse events, serious adverse events and infection rates were comparable among treatment groups. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">J&amp;J has progressed these findings and initiated a fixed-dose combination phase 2 clinical trial of guselkumab plus <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">golimumab (JNJ-4804) in UC/CD.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We believe synergistic improvements that may be achieved with advanced combination therapy should be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">balanced with patient adherence to multiple biologic injections and safety considerations associated with immune <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">suppression. Several of obefazimod&#8217;s attributes make it a potentially attractive candidate to pair with other advanced <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatments. First, the oral route of administration is preferred by a majority of patients, potentially resulting in higher <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">levels of medication adherence. Further, obefazimod&#8217;s proposed mechanism of action harnesses the body&#8217;s natural <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The novel <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">mechanism of action of obefazimod potentially lends itself as complementary to other oral or injectable agents with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the potential of improving the induction and remission efficacy over monotherapy. We believe the current clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results we have observed with obefazimod including a lack of safety signals up to 96 weeks of treatment support <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development as an agent to be used in potential combination therapy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have initiated a formal process evaluating oral and injectable combination therapy candidate with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod in UC. In September 2024, we announced results of initial preclinical combination data of obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">combined with etrasimod in a mouse model of IBD. The results showed that treatment with the combination <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">improved the response on body weight protection and Disease Activity Index with a synergistic and statistically <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant reduction of several cytokines (TNFa, IL-17, IL-6, IFNg) in the blood compared to each drug alone. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Additional preclinical data to support our decision-making on a combination agent is expected in 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Follow-On Compounds Program <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Based on the mechanistic concept of obefazimod, a research and development program is currently ongoing to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generate new potential drug candidates to strengthen our intellectual property portfolio on the miR-124 platform. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The first follow-on drug candidate is expected to be selected in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.9pt; position: var(--position); text-decoration: none; white-space: pre;"> 2<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.4pt; position: var(--position); text-decoration: none; white-space: pre;">025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.4pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.9pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">83<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Manufacturing and Supply <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our lead compound, obefazimod, is manufactured using commercially available, widely used raw materials <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and common chemical engineering and synthetic processes. The historical volatility in the prices of these raw <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">materials has not had a material impact on our operating results. Obefazimod is formulated as an oral solid capsule. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We have successfully scaled-up active pharmaceutical ingredients and drug product processes, and we have a large <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supply of active pharmaceutical ingredients and capsules available for clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We outsource all manufacturing operations and rely on European and North American third-party CMOs to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supply clinical trials and finalize the development of obefazimod. These operations are designed to be in compliance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with the standards imposed by Good Manufacturing Practice (&#8220;GMP&#8221;). We believe our outsourcing strategy and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">internal organization allow us to focus our resources on the development of different drug candidates and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management of third parties, without investing in expensive manufacturing facilities and equipment. All third parties <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are assessed under our quality system and agreements are in place to compel compliance and we maintain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreements with manufacturers which include confidentiality and intellectual property provisions to protect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proprietary rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are in the process of further optimizing and scaling up our supply chain for obefazimod to ensure capacity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for our expected commercial supply, if the FDA or foreign regulatory authority approved.&#160; In addition, w<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.87pt; position: var(--position); white-space: pre;">e are in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">process of establishing a second source manufacturer for obefazimod to ensure continuity of product supply.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Competition <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We compete with companies that have drugs on the market or are developing drug candidates for chronic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory disease. The biotechnology and pharmaceutical industries are highly competitive and subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant and rapid technological change, as researchers learn more about chronic inflammatory diseases and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">develop new technologies and treatments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Significant competitive factors in our industry include: (i)&#160;product efficacy and safety; (ii)&#160;quality and breadth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of an organization&#8217;s technology; (iii)&#160;skill of an organization&#8217;s employees and its ability to recruit and retain key <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employees; (iv)&#160;timing and scope of regulatory approvals; (v)&#160;government reimbursement rates for, and the average <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">selling price of, pharmaceutical products; (vi)&#160;the availability of raw materials and qualified manufacturing capacity; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(vii)&#160;manufacturing costs; intellectual property and patent rights and their protection; and (viii)&#160;sales and marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">capabilities. Given the intense competition in our industry, we cannot assure you that even if we are able to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">successfully develop any products, that they will have a higher benefit-risk profile or better cost effectiveness <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compared to products developed or introduced by our competitors. Our competitors in the chronic inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disease field are primarily large pharmaceuticals companies including, but not limited to, AbbVie, Eli Lilly, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Johnson&#160;&amp; Johnson, Pfizer and Takeda. Merck, Roche, and Teva/Sanofi are all potential future competitors based on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recent acquisitions of TL1A molecules. Several lines of research are being developed to improve the treatment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">IBD. Many companies are working to develop new, more effective and better tolerated treatments with more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">practical formulations, especially small molecules administered orally, better accepted than monoclonal antibodies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that require administration by injection or intravenous infusions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The molecules in development have various mechanisms of action and are primarily: (i)&#160;TNF-alpha inhibitors; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(ii)&#160;IL-12/23 inhibitors; (iii)&#160;anti-integrin antibodies; (iv)&#160;IL-23 inhibitors; (v)&#160;JAK inhibitors; (vi)&#160;S1P receptor <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agonists; or (vii)&#160;TL1A inhibitors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the TNF-alpha treatment class, Remicade<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 272.9pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.6pt; position: var(--position); text-decoration: none; white-space: pre;"> (Janssen) was first approved by the FDA in 1998. In 2012, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">European Commission approved AbbVie&#8217;s Humira<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 277.38pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.08000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> for the treatment of pediatric patients aged six to 17 years with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">severe active CD who have an inadequate response, are intolerant or have contraindications to conventional therapy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 613pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">IL-12/23 inhibitors entered the UC market in 2019 as ustekinumab (Johnson&#160;&amp; Johnson&#8217;s Stelara<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 484.78pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.48pt; position: var(--position); text-decoration: none; white-space: pre;">). In 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">AbbVie filed an authorization application with FDA and EMA for risankizumab (Anti-IL-23&#8212;Skyrizi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 481.86pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.56pt; position: var(--position); text-decoration: none; white-space: pre;">) for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatment of moderately to severely active CD and in 2024 it was approved for UC. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Etrolizumab, a selective anti-alpha-4/beta-7 monoclonal antibody developed by Roche/Genentech, recently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">failed in Phase 3 for CD after failing in Phase 3 in UC in 2020. The anti-integrin class is currently represented by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">vedolizumab/Entyvio<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 158.01pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.70999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> and natalizumab/Tysabri<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 263.23pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.93pt; position: var(--position); text-decoration: none; white-space: pre;">. We are also aware of Morphic Therapeutic&#8217;s MORF-057 and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Protagonist Therapeutics/Johnson&#160;&amp; Johnson&#8217;s PN-943 currently in development. The anti-integrin drugs work by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preventing the leukocytes to move from the blood vessels to sites of inflammation. They block the action of integrin <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on the surface of circulating immune cells and endothelial cell adhesion molecules, thereby inhibiting the <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">84<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interactions between leukocytes and intestinal blood vessels. Natalizumab and vedolizumab block alpha4-integrin <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and alpha4beta7-integrin respectively. These drugs are injectable (Humanized mAb). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In 2021, Eli Lilly reported that mirikizumab (Anti-IL-23) generated data in a Phase 3 maintenance trial in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patients with UC that led to EMA and FDA approvals for UC. Regulatory filings have also been submitted for CD. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">All these drugs are injectable (Humanized mAb). Abbvie received FDA approval in moderately to severely active <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UC for Skyrizi in June 2024 and J&amp;J recieved FDA approval for Tremfya in September 2024. IL-23 is a regulator of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">T-helper (Th)-17 cell. IL-23 prevents regulatory T-cell response in the intestine, and therefore increases <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammation in the gut. Anti-interleukins targeting the IL-23 have been shown to be effective for induction and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintenance of remission in patients with moderate-severe UC. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The JAK correspond to four intracellular tyrosine kinases: JAK1, JAK2, JAK3 and tyrosine kinase 2. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Inhibition of the JAK-STAT signal channel makes it possible to block the production of pro-inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cytokines, including TNF-alpha, to block other pathways of inflammation and to regulate innate and adaptive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immunity. Thus, several cytokines and several inflammation pathways are blocked simultaneously, unlike TNF-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">alpha inhibitors, which only have a single target. In September 2021, FDA published a black box warning, requiring <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical companies to provide a warning for increased risk of serious cardiac events, cancer, blood clots and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">death linked to JAK inhibitor treatments used for the treatment of certain IBD, including UC. Consequently, these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatments are only accessible to patients who do not respond to any other available treatment and who have certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">well-defined conditions. In the JAK inhibitor class, to our knowledge the following products are authorized or in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advanced development: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Pfizer&#8217;s tofacitinib (Xeljanz<span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 238.54000000000002pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.24pt; position: var(--position); text-decoration: none; white-space: pre;">) is a non-selective JAK inhibitor. It obtained marketing approval in UC <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">in June 2018. In September 2021, the FDA concluded that there was a high risk of serious side effects <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">following a randomized clinical trial conducted to assess the safety of tofacitinib. Consequently, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">molecule will be used as a third line treatment in patients who meet specific criteria. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Gilead and Galapagos&#8217; filgotinib (Jyseleca<span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 297.38pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.08pt; position: var(--position); text-decoration: none; white-space: pre;">) is a selective JAK1 inhibitor. Since November 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">filgotinib has been approved for the treatment of UC in the European Union (the &#8220;EU&#8221;). Authorization <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">requests have also been submitted to the UK Medicines and Healthcare products Regulatory Agency <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;MHRA&#8221;) and the Japanese PMDA for the treatment of moderately to severely active UC. In January <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">2024, Alfasigma acquired the rights to filgotinib from Galapagos.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">AbbVie&#8217;s upadacitinib (Rinvoq<span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 253.04000000000002pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.74pt; position: var(--position); text-decoration: none; white-space: pre;">), which is also a selective JAK1 inhibitor, was approved by the FDA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">in March 2022 for the treatment of moderately to severely active UC. EMA authorization for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">treatment of moderately to severely active UC was granted in July 2022. Rinvoq was then approved in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">moderately to severely active CD in 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">S1P receptor agonists allow sequestration of activated lymphocytes in lymph nodes and thus reduce their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">circulation in the GI tract. Ozanimod (Zeposia<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 257.02pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">&#174;<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.72pt; position: var(--position); text-decoration: none; white-space: pre;">) is a S1P receptor modulator that is selective for the S1P1 and S1P5 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">receptors. It was approved by the FDA and EMA for the treatment of moderately to severely active UC in 2021. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">March 2024, BMS annouced that ozanimod failed their first Phase 3 induction clinical trial for CD. In October 2023, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Pfizer announced approval of Velsipity for moderately to severely active UC. Phase 2/3 CD Velsipity clinical trials <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are underway. In addition, in October 2023, Ventyx Biosciences announced results from its Phase 2 clinical trial of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">VTX002 in UC. However, further development is contingent on finding a strategic partner to advance VTX002 to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are also aware of other types of treatments currently under various stages of development, such as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">NImmune Biopharma&#8217;s omilancor (a Lanthionine Synthetase C-Like 2 activator) as well as tyrosine kinase 2 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inhibitors from Bristol Myers Squibb&#8217;s Sotyktu (deucravacitinib &#8211; approved in the EU) and Ventyx Biosciences&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">VTX 958. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Furthermore, TL1A inhibitors have garnered interest from those seeking newer targets and agents with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">differentiated clinical profile. Merck-Prometheus and Pfizer-Roivant have generated promising early Phase 2 data in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">both biologics-experienced and biologics-na&#239;ve patients, and have recently initiated Phase 3 clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our competitors may also succeed in obtaining European Commission, FDA or other regulatory approvals for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their drug candidates more rapidly than us, which could place us at a significant competitive disadvantage. Market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">acceptance of our drug candidates will depend on a number of factors, including: (i)&#160;potential advantages over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">existing or alternative therapies or tests; (ii)&#160;the actual or perceived safety of similar classes of products; (iii)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">effectiveness of our sales, marketing, and distribution capabilities; and (iv)&#160;the scope of any approval provided by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the FDA or foreign regulatory authorities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We anticipate that we will face intense and increasing competition as new drugs and therapies enter the market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 708pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and advanced technologies become available. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">85<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Government Regulation <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Companies operating in the pharmaceutical industry are subject to increased scrutiny by the competent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities and must deal with an ever-changing and increasingly restrictive legal and regulatory environment. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The development of drugs involves several stages: research and development, preclinical tests, clinical trials, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorization, manufacturing, commercialization and post-marketing surveillance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">All of these stages are subject to specific requirements that impose substantial and onerous constraints, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compliance with which is ensured by various national (in France, the ANSM), regional (in the EU, the EMA) or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">federal (in the United States, the FDA) authorities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Failure to comply with these regulations may be subject to fines, to the suspension or withdrawal of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorizations and certifications required to perform pharmaceutical activities, to the seizure or withdrawal of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products from the market, or to partial or total suspension of their manufacturing. Regulatory authorities may also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">withdraw marketing authorizations (&#8220;MAs&#8221;) previously granted, reject MA applications (&#8220;MAAs&#8221;) and initiate legal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceedings whose outcome remains uncertain. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Although the regulatory constraints may differ from a country to another, development of therapeutic products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for human use must comply with requirements shared by all developed countries. The steps to be completed before <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtaining an MA in the EU and in the United States are generally as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">conduct of preclinical laboratory tests and studies in animals, in accordance with Good Laboratory <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Practice (&#8220;GLP&#8221;); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">conduct of clinical trials in humans to demonstrate the safety and efficacy of the product for each <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">considered indication, in accordance with Good Clinical Practice (&#8220;GCP&#8221;), after authorization by a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">competent authority and an ethics committee; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">if trial results are positive, preparation and submission of an MAA to the competent authority, in order <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">to market the product; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 378.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 379.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">inspection by the competent authority of the manufacturing facilities in which the product and/or its <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 389.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">ingredients are manufactured to assess compliance with Good Manufacturing Practices (&#8220;GMP&#8221;); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 405.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">inspection by the competent authority of establishments distributing medicinal products in order to <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 415.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">assess their compliance with Good Distribution Practice (&#8220;GDP&#8221;); and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 431.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">if needed, commitment by the applicant to comply with post-MA requirements. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 447.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Due to these regulatory constraints, the development and approval process of a drug candidate for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 457.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization, which varies according to its nature, complexity and novelty, usually extends over several years. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 485.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">EU Regulation <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 501.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Preclinical Studies <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Within all EU Member States, preclinical studies include laboratory evaluation of the composition, purity and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">stability of the active pharmaceutical ingredient and the formulated product, as well as studies to evaluate the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 537.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tolerance (toxicological studies), activity and behavior of the product candidate in vitro and in animals (in vivo). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 559.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The conduct of preclinical studies is subject to legal and regulatory provisions. Non-clinical studies are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 569.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">performed to demonstrate the health or environmental safety of new chemical or biological substances. Non-clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 579.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(pharmaco-toxicological) studies must be conducted in compliance with GLP, as set forth in EU Directive 2004/10/<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 589.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">EC (unless otherwise justified for certain particular medicinal products &#8211; e.g., radio-pharmaceutical precursors for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 599.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">radio-labelling purposes). In particular, non-clinical studies, both in vitro and in vivo, must be planned, performed, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">monitored, recorded, reported and archived in accordance with the GLP principles, which define a set of rules and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 619.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">criteria for a quality system for the organizational process and the conditions for non-clinical studies. These GLP <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 629.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">standards reflect the Organization for Economic Co-operation and Development requirements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 651.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Preclinical studies are a prerequisite for the initiation of clinical trials in humans: all the results of these trials <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 661.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are submitted to the regulatory authorities at the same time as the application to initiate clinical trials. However, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 671.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">while preclinical tests must be performed prior to conducting clinical trials in humans, certain long-term preclinical <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">86<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tests, such as tests on reproductive toxicity and carcinogenicity, may continue after the submission of an application <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to initiate clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Clinical Trials in Humans <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The various phases of clinical trials in the EU are subject to significant regulatory controls. They must be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conducted in accordance with EU and national regulations, the standards adopted by the International Conference on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Harmonization (&#8220;ICH&#8221;) and GCP. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Directive no. 2001/20/EC on the conduct of clinical trials sought to harmonize the regulatory framework for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials in the EU, setting out common rules for the monitoring and authorization of clinical trials in the EU. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">To reduce disparities between the transpositions by the Member States, Regulation 536/2014 on clinical trials on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">medicinal products for human use and repealing Directive 2001/20/EC, was adopted on April 16, 2014. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulation aims to further harmonize and streamline the clinical trial authorization process, improve their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supervision, simplify adverse event reporting procedures and increase the transparency of clinical trials. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulation became applicable on January 31, 2022. Following a three-year transition period, all clinical trials <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(including those ongoing and whose conduct was authorized in accordance with Directive no. 2001/20/EC), are fully <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to the provisions of the Regulation 536/2014 since January 31, 2025 and must have been brought into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compliance with the legal framework it provides. Failing this, the trial loses its authorization and must be stopped. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 277pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Under the clinical trials regulation, the sponsor may submit its application for a clinical trial authorization to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">one or several Member States, in which case the evaluation of Part I of the dossier (scientific part) is carried out <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">according to a coordinated procedure. In this framework, the sponsor must submit a single application for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorization via the portal associated with the EU database (&#8220;CTIS&#8221;), comprising a common scientific part <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evaluated jointly by all the EU Member States in which the trial will be carried out (with one of the Member States <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concerned acting as rapporteur Member State) and a national part covering the ethical aspects of the trial, evaluated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">independently by each Member State. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The conclusion of the rapporteur Member State with regard to Part I of the assessment report is deemed to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the conclusion of all Member States concerned. However, the Member States concerned may disagree with this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conclusion for a number of limited reasons, for example when they consider that participation in the clinical trial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would lead to a subject receiving a treatment inferior to that of normal clinical practice on their territory. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Member State concerned may then refuse the conduct of the clinical trial on its territory. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A &#8220;single&#8221; decision covering the conclusions of the Part I and Part II evaluations is issued by each of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Member States concerned and is notified to the sponsor on the dedicated European portal. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The sponsor of a clinical trial conducted in the EU notifies through the EudraVigilance database without delay <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and at the latest within the deadlines set by the clinical trials regulation, of all relevant information on suspected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">serious and unexpected adverse reactions to the investigational medicinal product. If the competent bodies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concerned consider that the adverse effects outweigh the benefits for the participants, they may require the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immediate suspension or early termination of the trial at any time. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the sponsor must submit through CTIS once a year, for the duration of the clinical trial, an Annual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Safety Report (ASR) for each investigational drug used in the clinical trial. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Finally, the EU framework applicable to clinical trials has also been significantly strengthened with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Regulation (EU) 2016/679 of the European Parliament and of the Council of April&#160;27, 2016, on the protection of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">natural persons with regard to the processing of personal data and on the free movement of such data, and repealing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Directive 95/46/EC (General Data Protection Regulation, &#8220;GDPR&#8221;), which entered into force on May&#160;25, 2018. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulation has significantly increased EU citizens&#8217; rights by giving them more control over their personal data. Thus, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">depending on the type of personal data processing carried out during clinical trials and the nature of such trials, it <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">might be necessary to carry out formalities by the local Data Protection Authority, in addition to seeking formal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">informed consent which must be obtained from each clinical trial subject. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Responsibility of the Sponsor and Insurance Obligation of the Sponsor <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the EU, the sponsor shall indemnify the subjects of the trial in case of damage arising as a consequence of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their participation in the research, unless he proves that the damage does not result from his fault or the fault of any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other person intervening in the trial. In the EU, Member States generally require a sponsor to have an insurance <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">87<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">covering its civil liability and the liability of any person intervening in the research. In addition, any breach to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provisions concerning clinical trials may lead to significant administrative, criminal and/or reputational penalties. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Marketing Approval <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Within the EU, marketing of medicinal products is governed by EU regulations (including but not limited to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Directive 2001/83/EC and Regulation 726/2004/EU). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On April&#160;26, 2023, the European Commission issued proposals for a revision of the current legal framework. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Although the proposal is subject to adoption by EU institutions, which become effective upon adoption, this new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">framework, which in particular aims at granting timely access to patients for safe, effective and affordable medicines <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and at enhancing supply of medicines, may significantly amend general principles described above, notably <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">timelines and market exclusivity periods. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 217pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the EU, medicinal product candidates can only be commercialized after obtaining an MA. To obtain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval of a product candidate under EU regulatory systems, we must submit an MAA. The process for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">doing this depends, among other things, on the nature of the medicinal product. There are two types of MAs: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">&#8220;Centralized MAs&#8221; are granted by the European Commission through the centralized procedure based <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">on the opinion of the Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;) of the EMA. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">MA issued under this procedure is valid in all EU Member States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">The centralized procedure is compulsory for some types of medicinal products such as biotechnology <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">products, designated orphan medicinal products, products containing a new active substance indicated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">for the treatment of AIDS, cancer, neurodegenerative disorders, diabetes or autoimmune and viral <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">diseases, advanced therapy medicinal products (such as gene therapy, somatic cell therapy and tissue <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">engineered products). The centralized procedure is optional for products containing a new active <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">substance that has not yet been authorized in the EU or for products which present a significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">therapeutic, scientific or technical innovation or are of interest for the public health in the EU. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">&#8220;National MAs&#8221; are issued at a national level by the competent authorities of the concerned Member <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">States. They are valid only on their territory. National MAs can be issued for products that do not fall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">within the mandatory scope of the centralized procedure. Medicinal products which have not received <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">a national MA in any of the Member States, may be authorized through the decentralized procedure. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">This procedure enables the simultaneous issuance of national MAs in several EU countries. Under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">decentralized procedure, an identical dossier is submitted to the competent authorities of each of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Member States in which an MA is sought. One of these Member States is designated by the applicant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">to act as the Reference Member State (&#8220;RMS&#8221;). The competent authority of the RMS drafts an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">assessment report and prepares an SmPC, a package leaflet and a draft labelling, which are sent to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">other Member States involved in the procedure, known as the Concerned Member States (&#8220;CMS&#8221;), for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">approval. If no CMS raises any objections based on a potential serious risk to public health, a national <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">MA is granted for the product in all Member States involved in the procedure (i.e., in the RMS and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">CMS). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">Where a product has already been authorized for marketing in an EU Member State, this national MA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">can be recognized in another Member State through the mutual recognition procedure. In this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">procedure, the Member State which issued the initial MA, known as the RMS, must prepare an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">assessment report on the medicinal product or update any existing report. This report is sent to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">CMS, together with the approved SmPC and the labelling and package leaflet. Unless an objection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">based on a potential serious risk to public health is raised, the CMS issue(s) a national MA for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">product, the terms of which are identical to the MA granted by the RMS. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Depending on the procedure used, the EMA or the national competent authority(ies) must, before granting a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">MA, make an assessment of the benefit/risk ratio of the product based on scientific criteria of quality, safety of use <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and efficacy. Under the centralized procedure the maximum timeframe for the evaluation of an MAA by the EMA is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">210 days, excluding clock stops. In exceptional cases, the CHMP might perform an accelerated review of an MAA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in no more than 150 days (not including clock stops). Innovative products that target an unmet medical need and are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">likely to be of major public health interest may be eligible for a number of expedited development and review <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">programs, such as the Priority Medicines (&#8220;PRIME&#8221;) scheme, which provides incentives similar to the breakthrough <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapy designation in the U.S. This program was launched by the EMA in March 2016, and aims at enhancing the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">EMA&#8217;s support for the development of medicines that target unmet medical needs. It is based on increased <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interaction through early dialogue with companies developing promising medicines, to optimize their development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">plans and speed up their evaluation to help them reach patients earlier. More specifically, product developers that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">benefit from PRIME access can benefit from early and proactive regulatory dialogue with the EMA and frequent <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">88<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discussions on clinical trial designs and other development program elements. Importantly, a dedicated contact and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rapporteur from the CHMP is appointed early in the PRIME scheme facilitating increased understanding of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product at EMA&#8217;s committee level. A team of multidisciplinary experts at the EMA is also composed to provide <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">guidance on the overall development and regulatory strategies. Thus, PRIME access is intended at speeding up the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assessment process of MAAs, without guarantee as to the outcome of the process. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Moreover, in the EU, a conditional MA may be granted by the European Commission for a period of one year <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and is renewable annually. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A conditional MA is granted in the absence of sufficient clinical data to obtain an ordinary MA if the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">following requirements are met: (i)&#160;the medicinal product is intended to treat, prevent or diagnose a fatal or seriously <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">debilitating disease, (ii)&#160;it fulfils to an unmet medical need, (iii)&#160;its benefit/risk ratio is, on the basis of the available <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">data, positive, (iv)&#160;it is likely that the applicant will be able to provide the required comprehensive post-MA clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">data and (v)&#160;in terms of public health, the benefits of the product&#8217;s immediate availability to patients outweigh the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks inherent to the lack of sufficient clinical data. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The granting of a conditional MA is accompanied by specific obligations, in particular relating to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completion of clinical trials, the performance of new studies and the collection of pharmacovigilance data in order to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">confirm the benefit/risk ratio of the product. Once the pending studies are provided, it can become an unconditional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">MA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">MAs may also be granted under exceptional circumstances to medicinal products for which a complete <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">evaluation file cannot be provided when the product&#8217;s indication is too rarely encountered and prevents the provision <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of comprehensive evidence, when the current state of scientific knowledge prevents the provision of such data or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">when the collection of the necessary data would be unethical. This MA is close to the conditional MA as it is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reserved to medicinal products to be approved for severe diseases or unmet medical needs and the applicant does not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">hold the complete data set legally required for the grant of an ordinary MA. However, unlike the conditional MA, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the applicant will not have to provide the missing data later. However, although the MA &#8220;under exceptional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">circumstances&#8221; is granted definitively, the risk-benefit balance of the medicinal product is reviewed annually and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">MA is withdrawn in case the risk-benefit ratio is no longer favorable. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Despite the granting of a MA, both the MA holder and the competent authorities may decide at any time to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">withdraw (voluntarily or compulsorily) a product from the market or a MA, when it appears that the product <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">presents more risks than benefits for the patients. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Data and Marketing Exclusivity <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the EU, new products authorized for marketing on the basis of a complete file (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 423.91pt; position: var(--position); text-decoration: none; white-space: pre;">i.e.<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.11pt; position: var(--position); text-decoration: none; white-space: pre;">, reference products) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generally receive eight years of data exclusivity and an additional two years of market exclusivity upon granting of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the MA. The data exclusivity period prevents generic and biosimilar applicants from relying on the preclinical and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar MA in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the EU during a period of eight years from the date on which the reference product was first authorized in the EU. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The market exclusivity period prevents generic or biosimilar from being commercialized in the EU until ten years <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have elapsed from the first MA of the reference product in the EU. The&#160; ten-year market exclusivity period can be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extended to a maximum of eleven years if, during the first eight years of those ten years, the MA holder obtains an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorization for one or more new therapeutic indications, which, during the scientific evaluation prior to their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorization, are held to bring a significant clinical benefit in comparison with existing therapies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Pediatric Development <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the EU, MAAs for new medicinal products must include the results of studies conducted in the pediatric <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">population, in compliance with a Pediatric Investigation Plan (&#8220;PIP&#8221;) agreed with the EMA&#8217;s Pediatric Committee <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;PDCO&#8221;). The PIP sets out the timing and measures proposed to generate data to support a pediatric indication of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the medicinal product for which MA is being sought. The PDCO can grant a deferral of the obligation to implement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">some or all of the measures of the PIP until there are sufficient data to demonstrate the efficacy and safety of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product in adults. Further, the obligation to provide pediatric clinical trial data can be waived by the PDCO when <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these data is not needed or appropriate because the product is likely to be ineffective or unsafe in children, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disease or condition for which the product is intended occurs only in adult populations, or when the product does not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">represent a significant therapeutic benefit over existing treatments for pediatric patients. Once the MA is obtained in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">all the EU member states and study results are included in the product information, even when negative, the product <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is eligible for six months&#8217; supplementary protection certificate extension (if any is in effect at the time of approval) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or, in the case of orphan pharmaceutical products, a two-year extension of the orphan market exclusivity is granted. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">89<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Manufacturing and Distribution-related Requirements <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">To ensure patients&#8217; safety, the manufacturing, distribution and import of active pharmaceutical ingredients and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">finished products into the EU are also subject to extensive requirements and both MA holders, manufacturers and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distributors of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Commission and/or the competent regulatory authorities of the Member States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Medicines (including their active substances) must be manufactured in accordance with GMP requirements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">These regulations govern manufacturing processes and procedures, and notably provide for requirements relating to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the implementation of quality systems to control and ensure the quality of materials and products. Manufacturing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">activities must be performed only within companies holding valid licenses from the competent regulatory authorities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the Member States which is issued following an inspection of the concerned facilities. In addition, routine <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inspections are conducted on a regularly basis to ensure that compliance is maintained. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Distributors must also comply with very strict requirements, including good distribution practices (&#8220;GDP&#8221;). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">These regulations provide for strict requirements including the implementation of an effective quality system and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adequate procedures to ensure the quality of the products all over the distribution chain and efficiently respond to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">claims, recalls, and risks of falsification, or the use of appropriate facilities, equipment and personnel. Similarly to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing, distribution activities are subject to a prior approval from the competent regulatory authorities of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Member States which is issued following an inspection of the concerned facilities which aims at ensuring that the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">establishment complies with the applicable regulations. Routine inspections are also conducted on a regularly basis. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Finally, the import of active pharmaceutical ingredients and medicines into the EU must also be authorized in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advance, in order to ensure that the products are manufactured and distributed in accordance with standards at least <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">equivalent to those existing for the EU market. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Failure to comply with the above requirements may be sanctioned by the suspension or withdrawal of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing/distribution/import authorization, civil, criminal or administrative penalties, or the withdrawal of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concerned active ingredients and finished products from the market. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Post-Approval Requirements <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: underline; white-space: pre;">Pharmacovigilance Requirements<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.67pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The MA holder must establish and maintain a pharmacovigilance system and designate a Qualified Person <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Responsible for Pharmacovigilance (&#8220;QPPV&#8221;) who is responsible for the establishment and maintenance of that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">system, and oversees the safety profiles of medicinal products and any emerging safety concerns. The main <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations of the QPPV include prompt reporting of suspected serious adverse reactions to competent authorities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and submission of periodic pharmacovigilance update reports (&#8220;PSURs&#8221;). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 475pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">All new MAA must include a risk management plan (&#8220;RMP&#8221;) describing the risk management system that the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company will put in place and setting out measures to prevent or minimize the risks associated with the medicinal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product. The regulatory authorities may also issue an MA subject to the fulfillment of specific obligations. These <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk reduction measures or post-authorization obligations may consist, in particular, of reinforced safety monitoring, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">more frequent submission of PSURs, the conduct of additional clinical trials or the performance of post- <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorization safety studies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: underline; white-space: pre;">Advertising Requirements<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the EU, the advertising and promotion of medicinal products is also subject to laws concerning promotion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of medicinal products, interactions with healthcare professionals, misleading and comparative advertising and unfair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercial practices. The general principles applicable to the advertising of medicines, which is broadly defined as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any form of door-to-door information, canvassing activity or inducement designed to promote the prescription, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supply, sale or consumption of medicinal products, are established by EU directives. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Any advertising or promotion of a medicinal product must comply with its approved SmPC. Consequently, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any promotion of off-label promotion is prohibited. Indeed, the advertising must encourage the rational use of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">medicines by presenting them objectively without exaggeration and thus, must not be misleading. Direct-to-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consumer advertising of prescription medicines is also prohibited in the EU. Although general requirements for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advertising and promotion of medicinal products are established under EU directives, the details are governed by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulations in each Member State and can differ from one country to another. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">90<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Depending on the Member States, advertising-related regulatory requirements may be sanctioned notably by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the suspension or withdrawal of regulatory authorizations, medicinal products recalls, medicinal products seizures, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operating restrictions and even criminal and/or civil prosecution and significant financial sanctions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The aforementioned EU rules are generally applicable in the European Economic Area (&#8220;EEA&#8221;) which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consists of the 27 EU member states plus Norway, Liechtenstein and Iceland. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Coverage and Reimbursement <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the EU, pricing and reimbursement systems widely vary from one country to another and remain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exclusively the responsibility of the Member States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Thus, Member States may restrict the range of medicines for which their national health insurance system <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provides reimbursement and control their price, provided that time limits for review of a reimbursement application <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provided in Directive 89/105/EEC of 21&#160;December 1988 must be complied with. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Some Member States use a system of positive and negative lists, whereby medicines can only be marketed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">after a reimbursement price has been agreed. Others may require additional studies comparing the cost-effectiveness <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of a medicinal product to existing therapies in order to obtain approval for reimbursement or pricing. Finally, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Member States can agree to a set price or, instead, allow companies to set their own prices while having their profits <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">monitored and controlled (e.g., control of the quantity of prescriptions). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Over the last few years, many EU Member States have increased the amount of rebates applied to medicinal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products, and these efforts may continue as Member States exercise greater control over their healthcare spending <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">due to often large debts. The downward pressure on healthcare costs in general, including medicinal products subject <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to mandatory prescription, has become considerable. Changing political, economic and regulatory conditions can <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">complicate price negotiations. This price negotiation can continue after reimbursement has been achieved and is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generally subject to periodic reviews. Finally, reference prices used by various EU Member States and parallel trade <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(i.e., arbitrage by distributors between low and high price Member States) may also lead to further price reductions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 383pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On December 13, 2021, Regulation No 2021/2282 on Health Technology Assessment (&#8220;HTA&#8221;) amending <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Directive 2011/24/EU, was adopted. While the Regulation entered into force in January 2022 it has only started to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">apply from January 12, 2025. Implementation is progressive. To date, it only applies to drugs containing new active <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">substances for the treatment of cancer and advanced therapy drugs. This regulation intends to boost cooperation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">among EU Member States in assessing health technologies, in order to speed up the availability of innovative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products on the EU market. The regulation permits EU Member States to use common HTA tools, methodologies, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and procedures across the EU. It also provides for joint clinical assessment of the innovative health technologies at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the EU level, joint scientific consultations whereby developers can seek advice from HTA authorities, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">identification of emerging health technologies to identify promising technologies early. Nonetheless, individual EU <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Member States continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">technology, and making decisions on pricing and reimbursement, provided they take into consideration the joint <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical assessment conducted at the EU level. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Other Healthcare Laws <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Relationships between the pharmaceutical industry and healthcare professionals are subject to national <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">restrictions and regulations in order to avoid any incentive to use or prescribe health products that is not exclusively <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">justified by the patient&#8217;s state of health and profile. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For example, in France, relations between the industry and healthcare professionals practicing in France are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">governed by the &#8220;anti-gift&#8221; and &#8220;transparency&#8221; laws. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">By way of principle, under the French anti-gift law, persons providing health services, manufacturing or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marketing healthcare products, regardless of their nationality and of the effective marketing of their health products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on the French market, are prohibited from promising or offering advantages of any kind whatsoever, in cash or in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">kind, either directly or indirectly, to healthcare professionals practicing in France, students intending to enter such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">professions or associations of these individuals, including learned societies and national professional councils. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The list of benefits that do that do not qualify as &#8220;advantages&#8221; under the anti-kickback regulation is very <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">limited and includes, for example, benefits that relate to the exercise of the beneficiary&#8217;s profession and of negligible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">value, which may not exceed the amounts provided for by a Ministerial Order. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">91<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">By way of exception, above-mentioned health stakeholders may provide advantages to the healthcare <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">professionals/associations mentioned above, subject to the conclusion of a written agreement and to a prior <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">declaration to or approval from the authority or board to which the concerned beneficiary belongs, depending on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amount of advantages granted. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">This exception is however limited to specific situations mainly including: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">The remuneration, compensation and expenses for research activities, research promotion, scientific <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">evaluation, consultancy, provision of services or commercial promotion, provided that the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">remuneration is proportionate to the service provided and that the compensation or expenses do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">exceed the costs actually incurred by the persons concerned; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Donations and gifts, in cash or in kind, exclusively intended to finance research activities, the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">promotion of research or scientific evaluation; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Hospitality offered during events of an exclusively professional or scientific nature, or during events <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">promoting healthcare products or services, provided that this hospitality is of a reasonable level, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">strictly limited to the main purpose of the event and to healthcare professionals (excluding students); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 251pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">When failing to comply with this regulation, in addition to a significant risk to their reputation, the companies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and professionals concerned may be subject to significant criminal penalties and, in the case of the latter, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disciplinary penalties. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The French transparency provision, for its part, provides citizens with access to certain information on a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">website so that they can more objectively assess the direct and indirect relationships between health actors (i.e., a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">broad list including healthcare professionals, associations of healthcare professionals, students, associations of users <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the health system, health establishments, academic institutions, foundations, learned societies and societies or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advisory bodies involved in the health product or health services sector, etc.) and companies producing or marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">health products or providing services associated with these products. Under the terms of this regulation, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">companies concerned must disclose the main information relating to their relationships with healthcare <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">professionals, such as compensation or benefits paid, and agreements entered into. Companies that knowingly fails <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to disclose such information may be subject to criminal penalties. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UK Regulation <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since the end of the Brexit transition period on January&#160;1, 2021, Great Britain (&#8220;GB&#8221;) (England, Scotland and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Wales) has not been directly subject to EU laws. However, under the terms of the Ireland/Northern Ireland Protocol, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">EU laws have generally applied to Northern Ireland. On February&#160;27, 2023, the UK government and the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Commission reached a political agreement on the so-called &#8220;Windsor Framework&#8221; which is intended to revise the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ireland/Northern Ireland Protocol in order to address some of the perceived shortcomings in its operation. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreement was adopted at the Withdrawal Agreement Joint Committee on March&#160;24, 2023. If the changes are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adopted in the form proposed, medicinal products to be placed on the market in the UK will be authorized solely in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with UK laws. Northern Ireland would be reintegrated back into a UK-only regulatory environment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">under the authority of the MHRA with respect to all medicinal products. The implementation of the Windsor <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Framework would occur in various stages, with new arrangements relating to the supply of medicines into Northern <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ireland anticipated to take effect in 2025. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The EU laws that have been transposed into United Kingdom (&#8220;UK&#8221;) law through secondary legislation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remain applicable in Great Britain. However, new EU legislation that was either adopted or entered into application <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">after Brexit such as the EU CTR is not applicable in Great Britain. The UK regulatory framework in relation to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials is derived from previously existing EU legislation (as implemented into UK law, through secondary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">legislation). On January&#160;17, 2022, the UK MHRA launched an 8-week consultation on reframing the UK legislation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for clinical trials. The consultation closed on March&#160;14, 2022, and aims to streamline clinical trial approvals, enable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">innovation, enhance clinical trials transparency, enable greater risk proportionality and promote patient and public <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">involvement in clinical trials. The outcome of the consultation is being closely watched and will determine whether <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the UK chooses to align with the (EU) CTR or diverge from it. Under the terms of the Ireland/Northern Ireland <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Protocol, provisions of the EU CTR which relate to the manufacture and import of investigational medicinal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products and auxiliary medicinal products currently apply in Northern Ireland. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since January&#160;1, 2021, the MHRA has been the sole regulatory of medicines and medical devices in GB and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for medicinal products that are not authorized through the centralized procedure in Northern Ireland. The MHRA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">has introduced changes to national licensing procedures, including procedures to prioritize access to new medicines <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that will benefit patients, including a 150-day assessment and a rolling review procedure. All existing EU MAs for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">centrally authorized products were automatically converted or grandfathered into UK MAs, effective in GB (only), <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">92<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">free of charge on January&#160;1, 2021, unless the MA holder opted-out. In order to use the centralized procedure to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtain an MA that will be valid throughout the EEA, companies must be established in the EEA. Therefore, since <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Brexit, companies established in the UK can no longer use the EU centralized procedure for authorization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">medicinal products intended to be marketed in the UK. In order to obtain a UK MA to commercialize products in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">UK, an applicant must be established in the UK and must follow one of the UK national authorization procedures or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">one of the remaining post-Brexit international cooperation procedures to obtain an MA to commercialize products in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the UK. Until December&#160;31, 2023, the MHRA may rely on a decision taken by the European Commission on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approval of a new (centralized procedure) MA when reviewing an application for authorization of a medicinal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product to be supplied in GB. Depending on the nature and intended therapeutic purpose of the medicinal product, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the MHRA may, alternatively, use its own decentralized or mutual recognition procedures which enable the MHRA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to have regard to MAs approved in EU Member States, Iceland, Liechtenstein, and Norway when granting an MA in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the UK or GB. From the first quarter of 2024, a new international recognition framework should be in place with an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">aim to extend the countries whose assessments the MHRA will take into account. The UK government will need to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adopt new legislation to introduce this route. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There is no pre-MA orphan designation procedure. Applications for orphan designation are made at the same <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">time as an application for MA and the MHRA will review applications for orphan designation in parallel to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding MA application. The criteria are essentially the same, but have been tailored for the market (i.e., the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prevalence of the condition in GB, rather than the EU, must not be more than five in 10,000). Should an orphan <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">designation be granted, the period or market exclusivity will be set from the date of first approval of the product in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">GB. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Government Regulation <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, (&#8220;FDCA&#8221;) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and its implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable federal, state, and local statutes and regulations requires the expenditure of substantial time and financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resources. Failure to comply with the applicable U.S. requirements at any time during the product development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">process, approval process, or after approval, may subject an applicant to a variety of administrative or judicial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sanctions, such as the FDA&#8217;s refusal to approve pending NDAs, withdrawal of an approval, imposition of a clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">hold on a clinical trial, issuance of warning letters, product recalls, product seizures, total or partial suspension of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">criminal penalties. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The process required by the FDA before a drug may be marketed in the United States generally involves the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Completion of preclinical laboratory studies, animal studies and formulation studies in compliance <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">with the FDA&#8217;s GLP regulations, and other applicable regulations; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Submission to the FDA of an IND which must become effective before human clinical trials may <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">begin; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Approval by the Institutional Review Board (&#8220;IRB&#8221;) or ethics committee, at each clinical site before <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">each trial may be initiated; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Performance of adequate and well-controlled human clinical trials, in accordance with GCP <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">requirements to establish the safety and effectiveness of the proposed drug product for each indication; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Submission to the FDA of an NDA; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Satisfactory completion of an FDA advisory committee review, if applicable; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">product is produced to assess compliance with current good manufacturing practice (&#8220;cGMP&#8221;) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">requirements and to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">identity, strength, quality and purity, and of potential inspection of selected clinical investigation sites <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">to assess compliance with GCPs; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">FDA review and approval of the NDA. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 661.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Preclinical Studies and INDs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Preclinical studies include laboratory evaluation of product chemistry, toxicity and formulation, as well as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">animal studies to assess potential safety and efficacy. An IND sponsor must submit the results of the preclinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">studies, together with manufacturing information, analytical data and any available clinical data or literature, among <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 708.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other things, to the FDA as part of an IND. Some preclinical studies may continue even after the IND is submitted. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">93<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concerns or questions related to one or more proposed clinical trials and places the clinical trial on a clinical hold. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As a result, submission of an IND may not result in the FDA allowing clinical trials to commence. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Clinical Trials <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Clinical trials involve the administration of the investigational drug to human patients under the supervision of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">qualified investigators in accordance with GCP requirements, which include, among other things, the requirement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that all research subjects provide their informed consent in writing for their participation in any clinical trial. Clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials are conducted under protocols detailing, among other things, the objectives of the trial, the parameters to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">used in monitoring safety and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent protocol amendments must be submitted to the FDA as part of the IND. In addition, the IRB(s) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">competent for the institution(s) participating in the clinical trial must review and approve the plan for any clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trial before it commences. Information about certain clinical trials must be submitted within specific timeframes to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the National Institutes of Health for public dissemination on their www.clinicaltrials.gov website. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">While the IND is active, progress reports detailing the results of the clinical trials and nonclinical studies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">performed since the last progress report, among other information, must be submitted at least annually to the FDA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and written IND safety reports must be submitted to the FDA and investigators for serious and unexpected suspected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">adverse events, findings from other studies suggesting a significant risk to humans exposed to the same or similar <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drugs, findings from animal or in vitro testing suggesting a significant risk to humans, and any clinically important <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increased incidence of a serious suspected adverse reaction compared to that listed in the protocol or investigator <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">brochure. Furthermore, the FDA or the sponsor may suspend or terminate a clinical trial at any time on various <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">grounds, including a finding that the research patients are being exposed to an unacceptable health risk. Similarly, an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">IRB can suspend or terminate approval of a clinical trial if the clinical trial is not being conducted in accordance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with the IRB&#8217;s requirements or if the drug has been associated with unexpected serious harm to patients. In addition, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">some clinical trials are overseen by an independent group of qualified experts organized by the sponsor, known as a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">data safety monitoring board or committee. Depending on its charter, this group may determine whether a trial may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">move forward at designated check points based on access to certain data from the trial. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For purposes of FDA approval, human clinical trials are generally conducted in three sequential phases that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may overlap or be combined: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.94pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 1:<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.3pt; position: var(--position); text-decoration: none; white-space: pre;"> The drug candidate is initially introduced into healthy human subjects and tested for safety, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">dosage tolerance, absorption, metabolism, distribution and excretion and, if possible, to gain an early <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">indication of its effectiveness. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.94pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2:<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.3pt; position: var(--position); text-decoration: none; white-space: pre;"> The drug candidate is administered to a limited patient population with a specified disease or <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">condition to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the drug candidate for specific targeted diseases and to determine dosage tolerance and appropriate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">dosage. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.94pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3:<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.3pt; position: var(--position); text-decoration: none; white-space: pre;"> The drug candidate is administered to an expanded patient population to further evaluate <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">dosage, to provide substantial evidence of efficacy and to further test for safety, generally at multiple <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">risk-benefit ratio of the drug candidate and provide an adequate basis for product labeling. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Post-approval trials, sometimes referred to as Phase 4 studies, may be conducted after initial marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approval. These trials are used to, among other things, gain additional experience from the treatment of patients in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the intended therapeutic indication. In certain instances, the FDA may mandate the performance of Phase 4 clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trials as a condition of approval of an NDA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Concurrent with clinical trials, companies usually complete additional animal studies and must also develop <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">additional information about the chemistry and physical characteristics of the drug and finalize a process for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing the product in commercial quantities in accordance with GMPs. The manufacturing process must be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">capable of consistently producing quality batches of the drug candidate and, among other things, the manufacturer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">must develop methods for testing the identity, strength, quality and purity of the final drug. In addition, appropriate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">packaging must be selected and tested, and stability studies must be conducted to demonstrate that the drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidate does not undergo unacceptable deterioration over its shelf life. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">94<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Marketing Approval <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Assuming successful completion of the required clinical testing, the results of the preclinical studies and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the product for one or more indications. In most cases, the submission of an NDA is subject to a substantial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">application user fee. Under the Prescription Drug User Fee Act guidelines that are currently in effect, the FDA has a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">goal of ten months from the date of &#8220;filing&#8221; of a standard NDA for a new molecular entity to review and act on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">submission. This review typically takes twelve months from the date the NDA is submitted to FDA because the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">FDA has approximately two months to make a &#8220;filing&#8221; decision. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, under the Pediatric Research Equity Act of 2003, as amended and reauthorized, certain NDAs or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supplements to an NDA must contain data that are adequate to assess the safety and effectiveness of the drug for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pediatric subpopulation for which the product is safe and effective. The FDA may, on its own initiative or at the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product for use in adults, or full or partial waivers from the pediatric data requirements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FDA also may require submission of a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) plan to ensure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that the benefits of the drug outweigh its risks. The REMS plan could include Medication Guides (FDA approved <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patient labeling to be provided to patients when the drug is dispensed), physician communication plans, assessment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">plans, or Elements to Assure Safe Use, such as restricted distribution methods, patient registries, or other risk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">minimization tools. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FDA conducts a preliminary review of all NDAs within the first 60 days after submission, before <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accepting them for filing, to determine whether they are sufficiently complete to permit substantive review. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">FDA may request additional information rather than accept an NDA for filing. In this event, the application must be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resubmitted with the additional information. The resubmitted application is also subject to review before the FDA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">FDA reviews an NDA to determine, among other things, whether the drug is safe and effective and whether the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">continued safety, quality and purity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FDA may refer an application for a novel drug to an Advisory Committee. An Advisory Committee is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates and provides a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recommendation as to whether the application should be approved and under what conditions. The FDA is not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bound by the recommendations of an Advisory Committee, but it considers such recommendations carefully when <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">making decisions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Before approving an NDA, the FDA typically will inspect the facility or facilities where the commercial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product would be manufactured. The FDA will not approve an application unless it determines that the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">production of the product within required specifications. Additionally, before approving an NDA, the FDA may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inspect one or more clinical trial sites to verify the clinical data submitted in the NDA, and to assure compliance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with GCP requirements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">After evaluating the NDA and all related information, including the Advisory Committee recommendation, if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approval letter, or, in some cases, a Complete Response Letter. An approval letter authorizes commercial marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the review cycle of the application is complete, and the application will not be approved in its present form, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">describes the specific deficiencies in the NDA identified by the FDA and may require additional clinical data, such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as an additional clinical trial or other significant and time-consuming requirements related to clinical trials, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">nonclinical studies or manufacturing. If a CRL is issued, the sponsor must resubmit the NDA, addressing all of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deficiencies identified in the letter, or withdraw the application. Even if such data and information are submitted, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">FDA may decide that the NDA does not satisfy the criteria for approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Even if the FDA approves a product, it may limit the approved indications for use of the product, require that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including Phase 4 clinical trials, be conducted to further assess a drug&#8217;s safety after approval, require testing and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">surveillance programs to monitor the product after commercialization, or impose other conditions, including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the potential market and profitability of the product. The FDA may at any time prevent or limit further marketing of <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">95<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a product based on the results of post-marketing studies or surveillance programs. After initial approval, some types <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">claims, are subject to further testing requirements and FDA review and approval. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Post-Approval Requirements <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product sampling and distribution, the submission of advertising and promotion, and reporting of adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">experiences with the product. After approval, most changes to the approved product, such as adding new indications <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or other labeling claims are subject to prior FDA review and approval. There also are continuing, annual program <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">user fee requirements for any marketed products, as well as new application fees for certain supplemental <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applications. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example, the FDA may require post-marketing testing, including Phase 4 clinical trials, and surveillance to further <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assess and monitor the product&#8217;s safety and effectiveness after commercialization. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drugs are required to register their establishments with the FDA and state agencies, and are subject to periodic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">FDA regulations also require manufacturers to investigate and correct of any deviations from cGMP requirements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of production and quality control to maintain cGMP compliance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and standards is not maintained or if problems occur after the product reaches the market. Later discovery of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with manufacturing processes, or failure to comply with regulatory requirements, may result in mandatory revisions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">new safety risks; or imposition of distribution or other restrictions under a REMS program. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Other potential consequences include, among other things: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Restrictions on the marketing or manufacturing of the product, complete withdrawal of the product <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">from the market or product recalls; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Fines, warning letters or holds on post-approval clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">revocation of product approvals; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Product seizure or detention, or refusal to permit the import or export of products; or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Injunctions or the imposition of civil or criminal penalties. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of unapproved uses (&#8220;off-label&#8221; uses), and a company that is found to have improperly promoted off-label uses may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be subject to significant liability. Physicians may prescribe legally available products for uses that are not described <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the product&#8217;s labeling and that differ from those tested by us and approved by the FDA. The FDA does not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">communications on the subject of off-label use of their products. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Marketing Exclusivity <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Market exclusivity provisions under the FDCA can delay the submission or the approval of certain marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applications. The FDCA provides a five-year period of non-patent data exclusivity within the United States to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">has not previously approved any other new drug containing the same active moiety, which is the molecule or ion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an abbreviated new drug application (&#8220;ANDA&#8221;), or an NDA submitted under Section&#160;505(b)(2) (&#8220;505(b)(2) NDA&#8221;) <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">96<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">submitted by another company for another drug based on the same active moiety, regardless of whether the drug is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intended for the same indication as the original innovative drug or for another indication, where the applicant does <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not own or have a legal right of reference to all the data required for approval. However, an application may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">submitted after four years if it contains a certification of patent invalidity or non-infringement to one of the patents <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">listed with the FDA by the innovator NDA holder. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The FDCA alternatively provides three years of marketing exclusivity for an NDA, or supplement to an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the applicant are deemed by the FDA to be essential to the approval of the application, for example new indications, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dosages or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ANDAs or 505(b)(2) NDAs for drugs containing the active agent for the original indication or condition of use. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">submitting a full NDA would be required to conduct, or obtain a right of reference to, all of the preclinical studies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Pediatric exclusivity is another type of marketing exclusivity available in the United States. Pediatric <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exclusivity provides for an additional six months of marketing exclusivity attached to another period of exclusivity if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a sponsor conducts clinical trials in children in response to a written request from the FDA. The issuance of a written <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">request does not require the sponsor to undertake the described clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Coverage and Reimbursement <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Sales of our drug candidates, if approved, will depend, in part, on the extent to which such products will be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">covered by third-party payors, such as government health care programs, commercial insurance and managed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">healthcare organizations. These third-party payors determine which medications they will cover and establish <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement levels. In addition, these third-party payors are increasingly limiting coverage or reducing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursements for medical products and services. In the United States, no uniform policy of coverage and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement for products exists among third-party payors. Therefore, coverage and reimbursement for products <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">can differ significantly from payor to payor. In addition, the U.S. government and state legislatures have continued <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for substitution of generic products. Patients who are prescribed medications for the treatment of their conditions, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and their prescribing physicians, generally rely on third-party payors to reimburse all or part of the costs associated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with their prescription drugs. Patients are unlikely to use our products unless coverage is provided and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement is adequate to cover all or a significant portion of the cost of our products. As a result, adoption of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">controls and measures, could further limit our net revenue and results. Decreases in third-party reimbursement for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates or a decision by a third-party payor to not cover our drug candidates could reduce physician <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">usage of our drug candidates, once approved, and have a material adverse effect on our sales, results of operations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and financial condition. Additionally, we or our collaborators may develop companion diagnostic tests for use with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our drug candidates. We or our collaborators will be required to obtain coverage and reimbursement for these tests <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">separate and apart from the coverage and reimbursement we seek for our drug candidates, once approved. Similar <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to companion diagnostics. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Other Healthcare Laws <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We will also be subject to other healthcare regulation and enforcement by the U.S. federal government and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">states in which we will conduct our business once our drug candidates are approved. Failure to comply with these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws, where applicable, can result in the imposition of significant administrative, civil, and criminal penalties. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">laws that may affect our ability to operate in the United States include: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">The federal healthcare programs&#8217; Anti-Kickback Statute, which prohibits, among other things, persons <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">recommendation of, any good or service for which payment may be made under federal healthcare <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">programs such as the Medicare and Medicaid programs; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Federal false claims act laws, including the civil False Claims Act, which prohibit, among other things, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">individuals or entities from knowingly presenting, or causing to be presented, claims for payment from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Medicare, Medicaid, or other third-party payors that are false or fraudulent; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">The federal health care fraud statutes, which created additional federal criminal statutes that impose <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">criminal and civil liability for, among other things, executing or attempting to execute a scheme to <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">97<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">defraud any healthcare benefit program or knowingly and willingly falsifying, concealing or covering <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">up a material fact or making false statements relating to healthcare matters; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 96.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 97.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">The Physician Payments Sunshine Act, which requires manufacturers of drugs, devices, biologics, and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 107.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">medical supplies to report annually to the Centers for Medicare&#160;&amp; Medicaid Services, information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 117.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">related to payments and other transfers of value to physicians (defined to include doctors, dentists, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 127.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">optometrists, podiatrists and chiropractors), other health care professionals (such as physicians <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 137.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">assistants and nurse practitioners), and teaching hospitals, as well as and ownership and investment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 147.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">interests held by physicians and their immediate family members; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 163.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">The U.S. federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 173.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">created additional federal criminal statutes that impose criminal and civil liability for, among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 183.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">things, executing or attempting to execute a scheme to defraud any healthcare benefit program or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 193.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">knowingly and willingly falsifying, concealing or covering up a material fact or making false <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 203.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">statements relating to healthcare matters; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 219.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 229.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;HITECH&#8221;), which governs the conduct of covered entities, business associates, and their covered <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 239.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">subcontractors regarding certain electronic healthcare transactions and protects the security and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 249.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">privacy of protected health information. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 271.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, many states have similar laws and regulations, such as anti-kickback and false claims laws that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 281.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may be broader in scope and may apply regardless of payor, in addition to items and services reimbursed under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 291.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Medicaid and other state programs. Further, certain states enacted laws that require: pharmaceutical companies to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 301.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 311.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">promulgated by the federal government; drug manufacturers to report information related to payments and other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 321.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">transfers of value to physicians and other healthcare providers or marketing expenditures; the reporting of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 331.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information related to drug pricing; the registration of pharmaceutical sales representatives. Certain states have also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 341.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">enacted legislation to govern the privacy and security of health information, many of which differ from each other in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 351.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. Additionally, to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 361.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extent that our product is sold in a foreign country, we may be subject to similar foreign laws. Violation of any of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 371.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these laws or any other governmental regulations, may result in significant civil, criminal and administrative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 381.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">penalties, damages, fines, disgorgement, imprisonment, possible exclusion from government funded healthcare <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 391.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">programs, such as Medicare and Medicaid, contractual damages, reputational harm, and diminished profits and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 401.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">future earnings.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 429.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: underline; white-space: pre;">Healthcare Reform <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 445.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The enactment of the Affordable Care Act (&#8220;ACA&#8221;) has substantially changed healthcare financing and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 455.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delivery by both governmental and private insurers, and significantly impacted the pharmaceutical industry. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 465.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ACA, among other things, expanded access to health care coverage through the creation of ACA marketplaces, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 475.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expanded Medicaid eligibility, established an annual, nondeductible fee on any entity that manufactures or imports <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 485.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certain specified branded prescription drugs and biologic agents, revised the methodology by which rebates owed by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 495.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturers to the state and federal government for covered outpatient drugs under the Medicaid Drug Rebate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 505.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Program are calculated, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 515.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Drug Rebate Program, extended the Medicaid Drug Rebate program to utilization of prescriptions of individuals <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">enrolled in Medicaid managed care organizations, and provided incentives to programs that increase the federal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 535.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">government&#8217;s comparative effectiveness research. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since its enactment, there have been judicial and congressional challenges to certain aspects of the ACA. Most <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 567.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recently, on June&#160;17, 2021, the United States Supreme Court dismissed a challenge on procedural grounds that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 577.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">argued the ACA is unconstitutional in its entirety because the individual mandate was repealed by Congress. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition, there have been a number of health reform initiatives that have impacted the ACA. For example, on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 597.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">August&#160;16, 2022, President Biden signed the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;), into law, which among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 607.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">things, extends enhanced subsidies for individuals purchasing health insurance coverage in ACA marketplaces <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 617.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">through plan year 2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 627.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2025 by significantly lowering the beneficiary maximum out-of-pocket cost through a newly established <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 637.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturer discount program. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Other legislative changes have been proposed and adopted since the ACA was enacted. For example, on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">August&#160;2, 2011, the Budget Control Act of 2011 was signed into law which among other things, led to aggregate <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">98<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reductions in Medicare payments to providers. These reductions went into effect on April&#160;1, 2013, and, due to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent legislative amendments, will remain in effect until 2032 unless additional Congressional action is taken.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, there has been heightened governmental scrutiny over the manner in which manufacturers set <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 115.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prices for their marketed products. For example, there have been several congressional inquiries and proposed bills <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 137.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and manufacturer patient programs, and reform government program reimbursement methodologies for drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">products. For example, on March 11, 2021, the American Rescue Plan Act of 2021 was signed into law, which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#8217;s average manufacturer price, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 171.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">beginning January 1, 2024. In addition, the IRA, among other things, (1)&#160;directs HHS to negotiate the price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certain single-source drugs and biologics that have been on the market for at least 7 years and covered under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 193.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Medicare and (2)&#160;imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outpace inflation. These provisions began to take effect progressively starting in fiscal year 2023, although the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Medicare drug price negotiation program is currently subject to litigation. On August 15, 2024, HHS announced the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 227.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreed-upon prices of the first ten drugs that were subject to price negotiations, which take effect in January 2026. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">HHS will select up to fifteen additional products covered under Part D for negotiation in 2025. Each year thereafter <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 249.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">more Part B and Part D products will become subject to the HHS price negotiation program. Further, on December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">7, 2023, the Biden administration announced an initiative to control the price of prescription drugs through the use <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of march-in rights under the Bayh-Dole Act. On December 8, 2023, the National Institute of Standards and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 283.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Technology published for comment a Draft Interagency Guidance Framework for Considering the Exercise of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">March-In Rights which for the first time includes the price of a product as one factor an agency can use when <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 305.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deciding to exercise march-in rights. While march-in rights have not previously been exercised, it is uncertain if that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will continue under the new framework. At the state level, legislatures are increasingly passing legislation and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">implementing regulations designed to control pharmaceutical and biological product pricing, including price or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 339.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 361.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">purchasing. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.85pt; position: var(--position); white-space: pre;">For example, on January 5, 2024, the FDA approved Florida&#8217;s Section 804 Importation Program ("SIP") <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 372.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">proposal to import certain drugs from Canada for specific state healthcare programs. It is unclear how this program <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">will be implemented, including which drugs will be chosen, and whether it will be subject to legal challenges in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 395.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">United States or Canada. Other states have also submitted SIP proposals that are pending review by the FDA. Any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">such approved importation plans, when implemented, may result in lower drug prices for products covered by those <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 417.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">programs.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We expect that additional U.S. federal healthcare reform measures will be adopted in the future, particularly in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">light of the recent U.S. Presidential and Congressional elections, any of which could limit the amounts that the U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">federal government will pay for healthcare products and services, which could result in reduced demand for our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates or additional pricing pressures. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Intellectual Property <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our success will depend upon our ability to obtain and maintain patents and other intellectual property for our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drug candidates in the United States and internationally, including composition-of-matter, pharmaceutical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composition, synthesis process, method of manufacture and method of treatment, as well as patent and other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property and proprietary protection for our novel discoveries and other important technology inventions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and know-how. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">One of our strategies is also to file new patents that could extend obefazimod&#8217;s intellectual property protection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the United States to 2039 and to generate new intellectual property through the protection of potential follow-on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compounds. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to patents, we rely upon unpatented trade secrets, know-how, and continuing technological <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">innovation to develop and maintain our competitive position. We protect our proprietary information, in part, using <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">confidentiality agreements with our commercial partners, collaborators, employees and consultants and invention <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assignment agreements with our employees. We also have confidentiality agreements or invention assignment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreements with our commercial partners and selected consultants. Despite these measures, any of our intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">property and proprietary rights could be challenged, invalidated, circumvented, infringed or misappropriated, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such intellectual property and proprietary rights may not be sufficient to permit us to take advantage of current <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market trends or otherwise to provide competitive advantages. In addition, such confidentiality agreements and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">invention assignment agreements can be breached and we may not have adequate remedies for any such breach. For <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 708.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">more information, please see &#8220;Risk Factors&#8212;Risks Related to Intellectual Property.&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301pt; position: var(--position); white-space: pre;">99<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 1pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 73pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The term of individual patents depends upon the legal term of the patents in the countries in which they are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obtained. In most countries in which we are seeking patent protection for our drug candidates, the patent term is 20 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 93pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">years from the earliest date of filing a non-provisional patent application. In the United States, the term of a patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 103pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may be lengthened by a patent term adjustment, which provides for term extension in the case of administrative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 113pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delays at the United States Patent and Trademark Office in granting a patent, or may be shortened if a patent is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 123pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terminally disclaimed over another patent with an earlier expiration date. Furthermore, in the United States, the term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 133pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of a patent covering an FDA approved drug may be eligible for patent term extension (&#8220;PTE&#8221;) under the Hatch-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 143pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Waxman Amendments as compensation for the loss of patent term during the FDA regulatory review process. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 153pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">period of extension may be up to five years beyond the expiration of the patent but cannot extend the term of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 163pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patent beyond a total of 14 years from the date of product approval. Only one patent covering a single FDA-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 173pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved product among those eligible for an extension may be extended. In the future, if any of our drug candidates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 183pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">receives FDA approval, we expect to apply for a PTE, if available, to extend the term of a patent covering such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 193pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved drug product. We also expect to seek PTEs in any jurisdictions where they are available, however, there is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 203pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">no guarantee that the applicable authorities, including the FDA, will agree with our assessment of whether such an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 213pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extension should be granted, and even if granted, the length of such an extension. See &#8220;Item 3.D. Risk Factors&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 223pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risks Related to Intellectual Property &#8212; Our ability to commercialize our drug candidates may decrease if we are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 233pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unable to protect our intellectual property rights or if these rights are insufficient for our purposes." <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 261pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Patents <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 277pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">All the patents and patent applications covering obefazimod are co-owned with the French National Centre for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 287pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Scientific Research (the &#8220;CNRS&#8221;), the University of Montpellier, and the Institut Curie, except U.S. patent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 297pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">10,464,903, U.S. patent 10,745,357, U.S. patent application 17/913,063, U.S. patent applications 18/729,018, U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 307pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">patent application 18/893,339, U.S. patent application 18/832,670 and PCT patent application PCT/IB2024/000410, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 317pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as described below. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 345pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 361pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, the principal patent rights related to obefazimod, include: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 377pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent 10,017,498, which is directed to the composition of matter of obefazimod generically and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 387pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">specifically and to a pharmaceutical composition comprising it. This patent is also granted in Europe <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 397pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and several other countries (Australia, Brazil, Canada, China, Hong Kong, Cuba, India, Japan, South <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 407pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Korea, Mexico, Russia, South Africa) and has an expiry date of 2030, not including patent term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 417pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">adjustment or any potential PTE. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 433pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent 10,975,063, which is directed specifically to obefazimod (composition of matter), free base <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 443pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and salts of obefazimod, a pharmaceutical composition comprising it, a process for preparing it and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 453pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">method for treating HIV infection. This patent has an expiry date of 2030, not including patent term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 463pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">adjustment or any potential PTE. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 479pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent 10,435,370, which is directed to methods of treating inflammatory diseases including UC <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 489pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and CD by obefazimod generically and specifically. This patent is also granted in Europe and several <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 499pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">other countries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 515pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. continuation patent 11,649,211 is directed to the method of treating inflammatory diseases <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">including UC and CD by obefazimod specifically. Divisional U.S. patents protect methods of treating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 535pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">additional inflammatory diseases (U.S. patent 10,981,874 and U.S. patent 11,649,210). These patents <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 545pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">have an expiry date of 2035, not including patent term adjustment or any potential PTE. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 561pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent 10,464,903 and U.S. patent 10,745,357, which are directed to a synthesis process for <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 571pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturing obefazimod and derivatives thereof, a polymorphic form of the free base of obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 581pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and crystalline forms of various salts of obefazimod. These patents have an expiry date of 2037, not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 591pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">including patent term adjustment or any potential PTE. A corresponding European patent has also been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 601pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">granted. These patents are solely owned by us. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 615.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">Further indications are also protected by other patents: U.S. patent 9,827,237, which is directed to the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">method of treating Human Leukemia virus infection. This patent is also granted in Europe and several <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">other countries and has an expiry date of 2034. U.S. patent 9,145,367, which is directed to the method <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">of treating AIDS by obefazimod generically and specifically. This patent is also granted in Europe and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">several other countries and has an expiry date of 2030. U.S. patent 9,108,919, which is directed to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">method of treating cancer by obefazimod generically and specifically. This patent is also granted in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Europe and several other countries and has an expiry date of 2030. Another patent application directed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">to a method of treating cancer has been filed worldwide in 2019. U.S. patent 10,806,729 which is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">directed to the method of treating HIV resistant patients by obefazimod generically and specifically. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">This patent is also granted in Europe and other countries and has an expiry date of 2036. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">100<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent applications 17/416,856, now granted under U.S. 11,992,499 and 17/416,679, which are <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">respectively directed to the method of treating other inflammatory diseases and cancer by obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">generically and specifically or its N-glucuronide metabolite have been filed in 2019, as well as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">counterpart applications in other countries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent application 17/913,063, which is directed to the method of treating Coronaviridae infection <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">by obefazimod generically and specifically or its N-glucuronide metabolite has been filed in 2021, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">well as counterpart applications in other countries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent application 17/796,834, which is directed to the amorphous solid dispersion (ASD) of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod, its method of preparation, pharmaceutical composition and method of treating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory disease, cancer and viral diseases therewith has been filed in 2021, as well as counterpart <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">applications in other countries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent application 17/793,133, which is directed to co-crystals and salts of obefazimod, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical composition and method of treating inflammatory disease, cancer and viral diseases <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">therewith has been filed in 2021, as well as counterpart applications in other countries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent application 18/284,253, which is directed to a synthesis process for manufacturing <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and derivatives thereof and was filed in 2022, as well as counterpart applications in other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">countries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">U.S. patent applications 18/729,018 and 18/893,339, which are directed to combinations products with <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and etrasimod or ozanimod were respectively filed in 2023 and 2024, as well as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">counterpart applications in other countries.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 7.62pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. patent application 18/832,670, which is directed to combinations products with obefazimod and <span style="display: inline-block; height: 7.62pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 319pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); text-decoration: none; white-space: pre;">Rinvoq, filed in 2023, as well as counterpart applications in other countries.<span style="display: inline-block; height: 7.62pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">PCT patent application PCT/IB2024/000410, which is directed to obefazimod for treatment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">ulcerative colitis, was filed in 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Trademarks and Domain Names <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We own a number of registered and pending trademarks and registered domain names. The URL for our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">website, as well as a number of domain names including the wording &#8220;abivax&#8221; or &#8220;obefazimod.&#8221; &#8220;Abivax&#8221; is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">registered trademark of our company in Australia, Brazil, Canada, Cuba, the EU, France, India, South Africa, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">United Kingdom and the United States. The &#8220;Abivax&#8221; trademark is pending in Canada, China, India, Japan, Mexico, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">South Africa, South Korea and the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">101<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_49"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span><span id="i004c22ff46594f7485f20a4e815f92a1"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Organizational Structure<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">Abivax SA is the parent company of Abivax, LLC, a wholly-owned subsidiary organized in Delaware, United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 120pt; width: 612pt;"><div style="left: 79.92pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="abvx-20241231_g24.jpg" alt="Organization Structure.jpg" style="height: 225.83pt; width: 452.16pt;"/></div></div></div><div style="position: absolute; top: 362.83pt;" id="ia894b143b6fc4522a0483350194c625e_52"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">D.<span style="display: inline-block; height: 6.77pt;"></span><span id="ib6cb81b3d05c40a38299a1be4820c5ae"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Property, Plants and Equipment.<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our corporate head<span style="display: inline-block; height: 6.93pt;"></span><span id="i2ee86e202c6944c2a58a88ec3e9adf97"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.63pt; position: var(--position); text-decoration: none; white-space: pre;">quarters is located in Paris, France, where we occupy approximately 850<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.85pt; position: var(--position); text-decoration: none; white-space: pre;"> m&#178;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.11pt; position: var(--position); text-decoration: none; white-space: pre;"> of office space <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398.03pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that we sublease and we lease 150 m<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 218.76pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.01pt; position: var(--position); text-decoration: none; white-space: pre;"> of office space in Jacou, Region of Occitanie in the south of France. We lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 409.23pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an additional 279 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.87pt; position: var(--position); white-space: pre;">m&#178;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.63pt; position: var(--position); text-decoration: none; white-space: pre;"> of office space in Boston, Massachusetts. We believe our existing facilities meet our current <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">needs.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 443.63pt;" id="ia894b143b6fc4522a0483350194c625e_55"></div><div style="line-height: 10pt; position: var(--position); top: 455.63pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 4A. <span style="display: inline-block; height: 6.77pt; width: 32.3pt;"></span></span><span style="left: 144pt; position: var(--position);">Unresolved Staff Comments.<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i32caf7541b704924ae356d7247aec86d"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 479.63pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">102<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_58"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 5.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Operating and Financial Review and Prospects<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i8e192020445745d0a526f53acc4e9e77"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">You should read the following discussion of our financial condition and results of operations in conjunction <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 106pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with our financial statements and the related notes thereto included elsewhere in this Annual Report on Form 20-F. <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 116pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to historical information, the following discussion and analysis contains forward-looking statements that <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reflect our plans, estimates and beliefs. Our actual results and the timing of events could differ materially from those <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">anticipated in the forward-looking statements. Factors that could cause or contribute to these differences include <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">those discussed below and elsewhere in this annual report, particularly in the sections titled &#8220;Item 3.D&#8212;Risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Factors&#8221; and &#8220;Special Note Regarding Forward-Looking Statements.&#8221; <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Overview <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are a clinical-stage biotechnology company focused on developing therapeutics that harness the body&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. We <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are currently evaluating our lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with moderately to severely active ulcerative colitis (&#8220;UC&#8221;). We also initiated a Phase 2b clinical trial of obefazimod <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in patients with Crohn&#8217;s disease (&#8220;CD&#8221;) in October 2024, as well as evaluating other potential inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">indications. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We focus on indications where existing treatments have left patients with significant unmet needs, and where <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we believe our investigational agents have the potential to be meaningfully differentiated from currently available <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapies. The indications we target have substantial populations and represent large commercial opportunities, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pending regulatory approvals and successful commercialization. Our initial focus is on inflammatory bowel diseases <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;IBD&#8221;), chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">forms are UC and CD. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We believe our lead drug candidate, obefazimod, is differentiated from competing approaches for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatment of IBD via its novel mechanism of action. Obefazimod was demonstrated to specifically enhance the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expression of a single micro-RNA, miR-124, which plays a critical role in the regulation of the inflammatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">response. In the context of inflammation, miR-124 is a natural regulator of the inflammatory response, controlling <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">progression of inflammation and restoring homeostasis of the immune system, without causing broader <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immunosuppression. In contrast to currently available advanced therapies, prescribed post-conventional therapies, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">some of which target only a single cytokine or pathway, miR-124 modulates the expression of several key cytokines <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and pathways. Modulating multiple inflammatory pathways simultaneously may lead to more durability of efficacy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">results over the long-term, which is critical in lifelong conditions such as IBD, potentially differentiating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod from currently available IBD treatments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We were incorporated as a <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 205.51pt; position: var(--position); text-decoration: none; white-space: pre;">soci&#233;t&#233; anonyme <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.31pt; position: var(--position); text-decoration: none; white-space: pre;">on December 4, 2013 and, in 2014, we acquired Splicos, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Wittycell and Zophis by means of a universal transfer of assets and liabilities (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 385.77pt; position: var(--position); text-decoration: none; white-space: pre;">Transmission Universelle du <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Patrimoine <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.45pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;TUP&#8221;)). We have been listed on Euronext Paris since June&#160;26, 2015, and on the Nasdaq Global Market <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">since October 24, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 505pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.75pt; position: var(--position); text-decoration: none; white-space: pre;">On March 20, 2023, our United States-based subsidiary Abivax LLC (the &#8220;Subsidiary&#8221;) was formed as a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 515pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">limited liability company under the laws of the State of Delaware. The Subsidiary hosts our operations in the United <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">States. We have prepared audited consolidated financial statements as of and for the year ended December 31, 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 535pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, the Subsidiary&#8217;s contribution to our consolidated results of operations was a net operating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">loss of &#8364;15.0<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.38pt; position: var(--position); text-decoration: none; white-space: pre;"> million.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 567pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since our inception<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 174.19pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.69pt; position: var(--position); text-decoration: none; white-space: pre;">in 2013, we have devoted substantially all of our efforts to organizing and staffing our <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 577pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company, business planning, raising capital, establishing our intellectual property portfolio, acquiring or discovering <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drug candidates, research and development activities for obefazimod and other compounds, establishing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 597pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">arrangements with third parties for the manufacture of our drug candidates and component materials, and providing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 607pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">general and administrative support for these operations. We do not have any products approved for sale and have not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 617pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generated any revenue from product sales or otherwise. We do not expect to generate significant revenue from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 627pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">product sales or royalties unless and until our drug candidates are approved for marketing and successfully <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 637pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 659pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have incurred significant operating losses since inception, and we expect to continue to incur significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expenses and operating losses for the foreseeable future. Our ability to generate product revenue sufficient to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 679pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achieve profitability will depend heavily on the successful development and eventual commercialization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and any future drug candidates. For the years ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.43pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.43pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.43pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.43pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.86pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.86pt; position: var(--position); text-decoration: none; white-space: pre;">, we reported <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 699pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">net losses of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176.2<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.4pt; position: var(--position); text-decoration: none; white-space: pre;"> million, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;147.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.6pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;60.7 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.88pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.13pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.11pt; position: var(--position); text-decoration: none; white-space: pre;">, we carried <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 709pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">forward accumulated tax losse<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.78pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">s of</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.5pt; position: var(--position); text-decoration: none; white-space: pre;"> &#8364;609,4<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.85pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.35pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.85pt; position: var(--position); text-decoration: none; white-space: pre;">We expect to continue to incur net operating losses for at least the <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">103<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">next several years, and we do not anticipate achieving profitability in the future unless we obtain regulatory <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approvals necessary to commercialize obefazimod and any additional drug candidates that we may pursue in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">future. We expect that our research and development expenses, general and administrative expenses, and capital <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expenditures will increase substantially in connection with our ongoing activities, particularly if and as we: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">continue to advance our existing drug candidates through clinical development; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">timely and successfully complete clinical development of obefazimod, our clinical-stage drug <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">candidate; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">seek and maintain regulatory and marketing approvals for obefazimod and any future drug candidates <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">for which we successfully complete clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">continue the preclinical and clinical development of our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">expand the scope of our current clinical trials for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">begin new clinical trials for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">develop, scale and validate our commercial manufacturing capabilities for our drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">establish a sales, marketing and distribution infrastructure to commercialize any drugs for which we <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">may obtain regulatory and marketing approval for which we have not entered into a collaboration with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">a third-party; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">seek to discover, identify and validate additional drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">acquire or in-license other drug candidates and technologies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">make milestone, royalty or other payments under in-license or collaboration agreements; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 332.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 333.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">obtain, maintain, protect, enforce and expand our intellectual property portfolio; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 349.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">manufacture, or have manufactured, non-clinical, clinical and potentially commercial supplies of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 359.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and any future drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 375.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">attract new and retain existing clinical, scientific, operational, financial and management personnel; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 385.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 401.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">incur additional legal, accounting, and other costs associated with operating as a dual-listed French and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 411.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. public company. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 433.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our net losses may fluctuate significantly from period to period, depending on the timing of expenditures <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 443.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related to our research and development activities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 465.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We will not generate revenue from product sales unless and until we successfully complete clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 475.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development and obtain regulatory approval for a drug candidate. In particular, following the issuance of royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 485.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certificates in September 2022 and other royalties that may become payable under our royalty agreements, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 495.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payment of royalties in the event of commercialization of obefazimod would result in a decrease in cash flows <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 505.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generated by sales of the product, which could have an unfavorable impact on our financial position, particularly at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 515.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the beginning of the commercialization phase. In addition, if we obtain regulatory approval for a drug candidate and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">do not enter into a third-party commercialization partnership, we expect to incur significant expenses related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 535.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">developing our commercialization capability to support product sales, marketing, manufacturing and distribution <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 545.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">activities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 567.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As a result, we will need substantial additional funding to support our continuing operations and pursue our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 577.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 587.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">finance our operations through equity offerings, debt financings or other capital sources, which could include <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 597.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">collaborations, strategic alliances or additional licensing arrangements. We may be unable to raise additional funds <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 607.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or enter into such arrangements when needed, on favorable terms, or at all. Our failure to raise capital or enter into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 617.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such agreements as, and when, needed, could have a material adverse effect on our business, results of operations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 627.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and financial condition, including requiring us to have to delay, reduce or eliminate product development or future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 637.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization efforts. The amount and timing of our future funding requirements will depend on many factors, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 647.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including the successful advancement of obefazimod or any future drug candidates. Our ability to raise additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 657.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">funds may also be adversely impacted by potential worsening global economic conditions and disruptions to and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 667.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">volatility in the credit and financial markets in the United States and worldwide, such as those resulting from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 677.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ongoing war in Ukraine. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 699.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Due to the numerous risks and uncertainties associated with development of treatment of chronic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 709.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory diseases, we are unable to predict the timing or amount of increased expenses or when or if we will be <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">104<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unable to continue our operations at planned levels and be forced to reduce or terminate our operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Principal Factors Affecting Our Results of Operations <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The following factors have affected, and we expect will continue to affect, our results of operations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Research and Development Activities <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development activities are central to our business. Since our inception, most of our resources <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">have been allocated to research and development and it accounts for the majority of our operating expenses. For the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.59pt; position: var(--position); text-decoration: none; white-space: pre;">, research and development expenses accounted for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.11pt; position: var(--position); text-decoration: none; white-space: pre;">79%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.44pt; position: var(--position); text-decoration: none; white-space: pre;"> of our total operating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expenses, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.05pt; position: var(--position); text-decoration: none; white-space: pre;">78%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.38pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.31pt; position: var(--position); text-decoration: none; white-space: pre;"> 87%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.14pt; position: var(--position); text-decoration: none; white-space: pre;"> (excluding goodwill impairment loss) for the years ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.43pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. Drug candidates in later stages of clinical development generally have higher <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development costs than those in earlier stages of clinical development, primarily due to the increased size and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">duration of later-stage clinical trials. Accordingly, we expect that our research and development expenses will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increase in the foreseeable future as we seek to advance the development of our drug candidates. The successful <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development of our drug candidates remains highly uncertain. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">At this time, we cannot accurately determine or estimate the nature, timing and costs of the research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development activities that will be necessary to complete the remainder of the development of obefazimod, and we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may never succeed in obtaining regulatory approval for obefazimod or any future drug candidates we may develop. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The duration, costs and timing of clinical trials and the development of our drug candidates will depend on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">numerous risks and uncertainties associated with clinical development, including risks and uncertainties related to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the scope, progress, outcome and expenses of our clinical trials and other research and development <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">activities; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the length of time required to enroll suitable patients and successful patient enrollment in, and the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">initiation and completion of, clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the results of our clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the timing, receipt and terms of any marketing approvals from applicable regulatory authorities; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the establishment of commercial manufacturing capabilities or making arrangements with third-party <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">manufacturers; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the expense of filing, prosecuting, maintaining, defending and enforcing patent claims and other <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">intellectual property rights; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">changing government regulation; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">launching commercial sales of our drug candidates, if and when approved, whether alone or in <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">collaboration with others; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">maintaining a continued acceptable safety profile of the drug candidates following regulatory approval; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the ability to market, commercialize and achieve market acceptance for obefazimod or any other drug <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">candidate that we may develop in the future; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">significant competition and rapidly changing technologies within the biopharmaceutical industry. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A change in the outcome of any of these variables with respect to the development of any of our drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates could significantly change the costs and timing associated with the development of that drug candidate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The actual probability of success for our drug candidates will be affected by a variety of factors, including the safety <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and efficacy of our drug candidates, investment in our clinical programs, manufacturing capability and competition <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with other products and drug candidates. As a result of these variables, we are unable to determine the duration and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completion costs of our research and development projects or when and to what extent we may generate revenue <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from the commercialization and sale of our drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Marketing Approval and Market Acceptance of our Drug Candidates <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We may never succeed in achieving marketing approval for any of our drug candidates. We may obtain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unexpected and/or negative results from our clinical trials. We may elect to discontinue, delay or modify the <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">105<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development plan and clinical trials of some drug candidates or focus on others. A change in the outcome of any of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these factors with respect to the development of drug candidates that we are developing could result in a significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">change in the costs and timing associated with the development of such drug candidates. For example, if the EMA or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the FDA or other regulatory authority were to require us to conduct non-clinical studies and clinical trials beyond <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">those that we currently anticipate will be required for the completion of clinical development, or if we experience <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant delays in enrollment in any clinical trials, we could be required to spend significant additional financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resources and time on the completion of clinical development of our drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Equity and Debt Financing <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">At this stage, we have not generated any revenue from sales of products or otherwise, and we do not expect to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">do so unless and until we successfully complete development of, obtain marketing approval for, and successfully <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialize, one or more of our drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.19pt; position: var(--position); text-decoration: none; white-space: pre;">Until such time<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.78pt; position: var(--position); text-decoration: none; white-space: pre;"> that we can generate substantial revenue from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sales of products, if ever, we expect to finance our operating activities through a combination of equity offerings, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">debt financings and government or other third-party funding. However, we may be unable to raise additional funds <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or enter into such arrangements when needed on favorable terms, or at all, which would have a negative impact on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our financial condition and could force us to delay, limit, reduce or terminate our development programs or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization efforts or grant to others the rights to develop or market drug candidates that we would otherwise <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prefer to develop and market ourselves. Failure to receive additional funding could cause us to cease operations, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">part or in full. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition of Prosynergia <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On April 1, 2022, we acquired 100% of the share capital of Prosynergia with the aim of strengthening our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">research and development portfolio, for an amount of &#8364;3.25&#160;million. On December 12, 2022, we completed the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">merger with Prosynergia through a TUP and all of Prosynergia&#8217;s assets and liabilities were transferred to us. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Following the merger, Prosynergia was dissolved. Accordingly, as Prosynergia was dissolved in December 2022, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">did not prepare consolidated financial statements as of December&#160;31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On December 12, 2024, we were notified of a claim from the seller of Prosynergia requesting the payment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an earn-out in connection with the transaction. Legal proceedings are ongoing in French court. We have not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">registered any provision in our accounts in connection with this claim due to uncertainty in the outcome of this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceeding.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.89pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Impact of the Russia-Ukraine War on our Business <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 435.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The Russia-Ukraine war continues. The conflict has already had major implications for the global economy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 445.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and the rate of inflation, particularly in relation to the supply of energy, raw materials and food products. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.46pt; position: var(--position); white-space: pre;">It has also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 455.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">caused intense volatility on the financial markets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99pt; position: var(--position); white-space: pre;">Given these developments, we have decided not to include Russia and Belarus in our global Phase 3 clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">trials for obefazimod in UC. However, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.06pt; position: var(--position); text-decoration: none; white-space: pre;">the global scale of this conflict <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.44pt; position: var(--position); text-decoration: none; white-space: pre;">cannot<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 381.07pt; position: var(--position); text-decoration: none; white-space: pre;"> be predicted at this stage. We, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therefore, cannot rule out an adverse impact of this conflict on our business, including in terms of access to raw <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">materials, logistics, the performance of clinical trials and in relation to any future financing we may seek. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 533.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.53pt; position: var(--position); white-space: pre;">long-term safety and efficacy extension of the<span style="display: inline-block; height: 8.25pt;"></span></span><span style="color: #ff0000; font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 298.18pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2b maintenance trial of obefazimod in moderately to <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">severely active UC is our only clinical trial <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.19pt; position: var(--position); white-space: pre;">with patients currently enrolled <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.8pt; position: var(--position); text-decoration: none; white-space: pre;">in Ukraine. The Phase 2b 12-month <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assessment was carried out in all the Ukrainian patients before the war broke out and these patients are therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">included in the one-year maintenance results that were reported on April&#160;6, 2022. Ukrainian patients who completed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the two-year Phase 2b maintenance trial have been transitioned to the long-term safety and efficacy trial that is still <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on-going. None of these sites are located i<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">n the Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">or the so-called Luhansk People&#8217;s Republic. We have a few sites active in the western part of Ukraine in the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ABTECT Phase 3 clinical trials. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Together with our CRO, we are making considerable efforts to ensure the follow-up of patients who are </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">unable to come to the study centers. Monitoring takes place through a remote monitoring system that was </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">established and used successfully during the COVID-19 pandemic. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">106<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_61"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="i9a7adda35dd348c9869df796b63b1f0d"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Operating Results<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Comparison of Years Ended <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 195.82999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022, 2023 and 2024 <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth our results of operations for the years ended December 31, 2022, 2023 and 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 150pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 523.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 196.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 196.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.85pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 0pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.85pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 0pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.85pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.9pt; position: var(--position); text-decoration: none; white-space: pre;">% 2023 Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.9pt; position: var(--position); text-decoration: none; white-space: pre;">% 2024 Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other operating income<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 122.64999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 123.22999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 123.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 123.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 123.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.77pt; position: var(--position); text-decoration: none; white-space: pre;">............................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 30.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 34.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">4,583<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 30.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 34.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">4,621<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 30.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 29.79pt;"></span></span><span style="left: 37.42pt; position: var(--position);">12,449<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 30.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 40.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 40.92pt; position: var(--position);">1<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 30.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 30.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 30.92pt; position: var(--position);">169<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 45pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 66.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 45pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 66.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 45pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 57.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 50.25pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total operating income<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 101.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 103.14999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 103.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 103.58999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 103.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 103.71pt; position: var(--position); text-decoration: none; white-space: pre;">....................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 39.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">4,583<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 39.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">4,621<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 34.79pt;"></span></span><span style="left: 37.42pt; position: var(--position);">12,449<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 50.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 40.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 40.92pt; position: var(--position);">1<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 50.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 30.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 30.92pt; position: var(--position);">169<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 64.5pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 64.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 64.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 64.5pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69.75pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 25.13pt; position: var(--position); text-decoration: none; white-space: pre;">Sales and marketing expenses<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 144.73pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 145.89000000000001pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 146.18pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.22pt; position: var(--position); text-decoration: none; white-space: pre;">...................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 69.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 53.4pt;"></span></span><span style="left: 56.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 69.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">(6,431)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 69.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">(5,954)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 69.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 34.4pt;"></span></span><span style="left: 37.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 13.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 69.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 37.59pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 37.59pt; position: var(--position);">(7)<span style="display: inline-block; height: 6.94pt; width: 1.67pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 172.28pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 173.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 173.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 173.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 173.71pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 173.73pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.74pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 84pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(48,295)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 84pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(103,176)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 84pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(146,532)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 84pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 30.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 30.92pt; position: var(--position);">114<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 84pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 35.92pt; position: var(--position);">42<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative expenses<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 175.07999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 176.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.25pt; position: var(--position); text-decoration: none; white-space: pre;">.......<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 98.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">(7,492)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 98.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(22,390)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 98.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(32,946)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 98.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 30.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 30.92pt; position: var(--position);">199<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 98.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 35.92pt; position: var(--position);">47<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 112.5pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill impairment loss<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 131.02pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 131.17000000000002pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 131.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.3pt; position: var(--position); text-decoration: none; white-space: pre;">.........................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 112.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(13,632)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 112.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 53.4pt;"></span></span><span style="left: 56.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 112.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 53.4pt;"></span></span><span style="left: 56.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 112.5pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 27.59pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 27.59pt; position: var(--position);">(100)<span style="display: inline-block; height: 6.94pt; width: 1.67pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 112.5pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 34.4pt;"></span></span><span style="left: 37.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 13.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 126.75pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 126.75pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 126.75pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total operating expenses<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 108.66pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 108.81pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 108.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108.86pt; position: var(--position); text-decoration: none; white-space: pre;">..................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 132pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(69,419)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 132pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(131,997)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 132pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(185,433)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 132pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 35.92pt; position: var(--position);">90<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 132pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 35.92pt; position: var(--position);">40<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 146.25pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 146.25pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 146.25pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 151.5pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income (loss)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 104.21pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.36999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 105.94999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 106.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 106.17999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">...................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 151.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(64,836)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 151.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(127,376)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 151.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(172,984)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 151.5pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 35.92pt; position: var(--position);">96<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 151.5pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 35.92pt; position: var(--position);">36<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165.75pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 165.75pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 165.75pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 165.75pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial expenses<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 103.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 103.75999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.83999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">....................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 171pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">(7,022)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 171pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(27,875)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 171pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(16,991)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 171pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 30.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 30.92pt; position: var(--position);">297<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 171pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 32.59pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(39)<span style="display: inline-block; height: 6.94pt; width: 1.67pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 185.25pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial income<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 96.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 97.97999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 98.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 98.64pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 98.67999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.69pt; position: var(--position); text-decoration: none; white-space: pre;">......................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 185.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 34.79pt;"></span></span><span style="left: 37.42pt; position: var(--position);">11,118<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 185.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 39.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">7,511<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 185.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 34.79pt;"></span></span><span style="left: 37.42pt; position: var(--position);">13,732<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 185.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 32.59pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(32)<span style="display: inline-block; height: 6.94pt; width: 1.67pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 185.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 35.92pt; position: var(--position);">83<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 50.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 199.5pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 199.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 199.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 199.5pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 204.75pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial income (loss)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 100.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 100.89999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 101.19pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 101.27pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 101.28pt; position: var(--position); text-decoration: none; white-space: pre;">.....................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 204.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 39.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">4,096<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 204.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(20,364)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 204.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">(3,258)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 204.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 27.59pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 27.59pt; position: var(--position);">(597)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 204.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 32.59pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(84)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 219pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 219pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 219pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 219pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 224.25pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss before tax<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 81.17pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 81.36pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 224.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 31.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(60,740)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 224.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(147,740)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 224.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(176,242)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 224.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 30.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 30.92pt; position: var(--position);">143<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 224.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 35.92pt; position: var(--position);">19<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 238.5pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 238.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 238.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 238.5pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 243.75pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Income Tax<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 73.53pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 73.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.84pt; position: var(--position); text-decoration: none; white-space: pre;">................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 243.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 53.4pt;"></span></span><span style="left: 56.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 243.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 53.4pt;"></span></span><span style="left: 56.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 243.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 53.4pt;"></span></span><span style="left: 56.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 243.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 37.03pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 37.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 13.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 243.75pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 37.03pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 37.03pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 13.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 258pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 258pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 258pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 59pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 263.25pt; width: 196.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 196.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 96.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 98.14999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 98.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 98.58999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 98.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 98.71pt; position: var(--position); text-decoration: none; white-space: pre;">......................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 263.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 26.46pt;"></span></span><span style="left: 34.09pt; position: var(--position);">(60,740)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 263.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 21.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(147,740)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 263.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 21.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">(176,242)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 263.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 30.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 30.92pt; position: var(--position);">143<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 263.25pt; width: 60pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 35.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 35.92pt; position: var(--position);">19<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 49.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 277.5pt; width: 196.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 196.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 277.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 277.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 463.5pt; position: var(--position); top: 277.5pt; width: 60pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 455.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Total Operating Income <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); white-space: pre;">, our total operating income was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.27pt; position: var(--position); white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.6 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.39pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.85pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.21pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.8pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.8 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.62pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.45pt; position: var(--position); text-decoration: none; white-space: pre;">169%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.78pt; position: var(--position); white-space: pre;">, as detailed below. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our total operating income was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.6 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.77pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 511.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.6 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 525.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.85pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.21pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.8pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.04&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.62pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.45pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.78pt; position: var(--position); text-decoration: none; white-space: pre;">, as detailed below. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 555.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Other Operating Income <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 571.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth our other operating income for the years ended December 31, 2024, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 581.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 591.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 603.59pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66.75pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 156.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.98pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.31pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.98pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.31pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.98pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.31pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 0pt; width: 66.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.27pt; position: var(--position); text-decoration: none; white-space: pre;">% 2023 Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 0pt; width: 66.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.27pt; position: var(--position); text-decoration: none; white-space: pre;">% 2024 Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 156.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CIR (Research Tax Credits)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 114.42pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 115.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 116.16pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 116.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.42999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">...............<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 30.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 25.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">4,476<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 30.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 25.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">4,493<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 30.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 25.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">6,651<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 30.75pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 42.67pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 42.67pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 13.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 30.75pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 42.67pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 42.67pt; position: var(--position);">48<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 57.67pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 156.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 40.940000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 41.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.56pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 45pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 37.54pt;"></span></span><span style="left: 45.17pt; position: var(--position);">29<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 45pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 37.54pt;"></span></span><span style="left: 45.17pt; position: var(--position);">81<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 45pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 25.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">4,140<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 45pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 37.67pt; position: var(--position);">179<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 57.67pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 45pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 32.67pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 32.67pt; position: var(--position);">5017<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 57.67pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 59.25pt; width: 156.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 25.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 25.959999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 26.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 26.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.52pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 59.25pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 37.54pt;"></span></span><span style="left: 45.17pt; position: var(--position);">78<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 59.25pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 37.54pt;"></span></span><span style="left: 45.17pt; position: var(--position);">47<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 59.25pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 25.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">1,657<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 59.25pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 39.34pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 39.34pt; position: var(--position);">(40)<span style="display: inline-block; height: 6.93pt; width: 1.67pt;"></span></span><span style="left: 57.67pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 59.25pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 32.67pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 32.67pt; position: var(--position);">3448<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 57.67pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 156.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 73.5pt; width: 59.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 58.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 73.5pt; width: 59.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 58.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 73.5pt; width: 66.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 65.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 156.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total other operating income<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 127.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 128.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 128.69pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 128.84pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 128.92000000000002pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 128.96pt; position: var(--position); text-decoration: none; white-space: pre;">..........<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 78.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 25.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">4,583<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 78.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 25.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">4,621<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 78.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 20.04pt;"></span></span><span style="left: 27.669999999999998pt; position: var(--position);">12,449<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 334.5pt; position: var(--position); top: 78.75pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 47.67pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 47.67pt; position: var(--position);">1<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 56pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 78.75pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 37.67pt; position: var(--position);">169<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 56pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 156.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 93pt; width: 59.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 93pt; width: 59.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 93pt; width: 66.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 33.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">107<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); white-space: pre;">, our other operating income was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.21pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.06pt; position: var(--position); white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.04pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.6 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 83.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.85pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.21pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.8pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.8&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.62pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.45pt; position: var(--position); text-decoration: none; white-space: pre;">169%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.78pt; position: var(--position); white-space: pre;">.&#160; This variation is due to an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">increase in subsidies by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.97pt; position: var(--position); white-space: pre;">, an increase in research tax credits by &#8364;2.2 million and an increase in other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 105.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">items by &#8364;1.6 million.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our other operating income was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.6 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.56pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.6 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.85pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.21pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.8pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.04&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.62pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.45pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.78pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.78pt; position: var(--position); white-space: pre;">There was no significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">variation during the period, as detailed below.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.67pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Research Tax Credits ("CIR")<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); white-space: pre;">, we recognized research tax credits for our research and development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">projects of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.95pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.7 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.8pt; position: var(--position); white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 233.78pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.5 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.63pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.99pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.58pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.85pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.68pt; position: var(--position); text-decoration: none; white-space: pre;">48%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.01pt; position: var(--position); white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.01pt; position: var(--position); text-decoration: none; white-space: pre;">The<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.54000000000002pt; position: var(--position); white-space: pre;"> increase corresponds <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.05pt; position: var(--position); text-decoration: none; white-space: pre;">to a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">n additional CIR payment received in 2024 related to the 2021 </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.84pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">tax </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.7pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">year</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.89pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, for an amount of &#8364;1.0 million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.13pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.06pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">to an increase in the CIR for the tax year 2024</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.84pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> as compared to the tax </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 251.04pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">year 2023 of &#8364;1.1 million, or 26%. This increase is mainly due to the reimbursements of conditional advances and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262.24pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">overpayment of conditional advances made to Bpifrance in relation to the RNP-VIR and CARENA projects, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 273.44pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">following the termination of both projects </span><span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.82pt; position: var(--position); white-space: pre;">(see <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 260.4pt; position: var(--position); white-space: pre;">Bpifrance - Conditional Advances and Subsidies<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.39pt; position: var(--position); white-space: pre;"> within the <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">"Liquidity and Capital Resources" section)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.78pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.28pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, we recognized research tax credits for our research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development projects of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.5 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.9pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.5 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.73pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.68pt; position: var(--position); text-decoration: none; white-space: pre;">, an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 331.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.89pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.05pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.55pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.05pt; position: var(--position); text-decoration: none; white-space: pre;">Although <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.31pt; position: var(--position); white-space: pre;">research and development expenses increased by 114% between 2022 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 343.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and 2023, there was no significant variation during the period due to the maximum amount of eligible outsourced <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 355.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">research and development expenses being capped and internal research and development costs being stable.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.56pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 381.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); white-space: pre;">, our subsidy income was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.85pt; position: var(--position); white-space: pre;"> as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.1800000000001pt; position: var(--position); white-space: pre;"> for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.7pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.29pt; position: var(--position); white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.29pt; position: var(--position); white-space: pre;">The increase is related to the RNP-VIR and CARENA conditional advances <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426.74pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">granted by Bpifrance between 2013 and 2019. Following the termination of both projects, in June 2024, Bpifrance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 437.94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">agreed to waive 60% of the remaining conditional advances and accrued interests, resulting in a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.57pt; position: var(--position); text-decoration: none; white-space: pre;"> non-cash <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.65pt; position: var(--position); text-decoration: none; white-space: pre;">subsid<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.2pt; position: var(--position); text-decoration: none; white-space: pre;">y<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 449.14pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">income of &#8364;4.1 million (see <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 184.66pt; position: var(--position); white-space: pre;">Bpifrance - Conditional Advances and Subsidies<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.65pt; position: var(--position); white-space: pre;"> within the "Liquidity and Capital <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Resources" section)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.26pt; position: var(--position); white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our subsidy income was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.35pt; position: var(--position); text-decoration: none; white-space: pre;">,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.85pt; position: var(--position); text-decoration: none; white-space: pre;"> as compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.03 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.86pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.45pt; position: var(--position); text-decoration: none; white-space: pre;">. Th<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.55pt; position: var(--position); text-decoration: none; white-space: pre;">ere was no significant variation for 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 525.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Other <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">For the year ended December 31, 2024, the line item "Other" was &#8364;1.7 million, as compared to &#8364;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.05<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 511.87pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558.74pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">million for the year ended December 31, 2023. The increase is driven by the issuance, cancellation and depositary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 569.94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">service fees collected from ADSs holders by Citibank, who is acting as our exclusive depositary for our publicly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 581.14pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">listed and freely traded ADSs. As part of our depositary agreement with Citibank, we are entitled to receive a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">portion of the collected fees.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 615.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Total Operating Expenses <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); white-space: pre;">, our total operating expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;185.4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 452.81pt; position: var(--position); white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 652.18pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;132.0 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.85pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.8pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;53.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.62pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.45pt; position: var(--position); text-decoration: none; white-space: pre;">40%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.78pt; position: var(--position); white-space: pre;">. This increase was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.38pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">primarily due to an increase in research and development expenses of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;43.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.33pt; position: var(--position); white-space: pre;"> and an increase in general and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 674.58pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">administrative expenses of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.6 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.88pt; position: var(--position); white-space: pre;">, each as described below.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 696.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our total operating expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;132.0 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.31pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 708.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;69.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.8pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;62.6&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.45pt; position: var(--position); text-decoration: none; white-space: pre;">90%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.78pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.78pt; position: var(--position); white-space: pre;">This increase was <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">108<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">primarily due to an increase in research and development expenses of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;54.9 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.33pt; position: var(--position); white-space: pre;"> and an increase in general and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">administrative expenses of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.9 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.88pt; position: var(--position); white-space: pre;">, partially offset by the absence of goodwill impairment loss as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">December 31, 2023 (compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.53pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.6 million <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.88pt; position: var(--position); white-space: pre;">as of December 31, 2022).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Sales and Marketing Expenses <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our total sales and marketing expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.07pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.92pt; position: var(--position); text-decoration: none; white-space: pre;">, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.01pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.37pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.96pt; position: var(--position); white-space: pre;">, a decrease of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.59pt; position: var(--position); text-decoration: none; white-space: pre;">(7)%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.58pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.58pt; position: var(--position); text-decoration: none; white-space: pre;">The decrease was primarily <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">driven by the restructuring of our sales and marketing department part way through 2024. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.49pt; position: var(--position); text-decoration: none; white-space: pre;">These expenses consist <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">primarily of consulting costs associated with market research in preparation for our future sales and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization efforts in the U.S.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); white-space: pre;">, our <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.51pt; position: var(--position); text-decoration: none; white-space: pre;">total sales and marketing expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.07pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.92pt; position: var(--position); white-space: pre;">. We did <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">not incur any sales and marketing expenses in 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Research and Development Expenses <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth our research and development expenses by drug candidate and therapeutic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">indication for the years ended December 31, 2024, 2023 and 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 306pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 120pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 79.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 79.5pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 0pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.85pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.98pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.31pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.73pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.06pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.37pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 0pt; width: 79.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.65pt; position: var(--position); text-decoration: none; white-space: pre;">% 2023 Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 0pt; width: 79.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.65pt; position: var(--position); text-decoration: none; white-space: pre;">% 2024 Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.81pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.870000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">.........................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 30.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 29.79pt;"></span></span><span style="left: 37.42pt; position: var(--position);">45,024<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 30.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 20.04pt;"></span></span><span style="left: 27.669999999999998pt; position: var(--position);">97,869<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 30.75pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 16.54pt;"></span></span><span style="left: 24.169999999999998pt; position: var(--position);">142,712<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 30.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 50.42pt; position: var(--position);">117<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 30.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 55.42pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 55.42pt; position: var(--position);">46<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ulcerative Colitis<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 97.89999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 99.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 99.64pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.67999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.69pt; position: var(--position); text-decoration: none; white-space: pre;">.......<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 45pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 34.79pt;"></span></span><span style="left: 37.42pt; position: var(--position);">38,555<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 45pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 25.04pt;"></span></span><span style="left: 27.669999999999998pt; position: var(--position);">83,788<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 45pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 21.54pt;"></span></span><span style="left: 24.169999999999998pt; position: var(--position);">115,818<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 45pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 50.42pt; position: var(--position);">117<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 45pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 55.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 55.42pt; position: var(--position);">38<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 59.25pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Crohn&#8217;s Disease<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 93.53pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 94.69pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 94.72999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.75pt; position: var(--position); text-decoration: none; white-space: pre;">.........<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 59.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 57.29pt;"></span></span><span style="left: 59.92pt; position: var(--position);">1<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 59.25pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 30.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">2,735<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 59.25pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 31.54pt;"></span></span><span style="left: 34.17pt; position: var(--position);">7,354<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 59.25pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 53.9pt;"></span></span><span style="left: 56.53pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 13.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 59.25pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 50.42pt; position: var(--position);">169<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Rheumatoid Arthritis<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 111.27pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 111.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 112.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 112.22pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 112.25999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.28pt; position: var(--position); text-decoration: none; white-space: pre;">..<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 73.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 47.29pt;"></span></span><span style="left: 49.92pt; position: var(--position);">848<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 73.5pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 37.54pt;"></span></span><span style="left: 40.17pt; position: var(--position);">368<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 73.5pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 44.04pt;"></span></span><span style="left: 46.67pt; position: var(--position);">12<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 73.5pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 52.09pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 52.09pt; position: var(--position);">(57)<span style="display: inline-block; height: 6.94pt; width: 1.67pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 73.5pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 52.09pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 52.09pt; position: var(--position);">(97)<span style="display: inline-block; height: 6.94pt; width: 1.67pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87.75pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Covid-19 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 66.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.9pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.19pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 67.27pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 67.28pt; position: var(--position); text-decoration: none; white-space: pre;">....................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 87.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 43.96pt;"></span></span><span style="left: 46.59pt; position: var(--position);">(768)<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 87.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 42.54pt;"></span></span><span style="left: 45.17pt; position: var(--position);">11<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 87.75pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 44.04pt;"></span></span><span style="left: 46.67pt; position: var(--position);">22<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 87.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 47.09pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 47.09pt; position: var(--position);">(101)<span style="display: inline-block; height: 6.94pt; width: 1.67pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 87.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 50.42pt; position: var(--position);">106<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Obefazimod Other <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 38.63pt; position: var(--position); text-decoration: none; white-space: pre;">Indication<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 79.7pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 79.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.86pt; position: var(--position); text-decoration: none; white-space: pre;">...............<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.64pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 52.29pt;"></span></span><span style="left: 54.92pt; position: var(--position);">68<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 102pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.64pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 37.54pt;"></span></span><span style="left: 40.17pt; position: var(--position);">169<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.64pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 39.04pt;"></span></span><span style="left: 41.67pt; position: var(--position);">474<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 102pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.64pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 50.42pt; position: var(--position);">148<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 102pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.64pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 50.42pt; position: var(--position);">181<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 125.25pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transversal activities<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 112.91pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 114.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 114.64999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.69pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 125.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 39.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">6,321<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 125.25pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 25.04pt;"></span></span><span style="left: 27.669999999999998pt; position: var(--position);">10,798<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 125.25pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 26.54pt;"></span></span><span style="left: 29.169999999999998pt; position: var(--position);">19,032<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 125.25pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 55.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 55.42pt; position: var(--position);">71<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 125.25pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 55.42pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt;"></span></span><span style="left: 55.42pt; position: var(--position);">76<span style="display: inline-block; height: 6.94pt; width: 5pt;"></span></span><span style="left: 70.42pt; position: var(--position);">%<span style="display: inline-block; height: 6.94pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ABX196<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 39.6pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 39.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 39.77pt; position: var(--position); text-decoration: none; white-space: pre;">...............................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 139.5pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 47.29pt;"></span></span><span style="left: 49.92pt; position: var(--position);">693<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 139.5pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 42.54pt;"></span></span><span style="left: 45.17pt; position: var(--position);">50<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 139.5pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 44.04pt;"></span></span><span style="left: 46.67pt; position: var(--position);">15<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 139.5pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 52.09pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 52.09pt; position: var(--position);">(93)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 139.5pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 52.09pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 52.09pt; position: var(--position);">(70)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153.75pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ABX711<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 39.6pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 39.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 39.77pt; position: var(--position); text-decoration: none; white-space: pre;">...............................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 153.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 47.29pt;"></span></span><span style="left: 49.92pt; position: var(--position);">287<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 153.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 37.54pt;"></span></span><span style="left: 40.17pt; position: var(--position);">604<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 153.75pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 44.04pt;"></span></span><span style="left: 46.67pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 153.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 50.42pt; position: var(--position);">111<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 153.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 47.09pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 47.09pt; position: var(--position);">(100)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168pt; width: 120pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 168pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 168pt; width: 59.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 58.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 168pt; width: 79.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 78.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 173.25pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Others<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 32.04pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 32.33pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 32.34pt; position: var(--position); text-decoration: none; white-space: pre;">..................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 173.25pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 39.79pt;"></span></span><span style="left: 42.42pt; position: var(--position);">2,291<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 173.25pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 30.04pt;"></span></span><span style="left: 32.67pt; position: var(--position);">4,653<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 173.25pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 31.54pt;"></span></span><span style="left: 34.17pt; position: var(--position);">3,805<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 173.25pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 50.42pt; position: var(--position);">103<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 173.25pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 52.09pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 52.09pt; position: var(--position);">(18)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 187.5pt; width: 120pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 187.5pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 68pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 187.5pt; width: 59.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 58.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 187.5pt; width: 79.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 78.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192.75pt; width: 120pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.63pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">development expenses<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 108.72pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 109.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.58999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 109.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 109.75999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 109.77pt; position: var(--position); text-decoration: none; white-space: pre;">...<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 192.75pt; width: 69pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 29.79pt;"></span></span><span style="left: 37.42pt; position: var(--position);">48,295<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 192.75pt; width: 59.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 15.04pt;"></span></span><span style="left: 22.669999999999998pt; position: var(--position);">103,176<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 248.25pt; position: var(--position); top: 192.75pt; width: 60.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 16.54pt;"></span></span><span style="left: 24.169999999999998pt; position: var(--position);">146,532<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 192.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 50.42pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 50.42pt; position: var(--position);">114<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 192.75pt; width: 79.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 55.42pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 55.42pt; position: var(--position);">42<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 68.75pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216pt; width: 120pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120pt; position: var(--position); top: 216pt; width: 69pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189pt; position: var(--position); top: 216pt; width: 59.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 216pt; width: 79.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 39.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); white-space: pre;">, our research and development expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.29pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;146.5 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.14pt; position: var(--position); white-space: pre;">, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;103.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.01pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.37pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.96pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;43.4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.78pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.61pt; position: var(--position); text-decoration: none; white-space: pre;">42%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.94pt; position: var(--position); white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.94pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.04pt; position: var(--position); text-decoration: none; white-space: pre;">his <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increase was primarily due to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;32.0<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.55pt; position: var(--position); text-decoration: none; white-space: pre;"> million, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.73pt; position: var(--position); text-decoration: none; white-space: pre;">38%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.06pt; position: var(--position); text-decoration: none; white-space: pre;">, increase in expenses related to our UC clinical program, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">driven by the progression of Phase 3 clinical trials for obefazimod in UC, a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.74pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.6<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.24pt; position: var(--position); text-decoration: none; white-space: pre;"> million, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.42pt; position: var(--position); text-decoration: none; white-space: pre;">169%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.75pt; position: var(--position); text-decoration: none; white-space: pre;">, increase in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 593.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expenses related to our CD clinical program, driven by costs incurred for the progression of the Phase 2b CD trial, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.86pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.2<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.36pt; position: var(--position); text-decoration: none; white-space: pre;"> million, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.54000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">76%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.87pt; position: var(--position); text-decoration: none; white-space: pre;">, increase in transversal activities related to the overall expansion of the research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development headcount to support our organizational growth and the issuance of new equity awards to officers and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.69pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employees in research and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.19pt; position: var(--position); text-decoration: none; white-space: pre;">development.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 652.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our research and development expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;103.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.64pt; position: var(--position); text-decoration: none; white-space: pre;">, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;48.3 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.01pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.37pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.96pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;54.9&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.78pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.61pt; position: var(--position); text-decoration: none; white-space: pre;">114%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.94pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.94pt; position: var(--position); white-space: pre;">This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">increase was primarily due to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.9pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.73pt; position: var(--position); text-decoration: none; white-space: pre;">117%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.06pt; position: var(--position); white-space: pre;">, increase in expenses related to our UC clinical program, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">driven by the progression of Phase 3 clinical trials for obefazimod in UC (where Phase 3 clinical trial costs were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 700.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">significantly higher than in Phase 2), a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.7 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.35pt; position: var(--position); white-space: pre;"> increase in expenses related to our CD clinical program, driven <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">109<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">by planning costs incurred for the Phase 2b CD trial, and a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.5 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.57pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.4pt; position: var(--position); text-decoration: none; white-space: pre;">71%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.73pt; position: var(--position); white-space: pre;">, increase in transversal activities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">related to the overall expansion of the research and development headcount to support our organizational growth and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the issuance of new equity awards to officers and employees in research and development.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.79pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 121.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">General and Administrative <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 186.05pt; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 223.22pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 148.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 500.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 206.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 57.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 206.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 206.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 0pt; width: 66.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.73pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.06pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.37pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 0pt; width: 57.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.23pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.56pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.87pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.85pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.19pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.62pt; position: var(--position); text-decoration: none; white-space: pre;">% 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.52pt; position: var(--position); text-decoration: none; white-space: pre;">Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.62pt; position: var(--position); text-decoration: none; white-space: pre;">% 2024 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.52pt; position: var(--position); text-decoration: none; white-space: pre;">Change<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 206.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 206.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 76.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 77.67999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 78.26pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 78.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.42999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 30.75pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 37.54pt;"></span></span><span style="left: 40.17pt; position: var(--position);">1,403<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 30.75pt; width: 57.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 23.54pt;"></span></span><span style="left: 26.169999999999998pt; position: var(--position);">13,104<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 30.75pt; width: 63pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 28.79pt;"></span></span><span style="left: 31.419999999999998pt; position: var(--position);">19,434<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 30.75pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 24.17pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 24.17pt; position: var(--position);">834<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 44.17pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 30.75pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 29.17pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 29.17pt; position: var(--position);">48<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 44.17pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 206.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 206.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 145.34pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 145.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 146pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 146.04pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.06pt; position: var(--position); text-decoration: none; white-space: pre;">.......................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 45pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.65pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 37.54pt;"></span></span><span style="left: 40.17pt; position: var(--position);">2,624<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 45pt; width: 57.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.65pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 28.54pt;"></span></span><span style="left: 31.169999999999998pt; position: var(--position);">6,393<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 45pt; width: 63pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.65pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 33.79pt;"></span></span><span style="left: 36.42pt; position: var(--position);">7,990<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 45pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.65pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 24.17pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 24.17pt; position: var(--position);">144<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 44.17pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 45pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.65pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 29.17pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 29.17pt; position: var(--position);">25<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 44.17pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 62.25pt; width: 206.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 206.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other general and administrative expenses<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 184.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 185.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 185.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 185.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.97pt; position: var(--position); text-decoration: none; white-space: pre;">.......<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 62.25pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.15pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 37.54pt;"></span></span><span style="left: 40.17pt; position: var(--position);">3,466<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 62.25pt; width: 57.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.15pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 28.54pt;"></span></span><span style="left: 31.169999999999998pt; position: var(--position);">2,893<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 62.25pt; width: 63pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.15pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 33.79pt;"></span></span><span style="left: 36.42pt; position: var(--position);">5,522<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 62.25pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.15pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 25.84pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 25.84pt; position: var(--position);">(17)<span style="display: inline-block; height: 6.93pt; width: 1.67pt;"></span></span><span style="left: 44.17pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 62.25pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.15pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 29.17pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 29.17pt; position: var(--position);">91<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 44.17pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 82.5pt; width: 206.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 206.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative expenses<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 172pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 173.16pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 173.45pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 173.47pt; position: var(--position); text-decoration: none; white-space: pre;">............<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 82.5pt; width: 66.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.23pt; width: 66.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 37.54pt;"></span></span><span style="left: 40.17pt; position: var(--position);">7,492<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 82.5pt; width: 57.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.23pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 23.54pt;"></span></span><span style="left: 26.169999999999998pt; position: var(--position);">22,390<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 82.5pt; width: 63pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.23pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 28.79pt;"></span></span><span style="left: 31.419999999999998pt; position: var(--position);">32,946<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 82.5pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.23pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 24.17pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 24.17pt; position: var(--position);">199<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 42.5pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 82.5pt; width: 53.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 6.23pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 29.17pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 29.17pt; position: var(--position);">47<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 42.5pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 268.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); white-space: pre;">, our general and administrative expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;32.9 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.29pt; position: var(--position); white-space: pre;">, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;22.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.01pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.37pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.96pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.6 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.78pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.61pt; position: var(--position); text-decoration: none; white-space: pre;">47%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.94pt; position: var(--position); white-space: pre;">. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">increase was primarily due to an increase in personnel costs of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.3<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.69pt; position: var(--position); white-space: pre;"> million, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.87pt; position: var(--position); text-decoration: none; white-space: pre;">48%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.2pt; position: var(--position); white-space: pre;">. This increase in personnel costs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">represents the full year impact of the build out of our G&amp;A organization (increased headcount and equity based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">compensation costs) which started in late 2023 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.51pt; position: var(--position); text-decoration: none; white-space: pre;">to support the expansion of the company, as well as increased legal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and professional fees and other costs associated with operating as a dual-listed public company.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 351.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our general and administrative expenses were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;22.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.29pt; position: var(--position); text-decoration: none; white-space: pre;">, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 363.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compared to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.5 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.01pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.37pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.96pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.9&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.78pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.61pt; position: var(--position); text-decoration: none; white-space: pre;">199%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.94pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.94pt; position: var(--position); white-space: pre;">This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">increase was primarily due to an increase in personnel costs of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;11.7<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.69pt; position: var(--position); white-space: pre;"> million, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.87pt; position: var(--position); text-decoration: none; white-space: pre;">834%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 417.2pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.2pt; position: var(--position); text-decoration: none; white-space: pre;">resulting from the issuance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of new equity awards to our officers and employees, management changes that occurred during the period and an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 399.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increased G&amp;A headcount to support the expansion of the company, as well as increased legal and professional fees <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 411.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and other costs associated with operating as a dual-listed public company.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 441.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill Impairment Loss <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 467.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">For the years ended December 31, 2024 and December 31, 2023, we did not record any goodwill <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478.65pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">impairment loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 501.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">We recorded a &#8364;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.74pt; position: var(--position); text-decoration: none; white-space: pre;">13.6 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.59pt; position: var(--position); text-decoration: none; white-space: pre;"> goodwill impairment loss for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.57pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 483.16pt; position: var(--position); text-decoration: none; white-space: pre;">. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 513.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">goodwill impairment loss in 2022 was primarily related to an impairment test conducted with respect to the ABX196 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 525.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cash-generating unit as a result of significant external changes in the hepatocellular carcinoma treatment landscape, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 537.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which are expected to require a new, lengthy, heavy and risky internal development process (use of a combination of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 549.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compounds). As such, while we considered the option of entering into a licensing partnership to fund the completion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 561.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the clinical development of ABX196, we made the decision to freeze the development program for ABX196 in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 573.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the treatment of hepatocellular cancer, which led to full impairment of ABX196 goodwill. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Operating Income (Loss) <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); white-space: pre;">, our net operating loss was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.53pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;173.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.38pt; position: var(--position); white-space: pre;">, as compared to a net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">operating loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.11pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;127.4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.95999999999998pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.32pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.91pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45.6&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.73pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.56pt; position: var(--position); text-decoration: none; white-space: pre;">36%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.89pt; position: var(--position); white-space: pre;">. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 651.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">increase was primarily due to an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;43.4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.94pt; position: var(--position); white-space: pre;"> in research and development expenses, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.65pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.6&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); white-space: pre;"> in general and administrative expenses<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.14pt; position: var(--position); text-decoration: none; white-space: pre;"> and the recognition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.5&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.95pt; position: var(--position); text-decoration: none; white-space: pre;"> of sales and marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expenses. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.07pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 696.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our net operating loss was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.53pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;127.4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.38pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to a net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 708.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operating loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.11pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;64.8&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.32pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.91pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;62.5&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.73pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 483.56pt; position: var(--position); text-decoration: none; white-space: pre;">96%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.89pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.89pt; position: var(--position); white-space: pre;">This <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">110<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">increase was primarily due to an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;54.9 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.94pt; position: var(--position); white-space: pre;"> in research and development expenses, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.9 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); white-space: pre;"> in general and administrative expenses and the recognition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.4 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.95pt; position: var(--position); white-space: pre;"> of sales and marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">expenses.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.07pt; position: var(--position); white-space: pre;">These increases were partially offset by the absence of goodwill impairment, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">as compared to the &#8364;13.6 </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">million loss recorded in 2022.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Income (Loss) <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); white-space: pre;">, our net financial loss was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.73pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3.3<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.23pt; position: var(--position); white-space: pre;"> million, as compared to a net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 175.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">financial loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20.4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); white-space: pre;"> and a financial income of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.68pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.1&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.53pt; position: var(--position); white-space: pre;"> for the years ended December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">2022, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208.8pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For the </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">year ended December 31, 2024</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.18pt; position: var(--position); white-space: pre;">our net financial loss was mainly driven by interest expenses of &#8364;11.5 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">million in relation to the first tranche of senior secured convertible bonds with warrants attached in the Kreos / <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 231.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Claret Financing (the &#8220;Kreos / Claret OCABSA&#8221;), the second and third tranches of senior secured bonds in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Kreos / Claret Financing (drawn on March 28, 2024 and June 21, 2024, respectively) and the senior convertible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 253.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">notes in the Heights Financing (the "Heights Convertible Notes"), &#8364;0.8 million in relation to our royalty certificates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">a &#8364;1.4 million increase in the fair value of the Heights Convertible Notes and transaction costs amounting to &#8364;1.6 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">million. These costs were partially offset mainly by an interest income of &#8364;8.2 million in relation to the invested <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">proceeds from our U.S. initial public and listing on Nasdaq and foreign exchange gains of &#8364;2.7 million <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.95pt; position: var(--position); text-decoration: none; white-space: pre;">(including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 298.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the &#8364;1.7 million non-cash impact of the revaluation of U.S. dollar-denominated cash and cash equivalents as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 309.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2024).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.18pt; position: var(--position); text-decoration: none; white-space: pre;">our net financial loss was mainly driven by interest expenses of &#8364;3.9 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million in relation to the Kreos / Claret OCABSA and the Heights Convertible Notes and &#8364;8.9 million in relation to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our royalty certificates, a &#8364;3.0 million increase in the fair value of derivatives, transaction costs amounting to &#8364;1.9 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million, a net &#8364;3.2 million loss on de-recognition of the OCEANE bonds and the recognition of the Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible notes, and foreign exchange losses of &#8364;5.6 million (including the &#8364;3.2 million non-cash impact of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">year-end revaluation of U.S. dollar-denominated cash and cash equivalents). These costs were partially offset by an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interest income of &#8364;2.4 million in relation to the invested proceeds from our U.S. initial public and listing on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Nasdaq, a decrease in the fair value of the Heights Convertible Notes by &#8364;3.2 million and a decrease in derivatives <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fair value by &#8364;1.0 million.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.34pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, our net financial income was mainly a result of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.55pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">decrease in the fair value of derivatives (mainly due to the decrease in our share price over the period) and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1.4&#160;million decrease in other liabilities at fair value through profit or loss (mainly in Prosynergia earn-out liability), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 464.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which was partially offset by an increase in interest expenses of &#8364;3.7&#160;million in relation to the Kreos bonds and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 474.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.6&#160;million in relation to our OCEANE bonds.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Income Taxes <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For each of the years ended December 31, 2024, 2023 and 2022, our income tax charge was zero. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Net Loss <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 572.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); white-space: pre;">, our net loss for the period was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.04pt; position: var(--position); white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;147.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.85pt; position: var(--position); white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.8pt; position: var(--position); white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;28.5&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.62pt; position: var(--position); white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.45pt; position: var(--position); text-decoration: none; white-space: pre;">19%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.78pt; position: var(--position); white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.68pt; position: var(--position); text-decoration: none; white-space: pre;">, our net loss for the period was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;147.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.04pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;60.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.8pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;87.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.45pt; position: var(--position); text-decoration: none; white-space: pre;">143%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.78pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 655.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">111<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_67"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="i806646b7188d4fb9ba77a64e984ab09b"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Liquidity and Capital Resources<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Sources of Liquidity <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have incurred substantial operating losses since inception and expect to continue to incur significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operating losses for the foreseeable future and may never become profitable. For the years ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024, 2023, and 2022, we reported net losses of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.62pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;147.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.47pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;60.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.75pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520pt; position: var(--position); text-decoration: none; white-space: pre;">As <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.37pt; position: var(--position); text-decoration: none; white-space: pre;">, we carried forward accumulated tax losse<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.52pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">s of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.74pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;609.4 million. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since inception, we have financed our operations through the issuance of ordinary shares with gross aggregate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceeds <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.84pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;557.2</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.34pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> million, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.69pt; position: var(--position); text-decoration: none; white-space: pre;">of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;130.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.28999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> of gross proceeds were from offerings of our ordinary shares on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Euronext Paris in February 2023, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;223.3&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.31pt; position: var(--position); text-decoration: none; white-space: pre;"> of gross proceeds (based on the exchange rate then in effect) were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.93pt; position: var(--position); text-decoration: none; white-space: pre;">offering<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.12pt; position: var(--position); text-decoration: none; white-space: pre;"> of our ordinary shares in the form of ADS on the Nasdaq Global Market as well as ordinary shares in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Europe (including France) and countries outside of the United States in a private placement in October 2023, bank <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">borrowings and structured loans for &#8364;175.0 million, reimbursements of CIR in an amount of &#8364;35.6 million, subsidies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">received from Bpifrance (including &#8364;17.1&#160;million of subsidies and &#8364;1.8 million of conditional advances) and royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certificates in an amount of &#8364;2.9&#160;million. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Based on (a) our existing cash and cash equivalents of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;144.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.56pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.06pt; position: var(--position); text-decoration: none; white-space: pre;">as of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.25pt; position: var(--position); text-decoration: none; white-space: pre;"> and (b) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expected reimbursement of the CIR from 2024 in the second half of 2025 amounting to &#8364;5.7&#160;million, we expect, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the date of issuance of the consolidated financial statements included in our Annual Report on Form 20-F, to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">able to fund our forecasted cash flow requirements into <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.36pt; position: var(--position); text-decoration: none; white-space: pre;">the fourth quarter of 2025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.61pt; position: var(--position); text-decoration: none; white-space: pre;">. This takes into account our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assumption that R&amp;D expenditure will be substantially increased in 2025 driven by the progression of the Phase 3 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials of obefazimod in UC and the continuation of the Phase 2b trial for CD. Under these assumptions and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">based on our current clinical and operational plans, we would have sufficient funds to finance our operations through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the announcement of our top-line data from the Phase 3 ABTECT-1 and ABTECT-2 induction trials for UC.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We expect we will be able to extend our financing horizon beyond the fourth quarter of 2025 through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">additional dilutive and non-dilutive financing, which could include a combination of capital increase, out-licensing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreements, venture loans and convertible bonds. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On November 19, 2024, we filed a registration statement on Form F-3 with the SEC, which covers the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">offering, issuance and sale, from time to time at prices and on terms to be determined at or prior to the time of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">offering, of up to $350.0 million of our ordinary shares, including ordinary shares represented by ADSs, as well <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warrants to purchase ordinary shares or ADSs, individually or in any combination, of which $150.0 million may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">issued pursuant to our ATM Program (as defined below). Also on November 19, 2024, we entered into an equity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distribution agreement with Piper Sandler &amp; Co. (&#8220;Piper Sandler&#8221;) allowing us to issue and sell from time to time, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">one or more "at the market" offerings through Piper Sandler acting as sales agent, ordinary shares in the form of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs, each ADS representing one ordinary share, nominal value of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.13pt; position: var(--position); text-decoration: none; white-space: pre;"> &#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.13pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, with aggregate gross sales <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceeds of up to $150.0 million (the "ATM Program"). For the year ended December 31, 2024, we did not sell any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs pursuant to the ATM Program.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Based on the above, management has concluded that these factors raise substantial doubt about our ability to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">continue as a going concern for a period of 12 months from the date of issuance of the financial statements <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accompanying this annual report. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Capital Increases <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our operations have been financed primarily by capital increases from our founders and investors, net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceeds from the initial public offering of our ordinary shares on Euronext Paris in France in 2015, and additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">follow-on capital increases, including the initial public offering of our ordinary shares in the form of ADS on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Nasdaq Global Market in 2023. We have not yet commercialized any of our drug candidates, which are in various <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">phases of clinical development, and we do not expect to generate revenue from sales of any products for several <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">years, if at all. Until such time as we can generate significant revenue from product sales, if ever, we expect to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">finance our operations through the sale of equity, debt financings or other capital sources, including potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">collaborations with other companies or other strategic transactions.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">112<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth our main capital increases carried out during the years ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2022, 2023 and 2024: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 469.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 384pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 85.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 384pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 384pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.66pt; position: var(--position); text-decoration: none; white-space: pre;">Gross proceeds <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.65pt; position: var(--position); text-decoration: none; white-space: pre;">amount<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 384pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 384pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">Capital increase from issuance of ordinary shares - September 2, 2022&#160; . . . . . . . . . . . . . . . .<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 377.65pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 378.23pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 378.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 378.67pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 378.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.77pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 21pt; width: 85.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 45.05pt;"></span></span><span style="left: 52.68pt; position: var(--position);">46,231<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 35.25pt; width: 384pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 384pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">Capital increase from issuance of ordinary shares - February 23, 2023&#160; . . . . . . . . . . . . . . . .<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 376.01pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 376.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.34pt; position: var(--position); text-decoration: none; white-space: pre;">..<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 35.25pt; width: 85.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 40.05pt;"></span></span><span style="left: 47.68pt; position: var(--position);">130,000<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 384pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 384pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">Initial Public Offering (Nasdaq) - October 24, 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 375.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 376.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 376.28pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.3pt; position: var(--position); text-decoration: none; white-space: pre;">..<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 49.5pt; width: 85.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.93pt; width: 40.05pt;"></span></span><span style="left: 47.68pt; position: var(--position);">223,300<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 184.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On September 7, 2022, we received gross proceeds of &#8364;46.2&#160;million from the issuance of 5,530,000 ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares at a subscription price of &#8364;8.36 per share, and the issuance of royalty certificates of &#8364;2.9&#160;million, for a total <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financing of &#8364;49.2&#160;million. See &#8220;Item 10.C. Material Contracts&#8212;Financing Arrangements&#8212;Royalty Certificates.&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On March&#160;1, 2023, we received gross proceeds of &#8364;130.0&#160;million from the issuance of 20,000,000 ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares at a subscription price of &#8364;6.50 per share. The proceeds were primarily used to finance the progress of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod clinical trials in chronic inflammatory diseases and for general corporate purposes (research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development expenses and loans maturities payments). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On October&#160;24, 2023, we received gross proceeds of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;223.3&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.67pt; position: var(--position); text-decoration: none; white-space: pre;"> from the issuance of 20,325,500 ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares (including ordinary shares in the form of ADSs) at a price of &#8364;10.99 per share in connection with our U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">initial public offering. The proceeds were primarily used to finance the progress of obefazimod clinical trials in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">chronic inflammatory diseases and for general corporate purposes (research and development expenses and loans <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maturities payments).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 346.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Equity Line <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We entered into an equity line agreement with Kepler Cheuvreux in September 2017. In accordance with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terms of this agreement, Kepler Cheuvreux, acting as financial intermediary and guarantor, committed to subscribe <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for 970,000 ordinary shares, at its option in line with a schedule lasting no longer than 24 months, at an issuance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price based on an average market price weighted according to the volumes traded over the two trading days <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preceding each issue, less a maximum discount of 7.0%. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We renewed this financing line and entered into an agreement on September 30, 2019, with Kepler <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Cheuvreux, who committed to subscribe for 730,000 ordinary shares (corresponding to the number of shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unsubscribed as of September 30, 2019, and granted under the previous agreement) under the same terms and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conditions for a period of 24 months. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On September 24, 2021, we extended the agreement for an additional 12-month period with respect to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unsubscribed shares at that date. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.51pt; position: var(--position); text-decoration: none; white-space: pre;">This agreement was terminated on September 30, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Research Tax Credits <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 530.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">From our inception to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.43pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.97pt; position: var(--position); text-decoration: none; white-space: pre;">, we have benefited from refunds of CIRs in a total amount of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;35.6&#160;million. In October 2022, we received CIRs of &#8364;4.2&#160;million with respect to the year ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2021. In November 2023, we received CIRs of &#8364;4.5 million with respect to the year ended December 31, 2022. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 560.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">November 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.68pt; position: var(--position); text-decoration: none; white-space: pre;">, we received CIRs of &#8364;4.5 million with respect to the year ended December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 584.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 585.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance&#8212;Conditional Advances and Subsidies <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 601.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have received several conditional advances and subsidies from Bpifrance since our inception. Funds <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 611.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">received from Bpifrance in the form of conditional advances are recognized as financial liabilities, as we have a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 621.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contractual obligation to reimburse Bpifrance for such conditional advances in cash based on a repayment schedule. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 631.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Each award of an advance is made to help fund a specific development milestone. Subsidies are non-repayable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 641.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">grants, which are recognized in the financial statements when there exists reasonable assurance that we will comply <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 651.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with the conditions attached to the subsidies and the subsidies will be received. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">113<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth the monies received from Bpifrance as of December 31, 2024, in relation to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contracts that were ongoing or terminated during the years ended December 31, 2022, 2023 and 2024:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 409.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 219pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 219pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 219pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div><div style="left: 219pt; position: var(--position); top: 0pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 219pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.12pt; width: 219pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 70.09pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 12pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.32pt; position: var(--position); text-decoration: none; white-space: pre;">Contract&#160;status<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 73.93pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.06pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 12pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.12pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.77pt; position: var(--position); text-decoration: none; white-space: pre;">Amount collected<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 32.25pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.53999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 95.69999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 95.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.17999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.19999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.21pt; position: var(--position); text-decoration: none; white-space: pre;">................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 32.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 32.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 61.04pt;"></span></span><span style="left: 68.67pt; position: var(--position);">1,802<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 46.5pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Carena (1)<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 70.77pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 71.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 71.21pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 71.28999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.33pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 46.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 31.52pt; position: var(--position); text-decoration: none; white-space: pre;">Stopped<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 46.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 68.54pt;"></span></span><span style="left: 76.17pt; position: var(--position);">234<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 60.75pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">RNP-VIR (2) <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.01pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.34pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 60.75pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 31.52pt; position: var(--position); text-decoration: none; white-space: pre;">Stopped<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 60.75pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 61.04pt;"></span></span><span style="left: 68.67pt; position: var(--position);">1,178<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ebola<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 50.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 51.08pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 51.230000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 51.269999999999996pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 51.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.3pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 75pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 31.52pt; position: var(--position); text-decoration: none; white-space: pre;">Stopped<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 75pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 68.54pt;"></span></span><span style="left: 76.17pt; position: var(--position);">390<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 89.25pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 42.620000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 43.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 43.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 43.64pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 43.720000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 43.760000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 43.77pt; position: var(--position); text-decoration: none; white-space: pre;">.....................................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 89.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 89.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 61.04pt;"></span></span><span style="left: 68.67pt; position: var(--position);">5,875<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 103.5pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Carena (1)<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 70.77pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 71.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 71.21pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 71.28999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.33pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 103.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 31.52pt; position: var(--position); text-decoration: none; white-space: pre;">Stopped<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 103.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 61.04pt;"></span></span><span style="left: 68.67pt; position: var(--position);">3,140<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 117.75pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">RNP-VIR (2) <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.01pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.34pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 117.75pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 31.52pt; position: var(--position); text-decoration: none; white-space: pre;">Stopped<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 117.75pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 61.04pt;"></span></span><span style="left: 68.67pt; position: var(--position);">2,735<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ebola<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 50.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 51.08pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 51.230000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 51.269999999999996pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 51.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.3pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 132pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 31.52pt; position: var(--position); text-decoration: none; white-space: pre;">Stopped<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 132pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.14pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.94pt; width: 74.65pt;"></span></span><span style="left: 82.28pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.94pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 219pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 219pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 146.25pt; width: 95.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 47.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 146.25pt; width: 95.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 94.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 151.5pt; width: 219pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 219pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 25.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 25.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 26.259999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 26.279999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">............................................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 151.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 151.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 6.77pt; width: 61.04pt;"></span></span><span style="left: 68.67pt; position: var(--position);">7,677<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165.75pt; width: 219pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 219pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 165.75pt; width: 95.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 165.75pt; width: 95.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 47.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 280pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 297.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 71.95pt; position: var(--position);">(1)<span style="display: inline-block; height: 6.93pt; width: 12.84pt;"></span></span><span style="left: 96.45pt; position: var(--position);">Following termination of the project due to technical failure in June 2024, the repayment of an amount of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">conditional advance of &#8364;2.0 million (excluding accrued interests) was waived by Bpifrance and therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified as a subsidy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 343.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 71.95pt; position: var(--position);">(2)<span style="display: inline-block; height: 6.93pt; width: 12.84pt;"></span></span><span style="left: 96.45pt; position: var(--position);">Following the termination of the project due to technical failure in June 2024, the repayment of an amount of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">conditional advance of &#8364;1.8 million (excluding accrued interests) was waived by Bpifrance and therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 365.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified as a subsidy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance&#8212;CARENA Contract <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the development of therapeutic and diagnostic solutions targeting alternative splicing and RNA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interference in the fields of virology (HIV-AIDS, HTLV-1) and metabolism (obesity), SPLICOS, which we acquired <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in October 2014, entered into a Master Support Agreement and a conditional advance contract on December 2013 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the &#8220;CARENA&#8221; Strategic Industrial Innovation Project (&#8220;CARENA project&#8221;), with Bpifrance. Under this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contract, we were eligible to receive up to &#8364;3.8&#160;million in conditional advances to develop a therapeutic HIV <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatment program with obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.98pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.96000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">, we had received &#8364;3.4 million of conditional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advances and subsidies.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 504.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Company and Bpifrance agreed to terminate the project due to technical failure. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 514.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance granted an additional amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.01pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1.1 million payable to the Company to reimburse additional expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 524.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">incurred as part of the project, and agreed to waive 60% of the remaining conditional advance of &#8364;3.3 million and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 534.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accrued interests, for which we recognized a subsidy income of &#8364;2.3 million in the aggregate. We repaid the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outstanding amounts<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.99pt; position: var(--position); text-decoration: none; white-space: pre;"> during the second half of 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance&#8212;RNP-VIR Contract <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the CARENA project, focused on the clinical development of a drug molecule and demonstrating <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the validity of an innovative therapeutic approach targeting viral RNPs, we entered into a Master Support <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Agreement with Bpifrance, as well as a beneficiary agreement dated March 21, 2017, with conditional advances for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the &#8220;RNP-VIR&#8221; structuring research and development project for competitiveness. Under the RNP-VIR contract, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">were eligible to receive up to &#8364;6.3&#160;million in conditional advances to develop methods for the discovery of new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">molecules for the treatment of viral infectious diseases through the development of the &#8220;Modulation of RNA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">biogenesis&#8221; platform. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.51pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.49pt; position: var(--position); text-decoration: none; white-space: pre;">, we had received &#8364;3.9 million of conditional advances and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsidies.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Company and Bpifrance agreed to terminate<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.61pt; position: var(--position); text-decoration: none; white-space: pre;"> the project due to technical failure. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance claimed the reimbursement of &#8364;1.2 million corresponding to overpayments of conditional advances and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 700.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsidies (for which the Group had not incurred the corresponding R&amp;D expenses) and agreed to waive 60% of the <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">114<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">remaining advances of &#8364;3.0 million and accrued interests, for which the we reco<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.17pt; position: var(--position); text-decoration: none; white-space: pre;">gnized a subsidy income of &#8364;1.9 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million in the aggregate. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.14pt; position: var(--position); text-decoration: none; white-space: pre;">We repaid the outstanding amounts<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.65pt; position: var(--position); text-decoration: none; white-space: pre;"> during the second half of 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.56pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance&#8212;Ebola <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 114.53pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">and Occitanie Region joint support agreement was entered into on June&#160;2, 2017 and provides <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for conditional advances for a total amount of &#8364;0.4&#160;million (&#8364;0.1&#160;million from the Languedoc Roussillon Midi <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Pyr&#233;n&#233;es Region and &#8364;0.3&#160;million from <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 232.14pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.53pt; position: var(--position); text-decoration: none; white-space: pre;">) for the Ebola program. All funds under this contract were <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">received. In September 2019, we terminated this program due to the imminent licensing of a competing vaccine for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">this indication, as well as changes in the macroeconomic climate for public funding. The reimbursement of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conditional advance was spread over the period from September 2019 to June 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Indebtedness <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">For a description of material financing agreements, see "Item 10.C. Material Contracts."<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Historical Changes in Cash Flows <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth our cash inflows and outflows for the years ended December 31, 2022, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 304pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 498.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 212.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 212.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 0pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.23pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.56pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.48pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.81pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.6pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.94pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.25pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.4pt; position: var(--position); text-decoration: none; white-space: pre;">Change <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.4pt; position: var(--position); text-decoration: none; white-space: pre;">Change <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 212.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net cash flows (used in) operating activities<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 178.51999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 179.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 179.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 179.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 179.51pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.53pt; position: var(--position); text-decoration: none; white-space: pre;">............<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 30.75pt; width: 63.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 26.21pt;"></span></span><span style="left: 28.84pt; position: var(--position);">(53,936)<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 30.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 30.71pt;"></span></span><span style="left: 33.34pt; position: var(--position);">(97,130)<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 30.75pt; width: 64.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 21.96pt;"></span></span><span style="left: 24.59pt; position: var(--position);">(154,072)<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 20.92pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 20.92pt; position: var(--position);">80<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 35.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 20.92pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 20.92pt; position: var(--position);">59<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 35.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 212.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net cash flows from (used in) investing activities <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 201.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 202pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 202.07999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 202.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.10999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">...<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 45pt; width: 63.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 26.21pt;"></span></span><span style="left: 28.84pt; position: var(--position);">(12,026)<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 45pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">(8,095)<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 45pt; width: 64.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 30.29pt;"></span></span><span style="left: 32.92pt; position: var(--position);">15,762<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 17.59pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 17.59pt; position: var(--position);">(33)<span style="display: inline-block; height: 6.93pt; width: 1.67pt;"></span></span><span style="left: 35.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 12.59pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 12.59pt; position: var(--position);">(295)<span style="display: inline-block; height: 6.93pt; width: 1.67pt;"></span></span><span style="left: 35.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 59.25pt; width: 212.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net cash flows provided by (used in) financing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.63pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">activities<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 50.660000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 51.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 51.970000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.99pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 59.25pt; width: 63.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.65pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 29.54pt;"></span></span><span style="left: 32.17pt; position: var(--position);">32,211<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 59.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.65pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 29.04pt;"></span></span><span style="left: 31.669999999999998pt; position: var(--position);">335,290<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 59.25pt; width: 64.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.65pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 30.29pt;"></span></span><span style="left: 32.92pt; position: var(--position);">28,207<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 59.25pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.65pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 15.92pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 15.92pt; position: var(--position);">941<span style="display: inline-block; height: 6.93pt; width: 5pt;"></span></span><span style="left: 35.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 59.25pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.65pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 17.59pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 17.59pt; position: var(--position);">(92)<span style="display: inline-block; height: 6.93pt; width: 1.67pt;"></span></span><span style="left: 35.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 82.5pt; width: 212.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.33pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 5.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of movements in exchange rates on cash <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.83pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">held<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 32.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 34.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 34.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 34.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 34.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 34.47pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 82.5pt; width: 63.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 9.15pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 47.04pt;"></span></span><span style="left: 49.67pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 82.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 9.15pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">(5,072)<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 9.15pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 35.29pt;"></span></span><span style="left: 37.92pt; position: var(--position);">2,382<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 82.5pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 9.15pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 20.92pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 20.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 13.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 82.5pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 9.15pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 12.59pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt;"></span></span><span style="left: 12.59pt; position: var(--position);">(147)<span style="display: inline-block; height: 6.93pt; width: 1.67pt;"></span></span><span style="left: 35.92pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108.75pt; width: 212.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.83pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net increase (decrease) in cash and cash <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.83pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">equivalents<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.09pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 64.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 64.47pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 108.75pt; width: 63.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 26.21pt;"></span></span><span style="left: 28.84pt; position: var(--position);">(33,751)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 108.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 29.04pt;"></span></span><span style="left: 31.669999999999998pt; position: var(--position);">224,992<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 108.75pt; width: 64.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 21.96pt;"></span></span><span style="left: 24.59pt; position: var(--position);">(107,720)<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 12.59pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 12.59pt; position: var(--position);">(767)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 34.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 12.59pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 12.59pt; position: var(--position);">(148)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 34.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132pt; width: 212.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 132pt; width: 63.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 62.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 132pt; width: 68.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 67.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 137.25pt; width: 212.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.83pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents at the beginning of <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.83pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">the period<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 58.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 59.36pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 59.440000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 59.480000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 59.5pt; position: var(--position); text-decoration: none; white-space: pre;">............................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 137.25pt; width: 63.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 29.54pt;"></span></span><span style="left: 32.17pt; position: var(--position);">60,701<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 137.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 34.04pt;"></span></span><span style="left: 36.67pt; position: var(--position);">26,950<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 137.25pt; width: 64.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 25.29pt;"></span></span><span style="left: 27.919999999999998pt; position: var(--position);">251,942<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 137.25pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 17.59pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 17.59pt; position: var(--position);">(56)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 34.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 137.25pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 15.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 15.92pt; position: var(--position);">835<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 34.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 160.5pt; width: 212.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165.75pt; width: 212.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.83pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents at the end of the <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.83pt; width: 212.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">period<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 42.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 43.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 44.12pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 44.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 165.75pt; width: 63.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 29.54pt;"></span></span><span style="left: 32.17pt; position: var(--position);">26,950<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 165.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 29.04pt;"></span></span><span style="left: 31.669999999999998pt; position: var(--position);">251,942<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 165.75pt; width: 64.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 25.29pt;"></span></span><span style="left: 27.919999999999998pt; position: var(--position);">144,221<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 165.75pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 15.92pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 15.92pt; position: var(--position);">835<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span><span style="left: 34.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 165.75pt; width: 45pt;"><div><div style="line-height: 10pt; position: var(--position); top: 7.73pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 17.59pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 17.59pt; position: var(--position);">(43)<span style="display: inline-block; height: 6.77pt;"></span></span><span style="left: 34.25pt; position: var(--position);">%<span style="display: inline-block; height: 6.77pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 212.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 212.25pt; position: var(--position); top: 189pt; width: 63.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 60.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276pt; position: var(--position); top: 189pt; width: 68.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 65.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 42.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 521.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Operating Activities <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, cash used in operating activities was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.32pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;154.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.17pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;97.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.8pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;56.9&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.45pt; position: var(--position); text-decoration: none; white-space: pre;">59%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.78pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, cash used in operating activities was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.32pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;97.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.17pt; position: var(--position); text-decoration: none; white-space: pre;">, as compared to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;53.9 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); text-decoration: none; white-space: pre;"> for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.8pt; position: var(--position); text-decoration: none; white-space: pre;">, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;43.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.45pt; position: var(--position); text-decoration: none; white-space: pre;">80%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.78pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.68pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: var(--position); text-decoration: none; white-space: pre;">cash used in operating activities is attributable to increased R&amp;D spend <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.45pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">driven by the progression of the UC Phase 3 clinical trial and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.96000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">the initiation of the Phase 2b CD trial, and the full year <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.65pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">impact of increased legal and professional fees and other infrastructure costs associated with operating as a dual-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">listed public company<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> and changes in working capital.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 661.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 674.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.09pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.68pt; position: var(--position); text-decoration: none; white-space: pre;">, cash used in operating activities is attributable to increased R&amp;D spend <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">driven by the progression of the UC Phase 3 clinical trial,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.03pt; position: var(--position); white-space: pre;"> increased headcount to support the expansion of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">overall organization, including a newly created sales and marketing department, increased legal and professional <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">115<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">fees and other infrastructure costs associated with operating as a dual-listed public company<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.87pt; position: var(--position); text-decoration: none; white-space: pre;"> and changes in working <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">capital. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.18pt; position: var(--position); text-decoration: none; white-space: pre;">cash used in operating activities mainly reflected our net loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;60.7 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.35pt; position: var(--position); text-decoration: none; white-space: pre;">and was primarily used for our research and development efforts (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;48.3&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 421.36pt; position: var(--position); text-decoration: none; white-space: pre;">) as a result of progression of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our portfolio development (partially offset by the elimination of the amortization of intangibles and depreciation of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">property and equipment on the ABX196 cash generating unit), enhanced by an increase in derivatives and liabilities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fair value of &#8364;10.8&#160;million, a decrease in trade payables of &#8364;2.4&#160;million and offset by an increase in interest expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of &#8364;7.0&#160;million.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Investing Activities <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, cash from investing activities was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.8&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.91pt; position: var(--position); text-decoration: none; white-space: pre;"> and was mainly due <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 219.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">to the payment of the Group's 6-month term deposit of &#8364;9.0 million and from interests received from cash, cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">equivalents and short-term investments of &#8364;8.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.94pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.89pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.48pt; position: var(--position); text-decoration: none; white-space: pre;">, cash used in investing activities was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.1 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.37pt; position: var(--position); text-decoration: none; white-space: pre;"> and was mainly due to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.0 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.85pt; position: var(--position); text-decoration: none; white-space: pre;"> investment in a 6-month term deposit and the payment of additional long-term CRO advances <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 277.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amounting to &#8364;1.6 million, partially offset by interests received amounting to &#8364;2.4 million.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, cash used in investing activities was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.07pt; position: var(--position); text-decoration: none; white-space: pre;">, and was mainly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 311.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composed of (i)&#160;CRO contracts advances for clinical trials which have to be recovered at the end of the trials, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 321.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amounting to &#8364;12.2&#160;million, and by (ii)&#160;the completion of the acquisition of Prosynergia in 2022 and the remaining <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 331.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payment of the acquisition price of &#8364;2.9&#160;million, partially offset by (iii)&#160;the non-recurring &#8364;3.3&#160;million advance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 341.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">repayment from University Hospital of Nice as part of the COVID-19 Program clinical trial. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 363.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financing Activities <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 385.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, cash from financing activities<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.62pt; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;28.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.01pt; position: var(--position); text-decoration: none; white-space: pre;">, which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.93pt; position: var(--position); text-decoration: none; white-space: pre;">mainly<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.67pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 395.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consisted of drawdowns on tranche B (in an amount of &#8364;25 million) and tranche C (in an amount of &#8364;25 million) of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 405.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the senior secured non-convertible bonds from the Kreos / Claret Financing, net of disbursed transaction costs and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 415.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deposits (in an amount of &#8364;2.6 million in the aggregate), partially offset by repayments of &#8364;13.2 million (of which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 425.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.8 million under the Heights convertible notes and &#8364;2.7 million under conditional advances) and interest payments <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 435.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of &#8364;7.7 million.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, cash from financing activities was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;335.3 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.01pt; position: var(--position); text-decoration: none; white-space: pre;">, which consisted of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 461.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">net proceeds from a capital raise with Euronext Paris of &#8364;123.3 million (including transaction costs of &#8364;6.7&#160;million), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 471.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a capital raise of &#8364;202.0 million of net proceeds (including transaction costs of &#8364;21.3 million) from our U.S. initial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 481.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">public offering and listing on Nasdaq and concurrent private placement (including transaction costs and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 491.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">underwriting commissions of &#8364;28.1 million), net proceeds of the August 2023 drawdown of the first tranches of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 501.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret Financing and the Heights Financing, collectively amounting to &#8364;27.2 million (net of repayments of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 511.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">all outstanding amounts that remained due under the First KC Agreement, the Second KC Agreement and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 521.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE bonds), partially offset by repayments under the First KC Notes and the Second KC Notes (in an amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 531.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of &#8364;5.0&#160;million), PGE (in an amount of &#8364;1.3 million) and interest paid (in an amount of &#8364;5.3 million). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 550.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 551.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;">, cash from financing activities was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;32.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.01pt; position: var(--position); text-decoration: none; white-space: pre;">, which consisted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 561.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">primarily of &#8364;46.2&#160;million of net proceeds from a capital increase (including transaction costs of &#8364;3.3 million), net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 571.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceeds from the issuance of the royalty certificates in an amount of &#8364;2.9&#160;million, partially offset by &#8364;13.4&#160;million <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 581.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of repayments under the First KC Notes and the Second KC Notes and interest paid. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 635.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 647.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Material Cash Requirements <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 665.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Contractual Obligations and Loans <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 681.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth aggregate information about material contractual obligations as of December&#160;31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 691.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">116<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The commitment amounts in the table below are associated with contracts that are enforceable and legally <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">binding and that specify all significant terms, including, fixed or minimum services to be used, fixed, minimum or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">variable price provisions, and the approximate timing of the actions under the contracts. Future events could cause <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">actual payments to differ from these estimates. All amounts except the retirement benefits in the table below are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">presented gross and are undiscounted. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 134pt; width: 612pt;"><div style="font-size: 0pt; left: 73.4pt; position: var(--position); top: 0pt; width: 468.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 174.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 90.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 0pt; width: 90.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.29pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 0pt; width: 93pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.42pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 0pt; width: 110.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.04pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 174.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 174.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 12pt; width: 90.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Less than<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 12pt; width: 93pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">More than<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 174.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 174.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 24pt; width: 90.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">1 year<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 24pt; width: 93pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">1 year<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 24pt; width: 110.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 174.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 174.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial debt obligations<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 106.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 106.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 107.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.06pt; position: var(--position); text-decoration: none; white-space: pre;">..........................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 36pt; width: 90.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 56.54pt;"></span></span><span style="left: 59.17pt; position: var(--position);">36,309<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 36pt; width: 93pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 58.79pt;"></span></span><span style="left: 61.42pt; position: var(--position);">79,072<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 36pt; width: 110.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 71.04pt;"></span></span><span style="left: 73.67pt; position: var(--position);">115,382<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 50.25pt; width: 174.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 174.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease obligations<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 72.81pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 73.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.25999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 74.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 74.44999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.46pt; position: var(--position); text-decoration: none; white-space: pre;">.......................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 50.25pt; width: 90.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 69.04pt;"></span></span><span style="left: 71.67pt; position: var(--position);">993<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 50.25pt; width: 93pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 63.79pt;"></span></span><span style="left: 66.42pt; position: var(--position);">1,519<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 50.25pt; width: 110.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 81.04pt;"></span></span><span style="left: 83.67pt; position: var(--position);">2,512<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 64.5pt; width: 174.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 174.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirements benefits<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.16pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.89pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.92999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">..................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 64.5pt; width: 90.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 74.04pt;"></span></span><span style="left: 76.67pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 64.5pt; width: 93pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 71.29pt;"></span></span><span style="left: 73.92pt; position: var(--position);">756<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 64.5pt; width: 110.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 88.54pt;"></span></span><span style="left: 91.17pt; position: var(--position);">756<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 174.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 174.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Off-balance sheet obligations<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 120.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 121.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 121.69999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 121.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 121.92999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 121.94999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.96pt; position: var(--position); text-decoration: none; white-space: pre;">....................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 78.75pt; width: 90.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 51.54pt;"></span></span><span style="left: 54.17pt; position: var(--position);">234,908<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 78.75pt; width: 93pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.15pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 76.29pt;"></span></span><span style="left: 78.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 78.75pt; width: 110.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 71.04pt;"></span></span><span style="left: 73.67pt; position: var(--position);">234,908<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 174.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 174.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 93pt; width: 90.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 89.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 93pt; width: 93pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 92pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 93pt; width: 110.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.74pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 109.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 174.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 174.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 25.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 26.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.84pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 26.919999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 26.959999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 26.97pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 98.25pt; width: 90.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 51.54pt;"></span></span><span style="left: 54.17pt; position: var(--position);">272,211<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 98.25pt; width: 93pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 58.79pt;"></span></span><span style="left: 61.42pt; position: var(--position);">81,348<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 98.25pt; width: 110.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 71.04pt;"></span></span><span style="left: 73.67pt; position: var(--position);">353,559<span style="display: inline-block; height: 6.77pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 112.5pt; width: 174.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 174.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 112.5pt; width: 90.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 45.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 112.5pt; width: 93pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 93pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 358.5pt; position: var(--position); top: 112.5pt; width: 110.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 55pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 256.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the ordinary course of our business, we regularly use the services of subcontractors and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.93pt; position: var(--position); text-decoration: none; white-space: pre;">enter<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.89pt; position: var(--position); text-decoration: none; white-space: pre;"> into research <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 267.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and partnership arrangements with various CROs and with public-sector partners or subcontractors, who conduct <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 279.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials and studies in relation to the drug candidates. Off-balance sheet obligations in the table above are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commitments related to these research and partnership agreements. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.45pt; position: var(--position); text-decoration: none; white-space: pre;">They are classified at less than one year maturity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in the absence of a fixed schedule in contracts, in case of multiple-year contracts, such as CRO contracts. CRO <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contracts include payments that are conditional to the completion of future development milestones.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.76pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.26pt; position: var(--position); text-decoration: none; white-space: pre;">The majority of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 323.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the commitments with our CROs are cancellable under certain circumstances such as insolvency, study put on hold <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">by competent authorities, breach in regulations or negligence in the provision of the services.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our material cash requirements in the above table do not include potential future royalty payments related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the royalty certificates, amounting to 2% of the future net sales of obefazimod (worldwide and for all indications). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The amount of royalties that may be paid under the royalty certificates is capped at &#8364;172.0 million in the aggregate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty payments are expected to take place before the expiry date of the certificates, which is 15 years after their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">issuance date (September 2, 2037). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">, our contractual obligations and loans were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;353.6<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;million comprising financial debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.73pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;115.4<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;million (in turn, comprising &#8364;88.7 million with respect of tranches A, B and C of the senior <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">secured non-convertible bonds from the Kreos / Claret Financing, &#8364;24.1 million with respect to Heights Convertible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Notes and &#8364;2.6&#160;million with respect to the State-guaranteed loan) and off-balance sheet obligations of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.4pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;234.9 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.25pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with respect to purchase obligations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Operating Capital and Capital Expenditures Requirements <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 504.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have incurred substantial operating losses since inception and expect to continue to incur significant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 514.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operating losses for the foreseeable future and may never become profitable. For the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.59pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 536.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 524.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we recorded a net loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.11pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.96pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our present and future funding requirements will depend on many factors, including, among other things: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the size, progress, timing, and completion of our preclinical studies and clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the number of potential new drug candidates we identify and decide to develop; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the costs involved in filing patent applications and maintaining and enforcing patents or defending <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">against claims or infringements raised by third parties; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the time and costs involved in obtaining regulatory approval for our drug candidates and any delays we <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">may encounter as a result of evolving regulatory requirements or adverse results with respect to any of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">these drug candidates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 654.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 655.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">selling and marketing activities undertaken in connection with the anticipated commercialization of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 665.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and any other current or future drug candidates and costs involved in the creation of an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 675.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">effective sales and marketing organization; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 691.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the amount of revenue, if any, we may derive either directly or in the form of milestones or royalty <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 701.85pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">payments from our existing or future partnership or collaboration agreements; and <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">117<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the severity, duration and impact of the Russia/Ukraine war, which may continue to adversely impact <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">our business and clinical trials. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">See <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.42pt; position: var(--position); white-space: pre;">&#8220;Risk Factors&#8212;Risks Related to our Financial Position and Need for Additional Capital&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.46pt; position: var(--position); text-decoration: none; white-space: pre;">for additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks associated with our substantial capital requirements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 146pt;" id="ia894b143b6fc4522a0483350194c625e_70"></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span><span id="i4196811ac5844692a9648c95a736db00"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Research and Development, Patents and Licenses, Etc.<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.89pt; position: var(--position); text-decoration: none; white-space: pre;">a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.32pt; position: var(--position); white-space: pre;"> discussion of our research and development activities, se<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.77pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">e &#8220;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.13pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Item 4.B&#8212;Business Overview</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.52pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8221; and &#8220;Item </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">5.A&#8212;Operating Results.&#8221;</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 220pt;" id="ia894b143b6fc4522a0483350194c625e_73"></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">D.<span style="display: inline-block; height: 6.77pt;"></span><span id="i3d98a1b126194f93b6584c23d9e78c06"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Trend Information<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.39pt; position: var(--position); white-space: pre;"> a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.82pt; position: var(--position); text-decoration: none; white-space: pre;">discussion<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.45999999999998pt; position: var(--position); white-space: pre;"> of trends, see &#8220;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.89pt; position: var(--position); text-decoration: none; white-space: pre;">Item 4.B&#8212;Business Overview<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.28pt; position: var(--position); white-space: pre;">,&#8221; &#8220;Item 5.A&#8212;Operating Results&#8221; and &#8220;Item <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">5.B&#8212;Liquidity and Capital Resources.&#8221;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 294pt;" id="ia894b143b6fc4522a0483350194c625e_76"></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">E.<span style="display: inline-block; height: 6.77pt;"></span><span id="i7c4a20800baf4d41b2654052ca509cd9"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Critical Accounting Estimates<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our audited financial statements as of, and for the years ended, December 31, 2024, 2023 and 2022 were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;), as issued by the International <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting Standards Board (&#8220;IASB&#8221;), and IFRS as adopted by the European Union ("EU") regulation n&#176;1606/2022 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of July 19, 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A description of accounting policies and estimates along with a description of the recently-issued accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pronouncements that may potentially impact our financial position and results of operations is disclosed in Notes 4 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and 2 respectively to our financial statements as of and for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.8pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.39pt; position: var(--position); text-decoration: none; white-space: pre;">, appearing elsewhere <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in this Annual Report on Form 20-F. We<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.22pt; position: var(--position); white-space: pre;"> applied the following amendments to IFRS that are effective as of and for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the year <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.39pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.93pt; position: var(--position); white-space: pre;">: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.2pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05000000000001pt; position: var(--position); white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); white-space: pre;">Non-current, and Non-current Liabilities with Covenants; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.35pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.85pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.85pt; position: var(--position); white-space: pre;">Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures &#8211; <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 459.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; white-space: pre;"><span style="left: 91.05pt; position: var(--position);">Supplier Finance <span style="display: inline-block; height: 6.93pt; width: 1.52pt;"></span></span><span style="left: 163.05pt; position: var(--position);">Agreements; and<span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 12pt; position: var(--position); top: 470.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.35pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.85pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.85pt; position: var(--position); white-space: pre;">Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We did not have to change our accounting policies or make retrospective adjustments as a result of adopting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these standards, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.76pt; position: var(--position); white-space: pre;">with the exception of the amendments to IAS 1, issued in 2020 and 2022, which aim at clarifying <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the requirements on determining whether a liability is current or non-current, and require new disclosures for non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">current liabilities that are subject to future covenants. The impacts resulting from the application of these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 530.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">amendments are described in N<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.95pt; position: var(--position); text-decoration: none; white-space: pre;">ote 2 to our financial statements as of and for the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.77pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.36pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">appearing elsewhere in this Annual Report on Form 20-F.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">We did not elect for early application of the new standards, amendments and interpretations, which were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">issued but not mandatory as of January 1, 2024. Our assessment of the impacts resulting from the application of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these recently issued accounting pronouncements is described in Note 2 to our financial statements as of and for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 602.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.59pt; position: var(--position); text-decoration: none; white-space: pre;">, appearing elsewhere in this Annual Report on Form 20-F.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">118<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_82"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 6.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Directors, Senior Management and Employees<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i7652ff9c52cb43d1b49f8758a9c1b94f"></span></span></div><div style="position: absolute; top: 96pt;" id="ia894b143b6fc4522a0483350194c625e_85"></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="ifbb218a58bc2435284a75f7203b5959d"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Directors and Senior Management<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets forth the name, age and position of each of our executive officers and directors as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the date of this Annual Report on Form 20-F. The business address of our executive officers and directors is our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">principal executive offices located at 7-11 boulevard Haussmann, 75009 Paris, France. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 156pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 469.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 227.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 43.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 198.75pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 227.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 112.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 0pt; width: 43.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.24pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.09pt; position: var(--position); text-decoration: none; white-space: pre;">Age<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 28.41pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 0pt; width: 198.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.24pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 81.39pt; position: var(--position); text-decoration: none; white-space: pre;">Position(s)<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Executive Officers<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 21pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 43.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 21pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 35.25pt; width: 227.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 227.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 35.25pt; width: 43.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 43.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 35.25pt; width: 198.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.08999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 69.39999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 69.47999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 41.25pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">67<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 41.25pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Chief Executive Officer and Director<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Blondel<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.28pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 63.440000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.02pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 64.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.41pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 55.5pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 15.67pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">62<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 55.5pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Executive Vice President, Chief Financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.13pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Officer and Board Secretary<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81.75pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 56.720000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 57.010000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.09pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 81.75pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">58<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 81.75pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Medical Officer<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">David Zhang<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 55.080000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 56.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 56.900000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 56.940000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 96pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">57<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 96pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Chief Strategy Officer<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 68.91pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 69.53pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 69.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.56pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 110.25pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">56<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 110.25pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Business Officer<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 124.5pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 64.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 64.61pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.62pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 124.5pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">55<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 124.5pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Scientific Officer<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 50.080000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 51.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 51.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 51.900000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.940000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">.....................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 138.75pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 15.67pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">50<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 138.75pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Chief People Officer and Chief Compliance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.13pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Officer<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 227.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 227.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 165pt; width: 43.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 43.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 165pt; width: 198.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Directors*<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 171pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 43.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 171pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 185.25pt; width: 227.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 227.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 185.25pt; width: 43.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 43.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 185.25pt; width: 198.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 191.25pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 66.17pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 66.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.89999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 66.97999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 67.02pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 67.03999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 67.05pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 191.25pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">64<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 191.25pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Board Chair, Independent Director, Member of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.13pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">the Audit Committee<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 217.5pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">June Lee<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.410000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 38.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 39.28pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 39.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 39.510000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.52pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 217.5pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">59<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 217.5pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Independent Director, Chair of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.13pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Appointments and Compensation Committee<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 243.75pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Troy Ignelzi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.45pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 54.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 54.400000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">....................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 243.75pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">57<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 243.75pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Independent Director, Chair of the Audit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.13pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Committee<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Corinna zur Bonsen-Thomas<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 118.08pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 119.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 119.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 119.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.49pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 270pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">65<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 270pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Independent Director, Member of the Audit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.13pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Committee <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 296.25pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kinam Hong (Sofinnova Partners)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 140.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 141.19pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.76999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.93pt; position: var(--position); text-decoration: none; white-space: pre;">.................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 296.25pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">52<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 296.25pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Director, Member of the Appointments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.13pt; width: 198.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Compensation Committee<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 322.5pt; width: 227.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Camilla Soenderby<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 79.47999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 79.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 79.6pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.61999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 322.5pt; width: 43.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 43.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">53<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 322.5pt; width: 198.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Independent Director, Member of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 15.67pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Appointments and Compensation Committee<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 509.75pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 71.95pt; position: var(--position);">*<span style="display: inline-block; height: 6.94pt; width: 7.25pt;"></span></span><span style="left: 84.2pt; position: var(--position);">Independence criteria assessed in accordance with the definition provided in the Middlenext Code of Corporate <span style="display: inline-block; height: 6.94pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 539pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 84.2pt; position: var(--position); text-decoration: none; white-space: pre;">Governance<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 133.03pt; position: var(--position); white-space: pre;">. Marc de Garidel is also a director but is listed with the Executive Officers.<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Executive Officers <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.51pt; position: var(--position); text-decoration: none; white-space: pre;"> has been our Chief Executive Officer since May 5, 2023 and Interim Chairman of the Board <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from May 5, 2023 to July 2024. He is currently the Chief Executive Officer and member of our Board and has more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">than 40 years of experience in the pharmaceutical and biotechnology sector, including 12 years of experience as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer of pharmaceutical and biotechnology companies. Between July 2021 and April 2023, he <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">served as Chief Executive Officer of CinCor Pharma and led its successful sale for up to $1.8&#160;billion, subject to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achievement of certain milestones, to AstraZeneca in February 2023. Between September 2020 and May 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mr.&#160;de Garidel served as Chief Executive Officer of AZTherapies. From April&#160;2018 until August 2020, he was Chief <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Executive Officer of Corvidia Therapeutics and led its sale to Novo Nordisk for $2.1 billion in total consideration. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mr. de Garidel was the Chief Executive Officer of Ipsen between November 2010 and July 2016, overseeing the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development of its U.S. presence. Prior to that, he worked for Amgen and Eli Lilly in jobs of increasing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responsibilities and in various markets, including the United States and Europe. Mr. de Garidel has served as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">chairman of the board of directors of Ipsen since 2010 and has been a member of the board of directors of Claris Bio <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 704.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">since 2020. He holds a degree in Civil Engineering from the Ecole des Travaux Publics in Paris, a Master&#8217;s degree <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">119<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in International Management from Thunderbird Global School Management and an executive MBA from Harvard <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Business School. We believe that Mr. de Garidel is qualified to serve on our Board because of his experience as an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">executive and member of the boards of companies in the life sciences industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Blondel<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.93pt; position: var(--position); text-decoration: none; white-space: pre;"> has been our <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.44pt; position: var(--position); text-decoration: none; white-space: pre;">Executive Vice President, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.4pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Financial Officer and Board Secretary since <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">January 2017. From January 2012 to December 2016, he was Chief Financial Officer at Sanofi Pasteur MSD, a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Lyon-based joint-venture between Sanofi and Merck and a European leader in human vaccines. Prior to that, over a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">20-year period, Mr.&#160;Blondel held a wide range of senior finance positions at Sanofi, in Commercial Operations and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">then research and development, where he became global research and development Chief Financial Officer. He <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">started his career as an auditor at PricewaterhouseCoopers, after graduating with a Master&#8217;s degree in Business and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Administration from the Commercial Institute of Nancy, a leading French business school. Mr.&#160;Blondel also holds a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Master&#8217;s degree in Finance and Accounting from Nancy II University, as well as a Graduate Diploma in Finance and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> has been our Chief Medical Officer since July 2024. Dr. Cataldi has over 20 years of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">experience in the development and commercialization of innovative therapies. He brings deep clinical, medical and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">scientific knowledge and expertise in immunology and gastroenterology, having served in senior research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development roles at Arena Pharmaceuticals, AbbVie, Shire, Pfizer, Biogen and Novartis. Most recently, he held the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">role of CMO at Landos Biopharma until the successful sale to AbbVie. Dr. Cataldi currently manages our clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">operations, clinical development, pharmacovigilance and medical affairs. Dr. Cataldi holds an M.D. in Medicine and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Surgery from the Seconda Universit&#224; degli Studi di Napoli.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">David Zhang <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.82999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">has been our Chief Strategy Officer since<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.18pt; position: var(--position); text-decoration: none; white-space: pre;"> July <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.84000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">2024. Mr. Zhang has over 25 years of experience <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in clinical development, diagnostics and biomarker research. Prior to joining us in July 2024, Mr. Zhang was Senior <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Vice President, Head of Biometrics and Data Management at Alumis Inc. As part of the founding management team <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">at Alumis, he served as Chief Information Officer responsible for building up capabilities in biometrics, IT, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">facilities, and investor relations during the early days of the company. Before joining Alumis, Mr. Zhang was Vice <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">President of Biometrics, Data Science and Digital Health at MyoKardia where he built the advanced analytics <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">capabilities from the ground up to enable the successful completion of critical Phase 3 trial design, data readouts, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and New Drug Application submission of CAMZYOS&#174; (mavacamten) until the company's acquisition by Bristol <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Myers Squibb in 2020. Prior to MyoKardia, Mr. Zhang spent 15 years at Roche/Genentech with increasing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responsibilities leading and building biostatistics and strategic innovation functions. He began his pharmaceutical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">industry career at Eli Lilly and Abbott Laboratories after receiving his Ph.D. in biostatistics with a minor in genetics <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from UCLA and completing post-doctoral research at Columbia University, New York, New York.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.3pt; position: var(--position); text-decoration: none; white-space: pre;"> has been our Chief Business Officer since May 2023. Prior to this appointment, he served <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as our Chief Commercial Officer and Vice President Business Development. Mr. Courteille has over 25 years of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">experience in marketing, sales and business development within the pharmaceutical industry (13 years based in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Japan). Prior to joining us in April 2015, he was Senior VP sales and marketing for Guerbet as well as Chief <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Executive Officer of MEDEX (medical devices company owned by Guerbet) from 2012. From 2009, Mr.&#160;Courteille <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">served as VP Sales for Asia, Latin America and EMEA and met the ambitious objective of optimizing commercial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">performance across these three regions. As President of Guerbet Japan and VP for Guerbet Asia, Mr.&#160;Courteille has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">successfully managed the roll-out of its Japanese subsidiary and led the development of other branches in Asia. Mr. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Courteille holds a pharmacy degree and MBA (with Honors) from The University of Chicago Booth School of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Business. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.88pt; position: var(--position); text-decoration: none; white-space: pre;"> has been our Chief Scientific Officer since August 2023. Prior to this appointment, he served <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as our Vice President of Research and Development. Mr. Scherrer has extensive experience in the development of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">portfolio of therapeutics in oncology, viral diseases and autoimmune / inflammatory&#160;diseases. Prior to joining our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">company in March 2009, he performed a combined role of Chief Executive Officer and Scientific Director at Splicos <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from September 2009. He also has experience from prior roles as Associate Director (Capability Pathways &#8211; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Discovery Enabling Capabilities and Sciences) of the Research Department of AstraZeneca and as Head of Research <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">at LFB Biotechnologies. Mr. Scherrer has a Ph.D. in Molecular Pharmacology from Universit&#233; Louis Pasteur <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(Strasbourg I). He completed his post-doctoral studies at Harvard Medical School and then at the Stanford <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">University School of Medicine. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.44pt; position: var(--position); text-decoration: none; white-space: pre;"> has been our Chief People Officer and Chief Compliance Officer since June 2023. Ms. Hatoum <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">has over 25 years experience in People Operations, Organizational Design and Build in the Biotech Industry. Prior <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to joining Abivax, Ms. Hatoum was the SVP and Head of People Talent and Culture for CinCor Pharma where she <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">was integral in the organizational build and subsequent merger and acquisition negotiations. She also has experience <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from prior roles as the Head of Organizational Development. Ms. Hatoum holds a bachelor's degree in pharmacy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from The University of Toledo in Ohio.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">120<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Directors <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.79000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> has been Chair of our Board and independent director since July 2024.&#160; Dr. Gr&#233;goire is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distinguished pharmaceutical and biotech executive with over 30 years in international leadership roles. Her <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expertise encompasses late-stage development, financial raises and commercial expansion. Dr. Gr&#233;goire is the Co-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Founder and was Executive Chair of the Board at EIP Pharma Inc., based in Boston, MA. Under her leadership, EIP <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Pharma transitioned into CervoMed, a publicly listed company on NASDAQ (CRVO), developing the first disease-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">modifying treatment for Dementia with Lewy Bodies. Dr. Gr&#233;goire has previously served on the board of Cubist, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Glycofi, Vifor Pharma, Revvity and chaired the board of IDM Pharma, Corvidia and CervoMed. Dr. Gr&#233;goire is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">currently a member of the board of Novo Nordisk, CervoMed and F2G Ltd. Dr. Gr&#233;goire holds a Science College <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">degree from S&#233;minaire de Sherbrooke in Canada, a BA in Pharmacy from Laval University in Canada, and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmacy Doctorate degree from the State University of New York at Buffalo. We believe that Dr. Gr&#233;goire is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">qualified to serve on our Board because of her experience as an executive and member of the boards of companies in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the life sciences industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">June Lee<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.07pt; position: var(--position); text-decoration: none; white-space: pre;"> has been one of our independent directors since July 2023. Dr. Lee has served as a venture partner at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">5AM Venture Management, LLC since July 2022. Dr. Lee was most recently Founder and Chief Executive Officer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of Esker Therapeutics until September 2021. Dr. Lee previously served as the Executive Vice President and Chief <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Development Officer of MyoKardia, Inc. from January 2019 to June 2020, and was the Chief Operating Officer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from February 2017 until January 2019, and the Chief Development Officer from October 2017 to January 2019. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">From April 2011 until February 2017, Dr. Lee served on the faculty of the University of California, San Francisco, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or UCSF, where she was director of the Catalyst program at the Clinical and Translational Science Institute and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">professor in the School of Medicine, and was responsible for overall strategy and operations for enabling and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">supporting translational research at the university. Catalyst is an internal UCSF accelerator for therapeutics, devices, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">diagnostics, and digital health technologies. Prior to UCSF, Dr. Lee was a disease area lead, early clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development, at Genentech, Inc. from 2006 to 2011, where she was responsible for all strategy and activities as well <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as management of staff, budget, and resource allocation in the early clinical development group in multiple <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therapeutic areas. Dr. Lee served as a Medical Director in the clinical development group at Genentech, Inc. from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2004 to 2006, where she was responsible for clinical activities for licensed product of the company. She currently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">serves on Johns Hopkins University Center for Therapeutic Translation&#8217;s Advisory Board, serves on the board of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directors of Tenaya Therapeutics Inc, Eledon Pharmaceuticals Inc. and GenEdit, is a member of the Scientific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Advisory Board for Foresite Labs, and previously served as a member of the board of directors of CinCor Pharma, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Inc. Dr. Lee holds a B.A. in chemistry from Johns Hopkins University and an M.D. from the University of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">California, Davis. We believe that Dr.&#160;Lee is qualified to serve on our Board because of her experience as an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">investor and member of the boards of companies in the life sciences industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Troy Ignelzi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.94pt; position: var(--position); text-decoration: none; white-space: pre;"> has been one of our independent directors since July 2023. Mr. Ignelzi has served as the Chief <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Officer of Rapport Therapeutics, Inc. since October 2023. Prior to that, Mr. Ignelzi served as the Chief <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Officer of Karuna Therapeutics, Inc. from March 2019 to October 2023 until its sale to Bristol Myers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Squibb. Prior to his position at Karuna Therapeutics, Mr. Ignelzi was the Chief Financial Officer of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">scPharmaceuticals Inc. from March 2016 to February 2019, and provided consulting services to scPharmaceuticals <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Inc. in February and March 2016. Mr. Ignelzi previously served as Chief Financial Officer and as a member of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">executive leadership teams at Juventas Therapeutics Inc., a privately held biotechnology company, from October <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2014 to February 2016. From October 2013 to October 2014, Mr. Ignelzi served as Senior Vice President&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Operations and Business Development of Pharmalex GmbH. Prior to Pharmalex, Mr. Ignelzi was Vice President&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Business Development at Esperion Therapeutics, Inc., a public pharmaceutical company, from January 2009 to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">September 2013. Mr. Ignelzi served as Vice President, Business Development &amp; Strategic Planning at Insys <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Therapeutics, Inc., a specialty pharmaceutical company, from February 2007 to February 2009. Previously, Mr. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ignelzi had served as a specialty senior sales representative at Eli Lilly from February 2002 to August 2005. Mr. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ignelzi currently serves as a member of the board of directors of Vedanta Biosciences, Inc. and previously served as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a member of the board of directors of CinCor Pharma, Inc. Mr. Ignelzi has a B.S. in accounting from Ferris State <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">University. We believe that Mr. Ignelzi is qualified to serve on our Board because of his experience as an executive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and member of the boards of companies in the life sciences industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Corinna zur Bonsen-Thomas <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.82999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">served as our Chair between August 2022 and May 2023 and has been one of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our independent directors since June 2017. Since April 2020, Ms. zur Bonsen-Thomas has held the position of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Managing Director and Chief Executive Officer of RetInSight GmbH, a company which she co-founded in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">April&#160;2020 and specializes in ophthalmic imaging. Ms. zur Bonsen-Thomas was General Counsel for Smart <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Reporting GmbH from February 2017 to December 2022. From 1999 to 2015, she served as a member of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Supervisory Board of Baxter AG, an Austrian company. She has more than thirty years of international professional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">experience in the pharmaceutical, biopharmaceutical, medical and biotechnology industries. Ms. zur Bonsen-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Thomas received her First Law State Examination from Ludwig Maximilian Universitaet and her Second Law State <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Examination from the Bavarian Ministry of Justice. We believe that Ms. zur Bonsen-Thomas is qualified to serve on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our Board because of her extensive professional experience in the life sciences industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">121<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Kinam Hong <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.26pt; position: var(--position); text-decoration: none; white-space: pre;">has served as the permanent representative of Sofinnova Partners on our Board since September <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2019. He has served as the partner responsible for Sofinnova&#8217;s strategy of crossover and growth investment in late <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development stage companies at Sofinnova Partners since January 2017. He has served as the permanent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">representative of Sofinnova Partners on the board of directors of CytoImmune Therapeutics, Inc. since July 2021 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and as an observer then board member of Limflow SA since April 2018. Prior to Sofinnova Partners, Dr. Hong spent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ten years as an investor and research analyst covering the biotechnology sector. Dr. Hong co-led the Exane Equinox <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Fund, a global healthcare fund investing in public biotech companies. He also worked at Citigroup investment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">research where he focused on small- and midcap biotechnology companies. Before his investment career, Dr. Hong <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">worked in new product development at Sanofi, a multinational pharmaceutical company, where he held positions in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business development and strategic/new product marketing. Dr. Hong is a doctor and scientist who holds a Bachelor <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of Science degrees in molecular biology/biochemistry and a Doctor of Medicine from the University of Florida. He <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">also holds a Chartered Financial Analyst and a Master of Business Administration from INSEAD, France. We <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">believe that Dr. Hong is qualified to serve on our Board because of his extensive experience as an investor and as a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">member of the boards of companies in the life sciences industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Camilla Soenderby<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.39pt; position: var(--position); text-decoration: none; white-space: pre;"> has been one of our independent directors since March 2024. Currently, Ms. Soenderby <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is a member of the Board of Directors for the investment company BB Biotech and the two biotech companies, F2G <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and Affibody. In addition, she is a member of Novo Holdings Advisory Group and industrial advisor for the private <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">equity group EQT. Most recently, Ms. Soenderby served as Chief Patient Value and Product Strategy Officer for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Takeda Pharmaceutical Co Ltd. from 2019 to 2020. Ms. Soenderby led and oversaw Global Product Strategy at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Shire from March 2018 until its acquisition by Takeda. Prior to joining Shire, Ms. Soenderby was Region Head for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Roche Pharma with profit and loss responsibility for 11 countries in Central, South and Eastern Europe. Prior to that, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">she worked as General Manager for Abbott (now AbbVie), first in Sweden and later in the United Kingdom. She <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">also held several operational and strategic roles of increasing responsibility at Schering Plough in Asia Pacific, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including General Manager for Taiwan. Ms. Soenderby began her career as a management consultant at McKinsey <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&amp; Company focusing on the bio-pharmaceutical and medical device industries. Ms. Soenderby holds a MSc in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Political Science from the University of Copenhagen. We believe that Ms. Soenderby is qualified to serve on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board because of her extensive experience as an executive and as a member of the boards of companies in the life <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sciences industry. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Family Relationships <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There are no family relationships among any of our executive officers or directors.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">122<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_88"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="i44918e8655fc4e31b4a80820e8bd077d"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Compensation<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 90pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Compensation of Chief Executive Officer <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets out the compensation awarded to our Chief Executive Officer in the applicable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">period: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 138pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 295.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 86.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 86.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 295.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 0pt; width: 172.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 172.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 31.31pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended December&#160;31,<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 14.25pt; width: 295.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 14.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 33.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 14.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.23pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 33.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 28.5pt; width: 295.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 28.5pt; width: 86.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.46pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 28.5pt; width: 86.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.46pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 40.5pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Marc de Garidel&#8212;Chief Executive Officer from May 5, 2023 and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">Chairman from May 5, 2023 until July 11, 2024<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 40.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 12.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fixed compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 83.36999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 84.53pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 85.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.19pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 63.75pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.55pt; position: var(--position); text-decoration: none; white-space: pre;">359,274<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 63.75pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.12pt; position: var(--position); text-decoration: none; white-space: pre;">577,500<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Variable annual compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: italic; font-weight: normal; left: 125.86999999999999pt; position: var(--position); text-decoration: none; top: -2.429pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.511pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 131.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 132.7pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 132.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.75pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 78pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.55pt; position: var(--position); text-decoration: none; white-space: pre;">217,582<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 78pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Variable multi-year compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.71pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.31pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 92.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;&#8194;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 92.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exceptional variable compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 144.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 144.71pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 145pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 145.15pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 145.23pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">...........................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 106.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;&#8194;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 106.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Remuneration allocated due to mandate as director<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 209.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 209.68pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 209.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 210.12pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 210.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 210.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 210.26pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">.................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 120.75pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;&#8194;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 120.75pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Benefits in kind<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.76pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 65.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 65.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 65.28pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 65.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.33pt; position: var(--position); text-decoration: none; white-space: pre;">...........................................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 135pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.55pt; position: var(--position); text-decoration: none; white-space: pre;">28,496<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 135pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;">53,442<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 149.25pt; width: 295.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 149.25pt; width: 86.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 83.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 154.5pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 25.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 27.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 27.419999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 27.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 27.65pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 154.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.55pt; position: var(--position); text-decoration: none; white-space: pre;">605,353<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 154.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 86.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 51.12pt; position: var(--position); text-decoration: none; white-space: pre;">630,942<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168.75pt; width: 295.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 168.75pt; width: 86.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 83.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Hartmut Ehrlich&#8212;Chief Executive Officer until May 5, 2023 <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: italic; font-weight: bold; left: 264.89pt; position: var(--position); text-decoration: none; top: -2.3694999999999995pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 4.4005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 174pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 188.25pt; width: 295.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 188.25pt; width: 86.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 83.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 194.25pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fixed compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 83.36999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 84.53pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 85.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.19pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 194.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 46.55pt; position: var(--position); text-decoration: none; white-space: pre;">111,773<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 194.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Variable annual compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: italic; font-weight: normal; left: 125.86999999999999pt; position: var(--position); text-decoration: none; top: -2.429pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.511pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 131.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 132.7pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 132.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.75pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 208.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 51.55pt; position: var(--position); text-decoration: none; white-space: pre;">64,381<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 208.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222.75pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Variable multi-year compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.71pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.31pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 222.75pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 222.75pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exceptional variable compensation<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 144.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 144.71pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 145pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 145.15pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 145.23pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">...........................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 237pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 237pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 251.25pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Remuneration allocated due to mandate as director<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 209.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 209.68pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 209.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 210.12pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 210.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 210.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 210.26pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">.................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 251.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 251.25pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 265.5pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Benefits in kind<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.76pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 65.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 65.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 65.28pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 65.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.33pt; position: var(--position); text-decoration: none; white-space: pre;">...........................................................................................<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 265.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 56.55pt; position: var(--position); text-decoration: none; white-space: pre;">3,083<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 265.5pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 279.75pt; width: 295.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 279.75pt; width: 86.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 83.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 295.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 295.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 25.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 27.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 27.419999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 27.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 27.65pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 285pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 86.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 51.12pt; position: var(--position); text-decoration: none; white-space: pre;">179,238<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 285pt; width: 86.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.66pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 70.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 299.25pt; width: 295.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 295.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 295.5pt; position: var(--position); top: 299.25pt; width: 86.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381.75pt; position: var(--position); top: 299.25pt; width: 86.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 2.85pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 459.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">(1)<span style="display: inline-block; height: 6.93pt; width: 10.84pt;"></span></span><span style="left: 94.5pt; position: var(--position);">Variable compensation paid for the financial year corresponds to the amount due for the previous year. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 469.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(2)&#160; &#160; Variable annual compensation will be granted under an equity plan in 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 481.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(3)&#160; &#160; Does not include departure indemnity equal to &#8364;1,209,825. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The aggregate compensation paid and benefits in-kind granted by us to our current executive officers and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directors, including share-based compensatio<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.34pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">n, for the years ended December 31, 2024 and 2023 were</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> &#8364;19.1 million </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 537.5pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and &#8364;9.8 million, respectively</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.03pt; position: var(--position); text-decoration: none; white-space: pre;">. For both years, we did not allocate any amounts to be set aside or accrued to provide <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">pension, retirement or similar benefits to our directors or executive officers. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">123<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Compensation of Directors <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.89pt; position: var(--position); text-decoration: none; white-space: pre;">table sets<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.76999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> out the compensation awarded to our directors during the year ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 120pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 416.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 326.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 90pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 326.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 326.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: underline; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.14pt; position: var(--position); text-decoration: underline; white-space: pre;">Gross Fees Earned (&#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 66.17pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 73.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.89999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 75.47999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.77pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 75.89pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.91pt; position: var(--position); text-decoration: none; white-space: pre;">...................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 12pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.87pt; position: var(--position); text-decoration: none; white-space: pre;">66,236<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 26.25pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">June Lee<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 38.410000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 38.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 38.6pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.61pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 26.25pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.87pt; position: var(--position); text-decoration: none; white-space: pre;">120,000<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 40.5pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Troy Ignelzi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 53.45pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 53.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.5pt; position: var(--position); text-decoration: none; white-space: pre;">............................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 40.5pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.87pt; position: var(--position); text-decoration: none; white-space: pre;">125,000<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Corinna zur Bonsen-Thomas<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 118.08pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 118.36999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 118.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 118.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.58pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 54.75pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.87pt; position: var(--position); text-decoration: none; white-space: pre;">115,000<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sofinnova Partners (permanent representative to the Board: Kinam Hong)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 297.86pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 298.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 298.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.56pt; position: var(--position); text-decoration: none; white-space: pre;">..........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 69pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 83.25pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 1.13pt; position: var(--position); text-decoration: none; white-space: pre;">Camilla Soenderby<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 77.97999999999999pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 85.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 85.83999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 85.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.08pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 83.25pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.87pt; position: var(--position); text-decoration: none; white-space: pre;">86,250<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sant&#233; Holdings SRL (permanent representative to the Board: Paolo Rampulla)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 315.87pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 323.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 323.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 97.5pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Truffle Capital (permanent representative to the Board: Philippe Pouletty)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 298.34pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 305.90999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 306.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 306.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.11pt; position: var(--position); text-decoration: none; white-space: pre;">.......<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 111.75pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Carol L. Brosgart<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 72.83pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 80.39999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 80.97999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.06pt; position: var(--position); text-decoration: none; white-space: pre;">.................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.87pt; position: var(--position); text-decoration: none; white-space: pre;">55,605<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Philippe Pouletty<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 71.72999999999999pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 79.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 80.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 80.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.89999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.96pt; position: var(--position); text-decoration: none; white-space: pre;">.................................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 140.25pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 154.5pt; width: 326.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 326.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 25.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 26.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 26.06pt; position: var(--position); text-decoration: none; white-space: pre;">.......................................................................................................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 154.5pt; width: 90pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 90pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.87pt; position: var(--position); text-decoration: none; white-space: pre;">568,091<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 1pt; position: var(--position); top: 302.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 303.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; As of July 2024, Dr. Gr&#233;goire was appointed to our Board following Dr. Brosgart's resignation from our Board.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 313.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(2)&#160; As of March 2024, Ms. Soenderby was appointed to our Board following Sant&#233; Holdings SRL's resignation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 323.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from our Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 333.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(3)&#160; Effective December 31, 2024, Truffle Capital resigned from our Board.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 355.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">At the general meeting of shareholders held on May&#160;30, 2024, our shareholders approved a package of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 365.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">attendance fees and the compensation policy applicable to the chairperson of the Board and the Chief Executive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 375.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Officer. For the fiscal year ended December 31, 2024, none of the amounts set aside or accrued to provide pension, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 385.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">retirement or similar benefits to our employees was attributable to our executive officers. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 407.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table sets<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.76999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> forth the AGAs allocated to the chairperson and chief executive officer as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 417.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2024: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 427.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 439.75pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 87.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Chairperson&#160;&amp; CEO<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 0pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.13pt; position: var(--position); text-decoration: none; white-space: pre;">Allocation date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 0pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.57pt; position: var(--position); text-decoration: none; white-space: pre;">Type&#160;of&#160;AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 0pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.12pt; width: 78pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.03pt; position: var(--position); text-decoration: none; white-space: pre;">Number&#160;of&#160;AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 78pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.68pt; position: var(--position); text-decoration: none; white-space: pre;">allocated<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.71pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription&#160;price<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 0pt; width: 87.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.24pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 27.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 55.02pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 55.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 55.330000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.34pt; position: var(--position); text-decoration: none; white-space: pre;">..........<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 27.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.67pt; position: var(--position); text-decoration: none; white-space: pre;">July-11-2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 27.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.91pt; position: var(--position); text-decoration: none; white-space: pre;">Free&#160;Shares&#160;2023-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 27.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 23pt; position: var(--position); text-decoration: none; white-space: pre;">1,382,796<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 27.75pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 27.75pt; width: 87.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 87.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.01pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum&#160;of&#160;1&#160;year (*)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 42pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 9.91pt; position: var(--position); text-decoration: none; white-space: pre;">February-01-2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 42pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.91pt; position: var(--position); text-decoration: none; white-space: pre;">Free Shares 2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 42pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26pt; position: var(--position); text-decoration: none; white-space: pre;">400,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 42pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 42pt; width: 87.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.45pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum of 2 years (**)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 1.13pt; position: var(--position); text-decoration: none; white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 51.970000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 53.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 53.21pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">...........<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 54pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.99pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.67pt; position: var(--position); text-decoration: none; white-space: pre;">July-11-2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 54pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.99pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.91pt; position: var(--position); text-decoration: none; white-space: pre;">Free Shares 2024-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 54pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.99pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 28pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 54pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.99pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 54pt; width: 87.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.99pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.11pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum of 2 years <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.99pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.21pt; position: var(--position); text-decoration: none; white-space: pre;">(***)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 19.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 20.66pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 20.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 21.099999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 21.18pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 21.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.209999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">...........................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 75.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 75.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 75.75pt; width: 78pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 78pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 23pt; position: var(--position); text-decoration: none; white-space: pre;">1,807,796<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 75.75pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 33.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 75.75pt; width: 87.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.49pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 546.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 71.95pt; position: var(--position);">(*)<span style="display: inline-block; height: 6.93pt; width: 12.84pt;"></span></span><span style="left: 96.45pt; position: var(--position);">Acquisition Periods shall be as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">For 212,738 Free Shares 2023-1: the Acquisition Period shall end on the first (1st) anniversary of the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">allocation date; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">For 638,214 Free Shares 2023-1: the Free Shares 2023-1 shall progressively be definitively acquired <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">on a monthly basis over a period of three (3) years starting after the first (1st) anniversary of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">allocation date (i.e. 17,728 Free Shares 2023-1 per month except for the last month of the three-year <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">period where 17,734 Free Shares 2023-1 shall be acquired). The duration of the Acquisition Period of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">these Free Shares 2023-1 shall be calculated accordingly; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">For 212,738 Free Shares 2023-1: the Acquisition Period shall end on the latest date between (i)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">first (1st) anniversary of the allocation date, and (ii)&#160;the date on which a specific performance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">condition is fulfilled (condition&#160;1); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">For 106,369 Free Shares 2023-1: the Acquisition Period shall end on the latest date between (i)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">first (1st) anniversary of the allocation date, and (ii)&#160;the date on which a specific performance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">condition is fulfilled (condition&#160;2); <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">124<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">For 106,369 Free Shares 2023-1: the Acquisition Period shall end on the latest date between (i)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">first (1st) anniversary of the allocation date, and (ii)&#160;the date on which a specific performance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">condition is fulfilled (condition&#160;3); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">For 106,368 Free Shares 2023-1: the Acquisition Period shall end on the first (1st)&#160;anniversary of the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">allocation date subject to the completion, prior to such date, of a specific performance condition <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">(condition&#160;4). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(**)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 88.66pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; &#160;  <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.66pt; position: var(--position); white-space: pre;">Acquisition Periods shall be as follows: <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.5pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); white-space: pre;">For 50% of the Free Shares 2024-1 (rounded down to the closest unit): the Acquisition Period shall <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">end on the second (2nd) anniversary of the allocation date;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.5pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); white-space: pre;">For 25% of the Free Shares 2024-1 (rounded down to the closest unit): the Acquisition Period shall <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">end on the third (3rd) anniversary of the allocation date;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.5pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); white-space: pre;">For the remainder of the Free Shares 2024-1: the Acquisition Period shall end on the fourth (4th) <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">anniversary of the allocation date.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(***)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 93.66pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.66pt; position: var(--position); white-space: pre;">Acquisition Periods shall be as follows: <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.5pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); white-space: pre;">For 50% of the Free Shares 2024-5 (rounded down to the closest unit): the Acquisition Period shall <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">end on the second (2nd) anniversary of the allocation date;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.5pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); white-space: pre;">For 25% of the Free Shares 2024-5 (rounded down to the closest unit): the Acquisition Period shall <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">end on the third (3rd) anniversary of the allocation date;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 111.5pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); white-space: pre;">For the remainder of the Free Shares 2024-5: the Acquisition Period shall end on the fourth (4th) <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126pt; position: var(--position); white-space: pre;">anniversary of the allocation date.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions or Allocations to Pay Pensions, Retirement or Other Benefits for Directors and Management <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the fiscal year ended December&#160;31, 2024, none of the amounts set aside or accrued to provide pension, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">retirement or similar benefits to our employees was attributable to our administrative, supervisory or management <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bodies. We have not set aside any provisions to pay pensions, retirement and other benefits for corporate directors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The directors&#8217; compensation does not include any profit-sharing plans. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Employment Agreements<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have entered into employment agreements with each of our executive officers, except for our Chief <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Executive Officer, who is a corporate officer (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 256.75pt; position: var(--position); text-decoration: none; white-space: pre;">mandataire social<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.19pt; position: var(--position); text-decoration: none; white-space: pre;">) with whom we have entered into a management <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contract. We have also entered into a management contract with Ms. Sylvie Gr&#233;goire. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Chief Executive Officer has been appointed for a term lasting until the end of the Board meeting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">following the general meeting of shareholders held to approve the financial statements for the year ending December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2026. He was also appointed as Chairman of the Board for a term lasting until the end of the Board meeting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">following the general meeting of shareholders held to approve the financial statements for the year ending December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2024; however, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.68pt; position: var(--position); white-space: pre;">Mr. de Garidel resigned from his office as Chairman of the Board on July 11, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.83pt; position: var(--position); text-decoration: none; white-space: pre;"> In case of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">termination of the Chief Executive Officer as a result of (i)&#160;non-renewal, (ii) revocation except for gross negligence <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or willful misconduct and/or (iii) resignation justified by invalidity or health issues or Mr. de Garidel&#8217;s definitive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">retirement (a &#8220;Qualifying Departure&#8221;), Mr. de Garidel shall be entitled to a severance payment equal to 12 months of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the higher of either (i) the monthly average fixed remuneration and variable remuneration received by Mr. de <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Garidel during the 12-month period preceding the effective date of the Qualifying Departure, or (ii) the monthly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">average fixed remuneration received by Mr. de Garidel during the 12-month period preceding the effective date of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Qualifying Departure plus 1/12th of the variable remuneration for the financial year immediately preceding the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">date of the Qualifying Departure, irrespective of the date of payment of that variable remuneration. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Ms. Gr&#233;goire was appointed, effective on July 11, 2024, as Chairperson of the Board. We entered into a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management contract with Ms. Sylvie Gr&#233;goire to set forth the terms and conditions of her office. For the duration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the contract and a period of twelve (12) months maximum from the effective date of the termination of her <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">functions as Chairperson, Ms. Gr&#233;goire is bound by non-compete and non-solicitation undertakings. It is specified <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that the compensation for the undertakings set forth above is included in the compensation paid to Ms. Gr&#233;goire <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">during the term of her office as Chairperson and that no additional compensation shall be paid to Ms. Gr&#233;goire in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">connection therewith (including after the term of her office as Chairperson). The corporate office of Ms. Gr&#233;goire <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terminates in accordance with the applicable law and the provisions of the by-laws of the Company.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In May 2023, we entered into an executive employment agreement with Ms. Hatoum. Ms. Hatoum may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terminate her employment with us without good reason (as defined in her offer letter) upon 30 days of notice, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we may terminate her employment with us without cause (as defined in her offer letter). If Ms. Hatoum&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 704pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employment is terminated by us without cause or Ms. Hatoum resigns with good reason (as defined in her offer <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">125<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">letter), then she will be entitled to receive severance pay in an amount equal to (i) 12 months of her then-current base <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation, (ii) the variable compensation and (iii) any premiums for healthcare plans provided by us (including <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any eligible COBRA coverage) for the earlier of a period of 12 months from the date of termination and the date on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which Ms. Hatoum becomes eligible to receive such benefits with a new employer, as well as twelve months of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accelerated vesting of the unvested portion of any outstanding equity awards. If Ms. Hatoum&#8217;s employment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terminated by us without cause or Ms. Hatoum resigns with good reason (as defined in her offer letter) within three <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">months before or twelve months after a change in control of the company, then she will be entitled to receive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">severance pay in an amount equal to (i) 12 months of her then-current base compensation, (ii) a prorated portion of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the variable compensation and (iii) any premiums for healthcare plans provided by us (including any eligible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">COBRA coverage) for the earlier of a period of twelve months from the date of termination and the date on which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ms. Hatoum becomes eligible to receive such benefits with a new employer, as well accelerated vesting of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unvested portion of any outstanding equity awards. The offer letter also includes a non-competition provision lasting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">during and for twelve months following her employment with us.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.33pt; position: var(--position); text-decoration: none; white-space: pre;">July<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.99pt; position: var(--position); text-decoration: none; white-space: pre;"> 2024, we entered into an executive employment agreement with Mr. Zhang. Mr. Zhang may terminate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">his employment with us without good reason (as defined in his offer letter) upon 30 days of notice, and we may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terminate his employment with us without cause (as defined in his offer letter). If Mr. Zhang is terminated by us <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 244pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">without cause or Mr. Zhang resigns with good reason (as defined in his offer letter), then he will be entitled to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">receive severance pay in an amount equal to (i) 12 months of her then-current base compensation, (ii) the variable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 264pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation and (iii) any premiums for healthcare plans provided by us (including any eligible COBRA coverage) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the earlier of a period of 12 months from the date of termination and the date on which Mr. Zhang becomes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">eligible to receive such benefits with a new employer, as well as twelve months of accelerated vesting of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">unvested portion of any outstanding equity awards. If Mr. Zhang's employment is terminated by us without cause or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mr. Zhang resigns with good reason (as defined in her offer letter) within three months before or twelve months <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">after a change in control of the company, then he will be entitled to receive severance pay in an amount equal to (i) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">12 months of her then-current base compensation, (ii) a prorated portion of the variable compensation and (iii) any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">premiums for healthcare plans provided by us (including any eligible COBRA coverage) for the earlier of a period <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of twelve months from the date of termination and the date on which Mr. Zhang becomes eligible to receive such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">benefits with a new employer, as well accelerated vesting of the unvested portion of any outstanding equity awards. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The offer letter also includes a non-competition provision lasting during and for twelve months following his <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employment with us.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In July 2024, we entered into an executive employment agreement with Mr. Cataldi. Mr. Cataldi may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terminate his employment with us without good reason (as defined in his offer letter) upon 30 days of notice, and we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may terminate his employment with us without cause (as defined in her offer letter). If Mr. Cataldi's employment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terminated by us without cause or Mr. Cataldi resigns with good reason (as defined in his offer letter), then he will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be entitled to receive severance pay in an amount equal to (i) 12 months of his then-current base compensation, (ii) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the variable compensation and (iii) any premiums for healthcare plans provided by us (including any eligible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">COBRA coverage) for the earlier of a period of 12 months from the date of termination and the date on which Mr. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Cataldi becomes eligible to receive such benefits with a new employer, as well as twelve months of accelerated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">vesting of the unvested portion of any outstanding equity awards. If Mr. Cataldi&#8217;s employment is terminated by us <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">without cause or Mr. Cataldi resigns with good reason (as defined in his offer letter) within three months before or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">twelve months after a change in control of the company, then he will be entitled to receive severance pay in an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amount equal to (i) 12 months of his then-current base compensation, (ii) a prorated portion of the variable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation and (iii) any premiums for healthcare plans provided by us (including any eligible COBRA coverage) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the earlier of a period of twelve months from the date of termination and the date on which Mr. Cataldi becomes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">eligible to receive such benefits with a new employer, as well accelerated vesting of the unvested portion of any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outstanding equity awards. The offer letter also includes a non-competition provision lasting during and for twelve <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 556pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">months following <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.29000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">his<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.95pt; position: var(--position); text-decoration: none; white-space: pre;"> employment with us.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Each of our executive officers has agreed to maintain the confidentiality of any confidential information, both <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">during and after the employment/management agreement expires or is earlier terminated. In addition, they are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to loyalty and confidentiality obligations and certain of them are bound by a non-solicitation covenant that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prohibits such executive officer from soliciting our customers, or soliciting or hiring our executive employees and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">those of our employees working in the same team as our executive officer, during his or her employment/office and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for one year after the termination of his or her employment/office.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Free Shares (AGA) <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We entered into a transition protocol with Dr. Hartmut Ehrlich, our previous Chief Executive Officer, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">according to which he was granted by a Board decision on July 11, 2023 100,000 free shares (AGAs) that are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to the achievement of specific performance conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">126<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Moreover, pursuant to a Board decision on July 11, 2023, we have allocated a total number of 1,382,796 free <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares (AGA) to Mr. Marc de Garidel, as our current Chief Executive Officer, to which performance conditions and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">presence conditions apply. In particular, 106,369 out of these 1,382,796 free shares (AGA) vested upon the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">successful completion of our initial public offering of our ADSs in the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">On September 28, 2023, we have allocated 311,250 free shares (AGA) in the aggregate to Mr. Didier Blondel, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mr. Didier Scherrer, Mr. Pierre Courteille and Ms. Ida Hatoum, the vesting of which is subject to certain conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to remaining employed with us, each such officer or employee&#8217;s free shares (AGA) will be vested as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">follows: (i) 50% at the end of a two-year period from the allocation date, (ii) 25% at the end of a three-year period <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from the allocation date and (iii) 25% at the end of a four-year period from the allocation date. Of the 985,750 free <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares (AGA), 254,250 free shares (AGA) were subject to an additional vesting condition that was satisfied upon the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">successful completion of our initial public offering of our ADSs in the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 205.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On February 1, 2024, Mr. de Garidel, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.9pt; position: var(--position); text-decoration: none; white-space: pre;">Mr. Didier Blondel, Mr. Didier Scherrer, Mr. Pierre Courteille and Ms. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.45pt; position: var(--position); white-space: pre;"> were allocated 755 000 free shares (AGA) in the aggregate, the vesting of which is subject to a presence <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 227.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">condition. Subject to remaining employed with us, each such officer or employee&#8217;s free shares (AGA) will be vested <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">as follows: (i) 50% at the end of a two-year period from the allocation date, (ii) 25% at the end of a three-year period <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">from the allocation date and (iii) 25% at the end of a four-year period from the allocation date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On July 11, 2024, Mr. David Zhang was allocated 80,000 free shares (AGA), the vesting of which is subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 283.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">a presence condition. Subject to remaining employed with us, each such officer or employee&#8217;s free shares (AGA) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">will be vested as follows: (i) 50% at the end of a two-year period from the allocation date, (ii) 25% at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">three-year period from the allocation date and (iii) 25% at the end of a four-year period from the allocation date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On July 11, 2024, Ms. Gr&#233;goire was allocated 25,000 free shares (AGA), the vesting of which is subject to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 339.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">presence condition. Subject to remaining Chairman of the Board, free shares (AGA) will be vested as follows: (i) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">50% at the end of a two-year period from the allocation date, (ii) 25% at the end of a three-year period from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">allocation date and (iii) 25% at the end of a four-year period from the allocation date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On September 5, 2024, Mr. Fabio Cataldi was allocated 150,000 free shares (AGA), the vesting of which is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 395.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">subject to a presence condition. Subject to remaining employed with us, each such officer or employee&#8217;s free shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(AGA) will be vested as follows: (i) 50% at the end of a two-year period from the allocation date, (ii) 25% at the end <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">of a three-year period from the allocation date and (iii) 25% at the end of a four-year period from the allocation date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On February 6, 2025, Mr. de Garidel, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.9pt; position: var(--position); text-decoration: none; white-space: pre;">Mr. Didier Blondel, Mr. Didier Scherrer, Mr. Pierre Courteille, Mr. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 451.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Fabio Cataldi, Mr. David Zhang and Ms. Ida Hatoum<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.41999999999996pt; position: var(--position); white-space: pre;"> were allocated 3,019,000 free shares (AGA) in the aggregate, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the vesting of which is subject to a presence condition. Subject to remaining employed with us, each such officer or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">employee&#8217;s free shares (AGA) will be vested as follows: (i) 50% at the end of a two-year period from the allocation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 485.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">date, (ii) 25% at the end of a three-year period from the allocation date and (iii) 25% at the end of a four-year period <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">from the allocation date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On February 6, 2025, Mr. de Garidel, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.9pt; position: var(--position); text-decoration: none; white-space: pre;">Mr. Didier Blondel, Mr. Pierre Courteille, Mr. Fabio Cataldi, Mr. David <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Zhang and Ms. Ida Hatoum<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.19pt; position: var(--position); white-space: pre;"> were further allocated 103,009 free shares (AGA) in the aggregate, the vesting of which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 541.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">is subject to a presence condition. Subject to remaining employed with us, each such officer or employee&#8217;s free <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">shares (AGA) will be fully vested at the end of a two-year period from the allocation date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On February 6, 2025, Ms. Gr&#233;goire was allocated 30,500 free shares (AGA), the vesting of which is subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">a presence condition. Subject to remaining Chairman of the Board, free shares (AGA) will be vested as follows: (i) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 597.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">50% at the end of a two-year period from the allocation date, (ii) 25% at the end of a three-year period from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">allocation date and (iii) 25% at the end of a four-year period from the allocation date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 633.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Transition Protocol <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In connection with Dr. Hartmut Ehrlich&#8217;s retirement as Chief Executive Officer, we entered into a transition <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">protocol with Dr. Ehrlich in April 2023. Pursuant to the transition protocol, Dr. Ehrlich remained our employee on a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">part-time basis until December 31, 2023 in a capacity as advisor to the new Chief Executive Officer against payment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of a total compensation of &#8364;100,000, and we paid Dr. Hartmut Ehrlich a departure indemnity equal to &#8364;1,209,825. In <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">127<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition, Dr. Ehrlich was granted by a Board decision on July 11, 2023 100,000 free shares that are subject to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achievement of specific performance conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Limitations on Liability and Indemnification <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Under French law, provisions of by-laws that limit the liability of directors are prohibited. However, French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">law allows <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 117.5pt; position: var(--position); text-decoration: none; white-space: pre;">soci&#233;t&#233;s anonyme <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.19pt; position: var(--position); text-decoration: none; white-space: pre;">to contract for and maintain liability insurance against civil liabilities incurred by any <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of their directors and officers involved in a third-party action, provided that they acted in good faith and within their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">capacities as directors or officers of Abivax SA. Criminal liability cannot be indemnified under French law, whether <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directly by us or through liability insurance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We maintain liability insurance for our directors and officers, including insurance against liability under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Securities Act and we intend to enter into agreements with our directors and executive officers to provide <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contractual indemnification. With certain exceptions and subject to limitations on indemnification under French law, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">these agreements will provide for indemnification for damages and expenses including, among other things, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proceeding arising out of his or her actions in that capacity.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">These agreements may discourage shareholders from bringing a lawsuit against our directors and executive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">officers for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">derivative litigation against directors and executive officers, even though such an action, if successful, might <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">otherwise benefit us and our shareholders. Furthermore, a shareholder&#8217;s investment may be adversely affected to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extent we pay the costs of settlement and damage awards against directors and officers pursuant to these insurance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">agreements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Certain of our non-employee directors may, through their relationships with their employers or partnerships, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be insured and/or indemnified against certain liabilities in their capacity as members of our Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In any underwriting agreement we enter into in connection with the sale of ordinary shares (including in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">form of ADSs) being registered hereby, the underwriters will agree to indemnify, under certain conditions, us, our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directors, our officers and persons who control us within the meaning of the Securities Act against certain liabilities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Equity Incentives<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We believe our ability to grant equity incentives is a valuable and necessary compensation tool that allows us <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to attract and retain the best personnel for positions of substantial responsibility, provides additional incentives to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employees and promotes the success of our business. Due to French corporate law and tax considerations, we have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">historically granted several different equity incentive instruments to our executive officers, Board members and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employees, including founder's share warrants (BCE), share warrants (BSA) and free shares (AGA).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Board's authority to grant these equity incentive instruments and the aggregate amount authorized to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">granted under these instruments must be approved by a two-thirds majority of the votes held by our shareholders <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">present, represented or voting by authorized means, at the relevant extraordinary shareholders&#8217; meeting. Once <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approved by our shareholders, our Board can grant share warrants (BSA) for up to 18 months, and stock options <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and/or free shares (AGA) for up to 38 months from the date of the applicable shareholders&#8217; approval. The authority <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of our Board to grant equity incentives may be extended or increased only by extraordinary shareholders&#8217; meetings. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As a result, we typically request that our shareholders authorize new pools of equity incentive instruments at every <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">annual shareholders&#8217; meeting.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Founder's Share Warrants (BCE)<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Founder&#8217;s share warrants (BCE) have traditionally been granted to certain of our employees who were French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tax residents because the warrants carry favorable tax and social security treatment for French tax residents. Similar <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to options, founder&#8217;s share warrants (BCE) entitle a holder to exercise the warrant for the underlying vested shares at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an exercise price per share determined by our Board and at least equal to the fair market value of an ordinary share <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on the date of grant. However, unlike options, the exercise price per share is fixed as of the date of implementation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the plans pursuant to which the warrants may be granted, rather than as of the date of grant of the individual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warrants.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our shareholders, or pursuant to delegations granted by our shareholders, our Board, determines the recipients <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the warrants, the dates of grant, the number and exercise price of the founder&#8217;s share warrants (BCE) to be <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">128<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">granted, the number of shares issuable upon exercise and certain other terms and conditions of the founder&#8217;s share <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warrants (BCE), including the period of their exercisability and their vesting schedule.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.94pt; position: var(--position); text-decoration: none; white-space: pre;">February 28<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, 2025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.51999999999998pt; position: var(--position); white-space: pre;">, we had issued several types of founder&#8217;s share warrants (BCE) as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 125.2pt; width: 612pt;"><div style="font-size: 0pt; left: 31.5pt; position: var(--position); top: 0pt; width: 510pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 38.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Category<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2014-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2014-2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); white-space: pre;">BCE- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); white-space: pre;">2014-3<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2014-4<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2014-5<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2014-6<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2014-7<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2015-9<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.55pt; position: var(--position); text-decoration: none; white-space: pre;">(G)<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2015-9<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 10.22pt; position: var(--position); text-decoration: none; white-space: pre;">(S)<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2015-9<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.72pt; position: var(--position); text-decoration: none; white-space: pre;">(D)<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2015-9<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.72pt; position: var(--position); text-decoration: none; white-space: pre;">(C)<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2016-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2017-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2017-2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 7.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2017-3<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2017-4<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 0pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.71pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">2017-5<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 38.25pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Expiration <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">date<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 13.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 13.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/ <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 13.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 13.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.8pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/20<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.12pt; position: var(--position); text-decoration: none; white-space: pre;">24<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.31pt; position: var(--position); text-decoration: none; white-space: pre;">Null and <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.46pt; position: var(--position); text-decoration: none; white-space: pre;">void<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.31pt; position: var(--position); text-decoration: none; white-space: pre;">Null and <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.46pt; position: var(--position); text-decoration: none; white-space: pre;">void<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.31pt; position: var(--position); text-decoration: none; white-space: pre;">Null and <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.46pt; position: var(--position); text-decoration: none; white-space: pre;">void<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.31pt; position: var(--position); text-decoration: none; white-space: pre;">Null and <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.46pt; position: var(--position); text-decoration: none; white-space: pre;">void<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.31pt; position: var(--position); text-decoration: none; white-space: pre;">Null and <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.46pt; position: var(--position); text-decoration: none; white-space: pre;">void<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.8pt; position: var(--position); text-decoration: none; white-space: pre;">7/11/202<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.8pt; position: var(--position); text-decoration: none; white-space: pre;">23/01/20<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.12pt; position: var(--position); text-decoration: none; white-space: pre;">27<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.8pt; position: var(--position); text-decoration: none; white-space: pre;">20/11/20<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.12pt; position: var(--position); text-decoration: none; white-space: pre;">27<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.8pt; position: var(--position); text-decoration: none; white-space: pre;">20/11/20<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.12pt; position: var(--position); text-decoration: none; white-space: pre;">27<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.8pt; position: var(--position); text-decoration: none; white-space: pre;">20/11/20<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.12pt; position: var(--position); text-decoration: none; white-space: pre;">27<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.8pt; position: var(--position); text-decoration: none; white-space: pre;">20/11/20<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.12pt; position: var(--position); text-decoration: none; white-space: pre;">27<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 61.5pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">or purchase <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">price (&#8364;)<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84.75pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">price per <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">share (&#8364;)<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">12.5<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">17.79<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">17.79<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">17.79<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">17.79<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">7.44<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.62pt; position: var(--position); text-decoration: none; white-space: pre;">6.39<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">11.14<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">11.14<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">11.14<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 84.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">11.14<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 36.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">conditions<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (1)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (2)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (3)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (4)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (5)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (6)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (7)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.15pt; position: var(--position); text-decoration: none; white-space: pre;">s Note (8<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 4.99pt; position: var(--position); text-decoration: none; white-space: pre;">Note (9)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 9.64pt; position: var(--position); text-decoration: none; white-space: pre;">s Note <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 17.13pt; position: var(--position); text-decoration: none; white-space: pre;">(10<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 108pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); text-decoration: none; white-space: pre;">Achieve<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.65pt; position: var(--position); text-decoration: none; white-space: pre;">ment of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.16pt; position: var(--position); text-decoration: none; white-space: pre;">objective<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 9.64pt; position: var(--position); text-decoration: none; white-space: pre;">s Note <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 17.13pt; position: var(--position); text-decoration: none; white-space: pre;">(11<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">shares <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">subscribed<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.62pt; position: var(--position); text-decoration: none; white-space: pre;">275,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.62pt; position: var(--position); text-decoration: none; white-space: pre;">275,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">76,300<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">98,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">2,800<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">19,700<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">40,006<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.12pt; position: var(--position); text-decoration: none; white-space: pre;">374<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">48,426<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 144.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 8.88pt;"></span></span><span style="left: 11.510000000000002pt; position: var(--position);">7,000<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="7" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168pt; width: 204.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 204.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Beneficiaries <span style="display: inline-block; height: 4.16pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 37.06pt; position: var(--position); white-space: pre;">(remaining number of shares that can be subscribed)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177.75pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Marc de <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Garidel<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 195pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">18,796<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 195pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 195pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 2.88pt;"></span></span><span style="left: 5.51pt; position: var(--position);">112,500<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 195pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,373<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 195pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">33,687<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 204.75pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cumulative <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">number of <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">cancelled or <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">lapsed BCEs<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">626<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.12pt; position: var(--position); text-decoration: none; white-space: pre;">169<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.12pt; position: var(--position); text-decoration: none; white-space: pre;">328<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;">1,650<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,687<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,374<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,687<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,374<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">25,198<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">37,500<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">52,635<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 204.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">26,687<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">BCEs <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">outstanding <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">as of <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">28/02/2025<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">18,796<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 2.88pt;"></span></span><span style="left: 5.51pt; position: var(--position);">112,500<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,373<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 234.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">33,687<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 264.75pt; width: 38.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">BCEs <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">exercisable <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">at <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">28/02/2025*<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 38.25pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 121.5pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 149.25pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 177pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 204.75pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 315.75pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">18,796<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 371.25pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 2.88pt;"></span></span><span style="left: 5.51pt; position: var(--position);">112,500<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 454.5pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 8.62pt; position: var(--position); text-decoration: none; white-space: pre;">67,373<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 482.25pt; position: var(--position); top: 264.75pt; width: 27.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 5.88pt;"></span></span><span style="left: 8.51pt; position: var(--position);">33,687<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 438.75pt; width: 612pt;"><div style="font-size: 0pt; left: 31.5pt; position: var(--position); top: 0pt; width: 538.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 249.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Category<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.62pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 0pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.25pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-2<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 0pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.25pt; position: var(--position); white-space: pre;">BCE-2018-3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 0pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.25pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-4<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.62pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-5<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Expiration date<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 56.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 56.720000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 57.010000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 57.03pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 12pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.93pt; position: var(--position); text-decoration: none; white-space: pre;">15/03/2028<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 12pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 23.18pt; position: var(--position); text-decoration: none; white-space: pre;">21/05/2028<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 12pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 23.18pt; position: var(--position); text-decoration: none; white-space: pre;">20/11/2028<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 12pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 23.18pt; position: var(--position); text-decoration: none; white-space: pre;">14/05/2028<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 12pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.93pt; position: var(--position); text-decoration: none; white-space: pre;">14/05/2028<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription or purchase price (&#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 119.39999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 120.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 120.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 120.92999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.97pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 24pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 24pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 24pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 24pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 24pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share (&#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 96.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.89pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 97.03999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 97.05pt; position: var(--position); text-decoration: none; white-space: pre;">...........................................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 36pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">8.96<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 36pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.62pt; position: var(--position); text-decoration: none; white-space: pre;">8.96<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 36pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.62pt; position: var(--position); text-decoration: none; white-space: pre;">7.33<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 36pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.62pt; position: var(--position); text-decoration: none; white-space: pre;">7.33<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 36pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">7.33<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 48pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Terms of exercise<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 62.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 62.86pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 63.010000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 63.050000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 63.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 63.080000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">............................................................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 48pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.51pt; position: var(--position); text-decoration: none; white-space: pre;">Note (12)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 48pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.33pt; position: var(--position); text-decoration: none; white-space: pre;">Achievement of <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.59pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 9.66pt; position: var(--position); text-decoration: none; white-space: pre;">objectives Note <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.55pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.96pt; position: var(--position); text-decoration: none; white-space: pre;">(13<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 48pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.33pt; position: var(--position); text-decoration: none; white-space: pre;">Achievement of <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.59pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.2pt; position: var(--position); text-decoration: none; white-space: pre;">objectives<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.55pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 28.76pt; position: var(--position); text-decoration: none; white-space: pre;">Note (14)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 48pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.33pt; position: var(--position); text-decoration: none; white-space: pre;">Achievement of <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.59pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 9.66pt; position: var(--position); text-decoration: none; white-space: pre;">objectives Note <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.55pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.96pt; position: var(--position); text-decoration: none; white-space: pre;">(15<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 48pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.51pt; position: var(--position); text-decoration: none; white-space: pre;">Note (16)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of shares subscribed<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 102.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 102.89pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 103.03999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 103.05pt; position: var(--position); text-decoration: none; white-space: pre;">........................................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 78pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">6,930<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 78pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 37.62pt; position: var(--position); text-decoration: none; white-space: pre;">44,916<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 78pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 37.62pt; position: var(--position); text-decoration: none; white-space: pre;">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 78pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 78pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">5,750<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="6" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 538.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 538.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Beneficiaries (number of shares that can be subscribed)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 59.470000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 60.63pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 60.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 60.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.970000000000006pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.16pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 26.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.029999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 114pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.37pt; position: var(--position); text-decoration: none; white-space: pre;">11,980<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 114pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 114pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 37.62pt; position: var(--position); text-decoration: none; white-space: pre;">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 114pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cumulative number of cancelled or lapsed BCEs<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 168.7pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 168.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 169.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 169.09pt; position: var(--position); text-decoration: none; white-space: pre;">.......................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 126pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">3,090<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 126pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 37.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,458<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 126pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.21pt;"></span></span><span style="left: 36.84pt; position: var(--position);">16,844<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 126pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 126pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">14,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs outstanding at February 28, 2025<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 137.65pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 138.81pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 138.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 138.98pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 138.99pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 138pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.37pt; position: var(--position); text-decoration: none; white-space: pre;">11,980<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 138pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 138pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 138pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 37.62pt; position: var(--position); text-decoration: none; white-space: pre;">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 138pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs exercisable at February 28, 2025*<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 138.98pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 139.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 139.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.41pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 139.12pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 150pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.37pt; position: var(--position); text-decoration: none; white-space: pre;">11,980<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 150pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 150pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 425.25pt; position: var(--position); top: 150pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 37.62pt; position: var(--position); text-decoration: none; white-space: pre;">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 150pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 12pt; position: var(--position); top: 605.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 71.95pt; position: var(--position); white-space: pre;">(*)<span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 83.61pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 101.61pt; position: var(--position); white-space: pre;">The number of shares to which the exercise of the BSAs and BCEs entitles the holder has been multiplied by <span style="display: inline-block; height: 8.33pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 619.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">100 for all BSAs and BCEs issued prior to the division by 100 of the nominal value of the shares, decided by our <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630.39pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">general meeting on February 20, 2015. According to the exercise conditions provided in the notes below and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 641.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">assuming that performance objectives have been achieved.<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 666.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(1)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">Service condition fully fulfilled on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 680.03pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(2)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">Service condition fully fulfilled on the date hereof. BCE 2014-2 has a warrant to share ratio of 1:100. <span style="display: inline-block; height: 8.32pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">129<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 12pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(3)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">BCE 2014-4 has a warrant to share ratio of 1:100. 246 BCE-2014-4 are exercisable subject to a service condition, which is fully fulfilled <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 85.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">on the date hereof. 369 BCE-2014-4 are exercisable exclusively in the event of the achievement of qualitative and/or quantitative objectives (non-<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 94.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">market conditions), as set by the Board on September 8, 2014. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 103.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(4)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">197 BCE-2014-6 are exercisable subject to a service condition, which is fully fulfilled on the date hereof. 328 BCE-2014-6 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 116.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of the achievement of qualitative and/or quantitative objectives (non-market conditions), as set by the Board <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 125.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">on September 8, 2014 and revised on November 20, 2017. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 134.72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(5)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">50% of the BCE-2014-7 granted to each beneficiary are exercisable subject to a presence condition, which is fully fulfilled on the date <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 148.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">hereof. 50% of the BCE-2014-7 are exercisable exclusively in the event of the achievement of qualitative and/or quantitative objectives (non-<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 157.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">market conditions), as set by the Board on September 8, 2014. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 166.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(6)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">Service condition fully fulfilled on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 179.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(7)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">33,687 BCE-2017-1 are exercisable subject to a service condition, which is fully fulfilled on the date hereof, 16,844 BCE-2017-1 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 192.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of achievement of the qualitative objectives (non-market conditions) set by the Board, and 16,843 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 201.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">BCE-2017-1 are exercisable exclusively in the event of achievement of the quantitative targets (market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 210.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(8)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">75,000 BCE-2017-2 are exercisable subject to a service condition, which is fully fulfilled on the date hereof: and 75,000 BCE-2017-2 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 224.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of the achievement of qualitative objectives (non-market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 233.28pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(9)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.41999999999999pt; position: var(--position); white-space: pre;">50,531 BCE-2017-3 are exercisable subject to a service condition, which is fully fulfilled on the date hereof, and 50,530 BCE-2017-3 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 246.72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of the achievement of qualitative objectives (non-market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 255.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(10)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 91.41999999999999pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.41999999999999pt; position: var(--position); white-space: pre;">33,687 BCE-2017-4 are exercisable subject to a service condition, which is fully fulfilled on the date hereof, and 33,687 BCE-2017-4 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 269.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of the achievement of qualitative objectives (non-market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 278.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(11)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 91.41999999999999pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.41999999999999pt; position: var(--position); white-space: pre;">16,843 BCE-2017-5 are exercisable subject to a service condition, which is fully fulfilled on the date hereof, and 16,844 BCE-2017-5 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 291.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of the achievement of qualitative objectives (non-market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 300.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(12)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 91.41999999999999pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.41999999999999pt; position: var(--position); white-space: pre;">Service condition fully fulfilled on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 313.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(13)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 91.41999999999999pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.41999999999999pt; position: var(--position); white-space: pre;">33,686 BCE-2018-2 are exercisable subject to a service condition, which is fully fulfilled on the date hereof, and 33,686 BCE-2018-2 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 327.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in case of achievement of qualitative objectives (non-market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 336.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(14)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 91.41999999999999pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.41999999999999pt; position: var(--position); white-space: pre;">16,843 BCE-2018-3 are exercisable subject to a service condition, which is fully fulfilled on the date hereof, and 16,844 BCE-2018-3 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 349.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of the achievement of qualitative objectives (non-market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 358.72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(15)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 91.41999999999999pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.41999999999999pt; position: var(--position); white-space: pre;">8,422 BCE-2018-4 are exercisable subject to a service condition, which is fully fulfilled on the date hereof, and 8,421 BCE-2018-4 are <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 372.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercisable exclusively in the event of the achievement of qualitative objectives (non-market conditions) set by the Board. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 381.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(16)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 91.41999999999999pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.41999999999999pt; position: var(--position); white-space: pre;">Service condition fully fulfilled on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">General note: all of our BCE plans provide for specific cases of acceleration resulting in the exercise of said BCEs in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 419.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the event of the occurrence of specific events and in particular in the event of a change of control of us. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 443.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Share Warrants (BSA)<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 467.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Share warrants (BSA) have historically been granted to our non-employee directors and consultants that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 477.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regularly work in partnership with us. Similar to options, share warrants (BSA) entitle a holder to exercise the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 487.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warrant for the underlying vested shares at an exercise price per share determined by our Board and at least equal to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 497.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the fair market value of an ordinary share on the date of grant. However, unlike options, the exercise price per share <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 507.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is fixed as of the date of implementation of the plans pursuant to which the warrants may be granted, rather than as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the date of grant of the individual warrants.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.94pt; position: var(--position); text-decoration: none; white-space: pre;">February 28, 2025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.51999999999998pt; position: var(--position); white-space: pre;">, we had <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.6pt; position: var(--position); text-decoration: none; white-space: pre;">issued<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.58pt; position: var(--position); white-space: pre;"> several types of share warrants (BSA) as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 562.8pt; width: 612pt;"><div style="font-size: 0pt; left: 31.5pt; position: var(--position); top: 0pt; width: 632.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 31.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 36pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Category<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 3.67pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014 <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 14pt; position: var(--position); text-decoration: none; white-space: pre;">-4<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 15pt; width: 31.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.92pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015 <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 10.01pt; position: var(--position); text-decoration: none; white-space: pre;">- 11- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 8.59pt; position: var(--position); text-decoration: none; white-space: pre;">Sant&#233; <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 4.26pt; position: var(--position); text-decoration: none; white-space: pre;">Holdings <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 14.08pt; position: var(--position); text-decoration: none; white-space: pre;">S<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 365.25pt; position: var(--position); top: 15pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 4.18pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">12<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2017- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 434.25pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2018- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 467.25pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2018- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 10.67pt; position: var(--position); white-space: pre;">BSA <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 8pt; position: var(--position); white-space: pre;">2024-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 533.25pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 10.67pt; position: var(--position); white-space: pre;">BSA <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 8pt; position: var(--position); white-space: pre;">2024-2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); white-space: pre;">BSA-2025-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); white-space: pre;">1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 599.25pt; position: var(--position); top: 15pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.68pt; position: var(--position); white-space: pre;">BSA-2025-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 15pt; position: var(--position); white-space: pre;">1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 51.75pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Date of general meeting<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20/02/2015<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 51.75pt; width: 31.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20/02/201<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 365.25pt; position: var(--position); top: 51.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20/02/2015<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">23/06/2017<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 434.25pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">23/06/2017<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 467.25pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">23/06/2017<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">5/6/2023<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 533.25pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">5/6/2023<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">30/05/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 599.25pt; position: var(--position); top: 51.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">30/05/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Date of Board meeting<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">21/02/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">21/02/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">21/02/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">21/02/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">21/02/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">21/02/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">21/02/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">14/09/2015<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 69pt; width: 31.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">04/12/201<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 365.25pt; position: var(--position); top: 69pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">04/12/2015<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">18/09/2017<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 434.25pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">22/01/2018<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 467.25pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">14/05/2018<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">28/3/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 533.25pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">28/3/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">8/1/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 599.25pt; position: var(--position); top: 69pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">8/1/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Date of decision of the <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 86.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 10.3pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4/4/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 533.25pt; position: var(--position); top: 86.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 10.3pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4/4/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 86.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 10.3pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">13/01/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 599.25pt; position: var(--position); top: 86.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 10.3pt; width: 33pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">13/01/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="14" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 103.5pt; width: 500.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 500.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total number of shares that may be subscribed or purchased (<span style="display: inline-block; height: 4.16pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 3.9000000000000004pt; font-style: normal; font-weight: normal; left: 150.41pt; position: var(--position); top: -1.456pt; vertical-align: super; white-space: pre;">*<span style="display: inline-block; height: 2.704pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 152.35999999999999pt; position: var(--position); white-space: pre;">) :<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 113.25pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Corinna zur Bonsen-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Thomas<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 23.279999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 23.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 23.59pt; position: var(--position); text-decoration: none; white-space: pre;">.............................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 113.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 113.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 10.3pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">19,455<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 113.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 10.3pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 130.5pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">June Lee<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 25.77pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 26.349999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 26.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 26.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 26.55pt; position: var(--position); text-decoration: none; white-space: pre;">...........................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 130.5pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">19,455<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 130.5pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Troy Ignelzi<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 34.09pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 34.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 34.12pt; position: var(--position); text-decoration: none; white-space: pre;">......................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 140.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">19,455<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 140.25pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">130<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 31.5pt; position: var(--position); top: 0pt; width: 632.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 31.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 36pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 33pt;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Camilla Soenderby<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 51.730000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 52.02pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 52.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 52.080000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 52.09pt; position: var(--position); text-decoration: none; white-space: pre;">..........<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 533.25pt; position: var(--position); top: 0pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">19455<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 566.25pt; position: var(--position); top: 0pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 9.75pt; width: 69.75pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Others<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 20.259999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 20.55pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 20.59pt; position: var(--position); text-decoration: none; white-space: pre;">...............................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">84,160<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">45,900<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 9.75pt; width: 31.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 31.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">96,924<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 365.25pt; position: var(--position); top: 9.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 434.25pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">16400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 467.25pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 500.25pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 533.25pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 599.25pt; position: var(--position); top: 9.75pt; width: 33pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.8pt; width: 33pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 12pt; position: var(--position); top: 110.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(*)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 81.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.32pt; position: var(--position); white-space: pre;">The number of shares to which the exercise of the BSAs and BCEs entitles the holder has been multiplied by 100 for all BSAs and BCEs <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 123.74pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">issued prior to the division by 100 of the nominal value of the shares, decided by our general meeting on February 20, 2015. Consequently, BSA <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 132.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">2014-3, BSA 2014-4 and BSA 2014-5 have a warrant to share ratio of 1:100. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="position: var(--position); top: 141.66pt; width: 612pt;"><div style="font-size: 0pt; left: 31.5pt; position: var(--position); top: 0pt; width: 738pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 36pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 36pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 36pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 36pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 40.5pt;"/></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Category<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.43pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 18.75pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.43pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 18.75pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.43pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 18.75pt; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 15.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 7.18pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-4<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 15.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 6.43pt; position: var(--position); text-decoration: none; white-space: pre;">BSA- 2014-5<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 15.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 11.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.5pt; position: var(--position); text-decoration: none; white-space: pre;">2014-6<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 15.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 11.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.5pt; position: var(--position); text-decoration: none; white-space: pre;">2014-7<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 13.42pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">2015-9<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 13.42pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.26pt; position: var(--position); text-decoration: none; white-space: pre;">2015-11- <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 13.09pt; position: var(--position); text-decoration: none; white-space: pre;">Sant&#233;<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.93pt; position: var(--position); text-decoration: none; white-space: pre;">Holding<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">SRL<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 15.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 11.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 8pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 15.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 11.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 9.5pt; position: var(--position); text-decoration: none; white-space: pre;">2017-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 13.42pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">2018-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 13.42pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-<span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">2018-2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.17pt; position: var(--position); white-space: pre;">BSA 2024-1 <span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 5.17pt; position: var(--position); white-space: pre;">BSA 2024-2<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 4.93pt; position: var(--position); white-space: pre;">BSA-2025-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 15.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 4.93pt; position: var(--position); white-space: pre;">BSA-2025-1<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td></tr><tr style="height: 44.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 52.5pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Starting date for <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">exercising options<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 48.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 49.550000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 49.7pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 49.74pt; position: var(--position); text-decoration: none; white-space: pre;">....<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.41pt; position: var(--position); text-decoration: none; white-space: pre;">According to <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.55pt; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 7.59pt; position: var(--position); text-decoration: none; white-space: pre;">achievement <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">of criteria (see <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;">Terms of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 36.23pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;">exercise)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.41pt; position: var(--position); text-decoration: none; white-space: pre;">According to <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.55pt; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 7.59pt; position: var(--position); text-decoration: none; white-space: pre;">achievement <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">of criteria (see <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;">Terms of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 36.23pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;">exercise)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.41pt; position: var(--position); text-decoration: none; white-space: pre;">According to <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.55pt; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 7.59pt; position: var(--position); text-decoration: none; white-space: pre;">achievement <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">of criteria (see <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;">Terms of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 36.23pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;">exercise)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.91pt; position: var(--position); text-decoration: none; white-space: pre;">According to <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.27pt; position: var(--position); text-decoration: none; white-space: pre;">the achievement <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 7.8pt; position: var(--position); text-decoration: none; white-space: pre;">of criteria (see <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 20.58pt; position: var(--position); text-decoration: none; white-space: pre;">Terms of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 20.76pt; position: var(--position); text-decoration: none; white-space: pre;">exercise)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.91pt; position: var(--position); text-decoration: none; white-space: pre;">According to <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.27pt; position: var(--position); text-decoration: none; white-space: pre;">the achievement <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 7.8pt; position: var(--position); text-decoration: none; white-space: pre;">of criteria (see <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 22.79pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 20.58pt; position: var(--position); text-decoration: none; white-space: pre;">Terms of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 29.51pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 20.76pt; position: var(--position); text-decoration: none; white-space: pre;">exercise)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 52.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 52.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2014<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">14/09/2015<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">10/12/2015<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 52.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">04/12/2016<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 52.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">18/09/2017<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">22/01/2018<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">14/05/2018<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.55pt; position: var(--position); text-decoration: none; white-space: pre;">1/1/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.55pt; position: var(--position); text-decoration: none; white-space: pre;">1/4/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.55pt; position: var(--position); text-decoration: none; white-space: pre;">1/1/2026<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 52.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.55pt; position: var(--position); text-decoration: none; white-space: pre;">1/1/2026<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Expiry date.<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 34.26pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 34.550000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 34.7pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 34.78pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 34.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 34.830000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">..............<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 15.05pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 15.05pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 96.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 96.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">11/03/2024<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">14/09/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">04/12/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 96.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">04/12/2025<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 96.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 6.05pt; position: var(--position); text-decoration: none; white-space: pre;">18/09/2027<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">22/01/2028<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); text-decoration: none; white-space: pre;">14/05/2028<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.55pt; position: var(--position); text-decoration: none; white-space: pre;">4/4/2034<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.55pt; position: var(--position); text-decoration: none; white-space: pre;">4/4/2034<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); white-space: pre;">13/01/2035<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 96.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 10.55pt; position: var(--position); white-space: pre;">13/01/2035<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="7" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 106.5pt; width: 283.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 283.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 14.34pt; position: var(--position); text-decoration: none; white-space: pre;">or at the end of a period of 90 days following the date on which the beneficiary ceases to work for us<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="6" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 106.5pt; width: 234pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 234pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 18.9pt; position: var(--position); text-decoration: none; white-space: pre;">or at the end of 90 days following the expiration of the beneficiary&#8217;s mandate<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription or <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">purchase price (&#8364;)<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 48.88pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.77pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 49.78pt; position: var(--position); text-decoration: none; white-space: pre;">....<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 116.25pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 116.25pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 116.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 116.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">2.07<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">1.78<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 116.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.87pt; position: var(--position); text-decoration: none; white-space: pre;">1.78<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 116.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.87pt; position: var(--position); text-decoration: none; white-space: pre;">1.29<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.9<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.73<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">2.57<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">2.57<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 116.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 133.5pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">share (&#8364;)<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 25.09pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.669999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 25.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.79pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 25.81pt; position: var(--position); text-decoration: none; white-space: pre;">....................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 31.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 31.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 133.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 133.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.87pt; position: var(--position); text-decoration: none; white-space: pre;">0.01<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 24.37pt; position: var(--position); text-decoration: none; white-space: pre;">20.73<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 24.37pt; position: var(--position); text-decoration: none; white-space: pre;">17.79<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 133.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.87pt; position: var(--position); text-decoration: none; white-space: pre;">17.79<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 133.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.87pt; position: var(--position); text-decoration: none; white-space: pre;">11.57<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">8.05<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">6.6<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">13.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">13.1<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">6.63<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 133.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">6.63<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Terms of exercise<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 47.550000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.28pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 48.300000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">.....<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 17.74pt; position: var(--position); text-decoration: none; white-space: pre;">Note (1)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.93pt; position: var(--position); text-decoration: none; white-space: pre;">Achievement of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 18.08pt; position: var(--position); text-decoration: none; white-space: pre;">objectives<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.24pt; position: var(--position); text-decoration: none; white-space: pre;">Note (2)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 3.93pt; position: var(--position); text-decoration: none; white-space: pre;">Achievement of <span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 18.08pt; position: var(--position); text-decoration: none; white-space: pre;">objectives<span style="display: inline-block; height: 4.16pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 22.24pt; position: var(--position); text-decoration: none; white-space: pre;">Note (3)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 17.74pt; position: var(--position); text-decoration: none; white-space: pre;">Note (4)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 150.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 13.24pt; position: var(--position); text-decoration: none; white-space: pre;">Note (5)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 150.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 13.24pt; position: var(--position); text-decoration: none; white-space: pre;">Note (6)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 17.74pt; position: var(--position); text-decoration: none; white-space: pre;">Note (7)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 17.74pt; position: var(--position); text-decoration: none; white-space: pre;">Note (8)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 17.74pt; position: var(--position); white-space: pre;">Note (9)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.74pt; position: var(--position); white-space: pre;">Note (10)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.74pt; position: var(--position); white-space: pre;">Note (11)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 150.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 14.74pt; position: var(--position); white-space: pre;">Note (12)<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of shares <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">subscribed<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 30.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 30.33pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 30.369999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">.................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">39,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">44,800<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 18.63pt;"></span></span><span style="left: 21.259999999999998pt; position: var(--position);">90,800<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 23.13pt;"></span></span><span style="left: 25.759999999999998pt; position: var(--position);">47,300<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 23.13pt;"></span></span><span style="left: 25.759999999999998pt; position: var(--position);">22,950<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 180pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.87pt; position: var(--position); text-decoration: none; white-space: pre;">5,200<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 180pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 19.87pt; position: var(--position); text-decoration: none; white-space: pre;">8,100<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 180pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 180pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 180pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 197.25pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cumulative number <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of BSA cancelled or <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">lapsed<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 18.939999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 19.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 19.669999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 19.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 19.79pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;">........................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 28.87pt; position: var(--position); text-decoration: none; white-space: pre;">229<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 28.87pt; position: var(--position); text-decoration: none; white-space: pre;">264<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 197.25pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 33.37pt; position: var(--position); text-decoration: none; white-space: pre;">842<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 197.25pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 28.87pt; position: var(--position); text-decoration: none; white-space: pre;">557.5<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 197.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 197.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 18.37pt; position: var(--position); text-decoration: none; white-space: pre;">122,274<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 197.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.87pt; position: var(--position); text-decoration: none; white-space: pre;">65,600<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 197.25pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">32,800<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 197.25pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs as of February <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">28, 2025<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 23.63pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 24.209999999999997pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 24.29pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 24.31pt; position: var(--position); text-decoration: none; white-space: pre;">.....................<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 220.5pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 39.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 220.5pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 39.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 220.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 220.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">96,924<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 220.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.87pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 220.5pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.87pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 18.63pt;"></span></span><span style="left: 21.259999999999998pt; position: var(--position);">58,365<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 18.63pt;"></span></span><span style="left: 21.259999999999998pt; position: var(--position);">19,455<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 15.63pt;"></span></span><span style="left: 18.26pt; position: var(--position);">100,000<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 220.5pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 18.63pt;"></span></span><span style="left: 21.259999999999998pt; position: var(--position);">25,000<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.75pt; width: 58.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA potentially <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 9.35pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">exercisable as of <span style="display: inline-block; height: 4.06pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 16.07pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">February 28 2025,*<span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 52.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 52.720000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 52.800000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 4.06pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 52.84pt; position: var(--position); text-decoration: none; white-space: pre;">..<span style="display: inline-block; height: 4.06pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 58.5pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 139.5pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 237.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 39.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 237.75pt; width: 45pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 39.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 237.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306pt; position: var(--position); top: 237.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 30.37pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 382.5pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">96,924<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423pt; position: var(--position); top: 237.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.87pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459pt; position: var(--position); top: 237.75pt; width: 36pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 36pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 16.87pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 495pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 21.37pt; position: var(--position); text-decoration: none; white-space: pre;">16,400<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 535.5pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 576pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.16pt; width: 18.63pt;"></span></span><span style="left: 21.259999999999998pt; position: var(--position);">14,591<span style="display: inline-block; height: 4.16pt; width: 1.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 616.5pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 657pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 697.5pt; position: var(--position); top: 237.75pt; width: 40.5pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 40.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 34.87pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 12pt; position: var(--position); top: 416.62pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(*)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">The number of shares to which the exercise of the BSAs and BCEs entitles the holder has been multiplied by 100 for all BSAs and BCEs <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 430.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">issued prior to the division by 100 of the nominal value of the shares, decided by our general meeting on February 20, 2015. According to the <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 439.02pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exercise conditions provided in the notes below and assuming that the objectives have been achieved. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 447.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(1)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">Progressive vesting in time fully vested on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 461.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(2)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">263 BSA-2014-4 are exercisable at any time as from March 11, 2014. 1,052 BSA-2014-4 are exercisable exclusively in the event of the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 474.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">achievement of qualitative and/or quantitative objectives (non-market conditions), as set by the Board on September 8, 2014. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 483.82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(3)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">Exercisable by their beneficiary according to the exercise conditions set by the Board on September 8, 2014. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 497.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(4)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">Progressive vesting in time fully vested on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 510.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(5)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">Progressive vesting in time fully vested on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 524.14pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(6)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">Progressive vesting in time fully vested on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 537.58pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(7)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">Progressive vesting in time fully vested on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 551.02pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(8)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 87.41999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.41999999999999pt; position: var(--position); white-space: pre;">Progressive vesting in time fully vested on the date hereof. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 564.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(9) Progressive vesting in time.<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 573.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(10) Progressive vesting in time.<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 582.38pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(11) Progressive vesting in time.<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 591.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.1pt; position: var(--position); white-space: pre;">(12) Progressive vesting in time.<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">General note: all of our BSA plans provide for specific cases of acceleration resulting in the exercise of said BSAs in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the event of the occurrence of specific events and in particular in the event of a change of control of us. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Free Shares (AGA)<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares (AGA) are employee equity incentive instruments pursuant to which the beneficiaries are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">granted, for free, the possibility to receive our ordinary shares under certain conditions.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 704.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As of February 28, 2025, we had <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.6pt; position: var(--position); text-decoration: none; white-space: pre;">issued<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.58pt; position: var(--position); white-space: pre;"> free shares (AGA) as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">131<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 82pt; width: 612pt;"><div style="font-size: 0pt; left: 96.5pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2023-1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">July 11, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">1,382,796<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">1,382,796<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 315.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 12pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">212,738 Free Shares 2023-1 shall vest on July 11, 2024;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 17.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">638,214 Free Shares 2023-1 shall progressively be definitively acquired on a monthly basis over a <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">period of three (3) years starting after July 11, 2024 (i.e. 17,728 Free Shares 2023-1 per month <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">except for the last month of the three-year period where 17,734 Free Shares 2023-1 shall be <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 62.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">acquired). The duration of the acquisition period of these Free Shares 2023-1 shall be calculated <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 77.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">accordingly;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 92.79pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">212,738 Free Shares 2023-1 shall vest on the latest date between (i) July 11, 2024, and (ii) the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 107.79pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">date of receipt by the Company of a Marketing Authorization for one of its products in a first <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 122.79pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">indication in the United States of America prior to June 30, 2026;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 137.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">106,369 Free Shares 2023-1 shall vest on the latest date between (i) July 11, 2024, and (ii) the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 152.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">date of the successful completion of the initial public offering of the Company&#8217;s shares (or <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 167.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">depositary receipts representing any such shares) on the NASDAQ stock exchange in New York <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 182.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">allowing the Company to raise an amount of gross proceeds at least equal to one hundred million <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 197.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">dollars ($100,000,000) on or before June 30, 2024;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 212.95pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">106,369 Free Shares 2023-1 shall vest on the latest date between (i) July 11, 2024, and (ii) the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 227.95pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">date on which that the market capitalization of the Company remains superior or equal to one <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 242.95pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">billion euros (&#8364;1,000,000,000) for a consecutive period of at least three (3) months prior to <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 257.95pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">December 31, 2024;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 273.03pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">106,368 Free Shares 2023-1 shall vest on July 11, 2024 subject to the completion, prior to such <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 288.03pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">date, of a M&amp;A transaction in which the valuation of the Company is at least equal to one billion <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 303.03pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">euros (&#8364;1,000,000,000) on a fully diluted basis.<span style="display: inline-block; height: 8.32pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 492pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 492pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">All ordinary shares vesting before July 11, 2025 shall be subject to a lock-up period ending on July 11, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Ordinary shares vesting after July 11, 2025 are not subject to a lock-up period.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 513.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 513.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">425,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 546pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 546pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">744,584<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">132<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 96.5pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">212,737<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 32.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.35pt; position: var(--position); white-space: pre;">Employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 32.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 153pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2023-2<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">July 11, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">100,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">100,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 90.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 12pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on July 11, 2024; and<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 17.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">75% of the ordinary shares allocated shall vest on the latest date between (i) July 11, 2024, and <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">(ii) the date of receipt by the Company, prior to the June 30, 2025, of positive induction data <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">(positive primary endpoint and favorable safety as solely assessed by the Board of Directors) for <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 62.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">its phase 3 clinical trials for obefazimod in the field of ulcerative colitis allowing continuation of <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 77.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">the phase 3 trials towards NDA submission to the FDA.<span style="display: inline-block; height: 8.32pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 267pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 267pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">All ordinary shares vesting before July 11, 2025 shall be subject to a lock-up period ending on July 11, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Ordinary shares vesting after July 11, 2025 are not subject to a lock-up period.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 288.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 288.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">25,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 321pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 321pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">75,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 353.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 353.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 385.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.35pt; position: var(--position); white-space: pre;">Employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 385.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">None<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 567pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2023-3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">September 28, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">731,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">133<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">131,250<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">540,250<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on September 28, 2025;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on September 28, 2026; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.79pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on September 28, 2027.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 56.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 56.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 100.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 100.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">480,375<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 132.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">251,125<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.35pt; position: var(--position); white-space: pre;">Employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 165pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 285.75pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2023-4<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">September 28, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">254,250<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">60,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">134,250<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 72pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on September 28, 2025;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on September 28, 2026; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.79pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on September 28, 2027.<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The acquisition of the Free Shares 2023-4 is subject to the successful completion of the initial public offering <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">of the Company&#8217;s shares (or depositary receipts representing any such shares) on the NASDAQ stock <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 52.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">exchange in New York allowing the Company to raise an amount of gross proceeds at least equal to two <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 62.87pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">hundred million dollars ($200,000,000) on or before the first anniversary of the allocation date.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 248.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 248.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 260.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 260.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 292.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 292.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">212,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 324.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 324.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">42,250<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 357pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.35pt; position: var(--position); white-space: pre;">Employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 357pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 691.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2023-5<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">134<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">December 1, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">132,750<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 44.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 44.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 56.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 56.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">132,750<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on December 1, 2025;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.71pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on December 1, 2026; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.79pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on December 1, 2027.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 184.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 184.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 196.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 196.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 228.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 228.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">81,250<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 261pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 261pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">51,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 293.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.35pt; position: var(--position); white-space: pre;">Employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 293.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.63pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">135<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2024-1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">February 1, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">1,549,125<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">400,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">120,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">65,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">80,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">90,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">794,125<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on February 1, 2026;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 1, 2027; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 1, 2028.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">1,345,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">203,625<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.35pt; position: var(--position); text-decoration: none; white-space: pre;">Employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">136<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2024-2<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">March 28, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">22,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">22,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on March 28, 2026;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on March 28, 2027; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on March 28, 2028.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">22,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">137<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2024-3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June 5, 2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">May 23, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">38,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">38,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on May 23, 2026;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on May 23, 2027; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on May 23, 2028.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">38,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">138<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2024-4<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">July 11, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">93,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">80,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">13,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 33.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.08pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on July 11, 2026;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.16pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on July 11, 2027; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on July 11, 2028.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 218.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 218.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 230.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 230.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 262.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 262.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">93,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 294.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 327pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 327pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">139<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2024-5<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">July 11, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on July 11, 2026;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on July 11, 2027; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on July 11, 2028.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">140<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2024-6<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">July 11, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 33.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.16pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on July 11, 2025; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on the latest date between July 11, 2025 and the <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">date on which the performance condition is fulfilled<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 218.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 218.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.99pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Each ordinary share vesting before July 11, 2026 shall be subject to a lock-up period ending on July 11, <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.99pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">2026. Ordinary shares vesting after July 11, 2026 are not subject to a lock-up period.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 240pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 240pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 272.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.13pt; position: var(--position); white-space: pre;">vested as of February 28 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 272.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 304.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 304.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 336.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 336.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Performance condition to be fulfilled relates to the publication of a scientific article on obefazimod's <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">mechanism of action authored by the beneficiary in a reputable journal prior to July 11, 2027. No <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">employment condition.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">141<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2024-7<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">September 5, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">198,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">150,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">48,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on September 5, 2026;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on September 5, 2027; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on September 5, 2028.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">198,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">142<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2025-1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">February 6, 2025<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4,319,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">936,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">480,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">430,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">170,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">338,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">185,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">480,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">1,300,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on February 6, 2027;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 6, 2028; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 6, 2029.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4,319,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">143<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2025-2<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">February 6, 2025<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">123,102<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">47,052<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">15,939<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7,148<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7,693<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">8,139<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">17,038<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">20,093<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">100% of the ordinary shares allocated shall vest on February 6, 2027.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 188.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 188.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 200.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 200.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 232.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 232.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">123,102<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 264.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 264.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 297pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 297pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">144<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2025-3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">February 6, 2025<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">17,625<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">17,625<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on February 6, 2027;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 6, 2028; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 6, 2029.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">17,625<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">145<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 456pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 356.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.78pt; position: var(--position); text-decoration: none; white-space: pre;">Plan name<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 0pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 113.17pt; position: var(--position); white-space: pre;">Free ordinary share plan AGA 2025-4<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.8pt; position: var(--position); text-decoration: none; white-space: pre;">General Meeting date<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 12pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">May 30, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.14pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors decision<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 24pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">February 6, 2025<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.02pt; position: var(--position); text-decoration: none; white-space: pre;">granted by the Board of <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.89pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 36pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">30,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.45pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 68.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 80.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.34pt; position: var(--position); white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 80.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">30,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.9pt; position: var(--position); white-space: pre;">Didier Blondel<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 92.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 104.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.45pt; position: var(--position); white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 104.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.55pt; position: var(--position); white-space: pre;">David Zhang<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 116.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 128.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.13pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 128.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.91pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 140.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 152.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.11pt; position: var(--position); white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 152.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 164.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.11pt; position: var(--position); white-space: pre;">Others<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 164.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: var(--position); text-decoration: none; white-space: pre;">Duration of vesting period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 176.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.33pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">50% of the ordinary shares allocated shall vest on February 6, 2027;<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.41pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 6, 2028; and<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.630000000000003pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.63pt; position: var(--position); white-space: pre;">25% of the ordinary shares allocated shall vest on February 6, 2029.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 208.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.45pt; position: var(--position); text-decoration: none; white-space: pre;">Date of availability<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 208.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The ordinary shares are not subject to a lock-up period once vested.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.36pt; position: var(--position); white-space: pre;">Free ordinary shares fully <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 220.5pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252.75pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.8pt; position: var(--position); white-space: pre;">Free ordinary shares being <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.13pt; position: var(--position); white-space: pre;">vested as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 252.75pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">30,500<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 285pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.13pt; position: var(--position); white-space: pre;">Free ordinary shares <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.9pt; position: var(--position); white-space: pre;">lapsed as of February 28, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.87pt; position: var(--position); white-space: pre;">2025<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 285pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 99.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.24pt; position: var(--position); text-decoration: none; white-space: pre;">Performance and <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.62pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.24pt; position: var(--position); text-decoration: none; white-space: pre;">employment conditions<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 317.25pt; width: 356.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">For all of the ordinary shares, the vesting is subject to the beneficiary of the plan retaining, on an ongoing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">basis, the status of corporate officer or employee of the Company and/or one of its direct and/or indirect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 356.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">subsidiaries, as applicable.<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 438.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">General note: all of our AGA plans provide for specific cases of acceleration resulting in the vesting of said AGAs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">in the event of the occurrence of specific events and in particular in the event of a change of control of us. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 458.5pt;" id="ia894b143b6fc4522a0483350194c625e_91"></div><div style="line-height: 10pt; position: var(--position); top: 458.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span><span id="i532c206a16a74bc79697f9947a45ccc3"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Board Practices<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 488.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board Composition<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Board currently consists of seven members<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.87pt; position: var(--position); text-decoration: none; white-space: pre;">. The rules of procedure of our Board set the principles guiding <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the composition of the Board. The most recent version of this document was adopted by our Board in April 2021 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and subsequently amended in September 2023.The Board has established two permanent, specialized committees to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assist the Board in its work: (1) the audit committee and (2) the appointments and compensation committee. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board has also established an ad hoc committee, the scientific committee. Subject to available exemptions, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composition and functioning of all of our committees will comply with applicable requirements of the French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Commercial Code, the Exchange Act, the Nasdaq Global Market and SEC rules and regulations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In accordance with French law, committees of our Board only have an advisory role and can only make <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recommendations to our Board. As a result, decisions will be made by our Board taking into account non-binding <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recommendations of the relevant Board committee. Since July 2024, our Board has been chaired by Ms. Gr&#233;goire. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 617.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Our Chief Executive Officer, Mr. de Garidel, represents us <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 309.5pt; position: var(--position); white-space: pre;">vis-&#224;-vis<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.34pt; position: var(--position); white-space: pre;"> third parties in his capacity as Chief Executive <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 625.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Officer.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">All members of the Board may serve for a maximum of four years, expiring at the end of the shareholders&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">meeting called to approve the financial statements from the previous year and held during the year in which the term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expires. Members of the Board may be re-elected. They may be dismissed at any time by a decision of the ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">general meeting of shareholders. The composition of our Board is described below:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 698pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 469.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 209.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 85.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 99pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14pt; position: var(--position); text-decoration: none; white-space: pre;">Current Position<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 0pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.3pt; position: var(--position); text-decoration: none; white-space: pre;">Year of Initial<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.59pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.86pt; position: var(--position); text-decoration: none; white-space: pre;">Appointment<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 0pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.9pt; position: var(--position); white-space: pre;">Term Expiration <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.59pt; width: 75.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.41pt; position: var(--position); white-space: pre;">Year<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 43.28pt; position: var(--position); top: -1.8935pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">146<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 469.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 209.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 85.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 99pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 209.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 209.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 33.87pt; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 0pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 0pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 209.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 209.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Marc de Garidel<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 12pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.43pt; position: var(--position); white-space: pre;">Director<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 12pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 12pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 209.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 209.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Corinna zur Bonsen-Thomas<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 24pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.43pt; position: var(--position); text-decoration: none; white-space: pre;">Director<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 24pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.5pt; position: var(--position); text-decoration: none; white-space: pre;">2017<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 24pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 209.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 209.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">June Lee<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 36pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.43pt; position: var(--position); text-decoration: none; white-space: pre;">Director<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 36pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 36pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 48pt; width: 209.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 209.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Troy Ignelzi<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 48pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.43pt; position: var(--position); text-decoration: none; white-space: pre;">Director<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 48pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 48pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 60pt; width: 209.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 209.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Sofinnova Partners (permanent representative to the Board: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.59pt; width: 209.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Kinam Hong)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 60pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.43pt; position: var(--position); text-decoration: none; white-space: pre;">Director<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 60pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.5pt; position: var(--position); text-decoration: none; white-space: pre;">2019<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 60pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81pt; width: 209.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 209.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Camilla Soenderby<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 81pt; width: 85.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.43pt; position: var(--position); white-space: pre;">Director<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 81pt; width: 99pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 81pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.87pt; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 12pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 71.95pt; position: var(--position); white-space: pre;">(1)<span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 83.61pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 101.61pt; position: var(--position); white-space: pre;">The mandates expire at the annual shareholders&#8217; meeting approving the financial statements closed on <span style="display: inline-block; height: 8.33pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 183.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">December 31 of the previous year. <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">During the fiscal year ended December&#160;31, 2024, the Board met six times.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-voting Board Members / Observers <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to our by-laws, the General Meeting or the Board may appoint non-voting board members (or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">observers). Sant&#233; Holdings S.R.L., represented by Mr. Antonino Ligresti and Mr. Aris Constantinides<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"> from Kreos Capital/Blackrock are Board observers. In November 2024, Mark Stenhouse has been appointed as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board observer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Director Independence<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As a foreign private issuer, under the listing requirements and rules of Nasdaq, we are not required to have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">independent directors on our Board, except to the extent that our audit committee is required to be consistent with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">independence requirements. In determining whether a director is an independent director, our Board considers the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relationships that each non-employee director has with the Board and all other facts and circumstances that our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board deems relevant in determining the director&#8217;s independence, including the number of ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">beneficially owned by the director and his or her affiliated entities, if any.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Based upon information requested from, and provided by, each director concerning such director&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">background, employment and affiliations, including family relationships, our Board has determined that all of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directors, except for Marc de Garidel, qualify as &#8220;independent directors&#8221; as defined under applicable rules of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Nasdaq Global Market and the independence requirements contemplated by the Exchange Act.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Furthermore, our Board has determined that, under the criteria of the Middlenext Code of Corporate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Governance, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">five</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.8pt; position: var(--position); text-decoration: none; white-space: pre;"> of our directors are &#8220;independent directors&#8221;: Sylvie Gr&#233;goire, June Lee, Troy Ignelzi, Corinna zur <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Bonsen-Thomas, and Camilla Soenderby. The Middlenext Code sets out the five following criteria justifying the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">independence of directors, characterized by the absence of any significant financial, contractual or family <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relationship likely to affect their independence of judgment: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">they must not be a salaried employee or corporate officer of us or our group and must not have held <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">such a position within the last five years; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">they must not be in a significant business relationship with us or our group (e.g., client, supplier, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">competitor, provider, creditor, banker, etc.) within the last two years; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">they must not be a reference shareholder or hold a significant number of voting rights; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">they must not have close relationships or family ties with any of our corporate officer or reference <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">shareholder; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">they must not have been our auditor within the last six years. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conflicts of Interest Among the Management and Supervisory Bodies and Executive Management <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 622.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.55pt; position: var(--position); text-decoration: none; white-space: pre;">Chairperson<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.39pt; position: var(--position); text-decoration: none; white-space: pre;"> and Chief Executive Officer, our Chief Financial Officer and Board Secretary and our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directors are direct <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.37pt; position: var(--position); white-space: pre;">or<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.7pt; position: var(--position); text-decoration: none; white-space: pre;"> indirect shareholders or holders of securities giving access to our share capital. See <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Compensation and Benefits&#8212;Compensation of Chief Executive Officer.&#8221;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Service agreements entered into with Board members<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 675.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">There are no existing service contracts between the Company or its subsidiaries on the one hand, and any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 687.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Board member on the other, providing for benefits upon termination of service as a board member.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 704.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board Committees<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">147<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Audit Committee<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mission and Responsibilities <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee monitors issues relating to the elaboration and control of accounting and financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information as provided for by French law and by our by-laws and by the rules of procedure of the Board. It then <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">formulates recommendations to the Board in its task of permanent control of our management. It also issues <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recommendations in relation to the proposed statutory auditors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee is responsible for: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">monitoring the preparation and development of accounting and financial information and, where <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">appropriate, formulating recommendations in this respect to ensure its accuracy; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">reviewing the efficiency of the internal control and risk management systems; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">ensuring proper legal oversight of the preparation of the annual financial statements and financial <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">statements by the statutory auditors; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">selecting and ensuring the independence of the statutory auditors. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee is also responsible for approving: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">non-audit services provided by the statutory auditors (including the permitted level of fees); and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">all budgets for statutory audits and other engagements provided by the statutory auditors. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee further controls the services provided by the auditors in relation to what is permitted by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">law or regulation. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee is responsible for formulating recommendations regarding the statutory auditors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proposed for nomination by the General Meeting of Shareholders and/or during the renewal of their term. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Within this context, the audit committee may examine our annual financial statements in the form that they are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">presented to the Board, hear the opinions of the statutory auditors and the finance director and receive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">communications in relation to their analysis work and their conclusions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee may use external experts at our expense, after approval of the chairperson of the Board or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the audit committee or of the Chief Executive Officer, and render any expert reports to the Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee may hear any director and carry out any internal or external audit on any subject it <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">considers relevant to its mission. The chairperson of the audit committee shall inform the Board in advance. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">particular, the audit committee has the power to interview the persons involved in the preparation of the accounts or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in their control (administrative and financial director and the main managers of the financial department). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Composition and Compensation <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee and chairperson of the audit committee are appointed by the Board from members of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board, excluding executive directors, with finance or accounting skills and at least one member must be independent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in accordance with the provisions of the Middlenext Code. Members of the audit committee are appointed for a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fixed period of time, which may not exceed the duration of their terms of office as director and may be revoked by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Board at any time and without reason. Appointments are renewable without limitation. The audit committee is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composed of at least two members and members receive no compensation other than attendance fees. Their duties <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on the audit committee may be taken into account in determining the allocation of such attendance fees. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 607pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The current members of the audit committee are Troy Ignelzi, Corinna zur Bonsen-Thomas and Sylvie <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Gr&#233;goire<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">. The current chairperson of the audit committee is Mr. Ignelzi. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The committee may invite any person, internal or external to us, to take part in its meetings and its work. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Board has determined that each of the members of our audit committee is independent within the meaning <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the applicable listing rules and the independence requirements contemplated by Rule 10A-3. Committee members <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">must be competent in financial or accounting matters and at least one member must be independent in accordance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with the provisions of the Middlenext Code. Our Board has further determined that Mr. Ignelzi is an &#8220;audit <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">148<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">committee financial expert&#8221; as defined by SEC rules and regulations and that Mr. Ignelzi qualifies as financially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sophisticated under the applicable exchange listing rules. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions of Functioning <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The audit committee meets when the chairperson of the audit committee, at least two members of the audit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">committee, the chairperson of the Board or the Chief Executive Officer deems useful and at least twice per year, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">particularly before publication of the financial statements. The committee may be convened by any means 24&#160;hours <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">before the meeting by the chairperson of the audit committee or of the Board or any individual to whom one of them <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shall have delegated the necessary authority. The committee meets at the registered office or in any other place <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">specified in the notice of the meeting. It may also meet by video conference or by any means of telecommunication <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as specified in the internal regulation of the Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">To deliberate validly, at least half of the members of the committee must be present. At meetings, one member <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 218pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the audit committee may be represented by another audit committee member and the audit committee&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">recommendations are adopted by simple majority. Upon completion of each meeting, if the members deem it <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">necessary, meeting minutes may be prepared. The chairperson of the audit committee regularly reports to the Board <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on the committee&#8217;s work and immediately report any difficulty encountered. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Appointments and Compensation Committee <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mission and Responsibilities <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The appointments and compensation committee makes recommendations to the Board in relation to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">nomination of, and compensation for, executive directors and the operational and functional management, and with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regard to appointments and compensation policy and internal profit sharing. In particular, the appointments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation committee: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">provides recommendations and proposals to the Board concerning the appointment, in particular in the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">research of a balanced representation of men and women on the Board, compensation, retirement and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">provident scheme, supplementary pension benefits, benefits in kind, various financial rights of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">managers and executive officers, the allocation of share warrants (BSA), founder&#8217;s share warrants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">(BCE), free shares (AGA), share subscription or share purchase options, for the benefit of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">employees, managers or consultants and, where applicable, its subsidiaries, in accordance with legal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">provisions; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">defines the methods for determining the variable portion of the compensation of corporate officers and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">monitors its application; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">proposes a general policy for awarding share warrants (BSA), founder&#8217;s share warrants (BCE), free <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 466pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">shares (AGA) and options to subscribe or purchase shares, and determines the frequency thereof, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">depending on the categories of beneficiaries; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">examines the system of for the allocation of directors&#8217; fees among the members of the Board, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">particularly according to their participation in our committees; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">expresses its opinion to senior management about the compensation of the principal senior executives. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 537pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The appointments and compensation committee is also involved in discussing each independent director&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">qualifications upon his or her nomination and during the exercise of his or her term of office, as applicable. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Composition and Compensation <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The appointments and compensation committee is composed of at least two members. The chairperson of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation committee and the committee&#8217;s members are appointed by the Board from members of the Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Members are appointed for a fixed period of time, which may not exceed, as applicable, the duration of their term of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">office as director and may be revoked by the Board at any time and without reason. Their appointments shall be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">renewable without limitation. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The chairperson of the Board, if not a member of the appointments and compensation committee, may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">invited to participate in the appointments and compensation committee&#8217;s meetings. The appointments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation committee shall invite him/her to present its proposals. He/she shall not have the right to vote and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shall not be present during the deliberations relating to his/her own situation. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">149<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The current members of the appointments and compensation committee are June Lee, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.33pt; position: var(--position); text-decoration: none; white-space: pre;">Kinam<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.52pt; position: var(--position); text-decoration: none; white-space: pre;"> Hong <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(representing Sofinnova Partners)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 206.87pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.87pt; position: var(--position); white-space: pre;">and Camilla Soenderby<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.65pt; position: var(--position); text-decoration: none; white-space: pre;">. The current chairperson of the appointments and <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation committee is Dr. Lee. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 116pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The appointments and compensation committee may invite any person, internal or external to us, to take part <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in its meetings and its work. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Appointments and compensation committee members shall receive no compensation other than attendance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fees. Their duties on the compensation committee may be taken into consideration in determining the allocation of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such attendance fees. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions of Functioning <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The appointments and compensation committee meets when the chairperson of the appointments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation committee, at least two members of the appointments and compensation committee, the chairperson <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the Board or the Chief Executive Officer deems useful and at least once a year. The appointments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation committee may be convened by any means, 24 hours before the meeting, by the chairperson of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">appointments and compensation committee or of the Board, or any individual to whom one of them shall have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">delegated the authority necessary for the convocation. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The committee meets at the registered office or in any other place specified in the notice of the meeting. It <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may also meet by video conference or by any means of telecommunication, as specified in the internal regulation of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">To deliberate validly, at least half of the members of the committee must be present. A member of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">appointments and compensation committee may be represented by another appointments and compensation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">committee member and the appointments and compensation committee&#8217;s recommendations are adopted by simple <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">majority. Upon completion of each meeting, if the members deem it necessary, meeting minutes may be prepared. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The appointments and compensation committee chairperson reports regularly to the Board on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">appointments and compensation committee&#8217;s work and shall immediately report any difficulty encountered. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 411.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Scientific Committee <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Mission and Responsibilities <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The scientific committee was created by a decision by the Board on September&#160;27, 2018. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 466.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The role of the scientific committee is to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">examine specific scientific questions submitted to it; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">make recommendations for determining the general guidelines to be adopted in the scientific field; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 514.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">make recommendations for defining our priorities in the field of research and development and the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 524.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">means for achieving such objectives. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The committee meets at least once a year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">It works in collaboration with the Chief Executive Officer, who may request its opinion on subjects related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">its mission. At the request of the Board, the chairperson of the scientific committee reports on the committee&#8217;s work <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to the Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Composition <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 632.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The scientific committee is composed of at least four members appointed by the Board upon proposal of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer. The members of the scientific committee do not have to be members of the Board. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The current members of the scientific committee are Prof. Ian McGowan, MD, PhD, (Chairman); Prof. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 674.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Christian Br&#233;chot; Prof. Christoph Huber; Prof. J&#252;rgen Rockstroh; Prof. Christian Trepo; Prof. Lawrence R. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 684.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Stanberry; Prof. Luc Teyton; and Claude Bertrand. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">150<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The composition of the scientific committee is currently under review in light of our needs for the continued <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development of our clinical programs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 106.5pt;" id="ia894b143b6fc4522a0483350194c625e_94"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">D.<span style="display: inline-block; height: 6.77pt;"></span><span id="ie60fe1d9f6504f0d9c521f21aa19bf08"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Employees<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, we had <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.56pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">69</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.56pt; position: var(--position); text-decoration: none; white-space: pre;"> full-time employees, consisting of 49 within the research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development department 17 within the general administrative department and 3 within the sales and marketing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">department. As of December 31, 2024, we had 42 employees located in France and 27 in the United States. Our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">employees based in France are subject to the national collective bargaining agreement for the pharmaceutical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">industry (the <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 125.28999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">convention collective nationale de l&#8217;industrie pharmaceutique<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.58pt; position: var(--position); text-decoration: none; white-space: pre;">). We believe that we maintain good <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relations with our employees.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.2pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We rely on skilled, experienced and innovative employees to conduct the operations of our company. We are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">committed to building an outstanding, committed team and we focus on a culture that values a focus on scientific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">innovation, inclusion, collaboration and equity. We focus on recruiting, retaining and developing employees from a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">diverse range of backgrounds to conduct our research, development, clinical, commercial, marketing and market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">access activities. We recognize that recruiting, motivating and retaining talented employees is vital to our success. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The principal purposes of our equity and cash incentive plans are to attract, retain and reward personnel through the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">granting of stock-based and cash-based compensation awards, in order to increase shareholder value and the success <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">We aim to create an equitable, inclusive and empowering environment in which our employees can grow and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advance their careers, with the overall goal of developing, expanding and retaining our workforce to support our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">current pipeline and future business goals. Employees are encouraged to attend scientific, clinical and technological <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">meetings and conferences and have access to broad resources they need to be successful. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 340.5pt;" id="ia894b143b6fc4522a0483350194c625e_97"></div><div style="line-height: 10pt; position: var(--position); top: 340.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">E.<span style="display: inline-block; height: 6.77pt;"></span><span id="ib12fb8b389d643b99d7b795ebdf554c1"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Share Ownership<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For information regarding the share ownership of our directors and executive officers, see &#8220;Item 6.B&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Compensation&#8221; and &#8220;Item 7.A&#8212;Major Shareholders and Related Party Transactions.&#8221;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 396.5pt;" id="ia894b143b6fc4522a0483350194c625e_100"></div><div style="line-height: 10pt; position: var(--position); top: 396.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">F.<span style="display: inline-block; height: 6.77pt;"></span><span id="i5b79888f9f484c278901f5cc6fccc619"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">None.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 444.5pt;" id="ia894b143b6fc4522a0483350194c625e_103"></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">151<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_106"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 7.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Major Shareholders and Related Party Transactions<span style="display: inline-block; height: 6.77pt;"></span></span><span id="if3eba5cf4ffa4d54bb14637296387901"></span></span></div><div style="position: absolute; top: 108pt;" id="ia894b143b6fc4522a0483350194c625e_109"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="ifa0a57474bca4a90986ad7eb368715e4"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Major Shareholders<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following table and accompanying footnotes set forth information with respect to the beneficial ownership <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of our ordinary shares as of February 28, 2025 for: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">each beneficial owner, known by us, of more than 5% of our outstanding ordinary shares; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">each of our directors and executive officers individually; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">all of our directors and executive officers as a group. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Beneficial ownership is determined in accordance with the rules of the SEC. These rules generally attribute <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">beneficial ownership of securities to persons who possess sole or shared voting power or investment power with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respect to those securities and include ordinary shares that can be acquired within 60 days of February 28, 2025. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">percentage ownership information shown in the table below is based upon <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.87pt; position: var(--position); text-decoration: none; white-space: pre;">63,383,293<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.87pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares outstanding as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of February 28, 2025. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Except as otherwise indicated, all of the shares reflected in the table are ordinary shares and all persons listed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">below have sole voting and investment power with respect to the shares beneficially owned by them, subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">applicable community property laws. The information is not necessarily indicative of beneficial ownership for any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other purpose. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In computing the number of ordinary shares beneficially owned by a person and the percentage ownership of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that person, we deemed outstanding ordinary shares subject to options and warrants held by that person that are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immediately exercisable or exercisable within 60 days of February 28, 2025. We did not deem these shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outstanding, however, for the purpose of computing the percentage ownership of any other person. Beneficial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ownership representing less than 1% is denoted with an asterisk (*). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 385pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">152<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The information in the table below is based on information known to us or ascertained by us from public <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">filings made by the shareholders (which may be in the form of ADSs). Except as otherwise indicated in the table <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">below, addresses of the directors, executive officers and named beneficial owners are in care of Abivax SA, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">7-11&#160;boulevard Haussmann, 75009 Paris, France. Our major shareholders do not have any special voting rights. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 124pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 459pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 254.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/></tr><tr style="height: 37.5pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 31.67pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Name of Beneficial Owner<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 42.67pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 10.94pt; position: var(--position); text-decoration: none; white-space: pre;">Number&#160;of<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.86pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 22.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 19.69pt; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 32.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 9.16pt; position: var(--position); text-decoration: none; white-space: pre;">Beneficially<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 42.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 18.85pt; position: var(--position); text-decoration: none; white-space: pre;">Owned<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 5.14pt; position: var(--position); text-decoration: none; white-space: pre;">Percentage&#160;of<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 12.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.86pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 22.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Shares&#160;Benefic<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 32.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 24.97pt; position: var(--position); text-decoration: none; white-space: pre;">ially<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 42.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 18.85pt; position: var(--position); text-decoration: none; white-space: pre;">Owned<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 22.83pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 5.14pt; position: var(--position); text-decoration: none; white-space: pre;">Percentage of <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 32.83pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 19.68pt; position: var(--position); text-decoration: none; white-space: pre;">Voting <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 42.83pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 17.69pt; position: var(--position); text-decoration: none; white-space: pre;">Power+<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="4" rowspan="1" style="display: none;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">5% Shareholders:<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 53.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TCG Crossover(1)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 77.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 78.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 78.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 78.89999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 78.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.96pt; position: var(--position); text-decoration: none; white-space: pre;">.....................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 67.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">6,056,596<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 67.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">9.56<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 67.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">8.52<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81.75pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Entities managed by Truffle Capital(2)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 157.97pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 158.54999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 158.84pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 158.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">.....................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 81.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">4,671,107<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 81.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">7.37<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 81.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">12.09<span style="display: inline-block; height: 6.93pt; width: 13.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sofinnova Crossover(3)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 98.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 98.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 99.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.06pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 96pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">5,264,739<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 96pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">8.31<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 96pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">10.97<span style="display: inline-block; height: 6.93pt; width: 13.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Invus(4)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 36.510000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 36.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 36.61pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36.620000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">......................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 110.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">6,535,569<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 110.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">10.31<span style="display: inline-block; height: 6.93pt; width: 13.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 110.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">9.19<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 124.5pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deep Track Capital(5)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 92.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 93.64999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 93.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 93.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.97pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 124.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">3,783,819<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 124.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">5.97<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 124.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">5.32<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Entities affiliated with Venrock(6)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 141.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.35999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.51pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 138.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">3,611,570<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 138.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">5.70<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 138.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">5.08<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 254.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 153pt; width: 68.25pt;"><div><div style="line-height: 1pt; position: var(--position); top: 3.11pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Directors and Officers:<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 159pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 173.25pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Marc de Garidel(7)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 79.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 80.91pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 81.19999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 81.42999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 81.44999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.46pt; position: var(--position); text-decoration: none; white-space: pre;">....................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 173.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">499,076<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 173.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 173.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 187.5pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Blondel(8)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 74.08999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.11pt; position: var(--position); text-decoration: none; white-space: pre;">.......................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 187.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">67,374<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 187.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 187.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201.75pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fabio Cataldi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 56.720000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 57.88pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 58.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 58.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.900000000000006pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 201.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 201.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 201.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">David Zhang<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 55.080000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 56.470000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 56.49pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 216pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 216pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 216pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 230.25pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Pierre Courteille(9)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 80.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.14999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 81.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.53pt; position: var(--position); text-decoration: none; white-space: pre;">....................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 230.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">67,374<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 230.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 230.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 244.5pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Didier Scherrer(10)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.14999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 81.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 81.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.58999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">....................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 244.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">35,773<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 244.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 244.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258.75pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ida Hatoum<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 50.080000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 51.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 51.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 51.470000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.49pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 258.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 258.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 258.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 273pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sylvie Gr&#233;goire<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.17pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 66.53999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 66.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.59pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 273pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 273pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 273pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 287.25pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">June Lee(11) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 57.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 58.730000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 58.88pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 58.96pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 58.980000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.99pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 287.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">4,863<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 287.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 287.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 301.5pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Troy Ignelzi(12)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 68.94999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 69.1pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.11pt; position: var(--position); text-decoration: none; white-space: pre;">.........................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 301.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">4,863<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 301.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 301.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 315.75pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Corinna zur Bonsen-Thomas(13)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 134.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 135.9pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 136.19pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.34pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.42pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.46pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 315.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">21,263<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 315.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 315.75pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 330pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kinam Hong (representing Sofinnova Partners)(14)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 208.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 208.85999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 209.01pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 209.04999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 209.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">.................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 330pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">5,264,739<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 330pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">8.31<span style="display: inline-block; height: 6.93pt; width: 18.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 330pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 7.2pt; position: var(--position);">10.97<span style="display: inline-block; height: 6.93pt; width: 13.5pt;"></span></span><span style="left: 43.2pt; position: var(--position);">%<span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 344.25pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Camilla Soenderby(15)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 96.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.42999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.58pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 344.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">4,863<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 344.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 344.25pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 358.5pt; width: 254.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 254.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">All directors and officers as a group (13&#160;persons)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 198.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 198.85pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 199pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">.....................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 358.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">5,970,189<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 358.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">9.41%<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 358.5pt; width: 68.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 68.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">12.01%<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 501.75pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 551.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 551.25pt;"><div><div style="line-height: 6pt; position: var(--position); top: 2.63pt; width: 551.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 5.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.16pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 519.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">*<span style="display: inline-block; height: 5.54pt; width: 14.35pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Represents beneficial ownership of less than 1%. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">+<span style="display: inline-block; height: 5.54pt; width: 13.84pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">A double voting right is attached to each registered ordinary share (except treasury share) that is held in the name of the same shareholder <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 535.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">for at least two years. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 543.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.44999999999999pt; position: var(--position); white-space: pre;">The information in this footnote is based on a Schedule 13G filed with the SEC on April 19, 2024 by TCG Crossover GPI I, LLC ("TCG <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 551.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); white-space: pre;">Crossover GP I"), TCG Crossover Fund I, L.P. ("TCG Crossover I") and Chen Yu. <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 363.58pt; position: var(--position); text-decoration: none; white-space: pre;">These securities are held by TCG Crossover I. TCG <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 559.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Crossover GP I is the general partner of TCG Crossover I. Chen Yu is the sole managing member of TCG Crossover GP I. TCG <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 567.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Crossover I, TCG Crossover GP I and Dr. Yu share voting and dispositive power with respect to the securities held by TCG Crossover I. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 575.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">The principal business address of each of TCG Crossover GP I, TCG Crossover I and Dr. Yu is 705 High St., Palo Alto, CA 94301, <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 583.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">United States. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 591.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of (i) 2,213,333 ordinary shares held by FCPR Truffle Capital II (&#8220;Truffle Capital II&#8221;), (ii)&#160;1,160,804 ordinary shares held by <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="line-height: 8pt; position: var(--position); top: 599.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">FCPI UFF Innovation 7 (&#8220;UFF Innovation&#160;7&#8221;), (iii)&#160;119,000 ordinary shares held by FCPI UFF Innovation 15 (&#8220;UFF Innovation&#160;15&#8221;), <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 607.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">(iv)&#160;171,600 ordinary shares held by FCPI Fortune 4 (&#8220;FCPI Fortune 4&#8221;), (v) 91,973 ordinary shares held by FCPI Fortune 3&#160;(&#8220;FCPI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 615.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Fortune 3&#8221;), (vi)&#160;157,100 ordinary shares held by FCPI UFF Innovation 12 (&#8220;UFF Innovation 12&#8221;), (vii)&#160;103,400 ordinary shares held by <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 623.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">FCPI UFF Innovation 14 (&#8220;UFF Innovation 14&#8221;), (viii)&#160;84,983 ordinary shares held by FCPI Truffle Fortune 5 (&#8220;FCPI Fortune 5&#8221;), <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 631.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">(ix)&#160;54,120 ordinary shares held by FCPI UFF Innovation&#160;16 (&#8220;UFF Innovation 16&#8221;), (x)&#160;16,394 ordinary shares held by FCPI Truffle <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 639.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Innocroissance 2015 (&#8220;Truffle Innocroissance 2015&#8221;), (xi)&#160;36,400 ordinary shares held by Truffle Developpement (&#8220;Truffle <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 647.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Developpement&#8221;), (xii) 197,000 ordinary shares held by FCPI BioMedTech (&#8220;BioMedTech&#8221;) and (xiii) 265,000 ordinary shares held by <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 655.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">FCPI Truffle Medeor (&#8220;Truffle Medeor&#8221;). Truffle Capital II, UFF Innovation 7, UFF Innovation 15, FCPI Fortune 4, FCPI Fortune 3, <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 663.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">UFF Innovation 12, UFF Innovation 8, UFF Innovation 14, FCPI Fortune 5, UFF Innovation 16, Truffle Innocroissance 2015, Truffle <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 671.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Developpement, BioMedTech, and Truffle Medeor are managed by Truffle Capital (&#8220;Truffle Capital&#8221; and together the &#8220;Truffle Entities&#8221;), <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 679.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">itself controlled at 36.85% (of the share capital) respectively by Dr.&#160;Philippe&#160;Pouletty, a member of our Board, and Mr.&#160;Bernard-Louis <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 687.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Roques. The principal business address of the Truffle Entities is 5 rue de la Baume, 75008, Paris, France. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 695.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.44999999999999pt; position: var(--position); white-space: pre;">The information in this footnote is based on a Schedule 13D/A filed with the SEC on February 14, 2025 by Sofinnova Crossover I SLP <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 704.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); white-space: pre;">and related entities and persons and the company&#8217;s records. <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 288.76pt; position: var(--position); text-decoration: none; white-space: pre;">Consists of 5,264,739 ordinary shares held by Sofinnova Crossover I SLP <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">153<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;Sofinnova Crossover&#8221;). Sofinnova Crossover is controlled by Sofinnova Partners SAS (&#8220;Sofinnova Partners&#8221; and together the <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 80.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Sofinnova Entities&#8221;). Each of Antoine Papiernik, Cedric Moreau, Kinam Hong, a member of our Board, Joseph Anderson and Jacques <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 89.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Theurillat is a member of the investment committee of Sofinnova Crossover and may be deemed to have shared voting and investment <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 98.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">control over the shares held by Sofinnova Crossover. The principal business address of the Sofinnova Entities is 7-11&#160;boulevard <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 107.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Haussmann, 75009 Paris, France. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 116.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of <span style="display: inline-block; height: 5.54pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 134.20999999999998pt; position: var(--position); white-space: pre;">6,535,569<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 166.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares directly held by Invus Public Equities, L.P. (&#8220;Invus PE&#8221;). Invus Public Equities Advisors, LLC <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 125.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;Invus PE Advisors&#8221;), controls Invus PE, as its general partner and accordingly, may be deemed to beneficially own the ordinary shares <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 134.72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">held by Invus PE. The Geneva branch of Artal International S.C.A. (&#8220;Artal International&#8221;), controls Invus PE Advisors, as its managing <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 143.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">member and accordingly, may be deemed to beneficially own the ordinary shares held by Invus PE. Artal International Management S.A. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 152.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;Artal International Management&#8221;), as the managing partner of Artal International, controls Artal International and accordingly, may be <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 161.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">deemed to beneficially own the ordinary shares that Artal International may be deemed to beneficially own. Artal Group S.A. (&#8220;Artal <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8221;), as the sole stockholder of Artal International Management, controls Artal International Management and accordingly, may be <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 179.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">deemed to beneficially own the ordinary shares that Artal International Management may be deemed to beneficially own. Westend S.A. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 188.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;Westend&#8221;), as the parent company of Artal Group, controls Artal Group and accordingly, may be deemed to beneficially own the <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 197.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares that Artal Group may be deemed to beneficially own. Stichting Administratiekantoor Westend (the &#8220;Stichting&#8221;), as <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 206.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">majority shareholder of Westend, controls Westend and accordingly, may be deemed to beneficially own the ordinary shares that Westend <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 215.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">may be deemed to beneficially own. Mr. Amaury Wittouck, as the sole member of the board of Stichting, controls the Stichting and <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 224.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">accordingly, may be deemed to beneficially own the ordinary shares that the Stichting may be deemed to beneficially own. The principal <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 233.28pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">business address for Invus PE and Invus PE Advisors is 750 Lexington Avenue, 30th Floor, New York, NY 10022. The principal business <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 242.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">address for Artal International, Artal International Management, Artal Group, Westend and Mr. Wittouck is Valley Park, 44, Rue de la <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 251.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Vall&#233;e, L-2661, Luxembourg. The principal business address for the Stichting is Claude Debussylaan, 46, 1082 MD Amsterdam, the <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 260.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Netherlands. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 269.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(5)<span style="display: inline-block; height: 8.32pt; width: 9.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">The information in this footnote is based on a Schedule 13G/A filed with the SEC on November 14, 2024.<span style="display: inline-block; height: 8.32pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 436.24pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 438.24pt; position: var(--position); text-decoration: none; white-space: pre;">Consists of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 476pt; position: var(--position); white-space: pre;">3,783,819<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 508pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 511pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 282.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">shares held by Deep Track Biotechnology Master Fund, Ltd. (&#8220;Deep Track Fund&#8221;) acting on behalf of funds it manages. Deep Track Fund <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 291.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">is controlled by Deep Track Capital GP, LLC. The latter is controlled by Mr.&#160;David Kroin who is also its managing member. The <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 300.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">principal business address of the Deep Track Entities is 200 Greenwich Avenue 3<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 357.58pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">rd<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 361.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> Floor, Greenwich, CT 06830, United States. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 309.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(6)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.44999999999999pt; position: var(--position); white-space: pre;">The information in this footnote is based on a Schedule 13G/A filed with the SEC on February 14, 2024 by Venrock Healthcare Capital <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 318.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); white-space: pre;">Partners III, L.P. and related entities and persons and the company&#8217;s records. <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 344.25pt; position: var(--position); text-decoration: none; white-space: pre;">Consists of (i)&#160;2,800,204 ordinary shares held by Venrock <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 327.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Healthcare Capital Partners EG, L.P. (&#8220;VHCP EG&#8221;), (ii)&#160;737,581 ordinary shares held by Venrock Healthcare Capital Partners III, L.P. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 336.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;VHCP III&#8221;) and (iii) 73,785 ordinary shares held by VHCP Co-Investment Holdings III, LLC (&#8220;VHCP Co-Investment&#8221;). VHCP <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 345.28pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Management III, LLC (&#8220;VHCPM&#8221;) is the sole general partner of VHCP III and the sole manager of VHCP Co-Investment. VHCP <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 354.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Management EG, LLC (&#8220;VHCPM EG&#8221;) is the sole general partner of VHCP EG. Dr. Bong Koh and Nimish Shah are the voting members <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 363.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">of VHCPM and VHCPM EG. The principal business address of the Venrock Entities is 7 Bryant Park, 23rd Floor, New York, NY 10018, <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 372.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">United States. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 381.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(7)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.44999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Consists of (a) <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 145.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">463,620<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 171.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares held as of February 28, 2025 and (b) 35,456 free shares that vest within 60 days of February 28, <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 390.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 399.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(8)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of (a) 374 ordinary shares held as of February 28, 2025 and (b) up to 67,000 ordinary shares issuable upon the exercise of <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 407.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">options and warrants that are immediately exercisable or exercisable within 60 days of February 28, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 415.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(9)<span style="display: inline-block; height: 5.54pt; width: 9.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of (a) one ordinary share held as of February 28, 2025 and (b) up to 67,373 ordinary shares issuable upon the exercise of options <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 423.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">and warrants that are immediately exercisable or exercisable within 60 days of February 28, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 431.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(10)<span style="display: inline-block; height: 5.54pt; width: 5.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of 35,773 ordinary shares held as of February 28, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 439.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(11)<span style="display: inline-block; height: 5.54pt; width: 5.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of up to 4,863 ordinary shares issuable upon the exercise of options and warrants that are immediately exercisable or exercisable <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 447.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">within 60 days of February 28, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 455.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(12)<span style="display: inline-block; height: 5.54pt; width: 5.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of up to 4,863 ordinary shares issuable upon the exercise of options and warrants that are immediately exercisable or exercisable <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 463.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">within 60 days of February 28, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 471.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(13)<span style="display: inline-block; height: 5.54pt; width: 5.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of up to 21,263 ordinary shares issuable upon the exercise of options and warrants that are immediately exercisable or <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 479.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">exercisable within 60 days of February 28, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 487.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(14)<span style="display: inline-block; height: 5.54pt; width: 5.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of 4,064,739 ordinary shares held by Sofinnova Crossover, as described in footnote 3 above. Kinam Hong, a member of our <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 495.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Board, is a member of the investment committee of Sofinnova Crossover and may be deemed to have shared voting and investment <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 503.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">control over the shares held by Sofinnova Crossover, as described in footnote 4 above. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 511.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(14)<span style="display: inline-block; height: 5.54pt; width: 5.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of (a) 741,541 ordinary shares held as of February 28, 2025 and (b) up to 96,924 ordinary shares issuable upon the exercise of <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 519.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">options and warrants that are immediately exercisable or exercisable within 60 days of February 28, 2025. Effective as of March 28, 2024, <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 527.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">Sant&#233; Holdings SRL resigned from our board of directors. <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 535.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.1pt; position: var(--position);">(15)<span style="display: inline-block; height: 5.54pt; width: 5.03pt;"></span></span><span style="left: 96.44999999999999pt; position: var(--position);">Consists of up to 4,863 ordinary shares issuable upon the exercise of options and warrants that are immediately exercisable or exercisable <span style="display: inline-block; height: 5.54pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 543.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.45pt; position: var(--position); text-decoration: none; white-space: pre;">within 60 days of February 28, 2025. <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 217.06pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of February 28<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, 2025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, to the best of our knowledge, we estimate that 13,542,585 of our outstanding <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 573.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares (including ordinary shares in the form of ADSs) were held by five shareholders of record in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 583.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">United States. The actual number of holders is greater than these numbers of record holders, and includes beneficial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 593.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">owners whose ordinary shares or ADSs are held in street name by brokers and other nominees. This number of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 603.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">holders of record also does not include holders whose shares may be held in trust by other entities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 637.04pt;" id="ia894b143b6fc4522a0483350194c625e_112"></div><div style="line-height: 10pt; position: var(--position); top: 637.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="i3af865cdfcdf4921a06639f5c19ce60a"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Related Party Transactions<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 661.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.69pt; position: var(--position); text-decoration: none; white-space: pre;"> January&#160;1, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.76999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, we have engaged in the following transactions with our directors, executive officers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 671.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and holders of more than 5% of our outstanding voting securities and their affiliates, which we refer to as to our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 681.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related parties. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 697.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Arrangements with our Directors and Executive Officers <span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">154<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Director and Executive Officer Compensation <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 90pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are parties to employment agreements and other compensation arrangements, including equity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 100pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">compensation arrangements, with our directors and executive officers in the ordinary course of business. See &#8220;Item <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 110pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">6.B Compensation and Benefits&#8221; for information regarding compensation of the Directors and Executive Officers.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Related Person Transaction Policy <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We comply with French law regarding approval of transactions with related parties. In particular, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with article L.225-38 and seq. of the French Commercial Code, transactions with our general managers, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directors, shareholders holding more than 10% of the voting rights of the company and any company controlling a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shareholder holding more than 10% of our voting rights, other than transactions in the ordinary course of business <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and at arm&#8217;s length, are (i)&#160;subject to a prior approval by the Board, (ii)&#160;reported to the statutory auditors who must <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">then prepare a report on such transaction, and (iii)&#160;ratified by the our shareholders at the annual general meeting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we have adopted a related-party transaction policy that sets forth our procedures for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">identification, review, consideration and approval or ratification of related-party transactions. For purposes of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">policy only, a related-party transaction is defined as (1)&#160;any individual or series of financial transactions, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">arrangements or relationships (including any indebtedness or guarantee of indebtedness), in which we and any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related parties are, were or will be participants, or otherwise have a direct or indirect interest, or (2)&#160;any agreement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or similar transaction under French law which falls within the scope of Article L. 225-38 of the French Commercial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Code. For purposes of this policy, a related party is any person who is or at any time since the beginning of the our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">last fiscal year was, a director, director nominee, executive officer, beneficial owner of more than 5% of any class of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our voting securities or any immediate family member(s) of the foregoing persons, or any firm, corporation or other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 316pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entity in which any of the foregoing persons is employed or is a partner or principal or in a similar position or in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 326pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which such person has more than a 5% beneficial ownership interest. Under the policy, related-party transactions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">must be reported to us by the relevant related parties. If a transaction has been identified as a related-party <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">transaction, management must present information regarding the related-party transaction to our Board for review, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consideration and approval or ratification. Regarding certain transactions, our Board may appoint an independent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expert whenever the signing of a related person transaction is likely to have a material impact on our balance sheet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or results. In this case, this expert review will be mentioned in the special report of the statutory auditors and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disclosed to the public subject, as the case may be, to any information likely to adversely affect trade secret. Our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board may also seek the opinion of the audit committee and/or of the independent statutory auditors if there is any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">doubt about the qualification of a related person transaction subject to his evaluation. When submitted to our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Board&#8217;s review, the persons who have a direct or indirect interest in the transaction shall not participate in its review. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 450pt;" id="ia894b143b6fc4522a0483350194c625e_115"></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span><span id="ic0af41dea8f04269ada83f0c78368020"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Interests of Experts and Counsel<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.02pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">155<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_118"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 8.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Financial Information<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i4d9c6a82e9464ef0ac2cf9da51e48b9a"></span></span></div><div style="position: absolute; top: 96pt;" id="ia894b143b6fc4522a0483350194c625e_121"></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="i53d10bffc7044c9abf0066bb49f99629"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Consolidated Statements and Other Financial Information<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Statements<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our consolidated financial statements are included at the end of this Annual Report on Form 20-F, starting at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">page F-1.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Legal Proceedings<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">From time to time, we may be involved in various claims and legal proceedings relating to claims arising out <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of our operations. W<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.70999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">e are not currently a party to any legal proceedings that, in the opinion of our management, are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">likely to have a material adverse effect on our business.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.93pt; position: var(--position); text-decoration: none; white-space: pre;"> Regardless of outcome, litigation can have an adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">impact on us because of defense and settlement costs, diversion of management resources and other factors.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend Policy <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have never declared or paid any cash dividends on our ordinary shares. We do not have any present plan <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to pay any cash dividends on our equity securities in the foreseeable future. We currently intend to retain all of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">available funds and any future earnings to operate and expand our business. For as long as any amount is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outstanding under the Kreos&#160;/ Claret Financing, we are not permitted to declare or make any dividend without <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consent from KC or Claret. In the event a dividend is made or declared, the terms and conditions of the OCABSAs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and BSAs issued to KC and Claret and the terms and conditions of the convertible notes issued to Heights provide <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for an adjustment of the conversion ratio. We do not anticipate paying cash dividends on our equity securities in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">foreseeable future and intend to retain all available funds and any future earnings for use in the operation and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">expansion of our business, given our state of development. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to the requirements of French law and our by-laws, dividends may only be distributed from our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distributable profits, plus any amount held in our available reserves, which are those reserves other than the legal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and statutory reserves and the revaluation surplus. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we pay any dividends, we will pay our ADS holders to the same extent as holders of our ordinary shares, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to the terms of the deposit agreement, including deduction in respect of the fees and expenses payable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thereunder. See &#8220;Description of American Depositary Shares&#8221; for further information. Cash dividends on our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares, if any, will be paid in euros and converted into U.S. dollars with respect to ADSs, as provided in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 456pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deposit agreement. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 478pt;" id="ia894b143b6fc4522a0483350194c625e_124"></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="i07bebe468a8e40a5899cdfb7de024ba0"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Significant Changes<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Except as disclosed elsewhere in this Annual Report on Form 20-F, no significant changes have occurred.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">156<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_127"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 9.<span style="display: inline-block; height: 6.77pt; width: 6.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">The Offer and Listing<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i6e0fa3c38e0f4dada2bfff4c2264f2de"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="ia5f5699837104571ae7c5c592935353a"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Offer and Listing Details<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Our ADSs have been listed on the Nasdaq Global Market under the symbol &#8220;ABVX&#8221; since October 20, 2023. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Prior to that date, there was no public trading market for our ADSs. Our ordinary shares have been trading on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Euronext Paris under the symbol &#8220;ABVX&#8221; since June 2015. Prior to that date, there was no public trading market for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">our ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); white-space: pre;">Plan of Distribution<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); white-space: pre;">Markets<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For information regarding the stock exchanges and regulated markets on which our ADSs and ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">are listed, see &#8220;Item 9.A. Offer and Listing Details".<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); white-space: pre;">D.<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); white-space: pre;">Selling Shareholders<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 274pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); white-space: pre;">E.<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); white-space: pre;">Dilution<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 336pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); white-space: pre;">F.<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); white-space: pre;">Expenses of the Issue<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">157<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_130"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 10.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Additional Information.<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ie19058836d894dd498ae3ece1a3f07fc"></span></span></div><div style="position: absolute; top: 96pt;" id="ia894b143b6fc4522a0483350194c625e_133"></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="id0a9d055d6db4832b60369d6c1a891a5"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Share capital<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 136pt;" id="ia894b143b6fc4522a0483350194c625e_136"></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="i989b7c664eab41219cb3876c5de02087"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Memorandum and articles of association<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The information set forth in Exhibit 2.1 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.9pt; position: var(--position); white-space: pre;">is<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.56pt; position: var(--position); white-space: pre;"> incorporated herein by reference.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 176pt;" id="ia894b143b6fc4522a0483350194c625e_139"></div><div style="line-height: 10pt; position: var(--position); top: 176pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span><span id="i443a2c15565c406ab4e86fe9fe5812b9"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Material contracts<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">ATM Agreement<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">On November 19, 2024, we entered into an Equity Distribution Agreement (the &#8220;ATM Agreement&#8221;) with Piper <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Sandler &amp; Co. (&#8220;Piper Sandler&#8221;) with respect to an equity offering program under which we may offer and sell <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ADSs from time to time, through Piper Sandler as sales agent, having an aggregate offering price of up to $150.0 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">million (subject to French regulatory limits). Sales of the ADSs, if any, may be made in sales deemed to be an &#8220;at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the market offering&#8221; as defined in Rule 415(a)(4) promulgated under the Securities Act. The ATM Agreement will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">terminate upon the earlier of (i) the sale of all ADSs subject to the ATM Agreement and (ii) the termination of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ATM Agreement as permitted therein. Piper Sandler may terminate the Agreement at any time, and we may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">terminate the ATM Agreement at any time upon ten days&#8217; prior notice.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Kreos / Claret Financing Agreements <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.22pt; position: var(--position); text-decoration: none; white-space: pre;">August<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.1pt; position: var(--position); white-space: pre;"> 20, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.6pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.6pt; position: var(--position); white-space: pre;">, we entered into the Framework Subscription Agreement with Kreos and Claret, as the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Secured Lenders. Under this Framework Subscription Agreement, we may draw up to &#8364;75 million in structured debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">financing in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.5pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.45999999999998pt; position: var(--position); white-space: pre;"> tranches of &#8364;25 million in aggregate principal amount each, as further described below.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.53pt; position: var(--position); text-decoration: none; white-space: pre;">first<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.62pt; position: var(--position); white-space: pre;"> tranche, with an aggregate principal amount of &#8364;25 million, takes the form of senior secured <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">convertible bonds with warrants attached, which we refer to as the Kreos / Claret OCABSA. We drew the first <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">tranche on <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.39pt; position: var(--position); text-decoration: none; white-space: pre;">August<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.26999999999998pt; position: var(--position); white-space: pre;"> 21, 2023. On the same date, we repaid all outstanding amounts that remained due under the First <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Kreos Agreement (as defined below) and the Second Kreos Agreement (as defined below). The Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">OCABSA are convertible into ordinary shares at any time from their issuance at the request of their holders at a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">fixed conversion price of &#8364;21.2209, subject to standard adjustments, including anti-dilution and dividend <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">protections.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The second tranche, with an aggregate principal amount of &#8364;25 million, takes the form of senior secured non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">convertible bonds. We drew the second tranche on <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.5pt; position: var(--position); text-decoration: none; white-space: pre;">March 28<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.08000000000004pt; position: var(--position); white-space: pre;">, 2024. The drawdown of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.64pt; position: var(--position); text-decoration: none; white-space: pre;">the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.84pt; position: var(--position); white-space: pre;"> second tranche was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">subject to a maximum 10% Debt-To-Market Capitalization Ratio at the time of drawdown. The &#8220;Debt-To-Market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Capitalization Ratio&#8221; is calculated, on any relevant date, by dividing (i) our indebtedness (including amounts due <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">under the Kreos / Claret Financing, but excluding amounts due under the Heights Financing), by (ii) our market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">capitalization calculated by multiplying the number of our outstanding ordinary shares by the closing price of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ordinary shares on such relevant date.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The third tranche, with an aggregate principal amount of &#8364;25 million, takes the form of senior secured non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">convertible <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.43pt; position: var(--position); text-decoration: none; white-space: pre;">bonds<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.32pt; position: var(--position); white-space: pre;"> and was drawn down on June 21, 2024. The drawdown of the third tranche was subject to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">maximum 10% Debt-To-Market Capitalization Ratio at the time of drawdown and was conditional on our raising of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">a minimum of $125 million in gross proceeds through a listing on Nasdaq before June 30, 2024 (which was achieved <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">in October 2023).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Interest <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.95pt; position: var(--position); text-decoration: none; white-space: pre;">on<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.95pt; position: var(--position); white-space: pre;"> the Kreos / Claret OCABSA accrues annually at a rate of 9% payable in quarterly installments. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Kreos / Claret OCABSA&#8217;s maturity date is March 31, 2027 and the final repayment date is January 1, 2027.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">A <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.22pt; position: var(--position); text-decoration: none; white-space: pre;">variable<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.38pt; position: var(--position); white-space: pre;"> interest rate of 7.5% plus European Central Bank Base Rate (subject to a minimum interest rate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">2.5% and a maximum interest rate of 4%) applies to each of the second and third tranches. These two tranches will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">be repaid <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.39pt; position: var(--position); text-decoration: none; white-space: pre;">monthly<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.7pt; position: var(--position); white-space: pre;"> through March 31, 2027, after a deferred repayment of the principal (i) until October 1, 2024, for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the second tranche, or February 1, 2025, if the conditions to draw the third tranche are met, and (ii) until February 1, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 660pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">2025, for the third tranche.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary exceptions), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">which include, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.32pt; position: var(--position); text-decoration: none; white-space: pre;">among<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.51999999999998pt; position: var(--position); white-space: pre;"> other things, restrictions on the incurrence of indebtedness, cross-default, the distribution of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">dividends and the grant of security interests. As security for the Kreos / Claret Financing, the Secured Lenders <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">benefit from the grant of first-ranking collateral on our principal tangible and intangible assets, including pledges <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">158<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">over our business (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 147.79000000000002pt; position: var(--position); white-space: pre;">fonds de commerce<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.93pt; position: var(--position); white-space: pre;">) as a going concern and intellectual property rights in our lead drug <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">candidate, as well as pledges over our bank accounts and receivables. Such securities apply to all tranches of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.53pt; position: var(--position); text-decoration: none; white-space: pre;">Financing<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.49pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.11pt; position: var(--position); text-decoration: none; white-space: pre;">part<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.64pt; position: var(--position); white-space: pre;"> of the Kreos / Claret Financing, we have issued warrants to the Secured Lenders for a global <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">subscription price of &#8364;1.00, giving them the right to subscribe to up to 214,198 new ordinary shares at an exercise <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">price of &#8364;18.6744.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">In the context of one of the conditions for the drawdown of the third tranche of the Kreos / Claret Financing&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">being met (raising of a minimum of $125 million in gross proceeds through a listing on Nasdaq before June 30, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">2024), we issued on November 2, 2023, 405,831 additional warrants to Kreos and Claret for a global subscription <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">price of &#8364;1.00 giving them the right to subscribe to up to 405,831 new ordinary shares at an exercise price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">&#8364;9.8563. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.53pt; position: var(--position); text-decoration: none; white-space: pre;">warrants<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.93pt; position: var(--position); white-space: pre;"> issued to the Secured Lenders can be exercised over a period of seven years from their issuance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">date or up until the date of the successful closing of a tender offer for our ordinary shares, whichever is earlier. At <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the time of exercise of the warrants, the holders of the warrants are eligible to sell part of their warrants to us in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">accordance with a put option agreement to allow for a cashless exercise of the warrants.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The Kreos / Claret OCABSA, the non-convertible bonds and the warrants issued in the framework of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Kreos / Claret Financing will not be listed on any market. The agreements relating to the Kreos / Claret Financing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">are governed by French law.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Prior Kreos Agreements<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On July 24, 2018, we entered into a &#8364;20 million venture loan agreement with Kreos (the "First Kreos <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Agreement"). The financing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.05pt; position: var(--position); text-decoration: none; white-space: pre;">consisted<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.23pt; position: var(--position); white-space: pre;"> of two tranches of structured debt financing: (i) a total principal amount of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">&#8364;10 million, comprised of (x) &#8364;8 million in non-convertible bonds issued in July 2018 and (y) &#8364;2 million in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">convertible bonds issued in August 2018 and (ii) a total principal amount of &#8364;10 million, comprised of (x) &#8364;8 million <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">in non-convertible bonds and (y) &#8364;2 million in convertible bonds, each issued in May 2019.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On October 12, 2020, we entered into a bonds issue agreement with Kreos (the "Second Kreos Agreement"), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">pursuant to which we <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.26pt; position: var(--position); text-decoration: none; white-space: pre;">issued<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.24pt; position: var(--position); white-space: pre;"> bonds in a total principal amount of &#8364;15 million, comprised of (i) a &#8364;10 million tranche <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and a &#8364;5 million tranche, with an option to issue an additional &#8364;5 million tranche.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On August 21, 2023, we repaid all outstanding amounts that remained due under the First Kreos Agreement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and the Second Kreos <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Agreement<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.3pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Heights Convertible Notes<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On August 20, 2023, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.6pt; position: var(--position); text-decoration: none; white-space: pre;">we entered into the Heights Subscription Agreement with Heights. Under the Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription Agreement, we<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.05pt; position: var(--position); white-space: pre;"> may draw up to &#8364;75 million of the Heights Convertible Notes in two tranches of &#8364;35 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">million and &#8364;40 million, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The first tranche in aggregate principal amount of &#8364;35 million was drawn on August 24, 2023. On the same <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">date, we repaid all <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.70999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">amounts<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.57pt; position: var(--position); white-space: pre;"> due under the OCEANE bonds. The Heights Convertible Notes are convertible into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ordinary shares at any time from their issuance at the request of the holder at a fixed conversion price set at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">&#8364;23.7674, subject to standard adjustments, including anti-dilution and dividend protections.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 514pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">We forewent our right to draw down on the second tranche of the Heights financing on August 4, 2024, which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">was the limit date for the drawdown.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Interest on the Heights Convertible Notes accrues annually at a rate of 6% payable in quarterly installments in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">cash or, at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.28pt; position: var(--position); text-decoration: none; white-space: pre;">our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.61pt; position: var(--position); white-space: pre;"> option, in ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The Heights Convertible Notes will be repaid through sixteen quarterly installment payments, beginning three <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">months after <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.72pt; position: var(--position); text-decoration: none; white-space: pre;">their<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.01999999999998pt; position: var(--position); white-space: pre;"> issuance date (corresponding, for the first tranche, to a final repayment date on August 24, 2027). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Installments are payable in cash or, at our option, in ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Any interest or installment payments in shares will be made on the basis of a share price equal to 90% of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Market Price <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.37pt; position: var(--position); text-decoration: none; white-space: pre;">of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.7pt; position: var(--position); white-space: pre;"> our ordinary shares at the time of payment. &#8220;Market Price&#8221; refers to the arithmetic average of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">daily VWAP for our ordinary shares on the two (2) days with the lowest daily VWAPs out of the five (5) trading <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">days immediately preceding the applicable date, but in no event greater than the VWAP of our ordinary shares on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the applicable date. The Market Price may not be higher than the applicable conversion price. Issuances of ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">shares may not be made at a price lower than a 15% discount to the 15-day VWAP at the time of the decision to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">issue the Heights Convertible Notes (i.e., &#8364;14.4303 per ordinary share for the first tranche).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Upon the occurrence of certain events (including a change of control of Abivax, a free float event or a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">delisting of our ordinary <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.89pt; position: var(--position); white-space: pre;"> on Euronext Paris), any noteholder will have the option to require us to redeem all, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and no less than all, of its Heights Convertible Notes at par plus accrued but unpaid interest. In the event that our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 708pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ordinary shares are targeted by a public offer (in cash or in securities, in cash and securities, etc.) which may result <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">159<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">in a change of control or filed following a change of control, upon conversion of the Heights Convertible Notes, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">shall (i) deliver new ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.5pt; position: var(--position); text-decoration: none; white-space: pre;">at<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.7pt; position: var(--position); white-space: pre;"> the conversion price, and (ii) pay a cash amount equal to the sum of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">remaining coupons scheduled until the maturity date, and any accrued interest.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The terms and conditions of the Heights Convertible Notes include a standard negative pledge providing that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">any security <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.05pt; position: var(--position); text-decoration: none; white-space: pre;">granted<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.01pt; position: var(--position); white-space: pre;"> in favor of other borrowed debt or debt instruments should also be granted in favor of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Heights Convertible Notes on an equal basis (with the exception of the securities issued pursuant to the Kreos / <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Claret Financing, as described above).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.53pt; position: var(--position); text-decoration: none; white-space: pre;">Heights<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.61pt; position: var(--position); white-space: pre;"> Financing is a senior, unsecured financing. The convertible bonds of the Heights Financing will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">not be listed on any market. The agreements relating to the Heights Financing are governed by French law.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">OCEANE Bonds <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On July 30, 2021, we issued &#8364;25 million 6% convertible senior unsecured and unsubordinated bonds due July <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">30, 2026 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.5pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.68pt; position: var(--position); white-space: pre;"> to 654,621 OCEANE bonds. The OCEANE bonds were exchangeable, at the option of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">bondholders, for new or existing shares and bear interest at a rate of 6% per annum, payable semi-annually on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">January 30 and July 30 of each year, beginning January 30, 2022. On August 24, 2023, we repaid all amounts due <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">under the OCEANE bonds.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Royalty <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 107.82pt; position: var(--position); text-decoration: none; white-space: pre;">Certificates<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 157.18pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.22pt; position: var(--position); text-decoration: none; white-space: pre;">August<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.1pt; position: var(--position); white-space: pre;"> 31, 2022, we issued &#8364;2.9 million in royalty certificates (the &#8220;Royalty Certificates&#8221;).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The terms <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.22pt; position: var(--position); text-decoration: none; white-space: pre;">and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.65pt; position: var(--position); white-space: pre;"> conditions of the Royalty Certificates provide holders with the right to royalties equal to 2% of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the future net sales of obefazimod (worldwide and for all indications) following its commercialization. The amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">of royalties <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.72pt; position: var(--position); text-decoration: none; white-space: pre;">that<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.69pt; position: var(--position); white-space: pre;"> may be paid under the Royalty Certificates is capped at &#8364;172 million (the &#8220;Royalty Cap&#8221;). The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Royalty Certificates do not provide for any dividend rights, coupon payments or any other additional financial rights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">other than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.72999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.93pt; position: var(--position); white-space: pre;"> right to royalties. In particular, the Royalty Certificates do not grant any financial rights in respect of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">any other products that may be developed by us beyond obefazimod.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The Royalty Certificates have a term of 15 years and do not provide for an accelerated repayment in case of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">change of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.62pt; position: var(--position); text-decoration: none; white-space: pre;">control<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.92000000000002pt; position: var(--position); white-space: pre;">. We may at any time repay the Royalty Certificates in full by paying an amount equal to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Royalty Cap minus any royalties paid prior to such reimbursement. The Royalty Certificates are subject to a one-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">year lock-up, after which they will become freely transferable by each holder thereof in whole, but not in part. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Royalty Certificates are not listed nor assigned an ISIN.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Share <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 99.48pt; position: var(--position); text-decoration: none; white-space: pre;">Purchase<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 138.88pt; position: var(--position); text-decoration: none; white-space: pre;"> Agreement <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On April 1, 2022, we entered into a share purchase agreement pursuant to which we acquired 100% of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">capital and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.03pt; position: var(--position); text-decoration: none; white-space: pre;">voting<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.57pt; position: var(--position); white-space: pre;"> rights of Prosynergia S.&#224;.r.L, a Luxembourg biotech company, registered in the Luxembourg <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Trade and Companies Register under no. B257479, with registered offices located at 241 route de Longwy &#8211; 1941 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Luxembourg City, Luxembourg for consideration of &#8364;3.25 million (the &#8220;Prosynergia Agreement&#8221;).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On December 1, 2021, we granted a loan to Prosynergia, for &#8364;1,400,000. On December 12, 2022, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">completed a merger with <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.82pt; position: var(--position); white-space: pre;"> through a <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 264.85pt; position: var(--position); white-space: pre;">Transmission Universelle du Patrimoine<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.21pt; position: var(--position); white-space: pre;"> (&#8220;TUP&#8221;) and all of <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Prosynergia&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); text-decoration: none; white-space: pre;">assets<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.76pt; position: var(--position); white-space: pre;"> and liabilities were transferred to us. Following the merger, Prosynergia was dissolved. See <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Note 3.2 to our audited financial statements as of and for the years ended December 31, 2021, 2022 and 2023 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">included in this Annual Report on Form 20-F.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 524pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">IQVIA Master Services Agreement <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On December <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.76pt; position: var(--position); text-decoration: none; white-space: pre;">17<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.76pt; position: var(--position); white-space: pre;">, 2018, we entered into a master services agreement with IQVIA Ltd (&#8220;IQVIA&#8221;) for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">provision of clinical trial services, research and other services for individual clinical trials on human beings (the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">&#8220;IQVIA Master Services Agreement&#8221;), as amended on September 9, 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 576pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Pursuant to the IQVIA Master Services Agreement and underlying Work Order, IQVIA agreed to perform <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">certain services on our behalf as we request, subject to IQVIA&#8217;s acceptance of the services and related budget in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 596pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">applicable Work <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.79000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Order<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.1pt; position: var(--position); white-space: pre;">, including, but not limited to, strategic planning, expert consultation, clinical trial services, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">statistical programming and analysis, data processing, data management, regulatory, project management, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">pharmacovigilance, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.99pt; position: var(--position); text-decoration: none; white-space: pre;">central<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.15pt; position: var(--position); white-space: pre;"> laboratory services, clinical pharmacology services, electrocardiogram services and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">device services. In <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.56pt; position: var(--position); text-decoration: none; white-space: pre;">consideration<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.38pt; position: var(--position); white-space: pre;"> therefore, we agreed to pay IQVIA an agreed set of fees based on our requests, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">set forth in the applicable Work Order. We have the right to terminate the IQVIA Master Services Agreement or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">requested work without cause and at any time upon 45 days&#8217; written notice. We and IQVIA each have the right to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 656pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">terminate the IQVIA Master Services Agreement in the event of a breach by the other party, if such breach has not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">been substantially cured within the 30-day period. We have the right to terminate the IQVIA Master Services <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Agreement and/or any Work Order with immediate effect by written notice and without any liability whatsoever in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">case IQVIA becomes debarred.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">160<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Pursuant to the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.95pt; position: var(--position); text-decoration: none; white-space: pre;">IQVIA<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.26999999999998pt; position: var(--position); white-space: pre;"> Master Services Agreement and a study specific Work Order executed with IQVIA, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">IQVIA is responsible for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.15pt; position: var(--position); text-decoration: none; white-space: pre;">coordinating<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.65pt; position: var(--position); white-space: pre;"> our Phase 3 clinical trial for obefazimod in moderately to severely active UC.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Evotec<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 100.85pt; position: var(--position); white-space: pre;"> Drug Discovery Services <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 210.17pt; position: var(--position); text-decoration: none; white-space: pre;">Agreement<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 257.33000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On September 1, 2017, we entered into a drug discovery services agreement with Evotec International GmbH <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(&#8220;Evotec&#8221;), pursuant to which Evotec <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.59pt; position: var(--position); text-decoration: none; white-space: pre;">provides<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.01pt; position: var(--position); white-space: pre;"> drug discovery services to us, in order to have optimized leads <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">obtained for various viral indications for further developments within the context of a global collaborative program <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and to any further development programs under which we would require the assistance of Evotec in the provision of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">services (the &#8220;Evotec Drug Discovery Services Agreement&#8221;). Under the Evotec Drug Discovery Services <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Agreement, Evotec must provide its services in accordance with common industry standard of current established <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">practices by suitably qualified staff, using equipment in an agreed premises, under allocated timelines agreed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">between the parties and in compliance with all relevant legislation. Evotec may not subcontract its obligations to us <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">other than to an affiliate without our express prior written consent.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">In consideration for services provided, we are required to pay Evotec an agreed set of fees as agreed in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">relevant project description <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.78pt; position: var(--position); text-decoration: none; white-space: pre;">relating<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.28pt; position: var(--position); white-space: pre;"> to such services. To the extent additional projects are completed under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">agreement, additional amounts may be payable to Evotec, but they are not determinable as of the date of this Annual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Report on Form 20-F. We own, and Evotec assigns to us to the extent permissible under applicable law, all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">intellectual property rights conceived, discovered, invented or made by Evotec in connection with the provision of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">drug discovery services. No milestone payments or royalties are payable pursuant to the Evotec Drug Discovery <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Services Agreement. No drug <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">candidate<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.53pt; position: var(--position); white-space: pre;"> has currently been discovered pursuant to this agreement.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">We have the right to terminate Evotec Drug Discovery Services Agreement or any project without cause at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">any time upon 60 days&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.32pt; position: var(--position); text-decoration: none; white-space: pre;">written<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.61pt; position: var(--position); white-space: pre;"> notice. We and Evotec each have the right to terminate any ongoing project upon 20 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 306pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">days&#8217; written notice for a breach by the other party, if such breach has not been remedied within the 20-day period.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Delpharm Agreement <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On November 24, 2016, we entered into a manufacturing agreement with Delpharm Lille S.A.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(&#8220;Delpharm&#8221;), pursuant to which Delpharm produces batches of capsules containing obefazimod required to carry <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">out clinical trials (the &#8220;Delpharm Agreement&#8221;). The Delpharm Agreement renews automatically for successive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">periods of one year until either party <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.44pt; position: var(--position); text-decoration: none; white-space: pre;">notifies<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.4pt; position: var(--position); white-space: pre;"> the other of its intention not to renew the agreement. The agreement is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">still in effect on the date hereof. Either party may terminate the agreement upon serious breach or a serious non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">execution of the agreement by the other party. Abivax may also terminate the Delpharm Agreement at any time, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">subject to certain reimbursement obligations to Delpharm.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Seqens Agreement <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On March 11, 2016, we entered into a clinical batch development and production agreement with &#8220;Produits <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Chimiques <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.78999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Auxiliaires<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.17000000000002pt; position: var(--position); white-space: pre;"> et de Synth&#232;se&#8221; (&#8220;Seqens&#8221;), under which Seqens provides services relating to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">development and production of active ingredients, including obefazimod (the &#8220;Seqens Agreement&#8221;). The Seqens <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Agreement was amended on March 2, 2021, in connection with our UC Phase 3 clinical trials. In accordance with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the Seqens Agreement, in consideration for services provided, we are required to pay Seqens an agreed set of fees as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">agreed in the relevant Work Order.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The Seqens <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.34pt; position: var(--position); text-decoration: none; white-space: pre;">Agreement<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.72pt; position: var(--position); white-space: pre;"> remains in full force and effect until the earlier of (i) the execution of an agreement for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the commercial manufacturing by Seqens of obefazimod under Phase IV, such agreement to be negotiated between <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Seqens and us in good faith, (ii) the failure to reach such a Phase IV agreement or (iii) the failure to obtain all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">marketing approval by the FDA and other relevant regulators in Europe.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">According <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.18pt; position: var(--position); text-decoration: none; white-space: pre;">to<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.95pt; position: var(--position); white-space: pre;"> the Seqens Agreement, either party may terminate the agreement in the event of the other party&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">failure to perform one or more of its obligations. This termination shall only become effective one month after the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">issuance by the complaining party of a registered letter with acknowledgement of receipt setting out the reasons for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the complaint, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.64pt; position: var(--position); text-decoration: none; white-space: pre;">unless<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.62pt; position: var(--position); white-space: pre;"> within this period the defaulting party has fulfilled its obligations or has provided proof of an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">impediment due to force majeure. The termination may take effect without delay by simple written notification in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">case of fraud or intentional fault by the party in default.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">According to the Seqens Agreement, we have the right to postpone or terminate any pending work at any time <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">upon 30 days prior written notice, subject to payment to Seqens of the sums due in proportion to the actual progress <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 628pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">of the work on <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.28pt; position: var(--position); white-space: pre;"> day of receipt by Seqens of its notification, as well as any costs incurred prior to such receipt by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 638pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Seqens that would be non-revocable and not subject to reallocation within a reasonable time.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">State-Guaranteed Loan<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 670pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On June 11, 2020, we obtained non-dilutive financing from Soci&#233;t&#233; G&#233;n&#233;rale in the form of a &#8364;5 million State-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">guaranteed loan (the &#8220;State-guaranteed loan&#8221;). The State-guaranteed loan had an initial duration of 12 months <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(subject to a five-year <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.87pt; position: var(--position); text-decoration: none; white-space: pre;">extension<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.16pt; position: var(--position); white-space: pre;"> option) and accrues interest at a rate of 0.25% with repayment of principal falling <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 700pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">due in June 2021. The State-guaranteed loan was immediately made available to us in June 2020. In March 2021, we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 710pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">entered into an amendment to the State-guaranteed loan, which extended the repayment date of the State- guaranteed <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">161<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">loan by five years until June 2026 with a one-year deferral of principal repayment, with the following conditions: (i) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">a revised interest rate of 0.58% per annum, excluding insurance and State-guaranteed premium; and (ii) a State-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">guaranteed premium of &#8364;0.1 million to be paid by installments over the contract period starting in June 2021. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">State-guaranteed loan <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.31pt; position: var(--position); text-decoration: none; white-space: pre;">includes<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.6pt; position: var(--position); white-space: pre;"> certain customary covenants and prepayment provisions, as well as a negative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">covenant restricting the disposal of assets representing more than 50% of the gross value of our fixed assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Royalties Agreement<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On December 18, 2008, we entered into an agreement with (i) the CNRS, (ii) the University of Montpellier, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and (iii) the Institut <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.9pt; position: var(--position); text-decoration: none; white-space: pre;">Curie<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.09pt; position: var(--position); white-space: pre;">, which sets out financial conditions under which we can use any intellectual property <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">rights and research results derived from certain research collaboration programs we had with the CNRS, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">University of Montpellier, and the Institut Curie and which have now been terminated (the &#8220;Royalties Agreement&#8221;).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Pursuant to the Royalties Agreement, the CNRS and the Institut Curie are entitled to receive milestone <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">payments, as well as <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.62pt; position: var(--position); text-decoration: none; white-space: pre;">royalty<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.92000000000002pt; position: var(--position); white-space: pre;"> payments on global net sales of products using the intellectual property rights and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">research results jointly developed with them (including obefazimod) (each, a &#8220;Qualifying Product&#8221;). The amounts of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the milestone payments for each Qualifying Product are limited and not material compared to the amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">expected royalties.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">In case we commercialize directly a Qualifying Product (either (i) implementing the jointly developed patents <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and the jointly <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.21pt; position: var(--position); text-decoration: none; white-space: pre;">developed<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.26999999999998pt; position: var(--position); white-space: pre;"> know-how or (ii) only implementing the jointly developed know-how), royalties due under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the Royalties Agreement are in the low single-digit percentages subject to an annual minimum.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">In the event we commercialize a Qualifying Product by way of a license granted to a third-party, we may elect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(i) to pay <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.13pt; position: var(--position); text-decoration: none; white-space: pre;">royalties<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.51999999999998pt; position: var(--position); white-space: pre;"> calculated in the same manner as if we were commercializing the Qualifying Product directly, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">(ii) to pay royalties (high single-digit to low double-digit percentages) calculated based on the revenues we receive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">under the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.96000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">license<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.68pt; position: var(--position); white-space: pre;"> granted to the third-party. We must notify the CNRS regarding which royalty amount we elect to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">pay at the same time that the third-party grants the license.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">For the avoidance of doubt, the Royalties Agreement does not include any cap on the total payments which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">may be due by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.06pt; position: var(--position); text-decoration: none; white-space: pre;">us<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.95pt; position: var(--position); white-space: pre;"> under such Royalties Agreement.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The Royalties Agreement survives until the expiration of the underlying intellectual property rights (without <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">any termination rights to either <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">party<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.76pt; position: var(--position); white-space: pre;">).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 396pt;" id="ia894b143b6fc4522a0483350194c625e_142"></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">D.<span style="display: inline-block; height: 6.77pt;"></span><span id="i536743c81f4d4076b77a55f53551eb9a"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Exchange Controls<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Under current French foreign exchange control regulations there are no limitations on the amount of cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payments that we may remit to residents of foreign countries. Laws and regulations concerning foreign exchange <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">controls do, however, require that all payments or transfers of funds made by a French resident to a non-resident <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such as dividend payments be handled by an accredited intermediary. All registered banks and substantially all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">credit institutions in France are accredited intermediaries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 488pt;" id="ia894b143b6fc4522a0483350194c625e_145"></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">E.<span style="display: inline-block; height: 6.77pt;"></span><span id="ib852a2a2b9294e89a33d05eb1d56ca31"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The summary set forth below describes certain French and U.S. federal income tax consequences relating to <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the purchase, ownership and disposition of the ADSs to U.S. Holders (as defined below) as of the date hereof. This <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">summary does not represent a detailed description of the tax consequences applicable to a U.S. Holder that is <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to special treatment under the U.S. federal tax laws, including, without limitation: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">certain financial institutions; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">traders in securities who use a mark-to-market method of tax accounting; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">dealers in securities or currencies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 606pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons holding ADSs as part of a hedging transaction, &#8220;straddle,&#8221; wash sale, conversion transaction or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">integrated transaction or persons entering into a constructive sale with respect to the ADSs; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">regulated investment companies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 648pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">insurance companies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">real estate investment trusts, grantor trusts or other trusts; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 680pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons whose &#8220;functional currency&#8221; for U.S. federal income tax purposes is not the U.S. dollar; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">expatriates of the United States; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">162<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">tax exempt entities, including &#8220;individual retirement accounts&#8221; and &#8220;Roth IRAs&#8221;; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">entities or arrangements classified as partnerships or other pass-through entities for U.S. federal <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">income tax purposes (and investors therein); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons that received ADSs as compensation for the performance of services; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons that own or are deemed to own ten percent or more of our shares (by vote or value); and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons holding ADSs in connection with a trade or business, permanent establishment, or fixed base <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">outside the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">This summary is for general information only. Prospective Investors considering the purchase, <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ownership or disposition of the ADSs are advised to consult their own tax advisers concerning the French and <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. federal income tax consequences in light of their particular facts and circumstances, as well as any <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consequences arising under the laws of any other taxing jurisdiction. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">French Income Tax Considerations <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following describes the material French income tax consequences to U.S. Holders (as defined below) of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">purchasing, owning and disposing of our ADSs and, unless otherwise noted, this discussion is the opinion of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Dechert, our French tax counsel, insofar as it relates to matters of French tax law and legal conclusions with respect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to those matters. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">This discussion does not purport to be a complete analysis or listing of all potential tax effects of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">acquisition, ownership or disposition of our ADSs to any particular investor, and does not discuss tax considerations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that arise from rules of general application or that are generally assumed to be known by investors. All of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">following is subject to change. Such changes could apply retroactively and could affect the consequences described <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">below. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In 2011, France introduced a comprehensive set of new tax rules applicable to French assets that are held by or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in foreign trusts. These rules, among other things, provide for the inclusion of trust assets in the settlor&#8217;s net assets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for purpose of applying the former French wealth tax (replaced by the French real estate wealth tax as from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">January&#160;1, 2018), for the application of French gift and death duties to French assets held in trust, for a specific tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on capital on the French assets of foreign trusts not already subject to the former French wealth tax (replaced by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">French real estate wealth tax as from January&#160;1, 2018) and for a number of French tax reporting and disclosure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations. The following discussion does not address the French tax consequences applicable to ADSs held in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 436pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trusts. If ADSs are held in trust, the grantor, trustee and beneficiary are urged to consult their own tax adviser <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 446pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regarding the specific tax consequences of acquiring, owning and disposing of ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The description of the French income tax and real estate wealth tax consequences set forth below is based on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 478pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Convention Between the Government of the United States of America and the Government of the French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 488pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Republic for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 498pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Income and Capital of August&#160;31, 1994 which came into force on December&#160;30, 1995 (as amended by any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 508pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent protocols, including the protocol of January&#160;13, 2009, or the "Treaty") and the tax guidelines issued by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the French tax authorities in force as of the date of this Annual Report on Form 20-F. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the purposes of this discussion, the term &#8220;U.S. Holder&#8221; means a beneficial owner of ADSs that is (or is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treated as), for U.S. federal income tax purposes: (1)&#160;an individual who is a U.S. citizen or resident, (2)&#160;a corporation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or other entity that is treated as a corporation for U.S. federal income tax purposes, created or organized in or under <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the laws of the United States or any state thereof, including the District of Colombia, (3)&#160;otherwise subject to U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">federal income taxation or (4)&#160;a trust, if a court within the United States is able to exercise primary supervision over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">its administration and one or more U.S. persons have the authority to control all of the substantial decisions of such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">trust or has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">person. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If a partnership (or any other entity treated as partnership for U.S. federal income tax purposes) holds ADSs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the tax treatment of the partnership and a partner in such partnership generally will depend upon the status of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">partner and the activities of the partnership. If a U.S. Holder is a partnership or a partner in a partnership that holds <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs, such holder is urged to consult its own tax adviser regarding the specific tax consequences of acquiring, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">owning and disposing of securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">This discussion applies only to investors that hold our ADSs as capital assets that have the U.S. dollar as their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 704pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">functional currency, that are entitled to Treaty benefits under the &#8220;Limitation on Benefits&#8221; provision contained in the <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">163<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Treaty, and whose ownership of the ADSs is not effectively connected to a permanent establishment or a fixed base <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in France. Certain U.S. Holders (including, but not limited to, U.S. expatriates, partnerships or other entities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">classified as partnerships for U.S. federal income tax purposes, banks, insurance companies, regulated investment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">companies, tax-exempt organizations, financial institutions, persons subject to the alternative minimum tax, persons <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">who acquired the securities pursuant to the exercise of employee share options or otherwise as compensation, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">persons that own (directly, indirectly or by attribution) 5% or more of our voting stock or 5% or more of our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outstanding share capital, dealers in securities or currencies, persons that elect to mark their securities to market for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. federal income tax purposes and persons holding securities as a position in a synthetic security, straddle or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conversion transaction) may be subject to special rules not discussed below. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holders are urged to consult their own tax advisers regarding the tax consequences of the purchase, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ownership and disposition of securities in light of their particular circumstances, especially with regard to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Limitations on Benefits&#8221; provision. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Estate and Gift Taxes and Transfer Taxes <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 238pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In general, a transfer of securities by gift or by reason of death of a U.S. Holder that would otherwise be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to French gift or inheritance tax, respectively, will not be subject to such French tax by reason of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Convention between the Government of the United States of America and the Government of the French Republic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Estates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Inheritances and Gifts, dated November&#160;24, 1978 (as amended by any subsequent protocols, including the protocol <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of December 8, 2004), unless (i)&#160;the donor or the transferor is domiciled in France at the time of making the gift or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">at the time of his or her death, or (ii)&#160;the securities were used in, or held for use in, the conduct of a business through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a permanent establishment or a fixed base in France. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 331.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Transactions Tax <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 354.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to Article 235 ter ZD of the French Tax Code (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 321.55pt; position: var(--position); text-decoration: none; white-space: pre;">Code g&#233;n&#233;ral des imp&#244;ts<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.63pt; position: var(--position); text-decoration: none; white-space: pre;">) (the &#8220;FTC&#8221;), purchases of <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 365.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">certain securities issued by a French company, including ordinary shares (which may be in the form of ADSs), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which are listed on a regulated market of the EU or an exchange market formally acknowledged by the Minister of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Economy, after consultation opinion from the AMF (in each case within the meaning of the French Monetary and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 399.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Code (the &#8220;FMFC&#8221;)) are subject in France to a 0.3% tax <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.63pt; position: var(--position); white-space: pre;">(increased to 0.4% as from April 1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.474000000000001pt; font-style: normal; font-weight: normal; left: 477.11pt; position: var(--position); top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">st<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.41pt; position: var(--position); white-space: pre;">, 2025) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.24pt; position: var(--position); text-decoration: none; white-space: pre;">on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial transactions (the &#8220;TFT&#8221;), provided <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 250.65pt; position: var(--position); text-decoration: none; white-space: pre;">inter alia<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.55pt; position: var(--position); text-decoration: none; white-space: pre;"> that the issuer&#8217;s market capitalization exceeds &#8364;1&#160;billion as of <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 421.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;1 of the year preceding the taxation year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 444.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The Nasdaq Global Market, on which ADSs are listed, is not currently acknowledged by the French Minister <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of Economy, but it may change in the future. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 476.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Moreover, a list of French relevant companies whose market capitalization exceeds &#8364;1&#160;billion as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 486.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;1 of the year preceding the taxation year is published annually by the French State. The last version of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such list was dated December&#160;23, 2024 (BOI-ANNX-000467). It did not include Abivax SA as its market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">capitalization did not exceed &#8364;1.0&#160;billion. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Purchases of our ADSs may thus be subject to the TFT if (1)&#160;Abivax SA&#8217;s market capitalization exceeds <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1.0&#160;billion, and (2)&#160;the Nasdaq Global Market is acknowledged by the French Minister of Economy. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 566.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Registration Duties <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In the case where the TFT is not applicable, (1)&#160;transfers of shares issued by a French company which are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">listed on a regulated or organized market within the meaning of the FMFC are subject to uncapped registration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">duties at the rate of 0.1% if the transfer is evidenced by a written statement (&#8220;acte&#8221;) executed either in France or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">outside France, whereas (2)&#160;transfers of shares issued by a French company which are not listed on a regulated or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">organized market within the meaning of the FMFC are subject to uncapped registration duties at the rate of 0.1% <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">notwithstanding the existence of a written statement. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As ordinary shares of Abivax SA are listed on Euronext Paris, which is a regulated market within the meaning <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the FMFC, their transfer should be subject to uncapped registration duties at the rate of 0.1% only if such transfer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 674.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is evidenced by a written agreement. Although the official guidelines published by the French tax authorities are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 684.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">silent on this point (BOI-ENR-DMTOM-40-10-10-24/04/2024), ADSs should remain outside of the scope of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 694.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">aforementioned 0.1% registration duties. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">164<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Real Estate Wealth Tax <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since January&#160;1, 2018, the French wealth tax (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 281.87pt; position: var(--position); text-decoration: none; white-space: pre;">imp&#244;t de solidarit&#233; sur la fortune<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.26pt; position: var(--position); text-decoration: none; white-space: pre;">) has been repealed and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">replaced by the French real estate wealth tax (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 255.6pt; position: var(--position); text-decoration: none; white-space: pre;">imp&#244;t sur la fortune immobili&#232;re<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.04pt; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The scope of such new tax is narrowed to real estate assets (and certain assets deemed to be real estate assets) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or rights, held directly or indirectly through one or more legal entities and whose net taxable assets amount at least <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to &#8364;1,300,000. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Broadly, subject to provisions of double tax treaties and to certain exceptions, individuals who are not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">residents of France for tax purposes within the meaning of Article 4 B of the FTC, are subject to real estate wealth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tax (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90.03pt; position: var(--position); text-decoration: none; white-space: pre;">imp&#244;t sur la fortune immobili&#232;re<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.47pt; position: var(--position); text-decoration: none; white-space: pre;">) in France in respect of the portion of the value of their shares of our company <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">representing real estate assets (Article 965, 2&#176; of the FTC). Some exceptions are provided by the FTC. For instance, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any participations representing less than 10% of the share capital of an operating company and shares representing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">real estate for the professional use of the company considered shall not fall within the scope of the French real estate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 222pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">wealth tax (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 119.15pt; position: var(--position); text-decoration: none; white-space: pre;">imp&#244;t sur la fortune immobili&#232;re<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.59pt; position: var(--position); text-decoration: none; white-space: pre;">). Under the Treaty (the provisions of which should be applicable to this <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">new real estate wealth tax (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 180.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">imp&#244;t sur la fortune immobili&#232;re<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.41999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">) in France), the French real estate wealth tax (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 497.81pt; position: var(--position); text-decoration: none; white-space: pre;">imp&#244;t sur <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 242pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">la fortune immobili&#232;re<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.9pt; position: var(--position); text-decoration: none; white-space: pre;">) will however generally not apply to securities held by an eligible U.S. Holder who is a U.S. <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">resident, as defined pursuant to the provisions of the Treaty, provided that such (i) U.S. Holder (a)&#160;does not own <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">directly or indirectly more than 25% of the issuer&#8217;s financial rights and (b)&#160;that the ADSs do not form part of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 272pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">business property of a permanent establishment or fixed base in France and (ii) that the issuer&#8217;s assets do not consist <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in at least 50 percent of real property located in France, or that the issuer&#8217;s shares do not derive at least 50 percent of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their value, directly or indirectly, from real property located in France. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holders are advised to consult their own tax advisor regarding the specific tax consequences which may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">apply to their particular situation with respect to such French real estate wealth tax (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 407.64pt; position: var(--position); text-decoration: none; white-space: pre;">imp&#244;t sur la fortune <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 334pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">immobili&#232;re<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Taxation of Dividends <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 384pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Dividends paid by a French corporation<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.52pt; position: var(--position); white-space: pre;">, when their beneficial owners are not French tax <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.61pt; position: var(--position); text-decoration: none; white-space: pre;">residents, are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 395.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generally subject to French withholding tax at a rate of currently (i) 25% for dividends <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.23pt; position: var(--position); white-space: pre;">the beneficial owners of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">which are<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.11pt; position: var(--position); text-decoration: none; white-space: pre;"> legal persons which are not French tax residents, and (ii) 12.8% for dividends <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.37pt; position: var(--position); white-space: pre;">the beneficial owners of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 417.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">which are<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.11pt; position: var(--position); text-decoration: none; white-space: pre;"> individuals who are not French tax residents. Dividends paid by a French corporation in a non-cooperative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">State or territory, as defined in Article 238-0 A of the FTC, other than those states or territories mentioned in 2&#176; of 2 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bis of the same Article 238-0 A will generally be subject to French withholding tax at a rate of 75%. However, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 451.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">eligible U.S. Holders entitled to Treaty benefits under the &#8220;Limitation on Benefits&#8221; provision contained in the Treaty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">who are U.S. residents, as defined pursuant to the provisions of the Treaty, will not be subject to this 12.8%, 25% or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 473.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">75% withholding tax rate, but may be subject to the withholding tax at a reduced rate (as described below). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 496.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Under the Treaty, the rate of French withholding tax on dividends paid to an eligible U.S. Holder who is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. resident as defined pursuant to the provisions of the Treaty and the beneficial owner of these dividends, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">whose ownership of the ordinary shares (which may be in the form of ADSs) is not effectively connected with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">permanent establishment or fixed base that such U.S. Holder has in France, is generally reduced to 15%, or to 5% if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such U.S. Holder is a corporation and owns directly or indirectly at least 10% of the share capital of the issuer; such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holder may claim a refund from the French tax authorities of the amount withheld in excess of the Treaty rates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 556.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of 15% or 5%, if any. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For U.S. Holders that are not individuals but are U.S. residents, as defined pursuant to the provisions of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 588.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Treaty, the requirements for eligibility for Treaty benefits, including the reduced 5% or 15% withholding tax rates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contained in the &#8220;Limitation on Benefits&#8221; provision of the Treaty, are complicated, and certain technical changes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">were made to these requirements by the protocol of January&#160;13, 2009. U.S. Holders are advised to consult their own <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 618.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tax advisers regarding their eligibility for Treaty benefits in light of their own particular circumstances. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Dividends paid to an eligible U.S. Holder may immediately be subject to the reduced rates of 5% or 15% <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provided that: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">such holder establishes before the date of payment that it is a U.S. resident under the Treaty by <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">completing and providing the depositary with a treaty form (Form 5000) in accordance with French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">guidelines (BOI-INT-DG-20-20-20-20-12/09/2012); or <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">165<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">the depositary or other financial institution managing the securities account in the U.S. of such U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Holder provides the French paying agent with a document listing certain information about the U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Holder and its ordinary shares or ADSs and a certificate (BOI-LETTRE-000138-28/07/2014) whereby <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">the financial institution managing the U.S. Holder&#8217;s securities account in the United States takes full <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">responsibility for the accuracy of the information provided in the document. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Otherwise, dividends paid to a U.S. Holder, if such U.S. Holder is a legal person, will be subject to French <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">withholding tax at the rate of 25%, or 75% if paid in a non-cooperative State or territory (as defined in Article 238-0 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">A of the FTC, but other than those states or territories mentioned in 2&#176; of 2 bis of the same Article 238-0 A), and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">then reduced at a later date to 5% or 15%, provided that such holder duly completes and provides the French tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">authorities with the treaty forms Form 5000 and Form 5001 before December&#160;31 of the second calendar year <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">following the year during which the dividend is paid. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Certain qualifying pension funds and certain other tax-exempt entities are subject to the same general filing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">requirements as other U.S. Holders except that they may have to supply additional documentation evidencing their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entitlement to these benefits. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 248pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Since the withholding tax rate applicable under French domestic law to U.S. Holders who are individuals does <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not exceed the cap provided in the Treaty (i.e., 15%), the 12.8% rate shall apply, without any reduction provided <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">under the Treaty. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Besides, please note that pursuant to Article 235 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 292.1pt; position: var(--position); text-decoration: none; white-space: pre;">quater<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of the FTC (introduced by the French finance bill <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">No.&#160;2019-1479 for 2020) and under certain conditions, a corporate U.S. Holder which is in a tax loss position for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fiscal year during which the dividend is received may be entitled to a deferral regime, and obtain a withholding tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">refund. The tax deferral ends in respect of the first financial year during which this U.S. Holder is in a profit making <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">position, as well as in the cases set out in Article 235 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 285.91999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">quater<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.01pt; position: var(--position); text-decoration: none; white-space: pre;"> of the FTC. Finance Bill for 2022 extended the deadline <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to claim the refund (December 31 of the second year following the year of payment instead of three months after the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">end of the fiscal year following the payment of the income) and clarify the order in which the deferred taxes become <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">due (the forfeiture of the deferral applies in priority to the oldest withholding taxes). Also, pursuant to newly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">introduced Article 235 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 164.95pt; position: var(--position); text-decoration: none; white-space: pre;">quinquies<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.81pt; position: var(--position); text-decoration: none; white-space: pre;"> of the FTC and under certain conditions, a corporate U.S. Holder may be entitled <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to a refund of a fraction of the withholding tax, up to the difference between the withholding tax paid (on a gross <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">basis) and the withholding tax based on the dividend net of the expenses incurred for the acquisition and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conservation directly related to the income, provided (i)&#160;that these expenses would have been tax deductible had the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holder been established in France, and (ii)&#160;that the tax rules in the United States do not allow the U.S. Holder <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to offset the withholding tax. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Tax on Sale or Other Disposition <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In general, under the Treaty, a U.S. Holder who is a U.S. resident for purposes of the Treaty will not be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to French tax on any capital gain from the redemption (other than redemption proceeds characterized as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dividends under French domestic tax law or administrative guidelines), sale or exchange of ADSs unless the ADSs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">form part of the business property of a permanent establishment or fixed base that the U.S. Holder has in France. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Special rules apply to U.S. Holders who are residents of more than one country. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Material U.S. Federal Income Tax Considerations for U.S. Holders <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following is a description of the material U.S. federal income tax consequences to the U.S. Holders <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">described below of acquiring, owning and disposing of the ADSs. It is not a comprehensive description of all tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">considerations that may be relevant to a particular person&#8217;s decision to acquire securities. This discussion applies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">only to a U.S. Holder that holds ADSs as &#8220;capital assets&#8221; (generally, property held for investment) under the U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). In addition, it does not describe all of the tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">considerations that may be relevant in light of a U.S. Holder&#8217;s particular circumstances, including U.S. federal estate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and gift taxes, the Medicare contribution tax on net investment income, the alternative minimum tax provisions of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the Code, the special tax accounting rules under Section&#160;451(b) of the Code, any state, local, or non-U.S. tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">considerations, and tax considerations applicable to U.S. Holders subject to special rules, including, without <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">limitation:<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 113.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">certain financial institutions; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">traders in securities who use a mark-to-market method of tax accounting; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">dealers in securities or currencies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 1pt; position: var(--position); top: 712.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">166<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons holding ADSs as part of a hedging transaction, &#8220;straddle,&#8221; wash sale, conversion transaction or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">integrated transaction or persons entering into a constructive sale with respect to the ADSs; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">regulated investment companies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">insurance companies; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">real estate investment trusts, grantor trusts or other trusts; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons whose &#8220;functional currency&#8221; for U.S. federal income tax purposes is not the U.S. dollar; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">expatriates of the United States; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">tax exempt entities, including &#8220;individual retirement accounts&#8221; and &#8220;Roth IRAs&#8221;; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">entities or arrangements classified as partnerships or other pass-through entities for U.S. federal <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">income tax purposes (and investors therein); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons that received ADSs as compensation for the performance of services; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons that own or are deemed to own ten percent or more of our shares (by vote or value); and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">persons holding ADSs in connection with a trade or business, permanent establishment, or fixed base <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">outside the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 284pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If an entity or arrangement that is classified as a partnership for U.S. federal income tax purposes holds the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 294pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs, the U.S. federal income tax treatment of a partner in that partnership will generally depend on the status of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 304pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the partner and the activities of the partnership. Partnerships holding the ADSs and partners in such partnerships are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 314pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">encouraged to consult their own tax advisers as to the particular U.S. federal income tax consequences of acquiring, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 324pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">owning, and disposing of the ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 346pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">This description is based on the Code, existing, proposed and temporary U.S. Treasury Regulations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">promulgated thereunder and administrative and judicial interpretations thereof, in each case as in effect and available <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on the date hereof. All of the foregoing is subject to change, which change could apply retroactively, and to differing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 376pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interpretations, all of which could affect the tax considerations described below. No rulings have been sought from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 386pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), regarding the matters discussed herein and there can be no assurance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 396pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that the IRS will not take a contrary position concerning the tax consequences of the acquisition, ownership and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 406pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disposition of the ADSs or that such a position would not be sustained. U.S. Holders should consult their own tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 416pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of acquiring, owning, and disposing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 426pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the ADSs in their particular circumstances. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As used for purposes of this section &#8220;&#8212;Material U.S. Federal Income Tax Considerations for U.S. Holders&#8221;, a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 458pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;U.S. Holder&#8221; is a holder who, for U.S. federal income tax purposes, is a beneficial owner of the ADSs that is an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 468pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">initial purchaser of the ADSs sold in our initial public offering of our ADSs in the United States and is: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">an individual who is a citizen or resident of the United States; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">United States, any state therein or the District of Columbia; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">an estate whose income is eligible for inclusion in gross income for U.S. federal income tax purposes, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 536pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">regardless of its source; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 127.05000000000001pt; position: var(--position);">a trust, if (A)&#160;a U.S. court is able to exercise primary supervision over the trust&#8217;s administration and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">one or more United States persons (as such term is defined under the Code) have authority to control <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">all substantial decisions of the trust, or (B)&#160;the trust has a valid election in place under applicable U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Treasury regulations to treat the trust as a United States person (as such term is defined under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.05pt; position: var(--position); text-decoration: none; white-space: pre;">Code). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The discussion below assumes that the representations contained in the depositary agreement are true and that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the obligations in the deposit agreement and any related agreement will be complied with in accordance with its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">terms. For U.S. federal income tax purposes, it is generally expected that a U.S. Holder of ADSs will be treated as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the beneficial owner of the underlying ordinary shares represented by the ADSs. The remainder of this discussion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assumes that a U.S. Holder of our ADSs will be treated in this manner. Accordingly, deposits or withdrawals of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 664pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs for ordinary shares will generally not be subject to U.S. federal income tax. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 686pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holders are encouraged to consult their own tax advisers concerning the U.S. federal, state, local <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 696pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and foreign tax consequences of acquiring, owning and disposing of the ADSs in their particular <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 706pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">circumstances. <span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">167<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Taxation of Distributions <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to the passive foreign investment company (&#8220;PFIC&#8221;) rules described below, distributions paid on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs, other than certain pro rata distributions of the ADSs, will generally be treated as dividends to the extent paid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). We <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">do not maintain calculations of our earnings and profits under U.S. federal income tax principles, and so we expect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that distributions generally will be reported to U.S. Holders as dividends. Subject to applicable limitations, dividends <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 138pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">paid by a &#8220;qualified foreign corporation&#8221; are eligible for taxation at a preferential capital gains rate rather than the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 148pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">marginal tax rates generally applicable to ordinary income provided that certain requirements are met. However, if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we are a PFIC (or treated as a PFIC with respect to the U.S. Holder) for the taxable year in which the dividend is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">paid or the preceding taxable year (see discussion below under &#8220;Passive Foreign Investment Company Rules&#8221;), we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 178pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will not be treated as a qualified foreign corporation, and therefore the preferential capital gains tax rate described <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">above will not apply. Each U.S. Holder is advised to consult its tax advisors regarding the availability of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">preferential tax rate on dividends with regard to its particular circumstances. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A non-U.S. corporation (other than a corporation classified as a PFIC for the taxable year in which the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dividend is paid or the preceding taxable year) generally will be considered to be a qualified foreign corporation if: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(i)&#160;it is eligible for the benefits of a comprehensive tax treaty with the United States, which the Secretary of Treasury <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the United States determines is satisfactory for purposes of this provision, and which includes an exchange of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information provision; or (ii)&#160;with respect to any dividend it pays on shares that are readily tradable on an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">established securities market in the United States. We believe that we qualify as a resident of France for the purposes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of, and are eligible for the benefits of, the income tax treaty between France and the United States, which the IRS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">has determined is satisfactory for purposes of the qualified dividend rules, and that it includes an exchange of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information provision, although there can be no assurance in this regard. Further, our ADSs will generally be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">considered to be readily tradable on an established securities marked in the United States, including the Nasdaq <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Global Market. Therefore, subject to the discussion below under &#8220;Passive Foreign Investment Company Rules&#8221;, if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the income tax treaty between France and the United States is applicable, or if the ADSs are readily tradable on an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">established securities market in the United States, dividends paid on the ADSs will generally be &#8220;qualified dividend <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">income&#8221; in the hands of individual U.S. Holders, provided that certain conditions are met, including conditions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">relating to the holding period and the absence of certain risk reduction transactions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A U.S. Holder must include the gross amount of a dividend without reduction for amounts withheld by us in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respect of French income taxes (see &#8220;Material United States Federal Income and French Tax Considerations&#8212;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Certain French Considerations&#8221;), even though the U.S. Holder did not in fact receive the amount associated with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 412pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">withheld French tax.<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 154.41pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.91pt; position: var(--position); text-decoration: none; white-space: pre;">The amount of the dividend will be treated as foreign-source dividend income to U.S. Holders <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 422pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and will not be eligible for the dividends-received deduction generally available to U.S. corporations under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Code. Dividends generally will be included in a U.S. Holder&#8217;s income on the date of the U.S. Holder&#8217;s receipt (or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deemed receipt) of the dividend. The amount of any distribution of property other than cash (excluding certain pro <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rata distributions of ordinary shares or ADSs or rights to acquire ordinary shares or ADSs) will be the fair market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">value of such property on the date of the distribution. The amount of any dividend income paid in euros will be the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regardless of whether the payment is in fact converted into U.S. dollars. If the dividend is converted into U.S. dollars <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">on the date of receipt, a U.S. Holder should not be required to recognize foreign currency gain or loss in respect of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the dividend income. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dollars after the date of receipt. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 534pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to applicable limitations, some of which vary depending upon the U.S. Holder&#8217;s particular <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 544pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">circumstances, French income taxes withheld from dividends on the ADSs at a rate not exceeding the rate provided <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 554pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">by the income tax treaty between France and the United States generally will be creditable against the U.S. Holder&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 564pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. federal income tax liability. Dividend distributions with respect to the ADSs generally will be treated as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8216;&#8216;passive category&#8217;&#8217; income from sources outside the United States for purposes of determining a U.S. Holder&#8217;s U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">foreign tax credit limitation. The rules governing foreign tax credits are complex and U.S. Holders should consult <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their tax advisers regarding the creditability of foreign taxes in their particular circumstances. In lieu of claiming a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">foreign tax credit, U.S. Holders may, at their election, deduct foreign taxes, including any French income tax, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">computing their taxable income, subject to generally applicable limitations under U.S. law. An election to deduct <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">foreign taxes instead of claiming foreign tax credits applies to all foreign taxes paid or accrued in the taxable year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Sale or Other Taxable Disposition of the ADSs <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A U.S. Holder generally will recognize gain or loss for U.S. federal income tax purposes upon the sale, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exchange or other taxable disposition of the ADSs in an amount equal to the difference between the U.S. dollar <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 688pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">value of the amount realized from such sale or exchange and the U.S. Holder&#8217;s tax basis for those ADSs. Subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the PFIC rules described below, this gain or loss generally will be a capital gain or loss. The adjusted tax basis in an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 708pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADS generally will be equal to the cost of such ADS. Capital gain from the sale, exchange or other taxable <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">168<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disposition of ADSs of a non-corporate U.S. Holder is generally eligible for a preferential rate of taxation applicable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to capital gains, if the non-corporate U.S. Holder&#8217;s holding period determined at the time of such sale, exchange or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">other taxable disposition for such ADSs exceeds one year (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 308.15pt; position: var(--position); text-decoration: none; white-space: pre;">i.e.,<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.85pt; position: var(--position); text-decoration: none; white-space: pre;"> such gain is long-term taxable gain). The <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deductibility of capital losses for U.S. federal income tax purposes is subject to limitations under the Code. Any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such gain or loss that a U.S. Holder recognizes generally will be treated as U.S. source income or loss for foreign tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">credit limitation purposes. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For a cash basis taxpayer, units of foreign currency paid or received are translated into U.S. dollars at the spot <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rate on the settlement date of the purchase or sale. In that case, no foreign currency exchange gain or loss will result <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from currency fluctuations between the trade date and the settlement date of such a purchase or sale. An accrual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">basis taxpayer, however, may elect the same treatment required of cash basis taxpayers with respect to purchases <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 184pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and sales of the ADSs that are traded on an established securities market, provided the election is applied <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consistently from year to year. Such election may not be changed without the consent of the IRS. For an accrual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">basis taxpayer who does not make such an election, units of foreign currency paid or received are translated into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. dollars at the spot rate on the trade date of the purchase or sale. Such an accrual basis taxpayer may recognize <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exchange gain or loss based on currency fluctuations between the trade date and the settlement date. Any foreign <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">currency gain or loss a U.S. Holder realizes will be U.S. source ordinary income or loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 262pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Passive Foreign Investment Company Rules <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Under the Code, we will be a PFIC for any taxable year in which, after the application of certain &#8220;look-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">through&#8221; rules with respect to subsidiaries, either (i) 75% or more of our gross income consists of &#8220;passive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">income,&#8221; (&#8220;income test&#8221;) or (ii) 50% or more of the average quarterly value of our assets (generally determined on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the basis of a weighted quarterly average) consist of assets that produce, or are held for the production of, &#8220;passive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">income.&#8221; Passive income generally includes dividends, interest, and gains from the sale or exchange of investment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">property and rents or royalties other than rents or royalties which are received from unrelated parties in connection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with the active conduct of a trade or business. Passive assets include, among others, cash and assets readily <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible into cash, while our goodwill and other unbooked intangibles associated with active business activities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may generally be treated as non-passive assets. In addition, for purposes of the above calculations, a non-U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporation that owns, directly or indirectly, at least 25% by value of the equity interests of another corporation is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treated as if it held its proportionate share of the assets of the other corporation, and received directly its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">proportionate share of the income of the other corporation. If a corporation is treated as a PFIC with respect to a U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Holder for any taxable year, the corporation will continue to be treated as a PFIC with respect to that U.S. Holder in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">all succeeding taxable years, regardless of whether the corporation continues to meet the PFIC requirements in such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">years, unless certain elections are made. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Based on our analysis of our financial statements, activities and relevant market and shareholder data, we do <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not believe that we were a PFIC for the taxable year ended December 31, 2024. The determination of whether we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are a PFIC is a fact-intensive determination made on an annual basis and the applicable law is subject to varying <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">interpretation. Whether we are a PFIC for any taxable year will depend on the composition of our income and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composition, nature and value of our assets from time to time (including the value or our goodwill, which may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">determined by reference to the value of our ADSs, which could fluctuate considerably). We currently do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">generate product revenues and therefore we may be a PFIC for any taxable year in which we do not generate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sufficient amounts of non-passive income to offset our passive income. As a result, there can be no assurance that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we will not be treated as a PFIC for the current or any future taxable year and our U.S. counsel expresses no opinion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with respect to our PFIC status for any prior, current or future taxable year. Even if we determine that we are not a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 540pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">PFIC for a taxable year, there can be no assurance that the IRS, will agree with our conclusion and that the IRS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 550pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would not successfully challenge our position. If we are a PFIC for any year during which a U.S. Holder holds the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs, unless certain elections have been made by the U.S. Holder, we generally will continue to be treated as a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">PFIC with respect to such U.S. Holder for all succeeding years during which the U.S. Holder holds the ADSs, even <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">if we cease to meet the threshold requirements for PFIC status. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If we are a PFIC for any taxable year during which a U.S. Holder holds the ADSs, the U.S. Holder may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 612pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to adverse tax consequences, regardless of whether we remain a PFIC. Generally, gain recognized upon a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 622pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disposition (including, under certain circumstances, a pledge) of the ADSs by the U.S. Holder would be allocated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 632pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ratably over the U.S. Holder&#8217;s holding period for such ADSs. The amounts allocated to the taxable year of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 642pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disposition and to years before we became a PFIC (&#8220;pre-PFIC Years&#8221;) would be taxed as ordinary income. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 652pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amount allocated to each other taxable years would be subject to tax at the highest rate in effect for that taxable year <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 662pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for individuals or corporations, as appropriate, and would be subject to an interest charge on the resulting tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">deemed deferred with respect to each such other taxable year. Further, to the extent that any distribution received by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a U.S. Holder on its ADSs exceeds 125% of the average of the annual distributions on such ADSs received by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holder during the (i)&#160;preceding three years or (ii)&#160;the U.S. Holder&#8217;s holding period, whichever is shorter, that <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">169<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distribution would be subject to taxation in the same manner described immediately above with respect to gain on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">disposition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Alternatively, if we are a PFIC and if the ADSs are &#8220;regularly traded&#8221; on a &#8220;qualified exchange,&#8221; a U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Holder could make a mark-to-market election that would result in tax treatment different from the general tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">treatment described in the preceding paragraph. The ADSs would be treated as &#8220;regularly traded&#8221; in any calendar <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">year in which more than a <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 178.54000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">de minimis <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.61pt; position: var(--position); text-decoration: none; white-space: pre;">quantity of the ADSs are traded on a qualified exchange, including the Nasdaq <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Global Market, on at least 15 days during each calendar quarter. The ADSs are listed on the Nasdaq Global Market, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and we expect, although no assurance can be given, that they will be regularly traded on the Nasdaq Global Market. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holders should consult with their own tax advisors regarding potential availability of the mark-to-market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">election. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If a U.S. Holder makes the mark-to-market election, the U.S. Holder generally will recognize as ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">income any excess of the fair market value of the ADSs at the end of each taxable year over their adjusted tax basis, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the ADSs over their fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market value at the end of the taxable year (but only to the extent of the net amount of income previously included <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as a result of the mark-to-market election). If a U.S. Holder makes the election, the U.S. Holder&#8217;s tax basis in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs will be adjusted to reflect these income or loss amounts. Any gain recognized on the sale or other disposition <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of ADSs in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">election). If a U.S. Holder makes a mark-to-market election in respect of a corporation classified as a PFIC and such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporation ceases to be classified as a PFIC, the holder will not be required to take into account the gain or loss <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 296pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">described above during any period that such corporation is not classified as a PFIC. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A timely election to treat a PFIC as a qualified electing fund under Section&#160;1295 of the Code (&#8220;QEF Election&#8221;) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">would result in alternative treatment. If a U.S. Holder makes a QEF Election for the first tax year of such U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Holder&#8217;s holding period in which we are classified as a PFIC, then such U.S. Holder generally would not be subject <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to the PFIC rules&#160;described above.&#160;Instead, a U.S. Holder that makes a timely and effective QEF Election will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 358pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">currently include in gross income such U.S. Holder&#8217;s (a) pro rata share of our ordinary earnings as ordinary income <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 368pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and (b)&#160;pro rata share of our net capital gain as long-term capital gain, regardless of whether we have made any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 378pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">distributions of such earnings or gain. The U.S. Holder&#8217;s basis in its ADSs would be increased to reflect the amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 388pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of such income inclusions.&#160;Generally, for this purpose, &#8220;ordinary earnings&#8221; are the excess of our (a) &#8220;earnings and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 398pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">profits&#8221; over (b)&#160;net capital gain, and &#8220;net capital gain&#8221; is the excess of our (a)&#160;net long-term capital gain over (b)&#160;net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">short-term capital loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A U.S. Holder that has made such a timely and effective QEF Election generally may receive a distribution <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tax-free as a return of capital to the extent that such distribution represents &#8220;earnings and profits&#8221; that were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">previously included in income by the U.S. Holder because of such QEF Election and such distribution&#160;will reduce <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such U.S. holder&#8217;s adjusted tax basis in our ADSs to reflect the amount allowed as a tax free distribution because of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such QEF Election.&#160;A U.S. Holder that makes a QEF Election would generally recognize capital gain or loss on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">sale, exchange or other taxable disposition of its ADSs<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 290.94pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.44pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">However, a U.S. Holder will only be able to make a QEF Election if we provide such U.S. Holder with certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tax information annually, and we may determine not to provide such information. Furthermore, if the IRS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">determines that we were a PFIC for a year with respect to which we had determined that we were not (or believed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">we were not) a PFIC, it might be too late for a U.S. Holder to make a timely QEF Election, unless the U.S. Holder <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">qualifies under the applicable Treasury Regulations to make a retroactive (late) election. U.S. Holders should consult <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their own tax advisors regarding the making of any such QEF Election. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 574pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, if we are a PFIC or, with respect to particular U.S. Holders, are treated as a PFIC for the taxable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 584pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">year in which we paid a dividend or for the prior taxable year, the preferential rates discussed above with respect to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dividends paid to certain non-corporate U.S. Holders would not apply. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 616pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">If a U.S. Holder owns ADSs during any year in which we are a PFIC, the holder generally must file an IRS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Form 8621, or such other form as is required by the U.S. Treasury Department, generally with the holder&#8217;s federal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">income tax return for that year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Holders should consult their tax advisers regarding whether we are or may become a PFIC and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 668pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">potential application of the PFIC rules.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">170<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Information Reporting and Backup Withholding <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Payments of distributions and sales proceeds that are made within the United States or through certain U.S.-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related financial intermediaries generally are subject to information reporting, and may be subject to backup <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">withholding, unless (i)&#160;the U.S. Holder is a corporation or other exempt recipient or (ii)&#160;in the case of backup <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 118pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 128pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">backup withholding. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Backup withholding is not an additional tax. The amount of any backup withholding from a payment to a U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Holder will be allowed as a credit against the holder&#8217;s U.S. federal income tax liability and may entitle it to a refund, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provided that the required information is timely furnished to the IRS. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 193.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 194.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Information With Respect to Foreign Financial Assets <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Certain U.S. Holders who are individuals may be required to report information relating to their ownership of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 220.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an interest in certain foreign financial assets, including stock of a non-U.S. person, generally on Form 8938, subject <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to exceptions (including an exception for stock held through a U.S. financial institution). In addition, certain U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Holders may be required to file a FinCEN Form 114 (Report of Foreign Bank and Financial Accounts) with the U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Treasury Department each year to report their interest in the ADSs. U.S. Holders should consult their tax advisers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">regarding their reporting obligations with respect to the ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 282.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The above description is not intended to constitute a complete analysis of all tax consequences relating <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 292.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to acquisition, ownership and disposition of the ADSs. You should consult your tax advisor concerning the tax <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">consequences of your particular situation. <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="position: absolute; top: 324.5pt;" id="ia894b143b6fc4522a0483350194c625e_148"></div><div style="line-height: 10pt; position: var(--position); top: 324.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">F.<span style="display: inline-block; height: 6.77pt;"></span><span id="ic12478365dd24e298effb426c7bda9b1"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Dividends and Paying Agent<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 348.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 370.5pt;" id="ia894b143b6fc4522a0483350194c625e_151"></div><div style="line-height: 10pt; position: var(--position); top: 370.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">G.<span style="display: inline-block; height: 6.77pt;"></span><span id="i03044fef26454146b0fd3e4d7c894516"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Statement by Experts<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 394.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 416.5pt;" id="ia894b143b6fc4522a0483350194c625e_154"></div><div style="line-height: 10pt; position: var(--position); top: 416.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">H.<span style="display: inline-block; height: 6.77pt;"></span><span id="iab80dee06a964d5f8a035b3fd2364b60"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Documents on Display<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are subject to the information reporting requirements of the Exchange Act applicable to foreign private <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 450.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">issuers and under those requirements we file reports with the SEC. Those reports may be inspected without charge at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 460.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the locations described below. As a foreign private issuer, we are exempt from the rules under the Exchange Act <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 470.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 480.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 490.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 500.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 510.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Nevertheless, we file with the SEC an Annual Report on Form 20-F containing financial statements that have been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 520.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">examined and reported on, with and opinion expressed by an independent registered public accounting firm.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We maintain a corporate website at www.abivax.com. We intend to post our annual report on our website <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">promptly following it being filed with the SEC. Information contained on, or that can be accessed through, our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">website does not constitute a part of this Annual Report. We have included our website address in this Annual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Report solely as an inactive textual reference.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 594.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The Securities and Exchange Commission maintains a website (www.sec.gov) that contains reports, proxy and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information statements and other information regarding registrants, such as us, that file electronically with the SEC.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 626.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">With respect to references made in this Annual Report to any contract or other document of our company, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">such references are not necessarily complete and you should refer to the exhibits attached or incorporated by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 646.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reference to this Annual Report for copies of the actual contract or document.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 668.5pt;" id="ia894b143b6fc4522a0483350194c625e_157"></div><div style="line-height: 10pt; position: var(--position); top: 668.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">I.<span style="display: inline-block; height: 6.77pt;"></span><span id="ibdeb2a5d51714ea696bd50581b82565f"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidiary Information<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 692.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">required<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.28pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">171<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_160"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">J.<span style="display: inline-block; height: 6.77pt;"></span><span id="iaaba0693a5414e73b4adaef144aed25f"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Annual Report to Security Holders<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 95.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">To the extent we furnish an annual report to security holders, we will furnish any such report under the cover </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 106.4pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">of Form 6-K</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.53999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">172<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_163"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 11.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Quantitative and Qualitative Disclosures About Market Risk<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ie54cb3b294e144bcb495313e21e35170"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A description of quantitative and qualitative disclosures about market risk is disclosed in Note 27 to our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financial statements as of and for the year ended December 31, 2024 appearing elsewhere in this Annual Report on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Form 20-F. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The principal financial instruments we hold are cash and cash equivalents. The purpose of holding these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">instruments is to finance our ongoing business activities. It is not our policy to invest in financial instruments for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">speculative purposes. We do not use derivative financial instruments for hedging purposes. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 186pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The principal risks to which we are exposed are liquidity risk, interest rate risk, foreign currency exchange risk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 196pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and credit risk. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Liquidity Risk <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Liquidity risk management aims to ensure that we dispose of sufficient liquidity and financial resources to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">able to meet our present and future obligations. We prepare short-term cash forecasts and annual operating cash flow <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">forecasts as part of our budget procedures. Prudent liquidity risk management involves maintaining sufficient <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 270pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">liquidity, having access to financial resources through appropriate credit facilities and being able to unwind market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">positions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our operations have required substantial amounts of cash since inception. Developing pharmaceutical drug <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">candidates, including conducting clinical trials, is expensive, lengthy, and risky, and we expect our research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">development expenses to increase substantially in connection with our ongoing activities. Accordingly, we will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">continue to require substantial add<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">itional capital to continue our clinical development activities and potentially </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">engage in commercialization activities. See "Item 5.B&#8212;Liquidity and Capital Resources.&#8221; </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In order to meet any additional financing needs, we may seek to obtain one or more dilutive or non-dilutive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 374pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">financings depending on market conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 402pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Interest Rate Risk <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are exposed to market risks in connection with our medium- and long-term borrowings that are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 428pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">variable interest rates. We have not adopted any other recurring mechanism of hedging to protect against interest <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 438pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rate fluctuations. We may consider in the future using a suitable policy to hedge interest rate risks in a more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 448pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">significant manner, if needed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">Over the year ended December 31, 2024, we have drawn down the second and third tranches of the Kreos / <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 483.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Claret Financing Agreement, bearing variable interest rates (consisting of a fixed margin of 7.5% + European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 494.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Central Bank Base Rate (MRO), with a floor at 2.5% and a cap at 4%) and have therefore performed a reassessment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">of our exposure to interest rate risk. Due to the interest rate collar having a range of 150 bps, we concluded that we <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">have limited exposure.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 546.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign Currency Exchange Risk <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We are exposed to a risk of exchange rate fluctuations on commercial transactions performed in currencies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">different from our functional currency in which we record the transactions. We have not adopted any other recurring <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">mechanism of hedging to protect against currency fluctuations. From time to time, we may nevertheless subscribe <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 592.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for currency term accounts in order to cover a commitment in currency. We may consider in the future using a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">suitable policy to hedge exchange risks in a more significant manner, if needed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 621.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">173<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables set forth the operating expenses we incurred in foreign currencies in the years ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022, 2023 and 2024. Some figures have been rounded. Accordingly, the totals in the tables may not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be the exact sums of component items.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 102pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 126pt; width: 612pt;"><div style="font-size: 0pt; left: 77.38pt; position: var(--position); top: 0pt; width: 464.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 176.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 0pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.52pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 0pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.52pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.52pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Year ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Currency (thousands)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 21.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.68pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.68pt; position: var(--position); text-decoration: none; white-space: pre;">currency<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 21.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.78pt; position: var(--position); text-decoration: none; white-space: pre;">Euros<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 21.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.68pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.68pt; position: var(--position); text-decoration: none; white-space: pre;">currency<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 21.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.78pt; position: var(--position); text-decoration: none; white-space: pre;">Euros<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 21.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.68pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.68pt; position: var(--position); text-decoration: none; white-space: pre;">currency<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 21.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.78pt; position: var(--position); text-decoration: none; white-space: pre;">Euros<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Australian dollar<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 56.580000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 57.160000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 57.45pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.53pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 45.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">19<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 45.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">13<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 45.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 45.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 45.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 45.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Canadian dollar<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 53.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 53.6pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.620000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">............................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.93pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.93pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.93pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">32<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">22<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Chinese yuan renminbi<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 76.81pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 77.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 77.53999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.55pt; position: var(--position); text-decoration: none; white-space: pre;">................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 68.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 68.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 68.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">61<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 68.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 68.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 68.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Czech crown <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 46.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 47.17pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 47.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 47.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 47.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.53pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 79.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.93pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 79.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.93pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 79.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.93pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 79.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 79.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">54<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 79.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">2<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Danish kroner<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 48.150000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 49.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.480000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.49pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">120<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">16<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">4<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">1<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Hungarian forints<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 59.25pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 59.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 59.580000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 59.59pt; position: var(--position); text-decoration: none; white-space: pre;">.........................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 102pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 102pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 102pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">3,517<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 102pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">9<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 102pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">408<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 102pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">1<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 113.25pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Israeli shekel<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 45.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 45.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 45.470000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 45.550000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 45.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.580000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 113.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">21<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 113.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 113.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 113.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 113.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">26<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 113.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 124.5pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Japanese yen<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 44.6pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 45.18pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 45.470000000000006pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 45.510000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.53pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 124.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">1,128<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 124.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 124.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 124.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 124.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">596<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 124.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.96pt;"></span></span><span style="left: 40.59pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135.75pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Pound sterling<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.050000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 49.34pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 49.49pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.580000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">..............................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 135.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">600<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 135.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">708<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 135.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">359<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 135.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">410<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 135.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">1,016<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 135.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">1,214<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Swedish krona<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 49.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 51.09pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 51.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 51.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.470000000000006pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 147pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">115<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 147pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">11<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 147pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">350<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 147pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">30<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 147pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">183<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 147pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">16<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 158.25pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Swiss franc<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 39.7pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 40.86pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.440000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 158.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">27<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 158.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">28<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 158.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">49<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 158.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.96pt;"></span></span><span style="left: 36.59pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 158.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">234<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 158.25pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">243<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 169.5pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">United States dollar<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 66.13pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 67.28999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 67.44pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 67.47999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 67.49pt; position: var(--position); text-decoration: none; white-space: pre;">.....................................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 169.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">1,426<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 169.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">1,390<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 169.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">10,861<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 169.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">10,112<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 169.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">12,031<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 169.5pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.49pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">10,547<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183.75pt; width: 176.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.62pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 183.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.62pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">3,336<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 183.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.62pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">2,164<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 272.25pt; position: var(--position); top: 183.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.62pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">15,317<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 183.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.62pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">10,636<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 183.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.62pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">14,591<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 416.25pt; position: var(--position); top: 183.75pt; width: 48pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.62pt; width: 48pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 19.96pt;"></span></span><span style="left: 22.59pt; position: var(--position);">12,060<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 356pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For the </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">year ended December 31, 2024</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, the total amount of operating expenses we incurred in foreign </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">currencies was </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.57999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;12.1</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;million, or </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.26pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">6.5%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of our total </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.49pt; position: var(--position); text-decoration: none; white-space: pre;">operating<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.22pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> expenses of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.12pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;185.4</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;million in that year. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For the </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">year ended December 31, 2023</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, the total amount of operating expenses we incurred in foreign </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">currencies was&#160; </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;10.6</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.57999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;million, or&#160; </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.26pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">1.6%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of our total </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.49pt; position: var(--position); text-decoration: none; white-space: pre;">operating<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.22pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> expenses of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.12pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;132.0</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;million in that year. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For the </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">year ended December 31, 2022</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, the total amount of operating expenses we incurred in foreign </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">currencies was </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.57999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;2.2</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;million, or </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.26pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">3.1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of our total </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.49pt; position: var(--position); text-decoration: none; white-space: pre;">operating<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.22pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> expenses of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.12pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;69.4</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;million in that year. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">For the years ended December 31, 2024, December 31, 2023 and December 31, 2022, expenses in U.S. dollars <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">totaled <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.17pt; position: var(--position); text-decoration: none; white-space: pre;"> million, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> million and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 233.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1.4<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.3pt; position: var(--position); text-decoration: none; white-space: pre;"> million respective<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.63pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ly, based on the average annual exchange rate in </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">effect as of December 31, 2024, December 31, 2023 and December 31, 2022. A</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.14pt; position: var(--position); text-decoration: none; white-space: pre;">s a result, an adverse 10% change in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 464pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the exchange rate for the U.S. dollar against the euro would have resulted in a foreign exchange rate loss of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 474pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">approxi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.53pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">mately &#8364;0,3 million for 2024, &#8364;0.4 million fo</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.39pt; position: var(--position); text-decoration: none; white-space: pre;">r 2023 and non material for 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Credit Risk <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 518pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to our cash and cash equivalents is not significant in light of the quality of our co-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">contracting financial institutions. As of December&#160;31, 2024, substantially all our cash and cash equivalents were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maintained with two financial institutions in France and in the United States. While our deposit accounts are insured <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">up to the legal limit, substantially all of our bank deposit balances exceed this insured limit. As of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024 we maintained <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">143.9<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;million in bank deposit accounts that are in excess of the legally insured limits in two <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 568pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">legally insured financial institutions. We have not experienced any losses in such accounts and we do not believe <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 578pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that we are exposed to any significant credit risk related to these instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 1pt; position: var(--position); top: 597pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 598pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to our other receivables and related account is minimal. In particular, the credit risk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 608pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related to advances made to CROs is deemed insignificant due to their credit ratings. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">174<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_166"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 12.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Description of Securities Other than Equity Securities<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i9beab7f30c164277953b192e0ae7b6dd"></span></span></div><div style="position: absolute; top: 96pt;" id="ia894b143b6fc4522a0483350194c625e_169"></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">A.<span style="display: inline-block; height: 6.77pt;"></span><span id="i3b122eb4deee4191b29988d3c54aa4e5"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Debt Securities<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 142pt;" id="ia894b143b6fc4522a0483350194c625e_172"></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">B.<span style="display: inline-block; height: 6.77pt;"></span><span id="i014041a0f0be4167a0adce8fd29fb393"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Warrants and Rights<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 188pt;" id="ia894b143b6fc4522a0483350194c625e_175"></div><div style="line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">C.<span style="display: inline-block; height: 6.77pt;"></span><span id="i0ac1a1363cf842b2b7e08c9084d5473f"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Other Securities<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 212pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.99pt; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 234pt;" id="ia894b143b6fc4522a0483350194c625e_178"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">D.<span style="display: inline-block; height: 6.77pt;"></span><span id="id3ee13a1c2fc4670890c602e3ceab6d2"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">American Depositary Shares<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 258pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Citibank, as depositary, registers and delivers our ADSs. Each ADS represents one ordinary share deposited <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 268pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with Citibank Europe plc, located at 1 North Wall Quay, Dublin 1 Ireland, or any successor, as custodian for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">depositary. Each ADS will also represent any other securities, cash or other property that may be held by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">depositary. The depositary&#8217;s corporate trust offices at which the ADSs will be administered are located at 388 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Greenwich Street, New York, New York 10013.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">A deposit agreement among us, the depositary and the ADS holders sets out the ADS holder rights as well as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.1pt; position: var(--position); text-decoration: none; white-space: pre;">A copy of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the deposit agreement is incorporated by reference as an exhibit to this Annual Report on Form 20-F. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Fees and Charges <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 383.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As an ADS holder, you will be required to pay the following fees under the terms of the deposit agreement: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 405.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 469.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 241.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 228pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 0pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 104.57pt; position: var(--position); text-decoration: none; white-space: pre;">Fees<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 59.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 14.25pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issuance of ADSs (e.g., an issuance of ADS upon a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">deposit of ordinary shares, upon a change in the ADS(s)-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">to-ordinary share ratio, or for any other reason), excluding <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ADS issuances as a result of distributions of ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 47.43pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">shares)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 14.25pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS issued<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cancellation of ADSs (e.g., a cancellation of ADSs for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">delivery of deposited property, upon a change in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ADS(s)-to-ordinary share ratio, or for any other reason)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 73.5pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS cancelled<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 109.5pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Distribution of cash dividends or other cash distributions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(e.g., upon a sale of rights and other entitlements)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 109.5pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS held<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Distribution of ADSs pursuant to (i) share dividends or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">other free share distributions, or (ii) exercise of rights to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">purchase additional ADSs<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 134.25pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS held<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 170.25pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Distribution of securities other than ADSs or rights to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">purchase additional ADSs (e.g., upon a spin-off)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 170.25pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS held<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ADS Services<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 195pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS held on the applicable record <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">date(s) established by the depositary bank<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">175<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 469.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 241.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 228pt;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Registration of ADS transfers (e.g., upon a registration of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">the transfer of registered ownership of ADSs, upon a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">transfer of ADSs into DTC and <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 130.31pt; position: var(--position); white-space: pre;">vice versa<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.51pt; position: var(--position); white-space: pre;">, or for any other <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">reason)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 0pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS (or fraction thereof) transferred<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 59.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 47.25pt; width: 241.5pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Conversion of ADSs of one series for ADSs of another <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">series (e.g., upon conversion of Partial Entitlement ADSs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">for Full Entitlement ADSs, or upon conversion of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Restricted ADSs (each as defined in the Deposit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 47.43pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Agreement) into freely transferable ADSs, and <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 192.13pt; position: var(--position); white-space: pre;">vice versa<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.32999999999998pt; position: var(--position); white-space: pre;">).<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 47.25pt; width: 228pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 228pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Up to U.S. 5&#162; per ADS (or fraction thereof) converted<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 195.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.11pt; position: var(--position); text-decoration: none; white-space: pre;">an<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.53999999999999pt; position: var(--position); white-space: pre;"> ADS holder, you will also be responsible to pay certain charges such as: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 217.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">taxes (including applicable interest and penalties) and other governmental charges; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 229pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">the registration fees as may from time to time be in effect for the registration of ordinary shares on the share <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 240.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">register and applicable to transfers of ordinary shares to or from the name of the custodian, the depositary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">bank or any nominees upon the making of deposits and withdrawals, respectively; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 263.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">certain cable, telex and facsimile transmission and delivery expenses; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 275pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">the fees, expenses, spreads, taxes and other charges of the depositary bank and/or service providers (which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">may be a division, branch or affiliate of the depositary bank) in the conversion of foreign currency; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">the reasonable and customary out-of-pocket expenses incurred by the depositary bank in connection with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 309.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">compliance with exchange control regulations and other regulatory requirements applicable to ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 321pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">shares, ADSs and American Despositary Receipts ("ADRs"); and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 332.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">the fees, charges, costs and expenses incurred by the depositary bank, the custodian, or any nominee in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">connection with the ADR program. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 367.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">ADS fees and charges for (i) the issuance of ADSs, and (ii) the cancellation of ADSs are charged to the person <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 377.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">for whom <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.65pt; position: var(--position); text-decoration: none; white-space: pre;">the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); white-space: pre;"> ADSs are issued (in the case of ADS issuances) and to the person for whom ADSs are cancelled (in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 387.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the case of ADS cancellations). In the case of ADSs issued by the depositary bank into DTC, the ADS issuance and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 397.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">cancellation fees and charges may be deducted from distributions made through DTC, and may be charged to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 407.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">DTC participant(s) receiving the ADSs being issued or the DTC participant(s) holding the ADSs being cancelled, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 417.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the case may be, on behalf of the beneficial owner(s) and will be charged by the DTC participant(s) to the account of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 427.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the applicable beneficial owner(s) in accordance with the procedures and practices of the DTC participants as in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 437.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">effect at the time. ADS fees and charges in respect of distributions and the ADS service fee are charged to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 447.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">holders as of the applicable ADS record date. In the case of distributions of cash, the amount of the applicable ADS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 457.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">fees and charges is deducted from the funds being distributed. In the case of (i) distributions other than cash and (ii) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 467.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the ADS service fee, holders as of the ADS record date will be invoiced for the amount of the ADS fees and charges <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 477.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and such ADS fees and charges may be deducted from distributions made to holders of ADSs. For ADSs held <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 487.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee may be deducted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 497.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">from distributions made through DTC, and may be charged to the DTC participants in accordance with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 507.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">procedures and practices prescribed by DTC and the DTC participants in turn charge the amount of such ADS fees <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 517.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and charges to the beneficial owners for whom they hold ADSs. In the case of (i) registration of ADS transfers, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 527.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ADS transfer fee will be payable by the ADS Holder whose ADSs are being transferred or by the person to whom <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 537.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the ADSs are transferred, and (ii) conversion of ADSs of one series for ADSs of another series, the ADS conversion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 547.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">fee will be payable by the Holder whose ADSs are converted or by the person to whom the converted ADSs are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 557.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">delivered. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 579.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">In the event of refusal to pay the depositary bank fees, the depositary bank may, under the terms of the deposit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 589.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">agreement, refuse the requested service until payment is received or may set off the amount of the depositary bank <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 599.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">fees from any distribution to be made to the ADS holder. Certain depositary fees and charges (such as the ADS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">services fee) may become payable shortly after the closing of the ADS offering. Note that the fees and charges you <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 619.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">may be required to pay may vary over time and may be changed by us and by the depositary bank. You will receive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 629.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">prior notice of such changes. The depositary bank may reimburse us for certain expenses incurred by us in respect of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 639.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.7pt; position: var(--position); text-decoration: none; white-space: pre;">ADR program, by making available a portion of the ADS fees charged in respect of the ADR <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.87pt; position: var(--position); white-space: pre;">program or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 649.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">otherwise, upon such terms and conditions as we and the depositary bank agree from time to time.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 671.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Taxes<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 693.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As an ADS holder, you will be responsible for the taxes and other governmental charges payable on the ADSs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 703.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and the securities represented by the ADSs. We, the depositary bank and the custodian may deduct from any <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">176<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">pay the taxes and governmental charges payable by holders. You will be liable for any deficiency if the sale <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">proceeds do not cover the taxes that are due.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The depositary bank may refuse to issue ADSs, to deliver, transfer, split and combine ADRs or to release <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 124pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">securities on deposit until all taxes and charges are paid by the applicable holder. The depositary bank and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 134pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding for any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 144pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">distributions on your behalf. However, you may be required to provide to the depositary bank and to the custodian <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 154pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">proof of taxpayer status and residence and such other information as the depositary bank and the custodian may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">require to fulfill legal obligations. You are required to indemnify us, the depositary bank and the custodian for any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 174pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">claims with respect to taxes based on any tax benefit obtained for you. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">177<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_181"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 287.26pt; position: var(--position); text-decoration: none; white-space: pre;">PART II<span style="display: inline-block; height: 6.77pt;"></span><span id="i74eb700c00f24f4db398b8c6a584c2d7"></span></span></div><div style="position: absolute; top: 108pt;" id="ia894b143b6fc4522a0483350194c625e_184"></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 13.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Defaults, Dividend Arrearages and Delinquencies<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i7feea7bb48364c06acccf8da29b446c3"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">178<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_187"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 14.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Material Modifications to the Rights of Security Holders and Use of Proceeds<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i0791810245f94442bc953c09756296ed"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Initial Public Offering<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 112pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">On October 24, 2023, we sold 20,325,500 new ordinary shares (the "New Shares"), consisting of a public <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 122pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">offering of 18,699,460 o<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.01999999999998pt; position: var(--position); white-space: pre;">rdinary shares in the form of ADSs, each representing the right to receive one ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">share, in the United States<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.59pt; position: var(--position); white-space: pre;"> (the "U.S. Offering") and a concurrent offering of 1,626,040 ordinary shares in certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 142pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">jurisdictions outside of the United States to certain investors (the "European Private Placement" and together with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 152pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">the U.S. Offering, the "<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Global<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.36pt; position: var(--position); white-space: pre;"> Offering"). The offering price was set at $11.60 per ADS in the U.S. Offering and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 162pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">corresponding offering price of &#8364;10.9864 per ordinary share in the European Private Placement. The aggregate gross <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 172pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">proceeds amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.18pt; position: var(--position); text-decoration: none; white-space: pre;">approximately<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.88pt; position: var(--position); white-space: pre;"> $235.8 million, equivalent to approximately &#8364;223.3 million (based on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">exchange rate then in effect), before deduction of underwriting commissions and expenses payable by us. All of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">ADSs and ordinary shares in the Global Offering were offered by Abivax.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">We incurred <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.65pt; position: var(--position); white-space: pre;">aggregate<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.47pt; position: var(--position); white-space: pre;"> underwriting discounts of approximately $16.5 million and expenses of approximately <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 224pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">$7.0 million, resulting <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.31pt; position: var(--position); white-space: pre;">in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.07999999999998pt; position: var(--position); white-space: pre;"> net proceeds to us of approximately $212.2 million. The effective date of the registration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 234pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">statement, File No. 333-274780, for our initial public offering was October 19, 2023. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">There has been <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.47pt; position: var(--position); text-decoration: none; white-space: pre;">no<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.47pt; position: var(--position); text-decoration: none; white-space: pre;"> material change in the use of proceeds from the Global Offering from that described in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">final prospectus related to the offering, which we filed with the SEC on October 23, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.19pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">179<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_190"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 15.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Controls and Procedures<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ib0f26dcd869d418d9f22f5f85cd85b71"></span></span></div><div style="position: absolute; top: 108pt;" id="ia894b143b6fc4522a0483350194c625e_193"></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Disclosure Controls and Proce<span style="display: inline-block; height: 6.77pt;"></span><span id="i4ccfe25233174880b087adfc78b05c16"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 201.6pt; position: var(--position); white-space: pre;">dures<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">officer), after evaluating the effectiveness of our &#8220;disclosure controls and procedures,&#8221; as such term is defined in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of December 31, 2024, have concluded that, as of such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">date, our disclosure controls and procedures were not effective as a result of the material weaknesses described <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">below. We are undertaking the remedial steps to address the material weaknesses in our disclosure controls and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">procedures as discussed below.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 202pt;" id="ia894b143b6fc4522a0483350194c625e_196"></div><div style="line-height: 10pt; position: var(--position); top: 202pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Management&#8217;s Annual Report on Internal Control Over Financial Reporting<span style="display: inline-block; height: 6.77pt;"></span><span id="ibfb8ec8f271a40bfa6f5558f12a88d67"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 226pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Our management is responsible for establishing and maintaining adequate internal control over financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) and for the assessment of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 246pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">effectiveness of our internal control over financial reporting. Our internal control over financial reporting is designed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 266pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">financial statements for external purposes in accordance with International Financial Reporting Standards.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 288pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 298pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">misstatements, including the possibility of human error, the circumvention or overriding of controls, or fraud. Also, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 308pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 318pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 328pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">deteriorate. Effective internal controls can provide only reasonable assurance with respect to the preparation and fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 338pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">presentation of financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, assessed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the effectiveness of our internal control over financial reporting as of December 31, 2024, using the criteria <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">established in the Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Organizations of the Treadway Commission (&#8220;COSO&#8221;)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.71000000000004pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.21000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> As previously disclosed in our Form 20-F for the period <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, 2023 and originally in our Form F-1, management identified material weaknesses in our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">internal controls over financial reporting. These material weaknesses continue to exist as of December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 518.39pt; position: var(--position); white-space: pre;">. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 420pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">material weaknesses related to a lack of risk assessment as well as formal, documented and implemented processes, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 430pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">controls and review procedures, specifically due to a lack of a sufficient number of professionals with an appropriate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 440pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">level of internal control knowledge, training and experience. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Remediation Efforts<span style="display: inline-block; height: 6.77pt;"></span><span id="ic731d63d5e214ecd9268dd1ff7213285"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">In response to the identified material weaknesses, management took a number of actions to improve the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 494pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">internal control over financial reporting during the year ended <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.97pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.51pt; position: var(--position); white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 516pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">These actions include, but are not limited to, the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">Reinforcing further the finance and accounting resources by: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 560pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144pt; position: var(--position); white-space: pre;">Hiring a SVP Finance based in the US, with experience in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.76pt; position: var(--position); text-decoration: none; white-space: pre;"> the life sciences industry and&#160; US <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 570pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">public listed companies, including SOX;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144pt; position: var(--position); white-space: pre;">H<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.22pt; position: var(--position); text-decoration: none; white-space: pre;">iring<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.09pt; position: var(--position); white-space: pre;"> additional qualified finance personnel, focusing on qualifications, certifications and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 602.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">relevant industry experience; and<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 624.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.5pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144pt; position: var(--position); white-space: pre;">Providing a structured onboarding program for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.86pt; position: var(--position); text-decoration: none; white-space: pre;">new<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.51pt; position: var(--position); white-space: pre;"> hires, including an introduction to current <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 636pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">financial systems, company processes, and internal controls<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 658.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">With the support of our external advisors, we are in the process of designing and implementing measures to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 669.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">enhance our internal control over financial reporting:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">We are currently conducting&#160; a comprehensive risk assessment in all areas, including cash management, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 701.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">financial reporting, compliance with regulations, fraud prevention and operational risks. The risk <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">180<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">assessment will be implemented as a framework, with specific objectives to identify new risks and update <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 82.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">regularly our processes based on emerging risks and/or changes in regulatory requirements,<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 104.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">We have started designing and implementing processes and controls, including segregation of duties, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 114.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">approval workflows and reconciliation procedures. In particular, we are implementing additional review <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 125.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">activities within our finance department and introducing further standard operating procedures for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">preparation of the financial statements, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 157.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">We<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.86pt; position: var(--position); white-space: pre;"> are in the process of enhancing our information technology and systems to create a more effective <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">control environment, which includes providing training to finance and accounting personnel on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 179pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108pt; position: var(--position); white-space: pre;">upgraded systems, focusing on new features, controls, and reporting capabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 201.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">As of December 31, 2024, management has concluded that, while it has made significant progress to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">remediate the previously disclosed<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.43pt; position: var(--position); text-decoration: none; white-space: pre;"> material weaknesses, they have not been remediat<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.36pt; position: var(--position); white-space: pre;">ed. With the oversight of senior <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 221.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">management and our audit committee, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.9pt; position: var(--position); text-decoration: none; white-space: pre;">we continue to strengthen ou<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.34pt; position: var(--position); white-space: pre;">r internal control over financial reporting and are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 231.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">taking several remedial actions to address the material weaknesses that have been identified.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 241.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 253.7pt;" id="ia894b143b6fc4522a0483350194c625e_199"></div><div style="line-height: 10pt; position: var(--position); top: 253.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Attestation Report of the Registered Public Accounting Firm<span style="display: inline-block; height: 6.77pt;"></span><span id="i8ecfa2df1d4a41dd8190cba247b93d55"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 277.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">This Annual Report <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.37pt; position: var(--position); white-space: pre;">does<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.69pt; position: var(--position); text-decoration: none; white-space: pre;"> not include an attestation report of our registered public accounting firm due to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 287.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">transition period <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.26pt; position: var(--position); white-space: pre;">established<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.64pt; position: var(--position); text-decoration: none; white-space: pre;"> by rules of the Securities and Exchange Commission for emerging growth companies <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 297.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(as defined in Rule 12b-2 under the Exchange Act).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 319.7pt;" id="ia894b143b6fc4522a0483350194c625e_202"></div><div style="line-height: 10pt; position: var(--position); top: 319.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in Control over Financial Reporting<span style="display: inline-block; height: 6.77pt;"></span><span id="i5f01b3e81ba149eeb099b74a818c2861"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 343.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: var(--position); white-space: pre;">Except as described above in the section titled "<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">Management&#8217;s Annual Report on Internal Control Over Financial <span style="display: inline-block; height: 6.93pt;"></span><span id="i925a6e23319b4059912dcf9f1f3e575f"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 355.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Reporting" t<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.31pt; position: var(--position); white-space: pre;">here has been no change in our internal control over financial reporting during the year ended December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 367.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 379.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">reporting.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">181<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_205"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">[Reserved]<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i6afb786a6f764c75a23cd2c306545822"></span></span></div><div style="position: absolute; top: 96pt;" id="ia894b143b6fc4522a0483350194c625e_208"></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16A.<span style="display: inline-block; height: 6.77pt; width: 29.8pt;"></span></span><span style="left: 144pt; position: var(--position);">Audit Committee Financial Expert<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i27bb8463fb01478b99f7ebcc6281a232"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 120pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Board has determined that each of the members of our audit committee is independent within the meaning <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 130pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the applicable listing rules of Nasdaq and the independence requirements contemplated by Rule 10A-3 under the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 140pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Exchange Act. Committee members must be competent in financial or accounting matters and at least one member <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 150pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">must be independent in accordance with the provisions of the Middlenext Code. Our Board has further determined <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 160pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">that Mr. Ignelzi is an &#8220;audit committee financial expert&#8221; as defined by SEC rules and regulations and that Mr. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 170pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Ignelzi qualifies as financially sophisticated under the listing rules of Nasdaq. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 192pt;" id="ia894b143b6fc4522a0483350194c625e_211"></div><div style="line-height: 10pt; position: var(--position); top: 192pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16B.<span style="display: inline-block; height: 6.77pt; width: 30.36pt;"></span></span><span style="left: 144pt; position: var(--position);">Code of Ethics<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i24898a84d7cc41e3ac8f4994e4884ee0"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 216pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have adopted a Code of Business Conduct and Ethics, applicable to all of our employees, senior <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 228pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management and directors, which is available on our website at www.abivax.com.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 252pt;" id="ia894b143b6fc4522a0483350194c625e_214"></div><div style="line-height: 10pt; position: var(--position); top: 252pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16C.<span style="display: inline-block; height: 6.77pt; width: 29.8pt;"></span></span><span style="left: 144pt; position: var(--position);">Principal Accountant Fees and Services<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ie58f9ca2d81c4cd28372bce4e7192e06"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 276pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">PricewaterhouseCoopers has served as our independent registered public accounting firm for 2022,&#160; 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 286pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">2024. Our accountants billed the following fees to us for professional services in each of those fiscal years:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 308pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 465.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/></tr><tr style="height: 34.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 13.27pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 46.95pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 222.75pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384.75pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 222.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Audit fees<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 222.75pt; position: var(--position); top: 34.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 59.29pt;"></span></span><span style="left: 61.92pt; position: var(--position);">100<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 34.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 51.79pt;"></span></span><span style="left: 54.42pt; position: var(--position);">1,714<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384.75pt; position: var(--position); top: 34.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 51.79pt;"></span></span><span style="left: 54.42pt; position: var(--position);">1,000<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 222.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Audit-related fees<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 222.75pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 64.29pt;"></span></span><span style="left: 66.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 64.29pt;"></span></span><span style="left: 66.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384.75pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 64.29pt;"></span></span><span style="left: 66.92pt; position: var(--position);">76<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 64.5pt; width: 222.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Tax fees<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 222.75pt; position: var(--position); top: 64.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 64.29pt;"></span></span><span style="left: 66.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 64.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 64.29pt;"></span></span><span style="left: 66.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384.75pt; position: var(--position); top: 64.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 64.29pt;"></span></span><span style="left: 66.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 222.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">All other fees<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 222.75pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 59.29pt;"></span></span><span style="left: 61.92pt; position: var(--position);">740<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 59.29pt;"></span></span><span style="left: 61.92pt; position: var(--position);">492<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384.75pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 4.42pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 69.29pt;"></span></span><span style="left: 71.92pt; position: var(--position);">7<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 222.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 5.17pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 222.75pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 5.17pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 59.29pt;"></span></span><span style="left: 61.92pt; position: var(--position);">840<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 5.17pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 51.79pt;"></span></span><span style="left: 54.42pt; position: var(--position);">2,206<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384.75pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 10pt; position: var(--position); top: 5.17pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 51.79pt;"></span></span><span style="left: 54.42pt; position: var(--position);">1,083<span style="display: inline-block; height: 6.93pt; width: 3.33pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 435.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Audit Fees<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 459.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.03pt; position: var(--position); white-space: pre;"> aggregate fees billed for the audit of our annual financial statements for the fiscal years ended December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 469.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">31, 2024 and 2023 were &#8364;1.0 million and &#8364;1.7 million, respectively, and related to audit services provided by our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 479.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">independent registered public accounting firm, PricewaterhouseCoopers Audit in connection with our annual audit, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 489.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">half-year review, and review and maintenance of registration statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 511.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Audit-Related Fees<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 533.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Audit-related Fees&#8221; are the aggregate fees billed for assurance and related services that are reasonably related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to the performance of the audit and are not reported under Audit Fees. The aggregate audit-related fees billed for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 553.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fiscal year ended December 31, 2024 were &#8364;0.1 million. We did not incur such fees for the fiscal year ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 585.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Tax Fees<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 609.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">None<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 631.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">All Other Fees<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 655.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The aggregate fees billed for all other services for the fiscal year ended December 31, 2024 and 2023 were &#8364;7 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 665.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">thousand and &#8364;0.5 million respectively. Other fees are the aggregate fees billed for other procedures required by law <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 675.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">related to services provided to our registration statements for capital increase and initial public offering on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 685.25pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Nasdaq Global Market.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">182<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Audit Committee&#8217;s Pre-Approval Policies and Procedures<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); white-space: pre;">The Audit Committee is responsible for the appointment, replacement, compensation, evaluation and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 106pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">oversight of the work of the independent auditors. As part of this responsibility, the Audit Committee pre-approves <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 116pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">all audit and non-audit services performed by the independent auditors in order to assure that they do not impair the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">auditor&#8217;s independence from the Company in accordance with the Audit Committee&#8217;s pre-approval policy.&#160; All fees <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">in 2024 and 2023 described in this Item 16C above were pre-approved by the Audit Committee.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 158pt;" id="ia894b143b6fc4522a0483350194c625e_217"></div><div style="line-height: 10pt; position: var(--position); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16D.<span style="display: inline-block; height: 6.77pt; width: 29.8pt;"></span></span><span style="left: 144pt; position: var(--position);">Exemptions from the Listing Standards for Audit Committees<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ie6a1a5f190d84977b8434ce7a6c3ce88"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 182pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 206pt;" id="ia894b143b6fc4522a0483350194c625e_220"></div><div style="line-height: 10pt; position: var(--position); top: 206pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16E.<span style="display: inline-block; height: 6.77pt; width: 30.36pt;"></span></span><span style="left: 144pt; position: var(--position);">Purchases of Equity Securities by the Issuer and Affiliated Purchasers<span style="display: inline-block; height: 6.77pt;"></span></span><span id="id16374bc2ff249fba6c409dc12484ea5"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">None.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 254pt;" id="ia894b143b6fc4522a0483350194c625e_223"></div><div style="line-height: 10pt; position: var(--position); top: 254pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16F.<span style="display: inline-block; height: 6.77pt; width: 30.92pt;"></span></span><span style="left: 144pt; position: var(--position);">Change in Registrant&#8217;s Certifying Accountant<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ib1f44c1cbe7b4319af9f420cdd4f639f"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 278pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 302pt;" id="ia894b143b6fc4522a0483350194c625e_226"></div><div style="line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16G.<span style="display: inline-block; height: 6.77pt; width: 29.25pt;"></span></span><span style="left: 144pt; position: var(--position);">Corporate Governance<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i2171f402b22a4a42b0641e479ae89474"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">As a French <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 147.29pt; position: var(--position); text-decoration: none; white-space: pre;">soci&#233;t&#233; anonyme <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.09pt; position: var(--position); text-decoration: none; white-space: pre;">(limited liability company) listed on Euronext Paris, we are subject to various <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 330pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corporate governance requirements under French law. In particular, we refer to the Code of Corporate Governance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 340pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for small and medium-sized firms as published in September 2021 by Middlenext, as amended from time to time. In <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 350pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">addition, as a foreign private issuer listed on the Nasdaq Global Market, we are subject to Nasdaq&#8217;s corporate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 360pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">governance listing standards. Nasdaq&#8217;s listing standards provide that foreign private issuers are permitted to follow <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 370pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">home country governance practices in lieu of Nasdaq rules, with certain exceptions. We currently rely on certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 380pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">exemptions for foreign private issuers and follow French corporate governance practices in lieu of Nasdaq corporate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 390pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">governance rules, which would require that (i)&#160;a majority of our Board consists of independent directors and (ii)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 400pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">quorum for any meeting of the holders of ordinary shares be at least 33<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 355.89pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.32pt; position: var(--position); text-decoration: none; white-space: pre;">/<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 361.09pt; position: var(--position); text-decoration: none; top: 2.4254999999999995pt; vertical-align: sub; white-space: pre;">3<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;% of the company's outstanding ordinary&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 410pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 432pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Nasdaq rules require that a listed company specify that the quorum for any meeting of the holders of ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 442pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares be at least 33<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 151.89pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.32pt; position: var(--position); text-decoration: none; white-space: pre;">/<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 157.09pt; position: var(--position); text-decoration: none; top: 2.4254999999999995pt; vertical-align: sub; white-space: pre;">3<span style="display: inline-block; height: 4.5045pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.51999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;% of the company's outstanding ordinary shares. Consistent with French Law, our by-laws <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 452pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provide that, for ordinary shareholders&#8217; meetings to be quorate, one-fifth of the holders of shares entitled to voting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 462pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">rights must be present in person or vote by mail or by proxy or by authorized intermediary or by any means of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 472pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">telecommunication permitting their identification. An extraordinary shareholders&#8217; meeting is quorate if one-fourth of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 482pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the holders of shares entitled to voting rights are present or vote by mail or by proxy or by authorized intermediary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 492pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">or by any means of telecommunication. As an exception, an extraordinary shareholders&#8217; meeting deciding upon a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 502pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">share capital increase by capitalization of reserves, profits or share premium as the same quorum requirement as an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shareholders&#8217; meeting. If the requirements for a quorum are not satisfied, the meeting is adjourned. When <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 522pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an adjourned ordinary shareholders&#8217; meeting is resumed, there is no quorum requirement. When an adjourned <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 532pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">extraordinary shareholders&#8217; meeting is resumed, there is a quorum of one-fifth of the holders of shares entitled to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 542pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">voting rights. If a quorum is not present, the reconvened extraordinary shareholders&#8217; meeting may be adjourned for a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 552pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maximum of two months. No deliberation by the shareholders may take place without a quorum. For special <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 562pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">meetings of holders of a certain class of shares, the quorum requirement is one-third of the certain class of shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 572pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entitled to voting rights for the meeting convened on the first call, notice and one-fifth of the holders of shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 582pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">entitled to voting rights, should the meeting be reconvened.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 604pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, we have opted out of shareholder approval requirements for the issuance of securities in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 614pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">connection with certain events such as the acquisition of stock or assets of another company, the establishment of or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 624pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amendments to equity-based compensation plans for employees, a change of control of us and certain private <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 634pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">placements. To this <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.45pt; position: var(--position); white-space: pre;">extent<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.85pt; position: var(--position); text-decoration: none; white-space: pre;">, our practice varies from the requirements of Nasdaq Listing Rule 5635, which generally <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 644pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">requires an issuer <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.42000000000002pt; position: var(--position); white-space: pre;">to<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.19pt; position: var(--position); text-decoration: none; white-space: pre;"> obtain shareholder approval for the issuance of securities in connection with such events.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We may <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.56pt; position: var(--position); white-space: pre;">choose<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.31pt; position: var(--position); text-decoration: none; white-space: pre;"> to take advantage of additional exemptions and follow home country practices in lieu of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 676pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Nasdaq rules in the future.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 708pt;" id="ia894b143b6fc4522a0483350194c625e_229"></div><div style="line-height: 10pt; position: var(--position); top: 708pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16H.<span style="display: inline-block; height: 6.77pt; width: 29.25pt;"></span></span><span style="left: 144pt; position: var(--position);">Mine Safety Disclosure<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ifb8131a68fda4c36bb0b5e209db753e6"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">183<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 108pt;" id="ia894b143b6fc4522a0483350194c625e_232"></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16I.<span style="display: inline-block; height: 6.77pt; width: 33.13pt;"></span></span><span style="left: 144pt; position: var(--position);">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i9392e6cfe72e41ef9ecec0f92c72fee9"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">Not applicable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 156pt;" id="ia894b143b6fc4522a0483350194c625e_235"></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16J.<span style="display: inline-block; height: 6.77pt; width: 32.02pt;"></span></span><span style="left: 144pt; position: var(--position);">Insider Trading Policies<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i2643e649e989428092c845066d0d0eb1"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our board <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.81pt; position: var(--position); white-space: pre;">of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.14pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.64pt; position: var(--position); white-space: pre;">directors<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.59pt; position: var(--position); text-decoration: none; white-space: pre;"> has <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.91pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-44">adopted</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.54pt; position: var(--position); text-decoration: none; white-space: pre;"> an insider trading policy that governs the purchase, sale, and other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 190pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">dispositions of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.07999999999998pt; position: var(--position); white-space: pre;">our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.41pt; position: var(--position); text-decoration: none; white-space: pre;"> securities by directors, senior management, and employees that is reasonably designed to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">promote compliance with applicable insider trading laws, rules and regulations, and any listing standards applicable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 210pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to us. A copy of our insider trading policy is filed as Exhibit 11.1 to this Annual Report on Form 20-F.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 232pt;" id="ia894b143b6fc4522a0483350194c625e_238"></div><div style="line-height: 10pt; position: var(--position); top: 232pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 16K.<span style="display: inline-block; height: 6.77pt; width: 29.25pt;"></span></span><span style="left: 144pt; position: var(--position);">Cybersecurity<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ia720e12b1a2d4c82a1b486218f51ba70"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 256pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Risk Management and Strategy<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-45" continuedAt="f-45-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have implemented and maintain various information security processes designed to identify, assess and <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-45-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manage material risks from cybersecurity threats to our critical information systems, third party hosted services, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">communications systems, hardware and software, and our critical data (including intellectual property, confidential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information that is proprietary, strategic or competitive in nature, and data related to our clinical trials and products) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(collectively, &#8220;Information Systems and Data&#8221;).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Chief Financial Officer as well as our external Data Protection Officer (&#8220;DPO&#8221;) and Information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Technology Director (&#8220;IT Director&#8221;), and other independent service providers help identify, assess and manage the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our cybersecurity threats and risks. Individuals in these roles identify and assess risks from cybersecurity threats by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">monitoring and evaluating our threat environment using various methods including, for example, maintaining <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manual and automated tools, conducting scans of our threat environment, and conducting vulnerability assessments.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-46" continuedAt="f-46-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Depending on the environment, we implement and maintain various technical, physical, and organizational <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-46-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">threats to our Information Systems and Data. These measures, processes, standards, and policies include, for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example: incident response plans and policies, personnel training, phishing test campaigns, penetration testing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">system backups, cybersecurity insurance, network security controls, segmentation for certain systems and data <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">access controls and physical security controls.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-47" continuedAt="f-47-1">Our assessment and management of material risks from cybersecurity threats are integrated into our overall </ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span></div><ix:continuation id="f-47-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk management processes.&#160; For example, our external DPO and IT Director work with management in an effort to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">impact to our business.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-48" continuedAt="f-48-1"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-49" continuedAt="f-49-1"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We use independent service provider<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.65pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.54pt; position: var(--position); text-decoration: none; white-space: pre;"> to assist us from time to time to identify, assess, and manage material <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-49-1"><ix:continuation id="f-48-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks from cybersecurity threats, including for example: professional service firms, including legal counsel, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">penetration testing firms, dark web monitoring services, cybersecurity consultants, and cybersecurity software <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">providers.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Further, we use independent service providers to perform a variety of functions throughout our business, such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as hosting companies and contract research organizations. We undertake efforts designed to manage cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks associated with our use of these providers.&#160; For certain vendors, these efforts include security questionnaires, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reviews of vendors&#8217; written security programs, reviews of security assessments, audits, and vulnerability scans <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related to the vendors. Depending on the nature of the services provided, the sensitivity of the Information Systems <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and Data at issue, and the identity of the provider, our vendor management process may involve different levels of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assessment designed to help identify cybersecurity risks associated with a provider and impose contractual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations related to cybersecurity on the provider.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 672pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-50" continuedAt="f-50-1">For a description of the risks from cybersecurity threats that may materially affect the Company and how they </ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span></div><ix:continuation id="f-50-1" continuedAt="f-50-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">may do so, see our risk factors under "Part I&#8212;Item 3D.&#8212;Risk Factors" in this Annual Report on Form 20-F, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">including &#8220;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.67pt; position: var(--position); text-decoration: underline; white-space: pre;">If our information technology systems or those of the third parties upon which we rely, or our data are or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: underline; white-space: pre;">were compromised, we could experience adverse consequences resulting from such compromise, including but not <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">184<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><ix:continuation id="f-50-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: underline; white-space: pre;">limited to: regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: underline; white-space: pre;">reputational harm; loss of revenue and profits; and other adverse consequences<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.19pt; position: var(--position); text-decoration: none; white-space: pre;">.&#8221;<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="line-height: 10pt; position: var(--position); top: 104pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: var(--position); white-space: pre;">Governance<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-52" continuedAt="f-52-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-51" continuedAt="f-51-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Board addresses our cybersecurity risk management as part of its general oversight function. The Board is <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-51-1"><ix:continuation id="f-52-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from cybersecurity threats.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.36pt; position: var(--position); text-decoration: none; white-space: pre;"> Our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.41pt; position: var(--position); text-decoration: none; white-space: pre;"> Committee of Executives (&#8220;COMEX&#8221;)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.54pt; position: var(--position); text-decoration: none; white-space: pre;">, in addition to those identified below, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provides input to the Board on cybersecurity threats. Our Committee of Executives consists of all our company's <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">officers along with our heads of manufacturing and quality.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-54" continuedAt="f-54-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-53" continuedAt="f-53-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-53-1"><ix:continuation id="f-54-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management team members, including our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.62pt; position: var(--position); text-decoration: none; white-space: pre;"> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-55">Chief Financial Officer (&#8220;CFO&#8221;)</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.77pt; position: var(--position); text-decoration: none; white-space: pre;"> who oversees our external <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.38pt; position: var(--position); text-decoration: none; white-space: pre;">IT Director <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and DPO<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.93pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-56" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO has prior significant experience in strategic business operations<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.66pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO as well as our external IT Director and DPO are responsible for helping to integrate cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk considerations into our overall risk management strategy, and communicating key priorities to relevant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personnel. Our CFO is responsible for approving cybersecurity-related budgets, approving cybersecurity processes, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and reviewing security assessments and other security-related reports.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-58" continuedAt="f-58-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-57" continuedAt="f-57-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-58-1"><ix:continuation id="f-57-1" continuedAt="f-57-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">members of management depending on circumstances, including our CFO. Our CFO works with our incident <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which they are notified.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"> In addition, our incident response process includes reporting to the Board for certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cybersecurity incidents.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></ix:continuation><ix:continuation id="f-57-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-59">The Board receives periodic communications from the CFO and others (such as the IT Director and DPO)</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concerning our significant cybersecurity threats, risk and the processes we have implemented in an effort to address <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">them.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">185<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_241"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 285.31pt; position: var(--position); text-decoration: none; white-space: pre;">PART III<span style="display: inline-block; height: 6.77pt;"></span><span id="iffa568ce6ad74ab1a41a85ba4ca61966"></span></span></div><div style="position: absolute; top: 108pt;" id="ia894b143b6fc4522a0483350194c625e_244"></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 17.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Financial Statements<span style="display: inline-block; height: 6.77pt;"></span></span><span id="ia148bf23629a45459756d04ceec8f419"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">See response to Item 18.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">186<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_247"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 18.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Financial Statements<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i72eace45f5f544a1b5a3f440b993546e"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); white-space: pre;">See pages F-1 through F-79 of this Annual Report on Form 20-F.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">187<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_250"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 72pt; position: var(--position);">Item 19.<span style="display: inline-block; height: 6.77pt; width: 1.02pt;"></span></span><span style="left: 108pt; position: var(--position);"><span style="display: inline-block; height: 6.77pt; width: 36pt;"></span></span><span style="left: 144pt; position: var(--position);">Exhibits<span style="display: inline-block; height: 6.77pt;"></span></span><span id="i9d70ca845c2740bab0cd62f30cf4df83"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The following exhibits are filed herewith or incorporated herein by reference:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 120pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 480pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 434.25pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exhibit <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 14.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 0pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Description of Exhibit<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 26.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">1.1*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 26.25pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex11bylaws6feb.htm">By-laws (statuts) of the registrant (English translation)</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 40.5pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2.1*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 40.5pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex21descriptio.htm">Description of Securities</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2.2<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 54.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Form of Deposit Agreement (incorporated by reference to Exhibit (a) to the Form F-6 Registration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statement (File No. 333-274845), filed with the Commission on October 3, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2.3<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 79.5pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Form of American Depositary Receipt (included in Exhibit 2.2)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.1 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 93.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OCABSA Issue Agreement between Abivax SA and Kreos Capital VII (UK) Limited and Claret European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Growth Capital Fund III SCSp dated August 20, 2023 (incorporated by reference to Exhibit 10.1 of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Company&#8217;s Registration Statement on Form F-1 (File No. 333-274780) filed with the Commission on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 59.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.2 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 141pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subscription Agreement between Abivax SA and Kreos Capital VII (UK) Limited, Kreos Capital VII <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Aggregator SCSp, Claret European Specialty Lending Company III, S.&#224; r.l., Claret European Growth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Capital Fund III SCSp dated August 20, 2023 (incorporated by reference to Exhibit 10.2 of the Company&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Registration Statement on Form F-1 (File No. 333-274780) filed with the Commission on September 29, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 47.43pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 200.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.3 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 200.25pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche A-B Warrants Issue Agreement between Abivax SA and Kreos Capital VII Aggregator SCSp and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Claret European Growth Capital Fund III SCSp dated August 20, 2023 (incorporated by reference to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exhibit 10.3 of the Company&#8217;s Registration Statement on Form F-1 (File No. 333-274780) filed with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 247.5pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.4<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 247.5pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex104.htm">Tranche A-B Put Option Agreement between Abivax SA and Kreos Capital VII Aggregator SCSp and </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex104.htm">Claret European Growth Capital Fund III SCSp dated August 20, 2023 </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.52pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exhibit 10.4 of the Company&#8217;s Registration Statement on Form F-1 (File No. 333-274780) filed with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.5 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 294.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex105.htm">Subscription Agreement between Abivax SA and CVI Investments, Inc. dated August 20, 2023</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.7pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.5 of the Company&#8217;s Registration Statement on Form F-1 (File No. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 330.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.6 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 330.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex106.htm">Intellectual Property Rights Pledge Deed between Abivax SA and Kreos Capital VII (UK) Ltd dated </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex106.htm">August 20, 2023 </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.6 of the Company&#8217;s Registration Statement on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Form F-1 (File No. 333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 366.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.7 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 366.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex107.htm">Terms and Conditions of the Royalty Certificates issued by Abivax SA dated August 31, 2022 </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.7 of the Company&#8217;s Registration Statement on Form F-1 (File No. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 402.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.8 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 402.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex108.htm">Drug Discovery Services Agreement between Abivax SA and Evotec International GmbH dated </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex108.htm">September 1, 2017 </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.35pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.8 of the Company&#8217;s Registration Statement on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Form F-1 (File No. 333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 438.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.9 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 438.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex109.htm">Amendment No. 1 to Drug Discovery Services Agreement between Abivax SA and Evotec International </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex109.htm">GmbH dated January 1, 2022 </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.55pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.9 of the Company&#8217;s Registration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statement on Form F-1 (File No. 333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 474.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.10 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 474.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1010.htm">Manufacturing Agreement between Abivax SA and Delpharm Lille S.A.S. dated November 24, 2016 </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.10 of the Company&#8217;s Registration Statement on Form F-1 (File <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">No. 333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 510.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.11 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 510.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1011.htm">Clinical Batch and Development Production Agreement between Abivax SA and Produits Chimiques </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1011.htm">Auxiliaires et de Synth&#232;se dated March 11, 2016 </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.93pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.11 of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Company&#8217;s Registration Statement on Form F-1 (File No. 333-274780) filed with the Commission on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">188<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: var(--position); top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 480pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 434.25pt;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.12 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 0pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1012.htm">Amendment No. 1 to Clinical Batch and Development Production Agreement between Abivax SA and </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1012.htm">Produits Chimiques Auxiliaires et de Synth&#232;se dated March 2, 2021 </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.54pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">10.12 of the Company&#8217;s Registration Statement on Form F-1 (File No. 333-274780) filed with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 47.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.13 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 47.25pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1013.htm">State-guaranteed loan agreement between Abivax SA and Soci&#233;t&#233; General dated June 16, 2020 </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.13 of the Company&#8217;s Registration Statement on Form F-1 (File <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">No. 333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 83.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.14 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 83.25pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1014.htm">Amendment No.1 to State-guaranteed loan between Abivax SA and Soci&#233;t&#233; General dated March 15, 2021 </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.14 of the Company&#8217;s Registration Statement on Form F-1 (File <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">No. 333-274780) filed with the Commission on September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 119.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.15 &#x5E;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 119.25pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1015.htm">Royalties Agreement with the French National Centre for Scientific Research, the University of </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/0001956827/000119312523247378/d609070dex1015.htm">Montpellier, and the Institut Curie dated December 18, 2008 </a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">(incorporated by reference to Exhibit 10.15 of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">the Company&#8217;s Registration Statement on Form F-1 (File No. 333-274780) filed with the Commission on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 36.23pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">September 29, 2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 166.5pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.16*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 166.5pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex416summaryof.htm">Summary of BSA 2015-11, BSA 2015-12, BSA 2017-1, BSA 2018-1, BSA 2024-1, BSA 2024-2, </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex416summaryof.htm">BSA-2025-1 and BSA-2025-2 Plans</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 191.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.17*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 191.25pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex417summaryof.htm">Summary of BCE 2016-1, BCE 2017-1, BCE 2017-2, BCE 2017-4, BCE 2017-5, BCE 2018-1, BCE </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex417summaryof.htm">2018-3, BCE 2018-4 and BCE 2018-5 Plans</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.18*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 216pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex418summaryof.htm">Summary of AGA-2023-1, AGA-2023-2, AGA-2023-3, AGA-2023-4, AGA-2023-5, AGA-2024-1, </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex418summaryof.htm">AGA-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5, AGA-2024-6, AGA-2024-7, AGA-2025-1, </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex418summaryof.htm">AGA-2025-2, AGA 2025-3 and AGA-2025-4 Free Share Plans</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 252pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">4.19<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 252pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Equity Distribution Agreement, dated as of November&#160; 19, 2024, by and between the registrant and Piper <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Sandler &amp; Co. (incorporated by reference to Exhibit 1.2 of the Company's Registration Statement on Form <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">F-3 (File No. 333-283336) filed with the Commission on November 19, 2025)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 288pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">8.1<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 288pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">List of subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 of the Company&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Registration Statement on Form F-1 (File No. 333-274780) filed with the Commission on September 29, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 25.03pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 324pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">11.1*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 324pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-codeofmarketconduct.htm">Abivax Code of Market Conduct</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 338.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">12.1*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 338.25pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit121ceo3.htm">Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit121ceo3.htm">15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 363pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">12.2*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 363pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit122cfo3.htm">Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit122cfo3.htm">15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 387.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">13.1**<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 387.75pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit131ceo3.htm">Certification by the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit131ceo3.htm">Section 906 of the Sarbanes-Oxley Act of 2002</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 412.5pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">13.2**<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 412.5pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit132cfo3.htm">Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to </a><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 13.83pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxexhibit132cfo3.htm">Section 906 of the Sarbanes-Oxley Act of 2002</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 437.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">15.1*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 437.25pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="a4abivaxfy24_consentforf3v.htm">Consent of PricewaterhouseCoopers Audit, independent registered accounting firm</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 451.5pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">97.1*<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 451.5pt; width: 434.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #0000ff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="abivax-20xfxex971incentive.htm">Incentive Compensation Recoupment Policy</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 465.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">101.INS<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 465.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Inline XBRL Instance Document<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 480pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">101.SCH<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 480pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">I<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 5.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nline XBRL Taxonomy Extension Schema Document</span><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 494.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">101.CAL<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 494.25pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Inline XBRL Taxonomy Extension Calculation Linkbase Document<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 508.5pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">101.DEF<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 508.5pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Inline XBRL Taxonomy Extension Definition Linkbase Document<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 522.75pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">101.LAB<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 522.75pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Inline XBRL Taxonomy Extension Label Linkbase Document<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 537pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">101.PRE<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 537pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Inline XBRL Taxonomy Extension Presentation Linkbase Document<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 551.25pt; width: 45.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 45.75pt; position: var(--position); top: 551.25pt; width: 434.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 434.25pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 10pt; position: var(--position); top: 654pt; width: 612pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">*&#160; &#160;  Filed herewith. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 666pt; width: 612pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">**&#160;  Furnished herewith.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 678pt; width: 612pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">#&#160; &#160;  Indicates a management contract or compensatory plan, contract or arrangement<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#x5E;&#160; &#160; &#160; &#160; &#160; &#160; Certain information has been excluded from this exhibit (indicated by &#8220;[***]&#8221;) because it is both not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 701.2pt; width: 612pt;"><span style="color: #008080; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">material and is the type that the registrant treats as private or confidential.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">189<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: var(--position); white-space: pre;">190<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_253"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 273.51pt; position: var(--position); text-decoration: none; white-space: pre;">SIGNATURES<span style="display: inline-block; height: 6.77pt;"></span><span id="i492b2a542c37444b90f19a3b924ab360"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99pt; position: var(--position); white-space: pre;">The registrant hereby certifies that it meets all of the requirements for filing this Annual Report on Form 20-F <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 132pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 351pt; position: var(--position); white-space: pre;">ABIVAX SA<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351pt; position: var(--position); white-space: pre;">By: <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 367.93pt; position: var(--position); text-decoration: underline; white-space: pre;">/s/ Marc de Garidel<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: underline; white-space: pre;"><span style="left: 447.02pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 11.98pt;"></span></span><span style="left: 459pt; position: var(--position);"><span style="display: inline-block; height: 6.94pt; width: 36pt;"></span></span></span></div><div style="line-height: 10pt; position: var(--position); top: 168pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351pt; position: var(--position); white-space: pre;">&#160; &#160; &#160;  Marc de Garidel<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351pt; position: var(--position); white-space: pre;">&#160; &#160; &#160;  <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 368.5pt; position: var(--position); white-space: pre;">Chief Executive Officer<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 204pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">Date: March 24, 2025<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-1<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_256"></div><div style="position: absolute; top: 102pt;" id="ia894b143b6fc4522a0483350194c625e_259"></div><div style="line-height: 10pt; position: var(--position); top: 103pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 174.68pt; position: var(--position); text-decoration: none; white-space: pre;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS<span style="display: inline-block; height: 6.77pt;"></span><span id="iac93c9067f034e888d4f684fd8b39ebd"></span></span></div><div style="position: var(--position); top: 158.75pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 523.45pt; position: var(--position); text-decoration: none; white-space: pre;">&#8195;<span style="display: inline-block; height: 225.75pt;"></span></span><div style="font-size: 0pt; left: 86.2pt; position: var(--position); top: 0pt; width: 437.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 395.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 395.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 395.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_262">Report of Independent Registered Public Accounting Firm</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.82999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> (PCAOB ID No. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.75pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-60">1347</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.75pt; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 332.08pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 332.37pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 332.52pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 332.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.58pt; position: var(--position); text-decoration: none; white-space: pre;">........................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 0pt; width: 42pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_262">2</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 14.25pt; width: 395.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 395.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_268">Consolidated Statements of Financial Position</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 187.42pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 187.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.60999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">..................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 14.25pt; width: 42pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_268">4</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 395.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 395.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_271">Consolidated Statements of Income (Loss)</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 173pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 174.16pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 174.74pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 174.89pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.93pt; position: var(--position); text-decoration: none; white-space: pre;">.......................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 49.5pt; width: 42pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_271">5</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84.75pt; width: 395.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 395.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_274">Consolidated Statements of Comprehensive Income (Loss)</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 238.21pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 239.37pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 239.66pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 239.81pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 239.89pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 239.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 239.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.96pt; position: var(--position); text-decoration: none; white-space: pre;">.............................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 84.75pt; width: 42pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_274">6</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120pt; width: 395.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 395.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_277">Consolidated Statements of Changes in Shareholders&#8217; Equity</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 246.82pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 247.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.54999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">..........................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 120pt; width: 42pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_277">7</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 155.25pt; width: 395.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 395.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_280">Consolidated Statements of Cash Flows</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 161.92pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 162.5pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 162.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.56pt; position: var(--position); text-decoration: none; white-space: pre;">............................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 155.25pt; width: 42pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_280">8</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 395.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 395.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_283">Notes to the Consolidated Financial Statements</a><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 192.10999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 192.4pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 192.54999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 192.57pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.57999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">................................................................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 10pt; position: var(--position); top: 24.67pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">F-<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.52pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia894b143b6fc4522a0483350194c625e_283">9</a><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-2<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_262"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 180.83pt; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting Firm<span style="display: inline-block; height: 6.77pt;"></span><span id="ic8713bd50006421382db164812f1ff3d"></span></span></div><div style="position: absolute; top: 108pt;" id="ia894b143b6fc4522a0483350194c625e_265"></div><div style="line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">To the Board of Directors and Shareholders of Abivax SA<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 133pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); white-space: pre; width: 152.67pt;">Opinion on the Financial Statements<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 158pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.99pt;">We have audited the accompanying consolidated statements of financial position of Abivax SA and its subsidiaries<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.99pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 169.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.91pt;">(the &#8220;Company&#8221;) as of December 31, 2024, 2023 and 2022, and the related consolidated statements of income (loss),<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9100000000001pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 180.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.9pt;">comprehensive income (loss), changes in shareholders&#8217; equity and cash flows for each of the three years in the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 191.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.97pt;">period ended December 31, 2024, including the related notes (collectively referred to as the &#8220;consolidated financial<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.97pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 202.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.97pt;">statements&#8221;).&#160; In our opinion, the consolidated financial statements present fairly, in all material respects, the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.97pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 214pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.89pt;">financial position of the Company as of December 31, 2024, 2023 and 2022, and the results of its operations and its<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.89pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 225.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.88pt;">cash flows for each of the three years in the period ended December 31, 2024 in conformity with International<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.88pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 236.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.97pt;">Financial Reporting Standards as issued by the International Accounting Standards Board and International<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.97pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 247.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 264.46pt;">Financial Reporting Standards as adopted by the European Union.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.46pt; position: var(--position); white-space: pre; width: 5pt;">&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 270.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 322.26pt;">Substantial Doubt about the Company&#8217;s Ability to Continue as a Going Concern<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 293pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.91pt;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9100000000001pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 304.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.84pt;">as a going concern. As discussed in Note 2 &#8220;Basis of preparation&#8221; to the consolidated financial statements, the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.8399999999999pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 315.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.91pt;">Company has incurred substantial operating losses since inception and expects to continue to incur significant<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9100000000001pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 326.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.87pt;">operating losses for the foreseeable future and may never become profitable. For the year ended December 31, 2024,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.87pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 337.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.84pt;">the Group had a net loss of &#8364;176.2 million and held at year end a total cash and cash equivalents of &#8364;144.2 million.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.8399999999999pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 349pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.86pt;">The Company expects, as of the date of issuance of these financial statements, to generate operating losses and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.86pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 360.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.96pt;">negative operating cash flows in the future and to need additional fundings to support its planned operations beyond<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.96pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 371.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 468pt;">the fourth quarter of 2025, and has stated that these events or conditions indicate that a material uncertainty exists<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 382.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.89pt;">that may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) on the Company&#8217;s<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.89pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 393.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.91pt;">ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9100000000001pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 405pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.94pt;">&#8220;Basis of preparation&#8221;. The consolidated financial statements do not include any adjustments that might result from<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.94pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 416.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 126.79pt;">the outcome of this uncertainty.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 438.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 126.82pt;">Change in accounting principle<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 461.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.92pt;">As discussed in Note 2 &#8220;Basis of preparation&#8221; to the consolidated financial statements, the Company changed in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9200000000001pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 472.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.98pt;">2024 the manner in which it classifies the non-current portion of the Heights convertible notes as of December 31,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.98pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 484pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.93pt;">2023 and the non-current portion of the OCEANE bonds as of December 31, 2022 following the application of the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9300000000001pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 495.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.99pt;">amendments to IAS 1 &#8220;Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-Current<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.99pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 506.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 182.84pt;">and Non-Current Liabilities with Covenants&#8221;.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 552.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: var(--position); white-space: pre; width: 73.31pt;">Basis for Opinion<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 574.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.96pt;">These consolidated financial statements are the responsibility of the Company&#8217;s management.&#160; Our responsibility is<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.96pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 586pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.87pt;">to express an opinion on the Company&#8217;s consolidated financial statements based on our audits.&#160; We are a public<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.87pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 597.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.87pt;">accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.87pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 608.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.9pt;">required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 619.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 375.97pt;">applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 642.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.98pt;">We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.98pt; position: var(--position); white-space: pre; width: 5pt;">&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 653.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.89pt;">Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.89pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 664.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.87pt;">consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.87pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 675.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.87pt;">not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.87pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 687.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 468pt;">part of our audits we are required to obtain an understanding of internal control over financial reporting but not for<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 698.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.96pt;">the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.96pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 709.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 167.93pt;">Accordingly, we express no such opinion.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-3<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 83.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 468pt;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 94.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.84pt;">statements, whether due to error or fraud, and performing procedures that respond to those risks.&#160; Such procedures<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.8399999999999pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 105.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.9pt;">included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 117.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.91pt;">statements.&#160; Our audits also included evaluating the accounting principles used and significant estimates made by<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.9100000000001pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 128.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 467.89pt;">management, as well as evaluating the overall presentation of the consolidated financial statements.&#160; We believe that<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.89pt; position: var(--position); white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 139.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre; width: 212.87pt;">our audits provide a reasonable basis for our opinion.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">/s/ <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.93pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-61">PricewaterhouseCoopers Audit</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 189.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-62">Neuilly-sur-Seine, France</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 200.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">March 24, 2025<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 225.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); white-space: pre;">We have served as the Company's auditor since 2013.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-4<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_268"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 138.03pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA CONSOLIDATED STATEMENTS OF FINANCIAL <span style="display: inline-block; height: 6.77pt;"></span><span id="if730a041fcf24e9f9fd5a7e6c4000f32"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 425.11pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="position: var(--position); top: 96pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 478.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 169.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.33pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.95pt; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.84pt; position: var(--position); text-decoration: none; white-space: pre;"> AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.84pt; position: var(--position); text-decoration: none; white-space: pre;"> AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.5pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-63">18,419</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-64">18,419</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-65">18,419</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.5pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-66">6,607</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-67">6,604</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-68">6,606</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.5pt; position: var(--position); text-decoration: none; white-space: pre;">8<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-69">1,592</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-70">878</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-71">2,666</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.5pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-72">11,708</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-73">12,870</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-74">5,919</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">10<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentNonfinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-75">1,037</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherNoncurrentNonfinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-76">2,320</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherNoncurrentNonfinancialAssets" scale="3" id="f-77">948</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-78">39,363</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-79">41,090</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-80">34,558</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Current assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 139.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.5pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 139.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherCurrentFinancialAssets" format="ixt:fixed-zero" scale="3" id="f-81">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 139.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherCurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-82">9,186</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 139.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherCurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-83">7,554</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 151.5pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 151.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">10<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 151.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentReceivablesAndCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-84">9,231</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 151.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentReceivablesAndCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-85">24,845</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 151.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentReceivablesAndCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-86">18,896</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 163.5pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 163.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">11<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 163.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-87">26,950</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 163.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-88">251,942</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 163.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-89">144,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 175.5pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 175.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-90">36,181</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 175.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-91">285,972</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 175.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-92">170,671</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 187.5pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 187.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-93">75,544</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 187.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-94">327,062</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 187.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-95">205,228</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 199.5pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.07pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES AND SHAREHOLDERS' <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.67pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">EQUITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 221.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Shareholders&#8217; equity<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 233.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Share capital<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 233.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:IssuedCapital" scale="3" id="f-96">223</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 233.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:IssuedCapital" scale="3" id="f-97">629</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 233.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:IssuedCapital" scale="3" id="f-98">633</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 245.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Premiums related to share capital<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 245.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:SharePremium" format="ixt:num-dot-decimal" scale="3" id="f-99">150,476</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 245.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:SharePremium" format="ixt:num-dot-decimal" scale="3" id="f-100">478,218</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 245.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:SharePremium" format="ixt:num-dot-decimal" scale="3" id="f-101">478,905</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 257.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Translation reserves<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 257.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:fixed-zero" scale="3" id="f-102">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 257.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-103">112</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 257.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-104">75</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 269.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retained earnings<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 269.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod" format="ixt:num-dot-decimal" scale="3" id="f-105">82,770</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 269.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" sign="-" name="ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod" format="ixt:num-dot-decimal" scale="3" id="f-106">135,209</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 269.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod" format="ixt:num-dot-decimal" scale="3" id="f-107">262,637</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 281.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 281.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:RetainedEarningsProfitLossForReportingPeriod" format="ixt:num-dot-decimal" scale="3" id="f-108">60,740</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 281.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" sign="-" name="ifrs-full:RetainedEarningsProfitLossForReportingPeriod" format="ixt:num-dot-decimal" scale="3" id="f-109">147,740</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 281.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:RetainedEarningsProfitLossForReportingPeriod" format="ixt:num-dot-decimal" scale="3" id="f-110">176,242</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 293.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total shareholders&#8217; equity<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 293.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">13<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 293.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-111">7,189</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 293.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-112">196,010</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 293.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-113">40,584</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 305.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligations<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 317.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 317.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" scale="3" id="f-114">610</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 317.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" scale="3" id="f-115">629</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 317.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" scale="3" id="f-116">756</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 329.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 329.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 329.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherLongtermProvisions" scale="3" id="f-117">40</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 329.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherLongtermProvisions" scale="3" id="f-118">30</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 329.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherLongtermProvisions" scale="3" id="f-119">819</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 341.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 341.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 341.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-120">9,127</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 341.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-121">2,563</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 341.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-122">29,056</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 353.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 353.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 353.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:NonCurrentConvertibleLoansNotes" format="ixt:fixed-zero" scale="3" id="f-123">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 353.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:NonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-124">21,643</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 353.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:NonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-125">23,370</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 365.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 365.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 365.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" scale="3" id="f-126">566</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 365.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-127">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 365.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-128">3,620</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 377.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 377.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 377.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:NonCurrentRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-129">3,287</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 377.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:NonCurrentRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-130">12,229</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 377.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:NonCurrentRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-131">13,023</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 389.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 389.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 389.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-132">3,262</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 389.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-133">3,262</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 389.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-134">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 401.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 401.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-135">16,891</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 401.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-136">40,356</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 401.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-137">70,645</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 413.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Current liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 425.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 425.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 425.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-138">10,077</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 425.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-139">1,655</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 425.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-140">22,195</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 437.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 437.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 437.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-141">19,957</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 437.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-142">29,605</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 437.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-143">21,574</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 449.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 449.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 449.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-144">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 449.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-145">2,579</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 449.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-146">1,166</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 461.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 461.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 461.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherCurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-147">3,521</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 461.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherCurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-148">3,509</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 461.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherCurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-149">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 473.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 473.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 33.5pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 473.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherShorttermProvisions" format="ixt:fixed-zero" scale="3" id="f-150">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 473.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherShorttermProvisions" format="ixt:fixed-zero" scale="3" id="f-151">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 473.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherShorttermProvisions" scale="3" id="f-152">532</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 485.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 485.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.5pt; position: var(--position); text-decoration: none; white-space: pre;">17.1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 485.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="3" id="f-153">15,475</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 485.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="3" id="f-154">47,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 485.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="3" id="f-155">43,824</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 497.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 497.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.5pt; position: var(--position); text-decoration: none; white-space: pre;">17.2<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 497.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentTaxAndEmployeeBenefitLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-156">2,300</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 497.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentTaxAndEmployeeBenefitLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-157">6,073</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 497.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentTaxAndEmployeeBenefitLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-158">4,709</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 509.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 509.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities" scale="3" id="f-159">133</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 509.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities" scale="3" id="f-160">52</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 509.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities" format="ixt:fixed-zero" scale="3" id="f-161">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 521.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 521.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-162">51,464</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 521.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-163">90,695</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 521.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-164">93,999</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 533.25pt; width: 169.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.07pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL LIABILITIES AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.67pt; width: 169.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">SHAREHOLDERS' EQUITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 247.5pt; position: var(--position); top: 533.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-165">75,544</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 533.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-166">327,062</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 533.25pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-167">205,228</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 669.3pt; width: 612pt;"><ix:footnote id="fn-1" continuedAt="fn-1-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span></ix:footnote></div><ix:continuation id="fn-1-1"><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-8" decimals="-3" sign="-" name="abvx:NonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-168"><ix:nonFraction unitRef="eur" contextRef="c-8" decimals="-3" name="abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-169">19,332</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-9" decimals="-3" sign="-" name="abvx:NonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-170"><ix:nonFraction unitRef="eur" contextRef="c-9" decimals="-3" name="abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-171">20,652</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-5<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 473pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_271"></div><div style="line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 155.74pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA CONSOLIDATED STATEMENTS OF INCOME (LOSS)<span style="display: inline-block; height: 6.77pt;"></span><span id="i5692c356f346423c91c820091e92c610"></span></span></div><div style="position: var(--position); top: 98.63pt; width: 612pt;"><div style="font-size: 0pt; left: 71.28pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 191.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.51pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 16.56pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros, except per share <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.11pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 80.74pt; position: var(--position); text-decoration: none; white-space: pre;">amounts)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.08pt; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other operating income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 30.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">18<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-172">4,583</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-173">4,621</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-174">12,449</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total operating income<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:RevenueAndOperatingIncome" format="ixt:num-dot-decimal" scale="3" id="f-175">4,583</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:RevenueAndOperatingIncome" format="ixt:num-dot-decimal" scale="3" id="f-176">4,621</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueAndOperatingIncome" format="ixt:num-dot-decimal" scale="3" id="f-177">12,449</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sales and marketing<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 54.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;">19.1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:fixed-zero" scale="3" id="f-178">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-179">6,431</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-180">5,954</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 66.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;">19.2<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-181">48,295</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-182">103,176</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-183">146,532</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 78.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;">19.3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-184">7,492</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-185">22,390</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-186">32,946</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill impairment loss<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 90.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.62pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-187">13,632</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-188">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-189">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total operating expenses<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-190">69,419</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-191">131,997</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-192">185,433</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">Operating loss<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-193">64,836</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-194">127,376</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-195">172,984</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:FinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-196">7,022</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:FinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-197">27,875</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:FinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-198">16,991</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:FinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-199">11,118</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:FinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-200">7,511</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:FinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-201">13,732</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial gain (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 150.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">21<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:FinanceIncomeCost" format="ixt:num-dot-decimal" scale="3" id="f-202">4,096</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:FinanceIncomeCost" format="ixt:num-dot-decimal" scale="3" id="f-203">20,364</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:FinanceIncomeCost" format="ixt:num-dot-decimal" scale="3" id="f-204">3,258</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss before tax<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-205">60,740</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-206">147,740</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-207">176,242</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Income tax<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 174.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">22<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:fixed-zero" scale="3" id="f-208">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:fixed-zero" scale="3" id="f-209">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:fixed-zero" scale="3" id="f-210">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-211">60,740</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-212">147,740</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-213">176,242</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loss per share (&#8364;/share)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of outstanding shares used <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.63pt; position: var(--position); text-decoration: none; white-space: pre;">for computing basic/diluted loss per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-214"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-215">19,092,442</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-216"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-217">43,066,012</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-218"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-219">63,046,350</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 231.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Basic / diluted loss per share (&#8364;/share)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 231.75pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">23<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 231.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(<ix:nonFraction unitRef="eurPerShare" contextRef="c-10" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-220"><ix:nonFraction unitRef="eurPerShare" contextRef="c-10" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-221">3.18</ix:nonFraction></ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 331.5pt; position: var(--position); top: 231.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(<ix:nonFraction unitRef="eurPerShare" contextRef="c-11" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-222"><ix:nonFraction unitRef="eurPerShare" contextRef="c-11" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-223">3.43</ix:nonFraction></ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 231.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(<ix:nonFraction unitRef="eurPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-224"><ix:nonFraction unitRef="eurPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-225">2.80</ix:nonFraction></ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-6<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_274"></div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 107.64pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)<span style="display: inline-block; height: 6.77pt;"></span><span id="i6948a5fb878c4c0da726d99e89c066f3"></span></span></div><div style="position: var(--position); top: 120.83pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: var(--position); top: 0pt; width: 467.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 215.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.56pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.21pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 215.25pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.83pt; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.07pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.28pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.07pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.28pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.07pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.28pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 41.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 30.05pt;"></span></span><span style="left: 32.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-226">60,740</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 41.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.05pt;"></span></span><span style="left: 28.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-227">147,740</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 41.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.05pt;"></span></span><span style="left: 28.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-228">176,242</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Items that will not be reclassified to profit or loss<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 53.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-229">235</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 53.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-230">112</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 53.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.05pt;"></span></span><span style="left: 46.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-231">31</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 65.25pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses on retirement benefit obligations<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 215.25pt; position: var(--position); top: 65.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.37pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 65.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-232">235</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 65.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-233">112</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 65.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.05pt;"></span></span><span style="left: 46.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-234">31</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 77.25pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Items that are or may be reclassified subsequently to profit <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">or loss<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 77.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-235">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 77.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-236">112</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 77.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.05pt;"></span></span><span style="left: 42.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-237">187</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign currency translation differences<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 98.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" format="ixt:fixed-zero" scale="3" id="f-238">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 98.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" id="f-239">112</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 98.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.05pt;"></span></span><span style="left: 42.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" id="f-240">187</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 110.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-241">235</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 110.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-242">225</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 110.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.05pt;"></span></span><span style="left: 42.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-243">219</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 215.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 215.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income (loss) for the period<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 122.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 30.05pt;"></span></span><span style="left: 32.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-244">60,506</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 122.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.05pt;"></span></span><span style="left: 28.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-245">147,516</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 122.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.05pt;"></span></span><span style="left: 28.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-246">176,461</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-7<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 583pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_277"></div><div style="line-height: 10pt; position: var(--position); top: 84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 94.99pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY <span style="display: inline-block; height: 6.77pt;"></span><span id="i0a3b68e4db244c6e9cd85bcc4370e69e"></span></span></div><div style="position: var(--position); top: 108pt; width: 612pt;"><div style="font-size: 0pt; left: 14.4pt; position: var(--position); top: 0pt; width: 570.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 38.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 34.89pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 19.02pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 0pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 18.37pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.58pt; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 0pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 10.41pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.81pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.38pt; position: var(--position); text-decoration: none; white-space: pre;">SHARES <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.21pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 14.74pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 14.61pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.83pt; position: var(--position); text-decoration: none; white-space: pre;">SHARE <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 10.14pt; position: var(--position); text-decoration: none; white-space: pre;">CAPITAL<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 0pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 6.21pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.95pt; position: var(--position); text-decoration: none; white-space: pre;">PREMIUMS <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 14.61pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.55pt; position: var(--position); text-decoration: none; white-space: pre;">RELATED TO <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.33pt; position: var(--position); text-decoration: none; white-space: pre;">SHARE <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 31.41pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.64pt; position: var(--position); text-decoration: none; white-space: pre;">CAPITAL<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 14.61pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">TRANSLATION <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.11pt; position: var(--position); text-decoration: none; white-space: pre;">RESERVE<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 14.61pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.17pt; position: var(--position); text-decoration: none; white-space: pre;">RETAINED <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.17pt; position: var(--position); text-decoration: none; white-space: pre;">EARNINGS<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 10.41pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.5pt; position: var(--position); text-decoration: none; white-space: pre;">NET LOSS <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.81pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.86pt; position: var(--position); text-decoration: none; white-space: pre;">FOR THE <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.21pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 10.41pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 17.76pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.8pt; position: var(--position); text-decoration: none; white-space: pre;">SHAREHOLDER<span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.21pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 12.42pt; position: var(--position); text-decoration: none; white-space: pre;">'S EQUITY<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.36pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.76pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 42.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 20.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-247">16,764,051</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 42.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.87pt;"></span></span><span style="left: 40.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-13" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-248">168</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 42.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.62pt;"></span></span><span style="left: 31.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-14" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-249">107,578</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 42.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-15" decimals="-3" name="ifrs-full:Equity" format="ixt:fixed-zero" scale="3" id="f-250">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 42.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.29pt;"></span></span><span style="left: 30.919999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-16" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-251">39,361</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 42.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 26.04pt;"></span></span><span style="left: 28.669999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-17" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-252">42,452</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 42.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.37pt;"></span></span><span style="left: 40pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-12" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-253">25,934</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.39pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 63pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 63pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 63pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 63pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 63pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 63pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 26.04pt;"></span></span><span style="left: 28.669999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-18" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-254">60,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 63pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-255">60,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 74.25pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income (loss)<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 74.25pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 74.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 74.25pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 74.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 74.25pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 74.25pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.37pt;"></span></span><span style="left: 42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-19" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-256">235</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 74.25pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 74.25pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.12pt;"></span></span><span style="left: 48.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-257">235</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive loss for the period<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 85.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 85.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 85.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 85.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 85.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 39.37pt;"></span></span><span style="left: 42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-19" decimals="-3" name="ifrs-full:ComprehensiveIncome" scale="3" id="f-258">235</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 85.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 26.04pt;"></span></span><span style="left: 28.669999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-18" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-259">60,740</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 85.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-260">60,506</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Appropriation of prior period net loss<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 96.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 96.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 96.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 96.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 96.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 28.29pt;"></span></span><span style="left: 30.919999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-19" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-261">42,452</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 96.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 28.37pt;"></span></span><span style="left: 31pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-18" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-262">42,452</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 96.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 49.62pt;"></span></span><span style="left: 52.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:fixed-zero" scale="3" id="f-263">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 0.69pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Capital increase from issuance of ordinary <span style="display: inline-block; height: 4.85pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 9.09pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 108pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 108pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.88pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 24.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-264">5,530,000</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 108pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.88pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-20" decimals="-3" name="ifrs-full:IssueOfEquity" scale="3" id="f-265">55</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 108pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.88pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 32.12pt;"></span></span><span style="left: 34.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-21" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">46,176</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 108pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.88pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 108pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.88pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 108pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.88pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 108pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.88pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 37.37pt;"></span></span><span style="left: 40pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-267">46,231</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs related to capital increase<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 123pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 123pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 123pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 123pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.29pt;"></span></span><span style="left: 35.92pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-21" decimals="-3" name="abvx:ShareIssueRelatedCostCredit" format="ixt:num-dot-decimal" scale="3" id="f-268">3,280</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 123pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 123pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 123pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 123pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 38.54pt;"></span></span><span style="left: 41.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:ShareIssueRelatedCostCredit" format="ixt:num-dot-decimal" scale="3" id="f-269">3,280</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercises of share warrants<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 134.25pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3, 14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 134.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 32.87pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-270">19,134</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 134.25pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 134.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 47.87pt;"></span></span><span style="left: 50.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-21" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="3" id="f-271">2</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 134.25pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 134.25pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 134.25pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 134.25pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 53.12pt;"></span></span><span style="left: 55.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="3" id="f-272">3</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 145.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Shares based compensation expense<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 145.5pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 145.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 145.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 145.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 145.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 145.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 31.79pt;"></span></span><span style="left: 34.42pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-19" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-273">1,164</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 145.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 145.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 38.54pt;"></span></span><span style="left: 41.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-274">1,164</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 156.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction on treasury shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 156.75pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 156.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 156.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 156.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 156.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 156.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.54pt;"></span></span><span style="left: 43.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-19" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="f-275">28</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 156.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 156.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 47.29pt;"></span></span><span style="left: 49.92pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="f-276">28</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.36pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.76pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 168pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 20.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-277">22,313,185</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 168pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.87pt;"></span></span><span style="left: 40.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-22" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-278">223</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 168pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.62pt;"></span></span><span style="left: 31.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-23" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-279">150,476</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 168pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-24" decimals="-3" name="ifrs-full:Equity" format="ixt:fixed-zero" scale="3" id="f-280">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 168pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.29pt;"></span></span><span style="left: 30.919999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-25" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-281">82,770</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 168pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 26.04pt;"></span></span><span style="left: 28.669999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-26" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-282">60,740</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 168pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 40.87pt;"></span></span><span style="left: 43.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-283">7,189</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 204pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.36pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.76pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2023<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 204pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 20.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-284">22,313,185</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 204pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.87pt;"></span></span><span style="left: 40.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-22" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-285">223</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 204pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.62pt;"></span></span><span style="left: 31.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-23" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-286">150,476</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 204pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);">&#8364;<span style="display: inline-block; height: 4.74pt; width: 43.04pt;"></span></span><span style="left: 49.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-24" decimals="-3" name="ifrs-full:Equity" format="ixt:fixed-zero" scale="0" id="f-287">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 204pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.29pt;"></span></span><span style="left: 30.919999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-25" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-288">82,770</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 204pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 26.04pt;"></span></span><span style="left: 28.669999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-26" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-289">60,740</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 40.87pt;"></span></span><span style="left: 43.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-290">7,189</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 224.25pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.39pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 224.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 224.25pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 224.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 224.25pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 224.25pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 224.25pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 22.54pt;"></span></span><span style="left: 25.169999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-27" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-291">147,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 224.25pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 31.54pt;"></span></span><span style="left: 34.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-292">147,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 235.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income (loss)<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 235.5pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 235.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 235.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 235.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 235.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 43.04pt;"></span></span><span style="left: 45.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-28" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-293">112</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 235.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.37pt;"></span></span><span style="left: 42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-29" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-294">112</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 235.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 235.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.12pt;"></span></span><span style="left: 48.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-295">225</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive loss for the period<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 246.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 246.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 246.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 246.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 43.04pt;"></span></span><span style="left: 45.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-28" decimals="-3" name="ifrs-full:ComprehensiveIncome" scale="3" id="f-296">112</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 246.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 39.37pt;"></span></span><span style="left: 42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-29" decimals="-3" name="ifrs-full:ComprehensiveIncome" scale="3" id="f-297">112</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 246.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 22.54pt;"></span></span><span style="left: 25.169999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-27" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-298">147,740</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 246.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 31.54pt;"></span></span><span style="left: 34.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-299">147,516</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Appropriation of prior period net loss<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 258pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 258pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 258pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 258pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 258pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 28.29pt;"></span></span><span style="left: 30.919999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-29" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-300">60,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 258pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 28.37pt;"></span></span><span style="left: 31pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-27" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-301">60,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 258pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 49.62pt;"></span></span><span style="left: 52.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:fixed-zero" scale="3" id="f-302">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 269.25pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 0.31pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Capital increase from issuance of ordinary <span style="display: inline-block; height: 4.85pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.71pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 269.25pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.12pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 269.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.51pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 20.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-303">40,325,500</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 269.25pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.51pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 37.87pt;"></span></span><span style="left: 40.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-30" decimals="-3" name="ifrs-full:IssueOfEquity" scale="3" id="f-304">403</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 269.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.51pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 28.62pt;"></span></span><span style="left: 31.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-31" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-305">352,974</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 269.25pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.51pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 269.25pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.51pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 269.25pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.51pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 269.25pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.51pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.87pt;"></span></span><span style="left: 36.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-306">353,377</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 283.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs related to capital increase<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 283.5pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 283.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 283.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 283.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 29.79pt;"></span></span><span style="left: 32.42pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-31" decimals="-3" name="abvx:ShareIssueRelatedCostCredit" format="ixt:num-dot-decimal" scale="3" id="f-307">28,111</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 283.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 283.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 283.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 283.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:ShareIssueRelatedCostCredit" format="ixt:num-dot-decimal" scale="3" id="f-308">28,111</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issue of convertible notes<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 294.75pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 294.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 294.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 294.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.62pt;"></span></span><span style="left: 38.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-31" decimals="-3" name="ifrs-full:IssueOfConvertibleInstruments" format="ixt:num-dot-decimal" scale="3" id="f-309">1,030</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 294.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 294.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 294.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 294.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.87pt;"></span></span><span style="left: 43.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IssueOfConvertibleInstruments" format="ixt:num-dot-decimal" scale="3" id="f-310">1,030</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 306pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercises of the Kreos share warrants<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 306pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3, 14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 306pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 32.87pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-311">99,583</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 306pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.87pt;"></span></span><span style="left: 47.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-33" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="3" id="f-312">1</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 306pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.62pt;"></span></span><span style="left: 38.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-34" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" format="ixt:num-dot-decimal" scale="3" id="f-313">1,849</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 306pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 306pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 306pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 306pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.87pt;"></span></span><span style="left: 43.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-32" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" format="ixt:num-dot-decimal" scale="3" id="f-314">1,850</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercises of other share warrants<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 317.25pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 317.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 29.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-315">190,550</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 317.25pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.87pt;"></span></span><span style="left: 47.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-36" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="3" id="f-316">2</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 317.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 317.25pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 317.25pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 317.25pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 317.25pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 53.12pt;"></span></span><span style="left: 55.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-35" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="3" id="f-317">2</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 328.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Shares based compensation expense<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 328.5pt; width: 38.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.62pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 328.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 328.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 328.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 328.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 328.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 34.12pt;"></span></span><span style="left: 36.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-29" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-318">8,179</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 328.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 328.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.87pt;"></span></span><span style="left: 43.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-319">8,179</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 339.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transactions on treasury shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 339.75pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 339.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 339.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 339.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 339.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 339.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-29" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="f-320">10</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 339.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 339.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 49.62pt;"></span></span><span style="left: 52.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="f-321">10</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 351pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.36pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.76pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 351pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 20.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-322">62,928,818</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 351pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.87pt;"></span></span><span style="left: 40.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-37" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-323">629</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 351pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.62pt;"></span></span><span style="left: 31.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-38" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-324">478,218</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 351pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 43.04pt;"></span></span><span style="left: 45.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-39" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-325">112</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 351pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 24.79pt;"></span></span><span style="left: 27.419999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-40" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-326">135,209</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 351pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 22.54pt;"></span></span><span style="left: 25.169999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-41" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-327">147,740</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 351pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.87pt;"></span></span><span style="left: 36.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-328">196,010</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 382.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.36pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.76pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2024<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 382.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 20.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-329">62,928,818</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 382.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.87pt;"></span></span><span style="left: 40.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-37" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-330">629</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 382.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.62pt;"></span></span><span style="left: 31.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-38" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-331">478,218</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 382.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 43.04pt;"></span></span><span style="left: 45.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-39" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-332">112</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 382.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 24.79pt;"></span></span><span style="left: 27.419999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-40" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-333">135,209</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 382.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 22.54pt;"></span></span><span style="left: 25.169999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-41" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-334">147,740</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 382.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.87pt;"></span></span><span style="left: 36.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-335">196,010</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 402.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.39pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 402.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 402.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 402.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 402.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 402.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 402.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 22.54pt;"></span></span><span style="left: 25.169999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-42" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-336">176,242</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 402.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 31.54pt;"></span></span><span style="left: 34.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-337">176,242</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 414pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income (loss)<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 414pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 414pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 414pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 414pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 414pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.71pt;"></span></span><span style="left: 43.34pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-43" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-338">187</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 414pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.54pt;"></span></span><span style="left: 43.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-44" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-339">31</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 414pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 414pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 43.79pt;"></span></span><span style="left: 46.42pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="f-340">219</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 425.25pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive loss for the period<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 425.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 425.25pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 425.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 425.25pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 40.71pt;"></span></span><span style="left: 43.34pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-43" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" scale="3" id="f-341">187</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 425.25pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 40.54pt;"></span></span><span style="left: 43.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-44" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" scale="3" id="f-342">31</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 425.25pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 22.54pt;"></span></span><span style="left: 25.169999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-42" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-343">176,242</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 425.25pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.56pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 31.54pt;"></span></span><span style="left: 34.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-344">176,461</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 439.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Appropriation of prior period net loss<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 439.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 439.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 439.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 439.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 439.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 24.79pt;"></span></span><span style="left: 27.419999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-44" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-345">147,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 439.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 24.87pt;"></span></span><span style="left: 27.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-42" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-346">147,740</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 439.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 49.62pt;"></span></span><span style="left: 52.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings" format="ixt:fixed-zero" scale="3" id="f-347">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 450.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs related to capital increase<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 450.75pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 450.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 450.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 450.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.87pt;"></span></span><span style="left: 43.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-45" decimals="-3" sign="-" name="abvx:ShareIssueRelatedCostCredit" scale="3" id="f-348">446</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 450.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 450.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 450.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 450.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.12pt;"></span></span><span style="left: 48.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:ShareIssueRelatedCostCredit" scale="3" id="f-349">446</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 462pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issue of share warrants<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 462pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 1.5pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 462pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 462pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 462pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.87pt;"></span></span><span style="left: 43.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-45" decimals="-3" name="abvx:IncreaseDecreaseThroughIssuanceOfWarrantsEquity" scale="3" id="f-350">200</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 462pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 462pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 462pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 462pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.89pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.12pt;"></span></span><span style="left: 48.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:IncreaseDecreaseThroughIssuanceOfWarrantsEquity" scale="3" id="f-351">200</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 471pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercises of share warrants<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 471pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.3, 14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 471pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 36.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-352">4,000</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 471pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 471pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-45" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="3" id="f-353">45</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 471pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 471pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 471pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 471pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 49.62pt;"></span></span><span style="left: 52.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="3" id="f-354">45</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 482.25pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issue of free shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 482.25pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 482.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 29.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="abvx:NumberOfFreeSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-355">415,019</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 482.25pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.87pt;"></span></span><span style="left: 47.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-46" decimals="-3" name="abvx:IncreaseDecreaseFromFreeSharesIssued" scale="3" id="f-356">4</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 482.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 45.54pt;"></span></span><span style="left: 48.17pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-45" decimals="-3" sign="-" name="abvx:IncreaseDecreaseFromFreeSharesIssued" scale="3" id="f-357">4</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 482.25pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 482.25pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.87pt;"></span></span><span style="left: 45.5pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 482.25pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 482.25pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 53.12pt;"></span></span><span style="left: 55.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:IncreaseDecreaseFromFreeSharesIssued" scale="3" id="f-358">1</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 493.5pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Shares based compensation expense<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 493.5pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.12pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 493.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 493.5pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 493.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 493.5pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 493.5pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 30.62pt;"></span></span><span style="left: 33.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-44" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-359">20,224</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 493.5pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 493.5pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 37.37pt;"></span></span><span style="left: 40pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-360">20,224</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 504.75pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction on treasury shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 504.75pt; width: 38.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.12pt; position: var(--position); text-decoration: none; white-space: pre;">13.1<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 504.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 48.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 504.75pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 41.37pt;"></span></span><span style="left: 44pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 504.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.37pt;"></span></span><span style="left: 47pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 504.75pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.54pt;"></span></span><span style="left: 49.17pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 504.75pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.37pt;"></span></span><span style="left: 42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-44" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="f-361">120</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 504.75pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 40.62pt;"></span></span><span style="left: 43.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 504.75pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 46.12pt;"></span></span><span style="left: 48.75pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="f-362">120</ix:nonFraction><span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 516pt; width: 129.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.36pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.76pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 516pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 20.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-363">63,347,837</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 516pt; width: 51.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.87pt;"></span></span><span style="left: 40.5pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-47" decimals="-3" name="ifrs-full:Equity" scale="3" id="f-364">633</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 516pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 28.62pt;"></span></span><span style="left: 31.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-48" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-365">478,905</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 338.25pt; position: var(--position); top: 516pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 44.21pt;"></span></span><span style="left: 46.84pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-49" decimals="-3" sign="-" name="ifrs-full:Equity" scale="3" id="f-366">75</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 516pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 24.79pt;"></span></span><span style="left: 27.419999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-50" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-367">262,637</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 456.75pt; position: var(--position); top: 516pt; width: 51pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 22.54pt;"></span></span><span style="left: 25.169999999999998pt; position: var(--position);">-<ix:nonFraction unitRef="eur" contextRef="c-51" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-368">176,242</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 510.75pt; position: var(--position); top: 516pt; width: 60pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.56pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 37.37pt;"></span></span><span style="left: 40pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-369">40,584</ix:nonFraction><span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 720pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 49.42pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-8<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 583pt;"></div></div><div><div style="position: absolute; top: 72pt;" id="ia894b143b6fc4522a0483350194c625e_280"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 158.85pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA CONSOLIDATED STA<span style="display: inline-block; height: 6.77pt;"></span><span id="i5d09b9068b3f42a381e355b0d20fe321"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 319.07pt; position: var(--position); text-decoration: none; white-space: pre;">TEMENTS OF CASH FLOWS<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="position: var(--position); top: 84pt; width: 612pt;"><div style="font-size: 0pt; left: 31.87pt; position: var(--position); top: 0pt; width: 548.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 302.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.39pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 105.27pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 0pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 9.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 19.02pt; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 360pt; overflow: hidden; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 0.67pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.36pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 9.07pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.93pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 17.47pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.37pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 423.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 0.67pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.36pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 9.07pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.93pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 17.47pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.37pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 487.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 0.67pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.36pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 9.07pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.93pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 17.47pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.37pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 23.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash flows used in operating activities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 34.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-370">60,740</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 34.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-371">147,740</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 34.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-372">176,242</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Adjustments for:<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Elimination of amortization of intangibles and depreciation of property, plant and equipment<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 57pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 22.12pt; position: var(--position); text-decoration: none; white-space: pre;">7, 8<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 57pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="3" id="f-373">485</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 57pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="3" id="f-374">707</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 57pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-375">1,100</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 68.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Elimination of Impairment loss of goodwill<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 68.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 68.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-376">13,632</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 68.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="3" id="f-377">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 68.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="3" id="f-378">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Elimination of retirement benefit obligations<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 79.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 79.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="f-379">143</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 79.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="f-380">109</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 79.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="f-381">74</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Elimination of share-based compensation expenses<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 90.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 90.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-382">1,164</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 90.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AdjustmentsForSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-383">8,179</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 90.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-384">20,224</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Net gain on sale of treasury shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares" scale="3" id="f-385">108</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares" scale="3" id="f-386">34</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares" scale="3" id="f-387">16</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 113.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest expenses and other financial expenses<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 113.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">21<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 113.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:AdjustmentsForOtherFinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-388">7,028</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 113.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:AdjustmentsForOtherFinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-389">24,827</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 113.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:AdjustmentsForOtherFinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-390">14,203</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 124.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial income<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 124.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">21<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 124.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:AdjustmentsForOtherFinanceIncome" scale="3" id="f-391">288</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 124.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:AdjustmentsForOtherFinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-392">2,953</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 124.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:AdjustmentsForOtherFinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-393">11,609</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of unwinding the discount related to advances<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 135.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 135.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 49.21pt;"></span></span><span style="left: 51.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" scale="3" id="f-394">2</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 135.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" scale="3" id="f-395">355</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 135.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" scale="3" id="f-396">710</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in derivatives and liabilities fair value<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 147pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 147pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForFairValueGainsLosses" format="ixt:num-dot-decimal" scale="3" id="f-397">10,817</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 147pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForFairValueGainsLosses" format="ixt:num-dot-decimal" scale="3" id="f-398">1,158</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 147pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForFairValueGainsLosses" format="ixt:num-dot-decimal" scale="3" id="f-399">1,416</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 158.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Income related to forgiveness of conditional advances<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 158.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">17<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 158.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances" format="ixt:fixed-zero" scale="3" id="f-400">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 158.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances" format="ixt:fixed-zero" scale="3" id="f-401">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 158.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-402">4,140</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 169.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 169.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="3" id="f-403">100</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 169.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="3" id="f-404">22</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 169.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="3" id="f-405">204</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash flows used in operating activities before change in working capital requirements<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 180.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" format="ixt:num-dot-decimal" scale="3" id="f-406">51,933</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 180.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" format="ixt:num-dot-decimal" scale="3" id="f-407">118,395</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 180.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" format="ixt:num-dot-decimal" scale="3" id="f-408">155,495</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease / (increase) in other receivables and other assets<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 192pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" scale="3" id="f-409">312</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 192pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-410">14,231</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 192pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-411">4,591</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 203.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase / (decrease) in trade payables<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 203.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" format="ixt:num-dot-decimal" scale="3" id="f-412">2,388</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 203.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" format="ixt:num-dot-decimal" scale="3" id="f-413">31,757</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 203.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" format="ixt:num-dot-decimal" scale="3" id="f-414">3,444</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 214.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase / (decrease) in tax and social security liabilities<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 214.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" scale="3" id="f-415">100</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 214.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-416">3,821</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 214.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-417">1,487</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 225.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase / (decrease) in deferred income and other liabilities<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 225.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" scale="3" id="f-418">26</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 225.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" scale="3" id="f-419">81</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 225.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-420">1,763</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in working capital requirements<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 237pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncreaseDecreaseInWorkingCapital" format="ixt:num-dot-decimal" scale="3" id="f-421">2,002</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 237pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInWorkingCapital" format="ixt:num-dot-decimal" scale="3" id="f-422">21,265</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 237pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInWorkingCapital" format="ixt:num-dot-decimal" scale="3" id="f-423">1,423</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 248.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash flows used in operating activities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 248.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-424">53,936</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 248.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-425">97,130</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 248.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-426">154,072</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 259.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash flows provided by (used in) investing activities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions of intangible assets<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 270.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 270.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="f-427">35</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 270.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 270.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 49.21pt;"></span></span><span style="left: 51.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="f-429">3</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 282pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions of property, plant and equipment<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 282pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">8<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 282pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="f-430">288</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 282pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="f-431">265</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 282pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="f-432">640</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 293.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment / (disbursement) of the advance made to the Nice CHU<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 293.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals" format="ixt:num-dot-decimal" scale="3" id="f-433">3,302</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 293.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 293.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals" format="ixt:fixed-zero" scale="3" id="f-435">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 304.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Advances made to CROs<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 304.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 304.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:PaymentsForAdvancesMadeToContractResearchOrganizations" format="ixt:num-dot-decimal" scale="3" id="f-436">12,187</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 304.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:PaymentsForAdvancesMadeToContractResearchOrganizations" format="ixt:num-dot-decimal" scale="3" id="f-437">1,620</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 304.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:PaymentsForAdvancesMadeToContractResearchOrganizations" scale="3" id="f-438">231</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 315.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Payments for the acquisition of Prosynergia, incl. related costs, net of cash acquired (1)<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 315.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">4.15 &amp; 10<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 315.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="f-439">2,913</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 315.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="f-440">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 315.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="f-441">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 327pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in Deposits<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 327pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 327pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:CashPaymentsForDeposits" scale="3" id="f-442">142</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 327pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:CashPaymentsForDeposits" format="ixt:num-dot-decimal" scale="3" id="f-443">9,351</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 327pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:CashPaymentsForDeposits" scale="3" id="f-444">591</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 338.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease in Deposits<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 338.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 25.62pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 338.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:ProceedsFromReimbursementsOfDeposits" scale="3" id="f-445">218</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 338.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:ProceedsFromReimbursementsOfDeposits" scale="3" id="f-446">741</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 338.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:ProceedsFromReimbursementsOfDeposits" format="ixt:num-dot-decimal" scale="3" id="f-447">9,050</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 349.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest received<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 349.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">21<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 349.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="3" id="f-448">19</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 349.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-449">2,400</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 349.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-450">8,178</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 360.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash flows provided by (used in) investing activities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 360.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-451">12,026</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 360.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-452">8,095</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 360.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-453">15,762</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 372pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash flows provided by (used in) financing activities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 383.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Capital increases<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 383.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">13<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 383.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="3" id="f-454">46,231</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 383.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 32.29pt;"></span></span><span style="left: 34.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="3" id="f-455">353,377</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 383.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:fixed-zero" scale="3" id="f-456">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 394.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs related to capital increase<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 394.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">13<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 394.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit" format="ixt:num-dot-decimal" scale="3" id="f-457">3,280</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 394.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit" format="ixt:num-dot-decimal" scale="3" id="f-458">28,111</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 394.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit" scale="3" id="f-459">446</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 405.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net proceeds from the issuance of non-convertible bond loans<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 405.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 405.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:NetProceedsFromNonConvertibleLoansNotes" format="ixt:fixed-zero" scale="3" id="f-460">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 405.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:NetProceedsFromNonConvertibleLoansNotes" format="ixt:fixed-zero" scale="3" id="f-461">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 405.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:NetProceedsFromNonConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-462">47,944</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 417pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments of non-convertible bond loans <span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 417pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 417pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:RepaymentsOfBondLoans" format="ixt:num-dot-decimal" scale="3" id="f-463">9,410</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 417pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:RepaymentsOfBondLoans" format="ixt:num-dot-decimal" scale="3" id="f-464">11,635</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 417pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:RepaymentsOfBondLoans" format="ixt:fixed-zero" scale="3" id="f-465">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 428.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net proceeds from the issuance of convertible bond loans<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 428.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 428.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:fixed-zero" scale="3" id="f-466">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 428.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-467">55,841</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 428.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:fixed-zero" scale="3" id="f-468">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 439.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.39pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments of convertible bond loans<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 439.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 439.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:fixed-zero" scale="3" id="f-469">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 439.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-470">27,188</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 439.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-471">8,750</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 450.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment of PGE<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 450.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 450.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:RepaymentsOfPGE" format="ixt:fixed-zero" scale="3" id="f-472">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 450.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:RepaymentsOfPGE" format="ixt:num-dot-decimal" scale="3" id="f-473">1,250</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 450.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:RepaymentsOfPGE" format="ixt:num-dot-decimal" scale="3" id="f-474">1,250</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 462pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments of conditional advances<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 462pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 462pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:RepaymentsOfConditionalAdvances" scale="3" id="f-475">90</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 462pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:RepaymentsOfConditionalAdvances" scale="3" id="f-476">110</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 462pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:RepaymentsOfConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-477">2,708</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 473.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Payments of the lease liabilities<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 473.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 473.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="f-478">301</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 473.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="f-479">529</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 473.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 42.21pt;"></span></span><span style="left: 44.84pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="f-480">458</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 484.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net proceeds from sale of royalty certificates<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 484.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 484.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:NetProceedsFromSaleOfRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-481">2,931</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 484.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:NetProceedsFromSaleOfRoyaltyCertificates" format="ixt:fixed-zero" scale="3" id="f-482">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 484.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:NetProceedsFromSaleOfRoyaltyCertificates" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 495.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net proceeds from sale of treasury shares<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 495.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 495.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares" scale="3" id="f-484">143</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 495.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares" scale="3" id="f-485">10</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 495.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares" scale="3" id="f-486">434</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 507pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 507pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 507pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-487">4,015</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 507pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-488">5,279</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 507pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-489">7,696</ix:nonFraction>)<span style="display: inline-block; height: 4.85pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 518.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 518.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 51.54pt;"></span></span><span style="left: 54.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="3" id="f-490">3</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 518.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="3" id="f-491">163</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 518.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 44.54pt;"></span></span><span style="left: 47.17pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="3" id="f-492">245</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 529.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash flows provided by (used in) financing activities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 529.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-493">32,211</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 529.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 32.29pt;"></span></span><span style="left: 34.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-494">335,290</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 529.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-495">28,207</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 540.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of movements in exchange rates on cash held<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 540.75pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">11<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 540.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 48.04pt;"></span></span><span style="left: 50.67pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-496">&#8212;</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 540.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-497">5,072</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 540.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 39.29pt;"></span></span><span style="left: 41.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-498">2,382</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 552pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase (decrease) in cash and cash equivalents<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 552pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-499">33,751</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 552pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 32.29pt;"></span></span><span style="left: 34.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-500">224,992</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 552pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-501">107,720</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 563.25pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents at the beginning of the year<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 563.25pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">11<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 563.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-12" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-502">60,701</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 563.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-503">26,950</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 563.25pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 32.29pt;"></span></span><span style="left: 34.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-504">251,942</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 574.5pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents at the end of the year<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 574.5pt; width: 54.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.5pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 23.87pt; position: var(--position); text-decoration: none; white-space: pre;">11<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 574.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 35.79pt;"></span></span><span style="left: 38.42pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-505">26,950</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 574.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 32.29pt;"></span></span><span style="left: 34.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-506">251,942</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 574.5pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.01pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.85pt; width: 32.29pt;"></span></span><span style="left: 34.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-507">144,221</ix:nonFraction><span style="display: inline-block; height: 4.85pt; width: 2.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 585.75pt; width: 302.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 302.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase (decrease) in cash and cash equivalents<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360pt; position: var(--position); top: 585.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 33.46pt;"></span></span><span style="left: 36.09pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-508">33,751</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 423.75pt; position: var(--position); top: 585.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 32.29pt;"></span></span><span style="left: 34.92pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-509">224,992</ix:nonFraction><span style="display: inline-block; height: 4.74pt; width: 2.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 487.5pt; position: var(--position); top: 585.75pt; width: 60.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.06pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 4.74pt; width: 29.96pt;"></span></span><span style="left: 32.59pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-510">107,720</ix:nonFraction>)<span style="display: inline-block; height: 4.74pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 698pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 50.4pt; position: var(--position);">(1)<span style="display: inline-block; height: 4.85pt; width: 27.84pt;"></span></span></span><ix:footnote id="fn-2" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 86.4pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia SARL (or "Prosynergia"<span style="display: inline-block; height: 4.85pt;"></span></span></ix:footnote><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 190.20000000000002pt; position: var(--position); white-space: pre;">)<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.05pt; position: var(--position); white-space: pre;">F-9<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 70.56pt;" id="ia894b143b6fc4522a0483350194c625e_283"></div><div style="line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 175.23pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA NOTES TO THE FINANCIAL STATEMENTS <span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="position: absolute; top: 92.56pt;" id="ia894b143b6fc4522a0483350194c625e_286"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 1. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" id="f-511" continuedAt="f-511-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">The Group <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><div style="position: absolute; top: 108.56pt;" id="ia894b143b6fc4522a0483350194c625e_289"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108.56pt; width: 612pt;"><ix:continuation id="f-511-1" continuedAt="f-511-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 1.1. Information on the Group and its business <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-511-2" continuedAt="f-511-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA (the &#8220;Company&#8221;) is a soci&#233;t&#233; anonyme incorporated under the laws of France on December 4, 2013. Its registered office <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">is located at 7-11 Boulevard Haussmann&#8212;75009 Paris, France. The Company is developing therapeutics that harness the body&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These consolidated financial statements as of and for the year ended December 31, 2024 comprise the Company and ABIVAX LLC <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 189.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(the &#8220;Subsidiary&#8221;), the United States subsidiary of ABIVAX SA, created on March 20, 2023 under the laws of the State of Delaware <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(together referred to as the &#8220;Group<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8221;).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has incurred losses since its inception and had shareholders&#8217; equity of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.67pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.17pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-512">40,584</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.67pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.17pt; position: var(--position); text-decoration: none; white-space: pre;">thousand as<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.08pt; position: var(--position); text-decoration: none; white-space: pre;"> of December 31, 2024. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group anticipates incurring additional losses until such time, if ever, that it can generate significant revenue from its drug candidates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which are currently under development. Substantial additional financing will be needed by the Group to fund its operations and to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commercially develop its drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group's future operations are highly dependent on a combination of factors, including: (i)&#160;the success of its research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">development activities; (ii)&#160;regulatory approval and market acceptance of its proposed future products; (iii)&#160;the timely and successful <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">completion of additional financing and (iv)&#160;the development of competitive therapies by other biotechnology and pharmaceutical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">companies. As a result, the Group is, and expects to continue to be, in the short to mid-term, financed through the issuance of new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">equity or debt instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is focusing its efforts on the following points: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 360.16pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Continuation of the Phase 3 clinical trial program (ABTECT) for obefazimod in moderately to severely active ulcerative <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">colitis (&#8220;UC&#8221;) <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 387.04pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Initiating the Phase 2b clinical trial (ENHANCE-CD) of obefazimod in Crohn&#8217;s disease (&#8220;CD&#8221;). <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 400.48pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Evaluating oral or injectable combination therapy candidates with obefazimod in UC.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 413.92pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Selecting a follow-on candidate for obefazimod. <span style="display: inline-block; height: 8.73pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 457.36pt;" id="ia894b143b6fc4522a0483350194c625e_292"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 457.36pt; width: 612pt;"><ix:continuation id="f-511-3" continuedAt="f-511-4"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 1.2. Date of authorization of issuance <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-511-4" continuedAt="f-511-5"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements and related notes (the &#8220;financial statements&#8221;) have been prepared under the responsibility of <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.36pt; width: 612pt;"><ix:continuation id="f-511-5" continuedAt="f-511-6"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">management of the Group and were approved and authorized for issuance by the Group&#8217;s board of directors on <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.24pt; position: var(--position); text-decoration: none; white-space: pre;">March 20, 2025<span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.8199999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-511-6">.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 511.36pt;" id="ia894b143b6fc4522a0483350194c625e_295"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 2. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" id="f-513" continuedAt="f-513-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Basis of preparation <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-513-1" continuedAt="f-513-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 533.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Except for share data and per share amounts, the financial statements are presented in thousands of euros. Amounts are rounded up or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">down the nearest whole number for the calculation of certain financial data and other information contained in these accounts. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accordingly, the total amounts presented in certain tables may not be the exact sum of the preceding figures. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-10<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-513-2" continuedAt="f-513-3"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:StatementOfIFRSCompliance" id="f-514" continuedAt="f-514-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Statement of compliance <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-514-1" continuedAt="f-514-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements of the Group as of and for the years ended December 31, 2022, 2023 and 2024 have been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prepared in accordance with both International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Standard Board (&#8220;IASB&#8221;) and IFRS as adopted by the European Union (&#8220;EU&#8221;) regulation n&#176;1606/2002 of July 19, 2002. The term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;IFRS&#8221; refers collectively to International Accounting Standards (&#8220;IAS&#8221;) and IFRS as well as the interpretations issued by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Standing Interpretations Committee (&#8220;SIC&#8221;) and the International Financial Reporting Interpretations Standards Committee (&#8220;IFRS <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-514-2">IC&#8221;), whose application is mandatory for the year ended December 31, 2024.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Preparation of the financial statements <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 209.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements of the Group were prepared on a historical cost basis, with the exception of certain asset and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">liability categories and in accordance with the provisions set out in IFRS such as employee benefits measured using the projected unit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit method, the Heights notes (classified under "Convertible loan notes") measured at fair value and derivative financial instruments <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 243.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured at fair value. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.47pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" id="f-515" continuedAt="f-515-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Going concern <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-515-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has incurre<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">d substantial operating losses since inception and expects to continue to incur significant operating losses for the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">foreseeab</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">le future and may never become profitable. For the year ended December 31, 2024, the Group had a net loss <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.08pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-516">176,242</ix:nonFraction> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Since inception, the Group has financed its operations through the issuance of ordinary shares wi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">th gross aggregate proceeds of </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-52" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="6" id="f-517">557.2</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.85pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, of which </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.6pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-53" decimals="-6" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="6" id="f-518">130</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of gross proceeds were from offerings of its ordinary shares on Euronext Paris in February 2023 </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.93pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-54" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="6" id="f-519">223.3</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.78pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of gross proceeds were from its </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.5pt; position: var(--position); text-decoration: none; white-space: pre;">offering of ordinary shares in the form of American Depository Shares ("ADS") on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 378.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Nasdaq Global Market as well as ordinary shares in Europe (including France) and countries outside of the United States in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">private placement in October 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, ba</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;">nk borrowings and structured loans<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.15pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> for </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-52" decimals="-5" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-520">175.0</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.66pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursements of Research Tax Credits <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Cr&#233;dit d&#8217;Imp&#244;t Recherche (&#8220;CIR&#8221;)) in an aggregate amo<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.85pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">unt of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-52" decimals="-5" name="abvx:ProceedsFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="6" id="f-521">35.6</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, subsidies received from Banque Publique </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">d&#8217;Investissement (&#8220;Bpifrance&#8221;) (including </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.17pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-55" decimals="-5" name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-522">17.1</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of subsidies and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-55" decimals="-5" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="6" id="f-523">1.8</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.27pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of conditional advances) and royalty certificates </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">in an amount of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-52" decimals="-5" name="abvx:NetProceedsFromSaleOfRoyaltyCertificates" format="ixt:num-dot-decimal" scale="6" id="f-524">2.9</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.35pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Based on (a) the Group&#8217;s existing cash and cash equivalents <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.52pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-5" name="ifrs-full:CashAndCashEquivalents" scale="6" id="f-525">144.2</ix:nonFraction> million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.2pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2024 and (b) the expected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement of the CIR from 2024 in the second half of 2025 amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-56" decimals="-5" name="abvx:ProceedsFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="6" id="f-526">5.7</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.47pt; position: var(--position); text-decoration: none; white-space: pre;">, the Group expects, as of the date of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance of these financial statements, to be able to fund its forecasted cash flow requirements into the fourth quarter of 2025. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">takes into account management's assumptions of higher R&amp;D expenditure in 2024 and into 2025 driven by the progression of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 clinical trials of obefazimod in UC and the initiation of the Phase 2b clinical trials for CD. Under these assumptions and based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on the Group's current clinical and operational plans, the Group would have sufficient funds to finance its operations in the fourth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">quarter of 2025, i.e. through the announcement of its top-line data from the Phase 3 ABTECT-1 and ABTECT-2 induction trials for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">UC in the third quarter of 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The elements referred to above, as well as (c) the Group's expectation to generate operating losses and negative operating cash flows <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the future, and (d) the need for additional fundi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.68pt; position: var(--position); text-decoration: none; white-space: pre;">ng to support its planned operations, result in a material uncertainty that may cast <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">significant doubt (or raise substantial doubt as contemplated by Public Company Accounting Oversight Board standards) regarding its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ability to continue as a going concern for a period of one year after the date that these consolidated financial statements ar<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.8299999999999pt; position: var(--position); text-decoration: none; white-space: pre;">e issued.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.24pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.74pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.84pt; position: var(--position); text-decoration: none; white-space: pre;">he<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.27pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group continues to monitor its spending of 2025 expenses, ensuring strict adherence to the approved budget, which may include <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">projected savings through the gating of non essential spend and to pursue additional cash resources through public or private equity or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">debt financing<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.43pt; position: var(--position); text-decoration: none; white-space: pre;">s, regional out licensing agreements and/or royalty financing<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.92pt; position: var(--position); text-decoration: none; white-space: pre;">. The Group has concluded that substantial doubt exists <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">about the Group&#8217;s ability to continue as a going concern for a period of at least 12 months from the date of issuance of these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consolidated financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary if the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group is unable to continue as a going concern.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-11<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-513-3" continuedAt="f-513-4"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" id="f-527" continuedAt="f-527-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Impact of the Ukraine/Russia Hostilities on the Group <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-527-1" continuedAt="f-527-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In February 2022, Russia invaded Ukraine. The conflict has already had major implications for the global economy and the rate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inflation, particularly in relation to the supply of energy, raw materials and food products. It has also caused intense volatility on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial markets, something that is still ongoing at the reporting date and has pushed down stock market prices around the world. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Given these developments, the Group has decided not to include Russia and Belarus in its global Phase 3 program for obefazimod in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">UC. However, the global scale of this conflict cannot be predicted at this stage. The Group, therefore, cannot rule out an adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impact of this conflict on its business, including in terms of access to raw materials, logistics, the performance of clinical studies and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in relation to any future financing the Group may seek. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 193.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The long-term safety and efficacy extension of the<span style="display: inline-block; height: 8.25pt;"></span></span><span style="color: #ff0000; font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 237.68pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.16pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2b maintenance trial of obefazimod in moderately to severely active UC is <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s only clinical trial with patients currently enrolled in Ukraine.&#160; The Phase 2b 12-month assessment was carried out in all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Ukrainian patients before the war broke out and these patients are therefore included in the one-year maintenance results that were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reported on April 6, 2022. Ukrainian patients who completed the two-year Phase 2b maintenance trial have been transitioned to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.28pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">long-term safety and efficacy trial that is still on-going. T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.7pt; position: var(--position); text-decoration: none; white-space: pre;">he Group also has a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.02pt; position: var(--position); text-decoration: none; white-space: pre;">few<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362pt; position: var(--position); text-decoration: none; white-space: pre;"> Ukrainian sites active in the western part of Ukraine <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the ABTECT Phase 3 clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.95pt; position: var(--position); text-decoration: none; white-space: pre;"> None of these sites are located in the Crimea Region of Ukraine, the so-called Donetsk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">People&#8217;s Republic, or the so-called Luhansk People&#8217;s Republic. We continue to monitor developments in the region, but any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instability as a result of the war may have material adverse impacts on these clinical sites, which could negatively impact our Phase 3 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Together with its CROs, the Group is making considerable efforts to ensure the follow-up of patients who are unable to come to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">study centers. Monitoring takes place through a remote monitoring system that was established and used successfully during the <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.88pt; width: 612pt;"><ix:continuation id="f-527-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 pandemic.<span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.81pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.08pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" id="f-528" continuedAt="f-528-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">New, revised or amended Standards and Interpretations <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-528-1" continuedAt="f-528-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group applied the following amendments to IFRS that are effective as of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.14pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.68pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.95pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 403.58pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.02pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants; <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 91.05pt; position: var(--position);">Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures &#8211; Supplier Finance <span style="display: inline-block; height: 6.93pt; width: 5.91pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 441.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Agreements; and<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group assessed the impacts resulting from the application of these issued accounting pronouncements and concluded that impacts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are not material, with the exception of the amendments to IAS 1, issued in 2020 and 2022, which aim at clarifying the requirements on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">determining whether a liability is current or non-current, and require new disclosures for non-current liabilities that are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future covenants. In accordance with these amendments, an entity shall classify a liability as current when it does not have the right at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These amendments can impact liabilities with covenants which breach can render the related liabilities repayable within 12 months. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">However, the Group has no such liabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Under the amendments, a settlement of a liability includes transferring an entity's own equity instruments to the counterparty. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Therefore, if a liability has any conversion options that involve a transfer of the entity's own equity instruments, then these generally </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">affect its classification as current or non-current. As an exception, if these conversion options are recognized as equity under IAS 32, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">then they do not affect the current or non-current classification of the liability.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As disclosed in Notes 15.1, 15.2 and 15.5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.3pt; position: var(--position); text-decoration: none; white-space: pre;"> the Group has co<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nvertible notes (respectively the Kreos / Claret OCABSA, the Heights </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.26pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">convertible notes (as of December 31, 2023 and 2024) and the OCEANE bonds (as of December 31, 2022), as defined below) that are </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">convertible into a potentially variable number of ordinary shares of the Group at any time at the option of the noteholders. Despite the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">fact that the Group has the unconditional right to defer the settlement of such convertible notes into cash beyond twelve months, in </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">application of these amendments, the Group will no longer be considered to have an unconditional right to defer the settlements of the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Heights convertible notes and the OCEANE bonds due to their conversion options that are embedded derivatives not recognized as </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 699.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">equity components. Consequently, the amendments led to the reclassification of these convertible notes as current liabilities on a </span><span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-12<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-513-4" continuedAt="f-513-5"><div><ix:continuation id="f-528-2" continuedAt="f-528-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">retrospective basis:</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2022, the carrying value of the OCEANE bonds </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.54pt; position: var(--position); text-decoration: none; white-space: pre;">was<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.08pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-57" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-529">19,957</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;">, of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.42pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-57" decimals="-3" name="abvx:NonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-530">19,332</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.51pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> were </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">classified within non-current financial liabilities in the Grou</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.95pt; position: var(--position); text-decoration: none; white-space: pre;">p&#8217;s annual financial statements for the year ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2022. In application of these amendments, all of the carrying value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-58" decimals="-3" name="abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-531">19,957</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.88pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> is now presented within current </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">financial liabilities.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 145.46pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2023, the carrying value of the Heights convertible notes was </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.77pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-59" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-532">29,605</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, of which </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-59" decimals="-3" name="abvx:NonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-533">20,652</ix:nonFraction> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> were classified within non-current financial liabilities in the Group&#8217;s annual financial statements for the year ended </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.86pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">December 31, 2023. In application of these amendments, all of the carrying value of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.33pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-60" decimals="-3" name="abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-534">29,605</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> is now presented </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">within current financial liabilities.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">The classification of the Kreos / Claret OCABSA will not be impacted since they are compound instruments with conversion option </span><span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 209.66pt; width: 612pt;"><ix:continuation id="f-528-3"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and attached OCABSA warrants recognized as an equity component.</span><span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.07pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.36pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" id="f-535" continuedAt="f-535-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-535-1" continuedAt="f-535-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2024 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group did not elect for early application of the following new standards, amendments and interpretations, which were issued but <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">not mandatory as of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.15pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.69pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-13<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-535-2" continuedAt="f-535-3"><ix:continuation id="f-513-5" continuedAt="f-513-6"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates &#8211; Lack of Exchangeability whose application <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">is for annual reporting periods beginning on or after January 1, 2025;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 103.56pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#8211; Amendments to the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Classification and Measurement of Financial Instruments, whose application is for annual reporting periods beginning on <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">or after January 1, 2026 (not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 143.88pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#8211; Contracts Referencing <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 157.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Nature-dependent Electricity, whose application is for annual reporting periods beginning on or after January 1, 2026 <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">(not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 184.2pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 18 Presentation and Disclosure in Financial Statements, whose application is for annual reporting periods <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 197.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">beginning on or after January 1, 2027 (not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 211.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.89pt;">IFRS 19 Subsidiaries without Public Accountability: Disclosures, whose application is for annual reporting periods<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.89pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 222.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 288.94pt;">beginning on or after January 1, 2027 (not yet approved by the UE), and<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 233.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.99pt;">Annual Improvements Volume 11, whose application is for annual reporting periods beginning on or after January 1,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.99pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 244.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 141.84pt;">2026 (not yet approved by the UE).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.58pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These texts have not been early adopted. The expected impacts are not considered significant, except for IFRS 18, for which the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 288.78pt; width: 612pt;"><ix:continuation id="f-535-3"><ix:continuation id="f-513-6"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">has not completed its assessment to date.<span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.41pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 317.98pt;" id="ia894b143b6fc4522a0483350194c625e_298"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" id="f-536" continuedAt="f-536-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 140.48pt; position: var(--position); text-decoration: none; white-space: pre;">Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><div style="position: absolute; top: 333.98pt;" id="ia894b143b6fc4522a0483350194c625e_301"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 333.98pt; width: 612pt;"><ix:continuation id="f-536-1" continuedAt="f-536-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.1. For the year ended December 31, 2022 <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-536-2" continuedAt="f-536-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition of Prosynergia SARL &#8211; April 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 365.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On April 1, 2022, the Company acquired <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.26pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-61" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-537">100</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.59pt; position: var(--position); text-decoration: none; white-space: pre;"> of the share capital of Prosynergia SARL (or &#8220;Prosynergia&#8221;), a Luxembourg biotech <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">company, in order to strengthen its portfolio. The terms of the share purchase acquisition (or the &#8220;Prosynergia SPA&#8221;) entered on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 385.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">November 15, 2021 included an early payment of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-62" decimals="-3" name="abvx:CashPrepaymentAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-538">325</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.79pt; position: var(--position); text-decoration: none; white-space: pre;"> made on November 25, 2021 (see Note 10), an additional payment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 395.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:CashTransferredAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-539">2,925</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> made on April 1, 2022, and possible earn-out payments for a maximum additional amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:EarnOutMaximumAmount" format="ixt:num-dot-decimal" scale="3" id="f-540">4,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 544.5pt; position: var(--position); text-decoration: none; white-space: pre;"> based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on the potential evolution of the Company&#8217;s market capitalization, a listing of the Company&#8217;s shares on Nasdaq or a M&amp;A transaction <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">incurred before March 31, 2023. In addition, the Company granted a loan of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-64" decimals="-3" name="ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-541">1,400</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.03pt; position: var(--position); text-decoration: none; white-space: pre;"> to Prosynergia on December 1, 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which term was at least on December 31, 2025 or at an earlier date in the event of a breach in the Prosynergia SPA (see Note 10, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Other receivables and assets&#8221;). Such prepayment was repayable in cash only in the event the transaction is not completed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 457.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement or out-licensed agreement, it does not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">April 1, 2022, without recognition of goodwill. Also, the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:LoanGrantedAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-542">1,400</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.65pt; position: var(--position); text-decoration: none; white-space: pre;"> loan granted to Prosynergia in December 2021 was included <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the acquisition cost to be allocated, as it is considered a prepayment for the acquisition of the group of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.89pt; position: var(--position); text-decoration: none; white-space: pre;">assets<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.19pt; position: var(--position); text-decoration: none; white-space: pre;">. Refer to Note 25.6 for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">information related to the claim initiated by the former owner of Prosynergia on December 12, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Merger with Prosynergia &#8211; December 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 551.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On December&#160;12, 2022, the Company completed the merger with Prosynergia under the French legal procedure called &#8220;Transmission <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 561.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Universelle de Patrimoine<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 140.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8221;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.86pt; position: var(--position); text-decoration: none; white-space: pre;"> (universal transfer of assets and liabilities). All of Prosynergia&#8217;s assets and liabilities were transferred to <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Company and Prosynergia was dissolved. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 593.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of ABX196 cash-generating unit <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the first half of 2022, management took into account significant external changes in the hepatocellular carcinoma (HC) treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">landscape. These changes are expected to require a new, lengthy, heavy and risky internal development process (use of a combination <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of compounds). In this context, entering into a licensing partnership to fund the completion of the clinical development of ABX196 is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the option being considered. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">However, due to the lack of progress made in the negotiation of a development partnership, the Company made the decision to freeze <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the development program for ABX196 in the treatment of hepatocellular cancer. This decision led to the full impairment of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 683.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ABX196 goodwill, i.e. an impairment loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-65" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-543">13,586</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.27pt; position: var(--position); text-decoration: none; white-space: pre;"> related to Wittycell&#8217;s goodwill and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-65" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-544">45</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.11pt; position: var(--position); text-decoration: none; white-space: pre;"> related to licenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December&#160;31, 2022, the value in use and the fair value less costs to sell of the ABX196 cash-generating unit (&#8220;CGU&#8221;) are <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 549.33pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-66" decimals="-3" name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" format="ixt:fixed-zero" scale="0" id="f-545">nil</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.87pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-14<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-536-3" continuedAt="f-536-4"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Forfeiture of AGA plans <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September 2021 were subject to vesting conditions including the completion of a M&amp;A transaction on or prior to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">July 31, 2022. As the non-market performance vesting conditions were not satisfied, the Company recognized a reversal of related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">compensation expense of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-67" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-546">1,026</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and accrual for social taxes of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-67" decimals="-3" sign="-" name="abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" format="ixt:num-dot-decimal" scale="3" id="f-547">205</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.73pt; position: var(--position); text-decoration: none; white-space: pre;"> in the financial statements for the period <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ended December&#160;31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment of the advance made to Nice CHU &#8211; August 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-68" decimals="-3" name="abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals" format="ixt:num-dot-decimal" scale="3" id="f-548">4,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.12pt; position: var(--position); text-decoration: none; white-space: pre;"> advance made to Nice CHU was reimbursed in August 2022 for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-69" decimals="-3" sign="-" name="abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals" format="ixt:num-dot-decimal" scale="3" id="f-549">3,302</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.31pt; position: var(--position); text-decoration: none; white-space: pre;">. The remaining <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-70" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-550">698</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.89pt; position: var(--position); text-decoration: none; white-space: pre;"> was settled by way of compensation with a payable due to the Nice CHU related to the recharge of third-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">party services expenses that had been invoiced to the Nice CHU as part of the miR-AGE project (see Note 10, &#8220;Other receivables and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets&#8221;). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance &#8211; August 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August&#160;16, 2022, the Company announced a transition in the chairmanship of its Board of Directors. Philippe Pouletty, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Company&#8217;s founder and Chairman of the Board of Directors since the Company was created in 2013, informed the Board of Directors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of his decision to resign as Chairman with immediate effect. However, after many years of successfully leading the Board of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Directors, Mr.&#160;Pouletty continued to support the Company&#8217;s development as a member of the Board of Directors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pending the appointment of a new, permanent independent Chair, Ms.&#160;Corinna zur Bonsen-Thomas, an independent member of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors of the Company, carried out the role of interim Chair.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Company completed <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 137.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-71" decimals="-5" name="abvx:FinancialAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="f-551">49.2</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 191.15pt; position: var(--position); text-decoration: none; white-space: pre;"> cross-over financing with top-tier US and European investors &#8211; September 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On September 2, 2022, the Company announced oversubscribed financing of around <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.11pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-71" decimals="-5" name="abvx:FinancialAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="f-552">49.2</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.96pt; position: var(--position); text-decoration: none; white-space: pre;">, led by TCGX with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">participation of Venrock Healthcare Capital Partners, Deep Track Capital, Sofinnova Partners, Invus and Truffle Capital, top-tier <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">investors specializing in the biotechnology sector. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The financing consists of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="transaction" contextRef="c-72" decimals="INF" name="abvx:FinancialAgreementNumberOfTransactions" format="ixt-sec:numwordsen" scale="0" id="f-553">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.22pt; position: var(--position); text-decoration: none; white-space: pre;"> transactions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">a reserved capital increase of a gross amount of approximately <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-72" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="6" id="f-554">46.2</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.34999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> through the issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.32pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-72" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-555">5,530,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.32pt; position: var(--position); text-decoration: none; white-space: pre;"> new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">shares with a nominal value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-71" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-556">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.41000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, representing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-71" decimals="2" name="abvx:EquityIssuancePercentageOfCurrentShareCapital" scale="-2" id="f-557">33</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> of its current share capital, at a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-71" decimals="2" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-558">8.36</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.55pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">an issue of royalty certificates with a subscription price amounting to <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-72" decimals="-5" name="abvx:NetProceedsFromSaleOfRoyaltyCertificates" format="ixt:num-dot-decimal" scale="6" id="f-559">2.9</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.72999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">. The royalty certificates give right to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">their holders to royalties equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-72" decimals="2" name="abvx:RoyaltyCertificatePercentageOfFutureSales" scale="-2" id="f-560">2</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.66000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> of the future net sales of obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-15<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-536-4" continuedAt="f-536-5"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(worldwide and for all indications) as from the commercialization of such product. The amount of royalties that may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">paid under the royalty certificates is capped at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-71" decimals="-6" name="abvx:RoyaltyCertificateMaximumAmount" format="ixt:num-dot-decimal" scale="6" id="f-561">172</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.79pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The proceeds of the financing were primarily used to fund the advancement of Phase 3 clinical trials for obefazimod in ulcerative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">colitis. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Related transaction costs amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-73" decimals="-5" name="ifrs-full:ShareIssueRelatedCost" format="ixt:num-dot-decimal" scale="6" id="f-562">3.3</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.81pt; position: var(--position); text-decoration: none; white-space: pre;"> and were deducted from the share premiums. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates are recorded as financial liabilities at amortized cost (see Note 15.10). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Company announces first U.S. patient enrollment in global Phase 3 program with obefazimod in UC&#160;&#8211;&#160;October 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October&#160;11, 2022, the Company announced that the first patient was enrolled in the United States into its global Phase 3 clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program with product candidate obefazimod for the treatment of moderately to severely active UC. IQVIA, a global premier contract <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">research organization, is responsible for coordinating the Company&#8217;s Phase 3 clinical trial for obefazimod in UC. As of December&#160;31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022, the undiscounted amount of the advance payments made by the Company in relation to the IQVIA agreement is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-74" decimals="-3" name="abvx:PaymentsForAdvancesMadeToContractResearchOrganizations" format="ixt:num-dot-decimal" scale="3" id="f-563">12,187</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">. They were recorded at inception at their fair value (discounted amount) and subsequently measured at amortized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">cost calculated using the effective interest rate method. As of December&#160;31, 2022, their carrying amount is <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:NonCurrentAdvancesToCROContracts" format="ixt:num-dot-decimal" scale="3" id="f-564">10,471</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.44pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540.44pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">repayment dates of these advances are scheduled between April 2025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.15pt; position: var(--position); text-decoration: none; white-space: pre;"> and July 2026 (see Note 9).<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 316.56pt;" id="ia894b143b6fc4522a0483350194c625e_304"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 326.56pt; width: 612pt;"><ix:continuation id="f-536-5" continuedAt="f-536-6"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.2. For the year ended December 31, 2023 <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-536-6" continuedAt="f-536-7"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Company announces successful oversubscribed <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 246.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-75" decimals="-3" name="abvx:FinancialAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="f-565">130.0</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 304.4pt; position: var(--position); text-decoration: none; white-space: pre;"> cross-over financing at market price with top-tier U.S. and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">European Biotech investors &#8211; February 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February&#160;22, 2023, the Company announced the successful pricing of an oversubscribed <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-75" decimals="-5" name="abvx:FinancialAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="f-566">130.0</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.82pt; position: var(--position); text-decoration: none; white-space: pre;"> financing with high-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">quality U.S. and European biotech specialist investors, led by TCGX, with participation from existing investors Invus, Deep Track <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Capital, Sofinnova Partners, and Venrock Healthcare Capital Partners, as well as from new investors Great Point Partners, LLC, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deerfield Management Company, Commodore Capital, Samsara BioCapital, Boxer Capital and others, by way of a reserved capital <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-76" decimals="-6" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="6" id="f-567">130</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.39pt; position: var(--position); text-decoration: none; white-space: pre;"> through the issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-568">20,000,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.36pt; position: var(--position); text-decoration: none; white-space: pre;"> newly-issued ordinary shares with a nominal value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-75" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-569">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 517.81pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">representing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.88pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-77" decimals="3" name="abvx:EquityIssuancePercentageOfCurrentShareCapital" scale="-2" id="f-570">89.6</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.71pt; position: var(--position); text-decoration: none; white-space: pre;"> of its current share capital, at a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.21pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-75" decimals="2" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-571">6.50</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.71pt; position: var(--position); text-decoration: none; white-space: pre;"> per share. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Related transaction costs amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-78" decimals="-5" name="ifrs-full:ShareIssueRelatedCost" format="ixt:num-dot-decimal" scale="6" id="f-572">6.7</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.81pt; position: var(--position); text-decoration: none; white-space: pre;"> and were deducted from the share premiums. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance and management &#8211; February-August 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On April&#160;5, 2023, the Company announced the appointment of Marc de Garidel as Chief Executive Officer (&#8220;CEO&#8221;) and Interim <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Board Chair, effective May&#160;5, 2023. Corinna zur Bonsen-Thomas stepped down as acting Chair, a position she held since August <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022, and remains a Board Member. Prof. Hartmut J. Ehrlich, M.D., retired from the CEO position, which he held since the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Company&#8217;s founding in 2013,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.95pt; position: var(--position); text-decoration: none; white-space: pre;"> and will stay on as a strategic advisor until the transition is complete. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February 17, 2023, and April 18, 2023, the Company respectively announced the appointments of Dr. Sheldon Sloan, M.D., M. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bioethics as new Chief Medical Officer and Michael Ferguson as new Chief Commercial Officer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On July 11, 2023, the Group announced the appointments of June Lee, M.D. and Troy Ignelzi as new independent members of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s Board of Directors, replacing Joy Amundson and Jean-Jacques Bertrand. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 23, 2023, the Group announced the appointment of Patrick Malloy as new Senior Vice President Investor Relations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 638.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Creation of Abivax LLC &#8211; March 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On March&#160;20, 2023, Abivax LLC (or the "Subsidiary&#8221;), was incorporated as a<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 347.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.81pt; position: var(--position); text-decoration: none; white-space: pre;">limited liability company<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 450.77pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.27pt; position: var(--position); text-decoration: none; white-space: pre;">under the laws of Delaware. <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of the issuance of the financial statements, the Company has full ownership over the Subsidiary. The Subsidiary hosts the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operations in the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-16<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-536-7" continuedAt="f-536-8"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Cashless exercise of the Kreos A&amp;B BSA &#8211; May 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, Kreos Capital V UK Ltd (or &#8220;Kreos&#8221;) opted for the cashless exercise option of the share warrants they held (as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">defined in Note 15.3), implemented through the repurchase by the Group of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.27pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="abvx:NumberOfOtherShareWarrantsRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-573">43,070</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.77pt; position: var(--position); text-decoration: none; white-space: pre;"> tranche A share warrants (&#8220;Kreos A BSA&#8221;) and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="0" name="abvx:NumberOfOtherShareWarrantsRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-574">43,070</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"> tranche B share warrants (&#8220;Kreos B BSA&#8221;) and the issuance of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.07pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-575">67,887</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.57pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 417pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-576">31,696</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.5pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares, as a result of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the exercise by Kreos of the outstanding Kreos A &amp; B BSA. The accounting treatment of the operation is set forth in Note 15.3.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Free shares compensation plans&#160; &#8211; July-December 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In July, September and December 2023, the Group issued <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.40999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="plan" contextRef="c-81" decimals="INF" name="abvx:NumberOfShareBasedCompensationPlansIssued" format="ixt-sec:numwordsen" scale="0" id="f-577">five</ix:nonFraction><span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.94pt; position: var(--position); text-decoration: none; white-space: pre;"> free shares compensation plans (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 417.84pt; position: var(--position); text-decoration: none; white-space: pre;">attributions gratuites d&#8217;actions<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;AGAs&#8221;) to certain of its officers and employees, representing a maximum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.24pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-81" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-578">2,601,296</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.24pt; position: var(--position); text-decoration: none; white-space: pre;"> shares in the aggregate. The detailed terms <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and conditions and the accounting treatment of these plans are presented in Note 14.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group secures financing up to <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 177.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-82" decimals="-6" name="abvx:FinancialAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="f-579">150</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 228.37pt; position: var(--position); text-decoration: none; white-space: pre;"> from <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 252.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="transaction" contextRef="c-83" decimals="INF" name="abvx:FinancialAgreementNumberOfTransactions" format="ixt-sec:numwordsen" scale="0" id="f-580">two</ix:nonFraction><span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 266.68pt; position: var(--position); text-decoration: none; white-space: pre;"> structured debt financing transactions &#8211; August 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 20, 2023, the Group concurrently signed <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.43pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="transaction" contextRef="c-83" decimals="INF" name="abvx:FinancialAgreementNumberOfTransactions" format="ixt-sec:numwordsen" scale="0" id="f-581">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.41999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> structured debt financing transactions for a total amount of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-82" decimals="-6" name="abvx:FinancialAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="f-582">150</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.26pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consisting of (i) up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-84" decimals="-6" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-583">75</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.9pt; position: var(--position); text-decoration: none; white-space: pre;"> from Kreos Capital and Claret European Growth Capital (the &#8220;Kreos / Claret Financing&#8221;) together <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with the issuance of warrants (&#8220;the Kreos / Claret BSA&#8221;) exercisable to receive ordinary shares of the Company, for an aggregate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercise price of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-85" decimals="-6" name="abvx:AggregateExercisePriceOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="6" id="f-584">8</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.62pt; position: var(--position); text-decoration: none; white-space: pre;"> and (ii) up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-86" decimals="-6" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-585">75</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;"> from a fund advised by Heights Capital Management, Inc. (the &#8220;Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financing&#8221; and together with the Kreos / Claret Financing, the &#8220;Transaction&#8221;). The detailed structure and characteristics of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction are set forth<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> in Notes 15.1 and 15.2.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The first tranches of the Kreos / Claret Financing and the Heights Financing, for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-87" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-586">25</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.6pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-88" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-587">35</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.38pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively, were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 327.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">drawn on August 22, 2023, and August 24, 2023, respectively. In addition, the Group concurrently granted to Kreos and Claret, for no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">additional consideration, warrants exercisable to receive ordinary shares of the Company for an aggregate exercise price of up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-89" decimals="-6" name="abvx:AggregateExercisePriceOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="6" id="f-588">4</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.35pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the Transaction, the Group is also repaying in full a total outstanding amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-90" decimals="-6" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="6" id="f-589">33</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.87pt; position: var(--position); text-decoration: none; white-space: pre;"> under (i) the pre-existing debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreements with Kreos for a total amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.24pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-91" decimals="-6" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="6" id="f-590">8</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> and (ii) the pre-existing OCEANE bonds for a total amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.68pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-92" decimals="-6" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="6" id="f-591">25</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.03pt; position: var(--position); text-decoration: none; white-space: pre;"> by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">way of set-off with the Heights Financing, thereby fully repaying such pre-existing indebtedness. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The net proceeds of the drawdown of the first tranche of the Kreos / Claret Financing and of the Heights Financing which, net of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">refinancing of the existing indebtedness, amount to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-93" decimals="-6" name="abvx:ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" format="ixt:num-dot-decimal" scale="6" id="f-592">27</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate, are expected to be allocated mainly to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">development of obefazimod for the treatment of adults with moderately to severely active UC and other potential chronic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory indications, as well for working capital and general corporate purposes of the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On November 2, 2023, the Group granted additional warrants to Kreos and Claret, for an aggregate exercise price of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.5899999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-94" decimals="-6" name="abvx:IssuanceOfOtherShareWarrants" format="ixt:num-dot-decimal" scale="6" id="f-593">4</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in order to secure the future drawdown of the third tranche of the Kreos / Claret debt financing. The detailed characteristics of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance is set forth in Note 15.1.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 518.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group announces closing of its Initial Public Offering on the Nasdaq Global Market &#8211; October 2023&#160;  <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October 24, 2023, the Group announced the closing of its previously announced initial public offering on the Nasdaq Global <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Market by way of a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.9pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-95" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-594">20,325,500</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.9pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares, consisting of a public offering of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.65pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-595">18,699,460</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.65pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the form of American Depositary Shares (&#8220;ADSs&#8221;), each representing the right to receive <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.83pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="INF" name="abvx:NumberOfSharesReceivedPerADS" format="ixt-sec:numwordsen" scale="0" id="f-596">one</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary share, in the United States <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(the &#8220;U.S. Offering&#8221;), and a concurrent offering of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.51pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-97" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-597">1,626,040</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.51pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares in certain jurisdictions outside of the United States to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 586.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certain investors (the &#8220;European Private Placement&#8221;, and together with the U.S. offering, the &#8220;Global Offering&#8221;). The offering price <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 598.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">was set at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.33pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-98" decimals="2" name="abvx:IssueOfEquityOfferingPricePerShare" scale="0" id="f-598">11.60</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.83pt; position: var(--position); text-decoration: none; white-space: pre;"> per ADS in the U.S. Offering and a corresponding offering price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-99" decimals="4" name="abvx:IssueOfEquityOfferingPricePerShare" scale="0" id="f-599">10.9864</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.27pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share in the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Private Placement. All of the ADSs and ordinary shares in the Global Offering were offered by the Group. The ADSs began trading on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Nasdaq Global Market on October 20, 2023. The aggregate gross proceeds were approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.47pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="6" id="f-600">235.8</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.32pt; position: var(--position); text-decoration: none; white-space: pre;">, equivalent to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 632.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-95" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="6" id="f-601">223.3</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.05pt; position: var(--position); text-decoration: none; white-space: pre;"> based on the exchange rate then in effect, before deduction of underwriting commissions and expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 644.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">payable by the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The net proceeds of the Global Offering were<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.78pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">$<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="abvx:ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" format="ixt:num-dot-decimal" scale="6" id="f-602">212.2</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.63pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> (</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-95" decimals="-5" name="abvx:ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" format="ixt:num-dot-decimal" scale="6" id="f-603">202.0</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.31pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">), after deducting </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.33pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">$<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="ifrs-full:PaymentsForShareIssueCosts" format="ixt:num-dot-decimal" scale="6" id="f-604">23.6</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> (</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.01pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-95" decimals="-5" name="ifrs-full:PaymentsForShareIssueCosts" format="ixt:num-dot-decimal" scale="6" id="f-605">21.3</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 528.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">) i</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.46pt; position: var(--position); text-decoration: none; white-space: pre;">n <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction costs. These costs were deducted from the share premiums.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-17<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 100.56pt;" id="ia894b143b6fc4522a0483350194c625e_307"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><ix:continuation id="f-536-8" continuedAt="f-536-9"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.3. For the year ended December 31, 2024 <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-536-9" continuedAt="f-536-10"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in governance &#8211; February-December 2024 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February 7, 2024, the Group announced the appointment of Ana Sharma as Vice President, Global Head of Quality. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On April 2, 2024, the Group announced the appointment of Camilla Soenderby as Independent Board Member and also a member of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Appointments and Compensation Committee. Ms. Soenderby replaces Sant&#233; Holdings S.R.L., represented by Mr. Paolo Rampulla, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">who will continue to contribute to the work of the Board of Directors as an observer alongside Mr. Maurizio PetitBon from Kreos <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 202.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Capital/Blackrock.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In July<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.489999999999995pt; position: var(--position); text-decoration: none; white-space: pre;"> 2024, the Group announced the appointment<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.17pt; position: var(--position); text-decoration: none; white-space: pre;"> of Sylvie Gr&#233;goire as Independent Board Member, Chairman of the Board and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">also a member of the Audit Committee. Ms. Gr&#233;goire replaces Ms. Brosgart as Director, Mr. de Garidel as Chairman, and Mr. Hong as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">member of the Audit Committee. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On November 13, 2024, the Group announced the appointment of Mark Stenhouse as Board Observer &amp; Advisor to the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On December 23, 2024, the Group announced the resignation of Dr. Philippe Pouletty, representative of Truffle Capital, as director of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group, effective on December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.71pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 311.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based compensation plans<span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 168.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 174.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211; February-September 2024 <span style="display: inline-block; height: 8.33pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In February, March, May, July and September 2024, the Group issued <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.85pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="plan" contextRef="c-100" decimals="INF" name="abvx:NumberOfFreeSharesPlansIssued" format="ixt-sec:numwordsen" scale="0" id="f-606">seven</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.6pt; position: var(--position); text-decoration: none; white-space: pre;"> free-share compensation plans to certain of its officers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and employees, representing a maximum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.3pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-101" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-607">1,946,125</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.3pt; position: var(--position); text-decoration: none; white-space: pre;"> shares in the aggregate, the vesting of which is subject to the following service <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 359.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">condition: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-102" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-608">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.34pt; position: var(--position); text-decoration: none; white-space: pre;"> of the AGAs vest at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-102" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-609"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.1pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.09pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.61pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.27pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-103" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-610">25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.6pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-103" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-611"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.19pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.15pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 517.6700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> period from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 369.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-104" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-612">25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-104" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-613"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.55pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.21pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.73pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (with the exception of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-105" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-614">20,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.54pt; position: var(--position); text-decoration: none; white-space: pre;"> 2024-6 AGAs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">whose vesting conditions are set forth in Note 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 399.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In March 2024, the Group granted its independent Board members the right to subscribe up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.27pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-106" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-615">77,820</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants (BSA) in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 409.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">aggregate, the vesting of which (if subscribed) is subject to a service condition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-106" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-616">four years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.37pt; position: var(--position); text-decoration: none; white-space: pre;">, by tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.48pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-106" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-617">25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.81pt; position: var(--position); text-decoration: none; white-space: pre;"> each, vested on each <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">anniversary date. All the BSAs have been subscribed.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 443.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Drawdown of Tranches B and C of the Kreos / Claret Financing &#8211; March-June 2024 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 469.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On March 28, 2024 and June 21, 2024, the Group drew down <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-107" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-618">25</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.85pt; position: var(--position); text-decoration: none; white-space: pre;"> related to tranche B and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-108" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-619">25</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.61pt; position: var(--position); text-decoration: none; white-space: pre;"> related to tranche C of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 480.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">senior secured non-convertible bonds from the Kreos / Claret Financing.<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 325.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.7pt; position: var(--position); text-decoration: none; white-space: pre;">These second and third tranches each consist of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-109" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-620">25,000,000</ix:nonFraction><span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.25pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">senior secured non-convertible bonds with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-109" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-621">1.00</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.99pt; position: var(--position); text-decoration: none; white-space: pre;"> each, that will not be listed on any market.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The detailed characteristics of these bond loans and their accounting treatments are set forth in Note 15.1.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance RNP-VIR and Carena conditional advances &#8211; June 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance renegotiated the RNP-VIR and CARENA conditional advances:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Between September 2017 and November 2019, the Group had received repayable conditional advances amounting <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 593.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-110" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-622">4,032</ix:nonFraction>&#160;thousands<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> and subsidies amounting to <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-110" decimals="-3" name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-623">1,123</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.15pt; position: var(--position); text-decoration: none; white-space: pre;"> in relation to the RNP-VIR project, which aimed at <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discovering new molecules for the treatment of viral infectious diseases through the development of the &#8220;Modulation of RNA <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">biogenesis&#8221; platform. In June 2024, the Group and Bpifrance agreed to terminate the project <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.24pt; position: var(--position); text-decoration: none; white-space: pre;">due to technical failure, and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">B<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.66pt; position: var(--position); text-decoration: none; white-space: pre;">pifrance agreed to waive <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-111" decimals="2" name="abvx:PercentageOfConditionalAdvancesWaived" scale="-2" id="f-624">60</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.95pt; position: var(--position); text-decoration: none; white-space: pre;"> of the remaining advance<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.7pt; position: var(--position); text-decoration: none; white-space: pre;">s. <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">See Note 15.7 "Conditional Advances".<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 662.8pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Between December 2013 and June 2016, the Group had received repayable conditional advances amounting <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-112" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-625">2,187</ix:nonFraction>&#160;thousands<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> in relation to the CARENA project, which aimed at developing an anti-HIV-AIDS therapeutic program <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with the compound ABX464 up to the Phase 2b study. In June 2024, the Group and Bpifrance agreed to terminate the project <span style="display: inline-block; height: 8.73pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-18<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-536-10" continuedAt="f-536-11"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">due to technical failure, and Bpifrance agreed to waive <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-113" decimals="2" name="abvx:PercentageOfConditionalAdvancesWaived" scale="-2" id="f-626">60</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.66999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> of the remaining conditional advance. See Note 15.7 <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 84.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">"Conditional Advances".<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 109.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group fully reimbursed the remaining conditional advances for both programs during the last quarter of 2024. The subsidy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 121.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">income recognized over the period, corresponding to the amounts waived by Bpifrance and related interests, amounts to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-114" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" format="ixt:num-dot-decimal" scale="3" id="f-627">4,123</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate (see Note 18).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 167.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Establishment of an At-the-Market ("ATM") Program on Nasdaq - November 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On November 19, 2024, the Group announced the implementation of an At-The-Market program (&#8220;ATM Program&#8221;) allowing the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in the form of ADSs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">each ADS representing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="INF" name="abvx:NumberOfADSPerOrdinaryShares" format="ixt-sec:numwordsen" scale="0" id="f-628">one</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.6pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary share, nominal value <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-115" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-629">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.41pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, of the Group, with aggregate gross sales proceeds of up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="abvx:ExpectedProceedsFromShareIssuance" format="ixt:num-dot-decimal" scale="3" id="f-630">150,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.09pt; position: var(--position); text-decoration: none; white-space: pre;"> (subject to French regulatory limits and within the limits of the investors&#8217; requests expressed in the context of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 236.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program), from time to time, pursuant to the terms of an equity distribution agreement with Piper Sandler &amp; Co. (&#8220;Piper Sandler&#8221;), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acting as sales agent. The timing of any issuances in the form of ADSs will depend on a variety of factors. The ATM Program will be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">effective until terminated in accordance with the equity distribution agreement or if ADSs representing the maximum gross sales <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">proceeds have been sold thereunder. To the extent that ADSs are sold pursuant to the ATM Program, the Group currently intends to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">use the net proceeds (after deduction of fees and expenses), if any, of sales of ADSs issued under the ATM Program primarily to fund <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the research and development of the Group's product candidates, for working capital and general corporate purposes, at its discretion.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">A shelf registration statement on Form F-3, including a base prospectus relating to the Group's securities and an equity distribution <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement prospectus relating to the ATM Program, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.43pt; position: var(--position); text-decoration: none; white-space: pre;">was filed with the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.73pt; position: var(--position); text-decoration: none; white-space: pre;"> SEC and went into effect during 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.76pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.76pt; position: var(--position); text-decoration: none; white-space: pre;">The base prospectus <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">provides for the potential sale of ADSs of the Group with aggregate gross sales proceeds of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.75pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="abvx:ExpectedProceedsFromShareIssuanceShelfRegistration" format="ixt:num-dot-decimal" scale="3" id="f-631">350,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.84pt; position: var(--position); text-decoration: none; white-space: pre;"> (including the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 351.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="abvx:ExpectedProceedsFromShareIssuance" format="ixt:num-dot-decimal" scale="3" id="f-632">150,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.09pt; position: var(--position); text-decoration: none; white-space: pre;"> covered by the equity distribution agreement prospectus) to grant additional flexibility to the Group in connection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with its financing strategy. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in one or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">more prospectus supplements to the base prospectus. A<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.9pt; position: var(--position); text-decoration: none; white-space: pre;">s of the date of issuance of these <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.97pt; position: var(--position); text-decoration: none; white-space: pre;">financial<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.9pt; position: var(--position); text-decoration: none; white-space: pre;"> statements, the Group has not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 385.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">utilized the ATM Program<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 421.16pt;" id="ia894b143b6fc4522a0483350194c625e_310"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 433.16pt; width: 612pt;"><ix:continuation id="f-536-11" continuedAt="f-536-12"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.4. Subsequent events&#160; <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-536-12"><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 457.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based compensation plans<span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 168.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 174.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211; January-February 2025<span style="display: inline-block; height: 8.33pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In January 2025, the Group granted its independent Board members, as well as one of its Board Observers and Advisor, the right to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subscribe up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-633">125,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.51pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants (BSA) in the aggregate, the vesting of which (if subscribed) is subject to a service condition of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-117" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-634">four years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">, by tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.35pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-118" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-635"><ix:nonFraction unitRef="number" contextRef="c-119" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-636"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-637"><ix:nonFraction unitRef="number" contextRef="c-121" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-638">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.68pt; position: var(--position); text-decoration: none; white-space: pre;"> each, vested on January, 1 of each year.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In February 2025,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.91pt; position: var(--position); text-decoration: none; white-space: pre;"> the Group issued <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.64pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="plan" contextRef="c-122" decimals="INF" name="abvx:NumberOfFreeSharesPlansIssued" format="ixt-sec:numwordsen" scale="0" id="f-639">four</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.3pt; position: var(--position); text-decoration: none; white-space: pre;"> free-share compensation plans to certain of its officers and employees, representing a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">maximum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.84pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-640">4,490,727</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.84pt; position: var(--position); text-decoration: none; white-space: pre;"> shares in the aggregate, the vesting of which is subject to the following service condition: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.48pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-124" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-641">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.81pt; position: var(--position); text-decoration: none; white-space: pre;"> of the AGAs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">vest at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-124" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-642"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.68pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.19pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.85pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-643">25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.18pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-125" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-644"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.77pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.73pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.25pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.3399999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-126" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-645">25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 563.67pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-126" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-646"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.39pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.05pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.57pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (with the exception of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.88pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-127" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-647">123,102</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.38pt; position: var(--position); text-decoration: none; white-space: pre;"> 2025-2 AGAs, which vest at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-127" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-648" continuedAt="f-648-1"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.86pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.85pt; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-648-1">year</ix:continuation><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date).<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 609.56pt;" id="ia894b143b6fc4522a0483350194c625e_313"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory" id="f-649" continuedAt="f-649-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting principles <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><div style="position: absolute; top: 625.56pt;" id="ia894b143b6fc4522a0483350194c625e_316"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.56pt; width: 612pt;"><ix:continuation id="f-649-1" continuedAt="f-649-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.1. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory" id="f-650" continuedAt="f-650-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-2" continuedAt="f-649-3"><ix:continuation id="f-650-1" continuedAt="f-650-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Following initial recognition, goodwill is stated at cost less any accumulated impairment losses (see Note 4.4). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In respect of business combinations prior to January 1, 2020, in accordance with IFRS 1 exemption, goodwill is included on the basis <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-650-2">of its deemed cost, which represents the amount recorded under the prior basis of accounting, French GAAP, (&#8220;Previous GAAP&#8221;).</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-19<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 70.56pt;" id="ia894b143b6fc4522a0483350194c625e_319"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><ix:continuation id="f-649-3" continuedAt="f-649-4"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.2. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" id="f-651" continuedAt="f-651-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-4" continuedAt="f-649-5"><ix:continuation id="f-651-1" continuedAt="f-651-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 38&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;">, intangible assets acquired are recognized as assets on the statements of financial position at <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their acquisition cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Licenses <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Payments for separately acquired research and development are capitalized within &#8220;Other intangible assets&#8221; provided that they meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the definition of an intangible asset: a resource that is (i)&#160;controlled by the Group, (ii) expected to provide future economic benefits for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group and (iii)&#160;identifiable (i.e., it is either separable or arises from contractual or legal rights). In accordance with paragraph 25 of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IAS 38&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.15pt; position: var(--position); text-decoration: none; white-space: pre;">, the recognition criterion relating to the likelihood of future economic benefits generated by the intangible <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">asset, is presumed to be achieved for research and development activities when they are acquired separately. In this context, amounts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">paid to third parties in the form of initial payments or milestone payments relating to pharmaceutical specialties that have not yet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obtained a marketing authorization are recognized as intangible assets. These rights will be amortized on a straight-line basis, after <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obtaining the marketing authorization, over their useful life. Unamortized rights (before marketing authorization) are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impairment tests in accordance with the method defined in Note 4.4. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development costs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 38 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;">, research costs are expensed in the period during which they are incurred. Development costs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are only recognized as intangible assets if the following criteria are met: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it is technically feasible to complete the development of the project; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it is the Group&#8217;s intention to complete the project and to utilize it; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it has capacity to utilize the intangible asset; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is proof of the probability of future economic benefits associated with the asset <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is availability of the technical, financial and other resources for completing the project; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is a reliable evaluation of the development expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The initial measurement of the asset is the sum of expenses incurred starting on the date on which the development project meets the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">above criteria. Because of the risks and uncertainties related to regulatory authorizations and to the research and development process, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group believes that the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.14pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="criteria" contextRef="c-1" decimals="INF" name="abvx:ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" format="ixt-sec:numwordsen" scale="0" id="f-652">six</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.8pt; position: var(--position); text-decoration: none; white-space: pre;"> criteria stipulated by IAS 38 have not been fulfilled to date and the application of this principle has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">resulted in all development costs being expensed as incurred in all periods presented. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets mainly consist of acquired software. Costs related to the acquisition of software licenses are recognized as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets based on the costs incurred to acquire and set up the related software. Other intangible assets are amortized using the straight-<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 492.56pt; width: 612pt;"><ix:continuation id="f-651-2" continuedAt="f-651-3"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">line method over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.99pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-128" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:durwordsen" id="f-653">one year</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-651-3">.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 520.56pt;" id="ia894b143b6fc4522a0483350194c625e_322"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.56pt; width: 612pt;"><ix:continuation id="f-649-5" continuedAt="f-649-6"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.3. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="f-654" continuedAt="f-654-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-654-1" continuedAt="f-654-2"><ix:continuation id="f-649-6" continuedAt="f-649-7"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 16 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Property, Plant and Equipment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.8pt; position: var(--position); text-decoration: none; white-space: pre;">, property, plant and equipment are recognized at their acquisition cost (purchase <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price and directly attributable costs) or at their production cost by the Group, as applicable. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-20<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-7" continuedAt="f-649-8"><ix:continuation id="f-654-2" continuedAt="f-654-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="f-655" continuedAt="f-655-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment are depreciated using the straight-line method over the estimated useful life of the asset. The principal <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-655-1" continuedAt="f-655-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">useful lives applied are as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 100.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"/></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 15.75pt; width: 173.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">DEPRECIATION PERIOD<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Buildings<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 30pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 44.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office fixtures and fittings<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 44.25pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-129" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-656">3</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.21pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.5045pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 44.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 58.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Equipment<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 58.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Industrial materials and equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 72.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-130" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-657">5</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-131" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-658">10</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 72.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Technical facilities<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 87pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-132" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-659">5</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-133" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-660">10</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 87pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture and computer equipment:<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 101.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 101.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 115.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 115.5pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-134" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-661">5</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-135" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-662">10</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 115.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">IT equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 129.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;  &#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-136" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-663">3</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 129.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 144pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.08pt; position: var(--position); white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.58pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-137" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-664">10</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 144pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);">(1)<span style="display: inline-block; height: 6.93pt; width: 12.84pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Office fixtures and fittings estimated useful lives correspond to the Paris headquarters and Boston offices residual estimated <span style="display: inline-block; height: 6.93pt;"></span></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-655-2">lease terms.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The useful lives of property, plant and equipment as well as any residual values are reviewed at each year-end and, in the event of a <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-654-3">significant change, the depreciation schedule is revised prospectively.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 345.81pt;" id="ia894b143b6fc4522a0483350194c625e_328"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.81pt; width: 612pt;"><ix:continuation id="f-649-8" continuedAt="f-649-9"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.4. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" id="f-665" continuedAt="f-665-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of goodwill, intangible assets, property and plant and equipment <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-9" continuedAt="f-649-10"><ix:continuation id="f-665-1" continuedAt="f-665-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill and intangible assets not yet available for use are not amortized and are tested for impairment annually. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the Group assesses at the end of each reporting period whether there is an indication that intangible assets and property, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 393.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">plant and equipment may be impaired. Pursuant to IAS 36&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 278.56pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.93pt; position: var(--position); text-decoration: none; white-space: pre;">, criteria for assessing indication of loss in value may <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">notably include performance levels lower than forecast, a significant change in market data or the regulatory environment, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obsolescence or physical damage of the asset not included in the amortization/depreciation schedule. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the purpose of impairment testing, goodwill and intangible assets not yet available for use are allocated to each of the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGUs expected to benefit from synergies arising from the business combination or from the use of the intangible assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">An impairment loss is recognized when the carrying amount of a CGU, including the goodwill, exceeds the recoverable amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGU. The recoverable amount of a CGU is the higher of the CGU&#8217;s fair value less cost to sell and value-in-use. The total impairment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">loss of a CGU is allocated first to reduce the carrying amount of goodwill allocated to the CGU and then to the other assets of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGU pro-rata on the basis of the carrying amount of each asset in the CGU. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">An impairment loss on goodwill is not reversed in a subsequent period. Impairment losses on intangible assets and property, plant and <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-665-2">equipment shall be reversed subsequently if the impairment loss no longer exists or has decreased.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 557.81pt;" id="ia894b143b6fc4522a0483350194c625e_331"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.81pt; width: 612pt;"><ix:continuation id="f-649-10" continuedAt="f-649-11"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.5. Financial assets <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-649-11" continuedAt="f-649-12"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 573.81pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" id="f-666" continuedAt="f-666-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financial assets at amortized cost <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-666-1" continuedAt="f-666-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (advances, loans and deposits granted to third parties and other short-term investments) and other receivables are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">non-derivative financial assets with fixed or determinable payments that are not listed on an active market. They are initially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized at fair value plus transaction costs that are directly attributable to the acquisition or issue of the financial asset. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 9 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Instruments <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.64pt; position: var(--position); text-decoration: none; white-space: pre;">requires an entity to recognize a loss allowance for expected credit losses on a financial asset at <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amortized cost at each statement of financial position date. The amount of the loss allowance for expected credit losses equal to: (i)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">12&#8212;month expected credit losses or (ii)&#160;the full lifetime expected credit losses. The latter applies if credit risk has increased <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-666-2">significantly since initial recognition of the financial instrument.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-21<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-12" continuedAt="f-649-13"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" id="f-667" continuedAt="f-667-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-667-1" continuedAt="f-667-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group classifies investments as cash equivalents in the statements of financial position and statements of cash flows when they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">meet the conditions of IAS 7&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 161.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Statement of Cash Flows, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.8pt; position: var(--position); text-decoration: none; white-space: pre;">i.e., when they are: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">held in order to face short-term cash commitments; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">short term and highly liquid assets at acquisition date, readily convertible into known amount of cash and not exposed to <span style="display: inline-block; height: 6.93pt;"></span></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-667-2">any material risk of change in value.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 166.56pt;" id="ia894b143b6fc4522a0483350194c625e_334"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.56pt; width: 612pt;"><ix:continuation id="f-649-13" continuedAt="f-649-14"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.6. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" id="f-668" continuedAt="f-668-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Share capital <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-14" continuedAt="f-649-15"><ix:continuation id="f-668-1" continuedAt="f-668-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares are classified in shareholders&#8217; equity. Costs associated with the issuance of new shares are directly accounted for in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; equity in diminution of issuance premium. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s own shares bought in the context of a brokering/liquidity agreement entered with an independent broker are presented as <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-668-2">a reduction of shareholders&#8217; equity until their cancellation, their reissuance or their disposal.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-22<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-15" continuedAt="f-649-16"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 80.56pt;" id="ia894b143b6fc4522a0483350194c625e_337"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><ix:continuation id="f-649-16" continuedAt="f-649-17"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.7. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" id="f-669" continuedAt="f-669-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-17" continuedAt="f-649-18"><ix:continuation id="f-669-1" continuedAt="f-669-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Since its inception, the Group has established several plans for compensation settled in equity instruments in the form of founders&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">share subscription warrants (&#8220;bons de souscription de parts de cr&#233;ateur d&#8217;entreprise&#8221; or &#8220;BCE&#8221;), share subscription warrants (&#8220;Bons de <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">souscription d&#8217;actions,&#8221; or &#8220;BSA&#8221;) and free shares (&#8220;Attributions gratuites d&#8217;actions,&#8221; or &#8220;AGA&#8221;), granted to its employees, corporate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">officers and scientific consultants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.78pt; position: var(--position); text-decoration: none; white-space: pre;">these awards are measured at their fair value on the date of grant. The values of the equity <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments are determined using the option pricing model (in particular, a Black and Scholes model for the BCE and BSA plans and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Monte-Carlo simulation for the AGA plans which include market performance vesting conditions) based on the value of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">underlying equity instrument at grant date, the volatility observed in a sample of comparable listed companies and the estimated life of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the related equity instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group recognizes the fair value of these awards as a share-based compensation expense over the period in which the related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">services are received, i.e. over the vesting period, with a corresponding increase in shareholders&#8217; equity. Share-based compensation is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized by installments in consistency with their graded vesting schedule, when applicable. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the related service and non-market performance conditions at the vesting date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For share-based payment awards with market vesting conditions and non-vesting conditions, the grant-date fair value of the share-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcome. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The measurement of the fair value of BSA, BCE and AGA incorporates the market-based vesting conditions and non-vesting <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-669-2">conditions as described in Note 4.16 &#8220;Use of judgments and estimates&#8221;.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 352.56pt;" id="ia894b143b6fc4522a0483350194c625e_340"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"><ix:continuation id="f-649-18" continuedAt="f-649-19"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.8. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" id="f-670" continuedAt="f-670-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-670-1" continuedAt="f-670-2"><ix:continuation id="f-649-19" continuedAt="f-649-20"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Note 4.8.1. Financial liabilities at amortized cost<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IFRS 9 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Instruments, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;">the borrowings, the debt component of the Kreos / Claret OCABSA (classified as <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">convertible loan notes &#8211; see <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.47pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.98pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments below) and Other financial liabilities (conditional <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">advances and royalty certificates) other than financial derivative liabilities are measured at amortized cost. They are initially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized at fair value and subsequently measured at amortized cost calculated using the effective interest rate (&#8220;EIR&#8221;) method. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction costs that are directly attributable to the issue of the financial liability reduce that financial liability. These expenses are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">then amortized over the lifetime of the liability, on the basis of the EIR. The EIR is the rate that exactly discounts estimated future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">cash payments through the expected life of the financial liability to the amortized cost of a financial liability. Financial liabilities that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are due within one year are presented as current financial liabilities in the statements of financial position.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 522.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates meet the definition of financial liabilities. The Group concluded that they do not include embedded derivatives <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">related to the variability of royalties that are based on future net sales. In addition, the Group concluded that the prepayment options <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">were separate derivative instruments as their redemption price did not reimburse holders for an amount up to the approximate present <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value of lost interest for the remaining term of the host contracts. However, their value at inception and subsequent dates is nil and has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">no impact on the financial statements. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-23<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-670-2" continuedAt="f-670-3"><ix:continuation id="f-649-20" continuedAt="f-649-21"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates are initially measured at fair value (refer to note 15.10 for valuation model applied). They are subsequently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured at amortized cost calculated using the EIR method. The EIR is calculated based on future cash flows, which are estimated on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the basis of development and commercialization plans and budgets approved by the Board of Directors of the Group, and probability-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">weighted to reflect the probability of success of clinical studies and any other uncertainty affecting them. If there is a change in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">timing or amount of estimated cash flows, then the gross carrying amount of the amortized cost of the financial liability is adjusted in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the period of change to reflect the revised actual and estimated cash flows, with a corresponding income or expense being recognized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss. The revised gross carrying amount of the amortized cost of the financial liability is calculated by discounting the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future revised estimated cash flows at the original EIR. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances and State guaranteed loan &#8211; &#8220;PGE&#8221; <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment for conditional advances and the State-guaranteed loan (Pr&#234;t garanti par l'Etat, or "PGE") is set forth in Note 4.9. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Leases <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment for lease liabilities is set forth in Note 4.12.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Note 4.8.2. Financial liabilities measured at fair value through profit or loss <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.9pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSA attached to Kreos 1 bonds, the conversion option of OCEANE, certain prepayment options of bonds, the Kreos / Claret warrants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and the Kreos / Claret Minimum Return Indemnifications ("MRI") are derivatives instruments. Derivatives are recognized initially at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value at the date the derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The resulting gain or loss from change in the fair value is recognized in profit or loss immediately, as financial expenses or income. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Hybrid instruments <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE bonds <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.41pt; position: var(--position); text-decoration: none; white-space: pre;">and Heights convertible notes (whose characteristics are described in Note 15.2 and Note 15.5)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.25pt; position: var(--position); text-decoration: none; white-space: pre;"> are hybrid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments. A &#8220;hybrid contract&#8221; is a contract that includes both a non-derivative host contract and one or more embedded derivatives. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Embedded derivatives are required to be separated from the host contract (bifurcated) if: the economic characteristics and risks of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">embedded derivative are not closely related to those of the host, a separate instrument with the same terms as the embedded derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">would meet the definition of a derivative, and the hybrid contract is not measured at fair value through profit or loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Separable embedded derivatives are required to be measured at fair value at each reporting date, with changes in fair value recognized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 460.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss. The initial bifurcation of a separable embedded derivative does not result in any gain or loss being recognized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Because the embedded derivative component is measured at fair value on initial recognition, the carrying amount of the host contract <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on initial recognition is the difference between the carrying amount of the hybrid instrument and the fair value of the embedded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derivative. If the fair values of the hybrid instrument and host contract are more reliably measurable than that of the derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">component - e.g. because of the availability of quoted market prices - then it may be acceptable to use those values to determine the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value of the derivative on initial recognition indirectly - i.e. as a residual amount. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights convertible notes issued on August 24, 2023 included embedded derivatives as detailed in Note 15. The Group concluded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">that these features were embedded derivatives that would modify the cash flows required under the contract and require to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">bifurcated from their host contract. The Group being unable to reliably value each embedded derivative at issuance date and on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent reporting dates, it measured the whole hybrid instrument at fair value through profit or loss (&#8220;FVTPL&#8221;) as permitted by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 9. Instruments measured at FVTPL under these conditions are measured at their fair value on issuance and on subsequent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reporting dates, with changes in fair value recognized in profit or loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret OCABSA are compound instruments (whose characteristics are describ<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ed in Note 15.1). </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.57pt; position: var(--position); text-decoration: none; white-space: pre;">A &#8220;compound contract&#8221; is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">a contract that includes both a debt component and an equity component.&#160; The debt component (excluding the conversion option and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the attached OCABSA warrants) is initially recognized at fair value and subsequently measured at amortized cost calculated using the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">EIR method. The equity component corresponding to the conversion option and the attached OCABSA warrants is recorded in equity, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the difference between the whole instrument&#8217;s fair value (its nominal value) and the standalone fair value of the debt component.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-24<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-21" continuedAt="f-649-22"><ix:continuation id="f-670-3" continuedAt="f-670-4"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value measurement <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">When measuring the fair value of an asset or a liability, the Company uses market observable data as far as possible. Fair values are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 1: fair value calculated using quoted prices in an active market for identical assets and liabilities; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 2: fair value calculated using valuation techniques based on observable market data such as prices for assets and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities or similar parameters quoted in an active market; &#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 3: fair value calculated using valuation techniques based in whole or in part on unobservable inputs such as prices <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">in an inactive market or a valuation based on multiples of unlisted securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-670-4">See Note 12 Financial assets and liabilities, Note 15 Financial liabilities.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 208.56pt;" id="ia894b143b6fc4522a0483350194c625e_343"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208.56pt; width: 612pt;"><ix:continuation id="f-649-22" continuedAt="f-649-23"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.9. Research tax credit, subsidies and conditional advances <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-649-23" continuedAt="f-649-24"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants" id="f-671" continuedAt="f-671-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-671-1" continuedAt="f-671-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group benefits from the provisions of Article 244 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 255.53pt; position: var(--position); text-decoration: none; white-space: pre;">quater <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.12pt; position: var(--position); text-decoration: none; white-space: pre;">B of the French General Tax Code relating to the French research tax <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit (&#8220;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 68.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Cr&#233;dit d&#8217;Imp&#244;t Recherche<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8221; or &#8220;CIR&#8221;). The CIR is granted to companies in order to encourage them to conduct technical and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scientific research. Companies that prove that they have expenditures which meet the required criteria (research expenditures located <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in France or, since January 1, 2005, within the European Union or in another state that is a party to the Agreement on the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Economic Area and has concluded a tax treaty with France that contains an administrative assistance clause) receive a tax credit that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">can be used for the payment of the corporate tax due for the fiscal year in which the expenditures were made and the next three fiscal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">years, or as applicable, companies may receive cash reimbursement for any excess portion at the three-year period following the fiscal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">year of the expenditures. Only those companies meeting the EU definition of a small or medium-sized entity (&#8220;SME&#8221;) are eligible for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">payment in cash of their research tax credit (to the extent not used to offset corporate tax payables) in the year following the request <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for reimbursement. The expenditures taken into account for the calculation of the CIR involve only research expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The CIR is presented under &#8220;Other operating income&#8221; in the statements of income (loss) as it is accounted for as a government grant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as defined in IAS 20 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 128.16pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting for Government Grants and Disclosure of Government Assistanc<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.67pt; position: var(--position); text-decoration: none; white-space: pre;">e, and as &#8220;Other receivables and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets&#8221; in the statement of financial position until its payment is received. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies are non-repayable grants received by the Group and recognized in the financial statements when there exists reasonable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assurance that the Group will comply with the conditions attached to the subsidies and the subsidies will be received. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies that are upfront payments are presented as deferred income and recognized through &#8220;Other operating income&#8221; for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount of the expenses incurred as part of the research program to which the subsidy relates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">A subsidy that is to be received either as compensation for expenses or for losses already incurred, or for immediate financial support <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the Group without associated future costs, is recognized in the Statements of income (loss) as &#8220;Other operating income&#8221; when there <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-671-2">exists reasonable assurance that the subsidies will be received.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory" id="f-672" continuedAt="f-672-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances and PGE <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-672-1" continuedAt="f-672-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group receives conditional advances to finance at below market interest rate research and development projects. Due to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">innovative nature of its drug candidate development programs, the Group has benefited from certain sources of financial assistance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from Bpifrance. Bpifrance provides financial assistance and support to emerging French enterprises to facilitate the development and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization of innovative technologies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Funds received from Bpifrance in the form of conditional advances are recognized as financial liabilities, as the Group has a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">contractual obligation to reimburse Bpifrance for such conditional advances in cash based on a repayment schedule. Each award of an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">advance is made to help fund a specific development milestone. More tails on conditional advances are provided in Note 15.7. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 626.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Receipts or reimbursements of conditional advances are reflected as financing transactions in the statements of cash flows. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The difference between the present value of the advance at market rate (i.e., present value of contractual cash flows including principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and interests, discounted using a market rate as effective interest rate in accordance with IFRS 9) and the amount received as cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the Bpifrance constitutes a subsidy within the meaning of IAS 20. Considering that these advances do not finance fixed assets, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">these subsidies are presented as &#8220;Deferred income&#8221; in the statement of financial position and recognized in the statement of net income <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(loss) as &#8220;Other operating income&#8220; on a systematic basis over the periods in which the Group recognizes as expenses the related costs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for which the grants are intended to compensate. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-25<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-24" continuedAt="f-649-25"><ix:continuation id="f-672-2" continuedAt="f-672-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The incremental interest expense resulting from the difference between (a)&#160;the market interest rate and the (b)&#160;below-market rate is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">spread over the contractual period until the last repayment and recognized in the statement of income (loss) accordingly, using the EIR <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">method. In the event of a change in estimate of contractual cash flows due under the conditional advances, the Group recalculates the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">book value of the debt resulting from the discounting of the anticipated new future cash flows at the initial EIR. The adjustment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in the statements of income (loss) for the period during which the modification is recognized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the statements of financial position, these conditional advances are recorded in &#8220;Other financial liabilities&#8221; as current or non-current <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">portion depending on their maturity. In the event Bpifrance waived the repayment of the advance, the corresponding liability is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derecognized and treated as a subsidy in the statements of income (loss). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The benefit resulting from the low interest of PGE loans is also recognized as a subsidy corresponding to the difference between the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">present value of the PGE at market rate and the amount received as cash. The accounting treatment is therefore similar to the above-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">mentioned accounting treatment for conditional advances. PGE are recorded in &#8220;Borrowings&#8221; as current or non-current portion <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-672-3">depending on their maturity.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 232.56pt;" id="ia894b143b6fc4522a0483350194c625e_346"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232.56pt; width: 612pt;"><ix:continuation id="f-649-25" continuedAt="f-649-26"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.10. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="f-673" continuedAt="f-673-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Employee benefits <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-26" continuedAt="f-649-27"><ix:continuation id="f-673-1" continuedAt="f-673-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s employees in France benefit from retirement benefits provided under French law, which consist in the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">compensation paid by the Group to employees upon their retirement (a defined benefit plan); and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">payments of retirement pensions by the social security agencies, which are financed by the contributions made by the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Group and employees. As they meet the definition of a defined contribution plan, the liabilities are presented as Tax and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">employee-related payables in the statement of financial position. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In accordance with IAS 19 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 153.11pt; position: var(--position); text-decoration: none; white-space: pre;">Employee Benefits<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.15pt; position: var(--position); text-decoration: none; white-space: pre;">, the liability with respect to defined benefit plans is estimated by using the projected <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit unit method. According to this method, the cost of the retirement benefit is recognized in the statements of income (loss). The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">retirement benefit commitments are valued at the current value of the estimated future payments, discounted using the market rate for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">high quality corporate bonds with a term and currency that correspond to that estimated for the payment of the benefits. The Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">applied the decision of the IFRS IC, published on May&#160;24, 2021, that concluded that, in the case that no rights were acquired in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">event of departure before retirement age and that the rights were capped after a certain number of years of seniority (&#8220;30 years&#8221;), the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commitment would only be recognized for the last 30 years of the employee&#8217;s career within the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The difference between the amount of the provision at the beginning of a period and at the close of that period is recognized through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operating expenses for the portion representing the costs of services rendered and financial expenses for the net interest costs, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">through other comprehensive income (loss) for the portion representing the actuarial gains and losses due to changes in assumptions <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-673-2">and experience adjustments.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-26<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-27" continuedAt="f-649-28"><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 71.56pt;" id="ia894b143b6fc4522a0483350194c625e_349"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><ix:continuation id="f-649-28" continuedAt="f-649-29"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.11. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="f-674" continuedAt="f-674-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-29" continuedAt="f-649-30"><ix:continuation id="f-674-1" continuedAt="f-674-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions correspond to commitments resulting from litigation and various risks to which the Group may face in the context of its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operations. In accordance with IAS 37 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 199.73pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions, Contingent Liabilities and<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.37pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 354.87pt; position: var(--position); text-decoration: none; white-space: pre;">Contingent Assets, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.74pt; position: var(--position); text-decoration: none; white-space: pre;">a provision is recorded when the <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group has an obligation to a third party resulting from a past event that will likely result in an outflow of resources to the third party, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and for which future cash outflows may be estimated reliably. The amount recorded as a provision is an estimate of the expenditure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">required to settle the obligation, discounted where necessary at year <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.25pt; position: var(--position); text-decoration: none; white-space: pre;">end.&#160; Contingent liabilities are not recognized, but are disclosed in <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.56pt; width: 612pt;"><ix:continuation id="f-674-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the notes to the financial statements unless the possibility of an outflow of economic resources is remote<span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.28pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 165.56pt;" id="ia894b143b6fc4522a0483350194c625e_352"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 165.56pt; width: 612pt;"><ix:continuation id="f-649-30" continuedAt="f-649-31"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.12. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="f-675" continuedAt="f-675-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Leases <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-31" continuedAt="f-649-32"><ix:continuation id="f-675-1" continuedAt="f-675-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">standalone price. The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases (value of the underlying asset below <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 221.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.0 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.09pt; position: var(--position); text-decoration: none; white-space: pre;">). For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">straight-line basis over the term of the lease. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to the end of the lease term. The lease terms used by the Group reflect the non-cancellable terms of each contract, plus any extension <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">or termination options that the Group is reasonably certain to exercise or not exercise for all of the leases periods covered by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">extension options. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group incremental borrowing rate for the asset subject to the lease in the respective markets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">portion of the lease payments attributable to the repayment of lease liabilities and the portion attributable to payment of interests are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in cash flows used in financing activities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">incentives received and any initial direct costs incurred by the Group, and expected costs for obligations to dismantle and remove <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">right-of-use assets when they are no longer used. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the right-of-use asset or the end of the lease term. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-675-2">recoverable using cash flow projections.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 489.56pt;" id="ia894b143b6fc4522a0483350194c625e_355"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 489.56pt; width: 612pt;"><ix:continuation id="f-649-32" continuedAt="f-649-33"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.13. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="f-676" continuedAt="f-676-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Translation of transactions denominated in foreign currency <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-649-33" continuedAt="f-649-34"><ix:continuation id="f-676-1" continuedAt="f-676-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 21 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">The Effects of Changes in Foreign Exchange Rates<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.3pt; position: var(--position); text-decoration: none; white-space: pre;">, transactions performed by the Group in currencies other than <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 515.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their functional currency, which is the Euro, are translated at the prevailing exchange rate on the transaction date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 537.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables and payables and liabilities denominated in a currency other than the functional currency are translated at the <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-676-2">period-end exchange rate. Unrealized gains and losses arising on translation are recognized in net financial income / (loss).</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-27<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-34" continuedAt="f-649-35"><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 71.56pt;" id="ia894b143b6fc4522a0483350194c625e_358"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><ix:continuation id="f-649-35" continuedAt="f-649-36"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.14. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Current and deferred tax <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-649-36" continuedAt="f-649-37"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="f-677" continuedAt="f-677-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Tax assets and liabilities for the current and prior periods are measured at the amount expected to be recovered from or paid to the <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-677-1" continuedAt="f-677-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">French tax authorities, using tax rates and tax laws enacted or substantively enacted at the end of the reporting period in accordance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with IAS 12 &#8211; Income Tax. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The income tax charge for the period comprises current tax due and the deferred tax charge. The tax expense is recognized in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">statement of income (loss) unless it relates to items recorded in other comprehensive income (loss) or directly in equity, in which case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the tax is also recorded in other comprehensive income (loss) or directly in equity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Current taxes <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The current tax expense is calculated based on taxable profit for the period, using tax rates enacted or substantively enacted at the <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-677-2">statement of financial position date. Considering the level of tax loss of the Group, no current tax expense is recognized.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory" id="f-678" continuedAt="f-678-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxes <span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-678-1" continuedAt="f-678-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxes are recognized when there are temporary differences between the carrying amount of assets and liabilities in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s financial statements and the corresponding tax basis used to calculate taxable profit. Deferred taxes are not recognized if they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 267.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">arise from the initial recognition of an asset or liability in a transaction other than a business combination which, at the time of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction, does not affect either the accounting or the taxable profit (tax loss). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group applies the Amendments to IAS 12 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 232.23pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred Tax related to Assets and Liabilities arising from a Single Transaction<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.79pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issued on May 7, 2021, and presents the deferred tax assets and liabilities arising from such transactions separately within Note 22 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 559.6pt; position: var(--position); text-decoration: none; white-space: pre;">- <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Income tax, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.11pt; position: var(--position); text-decoration: none; white-space: pre;">rather than on a net basis. The Amendments have no impact on the Statements of financial position and the Statement of <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">comprehensive income (loss) for the periods presented.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets are recognized for all deductible temporary differences, unused tax losses and unused tax credits to the extent that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">it is probable that the temporary difference will reverse in the foreseeable future and that taxable profit will be available against which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the deductible temporary difference, unused tax losses or unused tax credits can be utilized. See Note 4.16. Use of judgments and <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-678-2">estimates and Note 22. Income tax.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 419.56pt;" id="ia894b143b6fc4522a0483350194c625e_361"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"><ix:continuation id="f-649-37" continuedAt="f-649-38"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.15. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" id="f-679" continuedAt="f-679-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting of Prosynergia acquisition <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-679-1" continuedAt="f-679-2"><ix:continuation id="f-649-38" continuedAt="f-649-39"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">From April 1, 2022 up until the merger completed on December&#160;12, 2022, the Company owned a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.33pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-61" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-680">100</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.66pt; position: var(--position); text-decoration: none; white-space: pre;"> ownership interest of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia and as such, controlled Prosynergia. The Company had power over Prosynergia, was exposed or had rights to variable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 455.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">returns from its involvement with the entity and had the ability to affect those returns through its power over the entity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The financial statements of Prosynergia were therefore included in the consolidated financial statements of the Company from the date <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">control was obtained, i.e. April 1, 2022. Prosynergia was merged into the Company in December&#160;12, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement or out-licensed agreement, it did not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">April 1, 2022, without recognition of goodwill. For this purpose, the following approach was applied: first measurement of any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">identifiable asset or liability initially measured at an amount other than cost in accordance with the applicable standards, deduction <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the cost of the group of assets of the amounts allocated to these assets and liabilities, and then allocation of the residual cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acquisition to the remaining identifiable assets and liabilities based on their relative fair values at the date of acquisition. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-28<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-649-39" continuedAt="f-649-40"><ix:continuation id="f-679-2" continuedAt="f-679-3"><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Also, the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-64" decimals="-3" name="ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-681">1,400</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> loan granted to Prosynergia in December 2021 was included in the acquisition cost to be allocated, since, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">substance, it was considered as a prepayment for the acquisition of the group of assets, which is repayable in cash in the event of non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">completion of the transaction. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The potential earn-out payment to be paid in the first half of 2023 was measured at fair value on April 1, 2022, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:EarnOutAtFairValueAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-682">1,446</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">, and included in the acquisition cost. This earn out could be triggered in the event the Group&#8217;s market capitalization <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 133.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">was in excess of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-6" name="abvx:EarnOutMarketCapitalizationThreshold" format="ixt:num-dot-decimal" scale="6" id="f-683">300</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.06pt; position: var(--position); text-decoration: none; white-space: pre;"> (valued at certain specified record dates), a listing of the Group&#8217;s shares on Nasdaq or a merger and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 143.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acquisition transaction prior to March 31, 2023. The amount of the earn-out was equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-63" decimals="2" name="abvx:EarnOutPercentage" scale="-2" id="f-684">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.02pt; position: var(--position); text-decoration: none; white-space: pre;"> of the difference between the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 153.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market capitalization and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-6" name="abvx:EarnOutMarketCapitalizationThreshold" format="ixt:num-dot-decimal" scale="6" id="f-685">300</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to a maximum amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.08pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-5" name="abvx:EarnOutMaximumAmount" format="ixt:num-dot-decimal" scale="6" id="f-686">4.0</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.93pt; position: var(--position); text-decoration: none; white-space: pre;">. It was payable in the first half of 2023 if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions were met. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.01pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-5" name="abvx:EarnOutAmountPayableIfConditionsAreNotMet" format="ixt:fixed-zero" scale="0" id="f-687">No</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> amount was payable in the event the Group&#8217;s market capitalization was lower than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-6" name="abvx:EarnOutMarketCapitalizationThreshold" format="ixt:num-dot-decimal" scale="6" id="f-688">300</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.71pt; position: var(--position); text-decoration: none; white-space: pre;">. The related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial liability was subsequently remeasured to its fair value as of December&#160;31, 2022 estimated to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.65pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-138" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="0" id="f-689">nil</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.19pt; position: var(--position); text-decoration: none; white-space: pre;"> (see Note 15.9). The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement resulted in a financial income of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.99pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-139" decimals="-3" name="ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-690">1,446</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.08pt; position: var(--position); text-decoration: none; white-space: pre;"> over the year ended December&#160;31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As a consequence of the earn-out condition not being met on March 31, 2023, the related financial liability was derecognized.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" id="f-691" continuedAt="f-691-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The allocation of the acquisition cost is as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-691-1" continuedAt="f-691-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 237.56pt; width: 612pt;"><div style="font-size: 0pt; left: 28.8pt; position: var(--position); top: 0pt; width: 266.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"/></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 23.16pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 15.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.41pt; position: var(--position); text-decoration: none; white-space: pre;">Amount&#160;allocated&#160;as<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 23.96pt; position: var(--position); text-decoration: none; white-space: pre;">of&#160;April&#160;1,&#160;2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 23.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash prepayment made in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.17000000000002pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.59pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 49.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:CashPrepaymentAssetsAcquisitions" scale="3" id="f-692">325</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loan granted to Prosynergia in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.9pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 63.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:LoanGrantedAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-693">1,400</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash payment made in 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.06pt; position: var(--position); text-decoration: none; white-space: pre;">.............<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 78pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:CashTransferredAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-694">2,925</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition fees (1)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">...........................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 92.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:AcquisitionRelatedCostsAssetsAcquisition" scale="3" id="f-695">466</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Earn-out measured at fair value<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.14000000000001pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.51pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.53pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 106.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:EarnOutAtFairValueAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-696">1,446</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total acquisition cost allocated<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 134.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 134.54999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.60999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 134.62pt; position: var(--position); text-decoration: none; white-space: pre;">......<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 120.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-697">6,562</ix:nonFraction><span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 135pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 149.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Patents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.06pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 149.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:TechnologyBasedIntangibleAssetsAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-698">6,529</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 163.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.78pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 108.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.22999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.46pt; position: var(--position); text-decoration: none; white-space: pre;">................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 163.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.94pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:CashAndCashEquivalentsAssetsAcquisitions" scale="3" id="f-699">42</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">......................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 192pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:AssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="3" id="f-700">6,571</ix:nonFraction><span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 206.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 206.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.72pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.00999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 67.08999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">.................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 220.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 52.11pt; position: var(--position); text-decoration: none; white-space: pre;">(<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:LiabilitiesRecognisedAsOfAcquisitionDate" scale="3" id="f-701">9</ix:nonFraction>)<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 234.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total net assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.44999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;">................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 249pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-702">6,562</ix:nonFraction><span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 517.81pt; width: 612pt;"><ix:continuation id="f-691-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);"> (1)<span style="display: inline-block; height: 6.93pt; width: 10.34pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Of which <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-140" decimals="-3" name="abvx:PaymentsForAssetsAcquisitionsCosts" format="ixt:num-dot-decimal" scale="3" id="f-703">451</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); text-decoration: none; white-space: pre;"> were disbursed in 2021 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-141" decimals="-3" name="abvx:PaymentsForAssetsAcquisitionsCosts" format="ixt:num-dot-decimal" scale="3" id="f-704">15</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"> in 2022. Acquired cash amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:CashAndCashEquivalentsAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-705">42</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.44pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The acquisition cost was mainly allocated to Prosynergia&#8217;s patents US 10,464,903 (filed on March 20, 2017 and granted on November <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">5, 2019), EP3 429 998 (filed on March 20, 2017 and granted on September 1, 2021) and continuation US 10,745,357 (filed on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">November 1, 2019 and granted on August&#160;18, 2020). All patents will expire in 2037. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These patents cover alternative synthesis process for obefazimod and a family of close chemical analogues. They also cover <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">alternative forms of obefazimod (salts thereof and crystalline forms of said salts), the pharmaceutical composition comprising them, <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 601.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-679-3">that could be of interest to the Company for future development.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 629.81pt;" id="ia894b143b6fc4522a0483350194c625e_364"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.81pt; width: 612pt;"><ix:continuation id="f-649-40" continuedAt="f-649-41"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.16. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" id="f-706" continuedAt="f-706-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Use of judgments and estimates <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></ix:continuation></div><ix:continuation id="f-706-1" continuedAt="f-706-2"><ix:continuation id="f-649-41" continuedAt="f-649-42"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In order to prepare financial statements in accordance with IFRS, estimates, judgments and assumptions were made by the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">management which could affect the reported amounts of assets, liabilities, contingent liabilities, income and expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These estimates are based on the assumption of going concern and are prepared in accordance with information available at the date <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the financial statements were prepared. They are reviewed on an ongoing basis using past experience and various other factors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">considered to be reasonable as the basis to measure the carrying amount of assets and liabilities. Estimates may be revised due to <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-29<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-706-2"><ix:continuation id="f-649-42"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">changes in the underlying circumstances or subsequent to new information. Actual results may differ significantly from these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">estimates in line with assumptions or different conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">This note provides an overview of the areas that involved a higher degree of judgement or complexity, and of items which are more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">likely to be materially adjusted due to changes in estimates and assumptions. Detailed information about each of these estimates and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">judgements is included in other notes together with information about the basis of calculation for each affected line item in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial statements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Recognition and measurement of impairment of CGUs. The main assumptions used for the impairment test include <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(a)&#160;the amount of cash flows that are set on the basis of the development and commercialization plans and budgets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">approved by Board of Directors, (b)&#160;assumptions related to the achievement of the clinical trials and the launch of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization, (c)&#160;the discount rate, (d) assumptions on risk related to the development and (e)&#160;for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization, selling price and volume of sales. The sensitivity analysis in respect of the recoverable amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">CGUs is presented in Note 6. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Measurement of share-based payments granted to employees, corporate officers and scientific consultants, such as BCE, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">BSA and AGA, which is based on actuarial models; these models require the use by the Group of certain calculation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 237.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions such as the estimated vesting, the occurrence dates of a change of control or a M&amp;A transaction dates, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.11pt; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">percentage of success (&#8220;POS&#8221;) of obefazimod,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.94pt; position: var(--position); text-decoration: none; white-space: pre;"> the expected volatility and maturity of the underlying equity instrument <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(see Note 4.7 and Note 14), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement at inception and after of derivative financial instruments resulting from (i)&#160;the warrants issued <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">concomitantly with the issuance of the straight and convertible bonds to Kreos on July 24, 2018 (or &#8220;Kreos 1&#8221;), (ii) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">prepayment option attached to the straight and convertible bonds issued to Kreos on October 2, 2020 (or &#8220;Kreos 2&#8221;), and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(iii)&#160;the prepayment option attached to the issuance of bond convertible into new or existing shares in July 30, 2021 (or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;OCEANE&#8221;) (see Notes 15), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">(iv) the Kreos / Claret BSA issued on August 21, 2023 and November 2, 2023, related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">tranches A-B and tranche C, respectively, and (v) the Kreos / Claret Minimum Return Indemnifications related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">tranches B and C, issued in March 2024 and June 2024, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement of financial liabilities at inception (see Note 15), <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.62pt; position: var(--position); text-decoration: none; white-space: pre;">and after (for the Heights convertible notes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">issued on August 24, 2023) measured at fair value at each reporting period, with fair value changed recognized in profit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">or loss, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Amortized cost measurement of royalty certificates, based on the following assumptions: (a)&#160;future cash flows, estimated <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">on the basis of development and commercialization plans and budgets approved by the Board of Directors and (b)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">effective interest rate. The sensitivity analysis in respect of the measurement of royalty certificates is presented in Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">15,&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement of the call option resulting from the equity line contracts entered into on September 30, 2019 (or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Equity lines&#8221;) (see Note 13.2), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Estimation of CIR, based on internal and external expenses, which meet the required criteria, incurred by the Group each <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">year (see Note 4.9), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Recognition of deferred tax assets: availability of future taxable profit against which deductible temporary differences <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">and tax losses carried forward can be utilized and whether sufficient evidence exists (see Note 22). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Recognition of deferred tax assets: tax deductibility of future royalty payments related to the royalty certificates issued in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 541.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">September 2022 (see Notes 15 and 22).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Determination of the terms of the leases, including whether the Group is reasonably certain to exercise extension and/or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">termination options (see Note 15.8).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The main critical judgements made by the Group&#8217;s management impact the following items: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment of specific conditions of share-based compensation plans (see Notes 4.7 and 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 653.06pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.67pt;">&#8226;<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 173.62pt;">Accounting treatment of the 2018 &amp; 2020 <span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.67pt; position: var(--position); text-decoration: none; white-space: pre; width: 31.87pt;">Kreos 1<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.54pt; position: var(--position); text-decoration: none; white-space: pre; width: 279.42pt;"> &amp; 2 bonds, the 2021 OCEANE bonds, and the August 2023 Kreos /<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.96pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 664.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 215.9pt;">Claret and Heights Financings (see Notes 4.8 and 15).<span style="display: inline-block; height: 7.64pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-30<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 70.56pt;" id="ia894b143b6fc4522a0483350194c625e_367"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 5. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" id="f-707" continuedAt="f-707-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Segment information <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-707-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The assessment of the Group&#8217;s performance and the decisions about resources to be allocated are made by the chief operating decision <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">maker, based on the management reporting system of the Group. The Group identified the Chief Executive Officer of the Group as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;chief operating decision maker&#8221;. The chief operating decision maker reviews on an aggregated basis the incurred expenses for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">allocating and evaluating performance of the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group operates in a single operating segment: R&amp;D of pharmaceutical products in order to market them in the future. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Substantially all operations, assets, liabilities, and losses of the Group are located in France. As of December 31, 2023 and 2024, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Subsidiary<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.03pt; position: var(--position); text-decoration: none; white-space: pre;"> (created in 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.45pt; position: var(--position); text-decoration: none; white-space: pre;">) has contributions to the Group&#8217;s assets, liabilities and net losses<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.01pt; position: var(--position); text-decoration: none; white-space: pre;"> that were less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.07pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-142" decimals="2" name="abvx:ContributionToGroupsLiabilitiesPercentage" scale="-2" id="f-708"><ix:nonFraction unitRef="number" contextRef="c-143" decimals="2" name="abvx:ContributionToGroupsNetProfitsLossesPercentage" scale="-2" id="f-709"><ix:nonFraction unitRef="number" contextRef="c-142" decimals="2" name="abvx:ContributionToGroupsAssetsPercentage" scale="-2" id="f-710"><ix:nonFraction unitRef="number" contextRef="c-144" decimals="2" name="abvx:ContributionToGroupsNetProfitsLossesPercentage" scale="-2" id="f-711"><ix:nonFraction unitRef="number" contextRef="c-145" decimals="2" name="abvx:ContributionToGroupsLiabilitiesPercentage" scale="-2" id="f-712"><ix:nonFraction unitRef="number" contextRef="c-145" decimals="2" name="abvx:ContributionToGroupsAssetsPercentage" scale="-2" id="f-713">10</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.4pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 212.96pt;" id="ia894b143b6fc4522a0483350194c625e_373"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 212.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 6. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfGoodwillExplanatory" id="f-715" continuedAt="f-715-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill and impairment test <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-715-1" continuedAt="f-715-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill relates to the acquisition of Splicos SAS and Wittycel SAS that occurred in 2014 (i.e., prior the transition date to IFRS), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which were merged into the Group in the same year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill from Splicos SAS and Wittycel SAS acquisition corresponds to the &#8220;Modulation of RNA biogenesis / splicing&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">technological platform and the &#8220;iNKT agonists&#8221; technological platform, respectively, from which derived the lead drug candidates of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group: ABX464 and ABX196, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 3 was not applied to acquisitions of subsidiaries deemed to be a business within the meaning of IFRS, carried out before the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS transition date, i.e., January&#160;1 2020. Due to the application of this exemption, the previous accounting for business combinations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in accordance with French GAAP remains unchanged (no identified Intellectual Property, Research&#160;&amp; Development (&#8220;IPR&amp;D&#8221;) assets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are recognized in the statement of financial position). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The carrying amount of the goodwill resulting from the Splicos SAS acquisition was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.07pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-146" decimals="-3" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-716"><ix:nonFraction unitRef="eur" contextRef="c-147" decimals="-3" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-717"><ix:nonFraction unitRef="eur" contextRef="c-148" decimals="-3" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-718">18,419</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.16pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December&#160;31, 2022, 2023 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and 2024.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In accordance with IAS 36, goodwill is allocated to CGUs at a level corresponding to the lead drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.88pt; position: var(--position); text-decoration: none; white-space: pre;">Thus, goodwill from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Splicos SAS is allocated to the ABX464 CGU.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill impairment tests are undertaken annually or more frequently if events or changes in circumstances indicate a potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impairment, in accordance with IAS 36. The carrying amount of goodwill is compared to the recoverable amount, which is the higher <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value in use and the fair value less costs to disposal. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, the Group has not identified any indication of impairment loss related to goodwill, intangible or tangible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024 the recoverable amount used for the impairment test of each CGU was the value in use. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value in use was based on a net present value calculation, using the following assumptions as of December 31, 2022, 2023 and 2024: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Cash flows are set on the basis of the development and commercialization plans and budgets approved by Board of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Directors; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">A discount rate (or &#8220;WACC&#8221;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.57999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">) of</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.74pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.24pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" id="f-719">11.5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.07pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">as o</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.39pt; position: var(--position); text-decoration: none; white-space: pre;">f December 31, 2024;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">A risk of development is taken into consideration by applying probabilities of success (or &#8220;POS&#8221;) of reaching future <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">phases of development to cash flows related to the commercialization phase. Those average probabilities of success of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D projects are based on public sources (INFORMA databases).;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">For the commercialization phase, selling price and sales volume are estimated on the basis of the potential market and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 615.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">the observed performances of comparable drugs currently on the market. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 637.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the year ended December 31, 2022, management took into account significant external changes in the hepatocellular <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 647.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">carcinoma (HC) treatment landscape. These changes were expected to require a new, lengthy, heavy and risky internal development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">process (use of a combination of compounds). For this purpose, entering into a licensing partnership to fund the completion of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">clinical development of ABX196 was being considered. As of December&#160;31, 2022, due to the lack of progress made in the negotiation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of a development partnership, the Group made the decision to freeze the development program for ABX196 in the treatment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">hepatocellular cancer. In this context, the impairment test carried out as of December&#160;31, 2022 resulted in the full impairment of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">goodwill resulting from the acquisition of Wittycell SAS and other assets included in the ABX196 CGU, i.e. an impairment loss of <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-31<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-715-2" continuedAt="f-715-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-65" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-720">13,632</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December&#160;31, 2022 (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-65" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-721">13,586</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.7pt; position: var(--position); text-decoration: none; white-space: pre;"> related to goodwill and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-65" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-722">45</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.68pt; position: var(--position); text-decoration: none; white-space: pre;"> related to other assets &#8211; see Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">7). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The impairment tests resulted in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-723"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-724">no</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.21pt; position: var(--position); text-decoration: none; white-space: pre;"> impairment charges as of December 31, 2023, and 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Sensitivity testing as of December&#160;31, 2022, 2023 and 2024:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Regarding ABX464, as the product is currently under development, a clinical trial failure or a failure to obtain a marketing approval <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 167.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">could result in an impairment. The results of the impairment test indicate a headroom level that is high enough so that any reasonably <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-715-3">possible change in any of the key assumptions (except clinical failure) would not lead to any impairment.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 219.36pt;" id="ia894b143b6fc4522a0483350194c625e_376"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 219.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 7. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" id="f-725" continuedAt="f-725-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-725-1" continuedAt="f-725-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 235.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets are mainly comprised of the intellectual property underlying: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 66.55pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 4.45pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 262.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.55pt; position: var(--position); text-decoration: none; white-space: pre;">(i)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 75.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160;  <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">The exclusive license agreement with the Scripps Research Institute, University of Chicago and Brigham Young <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">University for which the Group paid a milestone of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-149" decimals="-3" name="abvx:CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" scale="3" id="f-726">45</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.94pt; position: var(--position); text-decoration: none; white-space: pre;"> in September 2019 as a result of an IND filling of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 288.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">ABX196. The value in use and the fair value less costs to disposal of the ABX196 CGU being <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.43pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-66" decimals="-3" name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" format="ixt:fixed-zero" scale="0" id="f-727">nil</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.97pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 299.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">2022, a<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-65" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-728">45</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.57pt; position: var(--position); text-decoration: none; white-space: pre;"> impairment loss was recorded during the year ended December 31, 2022 (see Note 6).<span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 522.87pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 66.55pt; position: var(--position);">(ii)<span style="display: inline-block; height: 6.93pt; width: 12.3pt;"></span></span><span style="left: 91.05pt; position: var(--position);">The collaboration and license agreement with the CNRS, Montpellier 2 university and the Curie for which the Group <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">paid a milestone of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.84pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-150" decimals="-3" name="abvx:CollaborationAgreementsDevelopmentMilestonePaymentPhase2" format="ixt:num-dot-decimal" scale="3" id="f-729">40</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.43pt; position: var(--position); text-decoration: none; white-space: pre;"> in September 2019 as a result of the entry in phase 2 of ABX464. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 66.55pt; position: var(--position);">(iii)<span style="display: inline-block; height: 6.93pt; width: 9.53pt;"></span></span><span style="left: 91.05pt; position: var(--position);">Patents acquired through the acquisition of Prosynergia of <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:TechnologyBasedIntangibleAssetsAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-730">6,529</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.91pt; position: var(--position); text-decoration: none; white-space: pre;"> (cf. Note 4). The patents are not yet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">amortized, similarly to licenses, and are included in the ABX464 CGU for impairment test purposes.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-32<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-725-2"><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Licenses and patents recognized as Intangible assets are not amortized since they are not operating in a manner intended by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">management. As a consequence, and in accordance with IAS 36, those assets were subject to an annual impairment test as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022, 2023 and 2024, which did <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.16pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-151" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="0" id="f-731"><ix:nonFraction unitRef="eur" contextRef="c-152" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="0" id="f-732">not</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.93pt; position: var(--position); text-decoration: none; white-space: pre;"> result in any impairment loss being recognized except for the above-mentioned <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 101.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-65" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-733">45</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.59pt; position: var(--position); text-decoration: none; white-space: pre;"> impairment loss recorded during the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.43pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.02pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.02pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 133.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" id="f-734" continuedAt="f-734-1" escape="true"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 461.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.82pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.16pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.26pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-153" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-735">85</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-154" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-736">24</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-155" xsi:nil="true" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" id="f-737"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-156" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-738">110</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-157" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="f-739">35</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-158" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-740">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-159" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-741">6,529</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-160" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-742">6,564</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-161" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-743">120</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-162" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-744">24</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-163" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-745">6,529</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-164" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-746">6,673</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-165" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-747">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-166" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-748">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-167" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-749">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-168" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-750">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-169" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-751">120</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-170" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-752">24</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-171" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-753">6,529</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-172" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-754">6,673</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-173" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-755">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.13pt;"></span></span><span style="left: 56.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-174" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="f-756">3</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-175" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-757">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.13pt;"></span></span><span style="left: 56.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-176" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="f-758">3</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-177" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-759">120</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-178" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-760">27</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-179" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-761">6,529</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-180" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-762">6,677</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-734-1"><div style="position: var(--position); top: 315.19pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-181" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="0" id="f-763">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-182" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-764">17</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-183" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="0" id="f-765">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-184" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-766">17</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-185" decimals="-3" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="0" id="f-767">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-186" decimals="-3" sign="-" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" scale="3" id="f-768">4</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-187" decimals="-3" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-769">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-188" decimals="-3" sign="-" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" scale="3" id="f-770">4</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-185" decimals="-3" sign="-" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="3" id="f-771">45</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-186" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-772">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-187" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-773">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-188" decimals="-3" sign="-" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="3" id="f-774">45</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-189" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-775">45</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-190" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-776">21</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-191" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-777">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-192" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-778">66</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-193" decimals="-3" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-779">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-194" decimals="-3" sign="-" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" scale="3" id="f-780">3</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-195" decimals="-3" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-781">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-196" decimals="-3" sign="-" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" scale="3" id="f-782">2</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-197" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-783">45</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-198" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-784">24</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-199" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-785">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-200" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-786">69</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-201" decimals="-3" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-787">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-202" decimals="-3" sign="-" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" scale="3" id="f-788">1</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-203" decimals="-3" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-789">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-204" decimals="-3" sign="-" name="abvx:IncreaseIntangibleAssetsOtherThanGoodwill" scale="3" id="f-790">1</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-205" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-791">45</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-206" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-792">25</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-207" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-793">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-208" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-794">70</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 521.54pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NET BOOK VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-209" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-795">85</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-210" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-796">8</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-211" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-797">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-12" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-798">93</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-212" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-799">75</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-213" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-800">3</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-214" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-801">6,529</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-802">6,607</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-215" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-803">75</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-216" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-804">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-217" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-805">6,529</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-806">6,604</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-218" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-807">75</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-219" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="f-808">3</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-220" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-809">6,529</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-810">6,606</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation><div style="position: absolute; top: 690.59pt;" id="ia894b143b6fc4522a0483350194c625e_379"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 8. <span style="display: inline-block; height: 6.77pt;"></span><span id="if4b74afb36214495aea2c77f47c9d0db"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="f-811" continuedAt="f-811-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-33<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-811-1" continuedAt="f-811-2"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory" id="f-812" continuedAt="f-812-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables present changes in property, plant and equipment including the right of use of assets (or &#8220;ROU&#8221;) as of <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-812-1" continuedAt="f-812-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022, 2023 and 2024:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 105.19pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 525.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 55.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.57pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.25pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.34pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.69pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.01pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.79pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.12pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-221" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-813">593</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-222" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-814">402</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-223" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-815">235</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-156" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-816">1,230</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-224" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-817">682</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-225" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-818">1,618</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-226" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-819">39</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-227" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-820">111</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-160" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-821">1,768</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-228" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-822">1,472</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-225" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-823">593</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.97pt;"></span></span><span style="left: 49.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-226" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-824">3</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.97pt;"></span></span><span style="left: 49.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-227" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-825">1</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-160" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-826">597</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-228" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-827">593</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-229" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-828">1,618</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-230" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-829">436</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-231" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-830">346</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-164" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-831">2,400</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-232" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-832">1,561</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-233" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-833">350</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-234" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-834">103</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-235" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-835">161</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-168" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-836">614</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-236" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-837">350</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-233" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-838">622</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.97pt;"></span></span><span style="left: 45.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-234" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-839">27</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-235" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-840">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-168" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-841">649</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-236" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-842">649</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-237" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-843">1,346</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-238" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-844">513</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-239" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-845">507</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-172" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-846">2,366</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-240" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-847">1,262</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-241" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-848">2,578</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-242" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-849">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-243" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-850">292</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-176" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-851">2,870</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-244" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-852">2,217</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.97pt;"></span></span><span style="left: 35.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-241" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-853">1,110</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-242" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-854">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-243" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-855">119</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.97pt;"></span></span><span style="left: 35.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-176" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-856">1,229</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-244" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-857">975</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 204pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of the change in foreign currency exchange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.63pt;"></span></span><span style="left: 52.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-241" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-858">4</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-242" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-859">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-243" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-860">17</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-176" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-861">22</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-244" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-862">22</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-245" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-863">2,818</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-246" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-864">513</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-247" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-865">698</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-180" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-866">4,029</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-248" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-867">2,504</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 361.82pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 528.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 49.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.07pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.75pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.84pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.19pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.29pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DEPRECIATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 65.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-249" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-868">445</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-250" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-869">346</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-251" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-870">134</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-252" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-871">925</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-253" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-872">470</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-254" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-873">407</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-255" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-874">35</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-256" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-875">38</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-257" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-876">481</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-258" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-877">414</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-254" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-878">593</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-255" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-879">3</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-256" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-880">1</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-257" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-881">597</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-258" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-882">593</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-259" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-883">259</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-260" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-884">378</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-261" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-885">171</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-262" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-886">808</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-263" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-887">290</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 131.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-264" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-888">578</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-265" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-889">36</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-266" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-890">94</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-267" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-891">707</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-268" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-892">498</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 143.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-264" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-893">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-265" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-894">27</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-266" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-895">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-267" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-896">27</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-268" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-897">27</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 155.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-269" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-898">837</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-270" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-899">387</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-271" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-900">265</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-272" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-901">1,488</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-273" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-902">761</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-274" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-903">886</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-275" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-904">32</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-276" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-905">171</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-277" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-906">1,089</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-278" decimals="-3" sign="-" name="abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" scale="3" id="f-907">788</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 188.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-274" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-908">1,111</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-275" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-909">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-276" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-910">104</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-277" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-911">1,215</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-278" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-912">975</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 200.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of the change in foreign currency exhange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-274" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-913">1</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-275" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-914">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-276" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:fixed-zero" scale="3" id="f-915">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-277" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-916">1</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.99pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-278" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-917">1</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-279" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-918">613</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-280" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-919">419</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-281" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-920">332</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-282" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-921">1,363</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-283" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-922">575</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-34<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-811-2"><ix:continuation id="f-812-2"><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 538.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.55pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.2pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.87pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.97pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.31pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NET BOOK VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-284" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-923">148</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-285" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-924">56</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-286" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-925">101</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-12" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-926">305</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-287" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-927">212</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 74.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-288" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-928">1,359</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-289" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-929">59</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-290" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-930">175</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-931">1,592</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-291" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-932">1,270</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 95.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-292" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-933">501</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-293" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-934">126</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-294" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-935">250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-936">878</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-295" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-937">501</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-296" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-938">2,205</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-297" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-939">94</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-298" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" scale="3" id="f-940">366</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-941">2,666</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-299" decimals="-3" name="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-942">1,929</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets relate to buildings, vehicles and furniture. The net book value of right of use assets related to buildings amounted to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-300" decimals="-3" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-943">1,224</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-301" decimals="-3" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-944">453</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.68pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.11pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-302" decimals="-3" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-945">1,846</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.2pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2022, 2023 and 2024 respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions over the year ended December 31, 2022 mainly include the right of use asset related to the new headquarters entered into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in July 2022 (see Note 15.8), as well as office fittings and IT equipment. Disposals over the period mainly include the right of use <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets related to the former headquarters. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions over the year ended December 31, 2023 mainly include the right of use asset related to the new Boston offices entered <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">into in November 2023. Decreases mainly include the remeasurement of the right of use asset related to the reassessment of the Paris <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 334.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Headquarters lease term, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-303" decimals="-3" name="abvx:DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-946">622</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;"> (see Note 15.8).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions over the period ended December 31, 2024 mainly include the right of use assets related to the new Paris headquarters and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Montpellier offices entered into in May and April 2024 respectively, as well as the 1-year renewal of the Boston offices lease (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.92pt; position: var(--position); text-decoration: none; white-space: pre;">15.8<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Disposals mainly include the right of use asset related to the former Paris headquarters lease, which ended in June <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.79pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 513.79pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 473.41pt;" id="ia894b143b6fc4522a0483350194c625e_382"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 9. <span style="display: inline-block; height: 6.77pt;"></span><span id="ibba67baaad5d4a7b8198925183f1833d"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherAssetsExplanatory" id="f-947" continuedAt="f-947-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-947-1" continuedAt="f-947-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.01pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinancialAssetsExplanatory" id="f-948" continuedAt="f-948-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-948-1"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 508.31pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 525.11pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 445.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 243.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 70.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OTHER FINANCIAL ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:NonCurrentAdvancesToCROContracts" format="ixt:num-dot-decimal" scale="3" id="f-949">10,471</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:NonCurrentAdvancesToCROContracts" format="ixt:num-dot-decimal" scale="3" id="f-950">12,172</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:NonCurrentAdvancesToCROContracts" format="ixt:num-dot-decimal" scale="3" id="f-951">4,929</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:LongtermDeposits" format="ixt:num-dot-decimal" scale="3" id="f-952">1,238</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:LongtermDeposits" scale="3" id="f-953">574</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:LongtermDeposits" scale="3" id="f-954">863</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:OtherNonCurrentMiscellaneousFinancialAssets" format="ixt:fixed-zero" scale="3" id="f-955">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:OtherNonCurrentMiscellaneousFinancialAssets" scale="3" id="f-956">124</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:OtherNonCurrentMiscellaneousFinancialAssets" scale="3" id="f-957">126</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total other non-current financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-958">11,708</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-959">12,870</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherNoncurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-960">5,919</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentAdvancesToCROContracts" format="ixt:fixed-zero" scale="3" id="f-961">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentAdvancesToCROContracts" format="ixt:fixed-zero" scale="3" id="f-962">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 3pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -1.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentAdvancesToCROContracts" format="ixt:num-dot-decimal" scale="3" id="f-963">7,418</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:OtherCurrentInvestments" format="ixt:fixed-zero" scale="3" id="f-964">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:OtherCurrentInvestments" format="ixt:num-dot-decimal" scale="3" id="f-965">9,050</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 3pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -5.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:OtherCurrentInvestments" format="ixt:fixed-zero" scale="3" id="f-966">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-6" xsi:nil="true" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" id="f-967"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="f-968">136</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="f-969">136</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total other current financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherCurrentFinancialAssets" format="ixt:fixed-zero" scale="3" id="f-970">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherCurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-971">9,186</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherCurrentFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-972">7,554</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-973">11,708</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-974">22,055</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherFinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-975">13,473</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-35<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-947-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 89.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These advances granted in 2022 for clinical studies are to be recovered at the end of the studies after final reconciliation with pass-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">through costs, which are being invoiced and paid as studies are carried out. These long-term advances were measured at fair value on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">initial recognition, using discount rates ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-304" decimals="4" name="abvx:DiscountRateAppliedToLongTermAdvances" scale="-2" id="f-976">0.19</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.94pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-305" decimals="4" name="abvx:DiscountRateAppliedToLongTermAdvances" scale="-2" id="f-977">7.16</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.54pt; position: var(--position); text-decoration: none; white-space: pre;">, and are subsequently measured at amortized cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 135.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the first half of 2023, additional advances related to CRO contracts amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-306" decimals="-3" name="abvx:PaymentsForAdvancesMadeToContractResearchOrganizations" format="ixt:num-dot-decimal" scale="3" id="f-978">1,620</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.64pt; position: var(--position); text-decoration: none; white-space: pre;"> were made (undiscounted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount). These long-term advances were measured at fair value on initial recognition, using discount rates ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.15pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-307" decimals="4" name="abvx:DiscountRateAppliedToLongTermAdvances" scale="-2" id="f-979">7.09</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.98pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-308" decimals="4" name="abvx:DiscountRateAppliedToLongTermAdvances" scale="-2" id="f-980">7.59</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.83pt; position: var(--position); text-decoration: none; white-space: pre;">, and are subsequently measured at amortized cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, a prepaid expenses asset was recognized for the difference between the advances&#8217; nominal value and fair value, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">spread over the term of the advances, at the rate of recognition of the related R&amp;D expenses (see Note 10).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In March 2024, a change order was signed with the CRO, extending the scope (addition of maintenance studies) and end date of one of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the studies to 2029, thus postponing the recovery date of the corresponding advance <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.02pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-309" decimals="-3" name="abvx:PaymentsForAdvancesMadeToContractResearchOrganizations" format="ixt:num-dot-decimal" scale="3" id="f-981">5,538</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.94pt; position: var(--position); text-decoration: none; white-space: pre;"> from June 2026 to June 2029. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group considered that this asset modification met the criteria for derecognition, and recognized a new financial asset at fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on that date, using a discount rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.34pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-310" decimals="4" name="abvx:DiscountRateAppliedToLongTermAdvances" scale="-2" id="f-982">6.83</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.17pt; position: var(--position); text-decoration: none; white-space: pre;">. Since the Group considers that these advances are made in exchange for a discount on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future services to be received from the CROs, a prepaid expense asset was also recognized for the difference between the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derecognized asset carrying value and new asset fair value, and spread over the term of the advance in a similar manner.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to these advances is deemed insignificant due to the CROs' credit ratings.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other investments consist of 6-month term deposits that do not qualify for a classification under cash and cas<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.47pt; position: var(--position); text-decoration: none; white-space: pre;">h equivalents. Term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 356.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deposits held by the Group as of December 31, 2024 qualify for a classification under cash equivalents.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits include the deposits paid under the Kreos 1 &amp; 2 bond loans (reimbursed in August 2023), the liquidity agreement, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.11pt; position: var(--position); text-decoration: none; white-space: pre;">the Paris <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and Boston offices lease contracts, the ATM Program, as well as other security <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.24pt; position: var(--position); text-decoration: none; white-space: pre;">deposits<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.99pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 448.16pt;" id="ia894b143b6fc4522a0483350194c625e_385"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 10. <span style="display: inline-block; height: 6.77pt;"></span><span id="ic7edcd9821ee4d2ea0eec3cb2c0b8222"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" id="f-983" continuedAt="f-983-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-983-1" continuedAt="f-983-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 469.26pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" id="f-984" continuedAt="f-984-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets break down as follows:<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 273.4pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-984-1"><div style="position: var(--position); top: 481.14pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 435pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 233.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 65.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OTHER RECEIVABLES AND OTHER ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses - non current<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:NonCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-985">1,037</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:NonCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-986">2,320</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:NonCurrentPrepaidExpenses" scale="3" id="f-987">948</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current other assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-988">1,037</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-989">2,320</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherNoncurrentAssets" scale="3" id="f-990">948</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit ("CIR")<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentResearchTaxCreditReceivables" format="ixt:num-dot-decimal" scale="3" id="f-991">4,595</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentResearchTaxCreditReceivables" format="ixt:num-dot-decimal" scale="3" id="f-992">4,600</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentResearchTaxCreditReceivables" format="ixt:num-dot-decimal" scale="3" id="f-993">5,774</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">VAT receivables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentValueAddedTaxReceivables" format="ixt:num-dot-decimal" scale="3" id="f-994">3,467</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentValueAddedTaxReceivables" format="ixt:num-dot-decimal" scale="3" id="f-995">14,439</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentValueAddedTaxReceivables" format="ixt:num-dot-decimal" scale="3" id="f-996">9,841</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="f-997">915</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-998">5,746</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-999">3,233</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentReceivablesFromCreditNotes" scale="3" id="f-1000">254</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentReceivablesFromCreditNotes" scale="3" id="f-1001">60</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentReceivablesFromCreditNotes" scale="3" id="f-1002">48</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current other receivables and assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentReceivablesAndCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1003">9,231</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentReceivablesAndCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1004">24,845</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentReceivablesAndCurrentPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1005">18,896</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-1006">10,268</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-1007">27,164</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-1008">19,843</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit (&#8220;CIR&#8221;) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The CIR is recognized as Other Operating Income (see note 4.9) in the year to which the eligible research expense relates. The Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">received the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> payments of the CIR for 2022 and 2023 tax years in the amount of respective<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.61pt; position: var(--position); text-decoration: none; white-space: pre;">ly&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:ProceedsFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-1009">4,476</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.47pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:ProceedsFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-1010">4,493</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.99pt; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively 2023 and 2024 and expects to receive the CIR for the 2024 tax year <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.25pt; position: var(--position); text-decoration: none; white-space: pre;">o<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.25pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">f </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.08pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentResearchTaxCreditReceivables" format="ixt:num-dot-decimal" scale="3" id="f-1011">5,774</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.17pt; position: var(--position); text-decoration: none; white-space: pre;"> in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.44pt; position: var(--position); text-decoration: none; white-space: pre;"> 2025. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-36<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-983-2" continuedAt="f-983-3"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">VAT Receivables <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Value-added tax (&#8220;VAT&#8221;) receivables relate primarily to the deductible VAT and VAT refunds claimed.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Their increase as of December 31, 2023 compared to December 31, 2022 is due to the increase in trade payables and accrued invoices <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">over the period (see Note 17.1).<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-37<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-983-3"><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses as of December&#160;31, 2022 include prepaid expenses related to CRO contracts for amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentPrepaidExpensesRelatedToCRO" format="ixt:num-dot-decimal" scale="3" id="f-1012">1,714</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.28pt; position: var(--position); text-decoration: none; white-space: pre;"> (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 9).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 125.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses as of December 31, 2023 include prepaid expenses related to CRO contracts for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentPrepaidExpensesRelatedToCRO" format="ixt:num-dot-decimal" scale="3" id="f-1013">1,347</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.21pt; position: var(--position); text-decoration: none; white-space: pre;"> (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 9) and deferred transactions costs related to tranches B and C of the Kreos / Claret financings for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.68pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-311" decimals="-3" sign="-" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="3" id="f-1014">3,152</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.77pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(most of which represents the issuance date fair value of the tranche A-B and C Kreos / Claret BSA, representing origination fees for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the future drawdowns of the tranches B and C of the Kreos / Claret Financing, See Note<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> 15.1) and other expenses from various </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">suppliers amounting to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentAdvancesToSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-1015">3,567</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses as of December 31, 2024 include prepaid expenses related to CRO contracts for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentPrepaidExpensesRelatedToCRO" format="ixt:num-dot-decimal" scale="3" id="f-1016">1,577</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.21pt; position: var(--position); text-decoration: none; white-space: pre;"> (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 9) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 68.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and other expenses from various suppliers amounting to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.22pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentAdvancesToSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-1017">2,604</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.31pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The decrease in prepaid expenses over the year ended December 31, 2024 mainly corresponds to the reclassification of the deferred <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction costs of tranche B of the Kreos / Claret Financing, from prepaid expenses to a reduction of the initial carrying value of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">debt component, in accordance with the effective interest rate method, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-312" decimals="-3" name="abvx:ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" format="ixt:num-dot-decimal" scale="3" id="f-1018">1,546</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.96pt; position: var(--position); text-decoration: none; white-space: pre;">, and to the amortization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the deferred transaction costs related to tranche C (already fully amortized on the date of drawdown).<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 299.16pt;" id="ia894b143b6fc4522a0483350194c625e_388"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 299.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 11. <span style="display: inline-block; height: 6.77pt;"></span><span id="i28657342886348cb8e4193b5a888ea49"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" id="f-1019" continuedAt="f-1019-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1019-1" continuedAt="f-1019-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.96pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" id="f-1020" continuedAt="f-1020-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1020-1"><div style="position: var(--position); top: 352.86pt; width: 612pt;"><div style="font-size: 0pt; left: 41pt; position: var(--position); top: 0pt; width: 474pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 243pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 69.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CASH AND CASH EQUIVALENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CashEquivalents" scale="3" id="f-1021">6</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1022">18,105</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1023">87,265</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="3" id="f-1024">26,944</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="3" id="f-1025">233,837</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="3" id="f-1026">56,956</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1027">26,950</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1028">251,942</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1029">144,221</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 447.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents mainly include term deposits with short-term maturities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 459.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023 and 2024, in addition to the Group&#8217;s bank accounts, cash includes notice accounts amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:OtherCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1030">231,562</ix:nonFraction> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:OtherCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1031">44,239</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.02pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand respectively. These funds are available on demand within 24 hours and without penalty.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in cash and cash equivalents over the year ended December 31, 2023 is mainly explained by the proceeds from (i) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret and Heights Financings from August 2023 and (ii) the Group&#8217;s Global Offering conducted in October 2023 (see Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.91pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">3.3</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">)</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.83pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023 and 2024, the impact of the revaluation of cash and cash equivalents held in U.S. dollars into the Group's <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 551.41pt; width: 612pt;"><ix:continuation id="f-1019-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">presentation currency is a net financial expense of<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-313" decimals="-3" sign="-" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1032">3,196</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and a net financial income of<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.81pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-314" decimals="-3" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-1033">2,035</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.9pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.4pt; position: var(--position); text-decoration: none; white-space: pre;">respectively.<span style="display: inline-block; height: 8.25pt;"></span></span></ix:continuation><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 545.15pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: absolute; top: 586.11pt;" id="ia894b143b6fc4522a0483350194c625e_391"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 586.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 12. <span style="display: inline-block; height: 6.77pt;"></span><span id="i20f3a179c38e400ebcec47f490aa6259"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory" id="f-1034" continuedAt="f-1034-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Financial assets and liabilities<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1034-1" continuedAt="f-1034-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.91pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory" id="f-1036" continuedAt="f-1036-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" id="f-1035" continuedAt="f-1035-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following table shows the carrying amounts and fair value of financial assets and financial liabilities, including their <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-1036-1" continuedAt="f-1036-2"><ix:continuation id="f-1035-1" continuedAt="f-1035-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">levels in the fair value hierarchy.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables are non-financial liabilities and are therefore excluded from the tables below. They are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">presented in Note 17.2.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-38<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1036-2" continuedAt="f-1036-3"><ix:continuation id="f-1035-2" continuedAt="f-1035-3"><ix:continuation id="f-1034-2" continuedAt="f-1034-3"><div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-315" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1037">11,708</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-316" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1038">11,271</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-317" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1039">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-318" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1040">11,271</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-319" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1041">9,231</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-320" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1042">9,231</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-321" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1043">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-322" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1044">9,231</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-323" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1045">26,950</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-324" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1046">26,950</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-325" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1047">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-326" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1048">26,950</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-327" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1049">47,889</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1050">47,452</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-328" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1051">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-329" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1052">47,452</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-330" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1053">16,241</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-331" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1054">9,439</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-332" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="3" id="f-1055">566</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-333" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1056">8,873</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-334" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1057">33,555</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-335" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1058">33,555</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-336" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1059">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-337" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1060">33,555</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-338" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1061">15,475</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-339" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1062">15,475</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-340" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1063">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-341" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1064">15,475</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-327" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1065">65,272</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1066">58,469</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-342" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="3" id="f-1067">566</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-343" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1068">57,903</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 273.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-344" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1069">22,055</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-345" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1070">22,394</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-346" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1071">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-347" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1072">22,394</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-348" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1073">27,164</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-349" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1074">27,164</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-350" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1075">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-351" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1076">27,164</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-352" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1077">251,942</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-353" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1078">251,942</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-354" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1079">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-355" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1080">251,942</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-356" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1081">301,161</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1082">301,500</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-357" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1083">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-358" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1084">301,500</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-359" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1085">39,697</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-360" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1086">40,622</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-361" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1087">18,506</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-362" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1088">42,768</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-363" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1089">37,348</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-364" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1090">37,348</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-365" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1091">11,531</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-366" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1092">5,165</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-367" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1093">47,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-368" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1094">47,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-369" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1095">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-370" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1096">47,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-356" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1097">124,266</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1098">125,191</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-371" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1099">30,037</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-372" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1100">95,154</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 476.56pt; width: 612pt;"><div style="font-size: 0pt; left: 40.12pt; position: var(--position); top: 0pt; width: 531.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 342pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 159.34pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 132.91pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.85pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.86pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-373" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1101">13,473</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-374" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1102">12,690</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-375" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1103">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-376" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1104">12,690</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-377" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1105">19,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-378" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1106">19,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-379" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1107">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-380" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1108">19,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-381" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1109">144,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-382" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1110">144,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-383" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1111">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-384" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1112">144,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-385" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1113">177,537</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1114">176,754</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-386" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1115">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-387" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1116">176,754</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-388" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1117">69,069</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-389" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1118">73,497</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-390" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1119">3,620</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-391" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1120">69,877</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-392" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1121">44,935</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-393" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1122">44,935</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-394" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1123">21,183</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-395" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1124">23,752</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-396" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1125">43,824</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-397" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1126">43,824</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-398" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1127">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-399" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1128">43,824</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-385" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1129">157,828</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1130">162,256</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-400" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1131">24,803</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-401" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1132">137,453</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; &#160;  The fair value of cash and cash equivalents is determined based on Level 1 fair value measurement and corresponds to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market value of the assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></ix:continuation></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-39<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1036-3"><ix:continuation id="f-1035-3"><ix:continuation id="f-1034-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(2)&#160; &#160;  The carrying amount of financial assets measured at amortized cost is deemed to be a reasonable estimate of fair value, except <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the long-term advances made to CROs, whose fair value is determined based on Level 3 fair value measurement and is estimated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based on future cash-flows discounted at market rates, using credit spreads ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.29pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-402" decimals="4" name="ifrs-full:SignificantUnobservableInputAssets" scale="-4" id="f-1133">16</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.29pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.56pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-403" decimals="4" name="ifrs-full:SignificantUnobservableInputAssets" scale="-4" id="f-1134">476</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.56pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-404" decimals="4" name="ifrs-full:SignificantUnobservableInputAssets" scale="-4" id="f-1135">104</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-405" decimals="4" name="ifrs-full:SignificantUnobservableInputAssets" scale="-4" id="f-1136">218</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.89pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-406" decimals="4" name="ifrs-full:SignificantUnobservableInputAssets" scale="-4" id="f-1137">131</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.89pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-407" decimals="4" name="ifrs-full:SignificantUnobservableInputAssets" scale="-4" id="f-1138">271</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2024. As of December 31, 2022, 2023, and 2024, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-408" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" scale="-4" id="f-1139">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.05pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the advances fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-409" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1140">240</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.96pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-410" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1141">23</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.55pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-411" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1142">235</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(3)&#160; &#160;  The carrying amount of short-term financial liabilities measured at amortized cost was deemed to be a reasonable estimate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(4)&#160; &#160;  The fair value of Kreos BSA A&amp;B, OCEANE conversion option, royalty certificates, Heights convertible notes, Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 199.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSA and Minimum Return Indemnifications is based on Level 3 fair value measurement and is estimated based on models and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions detailed in Note 15. The fair value of other long-term financial liabilities is determined based on Level 3 fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measurement and is estimated based on future cash-flows discounted at market rates, using the f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;">ollowing assumptions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of Kreos 1&amp;2 bonds, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.51pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-412" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="-4" id="f-1143">1,475</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.01pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.4pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-413" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-1144">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.03pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the Kreos 1&amp;2 bonds fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">value by&#160; and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-414" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1145">68</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.65pt; position: var(--position); text-decoration: none; white-space: pre;">.. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt component of OCEANE bonds, a credit spread similar to that detailed in Note 15. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31,&#160; 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.9pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-413" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-1146">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the OCEANE debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">component fair value by&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-415" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1147">476</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.98pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of the Kreos / Claret OCABSA (tranche A) and the tranches B and C of the Kreos / Claret straight <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bond loans, a credit spr<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ead of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="number" contextRef="c-416" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-4" id="f-1148">960</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp a</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.59pt; position: var(--position); text-decoration: none; white-space: pre;">s of August 22, 2023, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.19pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-417" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-4" id="f-1149">900</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.19pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.81pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-418" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-4" id="f-1150">750</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.81pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of August 22, 2023, December 31, 2023 (tranche A) and December 31, 2024 (all three tranches), an increase in the credit </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">spread by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.08pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-419" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-1151">100</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp would result in a decrease in the Kreos / Claret debt components fair value by respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-420" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1152">624</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">,&#160; </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-421" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1153">538</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-422" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1154">958</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 427.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.89pt; position: var(--position); text-decoration: none; white-space: pre;"> the conditional advances and the PGE loan, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.42pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-423" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="-4" id="f-1155">1,475</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.92pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="number" contextRef="c-424" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-4" id="f-1156">900</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">31, 2023 and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="number" contextRef="c-425" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-4" id="f-1157">730</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December 31, 2024. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">An increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.71pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-408" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-1158">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024, a decrease in the PGE loan fair value by, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-426" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1159">55</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.84pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-427" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1160">39</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-428" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1161">21</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the RNP-VIR conditional advance fair value by&#160;  <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-429" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1162">31</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.4pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-430" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1163">15</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the CARENA conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-431" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1164">37</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.5pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-432" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1165">37</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the Ebola conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.13pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-433" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1166">1</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.72pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-434" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1167">1</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(5) In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">non-current portion of the Heights convertible notes as of December 31, 2023 were reclassified within the current liabilities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></ix:continuation><div style="position: absolute; top: 655.06pt;" id="ia894b143b6fc4522a0483350194c625e_394"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13. <span style="display: inline-block; height: 6.77pt;"></span><span id="i1e6e43ec8ba1489aa65268df54c3a229"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="f-1168" continuedAt="f-1168-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Shareholders&#8217; equity<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><div style="position: absolute; top: 675.91pt;" id="ia894b143b6fc4522a0483350194c625e_397"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 675.91pt; width: 612pt;"><ix:continuation id="f-1168-1" continuedAt="f-1168-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.1. Share capital issued<span style="display: inline-block; height: 6.77pt;"></span><span id="i7bb188ecefa74b61b159fe36701c7a84"></span></span></ix:continuation></div><ix:continuation id="f-1168-2" continuedAt="f-1168-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 694.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group manages its capital to ensure that the Group will be able to continue as a going concern while maximizing the return to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 706.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders through the optimization of the debt and equity balance.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-40<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1168-3" continuedAt="f-1168-4"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the Group&#8217;s share capital amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="3" id="f-1169">223</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.39pt; position: var(--position); text-decoration: none; white-space: pre;"> divided into <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1170">22,313,185</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.4pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares issued with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-6" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1171">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.72pt; position: var(--position); text-decoration: none; white-space: pre;"> each, fully paid up, after taking into account the various capital increases that took place since the inception (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.3). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023, the Group&#8217;s share capital amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="3" id="f-1172">629</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.39pt; position: var(--position); text-decoration: none; white-space: pre;"> divided into <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1173">62,928,818</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.4pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares issued with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 141.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-7" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1174">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.65pt; position: var(--position); text-decoration: none; white-space: pre;"> each, fully paid up, after taking into account the various capital increases that took place since the inception (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.2). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, the Group&#8217;s share capital amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="3" id="f-1175">633</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.39pt; position: var(--position); text-decoration: none; white-space: pre;"> divided in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.13pt; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1176">63,347,837</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.4pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.9pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares issued with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 179.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-5" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1177">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.65pt; position: var(--position); text-decoration: none; white-space: pre;"> each, fully paid up, after taking into account the various capital increases that took place since the inception (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.3). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Share capital does not include founders&#8217; share subscription warrants (&#8220;bons de souscription de parts de cr&#233;ateur d&#8217;entreprise&#8221; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;BCE&#8221;), share subscription warrants (&#8220;Bons de souscription d&#8217;actions,&#8221; or &#8220;BSA&#8221;) and free shares (&#8220;Attributions gratuites <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 235.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">d&#8217;actions,&#8221; or &#8220;AGA&#8221;) that have been granted to certain investors or natural persons, both employees and non-employees of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Group, but not yet exercised.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Treasury shares<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 299.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group held <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.78pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="abvx:NumberOfTreasurySharesHeld" format="ixt:num-dot-decimal" scale="0" id="f-1178">12,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.28pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.28pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="abvx:NumberOfTreasurySharesHeld" format="ixt:num-dot-decimal" scale="0" id="f-1179">11,339</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.78pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="abvx:NumberOfTreasurySharesHeld" format="ixt:fixed-zero" scale="0" id="f-1180">none</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.64pt; position: var(--position); text-decoration: none; white-space: pre;"> of its own shares as of December 31, 2022, 2023 and 2024, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 321.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The number of outstanding ordinary shares (excluding treasury shares held by the Group) was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.55pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="ifrs-full:NumberOfSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1181">22,301,185</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.55pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.55pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="ifrs-full:NumberOfSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1182">62,917,479</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.55pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 528.98pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="ifrs-full:NumberOfSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1183">63,347,837</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 573.98pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as of December 31, 2022, 2023 and 2024, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 386.76pt;" id="ia894b143b6fc4522a0483350194c625e_400"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.76pt; width: 612pt;"><ix:continuation id="f-1168-4" continuedAt="f-1168-5"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 57.92pt; position: var(--position); text-decoration: none; white-space: pre;">13.2. Equity line instruments <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-1168-5" continuedAt="f-1168-6"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Equity line agreement with Kepler Cheuvreux <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into an equity line agreement with Kepler Cheuvreux in September 2019. In accordance with the terms of this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement, Kepler Cheuvreux, acting as financial intermediary and guarantor of the transaction, committed to subscribe for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.75pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-435" decimals="INF" name="abvx:UnderwritingAgreementMaximumNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1184">730,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.25pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 438.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shares, at its own initiative, following a schedule lasting no longer than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.9pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-435" name="abvx:UnderwritingAgreementMaximumPeriod" format="ixt-sec:durmonth" id="f-1185">24</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.83pt; position: var(--position); text-decoration: none; white-space: pre;">, at an issuance price based on an average market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price weighted according to the volumes traded over the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.22pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="criteria" contextRef="c-435" decimals="INF" name="abvx:UnderwritingAgreementIssuancePriceNumberOfTradingDays" format="ixt-sec:numwordsen" scale="0" id="f-1186">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.21000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> trading days preceding each issue, less a maximum discount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.6pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-435" decimals="3" name="abvx:UnderwritingAgreementIssuancePriceMaximumDiscount" scale="-2" id="f-1187">7.0</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 555.43pt; position: var(--position); text-decoration: none; white-space: pre;">. On <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">September 24, 2021, the Group extended the agreement for an additional period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.71pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-436" name="abvx:UnderwritingAgreementExtendedPeriod" format="ixt-sec:durmonth" id="f-1188">12</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.64pt; position: var(--position); text-decoration: none; white-space: pre;"> for the unsubscribed shares at that date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 468.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October&#160;1, 2022, the agreement ended and the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.18pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-437" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1189">300,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.68pt; position: var(--position); text-decoration: none; white-space: pre;"> outstanding BSAs lapsed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 478.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 490.76pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" id="f-1190" continuedAt="f-1190-1" escape="true"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 518.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 61.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.99pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 15.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.21pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.99pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.21pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.32pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.92pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.94pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 15.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.49pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.37pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.49pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.71pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;">SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.14pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.82pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 123.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 67.5pt; width: 61.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 67.5pt; width: 117pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 67.5pt; width: 64.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 79.5pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 79.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.32pt; position: var(--position); text-decoration: none; white-space: pre;">FOR THE YEAR ENDED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 79.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 91.5pt; width: 137.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JANUARY&#160;1, 2022<span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 91.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 91.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.86999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs granted under the Equity line <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">agreement<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 47.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.510000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.800000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 48.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.010000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.02pt; position: var(--position); text-decoration: none; white-space: pre;">....................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.81pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-438" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1191">300,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 111.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.69pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-438" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1192">300,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-439" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1193">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.53pt; position: var(--position); text-decoration: none; white-space: pre;">(<ix:nonFraction unitRef="shares" contextRef="c-439" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1194">300,000</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.81pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-440" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1195">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-440" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:fixed-zero" scale="0" id="f-1196">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 639.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Considering that the Group could terminate or suspend the Equity line agreement by buying back the BSAs or increasing the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 649.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">minimum exercise price and that Kepler Cheuvreux was committed to subscribe the shares if the conditions were met, the BSAs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granted to Kepler Cheuvreux under the Equity line agreements were off-balance sheet commitments rather than derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 691.76pt;" id="ia894b143b6fc4522a0483350194c625e_403"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 691.76pt; width: 612pt;"><ix:continuation id="f-1168-6" continuedAt="f-1168-7"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.3. Change in share capital<span style="display: inline-block; height: 6.77pt;"></span><span id="i6ad075e1c272438ea7f278d53e09ca0f"></span></span></ix:continuation></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-41<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1168-7" continuedAt="f-1168-8"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increases in the share capital for the year ended December 31, 2022 relate to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 98.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The completion of a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-441" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-1197">46,231</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> on September 7, 2022 by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.5pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-441" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-1198">5,530,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.5pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-442" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1199">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.72pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-442" decimals="2" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-1200">8.36</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.06pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The exercises of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="abvx:NumberOfWarrantsExercised" scale="0" id="f-1201">522</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants for the year ended December 31, 2022 (see Note 14), resulting in a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" format="ixt:num-dot-decimal" scale="3" id="f-1202">3</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.59pt; position: var(--position); text-decoration: none; white-space: pre;"> by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.41pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-1203">19,134</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.91pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.65pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-6" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1204">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.15pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an average subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-6" decimals="2" name="abvx:OtherShareWarrantsSubscriptionPricePerShare" scale="0" id="f-1205">0.14</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.04pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">per share; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Incremental costs directly attributable to the issue of new shares were classified as a deduction of shareholders&#8217; equity and amounted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.269999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:ShareIssueRelatedCost" format="ixt:num-dot-decimal" scale="3" id="f-1206">3,280</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.36pt; position: var(--position); text-decoration: none; white-space: pre;"> for the period ended December 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increases in the share capital for the year ended December 31, 2023 relate to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The completion of a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-443" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-1207">130,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> on February 22, 2023 by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-443" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-1208">20,000,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.86pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-444" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1209">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.91pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-444" decimals="2" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-1210">6.50</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.25pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The cash-less exercise of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-445" decimals="0" name="abvx:NumberOfWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1211">67,887</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.13pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos A BSA and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-446" decimals="0" name="abvx:NumberOfWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1212">31,696</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.09000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos B BSA on<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.06pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> May 24, 20</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.38pt; position: var(--position); text-decoration: none; white-space: pre;">23, resulting in a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-447" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" format="ixt:num-dot-decimal" scale="3" id="f-1213">1,850</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.09pt; position: var(--position); text-decoration: none; white-space: pre;"> by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.91pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-447" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-1214">99,583</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.41pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-448" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1215">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.65pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an average subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 268.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-449" decimals="2" name="abvx:OtherShareWarrantsSubscriptionPricePerShare" scale="0" id="f-1216">18.57</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.5pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, which includes the impact of the derecognition of the BSA derivative financial liability; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The completion of the Group&#8217;s Global Offering on the Nasdaq Global Market on October 24, 2023, by way of a capital <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-95" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-1217">20,325,500</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.04000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares, consisting of the U.S. Offering of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.59pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-1218">18,699,460</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.59pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares in the form of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs, and the European Private Placement of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.02pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-97" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-1219">1,626,040</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.02pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares, with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-450" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1220">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.76pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an offering <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price set at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.75pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-98" decimals="2" name="abvx:IssueOfEquityOfferingPricePerShare" scale="0" id="f-1221">11.60</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.25pt; position: var(--position); text-decoration: none; white-space: pre;"> per ADS in the U.S. Offering and a corresponding offering price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-99" decimals="4" name="abvx:IssueOfEquityOfferingPricePerShare" scale="0" id="f-1222">10.9864</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.69pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">European Private Placement. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The exercise of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.07pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="0" name="abvx:NumberOfWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1223">1,906</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.57pt; position: var(--position); text-decoration: none; white-space: pre;"> other share warrants, by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-1224">190,550</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.9pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-7" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1225">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.14pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">average subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-451" decimals="2" name="abvx:OtherShareWarrantsSubscriptionPricePerShare" scale="0" id="f-1226">0.01</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.69pt; position: var(--position); text-decoration: none; white-space: pre;"> per share (see Note 14). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Incremental costs directly attributable to the issue of new shares, including underwriting commissions and offering expenses related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Global Offering, were classified as a deduction of shareholders&#8217; equity and amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ShareIssueRelatedCost" format="ixt:num-dot-decimal" scale="3" id="f-1227">28,111</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.39pt; position: var(--position); text-decoration: none; white-space: pre;"> for the period ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2023. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increases in the share capital<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.28pt; position: var(--position); text-decoration: none; white-space: pre;"> for the year ended December 31, 2024 relate to<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.16pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 432.16pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the issue and subscription by members of the Board of Directors of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-452" decimals="0" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1228">77,820</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.36pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants, with a subscription price of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.6700000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-453" decimals="2" name="abvx:ShareWarrantsSubscriptionPricePerShare" scale="0" id="f-1229">2.57</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.1700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">each (see Note 14);<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 459.04pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a credit note received for transaction fees related to the Global Offering, amounting <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.21pt; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:ShareIssueRelatedCostCredit" scale="3" id="f-1230">446</ix:nonFraction> thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.07pt; position: var(--position); text-decoration: none; white-space: pre;"> and classified in the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">share premiums; and<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 485.92pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the exercise of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.74pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-454" decimals="0" name="abvx:NumberOfWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1231">4,000</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.24pt; position: var(--position); text-decoration: none; white-space: pre;"> other share warrants, by issuing <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.07pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-454" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-1232">4,000</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.57pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-5" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-1233">0.01</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.81pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">average subscription price of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-455" decimals="2" name="abvx:OtherShareWarrantsSubscriptionPricePerShare" scale="0" id="f-1234">11.14</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.69pt; position: var(--position); text-decoration: none; white-space: pre;"> per share (see Note 14).<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the issue of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="abvx:NumberOfFreeSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1235">415,019</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.51pt; position: var(--position); text-decoration: none; white-space: pre;"> vested free shares, as part of the AGA plans issued by the Group to certain of its officers and employees. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Distribution of dividends <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group did not distribute any dividends for any of the periods presented, does not have any present plan to pay any cash dividends <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on its equity securities in the foreseeable future and currently intends to retain all available funds and any future earnings to operate <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-1168-8">and expand our business.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 619.8pt;" id="ia894b143b6fc4522a0483350194c625e_406"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 619.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 14. <span style="display: inline-block; height: 6.77pt;"></span><span id="i4dbcdd73a9b34dffbda0ff2e493a9f50"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="f-1236" continuedAt="f-1236-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1236-1" continuedAt="f-1236-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has granted BCEs, BSAs and free shares (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 250.25pt; position: var(--position); text-decoration: none; white-space: pre;">attributions gratuities d&#8217;actions<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.36pt; position: var(--position); text-decoration: none; white-space: pre;">, or &#8220;AGAs&#8221;). These plans qualify as &#8220;equity <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">settled&#8221; under IFRS 2. The Group does not have any obligation to purchase these instruments in the event of departure or if a specific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">event does not occur. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Valuation methods of BCEs, BSAs and AGAs <span style="display: inline-block; height: 6.94pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-42<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1236-2" continuedAt="f-1236-3"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of share-based awards was determined at grant date using the Black Scholes model for the BCEs and BSAs and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Monte-Carlo simulation for AGAs plans with market performance conditions.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The assumptions used to estimate the fair value of the instruments are presented below and include: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Expected maturity of the options;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Expected volatility based on the historical market share price available; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Expected dividends based on management best estimate; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free interest rate based on French OAT rates measured at grant dates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Share price, including offered in case of change of control (only for the market conditions applicable to the free-share plans <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2021 and AGA 2023-1) is based on Monte-Carlo simulations and taking into account a change of control premium <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">based on the management best estimate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><ix:continuation id="f-1190-1" continuedAt="f-1190-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BCEs as well as the assumptions used for the measurement thereof in accordance <span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-1190-2" continuedAt="f-1190-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with IFRS 2 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 94.87pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.29pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 273.86pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 527.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/></tr><tr style="height: 98.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.18pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;D<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.28pt; position: var(--position); text-decoration: none; white-space: pre;">ATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 61.5pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.97pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 37.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.73pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 85.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.84pt; position: var(--position); text-decoration: none; white-space: pre;">D BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 74.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2016-11-07<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 129pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2016-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-456" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1237">84,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-457" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1238">22,495</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-458" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1239">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-458" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1240">3,699</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-458" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1241">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-459" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1242">18,796</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-459" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1243">18,796</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-459" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1244">18,796</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-01-23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 141pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-460" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1245">67,374</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-461" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1246">67,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-462" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1247">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-462" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1248">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-462" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1249">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-463" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1250">67,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-463" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1251">41,735</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-463" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1252">67,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 153pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-464" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1253">150,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-465" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1254">112,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-466" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1255">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-466" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1256">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-466" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1257">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-467" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1258">112,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-467" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1259">112,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-467" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1260">112,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 165pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-468" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1261">67,374</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-469" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1262">67,373</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1263">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1264">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1265">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-471" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1266">67,373</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-471" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1267">33,686</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-471" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1268">67,373</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 177pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-472" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1269">67,374</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-473" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1270">64,374</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-474" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1271">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-474" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1272">26,687</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-474" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1273">4,000</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-475" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1274">33,687</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-475" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1275">16,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-475" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1276">33,687</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-03-15<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 189pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-476" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1277">22,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-477" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1278">11,980</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-478" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1279">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-478" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1280">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-478" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1281">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-479" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1282">11,980</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-479" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1283">11,980</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-479" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1284">11,980</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 201pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE 2018-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-480" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1285">33,687</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-481" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1286">16,844</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-482" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1287">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-482" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1288">16,844</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-482" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1289">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-483" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1290">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-483" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1291">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-483" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:fixed-zero" scale="0" id="f-1292">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 213pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-484" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1293">16,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-485" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1294">16,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-486" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1295">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-486" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1296">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-486" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1297">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-487" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1298">16,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-487" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1299">8,422</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-487" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1300">16,843</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 225pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 225pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-488" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1301">22,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.62pt;"></span></span><span style="left: 32.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-489" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1302">6,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-490" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1303">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-490" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1304">4,000</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-490" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1305">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-491" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1306">2,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-491" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1307">2,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-491" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1308">2,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 237pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-492" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1309">530,652</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-493" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1310">385,409</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-494" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1311">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-494" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1312">51,230</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-494" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1313">4,000</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-495" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1314">330,179</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-495" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1315">245,962</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-495" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1316">330,179</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The BCEs include a service condition under which the beneficiary must still be an employee, a corporate officer or a scientific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consultant of the Group at the time of vesting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The exercise rights for most of the BCEs are vested annually and have the following vesting terms: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-496" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1317">25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.33pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award vests on the first anniversary of the date of grant for all currently issued BCEs; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 630.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the remaining <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-497" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1318">75</ix:nonFraction>%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award, the BCEs vest 1/48th per month over <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.56pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-497" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1319">four years</ix:nonNumeric><span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.8pt; position: var(--position); text-decoration: none; white-space: pre;"> from the anniversary date of the grant. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Most of the BCEs plans (all BCEs plans except BCE 2014-2 fully vested as of January 1, 2020) include or partially include non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market performance conditions (obtaining financing of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-498" decimals="-6" name="abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" format="ixt:num-dot-decimal" scale="6" id="f-1320">100</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.32pt; position: var(--position); text-decoration: none; white-space: pre;">, positive results on clinic studies, signature of informed consent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in a clinical phase, signing a license agreement, FDA authorization). The level of achievement of the non-market performance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions are taken into account in determining the number of BCEs allocated initially and reassessed at each closing date. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-43<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1236-3" continuedAt="f-1236-4"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the event of a change of control or a M&amp;A transaction, all the BCEs will become immediately exercisable. A change of control is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">defined as a new investor/company holding directly or indirectly more than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-494" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" scale="-2" id="f-1321">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.15pt; position: var(--position); text-decoration: none; white-space: pre;"> of the share capital or voting rights. As such the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probable vesting date of each plan corresponds to the weighted average of probable change of control dates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.5pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.15pt; width: 612pt;"><ix:continuation id="f-1190-3" continuedAt="f-1190-4"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BSAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-1190-4" continuedAt="f-1190-5"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.15pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 209.78pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/></tr><tr style="height: 69pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.82pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.15pt; position: var(--position); text-decoration: none; white-space: pre;">DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 46.87pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 70.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.29pt; position: var(--position); text-decoration: none; white-space: pre;">D&#160; BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69pt; left: 489pt; overflow: hidden; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: -6.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-499" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1322">96,924</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-500" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1323">96,924</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-501" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1324">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-501" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1325">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-501" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1326">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-502" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1327">96,924</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-502" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1328">96,924</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-502" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1329">96,924</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-12<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-503" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1330">82,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-504" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1331">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-505" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1332">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-505" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1333">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-505" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1334">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-506" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1335">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-506" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1336">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-506" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1337">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-09-18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-507" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1338">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-508" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1339">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-509" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1340">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-509" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1341">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-509" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1342">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-510" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1343">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-510" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1344">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-510" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1345">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-01-22<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-511" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1346">49,200</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-512" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1347">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-513" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1348">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-513" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1349">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-513" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1350">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-514" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1351">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-514" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1352">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-514" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1353">16,400</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-515" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1354">1,315</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-516" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="f-1355">842</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-517" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1356">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-517" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" scale="0" id="f-1357">842</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-517" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1358">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-518" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1359">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-518" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1360">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-518" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:fixed-zero" scale="0" id="f-1361">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-519" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="f-1362">787</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-520" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="f-1363">230</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-521" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1364">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-521" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" scale="0" id="f-1365">230</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-521" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1366">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-522" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1367">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-522" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1368">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-522" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:fixed-zero" scale="0" id="f-1369">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-523" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1370">58,365</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-524" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1371">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-525" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1372">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-525" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1373">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-525" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1374">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-526" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1375">58,365</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-526" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1376">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-526" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1377">58,365</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-527" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1378">19,455</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-528" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1379">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-529" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-1380">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-529" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1381">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-529" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1382">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-530" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1383">19,455</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-530" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1384">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-530" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1385">19,455</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 195.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-531" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1386">324,446</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-532" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1387">147,196</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="shares" contextRef="c-533" xsi:nil="true" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" id="f-1388"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-533" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1389">1,072</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-533" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1390">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-534" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1391">223,944</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-534" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1392">146,124</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-534" decimals="INF" name="abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" format="ixt:num-dot-decimal" scale="0" id="f-1393">223,944</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs issued prior to January 1, 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These BSAs include a service condition under which the beneficiary must still be an employee, a corporate officer or a scientific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.63pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consultant of the Group at the time of vesting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.03pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The exercise rights for most of these BSAs are vested annually and have the following vesting terms: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 507.23pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-535" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1394">25</ix:nonFraction>%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.33pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award vests on the first anniversary of the date of grant for all currently issued BSAs; and <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 520.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the remaining <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-536" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1395">75</ix:nonFraction>%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award, the BSAs vest 1/48th per month over <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.58pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-536" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1396">four years</ix:nonNumeric><span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.82pt; position: var(--position); text-decoration: none; white-space: pre;"> from the anniversary date of the grant. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">All of these BSAs plans include or partially include non-market performance conditions (positive results on clinic studies, signature of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">informed consent in a clinical phase, signing a license agreement, FDA authorization). The level of achievement of the non-market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">performance conditions are taken into account in determining the number of BSAs allocated initially and reassessed at each closing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.01pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the event of a change of control or a M&amp;A transaction, all these BSAs will become immediately exercisable. A change of control is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">defined as a new investor/company holding directly or indirectly more than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-537" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" scale="-2" id="f-1397">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.15pt; position: var(--position); text-decoration: none; white-space: pre;"> of the share capital or voting rights. As such the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probable vesting date of each plan corresponds to the weighted average of probable change of control dates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs granted in March 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In March 2024, the Group granted its independent Board members the right to subscribe up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.27pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-452" decimals="0" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1398">77,820</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants (BSA) in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 684.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">aggregate, the vesting of which<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.13pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.63pt; position: var(--position); text-decoration: none; white-space: pre;">is subject to a service condition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-452" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1399">four years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.87pt; position: var(--position); text-decoration: none; white-space: pre;">, by tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.98pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1400">25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.31pt; position: var(--position); text-decoration: none; white-space: pre;"> each, vested on each anniversary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 696.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">date. Additionally, the BSAs are subject to a vesting acceleration condition in case of a tender offer on the securities issued by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 707.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group and resulting in a change of control of the Group. All of the granted BSAs were subscribed by the beneficiaries in April 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-44<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1236-4" continuedAt="f-1236-5"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" id="f-1401" continuedAt="f-1401-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the BSAs was determined at grant date using the Black Scholes model, with the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1401-1" continuedAt="f-1401-2"><div style="position: var(--position); top: 92.96pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.84pt; position: var(--position); white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.62pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.38pt; position: var(--position); white-space: pre;">OF THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.07pt; position: var(--position); white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.61pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.5pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.49pt; position: var(--position); white-space: pre;">OF THE BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.94pt; position: var(--position); white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.92pt; position: var(--position); white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.27pt; position: var(--position); white-space: pre;">SUBSCRIPTI<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.82pt; position: var(--position); white-space: pre;">ON PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.15pt; position: var(--position); white-space: pre;">STRIKE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.83pt; position: var(--position); white-space: pre;">PRICE PER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.48pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.2pt; position: var(--position); white-space: pre;">RISK FREE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.52pt; position: var(--position); white-space: pre;">RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.49pt; position: var(--position); white-space: pre;">EXPECTED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.05pt; position: var(--position); white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.71pt; position: var(--position); white-space: pre;">VOLATILITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 41.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-523" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1402">14.06</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-538" decimals="1" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1403">5.7</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-539" decimals="1" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1404">6.5</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-523" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1405">58,365</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-523" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1406">2.57</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-523" decimals="2" name="abvx:EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" scale="0" id="f-1407">13.10</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 41.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-523" decimals="4" name="abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="f-1408">4.30</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-538" name="abvx:ExpectedMaturityOtherEquityInstrumentsGranted" format="ixt-sec:duryear" id="f-1409">5.4</ix:nonNumeric><span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-539" name="abvx:ExpectedMaturityOtherEquityInstrumentsGranted" format="ixt-sec:duryear" id="f-1410">6.9</ix:nonNumeric><span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-523" decimals="4" name="abvx:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="f-1411">60.41</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 53.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-527" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1412">14.06</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-540" decimals="1" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1413">5.8</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-541" decimals="1" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1414">6.6</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-527" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1415">19,455</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-527" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1416">2.57</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-527" decimals="2" name="abvx:EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" scale="0" id="f-1417">13.10</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 53.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-527" decimals="4" name="abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="f-1418">4.30</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-540" name="abvx:ExpectedMaturityOtherEquityInstrumentsGranted" format="ixt-sec:duryear" id="f-1419">5.5</ix:nonNumeric><span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-541" name="abvx:ExpectedMaturityOtherEquityInstrumentsGranted" format="ixt-sec:duryear" id="f-1420">7.0</ix:nonNumeric><span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-527" decimals="4" name="abvx:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="f-1421">60.41</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.41pt; width: 612pt;"><ix:continuation id="f-1190-5" continuedAt="f-1190-6"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to AGAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-1190-6"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.41pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 241.51pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 537pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 28.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.45pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANGIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.05pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">G AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 52.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 62.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.83pt; position: var(--position); text-decoration: none; white-space: pre;">VESTED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.22pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.81pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.61pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 35.02pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.14pt; position: var(--position); text-decoration: none; white-space: pre;">G <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 47.25pt; width: 199.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 199.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.33pt; position: var(--position); white-space: pre;">FOR THE YEAR ENDED DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 47.25pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.53pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.1pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.19pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-542" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1422">1,382,796</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-543" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1423">1,382,796</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-544" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1424">212,737</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-544" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1425">390,019</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-545" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1426">780,040</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-546" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1427">100,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-547" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1428">100,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-548" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1429">25,000</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-549" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1430">75,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-550" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1431">731,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-551" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1432">731,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-552" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1433">245,625</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-553" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1434">485,875</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-554" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1435">254,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-555" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1436">254,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-556" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1437">41,000</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-557" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1438">213,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">12/01/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-558" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1439">132,750</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-559" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1440">132,750</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-560" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1441">51,500</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-561" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1442">81,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">02/01/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-562" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1443">1,549,125</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-563" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1444">1,549,125</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-563" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1445">193,500</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-564" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1446">1,355,625</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">03/28/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-565" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1447">22,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-566" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1448">22,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-567" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1449">22,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">05/23/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-568" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1450">38,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-569" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1451">38,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-570" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1452">38,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-571" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1453">93,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-572" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1454">93,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-573" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1455">93,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-574" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1456">25,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-575" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1457">25,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-576" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1458">25,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-105" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1459">20,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-577" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1460">20,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-578" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1461">20,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/05/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-579" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1462">198,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-580" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1463">198,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-581" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1464">198,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-582" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1465">4,547,421</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-583" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1466">2,601,296</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-584" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1467">1,946,125</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-584" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1468">744,362</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-584" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1469">415,019</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-585" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1470">3,388,040</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-45<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1236-5" continuedAt="f-1236-6"><div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><ix:continuation id="f-1401-2" continuedAt="f-1401-3"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 72pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.84pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 0pt; width: 72pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.22pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE&#160;OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.56pt; position: var(--position); text-decoration: none; white-space: pre;">THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.69pt; position: var(--position); text-decoration: none; white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.02pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.2pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.18pt; position: var(--position); text-decoration: none; white-space: pre;">THE AGA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.19pt; position: var(--position); text-decoration: none; white-space: pre;">AGA PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.3pt; position: var(--position); text-decoration: none; white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.96pt; position: var(--position); text-decoration: none; white-space: pre;">VOLATILITY <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.97pt; position: var(--position); text-decoration: none; white-space: pre;">RISK&#160;FREE&#160;RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2021 <span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 41.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-586" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1471">31.60</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-586" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1472">23.92</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-586" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1473">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2022-07-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-586" decimals="3" name="abvx:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="f-1474">49.0</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.32pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-586" decimals="4" sign="-" name="abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="f-1475">1.00</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranches 1-4)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 53.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-587" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1476">15.98</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-587" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1477">15.98</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-587" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1478">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 5)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-588" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1479">15.98</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-588" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1480">3.62</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-588" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1481">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-12-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-588" decimals="3" name="abvx:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="f-1482">67.2</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-588" decimals="4" name="abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="f-1483">3.20</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 6)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 96.75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-589" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1484">15.98</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-589" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1485">0.74</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-589" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1486">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-07-11<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-589" decimals="3" name="abvx:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="f-1487">67.2</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-589" decimals="4" name="abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="f-1488">3.20</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 1)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 118.5pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-590" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1489">15.98</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-590" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1490">15.98</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-590" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1491">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 2)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 140.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-591" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1492">15.98</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-591" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1493">9.59</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-591" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1494">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 162pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-550" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1495">14.92</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-550" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1496">14.92</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-550" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1497">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 174pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-554" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1498">14.92</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-554" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1499">14.92</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-554" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1500">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 186pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-558" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1501">9.16</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-558" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1502">9.16</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-558" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1503">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-1<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 198pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-562" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1504">12.26</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-562" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1505">12.26</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-562" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1506">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-2<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 210pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-565" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1507">13.40</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-565" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1508">13.40</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-565" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1509">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 222pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-568" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1510">12.76</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-568" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1511">12.76</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-568" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1512">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 234pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-571" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1513">12.54</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-571" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1514">12.54</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-571" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1515">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 246pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-574" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1516">12.54</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-574" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1517">12.54</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-574" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1518">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 258pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-105" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1519">12.54</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-105" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1520">12.54</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-105" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1521">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 270pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-579" decimals="2" name="abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1522">10.80</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-579" decimals="2" name="abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted" scale="0" id="f-1523">10.80</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-579" decimals="2" name="abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted" scale="0" id="f-1524">0.00</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September 2021<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September 2021 are subject to a vesting service condition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-592" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" format="ixt-sec:durwordsen" id="f-1525">one year</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.51pt; position: var(--position); text-decoration: none; white-space: pre;"> following the grant date. The number of shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">that will be finally vested under this plan will depend on the following conditions: if a M&amp;A transaction is completed on or prior to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">July 31, 2022 and the price per ordinary share of the Group retained in the framework of the M&amp;A transaction is at least equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 553.78pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-592" decimals="0" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" scale="0" id="f-1526">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 573.78pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">per share (or lower than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.95pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-592" decimals="0" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" scale="0" id="f-1527">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.95pt; position: var(--position); text-decoration: none; white-space: pre;"> per share) then <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-593" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1528">100</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.65pt; position: var(--position); text-decoration: none; white-space: pre;"> (or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.31pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-594" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1529">75</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.64pt; position: var(--position); text-decoration: none; white-space: pre;">) of the shares initially granted will be vested. The AGAs are forfeited if a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">M&amp;A transaction is not completed on or prior to July 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These conditions qualify as both a non-market performance condition (occurrence or not of a M&amp;A transaction before July 31, 2022) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and a market condition (number of shares depending on the share price offered in case of a M&amp;A transaction before July 31, 2022) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">under IFRS 2 principles. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 518.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The level of achievement of the market condition is directly included in the unit fair value of the free shares and the probability of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">M&amp;A transaction before July 31, 2022 is included in the estimation of the number of shares that will be finally vested by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">beneficiaries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the period ended December 31, 2022, the AGAs were all forfeited since no M&amp;A transaction was completed on or prior to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">July 31, 2022. This resulted in a reversal of the related compensation expense of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-67" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1530">1,026</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.63pt; position: var(--position); text-decoration: none; white-space: pre;"> and the reversal of the accrual for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">social taxes of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-67" decimals="-3" sign="-" name="abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1531">205</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> that was recorded as of December 31, 2021. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in July 2023<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(a) Pursuant to a Board decision on July 11, 2023, the Group allocated a total number of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.95pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-595" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1532">1,382,796</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.95pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs to Mr. Marc de Garidel, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 652.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s Chief Executive Officer, to which performance conditions and service conditions apply (AGA plan 2023-1):<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 674.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-596" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1533">212,738</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 1): the acquisition period shall end on the first anniversary of the allocation date; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 686.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-597" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1534">638,214</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 2): the AGAs 2023-1 shall progressively be definitively acquired on a monthly basis over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.78999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-597" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1535">three years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> starting after the first anniversary of the allocation date;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-46<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1236-6" continuedAt="f-1236-7"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-598" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1536">212,738</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 3): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which a specific performance condition related to regulatory approval is fulfilled; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-599" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1537">106,369</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 4): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which the Group successfully completes a public offering raising at least <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.4200000000001pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-6" name="abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" format="ixt:num-dot-decimal" scale="6" id="f-1538">100</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.77pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in gross proceeds (the condition was met on October 24, 2023); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-600" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1539">106,369</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 5): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which a specific performance condition related to the Group&#8217;s market capitalization is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fulfilled; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-601" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1540">106,368</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 6): the acquisition period shall end on the first anniversary of the allocation date subject <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to the completion, prior to such date, of a tender offer on the securities issued by the Group, at a predetermined minimum <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price, and resulting in a change of control of the Group; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, AGAs related to tranches 1 to 5 are subject to a vesting acceleration condition in case of a tender offer on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">securities issued by the Group and resulting in a change of control of the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group qualified those conditions under IFRS 2 principles as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions related to tranches 1 and 2 qualify as service conditions under IFRS 2 principles.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 277pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions related to tranches 3 and 4 qualify as service and non-market performance conditions. Their levels of achievement <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are reflected in the number of instruments that are expected to vest and were estimated by management based on observable <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 303.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">industry-specific data.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 317.32pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions related to tranches 5 and 6 qualify as service and market performance conditions. The levels of achievement of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market conditions are reflected in the unit fair value of the free shares and were estimated by management using the valuation <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">methods and assumptions set out above. The valuation of tranche 6 also incorporates management&#8217;s estimate of the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 357.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">probability of a M&amp;A transaction prior to the limit date.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 371.08pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The vesting acceleration condition in case of a tender offer on the securities issued by the Group and resulting in a change of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control of the Group qualifies as a non-market performance condition.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 411.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(b) Pursuant to a Board decision on July 11, 2023, the Group allocated a total number of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.52pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-602" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1541">100,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.02pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs to Mr. Hartmut Ehrlich, as the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 422.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s former Chief Executive Officer, to which the following conditions apply (AGA plan 2023-2):<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 445.36pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-603" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1542">25,000</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-2 (tranche 1): the acquisition period shall end on the first anniversary of the allocation date, and is <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not subject to a future service condition; <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 472.24pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-604" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1543">75,000</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-2 (tranche 2): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which a specific condition, related to positive results on clinical studies, is fulfilled. <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The acquisition is not subject to a future service condition. Additionally, the tranche is subject to a vesting acceleration <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">condition in case of a tender offer on the securities issued by the Group and resulting in a change of control of the Group.&#160; <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">This tranche qualifies as a non-vesting condition. Its level of achievement is reflected in the unit fair value of the free shares, <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and was estimated by management based on observable industry-specific data.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September and December 2023<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On September 28, 2023 and December 1, 2023, certain of the Group&#8217;s officers and employees were allocated respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-605" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1544">985,750</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.22pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs (AGA plans 2023-3 and 2023-4) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.98pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-558" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1545">132,750</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.48pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plan 2023-5) in the aggregate, the vesting of which is subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certain conditions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 633.52pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to remaining employed with the Group, each such officer or employee&#8217;s AGAs will be vested as follows: (i) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.28pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-606" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1546">50</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.61pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><ix:nonNumeric contextRef="c-606" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1547"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.39pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.38pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.9pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, (ii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.26pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-607" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1548">25</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><ix:nonNumeric contextRef="c-607" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1549"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.18pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.14pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.66pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 660.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(iii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.47pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-608" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1550">25</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.8pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><ix:nonNumeric contextRef="c-608" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1551"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.39pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.05pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.57pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (service condition). <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 685.04pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Of the <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.75pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-609" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1552">1,118,500</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.75pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs, <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.8pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-609" decimals="INF" name="abvx:NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" format="ixt:num-dot-decimal" scale="0" id="f-1553">254,250</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.3pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs are subject to an additional non-market performance condition of the successful <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completion of a public offering raising at least <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-609" decimals="-6" name="abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" format="ixt:num-dot-decimal" scale="6" id="f-1554">200</ix:nonFraction>&#160;million<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.89pt; position: var(--position); text-decoration: none; white-space: pre;"> in gross proceeds. This condition was met on October 24, 2023.<span style="display: inline-block; height: 8.73pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-47<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1236-7"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, all the 2023-3, 2023-4 and 2023-5 AGAs are subject to a vesting acceleration condition in case of a tender offer on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">securities issued by the Group and resulting in a change of control of the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in February, March, May, July and September 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February 1, 2024, March 28, 2024, May 23, 2024, July 11, 2024 and September 5, 2024 certain of the Group&#8217;s officers and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 141.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">employees were allocated respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.41pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-562" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1555">1,549,125</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.41pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plans 2024-1), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.7pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-565" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1556">22,500</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.2pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plan 2024-2), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.6pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-568" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1557">38,500</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.1pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">plans 2024-3), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-610" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1558">138,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.75pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plans 2024-4, 5 and 6) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.9pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-579" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1559">198,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.4pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plans 2024-7), in the aggregate, the vesting of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which is subject to certain conditions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 189pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to remaining employed with the Group, each such officer or employee&#8217;s AGAs (with the exception of AGAs 2024-6) <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 202.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will be vested as follows: (i) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-611" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1560">50</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.31pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.9pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-611" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1561">two years</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.47pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, (ii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.83pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-612" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1562">25</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.16pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><ix:nonNumeric contextRef="c-612" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1563"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.75pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 551.71pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.23pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">period from the allocation date and (iii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.06pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-613" decimals="2" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" scale="-2" id="f-1564">25</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.39pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.98pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-613" name="abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-1565">four years</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.22pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (service condition).<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-614" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1566">20,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.53pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2024-6 granted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.64pt; position: var(--position); text-decoration: none; white-space: pre;">an employee <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.9pt; position: var(--position); text-decoration: none; white-space: pre;">are composed of (i) a first tranche of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.61pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-615" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1567">10,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.11pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs not subject to any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">presence of performance condition&#160; and (ii) a second tranche of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-616" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1568">10,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.02pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs subject to a non-vesting condition, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achievement of which was deemed certain on grant date.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 290.16pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, all the 2024-1 to 2024-7 AGA plans are subject to a vesting acceleration condition in case of a tender offer on <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the securities issued by the Group and resulting in a change of control of the G<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.4pt; position: var(--position); text-decoration: none; white-space: pre;">roup.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Social taxes related to AGAs<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGA plans granted to the Group's officers and employees are subject to employer's taxes, measured in accordance with the same <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">principles as the AGA plans. These taxes are classified as provisions before they are due.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 400.96pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss" id="f-1569" continuedAt="f-1569-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre; width: 439.91pt;">Breakdown of the compensation expenses accounted for the period ended December 31, 2022, 2023 and 2024<span style="display: inline-block; height: 6.94pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1569-1"><div style="position: var(--position); top: 424.31pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.88pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-617" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="f-1570">138</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-618" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="f-1571">112</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-494" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="f-1572">112</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-619" decimals="-3" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:fixed-zero" scale="3" id="f-1573">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-537" decimals="-3" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:fixed-zero" scale="3" id="f-1574">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-533" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="f-1575">211</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 65.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-620" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1576">1,026</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-621" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1577">8,067</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;">(<ix:nonFraction unitRef="eur" contextRef="c-584" decimals="-3" sign="-" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1578">19,900</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 77.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Social taxes related to AGAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-620" decimals="-3" sign="-" name="abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" scale="3" id="f-1579">205</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-621" decimals="-3" sign="-" name="abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" scale="3" id="f-1580">426</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.3pt; position: var(--position); text-decoration: none; white-space: pre;">(<ix:nonFraction unitRef="eur" contextRef="c-584" decimals="-3" sign="-" name="abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" scale="3" id="f-1581">717</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1582">1,369</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1583">8,605</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1584">20,941</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-48<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 70.56pt;" id="ia894b143b6fc4522a0483350194c625e_412"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15. <span style="display: inline-block; height: 6.77pt;"></span><span id="i308718f8742441999459776bcaeff59e"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory" id="f-1597" continuedAt="f-1597-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1597-1" continuedAt="f-1597-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.36pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory" id="f-1598" continuedAt="f-1598-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1598-1"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 101.66pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 110.46pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 422.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 191.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 44.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-628" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1599">4,730</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-629" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1600">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-630" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1601">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret bond loans <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-631" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1602">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-632" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1603">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-633" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1604">26,373</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-634" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" scale="3" id="f-1605">839</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-635" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" scale="3" id="f-1606">160</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-636" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1607">1,431</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-637" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1608">3,558</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-638" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1609">2,402</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-639" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1610">1,252</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-640" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1611">9,127</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-641" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1612">2,563</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-642" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1613">29,056</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret convertible notes (OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-643" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1614">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-644" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1615">21,643</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-645" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1616">23,370</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-646" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1617">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-647" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1618">21,643</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-648" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1619">23,370</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A &amp; B BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-649" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" scale="3" id="f-1620">424</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-650" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1621">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-651" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1622">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane conversion option<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-57" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" scale="3" id="f-1623">142</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-652" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1624">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-58" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1625">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret minimum return indemnifications <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-653" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1626">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-654" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1627">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-655" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1628">3,620</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-656" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" scale="3" id="f-1629">566</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-657" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1630">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-658" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1631">3,620</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-659" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1632">3,262</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-660" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1633">3,262</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-661" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1634">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-662" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1635">3,287</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-663" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1636">12,229</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-664" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1637">13,023</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-665" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1638">6,549</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-666" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1639">15,491</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-667" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1640">13,023</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1641">16,241</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1642">39,697</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:NoncurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1643">69,069</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 229.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-628" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1644">8,252</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-629" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1645">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-630" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1646">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 241.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret bond loans <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-631" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1647">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-632" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1648">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-633" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1649">20,028</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 253.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-634" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" scale="3" id="f-1650">545</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-635" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" scale="3" id="f-1651">379</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-636" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" scale="3" id="f-1652">932</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 265.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-637" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1653">1,280</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-638" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1654">1,276</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-639" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1655">1,235</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 277.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-640" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1656">10,077</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-641" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1657">1,655</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-642" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1658">22,195</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 289.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-668" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1659">19,957</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-669" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1660">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-670" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1661">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 301.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-671" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1662">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-59" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1663">29,605</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-60" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1664">21,574</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 313.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-646" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1665">19,957</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-647" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1666">29,605</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-648" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1667">21,574</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 325.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-659" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1668">3,521</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-660" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1669">3,509</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-661" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1670">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 337.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-665" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1671">3,521</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-666" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1672">3,509</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-667" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1673">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 349.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-672" xsi:nil="true" name="ifrs-full:CurrentFinancialLiabilities" id="f-1674"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 349.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-673" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1675">2,579</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 349.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-674" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1676">1,166</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 361.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-656" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-1677">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-657" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1678">2,579</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-658" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1679">1,166</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 373.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1680">33,555</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1681">37,348</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1682">44,935</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 385.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1683">49,797</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1684">77,045</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1685">114,004</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 524.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and Non-current Liabilities <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 535.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the non-current portion of the Heights convertible notes as of December <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 545.99pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2023 were reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></ix:continuation></ix:continuation><div style="position: absolute; top: 603.27pt;" id="ia894b143b6fc4522a0483350194c625e_415"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.27pt; width: 612pt;"><ix:continuation id="f-1597-2" continuedAt="f-1597-3"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.1. Structured debt financing with <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 209.22pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret subscribed in August 2023 &#8211; &#8220;Kreos / Claret Financing&#8221;<span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-1597-3" continuedAt="f-1597-4"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 20, 2023, the Group entered into a structured debt financing agreement with Kreos and Claret&#160; (the Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 636.87pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financing), for up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-84" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-1686">75,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.31pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.27pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing consists of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.99pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="tranche" contextRef="c-84" decimals="INF" name="abvx:BorrowingsNumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="f-1687">three</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.95pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-84" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacityPerTranche" format="ixt:num-dot-decimal" scale="3" id="f-1688">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.15pt; position: var(--position); text-decoration: none; white-space: pre;"> each in aggregate principal amount:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The first tranche (&#8220;tranche A&#8221;) in aggregate principal amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.53pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-87" decimals="-3" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1689">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.62pt; position: var(--position); text-decoration: none; white-space: pre;"> takes the form of senior secured <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.87pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bonds with warrants attached (the &#8220;Kreos / Claret OCABSA&#8221;) and was drawn on August 22, 2023. The Kreos / <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-49<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-4" continuedAt="f-1597-5"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Claret OCABSA are convertible into ordinary shares at any time from their issuance at the request of their holders at a fixed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conversion price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-675" decimals="4" name="abvx:BorrowingsFixedConversionPrice" scale="0" id="f-1690">21.2209</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to standard adjustments, including anti-dilution and dividend protections. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on the Kreos / Claret OCABSA accrues at a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.28999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-675" decimals="4" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-1691">9.00</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.12pt; position: var(--position); text-decoration: none; white-space: pre;"> annual fixed interest rate, payable in quarterly installments. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret OCBSA&#8217;s maturity date is March 31, 2027, it being specified that the scheduled date of final repayment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">January 1, 2027.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is allowed to prepay the amounts due under the Kreos / Claret OCABSA at any time. In such case, the Group will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be required to pay a sum equal to (i) the principal outstanding at the time of the prepayment (plus accrued interests), plus (ii) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an aggregate of all remaining interest payments that would have been paid throughout the remainder of the term of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tranche, discounted to present value by applying a discount rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.48pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-675" decimals="2" name="abvx:BorrowingsEarlyRepaymentDiscountRate" scale="-2" id="f-1692">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.81pt; position: var(--position); text-decoration: none; white-space: pre;">, plus (iii) an end-of-loan exit fee equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.05pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-675" decimals="3" name="abvx:BorrowingsExitFeePercentage" scale="-2" id="f-1693">8.0</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.88pt; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amounts drawn thereunder. In case of prepayment, the holders of the Kreos / Claret OCABSA will have the option to request <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a conversion of their Kreos / Claret OCABSA instead of a cash repayment, in which case, the end-of-loan exit fee is not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payable by the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The warrants included in the Kreos / Claret OCABSA will only become exercisable in case of prepayment in cash of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret convertible bonds by the Group. Upon exercise of the warrants, their holders will be able to subscribe to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">same number of ordinary shares (and at the same price conditions) as they would have been able to subscribe had they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">converted the Kreos / Claret OCABSA which have been prepaid in cash. Any warrants not exercised on or prior to January 1, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2027 will become automatically null and void. For the avoidance of doubt, if the Group does not prepay any Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">OCABSA in cash prior to their scheduled repayment dates, none of the warrants will be exercisable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The second tranche (&#8220;tranche B&#8221;) in aggregate principal amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-107" decimals="-3" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1694">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.72pt; position: var(--position); text-decoration: none; white-space: pre;"> takes the form of senior secured non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bonds and was drawn on March 28, 2024. The drawdown of the second tranche was subject to a maximum <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.79pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-676" decimals="2" name="abvx:BorrowingsDebtToMarketCapitalizationRatio" scale="-2" id="f-1695">10</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.12pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Debt-To-Market Capitalization Ratio at the time of drawdown. The &#8220;Debt-To-Market Capitalization Ratio&#8221; is calculated on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any relevant date, by dividing (i) the indebtedness of the Group (including amounts due under the Kreos / Claret Financing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 363.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">but excluding amounts due under the Heights Financing), by (ii) the market capitalization of the Group calculated by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">multiplying the number of outstanding ordinary shares by the closing price of the ordinary shares on such relevant date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The third tranche (&#8220;tranche C&#8221;) in aggregate principal amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-677" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-1696">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.84pt; position: var(--position); text-decoration: none; white-space: pre;"> takes the form of senior secured non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bonds and was drawn on June 21, 2024. The drawdown of the third tranche was subject to a maximum <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.15pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-677" decimals="2" name="abvx:BorrowingsDebtToMarketCapitalizationRatio" scale="-2" id="f-1697">10</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.48pt; position: var(--position); text-decoration: none; white-space: pre;"> Debt-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">To-Market Capitalization Ratio at the time of drawdown (excluding the Heights Financing) and was conditional on the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">raising a minimum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.8pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-678" decimals="-3" name="abvx:BorrowingsPerformanceConditionsMinimumFinancing" format="ixt:num-dot-decimal" scale="3" id="f-1698">125,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.89pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> in gross proceeds through a listing on Nasdaq before June 30, 2024. This condition </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.26pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">was met on October 24, 2023 (see Note 3.3).</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 464.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">A variable interest rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.56pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-679" decimals="3" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-1699">7.5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.39pt; position: var(--position); text-decoration: none; white-space: pre;"> + European Central Bank Base Rate (MRO) (with a floor at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.07pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-680" decimals="3" name="abvx:BorrowingsBasisInterestRate" scale="-2" id="f-1700">2.5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.9pt; position: var(--position); text-decoration: none; white-space: pre;"> and a cap at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.3199999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-681" decimals="2" name="abvx:BorrowingsBasisInterestRate" scale="-2" id="f-1701">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.65pt; position: var(--position); text-decoration: none; white-space: pre;">) applies to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the second and third tranche. These <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.99pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="tranche" contextRef="c-682" decimals="INF" name="abvx:BorrowingsNumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="f-1702">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.98pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches will be repaid monthly through March 31, 2027, after a deferred repayment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the principal until February 1, 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is allowed to prepay the amounts due under the second and third tranches of the Kreos / Claret Financing at any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">time. In such case, The Group will be required to pay a sum equal to (i) the principal outstanding at the time of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prepayment (plus accrued interests), plus (ii) an aggregate of all remaining interest payments that would have been paid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">throughout the remainder of the term of the applicable tranche, discounted to present value by applying a discount rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.9300000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-682" decimals="2" name="abvx:BorrowingsEarlyRepaymentDiscountRate" scale="-2" id="f-1703">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.26pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">plus (iii) an end-of-loan exit fee equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.24pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-682" decimals="3" name="abvx:BorrowingsExitFeePercentage" scale="-2" id="f-1704">6.0</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.07pt; position: var(--position); text-decoration: none; white-space: pre;"> of the amounts drawn under the applicable tranche.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing also provides for a Minimal Return Indemnification ("MRI") to the benefit of the bondholders. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 587.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum Cash Return amount is defined as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 599.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(i) with respect to tranche A and tranche B, 1.4 times the amount of the cumulated principal drawn under the relevant <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 543.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instrument, and; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(ii) with respect to tranche C, 1.3 times the amount of the cumulated principal drawn under the relevant instrument.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the event the amount of the cash generated by the tranche A (the Kreos / Claret OCABSA), tranche B or tranche C bond loans, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">including principal and interest payments, transaction fees, and the end-of-loan exit fees, (the &#8220;Actual Return&#8221; calculated as at the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 671.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">earlier of (i) March 31, 2027, or (ii) the date of any prepayment or acceleration of the tranche B and C bond loans or more generally <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">such earlier date as the same shall become repayable ("the Redemption Date")), is lower than the Minimum Cash Return, the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shall indemnify the bondholders for the difference between the Minimum Cash Return and the Actual Return (the &#8220;Minimal Return <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Indemnification"). <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-50<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-5" continuedAt="f-1597-6"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">If at the time of the Minimum Return Indemnification payment, the warrants related to both the OCABSA Bonds and the Tranche B <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amortized bonds (the &#8220;Kreos / Claret A-B warrants&#8221;) or the Kreos / Claret Tranche C warrants are still outstanding, the exercise price <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for such warrants shall be adjusted up by the amount of the Minimum Return Indemnification divided by the number of warrants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">outstanding. For any Kreos / Claret A-B or C warrants that were exercised prior to the last Redemption Date, any capital gains made <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the exercise of such warrants will be added to the Minimum Cash Return amount.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Unless the repayment of the Tranche A and B bond loans results from a change of control (in which case the calculation of the Actual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Return shall only include (i) interest accrued prior to conversion of any Tranche A OCABSA, (ii) transaction and end-of-loan exit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fees, and (iii) the net capital gain derived from the sale of shares underlying the Tranche A OCABSA within the framework of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">change of control transaction), neither the principal subscribed under Tranche A nor the Actual Return generated by Tranche A shall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 185.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">be included in the calculation of the Minimum Return Indemnification (i.e. the Minimum Cash Return and the Actual Return shall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">only be calculated, and the Minimum Return Indemnification shall only apply to Tranche B and Tranche C).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 219.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary exceptions) which include, among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">things, restrictions on the incurrence of indebtedness, cross-default, the distribution of dividends and the grant of security interests. As <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">security for the Kreos / Claret Financing, the lenders benefit from the grant of first-ranking collateral on The Group&#8217;s principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tangible and intangible assets, including pledges over The Group&#8217;s business (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 344.86pt; position: var(--position); text-decoration: none; white-space: pre;">fonds de commerce<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422pt; position: var(--position); text-decoration: none; white-space: pre;">) as a going concern and intellectual <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">property rights in The Group's lead drug candidate, as well as pledges over The Group&#8217;s bank accounts and receivables. Such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">securities apply to all tranches of the Kreos / Claret Financing.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to the Kreos / Claret OCABSA, the Group has issued warrants (the &#8220;tranche A-B BSA&#8221;) for a global subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-683" decimals="2" name="abvx:OtherShareWarrantsSubscriptionPricePerShare" scale="0" id="f-1705">1.00</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.5pt; position: var(--position); text-decoration: none; white-space: pre;">, giving Kreos and Claret the right to subscribe to up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.35pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-684" decimals="INF" name="abvx:NumberOfWarrantsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1706">214,198</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.85pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares at an exercise price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-683" decimals="4" name="abvx:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="f-1707">18.6744</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.96pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(corresponding to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-683" decimals="2" name="abvx:ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" scale="-2" id="f-1708">10</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.54000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> premium over the 15-day VWAP prior to the date on which their issuance was decided). On November 2, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 331.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2023, a second tranche of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.9pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-94" decimals="INF" name="abvx:NumberOfWarrantsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1709">405,832</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.4pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos / Claret warrants (the &#8220;tranche C BSA&#8221;) was issued. The exercise price of the additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">warrants is equal to approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.66pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-685" decimals="2" name="abvx:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="f-1710">9.86</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.16pt; position: var(--position); text-decoration: none; white-space: pre;"> (corresponding to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.94pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-685" decimals="2" name="abvx:ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" scale="-2" id="f-1711">110</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.27pt; position: var(--position); text-decoration: none; white-space: pre;"> of the 15-day VWAP prior to the date on which their issuance was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">decided). The number of warrants issued corresponds to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.73pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-94" decimals="-6" name="abvx:IssuanceOfOtherShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-1712">4,000,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.73pt; position: var(--position); text-decoration: none; white-space: pre;"> divided by the aforementioned exercise price (i.e. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.79pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-94" decimals="INF" name="abvx:NumberOfWarrantsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1713">405,832</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.29pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">warrants). Of these additional warrants, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.64pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="2" name="abvx:NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" scale="-2" id="f-1714">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.97pt; position: var(--position); text-decoration: none; white-space: pre;"> are exercisable immediately and the remaining <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.61pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="2" name="abvx:NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" scale="-2" id="f-1715">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.94pt; position: var(--position); text-decoration: none; white-space: pre;"> (&#8220;the conditional warrants&#8221;) shall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">only be exercisable if the third tranche of the Kreos / Claret Financing is drawn by the Group.&#160; The Kreos / Claret warrants can be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 389.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercised over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.26pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-686" name="abvx:OtherShareWarrantsExercisePeriod" format="ixt-sec:duryear" id="f-1716">7</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.84pt; position: var(--position); text-decoration: none; white-space: pre;"> from their issuance date or up until the date of the successful closing of a tender offer for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares, whichever is earlier. At the time of exercise of the Kreos / Claret warrants, the holders of the warrants are eligible to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">sell part of their warrants to the Group in accordance with a put option agreement to allow for a cashless exercise. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 22, 2023, the Group repaid in full the pre-existing debt agreements with Kreos for a total amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-687" decimals="-3" name="abvx:RepaymentsOfBondLoans" format="ixt:num-dot-decimal" scale="3" id="f-1717">7,661</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.9pt; position: var(--position); text-decoration: none; white-space: pre;">. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">accounting treatment of this transaction is explained in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.37pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Note 15.3.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 502.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret OCABSA<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 525.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret OCABSA are issued at market conditions: the net issuance proceeds reflect the fair value of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">instruments at inception. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The OCABSA are compound instruments, split between (i) a debt component (then measured at amortized cost) and (ii) an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">equity component corresponding to the conversion option and the attached OCABSA warrants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As the adjustment provisions of the OCABSA conversion ratio are aimed at preserving the rights of the bondholders and are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">anti-dilutive in nature rather than a down-round protection, the Group determined that the conversion option of the OCABSA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is considered to result in the delivery of a fixed number of shares, and is therefore an equity instrument (the equity component <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the bonds).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The OCABSA warrants were attached to each bond issued in the Tranche A closing and are not transferrable until after a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prepayment. The OCABSA warrants become exercisable (i) upon the Group electing to prepay the bonds and (ii) in the event <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the absence of the conversion notice from the bondholders for the full amount of the prepayment. As such, the warrants are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not freely transferable until the prepayment is made. Thus, the OCABSA warrants are considered as an embedded component <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the bonds rather than a separate stand-alone financial instrument. In all scenarios under which the exercisability conditions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are satisfied, and whereby the bondholder&#8217;s option to elect to convert the bonds was considered, the number of total ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-51<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-6" continuedAt="f-1597-7"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares issuable upon warrant exercise as a result of prepayment and/or conversion option exercise remains fixed. Thus, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warrants represent an equity-classified component of the bonds.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The issuer prepayment option was deemed closely related to the host debt instrument and therefore does not meet the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">definition of a derivative instrument to be bifurcated.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret B and C tranches<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The initial right granted to the Group to issue the amortized bonds under tranches B and C, upon meeting certain conditions, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">did not meet the definition of a liability and was considered an off-balance sheet loan commitment received from the issuer as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The interest rate collars related to tranches B and C were determined to be closely related to the host debt instruments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therefore do not meet the definition of a derivative instrument to be bifurcated.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The prepayment options related to tranches B and C were not determined to be closely related to the host debt instruments <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and therefore meet the definition of derivative instruments to be bifurcated. The Group determined that their fair value is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">insignificant at issuance and as of December 31, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Minimum Return Indemnifications are embedded derivative instruments, which are not deemed closely related to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">host debt instruments and therefore meet the definition of derivative instruments to be bifurcated. They are classified as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 311.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">derivative financial liabilities and measured at fair value through profit or loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret second and third tranches are therefore hybrid instruments, split between (i) debt host contracts accounted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for at amortized cost and (ii) bifurcated embedded derivatives accounted for at fair value through profit and loss, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 359.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding to the Minimal Return Indemnifications and the prepayment options (the fair value of the prepayment options <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">being deemed insignificant at issuance and as of December 31, 2024).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 395.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret BSA<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As the A-B and C warrants (the Kreos / Claret BSA) are contractually transferable separately from the bonds and are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">redeemable in a variable number of ordinary shares of the Group, they are classified as standalone derivative financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As the A-B and C warrants (the Kreos / Claret BSA) represent compensation for the realized and future bond issuances of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respectively tranches A-B and C and are an integral part of generating such bond issuances, the Group determined that they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are in nature origination fees. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.7pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As the A-B warrants are associated with both the OCABSA issued under tranche A and the amortized bonds issued under </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.9pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">tranche B, the Group allocated the initial fair value of the A-B warrants based on the pro-rata value of the proceeds to be </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.1pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">received under each tranche. At inception, the respective initial fair values of the A-B warrants allocated to tranche A and B </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.3pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">were deferred and subsequently accounted for as an adjustment to the EIR of the related debt components upon their </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.5pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">drawdown (on August 20, 2023 and March 28, 2024 for tranches A and B respectively). </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.75pt; position: var(--position); text-decoration: none; white-space: pre;">Subsequent changes in the fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will be <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.96000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">recognized through profit or loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">On November 2, 2023 (issuance date of the Kreos / Claret tranche C BSA), a derivative financial liability was recognized for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their initial fair value with a counterparty in prepaid expenses. On that date, the Group, based on management&#8217;s latest <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">projections, did not consider the drawdown of the tranche C bonds to be probable. Therefore, the amount of prepaid expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 632.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">allocated to the tranche C BSA <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.49pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> has been amortized on a straight-line basis until the drawdown of the tranche C bonds.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of the debt and equity components of the OCABSA<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the fair value of the debt component of the OCABSA amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 353.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-688" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1718">23,995</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.27pt; position: var(--position); text-decoration: none; white-space: pre;">, using a market rate assumption of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-689" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1719">12.6</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.83pt; position: var(--position); text-decoration: none; white-space: pre;">.&#160; The equity component amounts to the difference between the whole instrument&#8217;s fair value at inception (its nominal value of <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-52<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-7" continuedAt="f-1597-8"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-688" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-1720">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">) and the standalone fair value of the debt component. Therefore, the equity component amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-688" decimals="-3" name="abvx:ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" format="ixt:num-dot-decimal" scale="3" id="f-1721">1,005</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.06pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">It is not subsequently remeasured.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On the same date, using the same assumptions and an increase in market rate by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.39pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-690" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-1722">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.39pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the debt component and an increase in the value of the equity compone<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.1pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nt by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.87pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-691" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1723">624</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.46pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of the Kreos / Claret second and third tranches hybrid instruments<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 176.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the net cash proceeds are the tranches' initial fair values. The fair values of the Minimal Return Indemnifications were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deducted from the initial carrying values of the debt components of each tranche, which were subsequently measured at amortized cost <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">using the EIR method.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 212.2pt; width: 612pt;"><ix:continuation id="f-1401-3" continuedAt="f-1401-4"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.1pt; position: var(--position); text-decoration: none; white-space: pre;">he fair value of the Minimum Return Indemnifications was<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"> measured using the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-1401-4" continuedAt="f-1401-5"><div style="position: var(--position); top: 236.2pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche B Minimum Return Indemnification (issued in March <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.93pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF MARCH 28, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-692" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1724">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-693" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1725">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-694" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1726">1.40</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-695" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1727">1.40</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-696" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1728">13</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-697" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1729">8</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-698" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1730">1,959</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-699" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1731">68</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-700" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1732">2,635</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-701" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1733">136</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-702" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1734">1,066</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-703" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1735">104</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-704" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1736">1,410</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-705" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1737">241</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-706" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1738">1,615</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-707" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1739">68</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-708" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1740">2,499</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-709" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1741">136</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche B MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-710" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1742">1,683</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-711" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1743">2,636</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 409.5pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche C Minimum Return Indemnification (issued in June <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.03pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JUNE 21, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-712" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1744">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-713" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1745">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-714" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1746">1.30</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-715" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1747">1.30</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-716" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1748">15</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-717" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1749">8</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(a) Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-718" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1750">741</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-719" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1751">0</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-720" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1752">1,160</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-721" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1753">43</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(b) Probability-weighted fair value of tranche C warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-722" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1754">2,948</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-723" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1755">684</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(c) Probability-weighted fair value of tranche C warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-724" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1756">3,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-725" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1757">903</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-726" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1758">475</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-727" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1759">0</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-728" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1760">941</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-729" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="3" id="f-1761">43</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche C MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-730" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-1762">475</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-731" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-1763">984</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the purpose of measuring the fair value of the MRI (shortfall payment), the fair value of the tranche A-B and C BSA was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 597.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured with a Black Scholes model under the Final redemption scenario and with a Monte Carlo model under the Tender offer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario. As of March 28, 2024, the following assumptions were used: a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-732" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1764">13.40</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.07pt; position: var(--position); text-decoration: none; white-space: pre;">, a volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.38pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-733" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1765">60.3</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.21pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.83pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-734" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1766">61.9</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.66pt; position: var(--position); text-decoration: none; white-space: pre;"> (Monte Carlo), and a risk-free rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-735" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1767">2.6</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.92pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.28pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-736" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1768">2.8</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.11pt; position: var(--position); text-decoration: none; white-space: pre;"> (Monte Carlo).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 633.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of June 21, 2024, the following assumptions were used: a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.53pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-737" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1769">12.94</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.03pt; position: var(--position); text-decoration: none; white-space: pre;">, a volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.34pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-738" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1770">60.1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.17pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-739" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1771">59.9</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Monte Carlo), and a risk-free rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.93pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-740" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1772">3.0</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.76pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-741" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1773">3.1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.95pt; position: var(--position); text-decoration: none; white-space: pre;"> (Monte Carlo).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The assumptions used for the valuations as of December 31, 2024 are set f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.48pt; position: var(--position); text-decoration: none; white-space: pre;">orth below.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-53<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-8" continuedAt="f-1597-9"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of March 28, 2024, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.15pt; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.78pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-742" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1774">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.11pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.29pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eurPerShare" contextRef="c-743" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1775">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.29pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.96pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-744" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1776">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.29pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-745" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1777">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.05pt; position: var(--position); text-decoration: none; white-space: pre;"> in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probability of achieving the Final redemption scenario and +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.57pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-746" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1778">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.9pt; position: var(--position); text-decoration: none; white-space: pre;"> discount rate would result in changes of the MRI B value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-747" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1779">4</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-748" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1780">30</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.89pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.89pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-749" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1781">3</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.81pt; position: var(--position); text-decoration: none; white-space: pre;">, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.44pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-750" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1782">35</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.03pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-751" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1783">53</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.38pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of June 21, 2024, using the same assumption with an increase of +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.02pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-752" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1784">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.35pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eurPerShare" contextRef="c-753" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1785">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.53pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.2pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-754" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1786">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 457.53pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.96pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-755" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1787">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.29pt; position: var(--position); text-decoration: none; white-space: pre;"> i<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540.56pt; position: var(--position); text-decoration: none; white-space: pre;">n the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probability of achieving the Final redemption scenario and +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.57pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-756" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1788">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.9pt; position: var(--position); text-decoration: none; white-space: pre;">discount rate would result in changes of the MRI C fair value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-757" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1789">4</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-758" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1790">16</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.89pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.52pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-759" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1791">8</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.11pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.74pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-760" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1792">46</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.33pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.76pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-761" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1793">13</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.68pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, using the same assumption with an increase of +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.74pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-762" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1794">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eurPerShare" contextRef="c-763" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1795">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.92pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-764" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1796">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.25pt; position: var(--position); text-decoration: none; white-space: pre;">risk-free rate, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-765" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1797">10</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 560.51pt; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the probability of achieving the Final redemption scenario and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.14pt; position: var(--position); text-decoration: none; white-space: pre;"> +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.27pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-766" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1798">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.6pt; position: var(--position); text-decoration: none; white-space: pre;"> discount rate would result in changes of the MRI B and C fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-767" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1799">1</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-768" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1800">3</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.22pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-769" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1801">3</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.14pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.77pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-770" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1802">3</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.36pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-771" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1803">82</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.71pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of the Kreos / Claret tranche A-B-C BSA <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret tranche A-B and tranche C BSA are measured at fair value using a Black-Scholes valuation model. The model <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">considers <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="scenario" contextRef="c-772" decimals="INF" name="abvx:NumberOfProbabilityWeightedScenarios" format="ixt-sec:numwordsen" scale="0" id="f-1804">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.22999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> probability-weighted scenarios, i.e. (i) the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.52pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-772" name="abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted" format="ixt-sec:duryear" id="f-1805">7</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.1pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry of the BSA and (ii) an earlier exercise upon a tender offer. <span style="display: inline-block; height: 6.93pt;"></span></span><ix:continuation id="f-1401-5" continuedAt="f-1401-6"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.17pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-1401-6" continuedAt="f-1401-7"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">main data and assumptions are the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 311.06pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 497.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 120pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche A-B BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">August 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.32pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 22, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 37.65pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche A-B)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 0pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.25pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-773" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1806">214,198</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 24pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 91.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-774" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1807">214,198</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 24pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-775" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1808">214,198</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-776" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1809">18.67</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 39.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 95.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-777" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1810">18.67</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 39.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-778" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1811">18.67</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-779" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1812">17.10</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 55.5pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-780" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1813">9.82</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-781" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1814">6.76</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.99pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry) 18/02/2027 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 79.79pt; position: var(--position); text-decoration: none; white-space: pre;">(tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 71.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.18pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.1pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 71.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.43pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 92.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-782" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1815">50</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 92.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-783" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1816">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 92.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-784" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1817">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-785" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1818">71.9</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-786" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1819">65.2</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 108pt; width: 120pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.96pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-787" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1820">59.5</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 89.61999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.88pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-788" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1821">64.9</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.54pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 108pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-789" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1822">44.3</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-790" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1823">44.3</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 129pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-791" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1824">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 129pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-792" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1825">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 129pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-793" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1826">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-794" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1827">3.00</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 144.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 98.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 98.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-795" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1828">2.30</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 378pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0.52pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-796" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1829">2.9</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 10.6pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-797" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1830">2.9</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche A-B BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 162pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-773" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1831">2,092</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 162pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.96pt;"></span></span><span style="left: 100.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-774" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-1832">920</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 162pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-775" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-1833">243</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-54<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-9" continuedAt="f-1597-10"><ix:continuation id="f-1401-7" continuedAt="f-1401-8"><div style="position: var(--position); top: 81.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 522pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 137.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche C BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">November 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.43pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF NOVEMBER 2, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-798" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1834">405,832</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-799" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1835">405,832</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-800" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1836">405,832</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of which, number of conditional BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-798" decimals="INF" name="abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" format="ixt:num-dot-decimal" scale="0" id="f-1837">202,915</ix:nonFraction><span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-799" decimals="INF" name="abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" format="ixt:num-dot-decimal" scale="0" id="f-1838">202,916</ix:nonFraction><span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 118.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-800" decimals="INF" name="abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" scale="0" id="f-1839">0</ix:nonFraction><span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-801" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1840">9.86</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-802" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1841">9.86</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-803" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1842">9.86</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-804" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1843">8.89</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-805" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1844">9.82</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-806" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1845">6.67</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); white-space: pre;">01/11/2030 (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-807" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1846">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-808" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1847">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-809" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1848">95</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Probability of Drawdown of Tranche C <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">credit facility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-810" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1849">30</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-811" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1850">30</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.09pt; position: var(--position); text-decoration: none; white-space: pre;">Drawn on June 21, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-812" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1851">67.3</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-813" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1852">64.3</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-814" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1853">67.4</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-815" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1854">64.9</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-816" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1855">44.3</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-817" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1856">44.3</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-818" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1857">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-819" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1858">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-820" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1859">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 181.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-821" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1860">3.00</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-822" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1861">2.30</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 3.89pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-823" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1862">2.9</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 13.97pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 61.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-824" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1863">2.9</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 205.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche C BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-798" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1864">1,493</ix:nonFraction><span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-799" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1865">1,659</ix:nonFraction><span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 101.71pt;"></span></span><span style="left: 104.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-800" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-1866">923</ix:nonFraction><span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of August 20, 2023 (date of issuance of the tranche A-B BSA), using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.98pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-825" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1867">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.94pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.49pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="eurPerShare" contextRef="c-826" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1868">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.63pt; position: var(--position); text-decoration: none; white-space: pre;">share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.17pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-827" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1869">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.13pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.26pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-828" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1870">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.22pt; position: var(--position); text-decoration: none; white-space: pre;"> in the probability of achieving the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.39pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.89pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-829" name="abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted" format="ixt-sec:duryear" id="f-1871">7</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.47pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranche A-B BSA fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.28pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-830" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1872">48</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.87pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-831" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1873">197</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.46pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-832" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1874">64</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.05pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-833" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1875">64</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.07pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of November 2, 2023 (date of issuance of the tranche C BSA), using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.73pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-834" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1876">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.69pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.24pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="eurPerShare" contextRef="c-835" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1877">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.63pt; position: var(--position); text-decoration: none; white-space: pre;">share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.17pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-836" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1878">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.13pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.26pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-837" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1879">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.22pt; position: var(--position); text-decoration: none; white-space: pre;"> in the probability of achieving the <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-838" name="abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted" format="ixt-sec:durwordsen" id="f-1880"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.89pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.89pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.41pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranche A-B BSA fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.28pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-839" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1881">28</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.87pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-840" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1882">232</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.46pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-841" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1883">42</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.05pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-842" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1884">36</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.07pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-843" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1885">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-844" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1886">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;">share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.79pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-845" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1887">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.75pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.98pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-846" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1888">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 432.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the probability of achieving the <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-847" name="abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted" format="ixt-sec:durwordsen" id="f-1889"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.17pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.17pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.69pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of Kreos / Claret A-B and C BSA fair value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-848" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1890">96</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.34pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.34pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-849" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1891">401</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.93pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-850" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1892">95</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.52pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.95pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-851" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1893">76</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.54pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 468.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, using the same assumption with an increase of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-762" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1894">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-763" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1895">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.29pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-764" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1896">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.25pt; position: var(--position); text-decoration: none; white-space: pre;"> ri<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.85pt; position: var(--position); text-decoration: none; white-space: pre;">sk-free rate and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-852" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1897">10</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.96pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 62.46pt; position: var(--position); text-decoration: none; white-space: pre;">in the probability of achieving the <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-853" name="abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted" format="ixt-sec:durwordsen" id="f-1898"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.63pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.63pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.15pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of Kreos / Claret A-B and C BSA fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 492.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-854" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1899">37</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.97pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-855" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1900">350</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.56pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-856" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1901">61</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.15pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.08pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-857" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" scale="3" id="f-1902">75</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.67pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 546.46pt;" id="ia894b143b6fc4522a0483350194c625e_418"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.46pt; width: 612pt;"><ix:continuation id="f-1597-10" continuedAt="f-1597-11"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.2.&#160; Heights convertible notes&#160; <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-1597-11" continuedAt="f-1597-12"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 20, 2023, the Group entered into a convertible notes subscription agreement with Heights, which provided for up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-86" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-1903">75,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in financing, consisting of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.44pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="tranche" contextRef="c-86" decimals="INF" name="abvx:BorrowingsNumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="f-1904">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.43pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 602.06pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The first tranche (&#8220;tranche A&#8221;) of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-858" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-1905">35,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.56pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount was drawn on August 24, 2023 and is <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 615.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composed of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-859" decimals="INF" name="abvx:NumberOfConvertibleNotesIssued" scale="0" id="f-1906">350</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.85pt; position: var(--position); text-decoration: none; white-space: pre;"> amortizing senior convertible notes with a nominal value of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.45pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-859" decimals="INF" name="abvx:ConvertibleLoansNotesNominalValue" format="ixt:num-dot-decimal" scale="0" id="f-1907">100,000</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 421.95pt; position: var(--position); text-decoration: none; white-space: pre;"> each and a fixed conversion price of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 628.94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-859" decimals="4" name="abvx:BorrowingsFixedConversionPrice" scale="0" id="f-1908">23.7674</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.5pt; position: var(--position); text-decoration: none; white-space: pre;"> (corresponding to a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-859" decimals="2" name="abvx:ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" scale="-2" id="f-1909">40</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.54pt; position: var(--position); text-decoration: none; white-space: pre;"> premium over the 15-day VWAP prior to the date on which their issuance is decided, and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.38pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to standard adjustments, including anti-dilution and dividend protections).<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 667.02pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The second tranche (&#8220;tranche B&#8221;) of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-860" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1910">40,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount is composed of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.23pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-860" decimals="INF" name="abvx:NumberOfConvertibleNotesIssued" scale="0" id="f-1911">400</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.23pt; position: var(--position); text-decoration: none; white-space: pre;"> amortizing senior <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible notes with a nominal value of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-860" decimals="INF" name="abvx:ConvertibleLoansNotesNominalValue" format="ixt:num-dot-decimal" scale="0" id="f-1912">100,000</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> each, and a conversion price (if any) that is be equal to <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.52pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-860" decimals="2" name="abvx:ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" scale="-2" id="f-1913">130</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.85pt; position: var(--position); text-decoration: none; white-space: pre;"> of the 15-<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">day VWAP immediately preceding the date on which their issuance is decided.<span style="display: inline-block; height: 8.73pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-55<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-12" continuedAt="f-1597-13"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">It may be drawn during the period from the date immediately following the <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-861" name="abvx:ConvertibleLoansNotesPeriod" format="ixt-sec:durwordsen" id="f-1914"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.27pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.23pt; position: var(--position); text-decoration: none; white-space: pre;">-month<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.1pt; position: var(--position); text-decoration: none; white-space: pre;"> anniversary of the issuance of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">first tranche to the first-year anniversary of the issuance of the first tranche (i.e. August 24, 2024), in up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.33pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="closing" contextRef="c-861" decimals="INF" name="abvx:ConvertibleLoansNotesNumberOfSeparateClosings" format="ixt-sec:numwordsen" scale="0" id="f-1915">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.3199999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> separate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">closings to provide the Group with additional flexibility to request a partial drawdown.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">On the limit date for the drawdown of the second tranche of the Heights Financing (i.e. August 4, 2024), the Group had not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drawn down this tranche and has therefore forgone its right to do so in the future.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on the Heights convertible notes accrues at a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.32pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="4" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-1916">6.00</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.15pt; position: var(--position); text-decoration: none; white-space: pre;"> annual fixed interest rate payable in quarterly installments in cash or, at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the option of the Group, in ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights convertible notes will be repaid through <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.65pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="installment" contextRef="c-86" decimals="INF" name="abvx:BorrowingsNumberOfQuarterlyInstallments" format="ixt-sec:numwordsen" scale="0" id="f-1917">sixteen</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"> quarterly installment payments, beginning <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-862" name="abvx:BorrowingsMaturityDeferralPeriod" format="ixt-sec:durwordsen" id="f-1918">three months</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.52pt; position: var(--position); text-decoration: none; white-space: pre;"> after their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance date (corresponding, for the first tranche, to a final repayment date on August 24, 2027). Installments are payable in cash or, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">at the option of the Group, in ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Any interest or installment payments in shares will be made on the basis of a share price equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.81pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="INF" name="abvx:BorrowingsPercentageOfMarketPrice" scale="-2" id="f-1919">90</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.14pt; position: var(--position); text-decoration: none; white-space: pre;"> of the Market Price of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares at the time of payment, where &#8220;Market Price&#8221; refers to the arithmetic average of the daily volume weighted average <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price (&#8220;VWAP&#8221;) for the ordinary shares on the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.8pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.79pt; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-862" name="abvx:BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" format="ixt-sec:durday" id="f-1920">2</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.62pt; position: var(--position); text-decoration: none; white-space: pre;">) days with the lowest daily VWAPs out of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.9pt; position: var(--position); text-decoration: none; white-space: pre;">five<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.43pt; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.26pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-862" name="abvx:BorrowingsMarketPriceNumberOfTradingDays" format="ixt-sec:durday" id="f-1921">5</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.26pt; position: var(--position); text-decoration: none; white-space: pre;">) trading days immediately <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">preceding the applicable date, but in no event greater than the VWAP of the ordinary shares on the applicable date. The Market Price <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">may not be higher than the applicable conversion price. Issuances of ordinary shares may not be made at a price lower than a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-863" decimals="2" name="abvx:IssuancePricePercentageOfDiscountTo15DayWVAP" scale="-2" id="f-1922">15</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 555.95pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">discount to the 15-day VWAP at the time of the decision to issue the Heights convertible notes (i.e., <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-86" decimals="4" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-1923">14.4303</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.56pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share.).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 305.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights convertible notes include the following conversion and settlement options:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.96pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conversion at the option of the noteholders: the notes are convertible into the Group&#8217;s ordinary shares at the option of the <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">noteholders at any time during the period beginning on the tranche A notes closing until the fifth business day prior to the <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maturity date. The ordinary shares issued would be equal to the product of (i) the conversion ratio in effect on the exercise <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">date, (ii) a fraction, the numerator of which is the outstanding principal amount per note and the denominator of which is the <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">initial principal amount of <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-86" decimals="INF" name="abvx:ConvertibleLoansNotesNominalValue" format="ixt:num-dot-decimal" scale="0" id="f-1924">100,000</ix:nonFraction><span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.58pt; position: var(--position); text-decoration: none; white-space: pre;"> per note, and (iii) the number of notes for which the conversion right has been exercised.<span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Settlement in shares at the option of the Group: the Group has the option to settle any interest or principal due with its own <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares (with respect to all but not some of the notes outstanding), subject to a price limit. The ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">issuable will be the lower of the conversion ratio or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.1pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-864" decimals="2" name="abvx:ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" scale="-2" id="f-1925">90</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.43pt; position: var(--position); text-decoration: none; white-space: pre;"> of the fair market value of the Group&#8217;s ordinary shares. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 431.36pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Settlement in shares at the option of the noteholders (&#8220;SSO Investor Price Limit Option&#8221;): the noteholders may require a <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">principal payment to be settled in shares in the event the share settlement price on any principal payment date is below the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price limit in effect (initially <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-864" decimals="4" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-1926">14.4303</ix:nonFraction><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.68pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to adjustments as described in the key terms below) and the Cash Carve-Out <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(i.e. <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-864" decimals="-3" name="abvx:EquityIssuanceCashCarveOut" format="ixt:num-dot-decimal" scale="6" id="f-1927">13.125</ix:nonFraction>&#160;million<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.88pt; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; the amount of cash permitted to be paid to Heights for principal payments) has been utilized such that <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">it does not allow payment in full of the principal payment. The majority noteholder may agree to waive the cash payment <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(which would otherwise be deferred until the original maturity date) and require the Group to exercise the share settlement <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">option for the principal payment required. A number of the ordinary shares issuable is based on the price limit in effect.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 536.64pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment of the notes upon an Event of Default (as defined below): the noteholder may notify the Group of their decision <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 550.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to cause the notes to become payable at a price equal to the Early Redemption Amount (as defined below) upon an Event of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Default. The Early Redemption Amount means an amount equal to the greater of (a) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-865" decimals="2" name="abvx:ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" scale="-2" id="f-1928">120</ix:nonFraction>%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of the outstanding principal of the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">note and (b) the market price of a number of shares issuable per note had the conversion right been exercised. Events of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Default include the following: default in any payment due on the notes, failure to deliver shares upon exercise of conversion <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">right or share settlement option, default of the Group on any obligation under the agreement, and other events.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 628.48pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment or purchase of the notes upon change of control, a delisting, or free float event (each, a &#8220;Put Event&#8221;): Upon a Put <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Event, the noteholder has an option to require the Group to redeem or, at the Group&#8217;s option, to purchase all of the notes at <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 655.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the total aggregate amount equal to the outstanding principal and interest accrued through the date of a Put Event.<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 526.15pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights Financing is a senior, unsecured financing. The terms and conditions of the Heights convertible notes include a standard <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">negative pledge providing that any security granted in favor of other borrowed debt or debt instruments should also be granted in favor <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-56<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-13" continuedAt="f-1597-14"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the Heights convertible notes on an equal basis (with the exception of the securities issued pursuant to the Kreos / Claret Financing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as detailed above).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 24,<span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.6pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> 2023, the Group repaid in full an outstanding amount of</span><span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 320.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-92" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-1929">25,102</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.9pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, corresponding to the outstanding OCEANE </span><span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.6pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">bonds, by way of set-off with the Heights Financing. The accounting treatment for this transaction is explained in Note 15.5.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment and measurement<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the Heights convertible notes are classified <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.17pt; position: var(--position); text-decoration: none; white-space: pre;">as current financial liabilities as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.53999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">2023 and 2024 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.47pt; position: var(--position); text-decoration: none; white-space: pre;">(see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group concluded that, except for the repayment or purchase option of the notes upon a Put Event, the above-mentioned <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conversion and settlement options represented embedded derivatives that required to be bifurcated from their host contract. The Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">being unable to reliably value each embedded derivative at issuance date and on subsequent reporting dates, it measured the whole <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instrument at fair value through profit or loss (&#8220;FVTPL&#8221;) as permitted by IFRS 9. Instruments measured at FVTPL under these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions are measured at their fair value on issuance and on subsequent reporting dates, and the amount of change in the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 269.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the financial liability is presented in profit or loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the Heights convertible notes were measured at fair value, which differs from the issuance procee<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ds by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.32pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-862" decimals="-3" name="abvx:GainsArisingFromRecognitionOfFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1930">2,359</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.41pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 303.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Since the fair value measurement of the instrument is evidenced by a valuation technique that does not only use data from observable </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.4pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">markets, the carrying amount was adjusted to defer the difference between the fair value measurement and the transaction price, and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.6pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">the day one gain is therefore recognized in financial income on a straight-line basis over the term of the instrument. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.8pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2023 and 2024, the amounts by which the carrying value of the notes is adjusted to take into account the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">unrecognized day one gain are </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-866" decimals="-3" name="abvx:UnrecognitionDayOneGainOfFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1931">2,147</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.66pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-867" decimals="-3" name="abvx:UnrecognitionDayOneGainOfFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1932">1,557</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.18pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the Heights convertible notes (including the embedded features) has been measured with a Monte Carlo model, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">considering two probability-weighted scenarios: (i) a Put Event or Default/Dissolution scenario and (ii) a voluntary conversion at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">maturity scenario. <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" id="f-1933" continuedAt="f-1933-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.62pt; position: var(--position); text-decoration: none; white-space: pre;">The main data and assumptions are the following: <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1933-1" continuedAt="f-1933-2"><div style="position: var(--position); top: 415.2pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 519pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 143.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 128.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes - August 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.82pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 24, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 17.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 17.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 113.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-868" decimals="INF" name="abvx:NumberOfConvertibleNotesOutstanding" scale="0" id="f-1934">350</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 17.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-869" decimals="INF" name="abvx:NumberOfConvertibleNotesOutstanding" scale="0" id="f-1935">350</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 17.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-870" decimals="INF" name="abvx:NumberOfConvertibleNotesOutstanding" scale="0" id="f-1936">350</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Original principal amount (in thousands of <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 34.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-868" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1937">35,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 34.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-869" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1938">35,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 34.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-870" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1939">35,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 55.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 116.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 116.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-871" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1940">6</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 107.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 107.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-872" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1941">6</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 107.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 107.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-873" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1942">6</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conversion price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 72.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-874" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1943">23.77</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 72.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-875" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1944">23.77</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 72.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-876" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1945">23.77</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 90pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-877" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1946">16.74</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-878" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1947">9.82</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-879" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1948">6.76</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 107.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 10.43pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Maturity date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 107.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.88pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event) 24/08/2027 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.23pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.58pt; position: var(--position); text-decoration: none; white-space: pre;">(HTM/voluntary conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 277.5pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2027 (HTM/voluntary <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;">conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 399.75pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2027 (HTM/voluntary <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;">conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.76pt; width: 143.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Held to maturity / voluntary conversion <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.36pt; width: 143.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 134.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-880" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1949">75</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 134.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-881" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1950">75</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 134.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-882" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1951">75</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 151.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Initial price limit<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 151.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-883" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1952">14.43</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 151.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-884" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1953">14.43</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 151.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-885" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1954">14.43</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Early redemption amount (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 168.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 108.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-886" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1955">120</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 168.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 99.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 99.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-887" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1956">120</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 168.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 99.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 99.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-888" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1957">120</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 186pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-889" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1958">50</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 186pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-890" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1959">50</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 186pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-891" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1960">50</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 203.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit spread<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 203.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-892" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1961">20</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 203.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-893" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1962">20</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 203.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-894" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1963">25</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 220.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 110.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 110.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-895" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1964">2.9</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 220.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 101.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 101.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-896" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1965">2.3</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 220.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 101.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 101.84pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-897" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1966">2.9</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of Heights convertible notes <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 237.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 96.21pt;"></span></span><span style="left: 98.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-868" decimals="-3" name="abvx:AggregateFairValueConvertibleNotes" format="ixt:num-dot-decimal" scale="3" id="f-1967">32,641</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 237.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 87.21pt;"></span></span><span style="left: 89.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-869" decimals="-3" name="abvx:AggregateFairValueConvertibleNotes" format="ixt:num-dot-decimal" scale="3" id="f-1968">27,456</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 237.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 87.21pt;"></span></span><span style="left: 89.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-870" decimals="-3" name="abvx:AggregateFairValueConvertibleNotes" format="ixt:num-dot-decimal" scale="3" id="f-1969">20,017</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-57<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-14" continuedAt="f-1597-15"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of August 24, 2023, using the same assumptions with an increase of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.84pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-898" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1970">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> volatility, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.35pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-899" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1971">1</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.98pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> share price, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-900" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1972">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.98pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> risk-free rate and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.21pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-901" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1973">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.17pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-902" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1974">239</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-903" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1975">1,069</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-904" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1976">239</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.04pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-905" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1977">80</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2023, using the same assumptions with an increase of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-843" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1978">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> volatility, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.51pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-844" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1979">1</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> share price, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-845" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1980">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> risk-free rate and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-906" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1981">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-907" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1982">18</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-908" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1983">352</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-909" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1984">366</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-910" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1985">364</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.46pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2024, using the same assumptions with an increase of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-762" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1986">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> volatility, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.51pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-763" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-1987">1</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> share price, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-764" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1988">1</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> risk-free rate and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+<ix:nonFraction unitRef="number" contextRef="c-911" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-1989">10</ix:nonFraction>%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="eur" contextRef="c-912" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1990">2</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.6pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="eur" contextRef="c-913" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1991">39</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-914" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1992">219</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-915" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-1993">631</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 353.46pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 227.36pt;" id="ia894b143b6fc4522a0483350194c625e_424"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.36pt; width: 612pt;"><ix:continuation id="f-1597-15" continuedAt="f-1597-16"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.3. Structured debt financing with Kreos subscribed in July 2018 &#8211; &#8220;Kreos 1&#8221; <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-1597-16" continuedAt="f-1597-17"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On July 24, 2018, the Group entered into a Venture Loan Agreement, a Straight Bonds Issue Agreement and a Convertible Bonds <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Issue Agreement with Kreos Capital V (UK) Ltd., (or &#8220;Kreos&#8221;), which provided for up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-917" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-1996">20,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.76pt; position: var(--position); text-decoration: none; white-space: pre;"> in financing. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to the terms of the agreements, Kreos agreed to subscribe for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-918" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-1997">16,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.4pt; position: var(--position); text-decoration: none; white-space: pre;"> in non-convertible bonds and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-919" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-1998">4,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in convertible bonds, to be issued by the Group in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.38pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="tranche" contextRef="c-917" decimals="INF" name="abvx:BorrowingsNumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="f-1999">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.37pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-917" decimals="-3" name="abvx:BorrowingsMaximumBorrowingCapacityPerTranche" format="ixt:num-dot-decimal" scale="3" id="f-2000">10,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.57pt; position: var(--position); text-decoration: none; white-space: pre;"> each. The tranches were issued <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in July 2018 and May 2019, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The convertible bonds were convertible into new ordinary shares of the Group at any time from their issuance and at the discretion of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their holders. In October 2020, Kreos requi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.63pt; position: var(--position); text-decoration: none; white-space: pre;">red the conversion of all the convertible bonds they held (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.49pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-920" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="0" id="f-2001">2,000,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.49pt; position: var(--position); text-decoration: none; white-space: pre;"> for Tranche A and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 351.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-921" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="0" id="f-2002">2,000,000</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"> for Tranche B) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.3pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-922" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-2003">464,309</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.8pt; position: var(--position); text-decoration: none; white-space: pre;"> shares were issued<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Each tranche bears an <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-923" decimals="2" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-2004">8</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.19pt; position: var(--position); text-decoration: none; white-space: pre;"> annual interest rate, plus 3-month Euribor, including a floor at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-924" decimals="2" name="abvx:BorrowingsBasisInterestRate" scale="-2" id="f-2005">8</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.86pt; position: var(--position); text-decoration: none; white-space: pre;"> and a cap at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.28pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-925" decimals="2" name="abvx:BorrowingsBasisInterestRate" scale="-2" id="f-2006">9</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.61pt; position: var(--position); text-decoration: none; white-space: pre;">, and must be repaid in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="installment" contextRef="c-926" decimals="INF" name="abvx:BorrowingsNumberOfMonthlyInstallments" scale="0" id="f-2007">54</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.13pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">monthly installments, after a deferred repayment of the nominal value to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-927" name="abvx:BorrowingsMaturityDeferralPeriod" format="ixt-sec:durmonth" id="f-2008">12</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.33pt; position: var(--position); text-decoration: none; white-space: pre;"> for the first tranche (&#8220;Tranche A&#8221;) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.56pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-928" name="abvx:BorrowingsMaturityDeferralPeriod" format="ixt-sec:durmonth" id="f-2009">6</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 566.49pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the second tranche (&#8220;Tranche B&#8221;). In addition, each tranche bears exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-919" decimals="2" name="abvx:BorrowingsExitFeePercentage" scale="-2" id="f-2010">9</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.44pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total drawdown amount (i.e. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 407.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-919" decimals="-3" name="abvx:BorrowingsExitFeeAmount" format="ixt:num-dot-decimal" scale="3" id="f-2011">900</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"> per tranche), payable upon the last monthly installment (exit fees remain payable in full in case of early redemption).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to the terms of the agreements, the Group has the right, at any time but with no less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-929" name="abvx:BorrowingsNoticePeriod" format="ixt-sec:durday" id="f-2012">30</ix:nonNumeric> days<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: var(--position); text-decoration: none; white-space: pre;"> prior notice to Kreos, to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prepay or purchase the non-convertible and convertible bonds, exclusively in full. The prepayment will be equal to (i) the principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount outstanding, plus (ii) exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.84pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-917" decimals="2" name="abvx:BorrowingsExitFeePercentage" scale="-2" id="f-2013">9</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.17pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total draw down amount and (iii) the sum of all interest repayments which would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">have been paid throughout the remainder of the term of the relevant tranche discounted by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.18pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-917" decimals="2" name="abvx:BorrowingsAnnualDiscountRate" scale="-2" id="f-2014">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.51pt; position: var(--position); text-decoration: none; white-space: pre;"> per annum. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The agreements <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.01pt; position: var(--position); text-decoration: none; white-space: pre;">did<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.78pt; position: var(--position); text-decoration: none; white-space: pre;"> not contain any financial covenants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">In connection with each tranche, the Group issued </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.83pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="shares" contextRef="c-930" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-2015">110,957</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.33000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> tranche A share warrants (or &#8220;Kreos A BSA&#8221;) and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.23pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="shares" contextRef="c-931" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-2016">74,766</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.73pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> tranche B share </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">warrants (or &#8220;Kreos B BSA&#8221;), each, for a global subscription price of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-932" decimals="INF" name="abvx:OtherShareWarrantsSubscriptionPricePerShare" scale="0" id="f-2017">1</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. Each Kreos A BSA and Kreos B BSA gives rights to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 544.72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="shares" contextRef="c-933" decimals="INF" name="abvx:NumberOfSharesSubscribedPerWarrant" format="ixt-sec:numwordsen" scale="0" id="f-2018">one</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.15pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">new ordinary share at an exercise price of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.22pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-930" decimals="2" name="abvx:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="f-2019">7.21</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> less a discount and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.92pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-931" decimals="2" name="abvx:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="f-2020">10.70</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> less a discount, respectively. Both Kreos A BSA and Kreos </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">B BSA are freely transferrable among financial institutions and are exercisable over a </span><span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-933" name="abvx:BorrowingsMaturityTerm" format="ixt-sec:durwordsen" id="f-2021"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">10</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">-year</span><span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.32pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> period from the issue date. In addition, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">the Group granted to the holders of the Kreos A BSA and the Kreos B BSA the option to sell to the Group, upon each exercise of all or </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">parts of the Kreos A BSA, at the put price defined in the agreement, a proportion of the number of the warrants, for the sole purpose of </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">implementing a cash less exercise of the Kreos A BSA and Kreos B BSA. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The variation in the Kreos 1 &amp; 2 bond loans during the periods ended December 31, 2021 and 2022 is primarily related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursements of capital and interests. As of December 31, 2022, the A tranche of the Kreos 1 bond loan has come to maturity and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">was repaid in full. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August, 21, 2023, the B tranche of the Kreos 1 bond loan as well as the A &amp; B tranches of the Kreos 2 bond loan were repaid in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">full, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-934" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2022">7,661</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.35pt; position: var(--position); text-decoration: none; white-space: pre;">, using the proceeds from the new Kreos / Claret Fin<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ancing (see Note 3.3). </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group granted to the holders of the Kreos A BSA and the Kreos B BSA the option to sell to the Group, upon each exercise of all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">or parts of the Kreos A BSA, at the put price defined in the agreement, a proportion of the number of the warrants, for the sole purpose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of implementing a cashless exercise of the Kreos A BSA and Kreos B BSA. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-58<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-17" continuedAt="f-1597-18"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, the holders opted for the cashless exercise option of the share warrants they held, implemented through the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">repurchase by the Group of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.85pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="abvx:NumberOfOtherShareWarrantsRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-2023">43,070</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.35pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos A BSA and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.81pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="0" name="abvx:NumberOfOtherShareWarrantsRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-2024">43,070</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.31pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos B BSA and the issuance by the Group of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.0799999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-2025">67,887</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.58pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="0" name="abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" format="ixt:num-dot-decimal" scale="0" id="f-2026">31,696</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares, as the result of the cashless exercise by Kreos of the outstanding <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="abvx:NumberOfOtherShareWarrantsConverted" format="ixt:num-dot-decimal" scale="0" id="f-2027">67,887</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.54pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos A &amp; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="0" name="abvx:NumberOfOtherShareWarrantsConverted" format="ixt:num-dot-decimal" scale="0" id="f-2028">31,696</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.9pt; position: var(--position); text-decoration: none; white-space: pre;"> B BSA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos 1 financing package is issued at market conditions: the net issuance proceeds reflect the fair value of the instruments at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inception.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The straight bond tranches are split between i) a debt component (then measured at amortized cost), and ii) a premium corresponding <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to the initial fair value of attached BSA (then remeasured at fair value through profit and loss).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The BSA attached to all tranches (both straight and convertible) do not meet the &#8220;fixed for fixed&#8221; criteria (non cash settlement option <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which may result in exchanging a variable number of shares, for a variable price), and are accounted for as standalone derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The issuer prepayment options meet the definition of a separate derivative. However, their value at inception and subsequent dates is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-919" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="0" id="f-2029">nil</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.54pt; position: var(--position); text-decoration: none; white-space: pre;"> as per Schoenbucher model, and has no impact on the financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As the differences identified between the terms of the Kreos 1 &amp; 2 bond loans and the new Kreos / Claret Financing were considered <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">substantial, the repayment transaction on August 21, 2023 was accounted for as a debt extinguishment. The repayment of the Kreos 1 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&amp; 2 bond loans led to the recognition of a loss on extinguishment amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.45pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-935" decimals="-3" sign="-" name="ifrs-full:GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid" format="ixt:num-dot-decimal" scale="3" id="f-2030">170</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.04pt; position: var(--position); text-decoration: none; white-space: pre;">, primarily due to (i) the payment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future interests as per the terms of the prepayment option and (ii) unamortized exit and issuance fees, reducing the carrying value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the liabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of Kreos A BSA &amp; Kreos B BSA <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.96pt; width: 612pt;"><ix:continuation id="f-1401-8" continuedAt="f-1401-9"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos A BSA and Kreos B BSA are measured at fair value using a Black-Scholes valuation model. The main data and <span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-1401-9"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions are the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 419.36pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A BSA - June 1, 2018<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos A BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-936" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-2031">110,957</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-937" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-2032">110,957</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-938" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2033">7.21</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-939" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2034">7.21</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-940" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2035">6.18</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-941" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2036">18.57</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="y" contextRef="c-942" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-2037">5.6</ix:nonFraction> years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="y" contextRef="c-943" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-2038">0.0</ix:nonFraction> years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-944" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2039">44.01</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-945" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-2040">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-946" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2041">2.98</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos A BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-936" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-2042">275</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-937" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-2043">1,261</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 563.11pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos B BSA - June 1, 2019<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos B BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-947" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-2044">74,766</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-948" decimals="INF" name="abvx:NumberOfWarrantsOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-2045">74,766</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-949" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2046">10.70</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-950" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2047">10.70</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-951" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2048">6.18</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-952" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2049">18.57</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="y" contextRef="c-953" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-2050">6.4</ix:nonFraction> years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="y" contextRef="c-954" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-2051">0.0</ix:nonFraction> years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-955" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2052">44.01</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-956" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-2053">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-957" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2054">2.96</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos B BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-947" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-2055">149</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-948" decimals="-3" name="abvx:AggregateFairValueOtherEquityInstrumentsOutstanding" scale="3" id="f-2056">589</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-59<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-18" continuedAt="f-1597-19"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2021, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-958" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2057">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-959" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2058">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;">share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.22pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-960" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2059">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.18pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">result in an increase of Kreos A &amp; B BSA fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-961" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2060">16</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-962" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2061">176</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.89pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-963" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2062">69</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.41pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-964" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2063">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-965" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2064">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;">share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.22pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-966" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2065">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.18pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">result in an increase of Kreos A &amp; B BSA fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-967" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2066">6</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-968" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2067">78</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.89pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-969" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2068">12</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.41pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, the holders opted for the cashless exercise option of the share warrants they held. At this date, the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercised warrants of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-970" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" format="ixt:num-dot-decimal" scale="3" id="f-2069">1,850</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.03pt; position: var(--position); text-decoration: none; white-space: pre;"> was reclassified from derivative financial liabilities to equity. As of this date, due to the put <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">option being exercised by the holders, the fair value of the BSAs is deemed equal to their intrinsic value, which is equal to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 195.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">difference between the share price on May 24, 2023 and their exercise price.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 229.76pt;" id="ia894b143b6fc4522a0483350194c625e_427"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.76pt; width: 612pt;"><ix:continuation id="f-1597-19" continuedAt="f-1597-20"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.4 Structured debt financing with Kreos subscribed in October 2020 &#8211; &#8220;Kreos 2&#8221; <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-1597-20" continuedAt="f-1597-21"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October 13, 2020, the Group obtained a straight bond loan of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-971" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2070">15,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.56pt; position: var(--position); text-decoration: none; white-space: pre;"> from Kreos corresponding to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.31pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="tranche" contextRef="c-971" decimals="INF" name="abvx:BorrowingsNumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="f-2071">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.3pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-972" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2072">10,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> (&#8220;Tranche A&#8221;) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.98pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-973" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2073">5,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.07pt; position: var(--position); text-decoration: none; white-space: pre;"> (&#8220;Tranche B&#8221;), with an option for an additional <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.73pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-971" decimals="-3" name="abvx:BorrowingsAdditionalTrancheAmount" format="ixt:num-dot-decimal" scale="3" id="f-2074">5,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.8199999999999pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Tranches A and B were paid in October and November 2020, respectively, with the following conditions. Each tranche bears an <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.15pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-974" decimals="2" name="abvx:BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" scale="-2" id="f-2075">8</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 563.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">annual interest rate, plus 3-month Euribor, for the first <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.49pt; position: var(--position); text-decoration: none; white-space: pre;">12<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;"> monthly installments, after which the annual interest rate is increased to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fixed rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.32pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="4" name="abvx:BorrowingsInterestRateForFollowingInstallments" scale="-2" id="f-2076">9.75</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.15pt; position: var(--position); text-decoration: none; white-space: pre;"> for the following <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.87pt; position: var(--position); text-decoration: none; white-space: pre;">36<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.87pt; position: var(--position); text-decoration: none; white-space: pre;"> monthly installments. Each tranche is to be repaid in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.88pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="installment" contextRef="c-975" decimals="INF" name="abvx:BorrowingsNumberOfMonthlyInstallments" scale="0" id="f-2077">36</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.88pt; position: var(--position); text-decoration: none; white-space: pre;"> monthly installments starting from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">October 2021 and November 2021, for the tranche A and B, respectively. The agreements do not contain any financial covenants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, each tranche bears exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.71pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="2" name="abvx:BorrowingsExitFeePercentage" scale="-2" id="f-2078">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.04pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total drawdown amount (i.e. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-972" decimals="-3" name="abvx:BorrowingsExitFeeAmount" format="ixt:num-dot-decimal" scale="3" id="f-2079">400</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.1pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.6pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-973" decimals="-3" name="abvx:BorrowingsExitFeeAmount" format="ixt:num-dot-decimal" scale="3" id="f-2080">200</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.19pt; position: var(--position); text-decoration: none; white-space: pre;"> for Tranche A &amp; B, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively), payable upon the last monthly installment (exit fees remain payable, in full or partially, in case of early redemption). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to the terms of the agreements, the Group has the right, at any time but with no less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-976" name="abvx:BorrowingsNoticePeriod" format="ixt-sec:durday" id="f-2081">30</ix:nonNumeric> days<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: var(--position); text-decoration: none; white-space: pre;"> prior notice to Kreos, to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prepay or purchase the non-convertible exclusively in whole. The prepayment will be equal to (i) the principal amount outstanding, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">plus (ii) exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.74pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="2" name="abvx:BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" scale="-2" id="f-2082">2</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.07pt; position: var(--position); text-decoration: none; white-space: pre;"> of the outstanding amount in the event of prepayment occurring between the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.56pt; position: var(--position); text-decoration: none; white-space: pre;">18<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.56pt; position: var(--position); text-decoration: none; white-space: pre;">th and the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.46pt; position: var(--position); text-decoration: none; white-space: pre;">30<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.46pt; position: var(--position); text-decoration: none; white-space: pre;">th installment or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.88pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="2" name="abvx:BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" scale="-2" id="f-2083">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.21000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> of the outstanding amount in the event of prepayment occurring after the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.71pt; position: var(--position); text-decoration: none; white-space: pre;">30<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.71pt; position: var(--position); text-decoration: none; white-space: pre;">th installment and (iii) the sum of all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">interest repayments which would have been paid throughout the remainder of the term of the relevant tranche discounted by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.03pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="2" name="abvx:BorrowingsAnnualDiscountRate" scale="-2" id="f-2084">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.36pt; position: var(--position); text-decoration: none; white-space: pre;"> per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">annum. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 453.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August, 21, 2023, the B tranche of the Kreos 1 bond loan as well as the A &amp; B tranches of the Kreos 2 bond loan were repaid in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 464.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">full, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-934" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2085">7,661</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.35pt; position: var(--position); text-decoration: none; white-space: pre;">, using the proce<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.4pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">eds from the new Kreos / Claret Financing (see Note 3.2). The accounting </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">treatment of the extinguishment of these liabilities is set forth in Note 15.3.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos 2 straight bonds were initially measured at fair value, which corresponds to the net cash proceeds, and subsequently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured at amortized cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the prepayment option is a separate derivative instrument as the redemption price does not reimburse Kreos for an amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">up to the approximate present value of lost interest for the remaining term of the host contract. However, its fair value at inception and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent dates is nil as per Schoenbucher model, and has no impact on the financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 601.06pt;" id="ia894b143b6fc4522a0483350194c625e_430"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 601.06pt; width: 612pt;"><ix:continuation id="f-1597-21" continuedAt="f-1597-22"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.5. OCEANE <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-1597-22" continuedAt="f-1597-23"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 619.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group received a gross proceed of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.89pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-977" decimals="-3" name="abvx:ProceedsFromIssuingSharesAndConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2086">85,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.98pt; position: var(--position); text-decoration: none; white-space: pre;"> on July 30, 2021 through (i)&#160;the issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-977" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-2087">1,964,031</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.04pt; position: var(--position); text-decoration: none; white-space: pre;"> shares with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-978" decimals="2" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-2088">30.55</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.14pt; position: var(--position); text-decoration: none; white-space: pre;"> per share (see Note 13.3 (changes in share capital)) for gross amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-977" decimals="-3" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="3" id="f-2089">60,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.76pt; position: var(--position); text-decoration: none; white-space: pre;">, and (ii)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 639.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.17pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-977" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2090">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.26pt; position: var(--position); text-decoration: none; white-space: pre;"> in OCEANE, maturing on July 30, 2026. The proceeds of the transaction mainly serve to finance the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 649.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">progress of ABX464 clinical trials in chronic inflammatory diseases. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 671.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The OCEANE bears a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.56pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-978" decimals="2" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2091">6</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.89pt; position: var(--position); text-decoration: none; white-space: pre;"> interest rate per year, payable semi-annually January 30, and July, 31 from January 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The OCEANE shall be convertible into new ordinary shares and/or exchanged for existing ordinary shares of the group at any time <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 703.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from their issuance and at the discretion of their holders. The conversion ratio is <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.68pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-977" decimals="INF" name="abvx:NumberOfSharesSubscribedPerWarrant" format="ixt-sec:numwordsen" scale="0" id="f-2092">one</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.11pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary share of the Group per OCEANE, <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-60<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><ix:continuation id="f-1597-23" continuedAt="f-1597-24"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">representing a conversion price set to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-978" decimals="2" name="abvx:ConversionPriceOtherLiabilities" scale="0" id="f-2093">38.19</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.98pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share. This conversion price is updated (decrease only) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.34pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-979" name="abvx:ConversionPriceAdjustmentPeriod" format="ixt-sec:durmonth" id="f-2094">18</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 533.27pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.27pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-980" name="abvx:ConversionPriceAdjustmentPeriod" format="ixt-sec:durmonth" id="f-2095">24</ix:nonNumeric> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.43pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 70.43pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-981" name="abvx:ConversionPriceAdjustmentPeriod" format="ixt-sec:durmonth" id="f-2096">36</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.36pt; position: var(--position); text-decoration: none; white-space: pre;"> after OCEANE issuance date to match the volume weighted average price of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-2097">thirty</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.78pt; position: var(--position); text-decoration: none; white-space: pre;"> trading days that precedes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the update subjected to the following floor threshold. The floor threshold for the 18-month update matches <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.73pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-982" decimals="2" name="abvx:ConversionPricePercentageOfInitialPriceThreshold" scale="-2" id="f-2098">85</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 483.06pt; position: var(--position); text-decoration: none; white-space: pre;"> initial conversion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-979" decimals="3" name="abvx:ConversionPriceOtherLiabilities" scale="0" id="f-2099">32.462</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.28999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share). The floor threshold for the 24-month update matches <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.05pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-983" decimals="2" name="abvx:ConversionPricePercentageOfInitialPriceThreshold" scale="-2" id="f-2100">70</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.38pt; position: var(--position); text-decoration: none; white-space: pre;"> initial conversion price (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-980" decimals="3" name="abvx:ConversionPriceOtherLiabilities" scale="0" id="f-2101">26.733</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.3pt; position: var(--position); text-decoration: none; white-space: pre;"> per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary share). The floor threshold for the 36-month update matches <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-984" decimals="2" name="abvx:ConversionPricePercentageOfInitialPriceThreshold" scale="-2" id="f-2102">68</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.33pt; position: var(--position); text-decoration: none; white-space: pre;"> initial conversion price (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-981" decimals="3" name="abvx:ConversionPriceOtherLiabilities" scale="0" id="f-2103">25.969</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.25pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE terms and conditions anticipate a conversion ratio adjustment in order to preserve the rights of OCEANE holders with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">following achievements made by the group: issuance of new shares with the preemptive subscription right, attribution of free shares or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">securities for the benefit of all the shareholders, number of share multiplication, shares consolidation, increase of the nominal value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">incorporation of reserves, profits or bonuses, distribution of dividends, premiums or reserves, mergers, scission, repurchase of shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">above market value, capital reduction, creation of preferred shares. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 24, 2023, the outstanding OCEANE including accrued interests were repaid in full, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-92" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2104">25,102</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.51pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">using the proceeds from the new Heights Financings (see Note 3.2). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment and measurement <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 268.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the OCEANE bonds are classified <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.98pt; position: var(--position); text-decoration: none; white-space: pre;">as current financial liabilities<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.16pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 291.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2022 (see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As the conversion ratio is adjusted <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.41pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-979" name="abvx:ConversionPriceAdjustmentPeriod" format="ixt-sec:durmonth" id="f-2105">18</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.34pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.34pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-980" name="abvx:ConversionPriceAdjustmentPeriod" format="ixt-sec:durmonth" id="f-2106">24</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.27pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.2pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-981" name="abvx:ConversionPriceAdjustmentPeriod" format="ixt-sec:durmonth" id="f-2107">36</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.13pt; position: var(--position); text-decoration: none; white-space: pre;"> after the issuance date of the OCEANE bond with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">weighted average price of the shares and is subject to a floor and a cap, the conversion does not result in the delivery of a fixed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">number of shares. Consequently, the OCEANE bond is recorded as an hybrid instrument which includes i) a debt host contract <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">accounted for at amortized cost, and ii) a conversion option which is a embedded derivative accounted for at fair value through profit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.56pt; width: 612pt;"><ix:continuation id="f-1933-2" continuedAt="f-1933-3"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the net cash proceeds reflect the OCEANE initial fair value. The fair value of the bifurcated option at inception has been <span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-1933-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured with a Monte Carlo model using a Longstaff Schwartz algorithm, with a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-985" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2108">53</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.19pt; position: var(--position); text-decoration: none; white-space: pre;"> share price volatility, a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.71pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-986" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="-4" id="f-2109">1,400</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.21pt; position: var(--position); text-decoration: none; white-space: pre;"> bp credit spread <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumption and a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-987" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2110">31.50</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.38pt; position: var(--position); text-decoration: none; white-space: pre;"> share price. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 413.06pt; width: 612pt;"><div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 389.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.37pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.07pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 24, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 21pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-988" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2111">3.05</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 21pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-989" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2112">3.22</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit spread<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-990" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="-4" id="f-2113">1,475</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"> bp<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.12pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-991" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="-4" id="f-2114">1,398</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"> bp<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-992" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2115">6.18</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-993" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2116">16.74</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Expected term<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.79pt; position: var(--position); text-decoration: none; white-space: pre;">July 21, 2026<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.79pt; position: var(--position); text-decoration: none; white-space: pre;"> July 21, 2026 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 69pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-994" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2117">44.01</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 69pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-995" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2118">37</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 81pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-996" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="0" id="f-2119">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 81pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-997" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="0" id="f-2120">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued OCEANE (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 93pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-668" decimals="-3" name="abvx:AggregateFairValueConvertibleNotes" scale="3" id="f-2121">142</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 93pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.71pt;"></span></span><span style="left: 59.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-998" decimals="-3" name="abvx:AggregateFairValueConvertibleNotes" format="ixt:num-dot-decimal" scale="3" id="f-2122">1,762</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of July 30, 2021, the issuance price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-977" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2123">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.02pt; position: var(--position); text-decoration: none; white-space: pre;"> has been split between i) a financial liability for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-978" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2124">17,839</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 541.94pt; position: var(--position); text-decoration: none; white-space: pre;">, and ii) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">a financial derivative for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.95pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-978" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2125">7,161</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.04pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 589.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the fair value of conversion option amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-668" decimals="-3" name="abvx:AggregateFairValueConvertibleNotes" format="ixt:num-dot-decimal" scale="3" id="f-2126">142</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.61pt; position: var(--position); text-decoration: none; white-space: pre;">, based on the same valuation model, a credit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">spread assumption of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.43pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-990" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="-4" id="f-2127">1,475</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.93pt; position: var(--position); text-decoration: none; white-space: pre;"> bp, a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.23pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-992" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2128">6.18</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.73pt; position: var(--position); text-decoration: none; white-space: pre;">, and a price volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.43pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-994" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2129">44</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.76pt; position: var(--position); text-decoration: none; white-space: pre;">. As of December 31, 2022, using the same <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.38pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-964" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2130">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.34pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.89pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-965" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2131">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.52pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.99pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-966" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2132">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.95pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would result in an increase of the OCEANE <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 620.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conversion option fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.70999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-999" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2133">17</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1000" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2134">97</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.89pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1001" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2135">15</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.41pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of August 24, 2023, the date at which the OCEANE were repaid, the fair value of conversion option amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-998" decimals="-3" name="abvx:AggregateFairValueConvertibleNotes" format="ixt:num-dot-decimal" scale="3" id="f-2136">1,762</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.99pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 651.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based on the same valuation model, a credit spread assumption of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.7pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-991" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="-4" id="f-2137">1,398</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.2pt; position: var(--position); text-decoration: none; white-space: pre;"> bp, a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-993" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2138">16.74</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432pt; position: var(--position); text-decoration: none; white-space: pre;">, and a price volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.7pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-995" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2139">37</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 551.03pt; position: var(--position); text-decoration: none; white-space: pre;">. As <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of August 24, 2023, using the same assumptions, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.47pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-898" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2140">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.43pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.98pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-899" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2141">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.61pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.08pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-900" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2142">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.04pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would result in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">an increase of the OCEANE conversion option fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.4pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1002" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2143">80</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.99pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.99pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1003" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2144">364</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.58pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1004" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2145">121</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.1pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-61<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-24" continuedAt="f-1597-25"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As the differences identified between the terms of the OCEANE and the new Heights convertible notes were considered substantial, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the transaction was accounted for as a debt extinguishment. The repayment of the OCEANE led to the recognition of a loss on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">extinguishment amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1005" decimals="-3" sign="-" name="ifrs-full:GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid" format="ixt:num-dot-decimal" scale="3" id="f-2146">3,069</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.7pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 129.36pt;" id="ia894b143b6fc4522a0483350194c625e_433"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.36pt; width: 612pt;"><ix:continuation id="f-1597-25" continuedAt="f-1597-26"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.6. State guaranteed loan &#8211; &#8220;PGE&#8221;<span style="display: inline-block; height: 6.77pt;"></span><span id="i72e4f64c56664c4db7a276f1130c3e77"></span></span></ix:continuation></div><ix:continuation id="f-1597-26" continuedAt="f-1597-27"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2020, the Group subscribed to a PGE from Soci&#233;t&#233; G&#233;n&#233;rale with an initial maturity of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1006" name="abvx:BorrowingsMaturityTerm" format="ixt-sec:durmonth" id="f-2147">12</ix:nonNumeric> months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.65pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.85pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1007" decimals="4" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2148">0.25</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.68pt; position: var(--position); text-decoration: none; white-space: pre;"> and a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1006" name="abvx:BorrowingsMaturityExtensionTerm" format="ixt-sec:durwordsen" id="f-2149"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.04pt; position: var(--position); text-decoration: none; white-space: pre;">five<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.5699999999999pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.09pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">extension option. In March 2021, the Group exercised the <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1008" name="abvx:BorrowingsMaturityExtensionTerm" format="ixt-sec:durwordsen" id="f-2150"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.4pt; position: var(--position); text-decoration: none; white-space: pre;">five<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.93pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.45pt; position: var(--position); text-decoration: none; white-space: pre;"> extension option with a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1008" name="abvx:BorrowingsMaturityDeferralPeriod" format="ixt-sec:durwordsen" id="f-2151"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.97pt; position: var(--position); text-decoration: none; white-space: pre;">one<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.4pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.92pt; position: var(--position); text-decoration: none; white-space: pre;"> deferral of the principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">repayment, with the following conditions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Rate: <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.61pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1009" decimals="4" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2152">0.58</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.44pt; position: var(--position); text-decoration: none; white-space: pre;"> per annum excluding insurance and state guaranteed premium, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">State guaranteed premium of <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1009" decimals="-3" name="abvx:BorrowingsStateGuaranteedPremium" format="ixt:num-dot-decimal" scale="3" id="f-2153">138</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.82pt; position: var(--position); text-decoration: none; white-space: pre;"> to be paid by installments over the contract period starting in June 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Reimbursement by yearly installments from June 2021 to June 2026. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The benefit resulting from the low interest nature of the award as a subsidy was recognized as other income during the period ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2020 for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1010" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" format="ixt:num-dot-decimal" scale="3" id="f-2154">377</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.02pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The variation in the PGE loan over the periods ended December 31, 2022, 2023 and 2024 is primarily related to the reimbursement of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 291.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">capital and interests. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 315.06pt;" id="ia894b143b6fc4522a0483350194c625e_436"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.06pt; width: 612pt;"><ix:continuation id="f-1597-27" continuedAt="f-1597-28"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.7. Conditional advances<span style="display: inline-block; height: 6.77pt;"></span><span id="iba53c4e4c3cf4d75aecc5662b6c4ae1d"></span></span></ix:continuation></div><ix:continuation id="f-1597-28" continuedAt="f-1597-29"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 341.76pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfBorrowingsExplanatory" id="f-2155" continuedAt="f-2155-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances as of December 31, 2022, 2023 and 2024 are as follows<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 347.39pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 8.25pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2155-1"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 352.76pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 382.77pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 383.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIONAL ADVANCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">RNP VIR &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1011" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2156">4,171</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1012" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2157">4,232</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1013" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:fixed-zero" scale="3" id="f-2158">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CARENA &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1014" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2159">2,454</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1015" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2160">2,485</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1016" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:fixed-zero" scale="3" id="f-2161">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">EBOLA &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1017" decimals="-3" name="abvx:ConditionalAdvances" scale="3" id="f-2162">158</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1018" decimals="-3" name="abvx:ConditionalAdvances" scale="3" id="f-2163">55</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1019" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:fixed-zero" scale="3" id="f-2164">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total conditional advances<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2165">6,783</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2166">6,771</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:fixed-zero" scale="3" id="f-2167">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">RNP-VIR &#8211; Bpifrance <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Under the RNP-VIR contract, the Group was eligible to receive up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1020" decimals="-5" name="abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity" format="ixt:num-dot-decimal" scale="6" id="f-2168">6.3</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.26pt; position: var(--position); text-decoration: none; white-space: pre;"> in conditional advances to further develop methods <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the discovery of new molecules for the treatment of viral infectious diseases through the development of the &#8220;Modulation of RNA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">biogenesis&#8221; platform. As of December 31, 2022, the Group had received <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.49pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1021" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2169">4,032</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.58pt; position: var(--position); text-decoration: none; white-space: pre;">, of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1022" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2170">1,756</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.42pt; position: var(--position); text-decoration: none; white-space: pre;"> was received in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">September 2017, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1023" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2171">346</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.81pt; position: var(--position); text-decoration: none; white-space: pre;"> in August&#160;2018 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1024" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2172">1,930</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.48pt; position: var(--position); text-decoration: none; white-space: pre;"> in November 2019. The repayment of these funds is spread from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 572.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the date on which the repayments are called by BPI. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Bpifrance claimed the reimbursement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-111" decimals="-3" name="abvx:RepaymentOfExcessConditionalAdvancesClaimed" format="ixt:num-dot-decimal" scale="3" id="f-2173">1,241</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.42pt; position: var(--position); text-decoration: none; white-space: pre;"> corresponding to overpayments of conditional advances and subsidies (for which the Group had not incurred the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding R&amp;D expenses) and agreed to waive <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-111" decimals="2" name="abvx:PercentageOfConditionalAdvancesWaived" scale="-2" id="f-2174">60</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.73pt; position: var(--position); text-decoration: none; white-space: pre;"> of the remaining advances of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1025" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2175">2,945</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.79pt; position: var(--position); text-decoration: none; white-space: pre;"> and accrued interests, w<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.27pt; position: var(--position); text-decoration: none; white-space: pre;">hich <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 630.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">resulted in a subsidy<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.87pt; position: var(--position); text-decoration: none; white-space: pre;"> income of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-111" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" format="ixt:num-dot-decimal" scale="3" id="f-2176">1,872</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.19pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate (see Note 18). <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.81pt; position: var(--position); text-decoration: none; white-space: pre;">The outstanding amount was fully repaid by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group during the second half of 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">See Note 25.2. Commitments under BPI conditional advances. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-62<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-29" continuedAt="f-1597-30"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CARENA &#8211; Bpifrance <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Under the CARENA agreement, the Group was eligible to receive up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1026" decimals="-3" name="abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity" format="ixt:num-dot-decimal" scale="3" id="f-2177">3,840</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.03pt; position: var(--position); text-decoration: none; white-space: pre;"> to develop a therapeutic HIV treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program with ABX464. As of December 31, 2022, the Group received <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1027" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2178">2,187</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.86pt; position: var(--position); text-decoration: none; white-space: pre;">, of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1028" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2179">1,150</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.7pt; position: var(--position); text-decoration: none; white-space: pre;"> was received in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 2013, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1029" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2180">1,008</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.63pt; position: var(--position); text-decoration: none; white-space: pre;"> in September 2014 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1030" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2181">29</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.64pt; position: var(--position); text-decoration: none; white-space: pre;"> received in June 2016. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The repayment of the advance is spread from the date on which the repayments are called by Bpifrance. An additional repayment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">provided for based on the income the Group generates through this research and development program.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Bpifrance granted an additional amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.83pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-113" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2182">1,068</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.92pt; position: var(--position); text-decoration: none; white-space: pre;"> payable to the Group to reimburse additional expenses incurred as part of the project, and agreed to waive <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 541.3pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-113" decimals="2" name="abvx:PercentageOfConditionalAdvancesWaived" scale="-2" id="f-2183">60</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.63pt; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the remaining conditional advance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1031" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2184">3,255</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.28pt; position: var(--position); text-decoration: none; white-space: pre;"> and accrued interests, which resulted in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.35pt; position: var(--position); text-decoration: none; white-space: pre;"> a subsidy income<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.23pt; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-113" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" format="ixt:num-dot-decimal" scale="3" id="f-2185">2,251</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.65pt; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the aggregate (see Note 18).<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.35pt; position: var(--position); text-decoration: none; white-space: pre;"> The outstanding amount was fully repaid by the Group during the second half of 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 225.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">EBOLA &#8211; Bpifrance <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Under the Bpifrance and Occitanie region joint aid agreement, the Group received a total of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1032" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2186">390</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.53pt; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1033" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2187">300</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.95pt; position: var(--position); text-decoration: none; white-space: pre;"> as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2017 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1034" decimals="-3" name="abvx:ProceedsFromConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2188">90</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.56pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2019). The reimbursement is spread from 2019 to June 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 303.76pt;" id="ia894b143b6fc4522a0483350194c625e_439"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 303.76pt; width: 612pt;"><ix:continuation id="f-1597-30" continuedAt="f-1597-31"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.8. Lease liabilities<span style="display: inline-block; height: 6.77pt;"></span><span id="id18a1eac803844cea0e7d449e6dfcfb5"></span></span></ix:continuation></div><ix:continuation id="f-1597-31" continuedAt="f-1597-32"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.06pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfLeasesForLesseeTableTextBlock" id="f-2189" continuedAt="f-2189-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The variations in lease liabilities are set forth below:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2189-1"><div style="position: var(--position); top: 342.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 301.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 216.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 56.84pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.18pt; position: var(--position); text-decoration: none; white-space: pre;">LEASE LIABILITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 12pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-12" decimals="-3" name="ifrs-full:LeaseLiabilities" scale="3" id="f-2190">214</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:IncreaseInLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2191">1,476</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 64.05pt;"></span></span><span style="left: 66.67999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:DecreaseInLeaseLiabilities" scale="3" id="f-2192">305</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2193">1,384</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 78pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:IncreaseInLeaseLiabilities" scale="3" id="f-2194">350</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 90pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.05pt;"></span></span><span style="left: 60.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:DecreaseInLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2195">1,194</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 102pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:LeaseLiabilities" scale="3" id="f-2196">540</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 123pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:IncreaseInLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2197">2,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 135pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 64.05pt;"></span></span><span style="left: 66.67999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:DecreaseInLeaseLiabilities" scale="3" id="f-2198">398</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 147pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2199">2,363</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 527.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities mainly relate the Group&#8217;s headquarters in Paris, the Boston office entered into in November 2023, the Montpellier <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 538.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">offices entered into in April 2024, the new Paris headquarters entered into in May 2024 and to a lesser extent to vehicles, parking lots <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and printer<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.56pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">s (Note 8).</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 561.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The lease for the Group&#8217;s corporate headquarters in Paris, France at 5 Rue de la Baume, 75008 Paris ended in August 2022. A new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">lease for premises at 7-11 Boulevard Haussmann, 75009 Paris started in July 2022. It <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.03pt; position: var(--position); text-decoration: none; white-space: pre;">had<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.46pt; position: var(--position); text-decoration: none; white-space: pre;"> a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1035" name="abvx:LeaseDurationPeriod" format="ixt-sec:durwordsen" id="f-2200"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.89pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.85pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.37pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, with a tacit renewal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 587.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">option for approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1035" name="abvx:LeaseTacitRenewalPeriod" format="ixt-sec:durwordsen" id="f-2201">two years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.97pt; position: var(--position); text-decoration: none; white-space: pre;"> and the possibility to break the contract <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.55pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1035" name="abvx:LeaseBreakClausePeriod" format="ixt-sec:durwordsen" id="f-2202">one year</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.67pt; position: var(--position); text-decoration: none; white-space: pre;"> before the end. As of December 31, 2022, per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Management, renewal and termination options were not reasonably certain due to the forecasted development of the Group, which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">could lead the Group to relocate at the end of the initial term. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.88pt; position: var(--position); text-decoration: none; white-space: pre;">In September 2023, the Group was notified by the lessor of its intention <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 627.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to exercise its option to terminate the contract on June 30, 2024. Consequently, the Group reassessed the lease term and recorded a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">decrease in the related lease liability by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1036" decimals="-3" name="abvx:DecreaseInLeaseLiabilitiesThroughModificationOfTerm" format="ixt:num-dot-decimal" scale="3" id="f-2203">622</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and a corresponding decrease in the right of use asset for the same amount. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">A new lease for different premises within the same building was entered into on May 2, 2024. It has a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1037" name="abvx:LeaseDurationPeriod" format="ixt-sec:durwordsen" id="f-2204"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.58pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.54pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.06pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, and no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">renewal option. The Group also benefits from an initial eight-month rent-free period.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 691.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In November 2023, the Subsidiary entered a lease contract for its new Boston offices. It has a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1038" name="abvx:LeaseDurationPeriod" format="ixt-sec:durwordsen" id="f-2205"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.98pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.97pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.49pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, with an option to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">renew the contract for an additional period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-2206">one</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.09pt; position: var(--position); text-decoration: none; white-space: pre;"> or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.42pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1040" name="abvx:LeaseExtensionPeriod" format="ixt-sec:durwordsen" id="f-2207">two years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.99pt; position: var(--position); text-decoration: none; white-space: pre;">. In December 2024, the Group exercised its option to extend the lease <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-63<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-32" continuedAt="f-1597-33"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">up until December 2026. P<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.41pt; position: var(--position); text-decoration: none; white-space: pre;">er Management, additional renewal options are not reasonably certain due to the forecasted development of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Subsidiary, which may lead it to relocate at the end of the current term.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In April 2024, the Company entered a lease contract for a new Montpellier office. It has an initial <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1041" name="abvx:LeaseDurationPeriod" format="ixt-sec:durwordsen" id="f-2208"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.73pt; position: var(--position); text-decoration: none; white-space: pre;">six<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.39pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.91pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, with the option for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Company to terminate the lease at any time with a <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1041" name="abvx:LeaseBreakClausePeriod" format="ixt-sec:durwordsen" id="f-2209"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.74pt; position: var(--position); text-decoration: none; white-space: pre;">six<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.4pt; position: var(--position); text-decoration: none; white-space: pre;">-month<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.27pt; position: var(--position); text-decoration: none; white-space: pre;"> notice period, and a tacit renewal option for an additional period of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1041" name="abvx:LeaseTacitRenewalPeriod" format="ixt-sec:durwordsen" id="f-2210">six years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">. Based on Management's estimate, the initial lease period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1041" name="abvx:LeaseDurationPeriod" format="ixt-sec:durwordsen" id="f-2211">six years</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.28pt; position: var(--position); text-decoration: none; white-space: pre;"> is considered reasonably certain and is therefore used <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the measurement of the lease liability.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024, the lease liabilities of the Paris headquarters and Boston offices represented <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1042" decimals="2" name="abvx:LeaseLiabilityPercentageOfTotal" scale="-2" id="f-2212">97</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.05pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 536.05pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1043" decimals="2" name="abvx:LeaseLiabilityPercentageOfTotal" scale="-2" id="f-2213">93</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.38pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1044" decimals="2" name="abvx:LeaseLiabilityPercentageOfTotal" scale="-2" id="f-2214">93</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.33pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total lease liability, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Lease expenses related to contracts for which a lease liability and right of use asset is recognized under IFRS 16 were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:ExpenseOnLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2215">424</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.05pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:ExpenseOnLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2216">548</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:ExpenseOnLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2217">730</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.11pt; position: var(--position); text-decoration: none; white-space: pre;">for<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.77pt; position: var(--position); text-decoration: none; white-space: pre;"> the years ended December 31, 2022, 2023 and 2024, respectively. They were recognized for (i) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:DepreciationExpenseLease" format="ixt:num-dot-decimal" scale="3" id="f-2218">414</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.59pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:DepreciationExpenseLease" format="ixt:num-dot-decimal" scale="3" id="f-2219">498</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.18pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:DepreciationExpenseLease" format="ixt:num-dot-decimal" scale="3" id="f-2220">788</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.2pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.7pt; position: var(--position); text-decoration: none; white-space: pre;">as<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.02pt; position: var(--position); text-decoration: none; white-space: pre;"> Depreciation expenses and (ii) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2221">10</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.39pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2222">13</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.98pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2223">61</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559pt; position: var(--position); text-decoration: none; white-space: pre;"> as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest expenses, for the years ended December 31, 2022, 2023 and 2024, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Lease expenses related to short-term lease contracts and low value assets that are not included in the valuation of the lease liability <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.74000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" format="ixt:num-dot-decimal" scale="3" id="f-2224">331</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" format="ixt:num-dot-decimal" scale="3" id="f-2225">334</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.92pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" format="ixt:num-dot-decimal" scale="3" id="f-2226">352</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.94pt; position: var(--position); text-decoration: none; white-space: pre;"> for the years ended December 31, 2022, 2023 and 2024, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 292.16pt;" id="ia894b143b6fc4522a0483350194c625e_442"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292.16pt; width: 612pt;"><ix:continuation id="f-1597-33" continuedAt="f-1597-34"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.9. Prosynergia earn-out liability<span style="display: inline-block; height: 6.77pt;"></span><span id="i4b6734fd51c649bba629e570a8bbfd4c"></span></span></ix:continuation></div><ix:continuation id="f-1597-34" continuedAt="f-1597-35"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The terms of the share purchase acquisition of Prosynergia include a possible earn out triggered in the event the Company&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market capitalization is in excess of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-6" name="abvx:EarnOutMarketCapitalizationThreshold" format="ixt:num-dot-decimal" scale="6" id="f-2227">300</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: var(--position); text-decoration: none; white-space: pre;"> (evaluated at certain specified record dates), a listing of the Company&#8217;s shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on Nasdaq or a merger and acquisition transaction prior to March 31, 2023. The amount of the earn-out is equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.26pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-63" decimals="2" name="abvx:EarnOutPercentage" scale="-2" id="f-2228">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.59pt; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 353.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">difference between the Company&#8217;s market capitalization and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-6" name="abvx:EarnOutMarketCapitalizationThreshold" format="ixt:num-dot-decimal" scale="6" id="f-2229">300</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.82pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to a maximum amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-5" name="abvx:EarnOutMaximumAmount" format="ixt:num-dot-decimal" scale="6" id="f-2230">4.0</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.97pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">This potential earn-out payment was measured at fair value on April 1, 2022 (acquisition date), for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 389.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-63" decimals="-3" name="abvx:EarnOutAtFairValueAssetsAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-2231">1,446</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">, and included in the acquisition cost.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the fair value of the earn-out liability was insignificant. Since its payment was not triggered by March <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 437.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2023, the liability was extinguished and thus reversed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Prosynergia earn-out liability is measured at fair value using a Black-Scholes valuation model. <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" id="f-2232" continuedAt="f-2232-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.67pt; position: var(--position); text-decoration: none; white-space: pre;">The main data and <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2232-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions are the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 485.46pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 404.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 254.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia earn-out<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of April 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">period ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 52.27pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 52.27pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-1045" decimals="3" sign="-" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2233">0.3</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 54.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 54.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1046" decimals="3" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2234">2.3</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Market capitalization (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 45.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1047" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2235">403,118</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 45.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1048" decimals="-3" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2236">135,952</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 60.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price (&#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 60.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eurPerShare" contextRef="c-1049" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2237">24.15</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 60.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eurPerShare" contextRef="c-1050" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-2238">6.18</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Time to maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.61pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="y" contextRef="c-1051" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-2239">1</ix:nonFraction> year<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 39.5pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="y" contextRef="c-1052" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-2240">0.25</ix:nonFraction> years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 56.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 56.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1053" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2241">61</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 56.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 56.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1054" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-2242">44</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 105.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1055" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="0" id="f-2243">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 105.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1056" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="0" id="f-2244">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.37pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of the earn-out liability (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.64pt;"></span></span><span style="left: 44.27pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1057" decimals="-3" sign="-" name="abvx:EarnOutAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2245">1,446</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-138" decimals="-3" name="abvx:EarnOutAtFairValue" format="ixt:fixed-zero" scale="3" id="f-2246">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650.71pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of April 1, 2022, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.16pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1058" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2247">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.12pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-1059" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2248">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.3pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.77pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1060" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2249">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.73pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.71pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">result in an increase of the earn-out liability fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.96000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1061" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2250">12</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.55pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1062" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2251">132</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.14pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.07pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1063" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2252">17</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.16pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.21pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the fair value of the earn-out liability is approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.4pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-138" decimals="-3" name="ifrs-full:FinancialLiabilities" scale="0" id="f-2253">0</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.4pt; position: var(--position); text-decoration: none; white-space: pre;">. Using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.21pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-964" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2254">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.96pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-965" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2255">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.14pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.61pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-966" decimals="2" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2256">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.57pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would result in an increase of the earn-out liability fair value by an amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.21pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1064" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2257"><ix:nonFraction unitRef="eur" contextRef="c-1065" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2258"><ix:nonFraction unitRef="eur" contextRef="c-1066" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" format="ixt:num-dot-decimal" scale="3" id="f-2259">1</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.77pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-64<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 95.19pt;" id="ia894b143b6fc4522a0483350194c625e_445"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 95.19pt; width: 612pt;"><ix:continuation id="f-1597-35" continuedAt="f-1597-36"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.10. Royalty certificates <span style="display: inline-block; height: 6.77pt;"></span><span id="i929f6094c7664e43aa619f2ae0112c78"></span></span></ix:continuation></div><ix:continuation id="f-1597-36" continuedAt="f-1597-37"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.49pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On September 2, 2022, the Group completed a financing of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.78pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1067" decimals="-3" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2260">49,162</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.87pt; position: var(--position); text-decoration: none; white-space: pre;">, consisting of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="transaction" contextRef="c-1067" decimals="INF" name="abvx:OtherLiabilitiesNumberOfTransactions" format="ixt-sec:numwordsen" scale="0" id="f-2261">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.71pt; position: var(--position); text-decoration: none; white-space: pre;"> transactions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 142.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a reserved capital increase of a gross amount of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1068" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-2262">46,231</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.34pt; position: var(--position); text-decoration: none; white-space: pre;"> through the issuance of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.31pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1068" decimals="0" name="abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="f-2263">5,530,000</ix:nonFraction><span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.31pt; position: var(--position); text-decoration: none; white-space: pre;"> new shares with a <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">nominal value of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-1067" decimals="2" name="ifrs-full:ParValuePerShare" scale="0" id="f-2264">0.01</ix:nonFraction><span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.7pt; position: var(--position); text-decoration: none; white-space: pre;"> per share at a subscription price of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="c-1067" decimals="2" name="abvx:EquityIssuanceSubscriptionPricePerShare" scale="0" id="f-2265">8.36</ix:nonFraction><span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.81pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; and <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 169.77pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an issue of royalty certificates with a subscription price amounting to <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.83pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1069" decimals="-3" name="abvx:NetProceedsFromSaleOfRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2266">2,931</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.92pt; position: var(--position); text-decoration: none; white-space: pre;">. The royalty certificates give right to <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their holders to royalties equal to <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.28pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1069" decimals="2" name="abvx:RoyaltyCertificatePercentageOfFutureSales" scale="-2" id="f-2267">2</ix:nonFraction>%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.61pt; position: var(--position); text-decoration: none; white-space: pre;"> of the future net sales of obefazimod (worldwide and for all indications) as from the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.65pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization of such product. The amount of royalties that may be paid under the royalty certificates is capped at <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.09pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1070" decimals="-3" name="abvx:RoyaltyCertificateMaximumAmount" format="ixt:num-dot-decimal" scale="3" id="f-2268">172,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.73pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Related transaction costs amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1071" decimals="-3" name="ifrs-full:ShareIssueRelatedCost" format="ixt:num-dot-decimal" scale="3" id="f-2269">3,280</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.05pt; position: var(--position); text-decoration: none; white-space: pre;"> and are recorded in equity, since entirely related to the reserved capital <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 245.93pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.93pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, following a change in the estimate of future royalty cash flows, the certificates&#8217; amortized cost was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.13pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">remeasured at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:NonCurrentRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2270">3,287</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, using the original EIR calculated at the date of issuance. The change in estimate resulted in a decrease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the related interest expense by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:DecreaseInInterestExpenseOnRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2271">100</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.29pt; position: var(--position); text-decoration: none; white-space: pre;"> over the period ended December 31, 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.73pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In April 2023, the Group reassessed its estimate of the probability of future royalty cash flows related to the royalty c<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.65pt; position: var(--position); text-decoration: none; white-space: pre;">ertificates. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 549pt; position: var(--position); text-decoration: none; white-space: pre;">This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 326.93pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">change reflected the higher probability to reach the objectives of the development and commercialization plans following the recent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.13pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">changes in management and governance, as well as results from its Phase 2b open-label maintenance trial in UC, as released in April <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.33pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2023. Subsequently, in June 2023 and December 2023, the Group revised <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.01pt; position: var(--position); text-decoration: none; white-space: pre;">the development and commercialization plans of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.53pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and reassessed its estimate of future royalty cash flows accordingly. These changes in estimates resulted in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.73pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement of the certificates&#8217; amortized costs, using the original EIR of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.91pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-663" decimals="2" name="abvx:RoyaltyCertificatesEIR" scale="-2" id="f-2272">34</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.24pt; position: var(--position); text-decoration: none; white-space: pre;"> calculated at the date of issuance, which led to an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.93pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase by<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.21000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.71000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2273">6,421</ix:nonFraction> thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.8pt; position: var(--position); text-decoration: none; white-space: pre;"> of the royalty certificates liability. The expense was recorded within the interest expenses in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.13pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Statements of Income (Loss).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, the total interest expense (including the unwinding of discount) related to royalty certificates amounts to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:InterestExpenseOnRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2274">8,942</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> for the year ended December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">I<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.33pt; position: var(--position); text-decoration: none; white-space: pre;">n December 2024, the Group <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.12pt; position: var(--position); text-decoration: none; white-space: pre;">revised <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.47pt; position: var(--position); text-decoration: none; white-space: pre;">the development and commercialization plans of obefazimod to take into account the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.03pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">progression in the ongoing clinical trials, reassessment of the commercial schedule and forecasts&#160; and reassessed its estimate of future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.23pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">royalty cash flows accordingly.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> This<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.68pt; position: var(--position); text-decoration: none; white-space: pre;"> change in estimate resulted in a remeasurement of the certificates&#8217; amortized costs, using the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">original EIR of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-663" decimals="2" name="abvx:RoyaltyCertificatesEIR" scale="-2" id="f-2275">34</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.32pt; position: var(--position); text-decoration: none; white-space: pre;"> calculated at the date of issuance, which led to a decrease <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.67pt; position: var(--position); text-decoration: none; white-space: pre;">by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.17pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2276">3,404</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.26pt; position: var(--position); text-decoration: none; white-space: pre;"> of the royalty certificates liability.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.92pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.63pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The expense was recorded within the interest expenses in the Statements of Income (Loss).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, the total interest expense related to royalty certificates (including the effect of the unwinding of discount, amounting to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:UnwindingOfDiscountOnRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-2277">4,198</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">) amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:InterestExpenseOnRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2278">794</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.14pt; position: var(--position); text-decoration: none; white-space: pre;"> for the year ended December 31, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.47pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the royalty certificates, calculated using the same model as their initial measurement, amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-662" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2279">3,307</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 560.31pt; position: var(--position); text-decoration: none; white-space: pre;"> as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of December 31<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.37pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, 2022 and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-663" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2280">12,395</ix:nonFraction> thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> as </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.21pt; position: var(--position); text-decoration: none; white-space: pre;">of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.01pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-664" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2281">7,313</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.1pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 601.07pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the royalty certificates is based on the net present value of royalties, which depends on assumptions made by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.27pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group with regards to the probability of success of its studies (&#8220;POS&#8221;), the commercialization budget of obefazimod (&#8220;peak <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.47pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">penetration&#8221;) and the Group's WACC. In addition, royalty projections have been adjusted to reflect any difference between the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 634.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s value derived from management projections and the Group&#8217;s market <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.34pt; position: var(--position); text-decoration: none; white-space: pre;">capitalization<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.11pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.87pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The decrease in fair value of the royalty certificates over the year ended December 31, 2024 is mainly driven by the decrease in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.07pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group's share price over the period.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.07pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, using the same assumptions with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1074" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-2282">5</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1075" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2283">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (best case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.27pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1076" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2284">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC would result in a change in the royalty certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-1077" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2285">299</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.15pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.47pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="eur" contextRef="c-1078" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2286">221</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.22pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.65pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1079" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2287">191</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.57pt; position: var(--position); text-decoration: none; white-space: pre;">.&#160; Using the same assumptions with a decrease of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.97pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1074" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-4" id="f-2288">5</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.3pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.9pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1075" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-2" id="f-2289">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.56pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (worst <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-65<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-37" continuedAt="f-1597-38"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">case scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.72pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1076" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-2" id="f-2290">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.38pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC would result in a change in the royalty certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1077" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2291">294</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.23pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1078" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2292">347</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.92pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-1079" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2293">205</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.57pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.98pt; position: var(--position); text-decoration: none; white-space: pre;">2023, using the same assumptions with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1080" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-2294">5</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1081" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2295">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (best case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.61pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1082" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2296">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.57pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-1083" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2297">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.1pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.6pt; position: var(--position); text-decoration: none; white-space: pre;">sha<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.92pt; position: var(--position); text-decoration: none; white-space: pre;">re price would result in a change in the royalty certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 518.6pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="eur" contextRef="c-1084" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2298">1104</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.22pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-1085" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2299">1757</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.44pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1086" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2300">577</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.36pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.78999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-1087" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2301">1325</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: var(--position); text-decoration: none; white-space: pre;">. Using the same assumptions with a decrease of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1080" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-4" id="f-2302">5</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.24pt; position: var(--position); text-decoration: none; white-space: pre;"> points of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.34pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1081" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-2" id="f-2303">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (worst case scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.88pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1082" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-2" id="f-2304">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eurPerShare" contextRef="c-1083" decimals="INF" name="abvx:AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="0" id="f-2305">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share price would result in a change in the royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1084" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2306">1104</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1085" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2307">2311</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.86pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.86pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eur" contextRef="c-1086" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2308">612</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.08pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1087" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2309">1325</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.11pt; position: var(--position); text-decoration: none; white-space: pre;"> of December 31, 2024, using the same assumptions with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1088" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-4" id="f-2310">5</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1089" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2311">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (best case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.61pt; position: var(--position); text-decoration: none; white-space: pre;">+<ix:nonFraction unitRef="number" contextRef="c-1090" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="-2" id="f-2312">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.57pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+<ix:nonFraction unitRef="eurPerShare" contextRef="c-1091" decimals="INF" name="abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="0" id="f-2313">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.1pt; position: var(--position); text-decoration: none; white-space: pre;"> share price would result in a change in the royalty certificates fair value by respectively &#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1092" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2314">572</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.22pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.85pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1093" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2315">1,735</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1094" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2316">314</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.86pt; position: var(--position); text-decoration: none; white-space: pre;"> and &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.91999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1095" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2317">1,160</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: var(--position); text-decoration: none; white-space: pre;">. Using the same assumptions with a decrease of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1088" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-4" id="f-2318">5</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.24pt; position: var(--position); text-decoration: none; white-space: pre;"> points of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.34pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1089" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-2" id="f-2319">5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (worst case scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.88pt; position: var(--position); text-decoration: none; white-space: pre;">-<ix:nonFraction unitRef="number" contextRef="c-1090" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="-2" id="f-2320">1</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eurPerShare" contextRef="c-1091" decimals="INF" name="abvx:AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="0" id="f-2321">1</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share price would result in a change in the royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1092" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2322">572</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1093" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2323">2,527</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.36pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.99pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1094" decimals="-3" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2324">332</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.58pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.01pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-<ix:nonFraction unitRef="eur" contextRef="c-1095" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2325">1,160</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 274.66pt;" id="ia894b143b6fc4522a0483350194c625e_451"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.66pt; width: 612pt;"><ix:continuation id="f-1597-38" continuedAt="f-1597-39"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.11. Change in financial liabilities<span style="display: inline-block; height: 6.77pt;"></span><span id="ieb6c790a36b64ce287edfb0289428b41"></span></span></ix:continuation></div><ix:continuation id="f-1597-39" continuedAt="f-1597-40"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.96pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" id="f-2326" continuedAt="f-2326-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in financial liabilities, excluding derivative instruments, are presented below as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.28pt; position: var(--position); text-decoration: none; white-space: pre;">2022, 2023 a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.21pt; position: var(--position); text-decoration: none; white-space: pre;">nd 2024:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2326-1" continuedAt="f-2326-2"><div style="position: var(--position); top: 309.16pt; width: 612pt;"><div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;">euros) <span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 44.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9.52pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES (excluding <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 28.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives instruments)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 21.75pt; width: 41.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.65pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.39pt; position: var(--position); text-decoration: none; white-space: pre;">bond loans<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.93pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 21.75pt; width: 42.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.76pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.65pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.86pt; position: var(--position); text-decoration: none; white-space: pre;">Claret <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.68pt; position: var(--position); text-decoration: none; white-space: pre;">convertible <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.6pt; position: var(--position); text-decoration: none; white-space: pre;">notes <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.36pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.6pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA )<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.28pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.03pt; position: var(--position); text-decoration: none; white-space: pre;">Claret bond <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.22pt; position: var(--position); text-decoration: none; white-space: pre;">loans<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;">Heights <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.3pt; position: var(--position); text-decoration: none; white-space: pre;">convertible <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.23pt; position: var(--position); text-decoration: none; white-space: pre;">notes<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.81pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.31pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.4pt; position: var(--position); text-decoration: none; white-space: pre;">advances <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.17pt; position: var(--position); text-decoration: none; white-space: pre;">BPI<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 12.46pt; position: var(--position); text-decoration: none; white-space: pre;">Lease <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.41pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.94pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.18pt; position: var(--position); text-decoration: none; white-space: pre;">earn-out <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;">liability<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.34pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;">certificates<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.03pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 66pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.21pt;"></span></span><span style="left: 15.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1096" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2327">21,110</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1097" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2328">18,816</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 66pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1098" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2329">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1099" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2330">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1100" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2331">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1101" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2332">4,742</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1102" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2333">6,770</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1103" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="f-2334">214</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1104" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2335">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1105" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2336">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-12" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2337">51,653</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 87pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1106" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2338">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1107" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2339">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 87pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1108" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2340">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1109" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2341">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1110" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2342">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1111" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2343">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1112" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2344">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1113" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2345">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1114" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2346">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1115" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2347">2,931</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2348">2,931</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 99pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1106" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2349">9,410</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1107" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2350">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 99pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1108" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2351">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1109" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2352">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1110" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2353">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1111" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2354">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1112" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2355">90</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1113" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2356">305</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1114" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2357">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1115" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2358">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2359">9,806</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 111pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1106" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2360">2,456</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1107" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2361">1,496</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 111pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1108" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2362">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1109" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2363">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1110" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2364">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1111" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2365">54</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1112" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2366">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1113" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2367">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1114" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2368">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1115" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2369">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2370">4,006</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 123pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.21pt;"></span></span><span style="left: 19.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1106" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2371">3,738</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1107" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2372">2,636</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 123pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1108" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2373">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1109" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2374">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1110" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2375">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1111" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2376">150</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1112" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2377">102</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1113" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2378">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1114" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2379">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1115" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2380">356</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2381">6,983</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">recognition of earn-out <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">liability <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 144pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1106" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2382">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1107" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2383">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 144pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1108" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2384">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1109" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2385">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1110" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2386">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1111" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2387">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1112" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2388">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1113" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2389">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1114" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2390">1,446</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1115" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2391">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2392">1,446</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: fair <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1106" xsi:nil="true" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" id="f-2393"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1107" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2394">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 174.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1108" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2395">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1109" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2396">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1110" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2397">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1111" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2398">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1112" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2399">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1113" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2400">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1114" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2401">1,446</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1115" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2402">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2403">1,446</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1106" xsi:nil="true" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" id="f-2404"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1107" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2405">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 195.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1108" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2406">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1109" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2407">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1110" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2408">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1111" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2409">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1112" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2410">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1113" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2411">1,476</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1114" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2412">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1115" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2413">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2414">1,476</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 216.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.21pt;"></span></span><span style="left: 15.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1116" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2415">12,982</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1117" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2416">19,957</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 216.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1118" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2417">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1119" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2418">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1120" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2419">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1121" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2420">4,838</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1122" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2421">6,783</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1123" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2422">1,384</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1124" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2423">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1125" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2424">3,287</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2425">49,231</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1126" xsi:nil="true" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" id="f-2426"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1127" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2427">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 237.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1128" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2428">23,119</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1129" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2429">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1130" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2430">35,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1131" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2431">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1132" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2432">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1133" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2433">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1134" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2434">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2435">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2436">58,119</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 249.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 10.55pt;"></span></span><span style="left: 13.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1126" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2437">11,635</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1127" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2438">23,238</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 249.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1128" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2439">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1129" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2440">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1130" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2441">2,188</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1131" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2442">1,250</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1132" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2443">110</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1133" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2444">573</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1134" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2445">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2446">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2447">38,993</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 261.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 261.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1126" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2448">2,278</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1127" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2449">1,602</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 261.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.05pt;"></span></span><span style="left: 24.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1128" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2450">818</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1129" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2451">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1130" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2452">525</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1131" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2453">43</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1132" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2454">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1133" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2455">12</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1134" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2456">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2457">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2458">5,278</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 273.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1126" xsi:nil="true" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" id="f-2459"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1127" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2460">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 273.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1128" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2461">1,046</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1129" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2462">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1130" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2463">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1131" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2464">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1132" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2465">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1133" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2466">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1134" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2467">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2468">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2469">1,046</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">recognition of earn-out <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">liability <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1126" xsi:nil="true" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" id="f-2470"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1127" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2471">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 294.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1128" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2472">1,005</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1129" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2473">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1130" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2474">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1131" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2475">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1132" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2476">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1133" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2477">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1134" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2478">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2479">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2480">1,005</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 325.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: fair <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 325.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.21pt;"></span></span><span style="left: 25.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1126" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2481">170</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1127" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2482">3,069</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 325.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1128" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2483">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1129" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2484">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1130" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2485">212</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1131" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2486">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1132" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2487">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1133" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2488">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1134" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2489">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2490">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2491">3,027</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 346.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1126" xsi:nil="true" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" id="f-2492"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1127" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2493">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 346.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1128" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2494">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1129" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2495">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1130" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2496">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1131" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2497">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1132" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2498">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1133" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2499">272</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1134" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2500">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1072" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2501">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2502">272</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 367.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 367.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1135" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2503">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1136" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2504">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 367.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1137" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2505">21,643</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1138" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2506">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1139" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2507">29,605</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1140" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2508">3,678</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1141" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2509">6,771</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1142" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="f-2510">540</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1143" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2511">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1144" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2512">12,229</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2513">74,466</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-66<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-40" continuedAt="f-1597-41"><ix:continuation id="f-2326-2"><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;">euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES (excluding <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives instruments)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 52.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 52.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1135" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2514">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1136" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2515">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 52.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1137" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2516">21,643</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1138" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2517">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1139" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2518">29,605</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1140" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2519">3,678</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1141" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2520">6,771</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1142" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="f-2521">540</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1143" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2522">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1144" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2523">12,229</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2524">74,466</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" id="f-2525"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2526">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 73.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2527">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2528">47,444</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2529">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2530">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2531">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2532">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2533">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2534">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2535">47,444</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" id="f-2536"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2537">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 85.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2538">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2539">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2540">8,750</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2541">1,250</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2542">2,708</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2543">459</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2544">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2545">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2546">13,167</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" id="f-2547"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2548">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 97.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2549">2,250</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2550">3,639</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2551">1,772</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2552">18</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2553">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2554">17</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2555">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2556">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2557">7,696</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 50.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 109.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.09pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.69pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">classification of embedded <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.29pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives as separate <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.89pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derivative financial <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" id="f-2558"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2559">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 109.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2560">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2561">3,204</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2562">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2563">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2564">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2565">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2566">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2567">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2568">3,204</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: (gain)/<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">loss on recognition or <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derecognition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" id="f-2569"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2570">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 159.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2571">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2572">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2573">590</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2574">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2575">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2576">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2577">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2578">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2579">590</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" id="f-2580"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2581">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 190.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.71pt;"></span></span><span style="left: 21.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2582">3,977</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2583">5,800</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2584">1,714</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2585">77</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2586">7</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2587">61</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2588">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2589">4,198</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2590">15,834</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 211.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">amortized cost <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" id="f-2591"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2592">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 211.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2593">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2594">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2595">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2596">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2597">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2598">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2599">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2600">3,404</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2601">3,404</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 242.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: other <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">fair value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" id="f-2602"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2603">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 242.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2604">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2605">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2606">1,367</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2607">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2608">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2609">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2610">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2611">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2612">1,367</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 263.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes&#160;: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">subsidies <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 263.25pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1145" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2613">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2614">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 263.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2615">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2616">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2617">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2618">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2619">4,070</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2620">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2621">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2622">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2623">4,070</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 284.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.81pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" id="f-2624"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2625">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 284.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2626">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2627">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2628">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2629">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2630">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2631">2,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2632">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2633">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2634">2,221</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 306pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes : Effect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of the change in foreign <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">currency exhange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="eur" contextRef="c-1145" xsi:nil="true" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" id="f-2635"></ix:nonFraction></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1146" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2636">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 306pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1147" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2637">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1148" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2638">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1149" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2639">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1150" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2640">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1151" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2641">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1152" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2642">17</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1153" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2643">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1073" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2644">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="3" id="f-2645">17</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 338.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 338.25pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1154" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2646">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1155" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2647">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 338.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1156" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2648">23,370</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1157" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2649">46,401</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1158" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2650">21,574</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1159" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2651">2,488</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1160" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2652">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1161" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2653">2,363</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1162" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-2654">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1163" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2655">13,023</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 9.96pt;"></span></span><span style="left: 12.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-2656">109,218</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.89pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> the year ended December 31, 2023, proceeds from the issuance of the Kreos / Claret OCABSA are presented net of transaction </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">costs, amounting to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.49pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1164" decimals="-3" name="ifrs-full:PaymentsForDebtIssueCosts" format="ixt:num-dot-decimal" scale="3" id="f-2657">1,881</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.58pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. Net proceeds from convertible loan notes of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.99pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:NetProceedsFromConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2658">55,841</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.49pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> disclosed in the Consolidated Statements of </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Cash Flows also include transaction fees of (i) </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1165" decimals="-3" name="ifrs-full:PaymentsForDebtIssueCosts" format="ixt:num-dot-decimal" scale="3" id="f-2659">750</ix:nonFraction>&#160;thousands</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.05pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> related to the Kreos / Claret B and C tranches and recorded in prepaid </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">expenses (see Note 10) and (ii) </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-867" decimals="-3" name="ifrs-full:PaymentsForDebtIssueCosts" format="ixt:num-dot-decimal" scale="3" id="f-2660">1,528</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> related to the Heights convertible notes.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For the year ended December 31, 2023, repayments of the OCEANE are presented net of the repurchase of the conversion option, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">value</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.629999999999995pt; position: var(--position); text-decoration: none; white-space: pre;">d at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.83pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1166" decimals="-3" name="abvx:RepurchaseOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2661">1,762</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> on the date of repayment, which is presented in Note 15.12. The aggregate repayment amounts to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1167" decimals="-3" name="abvx:RepaymentsOfConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2662">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the year ended December 31,2024, proceeds from the issuance of the Kreos / Claret tranches B and C bond loans are presented net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of transaction costs and deposits (corresponding to the prepayments of half of the last debt installments on issuance date) included in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the debt discount using the EIR method, and amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-312" decimals="-3" name="ifrs-full:PaymentsForDebtIssueCosts" format="ixt:num-dot-decimal" scale="3" id="f-2663">1,475</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.71pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1168" decimals="-3" name="ifrs-full:PaymentsForDebtIssueCosts" format="ixt:num-dot-decimal" scale="3" id="f-2664">1,081</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.23pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. Net proceeds from non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bond loans of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:GrossProceedsFromNonConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2665">48,544</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.85pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand disclosed in the Unaudited Condensed Consolidated Statements of Cash Flows do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 602.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">include transaction fees of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.13pt; position: var(--position); text-decoration: none; white-space: pre;"> (i) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1169" decimals="-3" name="ifrs-full:PaymentsForDebtIssueCosts" format="ixt:num-dot-decimal" scale="3" id="f-2666">500</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.15pt; position: var(--position); text-decoration: none; white-space: pre;"> related to the Kreos / Claret tranche A-B warrants classified as prepaid expenses as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 670.91pt;" id="ia894b143b6fc4522a0483350194c625e_454"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.91pt; width: 612pt;"><ix:continuation id="f-1597-41" continuedAt="f-1597-42"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.12. Change in derivative instruments<span style="display: inline-block; height: 6.77pt;"></span><span id="i7c8dd868c7e14b8cb97f5969c9da56f9"></span></span></ix:continuation></div><ix:continuation id="f-1597-42" continuedAt="f-1597-43"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.71pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" id="f-2667" continuedAt="f-2667-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in derivative instruments, are presented below as of December 31, 2022, 2023 and 2024 :<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-67<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-43" continuedAt="f-1597-44"><ix:continuation id="f-2667-1"><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 44pt; position: var(--position); top: 0pt; width: 534.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 96pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 7.68pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.1pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 37.78pt; position: var(--position); text-decoration: none; white-space: pre;">euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.22pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos B BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.57pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.78pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 29.17pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.56pt; position: var(--position); text-decoration: none; white-space: pre;">conversion option<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.53pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.67pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.57pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum Return <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.97pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.01pt; position: var(--position); text-decoration: none; white-space: pre;">Indemnifications<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.77pt; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DERIVATIVE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.6pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">INSTRUMENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1170" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2668">2,478</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1171" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2669">1,525</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1172" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2670">5,929</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1173" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2671">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1174" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2672">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-12" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2673">9,932</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1175" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2674">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1176" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2675">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1177" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2676">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1178" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2677">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1179" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2678">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2679">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1175" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2680">2,203</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1176" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2681">1,376</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1177" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2682">5,787</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 87.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1178" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2683">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1179" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2684">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2685">9,366</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1180" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" scale="3" id="f-2686">275</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1181" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" scale="3" id="f-2687">149</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-57" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" scale="3" id="f-2688">142</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 99.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-643" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2689">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-653" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2690">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" scale="3" id="f-2691">566</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Issuance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1182" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2692">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1183" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2693">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1166" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2694">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1184" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2695">3,585</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1185" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2696">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2697">3,585</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1182" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" scale="3" id="f-2698">986</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1183" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" scale="3" id="f-2699">440</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1166" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2700">1,620</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 132.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1184" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2701">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1185" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2702">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2703">3,046</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1182" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2704">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1183" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2705">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1166" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2706">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 144.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1184" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2707">1,006</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1185" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2708">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2709">1,006</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 156.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Repurchases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1182" decimals="-3" name="abvx:RepurchaseOfDerivativeInstruments" scale="3" id="f-2710">489</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1183" decimals="-3" name="abvx:RepurchaseOfDerivativeInstruments" scale="3" id="f-2711">339</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1166" decimals="-3" name="abvx:RepurchaseOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2712">1,762</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 156.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1184" decimals="-3" name="abvx:RepurchaseOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2713">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1185" decimals="-3" name="abvx:RepurchaseOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2714">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:RepurchaseOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2715">2,591</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Exercises<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1182" decimals="-3" name="abvx:ExerciseOfDerivativeInstruments" scale="3" id="f-2716">771</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1183" decimals="-3" name="abvx:ExerciseOfDerivativeInstruments" scale="3" id="f-2717">250</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1166" decimals="-3" name="abvx:ExerciseOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2718">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 168.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1184" decimals="-3" name="abvx:ExerciseOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2719">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1185" decimals="-3" name="abvx:ExerciseOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2720">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:ExerciseOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2721">1,021</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1186" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2722">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1187" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2723">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-652" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2724">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 180.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-644" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2725">2,579</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-654" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2726">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2727">2,579</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1186" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2728">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1187" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2729">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-652" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2730">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 201.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-644" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2731">2,579</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-654" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2732">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2733">2,579</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Issuance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1188" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2734">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1189" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2735">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1190" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2736">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1191" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:fixed-zero" scale="3" id="f-2737">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1192" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2738">2,158</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:IssuanceOfDerivativeInstruments" format="ixt:num-dot-decimal" scale="3" id="f-2739">2,158</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1188" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2740">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1189" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2741">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1190" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2742">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1191" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2743">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1192" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2744">1,462</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2745">1,462</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1188" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2746">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1189" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2747">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1190" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2748">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1191" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2749">1,413</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1192" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-2750">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-2751">1,413</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1193" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2752">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1194" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2753">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-58" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-2754">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-645" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2755">1,166</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-655" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2756">3,620</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2757">4,786</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 355.31pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Details related to these instruments' accounting treatments and terms and conditions are set forth in Notes 15.1 to 15.5.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, t<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.31pt; position: var(--position); text-decoration: none; white-space: pre;">he holders<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.66pt; position: var(--position); text-decoration: none; white-space: pre;"> opted for the cashless exercise option of the Kreos A&amp;B BSAs they held. At this date, the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercised warrants <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.11pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1195" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" format="ixt:num-dot-decimal" scale="3" id="f-2758">1,850</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.03pt; position: var(--position); text-decoration: none; white-space: pre;"> (see line items "Repurchases" and "Exercises") <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.05pt; position: var(--position); text-decoration: none; white-space: pre;">was reclassified from derivative financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities to equity. As of this date, due to the put option being exercised by the holders, the fair value of the Kreos A&amp;B BSAs is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deemed equal to their intrinsic value, which is equal to the difference between the share price on May 24, 2023 and their exercise <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 469.35pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.48pt; position: var(--position); text-decoration: none; white-space: pre;">As of August 24, 2023, the date at which the OCEANE were reimbursed, their conversion option had a fair value of <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-998" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2759">1,762</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.79pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 8.25pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 503.67pt;" id="ia894b143b6fc4522a0483350194c625e_457"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.67pt; width: 612pt;"><ix:continuation id="f-1597-44" continuedAt="f-1597-45"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.13. Breakdown of financial liabilities by maturity<span style="display: inline-block; height: 6.77pt;"></span><span id="i25f84399b4e1453298aac16ba73c09ba"></span></span></ix:continuation></div><ix:continuation id="f-1597-45" continuedAt="f-1597-46"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.97pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities" id="f-2761" continuedAt="f-2761-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities" id="f-2760" continuedAt="f-2760-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following are the remaining contractual maturities of financial liabilities as of December 31, 2022, 2023 and 2024. The amounts <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-2761-1" continuedAt="f-2761-2"><ix:continuation id="f-2760-1" continuedAt="f-2760-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.17pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are gross and undiscounted, and include contractual interest payments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 561.67pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 147pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 0pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 184.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 21pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.39pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.83pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.64pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-628" decimals="-3" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="3" id="f-2762">12,982</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-628" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2763">14,098</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1196" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2764">9,034</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 54pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1197" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2765">5,065</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1198" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2766">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1199" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2767">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-57" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2768">19,957</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-57" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2769">31,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1200" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2770">1,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 66pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1201" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2771">1,500</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1202" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2772">28,000</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1203" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2773">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-637" decimals="-3" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="3" id="f-2774">4,838</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 78pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-637" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2775">5,173</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1204" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2776">1,293</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 78pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1205" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2777">1,293</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 78pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1206" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2778">2,586</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1207" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2779">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1208" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2780">6,783</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1208" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2781">6,813</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1209" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2782">3,697</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 90pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1210" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2783">1,490</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 90pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1211" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2784">1,626</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1212" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2785">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:NonCurrentRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2786">3,287</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2787">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1213" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2788">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1214" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2789">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 102pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1215" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2790">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1216" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2791">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2792">1,384</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2793">1,403</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1213" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2794">558</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 114pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1214" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2795">557</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 114pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1215" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2796">289</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1216" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="f-2797">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" scale="3" id="f-2798">566</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="f-2799">566</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1213" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="f-2800">142</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 126pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1214" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2801">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 126pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1215" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="f-2802">424</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1216" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2803">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2804">49,797</ix:nonFraction><span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2805">59,053</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1213" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2806">16,223</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 138pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1214" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2807">9,905</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 138pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1215" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2808">32,925</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1216" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2809">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-68<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-1597-46"><ix:continuation id="f-2761-2"><ix:continuation id="f-2760-2"><div style="position: var(--position); top: 82.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 187.09pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 160.66pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.67pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.56pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.55pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.89pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.01pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.46pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 21pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.8pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.58pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.58pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-59" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2810">29,605</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-59" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2811">36,750</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1217" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2812">10,522</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1218" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2813">9,997</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1219" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2814">16,231</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 54pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1220" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2815">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-644" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2816">21,643</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-644" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2817">30,903</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1221" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2818">2,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1222" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2819">2,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1223" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2820">26,403</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 66pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1224" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2821">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-638" decimals="-3" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="3" id="f-2822">3,678</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 86.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-638" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2823">3,880</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1225" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2824">1,293</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1226" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2825">1,293</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 86.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1227" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2826">1,293</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 86.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1228" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2827">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1229" decimals="-3" name="abvx:ConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-2828">6,771</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 98.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1229" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2829">6,813</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1230" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2830">3,697</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1231" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2831">1,490</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 98.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1232" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2832">1,626</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 98.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1233" decimals="-3" name="abvx:ConditionalAdvancesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2833">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:NonCurrentRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2834">12,229</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 110.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2835">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1234" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2836">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1235" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2837">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 110.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1236" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2838">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 110.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1237" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2839">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:LeaseLiabilities" scale="3" id="f-2840">540</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 122.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2841">575</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1234" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2842">406</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1235" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2843">162</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 122.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.96pt;"></span></span><span style="left: 52.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1236" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2844">7</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 122.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1237" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="f-2845">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2846">2,579</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 134.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2847">2,579</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1234" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2848">2,579</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1235" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2849">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 134.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1236" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2850">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 134.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1237" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2851">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2852">77,045</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 146.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2853">81,500</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1234" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2854">20,747</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1235" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2855">15,192</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 146.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1236" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2856">45,561</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 146.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1237" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2857">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 257.81pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 543pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 0pt; width: 401.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 188.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.32pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.09pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-60" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2858">21,574</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 54pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-60" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2859">24,063</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1238" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2860">8,750</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1239" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2861">8,750</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1240" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2862">6,563</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1241" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2863">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-645" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2864">23,370</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 66pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-645" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2865">30,653</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1242" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2866">2,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1243" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2867">19,943</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1244" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2868">8,460</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1245" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2869">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1246" decimals="-3" name="abvx:ConvertibleLoansNotes" format="ixt:num-dot-decimal" scale="3" id="f-2870">46,401</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 86.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1246" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2871">58,080</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1247" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2872">24,016</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1248" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2873">25,715</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1249" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2874">8,348</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1250" decimals="-3" name="abvx:ConvertibleLoansNotesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2875">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-639" decimals="-3" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="3" id="f-2876">2,488</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 98.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-639" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2877">2,586</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1251" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2878">1,293</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1252" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2879">1,293</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1253" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2880">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1254" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2881">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:NonCurrentRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-2882">13,023</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 110.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 57.21pt;"></span></span><span style="left: 59.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2883">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1255" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2884">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1256" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2885">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1257" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2886">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1258" decimals="-3" name="abvx:RoyaltyCertificatesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2887">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2888">2,363</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 122.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2889">2,512</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1255" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2890">993</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1256" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2891">996</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1257" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2892">516</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1258" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="f-2893">7</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2894">4,786</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 134.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2895">4,786</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1255" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2896">1,166</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1256" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2897">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1257" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2898">3,620</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1258" decimals="-3" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2899">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 30.96pt;"></span></span><span style="left: 33.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2900">114,004</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 146.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.21pt;"></span></span><span style="left: 41.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2901">122,680</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1255" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2902">38,468</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1256" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2903">56,698</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1257" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2904">27,507</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1258" decimals="-3" name="abvx:FinancialLiabilitiesUndiscountedCashFlows" scale="3" id="f-2905">7</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 421.06pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The contractual cash flows above do not include potential future royalty payments related to the royalty certificates, amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.99pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="2" name="abvx:RoyaltyCertificatePercentageOfFutureSales" scale="-2" id="f-2906">2</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.32pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the future net sales of obefazimod (worldwide and for all indications). The amount of royalties that may be paid under the royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates is capped at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1067" decimals="-3" name="abvx:RoyaltyCertificateMaximumAmount" format="ixt:num-dot-decimal" scale="6" id="f-2907">172.0</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate. Royalty payments are expected to take place before the expiry date of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates, which is <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1067" name="abvx:RoyaltyCertificateExpirationPeriod" format="ixt-sec:duryear" id="f-2908">15</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.44pt; position: var(--position); text-decoration: none; white-space: pre;"> after their issuance date (September 2, 2037), and would be included in the "<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.18pt; position: var(--position); text-decoration: none; white-space: pre;">f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.51pt; position: var(--position); text-decoration: none; white-space: pre;">ro<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.84pt; position: var(--position); text-decoration: none; white-space: pre;">m 2 to 5 year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.5699999999999pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.46pt; position: var(--position); text-decoration: none; white-space: pre;">" and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">"longer than 5 years" maturity categories according to management's projections.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 514.26pt;" id="ia894b143b6fc4522a0483350194c625e_460"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 514.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 16. <span style="display: inline-block; height: 6.77pt;"></span><span id="i0609ce86f5bc457ca6f7b9368aeda8c4"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEmployeeBenefitsExplanatory" id="f-2909" continuedAt="f-2909-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligations<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2909-1" continuedAt="f-2909-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 534.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligations include the liability for the defined benefit plan, measured based on the provisions stipulated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">under the applicable collective agreements, i.e. the French pharmaceutical industry&#8217;s collective agreement. This commitment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">only applies to employees subject to French law. <span style="display: inline-block; height: 6.93pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" id="f-2910" continuedAt="f-2910-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.28pt; position: var(--position); text-decoration: none; white-space: pre;">The main actuarial assumptions used to measure the retirement benefit <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2910-1" continuedAt="f-2910-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 570.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">obligations are as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-69<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-2909-2"><ix:continuation id="f-2910-2"><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ACTUARIAL ASSUMPTIONS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement age<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1259" name="ifrs-full:ActuarialAssumptionOfRetirementAge2019" format="ixt-sec:duryear" id="f-2911">65</ix:nonNumeric> years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1260" name="ifrs-full:ActuarialAssumptionOfRetirementAge2019" format="ixt-sec:duryear" id="f-2912">63</ix:nonNumeric> years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1261" name="ifrs-full:ActuarialAssumptionOfRetirementAge2019" format="ixt-sec:duryear" id="f-2913">65</ix:nonNumeric> years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1262" name="ifrs-full:ActuarialAssumptionOfRetirementAge2019" format="ixt-sec:duryear" id="f-2914">63</ix:nonNumeric> years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1263" name="ifrs-full:ActuarialAssumptionOfRetirementAge2019" format="ixt-sec:duryear" id="f-2915">65</ix:nonNumeric> years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1264" name="ifrs-full:ActuarialAssumptionOfRetirementAge2019" format="ixt-sec:duryear" id="f-2916">64</ix:nonNumeric> years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 61.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Collective agreement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Discount Rate (IBoxx Corporates AA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2917">0.90</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2918">3.34</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2919">3.40</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Mortality rate table<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Salary increase rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1265" decimals="2" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2920">3</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1266" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2921">2.55</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1267" decimals="2" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2922">3</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1268" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2923">2.55</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1269" decimals="2" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2924">3</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1270" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2925">2.55</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 56.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 25.06pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Turnover rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;">Decreasing from <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1271" decimals="4" name="abvx:ActuarialAssumptionOfExpectedRatesOfTurnover" scale="-2" id="f-2926">5.80</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"> at <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;">20 years-old to <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1272" decimals="4" name="abvx:ActuarialAssumptionOfExpectedRatesOfTurnover" scale="-2" id="f-2927">0.05</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"> from <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;">55 years-old<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;">Decreasing from <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1273" decimals="4" name="abvx:ActuarialAssumptionOfExpectedRatesOfTurnover" scale="-2" id="f-2928">5.80</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"> at <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;">20 years-old to <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1274" decimals="4" name="abvx:ActuarialAssumptionOfExpectedRatesOfTurnover" scale="-2" id="f-2929">0.05</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"> from <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;">55 years-old<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.72pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.68pt; position: var(--position); white-space: pre;">Decreasing rates by age <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 18.97pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.16pt; position: var(--position); white-space: pre;">and <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.4pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1275" decimals="4" name="abvx:ActuarialAssumptionOfExpectedRatesOfTurnover" format="ixt:fixed-zero" scale="-2" id="f-2930">zero</ix:nonFraction><span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 43.870000000000005pt; position: var(--position); white-space: pre;"> from age 55, <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.18pt; position: var(--position); white-space: pre;">generating an average exit <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 41.47pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.53pt; position: var(--position); white-space: pre;">rate for 2025 of <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.97pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="abvx:ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" scale="-2" id="f-2931">2.05</ix:nonFraction>%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.21000000000001pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195.75pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employee contribution rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="2" name="abvx:ActuarialAssumptionOfEmployeeContributionRate" scale="-2" id="f-2932">45</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="2" name="abvx:ActuarialAssumptionOfEmployeeContributionRate" scale="-2" id="f-2933">45</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="abvx:ActuarialAssumptionOfEmployeeContributionRate" scale="-2" id="f-2934">45</ix:nonFraction>%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.61pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" id="f-2935" continuedAt="f-2935-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in the projected benefit obligation for the periods presented were as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2935-1"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 313.91pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 322.71pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 321.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 153.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 168pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 25.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 0pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.72pt; position: var(--position); text-decoration: none; white-space: pre;">RETIREMENT BENEFIT OBLIGATIONS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 12pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1276" decimals="-3" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="f-2936">693</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 33pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1277" decimals="-3" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="3" id="f-2937">143</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 45pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 157.96pt;"></span></span><span style="left: 160.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1277" decimals="-3" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="f-2938">8</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 57pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1277" decimals="-3" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="f-2939">235</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 69pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1278" decimals="-3" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="f-2940">610</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 90pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1279" decimals="-3" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="3" id="f-2941">109</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 102pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1279" decimals="-3" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="f-2942">23</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 114pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1279" decimals="-3" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="f-2943">112</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 126pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1280" decimals="-3" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="f-2944">629</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 147pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1281" decimals="-3" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="3" id="f-2945">115</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 159pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1281" decimals="-3" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="f-2946">22</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 171pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 151.3pt;"></span></span><span style="left: 153.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1281" decimals="-3" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="3" id="f-2947">41</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 183pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1281" decimals="-3" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="f-2948">31</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 195pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1282" decimals="-3" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="f-2949">756</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 551.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Employees in the U.S. benefit from defined contribution plans (401(k)).<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 576.41pt;" id="ia894b143b6fc4522a0483350194c625e_463"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576.41pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Note 17. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" id="f-2950" continuedAt="f-2950-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 79.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Payables and other current liabilities<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><div style="position: absolute; top: 594.91pt;" id="ia894b143b6fc4522a0483350194c625e_466"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.91pt; width: 612pt;"><ix:continuation id="f-2950-1" continuedAt="f-2950-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 17.1. Trade payables and other current liabilities<span style="display: inline-block; height: 6.77pt;"></span><span id="idcc8371f18b54538a715889bed3a5f64"></span></span></ix:continuation></div><ix:continuation id="f-2950-2" continuedAt="f-2950-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.71pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" id="f-2951" continuedAt="f-2951-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-70<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-2950-3" continuedAt="f-2950-4"><ix:continuation id="f-2951-1"><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 447pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TRADE PAYABLES AND OTHER CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-2952">8,216</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-2953">21,953</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-2954">30,748</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Accrued invoices<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:AccrualsClassifiedAsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-2955">7,250</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:AccrualsClassifiedAsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-2956">25,269</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:AccrualsClassifiedAsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-2957">13,049</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 70.21pt;"></span></span><span style="left: 72.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:OtherCurrentPayablesIncludingAdjustments" scale="3" id="f-2958">9</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 67.55pt;"></span></span><span style="left: 70.17999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" sign="-" name="abvx:OtherCurrentPayablesIncludingAdjustments" scale="3" id="f-2959">1</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:OtherCurrentPayablesIncludingAdjustments" scale="3" id="f-2960">26</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="3" id="f-2961">15,475</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="3" id="f-2962">47,221</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="3" id="f-2963">43,824</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">No discount was applied to payables and related accounts for which maturity does not exceed one year. As a result, their fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.51pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">approximates their carrying amount. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in trade payable and other current liabilities over the year ended December 31, 2024 is mainly due to the increase in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operating expenses over the period. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 253.01pt;" id="ia894b143b6fc4522a0483350194c625e_469"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.01pt; width: 612pt;"><ix:continuation id="f-2950-4" continuedAt="f-2950-5"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 17.2. Tax and employee-related payables<span style="display: inline-block; height: 6.77pt;"></span><span id="i580b0f10a0a74186b2b84677d34024e5"></span></span></ix:continuation></div><ix:continuation id="f-2950-5"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.81pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" id="f-2964" continuedAt="f-2964-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables are presented below:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2964-1"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 284.11pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 295.44pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 195pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TAX AND EMPLOYEE-RELATED PAYABLES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employee-related payables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" format="ixt:num-dot-decimal" scale="3" id="f-2965">1,348</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" format="ixt:num-dot-decimal" scale="3" id="f-2966">3,694</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" format="ixt:num-dot-decimal" scale="3" id="f-2967">2,742</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Social security and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="3" id="f-2968">840</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" format="ixt:num-dot-decimal" scale="3" id="f-2969">2,251</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" format="ixt:num-dot-decimal" scale="3" id="f-2970">1,783</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other tax and related payments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentPayablesOnOtherTaxAndRelatedPayments" scale="3" id="f-2971">112</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentPayablesOnOtherTaxAndRelatedPayments" scale="3" id="f-2972">127</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentPayablesOnOtherTaxAndRelatedPayments" scale="3" id="f-2973">184</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:CurrentTaxAndEmployeeBenefitLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2974">2,300</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:CurrentTaxAndEmployeeBenefitLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2975">6,073</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:CurrentTaxAndEmployeeBenefitLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2976">4,709</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 401.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in employee-related, social security and other payables over the year ended December 31, 2023 is mainly related to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.39pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;">changes in the management team and recruitment of additional experienced employees, including C-levels, over the period (see Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 423.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;">3.3 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 58.1pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance and management &#8211; February-August 2023)<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.3pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.94pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 460.09pt;" id="ia894b143b6fc4522a0483350194c625e_472"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 460.09pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 18. <span style="display: inline-block; height: 6.77pt;"></span><span id="if3279828e52a46ed88ca94ca67c8c14a"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory" id="f-2977" continuedAt="f-2977-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2977-1" continuedAt="f-2977-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.89pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" id="f-2978" continuedAt="f-2978-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income is composed as below:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2978-1"><div style="font-size: 12pt; position: var(--position); top: 501.89pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 90.75pt;"></span></span><div style="font-size: 0pt; left: 38.5pt; position: var(--position); top: 0pt; width: 381pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OPERATING INCOME<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit ("CIR")<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:IncomeFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-2979">4,476</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:IncomeFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-2980">4,493</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:IncomeFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-2981">6,651</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" id="f-2982">29</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" id="f-2983">81</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" format="ixt:num-dot-decimal" scale="3" id="f-2984">4,140</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="3" id="f-2985">78</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="3" id="f-2986">47</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="3" id="f-2987">1,657</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total operating income<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-2988">4,583</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-2989">4,621</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-2990">12,449</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 608.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income is composed as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit (&#8220;CIR&#8221;) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group carries out research and development projects. As such, it has benefited from a research tax credit for the years ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Decem<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ber 31, 2022, 2023 and 2024 for an amount of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1283" decimals="-3" name="abvx:IncomeFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-2991">4,476</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1284" decimals="-3" name="abvx:IncomeFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-2992">4,493</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.04pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.47pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1285" decimals="-3" name="abvx:IncomeFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-2993">5,668</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.56pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, respectively (see Note </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 675.86pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">4.9). During the year ended December 31, 2024, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.94pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">the</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> Group also received an additional tax credit payment related to the 2021 tax year </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">for an amount of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.39pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1286" decimals="-3" name="abvx:IncomeFromResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-2994">984</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> after a claim from the Group following a clarification of "public subsidy" definition.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 709.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 6.94pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-71<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-2977-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies primarily relate to the Bpifrance RNP-VIR and CARENA conditional advances, the repayments of which were partly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">waived by Bpifrance in June 2024, f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.15pt; position: var(--position); text-decoration: none; white-space: pre;">or<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.98pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-111" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" format="ixt:num-dot-decimal" scale="3" id="f-2995">1,872</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.07pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-113" decimals="-3" name="ifrs-full:RevenueFromGovernmentGrants" format="ixt:num-dot-decimal" scale="3" id="f-2996">2,251</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.59pt; position: var(--position); text-decoration: none; white-space: pre;"> resp<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.74pt; position: var(--position); text-decoration: none; white-space: pre;">ectively (see Notes 3.3 and 15.7).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the year ended December 31, 2024, the line item "Other" mainly includes issuance, cancellation and depositary service fees <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">collected from ADSs holders by Citibank, who is acting as the Group's exclusive depositary for its publicly listed and freely traded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs. As part of the depositary agreement between Citibank and the Group, the latter is entitled to receive a portion of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">aforementioned fees collected by Citibank.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 239.66pt;" id="ia894b143b6fc4522a0483350194c625e_475"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 19. <span style="display: inline-block; height: 6.77pt;"></span><span id="i3ca665ffc9d74520ae5db32d9170f62c"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory" id="f-2997" continuedAt="f-2997-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Operating expenses<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><div style="position: absolute; top: 277.59pt;" id="ia894b143b6fc4522a0483350194c625e_478"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.59pt; width: 612pt;"><ix:continuation id="f-2997-1" continuedAt="f-2997-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 19.1. Sales and marketing<span style="display: inline-block; height: 6.77pt;"></span><span id="i36c21550f6ab4c06a26eca50fdd758de"></span></span></ix:continuation></div><ix:continuation id="f-2997-2" continuedAt="f-2997-3"><div style="position: var(--position); top: 310.89pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfExpensesByNatureExplanatory" id="f-2998" continuedAt="f-2998-1" escape="true"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">SALES AND MARKETING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1287" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:fixed-zero" scale="3" id="f-2999">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1288" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3000">1,710</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1289" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3001">2,323</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1287" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:fixed-zero" scale="3" id="f-3002">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1288" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3003">4,012</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1289" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3004">2,699</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other sales and marketing expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1287" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:fixed-zero" scale="3" id="f-3005">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1288" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="3" id="f-3006">709</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1289" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="3" id="f-3007">932</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sales &amp; Marketing<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1287" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:fixed-zero" scale="3" id="f-3008">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1288" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3009">6,431</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1289" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3010">5,954</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 432.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the years ended December 31, 2023 and 2024, sales and marketing expenses amount<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.38pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3011">6,431</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.65pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.17pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3012">5,954</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.1700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.76pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively. The decrease was primarily <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.86pt; position: var(--position); text-decoration: none; white-space: pre;">driven by the restructuring of the Group's sales and marketing department part way through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61pt; position: var(--position); text-decoration: none; white-space: pre;">These expenses consist primarily of consulting costs associated with market research in preparation for the Group's potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future sales and commercialization efforts in the U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group did not incur any sales and marketing expense for the year ended December 31, 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 510.64pt;" id="ia894b143b6fc4522a0483350194c625e_481"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.64pt; width: 612pt;"><ix:continuation id="f-2997-3" continuedAt="f-2997-4"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 19.2. Research and development<span style="display: inline-block; height: 6.77pt;"></span><span id="i02d53339738d4dda95bdbdb57157a5b7"></span></span></ix:continuation></div><ix:continuation id="f-2997-4" continuedAt="f-2997-5"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.94pt; width: 612pt;"><ix:continuation id="f-2998-1" continuedAt="f-2998-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses break down as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation></div><ix:continuation id="f-2998-2" continuedAt="f-2998-3"><div style="position: var(--position); top: 558.34pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">RESEARCH AND DEVELOPMENT EXPENSES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sub-contracting, studies and research<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1290" decimals="-3" name="abvx:SubContractingStudiesAndResearchExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3013">38,858</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="abvx:SubContractingStudiesAndResearchExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3014">85,726</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="abvx:SubContractingStudiesAndResearchExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3015">110,993</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1290" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3016">3,072</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3017">8,048</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3018">18,455</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1290" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3019">4,246</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3020">6,561</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3021">12,581</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Intellectual property fees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1290" decimals="-3" name="abvx:IntellectualPropertyFees" format="ixt:num-dot-decimal" scale="3" id="f-3022">1,187</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="abvx:IntellectualPropertyFees" format="ixt:num-dot-decimal" scale="3" id="f-3023">1,645</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="abvx:IntellectualPropertyFees" format="ixt:num-dot-decimal" scale="3" id="f-3024">1,741</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other research and development expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1290" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="3" id="f-3025">931</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3026">1,196</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3027">2,762</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1290" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3028">48,295</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3029">103,176</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3030">146,532</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-72<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-2997-5" continuedAt="f-2997-6"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses consist primarily of the following items: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Personnel expenses, including salaries, benefits, and share-based compensation expenses, for employees engaged in <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">research and development activities; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Sub-contracting, collaboration and consultant expenses that primarily include the cost of third-party contractors such as <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">CROs who conduct our non-clinical studies and clinical trials, and research related to proprietary platforms, as well as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">investigative sites and consultants that conduct our preclinical studies and clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses incurred under agreements with contract manufacturing organizations (&#8220;CMOs&#8221;), including manufacturing <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">scale-up expenses and the cost of acquiring and manufacturing preclinical study and clinical trial materials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses relating to preclinical studies and clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses relating to regulatory affairs; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Allocated expenses for facility costs, including rent, utilities and maintenance; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses relating to the implementation of the quality assurance system. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 255.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in research and development expenses for the years ended December 31, 2023 and 2024 is primarily due to (i) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 266.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase in UC expenses (of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.34pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="abvx:IncreaseDecreaseInUlcerativeColitisExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3031">45,233</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.43pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.86pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="abvx:IncreaseDecreaseInUlcerativeColitisExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3032">32,030</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.36pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand), due to the progress of Phase 3 clinical trials for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod in UC, (ii) the increase in CD expenses (of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="abvx:IncreaseDecreaseInCrohnsDiseaseResearchExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3033">2,734</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.64pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.07pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="abvx:IncreaseDecreaseInCrohnsDiseaseResearchExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3034">4,620</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.57pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand), due to the planning costs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and progression of the Phase 2b CD trial, and (iii) the increase in transversal activities related to the overall expansion of the research <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and development headcount to support the Group's organizational growth and the issuance of new equity awards to officers and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 311.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">employees in research and development (of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1291" decimals="-3" name="abvx:IncreaseDecreaseInTransversalActivities" format="ixt:num-dot-decimal" scale="3" id="f-3035">4,477</ix:nonFraction> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.29pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1292" decimals="-3" name="abvx:IncreaseDecreaseInTransversalActivities" format="ixt:num-dot-decimal" scale="3" id="f-3036">8,233</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.22pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand). <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 336.96pt;" id="ia894b143b6fc4522a0483350194c625e_484"></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 336.96pt; width: 612pt;"><ix:continuation id="f-2997-6" continuedAt="f-2997-7"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 19.3. General and administrative<span style="display: inline-block; height: 8.25pt;"></span><span id="ibf0d702474584c3fafbf3a5cbc6a8b0d"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 198.66pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span></ix:continuation></div><ix:continuation id="f-2997-7" continuedAt="f-2997-8"><div style="position: var(--position); top: 363.59pt; width: 612pt;"><ix:continuation id="f-2998-3"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GENERAL AND ADMINISTRATIVE EXPENSES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1293" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3037">1,403</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1294" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3038">13,105</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1295" decimals="-3" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="3" id="f-3039">19,434</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1293" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3040">2,624</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1294" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3041">6,393</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1295" decimals="-3" name="ifrs-full:ProfessionalFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-3042">7,990</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other general and administrative expenses&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1293" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3043">3,466</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1294" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3044">2,893</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1295" decimals="-3" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3045">5,522</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative expenses&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1293" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3046">7,492</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1294" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3047">22,391</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1295" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3048">32,946</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative expenses consist primarily of personnel-related expenses, including salaries, benefits and share-based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">compensation expenses, for personnel other than employees engaged in research and development activities. General and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">administrative expenses also include fees for professional services, mainly related to audit and legal services, consulting costs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">communications and travel costs, allocated expenses for facility costs, including rent, utilities and maintenance, directors&#8217; attendance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fees, and insurance costs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in general and administrative expenses for the years ended December 31, 2023 and 2024 is primarily due to the increase <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 556.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in personnel costs of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.68pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1294" decimals="-3" name="abvx:IncreaseDecreaseInEmployeeBenefitsExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3049">11,702</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.18pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1295" decimals="-3" name="abvx:IncreaseDecreaseInEmployeeBenefitsExpenses" format="ixt:num-dot-decimal" scale="3" id="f-3050">6,329</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.7pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.2pt; position: var(--position); text-decoration: none; white-space: pre;">t<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.97pt; position: var(--position); text-decoration: none; white-space: pre;">housand, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.29pt; position: var(--position); text-decoration: none; white-space: pre;">resulting from the issuance of new equity awards to officers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.74pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and employees, management changes that occurred over the period (see Notes 3.2 and 3.3 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 398.09pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance and management<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.63pt; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and the increased G&amp;A headcount to support the expansion of the overall organization, as well as increased legal and professional fees <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.14pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and other costs associated with operating as a dual-listed public company.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-73<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-2997-8"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" id="f-3051" continuedAt="f-3051-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Our principal audit fees and services are set forth below. For the years ended December 31, 2023 and 2024, they include fees due our <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3051-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">joint statutory auditor Agili3f, in addition to PricewaterhouseCoopers Audit. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 106.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 524.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 275.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/></tr><tr style="height: 34.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.18pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 86.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statutory Auditor, certification of individual and consolidated financial statements<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issuer<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-3052">100</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AuditorsRemunerationForAuditServices" format="ixt:num-dot-decimal" scale="6" id="f-3053">1,848</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AuditorsRemunerationForAuditServices" format="ixt:num-dot-decimal" scale="6" id="f-3054">1,144</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 64.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other procedures required by law<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issuer<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:AuditorsRemunerationForOtherServices" scale="6" id="f-3055">740</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AuditorsRemunerationForOtherServices" scale="6" id="f-3056">492</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AuditorsRemunerationForOtherServices" scale="6" id="f-3057">89</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:AuditorsRemuneration" scale="6" id="f-3058">840</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:AuditorsRemuneration" format="ixt:num-dot-decimal" scale="6" id="f-3059">2,340</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:AuditorsRemuneration" format="ixt:num-dot-decimal" scale="6" id="f-3060">1,233</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation><div style="position: absolute; top: 245.81pt;" id="ia894b143b6fc4522a0483350194c625e_487"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 245.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 20. <span style="display: inline-block; height: 6.77pt;"></span><span id="i78b83ee0e3534180be5e12bb7babab16"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory" id="f-3061" continuedAt="f-3061-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Employees<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3061-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.31pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfAverageNumberOfEmployeesTableTextBlock" id="f-3062" continuedAt="f-3062-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s average workforce during the periods ended December 31, 2022, 2023 and 2024 was as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3062-1"><div style="position: var(--position); top: 287.06pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 360pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">HEADCOUNTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">France<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-1296" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3063">23</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-1297" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3064">28</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-1298" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3065">38</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-1299" decimals="0" name="ifrs-full:AverageNumberOfEmployees" format="ixt:fixed-zero" scale="0" id="f-3066">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-1300" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3067">12</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-1301" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3068">29</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-10" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3069">23</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-11" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3070">40</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);"><ix:nonFraction unitRef="employee" contextRef="c-1" decimals="0" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="f-3071">67</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-74<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 70.56pt;" id="ia894b143b6fc4522a0483350194c625e_490"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 21. <span style="display: inline-block; height: 6.77pt;"></span><span id="i07eae03995034a3896cfa9b0f0331fdc"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="f-3072" continuedAt="f-3072-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Financial gain (loss)<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3072-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.06pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" id="f-3073" continuedAt="f-3073-1" escape="true"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The financial loss breaks down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3073-1"><div style="position: var(--position); top: 112.66pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 510pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 279pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 87.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL GAIN (LOSS)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on Kreos 1 &amp; 2 straight bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:InterestExpenseOnBonds" format="ixt:num-dot-decimal" scale="3" id="f-3074">3,737</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:InterestExpenseOnBonds" scale="3" id="f-3075">760</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnBonds" format="ixt:num-dot-decimal" scale="3" id="f-3076">5,800</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on convertible loan notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:InterestExpenseOnDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="3" id="f-3077">2,641</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:InterestExpenseOnDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="3" id="f-3078">3,935</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="3" id="f-3079">5,691</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on conditional advances<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" id="f-3080">196</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" id="f-3081">176</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" id="f-3082">85</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:InterestExpenseOnRoyaltyCertificates" scale="3" id="f-3083">356</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:InterestExpenseOnRoyaltyCertificates" format="ixt:num-dot-decimal" scale="3" id="f-3084">8,942</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:InterestExpenseOnRoyaltyCertificates" scale="3" id="f-3085">794</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="f-3086">10</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="f-3087">13</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="f-3088">61</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in derivatives fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="3" id="f-3089">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-3090">3,046</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:LossesOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-3091">1,462</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in other liabilities at fair value through profit and loss<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:fixed-zero" scale="0" id="f-3092">&#8212;</ix:nonFraction><span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:fixed-zero" scale="0" id="f-3093">&#8212;</ix:nonFraction><span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-3094">1,367</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loss on derecognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:LossesArisingFromDerecognitionOfFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-3095">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:LossesArisingFromDerecognitionOfFinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-3096">3,431</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:LossesArisingFromDerecognitionOfFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-3097">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:TransactionCosts" format="ixt:fixed-zero" scale="3" id="f-3098">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:TransactionCosts" format="ixt:num-dot-decimal" scale="3" id="f-3099">1,924</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:TransactionCosts" format="ixt:num-dot-decimal" scale="3" id="f-3100">1,615</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:ForeignExchangeLoss" format="ixt:fixed-zero" scale="3" id="f-3101">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ForeignExchangeLoss" format="ixt:num-dot-decimal" scale="3" id="f-3102">5,573</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:ForeignExchangeLoss" scale="3" id="f-3103">51</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherFinanceCost" scale="3" id="f-3104">83</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherFinanceCost" scale="3" id="f-3105">73</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OtherFinanceCost" scale="3" id="f-3106">64</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial expenses<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:FinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-3107">7,022</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:FinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-3108">27,875</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:FinanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-3109">16,991</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:fixed-zero" scale="3" id="f-3110">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-3111">2,418</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-3112">8,246</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in derivatives fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-3113">9,366</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-3114">1,006</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:GainsOnChangeInFairValueOfDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-3115">1,413</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in other liabilities at fair value through profit and loss<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-3116">1,446</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-3117">3,198</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:fixed-zero" scale="3" id="f-3118">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of unwinding the discount related to advances made to CROs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" format="ixt:fixed-zero" scale="3" id="f-3119">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" scale="3" id="f-3120">355</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" scale="3" id="f-3121">710</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Day-one gain on recognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:GainsArisingFromRecognitionOfFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-3122">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:GainsArisingFromRecognitionOfFinancialLiabilities" scale="3" id="f-3123">212</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:GainsArisingFromRecognitionOfFinancialLiabilities" scale="3" id="f-3124">590</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Gain on derecognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:GainsArisingFromDerecognitionOfFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-3125">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:GainsArisingFromDerecognitionOfFinancialLiabilities" scale="3" id="f-3126">192</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:GainsArisingFromDerecognitionOfFinancialLiabilities" format="ixt:fixed-zero" scale="3" id="f-3127">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange gains <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:ForeignExchangeGain" format="ixt:fixed-zero" scale="0" id="f-3128">&#8212;</ix:nonFraction><span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:ForeignExchangeGain" format="ixt:fixed-zero" scale="0" id="f-3129">&#8212;</ix:nonFraction><span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:ForeignExchangeGain" format="ixt:num-dot-decimal" scale="3" id="f-3130">2,774</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:OtherFinanceIncome" scale="3" id="f-3131">306</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:OtherFinanceIncome" scale="3" id="f-3132">130</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OtherFinanceIncome" format="ixt:fixed-zero" scale="3" id="f-3133">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 282.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial income<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:FinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-3134">11,118</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:FinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-3135">7,511</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:FinanceIncome" format="ixt:num-dot-decimal" scale="3" id="f-3136">13,732</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial gain (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:FinanceIncomeCost" format="ixt:num-dot-decimal" scale="3" id="f-3137">4,096</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:FinanceIncomeCost" format="ixt:num-dot-decimal" scale="3" id="f-3138">20,364</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:FinanceIncomeCost" format="ixt:num-dot-decimal" scale="3" id="f-3139">3,258</ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.71pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Increases and decreases in the fair value of derivatives are detailed in Notes 15.1, 15.3, 15.5 and 15.12.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 459.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Increases and decreases in other liabilities at FVTPL relate to the Prosynergia earn-out liability for the year ended December 31, 2022 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(see Note 15.9) and the Heights notes for the years ended December 31, 2023 and 2024 (see Note 15.2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interests on royalty certificates are detailed in Note 15.10.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs for the year ended December 31, 2023 mainly relate to Heights notes, and t<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.62pt; position: var(--position); text-decoration: none; white-space: pre;">ransaction costs for the year ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2024 mainly relate to the amortization of the prepaid expenses related to the transaction costs of the Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranche C bond loans (see Note 15.1).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Gains and losses on the recognition and derecognition of financial liabilities are set forth in Notes 15.2. to 15.5.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest income mainly relates to the invested proceeds from the Group's Global Offering and the Kreos / Claret and Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financings.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange losses for the year ended December 31, 2023 mainly relate to the translation of cash and cash equivalents held in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. dollars into the Group's presentation currency as of December 31, 2023 (see Note 11), resulting in a loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.28pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-313" decimals="-3" sign="-" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-3140">3,196</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.37pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-313" decimals="-3" sign="-" name="abvx:ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" format="ixt:num-dot-decimal" scale="3" id="f-3141">1,488</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.29pt; position: var(--position); text-decoration: none; white-space: pre;"> loss resulting from foreign exchange operations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange gains for the year ended December 31, 2024 mainly relate to the translation of cash and cash equivalents held in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. dollars into the Group's presentation currency as of December 31, 2024 (see Note 11), resulting in a gain of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.43pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 487.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-314" decimals="-3" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-3142">2,035</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.02pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-314" decimals="-3" name="abvx:ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" format="ixt:num-dot-decimal" scale="3" id="f-3143">714</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.79pt; position: var(--position); text-decoration: none; white-space: pre;"> gain resulting from foreign exchange operations.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-75<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 70.56pt;" id="ia894b143b6fc4522a0483350194c625e_493"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 22. <span style="display: inline-block; height: 6.77pt;"></span><span id="if5e781ffb5b5428b9e867192eff48118"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="f-3144" continuedAt="f-3144-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Income tax<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3144-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The income tax rate applicable to the Company is the French corporate income tax rate, i.e. 25% for the years ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 101.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022, 2023 and 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The income tax rates applicable to the Subsidiary are the federal income tax rate of 21% and the State income tax rates of 4.35% and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 135.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">5.36%, i.e. a total of 25.35% and 26.36% for the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.48pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> years ended December 31, 2023 and 2024 respectively.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 158.71pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="abvx:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" id="f-3145" escape="true"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 214.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 39.07pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros, except percentage)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loss before tax <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:AccountingProfit" format="ixt:num-dot-decimal" scale="3" id="f-3146">60,740</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.14pt;"></span></span><span style="left: 67.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:AccountingProfit" format="ixt:num-dot-decimal" scale="3" id="f-3147">147,740</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.14pt;"></span></span><span style="left: 67.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:AccountingProfit" format="ixt:num-dot-decimal" scale="3" id="f-3148">176,242</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statutory French tax rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="4" name="ifrs-full:ApplicableTaxRate" scale="-2" id="f-3149">25.00</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="4" name="ifrs-full:ApplicableTaxRate" scale="-2" id="f-3150">25.00</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="ifrs-full:ApplicableTaxRate" scale="-2" id="f-3151">25.00</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Nominal income tax using statutory French tax rate<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-3152">15,185</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-3153">36,935</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-3154">44,061</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax effect of:<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax rates in foreign jurisdictions<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:TaxEffectOfForeignTaxRates" format="ixt:fixed-zero" scale="3" id="f-3155">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:TaxEffectOfForeignTaxRates" format="ixt:fixed-zero" scale="3" id="f-3156">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:TaxEffectOfForeignTaxRates" format="ixt:fixed-zero" scale="3" id="f-3157">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payment<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:TaxEffectOfShareBasedPayment" scale="3" id="f-3158">342</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 73.14pt;"></span></span><span style="left: 75.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="abvx:TaxEffectOfShareBasedPayment" format="ixt:num-dot-decimal" scale="3" id="f-3159">2,045</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 73.14pt;"></span></span><span style="left: 75.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:TaxEffectOfShareBasedPayment" format="ixt:num-dot-decimal" scale="3" id="f-3160">5,056</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 103.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CIR<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:TaxEffectOfResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-3161">1,119</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:TaxEffectOfResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-3162">1,123</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:TaxEffectOfResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-3163">1,663</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 115.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs related to capital increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease" scale="3" id="f-3164">820</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease" format="ixt:num-dot-decimal" scale="3" id="f-3165">3,073</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease" scale="3" id="f-3166">112</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 127.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease / (increase) in derivatives fair value and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:TaxEffectOfChangesInDerivativeFairValueAndOther" scale="3" id="f-3167">895</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:TaxEffectOfChangesInDerivativeFairValueAndOther" scale="3" id="f-3168">748</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="abvx:TaxEffectOfChangesInDerivativeFairValueAndOther" scale="3" id="f-3169">207</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.89pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-recognition of deferred tax assets related to tax losses and <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.49pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">temporary differences<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" format="ixt:num-dot-decimal" scale="3" id="f-3170">18,169</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" format="ixt:num-dot-decimal" scale="3" id="f-3171">39,612</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" format="ixt:num-dot-decimal" scale="3" id="f-3172">40,399</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="f-3173">192</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="f-3174">222</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="f-3175">49</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-left: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; border-top: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effective income tax (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:fixed-zero" scale="3" id="f-3176">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:fixed-zero" scale="3" id="f-3177">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:fixed-zero" scale="3" id="f-3178">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="position: var(--position); top: 362.46pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" id="f-3179" escape="true"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 242.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.92pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DEFERRED TAX ASSETS AND LIABILITIES BY NATURE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligation<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1302" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3180">152</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1303" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3181">157</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1304" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3182">189</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1305" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:fixed-zero" scale="3" id="f-3183">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1306" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3184">135</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1307" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3185">591</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1308" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3186">198</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1309" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3187">351</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1310" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3188">1,678</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax losses carryforward<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1311" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3189">77,207</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1312" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3190">114,946</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1313" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3191">152,372</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other items<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1314" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:fixed-zero" scale="3" id="f-3192">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1315" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3193">417</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1316" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-3194">886</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3195">77,558</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3196">116,006</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3197">155,715</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1317" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3198">50</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1318" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3199">24</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1319" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3200">12</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 117pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1305" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-3201">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1306" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3202">124</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1307" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3203">485</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1308" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-3204">1,377</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1309" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3205">285</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1310" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-3206">1,075</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other items<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1314" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-3207">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1315" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3208">10</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1316" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3209">12</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-3210">1,427</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-3211">444</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-3212">1,584</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets, net<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-3213">76,130</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-3214">115,562</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-3215">154,131</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Unrecognized deferred tax assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 63.05pt;"></span></span><span style="left: 65.67999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:UnrecognizedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3216">76,130</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.05pt;"></span></span><span style="left: 61.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:UnrecognizedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3217">115,562</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.05pt;"></span></span><span style="left: 61.68pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:UnrecognizedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-3218">154,131</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total deferred taxes, net recognized in the statement of financial <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">position<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="abvx:DeferredTaxAssetsRecognisedInFinancialPosition" format="ixt:fixed-zero" scale="3" id="f-3219">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="abvx:DeferredTaxAssetsRecognisedInFinancialPosition" format="ixt:fixed-zero" scale="3" id="f-3220">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="abvx:DeferredTaxAssetsRecognisedInFinancialPosition" format="ixt:fixed-zero" scale="3" id="f-3221">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group incurred tax losses in the reporting periods ended December 31, 2022, 2023 and 2024. As the recoverability of these tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">losses is not considered probable in subsequent periods due to the uncertainties inherent in the Group&#8217;s business, the Group has not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized deferred tax assets beyond deferred tax liabilities arising within the same taxable entity under the same taxable regime and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with consistent timing of reversal, after considering, if applicable, limitations in the use of deductible tax losses carried forward from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prior periods applicable under tax laws in France and in the U.S..<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The accumulated tax loss carry<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.26pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> forwards for the Company amount to &#8364;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="3" id="f-3222">308,829</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.25pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;thousand,</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.34pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> &#8364;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.84pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="3" id="f-3223">459,752</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.34pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> thousand and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 490.36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="3" id="f-3224">609,390</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> thousand </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">as of December 31, 2022, 2023 and 2024,</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.12pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> respectively, and do not have any expiration date. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 694.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The accumulated tax loss carry forwards for the U.S. Subsidiary consist of federal Net Operating Loss ("NOL") carry forwards and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 706.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount to &#8364;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.74000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1320" decimals="-3" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="3" id="f-3225">38</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.76pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1321" decimals="-3" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="3" id="f-3226">112</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.35pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2023 and 2024, respectively. They do not have any expiration date.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-76<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 94.56pt;" id="ia894b143b6fc4522a0483350194c625e_496"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 23. <span style="display: inline-block; height: 6.77pt;"></span><span id="i8ed29e06f3c44f68bb27fb2a5feab164"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="f-3227" continuedAt="f-3227-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Income (loss) per share<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3227-1" continuedAt="f-3227-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.11pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Basic losses per share is calculated by dividing income (loss) attributable to equity holders of the Group by the weighted-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.11pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">average number of outstanding ordinary shares for the year.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.61pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Diluted losses per share are calculated by adjusting the weighted average number of ordinary outstanding shares to assume <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.61pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conversion of all dilutive potential ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 185.61pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:EarningsPerShareExplanatory" id="f-3228" escape="true"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 23.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros, except share data)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BASIC AND DILUTED LOSS PER SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of outstanding shares<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-3229"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-3230">19,092,442</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-3231"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-3232">43,066,012</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-3233"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-3234">63,046,350</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-3235">60,740</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-3236">147,740</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-3237">176,242</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Basic and diluted loss per share (&#8364;/share)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(<ix:nonFraction unitRef="eurPerShare" contextRef="c-10" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-3238"><ix:nonFraction unitRef="eurPerShare" contextRef="c-10" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-3239">3.18</ix:nonFraction></ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(<ix:nonFraction unitRef="eurPerShare" contextRef="c-11" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-3240"><ix:nonFraction unitRef="eurPerShare" contextRef="c-11" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-3241">3.43</ix:nonFraction></ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(<ix:nonFraction unitRef="eurPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-3242"><ix:nonFraction unitRef="eurPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-3243">2.80</ix:nonFraction></ix:nonFraction>)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Potential dilutive instruments (BCEs, BSAs, AGAs, Equity lines, BSA Kreos 1, OCEANE, Kreos/Claret BSA, Kreos/Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">OCABSA and Height notes) have been excluded from the computation of diluted weighted-average shares outstanding because such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">instruments had an antidilutive impact due to the losses reported. As of December 31, 2022, 2023 and 2024, the number of potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 326.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">dilutive instruments were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.04000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" format="ixt:num-dot-decimal" scale="0" id="f-3244">1,707,037</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.04pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" format="ixt:num-dot-decimal" scale="0" id="f-3245">28,754,280</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.04pt; position: var(--position); text-decoration: none; white-space: pre;"> a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nd </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.47pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" format="ixt:num-dot-decimal" scale="0" id="f-3246">29,570,132</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.47pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.97pt; position: var(--position); text-decoration: none; white-space: pre;">respectively, giving rights to a maximum number of shares to be <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.16pt; width: 612pt;"><ix:continuation id="f-3227-2" continuedAt="f-3227-3"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">issued of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.31pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="abvx:MaximumNumberOfSharesToBeIssued" format="ixt:num-dot-decimal" scale="0" id="f-3247">1,707,037</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.31pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.31pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="abvx:MaximumNumberOfSharesToBeIssued" format="ixt:num-dot-decimal" scale="0" id="f-3248">6,510,658</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.74pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="abvx:MaximumNumberOfSharesToBeIssued" format="ixt:num-dot-decimal" scale="0" id="f-3249">6,760,392</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.74pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.24pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-3227-3">respectively.</ix:continuation> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 371.36pt;" id="ia894b143b6fc4522a0483350194c625e_499"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">No<span style="display: inline-block; height: 6.77pt;"></span><span id="i4a6d77cc6d394217a5f33631dae254d9"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 48.22pt; position: var(--position); text-decoration: none; white-space: pre;">te 24. <span style="display: inline-block; height: 6.77pt;"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="f-3250" continuedAt="f-3250-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Related <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108.72pt; position: var(--position); text-decoration: none; white-space: pre;">parties<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3250-1" continuedAt="f-3250-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.91pt; width: 612pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" id="f-3251" continuedAt="f-3251-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The aggregate compensation of the members of the Group&#8217;s Board of Directors and to the Chief Executive Officer includes the <span style="display: inline-block; height: 6.93pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3251-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 423.31pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 241.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.54pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">COMPENSATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fixed compensation owed <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:KeyManagementPersonnelCompensationFixedCompensation" scale="3" id="f-3252">322</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:KeyManagementPersonnelCompensationFixedCompensation" scale="3" id="f-3253">471</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:KeyManagementPersonnelCompensationFixedCompensation" scale="3" id="f-3254">578</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Variable compensation owed <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:KeyManagementPersonnelCompensationVariableCompensation" scale="3" id="f-3255">193</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:KeyManagementPersonnelCompensationVariableCompensation" scale="3" id="f-3256">282</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:KeyManagementPersonnelCompensationVariableCompensation" format="ixt:fixed-zero" scale="3" id="f-3257">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Contributions in-kind <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 70.21pt;"></span></span><span style="left: 72.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:KeyManagementPersonnelCompensationInKindContributions" scale="3" id="f-3258">9</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:KeyManagementPersonnelCompensationInKindContributions" scale="3" id="f-3259">32</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:KeyManagementPersonnelCompensationInKindContributions" scale="3" id="f-3260">68</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="f-3261">17</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" format="ixt:fixed-zero" scale="3" id="f-3262">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" format="ixt:fixed-zero" scale="3" id="f-3263">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Attendance fees&#8212;Board of Directors <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="abvx:KeyManagementPersonnelCompensationAttendanceFees" scale="3" id="f-3264">103</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="abvx:KeyManagementPersonnelCompensationAttendanceFees" scale="3" id="f-3265">375</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="abvx:KeyManagementPersonnelCompensationAttendanceFees" scale="3" id="f-3266">495</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.55pt;"></span></span><span style="left: 62.18pt; position: var(--position);">(<ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" sign="-" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="f-3267">217</ix:nonFraction>)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" format="ixt:num-dot-decimal" scale="3" id="f-3268">6,561</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" format="ixt:num-dot-decimal" scale="3" id="f-3269">10,517</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Departure indemnities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits" format="ixt:fixed-zero" scale="3" id="f-3270">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits" format="ixt:num-dot-decimal" scale="3" id="f-3271">1,210</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits" format="ixt:fixed-zero" scale="3" id="f-3272">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-10" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="f-3273">427</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-11" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensation" format="ixt:num-dot-decimal" scale="3" id="f-3274">8,930</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);"><ix:nonFraction unitRef="eur" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensation" format="ixt:num-dot-decimal" scale="3" id="f-3275">11,657</ix:nonFraction><span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.11pt; position: var(--position); text-decoration: none; white-space: pre;"> of December 31, <span style="display: inline-block; height: 6.93pt;"></span><span id="id16aa006a71e4472b93adcaee881ab63_1564"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.98pt; position: var(--position); text-decoration: none; white-space: pre;">2022,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> the liability related to post-employment defined benefit obligations (corresponding to the legal retirement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 602.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">benefits obligations) for members of the Group&#8217;s Board of Directors and Chief Executive Officer amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1322" decimals="-3" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="3" id="f-3276">149</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.46pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;">2024,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.91pt; position: var(--position); text-decoration: none; white-space: pre;"> there was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.91pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1323" decimals="-3" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" format="ixt:fixed-zero" scale="0" id="f-3277"><ix:nonFraction unitRef="eur" contextRef="c-1324" decimals="-3" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" format="ixt:fixed-zero" scale="0" id="f-3278">no</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 233.91pt; position: var(--position); text-decoration: none; white-space: pre;"> liability related to post-employment defined benefit obligations for members of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 624.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s Board of Directors and Chief Executive Officer. No other post-employment benefits are granted.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 647.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other arrangements with our <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 155.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 194.21pt; position: var(--position); text-decoration: none; white-space: pre;"> and Executive Officers <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into an intellectual property assignment agreement with CEO Hartmut Ehrlich on July 7, 2021. The purpose of this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement is to transfer to the Group all the intellectual property rights held by Hartmut Ehrlich on certain patents of which he is a co-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inventor. No compensation has been paid in respect of this transfer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 691.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In connection with Dr. Hartmut Ehrlich&#8217;s retirement as CEO, the Group entered into a transition protocol with Dr. Ehrlich in April <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 703.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2023. Pursuant to the transition protocol, Dr. Ehrlich remained a Group employee on a part-time basis until December 31, 2023 in a <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-77<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-3250-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">capacity as advisor to the new Chief Executive Officer against payment of a total compensation of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.59pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1325" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="f-3279">100</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.59pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, and a departure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">indemnity equal to&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1325" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits" format="ixt:num-dot-decimal" scale="3" id="f-3280">1,210</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.41pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand was stated.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into a management contract with CEO Marc de Garidel on April 18, 202<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.92pt; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.92pt; position: var(--position); text-decoration: none; white-space: pre;">. In 2023 and 2024, the Group also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granted AGA plans to its CEO (see terms and conditions in Note 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into a management contract with Chairman of the Board Sylvie Gr&#233;goire in July 2024. In 2024, the Group also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granted AGA plan 2024-5 to its Chairman of the Board (see terms and conditions in Note 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 161.76pt;" id="ia894b143b6fc4522a0483350194c625e_502"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25. <span style="display: inline-block; height: 6.77pt;"></span><span id="i994a337f15ab4561a9d17a44f015e1f0"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCommitmentsExplanatory" id="f-3281" continuedAt="f-3281-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Off-balance sheet comm<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 176.72pt; position: var(--position); text-decoration: none; white-space: pre;">itments give<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 228.06pt; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><div style="position: absolute; top: 187.31pt;" id="ia894b143b6fc4522a0483350194c625e_505"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.31pt; width: 612pt;"><ix:continuation id="f-3281-1" continuedAt="f-3281-2"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.1. Commitments under collaboration, research, service provision and licensing agreements granted by the Group <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-3281-2" continuedAt="f-3281-3"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Collaboration, research and development, and licensing agreements, and licensing options related to the &#8220;Modulation of RNA <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">biogenesis&#8221; platform. <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 76.2pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">E<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 97.71000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">xclusive licensing agreement with the CNRS, the University of Montpellier and the Institut Curie<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.21pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 245.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">On December 4, 2008, the French National Centre for Scientific Research (CNRS), the University of Montpellier and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 255.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">the Institut Curie granted the Group <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.45pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="license" contextRef="c-1326" decimals="INF" name="abvx:NumberOfExclusiveLicenses" format="ixt-sec:numwordsen" scale="0" id="f-3282">four</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.11pt; position: var(--position); text-decoration: none; white-space: pre;"> exclusive licenses. These licenses cover the use of their technology and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">products by the Group in the field of human and veterinary health relating to the use of synthetic products modifying <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">mRNA splicing, for research, diagnosis, prevention and treatment of any possible indication. The licensing agreement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">includes low single-digit royalties based on future net sales to be paid by the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Research collaboration contract with the CNRS, the University of Montpellier and the Institut Curie<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Concomitantly with a research collaboration framework contract relating to the creation of a cooperative laboratory, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 327.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">ended in December 2021, the parties have signed a financial agreement defining the financial terms for the exploitation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 337.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">of patents. This contract was signed on 15&#160;April 2009 for a duration of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.53000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1327" name="abvx:AgreementPeriod" format="ixt-sec:durwordsen" id="f-3283">one year</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.65000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> and was subsequently renewed up until <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">March 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 363.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development contract with license option with the CNRS, the University of Montpellier and Theradiag<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">The CNRS, the University of Montpellier, the Group and Theradiag conducted since 2013 a collaborative project <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">notably in the fields of HIV and HTLV-1 called CARENA, in connection with a funding obtained through Bpifrance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">The overall project provided for co-ownership and cross-licenses on the project's results through various instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 407.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">The Group met all obligations and the project was closed in December 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 437.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Exclu<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 58.730000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">sive licensing contract with &#8220;The Scripps Research Institute, University of Chicago and Brigham Young University&#8221; with the <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 447.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Immune Stimulation&#8221; platform (ABX196 product) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On 11&#160;November 2006, The Scripps Research Institute (La Jolla, California, USA), in agreement with the University of Chicago <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Chicago, Illinois, USA) and Brigham Young University (Provo, Utah, USA), granted the Group an exclusive license in the field of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">human and veterinary health on its technology and products relating to the use of iNKT agonists for research, diagnosis, prevention <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and treatment of all possible indications. In consideration for the licensing rights granted to it under the agreement, the Group had to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">pay The Scripps Research Institute milestones at different stages of clinical and regulatory development of the first <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">product (the milestones amount to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.07pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1328" decimals="-3" name="abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" format="ixt:num-dot-decimal" scale="3" id="f-3284">50</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.66pt; position: var(--position); text-decoration: none; white-space: pre;"> at IND filing, paid in September 2019 and capitalized, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.62pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1328" decimals="-3" name="abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" format="ixt:num-dot-decimal" scale="3" id="f-3285">300</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.21pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.29pt; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1328" decimals="-3" name="abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" format="ixt:num-dot-decimal" scale="3" id="f-3286">500</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.88pt; position: var(--position); text-decoration: none; white-space: pre;"> at IND approval) and low single-digit royalties for vaccines, diagnostic tests and therapeutic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">products, according to the amount of net sales, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 296.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">give The Scripps Research Institute, University of Chicago and Brigham Young University an equitable interest in the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Group (as of the date of these financial statements, these <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.36pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="academic_institution" contextRef="c-1328" decimals="INF" name="abvx:NumberOfAcademicInstitutions" format="ixt-sec:numwordsen" scale="0" id="f-3287">three</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.32pt; position: var(--position); text-decoration: none; white-space: pre;"> academic institutions hold <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.18pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1329" decimals="4" name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" scale="-2" id="f-3288">0.41</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.01pt; position: var(--position); text-decoration: none; white-space: pre;"> of the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">undiluted capital). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 597.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the year ended December 31, 2022, the Group made the decision to freeze the development program for ABX196 in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">treatment of hepatocellular cancer (see Note 3.1 - <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 235.97pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of ABX196 cash-generating unit )<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.98pt; position: var(--position); text-decoration: none; white-space: pre;">. Subsequently, in 2024, the licensing <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">contract was terminated.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 669.31pt;" id="ia894b143b6fc4522a0483350194c625e_511"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.31pt; width: 612pt;"><ix:continuation id="f-3281-3" continuedAt="f-3281-4"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.2. Commitments under BPI conditional advances <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-3281-4" continuedAt="f-3281-5"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 685.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance CARENA contract <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the development of therapeutic and diagnostic solutions targeting alternative splicing and RNA interference in the fields of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 711.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">virology (HIV-AIDS, HTLV-1) and metabolism (obesity), SPLICOS (absorbed by the Group on 31&#160;October 2014) has entered into a <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-78<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-3281-5" continuedAt="f-3281-6"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Master Support Agreement with Bpifrance as well as a conditional advance contract in the name of the &#8220;CARENA&#8221; Strategic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Industrial Innovation Project dated December 16, 2013. The Group, acting as project leader for the CARENA project, was associated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as part of a consortium contract with Theradiag, a Group specializing in in vitro diagnostics and the development of theranostic tests <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for monitoring biotherapies, as well as at the CNRS and the University of Montpellier. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The CARENA project aimed to develop the anti-HIV-AIDS therapeutic program with the compound ABX464 up to the Phase 2b <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">study, as well as a companion test set up by Theradiag simultaneously with the clinical development. Beyond the anti-HIV-AIDS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program, the CARENA project could extend its pharmacological investigations to another retrovirus that could be combated by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">same approach: HTLV-1. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is committed to reimbursing the received conditional advances up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1026" decimals="-3" name="abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" format="ixt:num-dot-decimal" scale="3" id="f-3289">3,840</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.94pt; position: var(--position); text-decoration: none; white-space: pre;">. The Group will also have to pay an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 186.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">annuity of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.3pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1026" decimals="2" name="abvx:OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" scale="-2" id="f-3290">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.63pt; position: var(--position); text-decoration: none; white-space: pre;"> of the proceeds from the sale of the intellectual property rights resulting from the project, as well as the sale of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prototypes, preproduction and models produced under the project; the sum due to Bpifrance under this provision will be deducted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the repayment of the conditional advances. In addition, if the advance is repaid under the conditions outlined above, the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">will pay to Bpifrance, over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-3291">five</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.19pt; position: var(--position); text-decoration: none; white-space: pre;"> consecutive years after the date on which the repayment schedule ends and provided that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group has reached cumulative pre-tax revenue greater than or equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1331" decimals="-6" name="abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" format="ixt:num-dot-decimal" scale="6" id="f-3292">50</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 381.4pt; position: var(--position); text-decoration: none; white-space: pre;">, an amount equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.2pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1026" decimals="4" name="abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" scale="-2" id="f-3293">1.20</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.03pt; position: var(--position); text-decoration: none; white-space: pre;"> of the annual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">revenue generated from the sale of the products developed as part of the project. This supplementary payment amount is capped at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1332" decimals="-3" name="abvx:OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" format="ixt:num-dot-decimal" scale="3" id="f-3294">6,800</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">. The total period, including fixed payments and incentive payments, is limited to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.48pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1333" name="abvx:OtherFinancialLiabilitiesRepaymentPeriod" format="ixt-sec:duryear" id="f-3295">15</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.06pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Termination became effective in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 2024 after the Group refunded&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1334" decimals="-3" name="abvx:RepaymentsOfConditionalAdvances" format="ixt:num-dot-decimal" scale="3" id="f-3296">234</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.69pt; position: var(--position); text-decoration: none; white-space: pre;"> corresponding to a portion of the funding received. The Group is therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 305.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">released of its obligations to pay an annuities on the proceeds from the sale of the intellectual property rights resulting from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">project. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 346.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance RNP-VIR contract <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In pursuit of the CARENA project, focused on the clinical development of a drug molecule and demonstrating the validity of an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">innovative therapeutic approach targeting viral RNPs, the Group has entered into a Master Support Agreement with Bpifrance as well <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as a beneficiary agreement with conditional advance for the &#8220;RNP-VIR&#8221; structuring research and development project for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">competitiveness dated December 16, 2016. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The RNP-VIR project aimed to further the discovery of new molecules for the treatment of multiple infectious diseases by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">development of the antiviral technology platform. The Group, acting as project leader of the RNP-VIR project, was associated in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consortium contract with the CNRS and the University of Montpellier. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is committed to reimburse the received conditional advances up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1020" decimals="-3" name="abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" format="ixt:num-dot-decimal" scale="3" id="f-3297">6,576</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.6pt; position: var(--position); text-decoration: none; white-space: pre;">. If applicable, the Group will also have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 466.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to pay an annuity of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.43pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1020" decimals="2" name="abvx:OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" scale="-2" id="f-3298">50</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.76pt; position: var(--position); text-decoration: none; white-space: pre;"> of the proceeds from the sale of the intellectual property rights resulting from the project, as well as the sale <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the prototypes, preproduction and models produced under the project. The sum due to Bpifrance under this provision will be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deducted from the last payment (and if needed from the previous payments). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 508.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">If the advance is repaid under the conditions outlined above, the Group will pay to Bpifrance, over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.3pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-3299">five</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.83pt; position: var(--position); text-decoration: none; white-space: pre;"> consecutive years <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">following the date on which the repayment schedule ends and provided that the Group has reached cumulative pre-tax revenue greater <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">than or equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1336" decimals="-6" name="abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" format="ixt:num-dot-decimal" scale="6" id="f-3300">25</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.28pt; position: var(--position); text-decoration: none; white-space: pre;">, an amount equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.08pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1020" decimals="2" name="abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" scale="-2" id="f-3301">3</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.41pt; position: var(--position); text-decoration: none; white-space: pre;"> of the annual revenue generated from the sale of products developed as part of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">project. The supplementary payments amount is capped at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.99pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1337" decimals="-3" name="abvx:OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" format="ixt:num-dot-decimal" scale="3" id="f-3302">5,500</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.08pt; position: var(--position); text-decoration: none; white-space: pre;">. The total period, including fixed payments and incentive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">payments, is limited to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1338" name="abvx:OtherFinancialLiabilitiesRepaymentPeriod" format="ixt-sec:duryear" id="f-3303">15</ix:nonNumeric> years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Termination became effective in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 2024. The Group is therefore released of its obligations to pay an annuities on the proceeds from the sale of the intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">property rights resulting from the project. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 624.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance Ebola <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Bpifrance and Occitanie Region joint support agreement granted on June 2, 2017 consists of conditional advances to the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for a total amount of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.4pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1339" decimals="-3" name="abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity" format="ixt:num-dot-decimal" scale="3" id="f-3304">390</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.99pt; position: var(--position); text-decoration: none; white-space: pre;">, based on the success of the program (respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1340" decimals="-3" name="abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity" format="ixt:num-dot-decimal" scale="3" id="f-3305">130</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.46pt; position: var(--position); text-decoration: none; white-space: pre;"> from the Languedoc <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 660.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Roussillon Midi Pyr&#233;n&#233;es Region and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.04pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1341" decimals="-3" name="abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity" format="ixt:num-dot-decimal" scale="3" id="f-3306">260</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.63pt; position: var(--position); text-decoration: none; white-space: pre;"> from Bpifrance). In September 2019, the Group decided to terminate this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program, due to the existence of a vaccine in the process of being licensed for this indication as well as changes in the macroeconomic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">climate for public funding. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The reimbursement of the conditional advance was spread until June 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-79<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><div style="position: absolute; top: 70.56pt;" id="ia894b143b6fc4522a0483350194c625e_514"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><ix:continuation id="f-3281-6" continuedAt="f-3281-7"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.3. Pledge assets to Kreos, Claret and Heights <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-3281-7" continuedAt="f-3281-8"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the KREOS 1 &amp; 2 bonds, Kreos benefits from first-rate collateral on the Group&#8217;s principal tangible and intangible assets, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">including its commercial fund, intellectual property rights in its principal drug candidates, as well as a pledge of the Group&#8217;s bank <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">accounts and claims. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 21, 2023, the outstanding Kreos 1 &amp; 2 bond loans were repaid in full, using the proceeds from the new Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financing (see Note 3.3).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary exceptions) which include, among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">things, restrictions on the incurrence of indebtedness, cross-default, the distribution of dividends and the grant of security interests, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.55pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which would cause the bonds to become repayable on demand in case of breach. As of December 31, 2024, the Group complied with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 195.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">these restrictive covenants.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> As security for the Kreos / Claret Financing, the lenders benefit from the grant of first-ranking collateral on the Group&#8217;s principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tangible and intangible assets, including pledges over the Group&#8217;s business (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;">fonds de commerce<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.67pt; position: var(--position); text-decoration: none; white-space: pre;">) as a going concern and intellectual <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">property rights in the Group's lead drug candidate, as well as pledges over the Group&#8217;s bank accounts and receivables. Such securities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">apply to all tranches of the Kreos / Claret Financing.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights Financing is a senior, unsecured financing. The terms and conditions of the Heights convertible notes include a standard <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">negative pledge providing that any security granted in favor of other borrowed debt or debt instruments should also be granted in favor <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the Heights convertible notes on an equal basis (with the exception of the securities issued pursuant to the Kreos / Claret Financing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as detailed above).<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 348.16pt;" id="ia894b143b6fc4522a0483350194c625e_517"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.16pt; width: 612pt;"><ix:continuation id="f-3281-8" continuedAt="f-3281-9"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.4. Other commitments related to research and partnership arrangements <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-3281-9" continuedAt="f-3281-10"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the ordinary course of business, the Group regularly uses the services of subcontractors and enters into research and partnership <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">arrangements with various contract research organizations, or CROs, and with public- sector partners or subcontractors, who conduct <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials and studies in relation to the drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At December 31, 2022, 2023, and 2024 the Group&#8217;s commitments amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-6" decimals="-3" name="ifrs-full:CapitalCommitments" format="ixt:num-dot-decimal" scale="3" id="f-3307">194,731</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.56pt; position: var(--position); text-decoration: none; white-space: pre;">,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.06pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-7" decimals="-3" name="ifrs-full:CapitalCommitments" format="ixt:num-dot-decimal" scale="3" id="f-3308">201,777</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.65pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.5799999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.0799999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-5" decimals="-3" name="ifrs-full:CapitalCommitments" format="ixt:num-dot-decimal" scale="3" id="f-3309">234,908</ix:nonFraction> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;">. The cost of services performed by CROs is recognized as an operating expense as incurred.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 447.36pt;" id="ia894b143b6fc4522a0483350194c625e_520"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 447.36pt; width: 612pt;"><ix:continuation id="f-3281-10" continuedAt="f-3281-11"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.5. Leases <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-3281-11" continuedAt="f-3281-12"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Following the end (in December 31, 2021) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.19pt; position: var(--position); text-decoration: none; white-space: pre;">of the Framework agreement with <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.64pt; position: var(--position); text-decoration: none; white-space: pre;">CNRS <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.24pt; position: var(--position); text-decoration: none; white-space: pre;">(French National Centre for Scientific Research) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and the University of Montpellier for research collaboration to create a cooperative laboratory, a hosting agreement was signed in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 494.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022 with CNRS<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.86pt; position: var(--position); text-decoration: none; white-space: pre;">, so that the Group can continue its research program at the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.19pt; position: var(--position); text-decoration: none; white-space: pre;">CNRS<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.29pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.79pt; position: var(--position); text-decoration: none; white-space: pre;">center for the year 2023, and was subsequently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">renewed for 2024 and 2025. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In D<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.05pt; position: var(--position); text-decoration: none; white-space: pre;">ecember 2022, following the end of the Research collaboration contract with the CNRS, the University of Montpellier and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Institut Curie, the Company and the Institut Curie concluded a new contract for a duration of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.19pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1342" name="abvx:LeaseDurationPeriod" format="ixt-sec:durwordsen" id="f-3310">one year</ix:nonNumeric><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.31pt; position: var(--position); text-decoration: none; white-space: pre;">, renewable by amendment, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granting the Company access to some of the Institute&#8217;s equipment and consumables. The contract was subsequently renewed for 2024 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and 2025, under similar conditions.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The above agreements fall within the scope of the short-term lease exemption of IFRS 16, and the related rental expenses are therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in operating expenses as incurred.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 622.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group's commitments in relation to other ongoing leases are set forth in Note 15.8 and 15.13.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 640.96pt;" id="ia894b143b6fc4522a0483350194c625e_523"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.96pt; width: 612pt;"><ix:continuation id="f-3281-12" continuedAt="f-3281-13"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.6. Litigation related to Prosynergia acquisition <span style="display: inline-block; height: 6.77pt;"></span></span></ix:continuation></div><ix:continuation id="f-3281-13" continuedAt="f-3281-14"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On December 12, 2024, the Group was notified of a claim from the seller of Prosynergia requesting the payment of an earn-out in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">connection with the transaction. Legal proceedings are ongoing in French court. The Group has not recorded any provision in its <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.36pt; width: 612pt;"><ix:continuation id="f-3281-14"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial statements in connection with this claim <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.54pt; position: var(--position); text-decoration: none; white-space: pre;">due to uncertainty in the outcome of this proceeding.<span style="display: inline-block; height: 6.93pt;"></span></span></ix:continuation><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.69pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: absolute; top: 707.76pt;" id="ia894b143b6fc4522a0483350194c625e_526"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 707.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 26. <span style="display: inline-block; height: 6.77pt;"></span><span id="if12c9be442fe44a2909c5f9f5c9e02a1"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" id="f-3311" continuedAt="f-3311-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Off-balance sheet commitments received and contingent assets <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-80<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-3311-1"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The maximum amounts receivable by the Group after December 31, 2023 under the &#8220;RNP-VIR&#8221; and &#8220;CARENA&#8221; and innovation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreements entered into with Bpifrance, subject to the provision of evidence to support the forecast expenses and the achievement of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scientific milestones, are <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1012" decimals="-3" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="3" id="f-3312">3,255</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1016" decimals="-3" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="3" id="f-3313">1,853</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.11pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">terminate the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.9pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="project" contextRef="c-1343" decimals="INF" name="abvx:NumberOfProjectsTerminated" format="ixt-sec:numwordsen" scale="0" id="f-3314">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.89pt; position: var(--position); text-decoration: none; white-space: pre;"> projects due to technical failures (see Note 15.7).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the Kreos / Claret Financing agreement, the Group has received loan commitments from Kreos and Claret for the tranches B <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and C, of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1344" decimals="-3" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="3" id="f-3315">25,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.51pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount each (subject to the conditions set forth in Note 15.1.). The B and C <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranches were drawn in March 2024 and June 2024, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the Heights Financing agreement, the Group has received a loan commitment from Heights for the tranche B, of up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1345" decimals="-3" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="3" id="f-3316">40,000</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount (subject to the conditions set forth in Note 15.2.).&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.41pt; position: var(--position); text-decoration: none; white-space: pre;">On the limit date for the drawdown <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the second tranche of the Heights Financing (i.e. August 4, 2024), the Group had not drawn down this tranche and has therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">forgone its right to do so in the future.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has not received any significant off-balance sheet commitment and has no significant contingent asset as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 278.56pt;" id="ia894b143b6fc4522a0483350194c625e_529"></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 27. <span style="display: inline-block; height: 6.77pt;"></span><span id="ie3bfd85a56df44299c0dfeb943b78aac"></span></span><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinancialRiskManagementExplanatory" id="f-3317" continuedAt="f-3317-1" escape="true"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Management and assessment of financial risks <span style="display: inline-block; height: 6.77pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3317-1" continuedAt="f-3317-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The principal financial instruments held by the Group are cash and cash equivalents. The purpose of holding these instruments is to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 313.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">finance the ongoing business activities of the Group. It is not the Group&#8217;s policy to invest in financial instruments for speculative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">purposes. The Group does not use derivative financial instruments for hedging purposes. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The principal risks to which the Group is exposed to are liquidity risk, interest rate risk, foreign currency exchange risk, credit risk and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value risk. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Liquidity risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 409.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Liquidity risk management aims to ensure that the Group disposes of sufficient liquidity and financial resources to be able to meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">present and future obligations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 443.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group prepares short-term cash forecasts and annual operating cash flow forecasts as part of its budget procedures.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prudent liquidity risk management involves maintaining sufficient liquidity, having access to financial resources through appropriate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit facilities and being able to unwind market positions.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s operations have consumed substantial amounts of cash since inception. Developing pharmaceutical drug candidates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">including conducting clinical trials, is expensive, lengthy and risky, and the Group expects its research and development expenses to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 521.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase substantially in connection with its ongoing activities. Accordingly, the Group will continue to require substantial additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">capital to continue its clinical development activities and potentially engage in commercialization activities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group's estimate of its cash runway as of the date of approval of these financial statements is set forth in Note 2<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 500.59pt; position: var(--position); text-decoration: none; white-space: pre;"> - Going concern.<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 584.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest rate risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is exposed to market risks in connection with its medium and long-term borrowings subject to variable interest rates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 631.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Due to fluctuations in market interest rates<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 206.32pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.32pt; position: var(--position); text-decoration: none; white-space: pre;">and the refinancing of most of its indebtedness over the year ended December 31, 2023, the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group has performed a reassessment of its exposure to interest rate risk. As of December 31, 2023, following the full repayment of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 bonds, all the Group&#8217;s non-derivative financial liabilities accounted for at amortized cost bear fixed interest rates. Therefore, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group has limited exposure. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Over the year ended December 31, 2024, the Group has drawn down the second and third tranches of the Kreos / Claret Financing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">bearing variable interest rates (consisting of a fixed margin of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.13pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1346" decimals="3" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-3318">7.5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.96pt; position: var(--position); text-decoration: none; white-space: pre;"> + European Central Bank Base Rate (MRO), with a floor at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.81pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1347" decimals="3" name="abvx:BorrowingsBasisInterestRate" scale="-2" id="f-3319">2.5</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.64pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 721.44pt;"><div style="width: 468pt;"><div style="line-height: 10pt; position: var(--position); top: 47.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.55pt; position: var(--position); white-space: pre;">F-81<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 540pt;"></div></div><div><ix:continuation id="f-3317-2"><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and a cap at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.92pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1348" decimals="2" name="abvx:BorrowingsBasisInterestRate" scale="-2" id="f-3320">4</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.25pt; position: var(--position); text-decoration: none; white-space: pre;">) and has therefore performed a reassessment of its exposure to interest rate risk. Due to the interest rate collar having a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">range of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1346" decimals="4" name="abvx:InterestRateCollarRange" scale="-4" id="f-3321">150</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> bp, the Group concluded that it still has limited exposure.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign currency risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is exposed to a risk of exchange rates fluctuations on commercial transactions performed in currencies different from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">functional currency of the Group entity recording the transactions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the years ended December 31, 2024, 2023 and 2022, expenses in U.S. dollars totaled <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-314" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3322">10,547</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.98pt; position: var(--position); text-decoration: none; white-space: pre;"> thousands, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-313" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3323">10,112</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.96pt; position: var(--position); text-decoration: none; white-space: pre;"> thousands and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1349" decimals="-3" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-3324">1,390</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"> thousands respective<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ly, based on the average annual exchange rate in effect as of December 31, 2024, December 31, 2023 and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">December 31, 2022. A</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.76pt; position: var(--position); text-decoration: none; white-space: pre;">s a result, an adverse <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.21pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1350" decimals="2" name="abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" scale="-2" id="f-3325">10</ix:nonFraction>%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.54pt; position: var(--position); text-decoration: none; white-space: pre;"> change in the exchange rate for the U.S. dollar against the euro would have resulted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in a foreign exchange rate loss of approxi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.65pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">mately </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.32pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1350" decimals="-3" sign="-" name="abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-3326">291</ix:nonFraction>&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> for 2024, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1351" decimals="-3" sign="-" name="abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-3327">386</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> fo</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.99pt; position: var(--position); text-decoration: none; white-space: pre;">r 2023 and a non-material amount for 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At this stage, the Group has not adopted any other recurring mechanism of hedging to protect its activity against currency fluctuations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">From time to time, the Group may nevertheless subscribe currency term accounts in order to cover a commitment in currency as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">described above. The Group may consider in the future using a suitable policy to hedge exchange risks in a more significant manner if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">needed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Credit risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 298.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to the Group&#8217;s cash and cash equivalents is not significant in light of the quality of the co-contracting financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">institutions. As of December 31, 2024, substantially all of the Group&#8217;s cash and cash equivalents were maintained with <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.1pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="financial_institution" contextRef="c-1352" decimals="INF" name="abvx:NumberOfFinancialInstitutionsToMaintainCash" format="ixt-sec:numwordsen" scale="0" id="f-3328">two</ix:nonFraction><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.0899999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 321.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">institutions in France and in the United States. While the Group&#8217;s deposit accounts are i<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nsured up to the legal limit, the maintained </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">balances may, at times, exceed this insured limit. As of December 31, 2024, the Group m</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.83pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">aintained </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.93pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1352" decimals="-3" name="abvx:BalancesWithBanksInExcessOfLegallyInsuredLimit" format="ixt:num-dot-decimal" scale="3" id="f-3329">143,881</ix:nonFraction>&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> in bank deposit </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">accounts that are in excess of the legally insured limit in </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="financial_institution" contextRef="c-1352" decimals="INF" name="abvx:NumberOfFinancialInstitutionsToMaintainCash" format="ixt-sec:numwordsen" scale="0" id="f-3330">two</ix:nonFraction></span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> legally insured financial institutions. Th</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.2pt; position: var(--position); text-decoration: none; white-space: pre;">e Group has not experienced any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">losses in such accounts and does not believe that it is exposed to any significant credit risk related to these instruments.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to the Group&#8217;s other receivables and related account is minimal. In particular, the credit risk related to advances <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 388.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">made to C<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.06pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ROs (see Note 9) is</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: var(--position); text-decoration: none; white-space: pre;"> deemed insignificant due to their credit ratings.<span style="display: inline-block; height: 6.93pt;"></span></span></div></ix:continuation></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>abivax-20xfxex11bylaws6feb.htm
<DESCRIPTION>EX-1.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7a9bdb72f138481fbca6a64ac8522f21_1"></div><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ABIVAX</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A French </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Soci&#233;t&#233; Anonyme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (limited company) with share capital of &#8364;633,832.93</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Registered office&#58; 7-11 Boulevard Haussmann</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">75009 Paris </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Paris Trade and Companies Register No 799 363 718 </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_______________________________<br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEMORANDUM AND ARTICLES OF ASSOCIATION </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Updated on February 6, 2025</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certified as true to the original </font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="padding-left:360pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Signature&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">____________________________</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chief Executive Officer</font></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION I<br>LEGAL FORM &#8211; COMPANY NAME &#8211; OBJECTS &#8211; REGISTERED OFFICE &#8211; TERM OF INCORPORATION</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">LEGAL FORM</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Abivax (hereinafter, the &#8216;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;) is a French </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">soci&#233;t&#233; anonyme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (limited company) with a Board of Directors, which is governed by the laws and regulations in force and by these Articles.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">COMPANY NAME </font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The name of the Company is&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ABIVAX</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In all instruments and documents issued by the Company and intended for third parties, the company name must always be preceded or followed immediately and clearly by the words &#8216;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Soci&#233;t&#233; Anonyme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217; or the initials &#8216;SA&#8217;, the amount of share capital, the Company&#8217;s registration number and the Trade and Companies Register in which it is registered.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">REGISTERED OFFICE</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The registered office is at&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7-11 Boulevard Haussmann, 75009 Paris.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It may be transferred to any location within the same or a neighbouring county (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">d&#233;partement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) by ordinary decision of the Board of Directors, subject to ratification of that decision by the shareholders at their next Ordinary General Meeting, and to any other location by decision taken by the shareholders at an Extraordinary General Meeting. If a transfer is decided by the Board of Directors, the Board is authorised to vary these Articles accordingly.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">OBJECTS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s objects, directly or indirectly, in France and other countries, is&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">to engage in all research, development and marketing activities in relation to therapeutic and prophylactic vaccines and small therapeutic molecules administered primarily to combat infection&#59; to acquire, subscribe for, hold, manage and transfer, in any form whatsoever, all shares and all transferable securities in all existing or new French or foreign companies, and generally to manage equity interests in the Company&#8217;s area of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">to take part, directly or indirectly, in all operations and transactions that relate to, or are likely to promote the achievement of, any of the above objects, through the creation of new companies, contributions or the subscription or purchase of securities or members&#8217; rights, mergers, business alliances, joint ventures or otherwise&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">generally, to engage in all personal property, real estate, industrial, commercial and financial operations and transactions that relate directly or indirectly to this object or to any similar or related objects, or that may be useful for, or facilitate the achievement of, such object. </font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">TERM OF INCORPORATION</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is incorporated for a term of ninety-nine (99) years from the date it is registered in the Trade and Companies Register, unless it is wound up early or its term of incorporation is extended.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION II<br>SHARE CAPITAL &#8211; SHARES</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">SHARE CAPITAL </font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Contributions &#8211; Formation of share capital</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon the Company&#8217;s incorporation, by virtue of a legal document dated 4&#160;December 2013, the Company received cash contributions totalling forty thousand euros (&#8364;40,000), corresponding to 40,000 ordinary shares.</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">By decisions taken by the shareholders at their Extraordinary General Meeting of 25&#160;April 2014&#58;</font></div><div style="margin-bottom:12pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.08pt">the share capital was increased as a result of a cash contribution of nine thousand two hundred and fifty-nine euros (&#8364;9,259), from &#8364;40,000 to &#8364;49,259, through the creation of 9,259 new ordinary shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.03pt">the share capital was increased as a result of a cash contribution of thirteen thousand seven hundred and sixty euros (&#8364;13,760), from &#8364;49,259 to &#8364;63,019, through the creation of 13,760&#160;new ordinary shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.98pt">the share capital was increased as a result of a cash contribution of five hundred and seventy-six euros (&#8364;576), from &#8364;63,019 to &#8364;63,595, through the creation of 576 new ordinary shares&#59; and</font></div><div style="margin-bottom:12pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.58pt">the share capital was increased as a result of a cash contribution of two thousand four hundred euros (&#8364;2,400), from &#8364;63,595 to &#8364;65,995 euros, through the creation of 2,400 new ordinary shares.</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">By decision taken by the Board of Directors on 21&#160;May 2014, pursuant to the authority delegated to the Board by the shareholders at their Combined General Meeting of 11&#160;March 2014, the share capital was increased by five hundred and fifty-five euros (&#8364;555), from &#8364;65,995 to &#8364;66,550, through the creation of 555 new ordinary shares.</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">By decisions taken by the shareholders at their Extraordinary General Meeting of 30&#160;July 2014, the share capital was increased in cash by three million two hundred and fifty thousand (3,250,000) euros, from sixty-six thousand five hundred and fifty (66,550) euros to sixty-nine thousand one hundred and fifty (69,150) euros, through the issue of 2,600 new ordinary shares.</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">By decision taken by the shareholders at their Extraordinary General Meeting of 20&#160;February 2015, the par value of the shares that made up the share capital of the Company was divided by 100, thus reducing the par value from one (1) euro to one (1) euro cent (&#8364;0.01).</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">As a result of the exercise of 28 &#8216;BCE-2014-5&#8217; founders&#8217; warrants on 24&#160;April 2015, which was recorded by the Board of Directors in a decision of 3&#160;June 2015, the share capital was increased by twenty-eight euros (&#8364;28), from sixty-nine thousand one hundred and fifty euros (&#8364;69,150) to sixty-nine thousand one hundred and seventy-eight euros (&#8364;69,178).</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">By decision taken by the Board of Directors on 23&#160;June 2015, pursuant to the authority delegated to the Board by the shareholders at their Combined General Meeting of 20&#160;February 2015, the share capital was increased on 25&#160;June 2015 by twenty-seven thousand and seventy euros and eighty-nine cents (&#8364;27,070.89), from sixty-nine thousand one hundred and seventy-eight euros (&#8364;69,178) to ninety-six thousand two hundred and forty-eight euros and eighty-nine cents (&#8364;96,248.89), through the issue of 2,707,089 new shares.</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">As a result of the exercise of 64 &#8216;BSA-2014-3&#8217; share warrants on 25&#160;September 2015 and of 448 &#8216;BSA-2014-2&#8217; share warrants on 26&#160;September 2015, which was recorded by the Board of Directors in </font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a decision of 4&#160;December 2015, the share capital was increased by five hundred and twelve euros (&#8364;512), from ninety-six thousand two hundred and forty-eight euros and eighty-nine cents (&#8364;96,248.89) to ninety-six thousand seven hundred and sixty euros and eighty-nine cents (&#8364;96,760.89).</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">As a result of the exercise of 208 &#8216;BCE-2014-3&#8217; founders&#8217; warrants on 22&#160;December 2015, which was recorded by the Board of Directors in a decision of 18&#160;January 2016, the share capital was increased by two hundred and eight euros (&#8364;208), from ninety-six thousand seven hundred and sixty euros and eighty-nine cents (&#8364;96,760.89) to ninety-six thousand nine hundred and sixty-eight euros and eighty-nine cents (&#8364;96,968.89).</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.1pt">As a result of the exercise of 52 &#8216;BSA-2014-6&#8217; share warrants on 11&#160;April 2016, which was recorded by the Board of Directors in a decision of 7&#160;November 2016, the share capital was increased by fifty-two euros (&#8364;52), from ninety-six thousand nine hundred and sixty-eight euros and eighty-nine cents (&#8364;96,968.89) to ninety-seven thousand and twenty euros and eighty-nine cents (&#8364;97,020.89).</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.6pt">As a result of the exercise of 394 &#8216;BSA-2014-1&#8217; share warrants on 17&#160;March 2017, 473 &#8216;BSA-2014-4&#8217; share warrants on 1&#160;August 2017, 100 &#8216;BCE-2014-4&#8217; founders&#8217; warrants on 1&#160;August 2017 and 400 &#8216;BCE-2014-2&#8217; founders&#8217; warrants on 28&#160;September 2017, and as a result of the exercise of 60,000 Kepler share warrants, which was recorded by the Board of Directors on 20&#160;November 2017, the share capital was increased by one thousand nine hundred and sixty-seven euros and forty cents (&#8364;1,967.40), from ninety-seven thousand and twenty euros and eighty-nine cents (&#8364;97,020.89) to ninety-eight thousand nine hundred and eighty-eight euros and twenty-nine cents (&#8364;98,988.29).</font></div><div style="margin-bottom:12pt;padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.6pt">As a result of the exercise of 29 &#8216;BSA-2014-7&#8217; share warrants on 30&#160;October 2017 and 2,500 &#8216;BCE-2016-1&#8217; founders&#8217; warrants on 20&#160;December 2017, which was recorded by the Board of Directors on 22&#160;January 2018, the share capital was increased by fifty-four euros (&#8364;54), from ninety-eight thousand nine hundred and eighty-eight euros and twenty-nine cents (&#8364;98,988.29) to ninety-nine thousand and forty-two euros and twenty-nine cents (&#8364;99,042.29).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Share capital</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The share capital of the Company is set at six hundred and thirty-three thousand eight hundred and thirty-two euros and ninety-three cents (EUR 633,832.93).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It is divided into sixty-three million three hundred and eighty-three thousand two hundred and ninety-three (63,383,293) fully subscribed and paid-up ordinary shares of the same class, with a par value of one euro cent (&#8364;0.01) each.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">ALTERATION OF SHARE CAPITAL</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 - The share capital may be increased by any method and on any terms provided for by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shareholders at an Extraordinary General Meeting have exclusive authority to decide, on the basis of a report by the Board of Directors, to increase the share capital and to delegate powers or authority to the Board of Directors in order to carry out the capital increase in one or more stages in accordance with applicable laws and regulations, set the applicable terms, record the completion thereof and vary these Articles accordingly. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shareholders have a preferential right to subscribe for the shares issued for cash in the context of a capital increase, in proportion to the number of shares they already hold, and they may each waive their right. The shareholders at an Extraordinary General Meeting may decide to cancel this preferential subscription right in accordance with the law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2 - A capital reduction must be authorised or decided by the shareholders at an Extraordinary General Meeting and must not affect shareholder equality under any circumstances.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A capital reduction to an amount less than the minimum required by law may be decided on the condition that the share capital is first increased to an amount at least equal to the amount required by law, unless the legal form of the Company is changed to a form that does not require a share capital higher than that after the reduction thereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Otherwise, any interested person may petition a court of law to wind up the Company. A decision to that effect may not be made if, on the day on which the Court decides on the merits of the application, the matter has been resolved.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">CAPITAL REDEMPTION</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The share capital may be redeemed in accordance with Article L.&#160;225-198 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. of the French Commercial Code.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">PAYMENT FOR SHARES</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of a capital increase, at least one quarter of the par value of the shares issued for cash must be paid up upon subscription, together with the entire share premium (if applicable).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The balance must be paid in one or more instalments further to a call made by the Board of Directors, within five (5) years of the date of completion of the capital increase.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Calls for monies unpaid must be sent to the relevant subscribers and shareholders at least fifteen (15) days before the due date for each payment, by registered letter (with acknowledgement of receipt requested).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any shareholder that does not make the required payments in respect of their shares on the due date will be automatically liable, without notice, to pay the Company default interest calculated daily from the payment due date, at three (3) points above the statutory rate applicable in commercial matters.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to obtain monies unpaid, the Company has the right of enforcement and may impose the penalties provided for by Article L.&#160;228-27 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. of the French Commercial Code.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">FORM OF SHARES </font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shares may be bearer or registered shares, at the option of the shareholder and in accordance with the law. They shall be registered in an account in accordance with applicable laws and regulations. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to compliance with the terms and conditions provided for by law, the shares shall be registered in the name of their holders and at their discretion, either in a registered account managed by the issuing company, in a registered account managed by an outside entity or in bearer form with an approved intermediary. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">However, if a shareholder does not have their registered address in French territory within the meaning of Article&#160;102 of the French Civil Code, any intermediary may be registered on behalf of that holder, either in a collective account or in several individual accounts, one for each holder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shares may be involved in transactions carried out by the relevant securities clearing house.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">SHARE TRANSFERS &#8211; NOTIFICATION OF MAJOR HOLDINGS &#8211; RIGHTS AND OBLIGATIONS ATTACHING TO SHARES </font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Share transfers</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shares shall be freely negotiable upon issue, in accordance with the law.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">They shall be registered in an account in accordance with the terms and conditions provided for by the laws and regulations in force.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Share transfers, irrespective of the form thereof, shall be carried out by way of a transfer from one account to another in accordance with the terms and conditions provided for by law. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Notification of major holdings </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the statutory obligations to disclose information, to give notice of major holdings and, where applicable, to declare their intent, any natural or legal person and any legal entity, acting alone or in concert, who directly or indirectly holds, by any means whatsoever within the meaning of Article L.&#160;233-7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. of the French Commercial Code, a number of shares that represents 2% of the share capital and&#47;or voting rights in the Company, is required to inform the Company of the total number of shares and voting rights or securities they hold directly or indirectly and that grant future access to the share capital of the Company. Such notice must be sent by registered letter (with acknowledgement of receipt requested) to the registered office or by any other equivalent means for the shareholders or securities holders who are resident outside France, within five (5) trading days of the date on which this threshold is exceeded. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Such notice must be given again for each additional 2% of the share capital or voting rights, without limitation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This disclosure obligation applies on the above terms each time the fraction of share capital and&#47;or voting rights held by a shareholder falls below a multiple of 2% of the share capital or voting rights.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If no disclosure is duly made as stated above, further to a request made by one or more shareholders that hold at least 2% of the share capital or voting rights in the Company and that is recorded in the minutes of the General Meeting, the shares that exceed the percentage that should have been declared will be stripped of the right to vote at any Meeting of shareholders held within two (2) years of the date on which notice is given. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Rights and obligations associated with shares </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 - Each share entitles its holder to a portion of the Company&#8217;s profit, assets and liquidation surplus, in net proportion to the percentage of share capital it represents.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It also entitles its holder to take part in General Meetings and to vote on resolutions in accordance with the law and these Articles.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2 - Shareholder liability for the Company&#8217;s debts is limited to the amounts contributed by them. The rights and obligations attaching to shares shall remain attached thereto, irrespective of the holder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Share ownership automatically entails acceptance of, and an agreement to comply with, these Articles and the decisions taken at General Meetings of the Company&#8217;s shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3 - Whenever it is necessary to hold several shares in order to exercise a right of whatever kind (exchange, pooling, allotment of securities, capital increase or reduction, merger or any other corporate operation), the holders of single shares or of an insufficient number of shares may exercise this right on the condition that they arrange to pool and potentially purchase or sell the required number of securities.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Indivisibility of shares &#8211; Legal ownership &#8211; Beneficial ownership </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 - The Company recognises only one holder of each share.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The joint owners of undivided shares must be represented at General Meetings by one of their number or by a single representative. In the event of a disagreement, a representative shall be appointed by a court of law at the request of the first joint owner to act.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2 - Beneficial owners (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">usufruitiers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) have the right to vote at Ordinary General Meetings and legal owners (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">nus-propri&#233;taires</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) have the right to vote at Extraordinary General Meetings. However, the shareholders may agree to allocate the right to vote at General Meetings differently, providing that the beneficial owner is not deprived of the right to vote on decisions concerning distributions of profit. In such event, they must inform the Company of their agreement by sending a registered letter (with acknowledgement of receipt requested) to the registered office. The Company must apply the agreement for any meeting held more than one (1) month after that letter was received.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Voting rights shall be exercised by the holder of the securities pledged.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Legal owners may always take part in General Meetings, even if they do not have the right to vote. </font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">DOUBLE VOTING RIGHT</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The voting right attached to capital shares and dividend shares is proportionate to the amount of share capital they represent. Each share carries one voting right. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">However, a double voting right compared to that attached to the other shares in view of the portion of share capital they represent is allocated to all fully paid-up shares that are proven to have been registered for at least two (2) years in the name of the same shareholder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This double voting right shall also be granted, upon the issue of shares issued in the context of a capital increase through the capitalisation of reserves, profit or share premiums, in respect of the registered shares allotted to a shareholder free of charge on the basis of their existing shares for which they hold a double voting right.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A share transfer carried out as a result of an inheritance, division of marital property or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">inter vivos </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">gift made to a spouse or relative entitled to inherit will not result in the loss of the right acquired and will not suspend the above period.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing shall also apply in the event of a share transfer carried out as a result of a merger or spin-off involving a corporate shareholder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, any merger or spin-off involving the Company will not affect the double voting right, which may be exercised within the beneficiary company or companies if so provided by the Articles of the relevant company or companies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION III<br>MANAGEMENT</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">BOARD OF DIRECTORS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company shall be managed by a Board of Directors made up of no less than three (3) and no more than eighteen (18) members, subject to the exception provided for by law in the event of a merger. </font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">DIRECTORSHIPS</font></div></td></tr></table></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Appointment of directors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the Company&#8217;s existence, the directors shall be appointed by the shareholders at an Ordinary General Meeting. However, in the event of a merger or spin-off, they may be appointed by the shareholders at an Extraordinary General Meeting. The directors shall be appointed for a term of four (4) years. Their term of office shall end at the close of the Ordinary General Meeting of shareholders held in the year in which their term of office expires to decide on the financial statements for the previous financial year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The directors may be re-elected. They may be removed at any time by decision of the shareholders taken at an Ordinary General Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No individual over the age of eighty-five (85) may be a director. Any director who reaches this age limit whilst in office will be deemed to have automatically stepped down at the next General Meeting. Any appointment made in breach of the foregoing will be null and void, with the exception of interim appointments. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon their appointment and throughout their term of office, all natural person directors must comply with the law on the offices which an individual may concurrently hold in a limited company that has its registered office in mainland France, subject to the exceptions provided for by law. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">An employee of the Company may only be appointed as a director if their employment contract corresponds to an actual job position. No more than one third of the directors in office may have an employment contract with the Company.</font></div><div style="margin-bottom:12pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">14.2 Legal entity directors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The directors may be natural persons or legal entities. Upon the appointment of a legal entity, the latter must appoint a permanent representative, who shall be bound by the same requirements and obligations and shall incur the same liability in civil and criminal law as though they were a director in their own name, without prejudice to the joint and several liability of the legal entity they represent. The permanent representative of a legal entity director shall be subject to the same age limit as that applicable to natural person directors. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The permanent representative appointed by a legal entity director shall be appointed for the term of the legal entity&#8217;s directorship. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the legal entity removes its permanent representative from office, it must promptly notify the Company of the removal and of the identity of its new permanent representative by registered letter. The foregoing shall also apply if the permanent representative dies or resigns.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The appointment of a permanent representative and the termination of their office shall be subject to the same publicity formalities as would apply if the permanent representative were a director in their own name. </font></div><div style="margin-bottom:12pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">14.3 Board vacancies, death, resignation </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If one or more seats on the Board of Directors become vacant due to death or resignation, the Board may appoint interim directors between two General Meetings.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the number of directors falls below the minimum required by law, the remaining directors must immediately convene an Ordinary General Meeting in order to fill the vacancies.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interim appointments made by the Board shall be subject to ratification by the shareholders at their next Ordinary General Meeting. In the absence of ratification, the decisions and steps taken previously by the Board shall nevertheless remain valid.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">ORGANISATION AND DECISIONS OF THE BOARD</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Chairman of the Board</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors shall elect a Chairman from among its members, who must be a natural person, failing which their appointment will be null and void. The Board of Directors shall determine the Chairman&#8217;s remuneration in accordance with applicable laws and regulations. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chairman of the Board shall organise and oversee the work of the Board and report thereon to the shareholders at a General Meeting. The Chairman shall ensure that the Company&#8217;s bodies operate as required, and, in particular, that the directors are able to fulfil their duties.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chairman of the Board must be less than eighty-five (85) years of age. If the Chairman reaches this age limit whilst in office, they will be deemed to have automatically stepped down and a new Chairman must be appointed in accordance with this Article.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chairman shall be appointed for a term of office that must not exceed the term of their directorship, and they may be re-elected. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors may remove the Chairman from office at any time. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Chairman is subject to a temporary impediment or dies, the Board of Directors may appoint a director to fulfil the duties of Chairman.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of a temporary impediment, this authority shall be given for a limited period and may be renewed. If the Chairman dies, it shall apply until such time as a new Chairman has been elected. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Board meetings</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors shall meet as often as required in the interests of the Company, further to a meeting notice sent by the Chairman or two directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Board has not met for more than two (2) months, a minimum of one third of Board members may ask the Chairman to convene a Board meeting to decide on a specific agenda. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chief Executive Officer may also ask the Chairman to convene a Board meeting to decide on a specific agenda. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chairman shall be bound by any requests made to them pursuant to the previous two paragraphs. Meetings may be convened by any means, including verbally. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board shall meet at the registered office or at such other location (in France or another country) as may be stated in the meeting notice, and meetings shall be chaired by the Chairman of the Board or, if the Chairman is subject to an impediment, by a member appointed by the Board to act as Chairman. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chairman of the Board shall chair meetings. If the Chairman is subject to an impediment, the Board shall appoint a member present at the meeting to act as Chairman.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At each meeting, the Board may appoint a secretary, who may but need not be a member of the Board. </font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A register shall be kept and must be signed by the directors who take part in each Board meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The directors, as well as any person who is invited to attend a Board meeting, shall be bound by a duty of discretion with regard to information and data that are designated as confidential by the Chairman.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Quorum and majority</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board may only validly transact business if at least one half of the directors are present or deemed present, subject to the changes made by the Board&#8217;s rules of procedure for meetings held by video-conference or other method of telecommunication.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless these Articles state otherwise and subject to the changes made by the Board&#8217;s rules of procedure for meetings held by video-conference or other method of telecommunication, decisions must be taken by a majority of the votes cast by the members present, deemed present or represented. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of a tie, the Chairman shall have a casting vote.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the purpose of calculating the quorum and majority, the directors who take part in a Board meeting by video-conference or method of telecommunication in accordance with the Board&#8217;s rules of procedure shall be deemed present. However, directors must be present in person or by proxy for all Board decisions concerning the approval of the annual and consolidated financial statements, the drafting of the management report and the group management report (if applicable) and decisions concerning the removal of the Chairman of the Board of Directors, the Chief Executive Officer and the Deputy Chief Executive Officer.</font></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furthermore, one half of the directors in office may object to a Board meeting being held by video-conference or method of telecommunication. Notice of any such objection must be given in the form and within the time limit stated in the Board&#8217;s rules of procedure and&#47;or imposed by applicable law or regulations. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Representation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any director may give another director written permission to represent them at a Board meeting. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At any given meeting, each director may only hold one proxy form received pursuant to the previous paragraph. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These provisions apply to the permanent representative of a legal entity director.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Written consultations </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors may also make certain decisions within its remit by virtue of a written consultation, in accordance with the laws and regulations in force. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of a written consultation, the Chairman of the Board must send, by any means, including electronically, each of the directors, the statutory auditors and any representatives of the Economic and Social Committee, such documents as are needed to make decisions concerning items included on the agenda of the consultation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The directors shall have such period of time as shall be stated in the relevant documents in which to cast their vote and to submit their observations to the Chairman, by any written means, including electronically.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any director that does not respond within the specified time limit (which, if not stated in the relevant documents, shall be five (5) days from the date of transmission of the documents) shall be deemed to have abstained.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Minutes of written consultations shall be drawn up and signed by the Chairman&#59; they must then be sent along with each director&#8217;s response to the Company and retained in the same way as the minutes of Board meetings.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Minutes of decisions </font></div><div style="margin-bottom:12pt;padding-left:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Decisions taken by the Board of Directors shall be recorded in minutes entered in a special minute book, the pages of which must be initialled and signed, and which shall be held at the registered office as required by applicable regulations. </font></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">POWERS OF THE BOARD OF DIRECTORS &#8211; COMMITTEES &#8211; OBSERVERS</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Powers of the Board of Directors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors shall determine and oversee the implementation of the Company&#8217;s business strategy in its corporate interests, with consideration to be given to the social and environmental challenges associated with its business.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the powers expressly conferred on the shareholders and within the limit of the Company&#8217;s objects, the Board of Directors shall attend to all matters relating to the smooth running of the Company and shall settle matters concerning the Company by virtue of its decisions. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In dealings with third parties, the Company shall be bound even by the acts of the Board of Directors that fall outside the scope of its objects, unless it can prove that the third party involved knew that a particular act was outside the scope of the Company&#8217;s objects or could not have disregarded such fact in view of the circumstances, on the understanding that the publication of these Articles alone will not be sufficient proof of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors shall carry out such controls and checks as it deems appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chairman or the Chief Executive Officer is required to provide each director with the information needed to fulfil their duties. Each director may obtain such documents as they consider useful from the Chairman or the Chief Executive Officer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the decisions taken by the shareholders at their General Meeting of 19&#160;June 2020, the Board may vary these Articles as it sees fit in order to render them compliant with the laws and regulations in force, subject to ratification of the relevant decision by the shareholders at their next Extraordinary General Meeting. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Committees</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors may decide to set up committees responsible for examining and issuing an opinion on matters put to them by the Board or its Chairman. These committees shall report to the Board on their work.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors shall set the composition and duties of the committees, which shall operate under the responsibility of the Board. The Board shall set the remuneration of the committee members. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Observers</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the Company&#8217;s existence, the shareholders at an Ordinary General Meeting or the Board of Directors may appoint observers, who may but need not be shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No more than three (3) observers may be appointed. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">They shall be appointed for a period of one (1) year. Their duties will end at the close of the Ordinary General Meeting held in the year in which their mandates expire in order for the shareholders to decide on the financial statements for the previous financial year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any outgoing observer may be re-elected providing that they fulfil the requirements imposed under this Article. Their mandates may be renewed by decision taken by the shareholders at an Ordinary General Meeting or by the Board of Directors.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The observers may be removed and replaced at any time by the shareholders at an Ordinary General Meeting or by the Board of Directors, in which case they will not be entitled to any compensation. The duties of observers will also end due to the death or incapacity of a natural person member or the winding-up or compulsory administration of a legal entity member, or their resignation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">They may be natural persons or legal entities. In the latter case, upon its appointment, the legal entity must appoint a permanent representative, who shall be bound by the same requirements and obligations and shall incur the same liability in civil and criminal law as though they were an observer in their own name, without prejudice to the joint and several liability of the legal entity they represent. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The observers must strictly enforce these Articles and put forward their observations at Board meetings. They shall generally provide an ongoing advisory and monitoring service to the Company. However, they must not interfere under any circumstances in the management of the Company or generally act in place of the Company&#8217;s statutory bodies. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the context of their work, the observers may notably&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">put forward observations to the Board of Directors&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">ask to peruse any of the Company&#8217;s books, records, registers and documents at the registered office&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">request and obtain such information as is useful for their work from senior management and the Company&#8217;s statutory auditor&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">present a report on a specific matter to the shareholders at a General Meeting at the request of the Board. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The observers shall act both individually and collectively solely in an advisory capacity and shall not have the right to vote on the Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The observers may be invited to each Board meeting in the same way as the directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Decisions taken by the Board of Directors shall be valid notwithstanding any failure to invite an observer or members to a Board meeting or to provide them with documents prior to the meeting.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">SENIOR MANAGEMENT &#8211; DELEGATION OF POWERS </font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Senior management</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In accordance with the law, the Company shall be managed, under its responsibility, either by the Chairman of the Board of Directors or by another individual appointed by the Board of Directors with the title of Chief Executive Officer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors shall choose between the two management methods at any time and at least upon the expiry of the term of office of the Chief Executive Officer or of the Chairman of the Board of Directors if the latter is also the senior manager of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shareholders and third parties must be informed of this decision in accordance with the applicable decree. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board&#8217;s decision concerning the choice of management method must be taken by a majority of the directors present, represented or deemed present, on the understanding that the Chairman will not have a casting vote, subject to the specific provisions of Article 15.3 above if the directors take part in the Board meeting by video-conference or other method of telecommunication.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Company is managed by the Chairman of the Board of Directors, the following provisions concerning the Chief Executive Officer shall apply to the Chairman.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Chief Executive Officer</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chief Executive Officer has the broadest powers to act in all circumstances in the name of the Company. They shall exercise these powers within the limit of the Company&#8217;s objects and subject to the powers expressly conferred by law on the shareholders at a General Meeting and on the Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chief Executive Officer shall represent the Company in its dealings with third parties. The Company shall be bound even by the acts of the Chief Executive Officer that do not come within the scope of its objects, unless it can prove that the third party concerned knew that a particular act was not within the scope of its objects or could not have disregarded such fact in view of the circumstances, on the understanding that the publication of these Articles alone will not be sufficient proof of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Board of Directors chooses to separate the duties of Chairman and Chief Executive Officer, it shall appoint the Chief Executive Officer, set their term of office, determine their remuneration in accordance with the laws and regulations in force and, if applicable, set restrictions on their powers.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No-one aged seventy-five (75) or over may be appointed as Chief Executive Officer. The Chief Executive Officer&#8217;s term of office will automatically end at the annual Ordinary General Meeting convened to approve the Company&#8217;s financial statements and held after the date on which the Chief Executive Officer reaches such age. Subject to this reservation, the Chief Executive Officer may be re-elected.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Chief Executive Officer may be removed from office at any time by the Board of Directors. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Deputy Chief Executive Officers </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On a proposal by the Chief Executive Officer, whether they are also the Chairman of the Board of Directors or a different person, the Board of Directors may appoint one or more individuals as Deputy Chief Executive Officers &#8211; who may but need not be directors or shareholders &#8211; to assist the Chief Executive Officer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There may not be more than five (5) Deputy Chief Executive Officers. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a Deputy Chief Executive Officer is a director, their term of office shall not exceed the term of their directorship.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No-one aged seventy-five (75) or over may be appointed as Deputy Chief Executive Officer. The Deputy Chief Executive Officer&#8217;s term of office will automatically end at the annual Ordinary General Meeting convened to approve the Company&#8217;s financial statements and held after the date on which the Deputy Chief Executive Officer reaches such age. Subject to this reservation, the Deputy Chief Executive Officer may be re-elected.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Deputy Chief Executive Officers may be removed from office at any time by the Board of Directors, on a proposal by the Chief Executive Officer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In agreement with the Chief Executive Officer, the Board of Directors shall determine the scope and term of validity of the powers conferred on the Deputy Chief Executive Officers. The Board of Directors shall determine their remuneration in accordance with the law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In dealings with third parties, the Deputy Chief Executive Officers shall have the same powers as the Chief Executive Officer.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Chief Executive Officer ceases or is unable to perform their duties, unless the Board of Directors decides otherwise, the Deputy Chief Executive Officers shall retain their duties and responsibilities until a new Chief Executive Officer has been appointed.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Delegation of powers </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors may appoint agents &#8211; who may but need not be directors &#8211; to perform such occasional or permanent tasks as shall be determined by the Board, delegate powers to those agents and set their remuneration as it sees fit.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">DIRECTORS&#8217; REMUNERATION </font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shareholders at a General Meeting may allocate an annual fixed amount to the directors as remuneration for their work, which the shareholders shall determine without being bound by previous decisions. Any such remuneration shall be booked as operating expenses.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors shall distribute the full allotted amount between its members as it sees fit. It may notably allot to the directors who are members of specialist committees an amount higher than that allotted to the other directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board of Directors may allot exceptional fees in connection with the tasks or assignments allocated to directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board may authorise the reimbursement of the travel and other expenses incurred by the directors in the Company&#8217;s interests.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">AGREEMENTS BETWEEN THE COMPANY AND A DIRECTOR, THE CHIEF EXECUTIVE OFFICER, A DEPUTY CHIEF EXECUTIVE OFFICER OR A SHAREHOLDER THAT HOLDS MORE THAN 10% OF VOTING RIGHTS</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Agreements subject to authorisation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any agreement other than those concerning ordinary transactions entered into under arm&#8217;s length conditions that is entered into directly or through an intermediary between the Company and one of its directors, the Chief Executive Officer, a Deputy Chief Executive Officer or a shareholder that holds more than 10% of voting rights in the Company or, in the case of a legal entity shareholder, the company that controls it within the meaning of Article L.&#160;233-3 of the French Commercial Code, are subject to the prior authorisation of the Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing also applies to agreements in which any of the persons referred to in the previous paragraph has an indirect interest.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreements entered into between the Company and an undertaking are also subject to prior authorisation if the Chief Executive Officer, a Deputy Chief Executive Officer or a director of the Company is the owner, a partner or shareholder with unlimited liability, a manager, a director, a Supervisory Board member or, generally, an executive of that undertaking.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These agreements must be authorised and approved as required by law.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Prohibited agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The directors other than legal entity directors are prohibited from taking out any form of loan with the Company, from having the Company grant them an overdraft on a current account or otherwise, and from having the Company guarantee or endorse their commitments to third parties, failing which the relevant agreement will be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The same prohibition applies to the Chief Executive Officer, the Deputy Chief Executive Officers and the permanent representatives of legal entity directors. It also applies to the spouses, ascendants and descendants of the persons referred to in this Article and to any intermediary.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Ordinary agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreements concerning ordinary operations that are entered into under arm&#8217;s length conditions are not subject to the statutory authorisation and approval procedure. </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION IV<br>AUDITS OF THE COMPANY&#8217;S FINANCIAL STATEMENTS</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">APPOINTMENT OF STATUTORY AUDITORS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s financial statements shall be audited by one or more principal &#8211; and, if applicable, alternate &#8211; statutory auditors, who shall be appointed and who shall perform their duties as required by law. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the Company&#8217;s existence, the statutory auditors shall be appointed by the shareholders at an Ordinary General Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For each principal statutory auditor, an alternate statutory auditor may be appointed. Any alternate statutory auditors shall be appointed at the same time as the principal statutory auditors and for the same term, and shall replace the principal statutory auditors if the latter refuse to act, are subject to an impediment, resign or die.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The statutory auditors shall be appointed for six (6) financial years by the shareholders at an Ordinary General Meeting. Their engagements will expire after the Ordinary General Meeting held to decide on the financial statements for the sixth financial year.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">STATUTORY AUDITORS&#8217; DUTIES</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The statutory auditors are vested with the duties and powers conferred on them by the laws and regulations in force. They may carry out such checks and audits as they consider appropriate at any time of the year. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The statutory auditors must be convened to all shareholder meetings at the latest at the same time as the shareholders themselves.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The statutory auditors&#8217; remuneration shall be determined in accordance with the regulations in force.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">They must be convened to the Board of Directors&#8217; meeting at which the Board approves the financial statements for the previous year and, if applicable, to any other Board meeting, at the same time as the directors themselves.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The statutory auditors must be convened by registered letter (with acknowledgement of receipt requested).</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION V<br>SHAREHOLDER MEETINGS</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">QUORUM AND MAJORITY</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At General Meetings, the shareholders shall transact business in accordance with the law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ordinary and Extraordinary General Meetings shall be held when convened for the first &#8211; or second if applicable &#8211; time in accordance with the quorum requirements imposed by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Decisions taken at General Meetings must be taken in accordance with the majority requirements imposed by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shareholders at an Ordinary General Meeting shall make all decisions other than those that are within the exclusive remit of the shareholders at an Extraordinary General Meeting according to the law and these Articles.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shareholders at an Extraordinary General Meeting have exclusive remit to vary the provisions of these Articles, subject to the provisions of Articles 3 and 16 hereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a meeting is held by video-conference or other method of telecommunication permitted by law in accordance with Article&#160;23 below, for the purpose of calculating the quorum and majority, the shareholders who take part in the meeting by video-conference or method of telecommunication will be deemed to be present.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">NOTICE OF GENERAL MEETINGS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">General meetings shall be convened by the Board of Directors, by the statutory auditors or by an agent appointed by a court of law in accordance with the terms and conditions provided for by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">They shall be held at the registered office or at such other location as may be stated in the meeting notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For so long as the shares in the Company are admitted to trading on a regulated market or if the shares are not all registered shares, the Company is required, at least thirty-five (35) days before any meeting, to publish notice of the meeting &#8211; such notice to contain the information required by the laws and regulations in force &#8211; in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Bulletin des Annonces L&#233;gales Obligatoires</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (BALO, the Gazette of Compulsory Legal Announcements).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">General Meetings must be convened through publication of a notice in a newspaper authorised to publish legal announcements in the county in which the registered office is located and in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Bulletin des Annonces L&#233;gales Obligatoires</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (BALO).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">However, in place of the notices published as stated in the previous paragraph, notice may be given, at the Company&#8217;s expense, by letter sent by ordinary post or registered letter to each shareholder. Notice may also be given electronically in accordance with the regulations in force.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any shareholder may also, if the Board so decides when a meeting is convened, take part in and vote at meetings held by video-conference or any method of telecommunication by which they can be identified, in accordance with the terms and conditions of the laws and regulations in force. </font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any meeting that is not convened as required may be cancelled. However, action to declare a meeting null and void will be inadmissible if all the shareholders were present or represented.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">MEETING AGENDA</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The agenda of a meeting shall be set by the person who convenes the meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">However, one or more shareholders representing at least 5% of the share capital (or a group of shareholders that fulfil the requirements imposed by law) may, in accordance with the law, ask for draft resolutions to be added to the agenda of a meeting. Such requests must be sent along with the draft resolutions and may or may not be sent along with a brief explanation of the reasons for the request.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Such draft resolutions, of which the shareholders must be informed, shall be added to the agenda and put to the vote at the meeting. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At the meeting, the shareholders may only discuss items included on the agenda.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nonetheless, they may remove and replace one or more directors in any circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The agenda of a reconvened meeting must be identical to the agenda of the meeting originally convened.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">ADMISSION TO MEETINGS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any shareholder may take part, in person, by proxy or by correspondence, in all types of General Meetings.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to be entitled to take part in General Meetings, the shareholders must produce proof of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">for registered shares, that they were registered, within the time limit imposed by law prior to the Meeting, in the registered share accounts held by the Company&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7pt">for bearer shares, that they were registered, within the time limit imposed by law prior to the Meeting, in the bearer share accounts held by the authorised intermediary.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The booking or registration of securities in the bearer securities accounts kept by the authorised intermediary shall be recorded in a certificate issued by the said intermediary.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any shareholder whose shares have not been fully paid-up may not attend meetings.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">SHAREHOLDER REPRESENTATION AND POSTAL BALLOTS</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Shareholder representation </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A shareholder may be represented by another shareholder, by their spouse or partner with whom they have entered into a civil partnership or by any person of their choosing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any shareholder may receive a proxy form in order to represent another shareholder at a meeting. In this respect, no limits apply other than those imposed by law that set the maximum number of votes that may be held by the same person, in their own name and as a proxy.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Postal ballots</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When a meeting has been convened, a postal ballot form and its attachments must be delivered in person or sent, at the Company&#8217;s expense, to any shareholder who makes a written request to that effect.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company must accept any request deposited or received at the registered office at least six (6) days before the date of the meeting.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">MEETING OFFICERS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shareholder meetings must be chaired by the Chairman of the Board of Directors or, in their absence, by a director appointed for that purpose by the Board. Otherwise, the shareholders must elect a chairman themselves.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a meeting is convened by the statutory auditors, a court-appointed agent or the liquidators, it must be chaired by the person or one of the persons who convened it.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The two consenting persons present at the meeting who hold the most votes shall act as tellers.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The meeting officers must appoint a secretary, who may but need not be a shareholder.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">MINUTES OF DECISIONS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The decisions taken at shareholder meetings must be recorded in minutes drawn up and signed by the meeting officers.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">They must state the date and venue of the meeting, the method used to convene the meeting, the agenda, the meeting officers, the number of shares involved in the vote and the quorum reached, the documents and reports submitted to the shareholders, a summary of the discussions, the resolutions put to the vote and the results of the voting process.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Minutes must be entered in a special minute book kept at the registered office in accordance with the regulations in force.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If, in the absence of the required quorum, the shareholders cannot validly transact business, minutes must be drawn up by the officers of the meeting to record the foregoing.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">SHAREHOLDERS&#8217; RIGHT TO INFORMATION AND RIGHT OF SCRUTINY </font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Before each meeting, the Board of Directors must make available to the shareholders the documents they need to make informed decisions and to make an informed judgment on the management and running of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Following receipt of the above documents, any shareholder may submit written questions, in accordance with the laws and regulations in force, to which the Board of Directors must respond at the meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any shareholder has the right to obtain, at any time, the documents that the Board of Directors is required to make available to them at the registered office or to send to them in accordance with the laws and regulations in force.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION VI<br>FINANCIAL YEAR &#8211; ANNUAL FINANCIAL STATEMENTS &#8211; ACCOUNTING AND FINANCIAL INFORMATION &#8211; APPROPRIATION OF PROFIT&#47;LOSSES </font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">FINANCIAL YEAR</font></div></td></tr></table></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The financial year has a term of twelve months. It begins on the first of January and ends on the thirty-first of December each year.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">ANNUAL FINANCIAL STATEMENTS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At the end of each financial year, the Board of Directors must prepare a statement of the Company&#8217;s assets and liabilities at year end, as well as the annual financial statements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It must draw up a management report on the Company&#8217;s position and business during the past year, its operating results, the progress made and difficulties encountered, its foreseeable development and future prospects, any significant events that have occurred between year end and the date of the report, and its research and development activities.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The annual financial statements, the management report and, where applicable, the consolidated financial statements and group management report must be made available to the statutory auditors at the registered office at least one month before the meeting at which the shareholders are to decide on the Company&#8217;s annual financial statements is convened.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">APPROPRIATION AND DISTRIBUTION OF PROFIT&#47;LOSSES</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the annual financial statements approved by the shareholders at a General Meeting show that the Company has generated a distributable profit, as defined by law, the shareholders may decide to appropriate that profit to one or more reserves &#8211; in which case they must decide how it will be allocated or used &#8211;, carry the profit forward or distribute it.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shareholders at a General Meeting may choose to receive the whole or part of any dividend or interim dividend in cash or shares, in accordance with the law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Following the approval of the financial statements by the shareholders at a General Meeting, any loss must be carried forward and set off against profit for future financial years until it has been cleared.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The portion of profit to which each shareholder is entitled and each shareholder&#8217;s liability for any loss shall be proportionate to its interest in the share capital.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">EQUITY LESS THAN ONE HALF OF SHARE CAPITAL </font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If, owing to losses recorded in the accounting documents, the Company&#8217;s equity falls below one half of its share capital, the Board of Directors is required, within four (4) months of the approval of the financial statements showing the loss, to convene an Extraordinary General Meeting of shareholders to decide whether to wind up the Company early.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a decision is made not to wind up the Company, subject to the provisions of Article L.&#160;224-2 of the French Commercial Code, the Company is required, by the end of the second financial year following that in which the loss was recorded, to reduce its share capital at least by the amount of the loss that cannot be appropriated to the reserves unless, within that timeframe, it has rebuilt its equity to an amount equal to at least one half of its share capital. If these requirements are not met, any interested person may petition a court of law to wind up the Company. However, the Court may not make an order for the Company to be wound up if, on the day on which it decides the case, the situation has been remedied.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION VII<br>WINDING-UP &#8211; LIQUIDATION &#8211; DISPUTES</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">WINDING-UP &#8212; LIQUIDATION</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon the expiry of the term of incorporation set by the Company or if the Company is wound up early, the shareholders at a General Meeting must decide the terms of the liquidation proceedings and appoint one or more liquidators, whose powers shall be determined by the shareholders and who shall perform their duties as required by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If all shares in the Company are held by a sole shareholder, the expiry of the term of incorporation of the Company or the winding-up of the Company for whatever reason shall entail the transfer of all of its assets and liabilities to the legal entity sole shareholder, without the need to liquidate the Company, subject to the creditors&#8217; right of opposition, in accordance with the provisions of Article 1844-5 of the French Civil Code.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.73pt">DISPUTES</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any dispute that may arise during the Company&#8217;s existence or upon its liquidation between the Company and its shareholders or directors or between the shareholders themselves concerning the Company&#8217;s affairs shall be heard and decided in accordance with the law and referred to the competent courts.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Page 22</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>3
<FILENAME>abivax-20xfxex21descriptio.htm
<DESCRIPTION>EX-2.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i25f8291e4fe8475ab628fbcaa741fdab_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 2.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div><font><br></font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following description of the ordinary shares, the American Depositary Shares and the articles of association, or bylaws, of Abivax SA (&#8220;Abivax,&#8221; the &#8220;Company,&#8221; &#8220;us&#8221; or &#8220;we&#8221;) is a summary and does not purport to be complete. This summary is subject to, and qualified in its entirety by reference to, the complete text of the Company&#8217;s bylaws, which are incorporated by reference as Exhibit 3.1 of the Company&#8217;s Annual Report on Form 20-F to which this description is also an exhibit. The Company encourages you to read the Company&#8217;s bylaws carefully.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2023, Abivax had the following series of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.093%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Title of Each Class</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Trading Symbol</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Name of Each Exchange on Which Registered</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Ordinary shares, nominal value &#8364;0.01 per share</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Nasdaq Global Market*</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">American Depositary Shares, each representing one ordinary share, nominal value &#8364;0.01 per share</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">ABVX</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Nasdaq Global Market</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">* Not for trading, but only in connection with the registration of the American Depositary Shares.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ORDINARY SHARES</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2023, our issued share capital consisted of a total of 62,928,818 ordinary shares with a nominal value of &#8364;0.01 per share. Of these issued ordinary shares, 62,917,479 shares are outstanding and 11,339 are treasury shares.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The description below reflects the terms of our bylaws and summarizes the material rights of holders of our ordinary shares under French law. Please note that this is only a summary and is not intended to be exhaustive. For further information, please refer to the full text of our bylaws, which are incorporated by reference as Exhibit 3.1 of the Company&#8217;s Annual Report on Form 20-F to which this description is also an exhibit.</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; Meetings and Voting Rights (Articles 12, 22, 23, 24, 25 and 26 of the By-Laws) </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">General </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with the French Commercial Code (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Code de Commerce</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), there are three types of shareholders&#8217; meetings&#58; ordinary, extraordinary and special. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shareholders&#8217; meetings are required to elect, replace or remove directors, appoint independent statutory auditors, approve the annual financial statements, approve share repurchase programs, declare dividends or authorizing dividends to be paid in shares and approve regulated agreements. In addition, pursuant to recommendation of the French Market Authority (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Autorit&#233; des March&#233;s Financiers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) (&#8220;AMF&#8221;), French listed companies may be required to conduct a consultation of the Ordinary Shareholders Meeting prior to the disposal of the majority of their assets, under certain conditions. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extraordinary shareholders&#8217; meetings are required for approval of matters such as amendments to our by-laws, including amendments required in connection with extraordinary corporate actions (i.e., changing our name, corporate purpose or registered office, increasing or decreasing our share capital and creating a new class of equity securities (ordinary or preferred shares)). Shareholders&#8217; rights may be modified as allowed by French law. Only the extraordinary shareholders&#8217; meeting is authorized to amend any and all provisions of our by-laws. It may not, however, increase shareholder commitments without the prior approval of each shareholder. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special meetings of holders of a certain category of shares or of securities giving access to our share capital are required for any modification of the rights relating to such categories of shares. The resolutions of the shareholders&#8217; meeting modifying these rights are effective only after they have been approved by the relevant special meeting. </font></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Special Voting Rights of Warrant Holders </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, the holders of warrants of the same class (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">i.e.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> warrants that were issued at the same time and with the same rights), including founder&#8217;s share warrants (BCEs), are entitled to vote as a separate class at a general meeting of that class of warrant holders under certain circumstances, principally in connection with any proposed modification of the terms and conditions of the class of warrants or any proposed issuance of preferred shares or any modification of the rights of any outstanding class or series of preferred shares. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Shareholders&#8217; Meetings </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Board convenes an annual ordinary shareholders&#8217; meeting for the approval of the annual financial statements. This meeting is held within six months of the end of each fiscal year. This period may be extended by an order of the President of the French Commercial Court (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tribunal de Commerce</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) at the request of the Board. The Board may also convene an ordinary or extraordinary shareholders&#8217; meeting upon proper notice at any time during the year. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the Board fails to convene a shareholders&#8217; meeting at the shareholders&#8217; request, our statutory auditors may call the meeting. In the event of bankruptcy, the liquidator or court-appointed agent may also call a shareholders&#8217; meeting. In addition, any of the following may request the President of the French Commercial Court to appoint an agent to convene the shareholders&#8217; meeting&#58; one or several shareholders holding at least 5% of our share capital, any interested party in cases of urgency, the workers council in cases of urgency or duly qualified associations of shareholders who have held their shares in registered form for at least two years and who together hold a minimum number of the voting rights of our share capital. Shareholders holding a majority of the share capital or voting may also convene a shareholders&#8217; meeting after the filing of a public offer or sale of a controlling interest in our share capital. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; meetings shall be chaired by the chairperson of the Board or, in his or her absence, by a Deputy chairperson or by a director elected for this purpose. Failing that, the meeting itself shall elect a chairperson. Vote counting shall be performed by the two members of the meeting who are present and accept such duties, who represent, either on their own behalf or as proxies, the greatest number of votes. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Notice of Shareholders&#8217; Meeting </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to French law requirements in relation to notice of shareholders&#8217; meetings and announce shareholders&#8217; meetings at least 35 days in advance by means of a preliminary notice published in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Bulletin des annonces l&#233;gales obligatoires</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (BALO), as well as on our website at least 21&#160;days prior to the meeting. At least 15 days prior to the date set for a shareholders&#8217; meeting, or ten days if it is a second call, we must publish a final notice in accordance with French law requirements. In addition to the particulars relative to us, the final notice indicates, notably, the meeting&#8217;s agenda and the draft resolutions that will be presented. The requests for recording of issues or draft resolutions on the agenda must be addressed to the company under the conditions provided for in the current legislation. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, shareholders can only take action at shareholders&#8217; meetings on matters listed on the agenda for the meeting. As an exception to this rule, shareholders may take action, among other things, with respect to the dismissal of directors, even if these actions have not been included on the agenda. The Board must submit properly proposed resolutions to a vote of the shareholders. When a shareholder submits a blank proxy form without naming a representative, his vote is deemed to be in favor of the resolutions (or amendments) proposed or recommended by the Board and against all others. As of the date of the publication of the final notice of a meeting but no later than four business days before the shareholders&#8217; meeting, any shareholder may submit written questions to the Board relating to the agenda for the meeting. The Board must respond to these questions during the meeting. A common answer can be given to several questions if they have the same content or bear on the same topic. The answer to a written question is deemed to have been given insofar as it is published on our website in a section devoted to questions and answers. </font></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Agenda and Conduct of Annual Shareholders&#8217; Meetings. </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The agenda of the shareholders&#8217; meeting shall appear in the notice to convene the meeting and is set by the author of the notice. The shareholders&#8217; meeting may only deliberate on the items on the agenda except for the removal of directors and the appointment of their successors which may be put to vote by any shareholder during any shareholders&#8217; meeting. Pursuant to French law and our current share capital, one or more shareholders representing 5% of our share capital may request the inclusion of items or proposed resolutions on the agenda. Such request must be received at the latest on the 25th day preceding the date of the shareholders&#8217; meeting, and in any event no later than the 20th day following the date of the convening notice to the shareholders&#8217; meeting. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Attendance and Voting at Shareholders&#8217; Meetings </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership of one share implies, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">ipso jure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, adherence to our by-laws and the decision of the shareholders&#8217; meeting. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The voting rights attached to equity or dividend shares are proportional to the percentage of the share capital they represent. Each share entitles the holder to one vote. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">However, a double voting right compared to that conferred to other shares with regard to the percentage of share capital they represent is allocated to all fully paid-up ordinary shares with proof of being held in registered form by the same owner for at least two (2)&#160;years. Under French law, treasury shares or ordinary shares held by entities controlled by us are not entitled to voting rights and do not count for quorum purposes. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In order to participate in any general meeting, shareholders are required to have their shares registered under the conditions and time limits provided for the applicable laws before such general meeting in their name or in the name of an intermediary registered on their behalf, either in the registered shares shareholder account or in the bearer shares shareholder account. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Proxies and Votes by Mail or Videoconference </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, all shareholders who have properly registered and fully paid their shares or duly presented a certificate from their accredited intermediary may participate in shareholders&#8217; meetings. Shareholders may participate in shareholders&#8217; meetings either in person, by proxy or by mail or, if provided for by the by-laws, by videoconference or by any means of telecommunications in accordance with applicable regulations, if the Board provides for such possibility when convening the meeting. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proxies are sent to any shareholder upon request. In order to be counted, such proxies must be received at our registered office, or at any other address indicated on the notice convening the meeting, prior to the date of the meeting. A shareholder may grant proxies to his or her spouse, civil partner, to another shareholder or to any other person (individual or legal) of his&#47;her&#47;its choice. A shareholder that is a corporation may grant proxies to a legal representative. A shareholder who is a non-resident of France may be represented at a shareholders&#8217; meeting by an intermediary registered under the conditions set forth by French law. Alternatively, the shareholder may send a blank proxy to us without nominating a representative. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With respect to votes by mail, we will send shareholders a voting form. The completed form must be returned to us at least three days prior to the date of the shareholders&#8217; meeting. The final date for returning votes by mail is disclosed in the notice of meeting published in accordance with French law requirements. Under our by-laws, shareholders&#8217; meetings by means of telecommunications permitting their identification are possible if the Board so determines in the preliminary or final notice of the meeting. Shareholders voting by proxy, mail, authorized intermediary or, if provided for in the preliminary or final notice of the meeting by any means of telecommunications permitting them to be identified, will be considered to be present at the meeting for the computation of the quorum and the majority. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A shareholder who has voted by correspondence will no longer be able to participate directly in the meeting or to be represented. In the case of returning the proxy form and the voting by correspondence form, the proxy form is taken into account, subject to the votes cast in the voting by correspondence form. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Quorum </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For an ordinary shareholders&#8217; meeting to be quorate, one-fifth of the holders of shares entitled to voting rights must be present in person or vote by mail or by proxy or by authorized intermediary or by any means of telecommunication permitting their identification. An extraordinary shareholders&#8217; meeting is quorate if one-fourth of the holders of shares entitled to voting rights are present or vote by mail or by proxy or by authorized intermediary or by any means of telecommunication. As an exception, an extraordinary shareholders&#8217; meeting deciding upon a share capital increase by capitalization of reserves, profits or share premium has the same quorum requirement as an ordinary shareholders&#8217; meeting. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the requirements for a quorum are not satisfied, the meeting is adjourned. When an adjourned ordinary shareholders&#8217; meeting is resumed, there is no quorum requirement. Extraordinary shareholders&#8217; meetings require a quorum of one-fifth of the holders of shares entitled to voting rights. If a quorum is not present, the reconvened meeting may be adjourned for a maximum of two months. No deliberation by the shareholders may take place without a quorum. For special meetings of holders of a certain class of shares, the quorum requirement is one-third of the certain class of shares entitled to voting rights for the meeting convened on the first call. Should the special </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">meeting be reconvened, the quorum requirement is one-fifth of the certain class of shares entitled to voting rights for the meeting. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Majority </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A simple majority of shareholders may pass a resolution at either an ordinary shareholders&#8217; meeting or an extraordinary shareholders&#8217; meeting deciding upon a share capital increase by capitalization of reserves, profits or share premium. At any other extraordinary shareholders&#8217; meeting, a two-thirds majority of the shareholder votes cast is required. A unanimous shareholder vote is required to increase shareholders&#8217; liabilities. Abstention from voting by those present either in person or by means of telecommunications if provided for by the by-laws, or those represented by proxy or voting by mail is counted as a vote against the resolution submitted to a shareholder vote. In general, each shareholder is entitled to one vote per share at any shareholders&#8217; meeting. Under the French Commercial Code, shares of a company held by it or by entities controlled directly or indirectly by that company are not entitled to voting rights and do not count for quorum or majority purposes. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Financial Statements and Other Communications with Shareholders </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with the annual ordinary shareholders&#8217; meeting, we must provide or make available to any shareholder a set of documents including, among other things, our annual report, the annual and consolidated accounts, the statutory auditors&#8217; reports and a draft of the meeting&#8217;s resolutions. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The chairperson of the Board is required to deliver a special report to the annual ordinary shareholders&#8217; meeting regarding the composition of the Board, the representation of men and women in its composition, the status of the preparation and organization of the work of the Board, the status of the internal control procedures that we have implemented, including those in connection with the treatment of the accounting and financial statements and principles and rules that it establishes to determine management compensation and benefits. French law requires that a special report be provided annually to the ordinary shareholders&#8217; meeting regarding stock options authorized and&#47;or granted by the company. </font></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rights, Preferences and Restrictions Attaching to Ordinary Shares (Articles&#160;7, 11, 30, 31 and 32 of the By-Laws) </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Dividends </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We only distribute dividends out of our &#8220;distributable profits,&#8221; plus any amounts filed in its reserves that the shareholders decide to make available for distribution, other than those reserves that are specifically required by French law or our by-laws. &#8220;Distributable profits&#8221; consist of our net profit in each fiscal year, as increased or reduced by any profit or loss carried forward from prior years, less any contributions to the reserve accounts pursuant to French law or our by-laws. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Legal Reserve </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, we are required to allocate 5% of our net income for each fiscal year, after reduction for losses carried forward from previous years, if any, to a legal reserve fund until the amount in the legal reserve is equal to 10% of the aggregate nominal value of the share capital. The legal reserve subject to this requirement may only be used to offset losses when other reserves cannot be used and, in particular, may not be distributed to shareholders until our liquidation. As of December&#160;31, 2022, our legal reserve was &#8364;0. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Approval of Dividends </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders may decide in an ordinary shareholders&#8217; meeting, upon proposal of the Board, to allocate all or part of the distributable profits to special or general reserves, to carry them forward to the following fiscal year as retained earnings, or to allocate them to the shareholders as dividends. Dividends may be paid in cash or as shares upon the option of the shareholders if such option is granted at the annual ordinary shareholders&#8217; meeting. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we have earned distributable profits since the end of the preceding fiscal year, as reflected in an interim income statement certified by its auditors, the Board may distribute interim dividends to the extent of the distributable profits for the period covered by the interim income statement before approval of the annual financial statements. Subject to French law, the Board may declare interim dividends paid in cash without obtaining shareholder approval. For interim dividends paid in shares, prior authorization by an ordinary shareholders&#8217; meeting is required. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Distribution of Dividends and Timing of Payment </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In principle, dividends are distributed to shareholders pro rata according to their respective shareholdings. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Timing of Payment </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, we must pay any dividends within nine months of the end of our fiscal year, unless otherwise authorized by an order of the President of the French Commercial Court. Dividends on shares that are not claimed within five years of the date of declared payment revert to the French State. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the case of interim dividends, distributions are made to shareholders on the date set by our Board during the meeting in which the distribution of interim dividends is approved. The actual dividend payment date is decided by the shareholders at an annual shareholders&#8217; meeting or by our Board in the absence of such a decision by the shareholders. Shareholders that own shares on the actual payment date are entitled to the dividend. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders may be granted an option to receive dividends in cash or in shares, in accordance with legal conditions. The conditions for payment of dividends in cash shall be set at the shareholders&#8217; meeting or, failing this, by the Board. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Increases in Share Capital </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our share capital may only be increased by obtaining the approval of the shareholders at an extraordinary shareholders&#8217; meeting upon the recommendation of the Board. The decision to increase share capital through increases in the nominal value of existing shares requires unanimous approval at an extraordinary shareholders&#8217; meeting. The decision to increase share capital through the capitalization of reserves, profits and&#47;or share premiums must be submitted to an extraordinary shareholders&#8217; meeting applying the quorum and majority requirements applicable to ordinary shareholders&#8217; meetings. In the case of an increase in share capital in connection with the payment of a share dividend the voting and quorum procedures of an ordinary shareholders&#8217; meetings apply. All other share capital increases require the approval of an extraordinary shareholders&#8217; meeting. See &#8220;Description of Share Capital&#8212;Shareholders&#8217; Meetings and Voting Rights (Articles 6, 12 and 22 of the By-Laws)&#8221; above. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases in our share capital may be effected by&#58; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;issuing additional shares&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;increasing the par value of existing shares&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;creating a new class of equity securities&#59; and </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;exercising the rights attached to securities giving access to the share capital. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases in share capital by issuing additional securities may be effected through one or a combination of the following&#58; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;in consideration for cash&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;in consideration for assets contributed in kind&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;through an exchange offer&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;by conversion of previously issued debt instruments&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;by capitalization of profits, reserves or share premium&#59; and </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;subject to certain conditions, by way of offset against debt incurred by us. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to certain conditions, shareholders may delegate the authority (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d&#233;l&#233;gation de comp&#233;tence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) or the powers (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d&#233;l&#233;gation de pouvoirs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) to carry out certain increases in our share capital to the Board following approval at an extraordinary shareholders&#8217; meeting. The Board may further sub-delegate this right to the Chief Executive Officer. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Reduction in Share Capital </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, any reduction in our share capital requires approval of the shareholders at an extraordinary shareholders&#8217; meeting. The share capital may be reduced either by decreasing the nominal value of the outstanding shares or by reducing the number of outstanding shares. The number of outstanding shares may be reduced by the repurchase and cancellation of the shares. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of each class of shares must be treated equally unless each affected shareholder agrees otherwise. As a general matter, reductions of capital occur pro rata among all shareholders, except (i)&#160;in the case of a share buyback program, or a public tender offer to repurchase shares, where such a reduction occurs pro rata only among tendering shareholders and (ii)&#160;in the case where all shareholders unanimously consent to a non-pro-rata reduction. In any case, we must not own more than 10% of our outstanding share capital. The extraordinary shareholders&#8217; meeting may authorize the buy-back program for a period not exceeding 18 months. In addition, we may not cancel more than 10% of our outstanding share capital over any 24-month period. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Preferential Subscription Rights </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">According to French law, existing shareholders have preferential subscription rights to these securities on a pro rata basis if we issue certain kinds of additional securities. These preferential subscription rights require us to give priority treatment to existing shareholders. The rights entitle the individual or entity that holds them to subscribe to an issue of any securities that may increase our share capital by means of a cash payment or a settling of cash debts. Pursuant to applicable law, subscription rights are transferable during a period starting two days prior the opening of the subscription period (or, if such day is not a business day, the preceding trading day) and ending two days prior the closing of the subscription period (or, if such day is not a business day, the preceding trading day). </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A two-thirds majority of the shares entitled to vote at an extraordinary shareholders&#8217; meeting may vote to waive preferential subscription rights with respect to any particular offering or a portion of that offering. French law requires that the Board and our statutory auditors present reports that specifically address any proposal to waive preferential subscription rights. In the event of a waiver, the issue of securities must be completed within the period prescribed by French law. The shareholders may also decide at an extraordinary shareholders&#8217; meeting to give existing shareholders a non-transferable priority right to subscribe to such new securities during a limited period of time. Shareholders also may notify us that they wish to waive their own preferential subscription rights with respect to any particular offering if they so choose. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a share capital increase without preferential subscription rights to existing shareholders to the benefit of qualified investors under Article L. 411-2 of the French Monetary and Financial Code, French law requires that the capital increase be made at a price equal to or exceeding the weighted-average market price of the shares in the three trading days preceding the setting of the price (such weighted-average-market price may be reduced by a maximum discount of 10%). However, within the limit of 10% of the share capital per year, the extraordinary shareholders&#8217; meeting may authorize the Board to set the issuing price in accordance with terms established by the extraordinary shareholders&#8217; meeting. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form, Holding and Transfer of Shares (Articles 10 and 11 of the By-Laws) </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Form of Shares </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our by-laws provide that the shares once fully paid may be held in registered or bearer form at the option of the shareholder, subject to applicable laws. Shares not fully paid must be nominal. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Holding of Shares </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with French law, shareholders&#8217; ownership rights are represented by book entries instead of share certificates. Shares issued are registered in individual accounts opened by us or any authorized intermediary, in the name of each shareholder and kept according to the terms and conditions laid down by the legal and regulatory provisions. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any owner of our shares may elect to have its shares held in registered form and registered in its name in an account currently maintained by Uptevia, 12 place des Etats-Unis, CS 40083, 92549 Montrouge Cedex, France for and on our behalf or held in bearer form and recorded in its name in an account maintained by an accredited financial intermediary, such as a French broker, bank or other authorized financial institution. Any shareholder may, at its expense, change from one form of holding to the other. Both methods are operated through Euroclear. In addition, according to French law, shares held by any non-French resident may be held on the shareholder&#8217;s behalf in a collective account or in several individual accounts by an intermediary. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">When our shares are held in bearer form by a beneficial owner who is not a resident of France, Euroclear may agree to issue, upon our request, a bearer depository receipt with respect to such shares for use only outside France. In this case, the name of the holder is deleted from the accredited financial intermediary&#8217;s books. Title to the shares represented by a bearer depository receipt will pass upon delivery of the relevant receipt outside France. </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with applicable laws, we may request the information referred to in Article&#160;L.228-2 of the French Commercial Code at any time from the central depository responsible for holding our shares. Thus, we are at any time entitled to request the name and year of birth or, in the case of a legal entity, the name and the year of incorporation, nationality and address of the holders of our shares or other securities granting immediate or future voting rights, held in bearer form, and the number of shares or other securities so held and, if applicable, the restrictions relating to such securities. Furthermore, under French law, any intermediary who acts on behalf of one or more persons who are not domiciled in France must declare that it is acting as an intermediary. We may also request the identity of the shareholders on whose behalf it is acting. Consequently, the owner of shares recorded in a collective account or in several individual accounts by an intermediary will be represented in the shareholders&#8217; meetings by this intermediary. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Transfer of Shares </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our by-laws do not contain any restrictions relating to the transfer of shares. Shares are freely negotiable, subject to applicable legal and regulatory provisions. French and European law provide for standstill obligations and prohibition of insider trading. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidation Rights </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we are liquidated, any assets remaining after payment of our debts, liquidation expenses and all of our remaining obligations will be distributed first to repay in full the nominal value of our shares (up to the amount of the paid-up and non-liquidated share capital). Any surplus will be distributed pro rata among shareholders in proportion to the nominal value of their shareholdings, taking into account, where applicable, the rights attached to shares of different classes. Shareholders shall only bear losses up to the amount of their contributions. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Disclosure Requirements for Holdings Exceeding Certain Thresholds </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Declaration of Crossing of Ownership Thresholds (Article 11.2 of the By-laws) </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to certain disclosure requirements under French law. Any individual or entity, acting alone or in concert with others, that acquires, either directly or indirectly, shares representing more than 5%, 10%, 15%, 20%, 25%, 30%, 33</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:1.05pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%, 50%, 66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:1.05pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%, 90% or 95% of our outstanding share capital or voting rights or that increases or decreases its shareholding or voting rights above or below any of those percentage thresholds, must notify us and the AMF, within four trading days of the date on which such threshold was crossed. French law and AMF regulations impose additional reporting requirements on persons who acquire more than 10%, 15%, 20% or 25% of the outstanding shares or voting rights of a listed company. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If a shareholder fails to comply with the notification requirements under French law, the shares or voting rights in excess of the relevant threshold will be deprived of voting rights until the end of a two-year period following the date on which the owner of such shares has complied with the notification requirements. They may also be suspended for up to five years and may be subject to criminal fines. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our by-laws provide that any shareholder, acting alone or in concert, who comes into possession, in any manner whatsoever, either directly or indirectly, of a number of shares representing 2% of our share capital and&#47;or voting rights must, by registered letter with acknowledgment of receipt sent to the registered office, or any other equivalent means for the shareholders or security holders residing outside of France, within five trading days of crossing such threshold, notify us of the total number of shares and voting rights he or she owns and the number of securities he or she owns that give access to the capital and voting rights attached thereto. This disclosure requirement shall apply, under the conditions above, each time a new threshold of 2% of capital and&#47;or voting rights is met or exceeded, for whatever reason, including beyond the legal threshold of 5%. If the shares have not been reported under the above conditions, the shares exceeding the fraction that should have been reported are denied the right to vote in shareholders&#8217; meetings, if at a shareholders&#8217; meeting, the failure to report was recorded and if one or more shareholders holding together not less than 5% of capital or voting rights so request at that meeting. The denial of voting rights applies to any shareholders&#8217; meeting to be held until the expiration of a period of two years from the date of regularization of the reporting. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are required to publish the total number of voting rights and shares composing the share capital (if such numbers vary from the numbers previously published) on a monthly basis. The AMF makes this information public. We are subject to AMF regulations regarding public tender offers. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Further, and subject to certain exemptions, any shareholder crossing, alone or acting in concert, the 30% threshold shall file a mandatory public tender offer with the AMF. Also, any shareholder holding directly or indirectly a number between 30% and 50% of the capital or voting rights and who, in less than 12 consecutive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">months, increases his&#47;her&#47;its holding of capital or voting rights by at least 1% of the company&#8217;s capital or voting rights, shall file a mandatory public tender offer. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Treasury Shares and Purchases of our Own Shares </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are not permitted to hold more than 10% of our share capital in treasury shares or to have more than 10% of our share capital to be held for us by our subsidiaries. Treasury shares are not entitled to dividends, voting rights or preferential subscription rights. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Repurchase and Redemption of Shares </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, we may acquire our own shares. Such acquisition may be challenged on the ground of market abuse regulations. However, EU Market Abuse Regulation 596&#47;2014 of April&#160;16, 2014 (&#8220;MAR&#8221;) provides for safe harbor exemptions when the acquisition is made for the following purposes only&#58; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;to decrease our share capital, provided that such a decision is not driven by losses and that a purchase offer is made to all shareholders on a&#160;pro rata&#160;basis, with the approval of the shareholders at an extraordinary meeting. In this case, the shares repurchased must be cancelled within one month from the expiry of the purchase offer&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;to meet obligations arising from debt securities that are exchangeable into equity instruments&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;to provide shares for distribution to employees or managers under a profit-sharing, free share or share option plan. In this case the shares repurchased must be distributed within 12 months from their repurchase failing which they must be cancelled&#59; or </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;under a buy-back program to be authorized by the shareholders in accordance with the provisions of Article L.&#160;22-10-62 of the French Commercial Code and in accordance with the general regulations of, and market practices accepted by the AMF. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other purposes, and especially share buy-backs made for external growth operations in pursuance of Article L. 22-10-62 of the French Commercial Code, while not forbidden, must be pursued in strict compliance of market manipulation and insider dealing rules. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under MAR and in accordance with the general regulations (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">r&#233;glement g&#233;n&#233;ral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) of the AMF, or the General Regulations, a corporation shall report to the competent authority of the trading value on which the shares have been admitted to trading or are traded, no later than by the end of the seventh daily market session following the date of the execution of the transaction, all the transactions relating to the buy-back program, in a detailed form and in an aggregated form. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No such repurchase of shares may result in us holding, directly or through a person acting on our behalf, more than 10% of our issued share capital. Shares repurchased by us continue to be deemed &#8220;issued&#8221; under French law but are not entitled to dividends or voting rights so long as we hold them directly or indirectly, and we may not exercise the preferential subscription rights attached to them. </font></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Ownership of Shares by Non-French Persons </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU and non-EU residents are required to file an administrative notice (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d&#233;claration administrative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) with the French authorities in connection with certain direct or indirect investments in us, including through ownership of ADSs, on the date a binding purchase agreement is executed or a tender offer is made public. Under existing administrative rulings the following transactions qualify as foreign investments in us that require the filing of an administrative notice&#58; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;any transaction carried out on our capital by a non-French resident provided that after the transaction the cumulative amount of the capital or the voting rights held by non-French residents exceeds 1&#47;3 of our capital or voting rights&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;any transaction mentioned above by a corporation incorporated under French law whose capital or voting rights are held for more than 33.33% by non-French residents&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;any transaction carried out abroad resulting in a change of the controlling shareholder of a corporation incorporated under a foreign law that holds a shareholding or voting rights in us if our capital or voting rights are held for more than 33.33% by non-French residents&#59; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;loans and guarantees granted by the acquirer to us in amounts evidencing control over our financing&#59; and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;patent licenses granted by an acquirer or management or technical assistance agreements with such acquirer that place us in a dependent position </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">vis-&#224;-vis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> such party or its group. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-French residents must file a declaration for statistical purposes with the Bank of France (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Banque de France</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) within twenty working days following the date of certain direct foreign investments in us, including any purchase of our ADSs. In particular, such filings are required in connection with investments exceeding &#8364;15,000,000 that lead to the acquisition of at least 10% of our company&#8217;s share capital or voting rights or cross such 10% threshold. Violation of this filing requirement may be sanctioned by five years of imprisonment and a fine up to twice the amount of the relevant investment. This amount may be increased fivefold if the violation is made by a legal entity. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Differences in Corporate Law </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The laws applicable to French</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;soci&#233;t&#233;s anonymes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(limited liability companies) differ from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of certain differences between the provisions of the French Commercial Code applicable to us and the Delaware General Corporation Law relating to shareholders&#8217; rights and protections. This summary is not intended to be a complete discussion of the respective rights, and it is qualified in its entirety by reference to Delaware law and French law. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:3.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DELAWARE</font></div><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%">&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under&#160;French&#160;law,&#160;a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;soci&#233;t&#233;&#160;anonyme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;must have at least three and may have up to 18 directors. The number of directors is fixed by or in the manner provided in the by-laws. The number of directors of each gender may not be less than 40%. In case a board of directors comprises up to eight members, the difference between the number of directors of each gender may not exceed two. Any appointment made in violation of this limit that is not remedied within six months of this appointment will be null and void and payment of directors&#8217; compensation will be suspended.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, a corporation must have at least one director and the number of directors shall be fixed by or in the manner provided in the by-laws (unless specified in the certificate of incorporation of the corporation).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director Qualifications</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under French law, a corporation may prescribe qualifications for directors under its by-laws. In addition, under French law, members of a board of directors may be legal entities, and such legal entities must designate an individual to represent them and to act on their behalf at meetings of the board of directors.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, a corporation may prescribe qualifications for directors under its certificate of incorporation or by-laws.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Removal of Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under French law, directors may be removed from office, with or without cause, at any shareholders&#8217; meeting without notice or justification, by a simple majority vote of the shareholders present and voting at the meeting in person or by proxy.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, unless otherwise provided in the certificate of incorporation, directors may be removed from office, with or without cause, by a majority stockholder vote, though in the case of a corporation whose board is classified, shareholders may effect such removal only for cause.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Vacancies on the board of directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under&#160;French&#160;law,&#160;vacancies&#160;on&#160;the board of directors resulting from death or a resignation, provided that at least three directors remain in office, may be filled by a majority of the remaining directors pending ratification by the shareholders by the next shareholders&#8217; meeting.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, vacancies on a corporation&#8217;s board of directors, including those caused by an increase in the number of directors, unless otherwise provided in the certificate of incorporation, may be filled by the board of directors or other governing body.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:3.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Annual Shareholders&#8217; Meeting</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under French law, the annual shareholders&#8217; meeting shall be held at such place, on such date and at such time as decided each year by the board of directors and notified to the shareholders in the convening notice of the annual meeting, within six months after the close of the relevant fiscal year unless such period is extended by court order.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, the annual meeting of stockholders shall be held at such place, on such date and at such time as may be designated from time to time by the board of directors or as provided in the certificate of incorporation or by the by-laws.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Shareholders&#8217; Meeting</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under French law, shareholders&#8217; meetings may be called by the board of directors or, failing that, by the statutory auditors, or by a court appointed agent or liquidator in certain circumstances, or by the majority shareholder in capital or voting rights following a public tender offer or exchange offer or the transfer of a controlling block on the date decided by the board of directors or the relevant person.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be authorized by the certificate of incorporation or by the by-laws.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notice of Shareholders&#8217; Meetings</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A meeting notice (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">avis de r&#233;union</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) is published in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Bulletin des annonces l&#233;gales obligatoires </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(&#8220;BALO&#8221;), at least 35 days prior to a meeting and made available on the website of the company at least 21&#160;days prior to the meeting. Additionally, a convening notice (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">avis de convocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) is published at least 15&#160;days prior to the date of the meeting, in a legal announcement bulletin of the registered office department and in the BALO. Further, the holders of registered shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">actions nominatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) for at least a month at the time of the convening notice shall be summoned individually, by regular letter (or by registered letter if they request it and include an advance of expenses) sent to their last known address. This notice may also be transmitted by electronic means of telecommunication, in lieu of any such mailing, to any shareholder requesting it beforehand by registered letter with acknowledgment of receipt in accordance with legal and regulatory requirements, specifying his e-mail address.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, unless otherwise provided in the certificate of incorporation or by-laws, written notice of any meeting of the stockholders must be given to each stockholder entitled to vote at the meeting not less than ten nor more than 60 days before the date of the meeting and shall specify the place, date, hour, means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote, the record date for voting if it is different from the record date determining notice and, in the case of a special meeting, purpose or purposes of the meeting.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The meeting notice must also indicate the conditions under which the shareholders may vote by correspondence, the places and conditions in which they can obtain voting forms, and as the case may be, the e-mail address to which they may send written questions.</font></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:3.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Proxy</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Each shareholder has the right to attend the meetings and participate in the discussions (i)&#160;personally, (ii) by granting proxy to any individual or legal entity of his choosing, (iii)&#160;by sending a proxy to the company without indication of the mandate (in which case such proxy shall be cast in favor of the resolutions supported by the board of directors), (iv) by voting by correspondence or (v)&#160;by videoconference or another means of telecommunication allowing identification in accordance with applicable laws. The proxy is only valid for a single meeting or for successive meetings convened with the same agenda. It can also be granted for two meetings, one ordinary the other extraordinary, held on the same day or within a period of 15 days.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, at any meeting of stockholders, a stockholder may designate another person to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Shareholder Action by Written Consent</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, shareholders&#8217; action by written consent is not permitted in a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;soci&#233;t&#233; anonyme.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, a corporation&#8217;s certificate of incorporation (i)&#160;may permit stockholders to act by written consent if such action is signed by all stockholders, (ii)&#160;may permit stockholders to act by written consent signed by stockholders having the minimum number of votes that would be necessary to take such action at a meeting or (iii)&#160;may prohibit actions by written consent.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Preferential Subscription Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under French law, in case of issuance of additional shares or other securities for cash or set-off against cash debts, the existing shareholders have preferential subscription rights to these securities on a pro rata basis unless such rights are waived by a two-thirds majority of the votes held by</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, unless otherwise provided in a corporation&#8217;s certificate of incorporation, a stockholder does not, by operation of law, possess preemptive rights to subscribe to additional issuances of the corporation&#8217;s stock.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">the shareholders present at the extraordinary meeting deciding or authorizing the capital increase, voting in person or represented by proxy or voting by mail. In case such rights are not waived by the extraordinary general meeting, each shareholder may individually either exercise, assign or not exercise its preferential subscription rights.</font></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:3.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Sources of Dividends</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, dividends may only be paid by a French</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;soci&#233;t&#233; anonyme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;out of &#8220;distributable profits,&#8221; plus any distributable reserves and &#8220;distributable premium&#8221; that the shareholders decide to make available for distribution, other than those reserves that are specifically required by-law. &#8220;Distributable profits&#8221; consist of the unconsolidated net profits of the relevant corporation for each fiscal year, as increased or reduced by any profit or loss carried forward from prior years, minus the amounts to be set aside to the statutory reserve (at least 5% of the profit until the reserve has reached 10% of the amount of the share capital) and to the reserve set forth in the company&#8217;s by-laws (if any).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Distributable premium&#8221; refers to the contribution paid by the shareholders in addition to the par value of their shares for their subscription that the shareholders decide to make available for distribution.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except in the case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the by-laws.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, dividends may be paid by a Delaware corporation either out of (i)&#160;surplus, as defined in and computed in accordance with Delaware law, or (ii)&#160;in case there is no surplus, out of its net profits for the fiscal year in which the dividend is declared and&#47;or the preceding fiscal year, except when the capital is diminished by depreciation in the value of its property, or by losses or otherwise, to an amount less than the aggregate amount of capital represented by issued and outstanding stock having a preference on the distribution of assets.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Repurchase of Shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, a corporation may acquire its own shares. Such acquisition may be challenged on the ground of market abuse regulations. However, MAR provides for safe harbor exemptions when the acquisition is made for the following purposes only&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;to&#160;decrease&#160;its&#160;share&#160;capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction&#59; or to meet obligations arising from debt securities, that are exchangeable into equity instruments.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Delaware law, a corporation may generally redeem or repurchase shares of its stock unless the capital of the corporation is impaired or such redemption or repurchase would impair the capital of the corporation.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No such repurchase of shares may result in the company holding, directly or through a person acting on its behalf, more than 10% of its issued share capital.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DELAWARE</font></div><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%">&#160;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;with a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, free share or share option plan&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;under a buy-back program to be authorized by the shareholders in accordance with the provisions of Article L. 22-10-62 of the French Commercial Code and in accordance with the general regulations of the AMF.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other purposes, and especially share buy-backs for external growth operations by virtue of Article L. 22-10-62 of the French Commercial Code, while not forbidden, must be pursued in strict compliance of market manipulations and insider dealing rules.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No such repurchase of shares may result in the company holding, directly or through a person acting on its behalf, more than 10% of its issued share capital.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under MAR and in accordance with the General Regulations, a corporation shall report to the competent authority of the trading venue on which the shares have been admitted to trading or are traded, no later than by the end of the seventh daily market session following the date of the execution of the transaction, all the transactions relating to the buy-back program, in a detailed form and in an aggregated form.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability of Directors and Officers</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under French law, the by-laws may not include any provisions limiting the liability of directors.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Delaware law, a corporation&#8217;s certificate of incorporation may include a provision eliminating or limiting the personal liability of a director to the corporation and its stockholders for damages arising from a breach of fiduciary duty as a director. However, no provision can limit the liability of a director for&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;intentional or negligent payment of unlawful dividends or stock purchases or redemptions&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;any transaction from which the director derives an improper personal benefit.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Voting Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">French law provides that, unless otherwise provided in the by-laws, each shareholder is entitled to one vote for each share of share capital held by such shareholder. Further, pursuant to the introduction of Law No.&#160;2014-384 dated March&#160;29, 2014 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loi Florange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), shares registered for more than two years in the name of the same shareholder are automatically be granted double voting rights from 2016, unless the by-laws expressly reject this measure.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Delaware law provides that, unless otherwise provided in the certificate of incorporation, each stockholder is entitled to one vote for each share of capital stock held by such stockholder.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Shareholder Vote on Certain Transactions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generally, under French law, completion of a merger, dissolution or sale or exchange of all or substantially all of a corporation&#8217;s assets (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">apport partiel d&#8217;actifs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) requires&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the approval of the board of directors&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting or, in the case of a merger with a non-EU company, approval of all shareholders of the corporation.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generally, under Delaware law, unless the certificate of incorporation pro</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vides for the vote of a larger portion of shares, completion of a merger, consolidation, sale, lease or exchange of all or substantially all of a corporation&#8217;s assets or dissolution requires&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the approval of the board of directors&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;approval by the vote of the holders of a majority of the outstanding stock or, if the certificate of incorporation provides for more or less than one vote per share, a majority of the votes of the outstanding stock of a corporation entitled to vote on the matter.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Dissent or Dissenters Appraisal Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">French law does not provide for any such right but provides that a merger is subject to shareholders&#8217; approval by a two-thirds majority vote, as stated above.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, a holder of shares of any class or series has the right, in specified circumstances, to dissent from a merger or consolidation by demanding payment in cash for the stockholder&#8217;s shares equal to the fair value of those shares, as determined by the Delaware Chancery Court in an action timely brought by the corporation or a dissenting stockholder. Delaware law grants these appraisal rights only in the case of mergers or consolidations and not in the case of a sale or transfer of assets or a purchase of</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">assets for shares. Further, no appraisal rights are available for shares of any class or series that is listed on a national securities exchange or held of record by more than 2,000 stockholders, unless the agreement of merger or consolidation requires the holders to accept for their shares anything other than&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;shares of stock of the surviving corporation&#59;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:50%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;shares of another corporation that are either listed on a national securities exchange or held of record by more than 2,000 stockholders&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;cash in lieu of fractional shares of the stock described in the two preceding bullet points&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;any combination of the above.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, appraisal rights are not available to holders of shares of the surviving corporation in specified mergers that do not require the vote of the stockholders of the surviving corporation.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Standard of Conduct for Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">French law does not contain specific provisions setting forth the standard of conduct of a director. However, directors have a duty to act without self-interest, on a well-informed basis, and not to take any decision against a corporation&#8217;s corporate interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">int&#233;r&#234;t social</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Delaware law does not contain specific provisions setting forth the standard of conduct of a director. The scope of the fiduciary duties of directors is generally determined by the courts of the State of Delaware. In general, directors have a duty to act without self-interest, on a well-informed basis and in a manner they reasonably believe to be in the best interest of the stockholders.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Shareholder Suits</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a corporation in the corporation&#8217;s interest if it fails to bring such legal action itself. If so, any damages awarded by the court are paid to the corporation and any legal fees relating to such action are borne by the relevant shareholder or the group of shareholders.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The plaintiff must remain a shareholder through the duration of the legal action.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is no other case where shareholders may initiate a derivative action to enforce a right of a corporation.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A shareholder may alternatively or cumulatively bring individual legal action against the directors, provided he has suffered distinct damages from those suffered by the corporation. In this case, any damages awarded by the court are paid to the relevant shareholder.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Delaware law, a stockholder may initiate a derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;state that the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiff&#8217;s shares thereafter devolved on the plaintiff by operation of law&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;allege with particularity the efforts made by the plaintiff to obtain the action the plaintiff desires from the directors and the reasons for the plaintiff&#8217;s failure to obtain the action&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;state the reasons for not making the effort.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Additionally, the plaintiff must remain a stockholder through the duration of the derivative suit. The action will not be dismissed or compromised without the approval of the Delaware Court of Chancery.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Amendment of Certificate of Incorporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unlike companies incorporated under Delaware law, the organizational documents, which comprise both a certificate of incorporation and by-laws, companies incorporated under French law only have by-laws (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">statuts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) as organizational documents.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As indicated in the paragraph below, only the extraordinary shareholders&#8217; meeting is authorized under French law to adopt or amend the by-laws.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Delaware law, generally a corporation may amend its certificate of incorporation if&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;its board of directors has adopted a resolution setting forth the amendment proposed and declared its advisability&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;padding-left:48pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the amendment is adopted by the affirmative votes of a majority (or greater percentage as may be specified by the corporation) of the outstanding shares entitled to vote on the amendment and a majority (or greater percentage as may be specified by the corporation) of the outstanding shares of each class or series of stock, if any, entitled to vote on the amendment as a class or series.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Amendment of by-laws</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under French law, only the extraordinary shareholders&#8217; meeting is authorized to adopt or amend the by-laws (two-thirds majority). The extraordinary shareholders&#8217; meeting may authorize the board of directors to amend the by-laws to comply with legal provisions, subject to the ratification of such amendments by the next extraordinary shareholders&#8217; meeting. The board of directors is authorized to amend the by-laws as a result of a decision to relocate the company&#8217;s registered office in France, subject to ratification by the next ordinary shareholders&#8217; meeting.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Under Delaware law, the stockholders entitled to vote have the power to adopt, amend or repeal by-laws. A corporation may also confer, in its certificate of incorporation, that power upon the board of directors.</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AMERICAN DEPOSITARY SHARES</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank, N.A. (&#8220;Citibank&#8221;) is the depositary for the ADSs representing our ordinary shares pursuant to a deposit agreement. Citibank&#8217;s depositary offices are located at 388 Greenwich Street, New York, New York 10013. ADSs represent ownership interests in securities that are on deposit with the depositary bank. ADSs may be represented by certificates that are commonly known as &#8220;American Depositary Receipts&#8221; or &#8220;ADRs.&#8221; The depositary bank typically appoints a custodian to safekeep the securities on deposit. In this case, the custodian is Citibank Europe plc located at 1 North Wall Quay, Dublin 1, Ireland.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The form of the deposit agreement is on file with the SEC under cover of a registration statement on Form F-6. You may obtain a copy of the deposit agreement from the SEC&#8217;s website (www.sec.gov). Please refer to registration number 333-274845 when retrieving such copy. The portions of this summary description that are italicized describe matters that may be relevant to the ownership of ADSs but that may not be contained in the deposit agreement.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are providing you with a summary description of the material terms of the ADSs and of your material rights as an owner of ADSs. Please remember that summaries by their nature lack the precision of the information summarized and that the rights and obligations of an owner of ADSs will be determined by reference to the terms of the deposit agreement and not by this summary. We urge you to review the deposit agreement in its entirety. The portions of this summary description that are italicized describe matters that may be relevant to the ownership of ADSs but that may not be contained in the deposit agreement. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each ADS represents the right to receive, and to exercise the beneficial ownership interests in, one ordinary share that is on deposit with the depositary bank and&#47;or custodian. An ADS also represents the right to receive, and to exercise the beneficial interests in, any other property received by the depositary bank or the custodian on behalf of the owner of the ADS but that has not been distributed to the owners of ADSs because of legal restrictions or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">practical considerations. We and the depositary bank may agree to change the ADS-to-Share ratio by amending the deposit agreement. This amendment may give rise to, or change, the depositary fees payable by ADS owners. The custodian, the depositary bank and their respective nominees will hold all deposited property for the benefit of the holders and beneficial owners of ADSs. The deposited property does not constitute the proprietary assets of the depositary bank, the custodian or their nominees. Beneficial ownership in the deposited property will under the terms of the deposit agreement be vested in the beneficial owners of the ADSs. The depositary bank, the custodian and their respective nominees will be the record holders of the deposited property represented by the ADSs for the benefit of the holders and beneficial owners of the corresponding ADSs. A beneficial owner of ADSs may or may not be the holder of ADSs. Beneficial owners of ADSs will be able to receive, and to exercise beneficial ownership interests in, the deposited property only through the registered holders of the ADSs, the registered holders of the ADSs (on behalf of the applicable ADS owners) only through the depositary bank, and the depositary bank (on behalf of the owners of the corresponding ADSs) directly, or indirectly, through the custodian or their respective nominees, in each case upon the terms of the deposit agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If you become an owner of ADSs, you will become a party to the deposit agreement and therefore will be bound to its terms and to the terms of any ADR that represents your ADSs. The deposit agreement and the ADR specify our rights and obligations as well as your rights and obligations as an owner of ADSs and those of the depositary bank. As an ADS holder you appoint the depositary bank to act on your behalf in certain circumstances. The deposit agreement and the ADRs are governed by New York law. However, our obligations to the holders of ordinary shares will continue to be governed by the laws of France, which may be different from the laws in the United States. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, applicable laws and regulations may require you to satisfy reporting requirements and obtain regulatory approvals in certain circumstances. You are solely responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary bank, the custodian, us or any of their or our respective agents or affiliates shall be required to take any actions whatsoever on your behalf to satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations. </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">As an owner of ADSs, we will not treat you as one of our shareholders and you will not have direct shareholder rights. The depositary bank will hold on your behalf the shareholder rights attached to the ordinary shares underlying your ADSs. As an owner of ADSs you will be able to exercise the shareholders rights for the ordinary shares represented by your ADSs through the depositary bank only to the extent contemplated in the deposit agreement. To exercise any shareholder rights not contemplated in the deposit agreement you will, as an ADS owner, need to arrange for the cancellation of your ADSs and become a direct shareholder.&#8195; </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The manner in which you own the ADSs (e.g., in a brokerage account vs. as registered holder, or as holder of certificated vs. uncertificated ADSs) may affect your rights and obligations, and the manner in which, and extent to which, the depositary bank&#8217;s services are made available to you. As an owner of ADSs, you may hold your ADSs either by means of an ADR registered in your name, through a brokerage or safekeeping account, or through an account established by the depositary bank in your name reflecting the registration of uncertificated ADSs directly on the books of the depositary bank (commonly referred to as the &#8220;direct registration system&#8221; or &#8220;DRS&#8221;). The direct registration system reflects the uncertificated (book-entry) registration of ownership of ADSs by the depositary bank. Under the direct registration system, ownership of ADSs is evidenced by periodic statements issued by the depositary bank to the holders of the ADSs. The direct registration system includes automated transfers between the depositary bank and The Depository Trust Company (&#8220;DTC&#8221;), the central book-entry clearing and settlement system for equity securities in the United States. If you decide to hold your ADSs through your brokerage or safekeeping account, you must rely on the procedures of your broker or bank to assert your rights as ADS owner. Banks and brokers typically hold securities such as the ADSs through clearing and settlement systems such as DTC. The procedures of such clearing and settlement systems may limit your ability to exercise your rights as an owner of ADSs. Please consult with your broker or bank if you have any questions concerning these limitations and procedures. All ADSs held through DTC will be registered in the name of a nominee of DTC. This summary description assumes you have opted to own the ADSs directly by means of an ADS registered in your name and, as such, we will refer to you as the &#8220;holder.&#8221; When we refer to &#8220;you,&#8221; we assume the reader owns ADSs and will own ADSs at the relevant time. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registration of the ordinary shares in the name of the depositary bank or the custodian shall, to the maximum extent permitted by applicable law, vest in the depositary bank or the custodian the record ownership in the applicable ordinary shares with the beneficial ownership rights and interests in such ordinary shares being at all times vested with the beneficial owners of the ADSs representing the ordinary shares. The depositary bank or the custodian shall at all times be entitled to exercise the beneficial ownership rights in all deposited property, in each case only on behalf of the holders and beneficial owners of the ADSs representing the deposited property. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividends and Distributions </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a holder of ADSs, you generally have the right to receive the distributions we make on the securities deposited with the custodian. Your receipt of these distributions may be limited, however, by practical considerations and legal limitations. Holders of ADSs will receive such distributions under the terms of the deposit agreement in proportion to the number of ADSs held as of the specified record date, after deduction of the applicable fees, taxes and expenses. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distributions of Cash </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever we make a cash distribution for the securities on deposit with the custodian, we will deposit the funds with the custodian. Upon receipt of confirmation of the deposit of the requisite funds, the depositary bank will arrange for the funds received in a currency other than U.S. dollars to be converted into U.S. dollars and for the distribution of the U.S. dollars to the holders, subject to the laws and regulations of France. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The conversion into U.S. dollars will take place only if practicable and if the U.S. dollars are transferable to the United States. The depositary bank will apply the same method for distributing the proceeds of the sale of any property (such as undistributed rights) held by the custodian in respect of securities on deposit. </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The distribution of cash will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. The depositary bank will hold any cash amounts it is unable to distribute in a non-interest bearing account for the benefit of the applicable holders and beneficial owners of ADSs until the distribution can be effected or the funds that the depositary bank holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distributions of Shares </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever we make a free distribution of ordinary shares for the securities on deposit with the custodian, we will deposit the applicable number of ordinary shares with the custodian. Upon receipt of confirmation of such deposit, the depositary bank will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">either</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> distribute to holders new ADSs representing the ordinary shares deposited </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> modify the ADS-to-ordinary shares ratio, in which case each ADS you hold will represent rights and interests in the additional ordinary shares so deposited. Only whole new ADSs will be distributed. Fractional entitlements will be sold and the proceeds of such sale will be distributed as in the case of a cash distribution. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The distribution of new ADSs or the modification of the ADS-to-ordinary shares ratio upon a distribution of ordinary shares will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes or governmental charges, the depositary bank may sell all or a portion of the new ordinary shares so distributed. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No such distribution of new ADSs will be made if it would violate a law (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the U.S. securities laws) or if it is not operationally practicable. If the depositary bank does not distribute new ADSs as described above, it may sell the ordinary shares received upon the terms described in the deposit agreement and will distribute the proceeds of the sale as in the case of a distribution of cash. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distributions of Rights </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever we intend to distribute rights to subscribe for additional ordinary shares, we will give prior notice to the depositary bank and we will assist the depositary bank in determining whether it is lawful and reasonably practicable to distribute rights to subscribe for additional ADSs to holders. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will establish procedures to distribute rights to subscribe for additional ADSs to holders and to enable such holders to exercise such rights if it is lawful and reasonably practicable to make the rights available to holders of ADSs, and if we provide all of the documentation contemplated in the deposit agreement (such as opinions to address the lawfulness of the transaction). You may have to pay fees, expenses, taxes and other governmental charges to subscribe for the new ADSs upon the exercise of your rights. The depositary bank is not obligated to establish procedures to facilitate the distribution and exercise by holders of rights to subscribe for new ordinary shares other than in the form of ADSs. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> distribute the rights to you if&#58; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We do not timely request that the rights be distributed to you or we request that the rights not be distributed to you&#59; or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We fail to deliver satisfactory documents to the depositary bank&#59; or </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;It is not reasonably practicable to distribute the rights. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will sell the rights that are not exercised or not distributed if such sale is lawful and reasonably practicable. The proceeds of such sale will be distributed to holders as in the case of a cash distribution. If the depositary bank is unable to sell the rights, it will allow the rights to lapse. </font></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Elective Distributions </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever we intend to distribute a dividend payable at the election of shareholders either in cash or in additional shares, we will give prior notice thereof to the depositary bank and will indicate whether we wish the elective distribution to be made available to you. In such case, we will assist the depositary bank in determining whether such distribution is lawful and reasonably practicable. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will make the election available to you only if it is reasonably practicable and if we have provided all of the documentation contemplated in the deposit agreement. In such case, the depositary bank will establish procedures to enable you to elect to receive either cash or additional ADSs, in each case as described in the deposit agreement. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the election is not made available to you, you will receive either cash or additional ADSs, depending on what a shareholder in France would receive upon failing to make an election, as more fully described in the deposit agreement. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Distributions </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever we intend to distribute property other than cash, ordinary shares or rights to subscribe for additional ordinary shares, we will notify the depositary bank in advance and will indicate whether we wish such distribution to be made to you. If so, we will assist the depositary bank in determining whether such distribution to holders is lawful and reasonably practicable. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If it is reasonably practicable to distribute such property to you and if we provide to the depositary bank all of the documentation contemplated in the deposit agreement, the depositary bank will distribute the property to the holders in a manner it deems practicable. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The distribution will be made net of fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes and governmental charges, the depositary bank may sell all or a portion of the property received. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> distribute the property to you and will sell the property if&#58; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We do not request that the property be distributed to you or if we request that the property not be distributed to you&#59; or </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We do not deliver satisfactory documents to the depositary bank&#59; or </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;The depositary bank determines that all or a portion of the distribution to you is not reasonably practicable. </font></div><div style="margin-top:12pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;The proceeds of such a sale will be distributed to holders as in the case of a cash distribution. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever we decide to redeem any of the securities on deposit with the custodian, we will notify the depositary bank in advance. If it is practicable and if we provide all of the documentation contemplated in the deposit agreement, the depositary bank will provide notice of the redemption to the holders. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The custodian will be instructed to surrender the shares being redeemed against payment of the applicable redemption price. The depositary bank will convert into U.S. dollars upon the terms of the deposit agreement the redemption funds received in a currency other than U.S. dollars and will establish procedures to enable holders to receive the net proceeds from the redemption upon surrender of their ADSs to the depositary bank. You may have to pay fees, expenses, taxes and other governmental charges upon the redemption of your ADSs. If less than all ADSs are being redeemed, the ADSs to be retired will be selected by lot or on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> basis, as the depositary bank may determine. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes Affecting Ordinary Shares </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The ordinary shares held on deposit for your ADSs may change from time to time. For example, there may be a change in nominal or par value, split-up, cancellation, consolidation or any other reclassification of such ordinary shares or a recapitalization, reorganization, merger, consolidation or sale of our assets. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any such change were to occur, your ADSs would, to the extent permitted by law and the deposit agreement, represent the right to receive the property received or exchanged in respect of the ordinary shares held on deposit. The depositary bank may in such circumstances deliver new ADSs to you, amend the deposit agreement, the ADRs and the applicable Registration Statement(s) on Form F-6, call for the exchange of your existing ADSs for new ADSs and take any other actions that are appropriate to reflect as to the ADSs the change affecting the Shares. If the depositary bank may not lawfully distribute such property to you, the depositary bank may sell such property and distribute the net proceeds to you as in the case of a cash distribution. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance of ADSs upon Deposit of Ordinary Shares </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank may create ADSs on your behalf if you or your broker deposit ordinary shares with the custodian. The depositary bank will deliver these ADSs to the person you indicate only after you pay any applicable issuance fees and any charges and taxes payable for the transfer of the ordinary shares to the custodian. Your ability to deposit ordinary shares and receive ADSs may be limited by U.S. and French legal considerations applicable at the time of deposit. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The issuance of ADSs may be delayed until the depositary bank or the custodian receives confirmation that all required approvals have been given and that the ordinary shares have been duly transferred to the custodian. The depositary bank will only issue ADSs in whole numbers. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">When you make a deposit of ordinary shares, you will be responsible for transferring good and valid title to the depositary bank. As such, you will be deemed to represent and warrant that&#58; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The ordinary shares are duly authorized, validly issued, fully paid, non-assessable and legally obtained. </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All preemptive (and similar) rights, if any, with respect to such ordinary shares have been validly waived or exercised. </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You are duly authorized to deposit the ordinary shares. </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The ordinary shares presented for deposit are free and clear of any lien, encumbrance, security interest, charge, mortgage or adverse claim, and are not, and the ADSs issuable upon such deposit will not be, &#8220;restricted securities&#8221; (as defined in the deposit agreement). </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The ordinary shares presented for deposit have not been stripped of any rights or entitlements. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any of the representations or warranties are incorrect in any way, we and the depositary bank may, at your cost and expense, take any and all actions necessary to correct the consequences of the misrepresentations. </font></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer, Combination and Split Up of ADRs </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As an ADR holder, you will be entitled to transfer, combine or split up your ADRs and the ADSs evidenced thereby. For transfers of ADRs, you will have to surrender the ADRs to be transferred to the depositary bank and also must&#58; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ensure that the surrendered ADR is properly endorsed or otherwise in proper form for transfer&#59; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">provide such proof of identity and genuineness of signatures as the depositary bank deems appropriate&#59; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">provide any transfer stamps required by the State of New York or the United States&#59; and </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pay all applicable fees, charges, expenses, taxes and other government charges payable by ADR holders pursuant to the terms of the deposit agreement, upon the transfer of ADRs. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To have your ADRs either combined or split up, you must surrender the ADRs in question to the depositary bank with your request to have them combined or split up, and you must pay all applicable fees, charges and expenses payable by ADR holders, pursuant to the terms of the deposit agreement, upon a combination or split up of ADRs. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Withdrawal of Ordinary Shares Upon Cancellation of ADSs </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a holder, you will be entitled to present your ADSs to the depositary bank for cancellation and then receive the corresponding number of underlying ordinary shares at the custodian&#8217;s offices. Your ability to withdraw the ordinary shares held in respect of the ADSs may be limited by U.S. and French law considerations applicable at the time of withdrawal. In order to withdraw the ordinary shares represented by your ADSs, you will be required to pay to the depositary bank the fees for cancellation of ADSs and any charges and taxes payable upon the transfer of the ordinary shares. You assume the risk for delivery of all funds and securities upon withdrawal. Once canceled, the ADSs will not have any rights under the deposit agreement. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If you hold ADSs registered in your name, the depositary bank may ask you to provide proof of identity and genuineness of any signature and such other documents as the depositary bank may deem appropriate before it will cancel your ADSs. The withdrawal of the ordinary shares represented by your ADSs may be delayed until the depositary bank receives satisfactory evidence of compliance with all applicable laws and regulations. Please keep in mind that the depositary bank will only accept ADSs for cancellation that represent a whole number of securities on deposit. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will have the right to withdraw the securities represented by your ADSs at any time except for&#58; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary delays that may arise because (i)&#160;the transfer books for the ordinary shares or ADSs are closed, or (ii)&#160;ordinary shares are immobilized on account of a shareholders&#8217; meeting or a payment of dividends. </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligations to pay fees, taxes and similar charges. </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restrictions imposed because of laws or regulations applicable to ADSs or the withdrawal of securities on deposit. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The deposit agreement may not be modified to impair your right to withdraw the securities represented by your ADSs except to comply with mandatory provisions of law. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Voting Rights </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a holder, you generally have the right under the deposit agreement to instruct the depositary bank to exercise the voting rights for the ordinary shares represented by your ADSs. The voting rights of holders of ordinary shares are described in the section of this prospectus entitled &#8220;Description of Share Capital.&#8221; </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At our request, the depositary bank will distribute to you any notice of shareholders&#8217; meeting received from us together with information explaining how to instruct the depositary bank to exercise the voting rights of the securities represented by ADSs. In lieu of distributing such materials, the depositary bank may distribute to holders of ADSs instructions on how to retrieve such materials upon request. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the depositary bank timely receives voting instructions from a holder of ADSs, it will endeavor to vote the securities (in person or by proxy) represented by the holder&#8217;s ADSs in accordance with such voting instructions. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities for which no voting instructions have been received will not be voted (except as otherwise contemplated in the deposit agreement). Please note that the ability of the depositary bank to carry out voting instructions may be limited by practical and legal limitations and the terms of the securities on deposit. We cannot assure you that you will receive voting materials in time to enable you to return voting instructions to the depositary bank in a timely manner. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fees and Charges </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As an ADS holder, you will be required to pay the following fees under the terms of the deposit agreement&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Service</font></div><div style="margin-top:1pt;padding-right:-1.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees</font></div><div style="padding-left:2.27pt;padding-right:2.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%">&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ADSs (e.g., an issuance of ADS upon a deposit of ordinary shares, upon a change in the ADS(s)-to-ordinary share ratio, or for any other reason), excluding ADS issuances as a result of distributions of ordinary shares)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS issued</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of ADSs (e.g., a cancellation of ADSs for delivery of deposited property, upon a change in the ADS(s)-to-ordinary share ratio, or for any other reason)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS cancelled</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Distribution of cash dividends or other cash distributions (e.g., upon a sale of rights and other entitlements)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS held</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Distribution of ADSs pursuant to (i)&#160;share dividends or other free share distributions, or (ii)&#160;exercise of rights to purchase additional ADSs</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS held</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Distribution of securities other than ADSs or rights to purchase additional ADSs (e.g., upon a spin-off)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS held</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">ADS Services</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS held on the applicable record date(s) established by the depositary bank</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration of ADS transfers (e.g., upon a registration of the transfer of registered ownership of ADSs, upon a transfer of ADSs into DTC and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">vice versa</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, or for any other reason)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS (or fraction thereof) transferred</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:133%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of ADSs of one series for ADSs of another series (e.g., upon conversion of Partial Entitlement ADSs for Full Entitlement ADSs, or upon conversion of Restricted ADSs (each as defined in the Deposit Agreement) into freely transferable ADSs, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">vice versa</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Up to U.S. 5&#162; per ADS (or fraction thereof) converted</font></td></tr></table></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As an ADS holder you will also be responsible to pay certain charges such as&#58; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">taxes (including applicable interest and penalties) and other governmental charges&#59; </font></div><div style="margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the registration fees as may from time to time be in effect for the registration of ordinary shares on the share register and applicable to transfers of ordinary shares to or from the name of the custodian, the depositary bank or any nominees upon the making of deposits and withdrawals, respectively&#59; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">certain cable, telex and facsimile transmission and delivery expenses&#59; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fees, expenses, spreads, taxes and other charges of the depositary bank and&#47;or service providers (which may be a division, branch or affiliate of the depositary bank) in the conversion of foreign currency&#59; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the reasonable and customary out-of-pocket expenses incurred by the depositary bank in connection with compliance with exchange control regulations and other regulatory requirements applicable to ordinary shares, ADSs and ADRs&#59; and </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fees, charges, costs and expenses incurred by the depositary bank, the custodian, or any nominee in connection with the ADR program. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADS fees and charges for (i)&#160;the issuance of ADSs, and (ii)&#160;the cancellation of ADSs are charged to the person for whom the ADSs are issued (in the case of ADS issuances) and to the person for whom ADSs are cancelled (in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the case of ADS cancellations). In the case of ADSs issued by the depositary bank into DTC, the ADS issuance and cancellation fees and charges may be deducted from distributions made through DTC, and may be charged to the DTC participant(s) receiving the ADSs being issued or the DTC participant(s) holding the ADSs being cancelled, as the case may be, on behalf of the beneficial owner(s) and will be charged by the DTC participant(s) to the account of the applicable beneficial owner(s) in accordance with the procedures and practices of the DTC participants as in effect at the time. ADS fees and charges in respect of distributions and the ADS service fee are charged to the holders as of the applicable ADS record date. In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed. In the case of (i)&#160;distributions other than cash and (ii)&#160;the ADS service fee, holders as of the ADS record date will be invoiced for the amount of the ADS fees and charges and such ADS fees and charges may be deducted from distributions made to holders of ADSs. For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee may be deducted from distributions made through DTC, and may be charged to the DTC participants in accordance with the procedures and practices prescribed by DTC and the DTC participants in turn charge the amount of such ADS fees and charges to the beneficial owners for whom they hold ADSs. In the case of (i)&#160;registration of ADS transfers, the ADS transfer fee will be payable by the ADS Holder whose ADSs are being transferred or by the person to whom the ADSs are transferred, and (ii)&#160;conversion of ADSs of one series for ADSs of another series, the ADS conversion fee will be payable by the Holder whose ADSs are converted or by the person to whom the converted ADSs are delivered. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of refusal to pay the depositary bank fees, the depositary bank may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary bank fees from any distribution to be made to the ADS holder. You will receive prior notice of such changes. The depositary bank may reimburse us for certain expenses incurred by us in respect of the ADR program, by making available a portion of the ADS fees charged in respect of the ADR program or otherwise, upon such terms and conditions as we and the depositary bank agree from time to time. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amendments and Termination </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may agree with the depositary bank to modify the deposit agreement at any time without your consent. We undertake to give holders 30 days&#8217; prior notice of any modifications that would materially prejudice any of their substantial rights under the deposit agreement. We will not consider to be materially prejudicial to your substantial rights any modifications or supplements that are reasonably necessary for the ADSs to be registered under the Securities Act or to be eligible for book-entry settlement, in each case without imposing or increasing the fees and charges you are required to pay. In addition, we may not be able to provide you with prior notice of any modifications or supplements that are required to accommodate compliance with applicable provisions of law. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will be bound by the modifications to the deposit agreement if you continue to hold your ADSs after the modifications to the deposit agreement become effective. The deposit agreement cannot be amended to prevent you from withdrawing the ordinary shares represented by your ADSs (except as permitted by law). </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have the right to direct the depositary bank to terminate the deposit agreement. Similarly, the depositary bank may in certain circumstances on its own initiative terminate the deposit agreement. In either case, the depositary bank must give notice to the holders at least 30 days before termination. Until termination, your rights under the deposit agreement will be unaffected. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After termination, the depositary bank will continue to collect distributions received (but will not distribute any such property until you request the cancellation of your ADSs) and may sell the securities held on deposit. After the sale, the depositary bank will hold the proceeds from such sale and any other funds then held for the holders of ADSs in a non-interest bearing account. At that point, the depositary bank will have no further obligations to holders other than to account for the funds then held for the holders of ADSs still outstanding (after deduction of applicable fees, taxes and expenses). </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with any termination of the deposit agreement, the depositary bank may make available to owners of ADSs a means to withdraw the ordinary shares represented by ADSs and to direct the depositary of such ordinary shares into an unsponsored American depositary share program established by the depositary bank. The ability to receive unsponsored American depositary shares upon termination of the deposit agreement would be subject to satisfaction of certain U.S. regulatory requirements applicable to the creation of unsponsored American depositary shares and the payment of applicable depositary fees. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Books of Depositary </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will maintain ADS holder records at its depositary office. You may inspect such records at such office during regular business hours but solely for the purpose of communicating with other holders in the interest of business matters relating to the ADSs and the deposit agreement. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will maintain in New York facilities to record and process the issuance, cancellation, combination, split-up and transfer of ADSs. These facilities may be closed from time to time, to the extent not prohibited by law. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Limitations on Obligations and Liabilities </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;The deposit agreement limits our obligations and the depositary bank&#8217;s obligations to you. Please note the following&#58; </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank are obligated only to take the actions specifically stated in the deposit agreement without negligence or bad faith. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;The depositary bank disclaims any liability for any failure to carry out voting instructions, for any manner in which a vote is cast or for the effect of any vote, provided it acts in good faith and in accordance with the terms of the deposit agreement. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;The depositary bank disclaims any liability for any failure to determine the lawfulness or practicality of any action, for the content of any document forwarded to you on our behalf or for the accuracy of any translation of such a document, for the investment risks associated with investing in ordinary shares, for the validity or worth of the ordinary shares, for any tax consequences that result from the ownership of ADSs, for the credit-worthiness of any third party, for allowing any rights to lapse under the terms of the deposit agreement, for the timeliness of any of our notices or for our failure to give notice. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank will not be obligated to perform any act that is inconsistent with the terms of the deposit agreement. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank disclaim any liability if we or the depositary bank are prevented or forbidden from or subject to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement, by reason of any provision, present or future of any law or regulation, or by reason of present or future provision of any provision of our by-laws, or any provision of or governing the securities on deposit, or by reason of any act of God or war or other circumstances beyond our control. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank disclaim any liability by reason of any exercise of, or failure to exercise, any discretion provided for in the deposit agreement or in our by-laws or in any provisions of or governing the securities on deposit. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank further disclaim any liability for any action or inaction in reliance on the advice or information received from legal counsel, accountants, any person presenting Shares for deposit, any holder of ADSs or authorized representatives thereof, or any other person believed by either of us in good faith to be competent to give such advice or information. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank also disclaim liability for the inability by a holder to benefit from any distribution, offering, right or other benefit that is made available to holders of ordinary shares but is not, under the terms of the deposit agreement, made available to you. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank may rely without any liability upon any written notice, request or other document believed to be genuine and to have been signed or presented by the proper parties. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;We and the depositary bank also disclaim liability for any consequential or punitive damages for any breach of the terms of the deposit agreement. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;No disclaimer of any Securities Act liability is intended by any provision of the deposit agreement. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Nothing in the deposit agreement gives rise to a partnership or joint venture, or establishes a fiduciary relationship, among us, the depositary bank and you as ADS holder. </font></div><div style="margin-top:6pt;padding-left:55.05pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Nothing in the deposit agreement precludes Citibank (or its affiliates) from engaging in transactions in which parties adverse to us or the ADS owners have interests, and nothing in the deposit agreement obligates Citibank to disclose those transactions, or any information obtained in the course of those transactions, to us or to the ADS owners, or to account for any payment received as part of those transactions. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">As the above limitations relate to our obligations and the depositary&#8217;s obligations to you under the deposit agreement, we believe that, as a matter of construction of the clause, such limitations would likely to continue to apply to ADS holders who withdraw the ordinary shares from the ADS facility with respect to obligations or liabilities incurred under the deposit agreement before the cancellation of the ADSs and the withdrawal of the ordinary shares, and such limitations would most likely not apply to ADS holders who withdraw the ordinary shares from the ADS facility with respect to obligations or liabilities incurred after the cancellation of the ADSs and the withdrawal of the ordinary shares and not under the deposit agreement. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">In any event, you will not be deemed, by agreeing to the terms of the deposit agreement, to have waived our or the depositary&#8217;s compliance with U.S. federal securities laws and the rules and regulations promulgated thereunder. In fact, you cannot waive our or the depositary&#8217;s compliance with U.S. federal securities laws and the rules and regulations promulgated thereunder. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Taxes </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will be responsible for the taxes and other governmental charges payable on the ADSs and the securities represented by the ADSs. We, the depositary bank and the custodian may deduct from any distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to pay the taxes and governmental charges payable by holders. You will be liable for any deficiency if the sale proceeds do not cover the taxes that are due. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank may refuse to issue ADSs, to deliver, transfer, split and combine ADRs or to release securities on deposit until all taxes and charges are paid by the applicable holder. The depositary bank and the custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding for any distributions on your behalf. However, you may be required to provide to the depositary bank and to the custodian proof of taxpayer status and residence and such other information as the depositary bank and the custodian may require to fulfill legal obligations. You are required to indemnify us, the depositary bank and the custodian for any claims with respect to taxes based on any tax benefit obtained for you. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Conversion </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary bank will arrange for the conversion of all foreign currency received into U.S. dollars if such conversion is practical, and it will distribute the U.S. dollars in accordance with the terms of the deposit agreement. You may have to pay fees and expenses incurred in converting foreign currency, such as fees and expenses incurred in complying with currency exchange controls and other governmental requirements. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the conversion of foreign currency is not practical or lawful, or if any required approvals are denied or not obtainable at a reasonable cost or within a reasonable period, the depositary bank may take the following actions in its discretion&#58; </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convert the foreign currency to the extent practical and lawful and distribute the U.S. dollars to the holders for whom the conversion and distribution is lawful and practical. </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribute the foreign currency to holders for whom the distribution is lawful and practical. </font></div><div style="margin-top:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hold the foreign currency (without liability for interest) for the applicable holders. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Governing Law&#47;Waiver of Jury Trial </font></div><div style="margin-top:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The deposit agreement, the ADRs and the ADSs will be interpreted in accordance with the laws of the State of New York. The rights of holders of ordinary shares (including ordinary shares represented by ADSs) are governed by the laws of France. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As an owner of ADSs, you irrevocably agree that any legal action arising out of the Deposit Agreement, the ADSs or the ADRs involving us or the Depositary may only be instituted in a state or federal court in the city of New York. </font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AS A PARTY TO THE DEPOSIT AGREEMENT, YOU IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, YOUR RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF THE DEPOSIT AGREEMENT OR THE ADRs AGAINST US AND&#47;OR THE DEPOSITARY BANK. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our ordinary shares, the ADSs or the deposit agreement, including any claim under U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law. However, you will not be deemed, by agreeing to the terms of the deposit agreement, to have waived our or the depositary&#8217;s compliance with U.S. federal securities laws and the rules and regulations promulgated thereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.16
<SEQUENCE>4
<FILENAME>abivax-20xfxex416summaryof.htm
<DESCRIPTION>EX-4.16
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i9ba706eae91c408a9c1a1cec1f91b083_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 4.16</font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Summary of BSA Plans</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As at February 28, 2025, six BSA share warrant plans were outstanding&#58; BSA 2015-11, BSA 2015-12, BSA 2017-1, BSA 2018-1, BSA 2024-1, BSA 2024-2, BSA-2025-1 and BSA-2025-2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share warrants (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bons de souscription d&#8217;actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), or BSAs, entitle a holder to exercise the warrant for the underlying vested shares at an exercise price per share determined by our board of directors and at least equal to the fair market value of an ordinary share on the date of grant. In addition to any exercise price payable by a holder upon the exercise of any share warrant, share warrants need to be subscribed for at a price which is determined by the board of directors at the time of the grant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Pursuant to delegations granted at our annual meeting, our board of directors determines the recipients, dates of grant and exercise price of share warrants, the number of share warrants to be granted and the terms and conditions of the share warrants, including their exercise period and their vesting period. In its discretion, the board of directors has the authority to extend the exercise period of share warrants post-termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Underlying shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each BSA 2014-4, each BSA 2014-5, each BSA 2015-11, each BSA 2015-12, each BSA 2017-1, each BSA 2018-1, each BSA-2024-1, each BSA-2024-2, each BSA-2025-1 and each BSA-2025-2 gives the holder the right to purchase one (1)&#160;ordinary share. The number of shares to which the exercise of the BSAs entitles the holder has been multiplied by 100 for all BSAs issued prior to the division by 100 of the nominal value of the shares, decided by our general meeting on February 20, 2015. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Allocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Our BSAs are generally subscribed by officers, directors,&#160;employees, consultants or partners of our company. BSAs 2024-1, BSAs 2024-2, BSAs 2025-1 and BSAs 2025-2 may not be transferred. BSAs 2017-1 and BSAs 2018-1 may not be transferred except specific authorization granted by the Board of the Company. BSAs 2014-4 and BSAs 2014-5 may not be transferred save in case (i) the board of directors expressly authorizes such transfer or (ii) of the holder&#8217;s death to his&#47;her heirs, who may exercise the exercisable BSAs as of the holder&#8217;s death and for a period of 6 months thereafter, failing which the BSAs will become null and void. BSAs 2015-12 may not be transferred save in case (i) the board of directors expressly authorizes such transfer or (ii) of the holder&#8217;s death.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Standard terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The conditions to exercise our BSAs are as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.24pt">The BSAs 2015-11 will be exercisable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to the number of months elapsed from their allocation over a total period of thirty-six (36) months, in one or several occasions. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within ninety (90) days of ceasing to be a member of the Company&#8217;s Board of Directors. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The BSAs 2015-12 will be exercisable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to the number of months elapsed from their allocation over a total period of forty-eight (48) months, in one or several occasions, it being specified that the beneficiary may only exercise the BSAs at the end of a period of one (1) year from their allocation. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within ninety (90) days of ceasing to be a member of the Company&#8217;s Scientific Committee. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.46pt">The BSAs 2017-1 will be exercisable for one third on the allocation date, for one third on March 18, 2018 and the balance on September 19, 2019, in one or several occasions. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within three (3) months of ceasing to be a member of the Company&#8217;s board of directors. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void. Additionally, the BSAs will become fully exercisable (i) upon a change of control of the Company, (ii) if the Company is absorbed by another company or (iii) if the Company merges with one or several other companies resulting in the creation of a new entity or (iv) in case of a demerger. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.84pt">The BSAs 2018-1 will be exercisable for one third on the allocation date, for one third on July 22, 2018 and the balance on January 22, 2019, in one or several occasions. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within three (3) months of ceasing to be a member of the Company&#8217;s board of directors. If they are not exercised </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 4.16</font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void. Additionally, the BSAs will become fully exercisable (i) upon a change of control of the Company, (ii) if the Company is absorbed by another company or (iii) if the Company merges with one or several other companies resulting in the creation of a new entity or (iv) in case of a demerger. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:9.46pt">The BSAs 2024-1 will be exercisable for one fourth on January 1st, 2025, for one fourth on January 1st, 2026, for one fourth on January 1st, 2027 and the balance on January 1st, 2028, in one or several occasions. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within three (3) months of ceasing to be a member of the Company&#8217;s board of directors. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void. Additionally, the BSAs will become fully exercisable (i) upon a change of control of the Company, (ii) if the Company is absorbed by another company or (iii) if the Company merges with one or several other companies resulting in the creation of a new entity or (iv) in case of a demerger. </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:11.34pt">The BSAs 2024-2 will be exercisable for one fourth on April 1st, 2025, for one fourth on April 1st, 2026, for one fourth on April 1st, 2027 and the balance on April 1st, 2028, in one or several occasions. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within three (3) months of ceasing to be a member of the Company&#8217;s board of directors. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void. Additionally, the BSAs will become fully exercisable (i) upon a change of control of the Company, (ii) if the Company is absorbed by another company or (iii) if the Company merges with one or several other companies resulting in the creation of a new entity or (iv) in case of a demerger. </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:9.67pt">The BSAs 2025-1 will be exercisable for one fourth on January 1st, 2026, for one fourth on January 1st, 2027, for one fourth on January 1st, 2028 and the balance on January 1st, 2029, in one or several occasions.  In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within three (3) months of ceasing to be a member of the Company&#8217;s board of directors. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void. Additionally, the BSAs will become fully exercisable (i) upon a change of control of the Company, (ii) if the Company is absorbed by another company or (iii) if the Company merges with one or several other companies resulting in the creation of a new entity or (iv) in case of a demerger. </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:9.67pt">The BSAs 2025-2 will be exercisable for one fourth on January 1st, 2026, for one fourth on January 1st, 2027, for one fourth on January 1st, 2028 and the balance on January 1st, 2029, in one or several occasions.  In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs must be exercised by the holder within three (3) months of ceasing to be a member of the Company&#8217;s board of directors. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BSAs will become null and void. Additionally, the BSAs will become fully exercisable (i) upon a change of control of the Company, (ii) if the Company is absorbed by another company or (iii) if the Company merges with one or several other companies resulting in the creation of a new entity or (iv) in case of a demerger. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Validity period. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All BSAs have a maximum validity period of 10 years as from their issuance.</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.17
<SEQUENCE>5
<FILENAME>abivax-20xfxex417summaryof.htm
<DESCRIPTION>EX-4.17
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iff514ec4d0304a39930cd4938ded7320_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 4.17</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Summary of BCE Plans</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As at February 28, 2025, nine BCE share warrant plans were outstanding&#58; BCE 2016-1, BCE 2017-1, BCE 2017-2, BCE 2017-4, BCE 2017-5, BCE 2018-1, BCE 2018-3, BCE 2018-4 and BCE 2018-5.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Founder&#8217;s share warrants (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bons de souscription de parts de cr&#233;ateur d&#8217;entreprise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), or BCEs, entitle a holder to exercise the warrant for the underlying vested shares at an exercise price per share determined by our board of directors and at least equal to the fair market value of an ordinary share on the date of grant. Founder&#8217;s share warrants may only be issued by growth companies meeting certain criteria. Since our initial public offering in France, our eligibility to issue founder&#8217;s share warrants is subject to certain conditions, including that our market capitalization does not exceed &#8364;150M. Therefore, we are no longer eligible to issue founder&#8217;s share warrants.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Pursuant to delegations granted at our annual meeting of shareholders, our board of directors determines the recipients, dates of grant and exercise price of founder&#8217;s share warrants, the number of founder&#8217;s share warrants to be granted and the terms and conditions of the founder&#8217;s share warrants, including the period of their exercisability and their vesting schedule.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Underlying shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;The securities to which the BCE 2016-1 issued on November 7, 2016, BCE 2017-1 issued on January 23, 2017, BCE 2017-2 issued on November 20, 2017, BCE 2017-4 issued on 20 November 2017, BCE 2017-5 issued on November 20, 2017, BCE 2018-1 issued on March 15, 2018, BCE 2018-3 issued on May 14, 2018, BCE 2018-4 issued on May 14, 2018, and BCE 2018-5 issued on May 14, 2018 (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BCE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) give rights are ordinary shares. Each BCE gives the holder the right to purchase one (1)&#160;ordinary share.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Allocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Our founder&#8217;s share warrants are generally granted to executive officers, directors or employees of our company and its subsidiaries. Founder&#8217;s share warrants may not be transferred other than by inheritance.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Standard terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The vested BCE may be exercised in all or in part at the election of each holder as follows &#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.24pt">The BCEs 2016-1, 2018-1 and BCEs 2018-5 will be exercisable pro rata to the number of months elapsed from their allocation over a total period of 48 months, it being specified that the beneficiary may only exercise the BCEs at the end of a period of one year from their allocation. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BCEs must be exercised by the beneficiary within ninety (90) days of ceasing to be an employee. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BCEs will become null and void.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">A portion of the BCEs 2017-1 and of the BCEs 2017-2 will be exercisable pro rata to the number of months elapsed from their allocation over a total period of 48 months, it being specified that the beneficiary may only exercise the BCEs at the end of a period of one year from their allocation, while the rest of the BCEs will be exercisable only if qualitative and&#47;or quantitative objective(s) set by the Board are met. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BCEs must be exercised by the beneficiary within ninety (90) days of ceasing to be an employee. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BCEs will become null and void.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.24pt">A portion of the BCEs 2017-4, BCEs 2017-5, BCEs 2018-3 and BCEs 2018-4 became exercisable as from a specific date specified in their terms and conditions, another portion will be exercisable pro rata to the number of months elapsed from their allocation over a total period of 24 months, it being specified that the beneficiary may only exercise the BCEs at the end of a period of one year from their allocation, while the rest of the BCEs will be exercisable only if qualitative and&#47;or quantitative objectives set by the Board are met. In any event, except in the event of dismissal for serious misconduct or gross negligence, the exercisable BCEs must be exercised by the beneficiary within ninety (90) days of ceasing to be an employee. If they are not exercised within this period or in the event of dismissal for serious misconduct or gross negligence, the exercisable BCEs will become null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, each beneficiary will be able to subscribe for and exercise all of such BCEs even if the above-mentioned conditions have not been met, in the event of a Change of Control of the Company, defined as the execution of an agreement under which an industrial company or a member of an industrial group, acting alone or in concert industrial group, within the meaning of Article L. 233-10 of the French Commercial Code, comes to hold, directly or indirectly, more than 50% of the Company's capital or voting rights.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Validity period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. All BCEs have a maximum validity period of 10 years as from their issuance.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.18
<SEQUENCE>6
<FILENAME>abivax-20xfxex418summaryof.htm
<DESCRIPTION>EX-4.18
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ieb085c30e9be4031a98447d799890538_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 4.18</font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Summary of Free Share Plans</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As at February 28, 2025, twelve free share plans were outstanding&#58; AGA-2023-1, AGA-2023-2, AGA-2023-3, AGA-2023-4, AGA-2023-5, AGA-2024-1, AGA-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5, AGA-2024-6, AGA-2024-7, AGA-2025-1, AGA-2025-2, AGA 2025-3 and AGA-2025-4. Free Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">actions gratuites</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">) are allotted for free to holders. The issuance of the Free Shares occurs automatically at the end of the vesting period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">p&#233;riode d&#8217;acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">), subject to the fulfilment of the vesting conditions (if any), by way of a capital increase, which will be realized by debiting the unavailable reserve (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">r&#233;serve non disponible</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">) established for this matter.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. Pursuant to authorizations granted at our annual meeting, our board of directors determines the recipients, the number of free shares to be granted and the terms and conditions of the free shares, including their vesting calendar and conditions.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Underlying shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> Each Free Share gives the right to one (1)&#160;ordinary share.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Allocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. Our Free Shares are generally granted to executive officers, directors, employees, or consultants of our company or its subsidiaries.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Vesting periods and conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">.&#160;The Free Shares vest as follows&#58;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.24pt">for the Free Shares 2023-1&#58;</font></div><div style="padding-left:53.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">212,738 Free Shares 2023-1 shall vest one year from the grant (i.e., on July 11, 2024)&#59;</font></div><div style="padding-left:53.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">638,214 Free Shares 2023-1 shall progressively vest on a monthly basis over a period of three (3) years starting one year from the grant (i.e., 17,728 Free Shares 2023-1 per month except for the last month of the three-year period where 17,734 Free Shares 2023-1 shall be acquired)&#59;</font></div><div style="padding-left:53.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">212,738 Free Shares 2023-1 shall vest on the latest date between (i) one year from the grant (i.e., on July 11, 2024), and (ii) the date on which a performance condition related to regulatory approvals is fulfilled&#59;</font></div><div style="padding-left:53.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">106,369 Free Shares 2023-1 shall vest on the latest date between (i) one year from the grant (i.e., on July 11, 2024), and (ii) the date on which the Group successfully completes a public offering raising at least $100 million in gross proceeds (the condition was met on October 24, 2023)&#59;</font></div><div style="padding-left:53.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">106,369 Free Shares 2023-1 shall vest on the latest date between (i) one year from the grant (i.e., on July 11, 2024), and (ii) the date on which a specific performance condition related to the Group&#8217;s market capitalization is fulfilled&#59; and</font></div><div style="padding-left:53.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">106,368 Free Shares 2023-1 shall vest one year from the grant (i.e., on July 11, 2024) subject to the completion, prior to such date, of a tender offer on the securities issued by the Group, at a predetermined minimum price, and resulting in a change of control of the Group.</font></div><div style="padding-left:53.45pt"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2023-1.</font></div><div style="padding-left:53.45pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">for the Free Shares 2023-2&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2023-2 allocated shall vest one year from the grant (i.e., on July 11, 2024)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">75% of the Free Shares 2023-2 allocated shall vest on the latest date between (i) one year from the grant, on July 11, 2024, and (ii) the date on which a performance condition related to regulatory approvals is fulfilled.</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is no condition of presence applicable to the Free Shares 2023-2.</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.24pt">for the Free Shares 2023-3 and the Free Shares 2023-4&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the ordinary shares allocated shall vest two years from the grant (i.e., on September 28, 2025)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the ordinary shares allocated shall vest three years from the grant, (i.e., on September 28, 2026)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the ordinary shares allocated shall vest four years from the grant, (i.e., on September 28, 2027).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Free Shares 2023-4 were subject to a performance condition of the successful completion of a public offering raising at least $200 million in gross proceeds. This condition was met on October 24, 2024.</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2023-3 and 2023-4.</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">for the Free Shares 2024-1&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-1 allocated shall vest two years from the grant (i.e., on February 1, 2026)&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 4.18</font></div></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-1 allocated shall vest two years from the grant (i.e., on February 1, 2027)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-1 allocated shall vest two years from the grant (i.e., on February 1, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2024-1.</font></div><div style="margin-bottom:5pt;padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.24pt">for the Free Shares 2024-2&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-2 allocated shall vest two years from the grant (i.e., on March 28, 2026)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-2 allocated shall vest three years from the grant (i.e., on March 28, 2027)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-2 allocated shall vest four years from the grant (i.e., on March, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2024-2.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.34pt">for the Free Shares 2024-3&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-3 allocated shall vest two years from the grant (i.e., on May 23, 2026)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-3 allocated shall vest three years from the grant (i.e., on May 23, 2027)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-3 allocated shall vest four years from the grant (i.e., on May 23, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2024-3.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">for the Free Shares 2024-4&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-4 allocated shall vest two years from the grant (i.e., on July 11, 2026)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-4 allocated shall vest three years from the grant (i.e., on July 11, 2027)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-4 allocated shall vest four years from the grant (i.e., on July 11, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2024-4.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">for the Free Shares 2024-5&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-5 allocated shall vest two years from the grant (i.e., on July 11, 2026)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-5 allocated shall vest three years from the grant (i.e., on July 11, 2027)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-5 allocated shall vest four years from the grant (i.e., on July 11, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2024-5.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.9pt">for the Free Shares 2024-6&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-6 allocated shall vest one year from the grant (i.e., on July 11, 2026)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-6 allocated shall vest on the latest date between (i) one year from the grant (i.e., on July 11, 2026) and (ii) the date on which the performance condition is fulfilled.</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2024-6.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.9pt">for the Free Shares 2024-7&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2024-7 allocated shall vest two years from the grant (i.e., on September 5, 2026)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-7 allocated shall vest three years from the grant (i.e., on September 5, 2027)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2024-7 allocated shall vest four years from the grant (i.e., on September 5, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2024-7.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">for the Free Shares 2025-1&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Presence Free Shares 2025-1 allocated shall vest two years from the grant (i.e., on February 6, 2027)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Presence Free Shares 2025-1 allocated shall vest three years from the grant (i.e., on February 6, 2028)&#59; </font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Presence Free Shares 2025-1 allocated shall vest four years from the grant (i.e., on February 6, 2029)&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 4.18</font></div></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The M&#38;A Free Shares shall vest on the latest date between (i) the second anniversary of the grant (i.e. on February 6, 2027), and (ii) the date on which M&#38;A Performance Condition is fulfilled.</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2025-1.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.9pt">for the Free Shares 2025-2&#58; 100% of the Free Shares 2025-2 allocated shall vest two years from the grant (i.e., on February 6, 2027). A condition of presence is applicable to all Free Shares 2025-2.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.9pt">for the Free Shares 2025-3&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2025-3 allocated shall vest two years from the grant (i.e., on February 6, 2027)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2025-3 allocated shall vest three years from the grant (i.e., on February 6, 2028)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2025-3 allocated shall vest four years from the grant (i.e., on February 6, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2025-3.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">for the Free Shares 2025-4&#58;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">50% of the Free Shares 2025-4 allocated shall vest two years from the grant (i.e., on February 6, 2027)&#59;</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2025-4 allocated shall vest three years from the grant (i.e., on February 6, 2028)&#59; and</font></div><div style="padding-left:53.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">25% of the Free Shares 2025-4 allocated shall vest four years from the grant (i.e., on February 6, 2028).</font></div><div style="padding-left:53.45pt;text-align:justify"><font><br></font></div><div style="padding-left:53.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A condition of presence is applicable to all Free Shares 2025-4.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Standard terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pursuant to Article L.225-197-3, if a holder deceases during the vesting period, heirs may request, within six (6) months of the holder&#8217;s death, the immediate allocation of the Free Shares for which the condition of presence and&#47;or the applicable performance condition(s), if any, have been met as of the date of the holder&#8217;s death.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In the event that the vesting period expires prior to the second anniversary of the grant of the Free Shares, a lock-up period is applicable to the Free Shares until the date of the second anniversary of the grant. Free Shares vesting after the second anniversary of the grant are not subject to lock-up. </font></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additionally, all Free Shares are subject to a vesting acceleration condition in case of a tender offer on the securities issued by the company and resulting in a change of control of the company. </font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>7
<FILENAME>abivax-codeofmarketconduct.htm
<DESCRIPTION>EX-11.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ie086a8452ab74d21a55e3b04d374acc9_1"></div><div style="min-height:70.56pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><img alt="image_0b.jpg" src="image_0b.jpg" style="height:45px;margin-bottom:5pt;vertical-align:text-bottom;width:181px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.874%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ABIVAX </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Code of Market Conduct</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">concerning the confidentiality of information <br>and the prevention of insider dealing </font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Note&#58; Translation into English for information purposes only</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated September 28, 2023</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Introduction</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shares in Abivax SA (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Abivax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) are admitted to trading on the regulated Euronext Paris market and in the form of American Depositary Shares&#47;Receipts (ADS), on the Nasdaq Global Market in the United States. The Company is therefore required to comply with the regulations applicable to&#58; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">the processing of &#8220;Inside Information&#8221;&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">the prevention of market offences by persons in possession of Inside Information&#59; and </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">Transactions in the Company&#8217;s securities. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s objective is to ensure compliance with all of these rules, the purpose of which is to protect market integrity, and to follow recommendations made by the market authorities concerning the management of risk associated with the possession, disclosure and use of Inside Information. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Therefore, this Code of Market Conduct (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) sets out the market regulations applicable to the Members of Abivax and, generally, to all other persons who need to be aware of it. It will be sent to all persons likely to be classed as &#8220;Occasional Insiders&#8221;, who will be informed of the reason why they have been classed as such. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Code therefore draws the attention of the Members of Abivax to&#58; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">the market laws and regulations in force as well as the administrative and criminal sanctions imposed for failure to comply with those laws and regulations&#59; and </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">the preventive measures implemented to enable everyone to invest in Financial Instruments in accordance with the rules governing market integrity. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These rules come mainly from (i) the European Regulation of 16&#160;April 2014 on market abuse, which came into force on 3&#160;July 2016</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Market Abuse Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the relevant implementing decrees, and the positions and recommendations of the ESMA and the AMF and (ii) the Securities Exchange Act of 1934, as amended, from its rules of application, as adopted by the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and from the jurisprudence of the United States federal courts.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Capitalised terms that are not defined elsewhere in this Code have the meaning given to them in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:0.87pt;padding-right:0.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IMPORTANT</font></div><div style="padding-left:0.87pt;padding-right:0.87pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Each Member of Abivax must read and comply with this Code and ensure that their investment activities and, generally, the Transactions executed by them in the Financial Instruments of the Company or third parties, comply with the regulations in force. </font></div><div style="padding-left:0.87pt;padding-right:0.87pt;text-align:justify"><font><br></font></div><div style="padding-left:0.87pt;padding-right:0.87pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Failure to comply with this Code or, generally, with the regulations in force, could result in criminal, administrative, civil or disciplinary sanctions. Individuals who do not work for Abivax are required to comply with market regulations but will not receive this Code.</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The actions of each and every Member of Abivax could affect the Company&#8217;s image in the eyes of our partners and members of the public. Furthermore, Members of Abivax may enter into management mandates in relation to the Company&#8217;s Financial Instruments in order to protect themselves against the risk of executing Transactions which do not comply with the regulations in force or with this Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="border-bottom:0.54pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Regulation (EU) No 596&#47;2014 of the European Parliament and of the Council of 16&#160;April 2014 on market abuse. </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please do not hesitate to contact our designated &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Point of Contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;, Mr Didier Blondel (&#91;***&#93;), for any additional information concerning the interpretation, use or enforcement of this Code. </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.049%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.87pt;padding-right:0.87pt;text-align:center"><font><br></font></div><div style="padding-left:0.87pt;padding-right:0.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contents</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">General principles of financial communication </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company must </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">disclose to the public, &#8220;as soon as possible&#8221;, any Inside Information </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">which directly concerns the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">However, the Company may postpone the public disclosure of such information subject to the exceptions provided for by the Market Abuse Regulation, as set out in Section&#160;2.1 of this Code.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The purpose of Abivax&#8217;s financial communication policy is to ensure the effective, full and timely dissemination of accurate, precise and true information, which must be communicated to market players at the same time. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Only authorised persons within the Company are permitted to provide information concerning the Company to the financial market, either in the press or in any other media. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the non-disclosure obligation referred to in Section&#160;3 below, the Company implements quiet periods of 15&#160;days before publicly disclosing its annual and half-yearly results (and quarterly results if applicable), so as not to risk communicating fragmented financial information. During these periods, the Company generally refrains from contacting the financial community (financial analysts and investors), but is nevertheless required to provide the market with information pursuant to its ongoing information obligation during these quiet periods. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Inside Information </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Definition</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Inside information (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Inside Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is information which directly or indirectly concerns the Company or one or more of its Financial Instruments&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">which is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">of a precise nature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">which </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">has not been made public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">which, if it were made public, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">would be likely to have a significant effect on the price of those Financial Instruments or on the price of related derivative Financial Instruments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:8.84pt;text-decoration:underline">Information is deemed to be &#8220;of a precise nature&#8221; if</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">it indicates a set of circumstances which exists or which may reasonably be expected to come into existence, or an event which has occurred or which may reasonably be expected to occur&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">it is specific enough to enable a conclusion to be drawn as to the possible effect of that set of circumstances or event on the price of the relevant Financial Instruments. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:8.23pt;text-decoration:underline">Information must only be deemed &#8220;public&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> if it has been disclosed by the Company and&#47;or has been lawfully made public.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="border-bottom:0.54pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In compliance, in particular, with the dispositions of the Commission Implementing Regulation (EU) 2016&#47;1055 of June 29, 2016 laying down implementing technical standards with regard to the technical means for appropriate public disclosure of inside information and for delaying the public disclosure of inside information in accordance with Regulation (EU) No 596&#47;2014 of the European Parliament and of the Council.</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please be advised that the publication in the press or in any other media of rumours concerning information which has not been officially &#8220;publicly&#8221; confirmed by the Company remains inside information. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is required, as a matter of principle, to make public, as soon as possible, any Inside Information which concerns it. The Company may nevertheless decide to postpone the public disclosure of Inside Information, providing that each of the following three requirements are fulfilled&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:53.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.29pt">an immediate public disclosure would potentially harm the Company&#8217;s legitimate interests&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:53.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.24pt">postponing a public disclosure would not be likely to mislead the public&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:53.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.19pt">the Company is able to ensure that the information remains confidential. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In such scenario, the Company must estimate the date on which it must publicly disclose the Inside Information. The Company is therefore required to implement adequate internal procedures in order to protect the data which it may use in the future to prove that the requirements for postponing the public disclosure of Inside Information have indeed been satisfied.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the requirements for postponing a public disclosure cease to be satisfied, the Company must make the information public and immediately notify the AMF of the public disclosure of Inside Information which it had previously decided to postpone. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.46pt;text-decoration:underline">Sensitive information, which is to say, information which is likely to have a significant effect on the price of the Financial Instruments or on the price of related derivative Financial Instruments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be defined as information which a reasonable investor would be likely to use as part of the basis of their investment decisions.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.874%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Company will take appropriate steps in order to prevent the undue circulation of Inside Information and reduce the number of persons who have access to Inside Information, by limiting the number of people who attend meetings, using code names for transactions, regularly checking IT access rights and having the persons concerned sign non-disclosure letters. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Company also restricts data rooms solely to material transactions, as data rooms involve, or could potentially involve, the transmission of Inside Information. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Access to Inside Information is on a need-to-know basis, according to the duties and responsibilities of the relevant person. </font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Examples of Inside Information</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In practice, and by way of a non-exhaustive guide, the following can be deemed Inside Information, provided that it has not been made public&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">information which concerns the Company&#8217;s half-yearly or annual results, forecasts concerning the Company&#8217;s cash runway and, generally, any anticipated change to a financial aggregate and any report which shows a significant discrepancy compared to the forecasts communicated by the Company or the market consensus&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">any plan to dispose of or acquire Company assets for &#8364;10 million or more, any plan for the Company to merge or enter into a material partnership (including any M&#38;A transaction), as well as any draft material agreement or contract (including any licence concerning any of the Company&#8217;s products)&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">any legal proceedings, dispute, financial transaction (such as a capital increase, bank financing or a bond issue) or restructuring likely to have a significant effect on the Company&#8217;s financial position&#59; </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">the results of a clinical trial conducted by the Company, a material change to the Company&#8217;s product portfolio, the chances of obtaining marketing authorisation for a product, any important notification from a regulatory authority concerning a clinical trial (such as a clinical hold) and any material information concerning the safety of the Company&#8217;s products&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">any plan to replace the Company&#8217;s Chief Executive Officer or material change to its management team or governing bodies. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Defining Inside Information</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is responsible for determining whether information in its possession, and which concerns the Company directly or indirectly, is likely to constitute Inside Information.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For this purpose, the Company has adopted internal procedures to ensure the reporting of Inside Information and has determined its own specific criteria, by defining materiality thresholds and identifying events which must be subject to close scrutiny in order to determine whether information is inside information or not.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has appointed a Point of Contact who is in charge of enforcing these criteria. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anyone who receives information which is likely to be considered as inside information must immediately inform the Point of Contact who, following a discussion with the Board of Directors and (if necessary) the Company&#8217;s advisers, will issue an opinion as to whether he believes that the information is &#8220;inside&#8221; information, and will consider the consequences of disseminating the information. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Point of Contact will then inform the person concerned of his opinion. If the information is considered to be inside information, the Point of Contact will notify the person of their inclusion on the Company&#8217;s insider list. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.874%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Information should only be classified as Inside Information if all of the criteria set out in Section&#160;2.1 above have been fulfilled. </font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Insider lists</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the Market Abuse Regulation, the Company is required to draw up a list of all persons who have access to inside information and who work for the Company under a contract of employment, or otherwise perform tasks through which they have access to inside information, such as advisers or accountants. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These insider lists are kept by the Company for at least five years after they were drawn up or updated, and are intended to protect market integrity and permit the monitoring of Inside Information within the Company. They are confidential, but must be provided to the AMF upon request.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to Regulation (EU) 2016&#47;679 of the European Parliament and of the Council of 27&#160;April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (the General Data Protection Regulation), each person who is included on an insider list may exercise their right to access their personal data and to rectify any incorrect data by contacting the Data Protection Officer, Mr. Didier Blondel.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each person who is included on an insider list will be notified by the Company of their inclusion and provided (if necessary) with information on the obligations and sanctions imposed on holders of Inside Information. </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.874%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">By countersigning this Code, you confirm that you have familiarised yourself with the Company&#8217;s obligations to draw up an insider list using the template attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> to this Code. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">You agree to provide the information needed to include you on the Company&#8217;s insider list and therefore acknowledge that you are aware of the obligations imposed by law and regulations, and of the sanctions applicable to Insider Dealing and the unlawful disclosure of Inside Information. </font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:24pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Non-disclosure obligations </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Member of Abivax who possesses Inside Information must </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">refrain from disclosing it to any other person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including within the Company, other than in the ordinary course of their work, occupation or duties, providing that they first take steps to ensure that the recipient of Inside Information is bound by a legal, statutory, regulatory and&#47;or contractual non-disclosure obligation. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Inside Information must therefore not be disclosed to anyone</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including within the Company, who does not require such information in order to carry out their work or tasks.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furthermore, it is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">strictly prohibited to disseminate information or to spread rumours</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in the media or by any other means, which gives, or is likely to give, false or misleading information about the Financial Instruments and&#47;or the position, results or prospects of the Company. No interview, meeting or discussion with the press, investors or financial analysts may be held without the prior consent of a communications officer within the Company or the Point of Contact.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furthermore, the Company is not required to respond to any rumours which concern it. Therefore, all Members of Abivax must </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">refrain from commenting on any rumour</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> which concerns the Company, if the rumour has not been confirmed or denied by the Company. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the rumour is sufficiently precise and if it explicitly refers to Inside Information the public disclosure of which has been postponed, the Company must promptly disclose the Inside Information, as the confidentiality of the information is no longer guaranteed. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.874%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">All Members of Abivax are required to notify the Point of Contact immediately upon becoming aware of the disclosure or suspected disclosure of Inside Information (for example at an internal or external meeting). </font></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Abstention obligations applicable to Insiders </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:19.5pt">General abstention obligation</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Member of Abivax who possesses Inside Information must refrain from the following until the information has been made public&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:63.8pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:25.08pt">using or attempting to use the Inside Information by buying or selling, for their own account or for the account of a third party, directly or indirectly, Financial Instruments of the Company to which the Inside Information relates </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Insider Dealing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). Using Inside Information to cancel or amend an order concerning a Financial Instrument to which the Inside Information relates is also deemed to constitute Insider Dealing if the order was placed before the person concerned obtained the Inside Information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:63.8pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.03pt">making a recommendation or inducing another person to engage in Insider Dealing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Using a recommendation or inducement with the knowledge that it is based on Inside Information also constitutes Insider Dealing. </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the third person to whom a recommendation is made is a legal person, the above abstention obligations also apply to the natural persons who decide to carry out the acquisition, disposal, cancellation or amendment of an order on behalf of the legal person concerned.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.874%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">All Members of Abivax must therefore refrain from executing any transaction and from using any recommendation or inducement for as long as the Inside Information in their possession remains Inside Information (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">e.g.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> for as long as it has not been disclosed to the public or the project has not been abandoned). </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Any Member of Abivax who possesses Inside Information must notably refrain from imparting the Inside Information to persons close to them (including Persons Closely Associated) and, generally, to any person who, owing to their relationship with Members of Abivax, could be suspected of having relied on Inside Information.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Any Member of Abivax who has any doubts about the information which they are authorised to disclose, particularly during an oral presentation or in a written presentation, may seek advice from the Point of Contact. In case of doubt or if the Point of Contact does not reply immediately, the information must not be disclosed.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:19.5pt">Blackout periods</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:78pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.55pt">General rules </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the general abstention obligation described in Section&#160;4.1 above, and even if they are not in possession of Inside Information, every Person Discharging Managerial Responsibilities as well as every Permanent Insider and every Occasional Insider must </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">refrain from executing Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in the Company&#8217;s Financial Instruments, for their own account or for the account of a third party, directly or indirectly&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:63.8pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.08pt">for a period of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">30 calendar days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">prior</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the date on which the Company publishes its annual and half-yearly results, including the date of publication&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:63.8pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.03pt">for a period of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">15 calendar days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">prior</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the date on which the Company voluntarily publishes quarterly financial information, including the date of publication, if the Company decides in the future to publish such information on a quarterly basis.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It should be noted that, under exceptional circumstances, these periods could begin earlier than the dates indicated above, in which case every Person Discharging Managerial Responsibilities as well as every Permanent Insider and every Occasional Insider would be so informed (this information could constitute Inside Information).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The financial calendar containing the dates on which the Company plans to publish financial information is prepared annually by the Board of Directors and published on the Company&#8217;s website. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A form of blackout notice is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to this Code.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.874%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">All persons who have regular or occasional access to Inside Information are required to fulfil these obligations of abstention during Blackout Periods.</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:78pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.55pt">Exceptions </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company may authorise a Person Discharging Managerial Responsibilities to trade during a Blackout Period, for their own account or for the account of a third party&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.34pt">on a case-by-case basis due to exceptional circumstances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, on the understanding that circumstances are considered as exceptional if they are extremely urgent, unforeseeable and compelling, if they were not caused by the Person Discharging Managerial Responsibilities </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">concerned and if they are beyond the latter&#8217;s control (such as serious financial issues which require the immediate sale of shares)&#59; or</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.34pt">due to the specific nature of the trade concerned </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for transactions executed in the context of, or in relation to, a shareholding system or an employee savings scheme, the completion of formalities or the exercise of rights attached to the shares, or transactions that do not involve a change in ownership of the relevant security. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Person Discharging Managerial Responsibilities must submit their request in writing, give the reason for the request and describe the proposed Transaction. The request must be sent to the Point of Contact, who will issue his reply within eight business days of receipt of the request, following consultation with the Board of Directors and the Company&#8217;s advisers.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When the Point of Contact determines whether the circumstances described in the written request are exceptional, he will determine whether and to what extent the Person Discharging Managerial Responsibilities&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">is bound, at the time of submitting their request, by a financial commitment or an enforceable claim&#59; or</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">is required to make, or has put themselves in a situation prior to the beginning of the Blackout Period as a result of which they must make, a payment to a third party, including a tax liability, and cannot reasonably fulfil a financial commitment or claim other than by an immediate sale of shares. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In any case, the Person Discharging Managerial Responsibilities to whom permission is given must refrain from engaging in Insider Dealing under any circumstances. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Section&#160;4.2.2 of this Code also applies, in the same circumstances, to Permanent Insiders and Occasional Insiders, who must comply with the statutory Blackout Period pursuant to Section&#160;4.2.1 above. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:19.5pt">Specific terms applicable to stock options (if applicable)</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock options may not be granted&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">less than 20 trading sessions after the detachment of the shares from a coupon which entitles its holder to a dividend or a capital increase&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">during the 10 trading sessions before and after the date on which the Company&#8217;s consolidated (annual or half-yearly) financial statements are made public&#59; or</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">during the period between the date on which the Company&#8217;s corporate bodies become aware of Inside Information and the date which falls 10 trading sessions after the date on which the information was made public.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing provisions will apply solely in the event that the Company decides to implement a stock option plan in the future. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:19.5pt">Specific terms applicable to free shares (if applicable) </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The periods of abstention referred to above are without prejudice to the specific period of abstention provided for by the regulations applicable to allotments of free shares, which state that free shares may not be transferred at the end of the lock-up period&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">during the 10 trading sessions before and the 3 trading sessions after the date on which the Company&#8217;s consolidated financial statements (annual or half-yearly) are made public&#59; or</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">during the period between the date on which the Company&#8217;s corporate bodies become aware of Inside Information and the date which falls 10 trading sessions after the date on which the information was made public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing provisions will apply solely in the event that the Company decides to implement a free share allotment plan in the future. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Notification and lock-up obligations </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Major shareholding notification to the Company and the AMF in relation to thresholds laid down by law</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Member of Abivax, acting alone or in concert, who acquires, by any means, directly or indirectly, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">number of shares representing more than 5%, 10%, 15%, 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">, 25%, 30%, 33.33%, 50%, 66.66%, 90% or 95% of the Company&#8217;s share capital or voting rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is required to notify the Company and the AMF accordingly.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The notification made to the Company must state the nature of the transaction (purchase or sale) as a result of which the applicable threshold has been exceeded, as well as the total number of shares and voting rights held before and after the transaction. It must be sent by registered letter (with acknowledgement of receipt requested) to the registered office before the close of trading on the fourth trading day after the date on which the shareholding threshold was exceeded. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to make a notification to the AMF, the standard major shareholding notification and letter of intent must be completed (the Company may also complete it on the relevant person&#8217;s behalf). The form must be sent by e-mail, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">before close of trading on the fourth trading day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> after the date on which the shareholding threshold was exceeded, to the following address&#58; </font><font style="color:#4472c4;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">declarationseuil&#64;amf-france.org</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If these obligations are not fulfilled, the person concerned will forfeit the voting rights attached to the number of shares over and above the percentage not notified as required, for any general shareholders&#8217; meeting held within two years of the date a notification is made.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Major shareholding notification to the Company in relation to thresholds imposed under the Articles of Association </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Member of Abivax who is also a shareholder of the Company, acting alone or in concert, and who acquires, by any means, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2% or more of the Company&#8217;s share capital or voting rights, or any multiple of that percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, must notify the Company accordingly. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The notification must state the nature of the transaction (purchase or sale) as a result of which the applicable threshold has been exceeded, as well as the total number of shares and voting rights held before and after the transaction. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The notification must be sent to the Company by registered letter (with acknowledgement of receipt requested) to the registered office </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">before close of trading on the fourth trading day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> after the date on which the shareholding threshold was exceeded. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If this obligation is not fulfilled, the person concerned may forfeit the voting rights attached to the number of shares over and above the percentage not notified as required, for any general shareholders&#8217; meeting held within two years of the date a notification is made in accordance with the Company&#8217;s Articles of Association. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Notifications made by Persons Discharging Managerial Responsibilities and persons closely associated to them </font></div><div style="border-bottom:0.54pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Article L.&#160;22-10-49 of the French Commercial Code.</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Persons Discharging Managerial Responsibilities and persons closely associated to them </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Persons Closely Associated) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">are required to notify </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Company and the AMF, by e-mail, of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">any Transaction executed by them or by a third party acting on their behalf in the Company&#8217;s Financial Instruments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(as listed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex&#160;4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to this Code), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">within three business days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> following the date of the Transaction, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">if the total amount of the Transactions executed in the relevant calendar year exceeds &#8364;20,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It is not necessary to combine Transactions executed by Persons Discharging Managerial Responsibilities and Transactions executed by Persons Closely Associated to them in order to calculate this threshold. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The notification must be sent to the AMF within the above time limit, exclusively in electronic format, via an extranet system called &#8220;ONDE&#8221;, which is accessible on the AMF&#8217;s website at the following address&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#4472c4;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;onde.amf-france.org&#47;RemiseInformationEmetteur&#47;Client&#47;PTRemiseInformationEmetteur.aspx</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The filing of information with the AMF via ONDE requires the use of an account and associated login details. Such details can be obtained by creating an account at the above address. Notifications may be sent by a third party on behalf of the persons required to make them. The identity of the third party must be clearly stated in the notification accessible on the AMF&#8217;s website.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notifications must be completed under the responsibility of the person making them and are not examined by the AMF prior to publication. Notifications may be examined by the AMF in the future and are made public by the AMF.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notifications made by Persons Discharging Managerial Responsibilities and Persons Closely Associated to them must also be sent to the Company within the same timeframe.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Persons Discharging Managerial Responsibilities must send the Company, and update, if necessary, a list of the Persons Closely Associated to them. They are also required to notify the Persons Closely Associated to them in writing of their notification obligations and to keep a copy of that notice. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Compliance with this Code</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:19.5pt">The Point of Contact</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Point of Contact oversees compliance with this Code, on the understanding that each Permanent and Occasional Insider is ultimately responsible for complying with the applicable regulations.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the context of his work, the Point of Contact is notably responsible for&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">informing Permanent and Occasional Insiders in advance of Blackout Periods resulting from the publication of the Company&#8217;s financial information, according to the specified annual publication dates&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">receiving notifications made pursuant to the notification obligations referred to in Section&#160;5 above&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">informing the Company&#8217;s Board of Directors as soon as possible of any breach of this Code and of market regulations&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">drawing up a list of Insiders, in the standard form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to this Code, based on the information provided to him, ensuring that the list is kept up to date, sending it to the AMF upon request and keeping it for five years from the date it was drawn up and updated&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">informing Insiders of their inclusion in each section of the above list&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">drawing up and keeping up to date a list of Persons Discharging Managerial Responsibilities and Persons Closely Associated to them, based on the information provided to him&#59; and</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">providing, upon request, an advisory opinion prior to any Transaction in the Company&#8217;s Financial Instruments.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the performance of his work, the Point of Contact may, at his discretion, be assisted by the Company&#8217;s external legal adviser. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any opinion given by the Point of Contact will be given solely in an advisory capacity, as the person concerned is ultimately responsible for deciding whether to execute a Transaction in the Company&#8217;s Financial Instruments. Sanctions could be imposed on the person concerned if they fail to fulfil their statutory obligations, irrespective of the opinion of the Point of Contact.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:19.5pt">Information obligations </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To ensure compliance with this Code within the Company, you must take steps to prevent a breach of the Code, in particular by&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">informing the Point of Contact of any project, which has not yet been made public and which could inherently constitute Inside Information and, in such scenario, providing him or having a third party provide him with a list of the persons informed as the project progresses&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">having all employees and third parties who work on sensitive matters or matters involving Inside Information sign a non-disclosure letter drawn up in agreement with the Point of Contact&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">informing the Members of Abivax who work on sensitive matters of the existence and content of this Code and having them sign a letter in which they agree to comply with this Code&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">promptly notifying the Point of Contact if any Inside Information has been transmitted to a person not included on an insider list.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In case of doubt, you are reminded that you must seek advice from the Point of Contact on the type of transactions you are planning to carry out in the Financial Instruments and seek his advice in advance. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please also be aware that these preventive measures will not exempt you in any circumstances from criminal liability if an infringement is observed. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to this Code, the Company will also provide regular training on the topic of Insider Dealing. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Sanctions</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Persons who do not comply with the rules relating to the use and disclosure of Inside Information risk, either administrative penalties handed down by the AMF and the SEC, or criminal penalties handed down by the French or American federal judicial authorities, as well as disciplinary sanctions within the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">French criminal sanctions for insider dealing</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Insider Dealing carries a penalty of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">five years&#8217; imprisonment and a fine of &#8364;100 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The fine may be increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ten times the illegal gain</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and will not be less than the amount of such illegal gain</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fine imposed on legal persons is capped at the higher of the following&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8364;500 million, ten times the amount of the illegal gain or 15% of consolidated turnover</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">French administrative sanctions for insider dealing</font></div><div style="border-bottom:0.54pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> French Monetary and Financial Code, Articles L. 465-1 to L. 465-3. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> French Monetary and Financial Code, Article L. 465-3-5.</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Insider Dealing may carry a fine of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8364;100 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, which may be increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ten times the illegal gain if this can be established</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fine imposed on legal persons may be increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">15% of the legal person&#8217;s consolidated turnover</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Disciplinary sanctions </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any violation of this Policy and of these rules or the law on insider trading or insider misconduct by a Member of Abivax, Permanent Insider, Occasional Insider, or Person Discharging Managerial Responsibilities (including Persons Closely Associated, in each case), may lead to measures up to the dismissal or discharge of the person concerned. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The commission of insider trading or insider misconduct is the responsibility of the one who commits it. Abivax may not be held liable in place of the person who committed such an act. In this regard, the Company is not intended to assume the fines to which its collaborators may be liable. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anyone found in violation of the information contained in this Policy or having knowledge of the commission of such an offence by another person, must immediately inform the Point of Contact, who will take all appropriate measures internally and in relation to the market authorities.</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">*            *</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">*</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="border-bottom:0.54pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> French Monetary and Financial Code, Article L. 621-15 III c). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> French Monetary and Financial Code, Article L. 621-15 III </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">bis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Letter of agreement</font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">All Insiders and other recipients of this Code must complete and sign this letter and send it to Mr&#160;Didier Blondel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, the undersigned, </font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">insert first name, surname and position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">have read Abivax&#8217;s Code of Market Conduct and agree to comply with the Code at all times.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Place&#58; &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. Date&#58;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#58; Definitions </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the purposes of this Code, capitalised terms and expressions shall have the following meaning&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMF </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des March&#233;s Financiers </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the French Financial Markets Authority).</font></div></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Blackout Period(s) </font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">has the meaning ascribed to it in Section&#160;4.2 of this Code. </font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Corporate Officers</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">means the members of the Board of Directors.</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">ESMA</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">means the European Securities and Markets Authority. </font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Financial Instruments</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.68pt">the shares, bonds and transferable securities issued or to be issued by the Company, including founders&#8217; warrants (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">bons de souscription de parts de cr&#233;ateur d&#8217;entreprise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), share warrants (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">bons de souscription d&#8217;actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and free shares&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">the rights that may be separated from the securities referred to in point (i), particularly preferential subscription and allotment rights&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">any derivative or financial instrument linked to the rights or securities referred to in points (i) and (ii) above, particularly securities that give access to the Company&#8217;s share capital and futures (including equivalent cash-settled instruments, swaps and options, including stock options in particular).</font></div></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Inside Information </font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">has the meaning ascribed to in Section&#160;2 of this Code. </font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Insider(s)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">means any person who may or may not work for the Company, and who possesses Inside Information which concerns the Company. </font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Insider Dealing </font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">has the meaning ascribed to it in Section&#160;4 of this Code. </font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Member(s) of Abivax</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">means the Persons Discharging Managerial Responsibilities and any employee, including employees whose services are made available to another company and temporary employees, and any other agent of Abivax.</font></td></tr></table></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Occasional Insider(s)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means persons who occasionally have access to Inside Information which concerns the Company. These persons may belong to two categories&#58; </font></div><div style="margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">persons within the Company, such as employees, who have access to Inside Information due, for example, to their involvement in a project or transaction&#59;</font></div><div style="padding-left:38.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt">third parties acting in the name or on behalf of the Company, who have access to Inside Information in the context of their business relationships with the Company at the time of preparation or performance of an occasional transaction, such as service providers, including lawyers and financing and investment banks, who, for example, work with the Company on a transaction or proposed transaction, or a communications agency appointed in respect of the transaction. </font></div></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Permanent Insider(s)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means all persons who, owing to the nature of their duties or position, have permanent access to Inside Information which concerns the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Persons Closely Associated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means the persons who have close personal links to a Member of Abivax, namely&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.68pt">their spouse who shares the same household or their civil partner&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">children over whom they exercise parental authority or who live with them permanently or alternately, or for whom they are effectively and permanently responsible&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">blood relatives and relatives by marriage who have shared the same household for at least one year on the date of the transaction concerned&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">legal persons, trusts or partnerships, the managerial responsibilities of which are discharged by them or by a person referred to in point (i), (ii) or (iii) above&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.23pt">legal persons, trusts or partnerships that are controlled, directly or indirectly, by them or by a person referred to in point (i), (ii) or (iii) above&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">legal persons, trusts or partnerships that haven been incorporated or set up for their benefit or for the benefit of a person referred to in point (i), (ii) or (iii) above&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-39.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">legal persons, trusts or partnerships whose economic interests are substantially the same as their own or as those of a person referred to in point (i), (ii) or (iii) above. </font></div></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Persons Discharging Managerial Responsibilities&#160;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">means Corporate Officers and Similar Persons.</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Point of Contact</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">has the meaning ascribed to it in the Introduction and in Section&#160;2.3 of this Code.</font></td></tr></table></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Similar Person(s) </font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">means any person similar to a Corporate Officer who, on the one hand, has the power within the Company to make management decisions concerning the Company&#8217;s development and strategy and who, on the other hand, has regular access to Inside Information which directly or indirectly concerns the Company.</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Transaction</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, in particular, any acquisition, disposal, subscription, exchange or conversion of Financial Instruments, immediately or in the future, on the market or over the counter, the entering into of an undertaking to acquire or dispose of Financial Instruments, any derivatives transaction for which the underlying assets are Financial Instruments, any hedging transaction that results in the acquisition or transfer of the economic risk associated with Financial Instruments, which is executed directly or indirectly by a person for their own account or for the account of a third party.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing also applies to the exercise of stock options and the sale of securities resulting from the exercise of stock options and, generally, all transactions covered by the regulations in force. </font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#58; Template sections of insider list<br>in accordance with Commission Implementing Regulation (EU) 2016&#47;347 of 10 March 2016 laying down implementing technical standards with regard to the precise format of insider lists and for updating insider lists </font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Annex&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#58; Form of blackout notice </font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>8
<FILENAME>abivax-20xfxexhibit121ceo3.htm
<DESCRIPTION>EX-12.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iff9de61789474720868d9edee927fd61_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 12.1</font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER<br>PURSUANT TO EXCHANGE ACT RULE 13A-14(A) OR 15D-14(A) AS ADOPTED<br>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Marc de Garidel, certify that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">I have reviewed this annual report on Form 20-F of Abivax SA&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">The company&#8217;s other certifying officer and have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 24, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Marc de Garidel&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Marc de Garidel</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Chief Executive Officer and Chairman <br>(Principal Executive Officer)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>9
<FILENAME>abivax-20xfxexhibit122cfo3.htm
<DESCRIPTION>EX-12.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8ac4bfe2753c448985690c576f548c5d_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 12.2</font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER<br>PURSUANT TO EXCHANGE ACT RULE 13A-14(A) OR 15D-14(A) AS ADOPTED<br>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Didier Blondel, certify that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">I have reviewed this annual report on Form 20-F of Abivax SA&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">The company&#8217;s other certifying officer and have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 24, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Didier Blondel&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Didier Blondel</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Executive Vice President and Chief Financial Officer <br>(Principal Financial Officer)</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>10
<FILENAME>abivax-20xfxexhibit131ceo3.htm
<DESCRIPTION>EX-13.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8d0e6de16fd9455abc45650839597f1b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 13.1</font></div></div><div><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Certification by the Principal Executive Officer<br>Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with the Annual Report of Abivax SA (the &#8220;Company&#8221;) on Form 20-F for the fiscal year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Marc de Garidel, Chief Executive Officer and Chairman of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-bottom:12pt;padding-left:64.8pt;text-align:justify;text-indent:-28.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.14pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;padding-left:64.8pt;text-align:justify;text-indent:-28.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.14pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 24, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Marc de Garidel&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Marc de Garidel</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Chief Executive Officer and Chairman<br>(Principal Executive Officer)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Report), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>11
<FILENAME>abivax-20xfxexhibit132cfo3.htm
<DESCRIPTION>EX-13.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="idc034041417349308a9b653c949ecde0_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 13.2</font></div></div><div><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Certification by the Principal Financial Officer<br>Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with the Annual Report of Abivax SA (the &#8220;Company&#8221;) on Form 20-F for the fiscal year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Didier Blondel, Chief Financial Officer and Board Secretary of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-bottom:12pt;padding-left:64.8pt;text-align:justify;text-indent:-28.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.14pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;padding-left:64.8pt;text-align:justify;text-indent:-28.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.14pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 24, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Didier Blondel&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Didier Blondel</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Executive Vice President, Chief Financial Officer and Board Secretary<br>(Principal Financial Officer)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Report), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>12
<FILENAME>a4abivaxfy24_consentforf3v.htm
<DESCRIPTION>EX-15.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i831555d49e1842428ddc8a07659a4723_1"></div><div style="min-height:79.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:78px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font><br></font></div><div style="margin-top:4.05pt;padding-left:2.42pt;padding-right:2.42pt;text-align:center"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">CONSENT</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.06em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">OF</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.04em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">INDEPENDENT</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.05em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">REGISTERED</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.05em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">PUBLIC</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.055em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTING</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.055em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.02em;line-height:120%">FIRM</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:1.2pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:4.95pt;text-align:justify"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">We</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">hereby</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">consent</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">to</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">the</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.005em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">incorporation</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">by</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">reference</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">in</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">the</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">Registration</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">Statement</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">on</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">Form</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.015em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">F3</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%">            (</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">No.</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.005em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">333- 283336) of Abivax SA of our report dated March 24, 2025 relating to the financial statements, which appears in this Form 20-F.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:1.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:354.55pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Neuilly-sur-Seine,</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;letter-spacing:-0.065em;line-height:120%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:120%">France March 24, 2025</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:14.2pt;text-align:justify"><img alt="image_1.jpg" src="image_1.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-weight:400;line-height:145%">PricewaterhouseCoopers Audit</font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:145%">, </font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-weight:400;line-height:145%">63, rue de Villiers</font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:145%"> 92208</font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-weight:400;line-height:145%"> Neuilly-sur-Seine Cedex</font></div><div style="padding-right:14.2pt;text-align:justify"><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:145%">T&#233;l&#233;phone &#58; </font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-weight:400;line-height:145%">+33 (0)1 56 57 58 59</font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:145%">, Fax &#58; </font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-weight:400;line-height:145%">+33 (0)1 56 57 58 60</font><font style="color:#000000;font-family:'Georgia',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:145%">, www.pwc.fr</font></div><div style="padding-right:14.2pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:135%">Soci&#233;t&#233; d&#8217;expertise comptable inscrite au tableau de l&#8217;ordre de Paris - Ile de France. Soci&#233;t&#233; de commissariat aux comptes membre de la compagnie r&#233;gionale de Versailles.Soci&#233;t&#233; par Actions Simplifi&#233;e au capital de 2 510 460 &#8364;. Si&#232;ge social &#58; 63 rue de Villiers 92200 Neuilly-sur-Seine. RCS Nanterre 672 006 483. TVA n&#176; FR 76 672 006 483. Siret 672 006 483 00362. Code APE 6920 Z. Bureaux &#58; Bordeaux, Grenoble, Lille, Lyon, Marseille, Metz, Nantes, Neuilly-Sur-Seine, Nice, Poitiers, Rennes, Rouen,  Strasbourg, Toulouse. </font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>13
<FILENAME>abivax-20xfxex971incentive.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ie4711e0ff0684c709dd7bb949da05469_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:11pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Exhibit 97.1</font></div></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABIVAX SA </font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Incentive Compensation Recoupment Policy</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Introduction</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of Abivax SA, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">soci&#233;t&#233; anonyme </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">incorporated under the laws of France</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), has </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">determined that it is in the best interests of the Company and its shareholders to adopt this Incentive Compensation Recoupment Policy (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) providing for the Company&#8217;s recoupment of Recoverable Incentive Compensation that is received by Covered Officers of the Company under certain circumstances. Certain capitalized terms used in this Policy have the meanings given to such terms in Section 3 below.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy is designed to comply with, and shall be interpreted to be consistent with, Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Rule 10D-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Nasdaq Listing Rule 5608 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Listing Standards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Effective Date</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy shall apply to all Incentive Compensation that is received by a Covered Officer on or after September 28, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Incentive Compensation is deemed &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">received</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; in the Company&#8217;s fiscal period in which the Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of such Incentive Compensation occurs after the end of that period. </font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Definitions </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Accounting Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an accounting restatement that the Company is required to prepare due to the material noncompliance of the Company with any financial reporting requirement under the U.S. securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Accounting Restatement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the earlier to occur of (a) the date that the Board, a committee of the Board authorized to take such action, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (b) the date that a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Compensation Committee or, in the absence of such committee, the Board.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Appointments and Compensation Committee of the Board.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Covered Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each current and former Executive Officer.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Nasdaq Stock Market.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the U.S. Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Company&#8217;s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. Executive officers of the Company&#8217;s parent(s) or subsidiaries are deemed executive officers of the Company if they perform such policy-making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. Identification of an executive officer for purposes of this Policy would include at a minimum executive officers identified pursuant to Item 401(b) of Regulation S-K promulgated under the Exchange Act.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Financial Reporting Measures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means measures that are determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measures derived wholly or in part from such measures, including Company share price and total shareholder return (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">TSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). A measure need not be presented in the Company&#8217;s financial statements or included in a filing with the SEC in order to be a Financial Reporting Measure.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Lookback Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the three completed fiscal years immediately preceding the Accounting Restatement Date, as well as any transition period (resulting from a change in the Company&#8217;s fiscal year) within or immediately following those three completed fiscal years (except that a transition period of at least nine months shall count as a completed fiscal year). Notwithstanding the foregoing, the Lookback Period shall not include fiscal years completed prior to the Effective Date. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Recoverable Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Incentive Compensation received by a Covered Officer during the Lookback Period that exceeds the amount of Incentive Compensation that would have been received had such amount been determined based on the Accounting Restatement, computed without regard to any taxes paid (i.e., on a gross basis without regarding to tax withholdings and other deductions). For any compensation plans or programs that take into account Incentive Compensation, the amount of Recoverable Incentive Compensation for purposes of this Policy shall include, without limitation, the amount contributed to any notional account based on Recoverable Incentive Compensation and any earnings to date on that notional amount. For any Incentive Compensation that is based on share price or TSR, where the Recoverable Incentive Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the Administrator will determine the amount of Recoverable Incentive Compensation based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or TSR upon which the Incentive Compensation was received. The Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation to the Exchange in accordance with the Listing Standards.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Recoupment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:23.18pt">Applicability of Policy. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy applies to Incentive Compensation received by a Covered Officer (i) after beginning services as an Executive Officer, (ii) who served as an Executive Officer at any time during the performance period for such Incentive Compensation, (iii) while the Company had a class of securities listed on a U.S. national securities exchange or a national securities association, and (iv)&#160;during the Lookback Period. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Recoupment Generally.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pursuant to the provisions of this Policy, if there is an Accounting Restatement, the Company must reasonably promptly recoup the full amount of the Recoverable Incentive Compensation, unless the conditions of one or more subsections of Section 4(c) of this Policy are met and the Compensation Committee, or, if such committee does not consist solely of </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; This documentation must be affirmatively provided to the Exchange.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; This Policy includes as an attachment a form of acknowledgment that executive officers can sign to facilitate recoupment. The acknowledgment is not required by Rule 10D-1 or the Listing Standards, but is recommended in all (and may be required by some) US jurisdictions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">independent directors,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> a majority of the independent directors serving on the Board, has made a determination that recoupment would be impracticable. Recoupment is required regardless of whether the Covered Officer engaged in any misconduct and regardless of fault, and the Company&#8217;s obligation to recoup Recoverable Incentive Compensation is not dependent on whether or when any restated financial statements are filed.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:23.8pt">Impracticability of Recovery.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Recoupment may be determined to be impracticable if, and only if&#58;</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount of the applicable Recoverable Incentive Compensation&#59; provided that, before concluding that it would be impracticable to recover any amount of Recoverable Incentive Compensation based on expense of enforcement, the Company shall make a reasonable attempt to recover such Recoverable Incentive Compensation, document such reasonable attempt(s) to recover, and provide that documentation to the Exchange in accordance with the Listing Standards&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">recoupment of the applicable Recoverable Incentive Compensation would violate home country law where that law was adopted prior to November 28, 2022&#59; provided that, before concluding that it would be impracticable to recover any amount of Recoverable Incentive Compensation based on violation of home country law, the Company shall obtain an opinion of home country counsel, acceptable to the Exchange, that recoupment would result in such a violation, and shall provide such opinion to the Exchange in accordance with the Listing Standards&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">recoupment of the applicable Recoverable Incentive Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Code Section 401(a)(13) or Code Section 411(a) and regulations thereunder.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Sources of Recoupment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  To the extent permitted by applicable law, the Administrator shall, in its sole discretion, determine the timing and method for recouping Recoverable Incentive Compensation hereunder, provided that such recoupment is undertaken reasonably promptly. The Administrator may, in its discretion, seek recoupment from a Covered Officer from any of the following sources or a combination thereof, whether the applicable compensation was approved, awarded, granted, payable or paid to the Covered Officer prior to, on or after the Effective Date&#58; (i) direct repayment of Recoverable Incentive Compensation previously paid to the Covered Officer&#59; (ii) cancelling prior cash or equity-based awards (whether vested or unvested and whether paid or unpaid)&#59; (iii) cancelling or offsetting against any planned future cash or equity-based awards&#59; (iv) forfeiture of deferred compensation, subject to compliance with Code Section 409A&#59; and (v) any other method authorized by applicable law or contract. Subject to compliance with any applicable law, the Administrator may effectuate recoupment under this Policy from any amount otherwise payable to the Covered Officer, including amounts payable to such individual under any otherwise applicable Company plan or program(e.g., base salary, bonuses or commissions and compensation previously deferred by the Covered Officer). The Administrator need not utilize the same method of recovery for all Covered Officers or with respect to all types of Recoverable Incentive Compensation.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:23.8pt">No Indemnification of Covered Officers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Notwithstanding any indemnification agreement, applicable insurance policy or any other agreement or provision of the Company&#8217;s charter or bylaws to the contrary, no Covered Officer shall be entitled to indemnification or advancement of expenses in connection with any enforcement of this Policy by the Company, including paying or </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; A non-independent compensation committee (e.g., in the case of reliance on a phase-in or controlled company exception) would not be eligible under the Listing Standards to make the determination as to whether recoupment is impracticable.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; This documentation must be affirmatively provided to the Exchange.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; If the Company intends to rely on this exception, the opinion from home country counsel must be affirmatively provided to the Exchange. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reimbursing such Covered Officer for insurance premiums to cover potential obligations to the Company under this Policy.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.02pt">Indemnification of Administrator.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Any members of the Administrator, and any other members of the Board who assist in the administration of this Policy, shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Administration</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as specifically set forth herein, this Policy shall be administered by the Administrator. The Administrator shall have full and final authority to make any and all determinations required under this Policy.  Any determination by the Administrator with respect to this Policy shall be final, conclusive and binding on all interested parties and need not be uniform with respect to each individual covered by this Policy. In carrying out the administration of this Policy, the Administrator is authorized and directed to consult with the full Board or such other committees of the Board as may be necessary or appropriate as to matters within the scope of such other committee&#8217;s responsibility and authority. Subject to applicable law, the Administrator may authorize and empower any officer or employee of the Company to take any and all actions that the Administrator, in its sole discretion, deems necessary or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee).</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Severability</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any provision of this Policy or the application of any such provision to a Covered Officer shall be adjudicated to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Policy, and the invalid, illegal or unenforceable provisions shall be deemed amended to the minimum extent necessary to render any such provision or application enforceable.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">No Impairment of Other Remedies</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained in this Policy, and no recoupment or recovery as contemplated herein, shall limit any claims, damages or other legal remedies the Company or any of its affiliates may have against a Covered Officer arising out of or resulting from any actions or omissions by the Covered Officer. This Policy does not preclude the Company from taking any other action to enforce a Covered Officer&#8217;s obligations to the Company, including, without limitation, termination of employment and&#47;or institution of civil proceedings. This Policy is in addition to the requirements of Section 304 of the Sarbanes-Oxley Act of 2002 that are applicable to the Company&#8217;s Chief Executive Officer and Chief Financial Officer and to any other compensation recoupment policy and&#47;or similar provisions in any employment, equity plan, equity award, or other individual agreement, to which the Company is a party or which the Company has adopted or may adopt and maintain from time to time.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Amendment&#59; Termination</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrator may amend, terminate or replace this Policy or any portion of this Policy at any time and from time to time in its sole discretion. The Administrator shall amend this Policy as it deems necessary to comply with applicable law or any Listing Standard.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Successors</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy shall be binding and enforceable against all Covered Officers and, to the extent required by Rule 10D-1 and&#47;or the applicable Listing Standards, their beneficiaries, heirs, executors, administrators or other legal representatives.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.&#160;&#160;&#160;&#160;Required Filings</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Company shall make any disclosures and filings with respect to this Policy that are required by law, including as required by the SEC.</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:11pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><div id="ie4711e0ff0684c709dd7bb949da05469_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Abivax SA</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Incentive Compensation Recoupment Policy</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Form of Executive Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">6</font></div><div style="margin-bottom:11pt;text-align:justify"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I, the undersigned, agree and acknowledge that I am bound by, and subject to, the Abivax SA Incentive Compensation Recoupment Policy, as may be amended, restated, supplemented or otherwise modified from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). In the event of any inconsistency between the Policy and the terms of any employment agreement, offer letter or other individual agreement with Abivax SA (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to which I am a party, or the terms of any compensation plan, program or agreement, whether or not written, under which any compensation has been granted, awarded, earned or paid to me, the terms of the Policy shall govern.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that the Administrator (as defined in the Policy) determines that any compensation granted, awarded, earned or paid to me must be forfeited or reimbursed to the Company pursuant to the Policy, I will promptly take any action necessary to effectuate such forfeiture and&#47;or reimbursement. I further agree and acknowledge that I am not entitled to indemnification, and hereby waive any right to advancement of expenses, in connection with any enforcement of the Policy by the Company.</font></div><div style="margin-bottom:11pt;text-align:justify"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Agreed and Acknowledged&#58;</font></div><div style="margin-bottom:11pt;text-align:justify"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt;text-align:justify"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify"><font><br></font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; This acknowledgment is optional and is not required by Rule 10D-1 or the Listing Standards. The acknowledgment puts executives on notice of the clawback requirements and may aid the Company in its efforts to enforce the Policy and recoup amounts already paid, particularly from former executives. The acknowledgment also minimizes diligence otherwise required to confirm which arrangements are subject to potential recoupment under the Policy, not all of which would necessarily cross-reference a clawback policy maintained by the Company from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>abvx-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5b13969f-ba48-4e71-920c-2a5c64899678,g:b21d6730-553e-45e9-b346-3f9a3ffd9584-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:abvx="http://www.abivax.com/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.abivax.com/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:import namespace="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abvx-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abvx-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abvx-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abvx-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Coverpage" roleURI="http://www.abivax.com/role/Coverpage">
        <link:definition>0000001 - Document - Cover page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Auditorinformation" roleURI="http://www.abivax.com/role/Auditorinformation">
        <link:definition>0000002 - Document - Auditor information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
        <link:definition>9952151 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical" roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOMELOSS" roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheGroup" roleURI="http://www.abivax.com/role/TheGroup">
        <link:definition>9952157 - Disclosure - The Group</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Basisofpreparation" roleURI="http://www.abivax.com/role/Basisofpreparation">
        <link:definition>9952158 - Disclosure - Basis of preparation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents" roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents">
        <link:definition>9952159 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accountingprinciples" roleURI="http://www.abivax.com/role/Accountingprinciples">
        <link:definition>9952160 - Disclosure - Accounting principles</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentinformation" roleURI="http://www.abivax.com/role/Segmentinformation">
        <link:definition>9952161 - Disclosure - Segment information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwillandimpairmenttest" roleURI="http://www.abivax.com/role/Goodwillandimpairmenttest">
        <link:definition>9952162 - Disclosure - Goodwill and impairment test</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibleassets" roleURI="http://www.abivax.com/role/Intangibleassets">
        <link:definition>9952163 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Propertyplantandequipment" roleURI="http://www.abivax.com/role/Propertyplantandequipment">
        <link:definition>9952164 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otherfinancialassets" roleURI="http://www.abivax.com/role/Otherfinancialassets">
        <link:definition>9952165 - Disclosure - Other financial assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otherreceivablesandotherassets" roleURI="http://www.abivax.com/role/Otherreceivablesandotherassets">
        <link:definition>9952166 - Disclosure - Other receivables and other assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Cashandcashequivalents" roleURI="http://www.abivax.com/role/Cashandcashequivalents">
        <link:definition>9952167 - Disclosure - Cash and cash equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financialassetsandliabilities" roleURI="http://www.abivax.com/role/Financialassetsandliabilities">
        <link:definition>9952168 - Disclosure - Financial assets and liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Shareholdersequity" roleURI="http://www.abivax.com/role/Shareholdersequity">
        <link:definition>9952169 - Disclosure - Shareholders&#8217; equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Sharebasedpayments" roleURI="http://www.abivax.com/role/Sharebasedpayments">
        <link:definition>9952170 - Disclosure - Share-based payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financialliabilities" roleURI="http://www.abivax.com/role/Financialliabilities">
        <link:definition>9952171 - Disclosure - Financial liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Retirementbenefitobligations" roleURI="http://www.abivax.com/role/Retirementbenefitobligations">
        <link:definition>9952172 - Disclosure - Retirement benefit obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Payablesandothercurrentliabilities" roleURI="http://www.abivax.com/role/Payablesandothercurrentliabilities">
        <link:definition>9952173 - Disclosure - Payables and other current liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operatingincome" roleURI="http://www.abivax.com/role/Operatingincome">
        <link:definition>9952174 - Disclosure - Operating income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operatingexpenses" roleURI="http://www.abivax.com/role/Operatingexpenses">
        <link:definition>9952175 - Disclosure - Operating expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Employees" roleURI="http://www.abivax.com/role/Employees">
        <link:definition>9952176 - Disclosure - Employees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financialgainloss" roleURI="http://www.abivax.com/role/Financialgainloss">
        <link:definition>9952177 - Disclosure - Financial gain (loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometax" roleURI="http://www.abivax.com/role/Incometax">
        <link:definition>9952178 - Disclosure - Income tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incomelosspershare" roleURI="http://www.abivax.com/role/Incomelosspershare">
        <link:definition>9952179 - Disclosure - Income (loss) per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Relatedparties" roleURI="http://www.abivax.com/role/Relatedparties">
        <link:definition>9952180 - Disclosure - Related parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Offbalancesheetcommitmentsgiven" roleURI="http://www.abivax.com/role/Offbalancesheetcommitmentsgiven">
        <link:definition>9952181 - Disclosure - Off-balance sheet commitments given</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Offbalancesheetcommitmentsreceivedandcontingentassets" roleURI="http://www.abivax.com/role/Offbalancesheetcommitmentsreceivedandcontingentassets">
        <link:definition>9952182 - Disclosure - Off-balance sheet commitments received and contingent assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Managementandassessmentoffinancialrisks" roleURI="http://www.abivax.com/role/Managementandassessmentoffinancialrisks">
        <link:definition>9952183 - Disclosure - Management and assessment of financial risks</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesPolicies" roleURI="http://www.abivax.com/role/AccountingprinciplesPolicies">
        <link:definition>9955511 - Disclosure - Accounting principles (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesTables" roleURI="http://www.abivax.com/role/AccountingprinciplesTables">
        <link:definition>9955512 - Disclosure - Accounting principles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsTables" roleURI="http://www.abivax.com/role/IntangibleassetsTables">
        <link:definition>9955513 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentTables" roleURI="http://www.abivax.com/role/PropertyplantandequipmentTables">
        <link:definition>9955514 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherfinancialassetsTables" roleURI="http://www.abivax.com/role/OtherfinancialassetsTables">
        <link:definition>9955515 - Disclosure - Other financial assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherreceivablesandotherassetsTables" roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsTables">
        <link:definition>9955516 - Disclosure - Other receivables and other assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsTables" roleURI="http://www.abivax.com/role/CashandcashequivalentsTables">
        <link:definition>9955517 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialassetsandliabilitiesTables" roleURI="http://www.abivax.com/role/FinancialassetsandliabilitiesTables">
        <link:definition>9955518 - Disclosure - Financial assets and liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityTables" roleURI="http://www.abivax.com/role/ShareholdersequityTables">
        <link:definition>9955519 - Disclosure - Shareholders&#8217; equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsTables" roleURI="http://www.abivax.com/role/SharebasedpaymentsTables">
        <link:definition>9955520 - Disclosure - Share-based payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesTables" roleURI="http://www.abivax.com/role/FinancialliabilitiesTables">
        <link:definition>9955521 - Disclosure - Financial liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementbenefitobligationsTables" roleURI="http://www.abivax.com/role/RetirementbenefitobligationsTables">
        <link:definition>9955522 - Disclosure - Retirement benefit obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PayablesandothercurrentliabilitiesTables" roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesTables">
        <link:definition>9955523 - Disclosure - Payables and other current liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingincomeTables" roleURI="http://www.abivax.com/role/OperatingincomeTables">
        <link:definition>9955524 - Disclosure - Operating income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpensesTables" roleURI="http://www.abivax.com/role/OperatingexpensesTables">
        <link:definition>9955525 - Disclosure - Operating expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeesTables" roleURI="http://www.abivax.com/role/EmployeesTables">
        <link:definition>9955526 - Disclosure - Employees (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialgainlossTables" roleURI="http://www.abivax.com/role/FinancialgainlossTables">
        <link:definition>9955527 - Disclosure - Financial gain (loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxTables" roleURI="http://www.abivax.com/role/IncometaxTables">
        <link:definition>9955528 - Disclosure - Income tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomelosspershareTables" roleURI="http://www.abivax.com/role/IncomelosspershareTables">
        <link:definition>9955529 - Disclosure - Income (loss) per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartiesTables" roleURI="http://www.abivax.com/role/RelatedpartiesTables">
        <link:definition>9955530 - Disclosure - Related parties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheGroupDetails" roleURI="http://www.abivax.com/role/TheGroupDetails">
        <link:definition>9955531 - Disclosure - The Group (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofpreparationDetails" roleURI="http://www.abivax.com/role/BasisofpreparationDetails">
        <link:definition>9955532 - Disclosure - Basis of preparation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details" roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details">
        <link:definition>9955533 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2022 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details" roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details">
        <link:definition>9955534 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2023 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details" roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details">
        <link:definition>9955535 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2024 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails" roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails">
        <link:definition>9955536 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - Subsequent events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesIntangibleassetsDetails" roleURI="http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails">
        <link:definition>9955537 - Disclosure - Accounting principles - Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails" roleURI="http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails">
        <link:definition>9955538 - Disclosure - Accounting principles - Disclosure of depreciation period of property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesAccountingofProsynergiaacquisitionDetails" roleURI="http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails">
        <link:definition>9955539 - Disclosure - Accounting principles - Accounting of Prosynergia acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesDisclosureofallocationofacquisitioncostDetails" roleURI="http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails">
        <link:definition>9955540 - Disclosure - Accounting principles - Disclosure of allocation of acquisition cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationDetails" roleURI="http://www.abivax.com/role/SegmentinformationDetails">
        <link:definition>9955541 - Disclosure - Segment information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandimpairmenttestDetails" roleURI="http://www.abivax.com/role/GoodwillandimpairmenttestDetails">
        <link:definition>9955542 - Disclosure - Goodwill and impairment test (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsNarrativeDetails" roleURI="http://www.abivax.com/role/IntangibleassetsNarrativeDetails">
        <link:definition>9955543 - Disclosure - Intangible assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails" roleURI="http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails">
        <link:definition>9955544 - Disclosure - Intangible assets - Disclosure of reconciliation of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails" roleURI="http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails">
        <link:definition>9955545 - Disclosure - Property, plant and equipment - Disclosure of reconciliation of property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentNarrativeDetails" roleURI="http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails">
        <link:definition>9955546 - Disclosure - Property, plant and equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherfinancialassetsDisclosureofotherfinancialassetsDetails" roleURI="http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails">
        <link:definition>9955547 - Disclosure - Other financial assets - Disclosure of other financial assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherfinancialassetsNarrativeDetails" roleURI="http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails">
        <link:definition>9955548 - Disclosure - Other financial assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails" roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails">
        <link:definition>9955549 - Disclosure - Other receivables and other assets - Disclosure of other receivables and other assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherreceivablesandotherassetsNarrativeDetails" roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails">
        <link:definition>9955550 - Disclosure - Other receivables and other assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails" roleURI="http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails">
        <link:definition>9955551 - Disclosure - Cash and cash equivalents - Disclosure of composition of cash and cash equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsNarrativeDetails" roleURI="http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails">
        <link:definition>9955552 - Disclosure - Cash and cash equivalents - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialassetsandliabilitiesDetails" roleURI="http://www.abivax.com/role/FinancialassetsandliabilitiesDetails">
        <link:definition>9955553 - Disclosure - Financial assets and liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequitySharecapitalissuedDetails" roleURI="http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails">
        <link:definition>9955554 - Disclosure - Shareholders&#8217; equity - Share capital issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityEquitylineinstrumentsDetails" roleURI="http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails">
        <link:definition>9955555 - Disclosure - Shareholders&#8217; equity - Equity line instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails" roleURI="http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails">
        <link:definition>9955556 - Disclosure - Shareholders&#8217; equity - Disclosure of reconciliation of BSAs, equity line agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityChangeinsharecapitalDetails" roleURI="http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails">
        <link:definition>9955557 - Disclosure - Shareholders&#8217; equity - Change in share capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsDisclosureofreconciliationofBCEsDetails" roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails">
        <link:definition>9955558 - Disclosure - Share-based payments - Disclosure of reconciliation of BCEs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsNarrativeDetails" roleURI="http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails">
        <link:definition>9955559 - Disclosure - Share-based payments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsDisclosureofreconciliationofBSAsDetails" roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails">
        <link:definition>9955560 - Disclosure - Share-based payments - Disclosure of reconciliation of BSAs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails" roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails">
        <link:definition>9955561 - Disclosure - Share-based payments - Disclosure of assumptions used for the measurement of BSAs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsDisclosureofreconciliationofAGAsDetails" roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails">
        <link:definition>9955562 - Disclosure - Share-based payments - Disclosure of reconciliation of AGAs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails" roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails">
        <link:definition>9955563 - Disclosure - Share-based payments - Disclosure of assumptions used for the measurement of AGAs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails" roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails">
        <link:definition>9955564 - Disclosure - Share-based payments - Disclosure of breakdown of the compensation expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails">
        <link:definition>9955565 - Disclosure - Financial liabilities - Disclosure of financial liabilities breakdown (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesKreosClaretFinancingDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails">
        <link:definition>9955566 - Disclosure - Financial liabilities - Kreos / Claret Financing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails">
        <link:definition>9955567 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret minimum return indemnifications (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails">
        <link:definition>9955568 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret BSA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesHeightsconvertiblenotesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails">
        <link:definition>9955569 - Disclosure - Financial liabilities - Heights convertible notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails">
        <link:definition>9955570 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Heights convertible loan notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesKreos1Details" roleURI="http://www.abivax.com/role/FinancialliabilitiesKreos1Details">
        <link:definition>9955571 - Disclosure - Financial liabilities - Kreos 1 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails">
        <link:definition>9955572 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos BSA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesKreos2Details" roleURI="http://www.abivax.com/role/FinancialliabilitiesKreos2Details">
        <link:definition>9955573 - Disclosure - Financial liabilities - Kreos 2 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesOCEANEDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails">
        <link:definition>9955574 - Disclosure - Financial liabilities - OCEANE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails">
        <link:definition>9955575 - Disclosure - Financial liabilities - Financial liabilities - Disclosure of the main data and assumptions, OCEANE convertible loan notes (Details) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesStateguaranteedloanPGEDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails">
        <link:definition>9955576 - Disclosure - Financial liabilities - State guaranteed loan &#8211; &#8220;PGE&#8221; (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofconditionaladvancesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails">
        <link:definition>9955577 - Disclosure - Financial liabilities - Disclosure of conditional advances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesConditionaladvancesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails">
        <link:definition>9955578 - Disclosure - Financial liabilities - Conditional advances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails">
        <link:definition>9955579 - Disclosure - Financial liabilities - Disclosure of variation in lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesLeaseliabilitiesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails">
        <link:definition>9955580 - Disclosure - Financial liabilities - Lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesProsynergiaearnoutliabilityDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails">
        <link:definition>9955581 - Disclosure - Financial liabilities - Prosynergia earn-out liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails">
        <link:definition>9955582 - Disclosure - Financial liabilities - Disclosure of main data and assumptions used for the measurement of earn-out liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesRoyaltycertificatesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails">
        <link:definition>9955583 - Disclosure - Financial liabilities - Royalty certificates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails">
        <link:definition>9955584 - Disclosure - Financial liabilities - Disclosure of reconciliation of liabilities arising from financing activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesChangeinfinancialliabilitiesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails">
        <link:definition>9955585 - Disclosure - Financial liabilities - Change in financial liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails">
        <link:definition>9955586 - Disclosure - Financial liabilities - Disclosure of changes in derivative instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesChangeinderivativeinstrumentsDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails">
        <link:definition>9955587 - Disclosure - Financial liabilities - Change in derivative instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails">
        <link:definition>9955588 - Disclosure - Financial liabilities - Disclosure of remaining contractual maturities of financial liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails" roleURI="http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails">
        <link:definition>9955589 - Disclosure - Financial liabilities - Breakdown of financial liabilities by maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails" roleURI="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails">
        <link:definition>9955590 - Disclosure - Retirement benefit obligations - Disclosure of main actuarial assumptions used to measure the retirement benefit obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails" roleURI="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails">
        <link:definition>9955591 - Disclosure - Retirement benefit obligations - Disclosure of changes in projected benefit obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails" roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails">
        <link:definition>9955592 - Disclosure - Payables and other current liabilities - Disclosure of breakdown of trade and other payables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails" roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails">
        <link:definition>9955593 - Disclosure - Payables and other current liabilities - Disclosure of tax and employee-related payables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingincomeDisclosureofbreakdownofoperatingincomeDetails" roleURI="http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails">
        <link:definition>9955594 - Disclosure - Operating income - Disclosure of breakdown of operating income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingincomeNarrativeDetails" roleURI="http://www.abivax.com/role/OperatingincomeNarrativeDetails">
        <link:definition>9955595 - Disclosure - Operating income - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpensesDisclosureofsalesandmarketingexpensesDetails" roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails">
        <link:definition>9955596 - Disclosure - Operating expenses - Disclosure of sales and marketing expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpensesNarrativeDetails" roleURI="http://www.abivax.com/role/OperatingexpensesNarrativeDetails">
        <link:definition>9955597 - Disclosure - Operating expenses - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails" roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails">
        <link:definition>9955598 - Disclosure - Operating expenses - Disclosure of research and development expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails" roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails">
        <link:definition>9955599 - Disclosure - Operating expenses - Disclosure of general and administrative expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails" roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails">
        <link:definition>9955600 - Disclosure - Operating expenses - Disclosure of principal audit fees and services (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeesDetails" roleURI="http://www.abivax.com/role/EmployeesDetails">
        <link:definition>9955601 - Disclosure - Employees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialgainlossDisclosureofnetfinancialincomelossDetails" roleURI="http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails">
        <link:definition>9955602 - Disclosure - Financial gain (loss) - Disclosure of net financial income (loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialgainlossNarrativeDetails" roleURI="http://www.abivax.com/role/FinancialgainlossNarrativeDetails">
        <link:definition>9955603 - Disclosure - Financial gain (loss) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails" roleURI="http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails">
        <link:definition>9955604 - Disclosure - Income tax - Disclosure of reconciliation of effective income tax (loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails" roleURI="http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails">
        <link:definition>9955605 - Disclosure - Income tax - Disclosure of deferred tax assets and liabilities by nature (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxNarrativeDetails" roleURI="http://www.abivax.com/role/IncometaxNarrativeDetails">
        <link:definition>9955606 - Disclosure - Income tax - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomelosspershareScheduleofearningspershareDetails" roleURI="http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails">
        <link:definition>9955607 - Disclosure - Income (loss) per share - Schedule of earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomelosspershareNarrativeDetails" roleURI="http://www.abivax.com/role/IncomelosspershareNarrativeDetails">
        <link:definition>9955608 - Disclosure - Income (loss) per share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails" roleURI="http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails">
        <link:definition>9955609 - Disclosure - Related parties - Disclosure of aggregate compensation of the members of the Group&#8217;s Board of Directors and CEO (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartiesNarrativeDetails" roleURI="http://www.abivax.com/role/RelatedpartiesNarrativeDetails">
        <link:definition>9955610 - Disclosure - Related parties - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OffbalancesheetcommitmentsgivenDetails" roleURI="http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails">
        <link:definition>9955611 - Disclosure - Off-balance sheet commitments given (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OffbalancesheetcommitmentsreceivedandcontingentassetsDetails" roleURI="http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails">
        <link:definition>9955612 - Disclosure - Off-balance sheet commitments received and contingent assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ManagementandassessmentoffinancialrisksDetails" roleURI="http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails">
        <link:definition>9955613 - Disclosure - Management and assessment of financial risks (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="abvx_AmericanDepositorySharesNASDAQGlobalMarketMember" abstract="true" name="AmericanDepositorySharesNASDAQGlobalMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_OrdinarySharesNASDAQGlobalMarketMember" abstract="true" name="OrdinarySharesNASDAQGlobalMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_CurrentReceivablesAndCurrentPrepaidExpenses" abstract="false" name="CurrentReceivablesAndCurrentPrepaidExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NonCurrentConvertibleLoansNotes" abstract="false" name="NonCurrentConvertibleLoansNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NonCurrentRoyaltyCertificates" abstract="false" name="NonCurrentRoyaltyCertificates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" abstract="false" name="CurrentPortionOfNonCurrentConvertibleLoansNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CurrentTaxAndEmployeeBenefitLiabilities" abstract="false" name="CurrentTaxAndEmployeeBenefitLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_OceaneConversionOptionMember" abstract="true" name="OceaneConversionOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_HeightsConvertibleNotesMember" abstract="true" name="HeightsConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_FinancialAgreementAxis" abstract="true" name="FinancialAgreementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_FinancialAgreementDomain" abstract="true" name="FinancialAgreementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos1Member" abstract="true" name="Kreos1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_OtherEquityAgreementsMember" abstract="true" name="OtherEquityAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" abstract="false" name="IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" abstract="false" name="IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_NumberOfFreeSharesIssued" abstract="false" name="NumberOfFreeSharesIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_ShareIssueRelatedCostCredit" abstract="false" name="ShareIssueRelatedCostCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity" abstract="false" name="IncreaseDecreaseThroughIssuanceOfWarrantsEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseFromFreeSharesIssued" abstract="false" name="IncreaseDecreaseFromFreeSharesIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares" abstract="false" name="AdjustmentsForNetGainOnSaleOfTreasuryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AdjustmentsForOtherFinanceCosts" abstract="false" name="AdjustmentsForOtherFinanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AdjustmentsForOtherFinanceIncome" abstract="false" name="AdjustmentsForOtherFinanceIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" abstract="false" name="AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances" abstract="false" name="AdjustmentsForForgivenessOfCovid19ConditionalAdvances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" abstract="false" name="AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" abstract="false" name="AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" abstract="false" name="CashAdvancesAndLoansMadeToReimbursedFromHospitals" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" abstract="false" name="PaymentsForAdvancesMadeToContractResearchOrganizations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" abstract="false" name="PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CashPaymentsForDeposits" abstract="false" name="CashPaymentsForDeposits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ProceedsFromReimbursementsOfDeposits" abstract="false" name="ProceedsFromReimbursementsOfDeposits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit" abstract="false" name="PaymentsForProceedsFromShareIssueRelatedCostsCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NetProceedsFromNonConvertibleLoansNotes" abstract="false" name="NetProceedsFromNonConvertibleLoansNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RepaymentsOfBondLoans" abstract="false" name="RepaymentsOfBondLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NetProceedsFromConvertibleLoansNotes" abstract="false" name="NetProceedsFromConvertibleLoansNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RepaymentsOfConvertibleLoansNotes" abstract="false" name="RepaymentsOfConvertibleLoansNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RepaymentsOfPGE" abstract="false" name="RepaymentsOfPGE" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RepaymentsOfConditionalAdvances" abstract="false" name="RepaymentsOfConditionalAdvances" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NetProceedsFromSaleOfRoyaltyCertificates" abstract="false" name="NetProceedsFromSaleOfRoyaltyCertificates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AccountingPrinciplesAbstract" abstract="true" name="AccountingPrinciplesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" abstract="false" name="DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_FairValueMeasurementAbstract" abstract="true" name="FairValueMeasurementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_ShareBasedPaymentArrangementsAbstract" abstract="true" name="ShareBasedPaymentArrangementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_EmployeesAbstract" abstract="true" name="EmployeesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_FinancialIncomeLossAbstract" abstract="true" name="FinancialIncomeLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_OffBalanceSheetCommitmentsAbstract" abstract="true" name="OffBalanceSheetCommitmentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_FinancialRiskManagementAbstract" abstract="true" name="FinancialRiskManagementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" abstract="false" name="DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" abstract="false" name="DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" abstract="false" name="DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" abstract="false" name="DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" abstract="false" name="DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" abstract="false" name="DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" abstract="false" name="DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" abstract="false" name="DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfLeasesForLesseeTableTextBlock" abstract="false" name="DisclosureOfLeasesForLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" abstract="false" name="DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" abstract="false" name="DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" abstract="false" name="DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" abstract="false" name="DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock" abstract="false" name="DisclosureOfAverageNumberOfEmployeesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" abstract="false" name="DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="abvx_MajorRevenueTransactionsMember" abstract="true" name="MajorRevenueTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_SaleOfStockAxis" abstract="true" name="SaleOfStockAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_SaleOfStockDomain" abstract="true" name="SaleOfStockDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_RegisteredDirectOfferingMember" abstract="true" name="RegisteredDirectOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BanquePubliqueDInvestissementBPIMember" abstract="true" name="BanquePubliqueDInvestissementBPIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ProceedsFromResearchTaxCredit" abstract="false" name="ProceedsFromResearchTaxCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ProceedsFromConditionalAdvances" abstract="false" name="ProceedsFromConditionalAdvances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotes" abstract="false" name="ConvertibleLoansNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ProsynergiaMember" abstract="true" name="ProsynergiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AssetsAcquisitionsAxis" abstract="true" name="AssetsAcquisitionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_AssetsAcquisitionsDomain" abstract="true" name="AssetsAcquisitionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_WittycelSASABX196Member" abstract="true" name="WittycelSASABX196Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA2021Member" abstract="true" name="AGA2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_PrincipalAgreementsAxis" abstract="true" name="PrincipalAgreementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_PrincipalAgreementsDomain" abstract="true" name="PrincipalAgreementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember" abstract="true" name="ResearchAgreementWithUniversityHospitalCenterOfNiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_A49.2MillionCrossOverFinancingSeptember2022Member" abstract="true" name="A49.2MillionCrossOverFinancingSeptember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_CashPrepaymentAssetsAcquisitions" abstract="false" name="CashPrepaymentAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CashTransferredAssetsAcquisitions" abstract="false" name="CashTransferredAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_EarnOutMaximumAmount" abstract="false" name="EarnOutMaximumAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_LoanGrantedAssetsAcquisitions" abstract="false" name="LoanGrantedAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" abstract="false" name="ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_FinancialAgreementAmount" abstract="false" name="FinancialAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_FinancialAgreementNumberOfTransactions" abstract="false" name="FinancialAgreementNumberOfTransactions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_EquityIssuancePercentageOfCurrentShareCapital" abstract="false" name="EquityIssuancePercentageOfCurrentShareCapital" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_EquityIssuanceSubscriptionPricePerShare" abstract="false" name="EquityIssuanceSubscriptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_RoyaltyCertificatePercentageOfFutureSales" abstract="false" name="RoyaltyCertificatePercentageOfFutureSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_RoyaltyCertificateMaximumAmount" abstract="false" name="RoyaltyCertificateMaximumAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NonCurrentAdvancesToCROContracts" abstract="false" name="NonCurrentAdvancesToCROContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_A130.0MillionCrossOverFinancingFebruary2023Member" abstract="true" name="A130.0MillionCrossOverFinancingFebruary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_A150.0MillionFinancingAugust2023Member" abstract="true" name="A150.0MillionFinancingAugust2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos1ConvertibleBondLoansTrancheAMember" abstract="true" name="Kreos1ConvertibleBondLoansTrancheAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos1ConvertibleBondLoansTrancheBMember" abstract="true" name="Kreos1ConvertibleBondLoansTrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingMember" abstract="true" name="KreosClaretFinancingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingTrancheAMember" abstract="true" name="KreosClaretFinancingTrancheAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_OCEANEMember" abstract="true" name="OCEANEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember" abstract="true" name="KreosClaretFinancingAndHeightsConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AmericanDepositorySharesMember" abstract="true" name="AmericanDepositorySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_WarrantsAxis" abstract="true" name="WarrantsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_WarrantsDomain" abstract="true" name="WarrantsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosCBSAMember" abstract="true" name="KreosCBSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_FreeSharesAGAMember" abstract="true" name="FreeSharesAGAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_NumberOfOtherShareWarrantsRepurchased" abstract="false" name="NumberOfOtherShareWarrantsRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_NumberOfShareBasedCompensationPlansIssued" abstract="false" name="NumberOfShareBasedCompensationPlansIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_BorrowingsMaximumBorrowingCapacity" abstract="false" name="BorrowingsMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AggregateExercisePriceOtherEquityInstrumentsGranted" abstract="false" name="AggregateExercisePriceOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" abstract="false" name="ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IssuanceOfOtherShareWarrants" abstract="false" name="IssuanceOfOtherShareWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NumberOfSharesReceivedPerADS" abstract="false" name="NumberOfSharesReceivedPerADS" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_IssueOfEquityOfferingPricePerShare" abstract="false" name="IssueOfEquityOfferingPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" abstract="false" name="ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AGA2024Member" abstract="true" name="AGA2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA20246Member" abstract="true" name="AGA20246Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_BSA20241Member" abstract="true" name="BSA20241Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TranchesAxis" abstract="true" name="TranchesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_TranchesDomain" abstract="true" name="TranchesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TrancheOneMember" abstract="true" name="TrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TrancheTwoMember" abstract="true" name="TrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TrancheThreeMember" abstract="true" name="TrancheThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingTrancheBMember" abstract="true" name="KreosClaretFinancingTrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingTrancheCMember" abstract="true" name="KreosClaretFinancingTrancheCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingTrancheBAndCMember" abstract="true" name="KreosClaretFinancingTrancheBAndCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_RNPVIRConditionalAdvanceBPIMember" abstract="true" name="RNPVIRConditionalAdvanceBPIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_CARENAConditionalAdvanceBPIMember" abstract="true" name="CARENAConditionalAdvanceBPIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" abstract="true" name="RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AtTheMarketATMProgramMember" abstract="true" name="AtTheMarketATMProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_NumberOfFreeSharesPlansIssued" abstract="false" name="NumberOfFreeSharesPlansIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_PercentageOfConditionalAdvancesWaived" abstract="false" name="PercentageOfConditionalAdvancesWaived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_NumberOfADSPerOrdinaryShares" abstract="false" name="NumberOfADSPerOrdinaryShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_ExpectedProceedsFromShareIssuance" abstract="false" name="ExpectedProceedsFromShareIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ExpectedProceedsFromShareIssuanceShelfRegistration" abstract="false" name="ExpectedProceedsFromShareIssuanceShelfRegistration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_MajorShareBasedTransactionsMember" abstract="true" name="MajorShareBasedTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA20251Member" abstract="true" name="BSA20251Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA2025Member" abstract="true" name="AGA2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA20252Member" abstract="true" name="AGA20252Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_TrancheFourMember" abstract="true" name="TrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" abstract="false" name="ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_IndustrialMaterialsAndEquipmentMember" abstract="true" name="IndustrialMaterialsAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TechnicalFacilitiesMember" abstract="true" name="TechnicalFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_FurnitureMember" abstract="true" name="FurnitureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" abstract="true" name="DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_EarnOutLiabilityMember" abstract="true" name="EarnOutLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" abstract="true" name="DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_EarnOutAtFairValueAssetsAcquisitions" abstract="false" name="EarnOutAtFairValueAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_EarnOutMarketCapitalizationThreshold" abstract="false" name="EarnOutMarketCapitalizationThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_EarnOutPercentage" abstract="false" name="EarnOutPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_EarnOutAmountPayableIfConditionsAreNotMet" abstract="false" name="EarnOutAmountPayableIfConditionsAreNotMet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AcquisitionRelatedCostsAssetsAcquisition" abstract="false" name="AcquisitionRelatedCostsAssetsAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" abstract="false" name="ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions" abstract="false" name="TechnologyBasedIntangibleAssetsAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CashAndCashEquivalentsAssetsAcquisitions" abstract="false" name="CashAndCashEquivalentsAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AssetsRecognisedAsOfAcquisitionDate" abstract="false" name="AssetsRecognisedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_LiabilitiesRecognisedAsOfAcquisitionDate" abstract="false" name="LiabilitiesRecognisedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" abstract="false" name="IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_PaymentsForAssetsAcquisitionsCosts" abstract="false" name="PaymentsForAssetsAcquisitionsCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ContributionToGroupsAssetsPercentage" abstract="false" name="ContributionToGroupsAssetsPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ContributionToGroupsLiabilitiesPercentage" abstract="false" name="ContributionToGroupsLiabilitiesPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ContributionToGroupsNetProfitsLossesPercentage" abstract="false" name="ContributionToGroupsNetProfitsLossesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_NumberOfOperatingSegment" abstract="false" name="NumberOfOperatingSegment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_SplicosSASABX464Member" abstract="true" name="SplicosSASABX464Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" abstract="true" name="ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" abstract="true" name="ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" abstract="false" name="CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2" abstract="false" name="CollaborationAgreementsDevelopmentMilestonePaymentPhase2" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseIntangibleAssetsOtherThanGoodwill" abstract="false" name="IncreaseIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_FurnitureAndComputerEquipmentMember" abstract="true" name="FurnitureAndComputerEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" abstract="false" name="IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_LeaseFacilitiesParisMember" abstract="true" name="LeaseFacilitiesParisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" abstract="false" name="DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_OtherNonCurrentMiscellaneousFinancialAssets" abstract="false" name="OtherNonCurrentMiscellaneousFinancialAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CurrentAdvancesToCROContracts" abstract="false" name="CurrentAdvancesToCROContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_OtherCurrentInvestments" abstract="false" name="OtherCurrentInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DiscountRateAppliedToLongTermAdvances" abstract="false" name="DiscountRateAppliedToLongTermAdvances" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_NonCurrentPrepaidExpenses" abstract="false" name="NonCurrentPrepaidExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CurrentResearchTaxCreditReceivables" abstract="false" name="CurrentResearchTaxCreditReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CurrentReceivablesFromCreditNotes" abstract="false" name="CurrentReceivablesFromCreditNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable" abstract="true" name="DisclosureOfOtherReceivablesAndOtherAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DeferredFinancingCostsNettingMember" abstract="true" name="DeferredFinancingCostsNettingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems" abstract="true" name="DisclosureOfOtherReceivablesAndOtherAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_CurrentPrepaidExpensesRelatedToCRO" abstract="false" name="CurrentPrepaidExpensesRelatedToCRO" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" abstract="false" name="ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DisclosureOfCashAndCashEquivalentsTable" abstract="true" name="DisclosureOfCashAndCashEquivalentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DisclosureOfCashAndCashEquivalentsLineItems" abstract="true" name="DisclosureOfCashAndCashEquivalentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" abstract="true" name="DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_OtherFinancialAssetsMember" abstract="true" name="OtherFinancialAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_OtherReceivablesAndAssetsMember" abstract="true" name="OtherReceivablesAndAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_CashAndCashEquivalentMember" abstract="true" name="CashAndCashEquivalentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_NonCurrentAdvancesToCROContractsMember" abstract="true" name="NonCurrentAdvancesToCROContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_NonCurrentFinancialLiabilitiesMember" abstract="true" name="NonCurrentFinancialLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos12BondLoansMember" abstract="true" name="Kreos12BondLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingTrancheABAndCMember" abstract="true" name="KreosClaretFinancingTrancheABAndCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_ConditionalAdvancesAndPGELoanMember" abstract="true" name="ConditionalAdvancesAndPGELoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_PretGarantiParLEtatPGEMember" abstract="true" name="PretGarantiParLEtatPGEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EbolaConditionalAdvanceBPIMember" abstract="true" name="EbolaConditionalAdvanceBPIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_CurrentFinancialLiabilitiesMember" abstract="true" name="CurrentFinancialLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TradePayablesAndOtherCurrentLiabilitiesMember" abstract="true" name="TradePayablesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" abstract="true" name="DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_NumberOfTreasurySharesHeld" abstract="false" name="NumberOfTreasurySharesHeld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_EquityLineAgreementWithKeplerCheuvreuxMember" abstract="true" name="EquityLineAgreementWithKeplerCheuvreuxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ShareSubscriptionWarrantsBSAMember" abstract="true" name="ShareSubscriptionWarrantsBSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_UnderwritingAgreementMaximumNumberOfSharesIssued" abstract="false" name="UnderwritingAgreementMaximumNumberOfSharesIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_UnderwritingAgreementMaximumPeriod" abstract="false" name="UnderwritingAgreementMaximumPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays" abstract="false" name="UnderwritingAgreementIssuancePriceNumberOfTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_UnderwritingAgreementIssuancePriceMaximumDiscount" abstract="false" name="UnderwritingAgreementIssuancePriceMaximumDiscount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_UnderwritingAgreementExtendedPeriod" abstract="false" name="UnderwritingAgreementExtendedPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" abstract="false" name="MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_KreosABSAMember" abstract="true" name="KreosABSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosBBSAMember" abstract="true" name="KreosBBSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA20241AndBSA20242Member" abstract="true" name="BSA20241AndBSA20242Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_NumberOfWarrantsExercised" abstract="false" name="NumberOfWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_OtherShareWarrantsSubscriptionPricePerShare" abstract="false" name="OtherShareWarrantsSubscriptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_ShareWarrantsSubscriptionPricePerShare" abstract="false" name="ShareWarrantsSubscriptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_FoundersShareSubscriptionWarrantsBCEMember" abstract="true" name="FoundersShareSubscriptionWarrantsBCEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20161Member" abstract="true" name="BCE20161Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20171Member" abstract="true" name="BCE20171Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20172Member" abstract="true" name="BCE20172Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20174Member" abstract="true" name="BCE20174Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20175Member" abstract="true" name="BCE20175Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20181Member" abstract="true" name="BCE20181Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20183Member" abstract="true" name="BCE20183Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20184Member" abstract="true" name="BCE20184Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCE20185Member" abstract="true" name="BCE20185Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TrancheFiveMember" abstract="true" name="TrancheFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TrancheSixMember" abstract="true" name="TrancheSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BCEExceptBCE20142Member" abstract="true" name="BCEExceptBCE20142Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20231Member" abstract="true" name="AGA20231Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20232Member" abstract="true" name="AGA20232Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20233AndAGA20234Member" abstract="true" name="AGA20233AndAGA20234Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20235Member" abstract="true" name="AGA20235Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20233AGA20234AndAGA20235Member" abstract="true" name="AGA20233AGA20234AndAGA20235Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20241Member" abstract="true" name="AGA20241Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20242Member" abstract="true" name="AGA20242Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA20243Member" abstract="true" name="AGA20243Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA20244AGA20245AndAGA20246Member" abstract="true" name="AGA20244AGA20245AndAGA20246Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA20247Member" abstract="true" name="AGA20247Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" abstract="true" name="AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_VestingServiceConditionsAxis" abstract="true" name="VestingServiceConditionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_VestingServiceConditionsDomain" abstract="true" name="VestingServiceConditionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_VestingConditionsCompletedMember" abstract="true" name="VestingConditionsCompletedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_VestingConditionsNotCompletedMember" abstract="true" name="VestingConditionsNotCompletedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_FormerChiefExecutiveOfficerMember" abstract="true" name="FormerChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" abstract="false" name="NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_BSA201511Member" abstract="true" name="BSA201511Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA201512Member" abstract="true" name="BSA201512Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA20171Member" abstract="true" name="BSA20171Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA20181Member" abstract="true" name="BSA20181Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA20144Member" abstract="true" name="BSA20144Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA20145Member" abstract="true" name="BSA20145Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BSA20242Member" abstract="true" name="BSA20242Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted" abstract="false" name="UnderlyingShareFairValueOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" abstract="false" name="EquityInstrumentFairValueOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" abstract="false" name="EquityInstrumentPriceOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" abstract="false" name="EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted" abstract="false" name="RiskFreeInterestRateOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ExpectedMaturityOtherEquityInstrumentsGranted" abstract="false" name="ExpectedMaturityOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_ExpectedVolatilityOtherEquityInstrumentsGranted" abstract="false" name="ExpectedVolatilityOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="abvx_AGA20233Member" abstract="true" name="AGA20233Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20234Member" abstract="true" name="AGA20234Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AGA20244Member" abstract="true" name="AGA20244Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AGA20245Member" abstract="true" name="AGA20245Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_TranchesOneToFourMember" abstract="true" name="TranchesOneToFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BorrowingsByNameMember" abstract="true" name="BorrowingsByNameMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos1ClaretBondLoansMember" abstract="true" name="Kreos1ClaretBondLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesMember" abstract="true" name="ConvertibleLoansNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretMinimumReturnIndemnificationsMember" abstract="true" name="KreosClaretMinimumReturnIndemnificationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingBSAMember" abstract="true" name="KreosClaretFinancingBSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesMember" abstract="true" name="OtherFinancialLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ConditionalAdvancesMember" abstract="true" name="ConditionalAdvancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_RoyaltyCertificatesMember" abstract="true" name="RoyaltyCertificatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" abstract="true" name="KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos1BondLoansMember" abstract="true" name="Kreos1BondLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EuropeanCentralBankBaseRateMember" abstract="true" name="EuropeanCentralBankBaseRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosABBSAMember" abstract="true" name="KreosABBSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_KreosABCBSAMember" abstract="true" name="KreosABCBSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_MarketRateMeasurementInputMember" abstract="true" name="MarketRateMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_SharePriceMeasurementInputMember" abstract="true" name="SharePriceMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_RiskFreeInterestRateMeasurementInputMember" abstract="true" name="RiskFreeInterestRateMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember" abstract="true" name="FinalRedemptionScenarioProbabilityMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_ExpiryScenarioProbablityMeasurementInputMember" abstract="true" name="ExpiryScenarioProbablityMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BlackScholesModelMember" abstract="true" name="BlackScholesModelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_MonteCarloModel1Member" abstract="true" name="MonteCarloModel1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_BorrowingsNumberOfTranches" abstract="false" name="BorrowingsNumberOfTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_BorrowingsMaximumBorrowingCapacityPerTranche" abstract="false" name="BorrowingsMaximumBorrowingCapacityPerTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_BorrowingsFixedConversionPrice" abstract="false" name="BorrowingsFixedConversionPrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_BorrowingsEarlyRepaymentDiscountRate" abstract="false" name="BorrowingsEarlyRepaymentDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsExitFeePercentage" abstract="false" name="BorrowingsExitFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsDebtToMarketCapitalizationRatio" abstract="false" name="BorrowingsDebtToMarketCapitalizationRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsPerformanceConditionsMinimumFinancing" abstract="false" name="BorrowingsPerformanceConditionsMinimumFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_BorrowingsBasisInterestRate" abstract="false" name="BorrowingsBasisInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_NumberOfWarrantsGranted" abstract="false" name="NumberOfWarrantsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_ExercisePriceOtherEquityInstrumentsGranted" abstract="false" name="ExercisePriceOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" abstract="false" name="ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" abstract="false" name="ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" abstract="false" name="NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" abstract="false" name="NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_OtherShareWarrantsExercisePeriod" abstract="false" name="OtherShareWarrantsExercisePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" abstract="false" name="ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" abstract="false" name="AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted" abstract="false" name="ExpiryScenarioPeriodOtherEquityInstrumentsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_MinimalReturnMeasurementInputMember" abstract="true" name="MinimalReturnMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" abstract="true" name="FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" abstract="true" name="TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" abstract="true" name="FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" abstract="true" name="FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember" abstract="true" name="FinalRedemptionFairValueOfMRIMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_TenderOfferFairValueOfMRIMeasurementInputMember" abstract="true" name="TenderOfferFairValueOfMRIMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AmortizedCostEIRMethodMember" abstract="true" name="AmortizedCostEIRMethodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_TrancheBMember" abstract="true" name="TrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_TrancheCMember" abstract="true" name="TrancheCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_AggregateFairValueOtherEquityInstrumentsOutstanding" abstract="false" name="AggregateFairValueOtherEquityInstrumentsOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DisclosureOfWarrantsArrangementsTable" abstract="true" name="DisclosureOfWarrantsArrangementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_ExercisePricePerShareMeasurementInputMember" abstract="true" name="ExercisePricePerShareMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DrawdownProbablityMeasurementInputMember" abstract="true" name="DrawdownProbablityMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_VolatilityForSharesMeasurementInputExpiryMember" abstract="true" name="VolatilityForSharesMeasurementInputExpiryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_VolatilityForSharesMeasurementInputTenderOfferMember" abstract="true" name="VolatilityForSharesMeasurementInputTenderOfferMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ExpectedDividendMeasurementInputMember" abstract="true" name="ExpectedDividendMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_RiskFreeInterestRateMeasurementInputExpiryMember" abstract="true" name="RiskFreeInterestRateMeasurementInputExpiryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember" abstract="true" name="RiskFreeInterestRateMeasurementInputTenderOfferMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_DisclosureOfWarrantsArrangementsLineItems" abstract="true" name="DisclosureOfWarrantsArrangementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_NumberOfProbabilityWeightedScenarios" abstract="false" name="NumberOfProbabilityWeightedScenarios" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_NumberOfWarrantsOutstanding" abstract="false" name="NumberOfWarrantsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" abstract="false" name="NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_HeightsConvertibleNotesTrancheAMember" abstract="true" name="HeightsConvertibleNotesTrancheAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_HeightsConvertibleNotesTrancheBMember" abstract="true" name="HeightsConvertibleNotesTrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember" abstract="true" name="VoluntaryConversionScenarioProbabilityMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_NumberOfConvertibleNotesIssued" abstract="false" name="NumberOfConvertibleNotesIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesNominalValue" abstract="false" name="ConvertibleLoansNotesNominalValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesPeriod" abstract="false" name="ConvertibleLoansNotesPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesNumberOfSeparateClosings" abstract="false" name="ConvertibleLoansNotesNumberOfSeparateClosings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_BorrowingsNumberOfQuarterlyInstallments" abstract="false" name="BorrowingsNumberOfQuarterlyInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_BorrowingsMaturityDeferralPeriod" abstract="false" name="BorrowingsMaturityDeferralPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_BorrowingsPercentageOfMarketPrice" abstract="false" name="BorrowingsPercentageOfMarketPrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" abstract="false" name="BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_BorrowingsMarketPriceNumberOfTradingDays" abstract="false" name="BorrowingsMarketPriceNumberOfTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_IssuancePricePercentageOfDiscountTo15DayWVAP" abstract="false" name="IssuancePricePercentageOfDiscountTo15DayWVAP" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" abstract="false" name="ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" abstract="false" name="ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_EquityIssuanceCashCarveOut" abstract="false" name="EquityIssuanceCashCarveOut" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" abstract="false" name="ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_GainsArisingFromRecognitionOfFinancialLiabilities" abstract="false" name="GainsArisingFromRecognitionOfFinancialLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_UnrecognitionDayOneGainOfFinancialLiabilities" abstract="false" name="UnrecognitionDayOneGainOfFinancialLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConversionPricePerShareMeasurementInputMember" abstract="true" name="ConversionPricePerShareMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_InitialPriceLimitMeasurementInputMember" abstract="true" name="InitialPriceLimitMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EarlyRedemptionAmountMeasurementInputMember" abstract="true" name="EarlyRedemptionAmountMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_MonteCarloModelIFRSMember" abstract="true" name="MonteCarloModelIFRSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_NumberOfConvertibleNotesOutstanding" abstract="false" name="NumberOfConvertibleNotesOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_AggregateFairValueConvertibleNotes" abstract="false" name="AggregateFairValueConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_Kreos1NonConvertibleBondLoansMember" abstract="true" name="Kreos1NonConvertibleBondLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos1ConvertibleBondLoansMember" abstract="true" name="Kreos1ConvertibleBondLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EuriborMember" abstract="true" name="EuriborMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BorrowingsNumberOfMonthlyInstallments" abstract="false" name="BorrowingsNumberOfMonthlyInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_BorrowingsExitFeeAmount" abstract="false" name="BorrowingsExitFeeAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_BorrowingsNoticePeriod" abstract="false" name="BorrowingsNoticePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_BorrowingsAnnualDiscountRate" abstract="false" name="BorrowingsAnnualDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_NumberOfSharesSubscribedPerWarrant" abstract="false" name="NumberOfSharesSubscribedPerWarrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_BorrowingsMaturityTerm" abstract="false" name="BorrowingsMaturityTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_NumberOfOtherShareWarrantsConverted" abstract="false" name="NumberOfOtherShareWarrantsConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_ResidualMaturityMeasurementInputMember" abstract="true" name="ResidualMaturityMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos2Member" abstract="true" name="Kreos2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos2TrancheAMember" abstract="true" name="Kreos2TrancheAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_Kreos2TrancheBMember" abstract="true" name="Kreos2TrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_BorrowingsAdditionalTrancheAmount" abstract="false" name="BorrowingsAdditionalTrancheAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" abstract="false" name="BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsInterestRateForFollowingInstallments" abstract="false" name="BorrowingsInterestRateForFollowingInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" abstract="false" name="BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" abstract="false" name="BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_RemeasurementPeriodAxis" abstract="true" name="RemeasurementPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_RemeasurementPeriodDomain" abstract="true" name="RemeasurementPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_After18MonthsMember" abstract="true" name="After18MonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_After24MonthsMember" abstract="true" name="After24MonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_After36MonthsMember" abstract="true" name="After36MonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes" abstract="false" name="ProceedsFromIssuingSharesAndConvertibleLoansNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConversionPriceOtherLiabilities" abstract="false" name="ConversionPriceOtherLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_ConversionPriceAdjustmentPeriod" abstract="false" name="ConversionPriceAdjustmentPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_ConversionPriceVolumeWeightedAveragePricePeriod" abstract="false" name="ConversionPriceVolumeWeightedAveragePricePeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_ConversionPricePercentageOfInitialPriceThreshold" abstract="false" name="ConversionPricePercentageOfInitialPriceThreshold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_BorrowingsMaturityExtensionTerm" abstract="false" name="BorrowingsMaturityExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_BorrowingsStateGuaranteedPremium" abstract="false" name="BorrowingsStateGuaranteedPremium" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConditionalAdvances" abstract="false" name="ConditionalAdvances" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity" abstract="false" name="OtherFinancialLiabilitiesMaximumDrawdownCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RepaymentOfExcessConditionalAdvancesClaimed" abstract="false" name="RepaymentOfExcessConditionalAdvancesClaimed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseInLeaseLiabilities" abstract="false" name="IncreaseInLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DecreaseInLeaseLiabilities" abstract="false" name="DecreaseInLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DisclosureOfLeaseLiabilitiesTable" abstract="true" name="DisclosureOfLeaseLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_LeaseFacilitiesBostonMember" abstract="true" name="LeaseFacilitiesBostonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_LeaseFacilitiesMontpellierMember" abstract="true" name="LeaseFacilitiesMontpellierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_LeaseFacilitiesMember" abstract="true" name="LeaseFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DisclosureOfLeaseLiabilitiesLineItems" abstract="true" name="DisclosureOfLeaseLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_LeaseDurationPeriod" abstract="false" name="LeaseDurationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_LeaseTacitRenewalPeriod" abstract="false" name="LeaseTacitRenewalPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_LeaseBreakClausePeriod" abstract="false" name="LeaseBreakClausePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm" abstract="false" name="DecreaseInLeaseLiabilitiesThroughModificationOfTerm" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_LeaseExtensionPeriod" abstract="false" name="LeaseExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_LeaseLiabilityPercentageOfTotal" abstract="false" name="LeaseLiabilityPercentageOfTotal" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ExpenseOnLeaseLiabilities" abstract="false" name="ExpenseOnLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DepreciationExpenseLease" abstract="false" name="DepreciationExpenseLease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" abstract="false" name="ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_MarketCapitalizationMeasurementInputMember" abstract="true" name="MarketCapitalizationMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EarnOutAtFairValue" abstract="false" name="EarnOutAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ProbabilityOfSuccessMeasurementInputMember" abstract="true" name="ProbabilityOfSuccessMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_PeakPenetrationMeasurementInputMember" abstract="true" name="PeakPenetrationMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_OtherLiabilitiesNumberOfTransactions" abstract="false" name="OtherLiabilitiesNumberOfTransactions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_DecreaseInInterestExpenseOnRoyaltyCertificates" abstract="false" name="DecreaseInInterestExpenseOnRoyaltyCertificates" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RoyaltyCertificatesEIR" abstract="false" name="RoyaltyCertificatesEIR" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" abstract="false" name="IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_InterestExpenseOnRoyaltyCertificates" abstract="false" name="InterestExpenseOnRoyaltyCertificates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_UnwindingOfDiscountOnRoyalties" abstract="false" name="UnwindingOfDiscountOnRoyalties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" abstract="false" name="AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" abstract="false" name="IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" abstract="false" name="DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" abstract="false" name="DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" abstract="false" name="IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" abstract="false" name="IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" abstract="false" name="IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" abstract="false" name="IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_KreosClaretFinancingTrancheABMember" abstract="true" name="KreosClaretFinancingTrancheABMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_RepurchaseOfDerivativeInstruments" abstract="false" name="RepurchaseOfDerivativeInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_GrossProceedsFromNonConvertibleLoansNotes" abstract="false" name="GrossProceedsFromNonConvertibleLoansNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IssuanceOfDerivativeInstruments" abstract="false" name="IssuanceOfDerivativeInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ExerciseOfDerivativeInstruments" abstract="false" name="ExerciseOfDerivativeInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_KreosClaretBondLoansMember" abstract="true" name="KreosClaretBondLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_ConvertibleLoansNotesUndiscountedCashFlows" abstract="false" name="ConvertibleLoansNotesUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_ConditionalAdvancesUndiscountedCashFlows" abstract="false" name="ConditionalAdvancesUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RoyaltyCertificatesUndiscountedCashFlows" abstract="false" name="RoyaltyCertificatesUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_FinancialLiabilitiesUndiscountedCashFlows" abstract="false" name="FinancialLiabilitiesUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RoyaltyCertificateExpirationPeriod" abstract="false" name="RoyaltyCertificateExpirationPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_OtherEmployeesMember" abstract="true" name="OtherEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ActuarialAssumptionOfExpectedRatesOfTurnover" abstract="false" name="ActuarialAssumptionOfExpectedRatesOfTurnover" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" abstract="false" name="ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_ActuarialAssumptionOfEmployeeContributionRate" abstract="false" name="ActuarialAssumptionOfEmployeeContributionRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_OtherCurrentPayablesIncludingAdjustments" abstract="false" name="OtherCurrentPayablesIncludingAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CurrentPayablesOnOtherTaxAndRelatedPayments" abstract="false" name="CurrentPayablesOnOtherTaxAndRelatedPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncomeFromResearchTaxCredit" abstract="false" name="IncomeFromResearchTaxCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DisclosureOfOperatingIncomeTable" abstract="true" name="DisclosureOfOperatingIncomeTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_CIRTaxYearAxis" abstract="true" name="CIRTaxYearAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_CIRTaxYearDomain" abstract="true" name="CIRTaxYearDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_A2021TaxYearMember" abstract="true" name="A2021TaxYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_A2022TaxYearMember" abstract="true" name="A2022TaxYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_A2023TaxYearMember" abstract="true" name="A2023TaxYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="abvx_DisclosureOfOperatingIncomeLineItems" abstract="true" name="DisclosureOfOperatingIncomeLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_SalesAndMarketingExpenseMember" abstract="true" name="SalesAndMarketingExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ResearchAndDevelopmentExpensesMember" abstract="true" name="ResearchAndDevelopmentExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_GeneralAndAdministrativeExpensesMember" abstract="true" name="GeneralAndAdministrativeExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_IncreaseDecreaseInUlcerativeColitisExpenses" abstract="false" name="IncreaseDecreaseInUlcerativeColitisExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses" abstract="false" name="IncreaseDecreaseInCrohnsDiseaseResearchExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseInTransversalActivities" abstract="false" name="IncreaseDecreaseInTransversalActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IncreaseDecreaseInEmployeeBenefitsExpenses" abstract="false" name="IncreaseDecreaseInEmployeeBenefitsExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_SubContractingStudiesAndResearchExpenses" abstract="false" name="SubContractingStudiesAndResearchExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_IntellectualPropertyFees" abstract="false" name="IntellectualPropertyFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DisclosureOfEmployeeWorkforceTable" abstract="true" name="DisclosureOfEmployeeWorkforceTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DisclosureOfEmployeeWorkforceLineItems" abstract="true" name="DisclosureOfEmployeeWorkforceLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" abstract="false" name="LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_LossesArisingFromDerecognitionOfFinancialLiabilities" abstract="false" name="LossesArisingFromDerecognitionOfFinancialLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_TransactionCosts" abstract="false" name="TransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" abstract="false" name="GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" abstract="false" name="UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_GainsArisingFromDerecognitionOfFinancialLiabilities" abstract="false" name="GainsArisingFromDerecognitionOfFinancialLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DisclosureOfFinancialGainLossTable" abstract="true" name="DisclosureOfFinancialGainLossTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DisclosureOfFinancialGainLossLineItems" abstract="true" name="DisclosureOfFinancialGainLossLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" abstract="false" name="ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_TaxEffectOfShareBasedPayment" abstract="false" name="TaxEffectOfShareBasedPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_TaxEffectOfResearchTaxCredit" abstract="false" name="TaxEffectOfResearchTaxCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease" abstract="false" name="TaxEffectOfTransactionCostsRelatedToCapitalIncrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_TaxEffectOfChangesInDerivativeFairValueAndOther" abstract="false" name="TaxEffectOfChangesInDerivativeFairValueAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" abstract="false" name="TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember" abstract="true" name="RetirementBenefitObligationsRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_SubsidiesRelatedTemporaryDifferencesMember" abstract="true" name="SubsidiesRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_LeasesRelatedTemporaryDifferencesMember" abstract="true" name="LeasesRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" abstract="true" name="OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_UnrecognizedDeferredTaxAssets" abstract="false" name="UnrecognizedDeferredTaxAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_DeferredTaxAssetsRecognisedInFinancialPosition" abstract="false" name="DeferredTaxAssetsRecognisedInFinancialPosition" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_AbivaxLLCMember" abstract="true" name="AbivaxLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_MaximumNumberOfSharesToBeIssued" abstract="false" name="MaximumNumberOfSharesToBeIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="abvx_KeyManagementPersonnelCompensationFixedCompensation" abstract="false" name="KeyManagementPersonnelCompensationFixedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_KeyManagementPersonnelCompensationVariableCompensation" abstract="false" name="KeyManagementPersonnelCompensationVariableCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_KeyManagementPersonnelCompensationInKindContributions" abstract="false" name="KeyManagementPersonnelCompensationInKindContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_KeyManagementPersonnelCompensationAttendanceFees" abstract="false" name="KeyManagementPersonnelCompensationAttendanceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember" abstract="true" name="BoardOfDirectorsAndChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_AdvisorToTheChiefExecutiveOfficerMember" abstract="true" name="AdvisorToTheChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DisclosureOfOffBalanceSheetCommitmentsTable" abstract="true" name="DisclosureOfOffBalanceSheetCommitmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" abstract="true" name="ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" abstract="true" name="ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" abstract="true" name="ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" abstract="true" name="TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember" abstract="true" name="EbolaConditionalAdvanceBPILanguedocRoussillonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_EbolaConditionalAdvanceBPIFranceMember" abstract="true" name="EbolaConditionalAdvanceBPIFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems" abstract="true" name="DisclosureOfOffBalanceSheetCommitmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_NumberOfExclusiveLicenses" abstract="false" name="NumberOfExclusiveLicenses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_AgreementPeriod" abstract="false" name="AgreementPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" abstract="false" name="CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" abstract="false" name="CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" abstract="false" name="CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NumberOfAcademicInstitutions" abstract="false" name="NumberOfAcademicInstitutions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" abstract="false" name="OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" abstract="false" name="OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" abstract="false" name="OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" abstract="false" name="OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" abstract="false" name="OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" abstract="false" name="OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_OtherFinancialLiabilitiesRepaymentPeriod" abstract="false" name="OtherFinancialLiabilitiesRepaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="abvx_DisclosureOfCommitmentsReceivedTable" abstract="true" name="DisclosureOfCommitmentsReceivedTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="abvx_DisclosureOfCommitmentsReceivedLineItems" abstract="true" name="DisclosureOfCommitmentsReceivedLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="abvx_NumberOfProjectsTerminated" abstract="false" name="NumberOfProjectsTerminated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_InterestRateCollarRange" abstract="false" name="InterestRateCollarRange" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" abstract="false" name="SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" abstract="false" name="SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="abvx_NumberOfFinancialInstitutionsToMaintainCash" abstract="false" name="NumberOfFinancialInstitutionsToMaintainCash" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit" abstract="false" name="BalancesWithBanksInExcessOfLegallyInsuredLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>abvx-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5b13969f-ba48-4e71-920c-2a5c64899678,g:b21d6730-553e-45e9-b346-3f9a3ffd9584-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_16b03c56-bfaf-48f9-ad34-fabbe00127f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_76fd881f-0f92-4b13-9a56-4e24cf3eccb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_16b03c56-bfaf-48f9-ad34-fabbe00127f7" xlink:to="loc_ifrs-full_NoncurrentLiabilities_76fd881f-0f92-4b13-9a56-4e24cf3eccb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_2155feac-75a6-413b-9fcf-e623062446a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_16b03c56-bfaf-48f9-ad34-fabbe00127f7" xlink:to="loc_ifrs-full_CurrentLiabilities_2155feac-75a6-413b-9fcf-e623062446a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_b7765346-a95c-4363-88ff-da3daa92feb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_16b03c56-bfaf-48f9-ad34-fabbe00127f7" xlink:to="loc_ifrs-full_Equity_b7765346-a95c-4363-88ff-da3daa92feb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_a8d8e942-9241-48d1-b2c9-ed6dafe41f3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_c00b7d51-e82c-4692-be32-5d2ea8000426" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_a8d8e942-9241-48d1-b2c9-ed6dafe41f3b" xlink:to="loc_ifrs-full_Goodwill_c00b7d51-e82c-4692-be32-5d2ea8000426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_d8f78e9a-24c9-4ed5-b0dc-02278994c58a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_a8d8e942-9241-48d1-b2c9-ed6dafe41f3b" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_d8f78e9a-24c9-4ed5-b0dc-02278994c58a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_84989ffc-c293-4b79-b749-08f26e62beda" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_a8d8e942-9241-48d1-b2c9-ed6dafe41f3b" xlink:to="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_84989ffc-c293-4b79-b749-08f26e62beda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_4a9d1267-4317-4909-9bcf-98fe54e8a0a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_a8d8e942-9241-48d1-b2c9-ed6dafe41f3b" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_4a9d1267-4317-4909-9bcf-98fe54e8a0a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_1362f611-1a7b-4f19-b7b9-389040446b23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_a8d8e942-9241-48d1-b2c9-ed6dafe41f3b" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialAssets_1362f611-1a7b-4f19-b7b9-389040446b23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_d25f3d7a-c65b-4ef7-8430-784b69461002" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_cc2cb711-4d49-4fd8-bc01-3b3ec971c7dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_d25f3d7a-c65b-4ef7-8430-784b69461002" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_cc2cb711-4d49-4fd8-bc01-3b3ec971c7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_3c97c309-288f-4899-85e2-4a0876278b99" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_d25f3d7a-c65b-4ef7-8430-784b69461002" xlink:to="loc_ifrs-full_CashAndCashEquivalents_3c97c309-288f-4899-85e2-4a0876278b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_5f969b03-7b02-45ca-a997-71e4873a3bcf" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesAndCurrentPrepaidExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_d25f3d7a-c65b-4ef7-8430-784b69461002" xlink:to="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_5f969b03-7b02-45ca-a997-71e4873a3bcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_5f8775d6-7412-470a-a032-e711a17c9f4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_a94201ec-dd7d-4ef2-8b5e-d03e7a5e253f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_5f8775d6-7412-470a-a032-e711a17c9f4f" xlink:to="loc_ifrs-full_SharePremium_a94201ec-dd7d-4ef2-8b5e-d03e7a5e253f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_21c05c18-42e5-4b58-bc0e-c7cf1f6fb314" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriod"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_5f8775d6-7412-470a-a032-e711a17c9f4f" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_21c05c18-42e5-4b58-bc0e-c7cf1f6fb314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_dd065640-09fe-45c6-8798-0746bdd1611f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_5f8775d6-7412-470a-a032-e711a17c9f4f" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_dd065640-09fe-45c6-8798-0746bdd1611f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_2bdf328d-f817-4ecf-9cd4-14bb9b66223c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_5f8775d6-7412-470a-a032-e711a17c9f4f" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_2bdf328d-f817-4ecf-9cd4-14bb9b66223c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_46406cd4-7687-493e-b9ac-f79e31126b00" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_5f8775d6-7412-470a-a032-e711a17c9f4f" xlink:to="loc_ifrs-full_IssuedCapital_46406cd4-7687-493e-b9ac-f79e31126b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_f658ee49-0181-4d71-b87d-65233cf6fa74" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:to="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_f658ee49-0181-4d71-b87d-65233cf6fa74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions_f77154ec-20bb-4e94-8074-499d82e4475c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:to="loc_ifrs-full_OtherLongtermProvisions_f77154ec-20bb-4e94-8074-499d82e4475c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates_ac2e9672-e64b-436e-b120-24911ee0f3b8" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:to="loc_abvx_NonCurrentRoyaltyCertificates_ac2e9672-e64b-436e-b120-24911ee0f3b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_2ed67d60-bd11-4093-b9bf-93810e46df76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_2ed67d60-bd11-4093-b9bf-93810e46df76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_8aaaec82-6a0e-48bb-8cf6-15d1f46ef92b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_8aaaec82-6a0e-48bb-8cf6-15d1f46ef92b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentConvertibleLoansNotes_80910a55-359d-4491-9b68-7148d4486306" xlink:href="abvx-20241231.xsd#abvx_NonCurrentConvertibleLoansNotes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:to="loc_abvx_NonCurrentConvertibleLoansNotes_80910a55-359d-4491-9b68-7148d4486306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_add8c7d7-1f3e-491e-ba54-0a70a72c6094" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_fb15fb84-91be-4f3e-9d09-3611b0682b48" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_add8c7d7-1f3e-491e-ba54-0a70a72c6094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_7ca52d0f-eda6-4c5d-b3d6-63f014d53c71" xlink:href="abvx-20241231.xsd#abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_7ca52d0f-eda6-4c5d-b3d6-63f014d53c71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_5804eef6-a91e-4b00-b287-0a63bd4b00a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_5804eef6-a91e-4b00-b287-0a63bd4b00a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_74a4dd6b-1ee0-44cd-9550-423e147bd729" xlink:href="abvx-20241231.xsd#abvx_CurrentTaxAndEmployeeBenefitLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_74a4dd6b-1ee0-44cd-9550-423e147bd729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_634e6f3a-699a-4b43-ae11-7eadf76281b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_634e6f3a-699a-4b43-ae11-7eadf76281b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialLiabilities_6efca37b-d5e8-4a65-9e63-1b3f863da548" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_ifrs-full_OtherCurrentFinancialLiabilities_6efca37b-d5e8-4a65-9e63-1b3f863da548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_fe2a3670-22eb-4ac8-90f6-90f472356b26" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_fe2a3670-22eb-4ac8-90f6-90f472356b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherShorttermProvisions_26889a47-3f94-42ab-8a4e-f0af85343773" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherShorttermProvisions"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_ifrs-full_OtherShorttermProvisions_26889a47-3f94-42ab-8a4e-f0af85343773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_935bc295-f960-49b0-b143-86d09d3f2dc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_4c5f0d52-007f-4a4d-b092-b90872ab636e" xlink:to="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_935bc295-f960-49b0-b143-86d09d3f2dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_960b252a-4a01-44f3-ba2e-e8756752fce5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_62f59643-c649-4af0-88d9-c86fd98a25a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_960b252a-4a01-44f3-ba2e-e8756752fce5" xlink:to="loc_ifrs-full_CurrentAssets_62f59643-c649-4af0-88d9-c86fd98a25a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_6b7154fb-2df8-4862-a9d0-5e472fff07fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_960b252a-4a01-44f3-ba2e-e8756752fce5" xlink:to="loc_ifrs-full_NoncurrentAssets_6b7154fb-2df8-4862-a9d0-5e472fff07fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_ed81bb4c-7bd9-449b-a762-db849544216b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAndOperatingIncome_5adcb598-1f70-43df-a7f5-d8b5dfe1dd89" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAndOperatingIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_ed81bb4c-7bd9-449b-a762-db849544216b" xlink:to="loc_ifrs-full_RevenueAndOperatingIncome_5adcb598-1f70-43df-a7f5-d8b5dfe1dd89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_13d3747e-ba0f-429b-ba61-b1c6aceac638" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_ed81bb4c-7bd9-449b-a762-db849544216b" xlink:to="loc_ifrs-full_OperatingExpense_13d3747e-ba0f-429b-ba61-b1c6aceac638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAndOperatingIncome_68e9fa7b-d24b-47d5-837d-a74f1e7ea219" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAndOperatingIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_744754f9-7782-4f45-a721-ee1be607c252" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_RevenueAndOperatingIncome_68e9fa7b-d24b-47d5-837d-a74f1e7ea219" xlink:to="loc_ifrs-full_OtherIncome_744754f9-7782-4f45-a721-ee1be607c252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_98e0f611-42a0-480b-8fd7-18d9660b97be" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_74a9a5b7-9523-4b32-bcc7-5d50eb92825a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_98e0f611-42a0-480b-8fd7-18d9660b97be" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_74a9a5b7-9523-4b32-bcc7-5d50eb92825a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_c15d7971-a88a-40ba-89b5-f82fdf4493b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_98e0f611-42a0-480b-8fd7-18d9660b97be" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_c15d7971-a88a-40ba-89b5-f82fdf4493b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_3a84caaf-8a82-4f57-8c6f-e5b96c358c36" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_98e0f611-42a0-480b-8fd7-18d9660b97be" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_3a84caaf-8a82-4f57-8c6f-e5b96c358c36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_f8ef1bd3-8dc4-4e46-8264-5a6314da90d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_98e0f611-42a0-480b-8fd7-18d9660b97be" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_f8ef1bd3-8dc4-4e46-8264-5a6314da90d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_50611a30-8d56-46bc-b038-73c03e1c40ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_517ada8e-6165-4cac-af35-0ebf944b088e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_50611a30-8d56-46bc-b038-73c03e1c40ad" xlink:to="loc_ifrs-full_FinanceCosts_517ada8e-6165-4cac-af35-0ebf944b088e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_05306d34-8c86-4954-899a-93ca4d680090" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_50611a30-8d56-46bc-b038-73c03e1c40ad" xlink:to="loc_ifrs-full_FinanceIncome_05306d34-8c86-4954-899a-93ca4d680090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_38379792-faaa-4512-80a6-1a0e33867ee8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_b2e8e0c2-24a9-4bbb-998f-5ff411b3ce2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_38379792-faaa-4512-80a6-1a0e33867ee8" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_b2e8e0c2-24a9-4bbb-998f-5ff411b3ce2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_a84dc59b-1a8e-44fb-b388-d9bed07ea06f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_38379792-faaa-4512-80a6-1a0e33867ee8" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_a84dc59b-1a8e-44fb-b388-d9bed07ea06f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_386530e2-adc8-45d9-bf6e-a587dde7a6b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_c363cd28-0eef-44d7-bfc4-4b42ecbe23db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_386530e2-adc8-45d9-bf6e-a587dde7a6b3" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_c363cd28-0eef-44d7-bfc4-4b42ecbe23db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_e7de5728-16bb-42c6-b338-6219368390a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_386530e2-adc8-45d9-bf6e-a587dde7a6b3" xlink:to="loc_ifrs-full_FinanceIncomeCost_e7de5728-16bb-42c6-b338-6219368390a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_dc33d754-52f3-4932-827e-7c71a09816aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_43a30ba4-dd73-42d3-890f-00f000c1ac15" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_dc33d754-52f3-4932-827e-7c71a09816aa" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_43a30ba4-dd73-42d3-890f-00f000c1ac15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_f2eb1c87-240b-42a2-b981-fe9e5bbbdc90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_9fb825c5-af5b-4f60-a852-2fb2d77262ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_f2eb1c87-240b-42a2-b981-fe9e5bbbdc90" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_9fb825c5-af5b-4f60-a852-2fb2d77262ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_73d0d6f9-518d-4e0d-9754-1b88197eb841" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_bd370097-6644-4e9e-b30b-7d6fd6c5e704" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_73d0d6f9-518d-4e0d-9754-1b88197eb841" xlink:to="loc_ifrs-full_ProfitLoss_bd370097-6644-4e9e-b30b-7d6fd6c5e704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_32530d0c-8346-4fb0-811d-2ff27684e5c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_73d0d6f9-518d-4e0d-9754-1b88197eb841" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_32530d0c-8346-4fb0-811d-2ff27684e5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_2176356a-05fa-41d3-b5ba-f8f8ae966e55" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_b3d30243-ab32-4379-be67-6f9590c9129d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_2176356a-05fa-41d3-b5ba-f8f8ae966e55" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_b3d30243-ab32-4379-be67-6f9590c9129d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_6f1095e5-d6d1-44b8-a0f4-80800469556b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_2176356a-05fa-41d3-b5ba-f8f8ae966e55" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_6f1095e5-d6d1-44b8-a0f4-80800469556b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_4133fb48-83dd-4adf-8165-7c105f12a6a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_562752ba-11b5-41cf-beab-4faace2f5ebe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_4133fb48-83dd-4adf-8165-7c105f12a6a8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_562752ba-11b5-41cf-beab-4faace2f5ebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_86181901-17d4-430c-a2c4-45f17a4c3b12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_4133fb48-83dd-4adf-8165-7c105f12a6a8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_86181901-17d4-430c-a2c4-45f17a4c3b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_8eeab7b1-195a-47e6-bcd3-09932f5506ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_4133fb48-83dd-4adf-8165-7c105f12a6a8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_8eeab7b1-195a-47e6-bcd3-09932f5506ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_a558cd8a-1823-47bb-b1cd-35d0c4e65f83" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_4133fb48-83dd-4adf-8165-7c105f12a6a8" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_a558cd8a-1823-47bb-b1cd-35d0c4e65f83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired_5bc037e4-50f6-4906-b309-1f1aff9b1384" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired_5bc037e4-50f6-4906-b309-1f1aff9b1384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_aac57737-4023-4e40-94d6-417cc39210e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_aac57737-4023-4e40-94d6-417cc39210e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_587fe8fc-58d6-4cd4-8b5d-22b3aed7d50b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_587fe8fc-58d6-4cd4-8b5d-22b3aed7d50b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPaymentsForDeposits_34243acb-4ffb-496a-954c-df25a718a28d" xlink:href="abvx-20241231.xsd#abvx_CashPaymentsForDeposits"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_abvx_CashPaymentsForDeposits_34243acb-4ffb-496a-954c-df25a718a28d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_3797ef43-c809-4921-9e02-dd2b02cd0954" xlink:href="abvx-20241231.xsd#abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_3797ef43-c809-4921-9e02-dd2b02cd0954" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8c44ff4e-7e2f-4f25-8d03-18a415dc78bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8c44ff4e-7e2f-4f25-8d03-18a415dc78bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_12c8544d-d26c-4861-bda5-453ba8e7fa4d" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAdvancesMadeToContractResearchOrganizations"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_12c8544d-d26c-4861-bda5-453ba8e7fa4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromReimbursementsOfDeposits_d4ef18e1-3405-4895-9768-f6e93c4292c7" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromReimbursementsOfDeposits"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3bb3a63b-699e-448a-9722-2aab9a02203b" xlink:to="loc_abvx_ProceedsFromReimbursementsOfDeposits_d4ef18e1-3405-4895-9768-f6e93c4292c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_ed8d0436-4318-46b5-8daa-0f223eae1e60" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_ed8d0436-4318-46b5-8daa-0f223eae1e60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares_2803896c-596f-4d60-afab-1075d4d0f9a1" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares_2803896c-596f-4d60-afab-1075d4d0f9a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances_c302255e-ac76-4c7a-bd07-39e9d7412d89" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances_c302255e-ac76-4c7a-bd07-39e9d7412d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances_c7ee7877-0522-479e-8b2a-f1f2d80ee53c" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances_c7ee7877-0522-479e-8b2a-f1f2d80ee53c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_ad2abcb7-6560-41b1-82a9-adcf9bb57880" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_ad2abcb7-6560-41b1-82a9-adcf9bb57880" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_16bc6380-a955-4174-aa62-8cb5c575e853" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_16bc6380-a955-4174-aa62-8cb5c575e853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForOtherFinanceIncome_1a28991c-a8ea-4905-ac02-5a91fbc5bb30" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForOtherFinanceIncome"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_abvx_AdjustmentsForOtherFinanceIncome_1a28991c-a8ea-4905-ac02-5a91fbc5bb30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForOtherFinanceCosts_71100d90-102b-470d-87e0-f0cc3fae05a6" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForOtherFinanceCosts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_abvx_AdjustmentsForOtherFinanceCosts_71100d90-102b-470d-87e0-f0cc3fae05a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_ce936c4e-52c6-4745-bdd9-a51723cdaa3a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_ce936c4e-52c6-4745-bdd9-a51723cdaa3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_a9ddfd87-30e6-4e95-88ca-b7751ad607ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_a9ddfd87-30e6-4e95-88ca-b7751ad607ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_7f19ef66-c350-455c-a716-397cf30a5265" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_7f19ef66-c350-455c-a716-397cf30a5265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_049a784d-bc85-40a5-880b-9eb424295966" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0d150dbe-8a01-405c-8770-b78159c4ea6c" xlink:to="loc_ifrs-full_ProfitLoss_049a784d-bc85-40a5-880b-9eb424295966" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_27ac6cfb-52b1-4bd4-be54-9f06e8b0f6a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_048feead-e200-42a5-9a2c-96a22a15ddb9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_27ac6cfb-52b1-4bd4-be54-9f06e8b0f6a6" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_048feead-e200-42a5-9a2c-96a22a15ddb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_a5ffebea-4e16-457c-b047-590a6ba974dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_27ac6cfb-52b1-4bd4-be54-9f06e8b0f6a6" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_a5ffebea-4e16-457c-b047-590a6ba974dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_4a94f311-bd3b-444d-b736-340a35cbe51f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_373bffde-561a-4233-b544-de612f892828" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_4a94f311-bd3b-444d-b736-340a35cbe51f" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_373bffde-561a-4233-b544-de612f892828" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities_ab7f5fb2-bf47-46c3-b991-3cccaeab0509" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_4a94f311-bd3b-444d-b736-340a35cbe51f" xlink:to="loc_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities_ab7f5fb2-bf47-46c3-b991-3cccaeab0509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities_dac16745-ce62-4139-8892-c5886231e883" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_4a94f311-bd3b-444d-b736-340a35cbe51f" xlink:to="loc_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities_dac16745-ce62-4139-8892-c5886231e883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_d5f73d52-c9b9-4d21-8dac-b3cfcb5b2ab8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_4a94f311-bd3b-444d-b736-340a35cbe51f" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_d5f73d52-c9b9-4d21-8dac-b3cfcb5b2ab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_60de5e3d-ef9f-48b5-b7de-78d261451031" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_60de5e3d-ef9f-48b5-b7de-78d261451031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfBondLoans_cecf112a-fe0b-483e-b43b-7ac0033e6125" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfBondLoans"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_RepaymentsOfBondLoans_cecf112a-fe0b-483e-b43b-7ac0033e6125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfPGE_bb70b5ad-70de-438f-a00d-5fa7501a9950" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfPGE"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_RepaymentsOfPGE_bb70b5ad-70de-438f-a00d-5fa7501a9950" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_353091f6-7bbb-4365-a82e-4c9ddd441112" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_353091f6-7bbb-4365-a82e-4c9ddd441112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit_40fc3f39-7fbc-4cd2-bdc8-5226f7af643d" xlink:href="abvx-20241231.xsd#abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit_40fc3f39-7fbc-4cd2-bdc8-5226f7af643d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_dddcbd8a-5562-4083-bd71-075db94bf640" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_dddcbd8a-5562-4083-bd71-075db94bf640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConditionalAdvances_be513a8d-ab97-441f-8482-7b17517563b2" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConditionalAdvances"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_RepaymentsOfConditionalAdvances_be513a8d-ab97-441f-8482-7b17517563b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_b726b742-8f75-44da-a1e7-afb31b0b0b18" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_b726b742-8f75-44da-a1e7-afb31b0b0b18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_26ba05ee-ea9d-414f-8671-ded26279a9cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_26ba05ee-ea9d-414f-8671-ded26279a9cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_165f2d50-f55f-4f22-b5ce-e1ad760bd08c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_165f2d50-f55f-4f22-b5ce-e1ad760bd08c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_85487d5f-f3a6-4efd-b8f1-17e21652243e" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_85487d5f-f3a6-4efd-b8f1-17e21652243e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromNonConvertibleLoansNotes_807f27bd-a725-44ca-b7e7-1c51fabc7cf5" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromNonConvertibleLoansNotes"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_NetProceedsFromNonConvertibleLoansNotes_807f27bd-a725-44ca-b7e7-1c51fabc7cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_e674cdd4-76ef-45fc-897c-e55ac1e8f167" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_83528da3-1e57-4008-8a32-731f365e4004" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_e674cdd4-76ef-45fc-897c-e55ac1e8f167" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_6a2a6e53-092b-4528-a91d-c6722649634d" xlink:href="abvx-20241231.xsd#abvx_AssetsRecognisedAsOfAcquisitionDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions_bb0697e7-f750-4af4-9a96-79b6552be2af" xlink:href="abvx-20241231.xsd#abvx_CashAndCashEquivalentsAssetsAcquisitions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_6a2a6e53-092b-4528-a91d-c6722649634d" xlink:to="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions_bb0697e7-f750-4af4-9a96-79b6552be2af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_230955b5-27cd-4738-a65a-66297ba64068" xlink:href="abvx-20241231.xsd#abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_6a2a6e53-092b-4528-a91d-c6722649634d" xlink:to="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_230955b5-27cd-4738-a65a-66297ba64068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_61a19617-9d55-4841-8532-075a58f3dfc0" xlink:href="abvx-20241231.xsd#abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashTransferredAssetsAcquisitions_a56cf9d9-eecb-440c-a735-439061dc887b" xlink:href="abvx-20241231.xsd#abvx_CashTransferredAssetsAcquisitions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_61a19617-9d55-4841-8532-075a58f3dfc0" xlink:to="loc_abvx_CashTransferredAssetsAcquisitions_a56cf9d9-eecb-440c-a735-439061dc887b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LoanGrantedAssetsAcquisitions_1277ae14-c4ef-4c42-8c1c-bda98bfd2c00" xlink:href="abvx-20241231.xsd#abvx_LoanGrantedAssetsAcquisitions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_61a19617-9d55-4841-8532-075a58f3dfc0" xlink:to="loc_abvx_LoanGrantedAssetsAcquisitions_1277ae14-c4ef-4c42-8c1c-bda98bfd2c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition_93564e0d-ddf4-4d2b-9bfe-a3d3035247f0" xlink:href="abvx-20241231.xsd#abvx_AcquisitionRelatedCostsAssetsAcquisition"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_61a19617-9d55-4841-8532-075a58f3dfc0" xlink:to="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition_93564e0d-ddf4-4d2b-9bfe-a3d3035247f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_c5468d7c-f28a-4e29-bfb2-8cab3eeffd11" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_61a19617-9d55-4841-8532-075a58f3dfc0" xlink:to="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_c5468d7c-f28a-4e29-bfb2-8cab3eeffd11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPrepaymentAssetsAcquisitions_4582ea5e-d201-43cb-93d3-087a842ffbee" xlink:href="abvx-20241231.xsd#abvx_CashPrepaymentAssetsAcquisitions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_61a19617-9d55-4841-8532-075a58f3dfc0" xlink:to="loc_abvx_CashPrepaymentAssetsAcquisitions_4582ea5e-d201-43cb-93d3-087a842ffbee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_92104ea0-9713-4984-afa3-fb1e82b5941f" xlink:href="abvx-20241231.xsd#abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_6198469d-14ab-44b4-98a2-5fec24069183" xlink:href="abvx-20241231.xsd#abvx_LiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_92104ea0-9713-4984-afa3-fb1e82b5941f" xlink:to="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_6198469d-14ab-44b4-98a2-5fec24069183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_67bd0dac-89bc-4a0b-84b0-78fb7a774817" xlink:href="abvx-20241231.xsd#abvx_AssetsRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_92104ea0-9713-4984-afa3-fb1e82b5941f" xlink:to="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_67bd0dac-89bc-4a0b-84b0-78fb7a774817" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherfinancialassetsDisclosureofotherfinancialassetsDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_bd295cd1-813f-44fe-b2f5-4e984e3200d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContracts_7232656c-d3f4-4c0a-b5ee-984874175ea3" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContracts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialAssets_bd295cd1-813f-44fe-b2f5-4e984e3200d2" xlink:to="loc_abvx_NonCurrentAdvancesToCROContracts_7232656c-d3f4-4c0a-b5ee-984874175ea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermDeposits_0a2b29c8-7e16-43ff-9a6f-7d4aaf2f91b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermDeposits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialAssets_bd295cd1-813f-44fe-b2f5-4e984e3200d2" xlink:to="loc_ifrs-full_LongtermDeposits_0a2b29c8-7e16-43ff-9a6f-7d4aaf2f91b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherNonCurrentMiscellaneousFinancialAssets_11198e8d-fb6f-4f96-b7c4-eb25afcc9523" xlink:href="abvx-20241231.xsd#abvx_OtherNonCurrentMiscellaneousFinancialAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialAssets_bd295cd1-813f-44fe-b2f5-4e984e3200d2" xlink:to="loc_abvx_OtherNonCurrentMiscellaneousFinancialAssets_11198e8d-fb6f-4f96-b7c4-eb25afcc9523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_f2eea52e-59a5-4e64-b14e-362a4626819e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentAdvancesToCROContracts_81687c77-784d-430f-b893-8d7ab985bbd7" xlink:href="abvx-20241231.xsd#abvx_CurrentAdvancesToCROContracts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentFinancialAssets_f2eea52e-59a5-4e64-b14e-362a4626819e" xlink:to="loc_abvx_CurrentAdvancesToCROContracts_81687c77-784d-430f-b893-8d7ab985bbd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherCurrentInvestments_e42d1c63-30ec-4bb4-bb25-a1b7eba3838b" xlink:href="abvx-20241231.xsd#abvx_OtherCurrentInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentFinancialAssets_f2eea52e-59a5-4e64-b14e-362a4626819e" xlink:to="loc_abvx_OtherCurrentInvestments_e42d1c63-30ec-4bb4-bb25-a1b7eba3838b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_9e7485de-4f89-420d-a418-0ef087b4f82a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentFinancialAssets_f2eea52e-59a5-4e64-b14e-362a4626819e" xlink:to="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_9e7485de-4f89-420d-a418-0ef087b4f82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinancialAssets_aa3b3666-c0dc-4b12-848b-5ac93e1b861a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_479c0e2f-25c2-476a-a4ba-2c8e57582929" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherFinancialAssets_aa3b3666-c0dc-4b12-848b-5ac93e1b861a" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_479c0e2f-25c2-476a-a4ba-2c8e57582929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_90adb63c-8de1-4fe0-a467-481e837ab5d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherFinancialAssets_aa3b3666-c0dc-4b12-848b-5ac93e1b861a" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialAssets_90adb63c-8de1-4fe0-a467-481e837ab5d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_5154ed16-da04-48be-8709-2bb6e4f2674c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentPrepaidExpenses_ed579dc4-9307-4e85-aca7-4b07c2066c1a" xlink:href="abvx-20241231.xsd#abvx_NonCurrentPrepaidExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_5154ed16-da04-48be-8709-2bb6e4f2674c" xlink:to="loc_abvx_NonCurrentPrepaidExpenses_ed579dc4-9307-4e85-aca7-4b07c2066c1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_65b8a70e-e853-4a02-86d4-6dd9bb245465" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesAndCurrentPrepaidExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_c99b2826-df7b-4a91-b2c4-6d34db03c4ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_65b8a70e-e853-4a02-86d4-6dd9bb245465" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_c99b2826-df7b-4a91-b2c4-6d34db03c4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_e864f9e8-a5b8-4113-91cb-a5ebd0c0b12d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_65b8a70e-e853-4a02-86d4-6dd9bb245465" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_e864f9e8-a5b8-4113-91cb-a5ebd0c0b12d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentResearchTaxCreditReceivables_b80c4fbe-7f70-4a49-955b-4a05f38d1a56" xlink:href="abvx-20241231.xsd#abvx_CurrentResearchTaxCreditReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_65b8a70e-e853-4a02-86d4-6dd9bb245465" xlink:to="loc_abvx_CurrentResearchTaxCreditReceivables_b80c4fbe-7f70-4a49-955b-4a05f38d1a56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesFromCreditNotes_3e3feeff-e85f-440b-9eb7-974fb250b32c" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesFromCreditNotes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_65b8a70e-e853-4a02-86d4-6dd9bb245465" xlink:to="loc_abvx_CurrentReceivablesFromCreditNotes_3e3feeff-e85f-440b-9eb7-974fb250b32c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssets_88812dff-7aec-4b3f-8e47-d3a7f0582bc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_4421a9a4-5d31-42f9-a57e-655d350cdfdf" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesAndCurrentPrepaidExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherAssets_88812dff-7aec-4b3f-8e47-d3a7f0582bc6" xlink:to="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_4421a9a4-5d31-42f9-a57e-655d350cdfdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_0a12dea7-eaa3-4393-82f1-9ebc892c703e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherAssets_88812dff-7aec-4b3f-8e47-d3a7f0582bc6" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_0a12dea7-eaa3-4393-82f1-9ebc892c703e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_9d09f31b-801b-4058-b2cc-edc02d168f4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_3d93c82c-2921-48e8-8611-d28ca451d997" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_9d09f31b-801b-4058-b2cc-edc02d168f4c" xlink:to="loc_ifrs-full_CashEquivalents_3d93c82c-2921-48e8-8611-d28ca451d997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_b613412b-99cc-43be-94f3-95a7810f42ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_9d09f31b-801b-4058-b2cc-edc02d168f4c" xlink:to="loc_ifrs-full_Cash_b613412b-99cc-43be-94f3-95a7810f42ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_2a87bc19-00e5-4ff3-a287-e3ccd8fe4adb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0db66b4f-53a4-4a2a-b281-3d16e99ff282" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_2a87bc19-00e5-4ff3-a287-e3ccd8fe4adb" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0db66b4f-53a4-4a2a-b281-3d16e99ff282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_c638d877-2187-40e3-81be-179730443215" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_2a87bc19-00e5-4ff3-a287-e3ccd8fe4adb" xlink:to="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_c638d877-2187-40e3-81be-179730443215" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_0b91da31-052c-416d-9161-fc7c591392a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_eee668b3-be27-4605-8107-085506e444f3" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_0b91da31-052c-416d-9161-fc7c591392a2" xlink:to="loc_abvx_ConvertibleLoansNotes_eee668b3-be27-4605-8107-085506e444f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_f94c608e-acd2-4b6b-8912-50c16a783b18" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_0b91da31-052c-416d-9161-fc7c591392a2" xlink:to="loc_ifrs-full_Borrowings_f94c608e-acd2-4b6b-8912-50c16a783b18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances_4b796a48-2c53-4b94-b425-7a8abda207cc" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_0b91da31-052c-416d-9161-fc7c591392a2" xlink:to="loc_abvx_ConditionalAdvances_4b796a48-2c53-4b94-b425-7a8abda207cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates_f75a0888-aa14-4f6f-a9af-690a6a3c11f1" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_0b91da31-052c-416d-9161-fc7c591392a2" xlink:to="loc_abvx_NonCurrentRoyaltyCertificates_f75a0888-aa14-4f6f-a9af-690a6a3c11f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_9a9ea90e-b398-4c9d-aed3-360d07e32260" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_0b91da31-052c-416d-9161-fc7c591392a2" xlink:to="loc_ifrs-full_LeaseLiabilities_9a9ea90e-b398-4c9d-aed3-360d07e32260" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_f4115a53-3539-44a8-ad81-e1f87675134d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_0b91da31-052c-416d-9161-fc7c591392a2" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_f4115a53-3539-44a8-ad81-e1f87675134d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_cab0dd2b-1781-4788-a36e-0cd0e751dbfe" xlink:href="abvx-20241231.xsd#abvx_FinancialLiabilitiesUndiscountedCashFlows"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows_2abba4a5-59b8-47d4-b33f-7f0b034a3dad" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesUndiscountedCashFlows"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_cab0dd2b-1781-4788-a36e-0cd0e751dbfe" xlink:to="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows_2abba4a5-59b8-47d4-b33f-7f0b034a3dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_c4bf0ff8-ead9-4891-a1b1-6d31b51ab850" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_cab0dd2b-1781-4788-a36e-0cd0e751dbfe" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_c4bf0ff8-ead9-4891-a1b1-6d31b51ab850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_892f9d70-fa07-4f42-b8e4-f030cc9c71a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_cab0dd2b-1781-4788-a36e-0cd0e751dbfe" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_892f9d70-fa07-4f42-b8e4-f030cc9c71a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows_ea2e5e9e-630c-4c54-ad69-4215b32d0927" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesUndiscountedCashFlows"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_cab0dd2b-1781-4788-a36e-0cd0e751dbfe" xlink:to="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows_ea2e5e9e-630c-4c54-ad69-4215b32d0927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_438b0565-e5e4-4f41-a4f5-ebab3a6ee589" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_cab0dd2b-1781-4788-a36e-0cd0e751dbfe" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_438b0565-e5e4-4f41-a4f5-ebab3a6ee589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesUndiscountedCashFlows_4196f424-fcd6-4c46-b0f1-f6164528d984" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesUndiscountedCashFlows"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_cab0dd2b-1781-4788-a36e-0cd0e751dbfe" xlink:to="loc_abvx_ConditionalAdvancesUndiscountedCashFlows_4196f424-fcd6-4c46-b0f1-f6164528d984" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_7597fb7c-64a4-4a05-a2a1-b8d5200025c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_c8e71bae-f311-4325-8b31-209f9b4b1571" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_7597fb7c-64a4-4a05-a2a1-b8d5200025c0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_c8e71bae-f311-4325-8b31-209f9b4b1571" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent_a741bdb6-8b02-4dac-8da7-a07d4926cc5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_7597fb7c-64a4-4a05-a2a1-b8d5200025c0" xlink:to="loc_ifrs-full_AccrualsClassifiedAsCurrent_a741bdb6-8b02-4dac-8da7-a07d4926cc5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherCurrentPayablesIncludingAdjustments_87c207aa-cb41-409d-8db8-bf8ce222502b" xlink:href="abvx-20241231.xsd#abvx_OtherCurrentPayablesIncludingAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_7597fb7c-64a4-4a05-a2a1-b8d5200025c0" xlink:to="loc_abvx_OtherCurrentPayablesIncludingAdjustments_87c207aa-cb41-409d-8db8-bf8ce222502b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_3d9b9ea3-4395-452d-bd27-790059ce3d95" xlink:href="abvx-20241231.xsd#abvx_CurrentTaxAndEmployeeBenefitLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_e7044315-4812-4095-93b7-907c5a49a5f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_3d9b9ea3-4395-452d-bd27-790059ce3d95" xlink:to="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_e7044315-4812-4095-93b7-907c5a49a5f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments_ba3dc9ee-26c1-4022-ac6c-0d9ae84317db" xlink:href="abvx-20241231.xsd#abvx_CurrentPayablesOnOtherTaxAndRelatedPayments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_3d9b9ea3-4395-452d-bd27-790059ce3d95" xlink:to="loc_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments_ba3dc9ee-26c1-4022-ac6c-0d9ae84317db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_e48c094c-5776-4bde-aaa6-0c99c557e242" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_3d9b9ea3-4395-452d-bd27-790059ce3d95" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_e48c094c-5776-4bde-aaa6-0c99c557e242" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingincomeDisclosureofbreakdownofoperatingincomeDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_c526b9f8-61ac-40d9-9614-5bbd64c94180" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_a088cd9a-e8bb-402d-88c1-e710fa0ec20c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherIncome_c526b9f8-61ac-40d9-9614-5bbd64c94180" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_a088cd9a-e8bb-402d-88c1-e710fa0ec20c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncomeFromResearchTaxCredit_07b37891-14da-45be-9b51-d5321a057676" xlink:href="abvx-20241231.xsd#abvx_IncomeFromResearchTaxCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherIncome_c526b9f8-61ac-40d9-9614-5bbd64c94180" xlink:to="loc_abvx_IncomeFromResearchTaxCredit_07b37891-14da-45be-9b51-d5321a057676" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_ae18bbf1-64bf-4ecc-9063-939881a3ee2a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherIncome_c526b9f8-61ac-40d9-9614-5bbd64c94180" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_ae18bbf1-64bf-4ecc-9063-939881a3ee2a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_8977333a-bdee-42a9-95e0-89d5179a1d8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SubContractingStudiesAndResearchExpenses_813e86ca-6f8f-41b6-a91d-b007ba7ca378" xlink:href="abvx-20241231.xsd#abvx_SubContractingStudiesAndResearchExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_8977333a-bdee-42a9-95e0-89d5179a1d8b" xlink:to="loc_abvx_SubContractingStudiesAndResearchExpenses_813e86ca-6f8f-41b6-a91d-b007ba7ca378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_0f487a93-9a8b-420f-8191-eb46eade9bf0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_8977333a-bdee-42a9-95e0-89d5179a1d8b" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_0f487a93-9a8b-420f-8191-eb46eade9bf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_15b2bf30-badb-4f6b-82a8-df54bb5bb65a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_8977333a-bdee-42a9-95e0-89d5179a1d8b" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_15b2bf30-badb-4f6b-82a8-df54bb5bb65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IntellectualPropertyFees_335b82d3-6fc8-4552-abfd-a99bc5effdde" xlink:href="abvx-20241231.xsd#abvx_IntellectualPropertyFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_8977333a-bdee-42a9-95e0-89d5179a1d8b" xlink:to="loc_abvx_IntellectualPropertyFees_335b82d3-6fc8-4552-abfd-a99bc5effdde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_5b2bb13c-fab4-4f26-8213-ebb7c92309d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_8977333a-bdee-42a9-95e0-89d5179a1d8b" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_5b2bb13c-fab4-4f26-8213-ebb7c92309d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration_2a781679-83b3-4a43-960d-d1cbc492444f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_b2f368f8-3d86-49e0-a209-7c9fd85e4138" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AuditorsRemuneration_2a781679-83b3-4a43-960d-d1cbc492444f" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_b2f368f8-3d86-49e0-a209-7c9fd85e4138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_7ce9aad3-8712-4edf-8df1-c59b273739c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AuditorsRemuneration_2a781679-83b3-4a43-960d-d1cbc492444f" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_7ce9aad3-8712-4edf-8df1-c59b273739c5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialgainlossDisclosureofnetfinancialincomelossDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_67e00272-afb7-476b-9dd0-9d937018cfa6" xlink:href="abvx-20241231.xsd#abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_67e00272-afb7-476b-9dd0-9d937018cfa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs_f170f65c-eef9-4712-804c-3bb0065720a7" xlink:href="abvx-20241231.xsd#abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs_f170f65c-eef9-4712-804c-3bb0065720a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromInterest_ddfd3e35-5053-45d4-8c0a-5f9871259b66" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_ifrs-full_RevenueFromInterest_ddfd3e35-5053-45d4-8c0a-5f9871259b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities_f9575f39-d03f-424c-9d9b-a620ffed3b01" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromDerecognitionOfFinancialLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities_f9575f39-d03f-424c-9d9b-a620ffed3b01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncome_6f57d668-a93a-46b3-b0c2-16608d50de20" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncome"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_ifrs-full_OtherFinanceIncome_6f57d668-a93a-46b3-b0c2-16608d50de20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_b2d82a4c-1030-42dc-b431-bf98a6e3fdb5" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromRecognitionOfFinancialLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_b2d82a4c-1030-42dc-b431-bf98a6e3fdb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_a4dce758-fe46-4149-b7c9-1f56528f8374" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsOnChangeInFairValueOfDerivatives"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_a4dce758-fe46-4149-b7c9-1f56528f8374" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeGain_baea0445-49e5-4ee5-91e9-0ecf63e1d363" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignExchangeGain"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_e929a051-7384-4794-82a2-58d24b23a3be" xlink:to="loc_ifrs-full_ForeignExchangeGain_baea0445-49e5-4ee5-91e9-0ecf63e1d363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeLoss_32c0f514-41d7-489f-b105-8d7a9f7e5522" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_ifrs-full_ForeignExchangeLoss_32c0f514-41d7-489f-b105-8d7a9f7e5522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_72afe730-46f5-43ba-88dc-64d9b0ea4f69" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_72afe730-46f5-43ba-88dc-64d9b0ea4f69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_5381ae4c-157e-4283-aa37-7ff10af446eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_5381ae4c-157e-4283-aa37-7ff10af446eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TransactionCosts_02a0e820-8f5b-474a-bd12-75971952e14b" xlink:href="abvx-20241231.xsd#abvx_TransactionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_abvx_TransactionCosts_02a0e820-8f5b-474a-bd12-75971952e14b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceCost_5c07c2b7-de6b-4c09-9efd-6670bc9a535d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_ifrs-full_OtherFinanceCost_5c07c2b7-de6b-4c09-9efd-6670bc9a535d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestExpenseOnRoyaltyCertificates_25203994-4bb2-44a1-b834-5d96391e881e" xlink:href="abvx-20241231.xsd#abvx_InterestExpenseOnRoyaltyCertificates"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_abvx_InterestExpenseOnRoyaltyCertificates_25203994-4bb2-44a1-b834-5d96391e881e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities_216a2a25-0e19-499f-bf49-6f1d119241ff" xlink:href="abvx-20241231.xsd#abvx_LossesArisingFromDerecognitionOfFinancialLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities_216a2a25-0e19-499f-bf49-6f1d119241ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_8574686b-388e-4577-80f1-ceefd08c563b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnDebtInstrumentsIssued"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_8574686b-388e-4577-80f1-ceefd08c563b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_a9d3ff63-dc67-48e0-9feb-3744522e9c8d" xlink:href="abvx-20241231.xsd#abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_a9d3ff63-dc67-48e0-9feb-3744522e9c8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_850bf4ec-de17-4a91-95fd-4970c74ec2ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_850bf4ec-de17-4a91-95fd-4970c74ec2ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBonds_e4184b7c-43e7-4ed0-8475-7eeb96cf78f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBonds"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_177a02fb-25bd-48fa-87f7-f0c3fdc03cec" xlink:to="loc_ifrs-full_InterestExpenseOnBonds_e4184b7c-43e7-4ed0-8475-7eeb96cf78f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_c3d21f03-3f71-4b89-821b-789a6b636650" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_c3d21f03-3f71-4b89-821b-789a6b636650" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_8a42bcad-c331-4a01-a479-00ec4a63c7f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_8a42bcad-c331-4a01-a479-00ec4a63c7f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfShareBasedPayment_0bfd7b80-a4dd-4679-9cfb-06344b8c1a7c" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfShareBasedPayment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_abvx_TaxEffectOfShareBasedPayment_0bfd7b80-a4dd-4679-9cfb-06344b8c1a7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfResearchTaxCredit_6335f48a-a36e-4806-9e6b-89f7e358f409" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfResearchTaxCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_abvx_TaxEffectOfResearchTaxCredit_6335f48a-a36e-4806-9e6b-89f7e358f409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease_c4290727-c6fd-4831-82ba-729af6db9da1" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease_c4290727-c6fd-4831-82ba-729af6db9da1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther_a5fb8331-92ac-4baa-bf51-879fc119f090" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfChangesInDerivativeFairValueAndOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther_a5fb8331-92ac-4baa-bf51-879fc119f090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_f9924e70-9038-4ee7-9783-bbafe9f2d24d" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_f9924e70-9038-4ee7-9783-bbafe9f2d24d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_fef28780-fc6a-406c-a923-ccfc24da8a0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8368b092-be0f-4abf-bca2-dd7c49bafe0e" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_fef28780-fc6a-406c-a923-ccfc24da8a0a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_d1fa65b3-1812-40dc-84d8-b24fb2456e0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_a410f90e-9064-4590-86f9-37ab21b8c44e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_d1fa65b3-1812-40dc-84d8-b24fb2456e0f" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_a410f90e-9064-4590-86f9-37ab21b8c44e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_5f9891d9-5b18-4678-89e7-e2b1e63e7e44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_d1fa65b3-1812-40dc-84d8-b24fb2456e0f" xlink:to="loc_ifrs-full_DeferredTaxAssets_5f9891d9-5b18-4678-89e7-e2b1e63e7e44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_2288ab21-7351-46c0-81e4-574a3e32af28" xlink:href="abvx-20241231.xsd#abvx_DeferredTaxAssetsRecognisedInFinancialPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnrecognizedDeferredTaxAssets_378cf783-0445-4cff-aa6b-a117becb4a18" xlink:href="abvx-20241231.xsd#abvx_UnrecognizedDeferredTaxAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_2288ab21-7351-46c0-81e4-574a3e32af28" xlink:to="loc_abvx_UnrecognizedDeferredTaxAssets_378cf783-0445-4cff-aa6b-a117becb4a18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_955e4319-0acc-4cc1-92c5-3c5d00dc8a3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_2288ab21-7351-46c0-81e4-574a3e32af28" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_955e4319-0acc-4cc1-92c5-3c5d00dc8a3c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"/>
  <link:calculationLink xlink:role="http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationInKindContributions_ef9efaf0-cbef-40b4-8bbe-6fb4f533c33a" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationInKindContributions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:to="loc_abvx_KeyManagementPersonnelCompensationInKindContributions_ef9efaf0-cbef-40b4-8bbe-6fb4f533c33a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationAttendanceFees_b8ad9f9e-d4a1-480e-9173-b758816d1c1b" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationAttendanceFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:to="loc_abvx_KeyManagementPersonnelCompensationAttendanceFees_b8ad9f9e-d4a1-480e-9173-b758816d1c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_14643776-2afe-42aa-9102-2d200655e6f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_14643776-2afe-42aa-9102-2d200655e6f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationVariableCompensation_e1a892c4-8ce5-481c-8f9c-a331a4b2d296" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationVariableCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:to="loc_abvx_KeyManagementPersonnelCompensationVariableCompensation_e1a892c4-8ce5-481c-8f9c-a331a4b2d296" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationFixedCompensation_a5e3e69f-d498-4674-8c34-f9a627cbb74f" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationFixedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:to="loc_abvx_KeyManagementPersonnelCompensationFixedCompensation_a5e3e69f-d498-4674-8c34-f9a627cbb74f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_f5742dca-c7b6-46fd-89df-f179835e05b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_f5742dca-c7b6-46fd-89df-f179835e05b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_949d70c1-d384-4d83-b932-c7a317d8777d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0d5344a7-771e-4900-835e-9e7387eb8e30" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_949d70c1-d384-4d83-b932-c7a317d8777d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>abvx-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5b13969f-ba48-4e71-920c-2a5c64899678,g:b21d6730-553e-45e9-b346-3f9a3ffd9584-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.abivax.com/role/Coverpage" xlink:type="simple" xlink:href="abvx-20241231.xsd#Coverpage"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_ad1edd2c-9fcb-432d-9e3e-d39223ee6091" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:to="loc_dei_EntityListingsExchangeAxis_ad1edd2c-9fcb-432d-9e3e-d39223ee6091" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_ad1edd2c-9fcb-432d-9e3e-d39223ee6091_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_ad1edd2c-9fcb-432d-9e3e-d39223ee6091" xlink:to="loc_dei_ExchangeDomain_ad1edd2c-9fcb-432d-9e3e-d39223ee6091_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_ad1edd2c-9fcb-432d-9e3e-d39223ee6091" xlink:to="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember_fe6342a9-3ed1-4a0e-97c6-470b4f675d96" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesNASDAQGlobalMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:to="loc_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember_fe6342a9-3ed1-4a0e-97c6-470b4f675d96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OrdinarySharesNASDAQGlobalMarketMember_c650cfec-6ea2-4f2f-99a1-dd55f6a5dafe" xlink:href="abvx-20241231.xsd#abvx_OrdinarySharesNASDAQGlobalMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:to="loc_abvx_OrdinarySharesNASDAQGlobalMarketMember_c650cfec-6ea2-4f2f-99a1-dd55f6a5dafe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_a6823d39-19b1-4da8-9e36-1b35386eb514" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_a6823d39-19b1-4da8-9e36-1b35386eb514" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_a6823d39-19b1-4da8-9e36-1b35386eb514_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_a6823d39-19b1-4da8-9e36-1b35386eb514" xlink:to="loc_dei_AddressTypeDomain_a6823d39-19b1-4da8-9e36-1b35386eb514_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_442d894b-1c23-4871-bc8b-684135e7b6e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_a6823d39-19b1-4da8-9e36-1b35386eb514" xlink:to="loc_dei_AddressTypeDomain_442d894b-1c23-4871-bc8b-684135e7b6e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_089766a2-ff5b-4e04-8eaf-759a9a291953" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_442d894b-1c23-4871-bc8b-684135e7b6e3" xlink:to="loc_dei_BusinessContactMember_089766a2-ff5b-4e04-8eaf-759a9a291953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1616678c-cd9e-43b5-a0f7-fa6ecbf25994" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentType_1616678c-cd9e-43b5-a0f7-fa6ecbf25994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_40edb73a-0330-4ea0-ae09-aff53707e420" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentRegistrationStatement_40edb73a-0330-4ea0-ae09-aff53707e420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_a67f139f-4964-4882-b345-219047283097" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentAnnualReport_a67f139f-4964-4882-b345-219047283097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b3325230-539f-4c0b-9d5c-154986f30b53" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentPeriodEndDate_b3325230-539f-4c0b-9d5c-154986f30b53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b34cd300-1f58-449e-a205-3af2a0f6b8dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_CurrentFiscalYearEndDate_b34cd300-1f58-449e-a205-3af2a0f6b8dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_10f8bd43-24d2-47c4-88f9-2e7839b0b5b2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentTransitionReport_10f8bd43-24d2-47c4-88f9-2e7839b0b5b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_abec0200-8d14-47fb-92bf-bacb2526e419" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentShellCompanyReport_abec0200-8d14-47fb-92bf-bacb2526e419" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9d5a145a-c85e-4d89-856b-a6f9fcc7fbf2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityFileNumber_9d5a145a-c85e-4d89-856b-a6f9fcc7fbf2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1199f455-b70f-4a50-905d-e4fa7c0e84cb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityRegistrantName_1199f455-b70f-4a50-905d-e4fa7c0e84cb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8d29dd66-b936-4a2e-95b4-c40d10851989" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8d29dd66-b936-4a2e-95b4-c40d10851989" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_feca387b-3037-4453-a84b-1b3a09fa06ea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_ContactPersonnelName_feca387b-3037-4453-a84b-1b3a09fa06ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8967be64-d8c8-4ce9-bd85-5dab17bab6f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressAddressLine1_8967be64-d8c8-4ce9-bd85-5dab17bab6f8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fafe5e50-828a-4789-b9a0-14e61bebc5f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressPostalZipCode_fafe5e50-828a-4789-b9a0-14e61bebc5f8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a649e058-efa6-4115-a052-48fa31bc4f93" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressCityOrTown_a649e058-efa6-4115-a052-48fa31bc4f93" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_39f13eb7-7d1b-427c-b453-d5f13254e003" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressCountry_39f13eb7-7d1b-427c-b453-d5f13254e003" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_71d9ffa8-579d-47e5-a4d9-f0efd7b5f0b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_CityAreaCode_71d9ffa8-579d-47e5-a4d9-f0efd7b5f0b1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_02aadfb7-f17e-469d-8d38-41f26b13a993" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_LocalPhoneNumber_02aadfb7-f17e-469d-8d38-41f26b13a993" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_32ceeb9a-5a93-47dd-b417-e56af875745b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_Security12bTitle_32ceeb9a-5a93-47dd-b417-e56af875745b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_aad99ac2-3770-4f8d-8a21-ae10d922d101" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_TradingSymbol_aad99ac2-3770-4f8d-8a21-ae10d922d101" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8877fac2-cd3c-43b3-a604-de496a90ef41" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_SecurityExchangeName_8877fac2-cd3c-43b3-a604-de496a90ef41" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e082982e-c9ec-405e-b424-c32be2fe0315" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e082982e-c9ec-405e-b424-c32be2fe0315" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_0e677035-6425-4923-a3da-c53c0f161877" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_0e677035-6425-4923-a3da-c53c0f161877" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_216b0963-4065-4de3-9629-1cc97bfc0ac8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityVoluntaryFilers_216b0963-4065-4de3-9629-1cc97bfc0ac8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a13fa3f9-d47e-4852-af85-bcac11c21475" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityCurrentReportingStatus_a13fa3f9-d47e-4852-af85-bcac11c21475" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_851394e7-c7cf-41dc-bd77-b040bb6fe2dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityInteractiveDataCurrent_851394e7-c7cf-41dc-bd77-b040bb6fe2dc" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_011c6bfc-7a0a-4e49-8ac9-eba644f8e3fb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityFilerCategory_011c6bfc-7a0a-4e49-8ac9-eba644f8e3fb" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_66702145-bc0e-4951-b2e2-f65c4d9db854" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityEmergingGrowthCompany_66702145-bc0e-4951-b2e2-f65c4d9db854" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_5654692e-f2b2-4dd4-8a01-e1305a25d19c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityExTransitionPeriod_5654692e-f2b2-4dd4-8a01-e1305a25d19c" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_574ce067-1412-4a2b-a7c1-ac14afbfa0ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_574ce067-1412-4a2b-a7c1-ac14afbfa0ee" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_ceae69c2-9ed3-4b73-ad12-43c5e5c660f0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_ceae69c2-9ed3-4b73-ad12-43c5e5c660f0" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_9c0142f0-5ac0-4665-9eee-6c2f0f4db90b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentAccountingStandard_9c0142f0-5ac0-4665-9eee-6c2f0f4db90b" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_50c3a114-f79d-44f7-a1a5-5c184f992941" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityShellCompany_50c3a114-f79d-44f7-a1a5-5c184f992941" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_deec089d-bd71-43f5-9105-49f1856cd47e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_AmendmentFlag_deec089d-bd71-43f5-9105-49f1856cd47e" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_beba1f49-bb5c-48d7-b9cc-452229b3ddd3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentFiscalYearFocus_beba1f49-bb5c-48d7-b9cc-452229b3ddd3" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3b3a2acf-d60f-4a92-9f65-7c88b9c2a723" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3b3a2acf-d60f-4a92-9f65-7c88b9c2a723" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cf556b19-fda3-4b04-9920-7b689b8575b7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityCentralIndexKey_cf556b19-fda3-4b04-9920-7b689b8575b7" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_ae2c9c52-1d01-4135-8b21-07df58d4633e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_NoTradingSymbolFlag_ae2c9c52-1d01-4135-8b21-07df58d4633e" xlink:type="arc" order="36"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_569b5dd7-7ae7-49c5-9809-187213c60460" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_569b5dd7-7ae7-49c5-9809-187213c60460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_569b5dd7-7ae7-49c5-9809-187213c60460_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_569b5dd7-7ae7-49c5-9809-187213c60460" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_569b5dd7-7ae7-49c5-9809-187213c60460_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_569b5dd7-7ae7-49c5-9809-187213c60460" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_292dbc77-4778-4cff-bd6f-4acbb4b4356d" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:to="loc_abvx_OceaneConversionOptionMember_292dbc77-4778-4cff-bd6f-4acbb4b4356d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_7df46830-0f08-4432-8996-94265486cbb8" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:to="loc_abvx_HeightsConvertibleNotesMember_7df46830-0f08-4432-8996-94265486cbb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_fac2fa93-be8c-44d1-86cd-787b385161bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_fac2fa93-be8c-44d1-86cd-787b385161bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestatedMember_fac2fa93-be8c-44d1-86cd-787b385161bb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_fac2fa93-be8c-44d1-86cd-787b385161bb" xlink:to="loc_ifrs-full_RestatedMember_fac2fa93-be8c-44d1-86cd-787b385161bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestatedMember_811d9cab-732d-4f4f-8354-dafe288e5410" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_fac2fa93-be8c-44d1-86cd-787b385161bb" xlink:to="loc_ifrs-full_RestatedMember_811d9cab-732d-4f4f-8354-dafe288e5410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember_d094a7ca-9fe2-4db1-b772-93596d0bcfc1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_811d9cab-732d-4f4f-8354-dafe288e5410" xlink:to="loc_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember_d094a7ca-9fe2-4db1-b772-93596d0bcfc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentConvertibleLoansNotes_c7546ec6-4724-40b1-96f6-97b819738669" xlink:href="abvx-20241231.xsd#abvx_NonCurrentConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:to="loc_abvx_NonCurrentConvertibleLoansNotes_c7546ec6-4724-40b1-96f6-97b819738669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_90709ef0-8cfa-435a-a144-f5dd868262b1" xlink:href="abvx-20241231.xsd#abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:to="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_90709ef0-8cfa-435a-a144-f5dd868262b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_21d1e3ad-b267-42ae-893c-c8afd1862f62" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_21d1e3ad-b267-42ae-893c-c8afd1862f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_21d1e3ad-b267-42ae-893c-c8afd1862f62_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_21d1e3ad-b267-42ae-893c-c8afd1862f62" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_21d1e3ad-b267-42ae-893c-c8afd1862f62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_21d1e3ad-b267-42ae-893c-c8afd1862f62" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_acff1b9e-3d79-44fa-8258-f506a8e261b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_IssuedCapitalMember_acff1b9e-3d79-44fa-8258-f506a8e261b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_14dc6a42-0d8b-4f2c-9688-98e8bfbf7758" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_SharePremiumMember_14dc6a42-0d8b-4f2c-9688-98e8bfbf7758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_c9cb8e87-ca7d-4f32-89f2-699c6f5d6e28" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_c9cb8e87-ca7d-4f32-89f2-699c6f5d6e28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_38cf6695-280b-44fb-9a6d-0e1d7e870aef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_38cf6695-280b-44fb-9a6d-0e1d7e870aef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_be8cf8b6-7d25-41ac-a0ca-01d98ab24128" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_be8cf8b6-7d25-41ac-a0ca-01d98ab24128" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_223f6c1e-879a-41be-ae49-17ff4b391ee1" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:to="loc_abvx_FinancialAgreementAxis_223f6c1e-879a-41be-ae49-17ff4b391ee1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_223f6c1e-879a-41be-ae49-17ff4b391ee1_default" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_FinancialAgreementAxis_223f6c1e-879a-41be-ae49-17ff4b391ee1" xlink:to="loc_abvx_FinancialAgreementDomain_223f6c1e-879a-41be-ae49-17ff4b391ee1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_FinancialAgreementAxis_223f6c1e-879a-41be-ae49-17ff4b391ee1" xlink:to="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_483b31f0-a50d-406d-8200-e3d57a1b1afc" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:to="loc_abvx_Kreos1Member_483b31f0-a50d-406d-8200-e3d57a1b1afc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEquityAgreementsMember_1085efe2-bcd9-4d6e-bb62-7ef9cd699c52" xlink:href="abvx-20241231.xsd#abvx_OtherEquityAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:to="loc_abvx_OtherEquityAgreementsMember_1085efe2-bcd9-4d6e-bb62-7ef9cd699c52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_30c948b5-cdd0-47ee-bf47-486b0bd17412" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_NumberOfSharesIssued_30c948b5-cdd0-47ee-bf47-486b0bd17412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_16ae3d2b-c901-4524-a5be-18c0b13ff6ea" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_16ae3d2b-c901-4524-a5be-18c0b13ff6ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_018d0d2a-5b31-4128-a42a-ff1a9ffad5c2" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_018d0d2a-5b31-4128-a42a-ff1a9ffad5c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesIssued_31873c25-b702-4ff6-a972-0d032a8ec766" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:to="loc_abvx_NumberOfFreeSharesIssued_31873c25-b702-4ff6-a972-0d032a8ec766" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_5f7dd693-935c-455f-8fc9-6af543c3a3eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_f52ab608-4ebf-49f6-8638-47dd36a83fd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_Equity_f52ab608-4ebf-49f6-8638-47dd36a83fd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_264dbfce-449d-4e21-972f-5a1512eeb8d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_ProfitLoss_264dbfce-449d-4e21-972f-5a1512eeb8d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_e0d309cb-77a1-4e96-bbb9-a66cda2cedca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_e0d309cb-77a1-4e96-bbb9-a66cda2cedca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_efaf8c0c-b6f9-4813-b962-c17ed25976ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_ComprehensiveIncome_efaf8c0c-b6f9-4813-b962-c17ed25976ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_75690db5-0156-4f1c-af98-0223c9453f77" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_75690db5-0156-4f1c-af98-0223c9453f77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_f7dd6fd4-ce56-491c-bcba-e97c7a413604" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IssueOfEquity_f7dd6fd4-ce56-491c-bcba-e97c7a413604" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareIssueRelatedCostCredit_0ac2dfcc-7771-4c7e-8d22-c14926ec60b3" xlink:href="abvx-20241231.xsd#abvx_ShareIssueRelatedCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_abvx_ShareIssueRelatedCostCredit_0ac2dfcc-7771-4c7e-8d22-c14926ec60b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_1aa74e04-9916-4913-a305-1a6d2fe00890" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IssueOfConvertibleInstruments_1aa74e04-9916-4913-a305-1a6d2fe00890" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity_8cd1c948-6f80-4d49-a015-35ce4d5aef98" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity_8cd1c948-6f80-4d49-a015-35ce4d5aef98" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1f994b5b-8eb1-44d8-a3c9-242198bb17d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1f994b5b-8eb1-44d8-a3c9-242198bb17d2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseFromFreeSharesIssued_d0c2a014-53c8-44c0-b96f-447de4fe5353" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseFromFreeSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_abvx_IncreaseDecreaseFromFreeSharesIssued_d0c2a014-53c8-44c0-b96f-447de4fe5353" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0956ab9c-9b19-49d8-822c-d5440e12753b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0956ab9c-9b19-49d8-822c-d5440e12753b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_7443d012-8a4a-494d-b045-480ef299dac1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_7443d012-8a4a-494d-b045-480ef299dac1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_1859de04-411f-41a7-8972-bbe743972760" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/BasisofpreparationDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#BasisofpreparationDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/BasisofpreparationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8b4d5617-605e-4c4b-8bab-47db0b32324f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8b4d5617-605e-4c4b-8bab-47db0b32324f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_8b4d5617-605e-4c4b-8bab-47db0b32324f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8b4d5617-605e-4c4b-8bab-47db0b32324f" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_8b4d5617-605e-4c4b-8bab-47db0b32324f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_2bdc7161-8fb0-42db-8d2c-5939869f8a44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8b4d5617-605e-4c4b-8bab-47db0b32324f" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_2bdc7161-8fb0-42db-8d2c-5939869f8a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MajorRevenueTransactionsMember_24d2c585-b898-47e2-816b-3bcb375eed57" xlink:href="abvx-20241231.xsd#abvx_MajorRevenueTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_2bdc7161-8fb0-42db-8d2c-5939869f8a44" xlink:to="loc_abvx_MajorRevenueTransactionsMember_24d2c585-b898-47e2-816b-3bcb375eed57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e53467ba-5ca9-462a-872c-9195f3010602" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_srt_StatementScenarioAxis_e53467ba-5ca9-462a-872c-9195f3010602" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e53467ba-5ca9-462a-872c-9195f3010602_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_e53467ba-5ca9-462a-872c-9195f3010602" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e53467ba-5ca9-462a-872c-9195f3010602_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f59cc94d-49bc-41ee-ac3b-d7e317fef403" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_e53467ba-5ca9-462a-872c-9195f3010602" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f59cc94d-49bc-41ee-ac3b-d7e317fef403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_77273c11-3238-4060-8af3-54f869fb57b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f59cc94d-49bc-41ee-ac3b-d7e317fef403" xlink:to="loc_srt_ScenarioForecastMember_77273c11-3238-4060-8af3-54f869fb57b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockAxis_9fea2d9e-6e4f-4305-940b-75cd232f1e2d" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_abvx_SaleOfStockAxis_9fea2d9e-6e4f-4305-940b-75cd232f1e2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockDomain_9fea2d9e-6e4f-4305-940b-75cd232f1e2d_default" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_SaleOfStockAxis_9fea2d9e-6e4f-4305-940b-75cd232f1e2d" xlink:to="loc_abvx_SaleOfStockDomain_9fea2d9e-6e4f-4305-940b-75cd232f1e2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockDomain_fecd03e7-fea6-42d4-8f29-03b119397577" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_SaleOfStockAxis_9fea2d9e-6e4f-4305-940b-75cd232f1e2d" xlink:to="loc_abvx_SaleOfStockDomain_fecd03e7-fea6-42d4-8f29-03b119397577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RegisteredDirectOfferingMember_d0adccb6-3604-4763-8c09-a298ae21a181" xlink:href="abvx-20241231.xsd#abvx_RegisteredDirectOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_SaleOfStockDomain_fecd03e7-fea6-42d4-8f29-03b119397577" xlink:to="loc_abvx_RegisteredDirectOfferingMember_d0adccb6-3604-4763-8c09-a298ae21a181" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3d795c23-932b-4f81-9af9-24651efbea5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_srt_CounterpartyNameAxis_3d795c23-932b-4f81-9af9-24651efbea5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3d795c23-932b-4f81-9af9-24651efbea5a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_3d795c23-932b-4f81-9af9-24651efbea5a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3d795c23-932b-4f81-9af9-24651efbea5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b572a2d8-90dd-470e-9bf6-68664549dcb8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_3d795c23-932b-4f81-9af9-24651efbea5a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b572a2d8-90dd-470e-9bf6-68664549dcb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BanquePubliqueDInvestissementBPIMember_241f1747-8eb0-41bd-b3f7-829b840bc44e" xlink:href="abvx-20241231.xsd#abvx_BanquePubliqueDInvestissementBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b572a2d8-90dd-470e-9bf6-68664549dcb8" xlink:to="loc_abvx_BanquePubliqueDInvestissementBPIMember_241f1747-8eb0-41bd-b3f7-829b840bc44e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba229e2f-5a1a-4678-920d-7ff32ffb04f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba229e2f-5a1a-4678-920d-7ff32ffb04f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ba229e2f-5a1a-4678-920d-7ff32ffb04f1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba229e2f-5a1a-4678-920d-7ff32ffb04f1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ba229e2f-5a1a-4678-920d-7ff32ffb04f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba229e2f-5a1a-4678-920d-7ff32ffb04f1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_cc3a245a-1f26-4314-a9d3-06d9e8c4518e" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:to="loc_abvx_OceaneConversionOptionMember_cc3a245a-1f26-4314-a9d3-06d9e8c4518e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_4b94aa96-23c7-455a-8b45-2e0c0bf47624" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:to="loc_abvx_HeightsConvertibleNotesMember_4b94aa96-23c7-455a-8b45-2e0c0bf47624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_172d9f51-b85e-477e-985e-5d5bc2a4b1c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProfitLoss_172d9f51-b85e-477e-985e-5d5bc2a4b1c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_01f2bd78-f52c-4120-89f8-a3c1745d7f83" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_01f2bd78-f52c-4120-89f8-a3c1745d7f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_f074548b-825d-4bf2-98d4-c8788d5602ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_f074548b-825d-4bf2-98d4-c8788d5602ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromResearchTaxCredit_7aae23fe-c513-4ee0-ad64-a51104ca8d9c" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromResearchTaxCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_ProceedsFromResearchTaxCredit_7aae23fe-c513-4ee0-ad64-a51104ca8d9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_dc738476-0afa-4141-8cf9-5ea4fcc91c3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_dc738476-0afa-4141-8cf9-5ea4fcc91c3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromConditionalAdvances_1816ae74-ffa2-4b0c-b547-e9dd85bcf1f7" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromConditionalAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_ProceedsFromConditionalAdvances_1816ae74-ffa2-4b0c-b547-e9dd85bcf1f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_7a8e15a4-1ff5-417e-b217-96b266362173" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_7a8e15a4-1ff5-417e-b217-96b266362173" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_ce56d3dc-4b4f-4fe1-a233-adddbfa79d10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_CashAndCashEquivalents_ce56d3dc-4b4f-4fe1-a233-adddbfa79d10" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_c0958415-16e7-4eb3-a047-9ed2cf7e126d" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_ConvertibleLoansNotes_c0958415-16e7-4eb3-a047-9ed2cf7e126d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentConvertibleLoansNotes_3efa261c-ade5-4e59-9cc3-9eb39021fee3" xlink:href="abvx-20241231.xsd#abvx_NonCurrentConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_NonCurrentConvertibleLoansNotes_3efa261c-ade5-4e59-9cc3-9eb39021fee3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_29ecd7f9-8001-470f-af27-0148fae23f83" xlink:href="abvx-20241231.xsd#abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_29ecd7f9-8001-470f-af27-0148fae23f83" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_f3164963-b1ff-4137-a310-c565a686a8c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_f3164963-b1ff-4137-a310-c565a686a8c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_f3164963-b1ff-4137-a310-c565a686a8c4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_f3164963-b1ff-4137-a310-c565a686a8c4" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_f3164963-b1ff-4137-a310-c565a686a8c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_903a9596-76ec-4424-a2f8-ad056b4cf490" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_f3164963-b1ff-4137-a310-c565a686a8c4" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_903a9596-76ec-4424-a2f8-ad056b4cf490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_5b7fbb95-8e74-45e6-b8f3-ab3741f204cd" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_903a9596-76ec-4424-a2f8-ad056b4cf490" xlink:to="loc_abvx_ProsynergiaMember_5b7fbb95-8e74-45e6-b8f3-ab3741f204cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_7deb2d2a-028b-4d0d-93dc-882b30254e63" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_abvx_AssetsAcquisitionsAxis_7deb2d2a-028b-4d0d-93dc-882b30254e63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_7deb2d2a-028b-4d0d-93dc-882b30254e63_default" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_AssetsAcquisitionsAxis_7deb2d2a-028b-4d0d-93dc-882b30254e63" xlink:to="loc_abvx_AssetsAcquisitionsDomain_7deb2d2a-028b-4d0d-93dc-882b30254e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_f05198a6-fb1b-47dc-b6ec-b435eb422f94" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_AssetsAcquisitionsAxis_7deb2d2a-028b-4d0d-93dc-882b30254e63" xlink:to="loc_abvx_AssetsAcquisitionsDomain_f05198a6-fb1b-47dc-b6ec-b435eb422f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_f519a28d-cf55-4997-9d1d-b13a57511e78" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_AssetsAcquisitionsDomain_f05198a6-fb1b-47dc-b6ec-b435eb422f94" xlink:to="loc_abvx_ProsynergiaMember_f519a28d-cf55-4997-9d1d-b13a57511e78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ea77cb06-4937-4a6f-a6a3-881d822f0915" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_srt_CounterpartyNameAxis_ea77cb06-4937-4a6f-a6a3-881d822f0915" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ea77cb06-4937-4a6f-a6a3-881d822f0915_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ea77cb06-4937-4a6f-a6a3-881d822f0915" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ea77cb06-4937-4a6f-a6a3-881d822f0915_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a741ed5c-568e-47bb-ac14-c7e4f884e1e2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ea77cb06-4937-4a6f-a6a3-881d822f0915" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a741ed5c-568e-47bb-ac14-c7e4f884e1e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_badb32b7-78b2-4bfe-84f0-2893ab0d263d" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a741ed5c-568e-47bb-ac14-c7e4f884e1e2" xlink:to="loc_abvx_ProsynergiaMember_badb32b7-78b2-4bfe-84f0-2893ab0d263d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_fe745fc7-2568-41c9-8a59-d798769be5b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_fe745fc7-2568-41c9-8a59-d798769be5b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_fe745fc7-2568-41c9-8a59-d798769be5b1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_fe745fc7-2568-41c9-8a59-d798769be5b1" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_fe745fc7-2568-41c9-8a59-d798769be5b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_cd7d92b7-f529-4ba1-bafa-2921ff653cdb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_fe745fc7-2568-41c9-8a59-d798769be5b1" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_cd7d92b7-f529-4ba1-bafa-2921ff653cdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WittycelSASABX196Member_8c5ad02a-fd59-4bcc-88e4-256fd4a907ad" xlink:href="abvx-20241231.xsd#abvx_WittycelSASABX196Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_cd7d92b7-f529-4ba1-bafa-2921ff653cdb" xlink:to="loc_abvx_WittycelSASABX196Member_8c5ad02a-fd59-4bcc-88e4-256fd4a907ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_dc699d8f-be77-4809-b90b-f3cf42c8f3bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_dc699d8f-be77-4809-b90b-f3cf42c8f3bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_dc699d8f-be77-4809-b90b-f3cf42c8f3bc_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_dc699d8f-be77-4809-b90b-f3cf42c8f3bc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_dc699d8f-be77-4809-b90b-f3cf42c8f3bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cf45e501-b794-4173-853c-f9bf7335fdce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_dc699d8f-be77-4809-b90b-f3cf42c8f3bc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cf45e501-b794-4173-853c-f9bf7335fdce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2021Member_e74c6f88-d30c-4537-aaac-2212e6c1a129" xlink:href="abvx-20241231.xsd#abvx_AGA2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cf45e501-b794-4173-853c-f9bf7335fdce" xlink:to="loc_abvx_AGA2021Member_e74c6f88-d30c-4537-aaac-2212e6c1a129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsAxis_3dd7cefc-2cad-4310-9cb6-e724d09def4e" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_abvx_PrincipalAgreementsAxis_3dd7cefc-2cad-4310-9cb6-e724d09def4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_3dd7cefc-2cad-4310-9cb6-e724d09def4e_default" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_PrincipalAgreementsAxis_3dd7cefc-2cad-4310-9cb6-e724d09def4e" xlink:to="loc_abvx_PrincipalAgreementsDomain_3dd7cefc-2cad-4310-9cb6-e724d09def4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_ac29abdc-8d7a-4436-82d1-ae133d6cacd4" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_PrincipalAgreementsAxis_3dd7cefc-2cad-4310-9cb6-e724d09def4e" xlink:to="loc_abvx_PrincipalAgreementsDomain_ac29abdc-8d7a-4436-82d1-ae133d6cacd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember_d9152139-7c93-4348-b787-99d36d87eee7" xlink:href="abvx-20241231.xsd#abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_ac29abdc-8d7a-4436-82d1-ae133d6cacd4" xlink:to="loc_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember_d9152139-7c93-4348-b787-99d36d87eee7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_f265fd44-b3e5-4bde-a07d-30c400294548" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_abvx_FinancialAgreementAxis_f265fd44-b3e5-4bde-a07d-30c400294548" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_f265fd44-b3e5-4bde-a07d-30c400294548_default" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_FinancialAgreementAxis_f265fd44-b3e5-4bde-a07d-30c400294548" xlink:to="loc_abvx_FinancialAgreementDomain_f265fd44-b3e5-4bde-a07d-30c400294548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_6c7c16b6-b6d9-46ce-b849-80b25ec5dc5a" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_FinancialAgreementAxis_f265fd44-b3e5-4bde-a07d-30c400294548" xlink:to="loc_abvx_FinancialAgreementDomain_6c7c16b6-b6d9-46ce-b849-80b25ec5dc5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_3e13a656-4ca4-43de-afa9-10fb92b6de4b" xlink:href="abvx-20241231.xsd#abvx_A49.2MillionCrossOverFinancingSeptember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_6c7c16b6-b6d9-46ce-b849-80b25ec5dc5a" xlink:to="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_3e13a656-4ca4-43de-afa9-10fb92b6de4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_cbd6a74f-dbff-4d73-a52e-3052effc02b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_cbd6a74f-dbff-4d73-a52e-3052effc02b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_cbd6a74f-dbff-4d73-a52e-3052effc02b3_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_cbd6a74f-dbff-4d73-a52e-3052effc02b3" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_cbd6a74f-dbff-4d73-a52e-3052effc02b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_4a82b8c4-fbf4-4a3d-9a5e-1d833ad3dfc5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_cbd6a74f-dbff-4d73-a52e-3052effc02b3" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_4a82b8c4-fbf4-4a3d-9a5e-1d833ad3dfc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_39a99518-ad2d-4ef9-aef1-7df5b20b439c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_4a82b8c4-fbf4-4a3d-9a5e-1d833ad3dfc5" xlink:to="loc_ifrs-full_SharePremiumMember_39a99518-ad2d-4ef9-aef1-7df5b20b439c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_604282bc-b2f8-444d-a0a7-dc0d4506229d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_604282bc-b2f8-444d-a0a7-dc0d4506229d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPrepaymentAssetsAcquisitions_df80eb2d-cebf-48f4-88eb-b35b837a8b20" xlink:href="abvx-20241231.xsd#abvx_CashPrepaymentAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_CashPrepaymentAssetsAcquisitions_df80eb2d-cebf-48f4-88eb-b35b837a8b20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashTransferredAssetsAcquisitions_84b0d4e6-c39e-4dca-99f8-e4e4c62060d6" xlink:href="abvx-20241231.xsd#abvx_CashTransferredAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_CashTransferredAssetsAcquisitions_84b0d4e6-c39e-4dca-99f8-e4e4c62060d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMaximumAmount_89c66a45-9e0c-4bc7-9740-bdf6781a9010" xlink:href="abvx-20241231.xsd#abvx_EarnOutMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_EarnOutMaximumAmount_89c66a45-9e0c-4bc7-9740-bdf6781a9010" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_61aa5211-f25d-4807-b4db-dda91336a089" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_61aa5211-f25d-4807-b4db-dda91336a089" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LoanGrantedAssetsAcquisitions_e7022158-9162-430a-bc56-a09c90a2ea0d" xlink:href="abvx-20241231.xsd#abvx_LoanGrantedAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_LoanGrantedAssetsAcquisitions_e7022158-9162-430a-bc56-a09c90a2ea0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_337f4372-9943-46c8-8114-078a12c1d5ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_337f4372-9943-46c8-8114-078a12c1d5ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_7edfb3f2-afdd-474f-8dae-fbbf22c99295" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_7edfb3f2-afdd-474f-8dae-fbbf22c99295" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_af01f1a1-d746-4092-8513-b0ec8fff1210" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_af01f1a1-d746-4092-8513-b0ec8fff1210" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_3f4f376e-f00b-48a8-857e-6f369d804250" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_3f4f376e-f00b-48a8-857e-6f369d804250" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_1c2f15d7-1d00-4ef5-b5d8-b8b197165f56" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_1c2f15d7-1d00-4ef5-b5d8-b8b197165f56" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_b9cd8ccd-e926-4d36-90d3-2932ed8e60a0" xlink:href="abvx-20241231.xsd#abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_b9cd8ccd-e926-4d36-90d3-2932ed8e60a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_bf3a652f-c7a4-443d-9304-590574f6691b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_bf3a652f-c7a4-443d-9304-590574f6691b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAmount_929de482-0f31-46d9-b362-a297a9c11812" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_FinancialAgreementAmount_929de482-0f31-46d9-b362-a297a9c11812" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementNumberOfTransactions_f3b2cfe2-fb90-44e7-9aeb-14df0ebc579f" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementNumberOfTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_FinancialAgreementNumberOfTransactions_f3b2cfe2-fb90-44e7-9aeb-14df0ebc579f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_ce26a7a4-0140-4070-b28f-64be8f40d05a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_ce26a7a4-0140-4070-b28f-64be8f40d05a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_52f90fcc-a749-48ed-bd8f-678c537ae29a" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_52f90fcc-a749-48ed-bd8f-678c537ae29a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_fbcf3a76-4e8e-4fca-a53d-726613ed1283" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ParValuePerShare_fbcf3a76-4e8e-4fca-a53d-726613ed1283" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_672d16dc-2346-4bb6-a497-4d05f1f9316c" xlink:href="abvx-20241231.xsd#abvx_EquityIssuancePercentageOfCurrentShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_672d16dc-2346-4bb6-a497-4d05f1f9316c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_51bfda0f-ab97-42da-a343-1d40a3750411" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_51bfda0f-ab97-42da-a343-1d40a3750411" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_84744973-8996-47af-9c70-e8999ba4e52c" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_84744973-8996-47af-9c70-e8999ba4e52c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_84d192f1-f39c-42f3-9614-194774fd09c0" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatePercentageOfFutureSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_84d192f1-f39c-42f3-9614-194774fd09c0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateMaximumAmount_b8ff614a-a5b5-4ebf-9d6d-d606a40c8bb4" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_RoyaltyCertificateMaximumAmount_b8ff614a-a5b5-4ebf-9d6d-d606a40c8bb4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_d21bfc83-8573-40a6-ab09-154bca372d8f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_d21bfc83-8573-40a6-ab09-154bca372d8f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_9b6b7c07-62f0-4bba-97e4-792b1e93c2af" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAdvancesMadeToContractResearchOrganizations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_9b6b7c07-62f0-4bba-97e4-792b1e93c2af" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContracts_0853b363-ec3b-4efc-a582-a06b79e4074b" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_NonCurrentAdvancesToCROContracts_0853b363-ec3b-4efc-a582-a06b79e4074b" xlink:type="arc" order="25"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_44fe0743-12a6-401d-9381-c6e007b191d6" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_abvx_FinancialAgreementAxis_44fe0743-12a6-401d-9381-c6e007b191d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_44fe0743-12a6-401d-9381-c6e007b191d6_default" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_FinancialAgreementAxis_44fe0743-12a6-401d-9381-c6e007b191d6" xlink:to="loc_abvx_FinancialAgreementDomain_44fe0743-12a6-401d-9381-c6e007b191d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_FinancialAgreementAxis_44fe0743-12a6-401d-9381-c6e007b191d6" xlink:to="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A130.0MillionCrossOverFinancingFebruary2023Member_2d315dc0-2c02-47f6-a21c-1c5c7d3f615a" xlink:href="abvx-20241231.xsd#abvx_A130.0MillionCrossOverFinancingFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:to="loc_abvx_A130.0MillionCrossOverFinancingFebruary2023Member_2d315dc0-2c02-47f6-a21c-1c5c7d3f615a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_26916f94-89d4-4e9c-a18c-4f14ca9fcf01" xlink:href="abvx-20241231.xsd#abvx_A49.2MillionCrossOverFinancingSeptember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:to="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_26916f94-89d4-4e9c-a18c-4f14ca9fcf01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A150.0MillionFinancingAugust2023Member_9554a702-f655-4984-b2dc-81abff24f985" xlink:href="abvx-20241231.xsd#abvx_A150.0MillionFinancingAugust2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:to="loc_abvx_A150.0MillionFinancingAugust2023Member_9554a702-f655-4984-b2dc-81abff24f985" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_b424a23a-26a2-4c95-abce-ab970aafa5cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_b424a23a-26a2-4c95-abce-ab970aafa5cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_b424a23a-26a2-4c95-abce-ab970aafa5cf_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_b424a23a-26a2-4c95-abce-ab970aafa5cf" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_b424a23a-26a2-4c95-abce-ab970aafa5cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_42c42c01-1235-4d08-b0a5-8437f63900eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_b424a23a-26a2-4c95-abce-ab970aafa5cf" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_42c42c01-1235-4d08-b0a5-8437f63900eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_e0187239-d651-4a3b-ac35-a263180e70ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_42c42c01-1235-4d08-b0a5-8437f63900eb" xlink:to="loc_ifrs-full_SharePremiumMember_e0187239-d651-4a3b-ac35-a263180e70ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_7245f284-a2f1-4b2d-85ce-13b4e9d1d508" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_7245f284-a2f1-4b2d-85ce-13b4e9d1d508" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_7245f284-a2f1-4b2d-85ce-13b4e9d1d508_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7245f284-a2f1-4b2d-85ce-13b4e9d1d508" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_7245f284-a2f1-4b2d-85ce-13b4e9d1d508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7245f284-a2f1-4b2d-85ce-13b4e9d1d508" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_8adeb347-54bd-49c4-9a93-15c5e7375524" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_8adeb347-54bd-49c4-9a93-15c5e7375524" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_b5107de7-5b05-41e9-9fd5-67e97d0cb10c" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_b5107de7-5b05-41e9-9fd5-67e97d0cb10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingMember_bd0cc978-04a0-4462-b9ab-336b7a2bdd9e" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_KreosClaretFinancingMember_bd0cc978-04a0-4462-b9ab-336b7a2bdd9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_98012d54-fbc7-425c-91cd-164070bc9a98" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_HeightsConvertibleNotesMember_98012d54-fbc7-425c-91cd-164070bc9a98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_430a63a8-ace0-43ea-9528-1f65aeb5efe8" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_430a63a8-ace0-43ea-9528-1f65aeb5efe8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_95049464-c9f1-44b8-b7c8-e429705bd20b" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_OCEANEMember_95049464-c9f1-44b8-b7c8-e429705bd20b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember_12d69cae-e29e-4bd2-b576-693b4811a312" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember_12d69cae-e29e-4bd2-b576-693b4811a312" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_4ffa0811-1192-4c4a-8a05-d99018496763" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_4ffa0811-1192-4c4a-8a05-d99018496763" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_4ffa0811-1192-4c4a-8a05-d99018496763_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4ffa0811-1192-4c4a-8a05-d99018496763" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_4ffa0811-1192-4c4a-8a05-d99018496763_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4ffa0811-1192-4c4a-8a05-d99018496763" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesMember_61d8a4a2-5be9-4d31-8010-0bb54b8ffedd" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:to="loc_abvx_AmericanDepositorySharesMember_61d8a4a2-5be9-4d31-8010-0bb54b8ffedd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_c7b61265-ba30-43cd-be66-79b222cfbd38" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:to="loc_ifrs-full_OrdinarySharesMember_c7b61265-ba30-43cd-be66-79b222cfbd38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3880470a-7651-438e-800f-bcbd3935b47a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_srt_RangeAxis_3880470a-7651-438e-800f-bcbd3935b47a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3880470a-7651-438e-800f-bcbd3935b47a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3880470a-7651-438e-800f-bcbd3935b47a" xlink:to="loc_srt_RangeMember_3880470a-7651-438e-800f-bcbd3935b47a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cfc56486-3869-4248-b6da-20ca809e813a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3880470a-7651-438e-800f-bcbd3935b47a" xlink:to="loc_srt_RangeMember_cfc56486-3869-4248-b6da-20ca809e813a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c2c3b968-29e2-42e3-a510-120e13ef4c40" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cfc56486-3869-4248-b6da-20ca809e813a" xlink:to="loc_srt_MaximumMember_c2c3b968-29e2-42e3-a510-120e13ef4c40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_abvx_WarrantsAxis_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d_default" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_WarrantsAxis_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d" xlink:to="loc_abvx_WarrantsDomain_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_41e38f50-d83b-4536-9ffc-130ae4feca70" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_WarrantsAxis_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d" xlink:to="loc_abvx_WarrantsDomain_41e38f50-d83b-4536-9ffc-130ae4feca70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_3d7b38db-0116-4e3d-aae6-9f6f060db5e1" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_41e38f50-d83b-4536-9ffc-130ae4feca70" xlink:to="loc_abvx_KreosCBSAMember_3d7b38db-0116-4e3d-aae6-9f6f060db5e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6d89f0ad-b6ab-4797-a380-d3dcfa814d48" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6d89f0ad-b6ab-4797-a380-d3dcfa814d48" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_6d89f0ad-b6ab-4797-a380-d3dcfa814d48_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6d89f0ad-b6ab-4797-a380-d3dcfa814d48" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_6d89f0ad-b6ab-4797-a380-d3dcfa814d48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8149f238-3c54-4abf-a520-b4a3ec6c2a3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6d89f0ad-b6ab-4797-a380-d3dcfa814d48" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8149f238-3c54-4abf-a520-b4a3ec6c2a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FreeSharesAGAMember_9b976e2a-3be2-46c3-bf86-74efeed1e9fe" xlink:href="abvx-20241231.xsd#abvx_FreeSharesAGAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8149f238-3c54-4abf-a520-b4a3ec6c2a3d" xlink:to="loc_abvx_FreeSharesAGAMember_9b976e2a-3be2-46c3-bf86-74efeed1e9fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAmount_45da8167-ad77-4684-8d7f-0ddb1211134c" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_FinancialAgreementAmount_45da8167-ad77-4684-8d7f-0ddb1211134c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_5116d8ba-2c14-4917-bbc4-80d1232ad8c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_IssueOfEquity_5116d8ba-2c14-4917-bbc4-80d1232ad8c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_b98d57c7-93d7-4337-b07a-70aac1ab0986" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_b98d57c7-93d7-4337-b07a-70aac1ab0986" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_000a39a4-c5c5-4a75-b46f-cac56cc8b3de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ParValuePerShare_000a39a4-c5c5-4a75-b46f-cac56cc8b3de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_82bd65db-52c8-49e2-b2c1-de34248d3c87" xlink:href="abvx-20241231.xsd#abvx_EquityIssuancePercentageOfCurrentShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_82bd65db-52c8-49e2-b2c1-de34248d3c87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_4196c7b6-7403-4520-9a34-2552e65cfc65" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_4196c7b6-7403-4520-9a34-2552e65cfc65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_39662713-9231-4410-b879-00de37d59b7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_39662713-9231-4410-b879-00de37d59b7b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsRepurchased_d929d1c1-791d-4016-9a1c-d43ee65608ab" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_NumberOfOtherShareWarrantsRepurchased_d929d1c1-791d-4016-9a1c-d43ee65608ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_514179ca-de09-4414-a7ee-ad984d645994" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_514179ca-de09-4414-a7ee-ad984d645994" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfShareBasedCompensationPlansIssued_afa6f300-ac8f-4e60-b153-6dd08e8d4b56" xlink:href="abvx-20241231.xsd#abvx_NumberOfShareBasedCompensationPlansIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_NumberOfShareBasedCompensationPlansIssued_afa6f300-ac8f-4e60-b153-6dd08e8d4b56" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_faaa0487-8e26-4715-a05c-aefe32a66d78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_faaa0487-8e26-4715-a05c-aefe32a66d78" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementNumberOfTransactions_2e9bbba9-78f5-4219-8d11-8acff23ce50d" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementNumberOfTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_FinancialAgreementNumberOfTransactions_2e9bbba9-78f5-4219-8d11-8acff23ce50d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_ebbfc759-faa7-463d-a477-8b95cdc7bed1" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_ebbfc759-faa7-463d-a477-8b95cdc7bed1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted_bcf20297-d9ef-40ae-8599-5c4610076f10" xlink:href="abvx-20241231.xsd#abvx_AggregateExercisePriceOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted_bcf20297-d9ef-40ae-8599-5c4610076f10" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_7c374f88-c170-42b0-88bf-33faeaa8c29b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_7c374f88-c170-42b0-88bf-33faeaa8c29b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_4808fe83-2096-4ec1-b05a-8f91bb8b7855" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_4808fe83-2096-4ec1-b05a-8f91bb8b7855" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness_d08e1d43-c2f0-43d9-b8c8-d4922a7c8869" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness_d08e1d43-c2f0-43d9-b8c8-d4922a7c8869" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfOtherShareWarrants_15026fc2-9fca-452b-b917-87fd9fec9490" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfOtherShareWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IssuanceOfOtherShareWarrants_15026fc2-9fca-452b-b917-87fd9fec9490" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesReceivedPerADS_3dfe8abf-4a02-4c4a-b9fc-3baf544a6f5e" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesReceivedPerADS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_NumberOfSharesReceivedPerADS_3dfe8abf-4a02-4c4a-b9fc-3baf544a6f5e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssueOfEquityOfferingPricePerShare_b451ec92-9884-4e82-b336-44ade9e8037a" xlink:href="abvx-20241231.xsd#abvx_IssueOfEquityOfferingPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IssueOfEquityOfferingPricePerShare_b451ec92-9884-4e82-b336-44ade9e8037a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_987af75c-fe61-4062-b449-f8e8dafb6fb0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_987af75c-fe61-4062-b449-f8e8dafb6fb0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants_556cf902-9654-4bdc-9d35-6089c2bfefef" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants_556cf902-9654-4bdc-9d35-6089c2bfefef" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_80965511-6a1c-4574-8a78-e69ec5212971" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_80965511-6a1c-4574-8a78-e69ec5212971" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6a67f488-5dee-4528-b6b6-7ac4008b4f9b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6a67f488-5dee-4528-b6b6-7ac4008b4f9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_6a67f488-5dee-4528-b6b6-7ac4008b4f9b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6a67f488-5dee-4528-b6b6-7ac4008b4f9b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_6a67f488-5dee-4528-b6b6-7ac4008b4f9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6a67f488-5dee-4528-b6b6-7ac4008b4f9b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2024Member_88e5170c-5a37-4694-9646-a90c0c0408c3" xlink:href="abvx-20241231.xsd#abvx_AGA2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:to="loc_abvx_AGA2024Member_88e5170c-5a37-4694-9646-a90c0c0408c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_1b9835b8-9369-4727-adff-8c6fb210b9ce" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:to="loc_abvx_AGA20246Member_1b9835b8-9369-4727-adff-8c6fb210b9ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241Member_7fd33090-acda-415b-8f3b-ad25d8415166" xlink:href="abvx-20241231.xsd#abvx_BSA20241Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:to="loc_abvx_BSA20241Member_7fd33090-acda-415b-8f3b-ad25d8415166" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_f532d6d2-7f89-49b0-880c-d011fe753fdc" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_abvx_TranchesAxis_f532d6d2-7f89-49b0-880c-d011fe753fdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_f532d6d2-7f89-49b0-880c-d011fe753fdc_default" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_TranchesAxis_f532d6d2-7f89-49b0-880c-d011fe753fdc" xlink:to="loc_abvx_TranchesDomain_f532d6d2-7f89-49b0-880c-d011fe753fdc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_TranchesAxis_f532d6d2-7f89-49b0-880c-d011fe753fdc" xlink:to="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_8352e95f-422f-4bb0-ac09-43380e034e18" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:to="loc_abvx_TrancheOneMember_8352e95f-422f-4bb0-ac09-43380e034e18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_7b54f84a-c2b1-4ea4-81d9-9f15064889b3" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:to="loc_abvx_TrancheTwoMember_7b54f84a-c2b1-4ea4-81d9-9f15064889b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheThreeMember_2991030f-99c5-4d60-b9a0-d0a04881d703" xlink:href="abvx-20241231.xsd#abvx_TrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:to="loc_abvx_TrancheThreeMember_2991030f-99c5-4d60-b9a0-d0a04881d703" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_68ed6f4f-51c2-4b7d-a0b7-e5254327c137" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_68ed6f4f-51c2-4b7d-a0b7-e5254327c137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheCMember_feac5f63-5e9c-4f70-b586-939ab84a9b4a" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:to="loc_abvx_KreosClaretFinancingTrancheCMember_feac5f63-5e9c-4f70-b586-939ab84a9b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBAndCMember_fda3a43f-1974-461e-a984-49502bc700c5" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBAndCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:to="loc_abvx_KreosClaretFinancingTrancheBAndCMember_fda3a43f-1974-461e-a984-49502bc700c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cae117da-862c-459f-a1ef-c945fa2bb02d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cae117da-862c-459f-a1ef-c945fa2bb02d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_cae117da-862c-459f-a1ef-c945fa2bb02d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cae117da-862c-459f-a1ef-c945fa2bb02d" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_cae117da-862c-459f-a1ef-c945fa2bb02d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cae117da-862c-459f-a1ef-c945fa2bb02d" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_1a2b71c2-e41d-4fc2-a83f-109c7bbcc0fb" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_1a2b71c2-e41d-4fc2-a83f-109c7bbcc0fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_17a5b8e7-86ca-48b2-9399-cb10bc71eb5c" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_17a5b8e7-86ca-48b2-9399-cb10bc71eb5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember_13ff9984-c2b5-4d44-b2ed-03dbd1a5bf22" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember_13ff9984-c2b5-4d44-b2ed-03dbd1a5bf22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockAxis_d441b158-b3c6-43df-8aaf-93ef39425cc3" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_abvx_SaleOfStockAxis_d441b158-b3c6-43df-8aaf-93ef39425cc3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockDomain_d441b158-b3c6-43df-8aaf-93ef39425cc3_default" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_SaleOfStockAxis_d441b158-b3c6-43df-8aaf-93ef39425cc3" xlink:to="loc_abvx_SaleOfStockDomain_d441b158-b3c6-43df-8aaf-93ef39425cc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockDomain_55f28a34-5d08-4264-bbea-b44bb1a1a71d" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_SaleOfStockAxis_d441b158-b3c6-43df-8aaf-93ef39425cc3" xlink:to="loc_abvx_SaleOfStockDomain_55f28a34-5d08-4264-bbea-b44bb1a1a71d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AtTheMarketATMProgramMember_2f738ecc-2597-42a1-9f4f-4357d61eff24" xlink:href="abvx-20241231.xsd#abvx_AtTheMarketATMProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_SaleOfStockDomain_55f28a34-5d08-4264-bbea-b44bb1a1a71d" xlink:to="loc_abvx_AtTheMarketATMProgramMember_2f738ecc-2597-42a1-9f4f-4357d61eff24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesPlansIssued_394ecf2f-a72e-4dad-8ff0-4f10c83d33a8" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesPlansIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_NumberOfFreeSharesPlansIssued_394ecf2f-a72e-4dad-8ff0-4f10c83d33a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0194ca76-d7d0-4215-a3f8-05b9aaab8cc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0194ca76-d7d0-4215-a3f8-05b9aaab8cc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_460da567-93e7-41bb-a3f7-010f4b861de9" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_460da567-93e7-41bb-a3f7-010f4b861de9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_9e74ff8f-2226-4933-8923-59264ae34d77" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_9e74ff8f-2226-4933-8923-59264ae34d77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_e0d5606d-0b35-455d-b86a-55c9776d0ee0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_e0d5606d-0b35-455d-b86a-55c9776d0ee0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_dc5504ad-e8c7-42ab-8ec6-9f2d3156cc69" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_dc5504ad-e8c7-42ab-8ec6-9f2d3156cc69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_04de1ab2-70e3-4a73-b1eb-2c3430ab4595" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_ParValuePerShare_04de1ab2-70e3-4a73-b1eb-2c3430ab4595" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromConditionalAdvances_856ddd02-f075-4c3a-b801-dbcc9807e77b" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromConditionalAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_ProceedsFromConditionalAdvances_856ddd02-f075-4c3a-b801-dbcc9807e77b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_b3448770-8736-4397-b9ae-87c36d061bd8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_b3448770-8736-4397-b9ae-87c36d061bd8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PercentageOfConditionalAdvancesWaived_eab7e7ef-351a-4d3a-919f-93225feca3e7" xlink:href="abvx-20241231.xsd#abvx_PercentageOfConditionalAdvancesWaived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_PercentageOfConditionalAdvancesWaived_eab7e7ef-351a-4d3a-919f-93225feca3e7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_75332520-6ad9-4168-91a8-f53556043b10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_75332520-6ad9-4168-91a8-f53556043b10" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfADSPerOrdinaryShares_21085d6b-59ba-431b-92f7-60c8761a3e69" xlink:href="abvx-20241231.xsd#abvx_NumberOfADSPerOrdinaryShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_NumberOfADSPerOrdinaryShares_21085d6b-59ba-431b-92f7-60c8761a3e69" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedProceedsFromShareIssuance_21640746-61bb-4faf-b3df-6e209a64f33f" xlink:href="abvx-20241231.xsd#abvx_ExpectedProceedsFromShareIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_ExpectedProceedsFromShareIssuance_21640746-61bb-4faf-b3df-6e209a64f33f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration_30e78b24-50d6-4fda-b83d-f832b1e9d072" xlink:href="abvx-20241231.xsd#abvx_ExpectedProceedsFromShareIssuanceShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration_30e78b24-50d6-4fda-b83d-f832b1e9d072" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_bd53328a-0254-4a30-96b4-964b60ff7544" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_bd53328a-0254-4a30-96b4-964b60ff7544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_bd53328a-0254-4a30-96b4-964b60ff7544_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_bd53328a-0254-4a30-96b4-964b60ff7544" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_bd53328a-0254-4a30-96b4-964b60ff7544_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_a2f2dfcd-de47-4b0a-99f4-2675cc420349" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_bd53328a-0254-4a30-96b4-964b60ff7544" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_a2f2dfcd-de47-4b0a-99f4-2675cc420349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MajorShareBasedTransactionsMember_c107978a-d1e8-4a7f-9791-ba7541ad8bf4" xlink:href="abvx-20241231.xsd#abvx_MajorShareBasedTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_a2f2dfcd-de47-4b0a-99f4-2675cc420349" xlink:to="loc_abvx_MajorShareBasedTransactionsMember_c107978a-d1e8-4a7f-9791-ba7541ad8bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bc6094d-df06-452d-8d71-aadca836e862" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bc6094d-df06-452d-8d71-aadca836e862" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4bc6094d-df06-452d-8d71-aadca836e862_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bc6094d-df06-452d-8d71-aadca836e862" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4bc6094d-df06-452d-8d71-aadca836e862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bc6094d-df06-452d-8d71-aadca836e862" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20251Member_1fd8d568-e099-44b9-af7b-e190f7d677f6" xlink:href="abvx-20241231.xsd#abvx_BSA20251Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:to="loc_abvx_BSA20251Member_1fd8d568-e099-44b9-af7b-e190f7d677f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2025Member_c8a364df-1452-4ee9-a909-9050106e9606" xlink:href="abvx-20241231.xsd#abvx_AGA2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:to="loc_abvx_AGA2025Member_c8a364df-1452-4ee9-a909-9050106e9606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20252Member_7a699df9-6adc-4a43-9198-58ae8836b6dd" xlink:href="abvx-20241231.xsd#abvx_AGA20252Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:to="loc_abvx_AGA20252Member_7a699df9-6adc-4a43-9198-58ae8836b6dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_56b7655a-537a-474e-a986-ac95e9095b81" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:to="loc_abvx_TranchesAxis_56b7655a-537a-474e-a986-ac95e9095b81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_56b7655a-537a-474e-a986-ac95e9095b81_default" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_TranchesAxis_56b7655a-537a-474e-a986-ac95e9095b81" xlink:to="loc_abvx_TranchesDomain_56b7655a-537a-474e-a986-ac95e9095b81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_TranchesAxis_56b7655a-537a-474e-a986-ac95e9095b81" xlink:to="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_ff7b8ce6-c25f-4b33-8160-f2acaf718d7c" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheOneMember_ff7b8ce6-c25f-4b33-8160-f2acaf718d7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_79475422-4daa-475a-862c-1b3c8a30d932" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheTwoMember_79475422-4daa-475a-862c-1b3c8a30d932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheThreeMember_c56d612f-50fb-433a-9197-671ad030a363" xlink:href="abvx-20241231.xsd#abvx_TrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheThreeMember_c56d612f-50fb-433a-9197-671ad030a363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFourMember_1a2de0e2-b55e-4b7d-aac3-fbaac01ac272" xlink:href="abvx-20241231.xsd#abvx_TrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheFourMember_1a2de0e2-b55e-4b7d-aac3-fbaac01ac272" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_460effb8-6006-473c-ad9f-d780e1095274" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_460effb8-6006-473c-ad9f-d780e1095274" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_774c74c7-d57d-4222-9354-1d9d60274968" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_774c74c7-d57d-4222-9354-1d9d60274968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_e0983115-9e6e-415a-b876-9ac2cb04d2c6" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_e0983115-9e6e-415a-b876-9ac2cb04d2c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesPlansIssued_65471f2d-3776-4d91-9da2-1e6bf6a89315" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesPlansIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_abvx_NumberOfFreeSharesPlansIssued_65471f2d-3776-4d91-9da2-1e6bf6a89315" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesIntangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_64be3e07-9feb-4bea-ba95-f5438bb22325" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_64be3e07-9feb-4bea-ba95-f5438bb22325" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ecac7bd4-01e2-4d6e-90ed-cf768f124236" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_64be3e07-9feb-4bea-ba95-f5438bb22325" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ecac7bd4-01e2-4d6e-90ed-cf768f124236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_ecac7bd4-01e2-4d6e-90ed-cf768f124236_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ecac7bd4-01e2-4d6e-90ed-cf768f124236" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_ecac7bd4-01e2-4d6e-90ed-cf768f124236_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8feed53f-1728-49b7-9c8d-0f7f7819b49b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ecac7bd4-01e2-4d6e-90ed-cf768f124236" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8feed53f-1728-49b7-9c8d-0f7f7819b49b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_327c51ca-d7eb-44e3-8bfa-215c613b3c56" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8feed53f-1728-49b7-9c8d-0f7f7819b49b" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_327c51ca-d7eb-44e3-8bfa-215c613b3c56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias_5380e1fb-d813-4d4e-ad1b-140388f88c88" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:to="loc_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias_5380e1fb-d813-4d4e-ad1b-140388f88c88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_4230a2c6-196e-4561-bf3b-94a3dd2c2943" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_4230a2c6-196e-4561-bf3b-94a3dd2c2943" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_5ac7b5de-1073-4bd7-8886-5ce20bcb4780" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_5ac7b5de-1073-4bd7-8886-5ce20bcb4780" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9953c9b8-d3d0-4485-97ee-3a84e62947a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9953c9b8-d3d0-4485-97ee-3a84e62947a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_9953c9b8-d3d0-4485-97ee-3a84e62947a1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9953c9b8-d3d0-4485-97ee-3a84e62947a1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_9953c9b8-d3d0-4485-97ee-3a84e62947a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9953c9b8-d3d0-4485-97ee-3a84e62947a1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_450e0111-4bc9-4678-bd7b-c4cddfec24fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_450e0111-4bc9-4678-bd7b-c4cddfec24fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IndustrialMaterialsAndEquipmentMember_0647b7f6-c486-4f93-8705-4a38cc8a505c" xlink:href="abvx-20241231.xsd#abvx_IndustrialMaterialsAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_abvx_IndustrialMaterialsAndEquipmentMember_0647b7f6-c486-4f93-8705-4a38cc8a505c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnicalFacilitiesMember_f5b107f2-4d14-4000-ab19-08411237f2ac" xlink:href="abvx-20241231.xsd#abvx_TechnicalFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_abvx_TechnicalFacilitiesMember_f5b107f2-4d14-4000-ab19-08411237f2ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OfficeEquipmentMember_4b6900d7-e331-4ff4-a23b-73f3c725db9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_ifrs-full_OfficeEquipmentMember_4b6900d7-e331-4ff4-a23b-73f3c725db9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember_03b295ff-ec5a-4986-8f30-99aae204560c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_ifrs-full_ComputerEquipmentMember_03b295ff-ec5a-4986-8f30-99aae204560c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FurnitureMember_47b9bde3-e0e7-4c43-8f3b-cf054978abf3" xlink:href="abvx-20241231.xsd#abvx_FurnitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_abvx_FurnitureMember_47b9bde3-e0e7-4c43-8f3b-cf054978abf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_2c5741e2-575e-425b-bf4f-b7672331cbe2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:to="loc_ifrs-full_RangeAxis_2c5741e2-575e-425b-bf4f-b7672331cbe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_2c5741e2-575e-425b-bf4f-b7672331cbe2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_2c5741e2-575e-425b-bf4f-b7672331cbe2" xlink:to="loc_ifrs-full_RangeDomain_2c5741e2-575e-425b-bf4f-b7672331cbe2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_2c5741e2-575e-425b-bf4f-b7672331cbe2" xlink:to="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_28f9ea22-403d-4047-a531-db07eb58da0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:to="loc_ifrs-full_BottomOfRangeMember_28f9ea22-403d-4047-a531-db07eb58da0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_fee9d2c8-53fe-4de7-b902-770c8210d23e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:to="loc_ifrs-full_TopOfRangeMember_fee9d2c8-53fe-4de7-b902-770c8210d23e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_3c0e6f93-2ac7-4704-b739-368bee05d06c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_5ac7b5de-1073-4bd7-8886-5ce20bcb4780" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_3c0e6f93-2ac7-4704-b739-368bee05d06c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesAccountingofProsynergiaacquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_af55cd81-e64a-4d28-a7d2-168e3699f4cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_af55cd81-e64a-4d28-a7d2-168e3699f4cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_af55cd81-e64a-4d28-a7d2-168e3699f4cb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_af55cd81-e64a-4d28-a7d2-168e3699f4cb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_af55cd81-e64a-4d28-a7d2-168e3699f4cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d9c4bc8b-2dcb-4711-aae3-493c4aeafdf9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_af55cd81-e64a-4d28-a7d2-168e3699f4cb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d9c4bc8b-2dcb-4711-aae3-493c4aeafdf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_9145f156-97fb-4b26-8a41-bbbded37d7d6" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d9c4bc8b-2dcb-4711-aae3-493c4aeafdf9" xlink:to="loc_abvx_ProsynergiaMember_9145f156-97fb-4b26-8a41-bbbded37d7d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_347ddb62-bf45-481f-b8b0-f5d501aff9a1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_srt_CounterpartyNameAxis_347ddb62-bf45-481f-b8b0-f5d501aff9a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_347ddb62-bf45-481f-b8b0-f5d501aff9a1_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_347ddb62-bf45-481f-b8b0-f5d501aff9a1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_347ddb62-bf45-481f-b8b0-f5d501aff9a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a540d3a8-8834-48d2-ba5e-429c36f05143" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_347ddb62-bf45-481f-b8b0-f5d501aff9a1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a540d3a8-8834-48d2-ba5e-429c36f05143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_2e5b753d-a3a3-425d-86ff-748ce6b81f39" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a540d3a8-8834-48d2-ba5e-429c36f05143" xlink:to="loc_abvx_ProsynergiaMember_2e5b753d-a3a3-425d-86ff-748ce6b81f39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_1e6f073b-05ef-4127-9ffd-9144c7310d8a" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_abvx_AssetsAcquisitionsAxis_1e6f073b-05ef-4127-9ffd-9144c7310d8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_1e6f073b-05ef-4127-9ffd-9144c7310d8a_default" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_AssetsAcquisitionsAxis_1e6f073b-05ef-4127-9ffd-9144c7310d8a" xlink:to="loc_abvx_AssetsAcquisitionsDomain_1e6f073b-05ef-4127-9ffd-9144c7310d8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_189a062e-1ab0-42bf-a3b1-ef48149879cf" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_AssetsAcquisitionsAxis_1e6f073b-05ef-4127-9ffd-9144c7310d8a" xlink:to="loc_abvx_AssetsAcquisitionsDomain_189a062e-1ab0-42bf-a3b1-ef48149879cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_ec5e263a-0c57-4ea8-9688-3109510d4e5d" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_AssetsAcquisitionsDomain_189a062e-1ab0-42bf-a3b1-ef48149879cf" xlink:to="loc_abvx_ProsynergiaMember_ec5e263a-0c57-4ea8-9688-3109510d4e5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_767b66cc-0df6-4d0a-9dfe-018644944f92" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_767b66cc-0df6-4d0a-9dfe-018644944f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_7ed4a242-8cf9-44ae-9869-c3145c302c10" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_767b66cc-0df6-4d0a-9dfe-018644944f92" xlink:to="loc_abvx_EarnOutLiabilityMember_7ed4a242-8cf9-44ae-9869-c3145c302c10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0f98f711-d748-40c7-a66d-7907dbe46f43" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0f98f711-d748-40c7-a66d-7907dbe46f43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_38f20cc1-d037-4ee1-a851-dbc5434f595b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_38f20cc1-d037-4ee1-a851-dbc5434f595b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_76959a0d-1287-4b0c-9c1b-7650de416d28" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_76959a0d-1287-4b0c-9c1b-7650de416d28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMarketCapitalizationThreshold_4c37cff4-a09b-4e7e-bd00-50378b327076" xlink:href="abvx-20241231.xsd#abvx_EarnOutMarketCapitalizationThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutMarketCapitalizationThreshold_4c37cff4-a09b-4e7e-bd00-50378b327076" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutPercentage_894cfd08-5b52-4279-9a67-60e4b9d0e8da" xlink:href="abvx-20241231.xsd#abvx_EarnOutPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutPercentage_894cfd08-5b52-4279-9a67-60e4b9d0e8da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMaximumAmount_6f0679f5-d06e-4ebd-a7a0-e434ba20fc8c" xlink:href="abvx-20241231.xsd#abvx_EarnOutMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutMaximumAmount_6f0679f5-d06e-4ebd-a7a0-e434ba20fc8c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAmountPayableIfConditionsAreNotMet_6b90cefb-9520-4cbf-afdb-0bb25cfb9643" xlink:href="abvx-20241231.xsd#abvx_EarnOutAmountPayableIfConditionsAreNotMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutAmountPayableIfConditionsAreNotMet_6b90cefb-9520-4cbf-afdb-0bb25cfb9643" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_690c18b0-b24b-4bab-b415-44b809979aee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_FinancialLiabilities_690c18b0-b24b-4bab-b415-44b809979aee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_270c3d26-3caf-4bf3-9716-e75a3ee2a126" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_270c3d26-3caf-4bf3-9716-e75a3ee2a126" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_d67d6415-0ab0-4464-aca4-a3bbc1f09009" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_d67d6415-0ab0-4464-aca4-a3bbc1f09009" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_43606615-1f90-48b3-b1a4-b4d666bd16f3" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_d67d6415-0ab0-4464-aca4-a3bbc1f09009" xlink:to="loc_abvx_AssetsAcquisitionsAxis_43606615-1f90-48b3-b1a4-b4d666bd16f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_43606615-1f90-48b3-b1a4-b4d666bd16f3_default" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_AssetsAcquisitionsAxis_43606615-1f90-48b3-b1a4-b4d666bd16f3" xlink:to="loc_abvx_AssetsAcquisitionsDomain_43606615-1f90-48b3-b1a4-b4d666bd16f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_9ed373cb-5b6c-4007-a966-0c6df4fb4c31" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_AssetsAcquisitionsAxis_43606615-1f90-48b3-b1a4-b4d666bd16f3" xlink:to="loc_abvx_AssetsAcquisitionsDomain_9ed373cb-5b6c-4007-a966-0c6df4fb4c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_f48007fb-1d40-4a92-8df2-c6800e831939" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_AssetsAcquisitionsDomain_9ed373cb-5b6c-4007-a966-0c6df4fb4c31" xlink:to="loc_abvx_ProsynergiaMember_f48007fb-1d40-4a92-8df2-c6800e831939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPrepaymentAssetsAcquisitions_eff1fcb6-4b3c-4687-81ee-ea2b691d405e" xlink:href="abvx-20241231.xsd#abvx_CashPrepaymentAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_CashPrepaymentAssetsAcquisitions_eff1fcb6-4b3c-4687-81ee-ea2b691d405e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LoanGrantedAssetsAcquisitions_523394c7-8f51-44df-a358-8895682618c9" xlink:href="abvx-20241231.xsd#abvx_LoanGrantedAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_LoanGrantedAssetsAcquisitions_523394c7-8f51-44df-a358-8895682618c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashTransferredAssetsAcquisitions_d438339a-784b-425e-8c26-4c7af327457b" xlink:href="abvx-20241231.xsd#abvx_CashTransferredAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_CashTransferredAssetsAcquisitions_d438339a-784b-425e-8c26-4c7af327457b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition_08719f29-077f-4e3a-95df-1db9970dc06d" xlink:href="abvx-20241231.xsd#abvx_AcquisitionRelatedCostsAssetsAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition_08719f29-077f-4e3a-95df-1db9970dc06d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_151227ac-5bcf-496e-9ffa-062c863d3c0d" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_151227ac-5bcf-496e-9ffa-062c863d3c0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_0e0dd93f-8966-49ae-8563-de8b32eef344" xlink:href="abvx-20241231.xsd#abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_0e0dd93f-8966-49ae-8563-de8b32eef344" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_074b14cf-6cc9-4b56-ad12-f371cdc37e53" xlink:href="abvx-20241231.xsd#abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_074b14cf-6cc9-4b56-ad12-f371cdc37e53" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions_a7c2ff55-1248-4a6f-80d5-610084a9fbbf" xlink:href="abvx-20241231.xsd#abvx_CashAndCashEquivalentsAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions_a7c2ff55-1248-4a6f-80d5-610084a9fbbf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_4d20f926-eef2-4d6a-9032-e0ee10e5f27d" xlink:href="abvx-20241231.xsd#abvx_AssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_4d20f926-eef2-4d6a-9032-e0ee10e5f27d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_fa8953a3-6886-4c1a-a91f-d02c4f68db83" xlink:href="abvx-20241231.xsd#abvx_LiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_fa8953a3-6886-4c1a-a91f-d02c4f68db83" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_db7ab0d9-ce41-49ed-ae3e-1163cca0c468" xlink:href="abvx-20241231.xsd#abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_db7ab0d9-ce41-49ed-ae3e-1163cca0c468" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAssetsAcquisitionsCosts_f852ee35-0bb7-40ca-a69b-34c52fba6f5c" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAssetsAcquisitionsCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_PaymentsForAssetsAcquisitionsCosts_f852ee35-0bb7-40ca-a69b-34c52fba6f5c" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SegmentinformationDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SegmentinformationDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SegmentinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_faceb1bf-3a3d-4e59-9f6b-076cbaddce79" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:to="loc_ifrs-full_GeographicalAreasAxis_faceb1bf-3a3d-4e59-9f6b-076cbaddce79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_faceb1bf-3a3d-4e59-9f6b-076cbaddce79_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_faceb1bf-3a3d-4e59-9f6b-076cbaddce79" xlink:to="loc_ifrs-full_GeographicalAreasDomain_faceb1bf-3a3d-4e59-9f6b-076cbaddce79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_75202e3f-806d-466b-9e1e-3376e577b471" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_faceb1bf-3a3d-4e59-9f6b-076cbaddce79" xlink:to="loc_ifrs-full_GeographicalAreasDomain_75202e3f-806d-466b-9e1e-3376e577b471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_effa02f2-4357-4af9-aa85-4a1c8d083603" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_75202e3f-806d-466b-9e1e-3376e577b471" xlink:to="loc_country_US_effa02f2-4357-4af9-aa85-4a1c8d083603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_32c86cf9-78f5-43de-b06e-6384ca0499a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:to="loc_ifrs-full_RangeAxis_32c86cf9-78f5-43de-b06e-6384ca0499a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_32c86cf9-78f5-43de-b06e-6384ca0499a3_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_32c86cf9-78f5-43de-b06e-6384ca0499a3" xlink:to="loc_ifrs-full_RangeDomain_32c86cf9-78f5-43de-b06e-6384ca0499a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_ab1be398-5a7d-4d31-978e-a60b7d2b234b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_32c86cf9-78f5-43de-b06e-6384ca0499a3" xlink:to="loc_ifrs-full_RangeDomain_ab1be398-5a7d-4d31-978e-a60b7d2b234b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_22781515-ef21-4b6b-ac22-9658c68de454" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_ab1be398-5a7d-4d31-978e-a60b7d2b234b" xlink:to="loc_ifrs-full_TopOfRangeMember_22781515-ef21-4b6b-ac22-9658c68de454" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsAssetsPercentage_aa582fb0-5cd5-458f-8fe8-4e605b051438" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsAssetsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_ContributionToGroupsAssetsPercentage_aa582fb0-5cd5-458f-8fe8-4e605b051438" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsLiabilitiesPercentage_e7c6b443-79b6-412e-8364-d7bc05f4ebd1" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsLiabilitiesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_ContributionToGroupsLiabilitiesPercentage_e7c6b443-79b6-412e-8364-d7bc05f4ebd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsNetProfitsLossesPercentage_72c6465f-5256-4b9a-8f73-f2461dd14f59" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsNetProfitsLossesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_ContributionToGroupsNetProfitsLossesPercentage_72c6465f-5256-4b9a-8f73-f2461dd14f59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOperatingSegment_c1803646-7d9a-4ca3-ac7f-df71c422c893" xlink:href="abvx-20241231.xsd#abvx_NumberOfOperatingSegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_NumberOfOperatingSegment_c1803646-7d9a-4ca3-ac7f-df71c422c893" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/GoodwillandimpairmenttestDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#GoodwillandimpairmenttestDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/GoodwillandimpairmenttestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_0cf1e776-a458-4f3b-af9f-77b69b0e30d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_0cf1e776-a458-4f3b-af9f-77b69b0e30d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_0cf1e776-a458-4f3b-af9f-77b69b0e30d7" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SplicosSASABX464Member_c8657399-9159-4d0b-8cb0-e8000cc30f53" xlink:href="abvx-20241231.xsd#abvx_SplicosSASABX464Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:to="loc_abvx_SplicosSASABX464Member_c8657399-9159-4d0b-8cb0-e8000cc30f53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WittycelSASABX196Member_c4af583e-c34a-4fbd-a5a4-7b9ab60c301a" xlink:href="abvx-20241231.xsd#abvx_WittycelSASABX196Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:to="loc_abvx_WittycelSASABX196Member_c4af583e-c34a-4fbd-a5a4-7b9ab60c301a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_a4586030-d10d-4f4c-877d-d2fd251f0077" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_Goodwill_a4586030-d10d-4f4c-877d-d2fd251f0077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_958d5d33-d88d-4132-91d8-31d22bfa9cd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_958d5d33-d88d-4132-91d8-31d22bfa9cd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_3509b7bb-6a81-49f9-8ab4-8c3dbcc0f31d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_3509b7bb-6a81-49f9-8ab4-8c3dbcc0f31d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_bfae8dc5-8604-442c-8cf2-e989b2c05206" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_bfae8dc5-8604-442c-8cf2-e989b2c05206" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_a95bfbed-175d-4500-b919-4a97a2d1660c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_a95bfbed-175d-4500-b919-4a97a2d1660c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IntangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IntangibleassetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/IntangibleassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_b37f1eee-1024-4c51-ad0e-c30a30ba56e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_b37f1eee-1024-4c51-ad0e-c30a30ba56e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_b37f1eee-1024-4c51-ad0e-c30a30ba56e7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_b37f1eee-1024-4c51-ad0e-c30a30ba56e7" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_b37f1eee-1024-4c51-ad0e-c30a30ba56e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_671d9685-95dd-4fd3-bdb0-d02b8bf4e7e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_b37f1eee-1024-4c51-ad0e-c30a30ba56e7" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_671d9685-95dd-4fd3-bdb0-d02b8bf4e7e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WittycelSASABX196Member_be959deb-857d-4f35-b70d-ffb206ff0874" xlink:href="abvx-20241231.xsd#abvx_WittycelSASABX196Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_671d9685-95dd-4fd3-bdb0-d02b8bf4e7e1" xlink:to="loc_abvx_WittycelSASABX196Member_be959deb-857d-4f35-b70d-ffb206ff0874" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsAxis_8da1a0a9-822f-4bb6-8572-f8fee0122653" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:to="loc_abvx_PrincipalAgreementsAxis_8da1a0a9-822f-4bb6-8572-f8fee0122653" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_8da1a0a9-822f-4bb6-8572-f8fee0122653_default" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_PrincipalAgreementsAxis_8da1a0a9-822f-4bb6-8572-f8fee0122653" xlink:to="loc_abvx_PrincipalAgreementsDomain_8da1a0a9-822f-4bb6-8572-f8fee0122653_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_PrincipalAgreementsAxis_8da1a0a9-822f-4bb6-8572-f8fee0122653" xlink:to="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_31aab3aa-726d-4aaa-91dd-198538e55214" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:to="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_31aab3aa-726d-4aaa-91dd-198538e55214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_0d8b0958-84ec-4b09-ab43-487c00b793b1" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:to="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_0d8b0958-84ec-4b09-ab43-487c00b793b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:to="loc_abvx_AssetsAcquisitionsAxis_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28_default" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_AssetsAcquisitionsAxis_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28" xlink:to="loc_abvx_AssetsAcquisitionsDomain_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_54dc2283-4e29-4e24-aa49-1d3499c61dd8" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_AssetsAcquisitionsAxis_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28" xlink:to="loc_abvx_AssetsAcquisitionsDomain_54dc2283-4e29-4e24-aa49-1d3499c61dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_85bb28c5-2497-4adf-bd6a-cd8ace3836b6" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_AssetsAcquisitionsDomain_54dc2283-4e29-4e24-aa49-1d3499c61dd8" xlink:to="loc_abvx_ProsynergiaMember_85bb28c5-2497-4adf-bd6a-cd8ace3836b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval_e76b4063-dd4f-4fc6-bc5e-0601dd7b53df" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval_e76b4063-dd4f-4fc6-bc5e-0601dd7b53df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_7a91ace7-522d-48fc-b8cf-460bb5a0f047" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_7a91ace7-522d-48fc-b8cf-460bb5a0f047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_2e8cdfc6-37c6-4235-96b3-749ac11540c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_2e8cdfc6-37c6-4235-96b3-749ac11540c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2_09a3e4e2-78f2-44b6-9e05-34f2397083c6" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2_09a3e4e2-78f2-44b6-9e05-34f2397083c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_98848334-86c7-488b-968a-28f2185ab058" xlink:href="abvx-20241231.xsd#abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_98848334-86c7-488b-968a-28f2185ab058" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_cec7dabb-9014-4224-91d8-fb80e4f345a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_cec7dabb-9014-4224-91d8-fb80e4f345a8" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7aeb0883-dc3f-4692-b18e-2942c0f1a583" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7aeb0883-dc3f-4692-b18e-2942c0f1a583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_7aeb0883-dc3f-4692-b18e-2942c0f1a583_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7aeb0883-dc3f-4692-b18e-2942c0f1a583" xlink:to="loc_ifrs-full_CarryingAmountMember_7aeb0883-dc3f-4692-b18e-2942c0f1a583_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7aeb0883-dc3f-4692-b18e-2942c0f1a583" xlink:to="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_771c31c4-91ea-46aa-becf-e1a64aa562c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_771c31c4-91ea-46aa-becf-e1a64aa562c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9253b842-0d2b-411f-9f24-58b1c74536a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9253b842-0d2b-411f-9f24-58b1c74536a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_fd30eb53-46f6-4ef9-bd15-928404985eb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_fd30eb53-46f6-4ef9-bd15-928404985eb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_fd30eb53-46f6-4ef9-bd15-928404985eb8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_fd30eb53-46f6-4ef9-bd15-928404985eb8" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_fd30eb53-46f6-4ef9-bd15-928404985eb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_fd30eb53-46f6-4ef9-bd15-928404985eb8" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesMember_f4e6c3de-9847-4af1-a1cb-f8f10f127ede" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:to="loc_ifrs-full_LicencesMember_f4e6c3de-9847-4af1-a1cb-f8f10f127ede" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_594e0d3e-2828-444d-b398-edefd7a50814" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:to="loc_ifrs-full_ComputerSoftwareMember_594e0d3e-2828-444d-b398-edefd7a50814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_17f29acb-4b30-46fe-a5c0-fe191c81801b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_17f29acb-4b30-46fe-a5c0-fe191c81801b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_cec7dabb-9014-4224-91d8-fb80e4f345a8" xlink:to="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2d0fc1c4-96e9-451f-9cdb-79b3a1fdf8f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2d0fc1c4-96e9-451f-9cdb-79b3a1fdf8f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1c052b12-b2c6-4fdd-9c3d-691058013fb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1c052b12-b2c6-4fdd-9c3d-691058013fb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseIntangibleAssetsOtherThanGoodwill_2388cfa7-1001-4dd8-9bff-52a2fb6c122c" xlink:href="abvx-20241231.xsd#abvx_IncreaseIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_abvx_IncreaseIntangibleAssetsOtherThanGoodwill_2388cfa7-1001-4dd8-9bff-52a2fb6c122c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_1ae63c3b-c3a2-40ac-a975-3c65de64cc1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_1ae63c3b-c3a2-40ac-a975-3c65de64cc1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_3deddcd0-74b0-4c84-b452-9a6cc0c8e9ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2aba6b86-75c3-42dd-9e36-f8d35bebee8d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2aba6b86-75c3-42dd-9e36-f8d35bebee8d" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d694bd52-3652-455f-aa5f-64c303a1359b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d694bd52-3652-455f-aa5f-64c303a1359b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_d694bd52-3652-455f-aa5f-64c303a1359b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d694bd52-3652-455f-aa5f-64c303a1359b" xlink:to="loc_ifrs-full_CarryingAmountMember_d694bd52-3652-455f-aa5f-64c303a1359b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d694bd52-3652-455f-aa5f-64c303a1359b" xlink:to="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_ee7180d0-f315-4202-8bf6-c6aa0eb9bc71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_ee7180d0-f315-4202-8bf6-c6aa0eb9bc71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_f6f90227-d3eb-46f9-a937-4405e4749f1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_f6f90227-d3eb-46f9-a937-4405e4749f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6110eb47-fbe1-4721-900f-64b4e72f47c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6110eb47-fbe1-4721-900f-64b4e72f47c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_6110eb47-fbe1-4721-900f-64b4e72f47c7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6110eb47-fbe1-4721-900f-64b4e72f47c7" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_6110eb47-fbe1-4721-900f-64b4e72f47c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6110eb47-fbe1-4721-900f-64b4e72f47c7" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_07915979-3ccf-4bb1-aee5-ee2b004d9064" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:to="loc_ifrs-full_BuildingsMember_07915979-3ccf-4bb1-aee5-ee2b004d9064" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember_d158faf2-7fdc-48f2-a248-294a872dbf66" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:to="loc_ifrs-full_MachineryMember_d158faf2-7fdc-48f2-a248-294a872dbf66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FurnitureAndComputerEquipmentMember_31587a09-1a50-4d98-84b2-03feb1bab8c3" xlink:href="abvx-20241231.xsd#abvx_FurnitureAndComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:to="loc_abvx_FurnitureAndComputerEquipmentMember_31587a09-1a50-4d98-84b2-03feb1bab8c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_e9da8d0d-5116-43c2-b558-6fea5e03c608" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_e9da8d0d-5116-43c2-b558-6fea5e03c608" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_e9da8d0d-5116-43c2-b558-6fea5e03c608_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_e9da8d0d-5116-43c2-b558-6fea5e03c608" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_e9da8d0d-5116-43c2-b558-6fea5e03c608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_ae64e0e8-1b76-4ee4-ab97-6cafaffdf362" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_e9da8d0d-5116-43c2-b558-6fea5e03c608" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_ae64e0e8-1b76-4ee4-ab97-6cafaffdf362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssetsMember_b69adc33-21ff-4305-92cf-f61d6b4a4135" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_ae64e0e8-1b76-4ee4-ab97-6cafaffdf362" xlink:to="loc_ifrs-full_RightofuseAssetsMember_b69adc33-21ff-4305-92cf-f61d6b4a4135" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2aba6b86-75c3-42dd-9e36-f8d35bebee8d" xlink:to="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_ef91edd3-41db-43b2-b9c2-4986ffb4c332" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_ef91edd3-41db-43b2-b9c2-4986ffb4c332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_efc51704-46e1-4395-b769-cd788847bd9e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_efc51704-46e1-4395-b769-cd788847bd9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets_b9f40178-1546-4873-8c04-f997c2132394" xlink:href="abvx-20241231.xsd#abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets_b9f40178-1546-4873-8c04-f997c2132394" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_c5303050-11cf-4b4f-a0fb-44c63a973d68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_c5303050-11cf-4b4f-a0fb-44c63a973d68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_9cdee8af-e93d-4a1b-bc4d-1afbd7f01758" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_9cdee8af-e93d-4a1b-bc4d-1afbd7f01758" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_5eeba5c7-a9f7-48d4-88c2-41fc22848456" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PropertyplantandequipmentNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_44698eb2-053c-4370-b2e6-9a589c244d3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:to="loc_ifrs-full_TypesOfContractsAxis_44698eb2-053c-4370-b2e6-9a589c244d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_44698eb2-053c-4370-b2e6-9a589c244d3d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfContractsAxis_44698eb2-053c-4370-b2e6-9a589c244d3d" xlink:to="loc_ifrs-full_TypesOfContractsDomain_44698eb2-053c-4370-b2e6-9a589c244d3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_cb415f2d-7b1f-4fa4-8f05-cacb9cf27434" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfContractsAxis_44698eb2-053c-4370-b2e6-9a589c244d3d" xlink:to="loc_ifrs-full_TypesOfContractsDomain_cb415f2d-7b1f-4fa4-8f05-cacb9cf27434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesParisMember_a013265b-8941-452b-a776-ce3fb466adc0" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesParisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfContractsDomain_cb415f2d-7b1f-4fa4-8f05-cacb9cf27434" xlink:to="loc_abvx_LeaseFacilitiesParisMember_a013265b-8941-452b-a776-ce3fb466adc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1dbfe954-1f53-4f13-8f6b-c49933135738" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1dbfe954-1f53-4f13-8f6b-c49933135738" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_1dbfe954-1f53-4f13-8f6b-c49933135738_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1dbfe954-1f53-4f13-8f6b-c49933135738" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_1dbfe954-1f53-4f13-8f6b-c49933135738_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_ad804f95-b1ec-4be0-873f-f1adf6cb31d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1dbfe954-1f53-4f13-8f6b-c49933135738" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_ad804f95-b1ec-4be0-873f-f1adf6cb31d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_e3925c1e-61f7-4e36-909d-a339fbac1f5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_ad804f95-b1ec-4be0-873f-f1adf6cb31d7" xlink:to="loc_ifrs-full_BuildingsMember_e3925c1e-61f7-4e36-909d-a339fbac1f5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_38ad74f4-3ed5-403a-b31f-cc2e63166ae3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:to="loc_ifrs-full_RightofuseAssets_38ad74f4-3ed5-403a-b31f-cc2e63166ae3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets_04d182ac-a43d-4f64-95f1-2ac4d7e01ee5" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:to="loc_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets_04d182ac-a43d-4f64-95f1-2ac4d7e01ee5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherfinancialassetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_d6c40ff3-946a-4c2f-b649-7598e4733a98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_d6c40ff3-946a-4c2f-b649-7598e4733a98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_5d2896cc-3fc8-47cb-b6bb-54e80a798561" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_d6c40ff3-946a-4c2f-b649-7598e4733a98" xlink:to="loc_ifrs-full_RangeAxis_5d2896cc-3fc8-47cb-b6bb-54e80a798561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_5d2896cc-3fc8-47cb-b6bb-54e80a798561_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_5d2896cc-3fc8-47cb-b6bb-54e80a798561" xlink:to="loc_ifrs-full_RangeDomain_5d2896cc-3fc8-47cb-b6bb-54e80a798561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_5d2896cc-3fc8-47cb-b6bb-54e80a798561" xlink:to="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_12dd0e6f-1fd1-4036-8cfc-1a274dc9a342" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:to="loc_ifrs-full_BottomOfRangeMember_12dd0e6f-1fd1-4036-8cfc-1a274dc9a342" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_53975d29-eb4d-4f03-991f-340726de2edf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:to="loc_ifrs-full_TopOfRangeMember_53975d29-eb4d-4f03-991f-340726de2edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DiscountRateAppliedToLongTermAdvances_bb9984f4-d46a-47de-a551-7b3604fd0907" xlink:href="abvx-20241231.xsd#abvx_DiscountRateAppliedToLongTermAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:to="loc_abvx_DiscountRateAppliedToLongTermAdvances_bb9984f4-d46a-47de-a551-7b3604fd0907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_32004f62-6f01-482a-b929-07659e287872" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAdvancesMadeToContractResearchOrganizations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:to="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_32004f62-6f01-482a-b929-07659e287872" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherreceivablesandotherassetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d" xlink:to="loc_ifrs-full_CarryingAmountMember_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_41e40e21-976d-466d-a406-3804c922daee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d" xlink:to="loc_ifrs-full_CarryingAmountMember_41e40e21-976d-466d-a406-3804c922daee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DeferredFinancingCostsNettingMember_2d605446-0fa1-497a-b189-e7c8fbbb35e5" xlink:href="abvx-20241231.xsd#abvx_DeferredFinancingCostsNettingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_41e40e21-976d-466d-a406-3804c922daee" xlink:to="loc_abvx_DeferredFinancingCostsNettingMember_2d605446-0fa1-497a-b189-e7c8fbbb35e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_eaf30e1a-1e43-4be2-a995-a32bedfc3650" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_eaf30e1a-1e43-4be2-a995-a32bedfc3650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_7b497489-158f-4a5a-91e5-d6c80aaec174" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_eaf30e1a-1e43-4be2-a995-a32bedfc3650" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_7b497489-158f-4a5a-91e5-d6c80aaec174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromResearchTaxCredit_20b5dcf2-2f2a-4680-aa8c-4767198c8fbd" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromResearchTaxCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_ProceedsFromResearchTaxCredit_20b5dcf2-2f2a-4680-aa8c-4767198c8fbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentResearchTaxCreditReceivables_c10850a6-a826-4a2b-8db1-8873c9b22f8e" xlink:href="abvx-20241231.xsd#abvx_CurrentResearchTaxCreditReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_CurrentResearchTaxCreditReceivables_c10850a6-a826-4a2b-8db1-8873c9b22f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPrepaidExpensesRelatedToCRO_efacab02-3ae5-4899-9ffd-3b0b3a4e152b" xlink:href="abvx-20241231.xsd#abvx_CurrentPrepaidExpensesRelatedToCRO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_CurrentPrepaidExpensesRelatedToCRO_efacab02-3ae5-4899-9ffd-3b0b3a4e152b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_9a48be0a-df03-4256-981e-137666323a7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_ifrs-full_Borrowings_9a48be0a-df03-4256-981e-137666323a7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_af1292ca-fbde-4a20-9fe9-d6ef769e9a14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAdvancesToSuppliers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_ifrs-full_CurrentAdvancesToSuppliers_af1292ca-fbde-4a20-9fe9-d6ef769e9a14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent_f7ef298c-6c00-4b26-ab6a-0627cee86eeb" xlink:href="abvx-20241231.xsd#abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent_f7ef298c-6c00-4b26-ab6a-0627cee86eeb" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#CashandcashequivalentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCashAndCashEquivalentsTable_7f7bf110-fecc-47c8-946d-93fc7b88cbd7" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:to="loc_abvx_DisclosureOfCashAndCashEquivalentsTable_7f7bf110-fecc-47c8-946d-93fc7b88cbd7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_054278ed-6134-4152-9679-379ff21d1a5b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsTable_7f7bf110-fecc-47c8-946d-93fc7b88cbd7" xlink:to="loc_srt_CurrencyAxis_054278ed-6134-4152-9679-379ff21d1a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_054278ed-6134-4152-9679-379ff21d1a5b_default" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_054278ed-6134-4152-9679-379ff21d1a5b" xlink:to="loc_currency_AllCurrenciesDomain_054278ed-6134-4152-9679-379ff21d1a5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_833354e9-0a05-4bb2-aaac-fd951ecfd48c" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_054278ed-6134-4152-9679-379ff21d1a5b" xlink:to="loc_currency_AllCurrenciesDomain_833354e9-0a05-4bb2-aaac-fd951ecfd48c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_42d08276-b13e-4477-8217-dbeee180dfcf" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_833354e9-0a05-4bb2-aaac-fd951ecfd48c" xlink:to="loc_currency_USD_42d08276-b13e-4477-8217-dbeee180dfcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashAndCashEquivalents_49771076-bdd9-4d0b-a431-df1ba4af414f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:to="loc_ifrs-full_OtherCashAndCashEquivalents_49771076-bdd9-4d0b-a431-df1ba4af414f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_d06b43ae-adff-4dbc-b357-ebda83f353f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_d06b43ae-adff-4dbc-b357-ebda83f353f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialassetsandliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialassetsandliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialassetsandliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_14117025-e60d-47bf-950c-cfd6b47185b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_14117025-e60d-47bf-950c-cfd6b47185b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_14117025-e60d-47bf-950c-cfd6b47185b9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_14117025-e60d-47bf-950c-cfd6b47185b9" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_14117025-e60d-47bf-950c-cfd6b47185b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_14117025-e60d-47bf-950c-cfd6b47185b9" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialAssetsMember_f51fef1a-72f8-45a4-bcce-95a720f18200" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_OtherFinancialAssetsMember_f51fef1a-72f8-45a4-bcce-95a720f18200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherReceivablesAndAssetsMember_88605173-113a-4e57-b07b-20c1aee009ba" xlink:href="abvx-20241231.xsd#abvx_OtherReceivablesAndAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_OtherReceivablesAndAssetsMember_88605173-113a-4e57-b07b-20c1aee009ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAndCashEquivalentMember_c470098f-6123-47e1-b4d7-872ed594db7b" xlink:href="abvx-20241231.xsd#abvx_CashAndCashEquivalentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_CashAndCashEquivalentMember_c470098f-6123-47e1-b4d7-872ed594db7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContractsMember_9de626cc-92fa-4d27-93af-318db46e2e96" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_NonCurrentAdvancesToCROContractsMember_9de626cc-92fa-4d27-93af-318db46e2e96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_a897217c-0114-4308-bbf4-2cd19112ad11" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_MeasurementAxis_a897217c-0114-4308-bbf4-2cd19112ad11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_a897217c-0114-4308-bbf4-2cd19112ad11_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_a897217c-0114-4308-bbf4-2cd19112ad11" xlink:to="loc_ifrs-full_MeasurementDomain_a897217c-0114-4308-bbf4-2cd19112ad11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_2308600a-3488-43b5-9a05-a3f13b9434b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_a897217c-0114-4308-bbf4-2cd19112ad11" xlink:to="loc_ifrs-full_MeasurementDomain_2308600a-3488-43b5-9a05-a3f13b9434b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecurringFairValueMeasurementMember_42b3bb56-691a-4a5d-85de-8ecefd463a84" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_2308600a-3488-43b5-9a05-a3f13b9434b1" xlink:to="loc_ifrs-full_RecurringFairValueMeasurementMember_42b3bb56-691a-4a5d-85de-8ecefd463a84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_75778f97-5296-4660-8e53-1cb9a325655b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_75778f97-5296-4660-8e53-1cb9a325655b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_75778f97-5296-4660-8e53-1cb9a325655b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_75778f97-5296-4660-8e53-1cb9a325655b" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_75778f97-5296-4660-8e53-1cb9a325655b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_75778f97-5296-4660-8e53-1cb9a325655b" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_c14b6d77-c632-4106-b50b-e0e6d1d1c174" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_c14b6d77-c632-4106-b50b-e0e6d1d1c174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_e427f6b9-ac52-4a0b-8196-835872dd5aa8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_e427f6b9-ac52-4a0b-8196-835872dd5aa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a5af389a-3595-400f-9fd0-9378785c0045" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a5af389a-3595-400f-9fd0-9378785c0045" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_a5af389a-3595-400f-9fd0-9378785c0045_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a5af389a-3595-400f-9fd0-9378785c0045" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_a5af389a-3595-400f-9fd0-9378785c0045_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a5af389a-3595-400f-9fd0-9378785c0045" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_08aa41dd-9d91-454f-b9c8-bddb563db21f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_08aa41dd-9d91-454f-b9c8-bddb563db21f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_fa2fbe07-fa7e-40d7-b650-662df88cfcd3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_fa2fbe07-fa7e-40d7-b650-662df88cfcd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_f9ecc366-7eac-44b5-b251-c2a19a91b3d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_f9ecc366-7eac-44b5-b251-c2a19a91b3d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_f9ecc366-7eac-44b5-b251-c2a19a91b3d1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_f9ecc366-7eac-44b5-b251-c2a19a91b3d1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_f9ecc366-7eac-44b5-b251-c2a19a91b3d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_f9ecc366-7eac-44b5-b251-c2a19a91b3d1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:href="abvx-20241231.xsd#abvx_NonCurrentFinancialLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:to="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_50f968ad-89b0-4627-8888-dccd761e77b3" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_Kreos12BondLoansMember_50f968ad-89b0-4627-8888-dccd761e77b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_9ec5da3b-efac-4808-acd0-fb0db692e3a2" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_OCEANEMember_9ec5da3b-efac-4808-acd0-fb0db692e3a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_78f77eec-92e4-4768-a4b0-00f2af48d6e1" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_78f77eec-92e4-4768-a4b0-00f2af48d6e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheABAndCMember_2a6a90c4-7e3a-4e26-9281-7a0d6e47e0d6" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheABAndCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_KreosClaretFinancingTrancheABAndCMember_2a6a90c4-7e3a-4e26-9281-7a0d6e47e0d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesAndPGELoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_ea1c2e15-32ab-4a59-85a9-28d791d3ecf5" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_ea1c2e15-32ab-4a59-85a9-28d791d3ecf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_380101de-77fd-4d5c-ad81-b95e4d2c803b" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_380101de-77fd-4d5c-ad81-b95e4d2c803b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_b79266c2-70b4-4b30-9dd7-c2d93146f022" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_b79266c2-70b4-4b30-9dd7-c2d93146f022" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_2c3728ed-4f27-4740-b722-f9bf6763e6c2" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_2c3728ed-4f27-4740-b722-f9bf6763e6c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentFinancialLiabilitiesMember_37b7e608-526b-402f-9b45-89e1ab4c2292" xlink:href="abvx-20241231.xsd#abvx_CurrentFinancialLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:to="loc_abvx_CurrentFinancialLiabilitiesMember_37b7e608-526b-402f-9b45-89e1ab4c2292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TradePayablesAndOtherCurrentLiabilitiesMember_5cd7ed00-e0f5-45cd-b3c0-35b4fb27c92c" xlink:href="abvx-20241231.xsd#abvx_TradePayablesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:to="loc_abvx_TradePayablesAndOtherCurrentLiabilitiesMember_5cd7ed00-e0f5-45cd-b3c0-35b4fb27c92c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_55b678f6-f663-4bf7-967f-a05bc28c2c21" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_RangeAxis_55b678f6-f663-4bf7-967f-a05bc28c2c21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_55b678f6-f663-4bf7-967f-a05bc28c2c21_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_55b678f6-f663-4bf7-967f-a05bc28c2c21" xlink:to="loc_ifrs-full_RangeDomain_55b678f6-f663-4bf7-967f-a05bc28c2c21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_55b678f6-f663-4bf7-967f-a05bc28c2c21" xlink:to="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_edb8cdaa-568e-4150-b3d6-d65a5fce2ae6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:to="loc_ifrs-full_BottomOfRangeMember_edb8cdaa-568e-4150-b3d6-d65a5fce2ae6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_5d1ab669-0e4a-4207-ab97-d1149abd95cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:to="loc_ifrs-full_TopOfRangeMember_5d1ab669-0e4a-4207-ab97-d1149abd95cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_59766b7e-607e-4329-961b-89b3acb7fac2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_UnobservableInputsAxis_59766b7e-607e-4329-961b-89b3acb7fac2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_59766b7e-607e-4329-961b-89b3acb7fac2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_59766b7e-607e-4329-961b-89b3acb7fac2" xlink:to="loc_ifrs-full_UnobservableInputsDomain_59766b7e-607e-4329-961b-89b3acb7fac2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_03e24365-626c-4bd2-a1bc-4e4b7d01998a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_59766b7e-607e-4329-961b-89b3acb7fac2" xlink:to="loc_ifrs-full_UnobservableInputsDomain_03e24365-626c-4bd2-a1bc-4e4b7d01998a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_135125a0-4c63-433d-b8cc-86c602c094fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_03e24365-626c-4bd2-a1bc-4e4b7d01998a" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_135125a0-4c63-433d-b8cc-86c602c094fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_65a5037d-12cd-43f9-80b4-41a91aef363a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_65a5037d-12cd-43f9-80b4-41a91aef363a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_65a5037d-12cd-43f9-80b4-41a91aef363a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_65a5037d-12cd-43f9-80b4-41a91aef363a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_65a5037d-12cd-43f9-80b4-41a91aef363a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9b585b13-c827-4ea2-8bee-a729a4459665" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_65a5037d-12cd-43f9-80b4-41a91aef363a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9b585b13-c827-4ea2-8bee-a729a4459665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountedCashFlowMember_e5808a8a-ec7f-4db4-afed-c8ab007ad416" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9b585b13-c827-4ea2-8bee-a729a4459665" xlink:to="loc_ifrs-full_DiscountedCashFlowMember_e5808a8a-ec7f-4db4-afed-c8ab007ad416" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_e7135ff8-157c-4530-8860-710b5879aafc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_Assets_e7135ff8-157c-4530-8860-710b5879aafc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_971c52fd-b828-4a52-b577-a6f2ab3e483b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_971c52fd-b828-4a52-b577-a6f2ab3e483b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_6812a62c-f2ca-4c51-9950-4ab1e4fee70a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_Liabilities_6812a62c-f2ca-4c51-9950-4ab1e4fee70a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_5425d6fb-83ee-4f68-8b00-3b887a8ec1ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_5425d6fb-83ee-4f68-8b00-3b887a8ec1ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputAssets_c921e384-7ccd-4101-9fd3-77b06dcfb3c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_SignificantUnobservableInputAssets_c921e384-7ccd-4101-9fd3-77b06dcfb3c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_6b6bc620-b486-476f-8b5c-ff37c8448494" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_6b6bc620-b486-476f-8b5c-ff37c8448494" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_99ec684c-7b53-4157-81d5-7239eb501e5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_99ec684c-7b53-4157-81d5-7239eb501e5b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_09f9c4c5-2fd8-47ae-86f4-da58ca20e7fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_09f9c4c5-2fd8-47ae-86f4-da58ca20e7fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_953637ad-7e1f-4e3c-a675-90a5fec9e6c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_953637ad-7e1f-4e3c-a675-90a5fec9e6c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_413d7b3b-592d-4628-89b7-34c177e80730" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_413d7b3b-592d-4628-89b7-34c177e80730" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequityEquitylineinstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_fe7903e1-af91-4b2b-9742-947b980ed6b7" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:to="loc_abvx_FinancialAgreementAxis_fe7903e1-af91-4b2b-9742-947b980ed6b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_fe7903e1-af91-4b2b-9742-947b980ed6b7_default" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_FinancialAgreementAxis_fe7903e1-af91-4b2b-9742-947b980ed6b7" xlink:to="loc_abvx_FinancialAgreementDomain_fe7903e1-af91-4b2b-9742-947b980ed6b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_2d69b81e-cb5c-4b6c-a45c-49b0b8d30a06" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_FinancialAgreementAxis_fe7903e1-af91-4b2b-9742-947b980ed6b7" xlink:to="loc_abvx_FinancialAgreementDomain_2d69b81e-cb5c-4b6c-a45c-49b0b8d30a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_dff02ee0-ade7-4b99-9c5e-641f0f675a14" xlink:href="abvx-20241231.xsd#abvx_EquityLineAgreementWithKeplerCheuvreuxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_2d69b81e-cb5c-4b6c-a45c-49b0b8d30a06" xlink:to="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_dff02ee0-ade7-4b99-9c5e-641f0f675a14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_191625b9-6644-42f9-9796-b8726175a24c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_191625b9-6644-42f9-9796-b8726175a24c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_191625b9-6644-42f9-9796-b8726175a24c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_191625b9-6644-42f9-9796-b8726175a24c" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_191625b9-6644-42f9-9796-b8726175a24c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d3b2132a-5402-4e9b-9c91-0a10cab2a96b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_191625b9-6644-42f9-9796-b8726175a24c" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d3b2132a-5402-4e9b-9c91-0a10cab2a96b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_1130c111-1fcf-48c6-98b6-c79f41e26aaa" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d3b2132a-5402-4e9b-9c91-0a10cab2a96b" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_1130c111-1fcf-48c6-98b6-c79f41e26aaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued_fbc6c4b1-ca03-4cde-ad47-38c1bff93588" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementMaximumNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued_fbc6c4b1-ca03-4cde-ad47-38c1bff93588" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementMaximumPeriod_1b174034-2d49-4400-80f5-aab1a9627e7b" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementMaximumPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementMaximumPeriod_1b174034-2d49-4400-80f5-aab1a9627e7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays_82485a3e-d598-42d3-9db9-0337d0cea0b2" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays_82485a3e-d598-42d3-9db9-0337d0cea0b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount_292da862-7080-4942-8493-b0a78be5c091" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementIssuancePriceMaximumDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount_292da862-7080-4942-8493-b0a78be5c091" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementExtendedPeriod_6572a2d1-52ca-4242-907b-a5850eb8fd57" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementExtendedPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementExtendedPeriod_6572a2d1-52ca-4242-907b-a5850eb8fd57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_8208da6b-f0f3-40c9-b49e-6e3c0a67c3e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_8208da6b-f0f3-40c9-b49e-6e3c0a67c3e4" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_1e82e70e-923a-4614-b702-46a10b87f0bd" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:to="loc_abvx_FinancialAgreementAxis_1e82e70e-923a-4614-b702-46a10b87f0bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_1e82e70e-923a-4614-b702-46a10b87f0bd_default" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_FinancialAgreementAxis_1e82e70e-923a-4614-b702-46a10b87f0bd" xlink:to="loc_abvx_FinancialAgreementDomain_1e82e70e-923a-4614-b702-46a10b87f0bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_13090f1d-5cf2-4181-98e6-d7e3c6b0029b" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_FinancialAgreementAxis_1e82e70e-923a-4614-b702-46a10b87f0bd" xlink:to="loc_abvx_FinancialAgreementDomain_13090f1d-5cf2-4181-98e6-d7e3c6b0029b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_b7ac40bd-9f25-49d1-9024-c4ef651ec275" xlink:href="abvx-20241231.xsd#abvx_EquityLineAgreementWithKeplerCheuvreuxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_13090f1d-5cf2-4181-98e6-d7e3c6b0029b" xlink:to="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_b7ac40bd-9f25-49d1-9024-c4ef651ec275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_f26016f2-c3b8-42a0-b9da-3f77438a5a5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_f26016f2-c3b8-42a0-b9da-3f77438a5a5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f26016f2-c3b8-42a0-b9da-3f77438a5a5a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_f26016f2-c3b8-42a0-b9da-3f77438a5a5a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f26016f2-c3b8-42a0-b9da-3f77438a5a5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e36b865c-f747-447b-abf4-dbc6eb70c9ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_f26016f2-c3b8-42a0-b9da-3f77438a5a5a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e36b865c-f747-447b-abf4-dbc6eb70c9ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_c77da3f8-4a45-4809-bc25-c0ddbaaf0af5" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e36b865c-f747-447b-abf4-dbc6eb70c9ec" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_c77da3f8-4a45-4809-bc25-c0ddbaaf0af5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_a7cce091-c8b0-4c49-8666-039168ced7f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_a7cce091-c8b0-4c49-8666-039168ced7f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_fd240edc-bbec-44d9-9f87-06492a8a956b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_fd240edc-bbec-44d9-9f87-06492a8a956b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_887819d3-d509-48e7-a749-05c175576018" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_887819d3-d509-48e7-a749-05c175576018" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4b97f2a1-93ff-4973-bf52-3d8973a418a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_c3e63266-6448-444c-8576-8a6441355a58" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_c3e63266-6448-444c-8576-8a6441355a58" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequityChangeinsharecapitalDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0071d243-df57-4a90-b6f4-1472eed6a548" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0071d243-df57-4a90-b6f4-1472eed6a548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0071d243-df57-4a90-b6f4-1472eed6a548_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0071d243-df57-4a90-b6f4-1472eed6a548" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0071d243-df57-4a90-b6f4-1472eed6a548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0071d243-df57-4a90-b6f4-1472eed6a548" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_99f6b16f-059d-41ef-825f-c1c6d7504076" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:to="loc_abvx_KreosABSAMember_99f6b16f-059d-41ef-825f-c1c6d7504076" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_c310121d-21f8-40de-a10a-c19334462430" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:to="loc_abvx_KreosBBSAMember_c310121d-21f8-40de-a10a-c19334462430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_e6dfbbcc-a910-4287-b6fd-68a7c1f33bd0" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_e6dfbbcc-a910-4287-b6fd-68a7c1f33bd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241AndBSA20242Member_07fed22e-807b-469b-880b-98d875b7f70d" xlink:href="abvx-20241231.xsd#abvx_BSA20241AndBSA20242Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_e6dfbbcc-a910-4287-b6fd-68a7c1f33bd0" xlink:to="loc_abvx_BSA20241AndBSA20242Member_07fed22e-807b-469b-880b-98d875b7f70d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_7a652c88-79c3-4620-85fc-2e5fe2f3bc98" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:to="loc_abvx_FinancialAgreementAxis_7a652c88-79c3-4620-85fc-2e5fe2f3bc98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_7a652c88-79c3-4620-85fc-2e5fe2f3bc98_default" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_FinancialAgreementAxis_7a652c88-79c3-4620-85fc-2e5fe2f3bc98" xlink:to="loc_abvx_FinancialAgreementDomain_7a652c88-79c3-4620-85fc-2e5fe2f3bc98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_FinancialAgreementAxis_7a652c88-79c3-4620-85fc-2e5fe2f3bc98" xlink:to="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_675dd5ee-6452-4349-b5e8-d3c25b4a0118" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:to="loc_abvx_Kreos1Member_675dd5ee-6452-4349-b5e8-d3c25b4a0118" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEquityAgreementsMember_3ba934ae-2287-490a-af87-f08a07d14b36" xlink:href="abvx-20241231.xsd#abvx_OtherEquityAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:to="loc_abvx_OtherEquityAgreementsMember_3ba934ae-2287-490a-af87-f08a07d14b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_01a61f58-761a-4d94-b05c-98525e298bfa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_01a61f58-761a-4d94-b05c-98525e298bfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_01a61f58-761a-4d94-b05c-98525e298bfa_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_01a61f58-761a-4d94-b05c-98525e298bfa" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_01a61f58-761a-4d94-b05c-98525e298bfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_01a61f58-761a-4d94-b05c-98525e298bfa" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesMember_28b8715f-001f-48a3-807c-25d0621afe1f" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:to="loc_abvx_AmericanDepositorySharesMember_28b8715f-001f-48a3-807c-25d0621afe1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_4acb954c-1667-4651-a813-b137e804462e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:to="loc_ifrs-full_OrdinarySharesMember_4acb954c-1667-4651-a813-b137e804462e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_ac4dbab7-5309-44b4-b8ff-4d1cf712325d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_IssueOfEquity_ac4dbab7-5309-44b4-b8ff-4d1cf712325d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_51791d64-93a9-43b1-ad0e-418b02091f2f" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_51791d64-93a9-43b1-ad0e-418b02091f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_266362d1-7259-49f6-8722-324dbf38fb10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_ParValuePerShare_266362d1-7259-49f6-8722-324dbf38fb10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_bea8cf2f-0521-4b3c-b044-9c414d9316fe" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_bea8cf2f-0521-4b3c-b044-9c414d9316fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsExercised_ab4a5c23-8cf1-4200-a733-c5eb52fcb747" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_NumberOfWarrantsExercised_ab4a5c23-8cf1-4200-a733-c5eb52fcb747" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_e2741e5a-d474-4303-8dcf-7bb2eca5754f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_e2741e5a-d474-4303-8dcf-7bb2eca5754f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_f5da70d4-c0b2-4ef6-9bed-5460646eed3b" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_f5da70d4-c0b2-4ef6-9bed-5460646eed3b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_2b7008e7-59fb-445c-ba70-79383113c615" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_2b7008e7-59fb-445c-ba70-79383113c615" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_a37b0752-0e51-4328-b98a-08f510b5be1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_a37b0752-0e51-4328-b98a-08f510b5be1b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssueOfEquityOfferingPricePerShare_a21cb869-cb36-4c06-9809-9fff8e7fd474" xlink:href="abvx-20241231.xsd#abvx_IssueOfEquityOfferingPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_IssueOfEquityOfferingPricePerShare_a21cb869-cb36-4c06-9809-9fff8e7fd474" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5faa8799-527f-4a5b-a8ea-c58cee18eeba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5faa8799-527f-4a5b-a8ea-c58cee18eeba" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareWarrantsSubscriptionPricePerShare_afc6e2db-d4fd-4310-bb6c-ab5d06f6e2c5" xlink:href="abvx-20241231.xsd#abvx_ShareWarrantsSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_ShareWarrantsSubscriptionPricePerShare_afc6e2db-d4fd-4310-bb6c-ab5d06f6e2c5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareIssueRelatedCostCredit_e8cc9fe6-578d-4f37-8294-bcf3edc08f50" xlink:href="abvx-20241231.xsd#abvx_ShareIssueRelatedCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_ShareIssueRelatedCostCredit_e8cc9fe6-578d-4f37-8294-bcf3edc08f50" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesIssued_e8096df7-8c46-4a94-8fb8-80610e7cadd6" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_NumberOfFreeSharesIssued_e8096df7-8c46-4a94-8fb8-80610e7cadd6" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f9d161d1-bb3a-4f7d-b284-ae2ebe611738" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f9d161d1-bb3a-4f7d-b284-ae2ebe611738" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a66892bc-ab74-447b-913f-d02d9309b295" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f9d161d1-bb3a-4f7d-b284-ae2ebe611738" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a66892bc-ab74-447b-913f-d02d9309b295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_a66892bc-ab74-447b-913f-d02d9309b295_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a66892bc-ab74-447b-913f-d02d9309b295" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_a66892bc-ab74-447b-913f-d02d9309b295_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0fe091a6-8d31-4c5d-9521-0f8590d5349e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a66892bc-ab74-447b-913f-d02d9309b295" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0fe091a6-8d31-4c5d-9521-0f8590d5349e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:href="abvx-20241231.xsd#abvx_FoundersShareSubscriptionWarrantsBCEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0fe091a6-8d31-4c5d-9521-0f8590d5349e" xlink:to="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20161Member_33e6e707-7c2c-418f-a16e-3fa90dbccb50" xlink:href="abvx-20241231.xsd#abvx_BCE20161Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20161Member_33e6e707-7c2c-418f-a16e-3fa90dbccb50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20171Member_fa3c0512-4bcb-4fdc-a6de-d45a4a5e80e6" xlink:href="abvx-20241231.xsd#abvx_BCE20171Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20171Member_fa3c0512-4bcb-4fdc-a6de-d45a4a5e80e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20172Member_35b12fca-3dce-4a64-9476-23b08da6babc" xlink:href="abvx-20241231.xsd#abvx_BCE20172Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20172Member_35b12fca-3dce-4a64-9476-23b08da6babc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20174Member_5695c77f-dee3-4333-aa5d-7f2c7e3e5983" xlink:href="abvx-20241231.xsd#abvx_BCE20174Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20174Member_5695c77f-dee3-4333-aa5d-7f2c7e3e5983" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20175Member_661d5e1a-0958-44f4-8753-562a334999da" xlink:href="abvx-20241231.xsd#abvx_BCE20175Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20175Member_661d5e1a-0958-44f4-8753-562a334999da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20181Member_41da21f0-4308-4378-aec9-830ebd5d3779" xlink:href="abvx-20241231.xsd#abvx_BCE20181Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20181Member_41da21f0-4308-4378-aec9-830ebd5d3779" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20183Member_b194102f-c48e-4330-b879-12d31dfe9b7a" xlink:href="abvx-20241231.xsd#abvx_BCE20183Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20183Member_b194102f-c48e-4330-b879-12d31dfe9b7a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20184Member_e938c0dc-e891-4b67-a5ca-08f7de9fa0f5" xlink:href="abvx-20241231.xsd#abvx_BCE20184Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20184Member_e938c0dc-e891-4b67-a5ca-08f7de9fa0f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20185Member_03dd53f4-f6e8-4bd0-a1c2-a8314ab7ad72" xlink:href="abvx-20241231.xsd#abvx_BCE20185Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20185Member_03dd53f4-f6e8-4bd0-a1c2-a8314ab7ad72" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_d1a7f87a-9344-4011-a634-bcc3a0dbe392" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_d1a7f87a-9344-4011-a634-bcc3a0dbe392" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_72774085-2c64-4394-9ebe-9a83f7554e96" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_72774085-2c64-4394-9ebe-9a83f7554e96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_3b81d1c9-72b7-443f-9508-3e7f741c07ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_3b81d1c9-72b7-443f-9508-3e7f741c07ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2df8374e-5df3-4292-b356-671fdcd28d34" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2df8374e-5df3-4292-b356-671fdcd28d34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1b793475-9652-407d-9312-6b8952de1e1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_9b51f311-7e22-4026-9eb6-6f8e85e863cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_9b51f311-7e22-4026-9eb6-6f8e85e863cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_82485889-92b6-42cc-aea8-7e0dba7dacbf" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_82485889-92b6-42cc-aea8-7e0dba7dacbf" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_2de7451b-c293-456a-8ec8-56210a70785d" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_abvx_TranchesAxis_2de7451b-c293-456a-8ec8-56210a70785d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_2de7451b-c293-456a-8ec8-56210a70785d_default" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_TranchesAxis_2de7451b-c293-456a-8ec8-56210a70785d" xlink:to="loc_abvx_TranchesDomain_2de7451b-c293-456a-8ec8-56210a70785d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_TranchesAxis_2de7451b-c293-456a-8ec8-56210a70785d" xlink:to="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_fc400c99-eea8-49cd-b560-86a0124332e9" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheOneMember_fc400c99-eea8-49cd-b560-86a0124332e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_3b668aa8-12da-4e1a-a015-c65c0f068125" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheTwoMember_3b668aa8-12da-4e1a-a015-c65c0f068125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheThreeMember_26bb78f5-ca0a-4a8b-b293-dabee10a8c8b" xlink:href="abvx-20241231.xsd#abvx_TrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheThreeMember_26bb78f5-ca0a-4a8b-b293-dabee10a8c8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFourMember_278b1148-7e7b-489d-8e10-a319c6cf526e" xlink:href="abvx-20241231.xsd#abvx_TrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheFourMember_278b1148-7e7b-489d-8e10-a319c6cf526e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFiveMember_18a56bc4-c060-4de1-b8f2-90db1717d396" xlink:href="abvx-20241231.xsd#abvx_TrancheFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheFiveMember_18a56bc4-c060-4de1-b8f2-90db1717d396" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheSixMember_a80369fd-b867-4ee6-9f55-3ed344070090" xlink:href="abvx-20241231.xsd#abvx_TrancheSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheSixMember_a80369fd-b867-4ee6-9f55-3ed344070090" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_674f7c3e-0d50-4081-b793-b17cb2ca0054" xlink:href="abvx-20241231.xsd#abvx_FoundersShareSubscriptionWarrantsBCEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_674f7c3e-0d50-4081-b793-b17cb2ca0054" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCEExceptBCE20142Member_d2e30575-e5d2-4de5-8e70-99d9fb6b8ccd" xlink:href="abvx-20241231.xsd#abvx_BCEExceptBCE20142Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_BCEExceptBCE20142Member_d2e30575-e5d2-4de5-8e70-99d9fb6b8ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_68eb02f7-43b1-494f-b839-7608f31ed909" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_68eb02f7-43b1-494f-b839-7608f31ed909" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241AndBSA20242Member_9e3364de-dee1-4cfe-a39c-46405f743153" xlink:href="abvx-20241231.xsd#abvx_BSA20241AndBSA20242Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_BSA20241AndBSA20242Member_9e3364de-dee1-4cfe-a39c-46405f743153" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2021Member_ddbc25c5-c6d3-4805-9007-043ef7abe8f8" xlink:href="abvx-20241231.xsd#abvx_AGA2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA2021Member_ddbc25c5-c6d3-4805-9007-043ef7abe8f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20231Member_967ea42d-a065-4e48-83e5-50e5cf08cb6f" xlink:href="abvx-20241231.xsd#abvx_AGA20231Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20231Member_967ea42d-a065-4e48-83e5-50e5cf08cb6f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20232Member_dfb9d585-b723-4ead-88d8-8adf663b496c" xlink:href="abvx-20241231.xsd#abvx_AGA20232Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20232Member_dfb9d585-b723-4ead-88d8-8adf663b496c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233AndAGA20234Member_bf67ae5c-ddf6-4b5c-90a6-9e7a53ee28c7" xlink:href="abvx-20241231.xsd#abvx_AGA20233AndAGA20234Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20233AndAGA20234Member_bf67ae5c-ddf6-4b5c-90a6-9e7a53ee28c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20235Member_0369eb9d-66ca-4daa-9afe-01cc045e13f4" xlink:href="abvx-20241231.xsd#abvx_AGA20235Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20235Member_0369eb9d-66ca-4daa-9afe-01cc045e13f4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233AGA20234AndAGA20235Member_8d13268d-700e-441c-837c-efbdfadf7b3c" xlink:href="abvx-20241231.xsd#abvx_AGA20233AGA20234AndAGA20235Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20233AGA20234AndAGA20235Member_8d13268d-700e-441c-837c-efbdfadf7b3c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241Member_0f69b9a9-0989-41ab-86a5-3fead41fa7b7" xlink:href="abvx-20241231.xsd#abvx_AGA20241Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20241Member_0f69b9a9-0989-41ab-86a5-3fead41fa7b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20242Member_e5c46600-5077-47a9-98af-e0fe4f16e0f6" xlink:href="abvx-20241231.xsd#abvx_AGA20242Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20242Member_e5c46600-5077-47a9-98af-e0fe4f16e0f6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20243Member_7a8b8a77-0772-4593-8d1c-628039cdd56b" xlink:href="abvx-20241231.xsd#abvx_AGA20243Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20243Member_7a8b8a77-0772-4593-8d1c-628039cdd56b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244AGA20245AndAGA20246Member_dc198177-6d5c-40cf-863c-4cd33bb269e8" xlink:href="abvx-20241231.xsd#abvx_AGA20244AGA20245AndAGA20246Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20244AGA20245AndAGA20246Member_dc198177-6d5c-40cf-863c-4cd33bb269e8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20247Member_71489bd5-dfc1-44bc-a810-6eb32aee835b" xlink:href="abvx-20241231.xsd#abvx_AGA20247Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20247Member_71489bd5-dfc1-44bc-a810-6eb32aee835b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member_78fa390b-1846-4c0c-8ab6-8467d85203d4" xlink:href="abvx-20241231.xsd#abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member_78fa390b-1846-4c0c-8ab6-8467d85203d4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_7df01135-538b-42a1-b1c8-ff2810930d49" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20246Member_7df01135-538b-42a1-b1c8-ff2810930d49" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingServiceConditionsAxis_1c8b45d4-b5c1-4958-865b-0b2a1195495f" xlink:href="abvx-20241231.xsd#abvx_VestingServiceConditionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_abvx_VestingServiceConditionsAxis_1c8b45d4-b5c1-4958-865b-0b2a1195495f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingServiceConditionsDomain_1c8b45d4-b5c1-4958-865b-0b2a1195495f_default" xlink:href="abvx-20241231.xsd#abvx_VestingServiceConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_VestingServiceConditionsAxis_1c8b45d4-b5c1-4958-865b-0b2a1195495f" xlink:to="loc_abvx_VestingServiceConditionsDomain_1c8b45d4-b5c1-4958-865b-0b2a1195495f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:href="abvx-20241231.xsd#abvx_VestingServiceConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_VestingServiceConditionsAxis_1c8b45d4-b5c1-4958-865b-0b2a1195495f" xlink:to="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingConditionsCompletedMember_33396b75-d6aa-421c-a361-56d80b49e021" xlink:href="abvx-20241231.xsd#abvx_VestingConditionsCompletedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:to="loc_abvx_VestingConditionsCompletedMember_33396b75-d6aa-421c-a361-56d80b49e021" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingConditionsNotCompletedMember_7950ba81-6679-4d3d-a714-255a5f538b30" xlink:href="abvx-20241231.xsd#abvx_VestingConditionsNotCompletedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:to="loc_abvx_VestingConditionsNotCompletedMember_7950ba81-6679-4d3d-a714-255a5f538b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_srt_TitleOfIndividualAxis_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a674fcbb-288f-449f-8d72-8906faf1899a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a674fcbb-288f-449f-8d72-8906faf1899a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FormerChiefExecutiveOfficerMember_d7c3862c-7ee8-4367-b4b0-728a7476a44b" xlink:href="abvx-20241231.xsd#abvx_FormerChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:to="loc_abvx_FormerChiefExecutiveOfficerMember_d7c3862c-7ee8-4367-b4b0-728a7476a44b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EmployeeMember_7c763109-c01b-4b09-aa2c-7523378e16e0" xlink:href="abvx-20241231.xsd#abvx_EmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:to="loc_abvx_EmployeeMember_7c763109-c01b-4b09-aa2c-7523378e16e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_662810ba-545e-46f7-9b24-49fc4079afdc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_srt_RangeAxis_662810ba-545e-46f7-9b24-49fc4079afdc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_662810ba-545e-46f7-9b24-49fc4079afdc_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_662810ba-545e-46f7-9b24-49fc4079afdc" xlink:to="loc_srt_RangeMember_662810ba-545e-46f7-9b24-49fc4079afdc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_037a1999-15dc-4c8e-a144-3ed9c3be5128" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_662810ba-545e-46f7-9b24-49fc4079afdc" xlink:to="loc_srt_RangeMember_037a1999-15dc-4c8e-a144-3ed9c3be5128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b871fec6-66ea-461a-93cf-0e3358794b2c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_037a1999-15dc-4c8e-a144-3ed9c3be5128" xlink:to="loc_srt_MaximumMember_b871fec6-66ea-461a-93cf-0e3358794b2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_7340df83-3fed-4680-b007-78239a2f2893" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_7340df83-3fed-4680-b007-78239a2f2893" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_def0c44c-a7fb-46c8-a3ea-8255d2b71128" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_def0c44c-a7fb-46c8-a3ea-8255d2b71128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth_3291b55e-44d2-41ab-a791-8b4b45bceba0" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth_3291b55e-44d2-41ab-a791-8b4b45bceba0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing_a1c4aba0-f112-4208-8e13-af0f3d8755c0" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing_a1c4aba0-f112-4208-8e13-af0f3d8755c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold_7d0fe689-bc2b-45b9-b237-33bc4259a359" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold_7d0fe689-bc2b-45b9-b237-33bc4259a359" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2b720642-6dcd-4a4e-bfb2-e2b27bc69e99" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2b720642-6dcd-4a4e-bfb2-e2b27bc69e99" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod_c3337f34-0bb2-45cb-9385-d54f7d95942f" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod_c3337f34-0bb2-45cb-9385-d54f7d95942f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare_f3caffe3-2682-40cc-b1fd-7c64d610c5f8" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare_f3caffe3-2682-40cc-b1fd-7c64d610c5f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_128701bc-55b2-42e4-bc13-2ae9a772e978" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_128701bc-55b2-42e4-bc13-2ae9a772e978" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_c6d0dc6e-e16f-4069-8b03-f133e7314d39" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_c6d0dc6e-e16f-4069-8b03-f133e7314d39" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod_61e79c0b-b9dc-4da6-867e-50d8f77f8aa3" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod_61e79c0b-b9dc-4da6-867e-50d8f77f8aa3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition_bd5ec50c-6807-45a2-8417-30da2a73879c" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition_bd5ec50c-6807-45a2-8417-30da2a73879c" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_62261d90-4f88-448e-bade-9d831497508d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_62261d90-4f88-448e-bade-9d831497508d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_d41dcabe-241c-40db-a787-143c057dc3c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_62261d90-4f88-448e-bade-9d831497508d" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_d41dcabe-241c-40db-a787-143c057dc3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d41dcabe-241c-40db-a787-143c057dc3c0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_d41dcabe-241c-40db-a787-143c057dc3c0" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d41dcabe-241c-40db-a787-143c057dc3c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5e48b829-7410-4473-9769-68ce676a9248" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_d41dcabe-241c-40db-a787-143c057dc3c0" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5e48b829-7410-4473-9769-68ce676a9248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5e48b829-7410-4473-9769-68ce676a9248" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA201511Member_0f34ac5b-5da3-4b44-b5c8-2fe0a559730f" xlink:href="abvx-20241231.xsd#abvx_BSA201511Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA201511Member_0f34ac5b-5da3-4b44-b5c8-2fe0a559730f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA201512Member_fb8503d5-8fcf-4248-8ecd-a9eb3a82755d" xlink:href="abvx-20241231.xsd#abvx_BSA201512Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA201512Member_fb8503d5-8fcf-4248-8ecd-a9eb3a82755d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20171Member_a4d25ea4-1817-45f6-9235-637365b82e38" xlink:href="abvx-20241231.xsd#abvx_BSA20171Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20171Member_a4d25ea4-1817-45f6-9235-637365b82e38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20181Member_3c0d4ab1-f2a0-4ef5-b4f6-7d872569e43b" xlink:href="abvx-20241231.xsd#abvx_BSA20181Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20181Member_3c0d4ab1-f2a0-4ef5-b4f6-7d872569e43b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20144Member_3ecc8a2c-e792-4cfc-ab8b-79dfdd600ee1" xlink:href="abvx-20241231.xsd#abvx_BSA20144Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20144Member_3ecc8a2c-e792-4cfc-ab8b-79dfdd600ee1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20145Member_cb509fba-d7ec-4245-bc20-1e6c206f7660" xlink:href="abvx-20241231.xsd#abvx_BSA20145Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20145Member_cb509fba-d7ec-4245-bc20-1e6c206f7660" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241Member_d8799c05-35f7-46b3-b8f1-953c07f11fef" xlink:href="abvx-20241231.xsd#abvx_BSA20241Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20241Member_d8799c05-35f7-46b3-b8f1-953c07f11fef" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20242Member_3e4192f7-902d-4558-a25f-90fe7a7de3e3" xlink:href="abvx-20241231.xsd#abvx_BSA20242Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20242Member_3e4192f7-902d-4558-a25f-90fe7a7de3e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_86ea9f05-336d-42f7-a09f-6c0b26ff4d8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_86ea9f05-336d-42f7-a09f-6c0b26ff4d8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_c1abe380-db05-4dac-972a-57167715b1ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_c1abe380-db05-4dac-972a-57167715b1ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_b7930b4b-6bfb-471c-b269-667e39782757" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_b7930b4b-6bfb-471c-b269-667e39782757" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_331fed40-307d-4b08-9276-3768f0beb9e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_331fed40-307d-4b08-9276-3768f0beb9e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_c7b89e06-7fea-4477-9d79-40b51cc03e8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_4f956b57-7a7c-4016-9a71-b1c4a12ebf5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_4f956b57-7a7c-4016-9a71-b1c4a12ebf5a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_90f95823-26e6-4b89-bed1-a6407e0dda69" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_90f95823-26e6-4b89-bed1-a6407e0dda69" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e14d45d0-82b9-4407-81af-49121e66f6c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e14d45d0-82b9-4407-81af-49121e66f6c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e14d45d0-82b9-4407-81af-49121e66f6c3_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e14d45d0-82b9-4407-81af-49121e66f6c3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e14d45d0-82b9-4407-81af-49121e66f6c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e14d45d0-82b9-4407-81af-49121e66f6c3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241Member_ed541d9b-5d44-4dc2-9a10-b9bced162c2e" xlink:href="abvx-20241231.xsd#abvx_BSA20241Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:to="loc_abvx_BSA20241Member_ed541d9b-5d44-4dc2-9a10-b9bced162c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20242Member_02969352-9b57-4e57-95a5-0e09166aa4df" xlink:href="abvx-20241231.xsd#abvx_BSA20242Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:to="loc_abvx_BSA20242Member_02969352-9b57-4e57-95a5-0e09166aa4df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_c3b42e52-63db-4090-8cd3-195ffde0a23c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:to="loc_ifrs-full_RangeAxis_c3b42e52-63db-4090-8cd3-195ffde0a23c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_c3b42e52-63db-4090-8cd3-195ffde0a23c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_c3b42e52-63db-4090-8cd3-195ffde0a23c" xlink:to="loc_ifrs-full_RangeDomain_c3b42e52-63db-4090-8cd3-195ffde0a23c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_c3b42e52-63db-4090-8cd3-195ffde0a23c" xlink:to="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dc8c3342-749a-4a14-8233-fe8c515bb4af" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:to="loc_srt_MinimumMember_dc8c3342-749a-4a14-8233-fe8c515bb4af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_77e44785-4610-4196-9e87-c60651f864bc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:to="loc_srt_MaximumMember_77e44785-4610-4196-9e87-c60651f864bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_648cc274-d069-4cd8-af3a-dcaa296d94e0" xlink:href="abvx-20241231.xsd#abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_648cc274-d069-4cd8-af3a-dcaa296d94e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_7f9fc7dd-5a47-402d-ad4c-126738741285" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_7f9fc7dd-5a47-402d-ad4c-126738741285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_9959d68d-075c-47c6-b4e1-94bfe1a1d5ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_9959d68d-075c-47c6-b4e1-94bfe1a1d5ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_e34013e1-6b80-40d5-8514-8b77b58253da" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_e34013e1-6b80-40d5-8514-8b77b58253da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted_44de611c-1f0a-4ac1-8e92-bdbca1b239df" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted_44de611c-1f0a-4ac1-8e92-bdbca1b239df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_729fd23a-5950-4454-bb2d-e09d1e7db0aa" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_729fd23a-5950-4454-bb2d-e09d1e7db0aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedMaturityOtherEquityInstrumentsGranted_5b9d5ead-eda7-4a17-94a5-b97cca4f997e" xlink:href="abvx-20241231.xsd#abvx_ExpectedMaturityOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_ExpectedMaturityOtherEquityInstrumentsGranted_5b9d5ead-eda7-4a17-94a5-b97cca4f997e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_ad466d10-7d46-4e15-a80b-cdb5c9e8cda0" xlink:href="abvx-20241231.xsd#abvx_ExpectedVolatilityOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_ad466d10-7d46-4e15-a80b-cdb5c9e8cda0" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofreconciliationofAGAsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_5ca7ad67-6113-40aa-a74a-59917b84d9b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_5ca7ad67-6113-40aa-a74a-59917b84d9b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_5ca7ad67-6113-40aa-a74a-59917b84d9b4" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_846c8d8f-083c-46f0-95ba-1ca2c4bd860f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_846c8d8f-083c-46f0-95ba-1ca2c4bd860f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:href="abvx-20241231.xsd#abvx_FreeSharesAGAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_846c8d8f-083c-46f0-95ba-1ca2c4bd860f" xlink:to="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20231Member_60b26eef-6c1c-46c1-bc6c-23aff09e4c7d" xlink:href="abvx-20241231.xsd#abvx_AGA20231Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20231Member_60b26eef-6c1c-46c1-bc6c-23aff09e4c7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20232Member_adb41adf-ce9c-4ba6-8be2-8906611f6c37" xlink:href="abvx-20241231.xsd#abvx_AGA20232Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20232Member_adb41adf-ce9c-4ba6-8be2-8906611f6c37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233Member_739f012b-5981-4ae7-8d4d-9483d0f38eef" xlink:href="abvx-20241231.xsd#abvx_AGA20233Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20233Member_739f012b-5981-4ae7-8d4d-9483d0f38eef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20234Member_f8a34576-2d2b-4914-92a5-27ed971411ad" xlink:href="abvx-20241231.xsd#abvx_AGA20234Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20234Member_f8a34576-2d2b-4914-92a5-27ed971411ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20235Member_707b4eac-6d63-4068-88ce-9299b902b855" xlink:href="abvx-20241231.xsd#abvx_AGA20235Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20235Member_707b4eac-6d63-4068-88ce-9299b902b855" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241Member_fbf59037-67b0-4371-a225-183ca91bdf8b" xlink:href="abvx-20241231.xsd#abvx_AGA20241Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20241Member_fbf59037-67b0-4371-a225-183ca91bdf8b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20242Member_abd11b2f-c950-4f53-b287-2c9101b18ff4" xlink:href="abvx-20241231.xsd#abvx_AGA20242Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20242Member_abd11b2f-c950-4f53-b287-2c9101b18ff4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20243Member_ed3e483f-7173-40b4-8c2d-9bff2a6237e0" xlink:href="abvx-20241231.xsd#abvx_AGA20243Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20243Member_ed3e483f-7173-40b4-8c2d-9bff2a6237e0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244Member_4b7a816f-c734-46bc-89d2-1b92d8e234dc" xlink:href="abvx-20241231.xsd#abvx_AGA20244Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20244Member_4b7a816f-c734-46bc-89d2-1b92d8e234dc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20245Member_52484f26-353c-4d18-84d1-cb8257bd49ac" xlink:href="abvx-20241231.xsd#abvx_AGA20245Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20245Member_52484f26-353c-4d18-84d1-cb8257bd49ac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_3c7c53dc-1fa3-4fe2-bad3-451b12e4b48f" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20246Member_3c7c53dc-1fa3-4fe2-bad3-451b12e4b48f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20247Member_0be8b730-af0a-4cd3-87b1-c1517abe05d3" xlink:href="abvx-20241231.xsd#abvx_AGA20247Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20247Member_0be8b730-af0a-4cd3-87b1-c1517abe05d3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_10ad5140-c3a0-46f5-bb3a-39a73d3d682b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_10ad5140-c3a0-46f5-bb3a-39a73d3d682b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_839c040f-8388-41e2-a778-e0ec87ce8389" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_839c040f-8388-41e2-a778-e0ec87ce8389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_e12af140-8f73-482a-9e1c-3ce2dea69c7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_e12af140-8f73-482a-9e1c-3ce2dea69c7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_5c3d070d-a49b-4e34-b96e-df208239d8ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_5c3d070d-a49b-4e34-b96e-df208239d8ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_a751a1c7-2433-4433-8da0-80546198cd10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_743760ad-8ff2-445b-a6f9-55db5004330f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_743760ad-8ff2-445b-a6f9-55db5004330f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_743760ad-8ff2-445b-a6f9-55db5004330f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_743760ad-8ff2-445b-a6f9-55db5004330f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_743760ad-8ff2-445b-a6f9-55db5004330f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_743760ad-8ff2-445b-a6f9-55db5004330f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2021Member_b0291167-6f81-4a2f-a1bb-e48525653a0a" xlink:href="abvx-20241231.xsd#abvx_AGA2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA2021Member_b0291167-6f81-4a2f-a1bb-e48525653a0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20231Member_919cc720-2abc-40ee-ac78-0e168bc91c25" xlink:href="abvx-20241231.xsd#abvx_AGA20231Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20231Member_919cc720-2abc-40ee-ac78-0e168bc91c25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20232Member_26cec586-6df5-4124-89cd-2a10672a7ad5" xlink:href="abvx-20241231.xsd#abvx_AGA20232Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20232Member_26cec586-6df5-4124-89cd-2a10672a7ad5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233Member_40c564c2-c09f-420a-9345-e4a958785b38" xlink:href="abvx-20241231.xsd#abvx_AGA20233Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20233Member_40c564c2-c09f-420a-9345-e4a958785b38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20234Member_4117b272-85f2-4deb-bc3c-3d90fb45bfc2" xlink:href="abvx-20241231.xsd#abvx_AGA20234Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20234Member_4117b272-85f2-4deb-bc3c-3d90fb45bfc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20235Member_070edb76-2675-4361-90a6-f0955a8d4505" xlink:href="abvx-20241231.xsd#abvx_AGA20235Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20235Member_070edb76-2675-4361-90a6-f0955a8d4505" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241Member_b34a80a4-010f-444d-9503-f290099c2955" xlink:href="abvx-20241231.xsd#abvx_AGA20241Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20241Member_b34a80a4-010f-444d-9503-f290099c2955" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20242Member_a14efb12-2eac-4bae-8abe-24f04938fe19" xlink:href="abvx-20241231.xsd#abvx_AGA20242Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20242Member_a14efb12-2eac-4bae-8abe-24f04938fe19" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20243Member_b233ca2e-249c-4286-a3b4-f308d56a1f18" xlink:href="abvx-20241231.xsd#abvx_AGA20243Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20243Member_b233ca2e-249c-4286-a3b4-f308d56a1f18" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244Member_817891c4-175a-4469-97c1-c368197d2963" xlink:href="abvx-20241231.xsd#abvx_AGA20244Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20244Member_817891c4-175a-4469-97c1-c368197d2963" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20245Member_fdf308b3-0874-493b-8797-610974050c42" xlink:href="abvx-20241231.xsd#abvx_AGA20245Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20245Member_fdf308b3-0874-493b-8797-610974050c42" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_6c709358-e437-4783-bb86-d5232584c282" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20246Member_6c709358-e437-4783-bb86-d5232584c282" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20247Member_9c21cab4-5357-4422-9f56-fd638940fd82" xlink:href="abvx-20241231.xsd#abvx_AGA20247Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20247Member_9c21cab4-5357-4422-9f56-fd638940fd82" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:to="loc_abvx_TranchesAxis_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2_default" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_TranchesAxis_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2" xlink:to="loc_abvx_TranchesDomain_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_TranchesAxis_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2" xlink:to="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesOneToFourMember_c1ca2fda-6cce-4065-801d-152a02eec3dd" xlink:href="abvx-20241231.xsd#abvx_TranchesOneToFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TranchesOneToFourMember_c1ca2fda-6cce-4065-801d-152a02eec3dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFiveMember_14db4d58-03ac-4a57-8be4-5b0c347fe5ea" xlink:href="abvx-20241231.xsd#abvx_TrancheFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheFiveMember_14db4d58-03ac-4a57-8be4-5b0c347fe5ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheSixMember_10fbce2c-1aa2-4762-a6c1-2e486993e18d" xlink:href="abvx-20241231.xsd#abvx_TrancheSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheSixMember_10fbce2c-1aa2-4762-a6c1-2e486993e18d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_8de37559-555e-4843-a48f-197d1f339406" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheOneMember_8de37559-555e-4843-a48f-197d1f339406" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_59e71097-7536-4f45-841d-f0c238c6cf25" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheTwoMember_59e71097-7536-4f45-841d-f0c238c6cf25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_c438a33e-4502-4435-9d6f-56f5ad38bb39" xlink:href="abvx-20241231.xsd#abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_c438a33e-4502-4435-9d6f-56f5ad38bb39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_5e3e5295-7d59-409e-938d-b04d9af57bb0" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_5e3e5295-7d59-409e-938d-b04d9af57bb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_b9b5f71c-fdc1-4425-ba07-3c03e6c6342e" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_b9b5f71c-fdc1-4425-ba07-3c03e6c6342e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_1cf8294a-3c8c-45e2-bd11-568520090038" xlink:href="abvx-20241231.xsd#abvx_ExpectedVolatilityOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_1cf8294a-3c8c-45e2-bd11-568520090038" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_956abdc7-0a44-45d0-9a50-c89082be65a5" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_956abdc7-0a44-45d0-9a50-c89082be65a5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_83ce781f-12b1-4ccf-a683-89d8ff46bff3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_83ce781f-12b1-4ccf-a683-89d8ff46bff3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c262fa5c-853b-4d13-884b-3767e34497a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_83ce781f-12b1-4ccf-a683-89d8ff46bff3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c262fa5c-853b-4d13-884b-3767e34497a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_c262fa5c-853b-4d13-884b-3767e34497a6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c262fa5c-853b-4d13-884b-3767e34497a6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_c262fa5c-853b-4d13-884b-3767e34497a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c262fa5c-853b-4d13-884b-3767e34497a6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_dbb84f6c-9d2d-4174-a9ac-511737e03731" xlink:href="abvx-20241231.xsd#abvx_FoundersShareSubscriptionWarrantsBCEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:to="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_dbb84f6c-9d2d-4174-a9ac-511737e03731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_2bece2fa-04fe-41ab-8f81-2f6f23eb5682" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_2bece2fa-04fe-41ab-8f81-2f6f23eb5682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FreeSharesAGAMember_79e3e43c-1871-4d24-856b-636e52a312f9" xlink:href="abvx-20241231.xsd#abvx_FreeSharesAGAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:to="loc_abvx_FreeSharesAGAMember_79e3e43c-1871-4d24-856b-636e52a312f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_54e4f7ed-94ca-464e-8d5f-6a637fa48c4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_54e4f7ed-94ca-464e-8d5f-6a637fa48c4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_647e8b4f-1978-4f55-a4b1-886da3e186a0" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:to="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_647e8b4f-1978-4f55-a4b1-886da3e186a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_87d19ad2-d49d-47d5-8b70-cfe05cc41ece" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_87d19ad2-d49d-47d5-8b70-cfe05cc41ece" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d175e812-e333-44f1-8073-bcae13dbc943" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d175e812-e333-44f1-8073-bcae13dbc943" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_64410de0-25fa-4389-983d-847baf51dfab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d175e812-e333-44f1-8073-bcae13dbc943" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_64410de0-25fa-4389-983d-847baf51dfab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_64410de0-25fa-4389-983d-847baf51dfab_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_64410de0-25fa-4389-983d-847baf51dfab" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_64410de0-25fa-4389-983d-847baf51dfab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_64410de0-25fa-4389-983d-847baf51dfab" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:href="abvx-20241231.xsd#abvx_BorrowingsByNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_9d696f7f-f560-4d68-9cda-020fded228c0" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_abvx_Kreos12BondLoansMember_9d696f7f-f560-4d68-9cda-020fded228c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ClaretBondLoansMember_d8e50d4b-5554-428e-8d28-d92685d442d8" xlink:href="abvx-20241231.xsd#abvx_Kreos1ClaretBondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_abvx_Kreos1ClaretBondLoansMember_d8e50d4b-5554-428e-8d28-d92685d442d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_fe30982f-01d2-44f9-908d-edf9589df72e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_fe30982f-01d2-44f9-908d-edf9589df72e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_337fba63-0ac1-4bb6-9e08-575d9db5635d" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_337fba63-0ac1-4bb6-9e08-575d9db5635d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_44f3c37b-4b39-41e6-9f77-da6c1b1355ee" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_44f3c37b-4b39-41e6-9f77-da6c1b1355ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_467f7aec-c96c-49c1-a2dd-011ea236061f" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:to="loc_abvx_OCEANEMember_467f7aec-c96c-49c1-a2dd-011ea236061f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_cda85a63-0c70-487a-ad38-54cd636382c9" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:to="loc_abvx_HeightsConvertibleNotesMember_cda85a63-0c70-487a-ad38-54cd636382c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_65d03384-225f-4c29-b983-1f1b460ee19d" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_Kreos1Member_65d03384-225f-4c29-b983-1f1b460ee19d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_dec75f84-72fc-4339-8f5d-f66a7cc2261b" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_OceaneConversionOptionMember_dec75f84-72fc-4339-8f5d-f66a7cc2261b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_744791ee-085d-4707-b810-68aa470db106" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_744791ee-085d-4707-b810-68aa470db106" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingBSAMember_8b36f22e-9f87-4580-a99d-1bd03e17cf69" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_KreosClaretFinancingBSAMember_8b36f22e-9f87-4580-a99d-1bd03e17cf69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesMember_c5fbc75f-1cb7-4b46-8c03-d780e6b2b3cc" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:to="loc_abvx_ConditionalAdvancesMember_c5fbc75f-1cb7-4b46-8c03-d780e6b2b3cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_772b8e72-76ef-42f0-bd1e-d59947aea8ef" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:to="loc_abvx_RoyaltyCertificatesMember_772b8e72-76ef-42f0-bd1e-d59947aea8ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialLiabilities_74a9a7ba-6136-4a62-95dc-11820d31c220" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:to="loc_ifrs-full_NoncurrentFinancialLiabilities_74a9a7ba-6136-4a62-95dc-11820d31c220" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialLiabilities_29184dd7-c9d4-4357-9e20-64003b020d2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:to="loc_ifrs-full_CurrentFinancialLiabilities_29184dd7-c9d4-4357-9e20-64003b020d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_9978c819-3b79-4761-8066-c858ffa38957" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:to="loc_ifrs-full_FinancialLiabilities_9978c819-3b79-4761-8066-c858ffa38957" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesKreosClaretFinancingDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_69175095-2b6a-4f0b-8c97-9819b376b09d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_69175095-2b6a-4f0b-8c97-9819b376b09d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_69175095-2b6a-4f0b-8c97-9819b376b09d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_69175095-2b6a-4f0b-8c97-9819b376b09d" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_69175095-2b6a-4f0b-8c97-9819b376b09d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_69175095-2b6a-4f0b-8c97-9819b376b09d" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:to="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_9fa490d2-400e-4722-884c-8d6d623f08c2" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_9fa490d2-400e-4722-884c-8d6d623f08c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:to="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_ab361980-a16e-4993-bb3d-69f8ba7d0dc7" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_ab361980-a16e-4993-bb3d-69f8ba7d0dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheCMember_f6b6e91c-3d42-4605-a361-9fd45fd81051" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:to="loc_abvx_KreosClaretFinancingTrancheCMember_f6b6e91c-3d42-4605-a361-9fd45fd81051" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1BondLoansMember_1c113d7e-cea3-4622-ad7c-c6d177cf33f6" xlink:href="abvx-20241231.xsd#abvx_Kreos1BondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:to="loc_abvx_Kreos1BondLoansMember_1c113d7e-cea3-4622-ad7c-c6d177cf33f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_2886855f-b780-45d4-8c08-2bd7efeb047b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_2886855f-b780-45d4-8c08-2bd7efeb047b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_2886855f-b780-45d4-8c08-2bd7efeb047b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_2886855f-b780-45d4-8c08-2bd7efeb047b" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_2886855f-b780-45d4-8c08-2bd7efeb047b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_4bf490e8-cd10-44dd-8afc-0cc11f82c829" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_2886855f-b780-45d4-8c08-2bd7efeb047b" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_4bf490e8-cd10-44dd-8afc-0cc11f82c829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuropeanCentralBankBaseRateMember_f35b5593-cca8-41b5-85a9-35b3a00e6710" xlink:href="abvx-20241231.xsd#abvx_EuropeanCentralBankBaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_4bf490e8-cd10-44dd-8afc-0cc11f82c829" xlink:to="loc_abvx_EuropeanCentralBankBaseRateMember_f35b5593-cca8-41b5-85a9-35b3a00e6710" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_b15006aa-26c6-40dd-9e37-2282065825ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_RangeAxis_b15006aa-26c6-40dd-9e37-2282065825ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_b15006aa-26c6-40dd-9e37-2282065825ae_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_b15006aa-26c6-40dd-9e37-2282065825ae" xlink:to="loc_ifrs-full_RangeDomain_b15006aa-26c6-40dd-9e37-2282065825ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_b15006aa-26c6-40dd-9e37-2282065825ae" xlink:to="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_4c7a764c-7f6f-429f-91ba-c7897a5fde7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:to="loc_ifrs-full_BottomOfRangeMember_4c7a764c-7f6f-429f-91ba-c7897a5fde7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_6359b0ed-912d-4378-aee5-191c523db89f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:to="loc_ifrs-full_TopOfRangeMember_6359b0ed-912d-4378-aee5-191c523db89f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_c654fa03-9602-4089-82b3-b4677c401f24" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_abvx_WarrantsAxis_c654fa03-9602-4089-82b3-b4677c401f24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_c654fa03-9602-4089-82b3-b4677c401f24_default" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_WarrantsAxis_c654fa03-9602-4089-82b3-b4677c401f24" xlink:to="loc_abvx_WarrantsDomain_c654fa03-9602-4089-82b3-b4677c401f24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_WarrantsAxis_c654fa03-9602-4089-82b3-b4677c401f24" xlink:to="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_d1b04a48-9b0d-4fdf-8b62-8a5959f5279e" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:to="loc_abvx_KreosABBSAMember_d1b04a48-9b0d-4fdf-8b62-8a5959f5279e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_646b639b-981e-401f-afc0-35a05672d596" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:to="loc_abvx_KreosCBSAMember_646b639b-981e-401f-afc0-35a05672d596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABCBSAMember_a33c8210-0e4e-491a-a1c4-e69a11fc0bc8" xlink:href="abvx-20241231.xsd#abvx_KreosABCBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:to="loc_abvx_KreosABCBSAMember_a33c8210-0e4e-491a-a1c4-e69a11fc0bc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_84760d92-b12d-4959-8f4c-8b33c4040c60" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_UnobservableInputsAxis_84760d92-b12d-4959-8f4c-8b33c4040c60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_84760d92-b12d-4959-8f4c-8b33c4040c60_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_84760d92-b12d-4959-8f4c-8b33c4040c60" xlink:to="loc_ifrs-full_UnobservableInputsDomain_84760d92-b12d-4959-8f4c-8b33c4040c60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_84760d92-b12d-4959-8f4c-8b33c4040c60" xlink:to="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MarketRateMeasurementInputMember_7be2618f-a5cc-4639-8f8b-c062c0a0c1c6" xlink:href="abvx-20241231.xsd#abvx_MarketRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_MarketRateMeasurementInputMember_7be2618f-a5cc-4639-8f8b-c062c0a0c1c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_f3c0571e-ba6e-43f9-90da-bd37c650f5a7" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_SharePriceMeasurementInputMember_f3c0571e-ba6e-43f9-90da-bd37c650f5a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_a2b9b798-70e1-4969-8e73-d661c8f7a922" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_a2b9b798-70e1-4969-8e73-d661c8f7a922" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_36d4e825-915b-4350-a889-e8a14b643065" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_36d4e825-915b-4350-a889-e8a14b643065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_0c1a5440-6f8f-422c-80f4-701e6ac6eeb2" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_0c1a5440-6f8f-422c-80f4-701e6ac6eeb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountRateMeasurementInputMember_88778168-9cb2-4392-ad3f-ca6e2d1d4bc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_ifrs-full_DiscountRateMeasurementInputMember_88778168-9cb2-4392-ad3f-ca6e2d1d4bc8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_81c1a684-56ed-4d88-b136-6b0fe7f6e81c" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioProbablityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_81c1a684-56ed-4d88-b136-6b0fe7f6e81c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f9805673-bf12-4c9d-ae6f-f6de76f4e51e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f9805673-bf12-4c9d-ae6f-f6de76f4e51e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f9805673-bf12-4c9d-ae6f-f6de76f4e51e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f9805673-bf12-4c9d-ae6f-f6de76f4e51e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f9805673-bf12-4c9d-ae6f-f6de76f4e51e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f9805673-bf12-4c9d-ae6f-f6de76f4e51e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_7d3f8c88-e93f-42f8-a382-aba09c34e9ed" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosABBSAMember_7d3f8c88-e93f-42f8-a382-aba09c34e9ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_43812906-9a51-4e36-9556-843fa967f273" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosCBSAMember_43812906-9a51-4e36-9556-843fa967f273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABCBSAMember_ae1cf58f-7186-49f2-98d9-21d6efee5b2d" xlink:href="abvx-20241231.xsd#abvx_KreosABCBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosABCBSAMember_ae1cf58f-7186-49f2-98d9-21d6efee5b2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_62344c8a-ad36-41ed-9efc-5b2c9bf27d0a" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_62344c8a-ad36-41ed-9efc-5b2c9bf27d0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_1241143a-243a-4d82-9265-8df959afe221" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_1241143a-243a-4d82-9265-8df959afe221" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_1241143a-243a-4d82-9265-8df959afe221_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_1241143a-243a-4d82-9265-8df959afe221" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_1241143a-243a-4d82-9265-8df959afe221_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_1241143a-243a-4d82-9265-8df959afe221" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BlackScholesModelMember_d0b6c430-cbec-428a-b64a-16fdae0c6e3b" xlink:href="abvx-20241231.xsd#abvx_BlackScholesModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:to="loc_abvx_BlackScholesModelMember_d0b6c430-cbec-428a-b64a-16fdae0c6e3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModel1Member_290a2d47-df15-47ef-bb36-77765f2beba2" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:to="loc_abvx_MonteCarloModel1Member_290a2d47-df15-47ef-bb36-77765f2beba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_e05c7018-525b-4e8e-8770-83d180184f44" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_e05c7018-525b-4e8e-8770-83d180184f44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_217ccee7-4ea1-4cb5-81a4-971df1a3c537" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsNumberOfTranches_217ccee7-4ea1-4cb5-81a4-971df1a3c537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_690b3361-6d5f-4ecf-8aba-ff105c5d7670" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacityPerTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_690b3361-6d5f-4ecf-8aba-ff105c5d7670" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_5642054c-82ea-447c-9a13-1788d1326ba9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_5642054c-82ea-447c-9a13-1788d1326ba9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsFixedConversionPrice_3e16bb02-740e-4bce-8ae4-7fbbb625fac0" xlink:href="abvx-20241231.xsd#abvx_BorrowingsFixedConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsFixedConversionPrice_3e16bb02-740e-4bce-8ae4-7fbbb625fac0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_b91e2f4e-90b3-40cd-a827-896a14a36cf3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_BorrowingsInterestRate_b91e2f4e-90b3-40cd-a827-896a14a36cf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsEarlyRepaymentDiscountRate_a9a1c758-c4e5-467c-a63f-1fa6ef545607" xlink:href="abvx-20241231.xsd#abvx_BorrowingsEarlyRepaymentDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsEarlyRepaymentDiscountRate_a9a1c758-c4e5-467c-a63f-1fa6ef545607" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentage_b8d94119-f0d5-4755-99e9-c6408cf9e168" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsExitFeePercentage_b8d94119-f0d5-4755-99e9-c6408cf9e168" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsDebtToMarketCapitalizationRatio_3a1ee2d7-eac1-4e2f-b456-4b812d294a63" xlink:href="abvx-20241231.xsd#abvx_BorrowingsDebtToMarketCapitalizationRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsDebtToMarketCapitalizationRatio_3a1ee2d7-eac1-4e2f-b456-4b812d294a63" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsPerformanceConditionsMinimumFinancing_f2d7cdf8-3c8c-4872-8879-9ad80fb3352c" xlink:href="abvx-20241231.xsd#abvx_BorrowingsPerformanceConditionsMinimumFinancing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsPerformanceConditionsMinimumFinancing_f2d7cdf8-3c8c-4872-8879-9ad80fb3352c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_54504e0f-7cc7-4193-86f8-0e2d9da3313d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_54504e0f-7cc7-4193-86f8-0e2d9da3313d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsBasisInterestRate_de158ebb-3d1c-42b9-924d-0ec68f91ea74" xlink:href="abvx-20241231.xsd#abvx_BorrowingsBasisInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsBasisInterestRate_de158ebb-3d1c-42b9-924d-0ec68f91ea74" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_64785559-025b-4c94-9655-78372ccc839e" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_64785559-025b-4c94-9655-78372ccc839e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsGranted_de87a851-cd04-4500-a03c-6259c9d052d9" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_NumberOfWarrantsGranted_de87a851-cd04-4500-a03c-6259c9d052d9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_3be1745f-cea2-487e-8100-b98a728a5f15" xlink:href="abvx-20241231.xsd#abvx_ExercisePriceOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_3be1745f-cea2-487e-8100-b98a728a5f15" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_acc3ebde-cecf-4b62-9e6c-5ff394a58c27" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_acc3ebde-cecf-4b62-9e6c-5ff394a58c27" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_5170ae0a-372d-45c4-9254-78e5bae4ec54" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_5170ae0a-372d-45c4-9254-78e5bae4ec54" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfOtherShareWarrants_c1751cfd-7562-4436-ac13-71ae1e70a683" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfOtherShareWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_IssuanceOfOtherShareWarrants_c1751cfd-7562-4436-ac13-71ae1e70a683" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately_87823fff-9ff4-44d4-b55d-f1e99f5a79df" xlink:href="abvx-20241231.xsd#abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately_87823fff-9ff4-44d4-b55d-f1e99f5a79df" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable_068e4c55-e0e9-470b-bc0d-e8abca94c4f9" xlink:href="abvx-20241231.xsd#abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable_068e4c55-e0e9-470b-bc0d-e8abca94c4f9" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsExercisePeriod_938baf67-1b63-4867-bc4d-c5b7d156cb4e" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsExercisePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_OtherShareWarrantsExercisePeriod_938baf67-1b63-4867-bc4d-c5b7d156cb4e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfBondLoans_f962e0b3-3146-4527-8ed9-4f8a78e0f01f" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfBondLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_RepaymentsOfBondLoans_f962e0b3-3146-4527-8ed9-4f8a78e0f01f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_76c7a1e5-fd68-44a4-ad5b-fb2649aaef2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_76c7a1e5-fd68-44a4-ad5b-fb2649aaef2b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_8eee8805-557a-4548-9fe7-bfb55094722d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_8eee8805-557a-4548-9fe7-bfb55094722d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_06db1897-ff8e-4288-80ef-455b453aa628" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ConvertibleLoansNotes_06db1897-ff8e-4288-80ef-455b453aa628" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent_fd9dfcd2-4be9-46e1-9b45-f3e5215b68dd" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent_fd9dfcd2-4be9-46e1-9b45-f3e5215b68dd" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_bd8478b3-9536-4756-a1cc-cefcbee378f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_bd8478b3-9536-4756-a1cc-cefcbee378f0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_69071353-79a9-4e82-9ade-bac4e9a1cfb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_69071353-79a9-4e82-9ade-bac4e9a1cfb4" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a6626045-6a74-4726-9e3a-9b4d3e157f61" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a6626045-6a74-4726-9e3a-9b4d3e157f61" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_786a6278-5a7c-4a81-9da7-7e8094957932" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_786a6278-5a7c-4a81-9da7-7e8094957932" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_096b0c66-ff1c-46b5-98b0-8909ce5b0604" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_096b0c66-ff1c-46b5-98b0-8909ce5b0604" xlink:type="arc" order="30"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_9012c928-0486-4467-a4ef-0946a4f053a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_9012c928-0486-4467-a4ef-0946a4f053a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_9012c928-0486-4467-a4ef-0946a4f053a5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_9012c928-0486-4467-a4ef-0946a4f053a5" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_9012c928-0486-4467-a4ef-0946a4f053a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_95d22a16-2227-4a94-8b04-85fe2a353a2a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_9012c928-0486-4467-a4ef-0946a4f053a5" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_95d22a16-2227-4a94-8b04-85fe2a353a2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_47eb46f1-d0e9-4a40-a596-c0e9135b6818" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_95d22a16-2227-4a94-8b04-85fe2a353a2a" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_47eb46f1-d0e9-4a40-a596-c0e9135b6818" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_f3153a57-a360-4cf6-aca2-00f57c69973d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_ifrs-full_UnobservableInputsAxis_f3153a57-a360-4cf6-aca2-00f57c69973d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_f3153a57-a360-4cf6-aca2-00f57c69973d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_f3153a57-a360-4cf6-aca2-00f57c69973d" xlink:to="loc_ifrs-full_UnobservableInputsDomain_f3153a57-a360-4cf6-aca2-00f57c69973d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_f3153a57-a360-4cf6-aca2-00f57c69973d" xlink:to="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_53918e9f-1767-45d7-8a2b-f4c708fc37b4" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_53918e9f-1767-45d7-8a2b-f4c708fc37b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MinimalReturnMeasurementInputMember_4a213c60-941c-4c34-99ea-58a4d9990df3" xlink:href="abvx-20241231.xsd#abvx_MinimalReturnMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_MinimalReturnMeasurementInputMember_4a213c60-941c-4c34-99ea-58a4d9990df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountRateMeasurementInputMember_fbbaf965-632b-4aa9-a2e6-ecc249c86488" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_ifrs-full_DiscountRateMeasurementInputMember_fbbaf965-632b-4aa9-a2e6-ecc249c86488" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_c8d39d85-6580-4669-bfe8-48c71cb301e1" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_c8d39d85-6580-4669-bfe8-48c71cb301e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_aea01368-73ac-409e-80b3-4cf2975aa10d" xlink:href="abvx-20241231.xsd#abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_aea01368-73ac-409e-80b3-4cf2975aa10d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember_20975133-fde8-4580-a94b-dbd5d66d8f83" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember_20975133-fde8-4580-a94b-dbd5d66d8f83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember_98c01e13-8f3a-4346-91fd-237475d3b6d5" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember_98c01e13-8f3a-4346-91fd-237475d3b6d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember_e6f9ab80-66e6-4b14-a443-38d5677ca111" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember_e6f9ab80-66e6-4b14-a443-38d5677ca111" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TenderOfferFairValueOfMRIMeasurementInputMember_2f3a8582-432d-40a9-bba7-aeead5dcc492" xlink:href="abvx-20241231.xsd#abvx_TenderOfferFairValueOfMRIMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_TenderOfferFairValueOfMRIMeasurementInputMember_2f3a8582-432d-40a9-bba7-aeead5dcc492" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_9f5721d4-e873-4631-bae3-33191772b81a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_9f5721d4-e873-4631-bae3-33191772b81a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9f5721d4-e873-4631-bae3-33191772b81a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_9f5721d4-e873-4631-bae3-33191772b81a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9f5721d4-e873-4631-bae3-33191772b81a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_413e7a90-3fc2-48bb-864f-008f1928f719" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_9f5721d4-e873-4631-bae3-33191772b81a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_413e7a90-3fc2-48bb-864f-008f1928f719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmortizedCostEIRMethodMember_fe4d1958-7251-4076-8c16-72107e94ce6b" xlink:href="abvx-20241231.xsd#abvx_AmortizedCostEIRMethodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_413e7a90-3fc2-48bb-864f-008f1928f719" xlink:to="loc_abvx_AmortizedCostEIRMethodMember_fe4d1958-7251-4076-8c16-72107e94ce6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_73219fc7-35a0-460f-ab3e-0f24b2177e6b" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_abvx_TranchesAxis_73219fc7-35a0-460f-ab3e-0f24b2177e6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_73219fc7-35a0-460f-ab3e-0f24b2177e6b_default" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_TranchesAxis_73219fc7-35a0-460f-ab3e-0f24b2177e6b" xlink:to="loc_abvx_TranchesDomain_73219fc7-35a0-460f-ab3e-0f24b2177e6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_TranchesAxis_73219fc7-35a0-460f-ab3e-0f24b2177e6b" xlink:to="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheBMember_d8970151-ea82-4724-a12e-bd01f0d1991c" xlink:href="abvx-20241231.xsd#abvx_TrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:to="loc_abvx_TrancheBMember_d8970151-ea82-4724-a12e-bd01f0d1991c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheCMember_93cba4bb-af4f-48aa-8be2-29f2198a1856" xlink:href="abvx-20241231.xsd#abvx_TrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:to="loc_abvx_TrancheCMember_93cba4bb-af4f-48aa-8be2-29f2198a1856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_e1670ee5-0b4a-435f-8a2d-621a06c4db35" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_e1670ee5-0b4a-435f-8a2d-621a06c4db35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_786ee173-99f4-47b4-b84c-43bddc127493" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueOtherEquityInstrumentsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:to="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_786ee173-99f4-47b4-b84c-43bddc127493" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_abvx_WarrantsAxis_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d_default" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_WarrantsAxis_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d" xlink:to="loc_abvx_WarrantsDomain_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_WarrantsAxis_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d" xlink:to="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_e344ffb3-f655-4b53-a831-88248e0d93f7" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:to="loc_abvx_KreosABBSAMember_e344ffb3-f655-4b53-a831-88248e0d93f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_1cde1747-2c14-43b9-a157-f35058223382" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:to="loc_abvx_KreosCBSAMember_1cde1747-2c14-43b9-a157-f35058223382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_503b78a6-eaad-4bc1-8a94-1498723c9780" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_503b78a6-eaad-4bc1-8a94-1498723c9780" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_503b78a6-eaad-4bc1-8a94-1498723c9780_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_503b78a6-eaad-4bc1-8a94-1498723c9780" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_503b78a6-eaad-4bc1-8a94-1498723c9780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_503b78a6-eaad-4bc1-8a94-1498723c9780" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_f29b962f-b6b2-4d57-a117-e6fd82a91c5b" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:to="loc_abvx_KreosABBSAMember_f29b962f-b6b2-4d57-a117-e6fd82a91c5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_f8eb9641-c0eb-4c3e-a360-de993e822806" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:to="loc_abvx_KreosCBSAMember_f8eb9641-c0eb-4c3e-a360-de993e822806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a2d23215-b888-4940-a0fb-7b132ff18abd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a2d23215-b888-4940-a0fb-7b132ff18abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionPricingModelMember_5b9ac776-6f8d-4a27-a6e9-40c34733e217" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a2d23215-b888-4940-a0fb-7b132ff18abd" xlink:to="loc_ifrs-full_OptionPricingModelMember_5b9ac776-6f8d-4a27-a6e9-40c34733e217" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_5cc50547-34dd-41da-9129-c8824982ea76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_ifrs-full_UnobservableInputsAxis_5cc50547-34dd-41da-9129-c8824982ea76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_5cc50547-34dd-41da-9129-c8824982ea76_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_5cc50547-34dd-41da-9129-c8824982ea76" xlink:to="loc_ifrs-full_UnobservableInputsDomain_5cc50547-34dd-41da-9129-c8824982ea76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_5cc50547-34dd-41da-9129-c8824982ea76" xlink:to="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePerShareMeasurementInputMember_f950a05c-4b89-47dd-b9e9-b77c9c2c1429" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePerShareMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_ExercisePricePerShareMeasurementInputMember_f950a05c-4b89-47dd-b9e9-b77c9c2c1429" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_cf3d4223-ad85-4763-b9fe-e212b7f63e7a" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_SharePriceMeasurementInputMember_cf3d4223-ad85-4763-b9fe-e212b7f63e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_a8b3780b-2088-4550-acbf-5e8982d1cb0c" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioProbablityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_a8b3780b-2088-4550-acbf-5e8982d1cb0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DrawdownProbablityMeasurementInputMember_832dec7b-9660-48f3-ac0c-450ef65d7cae" xlink:href="abvx-20241231.xsd#abvx_DrawdownProbablityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_DrawdownProbablityMeasurementInputMember_832dec7b-9660-48f3-ac0c-450ef65d7cae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VolatilityForSharesMeasurementInputExpiryMember_f396e457-516d-4fce-862f-e6e030b8eeda" xlink:href="abvx-20241231.xsd#abvx_VolatilityForSharesMeasurementInputExpiryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_VolatilityForSharesMeasurementInputExpiryMember_f396e457-516d-4fce-862f-e6e030b8eeda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VolatilityForSharesMeasurementInputTenderOfferMember_44dc8a81-2ff3-4987-b88c-5b25dcc41757" xlink:href="abvx-20241231.xsd#abvx_VolatilityForSharesMeasurementInputTenderOfferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_VolatilityForSharesMeasurementInputTenderOfferMember_44dc8a81-2ff3-4987-b88c-5b25dcc41757" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_5f8ef073-d1e8-457f-8b03-3d001bf7a7a9" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_5f8ef073-d1e8-457f-8b03-3d001bf7a7a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c288e840-52f3-4da4-9a38-5ca8bbd2d8b9" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c288e840-52f3-4da4-9a38-5ca8bbd2d8b9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputExpiryMember_c9bab364-aa99-4c99-bd02-4a3392bc89cc" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputExpiryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputExpiryMember_c9bab364-aa99-4c99-bd02-4a3392bc89cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember_e7a8e64e-f9ed-4ae3-9f4d-6a2925ee8dd4" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember_e7a8e64e-f9ed-4ae3-9f4d-6a2925ee8dd4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfProbabilityWeightedScenarios_434a43b6-76b2-4498-8190-7da89aea05ec" xlink:href="abvx-20241231.xsd#abvx_NumberOfProbabilityWeightedScenarios"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_NumberOfProbabilityWeightedScenarios_434a43b6-76b2-4498-8190-7da89aea05ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_66d14cd6-0c53-4d9d-980b-4fab45ef7888" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_66d14cd6-0c53-4d9d-980b-4fab45ef7888" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstanding_04e3c64e-ed52-417d-a58d-0a40bc0659b6" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_NumberOfWarrantsOutstanding_04e3c64e-ed52-417d-a58d-0a40bc0659b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition_6cdb0f16-d553-4f0f-937b-bea14701bc83" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition_6cdb0f16-d553-4f0f-937b-bea14701bc83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_7ea1983f-f223-4294-a9ff-de3acba4027a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_7ea1983f-f223-4294-a9ff-de3acba4027a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_9c13b37f-44e1-4144-ab14-1faf103fe5d3" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueOtherEquityInstrumentsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_9c13b37f-44e1-4144-ab14-1faf103fe5d3" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesHeightsconvertiblenotesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_2f202c37-f8d8-4b25-856e-032f70f0f1b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_2f202c37-f8d8-4b25-856e-032f70f0f1b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_2f202c37-f8d8-4b25-856e-032f70f0f1b5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_2f202c37-f8d8-4b25-856e-032f70f0f1b5" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_2f202c37-f8d8-4b25-856e-032f70f0f1b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_2f202c37-f8d8-4b25-856e-032f70f0f1b5" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:to="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheAMember_ea2d5bc1-096e-4c50-a5a6-1fdc0967764e" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheAMember_ea2d5bc1-096e-4c50-a5a6-1fdc0967764e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheBMember_b5dace9f-26b6-4af6-aa92-ccba8b014c4b" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheBMember_b5dace9f-26b6-4af6-aa92-ccba8b014c4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_6ea349ba-c671-4dac-894f-a7d437664a8e" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:to="loc_abvx_OCEANEMember_6ea349ba-c671-4dac-894f-a7d437664a8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_caec35e8-cfb6-455a-b3af-f245c0588732" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_srt_RangeAxis_caec35e8-cfb6-455a-b3af-f245c0588732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_caec35e8-cfb6-455a-b3af-f245c0588732_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_caec35e8-cfb6-455a-b3af-f245c0588732" xlink:to="loc_srt_RangeMember_caec35e8-cfb6-455a-b3af-f245c0588732_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_caec35e8-cfb6-455a-b3af-f245c0588732" xlink:to="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a0e8a4fd-3194-482c-bdb3-646dbaa947a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:to="loc_srt_MinimumMember_a0e8a4fd-3194-482c-bdb3-646dbaa947a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e9fe4c9-4a4c-41b4-9c3b-4ed65b500be5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:to="loc_srt_MaximumMember_8e9fe4c9-4a4c-41b4-9c3b-4ed65b500be5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_23ae012b-80a1-430a-abe6-dea882a1b69e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_23ae012b-80a1-430a-abe6-dea882a1b69e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_23ae012b-80a1-430a-abe6-dea882a1b69e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_23ae012b-80a1-430a-abe6-dea882a1b69e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_23ae012b-80a1-430a-abe6-dea882a1b69e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b72dbfce-d0de-4b4e-bc29-7cdb6ab35a95" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_23ae012b-80a1-430a-abe6-dea882a1b69e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b72dbfce-d0de-4b4e-bc29-7cdb6ab35a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheAMember_b710ff5c-d741-47fc-b788-daf2a81b90ab" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b72dbfce-d0de-4b4e-bc29-7cdb6ab35a95" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheAMember_b710ff5c-d741-47fc-b788-daf2a81b90ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_ifrs-full_UnobservableInputsAxis_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0" xlink:to="loc_ifrs-full_UnobservableInputsDomain_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0" xlink:to="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9de196f9-e5f6-4432-b83d-bd4f0bb7362c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9de196f9-e5f6-4432-b83d-bd4f0bb7362c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_fbd45b87-c1ec-41ce-b1fb-35ee52652ac0" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_abvx_SharePriceMeasurementInputMember_fbd45b87-c1ec-41ce-b1fb-35ee52652ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_4be5f60e-ddac-43a8-bae0-d14a2bd76e34" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_4be5f60e-ddac-43a8-bae0-d14a2bd76e34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_0d71d82e-5ab2-4f38-82d9-354463361134" xlink:href="abvx-20241231.xsd#abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_0d71d82e-5ab2-4f38-82d9-354463361134" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_1f0f94b9-23a4-40eb-9a04-478270fdb9dc" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_1f0f94b9-23a4-40eb-9a04-478270fdb9dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_edebfbce-495d-4f77-a65d-d7fa2bffd263" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsNumberOfTranches_edebfbce-495d-4f77-a65d-d7fa2bffd263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_8a5fd89f-8ca9-4c4e-96c5-5f2394c5bf75" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_8a5fd89f-8ca9-4c4e-96c5-5f2394c5bf75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfConvertibleNotesIssued_54c89a60-425d-4e08-99fa-e585a9e7533a" xlink:href="abvx-20241231.xsd#abvx_NumberOfConvertibleNotesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_NumberOfConvertibleNotesIssued_54c89a60-425d-4e08-99fa-e585a9e7533a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesNominalValue_f505417b-d484-48a0-9325-e92d6e84e007" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesNominalValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesNominalValue_f505417b-d484-48a0-9325-e92d6e84e007" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsFixedConversionPrice_14c7210e-029c-4fc2-ae2d-2352b1890b6d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsFixedConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsFixedConversionPrice_14c7210e-029c-4fc2-ae2d-2352b1890b6d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_49047de4-82b9-4a61-b6e0-5f1c53a29155" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_49047de4-82b9-4a61-b6e0-5f1c53a29155" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_76340ba5-1907-4f08-972a-4eb6487709eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_NotionalAmount_76340ba5-1907-4f08-972a-4eb6487709eb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_1db53875-b6b8-4e0b-b64b-204f37d725dc" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_1db53875-b6b8-4e0b-b64b-204f37d725dc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesPeriod_8645bdef-9d94-4b82-8704-d58f0e0b7be8" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesPeriod_8645bdef-9d94-4b82-8704-d58f0e0b7be8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesNumberOfSeparateClosings_609af2d4-ec0a-4512-a1cc-fa24a5747563" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesNumberOfSeparateClosings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesNumberOfSeparateClosings_609af2d4-ec0a-4512-a1cc-fa24a5747563" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_6a69587e-86b2-4516-b3a5-82f5a1713fdb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_BorrowingsInterestRate_6a69587e-86b2-4516-b3a5-82f5a1713fdb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfQuarterlyInstallments_b0bd7766-da7e-4e18-bd2d-ef444af40da7" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfQuarterlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsNumberOfQuarterlyInstallments_b0bd7766-da7e-4e18-bd2d-ef444af40da7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityDeferralPeriod_86204555-41dc-4550-8fae-6c51c882fd45" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityDeferralPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMaturityDeferralPeriod_86204555-41dc-4550-8fae-6c51c882fd45" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsPercentageOfMarketPrice_248f76ae-7327-48d3-8944-63deb37d3b89" xlink:href="abvx-20241231.xsd#abvx_BorrowingsPercentageOfMarketPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsPercentageOfMarketPrice_248f76ae-7327-48d3-8944-63deb37d3b89" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP_d93efa41-3f09-4065-a613-d93d62f973f8" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP_d93efa41-3f09-4065-a613-d93d62f973f8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMarketPriceNumberOfTradingDays_fecbc034-ca84-4d2c-9afe-70aef334807b" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMarketPriceNumberOfTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMarketPriceNumberOfTradingDays_fecbc034-ca84-4d2c-9afe-70aef334807b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP_aec0c6a7-c3a4-48f9-ae22-21e303cc0604" xlink:href="abvx-20241231.xsd#abvx_IssuancePricePercentageOfDiscountTo15DayWVAP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP_aec0c6a7-c3a4-48f9-ae22-21e303cc0604" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_3a0b0182-7fc3-4071-b4d9-16d5ed31852f" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_3a0b0182-7fc3-4071-b4d9-16d5ed31852f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate_09443fdf-5e23-48a4-885d-b0bb8f33af1b" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate_09443fdf-5e23-48a4-885d-b0bb8f33af1b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue_5658ed67-62b7-4904-a8d3-1edba48b52bc" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue_5658ed67-62b7-4904-a8d3-1edba48b52bc" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceCashCarveOut_3d1a5c26-d696-44fc-8652-c35b28fc3d31" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceCashCarveOut"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_EquityIssuanceCashCarveOut_3d1a5c26-d696-44fc-8652-c35b28fc3d31" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal_bdf6edcc-1fc3-4396-ab4f-2c126ca791ce" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal_bdf6edcc-1fc3-4396-ab4f-2c126ca791ce" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_d02f2a29-6f75-4a8a-8dfd-7e77d5986ba9" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_d02f2a29-6f75-4a8a-8dfd-7e77d5986ba9" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_0ad0f2f9-938f-4e23-bbe2-199591da3528" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromRecognitionOfFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_0ad0f2f9-938f-4e23-bbe2-199591da3528" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnrecognitionDayOneGainOfFinancialLiabilities_fb989a46-c816-4ea8-bdf9-08e758430671" xlink:href="abvx-20241231.xsd#abvx_UnrecognitionDayOneGainOfFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_UnrecognitionDayOneGainOfFinancialLiabilities_fb989a46-c816-4ea8-bdf9-08e758430671" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3098a276-cd4d-40c9-955d-ddf60c12c908" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3098a276-cd4d-40c9-955d-ddf60c12c908" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_b276c0c8-93e0-4a5d-acb3-e57e6db9ee5b" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_b276c0c8-93e0-4a5d-acb3-e57e6db9ee5b" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_4da6a8c4-3ae7-471a-94bd-5809601f1bc4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_4da6a8c4-3ae7-471a-94bd-5809601f1bc4" xlink:type="arc" order="28"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7cf9a3eb-4013-479e-99fc-042c49a2b8a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7cf9a3eb-4013-479e-99fc-042c49a2b8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7cf9a3eb-4013-479e-99fc-042c49a2b8a9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7cf9a3eb-4013-479e-99fc-042c49a2b8a9" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7cf9a3eb-4013-479e-99fc-042c49a2b8a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_145d04ec-7459-4d6c-9d7e-f180fb755ca1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7cf9a3eb-4013-479e-99fc-042c49a2b8a9" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_145d04ec-7459-4d6c-9d7e-f180fb755ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheAMember_945e10a8-a21b-4416-b15c-79ae286970e6" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_145d04ec-7459-4d6c-9d7e-f180fb755ca1" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheAMember_945e10a8-a21b-4416-b15c-79ae286970e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_9e344137-ed14-4cf9-bdb6-6bc077673e12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:to="loc_ifrs-full_UnobservableInputsAxis_9e344137-ed14-4cf9-bdb6-6bc077673e12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_9e344137-ed14-4cf9-bdb6-6bc077673e12_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_9e344137-ed14-4cf9-bdb6-6bc077673e12" xlink:to="loc_ifrs-full_UnobservableInputsDomain_9e344137-ed14-4cf9-bdb6-6bc077673e12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_9e344137-ed14-4cf9-bdb6-6bc077673e12" xlink:to="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateMeasurementInputMember_93b565f6-468d-4910-af60-88582fbb1aeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_ifrs-full_InterestRateMeasurementInputMember_93b565f6-468d-4910-af60-88582fbb1aeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPricePerShareMeasurementInputMember_51786f93-0b41-4e4a-adcb-4ee9dfde49d8" xlink:href="abvx-20241231.xsd#abvx_ConversionPricePerShareMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_ConversionPricePerShareMeasurementInputMember_51786f93-0b41-4e4a-adcb-4ee9dfde49d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_6723a5e4-d9e4-4704-93f2-67ad7db7068d" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_SharePriceMeasurementInputMember_6723a5e4-d9e4-4704-93f2-67ad7db7068d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_af8198a0-f303-48de-8e15-cb36697f2696" xlink:href="abvx-20241231.xsd#abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_af8198a0-f303-48de-8e15-cb36697f2696" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InitialPriceLimitMeasurementInputMember_eba641f2-ff03-44b8-98c7-ddd1d91d3088" xlink:href="abvx-20241231.xsd#abvx_InitialPriceLimitMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_InitialPriceLimitMeasurementInputMember_eba641f2-ff03-44b8-98c7-ddd1d91d3088" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarlyRedemptionAmountMeasurementInputMember_095c027a-6d62-46a0-a320-04a76975d9ba" xlink:href="abvx-20241231.xsd#abvx_EarlyRedemptionAmountMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_EarlyRedemptionAmountMeasurementInputMember_095c027a-6d62-46a0-a320-04a76975d9ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9debb461-06db-4459-ac0f-6018a792fffc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9debb461-06db-4459-ac0f-6018a792fffc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_61656dbb-da84-4d47-8023-a6a02b98980d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_61656dbb-da84-4d47-8023-a6a02b98980d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_8d1c644b-abf5-4e3c-844a-cd6b9082f84f" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_8d1c644b-abf5-4e3c-844a-cd6b9082f84f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_947146f4-a397-47d5-9fca-d9d0a20e9f04" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_947146f4-a397-47d5-9fca-d9d0a20e9f04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_947146f4-a397-47d5-9fca-d9d0a20e9f04_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_947146f4-a397-47d5-9fca-d9d0a20e9f04" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_947146f4-a397-47d5-9fca-d9d0a20e9f04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_704b474d-7baa-4a29-89fb-33d8e29e8ef6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_947146f4-a397-47d5-9fca-d9d0a20e9f04" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_704b474d-7baa-4a29-89fb-33d8e29e8ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModelIFRSMember_c1389871-c273-4f52-8ac4-edd31b94183c" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModelIFRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_704b474d-7baa-4a29-89fb-33d8e29e8ef6" xlink:to="loc_abvx_MonteCarloModelIFRSMember_c1389871-c273-4f52-8ac4-edd31b94183c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfConvertibleNotesOutstanding_c4c85f1f-6689-4782-a09d-3a72aedf44f3" xlink:href="abvx-20241231.xsd#abvx_NumberOfConvertibleNotesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_abvx_NumberOfConvertibleNotesOutstanding_c4c85f1f-6689-4782-a09d-3a72aedf44f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_3ba42c09-a6a8-4b55-b54b-3f8a64ee214f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_ifrs-full_NotionalAmount_3ba42c09-a6a8-4b55-b54b-3f8a64ee214f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_5f849342-00f9-4015-9aef-d42c195ed2cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_5f849342-00f9-4015-9aef-d42c195ed2cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueConvertibleNotes_5216f050-46bf-475c-9fc9-8cc1d3537fcc" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_abvx_AggregateFairValueConvertibleNotes_5216f050-46bf-475c-9fc9-8cc1d3537fcc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesKreos1Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesKreos1Details"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesKreos1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_8c712686-959a-4bc0-b096-a39d3f9a7095" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_8c712686-959a-4bc0-b096-a39d3f9a7095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_8c712686-959a-4bc0-b096-a39d3f9a7095_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_8c712686-959a-4bc0-b096-a39d3f9a7095" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_8c712686-959a-4bc0-b096-a39d3f9a7095_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_8c712686-959a-4bc0-b096-a39d3f9a7095" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_28c58b2f-3ecf-4e86-a064-ec952dd7244c" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1Member_28c58b2f-3ecf-4e86-a064-ec952dd7244c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1NonConvertibleBondLoansMember_c37d6ba8-dab5-493a-a16f-cbb8a83c6497" xlink:href="abvx-20241231.xsd#abvx_Kreos1NonConvertibleBondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1NonConvertibleBondLoansMember_c37d6ba8-dab5-493a-a16f-cbb8a83c6497" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansMember_37a86ca2-ad2d-4744-8a8c-3c289865aabb" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansMember_37a86ca2-ad2d-4744-8a8c-3c289865aabb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_ea3871d3-c510-4f7e-9f76-0beba52f06ee" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_ea3871d3-c510-4f7e-9f76-0beba52f06ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_a90ff456-3e5d-41be-958e-b77e51932c7c" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_a90ff456-3e5d-41be-958e-b77e51932c7c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_988c0252-7808-4213-9a3d-db2bcdd48476" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos12BondLoansMember_988c0252-7808-4213-9a3d-db2bcdd48476" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_2c1b2fd1-6a2e-4a56-822a-f23547d97954" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_RangeAxis_2c1b2fd1-6a2e-4a56-822a-f23547d97954" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_2c1b2fd1-6a2e-4a56-822a-f23547d97954_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_2c1b2fd1-6a2e-4a56-822a-f23547d97954" xlink:to="loc_ifrs-full_RangeDomain_2c1b2fd1-6a2e-4a56-822a-f23547d97954_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_2c1b2fd1-6a2e-4a56-822a-f23547d97954" xlink:to="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_5995290e-5204-428c-a8bc-93c21a2d2f0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:to="loc_ifrs-full_BottomOfRangeMember_5995290e-5204-428c-a8bc-93c21a2d2f0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_83ad7f47-da91-40a7-b1f8-d9b08cc09c83" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:to="loc_ifrs-full_TopOfRangeMember_83ad7f47-da91-40a7-b1f8-d9b08cc09c83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_87c222e9-0e6f-4948-85f2-6152a76e29f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_87c222e9-0e6f-4948-85f2-6152a76e29f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuriborMember_9008f69a-fc59-45f1-b7cf-dffc36c8d2bc" xlink:href="abvx-20241231.xsd#abvx_EuriborMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_87c222e9-0e6f-4948-85f2-6152a76e29f9" xlink:to="loc_abvx_EuriborMember_9008f69a-fc59-45f1-b7cf-dffc36c8d2bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_abvx_WarrantsAxis_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f_default" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_WarrantsAxis_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f" xlink:to="loc_abvx_WarrantsDomain_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_WarrantsAxis_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f" xlink:to="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_3bc7cc43-e9a7-4774-b008-58d35f483b06" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:to="loc_abvx_KreosABSAMember_3bc7cc43-e9a7-4774-b008-58d35f483b06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_3022dd05-336a-4a6c-8a37-043ced46fcfd" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:to="loc_abvx_KreosBBSAMember_3022dd05-336a-4a6c-8a37-043ced46fcfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_45cefdd3-c22c-4930-9917-db66367fdd2d" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:to="loc_abvx_KreosABBSAMember_45cefdd3-c22c-4930-9917-db66367fdd2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_8641fba3-f37e-439e-a440-a190a1ad5fc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_UnobservableInputsAxis_8641fba3-f37e-439e-a440-a190a1ad5fc6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_8641fba3-f37e-439e-a440-a190a1ad5fc6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_8641fba3-f37e-439e-a440-a190a1ad5fc6" xlink:to="loc_ifrs-full_UnobservableInputsDomain_8641fba3-f37e-439e-a440-a190a1ad5fc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_8641fba3-f37e-439e-a440-a190a1ad5fc6" xlink:to="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_530885eb-38b7-48ff-98e1-dfa97e669339" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_530885eb-38b7-48ff-98e1-dfa97e669339" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_aa7c069f-51e4-495e-b9cb-471486b020ff" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:to="loc_abvx_SharePriceMeasurementInputMember_aa7c069f-51e4-495e-b9cb-471486b020ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_96207402-9f1e-42f7-925d-eb4ddc7a88e9" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_96207402-9f1e-42f7-925d-eb4ddc7a88e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3111e95f-4cdf-4950-8651-8745252d214c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3111e95f-4cdf-4950-8651-8745252d214c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_eed0549d-4ab1-402d-b2ab-dcf557d8230c" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3111e95f-4cdf-4950-8651-8745252d214c" xlink:to="loc_abvx_KreosABBSAMember_eed0549d-4ab1-402d-b2ab-dcf557d8230c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_6df4fb6e-69ca-464a-83b9-4e04209ce770" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_6df4fb6e-69ca-464a-83b9-4e04209ce770" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_63e20c70-84af-4608-8db9-c6084b360b9d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsNumberOfTranches_63e20c70-84af-4608-8db9-c6084b360b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_e03ee696-e95d-4ce6-9064-452a63ad7617" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacityPerTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_e03ee696-e95d-4ce6-9064-452a63ad7617" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_a3b47af1-4d08-46d4-85e0-d679838e3ddf" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_a3b47af1-4d08-46d4-85e0-d679838e3ddf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_40781db7-c991-4a48-b875-aa635ca001b1" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_40781db7-c991-4a48-b875-aa635ca001b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_c8dbbe42-3480-4ad2-9b01-77f98d3d4cbc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_c8dbbe42-3480-4ad2-9b01-77f98d3d4cbc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsBasisInterestRate_1d96a414-96eb-4841-8fb8-05b9eca9d841" xlink:href="abvx-20241231.xsd#abvx_BorrowingsBasisInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsBasisInterestRate_1d96a414-96eb-4841-8fb8-05b9eca9d841" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfMonthlyInstallments_0c320fa5-a6b8-4369-bf99-83793ab7f68c" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfMonthlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsNumberOfMonthlyInstallments_0c320fa5-a6b8-4369-bf99-83793ab7f68c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityDeferralPeriod_9715f629-4596-425d-baca-e3d3096aec1e" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityDeferralPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaturityDeferralPeriod_9715f629-4596-425d-baca-e3d3096aec1e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentage_05f664cf-6f6d-472d-8770-c86e7573fd6e" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsExitFeePercentage_05f664cf-6f6d-472d-8770-c86e7573fd6e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeeAmount_0470474a-5a97-4840-9969-72b093af1811" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsExitFeeAmount_0470474a-5a97-4840-9969-72b093af1811" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNoticePeriod_657adba8-f30f-4a61-9538-523ad41ac7ee" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNoticePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsNoticePeriod_657adba8-f30f-4a61-9538-523ad41ac7ee" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAnnualDiscountRate_59c8c41a-4df9-4c20-8094-666a349e2528" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAnnualDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsAnnualDiscountRate_59c8c41a-4df9-4c20-8094-666a349e2528" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstanding_81af8933-d1d8-49f7-9fb8-7bc7d41e2738" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfWarrantsOutstanding_81af8933-d1d8-49f7-9fb8-7bc7d41e2738" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_b9f64bce-7807-4323-8181-7dce831ae9b7" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_b9f64bce-7807-4323-8181-7dce831ae9b7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesSubscribedPerWarrant_e361d768-94e5-4ed0-8f5a-0dec591d80c8" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesSubscribedPerWarrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfSharesSubscribedPerWarrant_e361d768-94e5-4ed0-8f5a-0dec591d80c8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_86def585-929a-43eb-a0f6-40b55db90908" xlink:href="abvx-20241231.xsd#abvx_ExercisePriceOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_86def585-929a-43eb-a0f6-40b55db90908" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityTerm_e0ff31d2-9471-4e35-be23-92b90610a2d3" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaturityTerm_e0ff31d2-9471-4e35-be23-92b90610a2d3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_4d08f524-596e-43df-a21f-5b3fe9e48d86" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_4d08f524-596e-43df-a21f-5b3fe9e48d86" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsRepurchased_88d27e4a-a160-425f-b8b4-bc228d1bb3ce" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfOtherShareWarrantsRepurchased_88d27e4a-a160-425f-b8b4-bc228d1bb3ce" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_fa1a0ec3-b758-4a6b-b273-525d19e83e21" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsConverted_a0edbc10-cad6-4c1c-91d5-59858c6a44fc" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfOtherShareWarrantsConverted_a0edbc10-cad6-4c1c-91d5-59858c6a44fc" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_77efa668-d166-4ff6-a9e4-516ee8b3ff9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_77efa668-d166-4ff6-a9e4-516ee8b3ff9f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_5cd47596-ba15-4ad9-8d9a-b9e39e588def" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_5cd47596-ba15-4ad9-8d9a-b9e39e588def" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_459c63a3-96ee-485e-9645-67f26d95ca4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_459c63a3-96ee-485e-9645-67f26d95ca4a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_d0ad27a9-59fa-4aba-9163-1650be2d2b88" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_d0ad27a9-59fa-4aba-9163-1650be2d2b88" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_1cbad1d7-51fa-419f-ad6f-231b90c91ada" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_1cbad1d7-51fa-419f-ad6f-231b90c91ada" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0f0caecb-305f-4194-a587-cc2fdafba498" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0f0caecb-305f-4194-a587-cc2fdafba498" xlink:type="arc" order="27"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:to="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_a5485040-d8c5-4a92-aec6-b72049901584" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:to="loc_abvx_WarrantsAxis_a5485040-d8c5-4a92-aec6-b72049901584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_a5485040-d8c5-4a92-aec6-b72049901584_default" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_WarrantsAxis_a5485040-d8c5-4a92-aec6-b72049901584" xlink:to="loc_abvx_WarrantsDomain_a5485040-d8c5-4a92-aec6-b72049901584_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_WarrantsAxis_a5485040-d8c5-4a92-aec6-b72049901584" xlink:to="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_a51f6483-afbc-4d49-b751-78fb4be815a9" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:to="loc_abvx_KreosABSAMember_a51f6483-afbc-4d49-b751-78fb4be815a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_27d5f906-97fc-4ceb-820f-1ab7cb4beaeb" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:to="loc_abvx_KreosBBSAMember_27d5f906-97fc-4ceb-820f-1ab7cb4beaeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_599c8302-e41d-4293-a9af-2b7289692087" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:to="loc_ifrs-full_UnobservableInputsAxis_599c8302-e41d-4293-a9af-2b7289692087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_599c8302-e41d-4293-a9af-2b7289692087_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_599c8302-e41d-4293-a9af-2b7289692087" xlink:to="loc_ifrs-full_UnobservableInputsDomain_599c8302-e41d-4293-a9af-2b7289692087_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_599c8302-e41d-4293-a9af-2b7289692087" xlink:to="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePerShareMeasurementInputMember_f0aa7cc0-3343-4c1c-9cf0-3b563eb2a11a" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePerShareMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_ExercisePricePerShareMeasurementInputMember_f0aa7cc0-3343-4c1c-9cf0-3b563eb2a11a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_853923a2-0c52-45ad-89aa-52131b2e0ab0" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_SharePriceMeasurementInputMember_853923a2-0c52-45ad-89aa-52131b2e0ab0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResidualMaturityMeasurementInputMember_df743160-ddf6-46a9-af87-ebd3cacfb351" xlink:href="abvx-20241231.xsd#abvx_ResidualMaturityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_ResidualMaturityMeasurementInputMember_df743160-ddf6-46a9-af87-ebd3cacfb351" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9fb72d09-5c23-480c-a181-b2d28a498b5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9fb72d09-5c23-480c-a181-b2d28a498b5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_0cd3c434-c3d2-4806-b779-138971d0c3f5" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_0cd3c434-c3d2-4806-b779-138971d0c3f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_16f33835-ea16-4db6-b3f5-3f3553e84afc" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_16f33835-ea16-4db6-b3f5-3f3553e84afc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_b2fa641f-b6f6-42d8-b6e9-fd9f045decea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_b2fa641f-b6f6-42d8-b6e9-fd9f045decea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_b2fa641f-b6f6-42d8-b6e9-fd9f045decea_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_b2fa641f-b6f6-42d8-b6e9-fd9f045decea" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_b2fa641f-b6f6-42d8-b6e9-fd9f045decea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_0fea4bb4-6066-44a0-827c-4f66e2532c18" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_b2fa641f-b6f6-42d8-b6e9-fd9f045decea" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_0fea4bb4-6066-44a0-827c-4f66e2532c18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionPricingModelMember_afc449db-0af4-410c-a8f6-1b93cd41a91a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_0fea4bb4-6066-44a0-827c-4f66e2532c18" xlink:to="loc_ifrs-full_OptionPricingModelMember_afc449db-0af4-410c-a8f6-1b93cd41a91a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstanding_956685a8-7cae-473c-9dde-87ec0e9d71f5" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:to="loc_abvx_NumberOfWarrantsOutstanding_956685a8-7cae-473c-9dde-87ec0e9d71f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_cd7d792c-fa9c-4280-8fe0-f2e1e451e607" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_cd7d792c-fa9c-4280-8fe0-f2e1e451e607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_76ca3625-f9ff-497e-a607-8a79aa2ff586" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueOtherEquityInstrumentsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:to="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_76ca3625-f9ff-497e-a607-8a79aa2ff586" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesKreos2Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesKreos2Details"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesKreos2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_5fb8de5f-62f5-41af-8920-4271681e6b3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_5fb8de5f-62f5-41af-8920-4271681e6b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_5fb8de5f-62f5-41af-8920-4271681e6b3c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5fb8de5f-62f5-41af-8920-4271681e6b3c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_5fb8de5f-62f5-41af-8920-4271681e6b3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5fb8de5f-62f5-41af-8920-4271681e6b3c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:href="abvx-20241231.xsd#abvx_Kreos2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:to="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2TrancheAMember_3cd54a79-66d0-47d9-aff0-96e138590ed4" xlink:href="abvx-20241231.xsd#abvx_Kreos2TrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:to="loc_abvx_Kreos2TrancheAMember_3cd54a79-66d0-47d9-aff0-96e138590ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2TrancheBMember_03e0ece1-9687-43cf-970c-10971382feef" xlink:href="abvx-20241231.xsd#abvx_Kreos2TrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:to="loc_abvx_Kreos2TrancheBMember_03e0ece1-9687-43cf-970c-10971382feef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_f8159c11-be9d-4100-9535-d9c121ad0c71" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_f8159c11-be9d-4100-9535-d9c121ad0c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_8ff950af-54de-4b60-8a2b-1626d5388b44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_8ff950af-54de-4b60-8a2b-1626d5388b44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_8ff950af-54de-4b60-8a2b-1626d5388b44_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_8ff950af-54de-4b60-8a2b-1626d5388b44" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_8ff950af-54de-4b60-8a2b-1626d5388b44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_10fb1b6c-991f-4cdb-846a-0801efd4dccb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_8ff950af-54de-4b60-8a2b-1626d5388b44" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_10fb1b6c-991f-4cdb-846a-0801efd4dccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuriborMember_52b4356e-c961-475d-99cc-c95dfc54ed7e" xlink:href="abvx-20241231.xsd#abvx_EuriborMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_10fb1b6c-991f-4cdb-846a-0801efd4dccb" xlink:to="loc_abvx_EuriborMember_52b4356e-c961-475d-99cc-c95dfc54ed7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_edc23e27-0c78-4e72-b9df-28c70e56fa0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_ifrs-full_NotionalAmount_edc23e27-0c78-4e72-b9df-28c70e56fa0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_1b814cb8-3678-4e3c-a861-003eb5be12df" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsNumberOfTranches_1b814cb8-3678-4e3c-a861-003eb5be12df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAdditionalTrancheAmount_e72d9010-b7ac-45ca-b8ba-5c9722d6b974" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAdditionalTrancheAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsAdditionalTrancheAmount_e72d9010-b7ac-45ca-b8ba-5c9722d6b974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments_b94ef0b9-4928-427a-b6e8-c89339c8a222" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments_b94ef0b9-4928-427a-b6e8-c89339c8a222" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsInterestRateForFollowingInstallments_85f2d45f-d332-4e77-8122-995080da9c75" xlink:href="abvx-20241231.xsd#abvx_BorrowingsInterestRateForFollowingInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsInterestRateForFollowingInstallments_85f2d45f-d332-4e77-8122-995080da9c75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfMonthlyInstallments_84bca55c-7e74-4b5f-a01c-a75086a88fce" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfMonthlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsNumberOfMonthlyInstallments_84bca55c-7e74-4b5f-a01c-a75086a88fce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentage_c39858a7-24d0-492d-ac17-5cf39786422d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeePercentage_c39858a7-24d0-492d-ac17-5cf39786422d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeeAmount_4bc1d34a-4482-4617-a4d1-f58710826267" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeeAmount_4bc1d34a-4482-4617-a4d1-f58710826267" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNoticePeriod_f1496734-0e3b-43fe-a58d-84350021ad8d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNoticePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsNoticePeriod_f1496734-0e3b-43fe-a58d-84350021ad8d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments_1f2a0fc1-d8b8-491f-a216-edddf70b6a68" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments_1f2a0fc1-d8b8-491f-a216-edddf70b6a68" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment_d04d30e0-f52c-4425-b67b-d42f41f7f683" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment_d04d30e0-f52c-4425-b67b-d42f41f7f683" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAnnualDiscountRate_8680efb9-fb2f-46c1-821a-4b5800df84b0" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAnnualDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsAnnualDiscountRate_8680efb9-fb2f-46c1-821a-4b5800df84b0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_db16dcfc-8b53-4a10-ad45-9df7906f680b" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_db16dcfc-8b53-4a10-ad45-9df7906f680b" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesOCEANEDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_dbb3e57c-5cd1-445b-99e7-155a2f56ab3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_dbb3e57c-5cd1-445b-99e7-155a2f56ab3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_0139ff72-8974-4738-8b65-6419efe02b3a" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_dbb3e57c-5cd1-445b-99e7-155a2f56ab3c" xlink:to="loc_abvx_OCEANEMember_0139ff72-8974-4738-8b65-6419efe02b3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RemeasurementPeriodAxis_580cf3d2-a63f-4242-a330-f67295215326" xlink:href="abvx-20241231.xsd#abvx_RemeasurementPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_abvx_RemeasurementPeriodAxis_580cf3d2-a63f-4242-a330-f67295215326" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RemeasurementPeriodDomain_580cf3d2-a63f-4242-a330-f67295215326_default" xlink:href="abvx-20241231.xsd#abvx_RemeasurementPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_RemeasurementPeriodAxis_580cf3d2-a63f-4242-a330-f67295215326" xlink:to="loc_abvx_RemeasurementPeriodDomain_580cf3d2-a63f-4242-a330-f67295215326_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:href="abvx-20241231.xsd#abvx_RemeasurementPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_RemeasurementPeriodAxis_580cf3d2-a63f-4242-a330-f67295215326" xlink:to="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After18MonthsMember_31d3c517-1cd8-490e-a727-ad87b69084ec" xlink:href="abvx-20241231.xsd#abvx_After18MonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:to="loc_abvx_After18MonthsMember_31d3c517-1cd8-490e-a727-ad87b69084ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After24MonthsMember_f3530611-7f97-491e-bb09-dba3c734c85f" xlink:href="abvx-20241231.xsd#abvx_After24MonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:to="loc_abvx_After24MonthsMember_f3530611-7f97-491e-bb09-dba3c734c85f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After36MonthsMember_8a5c4b5c-43ca-4322-b32f-bb94601d981f" xlink:href="abvx-20241231.xsd#abvx_After36MonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:to="loc_abvx_After36MonthsMember_8a5c4b5c-43ca-4322-b32f-bb94601d981f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2dfb695b-252c-4711-bd9e-45c67278693b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_srt_RangeAxis_2dfb695b-252c-4711-bd9e-45c67278693b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2dfb695b-252c-4711-bd9e-45c67278693b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2dfb695b-252c-4711-bd9e-45c67278693b" xlink:to="loc_srt_RangeMember_2dfb695b-252c-4711-bd9e-45c67278693b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62ad87b8-b194-472c-b56f-476941c475a4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2dfb695b-252c-4711-bd9e-45c67278693b" xlink:to="loc_srt_RangeMember_62ad87b8-b194-472c-b56f-476941c475a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_853bf418-f914-4e5d-baec-8b679ba883a9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_62ad87b8-b194-472c-b56f-476941c475a4" xlink:to="loc_srt_MinimumMember_853bf418-f914-4e5d-baec-8b679ba883a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7d830236-e433-4a1e-9582-dc1c65e0d7e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7d830236-e433-4a1e-9582-dc1c65e0d7e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7d830236-e433-4a1e-9582-dc1c65e0d7e1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7d830236-e433-4a1e-9582-dc1c65e0d7e1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7d830236-e433-4a1e-9582-dc1c65e0d7e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_66acd22e-df57-4aff-aa55-733ca7250d44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7d830236-e433-4a1e-9582-dc1c65e0d7e1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_66acd22e-df57-4aff-aa55-733ca7250d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_513e7516-581f-4d30-84e7-7902e5390cf7" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_66acd22e-df57-4aff-aa55-733ca7250d44" xlink:to="loc_abvx_OCEANEMember_513e7516-581f-4d30-84e7-7902e5390cf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_d416c07f-020d-49ff-a39a-11131caec196" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_UnobservableInputsAxis_d416c07f-020d-49ff-a39a-11131caec196" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_d416c07f-020d-49ff-a39a-11131caec196_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_d416c07f-020d-49ff-a39a-11131caec196" xlink:to="loc_ifrs-full_UnobservableInputsDomain_d416c07f-020d-49ff-a39a-11131caec196_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_d416c07f-020d-49ff-a39a-11131caec196" xlink:to="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_cf708799-d76d-46e5-910c-ccc2bc8fd4d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_cf708799-d76d-46e5-910c-ccc2bc8fd4d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_9538198f-1817-4b11-84c2-2df58b8cd3d6" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_abvx_SharePriceMeasurementInputMember_9538198f-1817-4b11-84c2-2df58b8cd3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_6326fb22-6f73-4a8e-8706-effa324aa971" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_6326fb22-6f73-4a8e-8706-effa324aa971" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_113573b4-66c2-4840-8f3e-36538df7072d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_113573b4-66c2-4840-8f3e-36538df7072d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_a6af8163-88ee-481e-a30d-2555274db7b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_a6af8163-88ee-481e-a30d-2555274db7b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a6af8163-88ee-481e-a30d-2555274db7b2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_a6af8163-88ee-481e-a30d-2555274db7b2" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a6af8163-88ee-481e-a30d-2555274db7b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_261b245f-ba6c-48fb-af12-42866690c099" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_a6af8163-88ee-481e-a30d-2555274db7b2" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_261b245f-ba6c-48fb-af12-42866690c099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModelIFRSMember_ba4895da-15cf-4cb4-8c13-199d4e445aaa" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModelIFRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_261b245f-ba6c-48fb-af12-42866690c099" xlink:to="loc_abvx_MonteCarloModelIFRSMember_ba4895da-15cf-4cb4-8c13-199d4e445aaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes_69ff0029-e14b-418e-b39a-0e2c7bf369e7" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes_69ff0029-e14b-418e-b39a-0e2c7bf369e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_d747662d-6de2-4887-b1c2-5b0f0e80d1cf" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_d747662d-6de2-4887-b1c2-5b0f0e80d1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_d5e77163-7f5e-434f-9062-ef077cb428e0" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_d5e77163-7f5e-434f-9062-ef077cb428e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_0795c022-f71b-4e8e-9634-0cfce442d948" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_0795c022-f71b-4e8e-9634-0cfce442d948" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_cc61f7ce-b166-49f3-95f4-6c4782524e84" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_cc61f7ce-b166-49f3-95f4-6c4782524e84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_06e2d8b0-b48f-455d-b312-c98303f9c218" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_BorrowingsInterestRate_06e2d8b0-b48f-455d-b312-c98303f9c218" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesSubscribedPerWarrant_174b82bd-a285-4a62-9307-529f223accc5" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesSubscribedPerWarrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_NumberOfSharesSubscribedPerWarrant_174b82bd-a285-4a62-9307-529f223accc5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceOtherLiabilities_1c05216a-3fc4-45ed-b31d-08e04039e3b6" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPriceOtherLiabilities_1c05216a-3fc4-45ed-b31d-08e04039e3b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceAdjustmentPeriod_eba39339-ba94-4071-9252-f3b712257213" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceAdjustmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPriceAdjustmentPeriod_eba39339-ba94-4071-9252-f3b712257213" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceVolumeWeightedAveragePricePeriod_bdb769e5-fe6b-4d08-b360-c4fd6e77bf34" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceVolumeWeightedAveragePricePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPriceVolumeWeightedAveragePricePeriod_bdb769e5-fe6b-4d08-b360-c4fd6e77bf34" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPricePercentageOfInitialPriceThreshold_f23c4324-a81a-4fce-a932-4913e06a31a8" xlink:href="abvx-20241231.xsd#abvx_ConversionPricePercentageOfInitialPriceThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPricePercentageOfInitialPriceThreshold_f23c4324-a81a-4fce-a932-4913e06a31a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_efa97fb4-f187-48cb-a2c1-303d9a5f67bf" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_efa97fb4-f187-48cb-a2c1-303d9a5f67bf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_d5716388-c24b-4c8f-bdac-afdbe049d595" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConvertibleLoansNotes_d5716388-c24b-4c8f-bdac-afdbe049d595" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_5a90f213-25fa-4ad3-b673-1b96d6f662f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_5a90f213-25fa-4ad3-b673-1b96d6f662f6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueConvertibleNotes_a1289b90-2f58-4581-abae-c0442174f7cb" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_AggregateFairValueConvertibleNotes_a1289b90-2f58-4581-abae-c0442174f7cb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_46315aab-4a9b-4bc5-b67e-e8ab317e00e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_46315aab-4a9b-4bc5-b67e-e8ab317e00e4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_dfa5a130-374e-47e6-9eb7-68d4b7b184a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_dfa5a130-374e-47e6-9eb7-68d4b7b184a9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a796754f-b2b0-4f7c-9386-eee225b6edbd" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a796754f-b2b0-4f7c-9386-eee225b6edbd" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_8cb29e62-2108-4561-a02b-68acabf9dd9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_8cb29e62-2108-4561-a02b-68acabf9dd9d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_d51bce1b-1d01-41a8-b355-a5f2b165de07" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_d51bce1b-1d01-41a8-b355-a5f2b165de07" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cc55c727-a771-4eaf-9321-b4f8c491723f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cc55c727-a771-4eaf-9321-b4f8c491723f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_cc55c727-a771-4eaf-9321-b4f8c491723f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cc55c727-a771-4eaf-9321-b4f8c491723f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_cc55c727-a771-4eaf-9321-b4f8c491723f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7f347c0c-2aec-4cf0-a09b-4df024deb0e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cc55c727-a771-4eaf-9321-b4f8c491723f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7f347c0c-2aec-4cf0-a09b-4df024deb0e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_fcaf5980-2461-4e53-a31a-a8d233b5e940" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7f347c0c-2aec-4cf0-a09b-4df024deb0e9" xlink:to="loc_abvx_OCEANEMember_fcaf5980-2461-4e53-a31a-a8d233b5e940" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_aca330be-b087-477a-a22e-5eca4ebf3ebe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:to="loc_ifrs-full_UnobservableInputsAxis_aca330be-b087-477a-a22e-5eca4ebf3ebe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_aca330be-b087-477a-a22e-5eca4ebf3ebe_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_aca330be-b087-477a-a22e-5eca4ebf3ebe" xlink:to="loc_ifrs-full_UnobservableInputsDomain_aca330be-b087-477a-a22e-5eca4ebf3ebe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_aca330be-b087-477a-a22e-5eca4ebf3ebe" xlink:to="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_0fb24a8a-8ad2-4314-8ba3-64b908a261dc" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_0fb24a8a-8ad2-4314-8ba3-64b908a261dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_5fd90b58-6522-45b1-9fd9-c25b495a6d4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_5fd90b58-6522-45b1-9fd9-c25b495a6d4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_d196630c-abe6-4a6f-be99-eca0cd3df34f" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_abvx_SharePriceMeasurementInputMember_d196630c-abe6-4a6f-be99-eca0cd3df34f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_04bf6d86-a580-49e8-9e9e-38ef6db85e65" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_04bf6d86-a580-49e8-9e9e-38ef6db85e65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_7549fa68-62dd-4682-8595-fc6f8c016a7d" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_7549fa68-62dd-4682-8595-fc6f8c016a7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_ce36f335-9ea8-4844-bedd-6fe5779ea868" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_ce36f335-9ea8-4844-bedd-6fe5779ea868" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_ce36f335-9ea8-4844-bedd-6fe5779ea868_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_ce36f335-9ea8-4844-bedd-6fe5779ea868" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_ce36f335-9ea8-4844-bedd-6fe5779ea868_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_c147f60a-5810-44df-8d84-2bd2c672e774" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_ce36f335-9ea8-4844-bedd-6fe5779ea868" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_c147f60a-5810-44df-8d84-2bd2c672e774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModelIFRSMember_73515050-963e-4b49-9bd6-8fc77e9f2129" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModelIFRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_c147f60a-5810-44df-8d84-2bd2c672e774" xlink:to="loc_abvx_MonteCarloModelIFRSMember_73515050-963e-4b49-9bd6-8fc77e9f2129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_fd69ad79-14d3-4603-8d38-f377a05e02db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_fd69ad79-14d3-4603-8d38-f377a05e02db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueConvertibleNotes_290e29a9-6dd9-49b3-b52a-0d223acaf3d8" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:to="loc_abvx_AggregateFairValueConvertibleNotes_290e29a9-6dd9-49b3-b52a-0d223acaf3d8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesStateguaranteedloanPGEDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5f40955c-7b1d-4034-b967-d43d931574c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5f40955c-7b1d-4034-b967-d43d931574c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_712ae603-4001-46fc-9938-58aadaede35c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5f40955c-7b1d-4034-b967-d43d931574c4" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_712ae603-4001-46fc-9938-58aadaede35c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_712ae603-4001-46fc-9938-58aadaede35c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_712ae603-4001-46fc-9938-58aadaede35c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_712ae603-4001-46fc-9938-58aadaede35c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_9d910f7a-303d-4cbb-ab2d-4d52d4baad8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_712ae603-4001-46fc-9938-58aadaede35c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_9d910f7a-303d-4cbb-ab2d-4d52d4baad8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_3a08fb78-df3d-4506-adae-cf69b7b52509" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9d910f7a-303d-4cbb-ab2d-4d52d4baad8b" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_3a08fb78-df3d-4506-adae-cf69b7b52509" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityTerm_64753fe0-fe08-40ba-9589-02b870c87357" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsMaturityTerm_64753fe0-fe08-40ba-9589-02b870c87357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_d4f0c33f-6a1a-4087-a44f-9ea4cbef62d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_ifrs-full_BorrowingsInterestRate_d4f0c33f-6a1a-4087-a44f-9ea4cbef62d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityExtensionTerm_f42e2184-3468-445a-9794-3ef71348a693" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsMaturityExtensionTerm_f42e2184-3468-445a-9794-3ef71348a693" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityDeferralPeriod_75035619-f406-4935-a08c-7a4cc299330c" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityDeferralPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsMaturityDeferralPeriod_75035619-f406-4935-a08c-7a4cc299330c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsStateGuaranteedPremium_b997621c-396a-4020-ad07-7c6dfc899090" xlink:href="abvx-20241231.xsd#abvx_BorrowingsStateGuaranteedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsStateGuaranteedPremium_b997621c-396a-4020-ad07-7c6dfc899090" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_9b17af6c-2567-4716-8acb-8dfc249cdb3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_9b17af6c-2567-4716-8acb-8dfc249cdb3c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofconditionaladvancesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a091b8cf-4d4e-4f8a-82a8-0260314b66b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_c8ac2962-e756-4273-9908-282f320bc9ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a091b8cf-4d4e-4f8a-82a8-0260314b66b2" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_c8ac2962-e756-4273-9908-282f320bc9ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_334264fb-2e10-4970-a093-f09d41591cb7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_c8ac2962-e756-4273-9908-282f320bc9ad" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_334264fb-2e10-4970-a093-f09d41591cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_334264fb-2e10-4970-a093-f09d41591cb7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_334264fb-2e10-4970-a093-f09d41591cb7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_334264fb-2e10-4970-a093-f09d41591cb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_334264fb-2e10-4970-a093-f09d41591cb7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_d4f63e31-12ae-4721-9cd0-77cc3f214131" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_d4f63e31-12ae-4721-9cd0-77cc3f214131" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_9be01241-376d-4989-94fa-edc5aab52059" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_9be01241-376d-4989-94fa-edc5aab52059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_e9b9d53a-511d-418d-ab32-92afeaeb3346" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_e9b9d53a-511d-418d-ab32-92afeaeb3346" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances_0acaefed-0b3e-436f-9578-0bc5bb946997" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a091b8cf-4d4e-4f8a-82a8-0260314b66b2" xlink:to="loc_abvx_ConditionalAdvances_0acaefed-0b3e-436f-9578-0bc5bb946997" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesConditionaladvancesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4dcbd37c-2e02-4e14-a9e7-5dea07044f7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4dcbd37c-2e02-4e14-a9e7-5dea07044f7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f347c6c8-b2ca-4f24-831d-41f5077204d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4dcbd37c-2e02-4e14-a9e7-5dea07044f7e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f347c6c8-b2ca-4f24-831d-41f5077204d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f347c6c8-b2ca-4f24-831d-41f5077204d0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f347c6c8-b2ca-4f24-831d-41f5077204d0" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f347c6c8-b2ca-4f24-831d-41f5077204d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f347c6c8-b2ca-4f24-831d-41f5077204d0" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_c8d1268e-015c-4733-8d5e-b0f75cc3f3bc" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_c8d1268e-015c-4733-8d5e-b0f75cc3f3bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_2f4192c8-1871-4bfd-8f5a-235dff207087" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_2f4192c8-1871-4bfd-8f5a-235dff207087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_823972d1-21d8-4a51-92b1-a6a3b4e84610" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_823972d1-21d8-4a51-92b1-a6a3b4e84610" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_6eef81a7-6f8b-437d-bdb8-b3fd4d5ddc11" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_6eef81a7-6f8b-437d-bdb8-b3fd4d5ddc11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromConditionalAdvances_4be0f9df-a4a5-4f2f-97f1-53f3d47adfb7" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromConditionalAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_ProceedsFromConditionalAdvances_4be0f9df-a4a5-4f2f-97f1-53f3d47adfb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentOfExcessConditionalAdvancesClaimed_c020dce6-f256-426a-8ce4-1794b2704395" xlink:href="abvx-20241231.xsd#abvx_RepaymentOfExcessConditionalAdvancesClaimed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_RepaymentOfExcessConditionalAdvancesClaimed_c020dce6-f256-426a-8ce4-1794b2704395" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PercentageOfConditionalAdvancesWaived_51235d48-8402-4d18-8ba9-0c003127d01e" xlink:href="abvx-20241231.xsd#abvx_PercentageOfConditionalAdvancesWaived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_PercentageOfConditionalAdvancesWaived_51235d48-8402-4d18-8ba9-0c003127d01e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances_86c8699a-6e52-46ec-8ac7-3a8617dabc32" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_ConditionalAdvances_86c8699a-6e52-46ec-8ac7-3a8617dabc32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_bce1c6ca-a282-4c64-866a-0bad7d96f0c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_bce1c6ca-a282-4c64-866a-0bad7d96f0c4" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesLeaseliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeaseLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeaseLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_e920d11d-1669-47fc-aa83-1f87f7ad7dad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:to="loc_ifrs-full_TypesOfContractsAxis_e920d11d-1669-47fc-aa83-1f87f7ad7dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_e920d11d-1669-47fc-aa83-1f87f7ad7dad_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfContractsAxis_e920d11d-1669-47fc-aa83-1f87f7ad7dad" xlink:to="loc_ifrs-full_TypesOfContractsDomain_e920d11d-1669-47fc-aa83-1f87f7ad7dad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfContractsAxis_e920d11d-1669-47fc-aa83-1f87f7ad7dad" xlink:to="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesParisMember_5a0ef4ce-ce8d-483a-a2a3-47c8318db7a4" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesParisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesParisMember_5a0ef4ce-ce8d-483a-a2a3-47c8318db7a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesBostonMember_222365dc-52e4-4700-bd0f-f009c769b1b9" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesBostonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesBostonMember_222365dc-52e4-4700-bd0f-f009c769b1b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMontpellierMember_51688794-4a31-461b-854e-0c3a40af3b7d" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMontpellierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesMontpellierMember_51688794-4a31-461b-854e-0c3a40af3b7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMember_fd45683a-a8b4-42be-8d84-0e4c7d095942" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesMember_fd45683a-a8b4-42be-8d84-0e4c7d095942" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_c6cc3231-1459-427d-be75-f88224b8b78d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:to="loc_ifrs-full_RangeAxis_c6cc3231-1459-427d-be75-f88224b8b78d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_c6cc3231-1459-427d-be75-f88224b8b78d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_c6cc3231-1459-427d-be75-f88224b8b78d" xlink:to="loc_ifrs-full_RangeDomain_c6cc3231-1459-427d-be75-f88224b8b78d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_c6cc3231-1459-427d-be75-f88224b8b78d" xlink:to="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_72cea516-0898-4bcd-afb2-bc94d3270ef1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:to="loc_srt_MinimumMember_72cea516-0898-4bcd-afb2-bc94d3270ef1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_47446b28-99a4-487a-9557-40c04a66051a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:to="loc_srt_MaximumMember_47446b28-99a4-487a-9557-40c04a66051a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseDurationPeriod_4ab02da8-1444-48d3-acc4-e75a7819de70" xlink:href="abvx-20241231.xsd#abvx_LeaseDurationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseDurationPeriod_4ab02da8-1444-48d3-acc4-e75a7819de70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseTacitRenewalPeriod_155f6ac6-3d60-4016-b237-1f0c960ebee0" xlink:href="abvx-20241231.xsd#abvx_LeaseTacitRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseTacitRenewalPeriod_155f6ac6-3d60-4016-b237-1f0c960ebee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseBreakClausePeriod_9ac28d27-d7c2-458e-82a6-6317609442d0" xlink:href="abvx-20241231.xsd#abvx_LeaseBreakClausePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseBreakClausePeriod_9ac28d27-d7c2-458e-82a6-6317609442d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm_7b694cf7-bc64-48f6-b519-ac79b7afab84" xlink:href="abvx-20241231.xsd#abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm_7b694cf7-bc64-48f6-b519-ac79b7afab84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseExtensionPeriod_7614b7a9-598b-43c2-90b8-7702488ba700" xlink:href="abvx-20241231.xsd#abvx_LeaseExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseExtensionPeriod_7614b7a9-598b-43c2-90b8-7702488ba700" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseLiabilityPercentageOfTotal_da40a111-340e-48f8-aa98-a74eda92b71d" xlink:href="abvx-20241231.xsd#abvx_LeaseLiabilityPercentageOfTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseLiabilityPercentageOfTotal_da40a111-340e-48f8-aa98-a74eda92b71d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseOnLeaseLiabilities_1e38d467-8193-423a-bf1a-78b839457e1e" xlink:href="abvx-20241231.xsd#abvx_ExpenseOnLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_ExpenseOnLeaseLiabilities_1e38d467-8193-423a-bf1a-78b839457e1e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DepreciationExpenseLease_1ac7fad1-e4b5-4700-915d-738e1db39f76" xlink:href="abvx-20241231.xsd#abvx_DepreciationExpenseLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_DepreciationExpenseLease_1ac7fad1-e4b5-4700-915d-738e1db39f76" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2ea152c6-2346-446f-b21a-bb8b8a520cea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2ea152c6-2346-446f-b21a-bb8b8a520cea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_f3801759-88d2-4c56-b928-e214866e25f6" xlink:href="abvx-20241231.xsd#abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_f3801759-88d2-4c56-b928-e214866e25f6" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesProsynergiaearnoutliabilityDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_83895f9a-a751-4f14-832e-66e8a5ae4be6" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:to="loc_abvx_AssetsAcquisitionsAxis_83895f9a-a751-4f14-832e-66e8a5ae4be6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_83895f9a-a751-4f14-832e-66e8a5ae4be6_default" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_AssetsAcquisitionsAxis_83895f9a-a751-4f14-832e-66e8a5ae4be6" xlink:to="loc_abvx_AssetsAcquisitionsDomain_83895f9a-a751-4f14-832e-66e8a5ae4be6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_f329860b-1c7a-487e-8a95-ab58c177e687" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_AssetsAcquisitionsAxis_83895f9a-a751-4f14-832e-66e8a5ae4be6" xlink:to="loc_abvx_AssetsAcquisitionsDomain_f329860b-1c7a-487e-8a95-ab58c177e687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_0d396d57-48a8-4cb4-81a8-ef56a82b4fea" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_AssetsAcquisitionsDomain_f329860b-1c7a-487e-8a95-ab58c177e687" xlink:to="loc_abvx_ProsynergiaMember_0d396d57-48a8-4cb4-81a8-ef56a82b4fea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ef4c1920-6684-4e41-a716-729dba486a33" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ef4c1920-6684-4e41-a716-729dba486a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_1d65da9c-d5d5-4317-bf44-ff910b1a1466" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ef4c1920-6684-4e41-a716-729dba486a33" xlink:to="loc_abvx_EarnOutLiabilityMember_1d65da9c-d5d5-4317-bf44-ff910b1a1466" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_100c3700-1ece-49a9-a991-f6707523352d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:to="loc_ifrs-full_UnobservableInputsAxis_100c3700-1ece-49a9-a991-f6707523352d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_100c3700-1ece-49a9-a991-f6707523352d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_100c3700-1ece-49a9-a991-f6707523352d" xlink:to="loc_ifrs-full_UnobservableInputsDomain_100c3700-1ece-49a9-a991-f6707523352d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_100c3700-1ece-49a9-a991-f6707523352d" xlink:to="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_03cc72ac-e1d7-4225-adde-45cb49017a35" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_03cc72ac-e1d7-4225-adde-45cb49017a35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_dd46d0e4-f927-453f-86ef-76569f0c8e46" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:to="loc_abvx_SharePriceMeasurementInputMember_dd46d0e4-f927-453f-86ef-76569f0c8e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_81e5e1cf-9f69-471c-ba68-4a73dba60b99" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_81e5e1cf-9f69-471c-ba68-4a73dba60b99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMarketCapitalizationThreshold_8415551d-0d8d-4433-9929-054f2da70cf4" xlink:href="abvx-20241231.xsd#abvx_EarnOutMarketCapitalizationThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutMarketCapitalizationThreshold_8415551d-0d8d-4433-9929-054f2da70cf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutPercentage_c6481ece-9fc6-4ba5-8e21-5b5dd7c3f984" xlink:href="abvx-20241231.xsd#abvx_EarnOutPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutPercentage_c6481ece-9fc6-4ba5-8e21-5b5dd7c3f984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMaximumAmount_3b4998d1-3b4f-43ce-b1b9-58eabc0549bd" xlink:href="abvx-20241231.xsd#abvx_EarnOutMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutMaximumAmount_3b4998d1-3b4f-43ce-b1b9-58eabc0549bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_55ba5a4f-c351-4c61-8c92-c5c7df7590c4" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_55ba5a4f-c351-4c61-8c92-c5c7df7590c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_eedb8bb4-7722-4165-9362-3730047e2029" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_eedb8bb4-7722-4165-9362-3730047e2029" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_cfdcdf07-71ba-4fe8-bd64-1ef31b72c081" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_cfdcdf07-71ba-4fe8-bd64-1ef31b72c081" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_d93232f1-d924-49e8-a9be-c23e6a1d0866" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_d93232f1-d924-49e8-a9be-c23e6a1d0866" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_43fbd284-3df2-4207-89fa-a932f2b943af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_ifrs-full_FinancialLiabilities_43fbd284-3df2-4207-89fa-a932f2b943af" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_91e92ce1-1278-4c70-915e-3969f6da6ce0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_91e92ce1-1278-4c70-915e-3969f6da6ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_91e92ce1-1278-4c70-915e-3969f6da6ce0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_91e92ce1-1278-4c70-915e-3969f6da6ce0" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_91e92ce1-1278-4c70-915e-3969f6da6ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_609e7e78-a9b3-4b90-bf90-c86b8eddb02d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_91e92ce1-1278-4c70-915e-3969f6da6ce0" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_609e7e78-a9b3-4b90-bf90-c86b8eddb02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_221faa69-7b9f-4e79-ade7-28bf36b65c3e" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_609e7e78-a9b3-4b90-bf90-c86b8eddb02d" xlink:to="loc_abvx_EarnOutLiabilityMember_221faa69-7b9f-4e79-ade7-28bf36b65c3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_169d0a5f-b3d6-406b-bc09-161fa1c0d438" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_169d0a5f-b3d6-406b-bc09-161fa1c0d438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionPricingModelMember_d9394dde-f5ec-4f08-bb98-a73c3a43aebb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_169d0a5f-b3d6-406b-bc09-161fa1c0d438" xlink:to="loc_ifrs-full_OptionPricingModelMember_d9394dde-f5ec-4f08-bb98-a73c3a43aebb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_5c47cffd-e764-487c-8487-578b0b0139aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:to="loc_ifrs-full_UnobservableInputsAxis_5c47cffd-e764-487c-8487-578b0b0139aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_5c47cffd-e764-487c-8487-578b0b0139aa_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_5c47cffd-e764-487c-8487-578b0b0139aa" xlink:to="loc_ifrs-full_UnobservableInputsDomain_5c47cffd-e764-487c-8487-578b0b0139aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_5c47cffd-e764-487c-8487-578b0b0139aa" xlink:to="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c1eb0b49-9300-45a0-9f93-fd0136b7717b" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c1eb0b49-9300-45a0-9f93-fd0136b7717b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MarketCapitalizationMeasurementInputMember_f74a0ac4-615d-492e-ae6e-e8f4d3206e58" xlink:href="abvx-20241231.xsd#abvx_MarketCapitalizationMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_MarketCapitalizationMeasurementInputMember_f74a0ac4-615d-492e-ae6e-e8f4d3206e58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_595d04ec-d832-4e47-be97-e1220b3fd097" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_SharePriceMeasurementInputMember_595d04ec-d832-4e47-be97-e1220b3fd097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResidualMaturityMeasurementInputMember_0602cdd0-19a8-4bff-825c-8fa4dc3e54e9" xlink:href="abvx-20241231.xsd#abvx_ResidualMaturityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_ResidualMaturityMeasurementInputMember_0602cdd0-19a8-4bff-825c-8fa4dc3e54e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_58e31d62-c92b-472f-9e0c-18edf42813ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_58e31d62-c92b-472f-9e0c-18edf42813ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_3e0692d2-f5da-4990-9852-b569f1ee8d2e" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_3e0692d2-f5da-4990-9852-b569f1ee8d2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_a3497b00-2d58-4694-8d36-00b685a867f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_a3497b00-2d58-4694-8d36-00b685a867f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValue_74e3536e-282e-4ea0-a7dd-aee166cd6ef3" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:to="loc_abvx_EarnOutAtFairValue_74e3536e-282e-4ea0-a7dd-aee166cd6ef3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesRoyaltycertificatesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_bb4aa2aa-5401-441b-a55a-2eca8916805a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_bb4aa2aa-5401-441b-a55a-2eca8916805a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_bb4aa2aa-5401-441b-a55a-2eca8916805a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_bb4aa2aa-5401-441b-a55a-2eca8916805a" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_bb4aa2aa-5401-441b-a55a-2eca8916805a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_d6accb36-0430-4114-8b37-4c18af8a66f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_bb4aa2aa-5401-441b-a55a-2eca8916805a" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_d6accb36-0430-4114-8b37-4c18af8a66f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_c87ed9c6-62df-49a1-be97-31b51a81b56f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_d6accb36-0430-4114-8b37-4c18af8a66f8" xlink:to="loc_ifrs-full_SharePremiumMember_c87ed9c6-62df-49a1-be97-31b51a81b56f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_75aff47c-8db6-4cc3-a38b-26fcb9ca202e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_75aff47c-8db6-4cc3-a38b-26fcb9ca202e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_75aff47c-8db6-4cc3-a38b-26fcb9ca202e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_75aff47c-8db6-4cc3-a38b-26fcb9ca202e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_75aff47c-8db6-4cc3-a38b-26fcb9ca202e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_483bd941-a7db-4a70-8fb1-5b9cf9320c7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_75aff47c-8db6-4cc3-a38b-26fcb9ca202e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_483bd941-a7db-4a70-8fb1-5b9cf9320c7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_9e6c3087-4346-4b78-8e00-77b893190e9d" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_483bd941-a7db-4a70-8fb1-5b9cf9320c7a" xlink:to="loc_abvx_RoyaltyCertificatesMember_9e6c3087-4346-4b78-8e00-77b893190e9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_e0357ddd-159c-4a7d-a34f-a0ecba129b2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_e0357ddd-159c-4a7d-a34f-a0ecba129b2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_e0357ddd-159c-4a7d-a34f-a0ecba129b2e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_e0357ddd-159c-4a7d-a34f-a0ecba129b2e" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_e0357ddd-159c-4a7d-a34f-a0ecba129b2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_df62a158-cb86-448e-96db-83e4889b9f01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_e0357ddd-159c-4a7d-a34f-a0ecba129b2e" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_df62a158-cb86-448e-96db-83e4889b9f01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_6485906a-b75e-4f56-a2b7-d0701a4a7de7" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_df62a158-cb86-448e-96db-83e4889b9f01" xlink:to="loc_abvx_RoyaltyCertificatesMember_6485906a-b75e-4f56-a2b7-d0701a4a7de7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_53067978-acd7-4b6a-af53-ec32f2833784" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_UnobservableInputsAxis_53067978-acd7-4b6a-af53-ec32f2833784" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_53067978-acd7-4b6a-af53-ec32f2833784_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_53067978-acd7-4b6a-af53-ec32f2833784" xlink:to="loc_ifrs-full_UnobservableInputsDomain_53067978-acd7-4b6a-af53-ec32f2833784_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_53067978-acd7-4b6a-af53-ec32f2833784" xlink:to="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProbabilityOfSuccessMeasurementInputMember_36a551f4-14c9-4dc4-aaf8-76a9aaedd4cb" xlink:href="abvx-20241231.xsd#abvx_ProbabilityOfSuccessMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_abvx_ProbabilityOfSuccessMeasurementInputMember_36a551f4-14c9-4dc4-aaf8-76a9aaedd4cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PeakPenetrationMeasurementInputMember_d2241c9a-5164-4dd2-9837-03216e526b57" xlink:href="abvx-20241231.xsd#abvx_PeakPenetrationMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_abvx_PeakPenetrationMeasurementInputMember_d2241c9a-5164-4dd2-9837-03216e526b57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember_e6f0e24e-5580-42dd-8e12-005c055701fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember_e6f0e24e-5580-42dd-8e12-005c055701fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_509c85e4-0bf4-41d4-8ef9-03c411e19e3f" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_abvx_SharePriceMeasurementInputMember_509c85e4-0bf4-41d4-8ef9-03c411e19e3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_fe8115ba-03dc-4275-abef-057270a205b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_NotionalAmount_fe8115ba-03dc-4275-abef-057270a205b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherLiabilitiesNumberOfTransactions_7e70fc76-293d-4ab9-bcbb-164b7fb3e88c" xlink:href="abvx-20241231.xsd#abvx_OtherLiabilitiesNumberOfTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_OtherLiabilitiesNumberOfTransactions_7e70fc76-293d-4ab9-bcbb-164b7fb3e88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_227e7931-f076-4e5b-82bb-51be7f3479a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_IssueOfEquity_227e7931-f076-4e5b-82bb-51be7f3479a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_05c453d7-5b0d-4d9f-bf7c-c260fd291ee5" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_05c453d7-5b0d-4d9f-bf7c-c260fd291ee5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_0e86102b-e99d-4049-ab7c-a442e4071c37" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_ParValuePerShare_0e86102b-e99d-4049-ab7c-a442e4071c37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_29c26930-0729-42f9-849e-a783682cb3a7" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_29c26930-0729-42f9-849e-a783682cb3a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_777b0de8-1135-4586-bb96-9654c0eaaacc" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_777b0de8-1135-4586-bb96-9654c0eaaacc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_cc4f2211-d0fc-4fae-bc09-c029228ed87e" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatePercentageOfFutureSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_cc4f2211-d0fc-4fae-bc09-c029228ed87e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateMaximumAmount_fffa1079-055e-406a-aa47-3687125229fc" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_RoyaltyCertificateMaximumAmount_fffa1079-055e-406a-aa47-3687125229fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_cee45977-c5c8-4a82-aaa8-ce4c29e473bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_cee45977-c5c8-4a82-aaa8-ce4c29e473bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates_45ba4dc9-1342-4606-80b6-1c28dbe79871" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_NonCurrentRoyaltyCertificates_45ba4dc9-1342-4606-80b6-1c28dbe79871" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates_856afe06-49a6-402b-b6c7-10d712d87052" xlink:href="abvx-20241231.xsd#abvx_DecreaseInInterestExpenseOnRoyaltyCertificates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates_856afe06-49a6-402b-b6c7-10d712d87052" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesEIR_fe19ab1b-38cc-431b-98a1-309bdb0d12e1" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesEIR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_RoyaltyCertificatesEIR_fe19ab1b-38cc-431b-98a1-309bdb0d12e1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_d1d37142-e0ed-444b-ba41-83d81d1e3a83" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_d1d37142-e0ed-444b-ba41-83d81d1e3a83" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestExpenseOnRoyaltyCertificates_22ad1584-0839-4592-8013-d9af5cd2dc7a" xlink:href="abvx-20241231.xsd#abvx_InterestExpenseOnRoyaltyCertificates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_InterestExpenseOnRoyaltyCertificates_22ad1584-0839-4592-8013-d9af5cd2dc7a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnwindingOfDiscountOnRoyalties_bd80bff1-fcbd-4102-8966-0e54e304513e" xlink:href="abvx-20241231.xsd#abvx_UnwindingOfDiscountOnRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_UnwindingOfDiscountOnRoyalties_bd80bff1-fcbd-4102-8966-0e54e304513e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_cc698959-ce48-42a6-9896-882bbcf56899" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_cc698959-ce48-42a6-9896-882bbcf56899" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3670f498-99f0-4143-92b9-6df75b17bab4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3670f498-99f0-4143-92b9-6df75b17bab4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_d78764e9-698b-4886-a50b-c978ae688d67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_d78764e9-698b-4886-a50b-c978ae688d67" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_eada3598-d63c-43d8-8f78-d57903bfc0ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_eada3598-d63c-43d8-8f78-d57903bfc0ae" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_26838da6-d22f-4b77-977f-5b209c0d3770" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_26838da6-d22f-4b77-977f-5b209c0d3770" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_c57b497d-01bc-4b22-8c7f-5948b9730fac" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_c57b497d-01bc-4b22-8c7f-5948b9730fac" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_615af7a9-a952-4216-a0a4-1c0462f2e40e" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_615af7a9-a952-4216-a0a4-1c0462f2e40e" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_efdd048b-cf5a-41f7-aec4-fbff8ecddcc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_efdd048b-cf5a-41f7-aec4-fbff8ecddcc3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_efdd048b-cf5a-41f7-aec4-fbff8ecddcc3" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_5469c356-092c-44b4-b67f-8557d578b9fa" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_Kreos12BondLoansMember_5469c356-092c-44b4-b67f-8557d578b9fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_cb15e965-8f03-42c6-8b69-d91d47f24ad2" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_OCEANEMember_cb15e965-8f03-42c6-8b69-d91d47f24ad2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_8bf5e16e-fd60-4d6d-bfdc-088012a1039c" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_8bf5e16e-fd60-4d6d-bfdc-088012a1039c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ClaretBondLoansMember_d607bc9a-fdd8-4618-9315-6de857fbbd74" xlink:href="abvx-20241231.xsd#abvx_Kreos1ClaretBondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_Kreos1ClaretBondLoansMember_d607bc9a-fdd8-4618-9315-6de857fbbd74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_96c041bd-6898-4018-95cc-7c15a19bca46" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_HeightsConvertibleNotesMember_96c041bd-6898-4018-95cc-7c15a19bca46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_28e9b285-b453-4ed3-ad31-23f6326c3d25" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_28e9b285-b453-4ed3-ad31-23f6326c3d25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesMember_066bd15a-f0b7-4265-a099-690b46619092" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_ConditionalAdvancesMember_066bd15a-f0b7-4265-a099-690b46619092" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_48ba8372-fc68-4539-8ae0-2567085aed58" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_48ba8372-fc68-4539-8ae0-2567085aed58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_653f50fa-ad3e-434d-9c88-1efef827a987" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_EarnOutLiabilityMember_653f50fa-ad3e-434d-9c88-1efef827a987" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_241db29d-935d-4e1f-a4b9-5abfcf5f406b" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_RoyaltyCertificatesMember_241db29d-935d-4e1f-a4b9-5abfcf5f406b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_3e00fef7-969b-4b9c-b5e9-171722f15b41" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_3e00fef7-969b-4b9c-b5e9-171722f15b41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities_a8765ab7-61ac-44a3-98e7-b22f13875f5d" xlink:href="abvx-20241231.xsd#abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities_a8765ab7-61ac-44a3-98e7-b22f13875f5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_f4645357-73c7-469b-afd6-109dbf10df4c" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_f4645357-73c7-469b-afd6-109dbf10df4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities_98501029-0090-4272-9435-d4a6382c4e5f" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities_98501029-0090-4272-9435-d4a6382c4e5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities_7f05dec4-ef5a-4914-a95d-257c6730ac17" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities_7f05dec4-ef5a-4914-a95d-257c6730ac17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities_034282f5-de02-4493-9ad1-a2f5d409aa6f" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities_034282f5-de02-4493-9ad1-a2f5d409aa6f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_89fb7f7a-6f65-4f97-8197-8fbc55af4aeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_89fb7f7a-6f65-4f97-8197-8fbc55af4aeb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities_5abec047-23e8-4733-a05d-92b2218d9a50" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities_5abec047-23e8-4733-a05d-92b2218d9a50" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_2c560a1e-4d9e-4f42-b516-64657bcddc87" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_2c560a1e-4d9e-4f42-b516-64657bcddc87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_c27be95c-4fd0-48db-81c3-a0b9ce98bba5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_c27be95c-4fd0-48db-81c3-a0b9ce98bba5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities_4118c218-b572-4358-a01e-0d1594a36a57" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities_4118c218-b572-4358-a01e-0d1594a36a57" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_6c4ba1d8-d422-454d-8db3-af669310c6b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_6c4ba1d8-d422-454d-8db3-af669310c6b8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_8e944854-e41c-4dec-9c56-d8b6bd2e9370" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_8e944854-e41c-4dec-9c56-d8b6bd2e9370" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_7d32ec20-3f82-40e1-920a-72978954f763" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesChangeinfinancialliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_467347cd-c335-4adb-9c24-3c5176817a02" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_467347cd-c335-4adb-9c24-3c5176817a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_467347cd-c335-4adb-9c24-3c5176817a02_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_467347cd-c335-4adb-9c24-3c5176817a02" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_467347cd-c335-4adb-9c24-3c5176817a02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_467347cd-c335-4adb-9c24-3c5176817a02" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_eafe0eac-9e97-43d5-bfa1-cc55c8f499af" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_eafe0eac-9e97-43d5-bfa1-cc55c8f499af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_bebb064b-e50c-466e-9909-7b5c9783bc97" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_bebb064b-e50c-466e-9909-7b5c9783bc97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_8c7614a7-1693-4158-9a6d-71a2c497fa42" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_HeightsConvertibleNotesMember_8c7614a7-1693-4158-9a6d-71a2c497fa42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_3a7b3393-043d-48c5-a46e-92bb4e52c759" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_OCEANEMember_3a7b3393-043d-48c5-a46e-92bb4e52c759" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_34f8f1de-a5d3-407a-87bb-bfd2e988fad9" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_34f8f1de-a5d3-407a-87bb-bfd2e988fad9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheCMember_123e6ce1-4e4e-46cf-90c5-d26aa8341643" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheCMember_123e6ce1-4e4e-46cf-90c5-d26aa8341643" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheABMember_d91b4816-4f4f-4ad6-9014-2d65e47cab49" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheABMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheABMember_d91b4816-4f4f-4ad6-9014-2d65e47cab49" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f2cc4685-4983-437c-8bda-245e2d54614e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f2cc4685-4983-437c-8bda-245e2d54614e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f2cc4685-4983-437c-8bda-245e2d54614e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f2cc4685-4983-437c-8bda-245e2d54614e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f2cc4685-4983-437c-8bda-245e2d54614e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3dc139b5-64d2-4c64-81ff-f00694570316" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f2cc4685-4983-437c-8bda-245e2d54614e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3dc139b5-64d2-4c64-81ff-f00694570316" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_9d87a05b-28c2-45b1-89d1-d5d2d7d4ea49" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3dc139b5-64d2-4c64-81ff-f00694570316" xlink:to="loc_abvx_OceaneConversionOptionMember_9d87a05b-28c2-45b1-89d1-d5d2d7d4ea49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForDebtIssueCosts_bafa97ee-ab1c-45b5-a1b4-1a3a0715bef4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForDebtIssueCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_ifrs-full_PaymentsForDebtIssueCosts_bafa97ee-ab1c-45b5-a1b4-1a3a0715bef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_d6b06c6b-4d9e-4be7-8579-b3bb0499395e" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_d6b06c6b-4d9e-4be7-8579-b3bb0499395e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepurchaseOfDerivativeInstruments_aac35b34-a9d5-471e-bd78-4839fac34421" xlink:href="abvx-20241231.xsd#abvx_RepurchaseOfDerivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_RepurchaseOfDerivativeInstruments_aac35b34-a9d5-471e-bd78-4839fac34421" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_e1dfa375-36a8-4367-8d10-e0d3e7657095" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_e1dfa375-36a8-4367-8d10-e0d3e7657095" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GrossProceedsFromNonConvertibleLoansNotes_b9f08138-dc63-4431-a6a7-5c50a607f76c" xlink:href="abvx-20241231.xsd#abvx_GrossProceedsFromNonConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_GrossProceedsFromNonConvertibleLoansNotes_b9f08138-dc63-4431-a6a7-5c50a607f76c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_6f21f287-78b1-4db6-a81b-32e58754ed8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_6f21f287-78b1-4db6-a81b-32e58754ed8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_6ef1ae0f-c27a-464e-825d-32af8ec43502" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_6f21f287-78b1-4db6-a81b-32e58754ed8e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_6ef1ae0f-c27a-464e-825d-32af8ec43502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_6ef1ae0f-c27a-464e-825d-32af8ec43502_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_6ef1ae0f-c27a-464e-825d-32af8ec43502" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_6ef1ae0f-c27a-464e-825d-32af8ec43502_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_6ef1ae0f-c27a-464e-825d-32af8ec43502" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_a502073e-7fd6-4703-be24-1bf933d0da9b" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosABSAMember_a502073e-7fd6-4703-be24-1bf933d0da9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_bb7b7d60-aa83-42f2-990b-75932611c656" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosBBSAMember_bb7b7d60-aa83-42f2-990b-75932611c656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_77cc9422-26c3-47e6-becb-bfdb127d757e" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_OceaneConversionOptionMember_77cc9422-26c3-47e6-becb-bfdb127d757e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_a736b66b-3da7-4663-a2f1-14f00063aadf" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_a736b66b-3da7-4663-a2f1-14f00063aadf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_571b0a72-b367-4775-ad40-ebe21e9ed4ca" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_571b0a72-b367-4775-ad40-ebe21e9ed4ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_eb04597c-f00d-45fb-8b67-2f1cd3008f46" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_eb04597c-f00d-45fb-8b67-2f1cd3008f46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfDerivativeInstruments_4ecceba0-6f8a-48bc-9a7d-c54ccd192161" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfDerivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_abvx_IssuanceOfDerivativeInstruments_4ecceba0-6f8a-48bc-9a7d-c54ccd192161" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_4400f85d-8aea-48dc-b1f6-64b13f6a5299" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_4400f85d-8aea-48dc-b1f6-64b13f6a5299" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_d25086c7-cddb-4db7-80b3-2d246097858d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsOnChangeInFairValueOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_d25086c7-cddb-4db7-80b3-2d246097858d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepurchaseOfDerivativeInstruments_b95f0795-6380-4e66-bc1e-a0823db60f9b" xlink:href="abvx-20241231.xsd#abvx_RepurchaseOfDerivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_abvx_RepurchaseOfDerivativeInstruments_b95f0795-6380-4e66-bc1e-a0823db60f9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExerciseOfDerivativeInstruments_42dcd99d-0ad0-43a4-82b2-c45d125f3228" xlink:href="abvx-20241231.xsd#abvx_ExerciseOfDerivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_abvx_ExerciseOfDerivativeInstruments_42dcd99d-0ad0-43a4-82b2-c45d125f3228" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_c00bc866-2ec9-41dc-8b2e-6599a7d7361e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesChangeinderivativeinstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_7b124add-deda-454f-ab31-5fe0a5d83b9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_7b124add-deda-454f-ab31-5fe0a5d83b9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f1e189ab-861c-44be-bfd8-b49b0e32493f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_7b124add-deda-454f-ab31-5fe0a5d83b9f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f1e189ab-861c-44be-bfd8-b49b0e32493f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f1e189ab-861c-44be-bfd8-b49b0e32493f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f1e189ab-861c-44be-bfd8-b49b0e32493f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_f1e189ab-861c-44be-bfd8-b49b0e32493f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f1e189ab-861c-44be-bfd8-b49b0e32493f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_c17acfbf-710c-469d-80cf-a6993f24ad07" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:to="loc_abvx_KreosABBSAMember_c17acfbf-710c-469d-80cf-a6993f24ad07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_e941340e-4bcf-4c40-bd99-b9b20b578313" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:to="loc_abvx_OCEANEMember_e941340e-4bcf-4c40-bd99-b9b20b578313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_d1da9f04-d166-476c-98e8-20f0d75df9de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_d1da9f04-d166-476c-98e8-20f0d75df9de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_f99c88b5-a9b8-4102-9e27-dad9877687f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_f99c88b5-a9b8-4102-9e27-dad9877687f7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_b9476732-c4b8-4f13-8f96-d5e28c57aae7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_b9476732-c4b8-4f13-8f96-d5e28c57aae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b9476732-c4b8-4f13-8f96-d5e28c57aae7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_b9476732-c4b8-4f13-8f96-d5e28c57aae7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b9476732-c4b8-4f13-8f96-d5e28c57aae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_b9476732-c4b8-4f13-8f96-d5e28c57aae7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_a71fb868-3b87-4afa-8b2f-629e0147c6dd" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_Kreos12BondLoansMember_a71fb868-3b87-4afa-8b2f-629e0147c6dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_60058702-7efa-4e55-a895-0063140d5094" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_OceaneConversionOptionMember_60058702-7efa-4e55-a895-0063140d5094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_3842e502-f63f-43ba-a36c-ef71f0085fef" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_HeightsConvertibleNotesMember_3842e502-f63f-43ba-a36c-ef71f0085fef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_f378ff39-d30a-4402-97e9-ce32c1b6e297" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_f378ff39-d30a-4402-97e9-ce32c1b6e297" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretBondLoansMember_d54bc89d-ece1-4be0-bb08-d70c106d585e" xlink:href="abvx-20241231.xsd#abvx_KreosClaretBondLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_KreosClaretBondLoansMember_d54bc89d-ece1-4be0-bb08-d70c106d585e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_98a4183f-137f-457a-9add-05740e9be380" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_98a4183f-137f-457a-9add-05740e9be380" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BanquePubliqueDInvestissementBPIMember_d1aa17c7-828d-4ef1-874d-9cb69c17db9b" xlink:href="abvx-20241231.xsd#abvx_BanquePubliqueDInvestissementBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_BanquePubliqueDInvestissementBPIMember_d1aa17c7-828d-4ef1-874d-9cb69c17db9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_b579f320-0d4c-4bdc-ba50-6f38174aa28f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:to="loc_ifrs-full_MaturityAxis_b579f320-0d4c-4bdc-ba50-6f38174aa28f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_b579f320-0d4c-4bdc-ba50-6f38174aa28f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_b579f320-0d4c-4bdc-ba50-6f38174aa28f" xlink:to="loc_ifrs-full_MaturityDomain_b579f320-0d4c-4bdc-ba50-6f38174aa28f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_b579f320-0d4c-4bdc-ba50-6f38174aa28f" xlink:to="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_0a1a8046-36ee-4a2e-a9e0-5a6d670dbdd5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_0a1a8046-36ee-4a2e-a9e0-5a6d670dbdd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_a31ac040-7d5c-4288-a250-2b5b9152eaa8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_a31ac040-7d5c-4288-a250-2b5b9152eaa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_df43661b-87b6-46df-b891-6aa587ec9766" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_df43661b-87b6-46df-b891-6aa587ec9766" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_80090809-cd1a-4af0-9105-5bbbb1bf60e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_80090809-cd1a-4af0-9105-5bbbb1bf60e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_1551da37-474d-49a9-bed1-2d96ddb43c4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_Borrowings_1551da37-474d-49a9-bed1-2d96ddb43c4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_630e579c-9c6a-4c4c-a799-a8345ebd6723" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_630e579c-9c6a-4c4c-a799-a8345ebd6723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_84631dba-ee5d-4671-ae87-f351ca9ec48b" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConvertibleLoansNotes_84631dba-ee5d-4671-ae87-f351ca9ec48b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows_9e521b88-cd9d-4b22-8169-6d5e0f2f4845" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows_9e521b88-cd9d-4b22-8169-6d5e0f2f4845" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances_0dc0a377-192d-476d-8912-1c2482b87268" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConditionalAdvances_0dc0a377-192d-476d-8912-1c2482b87268" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesUndiscountedCashFlows_1f0abed9-4b48-4c2a-ba53-083ef42dc166" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConditionalAdvancesUndiscountedCashFlows_1f0abed9-4b48-4c2a-ba53-083ef42dc166" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates_615b8946-e4c9-40c6-b813-a8600131b30d" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_NonCurrentRoyaltyCertificates_615b8946-e4c9-40c6-b813-a8600131b30d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows_1a1b08d6-e9da-4d81-9f77-8e52bef2de06" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows_1a1b08d6-e9da-4d81-9f77-8e52bef2de06" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_d52ab084-93c4-4708-a532-38f5f630a0fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_LeaseLiabilities_d52ab084-93c4-4708-a532-38f5f630a0fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_bbd3b9b0-0f80-4ec5-a112-3f43fc84ecb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_bbd3b9b0-0f80-4ec5-a112-3f43fc84ecb2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_9bec0a1a-8dc5-49bd-b868-5c95ffb16e30" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_9bec0a1a-8dc5-49bd-b868-5c95ffb16e30" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_6e742d5a-2274-4d1b-92c0-4046b8d89b77" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_6e742d5a-2274-4d1b-92c0-4046b8d89b77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_10504042-84ac-4df3-9b8d-a4868d0c265e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_FinancialLiabilities_10504042-84ac-4df3-9b8d-a4868d0c265e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_5abb9fa2-5ea8-4e1a-8469-dee12686bbee" xlink:href="abvx-20241231.xsd#abvx_FinancialLiabilitiesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_5abb9fa2-5ea8-4e1a-8469-dee12686bbee" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_6b3df263-c538-4662-9ec9-c7ee9cf4768c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_6b3df263-c538-4662-9ec9-c7ee9cf4768c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4a172f30-94c7-4743-b227-f2c42f566e97" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_6b3df263-c538-4662-9ec9-c7ee9cf4768c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4a172f30-94c7-4743-b227-f2c42f566e97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a172f30-94c7-4743-b227-f2c42f566e97_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4a172f30-94c7-4743-b227-f2c42f566e97" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a172f30-94c7-4743-b227-f2c42f566e97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e796cd91-b142-4145-af1b-25c1d73e4d72" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4a172f30-94c7-4743-b227-f2c42f566e97" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e796cd91-b142-4145-af1b-25c1d73e4d72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_258de658-1e31-4719-952d-082e0a2283eb" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e796cd91-b142-4145-af1b-25c1d73e4d72" xlink:to="loc_abvx_RoyaltyCertificatesMember_258de658-1e31-4719-952d-082e0a2283eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_591ee23c-b9bb-451d-8c70-1b1c923edbbd" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatePercentageOfFutureSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:to="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_591ee23c-b9bb-451d-8c70-1b1c923edbbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateMaximumAmount_3f335109-2c2f-47a9-8e98-85eb538003c6" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:to="loc_abvx_RoyaltyCertificateMaximumAmount_3f335109-2c2f-47a9-8e98-85eb538003c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateExpirationPeriod_05cc633e-c728-4859-b58f-e8bc55599260" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:to="loc_abvx_RoyaltyCertificateExpirationPeriod_05cc633e-c728-4859-b58f-e8bc55599260" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b1252ec5-17af-46ec-b341-5753b07b7a17" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:to="loc_srt_TitleOfIndividualAxis_b1252ec5-17af-46ec-b341-5753b07b7a17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b1252ec5-17af-46ec-b341-5753b07b7a17_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_b1252ec5-17af-46ec-b341-5753b07b7a17" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b1252ec5-17af-46ec-b341-5753b07b7a17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_b1252ec5-17af-46ec-b341-5753b07b7a17" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ManagementMember_efabaacb-7899-44ef-835b-37201f2a3d14" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:to="loc_srt_ManagementMember_efabaacb-7899-44ef-835b-37201f2a3d14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEmployeesMember_282e7315-195d-4544-af6d-46a7c1a62e6d" xlink:href="abvx-20241231.xsd#abvx_OtherEmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:to="loc_abvx_OtherEmployeesMember_282e7315-195d-4544-af6d-46a7c1a62e6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_66fd268e-7d2e-44f8-a441-a61439cc11f4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:to="loc_srt_RangeAxis_66fd268e-7d2e-44f8-a441-a61439cc11f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_66fd268e-7d2e-44f8-a441-a61439cc11f4_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_66fd268e-7d2e-44f8-a441-a61439cc11f4" xlink:to="loc_srt_RangeMember_66fd268e-7d2e-44f8-a441-a61439cc11f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_66fd268e-7d2e-44f8-a441-a61439cc11f4" xlink:to="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_79b8656b-5b43-4ac1-80d3-84dd4c140dc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:to="loc_ifrs-full_TopOfRangeMember_79b8656b-5b43-4ac1-80d3-84dd4c140dc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_ce8df712-e7fc-49b3-936d-0d351da95943" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:to="loc_ifrs-full_BottomOfRangeMember_ce8df712-e7fc-49b3-936d-0d351da95943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_6ae19b7a-bacd-4ecb-ace4-bf393b403672" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfRetirementAge2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_6ae19b7a-bacd-4ecb-ace4-bf393b403672" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_ec1e0915-2222-4b9d-9bc5-ee06d5fe5cc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_ec1e0915-2222-4b9d-9bc5-ee06d5fe5cc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_573afe00-7cdf-4a26-b554-d53dbac15369" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_573afe00-7cdf-4a26-b554-d53dbac15369" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover_8a51b803-0c3a-4008-a617-a11daa84798e" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfExpectedRatesOfTurnover"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover_8a51b803-0c3a-4008-a617-a11daa84798e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate_ffe318e9-c5a7-4b81-adb6-ff1cccb53412" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate_ffe318e9-c5a7-4b81-adb6-ff1cccb53412" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfEmployeeContributionRate_024c807c-7e1b-474c-b010-31067ec7e2f3" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfEmployeeContributionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_abvx_ActuarialAssumptionOfEmployeeContributionRate_024c807c-7e1b-474c-b010-31067ec7e2f3" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_bda5b84b-8bd4-4145-88c5-422de9207d43" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_bda5b84b-8bd4-4145-88c5-422de9207d43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_a1eb21f5-c796-46c0-af5a-e6bea8546ff8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_bda5b84b-8bd4-4145-88c5-422de9207d43" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_a1eb21f5-c796-46c0-af5a-e6bea8546ff8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_a1eb21f5-c796-46c0-af5a-e6bea8546ff8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_a1eb21f5-c796-46c0-af5a-e6bea8546ff8" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_a1eb21f5-c796-46c0-af5a-e6bea8546ff8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6a5ea033-9180-4824-9cca-40a9427a6db4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_a1eb21f5-c796-46c0-af5a-e6bea8546ff8" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6a5ea033-9180-4824-9cca-40a9427a6db4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_4c3dd6cd-a716-4786-bafb-0aacf07084bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6a5ea033-9180-4824-9cca-40a9427a6db4" xlink:to="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_4c3dd6cd-a716-4786-bafb-0aacf07084bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_9f9b5d4c-2cf4-4e4c-befe-f8e58c0e1755" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_9f9b5d4c-2cf4-4e4c-befe-f8e58c0e1755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_ce17be56-be01-488f-a5b2-25e88fbd6d84" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_ce17be56-be01-488f-a5b2-25e88fbd6d84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_cfaabe9c-8be8-41e3-972b-0a9ff8520710" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_cfaabe9c-8be8-41e3-972b-0a9ff8520710" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_1f7abf10-b1b6-4c8a-8d6f-75657fc06649" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_1f7abf10-b1b6-4c8a-8d6f-75657fc06649" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_ebb4fa66-9b0c-4534-a65c-ed720429dca6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_ebb4fa66-9b0c-4534-a65c-ed720429dca6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_ef25ece3-fbfa-4021-9593-08d17c718001" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingincomeNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingincomeNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OperatingincomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOperatingIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOperatingIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:to="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CIRTaxYearAxis_36efd9ee-99fb-40bb-a871-accabb6d05de" xlink:href="abvx-20241231.xsd#abvx_CIRTaxYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:to="loc_abvx_CIRTaxYearAxis_36efd9ee-99fb-40bb-a871-accabb6d05de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CIRTaxYearDomain_36efd9ee-99fb-40bb-a871-accabb6d05de_default" xlink:href="abvx-20241231.xsd#abvx_CIRTaxYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_CIRTaxYearAxis_36efd9ee-99fb-40bb-a871-accabb6d05de" xlink:to="loc_abvx_CIRTaxYearDomain_36efd9ee-99fb-40bb-a871-accabb6d05de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:href="abvx-20241231.xsd#abvx_CIRTaxYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_CIRTaxYearAxis_36efd9ee-99fb-40bb-a871-accabb6d05de" xlink:to="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2021TaxYearMember_917a570a-b2d7-43e8-8665-3913a45209bb" xlink:href="abvx-20241231.xsd#abvx_A2021TaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:to="loc_abvx_A2021TaxYearMember_917a570a-b2d7-43e8-8665-3913a45209bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2022TaxYearMember_2b933b89-27e3-4062-be3c-40cd860fbfed" xlink:href="abvx-20241231.xsd#abvx_A2022TaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:to="loc_abvx_A2022TaxYearMember_2b933b89-27e3-4062-be3c-40cd860fbfed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2023TaxYearMember_d71c0889-b12b-4dc3-8da5-c7f3a1066f96" xlink:href="abvx-20241231.xsd#abvx_A2023TaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:to="loc_abvx_A2023TaxYearMember_d71c0889-b12b-4dc3-8da5-c7f3a1066f96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bad64afd-3d01-4f60-9216-00d9f8e4312c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bad64afd-3d01-4f60-9216-00d9f8e4312c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bad64afd-3d01-4f60-9216-00d9f8e4312c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bad64afd-3d01-4f60-9216-00d9f8e4312c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bad64afd-3d01-4f60-9216-00d9f8e4312c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bad64afd-3d01-4f60-9216-00d9f8e4312c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_49240140-64b7-4f4b-868f-c34c1a2c5772" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_49240140-64b7-4f4b-868f-c34c1a2c5772" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_46ec396d-d186-4346-a25f-4f4b38533d15" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_46ec396d-d186-4346-a25f-4f4b38533d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncomeFromResearchTaxCredit_8e2f7e0b-45f8-4523-8867-50bd965103af" xlink:href="abvx-20241231.xsd#abvx_IncomeFromResearchTaxCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:to="loc_abvx_IncomeFromResearchTaxCredit_8e2f7e0b-45f8-4523-8867-50bd965103af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_4300602c-df9e-483b-93cf-0915b483d3fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_4300602c-df9e-483b-93cf-0915b483d3fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofsalesandmarketingexpensesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_25cf180e-f8f6-4444-b708-4ac35120fc09" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_25cf180e-f8f6-4444-b708-4ac35120fc09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_044262e5-5a7c-4ec7-b0bc-24a7784deeca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_25cf180e-f8f6-4444-b708-4ac35120fc09" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_044262e5-5a7c-4ec7-b0bc-24a7784deeca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_044262e5-5a7c-4ec7-b0bc-24a7784deeca_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_044262e5-5a7c-4ec7-b0bc-24a7784deeca" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_044262e5-5a7c-4ec7-b0bc-24a7784deeca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_181d529c-98dd-475a-8b18-d7e623688917" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_044262e5-5a7c-4ec7-b0bc-24a7784deeca" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_181d529c-98dd-475a-8b18-d7e623688917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SalesAndMarketingExpenseMember_b4573fd1-366b-422b-9196-7174cd85a361" xlink:href="abvx-20241231.xsd#abvx_SalesAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_181d529c-98dd-475a-8b18-d7e623688917" xlink:to="loc_abvx_SalesAndMarketingExpenseMember_b4573fd1-366b-422b-9196-7174cd85a361" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_dd3e3ad0-3f2e-45da-8e47-142ca36631ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_dd3e3ad0-3f2e-45da-8e47-142ca36631ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_a5268dee-bf88-4e2b-ad25-1b07ca40f7e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_a5268dee-bf88-4e2b-ad25-1b07ca40f7e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_af615b6b-f02e-4303-b37e-f95800ec01f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_af615b6b-f02e-4303-b37e-f95800ec01f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_919619f1-2feb-4350-95e2-a0c2c6f73046" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_OperatingExpense_919619f1-2feb-4350-95e2-a0c2c6f73046" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OperatingexpensesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f216be98-207a-4716-b5b0-7fa2898a07d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f216be98-207a-4716-b5b0-7fa2898a07d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72ec8b67-0141-4969-a366-bbfab69844c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f216be98-207a-4716-b5b0-7fa2898a07d5" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72ec8b67-0141-4969-a366-bbfab69844c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_72ec8b67-0141-4969-a366-bbfab69844c6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72ec8b67-0141-4969-a366-bbfab69844c6" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_72ec8b67-0141-4969-a366-bbfab69844c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72ec8b67-0141-4969-a366-bbfab69844c6" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentExpensesMember_b70b7ae8-5bb7-4675-b946-d92e4466ccd2" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:to="loc_abvx_ResearchAndDevelopmentExpensesMember_b70b7ae8-5bb7-4675-b946-d92e4466ccd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GeneralAndAdministrativeExpensesMember_60ad3378-fb3f-4a88-9eac-ca7c90a8f406" xlink:href="abvx-20241231.xsd#abvx_GeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:to="loc_abvx_GeneralAndAdministrativeExpensesMember_60ad3378-fb3f-4a88-9eac-ca7c90a8f406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_0c374284-2a4c-4d68-9dd4-74118c8614b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_0c374284-2a4c-4d68-9dd4-74118c8614b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInUlcerativeColitisExpenses_34b1bed4-2633-4529-a7c6-657c956e6e57" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInUlcerativeColitisExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInUlcerativeColitisExpenses_34b1bed4-2633-4529-a7c6-657c956e6e57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses_76d314d7-e90d-459b-892d-0dda4ea0843d" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses_76d314d7-e90d-459b-892d-0dda4ea0843d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInTransversalActivities_4792ab3e-0a0f-4294-b583-149c3f536746" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInTransversalActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInTransversalActivities_4792ab3e-0a0f-4294-b583-149c3f536746" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses_f4ad267a-ae9a-4162-999f-3e5dd6e7a921" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInEmployeeBenefitsExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses_f4ad267a-ae9a-4162-999f-3e5dd6e7a921" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_60f23a55-dbbe-4460-a49f-087ee5eca676" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_60f23a55-dbbe-4460-a49f-087ee5eca676" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c7477d19-8628-4b25-b362-09753fda9011" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_60f23a55-dbbe-4460-a49f-087ee5eca676" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c7477d19-8628-4b25-b362-09753fda9011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_c7477d19-8628-4b25-b362-09753fda9011_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c7477d19-8628-4b25-b362-09753fda9011" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_c7477d19-8628-4b25-b362-09753fda9011_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8c3fa566-bef4-4186-afad-3201714ba92e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c7477d19-8628-4b25-b362-09753fda9011" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8c3fa566-bef4-4186-afad-3201714ba92e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentExpensesMember_763cf264-0cd4-42bb-bff3-ad76303e0883" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8c3fa566-bef4-4186-afad-3201714ba92e" xlink:to="loc_abvx_ResearchAndDevelopmentExpensesMember_763cf264-0cd4-42bb-bff3-ad76303e0883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SubContractingStudiesAndResearchExpenses_7b8249d4-6148-48a0-a507-35b57cf46234" xlink:href="abvx-20241231.xsd#abvx_SubContractingStudiesAndResearchExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_abvx_SubContractingStudiesAndResearchExpenses_7b8249d4-6148-48a0-a507-35b57cf46234" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_6acb9e69-53ac-4745-aae2-cce0f41fa306" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_6acb9e69-53ac-4745-aae2-cce0f41fa306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_618a157c-d1b1-4649-96d5-32fa4898dde4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_618a157c-d1b1-4649-96d5-32fa4898dde4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IntellectualPropertyFees_ed38e927-af80-4d22-ac63-34b33941c5be" xlink:href="abvx-20241231.xsd#abvx_IntellectualPropertyFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_abvx_IntellectualPropertyFees_ed38e927-af80-4d22-ac63-34b33941c5be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_0603e211-32a6-495a-a33d-6e1658504845" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_0603e211-32a6-495a-a33d-6e1658504845" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_493fb739-3e59-4fd7-b0ef-f82088d1564a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_OperatingExpense_493fb739-3e59-4fd7-b0ef-f82088d1564a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_5e33ccf2-9df7-4c9a-9fe1-52bdea34ec65" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_5e33ccf2-9df7-4c9a-9fe1-52bdea34ec65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_f101b0a0-e727-4b56-b18d-00e0d57c2cba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_5e33ccf2-9df7-4c9a-9fe1-52bdea34ec65" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_f101b0a0-e727-4b56-b18d-00e0d57c2cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_f101b0a0-e727-4b56-b18d-00e0d57c2cba_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_f101b0a0-e727-4b56-b18d-00e0d57c2cba" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_f101b0a0-e727-4b56-b18d-00e0d57c2cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_96b8848c-c213-44fd-8fcc-9bacf306d338" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_f101b0a0-e727-4b56-b18d-00e0d57c2cba" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_96b8848c-c213-44fd-8fcc-9bacf306d338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GeneralAndAdministrativeExpensesMember_b32d2a56-8f8b-4523-bf2c-dc576ff31830" xlink:href="abvx-20241231.xsd#abvx_GeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_96b8848c-c213-44fd-8fcc-9bacf306d338" xlink:to="loc_abvx_GeneralAndAdministrativeExpensesMember_b32d2a56-8f8b-4523-bf2c-dc576ff31830" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_7a1f057b-c6ca-4eb1-95dd-fee87006a9f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_7a1f057b-c6ca-4eb1-95dd-fee87006a9f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_17355717-f295-4ff6-8206-fc8fdefe78be" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_17355717-f295-4ff6-8206-fc8fdefe78be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_e9d13241-8aac-4ea3-a2c7-94a7d27521d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_e9d13241-8aac-4ea3-a2c7-94a7d27521d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_f4212188-b3ff-4854-ae3a-835c1ba3ab23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_OperatingExpense_f4212188-b3ff-4854-ae3a-835c1ba3ab23" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/EmployeesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#EmployeesDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/EmployeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfEmployeeWorkforceLineItems_82a74131-9dfe-423c-8d85-f499eef1624d" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfEmployeeWorkforceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfEmployeeWorkforceTable_f797f56b-1d78-404d-9935-4c24562573e5" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfEmployeeWorkforceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceLineItems_82a74131-9dfe-423c-8d85-f499eef1624d" xlink:to="loc_abvx_DisclosureOfEmployeeWorkforceTable_f797f56b-1d78-404d-9935-4c24562573e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_70a3a95e-dbda-4257-983a-2b0937373508" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceTable_f797f56b-1d78-404d-9935-4c24562573e5" xlink:to="loc_ifrs-full_GeographicalAreasAxis_70a3a95e-dbda-4257-983a-2b0937373508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_70a3a95e-dbda-4257-983a-2b0937373508_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_70a3a95e-dbda-4257-983a-2b0937373508" xlink:to="loc_ifrs-full_GeographicalAreasDomain_70a3a95e-dbda-4257-983a-2b0937373508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_70a3a95e-dbda-4257-983a-2b0937373508" xlink:to="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_f4e6d4b5-b406-4d9b-ae01-758e3f7d8dec" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:to="loc_country_FR_f4e6d4b5-b406-4d9b-ae01-758e3f7d8dec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b0cf6e80-6ece-43b7-bb94-9c7e373f9c52" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:to="loc_country_US_b0cf6e80-6ece-43b7-bb94-9c7e373f9c52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_ef47f74f-92d4-4747-b753-40677feb26b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceLineItems_82a74131-9dfe-423c-8d85-f499eef1624d" xlink:to="loc_ifrs-full_AverageNumberOfEmployees_ef47f74f-92d4-4747-b753-40677feb26b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialgainlossNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialgainlossNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/FinancialgainlossNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFinancialGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFinancialGainLossTable_78836cbd-63ee-4b45-a986-f0bd78ed746e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFinancialGainLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:to="loc_abvx_DisclosureOfFinancialGainLossTable_78836cbd-63ee-4b45-a986-f0bd78ed746e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfFinancialGainLossTable_78836cbd-63ee-4b45-a986-f0bd78ed746e" xlink:to="loc_srt_CurrencyAxis_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164_default" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164" xlink:to="loc_currency_AllCurrenciesDomain_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_b1113712-c003-4c5d-918a-59b09100db60" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164" xlink:to="loc_currency_AllCurrenciesDomain_b1113712-c003-4c5d-918a-59b09100db60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_fc692c10-8bd9-4b7d-82da-2e1cf91fc405" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_b1113712-c003-4c5d-918a-59b09100db60" xlink:to="loc_currency_USD_fc692c10-8bd9-4b7d-82da-2e1cf91fc405" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_1e40ad7f-bf60-448c-bc82-0aaff233cb01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_1e40ad7f-bf60-448c-bc82-0aaff233cb01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations_7bb87967-784f-4d7d-bc3c-f2b622f8f2a3" xlink:href="abvx-20241231.xsd#abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:to="loc_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations_7bb87967-784f-4d7d-bc3c-f2b622f8f2a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_30ba7e47-0d3f-4a06-9a1a-146b78cd7eb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_30ba7e47-0d3f-4a06-9a1a-146b78cd7eb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aae210f0-01ef-48c4-bb4e-9f45adab2894" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_30ba7e47-0d3f-4a06-9a1a-146b78cd7eb4" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aae210f0-01ef-48c4-bb4e-9f45adab2894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_aae210f0-01ef-48c4-bb4e-9f45adab2894_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aae210f0-01ef-48c4-bb4e-9f45adab2894" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_aae210f0-01ef-48c4-bb4e-9f45adab2894_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aae210f0-01ef-48c4-bb4e-9f45adab2894" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember_d78e5149-d7e2-446b-9703-01fbaa1969b8" xlink:href="abvx-20241231.xsd#abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember_d78e5149-d7e2-446b-9703-01fbaa1969b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SubsidiesRelatedTemporaryDifferencesMember_81b81ad0-02e5-4217-ae21-826d84a3f322" xlink:href="abvx-20241231.xsd#abvx_SubsidiesRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_SubsidiesRelatedTemporaryDifferencesMember_81b81ad0-02e5-4217-ae21-826d84a3f322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeasesRelatedTemporaryDifferencesMember_48a6b00d-4e31-48b9-9226-54754f2a6720" xlink:href="abvx-20241231.xsd#abvx_LeasesRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_LeasesRelatedTemporaryDifferencesMember_48a6b00d-4e31-48b9-9226-54754f2a6720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember_8600fcbb-7097-4b4f-b73c-a53edb70d872" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember_8600fcbb-7097-4b4f-b73c-a53edb70d872" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_6defa9f1-3f0c-4ec7-aa55-32c3ea523f29" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_6defa9f1-3f0c-4ec7-aa55-32c3ea523f29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_19310e36-89cf-47d0-8d31-42c77bc3d9b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_19310e36-89cf-47d0-8d31-42c77bc3d9b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_8d41ccc1-9140-405c-819c-66701df3a6f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_ifrs-full_DeferredTaxAssets_8d41ccc1-9140-405c-819c-66701df3a6f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_63902297-85ae-47ae-afd5-297eeccad8b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_63902297-85ae-47ae-afd5-297eeccad8b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_00463019-b62f-4275-a9b4-8f57aeb0c599" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_00463019-b62f-4275-a9b4-8f57aeb0c599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnrecognizedDeferredTaxAssets_3a09284c-e609-4127-a378-7f6f664e4966" xlink:href="abvx-20241231.xsd#abvx_UnrecognizedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_abvx_UnrecognizedDeferredTaxAssets_3a09284c-e609-4127-a378-7f6f664e4966" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_a2587aa4-5e85-48c5-89e8-3b6396bd7608" xlink:href="abvx-20241231.xsd#abvx_DeferredTaxAssetsRecognisedInFinancialPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_a2587aa4-5e85-48c5-89e8-3b6396bd7608" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/IncometaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_79b44ddb-0d33-4959-b761-ec845dc9ad52" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_ba625a6d-1006-44dc-a767-5866a6563dc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_79b44ddb-0d33-4959-b761-ec845dc9ad52" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_ba625a6d-1006-44dc-a767-5866a6563dc8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d61b30db-67ce-45cf-af6d-88ba6c5617fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_ba625a6d-1006-44dc-a767-5866a6563dc8" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d61b30db-67ce-45cf-af6d-88ba6c5617fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d61b30db-67ce-45cf-af6d-88ba6c5617fe_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d61b30db-67ce-45cf-af6d-88ba6c5617fe" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d61b30db-67ce-45cf-af6d-88ba6c5617fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_4dda6744-ae05-4921-9725-8deb1b0e78b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d61b30db-67ce-45cf-af6d-88ba6c5617fe" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_4dda6744-ae05-4921-9725-8deb1b0e78b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AbivaxLLCMember_dee67ff9-28ff-4a81-ab01-f2078fb26774" xlink:href="abvx-20241231.xsd#abvx_AbivaxLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_4dda6744-ae05-4921-9725-8deb1b0e78b9" xlink:to="loc_abvx_AbivaxLLCMember_dee67ff9-28ff-4a81-ab01-f2078fb26774" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_178f2dc0-2ce4-49b2-9486-22ae5a15af02" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_79b44ddb-0d33-4959-b761-ec845dc9ad52" xlink:to="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_178f2dc0-2ce4-49b2-9486-22ae5a15af02" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RelatedpartiesNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RelatedpartiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/RelatedpartiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:to="loc_srt_TitleOfIndividualAxis_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember_318ca62f-13e3-4b40-9eb4-78437bf57594" xlink:href="abvx-20241231.xsd#abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:to="loc_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember_318ca62f-13e3-4b40-9eb4-78437bf57594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdvisorToTheChiefExecutiveOfficerMember_697a8b30-1ba1-42f1-9f00-aa34c2edafb0" xlink:href="abvx-20241231.xsd#abvx_AdvisorToTheChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:to="loc_abvx_AdvisorToTheChiefExecutiveOfficerMember_697a8b30-1ba1-42f1-9f00-aa34c2edafb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_ee939a59-786a-471d-9f59-cda446d66196" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_ee939a59-786a-471d-9f59-cda446d66196" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_ee939a59-786a-471d-9f59-cda446d66196_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_ee939a59-786a-471d-9f59-cda446d66196" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_ee939a59-786a-471d-9f59-cda446d66196_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_fbf2a707-748f-4839-890a-e9b3fa8e7f7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_ee939a59-786a-471d-9f59-cda446d66196" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_fbf2a707-748f-4839-890a-e9b3fa8e7f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0ce2885b-aeb7-4544-8066-5afe2c6f2b0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_fbf2a707-748f-4839-890a-e9b3fa8e7f7b" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0ce2885b-aeb7-4544-8066-5afe2c6f2b0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_13063085-b967-4cff-ba2f-b90669ba9c79" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:to="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_13063085-b967-4cff-ba2f-b90669ba9c79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_4f43fd9f-783d-46bc-9300-dfe4113ad948" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_4f43fd9f-783d-46bc-9300-dfe4113ad948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_f4ae3bd0-da9a-494f-b2f5-568ac44c5c78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_f4ae3bd0-da9a-494f-b2f5-568ac44c5c78" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OffbalancesheetcommitmentsgivenDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOffBalanceSheetCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsAxis_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_abvx_PrincipalAgreementsAxis_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35_default" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abvx_PrincipalAgreementsAxis_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35" xlink:to="loc_abvx_PrincipalAgreementsDomain_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abvx_PrincipalAgreementsAxis_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35" xlink:to="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_bee5d228-cfde-4488-99ee-2c8b9278b5ec" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_bee5d228-cfde-4488-99ee-2c8b9278b5ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember_07a37c41-a797-456e-bade-571a878b815a" xlink:href="abvx-20241231.xsd#abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember_07a37c41-a797-456e-bade-571a878b815a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_04a19b46-ab5b-464d-b006-c517e6318218" xlink:href="abvx-20241231.xsd#abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_04a19b46-ab5b-464d-b006-c517e6318218" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember_53edd468-8521-4fee-9faf-e09180048bb6" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember_53edd468-8521-4fee-9faf-e09180048bb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_e24ca065-719e-43a4-ba59-714de45ba791" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_e24ca065-719e-43a4-ba59-714de45ba791" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_655a665a-8a6d-4853-ad49-42ed28e2f6f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_dei_LegalEntityAxis_655a665a-8a6d-4853-ad49-42ed28e2f6f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_655a665a-8a6d-4853-ad49-42ed28e2f6f8_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_655a665a-8a6d-4853-ad49-42ed28e2f6f8" xlink:to="loc_dei_EntityDomain_655a665a-8a6d-4853-ad49-42ed28e2f6f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4d7eb783-299a-4a13-8612-0b703e9082e6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_655a665a-8a6d-4853-ad49-42ed28e2f6f8" xlink:to="loc_dei_EntityDomain_4d7eb783-299a-4a13-8612-0b703e9082e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_b63790c8-851c-436f-85ce-acff09909e1e" xlink:href="abvx-20241231.xsd#abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4d7eb783-299a-4a13-8612-0b703e9082e6" xlink:to="loc_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_b63790c8-851c-436f-85ce-acff09909e1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_816190d1-894b-4673-b602-853d2305b556" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_srt_RangeAxis_816190d1-894b-4673-b602-853d2305b556" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_816190d1-894b-4673-b602-853d2305b556_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_816190d1-894b-4673-b602-853d2305b556" xlink:to="loc_srt_RangeMember_816190d1-894b-4673-b602-853d2305b556_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_816190d1-894b-4673-b602-853d2305b556" xlink:to="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dd651a87-dbc0-4c65-9a00-d7a09fd8e9cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:to="loc_srt_MinimumMember_dd651a87-dbc0-4c65-9a00-d7a09fd8e9cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_aca967ab-6194-485f-85cb-98eef358dff0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:to="loc_srt_MaximumMember_aca967ab-6194-485f-85cb-98eef358dff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4e060e01-e94e-449d-ab38-0ec224ec2a28" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4e060e01-e94e-449d-ab38-0ec224ec2a28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4e060e01-e94e-449d-ab38-0ec224ec2a28_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4e060e01-e94e-449d-ab38-0ec224ec2a28" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4e060e01-e94e-449d-ab38-0ec224ec2a28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4e060e01-e94e-449d-ab38-0ec224ec2a28" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_0354e854-fd9e-4d06-b97a-7ec563e4c4ef" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_0354e854-fd9e-4d06-b97a-7ec563e4c4ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_70ea6b7b-c31a-4f8c-b8b7-c977cd6abaa8" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_70ea6b7b-c31a-4f8c-b8b7-c977cd6abaa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember_0b7edae0-a261-4705-83d2-bf05ba74453f" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:to="loc_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember_0b7edae0-a261-4705-83d2-bf05ba74453f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIFranceMember_148b19a3-6f90-4a2c-aced-bfdc7bb28670" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIFranceMember_148b19a3-6f90-4a2c-aced-bfdc7bb28670" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_1e0ac058-4554-4409-a0f9-c7e0b8c2b630" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_ifrs-full_TypesOfContractsAxis_1e0ac058-4554-4409-a0f9-c7e0b8c2b630" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_1e0ac058-4554-4409-a0f9-c7e0b8c2b630_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfContractsAxis_1e0ac058-4554-4409-a0f9-c7e0b8c2b630" xlink:to="loc_ifrs-full_TypesOfContractsDomain_1e0ac058-4554-4409-a0f9-c7e0b8c2b630_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_e1a96fd6-fa5a-447c-8e35-de85299f370f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfContractsAxis_1e0ac058-4554-4409-a0f9-c7e0b8c2b630" xlink:to="loc_ifrs-full_TypesOfContractsDomain_e1a96fd6-fa5a-447c-8e35-de85299f370f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMontpellierMember_da925c05-1005-4463-9094-be7536af4d64" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMontpellierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfContractsDomain_e1a96fd6-fa5a-447c-8e35-de85299f370f" xlink:to="loc_abvx_LeaseFacilitiesMontpellierMember_da925c05-1005-4463-9094-be7536af4d64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfExclusiveLicenses_4efd92f6-c78e-4641-bd02-82b609ea3494" xlink:href="abvx-20241231.xsd#abvx_NumberOfExclusiveLicenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_NumberOfExclusiveLicenses_4efd92f6-c78e-4641-bd02-82b609ea3494" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AgreementPeriod_46e64dcf-bb80-4e71-89af-c9170a4f3df7" xlink:href="abvx-20241231.xsd#abvx_AgreementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_AgreementPeriod_46e64dcf-bb80-4e71-89af-c9170a4f3df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling_0ae9ae98-6740-44e4-ba78-54e3141050a1" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling_0ae9ae98-6740-44e4-ba78-54e3141050a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3_d6655208-aa8e-4c8f-adf7-6c6df7df068c" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3_d6655208-aa8e-4c8f-adf7-6c6df7df068c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval_e856ecd2-8467-42fa-b22e-d699da07a76e" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval_e856ecd2-8467-42fa-b22e-d699da07a76e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfAcademicInstitutions_a5bbc2d8-4261-4944-92d1-74e5a2713b9e" xlink:href="abvx-20241231.xsd#abvx_NumberOfAcademicInstitutions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_NumberOfAcademicInstitutions_a5bbc2d8-4261-4944-92d1-74e5a2713b9e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_5b4be52e-694b-4f2e-95e7-042b5dd692c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_5b4be52e-694b-4f2e-95e7-042b5dd692c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest_45d2cfe4-ce7c-4e19-a665-c4749024ccb1" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest_45d2cfe4-ce7c-4e19-a665-c4749024ccb1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight_3af2ce35-c03a-4ee5-8ce4-3399f1a92748" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight_3af2ce35-c03a-4ee5-8ce4-3399f1a92748" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod_7e62e386-e49f-460c-9b86-f1c5f2142b05" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod_7e62e386-e49f-460c-9b86-f1c5f2142b05" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold_e340ce44-bbc8-4077-a7d9-8e86039fa149" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold_e340ce44-bbc8-4077-a7d9-8e86039fa149" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped_79e03a5c-07b8-456e-bcad-47cba415b822" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped_79e03a5c-07b8-456e-bcad-47cba415b822" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped_d71e749e-7e65-489f-8c24-6efd7e960aa3" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped_d71e749e-7e65-489f-8c24-6efd7e960aa3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesRepaymentPeriod_05f5c6ed-b26a-4006-9245-7afaf0553e82" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesRepaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesRepaymentPeriod_05f5c6ed-b26a-4006-9245-7afaf0553e82" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConditionalAdvances_638b9b52-af14-4f5b-8e7d-0447ab02c41d" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConditionalAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_RepaymentsOfConditionalAdvances_638b9b52-af14-4f5b-8e7d-0447ab02c41d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_cf582fc3-bb86-4ec7-9fc4-3c8b6cf2cf99" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_cf582fc3-bb86-4ec7-9fc4-3c8b6cf2cf99" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitments_e780712f-59f2-4a24-90d8-e62222588fe5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_ifrs-full_CapitalCommitments_e780712f-59f2-4a24-90d8-e62222588fe5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseDurationPeriod_587318e3-9800-4188-98c7-536b34678d43" xlink:href="abvx-20241231.xsd#abvx_LeaseDurationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_LeaseDurationPeriod_587318e3-9800-4188-98c7-536b34678d43" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OffbalancesheetcommitmentsreceivedandcontingentassetsDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCommitmentsReceivedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCommitmentsReceivedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:to="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bdf4a6c3-11e3-4e47-a961-131feda6a166" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bdf4a6c3-11e3-4e47-a961-131feda6a166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bdf4a6c3-11e3-4e47-a961-131feda6a166_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bdf4a6c3-11e3-4e47-a961-131feda6a166" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bdf4a6c3-11e3-4e47-a961-131feda6a166_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bdf4a6c3-11e3-4e47-a961-131feda6a166" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_8ffa9d3e-49a7-42d9-a3c7-ef3426f309d5" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_8ffa9d3e-49a7-42d9-a3c7-ef3426f309d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_7e1997c9-32fd-44b3-8a2e-1a374a25d554" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_7e1997c9-32fd-44b3-8a2e-1a374a25d554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_dc500fa0-12bf-41ba-915b-915944f1e826" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_dc500fa0-12bf-41ba-915b-915944f1e826" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_dc500fa0-12bf-41ba-915b-915944f1e826_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_dc500fa0-12bf-41ba-915b-915944f1e826" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_dc500fa0-12bf-41ba-915b-915944f1e826_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_dc500fa0-12bf-41ba-915b-915944f1e826" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingMember_b32f3361-0834-4f95-b25a-0690bbe1bc06" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:to="loc_abvx_KreosClaretFinancingMember_b32f3361-0834-4f95-b25a-0690bbe1bc06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheBMember_a6d993aa-d6a6-4c4e-889e-3429424d2d2d" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheBMember_a6d993aa-d6a6-4c4e-889e-3429424d2d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_ce700272-ce86-48c2-bed3-2276234b48d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_ce700272-ce86-48c2-bed3-2276234b48d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfProjectsTerminated_d7bb1bed-50d5-4e1b-b628-5f493b5c10d8" xlink:href="abvx-20241231.xsd#abvx_NumberOfProjectsTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:to="loc_abvx_NumberOfProjectsTerminated_d7bb1bed-50d5-4e1b-b628-5f493b5c10d8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ManagementandassessmentoffinancialrisksDetails"/>
  <link:definitionLink xlink:role="http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_269e56a9-4742-4202-a7d7-4cecb9296c4c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_srt_CurrencyAxis_269e56a9-4742-4202-a7d7-4cecb9296c4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_269e56a9-4742-4202-a7d7-4cecb9296c4c_default" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_269e56a9-4742-4202-a7d7-4cecb9296c4c" xlink:to="loc_currency_AllCurrenciesDomain_269e56a9-4742-4202-a7d7-4cecb9296c4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_e2cca3fb-8dd4-415e-b99c-a7e07860022e" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_269e56a9-4742-4202-a7d7-4cecb9296c4c" xlink:to="loc_currency_AllCurrenciesDomain_e2cca3fb-8dd4-415e-b99c-a7e07860022e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_ee2de13b-b322-44ff-aebc-af08cc839b67" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_e2cca3fb-8dd4-415e-b99c-a7e07860022e" xlink:to="loc_currency_USD_ee2de13b-b322-44ff-aebc-af08cc839b67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_a375e025-a0e4-49c9-8d62-c582b0f15a40" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_TypesOfRisksAxis_a375e025-a0e4-49c9-8d62-c582b0f15a40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_a375e025-a0e4-49c9-8d62-c582b0f15a40_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_a375e025-a0e4-49c9-8d62-c582b0f15a40" xlink:to="loc_ifrs-full_TypesOfRisksDomain_a375e025-a0e4-49c9-8d62-c582b0f15a40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_a375e025-a0e4-49c9-8d62-c582b0f15a40" xlink:to="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyRiskMember_b9dd986a-6bfd-4813-b4f5-b88eb3c05288" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:to="loc_ifrs-full_CurrencyRiskMember_b9dd986a-6bfd-4813-b4f5-b88eb3c05288" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditRiskMember_b0c9ddf3-140d-40d9-920f-94709fd46d58" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:to="loc_ifrs-full_CreditRiskMember_b0c9ddf3-140d-40d9-920f-94709fd46d58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_7ef33259-5493-47ea-b9ba-0667f364431b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_7ef33259-5493-47ea-b9ba-0667f364431b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_7ef33259-5493-47ea-b9ba-0667f364431b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7ef33259-5493-47ea-b9ba-0667f364431b" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_7ef33259-5493-47ea-b9ba-0667f364431b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_0de2dced-d771-4c60-9e3d-c9a13ca9d714" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7ef33259-5493-47ea-b9ba-0667f364431b" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_0de2dced-d771-4c60-9e3d-c9a13ca9d714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_f4118354-ef36-4d3e-9e82-cfb4f4e8e5ed" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_0de2dced-d771-4c60-9e3d-c9a13ca9d714" xlink:to="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_f4118354-ef36-4d3e-9e82-cfb4f4e8e5ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_59ca8967-c043-44cd-8cdc-87caf1deb91c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_59ca8967-c043-44cd-8cdc-87caf1deb91c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuropeanCentralBankBaseRateMember_edfaa10c-9eaf-4c17-95c5-2c0476b89ba5" xlink:href="abvx-20241231.xsd#abvx_EuropeanCentralBankBaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_59ca8967-c043-44cd-8cdc-87caf1deb91c" xlink:to="loc_abvx_EuropeanCentralBankBaseRateMember_edfaa10c-9eaf-4c17-95c5-2c0476b89ba5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_521323d6-a0a8-409d-81d6-ca2f27c43ca2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_RangeAxis_521323d6-a0a8-409d-81d6-ca2f27c43ca2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_521323d6-a0a8-409d-81d6-ca2f27c43ca2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_521323d6-a0a8-409d-81d6-ca2f27c43ca2" xlink:to="loc_ifrs-full_RangeDomain_521323d6-a0a8-409d-81d6-ca2f27c43ca2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_521323d6-a0a8-409d-81d6-ca2f27c43ca2" xlink:to="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_576e18a8-1a09-43dd-87b2-15246aca92a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:to="loc_ifrs-full_BottomOfRangeMember_576e18a8-1a09-43dd-87b2-15246aca92a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_70394ba4-2a24-4baf-8bd9-a3c12a9d24a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:to="loc_ifrs-full_TopOfRangeMember_70394ba4-2a24-4baf-8bd9-a3c12a9d24a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_19c2ff96-ef92-4d77-a192-5c793baa6c2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_19c2ff96-ef92-4d77-a192-5c793baa6c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsBasisInterestRate_f442da7d-e58a-487b-ac7c-65b74cb9a2bd" xlink:href="abvx-20241231.xsd#abvx_BorrowingsBasisInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_BorrowingsBasisInterestRate_f442da7d-e58a-487b-ac7c-65b74cb9a2bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestRateCollarRange_52d3914d-a33a-4f89-a165-b7da3f51579a" xlink:href="abvx-20241231.xsd#abvx_InterestRateCollarRange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_InterestRateCollarRange_52d3914d-a33a-4f89-a165-b7da3f51579a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_dc5ee17b-e3da-44f3-8b5e-a7f81c75bc4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_ifrs-full_OperatingExpense_dc5ee17b-e3da-44f3-8b5e-a7f81c75bc4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_558f45b2-5546-4098-9b04-e0a1adfebfed" xlink:href="abvx-20241231.xsd#abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_558f45b2-5546-4098-9b04-e0a1adfebfed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss_e1609a8e-dcd0-4979-bcc0-eb6f181276dd" xlink:href="abvx-20241231.xsd#abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss_e1609a8e-dcd0-4979-bcc0-eb6f181276dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFinancialInstitutionsToMaintainCash_0cf1fd26-058c-44a8-af81-67db745d4efb" xlink:href="abvx-20241231.xsd#abvx_NumberOfFinancialInstitutionsToMaintainCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_NumberOfFinancialInstitutionsToMaintainCash_0cf1fd26-058c-44a8-af81-67db745d4efb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit_514a12d3-8e52-413a-aaab-1afb42ec6439" xlink:href="abvx-20241231.xsd#abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit_514a12d3-8e52-413a-aaab-1afb42ec6439" xlink:type="arc" order="7"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>abvx-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5b13969f-ba48-4e71-920c-2a5c64899678,g:b21d6730-553e-45e9-b346-3f9a3ffd9584-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_abvx_CashTransferredAssetsAcquisitions_2bd4e10b-4dc7-4c0e-b703-61f664756725_terseLabel_en-US" xlink:label="lab_abvx_CashTransferredAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payment made in 2022</link:label>
    <link:label id="lab_abvx_CashTransferredAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_CashTransferredAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Transferred, Assets Acquisitions</link:label>
    <link:label id="lab_abvx_CashTransferredAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_CashTransferredAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Transferred, Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashTransferredAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_CashTransferredAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CashTransferredAssetsAcquisitions" xlink:to="lab_abvx_CashTransferredAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition_e56f6f85-1ac7-4c7e-a328-20cfe5a22ba7_terseLabel_en-US" xlink:label="lab_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of outstanding warrants subject to non-market performance condition (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition_label_en-US" xlink:label="lab_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Warrants Outstanding Subject To Non-Market Performance Condition</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition_documentation_en-US" xlink:label="lab_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Warrants Outstanding Subject To Non-Market Performance Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" xlink:to="lab_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis_d65454c9-2203-4437-bd7e-ffa7ff20c613_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0e62cd12-d008-4fe5-982e-9dfeb9382a5f_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DEPRECIATION</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation and amortisation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_700bd7b0-61b5-4412-a106-4d171d2273e4_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsExitFeeAmount_b4f655e1-4f2d-4ef6-a59b-88cbc3b3b21b_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsExitFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, exit fee amount</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeeAmount_label_en-US" xlink:label="lab_abvx_BorrowingsExitFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Amount</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeeAmount_documentation_en-US" xlink:label="lab_abvx_BorrowingsExitFeeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeeAmount" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsExitFeeAmount" xlink:to="lab_abvx_BorrowingsExitFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SubContractingStudiesAndResearchExpenses_c42e04a2-b0e8-4966-bfcd-d652ebe78eaf_terseLabel_en-US" xlink:label="lab_abvx_SubContractingStudiesAndResearchExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sub-contracting, studies and research</link:label>
    <link:label id="lab_abvx_SubContractingStudiesAndResearchExpenses_label_en-US" xlink:label="lab_abvx_SubContractingStudiesAndResearchExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sub-Contracting, Studies And Research Expenses</link:label>
    <link:label id="lab_abvx_SubContractingStudiesAndResearchExpenses_documentation_en-US" xlink:label="lab_abvx_SubContractingStudiesAndResearchExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sub-Contracting, Studies And Research Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SubContractingStudiesAndResearchExpenses" xlink:href="abvx-20241231.xsd#abvx_SubContractingStudiesAndResearchExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SubContractingStudiesAndResearchExpenses" xlink:to="lab_abvx_SubContractingStudiesAndResearchExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfWarrantsExercised_91926c02-3f1d-4f58-8603-791ef41abdf3_terseLabel_en-US" xlink:label="lab_abvx_NumberOfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants exercised (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsExercised_label_en-US" xlink:label="lab_abvx_NumberOfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Warrants Exercised</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsExercised_documentation_en-US" xlink:label="lab_abvx_NumberOfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsExercised" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfWarrantsExercised" xlink:to="lab_abvx_NumberOfWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLiabilities_a3e60e08-79ac-4131-a58d-2aaff02f21bc_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="lab_ifrs-full_CurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss_84d1876d-ff57-475e-b95b-eb4734d901f6_terseLabel_en-US" xlink:label="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of breakdown of the compensation expenses</link:label>
    <link:label id="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Explanation of effect of share-based payments on entity's profit or loss [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss" xlink:to="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_ffd0ec2c-3b76-4633-9f9a-c65df3790291_terseLabel_en-US" xlink:label="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net defined benefit liability</link:label>
    <link:label id="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_label_en-US" xlink:label="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:to="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_34b242a7-da49-4609-9561-f71ab14f2bc0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_4d6ccb3c-0023-4b3e-ac63-c5428106ac01_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) per share</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of earnings per share [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_84c9a360-1c42-447e-8046-c6758e908f37_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loan granted</link:label>
    <link:label id="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash advances and loans made to other parties, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGoodwillExplanatory_7ce8177a-0843-4055-bbcf-0c60705a1217_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and impairment test</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_bea18be8-be54-40ac-b599-216f21296331_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of information for cash-generating units [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information for cash-generating units [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems" xlink:to="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_A2021TaxYearMember_1f94a7ce-9b71-4152-9fff-47ed8642d072_terseLabel_en-US" xlink:label="lab_abvx_A2021TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2021</link:label>
    <link:label id="lab_abvx_A2021TaxYearMember_label_en-US" xlink:label="lab_abvx_A2021TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021, Tax Year [Member]</link:label>
    <link:label id="lab_abvx_A2021TaxYearMember_documentation_en-US" xlink:label="lab_abvx_A2021TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Year 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2021TaxYearMember" xlink:href="abvx-20241231.xsd#abvx_A2021TaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_A2021TaxYearMember" xlink:to="lab_abvx_A2021TaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_ae20c5c0-6b1d-4b68-a588-94f7fdee5ba0_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS AT AMORTIZED COST</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at amortised cost, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OrdinarySharesMember_532ce2a4-7d30-42cc-b5f7-3c30789e6342_terseLabel_en-US" xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_ifrs-full_OrdinarySharesMember_label_en-US" xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary shares [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember" xlink:to="lab_ifrs-full_OrdinarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_47a43176-2dd1-4ba8-b242-db6644d98def_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_e9122ae2-f174-4d24-8ab4-d54ab133918a_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasDomain_689f9bcd-3531-4586-affa-7ab1a520837e_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical areas [domain]</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasDomain_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasDomain" xlink:to="lab_ifrs-full_GeographicalAreasDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_f553a2fe-2dab-43ae-80f3-58628d5ab663_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities [domain]</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_9e239201-25dc-4760-94d4-f38a3cd4e301_terseLabel_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unused tax losses for which no deferred tax asset recognised</link:label>
    <link:label id="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_label_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused tax losses for which no deferred tax asset recognised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20181Member_850c046b-51b9-4d4f-a5e5-d518e1560755_terseLabel_en-US" xlink:label="lab_abvx_BSA20181Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2018-1</link:label>
    <link:label id="lab_abvx_BSA20181Member_label_en-US" xlink:label="lab_abvx_BSA20181Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2018-1 [Member]</link:label>
    <link:label id="lab_abvx_BSA20181Member_documentation_en-US" xlink:label="lab_abvx_BSA20181Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2018-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20181Member" xlink:href="abvx-20241231.xsd#abvx_BSA20181Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20181Member" xlink:to="lab_abvx_BSA20181Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromGovernmentGrants_05ca176c-919a-46c3-b111-2d0e70f29aaa_verboseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income from government grants</link:label>
    <link:label id="lab_ifrs-full_RevenueFromGovernmentGrants_9c43844a-bf0e-42b4-a97e-ed5cac32da01_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidies</link:label>
    <link:label id="lab_ifrs-full_RevenueFromGovernmentGrants_label_en-US" xlink:label="lab_ifrs-full_RevenueFromGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income from government grants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromGovernmentGrants" xlink:to="lab_ifrs-full_RevenueFromGovernmentGrants" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TaxEffectOfResearchTaxCredit_c5934474-12ff-4937-837e-f6709663d650_terseLabel_en-US" xlink:label="lab_abvx_TaxEffectOfResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CIR</link:label>
    <link:label id="lab_abvx_TaxEffectOfResearchTaxCredit_label_en-US" xlink:label="lab_abvx_TaxEffectOfResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Research Tax Credit</link:label>
    <link:label id="lab_abvx_TaxEffectOfResearchTaxCredit_documentation_en-US" xlink:label="lab_abvx_TaxEffectOfResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Effect Of Research Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfResearchTaxCredit" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfResearchTaxCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TaxEffectOfResearchTaxCredit" xlink:to="lab_abvx_TaxEffectOfResearchTaxCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember_92373383-bfad-413b-b369-bb030c415eee_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret minimum return indemnifications</link:label>
    <link:label id="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember_ddbb4c1d-b19a-4fb3-b517-b58d930a48d7_verboseLabel_en-US" xlink:label="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Kreos/Claret Minimum Return Indemnifications</link:label>
    <link:label id="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember_label_en-US" xlink:label="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Minimum Return Indemnifications [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Minimum Return Indemnifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember" xlink:to="lab_abvx_KreosClaretMinimumReturnIndemnificationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20185Member_6173adb6-610b-446c-bbff-9db767ac40dd_terseLabel_en-US" xlink:label="lab_abvx_BCE20185Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2018-5</link:label>
    <link:label id="lab_abvx_BCE20185Member_label_en-US" xlink:label="lab_abvx_BCE20185Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2018-5 [Member]</link:label>
    <link:label id="lab_abvx_BCE20185Member_documentation_en-US" xlink:label="lab_abvx_BCE20185Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2018-5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20185Member" xlink:href="abvx-20241231.xsd#abvx_BCE20185Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20185Member" xlink:to="lab_abvx_BCE20185Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OfficeEquipmentMember_33d7b4c4-a7d3-4f88-b90e-5d417905e056_terseLabel_en-US" xlink:label="lab_ifrs-full_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_ifrs-full_OfficeEquipmentMember_label_en-US" xlink:label="lab_ifrs-full_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office equipment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OfficeEquipmentMember" xlink:to="lab_ifrs-full_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretBondLoansMember_f95d73fd-1d5e-4376-88a4-60f66283d731_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret bond loans</link:label>
    <link:label id="lab_abvx_KreosClaretBondLoansMember_label_en-US" xlink:label="lab_abvx_KreosClaretBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret bond loans [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretBondLoansMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret bond loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretBondLoansMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretBondLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretBondLoansMember" xlink:to="lab_abvx_KreosClaretBondLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_d022e928-b193-44c2-94f0-e5452135b0f1_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments exercised (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_b4c84b2e-a20b-49cc-965a-d261602b5a6e_terseLabel_en-US" xlink:label="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reasonably possible change in risk variable, percent</link:label>
    <link:label id="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_label_en-US" xlink:label="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percent</link:label>
    <link:label id="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_documentation_en-US" xlink:label="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" xlink:href="abvx-20241231.xsd#abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" xlink:to="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfRisksDomain_a0f40b85-fd75-4d53-b808-9168a2628a6e_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfRisksDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of risks [domain]</link:label>
    <link:label id="lab_ifrs-full_TypesOfRisksDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfRisksDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of risks [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksDomain" xlink:to="lab_ifrs-full_TypesOfRisksDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_274fafcc-c976-480c-bc45-15311ba20e0c_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="lab_ifrs-full_NoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnBonds_055e50e7-f381-4638-9c7c-1e46f7426164_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBonds" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest on Kreos 1 &amp; 2 straight bond loans</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnBonds_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBonds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBonds" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBonds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBonds" xlink:to="lab_ifrs-full_InterestExpenseOnBonds" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_1d043af9-ebda-4804-988f-1a6f4318fa76_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_b7f2ed46-3503-4572-8f57-36a1c0b08e31_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of preparation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ContributionToGroupsLiabilitiesPercentage_b20b3852-bbed-4553-b57d-1c017eb82020_terseLabel_en-US" xlink:label="lab_abvx_ContributionToGroupsLiabilitiesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution to Group's liabilities, percentage</link:label>
    <link:label id="lab_abvx_ContributionToGroupsLiabilitiesPercentage_label_en-US" xlink:label="lab_abvx_ContributionToGroupsLiabilitiesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contribution To Group's Liabilities, Percentage</link:label>
    <link:label id="lab_abvx_ContributionToGroupsLiabilitiesPercentage_documentation_en-US" xlink:label="lab_abvx_ContributionToGroupsLiabilitiesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contribution To Group's Liabilities, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsLiabilitiesPercentage" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsLiabilitiesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ContributionToGroupsLiabilitiesPercentage" xlink:to="lab_abvx_ContributionToGroupsLiabilitiesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_A2022TaxYearMember_6a527914-46d4-4b3f-a8ca-7f8706baafbc_terseLabel_en-US" xlink:label="lab_abvx_A2022TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2022</link:label>
    <link:label id="lab_abvx_A2022TaxYearMember_label_en-US" xlink:label="lab_abvx_A2022TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022, Tax Year [Member]</link:label>
    <link:label id="lab_abvx_A2022TaxYearMember_documentation_en-US" xlink:label="lab_abvx_A2022TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Year 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2022TaxYearMember" xlink:href="abvx-20241231.xsd#abvx_A2022TaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_A2022TaxYearMember" xlink:to="lab_abvx_A2022TaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DiscountRateMeasurementInputMember_d65d5e40-ea19-4bf2-b424-ba2445e31129_terseLabel_en-US" xlink:label="lab_ifrs-full_DiscountRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_ifrs-full_DiscountRateMeasurementInputMember_label_en-US" xlink:label="lab_ifrs-full_DiscountRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount rate, measurement input [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountRateMeasurementInputMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountRateMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DiscountRateMeasurementInputMember" xlink:to="lab_ifrs-full_DiscountRateMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20172Member_5bb280cb-416e-46ec-acd8-14095684d298_terseLabel_en-US" xlink:label="lab_abvx_BCE20172Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2017-2</link:label>
    <link:label id="lab_abvx_BCE20172Member_label_en-US" xlink:label="lab_abvx_BCE20172Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2017-2 [Member]</link:label>
    <link:label id="lab_abvx_BCE20172Member_documentation_en-US" xlink:label="lab_abvx_BCE20172Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2017-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20172Member" xlink:href="abvx-20241231.xsd#abvx_BCE20172Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20172Member" xlink:to="lab_abvx_BCE20172Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other current payables [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantUnobservableInputAssets_886d67ff-8ee2-45d8-8687-5582cd40087e_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantUnobservableInputAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant unobservable input, assets</link:label>
    <link:label id="lab_ifrs-full_SignificantUnobservableInputAssets_label_en-US" xlink:label="lab_ifrs-full_SignificantUnobservableInputAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant unobservable input, assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantUnobservableInputAssets" xlink:to="lab_ifrs-full_SignificantUnobservableInputAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarnOutMaximumAmount_e22880b4-610f-4745-a95e-51d662e39c28_terseLabel_en-US" xlink:label="lab_abvx_EarnOutMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earn-out, maximum amount</link:label>
    <link:label id="lab_abvx_EarnOutMaximumAmount_label_en-US" xlink:label="lab_abvx_EarnOutMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earn-Out, Maximum Amount</link:label>
    <link:label id="lab_abvx_EarnOutMaximumAmount_documentation_en-US" xlink:label="lab_abvx_EarnOutMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earn-Out, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMaximumAmount" xlink:href="abvx-20241231.xsd#abvx_EarnOutMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarnOutMaximumAmount" xlink:to="lab_abvx_EarnOutMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProceedsFromConditionalAdvances_3b1c9993-ca22-4921-a984-61b8fcbbc5bd_terseLabel_en-US" xlink:label="lab_abvx_ProceedsFromConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from conditional advances</link:label>
    <link:label id="lab_abvx_ProceedsFromConditionalAdvances_label_en-US" xlink:label="lab_abvx_ProceedsFromConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Conditional Advances</link:label>
    <link:label id="lab_abvx_ProceedsFromConditionalAdvances_documentation_en-US" xlink:label="lab_abvx_ProceedsFromConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Conditional Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromConditionalAdvances" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromConditionalAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProceedsFromConditionalAdvances" xlink:to="lab_abvx_ProceedsFromConditionalAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_4c041bb1-c6c4-42e3-9724-caa0ab06d7ba_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of carrying amounts and fair value of financial liabilities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_669fab2d-38b0-4bc1-ad6d-010e007fc7e4_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets and liabilities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c08efbca-7d4d-4421-98b3-5be6131888ea_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_db2b70b2-6811-48c9-9e05-71e8ef89f54c_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current borrowings and current portion of other non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:to="lab_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments_bbe79308-9b8b-4249-ab10-cafac5d7ef60_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate for first 12 installments</link:label>
    <link:label id="lab_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments_label_en-US" xlink:label="lab_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Adjustment To Interest Rate Basis For First 12 Installments</link:label>
    <link:label id="lab_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments_documentation_en-US" xlink:label="lab_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Adjustment To Interest Rate Basis For First 12 Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" xlink:to="lab_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6a15ccca-2f21-4e9e-a41d-e4d644fdba35_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheAMember_e70899e8-2079-47ae-aa31-556f4fe645dc_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos / Claret convertible notes (OCABSA)</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheAMember_5ee22c85-da83-473b-b4c6-37e7da8a3608_verboseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing, tranche A</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheAMember_a627b4c1-acdc-4360-9c09-662ebff24e29_netLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheAMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Kreos/Claret BSA</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheAMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche A [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheAMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingTrancheAMember" xlink:to="lab_abvx_KreosClaretFinancingTrancheAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_391c7835-ed81-4151-9d48-3847947b2b00_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase / (decrease) in trade payables</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA2024Member_42e4e6f3-b704-48f5-9a7f-30c23c0be092_terseLabel_en-US" xlink:label="lab_abvx_AGA2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024</link:label>
    <link:label id="lab_abvx_AGA2024Member_label_en-US" xlink:label="lab_abvx_AGA2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024 [Member]</link:label>
    <link:label id="lab_abvx_AGA2024Member_documentation_en-US" xlink:label="lab_abvx_AGA2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2024Member" xlink:href="abvx-20241231.xsd#abvx_AGA2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA2024Member" xlink:to="lab_abvx_AGA2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_96b13202-0cdd-4d97-8a5e-d17c8242a84b_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Translation reserves</link:label>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_label_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of exchange differences on translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_ef56a883-eb51-42f1-bef2-3cb71a273278_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_label_en-US" xlink:label="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings, excluding profit (loss) for reporting period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod" xlink:to="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses_1bc83dc0-70fb-4045-b636-aaabe5edb5b8_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in Crohn's Disease research expenses</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Crohn's Disease Research Expenses</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Crohn's Disease Research Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses" xlink:to="lab_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayables_a49e099a-3a87-4914-abbd-2286a9efae1c_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade payables and other current liabilities</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayables_3828bd76-7d57-4035-be41-af01e6115ab3_totalLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Trade payables and other current liabilities</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayables_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other current payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ShareWarrantsSubscriptionPricePerShare_93d8a2d2-82cf-4bd2-a7aa-5fdd2e5b2fa0_terseLabel_en-US" xlink:label="lab_abvx_ShareWarrantsSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share warrants, subscription price (in euro per share)</link:label>
    <link:label id="lab_abvx_ShareWarrantsSubscriptionPricePerShare_label_en-US" xlink:label="lab_abvx_ShareWarrantsSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Warrants, Subscription Price Per Share</link:label>
    <link:label id="lab_abvx_ShareWarrantsSubscriptionPricePerShare_documentation_en-US" xlink:label="lab_abvx_ShareWarrantsSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Warrants, Subscription Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareWarrantsSubscriptionPricePerShare" xlink:href="abvx-20241231.xsd#abvx_ShareWarrantsSubscriptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ShareWarrantsSubscriptionPricePerShare" xlink:to="lab_abvx_ShareWarrantsSubscriptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_f19e3b33-564f-4d47-85d9-5451bb977154_totalLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_label_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from share-based payment transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_3bfe07f8-19ed-4e4d-baf7-c42c91f79375_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment including right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsMaturityTerm_0844076d-c9d3-4bff-bfd2-7ac6720bd358_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsMaturityTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, maturity term</link:label>
    <link:label id="lab_abvx_BorrowingsMaturityTerm_label_en-US" xlink:label="lab_abvx_BorrowingsMaturityTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings Maturity, Term</link:label>
    <link:label id="lab_abvx_BorrowingsMaturityTerm_documentation_en-US" xlink:label="lab_abvx_BorrowingsMaturityTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings Maturity, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityTerm" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsMaturityTerm" xlink:to="lab_abvx_BorrowingsMaturityTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue_d434074b-2789-4b13-ad8a-93dc6cb05565_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settlement in shares, percentage of fair market value</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Settlement In Shares, Percentage Of Fair Market Value</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Settlement In Shares, Percentage Of Fair Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" xlink:to="lab_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_fbc6d72b-1a6c-42cd-889a-a50ee8da9f37_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of the change in foreign currency exchange rates</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment including right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EquityIssuancePercentageOfCurrentShareCapital_4b628208-e61c-4848-bf43-9feb6bcc60ed_terseLabel_en-US" xlink:label="lab_abvx_EquityIssuancePercentageOfCurrentShareCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity issuance, percentage of current share capital</link:label>
    <link:label id="lab_abvx_EquityIssuancePercentageOfCurrentShareCapital_label_en-US" xlink:label="lab_abvx_EquityIssuancePercentageOfCurrentShareCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Issuance, Percentage Of Current Share Capital</link:label>
    <link:label id="lab_abvx_EquityIssuancePercentageOfCurrentShareCapital_documentation_en-US" xlink:label="lab_abvx_EquityIssuancePercentageOfCurrentShareCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Issuance, Percentage Of Current Share Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital" xlink:href="abvx-20241231.xsd#abvx_EquityIssuancePercentageOfCurrentShareCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital" xlink:to="lab_abvx_EquityIssuancePercentageOfCurrentShareCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SaleOfStockDomain_efcc061e-c9e5-4ac3-a3fe-9f391868675d_terseLabel_en-US" xlink:label="lab_abvx_SaleOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale Of Stock [Domain]</link:label>
    <link:label id="lab_abvx_SaleOfStockDomain_label_en-US" xlink:label="lab_abvx_SaleOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock [Domain]</link:label>
    <link:label id="lab_abvx_SaleOfStockDomain_documentation_en-US" xlink:label="lab_abvx_SaleOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockDomain" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SaleOfStockDomain" xlink:to="lab_abvx_SaleOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncomeFromResearchTaxCredit_c3b27850-9477-41f4-b67e-5c74447428e5_terseLabel_en-US" xlink:label="lab_abvx_IncomeFromResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research tax credit ("CIR")</link:label>
    <link:label id="lab_abvx_IncomeFromResearchTaxCredit_label_en-US" xlink:label="lab_abvx_IncomeFromResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income From Research Tax Credit</link:label>
    <link:label id="lab_abvx_IncomeFromResearchTaxCredit_documentation_en-US" xlink:label="lab_abvx_IncomeFromResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income From Research Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncomeFromResearchTaxCredit" xlink:href="abvx-20241231.xsd#abvx_IncomeFromResearchTaxCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncomeFromResearchTaxCredit" xlink:to="lab_abvx_IncomeFromResearchTaxCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities_3fc00ae5-f353-4e79-ba73-5bb975bfe201_negatedTerseLabel_en-US" xlink:label="lab_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease Through Interest Paid, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease Through Interest Paid, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfConvertibleNotesIssued_e51795ba-7741-4791-968b-23910cd41806_terseLabel_en-US" xlink:label="lab_abvx_NumberOfConvertibleNotesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of convertible notes issued (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfConvertibleNotesIssued_label_en-US" xlink:label="lab_abvx_NumberOfConvertibleNotesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Convertible Notes Issued</link:label>
    <link:label id="lab_abvx_NumberOfConvertibleNotesIssued_documentation_en-US" xlink:label="lab_abvx_NumberOfConvertibleNotesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Convertible Notes Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfConvertibleNotesIssued" xlink:href="abvx-20241231.xsd#abvx_NumberOfConvertibleNotesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfConvertibleNotesIssued" xlink:to="lab_abvx_NumberOfConvertibleNotesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ff2520e6-0fc0-4ed5-bd48-6513b1d3d5c1_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20245Member_1b9fe160-5deb-409f-8ff2-933cf627fc97_terseLabel_en-US" xlink:label="lab_abvx_AGA20245Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-5</link:label>
    <link:label id="lab_abvx_AGA20245Member_label_en-US" xlink:label="lab_abvx_AGA20245Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-5 [Member]</link:label>
    <link:label id="lab_abvx_AGA20245Member_documentation_en-US" xlink:label="lab_abvx_AGA20245Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20245Member" xlink:href="abvx-20241231.xsd#abvx_AGA20245Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20245Member" xlink:to="lab_abvx_AGA20245Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RoyaltyCertificateMaximumAmount_82b87ccc-be44-432c-b884-f11e81a4b8f8_terseLabel_en-US" xlink:label="lab_abvx_RoyaltyCertificateMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty certificate, maximum amount</link:label>
    <link:label id="lab_abvx_RoyaltyCertificateMaximumAmount_label_en-US" xlink:label="lab_abvx_RoyaltyCertificateMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Certificate, Maximum Amount</link:label>
    <link:label id="lab_abvx_RoyaltyCertificateMaximumAmount_documentation_en-US" xlink:label="lab_abvx_RoyaltyCertificateMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Certificate, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateMaximumAmount" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RoyaltyCertificateMaximumAmount" xlink:to="lab_abvx_RoyaltyCertificateMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ResearchAndDevelopmentExpensesMember_13c9ef48-6fd1-45a8-b580-e809c78cc7c8_terseLabel_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_abvx_ResearchAndDevelopmentExpensesMember_label_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Expenses [Member]</link:label>
    <link:label id="lab_abvx_ResearchAndDevelopmentExpensesMember_documentation_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentExpensesMember" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ResearchAndDevelopmentExpensesMember" xlink:to="lab_abvx_ResearchAndDevelopmentExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_GrossProceedsFromNonConvertibleLoansNotes_bdf473ef-dd7c-4cd5-b7f3-ba83cc47fb9a_terseLabel_en-US" xlink:label="lab_abvx_GrossProceedsFromNonConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the issuance of non-convertible bond loans</link:label>
    <link:label id="lab_abvx_GrossProceedsFromNonConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_GrossProceedsFromNonConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Proceeds From Non-Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_GrossProceedsFromNonConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_GrossProceedsFromNonConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gross Proceeds From Non-Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GrossProceedsFromNonConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_GrossProceedsFromNonConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_GrossProceedsFromNonConvertibleLoansNotes" xlink:to="lab_abvx_GrossProceedsFromNonConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_026ccdb4-2742-41c8-91bf-b0d85b9981c7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired_5b97accf-f2d3-4b18-a553-af4afc6a4f81_negatedTerseLabel_en-US" xlink:label="lab_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments for the acquisition of Prosynergia, incl. related costs, net of cash acquired</link:label>
    <link:label id="lab_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired_label_en-US" xlink:label="lab_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Assets Acquisitions, Including Related Costs, Net Of Cash Acquired</link:label>
    <link:label id="lab_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired_documentation_en-US" xlink:label="lab_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Assets Acquisitions, Including Related Costs, Net Of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" xlink:to="lab_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_7a974605-8188-4119-9a34-96dc3fcd1f16_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash flows provided by (used in) investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_a19a71af-d197-4208-9c65-a237613c4623_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non cash changes : Effect of the change in foreign currency exhange rates</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfRisksAxis_34ec5f9a-1f00-4bb3-b0ad-ce48c3a3a227_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfRisksAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of risks [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfRisksAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfRisksAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of risks [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis" xlink:to="lab_ifrs-full_TypesOfRisksAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnrecognizedDeferredTaxAssets_5ad7bab1-2897-46d1-b084-6f764c419180_negatedTerseLabel_en-US" xlink:label="lab_abvx_UnrecognizedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized deferred tax assets</link:label>
    <link:label id="lab_abvx_UnrecognizedDeferredTaxAssets_label_en-US" xlink:label="lab_abvx_UnrecognizedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Deferred Tax Assets</link:label>
    <link:label id="lab_abvx_UnrecognizedDeferredTaxAssets_documentation_en-US" xlink:label="lab_abvx_UnrecognizedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognized Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnrecognizedDeferredTaxAssets" xlink:href="abvx-20241231.xsd#abvx_UnrecognizedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnrecognizedDeferredTaxAssets" xlink:to="lab_abvx_UnrecognizedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConversionPriceOtherLiabilities_381bfd54-611a-4c5e-aed6-62d318592e5d_terseLabel_en-US" xlink:label="lab_abvx_ConversionPriceOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price per share (in euro per share)</link:label>
    <link:label id="lab_abvx_ConversionPriceOtherLiabilities_label_en-US" xlink:label="lab_abvx_ConversionPriceOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Price, Other Liabilities</link:label>
    <link:label id="lab_abvx_ConversionPriceOtherLiabilities_documentation_en-US" xlink:label="lab_abvx_ConversionPriceOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Price, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceOtherLiabilities" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConversionPriceOtherLiabilities" xlink:to="lab_abvx_ConversionPriceOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances_b2a57592-3b6a-45be-a53d-39eef5b82d22_terseLabel_en-US" xlink:label="lab_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgiveness of conditional advances</link:label>
    <link:label id="lab_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances_label_en-US" xlink:label="lab_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Forgiveness Of Covid 19 Conditional Advances</link:label>
    <link:label id="lab_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances_documentation_en-US" xlink:label="lab_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Forgiveness Of Covid 19 Conditional Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances" xlink:to="lab_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_1a5e0ebd-64f9-463b-8625-79f7d67680fa_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_dfeb6c64-84a6-4a62-836b-c12e39394a9d_terseLabel_en-US" xlink:label="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation techniques used in fair value measurement [axis]</link:label>
    <link:label id="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_label_en-US" xlink:label="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation techniques used in fair value measurement [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:to="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities_fdf8feef-1b90-4699-b6bc-929142eccc86_negatedTerseLabel_en-US" xlink:label="lab_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on derecognition of financial liabilities</link:label>
    <link:label id="lab_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities_label_en-US" xlink:label="lab_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Losses Arising From Derecognition Of Financial Liabilities</link:label>
    <link:label id="lab_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities_documentation_en-US" xlink:label="lab_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Losses Arising From Derecognition Of Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities" xlink:href="abvx-20241231.xsd#abvx_LossesArisingFromDerecognitionOfFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities" xlink:to="lab_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval_a6d45624-30bc-4f6d-98af-aa63a08c1f53_terseLabel_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential development milestone payment, IND approval</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval_label_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Potential Development Milestone Payment, IND Approval</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval_documentation_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Potential Development Milestone Payment, IND Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" xlink:to="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_0c1afcb3-0d87-485f-925e-915d2feda17d_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_f62415c4-7d06-4742-ad23-624782f82383_terseLabel_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Probability-weighted present value of shortfall payment, final redemption</link:label>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_label_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Final Redemption, Probability-Weighted Present Value Of Shortfall Payment, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Final Redemption,Probability-Weighted Present Value Of Shortfall Payment, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:to="lab_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_0c71584a-8f1b-4a3c-8a2c-3add27ff0bf0_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CapitalCommitments_dfa129c2-e3d3-4aa6-8629-3dc01a740e9a_terseLabel_en-US" xlink:label="lab_ifrs-full_CapitalCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital commitments</link:label>
    <link:label id="lab_ifrs-full_CapitalCommitments_label_en-US" xlink:label="lab_ifrs-full_CapitalCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalCommitments" xlink:to="lab_ifrs-full_CapitalCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0a456213-c622-40b7-bcc5-6016cf8ff2fa_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee benefits</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseFacilitiesMontpellierMember_ba36c5f1-ec05-47e0-bcd3-1266433138f8_terseLabel_en-US" xlink:label="lab_abvx_LeaseFacilitiesMontpellierMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease facilities, Montpellier</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesMontpellierMember_label_en-US" xlink:label="lab_abvx_LeaseFacilitiesMontpellierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Facilities, Montpellier [Member]</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesMontpellierMember_documentation_en-US" xlink:label="lab_abvx_LeaseFacilitiesMontpellierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Facilities, Montpellier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMontpellierMember" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMontpellierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseFacilitiesMontpellierMember" xlink:to="lab_abvx_LeaseFacilitiesMontpellierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheBAndCMember_86cb5bb1-4a6f-4e7e-8c6b-a042eda26c5d_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheBAndCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing, tranche B and C</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheBAndCMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheBAndCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche B and C [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheBAndCMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheBAndCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche B and C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBAndCMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBAndCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingTrancheBAndCMember" xlink:to="lab_abvx_KreosClaretFinancingTrancheBAndCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseBreakClausePeriod_8550cabd-3834-4f09-98dd-8f67a30830f2_terseLabel_en-US" xlink:label="lab_abvx_LeaseBreakClausePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, break clause period</link:label>
    <link:label id="lab_abvx_LeaseBreakClausePeriod_label_en-US" xlink:label="lab_abvx_LeaseBreakClausePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Break Clause Period</link:label>
    <link:label id="lab_abvx_LeaseBreakClausePeriod_documentation_en-US" xlink:label="lab_abvx_LeaseBreakClausePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Break Clause Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseBreakClausePeriod" xlink:href="abvx-20241231.xsd#abvx_LeaseBreakClausePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseBreakClausePeriod" xlink:to="lab_abvx_LeaseBreakClausePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseLiabilitiesMember_402cc7ae-0987-49b6-87e8-8e52c8b26973_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilitiesMember_label_en-US" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingIncome_0f431609-74f0-4878-a0f8-96337cc41870_terseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingIncome_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous other operating income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:to="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentAdvancesToCROContracts_7653c388-47b6-4037-9824-9f5673c8ae1a_terseLabel_en-US" xlink:label="lab_abvx_CurrentAdvancesToCROContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advances related to CRO contracts</link:label>
    <link:label id="lab_abvx_CurrentAdvancesToCROContracts_label_en-US" xlink:label="lab_abvx_CurrentAdvancesToCROContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Advances To CRO Contracts</link:label>
    <link:label id="lab_abvx_CurrentAdvancesToCROContracts_documentation_en-US" xlink:label="lab_abvx_CurrentAdvancesToCROContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Advances To CRO Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentAdvancesToCROContracts" xlink:href="abvx-20241231.xsd#abvx_CurrentAdvancesToCROContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentAdvancesToCROContracts" xlink:to="lab_abvx_CurrentAdvancesToCROContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAbstract_227bdff9-9f38-45d9-a561-29e5f4b29ef8_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_ifrs-full_AssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract" xlink:to="lab_ifrs-full_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e498a397-50d7-4954-8833-adb17e2ecc5c_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseLiabilities_d77051a0-96ee-47df-b04f-2b2f0f0075d6_periodStartLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities at beginning of period</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_220a1041-3dde-46c5-8b1a-52ed78a71c34_periodEndLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities at end of period</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_b98a8789-fdae-4f8b-90b9-8ccb4a6d4cc9_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="lab_ifrs-full_LeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems_e6498b81-f1d6-4edf-bf93-c0470e3f24b0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_3a619b15-23c1-4308-9bac-213813ec9100_verboseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) through amortization cost remeasurement</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_9001bcae-6214-4f17-a75d-8c9050306ab8_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash changes: amortized cost remeasurement</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Amortization Cost Remeasurement, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Amortization Cost Remeasurement, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_0d0413a7-8b5e-4ae0-92c0-7a111875027c_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember_dd9cbe68-0108-4668-8e4b-d73f4faa1fcb_terseLabel_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Final redemption, probability-weighted fair value without MRI</link:label>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember_label_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Final Redemption, Probability-Weighted Fair Value Without MRI , Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Final Redemption, Probability-Weighted Fair Value Without MRI , Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" xlink:to="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxEffectOfForeignTaxRates_054b6d31-0c24-4621-8ac9-58f264ab95a0_terseLabel_en-US" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax rates in foreign jurisdictions</link:label>
    <link:label id="lab_ifrs-full_TaxEffectOfForeignTaxRates_label_en-US" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect of foreign tax rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_9ce43a02-8def-488e-8c49-58661a7284b9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of information for cash-generating units [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information for cash-generating units [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable" xlink:to="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_A2023TaxYearMember_24de69d1-6907-4915-ac47-1ca916af0a61_terseLabel_en-US" xlink:label="lab_abvx_A2023TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2023</link:label>
    <link:label id="lab_abvx_A2023TaxYearMember_label_en-US" xlink:label="lab_abvx_A2023TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023, Tax Year [Member]</link:label>
    <link:label id="lab_abvx_A2023TaxYearMember_documentation_en-US" xlink:label="lab_abvx_A2023TaxYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Year 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2023TaxYearMember" xlink:href="abvx-20241231.xsd#abvx_A2023TaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_A2023TaxYearMember" xlink:to="lab_abvx_A2023TaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_38218c78-e1d5-4816-a368-ba06432f94ed_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_1ec8ee96-07d0-4350-a5bc-51b0e9d9181e_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction on treasury shares</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through treasury share transactions, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member_19243197-c5de-494f-ab33-2bc84bf855ea_terseLabel_en-US" xlink:label="lab_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7</link:label>
    <link:label id="lab_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member_label_en-US" xlink:label="lab_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7 [Member]</link:label>
    <link:label id="lab_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member_documentation_en-US" xlink:label="lab_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" xlink:href="abvx-20241231.xsd#abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" xlink:to="lab_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember_4f1e8d4f-5019-4e1e-9477-4347d2aae6e4_terseLabel_en-US" xlink:label="lab_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RNP-VIR conditional advance and CARENA conditional advance</link:label>
    <link:label id="lab_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember_label_en-US" xlink:label="lab_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RNP-VIR Conditional Advance, BPI And CARENA Conditional Advance, BPI [Member]</link:label>
    <link:label id="lab_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember_documentation_en-US" xlink:label="lab_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RNP-VIR Conditional Advance, BPI And CARENA Conditional Advance, BPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" xlink:to="lab_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember_792150bc-691a-4434-bbd2-efcdfe48216e_terseLabel_en-US" xlink:label="lab_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">American Depositary Shares, each representing one ordinary share, nominal value &#8364;0.01 per share</link:label>
    <link:label id="lab_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember_label_en-US" xlink:label="lab_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">American Depository Shares, NASDAQ Global Market [Member]</link:label>
    <link:label id="lab_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember_documentation_en-US" xlink:label="lab_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">American Depository Shares, NASDAQ Global Select Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesNASDAQGlobalMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember" xlink:to="lab_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_e923a66d-cf85-4e71-ba04-32b33e25b540_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RegisteredDirectOfferingMember_7f273b50-ad44-450e-aabd-00c945e65a8f_terseLabel_en-US" xlink:label="lab_abvx_RegisteredDirectOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registered direct offering</link:label>
    <link:label id="lab_abvx_RegisteredDirectOfferingMember_label_en-US" xlink:label="lab_abvx_RegisteredDirectOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Registered Direct Offering [Member]</link:label>
    <link:label id="lab_abvx_RegisteredDirectOfferingMember_documentation_en-US" xlink:label="lab_abvx_RegisteredDirectOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Registered Direct Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RegisteredDirectOfferingMember" xlink:href="abvx-20241231.xsd#abvx_RegisteredDirectOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RegisteredDirectOfferingMember" xlink:to="lab_abvx_RegisteredDirectOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_575a8c3a-d572-44c9-abbc-598262548136_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Off-balance sheet commitments given</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of commitments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosABBSAMember_d8a23f8e-5a7c-4f3c-b3eb-5e5b6de1d203_terseLabel_en-US" xlink:label="lab_abvx_KreosABBSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos A &amp; B BSA</link:label>
    <link:label id="lab_abvx_KreosABBSAMember_label_en-US" xlink:label="lab_abvx_KreosABBSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos A &amp; B BSA [Member]</link:label>
    <link:label id="lab_abvx_KreosABBSAMember_documentation_en-US" xlink:label="lab_abvx_KreosABBSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos A &amp; B BSA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosABBSAMember" xlink:to="lab_abvx_KreosABBSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_dc1f7223-aab7-432b-97c4-bd8fd26ee520_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_055305af-f149-4465-8935-8222ddc1e994_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares based compensation expense</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsOnChangeInFairValueOfDerivatives_d52d9060-7789-4fa8-9eab-67918e0ef75d_negatedLabel_en-US" xlink:label="lab_ifrs-full_GainsOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Decrease in fair value</link:label>
    <link:label id="lab_ifrs-full_GainsOnChangeInFairValueOfDerivatives_6ed57577-bc5e-4e1b-8a77-b55c12606e39_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease/(increase) in derivatives fair value</link:label>
    <link:label id="lab_ifrs-full_GainsOnChangeInFairValueOfDerivatives_label_en-US" xlink:label="lab_ifrs-full_GainsOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains on change in fair value of derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsOnChangeInFairValueOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives" xlink:to="lab_ifrs-full_GainsOnChangeInFairValueOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseInTransversalActivities_ff35fedf-63dd-4f4f-868e-76fddd83171a_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseInTransversalActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in transversal activities</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInTransversalActivities_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseInTransversalActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Transversal Activities</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInTransversalActivities_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseInTransversalActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Transversal Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInTransversalActivities" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInTransversalActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseInTransversalActivities" xlink:to="lab_abvx_IncreaseDecreaseInTransversalActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_4acf3225-858e-4520-827e-084cbb000a61_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for:</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_6d23335b-6eae-4cda-a6f8-288f88c7b6ec_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShareIssueRelatedCost_ebd2c822-5448-47b8-ad3d-5cd6ddfe26ac_terseLabel_en-US" xlink:label="lab_ifrs-full_ShareIssueRelatedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share issue related cost</link:label>
    <link:label id="lab_ifrs-full_ShareIssueRelatedCost_8fc9163e-1483-4c0c-be8c-f7ab8d6ffea0_verboseLabel_en-US" xlink:label="lab_ifrs-full_ShareIssueRelatedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share issue related cost</link:label>
    <link:label id="lab_ifrs-full_ShareIssueRelatedCost_label_en-US" xlink:label="lab_ifrs-full_ShareIssueRelatedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share issue related cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost" xlink:to="lab_ifrs-full_ShareIssueRelatedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarlyRedemptionAmountMeasurementInputMember_b902ee42-6530-4a07-85db-b189f2c17c59_terseLabel_en-US" xlink:label="lab_abvx_EarlyRedemptionAmountMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Early redemption amount (put event)</link:label>
    <link:label id="lab_abvx_EarlyRedemptionAmountMeasurementInputMember_label_en-US" xlink:label="lab_abvx_EarlyRedemptionAmountMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Early Redemption Amount, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_EarlyRedemptionAmountMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_EarlyRedemptionAmountMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Early Redemption Amount, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarlyRedemptionAmountMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_EarlyRedemptionAmountMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarlyRedemptionAmountMeasurementInputMember" xlink:to="lab_abvx_EarlyRedemptionAmountMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarnOutLiabilityMember_1dde885a-e971-4ca3-92d4-c694ecb1c68d_terseLabel_en-US" xlink:label="lab_abvx_EarnOutLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prosynergia earn-out liability</link:label>
    <link:label id="lab_abvx_EarnOutLiabilityMember_label_en-US" xlink:label="lab_abvx_EarnOutLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earn-Out Liability [Member]</link:label>
    <link:label id="lab_abvx_EarnOutLiabilityMember_documentation_en-US" xlink:label="lab_abvx_EarnOutLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earn-Out Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarnOutLiabilityMember" xlink:to="lab_abvx_EarnOutLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock_a88398b4-7685-4e21-92d1-1223f162f3ad_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of other receivables and other assets</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Other Receivables And Other Assets [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Other Receivables And Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" xlink:to="lab_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_e760be9e-3608-4a09-9709-0ed153dc38b0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_6e03d59e-1ad0-459b-8f11-b22164654552_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_b5e4c51b-e44a-4947-bc7d-9d2ba8d27fc4_terseLabel_en-US" xlink:label="lab_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense relating to short-term leases</link:label>
    <link:label id="lab_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_label_en-US" xlink:label="lab_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense Relating To Short-Term Leases And Low Value Assets For Which Recognition Exemption Has Been Used</link:label>
    <link:label id="lab_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_documentation_en-US" xlink:label="lab_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expense Relating To Short-Term Leases And Low Value Assets For Which Recognition Exemption Has Been Used</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:href="abvx-20241231.xsd#abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="lab_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_InterestExpenseOnRoyaltyCertificates_630983ae-ee2f-4c97-96f3-2859f8297f8b_terseLabel_en-US" xlink:label="lab_abvx_InterestExpenseOnRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on royalty certificates</link:label>
    <link:label id="lab_abvx_InterestExpenseOnRoyaltyCertificates_40dfe3f8-d99a-446d-adb9-805a83d3e3c6_negatedTerseLabel_en-US" xlink:label="lab_abvx_InterestExpenseOnRoyaltyCertificates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest on royalty certificates</link:label>
    <link:label id="lab_abvx_InterestExpenseOnRoyaltyCertificates_label_en-US" xlink:label="lab_abvx_InterestExpenseOnRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense On Royalty Certificates</link:label>
    <link:label id="lab_abvx_InterestExpenseOnRoyaltyCertificates_documentation_en-US" xlink:label="lab_abvx_InterestExpenseOnRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense On Royalty Certificates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestExpenseOnRoyaltyCertificates" xlink:href="abvx-20241231.xsd#abvx_InterestExpenseOnRoyaltyCertificates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_InterestExpenseOnRoyaltyCertificates" xlink:to="lab_abvx_InterestExpenseOnRoyaltyCertificates" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_InitialPriceLimitMeasurementInputMember_9c89e9f8-9d36-4bf8-b41e-0af3b858a3a8_terseLabel_en-US" xlink:label="lab_abvx_InitialPriceLimitMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial price limit (in euro per share)</link:label>
    <link:label id="lab_abvx_InitialPriceLimitMeasurementInputMember_label_en-US" xlink:label="lab_abvx_InitialPriceLimitMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Price Limit, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_InitialPriceLimitMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_InitialPriceLimitMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Initial Price Limit, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InitialPriceLimitMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_InitialPriceLimitMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_InitialPriceLimitMeasurementInputMember" xlink:to="lab_abvx_InitialPriceLimitMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingConditionsNotCompletedMember_9e1ac7e5-e98e-4cd7-894d-22f93a98e522_terseLabel_en-US" xlink:label="lab_abvx_VestingConditionsNotCompletedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting conditions not completed</link:label>
    <link:label id="lab_abvx_VestingConditionsNotCompletedMember_label_en-US" xlink:label="lab_abvx_VestingConditionsNotCompletedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Conditions Not Completed [Member]</link:label>
    <link:label id="lab_abvx_VestingConditionsNotCompletedMember_documentation_en-US" xlink:label="lab_abvx_VestingConditionsNotCompletedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Conditions Not Completed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingConditionsNotCompletedMember" xlink:href="abvx-20241231.xsd#abvx_VestingConditionsNotCompletedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingConditionsNotCompletedMember" xlink:to="lab_abvx_VestingConditionsNotCompletedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_6cc20893-3860-496d-8f09-7f20ff869f4c_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss of extinguishment</link:label>
    <link:label id="lab_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_label_en-US" xlink:label="lab_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) arising from difference between carrying amount of financial liability extinguished and consideration paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid" xlink:to="lab_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RightofuseAssets_6a224e22-c041-4679-a250-d6fb72e57a50_terseLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets" xlink:to="lab_ifrs-full_RightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MarketCapitalizationMeasurementInputMember_6cac025e-8ff6-47ad-b512-1242fb5c3acd_terseLabel_en-US" xlink:label="lab_abvx_MarketCapitalizationMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market capitalization</link:label>
    <link:label id="lab_abvx_MarketCapitalizationMeasurementInputMember_label_en-US" xlink:label="lab_abvx_MarketCapitalizationMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Capitalization, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_MarketCapitalizationMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_MarketCapitalizationMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Capitalization, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MarketCapitalizationMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_MarketCapitalizationMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MarketCapitalizationMeasurementInputMember" xlink:to="lab_abvx_MarketCapitalizationMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_3a53bceb-0203-4af2-9ddc-4d1e7f62a608_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Liabilities_6f42603b-3313-48d8-b70c-b81ef36c494e_terseLabel_en-US" xlink:label="lab_ifrs-full_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_ifrs-full_Liabilities_label_en-US" xlink:label="lab_ifrs-full_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities" xlink:to="lab_ifrs-full_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_ddb504cd-7b34-437a-a6c3-b9b516dd0813_terseLabel_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOFTWARES</link:label>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_label_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer software [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember" xlink:to="lab_ifrs-full_ComputerSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates_78627505-9165-4e62-b5f4-b3a14de97255_terseLabel_en-US" xlink:label="lab_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in interest expense</link:label>
    <link:label id="lab_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates_label_en-US" xlink:label="lab_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Interest Expense On Royalty Certificates</link:label>
    <link:label id="lab_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates_documentation_en-US" xlink:label="lab_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease In Interest Expense On Royalty Certificates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates" xlink:href="abvx-20241231.xsd#abvx_DecreaseInInterestExpenseOnRoyaltyCertificates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates" xlink:to="lab_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesNominalValue_fc6eccdc-fdf8-4435-bc89-92c2ffa95681_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesNominalValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loan notes, nominal value</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesNominalValue_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesNominalValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Nominal Value</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesNominalValue_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesNominalValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Nominal Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesNominalValue" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesNominalValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesNominalValue" xlink:to="lab_abvx_ConvertibleLoansNotesNominalValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_f4cbf367-5291-4992-a983-e06486b20e44_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued at beginning of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_51c93978-ce55-4c9e-884c-140a92a8d9e2_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued at end of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_2e653630-c695-4fc8-817c-59c148281e5f_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_label_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued" xlink:to="lab_ifrs-full_NumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfWarrantsOutstanding_876581bb-a427-45de-91fe-ace2c156b3c0_terseLabel_en-US" xlink:label="lab_abvx_NumberOfWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of outstanding warrants (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsOutstanding_label_en-US" xlink:label="lab_abvx_NumberOfWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Warrants Outstanding</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsOutstanding_documentation_en-US" xlink:label="lab_abvx_NumberOfWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Warrants Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstanding" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfWarrantsOutstanding" xlink:to="lab_abvx_NumberOfWarrantsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilities_38c8598e-c9dd-481d-8960-9d8c7e12b479_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilities_8d248a2f-6ae7-4204-ae0b-38c18f03d13d_totalLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilities" xlink:to="lab_ifrs-full_FinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesMember_62cd592e-5460-45d5-9f04-14b6f7b1c967_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loan notes</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesMember_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes [Member]</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesMember_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesMember" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesMember" xlink:to="lab_abvx_ConvertibleLoansNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3_4ccf2242-fbf1-4fb6-a399-21c1fdd21457_terseLabel_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential development milestone payment, phase 3</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3_label_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Potential Development Milestone Payment, Phase 3</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3_documentation_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Potential Development Milestone Payment, Phase 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" xlink:to="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_64631db2-e1a3-4c96-868f-5f0fb2e509c6_verboseLabel_en-US" xlink:label="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE OF THE BSA (in euro per share)</link:label>
    <link:label id="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_c1151760-fb7f-4d58-b915-83ac122186d8_terseLabel_en-US" xlink:label="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE OF THE AGA (in euro per share)</link:label>
    <link:label id="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Instrument Fair Value, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Instrument Fair Value, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" xlink:to="lab_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_e1882554-2783-4846-a253-f915445c3c0f_terseLabel_en-US" xlink:label="lab_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and collaboration agreement with CNRS, University of Montpellier and Institut Curie</link:label>
    <link:label id="lab_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_label_en-US" xlink:label="lab_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Collaboration Agreement With CNRS, University Of Montpellier And Institut Curie [Member]</link:label>
    <link:label id="lab_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_documentation_en-US" xlink:label="lab_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Collaboration Agreement With CNRS, University Of Montpellier And Institut Curie</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:href="abvx-20241231.xsd#abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:to="lab_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_ac318d53-774a-4c99-8aed-1a802332a46d_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest on convertible loan notes</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on debt instruments issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnDebtInstrumentsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:to="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_e098972c-d5c2-4895-9dde-6009cb64a81b_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conditional advances and PGE</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for borrowings [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_66a6da23-bce9-453f-bcb0-35f0a2d5f111_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_0f521e78-6469-4ac4-875d-72a0b7613084_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_ae13006d-1fa8-4709-af2b-70ac15958cbb_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:to="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ForeignExchangeLoss_75a0eb40-0a3c-4b33-80b9-aca6977346f5_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ForeignExchangeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange losses</link:label>
    <link:label id="lab_ifrs-full_ForeignExchangeLoss_label_en-US" xlink:label="lab_ifrs-full_ForeignExchangeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ForeignExchangeLoss" xlink:to="lab_ifrs-full_ForeignExchangeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_8a3dbef5-2542-41be-ab21-4a4d26a41af0_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GROSS VALUES</link:label>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember" xlink:to="lab_ifrs-full_GrossCarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20241Member_d81b5210-02dc-472f-9dc0-82fdb455d6cd_terseLabel_en-US" xlink:label="lab_abvx_AGA20241Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-1</link:label>
    <link:label id="lab_abvx_AGA20241Member_label_en-US" xlink:label="lab_abvx_AGA20241Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-1 [Member]</link:label>
    <link:label id="lab_abvx_AGA20241Member_documentation_en-US" xlink:label="lab_abvx_AGA20241Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241Member" xlink:href="abvx-20241231.xsd#abvx_AGA20241Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20241Member" xlink:to="lab_abvx_AGA20241Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsMaturityExtensionTerm_48e95eca-fbb7-4e1d-83f1-8b0190ca5d30_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsMaturityExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings maturity, extension term</link:label>
    <link:label id="lab_abvx_BorrowingsMaturityExtensionTerm_label_en-US" xlink:label="lab_abvx_BorrowingsMaturityExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings Maturity, Extension Term</link:label>
    <link:label id="lab_abvx_BorrowingsMaturityExtensionTerm_documentation_en-US" xlink:label="lab_abvx_BorrowingsMaturityExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings Maturity, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityExtensionTerm" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsMaturityExtensionTerm" xlink:to="lab_abvx_BorrowingsMaturityExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets_a6b2cdc4-68fa-4912-a5ae-34d06d1b3471_terseLabel_en-US" xlink:label="lab_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase</link:label>
    <link:label id="lab_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets_label_en-US" xlink:label="lab_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase, Property Plant AndEquipment including right-of-use assets</link:label>
    <link:label id="lab_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets_documentation_en-US" xlink:label="lab_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase, Property Plant AndEquipment including right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" xlink:href="abvx-20241231.xsd#abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" xlink:to="lab_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_b4569914-54b6-4b78-9b22-a5d38eb53d6c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a410ce6d-07cf-414b-83aa-67190ce544e3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_55f173d7-3109-4476-acea-f34731463866_terseLabel_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [domain]</link:label>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_label_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EquityIssuanceCashCarveOut_5e008683-750b-4c2f-87ea-88daec6c659e_terseLabel_en-US" xlink:label="lab_abvx_EquityIssuanceCashCarveOut" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity issuance, cash carve-out</link:label>
    <link:label id="lab_abvx_EquityIssuanceCashCarveOut_label_en-US" xlink:label="lab_abvx_EquityIssuanceCashCarveOut" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Issuance, Cash Carve-Out</link:label>
    <link:label id="lab_abvx_EquityIssuanceCashCarveOut_documentation_en-US" xlink:label="lab_abvx_EquityIssuanceCashCarveOut" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Issuance, Cash Carve-Out</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceCashCarveOut" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceCashCarveOut"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EquityIssuanceCashCarveOut" xlink:to="lab_abvx_EquityIssuanceCashCarveOut" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheABMember_9e46c662-a5e3-4941-b2c0-9bde5fc8b654_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheABMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing, tranche A-B</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheABMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheABMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche A-B [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheABMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheABMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche A-B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheABMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheABMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingTrancheABMember" xlink:to="lab_abvx_KreosClaretFinancingTrancheABMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20233Member_0314efa8-1586-46ee-86c2-eabca3e99a62_terseLabel_en-US" xlink:label="lab_abvx_AGA20233Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2023-3</link:label>
    <link:label id="lab_abvx_AGA20233Member_label_en-US" xlink:label="lab_abvx_AGA20233Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2023-3 [Member]</link:label>
    <link:label id="lab_abvx_AGA20233Member_documentation_en-US" xlink:label="lab_abvx_AGA20233Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2023-3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233Member" xlink:href="abvx-20241231.xsd#abvx_AGA20233Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20233Member" xlink:to="lab_abvx_AGA20233Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashEquivalents_c5be9be1-2847-495f-a7e7-320fded92f48_terseLabel_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashEquivalents" xlink:to="lab_ifrs-full_CashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DecreaseInLeaseLiabilities_cefc9277-51bd-45af-a9ba-1c60e13900bc_negatedTerseLabel_en-US" xlink:label="lab_abvx_DecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease</link:label>
    <link:label id="lab_abvx_DecreaseInLeaseLiabilities_label_en-US" xlink:label="lab_abvx_DecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Lease Liabilities</link:label>
    <link:label id="lab_abvx_DecreaseInLeaseLiabilities_documentation_en-US" xlink:label="lab_abvx_DecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease In Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInLeaseLiabilities" xlink:href="abvx-20241231.xsd#abvx_DecreaseInLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DecreaseInLeaseLiabilities" xlink:to="lab_abvx_DecreaseInLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesNumberOfSeparateClosings_62f30b95-d44e-4019-be07-da2f1369f276_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesNumberOfSeparateClosings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loan notes, number of separate closings</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesNumberOfSeparateClosings_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesNumberOfSeparateClosings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Number Of Separate Closings</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesNumberOfSeparateClosings_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesNumberOfSeparateClosings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Number Of Separate Closings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesNumberOfSeparateClosings" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesNumberOfSeparateClosings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesNumberOfSeparateClosings" xlink:to="lab_abvx_ConvertibleLoansNotesNumberOfSeparateClosings" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock_c1e8abd4-d446-43ba-8e2e-c7e6124f8c7a_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of judgments and estimates</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For Accounting Judgements And Estimates Explanatory [Policy Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For Accounting Judgements And Estimates Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" xlink:to="lab_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_7b005ddc-c1f0-4499-ab5f-01c95999e238_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement benefit obligations</link:label>
    <link:label id="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_label_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current provisions for employee benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:to="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20233AndAGA20234Member_615e27d9-ec3c-429d-ab28-6dfb62aab46d_terseLabel_en-US" xlink:label="lab_abvx_AGA20233AndAGA20234Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2023-3 and AGA-2023-4</link:label>
    <link:label id="lab_abvx_AGA20233AndAGA20234Member_label_en-US" xlink:label="lab_abvx_AGA20233AndAGA20234Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2023-3 And AGA-2023-4 [Member]</link:label>
    <link:label id="lab_abvx_AGA20233AndAGA20234Member_documentation_en-US" xlink:label="lab_abvx_AGA20233AndAGA20234Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2023-3 And AGA-2023-4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233AndAGA20234Member" xlink:href="abvx-20241231.xsd#abvx_AGA20233AndAGA20234Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20233AndAGA20234Member" xlink:to="lab_abvx_AGA20233AndAGA20234Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RemeasurementPeriodDomain_312f8dd3-1175-4e95-8b62-12289205f681_terseLabel_en-US" xlink:label="lab_abvx_RemeasurementPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement Period [Domain]</link:label>
    <link:label id="lab_abvx_RemeasurementPeriodDomain_label_en-US" xlink:label="lab_abvx_RemeasurementPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurement Period [Domain]</link:label>
    <link:label id="lab_abvx_RemeasurementPeriodDomain_documentation_en-US" xlink:label="lab_abvx_RemeasurementPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remeasurement Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RemeasurementPeriodDomain" xlink:href="abvx-20241231.xsd#abvx_RemeasurementPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RemeasurementPeriodDomain" xlink:to="lab_abvx_RemeasurementPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NonCurrentConvertibleLoansNotes_424545bd-8462-47da-a7cf-eda42151f5d7_terseLabel_en-US" xlink:label="lab_abvx_NonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loan notes</link:label>
    <link:label id="lab_abvx_NonCurrentConvertibleLoansNotes_ce426d67-fa0e-43d6-ad72-e57d05361dec_negatedLabel_en-US" xlink:label="lab_abvx_NonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-current convertible loans notes</link:label>
    <link:label id="lab_abvx_NonCurrentConvertibleLoansNotes_676fd1ff-1072-46c8-9485-653ed2d188a0_verboseLabel_en-US" xlink:label="lab_abvx_NonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-current convertible loans notes</link:label>
    <link:label id="lab_abvx_NonCurrentConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_NonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_NonCurrentConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_NonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_NonCurrentConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NonCurrentConvertibleLoansNotes" xlink:to="lab_abvx_NonCurrentConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_3d3f38ee-771c-4830-9b1b-890788765367_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Actuarial gains and losses</link:label>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6fdf48d1-39aa-4088-baee-698c009aab3e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_03b1a2e3-3bfc-4484-beca-76fb2509f5c6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5be3c62a-c84f-463e-8754-9de41738ec7d_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Receivables And Other Assets [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_label_en-US" xlink:label="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Receivables And Other Assets [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Receivables And Other Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable" xlink:to="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesUndiscountedCashFlows_f6ec7438-dc27-4de0-858f-f49c847d21e8_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loans notes, undiscounted cash flows</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesUndiscountedCashFlows_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Undiscounted Cash Flows</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesUndiscountedCashFlows_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Undiscounted Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows" xlink:to="lab_abvx_ConvertibleLoansNotesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_4dbf099c-fea4-4f01-8c86-4edeb9c7cba7_terseLabel_en-US" xlink:label="lab_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_label_en-US" xlink:label="lab_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Historical volatility for shares, measurement input [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:to="lab_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_57912dbf-7a7f-4380-8de7-3271bd0bfd8b_terseLabel_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bottom of range</link:label>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bottom of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember" xlink:to="lab_ifrs-full_BottomOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_89fe0c24-f40d-43a8-96c3-ca61d2ca7c19_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercises of share warrants (in shares)</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" xlink:to="lab_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_20f537e3-56a5-47a6-b0e2-74b0fd516767_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheCMember_b1e655fc-1e96-434c-8dda-2d5476e5bbfe_terseLabel_en-US" xlink:label="lab_abvx_TrancheCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche C</link:label>
    <link:label id="lab_abvx_TrancheCMember_label_en-US" xlink:label="lab_abvx_TrancheCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche C [Member]</link:label>
    <link:label id="lab_abvx_TrancheCMember_documentation_en-US" xlink:label="lab_abvx_TrancheCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheCMember" xlink:href="abvx-20241231.xsd#abvx_TrancheCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheCMember" xlink:to="lab_abvx_TrancheCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesPeriod_eb8480f5-d020-43e2-8310-5b546a3374ca_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loan notes, period</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesPeriod_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Period</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesPeriod_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesPeriod" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesPeriod" xlink:to="lab_abvx_ConvertibleLoansNotesPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_fdbd3c14-6fb7-4178-92d8-bd9bbdd01b36_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsNoticePeriod_910c44d5-cce4-417c-9806-ba1eeac6406c_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, notice period</link:label>
    <link:label id="lab_abvx_BorrowingsNoticePeriod_label_en-US" xlink:label="lab_abvx_BorrowingsNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Notice Period</link:label>
    <link:label id="lab_abvx_BorrowingsNoticePeriod_documentation_en-US" xlink:label="lab_abvx_BorrowingsNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Notice Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNoticePeriod" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNoticePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsNoticePeriod" xlink:to="lab_abvx_BorrowingsNoticePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansMember_299e9b86-1217-4aae-8740-308d45ec3bbb_terseLabel_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 1, convertible bond loans</link:label>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansMember_label_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1, Convertible Bond Loans [Member]</link:label>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansMember_documentation_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1, Convertible Bond Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansMember" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos1ConvertibleBondLoansMember" xlink:to="lab_abvx_Kreos1ConvertibleBondLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d388d6d3-e970-40fe-8caa-9245e43b4fcf_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_33124ff6-0f70-41f6-80a3-3beac37a5580_terseLabel_en-US" xlink:label="lab_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Held to maturity / voluntary conversion scenario probability</link:label>
    <link:label id="lab_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_label_en-US" xlink:label="lab_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Voluntary Conversion Scenario Probability, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Voluntary Conversion Scenario Probability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember" xlink:to="lab_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_d7b35cc1-970d-4e1f-b00d-6dc41004eb53_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of intangible assets</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_c1598b2d-53e7-403d-bfb5-92bb7c3daeab_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ec4c5378-e8ae-4b66-94b6-5779f70ff984_verboseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_956c08c0-fbd8-44e7-8fab-87ca7311dbd3_terseLabel_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_label_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsForDebtIssueCosts_2cce777d-53ce-406c-8844-93673274c2dd_terseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsForDebtIssueCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for debt issue costs</link:label>
    <link:label id="lab_ifrs-full_PaymentsForDebtIssueCosts_label_en-US" xlink:label="lab_ifrs-full_PaymentsForDebtIssueCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for debt issue costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForDebtIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForDebtIssueCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForDebtIssueCosts" xlink:to="lab_ifrs-full_PaymentsForDebtIssueCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_a2adc3ff-8972-4925-b003-ffaabd919f8d_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_7098b689-a711-40f7-99d5-89f088b84456_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other operating expense [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinanceIncome_1efe9422-3150-4913-9046-c37542c44740_terseLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial income</link:label>
    <link:label id="lab_ifrs-full_FinanceIncome_2d88eecb-6e03-47b0-8811-71c0dce7c61d_totalLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Financial income</link:label>
    <link:label id="lab_ifrs-full_FinanceIncome_label_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="lab_ifrs-full_FinanceIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RoyaltyCertificatesEIR_e9697b78-1e15-45a1-9591-55041be0fc25_terseLabel_en-US" xlink:label="lab_abvx_RoyaltyCertificatesEIR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty certificates, EIR</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatesEIR_label_en-US" xlink:label="lab_abvx_RoyaltyCertificatesEIR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Certificates, EIR</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatesEIR_documentation_en-US" xlink:label="lab_abvx_RoyaltyCertificatesEIR" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Certificates, EIR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesEIR" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesEIR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RoyaltyCertificatesEIR" xlink:to="lab_abvx_RoyaltyCertificatesEIR" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingMember_72175f4b-ed21-4a63-a75b-85760abbb1ac_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingMember" xlink:to="lab_abvx_KreosClaretFinancingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20241Member_a5afe286-7038-4de8-819d-a9b74e603a85_terseLabel_en-US" xlink:label="lab_abvx_BSA20241Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA 2024-1</link:label>
    <link:label id="lab_abvx_BSA20241Member_label_en-US" xlink:label="lab_abvx_BSA20241Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2024-1 [Member]</link:label>
    <link:label id="lab_abvx_BSA20241Member_documentation_en-US" xlink:label="lab_abvx_BSA20241Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2024-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241Member" xlink:href="abvx-20241231.xsd#abvx_BSA20241Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20241Member" xlink:to="lab_abvx_BSA20241Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther_442af40f-fbc5-41e0-9661-3bd491023c3c_terseLabel_en-US" xlink:label="lab_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease / (increase) in derivatives fair value and other</link:label>
    <link:label id="lab_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther_label_en-US" xlink:label="lab_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Changes In Derivative Fair Value And Other</link:label>
    <link:label id="lab_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther_documentation_en-US" xlink:label="lab_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Effect Of Changes In Derivative Fair Value And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfChangesInDerivativeFairValueAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther" xlink:to="lab_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherShorttermProvisions_ee873565-3679-42f0-b0bb-f5fdbeb8f629_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherShorttermProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_ifrs-full_OtherShorttermProvisions_label_en-US" xlink:label="lab_ifrs-full_OtherShorttermProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherShorttermProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherShorttermProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherShorttermProvisions" xlink:to="lab_ifrs-full_OtherShorttermProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_868e1e8c-4763-4f78-84ab-1e06fa9e73c7_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsStateGuaranteedPremium_8a782442-ae5b-4101-8baa-f01f056b8c57_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsStateGuaranteedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, state guaranteed premium</link:label>
    <link:label id="lab_abvx_BorrowingsStateGuaranteedPremium_label_en-US" xlink:label="lab_abvx_BorrowingsStateGuaranteedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, State Guaranteed Premium</link:label>
    <link:label id="lab_abvx_BorrowingsStateGuaranteedPremium_documentation_en-US" xlink:label="lab_abvx_BorrowingsStateGuaranteedPremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, State Guaranteed Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsStateGuaranteedPremium" xlink:href="abvx-20241231.xsd#abvx_BorrowingsStateGuaranteedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsStateGuaranteedPremium" xlink:to="lab_abvx_BorrowingsStateGuaranteedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConversionPriceVolumeWeightedAveragePricePeriod_9e1420b9-b9f7-4dc0-b9ef-a5f81ac39934_terseLabel_en-US" xlink:label="lab_abvx_ConversionPriceVolumeWeightedAveragePricePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price, VWAP, period</link:label>
    <link:label id="lab_abvx_ConversionPriceVolumeWeightedAveragePricePeriod_label_en-US" xlink:label="lab_abvx_ConversionPriceVolumeWeightedAveragePricePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Price, Volume Weighted Average Price, Period</link:label>
    <link:label id="lab_abvx_ConversionPriceVolumeWeightedAveragePricePeriod_documentation_en-US" xlink:label="lab_abvx_ConversionPriceVolumeWeightedAveragePricePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Price, Volume Weighted Average Price, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceVolumeWeightedAveragePricePeriod" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceVolumeWeightedAveragePricePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConversionPriceVolumeWeightedAveragePricePeriod" xlink:to="lab_abvx_ConversionPriceVolumeWeightedAveragePricePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_8b51d2c9-4569-4c11-861b-1f78ac113410_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NET LOSS FOR THE YEAR</link:label>
    <link:label id="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_label_en-US" xlink:label="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings, profit (loss) for reporting period [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember" xlink:to="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_bda3e118-0423-43e9-9efc-c8c46d138671_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_aed39e27-e2ae-42d3-82c4-65b7be6bd19b_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_cd4be800-0ecb-48ec-a647-e4c8fafe2939_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_05ee21b9-585e-4f10-af02-feaa3ac1ac4c_verboseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Departure indemnities</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_02b99f74-bbaa-4791-b293-0e4c051099dd_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination benefits</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, termination benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsForShareIssueCosts_f82fefbf-94e0-4e5b-a960-dbf568e4f58e_terseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for share issue costs</link:label>
    <link:label id="lab_ifrs-full_PaymentsForShareIssueCosts_label_en-US" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for share issue costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities_02811b83-ee19-4052-958e-1474a39d91cf_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash changes&#160;: subsidies</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Subsidies, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Subsidies, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarnOutAtFairValueAssetsAcquisitions_e84bda74-714e-48be-a417-3dacb50590fe_terseLabel_en-US" xlink:label="lab_abvx_EarnOutAtFairValueAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earn-out measured at fair value</link:label>
    <link:label id="lab_abvx_EarnOutAtFairValueAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_EarnOutAtFairValueAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earn-Out At Fair Value, Assets Acquisitions</link:label>
    <link:label id="lab_abvx_EarnOutAtFairValueAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_EarnOutAtFairValueAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earn-Out At Fair Value, Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarnOutAtFairValueAssetsAcquisitions" xlink:to="lab_abvx_EarnOutAtFairValueAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountMember_52e59805-7136-420c-a5e4-2caf7a4f7620_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount [member]</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember" xlink:to="lab_ifrs-full_CarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_06cf0774-08d2-4469-aa41-842952f2a322_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_9a9b60f1-60a9-488c-81bb-310d917b70c2_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum drawdown capacity</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Maximum Drawdown Capacity</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Maximum Drawdown Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity" xlink:to="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal_22f04606-0fb8-42f0-aafc-297753fd9784_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Early redemption amount, percentage of outstandong principal</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Early Redemption Amount, Percentage Of Outstandong Principal</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Early Redemption Amount, Percentage Of Outstandong Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" xlink:to="lab_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_ca7f44f7-ba42-4c4d-98f8-f66a61102373_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseDurationPeriod_fe499e07-14f1-409f-8a5a-3010e18b7787_terseLabel_en-US" xlink:label="lab_abvx_LeaseDurationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, duration period</link:label>
    <link:label id="lab_abvx_LeaseDurationPeriod_label_en-US" xlink:label="lab_abvx_LeaseDurationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Duration Period</link:label>
    <link:label id="lab_abvx_LeaseDurationPeriod_documentation_en-US" xlink:label="lab_abvx_LeaseDurationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Duration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseDurationPeriod" xlink:href="abvx-20241231.xsd#abvx_LeaseDurationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseDurationPeriod" xlink:to="lab_abvx_LeaseDurationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_11c894b5-6197-410d-88b6-2386ca3d2891_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Translation of transactions denominated in foreign currency</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest_9fb5762d-f23f-4baf-89d2-4b077148c16c_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum drawdown capacity including interest</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Maximum Drawdown Capacity Including Interest</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Maximum Drawdown Capacity Including Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" xlink:to="lab_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfConvertibleNotesOutstanding_361a49d4-d3ba-4227-b19f-a70a339ec2c5_terseLabel_en-US" xlink:label="lab_abvx_NumberOfConvertibleNotesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of outstanding notes (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfConvertibleNotesOutstanding_label_en-US" xlink:label="lab_abvx_NumberOfConvertibleNotesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Convertible Notes Outstanding</link:label>
    <link:label id="lab_abvx_NumberOfConvertibleNotesOutstanding_documentation_en-US" xlink:label="lab_abvx_NumberOfConvertibleNotesOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Convertible Notes Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfConvertibleNotesOutstanding" xlink:href="abvx-20241231.xsd#abvx_NumberOfConvertibleNotesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfConvertibleNotesOutstanding" xlink:to="lab_abvx_NumberOfConvertibleNotesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_bcb34985-2d11-4eac-850a-afcc8765d25a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of geographical areas [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of geographical areas [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20232Member_dc5ac72e-53c7-4fbe-80ab-2af2a3289444_terseLabel_en-US" xlink:label="lab_abvx_AGA20232Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2023-2</link:label>
    <link:label id="lab_abvx_AGA20232Member_label_en-US" xlink:label="lab_abvx_AGA20232Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2023-2 [Member]</link:label>
    <link:label id="lab_abvx_AGA20232Member_documentation_en-US" xlink:label="lab_abvx_AGA20232Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2023-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20232Member" xlink:href="abvx-20241231.xsd#abvx_AGA20232Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20232Member" xlink:to="lab_abvx_AGA20232Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_4696e4e6-152e-4dd1-9c02-3972cf08e28a_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CashPrepaymentAssetsAcquisitions_6065fcf5-ecb9-40ce-ac39-036ddba9d379_terseLabel_en-US" xlink:label="lab_abvx_CashPrepaymentAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash prepayment made in 2021</link:label>
    <link:label id="lab_abvx_CashPrepaymentAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_CashPrepaymentAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Prepayment, Assets Acquisitions</link:label>
    <link:label id="lab_abvx_CashPrepaymentAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_CashPrepaymentAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Prepayment, Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPrepaymentAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_CashPrepaymentAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CashPrepaymentAssetsAcquisitions" xlink:to="lab_abvx_CashPrepaymentAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesAbstract_85396fd4-2e0e-456d-9daf-2bb098579b42_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent_a7d86ac1-6d12-4b81-85cb-ab0a15a2c5d5_terseLabel_en-US" xlink:label="lab_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of prepaid expenses to carrying value of debt component</link:label>
    <link:label id="lab_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent_label_en-US" xlink:label="lab_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification of Prepaid Expenses to Carrying Value of Debt Component</link:label>
    <link:label id="lab_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent_documentation_en-US" xlink:label="lab_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of Prepaid Expenses to Carrying Value of Debt Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" xlink:href="abvx-20241231.xsd#abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" xlink:to="lab_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NonCurrentPrepaidExpenses_5fa39baf-0a6c-46bc-bafb-6565747f41df_terseLabel_en-US" xlink:label="lab_abvx_NonCurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses - non current</link:label>
    <link:label id="lab_abvx_NonCurrentPrepaidExpenses_label_en-US" xlink:label="lab_abvx_NonCurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Prepaid Expenses</link:label>
    <link:label id="lab_abvx_NonCurrentPrepaidExpenses_documentation_en-US" xlink:label="lab_abvx_NonCurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentPrepaidExpenses" xlink:href="abvx-20241231.xsd#abvx_NonCurrentPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NonCurrentPrepaidExpenses" xlink:to="lab_abvx_NonCurrentPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Goodwill_9e35315d-5961-47a2-b54c-dc9802e3dc7c_terseLabel_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_Goodwill_label_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Goodwill" xlink:to="lab_ifrs-full_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_bde735c0-4838-4327-b514-8379cbe51a84_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [domain]</link:label>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CashPaymentsForDeposits_c75eec3c-8439-4eb0-90ce-4ceac042a7b6_negatedTerseLabel_en-US" xlink:label="lab_abvx_CashPaymentsForDeposits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in Deposits</link:label>
    <link:label id="lab_abvx_CashPaymentsForDeposits_label_en-US" xlink:label="lab_abvx_CashPaymentsForDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Payments For Deposits</link:label>
    <link:label id="lab_abvx_CashPaymentsForDeposits_documentation_en-US" xlink:label="lab_abvx_CashPaymentsForDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Payments For Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPaymentsForDeposits" xlink:href="abvx-20241231.xsd#abvx_CashPaymentsForDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CashPaymentsForDeposits" xlink:to="lab_abvx_CashPaymentsForDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable_fd68917e-b769-43f1-a132-865554385b9c_terseLabel_en-US" xlink:label="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments granted, remaining percentage exercisable</link:label>
    <link:label id="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable_label_en-US" xlink:label="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Instruments Granted, Other Equity Instruments, Remaining Percentage Exercisable</link:label>
    <link:label id="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable_documentation_en-US" xlink:label="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Instruments Granted, Other Equity Instruments, Remaining Percentage Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" xlink:href="abvx-20241231.xsd#abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" xlink:to="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_b3271575-b613-48c5-86b5-c62e15841f7b_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other tax effects for reconciliation between accounting profit and tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosBBSAMember_44566468-bfc3-4682-ad56-3592e51af3bb_terseLabel_en-US" xlink:label="lab_abvx_KreosBBSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos B BSA</link:label>
    <link:label id="lab_abvx_KreosBBSAMember_label_en-US" xlink:label="lab_abvx_KreosBBSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos B BSA [Member]</link:label>
    <link:label id="lab_abvx_KreosBBSAMember_documentation_en-US" xlink:label="lab_abvx_KreosBBSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos B BSA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosBBSAMember" xlink:to="lab_abvx_KreosBBSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_33ba8912-a8b5-46b0-87fb-e223d956f8f8_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries [domain]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfIFRSCompliance_fbdc82bb-7936-4536-8917-1e84118a44b3_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfIFRSCompliance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of compliance</link:label>
    <link:label id="lab_ifrs-full_StatementOfIFRSCompliance_label_en-US" xlink:label="lab_ifrs-full_StatementOfIFRSCompliance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of IFRS compliance [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfIFRSCompliance" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfIFRSCompliance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfIFRSCompliance" xlink:to="lab_ifrs-full_StatementOfIFRSCompliance" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness_2d3e38ff-e328-4e33-a6c8-a24c618b822f_terseLabel_en-US" xlink:label="lab_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from borrowings, net of refinancing of existing indebteness</link:label>
    <link:label id="lab_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness_label_en-US" xlink:label="lab_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Borrowings, Net Of Refinancing Of Existing Indebteness</link:label>
    <link:label id="lab_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness_documentation_en-US" xlink:label="lab_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Borrowings, Net Of Refinancing Of Existing Indebteness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" xlink:to="lab_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock_f93e23e2-7778-4021-9e1e-a6a518bf65f7_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of average workforce during the periods</link:label>
    <link:label id="lab_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Average Number Of Employees [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Average Number Of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock" xlink:to="lab_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesRepaymentPeriod_61e6da24-024a-42db-ae1a-40e8325a541c_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesRepaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayment period</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesRepaymentPeriod_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesRepaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Repayment Period</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesRepaymentPeriod_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesRepaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Repayment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesRepaymentPeriod" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesRepaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesRepaymentPeriod" xlink:to="lab_abvx_OtherFinancialLiabilitiesRepaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpectedProceedsFromShareIssuance_85e4ea2d-6541-40e5-b0eb-af827c5c0b84_terseLabel_en-US" xlink:label="lab_abvx_ExpectedProceedsFromShareIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected proceeds from share issuance</link:label>
    <link:label id="lab_abvx_ExpectedProceedsFromShareIssuance_label_en-US" xlink:label="lab_abvx_ExpectedProceedsFromShareIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Proceeds From Share Issuance</link:label>
    <link:label id="lab_abvx_ExpectedProceedsFromShareIssuance_documentation_en-US" xlink:label="lab_abvx_ExpectedProceedsFromShareIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected Proceeds From Share Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedProceedsFromShareIssuance" xlink:href="abvx-20241231.xsd#abvx_ExpectedProceedsFromShareIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpectedProceedsFromShareIssuance" xlink:to="lab_abvx_ExpectedProceedsFromShareIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_94b42490-11ad-43dc-b059-903670099a15_terseLabel_en-US" xlink:label="lab_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of number of shares outstanding [abstract]</link:label>
    <link:label id="lab_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of number of shares outstanding [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="lab_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherShareWarrantsSubscriptionPricePerShare_6369cd69-a350-4a98-9d1a-fe94a4bf1974_terseLabel_en-US" xlink:label="lab_abvx_OtherShareWarrantsSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other share warrants, subscripion price per share (in euro per share)</link:label>
    <link:label id="lab_abvx_OtherShareWarrantsSubscriptionPricePerShare_label_en-US" xlink:label="lab_abvx_OtherShareWarrantsSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Share Warrants, Subscription Price Per Share</link:label>
    <link:label id="lab_abvx_OtherShareWarrantsSubscriptionPricePerShare_documentation_en-US" xlink:label="lab_abvx_OtherShareWarrantsSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Share Warrants, Subscription Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsSubscriptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare" xlink:to="lab_abvx_OtherShareWarrantsSubscriptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20181Member_8d155674-dfdc-49a1-a284-357946822b30_terseLabel_en-US" xlink:label="lab_abvx_BCE20181Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2018-1</link:label>
    <link:label id="lab_abvx_BCE20181Member_label_en-US" xlink:label="lab_abvx_BCE20181Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2018-1 [Member]</link:label>
    <link:label id="lab_abvx_BCE20181Member_documentation_en-US" xlink:label="lab_abvx_BCE20181Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2018-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20181Member" xlink:href="abvx-20241231.xsd#abvx_BCE20181Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20181Member" xlink:to="lab_abvx_BCE20181Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_81f0ed3f-ac6c-458e-9f14-b24f3830a7be_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RoyaltyCertificatesUndiscountedCashFlows_39e230ee-e6c6-40ea-880d-785298c3d431_terseLabel_en-US" xlink:label="lab_abvx_RoyaltyCertificatesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty certificates, undiscounted cash flows</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatesUndiscountedCashFlows_label_en-US" xlink:label="lab_abvx_RoyaltyCertificatesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Certificates, Undiscounted Cash Flows</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatesUndiscountedCashFlows_documentation_en-US" xlink:label="lab_abvx_RoyaltyCertificatesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Certificates, Undiscounted Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows" xlink:to="lab_abvx_RoyaltyCertificatesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_68651492-7d5c-4cf5-9d67-6963ee858c0f_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_0d4263f4-e649-44f2-a1b8-58831845c14f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest on conditional advances</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:to="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NonCurrentAdvancesToCROContractsMember_5bfb0219-bf41-4de6-91ae-c0bc53c08c86_terseLabel_en-US" xlink:label="lab_abvx_NonCurrentAdvancesToCROContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term advances made to CROs</link:label>
    <link:label id="lab_abvx_NonCurrentAdvancesToCROContractsMember_label_en-US" xlink:label="lab_abvx_NonCurrentAdvancesToCROContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Advances To CRO Contracts [Member]</link:label>
    <link:label id="lab_abvx_NonCurrentAdvancesToCROContractsMember_documentation_en-US" xlink:label="lab_abvx_NonCurrentAdvancesToCROContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Advances To CRO Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContractsMember" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NonCurrentAdvancesToCROContractsMember" xlink:to="lab_abvx_NonCurrentAdvancesToCROContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingServiceConditionsDomain_74cef6d9-67de-4141-86e7-e07bfa4ecc42_terseLabel_en-US" xlink:label="lab_abvx_VestingServiceConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Service Conditions [Domain]</link:label>
    <link:label id="lab_abvx_VestingServiceConditionsDomain_label_en-US" xlink:label="lab_abvx_VestingServiceConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Service Conditions [Domain]</link:label>
    <link:label id="lab_abvx_VestingServiceConditionsDomain_documentation_en-US" xlink:label="lab_abvx_VestingServiceConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Service Conditions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingServiceConditionsDomain" xlink:href="abvx-20241231.xsd#abvx_VestingServiceConditionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingServiceConditionsDomain" xlink:to="lab_abvx_VestingServiceConditionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_cdf3443d-5599-4589-a0cd-1d672bb7a4ff_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1328fc67-ef30-4e83-9ea1-aa3ea182e15a_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_a916a5ea-2238-4350-8657-9a926e95e465_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Disposal</link:label>
    <link:label id="lab_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals, property, plant and equipment including right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_0ae6a06d-b6fc-4cdc-a259-7ed4364125c4_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_2d79be19-bdd2-439f-8946-6ec69c4959cd_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for provisions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FairValueMeasurementAbstract_label_en-US" xlink:label="lab_abvx_FairValueMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Abstract]</link:label>
    <link:label id="lab_abvx_FairValueMeasurementAbstract_documentation_en-US" xlink:label="lab_abvx_FairValueMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FairValueMeasurementAbstract" xlink:href="abvx-20241231.xsd#abvx_FairValueMeasurementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FairValueMeasurementAbstract" xlink:to="lab_abvx_FairValueMeasurementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SalesAndMarketingExpense_2d40c59f-0dd9-44f6-bd56-c383920bfb61_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_SalesAndMarketingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_ifrs-full_SalesAndMarketingExpense_26cb0865-0451-4165-9695-050300919840_terseLabel_en-US" xlink:label="lab_ifrs-full_SalesAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_ifrs-full_SalesAndMarketingExpense_label_en-US" xlink:label="lab_ifrs-full_SalesAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales and marketing expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense" xlink:to="lab_ifrs-full_SalesAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IssuanceOfDerivativeInstruments_1eec2c64-cdc2-4584-93e1-4506598584a8_terseLabel_en-US" xlink:label="lab_abvx_IssuanceOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance</link:label>
    <link:label id="lab_abvx_IssuanceOfDerivativeInstruments_label_en-US" xlink:label="lab_abvx_IssuanceOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance Of Derivative Instruments</link:label>
    <link:label id="lab_abvx_IssuanceOfDerivativeInstruments_documentation_en-US" xlink:label="lab_abvx_IssuanceOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance Of Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfDerivativeInstruments" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfDerivativeInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IssuanceOfDerivativeInstruments" xlink:to="lab_abvx_IssuanceOfDerivativeInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BanquePubliqueDInvestissementBPIMember_bef75526-faeb-4927-aef2-841a2164084f_terseLabel_en-US" xlink:label="lab_abvx_BanquePubliqueDInvestissementBPIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conditional advances BPI</link:label>
    <link:label id="lab_abvx_BanquePubliqueDInvestissementBPIMember_label_en-US" xlink:label="lab_abvx_BanquePubliqueDInvestissementBPIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Banque Publique d&#8217;Investissement (BPI) [Member]</link:label>
    <link:label id="lab_abvx_BanquePubliqueDInvestissementBPIMember_documentation_en-US" xlink:label="lab_abvx_BanquePubliqueDInvestissementBPIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Banque Publique d&#8217;Investissement (BPI)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BanquePubliqueDInvestissementBPIMember" xlink:href="abvx-20241231.xsd#abvx_BanquePubliqueDInvestissementBPIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BanquePubliqueDInvestissementBPIMember" xlink:to="lab_abvx_BanquePubliqueDInvestissementBPIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_08771c83-7408-4b00-95c9-fa46959f0331_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial gains and losses on retirement benefit obligations</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AverageNumberOfEmployees_bccec829-2dfb-4d47-a9c4-a1259d0c035d_terseLabel_en-US" xlink:label="lab_ifrs-full_AverageNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average number of employees</link:label>
    <link:label id="lab_ifrs-full_AverageNumberOfEmployees_label_en-US" xlink:label="lab_ifrs-full_AverageNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average number of employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageNumberOfEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageNumberOfEmployees" xlink:to="lab_ifrs-full_AverageNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_5a83de0e-913a-4916-889d-632330ab20a6_totalLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_bc89c4e5-40f7-4394-ab5e-aba770400c12_verboseLabel_en-US" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase in fair value</link:label>
    <link:label id="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_0088fe5b-7148-49ce-9b33-b1481304e97f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in derivatives fair value</link:label>
    <link:label id="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_label_en-US" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Losses on change in fair value of derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:to="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfOperatingSegment_3bd67ace-a0ce-4dd6-82f7-3fa2c0f821dc_terseLabel_en-US" xlink:label="lab_abvx_NumberOfOperatingSegment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_abvx_NumberOfOperatingSegment_label_en-US" xlink:label="lab_abvx_NumberOfOperatingSegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segment</link:label>
    <link:label id="lab_abvx_NumberOfOperatingSegment_documentation_en-US" xlink:label="lab_abvx_NumberOfOperatingSegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Operating Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOperatingSegment" xlink:href="abvx-20241231.xsd#abvx_NumberOfOperatingSegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfOperatingSegment" xlink:to="lab_abvx_NumberOfOperatingSegment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherAdjustmentsForNoncashItems_1b41865d-adfa-4602-b0e5-14876fc29ae3_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherAdjustmentsForNoncashItems_label_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other adjustments for non-cash items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="lab_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_854ef08a-121a-4f9e-aa17-da90808bd2aa_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_8a0f74b1-ca54-498b-8877-c5a23dcc2a15_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercises of share warrants</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through exercise of warrants, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_f29d05f9-996b-4060-887f-47d0b620efcf_terseLabel_en-US" xlink:label="lab_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of shares to be issued if all conditions are met (in shares)</link:label>
    <link:label id="lab_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_label_en-US" xlink:label="lab_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Number Of Other Equity Instruments To Be Issued In Share-Based Payment Arrangement If All Conditions Are Met</link:label>
    <link:label id="lab_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_documentation_en-US" xlink:label="lab_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Number Of Other Equity Instruments To Be Issued In Share-Based Payment Arrangement If All Conditions Are Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" xlink:to="lab_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_df361984-026e-408b-93de-034c1e136393_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Group</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of general information about financial statements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain_832c4ef5-6a2a-46d8-899a-b5c74149c4cd_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseByNatureAbstract_label_en-US" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expenses by nature [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TransactionCosts_d4f995aa-ead2-42e1-aa80-3414ad6f34a2_negatedLabel_en-US" xlink:label="lab_abvx_TransactionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_abvx_TransactionCosts_label_en-US" xlink:label="lab_abvx_TransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction Costs</link:label>
    <link:label id="lab_abvx_TransactionCosts_documentation_en-US" xlink:label="lab_abvx_TransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TransactionCosts" xlink:href="abvx-20241231.xsd#abvx_TransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TransactionCosts" xlink:to="lab_abvx_TransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_85a51e42-1ac5-4e83-842e-cf28d28935f4_totalLabel_en-US" xlink:label="lab_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total acquisition cost allocated</link:label>
    <link:label id="lab_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration Transferred, Acquisition-Date Fair Value, Assets Acquisitions</link:label>
    <link:label id="lab_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consideration Transferred, Acquisition-Date Fair Value, Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" xlink:to="lab_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1806251c-bf67-4058-8764-bc22d5373878_verboseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade payables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_5371f779-ee4c-45a5-89b3-aec05cb0a24e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of depreciation period of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CashAndCashEquivalentsAssetsAcquisitions_10b827bb-d700-4571-863d-67c41e6de718_terseLabel_en-US" xlink:label="lab_abvx_CashAndCashEquivalentsAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_abvx_CashAndCashEquivalentsAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_CashAndCashEquivalentsAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents, Assets Acquisitions</link:label>
    <link:label id="lab_abvx_CashAndCashEquivalentsAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_CashAndCashEquivalentsAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents, Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_CashAndCashEquivalentsAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions" xlink:to="lab_abvx_CashAndCashEquivalentsAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantUnobservableInputLiabilities_491e285f-418e-4bb2-9a80-1222d3e5a60e_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant unobservable input, liabilities</link:label>
    <link:label id="lab_ifrs-full_SignificantUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_SignificantUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantUnobservableInputLiabilities" xlink:to="lab_ifrs-full_SignificantUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLoss_4a186227-871c-4311-bc13-db8f60b4dc11_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss for the period</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_f3e4639c-1a87-4cfa-8afb-985846585e5f_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss for the period</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_81aac5e4-5ccb-435e-a01c-2d633b50db51_negatedLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_label_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="lab_ifrs-full_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_a0a26c9e-d715-410e-9fef-c20a20ac7539_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_label_en-US" xlink:label="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOffBalanceSheetCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:to="lab_abvx_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_27a6456a-53e9-4e2d-be23-47e53515bc1b_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease_d1d9623b-a35e-4dc9-8a35-02020935dbc9_terseLabel_en-US" xlink:label="lab_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs related to capital increase</link:label>
    <link:label id="lab_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease_label_en-US" xlink:label="lab_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Transaction Costs Related To Capital Increase</link:label>
    <link:label id="lab_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease_documentation_en-US" xlink:label="lab_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Effect Of Transaction Costs Related To Capital Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease" xlink:to="lab_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialAssetsMember_080225a7-69d2-44be-ad60-b95bb98345f4_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial assets</link:label>
    <link:label id="lab_abvx_OtherFinancialAssetsMember_label_en-US" xlink:label="lab_abvx_OtherFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Assets [Member]</link:label>
    <link:label id="lab_abvx_OtherFinancialAssetsMember_documentation_en-US" xlink:label="lab_abvx_OtherFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialAssetsMember" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialAssetsMember" xlink:to="lab_abvx_OtherFinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_329808cd-8296-434d-9c14-bfab34f779e7_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation differences</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of comprehensive income [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsFixedConversionPrice_da2c1245-0a98-49d8-928a-efcff50ee819_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsFixedConversionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, fixed conversion price</link:label>
    <link:label id="lab_abvx_BorrowingsFixedConversionPrice_label_en-US" xlink:label="lab_abvx_BorrowingsFixedConversionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Fixed Conversion Price</link:label>
    <link:label id="lab_abvx_BorrowingsFixedConversionPrice_documentation_en-US" xlink:label="lab_abvx_BorrowingsFixedConversionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Fixed Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsFixedConversionPrice" xlink:href="abvx-20241231.xsd#abvx_BorrowingsFixedConversionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsFixedConversionPrice" xlink:to="lab_abvx_BorrowingsFixedConversionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_9c9033d1-9f03-4958-b071-ad0de817ea4c_terseLabel_en-US" xlink:label="lab_abvx_EquityLineAgreementWithKeplerCheuvreuxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity line agreement with Kepler Cheuvreux</link:label>
    <link:label id="lab_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_label_en-US" xlink:label="lab_abvx_EquityLineAgreementWithKeplerCheuvreuxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Line Agreement With Kepler Cheuvreux [Member]</link:label>
    <link:label id="lab_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_documentation_en-US" xlink:label="lab_abvx_EquityLineAgreementWithKeplerCheuvreuxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Line Agreement With Kepler Cheuvreux</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember" xlink:href="abvx-20241231.xsd#abvx_EquityLineAgreementWithKeplerCheuvreuxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember" xlink:to="lab_abvx_EquityLineAgreementWithKeplerCheuvreuxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProceedsFromResearchTaxCredit_d0d49a18-6684-45dd-b282-e9b50dfabd2c_terseLabel_en-US" xlink:label="lab_abvx_ProceedsFromResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from research tax credit</link:label>
    <link:label id="lab_abvx_ProceedsFromResearchTaxCredit_label_en-US" xlink:label="lab_abvx_ProceedsFromResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Research Tax Credit</link:label>
    <link:label id="lab_abvx_ProceedsFromResearchTaxCredit_documentation_en-US" xlink:label="lab_abvx_ProceedsFromResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Research Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromResearchTaxCredit" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromResearchTaxCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProceedsFromResearchTaxCredit" xlink:to="lab_abvx_ProceedsFromResearchTaxCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments_3df8a70a-00d7-4802-8e78-37ea15de36f3_terseLabel_en-US" xlink:label="lab_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other tax and related payments</link:label>
    <link:label id="lab_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments_label_en-US" xlink:label="lab_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Payables On Other Tax And Related Payments</link:label>
    <link:label id="lab_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments_documentation_en-US" xlink:label="lab_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Payables On Other Tax And Related Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments" xlink:href="abvx-20241231.xsd#abvx_CurrentPayablesOnOtherTaxAndRelatedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments" xlink:to="lab_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesAxis_70b28b96-229b-48bd-856d-c2883c0fe806_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of interest rates [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of interest rates [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis" xlink:to="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NetProceedsFromConvertibleLoansNotes_de69ce37-2b17-423d-b7c6-b2554573e879_terseLabel_en-US" xlink:label="lab_abvx_NetProceedsFromConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from the issuance of convertible bond loans</link:label>
    <link:label id="lab_abvx_NetProceedsFromConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_NetProceedsFromConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Proceeds From Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_NetProceedsFromConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_NetProceedsFromConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Proceeds From Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NetProceedsFromConvertibleLoansNotes" xlink:to="lab_abvx_NetProceedsFromConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_9965d8b7-2bab-4d26-9903-6e62fcde11c2_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TranchesAxis_efc81c82-6230-4097-a42e-b022fbe8feb2_terseLabel_en-US" xlink:label="lab_abvx_TranchesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranches [Axis]</link:label>
    <link:label id="lab_abvx_TranchesAxis_label_en-US" xlink:label="lab_abvx_TranchesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranches [Axis]</link:label>
    <link:label id="lab_abvx_TranchesAxis_documentation_en-US" xlink:label="lab_abvx_TranchesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TranchesAxis" xlink:to="lab_abvx_TranchesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundAbstract_87a28136-0b5a-40f5-a2e1-6c7d7b4e41d0_terseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund) [abstract]</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundAbstract_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_ae23a4de-40af-42c7-8edc-c8233d0c5436_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_327ae43c-d02c-47ed-943d-035b0ce6cf83_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments exercisable (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments exercisable in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SharePremiumMember_5ea3338c-fc7e-469a-b7ec-a6b85ff8c92c_terseLabel_en-US" xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PREMIUMS RELATED TO SHARE CAPITAL</link:label>
    <link:label id="lab_ifrs-full_SharePremiumMember_8a48a0a3-d777-40d1-980c-4006d42ec886_verboseLabel_en-US" xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share premium</link:label>
    <link:label id="lab_ifrs-full_SharePremiumMember_label_en-US" xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share premium [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember" xlink:to="lab_ifrs-full_SharePremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShare_48e1f1cf-ad3d-4747-a648-0e39626de3a1_terseLabel_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted loss per share (in euro per share)</link:label>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShare_label_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdjustmentsForOtherFinanceIncome_053ab374-83cf-4f29-9fd2-df1644bafd59_negatedTerseLabel_en-US" xlink:label="lab_abvx_AdjustmentsForOtherFinanceIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Financial income</link:label>
    <link:label id="lab_abvx_AdjustmentsForOtherFinanceIncome_label_en-US" xlink:label="lab_abvx_AdjustmentsForOtherFinanceIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Other Finance Income</link:label>
    <link:label id="lab_abvx_AdjustmentsForOtherFinanceIncome_documentation_en-US" xlink:label="lab_abvx_AdjustmentsForOtherFinanceIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Other Finance Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForOtherFinanceIncome" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForOtherFinanceIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdjustmentsForOtherFinanceIncome" xlink:to="lab_abvx_AdjustmentsForOtherFinanceIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AgreementPeriod_e468c086-f817-4233-be3e-e28da2e4bab1_terseLabel_en-US" xlink:label="lab_abvx_AgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agreement, period</link:label>
    <link:label id="lab_abvx_AgreementPeriod_label_en-US" xlink:label="lab_abvx_AgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Agreement, Period</link:label>
    <link:label id="lab_abvx_AgreementPeriod_documentation_en-US" xlink:label="lab_abvx_AgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Agreement, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AgreementPeriod" xlink:href="abvx-20241231.xsd#abvx_AgreementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AgreementPeriod" xlink:to="lab_abvx_AgreementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosCBSAMember_25c8e9f9-0173-43fd-bd85-29fa8a3aed08_terseLabel_en-US" xlink:label="lab_abvx_KreosCBSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos C BSA</link:label>
    <link:label id="lab_abvx_KreosCBSAMember_label_en-US" xlink:label="lab_abvx_KreosCBSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos C BSA [Member]</link:label>
    <link:label id="lab_abvx_KreosCBSAMember_documentation_en-US" xlink:label="lab_abvx_KreosCBSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos C BSA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosCBSAMember" xlink:to="lab_abvx_KreosCBSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_44f9829d-169c-4a2e-8c27-a515b4eac1da_terseLabel_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax losses carryforward</link:label>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_label_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused tax losses [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesMember" xlink:to="lab_ifrs-full_UnusedTaxLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_68bcd2a8-142f-4149-abe8-381bc6eed52a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting principles</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of material accounting policy information [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingServiceConditionsAxis_0eaac74d-3d8d-4e0e-8153-1e20859cce9e_terseLabel_en-US" xlink:label="lab_abvx_VestingServiceConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Service Conditions [Axis]</link:label>
    <link:label id="lab_abvx_VestingServiceConditionsAxis_label_en-US" xlink:label="lab_abvx_VestingServiceConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Service Conditions [Axis]</link:label>
    <link:label id="lab_abvx_VestingServiceConditionsAxis_documentation_en-US" xlink:label="lab_abvx_VestingServiceConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Service Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingServiceConditionsAxis" xlink:href="abvx-20241231.xsd#abvx_VestingServiceConditionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingServiceConditionsAxis" xlink:to="lab_abvx_VestingServiceConditionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_5652fc9a-3639-4a40-beb9-9e8693061ec2_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfOperatingIncomeLineItems_c1108d4d-b199-4211-b610-fbc9bc8df508_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfOperatingIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Income [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfOperatingIncomeLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfOperatingIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Income [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfOperatingIncomeLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfOperatingIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOperatingIncomeLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOperatingIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfOperatingIncomeLineItems" xlink:to="lab_abvx_DisclosureOfOperatingIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseIntangibleAssetsOtherThanGoodwill_d5083ea6-ad0c-4ced-b51f-084ff2275d7d_terseLabel_en-US" xlink:label="lab_abvx_IncreaseIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase</link:label>
    <link:label id="lab_abvx_IncreaseIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_abvx_IncreaseIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase, Intangible Assets Other Than Goodwill</link:label>
    <link:label id="lab_abvx_IncreaseIntangibleAssetsOtherThanGoodwill_documentation_en-US" xlink:label="lab_abvx_IncreaseIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase, Intangible Assets Other Than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseIntangibleAssetsOtherThanGoodwill" xlink:href="abvx-20241231.xsd#abvx_IncreaseIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseIntangibleAssetsOtherThanGoodwill" xlink:to="lab_abvx_IncreaseIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheBMember_0162e2a9-687c-4b2d-9074-239b66bcd245_terseLabel_en-US" xlink:label="lab_abvx_TrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche B</link:label>
    <link:label id="lab_abvx_TrancheBMember_label_en-US" xlink:label="lab_abvx_TrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche B [Member]</link:label>
    <link:label id="lab_abvx_TrancheBMember_documentation_en-US" xlink:label="lab_abvx_TrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheBMember" xlink:href="abvx-20241231.xsd#abvx_TrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheBMember" xlink:to="lab_abvx_TrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdjustmentsForOtherFinanceCosts_c6b0ee85-757a-496f-b96e-0e180d389a1e_terseLabel_en-US" xlink:label="lab_abvx_AdjustmentsForOtherFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expenses and other financial expenses</link:label>
    <link:label id="lab_abvx_AdjustmentsForOtherFinanceCosts_label_en-US" xlink:label="lab_abvx_AdjustmentsForOtherFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Other Finance Costs</link:label>
    <link:label id="lab_abvx_AdjustmentsForOtherFinanceCosts_documentation_en-US" xlink:label="lab_abvx_AdjustmentsForOtherFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Other Finance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForOtherFinanceCosts" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForOtherFinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdjustmentsForOtherFinanceCosts" xlink:to="lab_abvx_AdjustmentsForOtherFinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities_6e86f6e8-0142-436a-8486-572313019ca1_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash changes: recognition of earn-out liability</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Recognition of Earn Out Liability, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Recognition of Earn Out Liability, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_b9e2c45d-70c8-4073-b668-c885c6bab6f3_terseLabel_en-US" xlink:label="lab_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, percentage of 15-day WVAP</link:label>
    <link:label id="lab_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price, Percentage Of 15-Day WVAP, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price, Percentage Of 15-Day WVAP, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" xlink:to="lab_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UndrawnBorrowingFacilities_72c6a3bf-ee69-4a7f-96f0-1c24b5952c5b_terseLabel_en-US" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Undrawn borrowing facilities</link:label>
    <link:label id="lab_ifrs-full_UndrawnBorrowingFacilities_label_en-US" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undrawn borrowing facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndrawnBorrowingFacilities" xlink:to="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfSharesSubscribedPerWarrant_eb71bed6-889c-42df-b2e3-f8bc62d6b724_terseLabel_en-US" xlink:label="lab_abvx_NumberOfSharesSubscribedPerWarrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares subscribed per warrant (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfSharesSubscribedPerWarrant_label_en-US" xlink:label="lab_abvx_NumberOfSharesSubscribedPerWarrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Shares Subscribed Per Warrant</link:label>
    <link:label id="lab_abvx_NumberOfSharesSubscribedPerWarrant_documentation_en-US" xlink:label="lab_abvx_NumberOfSharesSubscribedPerWarrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Shares Subscribed Per Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesSubscribedPerWarrant" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesSubscribedPerWarrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfSharesSubscribedPerWarrant" xlink:to="lab_abvx_NumberOfSharesSubscribedPerWarrant" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20171Member_1f2042a0-08c2-47af-92a8-beff16587ee1_terseLabel_en-US" xlink:label="lab_abvx_BCE20171Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2017-1</link:label>
    <link:label id="lab_abvx_BCE20171Member_label_en-US" xlink:label="lab_abvx_BCE20171Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2017-1 [Member]</link:label>
    <link:label id="lab_abvx_BCE20171Member_documentation_en-US" xlink:label="lab_abvx_BCE20171Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2017-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20171Member" xlink:href="abvx-20241231.xsd#abvx_BCE20171Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20171Member" xlink:to="lab_abvx_BCE20171Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfFreeSharesIssued_b76e4753-c748-458e-b343-2b4d20364b03_terseLabel_en-US" xlink:label="lab_abvx_NumberOfFreeSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of free shares (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfFreeSharesIssued_label_en-US" xlink:label="lab_abvx_NumberOfFreeSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Free Shares Issued</link:label>
    <link:label id="lab_abvx_NumberOfFreeSharesIssued_documentation_en-US" xlink:label="lab_abvx_NumberOfFreeSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Free Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesIssued" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfFreeSharesIssued" xlink:to="lab_abvx_NumberOfFreeSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsInterestRateForFollowingInstallments_a8a81629-7005-47c9-8f52-434a865765cd_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsInterestRateForFollowingInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate for following installments</link:label>
    <link:label id="lab_abvx_BorrowingsInterestRateForFollowingInstallments_label_en-US" xlink:label="lab_abvx_BorrowingsInterestRateForFollowingInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Interest Rate For Following Installments</link:label>
    <link:label id="lab_abvx_BorrowingsInterestRateForFollowingInstallments_documentation_en-US" xlink:label="lab_abvx_BorrowingsInterestRateForFollowingInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Interest Rate For Following Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsInterestRateForFollowingInstallments" xlink:href="abvx-20241231.xsd#abvx_BorrowingsInterestRateForFollowingInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsInterestRateForFollowingInstallments" xlink:to="lab_abvx_BorrowingsInterestRateForFollowingInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FixturesAndFittingsMember_09d74c29-186b-45e8-89ff-1c106129f678_terseLabel_en-US" xlink:label="lab_ifrs-full_FixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office fixtures and fittings</link:label>
    <link:label id="lab_ifrs-full_FixturesAndFittingsMember_label_en-US" xlink:label="lab_ifrs-full_FixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fixtures and fittings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember" xlink:to="lab_ifrs-full_FixturesAndFittingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock_bf8ae12b-0970-4a03-ab92-2ca5628ad47e_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, 2023</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For New Standards, Amendments And Interpretations Issued By IASB But Not Yet Mandatory [Policy Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For New Standards, Amendments And For Financial Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" xlink:to="lab_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod_4b21bece-e190-45f7-9ec4-e484bae66205_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting service period</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, Period</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EquityIssuanceSubscriptionPricePerShare_1f225adf-4e54-4f83-b5db-ae83a55dfba3_terseLabel_en-US" xlink:label="lab_abvx_EquityIssuanceSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity issuance, subscripion price per share (in euro per share)</link:label>
    <link:label id="lab_abvx_EquityIssuanceSubscriptionPricePerShare_label_en-US" xlink:label="lab_abvx_EquityIssuanceSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Issuance, Subscription Price Per Share</link:label>
    <link:label id="lab_abvx_EquityIssuanceSubscriptionPricePerShare_documentation_en-US" xlink:label="lab_abvx_EquityIssuanceSubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Issuance, Subscription Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EquityIssuanceSubscriptionPricePerShare" xlink:to="lab_abvx_EquityIssuanceSubscriptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20184Member_d59376a7-3211-48aa-869a-30a93e7b7121_terseLabel_en-US" xlink:label="lab_abvx_BCE20184Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2018-4</link:label>
    <link:label id="lab_abvx_BCE20184Member_label_en-US" xlink:label="lab_abvx_BCE20184Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2018-4 [Member]</link:label>
    <link:label id="lab_abvx_BCE20184Member_documentation_en-US" xlink:label="lab_abvx_BCE20184Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2018-4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20184Member" xlink:href="abvx-20241231.xsd#abvx_BCE20184Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20184Member" xlink:to="lab_abvx_BCE20184Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfTreasurySharesHeld_98965db6-1e00-4164-b3ef-439aa02c3699_terseLabel_en-US" xlink:label="lab_abvx_NumberOfTreasurySharesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of treasury shares held (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfTreasurySharesHeld_label_en-US" xlink:label="lab_abvx_NumberOfTreasurySharesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Treasury Shares Held</link:label>
    <link:label id="lab_abvx_NumberOfTreasurySharesHeld_documentation_en-US" xlink:label="lab_abvx_NumberOfTreasurySharesHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Treasury Shares Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfTreasurySharesHeld" xlink:href="abvx-20241231.xsd#abvx_NumberOfTreasurySharesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfTreasurySharesHeld" xlink:to="lab_abvx_NumberOfTreasurySharesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_9e1b51de-1531-47f9-b75d-2fb510d2b8a7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_9abb47c2-f3c2-4be8-b401-a960e206ccdd_verboseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SaleOfStockAxis_839bd28a-70c3-420b-9d33-649aa36f2d5e_terseLabel_en-US" xlink:label="lab_abvx_SaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale Of Stock [Axis]</link:label>
    <link:label id="lab_abvx_SaleOfStockAxis_label_en-US" xlink:label="lab_abvx_SaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock [Axis]</link:label>
    <link:label id="lab_abvx_SaleOfStockAxis_documentation_en-US" xlink:label="lab_abvx_SaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockAxis" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SaleOfStockAxis" xlink:to="lab_abvx_SaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_b4151031-dc87-4714-bcfa-2e26c19f9fc1_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of intangible assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_11100b8a-3dc1-45fc-a434-db8afe7d69ff_terseLabel_en-US" xlink:label="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables and assets</link:label>
    <link:label id="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_6f89e066-ddd4-4a8c-a2be-d9ff4ea4664f_totalLabel_en-US" xlink:label="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current other receivables and assets</link:label>
    <link:label id="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_label_en-US" xlink:label="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CurrentReceivablesAndCurrentPrepaidExpenses</link:label>
    <link:label id="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_documentation_en-US" xlink:label="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CurrentReceivablesAndCurrentPrepaidExpenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesAndCurrentPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses" xlink:to="lab_abvx_CurrentReceivablesAndCurrentPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansTrancheBMember_b9f1ec23-5829-47d9-aa18-f766eb3c5fad_terseLabel_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 1, convertible bond loans, tranche B</link:label>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansTrancheBMember_label_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1, Convertible Bond Loans, Tranche B [Member]</link:label>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansTrancheBMember_documentation_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1, Convertible Bond Loans, Tranche B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember" xlink:to="lab_abvx_Kreos1ConvertibleBondLoansTrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EmployeeMember_60d22b34-d5ac-4caf-814e-654433d1a0ff_terseLabel_en-US" xlink:label="lab_abvx_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_abvx_EmployeeMember_label_en-US" xlink:label="lab_abvx_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee [Member]</link:label>
    <link:label id="lab_abvx_EmployeeMember_documentation_en-US" xlink:label="lab_abvx_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EmployeeMember" xlink:href="abvx-20241231.xsd#abvx_EmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EmployeeMember" xlink:to="lab_abvx_EmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCurrentFinancialLiabilities_1cbbc11d-c522-4ee5-95bd-556ceb5e00bc_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial liabilities</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_OtherCurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentFinancialLiabilities" xlink:to="lab_ifrs-full_OtherCurrentFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_8851da90-9d1a-4f96-8f8c-1e513244eecd_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for deferred income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseLiabilityPercentageOfTotal_1ef6eca0-aed2-445c-a1b1-6f48d2e955bd_terseLabel_en-US" xlink:label="lab_abvx_LeaseLiabilityPercentageOfTotal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability, percentage of total</link:label>
    <link:label id="lab_abvx_LeaseLiabilityPercentageOfTotal_label_en-US" xlink:label="lab_abvx_LeaseLiabilityPercentageOfTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liability, Percentage Of Total</link:label>
    <link:label id="lab_abvx_LeaseLiabilityPercentageOfTotal_documentation_en-US" xlink:label="lab_abvx_LeaseLiabilityPercentageOfTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Liability, Percentage Of Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseLiabilityPercentageOfTotal" xlink:href="abvx-20241231.xsd#abvx_LeaseLiabilityPercentageOfTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseLiabilityPercentageOfTotal" xlink:to="lab_abvx_LeaseLiabilityPercentageOfTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentFinancialLiabilities_dca069fd-6212-4763-8696-b1605ebb0b81_verboseLabel_en-US" xlink:label="lab_ifrs-full_CurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current financial liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentFinancialLiabilities" xlink:to="lab_ifrs-full_CurrentFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OffBalanceSheetCommitmentsAbstract_label_en-US" xlink:label="lab_abvx_OffBalanceSheetCommitmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Off-Balance Sheet Commitments [Abstract]</link:label>
    <link:label id="lab_abvx_OffBalanceSheetCommitmentsAbstract_documentation_en-US" xlink:label="lab_abvx_OffBalanceSheetCommitmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Off-Balance Sheet Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OffBalanceSheetCommitmentsAbstract" xlink:href="abvx-20241231.xsd#abvx_OffBalanceSheetCommitmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OffBalanceSheetCommitmentsAbstract" xlink:to="lab_abvx_OffBalanceSheetCommitmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PrincipalAgreementsAxis_dc7179b2-b7f7-4f06-b7c2-efb6fc6edd20_terseLabel_en-US" xlink:label="lab_abvx_PrincipalAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Agreements [Axis]</link:label>
    <link:label id="lab_abvx_PrincipalAgreementsAxis_label_en-US" xlink:label="lab_abvx_PrincipalAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Agreements [Axis]</link:label>
    <link:label id="lab_abvx_PrincipalAgreementsAxis_documentation_en-US" xlink:label="lab_abvx_PrincipalAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsAxis" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PrincipalAgreementsAxis" xlink:to="lab_abvx_PrincipalAgreementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnderwritingAgreementExtendedPeriod_ba7a2467-c47c-496d-9c9c-1f254c408463_terseLabel_en-US" xlink:label="lab_abvx_UnderwritingAgreementExtendedPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extended period</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementExtendedPeriod_label_en-US" xlink:label="lab_abvx_UnderwritingAgreementExtendedPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Extended Period</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementExtendedPeriod_documentation_en-US" xlink:label="lab_abvx_UnderwritingAgreementExtendedPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Extended Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementExtendedPeriod" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementExtendedPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnderwritingAgreementExtendedPeriod" xlink:to="lab_abvx_UnderwritingAgreementExtendedPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_73f09272-7a1a-49c5-a663-c0aaa30a63b2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of aggregate compensation of the members of the Group&#8217;s Board of Directors and CEO</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingConditionsCompletedMember_c26bc52b-6da6-4510-9459-07f1f1a8f98b_terseLabel_en-US" xlink:label="lab_abvx_VestingConditionsCompletedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting conditions completed</link:label>
    <link:label id="lab_abvx_VestingConditionsCompletedMember_label_en-US" xlink:label="lab_abvx_VestingConditionsCompletedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Conditions Completed [Member]</link:label>
    <link:label id="lab_abvx_VestingConditionsCompletedMember_documentation_en-US" xlink:label="lab_abvx_VestingConditionsCompletedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Conditions Completed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingConditionsCompletedMember" xlink:href="abvx-20241231.xsd#abvx_VestingConditionsCompletedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingConditionsCompletedMember" xlink:to="lab_abvx_VestingConditionsCompletedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_e6532a97-1b51-4396-b571-80222391bc0f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of changes in projected benefit obligation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9d38f925-359b-40c6-bb23-c571ec056152_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod_a6e3f1a1-3bf5-4028-9ffd-1e24409dfbcf_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service period</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Service Period</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_After24MonthsMember_5e670337-b4df-4a55-b6ca-e6721c86b8e0_terseLabel_en-US" xlink:label="lab_abvx_After24MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After 24 months</link:label>
    <link:label id="lab_abvx_After24MonthsMember_label_en-US" xlink:label="lab_abvx_After24MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">After 24 Months [Member]</link:label>
    <link:label id="lab_abvx_After24MonthsMember_documentation_en-US" xlink:label="lab_abvx_After24MonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">After 24 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After24MonthsMember" xlink:href="abvx-20241231.xsd#abvx_After24MonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_After24MonthsMember" xlink:to="lab_abvx_After24MonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OrdinarySharesNASDAQGlobalMarketMember_8b88f414-0bc5-4d16-b211-e26689736a76_terseLabel_en-US" xlink:label="lab_abvx_OrdinarySharesNASDAQGlobalMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, nominal value &#8364;0.01 per share</link:label>
    <link:label id="lab_abvx_OrdinarySharesNASDAQGlobalMarketMember_label_en-US" xlink:label="lab_abvx_OrdinarySharesNASDAQGlobalMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary Shares, NASDAQ Global Market [Member]</link:label>
    <link:label id="lab_abvx_OrdinarySharesNASDAQGlobalMarketMember_documentation_en-US" xlink:label="lab_abvx_OrdinarySharesNASDAQGlobalMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ordinary Shares, NASDAQ Global Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OrdinarySharesNASDAQGlobalMarketMember" xlink:href="abvx-20241231.xsd#abvx_OrdinarySharesNASDAQGlobalMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OrdinarySharesNASDAQGlobalMarketMember" xlink:to="lab_abvx_OrdinarySharesNASDAQGlobalMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_c41176be-efe0-49cf-9e97-5dfa2c5c8613_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments of the lease liabilities</link:label>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_35ce22c9-14ff-4bf2-ba78-0e522777f753_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_4427ca4c-2fef-4150-b2ef-8004078c498e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Off-balance sheet commitments received and contingent assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions, contingent liabilities and contingent assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForOtherServices_ed889aa8-0f50-40de-bb3f-c84c78303611_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other procedures required by law</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForOtherServices_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor's remuneration for other services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForOtherServices" xlink:to="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarnOutAtFairValue_5b85b632-4393-4364-a4ee-e7c1911db0d1_terseLabel_en-US" xlink:label="lab_abvx_EarnOutAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of earn-out liability</link:label>
    <link:label id="lab_abvx_EarnOutAtFairValue_label_en-US" xlink:label="lab_abvx_EarnOutAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earn-Out At Fair Value</link:label>
    <link:label id="lab_abvx_EarnOutAtFairValue_documentation_en-US" xlink:label="lab_abvx_EarnOutAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earn-Out At Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValue" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarnOutAtFairValue" xlink:to="lab_abvx_EarnOutAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_82d344b2-c3a4-4176-aa0f-931d9631ec43_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis" xlink:to="lab_ifrs-full_GeographicalAreasAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_0291a39c-03d8-41b0-b2a3-80d7d7834609_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and other current liabilities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestRateMeasurementInputMember_9cf74ca2-c2ce-4f19-a6cf-2a9d282b948a_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_ifrs-full_InterestRateMeasurementInputMember_label_en-US" xlink:label="lab_ifrs-full_InterestRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest rate, measurement input [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateMeasurementInputMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestRateMeasurementInputMember" xlink:to="lab_ifrs-full_InterestRateMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CIRTaxYearDomain_0d35d15d-7cf3-450f-94db-3088d9634a8d_terseLabel_en-US" xlink:label="lab_abvx_CIRTaxYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CIR Tax Year [Domain]</link:label>
    <link:label id="lab_abvx_CIRTaxYearDomain_label_en-US" xlink:label="lab_abvx_CIRTaxYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIR Tax Year [Domain]</link:label>
    <link:label id="lab_abvx_CIRTaxYearDomain_documentation_en-US" xlink:label="lab_abvx_CIRTaxYearDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CIR Tax Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CIRTaxYearDomain" xlink:href="abvx-20241231.xsd#abvx_CIRTaxYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CIRTaxYearDomain" xlink:to="lab_abvx_CIRTaxYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAssets_e79adb67-1f7a-45f8-8c2e-9c6b8c5d3b21_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssets_label_en-US" xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="lab_ifrs-full_CurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfContractsAxis_a529a680-24c6-4d4a-b401-0d9428e00c62_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfContractsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of contracts [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfContractsAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfContractsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of contracts [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfContractsAxis" xlink:to="lab_ifrs-full_TypesOfContractsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_9875ec8f-10f6-4975-a3d6-c5c42ba0e969_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity_cb948bf4-a9f7-4891-a21b-d6b939c78d8c_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of share warrants</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Issuance of Warrants, Equity</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Issuance of Warrants, Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity" xlink:to="lab_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentFinancialLiabilities_bc51a8c8-10d9-44d9-905f-4d5befaf4759_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-current financial liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinancialLiabilities" xlink:to="lab_ifrs-full_NoncurrentFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_947544f3-cec0-4e63-9ecb-b0737a04b937_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments issued (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5377bb83-ad76-4346-9aae-6c01b1abfa71_verboseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">NUMBE OF BSAs ( in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_de57e02a-a895-412e-9de5-fd346792c74d_terseLabel_en-US" xlink:label="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loan notes</link:label>
    <link:label id="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_fcc53b0a-ad96-4ff0-95a8-4e85eba9626e_verboseLabel_en-US" xlink:label="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current convertible loans notes</link:label>
    <link:label id="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Portion Of Non-Current Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Portion Of Non-Current Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" xlink:to="lab_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RepaymentsOfPGE_57f116d7-66f3-4fcb-8910-44fe8fd26d1a_negatedTerseLabel_en-US" xlink:label="lab_abvx_RepaymentsOfPGE" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of PGE</link:label>
    <link:label id="lab_abvx_RepaymentsOfPGE_label_en-US" xlink:label="lab_abvx_RepaymentsOfPGE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments Of PGE</link:label>
    <link:label id="lab_abvx_RepaymentsOfPGE_documentation_en-US" xlink:label="lab_abvx_RepaymentsOfPGE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repayments Of PGE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfPGE" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfPGE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RepaymentsOfPGE" xlink:to="lab_abvx_RepaymentsOfPGE" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherCurrentPayablesIncludingAdjustments_0094b983-2104-4255-a05f-df6bd843ea67_terseLabel_en-US" xlink:label="lab_abvx_OtherCurrentPayablesIncludingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_abvx_OtherCurrentPayablesIncludingAdjustments_label_en-US" xlink:label="lab_abvx_OtherCurrentPayablesIncludingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Payables, Including Adjustments</link:label>
    <link:label id="lab_abvx_OtherCurrentPayablesIncludingAdjustments_documentation_en-US" xlink:label="lab_abvx_OtherCurrentPayablesIncludingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Current Payables, Including Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherCurrentPayablesIncludingAdjustments" xlink:href="abvx-20241231.xsd#abvx_OtherCurrentPayablesIncludingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherCurrentPayablesIncludingAdjustments" xlink:to="lab_abvx_OtherCurrentPayablesIncludingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued_d5d356c1-b99a-4c28-bcbd-0bfdd0fd2778_terseLabel_en-US" xlink:label="lab_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of shares issued (in shares)</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued_label_en-US" xlink:label="lab_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Maximum Number Of Shares Issued</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued_documentation_en-US" xlink:label="lab_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Maximum Number Of Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementMaximumNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued" xlink:to="lab_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_HeightsConvertibleNotesTrancheBMember_77771ffa-d766-4ba4-a14f-1e561c1bc50c_terseLabel_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Heights convertible notes, tranche B</link:label>
    <link:label id="lab_abvx_HeightsConvertibleNotesTrancheBMember_label_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Heights Convertible Notes, Tranche B [Member]</link:label>
    <link:label id="lab_abvx_HeightsConvertibleNotesTrancheBMember_documentation_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Heights Convertible Notes, Tranche B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheBMember" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_HeightsConvertibleNotesTrancheBMember" xlink:to="lab_abvx_HeightsConvertibleNotesTrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsDomain_487116a5-8331-4d7c-9605-7cfe84ea33e8_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial assets [domain]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_e815dc68-527a-4af6-9c26-84586bf010c5_terseLabel_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in property, plant and equipment [abstract]</link:label>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in property, plant and equipment [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_a9282480-8ec1-4016-bfc4-c03f8a3c6433_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_label_en-US" xlink:label="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:to="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpectedDividendMeasurementInputMember_8c50909a-c2ce-4b3e-9f16-5082a3625e77_terseLabel_en-US" xlink:label="lab_abvx_ExpectedDividendMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend</link:label>
    <link:label id="lab_abvx_ExpectedDividendMeasurementInputMember_label_en-US" xlink:label="lab_abvx_ExpectedDividendMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Dividend, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_ExpectedDividendMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_ExpectedDividendMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected Dividend, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpectedDividendMeasurementInputMember" xlink:to="lab_abvx_ExpectedDividendMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock_1e1898cd-238c-49b9-b214-97b045be1da2_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of conditions for conditional loans notes drawdown</link:label>
    <link:label id="lab_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Conditions For Conditional Loans Notes Drawdown [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Conditions For Conditional Loans Notes Drawdown</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" xlink:to="lab_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_350b587b-aa3a-4d6c-9bdf-3007313bdd60_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AssetsRecognisedAsOfAcquisitionDate_3f31e206-e148-4c9f-947e-27a14d7afa71_totalLabel_en-US" xlink:label="lab_abvx_AssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_abvx_AssetsRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_abvx_AssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Recognised As Of Acquisition Date</link:label>
    <link:label id="lab_abvx_AssetsRecognisedAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_abvx_AssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets Recognised As Of Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsRecognisedAsOfAcquisitionDate" xlink:href="abvx-20241231.xsd#abvx_AssetsRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AssetsRecognisedAsOfAcquisitionDate" xlink:to="lab_abvx_AssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_37ac0922-ac00-4766-ad26-9bdd20023034_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpiryScenarioProbablityMeasurementInputMember_e3eb2690-f5c3-43aa-be4c-abb4c2838b79_terseLabel_en-US" xlink:label="lab_abvx_ExpiryScenarioProbablityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">7-year expiry scenario probability</link:label>
    <link:label id="lab_abvx_ExpiryScenarioProbablityMeasurementInputMember_label_en-US" xlink:label="lab_abvx_ExpiryScenarioProbablityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expiry Scenario Probablity, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_ExpiryScenarioProbablityMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_ExpiryScenarioProbablityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expiry Scenario Probablity, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioProbablityMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember" xlink:to="lab_abvx_ExpiryScenarioProbablityMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2_a1566e0f-0e1a-44cd-b62b-de1b4b708615_terseLabel_en-US" xlink:label="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration agreements, development milestone payment, Phase 2</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2_label_en-US" xlink:label="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Development Milestone Payment, Phase 2</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2_documentation_en-US" xlink:label="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Development Milestone Payment, Phase 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2" xlink:to="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos1NonConvertibleBondLoansMember_7fad15e5-b42c-4845-82a5-fa0cf6881e76_terseLabel_en-US" xlink:label="lab_abvx_Kreos1NonConvertibleBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 1, non-convertible bond loans</link:label>
    <link:label id="lab_abvx_Kreos1NonConvertibleBondLoansMember_label_en-US" xlink:label="lab_abvx_Kreos1NonConvertibleBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1, Non-Convertible Bond Loans [Member]</link:label>
    <link:label id="lab_abvx_Kreos1NonConvertibleBondLoansMember_documentation_en-US" xlink:label="lab_abvx_Kreos1NonConvertibleBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1, Non-Convertible Bond Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1NonConvertibleBondLoansMember" xlink:href="abvx-20241231.xsd#abvx_Kreos1NonConvertibleBondLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos1NonConvertibleBondLoansMember" xlink:to="lab_abvx_Kreos1NonConvertibleBondLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d5d1608c-0848-4972-8499-2d0f1945b59c_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_9c75e082-8da2-4aed-87f6-572807da70da_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for leases [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs_17f551b2-e7ef-45fb-a444-7f5170bc79fd_terseLabel_en-US" xlink:label="lab_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of unwinding the discount related to advances made to CROs</link:label>
    <link:label id="lab_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs_label_en-US" xlink:label="lab_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unwinding Effect Of Discount Related To Advances Made To CROs</link:label>
    <link:label id="lab_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs_documentation_en-US" xlink:label="lab_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unwinding Effect Of Discount Related To Advances Made To CROs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" xlink:href="abvx-20241231.xsd#abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" xlink:to="lab_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember_19901e36-2700-417d-8f70-7ecb23941af6_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy</link:label>
    <link:label id="lab_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember_label_en-US" xlink:label="lab_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lab_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_56956b25-905f-4399-8965-3ec295d6ed3e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_5a6d3d49-e485-4cf6-9a11-48e5acb1b1a2_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsEarlyRepaymentDiscountRate_6b5c2e67-c792-4bd4-99f8-f9e091bbd634_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsEarlyRepaymentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, early repayment, discount rate</link:label>
    <link:label id="lab_abvx_BorrowingsEarlyRepaymentDiscountRate_label_en-US" xlink:label="lab_abvx_BorrowingsEarlyRepaymentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Early Repayment, Discount Rate</link:label>
    <link:label id="lab_abvx_BorrowingsEarlyRepaymentDiscountRate_documentation_en-US" xlink:label="lab_abvx_BorrowingsEarlyRepaymentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Early Repayment, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsEarlyRepaymentDiscountRate" xlink:href="abvx-20241231.xsd#abvx_BorrowingsEarlyRepaymentDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsEarlyRepaymentDiscountRate" xlink:to="lab_abvx_BorrowingsEarlyRepaymentDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMember_9a09c61f-2a81-4101-87ce-6e8ddee77b71_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial liabilities</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMember_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities [Member]</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesMember_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMember" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesMember" xlink:to="lab_abvx_OtherFinancialLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAssetsAbstract_c0e533a8-ad3c-44fe-b9c9-ac13ee3ec766_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract" xlink:to="lab_ifrs-full_CurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_840ca5f1-6ea2-4e88-a8c9-7bbd24426b28_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee-related payables</link:label>
    <link:label id="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_label_en-US" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term employee benefits accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesDomain_c330294b-c86f-4ef7-918d-638b6e7144b4_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of related parties [domain]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of related parties [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueAbstract_label_en-US" xlink:label="lab_ifrs-full_RevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueAbstract" xlink:to="lab_ifrs-full_RevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember_4566695c-4904-40f1-aca0-00fd3a22a337_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial liabilities</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities Related Temporary Differences [Member]</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities Related Temporary Differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" xlink:to="lab_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72a2a4ef-9015-4bc8-bfa5-8210fee2da04_terseLabel_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_label_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AccountingPrinciplesAbstract_5ab2af80-f531-4754-a7a1-1aeb21cf5746_terseLabel_en-US" xlink:label="lab_abvx_AccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Principles [Abstract]</link:label>
    <link:label id="lab_abvx_AccountingPrinciplesAbstract_label_en-US" xlink:label="lab_abvx_AccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Principles [Abstract]</link:label>
    <link:label id="lab_abvx_AccountingPrinciplesAbstract_documentation_en-US" xlink:label="lab_abvx_AccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounting Principles [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AccountingPrinciplesAbstract" xlink:to="lab_abvx_AccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_2cbac584-518d-4938-90e6-60e356a3fcc0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of main data and assumptions used for the measurement of other equity instruments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, other equity instruments granted during period [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_1d082fbc-aa72-4b6b-9944-26dc880de936_terseLabel_en-US" xlink:label="lab_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets, Assets Acquisitions</link:label>
    <link:label id="lab_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets, Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions" xlink:to="lab_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_aee655f2-9931-4b27-b773-278697ab38e4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_7f092060-0d21-4be2-8a98-470109bfd398_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConditionalAdvancesUndiscountedCashFlows_7ed44522-df96-49e6-a6bc-e1c8c2f14e72_terseLabel_en-US" xlink:label="lab_abvx_ConditionalAdvancesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conditional advances, undiscounted cash flows</link:label>
    <link:label id="lab_abvx_ConditionalAdvancesUndiscountedCashFlows_label_en-US" xlink:label="lab_abvx_ConditionalAdvancesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conditional Advances, Undiscounted Cash Flows</link:label>
    <link:label id="lab_abvx_ConditionalAdvancesUndiscountedCashFlows_documentation_en-US" xlink:label="lab_abvx_ConditionalAdvancesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conditional Advances, Undiscounted Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesUndiscountedCashFlows" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConditionalAdvancesUndiscountedCashFlows" xlink:to="lab_abvx_ConditionalAdvancesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock_c6357de4-e188-4714-96df-4784e4937084_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of changes in derivative instruments</link:label>
    <link:label id="lab_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Changes In Derivative Financial Instruments [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Changes In Derivative Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" xlink:to="lab_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherEquityAgreementsMember_8da281ec-fc29-4de7-a279-f04490c9fed3_terseLabel_en-US" xlink:label="lab_abvx_OtherEquityAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other equity agreement</link:label>
    <link:label id="lab_abvx_OtherEquityAgreementsMember_label_en-US" xlink:label="lab_abvx_OtherEquityAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Equity Agreements [Member]</link:label>
    <link:label id="lab_abvx_OtherEquityAgreementsMember_documentation_en-US" xlink:label="lab_abvx_OtherEquityAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Equity Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEquityAgreementsMember" xlink:href="abvx-20241231.xsd#abvx_OtherEquityAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherEquityAgreementsMember" xlink:to="lab_abvx_OtherEquityAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_f7f29b37-e580-4655-bf90-b0bea96bc0ae_terseLabel_en-US" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PATENTS</link:label>
    <link:label id="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_label_en-US" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Copyrights, patents and other industrial property rights, service and operating rights [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:to="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_299d4da4-609e-4695-9b59-b381eff105b1_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Period</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_4660c286-ba1f-45b4-a26e-aa5caa2c0134_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, adjustment to interest rate basis</link:label>
    <link:label id="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_label_en-US" xlink:label="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, adjustment to interest rate basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:to="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_ceb2201d-fc9a-4cd9-a836-bbfcd73ab06d_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits</link:label>
    <link:label id="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term deposits, not classified as cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:to="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherLongtermProvisions_cfeeeca9-1774-4fe0-b02a-dc49fc14d0ec_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherLongtermProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_ifrs-full_OtherLongtermProvisions_label_en-US" xlink:label="lab_ifrs-full_OtherLongtermProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherLongtermProvisions" xlink:to="lab_ifrs-full_OtherLongtermProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_0a2637b9-bcbb-40c2-bd78-07009870711d_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [table]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_db52103d-648a-4aad-9423-d8b70c0bb67f_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments lapsed (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_5908848b-bf2d-4fc1-a3e4-af5f73710d32_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments lapsed (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments expired in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock_a1fa792f-01e8-4507-b583-f895d1503bc0_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of principal audit fees and services</link:label>
    <link:label id="lab_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Principal Audit Fees And Services [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Principal Audit Fees And Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" xlink:to="lab_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod_f8b6da66-70d7-449d-a599-bf979716da42_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual revenue from sale of products developed, period</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Annual Revenue From Sale Of Products Developed, Period</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Annual Revenue From Sale Of Products Developed, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" xlink:to="lab_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_After18MonthsMember_66ce553e-43cd-433d-9446-073ceff27dd7_terseLabel_en-US" xlink:label="lab_abvx_After18MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After 18 months</link:label>
    <link:label id="lab_abvx_After18MonthsMember_label_en-US" xlink:label="lab_abvx_After18MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">After 18 Months [Member]</link:label>
    <link:label id="lab_abvx_After18MonthsMember_documentation_en-US" xlink:label="lab_abvx_After18MonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">After 18 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After18MonthsMember" xlink:href="abvx-20241231.xsd#abvx_After18MonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_After18MonthsMember" xlink:to="lab_abvx_After18MonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConditionalAdvances_5ee9ca71-8c86-45a6-a7eb-ee2f7979f1ff_terseLabel_en-US" xlink:label="lab_abvx_ConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conditional advances</link:label>
    <link:label id="lab_abvx_ConditionalAdvances_label_en-US" xlink:label="lab_abvx_ConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conditional Advances</link:label>
    <link:label id="lab_abvx_ConditionalAdvances_documentation_en-US" xlink:label="lab_abvx_ConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conditional Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConditionalAdvances" xlink:to="lab_abvx_ConditionalAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MachineryMember_1d3c3cc2-55cb-4c39-9e4b-a4819b72332d_terseLabel_en-US" xlink:label="lab_ifrs-full_MachineryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EQUIPMENT</link:label>
    <link:label id="lab_ifrs-full_MachineryMember_label_en-US" xlink:label="lab_ifrs-full_MachineryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MachineryMember" xlink:to="lab_ifrs-full_MachineryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAndLiabilities_886c2fc3-3da1-4ce0-95e1-e4e310099e9c_totalLabel_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_ifrs-full_EquityAndLiabilities_label_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="lab_ifrs-full_EquityAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputMember_f817ee66-eced-49fc-b18e-ec3a68ab4d5f_terseLabel_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputMember_label_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk-Free Interest Rate, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Risk-Free Interest Rate, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RiskFreeInterestRateMeasurementInputMember" xlink:to="lab_abvx_RiskFreeInterestRateMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments_1a32eab7-d825-4b0b-a191-be85a9850be7_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, exit fee percentage if prepayment between 18th and 30th installments</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments_label_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Percentage If Prepayment Between 18th And 30th Installments</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments_documentation_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Percentage If Prepayment Between 18th And 30th Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" xlink:to="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AmericanDepositorySharesMember_fa4bdf8c-5aaf-49d3-8acc-f7b732bdd7b3_terseLabel_en-US" xlink:label="lab_abvx_AmericanDepositorySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ADS</link:label>
    <link:label id="lab_abvx_AmericanDepositorySharesMember_label_en-US" xlink:label="lab_abvx_AmericanDepositorySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">American Depository Shares [Member]</link:label>
    <link:label id="lab_abvx_AmericanDepositorySharesMember_documentation_en-US" xlink:label="lab_abvx_AmericanDepositorySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">American Depository Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesMember" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AmericanDepositorySharesMember" xlink:to="lab_abvx_AmericanDepositorySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MarketRateMeasurementInputMember_5f55e1cd-de02-4174-a96d-25ead2f144a4_terseLabel_en-US" xlink:label="lab_abvx_MarketRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market rate</link:label>
    <link:label id="lab_abvx_MarketRateMeasurementInputMember_label_en-US" xlink:label="lab_abvx_MarketRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Rate, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_MarketRateMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_MarketRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Rate, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MarketRateMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_MarketRateMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MarketRateMeasurementInputMember" xlink:to="lab_abvx_MarketRateMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_d0d0c9eb-b7f4-4ad5-a4b3-26b3bc843e35_negatedTerseLabel_en-US" xlink:label="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Advances made to CROs</link:label>
    <link:label id="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_97ca909f-3d30-43f0-a7f1-ccd2b6547cfa_terseLabel_en-US" xlink:label="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash advances and loans made to CRO</link:label>
    <link:label id="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_label_en-US" xlink:label="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Advances Made to Contract Research Organizations</link:label>
    <link:label id="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_documentation_en-US" xlink:label="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Advances Made to Contract Research Organizations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAdvancesMadeToContractResearchOrganizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" xlink:to="lab_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FreeSharesAGAMember_8dd3559f-53f5-432e-932e-f6712fd91710_terseLabel_en-US" xlink:label="lab_abvx_FreeSharesAGAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Free Shares (AGA)</link:label>
    <link:label id="lab_abvx_FreeSharesAGAMember_6005d885-3463-4ad8-b9a5-91fe041b998a_verboseLabel_en-US" xlink:label="lab_abvx_FreeSharesAGAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">AGAs</link:label>
    <link:label id="lab_abvx_FreeSharesAGAMember_label_en-US" xlink:label="lab_abvx_FreeSharesAGAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Free Shares (AGA) [Member]</link:label>
    <link:label id="lab_abvx_FreeSharesAGAMember_documentation_en-US" xlink:label="lab_abvx_FreeSharesAGAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Free Shares (AGA)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FreeSharesAGAMember" xlink:href="abvx-20241231.xsd#abvx_FreeSharesAGAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FreeSharesAGAMember" xlink:to="lab_abvx_FreeSharesAGAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_7a416c21-a328-482e-b69d-ca5271b25be0_terseLabel_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of movements in exchange rates on cash held</link:label>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_a89b56f7-efd7-41e9-a581-aaf2bb8a4222_verboseLabel_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss) on translation of cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_47712635-d04f-4f99-b563-508affbaf8cf_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_74f1334a-bd5a-4372-986e-3ae409da54c3_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20144Member_ce3447db-c64d-436b-b6e1-bb83beadc727_terseLabel_en-US" xlink:label="lab_abvx_BSA20144Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2014-4</link:label>
    <link:label id="lab_abvx_BSA20144Member_label_en-US" xlink:label="lab_abvx_BSA20144Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2014-4 [Member]</link:label>
    <link:label id="lab_abvx_BSA20144Member_documentation_en-US" xlink:label="lab_abvx_BSA20144Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2014-4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20144Member" xlink:href="abvx-20241231.xsd#abvx_BSA20144Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20144Member" xlink:to="lab_abvx_BSA20144Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfExclusiveLicenses_2dfbf444-ac3c-4527-be1c-840f99ed8e24_terseLabel_en-US" xlink:label="lab_abvx_NumberOfExclusiveLicenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of exclusive licenses</link:label>
    <link:label id="lab_abvx_NumberOfExclusiveLicenses_label_en-US" xlink:label="lab_abvx_NumberOfExclusiveLicenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Exclusive Licenses</link:label>
    <link:label id="lab_abvx_NumberOfExclusiveLicenses_documentation_en-US" xlink:label="lab_abvx_NumberOfExclusiveLicenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Exclusive Licenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfExclusiveLicenses" xlink:href="abvx-20241231.xsd#abvx_NumberOfExclusiveLicenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfExclusiveLicenses" xlink:to="lab_abvx_NumberOfExclusiveLicenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueAndOperatingIncome_3342e0ec-0987-4abf-a3b7-bfedaed9e3f6_totalLabel_en-US" xlink:label="lab_ifrs-full_RevenueAndOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_ifrs-full_RevenueAndOperatingIncome_label_en-US" xlink:label="lab_ifrs-full_RevenueAndOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue and other operating income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAndOperatingIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAndOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueAndOperatingIncome" xlink:to="lab_ifrs-full_RevenueAndOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OperatingExpense_c19a498c-2027-49bc-bcda-15a7718ef3d9_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_OperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_ifrs-full_OperatingExpense_bb493cb8-84d2-4f79-abbf-31fb532a9d63_totalLabel_en-US" xlink:label="lab_ifrs-full_OperatingExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_ifrs-full_OperatingExpense_077ca331-4e7c-40f9-bef6-c339a88488d9_terseLabel_en-US" xlink:label="lab_ifrs-full_OperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expense</link:label>
    <link:label id="lab_ifrs-full_OperatingExpense_label_en-US" xlink:label="lab_ifrs-full_OperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense" xlink:to="lab_ifrs-full_OperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinanceIncomeCost_a12f04bb-780b-4aac-a88d-e16ca44584d3_totalLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Financial gain (loss)</link:label>
    <link:label id="lab_ifrs-full_FinanceIncomeCost_label_en-US" xlink:label="lab_ifrs-full_FinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance income (cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="lab_ifrs-full_FinanceIncomeCost" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsMaximumBorrowingCapacity_3db56f14-a0f4-4be4-9073-505687888055_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, maximum borrowing capacity</link:label>
    <link:label id="lab_abvx_BorrowingsMaximumBorrowingCapacity_label_en-US" xlink:label="lab_abvx_BorrowingsMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_abvx_BorrowingsMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_abvx_BorrowingsMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsMaximumBorrowingCapacity" xlink:to="lab_abvx_BorrowingsMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock_8c6b30e8-ae81-49f4-9426-5a66d6ce8078_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of breakdown of trade and other payables</link:label>
    <link:label id="lab_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Breakdown Of Trade And Other Payables [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Breakdown Of Trade And Other Payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" xlink:to="lab_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_ec606999-b725-4c61-b5d8-4d9e138766d2_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_3cb0dcf8-4d95-456a-b814-2859eb851e6c_totalLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective income tax (loss)</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e7a3a519-2d7d-455d-976b-8449517a7faa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfCommitmentsReceivedLineItems_9fea308a-05f8-4dd3-b320-5599f00832e5_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfCommitmentsReceivedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Commitments Received [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfCommitmentsReceivedLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfCommitmentsReceivedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Commitments Received [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfCommitmentsReceivedLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfCommitmentsReceivedLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Commitments Received [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCommitmentsReceivedLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCommitmentsReceivedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedLineItems" xlink:to="lab_abvx_DisclosureOfCommitmentsReceivedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP_f9af9f4b-73fa-41b8-a7c0-898a92121bf2_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, market price, number of days with lowest daily VWAP</link:label>
    <link:label id="lab_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP_label_en-US" xlink:label="lab_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Market Price, Number Of Days With Lowest Daily VWAP</link:label>
    <link:label id="lab_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP_documentation_en-US" xlink:label="lab_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Market Price, Number Of Days With Lowest Daily VWAP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" xlink:to="lab_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherReceivablesAbstract_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other receivables [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationVariableCompensation_00e644ce-99a2-46e2-a6e3-6100ea57fa51_terseLabel_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationVariableCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable compensation owed</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationVariableCompensation_label_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationVariableCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, Variable Compensation</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationVariableCompensation_documentation_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationVariableCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, Variable Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationVariableCompensation" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationVariableCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KeyManagementPersonnelCompensationVariableCompensation" xlink:to="lab_abvx_KeyManagementPersonnelCompensationVariableCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_HeightsConvertibleNotesTrancheAMember_227a5013-5dcf-4704-8740-b6b81bf2ff2d_terseLabel_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Heights convertible notes, tranche A</link:label>
    <link:label id="lab_abvx_HeightsConvertibleNotesTrancheAMember_label_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Heights Convertible Notes, Tranche A [Member]</link:label>
    <link:label id="lab_abvx_HeightsConvertibleNotesTrancheAMember_documentation_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Heights Convertible Notes, Tranche A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheAMember" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_HeightsConvertibleNotesTrancheAMember" xlink:to="lab_abvx_HeightsConvertibleNotesTrancheAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_bb91c78e-1ba1-4c35-85ec-ee5b57584257_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management and assessment of financial risks</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial risk management [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosABCBSAMember_586a49f6-cb22-4866-a6f5-c94bf1d42df5_terseLabel_en-US" xlink:label="lab_abvx_KreosABCBSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos A &amp; B &amp; C BSA</link:label>
    <link:label id="lab_abvx_KreosABCBSAMember_label_en-US" xlink:label="lab_abvx_KreosABCBSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos A &amp; B &amp; C BSA [Member]</link:label>
    <link:label id="lab_abvx_KreosABCBSAMember_documentation_en-US" xlink:label="lab_abvx_KreosABCBSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos A &amp; B &amp; C BSA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABCBSAMember" xlink:href="abvx-20241231.xsd#abvx_KreosABCBSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosABCBSAMember" xlink:to="lab_abvx_KreosABCBSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_27c429fd-fc23-4461-b3f3-dfc2bb383d9e_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial liabilities</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:to="lab_ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IssueOfEquityOfferingPricePerShare_f45567c2-aaab-421e-9da4-6fc0f3f11635_terseLabel_en-US" xlink:label="lab_abvx_IssueOfEquityOfferingPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of equity, offering price per share (in dollar/euro per share)</link:label>
    <link:label id="lab_abvx_IssueOfEquityOfferingPricePerShare_label_en-US" xlink:label="lab_abvx_IssueOfEquityOfferingPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issue Of Equity, Offering Price Per Share</link:label>
    <link:label id="lab_abvx_IssueOfEquityOfferingPricePerShare_documentation_en-US" xlink:label="lab_abvx_IssueOfEquityOfferingPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issue Of Equity, Offering Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssueOfEquityOfferingPricePerShare" xlink:href="abvx-20241231.xsd#abvx_IssueOfEquityOfferingPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IssueOfEquityOfferingPricePerShare" xlink:to="lab_abvx_IssueOfEquityOfferingPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_90b8d179-460f-43f8-8623-dd1866e6f120_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ResidualMaturityMeasurementInputMember_c6b54621-2611-4b62-89c2-a145b83389f7_terseLabel_en-US" xlink:label="lab_abvx_ResidualMaturityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Residual maturity</link:label>
    <link:label id="lab_abvx_ResidualMaturityMeasurementInputMember_4405563d-777c-4604-a5bc-4481b5fb5274_verboseLabel_en-US" xlink:label="lab_abvx_ResidualMaturityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Time to maturity</link:label>
    <link:label id="lab_abvx_ResidualMaturityMeasurementInputMember_label_en-US" xlink:label="lab_abvx_ResidualMaturityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Residual Maturity, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_ResidualMaturityMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_ResidualMaturityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Residual Maturity, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResidualMaturityMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_ResidualMaturityMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ResidualMaturityMeasurementInputMember" xlink:to="lab_abvx_ResidualMaturityMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_8c7465c8-31c3-4a9b-821b-d9eef8870ef3_periodStartLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities at beginning of period</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_e5a2b570-1f0e-4ac8-b9c1-00565fe1b7db_periodEndLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities at end of period</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsMarketPriceNumberOfTradingDays_24d293f3-ee72-4702-b679-97d26e50773a_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsMarketPriceNumberOfTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, market price, number of trading days</link:label>
    <link:label id="lab_abvx_BorrowingsMarketPriceNumberOfTradingDays_label_en-US" xlink:label="lab_abvx_BorrowingsMarketPriceNumberOfTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Market Price, Number Of Trading Days</link:label>
    <link:label id="lab_abvx_BorrowingsMarketPriceNumberOfTradingDays_documentation_en-US" xlink:label="lab_abvx_BorrowingsMarketPriceNumberOfTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Market Price, Number Of Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMarketPriceNumberOfTradingDays" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMarketPriceNumberOfTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsMarketPriceNumberOfTradingDays" xlink:to="lab_abvx_BorrowingsMarketPriceNumberOfTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeStatementAbstract_label_en-US" xlink:label="lab_ifrs-full_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit or loss [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract" xlink:to="lab_ifrs-full_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_cde87eb3-75a0-46df-8217-3afe07e853de_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of remaining contractual maturities of non-derivative financial liabilities</link:label>
    <link:label id="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:to="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA2025Member_6c764226-3c34-4d2f-8256-6f7640cddaf0_terseLabel_en-US" xlink:label="lab_abvx_AGA2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2025</link:label>
    <link:label id="lab_abvx_AGA2025Member_label_en-US" xlink:label="lab_abvx_AGA2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2025 [Member]</link:label>
    <link:label id="lab_abvx_AGA2025Member_documentation_en-US" xlink:label="lab_abvx_AGA2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2025Member" xlink:href="abvx-20241231.xsd#abvx_AGA2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA2025Member" xlink:to="lab_abvx_AGA2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_8a00126d-a8c9-49bf-bd05-789728ead3b8_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount Rate (IBoxx Corporates AA)</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of discount rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OCEANEMember_41f1127e-6fed-48a1-bfa7-6ea97cbd5881_terseLabel_en-US" xlink:label="lab_abvx_OCEANEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Oceane</link:label>
    <link:label id="lab_abvx_OCEANEMember_label_en-US" xlink:label="lab_abvx_OCEANEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCEANE [Member]</link:label>
    <link:label id="lab_abvx_OCEANEMember_documentation_en-US" xlink:label="lab_abvx_OCEANEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">OCEANE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OCEANEMember" xlink:to="lab_abvx_OCEANEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities_81310eed-add7-468e-94dc-9268ebe9d3da_terseLabel_en-US" xlink:label="lab_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase / (decrease) in deferred income and other liabilities</link:label>
    <link:label id="lab_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities_label_en-US" xlink:label="lab_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Increase (Decrease) In Deferred Income And Other Liabilities</link:label>
    <link:label id="lab_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities_documentation_en-US" xlink:label="lab_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Increase (Decrease) In Deferred Income And Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" xlink:to="lab_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DrawdownProbablityMeasurementInputMember_8ee4d038-2259-4966-b968-926d5b249d5c_terseLabel_en-US" xlink:label="lab_abvx_DrawdownProbablityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Probability of Drawdown of Tranche C credit facility</link:label>
    <link:label id="lab_abvx_DrawdownProbablityMeasurementInputMember_label_en-US" xlink:label="lab_abvx_DrawdownProbablityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Drawdown Probablity, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_DrawdownProbablityMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_DrawdownProbablityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Drawdown Probablity, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DrawdownProbablityMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_DrawdownProbablityMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DrawdownProbablityMeasurementInputMember" xlink:to="lab_abvx_DrawdownProbablityMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageShares_7dcb52a7-378b-4b72-8ec9-1f111178796c_verboseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of outstanding shares used for computing basic loss per share (in shares)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageShares_36447ac9-0d46-43b3-8926-33b37fb2a6e3_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of outstanding shares, basic loss per share (in shares)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares" xlink:to="lab_ifrs-full_WeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Borrowings_b227b8ef-0745-4887-9062-76aeb29d83b1_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_Borrowings_15916172-28cc-424e-8187-c3c629e47c0c_terseLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_Borrowings_label_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings" xlink:to="lab_ifrs-full_Borrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LongtermDeposits_a0a7c9cb-b550-42ed-92b2-5b656ba67e0d_terseLabel_en-US" xlink:label="lab_ifrs-full_LongtermDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits</link:label>
    <link:label id="lab_ifrs-full_LongtermDeposits_label_en-US" xlink:label="lab_ifrs-full_LongtermDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermDeposits" xlink:to="lab_ifrs-full_LongtermDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_95751792-8aa9-4c06-826e-bbfe9b5fb7d4_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total compensation</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfWarrantsArrangementsTable_d76961b5-1c78-476a-b4fc-e5342345bd92_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfWarrantsArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Warrants Arrangements [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfWarrantsArrangementsTable_label_en-US" xlink:label="lab_abvx_DisclosureOfWarrantsArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Warrants Arrangements [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfWarrantsArrangementsTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfWarrantsArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Warrants Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable" xlink:to="lab_abvx_DisclosureOfWarrantsArrangementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NetProceedsFromSaleOfRoyaltyCertificates_ee7b7444-03ae-4005-aabb-10cd29aab3be_terseLabel_en-US" xlink:label="lab_abvx_NetProceedsFromSaleOfRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from sale of royalty certificates</link:label>
    <link:label id="lab_abvx_NetProceedsFromSaleOfRoyaltyCertificates_label_en-US" xlink:label="lab_abvx_NetProceedsFromSaleOfRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Proceeds From Sale Of Royalty Certificates</link:label>
    <link:label id="lab_abvx_NetProceedsFromSaleOfRoyaltyCertificates_documentation_en-US" xlink:label="lab_abvx_NetProceedsFromSaleOfRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Proceeds From Sale Of Royalty Certificates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates" xlink:to="lab_abvx_NetProceedsFromSaleOfRoyaltyCertificates" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AggregateFairValueConvertibleNotes_bf080f02-88df-4c36-bdc0-85609a0cbe32_terseLabel_en-US" xlink:label="lab_abvx_AggregateFairValueConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of convertible notes</link:label>
    <link:label id="lab_abvx_AggregateFairValueConvertibleNotes_label_en-US" xlink:label="lab_abvx_AggregateFairValueConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Fair Value, Convertible Notes</link:label>
    <link:label id="lab_abvx_AggregateFairValueConvertibleNotes_documentation_en-US" xlink:label="lab_abvx_AggregateFairValueConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Fair Value, Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueConvertibleNotes" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AggregateFairValueConvertibleNotes" xlink:to="lab_abvx_AggregateFairValueConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_b7b56b0e-93bc-479b-ae9b-3ed6b5230ba4_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfLeaseLiabilitiesTable_d9a960c4-363d-4000-a1ac-01fb1eb04a05_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfLeaseLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Liabilities [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfLeaseLiabilitiesTable_label_en-US" xlink:label="lab_abvx_DisclosureOfLeaseLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Liabilities [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfLeaseLiabilitiesTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfLeaseLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeaseLiabilitiesTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeaseLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesTable" xlink:to="lab_abvx_DisclosureOfLeaseLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_057b0e43-54ae-4ed2-9946-755d736a2517_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employees</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about employees [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_8147d3c3-4c46-4331-8559-51dab35b4552_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Appropriation of prior period net loss</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through appropriation of retained earnings, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OptionPricingModelMember_d8a5565c-1d22-471a-8126-d18816c3efa9_terseLabel_en-US" xlink:label="lab_ifrs-full_OptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option pricing model</link:label>
    <link:label id="lab_ifrs-full_OptionPricingModelMember_label_en-US" xlink:label="lab_ifrs-full_OptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option pricing model [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionPricingModelMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionPricingModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OptionPricingModelMember" xlink:to="lab_ifrs-full_OptionPricingModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_3eebf0e3-c0a7-424d-b507-318423e34270_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, share-based payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrencyRiskMember_512511e6-f91e-4553-aac9-ac429a6dcfc9_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrencyRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency risk</link:label>
    <link:label id="lab_ifrs-full_CurrencyRiskMember_label_en-US" xlink:label="lab_ifrs-full_CurrencyRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency risk [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrencyRiskMember" xlink:to="lab_ifrs-full_CurrencyRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_cc3112c3-0764-4ccc-b755-39c401900876_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FROM 1 TO 2 YEARS</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year and not later than two years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP_72f96d8f-0d9e-4361-ac6b-8652ce4206e0_terseLabel_en-US" xlink:label="lab_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance price, percentage of discount to 15-day WVAP</link:label>
    <link:label id="lab_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP_label_en-US" xlink:label="lab_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance Price, Percentage Of Discount To 15-Day WVAP</link:label>
    <link:label id="lab_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP_documentation_en-US" xlink:label="lab_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance Price, Percentage Of Discount To 15-Day WVAP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP" xlink:href="abvx-20241231.xsd#abvx_IssuancePricePercentageOfDiscountTo15DayWVAP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP" xlink:to="lab_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_dac331c9-3e47-4c68-b2f1-0828bb519257_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and development expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37cb764e-87ab-47fb-8128-85492bf24dfa_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExercisePriceOtherEquityInstrumentsGranted_9df1c1d4-37ef-4054-a0ce-e5ed05ea0204_terseLabel_en-US" xlink:label="lab_abvx_ExercisePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, other equity instruments granted (in euro per share)</link:label>
    <link:label id="lab_abvx_ExercisePriceOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_ExercisePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_ExercisePriceOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_ExercisePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_ExercisePriceOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted" xlink:to="lab_abvx_ExercisePriceOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_fe8e5092-815b-4097-ba1f-58ddfdec8cf5_terseLabel_en-US" xlink:label="lab_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of reasonably possible increase in unobservable input, liabilities</link:label>
    <link:label id="lab_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</link:label>
    <link:label id="lab_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_documentation_en-US" xlink:label="lab_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:to="lab_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_A150.0MillionFinancingAugust2023Member_1a9be6a9-c077-496c-9417-fdec6b9ddde1_terseLabel_en-US" xlink:label="lab_abvx_A150.0MillionFinancingAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8364;150.0&#160;million financing, august 2023</link:label>
    <link:label id="lab_abvx_A150.0MillionFinancingAugust2023Member_label_en-US" xlink:label="lab_abvx_A150.0MillionFinancingAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">&#8364;150.0&#160;Million Financing, August 2023 [Member]</link:label>
    <link:label id="lab_abvx_A150.0MillionFinancingAugust2023Member_documentation_en-US" xlink:label="lab_abvx_A150.0MillionFinancingAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">&#8364;150.0&#160;Million Financing, August 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A150.0MillionFinancingAugust2023Member" xlink:href="abvx-20241231.xsd#abvx_A150.0MillionFinancingAugust2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_A150.0MillionFinancingAugust2023Member" xlink:to="lab_abvx_A150.0MillionFinancingAugust2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MonteCarloModel1Member_3128cc91-49a3-4f6b-97e5-da2a1999c1f8_terseLabel_en-US" xlink:label="lab_abvx_MonteCarloModel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monte Carlo Model</link:label>
    <link:label id="lab_abvx_MonteCarloModel1Member_label_en-US" xlink:label="lab_abvx_MonteCarloModel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Monte Carlo Model1 [Member]</link:label>
    <link:label id="lab_abvx_MonteCarloModel1Member_documentation_en-US" xlink:label="lab_abvx_MonteCarloModel1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Monte Carlo Model</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModel1Member" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MonteCarloModel1Member" xlink:to="lab_abvx_MonteCarloModel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfShareBasedCompensationPlansIssued_09c98939-4f7a-4275-8aa8-f2dd4be45b64_terseLabel_en-US" xlink:label="lab_abvx_NumberOfShareBasedCompensationPlansIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share-based compensation plans issued</link:label>
    <link:label id="lab_abvx_NumberOfShareBasedCompensationPlansIssued_label_en-US" xlink:label="lab_abvx_NumberOfShareBasedCompensationPlansIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Share-Based Compensation Plans Issued</link:label>
    <link:label id="lab_abvx_NumberOfShareBasedCompensationPlansIssued_documentation_en-US" xlink:label="lab_abvx_NumberOfShareBasedCompensationPlansIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Share-Based Compensation Plans Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfShareBasedCompensationPlansIssued" xlink:href="abvx-20241231.xsd#abvx_NumberOfShareBasedCompensationPlansIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfShareBasedCompensationPlansIssued" xlink:to="lab_abvx_NumberOfShareBasedCompensationPlansIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_e38e4bb7-e767-478c-934b-74dcf9af5223_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of conditional advances</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of borrowings [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_f4098ced-f54d-4da2-8b3f-909abaa3da82_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for issued capital [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_a987770b-a41e-43dc-ab68-0fa89b822d6d_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss before tax</link:label>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_label_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="lab_ifrs-full_ProfitLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherCurrentInvestments_4ce1f7bb-31ea-4767-b692-edf7c95a2b8f_terseLabel_en-US" xlink:label="lab_abvx_OtherCurrentInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_abvx_OtherCurrentInvestments_label_en-US" xlink:label="lab_abvx_OtherCurrentInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Investments</link:label>
    <link:label id="lab_abvx_OtherCurrentInvestments_documentation_en-US" xlink:label="lab_abvx_OtherCurrentInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Current Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherCurrentInvestments" xlink:href="abvx-20241231.xsd#abvx_OtherCurrentInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherCurrentInvestments" xlink:to="lab_abvx_OtherCurrentInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_738a7e51-3b37-46af-a486-dbd25b3dd49a_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Social security and other</link:label>
    <link:label id="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_label_en-US" xlink:label="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current payables on social security and taxes other than income tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:to="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_7c227da5-abbf-4457-a49e-3e63238aedc6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables and other assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseFacilitiesBostonMember_4fe28710-9984-45cf-b2d8-d78758930628_terseLabel_en-US" xlink:label="lab_abvx_LeaseFacilitiesBostonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease facilities, Boston</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesBostonMember_label_en-US" xlink:label="lab_abvx_LeaseFacilitiesBostonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Facilities, Boston [Member]</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesBostonMember_documentation_en-US" xlink:label="lab_abvx_LeaseFacilitiesBostonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Facilities, Boston</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesBostonMember" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesBostonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseFacilitiesBostonMember" xlink:to="lab_abvx_LeaseFacilitiesBostonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsDebtToMarketCapitalizationRatio_77efcba3-6a81-4600-bacf-50f17b94c626_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsDebtToMarketCapitalizationRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, debt-to-market capitalization ratio</link:label>
    <link:label id="lab_abvx_BorrowingsDebtToMarketCapitalizationRatio_label_en-US" xlink:label="lab_abvx_BorrowingsDebtToMarketCapitalizationRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Debt-To-Market Capitalization Ratio</link:label>
    <link:label id="lab_abvx_BorrowingsDebtToMarketCapitalizationRatio_documentation_en-US" xlink:label="lab_abvx_BorrowingsDebtToMarketCapitalizationRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Debt-To-Market Capitalization Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsDebtToMarketCapitalizationRatio" xlink:href="abvx-20241231.xsd#abvx_BorrowingsDebtToMarketCapitalizationRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsDebtToMarketCapitalizationRatio" xlink:to="lab_abvx_BorrowingsDebtToMarketCapitalizationRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_90118101-bed1-4926-a97e-a3324646e663_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets at amortized cost</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20145Member_068d1501-453e-4e82-b891-d21b3cc9d552_terseLabel_en-US" xlink:label="lab_abvx_BSA20145Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2014-5</link:label>
    <link:label id="lab_abvx_BSA20145Member_label_en-US" xlink:label="lab_abvx_BSA20145Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2014-5 [Member]</link:label>
    <link:label id="lab_abvx_BSA20145Member_documentation_en-US" xlink:label="lab_abvx_BSA20145Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2014-5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20145Member" xlink:href="abvx-20241231.xsd#abvx_BSA20145Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20145Member" xlink:to="lab_abvx_BSA20145Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInEquityAbstract_0d7e86a6-916e-48da-99cd-eb942d71671d_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in equity [abstract]</link:label>
    <link:label id="lab_ifrs-full_ChangesInEquityAbstract_label_en-US" xlink:label="lab_ifrs-full_ChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInEquityAbstract" xlink:to="lab_ifrs-full_ChangesInEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20252Member_053b5733-5aaf-4a0f-b325-d980a0749f32_terseLabel_en-US" xlink:label="lab_abvx_AGA20252Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2025-2</link:label>
    <link:label id="lab_abvx_AGA20252Member_label_en-US" xlink:label="lab_abvx_AGA20252Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2025-2 [Member]</link:label>
    <link:label id="lab_abvx_AGA20252Member_documentation_en-US" xlink:label="lab_abvx_AGA20252Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2025-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20252Member" xlink:href="abvx-20241231.xsd#abvx_AGA20252Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20252Member" xlink:to="lab_abvx_AGA20252Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ApplicableTaxRate_0535f8c9-3d20-495f-8e43-0305875b3f23_terseLabel_en-US" xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statutory French tax rates</link:label>
    <link:label id="lab_ifrs-full_ApplicableTaxRate_label_en-US" xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Applicable tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate" xlink:to="lab_ifrs-full_ApplicableTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_76a7772e-5637-4c4e-add1-c3946ecef91a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock_4f1ce1f5-1093-48df-a994-a4c2c462d719_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of composition of cash and cash equivalents</link:label>
    <link:label id="lab_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Composition Of Cash And Cash Equivalents [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Composition Of Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_8550d635-4f6f-4d1a-ac71-7055ff1990b2_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current taxes</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_ceff3e5b-5482-4bf8-91b4-7483baad03c8_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment including right-of-use assets [domain]</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment including right-of-use assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_305a5e03-78cc-4732-bd1f-4dc87415f9ed_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsDomain_814f69a6-6efb-4b71-b21d-ef2a28211df2_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of assets [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain" xlink:to="lab_ifrs-full_ClassesOfAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_01990e29-bf56-4133-8310-81d628e6d463_terseLabel_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash-generating units [axis]</link:label>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_label_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash-generating units [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:to="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheSixMember_67cb8f7a-d33f-43c0-987f-ea22e3869742_terseLabel_en-US" xlink:label="lab_abvx_TrancheSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 6</link:label>
    <link:label id="lab_abvx_TrancheSixMember_label_en-US" xlink:label="lab_abvx_TrancheSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Six [Member]</link:label>
    <link:label id="lab_abvx_TrancheSixMember_documentation_en-US" xlink:label="lab_abvx_TrancheSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheSixMember" xlink:href="abvx-20241231.xsd#abvx_TrancheSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheSixMember" xlink:to="lab_abvx_TrancheSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_5d61659e-f83e-4f2b-bf2d-4a0fa00c2869_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses_2e5ee047-caa0-40e3-97b2-33c8601af206_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in employee benefits expenses</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Employee Benefits Expenses</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Employee Benefits Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInEmployeeBenefitsExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses" xlink:to="lab_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_db7f4647-9b90-40c9-93db-42f6ffe30b82_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of main data and assumptions used for the measurement of earn-out liability</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TranchesOneToFourMember_aee437dc-676a-4317-bd7a-1b65ed4ee8a0_terseLabel_en-US" xlink:label="lab_abvx_TranchesOneToFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranches 1-4</link:label>
    <link:label id="lab_abvx_TranchesOneToFourMember_label_en-US" xlink:label="lab_abvx_TranchesOneToFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranches One To Four [Member]</link:label>
    <link:label id="lab_abvx_TranchesOneToFourMember_documentation_en-US" xlink:label="lab_abvx_TranchesOneToFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranches One To Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesOneToFourMember" xlink:href="abvx-20241231.xsd#abvx_TranchesOneToFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TranchesOneToFourMember" xlink:to="lab_abvx_TranchesOneToFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_5ea5089d-6e4a-4501-b6d5-b441e524a855_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_e0e04ba6-b2d7-4ac1-a44a-44c041ac1a11_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease in financial liabilities at fair value</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_90c45d7c-202f-4de4-adee-95e16ea4c227_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in financial liabilities at fair value due to reasonably possible increase in unobservable input</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:to="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_c91c0c55-2d51-4a21-91c9-9d84cf3b565e_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities, undiscounted cash flows</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_48058c13-720f-4479-a119-6d0a8b8f39a4_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other inflows (outflows) of cash, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsBasisInterestRate_9ee76b2f-159a-4ce7-a96d-098103e700c1_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsBasisInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate basis</link:label>
    <link:label id="lab_abvx_BorrowingsBasisInterestRate_label_en-US" xlink:label="lab_abvx_BorrowingsBasisInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Basis Interest Rate</link:label>
    <link:label id="lab_abvx_BorrowingsBasisInterestRate_documentation_en-US" xlink:label="lab_abvx_BorrowingsBasisInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Basis Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsBasisInterestRate" xlink:href="abvx-20241231.xsd#abvx_BorrowingsBasisInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsBasisInterestRate" xlink:to="lab_abvx_BorrowingsBasisInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheOneMember_1be6abec-cf2e-49f5-aee2-09d79ebd2c04_terseLabel_en-US" xlink:label="lab_abvx_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 1</link:label>
    <link:label id="lab_abvx_TrancheOneMember_label_en-US" xlink:label="lab_abvx_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche One [Member]</link:label>
    <link:label id="lab_abvx_TrancheOneMember_documentation_en-US" xlink:label="lab_abvx_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheOneMember" xlink:to="lab_abvx_TrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssueOfEquity_b94d7822-df25-4f8c-84f8-97b8b6f6a462_terseLabel_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital increase from issuance of ordinary shares</link:label>
    <link:label id="lab_ifrs-full_IssueOfEquity_647323b6-67a4-4324-b658-f0f4a0b96a94_verboseLabel_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issue of equity</link:label>
    <link:label id="lab_ifrs-full_IssueOfEquity_label_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issue of equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity" xlink:to="lab_ifrs-full_IssueOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_57f42aff-87b4-4391-b88d-b9d579447728_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Equity_516d7436-42c9-47e6-8b53-b233f8db9a8e_totalLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_ifrs-full_Equity_1d25a824-d564-4f47-81a8-b079dc73b52f_periodStartLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Equity at beginning of period</link:label>
    <link:label id="lab_ifrs-full_Equity_81699603-56d2-45d3-a499-0a9566c7cd3a_periodEndLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Equity at end of period</link:label>
    <link:label id="lab_ifrs-full_Equity_b2f24e19-25f4-443c-86e9-7c453e57e780_terseLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_ifrs-full_Equity_label_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity" xlink:to="lab_ifrs-full_Equity" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays_c74a6130-8a8d-4562-93a6-4c7df4fbd3df_terseLabel_en-US" xlink:label="lab_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of trading days</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays_label_en-US" xlink:label="lab_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Issuance Price, Number Of Trading Days</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays_documentation_en-US" xlink:label="lab_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Issuance Price, Number Of Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays" xlink:to="lab_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_96d5b40c-8a0f-43c5-b1ff-eef9894ce6ef_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Salary increase rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of salary increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinancialRiskManagementAbstract_label_en-US" xlink:label="lab_abvx_FinancialRiskManagementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Risk Management [Abstract]</link:label>
    <link:label id="lab_abvx_FinancialRiskManagementAbstract_documentation_en-US" xlink:label="lab_abvx_FinancialRiskManagementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Risk Management [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialRiskManagementAbstract" xlink:href="abvx-20241231.xsd#abvx_FinancialRiskManagementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinancialRiskManagementAbstract" xlink:to="lab_abvx_FinancialRiskManagementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold_ab70bbf1-6052-4673-8f64-07cfeb87254c_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-tax revenue threshold</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed, Pre-Tax Revenue Threshold</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed, Pre-Tax Revenue Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" xlink:to="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinancialAgreementAmount_70041501-d27f-4721-b7c4-2775c3ef92e8_terseLabel_en-US" xlink:label="lab_abvx_FinancialAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial agreement, amount</link:label>
    <link:label id="lab_abvx_FinancialAgreementAmount_label_en-US" xlink:label="lab_abvx_FinancialAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Agreement, Amount</link:label>
    <link:label id="lab_abvx_FinancialAgreementAmount_documentation_en-US" xlink:label="lab_abvx_FinancialAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAmount" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinancialAgreementAmount" xlink:to="lab_abvx_FinancialAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_2d041ad0-155c-4aac-891e-34b330438957_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherIncome_e5bff057-cdfe-4890-964a-c6fe70da1280_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_ifrs-full_OtherIncome_757f4d85-8d04-4c28-bf3d-e4251410ff8a_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_ifrs-full_OtherIncome_label_en-US" xlink:label="lab_ifrs-full_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome" xlink:to="lab_ifrs-full_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheABAndCMember_eb243508-4871-46ea-98e0-7f6ed3603041_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheABAndCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche A,B and C</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheABAndCMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheABAndCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche A,B and C [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheABAndCMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheABAndCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche A,B and C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheABAndCMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheABAndCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingTrancheABAndCMember" xlink:to="lab_abvx_KreosClaretFinancingTrancheABAndCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfOtherShareWarrantsRepurchased_18c7990f-93a5-483d-9ca4-fa59566b53ae_terseLabel_en-US" xlink:label="lab_abvx_NumberOfOtherShareWarrantsRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of other share warrants repurchased (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfOtherShareWarrantsRepurchased_label_en-US" xlink:label="lab_abvx_NumberOfOtherShareWarrantsRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Other Share Warrants Repurchased</link:label>
    <link:label id="lab_abvx_NumberOfOtherShareWarrantsRepurchased_documentation_en-US" xlink:label="lab_abvx_NumberOfOtherShareWarrantsRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Other Share Warrants Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsRepurchased" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfOtherShareWarrantsRepurchased" xlink:to="lab_abvx_NumberOfOtherShareWarrantsRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA2021Member_ed741611-a5c6-4664-ab0b-ae0454c4f4cb_terseLabel_en-US" xlink:label="lab_abvx_AGA2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA 2021</link:label>
    <link:label id="lab_abvx_AGA2021Member_label_en-US" xlink:label="lab_abvx_AGA2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA 2021 [Member]</link:label>
    <link:label id="lab_abvx_AGA2021Member_documentation_en-US" xlink:label="lab_abvx_AGA2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2021Member" xlink:href="abvx-20241231.xsd#abvx_AGA2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA2021Member" xlink:to="lab_abvx_AGA2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock_f4586c26-81e8-4be3-a9c7-c159f597c0c3_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New, revised or amended Standards and Interpretations</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For New, Revised Or Amended Standards And Interpretations [Policy Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For New, Revised Or Amended Standards And Interpretations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" xlink:to="lab_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CreditRiskMember_b9b80b1c-3eef-49f7-a2a1-805f7f85cb1b_terseLabel_en-US" xlink:label="lab_ifrs-full_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit risk</link:label>
    <link:label id="lab_ifrs-full_CreditRiskMember_label_en-US" xlink:label="lab_ifrs-full_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit risk [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditRiskMember" xlink:to="lab_ifrs-full_CreditRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_23f3039e-c16c-40f3-8b98-50e05247a229_negatedTerseLabel_en-US" xlink:label="lab_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in other liabilities at fair value through profit and loss</link:label>
    <link:label id="lab_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Losses On Financial Liabilities At Fair Value Through Profit Or Loss</link:label>
    <link:label id="lab_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_documentation_en-US" xlink:label="lab_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Losses On Financial Liabilities At Fair Value Through Profit Or Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="abvx-20241231.xsd#abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="lab_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RoyaltyCertificateExpirationPeriod_5951782b-77f9-4706-b321-5a0626af68bf_terseLabel_en-US" xlink:label="lab_abvx_RoyaltyCertificateExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty certificate, expiration period</link:label>
    <link:label id="lab_abvx_RoyaltyCertificateExpirationPeriod_label_en-US" xlink:label="lab_abvx_RoyaltyCertificateExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Certificate, Expiration Period</link:label>
    <link:label id="lab_abvx_RoyaltyCertificateExpirationPeriod_documentation_en-US" xlink:label="lab_abvx_RoyaltyCertificateExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Certificate, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateExpirationPeriod" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RoyaltyCertificateExpirationPeriod" xlink:to="lab_abvx_RoyaltyCertificateExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeasesRelatedTemporaryDifferencesMember_d8947fa2-0806-4cc8-869c-11b333745f44_terseLabel_en-US" xlink:label="lab_abvx_LeasesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_abvx_LeasesRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_abvx_LeasesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases Related Temporary Differences [Member]</link:label>
    <link:label id="lab_abvx_LeasesRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_abvx_LeasesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leases Related Temporary Differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeasesRelatedTemporaryDifferencesMember" xlink:href="abvx-20241231.xsd#abvx_LeasesRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeasesRelatedTemporaryDifferencesMember" xlink:to="lab_abvx_LeasesRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ActuarialAssumptionOfEmployeeContributionRate_da28d86b-ccc6-4227-8496-03225cb4a1c3_terseLabel_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfEmployeeContributionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contribution rate</link:label>
    <link:label id="lab_abvx_ActuarialAssumptionOfEmployeeContributionRate_label_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfEmployeeContributionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Employee Contribution Rate</link:label>
    <link:label id="lab_abvx_ActuarialAssumptionOfEmployeeContributionRate_documentation_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfEmployeeContributionRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Employee Contribution Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfEmployeeContributionRate" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfEmployeeContributionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ActuarialAssumptionOfEmployeeContributionRate" xlink:to="lab_abvx_ActuarialAssumptionOfEmployeeContributionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConversionPriceAdjustmentPeriod_071b0f22-30cc-4ee8-bad2-f5ef6131d656_terseLabel_en-US" xlink:label="lab_abvx_ConversionPriceAdjustmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price, adjustment, period</link:label>
    <link:label id="lab_abvx_ConversionPriceAdjustmentPeriod_label_en-US" xlink:label="lab_abvx_ConversionPriceAdjustmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Price, Adjustment, Period</link:label>
    <link:label id="lab_abvx_ConversionPriceAdjustmentPeriod_documentation_en-US" xlink:label="lab_abvx_ConversionPriceAdjustmentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Price, Adjustment, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceAdjustmentPeriod" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceAdjustmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConversionPriceAdjustmentPeriod" xlink:to="lab_abvx_ConversionPriceAdjustmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e0f45943-da22-4f25-bc5f-00f1d756eb3c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfWarrantsGranted_844b4c23-8fd6-4de1-88b5-76f8563f776b_terseLabel_en-US" xlink:label="lab_abvx_NumberOfWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants granted (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsGranted_label_en-US" xlink:label="lab_abvx_NumberOfWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Warrants Granted</link:label>
    <link:label id="lab_abvx_NumberOfWarrantsGranted_documentation_en-US" xlink:label="lab_abvx_NumberOfWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Warrants Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsGranted" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfWarrantsGranted" xlink:to="lab_abvx_NumberOfWarrantsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_88307340-6241-4e4a-86ce-44c29b5aa965_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment loss</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_1c5187b7-8cb6-4329-ba58-866c6273132d_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets and goodwill</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseInUlcerativeColitisExpenses_53e75f5b-86e5-45bf-98fd-e5e69f0c139b_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseInUlcerativeColitisExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in Ulcerative Colitis expenses</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInUlcerativeColitisExpenses_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseInUlcerativeColitisExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Ulcerative Colitis Expenses</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInUlcerativeColitisExpenses_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseInUlcerativeColitisExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Ulcerative Colitis Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInUlcerativeColitisExpenses" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInUlcerativeColitisExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseInUlcerativeColitisExpenses" xlink:to="lab_abvx_IncreaseDecreaseInUlcerativeColitisExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_9c89e56e-be4f-4e46-bda9-f594730e3d97_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AT&#160;AMORTIZED COST</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortised cost, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_28b8bd3d-97dc-484f-925e-439f48d3e3f3_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FROM 2 TO 5 YEARS</link:label>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than two years and not later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_b401ecb9-6806-47e7-8ef4-a580964c1dd2_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible increase in unobservable input, liabilities</link:label>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible increase in unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PrincipalAgreementsDomain_5fe5368b-5be9-45e0-9b4c-18dd1e8f81db_terseLabel_en-US" xlink:label="lab_abvx_PrincipalAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Agreements [Domain]</link:label>
    <link:label id="lab_abvx_PrincipalAgreementsDomain_label_en-US" xlink:label="lab_abvx_PrincipalAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Agreements [Domain]</link:label>
    <link:label id="lab_abvx_PrincipalAgreementsDomain_documentation_en-US" xlink:label="lab_abvx_PrincipalAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal Agreements [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PrincipalAgreementsDomain" xlink:to="lab_abvx_PrincipalAgreementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_cbda8f30-ba94-4cab-ac6d-66d2c9aaab52_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA201512Member_c059f999-d8ca-46c9-931b-7788e77e7ed5_terseLabel_en-US" xlink:label="lab_abvx_BSA201512Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2015-12</link:label>
    <link:label id="lab_abvx_BSA201512Member_label_en-US" xlink:label="lab_abvx_BSA201512Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2015-12 [Member]</link:label>
    <link:label id="lab_abvx_BSA201512Member_documentation_en-US" xlink:label="lab_abvx_BSA201512Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2015-12</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA201512Member" xlink:href="abvx-20241231.xsd#abvx_BSA201512Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA201512Member" xlink:to="lab_abvx_BSA201512Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherEmployeesMember_c6d9c4bb-22db-4624-b1ad-8fc4c04f0269_terseLabel_en-US" xlink:label="lab_abvx_OtherEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other employees</link:label>
    <link:label id="lab_abvx_OtherEmployeesMember_label_en-US" xlink:label="lab_abvx_OtherEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Employees [Member]</link:label>
    <link:label id="lab_abvx_OtherEmployeesMember_documentation_en-US" xlink:label="lab_abvx_OtherEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEmployeesMember" xlink:href="abvx-20241231.xsd#abvx_OtherEmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherEmployeesMember" xlink:to="lab_abvx_OtherEmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_3a7e8d39-128b-4ac6-a832-50ba4e04b0f2_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from government grants</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from government grants, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AssetsAcquisitionsAxis_f23d21d0-ecbe-47aa-af04-a3f5371ea8d6_terseLabel_en-US" xlink:label="lab_abvx_AssetsAcquisitionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets Acquisitions [Axis]</link:label>
    <link:label id="lab_abvx_AssetsAcquisitionsAxis_label_en-US" xlink:label="lab_abvx_AssetsAcquisitionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Acquisitions [Axis]</link:label>
    <link:label id="lab_abvx_AssetsAcquisitionsAxis_documentation_en-US" xlink:label="lab_abvx_AssetsAcquisitionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AssetsAcquisitionsAxis" xlink:to="lab_abvx_AssetsAcquisitionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareAbstract_75d07ec1-bc48-41d5-bff4-e8048fefe654_terseLabel_en-US" xlink:label="lab_ifrs-full_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss per share (&#8364;/share)</link:label>
    <link:label id="lab_ifrs-full_EarningsPerShareAbstract_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract" xlink:to="lab_ifrs-full_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccountingProfit_f5d41909-0f21-4a09-aa3a-3c9803e10c0f_terseLabel_en-US" xlink:label="lab_ifrs-full_AccountingProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss before tax</link:label>
    <link:label id="lab_ifrs-full_AccountingProfit_label_en-US" xlink:label="lab_ifrs-full_AccountingProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccountingProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccountingProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit" xlink:to="lab_ifrs-full_AccountingProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_f64a2f40-c376-4fe0-bd58-e53647fa9cca_terseLabel_en-US" xlink:label="lab_abvx_GainsArisingFromRecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Day-one gain on recognition of financial liabilities</link:label>
    <link:label id="lab_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_label_en-US" xlink:label="lab_abvx_GainsArisingFromRecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains Arising From Recognition Of Financial Liabilities</link:label>
    <link:label id="lab_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_documentation_en-US" xlink:label="lab_abvx_GainsArisingFromRecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gains Arising From Recognition Of Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromRecognitionOfFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities" xlink:to="lab_abvx_GainsArisingFromRecognitionOfFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_b2c34162-435b-4829-b3eb-94b6982920d7_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets with indefinite useful life</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets with indefinite useful life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_83b9ff0e-baf8-4b26-9a93-ce7f69689a6e_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase in net defined benefit liability (asset) resulting from current service cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinancialAgreementNumberOfTransactions_aaafc3c2-2d3e-44d5-972f-4ef1bb11dd90_terseLabel_en-US" xlink:label="lab_abvx_FinancialAgreementNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial agreement, number of transactions</link:label>
    <link:label id="lab_abvx_FinancialAgreementNumberOfTransactions_label_en-US" xlink:label="lab_abvx_FinancialAgreementNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Agreement, Number Of Transactions</link:label>
    <link:label id="lab_abvx_FinancialAgreementNumberOfTransactions_documentation_en-US" xlink:label="lab_abvx_FinancialAgreementNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Agreement, Number Of Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementNumberOfTransactions" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementNumberOfTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinancialAgreementNumberOfTransactions" xlink:to="lab_abvx_FinancialAgreementNumberOfTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TradePayablesAndOtherCurrentLiabilitiesMember_4c61df9f-3398-404d-90f9-a9e074649297_terseLabel_en-US" xlink:label="lab_abvx_TradePayablesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade payables and other current liabilities</link:label>
    <link:label id="lab_abvx_TradePayablesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_abvx_TradePayablesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Payables And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_abvx_TradePayablesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_abvx_TradePayablesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade Payables And Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TradePayablesAndOtherCurrentLiabilitiesMember" xlink:href="abvx-20241231.xsd#abvx_TradePayablesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TradePayablesAndOtherCurrentLiabilitiesMember" xlink:to="lab_abvx_TradePayablesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_b6c2711d-bdd0-41b3-99f5-70624ec1a9f0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities breakdown</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_d7333192-d4bf-4481-bde7-5c974cb27fbc_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AssetsAcquisitionsDomain_0f4e99d0-5705-4475-ab52-3213bce33e82_terseLabel_en-US" xlink:label="lab_abvx_AssetsAcquisitionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets Acquisitions [Domain]</link:label>
    <link:label id="lab_abvx_AssetsAcquisitionsDomain_label_en-US" xlink:label="lab_abvx_AssetsAcquisitionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Acquisitions [Domain]</link:label>
    <link:label id="lab_abvx_AssetsAcquisitionsDomain_documentation_en-US" xlink:label="lab_abvx_AssetsAcquisitionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets Acquisitions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AssetsAcquisitionsDomain" xlink:to="lab_abvx_AssetsAcquisitionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_f6d9949c-ad78-44fd-a169-4f7c3a138f9a_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments that are antidilutive in period presented (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_label_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of instruments that are antidilutive in period presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:to="lab_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsTable_caeba995-376b-4529-8565-0ac37ab2eaca_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_7b30d2a1-1221-4a58-8e42-c3e734e972dc_negatedTerseLabel_en-US" xlink:label="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Social taxes related to AGAs</link:label>
    <link:label id="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_8264c939-9e95-4d63-93c1-d1aa91339939_terseLabel_en-US" xlink:label="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Social taxes related to AGAs</link:label>
    <link:label id="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_label_en-US" xlink:label="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense From Equity-Settled Share-Based Payment Transactions, Social Taxes</link:label>
    <link:label id="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_documentation_en-US" xlink:label="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expense From Equity-Settled Share-Based Payment Transactions, Social Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" xlink:to="lab_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_c8c5b7f3-21f0-4546-a218-074d2ba5a3c5_terseLabel_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash-generating units [domain]</link:label>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_label_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash-generating units [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain" xlink:to="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MajorShareBasedTransactionsMember_be5ea8c9-7d7c-4125-b52b-f60cec56f174_terseLabel_en-US" xlink:label="lab_abvx_MajorShareBasedTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major share-based transactions</link:label>
    <link:label id="lab_abvx_MajorShareBasedTransactionsMember_label_en-US" xlink:label="lab_abvx_MajorShareBasedTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Share-Based Transactions [Member]</link:label>
    <link:label id="lab_abvx_MajorShareBasedTransactionsMember_documentation_en-US" xlink:label="lab_abvx_MajorShareBasedTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major Share-Based Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MajorShareBasedTransactionsMember" xlink:href="abvx-20241231.xsd#abvx_MajorShareBasedTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MajorShareBasedTransactionsMember" xlink:to="lab_abvx_MajorShareBasedTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCashAndCashEquivalents_4e93e70a-469b-4c58-855c-d19788729905_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notice accounts</link:label>
    <link:label id="lab_ifrs-full_OtherCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_OtherCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCashAndCashEquivalents" xlink:to="lab_ifrs-full_OtherCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling_31f6c5b5-fadb-454f-907f-f69093804901_terseLabel_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential development milestone payment, IND filing</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling_label_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Potential Development Milestone Payment, IND Filing</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling_documentation_en-US" xlink:label="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Potential Development Milestone Payment, IND Filing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" xlink:to="lab_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember_c69bb6b8-7c5a-4f84-ad9b-b9e60ff221cd_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">WACC</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average cost of capital, measurement input [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember" xlink:to="lab_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseExtensionPeriod_8a8c90ed-d3a3-43b3-9f0a-bd4b032c30e3_terseLabel_en-US" xlink:label="lab_abvx_LeaseExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, extension period</link:label>
    <link:label id="lab_abvx_LeaseExtensionPeriod_label_en-US" xlink:label="lab_abvx_LeaseExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Extension Period</link:label>
    <link:label id="lab_abvx_LeaseExtensionPeriod_documentation_en-US" xlink:label="lab_abvx_LeaseExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseExtensionPeriod" xlink:href="abvx-20241231.xsd#abvx_LeaseExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseExtensionPeriod" xlink:to="lab_abvx_LeaseExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfFinancialInstitutionsToMaintainCash_c5225deb-4355-4c4d-bd83-b1e7790e1035_terseLabel_en-US" xlink:label="lab_abvx_NumberOfFinancialInstitutionsToMaintainCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of financial institutions to maintain cash</link:label>
    <link:label id="lab_abvx_NumberOfFinancialInstitutionsToMaintainCash_label_en-US" xlink:label="lab_abvx_NumberOfFinancialInstitutionsToMaintainCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Financial Institutions To Maintain Cash</link:label>
    <link:label id="lab_abvx_NumberOfFinancialInstitutionsToMaintainCash_documentation_en-US" xlink:label="lab_abvx_NumberOfFinancialInstitutionsToMaintainCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Financial Institutions To Maintain Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFinancialInstitutionsToMaintainCash" xlink:href="abvx-20241231.xsd#abvx_NumberOfFinancialInstitutionsToMaintainCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfFinancialInstitutionsToMaintainCash" xlink:to="lab_abvx_NumberOfFinancialInstitutionsToMaintainCash" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseTacitRenewalPeriod_72460ebc-c9d6-4cbc-bfcb-1409854abfd8_terseLabel_en-US" xlink:label="lab_abvx_LeaseTacitRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, tacit renewal period</link:label>
    <link:label id="lab_abvx_LeaseTacitRenewalPeriod_label_en-US" xlink:label="lab_abvx_LeaseTacitRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Tacit Renewal Period</link:label>
    <link:label id="lab_abvx_LeaseTacitRenewalPeriod_documentation_en-US" xlink:label="lab_abvx_LeaseTacitRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Tacit Renewal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseTacitRenewalPeriod" xlink:href="abvx-20241231.xsd#abvx_LeaseTacitRenewalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseTacitRenewalPeriod" xlink:to="lab_abvx_LeaseTacitRenewalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_06ab06ff-6ec8-4f50-8fd6-19f8d3f1743a_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research tax credit and subsidies</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for government grants [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentFinancialAssets_2f126716-2b4f-4fec-938d-6baa8de6df83_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentFinancialAssets_3f35f5fe-359a-4bb4-a2f9-8112218f83e1_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other non-current financial assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialAssets" xlink:to="lab_ifrs-full_OtherNoncurrentFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_ec59102b-c15b-4877-83e5-1acedbe9cb23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_a71cb449-b5ee-4c7d-ac43-40f51dee8af5_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:to="lab_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherFinanceCost_42c574af-02bd-40c7-b5e8-17bf55d3603e_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_OtherFinanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherFinanceCost_label_en-US" xlink:label="lab_ifrs-full_OtherFinanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other finance cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceCost" xlink:to="lab_ifrs-full_OtherFinanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SalesAndMarketingExpenseMember_8b0bae8d-8392-42a7-a312-61119090674f_terseLabel_en-US" xlink:label="lab_abvx_SalesAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing expenses</link:label>
    <link:label id="lab_abvx_SalesAndMarketingExpenseMember_label_en-US" xlink:label="lab_abvx_SalesAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales And Marketing Expense [Member]</link:label>
    <link:label id="lab_abvx_SalesAndMarketingExpenseMember_documentation_en-US" xlink:label="lab_abvx_SalesAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales And Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SalesAndMarketingExpenseMember" xlink:href="abvx-20241231.xsd#abvx_SalesAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SalesAndMarketingExpenseMember" xlink:to="lab_abvx_SalesAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted_1c8ff115-6327-498f-ac91-8de311173b86_terseLabel_en-US" xlink:label="lab_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STRIKE PRICE PER SHARE ( in euro per share)</link:label>
    <link:label id="lab_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Instrument Strike Price, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Instrument Strike Price, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" xlink:to="lab_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfEquityDomain_117f0b7b-7596-4e0b-a912-6e6b18a4b830_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of equity [domain]</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfEquityDomain_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain" xlink:to="lab_ifrs-full_ComponentsOfEquityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfADSPerOrdinaryShares_fdbc047e-4d68-45ee-a496-3e37c8835824_terseLabel_en-US" xlink:label="lab_abvx_NumberOfADSPerOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of ADS per ordinary shares (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfADSPerOrdinaryShares_label_en-US" xlink:label="lab_abvx_NumberOfADSPerOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of ADS per Ordinary Shares</link:label>
    <link:label id="lab_abvx_NumberOfADSPerOrdinaryShares_documentation_en-US" xlink:label="lab_abvx_NumberOfADSPerOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of ADS per Ordinary Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfADSPerOrdinaryShares" xlink:href="abvx-20241231.xsd#abvx_NumberOfADSPerOrdinaryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfADSPerOrdinaryShares" xlink:to="lab_abvx_NumberOfADSPerOrdinaryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SubsidiesRelatedTemporaryDifferencesMember_a43f42a2-c73b-4cae-ae1a-5d625efb1216_terseLabel_en-US" xlink:label="lab_abvx_SubsidiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidies</link:label>
    <link:label id="lab_abvx_SubsidiesRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_abvx_SubsidiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidies Related Temporary Differences [Member]</link:label>
    <link:label id="lab_abvx_SubsidiesRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_abvx_SubsidiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Subsidies Related Temporary Differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SubsidiesRelatedTemporaryDifferencesMember" xlink:href="abvx-20241231.xsd#abvx_SubsidiesRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SubsidiesRelatedTemporaryDifferencesMember" xlink:to="lab_abvx_SubsidiesRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConversionPricePerShareMeasurementInputMember_9e01500d-037e-45f6-8d7f-e356a6ffbec6_terseLabel_en-US" xlink:label="lab_abvx_ConversionPricePerShareMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price per share (in euro per share)</link:label>
    <link:label id="lab_abvx_ConversionPricePerShareMeasurementInputMember_label_en-US" xlink:label="lab_abvx_ConversionPricePerShareMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Price Per Share, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_ConversionPricePerShareMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_ConversionPricePerShareMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Price Per Share, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPricePerShareMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_ConversionPricePerShareMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConversionPricePerShareMeasurementInputMember" xlink:to="lab_abvx_ConversionPricePerShareMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PeakPenetrationMeasurementInputMember_c057e7a2-7887-4359-b6f5-a77a213749c9_terseLabel_en-US" xlink:label="lab_abvx_PeakPenetrationMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peak penetration</link:label>
    <link:label id="lab_abvx_PeakPenetrationMeasurementInputMember_label_en-US" xlink:label="lab_abvx_PeakPenetrationMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peak Penetration, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_PeakPenetrationMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_PeakPenetrationMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Peak Penetration, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PeakPenetrationMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_PeakPenetrationMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PeakPenetrationMeasurementInputMember" xlink:to="lab_abvx_PeakPenetrationMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock_07ef7393-462d-4a6e-a109-31a7f799e15d_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of effective income tax (loss)</link:label>
    <link:label id="lab_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" xlink:to="lab_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DepreciationExpenseLease_d0627364-4ee4-4dcb-bd2b-c085d5fa30f2_terseLabel_en-US" xlink:label="lab_abvx_DepreciationExpenseLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense, lease</link:label>
    <link:label id="lab_abvx_DepreciationExpenseLease_label_en-US" xlink:label="lab_abvx_DepreciationExpenseLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation Expense, Lease</link:label>
    <link:label id="lab_abvx_DepreciationExpenseLease_documentation_en-US" xlink:label="lab_abvx_DepreciationExpenseLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Depreciation Expense, Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DepreciationExpenseLease" xlink:href="abvx-20241231.xsd#abvx_DepreciationExpenseLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DepreciationExpenseLease" xlink:to="lab_abvx_DepreciationExpenseLease" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_e34a0191-0100-4de0-a8ff-bc7ae4594c75_terseLabel_en-US" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nominal income tax using statutory French tax rate</link:label>
    <link:label id="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_label_en-US" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income) at applicable tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_f151e0e4-848f-4aea-83ad-f2d0efdba32f_terseLabel_en-US" xlink:label="lab_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Scripps Research Institute, University of Chicago and Brigham Young University</link:label>
    <link:label id="lab_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_label_en-US" xlink:label="lab_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Scripps Research Institute, University Of Chicago And Brigham Young University [Member]</link:label>
    <link:label id="lab_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_documentation_en-US" xlink:label="lab_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The Scripps Research Institute, University Of Chicago And Brigham Young University</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:href="abvx-20241231.xsd#abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:to="lab_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_24f5bf99-f8d4-46bc-9431-e09a065f36e3_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_de8c327c-3d62-49eb-9e52-8b31f71449de_periodStartLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities at beginning of period</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_094902b9-308e-4a46-ac09-6baa18bb66a0_periodEndLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities at end of period</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock_2b799b9b-cc0f-491c-98c8-c9e4f9a24a7d_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting of Prosynergia acquisition</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For Assets Acquisitions [Policy Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Policy For Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" xlink:to="lab_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fb5ff9fc-30e2-4d10-bb7a-355402c9e2c0_terseLabel_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [axis]</link:label>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_label_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_9c10a620-1586-4094-87b0-7586253eb521_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_9e05ef3f-f36f-40da-8a0f-cdeb786f1da2_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome" xlink:to="lab_ifrs-full_OtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped_d75f0297-7156-41cc-90f2-400b88543afa_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual revenue from sale of products developed</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Payable, Annual Revenue From Sale Of Products Developed</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Payable, Annual Revenue From Sale Of Products Developed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" xlink:to="lab_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExercisePricePerShareMeasurementInputMember_d14809d6-2461-4afb-b0fe-497b17fe1199_terseLabel_en-US" xlink:label="lab_abvx_ExercisePricePerShareMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price per share (in euro per share)</link:label>
    <link:label id="lab_abvx_ExercisePricePerShareMeasurementInputMember_label_en-US" xlink:label="lab_abvx_ExercisePricePerShareMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Per Share, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_ExercisePricePerShareMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_ExercisePricePerShareMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Per Share, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePerShareMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePerShareMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExercisePricePerShareMeasurementInputMember" xlink:to="lab_abvx_ExercisePricePerShareMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_ea745cb0-6199-43e0-9811-1b8d46f9049b_totalLabel_en-US" xlink:label="lab_abvx_DeferredTaxAssetsRecognisedInFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred taxes, net recognized in the statement of financial position</link:label>
    <link:label id="lab_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_label_en-US" xlink:label="lab_abvx_DeferredTaxAssetsRecognisedInFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Recognised In Financial Position</link:label>
    <link:label id="lab_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_documentation_en-US" xlink:label="lab_abvx_DeferredTaxAssetsRecognisedInFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Recognised In Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition" xlink:href="abvx-20241231.xsd#abvx_DeferredTaxAssetsRecognisedInFinancialPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition" xlink:to="lab_abvx_DeferredTaxAssetsRecognisedInFinancialPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseFacilitiesMember_ce2d450f-35c1-47f8-ab65-614293005460_terseLabel_en-US" xlink:label="lab_abvx_LeaseFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease facilities</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesMember_label_en-US" xlink:label="lab_abvx_LeaseFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Facilities [Member]</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesMember_documentation_en-US" xlink:label="lab_abvx_LeaseFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMember" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseFacilitiesMember" xlink:to="lab_abvx_LeaseFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EmployeesAbstract_label_en-US" xlink:label="lab_abvx_EmployeesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employees [Abstract]</link:label>
    <link:label id="lab_abvx_EmployeesAbstract_documentation_en-US" xlink:label="lab_abvx_EmployeesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EmployeesAbstract" xlink:href="abvx-20241231.xsd#abvx_EmployeesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EmployeesAbstract" xlink:to="lab_abvx_EmployeesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_5dc91597-2eaa-4ddb-8804-97b48aa37c36_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of carrying amounts and fair value of financial assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherFinanceIncome_8cbf6af6-6c2a-4506-8ea1-75e32c0ddba6_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial income</link:label>
    <link:label id="lab_ifrs-full_OtherFinanceIncome_label_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other finance income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceIncome" xlink:to="lab_ifrs-full_OtherFinanceIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromInterest_b7ed54a2-4bd1-4c73-8fda-093623aa35b0_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_ifrs-full_RevenueFromInterest_label_en-US" xlink:label="lab_ifrs-full_RevenueFromInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromInterest" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest" xlink:to="lab_ifrs-full_RevenueFromInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets_049019d7-7512-477a-bb72-bdd4af1561ac_terseLabel_en-US" xlink:label="lab_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease through reassessment of lease term</link:label>
    <link:label id="lab_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets_label_en-US" xlink:label="lab_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease Through Reassessment Of Lease Term, Right-Of-Use Assets</link:label>
    <link:label id="lab_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets_documentation_en-US" xlink:label="lab_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease Through Reassessment Of Lease Term, Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" xlink:to="lab_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProceedsFromReimbursementsOfDeposits_632f12ba-00f8-4239-be99-cb497386ca37_terseLabel_en-US" xlink:label="lab_abvx_ProceedsFromReimbursementsOfDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in Deposits</link:label>
    <link:label id="lab_abvx_ProceedsFromReimbursementsOfDeposits_label_en-US" xlink:label="lab_abvx_ProceedsFromReimbursementsOfDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Reimbursements Of Deposits</link:label>
    <link:label id="lab_abvx_ProceedsFromReimbursementsOfDeposits_documentation_en-US" xlink:label="lab_abvx_ProceedsFromReimbursementsOfDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Reimbursements Of Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromReimbursementsOfDeposits" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromReimbursementsOfDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProceedsFromReimbursementsOfDeposits" xlink:to="lab_abvx_ProceedsFromReimbursementsOfDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_a80277d6-4be5-44eb-a387-89ed3d3db3e9_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elimination of amortization of intangibles and depreciation of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for depreciation and amortisation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_f6594524-94d9-4cf7-97d4-8d1d3f14523f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_212d23c7-c9e5-4d98-aacc-1204620c215f_verboseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossLeaseLiabilities_5e2cb739-c889-4348-bff2-b3848ec2b3e3_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross lease liabilities</link:label>
    <link:label id="lab_ifrs-full_GrossLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_GrossLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities" xlink:to="lab_ifrs-full_GrossLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpenseOnLeaseLiabilities_e88f73fb-41b8-4d0b-a49a-5f90dc256dd6_terseLabel_en-US" xlink:label="lab_abvx_ExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense on lease liabilities</link:label>
    <link:label id="lab_abvx_ExpenseOnLeaseLiabilities_label_en-US" xlink:label="lab_abvx_ExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense On Lease Liabilities</link:label>
    <link:label id="lab_abvx_ExpenseOnLeaseLiabilities_documentation_en-US" xlink:label="lab_abvx_ExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expense On Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseOnLeaseLiabilities" xlink:href="abvx-20241231.xsd#abvx_ExpenseOnLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpenseOnLeaseLiabilities" xlink:to="lab_abvx_ExpenseOnLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfFinancialGainLossLineItems_cafb4677-9be5-48c2-b92d-d9b1406c4f2b_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfFinancialGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfFinancialGainLossLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfFinancialGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfFinancialGainLossLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfFinancialGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFinancialGainLossLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFinancialGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfFinancialGainLossLineItems" xlink:to="lab_abvx_DisclosureOfFinancialGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_GeneralAndAdministrativeExpensesMember_01e4df97-1de9-42ef-bde3-2b268e6c0803_terseLabel_en-US" xlink:label="lab_abvx_GeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_abvx_GeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_abvx_GeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General And Administrative Expenses [Member]</link:label>
    <link:label id="lab_abvx_GeneralAndAdministrativeExpensesMember_documentation_en-US" xlink:label="lab_abvx_GeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">General And Administrative Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GeneralAndAdministrativeExpensesMember" xlink:href="abvx-20241231.xsd#abvx_GeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_GeneralAndAdministrativeExpensesMember" xlink:to="lab_abvx_GeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PretGarantiParLEtatPGEMember_a0045d3d-e7c7-470f-b623-a11cd1b70a81_terseLabel_en-US" xlink:label="lab_abvx_PretGarantiParLEtatPGEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PGE</link:label>
    <link:label id="lab_abvx_PretGarantiParLEtatPGEMember_label_en-US" xlink:label="lab_abvx_PretGarantiParLEtatPGEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pr&#234;t Garanti Par l'Etat (PGE) [Member]</link:label>
    <link:label id="lab_abvx_PretGarantiParLEtatPGEMember_documentation_en-US" xlink:label="lab_abvx_PretGarantiParLEtatPGEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pr&#234;t Garanti Par l'Etat (PGE)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PretGarantiParLEtatPGEMember" xlink:to="lab_abvx_PretGarantiParLEtatPGEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarnOutAmountPayableIfConditionsAreNotMet_b6e42635-6a2d-440b-87f9-ebf6bded0be7_terseLabel_en-US" xlink:label="lab_abvx_EarnOutAmountPayableIfConditionsAreNotMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earn-out, amount payable if conditions are not met</link:label>
    <link:label id="lab_abvx_EarnOutAmountPayableIfConditionsAreNotMet_label_en-US" xlink:label="lab_abvx_EarnOutAmountPayableIfConditionsAreNotMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earn-Out, Amount Payable If Conditions Are Not Met</link:label>
    <link:label id="lab_abvx_EarnOutAmountPayableIfConditionsAreNotMet_documentation_en-US" xlink:label="lab_abvx_EarnOutAmountPayableIfConditionsAreNotMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earn-Out, Amount Payable If Conditions Are Not Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAmountPayableIfConditionsAreNotMet" xlink:href="abvx-20241231.xsd#abvx_EarnOutAmountPayableIfConditionsAreNotMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarnOutAmountPayableIfConditionsAreNotMet" xlink:to="lab_abvx_EarnOutAmountPayableIfConditionsAreNotMet" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_0c88365a-ea99-4422-a4c0-821266971f68_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis" xlink:to="lab_ifrs-full_BorrowingsByNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdvisorToTheChiefExecutiveOfficerMember_68133b38-0f70-4359-b085-638e9bc0a98e_terseLabel_en-US" xlink:label="lab_abvx_AdvisorToTheChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advisor to the Chief Executive Officer</link:label>
    <link:label id="lab_abvx_AdvisorToTheChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_abvx_AdvisorToTheChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advisor To The Chief Executive Officer [Member]</link:label>
    <link:label id="lab_abvx_AdvisorToTheChiefExecutiveOfficerMember_documentation_en-US" xlink:label="lab_abvx_AdvisorToTheChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Advisor To The Chief Executive Officer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdvisorToTheChiefExecutiveOfficerMember" xlink:href="abvx-20241231.xsd#abvx_AdvisorToTheChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdvisorToTheChiefExecutiveOfficerMember" xlink:to="lab_abvx_AdvisorToTheChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_375ca29e-0410-4e31-8d7e-5726ff799ff3_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosABSAMember_9a364a59-1a31-45ce-b43d-17f02e902666_terseLabel_en-US" xlink:label="lab_abvx_KreosABSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos A BSA</link:label>
    <link:label id="lab_abvx_KreosABSAMember_label_en-US" xlink:label="lab_abvx_KreosABSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos A BSA [Member]</link:label>
    <link:label id="lab_abvx_KreosABSAMember_documentation_en-US" xlink:label="lab_abvx_KreosABSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos A BSA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosABSAMember" xlink:to="lab_abvx_KreosABSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotes_2530216a-783b-4935-8f9b-77f7d88441c5_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible loans notes</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotes" xlink:to="lab_abvx_ConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20235Member_7bc26d7e-0533-443e-ab71-f23d2a151b22_terseLabel_en-US" xlink:label="lab_abvx_AGA20235Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2023-5</link:label>
    <link:label id="lab_abvx_AGA20235Member_label_en-US" xlink:label="lab_abvx_AGA20235Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2023-5 [Member]</link:label>
    <link:label id="lab_abvx_AGA20235Member_documentation_en-US" xlink:label="lab_abvx_AGA20235Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2023-5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20235Member" xlink:href="abvx-20241231.xsd#abvx_AGA20235Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20235Member" xlink:to="lab_abvx_AGA20235Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_caeecee0-32d5-4802-854e-d36e14d11bec_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComputerEquipmentMember_82a07c69-8fa9-468a-905a-229d190d6bce_verboseLabel_en-US" xlink:label="lab_ifrs-full_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">IT equipment</link:label>
    <link:label id="lab_ifrs-full_ComputerEquipmentMember_label_en-US" xlink:label="lab_ifrs-full_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer equipment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember" xlink:to="lab_ifrs-full_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember_85611cbd-d6a3-4f01-aa21-8902db2e7997_terseLabel_en-US" xlink:label="lab_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and collaboration agreement with CNRS and University of Montpellier</link:label>
    <link:label id="lab_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember_label_en-US" xlink:label="lab_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Collaboration Agreement With CNRS And University Of Montpellier [Member]</link:label>
    <link:label id="lab_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember_documentation_en-US" xlink:label="lab_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Collaboration Agreement With CNRS And University Of Montpellier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" xlink:href="abvx-20241231.xsd#abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" xlink:to="lab_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfEmployeeWorkforceLineItems_88daad9d-02cc-4ad6-b461-38895336ea08_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfEmployeeWorkforceLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Employee Workforce [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfEmployeeWorkforceLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfEmployeeWorkforceLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Employee Workforce [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfEmployeeWorkforceLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfEmployeeWorkforceLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Employee Workforce [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfEmployeeWorkforceLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfEmployeeWorkforceLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceLineItems" xlink:to="lab_abvx_DisclosureOfEmployeeWorkforceLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_47bdcc0b-d95f-4f16-8681-96459aba1cc5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherLiabilitiesNumberOfTransactions_53359ab9-6371-4292-90e6-08a0af5ca223_terseLabel_en-US" xlink:label="lab_abvx_OtherLiabilitiesNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities, number of transactions</link:label>
    <link:label id="lab_abvx_OtherLiabilitiesNumberOfTransactions_label_en-US" xlink:label="lab_abvx_OtherLiabilitiesNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Number Of Transactions</link:label>
    <link:label id="lab_abvx_OtherLiabilitiesNumberOfTransactions_documentation_en-US" xlink:label="lab_abvx_OtherLiabilitiesNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Liabilities, Number Of Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherLiabilitiesNumberOfTransactions" xlink:href="abvx-20241231.xsd#abvx_OtherLiabilitiesNumberOfTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherLiabilitiesNumberOfTransactions" xlink:to="lab_abvx_OtherLiabilitiesNumberOfTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember_b312298c-19b0-4a42-97c9-55a152a39eb2_terseLabel_en-US" xlink:label="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total BCEs</link:label>
    <link:label id="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember_f0e18c9a-e15e-4f39-b063-20ea8cb7e0af_verboseLabel_en-US" xlink:label="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">BCEs</link:label>
    <link:label id="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember_label_en-US" xlink:label="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Founders&#8217; Share Subscription Warrants (BCE) [Member]</link:label>
    <link:label id="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember_documentation_en-US" xlink:label="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Founders&#8217; Share Subscription Warrants (BCE)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember" xlink:href="abvx-20241231.xsd#abvx_FoundersShareSubscriptionWarrantsBCEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember" xlink:to="lab_abvx_FoundersShareSubscriptionWarrantsBCEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementDomain_7379ea45-6d5e-4b85-8789-0b1061e98ce1_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement [domain]</link:label>
    <link:label id="lab_ifrs-full_MeasurementDomain_label_en-US" xlink:label="lab_ifrs-full_MeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementDomain" xlink:to="lab_ifrs-full_MeasurementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_3644a5c9-26bf-4436-9fb2-9efcd036fbf4_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AMORTIZATION</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation, amortisation and impairment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangeAxis_5ce02417-0ac8-405f-9ac7-12a1a3d706c4_terseLabel_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [axis]</link:label>
    <link:label id="lab_ifrs-full_RangeAxis_label_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis" xlink:to="lab_ifrs-full_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20251Member_c56c9b17-385a-477a-819c-d393fa240137_terseLabel_en-US" xlink:label="lab_abvx_BSA20251Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2025-1</link:label>
    <link:label id="lab_abvx_BSA20251Member_label_en-US" xlink:label="lab_abvx_BSA20251Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2025-1 [Member]</link:label>
    <link:label id="lab_abvx_BSA20251Member_documentation_en-US" xlink:label="lab_abvx_BSA20251Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2025-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20251Member" xlink:href="abvx-20241231.xsd#abvx_BSA20251Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20251Member" xlink:to="lab_abvx_BSA20251Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_8ce9163d-6e4c-4934-b96f-c0555ea1e1b1_terseLabel_en-US" xlink:label="lab_abvx_A49.2MillionCrossOverFinancingSeptember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8364;49.2 million cross-over financing, september 2022</link:label>
    <link:label id="lab_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_label_en-US" xlink:label="lab_abvx_A49.2MillionCrossOverFinancingSeptember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">&#8364;49.2&#160;Million Cross-Over Financing, September 2022 [Member]</link:label>
    <link:label id="lab_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_documentation_en-US" xlink:label="lab_abvx_A49.2MillionCrossOverFinancingSeptember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">&#8364;49.2&#160;Million Cross-Over Financing, September 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member" xlink:href="abvx-20241231.xsd#abvx_A49.2MillionCrossOverFinancingSeptember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member" xlink:to="lab_abvx_A49.2MillionCrossOverFinancingSeptember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheCMember_8faab10d-1575-4bc5-8e46-adf492fb14f6_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing, tranche C</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheCMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche C [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheCMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheCMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingTrancheCMember" xlink:to="lab_abvx_KreosClaretFinancingTrancheCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_42d7c037-79c1-427f-94c2-8c7a41d67b16_terseLabel_en-US" xlink:label="lab_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</link:label>
    <link:label id="lab_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Share Fair Value, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underlying Share Fair Value, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted" xlink:to="lab_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1c9e7504-76d8-4f6b-b8df-80f1b0122060_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of instruments outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_8e2d7257-2da1-4908-9981-0a981fc9f5e9_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of instruments outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock_7bbbb602-06b1-4e7f-8dc2-f1d69e89057e_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of main data and assumptions used for the measurement of convertible loan notes</link:label>
    <link:label id="lab_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Indirect Measurement Of Convertible Loans Instruments [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" xlink:to="lab_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c0b87383-044e-4d34-be51-490054df5f83_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock_38b9dc14-5c51-45db-a519-44e0c92dd318_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of breakdown of operating income</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information Of Operating Income Explanatory [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information Of Operating Income Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" xlink:to="lab_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_dced51e9-1cdc-4c02-b61b-05b5bdca08a4_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember_cdacbd10-9da9-447c-99cc-021b7058cb5c_terseLabel_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Final redemption, probability-weighted fair value with MRI</link:label>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember_label_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Final Redemption, Probability-Weighted Fair Value With MRI , Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Final Redemption, Probability-Weighted Fair Value With MRI , Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" xlink:to="lab_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20243Member_6d5c3ab6-2f6f-42de-9a36-d7cb4420909e_terseLabel_en-US" xlink:label="lab_abvx_AGA20243Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-3</link:label>
    <link:label id="lab_abvx_AGA20243Member_label_en-US" xlink:label="lab_abvx_AGA20243Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-3 [Member]</link:label>
    <link:label id="lab_abvx_AGA20243Member_documentation_en-US" xlink:label="lab_abvx_AGA20243Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20243Member" xlink:href="abvx-20241231.xsd#abvx_AGA20243Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20243Member" xlink:to="lab_abvx_AGA20243Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4685bc08-4821-4970-bcb0-af747065384b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos2TrancheAMember_7164fd4c-dfd2-479d-b151-0f815f60a529_terseLabel_en-US" xlink:label="lab_abvx_Kreos2TrancheAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 2, tranche A</link:label>
    <link:label id="lab_abvx_Kreos2TrancheAMember_label_en-US" xlink:label="lab_abvx_Kreos2TrancheAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 2, Tranche A [Member]</link:label>
    <link:label id="lab_abvx_Kreos2TrancheAMember_documentation_en-US" xlink:label="lab_abvx_Kreos2TrancheAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 2, Tranche A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2TrancheAMember" xlink:href="abvx-20241231.xsd#abvx_Kreos2TrancheAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos2TrancheAMember" xlink:to="lab_abvx_Kreos2TrancheAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfSharesReceivedPerADS_b9e63d0d-b600-4d04-90f1-bc6b4e617364_terseLabel_en-US" xlink:label="lab_abvx_NumberOfSharesReceivedPerADS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares received per ADS (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfSharesReceivedPerADS_label_en-US" xlink:label="lab_abvx_NumberOfSharesReceivedPerADS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Shares Received Per ADS</link:label>
    <link:label id="lab_abvx_NumberOfSharesReceivedPerADS_documentation_en-US" xlink:label="lab_abvx_NumberOfSharesReceivedPerADS" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Shares Received Per ADS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesReceivedPerADS" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesReceivedPerADS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfSharesReceivedPerADS" xlink:to="lab_abvx_NumberOfSharesReceivedPerADS" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CIRTaxYearAxis_2272a3f1-0c48-4964-af89-00aa615ba3ca_terseLabel_en-US" xlink:label="lab_abvx_CIRTaxYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CIR Tax Year [Axis]</link:label>
    <link:label id="lab_abvx_CIRTaxYearAxis_label_en-US" xlink:label="lab_abvx_CIRTaxYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIR Tax Year [Axis]</link:label>
    <link:label id="lab_abvx_CIRTaxYearAxis_documentation_en-US" xlink:label="lab_abvx_CIRTaxYearAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CIR Tax Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CIRTaxYearAxis" xlink:href="abvx-20241231.xsd#abvx_CIRTaxYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CIRTaxYearAxis" xlink:to="lab_abvx_CIRTaxYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareExplanatory_8fbc3872-af69-4823-8889-51ea5da71f28_terseLabel_en-US" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of earnings per share</link:label>
    <link:label id="lab_ifrs-full_EarningsPerShareExplanatory_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FurnitureAndComputerEquipmentMember_1216de9a-5a91-4ece-bb19-96428b588f19_terseLabel_en-US" xlink:label="lab_abvx_FurnitureAndComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FURNITURE AND COMPUTER EQUIPMENT</link:label>
    <link:label id="lab_abvx_FurnitureAndComputerEquipmentMember_label_en-US" xlink:label="lab_abvx_FurnitureAndComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture And Computer Equipment [Member]</link:label>
    <link:label id="lab_abvx_FurnitureAndComputerEquipmentMember_documentation_en-US" xlink:label="lab_abvx_FurnitureAndComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Furniture And Computer Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FurnitureAndComputerEquipmentMember" xlink:href="abvx-20241231.xsd#abvx_FurnitureAndComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FurnitureAndComputerEquipmentMember" xlink:to="lab_abvx_FurnitureAndComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NonCurrentAdvancesToCROContracts_e356d722-0762-468d-9a8f-44ba12338053_terseLabel_en-US" xlink:label="lab_abvx_NonCurrentAdvancesToCROContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advances related to CRO contracts</link:label>
    <link:label id="lab_abvx_NonCurrentAdvancesToCROContracts_label_en-US" xlink:label="lab_abvx_NonCurrentAdvancesToCROContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Advances To CRO Contracts</link:label>
    <link:label id="lab_abvx_NonCurrentAdvancesToCROContracts_documentation_en-US" xlink:label="lab_abvx_NonCurrentAdvancesToCROContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Advances To CRO Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContracts" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NonCurrentAdvancesToCROContracts" xlink:to="lab_abvx_NonCurrentAdvancesToCROContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AuditorInformationAbstract_label_en-US" xlink:label="lab_abvx_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_abvx_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_abvx_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AuditorInformationAbstract" xlink:href="abvx-20241231.xsd#abvx_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AuditorInformationAbstract" xlink:to="lab_abvx_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_4fb4cd85-e2cd-4ad6-b0cc-c7b790580a2f_terseLabel_en-US" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, undiscounted cash flows</link:label>
    <link:label id="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank borrowings, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of financial position [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasTable_fe6d4f48-d675-418d-b8f3-6c35b7cc94a5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of geographical areas [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of geographical areas [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_7f76e83b-71e2-41c4-8679-db9b52d4120f_verboseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gains on financial liabilities at fair value through profit or loss</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on financial liabilities at fair value through profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="lab_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_e808713c-6ee3-4097-9f02-0788760fdc45_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_a60e8226-9b34-4fa2-91da-eeb6b0e52d35_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities" xlink:to="lab_ifrs-full_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LoanGrantedAssetsAcquisitions_f4b786a4-8073-4462-a258-f39482361560_terseLabel_en-US" xlink:label="lab_abvx_LoanGrantedAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loan granted to Prosynergia in 2021</link:label>
    <link:label id="lab_abvx_LoanGrantedAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_LoanGrantedAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loan Granted, Assets Acquisitions</link:label>
    <link:label id="lab_abvx_LoanGrantedAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_LoanGrantedAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loan Granted, Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LoanGrantedAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_LoanGrantedAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LoanGrantedAssetsAcquisitions" xlink:to="lab_abvx_LoanGrantedAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConversionPricePercentageOfInitialPriceThreshold_663358d4-45cb-4c45-98e4-f59ecb9e69b1_terseLabel_en-US" xlink:label="lab_abvx_ConversionPricePercentageOfInitialPriceThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price, percentage of initial price, threshold</link:label>
    <link:label id="lab_abvx_ConversionPricePercentageOfInitialPriceThreshold_label_en-US" xlink:label="lab_abvx_ConversionPricePercentageOfInitialPriceThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Price, Percentage Of Initial Price, Threshold</link:label>
    <link:label id="lab_abvx_ConversionPricePercentageOfInitialPriceThreshold_documentation_en-US" xlink:label="lab_abvx_ConversionPricePercentageOfInitialPriceThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Price, Percentage Of Initial Price, Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPricePercentageOfInitialPriceThreshold" xlink:href="abvx-20241231.xsd#abvx_ConversionPricePercentageOfInitialPriceThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConversionPricePercentageOfInitialPriceThreshold" xlink:to="lab_abvx_ConversionPricePercentageOfInitialPriceThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccrualsClassifiedAsCurrent_726dd2b6-0e47-40dd-9dd0-150529395790_terseLabel_en-US" xlink:label="lab_ifrs-full_AccrualsClassifiedAsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued invoices</link:label>
    <link:label id="lab_ifrs-full_AccrualsClassifiedAsCurrent_label_en-US" xlink:label="lab_ifrs-full_AccrualsClassifiedAsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accruals classified as current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccrualsClassifiedAsCurrent" xlink:to="lab_ifrs-full_AccrualsClassifiedAsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_b04bbbd2-f6e4-49d4-9e7e-8ae608e0315e_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MonteCarloModelIFRSMember_57b9ae9f-61d7-4dac-b541-0bde9ac971fa_terseLabel_en-US" xlink:label="lab_abvx_MonteCarloModelIFRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monte Carlo model</link:label>
    <link:label id="lab_abvx_MonteCarloModelIFRSMember_label_en-US" xlink:label="lab_abvx_MonteCarloModelIFRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Monte Carlo Model IFRS [Member]</link:label>
    <link:label id="lab_abvx_MonteCarloModelIFRSMember_documentation_en-US" xlink:label="lab_abvx_MonteCarloModelIFRSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Monte Carlo Model IFRS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModelIFRSMember" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModelIFRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MonteCarloModelIFRSMember" xlink:to="lab_abvx_MonteCarloModelIFRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20244AGA20245AndAGA20246Member_5aedf59a-42b4-4d80-a738-aad79751c665_terseLabel_en-US" xlink:label="lab_abvx_AGA20244AGA20245AndAGA20246Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-4, AGA-2024-5 and AGA-2024-6</link:label>
    <link:label id="lab_abvx_AGA20244AGA20245AndAGA20246Member_label_en-US" xlink:label="lab_abvx_AGA20244AGA20245AndAGA20246Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-4, AGA-2024-5 and AGA-2024-6 [Member]</link:label>
    <link:label id="lab_abvx_AGA20244AGA20245AndAGA20246Member_documentation_en-US" xlink:label="lab_abvx_AGA20244AGA20245AndAGA20246Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-4, AGA-2024-5 and AGA-2024-6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244AGA20245AndAGA20246Member" xlink:href="abvx-20241231.xsd#abvx_AGA20244AGA20245AndAGA20246Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20244AGA20245AndAGA20246Member" xlink:to="lab_abvx_AGA20244AGA20245AndAGA20246Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentFinancialLiabilitiesMember_2ffd3b85-f02e-4472-9f69-c160c9865fe1_terseLabel_en-US" xlink:label="lab_abvx_CurrentFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities-current portion</link:label>
    <link:label id="lab_abvx_CurrentFinancialLiabilitiesMember_label_en-US" xlink:label="lab_abvx_CurrentFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Financial Liabilities [Member]</link:label>
    <link:label id="lab_abvx_CurrentFinancialLiabilitiesMember_documentation_en-US" xlink:label="lab_abvx_CurrentFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentFinancialLiabilitiesMember" xlink:href="abvx-20241231.xsd#abvx_CurrentFinancialLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentFinancialLiabilitiesMember" xlink:to="lab_abvx_CurrentFinancialLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnobservableInputsAxis_33925e4a-e013-45ba-9c3a-ed39295dae1a_terseLabel_en-US" xlink:label="lab_ifrs-full_UnobservableInputsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unobservable inputs [axis]</link:label>
    <link:label id="lab_ifrs-full_UnobservableInputsAxis_label_en-US" xlink:label="lab_ifrs-full_UnobservableInputsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unobservable inputs [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnobservableInputsAxis" xlink:to="lab_ifrs-full_UnobservableInputsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_669d60ab-fc08-4884-b2fc-9bbb162bf2ed_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_4e92018b-4230-46a8-853c-3df57be92049_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_label_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other temporary differences [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:to="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities_b5eaa011-b354-4e90-9404-73df22331741_terseLabel_en-US" xlink:label="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax and employee-related payables</link:label>
    <link:label id="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities_2f44db62-1dd7-4290-8a0f-6975a682fb6f_totalLabel_en-US" xlink:label="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Tax and employee-related payables</link:label>
    <link:label id="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities_label_en-US" xlink:label="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Tax And Employee Benefit Liabilities</link:label>
    <link:label id="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities_documentation_en-US" xlink:label="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Tax And Employee Benefit Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities" xlink:href="abvx-20241231.xsd#abvx_CurrentTaxAndEmployeeBenefitLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities" xlink:to="lab_abvx_CurrentTaxAndEmployeeBenefitLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_1b6ba89a-79b9-47e5-b356-521a357b2325_periodStartLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) at beginning of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_5b4236bf-900a-4277-9d9a-d05a77ed2f8e_periodEndLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) at end of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherShareWarrantsExercisePeriod_e201fe4d-e0b8-44ab-aa1c-c1bb2aa85fab_terseLabel_en-US" xlink:label="lab_abvx_OtherShareWarrantsExercisePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other share warrants, exercise period</link:label>
    <link:label id="lab_abvx_OtherShareWarrantsExercisePeriod_label_en-US" xlink:label="lab_abvx_OtherShareWarrantsExercisePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Share Warrants, Exercise Period</link:label>
    <link:label id="lab_abvx_OtherShareWarrantsExercisePeriod_documentation_en-US" xlink:label="lab_abvx_OtherShareWarrantsExercisePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Share Warrants, Exercise Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsExercisePeriod" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsExercisePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherShareWarrantsExercisePeriod" xlink:to="lab_abvx_OtherShareWarrantsExercisePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RestatedMember_89427abd-1409-4304-be8e-23aa6e1ba4cc_terseLabel_en-US" xlink:label="lab_ifrs-full_RestatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currently stated [member]</link:label>
    <link:label id="lab_ifrs-full_RestatedMember_label_en-US" xlink:label="lab_ifrs-full_RestatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currently stated [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestatedMember" xlink:to="lab_ifrs-full_RestatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock_f6b52672-31fa-4b3b-b423-ebfb4a944c0b_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of allocation of acquisition cost</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions Explanatory [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" xlink:to="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20171Member_895d3a1e-8005-4530-8e3d-4461cbc73bf0_terseLabel_en-US" xlink:label="lab_abvx_BSA20171Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2017-1</link:label>
    <link:label id="lab_abvx_BSA20171Member_label_en-US" xlink:label="lab_abvx_BSA20171Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2017-1 [Member]</link:label>
    <link:label id="lab_abvx_BSA20171Member_documentation_en-US" xlink:label="lab_abvx_BSA20171Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2017-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20171Member" xlink:href="abvx-20241231.xsd#abvx_BSA20171Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20171Member" xlink:to="lab_abvx_BSA20171Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20242Member_bff7d0c7-50ab-4041-a322-8f1169d128ff_terseLabel_en-US" xlink:label="lab_abvx_BSA20242Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA 2024-2</link:label>
    <link:label id="lab_abvx_BSA20242Member_label_en-US" xlink:label="lab_abvx_BSA20242Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2024-2 [Member]</link:label>
    <link:label id="lab_abvx_BSA20242Member_documentation_en-US" xlink:label="lab_abvx_BSA20242Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2024-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20242Member" xlink:href="abvx-20241231.xsd#abvx_BSA20242Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20242Member" xlink:to="lab_abvx_BSA20242Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FurnitureMember_575c5a9e-5e60-48fd-beb8-5b1987827cf7_terseLabel_en-US" xlink:label="lab_abvx_FurnitureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture</link:label>
    <link:label id="lab_abvx_FurnitureMember_label_en-US" xlink:label="lab_abvx_FurnitureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture [Member]</link:label>
    <link:label id="lab_abvx_FurnitureMember_documentation_en-US" xlink:label="lab_abvx_FurnitureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Furniture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FurnitureMember" xlink:href="abvx-20241231.xsd#abvx_FurnitureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FurnitureMember" xlink:to="lab_abvx_FurnitureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_HeightsConvertibleNotesMember_5bf3607e-c6d3-401f-95a1-68cba3dd8677_terseLabel_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Heights convertible notes</link:label>
    <link:label id="lab_abvx_HeightsConvertibleNotesMember_label_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Heights Convertible Notes [Member]</link:label>
    <link:label id="lab_abvx_HeightsConvertibleNotesMember_documentation_en-US" xlink:label="lab_abvx_HeightsConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Heights Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_HeightsConvertibleNotesMember" xlink:to="lab_abvx_HeightsConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfessionalFeesExpense_9e3a45d7-b7fc-4fd9-b8a9-397a0d6051c5_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfessionalFeesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consulting and professional fees</link:label>
    <link:label id="lab_ifrs-full_ProfessionalFeesExpense_label_en-US" xlink:label="lab_ifrs-full_ProfessionalFeesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional fees expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense" xlink:to="lab_ifrs-full_ProfessionalFeesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_484c317e-74f7-4b21-a38e-d913d0c568ba_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsMaturityDeferralPeriod_79696bcd-f939-4914-b3e3-1518b112cbe4_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsMaturityDeferralPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings maturity, deferral period</link:label>
    <link:label id="lab_abvx_BorrowingsMaturityDeferralPeriod_label_en-US" xlink:label="lab_abvx_BorrowingsMaturityDeferralPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings Maturity, Deferral Period</link:label>
    <link:label id="lab_abvx_BorrowingsMaturityDeferralPeriod_documentation_en-US" xlink:label="lab_abvx_BorrowingsMaturityDeferralPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings Maturity, Deferral Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityDeferralPeriod" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityDeferralPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsMaturityDeferralPeriod" xlink:to="lab_abvx_BorrowingsMaturityDeferralPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentReceivablesFromCreditNotes_13c9f94f-724f-4750-9426-eb7bd8d8f4aa_terseLabel_en-US" xlink:label="lab_abvx_CurrentReceivablesFromCreditNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit notes</link:label>
    <link:label id="lab_abvx_CurrentReceivablesFromCreditNotes_label_en-US" xlink:label="lab_abvx_CurrentReceivablesFromCreditNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Receivables From Credit Notes</link:label>
    <link:label id="lab_abvx_CurrentReceivablesFromCreditNotes_documentation_en-US" xlink:label="lab_abvx_CurrentReceivablesFromCreditNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Receivables From Credit Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesFromCreditNotes" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesFromCreditNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentReceivablesFromCreditNotes" xlink:to="lab_abvx_CurrentReceivablesFromCreditNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfCommitmentsReceivedTable_87ca4247-c778-4929-b038-4cfa555adf2c_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfCommitmentsReceivedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Commitments Received [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfCommitmentsReceivedTable_label_en-US" xlink:label="lab_abvx_DisclosureOfCommitmentsReceivedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Commitments Received [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfCommitmentsReceivedTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfCommitmentsReceivedTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Commitments Received [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCommitmentsReceivedTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCommitmentsReceivedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedTable" xlink:to="lab_abvx_DisclosureOfCommitmentsReceivedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativesMember_bbe160ad-1175-4332-9d13-2623a53eaac5_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_ifrs-full_DerivativesMember_label_en-US" xlink:label="lab_ifrs-full_DerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativesMember" xlink:to="lab_ifrs-full_DerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_4e4d22eb-a701-4243-803a-f76ac5a5a2a5_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non cash changes: additional leases</link:label>
    <link:label id="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase through new leases, liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_e4dc15ce-05c4-46a7-ae09-f1f93cdfaf3e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_7c3725fa-da66-41ef-975b-3b1965ffc85f_negatedNetLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible decrease in unobservable input, liabilities</link:label>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible decrease in unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_70dd0bf6-6922-4acf-b218-3e1abc7849f9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfProbabilityWeightedScenarios_8071be01-cd93-4eaf-9fa4-1c4f72c04a84_terseLabel_en-US" xlink:label="lab_abvx_NumberOfProbabilityWeightedScenarios" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of probability-weighted scenarios</link:label>
    <link:label id="lab_abvx_NumberOfProbabilityWeightedScenarios_label_en-US" xlink:label="lab_abvx_NumberOfProbabilityWeightedScenarios" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Probability-Weighted Scenarios</link:label>
    <link:label id="lab_abvx_NumberOfProbabilityWeightedScenarios_documentation_en-US" xlink:label="lab_abvx_NumberOfProbabilityWeightedScenarios" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Probability-Weighted Scenarios</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfProbabilityWeightedScenarios" xlink:href="abvx-20241231.xsd#abvx_NumberOfProbabilityWeightedScenarios"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfProbabilityWeightedScenarios" xlink:to="lab_abvx_NumberOfProbabilityWeightedScenarios" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CreditSpreadMeasurementInputMember_4f4a6fc3-7622-42e6-9143-3b2a6d753bdf_terseLabel_en-US" xlink:label="lab_ifrs-full_CreditSpreadMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit spread</link:label>
    <link:label id="lab_ifrs-full_CreditSpreadMeasurementInputMember_label_en-US" xlink:label="lab_ifrs-full_CreditSpreadMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit spread, measurement input [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditSpreadMeasurementInputMember" xlink:to="lab_ifrs-full_CreditSpreadMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember_95539e9c-ff20-4c5d-9bf0-ee3fe6d67bb4_terseLabel_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development contract with license option with CNRS, University of Montpellier and Theradiag</link:label>
    <link:label id="lab_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember_label_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Contract With License Option With CNRS, University Of Montpellier And Theradiag [Member]</link:label>
    <link:label id="lab_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember_documentation_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Contract With License Option With CNRS, University Of Montpellier And Theradiag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" xlink:to="lab_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CashAndCashEquivalentMember_e25b4ca7-2f55-4282-b399-401b54b9125b_terseLabel_en-US" xlink:label="lab_abvx_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_abvx_CashAndCashEquivalentMember_label_en-US" xlink:label="lab_abvx_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent [Member]</link:label>
    <link:label id="lab_abvx_CashAndCashEquivalentMember_documentation_en-US" xlink:label="lab_abvx_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAndCashEquivalentMember" xlink:href="abvx-20241231.xsd#abvx_CashAndCashEquivalentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CashAndCashEquivalentMember" xlink:to="lab_abvx_CashAndCashEquivalentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_c33b0c7e-53de-48b5-bfcc-c7b5b1d2c991_negatedTerseLabel_en-US" xlink:label="lab_abvx_LiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_abvx_LiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities Recognised As Of Acquisition Date</link:label>
    <link:label id="lab_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_abvx_LiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liabilities Recognised As Of Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="abvx-20241231.xsd#abvx_LiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lab_abvx_LiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_50dac3e7-0561-4101-8773-b6065d6a4ea3_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LONGER THAN 5 YEARS</link:label>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SplicosSASABX464Member_f0aaf06a-fcb1-45b8-98ac-7bf81433cb75_terseLabel_en-US" xlink:label="lab_abvx_SplicosSASABX464Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Splicos SAS</link:label>
    <link:label id="lab_abvx_SplicosSASABX464Member_label_en-US" xlink:label="lab_abvx_SplicosSASABX464Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Splicos SAS - ABX464 [Member]</link:label>
    <link:label id="lab_abvx_SplicosSASABX464Member_documentation_en-US" xlink:label="lab_abvx_SplicosSASABX464Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Splicos SAS - ABX464</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SplicosSASABX464Member" xlink:href="abvx-20241231.xsd#abvx_SplicosSASABX464Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SplicosSASABX464Member" xlink:to="lab_abvx_SplicosSASABX464Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OceaneConversionOptionMember_34bec05c-f5ca-4906-81b6-c351262fe41e_terseLabel_en-US" xlink:label="lab_abvx_OceaneConversionOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Oceane conversion option</link:label>
    <link:label id="lab_abvx_OceaneConversionOptionMember_ea1d912b-7c10-4e2f-98a5-b708f9d499b5_verboseLabel_en-US" xlink:label="lab_abvx_OceaneConversionOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">OCEANE conversion option</link:label>
    <link:label id="lab_abvx_OceaneConversionOptionMember_label_en-US" xlink:label="lab_abvx_OceaneConversionOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oceane Conversion Option [Member]</link:label>
    <link:label id="lab_abvx_OceaneConversionOptionMember_documentation_en-US" xlink:label="lab_abvx_OceaneConversionOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Oceane Conversion Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OceaneConversionOptionMember" xlink:to="lab_abvx_OceaneConversionOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory_7b3a921b-e1ab-460f-a033-912518e27cb3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of other financial assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_408f2907-3397-4f56-b968-cd2dff801e89_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_04553ad6-209e-4d12-bd14-fa1defad6dd5_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible increase in unobservable input, assets</link:label>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_label_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible increase in unobservable input, assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_a06796cb-f603-4136-9a79-5580e339895f_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from sale of treasury shares</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale or issue of treasury shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:to="lab_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_cf2ccb82-76c2-4b8e-ad66-4100d500ae1b_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss_bb219863-f5bf-4466-9f94-227f4508578d_negatedTerseLabel_en-US" xlink:label="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reasonably possible change in risk variable, impact on foreign exchange</link:label>
    <link:label id="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss_label_en-US" xlink:label="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Foreign Exchange Gain (Loss)</link:label>
    <link:label id="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss_documentation_en-US" xlink:label="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Foreign Exchange Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" xlink:href="abvx-20241231.xsd#abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" xlink:to="lab_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfFreeSharesPlansIssued_2d03f611-35cb-4f3a-93eb-9dfa1a58f5e2_terseLabel_en-US" xlink:label="lab_abvx_NumberOfFreeSharesPlansIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of free shares plans issued</link:label>
    <link:label id="lab_abvx_NumberOfFreeSharesPlansIssued_label_en-US" xlink:label="lab_abvx_NumberOfFreeSharesPlansIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Free Shares Plans Issued</link:label>
    <link:label id="lab_abvx_NumberOfFreeSharesPlansIssued_documentation_en-US" xlink:label="lab_abvx_NumberOfFreeSharesPlansIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Free Shares Plans Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesPlansIssued" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesPlansIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfFreeSharesPlansIssued" xlink:to="lab_abvx_NumberOfFreeSharesPlansIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FormerChiefExecutiveOfficerMember_ebfc71fe-096a-4fbf-b22d-fe0e0c221443_terseLabel_en-US" xlink:label="lab_abvx_FormerChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Former Chief Executive Officer</link:label>
    <link:label id="lab_abvx_FormerChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_abvx_FormerChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former Chief Executive Officer [Member]</link:label>
    <link:label id="lab_abvx_FormerChiefExecutiveOfficerMember_documentation_en-US" xlink:label="lab_abvx_FormerChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Former Chief Executive Officer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FormerChiefExecutiveOfficerMember" xlink:href="abvx-20241231.xsd#abvx_FormerChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FormerChiefExecutiveOfficerMember" xlink:to="lab_abvx_FormerChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5c873d2d-2743-4816-9b03-3ce84a9561df_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_858d0dc7-743a-4be4-85f7-3fdca12cf1a7_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elimination of retirement benefit obligations</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in employee benefit liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinancialAgreementDomain_eb2398f7-6310-4d88-a283-8e1b1d1b2ad1_terseLabel_en-US" xlink:label="lab_abvx_FinancialAgreementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Agreement [Domain]</link:label>
    <link:label id="lab_abvx_FinancialAgreementDomain_label_en-US" xlink:label="lab_abvx_FinancialAgreementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Agreement [Domain]</link:label>
    <link:label id="lab_abvx_FinancialAgreementDomain_documentation_en-US" xlink:label="lab_abvx_FinancialAgreementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Agreement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinancialAgreementDomain" xlink:to="lab_abvx_FinancialAgreementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MinimalReturnMeasurementInputMember_b354f831-54d3-45ab-b1f0-e9cc5d17df15_terseLabel_en-US" xlink:label="lab_abvx_MinimalReturnMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimal return</link:label>
    <link:label id="lab_abvx_MinimalReturnMeasurementInputMember_label_en-US" xlink:label="lab_abvx_MinimalReturnMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimal Return, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_MinimalReturnMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_MinimalReturnMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimal Return, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MinimalReturnMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_MinimalReturnMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MinimalReturnMeasurementInputMember" xlink:to="lab_abvx_MinimalReturnMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Cash_ddd84e96-9245-41d7-b3f8-530206b8560b_terseLabel_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_ifrs-full_Cash_label_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash" xlink:to="lab_ifrs-full_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ContributionToGroupsNetProfitsLossesPercentage_d4378621-3d7b-4311-b19f-1a8d62e1b280_terseLabel_en-US" xlink:label="lab_abvx_ContributionToGroupsNetProfitsLossesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution to Group's net profits (losses), percentage</link:label>
    <link:label id="lab_abvx_ContributionToGroupsNetProfitsLossesPercentage_label_en-US" xlink:label="lab_abvx_ContributionToGroupsNetProfitsLossesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contribution To Group's Net Profits (Losses), Percentage</link:label>
    <link:label id="lab_abvx_ContributionToGroupsNetProfitsLossesPercentage_documentation_en-US" xlink:label="lab_abvx_ContributionToGroupsNetProfitsLossesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contribution To Group's Net Profits (Losses), Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsNetProfitsLossesPercentage" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsNetProfitsLossesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ContributionToGroupsNetProfitsLossesPercentage" xlink:to="lab_abvx_ContributionToGroupsNetProfitsLossesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0b7a66b8-d94d-40f1-8690-0d63fc82a2d9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IndustrialMaterialsAndEquipmentMember_cc280a69-87a0-4cf8-a8c5-cb020d9d8c40_terseLabel_en-US" xlink:label="lab_abvx_IndustrialMaterialsAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Industrial materials and equipment</link:label>
    <link:label id="lab_abvx_IndustrialMaterialsAndEquipmentMember_label_en-US" xlink:label="lab_abvx_IndustrialMaterialsAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Industrial Materials And Equipment [Member]</link:label>
    <link:label id="lab_abvx_IndustrialMaterialsAndEquipmentMember_documentation_en-US" xlink:label="lab_abvx_IndustrialMaterialsAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Industrial Materials And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IndustrialMaterialsAndEquipmentMember" xlink:href="abvx-20241231.xsd#abvx_IndustrialMaterialsAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IndustrialMaterialsAndEquipmentMember" xlink:to="lab_abvx_IndustrialMaterialsAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_WittycelSASABX196Member_04530e0c-69be-49a5-b619-68394cbb4082_terseLabel_en-US" xlink:label="lab_abvx_WittycelSASABX196Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wittycel SAS</link:label>
    <link:label id="lab_abvx_WittycelSASABX196Member_label_en-US" xlink:label="lab_abvx_WittycelSASABX196Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wittycel SAS - ABX196 [Member]</link:label>
    <link:label id="lab_abvx_WittycelSASABX196Member_documentation_en-US" xlink:label="lab_abvx_WittycelSASABX196Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wittycel SAS - ABX196</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WittycelSASABX196Member" xlink:href="abvx-20241231.xsd#abvx_WittycelSASABX196Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_WittycelSASABX196Member" xlink:to="lab_abvx_WittycelSASABX196Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_41cbb4fd-bccf-4baf-a8d3-5af6469803bb_negatedLabel_en-US" xlink:label="lab_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amount of reasonably possible decrease in unobservable input, liabilities</link:label>
    <link:label id="lab_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount Of Reasonably Possible Decrease In Unobservable Input, Liabilities</link:label>
    <link:label id="lab_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_documentation_en-US" xlink:label="lab_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount Of Reasonably Possible Decrease In Unobservable Input, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:to="lab_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7134fea6-c265-4c72-87b8-f84f5f26e6f3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20234Member_1f209732-102d-4ec0-bbb2-2f0d2788a27e_terseLabel_en-US" xlink:label="lab_abvx_AGA20234Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2023-4</link:label>
    <link:label id="lab_abvx_AGA20234Member_label_en-US" xlink:label="lab_abvx_AGA20234Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2023-4 [Member]</link:label>
    <link:label id="lab_abvx_AGA20234Member_documentation_en-US" xlink:label="lab_abvx_AGA20234Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2023-4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20234Member" xlink:href="abvx-20241231.xsd#abvx_AGA20234Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20234Member" xlink:to="lab_abvx_AGA20234Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_e5444e6e-fd1a-4cdd-9347-77ab1930c5c2_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of goodwill, intangible assets, property and plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for impairment of non-financial assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_8b6e9182-fff9-414e-aba0-168d57259798_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of entity's operating segments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_027485d4-bc22-4b90-a723-543d1ce1ca6e_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Items that are or may be reclassified subsequently to profit or loss</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfRetirementAge2019_93dc6a5f-770a-4a7c-b0ec-f99fc2fe4235_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfRetirementAge2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement age</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfRetirementAge2019_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfRetirementAge2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of retirement age</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfRetirementAge2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019" xlink:to="lab_ifrs-full_ActuarialAssumptionOfRetirementAge2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_aa68a294-6f0b-4b32-8650-8fa6aff9f544_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities_b9f1b565-c4c7-4338-b2fe-3ed55ca2a2b5_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Classification of Embedded Derivatives as Separate Financial Instruments, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Classification of Embedded Derivatives as Separate Financial Instruments, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingBSAMember_39d7b41a-5805-4abe-b512-eb4edeb19c21_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingBSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos / Claret BSA</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingBSAMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingBSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, BSA [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingBSAMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingBSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, BSA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingBSAMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingBSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingBSAMember" xlink:to="lab_abvx_KreosClaretFinancingBSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IntellectualPropertyFees_beb7588a-45bb-45a3-af0f-eaa249a9f1a1_terseLabel_en-US" xlink:label="lab_abvx_IntellectualPropertyFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intellectual property fees</link:label>
    <link:label id="lab_abvx_IntellectualPropertyFees_label_en-US" xlink:label="lab_abvx_IntellectualPropertyFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intellectual Property Fees</link:label>
    <link:label id="lab_abvx_IntellectualPropertyFees_documentation_en-US" xlink:label="lab_abvx_IntellectualPropertyFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intellectual Property Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IntellectualPropertyFees" xlink:href="abvx-20241231.xsd#abvx_IntellectualPropertyFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IntellectualPropertyFees" xlink:to="lab_abvx_IntellectualPropertyFees" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RoyaltyCertificatesMember_168155b1-ae0d-4a5b-b236-6ff147580d30_terseLabel_en-US" xlink:label="lab_abvx_RoyaltyCertificatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty certificates</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatesMember_label_en-US" xlink:label="lab_abvx_RoyaltyCertificatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Certificates [Member]</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatesMember_documentation_en-US" xlink:label="lab_abvx_RoyaltyCertificatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Certificates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RoyaltyCertificatesMember" xlink:to="lab_abvx_RoyaltyCertificatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_bf61e5e9-2ca2-4918-836b-2fdbb4f5d459_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current other assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="lab_ifrs-full_OtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20183Member_66c2d3af-2579-45e5-8807-326057d02fc7_terseLabel_en-US" xlink:label="lab_abvx_BCE20183Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE 2018-3</link:label>
    <link:label id="lab_abvx_BCE20183Member_label_en-US" xlink:label="lab_abvx_BCE20183Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2018-3 [Member]</link:label>
    <link:label id="lab_abvx_BCE20183Member_documentation_en-US" xlink:label="lab_abvx_BCE20183Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2018-3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20183Member" xlink:href="abvx-20241231.xsd#abvx_BCE20183Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20183Member" xlink:to="lab_abvx_BCE20183Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsNumberOfTranches_1f886720-a7da-4e87-8530-477d6607d655_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, number of tranches</link:label>
    <link:label id="lab_abvx_BorrowingsNumberOfTranches_label_en-US" xlink:label="lab_abvx_BorrowingsNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Number Of Tranches</link:label>
    <link:label id="lab_abvx_BorrowingsNumberOfTranches_documentation_en-US" xlink:label="lab_abvx_BorrowingsNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Number Of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsNumberOfTranches" xlink:to="lab_abvx_BorrowingsNumberOfTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DiscountedCashFlowMember_94524e59-5ed9-4ce0-8831-63fc0a7ea8f6_terseLabel_en-US" xlink:label="lab_ifrs-full_DiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discounted cash flow</link:label>
    <link:label id="lab_ifrs-full_DiscountedCashFlowMember_label_en-US" xlink:label="lab_ifrs-full_DiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discounted cash flow [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountedCashFlowMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DiscountedCashFlowMember" xlink:to="lab_ifrs-full_DiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ShareIssueRelatedCostCredit_f8192190-599d-40be-b10c-2d95efc61a8b_negatedTerseLabel_en-US" xlink:label="lab_abvx_ShareIssueRelatedCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs related to capital increase</link:label>
    <link:label id="lab_abvx_ShareIssueRelatedCostCredit_label_en-US" xlink:label="lab_abvx_ShareIssueRelatedCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Issue Related Cost (Credit)</link:label>
    <link:label id="lab_abvx_ShareIssueRelatedCostCredit_documentation_en-US" xlink:label="lab_abvx_ShareIssueRelatedCostCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Issue Related Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareIssueRelatedCostCredit" xlink:href="abvx-20241231.xsd#abvx_ShareIssueRelatedCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ShareIssueRelatedCostCredit" xlink:to="lab_abvx_ShareIssueRelatedCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_1092e204-71e6-4671-a2bb-cd3eef19e741_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_d61b6ac3-6dca-49d8-8dde-9cc3a7c9edbb_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, post-employment benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_fc4b7a18-f8b0-476f-b182-5ac996a6a201_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elimination of Impairment loss of goodwill</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e41631ec-3c5a-41f1-8ce7-1845de8a41cf_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValue_a853901b-f4fb-430b-8c74-5ea2c264f6e9_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets, at fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValue_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_c65e536a-3f42-412e-b804-6da5061aaf8b_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment including right-of-use assets [axis]</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment including right-of-use assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_c6edf46f-d652-4efb-af16-e98d48732bcc_terseLabel_en-US" xlink:label="lab_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VOLATILITY</link:label>
    <link:label id="lab_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Volatility, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected Volatility, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_ExpectedVolatilityOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:to="lab_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_d96a0de2-5068-4c5a-8397-0d90affb801d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of intangible assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_5842bb3a-f260-4f69-9a32-526bec1d639f_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in financial liabilities at fair value due to reasonably possible decrease in unobservable input</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:to="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherReceivablesAndAssetsMember_dd2e4ab9-2ddb-4553-8c05-da7c2a98a788_terseLabel_en-US" xlink:label="lab_abvx_OtherReceivablesAndAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables and assets</link:label>
    <link:label id="lab_abvx_OtherReceivablesAndAssetsMember_label_en-US" xlink:label="lab_abvx_OtherReceivablesAndAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables And Assets [Member]</link:label>
    <link:label id="lab_abvx_OtherReceivablesAndAssetsMember_documentation_en-US" xlink:label="lab_abvx_OtherReceivablesAndAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Receivables And Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherReceivablesAndAssetsMember" xlink:href="abvx-20241231.xsd#abvx_OtherReceivablesAndAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherReceivablesAndAssetsMember" xlink:to="lab_abvx_OtherReceivablesAndAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_label_en-US" xlink:label="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate information and statement of IFRS compliance [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_07548318-a70c-49dc-8920-dcf6edbce0e8_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_d6e1bb94-df8b-40be-864b-66501b94d0ca_periodStartLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill at beginning of period</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_c0e4869b-0173-4ae7-b030-dca9e0c066b5_periodEndLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill at end of period</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d46d75c9-332e-46db-8298-b6b9f91a1760_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_66e6b3ab-6aea-4ff6-9f2b-922fd52287cd_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [domain]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfAcademicInstitutions_65f135f1-b336-421f-b7cd-7343e8312f28_terseLabel_en-US" xlink:label="lab_abvx_NumberOfAcademicInstitutions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of academic institutions</link:label>
    <link:label id="lab_abvx_NumberOfAcademicInstitutions_label_en-US" xlink:label="lab_abvx_NumberOfAcademicInstitutions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Academic Institutions</link:label>
    <link:label id="lab_abvx_NumberOfAcademicInstitutions_documentation_en-US" xlink:label="lab_abvx_NumberOfAcademicInstitutions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Academic Institutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfAcademicInstitutions" xlink:href="abvx-20241231.xsd#abvx_NumberOfAcademicInstitutions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfAcademicInstitutions" xlink:to="lab_abvx_NumberOfAcademicInstitutions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalAxis_1bd20a5d-22bd-40f5-b85a-ae060e2a9b78_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_446ab2dd-1166-484a-a575-e42a9d52cb30_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_834d54f2-bc26-4204-98f8-27ad0993877c_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_af7f6312-dbce-4933-b445-b6c9e36f58d7_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLiabilitiesAbstract_6b241a46-058f-4240-b3ff-2bce035c326e_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfProjectsTerminated_4b273f18-f3b0-4a57-b1c4-ee3707ced39c_terseLabel_en-US" xlink:label="lab_abvx_NumberOfProjectsTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of projects terminated</link:label>
    <link:label id="lab_abvx_NumberOfProjectsTerminated_label_en-US" xlink:label="lab_abvx_NumberOfProjectsTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Projects Terminated</link:label>
    <link:label id="lab_abvx_NumberOfProjectsTerminated_documentation_en-US" xlink:label="lab_abvx_NumberOfProjectsTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Projects Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfProjectsTerminated" xlink:href="abvx-20241231.xsd#abvx_NumberOfProjectsTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfProjectsTerminated" xlink:to="lab_abvx_NumberOfProjectsTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansTrancheAMember_e1a7559d-d55c-447d-adc8-7be22322eece_terseLabel_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 1, convertible bond loans, tranche A</link:label>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansTrancheAMember_label_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1, Convertible Bond Loans, Tranche A [Member]</link:label>
    <link:label id="lab_abvx_Kreos1ConvertibleBondLoansTrancheAMember_documentation_en-US" xlink:label="lab_abvx_Kreos1ConvertibleBondLoansTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1, Convertible Bond Loans, Tranche A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember" xlink:to="lab_abvx_Kreos1ConvertibleBondLoansTrancheAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_WarrantsDomain_c103372e-9561-469b-8d55-3b1760db0b94_terseLabel_en-US" xlink:label="lab_abvx_WarrantsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants [Domain]</link:label>
    <link:label id="lab_abvx_WarrantsDomain_label_en-US" xlink:label="lab_abvx_WarrantsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants [Domain]</link:label>
    <link:label id="lab_abvx_WarrantsDomain_documentation_en-US" xlink:label="lab_abvx_WarrantsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_WarrantsDomain" xlink:to="lab_abvx_WarrantsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssuedCapital_b49bdb02-47ae-4e34-9772-acb77cd3aa62_terseLabel_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_ifrs-full_IssuedCapital_label_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital" xlink:to="lab_ifrs-full_IssuedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ContributionToGroupsAssetsPercentage_e0ed82d1-080f-4a65-bff5-3e7774b1bfe7_terseLabel_en-US" xlink:label="lab_abvx_ContributionToGroupsAssetsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution to Group's assets, percentage</link:label>
    <link:label id="lab_abvx_ContributionToGroupsAssetsPercentage_label_en-US" xlink:label="lab_abvx_ContributionToGroupsAssetsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contribution To Group's Assets, Percentage</link:label>
    <link:label id="lab_abvx_ContributionToGroupsAssetsPercentage_documentation_en-US" xlink:label="lab_abvx_ContributionToGroupsAssetsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contribution To Group's Assets, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsAssetsPercentage" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsAssetsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ContributionToGroupsAssetsPercentage" xlink:to="lab_abvx_ContributionToGroupsAssetsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsByNameMember_09d47c4c-1afb-4057-8dca-4e0d61748b43_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsByNameMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_abvx_BorrowingsByNameMember_label_en-US" xlink:label="lab_abvx_BorrowingsByNameMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings By Name [Member]</link:label>
    <link:label id="lab_abvx_BorrowingsByNameMember_documentation_en-US" xlink:label="lab_abvx_BorrowingsByNameMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings by name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsByNameMember" xlink:href="abvx-20241231.xsd#abvx_BorrowingsByNameMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsByNameMember" xlink:to="lab_abvx_BorrowingsByNameMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProbabilityOfSuccessMeasurementInputMember_554d32ef-da64-422c-9080-67f16705483d_terseLabel_en-US" xlink:label="lab_abvx_ProbabilityOfSuccessMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">POS</link:label>
    <link:label id="lab_abvx_ProbabilityOfSuccessMeasurementInputMember_label_en-US" xlink:label="lab_abvx_ProbabilityOfSuccessMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Probability Of Success, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_ProbabilityOfSuccessMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_ProbabilityOfSuccessMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Probability Of Success, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProbabilityOfSuccessMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_ProbabilityOfSuccessMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProbabilityOfSuccessMeasurementInputMember" xlink:to="lab_abvx_ProbabilityOfSuccessMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RepaymentsOfBondLoans_8c74ddcd-8cd2-4144-bf8e-de8382eadfb5_negatedTerseLabel_en-US" xlink:label="lab_abvx_RepaymentsOfBondLoans" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments of non-convertible bond loans</link:label>
    <link:label id="lab_abvx_RepaymentsOfBondLoans_c7ad8f19-c407-49c0-a723-a203abe52fb3_terseLabel_en-US" xlink:label="lab_abvx_RepaymentsOfBondLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of bond loans</link:label>
    <link:label id="lab_abvx_RepaymentsOfBondLoans_label_en-US" xlink:label="lab_abvx_RepaymentsOfBondLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments Of Bond Loans</link:label>
    <link:label id="lab_abvx_RepaymentsOfBondLoans_documentation_en-US" xlink:label="lab_abvx_RepaymentsOfBondLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repayments Of Bond Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfBondLoans" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfBondLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RepaymentsOfBondLoans" xlink:to="lab_abvx_RepaymentsOfBondLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_WarrantsAxis_a82c1dce-168e-4066-83a9-2eec9ce84c07_terseLabel_en-US" xlink:label="lab_abvx_WarrantsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants [Axis]</link:label>
    <link:label id="lab_abvx_WarrantsAxis_label_en-US" xlink:label="lab_abvx_WarrantsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants [Axis]</link:label>
    <link:label id="lab_abvx_WarrantsAxis_documentation_en-US" xlink:label="lab_abvx_WarrantsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_WarrantsAxis" xlink:to="lab_abvx_WarrantsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_ea4d7cea-b096-45f0-a966-c0fd1ad116fa_verboseLabel_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of outstanding shares used for computing diluted loss per share (in shares)</link:label>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_47b9e45d-a09a-4f5c-ac55-8b6a9d083896_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of outstanding shares, diluted loss per share (in shares)</link:label>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPIMember_1a647bb8-5bc0-46b4-927b-c7047a3bef42_terseLabel_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ebola conditional advance</link:label>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPIMember_a4ff37a1-01c4-4f46-82cd-e0ed2e315bae_verboseLabel_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">EBOLA &#8211; Bpifrance</link:label>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPIMember_label_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ebola Conditional Advance, BPI [Member]</link:label>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPIMember_documentation_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ebola Conditional Advance, BPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EbolaConditionalAdvanceBPIMember" xlink:to="lab_abvx_EbolaConditionalAdvanceBPIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_aa77cb85-c7bc-4f47-9da1-33e010da3aca_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Assets_50c2c263-340f-4f29-8eda-18db3dc48e9a_totalLabel_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_ifrs-full_Assets_f188bdbe-166f-41b1-a929-9b459ec4c266_terseLabel_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
    <link:label id="lab_ifrs-full_Assets_label_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets" xlink:to="lab_ifrs-full_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_640227f1-bf4d-42cb-b821-b7f52e3a3dac_terseLabel_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LESS THAN 1 YEAR</link:label>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_label_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not later than one year [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_246c7dec-f6cd-4e7d-85f7-bf57fae7f758_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Compensation expenses</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_649d2b39-ddd9-4b47-9098-ae119ddf6e08_verboseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_label_en-US" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from equity-settled share-based payment transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProsynergiaMember_0350a5a5-2869-466a-b2bc-a13c4fc14876_terseLabel_en-US" xlink:label="lab_abvx_ProsynergiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prosynergia</link:label>
    <link:label id="lab_abvx_ProsynergiaMember_label_en-US" xlink:label="lab_abvx_ProsynergiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prosynergia [Member]</link:label>
    <link:label id="lab_abvx_ProsynergiaMember_documentation_en-US" xlink:label="lab_abvx_ProsynergiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prosynergia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProsynergiaMember" xlink:to="lab_abvx_ProsynergiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_5a6bc065-a655-40aa-b300-466f50d93b80_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital increases</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from issuing shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnderwritingAgreementMaximumPeriod_284a18ab-7945-4e3c-b447-85d48ff1ddb5_terseLabel_en-US" xlink:label="lab_abvx_UnderwritingAgreementMaximumPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum period</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementMaximumPeriod_label_en-US" xlink:label="lab_abvx_UnderwritingAgreementMaximumPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Maximum Period</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementMaximumPeriod_documentation_en-US" xlink:label="lab_abvx_UnderwritingAgreementMaximumPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Maximum Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementMaximumPeriod" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementMaximumPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnderwritingAgreementMaximumPeriod" xlink:to="lab_abvx_UnderwritingAgreementMaximumPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember_10071a1d-c125-4dc3-bee5-42f55669c773_terseLabel_en-US" xlink:label="lab_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement benefit obligation</link:label>
    <link:label id="lab_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefit Obligations Related Temporary Differences [Member]</link:label>
    <link:label id="lab_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Retirement Benefit Obligations Related Temporary Differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember" xlink:href="abvx-20241231.xsd#abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember" xlink:to="lab_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent_437e2a36-0b52-4cfb-a072-92d46e01702a_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount of the equity component</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Carrying Amount Of The Equity Component</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Carrying Amount Of The Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" xlink:to="lab_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_75b9d4ec-154d-4c75-bd01-0a80c258a7bb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20174Member_32fb3860-5c56-4157-8de6-7dd84ed305af_terseLabel_en-US" xlink:label="lab_abvx_BCE20174Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2017-4</link:label>
    <link:label id="lab_abvx_BCE20174Member_label_en-US" xlink:label="lab_abvx_BCE20174Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2017-4 [Member]</link:label>
    <link:label id="lab_abvx_BCE20174Member_documentation_en-US" xlink:label="lab_abvx_BCE20174Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2017-4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20174Member" xlink:href="abvx-20241231.xsd#abvx_BCE20174Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20174Member" xlink:to="lab_abvx_BCE20174Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MaximumNumberOfSharesToBeIssued_32a16153-1197-42e8-b445-1e7544665e85_terseLabel_en-US" xlink:label="lab_abvx_MaximumNumberOfSharesToBeIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of shares to be issued (in shares)</link:label>
    <link:label id="lab_abvx_MaximumNumberOfSharesToBeIssued_label_en-US" xlink:label="lab_abvx_MaximumNumberOfSharesToBeIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Number Of Shares To Be Issued</link:label>
    <link:label id="lab_abvx_MaximumNumberOfSharesToBeIssued_documentation_en-US" xlink:label="lab_abvx_MaximumNumberOfSharesToBeIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Number Of Shares To Be Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfSharesToBeIssued" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfSharesToBeIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MaximumNumberOfSharesToBeIssued" xlink:to="lab_abvx_MaximumNumberOfSharesToBeIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare_e21984f2-b124-4bdd-b3fe-1e27def8dc72_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">M&amp;A transaction, minimum price per share</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, M&amp;A Transaction, Minimum Price Per Share</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, M&amp;A Transaction, Minimum Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted_51512865-508e-497e-9580-f04ed252f732_terseLabel_en-US" xlink:label="lab_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate exercise price</link:label>
    <link:label id="lab_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Exercise Price, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Exercise Price, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_AggregateExercisePriceOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted" xlink:to="lab_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssueOfConvertibleInstruments_49463bf2-7e9e-4f94-b4c7-8e3bf3cbadf2_terseLabel_en-US" xlink:label="lab_ifrs-full_IssueOfConvertibleInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of convertible notes</link:label>
    <link:label id="lab_ifrs-full_IssueOfConvertibleInstruments_label_en-US" xlink:label="lab_ifrs-full_IssueOfConvertibleInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issue of convertible instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfConvertibleInstruments" xlink:to="lab_ifrs-full_IssueOfConvertibleInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_e2ea62ca-213b-4771-aed8-4b9762da51c5_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets" xlink:to="lab_ifrs-full_DeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EuropeanCentralBankBaseRateMember_d31dc683-df74-41b1-8f34-653b912c17b7_terseLabel_en-US" xlink:label="lab_abvx_EuropeanCentralBankBaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">European Central Bank base rate</link:label>
    <link:label id="lab_abvx_EuropeanCentralBankBaseRateMember_label_en-US" xlink:label="lab_abvx_EuropeanCentralBankBaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">European Central Bank Base Rate [Member]</link:label>
    <link:label id="lab_abvx_EuropeanCentralBankBaseRateMember_documentation_en-US" xlink:label="lab_abvx_EuropeanCentralBankBaseRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">European Central Bank Base Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuropeanCentralBankBaseRateMember" xlink:href="abvx-20241231.xsd#abvx_EuropeanCentralBankBaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EuropeanCentralBankBaseRateMember" xlink:to="lab_abvx_EuropeanCentralBankBaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NonCurrentFinancialLiabilitiesMember_d15d566b-7e95-43a5-b32d-4f3a005fa680_terseLabel_en-US" xlink:label="lab_abvx_NonCurrentFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities-non current portion</link:label>
    <link:label id="lab_abvx_NonCurrentFinancialLiabilitiesMember_label_en-US" xlink:label="lab_abvx_NonCurrentFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Financial Liabilities [Member]</link:label>
    <link:label id="lab_abvx_NonCurrentFinancialLiabilitiesMember_documentation_en-US" xlink:label="lab_abvx_NonCurrentFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentFinancialLiabilitiesMember" xlink:href="abvx-20241231.xsd#abvx_NonCurrentFinancialLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember" xlink:to="lab_abvx_NonCurrentFinancialLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarnOutMarketCapitalizationThreshold_8bf96d92-6b56-4462-9a16-a6acdbea5bc4_terseLabel_en-US" xlink:label="lab_abvx_EarnOutMarketCapitalizationThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earn-out, market capitalization threshold</link:label>
    <link:label id="lab_abvx_EarnOutMarketCapitalizationThreshold_label_en-US" xlink:label="lab_abvx_EarnOutMarketCapitalizationThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earn-Out, Market Capitalization, Threshold</link:label>
    <link:label id="lab_abvx_EarnOutMarketCapitalizationThreshold_documentation_en-US" xlink:label="lab_abvx_EarnOutMarketCapitalizationThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earn-Out, Market Capitalization, Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMarketCapitalizationThreshold" xlink:href="abvx-20241231.xsd#abvx_EarnOutMarketCapitalizationThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarnOutMarketCapitalizationThreshold" xlink:to="lab_abvx_EarnOutMarketCapitalizationThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsPercentageOfMarketPrice_8ebff406-4365-404a-b27a-407416802bd0_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsPercentageOfMarketPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, percentage of market price</link:label>
    <link:label id="lab_abvx_BorrowingsPercentageOfMarketPrice_label_en-US" xlink:label="lab_abvx_BorrowingsPercentageOfMarketPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Percentage Of Market Price</link:label>
    <link:label id="lab_abvx_BorrowingsPercentageOfMarketPrice_documentation_en-US" xlink:label="lab_abvx_BorrowingsPercentageOfMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Percentage Of Market Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsPercentageOfMarketPrice" xlink:href="abvx-20241231.xsd#abvx_BorrowingsPercentageOfMarketPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsPercentageOfMarketPrice" xlink:to="lab_abvx_BorrowingsPercentageOfMarketPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfOtherShareWarrantsConverted_76f695e6-c91d-447c-9e36-0aeab79573ea_terseLabel_en-US" xlink:label="lab_abvx_NumberOfOtherShareWarrantsConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of other share warrants converted (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfOtherShareWarrantsConverted_label_en-US" xlink:label="lab_abvx_NumberOfOtherShareWarrantsConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Other Share Warrants Converted</link:label>
    <link:label id="lab_abvx_NumberOfOtherShareWarrantsConverted_documentation_en-US" xlink:label="lab_abvx_NumberOfOtherShareWarrantsConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Other Share Warrants Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsConverted" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfOtherShareWarrantsConverted" xlink:to="lab_abvx_NumberOfOtherShareWarrantsConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately_03ba1b42-be81-4518-9921-f612c5e2ebbe_terseLabel_en-US" xlink:label="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments granted, percentage exercisable immediately</link:label>
    <link:label id="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately_label_en-US" xlink:label="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Instruments Granted, Other Equity Instruments, Percentage Exercisable Immediately</link:label>
    <link:label id="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately_documentation_en-US" xlink:label="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Instruments Granted, Other Equity Instruments, Percentage Exercisable Immediately</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" xlink:href="abvx-20241231.xsd#abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" xlink:to="lab_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances_642d9e63-e462-43a1-a815-58df4cbb8847_terseLabel_en-US" xlink:label="lab_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of unwinding the discount related to advances</link:label>
    <link:label id="lab_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances_label_en-US" xlink:label="lab_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Unwinding Of Discount Related To Conditional Advances</link:label>
    <link:label id="lab_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances_documentation_en-US" xlink:label="lab_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Unwinding Of Discount Related To Conditional Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" xlink:to="lab_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_4486a4d5-6e61-40a0-b6e4-9c1d5aae3422_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, goodwill</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_a1e7e236-da5b-4e3c-95ed-dcb3958e13b4_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsExitFeePercentage_440b8512-dcfb-412e-a6b9-ac63c8eeafa2_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, exit fee percentage</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeePercentage_label_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Percentage</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeePercentage_documentation_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentage" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsExitFeePercentage" xlink:to="lab_abvx_BorrowingsExitFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm_69f7be83-839d-40e2-9d64-22335fbe4daf_terseLabel_en-US" xlink:label="lab_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in lease liabilities through modification of term</link:label>
    <link:label id="lab_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm_label_en-US" xlink:label="lab_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Lease Liabilities Through Modification Of Term</link:label>
    <link:label id="lab_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm_documentation_en-US" xlink:label="lab_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease In Lease Liabilities Through Modification Of Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm" xlink:href="abvx-20241231.xsd#abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm" xlink:to="lab_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ShareBasedPaymentArrangementsAbstract_8030e68f-083b-48a9-a746-12764935fb08_terseLabel_en-US" xlink:label="lab_abvx_ShareBasedPaymentArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements [Abstract]</link:label>
    <link:label id="lab_abvx_ShareBasedPaymentArrangementsAbstract_label_en-US" xlink:label="lab_abvx_ShareBasedPaymentArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements [Abstract]</link:label>
    <link:label id="lab_abvx_ShareBasedPaymentArrangementsAbstract_documentation_en-US" xlink:label="lab_abvx_ShareBasedPaymentArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract" xlink:to="lab_abvx_ShareBasedPaymentArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_SharePriceMeasurementInputMember_86ed5279-17a2-4307-9f80-2c0cae237914_verboseLabel_en-US" xlink:label="lab_abvx_SharePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share price</link:label>
    <link:label id="lab_abvx_SharePriceMeasurementInputMember_6f4f6305-9001-4122-ada7-c7797ac3e538_terseLabel_en-US" xlink:label="lab_abvx_SharePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary share price (in euro per share)</link:label>
    <link:label id="lab_abvx_SharePriceMeasurementInputMember_label_en-US" xlink:label="lab_abvx_SharePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_SharePriceMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_SharePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Price, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_SharePriceMeasurementInputMember" xlink:to="lab_abvx_SharePriceMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20175Member_fbde56f1-da94-48de-be14-3c3b8a0af9c6_terseLabel_en-US" xlink:label="lab_abvx_BCE20175Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2017-5</link:label>
    <link:label id="lab_abvx_BCE20175Member_label_en-US" xlink:label="lab_abvx_BCE20175Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2017-5 [Member]</link:label>
    <link:label id="lab_abvx_BCE20175Member_documentation_en-US" xlink:label="lab_abvx_BCE20175Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2017-5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20175Member" xlink:href="abvx-20241231.xsd#abvx_BCE20175Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20175Member" xlink:to="lab_abvx_BCE20175Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_417c5249-8faa-47d1-b3ce-1c9b7bf81341_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangeDomain_5592de31-b59b-4b9e-b031-75d9b6fd8d02_terseLabel_en-US" xlink:label="lab_ifrs-full_RangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [domain]</link:label>
    <link:label id="lab_ifrs-full_RangeDomain_label_en-US" xlink:label="lab_ifrs-full_RangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeDomain" xlink:to="lab_ifrs-full_RangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20231Member_9cab9907-a86d-463a-8377-6dd64c6cb922_terseLabel_en-US" xlink:label="lab_abvx_AGA20231Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2023-1</link:label>
    <link:label id="lab_abvx_AGA20231Member_label_en-US" xlink:label="lab_abvx_AGA20231Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2023-1 [Member]</link:label>
    <link:label id="lab_abvx_AGA20231Member_documentation_en-US" xlink:label="lab_abvx_AGA20231Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2023-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20231Member" xlink:href="abvx-20241231.xsd#abvx_AGA20231Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20231Member" xlink:to="lab_abvx_AGA20231Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_06a2cc2d-fb09-41fc-8a2a-8e06871bc482_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RelatedPartyTransactionsAbstract_d65e332b-366c-45dc-b26b-9af9d4423da5_terseLabel_en-US" xlink:label="lab_ifrs-full_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party transactions [abstract]</link:label>
    <link:label id="lab_ifrs-full_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_ifrs-full_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related party transactions [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="lab_ifrs-full_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShare_f62e0a54-ab6d-473c-a5d5-e734e481856b_terseLabel_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic loss per share (in euro per share)</link:label>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShare_label_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AcquisitionRelatedCostsAssetsAcquisition_56861bcd-fb6d-4867-96a1-0592889fe1f6_terseLabel_en-US" xlink:label="lab_abvx_AcquisitionRelatedCostsAssetsAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition fees</link:label>
    <link:label id="lab_abvx_AcquisitionRelatedCostsAssetsAcquisition_label_en-US" xlink:label="lab_abvx_AcquisitionRelatedCostsAssetsAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition-Related Costs, Assets Acquisition</link:label>
    <link:label id="lab_abvx_AcquisitionRelatedCostsAssetsAcquisition_documentation_en-US" xlink:label="lab_abvx_AcquisitionRelatedCostsAssetsAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition-Related Costs, Assets Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition" xlink:href="abvx-20241231.xsd#abvx_AcquisitionRelatedCostsAssetsAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition" xlink:to="lab_abvx_AcquisitionRelatedCostsAssetsAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfOperatingIncomeTable_354b47c9-0f60-46ec-ba94-daea2f7569ab_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfOperatingIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Income [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfOperatingIncomeTable_label_en-US" xlink:label="lab_abvx_DisclosureOfOperatingIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Income [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfOperatingIncomeTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfOperatingIncomeTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOperatingIncomeTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOperatingIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfOperatingIncomeTable" xlink:to="lab_abvx_DisclosureOfOperatingIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_After36MonthsMember_9d267c35-139c-48f8-b913-bc41fe2ee347_terseLabel_en-US" xlink:label="lab_abvx_After36MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After 36 months</link:label>
    <link:label id="lab_abvx_After36MonthsMember_label_en-US" xlink:label="lab_abvx_After36MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">After 36 Months [Member]</link:label>
    <link:label id="lab_abvx_After36MonthsMember_documentation_en-US" xlink:label="lab_abvx_After36MonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">After 36 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After36MonthsMember" xlink:href="abvx-20241231.xsd#abvx_After36MonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_After36MonthsMember" xlink:to="lab_abvx_After36MonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover_1d0d0bec-8d4f-4ce1-8a0c-a71f9b173746_terseLabel_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turnover rate</link:label>
    <link:label id="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover_label_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Expected Rates Of Turnover</link:label>
    <link:label id="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover_documentation_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Expected Rates Of Turnover</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfExpectedRatesOfTurnover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover" xlink:to="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationInKindContributions_2ae0483e-bcd6-470f-8ce1-7382ff345f29_terseLabel_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationInKindContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions in-kind</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationInKindContributions_label_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationInKindContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, In-Kind Contributions</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationInKindContributions_documentation_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationInKindContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, In-Kind Contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationInKindContributions" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationInKindContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KeyManagementPersonnelCompensationInKindContributions" xlink:to="lab_abvx_KeyManagementPersonnelCompensationInKindContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnrecognitionDayOneGainOfFinancialLiabilities_28ca404c-7c27-4b4d-b837-49c404c11859_terseLabel_en-US" xlink:label="lab_abvx_UnrecognitionDayOneGainOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognition day-one gain of financial liabilities</link:label>
    <link:label id="lab_abvx_UnrecognitionDayOneGainOfFinancialLiabilities_label_en-US" xlink:label="lab_abvx_UnrecognitionDayOneGainOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognition Day-One Gain Of Financial Liabilities</link:label>
    <link:label id="lab_abvx_UnrecognitionDayOneGainOfFinancialLiabilities_documentation_en-US" xlink:label="lab_abvx_UnrecognitionDayOneGainOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognition Day-One Gain Of Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnrecognitionDayOneGainOfFinancialLiabilities" xlink:href="abvx-20241231.xsd#abvx_UnrecognitionDayOneGainOfFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnrecognitionDayOneGainOfFinancialLiabilities" xlink:to="lab_abvx_UnrecognitionDayOneGainOfFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfContractsDomain_14206d47-f7fa-46a1-8ec6-58d35093d027_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfContractsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of contracts [domain]</link:label>
    <link:label id="lab_ifrs-full_TypesOfContractsDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfContractsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of contracts [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfContractsDomain" xlink:to="lab_ifrs-full_TypesOfContractsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_9196e6fa-a012-4988-a756-6977b84e591f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_a9dab17a-1f8b-4b07-83a5-adc50c8c0034_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows provided by (used in) financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_64120649-5241-46af-902b-df96c5901909_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of other equity instruments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesDomain_3533ced4-5be5-49e4-bff3-ce05d64d1033_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of interest rates [domain]</link:label>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of interest rates [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain" xlink:to="lab_ifrs-full_TypesOfInterestRatesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EuriborMember_6bec1303-74f3-410d-bada-6ec17cf9e5ec_terseLabel_en-US" xlink:label="lab_abvx_EuriborMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euribor</link:label>
    <link:label id="lab_abvx_EuriborMember_label_en-US" xlink:label="lab_abvx_EuriborMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euribor [Member]</link:label>
    <link:label id="lab_abvx_EuriborMember_documentation_en-US" xlink:label="lab_abvx_EuriborMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Euribor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuriborMember" xlink:href="abvx-20241231.xsd#abvx_EuriborMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EuriborMember" xlink:to="lab_abvx_EuriborMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_3cab3ae7-6731-4286-8474-70a8cfc7b3ba_totalLabel_en-US" xlink:label="lab_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_label_en-US" xlink:label="lab_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Identifiable Assets Acquired (Liabilities Assumed), Assets Acquisitions</link:label>
    <link:label id="lab_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_documentation_en-US" xlink:label="lab_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Identifiable Assets Acquired (Liabilities Assumed), Assets Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" xlink:href="abvx-20241231.xsd#abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" xlink:to="lab_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsNumberOfQuarterlyInstallments_43a291ea-a7b4-4897-8966-0d23e1e18a1c_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsNumberOfQuarterlyInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, number of quarterly installments</link:label>
    <link:label id="lab_abvx_BorrowingsNumberOfQuarterlyInstallments_label_en-US" xlink:label="lab_abvx_BorrowingsNumberOfQuarterlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Number Of Quarterly Installments</link:label>
    <link:label id="lab_abvx_BorrowingsNumberOfQuarterlyInstallments_documentation_en-US" xlink:label="lab_abvx_BorrowingsNumberOfQuarterlyInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Number Of Quarterly Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfQuarterlyInstallments" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfQuarterlyInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsNumberOfQuarterlyInstallments" xlink:to="lab_abvx_BorrowingsNumberOfQuarterlyInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember_0489777a-b478-4240-8cc9-015a2e8c84a2_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing and Heights convertible notes</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing And Heights Convertible Notes [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing And Heights Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember" xlink:to="lab_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_09e9075a-68be-4169-bfdf-44791ad35c46_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_496ae481-5b0e-4d42-b157-cfed9895e266_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash changes: fair value remeasurement</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through changes in fair values, liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConditionalAdvancesAndPGELoanMember_15a139bb-b3e4-4719-aabd-4a0c1ecf55c6_terseLabel_en-US" xlink:label="lab_abvx_ConditionalAdvancesAndPGELoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conditional advances and PGE loan</link:label>
    <link:label id="lab_abvx_ConditionalAdvancesAndPGELoanMember_label_en-US" xlink:label="lab_abvx_ConditionalAdvancesAndPGELoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conditional Advances And PGE Loan [Member]</link:label>
    <link:label id="lab_abvx_ConditionalAdvancesAndPGELoanMember_documentation_en-US" xlink:label="lab_abvx_ConditionalAdvancesAndPGELoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conditional Advances And PGE Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesAndPGELoanMember" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesAndPGELoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember" xlink:to="lab_abvx_ConditionalAdvancesAndPGELoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory_d0c9f3d8-0e3f-43e9-966b-7b30aabd3d4d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_7a78402e-4c5c-4f5d-a77c-d100fcd2b971_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in operating activities before change in working capital requirements</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operations before changes in working capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TechnicalFacilitiesMember_797f7192-ff1b-4cce-8407-ba8654b7d071_terseLabel_en-US" xlink:label="lab_abvx_TechnicalFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Technical facilities</link:label>
    <link:label id="lab_abvx_TechnicalFacilitiesMember_label_en-US" xlink:label="lab_abvx_TechnicalFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technical Facilities [Member]</link:label>
    <link:label id="lab_abvx_TechnicalFacilitiesMember_documentation_en-US" xlink:label="lab_abvx_TechnicalFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Technical Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnicalFacilitiesMember" xlink:href="abvx-20241231.xsd#abvx_TechnicalFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TechnicalFacilitiesMember" xlink:to="lab_abvx_TechnicalFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalDomain_b7193b54-2e05-48c7-8d99-ad5c2c64f1d9_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of share capital [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain" xlink:to="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesDomain_7e61448d-1405-4503-8190-d434fea16dc4_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of liabilities [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BlackScholesModelMember_f6212169-149d-40e4-8457-12b77beb16bb_terseLabel_en-US" xlink:label="lab_abvx_BlackScholesModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Black Scholes Model</link:label>
    <link:label id="lab_abvx_BlackScholesModelMember_label_en-US" xlink:label="lab_abvx_BlackScholesModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Black Scholes Model [Member]</link:label>
    <link:label id="lab_abvx_BlackScholesModelMember_documentation_en-US" xlink:label="lab_abvx_BlackScholesModelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Black Scholes Model</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BlackScholesModelMember" xlink:href="abvx-20241231.xsd#abvx_BlackScholesModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BlackScholesModelMember" xlink:to="lab_abvx_BlackScholesModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing_8b35f727-9514-4e8f-868a-bd6d8899d407_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance conditions, minimum financing</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Performance Conditions, Minimum Financing</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Performance Conditions, Minimum Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_0a3a815f-3e60-40e1-b81f-2dd98c978e38_terseLabel_en-US" xlink:label="lab_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease/(increase) in other liabilities at fair value through profit and loss</link:label>
    <link:label id="lab_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains On Financial Liabilities At Fair Value Through Profit Or Loss</link:label>
    <link:label id="lab_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_documentation_en-US" xlink:label="lab_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gains On Financial Liabilities At Fair Value Through Profit Or Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="abvx-20241231.xsd#abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="lab_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_87bbc7a6-edcd-444b-acbe-adff1ef10da7_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease in financial assets at fair value</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_ba9cfedf-4a39-4c8a-b743-e060fbb69958_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:to="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IssuanceOfOtherShareWarrants_e3edc681-ef46-42ec-9e5e-6f8b907a8e9b_terseLabel_en-US" xlink:label="lab_abvx_IssuanceOfOtherShareWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of other share warrants</link:label>
    <link:label id="lab_abvx_IssuanceOfOtherShareWarrants_label_en-US" xlink:label="lab_abvx_IssuanceOfOtherShareWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance Of Other Share Warrants</link:label>
    <link:label id="lab_abvx_IssuanceOfOtherShareWarrants_documentation_en-US" xlink:label="lab_abvx_IssuanceOfOtherShareWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance Of Other Share Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfOtherShareWarrants" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfOtherShareWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IssuanceOfOtherShareWarrants" xlink:to="lab_abvx_IssuanceOfOtherShareWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped_98de6b1a-a935-4e44-9857-fc7f13002ffd_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of annual revenue from sale of products developed</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" xlink:to="lab_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember_b8768f19-2eb0-424d-8c7c-b7fb9f754673_terseLabel_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ebola conditional advance, BPI Languedoc-Roussillon</link:label>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember_label_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ebola Conditional Advance, BPI Languedoc-Roussillon [Member]</link:label>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember_documentation_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ebola Conditional Advance, BPI Languedoc-Roussillon</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember" xlink:to="lab_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationFixedCompensation_d2bfae8b-011c-4d4c-b457-d6a353c98c58_terseLabel_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationFixedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed compensation owed</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationFixedCompensation_label_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationFixedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, Fixed Compensation</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationFixedCompensation_documentation_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationFixedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, Fixed Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationFixedCompensation" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationFixedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KeyManagementPersonnelCompensationFixedCompensation" xlink:to="lab_abvx_KeyManagementPersonnelCompensationFixedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos1BondLoansMember_10318f5e-0315-44fd-bc84-6abb33d9a946_terseLabel_en-US" xlink:label="lab_abvx_Kreos1BondLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 1 bond loans</link:label>
    <link:label id="lab_abvx_Kreos1BondLoansMember_label_en-US" xlink:label="lab_abvx_Kreos1BondLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1 Bond Loans [Member]</link:label>
    <link:label id="lab_abvx_Kreos1BondLoansMember_documentation_en-US" xlink:label="lab_abvx_Kreos1BondLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1 Bond Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1BondLoansMember" xlink:href="abvx-20241231.xsd#abvx_Kreos1BondLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos1BondLoansMember" xlink:to="lab_abvx_Kreos1BondLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentNonfinancialAssets_e7e6ed2a-9516-467b-9d2e-f08e2ad8f811_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentNonfinancialAssets_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current non-financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:to="lab_ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AmortizedCostEIRMethodMember_6d1658c2-d5ed-4dd1-8694-ff70f9ac852e_terseLabel_en-US" xlink:label="lab_abvx_AmortizedCostEIRMethodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost (EIR method)</link:label>
    <link:label id="lab_abvx_AmortizedCostEIRMethodMember_label_en-US" xlink:label="lab_abvx_AmortizedCostEIRMethodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortized Cost (EIR Method) [Member]</link:label>
    <link:label id="lab_abvx_AmortizedCostEIRMethodMember_documentation_en-US" xlink:label="lab_abvx_AmortizedCostEIRMethodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortized Cost (EIR Method)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmortizedCostEIRMethodMember" xlink:href="abvx-20241231.xsd#abvx_AmortizedCostEIRMethodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AmortizedCostEIRMethodMember" xlink:to="lab_abvx_AmortizedCostEIRMethodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval_4f74543d-41f2-4267-b1e8-b4a8d509b01d_terseLabel_en-US" xlink:label="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration agreements, development milestone payment, IND approval</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval_label_en-US" xlink:label="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Development Milestone Payment, IND Approval</link:label>
    <link:label id="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval_documentation_en-US" xlink:label="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration Agreements, Development Milestone Payment, IND Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" xlink:to="lab_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20244Member_902937eb-f703-438a-ac05-489bbc2c2e4b_terseLabel_en-US" xlink:label="lab_abvx_AGA20244Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-4</link:label>
    <link:label id="lab_abvx_AGA20244Member_label_en-US" xlink:label="lab_abvx_AGA20244Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-4 [Member]</link:label>
    <link:label id="lab_abvx_AGA20244Member_documentation_en-US" xlink:label="lab_abvx_AGA20244Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244Member" xlink:href="abvx-20241231.xsd#abvx_AGA20244Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20244Member" xlink:to="lab_abvx_AGA20244Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_6f2eaff5-0089-4c3f-b697-765c57194414_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_b2808510-e41c-431f-973a-184b3732a76f_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ParValuePerShare_f41cc728-52db-4ba4-9114-d41d830c6662_terseLabel_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Par value per share (in euro per share)</link:label>
    <link:label id="lab_ifrs-full_ParValuePerShare_label_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Par value per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare" xlink:to="lab_ifrs-full_ParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_53846a5e-fc22-42f0-b348-5416f1121c4b_terseLabel_en-US" xlink:label="lab_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Probability-weighted present value of shortfall payment, tender offer</link:label>
    <link:label id="lab_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_label_en-US" xlink:label="lab_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tender Offer, Probability-Weighted Present Value Of Shortfall Payment, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tender Offer, Probability-Weighted Present Value Of Shortfall Payment, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:to="lab_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_f67ad597-84d2-424c-af41-b9382121259e_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_2e6831b7-09ba-40d5-95da-8da25b8ebe09_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_18b4317c-ca96-4bbb-932b-5fd0e1986188_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_36402061-e8f8-4fd6-9224-b6ac0222606f_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheBMember_6c643ff1-c71e-4860-b5a2-66e8a6be47f5_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing, tranche B</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheBMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche B [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingTrancheBMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Tranche B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingTrancheBMember" xlink:to="lab_abvx_KreosClaretFinancingTrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_0d8c1698-73c5-4897-a82d-9414f91c2043_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnwindingOfDiscountOnRoyalties_bf66906c-c2e9-43f8-86ed-82cc2d438ad9_terseLabel_en-US" xlink:label="lab_abvx_UnwindingOfDiscountOnRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unwinding of discount on royalties</link:label>
    <link:label id="lab_abvx_UnwindingOfDiscountOnRoyalties_label_en-US" xlink:label="lab_abvx_UnwindingOfDiscountOnRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unwinding Of Discount On Royalties</link:label>
    <link:label id="lab_abvx_UnwindingOfDiscountOnRoyalties_documentation_en-US" xlink:label="lab_abvx_UnwindingOfDiscountOnRoyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unwinding Of Discount On Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnwindingOfDiscountOnRoyalties" xlink:href="abvx-20241231.xsd#abvx_UnwindingOfDiscountOnRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnwindingOfDiscountOnRoyalties" xlink:to="lab_abvx_UnwindingOfDiscountOnRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherIntangibleAssetsMember_4f04b895-1736-4c69-bfd2-98245b6b69db_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other intangible assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RecurringFairValueMeasurementMember_210c7a3b-8319-4383-b46b-073ab242cbc3_terseLabel_en-US" xlink:label="lab_ifrs-full_RecurringFairValueMeasurementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring fair value measurement</link:label>
    <link:label id="lab_ifrs-full_RecurringFairValueMeasurementMember_label_en-US" xlink:label="lab_ifrs-full_RecurringFairValueMeasurementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recurring fair value measurement [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecurringFairValueMeasurementMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RecurringFairValueMeasurementMember" xlink:to="lab_ifrs-full_RecurringFairValueMeasurementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsAdditionalTrancheAmount_1628d1e8-22f4-460f-8a7a-1b3d465ab4bb_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsAdditionalTrancheAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, additional tranche mount</link:label>
    <link:label id="lab_abvx_BorrowingsAdditionalTrancheAmount_label_en-US" xlink:label="lab_abvx_BorrowingsAdditionalTrancheAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Additional Tranche Amount</link:label>
    <link:label id="lab_abvx_BorrowingsAdditionalTrancheAmount_documentation_en-US" xlink:label="lab_abvx_BorrowingsAdditionalTrancheAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Additional Tranche Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAdditionalTrancheAmount" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAdditionalTrancheAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsAdditionalTrancheAmount" xlink:to="lab_abvx_BorrowingsAdditionalTrancheAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DiscountRateAppliedToLongTermAdvances_b00f9603-28c9-4ff6-902c-d4989c59fd72_terseLabel_en-US" xlink:label="lab_abvx_DiscountRateAppliedToLongTermAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disount rate applied to long-term advances</link:label>
    <link:label id="lab_abvx_DiscountRateAppliedToLongTermAdvances_label_en-US" xlink:label="lab_abvx_DiscountRateAppliedToLongTermAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount Rate Applied To Long-Term Advances</link:label>
    <link:label id="lab_abvx_DiscountRateAppliedToLongTermAdvances_documentation_en-US" xlink:label="lab_abvx_DiscountRateAppliedToLongTermAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discount Rate Applied To Long-Term Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DiscountRateAppliedToLongTermAdvances" xlink:href="abvx-20241231.xsd#abvx_DiscountRateAppliedToLongTermAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DiscountRateAppliedToLongTermAdvances" xlink:to="lab_abvx_DiscountRateAppliedToLongTermAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossFromOperatingActivities_46017ff9-627f-40df-bde4-7a9442b64c85_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NonCurrentRoyaltyCertificates_cdd29065-bcb4-481b-b964-fea62d2ea706_terseLabel_en-US" xlink:label="lab_abvx_NonCurrentRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty certificates</link:label>
    <link:label id="lab_abvx_NonCurrentRoyaltyCertificates_label_en-US" xlink:label="lab_abvx_NonCurrentRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Royalty Certificates</link:label>
    <link:label id="lab_abvx_NonCurrentRoyaltyCertificates_documentation_en-US" xlink:label="lab_abvx_NonCurrentRoyaltyCertificates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Royalty Certificates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NonCurrentRoyaltyCertificates" xlink:to="lab_abvx_NonCurrentRoyaltyCertificates" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold_20466eb3-edd6-4f40-8579-7f30c626ef96_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change of control, minimum percentage</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Change Of Control, Minimum Threshold</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Change Of Control, Minimum Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_e2bc44f8-167b-4141-ac0a-8969b04063c1_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinanceCosts_04b7c81a-6ad0-4a38-99d6-065d69e7c3fc_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Financial expenses</link:label>
    <link:label id="lab_ifrs-full_FinanceCosts_e52af178-6124-4fc6-8b02-7f521cfa1ad0_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Financial expenses</link:label>
    <link:label id="lab_ifrs-full_FinanceCosts_label_en-US" xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts" xlink:to="lab_ifrs-full_FinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_c4293bb0-3311-4696-a256-774e3eecd867_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows provided by (used in) investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VolatilityForSharesMeasurementInputExpiryMember_a7b01284-2b1f-4fe2-85f9-aaffdc7e848b_terseLabel_en-US" xlink:label="lab_abvx_VolatilityForSharesMeasurementInputExpiryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility, expiry</link:label>
    <link:label id="lab_abvx_VolatilityForSharesMeasurementInputExpiryMember_label_en-US" xlink:label="lab_abvx_VolatilityForSharesMeasurementInputExpiryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Volatility For Shares Measurement Input, Expiry [Member]</link:label>
    <link:label id="lab_abvx_VolatilityForSharesMeasurementInputExpiryMember_documentation_en-US" xlink:label="lab_abvx_VolatilityForSharesMeasurementInputExpiryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Volatility For Shares Measurement Input, Expiry</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VolatilityForSharesMeasurementInputExpiryMember" xlink:href="abvx-20241231.xsd#abvx_VolatilityForSharesMeasurementInputExpiryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VolatilityForSharesMeasurementInputExpiryMember" xlink:to="lab_abvx_VolatilityForSharesMeasurementInputExpiryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilityAsset_dfbbd56c-86d5-457d-a11a-5bcce612dcc6_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ManagementMember_b4771c02-4fee-4859-9211-835a72ae1d10_terseLabel_en-US" xlink:label="lab_srt_ManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Key magement</link:label>
    <link:label id="lab_srt_ManagementMember_label_en-US" xlink:label="lab_srt_ManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ManagementMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ManagementMember" xlink:to="lab_srt_ManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_a90fbff7-b6bf-41da-b229-ec0ee2b728b2_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash flows provided by (used in) financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsAbstract_2a546d3a-9e70-4b21-ba28-24e161496561_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_952c07e0-5900-4d37-b882-c9f439b4ccbd_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_0cc3a499-c37b-49d7-b007-db3d79d183d3_periodStartLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment including right-of-use assets at beginning of period</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_3dc7bce2-2a63-4d9d-9ee9-ec9e134d4781_periodEndLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment including right-of-use assets at end of period</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment including right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PercentageOfConditionalAdvancesWaived_37640eb2-7b4c-478e-b539-2821f92dea1b_terseLabel_en-US" xlink:label="lab_abvx_PercentageOfConditionalAdvancesWaived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of conditional advances waived</link:label>
    <link:label id="lab_abvx_PercentageOfConditionalAdvancesWaived_label_en-US" xlink:label="lab_abvx_PercentageOfConditionalAdvancesWaived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Conditional Advances Waived</link:label>
    <link:label id="lab_abvx_PercentageOfConditionalAdvancesWaived_documentation_en-US" xlink:label="lab_abvx_PercentageOfConditionalAdvancesWaived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Conditional Advances Waived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PercentageOfConditionalAdvancesWaived" xlink:href="abvx-20241231.xsd#abvx_PercentageOfConditionalAdvancesWaived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PercentageOfConditionalAdvancesWaived" xlink:to="lab_abvx_PercentageOfConditionalAdvancesWaived" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_e0477bd5-fb32-4e60-9744-52a01b9a285f_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" xlink:to="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_a08e1c09-de0a-4d62-bdea-63837f369338_terseLabel_en-US" xlink:label="lab_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exclusive licensing agreement with CNRS, University of Montpellier and Institut Curie</link:label>
    <link:label id="lab_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_label_en-US" xlink:label="lab_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exclusive Licensing Agreement With CNRS, University Of Montpellier And Institut Curie [Member]</link:label>
    <link:label id="lab_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_documentation_en-US" xlink:label="lab_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exclusive Licensing Agreement With CNRS, University Of Montpellier And Institut Curie</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:to="lab_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_fd85a2ae-29ac-4b21-b32f-041e42f431a7_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of remaining contractual maturities of derivative financial liabilities</link:label>
    <link:label id="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_5f0c5cc5-d528-4f10-8589-bfb87f66be71_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsMaximumBorrowingCapacityPerTranche" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, maximum borrowing capacity per tranche</link:label>
    <link:label id="lab_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_label_en-US" xlink:label="lab_abvx_BorrowingsMaximumBorrowingCapacityPerTranche" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Maximum Borrowing Capacity Per Tranche</link:label>
    <link:label id="lab_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_documentation_en-US" xlink:label="lab_abvx_BorrowingsMaximumBorrowingCapacityPerTranche" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Maximum Borrowing Capacity Per Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacityPerTranche"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche" xlink:to="lab_abvx_BorrowingsMaximumBorrowingCapacityPerTranche" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAbstract_f5ae90fa-e30c-42f5-8a38-9f27abec3592_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_ifrs-full_EquityAbstract_label_en-US" xlink:label="lab_ifrs-full_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract" xlink:to="lab_ifrs-full_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ForeignExchangeGain_0681ac46-adcd-47af-8da0-d0f8e2688cd2_terseLabel_en-US" xlink:label="lab_ifrs-full_ForeignExchangeGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange gains</link:label>
    <link:label id="lab_ifrs-full_ForeignExchangeGain_label_en-US" xlink:label="lab_ifrs-full_ForeignExchangeGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignExchangeGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ForeignExchangeGain" xlink:to="lab_ifrs-full_ForeignExchangeGain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ShareSubscriptionWarrantsBSAMember_b75648e8-e8f5-45be-912c-74d6cc4d305b_verboseLabel_en-US" xlink:label="lab_abvx_ShareSubscriptionWarrantsBSAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">BSAs</link:label>
    <link:label id="lab_abvx_ShareSubscriptionWarrantsBSAMember_e1164e6f-e4a1-472f-9deb-7dd6e48b1539_terseLabel_en-US" xlink:label="lab_abvx_ShareSubscriptionWarrantsBSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total BSAs</link:label>
    <link:label id="lab_abvx_ShareSubscriptionWarrantsBSAMember_label_en-US" xlink:label="lab_abvx_ShareSubscriptionWarrantsBSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Subscription Warrants (BSA) [Member]</link:label>
    <link:label id="lab_abvx_ShareSubscriptionWarrantsBSAMember_documentation_en-US" xlink:label="lab_abvx_ShareSubscriptionWarrantsBSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Subscription Warrants (BSA)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember" xlink:to="lab_abvx_ShareSubscriptionWarrantsBSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_a9dc9883-002f-4184-acd8-ba1074786e91_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RETAINED EARNINGS</link:label>
    <link:label id="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_label_en-US" xlink:label="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings, excluding profit (loss) for reporting period [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember" xlink:to="lab_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_013c041e-970e-4432-86a5-10fb4405750a_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_a03af549-9d33-43ed-83c1-d390af06d3ce_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate_83fc720a-2a19-4780-80e3-4532785e4fa0_terseLabel_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turnover rate, average exit rate</link:label>
    <link:label id="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate_label_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Expected Rates Of Turnover, Average Exit Rate</link:label>
    <link:label id="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate_documentation_en-US" xlink:label="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Expected Rates Of Turnover, Average Exit Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" xlink:to="lab_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RepaymentsOfConvertibleLoansNotes_f730deb7-c0ce-46c5-84dc-0435d3e9baeb_negatedTerseLabel_en-US" xlink:label="lab_abvx_RepaymentsOfConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments of convertible bond loans</link:label>
    <link:label id="lab_abvx_RepaymentsOfConvertibleLoansNotes_ea4d66dc-657b-4e82-80bb-d61f135e6e9a_terseLabel_en-US" xlink:label="lab_abvx_RepaymentsOfConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of convertible loan notes</link:label>
    <link:label id="lab_abvx_RepaymentsOfConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_RepaymentsOfConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments Of Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_RepaymentsOfConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_RepaymentsOfConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repayments Of Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RepaymentsOfConvertibleLoansNotes" xlink:to="lab_abvx_RepaymentsOfConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory_7531b0c1-21b7-4b26-abd2-c5a4e5c39097_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of expenses by nature</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of expenses by nature [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:to="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_46b4f099-81cc-4a49-9baf-9afae059771b_terseLabel_en-US" xlink:label="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retrospective application and retrospective restatement [axis]</link:label>
    <link:label id="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_label_en-US" xlink:label="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retrospective application and retrospective restatement [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_6a7de4ae-aa73-4f83-b3b9-63860b37fa8d_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_label_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Assets Acquisitions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" xlink:to="lab_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_5871a83a-8465-4208-a6b9-27d4916b1fb7_verboseLabel_en-US" xlink:label="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">BSA SUBSCRIPTION PRICE (in euro per share)</link:label>
    <link:label id="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_004be467-6d64-4e1d-903d-6858bf901fc1_terseLabel_en-US" xlink:label="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA PRICE (in euro per share)</link:label>
    <link:label id="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Instrument Price, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Instrument Price, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" xlink:to="lab_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock_999db8ef-0519-4235-aaba-6714bfc28b42_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events</link:label>
    <link:label id="lab_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Significant Events For The Period Reported And Events After Reporting Period [Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Significant Events For The Period Reported And Events After Reporting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" xlink:to="lab_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfLeasesForLesseeTableTextBlock_c3922d72-d169-49df-be1f-0786888e6b69_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfLeasesForLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of variation in lease liabilities</link:label>
    <link:label id="lab_abvx_DisclosureOfLeasesForLesseeTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfLeasesForLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Leases For Lessee [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfLeasesForLesseeTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfLeasesForLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Leases For Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeasesForLesseeTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeasesForLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfLeasesForLesseeTableTextBlock" xlink:to="lab_abvx_DisclosureOfLeasesForLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3f8159aa-dc95-4061-b7c4-a0d0d5f06660_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_89ac665b-db53-4b2e-8b30-970ea26823b8_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment_b5440b3c-52e4-467b-ab6e-203bdca2902b_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, exit fee percentage if prepayment after 30th installment</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment_label_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Percentage If Prepayment After 30th Installment</link:label>
    <link:label id="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment_documentation_en-US" xlink:label="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Exit Fee Percentage If Prepayment After 30th Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" xlink:to="lab_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA201511Member_72c98223-d4cb-4ddd-a165-4bf92cb7f8aa_terseLabel_en-US" xlink:label="lab_abvx_BSA201511Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2015-11</link:label>
    <link:label id="lab_abvx_BSA201511Member_label_en-US" xlink:label="lab_abvx_BSA201511Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2015-11 [Member]</link:label>
    <link:label id="lab_abvx_BSA201511Member_documentation_en-US" xlink:label="lab_abvx_BSA201511Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2015-11</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA201511Member" xlink:href="abvx-20241231.xsd#abvx_BSA201511Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA201511Member" xlink:to="lab_abvx_BSA201511Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities_d4e46d42-b6b9-4d0d-900f-12220cfac990_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash changes: (gain)/loss on recognition or derecognition</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Gain (Loss) On Recognition/Derecognition, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Gain (Loss) On Recognition/Derecognition, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAndLiabilitiesAbstract_2cbeddf6-df8a-4b42-9698-c9b89dad0638_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_ifrs-full_EquityAndLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_aa7ca7f7-d4ae-4eac-b5ee-ca7e40565683_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos2TrancheBMember_107fade9-e3c4-4b4e-9100-7d812f02b7e9_terseLabel_en-US" xlink:label="lab_abvx_Kreos2TrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 2, tranche B</link:label>
    <link:label id="lab_abvx_Kreos2TrancheBMember_label_en-US" xlink:label="lab_abvx_Kreos2TrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 2, Tranche B [Member]</link:label>
    <link:label id="lab_abvx_Kreos2TrancheBMember_documentation_en-US" xlink:label="lab_abvx_Kreos2TrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 2, Tranche B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2TrancheBMember" xlink:href="abvx-20241231.xsd#abvx_Kreos2TrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos2TrancheBMember" xlink:to="lab_abvx_Kreos2TrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LicencesMember_37c98a9f-6d8b-4dc6-b5e4-d6b960d2e9e5_terseLabel_en-US" xlink:label="lab_ifrs-full_LicencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LICENCES</link:label>
    <link:label id="lab_ifrs-full_LicencesMember_label_en-US" xlink:label="lab_ifrs-full_LicencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licences [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesMember" xlink:to="lab_ifrs-full_LicencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_ea3f413e-dc4a-4dba-80fb-c8b27c8d280f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial gain (loss)</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of finance income (cost) [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_e9095278-b782-4bd1-bba0-353ff192eaca_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate</link:label>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_label_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate" xlink:to="lab_ifrs-full_BorrowingsInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock_9e2f9d47-25f5-4ae3-b1e3-b15ab2b78992_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of the Ukraine/Russia Hostilities on the Group</link:label>
    <link:label id="lab_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Impact Of The Ukraine/Russia Hostilities On The Group [Policy Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Impact Of The Ukraine/Russia Hostilities On The Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" xlink:to="lab_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities_a3857cda-dc6a-4dd4-8b6a-07b24b95ded2_terseLabel_en-US" xlink:label="lab_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase / (decrease) in tax and social security liabilities</link:label>
    <link:label id="lab_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities_label_en-US" xlink:label="lab_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Increase (Decrease) In Tax And Social Security Liabilities</link:label>
    <link:label id="lab_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities_documentation_en-US" xlink:label="lab_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Increase (Decrease) In Tax And Social Security Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" xlink:to="lab_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_83a716fb-df78-4ce6-a885-00dfbcd6572f_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current deferred income other than current contract liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:to="lab_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsNumberOfMonthlyInstallments_0ed16c44-2f7b-48dc-95bc-0e26bc69cafb_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsNumberOfMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, number of monthly installments</link:label>
    <link:label id="lab_abvx_BorrowingsNumberOfMonthlyInstallments_label_en-US" xlink:label="lab_abvx_BorrowingsNumberOfMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Number Of Monthly Installments</link:label>
    <link:label id="lab_abvx_BorrowingsNumberOfMonthlyInstallments_documentation_en-US" xlink:label="lab_abvx_BorrowingsNumberOfMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Number Of Monthly Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfMonthlyInstallments" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfMonthlyInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsNumberOfMonthlyInstallments" xlink:to="lab_abvx_BorrowingsNumberOfMonthlyInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_bd760d55-d96c-447b-82db-2c21ec0bef70_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash changes: interest expense and other</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through other changes, liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_69ce49fb-b01c-40bf-863e-749c57cecac7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a55e5484-b9d8-475b-b1d1-641b2a74d72c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureTable_e942dd92-f38f-425f-a9d8-172662699431_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of credit risk exposure [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of credit risk exposure [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b1bdd7ba-4a97-4a7d-a2c8-cd72ea67f1c3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember_f355f2e5-f917-4a75-9a89-d86b9746c363_terseLabel_en-US" xlink:label="lab_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research agreement with University Hospital Center of Nice</link:label>
    <link:label id="lab_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember_label_en-US" xlink:label="lab_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Agreement With University Hospital Center Of Nice [Member]</link:label>
    <link:label id="lab_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember_documentation_en-US" xlink:label="lab_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Agreement With University Hospital Center Of Nice</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember" xlink:href="abvx-20241231.xsd#abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember" xlink:to="lab_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherFinancialAssets_a9d0c9a6-a39c-470e-972b-4554c8f5771a_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other financial assets</link:label>
    <link:label id="lab_ifrs-full_OtherFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_OtherFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinancialAssets" xlink:to="lab_ifrs-full_OtherFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RoyaltyCertificatePercentageOfFutureSales_4273a3cb-edcf-4fa7-a481-a386d69c0644_terseLabel_en-US" xlink:label="lab_abvx_RoyaltyCertificatePercentageOfFutureSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty certificate, percentage of future sales</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatePercentageOfFutureSales_label_en-US" xlink:label="lab_abvx_RoyaltyCertificatePercentageOfFutureSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Certificate, Percentage Of Future Sales</link:label>
    <link:label id="lab_abvx_RoyaltyCertificatePercentageOfFutureSales_documentation_en-US" xlink:label="lab_abvx_RoyaltyCertificatePercentageOfFutureSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Certificate, Percentage Of Future Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatePercentageOfFutureSales" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatePercentageOfFutureSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RoyaltyCertificatePercentageOfFutureSales" xlink:to="lab_abvx_RoyaltyCertificatePercentageOfFutureSales" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationAttendanceFees_56e68ac5-bd45-48b6-ba89-4b48373d8c14_terseLabel_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationAttendanceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attendance fees&#8212;Board of Directors</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationAttendanceFees_label_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationAttendanceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, Attendance Fees</link:label>
    <link:label id="lab_abvx_KeyManagementPersonnelCompensationAttendanceFees_documentation_en-US" xlink:label="lab_abvx_KeyManagementPersonnelCompensationAttendanceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, Attendance Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationAttendanceFees" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationAttendanceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KeyManagementPersonnelCompensationAttendanceFees" xlink:to="lab_abvx_KeyManagementPersonnelCompensationAttendanceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NetProceedsFromNonConvertibleLoansNotes_9aabdcf3-b56d-444c-94e3-c3f3b60db2ba_terseLabel_en-US" xlink:label="lab_abvx_NetProceedsFromNonConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from the issuance of non-convertible bond loans</link:label>
    <link:label id="lab_abvx_NetProceedsFromNonConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_NetProceedsFromNonConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Proceeds From Non-Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_NetProceedsFromNonConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_NetProceedsFromNonConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Proceeds From Non-Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromNonConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromNonConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NetProceedsFromNonConvertibleLoansNotes" xlink:to="lab_abvx_NetProceedsFromNonConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinancialAgreementAxis_2f1d4558-e551-47b0-be85-52df62ad78f4_terseLabel_en-US" xlink:label="lab_abvx_FinancialAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Agreement [Axis]</link:label>
    <link:label id="lab_abvx_FinancialAgreementAxis_label_en-US" xlink:label="lab_abvx_FinancialAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Agreement [Axis]</link:label>
    <link:label id="lab_abvx_FinancialAgreementAxis_documentation_en-US" xlink:label="lab_abvx_FinancialAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinancialAgreementAxis" xlink:to="lab_abvx_FinancialAgreementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfCashAndCashEquivalentsLineItems_29f98bc3-1e9d-410e-9533-4003a2564406_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfCashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Cash And Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfCashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfCashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Cash And Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfCashAndCashEquivalentsLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfCashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Cash And Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems" xlink:to="lab_abvx_DisclosureOfCashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BuildingsMember_883911bd-f679-414d-8334-eaa32aff4669_terseLabel_en-US" xlink:label="lab_ifrs-full_BuildingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BUILDINGS</link:label>
    <link:label id="lab_ifrs-full_BuildingsMember_b755d9e8-ead7-45ef-b0f8-eae089214714_verboseLabel_en-US" xlink:label="lab_ifrs-full_BuildingsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_ifrs-full_BuildingsMember_label_en-US" xlink:label="lab_ifrs-full_BuildingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buildings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember" xlink:to="lab_ifrs-full_BuildingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_b7817137-14a5-4697-a876-933e1d87cc16_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [domain]</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_219a66ce-b0e8-4b94-b9a0-4f1a0fd495e3_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Items that will not be reclassified to profit or loss</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingExpense_0b20f1a8-ed5d-41cb-a07c-c6b0a00b5d17_terseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingExpense_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous other operating expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_343c2805-e1a4-4089-8b69-82d81d5809df_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate_2c69d3c7-cb4c-445d-a76b-43d8a9d4e644_terseLabel_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion option, maximum period prior to maturity date</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate_label_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Conversion Option, Maximum Period Prior To Maturity Date</link:label>
    <link:label id="lab_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate_documentation_en-US" xlink:label="lab_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Loans Notes, Conversion Option, Maximum Period Prior To Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" xlink:to="lab_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_e1d34ada-e11f-4b42-a6be-3a71bbe092cf_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of related parties [axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of related parties [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsAnnualDiscountRate_a1451e53-f69a-44ff-8091-4c6723eb74e8_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsAnnualDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, annual discount rate</link:label>
    <link:label id="lab_abvx_BorrowingsAnnualDiscountRate_label_en-US" xlink:label="lab_abvx_BorrowingsAnnualDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Annual Discount Rate</link:label>
    <link:label id="lab_abvx_BorrowingsAnnualDiscountRate_documentation_en-US" xlink:label="lab_abvx_BorrowingsAnnualDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Annual Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAnnualDiscountRate" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAnnualDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsAnnualDiscountRate" xlink:to="lab_abvx_BorrowingsAnnualDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentPrepaidExpenses_2bdb01b1-ac21-42a9-975d-497a1bfa3710_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_ifrs-full_CurrentPrepaidExpenses_label_en-US" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current prepaid expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForAuditServices_ce40ca8f-ae13-45ad-8f61-98ef794ca32a_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForAuditServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statutory Auditor, certification of individual and consolidated financial statements</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForAuditServices_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForAuditServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor's remuneration for audit services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForAuditServices" xlink:to="lab_ifrs-full_AuditorsRemunerationForAuditServices" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ConditionalAdvancesMember_df7f12ba-fadf-48d0-981f-25bdfa747691_terseLabel_en-US" xlink:label="lab_abvx_ConditionalAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conditional advances Bpifrance</link:label>
    <link:label id="lab_abvx_ConditionalAdvancesMember_label_en-US" xlink:label="lab_abvx_ConditionalAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conditional Advances [Member]</link:label>
    <link:label id="lab_abvx_ConditionalAdvancesMember_documentation_en-US" xlink:label="lab_abvx_ConditionalAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conditional Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesMember" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ConditionalAdvancesMember" xlink:to="lab_abvx_ConditionalAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RightofuseAssetsMember_69419325-6b55-4c30-9e1c-7f738cf22b29_terseLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ROU</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssetsMember_label_en-US" xlink:label="lab_ifrs-full_RightofuseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-use assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsMember" xlink:to="lab_ifrs-full_RightofuseAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CARENAConditionalAdvanceBPIMember_b8a4ccc8-d467-4b14-9da2-c59157bc0d2c_terseLabel_en-US" xlink:label="lab_abvx_CARENAConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CARENA conditional advance</link:label>
    <link:label id="lab_abvx_CARENAConditionalAdvanceBPIMember_e3c37d86-9d3a-48cd-a134-543f22672d4a_verboseLabel_en-US" xlink:label="lab_abvx_CARENAConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">CARENA &#8211; Bpifrance</link:label>
    <link:label id="lab_abvx_CARENAConditionalAdvanceBPIMember_label_en-US" xlink:label="lab_abvx_CARENAConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CARENA Conditional Advance, BPI [Member]</link:label>
    <link:label id="lab_abvx_CARENAConditionalAdvanceBPIMember_documentation_en-US" xlink:label="lab_abvx_CARENAConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CARENA Conditional Advance, BPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CARENAConditionalAdvanceBPIMember" xlink:to="lab_abvx_CARENAConditionalAdvanceBPIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20233AGA20234AndAGA20235Member_8e7d0410-d872-4615-a071-70d052a7bd4f_terseLabel_en-US" xlink:label="lab_abvx_AGA20233AGA20234AndAGA20235Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2023-3 , AGA-2023-4 and AGA-2023-5</link:label>
    <link:label id="lab_abvx_AGA20233AGA20234AndAGA20235Member_label_en-US" xlink:label="lab_abvx_AGA20233AGA20234AndAGA20235Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2023-3 , AGA-2023-4 And AGA-2023-5 [Member]</link:label>
    <link:label id="lab_abvx_AGA20233AGA20234AndAGA20235Member_documentation_en-US" xlink:label="lab_abvx_AGA20233AGA20234AndAGA20235Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2023-3 , AGA-2023-4 And AGA-2023-5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233AGA20234AndAGA20235Member" xlink:href="abvx-20241231.xsd#abvx_AGA20233AGA20234AndAGA20235Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20233AGA20234AndAGA20235Member" xlink:to="lab_abvx_AGA20233AGA20234AndAGA20235Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_7cba4e68-5310-4dae-8d3c-c00d0dc1205d_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_0c8ebc47-72d3-4227-8075-94c56aa4a283_periodStartLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at the beginning of the year</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_6bba256d-4f8d-4745-b8b0-11809909be5f_periodEndLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at the end of the year</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_af120882-6ce2-487f-a3c1-e71666023ba2_totalLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents" xlink:to="lab_ifrs-full_CashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20242Member_08c753ad-a5c4-4b4e-b1bb-a952b5e616e7_terseLabel_en-US" xlink:label="lab_abvx_AGA20242Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-2</link:label>
    <link:label id="lab_abvx_AGA20242Member_label_en-US" xlink:label="lab_abvx_AGA20242Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-2 [Member]</link:label>
    <link:label id="lab_abvx_AGA20242Member_documentation_en-US" xlink:label="lab_abvx_AGA20242Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20242Member" xlink:href="abvx-20241231.xsd#abvx_AGA20242Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20242Member" xlink:to="lab_abvx_AGA20242Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_face93d4-e3a3-41f3-943d-1879bdae9e37_terseLabel_en-US" xlink:label="lab_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of other equity instruments</link:label>
    <link:label id="lab_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_label_en-US" xlink:label="lab_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Fair Value, Other Equity Instruments Outstanding</link:label>
    <link:label id="lab_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_documentation_en-US" xlink:label="lab_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Fair Value, Other Equity Instruments Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueOtherEquityInstrumentsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding" xlink:to="lab_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfCashAndCashEquivalentsTable_f3f0a8db-ce08-4df5-acdb-950b04ff9c70_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Cash And Cash Equivalents [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_abvx_DisclosureOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Cash And Cash Equivalents [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfCashAndCashEquivalentsTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Cash And Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCashAndCashEquivalentsTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsTable" xlink:to="lab_abvx_DisclosureOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherNonCurrentMiscellaneousFinancialAssets_a3bfc191-dabf-4b0e-b9ec-30a214a60b8b_terseLabel_en-US" xlink:label="lab_abvx_OtherNonCurrentMiscellaneousFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_abvx_OtherNonCurrentMiscellaneousFinancialAssets_label_en-US" xlink:label="lab_abvx_OtherNonCurrentMiscellaneousFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Non-Current Miscellaneous Financial Assets</link:label>
    <link:label id="lab_abvx_OtherNonCurrentMiscellaneousFinancialAssets_documentation_en-US" xlink:label="lab_abvx_OtherNonCurrentMiscellaneousFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Non-Current Miscellaneous Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherNonCurrentMiscellaneousFinancialAssets" xlink:href="abvx-20241231.xsd#abvx_OtherNonCurrentMiscellaneousFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherNonCurrentMiscellaneousFinancialAssets" xlink:to="lab_abvx_OtherNonCurrentMiscellaneousFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_0b2515b2-eecd-470f-bd23-5587a03a614f_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory_9d5c6126-7209-414d-b6ab-f602b3d85bf6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in property, plant and equipment, including right-of-use assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_c9858e58-f144-4627-9710-fd53b60e2d55_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Receivables And Other Assets [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Receivables And Other Assets [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Receivables And Other Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems" xlink:to="lab_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AbivaxLLCMember_f4618575-0f09-428a-88eb-58984d3afc54_terseLabel_en-US" xlink:label="lab_abvx_AbivaxLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Abivax LLC</link:label>
    <link:label id="lab_abvx_AbivaxLLCMember_label_en-US" xlink:label="lab_abvx_AbivaxLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Abivax LLC [Member]</link:label>
    <link:label id="lab_abvx_AbivaxLLCMember_documentation_en-US" xlink:label="lab_abvx_AbivaxLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Abivax LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AbivaxLLCMember" xlink:href="abvx-20241231.xsd#abvx_AbivaxLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AbivaxLLCMember" xlink:to="lab_abvx_AbivaxLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityAxis_e8c0219c-e673-424b-81e1-4b180d84aa9e_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity [axis]</link:label>
    <link:label id="lab_ifrs-full_MaturityAxis_label_en-US" xlink:label="lab_ifrs-full_MaturityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis" xlink:to="lab_ifrs-full_MaturityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfLeaseLiabilitiesLineItems_e82d8f22-909d-407d-8eb2-a0eadb596929_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfLeaseLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Liabilities [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfLeaseLiabilitiesLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfLeaseLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Liabilities [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfLeaseLiabilitiesLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfLeaseLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Liabilities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeaseLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems" xlink:to="lab_abvx_DisclosureOfLeaseLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities_fc8d438d-fa31-41e8-afee-fce908d019d0_terseLabel_en-US" xlink:label="lab_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds</link:label>
    <link:label id="lab_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Through Proceeds, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase Through Proceeds, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_d548ae62-c25d-42f4-8f9f-98aa40e17fc3_terseLabel_en-US" xlink:label="lab_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret financing, tranche B and C</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_label_en-US" xlink:label="lab_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Senior Secured Non-Convertible Loans [Member]</link:label>
    <link:label id="lab_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_documentation_en-US" xlink:label="lab_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret Financing, Senior Secured Non-Convertible Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" xlink:to="lab_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheFourMember_3e95af54-5d39-4657-a9ac-e6b6c5b9d7ea_terseLabel_en-US" xlink:label="lab_abvx_TrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 4</link:label>
    <link:label id="lab_abvx_TrancheFourMember_label_en-US" xlink:label="lab_abvx_TrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Four [Member]</link:label>
    <link:label id="lab_abvx_TrancheFourMember_documentation_en-US" xlink:label="lab_abvx_TrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFourMember" xlink:href="abvx-20241231.xsd#abvx_TrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheFourMember" xlink:to="lab_abvx_TrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RepaymentOfExcessConditionalAdvancesClaimed_918eb0b6-5966-4dd5-b0d9-a5ea32bfa934_terseLabel_en-US" xlink:label="lab_abvx_RepaymentOfExcessConditionalAdvancesClaimed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Excess conditional advances claimed</link:label>
    <link:label id="lab_abvx_RepaymentOfExcessConditionalAdvancesClaimed_label_en-US" xlink:label="lab_abvx_RepaymentOfExcessConditionalAdvancesClaimed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayment Of Excess Conditional Advances Claimed</link:label>
    <link:label id="lab_abvx_RepaymentOfExcessConditionalAdvancesClaimed_documentation_en-US" xlink:label="lab_abvx_RepaymentOfExcessConditionalAdvancesClaimed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repayment Of Excess Conditional Advances Claimed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentOfExcessConditionalAdvancesClaimed" xlink:href="abvx-20241231.xsd#abvx_RepaymentOfExcessConditionalAdvancesClaimed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RepaymentOfExcessConditionalAdvancesClaimed" xlink:to="lab_abvx_RepaymentOfExcessConditionalAdvancesClaimed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnobservableInputsDomain_f0705190-c386-4d64-8e13-5772563ec186_terseLabel_en-US" xlink:label="lab_ifrs-full_UnobservableInputsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unobservable inputs [domain]</link:label>
    <link:label id="lab_ifrs-full_UnobservableInputsDomain_label_en-US" xlink:label="lab_ifrs-full_UnobservableInputsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unobservable inputs [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnobservableInputsDomain" xlink:to="lab_ifrs-full_UnobservableInputsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares_34431a35-a45e-43fc-97c0-61232da745c8_terseLabel_en-US" xlink:label="lab_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net gain on sale of treasury shares</link:label>
    <link:label id="lab_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares_label_en-US" xlink:label="lab_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Net Gain On Sale Of Treasury Shares</link:label>
    <link:label id="lab_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares_documentation_en-US" xlink:label="lab_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Net Gain On Sale Of Treasury Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares" xlink:to="lab_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfSharesOutstanding_4306c3aa-67a0-4a92-9a68-f43a64a6d90a_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares outstanding (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesOutstanding_label_en-US" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputExpiryMember_5972a5eb-2fd1-4882-930d-926d2a25720f_terseLabel_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputExpiryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate, expiry</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputExpiryMember_label_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputExpiryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk-Free Interest Rate, Measurement Input, Expiry [Member]</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputExpiryMember_documentation_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputExpiryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Risk-Free Interest Rate, Measurement Input, Expiry</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputExpiryMember" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputExpiryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RiskFreeInterestRateMeasurementInputExpiryMember" xlink:to="lab_abvx_RiskFreeInterestRateMeasurementInputExpiryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember_99335cfb-65e0-4576-be47-705291e1cc2a_terseLabel_en-US" xlink:label="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RETIREMENT BENEFIT OBLIGATIONS</link:label>
    <link:label id="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember_label_en-US" xlink:label="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Present value of defined benefit obligation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:to="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_A130.0MillionCrossOverFinancingFebruary2023Member_89b38525-3c3d-4a35-8d18-a8b6ba9f3e80_terseLabel_en-US" xlink:label="lab_abvx_A130.0MillionCrossOverFinancingFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8364;130.0&#160;million cross-over financing, february 2023</link:label>
    <link:label id="lab_abvx_A130.0MillionCrossOverFinancingFebruary2023Member_label_en-US" xlink:label="lab_abvx_A130.0MillionCrossOverFinancingFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">&#8364;130.0&#160;Million Cross-Over Financing, February 2023 [Member]</link:label>
    <link:label id="lab_abvx_A130.0MillionCrossOverFinancingFebruary2023Member_documentation_en-US" xlink:label="lab_abvx_A130.0MillionCrossOverFinancingFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">&#8364;130.0&#160;Million Cross-Over Financing, February 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A130.0MillionCrossOverFinancingFebruary2023Member" xlink:href="abvx-20241231.xsd#abvx_A130.0MillionCrossOverFinancingFebruary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_A130.0MillionCrossOverFinancingFebruary2023Member" xlink:to="lab_abvx_A130.0MillionCrossOverFinancingFebruary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration_d72f041d-cabf-43ef-ba67-6616749e875b_terseLabel_en-US" xlink:label="lab_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected proceeds from share issuance, shelf registration</link:label>
    <link:label id="lab_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration_label_en-US" xlink:label="lab_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Proceeds From Share Issuance, Shelf Registration</link:label>
    <link:label id="lab_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration_documentation_en-US" xlink:label="lab_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected Proceeds From Share Issuance, Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration" xlink:href="abvx-20241231.xsd#abvx_ExpectedProceedsFromShareIssuanceShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration" xlink:to="lab_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseInLeaseLiabilities_7e5d30bf-caad-4032-95db-b03938474244_terseLabel_en-US" xlink:label="lab_abvx_IncreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase</link:label>
    <link:label id="lab_abvx_IncreaseInLeaseLiabilities_label_en-US" xlink:label="lab_abvx_IncreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase In Lease Liabilities</link:label>
    <link:label id="lab_abvx_IncreaseInLeaseLiabilities_documentation_en-US" xlink:label="lab_abvx_IncreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase In Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseInLeaseLiabilities" xlink:href="abvx-20241231.xsd#abvx_IncreaseInLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseInLeaseLiabilities" xlink:to="lab_abvx_IncreaseInLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_45de5b7c-3fe8-4c4e-a761-f8b72f8d1312_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e7300af9-e5cb-4262-8289-2a024a9167a1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_be500de5-04ee-4f22-8bd4-4902293352e9_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense on lease liabilities</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_20492a2e-0e1b-4c0b-b30d-0a5cf19a1418_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_2c061517-3922-448d-a3bd-43aba23804d5_negatedTerseLabel_en-US" xlink:label="lab_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-recognition of deferred tax assets related to tax losses and temporary differences</link:label>
    <link:label id="lab_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_label_en-US" xlink:label="lab_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Non-Recognition Of Deferred Tax Assets Related To Tax Losses And Temporary Differences</link:label>
    <link:label id="lab_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_documentation_en-US" xlink:label="lab_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Effect Of Non-Recognition Of Deferred Tax Assets Related To Tax Losses And Temporary Differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" xlink:to="lab_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EarnOutPercentage_23ac352c-e1f7-48ef-9c45-5eb2069d1fa7_terseLabel_en-US" xlink:label="lab_abvx_EarnOutPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earn-out, percentage</link:label>
    <link:label id="lab_abvx_EarnOutPercentage_label_en-US" xlink:label="lab_abvx_EarnOutPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earn-Out, Percentage</link:label>
    <link:label id="lab_abvx_EarnOutPercentage_documentation_en-US" xlink:label="lab_abvx_EarnOutPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earn-Out, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutPercentage" xlink:href="abvx-20241231.xsd#abvx_EarnOutPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EarnOutPercentage" xlink:to="lab_abvx_EarnOutPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameDomain_7b1ab234-7d9c-4378-a3ef-90458706ab6e_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [domain]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameDomain_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameDomain" xlink:to="lab_ifrs-full_BorrowingsByNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_9154f03f-01cd-4600-84ef-737ef9f31aaa_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of main actuarial assumptions used to measure the retirement benefit obligations</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheFiveMember_a2ad39cd-282b-44f8-b7d8-2699aab9ef9f_terseLabel_en-US" xlink:label="lab_abvx_TrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 5</link:label>
    <link:label id="lab_abvx_TrancheFiveMember_label_en-US" xlink:label="lab_abvx_TrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Five [Member]</link:label>
    <link:label id="lab_abvx_TrancheFiveMember_documentation_en-US" xlink:label="lab_abvx_TrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFiveMember" xlink:href="abvx-20241231.xsd#abvx_TrancheFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheFiveMember" xlink:to="lab_abvx_TrancheFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a75c4515-5888-4f31-83d3-5d8ddebb3d93_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_c0d332da-7c5a-465d-8b0c-7d687607915e_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate (WACC)</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount rate applied to cash flow projections</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants_40b1f3dc-b877-4cdd-a3ea-2b6ae5ef8527_terseLabel_en-US" xlink:label="lab_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital increases</link:label>
    <link:label id="lab_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants_label_en-US" xlink:label="lab_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuing Shares Other Than Through Exercise Of Warrants</link:label>
    <link:label id="lab_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants_documentation_en-US" xlink:label="lab_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuing Shares Other Than Through Exercise Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" xlink:to="lab_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_4b702192-4a69-4d9b-8310-4942659f3e77_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest received, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EmployeeBenefitsExpense_cc2410a3-7167-4b3b-bf60-ac6c23fbcdc4_terseLabel_en-US" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personnel costs</link:label>
    <link:label id="lab_ifrs-full_EmployeeBenefitsExpense_label_en-US" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee benefits expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_5f9bcbf4-6787-4f57-b705-3e5048ace0a0_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_e441e441-23cf-4c0b-a70e-d0d7f631e135_terseLabel_en-US" xlink:label="lab_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exclusive licensing contract with the Scripps Research Institute, University of Chicago and Brigham Young University</link:label>
    <link:label id="lab_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_label_en-US" xlink:label="lab_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exclusive Licensing Contract With The Scripps Research Institute, University Of Chicago And Brigham Young University [Member]</link:label>
    <link:label id="lab_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_documentation_en-US" xlink:label="lab_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exclusive Licensing Contract With The Scripps Research Institute, University Of Chicago And Brigham Young University</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:to="lab_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_InterestRateCollarRange_ac93c70c-4ae8-47b5-985b-d0f93cc5baa5_terseLabel_en-US" xlink:label="lab_abvx_InterestRateCollarRange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate collar range</link:label>
    <link:label id="lab_abvx_InterestRateCollarRange_label_en-US" xlink:label="lab_abvx_InterestRateCollarRange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Collar Range</link:label>
    <link:label id="lab_abvx_InterestRateCollarRange_documentation_en-US" xlink:label="lab_abvx_InterestRateCollarRange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Collar Range</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestRateCollarRange" xlink:href="abvx-20241231.xsd#abvx_InterestRateCollarRange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_InterestRateCollarRange" xlink:to="lab_abvx_InterestRateCollarRange" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityDomain_bd394176-a7ac-4bb5-9bd2-3628e1a89e5a_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity [domain]</link:label>
    <link:label id="lab_ifrs-full_MaturityDomain_label_en-US" xlink:label="lab_ifrs-full_MaturityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityDomain" xlink:to="lab_ifrs-full_MaturityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheTwoMember_e77d43c2-c69d-4c33-96c5-3f7b5bdda3f5_terseLabel_en-US" xlink:label="lab_abvx_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 2</link:label>
    <link:label id="lab_abvx_TrancheTwoMember_label_en-US" xlink:label="lab_abvx_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Two [Member]</link:label>
    <link:label id="lab_abvx_TrancheTwoMember_documentation_en-US" xlink:label="lab_abvx_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheTwoMember" xlink:to="lab_abvx_TrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20247Member_f42626e4-09bf-4608-8283-6fcc06eeaae8_terseLabel_en-US" xlink:label="lab_abvx_AGA20247Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-7</link:label>
    <link:label id="lab_abvx_AGA20247Member_label_en-US" xlink:label="lab_abvx_AGA20247Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-7 [Member]</link:label>
    <link:label id="lab_abvx_AGA20247Member_documentation_en-US" xlink:label="lab_abvx_AGA20247Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20247Member" xlink:href="abvx-20241231.xsd#abvx_AGA20247Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20247Member" xlink:to="lab_abvx_AGA20247Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock_49999bce-8218-4825-82f0-ca60d0560cc6_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of tax and employee-related payables</link:label>
    <link:label id="lab_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Tax And Employee-Related Payables Explanatory [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Tax And Employee-Related Payables Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" xlink:to="lab_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_9ccf0edf-c979-4ef2-9e63-1d0cc31ca18c_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss for the period</link:label>
    <link:label id="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_label_en-US" xlink:label="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings, profit (loss) for reporting period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod" xlink:to="lab_ifrs-full_RetainedEarningsProfitLossForReportingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3e96ff6d-436a-4286-a548-aae66a0a5f47_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_c286c02c-ce7c-4bfa-8473-d8cd62ac89fc_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_215d7b80-df28-4543-908c-f2627bdeb87c_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9e8b28bb-af4e-4be0-ba9e-75e83abee386_totalLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExerciseOfDerivativeInstruments_80bc630e-0045-4bc3-9ff4-8fc7bd6325d7_negatedTerseLabel_en-US" xlink:label="lab_abvx_ExerciseOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercises</link:label>
    <link:label id="lab_abvx_ExerciseOfDerivativeInstruments_label_en-US" xlink:label="lab_abvx_ExerciseOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Of Derivative Instruments</link:label>
    <link:label id="lab_abvx_ExerciseOfDerivativeInstruments_documentation_en-US" xlink:label="lab_abvx_ExerciseOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Of Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExerciseOfDerivativeInstruments" xlink:href="abvx-20241231.xsd#abvx_ExerciseOfDerivativeInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExerciseOfDerivativeInstruments" xlink:to="lab_abvx_ExerciseOfDerivativeInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations_abf0f3a3-ab8c-45d5-99f7-c7a544ca6156_terseLabel_en-US" xlink:label="lab_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation differences gain (loss)</link:label>
    <link:label id="lab_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations_label_en-US" xlink:label="lab_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Differences Gain (Losses) On Translation Of Foreign Operations</link:label>
    <link:label id="lab_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations_documentation_en-US" xlink:label="lab_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign Exchange Differences Gain (Losses) On Translation Of Foreign Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" xlink:href="abvx-20241231.xsd#abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" xlink:to="lab_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_ad7e7db5-ccb9-44b4-b962-bda63e220e5a_terseLabel_en-US" xlink:label="lab_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Final redemption scenario probability</link:label>
    <link:label id="lab_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_label_en-US" xlink:label="lab_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Final Redemption Scenario Probability, Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Final Redemption Scenario Probability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember" xlink:to="lab_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_5c113338-4a00-4fdf-ab65-cd2abb384678_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related parties</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of related party [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos1ClaretBondLoansMember_985713d9-8271-453e-8853-0284430857e2_terseLabel_en-US" xlink:label="lab_abvx_Kreos1ClaretBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos &amp; Claret bond loans</link:label>
    <link:label id="lab_abvx_Kreos1ClaretBondLoansMember_label_en-US" xlink:label="lab_abvx_Kreos1ClaretBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1 &amp; Claret Bond Loans [Member]</link:label>
    <link:label id="lab_abvx_Kreos1ClaretBondLoansMember_documentation_en-US" xlink:label="lab_abvx_Kreos1ClaretBondLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1 &amp; Claret Bond Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ClaretBondLoansMember" xlink:href="abvx-20241231.xsd#abvx_Kreos1ClaretBondLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos1ClaretBondLoansMember" xlink:to="lab_abvx_Kreos1ClaretBondLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit_fc551d6a-3540-4b09-8fc9-dd8efcaece0b_terseLabel_en-US" xlink:label="lab_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balances with banks in excess of legally insured limit</link:label>
    <link:label id="lab_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit_label_en-US" xlink:label="lab_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balances With Banks In Excess Of Legally Insured Limit</link:label>
    <link:label id="lab_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit_documentation_en-US" xlink:label="lab_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Balances With Banks In Excess Of Legally Insured Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit" xlink:href="abvx-20241231.xsd#abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit" xlink:to="lab_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_be7196bd-11fe-4f6d-ab8d-6a58b6e2e8bb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RepurchaseOfDerivativeInstruments_27ab674e-9ad9-4d55-a15e-57791ad53e99_terseLabel_en-US" xlink:label="lab_abvx_RepurchaseOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchases</link:label>
    <link:label id="lab_abvx_RepurchaseOfDerivativeInstruments_c74f6711-c687-4709-887a-1313dad1b9fe_negatedLabel_en-US" xlink:label="lab_abvx_RepurchaseOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchases</link:label>
    <link:label id="lab_abvx_RepurchaseOfDerivativeInstruments_label_en-US" xlink:label="lab_abvx_RepurchaseOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repurchase Of Derivative Instruments</link:label>
    <link:label id="lab_abvx_RepurchaseOfDerivativeInstruments_documentation_en-US" xlink:label="lab_abvx_RepurchaseOfDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repurchase Of Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepurchaseOfDerivativeInstruments" xlink:href="abvx-20241231.xsd#abvx_RepurchaseOfDerivativeInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RepurchaseOfDerivativeInstruments" xlink:to="lab_abvx_RepurchaseOfDerivativeInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPIFranceMember_e61c3b8f-f663-4c91-a106-ade22a2bec08_terseLabel_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPIFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ebola conditional advance, BPI France</link:label>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPIFranceMember_label_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPIFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ebola Conditional Advance, BPI France [Member]</link:label>
    <link:label id="lab_abvx_EbolaConditionalAdvanceBPIFranceMember_documentation_en-US" xlink:label="lab_abvx_EbolaConditionalAdvanceBPIFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ebola Conditional Advance, BPI France</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIFranceMember" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_EbolaConditionalAdvanceBPIFranceMember" xlink:to="lab_abvx_EbolaConditionalAdvanceBPIFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_c086e627-2805-4fc8-853c-66f7bff75e4c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement benefit obligations</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of employee benefits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_d160eff1-bb48-49c4-99b3-f556e394d223_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCE20161Member_7ad77883-d41a-4ad4-b0a3-3e26e76fa87b_terseLabel_en-US" xlink:label="lab_abvx_BCE20161Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE-2016-1</link:label>
    <link:label id="lab_abvx_BCE20161Member_label_en-US" xlink:label="lab_abvx_BCE20161Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE-2016-1 [Member]</link:label>
    <link:label id="lab_abvx_BCE20161Member_documentation_en-US" xlink:label="lab_abvx_BCE20161Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE-2016-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20161Member" xlink:href="abvx-20241231.xsd#abvx_BCE20161Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCE20161Member" xlink:to="lab_abvx_BCE20161Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_066cb0c9-a477-4533-96d6-5a63df4b03a0_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Changes in working capital requirements</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in working capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:to="lab_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth_39af0690-70fe-4594-afe9-7b624c0c7a60_terseLabel_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting percentage per month</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth_label_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage Per Month</link:label>
    <link:label id="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth_documentation_en-US" xlink:label="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage Per Month</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" xlink:to="lab_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems_991ba972-7f77-4f34-a0fe-6501e013df82_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of credit risk exposure [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of credit risk exposure [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RNPVIRConditionalAdvanceBPIMember_e28a785f-deb8-489c-b0e3-30375aff56d6_terseLabel_en-US" xlink:label="lab_abvx_RNPVIRConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RNP-VIR conditional advance</link:label>
    <link:label id="lab_abvx_RNPVIRConditionalAdvanceBPIMember_41d37eab-62c7-4039-9a01-c27c9f405a23_verboseLabel_en-US" xlink:label="lab_abvx_RNPVIRConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">RNP VIR &#8211; Bpifrance</link:label>
    <link:label id="lab_abvx_RNPVIRConditionalAdvanceBPIMember_label_en-US" xlink:label="lab_abvx_RNPVIRConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RNP-VIR Conditional Advance, BPI [Member]</link:label>
    <link:label id="lab_abvx_RNPVIRConditionalAdvanceBPIMember_documentation_en-US" xlink:label="lab_abvx_RNPVIRConditionalAdvanceBPIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RNP-VIR Conditional Advance, BPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RNPVIRConditionalAdvanceBPIMember" xlink:to="lab_abvx_RNPVIRConditionalAdvanceBPIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAdvancesToSuppliers_9d429066-6125-40be-a71e-4c12d43c4eff_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentAdvancesToSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current advances to suppliers</link:label>
    <link:label id="lab_ifrs-full_CurrentAdvancesToSuppliers_label_en-US" xlink:label="lab_ifrs-full_CurrentAdvancesToSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current advances to suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAdvancesToSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAdvancesToSuppliers" xlink:to="lab_ifrs-full_CurrentAdvancesToSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_73ae768f-1b08-4591-9c71-4d6dbb4edc99_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease / (increase) in other receivables and other assets</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in trade and other receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseFromFreeSharesIssued_e5c73532-f387-4f3d-8173-7b0601ce062f_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseFromFreeSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of free shares</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseFromFreeSharesIssued_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseFromFreeSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) From Free Shares Issued</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseFromFreeSharesIssued_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseFromFreeSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) From Free Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseFromFreeSharesIssued" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseFromFreeSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseFromFreeSharesIssued" xlink:to="lab_abvx_IncreaseDecreaseFromFreeSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentResearchTaxCreditReceivables_42b898b9-e23a-4019-8d34-245ce75a4950_terseLabel_en-US" xlink:label="lab_abvx_CurrentResearchTaxCreditReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research tax credit ("CIR")</link:label>
    <link:label id="lab_abvx_CurrentResearchTaxCreditReceivables_label_en-US" xlink:label="lab_abvx_CurrentResearchTaxCreditReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Research Tax Credit Receivables</link:label>
    <link:label id="lab_abvx_CurrentResearchTaxCreditReceivables_documentation_en-US" xlink:label="lab_abvx_CurrentResearchTaxCreditReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Research Tax Credit Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentResearchTaxCreditReceivables" xlink:href="abvx-20241231.xsd#abvx_CurrentResearchTaxCreditReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentResearchTaxCreditReceivables" xlink:to="lab_abvx_CurrentResearchTaxCreditReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_LeaseFacilitiesParisMember_1e2b08b6-ddcf-4e64-9e28-3205abddb663_terseLabel_en-US" xlink:label="lab_abvx_LeaseFacilitiesParisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease facilities, Paris</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesParisMember_label_en-US" xlink:label="lab_abvx_LeaseFacilitiesParisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Facilities, Paris [Member]</link:label>
    <link:label id="lab_abvx_LeaseFacilitiesParisMember_documentation_en-US" xlink:label="lab_abvx_LeaseFacilitiesParisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Facilities, Paris</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesParisMember" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesParisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_LeaseFacilitiesParisMember" xlink:to="lab_abvx_LeaseFacilitiesParisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock_a636c966-e022-4d6b-91f3-d6884e0cb55c_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of net financial income (loss)</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income (Cost) [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income (Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" xlink:to="lab_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TopOfRangeMember_227edba2-6ea9-4c52-8bb1-cb69f82ac943_terseLabel_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Top of range</link:label>
    <link:label id="lab_ifrs-full_TopOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Top of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember" xlink:to="lab_ifrs-full_TopOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_1e1a7623-fabd-43c7-897f-003fc287bd2f_terseLabel_en-US" xlink:label="lab_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Going concern</link:label>
    <link:label id="lab_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_label_en-US" xlink:label="lab_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Going Concern [Policy Text Block]</link:label>
    <link:label id="lab_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_documentation_en-US" xlink:label="lab_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Going Concern</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:href="abvx-20241231.xsd#abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:to="lab_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TaxEffectOfShareBasedPayment_a53fe35e-b6c2-4c3b-8354-d063b1676f45_terseLabel_en-US" xlink:label="lab_abvx_TaxEffectOfShareBasedPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment</link:label>
    <link:label id="lab_abvx_TaxEffectOfShareBasedPayment_label_en-US" xlink:label="lab_abvx_TaxEffectOfShareBasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Share-Based Payment</link:label>
    <link:label id="lab_abvx_TaxEffectOfShareBasedPayment_documentation_en-US" xlink:label="lab_abvx_TaxEffectOfShareBasedPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Effect Of Share-Based Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfShareBasedPayment" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfShareBasedPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TaxEffectOfShareBasedPayment" xlink:to="lab_abvx_TaxEffectOfShareBasedPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BSA20241AndBSA20242Member_f6e3caa9-4256-49b0-8eb9-071ae7062662_terseLabel_en-US" xlink:label="lab_abvx_BSA20241AndBSA20242Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BSA-2024-1 and BSA-2024-2</link:label>
    <link:label id="lab_abvx_BSA20241AndBSA20242Member_label_en-US" xlink:label="lab_abvx_BSA20241AndBSA20242Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BSA-2024-1 And BSA-2024-2 [Member]</link:label>
    <link:label id="lab_abvx_BSA20241AndBSA20242Member_documentation_en-US" xlink:label="lab_abvx_BSA20241AndBSA20242Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BSA-2024-1 And BSA-2024-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241AndBSA20242Member" xlink:href="abvx-20241231.xsd#abvx_BSA20241AndBSA20242Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BSA20241AndBSA20242Member" xlink:to="lab_abvx_BSA20241AndBSA20242Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PaymentsForAssetsAcquisitionsCosts_e26685e5-4d7b-4cfc-a056-801df1f8537a_terseLabel_en-US" xlink:label="lab_abvx_PaymentsForAssetsAcquisitionsCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for assets acquisition costs</link:label>
    <link:label id="lab_abvx_PaymentsForAssetsAcquisitionsCosts_label_en-US" xlink:label="lab_abvx_PaymentsForAssetsAcquisitionsCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Assets Acquisitions Costs</link:label>
    <link:label id="lab_abvx_PaymentsForAssetsAcquisitionsCosts_documentation_en-US" xlink:label="lab_abvx_PaymentsForAssetsAcquisitionsCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Assets Acquisitions Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAssetsAcquisitionsCosts" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAssetsAcquisitionsCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PaymentsForAssetsAcquisitionsCosts" xlink:to="lab_abvx_PaymentsForAssetsAcquisitionsCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AGA20246Member_1614f88c-ed7e-4198-bb3d-ecda61cb5c3f_terseLabel_en-US" xlink:label="lab_abvx_AGA20246Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGA-2024-6</link:label>
    <link:label id="lab_abvx_AGA20246Member_label_en-US" xlink:label="lab_abvx_AGA20246Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGA-2024-6 [Member]</link:label>
    <link:label id="lab_abvx_AGA20246Member_documentation_en-US" xlink:label="lab_abvx_AGA20246Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGA-2024-6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AGA20246Member" xlink:to="lab_abvx_AGA20246Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfEmployeeWorkforceTable_88c28e3a-9f5e-47ca-89e0-9b5aed0ffad8_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfEmployeeWorkforceTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Employee Workforce [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfEmployeeWorkforceTable_label_en-US" xlink:label="lab_abvx_DisclosureOfEmployeeWorkforceTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Employee Workforce [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfEmployeeWorkforceTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfEmployeeWorkforceTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Employee Workforce [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfEmployeeWorkforceTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfEmployeeWorkforceTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceTable" xlink:to="lab_abvx_DisclosureOfEmployeeWorkforceTable" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinancialLiabilitiesUndiscountedCashFlows_03d87ef4-a076-4f76-965c-ecaba46f0d82_totalLabel_en-US" xlink:label="lab_abvx_FinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities, undiscounted cash flows</link:label>
    <link:label id="lab_abvx_FinancialLiabilitiesUndiscountedCashFlows_label_en-US" xlink:label="lab_abvx_FinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Liabilities, Undiscounted Cash Flows</link:label>
    <link:label id="lab_abvx_FinancialLiabilitiesUndiscountedCashFlows_documentation_en-US" xlink:label="lab_abvx_FinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Liabilities, Undiscounted Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows" xlink:href="abvx-20241231.xsd#abvx_FinancialLiabilitiesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows" xlink:to="lab_abvx_FinancialLiabilitiesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition_be670094-95f0-406c-be55-470051464e5b_terseLabel_en-US" xlink:label="lab_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments issued subject to non-market performance condition (in shares)</link:label>
    <link:label id="lab_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition_label_en-US" xlink:label="lab_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Other Equity Instruments Granted Subject To Non-Market Performance Condition</link:label>
    <link:label id="lab_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition_documentation_en-US" xlink:label="lab_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Other Equity Instruments Granted Subject To Non-Market Performance Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" xlink:to="lab_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherAssets_7d7e51af-2650-47fb-9998-aac52bf6fef0_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other receivables and other assets</link:label>
    <link:label id="lab_ifrs-full_OtherAssets_label_en-US" xlink:label="lab_ifrs-full_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAssets" xlink:to="lab_ifrs-full_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TrancheThreeMember_5ef4fd4e-8f21-4039-a733-e434bf2fe71d_terseLabel_en-US" xlink:label="lab_abvx_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 3</link:label>
    <link:label id="lab_abvx_TrancheThreeMember_label_en-US" xlink:label="lab_abvx_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Three [Member]</link:label>
    <link:label id="lab_abvx_TrancheThreeMember_documentation_en-US" xlink:label="lab_abvx_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheThreeMember" xlink:href="abvx-20241231.xsd#abvx_TrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TrancheThreeMember" xlink:to="lab_abvx_TrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_947f4156-37ba-4b37-b182-80fac8e76efa_terseLabel_en-US" xlink:label="lab_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital increase from issuance of ordinary shares (in shares)</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_label_en-US" xlink:label="lab_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</link:label>
    <link:label id="lab_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_documentation_en-US" xlink:label="lab_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" xlink:to="lab_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_a5072be2-e07d-4256-aafe-0de02a56e8a5_terseLabel_en-US" xlink:label="lab_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RISK&#160;FREE&#160;RATE</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk Free Interest Rate, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Risk Free Interest Rate, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:to="lab_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit_d1b78bb2-70ce-45e7-a0c9-ba04e762bfa8_negatedTerseLabel_en-US" xlink:label="lab_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs related to capital increase</link:label>
    <link:label id="lab_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit_label_en-US" xlink:label="lab_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For (Proceeds From) Share Issue Related Costs (Credit)</link:label>
    <link:label id="lab_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit_documentation_en-US" xlink:label="lab_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For (Proceeds From) Share Issue Related Costs (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit" xlink:href="abvx-20241231.xsd#abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit" xlink:to="lab_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SharePremium_a7d1a226-e6ce-4dd5-a924-2290e3302db1_terseLabel_en-US" xlink:label="lab_ifrs-full_SharePremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Premiums related to share capital</link:label>
    <link:label id="lab_ifrs-full_SharePremium_label_en-US" xlink:label="lab_ifrs-full_SharePremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium" xlink:to="lab_ifrs-full_SharePremium" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_b27ec114-c8ed-4996-b3c7-5a5e8b940d7b_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from borrowings</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_ea08fa93-9505-4d2e-936c-db613088e4ae_terseLabel_en-US" xlink:label="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation techniques used in fair value measurement [domain]</link:label>
    <link:label id="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_label_en-US" xlink:label="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation techniques used in fair value measurement [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="lab_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCurrentFinancialAssets_c6ae3a88-91e1-4ddc-ba46-8d9f77382076_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial assets</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentFinancialAssets_abc2acb5-2918-4bc6-b175-bf841b4cd801_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other current financial assets</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentFinancialAssets" xlink:to="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_fadac16a-95f2-4dda-8737-2c01181075f7_negatedTerseLabel_en-US" xlink:label="lab_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments</link:label>
    <link:label id="lab_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease Through Repayments, Liabilities Arising From Financing Activities</link:label>
    <link:label id="lab_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_documentation_en-US" xlink:label="lab_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease Through Repayments, Liabilities Arising From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:to="lab_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemuneration_393c523b-4d55-4cb7-8a7b-71df6b00b440_totalLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemuneration_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor's remuneration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemuneration" xlink:to="lab_ifrs-full_AuditorsRemuneration" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember_ffc0e4c5-78de-4841-8105-5930d0e05b8d_terseLabel_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate, tender offer</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember_label_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk-Free Interest Rate, Measurement Input, Tender Offer [Member]</link:label>
    <link:label id="lab_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember_documentation_en-US" xlink:label="lab_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Risk-Free Interest Rate, Measurement Input, Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember" xlink:to="lab_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a5880198-1323-4e2f-af80-096910f0f8c3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_VolatilityForSharesMeasurementInputTenderOfferMember_1ec978af-b74e-4fae-bbfd-a18d4a2f421d_terseLabel_en-US" xlink:label="lab_abvx_VolatilityForSharesMeasurementInputTenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility, tender offer</link:label>
    <link:label id="lab_abvx_VolatilityForSharesMeasurementInputTenderOfferMember_label_en-US" xlink:label="lab_abvx_VolatilityForSharesMeasurementInputTenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Volatility For Shares Measurement Input, Tender Offer [Member]</link:label>
    <link:label id="lab_abvx_VolatilityForSharesMeasurementInputTenderOfferMember_documentation_en-US" xlink:label="lab_abvx_VolatilityForSharesMeasurementInputTenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Volatility For Shares Measurement Input, Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VolatilityForSharesMeasurementInputTenderOfferMember" xlink:href="abvx-20241231.xsd#abvx_VolatilityForSharesMeasurementInputTenderOfferMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_VolatilityForSharesMeasurementInputTenderOfferMember" xlink:to="lab_abvx_VolatilityForSharesMeasurementInputTenderOfferMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_092592ca-351e-4dad-b753-27be17925de9_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current portion of other non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:to="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeneralAndAdministrativeExpense_8ea29033-6cc6-44cd-b89c-28f77a40cd78_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_ifrs-full_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and administrative expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities_dba5daf4-7335-45a6-b8cd-44d5bc0ed413_terseLabel_en-US" xlink:label="lab_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on derecognition of financial liabilities</link:label>
    <link:label id="lab_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities_label_en-US" xlink:label="lab_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains Arising From Derecognition Of Financial Liabilities</link:label>
    <link:label id="lab_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities_documentation_en-US" xlink:label="lab_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gains Arising From Derecognition Of Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromDerecognitionOfFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities" xlink:to="lab_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementAxis_f244c5b9-7ef3-4584-9001-08ee405335e1_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement [axis]</link:label>
    <link:label id="lab_ifrs-full_MeasurementAxis_label_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis" xlink:to="lab_ifrs-full_MeasurementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_dc31eba4-6304-4f84-8f4f-cf6a07b952ab_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos12BondLoansMember_465c3401-abe7-4f79-99e4-e2d67fa1b08b_terseLabel_en-US" xlink:label="lab_abvx_Kreos12BondLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 1 &amp; 2 bond loans</link:label>
    <link:label id="lab_abvx_Kreos12BondLoansMember_label_en-US" xlink:label="lab_abvx_Kreos12BondLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1 &amp; 2 Bond Loans [Member]</link:label>
    <link:label id="lab_abvx_Kreos12BondLoansMember_documentation_en-US" xlink:label="lab_abvx_Kreos12BondLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1 &amp; 2 Bond Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos12BondLoansMember" xlink:to="lab_abvx_Kreos12BondLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TranchesDomain_cb48b3ae-56ee-4399-8398-b81c3346c953_terseLabel_en-US" xlink:label="lab_abvx_TranchesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranches [Domain]</link:label>
    <link:label id="lab_abvx_TranchesDomain_label_en-US" xlink:label="lab_abvx_TranchesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranches [Domain]</link:label>
    <link:label id="lab_abvx_TranchesDomain_documentation_en-US" xlink:label="lab_abvx_TranchesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranches [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TranchesDomain" xlink:to="lab_abvx_TranchesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfFinancialGainLossTable_e1eb6bab-c689-4333-acb6-06a16f87d627_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfFinancialGainLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Gain (Loss) [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfFinancialGainLossTable_label_en-US" xlink:label="lab_abvx_DisclosureOfFinancialGainLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Gain (Loss) [Table]</link:label>
    <link:label id="lab_abvx_DisclosureOfFinancialGainLossTable_documentation_en-US" xlink:label="lab_abvx_DisclosureOfFinancialGainLossTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFinancialGainLossTable" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFinancialGainLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfFinancialGainLossTable" xlink:to="lab_abvx_DisclosureOfFinancialGainLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssuedCapitalMember_dc617974-1faa-4a1b-a86b-8873e5e9d62f_terseLabel_en-US" xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SHARE CAPITAL</link:label>
    <link:label id="lab_ifrs-full_IssuedCapitalMember_label_en-US" xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember" xlink:to="lab_ifrs-full_IssuedCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_41e01552-7463-40ff-a239-b05708512c55_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b7bef731-489b-45b9-8a87-be0663268c60_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpectedMaturityOtherEquityInstrumentsGranted_6bc711ef-d889-48e0-ad0c-c78e6ce58be3_terseLabel_en-US" xlink:label="lab_abvx_ExpectedMaturityOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EXPECTED MATURITY</link:label>
    <link:label id="lab_abvx_ExpectedMaturityOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_ExpectedMaturityOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Maturity, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_ExpectedMaturityOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_ExpectedMaturityOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected Maturity, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedMaturityOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_ExpectedMaturityOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpectedMaturityOtherEquityInstrumentsGranted" xlink:to="lab_abvx_ExpectedMaturityOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentValueAddedTaxReceivables_a969f520-5226-4d3d-b54b-90e324c9add2_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VAT receivables</link:label>
    <link:label id="lab_ifrs-full_CurrentValueAddedTaxReceivables_label_en-US" xlink:label="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current value added tax receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BCEExceptBCE20142Member_d5466be8-adec-4c59-8ecc-7ff5429a9c40_terseLabel_en-US" xlink:label="lab_abvx_BCEExceptBCE20142Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCE except BCE 2014-2</link:label>
    <link:label id="lab_abvx_BCEExceptBCE20142Member_label_en-US" xlink:label="lab_abvx_BCEExceptBCE20142Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCE Except BCE 2014-2 [Member]</link:label>
    <link:label id="lab_abvx_BCEExceptBCE20142Member_documentation_en-US" xlink:label="lab_abvx_BCEExceptBCE20142Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCE Except BCE 2014-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCEExceptBCE20142Member" xlink:href="abvx-20241231.xsd#abvx_BCEExceptBCE20142Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BCEExceptBCE20142Member" xlink:to="lab_abvx_BCEExceptBCE20142Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_d9f61ae5-572a-4aaa-9aa4-1e50295293ec_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Key management personnel</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel of entity or parent [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4587fcae-4263-4451-8e26-d53a97ae0e65_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_ee8a1f52-611b-4c04-9d9f-cb8a8d867319_terseLabel_en-US" xlink:label="lab_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiry scenario period, other equity instruments granted</link:label>
    <link:label id="lab_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expiry Scenario Period, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expiry Scenario Period, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted" xlink:to="lab_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_2ed1d2c2-a95d-40d9-a403-5bcbe6f7bcd1_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in derivatives and liabilities fair value</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for fair value losses (gains)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_d892aa6c-41c5-461e-a67c-420989a24301_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elimination of share-based compensation expenses</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for share-based payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember_ca1138b0-b99e-48e9-97df-9d728814543e_terseLabel_en-US" xlink:label="lab_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of MRI, final redemption</link:label>
    <link:label id="lab_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember_label_en-US" xlink:label="lab_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Final Redemption, Fair Value Of MRI , Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Final Redemption, Fair Value Of MRI , Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember" xlink:to="lab_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos1Member_697beac9-5d15-481f-a1fc-91b2e47a0e5f_netLabel_en-US" xlink:label="lab_abvx_Kreos1Member" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Kreos share warrants</link:label>
    <link:label id="lab_abvx_Kreos1Member_b0fa3df6-4ae4-4745-8316-d0d4a70c8e8e_terseLabel_en-US" xlink:label="lab_abvx_Kreos1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos A &amp; B BSA</link:label>
    <link:label id="lab_abvx_Kreos1Member_d27cac9a-3ecd-46a0-b760-8505041ebc51_verboseLabel_en-US" xlink:label="lab_abvx_Kreos1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Kreos 1</link:label>
    <link:label id="lab_abvx_Kreos1Member_label_en-US" xlink:label="lab_abvx_Kreos1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 1 [Member]</link:label>
    <link:label id="lab_abvx_Kreos1Member_documentation_en-US" xlink:label="lab_abvx_Kreos1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos1Member" xlink:to="lab_abvx_Kreos1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_f1fd71ce-284d-4919-bfe3-29e60e994b28_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of ownership interests held by non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of ownership interests held by non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_94bc5649-c1f9-4ada-9e7d-61b02df4389a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other operating income [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssets_c68d9b4b-2d5d-43e4-b2a6-d0d57ff442f6_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="lab_ifrs-full_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_FinancialIncomeLossAbstract_label_en-US" xlink:label="lab_abvx_FinancialIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Income (Loss) [Abstract]</link:label>
    <link:label id="lab_abvx_FinancialIncomeLossAbstract_documentation_en-US" xlink:label="lab_abvx_FinancialIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialIncomeLossAbstract" xlink:href="abvx-20241231.xsd#abvx_FinancialIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_FinancialIncomeLossAbstract" xlink:to="lab_abvx_FinancialIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_3461de37-fa3e-4ec1-a04e-7131d458b0fa_totalLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income (loss) for the period</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="lab_ifrs-full_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DeferredFinancingCostsNettingMember_4265776b-9bfa-40d6-8370-f2595b1d0b5e_terseLabel_en-US" xlink:label="lab_abvx_DeferredFinancingCostsNettingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_abvx_DeferredFinancingCostsNettingMember_label_en-US" xlink:label="lab_abvx_DeferredFinancingCostsNettingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Financing Costs, Netting [Member]</link:label>
    <link:label id="lab_abvx_DeferredFinancingCostsNettingMember_documentation_en-US" xlink:label="lab_abvx_DeferredFinancingCostsNettingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Financing Costs, Netting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DeferredFinancingCostsNettingMember" xlink:href="abvx-20241231.xsd#abvx_DeferredFinancingCostsNettingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DeferredFinancingCostsNettingMember" xlink:to="lab_abvx_DeferredFinancingCostsNettingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias_350f4528-6962-40f6-a29b-fcb47dca3781_terseLabel_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development costs recognition, initial measurement, number of criterias</link:label>
    <link:label id="lab_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias_label_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Costs Recognition, Initial Measurement, Number Of Criterias</link:label>
    <link:label id="lab_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias_documentation_en-US" xlink:label="lab_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Costs Recognition, Initial Measurement, Number Of Criterias</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" xlink:to="lab_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_AtTheMarketATMProgramMember_dcc5cade-cc72-4091-80e2-b48b964ec2e2_terseLabel_en-US" xlink:label="lab_abvx_AtTheMarketATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market (ATM) Program</link:label>
    <link:label id="lab_abvx_AtTheMarketATMProgramMember_label_en-US" xlink:label="lab_abvx_AtTheMarketATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market (ATM) Program [Member]</link:label>
    <link:label id="lab_abvx_AtTheMarketATMProgramMember_documentation_en-US" xlink:label="lab_abvx_AtTheMarketATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market (ATM) Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AtTheMarketATMProgramMember" xlink:href="abvx-20241231.xsd#abvx_AtTheMarketATMProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_AtTheMarketATMProgramMember" xlink:to="lab_abvx_AtTheMarketATMProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock_2678403b-de77-42f0-9c4c-b1b695900a94_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis of key assumptions</link:label>
    <link:label id="lab_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock_label_en-US" xlink:label="lab_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Indirect Measurement Of Royalty Certificates [Table Text Block]</link:label>
    <link:label id="lab_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock_documentation_en-US" xlink:label="lab_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Indirect Measurement Of Royalty Certificates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" xlink:to="lab_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_c9275df5-1ad0-41da-9214-904df10064e9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BorrowingsPerformanceConditionsMinimumFinancing_17ed537c-1ae5-40cf-8ee0-d473cdbd0e95_terseLabel_en-US" xlink:label="lab_abvx_BorrowingsPerformanceConditionsMinimumFinancing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance conditions, minimum financing</link:label>
    <link:label id="lab_abvx_BorrowingsPerformanceConditionsMinimumFinancing_label_en-US" xlink:label="lab_abvx_BorrowingsPerformanceConditionsMinimumFinancing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Performance Conditions, Minimum Financing</link:label>
    <link:label id="lab_abvx_BorrowingsPerformanceConditionsMinimumFinancing_documentation_en-US" xlink:label="lab_abvx_BorrowingsPerformanceConditionsMinimumFinancing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Performance Conditions, Minimum Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsPerformanceConditionsMinimumFinancing" xlink:href="abvx-20241231.xsd#abvx_BorrowingsPerformanceConditionsMinimumFinancing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BorrowingsPerformanceConditionsMinimumFinancing" xlink:to="lab_abvx_BorrowingsPerformanceConditionsMinimumFinancing" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_f8fda744-ddf6-41b8-8cf1-dddaebf4a56d_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TRANSLATION RESERVE</link:label>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_label_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of exchange differences on translation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_MajorRevenueTransactionsMember_e1054f41-4124-446b-83da-9344a02cddcd_terseLabel_en-US" xlink:label="lab_abvx_MajorRevenueTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major revenue transactions</link:label>
    <link:label id="lab_abvx_MajorRevenueTransactionsMember_label_en-US" xlink:label="lab_abvx_MajorRevenueTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Revenue Transactions [Member]</link:label>
    <link:label id="lab_abvx_MajorRevenueTransactionsMember_documentation_en-US" xlink:label="lab_abvx_MajorRevenueTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major Revenue Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MajorRevenueTransactionsMember" xlink:href="abvx-20241231.xsd#abvx_MajorRevenueTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_MajorRevenueTransactionsMember" xlink:to="lab_abvx_MajorRevenueTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_f81a2b11-4bda-4eb2-b501-91b1ce54a2c9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of deferred tax assets and liabilities by nature</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount_f51c3d06-3609-4293-8a96-c237dff02d36_terseLabel_en-US" xlink:label="lab_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum discount</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount_label_en-US" xlink:label="lab_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Issuance Price, Maximum Discount</link:label>
    <link:label id="lab_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount_documentation_en-US" xlink:label="lab_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwriting Agreement, Issuance Price, Maximum Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementIssuancePriceMaximumDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount" xlink:to="lab_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_ee8cb7f4-5f10-4912-86e0-f55990afad8e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight_7d460dff-32e6-49b9-80a0-aee78f45d14d_terseLabel_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual percentage of proceeds from sale of intellectual property right</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight_label_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Annual Percentage Of Proceeds From Sale Of Intellectual Property Right</link:label>
    <link:label id="lab_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight_documentation_en-US" xlink:label="lab_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Financial Liabilities, Annual Percentage Of Proceeds From Sale Of Intellectual Property Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" xlink:to="lab_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5c1a3665-2a5f-4d95-938a-5cdaebd1e280_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_10b3a18b-3d0d-4316-a0ab-948d91ba4f2c_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest paid, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_7c236db1-bec5-4c87-b520-550110c5b311_negatedTerseLabel_en-US" xlink:label="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment / (disbursement) of the advance made to the Nice CHU</link:label>
    <link:label id="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_6755659f-0862-4800-85a4-4ae3a63e8e5d_terseLabel_en-US" xlink:label="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash advances and loans made to (reimbursed from) hospitals</link:label>
    <link:label id="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_label_en-US" xlink:label="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Advances And Loans Made To (Reimbursed From) Hospitals</link:label>
    <link:label id="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_documentation_en-US" xlink:label="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Advances And Loans Made To (Reimbursed From) Hospitals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" xlink:href="abvx-20241231.xsd#abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" xlink:to="lab_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_CurrentPrepaidExpensesRelatedToCRO_afd6dfbf-823c-4d74-bc5c-091911343d12_terseLabel_en-US" xlink:label="lab_abvx_CurrentPrepaidExpensesRelatedToCRO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current prepaid expenses related to CRO</link:label>
    <link:label id="lab_abvx_CurrentPrepaidExpensesRelatedToCRO_label_en-US" xlink:label="lab_abvx_CurrentPrepaidExpensesRelatedToCRO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Prepaid Expenses Related To CRO</link:label>
    <link:label id="lab_abvx_CurrentPrepaidExpensesRelatedToCRO_documentation_en-US" xlink:label="lab_abvx_CurrentPrepaidExpensesRelatedToCRO" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Prepaid Expenses Related To CRO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPrepaidExpensesRelatedToCRO" xlink:href="abvx-20241231.xsd#abvx_CurrentPrepaidExpensesRelatedToCRO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_CurrentPrepaidExpensesRelatedToCRO" xlink:to="lab_abvx_CurrentPrepaidExpensesRelatedToCRO" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_Kreos2Member_e8c9e90d-c073-4d35-b845-323bb6b0f013_terseLabel_en-US" xlink:label="lab_abvx_Kreos2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kreos 2</link:label>
    <link:label id="lab_abvx_Kreos2Member_label_en-US" xlink:label="lab_abvx_Kreos2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kreos 2 [Member]</link:label>
    <link:label id="lab_abvx_Kreos2Member_documentation_en-US" xlink:label="lab_abvx_Kreos2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kreos 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2Member" xlink:href="abvx-20241231.xsd#abvx_Kreos2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_Kreos2Member" xlink:to="lab_abvx_Kreos2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember_e94cbe2e-6a62-4f25-8178-6b169c6c4064_terseLabel_en-US" xlink:label="lab_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Board of Directors and Chief Executive Officer</link:label>
    <link:label id="lab_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Board Of Directors And Chief Executive Officer [Member]</link:label>
    <link:label id="lab_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember_documentation_en-US" xlink:label="lab_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Board Of Directors And Chief Executive Officer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:href="abvx-20241231.xsd#abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:to="lab_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RemeasurementPeriodAxis_3bd5593f-58b6-4b70-8023-4a7e0221aa28_terseLabel_en-US" xlink:label="lab_abvx_RemeasurementPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement Period [Axis]</link:label>
    <link:label id="lab_abvx_RemeasurementPeriodAxis_label_en-US" xlink:label="lab_abvx_RemeasurementPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurement Period [Axis]</link:label>
    <link:label id="lab_abvx_RemeasurementPeriodAxis_documentation_en-US" xlink:label="lab_abvx_RemeasurementPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remeasurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RemeasurementPeriodAxis" xlink:href="abvx-20241231.xsd#abvx_RemeasurementPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RemeasurementPeriodAxis" xlink:to="lab_abvx_RemeasurementPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_RepaymentsOfConditionalAdvances_690e678d-bcac-41ae-bec6-ed94ac67d541_negatedTerseLabel_en-US" xlink:label="lab_abvx_RepaymentsOfConditionalAdvances" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments of conditional advances</link:label>
    <link:label id="lab_abvx_RepaymentsOfConditionalAdvances_e41fe658-dc02-41c9-afff-c15b6c96ed98_terseLabel_en-US" xlink:label="lab_abvx_RepaymentsOfConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of conditional advances</link:label>
    <link:label id="lab_abvx_RepaymentsOfConditionalAdvances_label_en-US" xlink:label="lab_abvx_RepaymentsOfConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments Of Conditional Advances</link:label>
    <link:label id="lab_abvx_RepaymentsOfConditionalAdvances_documentation_en-US" xlink:label="lab_abvx_RepaymentsOfConditionalAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repayments Of Conditional Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConditionalAdvances" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConditionalAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_RepaymentsOfConditionalAdvances" xlink:to="lab_abvx_RepaymentsOfConditionalAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_f7824fbf-f561-4910-b7cc-0f5d76e12766_terseLabel_en-US" xlink:label="lab_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, percentage of premium</link:label>
    <link:label id="lab_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price, Percentage Of Premium Over 15-Day VWAP, Other Equity Instruments Granted</link:label>
    <link:label id="lab_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_documentation_en-US" xlink:label="lab_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price, Percentage Of Premium Over 15-Day VWAP, Other Equity Instruments Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" xlink:to="lab_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_TenderOfferFairValueOfMRIMeasurementInputMember_344e9326-e203-456b-83c3-0a6ca60e669e_terseLabel_en-US" xlink:label="lab_abvx_TenderOfferFairValueOfMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of MRI, tender offer</link:label>
    <link:label id="lab_abvx_TenderOfferFairValueOfMRIMeasurementInputMember_label_en-US" xlink:label="lab_abvx_TenderOfferFairValueOfMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tender Offer, Fair Value Of MRI , Measurement Input [Member]</link:label>
    <link:label id="lab_abvx_TenderOfferFairValueOfMRIMeasurementInputMember_documentation_en-US" xlink:label="lab_abvx_TenderOfferFairValueOfMRIMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tender Offer, Fair Value Of MRI , Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TenderOfferFairValueOfMRIMeasurementInputMember" xlink:href="abvx-20241231.xsd#abvx_TenderOfferFairValueOfMRIMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_TenderOfferFairValueOfMRIMeasurementInputMember" xlink:to="lab_abvx_TenderOfferFairValueOfMRIMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_890481c1-a289-405c-99b2-0220f108120d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_DisclosureOfWarrantsArrangementsLineItems_b5dd7eca-1cec-43a2-bebf-fe9a4f8969c5_terseLabel_en-US" xlink:label="lab_abvx_DisclosureOfWarrantsArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Warrants Arrangements [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfWarrantsArrangementsLineItems_label_en-US" xlink:label="lab_abvx_DisclosureOfWarrantsArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Warrants Arrangements [Line Items]</link:label>
    <link:label id="lab_abvx_DisclosureOfWarrantsArrangementsLineItems_documentation_en-US" xlink:label="lab_abvx_DisclosureOfWarrantsArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Warrants Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsLineItems" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems" xlink:to="lab_abvx_DisclosureOfWarrantsArrangementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes_1a805073-70e3-48bb-9005-691687e38250_terseLabel_en-US" xlink:label="lab_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuing shares and convertible loan notes</link:label>
    <link:label id="lab_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes_label_en-US" xlink:label="lab_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuing Shares And Convertible Loans Notes</link:label>
    <link:label id="lab_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes_documentation_en-US" xlink:label="lab_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuing Shares And Convertible Loans Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes" xlink:to="lab_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NotionalAmount_04411756-105e-43e5-9dc6-241b9df141a9_terseLabel_en-US" xlink:label="lab_ifrs-full_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_ifrs-full_NotionalAmount_99bb9486-4fb1-4d22-94db-03843d9d0a6a_verboseLabel_en-US" xlink:label="lab_ifrs-full_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Original principal amount</link:label>
    <link:label id="lab_ifrs-full_NotionalAmount_label_en-US" xlink:label="lab_ifrs-full_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notional amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount" xlink:to="lab_ifrs-full_NotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_a424743e-4c4b-400d-ae59-0285e593b9ed_terseLabel_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in intangible assets other than goodwill [abstract]</link:label>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_label_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in intangible assets other than goodwill [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>abvx-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5b13969f-ba48-4e71-920c-2a5c64899678,g:b21d6730-553e-45e9-b346-3f9a3ffd9584-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.abivax.com/role/Coverpage" xlink:type="simple" xlink:href="abvx-20241231.xsd#Coverpage"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_685fd83d-c77c-4a99-a4d4-3989d53d98e8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_685fd83d-c77c-4a99-a4d4-3989d53d98e8" xlink:to="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_ad1edd2c-9fcb-432d-9e3e-d39223ee6091" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:to="loc_dei_EntityListingsExchangeAxis_ad1edd2c-9fcb-432d-9e3e-d39223ee6091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_ad1edd2c-9fcb-432d-9e3e-d39223ee6091" xlink:to="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember_fe6342a9-3ed1-4a0e-97c6-470b4f675d96" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesNASDAQGlobalMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:to="loc_abvx_AmericanDepositorySharesNASDAQGlobalMarketMember_fe6342a9-3ed1-4a0e-97c6-470b4f675d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OrdinarySharesNASDAQGlobalMarketMember_c650cfec-6ea2-4f2f-99a1-dd55f6a5dafe" xlink:href="abvx-20241231.xsd#abvx_OrdinarySharesNASDAQGlobalMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_eddbea19-ecb3-43cc-b8b2-09a8724918ee" xlink:to="loc_abvx_OrdinarySharesNASDAQGlobalMarketMember_c650cfec-6ea2-4f2f-99a1-dd55f6a5dafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_a6823d39-19b1-4da8-9e36-1b35386eb514" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_a6823d39-19b1-4da8-9e36-1b35386eb514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_442d894b-1c23-4871-bc8b-684135e7b6e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_a6823d39-19b1-4da8-9e36-1b35386eb514" xlink:to="loc_dei_AddressTypeDomain_442d894b-1c23-4871-bc8b-684135e7b6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_089766a2-ff5b-4e04-8eaf-759a9a291953" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_442d894b-1c23-4871-bc8b-684135e7b6e3" xlink:to="loc_dei_BusinessContactMember_089766a2-ff5b-4e04-8eaf-759a9a291953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c56d6db2-332e-48d2-ae33-7f758b8c0232" xlink:to="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1616678c-cd9e-43b5-a0f7-fa6ecbf25994" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentType_1616678c-cd9e-43b5-a0f7-fa6ecbf25994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_40edb73a-0330-4ea0-ae09-aff53707e420" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentRegistrationStatement_40edb73a-0330-4ea0-ae09-aff53707e420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_a67f139f-4964-4882-b345-219047283097" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentAnnualReport_a67f139f-4964-4882-b345-219047283097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b3325230-539f-4c0b-9d5c-154986f30b53" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentPeriodEndDate_b3325230-539f-4c0b-9d5c-154986f30b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b34cd300-1f58-449e-a205-3af2a0f6b8dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_CurrentFiscalYearEndDate_b34cd300-1f58-449e-a205-3af2a0f6b8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_10f8bd43-24d2-47c4-88f9-2e7839b0b5b2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentTransitionReport_10f8bd43-24d2-47c4-88f9-2e7839b0b5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_abec0200-8d14-47fb-92bf-bacb2526e419" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentShellCompanyReport_abec0200-8d14-47fb-92bf-bacb2526e419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9d5a145a-c85e-4d89-856b-a6f9fcc7fbf2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityFileNumber_9d5a145a-c85e-4d89-856b-a6f9fcc7fbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1199f455-b70f-4a50-905d-e4fa7c0e84cb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityRegistrantName_1199f455-b70f-4a50-905d-e4fa7c0e84cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8d29dd66-b936-4a2e-95b4-c40d10851989" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8d29dd66-b936-4a2e-95b4-c40d10851989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_feca387b-3037-4453-a84b-1b3a09fa06ea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_ContactPersonnelName_feca387b-3037-4453-a84b-1b3a09fa06ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8967be64-d8c8-4ce9-bd85-5dab17bab6f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressAddressLine1_8967be64-d8c8-4ce9-bd85-5dab17bab6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fafe5e50-828a-4789-b9a0-14e61bebc5f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressPostalZipCode_fafe5e50-828a-4789-b9a0-14e61bebc5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a649e058-efa6-4115-a052-48fa31bc4f93" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressCityOrTown_a649e058-efa6-4115-a052-48fa31bc4f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_39f13eb7-7d1b-427c-b453-d5f13254e003" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityAddressCountry_39f13eb7-7d1b-427c-b453-d5f13254e003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_71d9ffa8-579d-47e5-a4d9-f0efd7b5f0b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_CityAreaCode_71d9ffa8-579d-47e5-a4d9-f0efd7b5f0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_02aadfb7-f17e-469d-8d38-41f26b13a993" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_LocalPhoneNumber_02aadfb7-f17e-469d-8d38-41f26b13a993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_32ceeb9a-5a93-47dd-b417-e56af875745b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_Security12bTitle_32ceeb9a-5a93-47dd-b417-e56af875745b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_aad99ac2-3770-4f8d-8a21-ae10d922d101" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_TradingSymbol_aad99ac2-3770-4f8d-8a21-ae10d922d101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8877fac2-cd3c-43b3-a604-de496a90ef41" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_SecurityExchangeName_8877fac2-cd3c-43b3-a604-de496a90ef41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e082982e-c9ec-405e-b424-c32be2fe0315" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e082982e-c9ec-405e-b424-c32be2fe0315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_0e677035-6425-4923-a3da-c53c0f161877" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_0e677035-6425-4923-a3da-c53c0f161877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_216b0963-4065-4de3-9629-1cc97bfc0ac8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityVoluntaryFilers_216b0963-4065-4de3-9629-1cc97bfc0ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a13fa3f9-d47e-4852-af85-bcac11c21475" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityCurrentReportingStatus_a13fa3f9-d47e-4852-af85-bcac11c21475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_851394e7-c7cf-41dc-bd77-b040bb6fe2dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityInteractiveDataCurrent_851394e7-c7cf-41dc-bd77-b040bb6fe2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_011c6bfc-7a0a-4e49-8ac9-eba644f8e3fb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityFilerCategory_011c6bfc-7a0a-4e49-8ac9-eba644f8e3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_66702145-bc0e-4951-b2e2-f65c4d9db854" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityEmergingGrowthCompany_66702145-bc0e-4951-b2e2-f65c4d9db854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_5654692e-f2b2-4dd4-8a01-e1305a25d19c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityExTransitionPeriod_5654692e-f2b2-4dd4-8a01-e1305a25d19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_574ce067-1412-4a2b-a7c1-ac14afbfa0ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_574ce067-1412-4a2b-a7c1-ac14afbfa0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_ceae69c2-9ed3-4b73-ad12-43c5e5c660f0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_ceae69c2-9ed3-4b73-ad12-43c5e5c660f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_9c0142f0-5ac0-4665-9eee-6c2f0f4db90b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentAccountingStandard_9c0142f0-5ac0-4665-9eee-6c2f0f4db90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_50c3a114-f79d-44f7-a1a5-5c184f992941" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityShellCompany_50c3a114-f79d-44f7-a1a5-5c184f992941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_deec089d-bd71-43f5-9105-49f1856cd47e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_AmendmentFlag_deec089d-bd71-43f5-9105-49f1856cd47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_beba1f49-bb5c-48d7-b9cc-452229b3ddd3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentFiscalYearFocus_beba1f49-bb5c-48d7-b9cc-452229b3ddd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3b3a2acf-d60f-4a92-9f65-7c88b9c2a723" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3b3a2acf-d60f-4a92-9f65-7c88b9c2a723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cf556b19-fda3-4b04-9920-7b689b8575b7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_EntityCentralIndexKey_cf556b19-fda3-4b04-9920-7b689b8575b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_ae2c9c52-1d01-4135-8b21-07df58d4633e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_fb8b655f-62d3-469c-8d17-9f286fbbaae5" xlink:to="loc_dei_NoTradingSymbolFlag_ae2c9c52-1d01-4135-8b21-07df58d4633e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Auditorinformation" xlink:type="simple" xlink:href="abvx-20241231.xsd#Auditorinformation"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Auditorinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AuditorInformationAbstract_5209cb76-6de8-4148-9355-b655280f33df" xlink:href="abvx-20241231.xsd#abvx_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_d49ff650-0886-4f32-9877-00e898c762d3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AuditorInformationAbstract_5209cb76-6de8-4148-9355-b655280f33df" xlink:to="loc_dei_AuditorName_d49ff650-0886-4f32-9877-00e898c762d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_f335e41a-373d-49f0-be83-ccbacc04fdae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AuditorInformationAbstract_5209cb76-6de8-4148-9355-b655280f33df" xlink:to="loc_dei_AuditorLocation_f335e41a-373d-49f0-be83-ccbacc04fdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_2878b0e9-af61-4d0b-9a2a-8d1617a68d25" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AuditorInformationAbstract_5209cb76-6de8-4148-9355-b655280f33df" xlink:to="loc_dei_AuditorFirmId_2878b0e9-af61-4d0b-9a2a-8d1617a68d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_959feaf0-0b7c-4d1e-a7c9-a9fe24feecf3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract_073cdd7c-aa17-455c-8be3-b07c0fc10250" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_959feaf0-0b7c-4d1e-a7c9-a9fe24feecf3" xlink:to="loc_ifrs-full_AssetsAbstract_073cdd7c-aa17-455c-8be3-b07c0fc10250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_073cdd7c-aa17-455c-8be3-b07c0fc10250" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_702a330d-7df7-460f-ac76-406697f31005" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:to="loc_ifrs-full_Goodwill_702a330d-7df7-460f-ac76-406697f31005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_4ebb5ab4-af2b-4fc7-9e71-273465afc06e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_4ebb5ab4-af2b-4fc7-9e71-273465afc06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_a6f79ead-4eff-458b-a5b3-685231c9fbe6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_a6f79ead-4eff-458b-a5b3-685231c9fbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_079fe516-6627-4541-b0ba-2619132362f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialAssets_079fe516-6627-4541-b0ba-2619132362f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_7be56eea-9609-4363-8aa4-0bd365014a86" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:to="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_7be56eea-9609-4363-8aa4-0bd365014a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_e1ea90d4-4308-436e-a5f8-0910f5448d5c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6901066e-608e-452e-8e54-495fb1af86c3" xlink:to="loc_ifrs-full_NoncurrentAssets_e1ea90d4-4308-436e-a5f8-0910f5448d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_dd120274-89c6-4e33-9a55-8017c36a5131" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_073cdd7c-aa17-455c-8be3-b07c0fc10250" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_dd120274-89c6-4e33-9a55-8017c36a5131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_d507a736-ed79-42c6-bbcb-38207835fdce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_dd120274-89c6-4e33-9a55-8017c36a5131" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_d507a736-ed79-42c6-bbcb-38207835fdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_46902060-c458-4d81-bd8f-d2db35635ac1" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesAndCurrentPrepaidExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_dd120274-89c6-4e33-9a55-8017c36a5131" xlink:to="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_46902060-c458-4d81-bd8f-d2db35635ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_dabc1df4-9b48-4c2a-853f-567783a9ebfb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_dd120274-89c6-4e33-9a55-8017c36a5131" xlink:to="loc_ifrs-full_CashAndCashEquivalents_dabc1df4-9b48-4c2a-853f-567783a9ebfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_e2a6d02a-5846-4a17-b3df-77e53a5b7ca8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_dd120274-89c6-4e33-9a55-8017c36a5131" xlink:to="loc_ifrs-full_CurrentAssets_e2a6d02a-5846-4a17-b3df-77e53a5b7ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_aa40f51b-33ad-4fc1-abce-9601fc0518f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_073cdd7c-aa17-455c-8be3-b07c0fc10250" xlink:to="loc_ifrs-full_Assets_aa40f51b-33ad-4fc1-abce-9601fc0518f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_42263c8a-ae2b-4f7e-be6a-386782dc328b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_959feaf0-0b7c-4d1e-a7c9-a9fe24feecf3" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_42263c8a-ae2b-4f7e-be6a-386782dc328b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_42263c8a-ae2b-4f7e-be6a-386782dc328b" xlink:to="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_090ac3b9-e6a8-4630-a140-bc4d9f962255" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:to="loc_ifrs-full_IssuedCapital_090ac3b9-e6a8-4630-a140-bc4d9f962255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_f3527f62-4bf3-4203-b4ff-f3d65457b2b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:to="loc_ifrs-full_SharePremium_f3527f62-4bf3-4203-b4ff-f3d65457b2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_79236851-88d0-4cb2-891b-844b90f4788b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_79236851-88d0-4cb2-891b-844b90f4788b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_d999af08-9321-450c-880e-0fd707681e92" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_d999af08-9321-450c-880e-0fd707681e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_eeed7729-b844-4b67-ae0f-5978b62d9e4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_eeed7729-b844-4b67-ae0f-5978b62d9e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_1c0d70db-957f-47d1-8ec7-5471a69e2055" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_f0ab2f58-300b-4fe5-8141-64d65d2e24ee" xlink:to="loc_ifrs-full_Equity_1c0d70db-957f-47d1-8ec7-5471a69e2055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_42263c8a-ae2b-4f7e-be6a-386782dc328b" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_3d204a08-4e67-43f9-ab77-478fd5ffee01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_3d204a08-4e67-43f9-ab77-478fd5ffee01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions_66ba3f2d-984b-4ca2-958a-9a8d302e7239" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_ifrs-full_OtherLongtermProvisions_66ba3f2d-984b-4ca2-958a-9a8d302e7239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_ca0da398-5f5c-4338-9697-fa09812f0f64" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_ca0da398-5f5c-4338-9697-fa09812f0f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentConvertibleLoansNotes_8a75e053-5423-4e75-9b54-60073f8a609f" xlink:href="abvx-20241231.xsd#abvx_NonCurrentConvertibleLoansNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_abvx_NonCurrentConvertibleLoansNotes_8a75e053-5423-4e75-9b54-60073f8a609f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_dfb6d0ac-7c3c-4cf1-af5f-ad34aad4927f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_dfb6d0ac-7c3c-4cf1-af5f-ad34aad4927f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates_671baec5-dbe0-4dc8-8c17-25400042710e" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_abvx_NonCurrentRoyaltyCertificates_671baec5-dbe0-4dc8-8c17-25400042710e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_fee6347c-e5e5-4b96-ba51-47ea154688e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_fee6347c-e5e5-4b96-ba51-47ea154688e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_25be4d8b-b522-4224-acf7-42215c82310b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_99e2fa85-0434-4564-a255-67a3f3a0cf5e" xlink:to="loc_ifrs-full_NoncurrentLiabilities_25be4d8b-b522-4224-acf7-42215c82310b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_42263c8a-ae2b-4f7e-be6a-386782dc328b" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_3245431f-7844-447a-9165-0dc6210caea5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_3245431f-7844-447a-9165-0dc6210caea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_42d4d204-7303-4ea5-bfa5-9f1307c64103" xlink:href="abvx-20241231.xsd#abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_42d4d204-7303-4ea5-bfa5-9f1307c64103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_82ff20c5-41f1-4f71-a6ba-0a6b7080a6e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_82ff20c5-41f1-4f71-a6ba-0a6b7080a6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialLiabilities_8feee27e-0679-4eda-a5fa-f72c87a104ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_ifrs-full_OtherCurrentFinancialLiabilities_8feee27e-0679-4eda-a5fa-f72c87a104ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherShorttermProvisions_f4fecec1-3873-4898-b39b-e92c8ab0b09b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherShorttermProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_ifrs-full_OtherShorttermProvisions_f4fecec1-3873-4898-b39b-e92c8ab0b09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_f84e8575-2af3-425a-a175-4f5cb1bd7517" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_f84e8575-2af3-425a-a175-4f5cb1bd7517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_17ff5861-0bd1-416f-997e-1c1d2a531f7a" xlink:href="abvx-20241231.xsd#abvx_CurrentTaxAndEmployeeBenefitLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_17ff5861-0bd1-416f-997e-1c1d2a531f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_e0a7ba4f-a1fd-4f67-ad81-d8d224812047" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_e0a7ba4f-a1fd-4f67-ad81-d8d224812047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_ab97798b-e6b5-4781-b188-5fcc53201430" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e4b2884e-fb47-4bdf-8d9a-4c9c3d9acb76" xlink:to="loc_ifrs-full_CurrentLiabilities_ab97798b-e6b5-4781-b188-5fcc53201430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_b264ee38-e199-4eaf-88ce-0d1edc2f3595" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_42263c8a-ae2b-4f7e-be6a-386782dc328b" xlink:to="loc_ifrs-full_EquityAndLiabilities_b264ee38-e199-4eaf-88ce-0d1edc2f3595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_e23aece2-c8f0-440d-aa73-9af9cd35b4b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_e23aece2-c8f0-440d-aa73-9af9cd35b4b8" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_569b5dd7-7ae7-49c5-9809-187213c60460" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_569b5dd7-7ae7-49c5-9809-187213c60460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_569b5dd7-7ae7-49c5-9809-187213c60460" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_292dbc77-4778-4cff-bd6f-4acbb4b4356d" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:to="loc_abvx_OceaneConversionOptionMember_292dbc77-4778-4cff-bd6f-4acbb4b4356d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_7df46830-0f08-4432-8996-94265486cbb8" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_9d2809b6-dcc5-4a52-b37f-6c084f095809" xlink:to="loc_abvx_HeightsConvertibleNotesMember_7df46830-0f08-4432-8996-94265486cbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_fac2fa93-be8c-44d1-86cd-787b385161bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_fac2fa93-be8c-44d1-86cd-787b385161bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestatedMember_811d9cab-732d-4f4f-8354-dafe288e5410" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_fac2fa93-be8c-44d1-86cd-787b385161bb" xlink:to="loc_ifrs-full_RestatedMember_811d9cab-732d-4f4f-8354-dafe288e5410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember_d094a7ca-9fe2-4db1-b772-93596d0bcfc1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_811d9cab-732d-4f4f-8354-dafe288e5410" xlink:to="loc_ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember_d094a7ca-9fe2-4db1-b772-93596d0bcfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_9fe5f0a4-6dfd-4de8-ac9e-693538c83cd7" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentConvertibleLoansNotes_c7546ec6-4724-40b1-96f6-97b819738669" xlink:href="abvx-20241231.xsd#abvx_NonCurrentConvertibleLoansNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:to="loc_abvx_NonCurrentConvertibleLoansNotes_c7546ec6-4724-40b1-96f6-97b819738669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_90709ef0-8cfa-435a-a144-f5dd868262b1" xlink:href="abvx-20241231.xsd#abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_469c3d24-bbf1-47a8-8b7f-983bdea7df9c" xlink:to="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_90709ef0-8cfa-435a-a144-f5dd868262b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_6d2d25ba-e5c6-4825-9023-96f75a0b80f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_OtherIncome_6d2d25ba-e5c6-4825-9023-96f75a0b80f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAndOperatingIncome_091d74ee-4719-406d-810e-476684fbb176" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAndOperatingIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_RevenueAndOperatingIncome_091d74ee-4719-406d-810e-476684fbb176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_55b29782-a24b-4ee1-a6e3-63ef44d94b9b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_55b29782-a24b-4ee1-a6e3-63ef44d94b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_506dbef6-06f6-498a-8311-71275c75ad86" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_506dbef6-06f6-498a-8311-71275c75ad86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_c367d866-56bd-44ee-a1a8-7030509d86f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_c367d866-56bd-44ee-a1a8-7030509d86f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_b31abc2e-d194-4678-8b29-5ff285313a3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_b31abc2e-d194-4678-8b29-5ff285313a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_91847eb0-0969-4f22-a4cc-5e6b73b175c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_OperatingExpense_91847eb0-0969-4f22-a4cc-5e6b73b175c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_63240e92-2bf7-4fe1-8538-47a0f55bed90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_63240e92-2bf7-4fe1-8538-47a0f55bed90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_b97ab703-cc26-4a8d-8b53-97732ef92562" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_FinanceCosts_b97ab703-cc26-4a8d-8b53-97732ef92562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_528aebcc-00cd-4327-9641-8eb1d1659b75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_FinanceIncome_528aebcc-00cd-4327-9641-8eb1d1659b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_ed2e5d27-1ddb-4b5d-9d64-e761ef33249c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_FinanceIncomeCost_ed2e5d27-1ddb-4b5d-9d64-e761ef33249c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_b1522740-2e39-490e-8628-ed901ce6a4b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_b1522740-2e39-490e-8628-ed901ce6a4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_db5abcd0-a284-4548-b164-5d6b556313c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_db5abcd0-a284-4548-b164-5d6b556313c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_cfafe8e7-2e7a-4210-bfe6-85a8627f3718" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_ProfitLoss_cfafe8e7-2e7a-4210-bfe6-85a8627f3718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_4013e0b7-d03a-40ac-bf04-97b1a219066f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_7948742b-a84c-4f82-aca8-92ceba75177a" xlink:to="loc_ifrs-full_EarningsPerShareAbstract_4013e0b7-d03a-40ac-bf04-97b1a219066f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_ca1068bc-868b-4b25-8f62-4ce9e2a5115b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_4013e0b7-d03a-40ac-bf04-97b1a219066f" xlink:to="loc_ifrs-full_WeightedAverageShares_ca1068bc-868b-4b25-8f62-4ce9e2a5115b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_038f47f4-c402-4839-8872-9ac683899ee2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_4013e0b7-d03a-40ac-bf04-97b1a219066f" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_038f47f4-c402-4839-8872-9ac683899ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_7f2ebbf7-8fd1-45f2-a7fb-6dfe59540ee2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_4013e0b7-d03a-40ac-bf04-97b1a219066f" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_7f2ebbf7-8fd1-45f2-a7fb-6dfe59540ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_75f0bfc7-bafc-41cc-b1de-2670dc35531d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_4013e0b7-d03a-40ac-bf04-97b1a219066f" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_75f0bfc7-bafc-41cc-b1de-2670dc35531d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_d7cb1d8b-1c22-432f-89d4-43a58387841f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:to="loc_ifrs-full_ProfitLoss_d7cb1d8b-1c22-432f-89d4-43a58387841f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_b108537e-6352-4964-b2b4-3507316c001b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_b108537e-6352-4964-b2b4-3507316c001b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_9d72b33d-9856-4d84-a69e-81b1eab4b740" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_9d72b33d-9856-4d84-a69e-81b1eab4b740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_a466d12d-a257-4622-9cf7-f520c8b3ec8c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_a466d12d-a257-4622-9cf7-f520c8b3ec8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0311f4a3-4e2a-4610-9ae4-aa818b989554" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0311f4a3-4e2a-4610-9ae4-aa818b989554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_db6905dd-779c-4500-9af3-361bc302a6d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_db6905dd-779c-4500-9af3-361bc302a6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_54b5060c-5146-4e75-b002-a939c21780fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_7e68bdcf-085e-4969-aea2-0e5c19cc3994" xlink:to="loc_ifrs-full_ComprehensiveIncome_54b5060c-5146-4e75-b002-a939c21780fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_7de77258-2def-47f1-a8d8-45acb56f25e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_7de77258-2def-47f1-a8d8-45acb56f25e8" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_21d1e3ad-b267-42ae-893c-c8afd1862f62" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_21d1e3ad-b267-42ae-893c-c8afd1862f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_21d1e3ad-b267-42ae-893c-c8afd1862f62" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_acff1b9e-3d79-44fa-8258-f506a8e261b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_IssuedCapitalMember_acff1b9e-3d79-44fa-8258-f506a8e261b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_14dc6a42-0d8b-4f2c-9688-98e8bfbf7758" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_SharePremiumMember_14dc6a42-0d8b-4f2c-9688-98e8bfbf7758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_c9cb8e87-ca7d-4f32-89f2-699c6f5d6e28" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_c9cb8e87-ca7d-4f32-89f2-699c6f5d6e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_38cf6695-280b-44fb-9a6d-0e1d7e870aef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_38cf6695-280b-44fb-9a6d-0e1d7e870aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_be8cf8b6-7d25-41ac-a0ca-01d98ab24128" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cd7b138b-fe61-48f1-a2c8-49abca10658f" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_be8cf8b6-7d25-41ac-a0ca-01d98ab24128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_223f6c1e-879a-41be-ae49-17ff4b391ee1" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:to="loc_abvx_FinancialAgreementAxis_223f6c1e-879a-41be-ae49-17ff4b391ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementAxis_223f6c1e-879a-41be-ae49-17ff4b391ee1" xlink:to="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_483b31f0-a50d-406d-8200-e3d57a1b1afc" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:to="loc_abvx_Kreos1Member_483b31f0-a50d-406d-8200-e3d57a1b1afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEquityAgreementsMember_1085efe2-bcd9-4d6e-bb62-7ef9cd699c52" xlink:href="abvx-20241231.xsd#abvx_OtherEquityAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_c6e26122-e57f-452c-97d2-55276c80f6b9" xlink:to="loc_abvx_OtherEquityAgreementsMember_1085efe2-bcd9-4d6e-bb62-7ef9cd699c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_d39f5227-95d0-430e-a893-a7b6e25f2118" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_30c948b5-cdd0-47ee-bf47-486b0bd17412" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_NumberOfSharesIssued_30c948b5-cdd0-47ee-bf47-486b0bd17412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_16ae3d2b-c901-4524-a5be-18c0b13ff6ea" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_16ae3d2b-c901-4524-a5be-18c0b13ff6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_018d0d2a-5b31-4128-a42a-ff1a9ffad5c2" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_018d0d2a-5b31-4128-a42a-ff1a9ffad5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesIssued_31873c25-b702-4ff6-a972-0d032a8ec766" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_51c2b4af-41f7-41eb-99e6-2550cc3c3161" xlink:to="loc_abvx_NumberOfFreeSharesIssued_31873c25-b702-4ff6-a972-0d032a8ec766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_5f7dd693-935c-455f-8fc9-6af543c3a3eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_NumberOfSharesIssued_5f7dd693-935c-455f-8fc9-6af543c3a3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_f52ab608-4ebf-49f6-8638-47dd36a83fd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_Equity_f52ab608-4ebf-49f6-8638-47dd36a83fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_264dbfce-449d-4e21-972f-5a1512eeb8d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_ProfitLoss_264dbfce-449d-4e21-972f-5a1512eeb8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_e0d309cb-77a1-4e96-bbb9-a66cda2cedca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_e0d309cb-77a1-4e96-bbb9-a66cda2cedca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_efaf8c0c-b6f9-4813-b962-c17ed25976ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_ComprehensiveIncome_efaf8c0c-b6f9-4813-b962-c17ed25976ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_75690db5-0156-4f1c-af98-0223c9453f77" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_75690db5-0156-4f1c-af98-0223c9453f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_f7dd6fd4-ce56-491c-bcba-e97c7a413604" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IssueOfEquity_f7dd6fd4-ce56-491c-bcba-e97c7a413604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareIssueRelatedCostCredit_0ac2dfcc-7771-4c7e-8d22-c14926ec60b3" xlink:href="abvx-20241231.xsd#abvx_ShareIssueRelatedCostCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_abvx_ShareIssueRelatedCostCredit_0ac2dfcc-7771-4c7e-8d22-c14926ec60b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_1aa74e04-9916-4913-a305-1a6d2fe00890" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IssueOfConvertibleInstruments_1aa74e04-9916-4913-a305-1a6d2fe00890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity_8cd1c948-6f80-4d49-a015-35ce4d5aef98" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity_8cd1c948-6f80-4d49-a015-35ce4d5aef98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1f994b5b-8eb1-44d8-a3c9-242198bb17d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1f994b5b-8eb1-44d8-a3c9-242198bb17d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseFromFreeSharesIssued_d0c2a014-53c8-44c0-b96f-447de4fe5353" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseFromFreeSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_abvx_IncreaseDecreaseFromFreeSharesIssued_d0c2a014-53c8-44c0-b96f-447de4fe5353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0956ab9c-9b19-49d8-822c-d5440e12753b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0956ab9c-9b19-49d8-822c-d5440e12753b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_7443d012-8a4a-494d-b045-480ef299dac1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_8ccfe16c-29fe-4262-9328-a5c91ebf28d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_7443d012-8a4a-494d-b045-480ef299dac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_1859de04-411f-41a7-8972-bbe743972760" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_6a904b8d-e88d-48e6-beec-b7a9e7dc049d" xlink:to="loc_ifrs-full_Equity_1859de04-411f-41a7-8972-bbe743972760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="abvx-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2cc98a4d-67ab-44fe-b8ac-d60fa5a319a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2cc98a4d-67ab-44fe-b8ac-d60fa5a319a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_6958899a-65f3-4593-b67f-1abf56952f36" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2cc98a4d-67ab-44fe-b8ac-d60fa5a319a8" xlink:to="loc_ifrs-full_ProfitLoss_6958899a-65f3-4593-b67f-1abf56952f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2cc98a4d-67ab-44fe-b8ac-d60fa5a319a8" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_d9f1bfb3-e668-4924-8acc-23f9cff35b41" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_d9f1bfb3-e668-4924-8acc-23f9cff35b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0158624e-4d96-4f72-a8f7-f524d5f4353b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0158624e-4d96-4f72-a8f7-f524d5f4353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_28e45c00-a4e3-43e0-a71c-07a59d916464" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_28e45c00-a4e3-43e0-a71c-07a59d916464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_57ca4ae5-426f-40ad-9ac2-a3bb3fb1c16b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_57ca4ae5-426f-40ad-9ac2-a3bb3fb1c16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares_fb41f283-5793-4ab3-a3a8-0f4703c4a44e" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares_fb41f283-5793-4ab3-a3a8-0f4703c4a44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForOtherFinanceCosts_7231ccd4-d798-4101-982d-dbb327c78efe" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForOtherFinanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_abvx_AdjustmentsForOtherFinanceCosts_7231ccd4-d798-4101-982d-dbb327c78efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForOtherFinanceIncome_e730526b-ec89-48d8-98f5-bd8dd336df07" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForOtherFinanceIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_abvx_AdjustmentsForOtherFinanceIncome_e730526b-ec89-48d8-98f5-bd8dd336df07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances_f6360995-f21b-400f-b808-1c665a30bbef" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances_f6360995-f21b-400f-b808-1c665a30bbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_7cff5369-4646-40ce-9108-692555f7dc66" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_7cff5369-4646-40ce-9108-692555f7dc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances_abeb1926-e077-4ead-8d1d-3381748597eb" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances_abeb1926-e077-4ead-8d1d-3381748597eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_7adae8bd-8e73-468d-aa76-a24f4272d9f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_7adae8bd-8e73-468d-aa76-a24f4272d9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_4ec168fe-e627-44c7-a199-16b77f4b2695" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_4ec168fe-e627-44c7-a199-16b77f4b2695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_5f34c96f-ae75-4823-8c93-3ffba6d741d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_5f34c96f-ae75-4823-8c93-3ffba6d741d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_e4e24622-a6bf-42b9-9332-538be9f711b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_e4e24622-a6bf-42b9-9332-538be9f711b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities_1f0ac3b6-d5fa-421c-a257-85d01a93153b" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities_1f0ac3b6-d5fa-421c-a257-85d01a93153b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities_5f14fc70-a806-4535-a96f-1817598940e8" xlink:href="abvx-20241231.xsd#abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities_5f14fc70-a806-4535-a96f-1817598940e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_6f02acde-525d-4121-a984-e564d959a1e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_459f818a-653a-455b-a550-eae803a1ca71" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_6f02acde-525d-4121-a984-e564d959a1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_5dd4cdac-c999-43ba-a3f8-8d8c10a659da" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2cc98a4d-67ab-44fe-b8ac-d60fa5a319a8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_5dd4cdac-c999-43ba-a3f8-8d8c10a659da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_7cb4765c-4a88-48b5-84be-9ce027bf315e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_7cb4765c-4a88-48b5-84be-9ce027bf315e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_26543dc7-d1b0-4626-8328-104d8e55b156" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_26543dc7-d1b0-4626-8328-104d8e55b156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_4d037505-a384-4c35-ba9c-3afa4ec9b83f" xlink:href="abvx-20241231.xsd#abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_4d037505-a384-4c35-ba9c-3afa4ec9b83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_4b63958f-6b15-4b7e-8fa4-385164b6d809" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAdvancesMadeToContractResearchOrganizations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_4b63958f-6b15-4b7e-8fa4-385164b6d809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired_1d3f6b25-c668-432e-b8cb-13dd6da756d5" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired_1d3f6b25-c668-432e-b8cb-13dd6da756d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPaymentsForDeposits_945ed0d9-bf69-4b19-8f17-dda701049bef" xlink:href="abvx-20241231.xsd#abvx_CashPaymentsForDeposits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_abvx_CashPaymentsForDeposits_945ed0d9-bf69-4b19-8f17-dda701049bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromReimbursementsOfDeposits_2a3909a5-47e6-40b3-a4e9-47ec82ce84f3" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromReimbursementsOfDeposits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_abvx_ProceedsFromReimbursementsOfDeposits_2a3909a5-47e6-40b3-a4e9-47ec82ce84f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_4288ff8b-5cba-45b6-9c32-09d3763cf870" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_4288ff8b-5cba-45b6-9c32-09d3763cf870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_2d7b8bbc-e5f0-4a35-b74e-6cdba7c20408" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_f801ad94-1b66-4340-b216-f7f10a9a1077" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_2d7b8bbc-e5f0-4a35-b74e-6cdba7c20408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_bea7be33-363b-465b-a001-8dbbc2870024" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_bea7be33-363b-465b-a001-8dbbc2870024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit_1032123f-5846-44f4-9d23-3a7733789aab" xlink:href="abvx-20241231.xsd#abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit_1032123f-5846-44f4-9d23-3a7733789aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromNonConvertibleLoansNotes_c2aa6724-0187-4d0e-9b14-1ee9213e0145" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromNonConvertibleLoansNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_NetProceedsFromNonConvertibleLoansNotes_c2aa6724-0187-4d0e-9b14-1ee9213e0145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfBondLoans_54a15c58-0fe9-4bf1-a535-3d70e710598f" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfBondLoans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_RepaymentsOfBondLoans_54a15c58-0fe9-4bf1-a535-3d70e710598f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_1c9bcecb-fcb0-4dd1-a4d5-fbe89d869c97" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_1c9bcecb-fcb0-4dd1-a4d5-fbe89d869c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_56e503e7-a0aa-43dd-81d8-9dfeb9fb18b5" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_56e503e7-a0aa-43dd-81d8-9dfeb9fb18b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfPGE_9a25af68-f647-4509-abfe-76468dff771a" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfPGE"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_RepaymentsOfPGE_9a25af68-f647-4509-abfe-76468dff771a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConditionalAdvances_beeac3ef-707e-473f-9c50-3c92d77a42e7" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConditionalAdvances"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_RepaymentsOfConditionalAdvances_beeac3ef-707e-473f-9c50-3c92d77a42e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_025b2d84-3d10-49be-888f-ed277bcf0846" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_025b2d84-3d10-49be-888f-ed277bcf0846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_85708828-40fe-4306-b451-b81524206df4" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_85708828-40fe-4306-b451-b81524206df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_e33bb6c9-ac1b-47e8-b85b-fa19c1e48d9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_e33bb6c9-ac1b-47e8-b85b-fa19c1e48d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_20f9132d-e31a-4123-a35a-30357b0bcd0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_20f9132d-e31a-4123-a35a-30357b0bcd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_a8161690-102a-4e9a-92b2-046c952183ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_a8161690-102a-4e9a-92b2-046c952183ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_720b6169-891f-4ab1-b5b1-e6c57dc63042" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_adc449c2-81c9-453f-a1ca-4e41afacfa6d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_720b6169-891f-4ab1-b5b1-e6c57dc63042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_9e793461-4fcb-4939-928f-8fb4d16839d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_9e793461-4fcb-4939-928f-8fb4d16839d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9fb968fc-9a69-4b86-b1a8-ee5c66e16b20" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9fb968fc-9a69-4b86-b1a8-ee5c66e16b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_5f323293-3db2-4586-aaf5-529afcfe7315" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:to="loc_ifrs-full_CashAndCashEquivalents_5f323293-3db2-4586-aaf5-529afcfe7315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_e429ef3e-6323-4f89-820f-ebb5db8a9831" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_fa98e71f-e163-44fa-9747-0e3a9480124d" xlink:to="loc_ifrs-full_CashAndCashEquivalents_e429ef3e-6323-4f89-820f-ebb5db8a9831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/TheGroup" xlink:type="simple" xlink:href="abvx-20241231.xsd#TheGroup"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/TheGroup" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_63d8063b-764e-4765-854c-eb9f41664447" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_e3a73c11-c0ed-448c-a03a-4d65937f29c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_63d8063b-764e-4765-854c-eb9f41664447" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_e3a73c11-c0ed-448c-a03a-4d65937f29c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Basisofpreparation" xlink:type="simple" xlink:href="abvx-20241231.xsd#Basisofpreparation"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Basisofpreparation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_347bc30a-4dfe-4972-a8c6-31f7a32b9cc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0d3ce5a0-7eec-4b9f-a1e4-24add289ac2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_347bc30a-4dfe-4972-a8c6-31f7a32b9cc9" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0d3ce5a0-7eec-4b9f-a1e4-24add289ac2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_c0e5c370-3d21-4b28-b48f-cc4c92debe10" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock_548136f4-1357-45b7-a625-19461d68b6fc" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_c0e5c370-3d21-4b28-b48f-cc4c92debe10" xlink:to="loc_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock_548136f4-1357-45b7-a625-19461d68b6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Accountingprinciples" xlink:type="simple" xlink:href="abvx-20241231.xsd#Accountingprinciples"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Accountingprinciples" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_3cbc3228-e3ce-4f3a-8e02-1355195c081a" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_23dea4d2-775a-4024-8939-955655fa075b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_3cbc3228-e3ce-4f3a-8e02-1355195c081a" xlink:to="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_23dea4d2-775a-4024-8939-955655fa075b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Segmentinformation" xlink:type="simple" xlink:href="abvx-20241231.xsd#Segmentinformation"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Segmentinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_726f9286-8e5c-491e-b15c-88a243ef0f90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_7c78cc36-799f-4bd5-85d7-a7a9082e4f73" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_726f9286-8e5c-491e-b15c-88a243ef0f90" xlink:to="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_7c78cc36-799f-4bd5-85d7-a7a9082e4f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Goodwillandimpairmenttest" xlink:type="simple" xlink:href="abvx-20241231.xsd#Goodwillandimpairmenttest"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Goodwillandimpairmenttest" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_776842c1-7608-4b87-a1ed-ff49102187c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGoodwillExplanatory_79d7fc75-4808-4fa7-a743-f710d496872e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_776842c1-7608-4b87-a1ed-ff49102187c2" xlink:to="loc_ifrs-full_DisclosureOfGoodwillExplanatory_79d7fc75-4808-4fa7-a743-f710d496872e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Intangibleassets" xlink:type="simple" xlink:href="abvx-20241231.xsd#Intangibleassets"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Intangibleassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_0c1af677-0138-4032-8865-fb9b59bee863" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_b9bb526a-ad18-4d7f-8500-22505a985250" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_0c1af677-0138-4032-8865-fb9b59bee863" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_b9bb526a-ad18-4d7f-8500-22505a985250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Propertyplantandequipment" xlink:type="simple" xlink:href="abvx-20241231.xsd#Propertyplantandequipment"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Propertyplantandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_a3ee377a-dd49-4683-aa16-95f81bfc4063" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0d9a4af9-7399-4a46-a5bc-d93d693d2e7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_a3ee377a-dd49-4683-aa16-95f81bfc4063" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0d9a4af9-7399-4a46-a5bc-d93d693d2e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Otherfinancialassets" xlink:type="simple" xlink:href="abvx-20241231.xsd#Otherfinancialassets"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Otherfinancialassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_08b34d62-e7b9-4351-808b-dc51fbc238f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_c9fffc29-830e-4974-86d7-9087fb7b0c3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_08b34d62-e7b9-4351-808b-dc51fbc238f7" xlink:to="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_c9fffc29-830e-4974-86d7-9087fb7b0c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Otherreceivablesandotherassets" xlink:type="simple" xlink:href="abvx-20241231.xsd#Otherreceivablesandotherassets"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Otherreceivablesandotherassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_c59abc76-a39a-41ff-886c-a4d636ca81b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_57222d8a-3d00-466d-9236-ae6b879b6dc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_c59abc76-a39a-41ff-886c-a4d636ca81b5" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_57222d8a-3d00-466d-9236-ae6b879b6dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Cashandcashequivalents" xlink:type="simple" xlink:href="abvx-20241231.xsd#Cashandcashequivalents"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Cashandcashequivalents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_cce12a1d-3e66-41b5-b5be-7662094686cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_65912f76-c212-4a5f-a73c-7d80654c7f0b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_cce12a1d-3e66-41b5-b5be-7662094686cb" xlink:to="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_65912f76-c212-4a5f-a73c-7d80654c7f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Financialassetsandliabilities" xlink:type="simple" xlink:href="abvx-20241231.xsd#Financialassetsandliabilities"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Financialassetsandliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FairValueMeasurementAbstract_24a2f31f-20cb-43ba-8b05-84ead47ede3c" xlink:href="abvx-20241231.xsd#abvx_FairValueMeasurementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_7df97fd3-20cc-4617-a129-147142f94077" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FairValueMeasurementAbstract_24a2f31f-20cb-43ba-8b05-84ead47ede3c" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_7df97fd3-20cc-4617-a129-147142f94077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Shareholdersequity" xlink:type="simple" xlink:href="abvx-20241231.xsd#Shareholdersequity"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Shareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_05f4b6be-6cc0-4084-bc37-23ce5828d015" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_cabec284-6367-4be8-ad92-28d8422370a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_05f4b6be-6cc0-4084-bc37-23ce5828d015" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_cabec284-6367-4be8-ad92-28d8422370a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Sharebasedpayments" xlink:type="simple" xlink:href="abvx-20241231.xsd#Sharebasedpayments"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Sharebasedpayments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_7d041a60-8f4b-433b-981f-b9e94ef3030d" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_b5bf94a6-3cbc-4e05-8823-2087f994c844" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_7d041a60-8f4b-433b-981f-b9e94ef3030d" xlink:to="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_b5bf94a6-3cbc-4e05-8823-2087f994c844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Financialliabilities" xlink:type="simple" xlink:href="abvx-20241231.xsd#Financialliabilities"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Financialliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_c2d15ec5-9626-4418-8954-ee1c8b1a6fa9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_cced098d-5af9-41a9-8766-cfa2fdba1084" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_c2d15ec5-9626-4418-8954-ee1c8b1a6fa9" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_cced098d-5af9-41a9-8766-cfa2fdba1084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Retirementbenefitobligations" xlink:type="simple" xlink:href="abvx-20241231.xsd#Retirementbenefitobligations"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Retirementbenefitobligations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_d97825a9-52dd-49ef-84b1-2a67c6dcaaef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_b87fa7f6-964b-45ff-ac79-e457b7ade617" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_d97825a9-52dd-49ef-84b1-2a67c6dcaaef" xlink:to="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_b87fa7f6-964b-45ff-ac79-e457b7ade617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Payablesandothercurrentliabilities" xlink:type="simple" xlink:href="abvx-20241231.xsd#Payablesandothercurrentliabilities"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Payablesandothercurrentliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0f6ac1f9-b65e-4a70-bf0b-4d0ce2096a32" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_b23b334b-349f-437f-b8a3-0ffbf1491049" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0f6ac1f9-b65e-4a70-bf0b-4d0ce2096a32" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_b23b334b-349f-437f-b8a3-0ffbf1491049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Operatingincome" xlink:type="simple" xlink:href="abvx-20241231.xsd#Operatingincome"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Operatingincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAbstract_6d757c50-547c-4444-b769-74e81de6f8cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_586baff7-3124-4ce8-aa1e-a8302c312978" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_6d757c50-547c-4444-b769-74e81de6f8cf" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_586baff7-3124-4ce8-aa1e-a8302c312978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Operatingexpenses" xlink:type="simple" xlink:href="abvx-20241231.xsd#Operatingexpenses"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Operatingexpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_686c9511-30d2-4f55-85e0-3dc593904505" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_8853b436-6605-49c4-9ca3-9d67754855d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_686c9511-30d2-4f55-85e0-3dc593904505" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_8853b436-6605-49c4-9ca3-9d67754855d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Employees" xlink:type="simple" xlink:href="abvx-20241231.xsd#Employees"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Employees" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EmployeesAbstract_f5d11967-7954-4e9b-a0d9-228d1d6bbb43" xlink:href="abvx-20241231.xsd#abvx_EmployeesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_27f79416-7ba9-4a55-9fbf-d8cf8d88948e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_EmployeesAbstract_f5d11967-7954-4e9b-a0d9-228d1d6bbb43" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_27f79416-7ba9-4a55-9fbf-d8cf8d88948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Financialgainloss" xlink:type="simple" xlink:href="abvx-20241231.xsd#Financialgainloss"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Financialgainloss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialIncomeLossAbstract_1a1748e2-f15d-4e58-8923-3e89e0ec439c" xlink:href="abvx-20241231.xsd#abvx_FinancialIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_45b5c82d-a761-42e1-8f39-218e41e6599d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_1a1748e2-f15d-4e58-8923-3e89e0ec439c" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_45b5c82d-a761-42e1-8f39-218e41e6599d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Incometax" xlink:type="simple" xlink:href="abvx-20241231.xsd#Incometax"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Incometax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_fb67af0f-086d-4edb-aa96-72f532399cff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_8989bed0-f4c8-4d53-af84-13b8c9a09a44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_fb67af0f-086d-4edb-aa96-72f532399cff" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_8989bed0-f4c8-4d53-af84-13b8c9a09a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Incomelosspershare" xlink:type="simple" xlink:href="abvx-20241231.xsd#Incomelosspershare"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Incomelosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_9830d554-78d9-4a49-a701-2789e96973ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_13e82c3e-88a8-4743-9afe-89b87a57d938" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_9830d554-78d9-4a49-a701-2789e96973ab" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_13e82c3e-88a8-4743-9afe-89b87a57d938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Relatedparties" xlink:type="simple" xlink:href="abvx-20241231.xsd#Relatedparties"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Relatedparties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_3b238a7c-158d-4cc7-803f-310067a2c85d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_b3f4df2b-30a8-4e00-b430-1d8b46698ed1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_3b238a7c-158d-4cc7-803f-310067a2c85d" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_b3f4df2b-30a8-4e00-b430-1d8b46698ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Offbalancesheetcommitmentsgiven" xlink:type="simple" xlink:href="abvx-20241231.xsd#Offbalancesheetcommitmentsgiven"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Offbalancesheetcommitmentsgiven" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OffBalanceSheetCommitmentsAbstract_b7a552c2-e1db-45d5-83cb-447e3609d018" xlink:href="abvx-20241231.xsd#abvx_OffBalanceSheetCommitmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_6d6988a1-99b6-4252-b761-eb1e3749404e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_OffBalanceSheetCommitmentsAbstract_b7a552c2-e1db-45d5-83cb-447e3609d018" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_6d6988a1-99b6-4252-b761-eb1e3749404e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Offbalancesheetcommitmentsreceivedandcontingentassets" xlink:type="simple" xlink:href="abvx-20241231.xsd#Offbalancesheetcommitmentsreceivedandcontingentassets"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Offbalancesheetcommitmentsreceivedandcontingentassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OffBalanceSheetCommitmentsAbstract_37555fd2-400c-4405-8d2f-4803c6328c6e" xlink:href="abvx-20241231.xsd#abvx_OffBalanceSheetCommitmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_7889b1e4-e60d-443a-aff0-9fa00243183d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_OffBalanceSheetCommitmentsAbstract_37555fd2-400c-4405-8d2f-4803c6328c6e" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_7889b1e4-e60d-443a-aff0-9fa00243183d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/Managementandassessmentoffinancialrisks" xlink:type="simple" xlink:href="abvx-20241231.xsd#Managementandassessmentoffinancialrisks"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/Managementandassessmentoffinancialrisks" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialRiskManagementAbstract_30b76d0f-8dce-476c-8fcf-a25d0ab16a16" xlink:href="abvx-20241231.xsd#abvx_FinancialRiskManagementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_a5ad1c21-eba7-40c7-91fe-ab65d6a24c5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialRiskManagementAbstract_30b76d0f-8dce-476c-8fcf-a25d0ab16a16" xlink:to="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_a5ad1c21-eba7-40c7-91fe-ab65d6a24c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesPolicies" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesPolicies"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/AccountingprinciplesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_8fc8da53-79c5-401b-979b-7f9901fef425" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_8fc8da53-79c5-401b-979b-7f9901fef425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_99266b2e-9455-4553-b5eb-acaa9e7c6cdd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_99266b2e-9455-4553-b5eb-acaa9e7c6cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_d7f6a8b2-e2ac-49db-8342-2825e70f252d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_d7f6a8b2-e2ac-49db-8342-2825e70f252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_3aa6a148-c85e-4fb6-bc96-db2705c6cdd9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_3aa6a148-c85e-4fb6-bc96-db2705c6cdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_3089ca0b-79c2-4b7f-8a0b-3209f1f7ae76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_3089ca0b-79c2-4b7f-8a0b-3209f1f7ae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_5936feaf-54c5-41d6-8c92-dcac158f3f3a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_5936feaf-54c5-41d6-8c92-dcac158f3f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_c6f7a291-8cb4-4533-8ebc-d5e2428d0812" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_c6f7a291-8cb4-4533-8ebc-d5e2428d0812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_32562af2-f42d-41e7-829c-d7ad5803ee8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_32562af2-f42d-41e7-829c-d7ad5803ee8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_2800077e-16ef-4572-b967-3c95503a37a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_2800077e-16ef-4572-b967-3c95503a37a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_6323f1d3-ec71-476c-b652-4cd275967dba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_6323f1d3-ec71-476c-b652-4cd275967dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_f794fae1-34cd-4d7d-90b4-35f412ae3e12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_f794fae1-34cd-4d7d-90b4-35f412ae3e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_f7b53ddf-5042-4f3a-abc8-9a02ed03b522" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_f7b53ddf-5042-4f3a-abc8-9a02ed03b522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_4e375f54-85cc-4dbc-a164-937aa69668d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_4e375f54-85cc-4dbc-a164-937aa69668d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_95fdc2ff-096c-4857-9363-18b038e7a163" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_95fdc2ff-096c-4857-9363-18b038e7a163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_b0cbe63d-ec74-49cc-adf1-d9e3e85b7c46" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_b0cbe63d-ec74-49cc-adf1-d9e3e85b7c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_6a09d00a-4b26-4398-99d2-5e7353db018f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_6a09d00a-4b26-4398-99d2-5e7353db018f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_5331d080-c117-40c6-be03-de2675737994" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_5331d080-c117-40c6-be03-de2675737994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock_b180a968-d411-4c8c-b55a-2d64d472bfa0" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock_b180a968-d411-4c8c-b55a-2d64d472bfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock_80f99ed8-af54-4699-96ab-9d919a05dd92" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock_80f99ed8-af54-4699-96ab-9d919a05dd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfIFRSCompliance_59d535fe-b19a-4c17-9ea0-004c7f61316d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfIFRSCompliance"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_ifrs-full_StatementOfIFRSCompliance_59d535fe-b19a-4c17-9ea0-004c7f61316d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_a5aaa1cb-775f-48cd-b1c9-a19ef993afe1" xlink:href="abvx-20241231.xsd#abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_a5aaa1cb-775f-48cd-b1c9-a19ef993afe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock_80cce833-58f5-4d3f-952e-c256f5056a4d" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock_80cce833-58f5-4d3f-952e-c256f5056a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock_5c260ccd-627b-4f81-8b5c-e5a34492cd73" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock_5c260ccd-627b-4f81-8b5c-e5a34492cd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock_a1654b0f-8fa9-459c-a8fa-c0ca62d5bac4" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_1071f1e4-69cf-43b5-a00e-2a9d97b7aa77" xlink:to="loc_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock_a1654b0f-8fa9-459c-a8fa-c0ca62d5bac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/AccountingprinciplesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_373ae928-c71c-4c6a-8245-958a0413507d" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_f6c69c93-6f29-41ad-a5d4-20d62c6a0895" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_373ae928-c71c-4c6a-8245-958a0413507d" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_f6c69c93-6f29-41ad-a5d4-20d62c6a0895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock_7b6c63a8-05de-4f52-9f4a-1ffc1e5dede2" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_373ae928-c71c-4c6a-8245-958a0413507d" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock_7b6c63a8-05de-4f52-9f4a-1ffc1e5dede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IntangibleassetsTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#IntangibleassetsTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IntangibleassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_df1cf2dd-d7aa-4908-8920-dcd7067e9d87" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2b878c2a-d075-4c2a-8b5d-b5c0034c06d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_df1cf2dd-d7aa-4908-8920-dcd7067e9d87" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2b878c2a-d075-4c2a-8b5d-b5c0034c06d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PropertyplantandequipmentTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#PropertyplantandequipmentTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/PropertyplantandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_afc5eac6-9fff-4dd8-96c7-626f23d73a57" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory_b370123b-6af5-467f-aacb-345dc21ed4f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_afc5eac6-9fff-4dd8-96c7-626f23d73a57" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory_b370123b-6af5-467f-aacb-345dc21ed4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherfinancialassetsTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherfinancialassetsTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OtherfinancialassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_c0b02405-091a-45c3-9140-5816dd267c74" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_ca8ecb98-ec7b-4e31-8474-270569292330" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_c0b02405-091a-45c3-9140-5816dd267c74" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_ca8ecb98-ec7b-4e31-8474-270569292330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherreceivablesandotherassetsTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OtherreceivablesandotherassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_444362c9-8ad5-4ada-a19d-ca1ffa8f9b12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock_a9828d9b-7980-4c6d-af25-c26bfb14e4f6" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_444362c9-8ad5-4ada-a19d-ca1ffa8f9b12" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock_a9828d9b-7980-4c6d-af25-c26bfb14e4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CashandcashequivalentsTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#CashandcashequivalentsTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CashandcashequivalentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_7701040f-6489-4781-982c-8a99c6ac8bba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock_b8004681-454c-496a-a223-cd674c55397b" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_7701040f-6489-4781-982c-8a99c6ac8bba" xlink:to="loc_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock_b8004681-454c-496a-a223-cd674c55397b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialassetsandliabilitiesTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialassetsandliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialassetsandliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FairValueMeasurementAbstract_4675601f-9026-4eda-9f0e-13369b907afb" xlink:href="abvx-20241231.xsd#abvx_FairValueMeasurementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_9c995169-b179-45d7-a763-f632eae98683" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FairValueMeasurementAbstract_4675601f-9026-4eda-9f0e-13369b907afb" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_9c995169-b179-45d7-a763-f632eae98683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_aba1a09a-a4b3-4049-8f84-64c054c47edb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FairValueMeasurementAbstract_4675601f-9026-4eda-9f0e-13369b907afb" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_aba1a09a-a4b3-4049-8f84-64c054c47edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequityTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequityTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/ShareholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_711c07b2-604a-4530-bed7-0f8ab22a9ebc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_9fadb1a9-a2f6-49a3-ada1-2a02cc724878" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_711c07b2-604a-4530-bed7-0f8ab22a9ebc" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_9fadb1a9-a2f6-49a3-ada1-2a02cc724878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_66a0f1cc-771d-40eb-9827-d4777b321473" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_f16046e1-df54-408d-b5c4-2a1a3e3925fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_66a0f1cc-771d-40eb-9827-d4777b321473" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_f16046e1-df54-408d-b5c4-2a1a3e3925fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_3c9c0174-12c5-4a2c-8ceb-159665426499" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_66a0f1cc-771d-40eb-9827-d4777b321473" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_3c9c0174-12c5-4a2c-8ceb-159665426499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss_fc5e4a0a-259f-4e32-a63f-88811c0cb4e5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_66a0f1cc-771d-40eb-9827-d4777b321473" xlink:to="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss_fc5e4a0a-259f-4e32-a63f-88811c0cb4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_77bf1439-eb8a-4ecf-80f4-9eb32e80b0ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_77bf1439-eb8a-4ecf-80f4-9eb32e80b0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_effb93ee-32bd-440b-98eb-e8acf4923c9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_effb93ee-32bd-440b-98eb-e8acf4923c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock_82f312d0-16a6-4ace-ae11-02b5d5a2bff1" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock_82f312d0-16a6-4ace-ae11-02b5d5a2bff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock_e8893edf-1c12-48a2-9a00-5cd1b8d0ebee" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock_e8893edf-1c12-48a2-9a00-5cd1b8d0ebee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_a0364a15-cb8e-433d-9ce3-a0e63348a342" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_a0364a15-cb8e-433d-9ce3-a0e63348a342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeasesForLesseeTableTextBlock_8938932e-7cd9-4b16-a51e-17c6e8596ba4" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeasesForLesseeTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_abvx_DisclosureOfLeasesForLesseeTableTextBlock_8938932e-7cd9-4b16-a51e-17c6e8596ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_291a3fd0-5b89-4862-b756-15bf67478ef0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_291a3fd0-5b89-4862-b756-15bf67478ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock_417aef2f-343b-47c4-93b1-30aeee15e0ba" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock_417aef2f-343b-47c4-93b1-30aeee15e0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_6f5ea970-9081-4658-a0b9-ff5054950c93" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_6f5ea970-9081-4658-a0b9-ff5054950c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock_7dc82409-922d-499f-a9e1-050a5342bd3e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock_7dc82409-922d-499f-a9e1-050a5342bd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_a90f07fe-6561-4c46-b3d3-d20e951b915c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_a90f07fe-6561-4c46-b3d3-d20e951b915c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_327595c7-d582-4762-9ebe-4b24049e79bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ee4f3de8-a4f2-441d-ae90-8b19b8ae07b6" xlink:to="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_327595c7-d582-4762-9ebe-4b24049e79bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RetirementbenefitobligationsTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#RetirementbenefitobligationsTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/RetirementbenefitobligationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_e5445274-c7f8-42bc-9b45-ad2b0052a978" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_04d4f16b-35f2-42a6-8dbe-06e8c2633127" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_e5445274-c7f8-42bc-9b45-ad2b0052a978" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_04d4f16b-35f2-42a6-8dbe-06e8c2633127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_88138099-55e9-4d94-9aa8-33986a2c0cd9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_e5445274-c7f8-42bc-9b45-ad2b0052a978" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_88138099-55e9-4d94-9aa8-33986a2c0cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#PayablesandothercurrentliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/PayablesandothercurrentliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_e747297b-0664-4ddb-94ea-1c6b17635745" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock_b63cded5-34dc-4896-a95a-cf4ba2336d42" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_e747297b-0664-4ddb-94ea-1c6b17635745" xlink:to="loc_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock_b63cded5-34dc-4896-a95a-cf4ba2336d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock_674884ed-28ae-4afa-b44d-fb174fa63cfa" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_e747297b-0664-4ddb-94ea-1c6b17635745" xlink:to="loc_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock_674884ed-28ae-4afa-b44d-fb174fa63cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingincomeTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingincomeTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingincomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAbstract_1406fe7f-4a0a-4d9f-a074-c39da3711dcf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock_fc563cf7-a06b-4eaf-8f68-7a9226358d82" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_1406fe7f-4a0a-4d9f-a074-c39da3711dcf" xlink:to="loc_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock_fc563cf7-a06b-4eaf-8f68-7a9226358d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingexpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_df643d91-8fe4-4a65-b8ec-c1a125ef56f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_7ff5f1ea-2539-4915-85b5-a56bbb9bfdf2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_df643d91-8fe4-4a65-b8ec-c1a125ef56f5" xlink:to="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_7ff5f1ea-2539-4915-85b5-a56bbb9bfdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock_b6f0176a-a4db-4a93-865c-40ddbd1f52ce" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_df643d91-8fe4-4a65-b8ec-c1a125ef56f5" xlink:to="loc_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock_b6f0176a-a4db-4a93-865c-40ddbd1f52ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/EmployeesTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#EmployeesTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/EmployeesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EmployeesAbstract_f46b1fce-77f4-4c97-a6b0-a76033728033" xlink:href="abvx-20241231.xsd#abvx_EmployeesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock_8b764577-39a4-4a6d-8859-5ade7dc760d1" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_EmployeesAbstract_f46b1fce-77f4-4c97-a6b0-a76033728033" xlink:to="loc_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock_8b764577-39a4-4a6d-8859-5ade7dc760d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialgainlossTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialgainlossTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialgainlossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialIncomeLossAbstract_7a0f29d1-b230-42cc-9239-844b8c12eef8" xlink:href="abvx-20241231.xsd#abvx_FinancialIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock_87d00705-0763-4903-a9b0-0121dd215863" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_7a0f29d1-b230-42cc-9239-844b8c12eef8" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock_87d00705-0763-4903-a9b0-0121dd215863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IncometaxTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_b459052f-05d3-45c8-b388-b3b848e46f00" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock_0780fc8b-700b-43a1-abd0-083a571320ac" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_b459052f-05d3-45c8-b388-b3b848e46f00" xlink:to="loc_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock_0780fc8b-700b-43a1-abd0-083a571320ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_e8c2f75f-3513-4441-a42c-3c0f5e915a76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_b459052f-05d3-45c8-b388-b3b848e46f00" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_e8c2f75f-3513-4441-a42c-3c0f5e915a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncomelosspershareTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncomelosspershareTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IncomelosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_eea3861f-780a-43cd-9992-866e7325d9d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_b01a705f-8726-4475-916b-1fec33729e13" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_eea3861f-780a-43cd-9992-866e7325d9d9" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_b01a705f-8726-4475-916b-1fec33729e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RelatedpartiesTables" xlink:type="simple" xlink:href="abvx-20241231.xsd#RelatedpartiesTables"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/RelatedpartiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_ab8357f5-6162-4dcd-b8b4-4e71a0d2c660" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_8298427b-3768-4f9c-acaa-f6e3d120bd83" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_ab8357f5-6162-4dcd-b8b4-4e71a0d2c660" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_8298427b-3768-4f9c-acaa-f6e3d120bd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/TheGroupDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#TheGroupDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/TheGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_251030fc-cdb1-461d-9d60-de1f5739d6d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_7a07ac79-39b3-4911-b0e5-04d99ed6512b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_251030fc-cdb1-461d-9d60-de1f5739d6d2" xlink:to="loc_ifrs-full_Equity_7a07ac79-39b3-4911-b0e5-04d99ed6512b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/BasisofpreparationDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#BasisofpreparationDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/BasisofpreparationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_e2db2da7-84a3-439e-8345-1d736b76dfea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_e2db2da7-84a3-439e-8345-1d736b76dfea" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8b4d5617-605e-4c4b-8bab-47db0b32324f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8b4d5617-605e-4c4b-8bab-47db0b32324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_2bdc7161-8fb0-42db-8d2c-5939869f8a44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8b4d5617-605e-4c4b-8bab-47db0b32324f" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_2bdc7161-8fb0-42db-8d2c-5939869f8a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MajorRevenueTransactionsMember_24d2c585-b898-47e2-816b-3bcb375eed57" xlink:href="abvx-20241231.xsd#abvx_MajorRevenueTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_2bdc7161-8fb0-42db-8d2c-5939869f8a44" xlink:to="loc_abvx_MajorRevenueTransactionsMember_24d2c585-b898-47e2-816b-3bcb375eed57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e53467ba-5ca9-462a-872c-9195f3010602" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_srt_StatementScenarioAxis_e53467ba-5ca9-462a-872c-9195f3010602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f59cc94d-49bc-41ee-ac3b-d7e317fef403" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_e53467ba-5ca9-462a-872c-9195f3010602" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f59cc94d-49bc-41ee-ac3b-d7e317fef403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_77273c11-3238-4060-8af3-54f869fb57b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f59cc94d-49bc-41ee-ac3b-d7e317fef403" xlink:to="loc_srt_ScenarioForecastMember_77273c11-3238-4060-8af3-54f869fb57b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockAxis_9fea2d9e-6e4f-4305-940b-75cd232f1e2d" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_abvx_SaleOfStockAxis_9fea2d9e-6e4f-4305-940b-75cd232f1e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockDomain_fecd03e7-fea6-42d4-8f29-03b119397577" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_SaleOfStockAxis_9fea2d9e-6e4f-4305-940b-75cd232f1e2d" xlink:to="loc_abvx_SaleOfStockDomain_fecd03e7-fea6-42d4-8f29-03b119397577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RegisteredDirectOfferingMember_d0adccb6-3604-4763-8c09-a298ae21a181" xlink:href="abvx-20241231.xsd#abvx_RegisteredDirectOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_SaleOfStockDomain_fecd03e7-fea6-42d4-8f29-03b119397577" xlink:to="loc_abvx_RegisteredDirectOfferingMember_d0adccb6-3604-4763-8c09-a298ae21a181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3d795c23-932b-4f81-9af9-24651efbea5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_srt_CounterpartyNameAxis_3d795c23-932b-4f81-9af9-24651efbea5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b572a2d8-90dd-470e-9bf6-68664549dcb8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_3d795c23-932b-4f81-9af9-24651efbea5a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b572a2d8-90dd-470e-9bf6-68664549dcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BanquePubliqueDInvestissementBPIMember_241f1747-8eb0-41bd-b3f7-829b840bc44e" xlink:href="abvx-20241231.xsd#abvx_BanquePubliqueDInvestissementBPIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b572a2d8-90dd-470e-9bf6-68664549dcb8" xlink:to="loc_abvx_BanquePubliqueDInvestissementBPIMember_241f1747-8eb0-41bd-b3f7-829b840bc44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba229e2f-5a1a-4678-920d-7ff32ffb04f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba229e2f-5a1a-4678-920d-7ff32ffb04f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba229e2f-5a1a-4678-920d-7ff32ffb04f1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_cc3a245a-1f26-4314-a9d3-06d9e8c4518e" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:to="loc_abvx_OceaneConversionOptionMember_cc3a245a-1f26-4314-a9d3-06d9e8c4518e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_4b94aa96-23c7-455a-8b45-2e0c0bf47624" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e7f2b057-0299-4826-966e-8eebad7f60af" xlink:to="loc_abvx_HeightsConvertibleNotesMember_4b94aa96-23c7-455a-8b45-2e0c0bf47624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ae6e893d-0c83-48db-bcf8-ee9d2d935c45" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_172d9f51-b85e-477e-985e-5d5bc2a4b1c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProfitLoss_172d9f51-b85e-477e-985e-5d5bc2a4b1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_01f2bd78-f52c-4120-89f8-a3c1745d7f83" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_01f2bd78-f52c-4120-89f8-a3c1745d7f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_f074548b-825d-4bf2-98d4-c8788d5602ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_f074548b-825d-4bf2-98d4-c8788d5602ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromResearchTaxCredit_7aae23fe-c513-4ee0-ad64-a51104ca8d9c" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromResearchTaxCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_ProceedsFromResearchTaxCredit_7aae23fe-c513-4ee0-ad64-a51104ca8d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_dc738476-0afa-4141-8cf9-5ea4fcc91c3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_dc738476-0afa-4141-8cf9-5ea4fcc91c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromConditionalAdvances_1816ae74-ffa2-4b0c-b547-e9dd85bcf1f7" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromConditionalAdvances"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_ProceedsFromConditionalAdvances_1816ae74-ffa2-4b0c-b547-e9dd85bcf1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_7a8e15a4-1ff5-417e-b217-96b266362173" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_7a8e15a4-1ff5-417e-b217-96b266362173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_ce56d3dc-4b4f-4fe1-a233-adddbfa79d10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_ifrs-full_CashAndCashEquivalents_ce56d3dc-4b4f-4fe1-a233-adddbfa79d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_c0958415-16e7-4eb3-a047-9ed2cf7e126d" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_ConvertibleLoansNotes_c0958415-16e7-4eb3-a047-9ed2cf7e126d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentConvertibleLoansNotes_3efa261c-ade5-4e59-9cc3-9eb39021fee3" xlink:href="abvx-20241231.xsd#abvx_NonCurrentConvertibleLoansNotes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_NonCurrentConvertibleLoansNotes_3efa261c-ade5-4e59-9cc3-9eb39021fee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_29ecd7f9-8001-470f-af27-0148fae23f83" xlink:href="abvx-20241231.xsd#abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_e3dc0f2a-2755-4acc-9010-3ad17c08b4ea" xlink:to="loc_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes_29ecd7f9-8001-470f-af27-0148fae23f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_37804b0a-7983-4d94-bd8f-7da5700384d1" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_37804b0a-7983-4d94-bd8f-7da5700384d1" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_f3164963-b1ff-4137-a310-c565a686a8c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_f3164963-b1ff-4137-a310-c565a686a8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_903a9596-76ec-4424-a2f8-ad056b4cf490" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_f3164963-b1ff-4137-a310-c565a686a8c4" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_903a9596-76ec-4424-a2f8-ad056b4cf490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_5b7fbb95-8e74-45e6-b8f3-ab3741f204cd" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_903a9596-76ec-4424-a2f8-ad056b4cf490" xlink:to="loc_abvx_ProsynergiaMember_5b7fbb95-8e74-45e6-b8f3-ab3741f204cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_7deb2d2a-028b-4d0d-93dc-882b30254e63" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_abvx_AssetsAcquisitionsAxis_7deb2d2a-028b-4d0d-93dc-882b30254e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_f05198a6-fb1b-47dc-b6ec-b435eb422f94" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsAxis_7deb2d2a-028b-4d0d-93dc-882b30254e63" xlink:to="loc_abvx_AssetsAcquisitionsDomain_f05198a6-fb1b-47dc-b6ec-b435eb422f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_f519a28d-cf55-4997-9d1d-b13a57511e78" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsDomain_f05198a6-fb1b-47dc-b6ec-b435eb422f94" xlink:to="loc_abvx_ProsynergiaMember_f519a28d-cf55-4997-9d1d-b13a57511e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ea77cb06-4937-4a6f-a6a3-881d822f0915" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_srt_CounterpartyNameAxis_ea77cb06-4937-4a6f-a6a3-881d822f0915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a741ed5c-568e-47bb-ac14-c7e4f884e1e2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ea77cb06-4937-4a6f-a6a3-881d822f0915" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a741ed5c-568e-47bb-ac14-c7e4f884e1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_badb32b7-78b2-4bfe-84f0-2893ab0d263d" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a741ed5c-568e-47bb-ac14-c7e4f884e1e2" xlink:to="loc_abvx_ProsynergiaMember_badb32b7-78b2-4bfe-84f0-2893ab0d263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_fe745fc7-2568-41c9-8a59-d798769be5b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_fe745fc7-2568-41c9-8a59-d798769be5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_cd7d92b7-f529-4ba1-bafa-2921ff653cdb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_fe745fc7-2568-41c9-8a59-d798769be5b1" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_cd7d92b7-f529-4ba1-bafa-2921ff653cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WittycelSASABX196Member_8c5ad02a-fd59-4bcc-88e4-256fd4a907ad" xlink:href="abvx-20241231.xsd#abvx_WittycelSASABX196Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_cd7d92b7-f529-4ba1-bafa-2921ff653cdb" xlink:to="loc_abvx_WittycelSASABX196Member_8c5ad02a-fd59-4bcc-88e4-256fd4a907ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_dc699d8f-be77-4809-b90b-f3cf42c8f3bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_dc699d8f-be77-4809-b90b-f3cf42c8f3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cf45e501-b794-4173-853c-f9bf7335fdce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_dc699d8f-be77-4809-b90b-f3cf42c8f3bc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cf45e501-b794-4173-853c-f9bf7335fdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2021Member_e74c6f88-d30c-4537-aaac-2212e6c1a129" xlink:href="abvx-20241231.xsd#abvx_AGA2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cf45e501-b794-4173-853c-f9bf7335fdce" xlink:to="loc_abvx_AGA2021Member_e74c6f88-d30c-4537-aaac-2212e6c1a129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsAxis_3dd7cefc-2cad-4310-9cb6-e724d09def4e" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_abvx_PrincipalAgreementsAxis_3dd7cefc-2cad-4310-9cb6-e724d09def4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_ac29abdc-8d7a-4436-82d1-ae133d6cacd4" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsAxis_3dd7cefc-2cad-4310-9cb6-e724d09def4e" xlink:to="loc_abvx_PrincipalAgreementsDomain_ac29abdc-8d7a-4436-82d1-ae133d6cacd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember_d9152139-7c93-4348-b787-99d36d87eee7" xlink:href="abvx-20241231.xsd#abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_ac29abdc-8d7a-4436-82d1-ae133d6cacd4" xlink:to="loc_abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember_d9152139-7c93-4348-b787-99d36d87eee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_f265fd44-b3e5-4bde-a07d-30c400294548" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_abvx_FinancialAgreementAxis_f265fd44-b3e5-4bde-a07d-30c400294548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_6c7c16b6-b6d9-46ce-b849-80b25ec5dc5a" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementAxis_f265fd44-b3e5-4bde-a07d-30c400294548" xlink:to="loc_abvx_FinancialAgreementDomain_6c7c16b6-b6d9-46ce-b849-80b25ec5dc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_3e13a656-4ca4-43de-afa9-10fb92b6de4b" xlink:href="abvx-20241231.xsd#abvx_A49.2MillionCrossOverFinancingSeptember2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_6c7c16b6-b6d9-46ce-b849-80b25ec5dc5a" xlink:to="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_3e13a656-4ca4-43de-afa9-10fb92b6de4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_cbd6a74f-dbff-4d73-a52e-3052effc02b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_cbd6a74f-dbff-4d73-a52e-3052effc02b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_4a82b8c4-fbf4-4a3d-9a5e-1d833ad3dfc5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_cbd6a74f-dbff-4d73-a52e-3052effc02b3" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_4a82b8c4-fbf4-4a3d-9a5e-1d833ad3dfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_39a99518-ad2d-4ef9-aef1-7df5b20b439c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_4a82b8c4-fbf4-4a3d-9a5e-1d833ad3dfc5" xlink:to="loc_ifrs-full_SharePremiumMember_39a99518-ad2d-4ef9-aef1-7df5b20b439c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1880d236-ded8-4c23-ab7f-fb0fcd566213" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_604282bc-b2f8-444d-a0a7-dc0d4506229d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_604282bc-b2f8-444d-a0a7-dc0d4506229d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPrepaymentAssetsAcquisitions_df80eb2d-cebf-48f4-88eb-b35b837a8b20" xlink:href="abvx-20241231.xsd#abvx_CashPrepaymentAssetsAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_CashPrepaymentAssetsAcquisitions_df80eb2d-cebf-48f4-88eb-b35b837a8b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashTransferredAssetsAcquisitions_84b0d4e6-c39e-4dca-99f8-e4e4c62060d6" xlink:href="abvx-20241231.xsd#abvx_CashTransferredAssetsAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_CashTransferredAssetsAcquisitions_84b0d4e6-c39e-4dca-99f8-e4e4c62060d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMaximumAmount_89c66a45-9e0c-4bc7-9740-bdf6781a9010" xlink:href="abvx-20241231.xsd#abvx_EarnOutMaximumAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_EarnOutMaximumAmount_89c66a45-9e0c-4bc7-9740-bdf6781a9010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_61aa5211-f25d-4807-b4db-dda91336a089" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_61aa5211-f25d-4807-b4db-dda91336a089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LoanGrantedAssetsAcquisitions_e7022158-9162-430a-bc56-a09c90a2ea0d" xlink:href="abvx-20241231.xsd#abvx_LoanGrantedAssetsAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_LoanGrantedAssetsAcquisitions_e7022158-9162-430a-bc56-a09c90a2ea0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_337f4372-9943-46c8-8114-078a12c1d5ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_337f4372-9943-46c8-8114-078a12c1d5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_7edfb3f2-afdd-474f-8dae-fbbf22c99295" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_7edfb3f2-afdd-474f-8dae-fbbf22c99295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_af01f1a1-d746-4092-8513-b0ec8fff1210" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_af01f1a1-d746-4092-8513-b0ec8fff1210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_3f4f376e-f00b-48a8-857e-6f369d804250" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_3f4f376e-f00b-48a8-857e-6f369d804250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_1c2f15d7-1d00-4ef5-b5d8-b8b197165f56" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_1c2f15d7-1d00-4ef5-b5d8-b8b197165f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_b9cd8ccd-e926-4d36-90d3-2932ed8e60a0" xlink:href="abvx-20241231.xsd#abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals_b9cd8ccd-e926-4d36-90d3-2932ed8e60a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_bf3a652f-c7a4-443d-9304-590574f6691b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_bf3a652f-c7a4-443d-9304-590574f6691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAmount_929de482-0f31-46d9-b362-a297a9c11812" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_FinancialAgreementAmount_929de482-0f31-46d9-b362-a297a9c11812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementNumberOfTransactions_f3b2cfe2-fb90-44e7-9aeb-14df0ebc579f" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementNumberOfTransactions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_FinancialAgreementNumberOfTransactions_f3b2cfe2-fb90-44e7-9aeb-14df0ebc579f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_ce26a7a4-0140-4070-b28f-64be8f40d05a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_ce26a7a4-0140-4070-b28f-64be8f40d05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_52f90fcc-a749-48ed-bd8f-678c537ae29a" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_52f90fcc-a749-48ed-bd8f-678c537ae29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_fbcf3a76-4e8e-4fca-a53d-726613ed1283" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ParValuePerShare_fbcf3a76-4e8e-4fca-a53d-726613ed1283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_672d16dc-2346-4bb6-a497-4d05f1f9316c" xlink:href="abvx-20241231.xsd#abvx_EquityIssuancePercentageOfCurrentShareCapital"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_672d16dc-2346-4bb6-a497-4d05f1f9316c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_51bfda0f-ab97-42da-a343-1d40a3750411" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_51bfda0f-ab97-42da-a343-1d40a3750411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_84744973-8996-47af-9c70-e8999ba4e52c" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_84744973-8996-47af-9c70-e8999ba4e52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_84d192f1-f39c-42f3-9614-194774fd09c0" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatePercentageOfFutureSales"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_84d192f1-f39c-42f3-9614-194774fd09c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateMaximumAmount_b8ff614a-a5b5-4ebf-9d6d-d606a40c8bb4" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateMaximumAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_RoyaltyCertificateMaximumAmount_b8ff614a-a5b5-4ebf-9d6d-d606a40c8bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_d21bfc83-8573-40a6-ab09-154bca372d8f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_d21bfc83-8573-40a6-ab09-154bca372d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_9b6b7c07-62f0-4bba-97e4-792b1e93c2af" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAdvancesMadeToContractResearchOrganizations"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_9b6b7c07-62f0-4bba-97e4-792b1e93c2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContracts_0853b363-ec3b-4efc-a582-a06b79e4074b" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContracts"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6c1fe55e-3392-433b-9aa7-65e677c200e8" xlink:to="loc_abvx_NonCurrentAdvancesToCROContracts_0853b363-ec3b-4efc-a582-a06b79e4074b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_f7b49f3a-be83-4cf1-988b-178b410958ba" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_f7b49f3a-be83-4cf1-988b-178b410958ba" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_44fe0743-12a6-401d-9381-c6e007b191d6" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_abvx_FinancialAgreementAxis_44fe0743-12a6-401d-9381-c6e007b191d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementAxis_44fe0743-12a6-401d-9381-c6e007b191d6" xlink:to="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A130.0MillionCrossOverFinancingFebruary2023Member_2d315dc0-2c02-47f6-a21c-1c5c7d3f615a" xlink:href="abvx-20241231.xsd#abvx_A130.0MillionCrossOverFinancingFebruary2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:to="loc_abvx_A130.0MillionCrossOverFinancingFebruary2023Member_2d315dc0-2c02-47f6-a21c-1c5c7d3f615a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_26916f94-89d4-4e9c-a18c-4f14ca9fcf01" xlink:href="abvx-20241231.xsd#abvx_A49.2MillionCrossOverFinancingSeptember2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:to="loc_abvx_A49.2MillionCrossOverFinancingSeptember2022Member_26916f94-89d4-4e9c-a18c-4f14ca9fcf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A150.0MillionFinancingAugust2023Member_9554a702-f655-4984-b2dc-81abff24f985" xlink:href="abvx-20241231.xsd#abvx_A150.0MillionFinancingAugust2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_e6823515-bcd5-43ee-8601-6a43be0550e2" xlink:to="loc_abvx_A150.0MillionFinancingAugust2023Member_9554a702-f655-4984-b2dc-81abff24f985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_b424a23a-26a2-4c95-abce-ab970aafa5cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_b424a23a-26a2-4c95-abce-ab970aafa5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_42c42c01-1235-4d08-b0a5-8437f63900eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_b424a23a-26a2-4c95-abce-ab970aafa5cf" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_42c42c01-1235-4d08-b0a5-8437f63900eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_e0187239-d651-4a3b-ac35-a263180e70ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_42c42c01-1235-4d08-b0a5-8437f63900eb" xlink:to="loc_ifrs-full_SharePremiumMember_e0187239-d651-4a3b-ac35-a263180e70ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_7245f284-a2f1-4b2d-85ce-13b4e9d1d508" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_7245f284-a2f1-4b2d-85ce-13b4e9d1d508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7245f284-a2f1-4b2d-85ce-13b4e9d1d508" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_8adeb347-54bd-49c4-9a93-15c5e7375524" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_8adeb347-54bd-49c4-9a93-15c5e7375524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_b5107de7-5b05-41e9-9fd5-67e97d0cb10c" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_b5107de7-5b05-41e9-9fd5-67e97d0cb10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingMember_bd0cc978-04a0-4462-b9ab-336b7a2bdd9e" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_KreosClaretFinancingMember_bd0cc978-04a0-4462-b9ab-336b7a2bdd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_98012d54-fbc7-425c-91cd-164070bc9a98" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_HeightsConvertibleNotesMember_98012d54-fbc7-425c-91cd-164070bc9a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_430a63a8-ace0-43ea-9528-1f65aeb5efe8" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_430a63a8-ace0-43ea-9528-1f65aeb5efe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_95049464-c9f1-44b8-b7c8-e429705bd20b" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_OCEANEMember_95049464-c9f1-44b8-b7c8-e429705bd20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember_12d69cae-e29e-4bd2-b576-693b4811a312" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9506b79f-a773-44ce-a06e-2e559d065497" xlink:to="loc_abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember_12d69cae-e29e-4bd2-b576-693b4811a312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_4ffa0811-1192-4c4a-8a05-d99018496763" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_4ffa0811-1192-4c4a-8a05-d99018496763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4ffa0811-1192-4c4a-8a05-d99018496763" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesMember_61d8a4a2-5be9-4d31-8010-0bb54b8ffedd" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:to="loc_abvx_AmericanDepositorySharesMember_61d8a4a2-5be9-4d31-8010-0bb54b8ffedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_c7b61265-ba30-43cd-be66-79b222cfbd38" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_4790dd0b-7edb-47af-9e9c-3ab28926ebfd" xlink:to="loc_ifrs-full_OrdinarySharesMember_c7b61265-ba30-43cd-be66-79b222cfbd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3880470a-7651-438e-800f-bcbd3935b47a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_srt_RangeAxis_3880470a-7651-438e-800f-bcbd3935b47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cfc56486-3869-4248-b6da-20ca809e813a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3880470a-7651-438e-800f-bcbd3935b47a" xlink:to="loc_srt_RangeMember_cfc56486-3869-4248-b6da-20ca809e813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c2c3b968-29e2-42e3-a510-120e13ef4c40" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cfc56486-3869-4248-b6da-20ca809e813a" xlink:to="loc_srt_MaximumMember_c2c3b968-29e2-42e3-a510-120e13ef4c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_abvx_WarrantsAxis_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_41e38f50-d83b-4536-9ffc-130ae4feca70" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsAxis_f0fd503b-fa1e-4429-9ddc-5a7b137bb60d" xlink:to="loc_abvx_WarrantsDomain_41e38f50-d83b-4536-9ffc-130ae4feca70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_3d7b38db-0116-4e3d-aae6-9f6f060db5e1" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_41e38f50-d83b-4536-9ffc-130ae4feca70" xlink:to="loc_abvx_KreosCBSAMember_3d7b38db-0116-4e3d-aae6-9f6f060db5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6d89f0ad-b6ab-4797-a380-d3dcfa814d48" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6d89f0ad-b6ab-4797-a380-d3dcfa814d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8149f238-3c54-4abf-a520-b4a3ec6c2a3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6d89f0ad-b6ab-4797-a380-d3dcfa814d48" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8149f238-3c54-4abf-a520-b4a3ec6c2a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FreeSharesAGAMember_9b976e2a-3be2-46c3-bf86-74efeed1e9fe" xlink:href="abvx-20241231.xsd#abvx_FreeSharesAGAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8149f238-3c54-4abf-a520-b4a3ec6c2a3d" xlink:to="loc_abvx_FreeSharesAGAMember_9b976e2a-3be2-46c3-bf86-74efeed1e9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_182c377b-89e0-4956-8d5d-d3358a1fcac0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAmount_45da8167-ad77-4684-8d7f-0ddb1211134c" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_FinancialAgreementAmount_45da8167-ad77-4684-8d7f-0ddb1211134c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_5116d8ba-2c14-4917-bbc4-80d1232ad8c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_IssueOfEquity_5116d8ba-2c14-4917-bbc4-80d1232ad8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_b98d57c7-93d7-4337-b07a-70aac1ab0986" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_b98d57c7-93d7-4337-b07a-70aac1ab0986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_000a39a4-c5c5-4a75-b46f-cac56cc8b3de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ParValuePerShare_000a39a4-c5c5-4a75-b46f-cac56cc8b3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_82bd65db-52c8-49e2-b2c1-de34248d3c87" xlink:href="abvx-20241231.xsd#abvx_EquityIssuancePercentageOfCurrentShareCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_EquityIssuancePercentageOfCurrentShareCapital_82bd65db-52c8-49e2-b2c1-de34248d3c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_4196c7b6-7403-4520-9a34-2552e65cfc65" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_4196c7b6-7403-4520-9a34-2552e65cfc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_39662713-9231-4410-b879-00de37d59b7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_39662713-9231-4410-b879-00de37d59b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsRepurchased_d929d1c1-791d-4016-9a1c-d43ee65608ab" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsRepurchased"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_NumberOfOtherShareWarrantsRepurchased_d929d1c1-791d-4016-9a1c-d43ee65608ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_514179ca-de09-4414-a7ee-ad984d645994" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_514179ca-de09-4414-a7ee-ad984d645994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfShareBasedCompensationPlansIssued_afa6f300-ac8f-4e60-b153-6dd08e8d4b56" xlink:href="abvx-20241231.xsd#abvx_NumberOfShareBasedCompensationPlansIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_NumberOfShareBasedCompensationPlansIssued_afa6f300-ac8f-4e60-b153-6dd08e8d4b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_faaa0487-8e26-4715-a05c-aefe32a66d78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_faaa0487-8e26-4715-a05c-aefe32a66d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementNumberOfTransactions_2e9bbba9-78f5-4219-8d11-8acff23ce50d" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementNumberOfTransactions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_FinancialAgreementNumberOfTransactions_2e9bbba9-78f5-4219-8d11-8acff23ce50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_ebbfc759-faa7-463d-a477-8b95cdc7bed1" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_ebbfc759-faa7-463d-a477-8b95cdc7bed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted_bcf20297-d9ef-40ae-8599-5c4610076f10" xlink:href="abvx-20241231.xsd#abvx_AggregateExercisePriceOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted_bcf20297-d9ef-40ae-8599-5c4610076f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_7c374f88-c170-42b0-88bf-33faeaa8c29b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_7c374f88-c170-42b0-88bf-33faeaa8c29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_4808fe83-2096-4ec1-b05a-8f91bb8b7855" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_4808fe83-2096-4ec1-b05a-8f91bb8b7855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness_d08e1d43-c2f0-43d9-b8c8-d4922a7c8869" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness_d08e1d43-c2f0-43d9-b8c8-d4922a7c8869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfOtherShareWarrants_15026fc2-9fca-452b-b917-87fd9fec9490" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfOtherShareWarrants"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IssuanceOfOtherShareWarrants_15026fc2-9fca-452b-b917-87fd9fec9490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesReceivedPerADS_3dfe8abf-4a02-4c4a-b9fc-3baf544a6f5e" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesReceivedPerADS"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_NumberOfSharesReceivedPerADS_3dfe8abf-4a02-4c4a-b9fc-3baf544a6f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssueOfEquityOfferingPricePerShare_b451ec92-9884-4e82-b336-44ade9e8037a" xlink:href="abvx-20241231.xsd#abvx_IssueOfEquityOfferingPricePerShare"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_IssueOfEquityOfferingPricePerShare_b451ec92-9884-4e82-b336-44ade9e8037a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_987af75c-fe61-4062-b449-f8e8dafb6fb0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_987af75c-fe61-4062-b449-f8e8dafb6fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants_556cf902-9654-4bdc-9d35-6089c2bfefef" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants_556cf902-9654-4bdc-9d35-6089c2bfefef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_80965511-6a1c-4574-8a78-e69ec5212971" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_55c697f6-200e-4d17-8b6e-da23937100ca" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_80965511-6a1c-4574-8a78-e69ec5212971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_477304bf-2db2-4dd7-a79c-1b71d6a3bf48" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_477304bf-2db2-4dd7-a79c-1b71d6a3bf48" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6a67f488-5dee-4528-b6b6-7ac4008b4f9b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6a67f488-5dee-4528-b6b6-7ac4008b4f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_6a67f488-5dee-4528-b6b6-7ac4008b4f9b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2024Member_88e5170c-5a37-4694-9646-a90c0c0408c3" xlink:href="abvx-20241231.xsd#abvx_AGA2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:to="loc_abvx_AGA2024Member_88e5170c-5a37-4694-9646-a90c0c0408c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_1b9835b8-9369-4727-adff-8c6fb210b9ce" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:to="loc_abvx_AGA20246Member_1b9835b8-9369-4727-adff-8c6fb210b9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241Member_7fd33090-acda-415b-8f3b-ad25d8415166" xlink:href="abvx-20241231.xsd#abvx_BSA20241Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4acbe8c0-0a1b-49c0-901e-28c46bd41ab5" xlink:to="loc_abvx_BSA20241Member_7fd33090-acda-415b-8f3b-ad25d8415166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_f532d6d2-7f89-49b0-880c-d011fe753fdc" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_abvx_TranchesAxis_f532d6d2-7f89-49b0-880c-d011fe753fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesAxis_f532d6d2-7f89-49b0-880c-d011fe753fdc" xlink:to="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_8352e95f-422f-4bb0-ac09-43380e034e18" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:to="loc_abvx_TrancheOneMember_8352e95f-422f-4bb0-ac09-43380e034e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_7b54f84a-c2b1-4ea4-81d9-9f15064889b3" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:to="loc_abvx_TrancheTwoMember_7b54f84a-c2b1-4ea4-81d9-9f15064889b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheThreeMember_2991030f-99c5-4d60-b9a0-d0a04881d703" xlink:href="abvx-20241231.xsd#abvx_TrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_21fd7cc8-a58f-4879-a48a-204c3a6098af" xlink:to="loc_abvx_TrancheThreeMember_2991030f-99c5-4d60-b9a0-d0a04881d703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6c9fd2d8-32c3-4cfa-8516-ba5a52bf3c4c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_68ed6f4f-51c2-4b7d-a0b7-e5254327c137" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_68ed6f4f-51c2-4b7d-a0b7-e5254327c137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheCMember_feac5f63-5e9c-4f70-b586-939ab84a9b4a" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:to="loc_abvx_KreosClaretFinancingTrancheCMember_feac5f63-5e9c-4f70-b586-939ab84a9b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBAndCMember_fda3a43f-1974-461e-a984-49502bc700c5" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBAndCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_d8cb3dca-8186-4be6-a6ca-eff1e8dd8cd0" xlink:to="loc_abvx_KreosClaretFinancingTrancheBAndCMember_fda3a43f-1974-461e-a984-49502bc700c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cae117da-862c-459f-a1ef-c945fa2bb02d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cae117da-862c-459f-a1ef-c945fa2bb02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cae117da-862c-459f-a1ef-c945fa2bb02d" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_1a2b71c2-e41d-4fc2-a83f-109c7bbcc0fb" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_1a2b71c2-e41d-4fc2-a83f-109c7bbcc0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_17a5b8e7-86ca-48b2-9399-cb10bc71eb5c" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_17a5b8e7-86ca-48b2-9399-cb10bc71eb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember_13ff9984-c2b5-4d44-b2ed-03dbd1a5bf22" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_73b338a3-0b99-4086-bea1-2a90ac870f6d" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember_13ff9984-c2b5-4d44-b2ed-03dbd1a5bf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockAxis_d441b158-b3c6-43df-8aaf-93ef39425cc3" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_abvx_SaleOfStockAxis_d441b158-b3c6-43df-8aaf-93ef39425cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SaleOfStockDomain_55f28a34-5d08-4264-bbea-b44bb1a1a71d" xlink:href="abvx-20241231.xsd#abvx_SaleOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_SaleOfStockAxis_d441b158-b3c6-43df-8aaf-93ef39425cc3" xlink:to="loc_abvx_SaleOfStockDomain_55f28a34-5d08-4264-bbea-b44bb1a1a71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AtTheMarketATMProgramMember_2f738ecc-2597-42a1-9f4f-4357d61eff24" xlink:href="abvx-20241231.xsd#abvx_AtTheMarketATMProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_SaleOfStockDomain_55f28a34-5d08-4264-bbea-b44bb1a1a71d" xlink:to="loc_abvx_AtTheMarketATMProgramMember_2f738ecc-2597-42a1-9f4f-4357d61eff24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_14690f8f-971e-4fbd-aee4-e94d8f059ef6" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesPlansIssued_394ecf2f-a72e-4dad-8ff0-4f10c83d33a8" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesPlansIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_NumberOfFreeSharesPlansIssued_394ecf2f-a72e-4dad-8ff0-4f10c83d33a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0194ca76-d7d0-4215-a3f8-05b9aaab8cc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0194ca76-d7d0-4215-a3f8-05b9aaab8cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_460da567-93e7-41bb-a3f7-010f4b861de9" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_460da567-93e7-41bb-a3f7-010f4b861de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_9e74ff8f-2226-4933-8923-59264ae34d77" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_9e74ff8f-2226-4933-8923-59264ae34d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_e0d5606d-0b35-455d-b86a-55c9776d0ee0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_e0d5606d-0b35-455d-b86a-55c9776d0ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_dc5504ad-e8c7-42ab-8ec6-9f2d3156cc69" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_dc5504ad-e8c7-42ab-8ec6-9f2d3156cc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_04de1ab2-70e3-4a73-b1eb-2c3430ab4595" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_ParValuePerShare_04de1ab2-70e3-4a73-b1eb-2c3430ab4595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromConditionalAdvances_856ddd02-f075-4c3a-b801-dbcc9807e77b" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromConditionalAdvances"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_ProceedsFromConditionalAdvances_856ddd02-f075-4c3a-b801-dbcc9807e77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_b3448770-8736-4397-b9ae-87c36d061bd8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_b3448770-8736-4397-b9ae-87c36d061bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PercentageOfConditionalAdvancesWaived_eab7e7ef-351a-4d3a-919f-93225feca3e7" xlink:href="abvx-20241231.xsd#abvx_PercentageOfConditionalAdvancesWaived"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_PercentageOfConditionalAdvancesWaived_eab7e7ef-351a-4d3a-919f-93225feca3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_75332520-6ad9-4168-91a8-f53556043b10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_75332520-6ad9-4168-91a8-f53556043b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfADSPerOrdinaryShares_21085d6b-59ba-431b-92f7-60c8761a3e69" xlink:href="abvx-20241231.xsd#abvx_NumberOfADSPerOrdinaryShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_NumberOfADSPerOrdinaryShares_21085d6b-59ba-431b-92f7-60c8761a3e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedProceedsFromShareIssuance_21640746-61bb-4faf-b3df-6e209a64f33f" xlink:href="abvx-20241231.xsd#abvx_ExpectedProceedsFromShareIssuance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_ExpectedProceedsFromShareIssuance_21640746-61bb-4faf-b3df-6e209a64f33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration_30e78b24-50d6-4fda-b83d-f832b1e9d072" xlink:href="abvx-20241231.xsd#abvx_ExpectedProceedsFromShareIssuanceShelfRegistration"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d11efa01-6d81-45f3-b7dc-bb3d9b838399" xlink:to="loc_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration_30e78b24-50d6-4fda-b83d-f832b1e9d072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_a0ce68cf-f1a9-4483-8005-996fd7bf6be1" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_a0ce68cf-f1a9-4483-8005-996fd7bf6be1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_bd53328a-0254-4a30-96b4-964b60ff7544" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_bd53328a-0254-4a30-96b4-964b60ff7544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_a2f2dfcd-de47-4b0a-99f4-2675cc420349" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_bd53328a-0254-4a30-96b4-964b60ff7544" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_a2f2dfcd-de47-4b0a-99f4-2675cc420349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MajorShareBasedTransactionsMember_c107978a-d1e8-4a7f-9791-ba7541ad8bf4" xlink:href="abvx-20241231.xsd#abvx_MajorShareBasedTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_a2f2dfcd-de47-4b0a-99f4-2675cc420349" xlink:to="loc_abvx_MajorShareBasedTransactionsMember_c107978a-d1e8-4a7f-9791-ba7541ad8bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bc6094d-df06-452d-8d71-aadca836e862" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bc6094d-df06-452d-8d71-aadca836e862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bc6094d-df06-452d-8d71-aadca836e862" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20251Member_1fd8d568-e099-44b9-af7b-e190f7d677f6" xlink:href="abvx-20241231.xsd#abvx_BSA20251Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:to="loc_abvx_BSA20251Member_1fd8d568-e099-44b9-af7b-e190f7d677f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2025Member_c8a364df-1452-4ee9-a909-9050106e9606" xlink:href="abvx-20241231.xsd#abvx_AGA2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:to="loc_abvx_AGA2025Member_c8a364df-1452-4ee9-a909-9050106e9606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20252Member_7a699df9-6adc-4a43-9198-58ae8836b6dd" xlink:href="abvx-20241231.xsd#abvx_AGA20252Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_4d167e25-2e4e-41e5-b4bb-490cdb39cbe9" xlink:to="loc_abvx_AGA20252Member_7a699df9-6adc-4a43-9198-58ae8836b6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_56b7655a-537a-474e-a986-ac95e9095b81" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:to="loc_abvx_TranchesAxis_56b7655a-537a-474e-a986-ac95e9095b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesAxis_56b7655a-537a-474e-a986-ac95e9095b81" xlink:to="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_ff7b8ce6-c25f-4b33-8160-f2acaf718d7c" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheOneMember_ff7b8ce6-c25f-4b33-8160-f2acaf718d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_79475422-4daa-475a-862c-1b3c8a30d932" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheTwoMember_79475422-4daa-475a-862c-1b3c8a30d932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheThreeMember_c56d612f-50fb-433a-9197-671ad030a363" xlink:href="abvx-20241231.xsd#abvx_TrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheThreeMember_c56d612f-50fb-433a-9197-671ad030a363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFourMember_1a2de0e2-b55e-4b7d-aac3-fbaac01ac272" xlink:href="abvx-20241231.xsd#abvx_TrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_54ef5426-21a3-4b23-afd4-1a848c301844" xlink:to="loc_abvx_TrancheFourMember_1a2de0e2-b55e-4b7d-aac3-fbaac01ac272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_ca5ba1fc-e79b-4c9c-9757-520926e824d8" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_460effb8-6006-473c-ad9f-d780e1095274" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_460effb8-6006-473c-ad9f-d780e1095274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_774c74c7-d57d-4222-9354-1d9d60274968" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_774c74c7-d57d-4222-9354-1d9d60274968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_e0983115-9e6e-415a-b876-9ac2cb04d2c6" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_e0983115-9e6e-415a-b876-9ac2cb04d2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesPlansIssued_65471f2d-3776-4d91-9da2-1e6bf6a89315" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesPlansIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_04f17e23-5a2e-4988-8840-9cfecbe803bd" xlink:to="loc_abvx_NumberOfFreeSharesPlansIssued_65471f2d-3776-4d91-9da2-1e6bf6a89315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesIntangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_2ef3b19b-d890-491c-bfbe-1eb2b8d423df" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_64be3e07-9feb-4bea-ba95-f5438bb22325" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_2ef3b19b-d890-491c-bfbe-1eb2b8d423df" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_64be3e07-9feb-4bea-ba95-f5438bb22325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ecac7bd4-01e2-4d6e-90ed-cf768f124236" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_64be3e07-9feb-4bea-ba95-f5438bb22325" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ecac7bd4-01e2-4d6e-90ed-cf768f124236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8feed53f-1728-49b7-9c8d-0f7f7819b49b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ecac7bd4-01e2-4d6e-90ed-cf768f124236" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8feed53f-1728-49b7-9c8d-0f7f7819b49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_327c51ca-d7eb-44e3-8bfa-215c613b3c56" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8feed53f-1728-49b7-9c8d-0f7f7819b49b" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_327c51ca-d7eb-44e3-8bfa-215c613b3c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_64be3e07-9feb-4bea-ba95-f5438bb22325" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias_5380e1fb-d813-4d4e-ad1b-140388f88c88" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:to="loc_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias_5380e1fb-d813-4d4e-ad1b-140388f88c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_4230a2c6-196e-4561-bf3b-94a3dd2c2943" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2a425c66-04d8-4d6e-9dc8-b0e1525f4e13" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_4230a2c6-196e-4561-bf3b-94a3dd2c2943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_164576f0-cac0-4d44-838d-866d3fa6e8bd" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_164576f0-cac0-4d44-838d-866d3fa6e8bd" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9953c9b8-d3d0-4485-97ee-3a84e62947a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9953c9b8-d3d0-4485-97ee-3a84e62947a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9953c9b8-d3d0-4485-97ee-3a84e62947a1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_450e0111-4bc9-4678-bd7b-c4cddfec24fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_450e0111-4bc9-4678-bd7b-c4cddfec24fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IndustrialMaterialsAndEquipmentMember_0647b7f6-c486-4f93-8705-4a38cc8a505c" xlink:href="abvx-20241231.xsd#abvx_IndustrialMaterialsAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_abvx_IndustrialMaterialsAndEquipmentMember_0647b7f6-c486-4f93-8705-4a38cc8a505c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnicalFacilitiesMember_f5b107f2-4d14-4000-ab19-08411237f2ac" xlink:href="abvx-20241231.xsd#abvx_TechnicalFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_abvx_TechnicalFacilitiesMember_f5b107f2-4d14-4000-ab19-08411237f2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OfficeEquipmentMember_4b6900d7-e331-4ff4-a23b-73f3c725db9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_ifrs-full_OfficeEquipmentMember_4b6900d7-e331-4ff4-a23b-73f3c725db9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember_03b295ff-ec5a-4986-8f30-99aae204560c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_ifrs-full_ComputerEquipmentMember_03b295ff-ec5a-4986-8f30-99aae204560c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FurnitureMember_47b9bde3-e0e7-4c43-8f3b-cf054978abf3" xlink:href="abvx-20241231.xsd#abvx_FurnitureMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_955e4caf-c282-4442-9877-f361be718e63" xlink:to="loc_abvx_FurnitureMember_47b9bde3-e0e7-4c43-8f3b-cf054978abf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_2c5741e2-575e-425b-bf4f-b7672331cbe2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:to="loc_ifrs-full_RangeAxis_2c5741e2-575e-425b-bf4f-b7672331cbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_2c5741e2-575e-425b-bf4f-b7672331cbe2" xlink:to="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_28f9ea22-403d-4047-a531-db07eb58da0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:to="loc_ifrs-full_BottomOfRangeMember_28f9ea22-403d-4047-a531-db07eb58da0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_fee9d2c8-53fe-4de7-b902-770c8210d23e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_70381f27-a17d-4d3f-9eca-c576f60122ba" xlink:to="loc_ifrs-full_TopOfRangeMember_fee9d2c8-53fe-4de7-b902-770c8210d23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_5ac7b5de-1073-4bd7-8886-5ce20bcb4780" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6b341a95-b8ed-4703-b039-e55ed20d5543" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_5ac7b5de-1073-4bd7-8886-5ce20bcb4780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_3c0e6f93-2ac7-4704-b739-368bee05d06c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_5ac7b5de-1073-4bd7-8886-5ce20bcb4780" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_3c0e6f93-2ac7-4704-b739-368bee05d06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesAccountingofProsynergiaacquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_075fd023-f48b-47ea-9338-1a37f89f6de9" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_075fd023-f48b-47ea-9338-1a37f89f6de9" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_af55cd81-e64a-4d28-a7d2-168e3699f4cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_af55cd81-e64a-4d28-a7d2-168e3699f4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d9c4bc8b-2dcb-4711-aae3-493c4aeafdf9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_af55cd81-e64a-4d28-a7d2-168e3699f4cb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d9c4bc8b-2dcb-4711-aae3-493c4aeafdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_9145f156-97fb-4b26-8a41-bbbded37d7d6" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d9c4bc8b-2dcb-4711-aae3-493c4aeafdf9" xlink:to="loc_abvx_ProsynergiaMember_9145f156-97fb-4b26-8a41-bbbded37d7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_347ddb62-bf45-481f-b8b0-f5d501aff9a1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_srt_CounterpartyNameAxis_347ddb62-bf45-481f-b8b0-f5d501aff9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a540d3a8-8834-48d2-ba5e-429c36f05143" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_347ddb62-bf45-481f-b8b0-f5d501aff9a1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a540d3a8-8834-48d2-ba5e-429c36f05143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_2e5b753d-a3a3-425d-86ff-748ce6b81f39" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a540d3a8-8834-48d2-ba5e-429c36f05143" xlink:to="loc_abvx_ProsynergiaMember_2e5b753d-a3a3-425d-86ff-748ce6b81f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_1e6f073b-05ef-4127-9ffd-9144c7310d8a" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_abvx_AssetsAcquisitionsAxis_1e6f073b-05ef-4127-9ffd-9144c7310d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_189a062e-1ab0-42bf-a3b1-ef48149879cf" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsAxis_1e6f073b-05ef-4127-9ffd-9144c7310d8a" xlink:to="loc_abvx_AssetsAcquisitionsDomain_189a062e-1ab0-42bf-a3b1-ef48149879cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_ec5e263a-0c57-4ea8-9688-3109510d4e5d" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsDomain_189a062e-1ab0-42bf-a3b1-ef48149879cf" xlink:to="loc_abvx_ProsynergiaMember_ec5e263a-0c57-4ea8-9688-3109510d4e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_767b66cc-0df6-4d0a-9dfe-018644944f92" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_669aebab-a0e9-4661-a1ec-4c6dfc1f82eb" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_767b66cc-0df6-4d0a-9dfe-018644944f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_7ed4a242-8cf9-44ae-9869-c3145c302c10" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_767b66cc-0df6-4d0a-9dfe-018644944f92" xlink:to="loc_abvx_EarnOutLiabilityMember_7ed4a242-8cf9-44ae-9869-c3145c302c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_b8d5affa-1618-42db-992b-194c9b200766" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0f98f711-d748-40c7-a66d-7907dbe46f43" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0f98f711-d748-40c7-a66d-7907dbe46f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_38f20cc1-d037-4ee1-a851-dbc5434f595b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_38f20cc1-d037-4ee1-a851-dbc5434f595b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_76959a0d-1287-4b0c-9c1b-7650de416d28" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_76959a0d-1287-4b0c-9c1b-7650de416d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMarketCapitalizationThreshold_4c37cff4-a09b-4e7e-bd00-50378b327076" xlink:href="abvx-20241231.xsd#abvx_EarnOutMarketCapitalizationThreshold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutMarketCapitalizationThreshold_4c37cff4-a09b-4e7e-bd00-50378b327076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutPercentage_894cfd08-5b52-4279-9a67-60e4b9d0e8da" xlink:href="abvx-20241231.xsd#abvx_EarnOutPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutPercentage_894cfd08-5b52-4279-9a67-60e4b9d0e8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMaximumAmount_6f0679f5-d06e-4ebd-a7a0-e434ba20fc8c" xlink:href="abvx-20241231.xsd#abvx_EarnOutMaximumAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutMaximumAmount_6f0679f5-d06e-4ebd-a7a0-e434ba20fc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAmountPayableIfConditionsAreNotMet_6b90cefb-9520-4cbf-afdb-0bb25cfb9643" xlink:href="abvx-20241231.xsd#abvx_EarnOutAmountPayableIfConditionsAreNotMet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_abvx_EarnOutAmountPayableIfConditionsAreNotMet_6b90cefb-9520-4cbf-afdb-0bb25cfb9643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_690c18b0-b24b-4bab-b415-44b809979aee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_FinancialLiabilities_690c18b0-b24b-4bab-b415-44b809979aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_270c3d26-3caf-4bf3-9716-e75a3ee2a126" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_129eae27-5a1f-43ba-877c-3739407b8695" xlink:to="loc_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_270c3d26-3caf-4bf3-9716-e75a3ee2a126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AccountingPrinciplesAbstract_fd236f44-bbb1-4feb-a5b5-e445c972064c" xlink:href="abvx-20241231.xsd#abvx_AccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_d67d6415-0ab0-4464-aca4-a3bbc1f09009" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AccountingPrinciplesAbstract_fd236f44-bbb1-4feb-a5b5-e445c972064c" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_d67d6415-0ab0-4464-aca4-a3bbc1f09009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_43606615-1f90-48b3-b1a4-b4d666bd16f3" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_d67d6415-0ab0-4464-aca4-a3bbc1f09009" xlink:to="loc_abvx_AssetsAcquisitionsAxis_43606615-1f90-48b3-b1a4-b4d666bd16f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_9ed373cb-5b6c-4007-a966-0c6df4fb4c31" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsAxis_43606615-1f90-48b3-b1a4-b4d666bd16f3" xlink:to="loc_abvx_AssetsAcquisitionsDomain_9ed373cb-5b6c-4007-a966-0c6df4fb4c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_f48007fb-1d40-4a92-8df2-c6800e831939" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsDomain_9ed373cb-5b6c-4007-a966-0c6df4fb4c31" xlink:to="loc_abvx_ProsynergiaMember_f48007fb-1d40-4a92-8df2-c6800e831939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_d67d6415-0ab0-4464-aca4-a3bbc1f09009" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashPrepaymentAssetsAcquisitions_eff1fcb6-4b3c-4687-81ee-ea2b691d405e" xlink:href="abvx-20241231.xsd#abvx_CashPrepaymentAssetsAcquisitions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_CashPrepaymentAssetsAcquisitions_eff1fcb6-4b3c-4687-81ee-ea2b691d405e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LoanGrantedAssetsAcquisitions_523394c7-8f51-44df-a358-8895682618c9" xlink:href="abvx-20241231.xsd#abvx_LoanGrantedAssetsAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_LoanGrantedAssetsAcquisitions_523394c7-8f51-44df-a358-8895682618c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashTransferredAssetsAcquisitions_d438339a-784b-425e-8c26-4c7af327457b" xlink:href="abvx-20241231.xsd#abvx_CashTransferredAssetsAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_CashTransferredAssetsAcquisitions_d438339a-784b-425e-8c26-4c7af327457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition_08719f29-077f-4e3a-95df-1db9970dc06d" xlink:href="abvx-20241231.xsd#abvx_AcquisitionRelatedCostsAssetsAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_AcquisitionRelatedCostsAssetsAcquisition_08719f29-077f-4e3a-95df-1db9970dc06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_151227ac-5bcf-496e-9ffa-062c863d3c0d" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_151227ac-5bcf-496e-9ffa-062c863d3c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_0e0dd93f-8966-49ae-8563-de8b32eef344" xlink:href="abvx-20241231.xsd#abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions_0e0dd93f-8966-49ae-8563-de8b32eef344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_074b14cf-6cc9-4b56-ad12-f371cdc37e53" xlink:href="abvx-20241231.xsd#abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_074b14cf-6cc9-4b56-ad12-f371cdc37e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions_a7c2ff55-1248-4a6f-80d5-610084a9fbbf" xlink:href="abvx-20241231.xsd#abvx_CashAndCashEquivalentsAssetsAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_CashAndCashEquivalentsAssetsAcquisitions_a7c2ff55-1248-4a6f-80d5-610084a9fbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_4d20f926-eef2-4d6a-9032-e0ee10e5f27d" xlink:href="abvx-20241231.xsd#abvx_AssetsRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_AssetsRecognisedAsOfAcquisitionDate_4d20f926-eef2-4d6a-9032-e0ee10e5f27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_fa8953a3-6886-4c1a-a91f-d02c4f68db83" xlink:href="abvx-20241231.xsd#abvx_LiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_LiabilitiesRecognisedAsOfAcquisitionDate_fa8953a3-6886-4c1a-a91f-d02c4f68db83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_db7ab0d9-ce41-49ed-ae3e-1163cca0c468" xlink:href="abvx-20241231.xsd#abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions_db7ab0d9-ce41-49ed-ae3e-1163cca0c468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAssetsAcquisitionsCosts_f852ee35-0bb7-40ca-a69b-34c52fba6f5c" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAssetsAcquisitionsCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_5eaabb81-8471-4d1b-bc7e-95d97b8f879b" xlink:to="loc_abvx_PaymentsForAssetsAcquisitionsCosts_f852ee35-0bb7-40ca-a69b-34c52fba6f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SegmentinformationDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SegmentinformationDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SegmentinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_63678213-71f9-4e68-b1a5-067499fff633" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_63678213-71f9-4e68-b1a5-067499fff633" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_faceb1bf-3a3d-4e59-9f6b-076cbaddce79" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:to="loc_ifrs-full_GeographicalAreasAxis_faceb1bf-3a3d-4e59-9f6b-076cbaddce79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_75202e3f-806d-466b-9e1e-3376e577b471" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_faceb1bf-3a3d-4e59-9f6b-076cbaddce79" xlink:to="loc_ifrs-full_GeographicalAreasDomain_75202e3f-806d-466b-9e1e-3376e577b471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_effa02f2-4357-4af9-aa85-4a1c8d083603" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_75202e3f-806d-466b-9e1e-3376e577b471" xlink:to="loc_country_US_effa02f2-4357-4af9-aa85-4a1c8d083603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_32c86cf9-78f5-43de-b06e-6384ca0499a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:to="loc_ifrs-full_RangeAxis_32c86cf9-78f5-43de-b06e-6384ca0499a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_ab1be398-5a7d-4d31-978e-a60b7d2b234b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_32c86cf9-78f5-43de-b06e-6384ca0499a3" xlink:to="loc_ifrs-full_RangeDomain_ab1be398-5a7d-4d31-978e-a60b7d2b234b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_22781515-ef21-4b6b-ac22-9658c68de454" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_ab1be398-5a7d-4d31-978e-a60b7d2b234b" xlink:to="loc_ifrs-full_TopOfRangeMember_22781515-ef21-4b6b-ac22-9658c68de454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_57d43215-5c8b-479d-908d-d506a19d331e" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsAssetsPercentage_aa582fb0-5cd5-458f-8fe8-4e605b051438" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsAssetsPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_ContributionToGroupsAssetsPercentage_aa582fb0-5cd5-458f-8fe8-4e605b051438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsLiabilitiesPercentage_e7c6b443-79b6-412e-8364-d7bc05f4ebd1" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsLiabilitiesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_ContributionToGroupsLiabilitiesPercentage_e7c6b443-79b6-412e-8364-d7bc05f4ebd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ContributionToGroupsNetProfitsLossesPercentage_72c6465f-5256-4b9a-8f73-f2461dd14f59" xlink:href="abvx-20241231.xsd#abvx_ContributionToGroupsNetProfitsLossesPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_ContributionToGroupsNetProfitsLossesPercentage_72c6465f-5256-4b9a-8f73-f2461dd14f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOperatingSegment_c1803646-7d9a-4ca3-ac7f-df71c422c893" xlink:href="abvx-20241231.xsd#abvx_NumberOfOperatingSegment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_9e4724a9-c42b-4665-bb4e-66fe6b0079d2" xlink:to="loc_abvx_NumberOfOperatingSegment_c1803646-7d9a-4ca3-ac7f-df71c422c893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/GoodwillandimpairmenttestDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#GoodwillandimpairmenttestDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/GoodwillandimpairmenttestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_f0f2ec39-61b2-4a64-b698-6fbef0d2d92d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_0cf1e776-a458-4f3b-af9f-77b69b0e30d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_f0f2ec39-61b2-4a64-b698-6fbef0d2d92d" xlink:to="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_0cf1e776-a458-4f3b-af9f-77b69b0e30d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_0cf1e776-a458-4f3b-af9f-77b69b0e30d7" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_dbeaabb2-13d1-4b06-ad72-6c8d43fcbaca" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SplicosSASABX464Member_c8657399-9159-4d0b-8cb0-e8000cc30f53" xlink:href="abvx-20241231.xsd#abvx_SplicosSASABX464Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:to="loc_abvx_SplicosSASABX464Member_c8657399-9159-4d0b-8cb0-e8000cc30f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WittycelSASABX196Member_c4af583e-c34a-4fbd-a5a4-7b9ab60c301a" xlink:href="abvx-20241231.xsd#abvx_WittycelSASABX196Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_eb729a75-8044-4b8a-8840-a6cb1fa815d1" xlink:to="loc_abvx_WittycelSASABX196Member_c4af583e-c34a-4fbd-a5a4-7b9ab60c301a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable_0cf1e776-a458-4f3b-af9f-77b69b0e30d7" xlink:to="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_a4586030-d10d-4f4c-877d-d2fd251f0077" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_Goodwill_a4586030-d10d-4f4c-877d-d2fd251f0077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_958d5d33-d88d-4132-91d8-31d22bfa9cd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_958d5d33-d88d-4132-91d8-31d22bfa9cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_3509b7bb-6a81-49f9-8ab4-8c3dbcc0f31d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_3509b7bb-6a81-49f9-8ab4-8c3dbcc0f31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_bfae8dc5-8604-442c-8cf2-e989b2c05206" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_bfae8dc5-8604-442c-8cf2-e989b2c05206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_a95bfbed-175d-4500-b919-4a97a2d1660c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems_fb37c34e-5864-49a7-a5ee-415d016234b3" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_a95bfbed-175d-4500-b919-4a97a2d1660c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IntangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IntangibleassetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IntangibleassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_b2a66d7b-07bc-40f3-a200-bb8b6708df0c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_b2a66d7b-07bc-40f3-a200-bb8b6708df0c" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_b37f1eee-1024-4c51-ad0e-c30a30ba56e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_b37f1eee-1024-4c51-ad0e-c30a30ba56e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_671d9685-95dd-4fd3-bdb0-d02b8bf4e7e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_b37f1eee-1024-4c51-ad0e-c30a30ba56e7" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_671d9685-95dd-4fd3-bdb0-d02b8bf4e7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WittycelSASABX196Member_be959deb-857d-4f35-b70d-ffb206ff0874" xlink:href="abvx-20241231.xsd#abvx_WittycelSASABX196Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain_671d9685-95dd-4fd3-bdb0-d02b8bf4e7e1" xlink:to="loc_abvx_WittycelSASABX196Member_be959deb-857d-4f35-b70d-ffb206ff0874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsAxis_8da1a0a9-822f-4bb6-8572-f8fee0122653" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:to="loc_abvx_PrincipalAgreementsAxis_8da1a0a9-822f-4bb6-8572-f8fee0122653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsAxis_8da1a0a9-822f-4bb6-8572-f8fee0122653" xlink:to="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_31aab3aa-726d-4aaa-91dd-198538e55214" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:to="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_31aab3aa-726d-4aaa-91dd-198538e55214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_0d8b0958-84ec-4b09-ab43-487c00b793b1" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_78c21206-2c98-434c-ac22-dc928c995719" xlink:to="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_0d8b0958-84ec-4b09-ab43-487c00b793b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:to="loc_abvx_AssetsAcquisitionsAxis_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_54dc2283-4e29-4e24-aa49-1d3499c61dd8" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsAxis_6c6bb659-4fb2-44a5-9d3f-fbba8778ac28" xlink:to="loc_abvx_AssetsAcquisitionsDomain_54dc2283-4e29-4e24-aa49-1d3499c61dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_85bb28c5-2497-4adf-bd6a-cd8ace3836b6" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsDomain_54dc2283-4e29-4e24-aa49-1d3499c61dd8" xlink:to="loc_abvx_ProsynergiaMember_85bb28c5-2497-4adf-bd6a-cd8ace3836b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e04fcf4b-d4e8-4437-a350-2c17a063b104" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval_e76b4063-dd4f-4fc6-bc5e-0601dd7b53df" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval_e76b4063-dd4f-4fc6-bc5e-0601dd7b53df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_7a91ace7-522d-48fc-b8cf-460bb5a0f047" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_7a91ace7-522d-48fc-b8cf-460bb5a0f047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_2e8cdfc6-37c6-4235-96b3-749ac11540c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_2e8cdfc6-37c6-4235-96b3-749ac11540c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2_09a3e4e2-78f2-44b6-9e05-34f2397083c6" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2_09a3e4e2-78f2-44b6-9e05-34f2397083c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_98848334-86c7-488b-968a-28f2185ab058" xlink:href="abvx-20241231.xsd#abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_67048730-744e-4034-9c81-bbd7f8ed8807" xlink:to="loc_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions_98848334-86c7-488b-968a-28f2185ab058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_88506991-274b-4e71-adba-fffcb1ebfc95" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_88506991-274b-4e71-adba-fffcb1ebfc95" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7aeb0883-dc3f-4692-b18e-2942c0f1a583" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7aeb0883-dc3f-4692-b18e-2942c0f1a583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7aeb0883-dc3f-4692-b18e-2942c0f1a583" xlink:to="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_771c31c4-91ea-46aa-becf-e1a64aa562c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_771c31c4-91ea-46aa-becf-e1a64aa562c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9253b842-0d2b-411f-9f24-58b1c74536a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_dbed6245-07d5-46f7-ad5e-263fd8bcd197" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9253b842-0d2b-411f-9f24-58b1c74536a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_fd30eb53-46f6-4ef9-bd15-928404985eb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_fd30eb53-46f6-4ef9-bd15-928404985eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_fd30eb53-46f6-4ef9-bd15-928404985eb8" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesMember_f4e6c3de-9847-4af1-a1cb-f8f10f127ede" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:to="loc_ifrs-full_LicencesMember_f4e6c3de-9847-4af1-a1cb-f8f10f127ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_594e0d3e-2828-444d-b398-edefd7a50814" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:to="loc_ifrs-full_ComputerSoftwareMember_594e0d3e-2828-444d-b398-edefd7a50814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_17f29acb-4b30-46fe-a5c0-fe191c81801b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8fc593e0-0fc6-40c3-8eab-4ce339cff210" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_17f29acb-4b30-46fe-a5c0-fe191c81801b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_cec7dabb-9014-4224-91d8-fb80e4f345a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_0da2bbe3-af55-439e-8dff-5c53224e47f1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_cec7dabb-9014-4224-91d8-fb80e4f345a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_cec7dabb-9014-4224-91d8-fb80e4f345a8" xlink:to="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2d0fc1c4-96e9-451f-9cdb-79b3a1fdf8f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2d0fc1c4-96e9-451f-9cdb-79b3a1fdf8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1c052b12-b2c6-4fdd-9c3d-691058013fb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1c052b12-b2c6-4fdd-9c3d-691058013fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseIntangibleAssetsOtherThanGoodwill_2388cfa7-1001-4dd8-9bff-52a2fb6c122c" xlink:href="abvx-20241231.xsd#abvx_IncreaseIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_abvx_IncreaseIntangibleAssetsOtherThanGoodwill_2388cfa7-1001-4dd8-9bff-52a2fb6c122c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_1ae63c3b-c3a2-40ac-a975-3c65de64cc1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_1ae63c3b-c3a2-40ac-a975-3c65de64cc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_3deddcd0-74b0-4c84-b452-9a6cc0c8e9ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_d7912170-5f43-491a-bfc9-14d27fdfa693" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_3deddcd0-74b0-4c84-b452-9a6cc0c8e9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_dcfac010-0b3b-4fda-a51e-23479977ed74" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_dcfac010-0b3b-4fda-a51e-23479977ed74" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d694bd52-3652-455f-aa5f-64c303a1359b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d694bd52-3652-455f-aa5f-64c303a1359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d694bd52-3652-455f-aa5f-64c303a1359b" xlink:to="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_ee7180d0-f315-4202-8bf6-c6aa0eb9bc71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_ee7180d0-f315-4202-8bf6-c6aa0eb9bc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_f6f90227-d3eb-46f9-a937-4405e4749f1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_9425afa2-a697-44e1-b3d2-588271b8c1a7" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_f6f90227-d3eb-46f9-a937-4405e4749f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6110eb47-fbe1-4721-900f-64b4e72f47c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6110eb47-fbe1-4721-900f-64b4e72f47c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6110eb47-fbe1-4721-900f-64b4e72f47c7" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_07915979-3ccf-4bb1-aee5-ee2b004d9064" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:to="loc_ifrs-full_BuildingsMember_07915979-3ccf-4bb1-aee5-ee2b004d9064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember_d158faf2-7fdc-48f2-a248-294a872dbf66" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:to="loc_ifrs-full_MachineryMember_d158faf2-7fdc-48f2-a248-294a872dbf66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FurnitureAndComputerEquipmentMember_31587a09-1a50-4d98-84b2-03feb1bab8c3" xlink:href="abvx-20241231.xsd#abvx_FurnitureAndComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fd765f42-1137-4151-a1d2-b5f8788cf560" xlink:to="loc_abvx_FurnitureAndComputerEquipmentMember_31587a09-1a50-4d98-84b2-03feb1bab8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_e9da8d0d-5116-43c2-b558-6fea5e03c608" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_e9da8d0d-5116-43c2-b558-6fea5e03c608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_ae64e0e8-1b76-4ee4-ab97-6cafaffdf362" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_e9da8d0d-5116-43c2-b558-6fea5e03c608" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_ae64e0e8-1b76-4ee4-ab97-6cafaffdf362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssetsMember_b69adc33-21ff-4305-92cf-f61d6b4a4135" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_ae64e0e8-1b76-4ee4-ab97-6cafaffdf362" xlink:to="loc_ifrs-full_RightofuseAssetsMember_b69adc33-21ff-4305-92cf-f61d6b4a4135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2aba6b86-75c3-42dd-9e36-f8d35bebee8d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_a932c245-1c69-4069-9713-6a42697bc6b8" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2aba6b86-75c3-42dd-9e36-f8d35bebee8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2aba6b86-75c3-42dd-9e36-f8d35bebee8d" xlink:to="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_ef91edd3-41db-43b2-b9c2-4986ffb4c332" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_ef91edd3-41db-43b2-b9c2-4986ffb4c332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_efc51704-46e1-4395-b769-cd788847bd9e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_efc51704-46e1-4395-b769-cd788847bd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets_b9f40178-1546-4873-8c04-f997c2132394" xlink:href="abvx-20241231.xsd#abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets_b9f40178-1546-4873-8c04-f997c2132394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_c5303050-11cf-4b4f-a0fb-44c63a973d68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_c5303050-11cf-4b4f-a0fb-44c63a973d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_9cdee8af-e93d-4a1b-bc4d-1afbd7f01758" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_9cdee8af-e93d-4a1b-bc4d-1afbd7f01758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_5eeba5c7-a9f7-48d4-88c2-41fc22848456" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4d3729d0-7735-4833-850f-2751353c029e" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_5eeba5c7-a9f7-48d4-88c2-41fc22848456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PropertyplantandequipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_84e174c3-e76f-46b9-b7fa-55d705fadfd3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_84e174c3-e76f-46b9-b7fa-55d705fadfd3" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_44698eb2-053c-4370-b2e6-9a589c244d3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:to="loc_ifrs-full_TypesOfContractsAxis_44698eb2-053c-4370-b2e6-9a589c244d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_cb415f2d-7b1f-4fa4-8f05-cacb9cf27434" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_44698eb2-053c-4370-b2e6-9a589c244d3d" xlink:to="loc_ifrs-full_TypesOfContractsDomain_cb415f2d-7b1f-4fa4-8f05-cacb9cf27434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesParisMember_a013265b-8941-452b-a776-ce3fb466adc0" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesParisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_cb415f2d-7b1f-4fa4-8f05-cacb9cf27434" xlink:to="loc_abvx_LeaseFacilitiesParisMember_a013265b-8941-452b-a776-ce3fb466adc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1dbfe954-1f53-4f13-8f6b-c49933135738" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1dbfe954-1f53-4f13-8f6b-c49933135738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_ad804f95-b1ec-4be0-873f-f1adf6cb31d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1dbfe954-1f53-4f13-8f6b-c49933135738" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_ad804f95-b1ec-4be0-873f-f1adf6cb31d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_e3925c1e-61f7-4e36-909d-a339fbac1f5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_ad804f95-b1ec-4be0-873f-f1adf6cb31d7" xlink:to="loc_ifrs-full_BuildingsMember_e3925c1e-61f7-4e36-909d-a339fbac1f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_e4857416-5059-4b63-aec7-88d54b0e06ae" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_38ad74f4-3ed5-403a-b31f-cc2e63166ae3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:to="loc_ifrs-full_RightofuseAssets_38ad74f4-3ed5-403a-b31f-cc2e63166ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets_04d182ac-a43d-4f64-95f1-2ac4d7e01ee5" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_69cb91a9-6f71-429c-acea-311708677ee5" xlink:to="loc_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets_04d182ac-a43d-4f64-95f1-2ac4d7e01ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherfinancialassetsDisclosureofotherfinancialassetsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContracts_0b0319b2-34dc-4086-a264-688fccd1786d" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContracts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_abvx_NonCurrentAdvancesToCROContracts_0b0319b2-34dc-4086-a264-688fccd1786d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermDeposits_9de9aa4b-418e-494d-993f-d9f93fd90094" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermDeposits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_ifrs-full_LongtermDeposits_9de9aa4b-418e-494d-993f-d9f93fd90094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherNonCurrentMiscellaneousFinancialAssets_0bc28cd3-2de8-48a6-bca9-3d9f7b114659" xlink:href="abvx-20241231.xsd#abvx_OtherNonCurrentMiscellaneousFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_abvx_OtherNonCurrentMiscellaneousFinancialAssets_0bc28cd3-2de8-48a6-bca9-3d9f7b114659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_fda355d9-9a85-40ce-8703-4e2e5bd12c72" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialAssets_fda355d9-9a85-40ce-8703-4e2e5bd12c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentAdvancesToCROContracts_fef6e2f3-9e8b-4a98-a21f-37faff459264" xlink:href="abvx-20241231.xsd#abvx_CurrentAdvancesToCROContracts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_abvx_CurrentAdvancesToCROContracts_fef6e2f3-9e8b-4a98-a21f-37faff459264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherCurrentInvestments_563ba228-fa5f-4fe8-b0a0-e11b9d3a48a5" xlink:href="abvx-20241231.xsd#abvx_OtherCurrentInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_abvx_OtherCurrentInvestments_563ba228-fa5f-4fe8-b0a0-e11b9d3a48a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_585fea36-a6c2-445d-8f04-294666dfa4dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_585fea36-a6c2-445d-8f04-294666dfa4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_444fa2e9-0e29-4d7b-aef1-7f68d45bdd14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_444fa2e9-0e29-4d7b-aef1-7f68d45bdd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinancialAssets_cea36254-335e-4cfc-8e42-0c748d899e68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_29fb27d5-615f-4a4c-a3ee-f753e8ff8263" xlink:to="loc_ifrs-full_OtherFinancialAssets_cea36254-335e-4cfc-8e42-0c748d899e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherfinancialassetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_95d31f00-ac2a-4682-a0ea-06cf607f5a01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_d6c40ff3-946a-4c2f-b649-7598e4733a98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_95d31f00-ac2a-4682-a0ea-06cf607f5a01" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_d6c40ff3-946a-4c2f-b649-7598e4733a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_5d2896cc-3fc8-47cb-b6bb-54e80a798561" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_d6c40ff3-946a-4c2f-b649-7598e4733a98" xlink:to="loc_ifrs-full_RangeAxis_5d2896cc-3fc8-47cb-b6bb-54e80a798561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_5d2896cc-3fc8-47cb-b6bb-54e80a798561" xlink:to="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_12dd0e6f-1fd1-4036-8cfc-1a274dc9a342" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:to="loc_ifrs-full_BottomOfRangeMember_12dd0e6f-1fd1-4036-8cfc-1a274dc9a342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_53975d29-eb4d-4f03-991f-340726de2edf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_e2cd4d9b-a290-456f-8eff-9095359538d6" xlink:to="loc_ifrs-full_TopOfRangeMember_53975d29-eb4d-4f03-991f-340726de2edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_d6c40ff3-946a-4c2f-b649-7598e4733a98" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DiscountRateAppliedToLongTermAdvances_bb9984f4-d46a-47de-a551-7b3604fd0907" xlink:href="abvx-20241231.xsd#abvx_DiscountRateAppliedToLongTermAdvances"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:to="loc_abvx_DiscountRateAppliedToLongTermAdvances_bb9984f4-d46a-47de-a551-7b3604fd0907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_32004f62-6f01-482a-b929-07659e287872" xlink:href="abvx-20241231.xsd#abvx_PaymentsForAdvancesMadeToContractResearchOrganizations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_ee73f0ea-b594-4fa2-bd85-b2fe4f7afddf" xlink:to="loc_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations_32004f62-6f01-482a-b929-07659e287872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentPrepaidExpenses_764128f0-63bc-4e96-ab08-cfc39098e529" xlink:href="abvx-20241231.xsd#abvx_NonCurrentPrepaidExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_abvx_NonCurrentPrepaidExpenses_764128f0-63bc-4e96-ab08-cfc39098e529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_4170c81a-aa21-44d5-a135-01de7f715b65" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_4170c81a-aa21-44d5-a135-01de7f715b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentResearchTaxCreditReceivables_c6dd678c-d981-497b-8111-33881d2dbdd0" xlink:href="abvx-20241231.xsd#abvx_CurrentResearchTaxCreditReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_abvx_CurrentResearchTaxCreditReceivables_c6dd678c-d981-497b-8111-33881d2dbdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_f2956c97-4e0b-4438-86c6-86086b494485" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_f2956c97-4e0b-4438-86c6-86086b494485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_d4764b6a-0976-4a7e-9db4-70a5405a435a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_d4764b6a-0976-4a7e-9db4-70a5405a435a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesFromCreditNotes_7f8d3e4d-5129-4263-8851-ac23e8c2bf33" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesFromCreditNotes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_abvx_CurrentReceivablesFromCreditNotes_7f8d3e4d-5129-4263-8851-ac23e8c2bf33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_5628af52-3535-460b-b6bf-c1479783ee4a" xlink:href="abvx-20241231.xsd#abvx_CurrentReceivablesAndCurrentPrepaidExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_abvx_CurrentReceivablesAndCurrentPrepaidExpenses_5628af52-3535-460b-b6bf-c1479783ee4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssets_55ec2a43-d705-4790-a357-e972f90136b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_e84cf955-8646-49e0-a4be-0a96d77b1e2a" xlink:to="loc_ifrs-full_OtherAssets_55ec2a43-d705-4790-a357-e972f90136b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OtherreceivablesandotherassetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_f1b066e9-7a7f-485b-8141-99d305dff6cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_f1b066e9-7a7f-485b-8141-99d305dff6cd" xlink:to="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_41e40e21-976d-466d-a406-3804c922daee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4eddaa32-6fed-4e0f-975e-9c116ffc0e2d" xlink:to="loc_ifrs-full_CarryingAmountMember_41e40e21-976d-466d-a406-3804c922daee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DeferredFinancingCostsNettingMember_2d605446-0fa1-497a-b189-e7c8fbbb35e5" xlink:href="abvx-20241231.xsd#abvx_DeferredFinancingCostsNettingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_41e40e21-976d-466d-a406-3804c922daee" xlink:to="loc_abvx_DeferredFinancingCostsNettingMember_2d605446-0fa1-497a-b189-e7c8fbbb35e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_eaf30e1a-1e43-4be2-a995-a32bedfc3650" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_d4e4bd5b-d08f-4edd-9085-f34c40ab7b06" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_eaf30e1a-1e43-4be2-a995-a32bedfc3650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_7b497489-158f-4a5a-91e5-d6c80aaec174" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_eaf30e1a-1e43-4be2-a995-a32bedfc3650" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_7b497489-158f-4a5a-91e5-d6c80aaec174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable_5f1ecbbb-a01b-42b3-bf3c-edaa2eb21974" xlink:to="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromResearchTaxCredit_20b5dcf2-2f2a-4680-aa8c-4767198c8fbd" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromResearchTaxCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_ProceedsFromResearchTaxCredit_20b5dcf2-2f2a-4680-aa8c-4767198c8fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentResearchTaxCreditReceivables_c10850a6-a826-4a2b-8db1-8873c9b22f8e" xlink:href="abvx-20241231.xsd#abvx_CurrentResearchTaxCreditReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_CurrentResearchTaxCreditReceivables_c10850a6-a826-4a2b-8db1-8873c9b22f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPrepaidExpensesRelatedToCRO_efacab02-3ae5-4899-9ffd-3b0b3a4e152b" xlink:href="abvx-20241231.xsd#abvx_CurrentPrepaidExpensesRelatedToCRO"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_CurrentPrepaidExpensesRelatedToCRO_efacab02-3ae5-4899-9ffd-3b0b3a4e152b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_9a48be0a-df03-4256-981e-137666323a7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_ifrs-full_Borrowings_9a48be0a-df03-4256-981e-137666323a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_af1292ca-fbde-4a20-9fe9-d6ef769e9a14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAdvancesToSuppliers"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_ifrs-full_CurrentAdvancesToSuppliers_af1292ca-fbde-4a20-9fe9-d6ef769e9a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent_f7ef298c-6c00-4b26-ab6a-0627cee86eeb" xlink:href="abvx-20241231.xsd#abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems_be260b91-be01-4588-834d-91c75678dadc" xlink:to="loc_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent_f7ef298c-6c00-4b26-ab6a-0627cee86eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_027b8ef2-c153-4022-a901-218c9d74e6d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_9b3484fa-c3da-4e6b-b914-d34fd9d65d5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_027b8ef2-c153-4022-a901-218c9d74e6d1" xlink:to="loc_ifrs-full_CashEquivalents_9b3484fa-c3da-4e6b-b914-d34fd9d65d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_664bddb4-11b2-4bf7-be66-fd19a23503ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_027b8ef2-c153-4022-a901-218c9d74e6d1" xlink:to="loc_ifrs-full_Cash_664bddb4-11b2-4bf7-be66-fd19a23503ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_0bb02dda-724a-4948-9d02-9c342b720868" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_027b8ef2-c153-4022-a901-218c9d74e6d1" xlink:to="loc_ifrs-full_CashAndCashEquivalents_0bb02dda-724a-4948-9d02-9c342b720868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#CashandcashequivalentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_7120fd7c-7d17-468c-99ab-5b52f490ef2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCashAndCashEquivalentsTable_7f7bf110-fecc-47c8-946d-93fc7b88cbd7" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_7120fd7c-7d17-468c-99ab-5b52f490ef2e" xlink:to="loc_abvx_DisclosureOfCashAndCashEquivalentsTable_7f7bf110-fecc-47c8-946d-93fc7b88cbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_054278ed-6134-4152-9679-379ff21d1a5b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsTable_7f7bf110-fecc-47c8-946d-93fc7b88cbd7" xlink:to="loc_srt_CurrencyAxis_054278ed-6134-4152-9679-379ff21d1a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_833354e9-0a05-4bb2-aaac-fd951ecfd48c" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_054278ed-6134-4152-9679-379ff21d1a5b" xlink:to="loc_currency_AllCurrenciesDomain_833354e9-0a05-4bb2-aaac-fd951ecfd48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_42d08276-b13e-4477-8217-dbeee180dfcf" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_833354e9-0a05-4bb2-aaac-fd951ecfd48c" xlink:to="loc_currency_USD_42d08276-b13e-4477-8217-dbeee180dfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsTable_7f7bf110-fecc-47c8-946d-93fc7b88cbd7" xlink:to="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashAndCashEquivalents_49771076-bdd9-4d0b-a431-df1ba4af414f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:to="loc_ifrs-full_OtherCashAndCashEquivalents_49771076-bdd9-4d0b-a431-df1ba4af414f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_d06b43ae-adff-4dbc-b357-ebda83f353f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCashAndCashEquivalentsLineItems_447594f1-9248-44e6-8131-82dc08ff7fbc" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_d06b43ae-adff-4dbc-b357-ebda83f353f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialassetsandliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialassetsandliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialassetsandliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FairValueMeasurementAbstract_62069979-b51e-4fe9-b2d5-1e4979ec874c" xlink:href="abvx-20241231.xsd#abvx_FairValueMeasurementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FairValueMeasurementAbstract_62069979-b51e-4fe9-b2d5-1e4979ec874c" xlink:to="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_14117025-e60d-47bf-950c-cfd6b47185b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_14117025-e60d-47bf-950c-cfd6b47185b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_14117025-e60d-47bf-950c-cfd6b47185b9" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialAssetsMember_f51fef1a-72f8-45a4-bcce-95a720f18200" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_OtherFinancialAssetsMember_f51fef1a-72f8-45a4-bcce-95a720f18200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherReceivablesAndAssetsMember_88605173-113a-4e57-b07b-20c1aee009ba" xlink:href="abvx-20241231.xsd#abvx_OtherReceivablesAndAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_OtherReceivablesAndAssetsMember_88605173-113a-4e57-b07b-20c1aee009ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CashAndCashEquivalentMember_c470098f-6123-47e1-b4d7-872ed594db7b" xlink:href="abvx-20241231.xsd#abvx_CashAndCashEquivalentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_CashAndCashEquivalentMember_c470098f-6123-47e1-b4d7-872ed594db7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentAdvancesToCROContractsMember_9de626cc-92fa-4d27-93af-318db46e2e96" xlink:href="abvx-20241231.xsd#abvx_NonCurrentAdvancesToCROContractsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_a78fe313-f1d2-43e7-8570-7805a23a862d" xlink:to="loc_abvx_NonCurrentAdvancesToCROContractsMember_9de626cc-92fa-4d27-93af-318db46e2e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_a897217c-0114-4308-bbf4-2cd19112ad11" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_MeasurementAxis_a897217c-0114-4308-bbf4-2cd19112ad11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_2308600a-3488-43b5-9a05-a3f13b9434b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_a897217c-0114-4308-bbf4-2cd19112ad11" xlink:to="loc_ifrs-full_MeasurementDomain_2308600a-3488-43b5-9a05-a3f13b9434b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecurringFairValueMeasurementMember_42b3bb56-691a-4a5d-85de-8ecefd463a84" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_2308600a-3488-43b5-9a05-a3f13b9434b1" xlink:to="loc_ifrs-full_RecurringFairValueMeasurementMember_42b3bb56-691a-4a5d-85de-8ecefd463a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_75778f97-5296-4660-8e53-1cb9a325655b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_75778f97-5296-4660-8e53-1cb9a325655b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_75778f97-5296-4660-8e53-1cb9a325655b" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_c14b6d77-c632-4106-b50b-e0e6d1d1c174" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_c14b6d77-c632-4106-b50b-e0e6d1d1c174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_e427f6b9-ac52-4a0b-8196-835872dd5aa8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_3c740efa-7a75-4095-b496-b8a0634c272b" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_e427f6b9-ac52-4a0b-8196-835872dd5aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a5af389a-3595-400f-9fd0-9378785c0045" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a5af389a-3595-400f-9fd0-9378785c0045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_a5af389a-3595-400f-9fd0-9378785c0045" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_08aa41dd-9d91-454f-b9c8-bddb563db21f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_08aa41dd-9d91-454f-b9c8-bddb563db21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_fa2fbe07-fa7e-40d7-b650-662df88cfcd3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_1c10f5d7-ff36-49d7-a7a2-5e0fb7dbf589" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_fa2fbe07-fa7e-40d7-b650-662df88cfcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_f9ecc366-7eac-44b5-b251-c2a19a91b3d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_f9ecc366-7eac-44b5-b251-c2a19a91b3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_f9ecc366-7eac-44b5-b251-c2a19a91b3d1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:href="abvx-20241231.xsd#abvx_NonCurrentFinancialLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:to="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_50f968ad-89b0-4627-8888-dccd761e77b3" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_Kreos12BondLoansMember_50f968ad-89b0-4627-8888-dccd761e77b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_9ec5da3b-efac-4808-acd0-fb0db692e3a2" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_OCEANEMember_9ec5da3b-efac-4808-acd0-fb0db692e3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_78f77eec-92e4-4768-a4b0-00f2af48d6e1" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_78f77eec-92e4-4768-a4b0-00f2af48d6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheABAndCMember_2a6a90c4-7e3a-4e26-9281-7a0d6e47e0d6" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheABAndCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_KreosClaretFinancingTrancheABAndCMember_2a6a90c4-7e3a-4e26-9281-7a0d6e47e0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesAndPGELoanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_NonCurrentFinancialLiabilitiesMember_a45385a8-4886-48e5-827e-b7545305284b" xlink:to="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_ea1c2e15-32ab-4a59-85a9-28d791d3ecf5" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_ea1c2e15-32ab-4a59-85a9-28d791d3ecf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_380101de-77fd-4d5c-ad81-b95e4d2c803b" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_380101de-77fd-4d5c-ad81-b95e4d2c803b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_b79266c2-70b4-4b30-9dd7-c2d93146f022" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_b79266c2-70b4-4b30-9dd7-c2d93146f022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_2c3728ed-4f27-4740-b722-f9bf6763e6c2" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ConditionalAdvancesAndPGELoanMember_27dc66d3-e077-4ee3-aa59-b3debef29a72" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_2c3728ed-4f27-4740-b722-f9bf6763e6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentFinancialLiabilitiesMember_37b7e608-526b-402f-9b45-89e1ab4c2292" xlink:href="abvx-20241231.xsd#abvx_CurrentFinancialLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:to="loc_abvx_CurrentFinancialLiabilitiesMember_37b7e608-526b-402f-9b45-89e1ab4c2292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TradePayablesAndOtherCurrentLiabilitiesMember_5cd7ed00-e0f5-45cd-b3c0-35b4fb27c92c" xlink:href="abvx-20241231.xsd#abvx_TradePayablesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1f7a98bc-9da0-4887-bd42-88d9abcee687" xlink:to="loc_abvx_TradePayablesAndOtherCurrentLiabilitiesMember_5cd7ed00-e0f5-45cd-b3c0-35b4fb27c92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_55b678f6-f663-4bf7-967f-a05bc28c2c21" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_RangeAxis_55b678f6-f663-4bf7-967f-a05bc28c2c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_55b678f6-f663-4bf7-967f-a05bc28c2c21" xlink:to="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_edb8cdaa-568e-4150-b3d6-d65a5fce2ae6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:to="loc_ifrs-full_BottomOfRangeMember_edb8cdaa-568e-4150-b3d6-d65a5fce2ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_5d1ab669-0e4a-4207-ab97-d1149abd95cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_cedc44b9-1c57-4212-9f03-34d0e0c3d5a5" xlink:to="loc_ifrs-full_TopOfRangeMember_5d1ab669-0e4a-4207-ab97-d1149abd95cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_59766b7e-607e-4329-961b-89b3acb7fac2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_UnobservableInputsAxis_59766b7e-607e-4329-961b-89b3acb7fac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_03e24365-626c-4bd2-a1bc-4e4b7d01998a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_59766b7e-607e-4329-961b-89b3acb7fac2" xlink:to="loc_ifrs-full_UnobservableInputsDomain_03e24365-626c-4bd2-a1bc-4e4b7d01998a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_135125a0-4c63-433d-b8cc-86c602c094fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_03e24365-626c-4bd2-a1bc-4e4b7d01998a" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_135125a0-4c63-433d-b8cc-86c602c094fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_65a5037d-12cd-43f9-80b4-41a91aef363a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_65a5037d-12cd-43f9-80b4-41a91aef363a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9b585b13-c827-4ea2-8bee-a729a4459665" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_65a5037d-12cd-43f9-80b4-41a91aef363a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9b585b13-c827-4ea2-8bee-a729a4459665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountedCashFlowMember_e5808a8a-ec7f-4db4-afed-c8ab007ad416" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_9b585b13-c827-4ea2-8bee-a729a4459665" xlink:to="loc_ifrs-full_DiscountedCashFlowMember_e5808a8a-ec7f-4db4-afed-c8ab007ad416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_0d6e20c9-03e8-46d2-a60a-fcf5783b0195" xlink:to="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_e7135ff8-157c-4530-8860-710b5879aafc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_Assets_e7135ff8-157c-4530-8860-710b5879aafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_971c52fd-b828-4a52-b577-a6f2ab3e483b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_971c52fd-b828-4a52-b577-a6f2ab3e483b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_6812a62c-f2ca-4c51-9950-4ab1e4fee70a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_Liabilities_6812a62c-f2ca-4c51-9950-4ab1e4fee70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_5425d6fb-83ee-4f68-8b00-3b887a8ec1ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_5425d6fb-83ee-4f68-8b00-3b887a8ec1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputAssets_c921e384-7ccd-4101-9fd3-77b06dcfb3c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_SignificantUnobservableInputAssets_c921e384-7ccd-4101-9fd3-77b06dcfb3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_6b6bc620-b486-476f-8b5c-ff37c8448494" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_6b6bc620-b486-476f-8b5c-ff37c8448494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_99ec684c-7b53-4157-81d5-7239eb501e5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_99ec684c-7b53-4157-81d5-7239eb501e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_09f9c4c5-2fd8-47ae-86f4-da58ca20e7fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_09f9c4c5-2fd8-47ae-86f4-da58ca20e7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_953637ad-7e1f-4e3c-a675-90a5fec9e6c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_953637ad-7e1f-4e3c-a675-90a5fec9e6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_413d7b3b-592d-4628-89b7-34c177e80730" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_632c6b90-4a74-4a75-8ffa-ed0043742161" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_413d7b3b-592d-4628-89b7-34c177e80730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequitySharecapitalissuedDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_5f080660-651f-4bd9-9df9-f3f0ef807e6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_2465e2e2-ba39-4ba2-99bf-db89d3ce7884" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5f080660-651f-4bd9-9df9-f3f0ef807e6b" xlink:to="loc_ifrs-full_IssuedCapital_2465e2e2-ba39-4ba2-99bf-db89d3ce7884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_5c12d7fa-cf7f-4fa3-b7b6-cd19b9c28cb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5f080660-651f-4bd9-9df9-f3f0ef807e6b" xlink:to="loc_ifrs-full_NumberOfSharesIssued_5c12d7fa-cf7f-4fa3-b7b6-cd19b9c28cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_178e0368-ce50-4294-94b5-6985ca08b2fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5f080660-651f-4bd9-9df9-f3f0ef807e6b" xlink:to="loc_ifrs-full_ParValuePerShare_178e0368-ce50-4294-94b5-6985ca08b2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfTreasurySharesHeld_ce291ce2-6a8f-4a24-98b1-08adaa0c28b0" xlink:href="abvx-20241231.xsd#abvx_NumberOfTreasurySharesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5f080660-651f-4bd9-9df9-f3f0ef807e6b" xlink:to="loc_abvx_NumberOfTreasurySharesHeld_ce291ce2-6a8f-4a24-98b1-08adaa0c28b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_11886667-af44-4600-9d69-c513fea50326" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5f080660-651f-4bd9-9df9-f3f0ef807e6b" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_11886667-af44-4600-9d69-c513fea50326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequityEquitylineinstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_905c949e-6216-45d0-97b6-10297ef71242" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_905c949e-6216-45d0-97b6-10297ef71242" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_fe7903e1-af91-4b2b-9742-947b980ed6b7" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:to="loc_abvx_FinancialAgreementAxis_fe7903e1-af91-4b2b-9742-947b980ed6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_2d69b81e-cb5c-4b6c-a45c-49b0b8d30a06" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementAxis_fe7903e1-af91-4b2b-9742-947b980ed6b7" xlink:to="loc_abvx_FinancialAgreementDomain_2d69b81e-cb5c-4b6c-a45c-49b0b8d30a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_dff02ee0-ade7-4b99-9c5e-641f0f675a14" xlink:href="abvx-20241231.xsd#abvx_EquityLineAgreementWithKeplerCheuvreuxMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_2d69b81e-cb5c-4b6c-a45c-49b0b8d30a06" xlink:to="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_dff02ee0-ade7-4b99-9c5e-641f0f675a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_191625b9-6644-42f9-9796-b8726175a24c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_191625b9-6644-42f9-9796-b8726175a24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d3b2132a-5402-4e9b-9c91-0a10cab2a96b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_191625b9-6644-42f9-9796-b8726175a24c" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d3b2132a-5402-4e9b-9c91-0a10cab2a96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_1130c111-1fcf-48c6-98b6-c79f41e26aaa" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d3b2132a-5402-4e9b-9c91-0a10cab2a96b" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_1130c111-1fcf-48c6-98b6-c79f41e26aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ed2f4c6a-8b6a-44a7-b844-e0858984dafd" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued_fbc6c4b1-ca03-4cde-ad47-38c1bff93588" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementMaximumNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued_fbc6c4b1-ca03-4cde-ad47-38c1bff93588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementMaximumPeriod_1b174034-2d49-4400-80f5-aab1a9627e7b" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementMaximumPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementMaximumPeriod_1b174034-2d49-4400-80f5-aab1a9627e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays_82485a3e-d598-42d3-9db9-0337d0cea0b2" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays_82485a3e-d598-42d3-9db9-0337d0cea0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount_292da862-7080-4942-8493-b0a78be5c091" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementIssuancePriceMaximumDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount_292da862-7080-4942-8493-b0a78be5c091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderwritingAgreementExtendedPeriod_6572a2d1-52ca-4242-907b-a5850eb8fd57" xlink:href="abvx-20241231.xsd#abvx_UnderwritingAgreementExtendedPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_abvx_UnderwritingAgreementExtendedPeriod_6572a2d1-52ca-4242-907b-a5850eb8fd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_8208da6b-f0f3-40c9-b49e-6e3c0a67c3e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8bc43175-bec8-42b8-b2b9-e87c0e4d2d75" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_8208da6b-f0f3-40c9-b49e-6e3c0a67c3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_25618faa-45c7-423a-8fb2-a4670e8c1a7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_25618faa-45c7-423a-8fb2-a4670e8c1a7a" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_1e82e70e-923a-4614-b702-46a10b87f0bd" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:to="loc_abvx_FinancialAgreementAxis_1e82e70e-923a-4614-b702-46a10b87f0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_13090f1d-5cf2-4181-98e6-d7e3c6b0029b" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementAxis_1e82e70e-923a-4614-b702-46a10b87f0bd" xlink:to="loc_abvx_FinancialAgreementDomain_13090f1d-5cf2-4181-98e6-d7e3c6b0029b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_b7ac40bd-9f25-49d1-9024-c4ef651ec275" xlink:href="abvx-20241231.xsd#abvx_EquityLineAgreementWithKeplerCheuvreuxMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_13090f1d-5cf2-4181-98e6-d7e3c6b0029b" xlink:to="loc_abvx_EquityLineAgreementWithKeplerCheuvreuxMember_b7ac40bd-9f25-49d1-9024-c4ef651ec275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_f26016f2-c3b8-42a0-b9da-3f77438a5a5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_f26016f2-c3b8-42a0-b9da-3f77438a5a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e36b865c-f747-447b-abf4-dbc6eb70c9ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_f26016f2-c3b8-42a0-b9da-3f77438a5a5a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e36b865c-f747-447b-abf4-dbc6eb70c9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_c77da3f8-4a45-4809-bc25-c0ddbaaf0af5" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e36b865c-f747-447b-abf4-dbc6eb70c9ec" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_c77da3f8-4a45-4809-bc25-c0ddbaaf0af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_c2a0dc0c-350b-4498-866f-8af4b4b5a4dc" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_a7cce091-c8b0-4c49-8666-039168ced7f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_a7cce091-c8b0-4c49-8666-039168ced7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_fd240edc-bbec-44d9-9f87-06492a8a956b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_fd240edc-bbec-44d9-9f87-06492a8a956b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_887819d3-d509-48e7-a749-05c175576018" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_887819d3-d509-48e7-a749-05c175576018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4b97f2a1-93ff-4973-bf52-3d8973a418a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4b97f2a1-93ff-4973-bf52-3d8973a418a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_c3e63266-6448-444c-8576-8a6441355a58" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_de773dc8-8e1b-4950-a3fa-5b7f177d7c1d" xlink:to="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_c3e63266-6448-444c-8576-8a6441355a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ShareholdersequityChangeinsharecapitalDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_944d03a1-1dd5-4406-bb99-66486759b88c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_944d03a1-1dd5-4406-bb99-66486759b88c" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0071d243-df57-4a90-b6f4-1472eed6a548" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0071d243-df57-4a90-b6f4-1472eed6a548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0071d243-df57-4a90-b6f4-1472eed6a548" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_99f6b16f-059d-41ef-825f-c1c6d7504076" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:to="loc_abvx_KreosABSAMember_99f6b16f-059d-41ef-825f-c1c6d7504076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_c310121d-21f8-40de-a10a-c19334462430" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:to="loc_abvx_KreosBBSAMember_c310121d-21f8-40de-a10a-c19334462430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_e6dfbbcc-a910-4287-b6fd-68a7c1f33bd0" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_d33a3ae0-675f-4f67-af38-42ca600678f2" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_e6dfbbcc-a910-4287-b6fd-68a7c1f33bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241AndBSA20242Member_07fed22e-807b-469b-880b-98d875b7f70d" xlink:href="abvx-20241231.xsd#abvx_BSA20241AndBSA20242Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_e6dfbbcc-a910-4287-b6fd-68a7c1f33bd0" xlink:to="loc_abvx_BSA20241AndBSA20242Member_07fed22e-807b-469b-880b-98d875b7f70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementAxis_7a652c88-79c3-4620-85fc-2e5fe2f3bc98" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:to="loc_abvx_FinancialAgreementAxis_7a652c88-79c3-4620-85fc-2e5fe2f3bc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:href="abvx-20241231.xsd#abvx_FinancialAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementAxis_7a652c88-79c3-4620-85fc-2e5fe2f3bc98" xlink:to="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_675dd5ee-6452-4349-b5e8-d3c25b4a0118" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:to="loc_abvx_Kreos1Member_675dd5ee-6452-4349-b5e8-d3c25b4a0118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEquityAgreementsMember_3ba934ae-2287-490a-af87-f08a07d14b36" xlink:href="abvx-20241231.xsd#abvx_OtherEquityAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialAgreementDomain_769b8533-3984-4854-a339-94ec92484f9a" xlink:to="loc_abvx_OtherEquityAgreementsMember_3ba934ae-2287-490a-af87-f08a07d14b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_01a61f58-761a-4d94-b05c-98525e298bfa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_01a61f58-761a-4d94-b05c-98525e298bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_01a61f58-761a-4d94-b05c-98525e298bfa" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmericanDepositorySharesMember_28b8715f-001f-48a3-807c-25d0621afe1f" xlink:href="abvx-20241231.xsd#abvx_AmericanDepositorySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:to="loc_abvx_AmericanDepositorySharesMember_28b8715f-001f-48a3-807c-25d0621afe1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_4acb954c-1667-4651-a813-b137e804462e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_403c3d62-7f43-4bf0-8e55-a83fe263349a" xlink:to="loc_ifrs-full_OrdinarySharesMember_4acb954c-1667-4651-a813-b137e804462e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_911cdfda-bd2a-4347-ae2d-294f3de1dd75" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_ac4dbab7-5309-44b4-b8ff-4d1cf712325d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_IssueOfEquity_ac4dbab7-5309-44b4-b8ff-4d1cf712325d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_51791d64-93a9-43b1-ad0e-418b02091f2f" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_51791d64-93a9-43b1-ad0e-418b02091f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_266362d1-7259-49f6-8722-324dbf38fb10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_ParValuePerShare_266362d1-7259-49f6-8722-324dbf38fb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_bea8cf2f-0521-4b3c-b044-9c414d9316fe" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_bea8cf2f-0521-4b3c-b044-9c414d9316fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsExercised_ab4a5c23-8cf1-4200-a733-c5eb52fcb747" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_NumberOfWarrantsExercised_ab4a5c23-8cf1-4200-a733-c5eb52fcb747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_e2741e5a-d474-4303-8dcf-7bb2eca5754f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_e2741e5a-d474-4303-8dcf-7bb2eca5754f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_f5da70d4-c0b2-4ef6-9bed-5460646eed3b" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_f5da70d4-c0b2-4ef6-9bed-5460646eed3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_2b7008e7-59fb-445c-ba70-79383113c615" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsSubscriptionPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_2b7008e7-59fb-445c-ba70-79383113c615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_a37b0752-0e51-4328-b98a-08f510b5be1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_a37b0752-0e51-4328-b98a-08f510b5be1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssueOfEquityOfferingPricePerShare_a21cb869-cb36-4c06-9809-9fff8e7fd474" xlink:href="abvx-20241231.xsd#abvx_IssueOfEquityOfferingPricePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_IssueOfEquityOfferingPricePerShare_a21cb869-cb36-4c06-9809-9fff8e7fd474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5faa8799-527f-4a5b-a8ea-c58cee18eeba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5faa8799-527f-4a5b-a8ea-c58cee18eeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareWarrantsSubscriptionPricePerShare_afc6e2db-d4fd-4310-bb6c-ab5d06f6e2c5" xlink:href="abvx-20241231.xsd#abvx_ShareWarrantsSubscriptionPricePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_ShareWarrantsSubscriptionPricePerShare_afc6e2db-d4fd-4310-bb6c-ab5d06f6e2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareIssueRelatedCostCredit_e8cc9fe6-578d-4f37-8294-bcf3edc08f50" xlink:href="abvx-20241231.xsd#abvx_ShareIssueRelatedCostCredit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_ShareIssueRelatedCostCredit_e8cc9fe6-578d-4f37-8294-bcf3edc08f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFreeSharesIssued_e8096df7-8c46-4a94-8fb8-80610e7cadd6" xlink:href="abvx-20241231.xsd#abvx_NumberOfFreeSharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_883bb5ee-4970-4ec8-9366-a598f21b68fd" xlink:to="loc_abvx_NumberOfFreeSharesIssued_e8096df7-8c46-4a94-8fb8-80610e7cadd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_d62edbf7-9ad9-425f-8a9f-172c4478ae35" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f9d161d1-bb3a-4f7d-b284-ae2ebe611738" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_d62edbf7-9ad9-425f-8a9f-172c4478ae35" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f9d161d1-bb3a-4f7d-b284-ae2ebe611738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a66892bc-ab74-447b-913f-d02d9309b295" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f9d161d1-bb3a-4f7d-b284-ae2ebe611738" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a66892bc-ab74-447b-913f-d02d9309b295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0fe091a6-8d31-4c5d-9521-0f8590d5349e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a66892bc-ab74-447b-913f-d02d9309b295" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0fe091a6-8d31-4c5d-9521-0f8590d5349e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:href="abvx-20241231.xsd#abvx_FoundersShareSubscriptionWarrantsBCEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0fe091a6-8d31-4c5d-9521-0f8590d5349e" xlink:to="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20161Member_33e6e707-7c2c-418f-a16e-3fa90dbccb50" xlink:href="abvx-20241231.xsd#abvx_BCE20161Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20161Member_33e6e707-7c2c-418f-a16e-3fa90dbccb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20171Member_fa3c0512-4bcb-4fdc-a6de-d45a4a5e80e6" xlink:href="abvx-20241231.xsd#abvx_BCE20171Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20171Member_fa3c0512-4bcb-4fdc-a6de-d45a4a5e80e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20172Member_35b12fca-3dce-4a64-9476-23b08da6babc" xlink:href="abvx-20241231.xsd#abvx_BCE20172Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20172Member_35b12fca-3dce-4a64-9476-23b08da6babc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20174Member_5695c77f-dee3-4333-aa5d-7f2c7e3e5983" xlink:href="abvx-20241231.xsd#abvx_BCE20174Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20174Member_5695c77f-dee3-4333-aa5d-7f2c7e3e5983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20175Member_661d5e1a-0958-44f4-8753-562a334999da" xlink:href="abvx-20241231.xsd#abvx_BCE20175Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20175Member_661d5e1a-0958-44f4-8753-562a334999da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20181Member_41da21f0-4308-4378-aec9-830ebd5d3779" xlink:href="abvx-20241231.xsd#abvx_BCE20181Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20181Member_41da21f0-4308-4378-aec9-830ebd5d3779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20183Member_b194102f-c48e-4330-b879-12d31dfe9b7a" xlink:href="abvx-20241231.xsd#abvx_BCE20183Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20183Member_b194102f-c48e-4330-b879-12d31dfe9b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20184Member_e938c0dc-e891-4b67-a5ca-08f7de9fa0f5" xlink:href="abvx-20241231.xsd#abvx_BCE20184Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20184Member_e938c0dc-e891-4b67-a5ca-08f7de9fa0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCE20185Member_03dd53f4-f6e8-4bd0-a1c2-a8314ab7ad72" xlink:href="abvx-20241231.xsd#abvx_BCE20185Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_5a1d44d7-4dac-4ac4-893f-60f510a11a17" xlink:to="loc_abvx_BCE20185Member_03dd53f4-f6e8-4bd0-a1c2-a8314ab7ad72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f9d161d1-bb3a-4f7d-b284-ae2ebe611738" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_d1a7f87a-9344-4011-a634-bcc3a0dbe392" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_d1a7f87a-9344-4011-a634-bcc3a0dbe392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_72774085-2c64-4394-9ebe-9a83f7554e96" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_72774085-2c64-4394-9ebe-9a83f7554e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_3b81d1c9-72b7-443f-9508-3e7f741c07ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_3b81d1c9-72b7-443f-9508-3e7f741c07ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2df8374e-5df3-4292-b356-671fdcd28d34" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2df8374e-5df3-4292-b356-671fdcd28d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1b793475-9652-407d-9312-6b8952de1e1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1b793475-9652-407d-9312-6b8952de1e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_9b51f311-7e22-4026-9eb6-6f8e85e863cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_9b51f311-7e22-4026-9eb6-6f8e85e863cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_82485889-92b6-42cc-aea8-7e0dba7dacbf" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82405b49-aec7-4c81-891b-0bb1960e5204" xlink:to="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_82485889-92b6-42cc-aea8-7e0dba7dacbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_9ff0cdd7-9deb-4ce6-bea9-1af6c4c3a908" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_9ff0cdd7-9deb-4ce6-bea9-1af6c4c3a908" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_2de7451b-c293-456a-8ec8-56210a70785d" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_abvx_TranchesAxis_2de7451b-c293-456a-8ec8-56210a70785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesAxis_2de7451b-c293-456a-8ec8-56210a70785d" xlink:to="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_fc400c99-eea8-49cd-b560-86a0124332e9" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheOneMember_fc400c99-eea8-49cd-b560-86a0124332e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_3b668aa8-12da-4e1a-a015-c65c0f068125" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheTwoMember_3b668aa8-12da-4e1a-a015-c65c0f068125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheThreeMember_26bb78f5-ca0a-4a8b-b293-dabee10a8c8b" xlink:href="abvx-20241231.xsd#abvx_TrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheThreeMember_26bb78f5-ca0a-4a8b-b293-dabee10a8c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFourMember_278b1148-7e7b-489d-8e10-a319c6cf526e" xlink:href="abvx-20241231.xsd#abvx_TrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheFourMember_278b1148-7e7b-489d-8e10-a319c6cf526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFiveMember_18a56bc4-c060-4de1-b8f2-90db1717d396" xlink:href="abvx-20241231.xsd#abvx_TrancheFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheFiveMember_18a56bc4-c060-4de1-b8f2-90db1717d396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheSixMember_a80369fd-b867-4ee6-9f55-3ed344070090" xlink:href="abvx-20241231.xsd#abvx_TrancheSixMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_2cfb8ef7-28db-4cf8-adcd-2bcb51ce8524" xlink:to="loc_abvx_TrancheSixMember_a80369fd-b867-4ee6-9f55-3ed344070090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7612ed9f-4b9c-4d2b-b77e-ecbe7114c846" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_674f7c3e-0d50-4081-b793-b17cb2ca0054" xlink:href="abvx-20241231.xsd#abvx_FoundersShareSubscriptionWarrantsBCEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_674f7c3e-0d50-4081-b793-b17cb2ca0054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BCEExceptBCE20142Member_d2e30575-e5d2-4de5-8e70-99d9fb6b8ccd" xlink:href="abvx-20241231.xsd#abvx_BCEExceptBCE20142Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_BCEExceptBCE20142Member_d2e30575-e5d2-4de5-8e70-99d9fb6b8ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_68eb02f7-43b1-494f-b839-7608f31ed909" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_68eb02f7-43b1-494f-b839-7608f31ed909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241AndBSA20242Member_9e3364de-dee1-4cfe-a39c-46405f743153" xlink:href="abvx-20241231.xsd#abvx_BSA20241AndBSA20242Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_BSA20241AndBSA20242Member_9e3364de-dee1-4cfe-a39c-46405f743153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2021Member_ddbc25c5-c6d3-4805-9007-043ef7abe8f8" xlink:href="abvx-20241231.xsd#abvx_AGA2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA2021Member_ddbc25c5-c6d3-4805-9007-043ef7abe8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20231Member_967ea42d-a065-4e48-83e5-50e5cf08cb6f" xlink:href="abvx-20241231.xsd#abvx_AGA20231Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20231Member_967ea42d-a065-4e48-83e5-50e5cf08cb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20232Member_dfb9d585-b723-4ead-88d8-8adf663b496c" xlink:href="abvx-20241231.xsd#abvx_AGA20232Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20232Member_dfb9d585-b723-4ead-88d8-8adf663b496c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233AndAGA20234Member_bf67ae5c-ddf6-4b5c-90a6-9e7a53ee28c7" xlink:href="abvx-20241231.xsd#abvx_AGA20233AndAGA20234Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20233AndAGA20234Member_bf67ae5c-ddf6-4b5c-90a6-9e7a53ee28c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20235Member_0369eb9d-66ca-4daa-9afe-01cc045e13f4" xlink:href="abvx-20241231.xsd#abvx_AGA20235Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20235Member_0369eb9d-66ca-4daa-9afe-01cc045e13f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233AGA20234AndAGA20235Member_8d13268d-700e-441c-837c-efbdfadf7b3c" xlink:href="abvx-20241231.xsd#abvx_AGA20233AGA20234AndAGA20235Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20233AGA20234AndAGA20235Member_8d13268d-700e-441c-837c-efbdfadf7b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241Member_0f69b9a9-0989-41ab-86a5-3fead41fa7b7" xlink:href="abvx-20241231.xsd#abvx_AGA20241Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20241Member_0f69b9a9-0989-41ab-86a5-3fead41fa7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20242Member_e5c46600-5077-47a9-98af-e0fe4f16e0f6" xlink:href="abvx-20241231.xsd#abvx_AGA20242Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20242Member_e5c46600-5077-47a9-98af-e0fe4f16e0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20243Member_7a8b8a77-0772-4593-8d1c-628039cdd56b" xlink:href="abvx-20241231.xsd#abvx_AGA20243Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20243Member_7a8b8a77-0772-4593-8d1c-628039cdd56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244AGA20245AndAGA20246Member_dc198177-6d5c-40cf-863c-4cd33bb269e8" xlink:href="abvx-20241231.xsd#abvx_AGA20244AGA20245AndAGA20246Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20244AGA20245AndAGA20246Member_dc198177-6d5c-40cf-863c-4cd33bb269e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20247Member_71489bd5-dfc1-44bc-a810-6eb32aee835b" xlink:href="abvx-20241231.xsd#abvx_AGA20247Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20247Member_71489bd5-dfc1-44bc-a810-6eb32aee835b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member_78fa390b-1846-4c0c-8ab6-8467d85203d4" xlink:href="abvx-20241231.xsd#abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member_78fa390b-1846-4c0c-8ab6-8467d85203d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_7df01135-538b-42a1-b1c8-ff2810930d49" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_f6720ef2-ffeb-4eae-84ca-7ec8a2230b1c" xlink:to="loc_abvx_AGA20246Member_7df01135-538b-42a1-b1c8-ff2810930d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingServiceConditionsAxis_1c8b45d4-b5c1-4958-865b-0b2a1195495f" xlink:href="abvx-20241231.xsd#abvx_VestingServiceConditionsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_abvx_VestingServiceConditionsAxis_1c8b45d4-b5c1-4958-865b-0b2a1195495f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:href="abvx-20241231.xsd#abvx_VestingServiceConditionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_VestingServiceConditionsAxis_1c8b45d4-b5c1-4958-865b-0b2a1195495f" xlink:to="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingConditionsCompletedMember_33396b75-d6aa-421c-a361-56d80b49e021" xlink:href="abvx-20241231.xsd#abvx_VestingConditionsCompletedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:to="loc_abvx_VestingConditionsCompletedMember_33396b75-d6aa-421c-a361-56d80b49e021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingConditionsNotCompletedMember_7950ba81-6679-4d3d-a714-255a5f538b30" xlink:href="abvx-20241231.xsd#abvx_VestingConditionsNotCompletedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_VestingServiceConditionsDomain_2a6da130-c163-4c50-a8dd-95070a338879" xlink:to="loc_abvx_VestingConditionsNotCompletedMember_7950ba81-6679-4d3d-a714-255a5f538b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_srt_TitleOfIndividualAxis_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_6a21853f-8fc1-4a1d-b7d4-7610d4b2d4a3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a674fcbb-288f-449f-8d72-8906faf1899a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a674fcbb-288f-449f-8d72-8906faf1899a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FormerChiefExecutiveOfficerMember_d7c3862c-7ee8-4367-b4b0-728a7476a44b" xlink:href="abvx-20241231.xsd#abvx_FormerChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:to="loc_abvx_FormerChiefExecutiveOfficerMember_d7c3862c-7ee8-4367-b4b0-728a7476a44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EmployeeMember_7c763109-c01b-4b09-aa2c-7523378e16e0" xlink:href="abvx-20241231.xsd#abvx_EmployeeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b04cddf-ef03-40bf-8f52-25afce818fda" xlink:to="loc_abvx_EmployeeMember_7c763109-c01b-4b09-aa2c-7523378e16e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_662810ba-545e-46f7-9b24-49fc4079afdc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_srt_RangeAxis_662810ba-545e-46f7-9b24-49fc4079afdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_037a1999-15dc-4c8e-a144-3ed9c3be5128" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_662810ba-545e-46f7-9b24-49fc4079afdc" xlink:to="loc_srt_RangeMember_037a1999-15dc-4c8e-a144-3ed9c3be5128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b871fec6-66ea-461a-93cf-0e3358794b2c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_037a1999-15dc-4c8e-a144-3ed9c3be5128" xlink:to="loc_srt_MaximumMember_b871fec6-66ea-461a-93cf-0e3358794b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4ce59014-ac87-4b9b-85ac-a2a9e89386d3" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_7340df83-3fed-4680-b007-78239a2f2893" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage_7340df83-3fed-4680-b007-78239a2f2893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_def0c44c-a7fb-46c8-a3ea-8255d2b71128" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_def0c44c-a7fb-46c8-a3ea-8255d2b71128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth_3291b55e-44d2-41ab-a791-8b4b45bceba0" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth_3291b55e-44d2-41ab-a791-8b4b45bceba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing_a1c4aba0-f112-4208-8e13-af0f3d8755c0" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing_a1c4aba0-f112-4208-8e13-af0f3d8755c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold_7d0fe689-bc2b-45b9-b237-33bc4259a359" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold_7d0fe689-bc2b-45b9-b237-33bc4259a359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2b720642-6dcd-4a4e-bfb2-e2b27bc69e99" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2b720642-6dcd-4a4e-bfb2-e2b27bc69e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod_c3337f34-0bb2-45cb-9385-d54f7d95942f" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod_c3337f34-0bb2-45cb-9385-d54f7d95942f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare_f3caffe3-2682-40cc-b1fd-7c64d610c5f8" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare_f3caffe3-2682-40cc-b1fd-7c64d610c5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_128701bc-55b2-42e4-bc13-2ae9a772e978" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_128701bc-55b2-42e4-bc13-2ae9a772e978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_c6d0dc6e-e16f-4069-8b03-f133e7314d39" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_c6d0dc6e-e16f-4069-8b03-f133e7314d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod_61e79c0b-b9dc-4da6-867e-50d8f77f8aa3" xlink:href="abvx-20241231.xsd#abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod_61e79c0b-b9dc-4da6-867e-50d8f77f8aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition_bd5ec50c-6807-45a2-8417-30da2a73879c" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0dfc53cb-7bc4-471d-99ce-d43291dc60d5" xlink:to="loc_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition_bd5ec50c-6807-45a2-8417-30da2a73879c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_1f077740-4431-45d8-afb1-258fb82d4eb8" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_62261d90-4f88-448e-bade-9d831497508d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_1f077740-4431-45d8-afb1-258fb82d4eb8" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_62261d90-4f88-448e-bade-9d831497508d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_d41dcabe-241c-40db-a787-143c057dc3c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_62261d90-4f88-448e-bade-9d831497508d" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_d41dcabe-241c-40db-a787-143c057dc3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5e48b829-7410-4473-9769-68ce676a9248" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_d41dcabe-241c-40db-a787-143c057dc3c0" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5e48b829-7410-4473-9769-68ce676a9248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5e48b829-7410-4473-9769-68ce676a9248" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA201511Member_0f34ac5b-5da3-4b44-b5c8-2fe0a559730f" xlink:href="abvx-20241231.xsd#abvx_BSA201511Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA201511Member_0f34ac5b-5da3-4b44-b5c8-2fe0a559730f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA201512Member_fb8503d5-8fcf-4248-8ecd-a9eb3a82755d" xlink:href="abvx-20241231.xsd#abvx_BSA201512Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA201512Member_fb8503d5-8fcf-4248-8ecd-a9eb3a82755d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20171Member_a4d25ea4-1817-45f6-9235-637365b82e38" xlink:href="abvx-20241231.xsd#abvx_BSA20171Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20171Member_a4d25ea4-1817-45f6-9235-637365b82e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20181Member_3c0d4ab1-f2a0-4ef5-b4f6-7d872569e43b" xlink:href="abvx-20241231.xsd#abvx_BSA20181Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20181Member_3c0d4ab1-f2a0-4ef5-b4f6-7d872569e43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20144Member_3ecc8a2c-e792-4cfc-ab8b-79dfdd600ee1" xlink:href="abvx-20241231.xsd#abvx_BSA20144Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20144Member_3ecc8a2c-e792-4cfc-ab8b-79dfdd600ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20145Member_cb509fba-d7ec-4245-bc20-1e6c206f7660" xlink:href="abvx-20241231.xsd#abvx_BSA20145Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20145Member_cb509fba-d7ec-4245-bc20-1e6c206f7660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241Member_d8799c05-35f7-46b3-b8f1-953c07f11fef" xlink:href="abvx-20241231.xsd#abvx_BSA20241Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20241Member_d8799c05-35f7-46b3-b8f1-953c07f11fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20242Member_3e4192f7-902d-4558-a25f-90fe7a7de3e3" xlink:href="abvx-20241231.xsd#abvx_BSA20242Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareSubscriptionWarrantsBSAMember_979bb7d7-44fb-496d-819f-b60157b53738" xlink:to="loc_abvx_BSA20242Member_3e4192f7-902d-4558-a25f-90fe7a7de3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_62261d90-4f88-448e-bade-9d831497508d" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_86ea9f05-336d-42f7-a09f-6c0b26ff4d8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_86ea9f05-336d-42f7-a09f-6c0b26ff4d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_c1abe380-db05-4dac-972a-57167715b1ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_c1abe380-db05-4dac-972a-57167715b1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_b7930b4b-6bfb-471c-b269-667e39782757" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_b7930b4b-6bfb-471c-b269-667e39782757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_331fed40-307d-4b08-9276-3768f0beb9e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_331fed40-307d-4b08-9276-3768f0beb9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_c7b89e06-7fea-4477-9d79-40b51cc03e8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_c7b89e06-7fea-4477-9d79-40b51cc03e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_4f956b57-7a7c-4016-9a71-b1c4a12ebf5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_4f956b57-7a7c-4016-9a71-b1c4a12ebf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_90f95823-26e6-4b89-bed1-a6407e0dda69" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_bde802af-3ed9-48a3-acec-bd9ee664b77b" xlink:to="loc_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet_90f95823-26e6-4b89-bed1-a6407e0dda69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e14d45d0-82b9-4407-81af-49121e66f6c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e14d45d0-82b9-4407-81af-49121e66f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e14d45d0-82b9-4407-81af-49121e66f6c3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20241Member_ed541d9b-5d44-4dc2-9a10-b9bced162c2e" xlink:href="abvx-20241231.xsd#abvx_BSA20241Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:to="loc_abvx_BSA20241Member_ed541d9b-5d44-4dc2-9a10-b9bced162c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BSA20242Member_02969352-9b57-4e57-95a5-0e09166aa4df" xlink:href="abvx-20241231.xsd#abvx_BSA20242Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5ab9c69c-345e-4b60-8139-d73e8d8bc0f9" xlink:to="loc_abvx_BSA20242Member_02969352-9b57-4e57-95a5-0e09166aa4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_c3b42e52-63db-4090-8cd3-195ffde0a23c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:to="loc_ifrs-full_RangeAxis_c3b42e52-63db-4090-8cd3-195ffde0a23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_c3b42e52-63db-4090-8cd3-195ffde0a23c" xlink:to="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dc8c3342-749a-4a14-8233-fe8c515bb4af" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:to="loc_srt_MinimumMember_dc8c3342-749a-4a14-8233-fe8c515bb4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_77e44785-4610-4196-9e87-c60651f864bc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_e91f6dda-ccc6-4407-bbf1-c08c9e7a92db" xlink:to="loc_srt_MaximumMember_77e44785-4610-4196-9e87-c60651f864bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_3334cd69-0e97-4811-a477-2d69015f591f" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_648cc274-d069-4cd8-af3a-dcaa296d94e0" xlink:href="abvx-20241231.xsd#abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_648cc274-d069-4cd8-af3a-dcaa296d94e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_7f9fc7dd-5a47-402d-ad4c-126738741285" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_7f9fc7dd-5a47-402d-ad4c-126738741285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_9959d68d-075c-47c6-b4e1-94bfe1a1d5ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_9959d68d-075c-47c6-b4e1-94bfe1a1d5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_e34013e1-6b80-40d5-8514-8b77b58253da" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_e34013e1-6b80-40d5-8514-8b77b58253da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted_44de611c-1f0a-4ac1-8e92-bdbca1b239df" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted_44de611c-1f0a-4ac1-8e92-bdbca1b239df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_729fd23a-5950-4454-bb2d-e09d1e7db0aa" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_729fd23a-5950-4454-bb2d-e09d1e7db0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedMaturityOtherEquityInstrumentsGranted_5b9d5ead-eda7-4a17-94a5-b97cca4f997e" xlink:href="abvx-20241231.xsd#abvx_ExpectedMaturityOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_ExpectedMaturityOtherEquityInstrumentsGranted_5b9d5ead-eda7-4a17-94a5-b97cca4f997e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_ad466d10-7d46-4e15-a80b-cdb5c9e8cda0" xlink:href="abvx-20241231.xsd#abvx_ExpectedVolatilityOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_a4225dd7-c3a5-43a5-8fed-5f0152360cb8" xlink:to="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_ad466d10-7d46-4e15-a80b-cdb5c9e8cda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofreconciliationofAGAsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_3e51ed27-793c-4b47-98cb-5c82eddfbb87" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_5ca7ad67-6113-40aa-a74a-59917b84d9b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_3e51ed27-793c-4b47-98cb-5c82eddfbb87" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_5ca7ad67-6113-40aa-a74a-59917b84d9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_5ca7ad67-6113-40aa-a74a-59917b84d9b4" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_846c8d8f-083c-46f0-95ba-1ca2c4bd860f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8f71b8d0-b6d0-4e5f-a6f7-d7dc54a871c5" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_846c8d8f-083c-46f0-95ba-1ca2c4bd860f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:href="abvx-20241231.xsd#abvx_FreeSharesAGAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_846c8d8f-083c-46f0-95ba-1ca2c4bd860f" xlink:to="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20231Member_60b26eef-6c1c-46c1-bc6c-23aff09e4c7d" xlink:href="abvx-20241231.xsd#abvx_AGA20231Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20231Member_60b26eef-6c1c-46c1-bc6c-23aff09e4c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20232Member_adb41adf-ce9c-4ba6-8be2-8906611f6c37" xlink:href="abvx-20241231.xsd#abvx_AGA20232Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20232Member_adb41adf-ce9c-4ba6-8be2-8906611f6c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233Member_739f012b-5981-4ae7-8d4d-9483d0f38eef" xlink:href="abvx-20241231.xsd#abvx_AGA20233Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20233Member_739f012b-5981-4ae7-8d4d-9483d0f38eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20234Member_f8a34576-2d2b-4914-92a5-27ed971411ad" xlink:href="abvx-20241231.xsd#abvx_AGA20234Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20234Member_f8a34576-2d2b-4914-92a5-27ed971411ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20235Member_707b4eac-6d63-4068-88ce-9299b902b855" xlink:href="abvx-20241231.xsd#abvx_AGA20235Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20235Member_707b4eac-6d63-4068-88ce-9299b902b855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241Member_fbf59037-67b0-4371-a225-183ca91bdf8b" xlink:href="abvx-20241231.xsd#abvx_AGA20241Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20241Member_fbf59037-67b0-4371-a225-183ca91bdf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20242Member_abd11b2f-c950-4f53-b287-2c9101b18ff4" xlink:href="abvx-20241231.xsd#abvx_AGA20242Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20242Member_abd11b2f-c950-4f53-b287-2c9101b18ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20243Member_ed3e483f-7173-40b4-8c2d-9bff2a6237e0" xlink:href="abvx-20241231.xsd#abvx_AGA20243Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20243Member_ed3e483f-7173-40b4-8c2d-9bff2a6237e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244Member_4b7a816f-c734-46bc-89d2-1b92d8e234dc" xlink:href="abvx-20241231.xsd#abvx_AGA20244Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20244Member_4b7a816f-c734-46bc-89d2-1b92d8e234dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20245Member_52484f26-353c-4d18-84d1-cb8257bd49ac" xlink:href="abvx-20241231.xsd#abvx_AGA20245Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20245Member_52484f26-353c-4d18-84d1-cb8257bd49ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_3c7c53dc-1fa3-4fe2-bad3-451b12e4b48f" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20246Member_3c7c53dc-1fa3-4fe2-bad3-451b12e4b48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20247Member_0be8b730-af0a-4cd3-87b1-c1517abe05d3" xlink:href="abvx-20241231.xsd#abvx_AGA20247Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FreeSharesAGAMember_e97bdfc4-f7b5-444d-be9c-1e3b9e271890" xlink:to="loc_abvx_AGA20247Member_0be8b730-af0a-4cd3-87b1-c1517abe05d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_5ca7ad67-6113-40aa-a74a-59917b84d9b4" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_10ad5140-c3a0-46f5-bb3a-39a73d3d682b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_10ad5140-c3a0-46f5-bb3a-39a73d3d682b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_839c040f-8388-41e2-a778-e0ec87ce8389" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_839c040f-8388-41e2-a778-e0ec87ce8389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_e12af140-8f73-482a-9e1c-3ce2dea69c7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_e12af140-8f73-482a-9e1c-3ce2dea69c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_5c3d070d-a49b-4e34-b96e-df208239d8ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_5c3d070d-a49b-4e34-b96e-df208239d8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_a751a1c7-2433-4433-8da0-80546198cd10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6274fd4d-1c25-4a46-9a11-0cb20b62306b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_a751a1c7-2433-4433-8da0-80546198cd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_5c940310-b4e7-4096-ba10-cd3e68e86e03" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_5c940310-b4e7-4096-ba10-cd3e68e86e03" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_743760ad-8ff2-445b-a6f9-55db5004330f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_743760ad-8ff2-445b-a6f9-55db5004330f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_743760ad-8ff2-445b-a6f9-55db5004330f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA2021Member_b0291167-6f81-4a2f-a1bb-e48525653a0a" xlink:href="abvx-20241231.xsd#abvx_AGA2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA2021Member_b0291167-6f81-4a2f-a1bb-e48525653a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20231Member_919cc720-2abc-40ee-ac78-0e168bc91c25" xlink:href="abvx-20241231.xsd#abvx_AGA20231Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20231Member_919cc720-2abc-40ee-ac78-0e168bc91c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20232Member_26cec586-6df5-4124-89cd-2a10672a7ad5" xlink:href="abvx-20241231.xsd#abvx_AGA20232Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20232Member_26cec586-6df5-4124-89cd-2a10672a7ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20233Member_40c564c2-c09f-420a-9345-e4a958785b38" xlink:href="abvx-20241231.xsd#abvx_AGA20233Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20233Member_40c564c2-c09f-420a-9345-e4a958785b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20234Member_4117b272-85f2-4deb-bc3c-3d90fb45bfc2" xlink:href="abvx-20241231.xsd#abvx_AGA20234Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20234Member_4117b272-85f2-4deb-bc3c-3d90fb45bfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20235Member_070edb76-2675-4361-90a6-f0955a8d4505" xlink:href="abvx-20241231.xsd#abvx_AGA20235Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20235Member_070edb76-2675-4361-90a6-f0955a8d4505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20241Member_b34a80a4-010f-444d-9503-f290099c2955" xlink:href="abvx-20241231.xsd#abvx_AGA20241Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20241Member_b34a80a4-010f-444d-9503-f290099c2955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20242Member_a14efb12-2eac-4bae-8abe-24f04938fe19" xlink:href="abvx-20241231.xsd#abvx_AGA20242Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20242Member_a14efb12-2eac-4bae-8abe-24f04938fe19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20243Member_b233ca2e-249c-4286-a3b4-f308d56a1f18" xlink:href="abvx-20241231.xsd#abvx_AGA20243Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20243Member_b233ca2e-249c-4286-a3b4-f308d56a1f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20244Member_817891c4-175a-4469-97c1-c368197d2963" xlink:href="abvx-20241231.xsd#abvx_AGA20244Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20244Member_817891c4-175a-4469-97c1-c368197d2963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20245Member_fdf308b3-0874-493b-8797-610974050c42" xlink:href="abvx-20241231.xsd#abvx_AGA20245Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20245Member_fdf308b3-0874-493b-8797-610974050c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20246Member_6c709358-e437-4783-bb86-d5232584c282" xlink:href="abvx-20241231.xsd#abvx_AGA20246Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20246Member_6c709358-e437-4783-bb86-d5232584c282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AGA20247Member_9c21cab4-5357-4422-9f56-fd638940fd82" xlink:href="abvx-20241231.xsd#abvx_AGA20247Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_7034fae8-ed5b-4de0-ba19-e6cb72177146" xlink:to="loc_abvx_AGA20247Member_9c21cab4-5357-4422-9f56-fd638940fd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:to="loc_abvx_TranchesAxis_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesAxis_8af6609c-a0b7-47e0-9ecf-4700f3ed8ab2" xlink:to="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesOneToFourMember_c1ca2fda-6cce-4065-801d-152a02eec3dd" xlink:href="abvx-20241231.xsd#abvx_TranchesOneToFourMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TranchesOneToFourMember_c1ca2fda-6cce-4065-801d-152a02eec3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheFiveMember_14db4d58-03ac-4a57-8be4-5b0c347fe5ea" xlink:href="abvx-20241231.xsd#abvx_TrancheFiveMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheFiveMember_14db4d58-03ac-4a57-8be4-5b0c347fe5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheSixMember_10fbce2c-1aa2-4762-a6c1-2e486993e18d" xlink:href="abvx-20241231.xsd#abvx_TrancheSixMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheSixMember_10fbce2c-1aa2-4762-a6c1-2e486993e18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheOneMember_8de37559-555e-4843-a48f-197d1f339406" xlink:href="abvx-20241231.xsd#abvx_TrancheOneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheOneMember_8de37559-555e-4843-a48f-197d1f339406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheTwoMember_59e71097-7536-4f45-841d-f0c238c6cf25" xlink:href="abvx-20241231.xsd#abvx_TrancheTwoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_ea388b15-08b3-4882-8480-6717c3d343df" xlink:to="loc_abvx_TrancheTwoMember_59e71097-7536-4f45-841d-f0c238c6cf25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ab4e9668-e57f-43af-88ae-98344697b33f" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_c438a33e-4502-4435-9d6f-56f5ad38bb39" xlink:href="abvx-20241231.xsd#abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted_c438a33e-4502-4435-9d6f-56f5ad38bb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_5e3e5295-7d59-409e-938d-b04d9af57bb0" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted_5e3e5295-7d59-409e-938d-b04d9af57bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_b9b5f71c-fdc1-4425-ba07-3c03e6c6342e" xlink:href="abvx-20241231.xsd#abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted_b9b5f71c-fdc1-4425-ba07-3c03e6c6342e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_1cf8294a-3c8c-45e2-bd11-568520090038" xlink:href="abvx-20241231.xsd#abvx_ExpectedVolatilityOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted_1cf8294a-3c8c-45e2-bd11-568520090038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_956abdc7-0a44-45d0-9a50-c89082be65a5" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_12b79a58-922e-421e-bd57-1fc4f481eb2b" xlink:to="loc_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted_956abdc7-0a44-45d0-9a50-c89082be65a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareBasedPaymentArrangementsAbstract_96f20f51-bfb9-4353-81bb-1b5654ddef37" xlink:href="abvx-20241231.xsd#abvx_ShareBasedPaymentArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_83ce781f-12b1-4ccf-a683-89d8ff46bff3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ShareBasedPaymentArrangementsAbstract_96f20f51-bfb9-4353-81bb-1b5654ddef37" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_83ce781f-12b1-4ccf-a683-89d8ff46bff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c262fa5c-853b-4d13-884b-3767e34497a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_83ce781f-12b1-4ccf-a683-89d8ff46bff3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c262fa5c-853b-4d13-884b-3767e34497a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c262fa5c-853b-4d13-884b-3767e34497a6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_dbb84f6c-9d2d-4174-a9ac-511737e03731" xlink:href="abvx-20241231.xsd#abvx_FoundersShareSubscriptionWarrantsBCEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:to="loc_abvx_FoundersShareSubscriptionWarrantsBCEMember_dbb84f6c-9d2d-4174-a9ac-511737e03731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ShareSubscriptionWarrantsBSAMember_2bece2fa-04fe-41ab-8f81-2f6f23eb5682" xlink:href="abvx-20241231.xsd#abvx_ShareSubscriptionWarrantsBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:to="loc_abvx_ShareSubscriptionWarrantsBSAMember_2bece2fa-04fe-41ab-8f81-2f6f23eb5682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FreeSharesAGAMember_79e3e43c-1871-4d24-856b-636e52a312f9" xlink:href="abvx-20241231.xsd#abvx_FreeSharesAGAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ab80817f-7013-4706-bf19-869caac54a82" xlink:to="loc_abvx_FreeSharesAGAMember_79e3e43c-1871-4d24-856b-636e52a312f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_83ce781f-12b1-4ccf-a683-89d8ff46bff3" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_54e4f7ed-94ca-464e-8d5f-6a637fa48c4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_54e4f7ed-94ca-464e-8d5f-6a637fa48c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_647e8b4f-1978-4f55-a4b1-886da3e186a0" xlink:href="abvx-20241231.xsd#abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:to="loc_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes_647e8b4f-1978-4f55-a4b1-886da3e186a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_87d19ad2-d49d-47d5-8b70-cfe05cc41ece" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7be051cf-f56e-46db-b971-bfa013b264a8" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_87d19ad2-d49d-47d5-8b70-cfe05cc41ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_1b4736a4-bc61-43a3-9fe0-6f2f0fdc0c4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d175e812-e333-44f1-8073-bcae13dbc943" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_1b4736a4-bc61-43a3-9fe0-6f2f0fdc0c4a" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d175e812-e333-44f1-8073-bcae13dbc943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_64410de0-25fa-4389-983d-847baf51dfab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d175e812-e333-44f1-8073-bcae13dbc943" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_64410de0-25fa-4389-983d-847baf51dfab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_64410de0-25fa-4389-983d-847baf51dfab" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:href="abvx-20241231.xsd#abvx_BorrowingsByNameMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_9d696f7f-f560-4d68-9cda-020fded228c0" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_abvx_Kreos12BondLoansMember_9d696f7f-f560-4d68-9cda-020fded228c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ClaretBondLoansMember_d8e50d4b-5554-428e-8d28-d92685d442d8" xlink:href="abvx-20241231.xsd#abvx_Kreos1ClaretBondLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_abvx_Kreos1ClaretBondLoansMember_d8e50d4b-5554-428e-8d28-d92685d442d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_fe30982f-01d2-44f9-908d-edf9589df72e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_fe30982f-01d2-44f9-908d-edf9589df72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_337fba63-0ac1-4bb6-9e08-575d9db5635d" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_BorrowingsByNameMember_f0148b21-8ad7-4a9a-984c-101178c810f7" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_337fba63-0ac1-4bb6-9e08-575d9db5635d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_44f3c37b-4b39-41e6-9f77-da6c1b1355ee" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_44f3c37b-4b39-41e6-9f77-da6c1b1355ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_467f7aec-c96c-49c1-a2dd-011ea236061f" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:to="loc_abvx_OCEANEMember_467f7aec-c96c-49c1-a2dd-011ea236061f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_cda85a63-0c70-487a-ad38-54cd636382c9" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_ConvertibleLoansNotesMember_84801ced-4108-4fcd-a550-09d67a7b5d2a" xlink:to="loc_abvx_HeightsConvertibleNotesMember_cda85a63-0c70-487a-ad38-54cd636382c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_65d03384-225f-4c29-b983-1f1b460ee19d" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_Kreos1Member_65d03384-225f-4c29-b983-1f1b460ee19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_dec75f84-72fc-4339-8f5d-f66a7cc2261b" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_OceaneConversionOptionMember_dec75f84-72fc-4339-8f5d-f66a7cc2261b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_744791ee-085d-4707-b810-68aa470db106" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_744791ee-085d-4707-b810-68aa470db106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingBSAMember_8b36f22e-9f87-4580-a99d-1bd03e17cf69" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingBSAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DerivativesMember_53482c73-3bc4-49bc-bde6-a003aebcf094" xlink:to="loc_abvx_KreosClaretFinancingBSAMember_8b36f22e-9f87-4580-a99d-1bd03e17cf69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4a863475-ebd9-4179-9da8-49c8e999e9d7" xlink:to="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesMember_c5fbc75f-1cb7-4b46-8c03-d780e6b2b3cc" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:to="loc_abvx_ConditionalAdvancesMember_c5fbc75f-1cb7-4b46-8c03-d780e6b2b3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_772b8e72-76ef-42f0-bd1e-d59947aea8ef" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_OtherFinancialLiabilitiesMember_2de600b7-ff02-4c6d-9a43-2f2fe50e93d1" xlink:to="loc_abvx_RoyaltyCertificatesMember_772b8e72-76ef-42f0-bd1e-d59947aea8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d175e812-e333-44f1-8073-bcae13dbc943" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialLiabilities_74a9a7ba-6136-4a62-95dc-11820d31c220" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:to="loc_ifrs-full_NoncurrentFinancialLiabilities_74a9a7ba-6136-4a62-95dc-11820d31c220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialLiabilities_29184dd7-c9d4-4357-9e20-64003b020d2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:to="loc_ifrs-full_CurrentFinancialLiabilities_29184dd7-c9d4-4357-9e20-64003b020d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_9978c819-3b79-4761-8066-c858ffa38957" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_af959249-e11d-4ee5-86c2-46e4287e37f9" xlink:to="loc_ifrs-full_FinancialLiabilities_9978c819-3b79-4761-8066-c858ffa38957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesKreosClaretFinancingDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_e717d9a1-7620-41fb-aff8-0eb68b3ff4b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_e717d9a1-7620-41fb-aff8-0eb68b3ff4b8" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_69175095-2b6a-4f0b-8c97-9819b376b09d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_69175095-2b6a-4f0b-8c97-9819b376b09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_69175095-2b6a-4f0b-8c97-9819b376b09d" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:to="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_9fa490d2-400e-4722-884c-8d6d623f08c2" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_9fa490d2-400e-4722-884c-8d6d623f08c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_KreosClaretFinancingMember_3d405b02-606e-46a9-9290-4c5cdb89ac90" xlink:to="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_ab361980-a16e-4993-bb3d-69f8ba7d0dc7" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_ab361980-a16e-4993-bb3d-69f8ba7d0dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheCMember_f6b6e91c-3d42-4605-a361-9fd45fd81051" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_84a54b9d-4c04-4c25-8b28-9f7856cecf30" xlink:to="loc_abvx_KreosClaretFinancingTrancheCMember_f6b6e91c-3d42-4605-a361-9fd45fd81051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1BondLoansMember_1c113d7e-cea3-4622-ad7c-c6d177cf33f6" xlink:href="abvx-20241231.xsd#abvx_Kreos1BondLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_93ecfa52-972f-471b-af9f-be810010529f" xlink:to="loc_abvx_Kreos1BondLoansMember_1c113d7e-cea3-4622-ad7c-c6d177cf33f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_2886855f-b780-45d4-8c08-2bd7efeb047b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_2886855f-b780-45d4-8c08-2bd7efeb047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_4bf490e8-cd10-44dd-8afc-0cc11f82c829" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_2886855f-b780-45d4-8c08-2bd7efeb047b" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_4bf490e8-cd10-44dd-8afc-0cc11f82c829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuropeanCentralBankBaseRateMember_f35b5593-cca8-41b5-85a9-35b3a00e6710" xlink:href="abvx-20241231.xsd#abvx_EuropeanCentralBankBaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_4bf490e8-cd10-44dd-8afc-0cc11f82c829" xlink:to="loc_abvx_EuropeanCentralBankBaseRateMember_f35b5593-cca8-41b5-85a9-35b3a00e6710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_b15006aa-26c6-40dd-9e37-2282065825ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_RangeAxis_b15006aa-26c6-40dd-9e37-2282065825ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_b15006aa-26c6-40dd-9e37-2282065825ae" xlink:to="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_4c7a764c-7f6f-429f-91ba-c7897a5fde7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:to="loc_ifrs-full_BottomOfRangeMember_4c7a764c-7f6f-429f-91ba-c7897a5fde7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_6359b0ed-912d-4378-aee5-191c523db89f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_0fd72f13-d642-4e08-802b-7d3e61cd3dd1" xlink:to="loc_ifrs-full_TopOfRangeMember_6359b0ed-912d-4378-aee5-191c523db89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_c654fa03-9602-4089-82b3-b4677c401f24" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_abvx_WarrantsAxis_c654fa03-9602-4089-82b3-b4677c401f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsAxis_c654fa03-9602-4089-82b3-b4677c401f24" xlink:to="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_d1b04a48-9b0d-4fdf-8b62-8a5959f5279e" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:to="loc_abvx_KreosABBSAMember_d1b04a48-9b0d-4fdf-8b62-8a5959f5279e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_646b639b-981e-401f-afc0-35a05672d596" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:to="loc_abvx_KreosCBSAMember_646b639b-981e-401f-afc0-35a05672d596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABCBSAMember_a33c8210-0e4e-491a-a1c4-e69a11fc0bc8" xlink:href="abvx-20241231.xsd#abvx_KreosABCBSAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_d04db3d3-a77b-4723-87d8-588daccbc5a1" xlink:to="loc_abvx_KreosABCBSAMember_a33c8210-0e4e-491a-a1c4-e69a11fc0bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_84760d92-b12d-4959-8f4c-8b33c4040c60" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_UnobservableInputsAxis_84760d92-b12d-4959-8f4c-8b33c4040c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_84760d92-b12d-4959-8f4c-8b33c4040c60" xlink:to="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MarketRateMeasurementInputMember_7be2618f-a5cc-4639-8f8b-c062c0a0c1c6" xlink:href="abvx-20241231.xsd#abvx_MarketRateMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_MarketRateMeasurementInputMember_7be2618f-a5cc-4639-8f8b-c062c0a0c1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_f3c0571e-ba6e-43f9-90da-bd37c650f5a7" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_SharePriceMeasurementInputMember_f3c0571e-ba6e-43f9-90da-bd37c650f5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_a2b9b798-70e1-4969-8e73-d661c8f7a922" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_a2b9b798-70e1-4969-8e73-d661c8f7a922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_36d4e825-915b-4350-a889-e8a14b643065" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_36d4e825-915b-4350-a889-e8a14b643065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_0c1a5440-6f8f-422c-80f4-701e6ac6eeb2" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_0c1a5440-6f8f-422c-80f4-701e6ac6eeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountRateMeasurementInputMember_88778168-9cb2-4392-ad3f-ca6e2d1d4bc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountRateMeasurementInputMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_ifrs-full_DiscountRateMeasurementInputMember_88778168-9cb2-4392-ad3f-ca6e2d1d4bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_81c1a684-56ed-4d88-b136-6b0fe7f6e81c" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioProbablityMeasurementInputMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_7d3f7a17-3f27-401c-8417-16b4124fb3af" xlink:to="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_81c1a684-56ed-4d88-b136-6b0fe7f6e81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f9805673-bf12-4c9d-ae6f-f6de76f4e51e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f9805673-bf12-4c9d-ae6f-f6de76f4e51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f9805673-bf12-4c9d-ae6f-f6de76f4e51e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_7d3f8c88-e93f-42f8-a382-aba09c34e9ed" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosABBSAMember_7d3f8c88-e93f-42f8-a382-aba09c34e9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_43812906-9a51-4e36-9556-843fa967f273" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosCBSAMember_43812906-9a51-4e36-9556-843fa967f273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABCBSAMember_ae1cf58f-7186-49f2-98d9-21d6efee5b2d" xlink:href="abvx-20241231.xsd#abvx_KreosABCBSAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosABCBSAMember_ae1cf58f-7186-49f2-98d9-21d6efee5b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_62344c8a-ad36-41ed-9efc-5b2c9bf27d0a" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_015a9a55-c083-4196-a13b-4b56e12177a1" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_62344c8a-ad36-41ed-9efc-5b2c9bf27d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_1241143a-243a-4d82-9265-8df959afe221" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_1241143a-243a-4d82-9265-8df959afe221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_1241143a-243a-4d82-9265-8df959afe221" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BlackScholesModelMember_d0b6c430-cbec-428a-b64a-16fdae0c6e3b" xlink:href="abvx-20241231.xsd#abvx_BlackScholesModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:to="loc_abvx_BlackScholesModelMember_d0b6c430-cbec-428a-b64a-16fdae0c6e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModel1Member_290a2d47-df15-47ef-bb36-77765f2beba2" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModel1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_debe46f0-87b3-422a-b5e3-b9865b78354b" xlink:to="loc_abvx_MonteCarloModel1Member_290a2d47-df15-47ef-bb36-77765f2beba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5ad40e31-6bef-4a3d-ba5b-2c8a8428df4a" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_e05c7018-525b-4e8e-8770-83d180184f44" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_e05c7018-525b-4e8e-8770-83d180184f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_217ccee7-4ea1-4cb5-81a4-971df1a3c537" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsNumberOfTranches_217ccee7-4ea1-4cb5-81a4-971df1a3c537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_690b3361-6d5f-4ecf-8aba-ff105c5d7670" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacityPerTranche"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_690b3361-6d5f-4ecf-8aba-ff105c5d7670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_5642054c-82ea-447c-9a13-1788d1326ba9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_5642054c-82ea-447c-9a13-1788d1326ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsFixedConversionPrice_3e16bb02-740e-4bce-8ae4-7fbbb625fac0" xlink:href="abvx-20241231.xsd#abvx_BorrowingsFixedConversionPrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsFixedConversionPrice_3e16bb02-740e-4bce-8ae4-7fbbb625fac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_b91e2f4e-90b3-40cd-a827-896a14a36cf3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_BorrowingsInterestRate_b91e2f4e-90b3-40cd-a827-896a14a36cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsEarlyRepaymentDiscountRate_a9a1c758-c4e5-467c-a63f-1fa6ef545607" xlink:href="abvx-20241231.xsd#abvx_BorrowingsEarlyRepaymentDiscountRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsEarlyRepaymentDiscountRate_a9a1c758-c4e5-467c-a63f-1fa6ef545607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentage_b8d94119-f0d5-4755-99e9-c6408cf9e168" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsExitFeePercentage_b8d94119-f0d5-4755-99e9-c6408cf9e168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsDebtToMarketCapitalizationRatio_3a1ee2d7-eac1-4e2f-b456-4b812d294a63" xlink:href="abvx-20241231.xsd#abvx_BorrowingsDebtToMarketCapitalizationRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsDebtToMarketCapitalizationRatio_3a1ee2d7-eac1-4e2f-b456-4b812d294a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsPerformanceConditionsMinimumFinancing_f2d7cdf8-3c8c-4872-8879-9ad80fb3352c" xlink:href="abvx-20241231.xsd#abvx_BorrowingsPerformanceConditionsMinimumFinancing"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsPerformanceConditionsMinimumFinancing_f2d7cdf8-3c8c-4872-8879-9ad80fb3352c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_54504e0f-7cc7-4193-86f8-0e2d9da3313d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_54504e0f-7cc7-4193-86f8-0e2d9da3313d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsBasisInterestRate_de158ebb-3d1c-42b9-924d-0ec68f91ea74" xlink:href="abvx-20241231.xsd#abvx_BorrowingsBasisInterestRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_BorrowingsBasisInterestRate_de158ebb-3d1c-42b9-924d-0ec68f91ea74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_64785559-025b-4c94-9655-78372ccc839e" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsSubscriptionPricePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_64785559-025b-4c94-9655-78372ccc839e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsGranted_de87a851-cd04-4500-a03c-6259c9d052d9" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsGranted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_NumberOfWarrantsGranted_de87a851-cd04-4500-a03c-6259c9d052d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_3be1745f-cea2-487e-8100-b98a728a5f15" xlink:href="abvx-20241231.xsd#abvx_ExercisePriceOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_3be1745f-cea2-487e-8100-b98a728a5f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_acc3ebde-cecf-4b62-9e6c-5ff394a58c27" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_acc3ebde-cecf-4b62-9e6c-5ff394a58c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_5170ae0a-372d-45c4-9254-78e5bae4ec54" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_5170ae0a-372d-45c4-9254-78e5bae4ec54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfOtherShareWarrants_c1751cfd-7562-4436-ac13-71ae1e70a683" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfOtherShareWarrants"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_IssuanceOfOtherShareWarrants_c1751cfd-7562-4436-ac13-71ae1e70a683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately_87823fff-9ff4-44d4-b55d-f1e99f5a79df" xlink:href="abvx-20241231.xsd#abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately_87823fff-9ff4-44d4-b55d-f1e99f5a79df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable_068e4c55-e0e9-470b-bc0d-e8abca94c4f9" xlink:href="abvx-20241231.xsd#abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable_068e4c55-e0e9-470b-bc0d-e8abca94c4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsExercisePeriod_938baf67-1b63-4867-bc4d-c5b7d156cb4e" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsExercisePeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_OtherShareWarrantsExercisePeriod_938baf67-1b63-4867-bc4d-c5b7d156cb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfBondLoans_f962e0b3-3146-4527-8ed9-4f8a78e0f01f" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfBondLoans"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_RepaymentsOfBondLoans_f962e0b3-3146-4527-8ed9-4f8a78e0f01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_76c7a1e5-fd68-44a4-ad5b-fb2649aaef2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_76c7a1e5-fd68-44a4-ad5b-fb2649aaef2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_8eee8805-557a-4548-9fe7-bfb55094722d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_8eee8805-557a-4548-9fe7-bfb55094722d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_06db1897-ff8e-4288-80ef-455b453aa628" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ConvertibleLoansNotes_06db1897-ff8e-4288-80ef-455b453aa628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent_fd9dfcd2-4be9-46e1-9b45-f3e5215b68dd" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent_fd9dfcd2-4be9-46e1-9b45-f3e5215b68dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_bd8478b3-9536-4756-a1cc-cefcbee378f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_bd8478b3-9536-4756-a1cc-cefcbee378f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_69071353-79a9-4e82-9ade-bac4e9a1cfb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_69071353-79a9-4e82-9ade-bac4e9a1cfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a6626045-6a74-4726-9e3a-9b4d3e157f61" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a6626045-6a74-4726-9e3a-9b4d3e157f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_786a6278-5a7c-4a81-9da7-7e8094957932" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_786a6278-5a7c-4a81-9da7-7e8094957932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_096b0c66-ff1c-46b5-98b0-8909ce5b0604" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ea607143-5283-4e70-b5a1-13cfd7fc4e81" xlink:to="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_096b0c66-ff1c-46b5-98b0-8909ce5b0604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_a5ba94f5-87d5-4b97-943b-f8ace655c3a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_a5ba94f5-87d5-4b97-943b-f8ace655c3a4" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_9012c928-0486-4467-a4ef-0946a4f053a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_9012c928-0486-4467-a4ef-0946a4f053a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_95d22a16-2227-4a94-8b04-85fe2a353a2a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_9012c928-0486-4467-a4ef-0946a4f053a5" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_95d22a16-2227-4a94-8b04-85fe2a353a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_47eb46f1-d0e9-4a40-a596-c0e9135b6818" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_95d22a16-2227-4a94-8b04-85fe2a353a2a" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_47eb46f1-d0e9-4a40-a596-c0e9135b6818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_f3153a57-a360-4cf6-aca2-00f57c69973d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_ifrs-full_UnobservableInputsAxis_f3153a57-a360-4cf6-aca2-00f57c69973d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_f3153a57-a360-4cf6-aca2-00f57c69973d" xlink:to="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_53918e9f-1767-45d7-8a2b-f4c708fc37b4" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember_53918e9f-1767-45d7-8a2b-f4c708fc37b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MinimalReturnMeasurementInputMember_4a213c60-941c-4c34-99ea-58a4d9990df3" xlink:href="abvx-20241231.xsd#abvx_MinimalReturnMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_MinimalReturnMeasurementInputMember_4a213c60-941c-4c34-99ea-58a4d9990df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountRateMeasurementInputMember_fbbaf965-632b-4aa9-a2e6-ecc249c86488" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountRateMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_ifrs-full_DiscountRateMeasurementInputMember_fbbaf965-632b-4aa9-a2e6-ecc249c86488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_c8d39d85-6580-4669-bfe8-48c71cb301e1" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_c8d39d85-6580-4669-bfe8-48c71cb301e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_aea01368-73ac-409e-80b3-4cf2975aa10d" xlink:href="abvx-20241231.xsd#abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember_aea01368-73ac-409e-80b3-4cf2975aa10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember_20975133-fde8-4580-a94b-dbd5d66d8f83" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember_20975133-fde8-4580-a94b-dbd5d66d8f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember_98c01e13-8f3a-4346-91fd-237475d3b6d5" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember_98c01e13-8f3a-4346-91fd-237475d3b6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember_e6f9ab80-66e6-4b14-a443-38d5677ca111" xlink:href="abvx-20241231.xsd#abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember_e6f9ab80-66e6-4b14-a443-38d5677ca111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TenderOfferFairValueOfMRIMeasurementInputMember_2f3a8582-432d-40a9-bba7-aeead5dcc492" xlink:href="abvx-20241231.xsd#abvx_TenderOfferFairValueOfMRIMeasurementInputMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef5d8133-b80c-4281-9bab-f6d6d7293676" xlink:to="loc_abvx_TenderOfferFairValueOfMRIMeasurementInputMember_2f3a8582-432d-40a9-bba7-aeead5dcc492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_9f5721d4-e873-4631-bae3-33191772b81a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_9f5721d4-e873-4631-bae3-33191772b81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_413e7a90-3fc2-48bb-864f-008f1928f719" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_9f5721d4-e873-4631-bae3-33191772b81a" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_413e7a90-3fc2-48bb-864f-008f1928f719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmortizedCostEIRMethodMember_fe4d1958-7251-4076-8c16-72107e94ce6b" xlink:href="abvx-20241231.xsd#abvx_AmortizedCostEIRMethodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_413e7a90-3fc2-48bb-864f-008f1928f719" xlink:to="loc_abvx_AmortizedCostEIRMethodMember_fe4d1958-7251-4076-8c16-72107e94ce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesAxis_73219fc7-35a0-460f-ab3e-0f24b2177e6b" xlink:href="abvx-20241231.xsd#abvx_TranchesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_abvx_TranchesAxis_73219fc7-35a0-460f-ab3e-0f24b2177e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:href="abvx-20241231.xsd#abvx_TranchesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesAxis_73219fc7-35a0-460f-ab3e-0f24b2177e6b" xlink:to="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheBMember_d8970151-ea82-4724-a12e-bd01f0d1991c" xlink:href="abvx-20241231.xsd#abvx_TrancheBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:to="loc_abvx_TrancheBMember_d8970151-ea82-4724-a12e-bd01f0d1991c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TrancheCMember_93cba4bb-af4f-48aa-8be2-29f2198a1856" xlink:href="abvx-20241231.xsd#abvx_TrancheCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_TranchesDomain_954fdf6c-9878-4e65-93de-645e16b5c00e" xlink:to="loc_abvx_TrancheCMember_93cba4bb-af4f-48aa-8be2-29f2198a1856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_2e4d5ff4-8fad-4222-8f58-329b6237b892" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_e1670ee5-0b4a-435f-8a2d-621a06c4db35" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_e1670ee5-0b4a-435f-8a2d-621a06c4db35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_786ee173-99f4-47b4-b84c-43bddc127493" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueOtherEquityInstrumentsOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_285aa83b-4c29-472d-bff1-b75bf0c7203c" xlink:to="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_786ee173-99f4-47b4-b84c-43bddc127493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_058c18cb-665a-4208-8115-5349b00267dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_058c18cb-665a-4208-8115-5349b00267dc" xlink:to="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_abvx_WarrantsAxis_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsAxis_ee5cc538-4fcb-4a23-acc9-55c0ec2dc51d" xlink:to="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_e344ffb3-f655-4b53-a831-88248e0d93f7" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:to="loc_abvx_KreosABBSAMember_e344ffb3-f655-4b53-a831-88248e0d93f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_1cde1747-2c14-43b9-a157-f35058223382" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_940fdcd7-bcd3-445b-8179-078d6a9863d0" xlink:to="loc_abvx_KreosCBSAMember_1cde1747-2c14-43b9-a157-f35058223382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_503b78a6-eaad-4bc1-8a94-1498723c9780" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_503b78a6-eaad-4bc1-8a94-1498723c9780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_503b78a6-eaad-4bc1-8a94-1498723c9780" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_f29b962f-b6b2-4d57-a117-e6fd82a91c5b" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:to="loc_abvx_KreosABBSAMember_f29b962f-b6b2-4d57-a117-e6fd82a91c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosCBSAMember_f8eb9641-c0eb-4c3e-a360-de993e822806" xlink:href="abvx-20241231.xsd#abvx_KreosCBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_d80194bc-e138-4f05-a8a7-cfddcf469ce4" xlink:to="loc_abvx_KreosCBSAMember_f8eb9641-c0eb-4c3e-a360-de993e822806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a2d23215-b888-4940-a0fb-7b132ff18abd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_99c6b23b-46cb-48c2-b7f3-6d7a3a87d39b" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a2d23215-b888-4940-a0fb-7b132ff18abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionPricingModelMember_5b9ac776-6f8d-4a27-a6e9-40c34733e217" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionPricingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_a2d23215-b888-4940-a0fb-7b132ff18abd" xlink:to="loc_ifrs-full_OptionPricingModelMember_5b9ac776-6f8d-4a27-a6e9-40c34733e217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_5cc50547-34dd-41da-9129-c8824982ea76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_ifrs-full_UnobservableInputsAxis_5cc50547-34dd-41da-9129-c8824982ea76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_5cc50547-34dd-41da-9129-c8824982ea76" xlink:to="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePerShareMeasurementInputMember_f950a05c-4b89-47dd-b9e9-b77c9c2c1429" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePerShareMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_ExercisePricePerShareMeasurementInputMember_f950a05c-4b89-47dd-b9e9-b77c9c2c1429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_cf3d4223-ad85-4763-b9fe-e212b7f63e7a" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_SharePriceMeasurementInputMember_cf3d4223-ad85-4763-b9fe-e212b7f63e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_a8b3780b-2088-4550-acbf-5e8982d1cb0c" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioProbablityMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_ExpiryScenarioProbablityMeasurementInputMember_a8b3780b-2088-4550-acbf-5e8982d1cb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DrawdownProbablityMeasurementInputMember_832dec7b-9660-48f3-ac0c-450ef65d7cae" xlink:href="abvx-20241231.xsd#abvx_DrawdownProbablityMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_DrawdownProbablityMeasurementInputMember_832dec7b-9660-48f3-ac0c-450ef65d7cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VolatilityForSharesMeasurementInputExpiryMember_f396e457-516d-4fce-862f-e6e030b8eeda" xlink:href="abvx-20241231.xsd#abvx_VolatilityForSharesMeasurementInputExpiryMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_VolatilityForSharesMeasurementInputExpiryMember_f396e457-516d-4fce-862f-e6e030b8eeda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VolatilityForSharesMeasurementInputTenderOfferMember_44dc8a81-2ff3-4987-b88c-5b25dcc41757" xlink:href="abvx-20241231.xsd#abvx_VolatilityForSharesMeasurementInputTenderOfferMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_VolatilityForSharesMeasurementInputTenderOfferMember_44dc8a81-2ff3-4987-b88c-5b25dcc41757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_5f8ef073-d1e8-457f-8b03-3d001bf7a7a9" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_5f8ef073-d1e8-457f-8b03-3d001bf7a7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c288e840-52f3-4da4-9a38-5ca8bbd2d8b9" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c288e840-52f3-4da4-9a38-5ca8bbd2d8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputExpiryMember_c9bab364-aa99-4c99-bd02-4a3392bc89cc" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputExpiryMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputExpiryMember_c9bab364-aa99-4c99-bd02-4a3392bc89cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember_e7a8e64e-f9ed-4ae3-9f4d-6a2925ee8dd4" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_a8b0e85f-feb3-4c04-8fc8-2dac71eb47a9" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember_e7a8e64e-f9ed-4ae3-9f4d-6a2925ee8dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_be58ead8-bfbd-420a-88ab-772697a825e3" xlink:to="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfProbabilityWeightedScenarios_434a43b6-76b2-4498-8190-7da89aea05ec" xlink:href="abvx-20241231.xsd#abvx_NumberOfProbabilityWeightedScenarios"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_NumberOfProbabilityWeightedScenarios_434a43b6-76b2-4498-8190-7da89aea05ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_66d14cd6-0c53-4d9d-980b-4fab45ef7888" xlink:href="abvx-20241231.xsd#abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted_66d14cd6-0c53-4d9d-980b-4fab45ef7888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstanding_04e3c64e-ed52-417d-a58d-0a40bc0659b6" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_NumberOfWarrantsOutstanding_04e3c64e-ed52-417d-a58d-0a40bc0659b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition_6cdb0f16-d553-4f0f-937b-bea14701bc83" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition_6cdb0f16-d553-4f0f-937b-bea14701bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_7ea1983f-f223-4294-a9ff-de3acba4027a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_7ea1983f-f223-4294-a9ff-de3acba4027a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_9c13b37f-44e1-4144-ab14-1faf103fe5d3" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueOtherEquityInstrumentsOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_8f393420-2225-4afe-b1be-b25ce1b593b2" xlink:to="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_9c13b37f-44e1-4144-ab14-1faf103fe5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesHeightsconvertiblenotesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_30490612-9a43-4a3a-b1c0-0ac56f2c7d38" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_30490612-9a43-4a3a-b1c0-0ac56f2c7d38" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_2f202c37-f8d8-4b25-856e-032f70f0f1b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_2f202c37-f8d8-4b25-856e-032f70f0f1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_2f202c37-f8d8-4b25-856e-032f70f0f1b5" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:to="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheAMember_ea2d5bc1-096e-4c50-a5a6-1fdc0967764e" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheAMember_ea2d5bc1-096e-4c50-a5a6-1fdc0967764e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheBMember_b5dace9f-26b6-4af6-aa92-ccba8b014c4b" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_HeightsConvertibleNotesMember_c4dcf3b7-b38e-4bc2-8b00-337c6c0cb42b" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheBMember_b5dace9f-26b6-4af6-aa92-ccba8b014c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_6ea349ba-c671-4dac-894f-a7d437664a8e" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_a8c7332d-9ba8-4ad3-9de5-fc6335e3996b" xlink:to="loc_abvx_OCEANEMember_6ea349ba-c671-4dac-894f-a7d437664a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_caec35e8-cfb6-455a-b3af-f245c0588732" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_srt_RangeAxis_caec35e8-cfb6-455a-b3af-f245c0588732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_caec35e8-cfb6-455a-b3af-f245c0588732" xlink:to="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a0e8a4fd-3194-482c-bdb3-646dbaa947a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:to="loc_srt_MinimumMember_a0e8a4fd-3194-482c-bdb3-646dbaa947a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e9fe4c9-4a4c-41b4-9c3b-4ed65b500be5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_826d8fbf-1a73-4599-91ce-933673ad2230" xlink:to="loc_srt_MaximumMember_8e9fe4c9-4a4c-41b4-9c3b-4ed65b500be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_23ae012b-80a1-430a-abe6-dea882a1b69e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_23ae012b-80a1-430a-abe6-dea882a1b69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b72dbfce-d0de-4b4e-bc29-7cdb6ab35a95" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_23ae012b-80a1-430a-abe6-dea882a1b69e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b72dbfce-d0de-4b4e-bc29-7cdb6ab35a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheAMember_b710ff5c-d741-47fc-b788-daf2a81b90ab" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b72dbfce-d0de-4b4e-bc29-7cdb6ab35a95" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheAMember_b710ff5c-d741-47fc-b788-daf2a81b90ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_ifrs-full_UnobservableInputsAxis_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_dfdcdf66-ae96-42f1-8efd-6c3a1bc613f0" xlink:to="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9de196f9-e5f6-4432-b83d-bd4f0bb7362c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9de196f9-e5f6-4432-b83d-bd4f0bb7362c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_fbd45b87-c1ec-41ce-b1fb-35ee52652ac0" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_abvx_SharePriceMeasurementInputMember_fbd45b87-c1ec-41ce-b1fb-35ee52652ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_4be5f60e-ddac-43a8-bae0-d14a2bd76e34" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_4be5f60e-ddac-43a8-bae0-d14a2bd76e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_0d71d82e-5ab2-4f38-82d9-354463361134" xlink:href="abvx-20241231.xsd#abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4c3a6aba-394a-48d7-9812-7b711fd2c157" xlink:to="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_0d71d82e-5ab2-4f38-82d9-354463361134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9bd31bc7-cb37-4b41-97c5-33b137b63802" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_1f0f94b9-23a4-40eb-9a04-478270fdb9dc" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_1f0f94b9-23a4-40eb-9a04-478270fdb9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_edebfbce-495d-4f77-a65d-d7fa2bffd263" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsNumberOfTranches_edebfbce-495d-4f77-a65d-d7fa2bffd263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_8a5fd89f-8ca9-4c4e-96c5-5f2394c5bf75" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_8a5fd89f-8ca9-4c4e-96c5-5f2394c5bf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfConvertibleNotesIssued_54c89a60-425d-4e08-99fa-e585a9e7533a" xlink:href="abvx-20241231.xsd#abvx_NumberOfConvertibleNotesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_NumberOfConvertibleNotesIssued_54c89a60-425d-4e08-99fa-e585a9e7533a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesNominalValue_f505417b-d484-48a0-9325-e92d6e84e007" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesNominalValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesNominalValue_f505417b-d484-48a0-9325-e92d6e84e007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsFixedConversionPrice_14c7210e-029c-4fc2-ae2d-2352b1890b6d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsFixedConversionPrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsFixedConversionPrice_14c7210e-029c-4fc2-ae2d-2352b1890b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_49047de4-82b9-4a61-b6e0-5f1c53a29155" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted_49047de4-82b9-4a61-b6e0-5f1c53a29155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_76340ba5-1907-4f08-972a-4eb6487709eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_NotionalAmount_76340ba5-1907-4f08-972a-4eb6487709eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_1db53875-b6b8-4e0b-b64b-204f37d725dc" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted_1db53875-b6b8-4e0b-b64b-204f37d725dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesPeriod_8645bdef-9d94-4b82-8704-d58f0e0b7be8" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesPeriod_8645bdef-9d94-4b82-8704-d58f0e0b7be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesNumberOfSeparateClosings_609af2d4-ec0a-4512-a1cc-fa24a5747563" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesNumberOfSeparateClosings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesNumberOfSeparateClosings_609af2d4-ec0a-4512-a1cc-fa24a5747563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_6a69587e-86b2-4516-b3a5-82f5a1713fdb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_BorrowingsInterestRate_6a69587e-86b2-4516-b3a5-82f5a1713fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfQuarterlyInstallments_b0bd7766-da7e-4e18-bd2d-ef444af40da7" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfQuarterlyInstallments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsNumberOfQuarterlyInstallments_b0bd7766-da7e-4e18-bd2d-ef444af40da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityDeferralPeriod_86204555-41dc-4550-8fae-6c51c882fd45" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityDeferralPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMaturityDeferralPeriod_86204555-41dc-4550-8fae-6c51c882fd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsPercentageOfMarketPrice_248f76ae-7327-48d3-8944-63deb37d3b89" xlink:href="abvx-20241231.xsd#abvx_BorrowingsPercentageOfMarketPrice"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsPercentageOfMarketPrice_248f76ae-7327-48d3-8944-63deb37d3b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP_d93efa41-3f09-4065-a613-d93d62f973f8" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP_d93efa41-3f09-4065-a613-d93d62f973f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMarketPriceNumberOfTradingDays_fecbc034-ca84-4d2c-9afe-70aef334807b" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMarketPriceNumberOfTradingDays"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_BorrowingsMarketPriceNumberOfTradingDays_fecbc034-ca84-4d2c-9afe-70aef334807b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP_aec0c6a7-c3a4-48f9-ae22-21e303cc0604" xlink:href="abvx-20241231.xsd#abvx_IssuancePricePercentageOfDiscountTo15DayWVAP"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP_aec0c6a7-c3a4-48f9-ae22-21e303cc0604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_3a0b0182-7fc3-4071-b4d9-16d5ed31852f" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_3a0b0182-7fc3-4071-b4d9-16d5ed31852f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate_09443fdf-5e23-48a4-885d-b0bb8f33af1b" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate_09443fdf-5e23-48a4-885d-b0bb8f33af1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue_5658ed67-62b7-4904-a8d3-1edba48b52bc" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue_5658ed67-62b7-4904-a8d3-1edba48b52bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceCashCarveOut_3d1a5c26-d696-44fc-8652-c35b28fc3d31" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceCashCarveOut"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_EquityIssuanceCashCarveOut_3d1a5c26-d696-44fc-8652-c35b28fc3d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal_bdf6edcc-1fc3-4396-ab4f-2c126ca791ce" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal_bdf6edcc-1fc3-4396-ab4f-2c126ca791ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_d02f2a29-6f75-4a8a-8dfd-7e77d5986ba9" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_d02f2a29-6f75-4a8a-8dfd-7e77d5986ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_0ad0f2f9-938f-4e23-bbe2-199591da3528" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromRecognitionOfFinancialLiabilities"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_0ad0f2f9-938f-4e23-bbe2-199591da3528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnrecognitionDayOneGainOfFinancialLiabilities_fb989a46-c816-4ea8-bdf9-08e758430671" xlink:href="abvx-20241231.xsd#abvx_UnrecognitionDayOneGainOfFinancialLiabilities"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_UnrecognitionDayOneGainOfFinancialLiabilities_fb989a46-c816-4ea8-bdf9-08e758430671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3098a276-cd4d-40c9-955d-ddf60c12c908" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3098a276-cd4d-40c9-955d-ddf60c12c908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_b276c0c8-93e0-4a5d-acb3-e57e6db9ee5b" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_b276c0c8-93e0-4a5d-acb3-e57e6db9ee5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_4da6a8c4-3ae7-471a-94bd-5809601f1bc4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_c09afc39-1bb1-46f0-9def-020883423e9c" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_4da6a8c4-3ae7-471a-94bd-5809601f1bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_95843ba9-87c4-4fbd-868f-c3b1c7181d06" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_95843ba9-87c4-4fbd-868f-c3b1c7181d06" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7cf9a3eb-4013-479e-99fc-042c49a2b8a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7cf9a3eb-4013-479e-99fc-042c49a2b8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_145d04ec-7459-4d6c-9d7e-f180fb755ca1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7cf9a3eb-4013-479e-99fc-042c49a2b8a9" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_145d04ec-7459-4d6c-9d7e-f180fb755ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheAMember_945e10a8-a21b-4416-b15c-79ae286970e6" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_145d04ec-7459-4d6c-9d7e-f180fb755ca1" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheAMember_945e10a8-a21b-4416-b15c-79ae286970e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_9e344137-ed14-4cf9-bdb6-6bc077673e12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:to="loc_ifrs-full_UnobservableInputsAxis_9e344137-ed14-4cf9-bdb6-6bc077673e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_9e344137-ed14-4cf9-bdb6-6bc077673e12" xlink:to="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateMeasurementInputMember_93b565f6-468d-4910-af60-88582fbb1aeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_ifrs-full_InterestRateMeasurementInputMember_93b565f6-468d-4910-af60-88582fbb1aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPricePerShareMeasurementInputMember_51786f93-0b41-4e4a-adcb-4ee9dfde49d8" xlink:href="abvx-20241231.xsd#abvx_ConversionPricePerShareMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_ConversionPricePerShareMeasurementInputMember_51786f93-0b41-4e4a-adcb-4ee9dfde49d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_6723a5e4-d9e4-4704-93f2-67ad7db7068d" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_SharePriceMeasurementInputMember_6723a5e4-d9e4-4704-93f2-67ad7db7068d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_af8198a0-f303-48de-8e15-cb36697f2696" xlink:href="abvx-20241231.xsd#abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember_af8198a0-f303-48de-8e15-cb36697f2696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InitialPriceLimitMeasurementInputMember_eba641f2-ff03-44b8-98c7-ddd1d91d3088" xlink:href="abvx-20241231.xsd#abvx_InitialPriceLimitMeasurementInputMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_InitialPriceLimitMeasurementInputMember_eba641f2-ff03-44b8-98c7-ddd1d91d3088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarlyRedemptionAmountMeasurementInputMember_095c027a-6d62-46a0-a320-04a76975d9ba" xlink:href="abvx-20241231.xsd#abvx_EarlyRedemptionAmountMeasurementInputMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_EarlyRedemptionAmountMeasurementInputMember_095c027a-6d62-46a0-a320-04a76975d9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9debb461-06db-4459-ac0f-6018a792fffc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9debb461-06db-4459-ac0f-6018a792fffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_61656dbb-da84-4d47-8023-a6a02b98980d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_61656dbb-da84-4d47-8023-a6a02b98980d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_8d1c644b-abf5-4e3c-844a-cd6b9082f84f" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_ef1a9e2e-9bf9-40e1-9b67-1e33e837b98d" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_8d1c644b-abf5-4e3c-844a-cd6b9082f84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_947146f4-a397-47d5-9fca-d9d0a20e9f04" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_947146f4-a397-47d5-9fca-d9d0a20e9f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_704b474d-7baa-4a29-89fb-33d8e29e8ef6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_947146f4-a397-47d5-9fca-d9d0a20e9f04" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_704b474d-7baa-4a29-89fb-33d8e29e8ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModelIFRSMember_c1389871-c273-4f52-8ac4-edd31b94183c" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModelIFRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_704b474d-7baa-4a29-89fb-33d8e29e8ef6" xlink:to="loc_abvx_MonteCarloModelIFRSMember_c1389871-c273-4f52-8ac4-edd31b94183c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_79236346-ea5f-4755-81d2-b816e62c7dc9" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfConvertibleNotesOutstanding_c4c85f1f-6689-4782-a09d-3a72aedf44f3" xlink:href="abvx-20241231.xsd#abvx_NumberOfConvertibleNotesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_abvx_NumberOfConvertibleNotesOutstanding_c4c85f1f-6689-4782-a09d-3a72aedf44f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_3ba42c09-a6a8-4b55-b54b-3f8a64ee214f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_ifrs-full_NotionalAmount_3ba42c09-a6a8-4b55-b54b-3f8a64ee214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_5f849342-00f9-4015-9aef-d42c195ed2cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_5f849342-00f9-4015-9aef-d42c195ed2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueConvertibleNotes_5216f050-46bf-475c-9fc9-8cc1d3537fcc" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueConvertibleNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_bacc26d1-5d8c-4628-a8b7-34d99f36265f" xlink:to="loc_abvx_AggregateFairValueConvertibleNotes_5216f050-46bf-475c-9fc9-8cc1d3537fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesKreos1Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesKreos1Details"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesKreos1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_a946c802-4e25-4269-a0dc-a08c10f4caf5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_a946c802-4e25-4269-a0dc-a08c10f4caf5" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_8c712686-959a-4bc0-b096-a39d3f9a7095" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_8c712686-959a-4bc0-b096-a39d3f9a7095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_8c712686-959a-4bc0-b096-a39d3f9a7095" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1Member_28c58b2f-3ecf-4e86-a064-ec952dd7244c" xlink:href="abvx-20241231.xsd#abvx_Kreos1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1Member_28c58b2f-3ecf-4e86-a064-ec952dd7244c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1NonConvertibleBondLoansMember_c37d6ba8-dab5-493a-a16f-cbb8a83c6497" xlink:href="abvx-20241231.xsd#abvx_Kreos1NonConvertibleBondLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1NonConvertibleBondLoansMember_c37d6ba8-dab5-493a-a16f-cbb8a83c6497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansMember_37a86ca2-ad2d-4744-8a8c-3c289865aabb" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansMember_37a86ca2-ad2d-4744-8a8c-3c289865aabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_ea3871d3-c510-4f7e-9f76-0beba52f06ee" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheAMember_ea3871d3-c510-4f7e-9f76-0beba52f06ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_a90ff456-3e5d-41be-958e-b77e51932c7c" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheBMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_a90ff456-3e5d-41be-958e-b77e51932c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_988c0252-7808-4213-9a3d-db2bcdd48476" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_b217ab1c-1675-468e-b58b-72164d117a25" xlink:to="loc_abvx_Kreos12BondLoansMember_988c0252-7808-4213-9a3d-db2bcdd48476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_2c1b2fd1-6a2e-4a56-822a-f23547d97954" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_RangeAxis_2c1b2fd1-6a2e-4a56-822a-f23547d97954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_2c1b2fd1-6a2e-4a56-822a-f23547d97954" xlink:to="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_5995290e-5204-428c-a8bc-93c21a2d2f0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:to="loc_ifrs-full_BottomOfRangeMember_5995290e-5204-428c-a8bc-93c21a2d2f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_83ad7f47-da91-40a7-b1f8-d9b08cc09c83" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_f38bdd70-fb23-4a66-9304-bc79e0d640ae" xlink:to="loc_ifrs-full_TopOfRangeMember_83ad7f47-da91-40a7-b1f8-d9b08cc09c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_87c222e9-0e6f-4948-85f2-6152a76e29f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_4c1eb542-fd06-482e-aba2-3f6f24ca8dc3" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_87c222e9-0e6f-4948-85f2-6152a76e29f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuriborMember_9008f69a-fc59-45f1-b7cf-dffc36c8d2bc" xlink:href="abvx-20241231.xsd#abvx_EuriborMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_87c222e9-0e6f-4948-85f2-6152a76e29f9" xlink:to="loc_abvx_EuriborMember_9008f69a-fc59-45f1-b7cf-dffc36c8d2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_abvx_WarrantsAxis_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsAxis_3bc12ecd-d3cb-4bf5-880d-d1daf45bba6f" xlink:to="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_3bc7cc43-e9a7-4774-b008-58d35f483b06" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:to="loc_abvx_KreosABSAMember_3bc7cc43-e9a7-4774-b008-58d35f483b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_3022dd05-336a-4a6c-8a37-043ced46fcfd" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:to="loc_abvx_KreosBBSAMember_3022dd05-336a-4a6c-8a37-043ced46fcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_45cefdd3-c22c-4930-9917-db66367fdd2d" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_515afea9-bebf-48aa-ae8f-af04a2900548" xlink:to="loc_abvx_KreosABBSAMember_45cefdd3-c22c-4930-9917-db66367fdd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_8641fba3-f37e-439e-a440-a190a1ad5fc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_UnobservableInputsAxis_8641fba3-f37e-439e-a440-a190a1ad5fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_8641fba3-f37e-439e-a440-a190a1ad5fc6" xlink:to="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_530885eb-38b7-48ff-98e1-dfa97e669339" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_530885eb-38b7-48ff-98e1-dfa97e669339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_aa7c069f-51e4-495e-b9cb-471486b020ff" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:to="loc_abvx_SharePriceMeasurementInputMember_aa7c069f-51e4-495e-b9cb-471486b020ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_96207402-9f1e-42f7-925d-eb4ddc7a88e9" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_39893ee7-a551-4a83-b6b2-aec0e17b435f" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_96207402-9f1e-42f7-925d-eb4ddc7a88e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3111e95f-4cdf-4950-8651-8745252d214c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3d724acf-e5b4-4834-a4c1-83b7b1aedbaa" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3111e95f-4cdf-4950-8651-8745252d214c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_eed0549d-4ab1-402d-b2ab-dcf557d8230c" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3111e95f-4cdf-4950-8651-8745252d214c" xlink:to="loc_abvx_KreosABBSAMember_eed0549d-4ab1-402d-b2ab-dcf557d8230c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4580ec22-c06d-49ff-9b59-0d4eef771f05" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacity_6df4fb6e-69ca-464a-83b9-4e04209ce770" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacity_6df4fb6e-69ca-464a-83b9-4e04209ce770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_63e20c70-84af-4608-8db9-c6084b360b9d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsNumberOfTranches_63e20c70-84af-4608-8db9-c6084b360b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_e03ee696-e95d-4ce6-9064-452a63ad7617" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaximumBorrowingCapacityPerTranche"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaximumBorrowingCapacityPerTranche_e03ee696-e95d-4ce6-9064-452a63ad7617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_a3b47af1-4d08-46d4-85e0-d679838e3ddf" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_a3b47af1-4d08-46d4-85e0-d679838e3ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_40781db7-c991-4a48-b875-aa635ca001b1" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_40781db7-c991-4a48-b875-aa635ca001b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_c8dbbe42-3480-4ad2-9b01-77f98d3d4cbc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_c8dbbe42-3480-4ad2-9b01-77f98d3d4cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsBasisInterestRate_1d96a414-96eb-4841-8fb8-05b9eca9d841" xlink:href="abvx-20241231.xsd#abvx_BorrowingsBasisInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsBasisInterestRate_1d96a414-96eb-4841-8fb8-05b9eca9d841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfMonthlyInstallments_0c320fa5-a6b8-4369-bf99-83793ab7f68c" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfMonthlyInstallments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsNumberOfMonthlyInstallments_0c320fa5-a6b8-4369-bf99-83793ab7f68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityDeferralPeriod_9715f629-4596-425d-baca-e3d3096aec1e" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityDeferralPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaturityDeferralPeriod_9715f629-4596-425d-baca-e3d3096aec1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentage_05f664cf-6f6d-472d-8770-c86e7573fd6e" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsExitFeePercentage_05f664cf-6f6d-472d-8770-c86e7573fd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeeAmount_0470474a-5a97-4840-9969-72b093af1811" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeeAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsExitFeeAmount_0470474a-5a97-4840-9969-72b093af1811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNoticePeriod_657adba8-f30f-4a61-9538-523ad41ac7ee" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNoticePeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsNoticePeriod_657adba8-f30f-4a61-9538-523ad41ac7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAnnualDiscountRate_59c8c41a-4df9-4c20-8094-666a349e2528" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAnnualDiscountRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsAnnualDiscountRate_59c8c41a-4df9-4c20-8094-666a349e2528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstanding_81af8933-d1d8-49f7-9fb8-7bc7d41e2738" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfWarrantsOutstanding_81af8933-d1d8-49f7-9fb8-7bc7d41e2738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_b9f64bce-7807-4323-8181-7dce831ae9b7" xlink:href="abvx-20241231.xsd#abvx_OtherShareWarrantsSubscriptionPricePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_OtherShareWarrantsSubscriptionPricePerShare_b9f64bce-7807-4323-8181-7dce831ae9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesSubscribedPerWarrant_e361d768-94e5-4ed0-8f5a-0dec591d80c8" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesSubscribedPerWarrant"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfSharesSubscribedPerWarrant_e361d768-94e5-4ed0-8f5a-0dec591d80c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_86def585-929a-43eb-a0f6-40b55db90908" xlink:href="abvx-20241231.xsd#abvx_ExercisePriceOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_ExercisePriceOtherEquityInstrumentsGranted_86def585-929a-43eb-a0f6-40b55db90908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityTerm_e0ff31d2-9471-4e35-be23-92b90610a2d3" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityTerm"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_BorrowingsMaturityTerm_e0ff31d2-9471-4e35-be23-92b90610a2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_4d08f524-596e-43df-a21f-5b3fe9e48d86" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_4d08f524-596e-43df-a21f-5b3fe9e48d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsRepurchased_88d27e4a-a160-425f-b8b4-bc228d1bb3ce" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsRepurchased"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfOtherShareWarrantsRepurchased_88d27e4a-a160-425f-b8b4-bc228d1bb3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants_fa1a0ec3-b758-4a6b-b273-525d19e83e21" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfOtherShareWarrantsConverted_a0edbc10-cad6-4c1c-91d5-59858c6a44fc" xlink:href="abvx-20241231.xsd#abvx_NumberOfOtherShareWarrantsConverted"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_NumberOfOtherShareWarrantsConverted_a0edbc10-cad6-4c1c-91d5-59858c6a44fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_77efa668-d166-4ff6-a9e4-516ee8b3ff9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_77efa668-d166-4ff6-a9e4-516ee8b3ff9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_5cd47596-ba15-4ad9-8d9a-b9e39e588def" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_5cd47596-ba15-4ad9-8d9a-b9e39e588def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_459c63a3-96ee-485e-9645-67f26d95ca4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_459c63a3-96ee-485e-9645-67f26d95ca4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_d0ad27a9-59fa-4aba-9163-1650be2d2b88" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_d0ad27a9-59fa-4aba-9163-1650be2d2b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_1cbad1d7-51fa-419f-ad6f-231b90c91ada" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_1cbad1d7-51fa-419f-ad6f-231b90c91ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0f0caecb-305f-4194-a587-cc2fdafba498" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_de09be1d-0c7a-4bd2-9d5d-0fb4e2369b71" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0f0caecb-305f-4194-a587-cc2fdafba498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_1c0757b9-d795-4115-9191-e1c6beea6c49" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_1c0757b9-d795-4115-9191-e1c6beea6c49" xlink:to="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsAxis_a5485040-d8c5-4a92-aec6-b72049901584" xlink:href="abvx-20241231.xsd#abvx_WarrantsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:to="loc_abvx_WarrantsAxis_a5485040-d8c5-4a92-aec6-b72049901584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:href="abvx-20241231.xsd#abvx_WarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsAxis_a5485040-d8c5-4a92-aec6-b72049901584" xlink:to="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_a51f6483-afbc-4d49-b751-78fb4be815a9" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:to="loc_abvx_KreosABSAMember_a51f6483-afbc-4d49-b751-78fb4be815a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_27d5f906-97fc-4ceb-820f-1ab7cb4beaeb" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_WarrantsDomain_8c685ac9-2ddb-47a4-909e-52758f8a3559" xlink:to="loc_abvx_KreosBBSAMember_27d5f906-97fc-4ceb-820f-1ab7cb4beaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_599c8302-e41d-4293-a9af-2b7289692087" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:to="loc_ifrs-full_UnobservableInputsAxis_599c8302-e41d-4293-a9af-2b7289692087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_599c8302-e41d-4293-a9af-2b7289692087" xlink:to="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExercisePricePerShareMeasurementInputMember_f0aa7cc0-3343-4c1c-9cf0-3b563eb2a11a" xlink:href="abvx-20241231.xsd#abvx_ExercisePricePerShareMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_ExercisePricePerShareMeasurementInputMember_f0aa7cc0-3343-4c1c-9cf0-3b563eb2a11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_853923a2-0c52-45ad-89aa-52131b2e0ab0" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_SharePriceMeasurementInputMember_853923a2-0c52-45ad-89aa-52131b2e0ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResidualMaturityMeasurementInputMember_df743160-ddf6-46a9-af87-ebd3cacfb351" xlink:href="abvx-20241231.xsd#abvx_ResidualMaturityMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_ResidualMaturityMeasurementInputMember_df743160-ddf6-46a9-af87-ebd3cacfb351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9fb72d09-5c23-480c-a181-b2d28a498b5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_9fb72d09-5c23-480c-a181-b2d28a498b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_0cd3c434-c3d2-4806-b779-138971d0c3f5" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_0cd3c434-c3d2-4806-b779-138971d0c3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_16f33835-ea16-4db6-b3f5-3f3553e84afc" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_e693eb33-5246-4624-ad04-393a00e6f569" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_16f33835-ea16-4db6-b3f5-3f3553e84afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_b2fa641f-b6f6-42d8-b6e9-fd9f045decea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_b2fa641f-b6f6-42d8-b6e9-fd9f045decea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_0fea4bb4-6066-44a0-827c-4f66e2532c18" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_b2fa641f-b6f6-42d8-b6e9-fd9f045decea" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_0fea4bb4-6066-44a0-827c-4f66e2532c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionPricingModelMember_afc449db-0af4-410c-a8f6-1b93cd41a91a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionPricingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_0fea4bb4-6066-44a0-827c-4f66e2532c18" xlink:to="loc_ifrs-full_OptionPricingModelMember_afc449db-0af4-410c-a8f6-1b93cd41a91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfWarrantsArrangementsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsTable_7f8634f6-9ee8-4153-a516-40ebb91e4bbd" xlink:to="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfWarrantsOutstanding_956685a8-7cae-473c-9dde-87ec0e9d71f5" xlink:href="abvx-20241231.xsd#abvx_NumberOfWarrantsOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:to="loc_abvx_NumberOfWarrantsOutstanding_956685a8-7cae-473c-9dde-87ec0e9d71f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_cd7d792c-fa9c-4280-8fe0-f2e1e451e607" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_cd7d792c-fa9c-4280-8fe0-f2e1e451e607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_76ca3625-f9ff-497e-a607-8a79aa2ff586" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueOtherEquityInstrumentsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfWarrantsArrangementsLineItems_c4b2525b-8643-4487-a2ab-2f4644166b31" xlink:to="loc_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding_76ca3625-f9ff-497e-a607-8a79aa2ff586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesKreos2Details" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesKreos2Details"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesKreos2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_c6c9d002-e921-41bc-997e-9565b2fbd281" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_c6c9d002-e921-41bc-997e-9565b2fbd281" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_5fb8de5f-62f5-41af-8920-4271681e6b3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_5fb8de5f-62f5-41af-8920-4271681e6b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5fb8de5f-62f5-41af-8920-4271681e6b3c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:href="abvx-20241231.xsd#abvx_Kreos2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:to="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2TrancheAMember_3cd54a79-66d0-47d9-aff0-96e138590ed4" xlink:href="abvx-20241231.xsd#abvx_Kreos2TrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:to="loc_abvx_Kreos2TrancheAMember_3cd54a79-66d0-47d9-aff0-96e138590ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos2TrancheBMember_03e0ece1-9687-43cf-970c-10971382feef" xlink:href="abvx-20241231.xsd#abvx_Kreos2TrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_Kreos2Member_398c0cda-10e2-4e74-8cc0-3992b2c0e300" xlink:to="loc_abvx_Kreos2TrancheBMember_03e0ece1-9687-43cf-970c-10971382feef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_f8159c11-be9d-4100-9535-d9c121ad0c71" xlink:href="abvx-20241231.xsd#abvx_Kreos1ConvertibleBondLoansTrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_cec0815a-a1c6-462b-9f0f-d33a80c36c01" xlink:to="loc_abvx_Kreos1ConvertibleBondLoansTrancheBMember_f8159c11-be9d-4100-9535-d9c121ad0c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_8ff950af-54de-4b60-8a2b-1626d5388b44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_8ff950af-54de-4b60-8a2b-1626d5388b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_10fb1b6c-991f-4cdb-846a-0801efd4dccb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_8ff950af-54de-4b60-8a2b-1626d5388b44" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_10fb1b6c-991f-4cdb-846a-0801efd4dccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuriborMember_52b4356e-c961-475d-99cc-c95dfc54ed7e" xlink:href="abvx-20241231.xsd#abvx_EuriborMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_10fb1b6c-991f-4cdb-846a-0801efd4dccb" xlink:to="loc_abvx_EuriborMember_52b4356e-c961-475d-99cc-c95dfc54ed7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_ba976393-ef6f-4e02-9c95-5e7f2942c391" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_edc23e27-0c78-4e72-b9df-28c70e56fa0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_ifrs-full_NotionalAmount_edc23e27-0c78-4e72-b9df-28c70e56fa0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfTranches_1b814cb8-3678-4e3c-a861-003eb5be12df" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfTranches"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsNumberOfTranches_1b814cb8-3678-4e3c-a861-003eb5be12df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAdditionalTrancheAmount_e72d9010-b7ac-45ca-b8ba-5c9722d6b974" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAdditionalTrancheAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsAdditionalTrancheAmount_e72d9010-b7ac-45ca-b8ba-5c9722d6b974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments_b94ef0b9-4928-427a-b6e8-c89339c8a222" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments_b94ef0b9-4928-427a-b6e8-c89339c8a222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsInterestRateForFollowingInstallments_85f2d45f-d332-4e77-8122-995080da9c75" xlink:href="abvx-20241231.xsd#abvx_BorrowingsInterestRateForFollowingInstallments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsInterestRateForFollowingInstallments_85f2d45f-d332-4e77-8122-995080da9c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNumberOfMonthlyInstallments_84bca55c-7e74-4b5f-a01c-a75086a88fce" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNumberOfMonthlyInstallments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsNumberOfMonthlyInstallments_84bca55c-7e74-4b5f-a01c-a75086a88fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentage_c39858a7-24d0-492d-ac17-5cf39786422d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeePercentage_c39858a7-24d0-492d-ac17-5cf39786422d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeeAmount_4bc1d34a-4482-4617-a4d1-f58710826267" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeeAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeeAmount_4bc1d34a-4482-4617-a4d1-f58710826267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsNoticePeriod_f1496734-0e3b-43fe-a58d-84350021ad8d" xlink:href="abvx-20241231.xsd#abvx_BorrowingsNoticePeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsNoticePeriod_f1496734-0e3b-43fe-a58d-84350021ad8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments_1f2a0fc1-d8b8-491f-a216-edddf70b6a68" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments_1f2a0fc1-d8b8-491f-a216-edddf70b6a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment_d04d30e0-f52c-4425-b67b-d42f41f7f683" xlink:href="abvx-20241231.xsd#abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment_d04d30e0-f52c-4425-b67b-d42f41f7f683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsAnnualDiscountRate_8680efb9-fb2f-46c1-821a-4b5800df84b0" xlink:href="abvx-20241231.xsd#abvx_BorrowingsAnnualDiscountRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_BorrowingsAnnualDiscountRate_8680efb9-fb2f-46c1-821a-4b5800df84b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_db16dcfc-8b53-4a10-ad45-9df7906f680b" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_451958d1-e119-4584-bdc7-b3c95000a58c" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_db16dcfc-8b53-4a10-ad45-9df7906f680b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesOCEANEDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_23125e6d-901e-4862-990c-c50294667140" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_23125e6d-901e-4862-990c-c50294667140" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_dbb3e57c-5cd1-445b-99e7-155a2f56ab3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_282ca15d-96f9-425b-9d5c-cfdf21e9ffb2" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_dbb3e57c-5cd1-445b-99e7-155a2f56ab3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_0139ff72-8974-4738-8b65-6419efe02b3a" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_dbb3e57c-5cd1-445b-99e7-155a2f56ab3c" xlink:to="loc_abvx_OCEANEMember_0139ff72-8974-4738-8b65-6419efe02b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RemeasurementPeriodAxis_580cf3d2-a63f-4242-a330-f67295215326" xlink:href="abvx-20241231.xsd#abvx_RemeasurementPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_abvx_RemeasurementPeriodAxis_580cf3d2-a63f-4242-a330-f67295215326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:href="abvx-20241231.xsd#abvx_RemeasurementPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_RemeasurementPeriodAxis_580cf3d2-a63f-4242-a330-f67295215326" xlink:to="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After18MonthsMember_31d3c517-1cd8-490e-a727-ad87b69084ec" xlink:href="abvx-20241231.xsd#abvx_After18MonthsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:to="loc_abvx_After18MonthsMember_31d3c517-1cd8-490e-a727-ad87b69084ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After24MonthsMember_f3530611-7f97-491e-bb09-dba3c734c85f" xlink:href="abvx-20241231.xsd#abvx_After24MonthsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:to="loc_abvx_After24MonthsMember_f3530611-7f97-491e-bb09-dba3c734c85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_After36MonthsMember_8a5c4b5c-43ca-4322-b32f-bb94601d981f" xlink:href="abvx-20241231.xsd#abvx_After36MonthsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_RemeasurementPeriodDomain_dc0e5179-2953-48f4-92a8-6b5c091e8322" xlink:to="loc_abvx_After36MonthsMember_8a5c4b5c-43ca-4322-b32f-bb94601d981f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2dfb695b-252c-4711-bd9e-45c67278693b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_srt_RangeAxis_2dfb695b-252c-4711-bd9e-45c67278693b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62ad87b8-b194-472c-b56f-476941c475a4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2dfb695b-252c-4711-bd9e-45c67278693b" xlink:to="loc_srt_RangeMember_62ad87b8-b194-472c-b56f-476941c475a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_853bf418-f914-4e5d-baec-8b679ba883a9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_62ad87b8-b194-472c-b56f-476941c475a4" xlink:to="loc_srt_MinimumMember_853bf418-f914-4e5d-baec-8b679ba883a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7d830236-e433-4a1e-9582-dc1c65e0d7e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7d830236-e433-4a1e-9582-dc1c65e0d7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_66acd22e-df57-4aff-aa55-733ca7250d44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_7d830236-e433-4a1e-9582-dc1c65e0d7e1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_66acd22e-df57-4aff-aa55-733ca7250d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_513e7516-581f-4d30-84e7-7902e5390cf7" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_66acd22e-df57-4aff-aa55-733ca7250d44" xlink:to="loc_abvx_OCEANEMember_513e7516-581f-4d30-84e7-7902e5390cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_d416c07f-020d-49ff-a39a-11131caec196" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_UnobservableInputsAxis_d416c07f-020d-49ff-a39a-11131caec196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_d416c07f-020d-49ff-a39a-11131caec196" xlink:to="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_cf708799-d76d-46e5-910c-ccc2bc8fd4d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_cf708799-d76d-46e5-910c-ccc2bc8fd4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_9538198f-1817-4b11-84c2-2df58b8cd3d6" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_abvx_SharePriceMeasurementInputMember_9538198f-1817-4b11-84c2-2df58b8cd3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_6326fb22-6f73-4a8e-8706-effa324aa971" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_6326fb22-6f73-4a8e-8706-effa324aa971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_113573b4-66c2-4840-8f3e-36538df7072d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_4a0922df-fecb-4e9e-91aa-f7a497c7cfc7" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_113573b4-66c2-4840-8f3e-36538df7072d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_a6af8163-88ee-481e-a30d-2555274db7b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_a6af8163-88ee-481e-a30d-2555274db7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_261b245f-ba6c-48fb-af12-42866690c099" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_a6af8163-88ee-481e-a30d-2555274db7b2" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_261b245f-ba6c-48fb-af12-42866690c099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModelIFRSMember_ba4895da-15cf-4cb4-8c13-199d4e445aaa" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModelIFRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_261b245f-ba6c-48fb-af12-42866690c099" xlink:to="loc_abvx_MonteCarloModelIFRSMember_ba4895da-15cf-4cb4-8c13-199d4e445aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_9ad2d7ba-f9e9-4d5b-bae4-09e2bbfdeaff" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes_69ff0029-e14b-418e-b39a-0e2c7bf369e7" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes_69ff0029-e14b-418e-b39a-0e2c7bf369e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_d747662d-6de2-4887-b1c2-5b0f0e80d1cf" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_d747662d-6de2-4887-b1c2-5b0f0e80d1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_d5e77163-7f5e-434f-9062-ef077cb428e0" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_d5e77163-7f5e-434f-9062-ef077cb428e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_0795c022-f71b-4e8e-9634-0cfce442d948" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_0795c022-f71b-4e8e-9634-0cfce442d948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_cc61f7ce-b166-49f3-95f4-6c4782524e84" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_cc61f7ce-b166-49f3-95f4-6c4782524e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_06e2d8b0-b48f-455d-b312-c98303f9c218" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_BorrowingsInterestRate_06e2d8b0-b48f-455d-b312-c98303f9c218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfSharesSubscribedPerWarrant_174b82bd-a285-4a62-9307-529f223accc5" xlink:href="abvx-20241231.xsd#abvx_NumberOfSharesSubscribedPerWarrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_NumberOfSharesSubscribedPerWarrant_174b82bd-a285-4a62-9307-529f223accc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceOtherLiabilities_1c05216a-3fc4-45ed-b31d-08e04039e3b6" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceOtherLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPriceOtherLiabilities_1c05216a-3fc4-45ed-b31d-08e04039e3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceAdjustmentPeriod_eba39339-ba94-4071-9252-f3b712257213" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceAdjustmentPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPriceAdjustmentPeriod_eba39339-ba94-4071-9252-f3b712257213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPriceVolumeWeightedAveragePricePeriod_bdb769e5-fe6b-4d08-b360-c4fd6e77bf34" xlink:href="abvx-20241231.xsd#abvx_ConversionPriceVolumeWeightedAveragePricePeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPriceVolumeWeightedAveragePricePeriod_bdb769e5-fe6b-4d08-b360-c4fd6e77bf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConversionPricePercentageOfInitialPriceThreshold_f23c4324-a81a-4fce-a932-4913e06a31a8" xlink:href="abvx-20241231.xsd#abvx_ConversionPricePercentageOfInitialPriceThreshold"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConversionPricePercentageOfInitialPriceThreshold_f23c4324-a81a-4fce-a932-4913e06a31a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_efa97fb4-f187-48cb-a2c1-303d9a5f67bf" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_efa97fb4-f187-48cb-a2c1-303d9a5f67bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_d5716388-c24b-4c8f-bdac-afdbe049d595" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_ConvertibleLoansNotes_d5716388-c24b-4c8f-bdac-afdbe049d595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_5a90f213-25fa-4ad3-b673-1b96d6f662f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_5a90f213-25fa-4ad3-b673-1b96d6f662f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueConvertibleNotes_a1289b90-2f58-4581-abae-c0442174f7cb" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueConvertibleNotes"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_AggregateFairValueConvertibleNotes_a1289b90-2f58-4581-abae-c0442174f7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_46315aab-4a9b-4bc5-b67e-e8ab317e00e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_46315aab-4a9b-4bc5-b67e-e8ab317e00e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_dfa5a130-374e-47e6-9eb7-68d4b7b184a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_dfa5a130-374e-47e6-9eb7-68d4b7b184a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a796754f-b2b0-4f7c-9386-eee225b6edbd" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_a796754f-b2b0-4f7c-9386-eee225b6edbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_8cb29e62-2108-4561-a02b-68acabf9dd9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_8cb29e62-2108-4561-a02b-68acabf9dd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_d51bce1b-1d01-41a8-b355-a5f2b165de07" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_cc7aa316-5c82-4dff-93b0-86cb4e5b05df" xlink:to="loc_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid_d51bce1b-1d01-41a8-b355-a5f2b165de07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_2fb69fdb-fa90-439b-a085-fe24072bd8d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_2fb69fdb-fa90-439b-a085-fe24072bd8d6" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cc55c727-a771-4eaf-9321-b4f8c491723f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cc55c727-a771-4eaf-9321-b4f8c491723f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7f347c0c-2aec-4cf0-a09b-4df024deb0e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cc55c727-a771-4eaf-9321-b4f8c491723f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7f347c0c-2aec-4cf0-a09b-4df024deb0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_fcaf5980-2461-4e53-a31a-a8d233b5e940" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7f347c0c-2aec-4cf0-a09b-4df024deb0e9" xlink:to="loc_abvx_OCEANEMember_fcaf5980-2461-4e53-a31a-a8d233b5e940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_aca330be-b087-477a-a22e-5eca4ebf3ebe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:to="loc_ifrs-full_UnobservableInputsAxis_aca330be-b087-477a-a22e-5eca4ebf3ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_aca330be-b087-477a-a22e-5eca4ebf3ebe" xlink:to="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_0fb24a8a-8ad2-4314-8ba3-64b908a261dc" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_0fb24a8a-8ad2-4314-8ba3-64b908a261dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditSpreadMeasurementInputMember_5fd90b58-6522-45b1-9fd9-c25b495a6d4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditSpreadMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_ifrs-full_CreditSpreadMeasurementInputMember_5fd90b58-6522-45b1-9fd9-c25b495a6d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_d196630c-abe6-4a6f-be99-eca0cd3df34f" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_abvx_SharePriceMeasurementInputMember_d196630c-abe6-4a6f-be99-eca0cd3df34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_04bf6d86-a580-49e8-9e9e-38ef6db85e65" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_04bf6d86-a580-49e8-9e9e-38ef6db85e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_7549fa68-62dd-4682-8595-fc6f8c016a7d" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_3654f78a-d96b-4329-b19c-bd15bd588207" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_7549fa68-62dd-4682-8595-fc6f8c016a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_ce36f335-9ea8-4844-bedd-6fe5779ea868" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_ce36f335-9ea8-4844-bedd-6fe5779ea868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_c147f60a-5810-44df-8d84-2bd2c672e774" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_ce36f335-9ea8-4844-bedd-6fe5779ea868" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_c147f60a-5810-44df-8d84-2bd2c672e774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MonteCarloModelIFRSMember_73515050-963e-4b49-9bd6-8fc77e9f2129" xlink:href="abvx-20241231.xsd#abvx_MonteCarloModelIFRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_c147f60a-5810-44df-8d84-2bd2c672e774" xlink:to="loc_abvx_MonteCarloModelIFRSMember_73515050-963e-4b49-9bd6-8fc77e9f2129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_e1b2e6cf-74fa-433f-a80d-21bafeb08cb4" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_fd69ad79-14d3-4603-8d38-f377a05e02db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_fd69ad79-14d3-4603-8d38-f377a05e02db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AggregateFairValueConvertibleNotes_290e29a9-6dd9-49b3-b52a-0d223acaf3d8" xlink:href="abvx-20241231.xsd#abvx_AggregateFairValueConvertibleNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_1a557635-a0da-4713-99c7-b6b530f7eac0" xlink:to="loc_abvx_AggregateFairValueConvertibleNotes_290e29a9-6dd9-49b3-b52a-0d223acaf3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesStateguaranteedloanPGEDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_15c00e44-9c31-4ebe-9993-aee064a7c9a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5f40955c-7b1d-4034-b967-d43d931574c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_15c00e44-9c31-4ebe-9993-aee064a7c9a1" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5f40955c-7b1d-4034-b967-d43d931574c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_712ae603-4001-46fc-9938-58aadaede35c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5f40955c-7b1d-4034-b967-d43d931574c4" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_712ae603-4001-46fc-9938-58aadaede35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_9d910f7a-303d-4cbb-ab2d-4d52d4baad8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_712ae603-4001-46fc-9938-58aadaede35c" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_9d910f7a-303d-4cbb-ab2d-4d52d4baad8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_3a08fb78-df3d-4506-adae-cf69b7b52509" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_9d910f7a-303d-4cbb-ab2d-4d52d4baad8b" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_3a08fb78-df3d-4506-adae-cf69b7b52509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_5f40955c-7b1d-4034-b967-d43d931574c4" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityTerm_64753fe0-fe08-40ba-9589-02b870c87357" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsMaturityTerm_64753fe0-fe08-40ba-9589-02b870c87357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_d4f0c33f-6a1a-4087-a44f-9ea4cbef62d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_ifrs-full_BorrowingsInterestRate_d4f0c33f-6a1a-4087-a44f-9ea4cbef62d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityExtensionTerm_f42e2184-3468-445a-9794-3ef71348a693" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityExtensionTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsMaturityExtensionTerm_f42e2184-3468-445a-9794-3ef71348a693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsMaturityDeferralPeriod_75035619-f406-4935-a08c-7a4cc299330c" xlink:href="abvx-20241231.xsd#abvx_BorrowingsMaturityDeferralPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsMaturityDeferralPeriod_75035619-f406-4935-a08c-7a4cc299330c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsStateGuaranteedPremium_b997621c-396a-4020-ad07-7c6dfc899090" xlink:href="abvx-20241231.xsd#abvx_BorrowingsStateGuaranteedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_abvx_BorrowingsStateGuaranteedPremium_b997621c-396a-4020-ad07-7c6dfc899090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_9b17af6c-2567-4716-8acb-8dfc249cdb3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_ef9f855b-3e31-4e4b-94ea-f0849908133c" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_9b17af6c-2567-4716-8acb-8dfc249cdb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofconditionaladvancesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_70d44854-edad-4b2e-8d03-9ab06f65212e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_c8ac2962-e756-4273-9908-282f320bc9ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_70d44854-edad-4b2e-8d03-9ab06f65212e" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_c8ac2962-e756-4273-9908-282f320bc9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_334264fb-2e10-4970-a093-f09d41591cb7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_c8ac2962-e756-4273-9908-282f320bc9ad" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_334264fb-2e10-4970-a093-f09d41591cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_334264fb-2e10-4970-a093-f09d41591cb7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_d4f63e31-12ae-4721-9cd0-77cc3f214131" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_d4f63e31-12ae-4721-9cd0-77cc3f214131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_9be01241-376d-4989-94fa-edc5aab52059" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_9be01241-376d-4989-94fa-edc5aab52059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_e9b9d53a-511d-418d-ab32-92afeaeb3346" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_88557eec-68d2-486d-958c-72944d5fff6b" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_e9b9d53a-511d-418d-ab32-92afeaeb3346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a091b8cf-4d4e-4f8a-82a8-0260314b66b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_c8ac2962-e756-4273-9908-282f320bc9ad" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a091b8cf-4d4e-4f8a-82a8-0260314b66b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances_0acaefed-0b3e-436f-9578-0bc5bb946997" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a091b8cf-4d4e-4f8a-82a8-0260314b66b2" xlink:to="loc_abvx_ConditionalAdvances_0acaefed-0b3e-436f-9578-0bc5bb946997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesConditionaladvancesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ad316da2-0d99-4639-a0db-d1730216b184" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4dcbd37c-2e02-4e14-a9e7-5dea07044f7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ad316da2-0d99-4639-a0db-d1730216b184" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4dcbd37c-2e02-4e14-a9e7-5dea07044f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f347c6c8-b2ca-4f24-831d-41f5077204d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4dcbd37c-2e02-4e14-a9e7-5dea07044f7e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f347c6c8-b2ca-4f24-831d-41f5077204d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f347c6c8-b2ca-4f24-831d-41f5077204d0" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_c8d1268e-015c-4733-8d5e-b0f75cc3f3bc" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_c8d1268e-015c-4733-8d5e-b0f75cc3f3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_2f4192c8-1871-4bfd-8f5a-235dff207087" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_2f4192c8-1871-4bfd-8f5a-235dff207087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_823972d1-21d8-4a51-92b1-a6a3b4e84610" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_815f071d-85bd-4d88-acba-bcb555d640fa" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_823972d1-21d8-4a51-92b1-a6a3b4e84610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_4dcbd37c-2e02-4e14-a9e7-5dea07044f7e" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_6eef81a7-6f8b-437d-bdb8-b3fd4d5ddc11" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_6eef81a7-6f8b-437d-bdb8-b3fd4d5ddc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProceedsFromConditionalAdvances_4be0f9df-a4a5-4f2f-97f1-53f3d47adfb7" xlink:href="abvx-20241231.xsd#abvx_ProceedsFromConditionalAdvances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_ProceedsFromConditionalAdvances_4be0f9df-a4a5-4f2f-97f1-53f3d47adfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentOfExcessConditionalAdvancesClaimed_c020dce6-f256-426a-8ce4-1794b2704395" xlink:href="abvx-20241231.xsd#abvx_RepaymentOfExcessConditionalAdvancesClaimed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_RepaymentOfExcessConditionalAdvancesClaimed_c020dce6-f256-426a-8ce4-1794b2704395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PercentageOfConditionalAdvancesWaived_51235d48-8402-4d18-8ba9-0c003127d01e" xlink:href="abvx-20241231.xsd#abvx_PercentageOfConditionalAdvancesWaived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_PercentageOfConditionalAdvancesWaived_51235d48-8402-4d18-8ba9-0c003127d01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances_86c8699a-6e52-46ec-8ac7-3a8617dabc32" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_abvx_ConditionalAdvances_86c8699a-6e52-46ec-8ac7-3a8617dabc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_bce1c6ca-a282-4c64-866a-0bad7d96f0c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a339579c-bb2c-4e8e-bf46-1704521d88e6" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_bce1c6ca-a282-4c64-866a-0bad7d96f0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_14520c1c-28b7-43c9-9345-8e01992372c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_07afbe98-2d85-4a30-adef-370677a735ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_14520c1c-28b7-43c9-9345-8e01992372c1" xlink:to="loc_ifrs-full_LeaseLiabilities_07afbe98-2d85-4a30-adef-370677a735ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseInLeaseLiabilities_d0957208-08aa-481b-945b-fc66b1fbddc3" xlink:href="abvx-20241231.xsd#abvx_IncreaseInLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_14520c1c-28b7-43c9-9345-8e01992372c1" xlink:to="loc_abvx_IncreaseInLeaseLiabilities_d0957208-08aa-481b-945b-fc66b1fbddc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInLeaseLiabilities_332e8aaa-c883-419d-bdcf-13aefc7f2288" xlink:href="abvx-20241231.xsd#abvx_DecreaseInLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_14520c1c-28b7-43c9-9345-8e01992372c1" xlink:to="loc_abvx_DecreaseInLeaseLiabilities_332e8aaa-c883-419d-bdcf-13aefc7f2288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_c48ee136-a4d6-477e-ab4f-361373071cba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_14520c1c-28b7-43c9-9345-8e01992372c1" xlink:to="loc_ifrs-full_LeaseLiabilities_c48ee136-a4d6-477e-ab4f-361373071cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesLeaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_42a62131-36c5-4f3f-8c47-bf7b4e0533a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeaseLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_42a62131-36c5-4f3f-8c47-bf7b4e0533a8" xlink:to="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_e920d11d-1669-47fc-aa83-1f87f7ad7dad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:to="loc_ifrs-full_TypesOfContractsAxis_e920d11d-1669-47fc-aa83-1f87f7ad7dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_e920d11d-1669-47fc-aa83-1f87f7ad7dad" xlink:to="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesParisMember_5a0ef4ce-ce8d-483a-a2a3-47c8318db7a4" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesParisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesParisMember_5a0ef4ce-ce8d-483a-a2a3-47c8318db7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesBostonMember_222365dc-52e4-4700-bd0f-f009c769b1b9" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesBostonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesBostonMember_222365dc-52e4-4700-bd0f-f009c769b1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMontpellierMember_51688794-4a31-461b-854e-0c3a40af3b7d" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMontpellierMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesMontpellierMember_51688794-4a31-461b-854e-0c3a40af3b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMember_fd45683a-a8b4-42be-8d84-0e4c7d095942" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0bf3a8ac-3f20-4447-8c82-e876ab0d507b" xlink:to="loc_abvx_LeaseFacilitiesMember_fd45683a-a8b4-42be-8d84-0e4c7d095942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_c6cc3231-1459-427d-be75-f88224b8b78d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:to="loc_ifrs-full_RangeAxis_c6cc3231-1459-427d-be75-f88224b8b78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_c6cc3231-1459-427d-be75-f88224b8b78d" xlink:to="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_72cea516-0898-4bcd-afb2-bc94d3270ef1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:to="loc_srt_MinimumMember_72cea516-0898-4bcd-afb2-bc94d3270ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_47446b28-99a4-487a-9557-40c04a66051a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_edf7ffa4-7e7e-4be6-9b7a-a416b8add864" xlink:to="loc_srt_MaximumMember_47446b28-99a4-487a-9557-40c04a66051a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfLeaseLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesTable_66bbae99-1c45-4bf7-a172-5bf114be8ecd" xlink:to="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseDurationPeriod_4ab02da8-1444-48d3-acc4-e75a7819de70" xlink:href="abvx-20241231.xsd#abvx_LeaseDurationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseDurationPeriod_4ab02da8-1444-48d3-acc4-e75a7819de70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseTacitRenewalPeriod_155f6ac6-3d60-4016-b237-1f0c960ebee0" xlink:href="abvx-20241231.xsd#abvx_LeaseTacitRenewalPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseTacitRenewalPeriod_155f6ac6-3d60-4016-b237-1f0c960ebee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseBreakClausePeriod_9ac28d27-d7c2-458e-82a6-6317609442d0" xlink:href="abvx-20241231.xsd#abvx_LeaseBreakClausePeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseBreakClausePeriod_9ac28d27-d7c2-458e-82a6-6317609442d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm_7b694cf7-bc64-48f6-b519-ac79b7afab84" xlink:href="abvx-20241231.xsd#abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm_7b694cf7-bc64-48f6-b519-ac79b7afab84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseExtensionPeriod_7614b7a9-598b-43c2-90b8-7702488ba700" xlink:href="abvx-20241231.xsd#abvx_LeaseExtensionPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseExtensionPeriod_7614b7a9-598b-43c2-90b8-7702488ba700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseLiabilityPercentageOfTotal_da40a111-340e-48f8-aa98-a74eda92b71d" xlink:href="abvx-20241231.xsd#abvx_LeaseLiabilityPercentageOfTotal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_LeaseLiabilityPercentageOfTotal_da40a111-340e-48f8-aa98-a74eda92b71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseOnLeaseLiabilities_1e38d467-8193-423a-bf1a-78b839457e1e" xlink:href="abvx-20241231.xsd#abvx_ExpenseOnLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_ExpenseOnLeaseLiabilities_1e38d467-8193-423a-bf1a-78b839457e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DepreciationExpenseLease_1ac7fad1-e4b5-4700-915d-738e1db39f76" xlink:href="abvx-20241231.xsd#abvx_DepreciationExpenseLease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_DepreciationExpenseLease_1ac7fad1-e4b5-4700-915d-738e1db39f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2ea152c6-2346-446f-b21a-bb8b8a520cea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2ea152c6-2346-446f-b21a-bb8b8a520cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_f3801759-88d2-4c56-b928-e214866e25f6" xlink:href="abvx-20241231.xsd#abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfLeaseLiabilitiesLineItems_eb1c2a4c-eb39-4c2f-8b8d-42aacfb14f71" xlink:to="loc_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_f3801759-88d2-4c56-b928-e214866e25f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesProsynergiaearnoutliabilityDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_bdc54684-c291-4069-9bea-9382bf3779ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_bdc54684-c291-4069-9bea-9382bf3779ae" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsAxis_83895f9a-a751-4f14-832e-66e8a5ae4be6" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:to="loc_abvx_AssetsAcquisitionsAxis_83895f9a-a751-4f14-832e-66e8a5ae4be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AssetsAcquisitionsDomain_f329860b-1c7a-487e-8a95-ab58c177e687" xlink:href="abvx-20241231.xsd#abvx_AssetsAcquisitionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsAxis_83895f9a-a751-4f14-832e-66e8a5ae4be6" xlink:to="loc_abvx_AssetsAcquisitionsDomain_f329860b-1c7a-487e-8a95-ab58c177e687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProsynergiaMember_0d396d57-48a8-4cb4-81a8-ef56a82b4fea" xlink:href="abvx-20241231.xsd#abvx_ProsynergiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_AssetsAcquisitionsDomain_f329860b-1c7a-487e-8a95-ab58c177e687" xlink:to="loc_abvx_ProsynergiaMember_0d396d57-48a8-4cb4-81a8-ef56a82b4fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ef4c1920-6684-4e41-a716-729dba486a33" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4b4a5ddd-af5f-4c4a-b5d2-c488b1934dfa" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ef4c1920-6684-4e41-a716-729dba486a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_1d65da9c-d5d5-4317-bf44-ff910b1a1466" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ef4c1920-6684-4e41-a716-729dba486a33" xlink:to="loc_abvx_EarnOutLiabilityMember_1d65da9c-d5d5-4317-bf44-ff910b1a1466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_100c3700-1ece-49a9-a991-f6707523352d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:to="loc_ifrs-full_UnobservableInputsAxis_100c3700-1ece-49a9-a991-f6707523352d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_100c3700-1ece-49a9-a991-f6707523352d" xlink:to="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_03cc72ac-e1d7-4225-adde-45cb49017a35" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_03cc72ac-e1d7-4225-adde-45cb49017a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_dd46d0e4-f927-453f-86ef-76569f0c8e46" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:to="loc_abvx_SharePriceMeasurementInputMember_dd46d0e4-f927-453f-86ef-76569f0c8e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_81e5e1cf-9f69-471c-ba68-4a73dba60b99" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8eabd7aa-1b3a-4360-be77-5d055e727eb5" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_81e5e1cf-9f69-471c-ba68-4a73dba60b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable_c5e960f5-b5cb-4587-ab18-7866c4f75e0e" xlink:to="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMarketCapitalizationThreshold_8415551d-0d8d-4433-9929-054f2da70cf4" xlink:href="abvx-20241231.xsd#abvx_EarnOutMarketCapitalizationThreshold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutMarketCapitalizationThreshold_8415551d-0d8d-4433-9929-054f2da70cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutPercentage_c6481ece-9fc6-4ba5-8e21-5b5dd7c3f984" xlink:href="abvx-20241231.xsd#abvx_EarnOutPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutPercentage_c6481ece-9fc6-4ba5-8e21-5b5dd7c3f984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutMaximumAmount_3b4998d1-3b4f-43ce-b1b9-58eabc0549bd" xlink:href="abvx-20241231.xsd#abvx_EarnOutMaximumAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutMaximumAmount_3b4998d1-3b4f-43ce-b1b9-58eabc0549bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_55ba5a4f-c351-4c61-8c92-c5c7df7590c4" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValueAssetsAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_EarnOutAtFairValueAssetsAcquisitions_55ba5a4f-c351-4c61-8c92-c5c7df7590c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_eedb8bb4-7722-4165-9362-3730047e2029" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_eedb8bb4-7722-4165-9362-3730047e2029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_cfdcdf07-71ba-4fe8-bd64-1ef31b72c081" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_cfdcdf07-71ba-4fe8-bd64-1ef31b72c081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_d93232f1-d924-49e8-a9be-c23e6a1d0866" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets_d93232f1-d924-49e8-a9be-c23e6a1d0866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_43fbd284-3df2-4207-89fa-a932f2b943af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems_805b023c-0984-44e1-8f03-18680611aa63" xlink:to="loc_ifrs-full_FinancialLiabilities_43fbd284-3df2-4207-89fa-a932f2b943af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_b056c77f-ae33-4205-8bb6-73422912644e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_b056c77f-ae33-4205-8bb6-73422912644e" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_91e92ce1-1278-4c70-915e-3969f6da6ce0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_91e92ce1-1278-4c70-915e-3969f6da6ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_609e7e78-a9b3-4b90-bf90-c86b8eddb02d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_91e92ce1-1278-4c70-915e-3969f6da6ce0" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_609e7e78-a9b3-4b90-bf90-c86b8eddb02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_221faa69-7b9f-4e79-ade7-28bf36b65c3e" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_609e7e78-a9b3-4b90-bf90-c86b8eddb02d" xlink:to="loc_abvx_EarnOutLiabilityMember_221faa69-7b9f-4e79-ade7-28bf36b65c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_169d0a5f-b3d6-406b-bc09-161fa1c0d438" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_210a3f5b-5cf1-4652-9713-ce0e8ed6f2bb" xlink:to="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_169d0a5f-b3d6-406b-bc09-161fa1c0d438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionPricingModelMember_d9394dde-f5ec-4f08-bb98-a73c3a43aebb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionPricingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain_169d0a5f-b3d6-406b-bc09-161fa1c0d438" xlink:to="loc_ifrs-full_OptionPricingModelMember_d9394dde-f5ec-4f08-bb98-a73c3a43aebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_5c47cffd-e764-487c-8487-578b0b0139aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:to="loc_ifrs-full_UnobservableInputsAxis_5c47cffd-e764-487c-8487-578b0b0139aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_5c47cffd-e764-487c-8487-578b0b0139aa" xlink:to="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c1eb0b49-9300-45a0-9f93-fd0136b7717b" xlink:href="abvx-20241231.xsd#abvx_RiskFreeInterestRateMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_RiskFreeInterestRateMeasurementInputMember_c1eb0b49-9300-45a0-9f93-fd0136b7717b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MarketCapitalizationMeasurementInputMember_f74a0ac4-615d-492e-ae6e-e8f4d3206e58" xlink:href="abvx-20241231.xsd#abvx_MarketCapitalizationMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_MarketCapitalizationMeasurementInputMember_f74a0ac4-615d-492e-ae6e-e8f4d3206e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_595d04ec-d832-4e47-be97-e1220b3fd097" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_SharePriceMeasurementInputMember_595d04ec-d832-4e47-be97-e1220b3fd097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResidualMaturityMeasurementInputMember_0602cdd0-19a8-4bff-825c-8fa4dc3e54e9" xlink:href="abvx-20241231.xsd#abvx_ResidualMaturityMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_ResidualMaturityMeasurementInputMember_0602cdd0-19a8-4bff-825c-8fa4dc3e54e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_58e31d62-c92b-472f-9e0c-18edf42813ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_58e31d62-c92b-472f-9e0c-18edf42813ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExpectedDividendMeasurementInputMember_3e0692d2-f5da-4990-9852-b569f1ee8d2e" xlink:href="abvx-20241231.xsd#abvx_ExpectedDividendMeasurementInputMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_8986f072-d6a9-41cc-8d6b-3e69531b88f6" xlink:to="loc_abvx_ExpectedDividendMeasurementInputMember_3e0692d2-f5da-4990-9852-b569f1ee8d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_8a10ad36-6abb-41db-98ff-4e0f20194d37" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_a3497b00-2d58-4694-8d36-00b685a867f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_a3497b00-2d58-4694-8d36-00b685a867f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutAtFairValue_74e3536e-282e-4ea0-a7dd-aee166cd6ef3" xlink:href="abvx-20241231.xsd#abvx_EarnOutAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_21f4c410-d726-4233-82d7-f1d7b170e23d" xlink:to="loc_abvx_EarnOutAtFairValue_74e3536e-282e-4ea0-a7dd-aee166cd6ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesRoyaltycertificatesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_f6dfa228-c0aa-4c7d-b031-18bfb095ab3a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_f6dfa228-c0aa-4c7d-b031-18bfb095ab3a" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_bb4aa2aa-5401-441b-a55a-2eca8916805a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_bb4aa2aa-5401-441b-a55a-2eca8916805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_d6accb36-0430-4114-8b37-4c18af8a66f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_bb4aa2aa-5401-441b-a55a-2eca8916805a" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_d6accb36-0430-4114-8b37-4c18af8a66f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_c87ed9c6-62df-49a1-be97-31b51a81b56f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_d6accb36-0430-4114-8b37-4c18af8a66f8" xlink:to="loc_ifrs-full_SharePremiumMember_c87ed9c6-62df-49a1-be97-31b51a81b56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_75aff47c-8db6-4cc3-a38b-26fcb9ca202e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_75aff47c-8db6-4cc3-a38b-26fcb9ca202e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_483bd941-a7db-4a70-8fb1-5b9cf9320c7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_75aff47c-8db6-4cc3-a38b-26fcb9ca202e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_483bd941-a7db-4a70-8fb1-5b9cf9320c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_9e6c3087-4346-4b78-8e00-77b893190e9d" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_483bd941-a7db-4a70-8fb1-5b9cf9320c7a" xlink:to="loc_abvx_RoyaltyCertificatesMember_9e6c3087-4346-4b78-8e00-77b893190e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_e0357ddd-159c-4a7d-a34f-a0ecba129b2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_e0357ddd-159c-4a7d-a34f-a0ecba129b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_df62a158-cb86-448e-96db-83e4889b9f01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_e0357ddd-159c-4a7d-a34f-a0ecba129b2e" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_df62a158-cb86-448e-96db-83e4889b9f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_6485906a-b75e-4f56-a2b7-d0701a4a7de7" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_df62a158-cb86-448e-96db-83e4889b9f01" xlink:to="loc_abvx_RoyaltyCertificatesMember_6485906a-b75e-4f56-a2b7-d0701a4a7de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_53067978-acd7-4b6a-af53-ec32f2833784" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_UnobservableInputsAxis_53067978-acd7-4b6a-af53-ec32f2833784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_53067978-acd7-4b6a-af53-ec32f2833784" xlink:to="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ProbabilityOfSuccessMeasurementInputMember_36a551f4-14c9-4dc4-aaf8-76a9aaedd4cb" xlink:href="abvx-20241231.xsd#abvx_ProbabilityOfSuccessMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_abvx_ProbabilityOfSuccessMeasurementInputMember_36a551f4-14c9-4dc4-aaf8-76a9aaedd4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PeakPenetrationMeasurementInputMember_d2241c9a-5164-4dd2-9837-03216e526b57" xlink:href="abvx-20241231.xsd#abvx_PeakPenetrationMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_abvx_PeakPenetrationMeasurementInputMember_d2241c9a-5164-4dd2-9837-03216e526b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember_e6f0e24e-5580-42dd-8e12-005c055701fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember_e6f0e24e-5580-42dd-8e12-005c055701fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SharePriceMeasurementInputMember_509c85e4-0bf4-41d4-8ef9-03c411e19e3f" xlink:href="abvx-20241231.xsd#abvx_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_69764bff-ee9d-4aa3-9c98-afe4438535b4" xlink:to="loc_abvx_SharePriceMeasurementInputMember_509c85e4-0bf4-41d4-8ef9-03c411e19e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_46cba441-a785-4d8e-a481-2f353e7a7be3" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_fe8115ba-03dc-4275-abef-057270a205b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_NotionalAmount_fe8115ba-03dc-4275-abef-057270a205b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherLiabilitiesNumberOfTransactions_7e70fc76-293d-4ab9-bcbb-164b7fb3e88c" xlink:href="abvx-20241231.xsd#abvx_OtherLiabilitiesNumberOfTransactions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_OtherLiabilitiesNumberOfTransactions_7e70fc76-293d-4ab9-bcbb-164b7fb3e88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_227e7931-f076-4e5b-82bb-51be7f3479a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_IssueOfEquity_227e7931-f076-4e5b-82bb-51be7f3479a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_05c453d7-5b0d-4d9f-bf7c-c260fd291ee5" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease_05c453d7-5b0d-4d9f-bf7c-c260fd291ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_0e86102b-e99d-4049-ab7c-a442e4071c37" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_ParValuePerShare_0e86102b-e99d-4049-ab7c-a442e4071c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EquityIssuanceSubscriptionPricePerShare_29c26930-0729-42f9-849e-a783682cb3a7" xlink:href="abvx-20241231.xsd#abvx_EquityIssuanceSubscriptionPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_EquityIssuanceSubscriptionPricePerShare_29c26930-0729-42f9-849e-a783682cb3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_777b0de8-1135-4586-bb96-9654c0eaaacc" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromSaleOfRoyaltyCertificates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_NetProceedsFromSaleOfRoyaltyCertificates_777b0de8-1135-4586-bb96-9654c0eaaacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_cc4f2211-d0fc-4fae-bc09-c029228ed87e" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatePercentageOfFutureSales"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_cc4f2211-d0fc-4fae-bc09-c029228ed87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateMaximumAmount_fffa1079-055e-406a-aa47-3687125229fc" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateMaximumAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_RoyaltyCertificateMaximumAmount_fffa1079-055e-406a-aa47-3687125229fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_cee45977-c5c8-4a82-aaa8-ce4c29e473bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_cee45977-c5c8-4a82-aaa8-ce4c29e473bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates_45ba4dc9-1342-4606-80b6-1c28dbe79871" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_NonCurrentRoyaltyCertificates_45ba4dc9-1342-4606-80b6-1c28dbe79871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates_856afe06-49a6-402b-b6c7-10d712d87052" xlink:href="abvx-20241231.xsd#abvx_DecreaseInInterestExpenseOnRoyaltyCertificates"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates_856afe06-49a6-402b-b6c7-10d712d87052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesEIR_fe19ab1b-38cc-431b-98a1-309bdb0d12e1" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesEIR"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_RoyaltyCertificatesEIR_fe19ab1b-38cc-431b-98a1-309bdb0d12e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_d1d37142-e0ed-444b-ba41-83d81d1e3a83" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_d1d37142-e0ed-444b-ba41-83d81d1e3a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestExpenseOnRoyaltyCertificates_22ad1584-0839-4592-8013-d9af5cd2dc7a" xlink:href="abvx-20241231.xsd#abvx_InterestExpenseOnRoyaltyCertificates"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_InterestExpenseOnRoyaltyCertificates_22ad1584-0839-4592-8013-d9af5cd2dc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnwindingOfDiscountOnRoyalties_bd80bff1-fcbd-4102-8966-0e54e304513e" xlink:href="abvx-20241231.xsd#abvx_UnwindingOfDiscountOnRoyalties"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_UnwindingOfDiscountOnRoyalties_bd80bff1-fcbd-4102-8966-0e54e304513e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_cc698959-ce48-42a6-9896-882bbcf56899" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_cc698959-ce48-42a6-9896-882bbcf56899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3670f498-99f0-4143-92b9-6df75b17bab4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_3670f498-99f0-4143-92b9-6df75b17bab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_d78764e9-698b-4886-a50b-c978ae688d67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_d78764e9-698b-4886-a50b-c978ae688d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_eada3598-d63c-43d8-8f78-d57903bfc0ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_eada3598-d63c-43d8-8f78-d57903bfc0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_26838da6-d22f-4b77-977f-5b209c0d3770" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_26838da6-d22f-4b77-977f-5b209c0d3770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_c57b497d-01bc-4b22-8c7f-5948b9730fac" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities_c57b497d-01bc-4b22-8c7f-5948b9730fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_615af7a9-a952-4216-a0a4-1c0462f2e40e" xlink:href="abvx-20241231.xsd#abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_468dc1a2-917c-41c7-ab8a-8b4535403a6f" xlink:to="loc_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities_615af7a9-a952-4216-a0a4-1c0462f2e40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_3ff10847-0359-408b-92a2-2cc1b1be5963" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_efdd048b-cf5a-41f7-aec4-fbff8ecddcc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_3ff10847-0359-408b-92a2-2cc1b1be5963" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_efdd048b-cf5a-41f7-aec4-fbff8ecddcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_efdd048b-cf5a-41f7-aec4-fbff8ecddcc3" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_16b67146-ed7a-4fba-9173-8f0bfbcc3e6a" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_5469c356-092c-44b4-b67f-8557d578b9fa" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_Kreos12BondLoansMember_5469c356-092c-44b4-b67f-8557d578b9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_cb15e965-8f03-42c6-8b69-d91d47f24ad2" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_OCEANEMember_cb15e965-8f03-42c6-8b69-d91d47f24ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_8bf5e16e-fd60-4d6d-bfdc-088012a1039c" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_8bf5e16e-fd60-4d6d-bfdc-088012a1039c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos1ClaretBondLoansMember_d607bc9a-fdd8-4618-9315-6de857fbbd74" xlink:href="abvx-20241231.xsd#abvx_Kreos1ClaretBondLoansMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_Kreos1ClaretBondLoansMember_d607bc9a-fdd8-4618-9315-6de857fbbd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_96c041bd-6898-4018-95cc-7c15a19bca46" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_HeightsConvertibleNotesMember_96c041bd-6898-4018-95cc-7c15a19bca46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_28e9b285-b453-4ed3-ad31-23f6326c3d25" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_28e9b285-b453-4ed3-ad31-23f6326c3d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesMember_066bd15a-f0b7-4265-a099-690b46619092" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_ConditionalAdvancesMember_066bd15a-f0b7-4265-a099-690b46619092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_48ba8372-fc68-4539-8ae0-2567085aed58" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_48ba8372-fc68-4539-8ae0-2567085aed58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EarnOutLiabilityMember_653f50fa-ad3e-434d-9c88-1efef827a987" xlink:href="abvx-20241231.xsd#abvx_EarnOutLiabilityMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_EarnOutLiabilityMember_653f50fa-ad3e-434d-9c88-1efef827a987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_241db29d-935d-4e1f-a4b9-5abfcf5f406b" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_b2e6365a-f83e-4f40-baac-3a25c032ccf4" xlink:to="loc_abvx_RoyaltyCertificatesMember_241db29d-935d-4e1f-a4b9-5abfcf5f406b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_efdd048b-cf5a-41f7-aec4-fbff8ecddcc3" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_3e00fef7-969b-4b9c-b5e9-171722f15b41" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_3e00fef7-969b-4b9c-b5e9-171722f15b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities_a8765ab7-61ac-44a3-98e7-b22f13875f5d" xlink:href="abvx-20241231.xsd#abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities_a8765ab7-61ac-44a3-98e7-b22f13875f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_f4645357-73c7-469b-afd6-109dbf10df4c" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_f4645357-73c7-469b-afd6-109dbf10df4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities_98501029-0090-4272-9435-d4a6382c4e5f" xlink:href="abvx-20241231.xsd#abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities_98501029-0090-4272-9435-d4a6382c4e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities_7f05dec4-ef5a-4914-a95d-257c6730ac17" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities_7f05dec4-ef5a-4914-a95d-257c6730ac17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities_034282f5-de02-4493-9ad1-a2f5d409aa6f" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities_034282f5-de02-4493-9ad1-a2f5d409aa6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_89fb7f7a-6f65-4f97-8197-8fbc55af4aeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_89fb7f7a-6f65-4f97-8197-8fbc55af4aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities_5abec047-23e8-4733-a05d-92b2218d9a50" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities_5abec047-23e8-4733-a05d-92b2218d9a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_2c560a1e-4d9e-4f42-b516-64657bcddc87" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities_2c560a1e-4d9e-4f42-b516-64657bcddc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_c27be95c-4fd0-48db-81c3-a0b9ce98bba5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_c27be95c-4fd0-48db-81c3-a0b9ce98bba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities_4118c218-b572-4358-a01e-0d1594a36a57" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities_4118c218-b572-4358-a01e-0d1594a36a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_6c4ba1d8-d422-454d-8db3-af669310c6b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_6c4ba1d8-d422-454d-8db3-af669310c6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_8e944854-e41c-4dec-9c56-d8b6bd2e9370" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_8e944854-e41c-4dec-9c56-d8b6bd2e9370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_7d32ec20-3f82-40e1-920a-72978954f763" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_60b2c027-866d-4342-800a-39fd3efebf9c" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_7d32ec20-3f82-40e1-920a-72978954f763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesChangeinfinancialliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_b95b3f8a-c3a9-4812-85e0-b6f8554b2182" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_b95b3f8a-c3a9-4812-85e0-b6f8554b2182" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_467347cd-c335-4adb-9c24-3c5176817a02" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_467347cd-c335-4adb-9c24-3c5176817a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_467347cd-c335-4adb-9c24-3c5176817a02" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_eafe0eac-9e97-43d5-bfa1-cc55c8f499af" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_eafe0eac-9e97-43d5-bfa1-cc55c8f499af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_bebb064b-e50c-466e-9909-7b5c9783bc97" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_bebb064b-e50c-466e-9909-7b5c9783bc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_8c7614a7-1693-4158-9a6d-71a2c497fa42" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_HeightsConvertibleNotesMember_8c7614a7-1693-4158-9a6d-71a2c497fa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_3a7b3393-043d-48c5-a46e-92bb4e52c759" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_OCEANEMember_3a7b3393-043d-48c5-a46e-92bb4e52c759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheBMember_34f8f1de-a5d3-407a-87bb-bfd2e988fad9" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheBMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheBMember_34f8f1de-a5d3-407a-87bb-bfd2e988fad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheCMember_123e6ce1-4e4e-46cf-90c5-d26aa8341643" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheCMember_123e6ce1-4e4e-46cf-90c5-d26aa8341643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheABMember_d91b4816-4f4f-4ad6-9014-2d65e47cab49" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheABMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5d768dc0-7e2c-4b73-87be-5c83565ede95" xlink:to="loc_abvx_KreosClaretFinancingTrancheABMember_d91b4816-4f4f-4ad6-9014-2d65e47cab49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f2cc4685-4983-437c-8bda-245e2d54614e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f2cc4685-4983-437c-8bda-245e2d54614e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3dc139b5-64d2-4c64-81ff-f00694570316" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f2cc4685-4983-437c-8bda-245e2d54614e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3dc139b5-64d2-4c64-81ff-f00694570316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_9d87a05b-28c2-45b1-89d1-d5d2d7d4ea49" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3dc139b5-64d2-4c64-81ff-f00694570316" xlink:to="loc_abvx_OceaneConversionOptionMember_9d87a05b-28c2-45b1-89d1-d5d2d7d4ea49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_44304055-a805-4ab8-8055-0a7732ccc84e" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForDebtIssueCosts_bafa97ee-ab1c-45b5-a1b4-1a3a0715bef4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForDebtIssueCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_ifrs-full_PaymentsForDebtIssueCosts_bafa97ee-ab1c-45b5-a1b4-1a3a0715bef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NetProceedsFromConvertibleLoansNotes_d6b06c6b-4d9e-4be7-8579-b3bb0499395e" xlink:href="abvx-20241231.xsd#abvx_NetProceedsFromConvertibleLoansNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_NetProceedsFromConvertibleLoansNotes_d6b06c6b-4d9e-4be7-8579-b3bb0499395e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepurchaseOfDerivativeInstruments_aac35b34-a9d5-471e-bd78-4839fac34421" xlink:href="abvx-20241231.xsd#abvx_RepurchaseOfDerivativeInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_RepurchaseOfDerivativeInstruments_aac35b34-a9d5-471e-bd78-4839fac34421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConvertibleLoansNotes_e1dfa375-36a8-4367-8d10-e0d3e7657095" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConvertibleLoansNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_RepaymentsOfConvertibleLoansNotes_e1dfa375-36a8-4367-8d10-e0d3e7657095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GrossProceedsFromNonConvertibleLoansNotes_b9f08138-dc63-4431-a6a7-5c50a607f76c" xlink:href="abvx-20241231.xsd#abvx_GrossProceedsFromNonConvertibleLoansNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_9c72a9f9-e907-4e36-a1fd-5cd31089f596" xlink:to="loc_abvx_GrossProceedsFromNonConvertibleLoansNotes_b9f08138-dc63-4431-a6a7-5c50a607f76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_7cf4151b-2cbf-4113-b251-168f9e76f752" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_6f21f287-78b1-4db6-a81b-32e58754ed8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_7cf4151b-2cbf-4113-b251-168f9e76f752" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_6f21f287-78b1-4db6-a81b-32e58754ed8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_6ef1ae0f-c27a-464e-825d-32af8ec43502" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_6f21f287-78b1-4db6-a81b-32e58754ed8e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_6ef1ae0f-c27a-464e-825d-32af8ec43502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_6ef1ae0f-c27a-464e-825d-32af8ec43502" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABSAMember_a502073e-7fd6-4703-be24-1bf933d0da9b" xlink:href="abvx-20241231.xsd#abvx_KreosABSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosABSAMember_a502073e-7fd6-4703-be24-1bf933d0da9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosBBSAMember_bb7b7d60-aa83-42f2-990b-75932611c656" xlink:href="abvx-20241231.xsd#abvx_KreosBBSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosBBSAMember_bb7b7d60-aa83-42f2-990b-75932611c656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_77cc9422-26c3-47e6-becb-bfdb127d757e" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_OceaneConversionOptionMember_77cc9422-26c3-47e6-becb-bfdb127d757e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_a736b66b-3da7-4663-a2f1-14f00063aadf" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_a736b66b-3da7-4663-a2f1-14f00063aadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_571b0a72-b367-4775-ad40-ebe21e9ed4ca" xlink:href="abvx-20241231.xsd#abvx_KreosClaretMinimumReturnIndemnificationsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_bf81b544-182c-4c44-86d5-19ccda93caa9" xlink:to="loc_abvx_KreosClaretMinimumReturnIndemnificationsMember_571b0a72-b367-4775-ad40-ebe21e9ed4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_6f21f287-78b1-4db6-a81b-32e58754ed8e" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_eb04597c-f00d-45fb-8b67-2f1cd3008f46" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_eb04597c-f00d-45fb-8b67-2f1cd3008f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IssuanceOfDerivativeInstruments_4ecceba0-6f8a-48bc-9a7d-c54ccd192161" xlink:href="abvx-20241231.xsd#abvx_IssuanceOfDerivativeInstruments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_abvx_IssuanceOfDerivativeInstruments_4ecceba0-6f8a-48bc-9a7d-c54ccd192161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_4400f85d-8aea-48dc-b1f6-64b13f6a5299" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_4400f85d-8aea-48dc-b1f6-64b13f6a5299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_d25086c7-cddb-4db7-80b3-2d246097858d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsOnChangeInFairValueOfDerivatives"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_d25086c7-cddb-4db7-80b3-2d246097858d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepurchaseOfDerivativeInstruments_b95f0795-6380-4e66-bc1e-a0823db60f9b" xlink:href="abvx-20241231.xsd#abvx_RepurchaseOfDerivativeInstruments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_abvx_RepurchaseOfDerivativeInstruments_b95f0795-6380-4e66-bc1e-a0823db60f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExerciseOfDerivativeInstruments_42dcd99d-0ad0-43a4-82b2-c45d125f3228" xlink:href="abvx-20241231.xsd#abvx_ExerciseOfDerivativeInstruments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_abvx_ExerciseOfDerivativeInstruments_42dcd99d-0ad0-43a4-82b2-c45d125f3228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_c00bc866-2ec9-41dc-8b2e-6599a7d7361e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_c4cd8e01-7c25-4c09-ba9f-630103e1cd5f" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_c00bc866-2ec9-41dc-8b2e-6599a7d7361e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesChangeinderivativeinstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_d2023325-8fdc-4aee-a0e2-092d3cb4b46b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_7b124add-deda-454f-ab31-5fe0a5d83b9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_d2023325-8fdc-4aee-a0e2-092d3cb4b46b" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_7b124add-deda-454f-ab31-5fe0a5d83b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f1e189ab-861c-44be-bfd8-b49b0e32493f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_7b124add-deda-454f-ab31-5fe0a5d83b9f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f1e189ab-861c-44be-bfd8-b49b0e32493f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f1e189ab-861c-44be-bfd8-b49b0e32493f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosABBSAMember_c17acfbf-710c-469d-80cf-a6993f24ad07" xlink:href="abvx-20241231.xsd#abvx_KreosABBSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:to="loc_abvx_KreosABBSAMember_c17acfbf-710c-469d-80cf-a6993f24ad07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OCEANEMember_e941340e-4bcf-4c40-bd99-b9b20b578313" xlink:href="abvx-20241231.xsd#abvx_OCEANEMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_c8d68625-6943-43d4-8607-83fc92695831" xlink:to="loc_abvx_OCEANEMember_e941340e-4bcf-4c40-bd99-b9b20b578313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_7b124add-deda-454f-ab31-5fe0a5d83b9f" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_d1da9f04-d166-476c-98e8-20f0d75df9de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_d1da9f04-d166-476c-98e8-20f0d75df9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_f99c88b5-a9b8-4102-9e27-dad9877687f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_144d1aea-bac6-4b5d-b1b5-01b02630c36f" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_f99c88b5-a9b8-4102-9e27-dad9877687f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ab30b3e6-70e7-4d93-9b5b-d1098f9a49c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ab30b3e6-70e7-4d93-9b5b-d1098f9a49c3" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_b9476732-c4b8-4f13-8f96-d5e28c57aae7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_b9476732-c4b8-4f13-8f96-d5e28c57aae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_b9476732-c4b8-4f13-8f96-d5e28c57aae7" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_Kreos12BondLoansMember_a71fb868-3b87-4afa-8b2f-629e0147c6dd" xlink:href="abvx-20241231.xsd#abvx_Kreos12BondLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_Kreos12BondLoansMember_a71fb868-3b87-4afa-8b2f-629e0147c6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OceaneConversionOptionMember_60058702-7efa-4e55-a895-0063140d5094" xlink:href="abvx-20241231.xsd#abvx_OceaneConversionOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_OceaneConversionOptionMember_60058702-7efa-4e55-a895-0063140d5094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesMember_3842e502-f63f-43ba-a36c-ef71f0085fef" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_HeightsConvertibleNotesMember_3842e502-f63f-43ba-a36c-ef71f0085fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingTrancheAMember_f378ff39-d30a-4402-97e9-ce32c1b6e297" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingTrancheAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_KreosClaretFinancingTrancheAMember_f378ff39-d30a-4402-97e9-ce32c1b6e297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretBondLoansMember_d54bc89d-ece1-4be0-bb08-d70c106d585e" xlink:href="abvx-20241231.xsd#abvx_KreosClaretBondLoansMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_KreosClaretBondLoansMember_d54bc89d-ece1-4be0-bb08-d70c106d585e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PretGarantiParLEtatPGEMember_98a4183f-137f-457a-9add-05740e9be380" xlink:href="abvx-20241231.xsd#abvx_PretGarantiParLEtatPGEMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_PretGarantiParLEtatPGEMember_98a4183f-137f-457a-9add-05740e9be380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BanquePubliqueDInvestissementBPIMember_d1aa17c7-828d-4ef1-874d-9cb69c17db9b" xlink:href="abvx-20241231.xsd#abvx_BanquePubliqueDInvestissementBPIMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_87686f7a-07c4-4c1c-b5e7-5a606d95cb3c" xlink:to="loc_abvx_BanquePubliqueDInvestissementBPIMember_d1aa17c7-828d-4ef1-874d-9cb69c17db9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_b579f320-0d4c-4bdc-ba50-6f38174aa28f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:to="loc_ifrs-full_MaturityAxis_b579f320-0d4c-4bdc-ba50-6f38174aa28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_b579f320-0d4c-4bdc-ba50-6f38174aa28f" xlink:to="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_0a1a8046-36ee-4a2e-a9e0-5a6d670dbdd5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_0a1a8046-36ee-4a2e-a9e0-5a6d670dbdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_a31ac040-7d5c-4288-a250-2b5b9152eaa8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_a31ac040-7d5c-4288-a250-2b5b9152eaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_df43661b-87b6-46df-b891-6aa587ec9766" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_df43661b-87b6-46df-b891-6aa587ec9766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_80090809-cd1a-4af0-9105-5bbbb1bf60e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_61f18a2c-d420-4920-9a3b-f9ba2525cd19" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_80090809-cd1a-4af0-9105-5bbbb1bf60e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_b0726a3f-64c4-44f9-aa35-5cf0829b44c4" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_1551da37-474d-49a9-bed1-2d96ddb43c4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_Borrowings_1551da37-474d-49a9-bed1-2d96ddb43c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_630e579c-9c6a-4c4c-a799-a8345ebd6723" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_630e579c-9c6a-4c4c-a799-a8345ebd6723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotes_84631dba-ee5d-4671-ae87-f351ca9ec48b" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConvertibleLoansNotes_84631dba-ee5d-4671-ae87-f351ca9ec48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows_9e521b88-cd9d-4b22-8169-6d5e0f2f4845" xlink:href="abvx-20241231.xsd#abvx_ConvertibleLoansNotesUndiscountedCashFlows"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConvertibleLoansNotesUndiscountedCashFlows_9e521b88-cd9d-4b22-8169-6d5e0f2f4845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvances_0dc0a377-192d-476d-8912-1c2482b87268" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvances"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConditionalAdvances_0dc0a377-192d-476d-8912-1c2482b87268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ConditionalAdvancesUndiscountedCashFlows_1f0abed9-4b48-4c2a-ba53-083ef42dc166" xlink:href="abvx-20241231.xsd#abvx_ConditionalAdvancesUndiscountedCashFlows"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_ConditionalAdvancesUndiscountedCashFlows_1f0abed9-4b48-4c2a-ba53-083ef42dc166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NonCurrentRoyaltyCertificates_615b8946-e4c9-40c6-b813-a8600131b30d" xlink:href="abvx-20241231.xsd#abvx_NonCurrentRoyaltyCertificates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_NonCurrentRoyaltyCertificates_615b8946-e4c9-40c6-b813-a8600131b30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows_1a1b08d6-e9da-4d81-9f77-8e52bef2de06" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesUndiscountedCashFlows"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_RoyaltyCertificatesUndiscountedCashFlows_1a1b08d6-e9da-4d81-9f77-8e52bef2de06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_d52ab084-93c4-4708-a532-38f5f630a0fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_LeaseLiabilities_d52ab084-93c4-4708-a532-38f5f630a0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_bbd3b9b0-0f80-4ec5-a112-3f43fc84ecb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_bbd3b9b0-0f80-4ec5-a112-3f43fc84ecb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_9bec0a1a-8dc5-49bd-b868-5c95ffb16e30" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_9bec0a1a-8dc5-49bd-b868-5c95ffb16e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_6e742d5a-2274-4d1b-92c0-4046b8d89b77" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_6e742d5a-2274-4d1b-92c0-4046b8d89b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_10504042-84ac-4df3-9b8d-a4868d0c265e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_ifrs-full_FinancialLiabilities_10504042-84ac-4df3-9b8d-a4868d0c265e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_5abb9fa2-5ea8-4e1a-8469-dee12686bbee" xlink:href="abvx-20241231.xsd#abvx_FinancialLiabilitiesUndiscountedCashFlows"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_8d88672d-b36f-4e89-a4b2-6c92e0ac25f5" xlink:to="loc_abvx_FinancialLiabilitiesUndiscountedCashFlows_5abb9fa2-5ea8-4e1a-8469-dee12686bbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_177d5981-db86-4b39-9dea-88bf84f7a0c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_6b3df263-c538-4662-9ec9-c7ee9cf4768c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_177d5981-db86-4b39-9dea-88bf84f7a0c8" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_6b3df263-c538-4662-9ec9-c7ee9cf4768c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4a172f30-94c7-4743-b227-f2c42f566e97" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_6b3df263-c538-4662-9ec9-c7ee9cf4768c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4a172f30-94c7-4743-b227-f2c42f566e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e796cd91-b142-4145-af1b-25c1d73e4d72" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4a172f30-94c7-4743-b227-f2c42f566e97" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e796cd91-b142-4145-af1b-25c1d73e4d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatesMember_258de658-1e31-4719-952d-082e0a2283eb" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_e796cd91-b142-4145-af1b-25c1d73e4d72" xlink:to="loc_abvx_RoyaltyCertificatesMember_258de658-1e31-4719-952d-082e0a2283eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_6b3df263-c538-4662-9ec9-c7ee9cf4768c" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_591ee23c-b9bb-451d-8c70-1b1c923edbbd" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificatePercentageOfFutureSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:to="loc_abvx_RoyaltyCertificatePercentageOfFutureSales_591ee23c-b9bb-451d-8c70-1b1c923edbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateMaximumAmount_3f335109-2c2f-47a9-8e98-85eb538003c6" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateMaximumAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:to="loc_abvx_RoyaltyCertificateMaximumAmount_3f335109-2c2f-47a9-8e98-85eb538003c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RoyaltyCertificateExpirationPeriod_05cc633e-c728-4859-b58f-e8bc55599260" xlink:href="abvx-20241231.xsd#abvx_RoyaltyCertificateExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_02b17ab4-d791-4944-b26f-9aa333e93c64" xlink:to="loc_abvx_RoyaltyCertificateExpirationPeriod_05cc633e-c728-4859-b58f-e8bc55599260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_3f4e1256-6341-40d5-b7fd-d706b7e3ce99" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_3f4e1256-6341-40d5-b7fd-d706b7e3ce99" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b1252ec5-17af-46ec-b341-5753b07b7a17" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:to="loc_srt_TitleOfIndividualAxis_b1252ec5-17af-46ec-b341-5753b07b7a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_b1252ec5-17af-46ec-b341-5753b07b7a17" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ManagementMember_efabaacb-7899-44ef-835b-37201f2a3d14" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ManagementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:to="loc_srt_ManagementMember_efabaacb-7899-44ef-835b-37201f2a3d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherEmployeesMember_282e7315-195d-4544-af6d-46a7c1a62e6d" xlink:href="abvx-20241231.xsd#abvx_OtherEmployeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e6b39b3-7085-45b6-a16b-3788d2cf8075" xlink:to="loc_abvx_OtherEmployeesMember_282e7315-195d-4544-af6d-46a7c1a62e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_66fd268e-7d2e-44f8-a441-a61439cc11f4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:to="loc_srt_RangeAxis_66fd268e-7d2e-44f8-a441-a61439cc11f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_66fd268e-7d2e-44f8-a441-a61439cc11f4" xlink:to="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_79b8656b-5b43-4ac1-80d3-84dd4c140dc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:to="loc_ifrs-full_TopOfRangeMember_79b8656b-5b43-4ac1-80d3-84dd4c140dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_ce8df712-e7fc-49b3-936d-0d351da95943" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0c400605-193a-4d84-a90c-02134081abfb" xlink:to="loc_ifrs-full_BottomOfRangeMember_ce8df712-e7fc-49b3-936d-0d351da95943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ab1a4b9c-d482-4ff1-9c9c-b1be9de16220" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_6ae19b7a-bacd-4ecb-ace4-bf393b403672" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfRetirementAge2019"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_6ae19b7a-bacd-4ecb-ace4-bf393b403672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_ec1e0915-2222-4b9d-9bc5-ee06d5fe5cc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_ec1e0915-2222-4b9d-9bc5-ee06d5fe5cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_573afe00-7cdf-4a26-b554-d53dbac15369" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_573afe00-7cdf-4a26-b554-d53dbac15369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover_8a51b803-0c3a-4008-a617-a11daa84798e" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfExpectedRatesOfTurnover"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover_8a51b803-0c3a-4008-a617-a11daa84798e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate_ffe318e9-c5a7-4b81-adb6-ff1cccb53412" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate_ffe318e9-c5a7-4b81-adb6-ff1cccb53412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ActuarialAssumptionOfEmployeeContributionRate_024c807c-7e1b-474c-b010-31067ec7e2f3" xlink:href="abvx-20241231.xsd#abvx_ActuarialAssumptionOfEmployeeContributionRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_47ff010e-e94c-42b2-a2d7-040507ce25cc" xlink:to="loc_abvx_ActuarialAssumptionOfEmployeeContributionRate_024c807c-7e1b-474c-b010-31067ec7e2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_e5c747f2-6744-4531-aa29-a251f449cd1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_bda5b84b-8bd4-4145-88c5-422de9207d43" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_e5c747f2-6744-4531-aa29-a251f449cd1e" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_bda5b84b-8bd4-4145-88c5-422de9207d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_a1eb21f5-c796-46c0-af5a-e6bea8546ff8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_bda5b84b-8bd4-4145-88c5-422de9207d43" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_a1eb21f5-c796-46c0-af5a-e6bea8546ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6a5ea033-9180-4824-9cca-40a9427a6db4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_a1eb21f5-c796-46c0-af5a-e6bea8546ff8" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6a5ea033-9180-4824-9cca-40a9427a6db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_4c3dd6cd-a716-4786-bafb-0aacf07084bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6a5ea033-9180-4824-9cca-40a9427a6db4" xlink:to="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_4c3dd6cd-a716-4786-bafb-0aacf07084bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_bda5b84b-8bd4-4145-88c5-422de9207d43" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_9f9b5d4c-2cf4-4e4c-befe-f8e58c0e1755" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_9f9b5d4c-2cf4-4e4c-befe-f8e58c0e1755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_ce17be56-be01-488f-a5b2-25e88fbd6d84" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_ce17be56-be01-488f-a5b2-25e88fbd6d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_cfaabe9c-8be8-41e3-972b-0a9ff8520710" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_cfaabe9c-8be8-41e3-972b-0a9ff8520710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_1f7abf10-b1b6-4c8a-8d6f-75657fc06649" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_1f7abf10-b1b6-4c8a-8d6f-75657fc06649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_ebb4fa66-9b0c-4534-a65c-ed720429dca6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_ebb4fa66-9b0c-4534-a65c-ed720429dca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_ef25ece3-fbfa-4021-9593-08d17c718001" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_208294b2-f20c-4e69-8249-5a97772842c6" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_ef25ece3-fbfa-4021-9593-08d17c718001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_a2aae32c-8894-4c6d-900d-6137c0cefc8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_b14c69c8-0976-4d36-bbd7-9e4a6b39358b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_a2aae32c-8894-4c6d-900d-6137c0cefc8b" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_b14c69c8-0976-4d36-bbd7-9e4a6b39358b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent_c768c3f9-a767-4156-a74b-d6fcb978f092" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_a2aae32c-8894-4c6d-900d-6137c0cefc8b" xlink:to="loc_ifrs-full_AccrualsClassifiedAsCurrent_c768c3f9-a767-4156-a74b-d6fcb978f092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherCurrentPayablesIncludingAdjustments_cf61375b-04ed-4de1-91a7-5e8bcae1f689" xlink:href="abvx-20241231.xsd#abvx_OtherCurrentPayablesIncludingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_a2aae32c-8894-4c6d-900d-6137c0cefc8b" xlink:to="loc_abvx_OtherCurrentPayablesIncludingAdjustments_cf61375b-04ed-4de1-91a7-5e8bcae1f689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_322106bc-e803-41d6-996f-12f3b67aa2a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_a2aae32c-8894-4c6d-900d-6137c0cefc8b" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_322106bc-e803-41d6-996f-12f3b67aa2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_c45e434b-4df7-4d3c-8b58-83e0efdc0b15" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_fcf532c8-9b07-4f3a-bd57-e4f8ca859653" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_c45e434b-4df7-4d3c-8b58-83e0efdc0b15" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_fcf532c8-9b07-4f3a-bd57-e4f8ca859653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_1e93f5f4-6b59-427e-9af1-da5aec33614f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_c45e434b-4df7-4d3c-8b58-83e0efdc0b15" xlink:to="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_1e93f5f4-6b59-427e-9af1-da5aec33614f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments_43feb0c5-84ee-4cc7-a685-b411d1958d81" xlink:href="abvx-20241231.xsd#abvx_CurrentPayablesOnOtherTaxAndRelatedPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_c45e434b-4df7-4d3c-8b58-83e0efdc0b15" xlink:to="loc_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments_43feb0c5-84ee-4cc7-a685-b411d1958d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_238584cb-f2a5-4c0e-8528-5cff58fef7e8" xlink:href="abvx-20241231.xsd#abvx_CurrentTaxAndEmployeeBenefitLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_c45e434b-4df7-4d3c-8b58-83e0efdc0b15" xlink:to="loc_abvx_CurrentTaxAndEmployeeBenefitLiabilities_238584cb-f2a5-4c0e-8528-5cff58fef7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingincomeDisclosureofbreakdownofoperatingincomeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAbstract_8edd22aa-b55f-4829-94ab-35ee5ae6bc9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncomeFromResearchTaxCredit_3c129b30-71d5-4f9b-8de7-40a0211f1488" xlink:href="abvx-20241231.xsd#abvx_IncomeFromResearchTaxCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_8edd22aa-b55f-4829-94ab-35ee5ae6bc9d" xlink:to="loc_abvx_IncomeFromResearchTaxCredit_3c129b30-71d5-4f9b-8de7-40a0211f1488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_730c8c28-f182-47dc-8371-38b278e8fc7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_8edd22aa-b55f-4829-94ab-35ee5ae6bc9d" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_730c8c28-f182-47dc-8371-38b278e8fc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_b9ec7691-7cb6-4460-8ada-0ce351b8833e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_8edd22aa-b55f-4829-94ab-35ee5ae6bc9d" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_b9ec7691-7cb6-4460-8ada-0ce351b8833e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_f9670b10-e542-4e40-a080-a60151122a49" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_8edd22aa-b55f-4829-94ab-35ee5ae6bc9d" xlink:to="loc_ifrs-full_OtherIncome_f9670b10-e542-4e40-a080-a60151122a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingincomeNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingincomeNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingincomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAbstract_b469254c-0f84-44a0-a43c-89a7c6ae6b40" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOperatingIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_b469254c-0f84-44a0-a43c-89a7c6ae6b40" xlink:to="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CIRTaxYearAxis_36efd9ee-99fb-40bb-a871-accabb6d05de" xlink:href="abvx-20241231.xsd#abvx_CIRTaxYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:to="loc_abvx_CIRTaxYearAxis_36efd9ee-99fb-40bb-a871-accabb6d05de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:href="abvx-20241231.xsd#abvx_CIRTaxYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_CIRTaxYearAxis_36efd9ee-99fb-40bb-a871-accabb6d05de" xlink:to="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2021TaxYearMember_917a570a-b2d7-43e8-8665-3913a45209bb" xlink:href="abvx-20241231.xsd#abvx_A2021TaxYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:to="loc_abvx_A2021TaxYearMember_917a570a-b2d7-43e8-8665-3913a45209bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2022TaxYearMember_2b933b89-27e3-4062-be3c-40cd860fbfed" xlink:href="abvx-20241231.xsd#abvx_A2022TaxYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:to="loc_abvx_A2022TaxYearMember_2b933b89-27e3-4062-be3c-40cd860fbfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_A2023TaxYearMember_d71c0889-b12b-4dc3-8da5-c7f3a1066f96" xlink:href="abvx-20241231.xsd#abvx_A2023TaxYearMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_CIRTaxYearDomain_8209b09b-77ca-400e-8be4-92e30136917e" xlink:to="loc_abvx_A2023TaxYearMember_d71c0889-b12b-4dc3-8da5-c7f3a1066f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bad64afd-3d01-4f60-9216-00d9f8e4312c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bad64afd-3d01-4f60-9216-00d9f8e4312c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bad64afd-3d01-4f60-9216-00d9f8e4312c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_49240140-64b7-4f4b-868f-c34c1a2c5772" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_49240140-64b7-4f4b-868f-c34c1a2c5772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_46ec396d-d186-4346-a25f-4f4b38533d15" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_49009419-ce6b-4f76-9ff6-23a5e5784f80" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_46ec396d-d186-4346-a25f-4f4b38533d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOperatingIncomeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOperatingIncomeTable_c468b6fe-6a44-4457-81cb-33f6d562521a" xlink:to="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncomeFromResearchTaxCredit_8e2f7e0b-45f8-4523-8867-50bd965103af" xlink:href="abvx-20241231.xsd#abvx_IncomeFromResearchTaxCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:to="loc_abvx_IncomeFromResearchTaxCredit_8e2f7e0b-45f8-4523-8867-50bd965103af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_4300602c-df9e-483b-93cf-0915b483d3fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOperatingIncomeLineItems_5fd7f929-23b8-449b-8948-c19d6d7c83a5" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_4300602c-df9e-483b-93cf-0915b483d3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofsalesandmarketingexpensesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_b60b9322-eb50-49de-be73-861206e3fffd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_25cf180e-f8f6-4444-b708-4ac35120fc09" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_b60b9322-eb50-49de-be73-861206e3fffd" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_25cf180e-f8f6-4444-b708-4ac35120fc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_044262e5-5a7c-4ec7-b0bc-24a7784deeca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_25cf180e-f8f6-4444-b708-4ac35120fc09" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_044262e5-5a7c-4ec7-b0bc-24a7784deeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_181d529c-98dd-475a-8b18-d7e623688917" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_044262e5-5a7c-4ec7-b0bc-24a7784deeca" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_181d529c-98dd-475a-8b18-d7e623688917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SalesAndMarketingExpenseMember_b4573fd1-366b-422b-9196-7174cd85a361" xlink:href="abvx-20241231.xsd#abvx_SalesAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_181d529c-98dd-475a-8b18-d7e623688917" xlink:to="loc_abvx_SalesAndMarketingExpenseMember_b4573fd1-366b-422b-9196-7174cd85a361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_25cf180e-f8f6-4444-b708-4ac35120fc09" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_dd3e3ad0-3f2e-45da-8e47-142ca36631ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_dd3e3ad0-3f2e-45da-8e47-142ca36631ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_a5268dee-bf88-4e2b-ad25-1b07ca40f7e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_a5268dee-bf88-4e2b-ad25-1b07ca40f7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_af615b6b-f02e-4303-b37e-f95800ec01f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_af615b6b-f02e-4303-b37e-f95800ec01f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_919619f1-2feb-4350-95e2-a0c2c6f73046" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_02463edb-ef13-4847-a4f9-63f3674ed5d7" xlink:to="loc_ifrs-full_OperatingExpense_919619f1-2feb-4350-95e2-a0c2c6f73046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingexpensesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_e1ef2fcd-5bc3-46ea-917d-93076d30e6c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f216be98-207a-4716-b5b0-7fa2898a07d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_e1ef2fcd-5bc3-46ea-917d-93076d30e6c4" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f216be98-207a-4716-b5b0-7fa2898a07d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72ec8b67-0141-4969-a366-bbfab69844c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f216be98-207a-4716-b5b0-7fa2898a07d5" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72ec8b67-0141-4969-a366-bbfab69844c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_72ec8b67-0141-4969-a366-bbfab69844c6" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentExpensesMember_b70b7ae8-5bb7-4675-b946-d92e4466ccd2" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:to="loc_abvx_ResearchAndDevelopmentExpensesMember_b70b7ae8-5bb7-4675-b946-d92e4466ccd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GeneralAndAdministrativeExpensesMember_60ad3378-fb3f-4a88-9eac-ca7c90a8f406" xlink:href="abvx-20241231.xsd#abvx_GeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1e0a8073-c4df-4c2a-9b5f-b1e7d50a860e" xlink:to="loc_abvx_GeneralAndAdministrativeExpensesMember_60ad3378-fb3f-4a88-9eac-ca7c90a8f406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f216be98-207a-4716-b5b0-7fa2898a07d5" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_0c374284-2a4c-4d68-9dd4-74118c8614b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_0c374284-2a4c-4d68-9dd4-74118c8614b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInUlcerativeColitisExpenses_34b1bed4-2633-4529-a7c6-657c956e6e57" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInUlcerativeColitisExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInUlcerativeColitisExpenses_34b1bed4-2633-4529-a7c6-657c956e6e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses_76d314d7-e90d-459b-892d-0dda4ea0843d" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses_76d314d7-e90d-459b-892d-0dda4ea0843d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInTransversalActivities_4792ab3e-0a0f-4294-b583-149c3f536746" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInTransversalActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInTransversalActivities_4792ab3e-0a0f-4294-b583-149c3f536746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses_f4ad267a-ae9a-4162-999f-3e5dd6e7a921" xlink:href="abvx-20241231.xsd#abvx_IncreaseDecreaseInEmployeeBenefitsExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_a6c3029c-0982-4b48-a7de-c2f0f6a5c3de" xlink:to="loc_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses_f4ad267a-ae9a-4162-999f-3e5dd6e7a921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_6cea73b4-8c4a-4495-bf64-deb86e292b7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_60f23a55-dbbe-4460-a49f-087ee5eca676" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_6cea73b4-8c4a-4495-bf64-deb86e292b7a" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_60f23a55-dbbe-4460-a49f-087ee5eca676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c7477d19-8628-4b25-b362-09753fda9011" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_60f23a55-dbbe-4460-a49f-087ee5eca676" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c7477d19-8628-4b25-b362-09753fda9011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8c3fa566-bef4-4186-afad-3201714ba92e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c7477d19-8628-4b25-b362-09753fda9011" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8c3fa566-bef4-4186-afad-3201714ba92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentExpensesMember_763cf264-0cd4-42bb-bff3-ad76303e0883" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8c3fa566-bef4-4186-afad-3201714ba92e" xlink:to="loc_abvx_ResearchAndDevelopmentExpensesMember_763cf264-0cd4-42bb-bff3-ad76303e0883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_60f23a55-dbbe-4460-a49f-087ee5eca676" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SubContractingStudiesAndResearchExpenses_7b8249d4-6148-48a0-a507-35b57cf46234" xlink:href="abvx-20241231.xsd#abvx_SubContractingStudiesAndResearchExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_abvx_SubContractingStudiesAndResearchExpenses_7b8249d4-6148-48a0-a507-35b57cf46234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_6acb9e69-53ac-4745-aae2-cce0f41fa306" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_6acb9e69-53ac-4745-aae2-cce0f41fa306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_618a157c-d1b1-4649-96d5-32fa4898dde4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_618a157c-d1b1-4649-96d5-32fa4898dde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_IntellectualPropertyFees_ed38e927-af80-4d22-ac63-34b33941c5be" xlink:href="abvx-20241231.xsd#abvx_IntellectualPropertyFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_abvx_IntellectualPropertyFees_ed38e927-af80-4d22-ac63-34b33941c5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_0603e211-32a6-495a-a33d-6e1658504845" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_0603e211-32a6-495a-a33d-6e1658504845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_493fb739-3e59-4fd7-b0ef-f82088d1564a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_3038c5e3-9f3f-4462-88c3-ce666e93f829" xlink:to="loc_ifrs-full_OperatingExpense_493fb739-3e59-4fd7-b0ef-f82088d1564a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_f9cf74a6-14d9-4e6d-a9fe-0841bf5a0d94" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_5e33ccf2-9df7-4c9a-9fe1-52bdea34ec65" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_f9cf74a6-14d9-4e6d-a9fe-0841bf5a0d94" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_5e33ccf2-9df7-4c9a-9fe1-52bdea34ec65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_f101b0a0-e727-4b56-b18d-00e0d57c2cba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_5e33ccf2-9df7-4c9a-9fe1-52bdea34ec65" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_f101b0a0-e727-4b56-b18d-00e0d57c2cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_96b8848c-c213-44fd-8fcc-9bacf306d338" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_f101b0a0-e727-4b56-b18d-00e0d57c2cba" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_96b8848c-c213-44fd-8fcc-9bacf306d338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GeneralAndAdministrativeExpensesMember_b32d2a56-8f8b-4523-bf2c-dc576ff31830" xlink:href="abvx-20241231.xsd#abvx_GeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_96b8848c-c213-44fd-8fcc-9bacf306d338" xlink:to="loc_abvx_GeneralAndAdministrativeExpensesMember_b32d2a56-8f8b-4523-bf2c-dc576ff31830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_5e33ccf2-9df7-4c9a-9fe1-52bdea34ec65" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_7a1f057b-c6ca-4eb1-95dd-fee87006a9f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_7a1f057b-c6ca-4eb1-95dd-fee87006a9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_17355717-f295-4ff6-8206-fc8fdefe78be" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_17355717-f295-4ff6-8206-fc8fdefe78be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_e9d13241-8aac-4ea3-a2c7-94a7d27521d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_e9d13241-8aac-4ea3-a2c7-94a7d27521d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_f4212188-b3ff-4854-ae3a-835c1ba3ab23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_d8ae9609-1865-4406-b2f2-014cfd504ba7" xlink:to="loc_ifrs-full_OperatingExpense_f4212188-b3ff-4854-ae3a-835c1ba3ab23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_5b3fa36d-6b47-43c9-b0a2-1ac2fb4c3ad4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_b040f702-5a97-44e2-b2d7-942caa2059ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_5b3fa36d-6b47-43c9-b0a2-1ac2fb4c3ad4" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_b040f702-5a97-44e2-b2d7-942caa2059ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_2157f9a7-8228-442b-91f6-8ed04334eaab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_5b3fa36d-6b47-43c9-b0a2-1ac2fb4c3ad4" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_2157f9a7-8228-442b-91f6-8ed04334eaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration_4b928248-ea22-417e-9728-26d55ce7e417" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_5b3fa36d-6b47-43c9-b0a2-1ac2fb4c3ad4" xlink:to="loc_ifrs-full_AuditorsRemuneration_4b928248-ea22-417e-9728-26d55ce7e417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/EmployeesDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#EmployeesDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/EmployeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EmployeesAbstract_94a336e0-da6c-4f3f-afd0-617528982fdd" xlink:href="abvx-20241231.xsd#abvx_EmployeesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfEmployeeWorkforceTable_f797f56b-1d78-404d-9935-4c24562573e5" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfEmployeeWorkforceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_EmployeesAbstract_94a336e0-da6c-4f3f-afd0-617528982fdd" xlink:to="loc_abvx_DisclosureOfEmployeeWorkforceTable_f797f56b-1d78-404d-9935-4c24562573e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_70a3a95e-dbda-4257-983a-2b0937373508" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceTable_f797f56b-1d78-404d-9935-4c24562573e5" xlink:to="loc_ifrs-full_GeographicalAreasAxis_70a3a95e-dbda-4257-983a-2b0937373508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_70a3a95e-dbda-4257-983a-2b0937373508" xlink:to="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_f4e6d4b5-b406-4d9b-ae01-758e3f7d8dec" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:to="loc_country_FR_f4e6d4b5-b406-4d9b-ae01-758e3f7d8dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b0cf6e80-6ece-43b7-bb94-9c7e373f9c52" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_fa5c030e-c5f9-45f5-aa79-351b90769e0e" xlink:to="loc_country_US_b0cf6e80-6ece-43b7-bb94-9c7e373f9c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfEmployeeWorkforceLineItems_82a74131-9dfe-423c-8d85-f499eef1624d" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfEmployeeWorkforceLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceTable_f797f56b-1d78-404d-9935-4c24562573e5" xlink:to="loc_abvx_DisclosureOfEmployeeWorkforceLineItems_82a74131-9dfe-423c-8d85-f499eef1624d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_ef47f74f-92d4-4747-b753-40677feb26b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfEmployeeWorkforceLineItems_82a74131-9dfe-423c-8d85-f499eef1624d" xlink:to="loc_ifrs-full_AverageNumberOfEmployees_ef47f74f-92d4-4747-b753-40677feb26b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialgainlossDisclosureofnetfinancialincomelossDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:href="abvx-20241231.xsd#abvx_FinancialIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBonds_665b7132-5d51-40f1-8f7f-244a59620240" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBonds"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_InterestExpenseOnBonds_665b7132-5d51-40f1-8f7f-244a59620240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_8375dfdd-1825-48c6-a64a-909a43075892" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnDebtInstrumentsIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_8375dfdd-1825-48c6-a64a-909a43075892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_1214f920-c663-46fa-8ee4-0979bd45e5af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_1214f920-c663-46fa-8ee4-0979bd45e5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestExpenseOnRoyaltyCertificates_a380779d-543b-492d-898c-4ef4cb7b2d73" xlink:href="abvx-20241231.xsd#abvx_InterestExpenseOnRoyaltyCertificates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_InterestExpenseOnRoyaltyCertificates_a380779d-543b-492d-898c-4ef4cb7b2d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_ca7bf20e-6878-4055-9631-d1919362930c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_ca7bf20e-6878-4055-9631-d1919362930c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_3ef31a65-1142-4fea-a7e9-5576e105c110" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_3ef31a65-1142-4fea-a7e9-5576e105c110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_63af1e27-239b-4eb8-9274-1b8d9fc2f807" xlink:href="abvx-20241231.xsd#abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_63af1e27-239b-4eb8-9274-1b8d9fc2f807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities_07597745-81b6-44df-9265-ae83fe2563f2" xlink:href="abvx-20241231.xsd#abvx_LossesArisingFromDerecognitionOfFinancialLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities_07597745-81b6-44df-9265-ae83fe2563f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TransactionCosts_59570032-cf55-45ec-9159-f1ac8521c265" xlink:href="abvx-20241231.xsd#abvx_TransactionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_TransactionCosts_59570032-cf55-45ec-9159-f1ac8521c265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeLoss_35a1787f-f6c0-4f77-b9b4-4ca5d595975e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_ForeignExchangeLoss_35a1787f-f6c0-4f77-b9b4-4ca5d595975e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceCost_a679c8d2-5d2c-4396-9226-11f45903164e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_OtherFinanceCost_a679c8d2-5d2c-4396-9226-11f45903164e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_d3167ce7-afdc-48b5-953d-905d1b1381e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_FinanceCosts_d3167ce7-afdc-48b5-953d-905d1b1381e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromInterest_a0605343-5079-46c5-b4e6-14688dffd1bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_RevenueFromInterest_a0605343-5079-46c5-b4e6-14688dffd1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_5f794f80-d03a-4ad8-9b76-c8c75fce4406" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsOnChangeInFairValueOfDerivatives"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_GainsOnChangeInFairValueOfDerivatives_5f794f80-d03a-4ad8-9b76-c8c75fce4406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_a02a8223-4b78-44aa-8190-1ccd0fe9dc6b" xlink:href="abvx-20241231.xsd#abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_a02a8223-4b78-44aa-8190-1ccd0fe9dc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs_bea1a0cc-f85d-438a-8107-4bcb2d5e8042" xlink:href="abvx-20241231.xsd#abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs_bea1a0cc-f85d-438a-8107-4bcb2d5e8042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_7a744f4d-4fc9-48ad-9833-f40479e321b0" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromRecognitionOfFinancialLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_GainsArisingFromRecognitionOfFinancialLiabilities_7a744f4d-4fc9-48ad-9833-f40479e321b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities_669f90d2-8593-40c3-b833-31a2727cb5c6" xlink:href="abvx-20241231.xsd#abvx_GainsArisingFromDerecognitionOfFinancialLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities_669f90d2-8593-40c3-b833-31a2727cb5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeGain_5f5ffe43-54fa-4a02-85dc-1ed39e608719" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignExchangeGain"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_ForeignExchangeGain_5f5ffe43-54fa-4a02-85dc-1ed39e608719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncome_bfb7d6a9-b1f2-49fc-be13-3602e6ca1a68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncome"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_OtherFinanceIncome_bfb7d6a9-b1f2-49fc-be13-3602e6ca1a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_ee3d65ad-9270-49a8-b30e-583518bac1af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_FinanceIncome_ee3d65ad-9270-49a8-b30e-583518bac1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_105284c1-cfa1-45c3-9404-29547fb8a46f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_cd1a0cb2-4e15-4999-b93d-4dddb211d626" xlink:to="loc_ifrs-full_FinanceIncomeCost_105284c1-cfa1-45c3-9404-29547fb8a46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/FinancialgainlossNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#FinancialgainlossNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/FinancialgainlossNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialIncomeLossAbstract_59a55c75-5716-471d-9990-1b281f54dd82" xlink:href="abvx-20241231.xsd#abvx_FinancialIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFinancialGainLossTable_78836cbd-63ee-4b45-a986-f0bd78ed746e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFinancialGainLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialIncomeLossAbstract_59a55c75-5716-471d-9990-1b281f54dd82" xlink:to="loc_abvx_DisclosureOfFinancialGainLossTable_78836cbd-63ee-4b45-a986-f0bd78ed746e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFinancialGainLossTable_78836cbd-63ee-4b45-a986-f0bd78ed746e" xlink:to="loc_srt_CurrencyAxis_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_b1113712-c003-4c5d-918a-59b09100db60" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_e7c4b6bd-4ae9-4bbc-b297-5a0e13d5e164" xlink:to="loc_currency_AllCurrenciesDomain_b1113712-c003-4c5d-918a-59b09100db60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_fc692c10-8bd9-4b7d-82da-2e1cf91fc405" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_b1113712-c003-4c5d-918a-59b09100db60" xlink:to="loc_currency_USD_fc692c10-8bd9-4b7d-82da-2e1cf91fc405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfFinancialGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFinancialGainLossTable_78836cbd-63ee-4b45-a986-f0bd78ed746e" xlink:to="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_1e40ad7f-bf60-448c-bc82-0aaff233cb01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_1e40ad7f-bf60-448c-bc82-0aaff233cb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations_7bb87967-784f-4d7d-bc3c-f2b622f8f2a3" xlink:href="abvx-20241231.xsd#abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfFinancialGainLossLineItems_5c1036da-d0f9-40a5-93d1-de55002ce4f2" xlink:to="loc_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations_7bb87967-784f-4d7d-bc3c-f2b622f8f2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccountingProfit_3c9bd457-3b89-46e1-8128-6048a9cd0b76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccountingProfit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_ifrs-full_AccountingProfit_3c9bd457-3b89-46e1-8128-6048a9cd0b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_bc9d0a20-be43-44ff-b511-ec26088cba87" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_ifrs-full_ApplicableTaxRate_bc9d0a20-be43-44ff-b511-ec26088cba87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3b2317ae-7136-4c82-a4fe-ba9eedf639f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3b2317ae-7136-4c82-a4fe-ba9eedf639f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_f3e0fddc-588b-4917-8842-734a14898718" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_f3e0fddc-588b-4917-8842-734a14898718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfShareBasedPayment_8bc6812c-a1c8-4e3e-9d6a-476fd7cf896f" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfShareBasedPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_abvx_TaxEffectOfShareBasedPayment_8bc6812c-a1c8-4e3e-9d6a-476fd7cf896f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfResearchTaxCredit_67938e71-4a00-4427-a904-c164d91197cd" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfResearchTaxCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_abvx_TaxEffectOfResearchTaxCredit_67938e71-4a00-4427-a904-c164d91197cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease_f46ab0d6-26b7-402d-ac64-7886fb7cf498" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease_f46ab0d6-26b7-402d-ac64-7886fb7cf498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther_522d2b9a-6ebf-4bc7-a312-2a4d36518c0c" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfChangesInDerivativeFairValueAndOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther_522d2b9a-6ebf-4bc7-a312-2a4d36518c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_07b2b07c-2090-44c7-8212-ba4efa26bc6f" xlink:href="abvx-20241231.xsd#abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_07b2b07c-2090-44c7-8212-ba4efa26bc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_ffcc0a7e-0616-481d-9a96-62ebe90b3355" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_ffcc0a7e-0616-481d-9a96-62ebe90b3355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_b9683f4e-87f4-4017-a878-4a8c8d6e1eb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2c3c46bc-d33d-4235-a2f6-016387f0f5cc" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_b9683f4e-87f4-4017-a878-4a8c8d6e1eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_175ceb2a-1444-4713-a57c-6bacd00bc81f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_30ba7e47-0d3f-4a06-9a1a-146b78cd7eb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_175ceb2a-1444-4713-a57c-6bacd00bc81f" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_30ba7e47-0d3f-4a06-9a1a-146b78cd7eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aae210f0-01ef-48c4-bb4e-9f45adab2894" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_30ba7e47-0d3f-4a06-9a1a-146b78cd7eb4" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aae210f0-01ef-48c4-bb4e-9f45adab2894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aae210f0-01ef-48c4-bb4e-9f45adab2894" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember_d78e5149-d7e2-446b-9703-01fbaa1969b8" xlink:href="abvx-20241231.xsd#abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember_d78e5149-d7e2-446b-9703-01fbaa1969b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SubsidiesRelatedTemporaryDifferencesMember_81b81ad0-02e5-4217-ae21-826d84a3f322" xlink:href="abvx-20241231.xsd#abvx_SubsidiesRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_SubsidiesRelatedTemporaryDifferencesMember_81b81ad0-02e5-4217-ae21-826d84a3f322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeasesRelatedTemporaryDifferencesMember_48a6b00d-4e31-48b9-9226-54754f2a6720" xlink:href="abvx-20241231.xsd#abvx_LeasesRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_LeasesRelatedTemporaryDifferencesMember_48a6b00d-4e31-48b9-9226-54754f2a6720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember_8600fcbb-7097-4b4f-b73c-a53edb70d872" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember_8600fcbb-7097-4b4f-b73c-a53edb70d872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_6defa9f1-3f0c-4ec7-aa55-32c3ea523f29" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_6defa9f1-3f0c-4ec7-aa55-32c3ea523f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_19310e36-89cf-47d0-8d31-42c77bc3d9b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_22791496-2fcb-42e6-a1b3-2c78634e16b1" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_19310e36-89cf-47d0-8d31-42c77bc3d9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_30ba7e47-0d3f-4a06-9a1a-146b78cd7eb4" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_8d41ccc1-9140-405c-819c-66701df3a6f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_ifrs-full_DeferredTaxAssets_8d41ccc1-9140-405c-819c-66701df3a6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_63902297-85ae-47ae-afd5-297eeccad8b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_63902297-85ae-47ae-afd5-297eeccad8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_00463019-b62f-4275-a9b4-8f57aeb0c599" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_00463019-b62f-4275-a9b4-8f57aeb0c599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_UnrecognizedDeferredTaxAssets_3a09284c-e609-4127-a378-7f6f664e4966" xlink:href="abvx-20241231.xsd#abvx_UnrecognizedDeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_abvx_UnrecognizedDeferredTaxAssets_3a09284c-e609-4127-a378-7f6f664e4966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_a2587aa4-5e85-48c5-89e8-3b6396bd7608" xlink:href="abvx-20241231.xsd#abvx_DeferredTaxAssetsRecognisedInFinancialPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9c21f803-9c6d-4b39-8e7d-32bc10f362c0" xlink:to="loc_abvx_DeferredTaxAssetsRecognisedInFinancialPosition_a2587aa4-5e85-48c5-89e8-3b6396bd7608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncometaxNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncometaxNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IncometaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_b28072e6-4677-4825-b632-649b1222ee0d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_ba625a6d-1006-44dc-a767-5866a6563dc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_b28072e6-4677-4825-b632-649b1222ee0d" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_ba625a6d-1006-44dc-a767-5866a6563dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d61b30db-67ce-45cf-af6d-88ba6c5617fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_ba625a6d-1006-44dc-a767-5866a6563dc8" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d61b30db-67ce-45cf-af6d-88ba6c5617fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_4dda6744-ae05-4921-9725-8deb1b0e78b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d61b30db-67ce-45cf-af6d-88ba6c5617fe" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_4dda6744-ae05-4921-9725-8deb1b0e78b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AbivaxLLCMember_dee67ff9-28ff-4a81-ab01-f2078fb26774" xlink:href="abvx-20241231.xsd#abvx_AbivaxLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_4dda6744-ae05-4921-9725-8deb1b0e78b9" xlink:to="loc_abvx_AbivaxLLCMember_dee67ff9-28ff-4a81-ab01-f2078fb26774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_79b44ddb-0d33-4959-b761-ec845dc9ad52" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_ba625a6d-1006-44dc-a767-5866a6563dc8" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_79b44ddb-0d33-4959-b761-ec845dc9ad52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_178f2dc0-2ce4-49b2-9486-22ae5a15af02" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_79b44ddb-0d33-4959-b761-ec845dc9ad52" xlink:to="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_178f2dc0-2ce4-49b2-9486-22ae5a15af02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncomelosspershareScheduleofearningspershareDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_3bfd8ec8-f99a-44cc-acb3-aed60b62ba4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_5540c46f-c873-43ec-bb0f-93d94276efa1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_3bfd8ec8-f99a-44cc-acb3-aed60b62ba4d" xlink:to="loc_ifrs-full_WeightedAverageShares_5540c46f-c873-43ec-bb0f-93d94276efa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_c897ae45-acfa-47d5-9971-65eec708eb8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_3bfd8ec8-f99a-44cc-acb3-aed60b62ba4d" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_c897ae45-acfa-47d5-9971-65eec708eb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_639a80ec-7f59-46c3-8e0e-a55e05f1b08d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_3bfd8ec8-f99a-44cc-acb3-aed60b62ba4d" xlink:to="loc_ifrs-full_ProfitLoss_639a80ec-7f59-46c3-8e0e-a55e05f1b08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_020665c0-81e8-4c41-b851-ebccb552202b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_3bfd8ec8-f99a-44cc-acb3-aed60b62ba4d" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_020665c0-81e8-4c41-b851-ebccb552202b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_4d378e77-819b-46a6-b617-6b7a505f7b15" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_3bfd8ec8-f99a-44cc-acb3-aed60b62ba4d" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_4d378e77-819b-46a6-b617-6b7a505f7b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/IncomelosspershareNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#IncomelosspershareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/IncomelosspershareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_77f70eb1-d1c9-4d2d-b0e5-1bedb71ba598" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_63e76ea0-3e81-4e30-9b76-18bdca651f62" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_77f70eb1-d1c9-4d2d-b0e5-1bedb71ba598" xlink:to="loc_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_63e76ea0-3e81-4e30-9b76-18bdca651f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_MaximumNumberOfSharesToBeIssued_5549f376-0c9a-4ba1-8eef-fccf51b6767e" xlink:href="abvx-20241231.xsd#abvx_MaximumNumberOfSharesToBeIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_77f70eb1-d1c9-4d2d-b0e5-1bedb71ba598" xlink:to="loc_abvx_MaximumNumberOfSharesToBeIssued_5549f376-0c9a-4ba1-8eef-fccf51b6767e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationFixedCompensation_51ac4ff6-9bc7-4493-ab04-f110309731a1" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationFixedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_abvx_KeyManagementPersonnelCompensationFixedCompensation_51ac4ff6-9bc7-4493-ab04-f110309731a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationVariableCompensation_adaba056-2065-4296-be7b-ab81e87717e4" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationVariableCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_abvx_KeyManagementPersonnelCompensationVariableCompensation_adaba056-2065-4296-be7b-ab81e87717e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationInKindContributions_51df9594-f269-4da2-ab83-912070d96aeb" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationInKindContributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_abvx_KeyManagementPersonnelCompensationInKindContributions_51df9594-f269-4da2-ab83-912070d96aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_f31fe16c-e430-4c9d-baf4-874fe6654be6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_f31fe16c-e430-4c9d-baf4-874fe6654be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KeyManagementPersonnelCompensationAttendanceFees_98e07852-d7fd-4f92-b38a-226dd79e2db0" xlink:href="abvx-20241231.xsd#abvx_KeyManagementPersonnelCompensationAttendanceFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_abvx_KeyManagementPersonnelCompensationAttendanceFees_98e07852-d7fd-4f92-b38a-226dd79e2db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_b07490ff-6f02-4df9-82a3-89bf1f3ec230" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_b07490ff-6f02-4df9-82a3-89bf1f3ec230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_2fbe69d9-a139-47dc-be5c-cc1f5e13939c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_2fbe69d9-a139-47dc-be5c-cc1f5e13939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_50d6bb71-e0fd-4398-be35-95b356ddf0fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_adc0aa90-7b63-41ba-ac29-52c768e7d6db" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_50d6bb71-e0fd-4398-be35-95b356ddf0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/RelatedpartiesNarrativeDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#RelatedpartiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/RelatedpartiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_20bf388e-a14c-4600-ab0b-0219c1ee7b47" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_20bf388e-a14c-4600-ab0b-0219c1ee7b47" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:to="loc_srt_TitleOfIndividualAxis_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_d6c60ed4-d7c8-4acf-a119-3825b5c4c6d1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember_318ca62f-13e3-4b40-9eb4-78437bf57594" xlink:href="abvx-20241231.xsd#abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:to="loc_abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember_318ca62f-13e3-4b40-9eb4-78437bf57594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AdvisorToTheChiefExecutiveOfficerMember_697a8b30-1ba1-42f1-9f00-aa34c2edafb0" xlink:href="abvx-20241231.xsd#abvx_AdvisorToTheChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a51e4cc-7f38-49cf-9c2d-234e80dd0486" xlink:to="loc_abvx_AdvisorToTheChiefExecutiveOfficerMember_697a8b30-1ba1-42f1-9f00-aa34c2edafb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_ee939a59-786a-471d-9f59-cda446d66196" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_ee939a59-786a-471d-9f59-cda446d66196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_fbf2a707-748f-4839-890a-e9b3fa8e7f7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_ee939a59-786a-471d-9f59-cda446d66196" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_fbf2a707-748f-4839-890a-e9b3fa8e7f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0ce2885b-aeb7-4544-8066-5afe2c6f2b0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_fbf2a707-748f-4839-890a-e9b3fa8e7f7b" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0ce2885b-aeb7-4544-8066-5afe2c6f2b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_bea850db-4ba6-4767-ae7f-ae175c56ea78" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_13063085-b967-4cff-ba2f-b90669ba9c79" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:to="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_13063085-b967-4cff-ba2f-b90669ba9c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_4f43fd9f-783d-46bc-9300-dfe4113ad948" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_4f43fd9f-783d-46bc-9300-dfe4113ad948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_f4ae3bd0-da9a-494f-b2f5-568ac44c5c78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_37dc79b3-8fb7-44bf-968e-15bb50938cc5" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_f4ae3bd0-da9a-494f-b2f5-568ac44c5c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OffbalancesheetcommitmentsgivenDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OffBalanceSheetCommitmentsAbstract_f10dc47b-2a3d-4935-a571-10b193c2cad5" xlink:href="abvx-20241231.xsd#abvx_OffBalanceSheetCommitmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOffBalanceSheetCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_OffBalanceSheetCommitmentsAbstract_f10dc47b-2a3d-4935-a571-10b193c2cad5" xlink:to="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsAxis_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_abvx_PrincipalAgreementsAxis_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:href="abvx-20241231.xsd#abvx_PrincipalAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsAxis_5fe9e189-11e1-4e17-b9e0-2b7d8d006f35" xlink:to="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_bee5d228-cfde-4488-99ee-2c8b9278b5ec" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_bee5d228-cfde-4488-99ee-2c8b9278b5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember_07a37c41-a797-456e-bade-571a878b815a" xlink:href="abvx-20241231.xsd#abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember_07a37c41-a797-456e-bade-571a878b815a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_04a19b46-ab5b-464d-b006-c517e6318218" xlink:href="abvx-20241231.xsd#abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember_04a19b46-ab5b-464d-b006-c517e6318218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember_53edd468-8521-4fee-9faf-e09180048bb6" xlink:href="abvx-20241231.xsd#abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember_53edd468-8521-4fee-9faf-e09180048bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_e24ca065-719e-43a4-ba59-714de45ba791" xlink:href="abvx-20241231.xsd#abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_PrincipalAgreementsDomain_07ee9f15-d24d-4472-a20c-c115155bd36e" xlink:to="loc_abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_e24ca065-719e-43a4-ba59-714de45ba791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_655a665a-8a6d-4853-ad49-42ed28e2f6f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_dei_LegalEntityAxis_655a665a-8a6d-4853-ad49-42ed28e2f6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4d7eb783-299a-4a13-8612-0b703e9082e6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_655a665a-8a6d-4853-ad49-42ed28e2f6f8" xlink:to="loc_dei_EntityDomain_4d7eb783-299a-4a13-8612-0b703e9082e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_b63790c8-851c-436f-85ce-acff09909e1e" xlink:href="abvx-20241231.xsd#abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4d7eb783-299a-4a13-8612-0b703e9082e6" xlink:to="loc_abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember_b63790c8-851c-436f-85ce-acff09909e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_816190d1-894b-4673-b602-853d2305b556" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_srt_RangeAxis_816190d1-894b-4673-b602-853d2305b556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_816190d1-894b-4673-b602-853d2305b556" xlink:to="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dd651a87-dbc0-4c65-9a00-d7a09fd8e9cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:to="loc_srt_MinimumMember_dd651a87-dbc0-4c65-9a00-d7a09fd8e9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_aca967ab-6194-485f-85cb-98eef358dff0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d983e8d7-8fa2-41a9-b126-aa79dc3eca4e" xlink:to="loc_srt_MaximumMember_aca967ab-6194-485f-85cb-98eef358dff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4e060e01-e94e-449d-ab38-0ec224ec2a28" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4e060e01-e94e-449d-ab38-0ec224ec2a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4e060e01-e94e-449d-ab38-0ec224ec2a28" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_0354e854-fd9e-4d06-b97a-7ec563e4c4ef" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_0354e854-fd9e-4d06-b97a-7ec563e4c4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_70ea6b7b-c31a-4f8c-b8b7-c977cd6abaa8" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_70ea6b7b-c31a-4f8c-b8b7-c977cd6abaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5856e0ff-4c9e-402e-87b0-22e8842f3b16" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember_0b7edae0-a261-4705-83d2-bf05ba74453f" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:to="loc_abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember_0b7edae0-a261-4705-83d2-bf05ba74453f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EbolaConditionalAdvanceBPIFranceMember_148b19a3-6f90-4a2c-aced-bfdc7bb28670" xlink:href="abvx-20241231.xsd#abvx_EbolaConditionalAdvanceBPIFranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_EbolaConditionalAdvanceBPIMember_5287ab8e-9612-4ee5-ac8d-8fcc6c259840" xlink:to="loc_abvx_EbolaConditionalAdvanceBPIFranceMember_148b19a3-6f90-4a2c-aced-bfdc7bb28670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_1e0ac058-4554-4409-a0f9-c7e0b8c2b630" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_ifrs-full_TypesOfContractsAxis_1e0ac058-4554-4409-a0f9-c7e0b8c2b630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_e1a96fd6-fa5a-447c-8e35-de85299f370f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_1e0ac058-4554-4409-a0f9-c7e0b8c2b630" xlink:to="loc_ifrs-full_TypesOfContractsDomain_e1a96fd6-fa5a-447c-8e35-de85299f370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseFacilitiesMontpellierMember_da925c05-1005-4463-9094-be7536af4d64" xlink:href="abvx-20241231.xsd#abvx_LeaseFacilitiesMontpellierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_e1a96fd6-fa5a-447c-8e35-de85299f370f" xlink:to="loc_abvx_LeaseFacilitiesMontpellierMember_da925c05-1005-4463-9094-be7536af4d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsTable_c5d5b09d-110d-465b-8560-4dc4feb265c3" xlink:to="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfExclusiveLicenses_4efd92f6-c78e-4641-bd02-82b609ea3494" xlink:href="abvx-20241231.xsd#abvx_NumberOfExclusiveLicenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_NumberOfExclusiveLicenses_4efd92f6-c78e-4641-bd02-82b609ea3494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_AgreementPeriod_46e64dcf-bb80-4e71-89af-c9170a4f3df7" xlink:href="abvx-20241231.xsd#abvx_AgreementPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_AgreementPeriod_46e64dcf-bb80-4e71-89af-c9170a4f3df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling_0ae9ae98-6740-44e4-ba78-54e3141050a1" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling_0ae9ae98-6740-44e4-ba78-54e3141050a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3_d6655208-aa8e-4c8f-adf7-6c6df7df068c" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3_d6655208-aa8e-4c8f-adf7-6c6df7df068c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval_e856ecd2-8467-42fa-b22e-d699da07a76e" xlink:href="abvx-20241231.xsd#abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval_e856ecd2-8467-42fa-b22e-d699da07a76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfAcademicInstitutions_a5bbc2d8-4261-4944-92d1-74e5a2713b9e" xlink:href="abvx-20241231.xsd#abvx_NumberOfAcademicInstitutions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_NumberOfAcademicInstitutions_a5bbc2d8-4261-4944-92d1-74e5a2713b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_5b4be52e-694b-4f2e-95e7-042b5dd692c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_5b4be52e-694b-4f2e-95e7-042b5dd692c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest_45d2cfe4-ce7c-4e19-a665-c4749024ccb1" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest_45d2cfe4-ce7c-4e19-a665-c4749024ccb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight_3af2ce35-c03a-4ee5-8ce4-3399f1a92748" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight_3af2ce35-c03a-4ee5-8ce4-3399f1a92748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod_7e62e386-e49f-460c-9b86-f1c5f2142b05" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod_7e62e386-e49f-460c-9b86-f1c5f2142b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold_e340ce44-bbc8-4077-a7d9-8e86039fa149" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold_e340ce44-bbc8-4077-a7d9-8e86039fa149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped_79e03a5c-07b8-456e-bcad-47cba415b822" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped_79e03a5c-07b8-456e-bcad-47cba415b822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped_d71e749e-7e65-489f-8c24-6efd7e960aa3" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped_d71e749e-7e65-489f-8c24-6efd7e960aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesRepaymentPeriod_05f5c6ed-b26a-4006-9245-7afaf0553e82" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesRepaymentPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesRepaymentPeriod_05f5c6ed-b26a-4006-9245-7afaf0553e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RepaymentsOfConditionalAdvances_638b9b52-af14-4f5b-8e7d-0447ab02c41d" xlink:href="abvx-20241231.xsd#abvx_RepaymentsOfConditionalAdvances"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_RepaymentsOfConditionalAdvances_638b9b52-af14-4f5b-8e7d-0447ab02c41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_cf582fc3-bb86-4ec7-9fc4-3c8b6cf2cf99" xlink:href="abvx-20241231.xsd#abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity_cf582fc3-bb86-4ec7-9fc4-3c8b6cf2cf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitments_e780712f-59f2-4a24-90d8-e62222588fe5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_ifrs-full_CapitalCommitments_e780712f-59f2-4a24-90d8-e62222588fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_LeaseDurationPeriod_587318e3-9800-4188-98c7-536b34678d43" xlink:href="abvx-20241231.xsd#abvx_LeaseDurationPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems_7c808589-141e-4e4d-9a01-24b8e004f08e" xlink:to="loc_abvx_LeaseDurationPeriod_587318e3-9800-4188-98c7-536b34678d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#OffbalancesheetcommitmentsreceivedandcontingentassetsDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_OffBalanceSheetCommitmentsAbstract_91964f04-ef83-4758-88d6-8131d2453412" xlink:href="abvx-20241231.xsd#abvx_OffBalanceSheetCommitmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCommitmentsReceivedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_OffBalanceSheetCommitmentsAbstract_91964f04-ef83-4758-88d6-8131d2453412" xlink:to="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bdf4a6c3-11e3-4e47-a961-131feda6a166" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bdf4a6c3-11e3-4e47-a961-131feda6a166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bdf4a6c3-11e3-4e47-a961-131feda6a166" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_RNPVIRConditionalAdvanceBPIMember_8ffa9d3e-49a7-42d9-a3c7-ef3426f309d5" xlink:href="abvx-20241231.xsd#abvx_RNPVIRConditionalAdvanceBPIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:to="loc_abvx_RNPVIRConditionalAdvanceBPIMember_8ffa9d3e-49a7-42d9-a3c7-ef3426f309d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_CARENAConditionalAdvanceBPIMember_7e1997c9-32fd-44b3-8a2e-1a374a25d554" xlink:href="abvx-20241231.xsd#abvx_CARENAConditionalAdvanceBPIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_16184dce-099f-4b80-9d41-a41e17ef6f3a" xlink:to="loc_abvx_CARENAConditionalAdvanceBPIMember_7e1997c9-32fd-44b3-8a2e-1a374a25d554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_dc500fa0-12bf-41ba-915b-915944f1e826" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_dc500fa0-12bf-41ba-915b-915944f1e826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_dc500fa0-12bf-41ba-915b-915944f1e826" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingMember_b32f3361-0834-4f95-b25a-0690bbe1bc06" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:to="loc_abvx_KreosClaretFinancingMember_b32f3361-0834-4f95-b25a-0690bbe1bc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_HeightsConvertibleNotesTrancheBMember_a6d993aa-d6a6-4c4e-889e-3429424d2d2d" xlink:href="abvx-20241231.xsd#abvx_HeightsConvertibleNotesTrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_ff35b30a-48bc-406d-bccb-19ed54fa55dc" xlink:to="loc_abvx_HeightsConvertibleNotesTrancheBMember_a6d993aa-d6a6-4c4e-889e-3429424d2d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:href="abvx-20241231.xsd#abvx_DisclosureOfCommitmentsReceivedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedTable_dc2f56fc-153f-483a-b5e0-086e7c185a9e" xlink:to="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_ce700272-ce86-48c2-bed3-2276234b48d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_ce700272-ce86-48c2-bed3-2276234b48d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfProjectsTerminated_d7bb1bed-50d5-4e1b-b628-5f493b5c10d8" xlink:href="abvx-20241231.xsd#abvx_NumberOfProjectsTerminated"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_DisclosureOfCommitmentsReceivedLineItems_963230df-1870-4a9a-9cd2-de1e11003d8a" xlink:to="loc_abvx_NumberOfProjectsTerminated_d7bb1bed-50d5-4e1b-b628-5f493b5c10d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails" xlink:type="simple" xlink:href="abvx-20241231.xsd#ManagementandassessmentoffinancialrisksDetails"/>
  <link:presentationLink xlink:role="http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abvx_FinancialRiskManagementAbstract_e2426b3a-4815-4761-a519-94ffc3988ff4" xlink:href="abvx-20241231.xsd#abvx_FinancialRiskManagementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvx_FinancialRiskManagementAbstract_e2426b3a-4815-4761-a519-94ffc3988ff4" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_269e56a9-4742-4202-a7d7-4cecb9296c4c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_srt_CurrencyAxis_269e56a9-4742-4202-a7d7-4cecb9296c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_e2cca3fb-8dd4-415e-b99c-a7e07860022e" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_269e56a9-4742-4202-a7d7-4cecb9296c4c" xlink:to="loc_currency_AllCurrenciesDomain_e2cca3fb-8dd4-415e-b99c-a7e07860022e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_ee2de13b-b322-44ff-aebc-af08cc839b67" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_e2cca3fb-8dd4-415e-b99c-a7e07860022e" xlink:to="loc_currency_USD_ee2de13b-b322-44ff-aebc-af08cc839b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_a375e025-a0e4-49c9-8d62-c582b0f15a40" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_TypesOfRisksAxis_a375e025-a0e4-49c9-8d62-c582b0f15a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_a375e025-a0e4-49c9-8d62-c582b0f15a40" xlink:to="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyRiskMember_b9dd986a-6bfd-4813-b4f5-b88eb3c05288" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:to="loc_ifrs-full_CurrencyRiskMember_b9dd986a-6bfd-4813-b4f5-b88eb3c05288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditRiskMember_b0c9ddf3-140d-40d9-920f-94709fd46d58" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_4aee3c34-6e79-482c-b06d-b91838bd22fd" xlink:to="loc_ifrs-full_CreditRiskMember_b0c9ddf3-140d-40d9-920f-94709fd46d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_7ef33259-5493-47ea-b9ba-0667f364431b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_7ef33259-5493-47ea-b9ba-0667f364431b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_0de2dced-d771-4c60-9e3d-c9a13ca9d714" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7ef33259-5493-47ea-b9ba-0667f364431b" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_0de2dced-d771-4c60-9e3d-c9a13ca9d714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_f4118354-ef36-4d3e-9e82-cfb4f4e8e5ed" xlink:href="abvx-20241231.xsd#abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_0de2dced-d771-4c60-9e3d-c9a13ca9d714" xlink:to="loc_abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember_f4118354-ef36-4d3e-9e82-cfb4f4e8e5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_59ca8967-c043-44cd-8cdc-87caf1deb91c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_fc496ef7-7dc2-4488-ba8a-7b1e23eb7e76" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_59ca8967-c043-44cd-8cdc-87caf1deb91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_EuropeanCentralBankBaseRateMember_edfaa10c-9eaf-4c17-95c5-2c0476b89ba5" xlink:href="abvx-20241231.xsd#abvx_EuropeanCentralBankBaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_59ca8967-c043-44cd-8cdc-87caf1deb91c" xlink:to="loc_abvx_EuropeanCentralBankBaseRateMember_edfaa10c-9eaf-4c17-95c5-2c0476b89ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_521323d6-a0a8-409d-81d6-ca2f27c43ca2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_RangeAxis_521323d6-a0a8-409d-81d6-ca2f27c43ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_521323d6-a0a8-409d-81d6-ca2f27c43ca2" xlink:to="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_576e18a8-1a09-43dd-87b2-15246aca92a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:to="loc_ifrs-full_BottomOfRangeMember_576e18a8-1a09-43dd-87b2-15246aca92a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_70394ba4-2a24-4baf-8bd9-a3c12a9d24a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_f7c89099-4aa1-496e-8156-98835f746cff" xlink:to="loc_ifrs-full_TopOfRangeMember_70394ba4-2a24-4baf-8bd9-a3c12a9d24a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_ca4e7df5-cd9c-4c1d-a45e-f90114ccdb3e" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_19c2ff96-ef92-4d77-a192-5c793baa6c2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_19c2ff96-ef92-4d77-a192-5c793baa6c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BorrowingsBasisInterestRate_f442da7d-e58a-487b-ac7c-65b74cb9a2bd" xlink:href="abvx-20241231.xsd#abvx_BorrowingsBasisInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_BorrowingsBasisInterestRate_f442da7d-e58a-487b-ac7c-65b74cb9a2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_InterestRateCollarRange_52d3914d-a33a-4f89-a165-b7da3f51579a" xlink:href="abvx-20241231.xsd#abvx_InterestRateCollarRange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_InterestRateCollarRange_52d3914d-a33a-4f89-a165-b7da3f51579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_dc5ee17b-e3da-44f3-8b5e-a7f81c75bc4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_ifrs-full_OperatingExpense_dc5ee17b-e3da-44f3-8b5e-a7f81c75bc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_558f45b2-5546-4098-9b04-e0a1adfebfed" xlink:href="abvx-20241231.xsd#abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_558f45b2-5546-4098-9b04-e0a1adfebfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss_e1609a8e-dcd0-4979-bcc0-eb6f181276dd" xlink:href="abvx-20241231.xsd#abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss_e1609a8e-dcd0-4979-bcc0-eb6f181276dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_NumberOfFinancialInstitutionsToMaintainCash_0cf1fd26-058c-44a8-af81-67db745d4efb" xlink:href="abvx-20241231.xsd#abvx_NumberOfFinancialInstitutionsToMaintainCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_NumberOfFinancialInstitutionsToMaintainCash_0cf1fd26-058c-44a8-af81-67db745d4efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit_514a12d3-8e52-413a-aaab-1afb42ec6439" xlink:href="abvx-20241231.xsd#abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_42899906-9efd-4f90-8946-80a71059b14f" xlink:to="loc_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit_514a12d3-8e52-413a-aaab-1afb42ec6439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>abvx-20241231_g1.jpg
<TEXT>
begin 644 abvx-20241231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (:!;D# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!C8ZUY]\9OBI_PJ7P
MW::L--_M0SW:VOD^?Y.,I(V[=M;^Y^M>@,,XKP/]LK_DFNF?]A:/_P!$S5W9
M?2A7Q=.E4^&3.'&U)4</*I3W.:_X;<;_ *$S_P J?_VFC_AMQO\ H3/_ "I_
M_::^7J*_4/[ R[_GW_Y,_P#,^ _MC&_\_/P1]0_\-N-_T)G_ )4__M-'_#;C
M?]"9_P"5/_[37R]11_8&7?\ /O\ \F?^8?VQC?\ GY^"/J'_ (;<;_H3/_*G
M_P#::/\ AMQO^A,_\J?_ -IKY>HH_L#+O^??_DS_ ,P_MC&_\_/P1]0_\-N-
M_P!"9_Y4_P#[31_PVXW_ $)G_E3_ /M-?+U%']@9=_S[_P#)G_F']L8W_GY^
M"/J'_AMQO^A,_P#*G_\ ::/^&W&_Z$S_ ,J?_P!IKY>HH_L#+O\ GW_Y,_\
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M]L8W_GY^"/J'_AMQO^A,_P#*G_\ ::/^&W&_Z$S_ ,J?_P!IKY>HH_L#+O\
MGW_Y,_\ ,/[8QO\ S\_!'U#_ ,-N-_T)G_E3_P#M-'_#;C?]"9_Y4_\ [37R
M]11_8&7?\^__ "9_YA_;&-_Y^?@CZ@_X;9;C_BC/_*G_ /::].^"?QM/QA;6
M1_8QTG^SO)/_ !\^=YGF>9_LKM_U?_CU?"-?4'[$WWO&7/\ SY_^UJ\;.,GP
M6&P,ZU&'O:=7W/6RW,L37Q,:=27N_+L?4U%%%?G1]N%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 1CK^%>"_MF?\DSTO\ ["T?_HF:O>EZ_A7@O[9G
M_),]+_["T?\ Z)FKU,I_WZE_B/.S'_=*A\;T445^V'Y6%%%% !1110 4444
M%%%% @HHHI#"BBBBZV ****- "BBBF 4444@"BBB@ HHHI@%%%% !1112 *^
MH?V)?O>,O^W/_P!KU\O5]0_L2]?&7_;G_P"UZ^?S_P#Y%U3_ +=_-'L9/_OM
M/Y_D?4M%%%?D!^FA7%_&C_DC_CK_ + -_P#^D\E=I7)_$[2KSQ!\-_%>EV$7
MG7]]I5U;6\657?))"RJNYOE^\U 'PI\ _P!A#PM\7/@-H?C&/Q!KFE^*M0AN
M)(6CEA:TAGCGDCC;9Y?F;?W:\>973>'_ -KOQQX-_9!T#Q<RVGB#Q%9^(/\
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M5=K'^]_JVKJ+/X5^*8?VV+[Q^^EE/"<GAY;);_[1%\TWR_+Y>[S/X?[M>/\
MAO\ 9#\:Z[^SI\0/"&KV$.B>(;KQ0VN:.LUU')'*JQJJ[FC9MNY?,7YO:@#O
M/A3^U?XAOOBKH/@GQM=^!-8;Q%;^98ZAX#U)KN.TF569H;E69OF;Y=K+\O\
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M:2R-/>^(I/$MK?S7-QM^\\<:[OF^ZO\ "N*^GJ "BBB@ KQ3]M#_ )-A\?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ('_ , #[:R*,BOB7^T/VN?[Y_[YTBC^T/VN?[Y_[YTBC^P7_P!!5+_P/_@
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M'[7/]\_]\Z11_8+_ .@JE_X'_P  #[:R*,BOB7^T/VN?[Y_[YTBC^TOVM_\
MGH?^^=(H_L%_]!5+_P #_P" !]M9%&17Q#_:O[6O_/8_]\Z11_:O[6O_ #V/
M_?.D4?V$_P#H*I?^!_\   ^WLBC(KXA_M7]K7_GL?^^=(H_M7]K7_GL?^^=(
MH_L)_P#052_\#_X 'V]D49%?$/\ :O[6O_/8_P#?.D4?VK^UK_SV/_?.D4?V
M$_\ H*I?^!_\ #[>R*,BOB'^U?VM?^>Q_P"^=(H_M7]K7_GL?^^=(H_L)_\
M052_\#_X 'V]D49%?$/]J_M:_P#/8_\ ?.D4?VK^UK_SV/\ WSI%']A/_H*I
M?^!_\ #[>R*,BOB'^U?VM?\ GL?^^=(H_M7]K7_GL?\ OG2*/["?_052_P#
M_P#@ ?;V11D5\0_VK^UK_P ]C_WSI%)_:_[6J]9?_'=(H_L)_P#052_\#_X
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M2_\  _\ @ ?=^11D5\%?\+"_:?\ ^@@?^_6E?_$T?\+"_:?_ .@@?^_6E?\
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M_O+]WYJH:)\2/#,G@_4?!6O:;JT_AQ+U[K3+VU\O[9#\_P JLK?)NVLVYO\
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M .&F?CI_T,7_ )(V'_QNC_AIGXZ?]#%_Y(V'_P ;KL]GC?Y(?^!O_P"0.?\
MLO"_]!2_KYF!Y3_W6_[YH\I_[K?]\UO_ /#3/QT_Z&+_ ,D;#_XW1_PTS\=/
M^AB_\D;#_P"-T>SQO\D/_ W_ /(!_9>%_P"@I?U\S \I_P"ZW_?-'E/_ '6_
M[YK?_P"&F?CI_P!#%_Y(V'_QNC_AIGXZ?]#%_P"2-A_\;HY,;_)#_P #?_R
M?V7A?^@I?U\S \I_[K?]\U].?L5 QMXPW#!_T/'_ )&KP'_AI;XY_P#0Q?\
MDE8?_&Z[C]G?]H3XF>+OCCH'AKQ)K_VRPN3/]HM6L[6,';:R2+\T<:L/F56^
M]7CYMA\=6P52,U"UN;23^SK_ "GHY?EU&G7C4IUE+E_KN?=@I:2EK\A/K1/2
MOBS_ (*.?>^'O_<0_P#;:OM/TKXL_P""CGWOA[_W$/\ VVKZ3AO_ )&M+_M[
M_P!)8'U@OW12TB_=%+7SDMV 4444@"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I'_U;?[M+2/\
MZMO]V@"G1114 %%%% !1110 4444 %%%% !1110 4V7_ %;_ .[3J;+_ *M_
M]V@"C11106%%%% !1110 4444 %%%% !1110 5%=?ZEZEJ*Z_P!2] %&BBBI
M ****0!1113 **** "BBB@ HHHH *ANO^/=ZFJ&Z_P"/=Z *%%%%4 4444 %
M%%% !1110 4444 %%%% !5+5_P#CW7_>J[5+5_\ CW7_ 'J ,:BBBK("BBB@
M HHHH **** "BBB@ HHHH *\Z^.?_(IVG_7\O_HN2O1:\Z^.?_(IVG_7\O\
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M.EMUF\GRXVC:3='MW?-\VUMM8>RR7EYGA'\7+M]K[QV+/_#:/C;_ *!F@?\
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M<6#V+7;2+/;S-'\N[;N5OW:_-\VYJSHQS:E3]E&/_I/;_,TJ2R^I+FE^O?\
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M?LXZ='K$&@Q>-[<^)KJR-Y::;)8,HE7:S!?,W,J_=;I\VWYMM=CI/@&RO(?
M\=OI>BP7,_ABXN;EK_2EN%ED7R/F9=R_O/F^\W^U5+XC_&GP_P"&_%ECJ6D:
M-IVNZ_'I206VN0WVY;9B'5E:-?E9EW-_=;YMM<AI/[1#::V@L^A"X;2]'DTH
MLU[_ *[S/*_>?ZOY?]7]W_:^]7G.&9XJG&3U^[L_PVW.SFP-"<H_Y^1)HG[/
M.F:E:>%OM'C)+'4?$5I]HL[)M-:3+;-[+N63:/\ >;[U'AG]F>^U;3(YM0U:
M33;NYN)K>VAATN:ZC;RV\LM)(ORQ*S+\K-_#\U9%I\<#;ZIX#O/[&#_\(K;-
M;A?M/_'S\FS=_J_W?_CU;-C^TFWV&2TU+1+NX$=S<36KV6N7%CY:S2&3RY/)
MV^9MS]ZNNI'.(Q]W_P!M\_\ @'-#^SOM?KY?\$\^\-_#N_\ $7Q$C\(K)';7
M_P!IDM)I&^94\O=YC?[7RJU>J7GP]\+:1\&/%#Z?K.GZ]/#J=O;-J\E@T,EH
MWFQ*R_Q-M_BW+NW;FKRCPMX^O?"OCV#Q5%$L]U'=27+Q22,WF>9N61=S,S?=
M9OF;<W^]7H4?[0FEZ7IL]EHG@FWTV*;4(=2D5KXS*9(Y59OE9?\ 97;MV[:Z
ML=#,*E2')\/N_P N]]?Z^\YL++"1A+VGQ:]RQ;?L\Z-<Z98:S;>+Y[G0YKZ&
MVFFET>:U9ED.U6C\S_6;F=5W?=^;_9VU%XP^$7@^/XI:AX?LO$TVEK'''Y=E
M#I5U?3+-LRT:[?O?*OF;O]K;4&M_M!6]YI^K6FE^%(],:_O[?4VFDOY+AFN(
MY%D9FW+\RMM5=J[=OS?\!LZE^T-HFK3>(!<^!(Y;771#]M1=5D5I9(_NLTBK
MNV_=^5=OW?\ :KC4,VYN9\W_ ))Y?+O_ , ['++^7ECR_CY_/L<%\4OAW-\,
M?%3:-+=K?KY,<T=PL?E[E;^\O\+?*U<=78_%/XBO\3O$-MJTE@NFRQV<=M)'
M')YBLR[OF7Y?E7YON_-_O5QU?4X3VWL(^W^+[1X.(]G[:7L?A"NB_9E_Y.P\
M-?\ ;Q_Z0R5SM=%^S+_R=AX:_P"WC_TADJ\9_N6(_P"O<OR/?R#_ 'J7I_D?
MI)1117X.??">E?%G_!1S[WP]_P"XA_[;5]I^E?%G_!1S[WP]_P"XA_[;5])P
MW_R-:7_;W_I+ ^L%^Z*6D7[HI:^<ENP"BBBD 45\NP^/?B_\<O$6LW?P[U#3
M_#/A;3;AK.&YOXU9KEE^\WS1R-N_B^555=VWYFJC?_M!>.M+^%WC[2]:\O2/
MB%X6^Q_Z9'#&RSQR31KYFUE:/=M;_=_>+M5:^@_L6O)QC&4>;2\;ZKFTU&?6
M%%>+>!OVF-"UB\\,Z/J=EK=C>:O"L=MJU_I_DVE_-M7=Y+?Q?,W]W;\U6=>_
M:B\)Z#KFH6/V/7-0LM,N%MM1UJPL/.LK*1FV[9)-V[Y6_NJW^SNK@GEN*53V
M?(_ZT ]@HKY?^-WQR\61?%31O"OA&YU;3+&:#SFO=-T:'4&OMT?F+);K(VV2
M-5^\RLNW]Y][;79ZI^U-X8T"YNX9=/\ $6J:;IUTMA>>(K+3E;3UF^56W2;O
MX6;^%?\ =W?+6LLKQ*A3:CS<WO!8]MHKRCX@?M$:7\/9[@W?A;Q3?:7#''(=
M8T_3E:Q99%7;^^:1?[RK_O5S@^.J^)_&_P -9-+U;5](TKQ#'-(-)FTJWD^T
M;69?WDWF;H_N_P .ZHIY?B*D>?E]W_@7 ]ZHKP-/VS/!S6C79T7Q+]BANOLE
MU=_8%:"U;^'S&63;\WS?+][Y6^6NI\'?M&>&O&7C:W\-6]GJ]A<WL4EQI]W?
MV7DP:A&O\4+;MS*RJS;F5?NM14RW%TU*4H2T$>IT5XOJ'[6'@VRU"[5+/7+O
M1K.X6TNO$-I8-)I\,G^U)NW?Q?W?F_AW5N>.OV@/#O@G5=+TJ*UU/Q/JFJ0_
M:+>R\/6ZW4K0[=RR?>7Y656^[_=K/^S\2I*/(]1GIE%>)?L[_%75?BAXD^(;
M7=])=Z18W\:Z9'):K"T,+>9\K?*K?PK]ZO;:RQ6&G@ZLJ-3XOZ8@HHHKE **
M** "BOE/X\?'7QE\//C9%8Z;J2IX:L[>UN[ZR:UA;=&TBK)\VW=\VY?XJK_M
M#_M!>+_#/Q1M-(\*ZLMGI%O':QWC+;PS>9)-ND7YF5O^6>W[M?14LBQ=7V?*
MU[\>;^M/,9]:45Y1XT_:.\.^#O$-WHD6FZYXDU"PA\_4$T.R^T+9K_TT9F7;
M][_@/\5+XD_:7\%^'/#WAS71+>:CI6N3-#;W-E#N\EE^]YBLRLNW^ZJLW^S7
MFQP&)DTHP>NP'JU%>8^!?V@/#_C;7]4T673]8\-:I86_VN2V\0VRVK-#_%)]
MYOE7Y?O;?O?[U8EK^UEX,NKV-GL]<M=!FNFM(_$UQI[+IK2?W?,W;OX?[O\
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M1O\ QU6K[/KS?Q/\&H/%/Q8T_P 8W.H;K:WTF329M+:W_P!<LGF;F\S=\O\
MK/[M>UE.*IX'$>VJ=F,^._VA?&#_ !AU)_$\(_T#2=+T^W;R_NK<7"M,R_\
M ?WB_P#;.OHV\\8>/_BK\4/%?ASP=X@M_!^E>%T6.:ZDL([J2ZN)/NJRR?=7
M]W)\R_\ CV[Y<N#]C6"U^%^H>$HO$[?:+S5([]M1;3_X8XV58_+\S_:;YMW\
M7W:[/Q9\ [^Z\::AXJ\&^+[KP3JFK0^1J0CLX[J.X7Y=K*K,OEM\OWOO?[OS
M;OI,3F&7U%&E1DO<NE>-U]G=6Z^]T \O/[2GC#Q!X%T+1[!+33O&]_K[>'YM
M2\L- C+Y?[Y5967YO,5?XONM\OW:K:Q<>)?AY^TEI5YXKUB'Q5<:7X8O+V&]
MAMELVFA6.XDVM&NY5;<K+\O\.VO2[[]EC0IOAOIGAFPU.\L=2T^\.HV^O?>G
M^UM]Z1E^7^ZOR_[*_-_>9H_[..I2?$2#Q7XK\9S>++G^SYM.N(9K!;=9(Y%9
M=J^6W[M=LGW=OWMS?Q5C'&9=%3Y.6,??TY?>=_AL[:+RN!XOH?[5_B&WN=&U
MN]\8V6JM>7WEWWA&/1VA2SA9F^:.XV_,R_[S?>_BKTCP?X@^)7Q(^+?CS1[/
MQH-$T'P_J2JJ_P!E6\TC1LS;859E_NJWS-N;[M='X5_9VUGPS=:;8K\2=9?P
M=I=TT]KHEO']GEV[MWER7$;;I%_O+M_[YKJ? OP?C\'>)O'FJ3ZE_:-OXKN%
MFDMOL_E_9U_>?+NW?-_K/O?+66*QF76FZ,5>VFG]Y?W5JE?_ #8'S9XC_:.\
M<Z1=OK.G>,8-=M8]2,<VFZ9HN_2[>/?\L;7DBQR,S*O\*_-][=71QVNNZ7^U
MYXOO5\2-&+#2/[1N-NGQM]HLU:%OL?\ L_+M7S/O?+_M5NW7['-_)X6D\-1_
M$.]7P[#>->V&GOIL;>3)N^](VY6F^7_=7=\VW^&N_P!9^!]Y??%9/&MCXF_L
M][JSCL-6T]M/6:.^A5E\R-69OW:LJJO\3+_>K:ICLN@N6A):Q:^'_#:_N^O^
M?49\]V7[6WB&WCM/$MQXPLKF22^VW'@A='95CM?F7<MUM^]_%]YOO?\  :W_
M !-?^(+7XZ?&35/"%\UCJ]MH5K>P2K#')YBK':LR[9%;[T>[_@6VO2_#_P"S
M?JWAN:STJR^(VLVG@NUO&NXM%M(%AG7=N;R_M2MNV[F^9=OS?[WS5M77@G2_
MAK\1/&?Q3US7-NE:A8PPW%I]A9OLZJL<>[<K,S;O+_N_Q4IX[ *M)8:.ZVMO
M[T;*W*NS[^K$<A!\;=:^('B3X2Z3X;U#^SVUFS;4]<9+>.3]S'\K1KN5MNZ2
M.9?^^:=^V]:WDOPABF@OO(LX;Z/[1:>2K?:-WW?F_AV_^/5B?L=> ;6'4?%W
MC*UM[J+2+RXDL-#:X7:S6?G,S?\ CWE_\"5J]M^,'PTB^+7@.^\-SWS:?]H:
M.2.Y6/S/+96W?=^7=7'5JX? YG24/A@]?S_#;Y >02>,/'@UCP1\+]$\2V\6
MM3:9_:-_XFFTV/<L.YO+CCA^[\JJJ_[7R_=^:NP^#/Q$\277CGQ9\/\ Q?<0
MZKJ_A_RY(=6@A6'[9#)\RM)&ORJVUH_N_P#LNYJ^I?L]:KJ4/AW4U\=7%MXX
MT.-K:+Q#!IL:K-;[FVPM;[MK;=S+][^)MVZNG^%/P@B^&]QK6IWFK7'B+Q+K
M,WG:AJES&L?F?,VU8XU_U:_-]W=_X[M5<L5B,'+#R4;7]->:^][;6Z?@!Y7^
MU%\,]<U[QQH/BF+PPWCGP[I]BUM=Z%#=20R[MS-N7R_F^;<OW=W^K^[7*_"_
MQUX4^%^C?$+4=#T77_#'B>UT^.ZN?".LS,UM'\RK&T;,JR-_K(]V[:VV3Y?[
MU>P?%K]GD?$'Q);>)=&\4:CX/\21QK;27NG[F\R'YOEVJRMN^9?FW?=7[M4/
M!?[+>GZ+:^(F\3^(=1\8:OKMG]@GO[MF5EM_EVJNYF;=N5?F9F^ZOR_WNRCC
M\++!1I8B=U&WNJ_>_P#A^>C \N^'W[2FMS>,/"%K>^-[7Q6OB*9;2]TF/1_L
MK:5)(RK'Y<WE_O-K-M_B^[_%]ZM._P#V@/%_AGP#XST/4=26\^(&FZ['I-C<
MK;PJTRR-^[D\O;M;Y8Y/X?XEKT[P+\#/$'A?5M%.J?$;5-:T/14:.QTF&#[&
MO\*JLS1MNF557[K?^@[E:?Q!^SWIWB'XV:7\0GU!HA:K')-IOD[EN)HU98Y/
M,W?+M^7^'^&JGB\K==WBN6U]NJ>B^&.ZT>GK<#RSXG_'/7_#?CU?!MSX\MO!
MBZ/ID+7FM-H_V]]1O&C5O]6L>V-?F_A5?XO]U<^7]HCQUXR\,?#9M#U*WTO6
M=8UB;2+Z;[*LD,S+Y*K)M9=R_+)N^6O9/'7P/O\ 7/'$GBWPKXMN/!NMW5G]
MBOI([-;N*XC^7;\K,NUOE^]_LK]W^*O=?L^R74GP_ED\4W][/X5OFO9KC5-U
MU-?,S1LR[FD_=K^[^7[U1#%Y;&%.\5?TZ\K_ +O5^;^0'F7Q&^,'BKX=^*M,
M\#:K\1X]-=;=K^^\62: LDC;MWEVZV\>Y=OW?F^]_M?PMQ7Q%^+-[\5/V=MV
MJ7$-]J6E^)8;22]AA\M;N/RY-LVW^%F^;Y?E_P!U:^D_B-\&;OQ7XOTWQ=X>
M\32^$O%%G;M:-=I9QW44T+;OE:-MJ[OF^]_]CMP_$W[.MUXJ^%MIX3OO&>HW
MM]'J2ZE<:QJ,;7#2,JLOEK&TG[M?F^[N^7_@5:4,=@*:I3E%*5U?3UOM';Y_
M) 84_P ;-=^'OBOXIZ-XFO\ [=_95G_:NAR-#&NZ%OE6/Y57=\TD:_\  6KT
M_P""=UX@U+X7Z#J'BF^;4-:OK?[7-*T,<>U9/FC7;&JK]W;_ ,"W5X+\?-+T
M/XT?';PGX8T=KBYU>S9K;7FCA95AM599/F9MN[^+_9^9?XJ^KO)\JU\FW\N#
M:NV/Y?E7^[\M>=F,:%/#TN2%ISUEIVT_'<#X;_:>\8Z/XW^*GB*TOM9_LU?#
M6F>1I6U)&\^^W+)(ORJVW^*/<VU=RK7LNL_M#7UG^S/HOB_2UAFUZ^:/3-TW
MS+#=?,LC,O\ VS9E7_:6NH^'7[-OAGPCI=]'X@L]-\9ZO>7DEW-JFHZ9&S-N
M_A56W;?^^OXJR-/_ &5].M?"/B_PO<ZQ-/H>L7W]HZ?#%;^6VER?-]UMS>9\
MNU?NK\J_[5>E/'9;4A3HRVI./S7VO\]0(/\ A'_C)I\?B#3=:\56&K:+<:,T
MJZT+"&.2SN-K;HXX5_UG^\W\.W;M;Y6^>=%O=;\-_LJOJJ:E:7UA-K:PV^EW
MNDV]Q%;M^\\R3=(K;MWR_P /R[?]JOJ'P1\"=8T7QHOB3Q/X[O\ Q7>0V']G
M0Q_9ULH_)^;<LBJS>9][=_O?-\U<9)^R'J#?#VZ\&CQZTFB->+>VL3:.NZW;
MYMWS+)N;=N_\=^[6F&S#"0O3J3C\4'I"RTO?IZ=O\PN^(/C1K?PS^(7Q#TGQ
M'J'VG3X=)_MC0/,@CC_V?)^5?F_>-M^;=_JZX_Q'\=O&/A7PA\/=-UOQ/'H>
MJ^(+5M3U'Q#<::MQ]CA9MT<:V\<>UF9=J_=^\W\/\/KGQN_9]L/C1J&@75QJ
M3::VFR,DVV'S/M4+,K>7]Y=OW?O?-]ZM+XF_!S_A-K_0=7T76I/"GB/0V9;'
M4K>W695C9=K1M&VU67;_ .S5QT<5EK5+GBN;[6FUE9='ON]'Z <O^S3\9+OX
MD?\ "2Z/J.J0^(9]%N%^SZU!:M:?;;>3=M9H=ORLNW_T'^[N;W"N.^&O@/4?
M!.GWG]L^)]1\5ZI?3-/<7=ZVV-?F;:L,.YEA7YONK_\ $JO8U\[C9T9XB4J$
M?=_KR7Y(04445Q %%%% !2/_ *MO]VEI'_U;?[M..Z _*[XO_P#)6O&G_8;O
M/_2AJW?V:]6LM!^.'A74-1O+?3[*&=VEN;N98XX_W3?>9OE6L+XO?\E:\:?]
MAN\_]*&KD:_H^C1^M9<J,OM1M_Y*,]>^,7QZ\9>*/$'BG13XJGN_#CZC<1Q0
MVSKY<EOYC>6NY?O+MV_[U>E?\+8TGPQXP^ ^HP:I9W5M9Z##IVJK#<JWV=9%
M$<BS;?N[=V[:W]VOE>BN.>38:=.%*"Y8QYOG>-@N?5FK>//!GPU^)'PO\,V.
MIVNL>#/#D\U_<WEK,MU']HN))-K.R_>\G]VW]ZF^-?%D?A?X>_$I=7\?Z=XN
MN_$&HPSZ!;Z7JK74MJRS-)YOR_ZG:NWY?]C;7RK17-_J_3O"4I[?%_>][F^6
MOX#N?:/B3Q5H>O?'+P#XG;XB:=;^&H[*-!'!J$;2170AD_UD;[O)W!MOF,N[
M^'Y?O54^('BK1)O!'A2V.O: U]:^-[/4;B"R\2-JK1V_ELK2-),V[[WWMORK
M_P!]5\<T5A_J[3C*G>M\/_!_S"YZ7^TIJUEKOQO\57^G7EOJ%E-.C0W-I,LD
M<G[I?NLORM7JOQ+^/FK^$OAG\*]/\%>+H8)4T..+48;&6"9HI%CB55D^]Y;?
M>KY?HKV)Y31G&A3J^]&G_P"3:6$>X_"WXH7V@?"OXPWW_"1M:>*=2_LW[-/+
M=9NY]TTBS-'N^9F\N1MS+\R[MU>P:7X_\-:EXF^$.J:AXQL4U2Q\,3+<737\
M>YKKRXML-S,V[RMVZ3YF^;[W]ZOBZBN'$9!1KU9U8SY>;_Y'EL.Y]?\ Q2\:
M:4O@GX<KIFO^&GUO2_%"7;1C7)-2AM_O,K23,S2M']W<P^6I?C9XL\&:QX-_
MM/5=4L'UA=5MYGT?PYXIEU.UU"/S/WFZ'Y53Y=_\*_P_-_#7QW16%/AR%.5.
M7M7[K_X(7/MCXF_%RXOH_$NJ:5\0?!<?A*ZTYC:626T=QJD^Z-5^SM#\K+N^
M;YF^[\M?*'PTT6P\1>,+*TU'Q';^%8_];#J=Q#YD:2+\R[OF7;_O5RU%>C@L
MJC@:,Z%.IK+RC_3%<^C?CWXFBUCX3Z+:^*O%.A>,OB!'JLAAO]!FCE6&Q\OY
MHY&C55_UG\/_ ,2U4OV:/']OX!\ ?%FY36K71];ETZ%M.\^>..269?/_ -6K
M?>;YE^6OG^BE')81P7U.4_=YN;\;_#V"YZGX<^+OB+QK\6O =]XP\12W=G8:
MW9R>9>2K'! JW"LTG\*K\OWFKU;0?C,FO?'3XCKJWBJ&Q-Y8ZEI7AO6I+G_1
M+']Y^[967Y55E56\S_9_VJ^5JVY_!'B*UN]2MI=!U..XTR'[1>PM92+):1[=
MWF2+M_=KM^;<U88K*,'4>_)[O+_Y-N.Y]5>&_$$,5]\'/"USXHL?%WC"RUR:
M\FU"PD;5([:U97_=M(OWMWRM_P!,]NYOE6LSXT1:EXB^&7B2W\*3Z#J^A1ZC
M_:^JM9>)6U6YC7YMK;6CC\N/_97=_P"A5\P>&_$FI^$=:M-7T>[DL-2M&W17
M$?WE^7;_ .@M73>(?C9XS\4:+<Z3?:LBZ?=,K7$-G96]KYVW[OF>3&N[_@5>
M:\AK4\1"I3G&T=^;U;^%?@%SZ$\4?%BS\2?M=6(NO'$-MX.TIEDL+NUN(S:>
M9]C^;]Y\T>69F5I/X?N_+3/BMXHT:[^&&AV?]N:!)J-OXPM[^:VL/$C:J\=O
MY++YC23-N^]][;\J_P#?5?*.L:+?^'=1GL-5L+K3=0AV^9:7L+0R1[EW+N5O
MF7Y65JIUTQX?HR="=*>D8K_MZW^=PN?:FN?'0+\1/C1);^-H/[/30470!'J*
M^09O(7_CW^;:TFYF^[\U>-_'CQC;^+OA=\)=^MQZSK-O872ZA_I*S3Q,TD6W
MS/FW*WR_Q5X?171A,AHX*K3K1?P__(\O_!%<]0\%7"^)O@QXR\*(V[4K&ZA\
M16<*_P#+98U:&X_[YCD\S;_LM7J1^+_A+X2^!_AAH$6EP>+;S3T76[BXM-5:
M/[%>2,S;?W+;695W+M;^';_>KYRM]/UW1;*R\006U_I]I)*RVVK1QR1QM(O\
M,<W][_=K*K6OE-/&S?-/W.;F_P"WK<H7/M#0=9\/>&_C)\5KSP[XU\.Z9_;V
MC_:M*U*34X1!'=29+*[%MNY9-S;?[O\ #7'?&'Q%!?? ^YL_&WC3P[XX\;KJ
M,;Z1<:%/'<-;Q?)YBR-&J_+\K_>_V?\ @/S!17+3X?5*M"JZOP\OV=?=\_S"
MYZM_;5A_PRO_ &1]NM?[5_X33[7]A\U?/\G[#M\SR_O;=WR[J]0_9_\ %]UI
M?[/6KZ9X?\<>'O"'BB3Q$TT;:U?PP[K?[/"K?+(K?W?[O\-?+-%=.)R:&(I3
MI.IO/F'<^GO!_BR/P7\6-;7X@>,M$\16WC;29-.OM7T&[CN(H&95C5I/+5=O
MRKM_X%NK@]4^#?A/P;X6U_4M=^(&BZS?*GEZ-9>&+U;J2XF;[K3+M_=Q_P![
M_P!"_O>.T5I2RF=*?/3J\OP\W+%?9_\ 2>PKGLW@?7M,L_V9/B1I,VH6<.J7
ME_8M!9R3JL\JK(FYEC^\VVLCX:31^%?A]X]\17?RK?V'_".V$;?\M[B9HY)-
MO_7.-=S?[R_WJ\PJQ+?75Q:P6LMQ-);6^[R86D9ECW?>VK_#NKI>7_Q(\_Q2
MYI?^2_\ R('<? '5+31?C-X1OK^YM[*RM[]6EN+B18XT7^\S-]VO8V^)UOX=
M\$_'F?0_$UM9:QJ7B9I+!K6[C6>>%KIMTD/S;F7RV^\M?+E%88S*J>.K^U;[
M+[I<P7/MK0/B1X<N/&G@75K[Q-I+WA^'[6FH7L]_'N^U;8F\N1F;_6;M_P K
M?-]ZO*;/Q(OB']D^+1K7Q=9:?J^FZG--=:=>:G]GGN+7R6_<QJW^LW;E^5?E
MKY[HKSX</0IQM&>UOPO_ )CN?;MUXT\)WWQN\::E;>+=*62;P[:VEHO]K1VE
MM=[E/F1M>+N:-EVK]UE;_OFLOQM\2- L?B7\$[V#Q+I1M]/62VU.33-4:ZC@
M^:/Y9)&9I&7_ &I/O?>KXVHK%<.TXS4G6^SR_P#DO**Y]D^'?'$'A[Q1\4;2
M+QOX9;Q)K<T=[HFK:AJ"WEA]E6XD;[*TC?+&RJWW?]I?[M0Z'\6+.Q^,F@'Q
M1XW\/:C=QZ%=6<6K:79QQV6F74VS:OG!MLB_*WS?*J[O]IJ^/**T7#E)\SE/
M>/9=K?T@N?1GQ5U"2Q_9OL-"U7Q]I7C/7D\4_:_]!U,WSPV_V61?O?>9=WS;
ML;?WFVOG.BBO;R[!K 494^>_-+F!A1117J<R[B"BBBJ **** "BBB@ HHHH
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M> ?%7BB[76=1L533],AM=&U>WT.:.UB969MGV4R-YFW<NU67;\K?+]W=\O\
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M1\:?&;X3:]IG@_7=%T6SCF@D@O=+:'[&JLRJLBKN6-?[O^S7L?\ PISP\_\
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M\L_VB[DD^UQ_PPS;F_>1K_"K?^S-N/\ A3OAYO\ 7+?77F?+/]HNY)/M<?\
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M95^]_#7''*8.G*KS->J_NW"Q]A6_Q,\(WEY#:P^*M&FN9IOLT,,=_"S22?\
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M*_ CX1_$RSCD:?PU?3+>>7]Y[.:ZD63YO_'?^VC5K6RK#2?+3]V_+;UE!O\
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M\OWFW?>^]\M,USX5>)O#>AZ3JMYIDJP:E\L2+&S/']W;YGR_*S;OE7[U=/\
M&76K#5/"GPXAL[VVNY+/18XYXX9ED:*38GRMM^ZU>L>&?B+I0TKX9ZIJ'BBT
M>VTZ&:"_M9KYC.)F41QS-#_$J[&^9ON[MRUURQV+I4*57EYOB_6QE'"X>I6E
M'FY=OTN?-6H>#M>TN[M+:]T74;*YNV\JVAN+22-IV^[M567YOO+]W^]4]UX%
MU[3/)DU+1=1TVU>58?M%W:21Q[MWW=S+]ZOH*QUZ+2K+2-%USQC9^-]:U#Q7
M97%A)97(NOLT:S1[G9C_ *OY=Z[5_O?+_%5GQIXB@\._\+!&O^,++Q!#JDZV
M^F:.DXDDM)%=N&A;Y8?+^4[A][9N^]MKG_MC$.48<G_I6OI_70U_LZC;FYOR
M/'O&GPAC\&S>+H9-5N+N?03:JGEZ9)Y4_G*K?-(K,L.W=_$WS5REYX%\3:?;
M7%U=^'=6MK:'_6S364BJG^\S+\OWEKW+XH>*M$U'3_C$MKK-C<OJ$^DFT6&[
MC;[1Y:P[O+^;YMNUMVVMO6/B58ZI\5O&-E<>)+6;PO+X<D@MHVO5^RO,RQ_*
MOS;6D^:3_:J*698RG3C*4>;_ /9A_FPJ8/#SG+EER_\ #O\ R/FC_A&=8_L7
M^V?[*OO[)_Y__LLGD_>V_P"LV[?O?+697UYJ'Q1\,2^$8K_39-%FTUM(^R2:
M7?:]+!)&N-K0_8ECD5FQ\N[JW^[S7R'7N9;CJV-Y_:4^7E/.QF'IX;E]G+F"
MBBBO9/-"NB_9E_Y.P\-?]O'_ *0R5SM=%^S+_P G8>&O^WC_ -(9*YL9_N6(
M_P"O<OR/I\@_WJ7I_D?I)1117X0??">E?%G_  4<^]\/?^XA_P"VU?:?I7Q9
M_P %'/O?#W_N(?\ MM7TG#?_ "-:7_;W_I+ ^L%^Z*6D7[HI:^<ENP"BBBD
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MJ*/];LS_ )U]P'PK_P ,,>/?^@KX=_\  JX_^,T?\,,>/?\ H*^'?_ JX_\
MC-?=5%'^MV9_SK[@/A7_ (88\>_]!7P[_P"!5Q_\9H_X88\>_P#05\._^!5Q
M_P#&:^ZJ*/\ 6[,_YU]P'PK_ ,,,>/?^@KX=_P# JX_^,T-^POX\5?\ D*^'
MO_ JX_\ C-?=5-E_U;_[M'^MV9_SK[@/A/\ X8B\=?\ 05\._P#@1-_\9H_X
M8B\=?]!7P[_X$3?_ !FOMZBG_K=F?\R^XL^(?^&(O'7_ $%?#O\ X$3?_&:/
M^&(O'7_05\._^!$W_P 9K[>HH_UNS/\ F7W ?$/_  Q%XZ_Z"OAW_P ")O\
MXS1_PQ%XZ_Z"OAW_ ,")O_C-?;U%'^MV9_S+[@/B'_AB+QU_T%?#O_@1-_\
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M\86L>Y]2T/[VWY;B;_XW7V55+5_^/=?]ZC_6_,OYH_<!\<?\,H^+O^@AHO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;]H'_HETG_A.ZA_\<H_X:&_:!_Z)=)_X3NH?_'*^PO.E_P">C_\ ?5'G2_\
M/1_^^J/[5P__ $"1_P#)O\PT/CW_ (:&_:!_Z)=)_P"$[J'_ ,<H_P"&AOV@
M?^B72?\ A.ZA_P#'*^PO.E_YZ/\ ]]4>=+_ST?\ [ZH_M7#_ /0)'_R;_,-#
MX]_X:&_:!_Z)=)_X3NH?_'*/^&AOV@?^B72?^$[J'_QROL+SI?\ GH__ 'U1
MYTO_ #T?_OJC^U</_P! D?\ R;_,-#X]_P"&AOV@?^B72?\ A.ZA_P#'*/\
MAH;]H'_HETG_ (3NH?\ QROL+SI?^>C_ /?5'G2_\]'_ .^J/[5P_P#T"1_\
MF_S#0^/?^&AOV@?^B72?^$[J'_QRC_AH;]H'_HETG_A.ZA_\<K["\Z7_ )Z/
M_P!]4>=+_P ]'_[ZH_M7#_\ 0)'_ ,F_S#0^/?\ AH;]H'_HETG_ (3NH?\
MQRC_ (:&_:!_Z)=)_P"$[J'_ ,<K["\Z7_GH_P#WU1YTO_/1_P#OJC^U</\
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M (:&_:!_Z)=)_P"$[J'_ ,<H_P"&AOV@?^B72?\ A.ZA_P#'*^PO.E_YZ/\
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M_M7#_P#0+'_R;_,-#X\_X: ^/W_1+G_\)[4/_CE'_#0'Q^_Z)<__ (3VH?\
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M +ZH_M7#_P#0+'_R;_,#Y%_X: ^/W_1+G_\ ">U#_P".4?\ #0'Q^_Z)<_\
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M9_PO;X^?]$OE_P#">OO_ (JC_A>WQ\_Z)?+_ .$]??\ Q5?6?VZY_P">\O\
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MI7?_ #\W'_?QJ/[2N_\ GYN/^_C4?VMA_P#H$C_Y-_F!\K?\+H^/7_1+Y_\
MP07W_P 51_PNCX]?]$OG_P#!!??_ !5?5/\ :5W_ ,_-Q_W\:C^TKO\ Y^;C
M_OXU']K8?_H$C_Y-_F!\K?\ "Z/CU_T2^?\ \$%]_P#%4?\ "Z/CU_T2^?\
M\$%]_P#%5]4_VE=_\_-Q_P!_&H_M*[_Y^;C_ +^-1_:V'_Z!(_\ DW^8'RM_
MPNCX]?\ 1+Y__!!??_%4?\+H^/7_ $2^?_P07W_Q5?5/]I7?_/S<?]_&H_M*
M[_Y^;C_OXU']K8?_ *!(_P#DW^8'RM_PNCX]?]$OG_\ !!??_%4?\+H^/7_1
M+Y__  07W_Q5?5/]I7?_ #\W'_?QJ/[2N_\ GYN/^_C4?VMA_P#H$C_Y-_F!
M\K?\+H^/7_1+Y_\ P07W_P 539?C)\>)(]K?"^?_ ,$%]_\ %5]5_P!I7?\
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MX_[_ #51U36M1BMUVW]TOS?PS-1_:^'_ .@2/_DP'S#_ ,+%^-__ $3.\_\
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MQ?C?_P!$SO/_  07W_Q5'_"Q?C?_ -$SO/\ P07W_P 57T3_ &_JG_02O/\
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M5'_"RO%W_0T:W_X,9O\ XJG[7'_RP_\ )@^O9?\ \^#E/^$2^*/_ $3[7/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGF;OO?\ ;3=\V:\ ^!?B?3?#'Q:GDU2YCLK:Y2XM5NI&55A9ONLS?P_=V_\
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M-=.\(>)+/P?I7AB;[&OFZ?'=27EQ\R_-N^ZNZ-OF7_9^5JXK5OVE/&VO>!_
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MCXHU&#7&\1K>7.J74,-\OV6WM9"LC_=:3YI9/D9F6-?E_N\;BWXF:2/#_P
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M,U9M%%;PA"G#D@K""BBBM "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\O;YG_CVZL*=;*IN47'W5Y/R?]?@;RIX^/++F^(S+7]H;Q-!J^M7UQ:Z5?\
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M?]N_FCT,G_WVG\_R/J6BBBOR _30JIJ/_'G+5NJFH_\ 'G+0!CT444 %%%%
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MG-O^?WX+_(#Y8_X8;'_0[?\ E)_^W4?\,-C_ *';_P I/_VZOJ>BC_6G-O\
MG]^"_P @/EC_ (8;'_0[?^4G_P"W4R7]A[RHV;_A-/\ RD__ &ZOJJH;K_CW
M>C_6G-O^?WX+_(#Y2_X8H_ZG+_RE_P#V^C_ABC_J<O\ RE__ &^OIZBJ_P!:
M,V_Y_?@O\@/F'_ABC_J<O_*7_P#;Z/\ ABC_ *G+_P I?_V^OIZBC_6C-O\
MG]^"_P @/F'_ (8H_P"IR_\ *7_]NKUOX._!NQ^$>FWD<5U_:>H74FZ:]:'R
M_E_A55W-\O\ P*O0Z*X\7GV8XRE['$5.:/H@"BBBO  **** "BBB@ JEJ_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_M:4>7V<3Z U+XG^&OB!IOC#0M;U]M(6_OX;R'6+?3)!!<+''%'M:'S&9?\
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M9WLYMFH7'R[OW:JS+& OW6Z_=Y7[WS]17%_8M.WQR_#T[=M#I_M&I_+'\?\
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M>^SZ+_SU;_QZC[/HO_/5O_'JPZ*"S<^SZ+_SU;_QZC[/HO\ SU;_ ,>K#HH
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M7]G_ /Z&&\_[^3?_ !NOF^BC^RJG_01/[_\ @!_:,?\ GS'[CZ0_X17]G_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCAXXGFC[WV>O]?B![917DOA#]I;PWXPUVPTU=-UK23J8D;3+O5K+R;;4=O\
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MIBW5I<V=PUO?:;J4/DW=I(O\,D?\/^?XE9:Z^N2<)TI\DX\LA!1114 %%%%
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M_P!N?_M>O$S[_D75/^W?S1ZN3_[[3^?Y'U+1117Y"?I@54U'_CSEJW534?\
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MC=;6W9_BW[MOW?XM^ZOBNBNJOE#J8>%!3^&_V>_^70YZ>8^SK2K<OQ6Z]O\
M,^R?AKIOB'0KZQ=M3CU+PQJ5[>--# ;:*"T=I)-L<C,IEG9F*KM7;M9=OS+5
M"XAU_P 2_#GP[IVFZE:Z5;P:Y+97=Q-%"T=M%#=,MLOEM]YMRPJJ_P 7R[NM
M?(M%<W]AOFY_:1YO\/KY^?X'3_:FG)R?CZ'U%\;;75[CX.WR^)&>[U>PU:-8
M[B5[=I'A8!5DVPJOE+)\W[MMS<_>:L7X1MJB_!Z9O!']G+KZZG_Q._MOE_\
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M^'[U>Y^ _@-:^$OA_P"*O"5_JLFJ6?B"\N+B::"'[,T*S1K'M7YF^9=OWO\
MQVN(T_\ 93UB&+PLEU\0[B^3PQ?1W6F0-I<:PQ*K>8RLJR;F9F5?F9OE567;
M\WR[+%Y?*=5NUOL^[TMZ7O?T \\\!:=X@TWXC?&Z[;Q%'<?V;9W#:A')IL+K
MJ3>3-Y>Y6^6/:WS;?FW?=:M[X>?$SQ+X5\-_!O5KBZM8_".MS7&EZC9VUC;V
ML,=PUQ,L<G[N-?+_ . [5_=M_>9J](N?V?+[_A._%NN:?XLDL--\3VLD.H:6
MU@LNYV@:-6$F[<NUF\S:O^[NJ>7]G:WNO@/9_#>?6/-EM6\RWU9;7:T<GG-)
MN\OS/]IE^]3KYA@JSC[2SORW]W9<C3Z='K]U@/-;[]HKQ58^!_'WC2&X6YTI
MM:72/#T,T,?E0K\VZ9MJ[F^7;]YOO5<^"OQ^U'5OBIIOA.Y\9V_Q L=6M&D6
M]CTEM.:SN(U:1H]NU?,7:OWO_0?XO2V_9]T2X^"=M\.Y[B3R+=%9=0C7;)]H
MW;O.V_[S-\O]WY=W\56/A[\+?$GAOQ$=7\3?$#4_%<L-JMI:VOD_8K:-?^>D
MD:LRS2?[3?\ CWR[>:IBLNE1JJ$5S:V_!1?POU>L?F!P_P"UK+<:Q-X!\(/?
MR:;HWB'6%AU"2-MNY5:/:O\ X]N_WE7^[5B]_9C\!^%?&OA36="U.3P9>VMY
MNCACNFD;4&V_ZM?.9OF_W=VY=WR_Q5Z/\5OA/HOQ@\*OHVKB2$JWG6]W#_K;
M>3^\O_H++_\ M5Y=X9_9/FA\6:;K?C3QWJ?CE-+?S+.SO%?:LFY6^;S))-R_
M+]WY=WR_[M8X7&0CA(P]NX<M[QM\5_P\M0$3Q=\2/B]XV\;VG@[Q):^$=,\+
MW#6$,;:?'=27UPNY?F:3[J[E;YE_O+\K5YYXB^*%S\7%^!^MWMK#9ZBOBO[)
M<QP[O+\Q9K?YEW?P[66O8?$W[/.I-XHUW5_!OC>\\%C7U;^U+1;1;J.9F^](
MNYE\MOF;YE^;YOE9:==?LS:5!9_#^PT;4I-.L?".I?VCB>W6>2\;S%D;<RLN
MUOE^]M_X#\M=5/&8"FU)6\M-5[C3N^MY>OR \.\=:AJNN^&?C_$EW::?;:=K
M-OYJV^F6\;74/G3+Y<DBJK,V[RV\QMS?+_M-6Y87FO>'=9^ %E?ZE9ZVM_$)
M(Y)M(M_,M86CA\N&.1E9EV_\]%96:O5?^&;XI+7XG6\^N22Q>-9EF_=VNW[&
MRM(R_P 7[SYF7^[]VJFG?LXZHNI^ [O5?&W]JMX2D?[.O]DK#YD.V-5A^63Y
M=OE_>^9FW5T?VC@G'ENN7_#_ -.TNW\PSRY?CE\05\9:A9ZQXUL/!>K0ZCMM
M_#GB'2/)LIK?^]]L5695^7[S;=W\+5]5^+M<D\,^#]:UCRXVET^QFN_+^\K-
M'&S;?_':\A\3?LW:]XEM[[1+CXEZK/X-O+J.XFTN_LX[JY559695NI&W+\R_
M+\OR_P!UOFW>MZAX4M;WP7<^&T9HK&33VTY6;YML;1^7_P "^6O(QU;"5G2E
M2MYV7I_=7_MWJ(^-O%&CFU_8W\.7[LTMYJFO_P!HWDC-_K)&:9=W_?*K7L/[
M:"[O 'A55/S-XEM?_1,U4O@_X)L?BK^SK/\ #_7_ #+2^T.^FL+CRF_>6\T<
MC2*VW_@6W_:^:E\._LA74.NZ/=>*?B!JGBO3-(99;73IHVCC1EV[57=-)M7Y
M?NJJU[$\5A8U^:M4Y90G-VMNG:U@,J\\'Z;\;OVH_%>E^+UFO-*T"QA6QTO[
M0T:MN6/<WR[6^\V[Y?\ 9KO?AS\!/"O@?Q'XUL](UN:?3]4M8[>Z\-_:%9;-
M9%;YF^9F^9=VUF_AW?>J7XM_LZV_Q!\20>)M$\0W_@_Q/''Y+:C8;OWD>W;\
MRJRMN_AW;ON_WJ@^'?P9TOX Z?XE\8:OKEUXEUR2UDDO-6N_E;R5_>,OS,WS
M-M7<S,WW5KCK8R-;#Q5*NUI%<ENJ_#SON!!^Q]K%SJ/PE?3[IO,?0]2N-,C;
M_97;(O\ Z,KW"O&?V3?"]UX?^$%M=7J^5<ZU=2:JRLOW5DVJO_?2JK?\"KV:
MO#S2498RK[/^804445Y@!1110 4444 %%%% !1110 4444 %(_\ JV_W:6D?
M_5M_NTX[H#\KOB__ ,E:\:?]AN\_]*&KD:Z[XO\ _)6O&G_8;O/_ $H:N1K^
MF<!_NM+_  Q ****[@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "OKO\ 8W^$'V6W;QUJD/[V96@TM67[J_=:;_@7W5_X%7@/P3^%]Q\6
M/'%GI:[ET^/]_?3K_P LX5_]F;[M?H_86%OI=C!9VD*P6UO&L<,:_=C5?E5:
M_-N+<V]C2^HT/BE\7I_P0)Z***_'2PJ*Z_U+U+45U_J7H HT445(!1110 44
M44 %%%% !1110 4444 %0W7_ ![O4U0W7_'N] %"BBBJ **** "BBB@ HHHH
M **** "BBB@ JEJ__'NO^]5VJ6K_ /'NO^]0!C44459 4444 %%%% !1110
M4444 %%%% !7G7QS_P"13M/^OY?_ $7)7HM>=?'/_D4[3_K^7_T7)7KY/_O]
M/U/,S+_=*AX97K6O_P#"J_\ A4=M_9G_ "//V>WW_P#'U_K-R^9][]W]W?7D
MM%?KU>A]8E&7-*/+_+_[<?FU.M[*,O=C+F"NO^#O_)5/"W_80A_]"KD*EL[R
MXTZ\BN;2XDMKF%MT<T,FUHV_O*RU6(I.M2G2_F(IR]G4C(^DOA[H&N:'\??%
MNLZE8WFF^'-^HSW5W=0M%;2PF1F4[F^5NS5T'ASP%X-M?!/AZ*\TF&\LK_2T
MEN;BW\/75Y=M)(O+)<Q[O)PW\)6OF/4O'?B37+1[34?$&J7]I+]^&ZO9)(V_
MX"S5%:^*];L]*;3+?6=0@TV161K..YD6%E;[W[O=M^:OEZF3XJHE)5.7X?A\
MOU/;IYC1I^[[/FWW\SW^V\*QZ;X=\&6.B?#FP\76.K:5Y]_?R+MF,S1_,JW+
M?\>^W_:_W5VM4EMH7AS1_P#A6]Q/X1_M;S]'N&F33[!;UFDQ$JS3+'_KE7<W
M_?7RU\]6WBK6K'2Y--MM8O[;3I=RO9QW,BPON^]NCW;?FI8_%6M126$B:S?K
M)8*RVC+=2;K96^5EC^;Y?^ UK_9-?7]YO?\ F[/_ #)^O4OY?R\CZ<L?A[8S
M?$S0[C4-&\/R:9>Z9=^5#;Z))9,S1E>9+69FVLN[Y6_B_P"^:Q?!_A.RL?#_
M ,/+?2O!-CXIT_74:36=6N+;SI(&9E5E63_EEY?S?]\?WMS5X"?&WB)]274&
MU[4CJ*Q>2MTUW)YRQ]=N[=NV_P"S46F^*=:T:QFLK#6+ZPLI69GM[>YDCC?<
MNUMRJWS?+6/]CXIP4?:_GY_YE?VA1YOX?]:?Y'T;>Z;X8\!^%=':P\/:'KBW
M'BB;2S<:A:+*WV?SY/EW=69=BJK-N^[7EOQ \*Z-8_'^;0T2.PT234K2.2.-
MMJI')Y;2;?[OWF_W:\^77M32QMK-=1O/L5K+YUO;_:&\N&3^\J_PM_M5'J&I
M7>K7DEW?W-Q>W3_?N+B1I)#_ +S-7?ALKJT*DI2J_$I(YJV,IU%&/+V/I/Q=
MX1LKBP\>V&I>!+'0-(T*S,VDZU;P-!)+(J%8PTV?WV[_ /:^;;6]J6A^&KOX
MC:MX-_X1#08K)M :^^U1VBK<+*2J_*R_=7_=_BYKY8U#Q1K.K:?#8WNKWUY8
M0;?*M;BYDDC3:NU=JLVU?E)6G_\ "9:]_:37_P#;NH_;VA\EKO[9)YC1_P#/
M/=NW;?\ 9KCCDV(4=:G_ *5Y:_@=']I4;_P_R\SN?V?_  _8:WX@UJ6YT^'6
MKVPTN:ZL-*N(]T=Q,NW;N_A;[WW?]K_9KT?P[X437]<AU36OAQ8Z-JL6BW5Q
M9Z,NV.'4IHRFW=!_RSV[MNU_O;]W\-?-^GZA=Z7=1W=C<S65U$VY)K>1HY$_
MW66KLWBK6KC58M3FUB_FU.'Y([R2YD::/_=DW;JZ\5EU>O5E.$_S_P SGP^,
MITZ<8RB?3WA#P9H^O:AX(U;7_"FFZ%KE])>6\^C+9>5#/#''(RR-;OT96V?-
M_M?[NW)T>^\/7_A/P+KZ^!_#L=QJ^M_V/+$;3?&+=Y2N['\4GRK^\;=_%_>K
MP>SUSQ?J^I2:Q;7^M7M_86[%[Z&::22"'^+=)]Y5^9J@TVZ\2W6FA+";5)K#
M26^V!;=I&CLF_P">WR_+'_'\U<']DSM[]7\]-]/Q1T_VA#[-/^M/\F?2.IZ7
M/X7^'_B*VT'PG9^*EM?%<_DZ;/:-/%;QM'][R5Y;;NV_\"W5'XV\ >%='L?&
MOV#2[-9([_2Y&B,*M]E:::+S(XV_A5E;[OW?G_NU\Z0^/O$]N93#XCU:$R2M
M+(T=_,NZ1OE9OO?>_P!JH;/6O$&H7$UE:7^IW$VH3K+-;PS2,US-NW*S*O\
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M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5(!1110 4444 %%%% !1110 4444 %0W7_'N]35#=?\ 'N] %"BBBJ ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/:K?\?R_P_\ 3.2O7R?_ 'ZGZGF9C_NM0\)HI_D2?\\V_P"^:/(D_P">;?\
M?-?L_-'N?EW*^PRBG^1)_P \V_[YH\B3_GFW_?-'-'N'*^PRBG^1)_SS;_OF
MCR)/^>;?]\T<T>X<K[#**?Y$G_/-O^^:/(D_YYM_WS1S1[AROL,HI_D2?\\V
M_P"^:/(D_P">;?\ ?-'-'N'*^PRBG^1)_P \V_[YH\B3_GFW_?-'-'N'*^PR
MBG^1)_SS;_OFCR)/^>;?]\T<R[AROL,HI_D2?\\V_P"^:/(D_P">;?\ ?-'-
M'N'*^PRBG^1)_P \V_[YH\B3_GFW_?-'-'N'*^PRBG^1)_SS;_OFCR)/^>;?
M]\T<T>X<K[#**?Y$G_/-O^^:/(D_YYM_WS1S+N'*^PRBG^1)_P \V_[YH\B3
M_GFW_?-'-'N'*^PRBG^1)_SS;_OFCR)/^>;?]\T<T>X<K[#**?Y$G_/-O^^:
M/(D_YYM_WS1S1[AROL,KZB_8D^]XR_[<_P#VO7S!Y$G_ #S;_OFOJ#]B=65O
M&6Y67_CS^]_VWKY[/I)Y=4L_Y?S1[64)_7:?S_(^HZ***_(C]*"H;F;R(6D
MW;:FJIJ/_'G+0!6_M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?
MVLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?
MVLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?
MVLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?
MVLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?
MVLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?
MVLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?
MVLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%%
M%_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:T?VLW_ #S6J%% %_\ M9O^>:TU
MM895_P!6M4J1_P#5M_NT 6O[?D_YXK_WU1_;\G_/%?\ OJLFBH UO[?D_P">
M*_\ ?5']OR?\\5_[ZK)HH UO[?D_YXK_ -]4?V_)_P \5_[ZK)HH UO[?D_Y
MXK_WU1_;\G_/%?\ OJLFB@#6_M^3_GBO_?5']OR?\\5_[ZK)HH UO[?D_P">
M*_\ ?5']OR?\\5_[ZK)HH UO[?D_YXK_ -]4Q_$$BJW[E?\ OJLRFR_ZM_\
M=H O_P#"52?\^Z_]]4?\)5)_S[K_ -]5A44%&[_PE4G_ #[K_P!]4?\ "52?
M\^Z_]]5A44 ;O_"52?\ /NO_ 'U1_P )5)_S[K_WU6%10!N_\)5)_P ^Z_\
M?5'_  E4G_/NO_?585% &[_PE4G_ #[K_P!]4?\ "52?\^Z_]]5A44 ;O_"5
M2?\ /NO_ 'U1_P )5)_S[K_WU6%10!N_\)5)_P ^Z_\ ?51R^+)HX]WV>/\
M[ZK&J*Z_U+T :W_";3?\^L?_ 'U1_P )M-_SZQ_]]5S=%2!TG_";3?\ /K'_
M -]4?\)M-_SZQ_\ ?5<W10!TG_";3?\ /K'_ -]4?\)M-_SZQ_\ ?5<W10!T
MG_";3?\ /K'_ -]4?\)M-_SZQ_\ ?5<W10!TG_";3?\ /K'_ -]4?\)M-_SZ
MQ_\ ?5<W10!TG_";3?\ /K'_ -]4?\)M-_SZQ_\ ?5<W10!TG_";3?\ /K'_
M -]4R7QS-%&S?98_^^JYZH;K_CW>@#>_X6%<?\^<?_?5'_"PKC_GSC_[ZKDJ
M*H9UO_"PKC_GSC_[ZH_X6%<?\^<?_?5<E10!UO\ PL*X_P"?./\ [ZH_X6%<
M?\^<?_?5<E10!UO_  L*X_Y\X_\ OJC_ (6%<?\ /G'_ -]5R5% '6_\+"N/
M^?./_OJC_A85Q_SYQ_\ ?5<E10!UO_"PKC_GSC_[ZH_X6%<?\^<?_?5<E10!
MUO\ PL*X_P"?./\ [ZJO>?$RYM8U9;*)OFV_>:N:JEJ__'NO^]0(Z3_A;EU_
MSX0_]_&H_P"%N77_ #X0_P#?QJX*BK).]_X6Y=?\^$/_ '\:C_A;EU_SX0_]
M_&K@J* .]_X6Y=?\^$/_ '\:C_A;EU_SX0_]_&K@J* .]_X6Y=?\^$/_ '\:
MC_A;EU_SX0_]_&K@J* .]_X6Y=?\^$/_ '\:C_A;EU_SX0_]_&K@J* .]_X6
MY=?\^$/_ '\:C_A;EU_SX0_]_&K@J* .\_X6U<\?Z!%_W\:N9^(7[0E_X/T>
M"\ATBVNFDN%AVM(R_P +-_[+637G7QS_ .13M/\ K^7_ -%R5Z66TJ=?%PIU
M/A.''5)4\+.I'XC:_P"&T=7_ .A;L?\ P(:C_AM'5_\ H6['_P "&KYRHK]1
M_L/+_P#GW^9^>_VKC/YSZ-_X;1U?_H6['_P(:C_AM'5_^A;L?_ AJ^<J*/[#
MR_\ Y]_F']JXS^<^C?\ AM'5_P#H6['_ ,"&H_X;1U?_ *%NQ_\  AJ^<J*/
M[#R__GW^8?VKC/YSZ-_X;1U?_H6['_P(:C_AM'5_^A;L?_ AJ^<J*/[#R_\
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MZ-_X;1U?_H6['_P(:C_AM'5_^A;L?_ AJ^<J*/[#R_\ Y]_F']JXS^<^C?\
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M)X"_Z'7P]_X-;?\ ^*H^J5_Y']P'7TV7_5O_ +M<E_PN3P%_T.OA[_P:V_\
M\536^,'@+RV_XK;P]]W_ *"MO_\ %4?5*_\ (_N Z&BN3_X6]X%_Z'3P[_X,
MX?\ XJC_ (6]X%_Z'3P[_P"#.'_XJG]3K_\ /N7W%G645R?_  M[P+_T.GAW
M_P &</\ \51_PM[P+_T.GAW_ ,&</_Q5'U.O_P ^Y?<!UE%<G_PM[P+_ -#I
MX=_\&</_ ,51_P +>\"_]#IX=_\ !G#_ /%4?4Z__/N7W =917)_\+>\"_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW_:J_H?B/2?%%G]LT;4K/5;/=Y?GV-PLT6[^[N6O(Q#Q-><J]?XF(T:***Y
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MI:3:Z?KGAS7O[,DO[&#6K%86N%\MF\R/YFW?=W?-][_:K ^%O[1"Z;\"]/\
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M5(!1110 4444 %%%% !1110 4444 %0W7_'N]35#=?\ 'N] %"BBBJ ****
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MB@ HHHH **** "BBBB[ ****+L HHHHNP"BBB@ HHHI %%%% !1110 4444
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M/=?]ZKM4M7_X]U_WJ ,:BBBK("BBB@ HHHH **** "BBB@ HHHH *\Z^.?\
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M,WJOR_[/\7R_-5?P[XZTSP?:^$M-\3^,K'Q5JJZT]RM]!=-=1V<+0O'\TO\
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MO?%=MXPUM-3DOVO+6;SEBM]KJJM)_>^8-M_A_P!W;7B5%:4<G5*K"<YWY?\
M@_YD5,QE*,H\OQ?U^@4445]&>0%%%% !1110 4444 %?4/[$O7QE_P!N?_M>
MOEZOJ']B7KXR_P"W/_VO7SV?_P#(NJ?]N_FCV,G_ -]I_/\ (^I:***_(#]-
M"JFH_P#'G+5NJFH_\><M &/1110 4444 %%%% !1110 4444 %%%% !1110
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MZ$KP]_X*K?\ ^)KKZ*/K=?\ G?W@<A_PIOP%_P!"5X>_\%5O_P#$TUO@_P"
MO+;_ (HGP]]W_H%6_P#\378TV7_5O_NT?6Z_\[^\#A/^%0^!?^A+\._^"J'_
M .)H_P"%0^!?^A+\._\ @JA_^)KK:*?URO\ \_)?>6<E_P *A\"_]"7X=_\
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M9<W^S_WU1_9<W^S_ -]4 5:*M?V7-_L_]]4?V7-_L_\ ?5 %6BK7]ES?[/\
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M_A&[S_IG_P!]4?\ "-WG_3/_ +ZH RJ*U?\ A&[S_IG_ -]4?\(W>?\ 3/\
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M'_"K-9_OVO\ W\;_ .)H XZBNQ_X59K/]^U_[^-_\31_PJS6?[]K_P!_&_\
MB: ..HKL?^%6:S_?M?\ OXW_ ,31_P *LUG^_:_]_&_^)H XZO.OCG_R*=I_
MU_+_ .BY*]U_X5;K']^T_P"_C?\ Q-<A\3/@/XD\5Z!!:64NGK+'=+(WF2LJ
M[=K+_=_VJ]3+*L*6+A4J?">?F%.57#5(Q/D:BO</^&0?'/\ SVTC_P "6_\
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M6_\ C=']L8'_ )_1#^S<7_S[9X?17N'_  R#XY_Y[:1_X$M_\;H_X9!\<_\
M/;2/_ EO_C=']L8'_G]$/[-Q?_/MGA]%>X?\,@^.?^>VD?\ @2W_ ,;H_P"&
M0?'/_/;2/_ EO_C=']L8'_G]$/[-Q?\ S[9X?17N'_#(/CG_ )[:1_X$M_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*2EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
:BBB@ HHHH **** "BBB@!*6BB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>abvx-20241231_g10.jpg
<TEXT>
begin 644 abvx-20241231_g10.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT#3)I?$5_)+):Q.[-*<DE 235_\ X6?XL_Z#]]_W]-<+X7_Y%K2?^O2'_P!
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M=KVL1+>UPHHHJR0HHHH ^T_"_P#R+6D_]>D/_H K3K,\+_\ (M:3_P!>D/\
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M:M7_ .O+_P!J+6%?^&S:E\:/I.BBBO#/5"BBB@ HHHH **** "BBB@ HHHH
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MP/\ \^\W_@2_^-<8O[0EB-.T:[?2MT>I7$D:-:ZE:W2>6DL$3,LD3LKOON4
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ME/\ A1/@/_GVF_\  F3_ !H_X43X#_Y]IO\ P)D_QKJZ*/:U/YF'LX=CE/\
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M'3_GHU']CI_ST:@#)HK6_L=/^>C4?V.G_/1J ,FBM;^QT_YZ-1_8Z?\ /1J
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MU%+BPOFQ;6D4;((D\^>5=V6(RB31P+M PEN@] OJO]CI_P ]&H_L=/\ GHU
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MS<-&\@C#6^</M1L(>3VZBNE^.OPK'QJ^%NK^#CJ0TC[?):R"\:V%R$,-S%.
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M,A+!/EVY).WX9_9+U3P))I$OACXA2Z3<1:8NCZE.VCQ7#75NM]-=H80[E89
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M;>6U\V'S1.DDIF7>/-22.)(2N5(C>89(DP #I?%GBA/"MKITSV[7 O-1MM/
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M^V$_YYM1_;"?\\VKSWXI_$6R^%/@?4/$E];3WR6[10PV=KCS;F>618HHER0
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M_GFU>36?[0GP]O\ 3-6U&'Q+!]@TN)9[BYDAECC,;2&-7B9D F5G&P&/<"Q
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MK$SV^BZK;:HMX8!NF,-[]J"%<X )^7.>G->Z?V1#_>?\Q_A1_9$/]Y_S'^%
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M VPHP/FD[]Q.5.RH=#_9\M_#<6FZ98:W*/#4$VF7EU836P::XN;".%()!,&
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M[V 02WQG^T3I_P /?'VOZ-J\%Q=VMC'H\=O;Z;9M)=/<7\\\,:Y+X8%HE
M(Y^]D8UX_P!G?P?!>-/!#=6X.OV?B-88I@(TNK:W2WA51CB,1QJ-OZU/XH^
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MR[\V&T>6(POY9*^8%V%@(RYC7<2J@XH$>I4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%>;?M'7VO:3\$O&6I^'-:_L'4-.TJZO?M:0"67;' [[8R2
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M>#ZCX0\9> _'7Q)UZR;Q=8Z3K7CV"+5M4TK3!<WZ:0-.1Q):*(&=XQ<%(69
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M@^AJC9^#= T^SMK2UT/3;:UM8);6""&TC1(H9"#)&B@85'*J64<':,]*V**
M.:;X9>#Y/#L>@-X4T-M"CE\]-+.G0FV63GYQ%MVAN3SC/)K<ETVTG>S>2UAD
G:S?S+9FC!,#[&3<G'RG8[KD=F8=":LT4 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>abvx-20241231_g11.jpg
<TEXT>
begin 644 abvx-20241231_g11.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_X0'X:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X])^^[OR<@:60])U<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"<_/@T*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(^/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R
M9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D
M-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N
M=',O,2XQ+R(^/&1C.G)I9VAT<SX\<F1F.D%L="!X;6QN<SIR9&8](FAT=' Z
M+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^/"]R9&8Z;&D^/"]R9&8Z06QT/@T*
M"0D)/"]D8SIR:6=H=',^/"]R9&8Z1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO
M>#IX;7!M971A/@T*/#]X<&%C:V5T(&5N9#TG=R<_/O_A ")%>&EF  !-30 J
M    "  !@I@  @    $          /_; $,  P(" P(" P,# P0# P0%" 4%
M! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0%A 1$Q05%14,#Q<8%A08$A05
M%/_; $,! P0$!00%"04%"10-"PT4%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%/_  !$( 'H"; ,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM="N]*T^*UL4%O#,+0K-"0P9L,3PS$?-QDY-<?6L.;7F,Y6Z!1116A 4444
M%%%% '9>&_\ D$Q?5OYFM2LOPW_R"8OJW\S6I6JV/H*7\./H%%%%,U"BBB@"
MUI5JE]JEG;.65)IDC8KU + ''YUWVN?">'3Y-5^S7CRP+<P0V-Q(<HP=Y$D#
M[5)W(T>#@>^.17GEI=/8W4-Q'CS(761<C(R#D5NS>/M9FL+VS^T;(;J\-^?+
MRK1RDDDH<Y49/Z5A4C4;7(P-#_A!(M'U*U@U2>2_%TKB"WTE7\V20%0$S)&
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MUO\ \]5H^W6__/5: +%%5_MUO_SU6C[=;_\ /5: +%%5_MUO_P ]5H^W6_\
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M_P @F+ZM_,UJ5Z]IO[,JZ?9I ?%,4FTD[OL1'4_[]6O^&<5_Z&>/_P  S_\
M%UI]<H?S?F>Q3]V"3/%Z*]H_X9Q7_H9X_P#P#/\ \71_PSBO_0SQ_P#@&?\
MXNCZY0_F_,TNCQ>BO:/^&<5_Z&>/_P  S_\ %T?\,XK_ -#/'_X!G_XNCZY0
M_F_,+H\@TN.*74[1)L>2TR!]QP-I89Y^E==XXM=$73;B33;6UM9;;5[BS3[/
M,SF6!0"CG<QSSGD8%=C_ ,,XK_T,\?\ X!G_ .+H_P"&<5_Z&>/_ , S_P#%
MU#Q5!R3Y]O4+HR%UR32=;L]+MEA%A=:5:JLTC$+$GD,TCG'49DE8KW(J:STV
MRGU:PU&.[#6-]9W$#VC;<16RVS$#(/5-HR2!\XS6Q<?L^R74<$<OBM)$@3RX
M@UF?E7); ^?IEB?QHMOV?9+/SA#XK2/SHS$^VS/S*<9'W^AQ6'MJ/2>OHQ71
MXA17M'_#.*_]#/'_ . 9_P#BZ/\ AG%?^AGC_P# ,_\ Q==7URA_-^8[H\7H
MKVC_ (9Q7_H9X_\ P#/_ ,71_P ,XK_T,\?_ (!G_P"+H^N4/YOS"Z/%Z*]H
M_P"&<5_Z&>/_ , S_P#%T?\ #.*_]#/'_P" 9_\ BZ/KE#^;\PNCQ>BO:/\
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MB\9:-X3T^VO=3OE@@NI5AM_+1I7GD92P2-$!9SM5FPH/"D] 37A/A?X=>-_
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M@=K$YY!YYOP=XHUFT^'/PIUBZU6[U*\NM033K][A\M>)-YJ;F  7<KK&^0.
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M&""#U!%<_I?PU\(Z'I<NFZ=X5T6PTZ6=+F2TM=.ACB>96#)(450"P8 AL9!
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M6BMK[/%_SS3_ +Y%'V>+_GFG_?(H Q:*VOL\7_/-/^^11]GB_P">:?\ ?(H
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ASQ?\\T_[Y% &+16U]GB_YYI_WR*/L\7_ #S3_OD4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>abvx-20241231_g12.jpg
<TEXT>
begin 644 abvx-20241231_g12.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>9(\:E8E:5-H+E1N.W)(-<M-^R+X:_L]X+77=<LKC;%Y-W&\#/"\6K2:I'(
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M ULZ'\1/#GB37+S1M,UFVO=4L_,\^UC8[D\N3RY/KM?Y3CH2,]1DL%V>C_\
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ML!6[NH[B<[TC**%D"=6&U2,]<UG:A\"KBXM])@&M17"6:0V.^ZLU;;916EY
M@"\AIC]K)+_*O ^7@JW<:[X%M->6W2:YN(HHM.NM-_=M\Y2=8U9MQ_B C&#Z
MF@9YCK7P.\&IX"M-'OO$WB#4/#*2F.TLXI([M>8Y4:-(T@8O\KR'.&9"@8%2
MN:KZM\%?AG<1-'J&L7]U;W$2ZA9PR3+)&C3W$#">!?+(D9I8;<;3O'*@K^\^
M;OYOAG<_\(W?Z9;ZTMG+J%XMU>206@2*1!$D1A6-7!166)-V&R3NZ!L#=O\
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ML%Q):2-&X(69&VNGU#<'WXJ/4O$^EZ3=:7;W5VL<VIW1LK15!;S)A&\A3(!
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MR(@5GX4\D=>>:WZYQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'_"U/%O_ $'[S_OO_P"M5S_A2OC3_H"-_P"!$7_Q='_"E?&G_0$;_P "(O\
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M%TYC#.JA0\;8(Y &0<<C.><5ZV6SH0KWK[6TOM<EWMH?)'_"X/'G_0[>(O\
MP;7'_P 71_PN#QY_T.WB+_P;7'_Q=>F?\,2_%+_H'Z?_ .!Z4?\ #$OQ2_Z!
M^G_^!Z5]=]8P7\T?P,[,\S_X7!X\_P"AV\1?^#:X_P#BZ/\ A<'CS_H=O$7_
M (-KC_XNO3/^&)?BE_T#]/\ _ ]*/^&)?BE_T#]/_P# ]*/K&"_FC^ 69YG_
M ,+@\>?]#MXB_P#!M<?_ !='_"X/'G_0[>(O_!M<?_%UZ9_PQ+\4O^@?I_\
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MT_\ \#TH^L8+^:/X!9GF?_"X/'G_ $.WB+_P;7'_ ,71_P +@\>?]#MXB_\
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M;6QM"$V1,5\QL DMCKUP!TXKW^O,_B-\(6\5:D=3TVYBMKR0 31SY"/@8#9
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MN/\ OZW^->A3? KQ+<322R7>G/)(Q9F,K\DG)/W*9_PH3Q%_S\Z=_P!_7_\
MB* . _M:^_Y_+C_OZW^-']K7W_/Y<?\ ?UO\:[__ (4)XB_Y^=._[^O_ /$4
M?\*$\1?\_.G?]_7_ /B* . _M:^_Y_+C_OZW^-']K7W_ #^7'_?UO\:[_P#X
M4)XB_P"?G3O^_K__ !%'_"A/$7_/SIW_ ']?_P"(H X#^UK[_G\N/^_K?XT?
MVM??\_EQ_P!_6_QKO_\ A0GB+_GYT[_OZ_\ \11_PH3Q%_S\Z=_W]?\ ^(H
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M 4444 %%%% !29I:JWEPL&S<<9S0!9W#UI:HVMVDTRJ#DFKU !1110 4444
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M"F.,G;,TP/RD Y4.X7<7S7 ]9HHHJ@*>L_\ ('OO^N$G_H)KE_V$?^2)3?\
M86N/_0(JZC6?^0/??]<)/_037+_L(_\ )$IO^PM<?^@15O+_ '2?K']2'N?1
M5%%%>* 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?%GBEM8_9G^
M+GB[5K[1+O5/!OB6Y-ZE]9KN,+EG?82> 09'&&(R,$'J***]7+7>M[)[2T?Y
MDR[DG_#9'@[_ *!6N?\ ?F'_ ..T?\-D>#O^@5KG_?F'_P".T45]=_9F'[/[
MR.=A_P -D>#O^@5KG_?F'_X[1_PV1X._Z!6N?]^8?_CM%%']F8?L_O#G8?\
M#9'@[_H%:Y_WYA_^.T?\-D>#O^@5KG_?F'_X[111_9F'[/[PYV'_  V1X._Z
M!6N?]^8?_CM5]0_:V\!ZO9RV=]H&K7MI*,26]Q:V\D;C.<%3+@\T44O[,P_9
M_>'.R2W_ &P/!-G;Q00:+K,,$2A(XX[>!510,  "7@ =JD_X;(\'?] K7/\
MOS#_ /':**/[,P_9_>'.P_X;(\'?] K7/^_,/_QVC_ALCP=_T"M<_P"_,/\
M\=HHI_V9A^S^\.=A_P -D>#O^@5KG_?F'_X[1_PV1X._Z!6N?]^8?_CM%%']
MF8?L_O#G8?\ #9'@[_H%:Y_WYA_^.T?\-D>#O^@5KG_?F'_X[111_9F'[/[P
MYV'_  V1X._Z!6N?]^8?_CM'_#9'@[_H%:Y_WYA_^.T44?V9A^S^\.=A_P -
MD>#O^@5KG_?F'_X[1_PV1X._Z!6N?]^8?_CM%%']F8?L_O#G8?\ #9'@[_H%
M:Y_WYA_^.U!_PUQX$^WB^_L'5OMOE>3]I^RP>9Y><[-WFYVYYQTS112_LS#]
MG]X<[)_^&R/!W_0*US_OS#_\=H_X;(\'?] K7/\ OS#_ /':**?]F8?L_O#G
M8?\ #9'@[_H%:Y_WYA_^.T?\-D>#O^@5KG_?F'_X[111_9F'[/[PYV'_  V1
MX._Z!6N?]^8?_CM'_#9'@[_H%:Y_WYA_^.T44?V9A^S^\.=A_P -D>#O^@5K
MG_?F'_X[1_PV1X._Z!6N?]^8?_CM%%']F8?L_O#G8?\ #9'@[_H%:Y_WYA_^
M.T?\-D>#O^@5KG_?F'_X[111_9F'[/[PYV4]8_:HL_%6F7.D^$?#FLZAKMY&
MT%O') I +#&[",Q;&>F/QKZ&_9G^&=]\*?A-IVD:H FJ3R/>742D$1.^,)D=
M2%50<<9SBBBO S6$<-&-&FM'J_D5%WU9ZK1117S984444 %%%% !1110 444
<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>abvx-20241231_g13.jpg
<TEXT>
begin 644 abvx-20241231_g13.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_X0'X:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X])^^[OR<@:60])U<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"<_/@T*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(^/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R
M9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D
M-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N
M=',O,2XQ+R(^/&1C.G)I9VAT<SX\<F1F.D%L="!X;6QN<SIR9&8](FAT=' Z
M+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^/"]R9&8Z;&D^/"]R9&8Z06QT/@T*
M"0D)/"]D8SIR:6=H=',^/"]R9&8Z1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO
M>#IX;7!M971A/@T*/#]X<&%C:V5T(&5N9#TG=R<_/O_A ")%>&EF  !-30 J
M    "  !@I@  @    $          /_; $,  P(" P(" P,# P0# P0%" 4%
M! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0%A 1$Q05%14,#Q<8%A08$A05
M%/_; $,! P0$!00%"04%"10-"PT4%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%/_  !$( +<"( ,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMP!P<9'.*R/M<_\ SVD_[Z->EZI::_J'A7^S?^$:OOMLB0QRW+QKRL98J!@
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M?E:__'Z/^%I'_H5=>_*U_P#C]'U>IV_%![:'])G<T5PW_"TC_P!"KKWY6O\
M\?H_X6D?^A5U[\K7_P"/T?5ZG;\4'MH?TF=S17#?\+2/_0JZ]^5K_P#'Z/\
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M\+2/_0JZ]^5K_P#'Z/\ A:1_Z%77ORM?_C]'U>IV_%![:'])G<U0UC_41_\
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M]'U>IV_%![:'])G645R?_">3_P#0K:W_ .2W_P ?H_X3R?\ Z%;6_P#R6_\
MC]'U>IV_%![:'])G65YCK7Q@N-%U;5X(]&FU1+>^DL+>&V=(V)ALUNII'9V
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M?\)Y/_T*VM_^2W_Q^CZO4[?B@]M#^DSK**Y/_A/)_P#H5M;_ /);_P"/T?\
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M:K>1^&->DN=2N!<3R2?9<Y6-8U48FX4*@X]2QZDT?5ZG;\4'MH?TF=]39/\
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M/&'B_P#M74[RZL9+BU^Q_:$'EP^8I'EQA5 V@XR3DYY)KR?1O$"ZIY%V-?\
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M'MB4JK.=Q&%!903T!8>HI>8SSV#4O$'A;X:_$2]>^O-6U;3'U">QGOHP6<I
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MVNO$MAI\141ZEJ&I3Q6L^Z7R5"R>:0'+E5$;[7.X86CVE/N_N_X(<M3LOO\
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M[_@A:KV7W_\  ,;389[?3K6*ZE$]TD2++*.CN -S?B<UD_$#_D1]?_Z\9O\
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M3S%0S<D\ <*HS@*.  !VK?\ M$7_ #U3_OH5BZ!XTT[Q)JVI6%E)YDEG%;W
MD!#1SP3H6BFC()RA*R+GUC;M@G>J'>^I2\B/[1%_SU3_ +Z%'VB+_GJG_?0J
M2BD,C^T1?\]4_P"^A1]HB_YZI_WT*DHH C^T1?\ /5/^^A1]HB_YZI_WT*DH
MH C^T1?\]4_[Z%'VB+_GJG_?0J2B@"/[1%_SU3_OH4?:(O\ GJG_ 'T*DHH
MC^T1?\]4_P"^A1]HB_YZI_WT*DKD=:^)VD>'_'VE^%+]9X+G4+&>^BO6"BV4
M1<M&S%LAR@D<<8VQ/DC ! .J^T1?\]4_[Z%8WB[0[7Q9H-QIDMQ'")BN)]JN
M\7(RT>3\L@&=KCE20W.,5SO@WXX>%/&6DZ1=I>G2I]31GAL-2VQ7" 2R1CS
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M_P">J?\ ?0H^T1?\]4_[Z%25'<2M#;RR)"]PZ*66&,J&<@?=&X@9/3D@>XH
MQ?&WAS3O'?@_6_#>H3;;'5K*:QF:-EW*DB%"1G(R <C((KRN\_9MT[4+B_O9
M]9LTU#5%G@U"2WTV..+R94MD(MDWDV\@%I&1)N;YG=MI.W;VNE_%VUOO"OBO
M7KO0-8TFT\-F=;J.Z%O(\S0Q[Y1"89I%?;RA^88=64\J<2Z/\7-*UGP/<^)H
MK:Y2WANC8BVW12/-<>:(DCC>-VC??(R*I5R,M@D$$  RO%/PAM/$7B-=9M]9
M72[D7L-QBVA"CRT!W 88?O6<EO-.> @*ML!KTG[1%_SU3_OH5RN@_$$ZWXVU
M7PT_AW5M.N-.MUN9+RZ:U:W='=DC"F*9V#/L=@K*IVKDXR <S3?C-IE[JEW8
MW&EZEIDMK=6=K,;L18C^UO)';LP21BA>1%78P#KYL990&S0!WOVB+_GJG_?0
MJ.XN(C;R?O$^Z?XAZ58J.X_X]Y?]T_RH X_QA\/7\87OA_4[77K[P_J.DK-Y
M%Q8QPR$B5 C@B5'7H..*YFQ_9QT72+[2I-/U;4[6RL?[/9K/,3K<26;R/$[L
MR;LDRONVD D@\5J_$CXJ:?\ #)O#]O<Z>+N;5O-6)GO(+6-/+16;=),ZJ,@\
M#/-7S\5?!]O)=V][JUG8WEE;FXO(97!$.%1G7>/E9E$B9523\R\<BM%SVT(]
MV^IS$W[.6ERV7A"R&NZJMCX:M[."WMB8FCD:VF25)""GRNQ0*S+@E<#CNV#]
MF_2[>&#R]>U1;FS$0L+D+#NMC%=O<QG!3:^&D93N!ROOS751_%;P7(=- U>$
M'4)?(@#12 ^9YOE;'RO[LF0A 'VY8XZUFO\ %S3Y/!OA[6[/1KN^N_$%U]BT
M[2XS&LLLH$C'+,P55"0R,6)Z#N<"G>8K1*%G^SOHEG#,O]IZA-+<&SDGFD,>
MZ26#4I-1,F @ +S2N"   N  .M:VO?!VPU[QE_;SZG?0137%E>7>FQ>7Y-S-
M:.7MW+%"Z[6QD*P#;1[YLVGQ,T2-=(@UR";PUJVI2>2FF:A'F1)#*8E#.FY
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M>%?^@LO_ 'YD_P#B:R:*/8TNS^__ ( >TJ=U]W_!-;_A:WA7_H++_P!^9/\
MXFN2OM3\)37&J7.G^,]4T2\U#4EU.6XL4!(D%I':[-LD+HR%(E;#*WS?,",
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MN_X)Z#_PM;PK_P!!9?\ OS)_\31_PM;PK_T%E_[\R?\ Q-9-%/V-+L_O_P"
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M:/;:C:;A#.I.R08>-@2K(P[,K J1V((I*W0-2_GV-&?8TM%4(3/L:,^QI:*
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MC:]KGB633+V]TVXCN;Z!+NZU&1K0JUHJPQQ0-D#;.V\2A> #R?NU[YX=\(^
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M)&LVFN5LBSDEFV&2S8EB2/+))X)KV#_A4OA?_GQN/_ ^X_\ CE'_  J7PO\
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M=PNR6"0921>ZL.X/<'@C@UO?\*E\+_\ /C<?^!]Q_P#'*/\ A4OA?_GQN/\
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ML\7_ #R3_OD4 245C^)=>TGPCH\FIZJPM[-)(H=R0-*QDED6*-%1%+,S.Z*
M 22PK*?QYHMQH^CZAIZ?;TU:_73K6+RFBD,N]EE5E=0R&(13,ZL P\IAC/%
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M=:5<K!*K $.K1)(DB_[)5\?[RL.<9(!N45']GB_YY)_WR*/L\7_/)/\ OD4
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MZ?H:/[0@_P">GZ&BB@ _M"#_ )Z?H:/[0@_YZ?H:** #^T(/^>GZ&C^T(/\
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1-,N+Z!H9 'Y*GL?2BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>abvx-20241231_g14.jpg
<TEXT>
begin 644 abvx-20241231_g14.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M7VVUO\#-!O!HMTMI+>@^49&B.=V<>OK7G7[0'[/>FZ'HP\2>&YUEL&!D>-0
M$4#MW[BN>.(4G9JQJZ+2T/FGBA:^I/A#\(]!\1?"/5=7N[.*6[A;Y'923]UC
MZ^HKYGO-/FCNK@)!)L61@"%.."1Z5M"HIMKL9R@XJ_<HTO/>E*D-@Y!]*F2P
MN).5@D(]E/\ A6I!#0<TYX7AX=&0_P"T"*7[/+MSY3X]=IQ0!'NI:F:QG"[S
M!(%]=IQ_*H=N..<T %)]*G^QW&S=Y$FWUVG'\J8UO)&NYHW ]2I _.@!E &*
M?'#)-Q&C.?\ 94FEDMIH/]9$Z#_:4B@",C-'2BNN^%/A,>-O'VCZ1(&$%U,$
M=@N<#!YJ6^5-OH-)MI(Y#[U!K[,^,'AKX=?"O38M(GTBVDU&2 LLS1MG.,9S
MGKDBOCR:WD:9S'"^QF.W"GUX XK*E5517-)TW!V*V>*6GR6\D.!)&R$_WE(J
M1+*XD&5@D(ZY"G_"MS(@HS3I(WCX=60_[0Q0(9&7(C<KZ[3B@!M&:E:SG";C
M#(%]=IQ_*A;.>1<K#(P'<*3_ $H AQWI:<RLAVL"&]",&B%0TT8/=@/UH ;C
MG-%?;'PU^$?@6/X8P:[KUI  "Q>5D)/ !]?>JVEV/P+\37L=A8W%N;F7A%$)
M']:XOK*O9)Z'1[!Z7>Y\845[9^T7\$8?AC?QW>GS-/I\ZJRMM  W8. /QKQ>
M.VEGQLB=_P#=4FNF$XS7,MC&47%V9%UI:DDLYH.7AD0?[2D?TIJ1O(<(C.?]
MD$UH2,4TG2K,EC<QJ";>0#KRA_PJ'!Z8YH ;MI:G2SN'4LL$A'J%/^%/L8-V
MH6\4BD!I%!##'4T 5:0<<U]0?$#X3Z%I'P4L]:M[2-+UX68R!>21[URWAB'X
M?M\-;EK[;_;>?DS$2>A[Y]<5S*LFKI&SIM.S/"<TF*FDC9Y9#$C,@8X*J3QG
MBE6SN)%RL$A'LI_PKI,2!:6@QM&Q# @^A&#4L=K/,,I#(X]54D?H* (J*<T;
MQG#HR'_:!%-X% @HKV3X'Q^")--O_P#A* OG[7\K=&6_A.._KBO,?$<=L^MW
M(T]2]MN^4*I]3VK-3NW$MQLDS(Y]:-M2K9SR,0L,A(]%/^%-DA>)L.C(?1@:
MT)&$4;32U]>?LI?!GPYX^^'\NH:K90W$XN73=(N3@$X'6LJM14H\S+IP=1V1
M\AT5[=^T]\,+/X=^)E.GPK#9W#L(U08' /2O<_@7^SEX>U?P3%>:O913W$RK
M(K2+DX(/O64L1",%,N-&4I<O8^'J0&O2?VA/"]EX/^*&IZ7I\2PVT04JBC Y
MS7G<=C/+]R&1_HI(K>,E*/,NIFTXMHB/6EISPO$<.C(?]I2*$C>0X1&<_P"R
M":LD;17H7P=\)Q>(/&EM9ZA;,8&*@B13CDUZ)\</ /A[P-\2-.M5@C@TXS$2
MA5.,8/:L752ER&BIMKF/GC.:45[)\8K/P;-_9D7A8 R.J+)LB*G<2 :]K\#?
M"?P9X-^%MOK?B/3XKZ>16/[Z,D\8/8CUJ)5U&*E8N-)MM'QA17TWX.N/A7JE
MOK\NHV\-L_F-]E186(QM.!UXYQ7S9J*HVHW(MQF+S6V8'\.[CCZ8JX5.=VL9
MRARE>D:K!LKA5W&"3'KM/^%0\],<UL0-![4=*G2SGD7<L,C#U"DC^5?4/PE^
M$.AZ]\'M4U>]LXWO82P5W4Y&%)_F*RJ5%!)LN$'-GRQ14ERHCN95'16('X$U
M'6IF%%%% !1110 4444 %%%% !1110 4444 %/B^^*93XOOB@#]BZ***^//H
MPHHHH **** "BBB@ HHHH **** "BBB@ K\N_P!HC_DKGB+_ *^F_D*_42OR
M[_:(_P"2N>(O^OIOY"O3P'QLX<7\*/-:***]T\H**** "BBB@ HHHH ****
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MY_PS\2-:\)ZF]Y87+Q%VRR*Q"GG."*Y?-!-+V<5I8.:7<]?O_P!IOQ5?6;P
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M25.*V0W.3ZG6>*_B5JWC'[/]ODW^0%"_,3T((_E4^I?%;6M4\/QZ/-)FT0$
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M?J)7Y=_M$?\ )7/$7_7TW\A7IX#XV<.+^%'FM%%%>Z>4%%%% !1110 4444
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M** "BBB@ I\7WQ3*?%]\4 ?L71117QY]&%%%% !1110 4444 %%%% !1110
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M_P ,?W8?^^31_P ,7^&/[L/_ 'R:^C.:.:/K-7^8/8P['SG_ ,,7^&/[L/\
MWR:/^&+_  Q_=A_[Y-?1G-'-'UFK_,'L8=CYS_X8O\,?W8?^^31_PQ?X8_NP
M_P#?)KZ,YHYH^LU?Y@]C#L>$VO[+6E6.FG3X9XTM&SF,*<<]>U9/_#%_AC^Y
M#_WS7T9MI:7UBJNH>RAV/G+_ (8O\,?W8?\ ODT?\,7^&/[L/_?)KZ,YHYI_
M6:O\P>QAV/G/_AB_PQ_=A_[Y-'_#%_AC^[#_ -\FOHSFCFCZS5_F#V,.Q\Y_
M\,7^&/[L/_?)H_X8O\,?W8?^^37T9S1S1]9J_P P>QAV/G/_ (8O\,?W8?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !2$XI:* "BJDVIVEO,L4DZ)(QP%)YJRI#*"#D4
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M\.Z'K N]2>_U/4XPDMQ-MW @@YS^%:O@#X/P^#?!^MZ,+TR#4)6DW,5R,@C
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MGC25@BM@<UI"FY@>G:U:IJFD7EGY@7SXFCR".X(S7GWP;^$\?PQDU%A=M/\
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MU1_8<']^3_OJ@"]YB_WQ^=*)%;HP/XU0_L.#^_)_WU3[?28;>02*SEO]IB:
M+U%%% !1110 4444 %%%% !1110 4E+10!SVH> ]!U2_%[=:;#-<@Y\QASFM
MR&W2WB2*-=D:# 4>E2T4 -VU2UO_ )![_45>QSFJ.M_\@]_J* +<'^IC_P!T
M?RJ2HX/]3'_NC^524 %%%% !1110 4444 %%%% !1110 5Q/QA/_ !0=_P#A
M_6NVKB?C%_R(5_\ A_6@#X>N/^/B7_>/\ZCJ2X_X^)?]XU'6I 4444 %%%%
M!1110 4444 %%%% 'OG[)?\ R'M7_P"N"_\ H1KZ?KYA_9-_Y#VK?]<%_G7T
M]6;W*0@I:**0PHHHH XWXL?\B-J/_7-O_037Y3:C_P ?]U_UU;_T*OU:^*__
M "(VH_\ 7)O_ $$U^4NH?\A"Y_ZZM_,U]?DGP2,Y%>BBBOIC,**** "BBB@
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M'_(CZE_UR;_T$U^4NH?\A"Y_ZZM_,U^K7Q8_Y$?4O^N3?^@FOREU#_D(7/\
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M\S7ZM?%C_D1]2_ZY-_Z":_*74/\ D(7/_75OYFOK\D^"1E(KT445],0%%%%
M!1110 4444 %%%% !7TM^Q+_ ,CC=?5:^::^EOV)?^1QNOJM>?C_ /=Y#6Z/
MOVBBBOSHW"BBB@ JCKG_ "![W_KBW\C5ZJ.N?\@>]_ZXM_(TX_$@/C+6/^0C
M-]:I5=UC_D(S?6J5?81V1J%%%%4 4444 %%%% !1110 4444 =[\%?\ D>['
MZU]55\J_!7_D>['ZU]55\]C_ .*B)"T445YI(4444 177_'O)]*\:UC_ )"E
MS_O5[+=?\>\GTKQK6/\ D*7/^]79A]QHIT445V%!1110 4444 %%%% !1110
M 5K^%?\ D-1?3_"LBM?PK_R&HOI_A43V8'KJ?='TIU-3[H^E.KRB HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I",TM(* .;\8> [#QM
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M_P#(/?ZBK]4-;_Y![_44 6X/]3'_ +H_E4E1P?ZF/_='\JDH **** "BBB@
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MY$*__#^M=M7$_&+_ )$*_P#P_K0!\/7'_'Q+_O&HZDN/^/B7_>-1UJ0%%%%
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MAJ+Z?X5D5K^%?^0U%]/\*B>S ]=3[H^E.IJ?='TIU>40%%%% !1110 4444
M%%%% !1110 4444 <AXZUK0)+-M"U:\BC.H?Z.(F?#'/I7RWXH\&Z'X:U_\
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M&'3;6.WMT6.)%"JJC X&*I>*(WFT.ZCCE$#%<"1FP!^-<Y\(?%\_C3PE'>7
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M\A2Y_P!ZO9;K_CWD^E>-:Q_R%+G_ 'J[,/N-%.BBBNPH**** "BBB@ HHHH
M**** "M?PK_R&HOI_A616OX5_P"0U%]/\*B>S ]=3[H^E.IJ?='TIU>40%%%
M% !1110 4444 %%%% !1110 4444 <W\0OL7_"&ZJ-021[/R&\P1(6;;WP*^
M3_"_@?3_ !A)]CL/$=[8:.S#;#>7/DLJCH I-?77B[4$TOP[?W4ELUXD43,8
M%P"^.PKXZUCP+JGQ@U+S]+\*WWADELI=S,"G)SG /2F@/K[P3H&G^&=#AL=/
MF2:%0,LK!MS8Y)(J]XBU)=(T>XNW7>L:Y(QFOG[X>^'O'WPO\66^F7VIMK6E
M/$I_=(0$8@9R2>U?0/B-X8]'N&GB,L07YD'>D!\G0>&/$GQ(;5=?CFLK:.SF
MDV1K,J@A<D9&>O%>V_L^^*[GQ#X52*]BACNX0=Y@'R'G'!KR+PW\)=9\72:I
M+X8\3P:5ICW+K/:,C,23G<,X],BOH'X8_#ZW^'7AV#3XG6651AY5SALT^@'9
M9YI:**0!24M% "8HQSFEHH *2EHH *H:W_R#W^HJ_5#6_P#D'O\ 44 6X/\
M4Q_[H_E4E1P?ZF/_ '1_*I* "BBB@ HHHH **** "BBB@ HHHH *XGXQ?\B%
M?_A_6NVKB?C%_P B%?\ X?UH ^'KC_CXE_WC4=27'_'Q+_O&HZU("BBB@ HH
MHH **** "BBB@ HHHH ]]_9-_P"0]JW_ %P7^=?3U?,/[)O_ "'M6_ZX+_.O
MIZLWN4@HHHI#"BBB@#COBQ_R(^I?]<F_]!-?E+J'_(0N?^NK?S-?JU\6/^1'
MU+_KDW_H)K\I=0_Y"%S_ -=6_F:^OR3X)&4BO1117TQ 4444 %%%% !1110
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M!_J8_P#='\JDJ.#_ %,?^Z/Y5)0 4444 %%%% !1110 4444 %%%% !1110
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M,\F"UQ. 7)'?-=UCG- "T444 %%%% !1110 4444 <=\6/\ D1]2_P"N3?\
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M6>V2XB@M1(ZD$Y4YX(]*^8IIO#=]JZWJZ4XC+96%;9BG7H/:@#ZJ^"/B&_\
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M'_NC^525'!_J8_\ ='\JDH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/Q(#XRUC_D(S?6J57=8_Y",WUJE7V$=D:A1115 %%%% !1110 4444 %%%%
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M_P"0A<_]=6_F:^OR3X)&4BO1117TQ 4444 %%%% !1110 4444 %?2W[$O\
MR.-U]5KYIKZ6_8E_Y'&Z^JUY^/\ ]WD-;H^_:***_.C<**** "J.N?\ ('O?
M^N+?R-7JHZY_R![W_KBW\C3C\2 ^,M8_Y",WUJE5W6/^0C-]:I5]A'9&H444
M50!1110 4444 %%%% !1110!WOP5_P"1[L?K7U57RK\%?^1[L?K7U57SV/\
MXJ(D+1117FDA1110!#<_-!(!UQBO*=6T>ZDU&X98B06R*];IC0H3RB_E6M.I
MR >.?V)=_P#/(T?V)=_\\C7LGDQ_\\U_*CR8_P#GFOY5K]8?8=SQO^Q+O_GD
M:/[$N_\ GD:]D\F/_GFOY"CR8_\ GFOY"G]8?8+GC?\ 8EW_ ,\C1_8MW_SR
M/ZU[%Y,?]Q?^^:/)C_YYK_WR*7UA]@N>._V)=_\ /(T?V)=_\\C7L?DQ_P!Q
M?^^12^3'_P \U_(4_K#[!<\;_L2[_P">1H_L2[_YY&O8S!&?X%_*D\F/IY:_
M]\BCZP^P7/'?[$N_^>1K4\-Z3<PZM$SQE1C_  KU#R8_^>:_E0L4:]$4?A2=
M=M6L%Q4^Z/I3J2EKE$%%%% !1110 4444 %%%% !1110 4444 %)FEI* $_B
MK,\26']JZ/<6@E\II5P&K3QZ5\[?M2-XPA;39_#@D,2;C,L>XG'..!0!Y1?:
M'XR\)ZSJ%I#X56Z2XD?;,9,$AB0#^.:^BOV??!^H>&?"ZR:E!]CNIE^:WSG;
MR#7RCIOC35;N=8M4>[L;@'!>Z+(.O8FOKWX'M*WA>)I+U+TE?OI)O'4=\TV)
M'I'WJ6DI:0PI",TM% %>^65K5Q#GS.V*X'3T\3V>H7%Q?/*;.-6?#$8X!]O2
MO1J9(@D0J1D,,$&@#R;Q7>Z!\1/!]W<7$B))"A.2,E.0,BMGX+W=S<>&Y(IR
MS0P,$@9NZX/-7=0^%.D:CJ!NBTT.XY,,3%4/L176:?I\.FVJ00($C08& !0!
M:JAK?_(/?ZBK]4-;_P"0>_U% %N#_4Q_[H_E4E1P?ZF/_='\JDH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X?X>_P#(:\2_]?0_]!%=
MQ7#_  ]_Y#7B7_KZ'_H(KN* "BBB@ HHHH **** "BBB@ HHHH X[XL?\B/J
M7_7)O_037Y2ZA_R$+G_KJW\S7ZU>.=#G\0^&[NPMBHFE1E7<>.01_6OAZ[_8
M?\=S74TBSV.'=F'[P=SGUKZ;*,12HQDJDK$239\W45]&?\,->//^>]A_W\%'
M_##7CS_GO8?]_!7T/U_#?SHSY7V/G.BOHS_AAKQY_P ][#_OX*/^&&O'G_/>
MP_[^"CZ_AOYT'*^Q\YT5]&?\,->//^>]A_W\%'_##7CS_GO8?]_!1]?PW\Z#
ME?8^<Z*^C/\ AAKQY_SWL/\ OX*/^&&O'G_/>P_[^"CZ_AOYT'*^Q\YT5]&?
M\,->//\ GO8?]_!1_P ,->//^>]A_P!_!1]?PW\Z#E?8^<Z^E_V(_P#D<KK_
M 'E_G5,_L,^/#_RWL/\ OY_]>O8OV<?V;_$OPK\03WNK2VSPL1@1,">#7#C<
M9AYT)1C*[*2=T?4U%)2U\,:A1110 51US_D#WO\ UQ;^1J]5'7/^0/>_]<6_
MD:J/Q(#XRUC_ )"$WUJE5S6/^0E+GUJG7U\=D:A1115 %%%% !1110 4444
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M3/XU]#5#<V\5Y"\,R+)$XPR,,@^U 'Y_Z]\0KCQY\1WOO$L#76CVTC"&UD;
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MR6HVLW'W<^F: /%/VD-&N](6VTJUTQH/#-JS"28(,;2#SN^OM7TM\+[JSN/
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M&M_\@]_J*0%N#_4Q_P"Z/Y5)4<'^IC_W1_*I* "BBB@ HHHH **** "BBB@
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MI5^&%+>,1QHJ(O15& *EI,4 +5#6_P#D'O\ 45?JAK?_ "#W^HH MP?ZF/\
MW1_*I*C@_P!3'_NC^524 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 </\/?\ D->)?^OH?^@BNXKA_A[_ ,AKQ+_U]#_T$5W% !1110 4
MUV"*6/0#)IU8?B_65T/1GG?[K,(SV^]Q0!P\OQ3FL/B(=+N$QIL^V.WDV\,Y
MZ\_A7J>:\+\?V>EMX9L+NWO8I[S2I6NXU7.68@<#BO5/!>L2>(_!]A>2?)/<
M0;FSU!.>M &CJ&JPV=I/*LBN\:EMBD$G'M7RYXJ^)'BJ\^,WA>WN<VFEW$C>
M2@!1F7_:'K7J-I\(O%D'BS^TI/%BR67F;OLOEGIG.,_2N<^/6FSW'QB^'<T,
M)>.,R;V4# Y- 'O,3R-IJ-'S+Y>5SZX_QKYK^)OACQ6K^(/$&J:J+*"V3S+2
M.&X*!CG!!&?0U[1K7Q B\,W5O8R6YD8PJV[(':OF7XL_$:^\<>/CIEY$Z>'+
M:3YXV(VS*0<@&F!]#_ ;Q)J/B7P:DVI+^\CVJK8/S#'7WKTNN*^%.I:??^%8
M$TZW^S6\"K&J YX KM:0!1110 4444 )4?G1B41EU$A&0N>:EKB;Z5A\4;",
M-\AM7)'Y4 =M1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44
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M !1110 4444 %%%% '#_  ]_Y#7B7_KZ'_H(KN*X?X>_\AKQ+_U]#_T$5W%
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M?P[_ - R+\JZ:B@#F#\./#H_YA</Y4O_  KGP[_T#(?RKI:6@#F?^%<^'?\
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MH **** .'^'O_(:\2_\ 7T/_ $$5W%</\/?^0UXE_P"OH?\ H(KN* "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!P_P]_P"0UXE_Z^A_Z"*[BN'^'O\ R&O$O_7T/_017<4
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MHHH **** "BBB@ KA=,_Y*MJ?_7JG\S7=5PNF?\ )5M3_P"O5/YF@#NJ***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!P_P]_P"0UXE_Z^A_Z"*[BN'^'O\
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MKPWXGABCU31[:^CB 5%E4D*!V%>7^!OCW<7&G^(8_$*JFHZ+&KW'EJ%4Y('
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!/3\:^G=2L-$U2QEM9I+4I(FPG<N<53\*>']"\'PRQV,]NHD;<WSJ/ZT@)O
MOAFZ\)Z''875^=0="<2$8X["NCJM_:EE_P _<'_?U?\ &C^U++_G[@_[^K_C
M2 M455_M2R_Y^X/^_J_XT?VI9?\ /W!_W]7_ !H M455_M2R_P"?N#_OZO\
MC1_:EE_S]P?]_5_QH M455_M2R_Y^X/^_J_XT?VI9?\ /W!_W]7_ !H M455
M_M2R_P"?N#_OZO\ C1_:EE_S]P?]_5_QH M455_M2R_Y^X/^_J_XT?VI9?\
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MY/\ GHW_ 'T://D_YZ-_WT:** #SY/\ GHW_ 'T://D_YZ-_WT:** #SY/\
MGHW_ 'T://D_YZ-_WT:** #SY/\ GHW_ 'T://D_YZ-_WT:** #SY/\ GHW_
M 'T://D_YZ-_WT:** #SY/\ GHW_ 'T://D_YZ-_WT:** #SY/\ GHW_ 'T:
M//D_YZ-_WT:** #SY/\ GHW_ 'T://D_YZ-_WT:** #SY/\ GHW_ 'T://D_
MYZ-_WT:** #SY/\ GHW_ 'T://D_YZ-_WT:** #SY/\ GHW_ 'T://D_YZ-_
MWT:** $:>3_GHWYFE\^3_GHWYFBB@ \^3_GHW_?1H\^3_GHW_?1HHH //D_Y
MZ-_WT://D_YZ-_WT:**  SR?\]&_,TBSR8_UC?\ ?1HHH 7SY/\ GHW_ 'T:
M19Y/^>C?F:** %\^3_GHW_?1H\^3_GHW_?1HHH //D_YZ-_WT://D_YZ-_WT
M:** #SY/^>C?]]&CSY/^>C?]]&BB@ \^3_GHW_?1H\^3_GHW_?1HHH //D_Y
MZ-_WT://D_YZ-_WT:** #SY/^>C?]]&CSY/^>C?]]&BB@ \^3_GHW_?1H\^3
M_GHW_?1HHH //D_YZ-_WT://D_YZ-_WT:** #SY/^>C?]]&CSY/^>C?]]&BB
M@ \^3_GHW_?1H\^3_GHW_?1HHH //D_YZ-_WT://D_YZ-_WT:** #SY/^>C?
M]]&O3/@@Q;6KPDY/E#D_6BB@I'M-%%% PHHHH **** "BBB@ HHHH **** "
2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>abvx-20241231_g15.jpg
<TEXT>
begin 644 abvx-20241231_g15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+L17AI9@  34T *@    @ ! $[  (
M   +   !2H=I  0    !   !5IR=  $    6   "SNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M36%T="!%<&QE>0    60 P "    %    J20!  "    %    KB2D0 "
M S@P  "2D@ "     S@P  #J'  '   !#    9@     '.H    !
M
M
M
M
M
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MTX;XS&M\)R=%%%=YR!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 45O:5X*\1:W9B[TW3))8&SMD9U0-]-Q&?PK)OK&ZTV]DM
M+^!X+B(X>-Q@BDI)NR8[/<KT444Q!1110 4444 %%%% !1110 5K>%?^1RT7
M_K_@_P#1BUDUK>%?^1RT7_K_ (/_ $8M*6S&MSZ8HHHKR#T#Y]^)W_)1M4_[
M9?\ HE*Y.NL^)W_)1M4_[9?^B4KDZ]6G\"."?Q,****LD**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9_"O3_B)_P DHL_^W?\ ]!JYI<D7BKX?V-AX;UK^R[F"*-9!"<R(57!4C(8
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M-I<S)<QLT<,ZNR@1N"2 <]2*-6UG3)/@C'8QZC:/>"VMU-NLZF3(D0D;<YX
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M)EUPG-T+G[0V#@,=V2/H>1]*]C\7>-M)B\&W<^DZC:S7EW$(XXXIE,B[AC)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_H ZG_X!R?X4?\(KXA_Z .I_^ <G^%?3%%'UE]@]BNY\S_\ "*^(?^@#J?\
MX!R?X4?\(KXA_P"@#J?_ (!R?X5],44?67V#V*[GS/\ \(KXA_Z .I_^ <G^
M%'_"*^(?^@#J?_@')_A7TQ11]9?8/8KN?,__  BOB'_H ZG_ . <G^%'_"*^
M(?\ H ZG_P" <G^%?3%%'UE]@]BNY\S_ /"*^(?^@#J?_@')_A1_PBOB'_H
MZG_X!R?X5],44?67V#V*[GS/_P (KXA_Z .I_P#@')_A1_PBOB'_ * .I_\
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M*^(?^@#J?_@')_A7TQ11]9?8/8KN?,__  BOB'_H ZG_ . <G^%'_"*^(?\
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M?_@')_A1_P (KXA_Z .I_P#@')_A7TQ11]9?8/8KN?,__"*^(?\ H ZG_P"
M<G^%'_"*^(?^@#J?_@')_A7TQ11]9?8/8KN?,_\ PBOB'_H ZG_X!R?X4?\
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M/_0!U/\ \ Y/\*^F**/K+[![%=SYG_X17Q#_ - '4_\ P#D_PH_X17Q#_P!
M'4__  #D_P *^F**/K+[![%=SYG_ .$5\0_] '4__ .3_"C_ (17Q#_T =3_
M / .3_"OIBBCZR^P>Q7<^9_^$5\0_P#0!U/_ , Y/\*/^$5\0_\ 0!U/_P
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M/_0!U/\ \ Y/\*^F**/K+[![%=SYG_X17Q#_ - '4_\ P#D_PH_X17Q#_P!
M'4__  #D_P *^F**/K+[![%=SYG_ .$5\0_] '4__ .3_"C_ (17Q#_T =3_
M / .3_"OIBBCZR^P>Q7<^9_^$5\0_P#0!U/_ , Y/\*/^$5\0_\ 0!U/_P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !14;W$4=Q%"[8DFSL&#S@9
M-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT62\M;J=;^XFLY1- UQJES+Y;CN TA'^-7?[!M/^>VH?^#*X_P#BZ/[!M/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUJ5G4N8P9G9(BYRY2,DJA8]2H!.3ZFM6@ HHHH **** "BBB@ HHHH ****
M"BBB@ K-G_Y&JQ_Z\KG_ -#@K2K-G_Y&JQ_Z\KG_ -#@H TJ*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** ,V^_Y#VE_P#;7_T$5I5FWW_(>TO_ +:_
M^@BM*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** ,262^3Q5=_8+>WGS96^_P ZX:+'SS8Q
MA&SW]*L^?KG_ $#M/_\  ]__ (S1!_R-5]_UY6W_ *'/6E0!F^?KG_0.T_\
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MK4=KIUS8W<MU9>'M$MKB;_6S0W!1Y._S$09/XUO44 9OGZY_T#M/_P# ]_\
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M-X$N$3Q-X0N]-O)9]:U&6\&MH9F9BH;Y-ZGI\N2/I7MEMX9TFTU;^T;>U*W
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M!]P#N^F?>J6G207OQV>?2MKVZ[S*\?W2?)*L?^^S^=95,-0O4I*#3@KWOO\
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M@L@"*-MI:E>.AW1\C\S^=5##X>"@I1YFY.-[OO:X&[?^,M,L?"<6OGS)+><
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MM % "O!M&.GRGI792H8?EI<\+N;:W?<#N+*\AU"P@O+5MT,\8D0^Q&:GKG_
MC%O NE%N3Y./R)%=!7C58*%245T; L6W\7X5/4%M_%^%3UF 4444 %%%% !1
M7(^,_'J^%+VQL+72+K5]0O0S1VUMUVKWX!)^@'8UE:)\1O$6J:Y:6-Y\/]4T
M^">0(]U*9-L0_O',0'ZB@#T.BBB@#-OO^0]I?_;7_P!!%:59M]_R'M+_ .VO
M_H(K2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *PM2/]J>);'3%Y@L\7]U]02(5/U8,_P#VS%;M84GAJ;^T[R]M
M/$&IVC7CJ\B1);,HPH4 ;X6(&!TSZGN: ,'P(/[ \3^(/"+\102_;[ ?],)>
MH'LK<?4FNRU'3K75M/FL=1A$]M,NV2,D@,,YQQ6)!X-1/%%KK]UK6I7E[:Q-
M"GG"!59&SE6"1*2,G/7K724 >36UM!9?M(1VUI#'!!%IFU(XU"JHV= !TKT#
M6X['7[>Y\/)K36=VZ!I%LKE4N40%3D#D@'(!XZ-[U!_PANG_ /"=?\)7YUS]
MN\GR/+W+Y6W&,XVYS^-5?$'P\TCQ!K"ZL;B_TW4@FPW>G7'E.RXQ@\$=.* .
M'^'NG0ZEIOB[P!=K&UI:3M&+V!0'<EF +=BP* CZ8[4:QX4O/#\L6G)KDNJ:
M]XBC32H9VA$7V:S3!D. 3G"@ G^M>D>&?"FE^$M/>UTB)QYK[YII7WR2MZL?
M\,"HX/#&/'%QXDO;O[2YMUMK2#RMHMDZMSD[BQ[X''% '!6'Q OM&E@BL]+L
MH_"MIJHT)#N;[2&5?O\ ]W&.>F?YUT^I>#KVXNK^UL_L*V&I7\-_/<NS"XA9
M"I*JH7#9,8PQ88WMP<<TC\*HF\0&X.LS_P!CG4O[4.E>2,?:/7S,YQVQCI^=
M>@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 5M2_Y!5W_P!<7_\ 031IO_(*M/\ KBG_ *"*
M-2_Y!5W_ -<7_P#031IO_(*M/^N*?^@B@"S1110 4444 %%%% !1110 4444
M 8LB7C^)[S[!/!"WV.VW&: R C?/T =<58\C7/\ H(Z?_P" #_\ QZB#_D:K
M[_KRMO\ T.>M*@#-\C7/^@CI_P#X /\ _'J/(US_ *".G_\ @ __ ,>K2HH
MS?(US_H(Z?\ ^ #_ /QZCR-<_P"@CI__ ( /_P#'JTJ* ,WR-<_Z".G_ /@
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M$<T/_H#:?_X"I_A6E10!F_\ ".:'_P! ;3__  %3_"C_ (1S0_\ H#:?_P"
MJ?X5I44 9O\ PCFA_P#0&T__ ,!4_P */^$<T/\ Z VG_P#@*G^%:5% &;_P
MCFA_] ;3_P#P%3_"C_A'-#_Z VG_ /@*G^%:5% &;_PCFA_] ;3_ /P%3_"C
M_A'-#_Z VG_^ J?X5I44 9O_  CFA_\ 0&T__P !4_PH_P"$<T/_ * VG_\
M@*G^%:5% &;_ ,(YH?\ T!M/_P# 5/\ "C_A'-#_ .@-I_\ X"I_A6E10!F_
M\(YH?_0&T_\ \!4_PH_X1S0_^@-I_P#X"I_A6E10!@:KHVEV5M!/9Z;:6\RW
MEJ%DB@56&9T!P0,\@D?C6_6;KW_(.B_Z_;7_ -*(ZTJ "BBB@ HHHH ****
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M6E10!F^1KG_01T__ , '_P#CU'D:Y_T$=/\ _ !__CU:5% &;Y&N?]!'3_\
MP ?_ ./4>1KG_01T_P#\ '_^/5I44 9OD:Y_T$=/_P# !_\ X]1Y&N?]!'3_
M /P ?_X]6E10!F^1KG_01T__ , '_P#CU'D:Y_T$=/\ _ !__CU:5% &;Y&N
M?]!'3_\ P ?_ ./4>1KG_01T_P#\ '_^/5I44 9OD:Y_T$=/_P# !_\ X]1Y
M&N?]!'3_ /P ?_X]6E10!F^1KG_01T__ , '_P#CU'D:Y_T$=/\ _ !__CU:
M5% &;Y&N?]!'3_\ P ?_ ./4>1KG_01T_P#\ '_^/5I44 9OD:Y_T$=/_P#
M!_\ X]1Y&N?]!'3_ /P ?_X]6E10!F^1KG_01T__ , '_P#CU'D:Y_T$=/\
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MA:^(+.?4?'<-_:QR@RVRR$F4>E 'IM%%% &;K/\ RX?]?L?]:TJS=9_Y</\
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MBFA^(+K3/A[K&FZ'-).;S69=-T%F8DE&P,@_W54YSV)KU/2=)B\*^$8=/TY
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M)_R*NK?]>4W_ * :TJS?$G_(JZM_UY3?^@&M*@ HHHH **** "BBB@ HHHH
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M)HTW_D%6G_7%/_010!9HHHH **** "BBB@ HHHH **** ,V#_D:K[_KRMO\
MT.>M*LV#_D:K[_KRMO\ T.>M*@ HHHH **** "BBL/QEK5QX=\)7NJ621//!
MLVK,"5.Z15.0"#T)[U<(.I-0CN] -RBO#_\ A=/B+_GRTO\ []2?_%T?\+I\
M1?\ /EI?_?J3_P"+KU/[(Q79?>![A17A_P#PNGQ%_P ^6E_]^I/_ (NC_A=/
MB+_GRTO_ +]2?_%T?V1BNR^\#W"BO#_^%T^(O^?+2_\ OU)_\71_PNGQ%_SY
M:7_WZD_^+H_LC%=E]X'N%%>'_P#"Z?$7_/EI?_?J3_XNO<*X\3@ZN&M[3J 4
M445R 5-6U%-(T6]U&8;DM('F9<XR%4G&?PKD?#/C;Q+XC6QNT\%F#2[MA_IA
MU2-MB9P6V;0QZ=*VO&]G;:CX-O[&]U:#2(;E5C:\N,;$!8<<LHY QU[UYW=6
ME]\-=9\)#1O$.H:M8ZC(MI+:7$OF1.I*?-$HX4?-D8R1P,D$Y .AUCXHW%MJ
MVL6N@^&YM7M]$3.H7/VI81$1G. 02P&T^_!XP,UV6@ZU:>(M"M=6T[?]GNDW
MH)!AEYP00,\@@C\*\9FT^_\ $.K_ !#O/#.H+HUE$'BO+?9YGVTJ'W$D_<W8
M;D?WL>M>E?#"^M;_ .'&DRV%I]CB2,QF(-D!E8ACGW()_&@"OK_B_P 4:))?
M3+X,6;3;7<PO7UB&,.@_BVD9'TZU1MOBC<W'A"PU9?#DHO-3OA9V%C]J \__
M &_,*@*,Y'3J!VY%?XMW4VI3:#X/M9&C.M78^T,O41*1_4Y_X!72>)/!D6LZ
M1IEKI=V=(GTF:.6QGCB$HAV# 4H3@C'OV'N" 4H?B/:2?#ZY\2RV,D4ML[6[
MV)?+&X!"B,,!SDD<XZ9..*ZZU>:6SADNX1!.T:M+$K[Q&Q'*AL#.#QG S7C=
MQ;6GAF\-G--+J6G>%LZKJ<A4+]JOI2!$N.0,9![XYZUZ!X/\9R>);F_L=0TJ
M32=1L?+>2W:82@QR+N1@P _+'''X '4T444 %%%% !1110 5FS_\C58_]>5S
M_P"AP5I5FS_\C58_]>5S_P"AP4 :5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >9?%VQ\(LUC>^*3J,MUL:*UMK!EWR <DX(Z#(YSW[UC>
M#_#7@6W\0^';RS.JV]]?1&\LEN)49&*D@J<+UP,X_6NE^(>A:M>ZU8:GX8>T
MGU."UF@:QN) K2Q2#!9<D<C)YR/Z'$\'^$?&,]_X>B\3V=MIVF>'MSP*DBO+
M.Y'&2K,,?ETZ4 >N4444 9NL_P#+A_U^Q_UK2K-UG_EP_P"OV/\ K6E0 444
M4 %%%% !1110 4444 %%%% &;KW_ "#HO^OVU_\ 2B.M*LW7O^0=%_U^VO\
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M9U96(*.>[*05SSG&<GJ=>J6CZ3;:)I<5A9;S''DEY&W/(Q)+.Q[DDDGZU=H
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ML'_(U7W_ %Y6W_H<]:5 !1110 4444 %<E\4/^2;ZI_VQ_\ 1R5UM<E\4/\
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MJT_ZXI_Z"*-2_P"05=_]<7_]!-&F_P#(*M/^N*?^@B@"S1110 4444 %%%%
M!1110 4444 9L'_(U7W_ %Y6W_H<]:59L'_(U7W_ %Y6W_H<]:5 !1110 44
M44 %<E\4/^2;ZI_VQ_\ 1R5UM<E\4/\ DF^J?]L?_1R5TX3_ 'BGZK\P/GFB
MBBOOP"BBB@ HHHH *^LZ^3*^LZ^;SS_EW\_T ****^; X[Q]_P P_P#[:?\
MLM<=78^/O^8?_P!M/_9:XZO>PG\"/]=0"BBBNH HHHH *V/"?_(T6G_ _P#T
M!JQZV/"?_(T6G_ __0&K*M_"EZ,#TJBBBOG "BBB@ HHHH *S9_^1JL?^O*Y
M_P#0X*TJS9_^1JL?^O*Y_P#0X* -*BBB@ HHHH **** "BBB@ HHHH ****
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M3CUW6O!5MH5O=?;-'AD74;G!$:PG/R^^2?S(_  ]WHHHH S;[_D/:7_VU_\
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M\@JT_P"N*?\ H(HU+_D%7?\ UQ?_ -!-&F_\@JT_ZXI_Z"* +-%%% !1110
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M444 %%%% !1110 4444 %9L'_(U7W_7E;?\ H<]:59L'_(U7W_7E;?\ H<]
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MFO8Y;J]OIQMDO+V7S)2O]W/  ^@J?0?#UIX=@NXK*2:1;NZ>[<S,"0[  @8
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M_P BKJW_ %Y3?^@&M*LWQ)_R*NK?]>4W_H!K2H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "LW2_P#D(ZS_ -?J_P#I/#6E6;I?
M_(1UG_K]7_TGAH TJ*** "BBB@ HHHH **** "BBB@#-T'_D'2_]?MU_Z425
MI5FZ#_R#I?\ K]NO_2B2M*@ HHHH **** "BBB@ HHHH **** "BBB@ J&\O
M+?3[&:\O95AMX$,DDC'A5 R34U<?\5R1\+=:P<?ND''_ %T6@#C=3N/A]\5O
M$,<$.H7MEJC1F-9D3RQ<(N3M.00?49P?RQ5_X??\(AHWC2XTCPY=76L:E) Q
MN=1E<,BJI'R*1UYQTR..O:O-_$>IZ!?^$?!EE87<4-U;(8[^2*(AH0VW))P-
MW\1XSW]:]A^'][X#M -'\&W4,UR8R\C^6WFR@=2S%1GKTZ>@H [JBBB@"MJ7
M_(*N_P#KB_\ Z":--_Y!5I_UQ3_T$4:E_P @J[_ZXO\ ^@FC3?\ D%6G_7%/
M_010!9HHHH **** "BBB@ HHHH **** ,V#_ )&J^_Z\K;_T.>M*LV#_ )&J
M^_Z\K;_T.>M*@ HHHH **** "N2^*'_)-]4_[8_^CDKK:Y+XH?\ )-]4_P"V
M/_HY*Z<)_O%/U7Y@?/-%%%??@%%%% !1110 5]9U\F5]9U\WGG_+OY_H 444
M5\V!QWC[_F'_ /;3_P!EKCJ['Q]_S#_^VG_LM<=7O83^!'^NH!11174 4444
M %;'A/\ Y&BT_P"!_P#H#5CUL>$_^1HM/^!_^@-65;^%+T8'I5%%%?. %<OX
MRT#7=5-C>^%]:?3KVQDW>1)(XM[H$CY9 OH >QZD>XZBB@#@]#\!7LVL:QK?
MC2YM;G4-4MFLC#8JPABA( (!89R0 /;GDYXQ(?A?XBGT_3_#6K:II\OAG3[L
MW"&)'%S,N6(1@1M ^8]SC/? KU>B@#GGL/$<OC226:_M7\-/;&,V14>89",$
MYV9QU_B_"N';X6>(ETF7PK!JU@/"\E[]I\PJ_P!K5.#Y>/N8R.N??_9KUFB@
M#(UU=0L/"=S%X8M!->QP"*SA#JH4\*#EB!\HYY/.*XO5? ^IZ)I?A-_#EE'J
ML^AR2-/;O,L7VAI%^9]S<?>R>><$5Z710!S'P[\/W?ACP/9:;J)7[4N^21$.
M5C+L6V@^V<<<9S73T44 %%%% !1110 4444 %%%% !1110 4444 %%%17=RE
MG93W,H8I#&TC!>I &3C\J /-?B?;ZI?^,?#=IIE_#H[%9GBU*1BA#X&8]P]1
M_#WS[4[0/#GC"U\06<^H^.X;^UCE!EMED),H]*X_Q=X[^'GC6\M[G6+/Q$KV
M\9C3R%A48)SSES4?@J;X<-XUTH:-;^(UOOM \@W)A\L-_M8.<?2@#Z!HHHH
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M!_R-5]_UY6W_ *'/6E6;!_R-5]_UY6W_ *'/0!I4444 %%%% !1110 4444
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MRSY%W$)%!ZKGJI]P<@_2J.O_ /$RO[#0P-R7#_:+OT\B,@[3_O/L7'<;JP?
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M_P"D\-:59NE_\A'6?^OU?_2>&@#2HHHH **** "BBB@ HHHH **** ,W0?\
MD'2_]?MU_P"E$E:59N@_\@Z7_K]NO_2B2M*@ HHHH **** "BBB@ HHHH **
M** "BBB@ J&[L[:_M7MKZWBN;>08>*9 Z-SGD'@U-6=KVG76K:'<V6GZC)IE
MQ,H"7<2DM%@@Y R.PQU[T 5?^$*\+?\ 0M:/_P" $7_Q-6;#PYH>EW/VC3-&
MT^SGVE?-M[5(VP>HR #BO,M6\,ZGH4D<>L?&"XLI)!N1)D*LP]<>;T]ZT_ B
M+'XG _X62_B4M ^++:<#I\^=[ 8^G>@#TRBBB@"MJ7_(*N_^N+_^@FC3?^05
M:?\ 7%/_ $$4:E_R"KO_ *XO_P"@FC3?^05:?]<4_P#010!9HHHH **** "B
MBB@ HHHH **** ,V#_D:K[_KRMO_ $.>M*LV#_D:K[_KRMO_ $.>M*@ HHHH
M **** "N2^*'_)-]4_[8_P#HY*ZVN2^*'_)-]4_[8_\ HY*Z<)_O%/U7Y@?/
M-%%%??@%%%% !1110 5]9U\F5]9U\WGG_+OY_H 4445\V!QWC[_F'_\ ;3_V
M6N.KL?'W_,/_ .VG_LM<=7O83^!'^NH!11174 4444 %;'A/_D:+3_@?_H#5
MCUL>$_\ D:+3_@?_ * U95OX4O1@>E4445\X 5AZCJ-U!?R1Q2[47&!M![#V
MK<KF=7_Y"DW_  '_ -!%;T$G+4 _M>]_Y[_^.+_A1_:][_SW_P#'%_PJG177
MR1[ 7/[7O?\ GO\ ^.+_ (4?VO>_\]__ !Q?\*IT4<D>P%S^U[W_ )[_ /CB
M_P"%']KWO_/?_P <7_"J=%')'L!OZ/=SW7G>>^_;MQP!CKZ5IUC>'_\ EX_X
M#_6MFN*JDIM( HHHK( HHHH **** "BBB@ HHHH **** "BBB@!LDL<6WS75
M-S!5W'&2>@'O3?/A^T?9_-3SMF_R]PW;<XSCKC/&:\T^)\UO8^,O#.H^(#>)
MH5LSN9+;/[NX&"A;'T&._!]ZHR:]H_B[XO>'[_P=-=W5U;AUOI]KI$MN%/&&
MQCECV R?7% 'KM%%% &;K/\ RX?]?L?]:TJS=9_Y</\ K]C_ *UI4 %%%% !
M1110 4444 %%%% !1110!F>("5TN,A2Q%Y:D*.I_TB/CFE_M2[_Z .H?]_+?
M_P".T:]_R#HO^OVU_P#2B.M*@#-_M2[_ .@#J'_?RW_^.T?VI=_] '4/^_EO
M_P#':TJ* ,W^U+O_ * .H?\ ?RW_ /CM']J7?_0!U#_OY;__ !VM*B@#-_M2
M[_Z .H?]_+?_ ..T?VI=_P#0!U#_ +^6_P#\=K2HH S?[4N_^@#J'_?RW_\
MCM']J7?_ $ =0_[^6_\ \=K2HH S?[4N_P#H ZA_W\M__CM":O)]LMX+G2[R
MU^T.8TDE:(KN",V#M<GHI[5I5FZI_P A'1O^OUO_ $GFH TJ*** "BBB@ HH
MHH **** "LV#_D:K[_KRMO\ T.>M*LV#_D:K[_KRMO\ T.>@#2HHHH ****
M"BBB@ HHKSJ[^)DK?%JS\*:7#;R6>\PW4[ABWF!22J$$ 8P <@\YH ]%HKD_
MB+XU7P3X:-W"D<U_.WEVL,F2K'JS, 0=H'IWP.]:GA+5Y]>\(Z;JEXD:3W4
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MV\-O<B298R40E> 6Z#-17%C=M\9K6]%K,;1=',9N!&?+#^8QV[NF<'I78T4
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M0NDV-(NW CZ<\YXR>O:@#UNBBB@#-OO^0]I?_;7_ -!%:59M]_R'M+_[:_\
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ME_R"KO\ ZXO_ .@FC3?^05:?]<4_]!% %FBBB@ HHHH **** "BBB@ HHHH
MS8/^1JOO^O*V_P#0YZTJS8/^1JOO^O*V_P#0YZTJ "BBB@ HHHH *Y+XH?\
M)-]4_P"V/_HY*ZVN2^*'_)-]4_[8_P#HY*Z<)_O%/U7Y@?/-%%%??@%%%% !
M1110 5]9U\F5]9U\WGG_ "[^?Z %%%%?-@<=X^_YA_\ VT_]EKCJ['Q]_P P
M_P#[:?\ LM<=7O83^!'^NH!11174 4444 %;'A/_ )&BT_X'_P"@-6/6QX3_
M .1HM/\ @?\ Z U95OX4O1@>E4445\X 5S.K_P#(4F_X#_Z"*Z:N9U?_ )"D
MW_ ?_0171A_B IT445V@%%%% !1110!L^'_^7C_@/]:V:QO#_P#R\?\  ?ZU
MLUY];XV 4445D 4444 %%%% !1110 4444 %%%% !45TTZV<S6BJ\XC8Q*W0
MMC@'VS4M% '!:U=?$272K".ST#1;N2: G4(;DY19-W"J#(,C&#WJKX9/Q!L]
M7MX;OPOX?T[39)!]I>R4(P7U $AR?P-0_$]5U+Q5H&B:KK3:3HEVLK7#QRA"
M[C[JL3P >Q/&<]36)8V.A^!_'^BIX2\4+-9W9<:A;37B/$D87[Q88 .>@/.>
MGI0![114%I>VM_!YUC<PW,6<>9#('7/ID5/0!FZS_P N'_7['_6M*LW6?^7#
M_K]C_K6E0 4444 %%%% !1110 4444 %%%% &;KW_(.B_P"OVU_]*(ZTJS=>
M_P"0=%_U^VO_ *41UI4 %%%% !1110 4444 %%%% !6;JG_(1T;_ *_6_P#2
M>:M*LW5/^0CHW_7ZW_I/-0!I4444 %%%% !1110 4444 %9L'_(U7W_7E;?^
MASUI5&MO$MT]PJXED149L]54L0/S9OSH DHHHH **** "BBB@# \;ZGJ>D^#
M[ZYT&RFO-1VB."."(R,"Q W8&2=H)/X5XE#>PZ'XX\)F#0-?1[*%C/%<66VY
MNY6W%W1-WS<GUX ]J^C*R[SPUI-_KUGK5W:>9J%DI6WF\QQL!S_"#@]3U!H
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MA,=U/,H"SR9)#<CCC^59_AZ#Q(OB*R-[\1]+U* 2CS+2*1"TP_NC'-5OBT=
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M;O4=0D!AL[2TD97D&<G@=AD<^]<CX9\.^!-;UP:-J_AC5="U&12\$-Y/(/-
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M-TO_ )".L_\ 7ZO_ *3PT :5%%% !1110 4444 %%%% !1110!FZ#_R#I?\
MK]NO_2B2M*LW0?\ D'2_]?MU_P"E$E:5 !1110 4444 %%%% !1110 4444
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M"?\ R-%I_P #_P#0&K'K8\)_\C1:?\#_ /0&K*M_"EZ,#TJBBBOG "N9U?\
MY"DW_ ?_ $$5TU<SJ_\ R%)O^ _^@BNC#_$!3HHHKM **** "BBB@#9\/_\
M+Q_P'^M;-8WA_P#Y>/\ @/\ 6MFO/K?&P"BBBL@"BBB@ HHHH **** "BBB@
M HHHH **** //?BAX:FOEM];LM>MM%EMX);2:6[;"/%(,$ X.#U[9YXQBLWP
MAX?TN_NO#<.C:_9WUAX>C>::. XDEN7)^8CJ%YZGT ^DOQ1_L^+Q;X<N/%D<
MLGAM!*)0@8HLQ'REPO)&/3T/O6393>%;SXI>'S\-XPLL9D.H/;1M'#Y.WH0P
M&3]!U([] #V6BBB@#-UG_EP_Z_8_ZUI5FZS_ ,N'_7['_6M*@ HHHH ****
M"BBB@ HHHH **** ,W7O^0=%_P!?MK_Z41UI5FZ]_P @Z+_K]M?_ $HCK2H
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MVAWTNI:-!=SJBR2;LA 0.&([_2O+*]*\)_\ (KVG_ __ $-JXL92A"FG%6U
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M$$:B"1)A+)=EF/\ #C*G/K]:N7?CG5M(2"ZU_P *RV.G32+&;A;Q)6CW="R
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MTCM!Y<@1LA5*#!'<N,G(P,GFDO/&5UIEG:QZAH<BZS>RM';:9!<+*7 Q\Q?
M 7GK_P#7P =717+6'C"Y&N6^D^(]%DT>YNP?LK^>LT<Q R5W #!]O_K9XN?_
M ) 'Q)_Z_3_Z%0!Z[17'CQ0FA>&O#UI;V<NHZE>V<0M[2%@I;$:Y))^Z/?\
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M'M+_ .VO_H(K2K-OO^0]I?\ VU_]!%:5 !1110 4444 %%%% !1110 4444
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M^OU?_2>&@#2HHHH **** "BBB@"MJ.HV>DZ?-?:E<QVUK"NZ261L*HZ?F20
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M@ HHHH **** "BBB@ HHK.U[4I]'T.YO[33YM2FA4%;6 $O)D@8& 3WST[4
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M/^%N_P#4$_\ )O\ ^PH ])HKS;_A;O\ U!/_ ";_ /L*/^%N_P#4$_\ )O\
M^PH ])HKS;_A;O\ U!/_ ";_ /L*/^%N_P#4$_\ )O\ ^PH ])HK-\/:O_;V
M@V^I>1Y'G;OW>_=MPQ7K@>GI6E0 5R7Q0_Y)OJG_ &Q_]')76UR7Q0_Y)OJG
M_;'_ -')73A/]XI^J_,#YYHHHK[\ HHHH **** "OK.ODROK.OF\\_Y=_/\
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M43Y>G-;R6K3G[L,AR06/;.<9]CZ5V/\ 9EANM6^PVV;,;;8^2O[@8 PG'R\
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MXGSY<4;.^!G@#)J6D(#*0P!!&"#WH ^?-?T#X;VVH6&K37FIVNGZI"]PEI#
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MX"T75K*]U[5]=LDTZ?5[L2K9I,LOE*H(Y9>"3GM7944 %%%% !1110 4444
M%%%% !1110 57U!+N33IUTV6.&[*'R9)5W(&[9'I5BL[Q!HZZ_H-SICW,UJM
MPH!F@.'7# \'\* /);.7XNIXJU*:/383<21Q"02\6X ''EDMM)]<$^]=9X2T
MSQS/XO.L>,9+:W@CLC;I;6LF5=BP;)4$C(YY^E<=X_ATBU\;S)K][XDTZ Q0
MK'=6JY@?"*,^N?7&><UTOPZT+PW!K']HZ!XON=8?RF0VT\XR <?,4(##ZXH
M]+HHHH K:E_R"KO_ *XO_P"@FC3?^05:?]<4_P#011J7_(*N_P#KB_\ Z":-
M-_Y!5I_UQ3_T$4 6:*** "BBB@ HHHH *^;:^DJ^;: "BBB@ HHHH **** /
M;OA[_P B)I__ &U_]&M725S?P]_Y$33_ /MK_P"C6KI* "N2^*'_ "3?5/\
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MX^E37NH:3HWCKPI9Z7X6T6!=6C68SBS02PD_W64#GWH ]0HHHH S=9_Y</\
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M>7Y( HHHKS@/':***^H **** "BBB@ KTKPG_P BO:?\#_\ 0VKS6O2O"?\
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M-00* ,C=@+QUQU.:Z_Q'\-T\5:]+=ZQKNHG3V"A-.@DV1K@ 'KD')&> *V-
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M7ADN-$OH85+R26\B(H[DJ0!5RB@#YU_X1SQ[_P *_P#^$4_X19_(^T_://\
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M110 5-9_\?T'_71?YU#4UG_Q_0?]=%_G4RV8'64445Y@!1110 4444 %%%%
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M]#^"W_(YW?\ V#W_ /1D=<.8?[K/T ]PHHHKX4 HHHH **** "BBB@ HHHH
M**** "BBB@##U'4;J"_DCBEVHN,#:#V'M57^U[W_ )[_ /CB_P"%&K_\A2;_
M (#_ .@BJ=>A"$>5: 7/[7O?^>__ (XO^%']KWO_ #W_ /'%_P *IT57)'L!
M<_M>]_Y[_P#CB_X4?VO>_P#/?_QQ?\*IT4<D>P%S^U[W_GO_ ..+_A4MMJEY
M)=PH\V59U!&T<C/TK.J:S_X_H/\ KHO\Z3A&VP'64445YP!1110 4444 %%%
M% !1110 445%<W5O96LES>3QV\$8W/+*X55'J2>!0!Q/B/XAW&BZ]K%I!8))
M::/IXN+B9VP3,^!$@]CD9//X54\ >-_$.K:Q#IWBJSMHFO[ :C8RVX(S&3C#
M#)^H_P#KBN>\4V?@OQIXVO?^*M73 L,(NW%Q%]GO0.5"-OY9>AR#@@5TN@W'
MAM_BK+_9NIC4;AM*2.T%M(DEO:P(0&3<&)WDC=C &#[T >A4444 5M2_Y!5W
M_P!<7_\ 031IO_(*M/\ KBG_ *"*-2_Y!5W_ -<7_P#031IO_(*M/^N*?^@B
M@"S1110 4444 %%%% !7S;7TE7S;0 4444 %%%% !1110![=\/?^1$T__MK_
M .C6KI*YOX>_\B)I_P#VU_\ 1K5TE !7)?%#_DF^J?\ ;'_T<E=;7)?%#_DF
M^J?]L?\ T<E=.$_WBGZK\P/GFBBBOOP"BBB@ HHHH *^LZ^3*^LZ^;SS_EW\
M_P! "BBBOFP..\??\P__ +:?^RUQU=CX^_YA_P#VT_\ 9:XZO>PG\"/]=0"B
MBBNH HHHH *V/"?_ "-%I_P/_P! :L>MCPG_ ,C1:?\  _\ T!JRK?PI>C ]
M*HHHKYP KF=7_P"0I-_P'_T$5TU<SJ__ "%)O^ _^@BNC#_$!3HHHKM ****
M "BBB@#9\/\ _+Q_P'^M;-8WA_\ Y>/^ _UK9KSZWQL HHHK( HHHH ****
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M._\ ;O\ ^U*]:KR7X&_\QW_MW_\ :E>M5\3FG^^3^7Y( HHHKS0/':***^H
M**** "BBB@ KTKPG_P BO:?\#_\ 0VKS6O2O"?\ R*]I_P #_P#0VK@Q_P#"
M7K_F!L4445XP&9KO_'BG_70?R-8%;^N_\>*?]=!_(U@5W4/@ ****W ****
M"IK/_C^@_P"NB_SJ&IK/_C^@_P"NB_SJ9;,#K****\P HHHH **** "BBB@
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M  X^B ****U **** "O0_@M_R.=W_P!@]_\ T9'7GE>A_!;_ )'.[_[![_\
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M;MSFDT_23H7BS11<_$C5-5-S<;4M1,TD<A SM?\ >' /T- 'K%%%% &;??\
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MW_D%6G_7%/\ T$4:E_R"KO\ ZXO_ .@FC3?^05:?]<4_]!% %FBBB@ HHHH
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MQ **** "BBB@#UGX&_\ ,=_[=_\ VI7K5>2_ W_F._\ ;O\ ^U*]:KXG-/\
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M -\M/[J_E1Y:?W5_*G44 -\M/[J_E1Y:?W5_*G44 (%"_= 'T%+110 4444
M%%%% 'B?CSP5\/\ POK$%_J\MY#%>&0_8+1=Q8YR6!R-JC(XIG@B]^&D?BVP
M7P]I6K2ZDTFV&2XY6,GJQ^;' ]N_XUWGB3P_/??$#0M5M4M+N.WCDM[RVG(W
M+$__ "T4'KC)KD/#?A/Q9I_BS1+"?38+?3M#GG9=41EW3POG"'G)SD#&/Y4
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MHJP"BBB@ J:S_P"/Z#_KHO\ .H:FL_\ C^@_ZZ+_ #J9;,#K****\P HHHH
M**** "BBB@ HHHH *KZA'=3:=/'ITZV]TR'R963<JMV)'<58HH \4L[3XN1^
M*M2N8HK87,L<0EDD \A@!QLSQGUQ76>$]$\9GQA_;7C.]M %LC;1V]JWW\L&
MR0!CCGGFN1^(NF7/B'QSKMM-J-U ^FZ2MWIUM&2%F"C+^W7(]3^%-^%5OH\'
MQ"A&DW]QJ?FZ/Y[O(3FUD+ /&>Q[<^N* /;Z*** *VI?\@J[_P"N+_\ H)HT
MW_D%6G_7%/\ T$4:E_R"KO\ ZXO_ .@FC3?^05:?]<4_]!% %FBBB@ HHHH
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MR2O<*\/^-/\ R.=I_P!@]/\ T9)7KY1_O2]&!YY1117V(!1110 4444 >L_
MW_F._P#;O_[4KUJO)?@;_P QW_MW_P#:E>M5\3FG^^3^7Y( HHHKS0/':***
M^H **** "BBB@ KTKPG_ ,BO:?\  _\ T-J\UKTKPG_R*]I_P/\ ]#:N#'_P
MEZ_Y@;%%%%>,!F:[_P >*?\ 70?R-8%;^N_\>*?]=!_(U@5W4/@ ****W **
M** "IK/_ (_H/^NB_P ZAJ:S_P"/Z#_KHO\ .IELP.LHHHKS "BBB@ HHHH
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M!FWW_(>TO_MK_P"@BM*LV^_Y#VE_]M?_ $$5I4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?,7BS_D<]:_["$_\ Z,:LFM;Q9_R.>M?]
MA"?_ -&-637Z'1_AQ]$ 4445J 4444 %>A_!;_D<[O\ [![_ /HR.O/*]#^"
MW_(YW?\ V#W_ /1D=<.8?[K/T ]PHHHKX4 KS7Q9_P C1=_\ _\ 0%KTJO-?
M%G_(T7?_  #_ - 6N_ ?Q7Z?Y 8]%%%>R 4444 %%%% &QX3_P"1HM/^!_\
MH#5Z57FOA/\ Y&BT_P"!_P#H#5Z57C8_^*O3_, HHHK@ YG5_P#D*3?\!_\
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ML?\ T<E=.$_WBGZK\P/GFBBBOOP"BBB@ HHHH *^LZ^3*^LZ^;SS_EW\_P!
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M_F._]N__ +4KUJOB<T_WR?R_) %%%%>:!X[1117U !1110 4444 %>E>$_\
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M:5)R>>G% 'IE%%% &;K/_+A_U^Q_UK2K-UG_ )</^OV/^M:5 !1110 4444
M%%%% !17'_$N]NK#PW;RV-S-;2&[52\,A0D;'XR.W KR_P#X237/^@SJ'_@4
M_P#C0!] 45\__P#"2:Y_T&=0_P# I_\ &C_A)-<_Z#.H?^!3_P"- 'T!17S_
M /\ "2:Y_P!!G4/_  *?_&C_ (237/\ H,ZA_P"!3_XT ?0%%?/_ /PDFN?]
M!G4/_ I_\:T- U_6)O$FF13:M?21O=Q*Z-<N0P+C((SR* /<**** "O#_C3_
M ,CG:?\ 8/3_ -&25[A7A_QI_P"1SM/^P>G_ *,DKU\H_P!Z7HP//****^Q
M**** "BBB@#UGX&_\QW_ +=__:E>M5Y+\#?^8[_V[_\ M2O6J^)S3_?)_+\D
M 4445YH'CM%%%?4 %%%% !1110 5Z5X3_P"17M/^!_\ H;5YK7I7A/\ Y%>T
M_P"!_P#H;5P8_P#A+U_S V****\8#,UW_CQ3_KH/Y&L"M_7?^/%/^N@_D:P*
M[J'P %%%%;@%%%% !4UG_P ?T'_71?YU#4UG_P ?T'_71?YU,MF!UE%%%>8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%,EE2"%YIF"1QJ69CT  R30!SWC#P58^,+:W^T3SV=Y:,
M6MKNW.'C)QGZ@X%9GAKX:0Z+KJ:UJVM7VNZC$I6&6\<D1 C!(!).<<=:ZT:G
M:2:6VHVTZ7-JL9E$D#!PR@9X(ZUYI9_%O4Y'L;^\T6S31[ZX6&,Q7Z/<)N8@
M$IG/;D8% 'JM%%% &;??\A[2_P#MK_Z"*TJS;[_D/:7_ -M?_016E0 4444
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M$_\ D:+3_@?_ * U>E5XV/\ XJ]/\P"BBBN #F=7_P"0I-_P'_T$53JYJ_\
MR%)O^ _^@BJ=>E#X4 44458!1110 5-9_P#']!_UT7^=0U-9_P#']!_UT7^=
M3+9@=91117F %%%% !1110 4444 %%%% !1110!YSXCM_$?A;QY<^)O#^C?V
MY:ZC;QPW-NC;9(F3IMZG! ]#S^%2>$;/Q#KWCB7Q;XCTH:,D=E]CM;4MF1@6
MW%F[\<]0.O2N_FFBMH'FN)$BBC4L\CL%50.I)/05D:3XP\/:[>-:Z1J]K=7"
M@L8D?YB!U(!Z_A0!M4444 5M2_Y!5W_UQ?\ ]!-&F_\ (*M/^N*?^@BC4O\
MD%7?_7%__031IO\ R"K3_KBG_H(H LT444 %%%% !1110 5\VU])5\VT %%%
M% !1110 4444 >W?#W_D1-/_ .VO_HUJZ2N;^'O_ "(FG_\ ;7_T:U=)0 5R
M7Q0_Y)OJG_;'_P!')76UR7Q0_P"2;ZI_VQ_]')73A/\ >*?JOS ^>:***^_
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MIESOBDQG(P,9QR4SSBO0=.\!>%[3Q%_PD>GV"K>2DRI('8H"PY95S@9!/YT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX?\ ^7C_ (#_ %K9K&\/_P#+Q_P'^M;->?6^-@%%%%9 %%%% !1110 4444
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M110 5-9_\?T'_71?YU#4UG_Q_0?]=%_G4RV8'64445Y@!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!FWW_(>TO\ [:_^@BM*LV^_Y#VE_P#;7_T$5I4 %%%% !11
M10 4444 %?-M?25?-M !1110 4444 %%%% 'I/PB_P"8O_VQ_P#:E>DUYM\(
MO^8O_P!L?_:E>DT %%%% 'S%XL_Y'/6O^PA/_P"C&K)K6\6?\CGK7_80G_\
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M -GP_P#\O'_ ?ZULUC>'_P#EX_X#_6MFO/K?&P"BBBL@"BBB@ HHHH ****
M"BBB@ HHHH *;+&DT3Q2J&1U*LIZ$'J*=10!XEXM^%_@KPM<1:GJFI75IICA
ME-HC;YI).H"''0#KG/UJ3X=Z)\.-3\207'AZ\U1-2LV\Z.WO'5=^.X &#] <
MUTGQ%BN-,\4Z'XH;2'UG3[!)8I[>-=S1%ND@'(__ %#ZUEVFL?\ "P_B)H>H
M:)H5W8VVEN\MSJ-U$$9P5P(^,@\\8R>IZ<T >LT444 9NL_\N'_7['_6M*LW
M6?\ EP_Z_8_ZUI4 %%%% !1110 4444 <1\5O^15MO\ K]7_ - >O)*];^*W
M_(JVW_7ZO_H#UY)0 4444 %%%% !6EX;_P"1JTG_ *_8?_0Q6;6EX;_Y&K2?
M^OV'_P!#% 'T!1110 5X?\:?^1SM/^P>G_HR2O<*\/\ C3_R.=I_V#T_]&25
MZ^4?[TO1@>>4445]B 4444 %%%% 'K/P-_YCO_;O_P"U*]:KR7X&_P#,=_[=
M_P#VI7K5?$YI_OD_E^2 ****\T#QVBBBOJ "BBB@ HHHH *]*\)_\BO:?\#_
M /0VKS6O2O"?_(KVG_ __0VK@Q_\)>O^8&Q1117C 9FN_P#'BG_70?R-8%;^
MN_\ 'BG_ %T'\C6!7=0^  HHHK< HHHH *FL_P#C^@_ZZ+_.H:FL_P#C^@_Z
MZ+_.IELP.LHHHKS "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-OO^0]I?\ VU_]
M!%:59M]_R'M+_P"VO_H(K2H **** "BBB@ HHHH *^;:^DJ^;: "BBB@ HHH
MH **** /2?A%_P Q?_MC_P"U*])KS;X1?\Q?_MC_ .U*])H **** /F+Q9_R
M.>M?]A"?_P!&-636MXL_Y'/6O^PA/_Z,:LFOT.C_  X^B ****U **** "O0
M_@M_R.=W_P!@]_\ T9'7GE>A_!;_ )'.[_[![_\ HR.N',/]UGZ >X4445\*
M 5YKXL_Y&B[_ . ?^@+7I5>:^+/^1HN_^ ?^@+7?@/XK]/\ (#'HHHKV0"BB
MB@ HHHH V/"?_(T6G_ __0&KTJO-?"?_ "-%I_P/_P! :O2J\;'_ ,5>G^8!
M1117 !S.K_\ (4F_X#_Z"*IU<U?_ )"DW_ ?_015.O2A\* ****L HHHH *F
ML_\ C^@_ZZ+_ #J&IK/_ (_H/^NB_P ZF6S ZRBBBO, **** "BBB@ HHHH
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M ./Z#_KHO\ZAJ:S_ ./Z#_KHO\ZF6S ZRBBBO, **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** *=Y:2375M<P,H>WW85\X.X8[4O\ Q,/^G7_QZK=% %3_ (F'_3K_
M ./4?\3#_IU_\>JW10!4_P")A_TZ_P#CU'_$P_Z=?_'JMT4 5/\ B8?].O\
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M$G&4Z<U7_P"%+:;_ ,_MU_W]7_XBO3J*[5C\2E938'F/_"EM-_Y_;K_OZO\
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M ./4?\3#_IU_\>JW10!4_P")A_TZ_P#CU'_$P_Z=?_'JMT4 5/\ B8?].O\
MX]1_Q,/^G7_QZK=% ")NV+OQNQ\V.F:6BB@ HHHH **** "BBB@!D\2SV\D+
MDA9%*DCK@C%58[.YAB2..\PB*%4>4. *NT4 5/L]Y_S_ '_D$4?9[S_G^_\
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M$7_? H^OR_E \I^Q77_/M-_W[->@>&)4M_#EK%.ZQ2+ORCG!'SGL:UOLEO\
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MH^R6_P#SPB_[X%% $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTTZ]N?B':7+LJ3W.DQV5N9 AYV,RG<O'? Q5Z\\-^#_!_P .+;2/%3^9IB3
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MLFG:A:ZMIL%_I\OFVUP@DBDVE=RGH<$ C\:LUS?P[_Y)QH/_ %Y1_P JZ2@
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M>N4N#X!7P'X8F\0^2+=8HOL1A\SS!)L!./)^;.1S[]>:YB!M?/QS\1?V5_9
MOS%^[_MGS,>3A?\ 5[>^W'X9]Z /1/$WBE&^&NHZ]X7U".0QPEH;B,!PK @=
M&'7V(K'\+?%/06\/Z5%XCUZ :O/"&FW1D ,2?O%5V+QCKBN(T6U:#X8>/)(]
M0L+NVF=65-/6810R9.]1YB+Q@IC!/ &3TS<G&BG]F5-@M?- 7&,;_M'F\^^[
M&?P]J /8-5UO3=$TTZAJU[#:VHP!*[<,3T ]3["L_0/&_ASQ1,\.AZI%<RH-
MQB*M&^/4*P!(]Q7DFL^<%^&0\39_LP11^;YH^3.5QOS_ +.W.>V?>M[QN(S\
M;/!_]B^5]NW+]I\K[WD[OXL?[&_\/:@#UNBBB@#@=0M_B+JFO:D;34K3P]I=
MM_QZ.T,<YN1SRQ.2@XR>F,C@\UFZ5\2K[4?@OJOB*<1P:C9%K82*HVM(0FUP
MIX_Y:#CID>G%5?'_ (JU7Q/KTO@3P4A:8@KJ%UG 1?XESV S@GN>![[;^%_"
M?@OX:II/BJ3S=-\T/<2L)!YLQ[XCY'3 ^@[T 9O@:^\1^(H=-O+GXB6DDS[9
M[G24L;<R>6&Y0D$,N5[XXS75ZA\1/"FE7UY9ZAJ\<%Q9$">-HI,@D9 'R_,?
M]W-><?$#3=%TC4/!USX&M[6"^FN5\@V?69,K@MC[W)QD\GD5I^%;6&?]H;Q1
M+-&KM#;Y0L,[2?+!(]\<?B: .MD^*7@N/3X[UM>@\F1BJA8W+Y'7*!=PZCJ*
MW(_$&DRZ#_;4=_ =-V&3[3NP@'3\\\8ZYXKQ_P"%]C:R:=X]=[>-F4/&"5!P
MN)>![<#\A6!,;@_LWP>1N\L:P?.QTV8;K[;MM 'K_P#PMGP1]E:X_MV/RUD$
M9_<2[LD$_=VYQP><8]^:[&O$?C0="_X0'P[_ &7Y.[>OV39C/V?RSGIVSL_&
MO;J "BBB@ KR?Q5XQUA_BJWA[3_%%MX>T^WM5:>XG@A=0^W=UDQR=RC&17K%
M<*-,^'6L>+M526VL[G6$5OMJW(<[1T)&_P"7(]5Y Q0 :GK^H>"OAS>:OJ.M
MQ>)+EG!M+A;=(4;=M55PA((!W-G//2N?_P"$I\7^%;KPU?>)=4M]2T_7&59H
M%M4B:T+8(PR\M@-W]"/0UPUO#>7'P9\1I;!Y-,M-5C>V/) 7.&Q[<H?Q)KJ?
MB++#K6@> ;/3Y5FFNWC,:H<G!5%SCV)Q^!]* /1]3^('A?1]2N[#4]6CMKJS
M56FC>-^ P!&#MPQPP.%R?R-56^*7@M=.6].O0>2[E !&Y?(Q_!MW#J.<8KE=
M'M8;C]IK7WF0.UO8))&2,[6\N!<_DQK+^%MA:RZSX_>2WC8QN8DRH^5&:;*C
MV.U?RH ]9MO$.DWF@_VU;ZA VF["YN2V%4#KG/3'H>:P!\6/!!MI)QKL>R-@
MK#R)=V3Z+MR1QU Q7D-N;D_LWW/D;O+&L#SL?W,+U]MVVNB^+!T/_A4_AS[!
MY&_,7V39C=Y?EG?T[9QGWH ]KCD6:))(SE'4,IQU!IU5M._Y!=K_ -<4_P#0
M15F@ KQGQ%\7+^^\4:5:>%1-;:8UZMO/=2P*?M)W ,J[@<  ]>#SV[^S5Y/\
M7;>&UU7P3#:PQPQ)J)VQQJ%5?GCZ 4 =#\1?%FHZ+-H^B^'S&FJ:S<"&.:10
MPA7*@M@\'EAU]#5+PYXDU_3/B-+X/\4WT6J&2V^T6MZD"PL>,E2J\= W_?/O
M6?\ %$?9/B)X'U*X.RT2\V/*>B'>AY]./Y&F3(-0_:8M)+1Q*MCIY:<IR$S&
MZX/_ '\7\Z *J>+_ !EXFTO7_$_A[4[>QTK27<0V;6R2?:%1=S%G/(.W!X]<
M>]=EIGQ&T:3PCHVLZW<)8'5/W:+L9E\T':PR <#(/)Q7G?@.Z@TSX+>-=.OI
M5ANK=[I)(W."&>%8U'XLI%8FJ:<T/PH\#PW:G%S?RN4(_A=^/S&#^- 'L=O\
M3_!ES/-#%K]ONA4LQ=712!UPQ #?@35_P_XS\/\ BF2:/0=2CNY(1ETV,C >
MN& )'N*\Y\>6-J_QR\(P-;Q&(Q1@Q[!M(5WP,>@P*LVJ-%^TAJ_V1521],R,
M# +>7'R?QQ0!V=W\1?"5CK#:7=:W!'=HVUDVL54^A<#:#[9K3T'Q%I?B?3C?
MZ'=?:K82&,OY;)\P )&& /<5Y1\*SI ^&7B<ZQY?VD22_;OM&-VS8-N<_P"U
MNQ_M9K?^ W_).Y?^O^3_ -!2@#TNBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH IZMI-EKFESZ;JD/GVDX DCWLNX @]5((Y [T[3-,M-
M&TR#3]-B\FUMUV11[BVT?4DD_C5JB@#+\0>&M)\4Z>EEKUI]JMXY1,J>8Z8<
M @'*D'HQ_.J.M> ?#'B&:&;6-)CN)8$$:/YCHVT= 2I&X?7-=%10!B:-X.T'
MP]J$][HNG)9SW"".3RW;:RC&/DSM'3J!GKZFL^7X8>#9M3-_)H-N9V;>?F<(
M3_N9V_I75T4 9.N^%M$\2VD=MK>G0W447^KSE63_ '64@CZ TFB^%=%\.Z?+
M8Z-I\=K!-_K0K,6?C'+$DGCWK7HH X\_"?P288HCH,>V(DK^_ESUSR=V2/8Y
M%=(VDZ>^D?V6]E UAY?E?9B@V;?3%7** .:TCX=^%-"U(7^EZ-##=*<K(SO)
ML/JH8D+^%=+110 5QDWPC\$7$\DTVBEY)&+NQNY^23DG[]=G10!@V'@CPYIN
M@W&BVFEQ_P!G7$AEEMY7:4,^ ,Y8DC[HZ=,5'H?@'PQX;OS>Z-I$5O<X($I=
MY&7/7;N)V^G&*Z*B@#*L/#.D:9K=[J]C:>5?7W_'Q+YCG?SGH3@?@!4&E^#=
M!T73[ZRTRP\FWU#/VE/.D;S,@@\EB1P3TQ6Y10!R&M>%3IW@.31/!VDZ?-%O
MR;+4&D>-U));#%LALX()/&*\^C^&VKZO)IMBO@^S\,VD-PL][="_%PTV.RC<
MS <G"D]2.:]PHH **** "BBB@#F-3^&_A'6-3;4-0T2&2Y=MSNKNF\]RP4@$
M^Y%;5SHVFW>CG2;BRA?3S&(_LVP! HZ  =,=L=*NT4 8.@>"/#GA>>2?0M+C
MM9I!M:3>SMCT!8D@>PJ?3O"VCZ3=:G<Z?9^5-JSF2];S7;S6RQS@D[>7;ICK
M6O10!A6'@KP_IGAZ[T.QL/*TV\9FG@\Z1MY8!3\Q;<.%'0]JR/%/ABX@\"Q:
M'X2T?3;RVB;!L=0:1@4R3E6W@A@QSDGUYKM** /%['X=:IJ.N:(/^$2M?#&G
M:=<"YN&%^+F2X8%3@$$G'RX )XR>:]HHHH **** ,J\\,Z1?^(+36[NT\S4;
M)=L$WF.-@Y_A!P?O'J*-?\,Z/XGLTMM=L8[N*-MR;B593[,I!'YUJT4 9NA^
M'=)\-6)M-#L8[2$MN8)DECZEB23^)K*/PW\(MK1U5M#MS=F3S"VYMF[.<[,[
M>OM73T4 95_X9TC4];LM7OK3S;ZQ_P"/>7S'&SG/0'!_$&D7PMHZ^*&\1+9X
MU5D\LW'FORN-N-N=O0>E:U% &+;^&-/TJZU74M#M(X=3U$,TLLSNZ2/R067=
MP,GG;BO)[CP-XAF@OX1\/=)@U&\W1C4K:_VPQ*W!*PL[8.,\C'7I7N5% &-X
M1T-O#7A+3M(>197M8MKNO0L22V,]LDULT44 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !61K7A;1_$-U8W.L6?VB;3W,ELWFNGE
ML2I)PI&>57KGI6O10 5D2^%M'F\40^(I;/=JL"&..X\UQM7!7&W.WHQ[=ZUZ
M* .5D^&7@Z;4I;^30;=IY22^6?82>IV9VC\!6C:>$M#L?#K:#!IZ'2V))MI7
M:1>3D\L2>O/7K6S10!SFB?#_ ,+^'+[[;H^D107."!*SO(5SUQN)Q^%)K/P]
M\*^(-0^W:MH\4UR<;I%=XR^/[VTC=^-=)10!D:CX4T35= CT2]L$;38MNRWC
M9HU7;TQM(-4+3X<^$K'6$U2UT2!+M&WH^YBJMZA"=H/OBNFHH RM=\,Z-XFM
M5M]=T^*\1#E"V0R?1@01^!IN@>%-$\+PO'H.G16@D^^RDLS>F68DG\ZUZ* "
MBBB@#$\1>#M"\6?9_P#A(+(W?V;=Y0\^1 N[&?NL,]!UK-TWX7^#](U*#4-.
MTCR;JW??%)]IF;:?7!<@_C76T4 <SJWPY\)ZWJ37^IZ+#+<L=SR*[Q[SZL%(
M!/UJYJOA#0=;T2WTC4=.1]/MG5X;>-VB5" 5&-A'9CQ[UM44 9&J^%M'UK5;
M#4M3L_/N].<26LGFNOEL&# X! /('4&G/X9TB3Q-'XA>TSJD4?E)<>8_"X(Q
MMSMZ$]JU:* /(]9\+Z[-XNN]1O?A_H^ML7S;75O>FW!P?E:5'<ASC&1M'0\U
MU'PO\(7GA'PU-#JIC^VWERUQ*L396/( "Y[],_C7:44 %%%% !6)X@\&^'_%
M+1MKVF17;QC:DFYD<#.<;E(./;/>MNB@#.T;0-+\/:?]AT:RBM+?)8H@SN/J
M2>2?K63;?#?PC9ZP-4M]#@2[5_,5MS%5;.<A"=H_ <5T]% &7<>&M)NO$UMX
M@GM-VJ6D1AAN/,<;$(88V@[3]]NH[TRT\+:/8^)+K7K6S\O4[M/+GG\USO7Y
M>-I.T?=7H.U:]% &!#X6L]#L=6?PO96\-]J :1Q=/))%+)SC>"W RQSC'6O*
M9_ /B"ZTN[L8/A_I>GW]VVU]3BU#,2)N!^2)G8KTQD=L\5[K10!G>']*&A^'
M-/TM7\S[';I"7_O$#!/XFM&BB@ K+U7PUI.MZAIU[JEIY]QIDOG6C^8Z^6^5
M.<*0#RB]<]*U** ,_6M"TSQ%IYL=:LX[NW)#;'R,'U!&"#[@U7\/^%-$\+0R
M1:#I\=H)2#(0S,S8Z99B2?SK8HH YG4?AUX3U76&U2_T6&:[=MSON<*Y]64$
M*?Q'-:&K^%]&UV2Q?5+(3'3W\RUQ(R"-N.RD _='!]*UJ* ,B[\+:/?>)+77
MKJS\S4[1/+@G\UQL7YN-H.T_>;J.].@\-:5;>);KQ!;VNS5;N(0S7'F.=R@*
M -N=H^XO0#I6K10!XO>>$/$3:G?W%S\/=&O-0G+"'4;2^,4*$Y_>&%W.3WZ
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M;5;Z2T@?[/#A6F=PH/L!ELD]  :F\702W/@G7(+:)YII=.N$CCC4LSL8V
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M!4U2]DT_2Y[J"SFO98EREO /GD/H*Y/PAXHU>ZL_$UUXG2.)],N6_P!&AP1
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M:96C<*[OD$<$<'VH FU)]0U;X=Q'P]*US>7,, 2:&Z$9(++O;S,\?+NY&3Z
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M$9E'E[RC #;N7H<>HXK*7Q%K$\MKIVH^(;?1#:Z?#<ZCJ$L<0+339*1+O&P
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M/8#'2KOPQTC4]+TS4?[3GN\2:A.4@N(%C_C/[T84$[NOIZ4 =O1110 4444
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MPI.51OO,3@#@XSR*R=%U?4[3Q+K.BW]XVM+86L=TDZ0JDJEMW[E@H"ECM!&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>abvx-20241231_g16.jpg
<TEXT>
begin 644 abvx-20241231_g16.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MNY&Y$5W=R222 ^H7S$KS/Q-\(_!%Y;_$#2?#T>L6.M^"D\R6^U&='@OPC[)
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MTK_P"B_^)KR?[07\IZ'U-_S'Y'45^N/_  @GAK_H7M*_\ HO_B:/^$$\-?\
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M+NWT^"2^0PV&I2:O;(MO& ER[!F?A>1D#Y3Q[5^HO_"">&O^A>TK_P  HO\
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MTK_P"B_^)I_7H;<@?59?S'Y@Z]\8?%OB9-774-6:;^UKN&^NV6&-&>:)0L;
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M04(1A?EQL7.W&<<YJQI_Q]\;Z;XDUK6X]626[UK9_:$<UI$\%SL "EHBNS(
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M'-PV-TJ';\C$#!VXK]//^$$\-?\ 0O:5_P" 47_Q-'_"">&O^A>TK_P"B_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(!SN..%HU3X#VFJ>%?%6CMJTT,VM:Z^OP7T40$EC.3&5V<\X\O&<CACTK/\
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M "GW-9&A_M":3XFT_P +'2=+OK[5O$'F/%I<93S+:!)&C>>9L[4C!3KG)S@
MFN'\*? 7QC\/;[P'K%IK:ZW<:7*T-]IS010;8+G+71\[.92KG< W7'&.E4?A
MQ\!/$GPIT3PEXBT6SW>+H)Y8=>TY[Q3'>6<DA^56)VAD549<$<DYSTH$?0/A
MGQ,GB7^U=EN;?[!J$U@<S1R;S'CYOD8[<Y^ZV&'<"N'\#?&N_P#'\.G7NG>!
M=9&BWLQC75))[81(JR%&<KYF[ *MVSQ6I\)?">I>%%\9?VE"L/\ :7B2]U*V
MVN&W02%-C'!X)P>#S7DGP=^$VL>!)-!74OAFDVIVMTS2Z\GB!1M5Y6/F>0#@
M[4;&WOM]Z!GT%%XPT&XCMI(];TZ2.Z$A@9+N,B41\R%#GYMN#G'3'-&E^+M"
MUNXE@T[6M.OYXHUFDBM;N.1D0@$.0I.%((P>G-?/^D_"_P 2>%?$_B_Q;>Z#
M8P6&NV.I!K.&=6?1\J2K#YMK>=MR^SH2.W%<]X.^$OB/X@>!O"CV&CV7A:WM
M_"MW:C5(;A2=3>YA41AU0;E .6;=W8XSU(!]/6OC;P[?:?<7]MK^EW%C;N(I
MKJ*\C:*)R0 K,&P"20,'N15&Q^(6E:IX@-A9W%M=V0T]M0_M."\A>':LIC9<
M!]W!!RV-HP1G/%?/[_ ?Q3JG@7Q/:/H\]IJ-Y8:;I\=O<W]F8YQ#<QR.0L$*
M* JJP5G8N0<$=*Z[XK?!'5_$^N:]'X<MK72],N?"0TNV,16*,7 O1.8MB]%9
M003C'S&@#V&U\:>'K[3?[1MM=TRXT_S1!]KBO(VB\PD )O!QN)(XSGFB'QIX
M>N='GU:'7=,ETJ!BDU\EY&8(V&,AG#;0>1U/>OG[_A1_B'5M#U<SZ+-;S:AJ
MFE22V5_>V<@D@MWS(Q2WACC7Y25')+ #(&.=+Q-\&-?_ .$@U_4=,T>SNM.7
MQ-I^M6^CF:.*.^ABMC'*F/NJV]MPW8!*Y]* /;I_&WAVUT>#5IM>TN'2IVVP
MWTEY&L$AYX5RVTG@]#VIGB+QOHGA?3UNK_5+*#SHFEMHI+E$:ZPN[$0)&\D8
MZ>HKPSQ-\*?%>K2>'M;MO"UII(M;G4'ET#1[BU#HLX0)*6GC>%G.PA\#H1M[
MBH?^%)^(] 335@\.VWB2"7PJV@FWO]0C<Z;,97DW;V10Z8<+\BY^0=N:!'J^
ML?&'3](^#\/Q!>PNI=/EMK>Y6S0KYV)G1%')VY!D&>>U-\+?&&VUGQ#J&A:S
MHU_X3U6RL1J3Q:JT7EM;;MAE$B.RX#<')'\\<IXF^&&OZI^RW9^"8;5&U^.Q
ML+=X/.55#131,X#YQP$;G/:KOBCX)VVA>"_$S^$=/75O%&HVT=N)O$%PUZ98
MUD5C'F<LHX#$ C;N"D]*0SJM>^,G@_0-"M]8?7;&]L)[R.P2:QN8YE\UR!@L
M&P  =S$G@ FKUC\0-,F_MR6\GM],L=*N%@DO;F\A$3@HK!LAOD'S 8?!]N17
M@$OP1\62Z?XEN6T#[5+<:UI.J6ME>W=J99D@&V9&,:K$K$=@ N#C)Q6IXH^#
M/BS5I-9O[:R\K=XHM]:BT^&X@WS0K;",A3(K1AU8G =<''TI@>\W'C3P]9V-
MO>SZ[ID%G<HTL%Q)>1K'*BXW,K%L,!D9(Z9%9=Y\5/#-GXD\/:)_:EO->:[&
M\MDT,J-&Z+T;=NQ\Q^5<9W$''0UY1X1^".J6NO> KO4=)!L+&]UB^OK6^NH+
MG[.UPB"(!8XT3EE+;44A2>#Z4O"OP9\1>')OAO+-X=M+X:2VK6U[%]IC7[/'
M<7!>"0'NJ@DX7+#/ S0(][T?Q;H?B&ZN+;2M:T_4[BVXFAL[J.5XN<?,%)(Y
M]:UJ\ ^!_P ,/%7@CQE$]SIO]G:!!826Q2^GMKN56+@JEM-&BRB+@DB3';@G
MFO?Z0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[0?^/&
M7_KZN?\ T>]:-9V@_P#'C+_U]7/_ */>@#1HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!&4,I!&0>"#21QK$BHBA$48"J, "G44 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <[
MXG\;6WA>^L[:>RN[K[1&\S26XCVPQK)%&S/N=3UF3A03@'CBFWGBB7P_X=EU
M'5[<%TN98O+A>.$%!*ZQG,TBKR@4_>YSD#M6Q?:/9:DX>ZM8KAA&T0,B@G:6
M5BOT)1#_ ,!%7* *>CZG'K6EVU]$A2.= ZJSHY /NC,I_ D5<HHH *XS5O%6
MKV/B@Z7'%8^5<P2/:32>9M5T,0*N0,,Y#R$1K@XC'S?/\O9UC77@W0[Z[N;J
MXTJUFN+E=LLCQ EON\_7Y$YZ_(O]T8 &^#=>D\2>';>_FB$$[/+%)& 5P\<C
M1ME3RIRARIR5/&3C-;=5M/TZVTFSCM;.".VMX\[8XUP!DDD_4DDD]R2:LT %
M%%% &%XTU;4=%T.6[TR&&XN(@SF&17=G549MJ(O+,2%'48!+<[<&OX=\57&N
MZ]>6IMH8[%-/L[ZVN(IO,,PF\W)/   \L8ZYR3QTK6UC0]/\06ZV^HV<5Y"C
M;U65<[6P5R/3AF'N&(Z$U/!I]M:SM-#;QQ2M$D)9% /EH6*+]!N; [9- %BB
MBB@ HHHH \\D^(&LVD6I1RV%G/=V<]GN,<CQQ^1.^W>I8$R!2&4,  Y!X7!K
MT.LBS\):-IUO-!;:9:P0S,C2(D8 ;:<H/HIZ#H.U:] !1110 5R_BKQ'J.BZ
MKIL%G#:W8N9$46>6-Q,"X$K+C"HL:'>6;()(7Y203U%95]X7TK4M6@U.YL89
MM0@55CN&'SJ%;<!GT!.: ,/X>>-KKQ:EY'>VPM[JW2"5@L,L07S5)\LB0 ED
M*LI/0XZ#D#L:S]'T'3O#]N\&FV4-E"S;F2% H) "C\@ !Z  #@5H4 %%%% !
M1110 4444 %9V@_\>,O_ %]7/_H]ZT:SM!_X\9?^OJY_]'O0!HT444 %%%%
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M$G )0D#)P#U- &U15>XU"VLV"SW$<+$9 =P"147]M:?_ ,_L'_?P4 7:\_\
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MSAAW]#BD,X.'X^:WIOB6\U#45MKGPT]QKEM%86\&VXA&G1E]_F%L,9 CY!
MRN#UK?M_VCX6O#%<>$M7M(8YM/6XN));=EACO2%MI"%D))+$Y4 E<'/85>F\
M ?#.XU;6-0DO+9I=4BNHIHCJA\I/M*A;AXX]^V-Y !N90"<?6K,WA+X=3K=!
M[ZT(N?L D_XF'7[&VZW_ (N-IZ^O?-.S[ )X=^.5KXB\2Z/IT.A:A%I^L7=[
M::?JLCQ>5.;4/YK;0V]1NC8#(YZ\5Z;7@/A/X9Z=H_Q2M/$+^*-%-C97E[=V
MEG9W$N2URK*5\MYFCC^^Q/EJ-S8.!TKW'^VM/_Y_8/\ OX*5@.&^*WC/Q'X3
MUCPA%I5I:#2M0UFTL;Z\GDS)MEDV^7''CJ1DER>.@!SQP-W\>/$.E>*M2NIT
ML[C0%U#6=+AT]8"LR-86S3"4R[OFWF-P5VX *X[UZ_XDM?#OB2/3QJ=U Z6%
M[#?P?Z1LVS1G*$X/.#V/!KG8_ ?P_C\57>OF2WDO+HS,\,E\S6X>9!'-(L);
M8KNBA68#)'U- '#>$_CUKFD[K7Q+;)K][=)H\MF-)@6W.^_20B$AWVX1H\!B
M1D-D]*VK7]IK2X[<W6J^'M4TFS%OJ$@FD:&3=+9$"XB4(Y/!.%8X!/IUK3T7
MX8?#K0((HK:X5_)O+6]CDN-3>5U:V!%N@9G)\N,$@)TY-&K?#GP->:/):V]Q
M8I,L>I"W:ZN#-$KWN3.73>-RECG&1CL1181N> _B6_C'7-4T>ZT&]T+4-.M;
M6ZEBNY(I R3^84VF-F' C.<XY..U=O7CWP7^'\?P]O\ 6M3U#7K&_NM2@M;8
M+;W,TJHD D )DFD=R3YF,9PH4 5ZI_;6G_\ /[!_W\%(9=HJE_;6G_\ /[!_
MW\%']M:?_P _L'_?P4 7:*C@N(KJ,20R++&>C(<CCBB@"2BBJ^H:A;:387-]
M>SQVMG;1M--/,P5(T4$LS$]  "2?:@"Q16%X3\<:%XXM9I]#U*+4(X2!($!5
MD)&1N5@",\]1V/I6[3VW X_PIX)N= OK)[B\BN+;3+*33K!(XBK>4[HQ,A).
M6 BB7C'W2>^!TFK,T>GS%6*'@;E.#R0.M7*I:Q_R#I?^ _\ H0I ']DP_P#/
M2Z_\"I?_ (JC^R8?^>EU_P"!4O\ \55VB@"E_9,/_/2Z_P# J7_XJN7^)TDW
MAWP#KFI:?=75O>VUN7BD^T.VULCG!)!_$5VM<5\:/^25^)?^O0_S%- ?*?\
MPO+QU_T,=U_WRG_Q-'_"\O'7_0QW7_?*?_$UPM%:$G=?\+R\=?\ 0QW7_?*?
M_$U[S^SKXDU7QWH>K7&N:C=7LT%RL<;>:8]JE<X^3&>:^3*^H?V1_P#D6=>_
MZ_$_] I/8$>V_P!DP_\ /2Z_\"I?_BJ^%_VA_C]\0/ OQD\2:'H?B:ZLM+M'
MA$,&R.38&AC8_,RECRQ/)[U]ZU^9/[6G_)PWB_\ ZZP?^DT5>SD].%6O)5(I
MJW7U0I;$7_#57Q5_Z'"Z_P"_$/\ \11_PU5\5?\ H<+K_OQ#_P#$5Y/17UWU
M3#_\^X_<C.[/H3X2_M'?$CQ-\3_"FD:EXJNKG3[[4[>WN(?+B7?&T@##*J",
M@]0<U^@7]DP_\]+K_P "I?\ XJORT^ __):O W_89M?_ $:M?JQ7RF<4X4JD
M%3BEITT-(GF?QJU*]\(^$[>]TF]NK6Y:\2(OY[OE2CDC#$CJ!7B'_"V?%W_0
M=NOT_P *]G_:._Y$.U_["$?_ *+DKYKJ<'3A*E>44S:)UO\ PMGQ=_T';K]/
M\*/^%L^+O^@[=?I_A7)45W^QI?RK[BK'UC\+99O$?@/2]1U&ZNKB\F$GF2?:
M'7.)74< @= *ZK^R8?\ GI=?^!4O_P 57)_!+_DE^B_2;_T<]=S7R];2I)+N
MS)GCUQX@U..XE5=0N@%8@?O6]?K4?_"1:I_T$;K_ +^M_C52[_X^IO\ ?;^=
M0UZ"A'L4:/\ PD6J?]!&Z_[^M_C6_P""[Z[U;6&@N[RZEB$3-M\]QSD>A]ZX
M^NI^'/\ R'W_ .N#?S6LZD8J+:0'H']DP_\ /2Z_\"I?_BJ/[)A_YZ77_@5+
M_P#%5=HKSB2E_9,/_/2Z_P# J7_XJB+3S;7<<D4DIBVL'629WR>,8#$^]7:*
M "BBB@ K.T'_ (\9?^OJY_\ 1[UHUG:#_P >,O\ U]7/_H]Z -&BBB@ HHHH
M AN+R"S"&>>. .VU3(X7<<9P,]3P:FKY\_:?\-OXHU[PM9V-K?7NJ_9KMEBA
MMK.:(6^^ 2G_ $J:)5<DHORELJSAE(KW/P_:BQT'3;95F58;:.,"X</(,*!\
MS D%N.2#@FK<;),F^K0[6-%M->M5M[R-V1765&CE>)T<=&5T(93UY!'!([U)
MINFVVCV$%E9Q"&VA78B DX'N3R3ZD\D\FK5%044D_P"0S-_U[I_Z$]7:I)_R
M&9O^O=/_ $)ZNT %%%% 'R[^UQ_R,^A?]>;?^AFO!J]Y_:X_Y&?0O^O-O_0S
M7@U:+8EA1113$?HCI?\ R#+3_KBG_H(KAOVAO^2'^-_^P7-_Z#7<Z7_R#+3_
M *XI_P"@BN&_:&_Y(?XW_P"P7-_Z#58?^-#U7YE/8_*^BBBOTXP"OM;_ ()Y
M_P#('\;?]=[3_P!!EKXIK[6_X)Y_\@?QM_UWM/\ T&6O)S7_ '2?R_-%1W/K
MVOE+XX?\E0UGZ0_^B4KZMKY2^.'_ "5#6?I#_P"B4KY/+_XK]/\ (Z([G"44
M45] 6=!\/?\ D?/#W_80@_\ 1@K[(KXW^'O_ "/GA[_L(0?^C!7V17A9A\<2
M)'+_ !%_Y%]?^NR_R->8UZ=\1?\ D7U_Z[+_ "->8UC0^ $%%%%= SU;P)_R
M+%K]7_\ 0S705S_@3_D6+7ZO_P"AFN@KRJGQ,EA1114"(K>W6W5E3.&=G.?5
MB2?U-%2T4 %<M\5)H+;X8^+9KJQ74[:/2;IY+)Y3$)U$3$H7'*Y'&1R.HK%^
M+7QAM/A0VAK=6L<W]J7(A\ZYO([2&)=\:,Q=^"P\T-M_NJ[9 4FJWCK5)_&'
MPALO$>GS)H]M+9+JLS:A=W5H8+=[9BX9K9@^]5?H,@$9'(4U<8O1DM[HY[]F
M&ULH='UV6VU2QUBXFN$>:[M;ZZNGYWL%=IT4CYF<@ =68GDU[;7C?[-]V;C2
M]:62]DN)UFC+0W%WJ4\L0PP^87Q++RK#"\95@>5('JUYK$%C?6EI)'=/+<DA
M&AM)9(UQC[[JI5.O\1%.I\3".Q>JEK'_ "#I?^ _^A"L3PU?:I-XL\2V>H7<
M=Q#;F![:.&+8L2.'.WJ2QX&23UZ #BMO6/\ D'2_\!_]"%9E%VBBB@ KBOC1
M_P DK\2_]>A_F*[6N*^-'_)*_$O_ %Z'^8IK<#X9HHHK0@*^H?V1_P#D6=>_
MZ_$_] KY>KZA_9'_ .19U[_K\3_T"D]AH]ZK\R?VM/\ DX;Q?_UU@_\ 2:*O
MTVK\R?VM/^3AO%__ %U@_P#2:*O=R3_>)>GZH4MCR*BBBOM#([OX#_\ ):O
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M/,%$DBJ SXZ9/?&3CZU7UC_D'2_\!_\ 0A5VJ6L?\@Z7_@/_ *$*S++M%%%
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M7_H K1H *\\_:&_Y(?XW_P"P7-_Z#7H=>>?M#?\ )#_&_P#V"YO_ $&M\/\
MQH>J_,3V/ROHHHK]., K[6_X)Y_\@?QM_P!=[3_T&6OBFOM;_@GG_P @?QM_
MUWM/_09:\G-?]TG\OS14=SZ]KY2^.'_)4-9^D/\ Z)2OJVOE+XX?\E0UGZ0_
M^B4KY/+_ .*_3_(Z([G"4445] 6=!\/?^1\\/?\ 80@_]&"OLBOC?X>_\CYX
M>_["$'_HP5]D5X68?'$B1R_Q%_Y%]?\ KLO\C7F->G?$7_D7U_Z[+_(UYC6-
M#X 04445T#/5O G_ "+%K]7_ /0S705S_@3_ )%BU^K_ /H9KH*\JI\3)844
M45 @HHHH \#_ &DM6MVU;05L_%FAZ+JFE>9</#<7VGP7XW-$5$1NU8)NC649
M&WYC&2=H-:WC3Q1IOA#]G=KKQ!>Z3#J&MZ+Y4U[.%FL[V^>Q9BTCQC$@<1$!
MA][Y57)*BN6^.WP;\9>//'_]HZ%HVC6]DL$2_P!L6>HR6&K.PZJ90CH4'0!D
M;K7KNK-'X:^$=P^MZ8VLIINC%[O3I2MTUQY<.7C)V*LA.TC.P YSM'2M]+1,
MM;LY/]G6[T:\TC6'TFWTN.3SH_M$UAXH.OO(=F%#S-\RA0,*I.,9QCFO7J\S
M^"/Q6LOBE8:K+9Z;960L9EBDFTR[6ZMI6.X$+($7)&W/3[KH?XL#TRLYWYG<
MN.P52UC_ )!TO_ ?_0A5VJ6L?\@Z7_@/_H0J"B[1110 5Q7QH_Y)7XE_Z]#_
M #%=K7%?&C_DE?B7_KT/\Q36X'PS1116A 5]0_LC_P#(LZ]_U^)_Z!7R]7U#
M^R/_ ,BSKW_7XG_H%)[#1[U7YD_M:?\ )PWB_P#ZZP?^DT5?IM7YD_M:?\G#
M>+_^NL'_ *315[N2?[Q+T_5"EL>14445]H9'=_ ?_DM7@;_L,VO_ *-6OU8K
M\I_@/_R6KP-_V&;7_P!&K7ZL5\?GG\6'H:QV/*_VCO\ D0[7_L(1_P#HN2OF
MNOI3]H[_ )$.U_["$?\ Z+DKYKJ,#_!^9M'8****]$H^K_@E_P DOT7Z3?\
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MS?\ 7NG_ *$]7:I)_P AF;_KW3_T)ZNT %%%% !1110!G>'?^1?TO_KUB_\
M0!6C6=X=_P"1?TO_ *]8O_0!6C0 5YY^T-_R0_QO_P!@N;_T&O0Z\^_:"1I/
M@CXU5%+,=+F 51DGY:WP_P#&AZK\Q/8_*VBK/]FWG_/I/_W[;_"C^S;S_GTG
M_P"_;?X5^G71@5J^UO\ @GG_ ,@?QM_UWM/_ $&6OC+^S;S_ )])_P#OVW^%
M?:/_  3YMIK?1_&OFQ/%F>UQO4C/RRUY&:O_ &2?R_-%1W/KFOE+XX?\E0UG
MZ0_^B4KZMKY2^.'_ "5#6?I#_P"B4KY3+_XK]/\ (Z([G"4445] 6=!\/?\
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MM':>7JVKF>ZO9O/VM?2HS?N@S2)&O W9!P,J*>H'HW_#.GP__P"@&W_@9/\
M_%UU7@_P'H?@.UN+?0[,V<,[B213*\F6 QG+$]J\"^&.N7,W[0EUNU*2<7=]
MK4,EF+R1[J-8Y$\O[5"3LCB4 B(J 2&7/4U].T %?F3^UI_R<-XO_P"NL'_I
M-%7Z;5^9/[6G_)PWB_\ ZZP?^DT5?09)_O$O3]41+8\BHHHK[0R.[^ __):O
M W_89M?_ $:M?JQ7Y3_ ?_DM7@;_ +#-K_Z-6OU8KX_//XL/0UCL>5_M'?\
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M )#,W_7NG_H3U=H **** "BBB@#.\._\B_I?_7K%_P"@"M&L[P[_ ,B_I?\
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M,NM(^VVQTE[:W72-/2YNIM);3Y5O5$@EMFR!YVS@^9R27.6.1CZ$HH ****
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MJ\T16:T>W6%2B,(D# '"$D<\]">M>HUFA=6&<&R'_ 7_ ,:7&K?WK+_OE_\
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M!/\ ]C1]KU+_ *!\?_@3_P#8UHT4 9WVO4O^@?'_ .!/_P!C1]KU+_H'Q_\
M@3_]C6C10!GZ/#/#!.;B-8I))WDVJ^X $\<UH444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %9V@_\ 'C+_ -?5S_Z/>M&L[0?^
M/&7_ *^KG_T>] &C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5G:#_QXR_\ 7U<_^CWK1K.T'_CQ
ME_Z^KG_T>] &C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>abvx-20241231_g17.jpg
<TEXT>
begin 644 abvx-20241231_g17.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M)FC^XTLB*'D*X&"Y/(!ZT[Q#\<?&_BJQ@M-3UQ[B"*>.Y.VWBC:66/&QY65
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M,]II*SPIJ!D^X986D,493.?W8Y(KV>BB@ HHHH **** "BBB@ HHHH ****
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M3?\ H(6O_?Y?\: +U%0V]Y!>*7MYHYU!P6C<, ?3BIJ "BBB@ HHHH ****
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M444 %%%% !1110!G:7_Q_:Q_U]+_ .B(JT:SM+_X_M8_Z^E_]$15HT %%%%
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M1]NO_P#H&_\ D=:T:* ,[[=?_P#0-_\ (ZT?;K__ *!O_D=:T:* ,[[=?_\
M0-_\CK1]NO\ _H&_^1UK1HH SOMU_P#] W_R.M'VZ_\ ^@;_ .1UK1HH SOM
MU_\ ] W_ ,CK5FQNUO[&WND4HLT:R!6Z@$ X/YU8K.\._P#(OZ7_ ->L7_H
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M5LO^?RW_ ._J_P"-']JV7_/Y;_\ ?U?\: +5%10W,-RI,,J2@<$HP/\ *I:
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MKA!)#<0MN213T(/<5;K&\'^&8?!OAFPT6VGFN8+./RTEN""Y&2><#WQ^%;-
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MP&R.N:8'F]UX^\2>._"7B?2O"T\D/C"=9;F""Y'V;[+;E%V1Q.5(,H5X=V[
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M6/\ KSF_] -?%=>K@J-.JI.:N5%'M/\ PTS??] .W_[_ +?X4?\ #3-]_P!
M.W_[_M_A7BU%>E]4H?RE61[3_P -,WW_ $ [?_O^W^%>T>$=<?Q)X:T[5'B6
M![J(2&-3D+GMFOBZOK[X5_\ ).] _P"O5?ZUY^,HTZ4$X*VI+1U5>0>+/^1C
MO_\ KI_05Z_7D'BS_D8[_P#ZZ?T%<6'^)B1D4445W%!7H'PQ_P"/6_\ ]]?Y
M&O/Z] ^&/_'K?_[Z_P C6-;X&)G;4445YI(4444 %%%% &=I?_']K'_7TO\
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M !1110 4444 9VE_\?VK_P#7TO\ Z(BK1K.TO_C^U?\ Z^E_]$15HT %%%%
M!1110!G2?\C!#_UZR?\ H:5HU7:T#:@EUNY6)H]N/4@Y_2K% !1110 4444
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M[B@KT#X8_P#'K?\ ^^O\C7G]>@?#'_CUO_\ ?7^1K&M\#$SMJ***\TD****
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M-%=7U6C_ "CLCZ6^#_Q2U;Q_J6H6^HP6<*6\2R(;9'4DEL<Y8UZE7SY^S/\
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MM (S69\)_#>HZ*VKWFI"]\[4FCN0;BX5XOFWMA4VAT<;L,'SP$ 9MI->@T4
M%4K_ /X^M-_Z^#_Z*DJ[5*__ ./K3?\ KX/_ **DH NT444 %%%% 'R9^U?_
M ,E'L?\ L%Q_^C9:\7KVC]J__DH]C_V"X_\ T;+7B]:+8EA1113$>S_LH_\
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M/AC_ ,>M_P#[Z_R->?UZ!\,?^/6__P!]?Y&L:WP,3.VHHHKS20HHHH ****
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M\-71Z/X[\3:/9ZA:^$]1DF\/O<ZK<Z=>ZI%+>NT-O9V\BHC.X8J9FF7))_B
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MKI!*OF?OB6;:2"GRJ. >:FC_ &;8$TN>U;73))<64-M-*UF/FD747OI) -_
M=Y"H7^$ <FMO3OB1JM[JUU9O%#!)->2V]C')$,%(;MH96+"0GB-6?#*O0XR
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MM TN]MU@N--M)X%(81RP*R@A0H(!'4* /H,5;AMXK=2(HDB#8)"*!G  '3V
M'T J2B@ HHHH *BNK6&]MY(+B&.>"0;7CE4,K#T(/!%2T4 9UQX<TFZMT@GT
MNRFAC(*1R6Z,JX4*, CC@ ?0 58M]-M+2XGG@M889Y\>;+'&%:3 P-Q R<#U
MJS10 4444 %,DB29=LB*ZY!VL,C@Y'ZT^B@"A?:#IFJ8%[IUI=@,7'GP*_S$
M $\CK@#\A4]OI]K9S3RP6T,$MPV^:2.,*TC>K$=3]:L44 %%%% !4%Y8V^I6
MKVUW;Q75O)P\,R!T;G/(/!J>B@#/NO#^EWRQ+<:99W"Q$F-98$8(3C)&1QG
LZ>E6+6PM;)YWM[:&!IW\R5HD"F1SU9L=3[FK%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>abvx-20241231_g18.jpg
<TEXT>
begin 644 abvx-20241231_g18.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U$U_\
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ML;P#G:!FI?&'Q&\&^-+SQ5!_PE-K;+-<Z)>PWMQ9SJEPMM;[)U55C)5\GA2
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M_P#T/<?_ (*3_P#'J/\ AWC/_P!#W'_X*3_\>K[.HH^N5_YOP0?5J78^,?\
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MX_\ P4G_ ./5]G44?7*_\WX(/JU+L?&/_#O&?_H>X_\ P4G_ ./4?\.\9_\
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M+L;8PW$9%TP^]LP?G([XS4KWFD: LD3SV6FJL;73HSI$ @(#2$<< D9;IR*
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M_P#OVW_I+#7CU>P_M=?\G$>+_P#?MO\ TEAKQZOTO"?[O3_PK\C)[A11174
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M_P"2@:!_U^1_SK["KX]^&/\ R4#0/^OR/^=?85>#F'QQ]")!1117E$A1110
MV3_5M]#7PS7W-)_JV^AKX9KVLN^W\OU+B%%%%>R4%%%% !7V/\//^1#\/?\
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M_DXCQ?\ []M_Z2PUX]7Z7A/]WI_X5^1D]PHHHKJ **** /T\_91_Y-\\'?\
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M1W'^HD_W3_*@"KH7_(#T_P#Z]X__ $$5>JCH7_(#T_\ Z]X__015Z@ HHHH
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M\MKU+]J#_DOGC/\ Z_!_Z+2O+:_3\-_ I^B_(P>X4445TB"BBB@#]2OV:?\
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M3C"*H[]<9/4DG)K5HHH *S]7CD9K&1(VD$-P'<*,G&UAG'U(K0HH J?V@/\
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M?V@/^?>X_P"_9JW14 5X;P32!?)F3W="!15BB@ HHHH **** "BBB@ HHHH
M**YO7O'%KX?U&2UGM+J18X%GDN(PGEH&$I4'+;B3Y+] >H_#GK/XD:I=/]@D
MTV&'5VENEBC4LZ3)"[IN7'/WT*L.2N5/\0% %'XV>'=9UR\\.3Z/:7E]+9R2
M.L,13[,TI:+;]HS(K!-HD^9<XY[X!X70?"_Q,TFXNQ8MJ.EM<W"I?7+203F>
M54U%WGC$N\!79K!<X!X P IKVR^\47&EQWES<Z7<FTC,:P^5L\R3=G<<,PQ@
M@=?6I;SQ!/&NA2P6F8-1F5)#,X5X5:,L.!D%LC'7'7D\9 / O'?CSXD> ]!D
M?5-6N+:22">2TF$5B)I;K[!;ND.UE"M&)S<KM4&0[4 W=_I2U9VMXC)_K"@+
M9&.<<UQ%Y\0;^Q^SM-IBJINIH)1%OFP$FCC495<*Q$A;+?+E=O.<BQ;>,M3N
MY)6M[*UNHC:M=QHDK*8U(5HO-;!"EP3\H!("EN<X !VE%<E;^)-7OKI$M;>U
ME1M,2_9/F#HSC]VF<X.XK)] G/6NMH **** "BBB@ HK.UO61HL,#?99KR2>
M98(X;?8&+$$]690!@'O7"ZK\7VL89K^*P631_L,ES%=.Q!#".,QAQV4NYC)'
M1@.Q) !U'Q%TVYUCP+KMA9_:OM%S:20K]A*B?##!\LLRC=@G&2/K7@]OX+^(
M5E>:=/9:9>V\MK%_Q+)EF15MXTFOF?SXS(5\R9)+3(PPR,?+MP/?[?5=4?4(
M8&T\F$W+I)< ;0D00E6P3R2XV\9Z9Z$&C1?$Q\06%U/::?<0S0_*D-XR)O;&
M1RC/@>_Z&@#QW5+[XL>'-)U;4)M2N)XK>WF(:\@LU1 +&&42Y5%^9;@SH-QV
MX4;@1\U=Y\$_%-]XO\,ZE?7E[<:C NIS0V5U<B#?);J$"DF >6W.[E>^1VQ5
MZ/X@206>EWM[9QQ6EYH_]HETERWF9A'E@$  9F W$_7 &:IVOQ%O=4T*TU"Q
MM[*:2:"$B%)6<RW#*[&WCP.3@+\QX4$L1@&@#T"BN/U#Q5JJQZHEM:VB75MJ
M::?!%*[.)P\<3*Q(QM_UA)ZX52>:Z>QDN)8&-S&L4OF2*%7IM#L$/XJ%/XT
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BB@#LK6TAL81%;Q+%&"3M48&3R:FHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>abvx-20241231_g19.jpg
<TEXT>
begin 644 abvx-20241231_g19.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTOPEJ\-[:6D=G+-+IDS!EBNI+B,@8QSYA1E((*CW-?HC]LG_ .>K?G7&:?\
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MFL_!7P[X@\40^(-0TE+C5(_+^<W$BQ.8]WEM)$&$<C)O;:SJ2N>"*PXOV8/
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MVLGEQQF+RC$HE.Q 7#,FT[@ >B^&/A[#X36\2R3;'<-'MC+9$4<<*0QQKGG
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MFK%%% !1110 4444 9?]LG_GE_X]_P#6H_MD_P#/+_Q[_P"M6;10!I?VR?\
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M ,>_^M3FU<JJGROO#/WO<CTK+J23[L7^[_4T 7O[9/\ SR_\>_\ K4?VR?\
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M^M674B_ZE_J/ZT 7O[9/_/+_ ,>_^M1_;)_YY?\ CW_UJS:* -+^V3_SR_\
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MIJIZ7_QYCZFKE !1110 4444 1^1'_SS7_OD4>1'_P \U_[Y%)]JA_YZQ_\
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M^1'_ ,\U_P"^16;XBUBR\,Z4]_=0M(@DB@2.% 7DEED6*-%S@99W51D@#/)
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M\]8_^^A1]JA_YZQ_]]"@!?(C_P">:_\ ?(H\B/\ YYK_ -\BD^U0_P#/6/\
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MGC?5];U*776M;W5;JXGFNUAE>4QRP^3Y#*TWE%%C6(#]V#^YCR3CD ]1\/\
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M@#A?#/Q4.N:#-<3:3'!J$>LVVC^68Y8D=I8X)2X$L:. L<YX91DQG'45A_\
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MP L^$OC1K&N>%?%&H74%M%?V<,$MO;+$-EJTTDL2QS,LK9,;1_.I", ,D#<
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MUWHH@D6\LM2TJ:Y6X6'RBLUO.L,V5W'"NTJ[1GCRVY.> #8HKIJ* .9J1?\
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MID@B0% ?O2NJYZ GG !K/TGXT>%-;OM2L[358&N-.?R[I92T0C;[3<6V-S@
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M_P#/"+_O@4?8K?\ YX1?]\"J']L2?\\U_6C^V)/^>:_K1=@7_L5O_P \(O\
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MXBNK)+B^N\PK>>4XM\+(ZDEB?,M00"<[H>N4KT?0_&UEXFTJ#4])NK74M.N
M3%=6T@>.0 E3A@<'D$?A1=@;WV*W_P">$7_? H^Q6_\ SPB_[X%4/[8D_P">
M:_K1_;$G_/-?UHNP+_V*W_YX1?\ ? H^Q6__ #PB_P"^!5#^V)/^>:_K1_;$
MG_/-?UHNP+_V*W_YX1?]\"C[%;_\\(O^^!5#^V)/^>:_K1_;$G_/-?UHNP+_
M -BM_P#GA%_WP*/L5O\ \\(O^^!5#^V)/^>:_K1_;$G_ #S7]:+L"_\ 8K?_
M )X1?]\"C[%;_P#/"+_O@50_MB3_ )YK^M']L2?\\U_6B[ O_8K?_GA%_P!\
M"C[%;_\ /"+_ +X%4/[8D_YYK^M']L2?\\U_6B[ O_8K?_GA%_WP*/L5O_SP
MB_[X%4/[8D_YYK^M']L2?\\U_6B[ \PL?B%=FQ\=-'/8:L-+6 VE[#;*L<3S
M,Z%9%!)7RF4%HW^< 98X9<:/A/QS/XC\6>+](O[<:#%:I$FF&\T]X9,L+@,^
M9%"RDB R@)P%Z]&-:US\2-$U?0_%)N8C/IVDR2V&HQ7%NX#D0H[(JL!O#+*H
M&.&SQFI5^*VE);>(YG:2&#PZ&_M"2:"0",+$)6*Y'S@+W7(R",DBB[ \]D\9
M>+]$\.Z%KFH2V%QI^J6OVCR_LB1W$$3L\F]UX4-'"81N+",.7#<,I'I'@OQ)
M!XJU+4ECMXWL3;6>H6DC0A66*XB)$;C^^"A8^TBCMD\]9_M!Z!?36D2QSB:Z
MCWQ)L5M[&5XD12K$,6>-@"I*],L"P!ZK2O$-F^J:S!:V\<5Y'.C7GRX:1FB3
M:_N-@5<_[!'\-%V!T?V*W_YX1?\ ? H^Q6__ #PB_P"^!5#^V)/^>:_K1_;$
MG_/-?UHNP+_V*W_YX1?]\"C[%;_\\(O^^!5#^V)/^>:_K3FU:150[%^89[^I
M%%V!=^Q6_P#SPB_[X%'V*W_YX1?]\"J']L2?\\U_6C^V)/\ GFOZT78$VJ6+
M_P!GW/V"*TCO?+/DO<0[XU;'!9002!Z C/J.M<-H?B?4-8T7X?D6UG%J.N:4
M;^YDEAQ$9!;(WE@=1F256]=L;CW'5ZAXG72[&>[N$/DPH7?RHWD? [*J@LQ]
M  2>U8+?$+1M2T_PYJKQ>='?)]OL&\IFD13;NYDVCD?NV93[N%_BHNP.%\5?
M$[5]'^%7A'4XVTJ/7-0BCEU*=XTBCMU-I<2A@CL=HDE@\M0Q.XDH&!.]="Q\
M?ZGI?C6+2O$$5N+.^NMMLUK;*'C\YE6WA?=C#*KJ[I\S@D-S'DKO:I\<M#TG
MP?H_B2<R#3]6"?8T:,QRR;HVD *N5VG8C':<'(V@%B 9]%^+VE>)M6O-*LHY
MI+RWFGADC*;2/*.QVSG@;B%YPV2#C!!HNP-SP'J \2^#M(U.ZMH%N;B!6E,<
M8".PX+K_ ++$;A[$5O?8K?\ YX1?]\"N>\-^(K.]\.Z9/I,$<>F/;1FVC1-@
M2/:-J[?X<# QVQBM+^V)/^>:_K1=@7_L5O\ \\(O^^!1]BM_^>$7_? JA_;$
MG_/-?UH_MB3_ )YK^M%V!?\ L5O_ ,\(O^^!1]BM_P#GA%_WP*I2:M(CE0B\
M4W^V)/\ GFOZT78%_P"Q6_\ SPB_[X%#65O@XMXL]LH/\*H?VQ)_SS7]:CN-
M?:UMY9GBRD:EV$:,[$ 9X49)/L!DT78'&:7XFU3_ (0JQN=0AL3JT_B&72)9
M[>VV0I&NHR0;@K$D9C0*"2<LRGOBLS6/'.K:/X&U^YG32CKEOK'V* +&(8H[
M8W4$3S'>3\L4<VYI#E1MW%<?+6\OQ)TK7M'GDO+"6(6^H6]E+97<6)8[EFB>
M$8!(SF2%P0?ESS@J<2:5\6K76M(U&^M-.OY'L;E;26R^S-]H\UEC95V9^7*R
MQD[B-F3OV;6P78'GG_"UM9T&RTS6=9%G-H-Q L\LEK;(95B1HT,BC(4^9)O
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MT 87]GW'_/,_F*/[/N/^>9_,5NT4 8DMA.TC$1DC/J*;_9]Q_P \S^8K=HH
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MOQ2_X0N2!9;26\S;3W\YBVCR;6 QB:7D_,5\Y/E')&?3GI_L$GJOYFL;Q!X
MTWQ4]LVIV_GM;[@FV>2/*L5+1OL(WQL43<C95MHR#B@#<_M2X]5_*C^U+CU7
M\J9]@D]5_,T?8)/5?S- #_[4N/5?RH_M2X]5_*F?8)/5?S-'V"3U7\S0 _\
MM2X]5_*G/J4ZJA!7D9/'N:B^P2>J_F:?)8R;4Y7A<=3ZF@ _M2X]5_*C^U+C
MU7\J9]@D]5_,T?8)/5?S- #_ .U+CU7\J/[4N/5?RIGV"3U7\S1]@D]5_,T
M<Q;_ !2^T>-+CP_]DE012M;"\.W8TZP17!CVYSCRYE(;IE6'&!NZK^U+CU7\
MJPX? &FP>))M>2WQJ<H(>3SY"F2J(6$>=@<K&B[PN["@9Q6S]@D]5_,T /\
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<=^3DU8JMI\9AMPIP3D]*LT %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>abvx-20241231_g2.jpg
<TEXT>
begin 644 abvx-20241231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+L17AI9@  34T *@    @ ! $[  (
M   +   !2H=I  0    !   !5IR=  $    6   "SNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M36%T="!%<&QE>0    60 P "    %    J20!  "    %    KB2D0 "
M S,X  "2D@ "     S,X  #J'  '   !#    9@     '.H    !
M
M
M
M
M
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M#=-[8S7BWPEF,/CC7I221'$S8)]"35'P]H[?$_X@:C-K5U-]FA8D*C8(&?E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;+4%VWMI#./^FB FEL].L]/398VL, [^6@&:2WBY:V&^O+I<\:^-426MYH$
M.!&54?@:[OQ:<?">X]/L0_\ 0:ZV>SMKDJ;FWAF*]#(@;'YT]X8I(O*>-&CQ
MC85!&/I4M-TY0[NXTTIQDNBL>9_ D@^#9\'/[X?RKT^HH+:"U39;0QPK_=C0
M*/TJ6M)2YG<B,>56"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'YT .HIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT
M.HIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN
M]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P
M_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>
MO]X?G0 ZD(!Z@'ZTF]?[P_.C>O\ >'YT * !T 'TI:;O7^\/SHWK_>'YT .H
MIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?
M[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.
MC>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]
MX?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0
M ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 ZBF
M[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .(!ZC-(%4= !^%)O7^\/SHWK_>
M'YT .HIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT
M.HIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN
M]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P
M_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>
MO]X?G0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?
MG0 ZBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 Z
MBF[U_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 ZBF[U
M_O#\Z-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 ZBF[U_O#\
MZ-Z_WA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_
MWA^= #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^=
M #J*;O7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 ZBF[U_O#\Z-Z_WA^= #J*
M;O7^\/SHWK_>'YT .HIN]?[P_.G4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7+^.M-L6\'ZI.UE;F;R@?,,2[OO#OC-=16!XX_P"1(U/_ *Y#_P!"
M% "VNCZ=;*KVUG%"S(,M&H4GCVJS]EB]&_[Z-21_ZF/_ '!_*G4 0_98O1O^
M^C1]EB]&_P"^C4U% $/V6+T;_OHT?98O1O\ OHU-10!#]EB]&_[Z-'V6+T;_
M +Z-344 0_98O1O^^C1]EB]&_P"^C4U% $/V6+T;_OHT?98O1O\ OHU-10!#
M]EB]&_[Z-'V6+T;_ +Z-344 0_98O1O^^C1]EB]&_P"^C4U% $/V6+T;_OHT
M?98O1O\ OHU-10!#]EB]&_[Z-'V6+T;_ +Z-344 0_98O1O^^C1]EB]&_P"^
MC4U% $/V6+T;_OHT?98O1O\ OHU-10!#]EB]&_[Z-'V6+T;_ +Z-344 0_98
MO1O^^C1]EB]&_P"^C4U% $/V6+T;_OHT?98O1O\ OHU-10!#]EB]&_[Z-'V6
M+T;_ +Z-344 0_98O1O^^C1]EB]&_P"^C4U% $/V6+T;_OHT?98O1O\ OHU-
M10!#]EB]&_[Z-'V6+T;_ +Z-344 0_98O1O^^C1]EB]&_P"^C4U% $/V6+T;
M_OHT?98O1O\ OHU-10!#]EB]&_[Z-'V6+T;_ +Z-344 0_98O1O^^C1]EB]&
M_P"^C4U% $/V6+T;_OHT?98O1O\ OHU-10!#]EB]&_[Z-'V6+T;_ +Z-344
M0_98O1O^^C1]EB]&_P"^C4U% $/V6+T;_OHT?98O1O\ OHU-10!#]EB]&_[Z
M-'V6+T;_ +Z-344 0_98O1O^^C1]EB]&_P"^C4U% $/V6+T;_OHT?98O1O\
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M_P"^C4U% $/V6+T;_OHT?98O1O\ OHU-10!#]EB]&_[Z-'V6+T;_ +Z-344
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M]EB]&_[Z-'V6+T;_ +Z-3X/I1@^E $'V6+T;_OHT?98O1O\ OHU/@^E&#Z4
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MY_S_ ,GYTX>+]<_Y_G_.L(4\5FZ-/^5?<!NCQ=K?_/\ /^=.'BW6_P#G^?\
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MK?K \<?\B1J?_7(?^A"@"]'_ *F/_<'\J=38_P#4Q_[@_E3J "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM<W)4?-!?9O;Y_\  )WCS/T^XOW/C"QU&SN;;4M+BP<BW:$;2OIFKB#/PMC
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M#>K'BI!48IXJ&(>*6D%+68!1110 4444 %%%% !1110 4444 %%%% !1110
M59T__D(P?[]5JLZ?_P A&#_?H ZRY_X]V_"M"#_CWC_W16?<_P#'NWX5H0?\
M>\?^Z* )**** "BBB@ HHHH **** "BBB@ HHHH **** "L#QQ_R)&I_]<A_
MZ$*WZP/''_(D:G_UR'_H0H O1_ZF/_<'\J=38_\ 4Q_[@_E3J "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'CC_ )$C4_\ KD/_ $(4 7H_]3'_ +@_E3J;'_J8_P#<'\J=0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?^A"@"]'_J8_]P?RIU-C_P!3'_N#^5.H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $(4 7H_]3'_ +@_E3J;'_J8_P#<'\J=0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7(^.M0T.QFT@:]ITEZTMP%M
MRAQY;Y')YKKJXOXA>&]2\0S:*VF1+(+2Y$DNYPN%R/6@#LXR#$A48!48'H*6
MFQ@K$BGJ% /Y4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH BN?^/=JT(/^/>/_ '16?<_\>[5H0?\ 'O'_ +HH DHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *P/''_(D:G_UR'_H0K?K \<?\
MB1J?_7(?^A"@"]'_ *F/_<'\J=38_P#4Q_[@_E3J "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\\^*M[=6EQX>%I<
MS0"2\ ?RW*[AN'!QUKT.N1\=:AH=A-I U[3I+UI;@+;E#CRWR.3S0!UD7,$>
M?[@_E3J2,@Q(5& 5&!Z"EH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;!1112&%%%% !1110 5@>./^1(U/_KD/_0A6_6!XX_Y$C4_^N0_]"% %Z/\
MU,?^X/Y4ZFQ_ZF/_ '!_*G4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!XIXI@IXK-@/6GBF"GBH8#UIXJ,4\5FP'T4"BH **** "BBB@ HHHH ****
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M'NW;2!UIMWJ=Y?\ E?;)S+Y0PF0!M%;8\"7@_P"7J/\ [Y-.'@:[_P"?J/\
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M/16Q_P (Y/\ \]E_*C_A')_^>R_E0!CT5L?\(Y/_ ,]E_*C_ (1R?_GLOY4
M8]%;'_".3_\ /9?RH_X1R?\ Y[+^5 &/16Q_PCD__/9?RH_X1R?_ )[+^5 &
M/16Q_P (Y/\ \]E_*C_A')_^>R_E0!CT5L?\(Y/_ ,]E_*C_ (1R?_GLOY4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M <AX[U'1K!],_MNR:Z,DX6';_ W/-=>/NKCI@8KB?B)X<U#Q!)I)TY%86UR)
M)-QQ@<UVPX51Z #]* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT&VTN"1I8[=2 S#!/.?ZUIU4M9,4=D%8'CC_ )$C4_\ KD/_ $(5OU@>./\
MD2-3_P"N0_\ 0A4C+T?^IC_W!_*G4V/_ %,?^X/Y4Z@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#SKXKWUS9R:']EN)(?,NU#;&QN'/%
M>B+]Q?\ ='\JY'QWJ.C6#Z9_;=BUV9)PL.W^!N>:Z\?=7'3 Q0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 17/_ ![M7G/Q*_Y"UI_UP'\J]&N?^/=J\Y^)7_(6M/\ K@/Y
M5Z&7?[PO1G)B_P"$<73E1I&"QJS,>BJ,DTVKND+.^KVZV;A)BWRL1G;ZFOI&
M[*YY!V.D6FJV/A:$?:QII\TL_GMC*_[IY-8WB74-(NK9([..*6\5OWES#&8U
M8?0U:O%T74-0-E>ZG?3W1?R_/=24#^PSTKF+VT:QOI;9R"8VQD=QZUPTH*4^
M:6^^UO\ ASJG)QCRKT*]/C_UR?[U,I\?^N3_ 'J[CE/H2Q_Y!]O_ -<E_D*G
MJ"Q_Y!]O_P!<E_D*GKXR6[/H5L%%%%(9XY\3/"GBK5/&EOJ?ANRY@C&RY0@,
M&R>.:I*?C.J8)=CZE8ZZ;QYXYUNW\10^&?!MJDVI2IN=WZ*/3VZ=:YJR\8^.
M=/\ #NJ7,^V[O--NE6X1CN"*"=P_2IA91\O^#;]2I7<O/_@'K/A<ZJ?#=I_P
MD'_(0VGSLXZY/I[5K5D^%]=C\2^&K/5H4V+<)DKZ$'!_45K5I._,[F<?A05@
M>./^1(U/_KD/_0A6_6!XX_Y$C4_^N0_]"%247H_]3'_N#^5.IL?^IC_W!_*G
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112[3Z'\
MJ $HI=I]#^5&T^A_*@!**7:?0_E1M/H?RH 2BEVGT/Y4;3Z'\J $HI=I]#^5
M&T^A_*@!**7:?0_E1M/H?RH 2BEVGT/Y4;3Z'\J $HI=I]#^5&T^A_*@!**7
M:?0_E1M/H?RH 2BEVGT/Y4;3Z'\J $HI=I]#^5&T^A_*@#B/B)X<O_$$FDG3
ME5A;7(DDW'&!S7;#A5'H /TKSOXKWEU9R:']EGDA\R[4-L.-PYXKT10=B\'[
MH_E0 44N#Z&C!]#0 E%+@^AHP?0T )12X/H:,'T- "44N#Z&C!]* $HI<'TH
MP?2@!**7!]*,'TH 2BEP?2C!]* $HI<'THP?2@!**7!]*,'TH 2BEP?2C!]*
M $HI<'THP?2@!**7!]*,'TH 2BEP?2C!]* $HI<'THP?2@!**7!]*,'TH 2B
MEP?2C!]* $HI<'THP?2@!**7!]*,'TH 2BEP?2C!]* $HI<4E !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRCLKA8X)Q.&&<KVK*Z8 -2N_^>[_ )T\:C=_\]W_ #JF >RG\JMV-C-?S^7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 444R::*WB,L\BQQKU9C@"@!]%4TUC39'")?V[,QP 'ZFG3ZG86TI
MCN+R&*0=5=\$4 6J*KIJ%G);M/'=1-"APT@;@5&NKZ:[A$O[=F8X #]30!<H
M/0USGC+Q;!X6T.:\1H9KB+&+=GP6]JI^%_B7H'B=%C2<6EV1@P3':2?]GUH
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M "BBB@"*Y_X]VKSGXE?\A:T_ZX#^5>C7/_'NU><_$K_D+6G_ %P'\J]#+O\
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MAA]:ZNB@ JSIW_(1@_WQ5:KND0M-J4>W^$[C^% '7'J:2EI* "BBB@ HHHH
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MW_/Y#_WS_P#7KV.BC^U\5W7W >.?\*@U;_G\A_[Y_P#KT[_A4.K?\_D/Y?\
MUZ]AHI?VMBNZ^X#Q\?"/5A_R^0_E_P#7IP^$FJ_\_</Y?_7KUZBE_:N*[K[@
M/(Q\)M5'_+W#^7_UZ</A1JG_ #]Q?E_]>O6J*7]J8GNON \G'PJU3_G[B_+_
M .O2_P#"J]4_Y^XORKU>BE_:>)[K[@/*A\+=3_Y^HORI?^%7:F/^7J+\J]4H
MI?VEB._X >6CX8:G_P _47Y4X?#+4A_R]1?E7J%%+^T*_?\  #S'_A6>I?\
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M>R?E78T4O:S X\>$;L?\MD_*G#PG=?\ /5/RKKJ*7M) <F/"ET/^6J?E3O\
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M]3'_ +@_E3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+QM_9?_"&W_P#;^[^S
M\+YVSKUX_6MVN9^(NGW6J_#_ %.RL(C-<2JNQ!U/S"@#4\.?8_\ A&M/_LO=
M]C\A?)W==N.*TJQ_"5K-8^#]+MKI#'-%;(CH>Q Z5L4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M (6'X6_Z"\/YT?\ "P_"W_07A_.N7_X4+X?_ .?NY_S^-'_"A?#_ /S]W/\
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M^OR[!]7RC_GY+[CJ/^%A^%O^@O#^='_"P_"W_07A_.N7_P"%"^'_ /G[N?\
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M^-'_  H7P_\ \_=S_G\:/K\NP?5\H_Y^2^XZC_A8?A;_ *"\/YT?\+#\+?\
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M^OR[!]7RC_GY+[CJ/^%A^%O^@O#^='_"P_"W_07A_.N7_P"%"^'_ /G[N?\
M/XT?\*%\/_\ /W<_Y_&CZ_+L'U?*/^?DON.H_P"%A^%O^@O#^='_  L/PM_T
M%X?SKE_^%"^'_P#G[N?\_C1_PH7P_P#\_=S_ )_&CZ_+L'U?*/\ GY+[CJ/^
M%A^%O^@O#^='_"P_"W_07A_.N7_X4+X?_P"?NY_S^-'_  H7P_\ \_=S_G\:
M/K\NP?5\H_Y^2^XZC_A8?A;_ *"\/YU)!X\\,7,JQQZQ;AF.!N< ?G7)_P#"
MA?#_ /S]W/\ G\:@O/@#I$ENPL]2GAE_A++N!_6CZ_+L'U;*'I[67W'J4<D<
MT8DA=9$;HZ'(/XTZO _#NNZ[\+_&0T/Q [2Z?,X&7<E0.SH3_*O? 0R@CH1D
M5Z%&LJL;H\_'X&6#FM>:,M4UU"BBBMSS@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@"*Y_X]VKSGXE?\A:T_ZX#^5>C7/_ ![M7G/Q*_Y"UI_U
MP'\J]#+O]X7HSDQ?\(XNMOP]KE[8WUO;KJ$T%H7^9%;"Y]ZQ*V[+P\VJZ9%)
MI<BS7>_$D!.&4>M?05.3E]_8\J-[^[N=+Y_B[_A(_.^UO]D\W.?-'E;,]?3I
M7':U(LNM73QR&12Y^<G.36VVE)I4?E>(-;E0 <VELY<X]".,5S=T8#=.;0,L
M.?D#=<5A0C%2O'MT5C>K)\NO5]R&GQ_ZY/\ >IE/C_UR?[U=9S'T)8_\@^W_
M .N2_P A4]06/_(/M_\ KDO\A4]?&2W9]"M@HHHI#/,_$?B[6Y?B;9Z!H;"*
MV@3SKIN[ 9)'TP*X6_\ $'C#Q1KFN:OH>IM;V6CL66,=-HSC'Y5U_C_P3XF?
MQ7_;_@[RY)9H3#-&[A<9R"?R-9\?P]\3Z)\.&TO2PC:EJ4P%YAONH>V[\341
MORWZK\V_R2+E;FMT=ON2U^;9Z1X'UR7Q)X,T_5+@ 2SQG?CN02,_I6_6-X1T
M+_A&O"MCI6_>;=,,?<G)_4ULUM.W,[&4?A05@>./^1(U/_KD/_0A6_6!XX_Y
M$C4_^N0_]"%047H_]3'_ +@_E3J;'_J8_P#<'\J=0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** (KG_ (]VKSGXE?\ (6M/^N _E7HUS_Q[M7G/Q*_Y
M"UI_UP'\J]#+O]X7HSDQ?\(XNG)(\3!HG9&'=3BFT5](>0;=OXIO1&(=0CBU
M"#ILG7^HYK)N9(Y;EW@B$,;'(C'1:BHJ8PC%W2*<I-684^/_ %R?[U,I\?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MONL6W&W\:;XW\!IXM>TNK>]>PO[1MT5PHSC\/PKKZ*GVL[J5]MBNK?<\QO\
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M0Z6L_GB+^/&,UMT45$I.<N:6X))*R/'OC_\ \@O3/^NW]#7H?A+_ )$[2_\
MKW6O//C_ /\ (+TS_KM_0UZ'X2_Y$[2_^O=:]+ ;L]K&?\BNAZLV****]4^?
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (KG_ (]VKSGXE?\
M(6M/^N _E7HUS_Q[M7G/Q*_Y"UI_UP'\J]#+O]X7HSDQ?\(XNBBBOI3R HHH
MH *?'_KD_P!ZF4^/_7)_O4@/H2Q_Y!]O_P!<E_D*GJ"Q_P"0?;_]<E_D*GKX
MR6[/H5L%%%%(84444 %%%% !6!XX_P"1(U/_ *Y#_P!"%;]8'CC_ )$C4_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@"*Y_X]VKSGXE?\A:T_ZX#^5>C7/_'N
MU>=?$L$:K9DC@P#'Y5Z&7?[PO1G)B_X1Q5%%%?2GD!1110 4^/\ UR?[U,I\
M0S,@'7<*0'T)8_\ (/M_^N2_R%3U!9<:?;Y_YY+_ "J>OC);GT*V"BBBD,**
M** "BBB@ K \<?\ (D:G_P!<A_Z$*WZP/''_ ")&I_\ 7(?^A"@"]'_J8_\
M<'\J=38_]3'_ +@_E3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "G)_K%^HIM*HRP'J: /,?A>I7QWXY)4C
M-Z,9[_,U>FUQO@SQ,=<\3>)+$Z?;VHTVY$8EB'S3<D9;CKQ794 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#T.:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"*Y_X]VK0@_X]X_\ =%9]S_Q[M6A!_P >\?\ NB@"2BFM
M(B'#NJGW-)Y\7_/1/^^A0 ^BF>?%_P ]$_[Z%'GQ?\]$_P"^A0 ^BF>?%_ST
M3_OH4\'(R* "BBB@ HHHH **** "BBB@ K \<?\ (D:G_P!<A_Z$*WZP/''_
M ")&I_\ 7(?^A"@"]'_J8_\ <'\J=38_]3'_ +@_E3J "BBB@ HHHH ****
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M_;G_ +^M_C3QJ%[_ ,_MQ_W];_&J@IXK-QCV MC4+W_G]N/^_K?XTX:A>_\
M/Y<?]_6JH*>*AQCV MB_O?\ G\N/^_IIXO[S_G\N/^_IJH*>*S<5V MB^O/^
M?RX_[^FG"^O/^?NX_P"_IJJM/%9N*[#)HII8F=XI7C:0Y=E8@L??UJ<7UW_S
M]S_]_#544X5FXKL(M"]N_P#GZG_[^&GB]N_^?J?_ +^&JM/%9N*&61>W?_/U
M/_W\-/%Y=?\ /U-_W\-514BU#B@+(O+K_GYF_P"_AIXO+K_GYF_[^&JHJ1:S
M:0%A;RY_Y^9O^_AI_P!KN?\ GYF_[^&JPIXK-I 61=W/_/S-_P!_#3A=W/\
MS\2_]]FJXIPK-I 61=7'_/Q+_P!]FGBZN/\ GXE_[[-5UIPK-I 6!=7'_/Q+
M_P!]FGBYN/\ GO+_ -]FJXIXJ&@+ N9_^>\O_?9IXN)_^>\G_?9JN*>*S: G
M%Q/_ ,]I/^^S3Q<3_P#/:3_OLU *<*S8%@7$W_/:3_OHT\3S?\]I/^^C5<5(
M*A@3">;_ )[2?]]&GB>7_GJ__?1J 4\5FP)A-+_SU?\ [Z-'G2_\]7_[Z-1B
MEJ '^=+_ ,]7_P"^C1YTO_/5_P#OHTRB@!_G2_\ /5_^^C1YTO\ SU?_ +Z-
M,HH ?YTO_/5_^^C1YTO_ #U?_OHTRB@!_G2_\]7_ .^C1YTO_/5_^^C3** '
M^=+_ ,]7_P"^C1YTO_/5_P#OHTRB@!_G2_\ /5_^^C1YTO\ SU?_ +Z-,HH
M?YTO_/5_^^C1YTO_ #U?_OHTRB@"1;B9&!65\C_:-=!H^J-='R+CF0=&]:YN
MK>EDKJ<)'K0!U]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIZATN5 :>*W_ !-9-_:=M#;6'V=Y% 6->=QJ]I/@W4;?5+26_MU>W9_G4')
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% $5S_P >[5X#^T;_ ,AO1?\ K@?Y"O?KG_CW:O ?VC?^0WHO
M_7 _R%;4/C,JOP'C%%%%>@<84444 %-D_P!4WTIU-D_U3?2@#[LT'_D6]-_Z
M](O_ $ 5?JAH/_(MZ;_UZ1?^@"K]>4]ST%L%%%%(84444 %%%% !6!XX_P"1
M(U/_ *Y#_P!"%;]8'CC_ )$C4_\ KD/_ $(4 7H_]3'_ +@_E3J;'_J8_P#<
M'\J=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M<)XA_P"$7U3X@6>BZWH"WUY-'E+ESPH].M=W7%:CX7U*Y^*=AKT2Q_88(]KD
MN-V?I0!NV'A'0-*M[B#3M*@MXKE=LR)G#CT/-44^&_@U&5D\/6H93D'YN/UK
MIJ* ,75/!WAW6YHY=6TF"ZDB38C/GY5].#3M/\(^']*M[B#3M*@MXKE=LR)G
M#CT/-;%% 'D.O_!A=4\7EM(C@TK1EB3A,DLV/FQUY^M=MX:^'V@^%4\RPMS)
M=!3FYD/SGCVXKJ*#]UOH?Y4 ?-.M_P#(>O?^NIJC5[6_^0]>_P#74U1K]%I_
M O0044458!1110 4444 %.C<1S(YZ*P)_ TVB@#U;Q_93Z]X0T34]+C-Q##%
MB01\E<@=JY>R\"7L_A6YUJ\E6R2'E$F4@N/8>M4/#_C/6_#<9CTRY'E$Y\J4
M;E'T%2:[XUUOQ)$(M3N%\H'/EQ+M4_45Y4*.)I+V4&N6][];7O:PX[)/H=G<
MM/!\%[,Z/N&\_P"DF+KG\*6S>:;X-W1UG<=LA$!EZ^W6N.\/>,M5\.1O!9/'
M);R'+0S+N7\!2Z_XPU3Q'&D-XR1V\?W885VK^(K%X6IS..EN;FOU]!1TM?H=
MSX[UF^TWPQHD=C</!YD*EBG4\5#;7-RWP9N)$DD:42XW DGJ*XC5_$VH:[:V
MUO?F+R[50L?EIM./>KVA^--2T/3)=/@2&6WD).V5-V":CZI.-%))<W-?\06G
M+Y'3)@_!H>;T-V-V?K4_Q"DO(K'1%TXRBV\E2/*!QNXQTKBY?%&HS:$^D/Y(
MM'D\T@1X;.<]?2M+2?'VKZ78)9XAN88_]7YR;BOXU+P]12YTD_>;MZH%HDO4
MZ#0%UF7QSIS>*U;?Y9\CS"O(P?2HOM.M?\+3QF?_ (^-N,';Y>?RZ5R>H>(M
M2U/5EU&YN"+A/N%. GL*WA\2M<,&W%MYVW;Y_E?-CZU,J%1-226UK=$%MUWL
M=6]__9WC?5?L]@UU:R(HN##C*' J&73K+4O#]Z_AO5+J&- 7EMI =A]>H_K7
M":7XDU/2=1DO;6?=++_K!)\P?ZBM+4?'6J:C8O:*L%M%)]_R4VEOQK"6%J1:
M4?+7T[HJ_O7-^TGG/PC=XG<N)B 5Y(&>E:!6T_X5S8K+/<00LWSM;CYB<GK7
M&:-XNU#1=.>Q@6&2!B2%D3.#3](\7ZEI$<D4/ERP2,6,4B9 )/;THJ8>;<K=
M[DK1+RN=+X@N89='T:(+.[1S+Y<TPY<9IWC_ %6Z@U*VM(YVC@:/YU7^('K7
M)ZIXDU#6;R&>[=1Y)!CC5<*N/:F:MK=WKERLU_Y9=5VC8N!BE&@TXN72_P"(
M_P#([#QP]U%8:4EAY@M?*!_=9QN_"I/$19_#FA27W_'X9%SG[QYKG=,\9ZGI
MUHMJ/*GA7[HF3<5JGJ.N7VK7R75Y(&>,@HH&%7'M41HS32>R=[@MOE8]#N1&
M?'VG>;C_ (]SMSZX&*R;.;4C\1F#F7;OPP(.W;7,7OB'4-0O8;R=T6:#&QHU
MVXQ6H_CO5WV%?(61>KB/EOK62HSBEZ-">JMZ?@;:WDUEXYU%XK1KF-AME"'E
M1ZU.EI9:C8WIT*^N;9MI,L# [3['(KD(_$>HQZN^I)(JSR?? 7Y6_"KUUXRU
M&[M7@588%D&',:8+?C42HSLK=D5?WKF)C;(5;L<'%:2Q:3@9FGSWZ5EYYIXK
MHDA=33$6D_\ /:?]*U-7BT[^R;>7>PO2O"\?,OJ:YH5*SM(VYV+'U)K"4=M0
MZCEKK?"O_("U3_KF?Y&N1%:-CJ]UI]K/!;[-DXP^Y<FIJ*\6D'5,M>&O^1AM
MO]^MK[3,WC[:9&VJY4#/&,5RUE>2V-VEQ!M\Q#D;AD59&JW/]JG4/D\_.?N\
M?E64HWE?R%T?F=9IX \5:ACCY34&C[ET;5'M?^/@.<8ZUA1:[>Q7TMVGE^;,
M,-E>*99:I=6%RTULX#.26!'!_"L>1VMY#ZW\S?\ #33O:7RW6XP;"?G]:E0R
MKX-;[+N^^?N]<5CWGB&\O;<PG9%&WWA&N,UJVVH&R\)HT$B>:)/NDYR/I4R3
MLWZ M&A8&D?P?-]IR<'Y-W6C7D9]/T_8I;CL,UE7VLW6HQK'+M2->0J# J:W
MU^\AM5MQY;*HPI9<D5+[BV-75P5BTI6X(QD?E3/$=W/'<0Q1R%4*#('>LFYU
M:ZO#"9RI,)RI _G3;R^FOY%DN-NY1@;1BH?ZC7Z&SK'_ !ZZ;]12Z]/(NI6B
MJY &#@&LBXU*XN4A679B$Y3"TEUJ$]Y,DLVW<G3:,4^OS#I\CII C>(K8OU\
MG(^M10R11ZM,PDN)'.0Z$<5S\^J7-Q<1SNP62,84J,5:D\17KQ%<1JS#!<+R
M:7_! N6%T(TNTEMG:U>0_,O\-%_;(^CM-974C0)R8W'%95EJES8EO*8,K_>5
MQD&GWFL7-[%Y3;4C_NH,9H>P(H4444 %%%% !1110 4444 %6M,_Y"4/UJK5
MK3/^0E#]: .PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBE'44 4?WE[.ZK(T<,9Q\O5CWIW]G1_\])/SHT[[D_\ UW?^=6Z
M*G]G1_\ /23\Z/[.C_YZ2?G5NB@"I_9T?_/23\Z/[.C_ .>DGYU;HH J?V='
M_P ])/SH_LZ/_GI)^=6Z* *G]G1_\])/SH_LZ/\ YZ2?G5NB@"I_9T?_ #TD
M_.C^SH_^>DGYU;HH J?V='_STD_.C^SH_P#GI)^=6Z* *G]G1_\ /23\Z/[.
MC_YZ2?G5NB@"I_9T?_/23\Z/[.C_ .>DGYU;HH J?V='_P ])/SH_LZ/_GI)
M^=6Z* *G]G1_\])/SH_LZ/\ YZ2?G5NB@"I_9T?_ #TD_.C^SH_^>DGYU;HH
M J?V='_STD_.F.LE@Z.)6DA8X96_A]Q5ZJNI?\>+?6@"6Y_X]V_"O ?VC?\
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MZU:JKJ7_ !XM]: );C_CV/T%> _M&_\ (;T7_K@?Y"O?KC_CV/T%> _M&_\
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MH^\[[VT_K^N@Y+E5MK_U_P 'YGW9H/\ R+>F_P#7I%_Z *OU0T'_ )%O3?\
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MD_XT?\*87_H,C_OR?\:]0HH_M3%_S_@O\@/+_P#A3"_]!D?]^3_C1_PIA?\
MH,C_ +\G_&O4**/[4Q?\_P""_P @/+_^%,+_ -!D?]^3_C1_PIA?^@R/^_)_
MQKU"BC^U,7_/^"_R \O_ .%,+_T&1_WY/^-+_P *:7_H,_\ D$_XUZ?12_M/
M%_S_ (+_ " \R_X4XH_YC(_[\G_&E'P>7_H,#_OR?\:],HI?VEBOY_P7^0'F
M@^#ZC_F,#_OR?\:</A"O_07_ /()_P :])HI?VCBOYOP0'G'_"HU_P"@O_Y!
M/^-*/A(O_07'_?D_XUZ-11_:&)_F_! >=?\ "IA_T%O_ ""?\:7_ (50/^@M
M_P"0O_KUZ)12^OXG^;\@//1\*A_T%?\ R%_]>E'PL _YBO\ Y"_^O7H-%+Z]
MB/YOR X#_A5P_P"@I_Y"_P#KTH^%X'_,4_\ (7_UZ[ZBE]=Q'\WY <%_PK$#
M_F)_^0O_ *]._P"%9C_H)_\ D+_Z]=W12^N5_P"8#A1\-0/^8E_Y"_\ KT[_
M (5L/^@E_P"0O_KUW%%+ZW6[@<0/AP!_S$O_ "'_ /7I?^%=#_H(_P#D/_Z]
M=M12^M5NX'%CX> ?\Q'_ ,A__7I?^%>C_H(?^0__ *]=G12^LU>X''#X?@?\
MQ#_R'_\ 7I1X! _Y?_\ R'_]>NPHI?6*G<#D/^$#'_/_ /\ D.G#P(!_R_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:G_UR'_H0H O1_ZF/_<'\J=38_\ 4Q_[@_E3J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KC[_ %;1HOB98Z?/I/F:G)'F.]S]
MP>E=A7%ZCX7U&Y^*5AKT2Q_8H(]KDN-V?I0!VE%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I1U%)2CJ*
M*>G?<G_Z[O\ SJW533ON3_\ 7=_YU;H 1N%/TK%8[F)/)S6T_P!QOH:Q#U-
M"8HQ2T4 6+(D7( Z$5J5E6?_ !]+6K0 5@7WC/2=.\30Z#<M(M[/MV8'R\].
M:WZ\:^($+'XA7-[$,RZ?;Q7(QUPH)-*Z4E?;6X[-Q=M_^">C#QGI)\6'PXK2
M&_&,X V_G6_QG&Y<^F:\*\+2M-XPTG7KO(DU!))6QUPI(J*#46_M_3-4TZ6:
M-;B]VF2>8-*X]& . /PJDG[L7OU];V);T<EL>UZ=K%OJ=Q=0P+(K6K[',@ !
M/M5YG5$+,ZA5&2<]*\8U.]N1I/BGR[EXV754174X*C>U:$6EKIWC Z9!=7#V
M]_I)EF5GSEOEYJ+^[?R_]MYB[:_UWL>G:=J=GJUI]JT^=)H,X#J>#5KCU'US
M7S]:,;3PCI-M:S2&WO+MENT24#H. 2>G/K6K-=7]OX)U6"*[D2WBOHEMR) Q
MBRQR PX/:K?E_6W^9/K_ %O_ )'MG'8@_0T9'JOYUY5:(OACQLL<-W<M;SZ4
M9YEW98M\O(]^:YK3;YX=?TN]L)9(HKOS<F68-)(-I^]@X'Z4EJTOZW:_0'HF
M_P"MK_J>]9']Y?S%&1W('U->&BVD7P>/$'VZX-[%JWE1G?\ *J[\8K9N_LFM
M^+]33Q7J<ME#:6T;VV'V[<JI+#U.31_7X)_J/^OQL>L\=R!]317C'B&\-]KU
MG9?:[J\TQ+#S+>5Y!$9&^;YR3CGCI[5Z#\/[B[N/!]NU_*9G5F5)#U*CI32N
MF_ZWL2W9I?UW.FHHHI#"JNI?\>+?6K55=2_X\6^M $MQ_P >Q^@KP']HW_D-
MZ+_UP/\ (5[]<?\ 'L?H*\!_:._Y#>B_]<#_ "%;4/C,JOP'">'/%_BG2-)>
MWT*&WDM(?F=I+".8K]68$U?U[QQ+XC\"?9=8BMH]06?=&T%HD7F)Q_= ]ZZC
MX=?VXW@[3G\/HH@CO<7\99!YZ$-S\W4#@50\<Z3=:1X'FM-:$(,-^PTT*ZLW
MEX'IVY/6NFHUS6:[>O3_ #^Z_8YZ:?+=>?Z_Y?BCRNNI\/>*-'T?3?L]]X53
M4YB<M<&[EC)'IA>*Y:O4O LFJ6?A!+G^V=(TNR:4K%]MA:1W//\ =K:7PLS7
MQ(H^)KG1_$/@#^VM-T%M/NHKGR99)+J24XP/N[^O6O.9/]4WTKVGQ!I+>*/"
M\DFH>.M+:*U<F.*"%UBW8[C&<UXQ=)Y32QA@^PD;AT/O65-J[7];(TFO=3_K
M=GW5H/\ R+>F_P#7I%_Z *OU0T'_ )%O3?\ KTB_] %7ZX'N=BV"BBBD,***
M* "BBB@ K \<?\B1J?\ UR'_ *$*WZP/''_(D:G_ -<A_P"A"@"]'_J8_P#<
M'\J>!GI38N8H_P#='\J\I^(OCNZ34)-'TB4PQQ<32J>6/I[8KJPN&GB:G) #
MU%KRU1BKW,2L.H+@4GV^S_Y^X?\ OL5\T->73,2US,Q/4F0TGVJX_P"?B7_O
MLU[7]A_W_P  /IC[?9_\_</_ 'V*/M]G_P _</\ WV*^9_M5Q_S\2_\ ?9H^
MU7'_ #\2_P#?9I_V&OY_P ^F/M]G_P _</\ WV*/M]G_ ,_</_?8KYG^U7'_
M #\2_P#?9H^U7'_/Q+_WV:/[#7\_X ?3'V^S_P"?N'_OL4?;[/\ Y^X?^^Q7
MS/\ :KC_ )^)?^^S1]JN/^?B7_OLT?V&OY_P ^F/M]G_ ,_</_?8H^WV?_/W
M#_WV*^:!<W'_ #\2_P#?9IPN;C_GXE_[[-+^Q%_/^ 'TK]NM/^?J'_OL4?;K
M3_GZA_[[%?-HN;C_ )^)?^^S3Q<S_P#/>7_OLU/]BK^?\ /H_P"W6G_/U#_W
MV*/MUI_S]0_]]BOG,7,__/>7_OLT\7,__/>7_OLU/]CK^?\  1]%?;;3_GYA
M_P"^Q1]MM?\ GYA_[[%?.XN)_P#GO+_WV:>+B?\ Y[R_]]FI_LC^_P#@,^A?
MMMK_ ,_,7_?8H^VVO_/S%_WV*^?1<3_\]Y/^^S3A<3?\]I/^^S4_V4OYOP ^
M@/MEK_S\Q?\ ?8H^V6O_ #\Q?]]BO A<3?\ /:3_ +[-/%Q-_P ]I/\ OLU/
M]E_W@/>OMEM_S\1?]]BN,U#0;BY^*5AK\4UL;&"/:Y,PW9^E>=BXF_Y[2?\
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MBB@ HHHH **** "BBB@ HHHH **** +>EG&I0X_O5V!KCM,_Y"4/^]78GK0
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M *^7_G7TH/\ CU'_ %S'\J^:];_Y&#4/^OE_YU]%D?Q3^0BE1117TP!1110
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MB@"UIG_(2A_WJ[$]:X[3/^0E#_O5V)ZT )1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/_(MZ;_UZ1?^@"K]4-!_Y%O3?^O2+_T 5?KSWN=BV"BBBD,**** "BBB@ K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* .9_P"$4OO^AANO^_2T?\(I??\ 0PW7_?I:Z:B@#F?^$4OO^AANO^_2T?\
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M%;[_ *&&Z_[])1_PBM]_T,-U_P!^DKIJ* .9_P"$5OO^AANO^_24?\(K??\
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M?\(K?_\ 0Q77_?I*Z:B@#F?^$5O_ /H8KK_OTE'_  BM_P#]#%=?]^DKIJ*
M.9_X16__ .ABNO\ OTE'_"*W_P#T,5U_WZ2NFHH YG_A%;__ *&*Z_[])1_P
MBM__ -#%=?\ ?I*Z:B@#F?\ A%;_ /Z&*Z_[])1_PBM__P!#%=?]^DKIJ* .
M9_X16_\ ^ABNO^_24?\ "*W_ /T,5U_WZ2NFHH YG_A%=0_Z&.Z_[\I1_P (
MKJ'_ $,=U_WY2NFHH YG_A%=0_Z&.Z_[\I1_PBNH?]#'=?\ ?E*Z:B@#F?\
MA%=0_P"ACNO^_*4?\(KJ'_0Q77_?E*Z:B@#F?^$5U#_H8KK_ +\I1_PBNH?]
M#%=?]^4KIJ* .9_X174/^ABNO^_*4?\ "*ZA_P!#%=?]^4KIJ* .9_X174/^
MABNO^_*4?\(KJ'_0Q77_ 'Y2NFHH YG_ (174/\ H8KK_ORE'_"*ZA_T,5U_
MWY2NFHH YG_A%=0_Z&*Z_P"_*4?\(KJ'_0Q77_?E*Z:B@#F?^$5U#_H8KK_O
MRE'_  BNH?\ 0Q77_?E*Z:B@#F?^$5U#_H8KK_ORE'_"*ZA_T,5U_P!^4KIJ
M* .9_P"$5U#_ *&*Z_[\I1_PBNH?]#%=?]^4KIJ* .9_X174/^ABNO\ ORE'
M_"*ZA_T,5U_WY2NFHH YG_A%=0_Z&*Z_[\I1_P (KJ'_ $,5U_WY2NFHH YG
M_A%=0_Z&.Z_[\I1_PBNH?]#'=?\ ?E*Z:B@#F?\ A%=0_P"ACNO^_*4?\(KJ
M'_0QW7_?E*Z:B@#F?^$6U#_H8[K_ +\I1_PBVH?]#'=?]^4KIJ* .9_X1;4/
M^ACNO^_*4?\ "+:A_P!#'=?]^4KIJ* .9_X1;4/^ACNO^_*4?\(MJ'_0QW7_
M 'Y2NFHH YG_ (1;4/\ H8[K_ORE'_"+:A_T,=U_WY2NFHH YG_A%M0_Z&.Z
M_P"_*4?\(MJ'_0QW7_?E*Z:B@#F?^$5U#_H8[K_ORE'_  BNH?\ 0QW7_?E*
MZ:B@#F?^$5U#_H8[K_ORE'_"*ZA_T,=U_P!^4KIJ* .9_P"$5U#_ *&.Z_[\
MI1_PBNH?]#'=?]^4KIJ* .9_X174/^ACNO\ ORE'_"*ZA_T,=U_WY2NFHH Y
MG_A%=0_Z&.Z_[\I1_P (KJ'_ $,=U_WY2NFHH YG_A%=0_Z&.Z_[\I1_PBNH
M?]#'=?\ ?E*Z:B@#F?\ A%=0_P"ACNO^_*4?\(KJ'_0QW7_?E*Z:B@#F?^$6
MU'_H8[K_ +\I1_PBVH_]#'=?]^4KIJ* .9_X1;4?^ACNO^_*4?\ "+:C_P!#
M'=?]^4KIJ* .9_X1;4?^ACNO^_*4?\(MJ/\ T,=U_P!^4KIJ* .9_P"$6U'_
M *&.Z_[\I1_PBVH_]#'=?]^4KIJ* .9_X1;4?^ACNO\ ORE'_"+:C_T,=U_W
MY2NFHH YG_A%M1_Z&.Z_[\I1_P (MJ/_ $,EU_WY2NFHH YG_A%M1_Z&2Z_[
M\I1_PBVH_P#0QW7_ 'Y2NFHH YG_ (1;4?\ H8[K_ORE'_"+:C_T,=U_WY2N
MFHH YG_A%M1_Z&.Z_P"_*4?\(MJ/_0QW7_?E*Z:B@#F?^$6U'_H8[K_ORE'_
M  BVH_\ 0QW7_?E*Z:B@#F?^$6U'_H8[K_ORE'_"+:C_ -#'=?\ ?E*Z:B@#
MF?\ A%M1_P"ACNO^_*4?\(MJ/_0QW7_?E*Z:B@#F?^$6U'_H8[K_ +\I1_PB
MVH_]#'=?]^4KIJ* .9_X1;4?^ACNO^_*4?\ "+:C_P!#'=?]^4KIJ* .9_X1
M;4?^ACNO^_*4?\(MJ/\ T,=U_P!^4KIJ* .9_P"$6U'_ *&.Z_[\I1_PBVH_
M]#'=?]^4KIJ* .9_X1;4?^ACNO\ ORE'_"+:C_T,=U_WY2NFHH YG_A%M1_Z
M&.Z_[\I1_P (MJ/_ $,=U_WY2NFHH YG_A%M1_Z&.Z_[\I7E_P 8/#.JM/I<
M$%W=:M-+E5A\I1CGKQ7NU(54L&*@D=#CI0!XI\/_ (2^(-/FCOM2U6334X86
ML)W$^S \"O:1$I@\IP'7;M(89!'TI]% ',7GPY\)WUTUQ<:+;&1CDE1M'Y"H
M/^%6^#?^@)!^9_QKKJ*KFEW%RKL<C_PJWP;_ - 2#\S_ (T?\*M\&_\ 0$@_
M,_XUUU%'-+N+E78Y'_A5O@W_ * D'YG_ !K=TG0-*T*'RM)L8;9>Y1 "?J>M
M:-%)R;W8[)!1112&%%%% !1110 4444 %%%% !1110 52OM6L].95NI0K-T'
MMZU=JAJ6CV^J-$;DM^Z;<H'K35KZB>VA(NI6[WJ6J-N>1/,4CH15NN:O,Q>)
MSM/*63X/X503[9!HMMJG]H3M,9<%"1M*Y/%6H)I?UU?^1+DU?^NB?ZG:56^W
M0C4!9Y/G%=V/:L*..?6+R_DDOY;9;:39&B$ +@ Y/YU7NY)$U"203"21=/8^
M:O\ $=O6A1[_ -:#OV_K5(ZZHYYDMX'ED^Z@R:YVZO)ET?2'$I#R3*&.?O#!
MJK)'<:MIVHWDE_+"8V9$C4C:H Z&CDW!2O;S.KMKA+JUCGB^Y(H9<^AJ6N'6
M[O)OL%A!%<O"EHCLMLZJ6)'?=5K=KCZ,T;+,K). %,B>:\>#D9Z9ING9[_U<
ME3NOZ[7.NK+OM?M;&\^RNDLDNW<1&N<"JGARZ#S7%N9KC>GS>1<8W1_EVJK=
MK?MXTE_LUK=7\A=WG@D?I24/>LQ\WNW_ *W-FVUNTNK26>$L?)_UD>/F7\*O
M1N)(U<<!AD9KC#)<V;:TEXR?;VB$GF0CY,# X!JY;_:-9U VTEY+!%! "%C(
M!8YZFFX+="YGL_ZV.IJ&YN4M8O,D#$9Q\HS7)FYU2YT\PQ22W MKAHY#&RB2
M50>,9XI&U!AI$R0W4YDCG4&.8#?&,=/2A4]1N=D=GFBN5N([F\UC45^VS11P
M0[T2,CKBH+9KQ+/3-0DOYI)9ITC=3C:5)I*%UN#EK8Z.35[>+'F!US*(AD=6
MQ5[-<9<322MB1BP34E"Y[#::-2NI)'O)K>YNYWA;Y3 0J18'0YHY-%_7;_,.
M;6W];O\ R.SHKDH7N=5U.P22[EC1[02.(R!N;%07<M[9W4LM_/=QHKCR[F)E
M,87T(ZT_9ZVO_5[!SZ77]:7.THIL3!XE93N!&0?6G5D6M0HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?#,W7CCXB#6]27*Z= %7/3/(Q7:_$OQ#XBAAGT/1/#-[?)=Q;?ML,3R(F>Q
M4_SJ[\*?",WA7PJ%OX]E[=.995(Y7/:JIOWI3Z=/78F:M&,/E\MSN:***0PH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF,NEW31:&J+*XS \K&1UXYSGK^-=910ZC?\ 7S!02.<\/VEU!J$K)#<6MEM
M$5R06S[')XKHZ**F4N9CC&P4445)04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>abvx-20241231_g20.jpg
<TEXT>
begin 644 abvx-20241231_g20.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *=!KP# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *0TE>=_'[5+O1/A1K-]8W$EM=V[6\D<T;;6
M5OM$=.,>:7*3*7*KGHO%%>3?!/XU6OQ+T_[%>;+7Q#;K^^ASM6=?^>D?_P 3
M_#7K/\-5.G*G+ED$9*2O$6BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** &]*0D4$_+7YQ_\)1K'_06OO\ P*;_ .*KJP^'>(O9G-6K
M>Q5S]'=U&ZOSB_X2C6/^@M??^!3?_%4?\)1K'_06OO\ P*;_ .*KN_LV?\QS
M?7H_RGZ.[J-U?G%_PE&L?]!:^_\  IO_ (JC_A*-8_Z"U]_X%-_\51_9L_Y@
M^O1_E/T=W4;J_.+_ (2C6/\ H+7W_@4W_P 51_PE&L?]!:^_\"F_^*H_LV?\
MP?7H_P I^CNZC=7YQ?\ "4:Q_P!!:^_\"F_^*H_X2C6/^@M??^!3?_%4?V;/
M^8/KT?Y3]'=U&ZOSB_X2C6/^@M??^!3?_%4?\)1K'_06OO\ P*;_ .*H_LV?
M\P?7H_RGZ.[J-U?G%_PE&L?]!:^_\"F_^*H_X2C6/^@M??\ @4W_ ,51_9L_
MY@^O1_E/T=W4;J_.+_A*-8_Z"U]_X%-_\51_PE&L?]!:^_\  IO_ (JC^S9_
MS!]>C_*?H[NHW5^<7_"4:Q_T%K[_ ,"F_P#BJ/\ A*-8_P"@M??^!3?_ !5'
M]FS_ )@^O1_E/T=W4;J_.+_A*-8_Z"U]_P"!3?\ Q5'_  E&L?\ 06OO_ IO
M_BJ/[-G_ #!]>C_*?H[NHW5^<7_"4:Q_T%K[_P "F_\ BJ/^$HUC_H+7W_@4
MW_Q5']FS_F#Z]'^4_1W=1NK\XO\ A*-8_P"@M??^!3?_ !5'_"4:Q_T%K[_P
M*;_XJC^S9_S!]>C_ "GZ.[J-U?G%_P )1K'_ $%K[_P*;_XJC_A*-8_Z"U]_
MX%-_\51_9L_Y@^O1_E/T=W4;J_.+_A*-8_Z"U]_X%-_\51_PE&L?]!:^_P#
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M?^!3?_%4?V;+^8/KT?Y3]'=U&ZOSB_X2C6/^@M??^!3?_%4?\)1K'_06OO\
MP*;_ .*H_LV7\P?7H_RGZ.[J-U?G%_PE&L?]!:^_\"F_^*H_X2C6/^@M??\
M@4W_ ,51_9L_Y@^O1_E/T=W4;J_.+_A*-8_Z"U]_X%-_\51_PE&L?]!:^_\
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M?]!:^_\  IO_ (JC^S9_S!]>C_*?H[NHW5^<7_"4:Q_T%K[_ ,"F_P#BJ/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8UJJY9?S%.G'WH_RG*2_LS^);74!9W>IZ%I\\DGEVJW%ZR_:VV_\LUV[F_\
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MO]ZND\9:7=Z/^S#X:M[^VFM)SK;/Y4T>UPK+<;?E_*KFFWVE_&'6M.\+^,]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_H6+'_OEO\:/^%'>!/\ H6+'_OEO\:/[0A_*'U.9\%T5]Z?\*.\"?]"Q8_\
M?+?XT?\ "CO G_0L6/\ WRW^-']H0_E#ZG,^"Z*^]/\ A1W@3_H6+'_OEO\
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M'WB#P7>7-UI&IS6D]SS.VU9%E_WE;<K5]J_\*.\"?]"O8_\ ?+?XT?\ "CO
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M^6_QI_7,/R\O(3]5J_S'Q1XN\=:[XZO(+C7=1>_DA7;'N556/_=5?EK4\/\
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M>!/^A7L?^^6H_P"%'>!/^A7L?^^6I?VA1_E%]3G_ #'Q/_PG&N_\);_PD_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG:KX\UT:'8ZA=+96K+:SW,DLS*S!5CAC9C]W^[7H4;;HPP[_ -X8H DHHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:?\ HE:_/6OT*^%__),_"?\ V";3_P!$K7CYEM$]+!?%(ZFBBBO"/6"BBB@
MHHHH **3</6C</6@#\W-,^'OPO\ VP/$7Q3\5_&7Q98^%?&&D:M=^'X-+@N;
M?3)-&L[:7]Q)<+)\UTS;=VZ?='\NU57;7T_^P[\3/$GQ4_9^T[5_$TT-]=6]
M[=:=:ZQ;VOV:/5;6WD:.*Z6/[J[U7^'Y?EKTKQ1\$_AWXYUA-7\2> _"_B#5
M8PHCU#5-'M[F<;>5Q)(K-77VMI!8V\5O;QQPV\2K&D<:[515^ZH% KGRS^VY
M=1?"WQ-\&_C7(&2S\'^)/[/UJX _U>EW\?V>9VV_>56\MMO]YJ\0U+P?J=K^
MP;I7QH6T:3QG:^,%^+KHIPS>9>[F7/\ =^QNNY?N_+[5^@?BCPIHOCK0[G1?
M$6DV&O:-<E?M&FZI;1W%M-M967?'(K*VUE5O]Y14C^&]'E\,MX??2K-M!:T_
ML]M+:W7[,;;9Y?D^5C;Y>WY=N-NV@9\/>&;35?C'\ /VK/BSX8CFN-3\?2:A
M8: ULK-)=:9I]LUK!Y7\6Z3;<?*O\35QFE>%3\7_ -CSP[X;U/\ :;\ :+X#
MNM(L;9M/_P"$7MXKBRDC\MEAW?;U;SED7;]U69OX?FK]$_#_ (9T;P;HEMI&
M@:59:)I-JNVWT_3H%MX(ESNPD:[57YCVKGT^"?P\C\4_\),G@+PNOB;?YO\
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MX-CYMU;*_#WPJOC!O%P\-Z.OBMH?LYUX:?#]M,>,>7Y^WS-O^SNKIJ* //\
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M/ ]*,#THYZ7\OXAR3_F/#/\ AK_P?_T#=;_[\0__ !ZC_AK_ ,'_ /0-UO\
M[\0__'J]SP/2C ]*.>E_+^(<D_YCPS_AK_P?_P! W6_^_$/_ ,>H_P"&O_!_
M_0-UO_OQ#_\ 'J]SP/2C ]*.>E_+^(<D_P"8\,_X:_\ !_\ T#=;_P"_$/\
M\>H_X:_\'_\ 0-UO_OQ#_P#'J]SP/2C ]*.>E_+^(<D_YCPS_AK_ ,'_ /0-
MUO\ [\0__'J/^&O_  ?_ - W6_\ OQ#_ /'J]SP/2C ]*.>E_+^(<D_YCPS_
M (:_\'_] W6_^_$/_P >H_X:_P#!_P#T#=;_ ._$/_QZO<\#THP/2CGI?R_B
M')/^8\,_X:_\'_\ 0-UO_OQ#_P#'J/\ AK_P?_T#=;_[\0__ !ZO<\#THP/2
MCGI?R_B')/\ F/#/^&O_  ?_ - W6_\ OQ#_ /'J/^&O_!__ $#=;_[\0_\
MQZO<\#THP/2CGI?R_B')/^8\,_X; \(?] W6_P#OQ!_\=K&\9?M2>%?$/A'6
M]+M[#6%N+ZQFMHVD@AVJTD;*N[][_M5]&8]A1QZ4_:4E]G\2?9S_ )CY:^$O
M[1WAOP#\/]+T*_L=5GO+7SO,:VAC,;;IG;Y2TB_WJ[+_ (:^\'_] W6_^_$'
M_P >KW/ ]*./2G*K2E*_+^(1ISBN7F/#/^&O_!__ $#=;_[\0_\ QZC_ (:_
M\'_] W6_^_$/_P >KW/ ]*,#TJ>>E_+^)7)/^8\,_P"&O_!__0-UO_OQ#_\
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MX:_\'_\ 0-UO_OQ#_P#'J]SP/2C ]*.>E_+^(<D_YCPS_AK_ ,'_ /0-UO\
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M)_WY7_Y'H_X1/X[_ /0Z:)_WY7_Y'KW/\*/PH]N_Y5]P>R_O,\,_X1/X[_\
M0Z:)_P!^5_\ D>C_ (1/X[_]#IHG_?E?_D>O<_PH_"CV[_E7W![+^\SPS_A$
M_CO_ -#IHG_?E?\ Y'H_X1/X[_\ 0Z:)_P!^5_\ D>O<_P */PH]N_Y5]P>R
M_O,\,_X1/X[_ /0Z:)_WY7_Y'H_X1/X[_P#0Z:)_WY7_ .1Z]S_"C\*/;O\
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M%H>#?^ALT/\ \&,/_P 57YZ44?V:OY@^NO\ E/T+_P"%H>#?^ALT/_P8P_\
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MW^]N^7;_ +-4/%/PBM-/\&R^*?#OB2+Q-I5K<?9KIEM6MVB;Y5^ZS?-]Y?\
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M3^M4A>QJ'D=%>I:'\%;27P_HVI^(_%$'AMM9;;86[6K7#3+_  LVUEV_>_\
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MFC_AZ%\//^A#^(W_ ()[?_Y)KXDHH_U+P7\\@/MO_AZ%\//^A#^(W_@GM_\
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M;_X>A?#S_H0_B-_X)[?_ .2:/^'H7P\_Z$/XC?\ @GM__DFOB2BC_4O!?SR
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M>W_^2:^)**/]2\%_/(#[;_X>A?#S_H0_B-_X)[?_ .2:/^'H7P\_Z$/XC?\
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MM#<QIN6%K>XA9MVUE*LWI1' 8#'5/9RK\M:7]WW3V\+_  S]&^M&*\8_9/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@ HHHH **** "BBB@!IZU\6?M2:'/IOQ4NKZ2-O(U**&:&3^%ML:QLO\
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M:M<6FIR+/JL?EWLLJK(TJ_[S*W]ZO=?^&+V_Z&\?^"S_ .W4?\,8-_T-X_\
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M_P ,@^,O^@CHG_@3-_\ &:^P<FC)K;Z]6[F7U2F?'W_#(/C+_H(Z)_X$S?\
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M_AD'QE_T$=$_\"9O_C-'_#(/C+_H(Z)_X$S?_&:^P<FC)H^O5NX?5*9\??\
M#(/C+_H(Z)_X$S?_ !FC_AD'QE_T$=$_\"9O_C-?8.31DT?7:W</JE,^/O\
MAD'QE_T$=$_\"9O_ (S1_P ,@^,O^@CHG_@3-_\ &:^P<FC)H^NUNX?5*9\?
M?\,@^,O^@CHG_@3-_P#&:/\ AD'QE_T$=$_\"9O_ (S7V#DT9-'UZMW#ZI3/
MC[_AD'QE_P!!'1/_  )F_P#C-'_#(/C+_H(Z)_X$S?\ QFOL')HR:/KU;N'U
M2F?'W_#(/C+_ *".B?\ @3-_\9H_X9!\9?\ 01T3_P "9O\ XS7V#DT9-'UZ
MMW#ZI3/C[_AD'QE_T$=$_P# F;_XS1_PR#XR_P"@CHG_ ($S?_&:^P<FC)H^
MNUNX?5*9\??\,@^,O^@CHG_@3-_\9H_X9!\9?]!'1/\ P)F_^,U]@Y-&31]=
MK=P^J4SX^_X9!\9?]!'1/_ F;_XS1_PR#XR_Z".B?^!,W_QFOL')HR:/KU;N
M'U2F?'W_  R#XR_Z".B?^!,W_P 9H_X9!\9?]!'1/_ F;_XS7V#DT9-'UVMW
M#ZI3/C[_ (9!\9?]!'1/_ F;_P",T?\ #(/C+_H(Z)_X$S?_ !FOL')HR:/K
MM;N'U2F?'W_#(/C+_H(Z)_X$S?\ QFC_ (9!\9?]!'1/_ F;_P",U]@Y-&31
M]>K=P^J4SX^_X9!\9?\ 01T3_P "9O\ XS1_PR#XR_Z".B?^!,W_ ,9K[!R:
M,FCZ]6[A]4IGQ]_PR#XR_P"@CHG_ ($S?_&:/^&0?&7_ $$=$_\  F;_ .,U
M]@Y-&31]>K=P^J4SX^_X9!\9?]!'1/\ P)F_^,T?\,@^,O\ H(Z)_P"!,W_Q
MFOL')HR:/KU;N'U2F?'W_#(/C+_H(Z)_X$S?_&:>G[(7C#<N_4]$5?XMLTW_
M ,;KZ^R:,FCZ[6[A]4IGGGPC^$-E\*=)FBBF-[J5SM:YNF7;NV_=55_A6O/O
MVYO^2#7?_7_;?^A5]"5\]_MS?\D&N_\ K_MO_0JZ\IE*IF5&4OYD=48J,>6(
M?L,_\D&M/^O^Y_\ 0J^A.]?/?[#/_)!K3_K_ +G_ -"KZ$[U&<?\C&M_B90=
MJ\4_;0UY_#/[*_Q)O(Y&C=M*>T#*>?WS+#_[4KVNOF[_ (*+?\F<_$#_ +AW
M_IQMJ\_#>]7@O[R _.32;5;/2;.W5=JQPJO_ ([5NBBOZ>IQY8*) 4445H 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4W[WWJ=12>P'WO_P3
M7U9K[]F>#3VD9AH^LW]@JL?]6OF>:%_\C5]5#M7QU_P2]_Y(UX[_ .QWO_\
MTGM*^Q?\*_F?,H\N+JK^\S0=1117 (**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** &]Z^>_P!N;_D@UW_U_P!M
M_P"A5]"=Z^>_VYO^2#7?_7_;?^A5ZV3?\C&C_B0!^PS_ ,D&M/\ K_N?_0J^
MA.]?/?[#/_)!K3_K_N?_ $*OH3O1G'_(QK?XF O>OFS_ (*+?\F;_$'_ +A_
M_IQMJ^D^]?-G_!1;_DS?X@_]P_\ ].-M7#A/]XI?XE^8'YX4445_3\=D0%%%
M%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW8UVU\K5679E1S*C[;#_  H HHHKTQ!117T3_P ,AS?\*-_X6+_PE"Y_LO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR,OR_P 7W6KW7]B,>,#\6+#^S&U!?"RI-_:?WOLFWRVV[OX?,\SR_P#:_P"
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MG\&?&5BVCADT+5XFDM89)&9H)(V7S(]S?>7YEV_[U?4'[;G_ ";TO_7]:_\
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M5W+>7"JV/N_NU/\ [+7KQPTL'F6'I>UE*-:+YKO^Z0>[?\)?X5_X47_PD_\
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MO_\ TGM*^QO\*_FK-/\ ?*O^)ECJ***\T HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@/2/CU\8F^.7C>#Q VE?V-Y=G':+;_:/.^ZS-NW;5_O?W:]"NOVQ+^X^":^
M$\-11R?V2NCG4VNV;$:Q^7N\GR_O;?\ :KYUHKSYY1@ITZ5"5/W:?PA<]O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQAH<MUX'\=W%Z_W4N6GM[ZVW?W6\I5KY67%.6J=N:7+_ #6=AV/B>BNB\?>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9Q_R,:W^)@+WKYL_X*+?\F;_ !!_[A__ *<;:OI/O7S9_P %%O\ DS?X@_\
M</\ _3C;5PX3_>*7^)?F!^>%%%%?T_'9$!1113 **** "BBB@ HHHH ****
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MIVEQ6EPL=U_9EK%!&\,WW9&VK\WS;5_[:51_X*,?\A#P$/\ IG>?^A05Z+\
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M"\;+FC]CE^SZ]P.._P""=NL2RV'C?2F_U$,MK=1_[SK(K?\ HM:^6_C5H_\
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M/QI;ZCXD\->&+>;=+IT4EW=*O\+2;?+5O]K:K-_P*O9/&'_)C=O_ -BG8_\
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MUX>AU_PO>Z6+R"3R8YI([A6D5E*-_"VU?F_A;_QW\\**];$<,X?$8OZS*?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHI/8#[;_P""7O\ R1OQW_V/%_\ ^D]I7V-_A7QS_P $
MO?\ DC?CO_L>+_\ ])[2OL;_  K^:LT_WRK_ (F6.HHHKS0"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!O>O
MGO\ ;F_Y(-=_]?\ ;?\ H5?0G>OGO]N;_D@UW_U_VW_H5>MDW_(QH_XD ?L,
M_P#)!K3_ *_[G_T*OH3O7SW^PS_R0:T_Z_[G_P!"KZ$[T9Q_R,:W^)@%?.'_
M  40MY+K]CSX@K&NY@MB_P#P%;^V9OT4U]'UY5^U%X1G\>?L\_$'0[2,2WEU
MH]PUO'_?EC7S$7_OI17G8:7+6@_-#/RQ5MRJR_=:G5F^&;]=4\/Z?<)_RTA7
M=_O?Q5I5_3]&7-!2,PHHHK0 HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;?'']F:21F?X)Z>S-]YF\+:;_P#%4S_A=G[,G_1$=-_\)33?_BJ]7^V\S_Z
MY"/C?_A*M%_Z#&G_ /@5'_\ %4?\)5HO_08T_P#\"H__ (JOLC_A=G[,G_1$
M=-_\)33?_BJ/^%V?LR?]$1TW_P )33?_ (JC^VLS_P"@.0'QO_PE6B_]!C3_
M /P*C_\ BJ/^$JT7_H,:?_X%1_\ Q5?9'_"[/V9/^B(Z;_X2FF__ !5'_"[/
MV9/^B(Z;_P"$IIO_ ,51_;>9[_4Y ?&__"5:+_T&-/\ _ J/_P"*H_X2K1?^
M@QI__@5'_P#%5]D?\+L_9D_Z(CIO_A*:;_\ %4?\+L_9D_Z(CIO_ (2FF_\
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M/\(/^B4^"O\ PG;/_P"-T?\ #,_P@_Z)3X*_\)VS_P#C='^O$O\ GR!^2?\
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M$I\%?^$[9_\ QNC_ %XE_P ^0/R3_P"$JT7_ *#&G_\ @5'_ /%4?\)5HO\
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M_P ^0/R3_P"$JT7_ *#&G_\ @5'_ /%4?\)5HO\ T&-/_P# J/\ ^*K];/\
MAF?X0?\ 1*?!7_A.V?\ \;H_X9G^$'_1*?!7_A.V?_QNC_7B7_/D#\D_^$JT
M7_H,:?\ ^!4?_P 51_PE6B_]!C3_ /P*C_\ BJ_6S_AF?X0?]$I\%?\ A.V?
M_P ;H_X9G^$'_1*?!7_A.V?_ ,;H_P!>)?\ /D#\D_\ A*M%_P"@QI__ (%1
M_P#Q5'_"5:+_ -!C3_\ P*C_ /BJ_6S_ (9G^$'_ $2GP5_X3MG_ /&Z/^&9
M_A!_T2GP5_X3MG_\;H_UXE_SY _)/_A*M%_Z#&G_ /@5'_\ %4?\)5HO_08T
M_P#\"H__ (JOUL_X9G^$'_1*?!7_ (3MG_\ &Z/^&9_A!_T2GP5_X3MG_P#&
MZ/\ 7B7_ #Y _)/_ (2K1?\ H,:?_P"!4?\ \51_PE6B_P#08T__ ,"H_P#X
MJOUL_P"&9_A!_P!$I\%?^$[9_P#QNC_AF?X0?]$I\%?^$[9__&Z/]>)?\^0/
MR3_X2K1?^@QI_P#X%1__ !5'_"5:+_T&-/\ _ J/_P"*K];/^&9_A!_T2GP5
M_P"$[9__ !NC_AF?X0?]$I\%?^$[9_\ QNC_ %XE_P ^0/R3_P"$JT7_ *#&
MG_\ @5'_ /%4?\)5HO\ T&-/_P# J/\ ^*K];/\ AF?X0?\ 1*?!7_A.V?\
M\;H_X9G^$'_1*?!7_A.V?_QNC_7B7_/D#\D_^$JT7_H,:?\ ^!4?_P 51_PE
M6B_]!C3_ /P*C_\ BJ_6S_AF?X0?]$I\%?\ A.V?_P ;H_X9G^$'_1*?!7_A
M.V?_ ,;H_P!>)?\ /D#\D_\ A*M%_P"@QI__ (%1_P#Q5'_"5:+_ -!C3_\
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M$I\%?^$[9_\ QNC_ %XE_P ^0/R3_P"$JT7_ *#&G_\ @5'_ /%4?\)5HO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** &]Z^>_VYO^2#7?_7_;?^A5]"=Z^>_VYO\ D@UW
M_P!?]M_Z%7K9-_R,:/\ B0!^PS_R0:T_Z_[G_P!"KZ$[U\]_L,_\D&M/^O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!,]JMN_A^]M^\M?I.7<-X+ZC'&X^=E+41]@?\ #P3P'G_D"^(\?]>UO_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\+^$=>\,ZC?^)_&/C*V\+N)= TGQ-JZW%CI,BKMC:.-8UW,BG:K2,[+_  T
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MW-K WBC5EFB@C9E9ML,,<<9;Y%_>,K-_M4 ?%7[+OC'6?'?B#P]\(+G6M2\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJM]ZJ>7T8[S%]:J'Z_?\/%/V>_\ H?\ _P HNH__ "/1_P /%/V>_P#H?_\
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M1110 4444 >:?M+?\FX_%7_L5-5_](Y:_ >OWX_:6_Y-Q^*O_8J:K_Z1RU^
M]>]EFTCS,9O$****]H\\**** "BBB@ K[-^$_P#RC!^-/_8S6?\ Z.TVOC*N
MRTGXP>,-$^%^L_#RRUCR/!VM72WM]IOV>%O.F5HV5O,9?,7_ %,?W6_AKFK4
MI5%%&M.7*?J7\2OB]KO@3]H[X$^$-)CT^'2/%&GPQ:LS6<9GN8]K*L;2-\RJ
MOWE5?XB:\UT_2;;X#>"_VJ/'/PZT6TM?&>D^(7LK*2*U6;^S[-F@9FCC;Y55
M?.GD^[M_=KN^5:^&M>_:6^)/BCQIX8\6:GXE:Y\0>&HUCTJ[^QVR_955MR_N
MUCVM_P "5JL^%OVJOBKX)\;Z_P"+=%\7SV6O:_)YNISK:VS1W+?WFA:/R]W^
MZORUP?4ZD8G5[:/,??7Q5\3:SXP^'?[)&N>)+*/3=9U#QSI-Q>6ZV_V==[2?
M>\O^'=][_@50?"?P]J4/_!2+XT:@^G7*Z>F@N#<F%O+#2+:-'\WW?FVOM_O;
M6_NU\"^/OVF_B?\ $_3]-LO%'BZ]U*#3K]M3LVV1QR0W'_/19(U5OEW_ "KN
MVK_#78/^WM\>IGA=OB#<,8HVC"_V?9[65EV_,OD_,W^TVYJ%A*MK1#VT>8^@
MM%\8Z[^S=^PG\.?%GPM@MAKOB/6&36=473UN9)?WDRK"VY6^7]VL7_H.UFKI
M?AW\>OBGI_['/QG\0PP?\(MXN\/^(8Q8Z=::/'&NF_:+J"2Y5;>16_Y^)F_>
M;MN[_9KXO^%G[4WQ4^"VAS:-X-\7W&D:7+(TK6C6\-Q&K-]YE6:-MO\ P';1
MX&_:I^*WPWU[Q!K?A_QE=V>HZ_-]IU.::&&X^TR?-\S+,K*K?-_#3EA9R)C6
MB?6?V%/B'^QG^S_:^*?](37/BK'#JC,/*9EFN[]9_N[=OWF^[7K4'Q0\8R?M
MR7/P1'AS3V^$"Z;Y+:+_ &/&MLEO]C\S[1NV_=\[]U_SS_AV[OFK\V?$WQW\
M>>,O ]MX.U?7FO/#MKJDFL0VGV>%=MU(TC-)YBKYGWII/EW;?FKM[K]N/XZ7
MGA9M D^(=^VGM;_9F9(;9;EEV[?^/CR_.W?[6[=3EA)R_$4:T3ZSL_$K? G]
MBCQOK'@=+)+GP_X[O[;1+VZMUNOLR_:?LZS1^9N7S/)9EW-N^\:Y;]I[QCKV
MG^/_ -FSXK^%O#%GJOQ$USP['J<UI;V4DZWMPT$3;?)C^9MOG2;=OS?=_NU\
M;P_&CQG;_"N?X;)K3)X*FNOMLFE_9X?FFW*V[S-OF?>5?EW;:U/^&D_B/_:7
M@;41XC87O@BU6RT"06=O_H,*QK'MV^7^\^557]YNJXX:49<WJ/VT>7E.?^+'
MB#7/%GQ*\3ZSXFTM=%\07VH33:AIZVS6_P!GF9OF7RV^9?F_O?-7*5K^+O%F
MJ^/O$^I>(==NVU#6=2N&N+JX:-5\R1OO-M7:J_\  :R*]"'PG*%%%%60%%%%
M !1110!]K?\ !)G_ )..\0_]BI<_^EEE7ZV5^0G_  2V\0:9X:^/WB6^U;4;
M/2[)?"URK7%[.L,8;[99?Q-7ZD?\+F\ ?]#SX:_\&]O_ /%U\OCHOVS/8PO\
M,[2BN&/QR^':]?'WA?\ \'-O_P#%T?\ "\OAW_T/_A?_ ,'-M_\ %UP<K.GF
M1W-)7!?\+]^&:]?B'X4_\'=K_P#'*/\ A?OPS_Z*)X3_ /!W:_\ QRCE8<R.
M\X]*./2O/_\ AH7X7?\ 12O"'_@]M?\ XY1_PT+\+?\ HI7A#_P>VO\ \<I<
MK[!S(] KXD_X*T?\FY^&_P#L:[?_ -([VO-O'G_!2C7?A7^T1XJTF$Z7\0/A
MTMS$;-[*:,2Q1M!&S>3<1[ED7<S?>W?W=RUE?MW?M4?#[]HS]FKP_P#\(IJK
M'5(?$MO-=:->Q^7=VZ_9;M=VW.UEW,J[E9E^:O0I4*E.I&31RU*L90DC\]Z*
M**^H/("BOH']B#X(:)\>/C>FD^)=\F@:7I\VKWMLCLGVA$>)!%N7YE7?*N[;
M_"M>W? [XO?#']H[XU+\,]1^!O@S1?"FN+<0:7>Z9IZV^J6OEPM(K27"_>9E
MC_AV[?\ :KDJ5^65N7X3>-/F/A"BOI&P_8=\4^)9_&U_I&O>';'PQX7\5W_A
MF\U+7]0^Q+;_ &?YOM,C>7M6/YHU^5MVYON[?FK*\1?L0_$_P_\ %K0?A\MI
MI^JZEK=NU[9:EI]PS:?);K_K)/,95VJO\6Y?XEV[MR[K^L4OYB?9R/ Z*]Y^
M('[&WB_P/X=MM>M?$'A3QAHDFHQ:5<:AX7U4WD5C<2,JJLWRKM^9E_O?>KM]
M0_X)J_$_3]0U'2QKG@VYUZUM6O8=%@U=OMM["O\ RTAC:-?EW?+NDV_-1]9I
M?S![.1\GT45][_MM?"'4OC)^T=X'T#2M0TC2)8_A]:W<U]K=U]EMH8X[FYW,
MTFUO[U*I6Y)1C((QYHGP117T_H?[+WB/X,_$SX/>*KC6_#7B[PKK'BZPM+?6
M/"VH_;+;SEN%_=[MJ_-\LGW=WW6KV#]KK]C'QI\5?CO\1?%7AO5?#%Y.(8=0
M7PW_ &G_ ,38PK;11^9Y.W:JLT;;=S+NJ/K5+FMT*]C+E/@"BO>?AA^QOXN^
M)7@O2_%$OB#PIX/TG5[EK72F\5:J;.349%;;MA55;=\VY?\ :KVK]G_X=ZU\
M*_@W^U]X4\26JV>LZ7HUC%<1JZLO^KO65E;^ZRLK+_O42Q48_ 3&G*1\.45]
M2_\ !./P/X?^('[13:?XDT73]?L(]'NIUM=4@6X@\S=$JMY; JWWFKMOC9^S
MEHGQ0^/GP8U+P1HMKH/@[XG6-O=M9:?&D*VS1JK7JK&J[5VP[6^7^+=3EB8P
MJ>SD5&G*4>8^)**_1#]L[X8^!/&'PS^&\OPY\)>'O#-_K'C2Z\-07EE:16:S
M&.XGM5:215^96DA1MS;J^;O'W[&'BOP3X%UOQ7:>+/!GC+3M"D6/58?"NKO>
M363,VW]XOEKM^;_V:E3Q4)1]\)4Y1/ **^UOC/\ LUZ_\6OB1\+_  KX<\)>
M"? &HZGX4_M%/[+NI/(N55=S23LMHK>9_#MVR?\ 72O,/&G[#OC?P+X.?Q+=
MZ_X0O=,M=2ATO56T[5_._LB:218_]+;R]L>UI%W;69EW4XXJG(GV<CYXHKZV
M_:*_8BTWX5?#_P #:SX8\8Z7K>K:Q8VOGZ8VKQSS:M=3- N[2HUA7SK?=)NW
M,V[;MKG?$'[ OQ#T'2-6D76?".J^(-(L?[0U#PIINK^=JUK#]YF:';M^7=_>
M^;^'=5QQ-.4>;F#V<CYKHKZ9\(_L!>._%WA7PIXA7Q-X,T?3?$]O%)IK:KJL
MMN\DDGW;?;Y'S3-_=7=7+:#^R+XKU+QKXU\,ZOKOA?P9<^$G@CU&]\3:J;2T
M_>;O*:.3:VY65=W_  ):/;TOY@]G(\/HKZ NOV)?'MK\7?!_@$:CX>N+CQ;9
MRWND:W:WLLVFW,<4+3.RR+'N^ZO]W^):?\0/V(?'OPZ^'&K^,;K4O#6KVVC/
M'#K&FZ+J/VJ[TN1MORSJJ[59?,7=M9MN[=]WYJ/K%+^8/9R/GRBOHQ?V$_B#
M#X*M->U#5?"VC7UWILVK6?AK4M6\G5KBWCC\QV6';M^[\WWOE_BVU+X-_8.\
M>>+/#_A^^EU[P?X?U+Q%:_:](\/:UK'DZE?P[=RM'#Y;;MR_-][_ 'MM'UFG
M_,'LY'S=17JL7[-OBW_A5?C?QW=2:?8Z?X.U9=%U33;F=OMJW'F11LJJJLK*
MK2+_ !?PM7JO_!.'P;H_CGXY:Y8ZUX=TGQ1%'X:NKBWT_6+..X@\Y98-K;9/
ME_BV[O\ :IRK1C&4OY11IRE+E/E6BOM7QQ\(?B!\0OB]\+/!7Q!^#7@_X76&
MJZKM:]\'Z;!;?:H0JM/&TT<TB[EC5MJ_>KU=/#GPR^+GQ.^,GP/B^%WAGPU!
MX9T:6XT;Q!I=BL=^LD!C5FDF^])^\D5MO]U65MVZN98R,;:&GL3\TZ*^FO!O
M_!/_ ,>^,O"_A37D\2>#-(L/$]O%-IO]K:G)#+-))]VWV^3\TVWYMJ[J-<_X
M)[_$_0= \1WUQ>^&)=4T&WDO;SP];:KYFI?959MLRQJNW:RQLR[F5F_N[OEK
M?ZS2_F(]G4_E/F6BOI+X9_L&>._B5X=\-:I'XA\(^'6\1QM/I&F:[J<D%[>Q
M+EO-CACC;<NT;O\ =Q7E.K?"&^TGXT1?#=M6TO4M3;5H=)_M#2YFN+1I)&5?
ME;:K-M9MK?+]Y6JXU:<I<L2?9R.#HK[J^/'Q%^&?[)OQ'LOACX;^#WA#Q;9Z
M+!;_ -N:IXGL/M>H74DD:R?NYF_U;>7(K;OF7YMJJNVO5O#'[+/P[\-_MP:7
M;V_AG3]0\&^(?"DVN6^A:I$MU!:W(E56VQR;EV_-N7[VUF;;M55KD^N1C'F<
M3?V/O<I^7]%?H#\))OA]^UQXO\;_  HUOX5>$O!^LVL%U-I'B'PCI_V%X6AD
M\M?,5?O?>W?>VMM^[]VOS^KHI5N?W3*4>0****Z=C-;GZ<_\+8_:6\9'R[2U
MUZ*-O^?71%A7_OYY?_LU+:?LL?&KXJ7\$WC"_GM(-^[SM:U'[2RK_LQJS?\
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MKYB_W5_[YK[&_P"%,V__ #Q7_OFG?\*9M?\ GBO_ 'S64<]<82I?5X>]Y/\
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MVAJ2ZA_:/G_ZO:L2^7Y>W_IG][=_%7J/_#*]C_S\ZE_W\C_^-TS_ (98L?\
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M2/%UGH]K=^';-84,,US:1_O?^>C*MW\V[^*/=\N[;7H.O6OPU^'_ .U/X6^
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MM#<),WVF3R%DD9?+7_5[?F_AVUTNF_M9?"RW_;VU7XB2>)]O@V;PVMA'J?\
M9]U\TVV/Y?+\OS/X6^;;7YW45?U.G:Q/MI'KFF_M8_%72_A>WP[M?%7E>#6L
M9-.;3?[-M6_T>3=N7S/+\S^)OFW;J^M9OVL/@Y/^UMX4\97NJ#4-!LO $>C1
MZL=*FE.F:E]ID;S/+>/S&VQLR[E5O];_ +U?G=15U,+3D*-243]$?C+^U?X
M\4>"_A3ILOQ/F\>Z[H'C_3M:U359/#TFGAK./SFDD6%8MNU/,5=OS2-M/WJT
M%_:0^ ?@SX\>._CEHWCK5M;\0:GI36%MX8.CW$*S3*L:K(LS*J^6RPQ_*V&7
MYF_V5_-ZBLOJ4+<MR_K$C]"?A+^V3X>E_9]\$^%E^+=[\&?$OAR/[#=%/#"Z
MS!J,"_ZME_=OM;;_ !;E^;=\K+MKCK7]IKP5<67[48O_ !=J6KWGC33;&QT2
M]U;3O*N=3:&VGA9F6W@6.'[R[=RK\NW=\VZOB>BG]3ID>VD?1W[!/Q>\*?!/
MX[/XA\9:I_8^C-I-Q:?:?L\DW[QFC95VQJS?PM_#7KO[,W[9OA7X8_LKZOX?
MUN\6/Q]X=^W?\(E$UG-+GSX_D_>*NU=LDDF[<R_+7PI16E3"TZCO((U)1/LW
MP3^T-\,--^!?[/?AOQ),VMW7ACQ-=:EKNDO:2/Y,,DUVT<C,R^7)_KHFVJS?
MW:]F^+'[8GPW\0_"?XNZ*/BW/XKE\06,L.@:,/"\UC!IR,K*MNLGD[I&^;YI
M)&V_*NW;\V?S,HJ'@Z;=[C]M(_1C2_VNOA3#^T%\(/$DGB=DT30?!LFE:C=G
M3[K_ $>Z:/\ U>WR]S?[RJR_[5>&:1\;/!L/[*/QP\'2:QY7B3Q+XDAU#2K+
M[+/_ *1 MU;2,WF;=J_+&WRLRU\M441P=.(O;2/M/QY\=OAAKG@'X >*+/Q3
M<2>,/AE:Z7#)X1;2IO\ 3'MY;;S&^U?ZM5VV[[?O;MR_=KUKXH?MJ>&-<_MW
M6M"^/^NVFEWFFR+:>!K/PA;_ &B.X:/:JM>30,OE[OO#=N^]M>OS2HI?4Z8_
M;2/KWQK\?/ ^L:+^R7;VFN>;-X#FB;Q"OV29?L.V:R;^[^\^6&7_ %>[[M>L
M^'/VK_A);_'3XY>(+?Q6OA?4/$T5DOA[QRV@S7YMUCM(HY%^SM'N7]XN[YE5
M6V_-]U:_.FBJEA(R5OZ[B]M(_27Q=^U]\+-6_:!^ 'B0^.KC6M/\*VFKPZUK
M5SI$\,OF36?DQ2M#'"O^L?\ AC7:N[^&O%O"_P ?/ ]C\&OVDM"GUKRM3\8:
MO+=Z)!]DF;[9&TS-NW*FV/Y?^>FVOD.BE'!TXC]M(^V_VA/B)\!/VE?['\?Z
MSX[UK0/$ECX>^P3>$;71Y9)9;B/S6B5;C;Y:KYDC?>W;EV_=KU:']N3PMXR\
M+^#KZ#XVZK\)KNRL([?6O#5OX2CU/[3(GRLT-PT,BQ[OX=S-\NWY5;=7YG44
M?4Z<ERW*]M(]I\32_##QMX1^)WB_4?%>O/\ $F\\0RW.B:;<P*L=_:S7*-)-
M<^7!Y:R;6G;:K1KN7Y5KF/@[X?\ AQXDU+5;'XA^*=2\&PM:[M/U:RL/MD$<
MV[_EM"O[QEV_W=M>>T5T>Q]WDYC#G/N?Q9^USX)^%WA/X+^#O FNZG\0K;P5
MKD>M7VO7]O):M-%^_C:WCCDVLO[NXD5=WRJJQ_>^;;M:M^T%\$?AMXP^*WQ9
M\&>,K_Q+XU\9:7)96'AZ?2)X5L))@K2-)(VU9%\R-&^7^%=J[MVZOS^HKG^I
MTS3VTCZ]\:?'SP/K&B_LF6]IKGFS> YHF\0K]DF7[#MFLF_N_O/EAE_U>[[M
M=MX7_:>^&NG?MH_&#QU=^)-O@_Q!X9DL+"^^PW)^TS>59+M\OR]R_P"ID^9E
M5?E_VJ^#**7U6-K#]M(_7#P'J$/AGX<?L_>&O[?T3PMX]U#PZJ:,OB;PE/K&
MH1R-$GFM!/'/&MNNUONR?P[=WW2M?FQ\1M-\1_!']H#5EU*^BU#Q/H&M_;&O
M@,1W$RR>>LGR_P![Y6V_[5=3X7_;<^-W@OPO9^'=(\=W5KI-G"MM;PM9VLS1
M1K\JJLDD;2?+C^]7C&J:I>:YJEUJ&HW4U]J%U(T]Q<W,C22S2,VYF9F^\U*A
M0G3E+F*J5(RC[I]J?%[Q%^S7^TUXVTSXC:]\0]7\ ZO<V\*ZWX=&B3W4MPT:
M[?W<\:[5;:JKN^;Y57Y5KWWQ;\6M$\"_M+>%/B[K/B#3?^%-W'AJ3P_H>K:5
M(]YLGRLK+/'&K2!FVLOW6V[%W;6K\HZ*4L''X>8/;'W%X'^*WP._9AU3QEX]
M\(>.;_XE>/\ 6(KF'3K9-$FT^TM/.;S-TGG?>VLJ_,K?=_A[U\.T45U4J/LC
M*4N8***DMX)+JXBA@5I99&58U7^)JV>QFMS^CZEI*6OB#Z(**** "BBB@ HH
MHH 3:/2F^2M/HH 9Y*T>2M/HH 9Y*T>2M/HH 9Y*T>2M/HH 9Y*T>2M/HH 9
MY*T>2M96O:5+K6C:A80:E>:/+=P20+?V#1BXMF92OF1^8K+N7.Y=RLO'W37R
MY^SCI]K\%_#_ .TRNBF\NET+Q3>W:3:K>274UQ*NDVDS2332,S.SR%F9F_O4
M ?7'DK1Y*U\-_ N2V\#Z-\%_'/C3X6^&]4U;QN]A&/B-_:*ZCK[ZA>VAD2:8
M26JM'&WS1JL5PZQJ455VK7JO[7GAO2_%_B3X#Z-K>F66M:1>>.U2YL-1MUN(
M)E_LR_;:T;?*W([T >P>(O KZYKL&K67B'4] OH[=K5I-.2V;SHMV[:RS0R?
M=;^[M^\:@_X5_KO_ $4CQ/\ ^ ^E_P#R%7SUXSAM_P!EWXY6$/PYTN'3?#_B
M'PCK^K:CX2T^,1Z?'>:?';-;745LFU8Y)/,\AO+V^9\N[<R[JZ3]G3X#^!_%
M_P '_ ?CKQ#H]KXD\?ZYI=CKU_XRN.=6>[DACD)CO%VS1QK_ *M8XV55C7R]
MNW*UHJDDK/\ )#/8O^%?Z_\ ]%)\3_\ @-I?_P AUE:YX9O=!M4N=3^*^MV%
ML\T=LLUVNDQ(TDLBQQQ[FL\;FD955?XF95K@OA[\=_$OB+XX:IX0\1WOA[PQ
M/#?W4-KX1U'3KNTU2ZL8S,L%_:7DDGDWRR>3N:.&%?+67YI-T>V2Y\<+HZS^
MT%\ O"LYW:;-J.J>()HR/EDDL;/;!N/^S)=+)M_O1JW\-/VLO+[E_D%SU'P_
MX$LO#>@V>EQ-)=1VZ[?/N OF2'.YF;:JKN9O]FK+>$K5O^6:U\[?&SX=VNG_
M +67P(\7W&K:QJ.HWOB"^M+>UO;LO96$/]C7.Z.VA7:JEFC5VD;=(S?Q;555
MT?VS/!/PZF^'GB#5_$7A6R\2>.M9L6T/PO%<1^??2:BR2?9H[+=\T#>8WF-)
M#M^5-S?=J'*4I<TA'JOB'6/!?A'5M%TK7_$6C:'JNM3^1IECJ.H0V\][)N5?
M+AC9MTC;I%7:N[[R_P!ZM.XL=#LM8L=*GO;.'5+Z.6>ULI)E6>XCBV^:T<?W
MF5?,CW;?N[E_O5\S?%SX-^,-'^'*ZOXE\0:3<03> =+\->+=;U:]F6\L9+.8
MS37MDJPR?:KB5II-L;-'NDC@^9NE=#\)_BI OQ9U75_%_A_7+?Q9K^I6WAR3
M4"MO)IOAYFM_MEKHV[S?,\[RI5DFD6-HVGF$?F?+&JR![UHVGZ)X@T^+4-+N
M[;4K&;=Y=S:RK-')M;:VUE^7[R[:O_\ "(6O_/-:\C_9CN&TGQI\<?!\9_XE
M^A^,Y+FS0+\L4=]:P7LD:_\ ;::9O^!U[_0!SG_"(6O_ #S6C_A$+7_GFM='
M10!SG_"(6O\ SS6C_A$+7_GFM='7SA^T]X[URS\>_"_P!I$'B2ZM?$LFH7VH
MV_A&XAM=2O+:SBC8V\=U)-"MNK/<1LTBR(VV-E5E9EW 'MG_  B%K_SS6C_A
M$+7_ )YK7!_L\^)/#^LZ+KVE:/:^*=(U#0]5>RU71_&6K3:E?V=QY<;*IFDN
M;G=&T;1R+Y<S1_/_ 'MU>9?##P WQ@\4?'&YU;Q?XVL-1TOQO=Z5I-QIGBO4
M;>+3H5L;*2/R[59OL[;9)I&VR1LK;MK*R_+0!]$_\(E:_P!Q:Y'_ (4X8-1O
MKG3/%>M:-'>7#7,EI9QV31+(RKOV^=;R-\VW=]ZOGOP;\9_&OQFTWX-^ M2U
MBXTC4];NM?A\4:UHI^R7%Y#H\WV=EA9?FM_M,CQLS1[6CVR+'M^5J]:^(&L:
M?^R;X(O_ !+:7FO:YIMYJ&G:>MKXJ\2SW%AI\T]PL/VJ:_NA/-;P?O8_,;=)
M&OEKMC5F=FN$Y0^$#O8/AOK4'W?B+XE7_MVTO_Y"J;_A7^O_ /12?$__ (#:
M7_\ (=6_A]XBU3Q9X7M=2U73;+3;V7YU32]274+*:-OFCF@N-D9DC9&5OFC1
MNORXVLWS!9:;XS^*?P+^/_B?P7+>OX\\2^)KZQT>73=0^Q7$=KI]PMG;Q13&
M11'\MO-)]Y?FFD_O57M9>7W+_(=SZ&O/A7>ZO;BVU/QSXBU*Q:1&FM)X=/5)
ME5E;:S1VJL!E?X66NPNM$AN/O+7RW<6T'B3PS\3OAAX8L?B!X(^)NI>%IKFQ
MT_QUXHNM1-S;MNC$UO-]NNXHQYCK&S*RR+YB[EQBN'DU%_ <GC7P1;:)>?"+
MPOXDU&QN+W1]+BCN+K0M-DMX+5EMX=.:95O+^XCDCAC@W-M6:X9=R[:F4W)6
M8C[.;PE:M_RS6E_X1*U_N+7SW\2O$?AG3-+^ ?CWP)Y,&@Z=XHMO"D,<4#6R
MIIUYNL9K0PLJM%Y4\=MNC9596M-K+\M?4]0!SG_")6O]Q:/^$2M?[BUT=% '
M.?\ ")6O]Q:/^$2M?[BUT=% '.?\(E:_W%H_X1*U_N+71T4 <Y_PB5K_ '%H
M_P"$2M?[BUT=% '.?\(E:_W%H_X1*U_N+71T4 84'A>WAZ1K6K;VB6Z_**L4
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MQ)_P5K_Y-U\-_P#8UV__ *1WM?DO7ZT?\%:_^3=?#?\ V-=O_P"D=[7Y+U])
MEW\)GD8K^(?87_!+'_DYZ;_L W7_ *%!5;P'^T+\"?V=?[1\0?"KPIXSUSQW
M)!);V.I>-I+7R;+S%VLRK;M\W_?.[[R[EW5Y/^RU^T'_ ,,T_$Y_%ZZ%_P )
M%NL9K+[%]L^R?ZQE;=N\MO[O]VO'JUEA^:M)R^$R]IRQCRGVY^RW\5-;^''[
M'_Q[\:Z;)'=>(;?5-/DCN+V/SMLTTZ1^?M;[TB^9YB[OXE6E^"?Q+\3_ !T_
M96_:*TKQ[KE]XHATFPM]8L9-1F,DL$V9Y/E9ONKN@B^7[JX;;]ZOGCP9\=O^
M$1^ /Q"^&?\ 8GVM/%MU9W/]I_:?+^S?9YEDV^7M_>;O+V_>7;_M5)\'_CY_
MPJ?X=?%#PM_88U7_ (3?3H[#[7]K\G['M$OS;?+;S/\ 6_=W+]VE*A+WI<OV
MO\BU4^$]G^%7AGQ]8_L]Z#J_BGXXO\&?AN]W,-#M[.&9KR]DW-YDGEV^V21=
MV[[S-_NJNW=U'[<6K:9I^C_LV>)YM07Q^BZ<TMQK%S;-!)K4,,ELZ^8LGS+N
MW-\K?\]&KQWPG^U)X=D^$.@?#[XD?#"U^(=AX<FDDTB\76IM,GMUD;<T;-&K
M,R_]\_*J_P!U6JM\9OVL#\7/^%9!_ ^C:5!X'FF\G3(_WEA=0M-$T=N\++\L
M:QPK&WS-YGS-\OW:S]G5]IS<H<T>7E/I;Q]K/B;]I'5/$OC7X$_&:XO7NM*9
M+_X::K(T,L%OY"QS)!;R;H9/]Y5V[F_UFZLKX0Z;H7P__8+TK6E^)#_"6^\6
M:_-'J/B.UTNXO;F81M.L=JK6_P"\C7;#NW?[W]ZO)-%_;$\'?#V77-9^''P7
MT[P9XRU.TDLSK/\ ;EQ>0P*_^L\FU955>5^7YOE_W?EKB_@_^TS'X%^'>J_#
MOQAX.L_B%X#OKC[:NF75Y):SV=QMV^9#,NYH_P#@*_\ H3;I]A4Y>6WY%>TC
MS'KOQN^*'PZU_P#95?P==?%V?XM^-]-UB.]T74KS1;ZTN8(6VK)"TDR_,NWS
M&^9O[O\ =6OC*O5_BI\5/ 7BKPI;:%X)^$^G^ U6^6]N-1;59M3O9ML;+Y?F
M2*NV/YMVU?XE7_@7#> ?$&F^%?&VB:QJ^AP^)=-T^\CN;C2;F3RXKQ5;=Y;-
MM;Y6_P!UO]VNVA%TH&%27-(^K/V<O"NF?LI^!$^/7Q C4:]>V\D/@KPU(VV>
M\D9=K73+_#'M;[W]UMWWFCI?^"<OB*]\3?M9^(->U)A<ZCJ&D:E>W3,ORR22
M2Q2-\O\ O-5+XH_MG?"KXS^(%UOQE^S_ #:WJ4<(MXY&\<WD:1QK_"L<<:JO
M_ 5KSWX2_M,Z+\$/CIJ_CWPAX!_LO2+K3Y-/L_#W]L23?8]RQ_O/M$D;-)\T
M;-M9?XMM<OLZDHSYH>](WYHQE'ED>N?LE_M5?$WXE?M6Z%8>(O$5SJFA^(6N
M+.\T$_\ 'A'"(9&58K?[L>W:OS?>VK\S-\U>':M\2?$O[-WQQ^)-G\.=6;P_
M;?VKJ.D#RX8YU-JMRRJNV16_NK\WWJ].TG]N?P_X6U"^\5^'?@GX<T/XG7T#
M1S>);:^D:VCD9=LDT=GMVQLVYONM\W\3-7C_ ,%?C+HWPZ\3^(-:\7>!--^)
MCZM:20K'K<B_N9I&W?:-S1R?-][^'=\WWEJH4WS2ER$RE]GF/*J***]$Y0K]
M:/\ @DI_R;KXD_[&NX_]([*OR7K]:/\ @DI_R;KXD_[&NX_]([*O,S'^"CLP
MO\0^VZ***^:/7"BBB@ HHHH **** "BBB@ HHHH **** ,3Q=X9L_&7A36O#
M]^#]AU6RFL+@)]XQRQM&W_CK5^%'QZ_9Q\:?L]^++O2?$>EW#:='(RV>MQPM
M]DO(_P"%E;[JM_L_>6OWP H.*ZL/B98?5&%6C&KN?S?5[K\"?VP/%/P \#ZW
MX5T?P]X6UO1]9N&GOEU^QDN&F5HEC\MMLRJT>U?NLK?>:OW,V_2DVKZ5W2S!
M5(\LJ9S1PKC\,C\+]2_:NU6;QQX6\5Z'X"\ ^#=2\/M<"./PYH"V\-\MQ%Y<
MD=RK,WF+Y>Y5^[M\QJN_$3]LKQA\1/A_-X%M=%\)^ O#-Y,LM[:>$]*:R6Y^
M;=^\^9OEW;6;;][;7[B[1Z4;1Z5E]<I_\^R_J\OYC\4_VS/C-X4\>-\//!GP
M\U)M5\#>#-$CLK>[:WD@:6X;:LC,LBJWW8X_X?O;JS/AK^VQXL^&OAW0-,B\
M*>"/$$_A]6BTG5M=T;SK^Q5FW;8YED7;]ZOV^VCTHVCTI+&0Y.3V8?5Y<W-S
M'X5>$?VP_B3X1^,.M_$>+4K?4M<UN/R=1M[^WW6ES'\JK&T:LORKM7;M967_
M ($V[IS^T]_PO#QE\//#OQ#C\/>"?A5H>IK>W&D^'-(DCL@J[F;]ROF,V[YH
M_E^[YK?+7[7[1Z4;1Z4?7(?\^P^KR_F/P?\ VN/C1%\>/CSXA\3V,TEQHBLM
MEI6Y-O\ HL*[5;:WS+N;=)M;YOWE=WX1_;Z\2>!O!LOAC2_AK\,XM(N+>.WO
MK?\ L"14OU5-NZX59E61F_BW+WK]I-H]*-H]*/KD.7E]F'U>7-S<Q^&7PX_:
M_P#%?PSC\7V%AX>\*:CX8\37TFHW?A75-)\_2X9&;=LAA61=JK\JJNYEVQK_
M ':9XB_;(^)?B+XQ:'\27O[6QUG0X_)T^QL;?;8V\/W6A6%F;Y65F5OFW?[7
MRKM_=':/2C:/2J^NT^;F]F'U>7\Q^'?Q6_;6\;_%?P5J?A1]'\+^%-)U:Z^W
M:JOAG36M'U&;=NW3,TC;FW*K,W\6VN'^ OQXU_\ 9W\=?\)7X;L]-O=0^QR6
M7EZI'))!MDV[OECD5MWR_P!ZOW[VCTHV^U'UZ"CR^S#ZO+FYN8_!KP_^TYXL
M\._"WQUX$M[72Y=+\8WC7NH7$UO)]IC9MN[RV\S:J_+_ !*U>[?LL_M9KK'Q
M'^$FA>/]1TOPOX7\"6MU'I=_#&T?G326_DJMU(S,JKL9_F55K];\#THQ42Q<
M)1Y?9E1H2C]H_-'X[ZM\(9O@[\0Y_%?_  IR\\57DTA\,O\ # +)>^8V65KJ
M1?FW;OF;^'[W\3+7PA\.?'FJ_"WQUHGBS0I$BU32+E;JW\P9C;;]Y6_V67<K
M?[+5_0[U[T;:=+&^RCR\H2P_-+FYC\*/B_\ M:>-?C9\2_#'C77;?28;[PWY
M#6-E96\BVFZ.;SMS1R2,S;FV[OF^ZJUR7QN^,FM?'KXA7OC#Q#;6%IJ=W''%
M)'ID+1PA8UVK\K,S?P_Q-7] FWVI/PJXX^,/AID/#.7VC\#_ !M^T5XE\>_!
MSP?\-M0M=+BT'PQ(TMI-;0R+<R-\W^L9I&5OO-]U5IWP'_:,\5_LYWWB"]\(
MKIZWNL6/V"2:^A:5H/FW+)'\RKYBM_>W+_LU^]W'I1QZ"CZ_'EY?9A]6?-S<
MQ^&OQ:_;(\;_ !:\%0^$9=-\/>%M CN_MTUKX8L&LUN;C=N\R3]XWS;OF^7;
M\WS5U]M_P45^)4$-I=2Z%X-O?%-M:?8XO%UWHN[5DC_ZZ>9M_P#'=O\ LU^S
MFT>E&T>E1]<I\O+[,?U>7\Q_.3JVK7FO:I>:EJ-Q)>:A>327-Q<R-N:21FW,
MS?[S-4=G87&I745O9V\EU<R-MC@@C9F9O]U:_HZVT;?:NC^TG_*1]4_O'PC_
M ,$T_P!EGQ!\*8-9\>>+M/DT?5=8M5LK#3[A=L\-MN61FD7^$LRQ_+_LU]W&
MEH)KR:M25:7-([*=.-./+$6BBBLS0**** "BBB@!.XKXD_X*U?\ )NOAO_L:
M[?\ ]([VOMON*^)/^"M7_)NOAO\ [&NW_P#2.]KHP_\ %B8UOX;/COX,_P#!
M//XA_'+X9Z)XW\/:YX9MM-U99O+AU*XN(YX_+FDA8-Y<++]Z/^]79_\ #ICX
MO?\ 0Q>"O_ Z\_\ D6OMG_@G3_R9SX _[B'_ *<;FOI)J[*F.K1G))G/3P].
M48R/R4_X=+_%_P#Z&+P5_P"!UY_\BT?\.E_B]_T,?@K_ ,#KS_Y%K];:*S^O
M5^Y7U6F?DE_PZ7^+W_0Q^"O_  .O/_D6C_ATO\7O^AC\%?\ @=>?_(M?K;11
M]>K]P^JTS\DO^'2_Q>_Z&/P5_P"!UY_\BT?\.E_B]_T,?@K_ ,#KS_Y%K];:
M*/KU?N/ZK3/R2_X=+_%[_H8_!7_@=>?_ "+1_P .E_B]_P!#'X*_\#KS_P"1
M:_6VBCZ]7[A]5IGY)?\ #I?XO?\ 0Q^"O_ Z\_\ D6C_ (=+_%[_ *&/P5_X
M'7G_ ,BU^MM%'UZOW%]5IGY)?\.E_B]_T,?@K_P.O/\ Y%H_X=+_ !>_Z&/P
M5_X'7G_R+7ZVT4?7J_</JM,_)+_ATO\ %[_H8_!7_@=>?_(M'_#I?XO?]#'X
M*_\  Z\_^1:_6VBCZ]7[C^JTS\DO^'2_Q>_Z&/P5_P"!UY_\BT?\.E_B]_T,
M?@K_ ,#KS_Y%K];:*/KU?N'U6F?DE_PZ7^+W_0Q^"O\ P.O/_D6C_ATO\7O^
MAC\%?^!UY_\ (M?K;11]>K]P^JTS\DO^'2_Q>_Z&/P5_X'7G_P BT?\ #I?X
MO?\ 0Q^"O_ Z\_\ D6OUMHH^O5^X?5:9^27_  Z7^+W_ $,?@K_P.O/_ )%H
M_P"'2_Q>_P"AC\%?^!UY_P#(M?K;11]>K]P^JTS\DO\ ATO\7O\ H8_!7_@=
M>?\ R+1_PZ7^+W_0Q^"O_ Z\_P#D6OUMHH^O5^X?5:9^27_#I?XO?]#'X*_\
M#KS_ .1:/^'2_P 7O^AC\%?^!UY_\BU^MM%'UZOW#ZK3/R2_X=+_ !>_Z&/P
M5_X'7G_R+1_PZ7^+W_0Q^"O_  .O/_D6OUMHH^O5^XOJM,_)+_ATO\7O^AC\
M%?\ @=>?_(M'_#I?XO?]#'X*_P# Z\_^1:_6VBCZ]7[A]5IGY)?\.E_B]_T,
M?@K_ ,#KS_Y%H_X=+_%[_H8_!7_@=>?_ "+7ZVT4?7J_<?U6F?DE_P .E_B]
M_P!#'X*_\#KS_P"1:/\ ATO\7O\ H8_!7_@=>?\ R+7ZVT4?7J_<7U6F?DE_
MPZ7^+W_0Q^"O_ Z\_P#D6C_ATO\ %[_H8_!7_@=>?_(M?K;11]>K]P^JTS\D
MO^'2_P 7O^AC\%?^!UY_\BT?\.E_B]_T,?@K_P #KS_Y%K];:*/KU?N'U6F?
MDE_PZ8^+_P#T,7@O_P #KS_Y%KV/]FO_ ()AR?#WQQIWB;XC:WIVM2:;.MQ9
MZ3I'F- TR_,KRR2*K,JGYMNWK_%U5OT)H.*SEC:TH\MRXX>$1:***XSI"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R]:L;G4])NK2VO[K2)[B)
MHTOK18FFMV9<>8HD5X]R]?F5E]5->8_#/]GG_A6OB+Q'J8\>^*/$D7B2ZDO=
M6TW6HM,:VO+AH8X?,;R;.-E_=PJNU65/]FO8J* /#_!7[*^@>#[OPS$WB3Q+
MK_ASPI,T_ASPWK%U;R66DR?,L;1M'"LTWDQL\<?VB2;:K?WE5EZGXN?!RV^+
MA\+S2^(=8\-7_AO5?[8T^_T7[-YJ3^3)#\RW$,T;+MF?^&O1Z* /,_ _P4TW
MPGXFU/Q-JFJZMXR\5ZC:_8)=<\1/"TL=GE6^RQ1P11PPQ[EW,L<:^8V&8MM7
M;B^&_P!FVU\%^5IWA_QUXPT;P=%<>?!X2M+JU6Q@7.[R8YOL_P!LCAW?-Y:7
M"A<[5VK\M>S44 >20_ &S_X3[1O$^K^+?%'B&+0;RXO]&T?5)[=[2PGF5XV9
M66%;B3;'+(BB::155O\ 97;'\9? FKZWXN^%_C+P]:->:MX7UW-Q9M,D?F:?
M=PM:W6W<P7='YD<V-W/DLJY9E%>OT4 >,?$;]GN?XC>-M'\42?$KQ?HT^B7C
M7VDV6F1:5]FL)FMVMW91-8222%HY)/\ 6L_+DKM^7;%XK_9Q;Q+\3[#Q]'\2
M/&.D:_9:;_9-L+1=+F@@C./-DCCN+&58Y)2J^8R[2VU5^ZJK7ME% 'GNI_"N
MV\11^$5\0ZUJOB'_ (1J\74HQ>_9T6_NHP1#-<I##&K-$S>8JJJJLFUMK,B[
M<:^_9[T*[^)3>+!JNKI#)JL>OS>'HWA_LV;4H[5;2.[=?+\[>L:Q_*LBQ[HU
M9EW?-7K=% 'D?[/O@+6/"=EXSUSQ):_8O$'BSQ+>:S/:>:LGV:'Y;>UCW+\I
M;[/;PLVW^)FKURBB@ HHHH *\L^+'PEOO'OB+P=XJ\.Z[!X;\7>%9KE[&]O-
M/^W6TL-Q'Y=Q!-"LD3,K;8V^6165HUKU.B@#S;X2_"MOAR?$U_J&L?V[XI\3
MZD=5U?4EM?LL+R>7'#''##N;RXHXXHT56>1OXF9BU<7I/P+^(/A'Q!X\F\+?
M$71='TGQAKTFN3K/X6>YU"RDD@@A98)S>^3N5;=65I+=UW?>5E^6O?:* /!;
M[]E/2-%\'?#W3?!.LW7A;7O 4\D^AZY<Q_;FD:?=]L6[C9E\Y;G<S2;6C;=\
MRM'72'P?\4;C2;MKGXCZ,-?:2$VZVWA7;I(A7?YBR6TEV\\C2>9\S+=1A?*A
MVJN)/.]6HH \K_9\^"<'P)\&7VAQ7MO=27^JW6JRIINGKI]A;M,P_<VMJK-Y
M$*JJX3<WS;FW?-7%_"?P+XN\)Z?\4?!>EWDWAF[M_%TVN:%KEUI8NK&>SO)%
MO&C*LR>8JR-<V\BK(LBJ%967<C5]$44 >0^!_@[K6F?$J]^(7C'Q+;>)?%DF
MF'1+%=+TQM.L+*R:1)G58&GFD:1I8U9I&EZ*BJJ[?FQKC]FR8^"1'%XE0^/F
M\06WBBZ\4W6G&6*[U"%UVF2V\X'[.L*_9UA69?+C5=K;EW'W>B@#Y>U[X)ZI
MI_\ PJ3P+&UUK>[QM=>.O$>OQ6+06GF1S37[+MW,L/F7EQ L<;.S>7&WWMK-
M7U#110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?$?_  5J_P"3=/#?_8UV_P#Z
M1WM?DQ7[H?M:_LVG]J+X<:;X6'B+_A&?L>JQZG]K^Q?:M^V&:/R]OF1_\]MV
M[=_#7R=_PYX/_16__+:_^ZZ]K!XJE2I<LV>;B*-24^:)^<%%?H__ ,.>#_T5
MO_RVO_NNC_ASP?\ HK?_ );7_P!UUW_7Z'\QA]7J?RGYP45^C_\ PYX/_16_
M_+:_^ZZ/^'/!_P"BM_\ EM?_ '71]?H?S!]7J?RGYP45^C__  YX/_16_P#R
MVO\ [KH_X<\'_HK?_EM?_=='U^A_,'U>I_*?G!17Z/\ _#G@_P#16_\ RVO_
M +KH_P"'/!_Z*W_Y;7_W71]?P_\ ,'U>I_*?G!17Z/\ _#G@_P#16_\ RVO_
M +KH_P"'/!_Z*W_Y;7_W71]?H?S!]7J?RGYP45^C_P#PYX/_ $5O_P MK_[K
MH_X<\'_HK?\ Y;7_ -UT?7Z'\P?5Y_RGYP45^C__  YX/_16_P#RVO\ [KH_
MX<\'_HK?_EM?_=='U^A_,'U>I_*?G!17Z/\ _#G@_P#16_\ RVO_ +KH_P"'
M/!_Z*V/_  FO_NNCZ_0_F#ZO4_E/S@K]9_\ @DK_ ,FZ>)/^QKN/_2.SKS?_
M (<\G_HK8_\ ":_^ZZ^L?V2OV;3^R[\.-2\+'Q%_PDWVS59-3^U_8OLNS=##
M'Y>WS)/^>.[=N_BK@QF*I5J7+!F^'HU(SYI'N=%%%>*>D%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )W%?$G_
M  5J_P"3=?#?_8UV_P#Z1WM?;?<5\2?\%:O^3=?#?_8UV_\ Z1WM=&'_ (L3
M&M_#9Q?[.7[1NH_!;X#_ ++OA:QTBVU.'QSK&HZ9<3S2LK6J_P!K>7N7;][_
M (^&_P"^:_0Y>M?DEX;_ .1'_81_[&S4_P#T^VU?K9FM<7%1ES+S_,FB_='T
M445Q'0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E+0 4444
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3N*^)/^"M7_)NOAO\
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M_P#E%U'_ .1Z]'_X9G^$/_1+/!7_ (3MG_\ &Z/^&9_A#_T2SP3_ .$[9_\
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M+11169H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@!.XKXD_X*U?\FZ^&_P#L:[?_ -([VOMON*^)/^"M7_)NOAO_ +&NW_\
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M^K:#JL7EW=C)\VW</[K;6^;_ &6'RM0![?1110 4444 %%%% !1110 4444
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M&5OF5E96KYMU3_@IQ\,1)>3>'?"WQ!\<:'9NRW&O^'/#C26$17[VZ222,_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI;X4Z_X,O_AYX;^&UG<6$GVYUUF&]N=795W+;VVUF6%9'"JS2-\J_P 7][]
M** /E[_A3?C#_AWC_P *P_LH_P#"<?\ ""?V/_9?VJ'_ (^_LVWRO,W>7][Y
M=V[;_M5W_P"R7X&USX9?LW?#SPIXDL_[-U[2=*CMKRT,L<OE2?-\NZ-F5O\
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M!^S?XI\)?%231-'\4>)+&^L'/AOS7MK2.966'_6'<S+N^;^]7S=\&=)_:_\
M@?\ #&P^$FD_#?PEJ2:4DEIIOC>XUZ-;.&)I&8/);#]])MW<?*O;<K5^@-%
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MHHK(T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDHS0
MM%%% !1110 4444 %%%% !1110 4444 %%%)0 M%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 44F:* %HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC*4H\OPE<U3E^(]R_P"&]OCY_P!%&OO_  #M/_C='_#>WQ\_Z*-??^ =K_\
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MS+]U?SJU+3;K2=0NK&]ADMKRUF:":"1=K1R*VUE;_@5?3WAW]L+P'X*\1?\
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M[+E+]WFYCO/#_P"V-\8;_P#:EL;N?Q+K$5K=>(H[&3PRTW^C1VS7>W[/Y/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?_XW7W9FC-'UNM_,'L*?\I\)_P##HWX<_P#0X^*/^^K?_P"-T?\ #HWX<_\
M0X^*/^^K?_XW7W9FC-'UNM_,'L*?\I\)_P##HWX<_P#0X^*/^^K?_P"-T?\
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MHS1]<K?S!["G_*?"?_#HWX<_]#CXH_[ZM_\ XW1_PZ-^'/\ T./BC_OJW_\
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M?_XW7W9FC-'UNM_,'L*?\I\)_P##HWX<_P#0X^*/^^K?_P"-T?\ #HWX<_\
M0X^*/^^K?_XW7W9FC-'UNM_,'L*?\I\)_P##HWX<_P#0X^*/^^K?_P"-T?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !24M% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+10!Y?
MXK^ WAGQQ\6O#WC[7K7^TM2\/VK0:;:S*&AAD:3=YY7^)U_A_N_>^]M*^G[:
M6DHYG(!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>abvx-20241231_g21.jpg
<TEXT>
begin 644 abvx-20241231_g21.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *8!P8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***3(]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI
M-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI
M-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI
M-P]:-P]: %HHHH **** "BBB@ HHHH **** "BBB@ HI,BC</6@!:*3</6C<
M/6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3-&: %
MHI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %
MHI-P]:-P]: %HI-P]:-P]: %HI-P]:6@ HHHH **** "BBB@ HHHH ***3(]
M: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]
M: %HI-P]:-P]: %HI,BC</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@
M!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C(H 6BBB@ HHHH **
M** "BBB@ HI,T;AZT +12;AZT;AZT +12;AZT;AZT +129HW#UH 6BDW#UHR
M/6@!:*3(]:-P]: %HI,BC</6@!:*3</6C</6@!:*3-&: %HI-P]:-P]: %HI
M-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:6@ HHHH
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M*[__ .,4?\/,/V:?^BGV_P#X*[__ .,5])_V-8?\^%O_ -^EH_L:P_Y\+?\
M[]+0!\V?\/,/V:?^BGV__@KO_P#XQ1_P\P_9I_Z*?;_^"N__ /C%?2?]C6'_
M #X6_P#WZ6C^QK#_ )\+?_OTM 'S9_P\P_9I_P"BGV__ (*[_P#^,4?\/,/V
M:?\ HI]O_P""N_\ _C%?2?\ 8UA_SX6__?I:/[&L/^?"W_[]+0!\V?\ #S#]
MFG_HI]O_ ."N_P#_ (Q1_P /,/V:?^BGV_\ X*[_ /\ C%?2?]C6'_/A;_\
M?I:/[&L/^?"W_P"_2T ?-G_#S#]FG_HI]O\ ^"N__P#C%'_#S#]FG_HI]O\
M^"N__P#C%?2?]C6'_/A;_P#?I:/[&L/^?"W_ ._2T ?-G_#S#]FG_HI]O_X*
M[_\ ^,4?\/,/V:?^BGV__@KO_P#XQ7TG_8UA_P ^%O\ ]^EH_L:P_P"?"W_[
M]+0!\V?\/,/V:?\ HI]O_P""N_\ _C%'_#S#]FG_ **?;_\ @KO_ /XQ7TG_
M &-8?\^%O_WZ6C^QK#_GPM_^_2T ?-G_  \P_9I_Z*?;_P#@KO\ _P",4?\
M#S#]FG_HI]O_ ."N_P#_ (Q7TG_8UA_SX6__ 'Z6C^QK#_GPM_\ OTM 'S9_
MP\P_9I_Z*?;_ /@KO_\ XQ1_P\P_9I_Z*?;_ /@KO_\ XQ7TG_8UA_SX6_\
MWZ6C^QK#_GPM_P#OTM 'S9_P\P_9I_Z*?;_^"N__ /C%'_#S#]FG_HI]O_X*
M[_\ ^,5])_V-8?\ /A;_ /?I:/[&L/\ GPM_^_2T ?-G_#S#]FG_ **?;_\
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M9=?LS_$*3XS>,/%6I>/-3T^RUO2-5G4Z2T-PD+;(K51M1E5BN[YF9OFW+TH
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M4444#"BBB@ HHHH **** "DI:2@#\F_C/_R6+QW_ -AV^_\ 2B2N.KL?C/\
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M6A 4444 %?LJOW17XU5^RJ_=%>#FF\3T\#]H6BBBO%/5"BBB@ HHHH ****
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MHHH *^5/V7_^3N/VK_\ L+:'_P"D#5]5U\J?LO\ _)W'[5__ &%M#_\ 2!J
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M-&_[ 4/_ *47-?-%?68/^!$^?Q'\204445V'.%%%% !1110!]B? C1]%T_\
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M%M#_ /2!J /JNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  3W'_Q-'_"E_B#_ -")XF_\$]Q_\37ZQ;:-M']I5/Y0^IQ[GY._\*7^(/\
MT(GB;_P3W'_Q-'_"E_B#_P!")XF_\$]Q_P#$U^L6VC;1_:53^4/J<>Y^3O\
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M$\3?^">X_P#B:_6+;1MH_M*I_*'U./<_)W_A2_Q!_P"A$\3?^">X_P#B:/\
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MW_@GN/\ XFC_ (4O\0?^A$\3?^">X_\ B:_6+;1MI?VE/^5!]3C_ #'Y._\
M"E_B#_T(GB;_ ,$]Q_\ $T?\*7^(/_0B>)O_  3W'_Q-?K%MHVT?VE/^5!]3
MC_,?D[_PI?X@_P#0B>)O_!/<?_$T?\*7^(/_ $(GB;_P3W'_ ,37ZQ;:-M']
MI3_E0?4U_,?D[_PI?X@_]")XF_\ !/<?_$T?\*7^(/\ T(GB;_P3W'_Q-?K%
MMHVT?VE/^5!]3C_,?D[_ ,*7^(/_ $(GB;_P3W'_ ,31_P *7^(/_0B>)O\
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M3Q-_X)[C_P")K]8MM&VG_:4_Y4'U./<_)W_A2_Q!_P"A$\3?^">X_P#B:/\
MA2_Q!_Z$3Q-_X)[C_P")K]8MM&VE_:4_Y4'U./<_)W_A2_Q!_P"A$\3?^">X
M_P#B:/\ A2_Q!_Z$3Q-_X)[C_P")K]8MM&VC^TI_RH/J<>Y^3O\ PI?X@_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'_"*1SS374S33W$C7*[I)&;[S-7T7K%W=66EWMQ96?\ :%Y%#(\-HLBQ_:)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$7V^'1+ZRDM[N>&.:T9FCCD56;Y8VV_WMG%??G[,/Q O_B)\)='N-0\%^)O
MMUID4.F2Z?XJL/L=S*\<$>Z:-/O>5N9E5F"[MK?**]@HH ^$M&^&?BU?V[OV
MF?$+>&M6&@ZQX,AL].U1[&1;:]F^QVB>7')MVR-NC==J_P!VO,]+^#_CF/\
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M_P 31_PN/]JW_HWCP_\ ^%M!_P#$U]644 ?*?_"X_P!JW_HWCP__ .%M!_\
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MI_\ "X_VK?\ HWCP_P#^%M!_\31_PN/]JW_HWCP__P"%M!_\37U910!\I_\
M"X_VK?\ HWCP_P#^%M!_\31_PN/]JW_HWCP__P"%M!_\37U910!\I_\ "X_V
MK?\ HWCP_P#^%M!_\31_PN/]JW_HWCP__P"%M!_\37U910!\I_\ "X_VK?\
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M7YOF_B_VJT_B1\)='^*TGAW^V[B^^QZ)J4>JQV4$B+!<S1_<\Y65MRKS\O%
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M_P#BJ/\ A*+O^[%_WRW_ ,56317?[*F<_M)&M_PE%W_=B_[Y;_XJC_A*+O\
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MR[?]FJ'AGP/X=\%PW$?A[0-+T%)V\R9=+LX[=9&_O-Y:KN-;^X>M% Q:***
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MKN\\=VTNGB>2V\O[,NG?ZP>7N^6/JK*O]VOT(H **** /E/XX?\ )_7[,O\
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M\>_^A\_\H]A_\9H_L?$=XA_:=+^5G[(45^-__#P#X]_]#Y_Y1[#_ .,T?\/
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MGF*=Q5?E7=]VNTHH S]-TVST73X+*QLX;&R@3RXK:WC6..-?[JJORJM:%%%
M!7RG\<O^3^?V8_\ KP\3?^D<=?5E?*?QR_Y/Y_9C_P"O#Q-_Z1QT ?5E%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8_\  6?_ .2*/^'B7Q)_Z!/AC_P%G_\ DBOEWBCBG_J]EO\ SY7XA_K!F?\
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MQ?\ \G+^#OK>?^D<U?J>>]?C/&'_ ",(_P"']6?M?!O^X3_Q?HCXU_X*H_\
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M_P#CE6?^&6/@O_T2+P'_ .$S9?\ QJC_ (98^"__ $2+P'_X3-E_\:H K?\
M#7'P-_Z+%X#_ /"DL_\ XY1_PUQ\#?\ HL7@/_PI+/\ ^.59_P"&6/@O_P!$
MB\!_^$S9?_&J/^&6/@O_ -$B\!_^$S9?_&J *W_#7'P-_P"BQ> __"DL_P#X
MY1_PUQ\#?^BQ> __  I+/_XY5G_AECX+_P#1(O ?_A,V7_QJC_AECX+_ /1(
MO ?_ (3-E_\ &J *W_#7'P-_Z+%X#_\ "DL__CE'_#7'P-_Z+%X#_P#"DL__
M (Y5G_AECX+_ /1(O ?_ (3-E_\ &J/^&6/@O_T2+P'_ .$S9?\ QJ@"M_PU
MQ\#?^BQ> _\ PI+/_P".4?\ #7'P-_Z+%X#_ /"DL_\ XY5G_AECX+_]$B\!
M_P#A,V7_ ,:H_P"&6/@O_P!$B\!_^$S9?_&J *W_  UQ\#?^BQ> _P#PI+/_
M ..4?\-<? W_ *+%X#_\*2S_ /CE6?\ AECX+_\ 1(O ?_A,V7_QJC_AECX+
M_P#1(O ?_A,V7_QJ@#Y>^,'[17PMU;]M3]GO7K+XD>$[S1-+LO$*7^I0ZW;/
M;6;26JK$LLF_;'N;Y5W?>KZ8_P"&N/@;_P!%B\!_^%)9_P#QROF_XQ? /X9:
M;^VQ^SUH=I\.?"EOHVIV/B%K[38-#M4MKDQVJM&TD8CVR;6^[N^[7TS_ ,,L
M?!?_ *)%X#_\)FR_^-4 5O\ AKCX&_\ 18O ?_A26?\ \<H_X:X^!O\ T6+P
M'_X4EG_\<JS_ ,,L?!?_ *)%X#_\)FR_^-4?\,L?!?\ Z)%X#_\ "9LO_C5
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M_P#A26?_ ,<JS_PRQ\%_^B1> _\ PF;+_P"-4?\ #+'P7_Z)%X#_ /"9LO\
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M_P#"DL__ (Y5G_AECX+_ /1(O ?_ (3-E_\ &J/^&6/@O_T2+P'_ .$S9?\
MQJ@"M_PUQ\#?^BQ> _\ PI+/_P".4?\ #7'P-_Z+%X#_ /"DL_\ XY5G_AEC
MX+_]$B\!_P#A,V7_ ,:H_P"&6/@O_P!$B\!_^$S9?_&J *W_  UQ\#?^BQ>
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M_P!JO_L-Z1_Z0U]5U\J?LL_\G5_M5_\ 8;TC_P!(: /JNBBB@ HHHH ****
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M>7_!)/[WQ4^FE?\ MY7Z&_Q5\'F7^]2_KH?7X'^!$=1117G'<%%%% !1110
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M<?+O_P" KN;=_>VU[510!XGX@^!L6F_LK:A\,=#"R31:#)9V[?<$]SM+;O\
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M?NM(S;I&9F:O9O\ A+M$_P"@SI__ (%1_P#Q5'_"7:)_T&=/_P# J/\ ^*H
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M=/\ _ J/_P"*H V**Q_^$NT3_H,Z?_X%1_\ Q5'_  EVB?\ 09T__P "H_\
MXJ@#YK^.'_)_7[,O_8.\3?\ I''7U97R%\;/$>E2?MW?LUW":E9O##8>)O,E
M6X78FZTCV[FS7U+_ ,)=HG_09T__ ,"H_P#XJ@#8HK'_ .$NT3_H,Z?_ .!4
M?_Q5'_"7:)_T&=/_ / J/_XJ@#8HK'_X2[1/^@SI_P#X%1__ !5'_"7:)_T&
M=/\ _ J/_P"*H V**Q_^$NT3_H,Z?_X%1_\ Q5'_  EVB?\ 09T__P "H_\
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M_P#A+M$_Z#.G_P#@5'_\51_PEVB?]!G3_P#P*C_^*H V**Q_^$NT3_H,Z?\
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M8?QPHHHKVCRPHHHH *_4S_@E=_R;_P"(/^QGN/\ TEM*_+.OU,_X)7?\F_\
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M_'J^EJY2Z^(>@V?CZR\$2:@5\37MA+J=O8^3)^\MHY%CDD\S;M^5I%^7=NH
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MFG_^!EW_ /'J/^'</[-W_1+-/_\  R[_ /CU?2U% 'S3_P .X?V;O^B6:?\
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M7\ VE[H_AS5=,MM*LY+JX5;6.2U\R15VR[FW-\WS9K]&J^5/V6?^3J_VJ_\
ML-Z1_P"D- &K_P .X?V;O^B6:?\ ^!EW_P#'J/\ AW#^S=_T2S3_ /P,N_\
MX]7TM10!\T_\.X?V;O\ HEFG_P#@9=__ !ZC_AW#^S=_T2S3_P#P,N__ (]7
MTM10!\T_\.X?V;O^B6:?_P"!EW_\>H_X=P_LW?\ 1+-/_P# R[_^/5]+44 ?
M-/\ P[A_9N_Z)9I__@9=_P#QZC_AW#^S=_T2S3__  ,N_P#X]7TM7&Z;\7O
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MZBBBO..X**** "BBB@ HHHH **** "BBB@ KD_%'_(07_KE_[,U=97)^*/\
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MF6?_ ,9KV<LR3$9M&3H27N]_^&/G\SSS#95.,*\7[W;_ (<_4[\*/PK\L/\
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MO7XX5^Q__!0#_DT?Q[]+#_TOMZ_'"O"R;_=Y?XCZ[-/XT?0****]T\<****
M"OLC_@EC_P G">(/^Q8N/_2NTKXWK[(_X)8_\G">(/\ L6+C_P!*[2O/S#_=
M)'9@_P#>(GZH4445\$?8A1110 4444 %%%% !1110 4444 %%%% '.>+.MI_
MP+_V6N?KH/%G6T_X%_[+7/UZE#^&<=3X@HHHK<S"BBB@ KL/#_\ R"X?^!?^
MA&N/KL/#_P#R"X?^!?\ H1KDQ'PF]/XC1D^X?I7X\_&O_DLGC_\ [&#4/_2B
M2OV&D^X?I7X\_&O_ )+)X_\ ^Q@U#_THDK[#@S_>:O\ A/@.-?\ =Z7^(XFB
MBBOUT_'PHHHH 4=Z[3X)_P#)9/ /_8P:?_Z41UQ8[UVGP3_Y+)X!_P"Q@T__
M -*(ZX<=_NM7_#([\#_O-/\ Q1/V$7I^%?/?_!0#_DT?QY_VX_\ I?;U]"+T
M_"OGO_@H!_R:/X\_[<?_ $OMZ_GG#_[Q3_Q(_I"M_"EZ'XX4445^B'Q84444
M %%%% 'Z$_\ !)/[WQ4^FE?^WE?H;_%7YY?\$D_O?%3Z:5_[>5^AO\5?!YE_
MO4OZZ'U^!_@1'4445YQW!1110 4444 %%%% !1110 4444 %<GXH_P"0@O\
MUR_]F:NLKD_%'_(07_KE_P"S-71A_P"(95/A,BBBBO3.0**** "BBBD!W&G?
M\@^V_P"N2_R%6)?]6_T-5]._Y!]M_P!<E_D*L2_ZM_H:\9_$=TOA9^(E%%%?
MTU'X4?RY/XF%%%%40%+24M,#VS]B_P#Y.7\'?6\_](YJ_4\]Z_+#]B__ ).7
M\'?6\_\ 2.:OU//>OQGC#_D81_P_JS]KX-_W"?\ B_1'QK_P51_Y-_\ #_\
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M'_#N+X;_ /0T_$3_ ,*RXH ^JZ*^5/\ AW%\-_\ H:?B)_X5EQ1_P[B^&_\
MT-/Q$_\ "LN* /JNBOE3_AW%\-_^AI^(G_A67%'_  [B^&__ $-/Q$_\*RXH
M ^JZ*^5/^'<7PW_Z&GXB?^%9<4?\.XOAO_T-/Q$_\*RXH ^JZ*^5/^'<7PW_
M .AI^(G_ (5EQ1_P[B^&_P#T-/Q$_P#"LN* /JNBOE3_ (=Q?#?_ *&GXB?^
M%9<4?\.XOAO_ -#3\1/_  K+B@!/CA_R?U^S+_V#O$W_ *1QU]65^:OQ2_8K
M\%^'?VN?@9X4@U[QG+I>OV>NRW,\_B":2YC:WME9?)D^]'][YMOWJ]__ .'<
M7PW_ .AI^(G_ (5EQ0!]5T5\J?\ #N+X;_\ 0T_$3_PK+BC_ (=Q?#?_ *&G
MXB?^%9<4 ?5=%?*G_#N+X;_]#3\1/_"LN*/^'<7PW_Z&GXB?^%9<4 ?5=%?*
MG_#N+X;_ /0T_$3_ ,*RXH_X=Q?#?_H:?B)_X5EQ0!]5T5\J?\.XOAO_ -#3
M\1/_  K+BC_AW%\-_P#H:?B)_P"%9<4 ?5=%?*G_  [B^&__ $-/Q$_\*RXH
M_P"'<7PW_P"AI^(G_A67% 'U717RI_P[B^&__0T_$3_PK+BC_AW%\-_^AI^(
MG_A67% 'U717RI_P[B^&_P#T-/Q$_P#"LN*/^'<7PW_Z&GXB?^%9<4 ?5=?*
MG[+/_)U?[5?_ &&](_\ 2&C_ (=Q?#?_ *&GXB?^%9<5\_\ P&_8M\$^+/CY
M^T!H%WKWC.&T\.ZIIUM:2VGB&:*>59+7S&,\B_ZQMWW=U 'Z5T5\J?\ #N+X
M;_\ 0T_$3_PK+BC_ (=Q?#?_ *&GXB?^%9<4 ?5=%?*G_#N+X;_]#3\1/_"L
MN*/^'<7PW_Z&GXB?^%9<4 ?5=%?*G_#N+X;_ /0T_$3_ ,*RXH_X=Q?#?_H:
M?B)_X5EQ0!]5T5\J?\.XOAO_ -#3\1/_  K+BC_AW%\-_P#H:?B)_P"%9<4
M?5=%?*G_  [B^&__ $-/Q$_\*RXH_P"'<7PW_P"AI^(G_A67% 'U717RI_P[
MB^&__0T_$3_PK+BC_AW%\-_^AI^(G_A67% 'U717RI_P[B^&_P#T-/Q$_P#"
MLN*/^'<7PW_Z&GXB?^%9<4 ?5=?*?QR_Y/Y_9C_Z\/$W_I''2_\ #N+X;_\
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M'X^_[&#4/_2B2N*]*_HK _[I2_PQ/YIQG^\U/\4A****[SA"BBB@!:_;J/\
MU*_2OQ%K]NH_]2OTK\OXVWP__;W_ +:?JO ^V(_[=_4^>?\ @H!_R:/X]^EA
M_P"E]O7XX5^Q_P#P4 _Y-'\>_2P_]+[>OQPKPLF_W>7^(^NS3^-'T"BBBO=/
M'"BBB@ K[(_X)8_\G">(/^Q8N/\ TKM*^-Z^R/\ @EC_ ,G">(/^Q8N/_2NT
MKS\P_P!TD=F#_P!XB?JA1117P1]B%%%% !1110 4444 %%%% !1110 4444
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MS+_V#O$W_I''7U97RG\</^3^OV9?^P=XF_\ 2..OJR@ HHHH **** "BBB@
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M%BX_]*[2O/S#_=)'9@_]XB?JA1117P1]B%%%% !1110 4444 %%%% !1110
M4444 <YXLZVG_ O_ &6N?KH/%G6T_P"!?^RUS]>I0_AG'4^(****W,PHHHH
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M^+]$?&O_  51_P"3?_#_ /V,]O\ ^DMW7Y9U^IG_  51_P"3?_#_ /V,]O\
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M>/\ P5L^]\*_IJO_ +9U^)Y;_O4?ZZ'[OCO]WD?GM1117WI\B%%%% !1113
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MB@ HHHH *^5/V6?^3J_VJ_\ L-Z1_P"D-?5=?*G[+/\ R=7^U7_V&](_](:
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M2_$B^\0^!M/DC,>AOIT<,DT<;!HHYKA6W2*NU?X>U>C>.OAROQ UCPZ-0O\
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M#_WB)^J%%%%?!'V(4444 %%%% !1110 4444 %%%% !1110!SGBSK:?\"_\
M9:Y^N@\6=;3_ (%_[+7/UZE#^&<=3X@HHHK<S"BBB@ KL/#_ /R"X?\ @7_H
M1KCZ[#P__P @N'_@7_H1KDQ'PF]/XC1D^X?I7X\_&O\ Y+)X_P#^Q@U#_P!*
M)*_8:3[A^E?CS\:_^2R>/_\ L8-0_P#2B2OL.#/]YJ_X3X#C7_=Z7^(XFBBB
MOUT_'PHHHH 4=Z[3X)_\ED\ _P#8P:?_ .E$=<6.]=I\$_\ DLG@'_L8-/\
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M%?TU'X4?RY/XF%%%%40%+24M,#VS]B__ ).7\'?6\_\ 2.:OU//>ORP_8O\
M^3E_!WUO/_2.:OU//>OQGC#_ )&$?\/ZL_:^#?\ <)_XOT1\:_\ !5'_ )-_
M\/\ _8SV_P#Z2W=?EG7ZF?\ !5'_ )-_\/\ _8SV_P#Z2W=?EG663_[LSU,P
M_CA1117M'EA1110 5^IG_!*[_DW_ ,0?]C/<?^DMI7Y9U^IG_!*[_DW_ ,0?
M]C/<?^DMI7C9O_NZ/4R_^.?9E%%%?%GU(4444 %%%% !1110 4444 %%%% !
M1110!QOB#_D+S_\  ?\ T&LZM'Q!_P A>?\ X#_Z#6=7K4O@B<4_B"BBBM2
MHHHH *]!["O/J]!["N+$_9.FCL<#\>/^2)_$#_L 7_\ Z3R5^0785^OOQX_Y
M(G\0/^P!?_\ I/)7Y!=A7Z-P7_"K^J/RKC;^-1]!****_23\S"BBB@!W\-?4
M/_!.W_DMNK_]@";_ -*+>OE[^&OJ'_@G;_R6W5_^P!-_Z46]?/<0_P#(MK>A
M]%P__P C.CZGZ-=Z_/'_ (*V?>^%?TU7_P!LZ_0[O7YX_P#!6S[WPK^FJ_\
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M^JZ* /E3_AB_QM_T<W\5/_ R#_XW1_PQ?XV_Z.;^*G_@9!_\;KZKHH ^5/\
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MXJ?^!D'_ ,;KZKHH ^5/^&+_ !M_T<W\5/\ P,@_^-T?\,7^-O\ HYOXJ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'G'QL^(5UX!\*Q)H\*W?BK6+A=-T:T8?ZRX?^)O]E5^9O]VO-/AG\;M>TO\
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MKW3QPHHHH *^R/\ @EC_ ,G">(/^Q8N/_2NTKXWK[(_X)8_\G">(/^Q8N/\
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M])/S,**** '?PU]0_P#!.W_DMNK_ /8 F_\ 2BWKY>_AKZA_X)V_\EMU?_L
M3?\ I1;U\]Q#_P BVMZ'T7#_ /R,Z/J?HUWK\\?^"MGWOA7]-5_]LZ_0[O7Y
MX_\ !6S[WPK^FJ_^V=?B>6_[U'^NA^[X[_=Y'Y[4445]Z?(A1110 4444P/V
M/_X)_P#_ ":/X#_[?O\ TON*^A3UKYZ_X)__ /)H_@/_ +?O_2^XKZ%/6OSG
M$_QZG^)GVU#^%'T)****YS<**** "BBB@ HHHH **** "BBB@ HHHH ****
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M\B%%%% !1113 _8__@G_ /\ )H_@/_M^_P#2^XKZ%/6OGK_@G_\ \FC^ _\
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M7NGCA1110 5]D?\ !+'_ ).$\0?]BQ<?^E=I7QO7V1_P2Q_Y.$\0?]BQ<?\
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MK\LZ_4S_ (*H_P#)O_A__L9[?_TENZ_+.LLG_P!V9ZF8?QPHHHKVCRPHHHH
M*_4S_@E=_P F_P#B#_L9[C_TEM*_+.OU,_X)7?\ )O\ X@_[&>X_]);2O&S?
M_=T>IE_\<^S****^+/J0HHHH **** "BBB@ HHHH **** "BBB@#C?$'_(7G
M_P" _P#H-9U:/B#_ )"\_P#P'_T&LZO6I?!$XI_$%%%%:D!1110 5Z#V%>?5
MZ#V%<6)^R=-'8X'X\?\ )$_B!_V +_\ ])Y*_(+L*_7WX\?\D3^('_8 O_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/L0HHHH **** "BBB@ HHHH **** "BBB@#G/%G6T_X%_P"RUS]=!XLZVG_
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MPC_A_5G[7P;_ +A/_%^B/C7_ (*H_P#)O_A__L9[?_TENZ_+.OU,_P""J/\
MR;_X?_[&>W_]);NORSK+)_\ =F>IF'\<****]H\L**** "OU,_X)7?\ )O\
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MJ/\ R;_X?_[&>W_]);NORSK+)_\ =F>IF'\<****]H\L**** "OU,_X)7?\
M)O\ X@_[&>X_]);2ORSK]3/^"5W_ ";_ .(/^QGN/_26TKQLW_W='J9?_'/L
MRBBBOBSZD**** "BBB@ HHHH **** "BBB@ HHHH XWQ!_R%Y_\ @/\ Z#6=
M6CX@_P"0O/\ \!_]!K.KUJ7P1.*?Q!1116I 4444 %>@]A7GU>@]A7%B?LG3
M1V.!^/'_ "1/X@?]@"__ /2>2OR"["OU]^/'_)$_B!_V +__ -)Y*_(+L*_1
MN"_X5?U1^5<;?QJ/H)1117Z2?F84444 ._AKZA_X)V_\EMU?_L 3?^E%O7R]
M_#7U#_P3M_Y+;J__ & )O_2BWKY[B'_D6UO0^BX?_P"1G1]3]&N]?GC_ ,%;
M/O?"OZ:K_P"V=?H=WK\\?^"MGWOA7]-5_P#;.OQ/+?\ >H_UT/W?'?[O(_/:
MBBBOO3Y$**** "BBBF!^Q_\ P3__ .31_ ?_ &_?^E]Q7T*>M?/7_!/_ /Y-
M'\!_]OW_ *7W%?0IZU^<XG^/4_Q,^VH?PH^A)1117.;A1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E7QA^.VG?".S>%=-O-?U
M[[')?II=DC<6\>[S)I)-NV.-=K?-_P".UO6'Q(L&^%%CX]U-?[,TV;1XM8FC
MW^9Y*M"LFW=QN;YMO^U4'QRMXS\&_B#-Y:B1O#E^K2;?F*_9Y.*\@^)RS-^P
M+9_9_P#6_P#"+Z0S?[O^C;O_ !W=0!KR_M.:[H^D:=XJU_X:ZAHO@2^DC"ZT
MVJ0RRQ1R,!'+);*NY5;=_>_]EJ]X_P#C)XML]9\>+X4L]%GTSP/86]]J']I>
M:TMYOA:9EA9755VQK]YMWS4W]H.]LO\ AD76)6DC^R2:1:^0X^Z=S1>7M_\
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M-.,_WFI_BD)1117><(4444 +7[=1_P"I7Z5^(M?MU'_J5^E?E_&V^'_[>_\
M;3]5X'VQ'_;OZGSS_P % /\ DT?Q[]+#_P!+[>OQPK]C_P#@H!_R:/X]^EA_
MZ7V]?CA7A9-_N\O\1]=FG\:/H%%%%>Z>.%%%% !7V1_P2Q_Y.$\0?]BQ<?\
MI7:5\;U]D?\ !+'_ ).$\0?]BQ<?^E=I7GYA_NDCLP?^\1/U0HHHKX(^Q"BB
MB@ HHHH **** "BBB@ HHHH **** .<\6=;3_@7_ ++7/UT'BSK:?\"_]EKG
MZ]2A_#..I\04445N9A1110 5V'A__D%P_P# O_0C7'UV'A__ )!</_ O_0C7
M)B/A-Z?Q&C)]P_2OQY^-?_)9/'__ &,&H?\ I1)7[#2?</TK\>?C7_R63Q__
M -C!J'_I1)7V'!G^\U?\)\!QK_N]+_$<31117ZZ?CX4444 *.]=I\$_^2R>
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M_P#P'_T&LZO6I?!$XI_$%%%%:D!1110 5Z#V%>?5Z#V%<6)^R=-'8X'X\?\
M)$_B!_V +_\ ])Y*_(+L*_7WX\?\D3^('_8 O_\ TGDK\@NPK]&X+_A5_5'Y
M5QM_&H^@E%%%?I)^9A1110 [^&OJ'_@G;_R6W5_^P!-_Z46]?+W\-?4/_!.W
M_DMNK_\ 8 F_]*+>OGN(?^1;6]#Z+A__ )&='U/T:[U^>/\ P5L^]\*_IJO_
M +9U^AW>OSQ_X*V?>^%?TU7_ -LZ_$\M_P!ZC_70_=\=_N\C\]J***^]/D0H
MHHH ****8'['_P#!/_\ Y-'\!_\ ;]_Z7W%?0IZU\]?\$_\ _DT?P'_V_?\
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M0785^C<%_P *OZH_*N-OXU'T$HHHK])/S,**** '?PU]0_\ !.W_ )+;J_\
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M]-5_]LZ_%,M_WF/]=#]WQW\"1^>U%%%?>W1\@%%%%%P"BBBBZ _8_P#X)_\
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MW"3_ ):K5^UJ?S$>RI_RG<_\,H_"?_H1/#__ ()[7_XU1_PRC\)_^A$\/_\
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M$]3_ / FC_A&C_T$]3_\":VZ* ,3_A&C_P!!/4__  )H_P"$:/\ T$]3_P#
MFMNB@#$_X1H_]!/4_P#P)H_X1H_]!/4__ FMNB@#$_X1H_\ 03U/_P ":/\
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MGI'_ (+K;_XW7J7XT?C1];Q'_/R7WA]2P_\ S[C]QY;_ ,,T_#?_ *%/2/\
MP6VW_P ;I^G_ +//@'3KRWN[+PUIEG>6\BS0W,%A;QR1R*VY65ECX96KT^BC
MZUB'HZC^\%A,.O\ EW'[C%_X1G_J)ZG_ .!-9GB'X<Z7XNTF?2=;,NLZ7<;1
M-8ZCMF@EVMN7=&R[6^95;_@-=?17,=AY%_PRC\)_^A$\/_\ @GM?_C5'_#*/
MPG_Z$3P__P"">U_^-5ZY16GM:G\QE[*G_*>1_P##*/PG_P"A$\/_ /@GM?\
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M / FMNB@#$_X1H_]!/4__ FC_A&C_P!!/4__  )K;HH Q/\ A&C_ -!/4_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M JVE_JFE07,]OM;>OER2(S+ACN^7O7:4 %%%% !1110 4444 %%%% !1110
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M!%MX]\-:QX1T/=&(Y/"EQ#J$T;2-(RFX_M%HU;+GYO)_X#0!] 4444 %%%%
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M;*.[T;P;>066FV_EV2^3-_Q,9/WDJQ[8VW+M9&;;)]U0"E\3_P!H+7;/Q/\
M&F'4/BL_PPUSP=M7PQX22SL)/[:C^SK)#<NMQ#)-=>?,_D[+9H]NU5_UC;F^
ML_AWJVLZ_P##_P ,ZGXBTK^Q-?O=+MKG4=,4Y^R7+PJTL/\ P%F9?^ U\;>+
M/!%GKFK_ !=_X6UX,\<>)?'<FLW$_@K4M*TC4;Z.QL4V/IG]F75LGDZ?-NCC
M\QFDA9I-S3,RU]8? ^U\5Z?\(?!MKX]E\_QI#I5NFKR;E<M<B-?,W,ORLV[[
MS+\N[I0!W]5;JSAO[6:WN(EEAF1HY(V^ZRMPPJU10!^?&E7=]8_L;Z_\#3=W
M']N6OC=OA7;3R#]XUG<7J,LF/[O]G3,RM_=3_>J>V\17?C3]CCX<_!F^9F\1
M:CXKA^&NL*O$D$.GW#-=MC_:L[3_ ,C5[+??LOZ[<?MC0?$V+4[ > V$.KW>
MD2R2?:6UJ&SFL8IE3;Y?E_9Y5^;=NW+]WO3/"_[+NOZ!^UUKGQ&N-4TY_ ,K
MW.K:9I$32?:X=6NK2TM;F9QMV[?+MGV[6W?O6H XC_A<=A\(_P!JCX_65IIK
M^)O&FL1>&;7PYX1TYU6[U29;*<X_NPPQ_>DN&^2%?F;^%6N?$34O"MW^T]%;
M_M#P>&[#PO\ \(?;W&@6/B:YCG\/_P!H?:&6_P#*ENDCCFN%W6ZJ6C63RVW*
MJJS5O>/OV1=7\8?%3XD>/+35[/1/$MW-H^H>#-;M'D-SIMY9VTL,JW"[=K6\
MWF>7)&&99(V;<NY5KU?5M4^,D.DZ9%IGA;P-=:O)IR&_N;SQ'>PP07WS;O+C
M6PD:2%?E8;I(V;<R_+MW, ?'F@_&#4]%_9A_X1;PQJNO-HO_  MAO &D:GIY
MG;55T3SO/CCMI6/F>9]G7[/')_"I7[NW<OT3\";KX9>$/B5<>"]$^#W_  I_
MQK_8JWL45UI.GPRZE8+)Y3,MU933+)MD\O<LDF[YE;:?O56\1_LFWK?!&P\/
M:-XA@N?B%I/B5/'%MXAU2V9;:]UM;IKAFFC1BR0R;FAVJS-'&5_UFWYNH\(_
M"[Q;X@^-UO\ $_QY'HNDWFDZ--H>D:'H%[-?QHLTD<D]S+<R00,S-Y2JL7E[
M57<VYF;Y0#V^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **\1U']J+1['QEXA\*Z?X6\6>)
MM>T"98KZWT338Y\*T:NL@8RJNWYMOS;69E;:IQ3_ !O\;[+7OV;=5\;^#KJ1
MWU*S:TTMB/+G2\FD^S1+M_A99F'_ 'S0![717Q+XJ^)'C/X+_M"7=U+K6J:]
MX&\,Z/H]IK]C<7$ESMAF7RVOE5O^6BR1JS-]YMW^]7M?CSQ5>-^T'\%+?2]7
MN!HFJV>MS30VMPWV:\5;>!H795^63;NW+_O4 >WT5PGQ*^,?A+X0QV$WBO4I
MM,COF9;<QV%Q<[MNW=_J8VV_>7[U8?@?]IGX=?$CQ+;Z%X=URXO=4N%9HX9-
M)O(%;:NYOFDA5?NC^]0!ZO1110 445P'CGXQ>&?A[X@\-:%JE^7USQ%?16-C
MI]N%:8F1MOF,N?EC7^]_.@#OZ*X#XL_&3PU\&?#\6K>([SRTGE6"VLX2IN;J
M1G5=L:,R[OO#=_=JSXT^(UIX/U72=*33=0U[7-6,C6FDZ4L?GR1QKNDD9II(
MXXT7*?,[+\SJJ[F;% ';45YU:_&+0[[X>ZEXN%K?Q0:;));WFFRPJM[%=HXC
M-LR;MOF;BJ_>VG<OS;>:E\4?&3PQX1\>>%_!UY>F?Q-K\S):6%L5,D<8C9C-
M(-WRQ_)M]6;[JG:VT ] HKS'Q=\;+#PKKFLZ=#HFN:[_ &+:K>ZQ<Z3#"\6G
M1LNY?,\R16D;:K-MB61MO\/2K>O?%W3M-O-"L]&TW4?%VI:Y:-J-G9:((MXM
M%53]HD>:2.-(\R1J-S;F9OE5L-M /0Z*YSP3XPTOX@>&K#Q#I$DDMA>*VT31
M-')&RL4DC=6^ZRLC*R_WE-='0 445PWC3XG6?@_6M'T6+2]2\0>(-7,K6NDZ
M2(O.:*)=TDSM-)'''&ORKN9EW,RJNZ@#N:*\RO/CAHT'@S3_ !!;6&J7TUYJ
M4>BKH\,44=]'?M*8WMY$DD559&5MWS;=J[E9EVL>BTWQI<2Z'J6J:QX<U3PO
M#8QO)(FJRVCLT:IN9E^SSRKCC^)EH ZNBO+O%WQ]\*^!= \*ZGJ\LUI=^)Y;
M6/3](8+]MD:9D'^KW;<1B0&1MVU?5F95;7^*OQ8\._!?P?>^)/$U\MG8PKB*
M!<&>ZE/*Q0KGYG;T_P"!-M56:@#NJ*X/Q5\5+#PO;^'T73-2UC5->8C3=*TU
M(C<3;8_,=MTDB1J%7[S,ZU?\">/-/^(&DS7=G%=64MK=26-W8WR*L]I<QMMD
MB?:S+D?WE9E;/RM0!UM%%% !117->-O&6F?#WPS=Z]K$DB6=OM4K!&TDLLC-
MMCCC5<LS,S*JK_M4 =+17!^$_B=!XI\2:AX<N]#U7PSXAL[>.[;3]76$M+;L
MVU9HW@EDC9=P9?O;E8<K1I?Q<\/:_P#%'6? -B\UQK&CV<=Y?2J%\F$R-A8L
M[MWF8VM]W;\R_-N^6@#O**\]F^)UQ,]ZNA>$->\2K8ZC-IUS+I[V,:K)&L;,
MW^D7,6Y=TC+\O\44G3Y=SOA?\5+;XL:?JE]9:+JFDPZ;?2:>S:C]G8331G]Y
MY;0S2*RJ?EW;L;@?[M 'H%%<'\,OBUH'Q<M->NO#DLT]IH^J3:.]U(JB.:6-
M8V9HMK?-'^\7YN*[R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***XNQ^*_A*^\(ZIXHM==M9O#VFR
M3Q76H;BL$;0L5D^?^+YOXESN_AW4 =I17%>$_BEX=\;ZO/ING7%Y%J4,"W36
M.IZ;<V$Y@9MJS+'<1QLT>Y=NY05W55\-?&SP;XPUJUTG2]6>>[O%F>R>6SN(
M;>_\EOWGV6XDC6.XV_>_=,WR_-]WF@#OZ*Q;?Q1I=YJ6KV$=TOVG2O+^VJRE
M5AW1^8OS'Y?N_-6+:_%7PE>> I/&\.NVY\)1K+(VJ,&6-E21HV*Y7<WSJ57:
M/FRNW=N6@#M**X[PS\3- \8+J@T^\FBDTO!OK?5+.>PN+567<CR0W"QR+&RA
MMK[=K;6^;Y6Q5\&_&'PGX]OEL=%U*>6ZDM_MMNMS87%J+JWW;?/@::-5FCY7
MYH]R_,O]Y: .[HHHH **YOQMXXT3X>>&[O7/$.HQ:5IEOM#W,FYAEFVJJJOS
M,W^RO-1>,/'FB> [>S?6KJ:)[Z;[-;6]K:S75S<2;2VV.&%6D8[59OE7Y<4
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M@^7[O[MEV_+5C1=$T[PWI4&FZ5I]MI5A;KMBM;*%88HU_P!E5^5: -.BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
G **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>abvx-20241231_g22.jpg
<TEXT>
begin 644 abvx-20241231_g22.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *?!WH# 2(  A$! Q$!_\0
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M2G_*?1W_  E6B?\ 08L/_ I/\:/^$JT3_H,6'_@4G^-?.-%']E0_F8?VE/\
ME/H[_A*M$_Z#%A_X%)_C1_PE6B?]!BP_\"D_QKYQHH_LJ'\S#^TI_P I]'?\
M)5HG_08L/_ I/\:/^$JT3_H,6'_@4G^-?.-%']E0_F8?VE/^4^CO^$JT3_H,
M6'_@4G^-'_"5:)_T&+#_ ,"D_P :^<:*/[*A_,P_M*?\I]'?\)5HG_08L/\
MP*3_ !H_X2K1/^@Q8?\ @4G^-?.-%']E0_F8?VE/^4^CO^$JT3_H,6'_ (%)
M_C1_PE6B?]!BP_\  I/\:^<:*/[*A_,P_M*?\I]'?\)5HG_08L/_  *3_&C_
M (2K1/\ H,6'_@4G^-?.-%']E0_F8?VE/^4^CO\ A*M$_P"@Q8?^!2?XT?\
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M?^!2?XT?\)5HG_08L/\ P*3_ !KYQHH_LJ'\S#^TI_RGT=_PE6B?]!BP_P#
MI/\ &C_A*M$_Z#%A_P"!2?XU\XT4?V5#^9A_:4_Y3Z._X2K1/^@Q8?\ @4G^
M-:BL'4,I#*PR".0:^7:]A^$WBO\ M"Q.DW+YN+89A9C]Z/T^H_D1Z5R8K+_8
MT^>#O8ZL/C?;3Y)*QZ%1117C'J!1110 4444 %%%% !1110 4444 %%%% !1
M110 57N-0M;1PD]S#"Y&0LD@4X]>35BO/_B!_P AF'_KW7_T)J .S_MK3_\
MG_M?^_R_XT?VUI__ #_VO_?Y?\:\FHH ]9_MK3_^?^U_[_+_ (T?VUI__/\
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ME_QKR:B@#UG^VM/_ .?^U_[_ "_XT?VUI_\ S_VO_?Y?\:\FHH ]9_MK3_\
MG_M?^_R_XT?VUI__ #_VO_?Y?\:\FHH ]9_MK3_^?^U_[_+_ (T?VUI__/\
MVO\ W^7_ !KR:B@#UG^VM/\ ^?\ M?\ O\O^-']M:?\ \_\ :_\ ?Y?\:\FH
MH ]9_MK3_P#G_M?^_P O^-']M:?_ ,_]K_W^7_&O)J* /6?[:T__ )_[7_O\
MO^-']M:?_P _]K_W^7_&O)J* /6?[:T__G_M?^_R_P"-']M:?_S_ -K_ -_E
M_P :\FHH ]9_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&O)J* /6?[:
MT_\ Y_[7_O\ +_C1_;6G_P#/_:_]_E_QKR:B@#UG^VM/_P"?^U_[_+_C1_;6
MG_\ /_:_]_E_QKR:B@#UG^VM/_Y_[7_O\O\ C2KK%@S!5OK8DG  F7G]:\EH
MH ]FHK"\):U_:VGA)&S<PX5_5AV:MV@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\I
MKU:O*:]'!_:^0!1117I %%%% !1110 4444 %%%% !117,?$?XA:9\,?"\VM
MZKYCQ*PBBAA&7FD.<(,\= 3D]@:TITYU9JG!7;V Z>BOG?\ X:UO;.&#4-3^
M'>K6.A3'Y-1\UBK#.,KNB53_ -]5[SX?UVR\3:+9:MITWGV-Y$LT4F,94CN.
MQ[$=B*Z\3@<1A$I5HV3\T_R; OT445P %%%% !1110 445R'Q.\::IX%T&WO
M](\,WGBNYDN5@:SLB^]%*.QD.U'. 5 Z?Q#FM*=.5::IPW?R_,#KZ*ALIWNK
M.":2)H))(U=HFZH2,E3]*FK-Z: %%%% !1110 4444 %%%% !1110 4444 %
M%%% '?>&M6_M*Q"N<SQ?*_N.QK8KS;2=2?2[Z.=>5Z.OJO<5Z-#*L\22(=R,
M P/J#7C8BG[.5ULP'T445R@%%%% 'SAXJ_Y&C6/^OR;_ -#-9=:GBK_D:-8_
MZ_)O_0S677WE/X(^A\;4^-A1116A 4444 %%%% !1110 4444 %%<'\:O'FH
M?#CP2VL:;#;3W(N(X=MTK,F&SGA64YX]:UM#\;64GA'P[JFM7]CIEQJMG!,%
MFF6%'D>-6*H';)Y;IDGI6GLY<JEW(YUS<ITU%9-OXNT*ZU(Z=!K6GS:@"0;2
M.ZC:4$=1L!S^E6M4UK3]#MOM&I7UMI]OG'G74RQ)GTRQ J.5[6*NBY17D?B[
MXS7>F?$SPGH6C-IFHZ/K'E>9=*3*WS2LAV,K[>@[@\UZ9'XATN76)-)34K-]
M4C7<]BLZ&=5P#DIG<!@@].XK25.44FUN1&<9-I&A16?'XATN76)-)34K-]4C
M7<]BLZ&=5P#DIG<!@@].XJ+5O%FAZ!,D.IZSI^G2N,K'=W21,P]0&(S4<KVL
M5=&K17*>.OB-I7@?PG+K<L\%VI3=;0)<(INCD#$9_BZY.,\<UR\/Q<N=:^$<
M_B+1YM%?7X4B>6RN+Q$AMR\P4+*6D782N[&YADCCTJXTIR7-;2]B74BG8]3H
MK#\(ZU<ZKX1T[4]4-I%<S6XFN&M95>!3C)*N&8%??<?K4NE^+]"URZ:VT[6]
M.O[A<YAM;N.1QCKPI)J'%J_D5S+0UZ*S[[Q#I6FWUO97FIV=K>7 S#;SSHDD
MG^ZI.3^%1:9XLT36KI[;3M9T^_N(^7AM;I)'7ZA22*.5VO8=UL:M%%>&:I\;
MO%_B3Q=JFC> ?#5MJD>FR&*>YO6(!8$@G[Z!02IQDDG&?:KITY5+VZ$2FH;G
MN=%>2?#'XU7OB'Q#J/AOQ7I<>@ZY91&9MK$1%5 +9W$[< ALY((Y[<VO"OQV
MTOQ1\0M3T%9K&TL;;$5K=272$WLQD"@1<X(/8#)/Z53H5$WIL2JL';7<]1HK
M/L/$.EZI>75G9:E9WEW:L5N(+>='DA8$@AU!RIR".?2BP\0Z7JEY=6=EJ5G>
M7=JQ6X@MYT>2%@2"'4'*G((Y]*QY7V-;HT**PM4\::-8R7-FNKZ=_:L<;,MD
MURGFE@"0-F=U>8> ?C/XB\8_#7Q+KKVVD0ZGIT@2W5F,%N<A3^\:24 =3SN%
M:QHSDN;^M2'4BG8]LHKF_ GB&\UOP38:OK)L8+J2-Y)VLIUDMU"LPRKAV4C
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M *$U ',T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%<!\<OB!J'PS^'MWKVEPVL]Y#-%
M&J7BLT>&8 Y"LI_6N:_9U^-NH_%RWUF'6K:SL]1L6B=$LT=%>)P<'#,QSD=<
M]&% 'LE%?+=K^U=XAU3XMVGAVSL-);0[G68]/CG:&7SFA:<1[\^9MW$9/3'M
M7T?KGBW0_#)C&L:SI^E&3E/MUU'#N^FXC- &K16+J/B**;PGJ.K:+=6-_P"5
M:RRV\WGH;=G5"1N?<%"Y R=PP.XKF/AG\0[S6/A^^O\ C"ZT/3&CG:.2XL;Z
M)[1%RH7,@E=026 QNZD<4 >@T5@S>/\ PQ;S6T,OB/28IKI%D@C>^B#2HP!5
ME&[Y@0001US7*?&[XT6?PA\/I.J0:AK%PZI!I[3JCA2&/FLOWM@*8R!U(&10
M!Z316'H/C#2=<\-QZQ#JMA/:*@-Q<P7"-#$^T%E+ D+C/0GC-3Z+XNT/Q*TB
MZ1K.GZJT8RXLKJ.8K]=I.* -6BLBX\8:#:WUY93ZWIT-Y9Q^=<V\EW&LD$9V
MX=U)RJ_.O)X^8>HJ;1/$ND>)H7FTC5;+58HSM>2QN$F53Z$J3B@#1HK$U;QS
MX;\/W@M-4\0:7IMT0"(+N]CB?GI\K,#5V]U[3--TDZI=ZC:6NF*%8WDTZI"
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M+]VS6MM7>UM>]]0/L.BBBOS@84444 %%%% !1110 4444 %%%% !7<>#O/\
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MC_M3^S/L$YFS]G\W?D#C[RXZ>]5_BK\%K+XEW%EJ$6H3:+K-F-L=] F\E,Y
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MO#T4EC#=2Q&2/S6?GS-C<L2>0>1TKU_QE\*!XL\>>&O$@U/[&-&92+7[/O\
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MF=]1117FG:%%%% !1110 4444 %%%% !1110 JYW#'7MBOI'PZ;TZ'9'4?\
MC]\H>;]??WQU]\UY/\*_"G]L:H=1N$S:6C#:#T>3J!^'!_*O::^;S.M&4E27
M0][+Z3C%U'U"BBBO#/7"BBB@ HHHH **** "BBB@ HHHH **** "O/\ X@?\
MAF'_ *]U_P#0FKT"O/\ X@?\AF'_ *]U_P#0FH YFBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<&@#RW]G)I8_AG\7;5T:".&VD(MBVX1,89@1]?E SWP*J:%_R9/XB_Z_U_\
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MN!AY,9P ,G R2>I))Y/3'3>,O!^F>//#EYHFKPF:RNEPVTX92#D,I[,",@T
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MQ7MTIO;I6Z^9)@@'W"A%_P" T >CT444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\K?_ +]+_A5NBCFEW J?V38_\^5O_P!^E_PH_LFQ_P"?*W_[]+_A5NBCFEW
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MT4>TG_,P]G#L97_"*Z)_T![#_P !4_PH_P"$5T3_ * ]A_X"I_A6K11[2?\
M,P]G#L97_"*Z)_T![#_P%3_"C_A%=$_Z ]A_X"I_A6K11[2?\S#V<.QE?\(K
MHG_0'L/_  %3_"C_ (171/\ H#V'_@*G^%:M%'M)_P S#V<.QE?\(KHG_0'L
M/_ 5/\*/^$5T3_H#V'_@*G^%:M%'M)_S,/9P[&5_PBNB?] >P_\  5/\*/\
MA%=$_P"@/8?^ J?X5JT4>TG_ #,/9P[&5_PBNB?] >P_\!4_PH_X171/^@/8
M?^ J?X5JT4>TG_,P]G#L97_"*Z)_T![#_P !4_PH_P"$5T3_ * ]A_X"I_A6
MK11[2?\ ,P]G#L97_"*Z)_T![#_P%3_"C_A%=$_Z ]A_X"I_A6K11[2?\S#V
M<.QE?\(KHG_0'L/_  %3_"C_ (171/\ H#V'_@*G^%:M%'M)_P S#V<.QE?\
M(KHG_0'L/_ 5/\*/^$5T3_H#V'_@*G^%:M%'M)_S,/9P[&5_PBNB?] >P_\
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M[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"
MU_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#S
MX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_
M[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"
MU_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#S
MX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_
M[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"
MU_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#S
MX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_
M[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"
MU_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#S
MX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_
M[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"
MU_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#S
MX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_
M[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"
MU_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#S
MX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_
M[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"
MU_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (5=HH I?V+I_P#S
MX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A5VB@"E_8NG_\ /A:_]^5_PH_L73_^?"U_
M[\K_ (5S%]\5M)L/BSIWP]DMKXZS?:8VJQ7"QI]F$2NRE2V[=NRIX"D8(YK
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH :S+&I9B%51DL3@ 5XM\2OB0VM/)I>F2%;!3B69>#,?0?[/\
M.M?XT>)+VS:VTJ!FBMIXO,E=>"_)&W/IQS]17D=?S5XC<9UO:U,CP-XI:5)=
M7=7Y5Y=WUVVW_0<ARF'+'&5M6_A7;S]>W8GL+^XTN\BNK65H;B)MR.O4&O??
M ?CRW\7V?ER;8=2B7][#V8?WE]OY5\]U/87]QI=Y%=6LK0W$3;D=>H-?F?"?
M%F)X8Q/-'WJ,OBC^J[27X[/HU]%FF5T\QIV>DUL_T?D?5-%9?AC5)=:\/V%]
M-'Y4L\0=E'3/J/8]?QK4K^V</7ABJ,*]/X9I->C5T?C]2#IS<);K0****Z"
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K&\4^%K/Q9IK6MTNUQS%,H^:-O4>WJ.];-%<N*PM
M#&T)X;$P4H25FGLT:4ZDZ,U4INS1\XZAX UW3]4-C_9\T[%L)+"A:-QZAN@_
M'IWKV#P#X!@\(VGFR[9M2D7]Y+V0?W5]O?O7745^>Y!P#E>08R6-IMSE]GFM
M[GIW?GV/=QV>8G'4E1EHNMNO]=@HHHK],/G@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK9-2C0GA'1Q&Y _VA(F?]P5]PU\3G. 66XV>'B[Q6J]'K_P!A1117B@%%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M17 P=HD<@$$%2.^#[5\^Z'??M'>*O@_H_AO2?".B6OAN\T6"SM]32>$3O9M
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M6O:9K1@.)1I]Y'/Y?^]L8X_&I/$'BS0_"-NEQKFLZ?HL$AVI+J%TD"L?0%R
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=M"JQ)QC"D]J^1?VP/AWX=^&'@OP!HWAC35TO3?[;EG,*R/(3(RH"Q9V9B<
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M[/N96;D2 ORB_?)Z?6O0ZZES=0"BBBJ Y;XK?\DM\8_]@:\_]$/7EG_!./\
MYJ'_ -P[_P!N:]3^*W_)+?&/_8&O/_1#UY9_P3C_ .:A_P#<._\ ;FOH8?\
M(AQ?K#_TJ(C[2HHHK\[&%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&3C/4URWQW^$?_"[/ ,GAK^U?[&W7,=Q]J^S>?C9GC;O7KGKFO0Z*'%-<KV
MXK_A6_\ Q9?_ (0#^T?^9?\ ["_M#R/^G;R/-\O=_P "V[O;/>O+K[]D?[9\
M ]/^&G_"5[/LFHG4/[4_L[._)D.SRO-X^_UW=NE?0U%2Z<9;H#Q/XO?LU_\
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M'+D G'( SG&<8G^*_P"RC9>.O&C>+_#GB?4/ WB64 7%YIZEEE( &["NC*Q
M )#8. <9R3[S16GLH6Y; >0_ W]F_2/@O<:AJC:E<^(_$NH#9<:M>+M;82"5
M5<G&2 22Q)P.:H_#7]FS_A7>A_$/3O\ A(O[0_X2X2#S/L/E?9-RRKT\P[\>
M;ZK]WWX]LHIJG%6LM@/*/AG\!_\ A7/P9U3P%_;G]H?;DND_M#[)Y6SSD*Y\
MO>V=N<_>&?:L[PC^S39^'_@3JGPSOM;EU&VOWD=M0AMA R%F5E(0NV=K*#UY
M]J]HHH]G'MY >"_#S]FC7?A[X#\3>'+;XE:I,VJ01P6-TL#Q_P!EA&=LPJ)C
MC)=L[2N:]3^&?A/4? W@C3=$U;Q!=>*M0M?,\W5KT-YL^Z5W&[<[GY0P498\
M*.G2NGHHC",=@"BBBM "BBB@#Y/_ ."?'_)9M9_[ $W_ *4VU?H-7Y\_\$^/
M^2S:S_V )O\ TIMJ_0:O1XN_Y&DO\*$@HHHKXL84444 %%%% !1110 4444
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MG_"0_'[1/B9_;_V?^S85B_LO['N\S:L@SYOF#'^L_NGI7L%%2Z<6[M >1?\
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ML/\ TJ(C[2HHHK\[&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS_-:NG*;:YG>Z ^AZ***ZP.6^*W_ "2WQC_V!KS_ -$/7EG_  3C_P":A_\
M<._]N:]3^*W_ "2WQC_V!KS_ -$/7EG_  3C_P":A_\ <._]N:^AA_R(<7ZP
M_P#2HB/M*BBBOSL84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)DM]1MDGC5P" P5P0#AF&>N"?6M VL)MOLYAC-OL\OR=HV;<8VXZ8QQBI**
M,7P]X'\.>$8[F/0M TO18[K'GII]E' )<9QN"*-V,GKZFH-)^'/A/0=2.HZ9
MX8T;3M0.<W=II\44ISU^=5!_6NAHI678#'N?!N@7GB"#7;C0]-GUN !8M2DM
M(VN8P,@!9"-P')Z'N:7_ (0_0/\ A(O^$@_L/3?[>V[/[4^R1_:MNW;CS<;L
M;>.O3BM>BG9 9-GX1T+3]>NM;M=%T^VUJZ3R[C4H;6-+B9?E^5Y -S#Y5X)_
MA'I1H7A'0O"[W;Z-HNGZ0UV_F7#6-K' 9F&<,^T#<>3R?4UK4460',GX7^#&
MU0:F?".A'4@V\7G]FP^=N]=^W.??-;FJ:38ZY926>HV5OJ%I)]^WNHEDC;ZJ
MP(-6J*+(##\.^!?#?@]I6T'P]I6B-*,2-IUE%;EQZ'8HST%36?A'0M/UZZUN
MUT73[;6KI/+N-2AM8TN)E^7Y7D W,/E7@G^$>E:U%%D!A>(/ ?AGQ9/%-KGA
MW2=9FB&(Y-0L8IV3Z%U.*TQI-B-+.FBRMQIQB,!L_*7R3&1@ILQC;CC&,5:H
MHL@,G3/".A:+HLND:=HNGV&DRAQ)86MK'' X888&-0%.1P>.:ET'PYI/A73Q
M8Z+I=EI%D&+BVL+=((]QZG:H R?6M&BBR ***BNKR"QA::XFCMXE&6DE<*H^
MI-/?1 <Q\6Y%A^%?C!G.!_8]VOXF%@/U->9?\$XXF6+X@R$?(S:>H/N/M.?Y
MBN1_::^/VFZMHTWA#PU=)?\ VA@+Z]A.Z/:"#Y:-_$20,D<8&.<G'T7^Q_\
M">Z^%OPIC;5(3!K.L3?;KB)AAHD*@1QGW"C<1V+D=J^DQ,)8'(JD*^DJLE9=
M;)IW_#\NXCW*BBBOS@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_Y'H_X=\?$3_H->&/\ P*N?_D>N@HH^OYI_S^C_ . ?\$+'/_\ #OCXB?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGGRUQ\OXD_\ CM?.]=U\7/!C^"=;L[4ZYK.O1S6_FK<:W=_:94.Y@55L#"\
MX]2:X6OT;*J<:>$@UUU ****]< HHHH *[7PC\/;3Q!X8U#7M2UL:-86<RPL
M_P!E:?).WL&!ZLO0'K7%5Z3H/Q"N_#/P]@L&\*Q7EA)<%C>W\;/;3-N)QMV@
M%@%P/F_AZ<5QXMU5!*CNVNVW7?0# D\'66I>(M.TCPYK2ZY)=\&5K5[81D9)
MR&R2 H)R/2MS6OA'#::9J]QI/B"#6;G2#_IUJL!B,0 )8@EB&Q@_D1U&*]&T
MG0=)TWXC>$M6L+1-,.L:?-*UDH"B-Q&K<#L<,00/[I]ZQ?AJRV^M_$N2[_U$
M?F^=D]MTN?T!KQI8VJUSPD[12>J5VW*SOI^5@/#:*U/"O_(SZ/\ ]?D/_H8K
MZ+U'Q5>V_P 9]/\ #Z" :;>6K/.AB4M(PC<@ENO&P#TQFO3Q6+EAY<L8WT;W
MMM\F!\P45]&^%]6/B;4O'/AZZM;5-%T\/;VUG%"JK&%+ID8'4[0?8]*Y;2-2
MF\!_!&SUG1HXX]4U&\:.>Z,8=D4-(!U!&,1@8/'S'N:Q682;Y>3WKQ2U_F5]
M[=O)@>-UM>#_  O<>,O$5II5LWEM,Q+RE2PC0#+,1]/IDX&>:]3^+U\^J?"O
MPG>21)#).Z2LD:[5!,1)P.P[_C6=^SQ;HNI:_>_\O$%EMC/H&.3_ .@BG+&R
M>$G72LU==];V \RU[3XM)UJ]LH+@W<5O,T0G*;-^TX)QDX&1ZU0KU[X'WGV'
MPOX^NFBCN/)LTE,4PW(^$G.UAW![U:OM>N/'/P+U74=56&>^L+U8XIA&JD#?
M%T   XD*\=A5/&2IU/9N-TG&+=^K2UM8#Q>NC\"^"YO'&L/9QW,5E%%$9IKB
M7D(H(' [GGU'>OHG_BY?_4J?^3->.?%G2/%.J^+!_:-E!>7L5FC-_8T4KQI'
MN?!;<,@Y#>W%84LP>);IQ:B[;WO;Y60&;XJ^&J:-X;@U_2M7CUO29)#$TRP-
M"R-DC[I)XR,9^GK6MIOP82:UTI-1\00Z9JNJ1F2UL&MV<L,9PS9&TX]O;DUM
M:U=6WB[X*RS:+ VAV&DW6V6Q+AUFY7G>>2?W@;GOQSP:T?B+#<3?%[P,\66@
M9;8IM/'RS$N?^^<5S_6J\E[-RLTY]%?W5=)].NM@/./#OPPU/7/$]_H\KQV/
M]G[C=W,G*1J.X]<]1TXYIWBWP#8Z!H=AJVG^(;?6+.Z<H L7DR\9!8(6)(!!
M!Z8X]:]GT=[9_&WQ.$D*W,)@M@\#?\M ('#K^/3\:\_\2Z?I?BKX2Q^)X])L
M]&U&VN/*9;&+RXY5+A<8[]0<GG@TZ>.JU*T>9VC[JV6\HW]=P.*\=>"9?!>H
M6T8N1?65W MQ;7:IL$BD<\9."/KT(]:YJO7/B%&EU\&?!=W( ;B,B!&[[-C9
M'_CB_E7D=>M@ZLJM*\]TVON=@"BBBNT HHHH *^HO@;XJD\2>"T@N'+W6GO]
MF9CU9,90_EQ_P&OEVO=_V95?[/XA8_ZLM !]<29_F*\/.:<981R>Z:_.P'M]
M%%%?GP!7*?$S_D7;/_L-:3_Z<;>NKKE/B9_R+MG_ -AK2?\ TXV] '5T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)?\ XF@"[15+^UH/^>=U_P" DO\ \31_:T'_ #SNO_ 27_XF@"[15+^UH/\
MGG=?^ DO_P 31_:T'_/.Z_\  27_ .)H NT52_M:#_GG=?\ @)+_ /$T?VM!
M_P \[K_P$E_^)H NT52_M:#_ )YW7_@)+_\ $T?VM!_SSNO_  $E_P#B: +M
M%4O[6@_YYW7_ ("2_P#Q-']K0?\ /.Z_\!)?_B: +M%5[6^BNW=(_,#H 662
M)D.#G!^8#T/Y58H **\X\2?'#2=+UJ;0]#T_4/%VNP\2VFCQ>8D!_P"FLGW4
M].^#UQ5#_A8_Q+D^:+X1N8ST,GB*V1OQ&WB@#U:BO*?^%B?$_P#Z)%_Y<MK_
M /$T?\+$^)__ $2+_P N6U_^)H ]6HKRG_A8GQ/_ .B1?^7+:_\ Q-'_  L3
MXG_]$B_\N6U_^)H ]6HKRG_A8GQ/_P"B1?\ ERVO_P 31_PL3XG_ /1(O_+E
MM?\ XF@#U:BO*?\ A8GQ/_Z)%_Y<MK_\31_PL3XG_P#1(O\ RY;7_P")H ]6
MHKRD_$KXCVX+W/PDF6(=3;Z];3-^"A>:VO!?QDT/Q?JCZ-+#>:!X@0;FTG6(
M?(G(]4[..O0YQSB@#O*\7^+&IW>N?$W2?!T_CFZ^'VCRZ8^H+=:?)#!=:E.)
M=AACFF5E41C:Q55+-Y@[ U[17RA\5/'^E>-M3LO#%Y\3OA1.VGV2S:@OB6QM
M[RV:Z\V1&\O?. C@*,QG+#@GK0!Z=\&-8N[7QMXJ\)IXRN/'^CZ7;6MS%JUX
MT4EQ:S2M,'M998E59"%C1QP&4/@CE:M_'[_FG'_8YZ;_ .U*YC]FG6HXM5UO
MPW8^)O!/B#3+.UAO$3P+ID=M9V[RO(I#M'*ZESY>=N <8/.:Z?X_?\TX_P"Q
MSTW_ -J4 >K4444 >7?'SP?+X@\-1:E:QF2ZTTL[*O4PD?/]<8!^@-?-5?<M
M>+?$'X K?7$E_P"&FCMW<[GL)#M3/K&>W^Z>/0CI7U64YE"C'V%9V71_H!X'
M1737WPU\5:?,8Y= OW8'&8(3*OYID56_X0/Q-_T+NK?^ ,O_ ,37UJKTFKJ:
M^] 85%;O_"!^)O\ H7=6_P# &7_XFC_A _$W_0NZM_X R_\ Q-/VU+^9?>!A
M5V'AGXH:KX:T=M)%O8ZEIV_>MMJ$'FHASGC!'?GGO69_P@?B;_H7=6_\ 9?_
M (FC_A _$W_0NZM_X R__$UE4>'K+EFTUZ@6-8^(>N:UXDM];ENO*O;8CR/)
M7:D0'95YXZYSG.>:T]?^+^MZ]I=W8F"PL$O"#=2V,!CDN,#&'8L<\8'T&.G%
M8G_"!^)O^A=U;_P!E_\ B:/^$#\3?]"[JW_@#+_\367)A/=^'W=M@,K3[Q]-
MOK:[B"M);RK*H8<$J01GVXKJ[GXJ:M=>-K7Q0]O9C4+:,Q)&J/Y1!5EY&[.<
M.>_I63_P@?B;_H7=6_\  &7_ .)H_P"$#\3?]"[JW_@#+_\ $UI/ZO4=YM/1
MK?H]P-/0_B?JN@:KKFH6]O9O-J[L\ZRHY52S,QV888Y8]<UUOPTU01>"[NS7
MQ%H0,DI)TCQ##^Y!R/F#[QP1SC:1D=NM>?\ _"!^)O\ H7=6_P# &7_XFC_A
M _$W_0NZM_X R_\ Q-<U6EAZD6HR2O;MTVW [_XT>+K35-!T+2(M1M=5OH#Y
MUU/98,(;;@!2.,<GCL *YWX->*;?POXSC:]D6*QO(FM9I)&PJ9P58_B ,]@3
M6%_P@?B;_H7=6_\  &7_ .)H_P"$#\3?]"[JW_@#+_\ $TH4</'#O#\ZL[]5
MU T;?Q1<^ Y/$^BZ<UG?66H!K5KACYFZ,!U5D9& R5<GOVXJE9^-KZQ\&7_A
MF.*W-A>3">21E;S0P*' .[&/W:]NYJ/_ (0/Q-_T+NK?^ ,O_P 31_P@?B;_
M *%W5O\ P!E_^)KHMA]Y--Z/?JMF!A5N>$?&6I^"=2-YILJJS+LDBD7='(OH
MP_PYI?\ A _$W_0NZM_X R__ !-'_"!^)O\ H7=6_P# &7_XFM9SH5(N,VFG
MZ :'B;XF:IXFTF/2S;V6F::K^8;73H?*1VSG)&3WY^O-7]'^,FN:/IMG:?9]
M/O'LD*6MU=6^^:!2,85LC'''3I6!_P ('XF_Z%W5O_ &7_XFC_A _$W_ $+N
MK?\ @#+_ /$USNGA''D?+8"3P_X\UGPYK\VL6USYEW<%C<><-RS9.3N'U],5
M9\4?$34_%UC;:=)!9:=I\+EUM+"+RHBYS\Q!)]3[<FJ7_"!^)O\ H7=6_P#
M&7_XFC_A _$W_0NZM_X R_\ Q-7RX5S532Z] .K^+&O6;:;X<\.:=>17UOI=
MHOG3V\@>-Y2H'!''&#_WU7F];O\ P@?B;_H7=6_\ 9?_ (FC_A _$W_0NZM_
MX R__$T4/8T*:@IK[UU PJ*W?^$#\3?]"[JW_@#+_P#$T?\ "!^)O^A=U;_P
M!E_^)KH]M2_F7W@85%;O_"!^)O\ H7=6_P# &7_XFKNF_"[Q7JDPCBT*\B)_
MBN8S"H_%\5+Q%**NYK[T!RRJ68 #)/  KZO^$/@^3P?X-@AN4V7MTQN9U/52
M0 %_  ?CFN=^&_P-M_#=Q%J6M/'?:A&0T4*<Q0MZ\_>/Z#]:]8KX_-LQAB$J
M-%WCU?< HHHKYD KE/B9_P B[9_]AK2?_3C;UU=<I\3/^1=L_P#L-:3_ .G&
MWH ZNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBO._$/[:WP8\*Z_J>B:IXR^RZGIMU+9W4']EWK^7-&Y1UW+"5.&4C()!QP:
M/<**\XC_ &B/AY<?#.7X@P>(DNO"$,GDS:A:VL\Q@?<%VR1*ADC.67[RCAE/
M0@F3Q/\ M!?#_P 'Z'X9U?4_$4:6'B4J-(>VMIKE[PL%(V1Q(S?Q*.0,%@#R
M<4 >AT5S?Q ^(GASX5^%[GQ%XJU2/2-'MV1'N)$=SN9@JJJ("S$D]%!. 3T!
M-9OB[XT>"O ?@6S\8Z_K\&F>';U(9+6ZE20O.)0&0)$%,C$J=Q4+D $D  D
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M"+&\+$X G  4I_M@ CJV<DC[:5ED4,I#*PR&!R"*^#S+*\3E=7V6(6^S6S]
M'4445Y(!7*?$S_D7;/\ [#6D_P#IQMZZNN4^)G_(NV?_ &&M)_\ 3C;T =71
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC(.,=30!Z!XY_:*^'GPX_LY->\1"WN-0MA>VUI:V=Q=W+P'I*888WD5/]IE
MSQ7G?[2GQ8@UK]G?3O%O@+Q-(UG>:YI4<.J:3<O$7C:^C21"5(89&Y64^X([
M5Y+\3@?A_P#M:?$/6O%OQ)U[X5:-X@T_2VT36;&RAEM;I(83'/;O-)#($=9/
MG"#;G>2<_+4?C3PKH7AO]DF^E\-ZYK?B73]8\>V6J'4];L_LLEQ+)?VXD>)/
M+C_=,ZE@0H!+-CC% 'V-X9^(GA_QAKGB/1M)U#[3J?AVY6TU2V:"2)K>1D#J
M/G4;@5.0RY4]C3_ WQ T#XE:++JWAN__ +3TV.ZFLS<K#)&IEB<I(%WJ-P#
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MS@>@P.E7/-*]#$NARIPC.$&VW=\Z6O;1OY@?/W_"DOB)_P!"#XG_ /!-<_\
MQ%/\/?!7QMXD\96_A:'PY?V>MS1?:/LVH0-;&.'=M,S;P,(#QGUX&3Q7V?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?&KQ!J'A+X-^/-<TFX^R:IIF@W][:7&Q7\N:.WD=&VL"IPR@X((..17Y.?\
M#P3X^_\ 0^_^4?3_ /XQ7ZI?M&_\F]_%#_L5M4_])):_"6NRA%-.Z.:K)IJQ
M]$?\/!/C[_T/O_E'T_\ ^,4?\/!/C[_T/O\ Y1]/_P#C%?.]%=/)'L8<TNY]
M$?\ #P3X^_\ 0^_^4?3_ /XQ1_P\$^/O_0^_^4?3_P#XQ7SO11R1[!S2[GT1
M_P /!/C[_P!#[_Y1]/\ _C%'_#P3X^_]#[_Y1]/_ /C%?.]%')'L'-+N?1'_
M  \$^/O_ $/O_E'T_P#^,4?\/!/C[_T/O_E'T_\ ^,5\[T4<D>P<TNY]$?\
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M $/O_E'T_P#^,4?\/!/C[_T/O_E'T_\ ^,5\[T4<D>P<TNY]$?\ #P3X^_\
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M_P"2L_\ \17RG11_86&_FE]Z_P @/JS_ (7=X*_Z#7_DK/\ _$4?\+N\%?\
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M_B*^4Z*/["PW\TOO7^0'U9_PN[P5_P!!K_R5G_\ B*/^%W>"O^@U_P"2L_\
M\17RG11_86&_FE]Z_P @/JS_ (7=X*_Z#7_DK/\ _$4?\+N\%?\ 0:_\E9__
M (BOE.BC^PL-_-+[U_D!]6?\+N\%?]!K_P E9_\ XBC_ (7=X*_Z#7_DK/\
M_$5\IT4?V%AOYI?>O\@/JS_A=W@K_H-?^2L__P 11_PN[P5_T&O_ "5G_P#B
M*^4Z*/["PW\TOO7^0'U9_P +N\%?]!K_ ,E9_P#XBC_A=W@K_H-?^2L__P 1
M7RG11_86&_FE]Z_R ^K/^%W>"O\ H-?^2L__ ,11_P +N\%?]!K_ ,E9_P#X
MBOE.BC^PL-_-+[U_D!]6?\+N\%?]!K_R5G_^(H_X7=X*_P"@U_Y*S_\ Q%?*
M=%']A8;^:7WK_(#ZL_X7=X*_Z#7_ )*S_P#Q%'_"[O!7_0:_\E9__B*^4Z*/
M["PW\TOO7^0'U9_PN[P5_P!!K_R5G_\ B*/^%W>"O^@U_P"2L_\ \17RG11_
M86&_FE]Z_P @/JS_ (7=X*_Z#7_DK/\ _$4?\+N\%?\ 0:_\E9__ (BOE.BC
M^PL-_-+[U_D!]6?\+N\%?]!K_P E9_\ XBC_ (7=X*_Z#7_DK/\ _$5\IT4?
MV%AOYI?>O\@/JS_A=W@K_H-?^2L__P 11_PN[P5_T&O_ "5G_P#B*^4Z*/["
MPW\TOO7^0'U9_P +N\%?]!K_ ,E9_P#XBC_A=W@K_H-?^2L__P 17RG11_86
M&_FE]Z_R ^K/^%W>"O\ H-?^2L__ ,11_P +N\%?]!K_ ,E9_P#XBOE.BC^P
ML-_-+[U_D!]6?\+N\%?]!K_R5G_^(H_X7=X*_P"@U_Y*S_\ Q%?*=%']A8;^
M:7WK_(#ZL_X7=X*_Z#7_ )*S_P#Q%'_"[O!7_0:_\E9__B*^4Z*/["PW\TOO
M7^0'U9_PN[P5_P!!K_R5G_\ B*/^%W>"O^@U_P"2L_\ \17RG11_86&_FE]Z
M_P @/JS_ (7=X*_Z#7_DK/\ _$4?\+N\%?\ 0:_\E9__ (BOE.BC^PL-_-+[
MU_D!]6?\+N\%?]!K_P E9_\ XBC_ (7=X*_Z#7_DK/\ _$5\IT4?V%AOYI?>
MO\@/JS_A=W@K_H-?^2L__P 11_PN[P5_T&O_ "5G_P#B*^4Z*/["PW\TOO7^
M0'U9_P +N\%?]!K_ ,E9_P#XBC_A=W@K_H-?^2L__P 17RG11_86&_FE]Z_R
M ^K/^%W>"O\ H-?^2L__ ,11_P +N\%?]!K_ ,E9_P#XBOE.BC^PL-_-+[U_
MD!]6?\+N\%?]!K_R5G_^(H_X7=X*_P"@U_Y*S_\ Q%?*=%']A8;^:7WK_(#Z
ML_X7=X*_Z#7_ )*S_P#Q%'_"[O!7_0:_\E9__B*^4Z*/["PW\TOO7^0'U9_P
MN[P5_P!!K_R5G_\ B*/^%W>"O^@U_P"2L_\ \17RG11_86&_FE]Z_P @/JU?
MC;X*8X_MK\[68?\ LE=#HGB_1?$G&F:I;7C]3''(-X]RIY_2OC&I+>XEM9DF
M@D>&9#N62-BK*?4$=*SGD-%KW)M/SL_\@/N*L?QCIL^L^$=<T^U4-<W=C/!$
MK' +M&RC)[<D5YQ\&_BY-XCF70]:D#:@%S;W/0S@#)5O]H#G/< ]^OK]?)XC
M#U,+4=.HM0/G3PSX7UCQ5X^\(:=X\^&TW]DZ/H+V4,E[+;7UA'=#RQYP"L?F
M=$91O0%<#'WB1W'P-\.RZ+<>,+BTT"X\)^&[W4A)IFBW*K&8]L:K-,L2DB))
M'!(0>A; W5K^(OC5X8\%>)+W2/$]V?#GDVWVR"^U$>7:WD8 WB*3HTBDX,?W
MN00#FKOPY^(1^(]G>:C;:'J6E:.LBI8W>IQ>2]\N,F5(C\RITP6 +9SBN4"3
MX9_\B[>?]AK5O_3C<5U=<I\,_P#D7;S_ +#6K?\ IQN*ZN@#SO\ :-_Y-[^*
M'_8K:I_Z22U^$M?NU^T;_P F]_%#_L5M4_\ 226OPEKNP^S.6MN@HHHKJ.8*
M*** "ONG_@F__P DT_:#_P"P1:_^B;^OA:OO+_@F7IMSK7@?X\:?9Q^=>7>G
M64$,>X+N=HKY5&20!DD<DXK*K\#-*?Q'P;7T=^SM^Q;K'QP\(WWC+5_$ECX%
M\%VI9!J^H1B3S2IP[*I=%"*<@NS@9&!G!Q#_ ,.^_C[_ -"%_P"5C3__ (_7
MT7X-\*W7[3?_  3TT;P7X"NK:'Q+X?O!]NT?STB\]DFE<(Y( 'F"1903@%UP
M6X)I2GI[K'&.NJ/G[]H3]BO5/@MX'L_'&A^*M/\ 'O@N=D1M5T^,1^7O.$?"
MO(K1DX <.>6 QR#7<>'/^"=]OJWPS\)>.M3^*>E^&]!UC3H=0O;C5;)88['S
M41DC#M.%D)+D9)3I[XKTW4/"=]^RO_P3\\4^%_B%<P'Q#XDNI18:.LZRFW:4
M1 1J0Q4[/+>9BOR@MW)R>;_:^D8?L)_ .,,0C16#%>Q(L&P?U/YUGS2=DGU+
MY8K6QXG^T[^QMK7[.O\ PCUW:ZU%XQT77)/L]K>6=L8I//P"L?EAWSO!RI5C
MG!Z<9],/_!-._P!-\,Z;_;WQ-\/Z#XVU2)C8>&[I !<38R(5F,H9FZ [(VP<
MXR.3Z+\<-?M/"_[,?[*>M:B3]@TW4-%N[@[2Q\J.V#-QW^53Q6I^V/\ LI^.
MOCY\:/"_C/P=>6$GAJ;3+>!]7:^6,6"H\DGG8R"R$.&4QY.<YP.:.>6EW8.5
M:V1\G?M7?LKM^R_J'AFT?Q+_ ,)&^LV\TS'[!]E\@QE!M_ULF[._KQTKR_X5
M_$C4_A#\0-&\8:/!:7.IZ5*TL$5\C/"Q*,AW!64D88]"*^_?^"AGC?2?AW\;
MOA%X@UKPU9^,M-L;34&GT*_*>3<A@J*&WHXP&8,,J>4_$?*?[0/[17@GXP>%
M;#2O#7P:T#X<WEO>K=2:EI+0&2:,1NOE'R[:([26#=2,J..XTA)RBKHB246[
M,^YO@1^U[XQ^*'[-OQ/^(.JZ;H=OK/A>.Y>S@LX)EMY#';"5?,5I68_,<':R
M\?G7SW8VOQ&_X*20V^K>*KKPUX%\)^#?M"/K5K;2A3),L3.I22<AMJQ(Q.Y
MH;DG( T_V0?^3%_C]_UPOO\ T@%==^P?JZ^+OV3?&_@WPYI_AW5/&%K?RW)T
M?Q% )[2]618BC31@J65MC1@D\%%)XXK&RC=HU^*R9\[?'S]BF\^$?P[@\?>&
MO&>E_$/P<9%BN-1TU%C\G<P16&V2170N0I(;()'&,D>D2?\ !-O2],\):)XF
MU[XR:5X;T34+..XENM5TY(%AED1&CB#/<A7SN?G*GY1@'/'3_'+4/C'\-_V8
M]=M?$_A#X2?#_P -:U(+:7P_H<$T%_),[J-\212- T@5 Y.X_+'STQ4G_!1.
M9U_9U^"L0=A&T<;,F>"1:1@$CU&3^9JE*3LKD\L5=V.&T/\ X)U6>O\ P\TK
MQM%\6M*LO#MS+(US?ZCI_P!G@@M%:5%G5VGPQ9DC^5M@Q(3NRN&FU[_@FE<Z
M!JMC>W/Q1T"V\ SVPGE\57D:P+&S%1&@C,VUM^X%6\T X/MGLOB](\?_  2]
M\"JKLJO)9JP!P&'FRG!]1D _@*J?M=,?^'?_ ,"ER<$Z82/^X=+0I3;WZARQ
MML?.W[5'[*^I?LPZUH<$^N6_B/2=:ADDL[^& P,6C*>8K1[FQ@21D$,<[O:O
M"Z^Z?^"D3%OAK^SZ2<DZ1=$D_P#7&PKX6K:FW**;,II*5D%%%%:$!1110 5^
M[7[.7_)O?PO_ .Q6TO\ ])(J_"6OW:_9R_Y-[^%__8K:7_Z215R8C9'11W9V
M]_\ \?6F_P#7P?\ T5)5VJ5__P ?6F_]?!_]%25=KB.L**** "OF_P#;ZC9/
M@3:W[#;9Z=XCTJ[NYOX885N5!=O0 L.?>OI"J>L:/8>(M)N],U2S@U#3KN)H
M;BUN8P\<L;##*RG@@CM0!X)^WAJ%O<_LF^+X()DN)M76SL]/CB8,;N:2ZA\M
M(\?>)&3QV!/05FZE=1>&O^"A&FW&M.L4&O\ @1M.T2>4@*UQ%>>;- N>K[,/
MQS@@5W_@_P#91^%7@7Q!8ZUH_A../4-/8O9-=7MS=1V;'^*"*:1TB/H448P,
M=*ZWXD?"?PC\7M%CTKQAH5MKEG#)YT(FW+)#)C&^.1"'C;'=2#0!U)N(EN%@
M,J"=E+B/<-Q4$ G'H"1S[BOF;]H;2[7XD?M*?";X=>)]\W@B^L=2U.?3//:*
M'4KJ%5$<<@4@N$!+[>^><BO7OAQ\!_ OPFU"[U#PQHAL]1NHA!-?75Y<7EP\
M8.[9YL\CL%R =H..!Z5>^)GPA\(?&#3+2P\7:-'JL-G.+FUD6:2":WD'\4<T
M3+(A]=K#.!F@#Y1T72=.^"?QT^/,7@":2<Z#\.UN[+3WNFNA8W"^?*ELFXDH
MH;:PC/3S.."*X'P-\$_B%XJ^%O@_QUX<\-^&-.\67$-EJZ_$.Y\873W\[,R2
M2BX4Q%"'^:-HB2JYQSMY^W?A]\ _ 'PKU:YU/PKX<@TB^NK1;&XFCFE<S1+(
MTGS[V(9BSL2YRS9Y)P*Y_3_V1?A%I6N)JEIX,MX9([D7:6:W=P;%)@VX.+0R
M>0"& (PG&.* /&-8^"O@?7O^"BTL6H>&K.[CE\!+XB=9 W.HKJ@C%SU^^$ 7
MTP*Y?QR3_P *7_;)&>/^$@E_])[:OLS_ (5WX>_X6)_PG?\ 9P_X2O\ LK^Q
M/[0\Z3/V/SO.\K9NV?ZSYMVW=VSCBL:^^!O@C4M%\9:1<Z)YFG^,+@W>N0_:
MIQ]KE*JI;<'RG"+PA4<>YH ^=/&GPET'X+^(O@/XT\+F^MO%&L>*[+1]9U2X
MO99YM5AN[:9IOM)9B'.Z,$<84G@# QQ=]X1\4?M ?&SXO?VCX'T'Q]'H.M#2
M;*W\0>([FQ.EVZQ@QM!#%&P7S.7\WAB<XZ5]K^(OAUX>\61>'8]5TX72>'M0
MAU33%\Z1/L]S$C)')\K#=A78;6R#GD' KE_'G[-OPX^)7B0^(=>\."76VB6&
M6_LKVXLI9XU^ZLK02)Y@  &'SP .@% 'S7XDT'Q;!X'_ &>/A;\2-734+#6/
M$%U8:]<6&I/(M[% )3:VDD^%9PPVHPZDQ\\UT7A7X:^$OA7^W1X?T7P@S65D
M?!U]/+HBWC30V+-<0\QQLQ,0<#=M& 2"0.37T'KOP+\!>)/AW:^!=0\,64GA
M2T*M;:='NB%NRDE7C="'1\LWSJP;YFYY-4/ G[./PY^&?B&WU[PWX:CT[6H;
M>:V%^;J>::1)61G\QI'8R,3&GS/N8 8! XH \W_;VA@N/@WH45U?2:9;2>+-
M(66^AF\E[=#< &19/X"HR0W;&:Y7Q!\+_"WP._::^#EMX!MWTT^+!J=CKVEB
MYEN(]3M$M?,\^<.S;F5\'>>6SSFOIGQW\._#GQ-TBWTOQ1I46LZ=!=PWR6L[
M,(S-$VY"P!&X ]5;*GH017,?#K]G'X<_"C7I=:\+^&H[#59(?LPNIKJ>Y>*'
M.?*B\YW\I,_PIM''2@#Y*DU?4O"_PO\ %'[,-I=/%XAD\6Q^&=*DR3(NA7Q:
M[^T$XY"0"X1B,[< >U?9EG\'?"&G^+-!\30:0(];T/2_[%T^Z6>4""S_ .>0
MCW;#]2I/O7G5O\'+_6_VR+WXEZGHD%EI.B^'(M)TF^WQM)?7$CNTTN%8LOEH
MQB^8*3O.,BO4;SX:^'-0^(6G^.+C3O,\4:?92:=;7WGRCRX';<R>6&V')[E2
M?>@#IZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I1?\AFZ
M_P"O>'_T*2O-O^;I_P#N3/\ V^KTF+_D,W7_ %[P_P#H4E>;?\W3_P#<F?\
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M4?\ "?>&/^ACTG_P.B_^*KXOHH ^T/\ A/O#'_0QZ3_X'1?_ !5'_"?>&/\
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MH()ET24)-C;NDC4\]-P+97\<5S>L:/=Z#J4]A?P^1=P';)'N#8. >H)'0U]
M7NA^(9/CQ;:DD=P='$0VW"D^4L7E89">F2_.WKR#VX\C^+__ "4C7/\ KJO_
M * M:8/&5*]50DTTX\VG37;<"Y:^%=-TWX3W/B'4(?/U"^N1;Z?F1@(P"0S8
M!&3\K]<CY1[U0L_A/XLU"&SFM](>6&\A\^&031[2A"D$G=\N0PX.#U]#78>/
MI$F^"/@YX#F(2!&QTWA'!_4-2_%74KJQ\#?#@6\\D(^Q+-A#@;TCAVM]1DX^
MM94\16;2B]92DM;NUEIU78#R_6M#O_#FH26.I6SVEU'@F-\'@]""."/<50KW
MCXK>,IO ?Q.BU&VM(;JYDT=8D^T9VHQF8[L#D\+C@CK6*WQ_CN/+N+OPGI]Q
MJ<7,=T7'R-CJ 4)'_?5;TL7B*E.-2-*]UW2_!@5OA+\)[?Q&+75M;DC_ +,G
M9X[>T$I5[AU#9Z$$ ;6/!R=OIUP]'\(V>J_%Z301"1IR:E/&80S?ZJ-G.W=G
M/W5QG.?>IO@K=33?$G0(9)I'BA^T".-F)5,PR$X';)YXJUIMMK5W\8M>BT"_
MMM.U(WEWLENL;2/-.5 *MDXYZ= :RJ2K0K54Y_9NNB6K7],"7Q]:Z#X?_M*T
MA\!7=FBN]O;:M-=W 1F&0'56&UAP2!GD5>L?"OA7PMX?\+2:]ITVJWVO,'\Q
M;AXEMXVVX("D9P'7KUYY[5O:*NOV_@KQNOCA[A[/RRL!O",F7#?ZHGMN\O;C
MC.,=ZJZ]H-YXQ\-_#2YTF%[R"VC2WN'B&[R6 C!+>@!1LGV]ZXE6>E*4VDGK
M)2;O[MUJ]M>@&/;?#C1]-^*MSX8U!'GLKRW8V,V\J\3%=RDX(!(VL.>#Q7F>
ML:9-HNJWEA.,36LK0OQP2I(R/:O9O$VI)JG[0NCQVK^8;0QP.4/<!F89]@V#
M]"*\_P#C!(DOQ)UPQD%?-53CU"*#^H-=^#K5)5(QF_B@G\[V_$#C:***]H H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH L:??3:7?6]Y;MLGMY%EC;T93D?RK[-@F'B+P
M]'+'-+:K?6H99H& DCWID,I((R,Y!P>E?%5?:/A6S?3O"^CVDHQ)!9PQ-GU5
M #_*OD\_C'EIRZZ@?*WQJ\!Z)IMS%H^K>+_BGXPDTZ6VOYVMKJR:'2RTFV&9
MY7@78Y()4)EB >,5[=\"Y(5M-?M#KOBS5=1L[P6]Y:>,'B:YM&"Y79Y:*IC=
M6#!AD$>F"!YI^TNMEHVOW4=CXWCT._\ $,%JFHZ-+I$NH)*D4N(K@F(AH.2$
M)8A6 ]17I7P'2VOM/U_6Y/$R^*M?OK[R]5N4LS9K;2PHJ+;K WS($7^]DMNW
M9P17QX'3?#/_ )%V\_[#6K?^G&XKJZY3X9_\B[>?]AK5O_3C<5U=(#SO]HW_
M )-[^*'_ &*VJ?\ I)+7X2U^[7[1O_)O?Q0_[%;5/_226OPEKNP^S.6MN@HK
MZ5^#/[ WQ!^.7P[TWQEH.L>&K32[]I5BAU&ZN$F!CD:-MP2!EZH<88\8K=\:
M_P#!-7XF^!/!NO>);_7?"<UCHUA<:C<1VUY=-*T<,;2,$!MP"Q"G&2!GN*V]
MI&]KF/)*U['R;114EO;RW4\<$$;S32,$2.-2S,Q.  !U)/:M"".NB\(_$;Q9
M\/\ [7_PB_BC6O#?VO9]H_LC4)K7SMF[9O\ +8;L;FQGIN/K6O\ %OX,>*/@
MAK&E:3XNM(]/U34-.34UM$E$CPQM))&%D(X#9B8X!. 1SG('#4M&AZH]$_X:
M-^+'_14/&?\ X4%W_P#'*Y+PSXPU[P5J!O\ P]K>HZ#?%=ANM,NY+:4KD'&Y
M"#C(''M61119!=FSXH\:>(?'%\E[XCUW4]?O$78MQJEY)<R*N<X#.Q(&>U2Z
MQX^\3^(="T_1-5\1ZMJ>C:>%%GIUY?2RV]L%7:HCC9BJ87@;0,#BL&B@#I+S
MXB>(]:TW2=)UO7=5US0-+>,VVCWVH3/;1*HVA(T+8C&W*_*!@'BON.#XA?LH
M>)O!^E:<OCGQWX%T.-,W?@^#4=5EM+@$@F&9")DVY!'[MUSN/.>GR?\ &S]F
MWQ-\!]#\':KK]]I-Y;^*;:2ZLETV:5WC5%A8B0/&@!Q.GW2W0^V?**AQ4U=,
MM-QW1]%?MP?M$:1^T1\5+._\.QS#0-)LA96TUQ'Y;W#%V=Y-O4*<@ 'GY<G&
M<#YUHHJXI15D2WS.[-[1_'WB?P]H6H:)I7B/5M,T;4 PO-.L[Z6*WN0R[6$D
M:L%?*\'<#D<54\.^)]9\(ZDFHZ%JU]HNH("JW>G7+V\H!Z@.A!Q^-9E==\+O
MA3XH^,OBR#PYX2TN35-3D4R, 0D<,8QNDD<\*HR.3U) &20":+<6IG>*_'GB
M;QY<0S^)O$6K>(IX05BEU:^ENFC!QD*9&) .!T]!4GB+XB>*_&&GV-AKWB;6
M-;L;$8M+74;^6XBM^ O[M78A> !QC@5]/7W_  2Y^+]KIKW,6H>%;V94+"S@
MOYA*QQG:"\"IGMRP'/6OF>7X:>)[?XAQ^!;C1[BU\5R7T>FC3;@!'\]V"HN2
M<8)92&SM((.<<U,91>Q3C);D-Y\1/%>H^%[?PU=^)M8N?#EN08='FOY7M(\$
MD;82VP8)/0=S2:Q\0O%/B#P_8:%JGB76-2T.PV_8],O+^66VMMJE5\N)F*IA
M25& , D5[#\2OV*_&'PQN-+TZ^\2>#]2\2:E>6UE;>&]-U5GU%GG8K&QB>-<
M)D'+YP,=:S?C=^R;X@^ 6C"[\2>+/!\^H;H@="T[5'DU%5DW;7,+1+\GRGYL
MXXHYH] Y9'EOB3QYXF\96NGVVO\ B+5M<M].0QV4.I7TMPEJI"@K&'8A 0B#
M"X^Z/05A4459(4444""BBO7_ /AF'Q3_ ,,\?\+D^WZ/_P (QYGE?9/.E^VY
M^T_9_N>5LQOY^_T]^*3:6X[-GD%?NU^SE_R;W\+_ /L5M+_])(J_"6OW:_9R
M_P"3>_A?_P!BMI?_ *215RXC9&]'=G;W_P#Q]:;_ -?!_P#14E7:I7__ !]:
M;_U\'_T5)5VN(ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I1?\
MAFZ_Z]X?_0I*\V_YNG_[DS_V^KTF+_D,W7_7O#_Z%)7F'Q,N!X'^+'@[QC/\
MFDW$4FA7\QZ0"0[X6/HN_.2>!B@#URBBB@#X\^"_AJ]M=4_:I\!PPF36;F]N
M;NSMY&5&F2\AG,)!) P<ISD ;AG&:SO%'[._Q!U+]A#PS\.[?P_YGC&SO/-G
MTW[;;C8OVJ=\^89/+/RNIX;O7UE#\/\ P_;^/+CQI%IXB\2W%@NF37J2N!+;
MJ^]5:,-L+ CARN['&<<5T5 'S1\3OV5OB%XZ\>:QKVD?'OQ-X4TZ]E#PZ/9+
M<>3:@*J[5VW:#!()X4=:YOQ_^RCX]M?ASX4FL_&%Q\2_&WA'Q%_;UG)KS-&;
MN/\ =$VNZ663'S1*1N<+RPXZU]=T4 ?//P#^&OC63XR>//BKXXT6W\)7VOP6
M]A;>'X;U+UXHXD13(\R?*<^6N,>K9 XS<\#_  Q\2Z/^U]\1_&UYIOD^&-7T
MFSM;*^\^)O-D2. .NP,77!1N64#BO>J* /A+3_!?QQU#XY77Q*\;?!E_&MW:
M-CP]ILOBFPMK32%#$JPCW2;Y -I#$C#;FP6V%/0_C1]O\=?M+_L[:5)8'3]4
ML8[K7]2M!*LWV1=D1V%Q@, \3)N'4XQ7U57.V_P]\/VOCR[\:1Z?_P 5-=62
MZ;+?M-(Q^S*P<1JI;:HW $[0,D9.: .BHHJ&[NH;&UFN;B58;>%&DDD<X5%
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M&;_$W_/]I/\ W^E_^-T?\,W^)O\ G^TG_O\ 2_\ QNC^T<)_S\0'E-%>K?\
M#-_B;_G^TG_O]+_\;H_X9O\ $W_/]I/_ '^E_P#C=']HX3_GX@/*:*]6_P"&
M;_$W_/\ :3_W^E_^-T?\,W^)O^?[2?\ O]+_ /&Z/[1PG_/Q >4T5ZM_PS?X
MF_Y_M)_[_2__ !NC_AF_Q-_S_:3_ -_I?_C=']HX3_GX@/*:*]6_X9O\3?\
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M (W1_P ,W^)O^?[2?^_TO_QNC^T<)_S\0'E-%>K?\,W^)O\ G^TG_O\ 2_\
MQNC_ (9O\3?\_P!I/_?Z7_XW1_:.$_Y^(#RFBO5O^&;_ !-_S_:3_P!_I?\
MXW1_PS?XF_Y_M)_[_2__ !NC^T<)_P _$!YY)XHUF6Q^Q/JU\]GMV?9VN7,>
MWTVYQBJVGZK>Z1.9K&\N+*8C:9+>5HVQZ9!KTS_AF_Q-_P _VD_]_I?_ (W1
M_P ,W^)O^?[2?^_TO_QNH^O8*S7.M0/,+R^N=2N'N+NXENKA_O2S.79OJ3S4
MVG:UJ&C^;]@OKFR\T;9/L\S1[QZ'!YZUZ3_PS?XF_P"?[2?^_P!+_P#&Z/\
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M '^E_P#C=']HX3_GX@/*:*]6_P"&;_$W_/\ :3_W^E_^-T?\,W^)O^?[2?\
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MR[E<CYNAP*7QW\0/V/?C-XL7XC^++_7(]=N+9?MWAU8+J-;B18PB^8T28WJ
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MSE_R;W\+_P#L5M+_ /22*C$;(5'=G;W_ /Q]:;_U\'_T5)5VJ5__ ,?6F_\
M7P?_ $5)5VN(ZPHHHH **** "LSQ-K/_  CGAO5M6\G[1]@M)KKR=VW?L0MM
MS@XSC&<&M.J.NZ1#X@T34-+N&D2WOK>2VD:(@.%=2I()!&<'N#0!\:?LZ?\
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MH+IK:<M]<C3V;<UH)F\HG(.2F<9R!V[5Z9_PS5XG_P"?[2?^_P!+_P#&Z/\
MAFKQ/_S_ &D_]_I?_C= 'FNF:]J>B[_[.U&[L-_WOLL[1[OKM(S5>:^N;F[-
MU-<2RW+-N,SN2Y([[CSFO4O^&:O$_P#S_:3_ -_I?_C='_#-7B?_ )_M)_[_
M $O_ ,;H \XU#Q+J^K6ZP7VJWM[ IR([BX>10?4 FNBOO&UI'\,[+PQIT4R3
M/<-<ZA-(BJLC9^55P22/N\G'W!ZUTO\ PS5XG_Y_M)_[_2__ !NC_AFKQ/\
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MX=\::OJ>G:%JUKJ\NG1037$ME*LT2B4R!!O4D%OW3Y7J.">HJ#XF?\B[9_\
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MLXIG_#P?X=_] 7Q/_P" MM_\D5^?-%?9?ZH97VE]X'Z#?\/!_AW_ - 7Q/\
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M2*/^'@_P[_Z OB?_ ,!;;_Y(K\^:*/\ 5'*^TOO _0;_ (>#_#O_ * OB?\
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M;;_Y(K\^:*/]4<K[2^\#]!O^'@_P[_Z OB?_ ,!;;_Y(H_X>#_#O_H"^)_\
MP%MO_DBOSYHH_P!4<K[2^\#]!O\ AX/\._\ H"^)_P#P%MO_ )(H_P"'@_P[
M_P"@+XG_ / 6V_\ DBOSYHH_U1ROM+[P/T&_X>#_  [_ .@+XG_\!;;_ .2*
M/^'@_P ._P#H"^)__ 6V_P#DBOSYHH_U1ROM+[P/T&_X>#_#O_H"^)__  %M
MO_DBC_AX/\._^@+XG_\  6V_^2*_/FBC_5'*^TOO _0;_AX/\._^@+XG_P#
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M#?XC7D5CIVO+9ZE*=J6>I1FW=SV"D_(Q/H&)]J_+6BN>MP;E\XVIN47WO?\
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M HHHH **** "BBB@"E%_R&;K_KWA_P#0I*NU2B_Y#-U_U[P_^A25=H ****
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M?$#_ ,$?_P!LH ]6HKRG_A?W_5./B!_X(_\ [91_PO[_ *IQ\0/_  1__;*
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M.K'&22!AMWR[MQY R_V;?A#:QZ+\6=0M/#ND^.+S3KQ]+T.#5[6*:.6:(O\
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M_P!L3Q[^S?\ &K3]'\-1Z3?Z5?>'K>[:TU:V>18YC<W2,Z&-T;)5$!!)'R#
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MMI 8YN!UPC,0/4"OTDF^%^E_L_\ QI^,WQXNXXVT5M"CO=/5"H62XE!-P@Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:/\ P[C_ .JA_P#E$_\ NBC_ (=Q_P#50_\ RB?_ '11_K1E'_/[_P EE_\
M(@?%U%?:/_#N/_JH?_E$_P#NBC_AW'_U4/\ \HG_ -T4?ZT91_S^_P#)9?\
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M'Q=17VC_ ,.X_P#JH?\ Y1/_ +HH_P"'<?\ U4/_ ,HG_P!T4?ZT91_S^_\
M)9?_ "('Q=5C3[PZ??VUT(H9S!*LHBN(Q)&^T@[64\,IQ@@]17V3_P .X_\
MJH?_ )1/_NBC_AW'_P!5#_\ *)_]T4GQ1D[5G6_\EE_\B!YWIO[4?@O2->L?
M$=C\&-'T[Q+91%(+O3]0:W@1B""WV=(@I/S'DY;&.>!7A'BWQ1?>-?$VJ:]J
M3(U_J-P]S-Y:[5#,<X4=@.@]A7UW_P .X_\ JH?_ )1/_NBC_AW'_P!5#_\
M*)_]T5P8?.<@PLW.E5=VK7:J/3LKIV7D@/G?0?C-)IOP8U_X=:AIC:E87]RE
MY970N?+>QE!4G"E&#*=H^4;?O/SEN/-J^T?^'<?_ %4/_P HG_W11_P[C_ZJ
M'_Y1/_NBNFEQ#DE%R=.K;F=W[L]]K[>0'Q=17VC_ ,.X_P#JH?\ Y1/_ +HH
M_P"'<?\ U4/_ ,HG_P!T5O\ ZT91_P _O_)9?_(@?%U%?:/_  [C_P"JA_\
ME$_^Z*/^'<?_ %4/_P HG_W11_K1E'_/[_R67_R('Q=17VC_ ,.X_P#JH?\
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M )1/_NBC_6C*/^?W_DLO_D0/BZBOM'_AW'_U4/\ \HG_ -T4?\.X_P#JH?\
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MNV H ZD\5]/T4 >(?LK^'-4\.6?Q4&J:9=Z8U]\0]<OK87<#1&>WDF4QS)N
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M!\Z?#6QUOXH?M-7OQ4D\,:QX1\-6'A;_ (1NSCU^V-I>ZA*]UY[R& _,D2@
M#?@DG([XN_L'>%]8\&?LH^!]'U_2KW1-6MOMWGV.H6[P3Q;KZX==R, 1E65A
MD<@@]Z]^HH ^;?'[:W\(_P!J)OB(_A/7/%?A77/#,>BRS>'+![Z[T^XAN&E
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MVX!W9&,U]144 ?'_ (A\.^)/"/PP_98\1'PIKFK#P=#8KK6EZ98O-?VP?3!
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M_CE'_#2OAC_GQU;_ +\Q?_'*^:J* /I7_AI7PQ_SXZM_WYB_^.4?\-*^&/\
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MFJB@#Z5_X:5\,?\ /CJW_?F+_P".4?\ #2OAC_GQU;_OS%_\<KYJHH ^E?\
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MP_\ L\Z;X_\ $DXF-OX:AUB^EPL?FO\ 9ED?  P"S$@ #J0 *P_@#J5_X-^
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MK[X+#QF+4^%O^$PC.H?;@?L_E"VF)\W_ &,XW9^7&=W&:KZ#'X3;]N30V^'
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M>M?"CX'W/@?QAKOC7Q/XHG\:^-]8@BLI=4>S2SAM[6,ED@@@0ML7<=QRS$D
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M^'M0N+SQ-!J^I%MMA!I$Z.#Z-*,''J1D=,9)- %JS^#<$<&E1ZUXC@T;5-4
M-K8M;M(3GH&;("DY Y[\=:Z[X)>&[SP[X@\9:/>!%NX8(XR5/RG.XJP/H00?
MQK=D\?1^)8=$O=,\:6/AZR5 -1L[CRA.,#G9YBG)SQZ=^>E8OP_\<:3>>,O%
M]Y?:THM)X8X8+G4&BADF50PR %0$^@QG!&: .%O?A3;R^&+_ %C0_$5OKO\
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M =)^SUXIU;Q4VMOJOC>_\17-H8XIM(U;PVNC7>GN<D,\?WB' X/3Y3@]:O\
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M KG?@UXIM_"_C.-KV18K&\B:UFDD;"IG!5C^( SV!-87_"!^)O\ H7=6_P#
M&7_XFC_A _$W_0NZM_X R_\ Q-*%'#QP[P_.K._5=0-&W\47/@.3Q/HNG-9W
MUEJ :U:X8^9NC =59&1@,E7)[]N*I6?C:^L?!E_X9CBMS87DPGDD96\T,"AP
M#NQC]VO;N:C_ .$#\3?]"[JW_@#+_P#$T?\ "!^)O^A=U;_P!E_^)KHMA]Y-
M-Z/?JMF!A5N>$?&6I^"=2-YILJJS+LDBD7='(OHP_P .:7_A _$W_0NZM_X
MR_\ Q-'_  @?B;_H7=6_\ 9?_B:UG.A4BXS::?H!H>)OB9JGB;28]+-O9:9I
MJOYAM=.A\I';.<D9/?GZ\U?T?XR:YH^FV=I]GT^\>R0I:W5U;[YH%(QA6R,<
M<=.E8'_"!^)O^A=U;_P!E_\ B:/^$#\3?]"[JW_@#+_\37.Z>$<>1\M@)/#_
M (\UGPYK\VL6USYEW<%C<><-RS9.3N'U],59\4?$34_%UC;:=)!9:=I\+EUM
M+"+RHBYS\Q!)]3[<FJ7_  @?B;_H7=6_\ 9?_B:/^$#\3?\ 0NZM_P" ,O\
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M#YJHKZ5_X9J\,?\ /]JW_?Z+_P"-T?\ #-7AC_G^U;_O]%_\;H ^:J*^E?\
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MQ!91S16>K:M=W\$=P )%CEF=U# $@-AAG!(SW-?MK^SE_P F]_"__L5M+_\
M22*OPEK]VOV<O^3>_A?_ -BMI?\ Z215AB-D;4=V=O?_ /'UIO\ U\'_ -%2
M5=JE?_\ 'UIO_7P?_14E7:XCJ"BOGW3?A?X-^(?[1OQ4D\5>$M"\326MGHJV
M[:QIL-V80T4^X(9%.T' SCK@5:^,?[._PITOX1>.+RS^&7@ZTO+?0KZ:&X@T
M"T22)UMW*LK"/(((!!'((H ]XHKY=_X)N>*-6\4_LLZ+)J^H3ZC+9WES9027
M#;F2!& 2//4A0<#/08'0"NP_;$\<>+_ GPGLY_ VKQZ'XBU'7-/TJ"^EMXYU
MB$\P0DI(K+W'8\9Q0![E17R;XH_::\2:A^Q7XN\:6$P\/?$KPR!I>KPF&*1K
M+48KB.*;]VX9<,&+*"",..XKW_XE?&/P;\(;6RG\6:Y%I9OG,=I;K%)/<7##
M&1'#$K2/C(SM4XR,T =G17'_  U^+OA#XO:9=7WA'6X=7AM9?(N8Q&\,UN_]
MV6&15DC)YQN49P:X#XO>(M5TO]I#X!Z99ZE>6NFZG<ZXM]9PSLD-T(].9XQ*
M@.'VL PW X/(H ]OHKR'PO\ %C1_"_AOXC:_XE^((\0:1H7B:ZL[BY.CO:_V
M,,PA+ JBEI_+,J?O@#N\SD_+3+7]KSX/75]?6@\=6$+V<#7+2W4<L$$L:G!:
M"5T"3C/'[IFH ]AHKSKP=\;O!WQ=T'Q%)X.\3*]QI<3)=/)92Q3V+,C%)'MY
MD1R."PRN&VG&:\9\6?M<6?PN\ _!V;_A*5\<R^)=0M8]0\02^';N 76G,)A-
M<Q0PJ!',&1 (OF;!)V$<@ ^JZ*R/"7BO3?''AVRUW1Y9IM-O$+PR7%M+;N0&
M*\QRJKKR#]Y17GGB[]J[X4^!O$5[H>L>+8H=0L'6.]^SV=S<PV;'HL\T4;1Q
M'V=ACO0!ZU17"^,OCEX#^'^G:'J.O^)[+3].UM9'TZ]8L\%PJ0F8D2*"H!09
M&2-Q("Y) )\,OCAX)^,3:G'X2UM=2N-,9%O;66VFM9X-X)0M%,B. P!PV,''
M!H [JBN5^(7Q2\*_"?3;#4/%VLP:%87UV+&"ZN5;RS,8Y)0K, 0@V12'<V!\
MN,Y(!R/AG\?? 7Q@U#4+#PGKZZC?V$:RW%I-:SVLRQM]V0),B,R'CYE!'(YY
M% 'H-%<3HGQH\&^(_AOJ/C[3M9%SX2TZ*ZFNM0%M,OEI;;_//EE YV^6W13G
M'&<BJ/BK]H3X>^"-/\.WNN>)(=.M?$5F]_I4DL$W^EPJL1)4!"=Q$\6$.&8O
MA02"  >B45XPW[8WP=70?[6_X32%H?/DMC:K8W1O5DC +AK01>> H()8I@ Y
MS7,?M-?%RU?X*^#?&7A+Q7]FT2]\3Z03K&GWC01R6K7($JNX(^3 8.K<<$,.
M#0!]'45YI\/_ -I#X<?%+Q)+H'AKQ-'?ZPD)N5M9+:>W::$''F1&5%$J?[49
M88YZ52\6?M5?"OP1XDNM"UGQ=#;7]G*L-V8K6XG@M)#T2>>.-HHCSR'9<=Z
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MWP7;20VUNH>0^;)O=R7<L%[#$8ZUT7Q^_P":<?\ 8YZ;_P"U*S/@KI.IVOQ
M\3ZA>>#[/X>17NG6(?08;RVFDGG1YP]WM@8JJD,L88X+>7R!M%:?Q^_YIQ_V
M.>F_^U* /5J*** "BL_7]>L/"^BWNKZK<I9Z=9Q--//)T10.3[_0<FOSG^.W
M[6_B?XI:A/9:-<W/AWPPI*QVMO*4FN%_O2NO)S_<' ]^M>_E.2XC-YM4M(K>
M3V7^; _076/B1X2\.W#0:KXHT73)UZQWFH0Q,/P9A6;_ ,+M^'?_ $/OAC_P
M<VW_ ,77Y(DDG)Y-%??1X(H6]ZN[^B _6[_A=OP[_P"A]\,?^#FV_P#BZ/\
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M (.;;_XNOR1HH_U(P_\ S^E]R _6[_A=OP[_ .A]\,?^#FV_^+H_X7;\._\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8U#_ ./U]$44<\NX<L>Q\[_\.^_@%_T(7_E8U#_X_1_P[[^ 7_0A?^5C4/\
MX_7T111SR[ARQ['SO_P[[^ 7_0A?^5C4/_C]'_#OOX!?]"%_Y6-0_P#C]?1%
M%'/+N'+'L?.__#OOX!?]"%_Y6-0_^/T?\.^_@%_T(7_E8U#_ ./U]$44<\NX
M<L>Q\[_\.^_@%_T(7_E8U#_X_1_P[[^ 7_0A?^5C4/\ X_7T111SR[ARQ['S
MO_P[[^ 7_0A?^5C4/_C]'_#OOX!?]"%_Y6-0_P#C]?1%%'/+N'+'L?.__#OO
MX!?]"%_Y6-0_^/T?\.^_@%_T(7_E8U#_ ./U]$44<\NX<L>Q\[_\.^_@%_T(
M7_E8U#_X_1_P[[^ 7_0A?^5C4/\ X_7T111SR[ARQ['SO_P[[^ 7_0A?^5C4
M/_C]'_#OOX!?]"%_Y6-0_P#C]?1%%'/+N'+'L?.__#OOX!?]"%_Y6-0_^/T?
M\.^_@%_T(7_E8U#_ ./U]$44<\NX<L>Q\[_\.^_@%_T(7_E8U#_X_7N_ASP_
MI_A+P]I>AZ3;_9-+TRUBLK2WWL_EPQH$1=S$L<*H&223CDUHT4G)O=C22V12
MO_\ CZTW_KX/_HJ2KM4K_P#X^M-_Z^#_ .BI*NU(SY$^+G[3.A_LF?'CQ?J/
MC/P[XDNM,\566FMIE]I-K#+"YMTE652TDR88&1>!DX.>A&?/_B-_P5)^%/C#
MX>^*-!L_#_C&*\U32[JQA>>RM!&KRPLBEB+DD#+#. 3CL:^^Z* /DG_@E[_R
M:K8_]A:\_P#0EKM/VU@?^%<^$>.GC70__2M:^@J* /@/_@H7X1U/X6Z5XO\
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MOJDJB5 VQUTVRPPST(/0]J^NJ* /G;X.Z19P_MC?M"7J6<*W1M/#H%P(QO\
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M!O5A-R8X%+!997C0*H8(S9( P#Z$UEZ]X%\2>%;6"YUKP]JNCV\YVQ37]E+
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MFN!F\698XV9<,(_*EX'MA8_R%?*M>WE&(J8C#?O7>492C?ORMJ_W %%%%>T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q7QM_P"2,^/O^P!?
M_P#I-)7:UQ7QM_Y(SX^_[ %__P"DTE=>$_WBG_B7Y@=K1117( 4444 %%%%
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M.;P]H>@QQZCI_A&[U)=232;AK!YL1RQL5QYB+(%4_*3M/(-7O%'P[\+?#_\
MX)JWVN^%](M=*U77/"NAWNIWEKG?<W"F!M[G)^8.\GXL: /NZBOBWXN_L[>%
M? OQ<^#MAX?GUK21XJO[K2?$EY;:M.MUK4"V_G?Z3+NW,Q:,Y88.'8#'&+6F
MZ>O[/?Q2^.^A_#^W?3](L_ <?B2PT59'D@BOU2X4-&K$[=Y1=P'4T ?9%%?G
M%X&^"?Q"\5?"WP?XZ\.>&_#&G>++B&RU=?B'<^,+I[^=F9))1<*8BA#_ #1M
M$257..=O/MGB+X4^'?BW^VMXLTSQ5;SZGHUOX0TZY;2C</';7$GVB=5:9%(\
MS:&;:&X!8G&<8 /HCXH?$33?A+\/]<\8:Q#=7&F:/;FYGBLD5YF4$#"!F4$\
M]R*Z'3[U-2L+:[B#+'<1+*H<<@, 1GWYKX \3>#=,O/V-_C[X=OX&U;3O /B
M_5+7PW]N=II-/BC2!HU5R<G:+B4#/9J^R?@G\-/"?PS\#V=MX1T6TT6SU".*
M]G6S!VS2M$@,AY/) 'Y4 <9XZ^+/C>\^/EM\,_ 4'AV.:ST)?$&J7WB!9Y%:
M-KCR5@B6)EVOP6+MN ##@U[C7QM8?!?P/JW_  4*\2&\\-V5P8?#%MXAC+J?
MEU WN3<CG[_ KRCX\76@^-?"7Q(\=>"_A)X@U&33KR\D'Q.OO$:VLUG=12G+
MVT3R^8848;%CC ^4 8R: /OV^USQ!;^.M,TJV\,_:O#=Q:2S7?B#[?&GV692
M-D/V<C>^\$G<#@8YKD?V>?BEJOQ:\)Z[J>KV]G;7%AXAU'28ULD=4:*WG,:,
M0S,=Q &3G&>@'2O,[C4[C6/VG_@)?W3[[F[\&ZG/,P&-S-';,Q_,UX3XB8Q_
MLGZS-G9%#\7I9)),X"*-3ZD]ADB@#]$Z*^>OC5J%O_PUE^SG9"YB^UB;7I6M
MPX\P1G37 8KUVDJ1GID&N0_9P^#_ (9\:?$[XM^,-=M9=4U;1/B+J$.DB:X<
M16#(L$IDB0$ .[2 ,QSD(HZ9! /K2BOS<\%_#?QS^T9X5\5^+)_!N@:_XFNM
M6U"WA\3:GXJNK6_T:6.1EBCABCC*PK" A"@_,,$]:]N^*7P7\;>-M%^&/B#Q
M%HFF_%NVT?0!;ZYX5_M9K>*\O&2,F^MWP(Y9/E8!9, A_EP3D 'UK17G7[//
MB3POXN^#'A;5/!=E=Z9X9DMVCL[&^9FFM_+D>-XF+,Q)5T=?O$<<'&*]%H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E%_P AFZ_Z]X?_ $*2
MO-O^;I_^Y,_]OJ])B_Y#-U_U[P_^A25YM_S=/_W)G_M]0!ZM1110 4444 9G
MB'Q-H_A'33J&NZM8Z+8!UC-UJ%RD$09CA5W.0,D]!GFCQ%XFT?PCI<FI:[JU
MCHNG1LJO>:C<I;PJ2< %W( )/ YKXE_X*$?#7Q'-87'C75_%4UQH$&J6-GHG
MAR 8A@#1?OII>!ND+B3'4A2/FQ\H]!_:,L;;QQ^UI\#_  =KL,-[X9DCO[^6
MQNHU>">9(790ZGAN8E&#G[QXY.0#Z>T/7M-\3:7;ZGH^HVNJZ;< M#>6,ZS0
MR $@E74D'D$<'J#67X5^(WA/QV]RGAKQ/HWB%[8*9UTK4(KHQ!L[2WEL=N<'
M&>N#7YV^.-<N_AU\-OVF?"7AW=IF@0^*;.V@MH"0D$5P\PF1!GY598(T(_NG
M%>M? *UB^'_[1'A/1/$_PZ\,>'-<UGPUYNA:IX3GN(MD"I([PWL3-LFF*K\T
MI4'<@Y;(V 'VU1110 4444 >4_#O_DNWQ=_[A'_I*U<'^T)X7T_6OBQHUSXD
M^&/B#XE^'8M':..+2T62*RN#,Q+!&E0,[J%!S]T*N,Y..\^'?_)=OB[_ -PC
M_P!)6KE?C\/#DWQ T6'XE/J2_#YM/8VPMVN5LSJ/F8;[28.<^7M\O?\ *#YG
M>@#5_9]T#PAHNH:RWAGX3ZY\-Y9(HQ/-J]I'"MT 6PJ[)Y,E>3SCK6K\?O\
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M7VB8JJNVQP#P$7D@<LW:O$J]I_X8V^,/_0H?^5.S_P#CU'_#&WQA_P"A0_\
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MW*BC"X QP!1\,_A/X6^#^ARZ/X3TZ33=.DE\YHI;R>Z.[:J !IG=@H55 4'
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M17R;10!]9?\ "\O!'_0;_P#)2?\ ^(J_IGQ8\(ZM*L=OKML';@"?=#G_ +[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCG(ZCL<UZK0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!2O\ _CZTW_KX/_HJ2KM4K_\ X^M-_P"O@_\
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M#\1M6T-K&QDT+QAKFMWD5P)-FH3RD0X!PZ[D7#9QR#FMJSD:3]F_4W=B[M?
MEF.23YT?)H I?#WP7IES\/=2U^_\.W'B&[6Z$-K:02RHSK\H)'E_[Q/0_=KG
M;P^&[SQ?86U[HMQX/TV+(O8C-+/+T+#AEW+G@=.^:V_#]GX_;X>6MQH&HO+I
M7GE19Z>?])C;<<EL*&QGG&X\,.,=.D^*OAV;Q?KGA#23<64'B>2Q/VQIGVJ6
M"J0N0#_%YN!0!G77A'PCXJ\$^(M7T339](&E.WD74D[NMVJC/*OTSTP.02/I
M7-7GA/3]1^$]IXCTZ'R;ZRN#;:B [$/DC:^"3@_,G3 ^8^E>AZ#I>KCP1XGT
M7QM#Y&BZ9 L=I<; F&0'#1G +C(4@G.2<>U<_P##^2.#X&^,WG.(FE*+GIO*
M(!^I6@#Q^BBB@ HHHH *^DOV;]>DU#PG>:;(V[^SY_W?LCY('_?0?\Z^;:^@
M/V8;.2/3M?NR/W4LL,2GW4,3_P"AB@#VZBBB@ KE/B9_R+MG_P!AK2?_ $XV
M]=77*?$S_D7;/_L-:3_Z<;>@#JZ*** "OBW4OBOXT\1?&[XFZ#/\?M'^%6D^
M'[Z&#3[35M+TZ4W".A+;&F*,=I49Y;[XZ=_M*OE.S_9-@^('C[XZ2^.?#EM'
MI_B2YMFT#6CY$MS"%1]\D)!+Q$-Y>5.W<!@@C- %CX,?M57%G\#=1\4?$&XE
MUZXL_$4OA[3;[1;$>;X@;Y3$UO"-JEVRX&-JX3U!KO--_:R\%W'@CQ=XBU*T
MUSPU+X56-M5T/6]/-OJ,/FX\@>5N(_>EE"G=CYADJ.:\&\2?L]_%7QU\!] \
M)>)O#UIJ^J> =93[#;R:E'%;^(],161461'#0N$ 4%_+.W!^]G&MX%_9GU_3
M_AG\2!9_"GPCX1OM<ABM;+PSJ6JWNI_:(8VWNMQ<+=;58G!C>+858 MC&0 >
MP^#/VK_"_C#3_%DKZ'XE\/:AX;TMM9NM)UW3UMKN6T5"_FQ+O(8$# RPY8=C
MFL?P9^VUX'\::[X8L$T7Q5I%GXDE%MI>LZII8BL+FXSM,"2AVW.'_=G:"H88
MSCFO&_!?PE^(?@;PO\5[V]T*]^'?P\7P9J$-MX/NO$8UB$730NS2V^TGRE^5
MB=Q+9DZL#\E3X6>"/B;\9OA=\$O#%YX7L=+\$:!?VFOOXJCU-':[BB\PI"MM
MC?&^V1D)(92R[@0." >[>*OVT/ OA7Q+JNFMIOB35=,T:Y2TU?Q)I>EF?2]-
ME9]A6:4-D%3UVJV<X7<>*L^-OVO/"7@WQDWAB'1/$WBC56TV+5;=?#FGK>BZ
M@DP08\2 \(2Y+ +M!Y)P#Y!??!WXP^"_"_Q%^%OASPEI?B#PUXPU*XNK;Q9<
M:K' -/CN2JR">!LR2,B+U0'!.1O^Z/0/A!\"?$'PW_:$CU.2U-QX8L? =EX=
M@U=IH\S7$+0AAY>XNN1&3R-O&,]* -^Y_;$\"1_#'PYXTM8-:U2+Q#=FPT[1
M;"R$NI37 ;:T0BW[=RG'\6#D8)R,^>?#/]K:74/B!\8]8\4WVH:5X$\-6EE/
M:Z7J>FI;WEC(X"20NH7>9#+\F&9ADC!QS7$^#_V<?BEX)^'/PVUBU\-0WWBS
MP;XFOM0;PY/J4$?VNUN/+!*3AS&K#9GD\9)P2-I9K_[-/Q5^,%U\:-3\0>';
M/PGJ'BB/3+K3;4:C#<0.]OC-N[QG.[: I<JH+\@XYH ^A/"_[5WACQ%;^(A>
M:!XH\+ZIHND2ZZ^C^(M,%I=W5E&&+30*7*NN5*\L.?;)&'8_MN>#[WP5=>+&
M\,>,K30D\F.SN[C255-2GE8J(+5O,(DD5E<-R%&P_,>,^5_#3]F77+.P\=7\
M?P@T?X=W-QX6O=*L+6/Q!/J5[>7<T+*2)&N6@CB/3#KN!(^;&37>ZC\&?%4W
M['OA7P2_@[1?$&N:?#;F_P##NLW+()0C,SI#<02J(YLE<2;]N-P.0U 'J_P>
M^.FA_&==;BT[3M8T+5M%G2#4-'U^S^RWEN74M&S(&8 , V.<_*<@<9]&KYL_
M9)^&OQ!\!ZQXLE\16%]X4\'3^3%HGA'4->76&L N2WE2KPD7S%0OWC@;L[0S
M?2= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5\QWW[,</Q$_:&^*^K>-?"]M>>$]=TNRM=+U*1H7FCE2!$D>'DR1.I7[Q
MSCN*^G** /B#4OV<?BIXA_9WU/X6ZMIMK?-X3UB._P##M])>11P:W9H)!]E8
M(_F1/AVP7VCYE&Y=I>CPW^R_K\?P_P#BG+IGPFTGX?:AJ^C-I.E:/#X@FU*^
MN"6C=VDGDG-NL99!M^56RIR0 "_V_10!\4^/O@7\5_$"^"M N- F\4>"O^$/
ML=&NM#_X2;^S+/3M118P;FZ6-B;E8V7> @;.T8^Z W#WG@_QS\(]%_9;T&30
M(3XST?5-;==)N+V()=9G681K,A=5+QOM#'A6(W# -?H=69J7AG1]:U+3=0U#
M2;&^O]-=I+&ZN;9));5F #-$S E"0!DJ1G H ^3F^!?Q'\<:;\8_&/B#P;X>
M@\1>,/L,5KX,U:]:Y@,%J@7#7$$B;96"H4<, &7YMH;*X_@+]FGXDZYX=^)'
MAVYL+OX;^"M6T4V6C>%=2\1_VS!:WAE6421NF?+B)5PV06/FD_-BOMRB@#XE
M_9\_9BUOP[XVTC4]3^$&B^"7T;3I$FU=O$-Q?W.HW;0O%YD$:W!BA4[B661&
MP&PIS]WLOAG\#O&FA?L52^ ;[PWHLWBEQ<F71==D\VUN%:Y:0*9+>4;7*[2K
MJXVL%R1C(^J** /E+]E;X2_$/P-\1M5O;W0KWX=_#Q=.\FV\'W7B,:Q"+IG#
M-+;[2?*7Y6)W$MF3JP/R?5M%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% %*_P#^/K3?^O@_^BI*NU2O
M_P#CZTW_ *^#_P"BI*NT ?(GQ<_:9T/]DSX\>+]1\9^'?$EUIGBJRTUM,OM)
MM8987-NDJRJ6DF3# R+P,G!ST(SY_P#$;_@J3\*?&'P]\4:#9^'_ !C%>:II
M=U8PO/96@C5Y8612Q%R2!EAG )QV-??=% 'R3_P2]_Y-5L?^PM>?^A+7UM11
M0!\Z?L47EQI_[(6@W5I:M?74#ZS+%:J<&9UU*[*H#ZD@#\:^2_'7QF\3_%/X
M>^'WU7X@Z;]MAUS39;GX=:-X2DA;1-EY&B"6[<[H=A94&0 Q(52<YK]/Z* /
MG;P[I]O-^WEXRNY+>-[F#P1IZ13,@+1AKJ7<%/;.T9]<5X;\1OBYJG@+]H;X
MZ:=I5UH>DKKHT^UO'U[2]2O6C5=/6-;B,V=O*A3#,/*E9>4)R 6%??=>"S_L
M]>-/#GC/Q;K/@'XI?\(M8^)[XZG?6&H>'X=39+DHJ,\4K2(5&$&%8,HQP,<$
M \#^)WA[3-'\!?LT:WX9\;ZE+\-?"@N[*_\ &6@VJW;VLCVRQ0W+1,D@11(D
MB'<I\L/C[VVO5OV:]+\)>(/B[K?C/0OB=XB^)^I_V(FEW&HWEC''8I%Y_F(@
MECAC5Y0P?@$D*QSVKVGX,_"C3O@K\/K#PKIMW<Z@EN\L\][>$>;<3RR-)+(0
M  N68X4# &!SU/;T ?,/[ ?CS0YO@?X?^'_VPQ^,_#4%Q%J^CR1.DUF1=2 ;
M\C'.Y2.>0?8X^GJ** /+?VHO!NI_$#]GGQ_H&C0-=:K>:3,+:W09::11O$:_
M[3;=H]R*^5M>\0_#GXM>"?A/X6^%>@6MI\2;/6=+NI;?2]):UN- $+!KI[F0
M1CRU7#*03\Y((W=:^^Z* /D7P/\ $SPU^S#\8?C-I7Q!O9?#MMX@UP>(]&O[
MBWD>'48IH5\R.)D4Y='4J4^\<C&>M7/@SI6@^%OV=?'GC3XI^&H4T/Q-XFU+
MQ=+HFLZ<L\@2XF5;>,P/NS*^V,*O7,BCJ:^KJ* /B?Q5X/U3X>Z!X3\8^*9I
MO D?B;6K>QU^309#9KX9T-8IGMM.BEBP8(_-\HRR)MS(Q^8 +7NG[*NM:IKW
MPXU&>]U._P!<TF/7=0@T'5M3=I+B\TQ9B+>5I&&Z0$;@';EE />O9** /D.S
M^+7@WX-_M@_&G4_&DYT:UO[+1+>UUN:S=[>-DMG:2!IE4^6SAHV"G ?RCW4"
MO,[S3;A?V4_&.N+IEQI.C>)OBK%K>BV=Q$T3+8RZA;"(B,@% Q1V"X'##'&*
M_0BB@#Y.?XA>'O@+^UO\4];^(\QT'3O$^GZ4?#^O7<,CV[0P0%+BV$@4A&\T
M;]N1G@^E<UX6\=7GPX^&?[0/Q2T?3;O3M+\4ZWN\(V<\#02WMS)&ENERD3 ,
M!+.P<9 )"$^]?:U<=\0?A;I/Q+OO"L^L7%X(?#NK1ZU;VEO(JPSW$:L(O.!4
MEE4MN !'S 'G&* ./\*R^%_V2_@/X/TGQ'??V=I6FP16-UJ(A>2%;ET>2660
MHIV*\N_YFXW.HSEA7RUX5CUR/]A_P?\ #RQ\[2M>^)_B*YTFTDF@??#83W<L
MD]PR'!V_9U8X."5D![U^@U% 'Q9\;? /Q!^"=KX%^*>L^.-,\3:5\/=0A1[#
M3O#2Z=)%IMP4MKA5D%Q)N4(5^7;_  @Y^6L[XB?!\_&C]KSXB'2-1_LGQ3H_
MAW2-8\.:W$<BWO$=C&21G=&XRK#D$'."0*^Y** /C#XV?&4_&3]BGQC)J%@V
MB^,-&U/2],\0:)(/GL[Q-3M P'K&_P!Y&YR#C)(->F>-L?%/]K7P;X94";1O
M &GR>)M1')0W\^8+*,^C(OG2C\*^@ZX[P7\+M*\#^)_&/B"TN+R\U7Q5>QWM
M_/>R*Y7RXQ'%#'A1B-%&%!R1D\T >6?M&>-O@EJE[+X)^,E@+6W2%;FQU#5;
M&58)"X(8VMU&"5D7&& *MTX(K"_9=\?'X9? #6=;^(.O7]CX-M?$-W#X<U3Q
M,'6Z?1RZ+9M+N7?ECOQN X*XP,5]0T4 ?)7[%7QJ\#ZYJWQ'\/6'B6RNM:UC
MQWKNK6%E&QWW%H\@=)EX^Z5!/X5R'[-?[/\ 9_%WPO\ $L:YXN\76F@W'CC6
M+:[\-Z9J*6MA=H)5W"0+'YIW9PP$@!  QUK[DHH J:3I5GH6EV>FZ?;1V=A9
MPI;V]O"NU(HT4*B*.P   ^E6Z** "BBB@ HHHH I1?\ (9NO^O>'_P!"DKBO
MC#X,U'7K#3-=\/D#Q/X>G-Y8JW2=2,2P'V=1CZ@#C-=K%_R&;K_KWA_]"DJ[
M0!Q_P]^*&C?$.S/V20V>K0#;>:3=?)<VKCAE93@D9_B Q]#Q785Q?C3X/^%?
M'MTEYJ>G;-3C'[O4;.1H+A<=/G4C..V[.*YW_AG^->(OB#X]@C[1QZX0H^GR
M4 >K45Y3_P *!_ZJ/\0/_!Y_]KH_X4#_ -5'^('_ (//_M= 'JU%>4_\*!_Z
MJ/\ $#_P>?\ VNC_ (4#_P!5'^('_@\_^UT >K45Y3_PH'_JH_Q _P#!Y_\
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M?V[J6Z7_ %A^V29?C'///%>@?\,U>)_^?[2?^_TO_P ;H_X9J\3_ //]I/\
MW^E_^-T >66MW/8W"3VTTEO.ARLD3%67Z$=*LZGKVIZUL_M'4;N_V?=^U3M)
MM^FXG%>E?\,U>)_^?[2?^_TO_P ;H_X9J\3_ //]I/\ W^E_^-T >7:??3:7
M?VUY;MMGMY5FC;'1E((/YBNM\>>.H=<\6C7]!>^TFZF@1;AE?RV$@&T[65LE
M2 H[=.E=)_PS5XG_ .?[2?\ O]+_ /&Z/^&:O$__ #_:3_W^E_\ C= 'FUGX
M@U33[J>YM=2O+:XN,^=-#.Z/)DY.X@Y///-9]>L_\,U>)_\ G^TG_O\ 2_\
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M7_AFKQ/_ ,_VD_\ ?Z7_ .-T?\,U>)_^?[2?^_TO_P ;H \FHKUG_AFKQ/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5Q7QM_P"2,^/O^P!?_P#I-)7:UQ7QM_Y(
MSX^_[ %__P"DTE=>$_WBG_B7Y@=K1117( 4444 %%%% !1110 4444 %%%%
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M6'!'0C@T ?H#17B'Q>\1:KI?[2'P#TRSU*\M=-U.YUQ;ZSAG9(;H1Z<SQB5
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MOX)_8Z^+-UX@/B70+_1[R-O#FIZQ>QMJQLVG@($TT#G<ZDNI;(+*<&@#[;K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .*\??\ (U?#;_L/R_\ IJOZ[6N*\??\C5\-O^P_+_Z:K^NUKJK?!2_P
M_P#MT@"BBBN4 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "N*^-O_)&?'W_ & +_P#])I*[6N*^
M-O\ R1GQ]_V +_\ ])I*Z\)_O%/_ !+\P.UHHHKD **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@"E?\ _'UIO_7P?_14E7:I7_\ Q]:;_P!?!_\ 14E7: /+_&?[/^D>+OB;
MI_CR#7_$7AKQ!;V::=.^A7B01WULLOFK%.K1MN&XGE2K8.,],;_@SX7:5X&\
M5>,M?L)[R6]\57L5]>I<.K1QO'$L2B(!00NU0?F+')//:NQHH \8UC]EO1+C
MQ9K>OZ!XM\8>!IM=G^U:K9^&=46WMKR<C#3,CQOLD8=6C*D]>O-7/&'[-7AW
MQ5;>$C:ZUXD\-:MX6MWM=-UO1]2(OEA=561)))5D$H;:"=X)SSD9KUNB@#RO
MX>?LY>&?AVOC+R;[6M=?Q='$FL2ZY>_:I+C9$T1;?M#997;(S@<!0H %8%G^
MR/X=M_@_K_PSN/%?B[4_"VJPP6T<-]?Q2/IT,4F](K8^3A5S@'<&)"@9X%>Y
MT4 <=XR^%VE>./%G@SQ!?SWD5YX5O);ZRCMW58Y))(6B(E!4D@*Q(VE><<GI
M4 ^$&A-\2M=\:SFXN[_6M'BT.[LK@HUHUNCNWW-F[)WL#EB".U=Q10!X9X=_
M9)T+PK]EL=.\:^.H?"MK,)8/"HUPC3XU#[Q$"$$WE@_P&7!'!S7H5A\+M*T_
MXK:M\0(Y[QM9U+2X-)EA9U^SK#%([J57;N#$N<DL1@#@5V-% 'F=M^SWX5B\
M)_$/PW.;V^TOQUJ5WJFJQW$J[EEN(XT<1%5&U0(U*YR0><FMGX5?#-?A5X;_
M +%C\2^(/$\*LOE7'B*[2XFAC5%18D*(@" +Z9R22379T4 <19_"/1K+XQ:A
M\28[B].NWNCQZ)) TB?9A"DOF!@NW=OSQG=C';O7F>L?L4^$M5T_Q#HZ>*O&
MFG>%=;DN)Y_#-CK CT^.:;)>1$,9;ASO",S1[@,H1Q7T'10!P,?P7T./QKX-
M\3BYO_M_A72IM(L8O,3RGAD6-6:0;,EP(UP00.3P>V"W[,/@VX^%OB+P!=G4
M;[1-<U.XU>>2:=5N(;F6<3[HG15V[' *\'@8.[)SZY10!XGX9_93T#0?B%X7
M\;W_ (J\7>*O$_AT3I:7WB#4TN"T<L#PF-E$:J% D9AL"DL<L6Q7>_#SX8:5
M\,Y?%4FESWD[>)-<N/$%Y]K=6V7$RQJRQ[57" 1+@')Z\FNOHH \1N/V4-"M
M]:UB\\/>,/&G@S3]7NGO;[1/#NKBWL99W_UDBJ8V:(MU/ELG;I@8]CTG2[?1
M-*LM.M ZVMG"EO$)'9V"(H5<LQ)8X Y)R:MT4 ?'GPI_98;QC<?%J[US6/''
M@M=:\;ZV+BQTR]:RM]7L7GS&[1R1MN1E9P)(]I93C<1BO9O%?[,7A37['P?%
MI%[K7@F[\)6S66CZAX9O!;W$%NRJKQ$NCJZL$7.]2<Y.<DFO7:* /*_AY^SE
MX9^':^,O)OM:UU_%T<2:Q+KE[]JDN-D31%M^T-EE=LC.!P%"@ 5@6?[(_AVW
M^#^O_#.X\5^+M3\+:K#!;1PWU_%(^G0Q2;TBMCY.%7. =P8D*!G@5[G10!Y?
M\2OV?=#^(OBNR\50ZQKWA#Q9:VIL1KGAF]6VN);8MN\B0.CI(F[D!E.#R#5?
M6/V<-!\0?"'Q%\/=5UWQ)JECK\HGU#5;[41/?R.#$00[H408AC4*J!0 < $Y
MKUBB@#CO'?PNTKXA:UX0U34I[R&?POJ@U:S6U=52281O'B3*DE<.3@%3D#GM
M6#<? '2?^%P7/Q$T_P 0>(M$U2^^S?VII^FWJ1V.I_9UVP_:(S&6;:O'RLN1
MP>"<^GT4 >,:?^R]I2>)M'U?6_&OC7QA!H]\NI:?I/B#5EGM+>Y7/ERX6-7=
MD+';O=L5[/110 4444 %%%% !1110 4444 4HO\ D,W7_7O#_P"A25=JE%_R
M&;K_ *]X?_0I*NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-;=
MM.W&['&>F:=10!\.?$']M76=/\::=9:IX&ALM0\+ZO-+- -2+"1Q;W%L5SY7
M3]^6#<YVCUS7T]\"/B9JGQ=\"1^)=1T)-!BN9G6TA6X,QEC7CS"2BX!8,!UZ
M9[UX5^U5^S/>?$#XK>%=:T.%E37)TT_5I8UR(2BDB<_]LE9?3,:#JU?5>@Z)
M9^&]%L=)TZ%;>QLH$MX(EZ*B@ #\A7V6;5,LE@,.\+32J26NK?+9NZU?65[>
M0B_1117QHPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "ODG]KC]H#Q7\/-0UGP7)H6GS:'KVER1
M6VHDR"0QRQM')WV[U8GCT*GO7UM7B7[6WPA?XK?"VX:PMC<:_HY-[8K&N7D&
M/WL0]=RC( ZLBBO=R2IAJ>.I_6XIP;MKT?1_)_@!C?LR_M"^*_CQJVK-?:%I
M^F:)IT2A[JW,A=YF/RH-QQ]T,3Z?+ZU]#5YU\ /A;'\(?A?I.A%%&H,OVG4)
M%_CN' +\]PO" ^B"O1:YLSJ8>IBYO"1Y::=E\NOSW ****\L HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH H:FWER6,I21TCG);RT9R!Y;C. ">I'YT[^UH/^>=U_X"2__$U=HH I
M?VM!_P \[K_P$E_^)H_M:#_GG=?^ DO_ ,35VB@"E_:T'_/.Z_\  27_ .)H
M_M:#_GG=?^ DO_Q-7:* *7]K0?\ /.Z_\!)?_B:/[6@_YYW7_@)+_P#$U=HH
M I?VM!_SSNO_  $E_P#B:/[6@_YYW7_@)+_\35VB@"E_:T'_ #SNO_ 27_XF
MC^UH/^>=U_X"2_\ Q-7:* *7]K0?\\[K_P !)?\ XFC^UH/^>=U_X"2__$U=
MHH I?VM!_P \[K_P$E_^)H_M:#_GG=?^ DO_ ,35VB@"E_:T'_/.Z_\  27_
M .)H_M:#_GG=?^ DO_Q-7:* *7]K0?\ /.Z_\!)?_B:/[6@_YYW7_@)+_P#$
MU=HH I?VM!_SSNO_  $E_P#B:/[6@_YYW7_@)+_\35VB@"E_:T'_ #SNO_ 2
M7_XFC^UH/^>=U_X"2_\ Q-7:* *7]K0?\\[K_P !)?\ XFC^UH/^>=U_X"2_
M_$U=HH I?VM!_P \[K_P$E_^)H_M:#_GG=?^ DO_ ,35VB@"E_:T'_/.Z_\
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MJ>DWTVHV*3W&GW.ERLSJ;6[:)I% 8@$F-W7# !AALX89P<@ %RBBB@ HHHH
M***PO%OC33?!5OIDNI-(/[2U&VTNV2)-Q>>>0(@] !DL23T4XR< @&[1110
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M(8W('7&Y3C./I704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %%%% !1110 4444 %%%% !1110 4454OKM[79L"G=G.[\* +=%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%9/]K3?W4_(_P"-']K3?W4_(_XT :U%9/\
M:TW]U/R/^-']K3?W4_(_XT :U%5;&\^U!@P <>GI5J@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "LW6/^6/X_TK2K-UC_ )8_C_2@#.HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** 'PS&&177J*WHY!+&KKT(
MS7/5?TRYV-Y3'ANGUH U**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV:^SZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH * 2.1P:*.O ZT ;EG<?:(0?XAPU3U7L[?[/" ?O'DU8H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "LW6/^6/X_P!*TJS=8_Y8_C_2@#.HHHH *YWQ]\/?#_Q0\-3^'_$^
MG_VGI$SI));^=)%EE8,IW1LK<$>M=%10!@-X#T"3P*G@V338Y?#26"Z8+"5F
M=?LZH$5-Q.[A0/FSNXSG/-4?AO\ "?PK\(M N-%\)Z4-*TRXN&NY;<W$L^Z5
MD5"V968\JBC&<<=.M=;10!X]>_LA?![4->;6)O MC]L9_,*QRS) 6SG_ %"N
M(\>VW%=OXZ^%WA?XE>%4\->(M)2]T-&C=+..62W52@PF#$RD #L#BNJHH X[
MQ7\(?"7C?P-:>#M:TG[;X<M%A6&R^TS1[1$NV/YT<.<#U;GOFNFT?2;70=)L
MM,L(O(L;*!+:"+<6V1HH55R22< #DG-6Z* .*^(?P:\'?%:]T2[\4Z/_ &I<
M:+(\M@_VF:'R68H6.(W4-DQI][/3W-=+K^@:;XJT:[TG5[&#4M-NT,<]K<H'
M21?0@_@?8@&M"B@#RSP3^R[\+OAWXACUS0/"-M9ZK$2T5Q)/-.8B<\H)'8(>
M3RH%:OQ(^ O@'XNS0S^+?#5MJUS"NQ+G?)#,%SG;YD;*Q&>Q..:[ZB@#SWPW
M\&_"/PK\(ZW8>#?#T&E?:K:02>3OEFF.Q@H+N6=NO )[^]?+G['_ .R[H_BS
MX;ZY:?%'P%>0W<6J^9:?VI!<6,^PQ(#M8%'*9'3.,BON6B@#&\*>#M$\#^'[
M;0]!TVWTO2;=2L=K N%&3DDYY)))R3DFO-[W]D+X/:AKS:Q-X%L?MC/YA6.6
M9("V<_ZA7$>/;;BO8:* .5\=?"[PO\2O"J>&O$6DI>Z&C1NEG'+);JI083!B
M92 !V!Q4'BOX0^$O&_@:T\':UI/VWPY:+"L-E]IFCVB)=L?SHX<X'JW/?-=C
M10!RGB#X5^%/%?@FW\(:QHMOJ/AZWBBAALYRS>4L:[4*OG>&"\;@=V">>37!
M1_L;_!R&Q@M(_!4"1PSBX1EO;D2;QTS)YNY@.RDD#TKVBB@#B_B1\&O!?Q>M
M;:#Q=H%OK*VQ/DR.SQRQYZA9$96 .!P#C@5)\./A#X/^$=A/9^$="M]&AN"&
MF:-GDDE(Z;I'+,V,G&3QDUV%% '%?#'X->#O@W97UIX/T?\ LBWO9%EN$^TS
M3[V48!S*[$<'M7:T44 <G\2OA3X6^,&A0:-XNTO^UM-@N5NXX?M$L.V55= V
MZ-E)^5V&,XY^E:FO>$-(\3>%;KPWJ5I]IT6ZMOLDUKYCINBQC;N4AAQW!S6Q
M10!SO@'X>^'_ (7^&H/#_AC3_P"S-(A=Y([?SI)<,S%F.Z1F;DGUKB/%'[*7
MPG\9^(IM=U?P;:W&IS.9998YYH5D<\EF2-U5B3U)'->LT4 <GXG^$_A#QEX,
MA\)ZOH%G=>'80@AT]5,20[ 0IC*$%" 2,J0<$^M<+#^QS\'K>RM[:'P7#"MO
M.+F.6.]N5F$@Z'S1+O('8%L9YQ7LU% ' _$OX#^ _C!<65QXN\.PZO<6:E(9
MC-+#(JYSM+1LI*YR<'(Y/K3=(^ O@30?&]EXOL-!%OXAL[1+&WO!=SD)"D(A
M5/++[#B,!<E<]\YYKT"B@#B=+^"_@W1?B-?^/++1_)\5WR-'<:A]JF;>I"@C
MRRY0<(O11TJ7PO\ "'PEX+\8:[XIT;2?L>NZXS-J%W]IF?SB6WGY&<JOS<_*
M!78T4 >2>(/V3?A+XH\13:YJ7@NSFU*:0RRO'--%'(Y.2S1HX0DGDY7GO75>
M-OA!X/\ B)X1M/"^O:)'=:!:O')!8PRR6R1E%*IM\IE( #$8SBNQHH X[QM\
M(?"7Q$\'V?A;Q#I/]H:%9M$T%I]IFBV&-2B?.CACA21R>>],\;?!GP9\1O"]
MAX>\1Z%#J>DV 46L,DDBO#M7:-LBL''R\'YN>^:[2B@#"\#^!M#^&_AJU\/^
M'+!=-TBUW&&V61Y NYBS<N23DDGD]ZQ?#WP5\&>%?'VJ^-=-T;R?%&J!UN]0
MDNII6<.RLP"NY5.57[H& ,#CBNWHH Y[QYX T#XG>&;GP_XFTY-4TBX9&DMV
M=XSN5@RD.A#*00.01QD="17)7?[-/PXO[?PK#<>'FEC\+\:0&U"ZS:CS!)C/
MFY<;@#\^[&,=.*].HH X[XF?"#PC\8M+M-.\7Z3_ &O9VLWVB&/[3-!MDVE<
MYB=2>">"<57\??!'P5\4+71;?Q-HO]IPZ,2UBOVJ>+R20H/,;KNX1?O9Z5W-
M% ''>,/A!X1\>^)O#WB'7=)^W:QH$RW&FW/VF:/R)%=7!VHX5OF13A@1Q78T
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5>TRVWMYK#Y5Z?6JD,332*B]36['&(HU1>@% #Z*** "BBB@ HHHH
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(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>abvx-20241231_g23.jpg
<TEXT>
begin 644 abvx-20241231_g23.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+L17AI9@  34T *@    @ ! $[  (
M   +   !2H=I  0    !   !5IR=  $    6   "SNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M36%T="!%<&QE>0    60 P "    %    J20!  "    %    KB2D0 "
M SDT  "2D@ "     SDT  #J'  '   !#    9@     '.H    !
M
M
M
M
M
M                                         #(P,C4Z,#,Z,3<@,38Z
M,3@Z,SD ,C R-3HP,SHQ-R Q-CHQ.#HS.0   $T 80!T '0 ( !% '  ; !E
M 'D   #_X00=:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K
M970@8F5G:6X])^^[OR<@:60])U<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"<_
M/@T*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(^/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I
M9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS
M.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(O/CQR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D
M82UA9#,Q+60S,V0W-3$X,F8Q8B(@>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O(CX\>&UP.D-R96%T941A=&4^,C R-2TP,RTQ-U0Q
M-CHQ.#HS.2XY,SD\+WAM<#I#<F5A=&5$871E/CPO<F1F.D1E<V-R:7!T:6]N
M/CQR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A
M,V0M,3%D82UA9#,Q+60S,V0W-3$X,F8Q8B(@>&UL;G,Z9&,](FAT=' Z+R]P
M=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(CX\9&,Z8W)E871O<CX\<F1F.E-E
M<2!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F
M+7-Y;G1A>"UN<R,B/CQR9&8Z;&D^36%T="!%<&QE>3PO<F1F.FQI/CPO<F1F
M.E-E<3X-"@D)"3PO9&,Z8W)E871O<CX\+W)D9CI$97-C<FEP=&EO;CX\+W)D
M9CI21$8^/"]X.GAM<&UE=&$^#0H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*
M$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR
M)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_  !$( P('@ ,!(@ "$0$#
M$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,#
M @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S
M8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 #
M 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  !
M G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q
M%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X
M>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(
MR<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /I&
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S/QQ\8/^$-\32:1_8?V
MW9&DGF_:_+SN&<8V'^=<]_PT5_U*_P#Y4/\ [57MM>!^%O\ DY:__P"OJ[_]
M!:@#OOA[\3_^$\U&[M?[(^P?9HA)N^T^;NR<8QL7%=]7%_$GQ^G@;1XF@B6X
MU&[)6WC<_*H'5V[X&1QWS7'&[^,2Z"?$!NK,P;/._L_R8_,"8SG&S/3MNW>U
M 'LM<MH7C_2?$GBJ[T71]\XM(#+)==$)#!=JCJ>O7^=8?AWQMJGQ#\"WH\.3
M6^E^([<QJQD&8ERP)8 AN"H8<@X/YUY/\,;/Q1=>++U/"NI6ME=I$3<R3J"K
MIY@R!E&YSCL* /IVBO.O&NL?$"3Q/#I'@_3?LUJP .I2QJZ,2,DDG(51TY&2
M?P%<GJ7CKQ[\/O$UG:^,+RSU2UG =O*C4 IG!VE54@CW% '??$3X@_\ " P6
M$G]F?;_MC.N/M'E;-H'^RV?O5U.EWO\ :6CV=]Y?E?:H$FV;L[=R@XSWZUY%
M^T1_QXZ#_P!=)_Y)7J7A;_D3]&_Z\(/_ $6M %^\O+?3[&:\O95AMX$,DDC'
MA5 R37D6H?M"V,-TR:9H,UU""0))KD1%O?:%:N^^(>D7>O?#_5=.TT$W,L2M
M&HZOM=6*_B%(_&O&/AQ\2[/P+:S:5K&B.&,Q,ES"H$PZ?*RMC.,>HQZ4 >F^
M"OB[H_B_4%TY[>33KYP3''(P=9,#)"L,<^Q K=\8^-M*\%::ESJK.TLVX6]O
M&,M*1C..P R,D^M<[X>C^&WB[Q$FM:-%#_;$;";9ODA=67OY>0I]R 1ZUY]\
M=K;78M>LY=6O8)]-E:4Z=#&H#0@"/>&^49R<8Y;IVH ]^L;G[;IUM=;-GGQ+
M)MSG;N .,_C4]>6I=>,_#/PAU+4M5U>VFN8X('T^2")3Y,9*C# Q@$X/?/UK
M9^$GB+5/$_@Q[_7+K[5<B[>,/Y:I\H52!A0!W- '<T5Y!X!\<^(M:^*NHZ/J
M>H^?80_:/+A\B-=NUP%Y"@\#WI/%GQ%\2ZEX\/A3P$L<<T+F*2=T5BS@9;[P
M(55Y'3M]* .P^(?CW_A K&RN/[-^W_:I&CV^?Y6W SG.ULUT>BZC_;&@:?J?
ME>3]MM8[CR]V[9O4-C.!G&>N*^?OBM-XPMK#3M,\:_9+HK(TMO?VO DX 92-
MJ\C([#KWKH_%?B7Q/X2\"^"]0T*_\FQFTVWBGB,$;C>(E8<LI/(R.#_#0![7
M17*>)_&$>F_#.;Q)8NJM-:J]J3@X>0 )QWP3DCV-4?A-JOB#7O"3ZMXEO3=-
M<3,+8&%(PL:\$_*!G+;NOI0!W->)?\-%?]2O_P"5#_[57MM>!_L]?\C%J_\
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M/[H9&..V21FKGPW^(&N>-]$UG3IG@BUFWMBUI=A-JEF!"EEP1PV#P,$'IQR
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M9Y6_?LY(QG ST]*U:\QL]6O=#_9UM]1TN;R+N"S0QR;%;:3*!T8$'@GM7/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "JFH:3INKQI'JNGVM\B'<JW,*R!3Z@,#BK=%
M $-I9VMA;B"QMH;:%>D<,811^ XJ:BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** (;NSMK^U>VOK>*YMY!AXID#HW.>0>
M#3+#3;'2K<V^EV5O90EBQCMXEC7)[X4 9XJS10 4444 %%%% !1110 4444
M%%%% %+4=&TO6!&-6TVTOA%DQBY@639GKC<#CH/RJQ;VT%G L%I#'!$OW8XD
M"J/H!4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !14-Y<?9+&>XV[_ "8V?;G&
M<#.,UROA/XG^'/%FR&WNOL=\V!]DNB$9CZ*>C?0'/L*TC2G.+G%72W ["BBB
MLP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVO\ \=KZ(HH_M2I_)'[O^"!\[_\ ")?&3_GYUC_P=K_\=H_X1+XR?\_.L?\
M@[7_ ..U]$44?VI4_DC]W_! ^=_^$2^,G_/SK'_@[7_X[1_PB7QD_P"?G6/_
M  =K_P#':^B**/[4J?R1^[_@@?.__")?&3_GYUC_ ,':_P#QVC_A$OC)_P _
M.L?^#M?_ ([7T111_:E3^2/W?\$#YW_X1+XR?\_.L?\ @[7_ ..T?\(E\9/^
M?G6/_!VO_P =KZ(HH_M2I_)'[O\ @@?._P#PB7QD_P"?G6/_  =K_P#':/\
MA$OC)_S\ZQ_X.U_^.U]$44?VI4_DC]W_  0/G?\ X1+XR?\ /SK'_@[7_P".
MT?\ ")?&3_GYUC_P=K_\=KZ(HH_M2I_)'[O^"!\[_P#")?&3_GYUC_P=K_\
M':/^$2^,G_/SK'_@[7_X[7T111_:E3^2/W?\$#YW_P"$2^,G_/SK'_@[7_X[
M1_PB7QD_Y^=8_P#!VO\ \=KZ(HH_M2I_)'[O^"!\[_\ ")?&3_GYUC_P=K_\
M=H_X1+XR?\_.L?\ @[7_ ..U]$44?VI4_DC]W_! ^=_^$2^,G_/SK'_@[7_X
M[1_PB7QD_P"?G6/_  =K_P#':^B**/[4J?R1^[_@@?.__")?&3_GYUC_ ,':
M_P#QVC_A$OC)_P _.L?^#M?_ ([7T111_:E3^2/W?\$#YW_X1+XR?\_.L?\
M@[7_ ..T?\(E\9/^?G6/_!VO_P =KZ(HH_M2I_)'[O\ @@?._P#PB7QD_P"?
MG6/_  =K_P#':/\ A$OC)_S\ZQ_X.U_^.U]$44?VI4_DC]W_  0/G?\ X1+X
MR?\ /SK'_@[7_P".T?\ ")?&3_GYUC_P=K_\=KZ(HH_M2I_)'[O^"!\[_P#"
M)?&3_GYUC_P=K_\ ':/^$2^,G_/SK'_@[7_X[7T111_:E3^2/W?\$#YW_P"$
M2^,G_/SK'_@[7_X[1_PB7QD_Y^=8_P#!VO\ \=KZ(HH_M2I_)'[O^"!\[_\
M")?&3_GYUC_P=K_\=H_X1+XR?\_.L?\ @[7_ ..U]$44?VI4_DC]W_! ^=_^
M$2^,G_/SK'_@[7_X[1_PB7QD_P"?G6/_  =K_P#':^B**/[4J?R1^[_@@?._
M_")?&3_GYUC_ ,':_P#QVC_A$OC)_P _.L?^#M?_ ([7T111_:E3^2/W?\$#
MYW_X1+XR?\_.L?\ @[7_ ..T?\(E\9/^?G6/_!VO_P =KZ(HH_M2I_)'[O\
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M_P"?G6/_  =K_P#':/\ A$OC)_S\ZQ_X.U_^.U]$44?VI4_DC]W_  0/G?\
MX1+XR?\ /SK'_@[7_P".T?\ ")?&3_GYUC_P=K_\=KZ(HH_M2I_)'[O^"!\[
M_P#")?&3_GYUC_P=K_\ ':/^$2^,G_/SK'_@[7_X[7T111_:E3^2/W?\$#YW
M_P"$2^,G_/SK'_@[7_X[1_PB7QD_Y^=8_P#!VO\ \=KZ(HH_M2I_)'[O^"!\
M[_\ ")?&3_GYUC_P=K_\=H_X1+XR?\_.L?\ @[7_ ..U]$44?VI4_DC]W_!
M^=_^$2^,G_/SK'_@[7_X[1_PB7QD_P"?G6/_  =K_P#':^B**/[4J?R1^[_@
M@?.__")?&3_GYUC_ ,':_P#QVC_A$OC)_P _.L?^#M?_ ([7T111_:E3^2/W
M?\$#YW_X1+XR?\_.L?\ @[7_ ..T?\(E\9/^?G6/_!VO_P =KZ(HH_M2I_)'
M[O\ @@?._P#PB7QD_P"?G6/_  =K_P#':/\ A$OC)_S\ZQ_X.U_^.U]$44?V
MI4_DC]W_  0/G?\ X1+XR?\ /SK'_@[7_P".T?\ ")?&3_GYUC_P=K_\=KZ(
MHH_M2I_)'[O^"!\[_P#")?&3_GYUC_P=K_\ ':/^$2^,G_/SK'_@[7_X[7T1
M11_:E3^2/W?\$#YW_P"$2^,G_/SK'_@[7_X[1_PB7QD_Y^=8_P#!VO\ \=KZ
M(HH_M2I_)'[O^"!\[_\ ")?&3_GYUC_P=K_\=H_X1+XR?\_.L?\ @[7_ ..U
M]$44?VI4_DC]W_! ^=_^$2^,G_/SK'_@[7_X[1_PB7QD_P"?G6/_  =K_P#'
M:^B**/[4J?R1^[_@@?.__")?&3_GYUC_ ,':_P#QVC_A$OC)_P _.L?^#M?_
M ([7T111_:E3^2/W?\$#YW_X1+XR?\_.L?\ @[7_ ..T?\(E\9/^?G6/_!VO
M_P =KZ(HH_M2I_)'[O\ @@?._P#PB7QD_P"?G6/_  =K_P#':/\ A$OC)_S\
MZQ_X.U_^.U]$44?VI4_DC]W_  0/G?\ X1+XR?\ /SK'_@[7_P".T?\ ")?&
M3_GYUC_P=K_\=KZ(HH_M2I_)'[O^"!\[_P#")?&3_GYUC_P=K_\ ':/^$2^,
MG_/SK'_@[7_X[7T111_:E3^2/W?\$#YW_P"$2^,G_/SK'_@[7_X[1_PB7QD_
MY^=8_P#!VO\ \=KZ(HH_M2I_)'[O^"!\[_\ ")?&3_GYUC_P=K_\=H_X1+XR
M?\_.L?\ @[7_ ..U]$44?VI4_DC]W_! ^=_^$2^,G_/SK'_@[7_X[1_PB7QD
M_P"?G6/_  =K_P#':^B**/[4J?R1^[_@@?.__")?&3_GYUC_ ,':_P#QVC_A
M$OC)_P _.L?^#M?_ ([7T111_:E3^2/W?\$#YW_X1+XR?\_.L?\ @[7_ ..T
M?\(E\9/^?G6/_!VO_P =KZ(HH_M2I_)'[O\ @@?._P#PB7QD_P"?G6/_  =K
M_P#':/\ A$OC)_S\ZQ_X.U_^.U]$44?VI4_DC]W_  0/G?\ X1+XR?\ /SK'
M_@[7_P".T?\ ")?&3_GYUC_P=K_\=KZ(HH_M2I_)'[O^"!\[_P#")?&3_GYU
MC_P=K_\ ':/^$2^,G_/SK'_@[7_X[7T111_:E3^2/W?\$#YW_P"$2^,G_/SK
M'_@[7_X[1_PB7QD_Y^=8_P#!VO\ \=KZ(HH_M2I_)'[O^"!\[_\ ")?&3_GY
MUC_P=K_\=H_X1+XR?\_.L?\ @[7_ ..U]$44?VI4_DC]W_! ^=_^$2^,G_/S
MK'_@[7_X[1_PB7QD_P"?G6/_  =K_P#':^B**/[4J?R1^[_@@?.__")?&3_G
MYUC_ ,':_P#QVC_A$OC)_P _.L?^#M?_ ([7T111_:E3^2/W?\$#YW_X1+XR
M?\_.L?\ @[7_ ..T?\(E\9/^?G6/_!VO_P =KZ(HH_M2I_)'[O\ @@?._P#P
MB7QD_P"?G6/_  =K_P#':/\ A$OC)_S\ZQ_X.U_^.U]$44?VI4_DC]W_  0/
MG?\ X1+XR?\ /SK'_@[7_P".T?\ ")?&3_GYUC_P=K_\=KZ(HH_M2I_)'[O^
M"!\[_P#")?&3_GYUC_P=K_\ ':/^$2^,G_/SK'_@[7_X[7T111_:E3^2/W?\
M$#YW_P"$2^,G_/SK'_@[7_X[1_PB7QD_Y^=8_P#!VO\ \=KZ(HH_M2I_)'[O
M^"!\[_\ ")?&3_GYUC_P=K_\=H_X1+XR?\_.L?\ @[7_ ..U]$44?VI4_DC]
MW_! ^<KGPK\7TM97N;C5S"J$R;M94C;CGCS>>*\WMK6>]N4M[."2>:0X2.)"
MS,?8"OM&X@6YM98),A)4*-CK@C%9/AWPAH?A6V\K1;".!B,/,1ND?ZL>?PZ5
MTT<WY(OF@K]+:?>!R'PNT?Q[IMNG_"37Z#3MN$L[K][.OIAP?E'3@EN.,"O2
M:**\:M5=:;FTEZ %%%%8@%%%4?[5@_N2?D/\::BWL!>HJC_:L']R3\A_C1_:
ML']R3\A_C5<DNP%ZBJ/]JP?W)/R'^-']JP?W)/R'^-')+L!>HJC_ &K!_<D_
M(?XT?VK!_<D_(?XT<DNP%ZBJ/]JP?W)/R'^-']JP?W)/R'^-')+L!>HJC_:L
M']R3\A_C1_:L']R3\A_C1R2[ 7J*H_VK!_<D_(?XT?VK!_<D_(?XT<DNP%ZB
MJ/\ :L']R3\A_C1_:L']R3\A_C1R2[ 7J*H_VK!_<D_(?XT?VK!_<D_(?XT<
MDNP%ZBJ/]JP?W)/R'^-']JP?W)/R'^-')+L!>HJC_:L']R3\A_C1_:L']R3\
MA_C1R2[ 7J*H_P!JP?W)/R'^-']JP?W)/R'^-')+L!>HJC_:L']R3\A_C1_:
ML']R3\A_C1R2[ 7J*H_VK!_<D_(?XT?VK!_<D_(?XT<DNP%ZBJ/]JP?W)/R'
M^-']JP?W)/R'^-')+L!>HJC_ &K!_<D_(?XT?VK!_<D_(?XT<DNP%ZBJ/]JP
M?W)/R'^-']JP?W)/R'^-')+L!>HJC_:L']R3\A_C1_:L']R3\A_C1R2[ 7J*
MH_VK!_<D_(?XT?VK!_<D_(?XT<DNP%ZBJ/\ :L']R3\A_C1_:L']R3\A_C1R
M2[ 7J*H_VK!_<D_(?XT?VK!_<D_(?XT<DNP%ZBJ/]JP?W)/R'^-']JP?W)/R
M'^-')+L!>HJC_:L']R3\A_C5BWN8[E28\C!Y!ZTG&2W FHHHJ0"BBB@ HHHH
M ***9-*L%O)*X)6-2Q ZX S0 ^BL7_A*;+_GE<?]\K_C1_PE-E_SRN/^^5_Q
MK7V-3L9^UAW-JBL7_A*;+_GE<?\ ?*_XT?\ "4V7_/*X_P"^5_QH]C4[![6'
M<VJ*Q?\ A*;+_GE<?]\K_C1_PE-E_P \KC_OE?\ &CV-3L'M8=S:HK%_X2FR
M_P">5Q_WRO\ C1_PE-E_SRN/^^5_QH]C4[![6'<VJ*Q?^$ILO^>5Q_WRO^-'
M_"4V7_/*X_[Y7_&CV-3L'M8=S:HK%_X2FR_YY7'_ 'RO^-'_  E-E_SRN/\
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M_/*X_P"^5_QH]C4[![6'<VJ*Q?\ A*;+_GE<?]\K_C1_PE-E_P \KC_OE?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5);SM;W"R+V/(
M]14=% '4HZR1JZ'*L,BG5DZ/==;=S[I_45K4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5S==)7-UO1Z@%%%%= !1110
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M# 'KWX%6OA/_ ,@_4?\ KJG\C16PU.%.;2:Y;:OJ,]!HHHKRP"BBB@ HHHH
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M-Q=+;?O/GD+L%"DD#)]J[BO-O!__ ")?B+_K@_\ Z+:LX).+^1<W:2^9O/\
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M5H^]@YY/;M<[B">.YMXYX'#Q2*&1AW!Y!KC/&4U\_B?2[&RU"XLUN0$8Q2,
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MH'4DCGBJ&BWNM^%/B%;^'=:U:35+6_BWQRS$DJ?FQU)(Y4C&>X-4/$NIS?\
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M/NI?&D.JZG%@JEMIP42* 207C.WIGDUQ1T#4-<U/Q(VGOE+.5YY(LG,F';
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MUN+=9%[CD>AKF:W=*@:&TW,3^\.X#T% %ZBBB@ HHHH **** "BBB@ HHHH
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MS:A%YL.X-MW%>1[@BH[O1K"_TV.PNH-]M%MV1[V&-HP.0<]*O44[M"LCG_\
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M".A7-T;B73HS(QR=K,H)^@.*V:*.:5[W#E6UBK=:99WFFG3YX%-JP ,2DJ,
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M:NZ?9,'\V92NW[JD=_6M.BDZK:L 4445D 4444 %%%% !4%^K/IMRJ LS1,
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M@^KKN<%_9U[_ ,^=Q_WZ;_"C^SKW_GSN/^_3?X5WM%'UJ78/JZ[G!?V=>_\
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M-^/I7445,L3*2M8<:$4[A1117*= 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5%<@M:3!022C  =^*EHH YG[)<?\
M\)/^^#1]DN/^>$G_ 'P:Z:B@#F?LEQ_SPD_[X-'V2X_YX2?]\&NFHH YG[)<
M?\\)/^^#1]DN/^>$G_?!KIJ* .9^R7'_ #PD_P"^#1]DN/\ GA)_WP:Z:B@#
MF?LEQ_SPD_[X-'V2X_YX2?\ ?!KIJ* .9^R7'_/"3_O@T?9+C_GA)_WP:Z:B
M@#F?LEQ_SPD_[X-'V2X_YX2?]\&NFHH YG[)<?\ /"3_ +X-'V2X_P">$G_?
M!KIJ* .9^R7'_/"3_O@T?9+C_GA)_P!\&NFHH YG[)<?\\)/^^#1]DN/^>$G
M_?!KIJ* .9^R7'_/"3_O@T?9+C_GA)_WP:Z:B@#F?LEQ_P \)/\ O@T?9+C_
M )X2?]\&NFHH YG[)<?\\)/^^#1]DN/^>$G_ 'P:Z:B@#F?LEQ_SPD_[X-'V
M2X_YX2?]\&NFHH YG[)<?\\)/^^#1]DN/^>$G_?!KIJ* .9^R7'_ #PD_P"^
M#1]DN/\ GA)_WP:Z:B@#F?LEQ_SPD_[X-'V2X_YX2?\ ?!KIJ* .9^R7'_/"
M3_O@T?9+C_GA)_WP:Z:B@#F?LEQ_SPD_[X-'V2X_YX2?]\&NFHH YG[)<?\
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M?9+C_GA)_P!\&NFHH YG[)<?\\)/^^#5S3;%S<^9/&RJG(##&36U10 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS4RE9&U&G[67*=%;Z/H\=A+:6FG6*VDO$D$4""-_8J!@T]M'TQM+&FMIUH;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC((E."*.5A<Z6BN;_L^/_GK-_P!_#1_9\?\ SUF_[^&CE87.DHKF_P"SX_\
MGK-_W\-']GQ_\]9O^_AHY6%SI**YO^SX_P#GK-_W\-']GQ_\]9O^_AHY6%SI
M**YO^SX_^>LW_?PT?V?'_P ]9O\ OX:.5A<Z2BN;_L^/_GK-_P!_#1_9\?\
MSUF_[^&CE87-+Q#_ ,@&X_X#_P"A"L^*632IC+""]LQS+$/X?]H5&VFPNNUW
MF8'J#(35RA(5S7AFCN(5EA8.C#((I]<[%+)I4QEA!>V8YEB'\/\ M"M^&:.X
MA66%@Z,,@BEL4/HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSI16R"BBBK.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@".XB\ZVEBX^="O/N*X(6=R+P0B)Q+NX7'/6O0:,#.<
M<U$H\QT4:[I7T(%D^RV*O=R#*(-['N:P]6\:Z9I5H;F::..%2-\LSA%7)P.3
MZUI:]&TFBS!.2,']:\T\,:)%XN\3W.IWVZ2"PEDMK)"#LCV?*\NTXRY?<H/8
M#CJ:4FT[(NE3A*+G(Z.]U)M=L[+4("CP72DP!%8-C/<'G/X"ND\/6#65@3-'
MLED;)!ZX[?UJ2RT.SLBKA/,E'.]C_2M&G&.MV*K63A[..Q@/_P A[4/^V?\
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M71@RL,A@<@CUI:BC:"&)(XFC5$4*J@C  Z"G>='_ ,]$_P"^A3$/HIGG1_\
M/1/^^A1YT?\ ST3_ +Z% #Z*9YT?_/1/^^A1YT?_ #T3_OH4 /HIGG1_\]$_
M[Z%'G1_\]$_[Z% #Z*9YT?\ ST3_ +Z%/I@%064DEKJRP68\R.7F6+M'_M>W
MTI)99)9Q:V8W3MU/:,>IK8L+".P@V)\SMR\AZL:B3&BU1114E!1110 4444
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MLOQ!XDTGPM8)>Z[=_9;>240J_EN^7() PH)Z*?RK>,7)\L5=G :E%<;'\6O
M\APNO1C_ 'H)5_FM:-KX^\)WA @\1:=D] ]PJ$_]]8K5X>M'>#^Y@=#14<%Q
M#=0B6VFCFC/1XV# _B*DK  HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***@2X9T5UMY2K#(.5Z?G0!/147G/_S[2_FO^-'G/_S[
M2_FO^- $M%1><_\ S[2_FO\ C1YS_P#/M+^:_P"- $M%1><__/M+^:_XT><_
M_/M+^:_XT 2T5%YS_P#/M+^:_P"-'G/_ ,^TOYK_ (T 2T5%YS_\^TOYK_C1
MYS_\^TOYK_C0!+147G/_ ,^TOYK_ (T><_\ S[2_FO\ C0!+147G/_S[2_FO
M^-'G/_S[2_FO^- $M%1><_\ S[2_FO\ C1YS_P#/M+^:_P"- $M%1><__/M+
M^:_XT><__/M+^:_XT 2T5%YS_P#/M+^:_P"-'G/_ ,^TOYK_ (T 2T5%YS_\
M^TOYK_C1YS_\^TOYK_C0!+147G/_ ,^TOYK_ (T><_\ S[2_FO\ C0!+147G
M/_S[2_FO^-'G/_S[2_FO^- $M%1><_\ S[2_FO\ C1YS_P#/M+^:_P"- $M%
M1><__/M+^:_XT><__/M+^:_XT 2T5%YS_P#/M+^:_P"-'G/_ ,^TOYK_ (T
M2T5%YS_\^TOYK_C1YS_\^TOYK_C0!@?$*V>Z^'^L)$CO(ML[*L:%F.!T ')/
MTK7T==ND6_RE-R[L%<'DYY!JQYS_ //M+^:_XT><_P#S[2_FO^-*VMR^=\O*
M2T5%YS_\^TOYK_C1YS_\^TOYK_C3():*B\Y_^?:7\U_QH\Y_^?:7\U_QH EH
MJ+SG_P"?:7\U_P :/.?_ )]I?S7_ !H EHJ+SG_Y]I?S7_&CSG_Y]I?S7_&@
M"6BHO.?_ )]I?S7_ !IKW#(C.UO*%49)RO3\Z )Z*** "BBB@ HHHH ****
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MH_L73O\ GTC_ "J]10!1_L73O^?2/\J/[%T[_GTC_*KU% %'^Q=._P"?2/\
M*C^Q=._Y](_RJ]10!1_L73O^?2/\J/[%T[_GTC_*KU% %'^Q=._Y](_RH_L7
M3O\ GTC_ "J]10!1_L73O^?2/\J/[%T[_GTC_*KU% %'^Q=._P"?2/\ *C^Q
M=._Y](_RJ]10!1_L73O^?2/\J/[%T[_GTC_*KU% %'^Q=._Y](_RH_L73O\
MGTC_ "J]10!1_L73O^?2/\J/[%T[_GTC_*KU% %'^Q=._P"?2/\ *C^Q=._Y
M](_RJ]10!A:WIEE;Z//+#;HCKMPP[?,*BEEDEG%K9C=.W4]HQZFM;5K62\TR
M6WAQO<J!GM\P-.L+".P@V)\SMR\AZL:=[""PL(["#8GS.W+R'JQJU112&%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ+I2M8!?[8U/_H(W?_?]O\:/[8U/_H(W?_?]O\:IT5IR1[ 7/[8U/_H(W?\
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MU/\ Z"-W_P!_V_QH_MC4_P#H(W?_ '_;_&J=%')'L!<_MC4_^@C=_P#?]O\
M&C^V-3_Z"-W_ -_V_P :IT4<D>P%S^V-3_Z"-W_W_;_&G+K6J(V1J%U^,K'^
M9JC12Y(]@.ETWQI>V[JM^!<Q=V  <?T/X_G7;VEW#>VJ7%JX>-QD$5Y'72>#
M-2:VU3[$Y/E7 X&?NL!G/XCC\JX<5A8\KG!6: [ZBBBO( **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ"]N?L=A<7)7>(
M8FDVYQG SC]*P?#GCW0O$H6.UN?(NC_R[7&%<GV[-^%:1I3E%SBKI =+1116
M8!1110 445#=W*6=G+<2?=B0L??%-*[L@,[7/$-OHT84CS;AAE8P<8'J?:N+
MN_%&K7;D_:FA7LL/R@?CUK.N[J6]NY+B=MTDC9)_I4->Y1PL*:U5V!<_MC4_
M^@C=_P#?]O\ &C^V-3_Z"-W_ -_V_P :IT5T\D>P%S^V-3_Z"-W_ -_V_P :
M/[8U/_H(W?\ W_;_ !JG11R1[ 7/[8U/_H(W?_?]O\:/[8U/_H(W?_?]O\:I
MT4<D>P%S^V-3_P"@C=_]_P!O\:/[8U/_ *"-W_W_ &_QJG11R1[ 7/[8U/\
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M>RX^7KQCC/&>_@W46\!^!=7?P_\ VG/H<;I>Z/=0C?-%)PPV.,%EQD ^N>U
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M** "BBB@ HHHH **** "BBB@ J*T_P"/.'_KFO\ *I:BM/\ CSA_ZYK_ "H
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MV5&DB:-RWSYV[0 =Q.T\+D\4 =#163X>\4:-XJL6N] OX[R%&V/M!5D/HRL
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M_P"-'_"6>'?^@_I?_@9'_C1]:K?R?F!Y_P#V/J?_ $#KO_OPW^%']CZG_P!
MZ[_[\-_A7H'_  EGAW_H/Z7_ .!D?^-'_"6>'?\ H/Z7_P"!D?\ C1]:K?R?
MF!Y__8^I_P#0.N_^_#?X4?V/J?\ T#KO_OPW^%>@?\)9X=_Z#^E_^!D?^-'_
M  EGAW_H/Z7_ .!D?^-'UJM_)^8'G_\ 8^I_] Z[_P"_#?X4?V/J?_0.N_\
MOPW^%>@?\)9X=_Z#^E_^!D?^-'_"6>'?^@_I?_@9'_C1]:K?R?F!Y_\ V/J?
M_0.N_P#OPW^%']CZG_T#KO\ [\-_A7H'_"6>'?\ H/Z7_P"!D?\ C1_PEGAW
M_H/Z7_X&1_XT?6JW\GY@>?\ ]CZG_P! Z[_[\-_A1_8^I_\ 0.N_^_#?X5Z!
M_P )9X=_Z#^E_P#@9'_C1_PEGAW_ *#^E_\ @9'_ (T?6JW\GY@>?_V/J?\
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M_OPW^%>@?\)9X=_Z#^E_^!D?^-'_  EGAW_H/Z7_ .!D?^-'UJM_)^8'G_\
M8^I_] Z[_P"_#?X4?V/J?_0.N_\ OPW^%>@?\)9X=_Z#^E_^!D?^-'_"6>'?
M^@_I?_@9'_C1]:K?R?F!Y_\ V/J?_0.N_P#OPW^%']CZG_T#KO\ [\-_A7H'
M_"6>'?\ H/Z7_P"!D?\ C1_PEGAW_H/Z7_X&1_XT?6JW\GY@>?\ ]CZG_P!
MZ[_[\-_A1_8^I_\ 0.N_^_#?X5Z!_P )9X=_Z#^E_P#@9'_C1_PEGAW_ *#^
ME_\ @9'_ (T?6JW\GY@>?_V/J?\ T#KO_OPW^%']CZG_ - Z[_[\-_A7H'_"
M6>'?^@_I?_@9'_C1_P )9X=_Z#^E_P#@9'_C1]:K?R?F!Y__ &/J?_0.N_\
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M3\IZGWQ6AHFBZOINL>-+S6+O0DFOM/#SZ?I-P[&.0(<2,C*"NX'KWS76>(/
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MJ*!@* .  .,5)5>PM/L&FVUGY\]S]GB2+S[A]\DFT ;G;NQQDGN:L4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5%=_\ 'G-_US;^52U%=_\
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M.YU)8#!.0#E3\PX.*N^"/#P\3>*K:QES]G7,MQ@X^1>H_$D#\:<JT%3=2^B
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MJ6*IU>7E^TFU\MP.;HHHKJ **** "BBB@ HHHH **** "BBB@ HHHH ****
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M21BSLQY8GJ:97W6%PE/#0Y8K7JQ!11178 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4MXB_P"?W2_^_LG_ ,17N%%']KXKNON \*NO@]K]I9S7,EYII2&-I&"RR9(
MR<?)7'Z3HFI:Y=?9])LY;F3OL'"^Y/0?C7U%-#'<6\D,R[HY%*.N<9!&"*BL
M=/M-,M5MM/MHK:%>B1*%%;4\ZJQ@^=7?3L!R'@'P9J_AJ'=J6LR.C#_CPB.Z
M)3]6'7_=Q]37;T45Y%:M.M-SGN 4445B 5S'Q(B>;X=ZLL><B-&.!V5U)_0&
MNGJ*ZMHKVSFM;E \,R-'(I[J1@BM:,_9U(S[-,#Y1HK5\2^'[KPUKL^G7@/R
M',4F.)4/1A_G@Y%95?H,91G%2CLQ!1115 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ;'A;PW=>*=<CT^T(08WRRD
M9$:#J<=^H 'J:[;QGXETOP]X??P=X5&X#*7EQG//\2Y[L>A/0=/IPNA^)=6\
M-R32:+=?9FF $A\I'R!T^\#CK6G=_$;Q5?64]I=:KYD$\;12)]GB&Y6&",A<
MC@UY]:A6J5E)V<%LKM:]WH[^0%Y]0\?:;H>D%9KJ&PD"?8?("'=P-JG9R<@C
MANO/'6M#XRQVJ^)+%XP!>/:@W 'U(4GWZ_@!7,:5XW\1Z)9"TTS5)(K<9VQL
MBN%^FX''X5D7M]<ZE>RWE_.\]Q,VYY'.23_GMVHAAIJNJC225]NM^_\ P[U
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MXCGMED:$.L@8;7'(RH(Z'&.G->E7%Q%:6LMS<R+%#"ADD=C@*H&23]!7DWQ
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M_P"25Q_\;H_X7;\/O^A@_P#)*X_^-T?VGCO^?:^Y_P"8'FO_  J_QA_T"/\
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M_P"+H_X5?XP_Z!'_ )-0_P#Q=>E?\+M^'W_0P?\ DE<?_&Z/^%V_#[_H8/\
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MN/\ XW1_:>._Y]K[G_F!YK_PJ_QA_P! C_R:A_\ BZ/^%7^,/^@1_P"34/\
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MX5?XP_Z!'_DU#_\ %UZ5_P +M^'W_0P?^25Q_P#&Z/\ A=OP^_Z&#_R2N/\
MXW1_:>._Y]K[G_F!YK_PJ_QA_P! C_R:A_\ BZ/^%7^,/^@1_P"34/\ \77I
M7_"[?A]_T,'_ ))7'_QNC_A=OP^_Z&#_ ,DKC_XW1_:>._Y]K[G_ )@>:_\
M"K_&'_0(_P#)J'_XNC_A5_C#_H$?^34/_P 77I7_  NWX??]#!_Y)7'_ ,;H
M_P"%V_#[_H8/_)*X_P#C=']IX[_GVON?^8'FO_"K_&'_ $"/_)J'_P"+H_X5
M?XP_Z!'_ )-0_P#Q=>E?\+M^'W_0P?\ DE<?_&Z/^%V_#[_H8/\ R2N/_C='
M]IX[_GVON?\ F!YK_P *O\8?] C_ ,FH?_BZ/^%7^,/^@1_Y-0__ !=>E?\
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M_0P?^25Q_P#&Z/\ A=OP^_Z&#_R2N/\ XW1_:>._Y]K[G_F!YK_PJ_QA_P!
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MA@_\DKC_ .-T?VGCO^?:^Y_Y@>:_\*O\8?\ 0(_\FH?_ (NC_A5_C#_H$?\
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M^8'FO_"K_&'_ $"/_)J'_P"+H_X5?XP_Z!'_ )-0_P#Q=>E?\+M^'W_0P?\
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M_P#&Z/\ A=OP^_Z&#_R2N/\ XW1_:>._Y]K[G_F!YK_PJ_QA_P! C_R:A_\
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MOB+_ +!=S_Z*:OC2O-C%,B4FCZN_X71X!_Z#W_DG/_\ $4?\+H\ _P#0>_\
M).?_ .(KY1HJO9HGG9]7?\+H\ _]![_R3G_^(H_X71X!_P"@]_Y)S_\ Q%?*
M-%'LT'.SZN_X71X!_P"@]_Y)S_\ Q%'_  NCP#_T'O\ R3G_ /B*^4:*/9H.
M=GU=_P +H\ _]![_ ,DY_P#XBC_A='@'_H/?^2<__P 17RC11[-!SL^KO^%T
M> ?^@]_Y)S__ !%'_"Z/ /\ T'O_ "3G_P#B*^4:*/9H.=GU=_PNCP#_ -![
M_P DY_\ XBC_ (71X!_Z#W_DG/\ _$5\HT4>S0<[/J[_ (71X!_Z#W_DG/\
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M 75S)//H&Z65R[M]LG&23DGAZ[JB@#$\,^#M"\'6T\'ARQ^QQ7#AY5\YY-Q
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M%ZC .,>O4\+X>\7^%O#O@U88O"MOJ_B.6;][-JD"RVZIDX"#.<XVC&!R2<\
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M)9X=_P"@_I?_ (&1_P"-'_"6>'?^@_I?_@9'_C1[&I_*_N UJ*R?^$L\._\
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M=?#AS^U!XDQ_SX_^RP4SPQ\2/$.J_&N\\-WB1-I?G7%NL A \A8@V&SC)SM
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M-/\ V):?:+F"*YU-8Y3:W,D#,OE2'&]"&QD#OVJ3_A#-+_Y^M;_\'U]_\>H
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MH^?.>G'7I6BIS4.162L![-HMG?>&?V??$\'C2":U^T3/'9V]YG<9" %*J?\
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M#C.PE0=J XSW8^PX\ O-=U?49;>74-4O;J2U_P!0\]P[F+I]TD_+T'3TJ_\
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MYK?B[Q%X6U;PL)+G3IK9!#/"N8[5MV[S6;^$;2O)_N5SO[1W_)1;#_L%1_\
MHV6H;/QM\/VT"TL+BR\5:9'&/])L=.U%GM;DG[P99)/NDYZ 'D]:Y;XD>-3X
M\\7-JJ6QMK>.%;>WC8Y8(I)RW;)+$\=.G/6LJ%.:G%-:1N!R=%%%>B 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M]N^%;.33O!VC64X(EMK"")P>S+&H/\J^9_@[X!F\7>*HKZ[B(TG3I%DF<CB5
MQRL8]<\$^WU%?5M>+F-1-J"Z >/_ +0O_( T?_KY?_T&NW^&?_),]#_Z]A_,
MUQ'[0O\ R -'_P"OE_\ T&NW^&?_ "3/0_\ KV'\S3J_\BZGZO\ 4"YXX_Y)
M[XB_[!=S_P"BFKXTK[+\<?\ )/?$7_8+N?\ T4U?&E>?3V,YA1116AF%%%%
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MW0M;DQSV\@.#N(QD]]Q6J.@7]Y#8^/\ PXNLS:[I.E6#"UO9VWNC-"^Z(O\
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MTB*6-8@A\XDH%' 8KD\'H?>M76G6Y_:"\-1V#JTUIIURU^$.2D3+A WI\Q!
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M7ZX'AW_#./B[_H(Z+_W_ )?_ (U1_P ,X^+O^@CHO_?^7_XU7N/_  GFF?\
M/"[_ .^%_P#BJ/\ A/-,_P">%W_WPO\ \51]?K@>'?\ #./B[_H(Z+_W_E_^
M-4?\,X^+O^@CHO\ W_E_^-5[C_PGFF?\\+O_ +X7_P"*H_X3S3/^>%W_ -\+
M_P#%4?7ZX'AW_#./B[_H(Z+_ -_Y?_C5'_#./B[_ *".B_\ ?^7_ .-5[C_P
MGFF?\\+O_OA?_BJ/^$\TS_GA=_\ ?"__ !5'U^N!X=_PSCXN_P"@CHO_ '_E
M_P#C5'_#./B[_H(Z+_W_ )?_ (U7N/\ PGFF?\\+O_OA?_BJ/^$\TS_GA=_]
M\+_\51]?K@>'?\,X^+O^@CHO_?\ E_\ C5'_  SCXN_Z".B_]_Y?_C5>X_\
M">:9_P \+O\ [X7_ .*H_P"$\TS_ )X7?_?"_P#Q5'U^N!X=_P ,X^+O^@CH
MO_?^7_XU1_PSCXN_Z".B_P#?^7_XU7N/_">:9_SPN_\ OA?_ (JC_A/-,_YX
M7?\ WPO_ ,51]?K@>'?\,X^+O^@CHO\ W_E_^-4?\,X^+O\ H(Z+_P!_Y?\
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M\,X^+O\ H(Z+_P!_Y?\ XU7N/_">:9_SPN_^^%_^*H_X3S3/^>%W_P!\+_\
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MP[_AG'Q=_P!!'1?^_P#+_P#&J/\ AG'Q=_T$=%_[_P O_P :KW'_ (3S3/\
MGA=_]\+_ /%4?\)YIG_/"[_[X7_XJCZ_7 \._P"&<?%W_01T7_O_ "__ !JC
M_AG'Q=_T$=%_[_R__&J]Q_X3S3/^>%W_ -\+_P#%4?\ ">:9_P \+O\ [X7_
M .*H^OUP/#O^&<?%W_01T7_O_+_\:H_X9Q\7?]!'1?\ O_+_ /&J]Q_X3S3/
M^>%W_P!\+_\ %4?\)YIG_/"[_P"^%_\ BJ/K]<#P[_AG'Q=_T$=%_P"_\O\
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M_01T7_O_ "__ !JC_AG'Q=_T$=%_[_R__&J]Q_X3S3/^>%W_ -\+_P#%4?\
M">:9_P \+O\ [X7_ .*H^OUP/#O^&<?%W_01T7_O_+_\:H_X9Q\7?]!'1?\
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MA=_]\+_\51_PGFF?\\+O_OA?_BJ/K]<#P[_AG'Q=_P!!'1?^_P#+_P#&J/\
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M_/"[_P"^%_\ BJ/K]<#P[_AG'Q=_T$=%_P"_\O\ \:H_X9Q\7?\ 01T7_O\
MR_\ QJO<?^$\TS_GA=_]\+_\51_PGFF?\\+O_OA?_BJ/K]<#P[_AG'Q=_P!!
M'1?^_P#+_P#&J/\ AG'Q=_T$=%_[_P O_P :KW'_ (3S3/\ GA=_]\+_ /%4
M?\)YIG_/"[_[X7_XJCZ_7 \._P"&<?%W_01T7_O_ "__ !JC_AG'Q=_T$=%_
M[_R__&J]Q_X3S3/^>%W_ -\+_P#%4?\ ">:9_P \+O\ [X7_ .*H^OUP/#O^
M&<?%W_01T7_O_+_\:H_X9Q\7?]!'1?\ O_+_ /&J]Q_X3S3/^>%W_P!\+_\
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M1H;AW!MRBC* XQR.G?\ #WH XFBNENHUU+P/;WA_UU@_DL<=5R !^J_K7-4
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M_P 11]4Q'_/M_<P.MHKDO^%H>#_^@O\ ^2LW_P 11_PM#P?_ -!?_P E9O\
MXBCZIB/^?;^Y@=;17)?\+0\'_P#07_\ )6;_ .(H_P"%H>#_ /H+_P#DK-_\
M11]4Q'_/M_<P.MHKDO\ A:'@_P#Z"_\ Y*S?_$4?\+0\'_\ 07_\E9O_ (BC
MZIB/^?;^Y@=;17%:A\3O"KZ9=+::P1.T+B+;;R@[MIQSMXYKC/#?QBOK/9!X
MB@^VPCC[1$ LH^HZ-^GXUO3R[$U(.2CMT>GW7 ]HHK,T7Q'I7B&W\[2+V.?
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M[G&2,A5!_7%?186-*>"2Q.D;Z.X'IGB3XL^#]7\$ZU9VVI.MS<Z?/%%%);2
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M#QP.36YJ>@>(?#GCE_$WA6RCUF*^M([:_L9+A89&:, )*KMQG P0?Z\>@T4
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M6/%5]XL\46<.GW']GM8:?IL<PE,2D[BSN/E+$G''&#[5Z!10!RWPUT>_\/\
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M[..[BN+6&%E\_P MT,;2'.",$'S/4=*UIZJ2[K]4!F>/H&>QM)P,B.1E/MN
M_P#B:X6O1]0N+W4-/EM+GP[?%9%QF.:W.#V/,@[UP%W8W5A-Y5[ \$F =KX/
M'U!(/X$U,H.._P": KT445 !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !73^ _P#D.S?]>S?^A+7,44 ;EYXGUAIIH?MK!-S+\J*"!GU
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MMX=_Y_=4_P"_L?\ \17H=%']H8K^=@>>?\*6\._\_NJ?]_8__B*/^%+>'?\
MG]U3_O['_P#$5Z'11_:&*_G8'GG_  I;P[_S^ZI_W]C_ /B*/^%+>'?^?W5/
M^_L?_P 17H=%']H8K^=@>>?\*6\._P#/[JG_ ']C_P#B*/\ A2WAW_G]U3_O
M['_\17H=%']H8K^=@>>?\*6\._\ /[JG_?V/_P"(H_X4MX=_Y_=4_P"_L?\
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MLJPW=J8WC3[/Y;JV-RCYN5[GD#WHL.YW'_"&:/=ZK-HEQ\.;2WTCRRD>K))
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M'CBPJQ1+EY78X5%'J2:\J^)?B76=1T+2+;Q!X7N-$,VKVTEM(;E)T< G*L5
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MNSHH XS_ (5]_P!1/_R7_P#LJ/\ A7W_ %$__)?_ .RKLZ* .,_X5]_U$_\
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MI$CV@Q_[-7944 8^F>%].TMQ(B&:8=))><?0=!6Q110 4444 %%%% !1110
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MNSHH XS_ (5]_P!1/_R7_P#LJ/\ A7W_ %$__)?_ .RKLZ* .,_X5]_U$_\
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M*]>^(?PDN3XRBL?A_H,GV1;!)9OWYVB0R2#[\K=<*. ?PKS._P##^K:7K?\
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M2- EG&$+#HVT#&1V-78["SAOIKV&T@CN[A56:=8P)) OW0S=2!VSTJ<YVG:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >/\ [0O_ " -'_Z^7_\ 0:[?X9_\DST/_KV'
M\S7$?M"_\@#1_P#KY?\ ]!KM_AG_ ,DST/\ Z]A_,UZU7_D74_5_J!<\<?\
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MV;/^9E_[=?\ VM4S^$J.Y[I45I_QYP_]<U_E4M16G_'G#_US7^5<YL2T444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#Q_]H7_ ) &C_\ 7R__ *#7;_#/_DF>A_\ 7L/YFN(_:%_Y &C_
M /7R_P#Z#7;_  S_ .29Z'_U[#^9KUJO_(NI^K_4#J:***\D HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*T_P"/.'_KFO\ *I:BM/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%IEV_=XB*'S/EXY/;-=Q:7]G?^=]ANX+G[/,T$WDR!_+D7[R-CHPR,@\BK%
M' ZMX(UKR/"NHZ!>64.M^'[;[.5N@[6]PK1JCJ2!N'3@XSS4>E>#O%,GQ*L_
M%GB34--E,=G);/;68=5A!^Z$W#+<DDL2#STXKT*B@#E_ ?ABZ\,>';G3]3>W
MF>:]GG_<DLI21L@'('..M<_IWA'QOX1M)]'\':GH\NC-([6IU-9?.LPQR57:
M"K@$DC/>O2** ,KPSI%SH?A^VL+_ %.XU6ZC!,UW<L2TC$Y/4G '0#L!6%XF
M\):O+XJMO%/A"^MK;5HK<VD\%ZK&"ZASN 8KRI!YR/;TY[*B@#C/#OA/6/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIG_/"[_[X7_XJCZM6_E Z6BN:_X3K3/^>%W_ -\+_P#%4?\ "=:9_P \+O\
M[X7_ .*H^K5OY0.EHKFO^$ZTS_GA=_\ ?"__ !5'_"=:9_SPN_\ OA?_ (JC
MZM6_E Z6BN:_X3K3/^>%W_WPO_Q5'_"=:9_SPN_^^%_^*H^K5OY0.EHKFO\
MA.M,_P">%W_WPO\ \51_PG6F?\\+O_OA?_BJ/JU;^4#I:*YK_A.M,_YX7?\
MWPO_ ,51_P )UIG_ #PN_P#OA?\ XJCZM6_E Z6BN:_X3K3/^>%W_P!\+_\
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M_P \+O\ [X7_ .*H^K5OY0.EHKFO^$ZTS_GA=_\ ?"__ !5'_"=:9_SPN_\
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M@SWD3C],TGAZJ^R!OT4R&>*XA66"19(VZ,IR#3ZPV \?_:%_Y &C_P#7R_\
MZ#7;_#/_ ))GH?\ U[#^9KB/VA?^0!H__7R__H-=O\,_^29Z'_U[#^9KUJO_
M "+J?J_U ZFBBBO) **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M VJ:CK5['>ZQJ\XFNY(4V1KM&$1 >< =S74T44 %%%% !1110 4444 %%%%
M!1110 5%=_\ 'G-_US;^52U%=_\ 'G-_US;^5 $M%%% !1110 4444 %%%%
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MTG38K2#HHRS?WF[FN/&5_90Y5NP,Q_\ D.ZA_P!L_P#T&I:B?_D/:A_VS_\
M0:EKQ%L2]PJ.>XAM;=Y[J6.&&,;GDD8*JCU)/ J2N?\ '?\ R(.M?]>C_P J
M8&A'X@T:6&::+5K%XH%5YG6Y0K&K?=+'/ /;/6IH=4T^YL'OK>^MI;1 Q:XC
MF5HU"]26!P,=Z\F\0:)%9_#/PQ<6%NEK:N;:XU*XCM5E/*9#R)_RT4%FX;CG
M'>H-.TRTG\%^*9H;S4K[3K@PYFLM)2W0LC9WQQ[P"HP-PPO'/N%<=CUVVUK2
M[RTFNK34K.>W@!,TT4ZLD8 R2Q!P..>:;;:YI-Y="VL]4LI[AE#B**X1G*D9
M!P#G&"#GT->1^'[B%K/Q9#IT=I?6JZ)-NU6TM9+4.VT[4>(X0-@G[JYXSDY-
M0:0=)O8O!MEX>LC%K]O=1S7K+;LK"+JS.^/F4@@CKP<<9Q1<+'LLVLZ9;Z@E
MC/J-I%>28"6[SJ)&STPI.3FDNM<TFQEDBO=3L[:2-0SI-<(A0'@$@G@&O&KP
M:5;:-XBTG7].DF\5W5XYMLVS/+-N8;#&X!P.IQD9''/2NBTG0X=2^)TMOXFM
M8KZX@T.#S5G D'FX16;W/7GWHN%CT6;6-,M[".^N-1M(K23&RX>=5C?/3#$X
M-/&I6+:=]O%[;FRV[OM(E7R\>N[.,5X?9QV<_P -O#TFJ7-S916U[<!+O[$M
MW;Q@G.V2,GN>G![\=ZEE^V7WPQ1X+*.STR'6M\T]G#))%)$!@S+'(<E W\/"
MYXP,'!<+'MEEJ%GJ5OY^G7<%W#DKYD$@=<^F1Q5 ZX8_$\^F316\5O#9_:FN
M6O$W## $&+[P7!SO/':N.^%UI"-4U>]T[4);ZTD$<9E73%L[>1P.J*K=0.#\
MHZ]\TW6_^2E^(/\ L5I?_0A3$=U!KVCW5U';6NJV,T\R[HXH[E&9QC.0 <D8
M!/X59O+ZTT^$37]U#:Q%@H>:0(I)Z#)[UXU'IECIWA7P%J%G:0QWDNIQ&6=5
MP\F7)PS=2..E=A\7U#^"HD<95KZ($>W-*X6.J_X2/1/L\D_]LZ?Y,3B.23[4
MFU&/12<X!X/'M4]UJNG6-G'=7M_:VUM*0(YIIE1')&1AB<'(!->777A[1U^(
M7B:V73+406^BF6&(1 (C[!\P7IGWZUD&^A_X1OP?;:E';P0/:3A=1N[5[M8F
MWD!4A!VLW"_>!ZCICDN.QZSJ/B)+==+DTX6M]!J%TD F^W1QJ%)QN3/^L(_N
MKR:L3^(]$M6=;G6-/A:-S&XDND7:XZJ<G@^U>.Z'N7PUX5CDW*\?BI49&7:4
M.5X*]OI6A+I&GW=G\1;VZM(9KF"YD$4LB!FCQN.5)Z'/I1<+'H5_XST[3_&%
MGX?F>-9;B,N\KS*JQ'^%?]YO3CJ.N:UDUC3)=1;3X]1M'O5SNMEG4R# R?ES
MFO)$-A:^(O!E_JL,"QW.C)&LTL!=7G"[4)X.2"4Y[<=*Q- TWS=0T^RN-1N8
MM<CU#?)9Q:.C3Q,&)WM<%E)3')Y.,]"!FBX6/<)_$>B6K.MSK&GPM&YC<272
M+M<=5.3P?:I[_5M.TI4.J7]K9"0D(;B98]V.N-Q&>M>32Z1I]W9_$6]NK2&:
MY@N9!%+(@9H\;CE2>ASZ50U2\2\AT:SN[>W@FDT"%+:[FLGO)+A^,1Q1Y*!B
M>-Q&1ZC(HN%CV>;6-,MXX'N-1M(DN$,D+/.JB50-Q9<GD $'([4ZVU33[VS>
M[L[ZVN+9,[YHIE9%P,G+ X&!7CNE6MMJEC\-K:]C2YA:2]#QO\RG:X(!'<<#
MBDU#3YEL?'=CI%L1;0:A;N]M;+C]UEBP"CMP#@=A[47"Q[%8:KI^J([Z9?6U
MXJ'#M;S+(%/H<$XI+'6-,U1I%TS4;2\:/&\6\ZR;,],X)QT->;33>']9T;7E
M^'FDW O&TX))/;0M'$RY&8MN1F0@'HN3SR:S_AU:VD_B_3;C3=4ENVMK0_:4
M@T=+:.+<A'ERR!@6;=CG#9*]>IHN%CV6BBBJ$%%%1SSI;Q%Y#@=AW)]*0!/.
MEO$7D.!V'<GTJ?3M.>25;V_7#]8HCTC'J?>C3M.>25;R_7#]8HCTC'J?>M>H
M;N4D>>>,H&B\0O(1Q,BL#]!C^E8%>D^)=%.KZ>##C[3#EH_]KU6O.'C>*1DD
M5D=3AE88(->YA:BG32ZH8VBBBNL HHHH **** "BBB@ HHHH **** "BBB@
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M*=^<9KCJU]1UP7>G16%I:+:6L;;M@<L2?K^-9%:T(RC%\W5W ****W ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KM_ <#+9W<Y'$CJH]]H/\
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MD>'M(C\C27T47RVR?ZN"5EPP4?PALYQ[#L*Z%OAY;ZC\%;>Q\.VUI:ZK>:=
MSW31A7N22DCK)(/F(<CGGT["MB#X:QQ^&M?L[G5IKS5M?C*7FJSQ L>,* @(
M 5<\*#_3&MJ/@ZUU;P)#X:O+F4+#;Q1)=0_(ZO&!M<=<<CISZ4 >=03:;8>)
M_#__  E?@BX\)7UM=K%:7^F>6UM,Y&T1NZC[K>G)]P,U[/7")\/M8U"_T]_%
MWBZ;6K/3KA;F"T6Q2W#2+]UI&4DOCTXKNZ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN_\ CSF_
MZYM_*I:BN_\ CSF_ZYM_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** ,+Q5H?]L:;OA7-U!EH_\ :'=?Q_G7F!&#@]:]LKE[
MWP?%=>)DO!M%H_[R:/U<=OH?\?6O2PF*5-.$]N@#/!6A?8[7^T+E?W\P_=@C
M[B?_ %_Y5U= &!@<"BN&K4=2;DP,*ZM;]-6NIK>T\Z.79@^:J]%QWINS5/\
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M?] W_P CK6_11=A9&!LU3_H&_P#D=:-FJ?\ 0-_\CK6_11=A9&!LU3_H&_\
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MH_X0'_J)?^0/_LJ[&BCZW7_F_(#CO^$!_P"HE_Y _P#LJ/\ A ?^HE_Y _\
MLJ[&BCZW7_F_(#CO^$!_ZB7_ ) _^RH_X0'_ *B7_D#_ .RKL:*/K=?^;\@.
M._X0'_J)?^0/_LJ/^$!_ZB7_ ) _^RKL:*/K=?\ F_(#CO\ A ?^HE_Y _\
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MP1GD9_ UZ.)IRI8&G":L[O\ 4#I****\8 HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J*T_X\X?\ KFO\JEJ*T_X\X?\ KFO\J ):***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKO_CSF
M_P"N;?RJ6HKO_CSF_P"N;?RH EHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+?\ YX1?]\"C[);_ //"+_O@5+10!%]DM_\ GA%_WP*/LEO_ ,\(O^^!4M%
M$7V2W_YX1?\ ? H^R6__ #PB_P"^!4M% $7V2W_YX1?]\"C[);_\\(O^^!4M
M% $7V2W_ .>$7_? H^R6_P#SPB_[X%2T4 1?9+?_ )X1?]\"C[);_P#/"+_O
M@5+10!%]DM_^>$7_ 'P*/LEO_P \(O\ O@5+10!%]DM_^>$7_? H^R6__/"+
M_O@5+10!%]DM_P#GA%_WP*/LEO\ \\(O^^!4M% $7V2W_P">$7_? H^R6_\
MSPB_[X%2T4 1?9+?_GA%_P!\"C[);_\ /"+_ +X%2T4 1?9+?_GA%_WP*/LE
MO_SPB_[X%2T4 1?9+?\ YX1?]\"C[);_ //"+_O@5+10!%]DM_\ GA%_WP*/
MLEO_ ,\(O^^!4M% $7V2W_YX1?\ ? H^R6__ #PB_P"^!4M% $7V2W_YX1?]
M\"C[);_\\(O^^!4M% $7V2W_ .>$7_? H^R6_P#SPB_[X%2T4 1?9+?_ )X1
M?]\"C[);_P#/"+_O@5+10!%]DM_^>$7_ 'P*/LEO_P \(O\ O@5+10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7,^+/'>E^$XPEP3<WK#*6L1&['JQ_A'^<5+XU\3IX5\.2W@"M<N?+M
MXV_B<]S[ <_IWKR3PEX6F\5WTNLZ[)));M(2Q8_-</WY[ ?_ %A7J8/"0G!U
MZ[M!?BP)[CX@^-/$UPT>CH\$>?N6<6=H[9<Y(_,5&;#XDS?/]KU,9_ZB(7]-
MXKU"VMH+.W6"UA2&)!A41< 5+79]<A#2E3BEZ >5?V7\2?\ G\U3_P &@_\
MCE']E_$G_G\U3_P:#_XY7JM%']H2_DC]W_! \J_LOXD_\_FJ?^#0?_'*/[+^
M)/\ S^:I_P"#0?\ QRO5:*/[0E_)'[O^"!Y5_9?Q)_Y_-4_\&@_^.4?V7\2?
M^?S5/_!H/_CE>JT4?VA+^2/W?\$#RK^R_B3_ ,_FJ?\ @T'_ ,<H_LOXD_\
M/YJG_@T'_P <KU6BC^T)?R1^[_@@>5?V7\2?^?S5/_!H/_CE']E_$G_G\U3_
M ,&@_P#CE>JT4?VA+^2/W?\ ! \J_LOXD_\ /YJG_@T'_P <H_LOXD_\_FJ?
M^#0?_'*]5HH_M"7\D?N_X('E7]E_$G_G\U3_ ,&@_P#CE']E_$G_ )_-4_\
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M_'*/[+^)/_/YJG_@T'_QRO5:*/[0E_)'[O\ @@>5?V7\2?\ G\U3_P &@_\
MCE']E_$G_G\U3_P:#_XY7JM%']H2_DC]W_! \J_LOXD_\_FJ?^#0?_'*/[+^
M)/\ S^:I_P"#0?\ QRO5:*/[0E_)'[O^"!Y5_9?Q)_Y_-4_\&@_^.4?V7\2?
M^?S5/_!H/_CE>JT4?VA+^2/W?\$#RK^R_B3_ ,_FJ?\ @T'_ ,<H_LOXD_\
M/YJG_@T'_P <KU6BC^T)?R1^[_@@>5?V7\2?^?S5/_!H/_CE']E_$G_G\U3_
M ,&G_P!LKU6BC^T)?R1^[_@@>5'5_B+H'[^>:_:-/O&7$ZX]^N/K75^%OC!;
MWLB6GB2%+21C@747^K/^\#ROUY'TKJJY#Q;X&M=9MY+K3HTM]04%AM&%F]C[
M^_YT>UPV(]VM!+S6@'J2LKJ&0AE89!!R"*6O(_A1XNG@O3X8U5B!\WV4R=8V
M'6/^>/?CO7KE>1BL/+#5'"7R\T 4445S %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!XI\7KV74O&5GI,72WB55!/5Y#_AMKOM.L8M,TVWLK<?NX(P@
M]\=_J>M><>,/G^-X5N1]KM!CVVQUZA7OXCW</1@MK7^\ HHHKSP"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /)O'MLVA>-+?5;+Y&E*W"X[2*>?Y
M_B:]XM+A;RR@N8QA9HUD4'T(S7B_Q: W:2>Y$P_] KUCPJQ;P=HS,<DV$!)_
M[9K77CO?PM*;WU0&K1117B@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1137D2,9D=5_P!XXH =147VNW_Y[Q?]]BC[7;_\]XO^
M^Q0!+147VNW_ .>\7_?8H^UV_P#SWB_[[% $M%1?:[?_ )[Q?]]BC[7;_P#/
M>+_OL4 2T5%]KM_^>\7_ 'V*/M=O_P ]XO\ OL4 2T5%]KM_^>\7_?8H^UV_
M_/>+_OL4 2T5%]KM_P#GO%_WV*/M=O\ \]XO^^Q0!+147VNW_P">\7_?8H^U
MV_\ SWB_[[% $M%1?:[?_GO%_P!]BC[7;_\ />+_ +[% $M%1?:[?_GO%_WV
M*/M=O_SWB_[[% $M%1?:[?\ Y[Q?]]BC[7;_ //>+_OL4 2T5%]KM_\ GO%_
MWV*/M=O_ ,]XO^^Q0!+147VNW_Y[Q?\ ?8H^UV__ #WB_P"^Q0!+147VNW_Y
M[Q?]]BC[7;_\]XO^^Q0!+147VNW_ .>\7_?8H^UV_P#SWB_[[% $M%1?:[?_
M )[Q?]]BC[7;_P#/>+_OL4 2T5%]JM_^>\7_ 'V*D5@PRI!'J#0 M%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 4;FYDDF,%N=H7[\GI["J_P!DB;F3<Y]68T6GS6^\
M]78L?SJ>@"#[%;_\\_\ QXT?8K?_ )Y_^/&IZ* (/L5O_P \_P#QXT?8K?\
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M\D_[Y%/HH 9Y$7_/)/\ OD4>1%_SR3_OD4^B@!GD1?\ /)/^^11Y$7_/)/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&LB2VTFU@03USD,#T(8$>W2K">"["+38[6"XN8FCOOMXG3RPWG8QG&S9C'&
MN.*3>'A.2E'52?W:@=",[1N&#W -% &% ))]SWHKS "BBB@ HHHH BF_UEO_
M -=EK4K+F_UEO_UV6M2@ HHHH **** "BBB@ HHHH \*\7?\EQ'_ %^VG_H$
M=>HUY=XN_P"2XC_K]M/_ $".O4:]_%_PJ/\ A0!1117G@%%%% !1110 4444
M %%%% !1110 4444 %<UX[\.W?BCPRVG:?)#',94?=.Q"X'T!/Z5TM4[[2=.
MU3R_[3T^UO/+SL^T0K)LSC.,@XS@?E2:NK 5?"^E3Z)X7L--NVC>:WBV.T9)
M4G)Z9 /Z5K5D?\(GX<_Z &E_^ 4?^%'_  B?AS_H :7_ . 4?^%+5 <Y\/\
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M^NRUJ5ES?ZRW_P"NRUJ4 %%%% !1110 4444 %%%% 'A7B[_ )+B/^OVT_\
M0(Z]1KR[Q=_R7$?]?MI_Z!'7J->_B_X5'_"@"BBBO/ **** "BBB@ HHHH *
M*** "BBB@ KB/''C2]TG4K30O#MNMQJ]Y@C>,K&"2!QZG!//  R:[>O)]?F3
M1?CQI^H:DWEVDT8VR-PJYC:/K[-R?3-1-M("W<2_%'1#%=3O::Q$S /;01*2
MN>QPJG\03BK_ (\\3ZQI$?AY[!VL&OI<7,+HCD?<^4D@],D9%=;JFOZ5HMJE
MQJE]#;Q2$!&8YW9Z8 Y(]Z\\^+KP:I!X::"59+>ZF;;(AR&5MG(_.IEHG9@=
MK:^./#=[JPTVUU:&2Z+;%0!@&;T#8VG\#5G6O$VC^'5C.LWT=L9/N*069O?:
MH)Q7G7Q)T+2]$O\ PV^D6,-FQN-A,*[2P!3&?4\]3S6KXAU6$_$E+70= 74O
M$%O"/](N+AECA7;G 7..C9SQR:?,]F!V6B^)-(\11N^C7T=R(\;P 59?JI -
M9C?$;PHELT[:N@19#&08I-VX=<+MR1R.<8KCOAP+I?B=X@%^D$=SY3F9+;_5
MJ_F+D#\:A^%?A[2M776I]4L8;MUF$2><FX(#DG&>A]^O%)2D[6 ]0TS6-/UG
M3_MNF7<=Q;9(,BG&".H.>0?K64GQ \+2WDEM'K$+2QAB<*VT[1DX;&&Z=B<]
MJ\S\+/-;?##Q@+1F!5PHP>BGAO\ QW-:6G:+X8?X+S7TT-J;P6\C&X8CS5G!
M;8N>HY &WN*.=O8#TFP\1Z3J6C/JUI>HUC&6#SNIC5<=<[@*I:;X[\-:M?K9
M6&K127#':J,C)N/H"P /X5Y%<RW"?!&S2+(ADU1A*1[*2 ?;(S^ K3U3PE>7
M&DZ=*UUX.TF,;7M[N">2%Y>.[,#N]?7(I<[ ]KKR_5O&U]J/Q!;1=)\1V6DZ
M=&@_TW9'*KMM!(RQQG)VX!'2O381(((Q.09-HWE>F<<XKR:UTG3F^/=Y9-86
MIM%B#+ 85\L'R4.=N,9R2?K53OI8#MI_'GAW3)9;/4M747=H EQF!QEN^,+@
M_09J]<^+-#L]'@U2ZU&.*SN!F%V!S(/9<;C^5><Z)I%CK'QNUV/4[:.YBA62
M58Y5#*6W(O(/!X8U)K=K8W7QJLM/UM(TTR&V1+6!P%BQL.U<=,;LC'? %+F=
M@/0]%\5:)XB+C1]0CN7099,%& ]=K ''O52Y\>^&;.YN[>ZU5(I;-MDR-&X(
M;.,#Y?F/TS7#:[9V.C?&+04\-116\LC(+J&VP%4%B&RHX'R9X]@:9X8TBPU?
MXP>(QJ=K%=)"\KI',H9=WF 9(/!X)HYGL!WI\=^&1I(U(ZO#]E9_+#8;=N]-
MF-WZ5J:5K%AKEB+S2KE+FW)*[UR,$=B#R#[&O*/AQX?TK4/%WB&&^L8;B&U=
MDACE7<J NPX![X YK7^"Z[-/UF-<[5NE &>G!HC)MJX'0_$?6M0T'PBU[I,_
MV>X$Z('V*W!SGA@146D_$30/[-TR'5=9A&H36L3394A1(4!;+ ;5Y)XR,56^
M+_\ R(+_ /7S'_6N;UC1O#$?P9@OK2"U%UY,12X&/-:8E=ZD]3_%QVHDVI.P
M'J&IZSI^C6/VS4[N.WM\@!V/WB>PQR?PJCHWC/P_X@NC;:3J4<\X!/EE&1B!
MUP& S^%>>W&K6B>$/"%KJ.COK&JR(#9Q/.T:K\P52V#AL@+@'CKT'6'?JS_&
MK1I-=MK2UNWC!\JT;< NUP-QR?FX_+%'.[@>B:MXX\.:'>&TU/5(XIU^]&J/
M(5^NT''XUJ:?JMCJM@+W3KJ.XMCG]XAX&.N?3\:\MN=+\0Z=XLUG4O!=YI^L
M174K-=6ZR1RN@9B=CJ3D#.1P><>U4]/UB%_AKXIM=.TG^R[Z#R_M*122,C!G
MVL0&)VX 8$9HYW?4#T9?B%X5>_\ L:ZU!YN[;DA@F?\ ?QM_6LKXB^(M4T*X
MT-=)NO(6[N"DW[M6WKE?[P..IZ5PMCX9N=2\ P2 ^$[6TDQ_IUQ))'<(V[HS
M] >,8Z5H^,X)K7P_X)@N;J&[DCDV^?!)O20 I@AL#(QBDY2: [+5]7OK?XE:
M5IT.LV]O:30!I+!X6,DQS)R&\L@=!_$/NG\=&[\;^';&]N[2\U-(9[, S(Z.
M-N<< XPQY' S7)>)?^2[>'?^O1?YS52TW1['6?CGK4>IV\=S%!$9ECD7<I;]
MVO(/!^\>M/F=].X'HFB>)M'\1)(VC7R7/E_?4*RLOOM8 X]ZIZCX[\-:3J#6
M5_JT4=PIPR*C/M/H2H(!^M</X;METKXM>)X-)A6)8;"5H8D'RALQD #ZGI7/
M>#-'N]7T'4988O#DWSM]HFU8R>=$,#Y@1PHZG/7.<TN=@>ZVUS!>6L=Q:2I-
M#(NY)$;*L/4&N5\=:O?:5/I"V&LV^F"><K()H6?SAE>!B-\=3Z=:3X9Z9-I'
MA9[274;'4(UN6:*6QG\U%! RN<#G.3^-8?Q=_P"/SPU_U]M_-*J3?+<#M=1\
M5:+I&J1Z=J5^EM=20F95=6 V#=SNQM'W6XSGCW%1:/XR\/Z_=M:Z3J4<\Z@G
MRRC(2!UQN S^%<-XUT^WU3XT:#9WL8E@DM4WH>C /*<'\J;J>EV6D?'+0H]+
MMH[2.6 2-'"H1=Q\U3@#@< 4N9W ]7HHHK4 HHHH **** "BBB@ HHHH ***
M* "BBB@#S?XM_P#,(_[;?^R5ZMX3_P"1,T7_ +!\'_HM:\I^+?\ S"/^VW_L
ME>K>$_\ D3-%_P"P?!_Z+6NO&?[E2]7^H&M1117B@%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &?<_\ (4'_ %Q_]FI:2Y_Y"@_Z
MX_\ LU+0 4444 %%%% !6#X?\,_V%JNL7OVOS_[3N//V>5M\KYF.,Y.?O=>.
ME:NI.T>E7;HQ5E@<A@<$':>:\B\/)=:SI?VJ^^(DVF2[ROD379W8'?F4=?I7
MH8:C*I2F^:RT3T;\^GH![-17(0ZQ#X-\*V]QJ.HW6O6\LQ OX<28STR2YXX(
MR":TK7Q=IU]KD^F6"37+6\/G2W$04Q*N <;MV2>0, ?R..>6'J:N*NE?7T W
M:*XJ/XHZ1-9O=0Z?JLD,9Q,Z6P*PYZ%CNP,]N>U;.I>+]*T[3K.[5I;P7Y'V
M6*UCWR3=.@XZ9&0<>G7BG+"UXM)Q>H&Y16-HOBK3];CNO+\ZTEM#_I$%XGEO
M$/4C.,<>OUK)7XF:(9H]T%^EI)*8DOGM\0,1[YS^F:2PU9MQ47= =?17GTGC
M*^_X6>=/-K?M90*T0MHH/F9L@>:PSRG<'IC!Q6O>?$+2;2\N(EM[^YAM7"7%
MW;V^^&$DX^9L]OI],UI+!UE9)7NK@=516'K/B[2]$T^TNYFEN!>X^S1VZ;GF
M!P<@$CU'YBN6TSQ'<:M\6(XXI+^WM?LQWV5SNCV.%_B3.,]#2IX6I.#G:R2;
M^X#T6BLGQ+:ZQ>:,]OX>N8;6ZD8 RRDC:G.<$ X/3G^M<C'->^&_B)I>D6VM
M7VJQW<7^E17<OFE#@G</[O SCT')-*EA_:Q;4E?5V] /1**\\\#^)8X[[74U
MW6D3;=X@6]NP,+ELA=QZ=.E6?!&JSZEXP\2AK^2[M$F!MP9B\:J6;[O. ,8Z
M5I4P<X<]_LI/UO;_ # [JBL/Q/IVM:I#:VVBZ@MA"TG^ERABLNS(X0@'GKW'
M;G&:Y33]8N_#_C+5M+BU*ZU:QM;)[EC=2^:\3HH)&[Z\8]_6HI89U8.49*^]
M@/1Z*\D.H:[9^$K3QFVLW<MQ+=G?9O)_HYCRR[=G0=.W8\8/-=?J.DZMKFK+
M>2ZY-INA+;B2-;.<Q39(!)<XQCKW.,#U-:3P?LW[TU;5==UN@.LHKRBS\;ZM
M9?#V^G-RUS/#>BTM;R1=Q((W9.?O$ 'K_>&:U?!\XD\4+'8>,)=4MTMO])M[
MII'9Y>A,>X ;>^02>QSG-5/ 3A&4I/;UZ?EOU ]"HHHKS@"BBB@ HHHH =IG
M^KG_ .NS?TJ[5+3/]7/_ -=F_I5V@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*;_66_\ UV6M2LN;_6V__79:U* "BBB@ HHHH **** "BBB@#PKQ=_R7$?\
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M*TGQ'!:)<K+;/9\6\MHP1HQQP.",<#MQVJE;?#C2K;6K35EO=2DO;9]YFEN
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MM]"*DHL@"BBBF 4444 %%%% !1110 4444 %%%% !1110!YO\6_^81_VV_\
M9*]6\)_\B9HO_8/@_P#1:UY3\6_^81_VV_\ 9*]6\)_\B9HO_8/@_P#1:UUX
MS_<J7J_U UJ***\4 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH S[G_D*#_KC_P"S4M)<\:HOO#_6EH **** "BBB@"KJO_('O/\
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M_/Q<?]]__6H_LU/^?BX_[[_^M0 VBG?V:G_/Q<?]]_\ UJ/[-3_GXN/^^_\
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MY%,UZ77*^!O$^B:[8S6?AVRGL[?3P@\N5%4?-NQC#'/W3G-=56D/A ****L
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MG]F6?_/'_P >/^-']F6?_/'_ ,>/^- $=%2?V99_\\?_ !X_XT?V99_\\?\
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M%>_B?>H49+:UON FHHHKSP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /-_BV?^01_VV_]DKU;PH,>#-%!_P"@?!_Z+6O&_B3=_P!I>*+73;4;Y($"
M8'_/1R./RV_G7N5A:_8M-MK4'(@A2/([[0!_2NO'>[A*47OJ_P"OO L4445X
MH!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 <G\1/"I\4>&RMLH-]:DR
MV_\ M?WD_$?J!7G/@3Q>NF_\276F,**Y$,DG'EG/*-Z#/Y5[E7#>-/AI9>)9
M&O=/=;+43]YMOR3?[P'0^X_6O6P>*I^S>'K_  ]'V8&H"&4%3D'D$=Z6O)OL
MOCKP6QC\BZ^S*<#"^?"1[$9V_H:#\3]?A^26ULMPZ[XG!_\ 0JZ_[/G+6E)2
M7J!ZS17DO_"U-;_Y]=/_ ._;_P#Q='_"U-;_ .?73_\ OV__ ,71_9N(\OO
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M_P#Q='_"U-;_ .?73_\ OV__ ,71_9N(\OO ]:HKR7_A:FM_\^NG_P#?M_\
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M ,71_9N(\OO ]:HKR7_A:FM_\^NG_P#?M_\ XNC_ (6IK?\ SZZ?_P!^W_\
MBZ/[-Q'E]X'K5%>2_P#"U-;_ .?73_\ OV__ ,71_P +4UO_ )]=/_[]O_\
M%T?V;B/+[P/6J*\E_P"%J:W_ ,^NG_\ ?M__ (NC_A:FM_\ /KI__?M__BZ/
M[-Q'E]X'K5%>2_\ "U-;_P"?73_^_;__ !='_"U-;_Y]=/\ ^_;_ /Q=']FX
MCR^\#UJBO)?^%J:W_P ^NG_]^W_^+H_X6IK?_/KI_P#W[?\ ^+H_LW$>7W@>
MM45Y+_PM36_^?73_ /OV_P#\71_PM36_^?73_P#OV_\ \71_9N(\OO ]:HKR
M7_A:FM_\^NG_ /?M_P#XNC_A:FM_\^NG_P#?M_\ XNC^S<1Y?>!ZU17DO_"U
M-;_Y]=/_ ._;_P#Q='_"U-;_ .?73_\ OV__ ,71_9N(\OO ]:HKR7_A:FM_
M\^NG_P#?M_\ XNC_ (6IK?\ SZZ?_P!^W_\ BZ/[-Q'E]X'K5%>2_P#"U-;_
M .?73_\ OV__ ,71_P +4UO_ )]=/_[]O_\ %T?V;B/+[P/6J*\E_P"%J:W_
M ,^NG_\ ?M__ (NC_A:FM_\ /KI__?M__BZ/[-Q'E]X'K5%>2_\ "U-;_P"?
M73_^_;__ !='_"U-;_Y]=/\ ^_;_ /Q=']FXCR^\#UJL#Q1XKM/#EFV666]=
M?W4 /.?5O0?SKA3XJ\9Z]^XTZWE4O_SYVQSC_>.<?7(K;\-_"2_OKE;[Q;,T
M2%MS6X?=+)_O-V_4_2CZK2H>]B9KT6[ A^&'ANYUWQ"_B755+P0R%XV<?ZV;
MU'LO7ZX]Z]HJ*UM8+&UCMK.)(8(EVI&@P%%2UY.+Q+Q-3GV71>0!1117( 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>abvx-20241231_g24.jpg
<TEXT>
begin 644 abvx-20241231_g24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '* Y4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW_XU1]1Q7_/J7W,#Z*S1FOG7_AOCX0?]!/6/_!#>_P#QJC_AOCX0?]!/6/\
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M:,U\Z_\ #?'P@_Z">L?^"&]_^-4?\-\?"#_H)ZQ_X(;W_P"-4?4<5_SZE]S
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M;X^$'_03UC_P0WO_ ,:H^HXK_GT_N8'T26HW5\Z_\-[_  A_Z">L?^"&\_\
MC52Z?^W;\)-2O[:TCU75$DN)4A0S:+=HNYF"KEC'@<D<FI>"Q45=TVODP/H:
MEIBMD<\4^N, HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS2O^05:?]<4_D*_3N"/CK>B$RS1117ZT2%%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M04444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKXL_[!-W_P"B7K\?-*_Y!5I_UQ3^0K]@_BC_ ,DV\6?]@F[_ /1+U^/FE?\
M(*M/^N*?R%?IW!'QUO1"99HHHK]:)"BBB@ HHHH **** "BBB@ HHHH ****
M "BBBA:; %%%% !1110 4444 %%%% !1110M-@"BBB@ HHHH **** "BBB@
MHHHH **** "IK'_D*Z5_V$+7_P!'I4-36/\ R%=*_P"PA:_^CTKSLR_W.IZ,
M9^S2_<'TI],7[@^E/K^9R@HHHI@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!RWQ2_Y)KXL_P"P3=_^B7K\?-*_
MY!5I_P!<4_D*_8/XH_\ )-O%G_8)N_\ T2]?CYI7_(*M/^N*?R%?IW!'QUO1
M"99HHHK]:)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I;'_D*Z5_V$+7
M_P!'I452V/\ R%=*_P"PA:_^CTKSLQ_W.IZ/\AG[-K]P?2GTQ?N#Z4^OYG*"
MBBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%)0!R_Q1/_%M?%G_ &";O_T2]?CYI7_(+M/^N*?R%?L-\1+6?4/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS0!Z'2UX5\?OC7XG\(^*_"7@#P%IVGWWC;Q.9'AGU9V6TLK>,?O)I OS-C.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=5COY[Z\*;5),?RJB@GJ<FOJ?RUYZ]<]:3R5]_6@#Y!\+^!_C1^SCK'C'0/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 444E "-SD5\3_#!?^,\/
M% _VKO\ ] 6OK'XB>,G\!^$=0UU=/FU-;-/,>WM\;RHZD9]*_/GPA\?K#0?V
MB]5^(+:7=SVE^TWEV<>WS1O4  \XSD5]%E.#KXBE7E3C?W1GZ6JU+GFLGPWK
M4NN:'8W\UG)8R7,2RFVE(+1Y&<''&:UJ^=E>+L]Q"T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E $;2XSR!]:7S/<8
MKG/B--)9_#_Q-<02/#/%IEU)')&Q5E81,001T(-?/?A'X8Z/JGA/1;RZO/$,
MMS<64,TLG_"2ZD-SM&I)P+C Y)Z5I"GS=27*Q]4;_<4;_<5\V_\ "H= _P"?
MGQ#_ .%-J?\ \D4?\*AT#_GY\0_^%/J?_P D5K['^]^!'.?26_W%&_W%?-O_
M  J'0/\ GY\0_P#A3ZG_ /)%'_"H= _Y^?$/_A3ZG_\ )%'L?[WX!SGTEO\
M<4;_ '%?-O\ PJ'0/^?GQ#_X4^I__)%'_"H= _Y^?$/_ (4^I_\ R11['^]^
M <Y]);_<4;_<5\V_\*AT#_GY\0_^%/J?_P D4?\ "H= _P"?GQ#_ .%/J?\
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M^(?_  I]3_\ DBCV/]X.<^DMX]:C:4C_ .N*^</^%0Z!_P _/B+_ ,*?4O\
MY(KG/B)X'L?"/A"ZU?2K_7[?4+6:W:*1O$-_( 3/&#E7G*D8)&"#UI.C;[17
M,CZU5RV*?357%.KG+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSJ&]111708!1110 4444 %%%% !1110 4444 %%%% !11@\_TYI,\X[_ )T
M+11_.B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *X?XT_\DWU3_KI;?^E$5=Q7#_&G_DF^J?\ 72V_]*(J?0N.Y]++VIU-7M3J
M\XZ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\,?$7C_0?$IAN;6Z\.RSF:RE"8>.6**1#CT;!%+W@T/6$_:QLH/A!K?BV_\
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MT!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM_Z415W%</\ &G_DF^J?]=+;_P!*(J?0N.Y]++VIU-7M3J\XZ HHHH ****
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MH **** "BBB@ HHHH **** "BBB@ HHHH Y7XG_\DW\5_P#8)N__ $2]>5^
M?^1%\.?]@VV_]%+7JGQ/_P"2;^*_^P3=_P#HEZ\K\ _\B+X<_P"P;;?^BEKH
MH[&=0WJ***Z# **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X?XT_\DWU3
M_KI;?^E$5=O7#_&D_P#%M]3_ .NEM_Z41T^A<=SZ77M3J:O:G5YQT!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]M .0I<>OZ4<>OZ5=_X9E\ _\^FM?^%)J7_R11_PS+X!_P"?36O_  I-2_\
MDBCVL Y"EQZUPWQJPOPUU0YY$EMU_P"OB.O1?^&9? /_ #Z:S_X4FI?_ "11
M_P ,Q_#UI(VDTW5+@1NL@CN-?U"6,LK!ERC3E3@@'!&.*/:QM9#43U%&R!3Z
M;M%.KE- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ I,4M% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>abvx-20241231_g3.jpg
<TEXT>
begin 644 abvx-20241231_g3.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M?_"+:+_T"+#_ ,!D_P */^$6T7_H$6'_ (#)_A6I10!E_P#"+:+_ - BP_\
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MT7=/*A_>88CRV))(4#OGB@#TC_A%M%_Z!%A_X#)_A1_PBVB_] BP_P# 9/\
M"O/E_:,\/-I\TRZ7K7V^/5FT5=):V1;N2Z6,2.JJ9 H55/+,P'!Z\9SE_:+M
MM3\8>"K#2=(O;G2-<AO)+JZDA DM6@;8Z%=W!C8$OUP-NW=G@ ]2_P"$6T7_
M *!%A_X#)_A1_P (MHO_ $"+#_P&3_"N3^&?QHTGXJ32?V3INJ0VOD^?'>W,
M49@E7=MP&CD?8W?8^UL<XIOQ!^-6E?#74!#JVDZT]DHB\[5(+5?LL/F/M4%F
M=2Y!QD1AB 1F@#KO^$6T7_H$6'_@,G^%'_"+:+_T"+#_ ,!D_P *X+4/VA-
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M?^O2'_T 5IUF>%_^1:TG_KTA_P#0!6G2 **** "BBB@ HHHH **** "BBB@
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MTFX\&75AKTMG=^'_ +4LDD-C!&MVEP5,J[$55C/R  J,@>IYKU:B@#R;X=_
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MJ/X:_L[Z9\-/$-O?6=_'<6=DLRV5NVFVR31B0G/F7 7S)-H)4<C@X.:]<HH
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M(?\ T 5I4 +14?VB+_GHG_?0H^T1?\]4_P"^A0!)14?VB+_GJG_?0H^T1?\
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M\062T-RB(YD +$#;\V,_,1PM9%OI?CW0[&2>"T\1Z?9K%O>2.*XBC$:$G)(
M&U=Q/H,GUJ Z7XTN+?3K VFO2021.UE;>7,5:,@;S$N,%2&&=O&&'K6?OW?[
MS0#J+?X0V$\MQ&-6O ;%4:[86(.[?937:^3^\^?B KSC.X,..*LGX6Z&VA6"
MB^NH[[4)));.8VXR4^QQSK'*OF87!)&5!)#ANF%K&TNT\=:&FGW;/?VD,*:A
M:6HOGD5;;R[9OM 53_JV".V, '*^U8]QHOC2XU* 3V.O27]X7N(1)#.99CM
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M HHHH **** "N9^)/_(EZC_VS_\ 1BUTU<S\2?\ D2]1_P"V?_HQ: -/PO\
M\BUI/_7I#_Z *AU;_CZ_X"*F\+_\BUI/_7I#_P"@"H=6_P"/K_@(H I4444
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MZC9:=<MIEO=26UQ.TBVT]PLQCD14"K&=R%@^2#NP>/FZGK%^$^D1VD5O%9O
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M,!N(!/&<9P.,DGJ36-6$)1M3@T]/RU7W]?P*4EU8ZBK7]FS_ -T?G1_9L_\
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MYSSU->R?\,6_%7_H#6G_ (,(?_BJ/^&+?BK_ - :T_\ !A#_ /%5Z_UO"_\
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MC.MO=11RXFDMI %=8!DJUH@W.'9@S9.<$=!_PQ;\5?\ H#6G_@PA_P#BJ/\
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M@-:?^#"'_P"*KZ,_9'_9Y\0_"&\UO5_$K6\%W>Q);0V<$HD*J&W,S,..2!@
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MPUZO]#-?&_1?J8.N:Q/9W0AA(0!<EL DUG?\)!??\]A_WPO^%/\ $G_(2/\
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MO^>P_P"^%_PH_P"$@OO^>P_[X7_"LZBCDCV#FEW-'_A(+[_GL/\ OA?\*/\
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M_P#0?M__  7V_P#\17B%%'U/#?\ /M?<@NSV_P#X;.^*_P#T'[?_ ,%]O_\
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MGW%A+;6RW;07D3Q2/"9!'O4,!D!B ?Q]#BN>/<1B5]'_ +!?_):;W_L#3_\
MHV&OG"OH']B71;?7?B]>6]S)=Q1C2)GW6=Y-:OD2Q#[\3*V.>F<?E7)CK?5J
ME^PUN?HE436\4C%FB1B>Y4&N;_X5OI7_ #^:]_X4-_\ _'Z/^%;Z5_S^:]_X
M4-__ /'Z_/;0[O[O^";EC2?!WAK2_$FJ:O8:;91Z[=,IO+M%#3GY %!/51M
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M -L__1BUTU<S\2?^1+U'_MG_ .C%H T_"_\ R+6D_P#7I#_Z *AU;_CZ_P"
MBIO"_P#R+6D_]>D/_H J'5O^/K_@(H I4444 %%%% !1110 4444 %;.D_\
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M)H+!O/A:"22>:7RV*DJ&E9AG:2,X(Z&OSZUHFQI4445 !1110 4444 %%%%
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M_?9M_P N!SS6^@W6EZA)8VUK9V\FDW374,$[RB*2*X MY/G9BK,3&O4 AS@
M,:\PJ1+B6.&2))72*3&]%8A7P<C([XIJBU]IA<CKZK_X)]?\CYXH_P"P:O\
MZ-6OE2OJO_@GU_R/GBC_ +!J_P#HU:Y\R_W2I_74<=S[HHHHK\\-@HHHH **
M** "BBB@ HHHH **** "N9^)/_(EZC_VS_\ 1BUTU<S\2?\ D2]1_P"V?_HQ
M: -/PO\ \BUI/_7I#_Z *TZ\XT/XK:39Z+I]N]O>EXK>.-BJ)C(4#CYJO?\
M"X-&_P"?:^_[]I_\70([FBN&_P"%P:-_S[7W_?M/_BZ/^%P:-_S[7W_?M/\
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MG_Q==/\ :^+[K[A<J/D7_AW_ .-O^A@T#_ON?_XW1_P[_P#&W_0P:!_WW/\
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M[_\ &W_0P:!_WW/_ /&Z^NO^%P:-_P ^U]_W[3_XNC_A<&C?\^U]_P!^T_\
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0\6239@R(@'#J>S>U,1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>abvx-20241231_g4.jpg
<TEXT>
begin 644 abvx-20241231_g4.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#Y@#GY:^NZ\7&4:="IRTG>+2=Q,****X1!1110 4444 %%%% !1110 4444
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M4[:H5I]&<_J/Q3UO1['4H;O2[47^G:K'I]U>6XFFM(8GMUG6=E5#)CYE0C&
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MNY/0$><#Z[4]*[:N.A\*WK^*/#KW4\UW9:#92;+VX93+=7,BB/<0O=8U?)P
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M% !6=JUNSJLJC.T8/^-:-% ',T5OM9P,V3$N?I2?8;?_ )Y+0!@T5O?8;?\
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MYV&#=:7IT<4^#_=D(++_ ,!(KC?])U.\_P"6MW=SO[O)(Y/YDDU]RZ-^RO\
M#S28U$VESZG(O_+6\NI,G\$*K^E=WX=^'?ACPC()-'T&PT^;&/.A@428]-_W
MOUKSWG&&I7]E!W^[_@G4LOK3_B2//OV9_A//\.?"4UYJD/DZWJA626)OO0Q
M'9&?0\DGZ@=J]CHHKY:M6EB*CJ3W9[E.FJ4%".R"BBBL#0**** "J>K8_L^7
M/3CT]1ZU<JIJO_'A+U[=,^H]* )++_CS@_ZYK_*IZ@L<?8K?'3RU_E4] !11
M10 4444 %%%% !69HFFI8_;)@NV2ZG:9SCD]A^@%:=%*UVF*P4444QA1110
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M9XEL9H9[BZE<Q"6SE# R9R5,FT<D@%R. <5[I%_Q\3_\!_E0!-1110 4444
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M*N5'?U+X?V]WI>O>+=+DN;^ZTZUNX39MJ$\D[JKV\;.HD<EF7?N/).,D=.*
M.VJIJN?L$N,YXZ9]1Z5;JIJO.GRXYZ?S% $EC_QY6^.GEK_(5-@'!QR.E0V7
M_'G!_P!<U_E4] !1110 4444 (RAE*GD$8-4]%T>S\.Z/8:5I\/V>PL8([:W
MAW,VR-%"JN6))P !DDFKM% !6#XD\$Z5XLD@EOUNEEAC>)9+.]FM7,;XWHQB
M=2RG:O!R.*WJ* (+&RM]-LK>TM84M[6WC6**&,85$4850.P  %3T44 %%%%
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MD?RJ"0&CP"3G#'.>, "ZU\5+72Y]0B@TN\OELKO[')<"2&&W#B))6S++(JC
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M)LYK34]2FO5EAU-0 L'EH)&;C 8;E78 5'6@#VJH8O\ CXG_ . _RJ:H(O\
MCXG_ . _RH GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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/.#]G[\X+_P#UO\* /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>abvx-20241231_g5.jpg
<TEXT>
begin 644 abvx-20241231_g5.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M 'OP/R*\I_[C?E1Y3_W&_*OUU^UZO_T#;?\ \"O_ +"C[7J__0-M_P#P*_\
ML*/[0_N?C_P ^I_WOP/R*\I_[C?E7I!\7>&M8\(Z)#J\&M1:SH>G7&G6T.GA
M%M[C?)+(DCR%MR8,S;E"-O"CD9-?I;]KU?\ Z!MO_P"!7_V%'VO5_P#H&V__
M (%?_85,L=S?9_'_ (!2PMOM?@?!$OQX\/[K)UL=4E1-QBM'MXECTM3I\UL8
M+8A\LCR2*[$A.$'RLW-+'\>M!M_L$B6.J2F$ P6<EM$(M)Q836YCMCO^=7DD
M1VR$^X.&;FOO;[7J_P#T#;?_ ,"O_L*/M>K_ /0-M_\ P*_^PK+ZS#^3\?\
M@&GL9?S?@? 5C\=]%W:?/J&GZE=7ZM8O=7K11O*98K"YMGG!+?-())HY%W8S
MY?)4XKS3Q+XD@U+QY!K$=SJ6J0Q/;M)>:C%&ES<&-4#,RH2 3M.,LQZ98G)K
M]2/M>K_] VW_ / K_P"PH^UZO_T#;?\ \"O_ +"JCC(Q=U#\?^ 2\.Y*SE^!
M^>^C_&K2-/\ $VLZE]BOH_MWB>ZUF*0VRR-'#+#.@! E0[P9E/RNI&"0X(%7
MM5^-GAB^T3QEIT=EK @U9I)8(V0AGF:WBC#R2?:#\HD0MLD68@'A@26/WU]K
MU?\ Z!MO_P"!7_V%'VO5_P#H&V__ (%?_85/UJ-[\GX_\ ?L)?S?@?",'QU\
M(V>K7-Y!INJM+?7<]X\TEHBM8O):K"#%LG5G*LI.X-&<,<;2.?/YOB'ITWQ
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MI-]F\L2^6DB[ 7RVR.1=H.%88K](OM>K_P#0-M__  *_^PH^UZO_ - VW_\
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MO_T#;?\ \"O_ +"C[7J__0-M_P#P*_\ L*]+^T/[GX_\ X?J?][\#\BO*?\
MN-^5'E/_ '&_*OUU^UZO_P! VW_\"O\ ["C[7J__ $#;?_P*_P#L*/[0_N?C
M_P  /J?][\#\BO*?^XWY4>4_]QORK]=?M>K_ /0-M_\ P*_^PH^UZO\ ] VW
M_P# K_["C^T/[GX_\ /J?][\#\N/A=XCL/"?B:>ZU:.\^P7&G7EA(UE$LDJ>
M?;O$&"LR@X+YQN'2O2?"_C'PUX,^'MW/;7$VHSVU[Y&C_:XXH[U8YPGVTM"D
MC[4"1!48M@F9L=Z^_OM>K_\ 0-M__ K_ .PH^UZO_P! VW_\"O\ ["LI8Q2>
ML?Q_X!I'#./VOP/@#7OC]:^(=/U.QGBU*2WO(M1B6.:--@\VZ26UW#=TB0.!
M_<W$+P36_P#$#X[Z/8^(/$L.DW6IZG<M-JB66J)%&JV@F$:Q1V[*Y)B#(9-W
MRD%@0N<D_<'VO5_^@;;_ /@5_P#84?:]7_Z!MO\ ^!7_ -A4?68?R?C_ , K
MV,OYOP/S;C^*5I;?&F7QK;V]]#"T$@78BK.)VLC"9.&QGS3N)SG!)Z\5U\OQ
M^T74_LDIL]4\.:FVE_9[C5-)MXY)(;IKLW$SPJSK\DN6W<KC<1@CK]Z_:]7_
M .@;;_\ @5_]A1]KU?\ Z!MO_P"!7_V%4\5%V]S;S_X EAY+[7X'P5)\?/#K
MZ7J\4&DZCIL-VFI1C0[:"/[%.;B;S(Y9&W@AE7]V0$.%'! RIU9OVCO#LGC!
M=12QU""S,$T9DCLF%Q&DD\<BP*PO P1%0A2CHHW$>7M.VON#[7J__0-M_P#P
M*_\ L*/M>K_] VW_ / K_P"PJ?K,/Y/Q_P" /V,OYOP/S5\"_$+1_"OB+Q'>
M3:=>O9:A=6TUK$JI(\<<6H0W!5R2!GRXV7(ZDCH.0[Q5\4H/$VL>$-1GAO9K
MC1[N66XEF1=[PFZ,L4:'=T5#M . .@XK]*/M>K_] VW_ / K_P"PH^UZO_T#
M;?\ \"O_ +"M/KD;WY/Q_P" 3]7=K<WX'Y^-\8/#>EZL6TG_ (2);:\UZXUR
MYO&@@BGMV>&2-$BCWNDBCS6+!R X&W SFIH_C'X6C\17,\$&I6-M-86]M<30
MZ+9O!?21R.[M+8,_E*&#* 4?*E2W.XU]^_:]7_Z!MO\ ^!7_ -A1]KU?_H&V
M_P#X%?\ V%1]:C_+^/\ P!^PE_-^!^;W@WXCZ#X<^)WB3Q&EAJ6F6-YYK:?!
M9$NT&Z9'"/B2-L; R_*XP2,AER#TFH?'C19?M]K#I5])HMPFH'^S9(8UBDDF
MO_M,!=0Q&$C^7/)4D[<@DU]^_:]7_P"@;;_^!7_V%'VO5_\ H&V__@5_]A3>
M+C)W</Q_X +#R6G-^!^<7QB^*.G^/K/28+&76+LVFIWU\7U."./RHI_)\N!-
MCME8Q$5'08Q@ <#M-8_:4T37M0EN]0T&\NYAXD34(YGCCW/8(+GR4<%B#+$;
MD[>H(503\HK[I^UZO_T#;?\ \"O_ +"C[7J__0-M_P#P*_\ L*7UJ%DN3;S_
M . 'L)7OS?@?GSJ_QRM%TN]M=/?5[G4+B"QMI]:NH(X[F^2.6X:8RA7;!*3)
M&/F8E4^8]JM>(OV@K+Q!;ZO:7$&JRV-[_:R"!XX\>7/*CV:GYB/W0#^H4M\N
M<FOOS[7J_P#T#;?_ ,"O_L*/M>K_ /0-M_\ P*_^PH^M0_D_'_@!["7\WX'P
M+XZ^./AWQ!I5_:6-IJ[R3:9>Z=%->0@,%EN+66)6)F<X189 =N%!8;44$@,^
M&?Q^TOP/X)TO1KG3+^YN]/#R0S1HFV*9YI0S+E@>;>XE7I][;VY'W[]KU?\
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MI:XSQO\ #K_A+O$GA;78=2;3[_P_+/+;J81+%(94",'7(/ '&".30!V08$D
MY(ZTM<IX0\ Q^$=>\2:JNIW6H2ZY/%/*MTL?[MD3;\I50<$8XZ  8 Y)ZN@
MHHHH **** "BBB@ HHHH *YOQK_J]'_["$?_ *"]=)7-^-?]7H__ &$(_P#T
M%Z .CI:2EH *S!_R,K?]>@_]#K3K,'_(RM_UZ#_T.@#3HHHH **** "BBB@
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MCPKI L/L&JZM^^DE^TZGJ44TWSN6V[N/E&< =@ *U_[;U?\ Z%Z7_P "XO\
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M59Y=S ,45-VTG:3M51R.,9ZUF?!>PCTOP.UK"(EABU75%18<;%7[?<8 P ,
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MQOI(72WNGB\U89"I"N4R-P!P=N1G&,T[38;JWTVTBO;E;R\CB19[A(_+660
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M=8_Z]G_E6AH?_('LO^N2_P J!=2#1?\ C\UK_K]_]HQ5JUE:+_Q^:U_U^_\
MM&*M6@84444 %<#9^!M1@^-M_P"+7:$Z9/HZV"*)W,GF"0-_J]NT# /S;O08
M')/?4E '._$B-Y?A[XF2/=O;3;D#8P4_ZINA(XK<L?\ CRM_^N:_R%<#H_P7
MM-+FU)YO$.NZ@MY;K;".ZO#(L2>64; ;.68'EFR> >O-=A'HUQ%&J+K-\%4
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MN?3N:F5"4/BT#F.^HHHKF+"N;\:_ZO1_^PA'_P"@O725S?C7_5Z/_P!A"/\
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M:=W%*]@YA\/@[XI6^GBWM?B1H]@(U$<,::=&Z1J)00%&U<?NQM]!TQ_$/0?
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M_P"N2_RH%U(-%_X_-:_Z_?\ VC%6K65HO_'YK7_7[_[1BK5H&%07W_'C<?\
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M:N02,UGS? ?PJ^DVNGQ17%O';SS3QR*ZLX\T!63YU(V[511QE0BX((S7N?\
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MB:1;:-U1I,#.T%B #]37END_M*Z)JECI[OHVK6U]>7&FPBS:)6\M;TPB&5I
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M""BBB@84444 %%%% !1110!@^//^1-UC_KV?^5:&A_\ ('LO^N2_RK/\>?\
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M^H7)Q],U8JII=@-+L(K47%Q=B//[ZZD\R1LDGEN_7]*MTA1V04444%!1110
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MCS@/LM]Y0VJ-I'E[23G(/&#C<>E^('Q*\.?#31Y+_7]7LM.&W,4=S,$:5LX
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M HHHH **** ,'QY_R)NL?]>S_P JT-#_ .0/9?\ 7)?Y5G^//^1-UC_KV?\
ME6AH?_('LO\ KDO\J!=2#1?^/S6O^OW_ -HQ5JUE:+_Q^:U_U^_^T8JU:!A1
M110 4444 %%%% ' _'31]6U[X8ZO9:,8?M;^6S)-IZWV^-9%9@L32("V!D<D
MC'R@MBK'P^8:%\._".CZI<0Z+K$^G10):_NX9/-6(%UCC+,"5Y./FQCFL#]I
MKPU9>+_A%JNDWEIIU\TQ#V]MJ2(R/(@,F5+LH5E5'?//RHW!Z5/X'^$NE?\
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M-?\ 5Z/_ -A"/_T%Z .CI:2EH *S!_R,K?\ 7H/_ $.M.LP?\C*W_7H/_0Z
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M4GC++ILHY02QD ^6W4R9 VAMA=P$;M?A3\'-#^%&F^78JUWJ4J!+C49LF24
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M_P!?\:.1AS(Z6BN:_P"$HN/^>4?Z_P"-'_"47'_/*/\ 7_&CD8<R.EHKFO\
MA*+C_GE'^O\ C1_PE%Q_SRC_ %_QHY&',CI:*YK_ (2BX_YY1_K_ (T?\)1<
M?\\H_P!?\:.1AS(Z6BBBH*"N;\:_ZO1_^PA'_P"@O725S?C7_5Z/_P!A"/\
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MM+MI=2N[Y?M0L4>4Z='OB=[QHI$C4)RQCV-M()R<C (%>S?VKI__ $$]/_\
M R+_ .*J.>\TFZ55FOM-E565U$EU$P# Y##+=01D&E*E=MJ5B:F73DY2IU9)
MN_5VU\D^AY*WBKQX)M%1+?5'3[2"\LFGA1<6YO"FZ51"?+?R '(W18R" >5#
M7U#Q?JFFV;W<_B""ZAU*TEOH8=+5(X1YSATB(3=-&!L8G#C@$MR0/8/[5T__
M *">G_\ @9%_\51_:NG_ /03T_\ \#(O_BJ/8OK-D_V;4?Q5Y-6[OMZ_UZZG
MGWCS6O%UCXLC@TA+S[+Y5L;2*WL1-!=2-,1.MQ*5/DJL84@[DZGEL;:?\/\
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MOH&Z_&K2W5U:Z;+YL.G(KVLLAF%P@"P/PH2/.8W92_8'CV;^U=/_ .@GI_\
MX&1?_%4?VKI__03T_P#\#(O_ (JE]8CLX(+'F7PW_P"$DU"W\0WVO6EU!J%Y
MI5D#YL#1;IA%*) JX !R1D#U%>9^#_"?C.SO/#<5YI^IBUT6TFBA,L;L)&N;
M"XFDW@CG9(8HN?XN*^F?[5T__H)Z?_X&1?\ Q5']JZ?_ -!/3_\ P,B_^*JX
MXOEYK):_AI;\@L>.6&O>.[.PN(8[74EU&WTU18:<NEJ;-\6*L'>8@%9//W+L
MW=@-F"6'=?"W4->U+0;F77S*\HNF6W>X@:&5HMB??5H8N=Q< [%X Z]3U/\
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MU=/_ .@GI_\ X&1?_%5M=$%FBJW]JZ?_ -!/3_\ P,B_^*H_M73_ /H)Z?\
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MK&;/,TCR[,AQ.SH4+< #Y>]=3XF\"VNH?%?1M3_LIIHFL+J6XN%5MGVA&MQ
M6(XW !\?0UZ!_:NG_P#03T__ ,#(O_BJ/[5T_P#Z">G_ /@9%_\ %4/$:IQ5
MM+ >):'H?BZ;X9W^A7UQK'EKX5M;BW58!%,EUY<RO:AE0,?N194DO\W7#8KL
M?'6G7]QX%\.Q?9+RZLX;BT;5K.U5C/+;!"'7:OS-A]A*CD@$8/2N\_M73_\
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M #Y0_P#? H_L/3_^?*'_ +X%%% !_8>G_P#/E#_WP*/[#T__ )\H?^^!110
M?V'I_P#SY0_]\"C^P]/_ .?*'_O@444 ']AZ?_SY0_\ ? H_L/3_ /GRA_[X
M%%% !_8>G_\ /E#_ -\"C^P]/_Y\H?\ O@444 ']AZ?_ ,^4/_? H_L/3_\
MGRA_[X%%% !_8>G_ //E#_WP*/[#T_\ Y\H?^^!110 ?V'I__/E#_P!\"C^P
M]/\ ^?*'_O@444 ']AZ?_P ^4/\ WP*/[#T__GRA_P"^!110 ?V'I_\ SY0_
M]\"C^P]/_P"?*'_O@444 ']AZ?\ \^4/_? H_L/3_P#GRA_[X%%% !_8>G_\
M^4/_ 'P*/[#T_P#Y\H?^^!110 ?V'I__ #Y0_P#? H_L/3_^?*'_ +X%%% !
M_8>G_P#/E#_WP*/[#T__ )\H?^^!110 ?V'I_P#SY0_]\"C^P]/_ .?*'_O@
;444 ']AZ>O(LX0?]P5<50J@ 8 X %%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>abvx-20241231_g6.jpg
<TEXT>
begin 644 abvx-20241231_g6.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ .5\1?\
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M'U1?S'Y,?\(3XB_Z &J?^ <G_P 31_PA/B+_ * &J?\ @')_\37ZS_VS9?\
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M *!MU_WU%_\ %T?V@_Y?Q#ZHOYC\F/\ A"?$7_0 U3_P#D_^)H_X0GQ%_P!
M#5/_  #D_P#B:_6?[?/_ - VZ_[ZB_\ BZ/M\_\ T#;K_OJ+_P"+H_M!_P O
MXA]47\Q^3'_"$^(O^@!JG_@')_\ $T?\(3XB_P"@!JG_ (!R?_$U^L_V^?\
MZ!MU_P!]1?\ Q='V^?\ Z!MU_P!]1?\ Q=']H/\ E_$/JB_F/R8_X0GQ%_T
M-4_\ Y/_ (FC_A"?$7_0 U3_ , Y/_B:_6?[?/\ ] VZ_P"^HO\ XNC[?/\
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M31_PA/B+_H :I_X!R?\ Q-?K/]OG_P"@;=?]]1?_ !='V^?_ *!MU_WU%_\
M%T?V@_Y?Q#ZHOYC\F/\ A"?$7_0 U3_P#D_^)H_X0GQ%_P! #5/_  #D_P#B
M:_62;5);>%Y7TZZ"(I9CNBZ 9/\ '5]3N4$=Z/[0?\H?4U_,?D9_PA/B+_H
M:I_X!R?_ !-'_"$^(O\ H :I_P" <G_Q-?KI11_:#_E#ZFOYC\B_^$)\1?\
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MD-C/4'![5>JII&DVF@Z39:9I\"VMA90);6\"9VQQHH55&>P  _"K= !1110
M4444 4H?^0Q=?]<(O_0I*NU2A_Y#%U_UPB_]"DJ[0!&W^O3_ '6_F*DJ-O\
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MW$,"M.A=%WN%)*@@G@GN* -6BL+[+XF_Z">D_P#@NE_^/T?9?$W_ $$])_\
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M>WAC<327_P N'B)'$?7"GG!.>U=_7.?\*Y\*_P#0N:7_ . D?^%'_"N?"O\
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M\;1316,"/&PP581J""/7-<Q\:/BU;_!WPK'K$^FW&J&:<6\<4)V@,5)!9L'
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MDN9[BXD$<<:(I9F9CP  ,DU\]77[6WP8U*X^U7GC[PX\^S:8TUB$1GT_BR*
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MJ\CC=2:_,UG%M;['E_[+O[0%MHMOI'@37+/4(YKF7;8WTK&0.TC'"D$ JN>
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M HHHH *CN+>*ZA:*:-98F&&1U!!^H-244 (JA%"J, #  I:** *4/_(8NO\
MKA%_Z%)5VJ4/_(8NO^N$7_H4E7: (F_X^$]=K?S%2U&W^N3_ '6_F*DH ***
M* "BBB@ HHHH **** *6D_\ 'J__ %\3_P#HUZKZYX5T3Q.(1K&CV&K"'/E?
M;K5)O+SC.W<#C.!T]!5C2?\ CU?_ *^)_P#T:]7: ,^Z\/Z7?-;-<Z;9W!M<
M>098$;RL=-F1\OX5'XGTF37/#NHZ=#>76GR7,#1+<V,@CFCR,91B#M/OU';F
MM2L+QEXYT'X?:3'J?B+5(-*LI+B*TCDF)_>32,%CC4#)9B3T ]3T!H ^;/"7
MP-^(MQJ7A*RUV>]M;%?"UMI6I7ZZBLGE#^S)[>>WV[R7D^TR13;\%3L^]D 5
M[KI_AN[\*OX,TL7T-SIUG,857[,5E+BUG^;=O("]0%V\<<\5IZ'\3/#GB2^U
MRSTS4#>7.BDB]CCMY<KAY(R4RO[T;X94S'N&Z-EZ@BF)KUIXHM_!6LZ>[26.
MH3BZ@9T*,8WLYV4E2,@X(X/- &3\:-#\1:]X;@A\->*-/\*WB3>8\^H:7]O6
M90I_=JOF)M.<'=D],8YKP-O OQDG$DI^*FA1!0 %7PB #[#_ $G\:^L=3TJW
MU:W\JX3=C.UNZDCJ*X^3PG:C7+:P29SB/?*67[W)Z>E %;X*Z/XFT70+B'Q/
MXKT_Q3=.ZO&^GZ2+#R%*\HRB63<<]\CTQ7HM5-/TJUTM66UA6(-][!))_.K=
M &;I]K+]NNKBXMHHI"=J2(>67W_2M*BBFW=B2L0W5K%?6LMO.@DAE4HZ'H0>
M"*CTW3;;1[**TM(A#;QC"H,G'.?YU:HHN[6Z!97N%>>_&_X9W?Q5\(0Z/9WU
MOI\B7L5RTMS;"=2J9RN#TZY]\8/!->A45=.<J<E..Z!J^C,[0=!L/#.DV^G:
M;:065I",+#;1"- 3R2%' R23^-:-%%0VV[L94U;_ )!5[_UQ?_T$U9C_ -6O
MT%5M6_Y!5[_UQ?\ ]!-68_\ 5K]!2 =1110 4444 %%%% !1110!2T7_ ) ]
MA_UPC_\ 015VJ6B_\@>P_P"N$?\ Z"*NT 8'B[2=#U;^QEUN2./[/J4-Q8B2
M;R]UTN[RU'(W'[WR]ZY?P+H?P[^'.@^(+S0;ZQBTE)=FHW#ZA]HCM_+4((69
MF.Q47Y0G&,].:TOB)\,[/Q_J'A2_E,<-[X?U6/48)WCWL% (=%Y^4L,#=[8[
MFN+^'7[-=CX1T'6-,U;4FU5+PPQP2VJ-:O#%#"84.0Q)E92VYA@'/04 >@ZN
M+"^NO#&HVBV\ZSWJ2174(5MZ&WEVD,.H(Q^%=,\:R*5=0RGJK#(KG9O UM*E
MDBZAJ,,5D$$$<4^U4VIL!Z=<$_G4W_"*M_T&M6_\"!_\30!'-X>NM2O9UOY]
MUAG=%'&<%3V[>F:WX8E@A2-!A$ 4#V%<U-X3O#J-J8]<U06@23SE-PN2WR[,
M?+_O5:_X15O^@UJW_@0/_B: -ZBL+_A%6_Z#6K?^! _^)JG#X3OO[6NFDUS5
M#8&&(0J+A=PDS)YA/R],>7^1H ZFBL+_ (15O^@UJW_@0/\ XFC_ (15O^@U
MJW_@0/\ XF@#=HKEM/\ "=ZOVG[7KFJ-F=C%MN%XCXV@_+UJY_PBK?\ 0:U;
M_P "!_\ $T ;M%87_"*M_P!!K5O_  ('_P 35/2/"=ZNDV2W^N:H]\(4%PR7
M"X,FT;B,+TSF@#J:*PAX68$'^V=6/_;P/_B:W* ,;PS_ ,>]S_UT'_HM:VJQ
M?#/_ ![W/_70?^BUK:H *K:C9Q:EI]S:3$B&>)HG*G!"L"#C\ZLUB>-?#<7C
M#PEJ^B3EQ%?6SP'RYGA)R.A9"& /0XZC(Z&@#C?"'P+\+^$?$FD:MIUW>RS:
M;I\5M;VTMPC1'9;I:K<$!03(88T3(.W'.W)S6OXTT3PYKO@G6[A+#2]06&UO
M"DJPQRA)2',F#@X;?DGONSGFO*_ 7[-NM>'_ !=X?O\ 4[ZS-E9:);V%Q<Z?
M=3PWC,EA#:M;(ZJK+#OB:8,'!W-]T=:]-T'X1VWAWPI=>'[/7=3CL[I[AYG$
M5HKOYQ.1Q % 4':N!P !T P =GJA5=-NM\C0IY39D49*\=17.Z>L3>#9EA23
M45!(\IP5.<C@ 'MUXK1/A^]92K>(]38$8(,5KS_Y!JA?>'M4L[:W33]>U%?]
M(C#JL-H (RXWG_4^F: +'AVXU#S4@DT];.Q6+*=<@_B><\UT58O]@WW_ $,F
MI_\ ?NU_^,4?V#??]#)J?_?NU_\ C% &U17*PZ-K;>(+V*3Q!J0TU;6!H9/*
MM,F4O-Y@_P!3V41?G6A_8-]_T,FI_P#?NU_^,4 ;5%8O]@WW_0R:G_W[M?\
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ME$5RWW<&/Q9XJ^)MI<ZH([2WTJ!O#\%S;K#ILET;.[:X1)E=XQ+YI"%R%1"
M "0PR:Z+X*^-M>\63:G:Z]8R6DUG9Z=/Y=PBK-;S36P:6"3:J@NI4/\ =7B8
M# QB@#B_B%^T=J_AKQ-XVTO2#X=O(_#Z6I>6[N#$;>21DW1.&D7S'\MF8!=J
MAFB0L2Q"]%X^_:+C\!S:/"?#&HZH]_I\-\6C:. Q>:LA5&5VR#^Z;(R<>]9D
M?QD\8KX@G@MO!XUNR;6[BPN)8BZ/9Q)?PVD8P(V#DI(;DEF7" ]N0GB3XB?$
MB'4O"5L_AZ71=0OM2,<UJMH+VU:U4QEGFN(V?R20SJBC!+D,2$1L@'1_#_\
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M_P"@FK,?^K7Z"JVK?\@J]_ZXO_Z":LQ_ZM?H* '4444 %%%% !1110 4444
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M_P#/K:_^!+?_ !N@"T88VF64HIE52H? W $@D9]#@?D*%ACCD=UC57D(+L
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MN+_^@FK,?^K7Z"J%QI]W<021/>C9(I0XA&<$8]:T%7:H'H,4 +1110 4444
M%%%% !1110!QLFI70D<"XD R?XJ;_:EW_P _,G_?1J";_6O_ +QIE=5D9'.^
M-/B]!X%G2*^&I7!-K)>NUH@<10QNBN[98< R+P,GT%<MXH_:"N=,TZ]GL(;A
M+FTMKYY;2_4JZRV[0 J2C$8(G!X)SD=.173ZIH/ASQGJ&H6]Y$M[=VULVGW*
M"5T*13>7(4.TC[VR,Y'(QU&367XH\'^"K-9)]9M G]IS2VQ_>S$S27'EEU 5
MLY;R$/ X"$C'-=M/V*Y5*+;%J1^!_C5/K*ZH^MZC96%I;7<=E;ZAYDEM%<3L
MI+0A9PK>8N.1WSQT-,;XN^))-%\2WCV]IH[Z/J7V63^TKLE(H/(CEWN4SN<F
M0*$4]6')QSU=OX8TNUU:_P!2BM%6\OC&UR^XE9&0%5;:3M# '&X#) &3P*Q=
M0\">%O%RZC!/;2S?\3-;RY\FZG@/VM(D57RK*>$"=.,@'KS24J/,WRZ:?H&I
MF:9\<[[4/%GA?0GMVL[K4+42ZDDT_P UG,T'FK !P2V.N1P&7N>-*X^.NFP^
M)K_08IKZ[U&T$H,5OL8RR1QB1XT7>&+!3U("D@@$D8J_%\/_  ]#?Z=?#2XG
MO]/_ ./>[E+/,/DV9=V):0[>,N2>_6J.L>#_  O#J4LUZLUO/KDC6C1I>SQQ
MSR/$0V$5PH<QQ'+  X7K1_L\GI%[?C_7]=0U*K?M Z?)IMGJ%K#K-]:7<5U<
M0200CYX;<H)90&8':-_&>3M.!TRV]_:(TJS@GG+:D]LET+*.XQ&D<\OEF0JC
M/(HX3YLM@<@<GBHK[X)^'+N]L3'#+9Z9;QW:MI]K/+$CFX,6_!5QL7$1!0?*
M=YR.N=JX^'/A^XLFM18M;Q&[-\K6MQ+"\<Q3861T8,GR?+A2!@D8YI_[*K:,
M-3.M?V@M&OM0>UM[F^EVV(U 2*%^>(P>>-L>[S&^0]0F-WRYSQ5:/]H2PN+.
MQU-+J:'2Y$NWG9V25U$,:R':8G9<X<<9)SQP:UYOAGX=N+^*\ELYI)88_+C5
MKN8QI^Z\K<$W[0WEDKNQN]\\U#!\)O"L,<B-IC7/F^=YCW5S+,\GFQK&^YG<
MELHBKSTQQBC_ &;LPU(;CX\6]L3!)9:VNI+(\;Z:8D\]-L(F)/[S;@Q\@ANQ
M'7BK/B#XQ1Z'9Z1J9N)Y-*OM/N-2+*I,ABCA67Y1D '!Z']*?8_#/P[8,CQV
M4DDRO(_GW%W-+*Q>+RFW.[EF_=X49)P!QBH[WPEX5U?[/X=N+99FT[33!':>
M=(&CM)E,)&0V2&$97))/RY]ZG]Q=6B[=?Z^X-1\WQ@;_ (17Q/J\%MJ'GZ"D
MC3V-P5CD)$*S+R"0%*.ISU )XR,5CZ;\?'75+VWUBVO=-M8YHHH[K 9$9K%;
MHI)AB=V/,^Z"/E&3R,])?>'=#L]-\0/<VP6SU*)GU++N?-00B(\ Y'[M /EQ
MT]:P;?PWX':>WL ([J>6\5ECFNI9G>XCLPF'W,22+8C*MU!!(R<TX^QL[Q?]
M6_X(:DUK\<X->\#>)=>T:6:2;1[.2Y-O<.O)$)E3)1F&& Z9R,$$ C%4IOC^
M+>ZT]+A+K3D5Y/[16\&'@B6RDN5D0*2"&$?UZ@@&NBL? >BZ?X?O]%C@GDTV
M^B:">*XNYI2T93R]@9W+*NS@!2,=JR--^'_@R:ZO;."S%Y<V<I%RMQ<S3,K2
M6WEA&+L<KY$FT*<@!N #33P^ONNP:DR?'2WD9;86>M?VNTJQII/E+]I8-$90
MX&_;MV*QR6SQC&>*I7'Q]COKC28]$6\U""[N[*WEO&7;#"+@!E4\[M^P@XVX
M&0"<\5?7X3>&4M! MG<AA*)A=?;[C[2K!#&,3^9Y@ 0E=H;&"1BH/^%?^#+7
MQ%IL"6:V^HQ11W-K:PW$J1E;8JB2&-6",4WJNY@3AL=*%]6Z18:AXD^.4/@_
M5M3M=3EN&CMIH((_)*I\TD32?,\CJ@X4XY!)P ":T_&'Q@M/!5GI=Q?37;QZ
MB2(3&Z*.%#<L[JN<'A0=Q[ TFM?#O0M?FO)KNUF\Z\*&>2"[FA9]J% "4<<;
M6((Z'/-0>+O"OAB3PNL>M(UKHFF6S*1'<RP(D 0*4;RV!9=H VG/2I7L&XZ/
MS_X'S#4S+S]H!-'AUZXU*SU"WM=,U%[%94DB_>A8ED+C<Z]CPO)(*X!)($47
MQ\EDU2ZCDM[NWL;:^GMO.(,C3QQV/VHLBJ<AL?PD'(*]R0)H?AWX)\6+=7=O
M;O,LLA\Y8+VXA"LT"HR%%<;-T6P,N!D!=PXK33X7^&X[J2X%C)YCL7(^US;0
MQMS;E@N_ 8Q':2!DX!Z@$7_LRT<7?^O,-3&_X:$%_!I4VEVUY<V]]]K#3F:)
MU@,,(DR?+D8-G(Z-D8/?BM71?C0NK6S2)#JEQ'!;++<WEO#FWCD^SK.8L[MP
M;8Z]1C) W9XJCH?@/P3K%J\NFJU\D-Y-YETE_/([3&,0RJ\A?<XV *021Q5R
M7X1^%)O-#Z8QBEM_LSP?:IO*9?)$.XIOV[_+ 3?C=@=:4OJ^W*U_7J&IS6K?
MM)2O9O=:-&\T<5K>R2K=2J2LL#6V%#1NRD%;G.0QZ#WKNM#^*5OX@U@Z7:S7
M@O8Q<&:.0 >1Y,WE$/SP6;E<9R 365_PJ/PJ8YTDTZ6?[0)1*\][/([^:(A)
MEF<G)$$7?^'CJ<IX#\.V%OJ7B#Q+:WL.HSZ[<AGG@A\I%2(&-8P"2200V6[D
MDX%$OJ[A[B::#4Q]+_: N+[1X7N(+FRU"26+;YBYAEC:^6U+(0V[@L/O <G(
MR*DUC]H98=-FFTZVU&:7:L]NUP@6*YA^UQ6SNF&SUEX! )QG&",[O_"LO#7E
MVR?V;\MNH6(>?+\H%PMP/XN?WJ*W/ICIQ7(V?PCT3PSJT^H:UJ"W%G=R+9VU
MJ$DB57DNTF1>)&&?-1,! B]<KR:N/U:3ORO?8-3:N/VC-%L9[:"[GO[.YDED
MAF@F\M7MBDOE,7^?YAO/_+/>< G& :V+7XO0W/AW5-=\O4XM+T^62.2>1%'F
M".0QR.@#<JI5LDXX!QFL6\T'P+;^+H+*21;77II6N1%%>31M*TCF4J^U@&#-
M&6$;<?*<#&:ZJV\+Z79Z%<:-%: :9/YPEMV=F#><S-("2<_,7;OQGC%935!)
M6B_^!Y!J<M/^T#8W5O<#2[BZFG@N5@D,B'8@-U%;Y.&S\WF[D]0"3Z5EV?[1
MUU^XN[[2=0M=.-I>74YC99)(5@N5AWGY@"F"2<<Y! !')Z:S^%?A73[>X@MM
M(2&.X6S24++)EA:E3;Y.[/RE5^N/FS50_#_P<MY<:,UJ6N+VSN=]JUU,<V\L
MJM,%^;Y5,FTX7&">,9-:)X;;E;_R#4] _M2[_P"?F3_OHT?VI=_\_,G_ 'T:
MJT5P60SJ/#MQ+<6\IED:0AL L<]JUJQ?"_\ Q[3?[_\ 2MJN>6YHMB-O]<G^
MZW\Q4E1M_KT_W6_F/:I*D9%<L5MY2#@A"0?PKSCQ5XZD\):6M]<?;+I7N(;5
M(;7:9'DED6- -S*/O,.IKT>Z_P"/6;_<;^5>=ZII%IK5O'#>PB>*.:*X122,
M21N'1N#V90?PK>CRW][8B1P\G[00NK!Y+>UU.QF!C*&^CC97'VQ+64 )+U5V
M(Y('<;AUR/!_Q]US6O$B6M_-:QV %]-=,L$\!L[>!W03&60^7*I* '9]TMST
M-=NWPY\.-&J'3$*+NP/,?O<"Y/?_ )[ /^&.G%3VO@G1+.337@L$B?3I9IK5
MU=MT;3%C+SGD,6)(.1TXX%>ASX=1:4?Z_K^NA&IF-\4]7OO%NGZ?I*V][I-_
MIEU>VE_]KRMS)$8@ "N=J9EP6()/.!QSQVL?M%:SX?\ !NHWUPUC>:FMU)!I
M\MO*Z6EVD<:--(NYLE8V9H\@_.P7&,\=CX@U+PE=-+<ZK,BR6]I=VS%_,CD6
M!I(XI\*,':7$8W >A![U):_"SPK:Z%+HZ:3')ILB[3!/+)+M& ,(78E!@#A2
M.E.+HQLYP_K^K!J.\9?&O3O!-W86]Y=7,[7D1N%:WDCVK"&5=_S.N[EQA4W,
M0"0.*J77QXMK6?7(&M-::?1I88+N-8TRLDTRQ0JI,F&W[@XP<;>N#\M7M>T3
MPUK&N:5::A$IU)8))+2.-Y(BT*-'O4[" R!C%\C9!XXXK$\9?#3PFF@ZO=W*
M+I,3!;J_OE9V9XX[A;E]_.6R4/)R0"0N.E3!4/=4HN[_ ,PU)F_:"LXGN$EM
M-9ADLX;FXOU98C]C2!MLF\B3#<E<;-V=PQWQ6D_:4TJ&QMKETU)5FN7MFS+;
MA(F58V^:7SO+.1(N KDDAAC*D#:T/P/X8;3A+9Z9F"\M)(7^U"4R2Q3-OD$@
ME.XECR=_S=JK3?#OPI<*NB2V=Q)B-YRC75R3(C[497DW_.I"J"C,1A1QBFOJ
M][.+#4J:Q\?H;:3Q'9VQNXK[1U+.;CRR'Q(B$K&)1(5.\88A01R">\U]^T!8
M:>EW-/#JRV<0N3!=!$*79MY!',(AOW95C_&%S@XS6A<?#/PS>7-U/-IHF>Y1
ME=6GD**'96;8F[:FYD4G:!G'-4M<\#^#-'LM8UC4K".&T>&62[D:21D1&(>4
MJ@)";BH9M@!8CG-"^KNRY6&I9O?B]/\ \(?KNL11WMC<:3<&TGMKQ5=TD!3L
MDFU@5D4\/W_"I]!^+\>O^(CI$<.IVSLUXD-S<!!%,UM,(I@NURW#,I&Y1D'U
M!%79_".CW-CJ=G+9*]MJ<WVB[CWM^]DPHW'GCA%Z8Z46/A'2-/OH;NVLECN8
M&N7CD#L=K7#B28\G^)E!]L<8K*]'E:MK_P #_/\  -3AIOVA-6L[YFN-%OA8
M0/JPG6&2-YMEF\0,@S(%QAWW \Y "YZGIM"^-VG>(O%<F@6=Q=M<+O59BR;'
M9%5F7:'WK@-U90IPP!.*F;X<^'))KR4Z<&:\%R)LS2$,+@+Y^!NPN_8N<8Y&
M>I-6-,\$Z)HVK/J5E9_9[J0%25F?9DA06$9;:&(106 R<<FM)2P[6D=0U.?U
M3]H:RT?[29[;5E2*^GL(W9X$6>2$OYQ0O*.%V?Q8+%U"@G($FJ?'9X]%US4=
M*T[5=4MM,M9)C>+L2W,BP+-Y9)?>ORNN3LQU R>*U[[X?^']0M?L\UCB/[5+
M>!HIY(G$LI;S&#JP8;MS9 ."#C&*SM4\%>#8];B6]L(A?:NDMHD)>39-^X*R
M80':&,*E2^ VT8S0OJ_\K_K_ ( :F;K_ .T&VDV]_:K;W<.LPZ5-?1QW$L+1
MB6.U\_RW"2EQQQG !P<,:O>-?C#JGA5;%4M9YQ<Z/>ZF]TK*R0F")7QL+J6&
M6&<$=1CJ2M@?"7PIND)TQG\R-XG$EW,P(>'R'."^-S1X4MU. 2<@&JWB7_A"
M=7M8VUAD*6=O/ J.TT;K"["VE!488HS87)!!P".F:I>P;CRP;[_U<-1/^&@+
M*.\U:SDCU(W&F6K7,JKY>^4*JD^7'YGF$?,,,5"\'YN]/A^/VFS:.VHAKYH5
MTZ\U,B*2&7]W;,BR+N20J6)D7 SZY(Z5?D^&OAN>[FN9-/+RS1O&=UQ*54,%
M#%%W;48A5RR@$XZUEWGP\\$7-W!H5S9>9=R6]S<B-KF<R31.T:SM))NS("QC
MSO)Y"D=.$OJ[^RPU-/PY\:K'Q1XIN]"LY[L7-N9E\QV0H[1,$D&%<NN&;C>J
MAL$KD"LG2OCY#-J6E:;=F[%YJ-Q-#%,/+AA^6ZE@ &^7+-F+D)N/(.!D"NDT
MOP=H^BZM<:E96OD75QN+D3.4RQ!<JA;:I8J"2H!..<UC:EX,\'Z/)IT]W:BW
M O$2W7SIO+>X>=I4W(&VN?-=F&\$*3QBI7L&[*+#4NZS\8(=%\80>&I%OI-0
MGB$D3"2*-),AB%3S)%9S\F/E! )&2.<8.C_M#"ZT_P +O?V-_;7NN0PR)#'/
M P1I6*QC!E#D,1]X+@!ANVG('4W_ (-T;5-:M]6NK4RWL+(Z,9I!'N3.QC&&
MV,R[CAB"1GBLNS^$_A73I;)[?3&B:S\HP+]JF*KY3F2+*E\-L9FVY!P"0..*
M(O#\NL7?^O,-3G=-_:-G.DQZGJ=E>VL+Z?;WAMHMC,OFSRQ!C*9 @3]V#EMN
M.YYP+C?'J\NM:@M;6UN(["9-+DCO7DCE5OM<[1;<)+P1M.&!895NHV[E\-^'
M_ &NP>1HR%OW0">7<7$4BQ1S.RM&Q8,$$COM9#CJ <# W(/ACX8MI[.:+2UC
M>UCACAVS2!0(I?-C)7=ABKDMN()Y//)K63P\6[P:_KU#4I_\+TC_ .$?.M?8
M-773I#']EFE>WB6[5RP#1L\P ^Z3M<JV"O'-8:?M!:A>:M:&R@DN=*N6MWC5
M0?M+Q26$]U@#=MWYB50,XY/UJQIGA;X=:EKEWH]C K:E;2><T<4]PAB,996$
M3[@%53,P9(S@>801S70VOPXT'2U@?3K".SN;4(;68L[B%DA>&,X+<A4=EP>H
M/XTO]GA>\'Y7_P"'#4I:G\:C<> _$WB#0I)KI=)M!/')/_J97,"S!1ALG"NF
M>F"<54U#X_1Z;.QNTU#3X[1[J.]M[B-6F4Q6Z3#:4D*_,LBXZ]<';BM/PW\-
M])T'P*_A>5%O;"=91=;E\OSC(Q+\*?E'S8 !X  [5!J7@_PQXHN]?M(HHQJW
MSK=R[2YBDGMUCW%7RC9B5!C!''K4KZO=KE=N_P!P:F;J7Q\OK75K>TBT?51)
M#//#?V<IA^T(4M5N 4(F\LC:XSEO4#G%3-^TAHGVJ>))M0E6&T:Z,B&/G%M]
MI*!"^_/E_P 14)N^7=GBI/"'PBTKPW#.UT_]J7<T[S&=@R!=\"P, -Q/*)R2
M2<DGBM)?AAX91I=NF;4DMOLCQK/*(VC\H0\INV[O+ 3?C=@8S3;PU[6?_!#4
MZ/0?%5YKVCVVH&.]L!<+O6"[9?,"Y^4G8S 9&#US@\X.113X(4MH8XHEV1QJ
M$5?0 8 HKB=KZ(9--_K7_P!XUQ/Q*\(WOBN'2?LL-GJ$-I<-+/IFH3/#!<@Q
MLB[F16.49@P!4CCL<&O5]:NM'\/V\=QJ"+%%)((E986DRQ!(&%!(Z'GI698>
M+_!^HQN\>H64.T;BMT?L[[=H8MMDVG;@]<8X(Z@XF%;D?,BN4^?]/^"?B.SU
M:VG?4;.2X5K)FUSSY?MB"&V$4BJFW#"1ASE^@!.3C">'/@7JMC;Z3]NFLYY[
M+48+MA).98V\NWE1I% AC(=Y&C8@DD[ 2Y(Y]]D\:^#X[.[NC=PO;VI DDCA
M=P<EQE,*=ZYCDRRY \M\D;3BQI/B;PMKEXEK8W$,]Q)YA1/*9=P18V9AD#*[
M98V#=&# @D5U?7JEK"Y3YG_X49XK;1;NQECT*>.\FM99XVO)(]OEJXF,3+;?
M(TA*C<0S8SEBV&K;U;X*ZOK,.HK+)IT2S+?O;6XN)62"26UMHH,'8.$DA8YQ
MD?*0,\#Z&76/"[B<KJ.EL+>/S9B+F/\ =H<89N>!R.3QR*K1>*O!TT9D75]*
M5 I?+W*+\@?9OY/*[OE#="2,'FG]?J7N'*>!:E\%]847$=J--O-/:ZEFBTRZ
MNI8X09+6"+SB0C?O$ECE<#'/F$[@U6=,^$>N6?BW2=0N[FRU3['>P7<FK7$T
M@NW1++R&AV;"N/,S)G=_$>,]?<O^$M\&?:)H#K&D"2&)9GW7,8 1F9 <YQ]Y
M2/8XSU%;Z:;92(KI!$RL,AE&01ZU/UZI:P<I\[:U\+]=U#6/$\UO-8PR:FL_
MV?66N)A=Q*\*(MOL4!0BLI.=QX.0H;FLJX^".K:E;W"2IIEA:2"\:#28+F62
MWM7DM4BC*,8QG]XAD/RC:3D GFOI_P#LNT_Y]X_RH_LNT_Y]X_RI+&SCL'*?
M*FK_  EUFQU:QM;>PL]5T^XN9)C:S3RK;H?L"1,TK!#@M,K.#@[C@G!.1+<?
M!;Q9-?Q2MJ=A.\6FO8&]:9UEGW:>UO\ ./*+']\0_P#K,8P=NX9/U-_9=I_S
M[Q_E1_9=I_S[Q_E5_7Y]O(.4^:O^%*ZE:>*M)O+&]2TL+6"W4-#/MDMW3S#+
MM!B8N)&?+?.F<G.>,:'PT^%=_P"&;J^;58=.6"YTBWTR7[%/)(]S(C2^9/)N
M1<-)Y@) )YSR>M?0O]EVG_/O'^5']EVG_/O'^51+&SE%Q8<I\L:;\#?%4<-^
M-0U^WO6N-,N(5'F28^V>2]M!*?EX7R&&[OO&0#UJW'\"[J;7+F6ZM]+EL9;Q
M[QF\QR\I>P\C:R[,?+*"X.XYWDX!&#].?V7:?\^\?Y4?V7:?\^\?Y53Q]1AR
MGS?XN\#ZW>:3X TEK*WUR>RM)+>^-U-(ML\@M0F]Y C'[XW E>2!T/(Q]8^"
M'B>\TFZLAJ&GWS7 AWW%U(PD,D=A';B7F)QGS$9NF[!!#J:^J/[+M/\ GWC_
M "H_LNT_Y]X_RI1QTXVLOZO<.4^9[KX2>)+I=<3[3IZWE_;NJ:V;J?[4H:&-
M!;[0H'EAD;YB6X;(0-DUFWGP-UV73X(T339V6VOX$AN[UMMD\[0F.2$QVZ#Y
M#&S[0J_,W![CZJ_LNT_Y]X_RH_LNT_Y]X_RIK'5%L'*?/GA_X9ZWI7CR+5KB
M\MKB*.YFGDU+SY#=W<3P[$MGC*[0B-A@=Q^Z, $DUSWBCX)^(/$VL^)KF272
MU@U*WNH(\RL-^^2)X&D BSE!&<Y=\$_*%&17U)_9=I_S[Q_E1_9=I_S[Q_E4
MK&SC+F6X<I\LZ[\"=5FDU&+2QI]K83:E-=I!'<&'>LD"HA;,$@5HF#%< GYR
M05(%>@>!? )\-3:[<:@T=_>:C<D_:68R.T'EHH1R0/X@Y(''S>]>S?V7:?\
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M!2^O5+)=@Y3Y>7X"7=G9RQ64NG6YDBF2:%598[I?[06XBADPN?+$*F$^@8@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>abvx-20241231_g7.jpg
<TEXT>
begin 644 abvx-20241231_g7.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MR*%8!E$<: !LC@YR#BC][?38/<MYF'9_"7QK<M>QRZ?>VEU;VBW<=K.D@EN
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MY^?L(_\ ):KK_L#S_P#HR*OT#KY['?QCV,+_  S\<:*_1#_AB'X9?\^^J?\
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M_P#^?N#_ ,!S_P#%T>3?_P#/W!_X#G_XNKM% %+R;_\ Y^X/_ <__%T>3?\
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MKW2B35+93G#0R@X)!ZIWKP_P#MUYOB/X8\+CQ1X=U'P^LNFZ?-J-Y(ULCN9
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M1110 4444 %%%% %*\_X_=/_ .NC?^@-5VJ5Y_Q^Z?\ ]=&_] :KM !1110
M4444 %%%% !1110!0O"RZE;E!N<03;1ZG*>]>'_LRR%O%GQ(\RW6RNGU#SKB
MU_T+?%,\UP\BL;>YF8X=F'SD8((&<$#W*;_D+6G_ %RE_FE?-_P@U#4=,\9?
M'Z[T>VBN=8AN9+BUM7TZ&!9)%DNP@S$3)("R'E@"QSCG<Q /IVLFUO))/%&I
M6I(\F*TMI%&.=S/.#^B+7CVI_%#XHVGBC2+.#P@EQIUS?:?%+,EG.=L4L41G
MR^0(RA:9MY!5?)"'+.#7J.@R:A-XBU*\O[%-/#V=NGE^>)"-KS'.0,8.[]*
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M -%M6?KNE>%+C5F_M*Q@EOI&5F9XR2Y^4#..H^1.#_=%:'CG_D2]>_Z\)_\
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M$Y.$7J=;1117.;%+5O\ CS'_ %UB_P#1BT1?\ABZ_P"N$/\ Z%)1JW_'F/\
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M*** "BBB@ HHHH CN/\ CWD_W3_*I*CN/^/>7_=/\JDH *I7?_'_ &'^\_\
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MZ79Z1I5O!8VD-G!M#>7;QA%R0,G '6J'C:YM)/#^IZ;-J-EI]Q>64ZHUY,$
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M5KJR^TRQRK/)!)&&4-'M.0<9^\#Z"H_L,_\ T$;G_OF+_P"(H NT52^PS_\
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M,)&A$;OY_GAF9R"S%@V2>W6O<?L-Q_T$)_\ OB/_ .)H^PW'_00G_P"^(_\
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M)!-<_:_M :1;Z+8S:M8WECJ=Q;VT_P!C81+YBRQ/()(V:0+L_=2?>8-P!C)
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M;?4+8?O/.$;)(P!_NX0C([FL'X=_#G6?AO-<V<%P-4TR^OO.D>2)8WAC6V1
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M '4TU5KC5'TVYMIKNVN+FWBMML<_E/<%BR! ,L)E&#N/R\LU#C&+<75T_/\
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MEPYWJO*J,9"KR%Z$<8RB_P!Y??\ K?J![#14GD2?\\V_[Y-'D2?\\V_[Y-<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"-!URWB@O=*MI88Y/-5%38-V<\[<9!/4'@]Q6Y10!G2>'-)DNKFY?2[-[BY
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I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>abvx-20241231_g8.jpg
<TEXT>
begin 644 abvx-20241231_g8.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/(XR8@NSEB-Q5^S8<Z/H;:*-HKE?#OBK5=7\.^%[]]!NC+J<$<EZ'"6S61*
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MV/\ U:_04Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&9X.&"KJE!MJU]3MP]5UH<S"BBBO).H**** "BBB@ KSKXW?\@'1/^PS;?\
MLU>BUYU\;O\ D Z)_P!AFV_]FH ]#C_U:_04ZFQ_ZM?H*=0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &7XIUQ?"_AC5]9
M>$W":=9S79A5MI<1H7V@]LXQ7SIX9_;ETO6(;=KWPTT1F?226TG4DU1(X[^2
M1$#>2A83H8SF#;O.1C.:^C_$&BP>)-!U+2+II%M;^VDM96B(#A'0JQ!(.#@G
MM7()\$O#4'A+PKX=MXIK2Q\.W=C>VS6_EI)-+:8\LRD)AL[1NP 3[4 5K?\
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M'(L3['9+R93NC=,' 1>" #M[3]I[X:7UUI<%OXC:9M2%LUO(FGW1BVW$\EO
M7D\K;$'FB>,%RHW #^(9]3KP+X>_LDZ-X=\#V6EZUJ=[>ZJ;;2H[R>UE B9[
M#4);^'9O4M@RS,K%CEE ^Z>:]]H$%%%% !1110 4UNGXC^=.ILC!5R3@#DDT
M .HK,;Q-HZ,5;5K%6'!!N4!_G2?\)3HO_07L/_ E/\: -2BLO_A*=%_Z"]A_
MX$I_C1_PE.B_]!>P_P# E/\ &@#4HK+_ .$IT7_H+V'_ ($I_C1_PE.B_P#0
M7L/_  )3_&@#4K\]O^"FFCW^I>./!;6=C<7:KITP9H8F< ^:.N!7WK_PE.B_
M]!>P_P# E/\ &C_A*=%_Z"]A_P"!*?XUW8+%/!UE62O8QK4_:P<+V/Q%B\.Z
MJUFT$VAWX*[GBDCLVW%B5&&)&2H ; ]3[U+-X9O[6.XBM=(U"Z,C/'YT]@P_
M=AE*,HP2K'#9YZ''<U^VO_"4Z+_T%[#_ ,"4_P :/^$IT7_H+V'_ ($I_C7N
M_P!O.]_9Z;VOI^1Q?4O[WX'YC_L!Z#J=A^TCI,USIUU;Q"RN\R2P,J\Q'')%
M?J967_PE.B_]!>P_\"4_QH_X2G1?^@O8?^!*?XUXV/QCQU7VKC;2QUT:7L8\
MM[FI167_ ,)3HO\ T%[#_P "4_QH_P"$IT7_ *"]A_X$I_C7FG0:E%9?_"4Z
M+_T%[#_P)3_&C_A*=%_Z"]A_X$I_C0!J45E_\)3HO_07L/\ P)3_ !H_X2G1
M?^@O8?\ @2G^- &I7G7QN_Y .B?]AFV_]FKL?^$IT7_H+V'_ ($I_C7!?&+6
MM.U#1M$BM;^UN9?[8MFV0S*[8^;G - 'I\?^K7Z"G4V/_5K]!3J (_M$7_/5
M/^^A1]HB_P">J?\ ?0KR^3_6-]:;75['S'8]2^T1?\]4_P"^A1]HB_YZI_WT
M*\MHH]CYA8]2^T1?\]4_[Z%'VB+_ )ZI_P!]"O+68*I+' '4FCKR.E'L?,+'
MJ7VB+_GJG_?0H^T1?\]4_P"^A7EM%'L?,+'J7VB+_GJG_?0H^T1?\]4_[Z%>
M6T4>Q\PL>I?:(O\ GJG_ 'T*/M$7_/5/^^A7EM%'L?,+'J7VB+_GJG_?0IX.
M<$'(->55V/A#5O/A-E*WSQC,9/=?3\*B5+E5T%CI:***P$)3//C_ .>B_P#?
M0IE]_P >-Q_US;^1KYHKNPV&^L)ZVL<E?$>QMI>Y]->?'_ST7_OH4>?'_P ]
M%_[Z%?,M%=G]G?W_ ,/^"<GU[^[^)]->?'_ST7_OH4>?'_ST7_OH5\RT4?V=
M_?\ P_X(?7O[OXGTUY\?_/1?^^A1Y\?_ #T7_OH5\RT4?V=_?_#_ ((?7O[O
MXGTUY\?_ #T7_OH4>?'_ ,]%_P"^A7S+11_9W]_\/^"'U[^[^)]->?'_ ,]%
M_P"^A1Y\?_/1?^^A7S+11_9W]_\ #_@A]>_N_B?37GQ_\]%_[Z%'GQ_\]%_[
MZ%?,M%']G?W_ ,/^"'U[^[^)]->?'_ST7_OH4>?'_P ]%_[Z%?,M%']G?W_P
M_P""'U[^[^)]->?'_P ]%_[Z%'GQ_P#/1?\ OH5\RT4?V=_?_#_@A]>_N_B?
M37GQ_P#/1?\ OH4>?'_ST7_OH5\RT4?V=_?_  _X(?7O[OXGTUY\?_/1?^^A
M1Y\?_/1?^^A7S+11_9W]_P##_@A]>_N_B?37GQ_\]%_[Z%'GQ_\ /1?^^A7S
M+11_9W]_\/\ @A]>_N_B?37GQ_\ /1?^^A1Y\?\ ST7_ +Z%?,M%']G?W_P_
MX(?7O[OXGTUY\?\ ST7_ +Z%'GQ_\]%_[Z%?,M%']G?W_P /^"'U[^[^)]->
M?'_ST7_OH4>?'_ST7_OH5\RT4?V=_?\ P_X(?7O[OXGTUY\?_/1?^^A1Y\?_
M #T7_OH5\RT4?V=_?_#_ ((?7O[OXGTUY\?_ #T7_OH4>?'_ ,]%_P"^A7S+
M11_9W]_\/^"'U[^[^)]->?'_ ,]%_P"^A1Y\?_/1?^^A7S+2T?V=_?\ P_X(
M?7O[OXGT[3)$62-E<91A@@^E<M\._%/_  D6C".9\WUJ DN>K#LWX]_<5TM]
M_P >5Q_US;^1KR*D'3DXRZ'IPDIQ4D<C-\)?!EQ*\DFC6;.QR6(')IG_  I_
MP3_T!+/\A7.45-BKG1_\*?\ !/\ T!+/\A1_PI_P3_T!+/\ (5Q^M:HFB:/?
MZC)&\L=G;R7#1QC+,$4L0/<XKQ72_P!HG5-+GT-?$FB6]W_PD6F6NIZ7#X=F
M$LB^?<0P)!(9F12=UQ'B3<JG#\#;R6"Y]-?\*?\ !/\ T!+/\A1_PI_P3_T!
M+/\ (5\R1_M5:?/?22OHM[I^A6[PB:^NA&[C-M>33*420E60V;KD;@2&QP5)
MT=0_:DT'28IQ=^'/$,-W:PSW5Y9F.U,EK;Q16\S2N1.5(,=U&P",S<,, C!!
MZGT5_P *?\$_] 2S_(4?\*?\$_\ 0$L_R%?/TG[1&GWWC*+PWIFG7!NDU>'3
MYI[AHFADC=[B,R1-%(W(>W8%7"D9Y&<@1ZQ\:-9T_P 3:H\.FZ>_AO2O$5CX
M:N(Y)G%_+-<_9P)HU V[5-TGRG)94<Y' H ^A?\ A3_@G_H"6?Y"C_A3_@G_
M * EG^0KYJ7]KKPM_9]G</H7B".>]MK>^M;(PVYFGM9HII$F7$Y7&+>4;2P?
M( "G(KLO!_QHTGQIXNET"TT[4[:0+>-#>74<:PW'V6:**<)B0N,-/%C>JY#'
MN"* U/8_^%/^"?\ H"6?Y"C_ (4_X)_Z EG^0KP6/X]6NE_!_1_'&L:;,[7Y
M918Z=)%YA9?-)">;(@;"1,< EN#@=:P8?VK-'L4U2XUC1]0@L$NY(--NK=(F
M2\PMN5BP9 RRDW*?>"I_M<&@#Z8_X4_X)_Z EG^0H_X4_P""?^@)9_D*^>X?
MCXVJZ!X[U?3]*>*#P_X<36H(;\%)7E_TT/%(%)& UH &4D$-D$C!KC_!W[7,
MFM:EJ$>HZ $MM/L($GCLYT$[ZF7C2>WC\YT4JC2@#YMQ((P3Q0&I]:?\*?\
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MT)5U.01V->DZ'JBZM8)+TD'RR+Z-0!YW)_K&^M-J>2TGWM^YDZ_W32?9)_\
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M=S5BX^&OA2[M7MY_#>ERP.LR-&]HA!$K(\HZ?Q-%$Q]3&IZ@5U'V>7_GF_\
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M"1+.URK,+8*@5F968,2V\YXZCBNFHKV#D"BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N$^)'PV3QA&MY9LL.JQKM#,<)*O]T^A'8_Y'=T5YN89?ALTPTL+BH\
MT9?AYKLT=&'Q%3#5%5I.S1R/P]\ P>"M/8LPGU&<#SYAT'^ROL/U_0==116F
M"P5#+\/'"X:/+".R_KJ^K)K5IXBHZE1W;"BBBNXQ"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@/J7C/Q%XFO;74[6UL]>M5MKNWD#;I?)B!M22!QY<X9N.JNP]J /9_(7U?\
M[[;_ !J*Z:WLK>6XN)_(@B4O)++,55%'))). !7B%C\,?B+I^L68D\37C17U
MV@O7M]1FG@M[<*SSE%E*LAD>.!$ +L@>7YN2:Z#3_AAXB_X5_JNBZK?0ZM=S
MR6DD4=WJ-U,A>'RB\GGM^\B:1XRX"AEC8@X?Y@P!Z=:R6U];17%M.+BWE4/'
M+%,61U/0@@X(J;R%]7_[[;_&O$[3X0^-K6UCB76X(^3)MMM1N+58P;B>62';
M!'&CF5945K@H'!!<*6"D1:A\%O&UWI-PJ>,M1@O9+]IDCM]<N8UBM3'*$MQ*
MR/\ ZMY(SO\ +W/Y0SM)X /:I)K2&ZBMGN52YF#-'"TQ#N!U(&<G&1G'K3;R
M\L=/BEDN[R.VCB"M(\UQL"!CA223P"00/I7G6O\ PJUC4OB-8>([;6%B\JSM
MK9KJ0AI86B6Z#,D)0QN7^TK\S8*;&QG>13/%GPMU:;4M8U+1$TFXU#4[;3X)
MKC40(Y \!NA+<*1%(HE,<ZHA*$+@\$ *0#U#R4]7_P"^V_QI8,^7R<X9AS]3
M530=-CT70].T^&!;6*TMHX$@CD:18U50H4.P!8 #&2 3C-6X/N'_ 'F_]"-
M$E%%% !15'6M6CT/2KF_FCDEBMTWLD6-Q'MD@?F0*=I>IQ:IID%]&#'#,GF
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M!65(0CX0!45A;H>  26Q@'@ W+KXL>%+7;C6[*X_?1P2"WN8Y#$[RQQ . W
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M\,\^*_\ IQ_[_G_XFCVU#N@NC$\*76K>(KBXBD\1:E;NJ#R42=V::0G"H,N
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MR ,XP/>O-/\ A,M?_P"@YJ7_ (%R?XUZ=/ SG%2;M<KE/M"BOB__ (3+7_\
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MQK)(T0CC+@AY-_RL?+? P>W//$'BNXUGP_O:W\4ZM>1QWD]C(99'B(DBVY(
MD;*G<.<@^U/ZEKR\VOH'*?5U%?%__"9:_P#]!S4O_ N3_&C_ (3+7_\ H.:E
M_P"!<G^-:?V=+^8.4^T**^+_ /A,M?\ ^@YJ7_@7)_C1_P )EK__ $'-2_\
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M[9/_ ,]Y/^^S1]LG_P">\G_?9KTK_AG_ %O_ *"&G_\ ?3__ !-'_#/^M_\
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MSG.3$I.3S1;?!SP19V]O%#IVPVR".";[?.9H4'E +'+YF] !#& %(  (& S
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M_?0H DHJ/[1%_P ]4_[Z%'VB+_GJG_?0H DJ.#[A_P!YO_0C1]HB_P">J?\
M?0I+<YCR.068C\S0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444UFVT .HIJMNIU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>=_%5O$T>H:#
M)X?_ +0DC1I#-;V2HJS/NBV!Y#G9\OFXW(T9!;<5(0UZ)7(_$K6M:T72[ Z%
M!)/>7-X(&$5NLS!?*D;(5G1?O*HR6 P3WQ0!P.F^*/BU:V6B1W.EVE[-)<6E
MO=O)8,C!!':_:9"5F(W;I+HK\JIB#KDJKY>B:E\7X9;2_OK5KC9!8PS0R6^
M"T$YNY_+64;V5UBQ&.#P%QN)K<;5/BU;_:+A]*M9+B4$QPP!6CC=9+H1Q?-,
M/D8+;%I/O8DZ<?)L:IJGQ(L]!\)O:Z=:7VHW.'U@85/LS'81&J[B"H!D!8'/
MR*>] '*Z]XN^+=S=21:?HJI91PL_F_8#'+(_V<;$*^<P4/*^<JY*!,-C!SO6
M?BCXFW6K0QMHME#8KM>X:2T8,&^T1)) A\_Y@L3R.)L8;;]P8P<>/QA\6WDG
MM?["@.JPV@G6 V\8@;=YX3=)Y_#8CB)0$C>SKN";9#HV/B;XHP:IFZ\/"YTQ
M<$,BQ),T8O$7)7S<;S;%W/S###&T8&X M>(_$GQ+37[NTT;2+(V:M<;9[BT=
MUC5(2\&&$Z^:97&TX"^7P#G()]1MV>2"-I$\N1E!9?0XY%>2Z+K7Q9:^\.-J
M.CV*VUTZ_P!HHFP&U&8@PXD.?E,S @]5 YQA_7J "BBB@ HHHH **** "BBB
M@ HHHH **** "J=Y<+%* 3CC-7*Y7Q1??9M01,X_= _J: -ZSG621@#GC-7*
MY?PK??:KZ5<YQ'G]1744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >9Z@?B!:^/+D644
MMSH$VHPNC.UL8X[?99I(O+"0 #[:W )WA/X<@X^I+\4+769UTZVFN=.&J2R%
MYYK?<MJQFV_9_P!X-Y"LN%F  ?R^-H8CV2N"\:)XIDU9O[)L[N:TDFL(U>WN
MXX_*5+D2W$A5G7*O'^[XRV5QMVL30!Q,VH?%_2;?7KTV/F$#[19(_D2IM6V4
M,)D5RRME 52'(,K29^0J:?H.N_$W5XXK^WLKO[#*+A8Y)XK;SF9+N1(#+$TR
MIL:#YRT1!8["#MR*J0^&?BZ;E1=7>;4QS7]S%;:ADS>;);,]A$Y*&)U\NX"2
MX*HLP4,OWU]E\*1ZA%X=L4U5=NH!/WRE]^#D_P 63GC'<T 4_A_/KUQX3LW\
M36QM-9W2K-&TD<AVB1@C$Q@+DH%. .,XKHJ** "BBB@ HHHH **** "BBB@
MHHHH **** *^H7G]GV<EP899Q&,E(0"V/8$BO*/%?B^VUK4DGM1(D:Q!")0
M<Y)[$^M>OUY?\1_ K0B75M-CRGWKB!!T]74>GJ/QH I>$_&%MHM]++="1T:/
M8!$ 3G(/<CTKU:SN?MEK'-Y4D&\;O+F ##Z@$XKSSX<^!2JQ:MJ4>&/S6\#C
MIZ.P]?0?C7I5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#483-:?$WQ9=1+(\1DAU"!U#HY1UR(>JLK*1V*D'D4?5H_SK[F&I]$4E?/\
M_P (7K/_ $47QC_X&P__ !FJ^H>&[_2;&>]OOB=XKLK.W0R37%QJ-O''&H&2
MS,8< #U-'U:/\Z^YAJ?1-%?-&BPQ^)([>32/B_X@U1+B-Y86LM7M9A*B,%=E
M*Q'(5F4$C@%@#UJ_8^&M0U2SAN[/XF^++NUF4/%/!J$#HZGH580X(]Q1]6C_
M #K[F&I]$45\YOH5U'?1V3_%+Q0MY(VQ+=M2MQ(S;2V OE9)V@M]!FK?_"%Z
MS_T47QC_ .!L/_QFCZM'^=?<PU/H&BOG[_A"]9_Z*+XQ_P# V'_XS1_PA>L_
M]%%\8_\ @;#_ /&:/JT?Y_P8:GT#17S]_P (7K/_ $47QC_X&P__ !FC_A"]
M9_Z*+XQ_\#8?_C-'U:/\_P"##4^@:*^?O^$+UG_HHOC'_P #8?\ XS1_PA>L
M_P#11?&/_@;#_P#&:/JT?Y_P8:GT#17S]_PA>L_]%%\8_P#@;#_\9H_X0O6?
M^BB^,?\ P-A_^,T?5H_S_@PU/H&BOG[_ (0O6?\ HHOC'_P-A_\ C-'_  A>
ML_\ 11?&/_@;#_\ &:/JT?Y_P8:GT#17S]_PA>L_]%%\8_\ @;#_ /&:/^$+
MUG_HHOC'_P #8?\ XS1]6C_/^##4^@:*^<=9NO%OPRTVX\2:?XOU;Q!!IR&Y
MO-*UQHI8[B!>9 CJBM&X4$@C(R ",5]#:??1:E8VUW 28;B-94)&#M8 C]#6
M-6BZ:4D[I@6****YP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\D0]S9HHHKSP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY6_:I
MNKKX,7B>*_"UU)97>N2XO[.0+):RR*H E"$95R, E2 <#(SS117J9:N:NHO9
MH3V/GC_AK#Q]_P _%A_X"#_&C_AK#Q]_S\6'_@(/\:**^L]A2_D7W(B[#_AK
M#Q]_S\6'_@(/\:/^&L/'W_/Q8?\ @(/\:**/84OY%]R"[#_AK#Q]_P _%A_X
M"#_&C_AK#Q]_S\6'_@(/\:**/84OY%]R"[#_ (:P\??\_%A_X"#_ !H_X:P\
M??\ /Q8?^ @_QHHH]A2_D7W(+L/^&L/'W_/Q8?\ @(/\:/\ AK#Q]_S\6'_@
M(/\ &BBCV%+^1?<@NP_X:P\??\_%A_X"#_&C_AK#Q]_S\6'_ ("#_&BBCV%+
M^1?<@NP_X:P\??\ /Q8?^ @_QH_X:P\??\_%A_X"#_&BBCV%+^1?<@NP_P"&
ML/'W_/Q8?^ @_P :/^&L/'W_ #\6'_@(/\:**/84OY%]R"[#_AK#Q]_S\6'_
M ("#_&C_ (:P\??\_%A_X"#_ !HHH]A2_D7W(+L/^&L/'W_/Q8?^ @_QH_X:
MP\??\_%A_P" @_QHHH]A2_D7W(+L/^&L/'W_ #\6'_@(/\:/^&L/'W_/Q8?^
M @_QHHH]A2_D7W(+L/\ AK#Q]_S\6'_@(/\ &C_AK#Q]_P _%A_X"#_&BBCV
M%+^1?<@NP_X:P\??\_%A_P" @_QH_P"&L/'W_/Q8?^ @_P :**/84OY%]R"[
M#_AK#Q]_S\6'_@(/\:/^&L/'W_/Q8?\ @(/\:**/84OY%]R"[#_AK#Q]_P _
M%A_X"#_&C_AK#Q]_S\6'_@(/\:**/84OY%]R"[#_ (:P\??\_%A_X"#_ !H_
MX:P\??\ /Q8?^ @_QHHH]A2_D7W(+L].^ ?BS5OVB?%IT/Q?>&31K=1=26-F
MBPI=%2"$E."S)D#*@C/>ON' 7  P***^9S1*-2,8JRL5$6BBBO%*"BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>abvx-20241231_g9.jpg
<TEXT>
begin 644 abvx-20241231_g9.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /QHUKXK>-H]8OU7QAKZJL\@"C4YP -Q_VJ
MI_\ "V/&_P#T.7B#_P &D_\ \76%KG_(;U#_ *^)/_0C5&O>45V/+NSJ_P#A
M;'C?_H<O$'_@TG_^+H_X6QXW_P"AR\0?^#2?_P"+KE**?*NP79U?_"V/&_\
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M=KHF;&M:B/\ M[D_QJO5"X_US5C5C&VQQXK2"L:?_"7Z]_T&]1_\"Y/\:/\
MA+]>_P"@WJ/_ (%R?XUD45S<J['F\S[FO_PE^O?]!O4?_ N3_&C_ (2_7O\
MH-ZC_P"!<G^-9%%'*NP<S[FO_P )?KW_ $&]1_\  N3_ !H_X2_7O^@WJ/\
MX%R?XUJV7@JSO/"[ZR-<B79(L#6XM9&?SF5F6,$#G.T\]*;8_##Q'>:BMD^G
MR6DK0RSJ;CY01&,LN?[W08]2,XJ+P*M(S/\ A+]>_P"@WJ/_ (%R?XT?\)?K
MW_0;U'_P+D_QJ]I?P]UK4+K3%DM)+2VOYXH$N9%RJ^8<*2!R >2/7M7/3PF"
M>2(G)1BN?H<52Y7L+WEJS3_X2_7O^@WJ/_@7)_C1_P )?KW_ $&]1_\  N3_
M !K(HI\J["YGW-?_ (2_7O\ H-ZC_P"!<G^-'_"7Z]_T&]1_\"Y/\:R**.5=
M@YGW.L\)>*];F\5:-')K&H/&U["K*UTY!!D7((S167X._P"1NT/_ *_H/_1B
MT5PXA*Z.N@W9GW'1117F'<%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X?ZY_P AO4/^
MOB3_ -"-4:O:Y_R&]0_Z^)/_ $(U1KWUL>4%%%%,#V/Q%^TUXE\3?%C3?%MY
M/?RZ1I^JVVJ6_AN74I'M8FB*D*N1M7.T_,%XW&K]C^TQ%H_A.;3--\)V]C?S
M1(DMW'<+Y<DB7JW23.GE;G?*A#ND(( VA><^&U]@? ?P3X-\8>$_@_IFI:?8
M0>(YM4NM1@NIX4*ZA#!=J)[2;(^?,1+)NSS&5XW5A-0@EH:1YI/<\RL_VC])
MTKQ1JVK:=X)^RKKD5XFKJ^J&:29KB2.4F(R1&.,*\0(!C<D$ABW&+EG^U3&F
MH1:A>>$S>WMCKDFNZ=(VJ,H@E-O#!$D@\O\ >(JP*3C:6.,;1D$M_"GPLAT&
M*_NIK2ZUM7#RZ='K\J22,)/FC$'V$("1D;?/ ']ZM']K+PUI6B:/X:N$TZWT
MG6I]0U*/[-%I":8XL5>/[.'B4 -LRZ"7^/:V&8 ,9]RZ5A^]:]SC-3^/_P#:
M7A6YM/\ A'TC\176A0^&[C5OM;&)K*-T8;;?;A9"(T!;<1P2%!.:\BHHK=14
M=C-MO<****H05ZK^SC_R/-Y_V#Y/_1D=>55ZK^SC_P CS>?]@^3_ -&1U</B
M1I2^-'TC1117H'K!1110!WVA^"=*UWP]9?99OM&LRE6N%2Z ^S(TXC#&/9\P
MP5)^<'YAQBJ'C;PQI^DI83Z9Y\<5Q<7-JT=S(';=#(%WY"CA@P.,<'-4+7Q-
MK_\ 83VUN\GV&U5$>>*W7?$F_<J-*%W!=_(!.,U#XDU[6-6O(3JQ9)H5WI&8
M%AQO^<OM  RV=V['.<URQC/GNWIJ(Z.3X2W"W#6ZZS8/.MS+9[ )>9D3?LSL
M_N]^F>*RKWP'/8Z-<7KW]J9K:UANYK-0_F(DK*$YV[2<."<'BG?\)%XK$::M
MBX$,EX]TMU]D'EM.Z[&(.W!) QCI[5IZ]XPN[7PN= O-)N[*[EM8('>\PI,<
M;!E(!C#G)7 W,0!D"I_>IK6_]:AJ<%11178,**** "J%Q_KFJ_5"X_US5A5V
M./%? B.BBBN8\L**** .AT7QA-H>CK90VZM(FHP:BDSMP&B# *5QR#N]>U;\
M?Q2M[>X @T4QV,LMU/=0-=EGDDGB,;%7*_* #P,'W)KK]'T'0]4L=$_T6VBU
M.ST&2[E5HUVW<;Q3*&QCET<*<]<-_LURW]A^'EM]/?1A9ZCK32P^79S:@TB2
M,2,JR-!&,'TW_G7+S1D]4=%I16C$L/BU!I=I906NA)"MO+:S,J3@*S0'.<"/
M.6R<DECG\J\^N)OM%Q++C;O8MCTR<U[?;^&[N[\1V4]MH=I$&TR*;4/M.EHT
M\6V5PV+<#:'D"[1@9*C.1R:\<\0A!K^I".S;3T^TR;;-QAH!N.$(]5Z?A5TW
M&[LB9J5M3/HHHK<Q"BBB@#8\'?\ (W:'_P!?T'_HQ:*/!W_(W:'_ -?T'_HQ
M:*X,3NCLH;,^XZ***\L[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _#_7/^0WJ'_7Q)
M_P"A&J-7M<_Y#>H?]?$G_H1JC7OK8\H****8#X89+F:.&&-I99&")&@)9F)P
M  .I)K6UKPQXA\*K:/J^DZGHZR[C;->VTD ?:<-LW 9P>N.E5_#FJ+HGB'2]
M1=&E2SNHKAD4X+!'#8'Y5Z!\3_C)'\0]!O[$VUTLMQXJU#7XY+B4/Y<-PL:K
M#]5\L]..:EMWT'I8@A^ ?B2;1;[46N-/B-II\6HR6LDK^=MDMI;I8\!" _V>
M%I<,0,,HR6.VLC4OAMK<=YXAMYKFWNK_ ,/V45W?6PE=I(T)C5T&5Y:)I55U
MS\I#8R%)KMO$GQ8MK/XG#Q38WUS/I^H:39SR:7:S%8FNX;58TAN4R T:3Q[M
MI!W)CCYLUK_\+>\*:AH.JWMOIL>F:LGAJZTZ=FBC26_N;F.V@(RG,NUDN;@R
MR?-F7;V7.?-,JT3Y_HHHK8@**** "O5?V<?^1YO/^P?)_P"C(Z\JKU7]G'_D
M>;S_ +!\G_HR.KA\2-*7QH^D:***] ]8**** .V\ >*;+PWHNNQWBK<1WC6\
M4EHPYFARXD /8@,"#ZXK>U;QIX:LM>O@L/\ :UL5MUAN/LEO)E4@C3GS4)!R
MIX'%<'H'A>Z\0PW4T,UM;PVQC662YDV*-Y*KVYY%3V/A63^V-7LK\F#^RX9Y
M;GRR"<Q_*%!Z<N5&?0YKDE3IN;DWK_PPCJO[3M;?PD@@\20B[NWA$RL\GF6<
M*RAT2)%7&5/S$Y&,8'OC?$#4+6ZM=#MXK^&_N;6&2.9[8NT7,A96W/\ ,7;)
M+<X!(QCI4UWX%L3:I/IUW+J6+?)BMBLKO,P&Q0%SMS\[%3R!$WJ*Y_6M$73;
M#2;R-G:*^@9BL@^9)$<HZ_3(!'LU*$8<R:8&311178,**** "J%Q_KFJ_5"X
M_P!<U85=CCQ7P(CHHHKF/+"BBB@#0;1]4CL?MQL;Q;,*/])\IQ&%/ ^;&,&K
M^A^#+W7+6.YCE@MH)'E17G9AQ%'YDC8522%&WISEA@=<:S?$%&TLV7D3>7_8
M8TH+O&WS!,)/,QZ8X]:IMKBKX3T-;:\DL[[3;NX5O)8K)LE"$.N"/[K@\^GK
M65Y&EHD<WA'5;?6+:PGN8H;V[NY+1%>5N61_+W$X^Z7RH/JIZ 5SL\<D,TD<
MJLLJL5=6Z@@\@UZ-9^-M&U::*WN;06K_ &R/R;R958P0(\1#%_O;@L<F0.&:
M5CUZ\)KVHKJ^N:C?JGEK=7,DX7T#,6Q^M$7*^J"270HT445J9A1110!L>#O^
M1NT/_K^@_P#1BT4>#O\ D;M#_P"OZ#_T8M%<&)W1V4-F?<=%8'VZ?_GJU'VZ
M?_GJU>6=YOT5@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5
M@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'V
MZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5
M@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'V
MZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5
M@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!OT5@?;I_P#GJU'V
MZ?\ YZM0!OT5@?;I_P#GJU'VZ?\ YZM0!^1.M?";QQ)K%^R^#?$#*T\A#+I<
MY!&X\_<JE_PJ/QU_T)?B'_P53_\ Q%?L']NG_P">K4?;I_\ GJU=WUI]CE]@
MNY^/G_"H_'7_ $)?B'_P53__ !%'_"H_'7_0E^(?_!5/_P#$5^P?VZ?_ )ZM
M1]NG_P">K4_K3[![!=S\?/\ A4?CK_H2_$/_ (*I_P#XBC_A4?CK_H2_$/\
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M%O\ Z^/_ 'A_.B@#H/+3^ZOY4>6G]U?RIU?._P 8/^$YM_V@/A]H6B_$S6M
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M/^>IH WJ*P?M]Q_SU-'V^X_YZF@#>HK!^WW'_/4T?;[C_GJ: -ZBL'[?<?\
M/4T?;[C_ )ZF@";5/!^@ZW8WMEJ.B:;?V=[,MQ=6]U:1R1SR@* [JP(9@$0
MGGY5]!5?6/ ^DZMX3'AU+9=-TZ,1&U2P18OLCQ.LD+Q#&U3&Z(R\$ J.".*=
M]ON/^>IH^WW'_/4T :/]C:?MOU^PVVW4&W7@\E<7+>6L>9./G.Q$3G/RJ!T
MK.T?P%X9\/6UM;Z5X<TG3;>VF:Y@BL[&*)8I60QM(H50%8HS*6')4D=#1]ON
M/^>IH^WW'_/4T 9[?"CPM#I::;IVC66B:=]N@U">TTJUBMH[F6%U>/S JC<
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M;E4L)<@ID%"C8!)4<[H_Q0\46_@F?7-=&GB[T_Q;_9%]:Z>K-#]F>[6U 1V
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MSBZN?,FNKJX5=HFN9Y7FG<+V#2R.0,G (':M^@ HHHH DM_]?'_O#^=%%O\
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M[4;'- '5_P!EV_\ =/YFC^R[?^Z?S-<)I/Q8?7?C _A.RL%?1HM.NYSJY?\
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M2*Z31])AU"Z,SLH\RYN3;V:94$A6>.<NV"5$8P#G@ ]%_LNW_NG\S1_9=O\
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MT?VP_P#SS7\Z -6BLK^V'_YYK^=']L/_ ,\U_.@#5HK*_MA_^>:_G1_;#_\
M/-?SH U:*RO[8?\ YYK^=']L/_SS7\Z -6BLK^V'_P">:_G1_;#_ //-?SH
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M@ _LV+^\_P"8_P */[-B_O/^8_PHHH /[-B_O/\ F/\ "C^S8O[S_F/\***
M#^S8O[S_ )C_  H_LV+^\_YC_"BB@ _LV+^\_P"8_P */[-B_O/^8_PHHH /
M[-B_O/\ F/\ "C^S8O[S_F/\*** #^S8O[S_ )C_  H_LV+^\_YC_"BB@ _L
MV+^\_P"8_P */[-B_O/^8_PHHH /[-B_O/\ F/\ "C^S8O[S_F/\*** #^S8
MO[S_ )C_  H_LV+^\_YC_"BB@ _LV+^\_P"8_P */[-B_O/^8_PHHH /[-B_
MO/\ F/\ "C^S8O[S_F/\*** #^S8O[S_ )C_  H_LV+^\_YC_"BB@ _LV+^\
M_P"8_P */[-B_O/^8_PHHH /[-B_O/\ F/\ "C^S8O[S_F/\*** #^S8O[S_
M )C_  H_LV+^\_YC_"BB@ _LV+^\_P"8_P */[-B_O/^8_PHHH /[-B_O/\
MF/\ "C^S8O[S_F/\*** #^S8O[S_ )C_  H_LV+^\_YC_"BB@ _LV+^\_P"8
M_P */[-B_O/^8_PHHH /[-B_O/\ F/\ "C^S8O[S_F/\*** %CTZ-9%8,V0<
)]1_A1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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MTJ52H=>K&9B>.]]#HUXW=[Z^"[^3_ZUC5":76_6]D9-+5XS,%.E2$>A? 08
4OX#YFV:!&\<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>image_0b.jpg
<TEXT>
begin 644 image_0b.jpg
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M.M)Q%Q-3RYF<>H&T'1% AQO1/P9&GS6B3QK1)W/_OD>$3VSJB6S1HD7UU"V
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MZ>"1MFW9*7J"_UG]7GZS\ET<-/@;TAW3B+-3./[^9;SIV?6LZDX1!16%T%G
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M] $:L]3SX73<_EJUDK05$KA[Q\>-?PGUU4.ZO('SDF<'_![6:W%_L]D)[18
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M:JX4L5\*)%IM3+Q0568RNK]7C"OJ=">NYG*+%BU>X?Q_A+U]M7R:]W\
(245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
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M/=2<0>6['R4?0X@J,,S -7#_[08           " ZX0+
M^!.=                ,(A.                &&*MU6=5Y1$
M       Z7GV6F1X!              ! = (              , D.@$
M         & 0G0               #"(3@               !AB[]W? 0
MP&4>    ___LVZ$-P$ ,!$$#8TONOU@GY,E;"@J<D:Z!XSL#          #\
M+EP               # 370"              # (CH!              !@
M$9T               "PB$X               !8HJKFK+L] @
M    P,1KSC+3(P               (A.                V$0G
M        +*(3      "^/0   /__[-LQ$00Q$ /!#0S @?ESL@GI/G'R"^""
MZZX2 >63         !]4<\[<K;4\ @              0,H%
M    _!.=                T(A.                :$0G
M    -*(3                FMI[Y^Z<XQ$               !2/[D;8W@$
M                T0D               "=Z 0       #@70\   #__^S;
ML0W$,! #P0NN$P7JOP&I-+X3):\&#&,&8 /,-P$     >*%ZY*R[/0(
M         $!JC)&S.:='                2+D               " ?Z(3
M                +J(3                +J(3                +J(3
M                +K76RMG>VR,               "D'CGK;H\
M       @.@$          #[N!P  ___LV[$-P" ,1%$7[(F\"F)ODX8FKI+Z
M/>D6N/Y7 0  \$,\ZFZ,X1$               !$)P               '2B
M$P               )J8<]9=9GH$              " "A<
M  #P)CH!              "@$9T               #0B$X
M  !H1"<                TL=:JN[VW1P            " +PX   #__^S;
ML0W , P#017>?P%Y5R6-&W.!(+@#N #[GP'@E^HU9VLMCP
M " Z 0              ((E.                "*(3
M@N@$              " 4-T]9WMOCP               ##E @
M     &ZB$P               (+H!               @" Z 0
M    ((A./N0!  #__^W;,0$ , R L/DWW?W%0(]$ C\S
M-SP)                V$PG                A.D$              "
M,)T                0IA,               #"= (              $"8
C3@               (@/<"P WX4PYD@     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover page<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Abivax SA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">I0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7-11 boulevard Haussmann<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Paris<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">FR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">63,347,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001956827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Marc de Garidel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7-11 boulevard Haussmann<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Paris<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">FR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1 53 83 09 63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=abvx_AmericanDepositorySharesNASDAQGlobalMarketMember', window );">American Depositary Shares, each representing one ordinary share, nominal value &#8364;0.01 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value &#8364;0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABVX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=abvx_OrdinarySharesNASDAQGlobalMarketMember', window );">Ordinary shares, nominal value &#8364;0.01 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, nominal value &#8364;0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=abvx_AmericanDepositorySharesNASDAQGlobalMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=abvx_AmericanDepositorySharesNASDAQGlobalMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=abvx_OrdinarySharesNASDAQGlobalMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=abvx_OrdinarySharesNASDAQGlobalMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Auditor information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers Audit<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Neuilly-sur-Seine, France<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1347<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">&#8364; 18,419<span></span>
</td>
<td colspan="2" class="nump">&#8364; 18,419<span></span>
</td>
<td colspan="2" class="nump">&#8364; 18,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">6,606<span></span>
</td>
<td colspan="2" class="nump">6,604<span></span>
</td>
<td colspan="2" class="nump">6,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment</a></td>
<td class="nump">2,666<span></span>
</td>
<td colspan="2" class="nump">878<span></span>
</td>
<td colspan="2" class="nump">1,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Other financial assets</a></td>
<td class="nump">5,919<span></span>
</td>
<td colspan="2" class="nump">12,870<span></span>
</td>
<td colspan="2" class="nump">11,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentNonfinancialAssets', window );">Other assets</a></td>
<td class="nump">948<span></span>
</td>
<td colspan="2" class="nump">2,320<span></span>
</td>
<td colspan="2" class="nump">1,037<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">34,558<span></span>
</td>
<td colspan="2" class="nump">41,090<span></span>
</td>
<td colspan="2" class="nump">39,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Other financial assets</a></td>
<td class="nump">7,554<span></span>
</td>
<td colspan="2" class="nump">9,186<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentReceivablesAndCurrentPrepaidExpenses', window );">Other receivables and assets</a></td>
<td class="nump">18,896<span></span>
</td>
<td colspan="2" class="nump">24,845<span></span>
</td>
<td colspan="2" class="nump">9,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">144,221<span></span>
</td>
<td colspan="2" class="nump">251,942<span></span>
</td>
<td colspan="2" class="nump">26,950<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">170,671<span></span>
</td>
<td colspan="2" class="nump">285,972<span></span>
</td>
<td colspan="2" class="nump">36,181<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">205,228<span></span>
</td>
<td colspan="2" class="nump">327,062<span></span>
</td>
<td colspan="2" class="nump">75,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">633<span></span>
</td>
<td colspan="2" class="nump">629<span></span>
</td>
<td colspan="2" class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Premiums related to share capital</a></td>
<td class="nump">478,905<span></span>
</td>
<td colspan="2" class="nump">478,218<span></span>
</td>
<td colspan="2" class="nump">150,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Translation reserves</a></td>
<td class="num">(75)<span></span>
</td>
<td colspan="2" class="nump">112<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod', window );">Retained earnings</a></td>
<td class="num">(262,637)<span></span>
</td>
<td colspan="2" class="num">(135,209)<span></span>
</td>
<td colspan="2" class="num">(82,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarningsProfitLossForReportingPeriod', window );">Net loss for the period</a></td>
<td class="num">(176,242)<span></span>
</td>
<td colspan="2" class="num">(147,740)<span></span>
</td>
<td colspan="2" class="num">(60,740)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">40,584<span></span>
</td>
<td colspan="2" class="nump">196,010<span></span>
</td>
<td colspan="2" class="nump">7,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits', window );">Retirement benefit obligations</a></td>
<td class="nump">756<span></span>
</td>
<td colspan="2" class="nump">629<span></span>
</td>
<td colspan="2" class="nump">610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLongtermProvisions', window );">Provisions</a></td>
<td class="nump">819<span></span>
</td>
<td colspan="2" class="nump">30<span></span>
</td>
<td colspan="2" class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Borrowings</a></td>
<td class="nump">29,056<span></span>
</td>
<td colspan="2" class="nump">2,563<span></span>
</td>
<td colspan="2" class="nump">9,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Convertible loan notes</a></td>
<td class="nump">23,370<span></span>
</td>
<td colspan="2" class="nump">21,643<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative instruments</a></td>
<td class="nump">3,620<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
<td colspan="2" class="nump">566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentRoyaltyCertificates', window );">Royalty certificates</a></td>
<td class="nump">13,023<span></span>
</td>
<td colspan="2" class="nump">12,229<span></span>
</td>
<td colspan="2" class="nump">3,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Other financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">3,262<span></span>
</td>
<td colspan="2" class="nump">3,262<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">70,645<span></span>
</td>
<td colspan="2" class="nump">40,356<span></span>
</td>
<td colspan="2" class="nump">16,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings', window );">Borrowings</a></td>
<td class="nump">22,195<span></span>
</td>
<td colspan="2" class="nump">1,655<span></span>
</td>
<td colspan="2" class="nump">10,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes', window );">Convertible loan notes</a></td>
<td class="nump">21,574<span></span>
</td>
<td colspan="2" class="nump">29,605<span></span>
</td>
<td colspan="2" class="nump">19,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative instruments</a></td>
<td class="nump">1,166<span></span>
</td>
<td colspan="2" class="nump">2,579<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Other financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">3,509<span></span>
</td>
<td colspan="2" class="nump">3,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherShorttermProvisions', window );">Provisions</a></td>
<td class="nump">532<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade payables and other current liabilities</a></td>
<td class="nump">43,824<span></span>
</td>
<td colspan="2" class="nump">47,221<span></span>
</td>
<td colspan="2" class="nump">15,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentTaxAndEmployeeBenefitLiabilities', window );">Tax and employee-related payables</a></td>
<td class="nump">4,709<span></span>
</td>
<td colspan="2" class="nump">6,073<span></span>
</td>
<td colspan="2" class="nump">2,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">52<span></span>
</td>
<td colspan="2" class="nump">133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">93,999<span></span>
</td>
<td colspan="2" class="nump">90,695<span></span>
</td>
<td colspan="2" class="nump">51,464<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</a></td>
<td class="nump">&#8364; 205,228<span></span>
</td>
<td colspan="2" class="nump">&#8364; 327,062<span></span>
</td>
<td colspan="2" class="nump">&#8364; 75,544<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Portion Of Non-Current Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentReceivablesAndCurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CurrentReceivablesAndCurrentPrepaidExpenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentReceivablesAndCurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentTaxAndEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Tax And Employee Benefit Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentTaxAndEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income other than current contract liabilities. [Refer: Deferred income other than contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other borrowings and the current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherLongtermProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherLongtermProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentNonfinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentNonfinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherShorttermProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherShorttermProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment including right-of-use assets whose underlying assets would be presented as property, plant and equipment if they were owned. [Refer: Property, plant and equipment; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2024-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity&#8217;s cumulative undistributed earnings or deficit excluding the profit or loss for the reporting period. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarningsProfitLossForReportingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity&#8217;s undistributed profit or loss for the reporting period. [Refer: Retained earnings; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarningsProfitLossForReportingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (21,643)<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes', window );">Current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">29,605<span></span>
</td>
<td class="nump">19,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,332)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option | Increase (decrease) due to changes in accounting policy</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes', window );">Current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 19,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(20,652)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | Increase (decrease) due to changes in accounting policy</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes', window );">Current convertible loans notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 20,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Portion Of Non-Current Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME (LOSS) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other operating income</a></td>
<td class="nump">&#8364; 12,449<span></span>
</td>
<td class="nump">&#8364; 4,621<span></span>
</td>
<td class="nump">&#8364; 4,583<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAndOperatingIncome', window );">Total operating income</a></td>
<td class="nump">12,449<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
<td class="nump">4,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="num">(5,954)<span></span>
</td>
<td class="num">(6,431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(146,532)<span></span>
</td>
<td class="num">(103,176)<span></span>
</td>
<td class="num">(48,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="num">(32,946)<span></span>
</td>
<td class="num">(22,390)<span></span>
</td>
<td class="num">(7,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Goodwill impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,632)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Total operating expenses</a></td>
<td class="num">(185,433)<span></span>
</td>
<td class="num">(131,997)<span></span>
</td>
<td class="num">(69,419)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(172,984)<span></span>
</td>
<td class="num">(127,376)<span></span>
</td>
<td class="num">(64,836)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">(16,991)<span></span>
</td>
<td class="num">(27,875)<span></span>
</td>
<td class="num">(7,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">13,732<span></span>
</td>
<td class="nump">7,511<span></span>
</td>
<td class="nump">11,118<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial gain (loss)</a></td>
<td class="num">(3,258)<span></span>
</td>
<td class="num">(20,364)<span></span>
</td>
<td class="nump">4,096<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Net loss before tax</a></td>
<td class="num">(176,242)<span></span>
</td>
<td class="num">(147,740)<span></span>
</td>
<td class="num">(60,740)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">&#8364; (176,242)<span></span>
</td>
<td class="num">&#8364; (147,740)<span></span>
</td>
<td class="num">&#8364; (60,740)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss per share (&#8364;/share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of outstanding shares used for computing basic loss per share (in shares)</a></td>
<td class="nump">63,046,350<span></span>
</td>
<td class="nump">43,066,012<span></span>
</td>
<td class="nump">19,092,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of outstanding shares used for computing diluted loss per share (in shares)</a></td>
<td class="nump">63,046,350<span></span>
</td>
<td class="nump">43,066,012<span></span>
</td>
<td class="nump">19,092,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share (in euro per share)</a></td>
<td class="num">&#8364; (2.80)<span></span>
</td>
<td class="num">&#8364; (3.43)<span></span>
</td>
<td class="num">&#8364; (3.18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share (in euro per share)</a></td>
<td class="num">&#8364; (2.80)<span></span>
</td>
<td class="num">&#8364; (3.43)<span></span>
</td>
<td class="num">&#8364; (3.18)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAndOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of the entity's revenue and other operating income. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAndOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Statement of comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">&#8364; (176,242)<span></span>
</td>
<td class="num">&#8364; (147,740)<span></span>
</td>
<td class="num">&#8364; (60,740)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Items that will not be reclassified to profit or loss</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Actuarial gains and losses on retirement benefit obligations</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items that are or may be reclassified subsequently to profit or loss</a></td>
<td class="num">(187)<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Foreign currency translation differences</a></td>
<td class="num">(187)<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="num">(219)<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss) for the period</a></td>
<td class="num">&#8364; (176,461)<span></span>
</td>
<td class="num">&#8364; (147,516)<span></span>
</td>
<td class="num">&#8364; (60,506)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [domain]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th"><div>Kreos share warrants</div></th>
<th class="th"><div>Other equity agreement</div></th>
<th class="th"><div>SHARE CAPITAL</div></th>
<th class="th">
<div>SHARE CAPITAL </div>
<div>Kreos share warrants</div>
</th>
<th class="th">
<div>SHARE CAPITAL </div>
<div>Other equity agreement</div>
</th>
<th class="th"><div>PREMIUMS RELATED TO SHARE CAPITAL</div></th>
<th class="th">
<div>PREMIUMS RELATED TO SHARE CAPITAL </div>
<div>Kreos share warrants</div>
</th>
<th class="th"><div>TRANSLATION RESERVE</div></th>
<th class="th"><div>RETAINED EARNINGS</div></th>
<th class="th"><div>NET LOSS FOR THE YEAR</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">16,764,051<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract', window );"><strong>Reconciliation of number of shares outstanding [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares)</a></td>
<td class="nump">5,530,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares)</a></td>
<td class="nump">19,134<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued at end of period (in shares) at Dec. 31, 2022</a></td>
<td class="nump">22,313,185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">&#8364; 25,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 107,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="num">&#8364; (39,361)<span></span>
</td>
<td class="num">&#8364; (42,452)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">(60,740)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="nump">235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss) for the period</a></td>
<td class="num">(60,506)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="num">(60,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings', window );">Appropriation of prior period net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,452)<span></span>
</td>
<td class="nump">42,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Capital increase from issuance of ordinary shares</a></td>
<td class="nump">46,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ShareIssueRelatedCostCredit', window );">Transaction costs related to capital increase</a></td>
<td class="num">(3,280)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants</a></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Shares based compensation expense</a></td>
<td class="num">(1,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,164)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Transaction on treasury shares</a></td>
<td class="num">(28)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2022</a></td>
<td class="nump">&#8364; 7,189<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(82,770)<span></span>
</td>
<td class="num">(60,740)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract', window );"><strong>Reconciliation of number of shares outstanding [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares)</a></td>
<td class="nump">40,325,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">99,583<span></span>
</td>
<td class="nump">190,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued at end of period (in shares) at Dec. 31, 2023</a></td>
<td class="nump">62,928,818<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">&#8364; (147,740)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,740)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="nump">225<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss) for the period</a></td>
<td class="num">(147,516)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="num">(147,740)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings', window );">Appropriation of prior period net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,740)<span></span>
</td>
<td class="nump">60,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Capital increase from issuance of ordinary shares</a></td>
<td class="nump">353,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ShareIssueRelatedCostCredit', window );">Transaction costs related to capital increase</a></td>
<td class="num">(28,111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,111)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfConvertibleInstruments', window );">Issue of convertible notes</a></td>
<td class="nump">1,030<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="nump">&#8364; 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Shares based compensation expense</a></td>
<td class="nump">8,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Transaction on treasury shares</a></td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2023</a></td>
<td class="nump">&#8364; 196,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">478,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="num">(135,209)<span></span>
</td>
<td class="num">(147,740)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract', window );"><strong>Reconciliation of number of shares outstanding [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares)</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfFreeSharesIssued', window );">Issue of free shares (in shares)</a></td>
<td class="nump">415,019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued at end of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">63,347,837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">&#8364; (176,242)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(176,242)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="num">(219)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss) for the period</a></td>
<td class="num">(176,461)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(176,242)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings', window );">Appropriation of prior period net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,740)<span></span>
</td>
<td class="nump">147,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ShareIssueRelatedCostCredit', window );">Transaction costs related to capital increase</a></td>
<td class="nump">446<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity', window );">Issue of share warrants</a></td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants</a></td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseFromFreeSharesIssued', window );">Issue of free shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Shares based compensation expense</a></td>
<td class="nump">20,224<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Transaction on treasury shares</a></td>
<td class="nump">120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2024</a></td>
<td class="nump">&#8364; 40,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 478,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (75)<span></span>
</td>
<td class="num">&#8364; (262,637)<span></span>
</td>
<td class="num">&#8364; (176,242)<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseFromFreeSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) From Free Shares Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseFromFreeSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Issuance of Warrants, Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfFreeSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Free Shares Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfFreeSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ShareIssueRelatedCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Issue Related Cost (Credit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ShareIssueRelatedCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the appropriation of retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in equity resulting from the issuing of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS<br> &#8364; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (176,242)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (147,740)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (60,740)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments for:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Elimination of amortization of intangibles and depreciation of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">707<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Elimination of Impairment loss of goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,632<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Elimination of retirement benefit obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">109<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Elimination of share-based compensation expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,224<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares', window );">Net gain on sale of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(34)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(108)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AdjustmentsForOtherFinanceCosts', window );">Interest expenses and other financial expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,203<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,028<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AdjustmentsForOtherFinanceIncome', window );">Financial income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11,609)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,953)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(288)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances', window );">Effect of unwinding the discount related to advances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(710)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(355)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFairValueGainsLosses', window );">Increase/(decrease) in derivatives and liabilities fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,416<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,158)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,817)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances', window );">Forgiveness of conditional advances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,140)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">204<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(100)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital', window );">Cash flows used in operating activities before change in working capital requirements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(155,495)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(118,395)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(51,933)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Decrease / (increase) in other receivables and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,591<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14,231)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">312<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase / (decrease) in trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,444)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31,757<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,388)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities', window );">Increase / (decrease) in tax and social security liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,821<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities', window );">Increase / (decrease) in deferred income and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(81)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInWorkingCapital', window );">Changes in working capital requirements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,423<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,265<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,002)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Cash flows used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(154,072)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(97,130)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(53,936)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows provided by (used in) investing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisitions of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(35)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisitions of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(640)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(265)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(288)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals', window );">Repayment / (disbursement) of the advance made to the Nice CHU</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,302<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations', window );">Advances made to CROs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(231)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,620)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,187)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired', window );">Payments for the acquisition of Prosynergia, incl. related costs, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,913)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashPaymentsForDeposits', window );">Increase in Deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(591)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,351)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(142)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromReimbursementsOfDeposits', window );">Decrease in Deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">741<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities', window );">Interest received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Cash flows provided by (used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,095)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,026)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by (used in) financing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">353,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit', window );">Transaction costs related to capital increase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">446<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28,111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,280)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromNonConvertibleLoansNotes', window );">Net proceeds from the issuance of non-convertible bond loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,944<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfBondLoans', window );">Repayments of non-convertible bond loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,635)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,410)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">55,841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible bond loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,188)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfPGE', window );">Repayment of PGE</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,250)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,250)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConditionalAdvances', window );">Repayments of conditional advances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,708)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(110)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(90)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of the lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(458)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(529)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(301)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates', window );">Net proceeds from sale of royalty certificates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,931<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares', window );">Net proceeds from sale of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">434<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,696)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,279)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,015)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">245<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Cash flows provided by (used in) financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">335,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,211<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of movements in exchange rates on cash held</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,382<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,072)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(107,720)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">224,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,751)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the beginning of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">26,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">60,701<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the end of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 144,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">&#8364; 26,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 86.4pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia SARL (or "Prosynergia"<span style="display: inline-block; height: 4.85pt;"></span></span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Forgiveness Of Covid 19 Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Increase (Decrease) In Deferred Income And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Increase (Decrease) In Tax And Social Security Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Net Gain On Sale Of Treasury Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AdjustmentsForOtherFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Other Finance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AdjustmentsForOtherFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AdjustmentsForOtherFinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Other Finance Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AdjustmentsForOtherFinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Unwinding Of Discount Related To Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Advances And Loans Made To (Reimbursed From) Hospitals</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashPaymentsForDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Payments For Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashPaymentsForDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromNonConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Non-Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromNonConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Sale Of Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromSaleOfRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Advances Made to Contract Research Organizations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PaymentsForAdvancesMadeToContractResearchOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Assets Acquisitions, Including Related Costs, Net Of Cash Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Share Issue Related Costs (Credit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromReimbursementsOfDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Reimbursements Of Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromReimbursementsOfDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfBondLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Bond Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfBondLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfPGE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of PGE</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfPGE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFairValueGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFairValueGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) from the entity's operations before changes in working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsForNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsForNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 21<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Group<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate information and statement of IFRS compliance [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">The Group</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">The Group <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 1.1. Information on the Group and its business <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ABIVAX SA (the &#8220;Company&#8221;) is a soci&#233;t&#233; anonyme incorporated under the laws of France on December 4, 2013. Its registered office <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">is located at 7-11 Boulevard Haussmann&#8212;75009 Paris, France. The Company is developing therapeutics that harness the body&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These consolidated financial statements as of and for the year ended December 31, 2024 comprise the Company and ABIVAX LLC <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 189.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(the &#8220;Subsidiary&#8221;), the United States subsidiary of ABIVAX SA, created on March 20, 2023 under the laws of the State of Delaware <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(together referred to as the &#8220;Group<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8221;).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has incurred losses since its inception and had shareholders&#8217; equity of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.67pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.17pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;40,584<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.67pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.17pt; position: var(--position); text-decoration: none; white-space: pre;">thousand as<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.08pt; position: var(--position); text-decoration: none; white-space: pre;"> of December 31, 2024. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group anticipates incurring additional losses until such time, if ever, that it can generate significant revenue from its drug candidates <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which are currently under development. Substantial additional financing will be needed by the Group to fund its operations and to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commercially develop its drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group's future operations are highly dependent on a combination of factors, including: (i)&#160;the success of its research and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">development activities; (ii)&#160;regulatory approval and market acceptance of its proposed future products; (iii)&#160;the timely and successful <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">completion of additional financing and (iv)&#160;the development of competitive therapies by other biotechnology and pharmaceutical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">companies. As a result, the Group is, and expects to continue to be, in the short to mid-term, financed through the issuance of new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">equity or debt instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is focusing its efforts on the following points: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 360.16pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Continuation of the Phase 3 clinical trial program (ABTECT) for obefazimod in moderately to severely active ulcerative <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">colitis (&#8220;UC&#8221;) <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 387.04pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Initiating the Phase 2b clinical trial (ENHANCE-CD) of obefazimod in Crohn&#8217;s disease (&#8220;CD&#8221;). <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 400.48pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Evaluating oral or injectable combination therapy candidates with obefazimod in UC.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 413.92pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Selecting a follow-on candidate for obefazimod. <span style="display: inline-block; height: 8.73pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 1.2. Date of authorization of issuance <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements and related notes (the &#8220;financial statements&#8221;) have been prepared under the responsibility of <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">management of the Group and were approved and authorized for issuance by the Group&#8217;s board of directors on <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.24pt; position: var(--position); text-decoration: none; white-space: pre;">March 20, 2025<span style="display: inline-block; height: 6.93pt;"></span></span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of preparation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate information and statement of IFRS compliance [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of preparation</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Basis of preparation <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 533.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Except for share data and per share amounts, the financial statements are presented in thousands of euros. Amounts are rounded up or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">down the nearest whole number for the calculation of certain financial data and other information contained in these accounts. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accordingly, the total amounts presented in certain tables may not be the exact sum of the preceding figures. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Statement of compliance <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements of the Group as of and for the years ended December 31, 2022, 2023 and 2024 have been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prepared in accordance with both International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Standard Board (&#8220;IASB&#8221;) and IFRS as adopted by the European Union (&#8220;EU&#8221;) regulation n&#176;1606/2002 of July 19, 2002. The term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;IFRS&#8221; refers collectively to International Accounting Standards (&#8220;IAS&#8221;) and IFRS as well as the interpretations issued by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Standing Interpretations Committee (&#8220;SIC&#8221;) and the International Financial Reporting Interpretations Standards Committee (&#8220;IFRS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IC&#8221;), whose application is mandatory for the year ended December 31, 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Preparation of the financial statements <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 209.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements of the Group were prepared on a historical cost basis, with the exception of certain asset and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">liability categories and in accordance with the provisions set out in IFRS such as employee benefits measured using the projected unit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit method, the Heights notes (classified under "Convertible loan notes") measured at fair value and derivative financial instruments <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 243.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured at fair value. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.47pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Going concern <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has incurre<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">d substantial operating losses since inception and expects to continue to incur significant operating losses for the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">foreseeab</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">le future and may never become profitable. For the year ended December 31, 2024, the Group had a net loss <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.08pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176,242 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Since inception, the Group has financed its operations through the issuance of ordinary shares wi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">th gross aggregate proceeds of </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;557.2&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.85pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, of which </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.6pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;130&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of gross proceeds were from offerings of its ordinary shares on Euronext Paris in February 2023 </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.93pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;223.3&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.78pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of gross proceeds were from its </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.5pt; position: var(--position); text-decoration: none; white-space: pre;">offering of ordinary shares in the form of American Depository Shares ("ADS") on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 378.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Nasdaq Global Market as well as ordinary shares in Europe (including France) and countries outside of the United States in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">private placement in October 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, ba</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;">nk borrowings and structured loans<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.15pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> for </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;175.0&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.66pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursements of Research Tax Credits <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Cr&#233;dit d&#8217;Imp&#244;t Recherche (&#8220;CIR&#8221;)) in an aggregate amo<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.85pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">unt of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;35.6&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, subsidies received from Banque Publique </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">d&#8217;Investissement (&#8220;Bpifrance&#8221;) (including </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.17pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;17.1&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of subsidies and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;1.8&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.27pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of conditional advances) and royalty certificates </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">in an amount of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;2.9&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.35pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Based on (a) the Group&#8217;s existing cash and cash equivalents <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.52pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;144.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.2pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2024 and (b) the expected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement of the CIR from 2024 in the second half of 2025 amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.47pt; position: var(--position); text-decoration: none; white-space: pre;">, the Group expects, as of the date of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance of these financial statements, to be able to fund its forecasted cash flow requirements into the fourth quarter of 2025. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">takes into account management's assumptions of higher R&amp;D expenditure in 2024 and into 2025 driven by the progression of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 clinical trials of obefazimod in UC and the initiation of the Phase 2b clinical trials for CD. Under these assumptions and based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on the Group's current clinical and operational plans, the Group would have sufficient funds to finance its operations in the fourth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">quarter of 2025, i.e. through the announcement of its top-line data from the Phase 3 ABTECT-1 and ABTECT-2 induction trials for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">UC in the third quarter of 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The elements referred to above, as well as (c) the Group's expectation to generate operating losses and negative operating cash flows <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the future, and (d) the need for additional fundi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.68pt; position: var(--position); text-decoration: none; white-space: pre;">ng to support its planned operations, result in a material uncertainty that may cast <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">significant doubt (or raise substantial doubt as contemplated by Public Company Accounting Oversight Board standards) regarding its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ability to continue as a going concern for a period of one year after the date that these consolidated financial statements ar<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.8299999999999pt; position: var(--position); text-decoration: none; white-space: pre;">e issued.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.24pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.74pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.84pt; position: var(--position); text-decoration: none; white-space: pre;">he<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.27pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group continues to monitor its spending of 2025 expenses, ensuring strict adherence to the approved budget, which may include <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">projected savings through the gating of non essential spend and to pursue additional cash resources through public or private equity or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">debt financing<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.43pt; position: var(--position); text-decoration: none; white-space: pre;">s, regional out licensing agreements and/or royalty financing<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.92pt; position: var(--position); text-decoration: none; white-space: pre;">. The Group has concluded that substantial doubt exists <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">about the Group&#8217;s ability to continue as a going concern for a period of at least 12 months from the date of issuance of these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consolidated financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary if the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group is unable to continue as a going concern.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Impact of the Ukraine/Russia Hostilities on the Group <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In February 2022, Russia invaded Ukraine. The conflict has already had major implications for the global economy and the rate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inflation, particularly in relation to the supply of energy, raw materials and food products. It has also caused intense volatility on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial markets, something that is still ongoing at the reporting date and has pushed down stock market prices around the world. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Given these developments, the Group has decided not to include Russia and Belarus in its global Phase 3 program for obefazimod in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">UC. However, the global scale of this conflict cannot be predicted at this stage. The Group, therefore, cannot rule out an adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impact of this conflict on its business, including in terms of access to raw materials, logistics, the performance of clinical studies and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in relation to any future financing the Group may seek. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 193.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The long-term safety and efficacy extension of the<span style="display: inline-block; height: 8.25pt;"></span></span><span style="color: #ff0000; font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 237.68pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.16pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2b maintenance trial of obefazimod in moderately to severely active UC is <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s only clinical trial with patients currently enrolled in Ukraine.&#160; The Phase 2b 12-month assessment was carried out in all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Ukrainian patients before the war broke out and these patients are therefore included in the one-year maintenance results that were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reported on April 6, 2022. Ukrainian patients who completed the two-year Phase 2b maintenance trial have been transitioned to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.28pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">long-term safety and efficacy trial that is still on-going. T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.7pt; position: var(--position); text-decoration: none; white-space: pre;">he Group also has a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.02pt; position: var(--position); text-decoration: none; white-space: pre;">few<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362pt; position: var(--position); text-decoration: none; white-space: pre;"> Ukrainian sites active in the western part of Ukraine <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the ABTECT Phase 3 clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.95pt; position: var(--position); text-decoration: none; white-space: pre;"> None of these sites are located in the Crimea Region of Ukraine, the so-called Donetsk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">People&#8217;s Republic, or the so-called Luhansk People&#8217;s Republic. We continue to monitor developments in the region, but any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instability as a result of the war may have material adverse impacts on these clinical sites, which could negatively impact our Phase 3 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Together with its CROs, the Group is making considerable efforts to ensure the follow-up of patients who are unable to come to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">study centers. Monitoring takes place through a remote monitoring system that was established and used successfully during the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 pandemic.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.81pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">New, revised or amended Standards and Interpretations <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group applied the following amendments to IFRS that are effective as of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.14pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.68pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.95pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 403.58pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.02pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants; <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 91.05pt; position: var(--position);">Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures &#8211; Supplier Finance <span style="display: inline-block; height: 6.93pt; width: 5.91pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 441.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Agreements; and<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group assessed the impacts resulting from the application of these issued accounting pronouncements and concluded that impacts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are not material, with the exception of the amendments to IAS 1, issued in 2020 and 2022, which aim at clarifying the requirements on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">determining whether a liability is current or non-current, and require new disclosures for non-current liabilities that are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future covenants. In accordance with these amendments, an entity shall classify a liability as current when it does not have the right at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These amendments can impact liabilities with covenants which breach can render the related liabilities repayable within 12 months. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">However, the Group has no such liabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Under the amendments, a settlement of a liability includes transferring an entity's own equity instruments to the counterparty. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Therefore, if a liability has any conversion options that involve a transfer of the entity's own equity instruments, then these generally </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">affect its classification as current or non-current. As an exception, if these conversion options are recognized as equity under IAS 32, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">then they do not affect the current or non-current classification of the liability.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As disclosed in Notes 15.1, 15.2 and 15.5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.3pt; position: var(--position); text-decoration: none; white-space: pre;"> the Group has co<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nvertible notes (respectively the Kreos / Claret OCABSA, the Heights </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.26pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">convertible notes (as of December 31, 2023 and 2024) and the OCEANE bonds (as of December 31, 2022), as defined below) that are </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">convertible into a potentially variable number of ordinary shares of the Group at any time at the option of the noteholders. Despite the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">fact that the Group has the unconditional right to defer the settlement of such convertible notes into cash beyond twelve months, in </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">application of these amendments, the Group will no longer be considered to have an unconditional right to defer the settlements of the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Heights convertible notes and the OCEANE bonds due to their conversion options that are embedded derivatives not recognized as </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 699.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">equity components. Consequently, the amendments led to the reclassification of these convertible notes as current liabilities on a </span><span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">retrospective basis:</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2022, the carrying value of the OCEANE bonds </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.54pt; position: var(--position); text-decoration: none; white-space: pre;">was<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.08pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,957&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;">, of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.42pt; position: var(--position); text-decoration: none; white-space: pre;">19,332 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.51pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> were </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">classified within non-current financial liabilities in the Grou</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.95pt; position: var(--position); text-decoration: none; white-space: pre;">p&#8217;s annual financial statements for the year ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2022. In application of these amendments, all of the carrying value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,957&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.88pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> is now presented within current </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">financial liabilities.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 145.46pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2023, the carrying value of the Heights convertible notes was </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.77pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;29,605&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, of which </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> were classified within non-current financial liabilities in the Group&#8217;s annual financial statements for the year ended </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.86pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">December 31, 2023. In application of these amendments, all of the carrying value of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.33pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;29,605&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> is now presented </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">within current financial liabilities.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">The classification of the Kreos / Claret OCABSA will not be impacted since they are compound instruments with conversion option </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 209.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and attached OCABSA warrants recognized as an equity component.</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.07pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2024 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group did not elect for early application of the following new standards, amendments and interpretations, which were issued but <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">not mandatory as of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.15pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.69pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates &#8211; Lack of Exchangeability whose application <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">is for annual reporting periods beginning on or after January 1, 2025;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 103.56pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#8211; Amendments to the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Classification and Measurement of Financial Instruments, whose application is for annual reporting periods beginning on <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">or after January 1, 2026 (not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 143.88pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#8211; Contracts Referencing <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 157.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Nature-dependent Electricity, whose application is for annual reporting periods beginning on or after January 1, 2026 <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">(not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 184.2pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 18 Presentation and Disclosure in Financial Statements, whose application is for annual reporting periods <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 197.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">beginning on or after January 1, 2027 (not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 211.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.89pt;">IFRS 19 Subsidiaries without Public Accountability: Disclosures, whose application is for annual reporting periods<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.89pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 222.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 288.94pt;">beginning on or after January 1, 2027 (not yet approved by the UE), and<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 233.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.99pt;">Annual Improvements Volume 11, whose application is for annual reporting periods beginning on or after January 1,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.99pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 244.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 141.84pt;">2026 (not yet approved by the UE).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.58pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These texts have not been early adopted. The expected impacts are not considered significant, except for IFRS 18, for which the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">has not completed its assessment to date.<span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AccountingPrinciplesAbstract', window );"><strong>Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock', window );">Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 140.48pt; position: var(--position); text-decoration: none; white-space: pre;">Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.1. For the year ended December 31, 2022 <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition of Prosynergia SARL &#8211; April 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 365.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On April 1, 2022, the Company acquired <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.26pt; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.59pt; position: var(--position); text-decoration: none; white-space: pre;"> of the share capital of Prosynergia SARL (or &#8220;Prosynergia&#8221;), a Luxembourg biotech <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">company, in order to strengthen its portfolio. The terms of the share purchase acquisition (or the &#8220;Prosynergia SPA&#8221;) entered on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 385.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">November 15, 2021 included an early payment of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;325&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.79pt; position: var(--position); text-decoration: none; white-space: pre;"> made on November 25, 2021 (see Note 10), an additional payment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 395.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,925&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> made on April 1, 2022, and possible earn-out payments for a maximum additional amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 544.5pt; position: var(--position); text-decoration: none; white-space: pre;"> based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on the potential evolution of the Company&#8217;s market capitalization, a listing of the Company&#8217;s shares on Nasdaq or a M&amp;A transaction <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">incurred before March 31, 2023. In addition, the Company granted a loan of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,400&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.03pt; position: var(--position); text-decoration: none; white-space: pre;"> to Prosynergia on December 1, 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which term was at least on December 31, 2025 or at an earlier date in the event of a breach in the Prosynergia SPA (see Note 10, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Other receivables and assets&#8221;). Such prepayment was repayable in cash only in the event the transaction is not completed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 457.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement or out-licensed agreement, it does not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">April 1, 2022, without recognition of goodwill. Also, the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,400&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.65pt; position: var(--position); text-decoration: none; white-space: pre;"> loan granted to Prosynergia in December 2021 was included <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the acquisition cost to be allocated, as it is considered a prepayment for the acquisition of the group of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.89pt; position: var(--position); text-decoration: none; white-space: pre;">assets<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.19pt; position: var(--position); text-decoration: none; white-space: pre;">. Refer to Note 25.6 for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">information related to the claim initiated by the former owner of Prosynergia on December 12, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Merger with Prosynergia &#8211; December 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 551.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On December&#160;12, 2022, the Company completed the merger with Prosynergia under the French legal procedure called &#8220;Transmission <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 561.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Universelle de Patrimoine<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 140.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8221;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.86pt; position: var(--position); text-decoration: none; white-space: pre;"> (universal transfer of assets and liabilities). All of Prosynergia&#8217;s assets and liabilities were transferred to <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Company and Prosynergia was dissolved. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 593.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of ABX196 cash-generating unit <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the first half of 2022, management took into account significant external changes in the hepatocellular carcinoma (HC) treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">landscape. These changes are expected to require a new, lengthy, heavy and risky internal development process (use of a combination <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of compounds). In this context, entering into a licensing partnership to fund the completion of the clinical development of ABX196 is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the option being considered. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">However, due to the lack of progress made in the negotiation of a development partnership, the Company made the decision to freeze <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the development program for ABX196 in the treatment of hepatocellular cancer. This decision led to the full impairment of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 683.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ABX196 goodwill, i.e. an impairment loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13,586&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.27pt; position: var(--position); text-decoration: none; white-space: pre;"> related to Wittycell&#8217;s goodwill and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.11pt; position: var(--position); text-decoration: none; white-space: pre;"> related to licenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.98pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December&#160;31, 2022, the value in use and the fair value less costs to sell of the ABX196 cash-generating unit (&#8220;CGU&#8221;) are <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 549.33pt; position: var(--position); text-decoration: none; white-space: pre;">nil<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.87pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Forfeiture of AGA plans <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September 2021 were subject to vesting conditions including the completion of a M&amp;A transaction on or prior to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">July 31, 2022. As the non-market performance vesting conditions were not satisfied, the Company recognized a reversal of related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">compensation expense of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,026&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and accrual for social taxes of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;205&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.73pt; position: var(--position); text-decoration: none; white-space: pre;"> in the financial statements for the period <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ended December&#160;31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment of the advance made to Nice CHU &#8211; August 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.12pt; position: var(--position); text-decoration: none; white-space: pre;"> advance made to Nice CHU was reimbursed in August 2022 for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,302&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.31pt; position: var(--position); text-decoration: none; white-space: pre;">. The remaining <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;698&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.89pt; position: var(--position); text-decoration: none; white-space: pre;"> was settled by way of compensation with a payable due to the Nice CHU related to the recharge of third-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">party services expenses that had been invoiced to the Nice CHU as part of the miR-AGE project (see Note 10, &#8220;Other receivables and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets&#8221;). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance &#8211; August 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August&#160;16, 2022, the Company announced a transition in the chairmanship of its Board of Directors. Philippe Pouletty, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Company&#8217;s founder and Chairman of the Board of Directors since the Company was created in 2013, informed the Board of Directors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of his decision to resign as Chairman with immediate effect. However, after many years of successfully leading the Board of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Directors, Mr.&#160;Pouletty continued to support the Company&#8217;s development as a member of the Board of Directors. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pending the appointment of a new, permanent independent Chair, Ms.&#160;Corinna zur Bonsen-Thomas, an independent member of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors of the Company, carried out the role of interim Chair.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Company completed <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 137.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;49.2&#160;million<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 191.15pt; position: var(--position); text-decoration: none; white-space: pre;"> cross-over financing with top-tier US and European investors &#8211; September 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On September 2, 2022, the Company announced oversubscribed financing of around <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.11pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;49.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.96pt; position: var(--position); text-decoration: none; white-space: pre;">, led by TCGX with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">participation of Venrock Healthcare Capital Partners, Deep Track Capital, Sofinnova Partners, Invus and Truffle Capital, top-tier <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">investors specializing in the biotechnology sector. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The financing consists of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.22pt; position: var(--position); text-decoration: none; white-space: pre;"> transactions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">a reserved capital increase of a gross amount of approximately <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;46.2&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.34999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> through the issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.32pt; position: var(--position); text-decoration: none; white-space: pre;">5,530,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.32pt; position: var(--position); text-decoration: none; white-space: pre;"> new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">shares with a nominal value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.41000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, representing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.13pt; position: var(--position); text-decoration: none; white-space: pre;">33%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> of its current share capital, at a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.36<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.55pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">an issue of royalty certificates with a subscription price amounting to <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.9&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.72999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">. The royalty certificates give right to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">their holders to royalties equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.66000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> of the future net sales of obefazimod. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(worldwide and for all indications) as from the commercialization of such product. The amount of royalties that may be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">paid under the royalty certificates is capped at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;172&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.79pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The proceeds of the financing were primarily used to fund the advancement of Phase 3 clinical trials for obefazimod in ulcerative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">colitis. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Related transaction costs amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3.3&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.81pt; position: var(--position); text-decoration: none; white-space: pre;"> and were deducted from the share premiums. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates are recorded as financial liabilities at amortized cost (see Note 15.10). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Company announces first U.S. patient enrollment in global Phase 3 program with obefazimod in UC&#160;&#8211;&#160;October 2022 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October&#160;11, 2022, the Company announced that the first patient was enrolled in the United States into its global Phase 3 clinical <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program with product candidate obefazimod for the treatment of moderately to severely active UC. IQVIA, a global premier contract <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">research organization, is responsible for coordinating the Company&#8217;s Phase 3 clinical trial for obefazimod in UC. As of December&#160;31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022, the undiscounted amount of the advance payments made by the Company in relation to the IQVIA agreement is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12,187&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">. They were recorded at inception at their fair value (discounted amount) and subsequently measured at amortized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">cost calculated using the effective interest rate method. As of December&#160;31, 2022, their carrying amount is <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10,471&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.44pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540.44pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">repayment dates of these advances are scheduled between April 2025<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.15pt; position: var(--position); text-decoration: none; white-space: pre;"> and July 2026 (see Note 9).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.2. For the year ended December 31, 2023 <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Company announces successful oversubscribed <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 246.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;130.0&#160;million<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 304.4pt; position: var(--position); text-decoration: none; white-space: pre;"> cross-over financing at market price with top-tier U.S. and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">European Biotech investors &#8211; February 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February&#160;22, 2023, the Company announced the successful pricing of an oversubscribed <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;130.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.82pt; position: var(--position); text-decoration: none; white-space: pre;"> financing with high-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">quality U.S. and European biotech specialist investors, led by TCGX, with participation from existing investors Invus, Deep Track <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Capital, Sofinnova Partners, and Venrock Healthcare Capital Partners, as well as from new investors Great Point Partners, LLC, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deerfield Management Company, Commodore Capital, Samsara BioCapital, Boxer Capital and others, by way of a reserved capital <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;130&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.39pt; position: var(--position); text-decoration: none; white-space: pre;"> through the issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.36pt; position: var(--position); text-decoration: none; white-space: pre;">20,000,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.36pt; position: var(--position); text-decoration: none; white-space: pre;"> newly-issued ordinary shares with a nominal value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 517.81pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">representing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.88pt; position: var(--position); text-decoration: none; white-space: pre;">89.6%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.71pt; position: var(--position); text-decoration: none; white-space: pre;"> of its current share capital, at a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.21pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.50<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.71pt; position: var(--position); text-decoration: none; white-space: pre;"> per share. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Related transaction costs amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.81pt; position: var(--position); text-decoration: none; white-space: pre;"> and were deducted from the share premiums. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance and management &#8211; February-August 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On April&#160;5, 2023, the Company announced the appointment of Marc de Garidel as Chief Executive Officer (&#8220;CEO&#8221;) and Interim <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Board Chair, effective May&#160;5, 2023. Corinna zur Bonsen-Thomas stepped down as acting Chair, a position she held since August <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022, and remains a Board Member. Prof. Hartmut J. Ehrlich, M.D., retired from the CEO position, which he held since the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Company&#8217;s founding in 2013,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.95pt; position: var(--position); text-decoration: none; white-space: pre;"> and will stay on as a strategic advisor until the transition is complete. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February 17, 2023, and April 18, 2023, the Company respectively announced the appointments of Dr. Sheldon Sloan, M.D., M. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bioethics as new Chief Medical Officer and Michael Ferguson as new Chief Commercial Officer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On July 11, 2023, the Group announced the appointments of June Lee, M.D. and Troy Ignelzi as new independent members of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s Board of Directors, replacing Joy Amundson and Jean-Jacques Bertrand. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 23, 2023, the Group announced the appointment of Patrick Malloy as new Senior Vice President Investor Relations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 638.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Creation of Abivax LLC &#8211; March 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On March&#160;20, 2023, Abivax LLC (or the "Subsidiary&#8221;), was incorporated as a<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 347.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.81pt; position: var(--position); text-decoration: none; white-space: pre;">limited liability company<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 450.77pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.27pt; position: var(--position); text-decoration: none; white-space: pre;">under the laws of Delaware. <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of the issuance of the financial statements, the Company has full ownership over the Subsidiary. The Subsidiary hosts the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operations in the United States. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Cashless exercise of the Kreos A&amp;B BSA &#8211; May 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, Kreos Capital V UK Ltd (or &#8220;Kreos&#8221;) opted for the cashless exercise option of the share warrants they held (as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">defined in Note 15.3), implemented through the repurchase by the Group of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.27pt; position: var(--position); text-decoration: none; white-space: pre;">43,070<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.77pt; position: var(--position); text-decoration: none; white-space: pre;"> tranche A share warrants (&#8220;Kreos A BSA&#8221;) and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">43,070<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"> tranche B share warrants (&#8220;Kreos B BSA&#8221;) and the issuance of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.07pt; position: var(--position); text-decoration: none; white-space: pre;">67,887<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.57pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 417pt; position: var(--position); text-decoration: none; white-space: pre;">31,696<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.5pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares, as a result of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the exercise by Kreos of the outstanding Kreos A &amp; B BSA. The accounting treatment of the operation is set forth in Note 15.3.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Free shares compensation plans&#160; &#8211; July-December 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In July, September and December 2023, the Group issued <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.40999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">five<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.94pt; position: var(--position); text-decoration: none; white-space: pre;"> free shares compensation plans (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 417.84pt; position: var(--position); text-decoration: none; white-space: pre;">attributions gratuites d&#8217;actions<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;">, or <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;AGAs&#8221;) to certain of its officers and employees, representing a maximum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.24pt; position: var(--position); text-decoration: none; white-space: pre;">2,601,296<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.24pt; position: var(--position); text-decoration: none; white-space: pre;"> shares in the aggregate. The detailed terms <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and conditions and the accounting treatment of these plans are presented in Note 14.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group secures financing up to <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 177.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;150&#160;million<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 228.37pt; position: var(--position); text-decoration: none; white-space: pre;"> from <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 252.25pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 266.68pt; position: var(--position); text-decoration: none; white-space: pre;"> structured debt financing transactions &#8211; August 2023 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 20, 2023, the Group concurrently signed <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.43pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.41999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> structured debt financing transactions for a total amount of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;150&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.26pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consisting of (i) up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;75&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.9pt; position: var(--position); text-decoration: none; white-space: pre;"> from Kreos Capital and Claret European Growth Capital (the &#8220;Kreos / Claret Financing&#8221;) together <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with the issuance of warrants (&#8220;the Kreos / Claret BSA&#8221;) exercisable to receive ordinary shares of the Company, for an aggregate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercise price of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.62pt; position: var(--position); text-decoration: none; white-space: pre;"> and (ii) up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;75&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;"> from a fund advised by Heights Capital Management, Inc. (the &#8220;Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financing&#8221; and together with the Kreos / Claret Financing, the &#8220;Transaction&#8221;). The detailed structure and characteristics of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction are set forth<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> in Notes 15.1 and 15.2.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The first tranches of the Kreos / Claret Financing and the Heights Financing, for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.6pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;35&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.38pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively, were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 327.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">drawn on August 22, 2023, and August 24, 2023, respectively. In addition, the Group concurrently granted to Kreos and Claret, for no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">additional consideration, warrants exercisable to receive ordinary shares of the Company for an aggregate exercise price of up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.35pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the Transaction, the Group is also repaying in full a total outstanding amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;33&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.87pt; position: var(--position); text-decoration: none; white-space: pre;"> under (i) the pre-existing debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreements with Kreos for a total amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.24pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> and (ii) the pre-existing OCEANE bonds for a total amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.68pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.03pt; position: var(--position); text-decoration: none; white-space: pre;"> by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">way of set-off with the Heights Financing, thereby fully repaying such pre-existing indebtedness. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The net proceeds of the drawdown of the first tranche of the Kreos / Claret Financing and of the Heights Financing which, net of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">refinancing of the existing indebtedness, amount to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;27&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate, are expected to be allocated mainly to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">development of obefazimod for the treatment of adults with moderately to severely active UC and other potential chronic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inflammatory indications, as well for working capital and general corporate purposes of the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On November 2, 2023, the Group granted additional warrants to Kreos and Claret, for an aggregate exercise price of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.5899999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in order to secure the future drawdown of the third tranche of the Kreos / Claret debt financing. The detailed characteristics of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance is set forth in Note 15.1.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 518.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group announces closing of its Initial Public Offering on the Nasdaq Global Market &#8211; October 2023&#160;  <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October 24, 2023, the Group announced the closing of its previously announced initial public offering on the Nasdaq Global <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Market by way of a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.9pt; position: var(--position); text-decoration: none; white-space: pre;">20,325,500<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.9pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares, consisting of a public offering of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.65pt; position: var(--position); text-decoration: none; white-space: pre;">18,699,460<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.65pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the form of American Depositary Shares (&#8220;ADSs&#8221;), each representing the right to receive <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.83pt; position: var(--position); text-decoration: none; white-space: pre;">one<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary share, in the United States <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(the &#8220;U.S. Offering&#8221;), and a concurrent offering of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.51pt; position: var(--position); text-decoration: none; white-space: pre;">1,626,040<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.51pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares in certain jurisdictions outside of the United States to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 586.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certain investors (the &#8220;European Private Placement&#8221;, and together with the U.S. offering, the &#8220;Global Offering&#8221;). The offering price <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 598.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">was set at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.33pt; position: var(--position); text-decoration: none; white-space: pre;">$11.60<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.83pt; position: var(--position); text-decoration: none; white-space: pre;"> per ADS in the U.S. Offering and a corresponding offering price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.9864<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.27pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share in the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Private Placement. All of the ADSs and ordinary shares in the Global Offering were offered by the Group. The ADSs began trading on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Nasdaq Global Market on October 20, 2023. The aggregate gross proceeds were approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.47pt; position: var(--position); text-decoration: none; white-space: pre;">$235.8&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.32pt; position: var(--position); text-decoration: none; white-space: pre;">, equivalent to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 632.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;223.3&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.05pt; position: var(--position); text-decoration: none; white-space: pre;"> based on the exchange rate then in effect, before deduction of underwriting commissions and expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 644.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">payable by the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The net proceeds of the Global Offering were<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.78pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">$212.2&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.63pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> (</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;202.0&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.31pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">), after deducting </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.33pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">$23.6&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> (</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.01pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;21.3&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 528.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">) i</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.46pt; position: var(--position); text-decoration: none; white-space: pre;">n <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction costs. These costs were deducted from the share premiums.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.3. For the year ended December 31, 2024 <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in governance &#8211; February-December 2024 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February 7, 2024, the Group announced the appointment of Ana Sharma as Vice President, Global Head of Quality. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On April 2, 2024, the Group announced the appointment of Camilla Soenderby as Independent Board Member and also a member of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Appointments and Compensation Committee. Ms. Soenderby replaces Sant&#233; Holdings S.R.L., represented by Mr. Paolo Rampulla, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">who will continue to contribute to the work of the Board of Directors as an observer alongside Mr. Maurizio PetitBon from Kreos <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 202.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Capital/Blackrock.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In July<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.489999999999995pt; position: var(--position); text-decoration: none; white-space: pre;"> 2024, the Group announced the appointment<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.17pt; position: var(--position); text-decoration: none; white-space: pre;"> of Sylvie Gr&#233;goire as Independent Board Member, Chairman of the Board and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">also a member of the Audit Committee. Ms. Gr&#233;goire replaces Ms. Brosgart as Director, Mr. de Garidel as Chairman, and Mr. Hong as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">member of the Audit Committee. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On November 13, 2024, the Group announced the appointment of Mark Stenhouse as Board Observer &amp; Advisor to the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On December 23, 2024, the Group announced the resignation of Dr. Philippe Pouletty, representative of Truffle Capital, as director of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group, effective on December 31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.71pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 311.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based compensation plans<span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 168.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 174.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211; February-September 2024 <span style="display: inline-block; height: 8.33pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In February, March, May, July and September 2024, the Group issued <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.85pt; position: var(--position); text-decoration: none; white-space: pre;">seven<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.6pt; position: var(--position); text-decoration: none; white-space: pre;"> free-share compensation plans to certain of its officers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and employees, representing a maximum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.3pt; position: var(--position); text-decoration: none; white-space: pre;">1,946,125<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.3pt; position: var(--position); text-decoration: none; white-space: pre;"> shares in the aggregate, the vesting of which is subject to the following service <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 359.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">condition: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.34pt; position: var(--position); text-decoration: none; white-space: pre;"> of the AGAs vest at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.1pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.09pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.61pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.27pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.6pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.19pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.15pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 517.6700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> period from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 369.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.63pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.55pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.21pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.73pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (with the exception of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.04pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.54pt; position: var(--position); text-decoration: none; white-space: pre;"> 2024-6 AGAs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">whose vesting conditions are set forth in Note 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 399.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In March 2024, the Group granted its independent Board members the right to subscribe up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.27pt; position: var(--position); text-decoration: none; white-space: pre;">77,820<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants (BSA) in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 409.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">aggregate, the vesting of which (if subscribed) is subject to a service condition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.13pt; position: var(--position); text-decoration: none; white-space: pre;">four years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.37pt; position: var(--position); text-decoration: none; white-space: pre;">, by tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.48pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.81pt; position: var(--position); text-decoration: none; white-space: pre;"> each, vested on each <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">anniversary date. All the BSAs have been subscribed.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 443.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Drawdown of Tranches B and C of the Kreos / Claret Financing &#8211; March-June 2024 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 469.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On March 28, 2024 and June 21, 2024, the Group drew down <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.85pt; position: var(--position); text-decoration: none; white-space: pre;"> related to tranche B and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.61pt; position: var(--position); text-decoration: none; white-space: pre;"> related to tranche C of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 480.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">senior secured non-convertible bonds from the Kreos / Claret Financing.<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 325.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.7pt; position: var(--position); text-decoration: none; white-space: pre;">These second and third tranches each consist of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.25pt; position: var(--position); text-decoration: none; white-space: pre;">25,000,000<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.25pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">senior secured non-convertible bonds with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1.00<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.99pt; position: var(--position); text-decoration: none; white-space: pre;"> each, that will not be listed on any market.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The detailed characteristics of these bond loans and their accounting treatments are set forth in Note 15.1.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance RNP-VIR and Carena conditional advances &#8211; June 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance renegotiated the RNP-VIR and CARENA conditional advances:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Between September 2017 and November 2019, the Group had received repayable conditional advances amounting <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 593.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,032&#160;thousands<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> and subsidies amounting to <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,123&#160;thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.15pt; position: var(--position); text-decoration: none; white-space: pre;"> in relation to the RNP-VIR project, which aimed at <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">discovering new molecules for the treatment of viral infectious diseases through the development of the &#8220;Modulation of RNA <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">biogenesis&#8221; platform. In June 2024, the Group and Bpifrance agreed to terminate the project <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.24pt; position: var(--position); text-decoration: none; white-space: pre;">due to technical failure, and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">B<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.66pt; position: var(--position); text-decoration: none; white-space: pre;">pifrance agreed to waive <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.62pt; position: var(--position); text-decoration: none; white-space: pre;">60%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.95pt; position: var(--position); text-decoration: none; white-space: pre;"> of the remaining advance<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.7pt; position: var(--position); text-decoration: none; white-space: pre;">s. <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">See Note 15.7 "Conditional Advances".<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 662.8pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Between December 2013 and June 2016, the Group had received repayable conditional advances amounting <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,187&#160;thousands<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> in relation to the CARENA project, which aimed at developing an anti-HIV-AIDS therapeutic program <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with the compound ABX464 up to the Phase 2b study. In June 2024, the Group and Bpifrance agreed to terminate the project <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">due to technical failure, and Bpifrance agreed to waive <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">60%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.66999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> of the remaining conditional advance. See Note 15.7 <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 84.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">"Conditional Advances".<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 109.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group fully reimbursed the remaining conditional advances for both programs during the last quarter of 2024. The subsidy <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 121.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">income recognized over the period, corresponding to the amounts waived by Bpifrance and related interests, amounts to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,123&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate (see Note 18).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 167.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Establishment of an At-the-Market ("ATM") Program on Nasdaq - November 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On November 19, 2024, the Group announced the implementation of an At-The-Market program (&#8220;ATM Program&#8221;) allowing the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in the form of ADSs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">each ADS representing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">one<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.6pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary share, nominal value <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.41pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, of the Group, with aggregate gross sales proceeds of up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">$150,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.09pt; position: var(--position); text-decoration: none; white-space: pre;"> (subject to French regulatory limits and within the limits of the investors&#8217; requests expressed in the context of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 236.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program), from time to time, pursuant to the terms of an equity distribution agreement with Piper Sandler &amp; Co. (&#8220;Piper Sandler&#8221;), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acting as sales agent. The timing of any issuances in the form of ADSs will depend on a variety of factors. The ATM Program will be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">effective until terminated in accordance with the equity distribution agreement or if ADSs representing the maximum gross sales <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">proceeds have been sold thereunder. To the extent that ADSs are sold pursuant to the ATM Program, the Group currently intends to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">use the net proceeds (after deduction of fees and expenses), if any, of sales of ADSs issued under the ATM Program primarily to fund <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the research and development of the Group's product candidates, for working capital and general corporate purposes, at its discretion.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">A shelf registration statement on Form F-3, including a base prospectus relating to the Group's securities and an equity distribution <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement prospectus relating to the ATM Program, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.43pt; position: var(--position); text-decoration: none; white-space: pre;">was filed with the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.73pt; position: var(--position); text-decoration: none; white-space: pre;"> SEC and went into effect during 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.76pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.76pt; position: var(--position); text-decoration: none; white-space: pre;">The base prospectus <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">provides for the potential sale of ADSs of the Group with aggregate gross sales proceeds of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.75pt; position: var(--position); text-decoration: none; white-space: pre;">$350,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.84pt; position: var(--position); text-decoration: none; white-space: pre;"> (including the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 351.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">$150,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.09pt; position: var(--position); text-decoration: none; white-space: pre;"> covered by the equity distribution agreement prospectus) to grant additional flexibility to the Group in connection <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with its financing strategy. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in one or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">more prospectus supplements to the base prospectus. A<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.9pt; position: var(--position); text-decoration: none; white-space: pre;">s of the date of issuance of these <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.97pt; position: var(--position); text-decoration: none; white-space: pre;">financial<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.9pt; position: var(--position); text-decoration: none; white-space: pre;"> statements, the Group has not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 385.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">utilized the ATM Program<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 3.4. Subsequent events&#160; <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 457.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based compensation plans<span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 168.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.33pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 174.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211; January-February 2025<span style="display: inline-block; height: 8.33pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In January 2025, the Group granted its independent Board members, as well as one of its Board Observers and Advisor, the right to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subscribe up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">125,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.51pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants (BSA) in the aggregate, the vesting of which (if subscribed) is subject to a service condition of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">four years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">, by tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.35pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.68pt; position: var(--position); text-decoration: none; white-space: pre;"> each, vested on January, 1 of each year.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In February 2025,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.91pt; position: var(--position); text-decoration: none; white-space: pre;"> the Group issued <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.64pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.3pt; position: var(--position); text-decoration: none; white-space: pre;"> free-share compensation plans to certain of its officers and employees, representing a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">maximum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.84pt; position: var(--position); text-decoration: none; white-space: pre;">4,490,727<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.84pt; position: var(--position); text-decoration: none; white-space: pre;"> shares in the aggregate, the vesting of which is subject to the following service condition: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.48pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.81pt; position: var(--position); text-decoration: none; white-space: pre;"> of the AGAs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">vest at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.68pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.19pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.85pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.18pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.77pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.73pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.25pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.3399999999999pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 563.67pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.39pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.05pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.57pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (with the exception of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.88pt; position: var(--position); text-decoration: none; white-space: pre;">123,102<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.38pt; position: var(--position); text-decoration: none; white-space: pre;"> 2025-2 AGAs, which vest at the end of a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.86pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.85pt; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting Principles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Significant Events For The Period Reported And Events After Reporting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting principles<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AccountingPrinciplesAbstract', window );"><strong>Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory', window );">Accounting principles</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting principles <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.1. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Following initial recognition, goodwill is stated at cost less any accumulated impairment losses (see Note 4.4). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In respect of business combinations prior to January 1, 2020, in accordance with IFRS 1 exemption, goodwill is included on the basis <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of its deemed cost, which represents the amount recorded under the prior basis of accounting, French GAAP, (&#8220;Previous GAAP&#8221;). <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.2. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 38&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;">, intangible assets acquired are recognized as assets on the statements of financial position at <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their acquisition cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Licenses <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Payments for separately acquired research and development are capitalized within &#8220;Other intangible assets&#8221; provided that they meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the definition of an intangible asset: a resource that is (i)&#160;controlled by the Group, (ii) expected to provide future economic benefits for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group and (iii)&#160;identifiable (i.e., it is either separable or arises from contractual or legal rights). In accordance with paragraph 25 of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IAS 38&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.15pt; position: var(--position); text-decoration: none; white-space: pre;">, the recognition criterion relating to the likelihood of future economic benefits generated by the intangible <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">asset, is presumed to be achieved for research and development activities when they are acquired separately. In this context, amounts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">paid to third parties in the form of initial payments or milestone payments relating to pharmaceutical specialties that have not yet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obtained a marketing authorization are recognized as intangible assets. These rights will be amortized on a straight-line basis, after <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obtaining the marketing authorization, over their useful life. Unamortized rights (before marketing authorization) are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impairment tests in accordance with the method defined in Note 4.4. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development costs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 38 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;">, research costs are expensed in the period during which they are incurred. Development costs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are only recognized as intangible assets if the following criteria are met: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it is technically feasible to complete the development of the project; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it is the Group&#8217;s intention to complete the project and to utilize it; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it has capacity to utilize the intangible asset; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is proof of the probability of future economic benefits associated with the asset <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is availability of the technical, financial and other resources for completing the project; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is a reliable evaluation of the development expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The initial measurement of the asset is the sum of expenses incurred starting on the date on which the development project meets the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">above criteria. Because of the risks and uncertainties related to regulatory authorizations and to the research and development process, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group believes that the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.14pt; position: var(--position); text-decoration: none; white-space: pre;">six<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.8pt; position: var(--position); text-decoration: none; white-space: pre;"> criteria stipulated by IAS 38 have not been fulfilled to date and the application of this principle has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">resulted in all development costs being expensed as incurred in all periods presented. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets mainly consist of acquired software. Costs related to the acquisition of software licenses are recognized as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets based on the costs incurred to acquire and set up the related software. Other intangible assets are amortized using the straight-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 492.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">line method over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.99pt; position: var(--position); text-decoration: none; white-space: pre;">one year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.11pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.3. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 16 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Property, Plant and Equipment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.8pt; position: var(--position); text-decoration: none; white-space: pre;">, property, plant and equipment are recognized at their acquisition cost (purchase <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price and directly attributable costs) or at their production cost by the Group, as applicable. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment are depreciated using the straight-line method over the estimated useful life of the asset. The principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">useful lives applied are as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 100.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 15.75pt; width: 173.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">DEPRECIATION PERIOD<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Buildings<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 30pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 44.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office fixtures and fittings<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 44.25pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;">3 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.21pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.5045pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 44.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 58.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Equipment<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 58.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Industrial materials and equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 72.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 72.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Technical facilities<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 87pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 87pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture and computer equipment:<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 101.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 101.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 115.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 115.5pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 115.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">IT equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 129.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;  &#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;">3 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 129.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 144pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.08pt; position: var(--position); white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.58pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 144pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);">(1)<span style="display: inline-block; height: 6.93pt; width: 12.84pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Office fixtures and fittings estimated useful lives correspond to the Paris headquarters and Boston offices residual estimated <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.45pt; position: var(--position); text-decoration: none; white-space: pre;">lease terms. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The useful lives of property, plant and equipment as well as any residual values are reviewed at each year-end and, in the event of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">significant change, the depreciation schedule is revised prospectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.4. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of goodwill, intangible assets, property and plant and equipment <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill and intangible assets not yet available for use are not amortized and are tested for impairment annually. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the Group assesses at the end of each reporting period whether there is an indication that intangible assets and property, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 393.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">plant and equipment may be impaired. Pursuant to IAS 36&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 278.56pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.93pt; position: var(--position); text-decoration: none; white-space: pre;">, criteria for assessing indication of loss in value may <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">notably include performance levels lower than forecast, a significant change in market data or the regulatory environment, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obsolescence or physical damage of the asset not included in the amortization/depreciation schedule. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the purpose of impairment testing, goodwill and intangible assets not yet available for use are allocated to each of the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGUs expected to benefit from synergies arising from the business combination or from the use of the intangible assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">An impairment loss is recognized when the carrying amount of a CGU, including the goodwill, exceeds the recoverable amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGU. The recoverable amount of a CGU is the higher of the CGU&#8217;s fair value less cost to sell and value-in-use. The total impairment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">loss of a CGU is allocated first to reduce the carrying amount of goodwill allocated to the CGU and then to the other assets of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGU pro-rata on the basis of the carrying amount of each asset in the CGU. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">An impairment loss on goodwill is not reversed in a subsequent period. Impairment losses on intangible assets and property, plant and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">equipment shall be reversed subsequently if the impairment loss no longer exists or has decreased. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.5. Financial assets <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 573.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financial assets at amortized cost <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (advances, loans and deposits granted to third parties and other short-term investments) and other receivables are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">non-derivative financial assets with fixed or determinable payments that are not listed on an active market. They are initially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized at fair value plus transaction costs that are directly attributable to the acquisition or issue of the financial asset. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 9 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Instruments <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.64pt; position: var(--position); text-decoration: none; white-space: pre;">requires an entity to recognize a loss allowance for expected credit losses on a financial asset at <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amortized cost at each statement of financial position date. The amount of the loss allowance for expected credit losses equal to: (i)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">12&#8212;month expected credit losses or (ii)&#160;the full lifetime expected credit losses. The latter applies if credit risk has increased <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">significantly since initial recognition of the financial instrument. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group classifies investments as cash equivalents in the statements of financial position and statements of cash flows when they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">meet the conditions of IAS 7&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 161.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Statement of Cash Flows, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.8pt; position: var(--position); text-decoration: none; white-space: pre;">i.e., when they are: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">held in order to face short-term cash commitments; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">short term and highly liquid assets at acquisition date, readily convertible into known amount of cash and not exposed to <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">any material risk of change in value. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.6. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Share capital <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares are classified in shareholders&#8217; equity. Costs associated with the issuance of new shares are directly accounted for in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; equity in diminution of issuance premium. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s own shares bought in the context of a brokering/liquidity agreement entered with an independent broker are presented as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">a reduction of shareholders&#8217; equity until their cancellation, their reissuance or their disposal. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.7. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Since its inception, the Group has established several plans for compensation settled in equity instruments in the form of founders&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">share subscription warrants (&#8220;bons de souscription de parts de cr&#233;ateur d&#8217;entreprise&#8221; or &#8220;BCE&#8221;), share subscription warrants (&#8220;Bons de <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">souscription d&#8217;actions,&#8221; or &#8220;BSA&#8221;) and free shares (&#8220;Attributions gratuites d&#8217;actions,&#8221; or &#8220;AGA&#8221;), granted to its employees, corporate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">officers and scientific consultants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.78pt; position: var(--position); text-decoration: none; white-space: pre;">these awards are measured at their fair value on the date of grant. The values of the equity <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments are determined using the option pricing model (in particular, a Black and Scholes model for the BCE and BSA plans and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Monte-Carlo simulation for the AGA plans which include market performance vesting conditions) based on the value of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">underlying equity instrument at grant date, the volatility observed in a sample of comparable listed companies and the estimated life of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the related equity instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group recognizes the fair value of these awards as a share-based compensation expense over the period in which the related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">services are received, i.e. over the vesting period, with a corresponding increase in shareholders&#8217; equity. Share-based compensation is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized by installments in consistency with their graded vesting schedule, when applicable. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the related service and non-market performance conditions at the vesting date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For share-based payment awards with market vesting conditions and non-vesting conditions, the grant-date fair value of the share-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcome. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The measurement of the fair value of BSA, BCE and AGA incorporates the market-based vesting conditions and non-vesting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions as described in Note 4.16 &#8220;Use of judgments and estimates&#8221;. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.8. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Note 4.8.1. Financial liabilities at amortized cost<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IFRS 9 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Instruments, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;">the borrowings, the debt component of the Kreos / Claret OCABSA (classified as <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">convertible loan notes &#8211; see <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.47pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.98pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments below) and Other financial liabilities (conditional <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">advances and royalty certificates) other than financial derivative liabilities are measured at amortized cost. They are initially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized at fair value and subsequently measured at amortized cost calculated using the effective interest rate (&#8220;EIR&#8221;) method. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction costs that are directly attributable to the issue of the financial liability reduce that financial liability. These expenses are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">then amortized over the lifetime of the liability, on the basis of the EIR. The EIR is the rate that exactly discounts estimated future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">cash payments through the expected life of the financial liability to the amortized cost of a financial liability. Financial liabilities that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are due within one year are presented as current financial liabilities in the statements of financial position.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 522.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates meet the definition of financial liabilities. The Group concluded that they do not include embedded derivatives <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">related to the variability of royalties that are based on future net sales. In addition, the Group concluded that the prepayment options <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">were separate derivative instruments as their redemption price did not reimburse holders for an amount up to the approximate present <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value of lost interest for the remaining term of the host contracts. However, their value at inception and subsequent dates is nil and has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">no impact on the financial statements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates are initially measured at fair value (refer to note 15.10 for valuation model applied). They are subsequently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured at amortized cost calculated using the EIR method. The EIR is calculated based on future cash flows, which are estimated on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the basis of development and commercialization plans and budgets approved by the Board of Directors of the Group, and probability-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">weighted to reflect the probability of success of clinical studies and any other uncertainty affecting them. If there is a change in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">timing or amount of estimated cash flows, then the gross carrying amount of the amortized cost of the financial liability is adjusted in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the period of change to reflect the revised actual and estimated cash flows, with a corresponding income or expense being recognized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss. The revised gross carrying amount of the amortized cost of the financial liability is calculated by discounting the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future revised estimated cash flows at the original EIR. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances and State guaranteed loan &#8211; &#8220;PGE&#8221; <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment for conditional advances and the State-guaranteed loan (Pr&#234;t garanti par l'Etat, or "PGE") is set forth in Note 4.9. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Leases <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment for lease liabilities is set forth in Note 4.12.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Note 4.8.2. Financial liabilities measured at fair value through profit or loss <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.9pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSA attached to Kreos 1 bonds, the conversion option of OCEANE, certain prepayment options of bonds, the Kreos / Claret warrants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and the Kreos / Claret Minimum Return Indemnifications ("MRI") are derivatives instruments. Derivatives are recognized initially at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value at the date the derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The resulting gain or loss from change in the fair value is recognized in profit or loss immediately, as financial expenses or income. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Hybrid instruments <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE bonds <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.41pt; position: var(--position); text-decoration: none; white-space: pre;">and Heights convertible notes (whose characteristics are described in Note 15.2 and Note 15.5)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.25pt; position: var(--position); text-decoration: none; white-space: pre;"> are hybrid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments. A &#8220;hybrid contract&#8221; is a contract that includes both a non-derivative host contract and one or more embedded derivatives. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Embedded derivatives are required to be separated from the host contract (bifurcated) if: the economic characteristics and risks of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">embedded derivative are not closely related to those of the host, a separate instrument with the same terms as the embedded derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">would meet the definition of a derivative, and the hybrid contract is not measured at fair value through profit or loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Separable embedded derivatives are required to be measured at fair value at each reporting date, with changes in fair value recognized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 460.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss. The initial bifurcation of a separable embedded derivative does not result in any gain or loss being recognized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Because the embedded derivative component is measured at fair value on initial recognition, the carrying amount of the host contract <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on initial recognition is the difference between the carrying amount of the hybrid instrument and the fair value of the embedded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derivative. If the fair values of the hybrid instrument and host contract are more reliably measurable than that of the derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">component - e.g. because of the availability of quoted market prices - then it may be acceptable to use those values to determine the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value of the derivative on initial recognition indirectly - i.e. as a residual amount. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights convertible notes issued on August 24, 2023 included embedded derivatives as detailed in Note 15. The Group concluded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">that these features were embedded derivatives that would modify the cash flows required under the contract and require to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">bifurcated from their host contract. The Group being unable to reliably value each embedded derivative at issuance date and on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent reporting dates, it measured the whole hybrid instrument at fair value through profit or loss (&#8220;FVTPL&#8221;) as permitted by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 9. Instruments measured at FVTPL under these conditions are measured at their fair value on issuance and on subsequent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reporting dates, with changes in fair value recognized in profit or loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret OCABSA are compound instruments (whose characteristics are describ<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ed in Note 15.1). </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.57pt; position: var(--position); text-decoration: none; white-space: pre;">A &#8220;compound contract&#8221; is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">a contract that includes both a debt component and an equity component.&#160; The debt component (excluding the conversion option and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the attached OCABSA warrants) is initially recognized at fair value and subsequently measured at amortized cost calculated using the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">EIR method. The equity component corresponding to the conversion option and the attached OCABSA warrants is recorded in equity, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the difference between the whole instrument&#8217;s fair value (its nominal value) and the standalone fair value of the debt component.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value measurement <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">When measuring the fair value of an asset or a liability, the Company uses market observable data as far as possible. Fair values are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 1: fair value calculated using quoted prices in an active market for identical assets and liabilities; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 2: fair value calculated using valuation techniques based on observable market data such as prices for assets and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities or similar parameters quoted in an active market; &#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 3: fair value calculated using valuation techniques based in whole or in part on unobservable inputs such as prices <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">in an inactive market or a valuation based on multiples of unlisted securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">See Note 12 Financial assets and liabilities, Note 15 Financial liabilities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.9. Research tax credit, subsidies and conditional advances <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group benefits from the provisions of Article 244 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 255.53pt; position: var(--position); text-decoration: none; white-space: pre;">quater <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.12pt; position: var(--position); text-decoration: none; white-space: pre;">B of the French General Tax Code relating to the French research tax <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit (&#8220;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 68.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Cr&#233;dit d&#8217;Imp&#244;t Recherche<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8221; or &#8220;CIR&#8221;). The CIR is granted to companies in order to encourage them to conduct technical and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scientific research. Companies that prove that they have expenditures which meet the required criteria (research expenditures located <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in France or, since January 1, 2005, within the European Union or in another state that is a party to the Agreement on the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Economic Area and has concluded a tax treaty with France that contains an administrative assistance clause) receive a tax credit that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">can be used for the payment of the corporate tax due for the fiscal year in which the expenditures were made and the next three fiscal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">years, or as applicable, companies may receive cash reimbursement for any excess portion at the three-year period following the fiscal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">year of the expenditures. Only those companies meeting the EU definition of a small or medium-sized entity (&#8220;SME&#8221;) are eligible for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">payment in cash of their research tax credit (to the extent not used to offset corporate tax payables) in the year following the request <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for reimbursement. The expenditures taken into account for the calculation of the CIR involve only research expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The CIR is presented under &#8220;Other operating income&#8221; in the statements of income (loss) as it is accounted for as a government grant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as defined in IAS 20 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 128.16pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting for Government Grants and Disclosure of Government Assistanc<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.67pt; position: var(--position); text-decoration: none; white-space: pre;">e, and as &#8220;Other receivables and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets&#8221; in the statement of financial position until its payment is received. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies are non-repayable grants received by the Group and recognized in the financial statements when there exists reasonable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assurance that the Group will comply with the conditions attached to the subsidies and the subsidies will be received. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies that are upfront payments are presented as deferred income and recognized through &#8220;Other operating income&#8221; for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount of the expenses incurred as part of the research program to which the subsidy relates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">A subsidy that is to be received either as compensation for expenses or for losses already incurred, or for immediate financial support <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the Group without associated future costs, is recognized in the Statements of income (loss) as &#8220;Other operating income&#8221; when there <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exists reasonable assurance that the subsidies will be received. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances and PGE <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group receives conditional advances to finance at below market interest rate research and development projects. Due to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">innovative nature of its drug candidate development programs, the Group has benefited from certain sources of financial assistance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from Bpifrance. Bpifrance provides financial assistance and support to emerging French enterprises to facilitate the development and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization of innovative technologies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Funds received from Bpifrance in the form of conditional advances are recognized as financial liabilities, as the Group has a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">contractual obligation to reimburse Bpifrance for such conditional advances in cash based on a repayment schedule. Each award of an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">advance is made to help fund a specific development milestone. More tails on conditional advances are provided in Note 15.7. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 626.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Receipts or reimbursements of conditional advances are reflected as financing transactions in the statements of cash flows. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The difference between the present value of the advance at market rate (i.e., present value of contractual cash flows including principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and interests, discounted using a market rate as effective interest rate in accordance with IFRS 9) and the amount received as cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the Bpifrance constitutes a subsidy within the meaning of IAS 20. Considering that these advances do not finance fixed assets, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">these subsidies are presented as &#8220;Deferred income&#8221; in the statement of financial position and recognized in the statement of net income <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(loss) as &#8220;Other operating income&#8220; on a systematic basis over the periods in which the Group recognizes as expenses the related costs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for which the grants are intended to compensate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The incremental interest expense resulting from the difference between (a)&#160;the market interest rate and the (b)&#160;below-market rate is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">spread over the contractual period until the last repayment and recognized in the statement of income (loss) accordingly, using the EIR <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">method. In the event of a change in estimate of contractual cash flows due under the conditional advances, the Group recalculates the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">book value of the debt resulting from the discounting of the anticipated new future cash flows at the initial EIR. The adjustment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in the statements of income (loss) for the period during which the modification is recognized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the statements of financial position, these conditional advances are recorded in &#8220;Other financial liabilities&#8221; as current or non-current <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">portion depending on their maturity. In the event Bpifrance waived the repayment of the advance, the corresponding liability is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derecognized and treated as a subsidy in the statements of income (loss). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The benefit resulting from the low interest of PGE loans is also recognized as a subsidy corresponding to the difference between the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">present value of the PGE at market rate and the amount received as cash. The accounting treatment is therefore similar to the above-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">mentioned accounting treatment for conditional advances. PGE are recorded in &#8220;Borrowings&#8221; as current or non-current portion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">depending on their maturity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.10. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Employee benefits <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s employees in France benefit from retirement benefits provided under French law, which consist in the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">compensation paid by the Group to employees upon their retirement (a defined benefit plan); and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">payments of retirement pensions by the social security agencies, which are financed by the contributions made by the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Group and employees. As they meet the definition of a defined contribution plan, the liabilities are presented as Tax and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">employee-related payables in the statement of financial position. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In accordance with IAS 19 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 153.11pt; position: var(--position); text-decoration: none; white-space: pre;">Employee Benefits<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.15pt; position: var(--position); text-decoration: none; white-space: pre;">, the liability with respect to defined benefit plans is estimated by using the projected <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit unit method. According to this method, the cost of the retirement benefit is recognized in the statements of income (loss). The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">retirement benefit commitments are valued at the current value of the estimated future payments, discounted using the market rate for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">high quality corporate bonds with a term and currency that correspond to that estimated for the payment of the benefits. The Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">applied the decision of the IFRS IC, published on May&#160;24, 2021, that concluded that, in the case that no rights were acquired in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">event of departure before retirement age and that the rights were capped after a certain number of years of seniority (&#8220;30 years&#8221;), the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commitment would only be recognized for the last 30 years of the employee&#8217;s career within the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The difference between the amount of the provision at the beginning of a period and at the close of that period is recognized through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operating expenses for the portion representing the costs of services rendered and financial expenses for the net interest costs, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">through other comprehensive income (loss) for the portion representing the actuarial gains and losses due to changes in assumptions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and experience adjustments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.11. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions correspond to commitments resulting from litigation and various risks to which the Group may face in the context of its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operations. In accordance with IAS 37 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 199.73pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions, Contingent Liabilities and<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.37pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 354.87pt; position: var(--position); text-decoration: none; white-space: pre;">Contingent Assets, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.74pt; position: var(--position); text-decoration: none; white-space: pre;">a provision is recorded when the <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group has an obligation to a third party resulting from a past event that will likely result in an outflow of resources to the third party, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and for which future cash outflows may be estimated reliably. The amount recorded as a provision is an estimate of the expenditure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">required to settle the obligation, discounted where necessary at year <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.25pt; position: var(--position); text-decoration: none; white-space: pre;">end.&#160; Contingent liabilities are not recognized, but are disclosed in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the notes to the financial statements unless the possibility of an outflow of economic resources is remote<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.28pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.12. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Leases <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">standalone price. The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases (value of the underlying asset below <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 221.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.0 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.09pt; position: var(--position); text-decoration: none; white-space: pre;">). For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">straight-line basis over the term of the lease. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to the end of the lease term. The lease terms used by the Group reflect the non-cancellable terms of each contract, plus any extension <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">or termination options that the Group is reasonably certain to exercise or not exercise for all of the leases periods covered by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">extension options. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group incremental borrowing rate for the asset subject to the lease in the respective markets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">portion of the lease payments attributable to the repayment of lease liabilities and the portion attributable to payment of interests are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in cash flows used in financing activities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">incentives received and any initial direct costs incurred by the Group, and expected costs for obligations to dismantle and remove <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">right-of-use assets when they are no longer used. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the right-of-use asset or the end of the lease term. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recoverable using cash flow projections. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.13. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Translation of transactions denominated in foreign currency <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 21 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">The Effects of Changes in Foreign Exchange Rates<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.3pt; position: var(--position); text-decoration: none; white-space: pre;">, transactions performed by the Group in currencies other than <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 515.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their functional currency, which is the Euro, are translated at the prevailing exchange rate on the transaction date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 537.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables and payables and liabilities denominated in a currency other than the functional currency are translated at the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">period-end exchange rate. Unrealized gains and losses arising on translation are recognized in net financial income / (loss). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.14. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Current and deferred tax <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Tax assets and liabilities for the current and prior periods are measured at the amount expected to be recovered from or paid to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">French tax authorities, using tax rates and tax laws enacted or substantively enacted at the end of the reporting period in accordance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with IAS 12 &#8211; Income Tax. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The income tax charge for the period comprises current tax due and the deferred tax charge. The tax expense is recognized in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">statement of income (loss) unless it relates to items recorded in other comprehensive income (loss) or directly in equity, in which case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the tax is also recorded in other comprehensive income (loss) or directly in equity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Current taxes <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The current tax expense is calculated based on taxable profit for the period, using tax rates enacted or substantively enacted at the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">statement of financial position date. Considering the level of tax loss of the Group, no current tax expense is recognized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxes <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxes are recognized when there are temporary differences between the carrying amount of assets and liabilities in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s financial statements and the corresponding tax basis used to calculate taxable profit. Deferred taxes are not recognized if they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 267.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">arise from the initial recognition of an asset or liability in a transaction other than a business combination which, at the time of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction, does not affect either the accounting or the taxable profit (tax loss). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group applies the Amendments to IAS 12 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 232.23pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred Tax related to Assets and Liabilities arising from a Single Transaction<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.79pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issued on May 7, 2021, and presents the deferred tax assets and liabilities arising from such transactions separately within Note 22 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 559.6pt; position: var(--position); text-decoration: none; white-space: pre;">- <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Income tax, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.11pt; position: var(--position); text-decoration: none; white-space: pre;">rather than on a net basis. The Amendments have no impact on the Statements of financial position and the Statement of <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">comprehensive income (loss) for the periods presented.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets are recognized for all deductible temporary differences, unused tax losses and unused tax credits to the extent that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">it is probable that the temporary difference will reverse in the foreseeable future and that taxable profit will be available against which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the deductible temporary difference, unused tax losses or unused tax credits can be utilized. See Note 4.16. Use of judgments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">estimates and Note 22. Income tax. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.15. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting of Prosynergia acquisition <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">From April 1, 2022 up until the merger completed on December&#160;12, 2022, the Company owned a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.33pt; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.66pt; position: var(--position); text-decoration: none; white-space: pre;"> ownership interest of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia and as such, controlled Prosynergia. The Company had power over Prosynergia, was exposed or had rights to variable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 455.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">returns from its involvement with the entity and had the ability to affect those returns through its power over the entity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The financial statements of Prosynergia were therefore included in the consolidated financial statements of the Company from the date <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">control was obtained, i.e. April 1, 2022. Prosynergia was merged into the Company in December&#160;12, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement or out-licensed agreement, it did not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">April 1, 2022, without recognition of goodwill. For this purpose, the following approach was applied: first measurement of any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">identifiable asset or liability initially measured at an amount other than cost in accordance with the applicable standards, deduction <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the cost of the group of assets of the amounts allocated to these assets and liabilities, and then allocation of the residual cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acquisition to the remaining identifiable assets and liabilities based on their relative fair values at the date of acquisition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Also, the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,400&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> loan granted to Prosynergia in December 2021 was included in the acquisition cost to be allocated, since, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">substance, it was considered as a prepayment for the acquisition of the group of assets, which is repayable in cash in the event of non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">completion of the transaction. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The potential earn-out payment to be paid in the first half of 2023 was measured at fair value on April 1, 2022, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,446&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">, and included in the acquisition cost. This earn out could be triggered in the event the Group&#8217;s market capitalization <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 133.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">was in excess of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.06pt; position: var(--position); text-decoration: none; white-space: pre;"> (valued at certain specified record dates), a listing of the Group&#8217;s shares on Nasdaq or a merger and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 143.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acquisition transaction prior to March 31, 2023. The amount of the earn-out was equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.69pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.02pt; position: var(--position); text-decoration: none; white-space: pre;"> of the difference between the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 153.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market capitalization and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to a maximum amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.08pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.93pt; position: var(--position); text-decoration: none; white-space: pre;">. It was payable in the first half of 2023 if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions were met. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.01pt; position: var(--position); text-decoration: none; white-space: pre;">No<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> amount was payable in the event the Group&#8217;s market capitalization was lower than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.71pt; position: var(--position); text-decoration: none; white-space: pre;">. The related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial liability was subsequently remeasured to its fair value as of December&#160;31, 2022 estimated to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.65pt; position: var(--position); text-decoration: none; white-space: pre;">nil<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.19pt; position: var(--position); text-decoration: none; white-space: pre;"> (see Note 15.9). The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement resulted in a financial income of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.99pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,446&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.08pt; position: var(--position); text-decoration: none; white-space: pre;"> over the year ended December&#160;31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As a consequence of the earn-out condition not being met on March 31, 2023, the related financial liability was derecognized.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The allocation of the acquisition cost is as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 237.56pt; width: 612pt;"><div style="font-size: 0pt; left: 28.8pt; position: var(--position); top: 0pt; width: 266.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 23.16pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 15.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.41pt; position: var(--position); text-decoration: none; white-space: pre;">Amount&#160;allocated&#160;as<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 23.96pt; position: var(--position); text-decoration: none; white-space: pre;">of&#160;April&#160;1,&#160;2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 23.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash prepayment made in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.17000000000002pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.59pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 49.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;">325<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loan granted to Prosynergia in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.9pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 63.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">1,400<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash payment made in 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.06pt; position: var(--position); text-decoration: none; white-space: pre;">.............<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 78pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">2,925<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition fees (1)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">...........................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 92.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;">466<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Earn-out measured at fair value<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.14000000000001pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.51pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.53pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 106.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">1,446<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total acquisition cost allocated<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 134.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 134.54999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.60999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 134.62pt; position: var(--position); text-decoration: none; white-space: pre;">......<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 120.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,562<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 135pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 149.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Patents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.06pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 149.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,529<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 163.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.78pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 108.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.22999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.46pt; position: var(--position); text-decoration: none; white-space: pre;">................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 163.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.94pt; position: var(--position); text-decoration: none; white-space: pre;">42<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">......................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 192pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,571<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 206.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 206.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.72pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.00999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 67.08999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">.................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 220.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 52.11pt; position: var(--position); text-decoration: none; white-space: pre;">(9)<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 234.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total net assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.44999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;">................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 249pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,562<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 517.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);"> (1)<span style="display: inline-block; height: 6.93pt; width: 10.34pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Of which <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;451&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); text-decoration: none; white-space: pre;"> were disbursed in 2021 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"> in 2022. Acquired cash amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;42&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.44pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The acquisition cost was mainly allocated to Prosynergia&#8217;s patents US 10,464,903 (filed on March 20, 2017 and granted on November <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">5, 2019), EP3 429 998 (filed on March 20, 2017 and granted on September 1, 2021) and continuation US 10,745,357 (filed on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">November 1, 2019 and granted on August&#160;18, 2020). All patents will expire in 2037. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These patents cover alternative synthesis process for obefazimod and a family of close chemical analogues. They also cover <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">alternative forms of obefazimod (salts thereof and crystalline forms of said salts), the pharmaceutical composition comprising them, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 601.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">that could be of interest to the Company for future development. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 4.16. <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Use of judgments and estimates <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In order to prepare financial statements in accordance with IFRS, estimates, judgments and assumptions were made by the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">management which could affect the reported amounts of assets, liabilities, contingent liabilities, income and expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These estimates are based on the assumption of going concern and are prepared in accordance with information available at the date <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the financial statements were prepared. They are reviewed on an ongoing basis using past experience and various other factors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">considered to be reasonable as the basis to measure the carrying amount of assets and liabilities. Estimates may be revised due to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">changes in the underlying circumstances or subsequent to new information. Actual results may differ significantly from these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">estimates in line with assumptions or different conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">This note provides an overview of the areas that involved a higher degree of judgement or complexity, and of items which are more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">likely to be materially adjusted due to changes in estimates and assumptions. Detailed information about each of these estimates and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">judgements is included in other notes together with information about the basis of calculation for each affected line item in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial statements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Recognition and measurement of impairment of CGUs. The main assumptions used for the impairment test include <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(a)&#160;the amount of cash flows that are set on the basis of the development and commercialization plans and budgets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">approved by Board of Directors, (b)&#160;assumptions related to the achievement of the clinical trials and the launch of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization, (c)&#160;the discount rate, (d) assumptions on risk related to the development and (e)&#160;for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization, selling price and volume of sales. The sensitivity analysis in respect of the recoverable amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">CGUs is presented in Note 6. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Measurement of share-based payments granted to employees, corporate officers and scientific consultants, such as BCE, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">BSA and AGA, which is based on actuarial models; these models require the use by the Group of certain calculation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 237.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions such as the estimated vesting, the occurrence dates of a change of control or a M&amp;A transaction dates, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.11pt; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">percentage of success (&#8220;POS&#8221;) of obefazimod,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.94pt; position: var(--position); text-decoration: none; white-space: pre;"> the expected volatility and maturity of the underlying equity instrument <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(see Note 4.7 and Note 14), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement at inception and after of derivative financial instruments resulting from (i)&#160;the warrants issued <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">concomitantly with the issuance of the straight and convertible bonds to Kreos on July 24, 2018 (or &#8220;Kreos 1&#8221;), (ii) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">prepayment option attached to the straight and convertible bonds issued to Kreos on October 2, 2020 (or &#8220;Kreos 2&#8221;), and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(iii)&#160;the prepayment option attached to the issuance of bond convertible into new or existing shares in July 30, 2021 (or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;OCEANE&#8221;) (see Notes 15), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">(iv) the Kreos / Claret BSA issued on August 21, 2023 and November 2, 2023, related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">tranches A-B and tranche C, respectively, and (v) the Kreos / Claret Minimum Return Indemnifications related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">tranches B and C, issued in March 2024 and June 2024, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement of financial liabilities at inception (see Note 15), <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.62pt; position: var(--position); text-decoration: none; white-space: pre;">and after (for the Heights convertible notes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">issued on August 24, 2023) measured at fair value at each reporting period, with fair value changed recognized in profit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">or loss, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Amortized cost measurement of royalty certificates, based on the following assumptions: (a)&#160;future cash flows, estimated <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">on the basis of development and commercialization plans and budgets approved by the Board of Directors and (b)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">effective interest rate. The sensitivity analysis in respect of the measurement of royalty certificates is presented in Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">15,&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement of the call option resulting from the equity line contracts entered into on September 30, 2019 (or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Equity lines&#8221;) (see Note 13.2), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Estimation of CIR, based on internal and external expenses, which meet the required criteria, incurred by the Group each <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">year (see Note 4.9), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Recognition of deferred tax assets: availability of future taxable profit against which deductible temporary differences <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">and tax losses carried forward can be utilized and whether sufficient evidence exists (see Note 22). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Recognition of deferred tax assets: tax deductibility of future royalty payments related to the royalty certificates issued in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 541.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">September 2022 (see Notes 15 and 22).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Determination of the terms of the leases, including whether the Group is reasonably certain to exercise extension and/or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">termination options (see Note 15.8).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The main critical judgements made by the Group&#8217;s management impact the following items: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment of specific conditions of share-based compensation plans (see Notes 4.7 and 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 653.06pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.67pt;">&#8226;<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 173.62pt;">Accounting treatment of the 2018 &amp; 2020 <span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.67pt; position: var(--position); text-decoration: none; white-space: pre; width: 31.87pt;">Kreos 1<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.54pt; position: var(--position); text-decoration: none; white-space: pre; width: 279.42pt;"> &amp; 2 bonds, the 2021 OCEANE bonds, and the August 2023 Kreos /<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.96pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 664.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 215.9pt;">Claret and Heights Financings (see Notes 4.8 and 15).<span style="display: inline-block; height: 7.64pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting Principles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of material accounting policy information applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segment information</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Segment information <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The assessment of the Group&#8217;s performance and the decisions about resources to be allocated are made by the chief operating decision <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">maker, based on the management reporting system of the Group. The Group identified the Chief Executive Officer of the Group as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;chief operating decision maker&#8221;. The chief operating decision maker reviews on an aggregated basis the incurred expenses for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">allocating and evaluating performance of the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group operates in a single operating segment: R&amp;D of pharmaceutical products in order to market them in the future. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Substantially all operations, assets, liabilities, and losses of the Group are located in France. As of December 31, 2023 and 2024, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. Subsidiary<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.03pt; position: var(--position); text-decoration: none; white-space: pre;"> (created in 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.45pt; position: var(--position); text-decoration: none; white-space: pre;">) has contributions to the Group&#8217;s assets, liabilities and net losses<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.01pt; position: var(--position); text-decoration: none; white-space: pre;"> that were less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.07pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.4pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and impairment test<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGoodwillExplanatory', window );">Goodwill and impairment test</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill and impairment test <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill relates to the acquisition of Splicos SAS and Wittycel SAS that occurred in 2014 (i.e., prior the transition date to IFRS), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which were merged into the Group in the same year. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill from Splicos SAS and Wittycel SAS acquisition corresponds to the &#8220;Modulation of RNA biogenesis / splicing&#8221; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">technological platform and the &#8220;iNKT agonists&#8221; technological platform, respectively, from which derived the lead drug candidates of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group: ABX464 and ABX196, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 3 was not applied to acquisitions of subsidiaries deemed to be a business within the meaning of IFRS, carried out before the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS transition date, i.e., January&#160;1 2020. Due to the application of this exemption, the previous accounting for business combinations <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in accordance with French GAAP remains unchanged (no identified Intellectual Property, Research&#160;&amp; Development (&#8220;IPR&amp;D&#8221;) assets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are recognized in the statement of financial position). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The carrying amount of the goodwill resulting from the Splicos SAS acquisition was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.07pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18,419&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.16pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December&#160;31, 2022, 2023 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and 2024.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In accordance with IAS 36, goodwill is allocated to CGUs at a level corresponding to the lead drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.88pt; position: var(--position); text-decoration: none; white-space: pre;">Thus, goodwill from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Splicos SAS is allocated to the ABX464 CGU.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill impairment tests are undertaken annually or more frequently if events or changes in circumstances indicate a potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impairment, in accordance with IAS 36. The carrying amount of goodwill is compared to the recoverable amount, which is the higher <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value in use and the fair value less costs to disposal. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, the Group has not identified any indication of impairment loss related to goodwill, intangible or tangible <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024 the recoverable amount used for the impairment test of each CGU was the value in use. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value in use was based on a net present value calculation, using the following assumptions as of December 31, 2022, 2023 and 2024: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Cash flows are set on the basis of the development and commercialization plans and budgets approved by Board of <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Directors; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">A discount rate (or &#8220;WACC&#8221;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.57999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">) of</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.74pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.24pt; position: var(--position); text-decoration: none; white-space: pre;">11.5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.07pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">as o</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.39pt; position: var(--position); text-decoration: none; white-space: pre;">f December 31, 2024;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">A risk of development is taken into consideration by applying probabilities of success (or &#8220;POS&#8221;) of reaching future <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">phases of development to cash flows related to the commercialization phase. Those average probabilities of success of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D projects are based on public sources (INFORMA databases).;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">For the commercialization phase, selling price and sales volume are estimated on the basis of the potential market and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 615.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">the observed performances of comparable drugs currently on the market. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 637.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the year ended December 31, 2022, management took into account significant external changes in the hepatocellular <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 647.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">carcinoma (HC) treatment landscape. These changes were expected to require a new, lengthy, heavy and risky internal development <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">process (use of a combination of compounds). For this purpose, entering into a licensing partnership to fund the completion of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">clinical development of ABX196 was being considered. As of December&#160;31, 2022, due to the lack of progress made in the negotiation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of a development partnership, the Group made the decision to freeze the development program for ABX196 in the treatment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">hepatocellular cancer. In this context, the impairment test carried out as of December&#160;31, 2022 resulted in the full impairment of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">goodwill resulting from the acquisition of Wittycell SAS and other assets included in the ABX196 CGU, i.e. an impairment loss of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13,632&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December&#160;31, 2022 (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13,586&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.7pt; position: var(--position); text-decoration: none; white-space: pre;"> related to goodwill and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.68pt; position: var(--position); text-decoration: none; white-space: pre;"> related to other assets &#8211; see Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">7). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The impairment tests resulted in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.21pt; position: var(--position); text-decoration: none; white-space: pre;">no<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.21pt; position: var(--position); text-decoration: none; white-space: pre;"> impairment charges as of December 31, 2023, and 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Sensitivity testing as of December&#160;31, 2022, 2023 and 2024:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Regarding ABX464, as the product is currently under development, a clinical trial failure or a failure to obtain a marketing approval <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 167.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">could result in an impairment. The results of the impairment test indicate a headroom level that is high enough so that any reasonably <span style="display: inline-block; height: 6.93pt;"></span></span></div>possible change in any of the key assumptions (except clinical failure) would not lead to any impairment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 235.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets are mainly comprised of the intellectual property underlying: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 66.55pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 4.45pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 262.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.55pt; position: var(--position); text-decoration: none; white-space: pre;">(i)<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 75.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160;  <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">The exclusive license agreement with the Scripps Research Institute, University of Chicago and Brigham Young <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">University for which the Group paid a milestone of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.94pt; position: var(--position); text-decoration: none; white-space: pre;"> in September 2019 as a result of an IND filling of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 288.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">ABX196. The value in use and the fair value less costs to disposal of the ABX196 CGU being <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.43pt; position: var(--position); text-decoration: none; white-space: pre;">nil<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.97pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 299.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">2022, a<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.57pt; position: var(--position); text-decoration: none; white-space: pre;"> impairment loss was recorded during the year ended December 31, 2022 (see Note 6).<span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 522.87pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 66.55pt; position: var(--position);">(ii)<span style="display: inline-block; height: 6.93pt; width: 12.3pt;"></span></span><span style="left: 91.05pt; position: var(--position);">The collaboration and license agreement with the CNRS, Montpellier 2 university and the Curie for which the Group <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">paid a milestone of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.84pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;40&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.43pt; position: var(--position); text-decoration: none; white-space: pre;"> in September 2019 as a result of the entry in phase 2 of ABX464. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 66.55pt; position: var(--position);">(iii)<span style="display: inline-block; height: 6.93pt; width: 9.53pt;"></span></span><span style="left: 91.05pt; position: var(--position);">Patents acquired through the acquisition of Prosynergia of <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6,529&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.91pt; position: var(--position); text-decoration: none; white-space: pre;"> (cf. Note 4). The patents are not yet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">amortized, similarly to licenses, and are included in the ABX464 CGU for impairment test purposes.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Licenses and patents recognized as Intangible assets are not amortized since they are not operating in a manner intended by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">management. As a consequence, and in accordance with IAS 36, those assets were subject to an annual impairment test as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022, 2023 and 2024, which did <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.16pt; position: var(--position); text-decoration: none; white-space: pre;">not<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.93pt; position: var(--position); text-decoration: none; white-space: pre;"> result in any impairment loss being recognized except for the above-mentioned <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 101.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.59pt; position: var(--position); text-decoration: none; white-space: pre;"> impairment loss recorded during the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.43pt; position: var(--position); text-decoration: none; white-space: pre;">year ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.02pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.02pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 133.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 461.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.82pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.16pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.26pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">85<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">24<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">110<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">35<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,564<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">120<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">24<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,673<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">120<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">24<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,673<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.13pt;"></span></span><span style="left: 56.760000000000005pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.13pt;"></span></span><span style="left: 56.760000000000005pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">120<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">27<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,677<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 315.19pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(17)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(17)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(21)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(66)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(24)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(69)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(25)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(70)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 521.54pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NET BOOK VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">85<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">93<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,607<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,604<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,606<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 6.77pt;"></span></span><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables present changes in property, plant and equipment including the right of use of assets (or &#8220;ROU&#8221;) as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022, 2023 and 2024:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 105.19pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 525.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 55.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.57pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.25pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.34pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.69pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.01pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.79pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.12pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">593<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">402<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">235<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,230<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">682<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,618<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">39<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">111<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,768<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,472<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(593)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.97pt;"></span></span><span style="left: 49.6pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.97pt;"></span></span><span style="left: 49.6pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(597)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(593)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,618<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">436<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">346<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,400<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,561<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">350<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">103<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">161<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">614<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">350<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(622)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.97pt;"></span></span><span style="left: 45.6pt; position: var(--position);">(27)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(649)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(649)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,346<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">513<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">507<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,366<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,262<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,578<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">292<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,870<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,217<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.97pt;"></span></span><span style="left: 35.6pt; position: var(--position);">(1,110)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(119)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.97pt;"></span></span><span style="left: 35.6pt; position: var(--position);">(1,229)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(975)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 204pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of the change in foreign currency exchange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.63pt;"></span></span><span style="left: 52.260000000000005pt; position: var(--position);">4<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">22<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">22<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,818<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">513<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">698<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">4,029<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,504<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 361.82pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 528.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 49.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.07pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.75pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.84pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.19pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.29pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DEPRECIATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 65.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(445)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(346)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(134)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(925)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(470)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(407)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(35)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(38)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(481)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(414)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">593<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">1<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">597<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">593<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(259)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(378)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(171)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(808)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(290)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 131.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(578)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(36)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(94)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(707)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(498)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 143.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">27<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">27<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">27<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 155.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(837)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(387)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(265)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(1,488)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(761)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(886)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(32)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(171)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(1,089)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(788)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 188.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,111<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">104<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,215<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">975<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 200.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of the change in foreign currency exhange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.99pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(613)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(419)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(332)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(1,363)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(575)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 538.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.55pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.2pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.87pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.97pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.31pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NET BOOK VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">148<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">56<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">101<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">305<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">212<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 74.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,359<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">59<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">175<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,592<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,270<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 95.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">501<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">126<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">878<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">501<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,205<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">94<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">366<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,666<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,929<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets relate to buildings, vehicles and furniture. The net book value of right of use assets related to buildings amounted to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,224&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;453&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.68pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.11pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,846 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.2pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2022, 2023 and 2024 respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions over the year ended December 31, 2022 mainly include the right of use asset related to the new headquarters entered into <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in July 2022 (see Note 15.8), as well as office fittings and IT equipment. Disposals over the period mainly include the right of use <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets related to the former headquarters. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions over the year ended December 31, 2023 mainly include the right of use asset related to the new Boston offices entered <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">into in November 2023. Decreases mainly include the remeasurement of the right of use asset related to the reassessment of the Paris <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 334.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Headquarters lease term, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;622&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;"> (see Note 15.8).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions over the period ended December 31, 2024 mainly include the right of use assets related to the new Paris headquarters and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Montpellier offices entered into in May and April 2024 respectively, as well as the 1-year renewal of the Boston offices lease (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.92pt; position: var(--position); text-decoration: none; white-space: pre;">15.8<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Disposals mainly include the right of use asset related to the former Paris headquarters lease, which ended in June <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.79pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 513.79pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other financial assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Disclosure of financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherAssetsExplanatory', window );">Other financial assets</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.01pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 508.31pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 525.11pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 445.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 243.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 70.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OTHER FINANCIAL ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">10,471<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,172<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">4,929<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,238<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">574<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">863<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">124<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">126<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total other non-current financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">11,708<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,870<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">5,919<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 3pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -1.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">7,418<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,050<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 3pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -5.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">136<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">136<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total other current financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,186<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">7,554<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">11,708<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">22,055<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">13,473<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 89.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These advances granted in 2022 for clinical studies are to be recovered at the end of the studies after final reconciliation with pass-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">through costs, which are being invoiced and paid as studies are carried out. These long-term advances were measured at fair value on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">initial recognition, using discount rates ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.11pt; position: var(--position); text-decoration: none; white-space: pre;">0.19%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.94pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">7.16%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.54pt; position: var(--position); text-decoration: none; white-space: pre;">, and are subsequently measured at amortized cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 135.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the first half of 2023, additional advances related to CRO contracts amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,620&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.64pt; position: var(--position); text-decoration: none; white-space: pre;"> were made (undiscounted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount). These long-term advances were measured at fair value on initial recognition, using discount rates ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.15pt; position: var(--position); text-decoration: none; white-space: pre;">7.09%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.98pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">7.59%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.83pt; position: var(--position); text-decoration: none; white-space: pre;">, and are subsequently measured at amortized cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, a prepaid expenses asset was recognized for the difference between the advances&#8217; nominal value and fair value, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">spread over the term of the advances, at the rate of recognition of the related R&amp;D expenses (see Note 10).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In March 2024, a change order was signed with the CRO, extending the scope (addition of maintenance studies) and end date of one of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the studies to 2029, thus postponing the recovery date of the corresponding advance <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.02pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5,538&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.94pt; position: var(--position); text-decoration: none; white-space: pre;"> from June 2026 to June 2029. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group considered that this asset modification met the criteria for derecognition, and recognized a new financial asset at fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on that date, using a discount rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.34pt; position: var(--position); text-decoration: none; white-space: pre;">6.83%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.17pt; position: var(--position); text-decoration: none; white-space: pre;">. Since the Group considers that these advances are made in exchange for a discount on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future services to be received from the CROs, a prepaid expense asset was also recognized for the difference between the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derecognized asset carrying value and new asset fair value, and spread over the term of the advance in a similar manner.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to these advances is deemed insignificant due to the CROs' credit ratings.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other investments consist of 6-month term deposits that do not qualify for a classification under cash and cas<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.47pt; position: var(--position); text-decoration: none; white-space: pre;">h equivalents. Term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 356.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deposits held by the Group as of December 31, 2024 qualify for a classification under cash equivalents.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits include the deposits paid under the Kreos 1 &amp; 2 bond loans (reimbursed in August 2023), the liquidity agreement, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.11pt; position: var(--position); text-decoration: none; white-space: pre;">the Paris <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and Boston offices lease contracts, the ATM Program, as well as other security <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.24pt; position: var(--position); text-decoration: none; white-space: pre;">deposits<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.99pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other assets. [Refer: Other assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other receivables and other assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Other receivables and other assets</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 469.26pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets break down as follows:<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 273.4pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 481.14pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 435pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 233.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 65.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OTHER RECEIVABLES AND OTHER ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses - non current<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,037<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,320<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">948<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current other assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,037<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,320<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">948<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit ("CIR")<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">4,595<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">4,600<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">5,774<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">VAT receivables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">3,467<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">14,439<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,841<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">915<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">5,746<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">3,233<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">254<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">60<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">48<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current other receivables and assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,231<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">24,845<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">18,896<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">10,268<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">27,164<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit (&#8220;CIR&#8221;) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The CIR is recognized as Other Operating Income (see note 4.9) in the year to which the eligible research expense relates. The Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">received the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> payments of the CIR for 2022 and 2023 tax years in the amount of respective<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.61pt; position: var(--position); text-decoration: none; white-space: pre;">ly&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,476&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.47pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,493&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.99pt; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively 2023 and 2024 and expects to receive the CIR for the 2024 tax year <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.25pt; position: var(--position); text-decoration: none; white-space: pre;">o<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.25pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">f </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.08pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5,774 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.17pt; position: var(--position); text-decoration: none; white-space: pre;"> in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.44pt; position: var(--position); text-decoration: none; white-space: pre;"> 2025. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">VAT Receivables <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Value-added tax (&#8220;VAT&#8221;) receivables relate primarily to the deductible VAT and VAT refunds claimed.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Their increase as of December 31, 2023 compared to December 31, 2022 is due to the increase in trade payables and accrued invoices <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">over the period (see Note 17.1).<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses as of December&#160;31, 2022 include prepaid expenses related to CRO contracts for amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,714&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.28pt; position: var(--position); text-decoration: none; white-space: pre;"> (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 9).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 125.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses as of December 31, 2023 include prepaid expenses related to CRO contracts for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,347&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.21pt; position: var(--position); text-decoration: none; white-space: pre;"> (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 9) and deferred transactions costs related to tranches B and C of the Kreos / Claret financings for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.68pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,152&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.77pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(most of which represents the issuance date fair value of the tranche A-B and C Kreos / Claret BSA, representing origination fees for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the future drawdowns of the tranches B and C of the Kreos / Claret Financing, See Note<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> 15.1) and other expenses from various </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">suppliers amounting to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;3,567&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses as of December 31, 2024 include prepaid expenses related to CRO contracts for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,577&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.21pt; position: var(--position); text-decoration: none; white-space: pre;"> (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 9) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 68.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and other expenses from various suppliers amounting to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.22pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;2,604&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.31pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The decrease in prepaid expenses over the year ended December 31, 2024 mainly corresponds to the reclassification of the deferred <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction costs of tranche B of the Kreos / Claret Financing, from prepaid expenses to a reduction of the initial carrying value of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">debt component, in accordance with the effective interest rate method, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,546&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.96pt; position: var(--position); text-decoration: none; white-space: pre;">, and to the amortization of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the deferred transaction costs related to tranche C (already fully amortized on the date of drawdown).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.96pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 352.86pt; width: 612pt;"><div style="font-size: 0pt; left: 41pt; position: var(--position); top: 0pt; width: 474pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 243pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 69.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CASH AND CASH EQUIVALENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.37pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">18,105<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">87,265<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">26,944<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">233,837<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">56,956<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">144,221<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 447.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents mainly include term deposits with short-term maturities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 459.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023 and 2024, in addition to the Group&#8217;s bank accounts, cash includes notice accounts amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;231,562 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;44,239<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.02pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand respectively. These funds are available on demand within 24 hours and without penalty.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in cash and cash equivalents over the year ended December 31, 2023 is mainly explained by the proceeds from (i) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret and Heights Financings from August 2023 and (ii) the Group&#8217;s Global Offering conducted in October 2023 (see Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.91pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">3.3</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">)</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.83pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023 and 2024, the impact of the revaluation of cash and cash equivalents held in U.S. dollars into the Group's <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">presentation currency is a net financial expense of<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,196&#160;thousand<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and a net financial income of<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.81pt; position: var(--position); text-decoration: none; white-space: pre;">2,035&#160;thousand<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.9pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.4pt; position: var(--position); text-decoration: none; white-space: pre;">respectively.<span style="display: inline-block; height: 8.25pt;"></span></span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FairValueMeasurementAbstract', window );"><strong>Fair Value Measurement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory', window );">Financial assets and liabilities</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Financial assets and liabilities<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following table shows the carrying amounts and fair value of financial assets and financial liabilities, including their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">levels in the fair value hierarchy.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables are non-financial liabilities and are therefore excluded from the tables below. They are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">presented in Note 17.2.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,708<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,271<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,271<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,889<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,452<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,452<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">16,241<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,439<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">8,873<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">65,272<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">58,469<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">57,903<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 273.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,055<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,394<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,394<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,161<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,500<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,500<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">39,697<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">40,622<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">18,506<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">42,768<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">37,348<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">37,348<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,531<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">5,165<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">124,266<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">125,191<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">30,037<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">95,154<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 476.56pt; width: 612pt;"><div style="font-size: 0pt; left: 40.12pt; position: var(--position); top: 0pt; width: 531.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 342pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 159.34pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 132.91pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.85pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.86pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">13,473<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,690<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,690<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">177,537<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">176,754<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">176,754<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">69,069<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">73,497<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">69,877<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">21,183<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">23,752<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">157,828<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">162,256<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">24,803<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">137,453<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; &#160;  The fair value of cash and cash equivalents is determined based on Level 1 fair value measurement and corresponds to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market value of the assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(2)&#160; &#160;  The carrying amount of financial assets measured at amortized cost is deemed to be a reasonable estimate of fair value, except <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the long-term advances made to CROs, whose fair value is determined based on Level 3 fair value measurement and is estimated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based on future cash-flows discounted at market rates, using credit spreads ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.29pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.29pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.56pt; position: var(--position); text-decoration: none; white-space: pre;">476<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.56pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">218<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.89pt; position: var(--position); text-decoration: none; white-space: pre;">131<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.89pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">271<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2024. As of December 31, 2022, 2023, and 2024, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.05pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the advances fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;240&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.96pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.55pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;235&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(3)&#160; &#160;  The carrying amount of short-term financial liabilities measured at amortized cost was deemed to be a reasonable estimate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(4)&#160; &#160;  The fair value of Kreos BSA A&amp;B, OCEANE conversion option, royalty certificates, Heights convertible notes, Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 199.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSA and Minimum Return Indemnifications is based on Level 3 fair value measurement and is estimated based on models and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions detailed in Note 15. The fair value of other long-term financial liabilities is determined based on Level 3 fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measurement and is estimated based on future cash-flows discounted at market rates, using the f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;">ollowing assumptions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of Kreos 1&amp;2 bonds, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.51pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.01pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.4pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.03pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the Kreos 1&amp;2 bonds fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">value by&#160; and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;68&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.65pt; position: var(--position); text-decoration: none; white-space: pre;">.. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt component of OCEANE bonds, a credit spread similar to that detailed in Note 15. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31,&#160; 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.9pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the OCEANE debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">component fair value by&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;476&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.98pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of the Kreos / Claret OCABSA (tranche A) and the tranches B and C of the Kreos / Claret straight <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bond loans, a credit spr<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ead of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">960</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp a</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.59pt; position: var(--position); text-decoration: none; white-space: pre;">s of August 22, 2023, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.19pt; position: var(--position); text-decoration: none; white-space: pre;">900<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.19pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.81pt; position: var(--position); text-decoration: none; white-space: pre;">750<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.81pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of August 22, 2023, December 31, 2023 (tranche A) and December 31, 2024 (all three tranches), an increase in the credit </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">spread by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.08pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+100</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp would result in a decrease in the Kreos / Claret debt components fair value by respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;624&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">,&#160; </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;538&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;958&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 427.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.89pt; position: var(--position); text-decoration: none; white-space: pre;"> the conditional advances and the PGE loan, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.42pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.92pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">900</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">31, 2023 and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">730</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December 31, 2024. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">An increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.71pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024, a decrease in the PGE loan fair value by, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;55&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.84pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;39&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;21&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the RNP-VIR conditional advance fair value by&#160;  <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.4pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the CARENA conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;37&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.5pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;37&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the Ebola conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.13pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.72pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(5) In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">non-current portion of the Heights convertible notes as of December 31, 2023 were reclassified within the current liabilities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Shareholders&#8217; equity</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Shareholders&#8217; equity<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.1. Share capital issued<span style="display: inline-block; height: 6.77pt;"></span><span id="i7bb188ecefa74b61b159fe36701c7a84"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 694.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group manages its capital to ensure that the Group will be able to continue as a going concern while maximizing the return to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 706.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders through the optimization of the debt and equity balance.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the Group&#8217;s share capital amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;223&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.39pt; position: var(--position); text-decoration: none; white-space: pre;"> divided into <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.4pt; position: var(--position); text-decoration: none; white-space: pre;">22,313,185<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.4pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares issued with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.72pt; position: var(--position); text-decoration: none; white-space: pre;"> each, fully paid up, after taking into account the various capital increases that took place since the inception (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.3). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023, the Group&#8217;s share capital amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;629&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.39pt; position: var(--position); text-decoration: none; white-space: pre;"> divided into <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.4pt; position: var(--position); text-decoration: none; white-space: pre;">62,928,818<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.4pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares issued with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 141.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.65pt; position: var(--position); text-decoration: none; white-space: pre;"> each, fully paid up, after taking into account the various capital increases that took place since the inception (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.2). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, the Group&#8217;s share capital amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;633&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.39pt; position: var(--position); text-decoration: none; white-space: pre;"> divided in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.13pt; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.4pt; position: var(--position); text-decoration: none; white-space: pre;">63,347,837<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.4pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.9pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares issued with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 179.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.65pt; position: var(--position); text-decoration: none; white-space: pre;"> each, fully paid up, after taking into account the various capital increases that took place since the inception (see <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.3). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Share capital does not include founders&#8217; share subscription warrants (&#8220;bons de souscription de parts de cr&#233;ateur d&#8217;entreprise&#8221; or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;BCE&#8221;), share subscription warrants (&#8220;Bons de souscription d&#8217;actions,&#8221; or &#8220;BSA&#8221;) and free shares (&#8220;Attributions gratuites <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 235.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">d&#8217;actions,&#8221; or &#8220;AGA&#8221;) that have been granted to certain investors or natural persons, both employees and non-employees of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Group, but not yet exercised.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Treasury shares<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 299.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group held <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.78pt; position: var(--position); text-decoration: none; white-space: pre;">12,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.28pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.28pt; position: var(--position); text-decoration: none; white-space: pre;">11,339<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.78pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.21pt; position: var(--position); text-decoration: none; white-space: pre;">none<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.64pt; position: var(--position); text-decoration: none; white-space: pre;"> of its own shares as of December 31, 2022, 2023 and 2024, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 321.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The number of outstanding ordinary shares (excluding treasury shares held by the Group) was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.55pt; position: var(--position); text-decoration: none; white-space: pre;">22,301,185<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.55pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.55pt; position: var(--position); text-decoration: none; white-space: pre;">62,917,479<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.55pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 528.98pt; position: var(--position); text-decoration: none; white-space: pre;">63,347,837<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 573.98pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as of December 31, 2022, 2023 and 2024, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 57.92pt; position: var(--position); text-decoration: none; white-space: pre;">13.2. Equity line instruments <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Equity line agreement with Kepler Cheuvreux <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into an equity line agreement with Kepler Cheuvreux in September 2019. In accordance with the terms of this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement, Kepler Cheuvreux, acting as financial intermediary and guarantor of the transaction, committed to subscribe for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.75pt; position: var(--position); text-decoration: none; white-space: pre;">730,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.25pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 438.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shares, at its own initiative, following a schedule lasting no longer than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.9pt; position: var(--position); text-decoration: none; white-space: pre;">24 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.83pt; position: var(--position); text-decoration: none; white-space: pre;">, at an issuance price based on an average market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price weighted according to the volumes traded over the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.22pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.21000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> trading days preceding each issue, less a maximum discount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.6pt; position: var(--position); text-decoration: none; white-space: pre;">7.0%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 555.43pt; position: var(--position); text-decoration: none; white-space: pre;">. On <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">September 24, 2021, the Group extended the agreement for an additional period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.71pt; position: var(--position); text-decoration: none; white-space: pre;">12 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.64pt; position: var(--position); text-decoration: none; white-space: pre;"> for the unsubscribed shares at that date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 468.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October&#160;1, 2022, the agreement ended and the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.18pt; position: var(--position); text-decoration: none; white-space: pre;">300,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.68pt; position: var(--position); text-decoration: none; white-space: pre;"> outstanding BSAs lapsed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 478.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="position: var(--position); top: 490.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 518.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 61.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 51.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.99pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 15.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.21pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.99pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.21pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.32pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.92pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.94pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 15.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.49pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.37pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.49pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.71pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;">SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.14pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.82pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 123.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 67.5pt; width: 61.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 67.5pt; width: 117pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 67.5pt; width: 64.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 79.5pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 79.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.32pt; position: var(--position); text-decoration: none; white-space: pre;">FOR THE YEAR ENDED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 79.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 91.5pt; width: 137.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JANUARY&#160;1, 2022<span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 91.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 91.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.86999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs granted under the Equity line <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">agreement<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 47.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.510000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.800000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 48.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.010000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.02pt; position: var(--position); text-decoration: none; white-space: pre;">....................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.81pt; position: var(--position); text-decoration: none; white-space: pre;">300,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 111.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.69pt; position: var(--position); text-decoration: none; white-space: pre;">300,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.53pt; position: var(--position); text-decoration: none; white-space: pre;">(300,000)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 639.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Considering that the Group could terminate or suspend the Equity line agreement by buying back the BSAs or increasing the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 649.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">minimum exercise price and that Kepler Cheuvreux was committed to subscribe the shares if the conditions were met, the BSAs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granted to Kepler Cheuvreux under the Equity line agreements were off-balance sheet commitments rather than derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 13.3. Change in share capital<span style="display: inline-block; height: 6.77pt;"></span><span id="i6ad075e1c272438ea7f278d53e09ca0f"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increases in the share capital for the year ended December 31, 2022 relate to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 98.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The completion of a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;46,231&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> on September 7, 2022 by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.5pt; position: var(--position); text-decoration: none; white-space: pre;">5,530,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.5pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.72pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.36<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.06pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The exercises of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">522<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants for the year ended December 31, 2022 (see Note 14), resulting in a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.59pt; position: var(--position); text-decoration: none; white-space: pre;"> by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.41pt; position: var(--position); text-decoration: none; white-space: pre;">19,134<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.91pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.65pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.15pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an average subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.14<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.04pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">per share; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Incremental costs directly attributable to the issue of new shares were classified as a deduction of shareholders&#8217; equity and amounted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.269999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,280&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.36pt; position: var(--position); text-decoration: none; white-space: pre;"> for the period ended December 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increases in the share capital for the year ended December 31, 2023 relate to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The completion of a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;130,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> on February 22, 2023 by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.86pt; position: var(--position); text-decoration: none; white-space: pre;">20,000,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.86pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.91pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and a subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.50<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.25pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The cash-less exercise of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.63pt; position: var(--position); text-decoration: none; white-space: pre;">67,887<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.13pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos A BSA and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">31,696<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.09000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos B BSA on<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.06pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> May 24, 20</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.38pt; position: var(--position); text-decoration: none; white-space: pre;">23, resulting in a capital increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,850&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.09pt; position: var(--position); text-decoration: none; white-space: pre;"> by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.91pt; position: var(--position); text-decoration: none; white-space: pre;">99,583<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.41pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.65pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an average subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 268.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.57<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.5pt; position: var(--position); text-decoration: none; white-space: pre;"> per share, which includes the impact of the derecognition of the BSA derivative financial liability; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The completion of the Group&#8217;s Global Offering on the Nasdaq Global Market on October 24, 2023, by way of a capital <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">20,325,500<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.04000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares, consisting of the U.S. Offering of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.59pt; position: var(--position); text-decoration: none; white-space: pre;">18,699,460<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.59pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares in the form of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs, and the European Private Placement of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.02pt; position: var(--position); text-decoration: none; white-space: pre;">1,626,040<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.02pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares, with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.76pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an offering <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price set at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.75pt; position: var(--position); text-decoration: none; white-space: pre;">$11.60<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.25pt; position: var(--position); text-decoration: none; white-space: pre;"> per ADS in the U.S. Offering and a corresponding offering price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.9864<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.69pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">European Private Placement. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The exercise of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.07pt; position: var(--position); text-decoration: none; white-space: pre;">1,906<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.57pt; position: var(--position); text-decoration: none; white-space: pre;"> other share warrants, by issuing <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.4pt; position: var(--position); text-decoration: none; white-space: pre;">190,550<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.9pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.14pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">average subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.69pt; position: var(--position); text-decoration: none; white-space: pre;"> per share (see Note 14). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Incremental costs directly attributable to the issue of new shares, including underwriting commissions and offering expenses related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Global Offering, were classified as a deduction of shareholders&#8217; equity and amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;28,111&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.39pt; position: var(--position); text-decoration: none; white-space: pre;"> for the period ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2023. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increases in the share capital<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.28pt; position: var(--position); text-decoration: none; white-space: pre;"> for the year ended December 31, 2024 relate to<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.16pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 432.16pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the issue and subscription by members of the Board of Directors of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.86pt; position: var(--position); text-decoration: none; white-space: pre;">77,820<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.36pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants, with a subscription price of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.6700000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.57<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.1700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">each (see Note 14);<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 459.04pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a credit note received for transaction fees related to the Global Offering, amounting <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.21pt; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;446 thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.07pt; position: var(--position); text-decoration: none; white-space: pre;"> and classified in the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">share premiums; and<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 485.92pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the exercise of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.74pt; position: var(--position); text-decoration: none; white-space: pre;">4,000<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.24pt; position: var(--position); text-decoration: none; white-space: pre;"> other share warrants, by issuing <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.07pt; position: var(--position); text-decoration: none; white-space: pre;">4,000<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.57pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares with a par value of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.81pt; position: var(--position); text-decoration: none; white-space: pre;"> per share and an <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">average subscription price of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;11.14<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.69pt; position: var(--position); text-decoration: none; white-space: pre;"> per share (see Note 14).<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the issue of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">415,019<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.51pt; position: var(--position); text-decoration: none; white-space: pre;"> vested free shares, as part of the AGA plans issued by the Group to certain of its officers and employees. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Distribution of dividends <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group did not distribute any dividends for any of the periods presented, does not have any present plan to pay any cash dividends <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on its equity securities in the foreseeable future and currently intends to retain all available funds and any future earnings to operate <span style="display: inline-block; height: 6.93pt;"></span></span></div>and expand our business.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ShareBasedPaymentArrangementsAbstract', window );"><strong>Share-Based Payment Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based payments</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has granted BCEs, BSAs and free shares (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 250.25pt; position: var(--position); text-decoration: none; white-space: pre;">attributions gratuities d&#8217;actions<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.36pt; position: var(--position); text-decoration: none; white-space: pre;">, or &#8220;AGAs&#8221;). These plans qualify as &#8220;equity <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">settled&#8221; under IFRS 2. The Group does not have any obligation to purchase these instruments in the event of departure or if a specific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">event does not occur. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Valuation methods of BCEs, BSAs and AGAs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of share-based awards was determined at grant date using the Black Scholes model for the BCEs and BSAs and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Monte-Carlo simulation for AGAs plans with market performance conditions.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The assumptions used to estimate the fair value of the instruments are presented below and include: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Expected maturity of the options;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Expected volatility based on the historical market share price available; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Expected dividends based on management best estimate; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free interest rate based on French OAT rates measured at grant dates; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Share price, including offered in case of change of control (only for the market conditions applicable to the free-share plans <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2021 and AGA 2023-1) is based on Monte-Carlo simulations and taking into account a change of control premium <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">based on the management best estimate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BCEs as well as the assumptions used for the measurement thereof in accordance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with IFRS 2 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 94.87pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.29pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 273.86pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 527.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td></tr><tr style="height: 98.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.18pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;D<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.28pt; position: var(--position); text-decoration: none; white-space: pre;">ATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 61.5pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.97pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 37.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.73pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 85.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.84pt; position: var(--position); text-decoration: none; white-space: pre;">D BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 74.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2016-11-07<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 129pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2016-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">84,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,495<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(3,699)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-01-23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 141pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">41,735<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 153pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">150,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 165pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,686<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 177pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">64,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(26,687)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-03-15<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 189pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 201pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE 2018-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,844<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(16,844)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 213pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">8,422<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 225pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 225pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.62pt;"></span></span><span style="left: 32.25pt; position: var(--position);">6,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 237pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">530,652<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">385,409<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(51,230)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">330,179<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">245,962<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">330,179<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The BCEs include a service condition under which the beneficiary must still be an employee, a corporate officer or a scientific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consultant of the Group at the time of vesting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The exercise rights for most of the BCEs are vested annually and have the following vesting terms: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.33pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award vests on the first anniversary of the date of grant for all currently issued BCEs; and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 630.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the remaining <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.09pt; position: var(--position); text-decoration: none; white-space: pre;">75%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award, the BCEs vest 1/48th per month over <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.56pt; position: var(--position); text-decoration: none; white-space: pre;">four years<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.8pt; position: var(--position); text-decoration: none; white-space: pre;"> from the anniversary date of the grant. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.04pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Most of the BCEs plans (all BCEs plans except BCE 2014-2 fully vested as of January 1, 2020) include or partially include non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market performance conditions (obtaining financing of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.32pt; position: var(--position); text-decoration: none; white-space: pre;">, positive results on clinic studies, signature of informed consent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in a clinical phase, signing a license agreement, FDA authorization). The level of achievement of the non-market performance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions are taken into account in determining the number of BCEs allocated initially and reassessed at each closing date. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the event of a change of control or a M&amp;A transaction, all the BCEs will become immediately exercisable. A change of control is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">defined as a new investor/company holding directly or indirectly more than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.82pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.15pt; position: var(--position); text-decoration: none; white-space: pre;"> of the share capital or voting rights. As such the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probable vesting date of each plan corresponds to the weighted average of probable change of control dates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.5pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.15pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BSAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.15pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 209.78pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.82pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.15pt; position: var(--position); text-decoration: none; white-space: pre;">DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 46.87pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 70.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.29pt; position: var(--position); text-decoration: none; white-space: pre;">D&#160; BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69pt; left: 489pt; overflow: hidden; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: -6.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-12<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">82,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-09-18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-01-22<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">49,200<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">1,315<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">842<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(842)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">787<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">230<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(230)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 195.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">324,446<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">147,196<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(1,072)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">223,944<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">146,124<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">223,944<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs issued prior to January 1, 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These BSAs include a service condition under which the beneficiary must still be an employee, a corporate officer or a scientific <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.63pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consultant of the Group at the time of vesting. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.03pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The exercise rights for most of these BSAs are vested annually and have the following vesting terms: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 507.23pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.33pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award vests on the first anniversary of the date of grant for all currently issued BSAs; and <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 520.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the remaining <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.09pt; position: var(--position); text-decoration: none; white-space: pre;">75%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> of the award, the BSAs vest 1/48th per month over <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.58pt; position: var(--position); text-decoration: none; white-space: pre;">four years<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.82pt; position: var(--position); text-decoration: none; white-space: pre;"> from the anniversary date of the grant. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">All of these BSAs plans include or partially include non-market performance conditions (positive results on clinic studies, signature of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">informed consent in a clinical phase, signing a license agreement, FDA authorization). The level of achievement of the non-market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">performance conditions are taken into account in determining the number of BSAs allocated initially and reassessed at each closing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.01pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.41pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the event of a change of control or a M&amp;A transaction, all these BSAs will become immediately exercisable. A change of control is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">defined as a new investor/company holding directly or indirectly more than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.82pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.15pt; position: var(--position); text-decoration: none; white-space: pre;"> of the share capital or voting rights. As such the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probable vesting date of each plan corresponds to the weighted average of probable change of control dates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs granted in March 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In March 2024, the Group granted its independent Board members the right to subscribe up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.27pt; position: var(--position); text-decoration: none; white-space: pre;">77,820<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share warrants (BSA) in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 684.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">aggregate, the vesting of which<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.13pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.63pt; position: var(--position); text-decoration: none; white-space: pre;">is subject to a service condition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.63pt; position: var(--position); text-decoration: none; white-space: pre;">four years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.87pt; position: var(--position); text-decoration: none; white-space: pre;">, by tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.98pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.31pt; position: var(--position); text-decoration: none; white-space: pre;"> each, vested on each anniversary <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 696.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">date. Additionally, the BSAs are subject to a vesting acceleration condition in case of a tender offer on the securities issued by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 707.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group and resulting in a change of control of the Group. All of the granted BSAs were subscribed by the beneficiaries in April 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the BSAs was determined at grant date using the Black Scholes model, with the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 92.96pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.84pt; position: var(--position); white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.62pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.38pt; position: var(--position); white-space: pre;">OF THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.07pt; position: var(--position); white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.61pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.5pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.49pt; position: var(--position); white-space: pre;">OF THE BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.94pt; position: var(--position); white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.92pt; position: var(--position); white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.27pt; position: var(--position); white-space: pre;">SUBSCRIPTI<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.82pt; position: var(--position); white-space: pre;">ON PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.15pt; position: var(--position); white-space: pre;">STRIKE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.83pt; position: var(--position); white-space: pre;">PRICE PER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.48pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.2pt; position: var(--position); white-space: pre;">RISK FREE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.52pt; position: var(--position); white-space: pre;">RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.49pt; position: var(--position); white-space: pre;">EXPECTED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.05pt; position: var(--position); white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.71pt; position: var(--position); white-space: pre;">VOLATILITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 41.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.06<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.7<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.5<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;">58,365<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 41.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;">4.30%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">5.4<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;">6.9<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;">60.41%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 53.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.06<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.8<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;">19,455<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 53.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;">4.30%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">5.5<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;">7.0<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;">60.41%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.41pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to AGAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.41pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 241.51pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 537pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 28.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.45pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANGIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.05pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">G AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 52.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 62.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.83pt; position: var(--position); text-decoration: none; white-space: pre;">VESTED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.22pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.81pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.61pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 35.02pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.14pt; position: var(--position); text-decoration: none; white-space: pre;">G <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 47.25pt; width: 199.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 199.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.33pt; position: var(--position); white-space: pre;">FOR THE YEAR ENDED DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 47.25pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.53pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.1pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.19pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,382,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,382,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(212,737)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(390,019)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">780,040<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">100,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">100,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(25,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">75,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">731,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">731,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(245,625)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">485,875<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">254,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">254,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(41,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">213,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">12/01/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">132,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">132,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(51,500)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">81,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">02/01/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,549,125<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,549,125<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(193,500)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,355,625<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">03/28/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">05/23/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/05/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">4,547,421<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">2,601,296<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,946,125<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(744,362)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(415,019)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">3,388,040<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 72pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.84pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 0pt; width: 72pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.22pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE&#160;OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.56pt; position: var(--position); text-decoration: none; white-space: pre;">THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.69pt; position: var(--position); text-decoration: none; white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.02pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.2pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.18pt; position: var(--position); text-decoration: none; white-space: pre;">THE AGA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.19pt; position: var(--position); text-decoration: none; white-space: pre;">AGA PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.3pt; position: var(--position); text-decoration: none; white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.96pt; position: var(--position); text-decoration: none; white-space: pre;">VOLATILITY <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.97pt; position: var(--position); text-decoration: none; white-space: pre;">RISK&#160;FREE&#160;RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2021 <span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 41.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31.60<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2022-07-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">49.0%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.32pt; position: var(--position); text-decoration: none; white-space: pre;">-1.00%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranches 1-4)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 53.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 5)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3.62<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-12-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">67.2%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">3.20%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 6)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 96.75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.74<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-07-11<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">67.2%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">3.20%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 1)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 118.5pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 2)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 140.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.59<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 162pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 174pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 186pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.16<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.16<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-1<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 198pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.26<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.26<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-2<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 210pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.40<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.40<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 222pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.76<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.76<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 234pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 246pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 258pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 270pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.80<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.80<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September 2021<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September 2021 are subject to a vesting service condition of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.39pt; position: var(--position); text-decoration: none; white-space: pre;">one year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.51pt; position: var(--position); text-decoration: none; white-space: pre;"> following the grant date. The number of shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">that will be finally vested under this plan will depend on the following conditions: if a M&amp;A transaction is completed on or prior to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">July 31, 2022 and the price per ordinary share of the Group retained in the framework of the M&amp;A transaction is at least equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 553.78pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 573.78pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">per share (or lower than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.95pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.95pt; position: var(--position); text-decoration: none; white-space: pre;"> per share) then <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.65pt; position: var(--position); text-decoration: none; white-space: pre;"> (or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.31pt; position: var(--position); text-decoration: none; white-space: pre;">75%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.64pt; position: var(--position); text-decoration: none; white-space: pre;">) of the shares initially granted will be vested. The AGAs are forfeited if a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">M&amp;A transaction is not completed on or prior to July 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These conditions qualify as both a non-market performance condition (occurrence or not of a M&amp;A transaction before July 31, 2022) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and a market condition (number of shares depending on the share price offered in case of a M&amp;A transaction before July 31, 2022) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">under IFRS 2 principles. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 518.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The level of achievement of the market condition is directly included in the unit fair value of the free shares and the probability of a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">M&amp;A transaction before July 31, 2022 is included in the estimation of the number of shares that will be finally vested by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">beneficiaries. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the period ended December 31, 2022, the AGAs were all forfeited since no M&amp;A transaction was completed on or prior to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">July 31, 2022. This resulted in a reversal of the related compensation expense of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,026&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.63pt; position: var(--position); text-decoration: none; white-space: pre;"> and the reversal of the accrual for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">social taxes of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;205&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> that was recorded as of December 31, 2021. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in July 2023<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(a) Pursuant to a Board decision on July 11, 2023, the Group allocated a total number of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.95pt; position: var(--position); text-decoration: none; white-space: pre;">1,382,796<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.95pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs to Mr. Marc de Garidel, as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 652.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s Chief Executive Officer, to which performance conditions and service conditions apply (AGA plan 2023-1):<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 674.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">212,738<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 1): the acquisition period shall end on the first anniversary of the allocation date; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 686.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">638,214<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 2): the AGAs 2023-1 shall progressively be definitively acquired on a monthly basis over <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.78999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">three years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> starting after the first anniversary of the allocation date;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">212,738<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 3): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which a specific performance condition related to regulatory approval is fulfilled; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">106,369<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 4): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which the Group successfully completes a public offering raising at least <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.4200000000001pt; position: var(--position); text-decoration: none; white-space: pre;">$100&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.77pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">in gross proceeds (the condition was met on October 24, 2023); <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">106,369<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 5): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which a specific performance condition related to the Group&#8217;s market capitalization is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">fulfilled; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">106,368<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-1 (tranche 6): the acquisition period shall end on the first anniversary of the allocation date subject <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to the completion, prior to such date, of a tender offer on the securities issued by the Group, at a predetermined minimum <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price, and resulting in a change of control of the Group; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, AGAs related to tranches 1 to 5 are subject to a vesting acceleration condition in case of a tender offer on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">securities issued by the Group and resulting in a change of control of the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group qualified those conditions under IFRS 2 principles as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions related to tranches 1 and 2 qualify as service conditions under IFRS 2 principles.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 277pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions related to tranches 3 and 4 qualify as service and non-market performance conditions. Their levels of achievement <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are reflected in the number of instruments that are expected to vest and were estimated by management based on observable <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 303.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">industry-specific data.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 317.32pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conditions related to tranches 5 and 6 qualify as service and market performance conditions. The levels of achievement of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">market conditions are reflected in the unit fair value of the free shares and were estimated by management using the valuation <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">methods and assumptions set out above. The valuation of tranche 6 also incorporates management&#8217;s estimate of the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 357.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">probability of a M&amp;A transaction prior to the limit date.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 371.08pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The vesting acceleration condition in case of a tender offer on the securities issued by the Group and resulting in a change of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">control of the Group qualifies as a non-market performance condition.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 411.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(b) Pursuant to a Board decision on July 11, 2023, the Group allocated a total number of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.52pt; position: var(--position); text-decoration: none; white-space: pre;">100,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.02pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs to Mr. Hartmut Ehrlich, as the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 422.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s former Chief Executive Officer, to which the following conditions apply (AGA plan 2023-2):<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 445.36pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">25,000<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-2 (tranche 1): the acquisition period shall end on the first anniversary of the allocation date, and is <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not subject to a future service condition; <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 472.24pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;">75,000<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.89pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2023-2 (tranche 2): the acquisition period shall end on the latest date between (i) the first anniversary of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the allocation date, and (ii) the date on which a specific condition, related to positive results on clinical studies, is fulfilled. <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The acquisition is not subject to a future service condition. Additionally, the tranche is subject to a vesting acceleration <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">condition in case of a tender offer on the securities issued by the Group and resulting in a change of control of the Group.&#160; <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">This tranche qualifies as a non-vesting condition. Its level of achievement is reflected in the unit fair value of the free shares, <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and was estimated by management based on observable industry-specific data.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in September and December 2023<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.72pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On September 28, 2023 and December 1, 2023, certain of the Group&#8217;s officers and employees were allocated respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.72pt; position: var(--position); text-decoration: none; white-space: pre;">985,750<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.22pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs (AGA plans 2023-3 and 2023-4) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.98pt; position: var(--position); text-decoration: none; white-space: pre;">132,750<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.48pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plan 2023-5) in the aggregate, the vesting of which is subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certain conditions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 633.52pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to remaining employed with the Group, each such officer or employee&#8217;s AGAs will be vested as follows: (i) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.28pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.61pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.39pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.38pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.9pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, (ii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.26pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.18pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.14pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.66pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 660.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(iii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.47pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.8pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.39pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.05pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.57pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (service condition). <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 685.04pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Of the <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.75pt; position: var(--position); text-decoration: none; white-space: pre;">1,118,500<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.75pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs, <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.8pt; position: var(--position); text-decoration: none; white-space: pre;">254,250<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.3pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs are subject to an additional non-market performance condition of the successful <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">completion of a public offering raising at least <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">$200&#160;million<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.89pt; position: var(--position); text-decoration: none; white-space: pre;"> in gross proceeds. This condition was met on October 24, 2023.<span style="display: inline-block; height: 8.73pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, all the 2023-3, 2023-4 and 2023-5 AGAs are subject to a vesting acceleration condition in case of a tender offer on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">securities issued by the Group and resulting in a change of control of the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs granted in February, March, May, July and September 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On February 1, 2024, March 28, 2024, May 23, 2024, July 11, 2024 and September 5, 2024 certain of the Group&#8217;s officers and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 141.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">employees were allocated respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.41pt; position: var(--position); text-decoration: none; white-space: pre;">1,549,125<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.41pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plans 2024-1), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.7pt; position: var(--position); text-decoration: none; white-space: pre;">22,500<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.2pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plan 2024-2), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.6pt; position: var(--position); text-decoration: none; white-space: pre;">38,500<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.1pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">plans 2024-3), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.25pt; position: var(--position); text-decoration: none; white-space: pre;">138,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.75pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plans 2024-4, 5 and 6) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.9pt; position: var(--position); text-decoration: none; white-space: pre;">198,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.4pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs (AGA plans 2024-7), in the aggregate, the vesting of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which is subject to certain conditions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 189pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Subject to remaining employed with the Group, each such officer or employee&#8217;s AGAs (with the exception of AGAs 2024-6) <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 202.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will be vested as follows: (i) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.31pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.9pt; position: var(--position); text-decoration: none; white-space: pre;">two years<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.47pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date, (ii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.83pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.16pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.75pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 551.71pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.23pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">period from the allocation date and (iii) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.06pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.39pt; position: var(--position); text-decoration: none; white-space: pre;"> at the end of a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.98pt; position: var(--position); text-decoration: none; white-space: pre;">four years<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.22pt; position: var(--position); text-decoration: none; white-space: pre;"> period from the allocation date (service condition).<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03pt; position: var(--position); text-decoration: none; white-space: pre;">20,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.53pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs 2024-6 granted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.64pt; position: var(--position); text-decoration: none; white-space: pre;">an employee <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.9pt; position: var(--position); text-decoration: none; white-space: pre;">are composed of (i) a first tranche of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.61pt; position: var(--position); text-decoration: none; white-space: pre;">10,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.11pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs not subject to any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">presence of performance condition&#160; and (ii) a second tranche of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;">10,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.02pt; position: var(--position); text-decoration: none; white-space: pre;"> AGAs subject to a non-vesting condition, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">achievement of which was deemed certain on grant date.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 290.16pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Additionally, all the 2024-1 to 2024-7 AGA plans are subject to a vesting acceleration condition in case of a tender offer on <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the securities issued by the Group and resulting in a change of control of the G<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.4pt; position: var(--position); text-decoration: none; white-space: pre;">roup.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Social taxes related to AGAs<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">AGA plans granted to the Group's officers and employees are subject to employer's taxes, measured in accordance with the same <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">principles as the AGA plans. These taxes are classified as provisions before they are due.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 400.96pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre; width: 439.91pt;">Breakdown of the compensation expenses accounted for the period ended December 31, 2022, 2023 and 2024<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 424.31pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.88pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(138)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(211)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 65.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(1,026)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(8,067)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;">(19,900)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 77.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Social taxes related to AGAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(205)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(426)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.3pt; position: var(--position); text-decoration: none; white-space: pre;">(717)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(1,369)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(8,605)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;">(20,941)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ShareBasedPaymentArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ShareBasedPaymentArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Disclosure of financial liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial liabilities</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.36pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 101.66pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 110.46pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 422.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 191.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 44.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">4,730<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret bond loans <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">26,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">839<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">160<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,431<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,558<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,402<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,252<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">9,127<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,563<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">29,056<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret convertible notes (OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A &amp; B BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">424<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane conversion option<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">142<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret minimum return indemnifications <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">566<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,262<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,262<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,287<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">12,229<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">6,549<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">15,491<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">16,241<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">39,697<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">69,069<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 229.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">8,252<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 241.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret bond loans <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">20,028<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 253.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">545<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">379<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">932<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 265.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,280<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,276<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,235<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 277.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">10,077<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,655<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">22,195<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 289.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">19,957<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 301.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 313.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">19,957<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 325.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,521<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,509<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 337.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,521<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,509<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 349.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 349.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 349.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 361.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 373.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">33,555<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">37,348<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 385.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">49,797<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">77,045<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);">114,004<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 524.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and Non-current Liabilities <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 535.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the non-current portion of the Heights convertible notes as of December <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 545.99pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2023 were reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.1. Structured debt financing with <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 209.22pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret subscribed in August 2023 &#8211; &#8220;Kreos / Claret Financing&#8221;<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 20, 2023, the Group entered into a structured debt financing agreement with Kreos and Claret&#160; (the Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 636.87pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financing), for up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;75,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.31pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.27pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing consists of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.99pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.95pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.15pt; position: var(--position); text-decoration: none; white-space: pre;"> each in aggregate principal amount:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The first tranche (&#8220;tranche A&#8221;) in aggregate principal amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.53pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.62pt; position: var(--position); text-decoration: none; white-space: pre;"> takes the form of senior secured <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.87pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bonds with warrants attached (the &#8220;Kreos / Claret OCABSA&#8221;) and was drawn on August 22, 2023. The Kreos / <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Claret OCABSA are convertible into ordinary shares at any time from their issuance at the request of their holders at a fixed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">conversion price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;21.2209<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to standard adjustments, including anti-dilution and dividend protections. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on the Kreos / Claret OCABSA accrues at a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.28999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">9.00%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.12pt; position: var(--position); text-decoration: none; white-space: pre;"> annual fixed interest rate, payable in quarterly installments. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret OCBSA&#8217;s maturity date is March 31, 2027, it being specified that the scheduled date of final repayment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">January 1, 2027.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is allowed to prepay the amounts due under the Kreos / Claret OCABSA at any time. In such case, the Group will <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">be required to pay a sum equal to (i) the principal outstanding at the time of the prepayment (plus accrued interests), plus (ii) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an aggregate of all remaining interest payments that would have been paid throughout the remainder of the term of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">tranche, discounted to present value by applying a discount rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.48pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.81pt; position: var(--position); text-decoration: none; white-space: pre;">, plus (iii) an end-of-loan exit fee equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.05pt; position: var(--position); text-decoration: none; white-space: pre;">8.0%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.88pt; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">amounts drawn thereunder. In case of prepayment, the holders of the Kreos / Claret OCABSA will have the option to request <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a conversion of their Kreos / Claret OCABSA instead of a cash repayment, in which case, the end-of-loan exit fee is not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">payable by the Group.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The warrants included in the Kreos / Claret OCABSA will only become exercisable in case of prepayment in cash of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret convertible bonds by the Group. Upon exercise of the warrants, their holders will be able to subscribe to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">same number of ordinary shares (and at the same price conditions) as they would have been able to subscribe had they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">converted the Kreos / Claret OCABSA which have been prepaid in cash. Any warrants not exercised on or prior to January 1, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2027 will become automatically null and void. For the avoidance of doubt, if the Group does not prepay any Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">OCABSA in cash prior to their scheduled repayment dates, none of the warrants will be exercisable.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The second tranche (&#8220;tranche B&#8221;) in aggregate principal amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.72pt; position: var(--position); text-decoration: none; white-space: pre;"> takes the form of senior secured non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bonds and was drawn on March 28, 2024. The drawdown of the second tranche was subject to a maximum <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.79pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.12pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Debt-To-Market Capitalization Ratio at the time of drawdown. The &#8220;Debt-To-Market Capitalization Ratio&#8221; is calculated on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">any relevant date, by dividing (i) the indebtedness of the Group (including amounts due under the Kreos / Claret Financing <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 363.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">but excluding amounts due under the Heights Financing), by (ii) the market capitalization of the Group calculated by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">multiplying the number of outstanding ordinary shares by the closing price of the ordinary shares on such relevant date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The third tranche (&#8220;tranche C&#8221;) in aggregate principal amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.84pt; position: var(--position); text-decoration: none; white-space: pre;"> takes the form of senior secured non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bonds and was drawn on June 21, 2024. The drawdown of the third tranche was subject to a maximum <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.15pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.48pt; position: var(--position); text-decoration: none; white-space: pre;"> Debt-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">To-Market Capitalization Ratio at the time of drawdown (excluding the Heights Financing) and was conditional on the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">raising a minimum of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.8pt; position: var(--position); text-decoration: none; white-space: pre;">$125,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.89pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> in gross proceeds through a listing on Nasdaq before June 30, 2024. This condition </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.26pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">was met on October 24, 2023 (see Note 3.3).</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 464.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">A variable interest rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.56pt; position: var(--position); text-decoration: none; white-space: pre;">7.5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.39pt; position: var(--position); text-decoration: none; white-space: pre;"> + European Central Bank Base Rate (MRO) (with a floor at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.07pt; position: var(--position); text-decoration: none; white-space: pre;">2.5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.9pt; position: var(--position); text-decoration: none; white-space: pre;"> and a cap at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.3199999999999pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.65pt; position: var(--position); text-decoration: none; white-space: pre;">) applies to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the second and third tranche. These <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.99pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.98pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches will be repaid monthly through March 31, 2027, after a deferred repayment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the principal until February 1, 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is allowed to prepay the amounts due under the second and third tranches of the Kreos / Claret Financing at any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">time. In such case, The Group will be required to pay a sum equal to (i) the principal outstanding at the time of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prepayment (plus accrued interests), plus (ii) an aggregate of all remaining interest payments that would have been paid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">throughout the remainder of the term of the applicable tranche, discounted to present value by applying a discount rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.9300000000001pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.26pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">plus (iii) an end-of-loan exit fee equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.24pt; position: var(--position); text-decoration: none; white-space: pre;">6.0%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.07pt; position: var(--position); text-decoration: none; white-space: pre;"> of the amounts drawn under the applicable tranche.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing also provides for a Minimal Return Indemnification ("MRI") to the benefit of the bondholders. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 587.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum Cash Return amount is defined as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 599.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(i) with respect to tranche A and tranche B, 1.4 times the amount of the cumulated principal drawn under the relevant <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 543.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instrument, and; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(ii) with respect to tranche C, 1.3 times the amount of the cumulated principal drawn under the relevant instrument.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the event the amount of the cash generated by the tranche A (the Kreos / Claret OCABSA), tranche B or tranche C bond loans, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">including principal and interest payments, transaction fees, and the end-of-loan exit fees, (the &#8220;Actual Return&#8221; calculated as at the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 671.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">earlier of (i) March 31, 2027, or (ii) the date of any prepayment or acceleration of the tranche B and C bond loans or more generally <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">such earlier date as the same shall become repayable ("the Redemption Date")), is lower than the Minimum Cash Return, the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shall indemnify the bondholders for the difference between the Minimum Cash Return and the Actual Return (the &#8220;Minimal Return <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Indemnification"). <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">If at the time of the Minimum Return Indemnification payment, the warrants related to both the OCABSA Bonds and the Tranche B <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amortized bonds (the &#8220;Kreos / Claret A-B warrants&#8221;) or the Kreos / Claret Tranche C warrants are still outstanding, the exercise price <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for such warrants shall be adjusted up by the amount of the Minimum Return Indemnification divided by the number of warrants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">outstanding. For any Kreos / Claret A-B or C warrants that were exercised prior to the last Redemption Date, any capital gains made <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the exercise of such warrants will be added to the Minimum Cash Return amount.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Unless the repayment of the Tranche A and B bond loans results from a change of control (in which case the calculation of the Actual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Return shall only include (i) interest accrued prior to conversion of any Tranche A OCABSA, (ii) transaction and end-of-loan exit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fees, and (iii) the net capital gain derived from the sale of shares underlying the Tranche A OCABSA within the framework of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">change of control transaction), neither the principal subscribed under Tranche A nor the Actual Return generated by Tranche A shall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 185.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">be included in the calculation of the Minimum Return Indemnification (i.e. the Minimum Cash Return and the Actual Return shall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">only be calculated, and the Minimum Return Indemnification shall only apply to Tranche B and Tranche C).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 219.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary exceptions) which include, among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">things, restrictions on the incurrence of indebtedness, cross-default, the distribution of dividends and the grant of security interests. As <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">security for the Kreos / Claret Financing, the lenders benefit from the grant of first-ranking collateral on The Group&#8217;s principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tangible and intangible assets, including pledges over The Group&#8217;s business (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 344.86pt; position: var(--position); text-decoration: none; white-space: pre;">fonds de commerce<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422pt; position: var(--position); text-decoration: none; white-space: pre;">) as a going concern and intellectual <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">property rights in The Group's lead drug candidate, as well as pledges over The Group&#8217;s bank accounts and receivables. Such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">securities apply to all tranches of the Kreos / Claret Financing.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition to the Kreos / Claret OCABSA, the Group has issued warrants (the &#8220;tranche A-B BSA&#8221;) for a global subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1.00<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.5pt; position: var(--position); text-decoration: none; white-space: pre;">, giving Kreos and Claret the right to subscribe to up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.35pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.85pt; position: var(--position); text-decoration: none; white-space: pre;"> new ordinary shares at an exercise price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.6744<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.96pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(corresponding to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.21pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.54000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> premium over the 15-day VWAP prior to the date on which their issuance was decided). On November 2, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 331.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2023, a second tranche of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.9pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.4pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos / Claret warrants (the &#8220;tranche C BSA&#8221;) was issued. The exercise price of the additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">warrants is equal to approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.66pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.16pt; position: var(--position); text-decoration: none; white-space: pre;"> (corresponding to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.94pt; position: var(--position); text-decoration: none; white-space: pre;">110%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.27pt; position: var(--position); text-decoration: none; white-space: pre;"> of the 15-day VWAP prior to the date on which their issuance was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">decided). The number of warrants issued corresponds to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.73pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,000,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.73pt; position: var(--position); text-decoration: none; white-space: pre;"> divided by the aforementioned exercise price (i.e. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.79pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.29pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">warrants). Of these additional warrants, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.64pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.97pt; position: var(--position); text-decoration: none; white-space: pre;"> are exercisable immediately and the remaining <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.61pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.94pt; position: var(--position); text-decoration: none; white-space: pre;"> (&#8220;the conditional warrants&#8221;) shall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">only be exercisable if the third tranche of the Kreos / Claret Financing is drawn by the Group.&#160; The Kreos / Claret warrants can be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 389.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercised over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.26pt; position: var(--position); text-decoration: none; white-space: pre;">7 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.84pt; position: var(--position); text-decoration: none; white-space: pre;"> from their issuance date or up until the date of the successful closing of a tender offer for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares, whichever is earlier. At the time of exercise of the Kreos / Claret warrants, the holders of the warrants are eligible to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">sell part of their warrants to the Group in accordance with a put option agreement to allow for a cashless exercise. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 22, 2023, the Group repaid in full the pre-existing debt agreements with Kreos for a total amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7,661&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.9pt; position: var(--position); text-decoration: none; white-space: pre;">. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">accounting treatment of this transaction is explained in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.37pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Note 15.3.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 502.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret OCABSA<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 525.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret OCABSA are issued at market conditions: the net issuance proceeds reflect the fair value of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">instruments at inception. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The OCABSA are compound instruments, split between (i) a debt component (then measured at amortized cost) and (ii) an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">equity component corresponding to the conversion option and the attached OCABSA warrants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As the adjustment provisions of the OCABSA conversion ratio are aimed at preserving the rights of the bondholders and are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">anti-dilutive in nature rather than a down-round protection, the Group determined that the conversion option of the OCABSA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">is considered to result in the delivery of a fixed number of shares, and is therefore an equity instrument (the equity component <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the bonds).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The OCABSA warrants were attached to each bond issued in the Tranche A closing and are not transferrable until after a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prepayment. The OCABSA warrants become exercisable (i) upon the Group electing to prepay the bonds and (ii) in the event <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the absence of the conversion notice from the bondholders for the full amount of the prepayment. As such, the warrants are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">not freely transferable until the prepayment is made. Thus, the OCABSA warrants are considered as an embedded component <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of the bonds rather than a separate stand-alone financial instrument. In all scenarios under which the exercisability conditions <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are satisfied, and whereby the bondholder&#8217;s option to elect to convert the bonds was considered, the number of total ordinary <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">shares issuable upon warrant exercise as a result of prepayment and/or conversion option exercise remains fixed. Thus, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">warrants represent an equity-classified component of the bonds.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The issuer prepayment option was deemed closely related to the host debt instrument and therefore does not meet the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">definition of a derivative instrument to be bifurcated.&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret B and C tranches<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The initial right granted to the Group to issue the amortized bonds under tranches B and C, upon meeting certain conditions, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">did not meet the definition of a liability and was considered an off-balance sheet loan commitment received from the issuer as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">of December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The interest rate collars related to tranches B and C were determined to be closely related to the host debt instruments and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">therefore do not meet the definition of a derivative instrument to be bifurcated.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The prepayment options related to tranches B and C were not determined to be closely related to the host debt instruments <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and therefore meet the definition of derivative instruments to be bifurcated. The Group determined that their fair value is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">insignificant at issuance and as of December 31, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Minimum Return Indemnifications are embedded derivative instruments, which are not deemed closely related to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">host debt instruments and therefore meet the definition of derivative instruments to be bifurcated. They are classified as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 311.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">derivative financial liabilities and measured at fair value through profit or loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret second and third tranches are therefore hybrid instruments, split between (i) debt host contracts accounted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">for at amortized cost and (ii) bifurcated embedded derivatives accounted for at fair value through profit and loss, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 359.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding to the Minimal Return Indemnifications and the prepayment options (the fair value of the prepayment options <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">being deemed insignificant at issuance and as of December 31, 2024).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 395.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret BSA<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As the A-B and C warrants (the Kreos / Claret BSA) are contractually transferable separately from the bonds and are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">redeemable in a variable number of ordinary shares of the Group, they are classified as standalone derivative financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As the A-B and C warrants (the Kreos / Claret BSA) represent compensation for the realized and future bond issuances of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">respectively tranches A-B and C and are an integral part of generating such bond issuances, the Group determined that they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">are in nature origination fees. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.7pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As the A-B warrants are associated with both the OCABSA issued under tranche A and the amortized bonds issued under </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.9pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">tranche B, the Group allocated the initial fair value of the A-B warrants based on the pro-rata value of the proceeds to be </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.1pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">received under each tranche. At inception, the respective initial fair values of the A-B warrants allocated to tranche A and B </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.3pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">were deferred and subsequently accounted for as an adjustment to the EIR of the related debt components upon their </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.5pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">drawdown (on August 20, 2023 and March 28, 2024 for tranches A and B respectively). </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.75pt; position: var(--position); text-decoration: none; white-space: pre;">Subsequent changes in the fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">will be <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.96000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">recognized through profit or loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.3pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">On November 2, 2023 (issuance date of the Kreos / Claret tranche C BSA), a derivative financial liability was recognized for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their initial fair value with a counterparty in prepaid expenses. On that date, the Group, based on management&#8217;s latest <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.7pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">projections, did not consider the drawdown of the tranche C bonds to be probable. Therefore, the amount of prepaid expenses <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 632.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">allocated to the tranche C BSA <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.49pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> has been amortized on a straight-line basis until the drawdown of the tranche C bonds.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of the debt and equity components of the OCABSA<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the fair value of the debt component of the OCABSA amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 353.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23,995&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.27pt; position: var(--position); text-decoration: none; white-space: pre;">, using a market rate assumption of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">12.6%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.83pt; position: var(--position); text-decoration: none; white-space: pre;">.&#160; The equity component amounts to the difference between the whole instrument&#8217;s fair value at inception (its nominal value of <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">) and the standalone fair value of the debt component. Therefore, the equity component amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,005&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.06pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">It is not subsequently remeasured.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On the same date, using the same assumptions and an increase in market rate by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.39pt; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.39pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the debt component and an increase in the value of the equity compone<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.1pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nt by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.87pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;624&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.46pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of the Kreos / Claret second and third tranches hybrid instruments<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 176.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the net cash proceeds are the tranches' initial fair values. The fair values of the Minimal Return Indemnifications were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deducted from the initial carrying values of the debt components of each tranche, which were subsequently measured at amortized cost <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">using the EIR method.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 212.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.1pt; position: var(--position); text-decoration: none; white-space: pre;">he fair value of the Minimum Return Indemnifications was<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"> measured using the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 236.2pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche B Minimum Return Indemnification (issued in March <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.93pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF MARCH 28, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.40<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.40<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">13<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,959<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">68<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">2,635<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;">136<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,066<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,410<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">241<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;">1,615<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">68<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;">2,499<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;">136<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche B MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);">1,683<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);">2,636<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 409.5pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche C Minimum Return Indemnification (issued in June <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.03pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JUNE 21, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">15<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(a) Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">741<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,160<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">43<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(b) Probability-weighted fair value of tranche C warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">2,948<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">684<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(c) Probability-weighted fair value of tranche C warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">3,250<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">903<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;">475<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;">941<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">43<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche C MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);">475<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);">984<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the purpose of measuring the fair value of the MRI (shortfall payment), the fair value of the tranche A-B and C BSA was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 597.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured with a Black Scholes model under the Final redemption scenario and with a Monte Carlo model under the Tender offer <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario. As of March 28, 2024, the following assumptions were used: a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.40<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.07pt; position: var(--position); text-decoration: none; white-space: pre;">, a volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.38pt; position: var(--position); text-decoration: none; white-space: pre;">60.3%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.21pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.83pt; position: var(--position); text-decoration: none; white-space: pre;">61.9%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.66pt; position: var(--position); text-decoration: none; white-space: pre;"> (Monte Carlo), and a risk-free rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.09pt; position: var(--position); text-decoration: none; white-space: pre;">2.6%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.92pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.28pt; position: var(--position); text-decoration: none; white-space: pre;">2.8%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.11pt; position: var(--position); text-decoration: none; white-space: pre;"> (Monte Carlo).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 633.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of June 21, 2024, the following assumptions were used: a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.53pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.94<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.03pt; position: var(--position); text-decoration: none; white-space: pre;">, a volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.34pt; position: var(--position); text-decoration: none; white-space: pre;">60.1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.17pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.53pt; position: var(--position); text-decoration: none; white-space: pre;">59.9%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Monte Carlo), and a risk-free rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.93pt; position: var(--position); text-decoration: none; white-space: pre;">3.0%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.76pt; position: var(--position); text-decoration: none; white-space: pre;"> (Black Scholes) or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.12pt; position: var(--position); text-decoration: none; white-space: pre;">3.1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.95pt; position: var(--position); text-decoration: none; white-space: pre;"> (Monte Carlo).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.05pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The assumptions used for the valuations as of December 31, 2024 are set f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.48pt; position: var(--position); text-decoration: none; white-space: pre;">orth below.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of March 28, 2024, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.15pt; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.78pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.11pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.29pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.29pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.96pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.29pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.72pt; position: var(--position); text-decoration: none; white-space: pre;">5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.05pt; position: var(--position); text-decoration: none; white-space: pre;"> in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probability of achieving the Final redemption scenario and +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.57pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.9pt; position: var(--position); text-decoration: none; white-space: pre;"> discount rate would result in changes of the MRI B value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;">4&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-30&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.89pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.89pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-3&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.81pt; position: var(--position); text-decoration: none; white-space: pre;">, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.44pt; position: var(--position); text-decoration: none; white-space: pre;">35&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.03pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-53&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.38pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of June 21, 2024, using the same assumption with an increase of +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.02pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.35pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.53pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.53pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.2pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 457.53pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.96pt; position: var(--position); text-decoration: none; white-space: pre;">5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.29pt; position: var(--position); text-decoration: none; white-space: pre;"> i<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540.56pt; position: var(--position); text-decoration: none; white-space: pre;">n the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">probability of achieving the Final redemption scenario and +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.57pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.9pt; position: var(--position); text-decoration: none; white-space: pre;">discount rate would result in changes of the MRI C fair value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;">4&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-16&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.89pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.52pt; position: var(--position); text-decoration: none; white-space: pre;">8&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.11pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.74pt; position: var(--position); text-decoration: none; white-space: pre;">46&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.33pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.76pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-13&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.68pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, using the same assumption with an increase of +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.74pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.25pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.92pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.25pt; position: var(--position); text-decoration: none; white-space: pre;">risk-free rate, +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 560.51pt; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the probability of achieving the Final redemption scenario and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.14pt; position: var(--position); text-decoration: none; white-space: pre;"> +<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.27pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.6pt; position: var(--position); text-decoration: none; white-space: pre;"> discount rate would result in changes of the MRI B and C fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-3&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.22pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-3&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.14pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.77pt; position: var(--position); text-decoration: none; white-space: pre;">3&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.36pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-82&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.71pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of the Kreos / Claret tranche A-B-C BSA <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret tranche A-B and tranche C BSA are measured at fair value using a Black-Scholes valuation model. The model <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">considers <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.22999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> probability-weighted scenarios, i.e. (i) the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.52pt; position: var(--position); text-decoration: none; white-space: pre;">7 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.1pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry of the BSA and (ii) an earlier exercise upon a tender offer. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.17pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">main data and assumptions are the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 311.06pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 497.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 120pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche A-B BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">August 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.32pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 22, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 37.65pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche A-B)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 0pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.25pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 24pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 91.37pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 24pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.62pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 39.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 95.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 39.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;17.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 55.5pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.76<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.99pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry) 18/02/2027 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 79.79pt; position: var(--position); text-decoration: none; white-space: pre;">(tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 71.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.18pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.1pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 71.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.43pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 92.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 92.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 92.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">71.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">65.2%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 108pt; width: 120pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.96pt; position: var(--position); text-decoration: none; white-space: pre;">59.5%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 89.61999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.88pt; position: var(--position); text-decoration: none; white-space: pre;">64.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.54pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 108pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.21pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.13pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 129pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 129pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 129pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">3.00<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 144.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 98.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 98.59pt; position: var(--position);">2.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 378pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0.52pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.21pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 10.6pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.13pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche A-B BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 162pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);">2,092<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 162pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.96pt;"></span></span><span style="left: 100.58999999999999pt; position: var(--position);">920<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 162pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);">243<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div style="position: var(--position); top: 81.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 522pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 137.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche C BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">November 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.43pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF NOVEMBER 2, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of which, number of conditional BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">202,915<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">202,916<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 118.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.89<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); white-space: pre;">01/11/2030 (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Probability of Drawdown of Tranche C <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">credit facility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.09pt; position: var(--position); text-decoration: none; white-space: pre;">Drawn on June 21, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">67.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">64.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">67.4%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">64.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 181.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">3.00<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">2.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 3.89pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.21pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 13.97pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 61.13pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 205.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche C BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);">1,493<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);">1,659<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 101.71pt;"></span></span><span style="left: 104.33999999999999pt; position: var(--position);">923<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of August 20, 2023 (date of issuance of the tranche A-B BSA), using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.98pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.94pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.49pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.63pt; position: var(--position); text-decoration: none; white-space: pre;">share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.17pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.13pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.26pt; position: var(--position); text-decoration: none; white-space: pre;">+5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.22pt; position: var(--position); text-decoration: none; white-space: pre;"> in the probability of achieving the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.39pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.89pt; position: var(--position); text-decoration: none; white-space: pre;">7 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.47pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranche A-B BSA fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.28pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;48&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.87pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;197&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.46pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;64&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.05pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;64&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.07pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of November 2, 2023 (date of issuance of the tranche C BSA), using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.73pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.69pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.24pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.63pt; position: var(--position); text-decoration: none; white-space: pre;">share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.17pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.13pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.26pt; position: var(--position); text-decoration: none; white-space: pre;">+5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.22pt; position: var(--position); text-decoration: none; white-space: pre;"> in the probability of achieving the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.89pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.89pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.41pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranche A-B BSA fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.28pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;28&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.87pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;232&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.46pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;42&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.05pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;36&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.07pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;">share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.79pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.75pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.98pt; position: var(--position); text-decoration: none; white-space: pre;">+5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 432.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the probability of achieving the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.17pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.17pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.69pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of Kreos / Claret A-B and C BSA fair value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;96&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.34pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.34pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;401&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.93pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;95&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.52pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.95pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;76&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.54pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 468.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2024, using the same assumption with an increase of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"> share price, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.29pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.25pt; position: var(--position); text-decoration: none; white-space: pre;"> ri<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.85pt; position: var(--position); text-decoration: none; white-space: pre;">sk-free rate and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.63pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.96pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 62.46pt; position: var(--position); text-decoration: none; white-space: pre;">in the probability of achieving the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.63pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.63pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.15pt; position: var(--position); text-decoration: none; white-space: pre;"> expiry scenario would result in an increase of Kreos / Claret A-B and C BSA fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 492.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.38pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;37&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.97pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;350&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.56pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;61&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.15pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.08pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;75 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.67pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.2.&#160; Heights convertible notes&#160; <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 20, 2023, the Group entered into a convertible notes subscription agreement with Heights, which provided for up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;75,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in financing, consisting of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.44pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.43pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 602.06pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The first tranche (&#8220;tranche A&#8221;) of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;35,000&#160;thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.56pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount was drawn on August 24, 2023 and is <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 615.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">composed of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); text-decoration: none; white-space: pre;">350<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.85pt; position: var(--position); text-decoration: none; white-space: pre;"> amortizing senior convertible notes with a nominal value of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.45pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100,000<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 421.95pt; position: var(--position); text-decoration: none; white-space: pre;"> each and a fixed conversion price of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 628.94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.7674<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.5pt; position: var(--position); text-decoration: none; white-space: pre;"> (corresponding to a <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">40%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.54pt; position: var(--position); text-decoration: none; white-space: pre;"> premium over the 15-day VWAP prior to the date on which their issuance is decided, and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.38pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">subject to standard adjustments, including anti-dilution and dividend protections).<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 667.02pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">The second tranche (&#8220;tranche B&#8221;) of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;40,000&#160;thousand<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount is composed of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.23pt; position: var(--position); text-decoration: none; white-space: pre;">400<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.23pt; position: var(--position); text-decoration: none; white-space: pre;"> amortizing senior <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">convertible notes with a nominal value of <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100,000<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> each, and a conversion price (if any) that is be equal to <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.52pt; position: var(--position); text-decoration: none; white-space: pre;">130%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.85pt; position: var(--position); text-decoration: none; white-space: pre;"> of the 15-<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">day VWAP immediately preceding the date on which their issuance is decided.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">It may be drawn during the period from the date immediately following the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.27pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.23pt; position: var(--position); text-decoration: none; white-space: pre;">-month<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.1pt; position: var(--position); text-decoration: none; white-space: pre;"> anniversary of the issuance of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">first tranche to the first-year anniversary of the issuance of the first tranche (i.e. August 24, 2024), in up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.33pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.3199999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> separate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">closings to provide the Group with additional flexibility to request a partial drawdown.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">On the limit date for the drawdown of the second tranche of the Heights Financing (i.e. August 4, 2024), the Group had not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">drawn down this tranche and has therefore forgone its right to do so in the future.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on the Heights convertible notes accrues at a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.32pt; position: var(--position); text-decoration: none; white-space: pre;">6.00%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.15pt; position: var(--position); text-decoration: none; white-space: pre;"> annual fixed interest rate payable in quarterly installments in cash or, at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the option of the Group, in ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights convertible notes will be repaid through <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.65pt; position: var(--position); text-decoration: none; white-space: pre;">sixteen<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"> quarterly installment payments, beginning <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.63pt; position: var(--position); text-decoration: none; white-space: pre;">three months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.52pt; position: var(--position); text-decoration: none; white-space: pre;"> after their <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance date (corresponding, for the first tranche, to a final repayment date on August 24, 2027). Installments are payable in cash or, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">at the option of the Group, in ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Any interest or installment payments in shares will be made on the basis of a share price equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.81pt; position: var(--position); text-decoration: none; white-space: pre;">90%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.14pt; position: var(--position); text-decoration: none; white-space: pre;"> of the Market Price of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares at the time of payment, where &#8220;Market Price&#8221; refers to the arithmetic average of the daily volume weighted average <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price (&#8220;VWAP&#8221;) for the ordinary shares on the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.8pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.79pt; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.62pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.62pt; position: var(--position); text-decoration: none; white-space: pre;">) days with the lowest daily VWAPs out of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.9pt; position: var(--position); text-decoration: none; white-space: pre;">five<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.43pt; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.26pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.26pt; position: var(--position); text-decoration: none; white-space: pre;">) trading days immediately <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">preceding the applicable date, but in no event greater than the VWAP of the ordinary shares on the applicable date. The Market Price <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">may not be higher than the applicable conversion price. Issuances of ordinary shares may not be made at a price lower than a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.62pt; position: var(--position); text-decoration: none; white-space: pre;">15%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 555.95pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">discount to the 15-day VWAP at the time of the decision to issue the Heights convertible notes (i.e., <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.4303<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.56pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share.).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 305.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights convertible notes include the following conversion and settlement options:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.96pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Conversion at the option of the noteholders: the notes are convertible into the Group&#8217;s ordinary shares at the option of the <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">noteholders at any time during the period beginning on the tranche A notes closing until the fifth business day prior to the <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">maturity date. The ordinary shares issued would be equal to the product of (i) the conversion ratio in effect on the exercise <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">date, (ii) a fraction, the numerator of which is the outstanding principal amount per note and the denominator of which is the <span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">initial principal amount of <span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100,000<span style="display: inline-block; height: 7.28pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.58pt; position: var(--position); text-decoration: none; white-space: pre;"> per note, and (iii) the number of notes for which the conversion right has been exercised.<span style="display: inline-block; height: 7.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Settlement in shares at the option of the Group: the Group has the option to settle any interest or principal due with its own <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary shares (with respect to all but not some of the notes outstanding), subject to a price limit. The ordinary shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">issuable will be the lower of the conversion ratio or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.1pt; position: var(--position); text-decoration: none; white-space: pre;">90%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.43pt; position: var(--position); text-decoration: none; white-space: pre;"> of the fair market value of the Group&#8217;s ordinary shares. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 431.36pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Settlement in shares at the option of the noteholders (&#8220;SSO Investor Price Limit Option&#8221;): the noteholders may require a <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">principal payment to be settled in shares in the event the share settlement price on any principal payment date is below the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.24pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">price limit in effect (initially <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.4303<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.68pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to adjustments as described in the key terms below) and the Cash Carve-Out <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(i.e. <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.125&#160;million<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.88pt; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; the amount of cash permitted to be paid to Heights for principal payments) has been utilized such that <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.12pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">it does not allow payment in full of the principal payment. The majority noteholder may agree to waive the cash payment <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(which would otherwise be deferred until the original maturity date) and require the Group to exercise the share settlement <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">option for the principal payment required. A number of the ordinary shares issuable is based on the price limit in effect.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 536.64pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment of the notes upon an Event of Default (as defined below): the noteholder may notify the Group of their decision <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 550.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">to cause the notes to become payable at a price equal to the Early Redemption Amount (as defined below) upon an Event of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Default. The Early Redemption Amount means an amount equal to the greater of (a) <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.86pt; position: var(--position); text-decoration: none; white-space: pre;">120%<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of the outstanding principal of the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">note and (b) the market price of a number of shares issuable per note had the conversion right been exercised. Events of <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Default include the following: default in any payment due on the notes, failure to deliver shares upon exercise of conversion <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.84pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">right or share settlement option, default of the Group on any obligation under the agreement, and other events.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 628.48pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Repayment or purchase of the notes upon change of control, a delisting, or free float event (each, a &#8220;Put Event&#8221;): Upon a Put <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.92pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Event, the noteholder has an option to require the Group to redeem or, at the Group&#8217;s option, to purchase all of the notes at <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 655.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">the total aggregate amount equal to the outstanding principal and interest accrued through the date of a Put Event.<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 526.15pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights Financing is a senior, unsecured financing. The terms and conditions of the Heights convertible notes include a standard <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">negative pledge providing that any security granted in favor of other borrowed debt or debt instruments should also be granted in favor <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the Heights convertible notes on an equal basis (with the exception of the securities issued pursuant to the Kreos / Claret Financing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as detailed above).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 24,<span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.6pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> 2023, the Group repaid in full an outstanding amount of</span><span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 320.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;25,102&#160;thousand</span><span style="display: inline-block; height: 8.32pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.9pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, corresponding to the outstanding OCEANE </span><span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.6pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">bonds, by way of set-off with the Heights Financing. The accounting treatment for this transaction is explained in Note 15.5.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment and measurement<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the Heights convertible notes are classified <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.17pt; position: var(--position); text-decoration: none; white-space: pre;">as current financial liabilities as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.53999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">2023 and 2024 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.47pt; position: var(--position); text-decoration: none; white-space: pre;">(see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group concluded that, except for the repayment or purchase option of the notes upon a Put Event, the above-mentioned <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conversion and settlement options represented embedded derivatives that required to be bifurcated from their host contract. The Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">being unable to reliably value each embedded derivative at issuance date and on subsequent reporting dates, it measured the whole <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instrument at fair value through profit or loss (&#8220;FVTPL&#8221;) as permitted by IFRS 9. Instruments measured at FVTPL under these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions are measured at their fair value on issuance and on subsequent reporting dates, and the amount of change in the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 269.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the financial liability is presented in profit or loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the Heights convertible notes were measured at fair value, which differs from the issuance procee<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ds by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.32pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;2,359&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.41pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 303.2pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Since the fair value measurement of the instrument is evidenced by a valuation technique that does not only use data from observable </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.4pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">markets, the carrying amount was adjusted to defer the difference between the fair value measurement and the transaction price, and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.6pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">the day one gain is therefore recognized in financial income on a straight-line basis over the term of the instrument. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.8pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2023 and 2024, the amounts by which the carrying value of the notes is adjusted to take into account the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">unrecognized day one gain are </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,147&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.66pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.09pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,557&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.18pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the Heights convertible notes (including the embedded features) has been measured with a Monte Carlo model, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.6pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">considering two probability-weighted scenarios: (i) a Put Event or Default/Dissolution scenario and (ii) a voluntary conversion at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">maturity scenario. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.62pt; position: var(--position); text-decoration: none; white-space: pre;">The main data and assumptions are the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 415.2pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 519pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 143.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 128.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes - August 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.82pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 24, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 17.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 17.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 113.62pt; position: var(--position); text-decoration: none; white-space: pre;">350<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 17.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">350<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 17.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">350<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Original principal amount (in thousands of <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 34.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">35,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 34.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">35,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 34.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">35,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 55.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 116.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 116.84pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 107.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 107.84pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 107.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 107.84pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conversion price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 72.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.77<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 72.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.77<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 72.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.77<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 90pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;16.74<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.76<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 107.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 10.43pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Maturity date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 107.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.88pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event) 24/08/2027 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.23pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.58pt; position: var(--position); text-decoration: none; white-space: pre;">(HTM/voluntary conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 277.5pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2027 (HTM/voluntary <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;">conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 399.75pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2027 (HTM/voluntary <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;">conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.76pt; width: 143.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Held to maturity / voluntary conversion <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.36pt; width: 143.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 134.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 134.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 134.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 151.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Initial price limit<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 151.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.43<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 151.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.43<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 151.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.43<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Early redemption amount (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 168.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 108.84pt; position: var(--position);">120<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 168.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 99.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 99.84pt; position: var(--position);">120<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 168.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 99.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 99.84pt; position: var(--position);">120<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 186pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 186pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 186pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 203.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit spread<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 203.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);">20<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 203.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">20<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 203.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">25<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 220.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 110.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 110.84pt; position: var(--position);">2.9<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 220.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 101.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 101.84pt; position: var(--position);">2.3<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 220.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 101.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 101.84pt; position: var(--position);">2.9<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of Heights convertible notes <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 237.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 96.21pt;"></span></span><span style="left: 98.83999999999999pt; position: var(--position);">32,641<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 237.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 87.21pt;"></span></span><span style="left: 89.83999999999999pt; position: var(--position);">27,456<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 237.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 87.21pt;"></span></span><span style="left: 89.83999999999999pt; position: var(--position);">20,017<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of August 24, 2023, using the same assumptions with an increase of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.84pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> volatility, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.35pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+1</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.98pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> share price, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.98pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> risk-free rate and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.21pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.17pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+239&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+1,069&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-239&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.04pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-80&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2023, using the same assumptions with an increase of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> volatility, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.51pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+1</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> share price, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> risk-free rate and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+18&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+352&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-366&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-364&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.46pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2024, using the same assumptions with an increase of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> volatility, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.51pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+1</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> share price, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+1%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> risk-free rate and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+10%</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.96pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">2&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;+</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.6pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">39&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-219&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;-631&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 353.46pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.3. Structured debt financing with Kreos subscribed in July 2018 &#8211; &#8220;Kreos 1&#8221; <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On July 24, 2018, the Group entered into a Venture Loan Agreement, a Straight Bonds Issue Agreement and a Convertible Bonds <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Issue Agreement with Kreos Capital V (UK) Ltd., (or &#8220;Kreos&#8221;), which provided for up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.76pt; position: var(--position); text-decoration: none; white-space: pre;"> in financing. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to the terms of the agreements, Kreos agreed to subscribe for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;16,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.4pt; position: var(--position); text-decoration: none; white-space: pre;"> in non-convertible bonds and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in convertible bonds, to be issued by the Group in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.38pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.37pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.57pt; position: var(--position); text-decoration: none; white-space: pre;"> each. The tranches were issued <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in July 2018 and May 2019, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The convertible bonds were convertible into new ordinary shares of the Group at any time from their issuance and at the discretion of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their holders. In October 2020, Kreos requi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.63pt; position: var(--position); text-decoration: none; white-space: pre;">red the conversion of all the convertible bonds they held (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.49pt; position: var(--position); text-decoration: none; white-space: pre;">2,000,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.49pt; position: var(--position); text-decoration: none; white-space: pre;"> for Tranche A and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 351.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2,000,000<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"> for Tranche B) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.3pt; position: var(--position); text-decoration: none; white-space: pre;">464,309<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.8pt; position: var(--position); text-decoration: none; white-space: pre;"> shares were issued<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Each tranche bears an <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.86pt; position: var(--position); text-decoration: none; white-space: pre;">8%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.19pt; position: var(--position); text-decoration: none; white-space: pre;"> annual interest rate, plus 3-month Euribor, including a floor at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.53pt; position: var(--position); text-decoration: none; white-space: pre;">8%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.86pt; position: var(--position); text-decoration: none; white-space: pre;"> and a cap at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.28pt; position: var(--position); text-decoration: none; white-space: pre;">9%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.61pt; position: var(--position); text-decoration: none; white-space: pre;">, and must be repaid in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.13pt; position: var(--position); text-decoration: none; white-space: pre;">54<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.13pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">monthly installments, after a deferred repayment of the nominal value to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.4pt; position: var(--position); text-decoration: none; white-space: pre;">12 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.33pt; position: var(--position); text-decoration: none; white-space: pre;"> for the first tranche (&#8220;Tranche A&#8221;) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.56pt; position: var(--position); text-decoration: none; white-space: pre;">6 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 566.49pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the second tranche (&#8220;Tranche B&#8221;). In addition, each tranche bears exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.11pt; position: var(--position); text-decoration: none; white-space: pre;">9%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.44pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total drawdown amount (i.e. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 407.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;900&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"> per tranche), payable upon the last monthly installment (exit fees remain payable in full in case of early redemption).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to the terms of the agreements, the Group has the right, at any time but with no less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.37pt; position: var(--position); text-decoration: none; white-space: pre;">30 days<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: var(--position); text-decoration: none; white-space: pre;"> prior notice to Kreos, to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prepay or purchase the non-convertible and convertible bonds, exclusively in full. The prepayment will be equal to (i) the principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount outstanding, plus (ii) exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.84pt; position: var(--position); text-decoration: none; white-space: pre;">9%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.17pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total draw down amount and (iii) the sum of all interest repayments which would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">have been paid throughout the remainder of the term of the relevant tranche discounted by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.18pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.51pt; position: var(--position); text-decoration: none; white-space: pre;"> per annum. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The agreements <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.01pt; position: var(--position); text-decoration: none; white-space: pre;">did<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.78pt; position: var(--position); text-decoration: none; white-space: pre;"> not contain any financial covenants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">In connection with each tranche, the Group issued </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.83pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">110,957</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.33000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> tranche A share warrants (or &#8220;Kreos A BSA&#8221;) and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.23pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">74,766</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.73pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> tranche B share </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">warrants (or &#8220;Kreos B BSA&#8221;), each, for a global subscription price of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;1</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. Each Kreos A BSA and Kreos B BSA gives rights to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 544.72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">one</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.15pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">new ordinary share at an exercise price of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.22pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;7.21</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> less a discount and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.92pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;10.70</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> less a discount, respectively. Both Kreos A BSA and Kreos </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">B BSA are freely transferrable among financial institutions and are exercisable over a </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">10</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">-year</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.32pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> period from the issue date. In addition, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">the Group granted to the holders of the Kreos A BSA and the Kreos B BSA the option to sell to the Group, upon each exercise of all or </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">parts of the Kreos A BSA, at the put price defined in the agreement, a proportion of the number of the warrants, for the sole purpose of </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">implementing a cash less exercise of the Kreos A BSA and Kreos B BSA. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The variation in the Kreos 1 &amp; 2 bond loans during the periods ended December 31, 2021 and 2022 is primarily related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursements of capital and interests. As of December 31, 2022, the A tranche of the Kreos 1 bond loan has come to maturity and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">was repaid in full. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August, 21, 2023, the B tranche of the Kreos 1 bond loan as well as the A &amp; B tranches of the Kreos 2 bond loan were repaid in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">full, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7,661&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.35pt; position: var(--position); text-decoration: none; white-space: pre;">, using the proceeds from the new Kreos / Claret Fin<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ancing (see Note 3.3). </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group granted to the holders of the Kreos A BSA and the Kreos B BSA the option to sell to the Group, upon each exercise of all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">or parts of the Kreos A BSA, at the put price defined in the agreement, a proportion of the number of the warrants, for the sole purpose <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of implementing a cashless exercise of the Kreos A BSA and Kreos B BSA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, the holders opted for the cashless exercise option of the share warrants they held, implemented through the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">repurchase by the Group of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.85pt; position: var(--position); text-decoration: none; white-space: pre;">43,070<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.35pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos A BSA and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.81pt; position: var(--position); text-decoration: none; white-space: pre;">43,070<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.31pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos B BSA and the issuance by the Group of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.0799999999999pt; position: var(--position); text-decoration: none; white-space: pre;">67,887<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.58pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31,696<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary shares, as the result of the cashless exercise by Kreos of the outstanding <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.04pt; position: var(--position); text-decoration: none; white-space: pre;">67,887<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.54pt; position: var(--position); text-decoration: none; white-space: pre;"> Kreos A &amp; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.4pt; position: var(--position); text-decoration: none; white-space: pre;">31,696<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.9pt; position: var(--position); text-decoration: none; white-space: pre;"> B BSA. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos 1 financing package is issued at market conditions: the net issuance proceeds reflect the fair value of the instruments at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inception.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The straight bond tranches are split between i) a debt component (then measured at amortized cost), and ii) a premium corresponding <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to the initial fair value of attached BSA (then remeasured at fair value through profit and loss).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The BSA attached to all tranches (both straight and convertible) do not meet the &#8220;fixed for fixed&#8221; criteria (non cash settlement option <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which may result in exchanging a variable number of shares, for a variable price), and are accounted for as standalone derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The issuer prepayment options meet the definition of a separate derivative. However, their value at inception and subsequent dates is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">nil<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.54pt; position: var(--position); text-decoration: none; white-space: pre;"> as per Schoenbucher model, and has no impact on the financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As the differences identified between the terms of the Kreos 1 &amp; 2 bond loans and the new Kreos / Claret Financing were considered <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">substantial, the repayment transaction on August 21, 2023 was accounted for as a debt extinguishment. The repayment of the Kreos 1 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&amp; 2 bond loans led to the recognition of a loss on extinguishment amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.45pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;170&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.04pt; position: var(--position); text-decoration: none; white-space: pre;">, primarily due to (i) the payment of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future interests as per the terms of the prepayment option and (ii) unamortized exit and issuance fees, reducing the carrying value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the liabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Measurement of Kreos A BSA &amp; Kreos B BSA <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos A BSA and Kreos B BSA are measured at fair value using a Black-Scholes valuation model. The main data and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions are the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 419.36pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A BSA - June 1, 2018<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos A BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;">110,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;">110,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.21<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.21<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">5.6 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">0.0 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2.98<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos A BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">275<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">1,261<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 563.11pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos B BSA - June 1, 2019<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos B BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">74,766<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">74,766<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.70<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.70<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">6.4 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">0.0 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2.96<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos B BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">149<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">589<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2021, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;">share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.22pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.18pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">result in an increase of Kreos A &amp; B BSA fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;16&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.89pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;69&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.41pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;">share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.22pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.18pt; position: var(--position); text-decoration: none; white-space: pre;"> risk-free rate would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">result in an increase of Kreos A &amp; B BSA fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;78&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.89pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.41pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, the holders opted for the cashless exercise option of the share warrants they held. At this date, the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercised warrants of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,850&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.03pt; position: var(--position); text-decoration: none; white-space: pre;"> was reclassified from derivative financial liabilities to equity. As of this date, due to the put <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">option being exercised by the holders, the fair value of the BSAs is deemed equal to their intrinsic value, which is equal to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 195.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">difference between the share price on May 24, 2023 and their exercise price.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.4 Structured debt financing with Kreos subscribed in October 2020 &#8211; &#8220;Kreos 2&#8221; <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On October 13, 2020, the Group obtained a straight bond loan of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.56pt; position: var(--position); text-decoration: none; white-space: pre;"> from Kreos corresponding to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.31pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.3pt; position: var(--position); text-decoration: none; white-space: pre;"> tranches of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> (&#8220;Tranche A&#8221;) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.98pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.07pt; position: var(--position); text-decoration: none; white-space: pre;"> (&#8220;Tranche B&#8221;), with an option for an additional <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.73pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.8199999999999pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Tranches A and B were paid in October and November 2020, respectively, with the following conditions. Each tranche bears an <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.15pt; position: var(--position); text-decoration: none; white-space: pre;">8%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 563.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">annual interest rate, plus 3-month Euribor, for the first <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.49pt; position: var(--position); text-decoration: none; white-space: pre;">12<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;"> monthly installments, after which the annual interest rate is increased to a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fixed rate of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.32pt; position: var(--position); text-decoration: none; white-space: pre;">9.75%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.15pt; position: var(--position); text-decoration: none; white-space: pre;"> for the following <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.87pt; position: var(--position); text-decoration: none; white-space: pre;">36<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.87pt; position: var(--position); text-decoration: none; white-space: pre;"> monthly installments. Each tranche is to be repaid in <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.88pt; position: var(--position); text-decoration: none; white-space: pre;">36<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.88pt; position: var(--position); text-decoration: none; white-space: pre;"> monthly installments starting from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">October 2021 and November 2021, for the tranche A and B, respectively. The agreements do not contain any financial covenants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, each tranche bears exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.71pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.04pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total drawdown amount (i.e. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;400&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.1pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.6pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;200&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.19pt; position: var(--position); text-decoration: none; white-space: pre;"> for Tranche A &amp; B, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively), payable upon the last monthly installment (exit fees remain payable, in full or partially, in case of early redemption). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to the terms of the agreements, the Group has the right, at any time but with no less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.37pt; position: var(--position); text-decoration: none; white-space: pre;">30 days<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: var(--position); text-decoration: none; white-space: pre;"> prior notice to Kreos, to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prepay or purchase the non-convertible exclusively in whole. The prepayment will be equal to (i) the principal amount outstanding, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">plus (ii) exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.74pt; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.07pt; position: var(--position); text-decoration: none; white-space: pre;"> of the outstanding amount in the event of prepayment occurring between the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.56pt; position: var(--position); text-decoration: none; white-space: pre;">18<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.56pt; position: var(--position); text-decoration: none; white-space: pre;">th and the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.46pt; position: var(--position); text-decoration: none; white-space: pre;">30<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.46pt; position: var(--position); text-decoration: none; white-space: pre;">th installment or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exit fees of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.88pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.21000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> of the outstanding amount in the event of prepayment occurring after the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.71pt; position: var(--position); text-decoration: none; white-space: pre;">30<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.71pt; position: var(--position); text-decoration: none; white-space: pre;">th installment and (iii) the sum of all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">interest repayments which would have been paid throughout the remainder of the term of the relevant tranche discounted by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.03pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.36pt; position: var(--position); text-decoration: none; white-space: pre;"> per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">annum. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 453.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August, 21, 2023, the B tranche of the Kreos 1 bond loan as well as the A &amp; B tranches of the Kreos 2 bond loan were repaid in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 464.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">full, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.26pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7,661&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.35pt; position: var(--position); text-decoration: none; white-space: pre;">, using the proce<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.4pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">eds from the new Kreos / Claret Financing (see Note 3.2). The accounting </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">treatment of the extinguishment of these liabilities is set forth in Note 15.3.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos 2 straight bonds were initially measured at fair value, which corresponds to the net cash proceeds, and subsequently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured at amortized cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the prepayment option is a separate derivative instrument as the redemption price does not reimburse Kreos for an amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">up to the approximate present value of lost interest for the remaining term of the host contract. However, its fair value at inception and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent dates is nil as per Schoenbucher model, and has no impact on the financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.5. OCEANE <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 619.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group received a gross proceed of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.89pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;85,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.98pt; position: var(--position); text-decoration: none; white-space: pre;"> on July 30, 2021 through (i)&#160;the issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.04pt; position: var(--position); text-decoration: none; white-space: pre;">1,964,031<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.04pt; position: var(--position); text-decoration: none; white-space: pre;"> shares with a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subscription price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.64pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;30.55<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.14pt; position: var(--position); text-decoration: none; white-space: pre;"> per share (see Note 13.3 (changes in share capital)) for gross amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;60,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.76pt; position: var(--position); text-decoration: none; white-space: pre;">, and (ii)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 639.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.17pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.26pt; position: var(--position); text-decoration: none; white-space: pre;"> in OCEANE, maturing on July 30, 2026. The proceeds of the transaction mainly serve to finance the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 649.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">progress of ABX464 clinical trials in chronic inflammatory diseases. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 671.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The OCEANE bears a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.56pt; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.89pt; position: var(--position); text-decoration: none; white-space: pre;"> interest rate per year, payable semi-annually January 30, and July, 31 from January 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The OCEANE shall be convertible into new ordinary shares and/or exchanged for existing ordinary shares of the group at any time <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 703.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from their issuance and at the discretion of their holders. The conversion ratio is <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.68pt; position: var(--position); text-decoration: none; white-space: pre;">one<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.11pt; position: var(--position); text-decoration: none; white-space: pre;"> ordinary share of the Group per OCEANE, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">representing a conversion price set to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;38.19<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.98pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share. This conversion price is updated (decrease only) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.34pt; position: var(--position); text-decoration: none; white-space: pre;">18 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 533.27pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.27pt; position: var(--position); text-decoration: none; white-space: pre;">24 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.43pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 70.43pt; position: var(--position); text-decoration: none; white-space: pre;">36 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.36pt; position: var(--position); text-decoration: none; white-space: pre;"> after OCEANE issuance date to match the volume weighted average price of the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-2097">thirty</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.78pt; position: var(--position); text-decoration: none; white-space: pre;"> trading days that precedes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the update subjected to the following floor threshold. The floor threshold for the 18-month update matches <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.73pt; position: var(--position); text-decoration: none; white-space: pre;">85%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 483.06pt; position: var(--position); text-decoration: none; white-space: pre;"> initial conversion <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;32.462<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.28999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share). The floor threshold for the 24-month update matches <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.05pt; position: var(--position); text-decoration: none; white-space: pre;">70%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.38pt; position: var(--position); text-decoration: none; white-space: pre;"> initial conversion price (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;26.733<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.3pt; position: var(--position); text-decoration: none; white-space: pre;"> per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ordinary share). The floor threshold for the 36-month update matches <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316pt; position: var(--position); text-decoration: none; white-space: pre;">68%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.33pt; position: var(--position); text-decoration: none; white-space: pre;"> initial conversion price (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25.969<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.25pt; position: var(--position); text-decoration: none; white-space: pre;"> per ordinary share). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE terms and conditions anticipate a conversion ratio adjustment in order to preserve the rights of OCEANE holders with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">following achievements made by the group: issuance of new shares with the preemptive subscription right, attribution of free shares or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">securities for the benefit of all the shareholders, number of share multiplication, shares consolidation, increase of the nominal value by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">incorporation of reserves, profits or bonuses, distribution of dividends, premiums or reserves, mergers, scission, repurchase of shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">above market value, capital reduction, creation of preferred shares. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 24, 2023, the outstanding OCEANE including accrued interests were repaid in full, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,102&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.51pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">using the proceeds from the new Heights Financings (see Note 3.2). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment and measurement <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 268.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the OCEANE bonds are classified <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.98pt; position: var(--position); text-decoration: none; white-space: pre;">as current financial liabilities<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.16pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 291.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2022 (see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As the conversion ratio is adjusted <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.41pt; position: var(--position); text-decoration: none; white-space: pre;">18 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.34pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.34pt; position: var(--position); text-decoration: none; white-space: pre;">24 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.27pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.2pt; position: var(--position); text-decoration: none; white-space: pre;">36 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.13pt; position: var(--position); text-decoration: none; white-space: pre;"> after the issuance date of the OCEANE bond with the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">weighted average price of the shares and is subject to a floor and a cap, the conversion does not result in the delivery of a fixed <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">number of shares. Consequently, the OCEANE bond is recorded as an hybrid instrument which includes i) a debt host contract <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">accounted for at amortized cost, and ii) a conversion option which is a embedded derivative accounted for at fair value through profit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the net cash proceeds reflect the OCEANE initial fair value. The fair value of the bifurcated option at inception has been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured with a Monte Carlo model using a Longstaff Schwartz algorithm, with a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.86pt; position: var(--position); text-decoration: none; white-space: pre;">53%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.19pt; position: var(--position); text-decoration: none; white-space: pre;"> share price volatility, a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.71pt; position: var(--position); text-decoration: none; white-space: pre;">1,400<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.21pt; position: var(--position); text-decoration: none; white-space: pre;"> bp credit spread <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumption and a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31.50<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.38pt; position: var(--position); text-decoration: none; white-space: pre;"> share price. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 413.06pt; width: 612pt;"><div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 389.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.37pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.07pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 24, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 21pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">3.05<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 21pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">3.22<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit spread<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"> bp<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.12pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;">1,398<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"> bp<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;16.74<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Expected term<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.79pt; position: var(--position); text-decoration: none; white-space: pre;">July 21, 2026<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.79pt; position: var(--position); text-decoration: none; white-space: pre;"> July 21, 2026 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 69pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 69pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">37<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 81pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 81pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued OCEANE (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 93pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">142<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 93pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.71pt;"></span></span><span style="left: 59.34pt; position: var(--position);">1,762<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of July 30, 2021, the issuance price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.02pt; position: var(--position); text-decoration: none; white-space: pre;"> has been split between i) a financial liability for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;17,839&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 541.94pt; position: var(--position); text-decoration: none; white-space: pre;">, and ii) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">a financial derivative for <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.95pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7,161&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.04pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 589.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the fair value of conversion option amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;142&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.61pt; position: var(--position); text-decoration: none; white-space: pre;">, based on the same valuation model, a credit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">spread assumption of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.43pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.93pt; position: var(--position); text-decoration: none; white-space: pre;"> bp, a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.23pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.73pt; position: var(--position); text-decoration: none; white-space: pre;">, and a price volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.43pt; position: var(--position); text-decoration: none; white-space: pre;">44%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.76pt; position: var(--position); text-decoration: none; white-space: pre;">. As of December 31, 2022, using the same <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.38pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.34pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.89pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.52pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.99pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.95pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would result in an increase of the OCEANE <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 620.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conversion option fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.70999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;17&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;97&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.89pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.82pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.41pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of August 24, 2023, the date at which the OCEANE were repaid, the fair value of conversion option amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.9pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,762&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.99pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 651.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based on the same valuation model, a credit spread assumption of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.7pt; position: var(--position); text-decoration: none; white-space: pre;">1,398<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.2pt; position: var(--position); text-decoration: none; white-space: pre;"> bp, a share price of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;16.74<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432pt; position: var(--position); text-decoration: none; white-space: pre;">, and a price volatility of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.7pt; position: var(--position); text-decoration: none; white-space: pre;">37%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 551.03pt; position: var(--position); text-decoration: none; white-space: pre;">. As <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of August 24, 2023, using the same assumptions, an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.47pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.43pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.98pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.61pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.08pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.04pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would result in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">an increase of the OCEANE conversion option fair value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.4pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;80&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.99pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.99pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;364&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.58pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;121&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.1pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As the differences identified between the terms of the OCEANE and the new Heights convertible notes were considered substantial, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the transaction was accounted for as a debt extinguishment. The repayment of the OCEANE led to the recognition of a loss on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">extinguishment amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,069&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.7pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.6. State guaranteed loan &#8211; &#8220;PGE&#8221;<span style="display: inline-block; height: 6.77pt;"></span><span id="i72e4f64c56664c4db7a276f1130c3e77"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2020, the Group subscribed to a PGE from Soci&#233;t&#233; G&#233;n&#233;rale with an initial maturity of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.72pt; position: var(--position); text-decoration: none; white-space: pre;">12 months<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.65pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.85pt; position: var(--position); text-decoration: none; white-space: pre;">0.25%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.68pt; position: var(--position); text-decoration: none; white-space: pre;"> and a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.04pt; position: var(--position); text-decoration: none; white-space: pre;">five<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.5699999999999pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.09pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">extension option. In March 2021, the Group exercised the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.4pt; position: var(--position); text-decoration: none; white-space: pre;">five<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.93pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.45pt; position: var(--position); text-decoration: none; white-space: pre;"> extension option with a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.97pt; position: var(--position); text-decoration: none; white-space: pre;">one<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.4pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.92pt; position: var(--position); text-decoration: none; white-space: pre;"> deferral of the principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">repayment, with the following conditions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Rate: <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.61pt; position: var(--position); text-decoration: none; white-space: pre;">0.58%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.44pt; position: var(--position); text-decoration: none; white-space: pre;"> per annum excluding insurance and state guaranteed premium, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">State guaranteed premium of <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;138&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.82pt; position: var(--position); text-decoration: none; white-space: pre;"> to be paid by installments over the contract period starting in June 2021, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Reimbursement by yearly installments from June 2021 to June 2026. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The benefit resulting from the low interest nature of the award as a subsidy was recognized as other income during the period ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2020 for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;377&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.02pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The variation in the PGE loan over the periods ended December 31, 2022, 2023 and 2024 is primarily related to the reimbursement of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 291.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">capital and interests. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.7. Conditional advances<span style="display: inline-block; height: 6.77pt;"></span><span id="iba53c4e4c3cf4d75aecc5662b6c4ae1d"></span></span><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 341.76pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances as of December 31, 2022, 2023 and 2024 are as follows<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 347.39pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 352.76pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 382.77pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 383.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIONAL ADVANCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">RNP VIR &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">4,171<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">4,232<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CARENA &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">2,454<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">2,485<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">EBOLA &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">158<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">55<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total conditional advances<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">6,783<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">RNP-VIR &#8211; Bpifrance <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Under the RNP-VIR contract, the Group was eligible to receive up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.3&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.26pt; position: var(--position); text-decoration: none; white-space: pre;"> in conditional advances to further develop methods <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the discovery of new molecules for the treatment of viral infectious diseases through the development of the &#8220;Modulation of RNA <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">biogenesis&#8221; platform. As of December 31, 2022, the Group had received <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.49pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,032&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.58pt; position: var(--position); text-decoration: none; white-space: pre;">, of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,756&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.42pt; position: var(--position); text-decoration: none; white-space: pre;"> was received in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">September 2017, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;346&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.81pt; position: var(--position); text-decoration: none; white-space: pre;"> in August&#160;2018 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,930&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.48pt; position: var(--position); text-decoration: none; white-space: pre;"> in November 2019. The repayment of these funds is spread from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 572.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the date on which the repayments are called by BPI. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Bpifrance claimed the reimbursement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,241 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.42pt; position: var(--position); text-decoration: none; white-space: pre;"> corresponding to overpayments of conditional advances and subsidies (for which the Group had not incurred the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding R&amp;D expenses) and agreed to waive <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.4pt; position: var(--position); text-decoration: none; white-space: pre;">60%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.73pt; position: var(--position); text-decoration: none; white-space: pre;"> of the remaining advances of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,945&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.79pt; position: var(--position); text-decoration: none; white-space: pre;"> and accrued interests, w<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.27pt; position: var(--position); text-decoration: none; white-space: pre;">hich <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 630.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">resulted in a subsidy<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.87pt; position: var(--position); text-decoration: none; white-space: pre;"> income of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,872&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.19pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate (see Note 18). <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.81pt; position: var(--position); text-decoration: none; white-space: pre;">The outstanding amount was fully repaid by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group during the second half of 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.52pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">See Note 25.2. Commitments under BPI conditional advances. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CARENA &#8211; Bpifrance <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Under the CARENA agreement, the Group was eligible to receive up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,840&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.03pt; position: var(--position); text-decoration: none; white-space: pre;"> to develop a therapeutic HIV treatment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program with ABX464. As of December 31, 2022, the Group received <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,187&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.86pt; position: var(--position); text-decoration: none; white-space: pre;">, of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,150&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.7pt; position: var(--position); text-decoration: none; white-space: pre;"> was received in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 2013, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,008&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.63pt; position: var(--position); text-decoration: none; white-space: pre;"> in September 2014 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;29&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.64pt; position: var(--position); text-decoration: none; white-space: pre;"> received in June 2016. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The repayment of the advance is spread from the date on which the repayments are called by Bpifrance. An additional repayment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">provided for based on the income the Group generates through this research and development program.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Bpifrance granted an additional amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.83pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,068&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.92pt; position: var(--position); text-decoration: none; white-space: pre;"> payable to the Group to reimburse additional expenses incurred as part of the project, and agreed to waive <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 541.3pt; position: var(--position); text-decoration: none; white-space: pre;">60%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.63pt; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the remaining conditional advance of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,255&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.28pt; position: var(--position); text-decoration: none; white-space: pre;"> and accrued interests, which resulted in<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.35pt; position: var(--position); text-decoration: none; white-space: pre;"> a subsidy income<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.23pt; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,251&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.65pt; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the aggregate (see Note 18).<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.35pt; position: var(--position); text-decoration: none; white-space: pre;"> The outstanding amount was fully repaid by the Group during the second half of 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 225.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">EBOLA &#8211; Bpifrance <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Under the Bpifrance and Occitanie region joint aid agreement, the Group received a total of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;390&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.53pt; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.95pt; position: var(--position); text-decoration: none; white-space: pre;"> as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2017 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.97pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;90&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.56pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2019). The reimbursement is spread from 2019 to June 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.8. Lease liabilities<span style="display: inline-block; height: 6.77pt;"></span><span id="id18a1eac803844cea0e7d449e6dfcfb5"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The variations in lease liabilities are set forth below:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 342.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 301.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 216.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 56.84pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.18pt; position: var(--position); text-decoration: none; white-space: pre;">LEASE LIABILITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 12pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">214<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">1,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 64.05pt;"></span></span><span style="left: 66.67999999999999pt; position: var(--position);">(305)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">1,384<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 78pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">350<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 90pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.05pt;"></span></span><span style="left: 60.68pt; position: var(--position);">(1,194)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 102pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">540<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 123pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 135pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 64.05pt;"></span></span><span style="left: 66.67999999999999pt; position: var(--position);">(398)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 147pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2,363<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 527.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities mainly relate the Group&#8217;s headquarters in Paris, the Boston office entered into in November 2023, the Montpellier <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 538.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">offices entered into in April 2024, the new Paris headquarters entered into in May 2024 and to a lesser extent to vehicles, parking lots <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and printer<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.56pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">s (Note 8).</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 561.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The lease for the Group&#8217;s corporate headquarters in Paris, France at 5 Rue de la Baume, 75008 Paris ended in August 2022. A new <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">lease for premises at 7-11 Boulevard Haussmann, 75009 Paris started in July 2022. It <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.03pt; position: var(--position); text-decoration: none; white-space: pre;">had<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.46pt; position: var(--position); text-decoration: none; white-space: pre;"> a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.89pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.85pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.37pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, with a tacit renewal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 587.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">option for approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.4pt; position: var(--position); text-decoration: none; white-space: pre;">two years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.97pt; position: var(--position); text-decoration: none; white-space: pre;"> and the possibility to break the contract <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.55pt; position: var(--position); text-decoration: none; white-space: pre;">one year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.67pt; position: var(--position); text-decoration: none; white-space: pre;"> before the end. As of December 31, 2022, per <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Management, renewal and termination options were not reasonably certain due to the forecasted development of the Group, which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">could lead the Group to relocate at the end of the initial term. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.88pt; position: var(--position); text-decoration: none; white-space: pre;">In September 2023, the Group was notified by the lessor of its intention <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 627.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to exercise its option to terminate the contract on June 30, 2024. Consequently, the Group reassessed the lease term and recorded a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">decrease in the related lease liability by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;622&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and a corresponding decrease in the right of use asset for the same amount. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">A new lease for different premises within the same building was entered into on May 2, 2024. It has a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.58pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.54pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.06pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, and no <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">renewal option. The Group also benefits from an initial eight-month rent-free period.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 691.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In November 2023, the Subsidiary entered a lease contract for its new Boston offices. It has a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.98pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.97pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.49pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, with an option to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">renew the contract for an additional period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-2206">one</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.09pt; position: var(--position); text-decoration: none; white-space: pre;"> or <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.42pt; position: var(--position); text-decoration: none; white-space: pre;">two years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.99pt; position: var(--position); text-decoration: none; white-space: pre;">. In December 2024, the Group exercised its option to extend the lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">up until December 2026. P<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.41pt; position: var(--position); text-decoration: none; white-space: pre;">er Management, additional renewal options are not reasonably certain due to the forecasted development of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Subsidiary, which may lead it to relocate at the end of the current term.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In April 2024, the Company entered a lease contract for a new Montpellier office. It has an initial <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.73pt; position: var(--position); text-decoration: none; white-space: pre;">six<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.39pt; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.91pt; position: var(--position); text-decoration: none; white-space: pre;"> duration, with the option for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Company to terminate the lease at any time with a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.74pt; position: var(--position); text-decoration: none; white-space: pre;">six<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.4pt; position: var(--position); text-decoration: none; white-space: pre;">-month<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.27pt; position: var(--position); text-decoration: none; white-space: pre;"> notice period, and a tacit renewal option for an additional period of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">six years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">. Based on Management's estimate, the initial lease period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.04pt; position: var(--position); text-decoration: none; white-space: pre;">six years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.28pt; position: var(--position); text-decoration: none; white-space: pre;"> is considered reasonably certain and is therefore used <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the measurement of the lease liability.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024, the lease liabilities of the Paris headquarters and Boston offices represented <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.72pt; position: var(--position); text-decoration: none; white-space: pre;">97%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.05pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 536.05pt; position: var(--position); text-decoration: none; white-space: pre;">93%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.38pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">93%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.33pt; position: var(--position); text-decoration: none; white-space: pre;"> of the total lease liability, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Lease expenses related to contracts for which a lease liability and right of use asset is recognized under IFRS 16 were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;424&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.05pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;548&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;730&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.11pt; position: var(--position); text-decoration: none; white-space: pre;">for<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.77pt; position: var(--position); text-decoration: none; white-space: pre;"> the years ended December 31, 2022, 2023 and 2024, respectively. They were recognized for (i) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;414&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.59pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;498&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.18pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;788&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.2pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.7pt; position: var(--position); text-decoration: none; white-space: pre;">as<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.02pt; position: var(--position); text-decoration: none; white-space: pre;"> Depreciation expenses and (ii) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.39pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.98pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;61&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559pt; position: var(--position); text-decoration: none; white-space: pre;"> as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest expenses, for the years ended December 31, 2022, 2023 and 2024, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Lease expenses related to short-term lease contracts and low value assets that are not included in the valuation of the lease liability <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.74000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;331&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;334&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.92pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;352&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.94pt; position: var(--position); text-decoration: none; white-space: pre;"> for the years ended December 31, 2022, 2023 and 2024, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.9. Prosynergia earn-out liability<span style="display: inline-block; height: 6.77pt;"></span><span id="i4b6734fd51c649bba629e570a8bbfd4c"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The terms of the share purchase acquisition of Prosynergia include a possible earn out triggered in the event the Company&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market capitalization is in excess of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.33pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: var(--position); text-decoration: none; white-space: pre;"> (evaluated at certain specified record dates), a listing of the Company&#8217;s shares <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on Nasdaq or a merger and acquisition transaction prior to March 31, 2023. The amount of the earn-out is equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.26pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.59pt; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 353.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">difference between the Company&#8217;s market capitalization and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.82pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to a maximum amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.97pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">This potential earn-out payment was measured at fair value on April 1, 2022 (acquisition date), for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 389.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,446&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">, and included in the acquisition cost.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the fair value of the earn-out liability was insignificant. Since its payment was not triggered by March <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 437.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2023, the liability was extinguished and thus reversed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Prosynergia earn-out liability is measured at fair value using a Black-Scholes valuation model. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.67pt; position: var(--position); text-decoration: none; white-space: pre;">The main data and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions are the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 485.46pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 404.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 254.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia earn-out<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of April 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">period ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 52.27pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 52.27pt; position: var(--position);">(0.3)<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 54.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 54.93pt; position: var(--position);">2.3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Market capitalization (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 45.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">403,118<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 45.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">135,952<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 60.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price (&#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 60.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.37pt; position: var(--position); text-decoration: none; white-space: pre;">24.15<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 60.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.37pt; position: var(--position); text-decoration: none; white-space: pre;">6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Time to maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.61pt; position: var(--position); text-decoration: none; white-space: pre;">1 year<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 39.5pt; position: var(--position); text-decoration: none; white-space: pre;">0.25 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 56.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 56.93pt; position: var(--position);">61<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 56.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 56.93pt; position: var(--position);">44<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 105.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 105.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.37pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of the earn-out liability (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.64pt;"></span></span><span style="left: 44.27pt; position: var(--position);">(1,446)<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650.71pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of April 1, 2022, using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.16pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.12pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.3pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.77pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.73pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.71pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">result in an increase of the earn-out liability fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.96000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.55pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;132&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.14pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.07pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.57pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;17&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.16pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.21pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, the fair value of the earn-out liability is approximately <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.4pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.4pt; position: var(--position); text-decoration: none; white-space: pre;">. Using the same assumption with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.21pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.96pt; position: var(--position); text-decoration: none; white-space: pre;"> volatility, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.14pt; position: var(--position); text-decoration: none; white-space: pre;"> share price and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.61pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.57pt; position: var(--position); text-decoration: none; white-space: pre;"> risk free rate would result in an increase of the earn-out liability fair value by an amount <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.21pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">less than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.18pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.77pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.10. Royalty certificates <span style="display: inline-block; height: 6.77pt;"></span><span id="i929f6094c7664e43aa619f2ae0112c78"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.49pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On September 2, 2022, the Group completed a financing of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.78pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;49,162&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.87pt; position: var(--position); text-decoration: none; white-space: pre;">, consisting of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.72pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.71pt; position: var(--position); text-decoration: none; white-space: pre;"> transactions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 142.89pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">a reserved capital increase of a gross amount of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;46,231&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.34pt; position: var(--position); text-decoration: none; white-space: pre;"> through the issuance of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.31pt; position: var(--position); text-decoration: none; white-space: pre;">5,530,000<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.31pt; position: var(--position); text-decoration: none; white-space: pre;"> new shares with a <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">nominal value of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.01<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.7pt; position: var(--position); text-decoration: none; white-space: pre;"> per share at a subscription price of <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.36<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.81pt; position: var(--position); text-decoration: none; white-space: pre;"> per share; and <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 169.77pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">an issue of royalty certificates with a subscription price amounting to <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.83pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,931&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.92pt; position: var(--position); text-decoration: none; white-space: pre;">. The royalty certificates give right to <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">their holders to royalties equal to <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.28pt; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.61pt; position: var(--position); text-decoration: none; white-space: pre;"> of the future net sales of obefazimod (worldwide and for all indications) as from the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.65pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization of such product. The amount of royalties that may be paid under the royalty certificates is capped at <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.09pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;172,000&#160;thousand<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.73pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Related transaction costs amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,280&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.05pt; position: var(--position); text-decoration: none; white-space: pre;"> and are recorded in equity, since entirely related to the reserved capital <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 245.93pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.93pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, following a change in the estimate of future royalty cash flows, the certificates&#8217; amortized cost was <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.13pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">remeasured at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,287&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">, using the original EIR calculated at the date of issuance. The change in estimate resulted in a decrease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the related interest expense by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.29pt; position: var(--position); text-decoration: none; white-space: pre;"> over the period ended December 31, 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.73pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In April 2023, the Group reassessed its estimate of the probability of future royalty cash flows related to the royalty c<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.65pt; position: var(--position); text-decoration: none; white-space: pre;">ertificates. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 549pt; position: var(--position); text-decoration: none; white-space: pre;">This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 326.93pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">change reflected the higher probability to reach the objectives of the development and commercialization plans following the recent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.13pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">changes in management and governance, as well as results from its Phase 2b open-label maintenance trial in UC, as released in April <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.33pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2023. Subsequently, in June 2023 and December 2023, the Group revised <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.01pt; position: var(--position); text-decoration: none; white-space: pre;">the development and commercialization plans of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.53pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod and reassessed its estimate of future royalty cash flows accordingly. These changes in estimates resulted in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.73pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement of the certificates&#8217; amortized costs, using the original EIR of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.91pt; position: var(--position); text-decoration: none; white-space: pre;">34%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.24pt; position: var(--position); text-decoration: none; white-space: pre;"> calculated at the date of issuance, which led to an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.93pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase by<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.21000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.71000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;6,421 thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.8pt; position: var(--position); text-decoration: none; white-space: pre;"> of the royalty certificates liability. The expense was recorded within the interest expenses in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.13pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Statements of Income (Loss).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, the total interest expense (including the unwinding of discount) related to royalty certificates amounts to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8,942&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"> for the year ended December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">I<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.33pt; position: var(--position); text-decoration: none; white-space: pre;">n December 2024, the Group <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.12pt; position: var(--position); text-decoration: none; white-space: pre;">revised <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.47pt; position: var(--position); text-decoration: none; white-space: pre;">the development and commercialization plans of obefazimod to take into account the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.03pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">progression in the ongoing clinical trials, reassessment of the commercial schedule and forecasts&#160; and reassessed its estimate of future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.23pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">royalty cash flows accordingly.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> This<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.68pt; position: var(--position); text-decoration: none; white-space: pre;"> change in estimate resulted in a remeasurement of the certificates&#8217; amortized costs, using the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.43pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">original EIR of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">34%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.32pt; position: var(--position); text-decoration: none; white-space: pre;"> calculated at the date of issuance, which led to a decrease <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.67pt; position: var(--position); text-decoration: none; white-space: pre;">by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.17pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,404&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.26pt; position: var(--position); text-decoration: none; white-space: pre;"> of the royalty certificates liability.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.92pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.63pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The expense was recorded within the interest expenses in the Statements of Income (Loss).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Consequently, the total interest expense related to royalty certificates (including the effect of the unwinding of discount, amounting to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.33pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,198&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">) amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;794&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.14pt; position: var(--position); text-decoration: none; white-space: pre;"> for the year ended December 31, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.83pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.47pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the royalty certificates, calculated using the same model as their initial measurement, amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,307&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 560.31pt; position: var(--position); text-decoration: none; white-space: pre;"> as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of December 31<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.37pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, 2022 and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;12,395 thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> as </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.21pt; position: var(--position); text-decoration: none; white-space: pre;">of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.01pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7,313&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.1pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 601.07pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the royalty certificates is based on the net present value of royalties, which depends on assumptions made by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.27pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group with regards to the probability of success of its studies (&#8220;POS&#8221;), the commercialization budget of obefazimod (&#8220;peak <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.47pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">penetration&#8221;) and the Group's WACC. In addition, royalty projections have been adjusted to reflect any difference between the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 634.67pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s value derived from management projections and the Group&#8217;s market <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.34pt; position: var(--position); text-decoration: none; white-space: pre;">capitalization<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.11pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.87pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The decrease in fair value of the royalty certificates over the year ended December 31, 2024 is mainly driven by the decrease in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.07pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group's share price over the period.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.07pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, using the same assumptions with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;">+5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;">+5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (best case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.27pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC would result in a change in the royalty certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+299&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.15pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.47pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+221&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.22pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.65pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-191&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.57pt; position: var(--position); text-decoration: none; white-space: pre;">.&#160; Using the same assumptions with a decrease of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.97pt; position: var(--position); text-decoration: none; white-space: pre;">-5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.3pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.9pt; position: var(--position); text-decoration: none; white-space: pre;">-5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.56pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (worst <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">case scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.72pt; position: var(--position); text-decoration: none; white-space: pre;">-1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.38pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC would result in a change in the royalty certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-294&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.23pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-347&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.92pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+205&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.57pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.98pt; position: var(--position); text-decoration: none; white-space: pre;">2023, using the same assumptions with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;">+5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;">+5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (best case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.61pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.57pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.1pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.6pt; position: var(--position); text-decoration: none; white-space: pre;">sha<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.92pt; position: var(--position); text-decoration: none; white-space: pre;">re price would result in a change in the royalty certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 518.6pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+1104&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.22pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1757&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.44pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-577&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.36pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.78999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1325&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: var(--position); text-decoration: none; white-space: pre;">. Using the same assumptions with a decrease of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">-5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.24pt; position: var(--position); text-decoration: none; white-space: pre;"> points of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.34pt; position: var(--position); text-decoration: none; white-space: pre;">-5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (worst case scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.88pt; position: var(--position); text-decoration: none; white-space: pre;">-1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share price would result in a change in the royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-1104&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-2311&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.86pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.86pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+612&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.08pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-1325&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.11pt; position: var(--position); text-decoration: none; white-space: pre;"> of December 31, 2024, using the same assumptions with an increase of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;">+5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"> points of POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;">+5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (best case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scenario), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.61pt; position: var(--position); text-decoration: none; white-space: pre;">+1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.57pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;+1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.1pt; position: var(--position); text-decoration: none; white-space: pre;"> share price would result in a change in the royalty certificates fair value by respectively &#8364;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.63pt; position: var(--position); text-decoration: none; white-space: pre;">572&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.22pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.85pt; position: var(--position); text-decoration: none; white-space: pre;">1,735&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-314&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.86pt; position: var(--position); text-decoration: none; white-space: pre;"> and &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.91999999999996pt; position: var(--position); text-decoration: none; white-space: pre;">1,160&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: var(--position); text-decoration: none; white-space: pre;">. Using the same assumptions with a decrease of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">-5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.24pt; position: var(--position); text-decoration: none; white-space: pre;"> points of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">POS, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.34pt; position: var(--position); text-decoration: none; white-space: pre;">-5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"> of peak penetration (worst case scenario) and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.88pt; position: var(--position); text-decoration: none; white-space: pre;">-1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"> WACC and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.44pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-1<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.77pt; position: var(--position); text-decoration: none; white-space: pre;"> share price would result in a change in the royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates fair value by respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-572&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-2,527&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.36pt; position: var(--position); text-decoration: none; white-space: pre;">, &#8364;+<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.99pt; position: var(--position); text-decoration: none; white-space: pre;">332&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.58pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.01pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;-1,160&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.11. Change in financial liabilities<span style="display: inline-block; height: 6.77pt;"></span><span id="ieb6c790a36b64ce287edfb0289428b41"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in financial liabilities, excluding derivative instruments, are presented below as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.28pt; position: var(--position); text-decoration: none; white-space: pre;">2022, 2023 a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.21pt; position: var(--position); text-decoration: none; white-space: pre;">nd 2024:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 309.16pt; width: 612pt;"><div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;">euros) <span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 44.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9.52pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES (excluding <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 28.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives instruments)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 21.75pt; width: 41.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.65pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.39pt; position: var(--position); text-decoration: none; white-space: pre;">bond loans<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.93pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 21.75pt; width: 42.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.76pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.65pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.86pt; position: var(--position); text-decoration: none; white-space: pre;">Claret <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.68pt; position: var(--position); text-decoration: none; white-space: pre;">convertible <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.6pt; position: var(--position); text-decoration: none; white-space: pre;">notes <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.36pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.6pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA )<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.28pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.03pt; position: var(--position); text-decoration: none; white-space: pre;">Claret bond <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.22pt; position: var(--position); text-decoration: none; white-space: pre;">loans<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;">Heights <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.3pt; position: var(--position); text-decoration: none; white-space: pre;">convertible <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.23pt; position: var(--position); text-decoration: none; white-space: pre;">notes<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.81pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.31pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.4pt; position: var(--position); text-decoration: none; white-space: pre;">advances <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.17pt; position: var(--position); text-decoration: none; white-space: pre;">BPI<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 12.46pt; position: var(--position); text-decoration: none; white-space: pre;">Lease <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.41pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.94pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.18pt; position: var(--position); text-decoration: none; white-space: pre;">earn-out <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;">liability<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.34pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;">certificates<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.03pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 66pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.21pt;"></span></span><span style="left: 15.84pt; position: var(--position);">21,110<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">18,816<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 66pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">4,742<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,770<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">214<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">51,653<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 87pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 87pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,931<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,931<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 99pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(9,410)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 99pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(90)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(305)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(9,806)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 111pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(2,456)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,496)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 111pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(54)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(4,006)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 123pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.21pt;"></span></span><span style="left: 19.84pt; position: var(--position);">3,738<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,636<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 123pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">150<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">102<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">356<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,983<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">recognition of earn-out <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">liability <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 144pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 144pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,446<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,446<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: fair <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 174.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,446)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,446)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 195.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 216.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.21pt;"></span></span><span style="left: 15.84pt; position: var(--position);">12,982<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">19,957<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 216.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">4,838<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,783<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,384<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,287<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">49,231<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 237.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">23,119<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">35,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">58,119<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 249.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 10.55pt;"></span></span><span style="left: 13.18pt; position: var(--position);">(11,635)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(23,238)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 249.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(2,188)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(110)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(573)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(38,993)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 261.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 261.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(2,278)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,602)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 261.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.05pt;"></span></span><span style="left: 24.68pt; position: var(--position);">(818)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(525)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(43)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(12)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(5,278)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 273.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 273.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(1,046)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,046)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">recognition of earn-out <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">liability <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 294.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(1,005)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,005)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 325.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: fair <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 325.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.21pt;"></span></span><span style="left: 25.84pt; position: var(--position);">170<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,069<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 325.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(212)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,027<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 346.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 346.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">272<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">272<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 367.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 367.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 367.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,678<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">540<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">12,229<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">74,466<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;">euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES (excluding <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives instruments)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 52.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 52.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 52.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,678<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">540<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">12,229<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">74,466<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 73.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">47,444<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">47,444<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 85.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(8,750)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(2,708)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(459)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(13,167)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 97.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(2,250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,639)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,772)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(18)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(17)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(7,696)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 50.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 109.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.09pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.69pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">classification of embedded <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.29pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives as separate <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.89pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derivative financial <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 109.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,204)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,204)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: (gain)/<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">loss on recognition or <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derecognition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 159.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(590)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(590)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 190.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.71pt;"></span></span><span style="left: 21.34pt; position: var(--position);">3,977<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">5,800<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,714<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">77<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">61<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">4,198<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">15,834<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 211.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">amortized cost <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 211.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,404)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,404)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 242.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: other <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">fair value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 242.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,367<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,367<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 263.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes&#160;: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">subsidies <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 263.25pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 263.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(4,070)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(4,070)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 284.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.81pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 284.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 306pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes : Effect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of the change in foreign <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">currency exhange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 306pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 338.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 338.25pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 338.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">46,401<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,488<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,363<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 9.96pt;"></span></span><span style="left: 12.59pt; position: var(--position);">109,218<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.89pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> the year ended December 31, 2023, proceeds from the issuance of the Kreos / Claret OCABSA are presented net of transaction </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">costs, amounting to </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.49pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;1,881&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.58pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. Net proceeds from convertible loan notes of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.99pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;55,841</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.49pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> disclosed in the Consolidated Statements of </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Cash Flows also include transaction fees of (i) </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;750&#160;thousands</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.05pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> related to the Kreos / Claret B and C tranches and recorded in prepaid </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">expenses (see Note 10) and (ii) </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;1,528&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> related to the Heights convertible notes.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For the year ended December 31, 2023, repayments of the OCEANE are presented net of the repurchase of the conversion option, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">value</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.629999999999995pt; position: var(--position); text-decoration: none; white-space: pre;">d at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.83pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,762&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> on the date of repayment, which is presented in Note 15.12. The aggregate repayment amounts to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the year ended December 31,2024, proceeds from the issuance of the Kreos / Claret tranches B and C bond loans are presented net <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of transaction costs and deposits (corresponding to the prepayments of half of the last debt installments on issuance date) included in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the debt discount using the EIR method, and amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,475&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.71pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.14pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,081 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.23pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. Net proceeds from non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">convertible bond loans of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;48,544<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.85pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand disclosed in the Unaudited Condensed Consolidated Statements of Cash Flows do not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 602.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">include transaction fees of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.13pt; position: var(--position); text-decoration: none; white-space: pre;"> (i) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;500&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.15pt; position: var(--position); text-decoration: none; white-space: pre;"> related to the Kreos / Claret tranche A-B warrants classified as prepaid expenses as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2023.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.12. Change in derivative instruments<span style="display: inline-block; height: 6.77pt;"></span><span id="i7c8dd868c7e14b8cb97f5969c9da56f9"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in derivative instruments, are presented below as of December 31, 2022, 2023 and 2024 :<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 44pt; position: var(--position); top: 0pt; width: 534.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 96pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 7.68pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.1pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 37.78pt; position: var(--position); text-decoration: none; white-space: pre;">euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.22pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos B BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.57pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.78pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 29.17pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.56pt; position: var(--position); text-decoration: none; white-space: pre;">conversion option<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.53pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.67pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.57pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum Return <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.97pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.01pt; position: var(--position); text-decoration: none; white-space: pre;">Indemnifications<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.77pt; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DERIVATIVE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.6pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">INSTRUMENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,478<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,525<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">5,929<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">9,932<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(2,203)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,376)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(5,787)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 87.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(9,366)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">275<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">149<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">142<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 99.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">566<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Issuance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,585<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">3,585<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">986<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">440<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 132.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">3,046<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 144.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,006)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,006)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 156.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Repurchases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(489)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(339)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,762)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 156.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(2,591)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Exercises<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(771)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 168.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,021)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 180.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 201.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Issuance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,158<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,158<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,462<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,462<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,413)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,413)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 355.31pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Details related to these instruments' accounting treatments and terms and conditions are set forth in Notes 15.1 to 15.5.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.15pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On May 24, 2023, t<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.31pt; position: var(--position); text-decoration: none; white-space: pre;">he holders<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.66pt; position: var(--position); text-decoration: none; white-space: pre;"> opted for the cashless exercise option of the Kreos A&amp;B BSAs they held. At this date, the fair value of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">exercised warrants <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.11pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.94pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,850&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.03pt; position: var(--position); text-decoration: none; white-space: pre;"> (see line items "Repurchases" and "Exercises") <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.05pt; position: var(--position); text-decoration: none; white-space: pre;">was reclassified from derivative financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.55pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities to equity. As of this date, due to the put option being exercised by the holders, the fair value of the Kreos A&amp;B BSAs is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.75pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deemed equal to their intrinsic value, which is equal to the difference between the share price on May 24, 2023 and their exercise <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446.95pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 469.35pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.48pt; position: var(--position); text-decoration: none; white-space: pre;">As of August 24, 2023, the date at which the OCEANE were reimbursed, their conversion option had a fair value of <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,762&#160;thousand<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.79pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 8.25pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 15.13. Breakdown of financial liabilities by maturity<span style="display: inline-block; height: 6.77pt;"></span><span id="i25f84399b4e1453298aac16ba73c09ba"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.97pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following are the remaining contractual maturities of financial liabilities as of December 31, 2022, 2023 and 2024. The amounts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.17pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are gross and undiscounted, and include contractual interest payments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 561.67pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 147pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 0pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 184.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 21pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.39pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.83pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.64pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">12,982<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">14,098<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">9,034<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 54pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">5,065<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">19,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">31,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 66pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);">28,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">4,838<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 78pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">5,173<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 78pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 78pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);">2,586<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">6,783<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">6,813<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">3,697<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 90pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,490<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 90pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);">1,626<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">3,287<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 102pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">1,384<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">1,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">558<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 114pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);">557<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 114pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">289<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.37pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">566<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">142<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 126pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 126pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">424<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">49,797<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">59,053<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">16,223<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 138pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">9,905<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 138pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);">32,925<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 82.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 187.09pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 160.66pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.67pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.56pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.55pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.89pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.01pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.46pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 21pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.8pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.58pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.58pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">36,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">10,522<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">9,997<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">16,231<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 54pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">30,903<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">26,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 66pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">3,678<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 86.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">3,880<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 86.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 86.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 98.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">6,813<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">3,697<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,490<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 98.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);">1,626<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 98.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">12,229<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 110.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 110.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 110.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">540<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 122.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">575<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">406<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">162<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 122.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.96pt;"></span></span><span style="left: 52.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 122.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 134.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 134.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 134.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">77,045<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 146.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">81,500<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">20,747<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">15,192<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 146.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">45,561<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 146.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 257.81pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 543pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 0pt; width: 401.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 188.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.32pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.09pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 54pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">24,063<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">6,563<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 66pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">30,653<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">19,943<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,460<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">46,401<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 86.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">58,080<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">24,016<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">25,715<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,348<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,488<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 98.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">2,586<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 110.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 57.21pt;"></span></span><span style="left: 59.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,363<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 122.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">2,512<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">993<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">996<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">516<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 134.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 30.96pt;"></span></span><span style="left: 33.59pt; position: var(--position);">114,004<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 146.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.21pt;"></span></span><span style="left: 41.84pt; position: var(--position);">122,680<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">38,468<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">56,698<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">27,507<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 421.06pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The contractual cash flows above do not include potential future royalty payments related to the royalty certificates, amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.99pt; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.32pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the future net sales of obefazimod (worldwide and for all indications). The amount of royalties that may be paid under the royalty <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates is capped at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;172.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;"> in the aggregate. Royalty payments are expected to take place before the expiry date of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">certificates, which is <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.86pt; position: var(--position); text-decoration: none; white-space: pre;">15 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.44pt; position: var(--position); text-decoration: none; white-space: pre;"> after their issuance date (September 2, 2037), and would be included in the "<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.18pt; position: var(--position); text-decoration: none; white-space: pre;">f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.51pt; position: var(--position); text-decoration: none; white-space: pre;">ro<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.84pt; position: var(--position); text-decoration: none; white-space: pre;">m 2 to 5 year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.5699999999999pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.46pt; position: var(--position); text-decoration: none; white-space: pre;">" and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">"longer than 5 years" maturity categories according to management's projections.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Disclosure of defined benefit plans [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory', window );">Retirement benefit obligations</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligations<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 534.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligations include the liability for the defined benefit plan, measured based on the provisions stipulated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">under the applicable collective agreements, i.e. the French pharmaceutical industry&#8217;s collective agreement. This commitment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">only applies to employees subject to French law. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.28pt; position: var(--position); text-decoration: none; white-space: pre;">The main actuarial assumptions used to measure the retirement benefit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 570.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">obligations are as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ACTUARIAL ASSUMPTIONS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement age<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;">65 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;">63 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;">65 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;">63 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;">65 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;">64 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 61.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Collective agreement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Discount Rate (IBoxx Corporates AA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;">0.90%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;">3.34%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;">3.40%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Mortality rate table<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Salary increase rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;">2.55%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;">2.55%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;">2.55%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 56.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 25.06pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Turnover rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;">Decreasing from <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;">5.80%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"> at <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;">20 years-old to <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">0.05%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"> from <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;">55 years-old<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;">Decreasing from <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;">5.80%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"> at <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;">20 years-old to <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">0.05%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"> from <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;">55 years-old<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.72pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.68pt; position: var(--position); white-space: pre;">Decreasing rates by age <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 18.97pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.16pt; position: var(--position); white-space: pre;">and <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.4pt; position: var(--position); text-decoration: none; white-space: pre;">zero<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 43.870000000000005pt; position: var(--position); white-space: pre;"> from age 55, <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.18pt; position: var(--position); white-space: pre;">generating an average exit <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 41.47pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.53pt; position: var(--position); white-space: pre;">rate for 2025 of <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.97pt; position: var(--position); text-decoration: none; white-space: pre;">2.05%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.21000000000001pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195.75pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employee contribution rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;">45%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;">45%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;">45%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.61pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in the projected benefit obligation for the periods presented were as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 313.91pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 322.71pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 321.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 153.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 168pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 25.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 0pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.72pt; position: var(--position); text-decoration: none; white-space: pre;">RETIREMENT BENEFIT OBLIGATIONS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 12pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">693<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 33pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">143<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 45pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 157.96pt;"></span></span><span style="left: 160.59pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 57pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">(235)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 69pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">610<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 90pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">109<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 102pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);">23<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 114pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 126pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">629<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 147pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">115<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 159pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);">22<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 171pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 151.3pt;"></span></span><span style="left: 153.93pt; position: var(--position);">(41)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 183pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);">31<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 195pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">756<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 551.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Employees in the U.S. benefit from defined contribution plans (401(k)).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS19_g2-7_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Payables and other current liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">Payables and other current liabilities</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 79.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Payables and other current liabilities<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 17.1. Trade payables and other current liabilities<span style="display: inline-block; height: 6.77pt;"></span><span id="idcc8371f18b54538a715889bed3a5f64"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.71pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 447pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TRADE PAYABLES AND OTHER CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">8,216<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">21,953<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">30,748<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Accrued invoices<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">7,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">25,269<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">13,049<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 70.21pt;"></span></span><span style="left: 72.83999999999999pt; position: var(--position);">9<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 67.55pt;"></span></span><span style="left: 70.17999999999999pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">26<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">15,475<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">47,221<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">No discount was applied to payables and related accounts for which maturity does not exceed one year. As a result, their fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.51pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">approximates their carrying amount. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in trade payable and other current liabilities over the year ended December 31, 2024 is mainly due to the increase in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operating expenses over the period. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 17.2. Tax and employee-related payables<span style="display: inline-block; height: 6.77pt;"></span><span id="i580b0f10a0a74186b2b84677d34024e5"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.81pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables are presented below:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 284.11pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 295.44pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 195pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TAX AND EMPLOYEE-RELATED PAYABLES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employee-related payables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,348<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">3,694<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,742<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Social security and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">840<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,251<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,783<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other tax and related payments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">112<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">127<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">184<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,300<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,073<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,709<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 401.19pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in employee-related, social security and other payables over the year ended December 31, 2023 is mainly related to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.39pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;">changes in the management team and recruitment of additional experienced employees, including C-levels, over the period (see Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 423.59pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;">3.3 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 58.1pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance and management &#8211; February-August 2023)<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.3pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.94pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory', window );">Operating income</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.89pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income is composed as below:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; position: var(--position); top: 501.89pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 90.75pt;"></span></span><div style="font-size: 0pt; left: 38.5pt; position: var(--position); top: 0pt; width: 381pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OPERATING INCOME<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit ("CIR")<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,493<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,651<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">29<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">81<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,140<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">78<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">47<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,657<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total operating income<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,583<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,621<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">12,449<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 608.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income is composed as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit (&#8220;CIR&#8221;) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group carries out research and development projects. As such, it has benefited from a research tax credit for the years ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Decem<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ber 31, 2022, 2023 and 2024 for an amount of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;4,476&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;4,493&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.04pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.47pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;5,668&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.56pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, respectively (see Note </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 675.86pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">4.9). During the year ended December 31, 2024, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.94pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">the</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.14pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> Group also received an additional tax credit payment related to the 2021 tax year </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">for an amount of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.39pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;984&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> after a claim from the Group following a clarification of "public subsidy" definition.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 709.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies primarily relate to the Bpifrance RNP-VIR and CARENA conditional advances, the repayments of which were partly <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">waived by Bpifrance in June 2024, f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.15pt; position: var(--position); text-decoration: none; white-space: pre;">or<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.98pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,872&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.07pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,251&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.59pt; position: var(--position); text-decoration: none; white-space: pre;"> resp<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.74pt; position: var(--position); text-decoration: none; white-space: pre;">ectively (see Notes 3.3 and 15.7).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the year ended December 31, 2024, the line item "Other" mainly includes issuance, cancellation and depositary service fees <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">collected from ADSs holders by Citibank, who is acting as the Group's exclusive depositary for its publicly listed and freely traded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ADSs. As part of the depositary agreement between Citibank and the Group, the latter is entitled to receive a portion of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">aforementioned fees collected by Citibank.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses by nature [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory', window );">Operating expenses</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Operating expenses<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 19.1. Sales and marketing<span style="display: inline-block; height: 6.77pt;"></span><span id="i36c21550f6ab4c06a26eca50fdd758de"></span></span><div style="position: var(--position); top: 310.89pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">SALES AND MARKETING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,710<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,323<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,012<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,699<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other sales and marketing expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">709<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">932<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sales &amp; Marketing<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,431<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">5,954<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 432.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the years ended December 31, 2023 and 2024, sales and marketing expenses amount<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.38pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6,431<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.65pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.17pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5,954<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.1700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.76pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">respectively. The decrease was primarily <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.86pt; position: var(--position); text-decoration: none; white-space: pre;">driven by the restructuring of the Group's sales and marketing department part way through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61pt; position: var(--position); text-decoration: none; white-space: pre;">These expenses consist primarily of consulting costs associated with market research in preparation for the Group's potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future sales and commercialization efforts in the U.S. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group did not incur any sales and marketing expense for the year ended December 31, 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 19.2. Research and development<span style="display: inline-block; height: 6.77pt;"></span><span id="i02d53339738d4dda95bdbdb57157a5b7"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses break down as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 558.34pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">RESEARCH AND DEVELOPMENT EXPENSES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sub-contracting, studies and research<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">38,858<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">85,726<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">110,993<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">3,072<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">8,048<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">18,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,246<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,561<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">12,581<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Intellectual property fees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,187<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,645<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,741<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other research and development expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">931<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,196<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,762<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">48,295<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">103,176<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">146,532<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses consist primarily of the following items: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Personnel expenses, including salaries, benefits, and share-based compensation expenses, for employees engaged in <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">research and development activities; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Sub-contracting, collaboration and consultant expenses that primarily include the cost of third-party contractors such as <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">CROs who conduct our non-clinical studies and clinical trials, and research related to proprietary platforms, as well as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">investigative sites and consultants that conduct our preclinical studies and clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses incurred under agreements with contract manufacturing organizations (&#8220;CMOs&#8221;), including manufacturing <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">scale-up expenses and the cost of acquiring and manufacturing preclinical study and clinical trial materials; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses relating to preclinical studies and clinical trials; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses relating to regulatory affairs; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Allocated expenses for facility costs, including rent, utilities and maintenance; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Expenses relating to the implementation of the quality assurance system. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 255.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in research and development expenses for the years ended December 31, 2023 and 2024 is primarily due to (i) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 266.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase in UC expenses (of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.34pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;45,233 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.43pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.86pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;32,030<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.36pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand), due to the progress of Phase 3 clinical trials for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obefazimod in UC, (ii) the increase in CD expenses (of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.55pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,734 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.64pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.07pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,620<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.57pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand), due to the planning costs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and progression of the Phase 2b CD trial, and (iii) the increase in transversal activities related to the overall expansion of the research <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and development headcount to support the Group's organizational growth and the issuance of new equity awards to officers and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 311.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">employees in research and development (of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4,477 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.29pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8,233<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.22pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand). <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 19.3. General and administrative<span style="display: inline-block; height: 8.25pt;"></span><span id="ibf0d702474584c3fafbf3a5cbc6a8b0d"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 198.66pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span><div style="position: var(--position); top: 363.59pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GENERAL AND ADMINISTRATIVE EXPENSES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">13,105<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">19,434<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,624<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,393<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">7,990<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other general and administrative expenses&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">3,466<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,893<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">5,522<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative expenses&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">7,492<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">22,391<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">32,946<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative expenses consist primarily of personnel-related expenses, including salaries, benefits and share-based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">compensation expenses, for personnel other than employees engaged in research and development activities. General and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">administrative expenses also include fees for professional services, mainly related to audit and legal services, consulting costs, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">communications and travel costs, allocated expenses for facility costs, including rent, utilities and maintenance, directors&#8217; attendance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fees, and insurance costs. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.34pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The increase in general and administrative expenses for the years ended December 31, 2023 and 2024 is primarily due to the increase <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 556.54pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in personnel costs of respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.68pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;11,702<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.18pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6,329<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.7pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.2pt; position: var(--position); text-decoration: none; white-space: pre;">t<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.97pt; position: var(--position); text-decoration: none; white-space: pre;">housand, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.29pt; position: var(--position); text-decoration: none; white-space: pre;">resulting from the issuance of new equity awards to officers <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.74pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and employees, management changes that occurred over the period (see Notes 3.2 and 3.3 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 398.09pt; position: var(--position); text-decoration: none; white-space: pre;">Change in governance and management<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.63pt; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.94pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and the increased G&amp;A headcount to support the expansion of the overall organization, as well as increased legal and professional fees <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.14pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and other costs associated with operating as a dual-listed public company.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Our principal audit fees and services are set forth below. For the years ended December 31, 2023 and 2024, they include fees due our <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">joint statutory auditor Agili3f, in addition to PricewaterhouseCoopers Audit. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 106.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 524.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 275.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td></tr><tr style="height: 34.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.18pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 86.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statutory Auditor, certification of individual and consolidated financial statements<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issuer<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">100<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">1,848<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">1,144<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 64.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other procedures required by law<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issuer<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">740<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">492<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">89<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">840<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">2,340<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">1,233<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating expense. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employees<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EmployeesAbstract', window );"><strong>Employees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory', window );">Employees</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Employees<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.31pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s average workforce during the periods ended December 31, 2022, 2023 and 2024 was as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 287.06pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 360pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">HEADCOUNTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">France<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">23<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">28<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">38<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">12<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">29<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">23<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">40<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">67<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EmployeesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employees [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EmployeesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial gain (loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialIncomeLossAbstract', window );"><strong>Financial Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Financial gain (loss)</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Financial gain (loss)<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The financial loss breaks down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 112.66pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 510pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 279pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 87.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL GAIN (LOSS)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on Kreos 1 &amp; 2 straight bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,737)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(760)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(5,800)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on convertible loan notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(2,641)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,935)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(5,691)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on conditional advances<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(196)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(176)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(85)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(356)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(8,942)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(794)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(10)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(13)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(61)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in derivatives fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,046)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,462)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in other liabilities at fair value through profit and loss<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,367)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loss on derecognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,431)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,924)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,615)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(5,573)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(51)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(83)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(73)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(64)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial expenses<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(7,022)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(27,875)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(16,991)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,418<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">8,246<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in derivatives fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">9,366<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,006<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,413<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in other liabilities at fair value through profit and loss<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,446<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,198<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of unwinding the discount related to advances made to CROs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">355<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">710<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Day-one gain on recognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">212<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">590<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Gain on derecognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">192<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange gains <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,774<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">306<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">130<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 282.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial income<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">11,118<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">7,511<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">13,732<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial gain (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">4,096<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(20,364)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,258)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.71pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Increases and decreases in the fair value of derivatives are detailed in Notes 15.1, 15.3, 15.5 and 15.12.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 459.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Increases and decreases in other liabilities at FVTPL relate to the Prosynergia earn-out liability for the year ended December 31, 2022 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(see Note 15.9) and the Heights notes for the years ended December 31, 2023 and 2024 (see Note 15.2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interests on royalty certificates are detailed in Note 15.10.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs for the year ended December 31, 2023 mainly relate to Heights notes, and t<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.62pt; position: var(--position); text-decoration: none; white-space: pre;">ransaction costs for the year ended <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2024 mainly relate to the amortization of the prepaid expenses related to the transaction costs of the Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranche C bond loans (see Note 15.1).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Gains and losses on the recognition and derecognition of financial liabilities are set forth in Notes 15.2. to 15.5.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest income mainly relates to the invested proceeds from the Group's Global Offering and the Kreos / Claret and Heights <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financings.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange losses for the year ended December 31, 2023 mainly relate to the translation of cash and cash equivalents held in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. dollars into the Group's presentation currency as of December 31, 2023 (see Note 11), resulting in a loss of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.28pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,196&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.37pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,488&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.29pt; position: var(--position); text-decoration: none; white-space: pre;"> loss resulting from foreign exchange operations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange gains for the year ended December 31, 2024 mainly relate to the translation of cash and cash equivalents held in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. dollars into the Group's presentation currency as of December 31, 2024 (see Note 11), resulting in a gain of<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.43pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 487.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2,035&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.02pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;714&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.79pt; position: var(--position); text-decoration: none; white-space: pre;"> gain resulting from foreign exchange operations.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income tax</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Income tax<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The income tax rate applicable to the Company is the French corporate income tax rate, i.e. 25% for the years ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 101.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022, 2023 and 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The income tax rates applicable to the Subsidiary are the federal income tax rate of 21% and the State income tax rates of 4.35% and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 135.21pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">5.36%, i.e. a total of 25.35% and 26.36% for the<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.48pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> years ended December 31, 2023 and 2024 respectively.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 158.71pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 214.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 39.07pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros, except percentage)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loss before tax <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(60,740)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.14pt;"></span></span><span style="left: 67.77pt; position: var(--position);">(147,740)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.14pt;"></span></span><span style="left: 67.77pt; position: var(--position);">(176,242)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statutory French tax rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);">25.00<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);">25.00<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);">25.00<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Nominal income tax using statutory French tax rate<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);">15,185<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);">36,935<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);">44,061<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax effect of:<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax rates in foreign jurisdictions<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payment<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">342<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 73.14pt;"></span></span><span style="left: 75.77pt; position: var(--position);">(2,045)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 73.14pt;"></span></span><span style="left: 75.77pt; position: var(--position);">(5,056)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 103.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CIR<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">1,119<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">1,123<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">1,663<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 115.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs related to capital increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">820<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">3,073<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 127.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease / (increase) in derivatives fair value and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">895<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">748<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(207)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.89pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-recognition of deferred tax assets related to tax losses and <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.49pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">temporary differences<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(18,169)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(39,612)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(40,399)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(192)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(222)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">49<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-left: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; border-top: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effective income tax (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 362.46pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 242.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.92pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DEFERRED TAX ASSETS AND LIABILITIES BY NATURE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligation<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">152<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">157<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">189<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">135<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">591<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">198<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">351<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,678<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax losses carryforward<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);">77,207<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">114,946<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">152,372<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other items<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">417<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">886<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);">77,558<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">116,006<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">155,715<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">24<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">12<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 117pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">124<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">485<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,377<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">285<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,075<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other items<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">10<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">12<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,427<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">444<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,584<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets, net<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);">76,130<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">115,562<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">154,131<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Unrecognized deferred tax assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 63.05pt;"></span></span><span style="left: 65.67999999999999pt; position: var(--position);">(76,130)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.05pt;"></span></span><span style="left: 61.68pt; position: var(--position);">(115,562)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.05pt;"></span></span><span style="left: 61.68pt; position: var(--position);">(154,131)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total deferred taxes, net recognized in the statement of financial <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">position<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group incurred tax losses in the reporting periods ended December 31, 2022, 2023 and 2024. As the recoverability of these tax <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">losses is not considered probable in subsequent periods due to the uncertainties inherent in the Group&#8217;s business, the Group has not <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized deferred tax assets beyond deferred tax liabilities arising within the same taxable entity under the same taxable regime and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with consistent timing of reversal, after considering, if applicable, limitations in the use of deductible tax losses carried forward from <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prior periods applicable under tax laws in France and in the U.S..<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The accumulated tax loss carry<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.26pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> forwards for the Company amount to &#8364;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.75pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">308,829</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.25pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#160;thousand,</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.34pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> &#8364;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.84pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">459,752</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.34pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> thousand and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 490.36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;609,390</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> thousand </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">as of December 31, 2022, 2023 and 2024,</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.12pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> respectively, and do not have any expiration date. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 694.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The accumulated tax loss carry forwards for the U.S. Subsidiary consist of federal Net Operating Loss ("NOL") carry forwards and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 706.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount to &#8364;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.74000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">38&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.76pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;112&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.35pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2023 and 2024, respectively. They do not have any expiration date.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (loss) per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Income (loss) per share</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Income (loss) per share<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.11pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Basic losses per share is calculated by dividing income (loss) attributable to equity holders of the Group by the weighted-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.11pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">average number of outstanding ordinary shares for the year.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.61pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Diluted losses per share are calculated by adjusting the weighted average number of ordinary outstanding shares to assume <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.61pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conversion of all dilutive potential ordinary shares.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 185.61pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 23.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros, except share data)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BASIC AND DILUTED LOSS PER SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of outstanding shares<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">19,092,442<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">43,066,012<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">63,046,350<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(60,740)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(147,740)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(176,242)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Basic and diluted loss per share (&#8364;/share)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(3.18)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(3.43)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(2.80)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Potential dilutive instruments (BCEs, BSAs, AGAs, Equity lines, BSA Kreos 1, OCEANE, Kreos/Claret BSA, Kreos/Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">OCABSA and Height notes) have been excluded from the computation of diluted weighted-average shares outstanding because such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">instruments had an antidilutive impact due to the losses reported. As of December 31, 2022, 2023 and 2024, the number of potential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 326.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">dilutive instruments were <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.04000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">1,707,037<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.04pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.04pt; position: var(--position); text-decoration: none; white-space: pre;">28,754,280<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.04pt; position: var(--position); text-decoration: none; white-space: pre;"> a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nd </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.47pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">29,570,132</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.47pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.97pt; position: var(--position); text-decoration: none; white-space: pre;">respectively, giving rights to a maximum number of shares to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">issued of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.31pt; position: var(--position); text-decoration: none; white-space: pre;">1,707,037<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.31pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.31pt; position: var(--position); text-decoration: none; white-space: pre;">6,510,658<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.74pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">6,760,392</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.74pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span>respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Related <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108.72pt; position: var(--position); text-decoration: none; white-space: pre;">parties<span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.91pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The aggregate compensation of the members of the Group&#8217;s Board of Directors and to the Chief Executive Officer includes the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 423.31pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 241.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.54pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">COMPENSATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fixed compensation owed <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">322<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">471<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">578<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Variable compensation owed <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">193<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">282<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Contributions in-kind <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 70.21pt;"></span></span><span style="left: 72.83999999999999pt; position: var(--position);">9<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">32<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">68<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Attendance fees&#8212;Board of Directors <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">103<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">375<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">495<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.55pt;"></span></span><span style="left: 62.18pt; position: var(--position);">(217)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,561<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">10,517<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Departure indemnities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,210<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">427<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">8,930<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">11,657<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.11pt; position: var(--position); text-decoration: none; white-space: pre;"> of December 31, <span style="display: inline-block; height: 6.93pt;"></span><span id="id16aa006a71e4472b93adcaee881ab63_1564"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.98pt; position: var(--position); text-decoration: none; white-space: pre;">2022,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> the liability related to post-employment defined benefit obligations (corresponding to the legal retirement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 602.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">benefits obligations) for members of the Group&#8217;s Board of Directors and Chief Executive Officer amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;149&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.46pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2023 <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;">2024,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.91pt; position: var(--position); text-decoration: none; white-space: pre;"> there was <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.91pt; position: var(--position); text-decoration: none; white-space: pre;">no<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 233.91pt; position: var(--position); text-decoration: none; white-space: pre;"> liability related to post-employment defined benefit obligations for members of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 624.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s Board of Directors and Chief Executive Officer. No other post-employment benefits are granted.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 647.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other arrangements with our <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 155.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 194.21pt; position: var(--position); text-decoration: none; white-space: pre;"> and Executive Officers <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into an intellectual property assignment agreement with CEO Hartmut Ehrlich on July 7, 2021. The purpose of this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement is to transfer to the Group all the intellectual property rights held by Hartmut Ehrlich on certain patents of which he is a co-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inventor. No compensation has been paid in respect of this transfer. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 691.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In connection with Dr. Hartmut Ehrlich&#8217;s retirement as CEO, the Group entered into a transition protocol with Dr. Ehrlich in April <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 703.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2023. Pursuant to the transition protocol, Dr. Ehrlich remained a Group employee on a part-time basis until December 31, 2023 in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">capacity as advisor to the new Chief Executive Officer against payment of a total compensation of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.59pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.59pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, and a departure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">indemnity equal to&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,210<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.41pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand was stated.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into a management contract with CEO Marc de Garidel on April 18, 202<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.92pt; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.92pt; position: var(--position); text-decoration: none; white-space: pre;">. In 2023 and 2024, the Group also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granted AGA plans to its CEO (see terms and conditions in Note 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group entered into a management contract with Chairman of the Board Sylvie Gr&#233;goire in July 2024. In 2024, the Group also <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granted AGA plan 2024-5 to its Chairman of the Board (see terms and conditions in Note 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off-balance sheet commitments given<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OffBalanceSheetCommitmentsAbstract', window );"><strong>Off-Balance Sheet Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsExplanatory', window );">Off-balance sheet commitments given</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Off-balance sheet comm<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 176.72pt; position: var(--position); text-decoration: none; white-space: pre;">itments give<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 228.06pt; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.1. Commitments under collaboration, research, service provision and licensing agreements granted by the Group <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Collaboration, research and development, and licensing agreements, and licensing options related to the &#8220;Modulation of RNA <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">biogenesis&#8221; platform. <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.7pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 76.2pt; position: var(--position);"><span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">E<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 97.71000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">xclusive licensing agreement with the CNRS, the University of Montpellier and the Institut Curie<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.21pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 245.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">On December 4, 2008, the French National Centre for Scientific Research (CNRS), the University of Montpellier and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 255.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">the Institut Curie granted the Group <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.45pt; position: var(--position); text-decoration: none; white-space: pre;">four<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.11pt; position: var(--position); text-decoration: none; white-space: pre;"> exclusive licenses. These licenses cover the use of their technology and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">products by the Group in the field of human and veterinary health relating to the use of synthetic products modifying <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">mRNA splicing, for research, diagnosis, prevention and treatment of any possible indication. The licensing agreement <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">includes low single-digit royalties based on future net sales to be paid by the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Research collaboration contract with the CNRS, the University of Montpellier and the Institut Curie<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Concomitantly with a research collaboration framework contract relating to the creation of a cooperative laboratory, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 327.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">ended in December 2021, the parties have signed a financial agreement defining the financial terms for the exploitation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 337.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">of patents. This contract was signed on 15&#160;April 2009 for a duration of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.53000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">one year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.65000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> and was subsequently renewed up until <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">March 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 363.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development contract with license option with the CNRS, the University of Montpellier and Theradiag<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">The CNRS, the University of Montpellier, the Group and Theradiag conducted since 2013 a collaborative project <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">notably in the fields of HIV and HTLV-1 called CARENA, in connection with a funding obtained through Bpifrance. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">The overall project provided for co-ownership and cross-licenses on the project's results through various instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 407.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">The Group met all obligations and the project was closed in December 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 437.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Exclu<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 58.730000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">sive licensing contract with &#8220;The Scripps Research Institute, University of Chicago and Brigham Young University&#8221; with the <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 447.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Immune Stimulation&#8221; platform (ABX196 product) <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On 11&#160;November 2006, The Scripps Research Institute (La Jolla, California, USA), in agreement with the University of Chicago <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Chicago, Illinois, USA) and Brigham Young University (Provo, Utah, USA), granted the Group an exclusive license in the field of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">human and veterinary health on its technology and products relating to the use of iNKT agonists for research, diagnosis, prevention <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and treatment of all possible indications. In consideration for the licensing rights granted to it under the agreement, the Group had to: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">pay The Scripps Research Institute milestones at different stages of clinical and regulatory development of the first <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">product (the milestones amount to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.07pt; position: var(--position); text-decoration: none; white-space: pre;">$50&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.66pt; position: var(--position); text-decoration: none; white-space: pre;"> at IND filing, paid in September 2019 and capitalized, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.62pt; position: var(--position); text-decoration: none; white-space: pre;">$300&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.21pt; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.29pt; position: var(--position); text-decoration: none; white-space: pre;">$500&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.88pt; position: var(--position); text-decoration: none; white-space: pre;"> at IND approval) and low single-digit royalties for vaccines, diagnostic tests and therapeutic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">products, according to the amount of net sales, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 296.67pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">give The Scripps Research Institute, University of Chicago and Brigham Young University an equitable interest in the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Group (as of the date of these financial statements, these <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.36pt; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.32pt; position: var(--position); text-decoration: none; white-space: pre;"> academic institutions hold <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.18pt; position: var(--position); text-decoration: none; white-space: pre;">0.41%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.01pt; position: var(--position); text-decoration: none; white-space: pre;"> of the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">undiluted capital). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 597.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">During the year ended December 31, 2022, the Group made the decision to freeze the development program for ABX196 in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">treatment of hepatocellular cancer (see Note 3.1 - <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 235.97pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of ABX196 cash-generating unit )<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.98pt; position: var(--position); text-decoration: none; white-space: pre;">. Subsequently, in 2024, the licensing <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">contract was terminated.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.2. Commitments under BPI conditional advances <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 685.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance CARENA contract <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the development of therapeutic and diagnostic solutions targeting alternative splicing and RNA interference in the fields of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 711.31pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">virology (HIV-AIDS, HTLV-1) and metabolism (obesity), SPLICOS (absorbed by the Group on 31&#160;October 2014) has entered into a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Master Support Agreement with Bpifrance as well as a conditional advance contract in the name of the &#8220;CARENA&#8221; Strategic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Industrial Innovation Project dated December 16, 2013. The Group, acting as project leader for the CARENA project, was associated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as part of a consortium contract with Theradiag, a Group specializing in in vitro diagnostics and the development of theranostic tests <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for monitoring biotherapies, as well as at the CNRS and the University of Montpellier. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The CARENA project aimed to develop the anti-HIV-AIDS therapeutic program with the compound ABX464 up to the Phase 2b <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">study, as well as a companion test set up by Theradiag simultaneously with the clinical development. Beyond the anti-HIV-AIDS <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program, the CARENA project could extend its pharmacological investigations to another retrovirus that could be combated by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">same approach: HTLV-1. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is committed to reimbursing the received conditional advances up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.85pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,840&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.94pt; position: var(--position); text-decoration: none; white-space: pre;">. The Group will also have to pay an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 186.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">annuity of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.3pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.63pt; position: var(--position); text-decoration: none; white-space: pre;"> of the proceeds from the sale of the intellectual property rights resulting from the project, as well as the sale of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prototypes, preproduction and models produced under the project; the sum due to Bpifrance under this provision will be deducted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the repayment of the conditional advances. In addition, if the advance is repaid under the conditions outlined above, the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">will pay to Bpifrance, over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-3291">five</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.19pt; position: var(--position); text-decoration: none; white-space: pre;"> consecutive years after the date on which the repayment schedule ends and provided that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group has reached cumulative pre-tax revenue greater than or equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;50&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 381.4pt; position: var(--position); text-decoration: none; white-space: pre;">, an amount equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.2pt; position: var(--position); text-decoration: none; white-space: pre;">1.20%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.03pt; position: var(--position); text-decoration: none; white-space: pre;"> of the annual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">revenue generated from the sale of the products developed as part of the project. This supplementary payment amount is capped at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6,800&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">. The total period, including fixed payments and incentive payments, is limited to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.48pt; position: var(--position); text-decoration: none; white-space: pre;">15 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.06pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Termination became effective in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 2024 after the Group refunded&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.1pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;234&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.69pt; position: var(--position); text-decoration: none; white-space: pre;"> corresponding to a portion of the funding received. The Group is therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 305.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">released of its obligations to pay an annuities on the proceeds from the sale of the intellectual property rights resulting from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">project. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 346.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance RNP-VIR contract <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In pursuit of the CARENA project, focused on the clinical development of a drug molecule and demonstrating the validity of an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">innovative therapeutic approach targeting viral RNPs, the Group has entered into a Master Support Agreement with Bpifrance as well <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as a beneficiary agreement with conditional advance for the &#8220;RNP-VIR&#8221; structuring research and development project for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">competitiveness dated December 16, 2016. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The RNP-VIR project aimed to further the discovery of new molecules for the treatment of multiple infectious diseases by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">development of the antiviral technology platform. The Group, acting as project leader of the RNP-VIR project, was associated in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consortium contract with the CNRS and the University of Montpellier. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is committed to reimburse the received conditional advances up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.51pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6,576&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.6pt; position: var(--position); text-decoration: none; white-space: pre;">. If applicable, the Group will also have <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 466.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to pay an annuity of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.43pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.76pt; position: var(--position); text-decoration: none; white-space: pre;"> of the proceeds from the sale of the intellectual property rights resulting from the project, as well as the sale <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the prototypes, preproduction and models produced under the project. The sum due to Bpifrance under this provision will be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">deducted from the last payment (and if needed from the previous payments). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 508.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">If the advance is repaid under the conditions outlined above, the Group will pay to Bpifrance, over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.3pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="-sec-ix-hidden:f-3299">five</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.83pt; position: var(--position); text-decoration: none; white-space: pre;"> consecutive years <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">following the date on which the repayment schedule ends and provided that the Group has reached cumulative pre-tax revenue greater <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">than or equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.28pt; position: var(--position); text-decoration: none; white-space: pre;">, an amount equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.08pt; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.41pt; position: var(--position); text-decoration: none; white-space: pre;"> of the annual revenue generated from the sale of products developed as part of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">project. The supplementary payments amount is capped at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.99pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5,500&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.08pt; position: var(--position); text-decoration: none; white-space: pre;">. The total period, including fixed payments and incentive <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">payments, is limited to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); text-decoration: none; white-space: pre;">15 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Termination became effective in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">December 2024. The Group is therefore released of its obligations to pay an annuities on the proceeds from the sale of the intellectual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">property rights resulting from the project. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 624.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Bpifrance Ebola <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Bpifrance and Occitanie Region joint support agreement granted on June 2, 2017 consists of conditional advances to the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for a total amount of up to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.4pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;390&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.99pt; position: var(--position); text-decoration: none; white-space: pre;">, based on the success of the program (respectively <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;130&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.46pt; position: var(--position); text-decoration: none; white-space: pre;"> from the Languedoc <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 660.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Roussillon Midi Pyr&#233;n&#233;es Region and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.04pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;260&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.63pt; position: var(--position); text-decoration: none; white-space: pre;"> from Bpifrance). In September 2019, the Group decided to terminate this <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">program, due to the existence of a vaccine in the process of being licensed for this indication as well as changes in the macroeconomic <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">climate for public funding. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The reimbursement of the conditional advance was spread until June 2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.3. Pledge assets to Kreos, Claret and Heights <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the KREOS 1 &amp; 2 bonds, Kreos benefits from first-rate collateral on the Group&#8217;s principal tangible and intangible assets, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">including its commercial fund, intellectual property rights in its principal drug candidates, as well as a pledge of the Group&#8217;s bank <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">accounts and claims. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On August 21, 2023, the outstanding Kreos 1 &amp; 2 bond loans were repaid in full, using the proceeds from the new Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financing (see Note 3.3).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary exceptions) which include, among other <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">things, restrictions on the incurrence of indebtedness, cross-default, the distribution of dividends and the grant of security interests, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.55pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">which would cause the bonds to become repayable on demand in case of breach. As of December 31, 2024, the Group complied with <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 195.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">these restrictive covenants.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> As security for the Kreos / Claret Financing, the lenders benefit from the grant of first-ranking collateral on the Group&#8217;s principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tangible and intangible assets, including pledges over the Group&#8217;s business (<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;">fonds de commerce<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.67pt; position: var(--position); text-decoration: none; white-space: pre;">) as a going concern and intellectual <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">property rights in the Group's lead drug candidate, as well as pledges over the Group&#8217;s bank accounts and receivables. Such securities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">apply to all tranches of the Kreos / Claret Financing.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights Financing is a senior, unsecured financing. The terms and conditions of the Heights convertible notes include a standard <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">negative pledge providing that any security granted in favor of other borrowed debt or debt instruments should also be granted in favor <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the Heights convertible notes on an equal basis (with the exception of the securities issued pursuant to the Kreos / Claret Financing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as detailed above).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.4. Other commitments related to research and partnership arrangements <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the ordinary course of business, the Group regularly uses the services of subcontractors and enters into research and partnership <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">arrangements with various contract research organizations, or CROs, and with public- sector partners or subcontractors, who conduct <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials and studies in relation to the drug candidates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At December 31, 2022, 2023, and 2024 the Group&#8217;s commitments amounted to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.47pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;194,731&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.56pt; position: var(--position); text-decoration: none; white-space: pre;">,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.06pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.56pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;201,777&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.65pt; position: var(--position); text-decoration: none; white-space: pre;"> and<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.5799999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.0799999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;234,908 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;">. The cost of services performed by CROs is recognized as an operating expense as incurred.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.5. Leases <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Following the end (in December 31, 2021) <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.19pt; position: var(--position); text-decoration: none; white-space: pre;">of the Framework agreement with <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.64pt; position: var(--position); text-decoration: none; white-space: pre;">CNRS <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.24pt; position: var(--position); text-decoration: none; white-space: pre;">(French National Centre for Scientific Research) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and the University of Montpellier for research collaboration to create a cooperative laboratory, a hosting agreement was signed in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 494.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2022 with CNRS<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.86pt; position: var(--position); text-decoration: none; white-space: pre;">, so that the Group can continue its research program at the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.19pt; position: var(--position); text-decoration: none; white-space: pre;">CNRS<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.29pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.79pt; position: var(--position); text-decoration: none; white-space: pre;">center for the year 2023, and was subsequently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">renewed for 2024 and 2025. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In D<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.05pt; position: var(--position); text-decoration: none; white-space: pre;">ecember 2022, following the end of the Research collaboration contract with the CNRS, the University of Montpellier and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Institut Curie, the Company and the Institut Curie concluded a new contract for a duration of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.19pt; position: var(--position); text-decoration: none; white-space: pre;">one year<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.31pt; position: var(--position); text-decoration: none; white-space: pre;">, renewable by amendment, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">granting the Company access to some of the Institute&#8217;s equipment and consumables. The contract was subsequently renewed for 2024 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and 2025, under similar conditions.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The above agreements fall within the scope of the short-term lease exemption of IFRS 16, and the related rental expenses are therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in operating expenses as incurred.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 622.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group's commitments in relation to other ongoing leases are set forth in Note 15.8 and 15.13.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Note 25.6. Litigation related to Prosynergia acquisition <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">On December 12, 2024, the Group was notified of a claim from the seller of Prosynergia requesting the payment of an earn-out in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">connection with the transaction. Legal proceedings are ongoing in French court. The Group has not recorded any provision in its <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial statements in connection with this claim <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.54pt; position: var(--position); text-decoration: none; white-space: pre;">due to uncertainty in the outcome of this proceeding.<span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OffBalanceSheetCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Off-Balance Sheet Commitments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OffBalanceSheetCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off-balance sheet commitments received and contingent assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OffBalanceSheetCommitmentsAbstract', window );"><strong>Off-Balance Sheet Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory', window );">Off-balance sheet commitments received and contingent assets</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Off-balance sheet commitments received and contingent assets <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The maximum amounts receivable by the Group after December 31, 2023 under the &#8220;RNP-VIR&#8221; and &#8220;CARENA&#8221; and innovation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreements entered into with Bpifrance, subject to the provision of evidence to support the forecast expenses and the achievement of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scientific milestones, are <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3,255&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.59pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.02pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,853&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.11pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.36pt; position: var(--position); text-decoration: none; white-space: pre;">In June 2024, the Group and Bpifrance agreed to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">terminate the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.9pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.89pt; position: var(--position); text-decoration: none; white-space: pre;"> projects due to technical failures (see Note 15.7).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the Kreos / Claret Financing agreement, the Group has received loan commitments from Kreos and Claret for the tranches B <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and C, of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;25,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.51pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount each (subject to the conditions set forth in Note 15.1.). The B and C <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">tranches were drawn in March 2024 and June 2024, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As part of the Heights Financing agreement, the Group has received a loan commitment from Heights for the tranche B, of up to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;40,000&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"> in aggregate principal amount (subject to the conditions set forth in Note 15.2.).&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.41pt; position: var(--position); text-decoration: none; white-space: pre;">On the limit date for the drawdown <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the second tranche of the Heights Financing (i.e. August 4, 2024), the Group had not drawn down this tranche and has therefore <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">forgone its right to do so in the future.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has not received any significant off-balance sheet commitment and has no significant contingent asset as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2024.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OffBalanceSheetCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Off-Balance Sheet Commitments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OffBalanceSheetCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other provisions, contingent liabilities and contingent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS37_g84-92_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Management and assessment of financial risks<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialRiskManagementAbstract', window );"><strong>Financial Risk Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">Management and assessment of financial risks</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">Management and assessment of financial risks <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The principal financial instruments held by the Group are cash and cash equivalents. The purpose of holding these instruments is to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 313.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">finance the ongoing business activities of the Group. It is not the Group&#8217;s policy to invest in financial instruments for speculative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">purposes. The Group does not use derivative financial instruments for hedging purposes. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The principal risks to which the Group is exposed to are liquidity risk, interest rate risk, foreign currency exchange risk, credit risk and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value risk. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Liquidity risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 409.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Liquidity risk management aims to ensure that the Group disposes of sufficient liquidity and financial resources to be able to meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">present and future obligations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 443.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group prepares short-term cash forecasts and annual operating cash flow forecasts as part of its budget procedures.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prudent liquidity risk management involves maintaining sufficient liquidity, having access to financial resources through appropriate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit facilities and being able to unwind market positions.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s operations have consumed substantial amounts of cash since inception. Developing pharmaceutical drug candidates, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">including conducting clinical trials, is expensive, lengthy and risky, and the Group expects its research and development expenses to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 521.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">increase substantially in connection with its ongoing activities. Accordingly, the Group will continue to require substantial additional <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">capital to continue its clinical development activities and potentially engage in commercialization activities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group's estimate of its cash runway as of the date of approval of these financial statements is set forth in Note 2<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 500.59pt; position: var(--position); text-decoration: none; white-space: pre;"> - Going concern.<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 584.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Interest rate risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is exposed to market risks in connection with its medium and long-term borrowings subject to variable interest rates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 631.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Due to fluctuations in market interest rates<span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 206.32pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.32pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.32pt; position: var(--position); text-decoration: none; white-space: pre;">and the refinancing of most of its indebtedness over the year ended December 31, 2023, the <span style="display: inline-block; height: 8.32pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group has performed a reassessment of its exposure to interest rate risk. As of December 31, 2023, following the full repayment of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.2pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 bonds, all the Group&#8217;s non-derivative financial liabilities accounted for at amortized cost bear fixed interest rates. Therefore, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.4pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group has limited exposure. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.8pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Over the year ended December 31, 2024, the Group has drawn down the second and third tranches of the Kreos / Claret Financing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">bearing variable interest rates (consisting of a fixed margin of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.13pt; position: var(--position); text-decoration: none; white-space: pre;">7.5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.96pt; position: var(--position); text-decoration: none; white-space: pre;"> + European Central Bank Base Rate (MRO), with a floor at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.81pt; position: var(--position); text-decoration: none; white-space: pre;">2.5%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.64pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and a cap at <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.92pt; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.25pt; position: var(--position); text-decoration: none; white-space: pre;">) and has therefore performed a reassessment of its exposure to interest rate risk. Due to the interest rate collar having a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">range of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">150<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> bp, the Group concluded that it still has limited exposure.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign currency risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group is exposed to a risk of exchange rates fluctuations on commercial transactions performed in currencies different from the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">functional currency of the Group entity recording the transactions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the years ended December 31, 2024, 2023 and 2022, expenses in U.S. dollars totaled <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.48pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10,547<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.98pt; position: var(--position); text-decoration: none; white-space: pre;"> thousands, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.46pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10,112<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.96pt; position: var(--position); text-decoration: none; white-space: pre;"> thousands and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,390<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"> thousands respective<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ly, based on the average annual exchange rate in effect as of December 31, 2024, December 31, 2023 and </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">December 31, 2022. A</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.76pt; position: var(--position); text-decoration: none; white-space: pre;">s a result, an adverse <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.21pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.54pt; position: var(--position); text-decoration: none; white-space: pre;"> change in the exchange rate for the U.S. dollar against the euro would have resulted <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in a foreign exchange rate loss of approxi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.65pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">mately </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.32pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;291&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> for 2024, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.57pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;386&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> fo</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.99pt; position: var(--position); text-decoration: none; white-space: pre;">r 2023 and a non-material amount for 2022.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At this stage, the Group has not adopted any other recurring mechanism of hedging to protect its activity against currency fluctuations. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">From time to time, the Group may nevertheless subscribe currency term accounts in order to cover a commitment in currency as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">described above. The Group may consider in the future using a suitable policy to hedge exchange risks in a more significant manner if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">needed. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Credit risk <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 298.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to the Group&#8217;s cash and cash equivalents is not significant in light of the quality of the co-contracting financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">institutions. As of December 31, 2024, substantially all of the Group&#8217;s cash and cash equivalents were maintained with <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.1pt; position: var(--position); text-decoration: none; white-space: pre;">two<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.0899999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> financial <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 321.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">institutions in France and in the United States. While the Group&#8217;s deposit accounts are i<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nsured up to the legal limit, the maintained </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">balances may, at times, exceed this insured limit. As of December 31, 2024, the Group m</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.83pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">aintained </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.93pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;143,881&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> in bank deposit </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">accounts that are in excess of the legally insured limit in </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">two</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.18pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> legally insured financial institutions. Th</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.2pt; position: var(--position); text-decoration: none; white-space: pre;">e Group has not experienced any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">losses in such accounts and does not believe that it is exposed to any significant credit risk related to these instruments.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The credit risk related to the Group&#8217;s other receivables and related account is minimal. In particular, the credit risk related to advances <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 388.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">made to C<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.06pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ROs (see Note 9) is</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: var(--position); text-decoration: none; white-space: pre;"> deemed insignificant due to their credit ratings.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialRiskManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Risk Management [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialRiskManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We have implemented and maintain various information security processes designed to identify, assess and <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manage material risks from cybersecurity threats to our critical information systems, third party hosted services, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">communications systems, hardware and software, and our critical data (including intellectual property, confidential <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">information that is proprietary, strategic or competitive in nature, and data related to our clinical trials and products) <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">(collectively, &#8220;Information Systems and Data&#8221;).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Chief Financial Officer as well as our external Data Protection Officer (&#8220;DPO&#8221;) and Information <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Technology Director (&#8220;IT Director&#8221;), and other independent service providers help identify, assess and manage the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">our cybersecurity threats and risks. Individuals in these roles identify and assess risks from cybersecurity threats by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">monitoring and evaluating our threat environment using various methods including, for example, maintaining <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">manual and automated tools, conducting scans of our threat environment, and conducting vulnerability assessments.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Depending on the environment, we implement and maintain various technical, physical, and organizational <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">threats to our Information Systems and Data. These measures, processes, standards, and policies include, for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example: incident response plans and policies, personnel training, phishing test campaigns, penetration testing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">system backups, cybersecurity insurance, network security controls, segmentation for certain systems and data <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">access controls and physical security controls.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our assessment and management of material risks from cybersecurity threats are integrated into our overall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk management processes.&#160; For example, our external DPO and IT Director work with management in an effort to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">impact to our business.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">We use independent service provider<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.65pt; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.54pt; position: var(--position); text-decoration: none; white-space: pre;"> to assist us from time to time to identify, assess, and manage material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks from cybersecurity threats, including for example: professional service firms, including legal counsel, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">penetration testing firms, dark web monitoring services, cybersecurity consultants, and cybersecurity software <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">providers.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Further, we use independent service providers to perform a variety of functions throughout our business, such <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">as hosting companies and contract research organizations. We undertake efforts designed to manage cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risks associated with our use of these providers.&#160; For certain vendors, these efforts include security questionnaires, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reviews of vendors&#8217; written security programs, reviews of security assessments, audits, and vulnerability scans <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">related to the vendors. Depending on the nature of the services provided, the sensitivity of the Information Systems <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and Data at issue, and the identity of the provider, our vendor management process may involve different levels of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">assessment designed to help identify cybersecurity risks associated with a provider and impose contractual <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">obligations related to cybersecurity on the provider.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Depending on the environment, we implement and maintain various technical, physical, and organizational <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">threats to our Information Systems and Data. These measures, processes, standards, and policies include, for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">example: incident response plans and policies, personnel training, phishing test campaigns, penetration testing, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">system backups, cybersecurity insurance, network security controls, segmentation for certain systems and data <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">access controls and physical security controls.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our assessment and management of material risks from cybersecurity threats are integrated into our overall <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk management processes.&#160; For example, our external DPO and IT Director work with management in an effort to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">impact to our business.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Board addresses our cybersecurity risk management as part of its general oversight function. The Board is <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from cybersecurity threats.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.36pt; position: var(--position); text-decoration: none; white-space: pre;"> Our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.41pt; position: var(--position); text-decoration: none; white-space: pre;"> Committee of Executives (&#8220;COMEX&#8221;)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.54pt; position: var(--position); text-decoration: none; white-space: pre;">, in addition to those identified below, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provides input to the Board on cybersecurity threats. Our Committee of Executives consists of all our company's <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">officers along with our heads of manufacturing and quality.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management team members, including our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.62pt; position: var(--position); text-decoration: none; white-space: pre;"> Chief Financial Officer (&#8220;CFO&#8221;)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.77pt; position: var(--position); text-decoration: none; white-space: pre;"> who oversees our external <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.38pt; position: var(--position); text-decoration: none; white-space: pre;">IT Director <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and DPO<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.93pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO has prior significant experience in strategic business operations<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.66pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO as well as our external IT Director and DPO are responsible for helping to integrate cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk considerations into our overall risk management strategy, and communicating key priorities to relevant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personnel. Our CFO is responsible for approving cybersecurity-related budgets, approving cybersecurity processes, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and reviewing security assessments and other security-related reports.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">members of management depending on circumstances, including our CFO. Our CFO works with our incident <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which they are notified.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"> In addition, our incident response process includes reporting to the Board for certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cybersecurity incidents.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The Board receives periodic communications from the CFO and others (such as the IT Director and DPO)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concerning our significant cybersecurity threats, risk and the processes we have implemented in an effort to address <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">them.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our Board addresses our cybersecurity risk management as part of its general oversight function. The Board is <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">from cybersecurity threats.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.36pt; position: var(--position); text-decoration: none; white-space: pre;"> Our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.41pt; position: var(--position); text-decoration: none; white-space: pre;"> Committee of Executives (&#8220;COMEX&#8221;)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.54pt; position: var(--position); text-decoration: none; white-space: pre;">, in addition to those identified below, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">provides input to the Board on cybersecurity threats. Our Committee of Executives consists of all our company's <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">officers along with our heads of manufacturing and quality.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">members of management depending on circumstances, including our CFO. Our CFO works with our incident <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which they are notified.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"> In addition, our incident response process includes reporting to the Board for certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cybersecurity incidents.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">The Board receives periodic communications from the CFO and others (such as the IT Director and DPO)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.48pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">concerning our significant cybersecurity threats, risk and the processes we have implemented in an effort to address <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">them.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management team members, including our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.62pt; position: var(--position); text-decoration: none; white-space: pre;"> Chief Financial Officer (&#8220;CFO&#8221;)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.77pt; position: var(--position); text-decoration: none; white-space: pre;"> who oversees our external <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.38pt; position: var(--position); text-decoration: none; white-space: pre;">IT Director <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and DPO<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.93pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO has prior significant experience in strategic business operations<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.66pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO as well as our external IT Director and DPO are responsible for helping to integrate cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk considerations into our overall risk management strategy, and communicating key priorities to relevant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personnel. Our CFO is responsible for approving cybersecurity-related budgets, approving cybersecurity processes, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and reviewing security assessments and other security-related reports.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">members of management depending on circumstances, including our CFO. Our CFO works with our incident <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which they are notified.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"> In addition, our incident response process includes reporting to the Board for certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cybersecurity incidents.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">management team members, including our<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.62pt; position: var(--position); text-decoration: none; white-space: pre;"> Chief Financial Officer (&#8220;CFO&#8221;)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.77pt; position: var(--position); text-decoration: none; white-space: pre;"> who oversees our external <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.38pt; position: var(--position); text-decoration: none; white-space: pre;">IT Director <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and DPO<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.93pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO has prior significant experience in strategic business operations<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.66pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO as well as our external IT Director and DPO are responsible for helping to integrate cybersecurity <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">risk considerations into our overall risk management strategy, and communicating key priorities to relevant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">personnel. Our CFO is responsible for approving cybersecurity-related budgets, approving cybersecurity processes, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">and reviewing security assessments and other security-related reports.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;">Our CFO has prior significant experience in strategic business operations<span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;">Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">members of management depending on circumstances, including our CFO. Our CFO works with our incident <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">which they are notified.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"> In addition, our incident response process includes reporting to the Board for certain <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">cybersecurity incidents.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting principles (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AccountingPrinciplesAbstract', window );"><strong>Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory', window );">Goodwill</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Following initial recognition, goodwill is stated at cost less any accumulated impairment losses (see Note 4.4). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In respect of business combinations prior to January 1, 2020, in accordance with IFRS 1 exemption, goodwill is included on the basis <span style="display: inline-block; height: 6.93pt;"></span></span></div>of its deemed cost, which represents the amount recorded under the prior basis of accounting, French GAAP, (&#8220;Previous GAAP&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 38&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;">, intangible assets acquired are recognized as assets on the statements of financial position at <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their acquisition cost. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Licenses <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Payments for separately acquired research and development are capitalized within &#8220;Other intangible assets&#8221; provided that they meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the definition of an intangible asset: a resource that is (i)&#160;controlled by the Group, (ii) expected to provide future economic benefits for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group and (iii)&#160;identifiable (i.e., it is either separable or arises from contractual or legal rights). In accordance with paragraph 25 of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IAS 38&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.15pt; position: var(--position); text-decoration: none; white-space: pre;">, the recognition criterion relating to the likelihood of future economic benefits generated by the intangible <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">asset, is presumed to be achieved for research and development activities when they are acquired separately. In this context, amounts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">paid to third parties in the form of initial payments or milestone payments relating to pharmaceutical specialties that have not yet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obtained a marketing authorization are recognized as intangible assets. These rights will be amortized on a straight-line basis, after <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obtaining the marketing authorization, over their useful life. Unamortized rights (before marketing authorization) are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impairment tests in accordance with the method defined in Note 4.4. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development costs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 38 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Intangible Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;">, research costs are expensed in the period during which they are incurred. Development costs <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are only recognized as intangible assets if the following criteria are met: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it is technically feasible to complete the development of the project; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it is the Group&#8217;s intention to complete the project and to utilize it; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">it has capacity to utilize the intangible asset; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is proof of the probability of future economic benefits associated with the asset <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is availability of the technical, financial and other resources for completing the project; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">there is a reliable evaluation of the development expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The initial measurement of the asset is the sum of expenses incurred starting on the date on which the development project meets the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">above criteria. Because of the risks and uncertainties related to regulatory authorizations and to the research and development process, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group believes that the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.14pt; position: var(--position); text-decoration: none; white-space: pre;">six<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.8pt; position: var(--position); text-decoration: none; white-space: pre;"> criteria stipulated by IAS 38 have not been fulfilled to date and the application of this principle has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">resulted in all development costs being expensed as incurred in all periods presented. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets mainly consist of acquired software. Costs related to the acquisition of software licenses are recognized as <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets based on the costs incurred to acquire and set up the related software. Other intangible assets are amortized using the straight-<span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">line method over a period of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.99pt; position: var(--position); text-decoration: none; white-space: pre;">one year<span style="display: inline-block; height: 6.93pt;"></span></span>.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 16 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Property, Plant and Equipment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.8pt; position: var(--position); text-decoration: none; white-space: pre;">, property, plant and equipment are recognized at their acquisition cost (purchase <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">price and directly attributable costs) or at their production cost by the Group, as applicable. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment are depreciated using the straight-line method over the estimated useful life of the asset. The principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">useful lives applied are as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 100.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 15.75pt; width: 173.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">DEPRECIATION PERIOD<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Buildings<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 30pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 44.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office fixtures and fittings<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 44.25pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;">3 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.21pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.5045pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 44.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 58.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Equipment<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 58.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Industrial materials and equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 72.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 72.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Technical facilities<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 87pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 87pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture and computer equipment:<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 101.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 101.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 115.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 115.5pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 115.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">IT equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 129.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;  &#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;">3 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 129.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 144pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.08pt; position: var(--position); white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.58pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 144pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);">(1)<span style="display: inline-block; height: 6.93pt; width: 12.84pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Office fixtures and fittings estimated useful lives correspond to the Paris headquarters and Boston offices residual estimated <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.45pt; position: var(--position); text-decoration: none; white-space: pre;">lease terms. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The useful lives of property, plant and equipment as well as any residual values are reviewed at each year-end and, in the event of a <span style="display: inline-block; height: 6.93pt;"></span></span></div>significant change, the depreciation schedule is revised prospectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory', window );">Impairment of goodwill, intangible assets, property and plant and equipment</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of goodwill, intangible assets, property and plant and equipment <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Goodwill and intangible assets not yet available for use are not amortized and are tested for impairment annually. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In addition, the Group assesses at the end of each reporting period whether there is an indication that intangible assets and property, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 393.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">plant and equipment may be impaired. Pursuant to IAS 36&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 278.56pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment of Assets<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.93pt; position: var(--position); text-decoration: none; white-space: pre;">, criteria for assessing indication of loss in value may <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">notably include performance levels lower than forecast, a significant change in market data or the regulatory environment, or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">obsolescence or physical damage of the asset not included in the amortization/depreciation schedule. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For the purpose of impairment testing, goodwill and intangible assets not yet available for use are allocated to each of the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGUs expected to benefit from synergies arising from the business combination or from the use of the intangible assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">An impairment loss is recognized when the carrying amount of a CGU, including the goodwill, exceeds the recoverable amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGU. The recoverable amount of a CGU is the higher of the CGU&#8217;s fair value less cost to sell and value-in-use. The total impairment <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">loss of a CGU is allocated first to reduce the carrying amount of goodwill allocated to the CGU and then to the other assets of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">CGU pro-rata on the basis of the carrying amount of each asset in the CGU. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">An impairment loss on goodwill is not reversed in a subsequent period. Impairment losses on intangible assets and property, plant and <span style="display: inline-block; height: 6.93pt;"></span></span></div>equipment shall be reversed subsequently if the impairment loss no longer exists or has decreased.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory', window );">Financial assets at amortized cost</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Financial assets at amortized cost <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (advances, loans and deposits granted to third parties and other short-term investments) and other receivables are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">non-derivative financial assets with fixed or determinable payments that are not listed on an active market. They are initially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized at fair value plus transaction costs that are directly attributable to the acquisition or issue of the financial asset. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 9 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Instruments <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.64pt; position: var(--position); text-decoration: none; white-space: pre;">requires an entity to recognize a loss allowance for expected credit losses on a financial asset at <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amortized cost at each statement of financial position date. The amount of the loss allowance for expected credit losses equal to: (i)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">12&#8212;month expected credit losses or (ii)&#160;the full lifetime expected credit losses. The latter applies if credit risk has increased <span style="display: inline-block; height: 6.93pt;"></span></span></div>significantly since initial recognition of the financial instrument.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group classifies investments as cash equivalents in the statements of financial position and statements of cash flows when they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">meet the conditions of IAS 7&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 161.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">Statement of Cash Flows, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.8pt; position: var(--position); text-decoration: none; white-space: pre;">i.e., when they are: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">held in order to face short-term cash commitments; and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">short term and highly liquid assets at acquisition date, readily convertible into known amount of cash and not exposed to <span style="display: inline-block; height: 6.93pt;"></span></span></span></div>any material risk of change in value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory', window );">Share capital</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Share capital <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares are classified in shareholders&#8217; equity. Costs associated with the issuance of new shares are directly accounted for in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; equity in diminution of issuance premium. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s own shares bought in the context of a brokering/liquidity agreement entered with an independent broker are presented as <span style="display: inline-block; height: 6.93pt;"></span></span></div>a reduction of shareholders&#8217; equity until their cancellation, their reissuance or their disposal.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Since its inception, the Group has established several plans for compensation settled in equity instruments in the form of founders&#8217; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">share subscription warrants (&#8220;bons de souscription de parts de cr&#233;ateur d&#8217;entreprise&#8221; or &#8220;BCE&#8221;), share subscription warrants (&#8220;Bons de <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">souscription d&#8217;actions,&#8221; or &#8220;BSA&#8221;) and free shares (&#8220;Attributions gratuites d&#8217;actions,&#8221; or &#8220;AGA&#8221;), granted to its employees, corporate <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">officers and scientific consultants. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.78pt; position: var(--position); text-decoration: none; white-space: pre;">these awards are measured at their fair value on the date of grant. The values of the equity <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments are determined using the option pricing model (in particular, a Black and Scholes model for the BCE and BSA plans and a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Monte-Carlo simulation for the AGA plans which include market performance vesting conditions) based on the value of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">underlying equity instrument at grant date, the volatility observed in a sample of comparable listed companies and the estimated life of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the related equity instruments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group recognizes the fair value of these awards as a share-based compensation expense over the period in which the related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">services are received, i.e. over the vesting period, with a corresponding increase in shareholders&#8217; equity. Share-based compensation is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized by installments in consistency with their graded vesting schedule, when applicable. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the related service and non-market performance conditions at the vesting date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">For share-based payment awards with market vesting conditions and non-vesting conditions, the grant-date fair value of the share-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcome. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The measurement of the fair value of BSA, BCE and AGA incorporates the market-based vesting conditions and non-vesting <span style="display: inline-block; height: 6.93pt;"></span></span></div>conditions as described in Note 4.16 &#8220;Use of judgments and estimates&#8221;.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory', window );">Financial liabilities</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Note 4.8.1. Financial liabilities at amortized cost<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IFRS 9 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Instruments, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;">the borrowings, the debt component of the Kreos / Claret OCABSA (classified as <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">convertible loan notes &#8211; see <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.47pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.98pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments below) and Other financial liabilities (conditional <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">advances and royalty certificates) other than financial derivative liabilities are measured at amortized cost. They are initially <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized at fair value and subsequently measured at amortized cost calculated using the effective interest rate (&#8220;EIR&#8221;) method. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction costs that are directly attributable to the issue of the financial liability reduce that financial liability. These expenses are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">then amortized over the lifetime of the liability, on the basis of the EIR. The EIR is the rate that exactly discounts estimated future <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">cash payments through the expected life of the financial liability to the amortized cost of a financial liability. Financial liabilities that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are due within one year are presented as current financial liabilities in the statements of financial position.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 522.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates meet the definition of financial liabilities. The Group concluded that they do not include embedded derivatives <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">related to the variability of royalties that are based on future net sales. In addition, the Group concluded that the prepayment options <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">were separate derivative instruments as their redemption price did not reimburse holders for an amount up to the approximate present <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">value of lost interest for the remaining term of the host contracts. However, their value at inception and subsequent dates is nil and has <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">no impact on the financial statements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates are initially measured at fair value (refer to note 15.10 for valuation model applied). They are subsequently <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured at amortized cost calculated using the EIR method. The EIR is calculated based on future cash flows, which are estimated on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the basis of development and commercialization plans and budgets approved by the Board of Directors of the Group, and probability-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">weighted to reflect the probability of success of clinical studies and any other uncertainty affecting them. If there is a change in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">timing or amount of estimated cash flows, then the gross carrying amount of the amortized cost of the financial liability is adjusted in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the period of change to reflect the revised actual and estimated cash flows, with a corresponding income or expense being recognized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss. The revised gross carrying amount of the amortized cost of the financial liability is calculated by discounting the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future revised estimated cash flows at the original EIR. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances and State guaranteed loan &#8211; &#8220;PGE&#8221; <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment for conditional advances and the State-guaranteed loan (Pr&#234;t garanti par l'Etat, or "PGE") is set forth in Note 4.9. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Leases <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment for lease liabilities is set forth in Note 4.12.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;">Note 4.8.2. Financial liabilities measured at fair value through profit or loss <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.9pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSA attached to Kreos 1 bonds, the conversion option of OCEANE, certain prepayment options of bonds, the Kreos / Claret warrants <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and the Kreos / Claret Minimum Return Indemnifications ("MRI") are derivatives instruments. Derivatives are recognized initially at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value at the date the derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The resulting gain or loss from change in the fair value is recognized in profit or loss immediately, as financial expenses or income. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Hybrid instruments <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE bonds <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.41pt; position: var(--position); text-decoration: none; white-space: pre;">and Heights convertible notes (whose characteristics are described in Note 15.2 and Note 15.5)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.25pt; position: var(--position); text-decoration: none; white-space: pre;"> are hybrid <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instruments. A &#8220;hybrid contract&#8221; is a contract that includes both a non-derivative host contract and one or more embedded derivatives. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Embedded derivatives are required to be separated from the host contract (bifurcated) if: the economic characteristics and risks of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">embedded derivative are not closely related to those of the host, a separate instrument with the same terms as the embedded derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">would meet the definition of a derivative, and the hybrid contract is not measured at fair value through profit or loss. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Separable embedded derivatives are required to be measured at fair value at each reporting date, with changes in fair value recognized <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 460.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss. The initial bifurcation of a separable embedded derivative does not result in any gain or loss being recognized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Because the embedded derivative component is measured at fair value on initial recognition, the carrying amount of the host contract <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on initial recognition is the difference between the carrying amount of the hybrid instrument and the fair value of the embedded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derivative. If the fair values of the hybrid instrument and host contract are more reliably measurable than that of the derivative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">component - e.g. because of the availability of quoted market prices - then it may be acceptable to use those values to determine the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value of the derivative on initial recognition indirectly - i.e. as a residual amount. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Heights convertible notes issued on August 24, 2023 included embedded derivatives as detailed in Note 15. The Group concluded <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">that these features were embedded derivatives that would modify the cash flows required under the contract and require to be <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">bifurcated from their host contract. The Group being unable to reliably value each embedded derivative at issuance date and on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">subsequent reporting dates, it measured the whole hybrid instrument at fair value through profit or loss (&#8220;FVTPL&#8221;) as permitted by <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 9. Instruments measured at FVTPL under these conditions are measured at their fair value on issuance and on subsequent <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reporting dates, with changes in fair value recognized in profit or loss.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Compound instruments <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos / Claret OCABSA are compound instruments (whose characteristics are describ<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ed in Note 15.1). </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.57pt; position: var(--position); text-decoration: none; white-space: pre;">A &#8220;compound contract&#8221; is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">a contract that includes both a debt component and an equity component.&#160; The debt component (excluding the conversion option and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the attached OCABSA warrants) is initially recognized at fair value and subsequently measured at amortized cost calculated using the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">EIR method. The equity component corresponding to the conversion option and the attached OCABSA warrants is recorded in equity, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the difference between the whole instrument&#8217;s fair value (its nominal value) and the standalone fair value of the debt component.<span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value measurement <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">When measuring the fair value of an asset or a liability, the Company uses market observable data as far as possible. Fair values are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 1: fair value calculated using quoted prices in an active market for identical assets and liabilities; <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 2: fair value calculated using valuation techniques based on observable market data such as prices for assets and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities or similar parameters quoted in an active market; &#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">level 3: fair value calculated using valuation techniques based in whole or in part on unobservable inputs such as prices <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">in an inactive market or a valuation based on multiples of unlisted securities. <span style="display: inline-block; height: 6.93pt;"></span></span></div>See Note 12 Financial assets and liabilities, Note 15 Financial liabilities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Research tax credit and subsidies</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group benefits from the provisions of Article 244 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 255.53pt; position: var(--position); text-decoration: none; white-space: pre;">quater <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.12pt; position: var(--position); text-decoration: none; white-space: pre;">B of the French General Tax Code relating to the French research tax <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit (&#8220;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 68.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Cr&#233;dit d&#8217;Imp&#244;t Recherche<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.3pt; position: var(--position); text-decoration: none; white-space: pre;">&#8221; or &#8220;CIR&#8221;). The CIR is granted to companies in order to encourage them to conduct technical and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">scientific research. Companies that prove that they have expenditures which meet the required criteria (research expenditures located <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in France or, since January 1, 2005, within the European Union or in another state that is a party to the Agreement on the European <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Economic Area and has concluded a tax treaty with France that contains an administrative assistance clause) receive a tax credit that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">can be used for the payment of the corporate tax due for the fiscal year in which the expenditures were made and the next three fiscal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">years, or as applicable, companies may receive cash reimbursement for any excess portion at the three-year period following the fiscal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">year of the expenditures. Only those companies meeting the EU definition of a small or medium-sized entity (&#8220;SME&#8221;) are eligible for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">payment in cash of their research tax credit (to the extent not used to offset corporate tax payables) in the year following the request <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for reimbursement. The expenditures taken into account for the calculation of the CIR involve only research expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The CIR is presented under &#8220;Other operating income&#8221; in the statements of income (loss) as it is accounted for as a government grant <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">as defined in IAS 20 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 128.16pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting for Government Grants and Disclosure of Government Assistanc<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.67pt; position: var(--position); text-decoration: none; white-space: pre;">e, and as &#8220;Other receivables and <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assets&#8221; in the statement of financial position until its payment is received. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies are non-repayable grants received by the Group and recognized in the financial statements when there exists reasonable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assurance that the Group will comply with the conditions attached to the subsidies and the subsidies will be received. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies that are upfront payments are presented as deferred income and recognized through &#8220;Other operating income&#8221; for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">amount of the expenses incurred as part of the research program to which the subsidy relates. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">A subsidy that is to be received either as compensation for expenses or for losses already incurred, or for immediate financial support <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the Group without associated future costs, is recognized in the Statements of income (loss) as &#8220;Other operating income&#8221; when there <span style="display: inline-block; height: 6.93pt;"></span></span></div>exists reasonable assurance that the subsidies will be received.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory', window );">Conditional advances and PGE</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances and PGE <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group receives conditional advances to finance at below market interest rate research and development projects. Due to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">innovative nature of its drug candidate development programs, the Group has benefited from certain sources of financial assistance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from Bpifrance. Bpifrance provides financial assistance and support to emerging French enterprises to facilitate the development and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization of innovative technologies. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Funds received from Bpifrance in the form of conditional advances are recognized as financial liabilities, as the Group has a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">contractual obligation to reimburse Bpifrance for such conditional advances in cash based on a repayment schedule. Each award of an <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">advance is made to help fund a specific development milestone. More tails on conditional advances are provided in Note 15.7. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 626.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Receipts or reimbursements of conditional advances are reflected as financing transactions in the statements of cash flows. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The difference between the present value of the advance at market rate (i.e., present value of contractual cash flows including principal <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and interests, discounted using a market rate as effective interest rate in accordance with IFRS 9) and the amount received as cash <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the Bpifrance constitutes a subsidy within the meaning of IAS 20. Considering that these advances do not finance fixed assets, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">these subsidies are presented as &#8220;Deferred income&#8221; in the statement of financial position and recognized in the statement of net income <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(loss) as &#8220;Other operating income&#8220; on a systematic basis over the periods in which the Group recognizes as expenses the related costs <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for which the grants are intended to compensate. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The incremental interest expense resulting from the difference between (a)&#160;the market interest rate and the (b)&#160;below-market rate is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">spread over the contractual period until the last repayment and recognized in the statement of income (loss) accordingly, using the EIR <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">method. In the event of a change in estimate of contractual cash flows due under the conditional advances, the Group recalculates the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">book value of the debt resulting from the discounting of the anticipated new future cash flows at the initial EIR. The adjustment is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in the statements of income (loss) for the period during which the modification is recognized. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In the statements of financial position, these conditional advances are recorded in &#8220;Other financial liabilities&#8221; as current or non-current <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">portion depending on their maturity. In the event Bpifrance waived the repayment of the advance, the corresponding liability is <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">derecognized and treated as a subsidy in the statements of income (loss). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The benefit resulting from the low interest of PGE loans is also recognized as a subsidy corresponding to the difference between the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">present value of the PGE at market rate and the amount received as cash. The accounting treatment is therefore similar to the above-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">mentioned accounting treatment for conditional advances. PGE are recorded in &#8220;Borrowings&#8221; as current or non-current portion <span style="display: inline-block; height: 6.93pt;"></span></span></div>depending on their maturity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefits</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Employee benefits <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s employees in France benefit from retirement benefits provided under French law, which consist in the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">compensation paid by the Group to employees upon their retirement (a defined benefit plan); and <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">payments of retirement pensions by the social security agencies, which are financed by the contributions made by the <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Group and employees. As they meet the definition of a defined contribution plan, the liabilities are presented as Tax and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">employee-related payables in the statement of financial position. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In accordance with IAS 19 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 153.11pt; position: var(--position); text-decoration: none; white-space: pre;">Employee Benefits<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.15pt; position: var(--position); text-decoration: none; white-space: pre;">, the liability with respect to defined benefit plans is estimated by using the projected <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">credit unit method. According to this method, the cost of the retirement benefit is recognized in the statements of income (loss). The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">retirement benefit commitments are valued at the current value of the estimated future payments, discounted using the market rate for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">high quality corporate bonds with a term and currency that correspond to that estimated for the payment of the benefits. The Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">applied the decision of the IFRS IC, published on May&#160;24, 2021, that concluded that, in the case that no rights were acquired in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">event of departure before retirement age and that the rights were capped after a certain number of years of seniority (&#8220;30 years&#8221;), the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">commitment would only be recognized for the last 30 years of the employee&#8217;s career within the Group. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The difference between the amount of the provision at the beginning of a period and at the close of that period is recognized through <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operating expenses for the portion representing the costs of services rendered and financial expenses for the net interest costs, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">through other comprehensive income (loss) for the portion representing the actuarial gains and losses due to changes in assumptions <span style="display: inline-block; height: 6.93pt;"></span></span></div>and experience adjustments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions correspond to commitments resulting from litigation and various risks to which the Group may face in the context of its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">operations. In accordance with IAS 37 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 199.73pt; position: var(--position); text-decoration: none; white-space: pre;">Provisions, Contingent Liabilities and<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.37pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 354.87pt; position: var(--position); text-decoration: none; white-space: pre;">Contingent Assets, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.74pt; position: var(--position); text-decoration: none; white-space: pre;">a provision is recorded when the <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group has an obligation to a third party resulting from a past event that will likely result in an outflow of resources to the third party, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">and for which future cash outflows may be estimated reliably. The amount recorded as a provision is an estimate of the expenditure <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">required to settle the obligation, discounted where necessary at year <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.25pt; position: var(--position); text-decoration: none; white-space: pre;">end.&#160; Contingent liabilities are not recognized, but are disclosed in <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the notes to the financial statements unless the possibility of an outflow of economic resources is remote<span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Leases <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">standalone price. The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases (value of the underlying asset below <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 221.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.0 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.09pt; position: var(--position); text-decoration: none; white-space: pre;">). For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">straight-line basis over the term of the lease. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">to the end of the lease term. The lease terms used by the Group reflect the non-cancellable terms of each contract, plus any extension <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">or termination options that the Group is reasonably certain to exercise or not exercise for all of the leases periods covered by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">extension options. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group incremental borrowing rate for the asset subject to the lease in the respective markets. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">portion of the lease payments attributable to the repayment of lease liabilities and the portion attributable to payment of interests are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recognized in cash flows used in financing activities. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">incentives received and any initial direct costs incurred by the Group, and expected costs for obligations to dismantle and remove <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">right-of-use assets when they are no longer used. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">of the right-of-use asset or the end of the lease term. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be <span style="display: inline-block; height: 6.93pt;"></span></span></div>recoverable using cash flow projections.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Translation of transactions denominated in foreign currency</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Translation of transactions denominated in foreign currency <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Pursuant to IAS 21 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;">The Effects of Changes in Foreign Exchange Rates<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.3pt; position: var(--position); text-decoration: none; white-space: pre;">, transactions performed by the Group in currencies other than <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 515.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">their functional currency, which is the Euro, are translated at the prevailing exchange rate on the transaction date. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 537.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables and payables and liabilities denominated in a currency other than the functional currency are translated at the <span style="display: inline-block; height: 6.93pt;"></span></span></div>period-end exchange rate. Unrealized gains and losses arising on translation are recognized in net financial income / (loss).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Current taxes</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Tax assets and liabilities for the current and prior periods are measured at the amount expected to be recovered from or paid to the <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">French tax authorities, using tax rates and tax laws enacted or substantively enacted at the end of the reporting period in accordance <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with IAS 12 &#8211; Income Tax. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The income tax charge for the period comprises current tax due and the deferred tax charge. The tax expense is recognized in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">statement of income (loss) unless it relates to items recorded in other comprehensive income (loss) or directly in equity, in which case <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the tax is also recorded in other comprehensive income (loss) or directly in equity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Current taxes <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The current tax expense is calculated based on taxable profit for the period, using tax rates enacted or substantively enacted at the <span style="display: inline-block; height: 6.93pt;"></span></span></div>statement of financial position date. Considering the level of tax loss of the Group, no current tax expense is recognized.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory', window );">Deferred taxes</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxes <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxes are recognized when there are temporary differences between the carrying amount of assets and liabilities in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s financial statements and the corresponding tax basis used to calculate taxable profit. Deferred taxes are not recognized if they <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 267.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">arise from the initial recognition of an asset or liability in a transaction other than a business combination which, at the time of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">transaction, does not affect either the accounting or the taxable profit (tax loss). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group applies the Amendments to IAS 12 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 232.23pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred Tax related to Assets and Liabilities arising from a Single Transaction<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.79pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issued on May 7, 2021, and presents the deferred tax assets and liabilities arising from such transactions separately within Note 22 <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 559.6pt; position: var(--position); text-decoration: none; white-space: pre;">- <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Income tax, <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.11pt; position: var(--position); text-decoration: none; white-space: pre;">rather than on a net basis. The Amendments have no impact on the Statements of financial position and the Statement of <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">comprehensive income (loss) for the periods presented.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets are recognized for all deductible temporary differences, unused tax losses and unused tax credits to the extent that <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">it is probable that the temporary difference will reverse in the foreseeable future and that taxable profit will be available against which <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the deductible temporary difference, unused tax losses or unused tax credits can be utilized. See Note 4.16. Use of judgments and <span style="display: inline-block; height: 6.93pt;"></span></span></div>estimates and Note 22. Income tax.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock', window );">Accounting of Prosynergia acquisition</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting of Prosynergia acquisition <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">From April 1, 2022 up until the merger completed on December&#160;12, 2022, the Company owned a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.33pt; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.66pt; position: var(--position); text-decoration: none; white-space: pre;"> ownership interest of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia and as such, controlled Prosynergia. The Company had power over Prosynergia, was exposed or had rights to variable <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 455.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">returns from its involvement with the entity and had the ability to affect those returns through its power over the entity. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The financial statements of Prosynergia were therefore included in the consolidated financial statements of the Company from the date <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">control was obtained, i.e. April 1, 2022. Prosynergia was merged into the Company in December&#160;12, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">agreement or out-licensed agreement, it did not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">April 1, 2022, without recognition of goodwill. For this purpose, the following approach was applied: first measurement of any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">identifiable asset or liability initially measured at an amount other than cost in accordance with the applicable standards, deduction <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">from the cost of the group of assets of the amounts allocated to these assets and liabilities, and then allocation of the residual cost of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acquisition to the remaining identifiable assets and liabilities based on their relative fair values at the date of acquisition. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Also, the <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,400&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> loan granted to Prosynergia in December 2021 was included in the acquisition cost to be allocated, since, in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">substance, it was considered as a prepayment for the acquisition of the group of assets, which is repayable in cash in the event of non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">completion of the transaction. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The potential earn-out payment to be paid in the first half of 2023 was measured at fair value on April 1, 2022, for an amount of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,446&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;">, and included in the acquisition cost. This earn out could be triggered in the event the Group&#8217;s market capitalization <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 133.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">was in excess of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.06pt; position: var(--position); text-decoration: none; white-space: pre;"> (valued at certain specified record dates), a listing of the Group&#8217;s shares on Nasdaq or a merger and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 143.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">acquisition transaction prior to March 31, 2023. The amount of the earn-out was equal to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.69pt; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.02pt; position: var(--position); text-decoration: none; white-space: pre;"> of the difference between the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 153.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market capitalization and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;">, subject to a maximum amount of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.08pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;4.0&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.93pt; position: var(--position); text-decoration: none; white-space: pre;">. It was payable in the first half of 2023 if <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">conditions were met. <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.01pt; position: var(--position); text-decoration: none; white-space: pre;">No<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"> amount was payable in the event the Group&#8217;s market capitalization was lower than <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;300&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.71pt; position: var(--position); text-decoration: none; white-space: pre;">. The related <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial liability was subsequently remeasured to its fair value as of December&#160;31, 2022 estimated to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.65pt; position: var(--position); text-decoration: none; white-space: pre;">nil<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.19pt; position: var(--position); text-decoration: none; white-space: pre;"> (see Note 15.9). The <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement resulted in a financial income of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.99pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1,446&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.08pt; position: var(--position); text-decoration: none; white-space: pre;"> over the year ended December&#160;31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As a consequence of the earn-out condition not being met on March 31, 2023, the related financial liability was derecognized.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The allocation of the acquisition cost is as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 237.56pt; width: 612pt;"><div style="font-size: 0pt; left: 28.8pt; position: var(--position); top: 0pt; width: 266.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 23.16pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 15.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.41pt; position: var(--position); text-decoration: none; white-space: pre;">Amount&#160;allocated&#160;as<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 23.96pt; position: var(--position); text-decoration: none; white-space: pre;">of&#160;April&#160;1,&#160;2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 23.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash prepayment made in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.17000000000002pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.59pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 49.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;">325<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loan granted to Prosynergia in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.9pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 63.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">1,400<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash payment made in 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.06pt; position: var(--position); text-decoration: none; white-space: pre;">.............<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 78pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">2,925<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition fees (1)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">...........................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 92.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;">466<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Earn-out measured at fair value<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.14000000000001pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.51pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.53pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 106.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">1,446<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total acquisition cost allocated<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 134.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 134.54999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.60999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 134.62pt; position: var(--position); text-decoration: none; white-space: pre;">......<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 120.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,562<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 135pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 149.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Patents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.06pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 149.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,529<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 163.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.78pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 108.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.22999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.46pt; position: var(--position); text-decoration: none; white-space: pre;">................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 163.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.94pt; position: var(--position); text-decoration: none; white-space: pre;">42<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">......................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 192pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,571<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 206.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 206.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.72pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.00999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 67.08999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">.................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 220.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 52.11pt; position: var(--position); text-decoration: none; white-space: pre;">(9)<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 234.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total net assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.44999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;">................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 249pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,562<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 517.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);"> (1)<span style="display: inline-block; height: 6.93pt; width: 10.34pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Of which <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;451&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); text-decoration: none; white-space: pre;"> were disbursed in 2021 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"> in 2022. Acquired cash amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;42&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.44pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The acquisition cost was mainly allocated to Prosynergia&#8217;s patents US 10,464,903 (filed on March 20, 2017 and granted on November <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">5, 2019), EP3 429 998 (filed on March 20, 2017 and granted on September 1, 2021) and continuation US 10,745,357 (filed on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">November 1, 2019 and granted on August&#160;18, 2020). All patents will expire in 2037. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These patents cover alternative synthesis process for obefazimod and a family of close chemical analogues. They also cover <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">alternative forms of obefazimod (salts thereof and crystalline forms of said salts), the pharmaceutical composition comprising them, <span style="display: inline-block; height: 6.93pt;"></span></span></div>that could be of interest to the Company for future development.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock', window );">Use of judgments and estimates</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;">Use of judgments and estimates <span style="display: inline-block; height: 6.77pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In order to prepare financial statements in accordance with IFRS, estimates, judgments and assumptions were made by the Group&#8217;s <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">management which could affect the reported amounts of assets, liabilities, contingent liabilities, income and expenses. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These estimates are based on the assumption of going concern and are prepared in accordance with information available at the date <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the financial statements were prepared. They are reviewed on an ongoing basis using past experience and various other factors <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">considered to be reasonable as the basis to measure the carrying amount of assets and liabilities. Estimates may be revised due to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">changes in the underlying circumstances or subsequent to new information. Actual results may differ significantly from these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">estimates in line with assumptions or different conditions. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">This note provides an overview of the areas that involved a higher degree of judgement or complexity, and of items which are more <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">likely to be materially adjusted due to changes in estimates and assumptions. Detailed information about each of these estimates and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">judgements is included in other notes together with information about the basis of calculation for each affected line item in the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial statements. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Recognition and measurement of impairment of CGUs. The main assumptions used for the impairment test include <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(a)&#160;the amount of cash flows that are set on the basis of the development and commercialization plans and budgets <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">approved by Board of Directors, (b)&#160;assumptions related to the achievement of the clinical trials and the launch of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization, (c)&#160;the discount rate, (d) assumptions on risk related to the development and (e)&#160;for the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">commercialization, selling price and volume of sales. The sensitivity analysis in respect of the recoverable amount of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">CGUs is presented in Note 6. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Measurement of share-based payments granted to employees, corporate officers and scientific consultants, such as BCE, <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">BSA and AGA, which is based on actuarial models; these models require the use by the Group of certain calculation <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 237.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions such as the estimated vesting, the occurrence dates of a change of control or a M&amp;A transaction dates, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.11pt; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">percentage of success (&#8220;POS&#8221;) of obefazimod,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.94pt; position: var(--position); text-decoration: none; white-space: pre;"> the expected volatility and maturity of the underlying equity instrument <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(see Note 4.7 and Note 14), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement at inception and after of derivative financial instruments resulting from (i)&#160;the warrants issued <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">concomitantly with the issuance of the straight and convertible bonds to Kreos on July 24, 2018 (or &#8220;Kreos 1&#8221;), (ii) the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">prepayment option attached to the straight and convertible bonds issued to Kreos on October 2, 2020 (or &#8220;Kreos 2&#8221;), and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">(iii)&#160;the prepayment option attached to the issuance of bond convertible into new or existing shares in July 30, 2021 (or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;OCEANE&#8221;) (see Notes 15), <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;">(iv) the Kreos / Claret BSA issued on August 21, 2023 and November 2, 2023, related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">tranches A-B and tranche C, respectively, and (v) the Kreos / Claret Minimum Return Indemnifications related to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">tranches B and C, issued in March 2024 and June 2024, respectively.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement of financial liabilities at inception (see Note 15), <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.62pt; position: var(--position); text-decoration: none; white-space: pre;">and after (for the Heights convertible notes <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">issued on August 24, 2023) measured at fair value at each reporting period, with fair value changed recognized in profit <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">or loss, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Amortized cost measurement of royalty certificates, based on the following assumptions: (a)&#160;future cash flows, estimated <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">on the basis of development and commercialization plans and budgets approved by the Board of Directors and (b)&#160;the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">effective interest rate. The sensitivity analysis in respect of the measurement of royalty certificates is presented in Note <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">15,&#160; <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Fair value measurement of the call option resulting from the equity line contracts entered into on September 30, 2019 (or <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Equity lines&#8221;) (see Note 13.2), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Estimation of CIR, based on internal and external expenses, which meet the required criteria, incurred by the Group each <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">year (see Note 4.9), <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span><span style="left: 91.05000000000001pt; position: var(--position);">Recognition of deferred tax assets: availability of future taxable profit against which deductible temporary differences <span style="display: inline-block; height: 6.93pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">and tax losses carried forward can be utilized and whether sufficient evidence exists (see Note 22). <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Recognition of deferred tax assets: tax deductibility of future royalty payments related to the royalty certificates issued in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 541.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">September 2022 (see Notes 15 and 22).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Determination of the terms of the leases, including whether the Group is reasonably certain to exercise extension and/or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">termination options (see Note 15.8).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The main critical judgements made by the Group&#8217;s management impact the following items: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Accounting treatment of specific conditions of share-based compensation plans (see Notes 4.7 and 14).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 653.06pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.67pt;">&#8226;<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 173.62pt;">Accounting treatment of the 2018 &amp; 2020 <span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.67pt; position: var(--position); text-decoration: none; white-space: pre; width: 31.87pt;">Kreos 1<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.54pt; position: var(--position); text-decoration: none; white-space: pre; width: 279.42pt;"> &amp; 2 bonds, the 2021 OCEANE bonds, and the August 2023 Kreos /<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.96pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 664.61pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 215.9pt;">Claret and Heights Financings (see Notes 4.8 and 15).<span style="display: inline-block; height: 7.64pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfIFRSCompliance', window );">Statement of compliance</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Statement of compliance <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements of the Group as of and for the years ended December 31, 2022, 2023 and 2024 have been <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">prepared in accordance with both International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Standard Board (&#8220;IASB&#8221;) and IFRS as adopted by the European Union (&#8220;EU&#8221;) regulation n&#176;1606/2002 of July 19, 2002. The term <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;IFRS&#8221; refers collectively to International Accounting Standards (&#8220;IAS&#8221;) and IFRS as well as the interpretations issued by the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Standing Interpretations Committee (&#8220;SIC&#8221;) and the International Financial Reporting Interpretations Standards Committee (&#8220;IFRS <span style="display: inline-block; height: 6.93pt;"></span></span></div>IC&#8221;), whose application is mandatory for the year ended December 31, 2024.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock', window );">Going concern</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Going concern <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group has incurre<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.19pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">d substantial operating losses since inception and expects to continue to incur significant operating losses for the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">foreseeab</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">le future and may never become profitable. For the year ended December 31, 2024, the Group had a net loss <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.08pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;176,242 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Since inception, the Group has financed its operations through the issuance of ordinary shares wi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">th gross aggregate proceeds of </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;557.2&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.85pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, of which </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.6pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;130&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of gross proceeds were from offerings of its ordinary shares on Euronext Paris in February 2023 </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.93pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;223.3&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.78pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of gross proceeds were from its </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.5pt; position: var(--position); text-decoration: none; white-space: pre;">offering of ordinary shares in the form of American Depository Shares ("ADS") on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 378.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Nasdaq Global Market as well as ordinary shares in Europe (including France) and countries outside of the United States in a <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">private placement in October 2023<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, ba</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;">nk borrowings and structured loans<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.15pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> for </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.81pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;175.0&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.66pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.66pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursements of Research Tax Credits <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Cr&#233;dit d&#8217;Imp&#244;t Recherche (&#8220;CIR&#8221;)) in an aggregate amo<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.85pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">unt of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.95pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;35.6&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, subsidies received from Banque Publique </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">d&#8217;Investissement (&#8220;Bpifrance&#8221;) (including </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.17pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;17.1&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.02pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of subsidies and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;1.8&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.27pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of conditional advances) and royalty certificates </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">in an amount of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.5pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;2.9&#160;million</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.35pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Based on (a) the Group&#8217;s existing cash and cash equivalents <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.52pt; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;144.2 million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.2pt; position: var(--position); text-decoration: none; white-space: pre;"> as of December 31, 2024 and (b) the expected <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reimbursement of the CIR from 2024 in the second half of 2025 amounting to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.7&#160;million<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.47pt; position: var(--position); text-decoration: none; white-space: pre;">, the Group expects, as of the date of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">issuance of these financial statements, to be able to fund its forecasted cash flow requirements into the fourth quarter of 2025. This <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">takes into account management's assumptions of higher R&amp;D expenditure in 2024 and into 2025 driven by the progression of the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 3 clinical trials of obefazimod in UC and the initiation of the Phase 2b clinical trials for CD. Under these assumptions and based <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">on the Group's current clinical and operational plans, the Group would have sufficient funds to finance its operations in the fourth <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">quarter of 2025, i.e. through the announcement of its top-line data from the Phase 3 ABTECT-1 and ABTECT-2 induction trials for <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">UC in the third quarter of 2025.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The elements referred to above, as well as (c) the Group's expectation to generate operating losses and negative operating cash flows <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the future, and (d) the need for additional fundi<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.68pt; position: var(--position); text-decoration: none; white-space: pre;">ng to support its planned operations, result in a material uncertainty that may cast <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">significant doubt (or raise substantial doubt as contemplated by Public Company Accounting Oversight Board standards) regarding its <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">ability to continue as a going concern for a period of one year after the date that these consolidated financial statements ar<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.8299999999999pt; position: var(--position); text-decoration: none; white-space: pre;">e issued.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.24pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.74pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.84pt; position: var(--position); text-decoration: none; white-space: pre;">he<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.27pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group continues to monitor its spending of 2025 expenses, ensuring strict adherence to the approved budget, which may include <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">projected savings through the gating of non essential spend and to pursue additional cash resources through public or private equity or <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">debt financing<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.43pt; position: var(--position); text-decoration: none; white-space: pre;">s, regional out licensing agreements and/or royalty financing<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.92pt; position: var(--position); text-decoration: none; white-space: pre;">. The Group has concluded that substantial doubt exists <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">about the Group&#8217;s ability to continue as a going concern for a period of at least 12 months from the date of issuance of these <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">consolidated financial statements.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary if the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Group is unable to continue as a going concern.<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock', window );">Impact of the Ukraine/Russia Hostilities on the Group</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Impact of the Ukraine/Russia Hostilities on the Group <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">In February 2022, Russia invaded Ukraine. The conflict has already had major implications for the global economy and the rate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">inflation, particularly in relation to the supply of energy, raw materials and food products. It has also caused intense volatility on the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">financial markets, something that is still ongoing at the reporting date and has pushed down stock market prices around the world. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Given these developments, the Group has decided not to include Russia and Belarus in its global Phase 3 program for obefazimod in <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">UC. However, the global scale of this conflict cannot be predicted at this stage. The Group, therefore, cannot rule out an adverse <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">impact of this conflict on its business, including in terms of access to raw materials, logistics, the performance of clinical studies and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in relation to any future financing the Group may seek. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 193.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The long-term safety and efficacy extension of the<span style="display: inline-block; height: 8.25pt;"></span></span><span style="color: #ff0000; font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 237.68pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.16pt; position: var(--position); text-decoration: none; white-space: pre;">Phase 2b maintenance trial of obefazimod in moderately to severely active UC is <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s only clinical trial with patients currently enrolled in Ukraine.&#160; The Phase 2b 12-month assessment was carried out in all <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the Ukrainian patients before the war broke out and these patients are therefore included in the one-year maintenance results that were <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">reported on April 6, 2022. Ukrainian patients who completed the two-year Phase 2b maintenance trial have been transitioned to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.28pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">long-term safety and efficacy trial that is still on-going. T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.7pt; position: var(--position); text-decoration: none; white-space: pre;">he Group also has a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.02pt; position: var(--position); text-decoration: none; white-space: pre;">few<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362pt; position: var(--position); text-decoration: none; white-space: pre;"> Ukrainian sites active in the western part of Ukraine <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">in the ABTECT Phase 3 clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.95pt; position: var(--position); text-decoration: none; white-space: pre;"> None of these sites are located in the Crimea Region of Ukraine, the so-called Donetsk <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">People&#8217;s Republic, or the so-called Luhansk People&#8217;s Republic. We continue to monitor developments in the region, but any <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.88pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">instability as a result of the war may have material adverse impacts on these clinical sites, which could negatively impact our Phase 3 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">clinical trials.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.48pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Together with its CROs, the Group is making considerable efforts to ensure the follow-up of patients who are unable to come to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.68pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">study centers. Monitoring takes place through a remote monitoring system that was established and used successfully during the <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 pandemic.<span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock', window );">New, revised or amended Standards and Interpretations</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">New, revised or amended Standards and Interpretations <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group applied the following amendments to IFRS that are effective as of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.14pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.68pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.95pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 403.58pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.02pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants; <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 91.05pt; position: var(--position);">Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures &#8211; Supplier Finance <span style="display: inline-block; height: 6.93pt; width: 5.91pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 441.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Agreements; and<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group assessed the impacts resulting from the application of these issued accounting pronouncements and concluded that impacts <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.26pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are not material, with the exception of the amendments to IAS 1, issued in 2020 and 2022, which aim at clarifying the requirements on <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.46pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">determining whether a liability is current or non-current, and require new disclosures for non-current liabilities that are subject to <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.66pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">future covenants. In accordance with these amendments, an entity shall classify a liability as current when it does not have the right at <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.86pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These amendments can impact liabilities with covenants which breach can render the related liabilities repayable within 12 months. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">However, the Group has no such liabilities.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Under the amendments, a settlement of a liability includes transferring an entity's own equity instruments to the counterparty. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Therefore, if a liability has any conversion options that involve a transfer of the entity's own equity instruments, then these generally </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">affect its classification as current or non-current. As an exception, if these conversion options are recognized as equity under IAS 32, </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.16pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">then they do not affect the current or non-current classification of the liability.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">As disclosed in Notes 15.1, 15.2 and 15.5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.3pt; position: var(--position); text-decoration: none; white-space: pre;"> the Group has co<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.8pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">nvertible notes (respectively the Kreos / Claret OCABSA, the Heights </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.26pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">convertible notes (as of December 31, 2023 and 2024) and the OCEANE bonds (as of December 31, 2022), as defined below) that are </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">convertible into a potentially variable number of ordinary shares of the Group at any time at the option of the noteholders. Despite the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">fact that the Group has the unconditional right to defer the settlement of such convertible notes into cash beyond twelve months, in </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.36pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">application of these amendments, the Group will no longer be considered to have an unconditional right to defer the settlements of the </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Heights convertible notes and the OCEANE bonds due to their conversion options that are embedded derivatives not recognized as </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 699.76pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">equity components. Consequently, the amendments led to the reclassification of these convertible notes as current liabilities on a </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">retrospective basis:</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2022, the carrying value of the OCEANE bonds </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.54pt; position: var(--position); text-decoration: none; white-space: pre;">was<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.08pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,957&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;">, of which <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.42pt; position: var(--position); text-decoration: none; white-space: pre;">19,332 thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.51pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> were </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.66pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">classified within non-current financial liabilities in the Grou</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.95pt; position: var(--position); text-decoration: none; white-space: pre;">p&#8217;s annual financial statements for the year ended December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2022. In application of these amendments, all of the carrying value of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.79pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,957&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.88pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> is now presented within current </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">financial liabilities.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 145.46pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">As of December 31, 2023, the carrying value of the Heights convertible notes was </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.77pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;29,605&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.86pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">, of which </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652 <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.09pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> were classified within non-current financial liabilities in the Group&#8217;s annual financial statements for the year ended </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.86pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">December 31, 2023. In application of these amendments, all of the carrying value of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.33pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;29,605&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.42pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> is now presented </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">within current financial liabilities.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.96pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">The classification of the Kreos / Claret OCABSA will not be impacted since they are compound instruments with conversion option </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">and attached OCABSA warrants recognized as an equity component.</span><span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock', window );">New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, 2023</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, <span style="display: inline-block; height: 6.94pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">2024 <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Group did not elect for early application of the following new standards, amendments and interpretations, which were issued but <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.36pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">not mandatory as of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.15pt; position: var(--position); text-decoration: none; white-space: pre;">December&#160;31, 2024<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.69pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 72.7pt; position: var(--position);">&#8226;<span style="display: inline-block; height: 6.93pt; width: 14.85pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates &#8211; Lack of Exchangeability whose application <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;">is for annual reporting periods beginning on or after January 1, 2025;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 103.56pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#8211; Amendments to the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Classification and Measurement of Financial Instruments, whose application is for annual reporting periods beginning on <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.44pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">or after January 1, 2026 (not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 143.88pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#8211; Contracts Referencing <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 157.32pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">Nature-dependent Electricity, whose application is for annual reporting periods beginning on or after January 1, 2026 <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">(not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 184.2pt; width: 612pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">IFRS 18 Presentation and Disclosure in Financial Statements, whose application is for annual reporting periods <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 197.64pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;">beginning on or after January 1, 2027 (not yet approved by the EU); <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 211.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.89pt;">IFRS 19 Subsidiaries without Public Accountability: Disclosures, whose application is for annual reporting periods<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.89pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 222.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 288.94pt;">beginning on or after January 1, 2027 (not yet approved by the UE), and<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 233.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.99pt;">Annual Improvements Volume 11, whose application is for annual reporting periods beginning on or after January 1,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.99pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 244.08pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 141.84pt;">2026 (not yet approved by the UE).<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.58pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">These texts have not been early adopted. The expected impacts are not considered significant, except for IFRS 18, for which the Group <span style="display: inline-block; height: 6.93pt;"></span></span></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">has not completed its assessment to date.<span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting Principles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description Of Accounting Policy For Going Concern</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Accounting Policy For Accounting Judgements And Estimates Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Accounting Policy For Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Accounting Policy For New, Revised Or Amended Standards And Interpretations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Accounting Policy For New Standards, Amendments And For Financial Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Impact Of The Ukraine/Russia Hostilities On The Group</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for deferred income tax. [Refer: Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfIFRSCompliance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An explicit and unreserved statement of compliance with all the requirements of IFRSs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfIFRSCompliance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting principles (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AccountingPrinciplesAbstract', window );"><strong>Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Disclosure of depreciation period of property, plant and equipment</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment are depreciated using the straight-line method over the estimated useful life of the asset. The principal <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">useful lives applied are as follows: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 100.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 15.75pt; width: 173.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">DEPRECIATION PERIOD<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Buildings<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 30pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 44.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office fixtures and fittings<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 44.25pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;">3 years<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.21pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.5045pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 44.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 58.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Equipment<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 58.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Industrial materials and equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 72.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 72.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Technical facilities<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 87pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 87pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture and computer equipment:<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 101.25pt; width: 95.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 101.25pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 115.5pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Office equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 115.5pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 115.5pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129.75pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">IT equipment<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 129.75pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;  &#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;">3 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 129.75pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144pt; width: 150.75pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Furniture<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 144pt; width: 95.25pt;"><div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.08pt; position: var(--position); white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.58pt; position: var(--position); text-decoration: none; white-space: pre;">10 years<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 144pt; width: 78pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.81pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);">(1)<span style="display: inline-block; height: 6.93pt; width: 12.84pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Office fixtures and fittings estimated useful lives correspond to the Paris headquarters and Boston offices residual estimated <span style="display: inline-block; height: 6.93pt;"></span></span></span></div>lease terms.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock', window );">Disclosure of allocation of acquisition cost</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The allocation of the acquisition cost is as follows: <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 237.56pt; width: 612pt;"><div style="font-size: 0pt; left: 28.8pt; position: var(--position); top: 0pt; width: 266.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 23.16pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of euros)<span style="display: inline-block; height: 6.94pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 15.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.41pt; position: var(--position); text-decoration: none; white-space: pre;">Amount&#160;allocated&#160;as<span style="display: inline-block; height: 6.77pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 13.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 23.96pt; position: var(--position); text-decoration: none; white-space: pre;">of&#160;April&#160;1,&#160;2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 10pt; position: var(--position); top: 23.17pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash prepayment made in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.17000000000002pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.54pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.58pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.59pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 49.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;">325<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loan granted to Prosynergia in 2021<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.9pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 63.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">1,400<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash payment made in 2022<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.03pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.05pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.06pt; position: var(--position); text-decoration: none; white-space: pre;">.............<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 78pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">2,925<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition fees (1)<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.07pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.11pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">...........................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 92.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;">466<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Earn-out measured at fair value<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.56pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.14000000000001pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.43pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.51pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.53pt; position: var(--position); text-decoration: none; white-space: pre;">........<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 106.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">1,446<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total acquisition cost allocated<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 134.47pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 134.54999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.60999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 134.62pt; position: var(--position); text-decoration: none; white-space: pre;">......<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 120.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,562<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 135pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 149.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Patents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.48pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.06pt; position: var(--position); text-decoration: none; white-space: pre;">...............................................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 149.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,529<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 163.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.78pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 108.94pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.22999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.38pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.46pt; position: var(--position); text-decoration: none; white-space: pre;">................<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 163.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.94pt; position: var(--position); text-decoration: none; white-space: pre;">42<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.32pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.06pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.35pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.39pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">......................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 192pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,571<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 206.25pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 206.25pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.72pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.00999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 67.08999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">.................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 220.5pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 52.11pt; position: var(--position); text-decoration: none; white-space: pre;">(9)<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 234.75pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249pt; width: 152.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total net assets<span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.14pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.3pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.44999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.77pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;">................................<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 249pt; width: 114pt;"><div><div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;">6,562<span style="display: inline-block; height: 6.77pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 35.95pt; position: var(--position);"> (1)<span style="display: inline-block; height: 6.93pt; width: 10.34pt;"></span></span><span style="left: 60.45pt; position: var(--position);">Of which <span style="display: inline-block; height: 6.93pt;"></span></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.42pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;451&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); text-decoration: none; white-space: pre;"> were disbursed in 2021 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.93pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"> in 2022. Acquired cash amounts to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;42&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.44pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.93pt;"></span></span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting Principles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Assets Acquisitions Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Disclosure of reconciliation of intangible assets</a></td>
<td class="text"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 461.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.82pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.16pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.26pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">85<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">24<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">110<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">35<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,564<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">120<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">24<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,673<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">120<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">24<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 108pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,673<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.13pt;"></span></span><span style="left: 56.760000000000005pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 129pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.13pt;"></span></span><span style="left: 56.760000000000005pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.13pt;"></span></span><span style="left: 48.760000000000005pt; position: var(--position);">120<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261.75pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.13pt;"></span></span><span style="left: 52.760000000000005pt; position: var(--position);">27<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 141pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.13pt;"></span></span><span style="left: 42.760000000000005pt; position: var(--position);">6,677<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div><div style="position: var(--position); top: 315.19pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(17)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(17)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Impairment<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 75.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(21)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(66)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(24)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(69)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.55pt;"></span></span><span style="left: 55.18pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(45)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(25)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.55pt;"></span></span><span style="left: 51.18pt; position: var(--position);">(70)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 521.54pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;">LICENCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">SOFTWARES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;">PATENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NET BOOK VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">85<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">93<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,607<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,604<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.21pt;"></span></span><span style="left: 57.84pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330.75pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,529<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">6,606<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory', window );">Disclosure of reconciliation of property, plant and equipment</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables present changes in property, plant and equipment including the right of use of assets (or &#8220;ROU&#8221;) as of <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022, 2023 and 2024:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 105.19pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 525.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 55.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.57pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.25pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.34pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.69pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.01pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.79pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.12pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">593<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">402<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">235<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,230<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 69pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">682<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,618<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">39<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">111<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,768<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,472<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(593)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.97pt;"></span></span><span style="left: 49.6pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.97pt;"></span></span><span style="left: 49.6pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(597)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(593)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,618<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">436<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">346<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,400<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,561<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">350<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">103<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">161<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">614<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 135pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">350<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(622)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.97pt;"></span></span><span style="left: 45.6pt; position: var(--position);">(27)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(649)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 147pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(649)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,346<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">513<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">507<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,366<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 159pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">1,262<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Acquisition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,578<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">292<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,870<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 180pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,217<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 192pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.97pt;"></span></span><span style="left: 35.6pt; position: var(--position);">(1,110)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(119)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.97pt;"></span></span><span style="left: 35.6pt; position: var(--position);">(1,229)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 192pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.97pt;"></span></span><span style="left: 41.6pt; position: var(--position);">(975)<span style="display: inline-block; height: 5.54pt; width: 0.33pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 204pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of the change in foreign currency exchange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.63pt;"></span></span><span style="left: 52.260000000000005pt; position: var(--position);">4<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">22<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 204pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.63pt;"></span></span><span style="left: 48.260000000000005pt; position: var(--position);">22<span style="display: inline-block; height: 5.54pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,818<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">513<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.63pt;"></span></span><span style="left: 44.260000000000005pt; position: var(--position);">698<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">4,029<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 216pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.63pt;"></span></span><span style="left: 38.260000000000005pt; position: var(--position);">2,504<span style="display: inline-block; height: 5.41pt; width: 2.99pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 361.82pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 528.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 49.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.07pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.75pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.84pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.19pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.29pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DEPRECIATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 65.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(445)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(346)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(134)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(925)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 65.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(470)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(407)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(35)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(38)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(481)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(414)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">593<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">1<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">597<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">593<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(259)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(378)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(171)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(808)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(290)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 131.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(578)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(36)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(94)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(707)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 131.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(498)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 143.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">27<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">27<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 143.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">27<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 155.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(837)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(387)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(265)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(1,488)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 155.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(761)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 176.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(886)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.3pt;"></span></span><span style="left: 48.93pt; position: var(--position);">(32)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(171)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(1,089)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 176.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(788)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 188.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Disposal<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,111<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">104<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,215<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 188.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">975<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 200.25pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of the change in foreign currency exhange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 200.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.99pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.3pt;"></span></span><span style="left: 52.93pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213pt; width: 201.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(613)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(419)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 333.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(332)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.3pt;"></span></span><span style="left: 38.93pt; position: var(--position);">(1,363)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465.75pt; position: var(--position); top: 213pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.3pt;"></span></span><span style="left: 44.93pt; position: var(--position);">(575)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 538.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.55pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.2pt; position: var(--position); text-decoration: none; white-space: pre;">BUILDINGS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.87pt; position: var(--position); text-decoration: none; white-space: pre;">FURNITURE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.97pt; position: var(--position); text-decoration: none; white-space: pre;">AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.31pt; position: var(--position); text-decoration: none; white-space: pre;">COMPUTER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;">EQUIPMENT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">OF WHICH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: var(--position); text-decoration: none; white-space: pre;">ROU<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NET BOOK VALUES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">148<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">56<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">101<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">305<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">212<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 74.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,359<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">59<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">175<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,592<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,270<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 95.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">501<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">126<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">878<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">501<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 116.25pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,205<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">94<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">366<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,666<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 473.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,929<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in property, plant and equipment, including right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other financial assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Disclosure of financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory', window );">Disclosure of other financial assets</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 508.31pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 525.11pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 445.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 243.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 70.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OTHER FINANCIAL ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">10,471<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,172<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">4,929<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,238<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">574<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">863<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">124<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">126<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total other non-current financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">11,708<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,870<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">5,919<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Advances related to CRO contracts<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 3pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -1.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">7,418<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,050<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 3pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -5.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deposits<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">136<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">136<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total other current financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,186<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">7,554<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 243.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">11,708<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">22,055<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 380.25pt; position: var(--position); top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">13,473<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other receivables and other assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock', window );">Disclosure of other receivables and other assets</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets break down as follows:<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 273.4pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><div style="position: var(--position); top: 481.14pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 435pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 233.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 65.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OTHER RECEIVABLES AND OTHER ASSETS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses - non current<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,037<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,320<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">948<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current other assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">1,037<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">2,320<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">948<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit ("CIR")<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">4,595<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">4,600<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">5,774<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">VAT receivables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">3,467<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">14,439<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,841<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prepaid expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">915<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">5,746<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">3,233<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">254<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">60<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">48<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current other receivables and assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">9,231<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">24,845<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">18,896<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 233.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and other assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 233.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">10,268<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 301.5pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">27,164<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 369.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Other Receivables And Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock', window );">Disclosure of composition of cash and cash equivalents</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 352.86pt; width: 612pt;"><div style="font-size: 0pt; left: 41pt; position: var(--position); top: 0pt; width: 474pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 243pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 69.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CASH AND CASH EQUIVALENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.37pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">18,105<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">87,265<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">26,944<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">233,837<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">56,956<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">144,221<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Composition Of Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FairValueMeasurementAbstract', window );"><strong>Fair Value Measurement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory', window );">Disclosure of carrying amounts and fair value of financial assets</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following table shows the carrying amounts and fair value of financial assets and financial liabilities, including their <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">levels in the fair value hierarchy.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables are non-financial liabilities and are therefore excluded from the tables below. They are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">presented in Note 17.2.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,708<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,271<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,271<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,889<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,452<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,452<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">16,241<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,439<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">8,873<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">65,272<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">58,469<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">57,903<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 273.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,055<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,394<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,394<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,161<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,500<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,500<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">39,697<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">40,622<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">18,506<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">42,768<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">37,348<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">37,348<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,531<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">5,165<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">124,266<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">125,191<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">30,037<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">95,154<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 476.56pt; width: 612pt;"><div style="font-size: 0pt; left: 40.12pt; position: var(--position); top: 0pt; width: 531.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 342pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 159.34pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 132.91pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.85pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.86pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">13,473<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,690<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,690<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">177,537<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">176,754<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">176,754<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">69,069<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">73,497<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">69,877<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">21,183<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">23,752<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">157,828<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">162,256<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">24,803<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">137,453<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; &#160;  The fair value of cash and cash equivalents is determined based on Level 1 fair value measurement and corresponds to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market value of the assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(2)&#160; &#160;  The carrying amount of financial assets measured at amortized cost is deemed to be a reasonable estimate of fair value, except <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the long-term advances made to CROs, whose fair value is determined based on Level 3 fair value measurement and is estimated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based on future cash-flows discounted at market rates, using credit spreads ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.29pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.29pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.56pt; position: var(--position); text-decoration: none; white-space: pre;">476<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.56pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">218<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.89pt; position: var(--position); text-decoration: none; white-space: pre;">131<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.89pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">271<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2024. As of December 31, 2022, 2023, and 2024, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.05pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the advances fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;240&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.96pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.55pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;235&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(3)&#160; &#160;  The carrying amount of short-term financial liabilities measured at amortized cost was deemed to be a reasonable estimate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(4)&#160; &#160;  The fair value of Kreos BSA A&amp;B, OCEANE conversion option, royalty certificates, Heights convertible notes, Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 199.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSA and Minimum Return Indemnifications is based on Level 3 fair value measurement and is estimated based on models and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions detailed in Note 15. The fair value of other long-term financial liabilities is determined based on Level 3 fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measurement and is estimated based on future cash-flows discounted at market rates, using the f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;">ollowing assumptions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of Kreos 1&amp;2 bonds, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.51pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.01pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.4pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.03pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the Kreos 1&amp;2 bonds fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">value by&#160; and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;68&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.65pt; position: var(--position); text-decoration: none; white-space: pre;">.. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt component of OCEANE bonds, a credit spread similar to that detailed in Note 15. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31,&#160; 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.9pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the OCEANE debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">component fair value by&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;476&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.98pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of the Kreos / Claret OCABSA (tranche A) and the tranches B and C of the Kreos / Claret straight <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bond loans, a credit spr<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ead of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">960</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp a</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.59pt; position: var(--position); text-decoration: none; white-space: pre;">s of August 22, 2023, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.19pt; position: var(--position); text-decoration: none; white-space: pre;">900<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.19pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.81pt; position: var(--position); text-decoration: none; white-space: pre;">750<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.81pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of August 22, 2023, December 31, 2023 (tranche A) and December 31, 2024 (all three tranches), an increase in the credit </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">spread by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.08pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+100</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp would result in a decrease in the Kreos / Claret debt components fair value by respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;624&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">,&#160; </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;538&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;958&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 427.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.89pt; position: var(--position); text-decoration: none; white-space: pre;"> the conditional advances and the PGE loan, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.42pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.92pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">900</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">31, 2023 and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">730</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December 31, 2024. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">An increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.71pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024, a decrease in the PGE loan fair value by, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;55&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.84pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;39&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;21&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the RNP-VIR conditional advance fair value by&#160;  <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.4pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the CARENA conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;37&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.5pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;37&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the Ebola conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.13pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.72pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(5) In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">non-current portion of the Heights convertible notes as of December 31, 2023 were reclassified within the current liabilities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory', window );">Disclosure of carrying amounts and fair value of financial liabilities</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following table shows the carrying amounts and fair value of financial assets and financial liabilities, including their <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">levels in the fair value hierarchy.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables are non-financial liabilities and are therefore excluded from the tables below. They are <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.91pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">presented in Note 17.2.<span style="display: inline-block; height: 6.93pt;"></span></span></div><div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,708<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,271<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,271<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,231<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">26,950<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,889<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,452<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,452<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">16,241<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;">9,439<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">8,873<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">33,555<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">15,475<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">65,272<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">58,469<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">57,903<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 273.56pt; width: 612pt;"><div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,055<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,394<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">22,394<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">27,164<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">251,942<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,161<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,500<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">301,500<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">39,697<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">40,622<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">18,506<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">42,768<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">37,348<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">37,348<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">11,531<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;">5,165<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">47,221<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">124,266<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;">125,191<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;">30,037<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;">95,154<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 476.56pt; width: 612pt;"><div style="font-size: 0pt; left: 40.12pt; position: var(--position); top: 0pt; width: 531.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 342pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 159.34pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 342pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 132.91pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;">RECOGNIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;">IN THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">STATEMENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;">POSITION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS/ <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;">AT FAIR <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;">THROUGH <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;">PROFIT&#160;AND <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;">LOSS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;">ASSETS AT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;">AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.85pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.86pt; position: var(--position); text-decoration: none; white-space: pre;">AT&#160;AMORTIZED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">COST<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">13,473<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,690<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">12,690<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other receivables and assets (2)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">19,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (1)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">144,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">177,537<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">176,754<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">176,754<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;non-current portion (4, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">69,069<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">73,497<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">69,877<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities&#8212;current portion (3, Note 15)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">21,183<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 150pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">23,752<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities (3)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 162pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">157,828<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 33.21pt;"></span></span><span style="left: 35.84pt; position: var(--position);">162,256<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 37.21pt;"></span></span><span style="left: 39.84pt; position: var(--position);">24,803<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 462.75pt; position: var(--position); top: 174pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">137,453<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; &#160;  The fair value of cash and cash equivalents is determined based on Level 1 fair value measurement and corresponds to the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">market value of the assets. <span style="display: inline-block; height: 6.93pt;"></span></span></div></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(2)&#160; &#160;  The carrying amount of financial assets measured at amortized cost is deemed to be a reasonable estimate of fair value, except <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">for the long-term advances made to CROs, whose fair value is determined based on Level 3 fair value measurement and is estimated <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">based on future cash-flows discounted at market rates, using credit spreads ranging from <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.29pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.29pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.56pt; position: var(--position); text-decoration: none; white-space: pre;">476<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.56pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">218<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.89pt; position: var(--position); text-decoration: none; white-space: pre;">131<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.89pt; position: var(--position); text-decoration: none; white-space: pre;"> bp to <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">271<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2024. As of December 31, 2022, 2023, and 2024, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.05pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the advances fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;240&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.96pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.96pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.55pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;235&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(3)&#160; &#160;  The carrying amount of short-term financial liabilities measured at amortized cost was deemed to be a reasonable estimate of <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">fair value. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(4)&#160; &#160;  The fair value of Kreos BSA A&amp;B, OCEANE conversion option, royalty certificates, Heights convertible notes, Kreos / Claret <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 199.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">BSA and Minimum Return Indemnifications is based on Level 3 fair value measurement and is estimated based on models and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions detailed in Note 15. The fair value of other long-term financial liabilities is determined based on Level 3 fair value <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measurement and is estimated based on future cash-flows discounted at market rates, using the f<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;">ollowing assumptions: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of Kreos 1&amp;2 bonds, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.51pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.01pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.4pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.03pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the Kreos 1&amp;2 bonds fair <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">value by&#160; and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.06pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;68&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.65pt; position: var(--position); text-decoration: none; white-space: pre;">.. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt component of OCEANE bonds, a credit spread similar to that detailed in Note 15. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31,&#160; 2022, an increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.9pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in a decrease in the OCEANE debt <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">component fair value by&#160; <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.39pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;476&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.98pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">For the debt components of the Kreos / Claret OCABSA (tranche A) and the tranches B and C of the Kreos / Claret straight <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">bond loans, a credit spr<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.97pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">ead of </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">960</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp a</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.59pt; position: var(--position); text-decoration: none; white-space: pre;">s of August 22, 2023, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.19pt; position: var(--position); text-decoration: none; white-space: pre;">900<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.19pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2023 and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.81pt; position: var(--position); text-decoration: none; white-space: pre;">750<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.81pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of August 22, 2023, December 31, 2023 (tranche A) and December 31, 2024 (all three tranches), an increase in the credit </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">spread by </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.08pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">+100</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.71pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp would result in a decrease in the Kreos / Claret debt components fair value by respectively </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.69pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;624&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.28pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">,&#160; </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;538&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.59pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8364;958&#160;thousand</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">.</span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 427.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#8226;</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">For</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.89pt; position: var(--position); text-decoration: none; white-space: pre;"> the conditional advances and the PGE loan, a credit spread of <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.42pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.92pt; position: var(--position); text-decoration: none; white-space: pre;"> bp as of December 31, 2022,<span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.61pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">900</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.11pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.06pt; width: 612pt;"><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">31, 2023 and </span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">730</span><span style="display: inline-block; height: 6.93pt;"></span></span><span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.43pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> bp as of December 31, 2024. </span><span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">An increase in the credit spread by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.71pt; position: var(--position); text-decoration: none; white-space: pre;">+100<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> bp would result in the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022, 2023 and 2024, a decrease in the PGE loan fair value by, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.25pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;55&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.84pt; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.77pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;39&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;21&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the RNP-VIR conditional advance fair value by&#160;  <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.4pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the CARENA conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.91pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;37&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.5pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;37&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"> respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">As of December 31, 2022 and 2023, a decrease in the Ebola conditional advance fair value by <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.13pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.72pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;1&#160;thousand<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: var(--position); text-decoration: none; white-space: pre;">, respectively. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(5) In application of the Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">current, and Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">non-current portion of the Heights convertible notes as of December 31, 2023 were reclassified within the current liabilities <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">(Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 6.93pt;"></span></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Disclosure of reconciliation of other equity instruments</a></td>
<td class="text"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 518.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 61.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 51.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.99pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 15.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.21pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.99pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.21pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.32pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.92pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.94pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 15.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.49pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.37pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.49pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.71pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;">SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.14pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.82pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 123.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 67.5pt; width: 61.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 67.5pt; width: 117pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 67.5pt; width: 64.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 79.5pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 79.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.32pt; position: var(--position); text-decoration: none; white-space: pre;">FOR THE YEAR ENDED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 79.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 91.5pt; width: 137.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JANUARY&#160;1, 2022<span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 91.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 91.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.86999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs granted under the Equity line <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">agreement<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 47.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.510000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.800000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 48.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.010000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.02pt; position: var(--position); text-decoration: none; white-space: pre;">....................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.81pt; position: var(--position); text-decoration: none; white-space: pre;">300,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 111.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.69pt; position: var(--position); text-decoration: none; white-space: pre;">300,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.53pt; position: var(--position); text-decoration: none; white-space: pre;">(300,000)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BCEs as well as the assumptions used for the measurement thereof in accordance <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with IFRS 2 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 94.87pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.29pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 273.86pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 527.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td></tr><tr style="height: 98.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.18pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;D<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.28pt; position: var(--position); text-decoration: none; white-space: pre;">ATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 61.5pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.97pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 37.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.73pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 85.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.84pt; position: var(--position); text-decoration: none; white-space: pre;">D BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 74.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2016-11-07<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 129pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2016-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">84,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,495<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(3,699)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-01-23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 141pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">41,735<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 153pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">150,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 165pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,686<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 177pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">64,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(26,687)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-03-15<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 189pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 201pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE 2018-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,844<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(16,844)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 213pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">8,422<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 225pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 225pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.62pt;"></span></span><span style="left: 32.25pt; position: var(--position);">6,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 237pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">530,652<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">385,409<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(51,230)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">330,179<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">245,962<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">330,179<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BSAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.15pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 209.78pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.82pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.15pt; position: var(--position); text-decoration: none; white-space: pre;">DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 46.87pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 70.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.29pt; position: var(--position); text-decoration: none; white-space: pre;">D&#160; BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69pt; left: 489pt; overflow: hidden; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: -6.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-12<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">82,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-09-18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-01-22<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">49,200<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">1,315<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">842<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(842)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">787<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">230<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(230)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 195.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">324,446<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">147,196<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(1,072)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">223,944<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">146,124<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">223,944<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to AGAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.41pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 241.51pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 537pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 28.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.45pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANGIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.05pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">G AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 52.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 62.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.83pt; position: var(--position); text-decoration: none; white-space: pre;">VESTED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.22pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.81pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.61pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 35.02pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.14pt; position: var(--position); text-decoration: none; white-space: pre;">G <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 47.25pt; width: 199.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 199.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.33pt; position: var(--position); white-space: pre;">FOR THE YEAR ENDED DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 47.25pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.53pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.1pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.19pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,382,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,382,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(212,737)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(390,019)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">780,040<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">100,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">100,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(25,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">75,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">731,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">731,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(245,625)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">485,875<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">254,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">254,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(41,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">213,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">12/01/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">132,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">132,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(51,500)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">81,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">02/01/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,549,125<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,549,125<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(193,500)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,355,625<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">03/28/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">05/23/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/05/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">4,547,421<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">2,601,296<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,946,125<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(744,362)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(415,019)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">3,388,040<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ShareBasedPaymentArrangementsAbstract', window );"><strong>Share-Based Payment Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Disclosure of reconciliation of other equity instruments</a></td>
<td class="text"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 518.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 61.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 51.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.99pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 15.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.21pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.99pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.21pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.32pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.92pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.94pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 15.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.49pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.37pt; position: var(--position); text-decoration: none; white-space: pre;">OF&#160;BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.49pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 15.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 15.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.71pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER&#160;OF<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;">SHARES<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.14pt; position: var(--position); text-decoration: none; white-space: pre;">TO&#160;BE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.82pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 123.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 67.5pt; width: 61.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 67.5pt; width: 117pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 67.5pt; width: 75.75pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 67.5pt; width: 64.5pt;"><div><div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 0.69pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 79.5pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 79.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 117pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.32pt; position: var(--position); text-decoration: none; white-space: pre;">FOR THE YEAR ENDED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 79.5pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 79.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 91.5pt; width: 137.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JANUARY&#160;1, 2022<span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.39pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.75pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 4.85pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 91.5pt; width: 117pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.59pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 117pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.5pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 91.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER&#160;31, 2022<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.86999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 140.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs granted under the Equity line <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.63pt; width: 123.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">agreement<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 47.93pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.510000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.800000000000004pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 48.95pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.99pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.010000000000005pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.02pt; position: var(--position); text-decoration: none; white-space: pre;">....................................<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 123.75pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.81pt; position: var(--position); text-decoration: none; white-space: pre;">300,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 199.5pt; position: var(--position); top: 111.75pt; width: 61.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 61.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.69pt; position: var(--position); text-decoration: none; white-space: pre;">300,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 261pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.53pt; position: var(--position); text-decoration: none; white-space: pre;">(300,000)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 111.75pt; width: 75.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.81pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 111.75pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BCEs as well as the assumptions used for the measurement thereof in accordance <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with IFRS 2 &#8211; <span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 94.87pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.29pt; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 273.86pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 527.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td></tr><tr style="height: 98.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.18pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;D<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.28pt; position: var(--position); text-decoration: none; white-space: pre;">ATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 61.5pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.97pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 37.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.73pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 85.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.84pt; position: var(--position); text-decoration: none; white-space: pre;">D BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCEs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.32pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 74.92pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.52pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 98.25pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2016-11-07<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 129pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2016-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">84,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,495<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(3,699)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 129pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">18,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-01-23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 141pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">41,735<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 141pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 153pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">150,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 153pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">112,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 165pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,686<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 165pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">67,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-11-20<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 177pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2017-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">67,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">64,374<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(26,687)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 177pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-03-15<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 189pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 189pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">11,980<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 201pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE 2018-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">33,687<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,844<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(16,844)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 201pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 213pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">8,422<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 213pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,843<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 225pt; width: 45pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-05-14<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 225pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCE-2018-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">22,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.62pt;"></span></span><span style="left: 32.25pt; position: var(--position);">6,000<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 225pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">2,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 237pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BCEs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 98.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">530,652<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 152.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 21.62pt;"></span></span><span style="left: 24.25pt; position: var(--position);">385,409<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.62pt;"></span></span><span style="left: 42.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 260.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 20.3pt;"></span></span><span style="left: 22.93pt; position: var(--position);">(51,230)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(4,000)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">330,179<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 422.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">245,962<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 476.25pt; position: var(--position); top: 237pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">330,179<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to BSAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.15pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 209.78pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td></tr><tr style="height: 69pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.82pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 52.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.15pt; position: var(--position); text-decoration: none; white-space: pre;">DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 0pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 46.87pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF BCAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;">ING AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 70.87pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;">1, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;">OF ISSUED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;">OF LAPSED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;">OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.29pt; position: var(--position); text-decoration: none; white-space: pre;">D&#160; BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTAND<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">ING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;">OF BSAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">EXERCISA<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;">BLE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69pt; left: 489pt; overflow: hidden; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: -6.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;">MAXIMUM <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;">OF SHARES <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;">TO BE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED IF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;">ALL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.7pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIO<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.3pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;">NS ARE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.9pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;">MET<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 69pt; width: 159pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 99.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 99.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">96,924<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2015-12-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2015-12<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">82,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 111.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2017-09-18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 123.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2017-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 123.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2018-01-22<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 135.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2018-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">49,200<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 135.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">16,400<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 147.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.96pt;"></span></span><span style="left: 29.59pt; position: var(--position);">1,315<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">842<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(842)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 147.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2014-03-11<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 159.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2014-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">787<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">230<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 30.3pt;"></span></span><span style="left: 32.93pt; position: var(--position);">(230)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 159.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 171.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 171.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">58,365<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024-04-04<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 183.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 183.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.96pt;"></span></span><span style="left: 25.59pt; position: var(--position);">19,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 195.75pt; width: 52.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 52.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 111pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">324,446<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">147,196<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);">(1,072)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 36.96pt;"></span></span><span style="left: 39.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">223,944<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">146,124<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 489pt; position: var(--position); top: 195.75pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 18.96pt;"></span></span><span style="left: 21.59pt; position: var(--position);">223,944<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The following tables summarize the data relating to AGAs as well as the assumptions used for the measurement thereof in <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.41pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS 2&#8212;<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based Payment<span style="display: inline-block; height: 6.94pt;"></span></span><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.94pt;"></span></span></div><div style="position: var(--position); top: 241.51pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 537pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GRANT&#160;DATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 28.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TOTAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs ISSUED<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.45pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANGIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 43.05pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">G AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 52.65pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 62.25pt; width: 64.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ISSUED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LAPSED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.83pt; position: var(--position); text-decoration: none; white-space: pre;">VESTED AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 0pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.22pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.81pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.61pt; position: var(--position); text-decoration: none; white-space: pre;">OUTSTANDIN<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 35.02pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.14pt; position: var(--position); text-decoration: none; white-space: pre;">G <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 47.25pt; width: 199.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 199.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.33pt; position: var(--position); white-space: pre;">FOR THE YEAR ENDED DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 47.25pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.53pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.1pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.19pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,382,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,382,796<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(212,737)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(390,019)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">780,040<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">100,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">100,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(25,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">75,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">731,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">731,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(245,625)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">485,875<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/28/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">254,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">254,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(41,000)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">213,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">12/01/23<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2023-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">132,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">132,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 33.8pt;"></span></span><span style="left: 36.43pt; position: var(--position);">(51,500)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">81,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">02/01/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,549,125<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,549,125<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(193,500)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,355,625<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">03/28/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">22,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">05/23/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">38,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">93,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">25,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">07/11/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.46pt;"></span></span><span style="left: 39.09pt; position: var(--position);">20,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">09/05/24<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.46pt;"></span></span><span style="left: 53.09pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.46pt;"></span></span><span style="left: 35.09pt; position: var(--position);">198,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 67.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total AGAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">4,547,421<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 202.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">2,601,296<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">1,946,125<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 337.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(744,362)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">(415,019)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 472.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 26.46pt;"></span></span><span style="left: 29.09pt; position: var(--position);">3,388,040<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory', window );">Disclosure of main data and assumptions used for the measurement of other equity instruments</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the BSAs was determined at grant date using the Black Scholes model, with the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 92.96pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.84pt; position: var(--position); white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.62pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.38pt; position: var(--position); white-space: pre;">OF THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.07pt; position: var(--position); white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.61pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.5pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.49pt; position: var(--position); white-space: pre;">OF THE BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.94pt; position: var(--position); white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.92pt; position: var(--position); white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.27pt; position: var(--position); white-space: pre;">SUBSCRIPTI<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.82pt; position: var(--position); white-space: pre;">ON PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.15pt; position: var(--position); white-space: pre;">STRIKE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.83pt; position: var(--position); white-space: pre;">PRICE PER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.48pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.2pt; position: var(--position); white-space: pre;">RISK FREE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.52pt; position: var(--position); white-space: pre;">RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.49pt; position: var(--position); white-space: pre;">EXPECTED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.05pt; position: var(--position); white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.71pt; position: var(--position); white-space: pre;">VOLATILITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 41.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.06<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.7<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.5<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;">58,365<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 41.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;">4.30%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">5.4<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;">6.9<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;">60.41%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 53.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.06<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.8<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;">19,455<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 53.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;">4.30%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">5.5<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;">7.0<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;">60.41%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 72pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.84pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 0pt; width: 72pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.22pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE&#160;OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.56pt; position: var(--position); text-decoration: none; white-space: pre;">THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.69pt; position: var(--position); text-decoration: none; white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.02pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.2pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.18pt; position: var(--position); text-decoration: none; white-space: pre;">THE AGA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.19pt; position: var(--position); text-decoration: none; white-space: pre;">AGA PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.3pt; position: var(--position); text-decoration: none; white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.96pt; position: var(--position); text-decoration: none; white-space: pre;">VOLATILITY <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.97pt; position: var(--position); text-decoration: none; white-space: pre;">RISK&#160;FREE&#160;RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2021 <span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 41.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31.60<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2022-07-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">49.0%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.32pt; position: var(--position); text-decoration: none; white-space: pre;">-1.00%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranches 1-4)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 53.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 5)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3.62<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-12-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">67.2%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">3.20%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 6)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 96.75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.74<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-07-11<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">67.2%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">3.20%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 1)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 118.5pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 2)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 140.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.59<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 162pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 174pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 186pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.16<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.16<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-1<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 198pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.26<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.26<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-2<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 210pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.40<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.40<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 222pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.76<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.76<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 234pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 246pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 258pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 270pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.80<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.80<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr></tbody></table></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.1pt; position: var(--position); text-decoration: none; white-space: pre;">he fair value of the Minimum Return Indemnifications was<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"> measured using the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 236.2pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche B Minimum Return Indemnification (issued in March <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.93pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF MARCH 28, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.40<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.40<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">13<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,959<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">68<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">2,635<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;">136<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,066<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,410<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">241<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;">1,615<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">68<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;">2,499<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;">136<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche B MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);">1,683<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);">2,636<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 409.5pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche C Minimum Return Indemnification (issued in June <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.03pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JUNE 21, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">15<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(a) Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">741<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,160<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">43<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(b) Probability-weighted fair value of tranche C warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">2,948<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">684<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(c) Probability-weighted fair value of tranche C warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">3,250<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">903<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;">475<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;">941<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">43<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche C MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);">475<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);">984<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.17pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">main data and assumptions are the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 311.06pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 497.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 120pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche A-B BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">August 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.32pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 22, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 37.65pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche A-B)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 0pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.25pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 24pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 91.37pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 24pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.62pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 39.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 95.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 39.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;17.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 55.5pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.76<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.99pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry) 18/02/2027 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 79.79pt; position: var(--position); text-decoration: none; white-space: pre;">(tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 71.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.18pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.1pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 71.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.43pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 92.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 92.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 92.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">71.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">65.2%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 108pt; width: 120pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.96pt; position: var(--position); text-decoration: none; white-space: pre;">59.5%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 89.61999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.88pt; position: var(--position); text-decoration: none; white-space: pre;">64.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.54pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 108pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.21pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.13pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 129pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 129pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 129pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">3.00<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 144.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 98.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 98.59pt; position: var(--position);">2.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 378pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0.52pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.21pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 10.6pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.13pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche A-B BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 162pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);">2,092<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 162pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.96pt;"></span></span><span style="left: 100.58999999999999pt; position: var(--position);">920<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 162pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);">243<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 81.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 522pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 137.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche C BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">November 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.43pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF NOVEMBER 2, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of which, number of conditional BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">202,915<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">202,916<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 118.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.89<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); white-space: pre;">01/11/2030 (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Probability of Drawdown of Tranche C <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">credit facility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.09pt; position: var(--position); text-decoration: none; white-space: pre;">Drawn on June 21, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">67.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">64.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">67.4%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">64.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 181.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">3.00<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">2.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 3.89pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.21pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 13.97pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 61.13pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 205.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche C BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);">1,493<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);">1,659<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 101.71pt;"></span></span><span style="left: 104.33999999999999pt; position: var(--position);">923<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos A BSA and Kreos B BSA are measured at fair value using a Black-Scholes valuation model. The main data and <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions are the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 419.36pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A BSA - June 1, 2018<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos A BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;">110,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;">110,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.21<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.21<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">5.6 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">0.0 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2.98<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos A BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">275<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">1,261<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 563.11pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos B BSA - June 1, 2019<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos B BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">74,766<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">74,766<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.70<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.70<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">6.4 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">0.0 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2.96<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos B BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">149<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">589<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss', window );">Disclosure of breakdown of the compensation expenses</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre; width: 439.91pt;">Breakdown of the compensation expenses accounted for the period ended December 31, 2022, 2023 and 2024<span style="display: inline-block; height: 6.94pt;"></span></span><div style="position: var(--position); top: 424.31pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.88pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BCEs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(138)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BSAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.21pt;"></span></span><span style="left: 53.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(211)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 65.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(1,026)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(8,067)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;">(19,900)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 77.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Social taxes related to AGAs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(205)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.55pt;"></span></span><span style="left: 47.18pt; position: var(--position);">(426)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.3pt; position: var(--position); text-decoration: none; white-space: pre;">(717)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(1,369)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 190.5pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 38.55pt;"></span></span><span style="left: 41.18pt; position: var(--position);">(8,605)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 90pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;">(20,941)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ShareBasedPaymentArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ShareBasedPaymentArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Disclosure of financial liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory', window );">Disclosure of financial liabilities breakdown</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 101.66pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 110.46pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 422.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 191.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 44.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.5165pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">4,730<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret bond loans <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">26,373<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">839<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">160<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,431<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,558<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,402<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,252<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">9,127<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,563<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">29,056<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret convertible notes (OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A &amp; B BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">424<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane conversion option<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">142<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret minimum return indemnifications <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">566<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,262<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,262<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,287<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;">12,229<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">6,549<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">15,491<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210.75pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total non-current financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">16,241<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">39,697<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">69,069<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 229.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">8,252<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 229.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 241.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; Claret bond loans <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 241.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">20,028<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 253.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">545<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">379<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 253.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">932<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 265.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,280<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,276<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 265.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,235<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 277.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">10,077<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,655<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 277.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">22,195<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 289.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">19,957<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 289.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 301.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 301.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 313.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Convertible loan notes<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">19,957<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 313.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 325.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,521<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,509<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 325.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 337.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,521<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,509<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 337.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 349.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos / Claret BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 349.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 349.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 361.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 361.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 373.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total current financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">33,555<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">37,348<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 373.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">44,935<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 385.5pt; width: 191.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 191.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">49,797<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 269.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">77,045<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 385.5pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 42.96pt;"></span></span><span style="left: 45.59pt; position: var(--position);">114,004<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 524.71pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and Non-current Liabilities <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 535.35pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the non-current portion of the Heights convertible notes as of December <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 545.99pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2023 were reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory', window );">Disclosure of main data and assumptions used for the measurement of other equity instruments</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the BSAs was determined at grant date using the Black Scholes model, with the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 92.96pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.84pt; position: var(--position); white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.62pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.38pt; position: var(--position); white-space: pre;">OF THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.07pt; position: var(--position); white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 60.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.61pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.5pt; position: var(--position); white-space: pre;">FAIR VALUE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.49pt; position: var(--position); white-space: pre;">OF THE BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.94pt; position: var(--position); white-space: pre;">NUMBER OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.92pt; position: var(--position); white-space: pre;">BSAs<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.27pt; position: var(--position); white-space: pre;">SUBSCRIPTI<span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.82pt; position: var(--position); white-space: pre;">ON PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.15pt; position: var(--position); white-space: pre;">STRIKE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.83pt; position: var(--position); white-space: pre;">PRICE PER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.48pt; position: var(--position); white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.2pt; position: var(--position); white-space: pre;">RISK FREE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 53.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.52pt; position: var(--position); white-space: pre;">RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.49pt; position: var(--position); white-space: pre;">EXPECTED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.05pt; position: var(--position); white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.71pt; position: var(--position); white-space: pre;">VOLATILITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-1<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 41.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.06<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.7<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.5<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;">58,365<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 41.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;">4.30%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">5.4<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;">6.9<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;">60.41%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 51pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">BSA 2024-2<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 53.25pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.06<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 117.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;5.8<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;">]<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;">19,455<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;2.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 53.25pt; width: 53.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;">4.30%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;">[<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">5.5<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;">-<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;">7.0<span style="display: inline-block; height: 5.41pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"> years]<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 481.5pt; position: var(--position); top: 53.25pt; width: 58.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;">60.41%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 72pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.84pt; position: var(--position); text-decoration: none; white-space: pre;">TYPE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 0pt; width: 72pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.22pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE&#160;OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.56pt; position: var(--position); text-decoration: none; white-space: pre;">THE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.69pt; position: var(--position); text-decoration: none; white-space: pre;">UNDERLYING <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 32.02pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;">SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.2pt; position: var(--position); text-decoration: none; white-space: pre;">FAIR&#160;VALUE OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.18pt; position: var(--position); text-decoration: none; white-space: pre;">THE AGA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.19pt; position: var(--position); text-decoration: none; white-space: pre;">AGA PRICE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.3pt; position: var(--position); text-decoration: none; white-space: pre;">MATURITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.96pt; position: var(--position); text-decoration: none; white-space: pre;">VOLATILITY <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.97pt; position: var(--position); text-decoration: none; white-space: pre;">RISK&#160;FREE&#160;RATE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2021 <span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 41.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31.60<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2022-07-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">49.0%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 41.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.32pt; position: var(--position); text-decoration: none; white-space: pre;">-1.00%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranches 1-4)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 53.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 53.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 5)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;3.62<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-12-31<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">67.2%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">3.20%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-1 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 6)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 96.75pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.74<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;">2024-07-11<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">67.2%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 96.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;">3.20%<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 1)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 118.5pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 118.5pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-2 <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche 2)<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 140.25pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;15.98<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.59<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 140.25pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 162pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 162pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 174pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.92<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 174pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2023-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 186pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.16<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.16<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 186pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-1<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 198pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.26<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.26<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 198pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA 2024-2<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 210pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.40<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;13.40<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 210pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-3<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 222pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.76<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.76<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 222pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-4<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 234pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 234pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-5<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 246pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 246pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-6<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 258pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;12.54<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 258pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AGA-2024-7<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78pt; position: var(--position); top: 270pt; width: 72pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.80<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.80<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;0.00<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 270pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr></tbody></table></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.1pt; position: var(--position); text-decoration: none; white-space: pre;">he fair value of the Minimum Return Indemnifications was<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"> measured using the following assumptions:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 236.2pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche B Minimum Return Indemnification (issued in March <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.93pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF MARCH 28, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.40<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.40<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">13<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,959<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">68<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">2,635<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;">136<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,066<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 78.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Probability-weighted fair value of tranche A-B warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,410<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 99.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">241<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;">1,615<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">68<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 120.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;">2,499<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;">136<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 142.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche B MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);">1,683<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 142.5pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 115.55pt;"></span></span><span style="left: 118.17999999999999pt; position: var(--position);">2,636<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 409.5pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Tranche C Minimum Return Indemnification (issued in June <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">2024)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.03pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF JUNE 21, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Final redemption scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 21.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Minimal return<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 33.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;">1.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;">x<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Discount rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 128.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 128.18pt; position: var(--position);">15<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 45.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 132.18pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 132.18pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 138.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(a) Probability-weighted present value of shortfall payment (in <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">741<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 57.75pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">1,160<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">43<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(b) Probability-weighted fair value of tranche C warrants with MRI <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">2,948<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 79.5pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">684<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 101.25pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">(c) Probability-weighted fair value of tranche C warrants without <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;">3,250<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 101.25pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;">903<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"> (Final redemption)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Total fair value of MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;">475<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 123pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;">941<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"> (Final redemption, i.e. a+b-c)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;">43<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"> (Tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;">Fair value of Tranche C MRI (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225.75pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);">475<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375pt; position: var(--position); top: 144.75pt; width: 146.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 121.55pt;"></span></span><span style="left: 124.17999999999999pt; position: var(--position);">984<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.17pt; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">main data and assumptions are the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 311.06pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 497.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 120pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche A-B BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">August 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.32pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 22, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 37.65pt; position: var(--position); text-decoration: none; white-space: pre;">(Tranche A-B)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 0pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.25pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 24pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 91.37pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 24pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.62pt; position: var(--position); text-decoration: none; white-space: pre;">214,198<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 39.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 95.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 39.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;17.10<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 55.5pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.37pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.76<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.99pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry) 18/02/2027 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 79.79pt; position: var(--position); text-decoration: none; white-space: pre;">(tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 71.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.18pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.1pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 71.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.43pt; position: var(--position); text-decoration: none; white-space: pre;">19/08/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 92.25pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 92.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 92.25pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 92.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">71.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">65.2%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 108pt; width: 120pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.96pt; position: var(--position); text-decoration: none; white-space: pre;">59.5%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 89.61999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 120pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.88pt; position: var(--position); text-decoration: none; white-space: pre;">64.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.54pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 108pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.21pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.13pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 129pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 129pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 104.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 104.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 129pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">3.00<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 144.75pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 98.59pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 98.59pt; position: var(--position);">2.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 378pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 119.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0.52pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.21pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 10.6pt; width: 119.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.13pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162pt; width: 123.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche A-B BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126.75pt; position: var(--position); top: 162pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);">2,092<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 255pt; position: var(--position); top: 162pt; width: 120pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 120pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.96pt;"></span></span><span style="left: 100.58999999999999pt; position: var(--position);">920<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 162pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 97.21pt;"></span></span><span style="left: 99.83999999999999pt; position: var(--position);">243<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 81.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 522pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 137.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret Tranche C BSA - <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">November 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.43pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF NOVEMBER 2, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 24pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">405,832<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 39.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of which, number of conditional BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">202,915<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;">202,916<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 118.62pt; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.86<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 71.25pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;8.89<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.67<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); white-space: pre;">01/11/2030 (expiry) <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 87pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;">01/11/2030 (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;">18/02/2027 (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 108pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">7-year expiry scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 108pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">95<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Probability of Drawdown of Tranche C <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">credit facility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 123.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.09pt; position: var(--position); text-decoration: none; white-space: pre;">Drawn on June 21, 2024<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">67.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">64.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">67.4%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">64.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;">44.3%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165.75pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 165.75pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 109.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 109.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 181.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 137.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">3.00<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">2.30<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 117.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 181.5pt; width: 125.25pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 3.89pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.21pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"> (expiry)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 13.97pt; width: 125.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 61.13pt; position: var(--position); text-decoration: none; white-space: pre;">2.9%<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"> (tender offer)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 205.5pt; width: 137.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 137.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tranche C BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);">1,493<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 268.5pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 94.96pt;"></span></span><span style="left: 97.58999999999999pt; position: var(--position);">1,659<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396.75pt; position: var(--position); top: 205.5pt; width: 125.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.09pt; width: 101.71pt;"></span></span><span style="left: 104.33999999999999pt; position: var(--position);">923<span style="display: inline-block; height: 6.09pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The Kreos A BSA and Kreos B BSA are measured at fair value using a Black-Scholes valuation model. The main data and <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions are the following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 419.36pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A BSA - June 1, 2018<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos A BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;">110,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;">110,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.21<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;7.21<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">5.6 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">0.0 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2.98<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos A BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">275<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">1,261<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 563.11pt; width: 612pt;"><div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos B BSA - June 1, 2019<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the year <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ended December 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of May 24, 2023 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(exercise date)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding Kreos B BSA<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">74,766<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">74,766<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Exercise price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.70<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;10.70<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;18.57<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Residual maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">6.4 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;">0.0 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2.96<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued Kreos B BSA (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">149<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">589<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock', window );">Disclosure of main data and assumptions used for the measurement of convertible loan notes</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.62pt; position: var(--position); text-decoration: none; white-space: pre;">The main data and assumptions are the following: <span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 415.2pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 519pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 143.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 128.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes - August 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.82pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 24, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 17.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Number of outstanding notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 17.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 113.62pt; position: var(--position); text-decoration: none; white-space: pre;">350<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 17.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">350<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 17.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;">350<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Original principal amount (in thousands of <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 34.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">35,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 34.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">35,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 34.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">35,000<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 55.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 116.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 116.84pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 107.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 107.84pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 55.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 107.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 107.84pt; position: var(--position);">6<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conversion price per share<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 72.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.77<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 72.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.77<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 72.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;23.77<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 90pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;16.74<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;9.82<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 90pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.76<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 107.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 10.43pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Maturity date<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 107.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.88pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event) 24/08/2027 <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.23pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.58pt; position: var(--position); text-decoration: none; white-space: pre;">(HTM/voluntary conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 277.5pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2027 (HTM/voluntary <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;">conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 399.75pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2025 (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;">24/08/2027 (HTM/voluntary <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;">conversion)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 0.76pt; width: 143.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Held to maturity / voluntary conversion <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 10.36pt; width: 143.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">scenario probability<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 134.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 134.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 134.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">75<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 151.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Initial price limit<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 151.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.43<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 151.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.43<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 151.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;14.43<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Early redemption amount (put event)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 168.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 108.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 108.84pt; position: var(--position);">120<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 168.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 99.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 99.84pt; position: var(--position);">120<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 168.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 99.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 99.84pt; position: var(--position);">120<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 186pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 186pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 186pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 203.25pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit spread<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 203.25pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 112.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 112.84pt; position: var(--position);">20<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 203.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">20<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 203.25pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 103.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 103.84pt; position: var(--position);">25<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 220.5pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk-free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 220.5pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 110.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 110.84pt; position: var(--position);">2.9<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 120.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 220.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 101.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 101.84pt; position: var(--position);">2.3<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 220.5pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 101.84pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 101.84pt; position: var(--position);">2.9<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 111.84pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.75pt; width: 143.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of Heights convertible notes <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 143.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 237.75pt; width: 128.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 96.21pt;"></span></span><span style="left: 98.83999999999999pt; position: var(--position);">32,641<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 277.5pt; position: var(--position); top: 237.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 87.21pt;"></span></span><span style="left: 89.83999999999999pt; position: var(--position);">27,456<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 237.75pt; width: 119.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 87.21pt;"></span></span><span style="left: 89.83999999999999pt; position: var(--position);">20,017<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">At inception, the net cash proceeds reflect the OCEANE initial fair value. The fair value of the bifurcated option at inception has been <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">measured with a Monte Carlo model using a Longstaff Schwartz algorithm, with a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.86pt; position: var(--position); text-decoration: none; white-space: pre;">53%<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.19pt; position: var(--position); text-decoration: none; white-space: pre;"> share price volatility, a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.71pt; position: var(--position); text-decoration: none; white-space: pre;">1,400<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.21pt; position: var(--position); text-decoration: none; white-space: pre;"> bp credit spread <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumption and a <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.88pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;31.50<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.38pt; position: var(--position); text-decoration: none; white-space: pre;"> share price. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 413.06pt; width: 612pt;"><div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 389.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.37pt; position: var(--position); text-decoration: none; white-space: pre;">31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.07pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF AUGUST 24, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 21pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">3.05<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 21pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 63.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 63.34pt; position: var(--position);">3.22<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Credit spread<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;">1,475<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"> bp<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.12pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;">1,398<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"> bp<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;16.74<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Expected term<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.79pt; position: var(--position); text-decoration: none; white-space: pre;">July 21, 2026<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.79pt; position: var(--position); text-decoration: none; white-space: pre;"> July 21, 2026 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 69pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 59.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 59.34pt; position: var(--position);">44.01<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 69pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 69.34pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 69.34pt; position: var(--position);">37<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 77.34pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 81pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 81pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 213.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of issued OCEANE (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 93pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.71pt;"></span></span><span style="left: 65.34pt; position: var(--position);">142<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 93pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.71pt;"></span></span><span style="left: 59.34pt; position: var(--position);">1,762<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">Disclosure of conditional advances</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances as of December 31, 2022, 2023 and 2024 are as follows<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 347.39pt; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 8.25pt;"></span></span><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 352.76pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 382.77pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 383.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CONDITIONAL ADVANCES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 12pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">RNP VIR &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">4,171<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">4,232<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 42.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CARENA &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">2,454<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">2,485<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">EBOLA &#8211; Bpifrance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">158<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">55<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 66.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total conditional advances<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">6,783<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 302.25pt; position: var(--position); top: 78.75pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeasesForLesseeTableTextBlock', window );">Disclosure of variation in lease liabilities</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The variations in lease liabilities are set forth below:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 342.76pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 301.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 216.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 56.84pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.18pt; position: var(--position); text-decoration: none; white-space: pre;">LEASE LIABILITY<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 12pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">214<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">1,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 64.05pt;"></span></span><span style="left: 66.67999999999999pt; position: var(--position);">(305)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">1,384<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 78pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">350<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 90pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.05pt;"></span></span><span style="left: 60.68pt; position: var(--position);">(1,194)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 102pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.71pt;"></span></span><span style="left: 69.33999999999999pt; position: var(--position);">540<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 123pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 135pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 135pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 64.05pt;"></span></span><span style="left: 66.67999999999999pt; position: var(--position);">(398)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 216.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216.75pt; position: var(--position); top: 147pt; width: 84.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.71pt;"></span></span><span style="left: 63.34pt; position: var(--position);">2,363<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory', window );">Disclosure of main data and assumptions used for the measurement of earn-out liability</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.67pt; position: var(--position); text-decoration: none; white-space: pre;">The main data and <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.46pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">assumptions are the following:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 485.46pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 404.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 254.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia earn-out<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of April 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">As of and for the <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">period ended <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">December 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Risk free rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 52.27pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 52.27pt; position: var(--position);">(0.3)<span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 30.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 54.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 54.93pt; position: var(--position);">2.3<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Market capitalization (in thousands of &#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 45.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">403,118<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 45.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;">135,952<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 60.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share price (&#8364;)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 60.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.37pt; position: var(--position); text-decoration: none; white-space: pre;">24.15<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 60.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.37pt; position: var(--position); text-decoration: none; white-space: pre;">6.18<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Time to maturity<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.61pt; position: var(--position); text-decoration: none; white-space: pre;">1 year<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 39.5pt; position: var(--position); text-decoration: none; white-space: pre;">0.25 years<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Volatility&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 56.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 56.93pt; position: var(--position);">61<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 56.93pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 56.93pt; position: var(--position);">44<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 67.59pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 105.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 105.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 254.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 6.37pt; width: 254.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fair value of the earn-out liability (in thousands of &#8364;)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 41.64pt;"></span></span><span style="left: 44.27pt; position: var(--position);">(1,446)<span style="display: inline-block; height: 5.41pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Disclosure of reconciliation of liabilities arising from financing activities</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in financial liabilities, excluding derivative instruments, are presented below as of December 31, <span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.28pt; position: var(--position); text-decoration: none; white-space: pre;">2022, 2023 a<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.21pt; position: var(--position); text-decoration: none; white-space: pre;">nd 2024:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 309.16pt; width: 612pt;"><div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;">euros) <span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 44.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 9.52pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES (excluding <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 28.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives instruments)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 21.75pt; width: 41.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.65pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.39pt; position: var(--position); text-decoration: none; white-space: pre;">bond loans<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.93pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 21.75pt; width: 42.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.76pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.65pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.86pt; position: var(--position); text-decoration: none; white-space: pre;">Claret <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.68pt; position: var(--position); text-decoration: none; white-space: pre;">convertible <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.6pt; position: var(--position); text-decoration: none; white-space: pre;">notes <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.36pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.6pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA )<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.28pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos &amp; <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.03pt; position: var(--position); text-decoration: none; white-space: pre;">Claret bond <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.22pt; position: var(--position); text-decoration: none; white-space: pre;">loans<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;">Heights <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.3pt; position: var(--position); text-decoration: none; white-space: pre;">convertible <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.23pt; position: var(--position); text-decoration: none; white-space: pre;">notes<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.81pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.31pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.4pt; position: var(--position); text-decoration: none; white-space: pre;">advances <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.17pt; position: var(--position); text-decoration: none; white-space: pre;">BPI<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 12.46pt; position: var(--position); text-decoration: none; white-space: pre;">Lease <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.41pt; position: var(--position); text-decoration: none; white-space: pre;">liabilities<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.94pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.18pt; position: var(--position); text-decoration: none; white-space: pre;">earn-out <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;">liability<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.34pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty <span style="display: inline-block; height: 4.74pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;">certificates<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 21.75pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.03pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.74pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 66pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.21pt;"></span></span><span style="left: 15.84pt; position: var(--position);">21,110<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">18,816<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 66pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">4,742<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,770<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">214<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 66pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">51,653<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 87pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 87pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,931<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 87pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,931<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 99pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(9,410)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 99pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(90)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(305)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 99pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(9,806)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 111pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 111pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(2,456)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,496)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 111pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(54)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 111pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(4,006)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 123pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 123pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.21pt;"></span></span><span style="left: 19.84pt; position: var(--position);">3,738<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,636<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 123pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">150<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">102<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">356<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 123pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,983<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">recognition of earn-out <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">liability <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 144pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 144pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,446<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 144pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,446<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: fair <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 174.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,446)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 174.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,446)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 195.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 195.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 216.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 216.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.21pt;"></span></span><span style="left: 15.84pt; position: var(--position);">12,982<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">19,957<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 216.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">4,838<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,783<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,384<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,287<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 216.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">49,231<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 237.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 237.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">23,119<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">35,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 237.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">58,119<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 249.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 10.55pt;"></span></span><span style="left: 13.18pt; position: var(--position);">(11,635)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(23,238)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 249.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(2,188)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(110)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(573)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 249.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(38,993)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 261.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 261.75pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">(2,278)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,602)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 261.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 22.05pt;"></span></span><span style="left: 24.68pt; position: var(--position);">(818)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(525)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(43)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(12)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 261.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(5,278)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 273.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 273.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(1,046)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 273.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,046)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">recognition of earn-out <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">liability <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 294.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(1,005)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 294.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,005)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 325.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: fair <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 325.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.21pt;"></span></span><span style="left: 25.84pt; position: var(--position);">170<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,069<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 325.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(212)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 325.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,027<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 346.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 346.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">272<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 346.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">272<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 367.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 367.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 367.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,678<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">540<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">12,229<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 367.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">74,466<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;">(Amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;">euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES (excluding <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives instruments)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 52.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 52.5pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 52.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">3,678<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 23.96pt;"></span></span><span style="left: 26.59pt; position: var(--position);">540<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">12,229<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 52.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">74,466<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Proceeds<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 73.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">47,444<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 73.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">47,444<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Repayments <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 85.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(8,750)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(2,708)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(459)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 85.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 11.3pt;"></span></span><span style="left: 13.93pt; position: var(--position);">(13,167)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 97.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 16.05pt;"></span></span><span style="left: 18.68pt; position: var(--position);">(2,250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,639)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(1,772)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(18)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 25.3pt;"></span></span><span style="left: 27.93pt; position: var(--position);">(17)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 97.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(7,696)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 50.25pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 109.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.09pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.69pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">classification of embedded <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.29pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derivatives as separate <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.89pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derivative financial <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 109.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,204)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 109.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,204)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159.75pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: (gain)/<span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">loss on recognition or <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">derecognition<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 159.75pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(590)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 159.75pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);">(590)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 190.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: interest <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">expense and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 190.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 18.71pt;"></span></span><span style="left: 21.34pt; position: var(--position);">3,977<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">5,800<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,714<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">77<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">61<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">4,198<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 190.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">15,834<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 211.5pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">amortized cost <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 211.5pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,404)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 211.5pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(3,404)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 242.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes: other <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">fair value remeasurement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 242.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,367<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 242.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">1,367<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 263.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cash changes&#160;: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">subsidies <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 263.25pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 263.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(4,070)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 263.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">(4,070)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 284.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes: <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.81pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">additional leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 284.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 284.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,221<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 306pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non cash changes : Effect <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">of the change in foreign <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">currency exhange rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 306pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 28.71pt;"></span></span><span style="left: 31.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 306pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 338.25pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 338.25pt; width: 41.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.21pt;"></span></span><span style="left: 29.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183pt; position: var(--position); top: 338.25pt; width: 42.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 14.71pt;"></span></span><span style="left: 17.34pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 228.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">46,401<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,488<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 17.96pt;"></span></span><span style="left: 20.59pt; position: var(--position);">2,363<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 453.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 27.96pt;"></span></span><span style="left: 30.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 498.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 13.96pt;"></span></span><span style="left: 16.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 543.75pt; position: var(--position); top: 338.25pt; width: 42pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 9.96pt;"></span></span><span style="left: 12.59pt; position: var(--position);">109,218<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock', window );">Disclosure of changes in derivative instruments</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in derivative instruments, are presented below as of December 31, 2022, 2023 and 2024 :<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 44pt; position: var(--position); top: 0pt; width: 534.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 96pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 7.68pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of <span style="display: inline-block; height: 5.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.1pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 37.78pt; position: var(--position); text-decoration: none; white-space: pre;">euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos A BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.22pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos B BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 19.57pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.78pt; position: var(--position); text-decoration: none; white-space: pre;">OCEANE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 29.17pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.56pt; position: var(--position); text-decoration: none; white-space: pre;">conversion option<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.53pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret BSA<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.67pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.57pt; position: var(--position); text-decoration: none; white-space: pre;">Minimum Return <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.97pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.01pt; position: var(--position); text-decoration: none; white-space: pre;">Indemnifications<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.77pt; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DERIVATIVE <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.6pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">INSTRUMENTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,478<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,525<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">5,929<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 54.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">9,932<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 75.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 75.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 75.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 87.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(2,203)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,376)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(5,787)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 87.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(9,366)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 99.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">275<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">149<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">142<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 99.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">566<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 120.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Issuance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 120.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,585<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 120.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">3,585<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 132.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">986<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 51.71pt;"></span></span><span style="left: 54.34pt; position: var(--position);">440<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 132.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 132.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">3,046<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 144.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,006)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,006)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 156.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Repurchases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(489)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(339)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,762)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 156.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 156.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(2,591)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 168.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Exercises<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(771)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.05pt;"></span></span><span style="left: 51.68pt; position: var(--position);">(250)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 168.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 168.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,021)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 180.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 180.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 180.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 201.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 201.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Issuance<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,158<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 222.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">2,158<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(+) Increase in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,462<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 234.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">1,462<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(-) Decrease in fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,413)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 246.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.05pt;"></span></span><span style="left: 45.68pt; position: var(--position);">(1,413)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258.75pt; width: 96pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168.75pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 55.71pt;"></span></span><span style="left: 58.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 465pt; position: var(--position); top: 258.75pt; width: 69.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities', window );">Disclosure of remaining contractual maturities of derivative financial liabilities</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following are the remaining contractual maturities of financial liabilities as of December 31, 2022, 2023 and 2024. The amounts <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.17pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are gross and undiscounted, and include contractual interest payments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 561.67pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 147pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 0pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 184.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 21pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.39pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.83pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.64pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">12,982<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">14,098<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">9,034<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 54pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">5,065<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">19,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">31,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 66pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);">28,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">4,838<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 78pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">5,173<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 78pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 78pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);">2,586<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">6,783<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">6,813<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">3,697<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 90pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,490<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 90pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);">1,626<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">3,287<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 102pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">1,384<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">1,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">558<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 114pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);">557<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 114pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">289<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.37pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">566<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">142<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 126pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 126pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">424<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">49,797<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">59,053<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">16,223<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 138pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">9,905<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 138pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);">32,925<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 82.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 187.09pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 160.66pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.67pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.56pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.55pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.89pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.01pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.46pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 21pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.8pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.58pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.58pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">36,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">10,522<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">9,997<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">16,231<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 54pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">30,903<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">26,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 66pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">3,678<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 86.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">3,880<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 86.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 86.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 98.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">6,813<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">3,697<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,490<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 98.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);">1,626<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 98.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">12,229<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 110.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 110.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 110.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">540<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 122.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">575<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">406<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">162<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 122.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.96pt;"></span></span><span style="left: 52.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 122.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 134.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 134.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 134.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">77,045<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 146.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">81,500<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">20,747<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">15,192<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 146.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">45,561<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 146.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 257.81pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 543pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 0pt; width: 401.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 188.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.32pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.09pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 54pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">24,063<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">6,563<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 66pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">30,653<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">19,943<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,460<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">46,401<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 86.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">58,080<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">24,016<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">25,715<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,348<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,488<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 98.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">2,586<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 110.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 57.21pt;"></span></span><span style="left: 59.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,363<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 122.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">2,512<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">993<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">996<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">516<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 134.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 30.96pt;"></span></span><span style="left: 33.59pt; position: var(--position);">114,004<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 146.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.21pt;"></span></span><span style="left: 41.84pt; position: var(--position);">122,680<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">38,468<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">56,698<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">27,507<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities', window );">Disclosure of remaining contractual maturities of non-derivative financial liabilities</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">The following are the remaining contractual maturities of financial liabilities as of December 31, 2022, 2023 and 2024. The amounts <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.17pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">are gross and undiscounted, and include contractual interest payments. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 561.67pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 147pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 0pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 184.84pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 393pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 21pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.39pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.83pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.64pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos 1 &amp; 2 bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">12,982<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">14,098<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">9,034<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 54pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">5,065<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Oceane<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">19,957<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">31,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 66pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,500<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);">28,000<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">4,838<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 78pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">5,173<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 78pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 78pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);">2,586<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 78pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">6,783<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 90pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">6,813<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">3,697<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 90pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">1,490<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 90pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.21pt;"></span></span><span style="left: 37.84pt; position: var(--position);">1,626<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 90pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">3,287<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 102pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 102pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 102pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.21pt;"></span></span><span style="left: 47.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 102pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;">1,384<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 114pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">1,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">558<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 114pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 42.71pt;"></span></span><span style="left: 45.34pt; position: var(--position);">557<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 114pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">289<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 114pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.37pt; position: var(--position); text-decoration: none; white-space: pre;">566<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 126pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">566<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">142<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 126pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 46.71pt;"></span></span><span style="left: 49.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 126pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 41.21pt;"></span></span><span style="left: 43.84pt; position: var(--position);">424<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 126pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138pt; width: 147pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 147pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;">49,797<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 138pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">59,053<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">16,223<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 138pt; width: 60.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 36.71pt;"></span></span><span style="left: 39.34pt; position: var(--position);">9,905<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 138pt; width: 59.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.21pt;"></span></span><span style="left: 33.84pt; position: var(--position);">32,925<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477pt; position: var(--position); top: 138pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 82.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 187.09pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 160.66pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.67pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 21pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.56pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.55pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.89pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 21pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.01pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.46pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 21pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.8pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.58pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.58pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">29,605<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">36,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">10,522<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">9,997<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">16,231<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 54pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">21,643<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">30,903<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">26,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 66pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">3,678<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 86.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">3,880<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 86.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 86.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Conditional advances BPI<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">6,771<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 98.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">6,813<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">3,697<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">1,490<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 98.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.96pt;"></span></span><span style="left: 38.59pt; position: var(--position);">1,626<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 98.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">12,229<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 110.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.96pt;"></span></span><span style="left: 57.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 110.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 110.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">540<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 122.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">575<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">406<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.71pt;"></span></span><span style="left: 48.34pt; position: var(--position);">162<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 122.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.96pt;"></span></span><span style="left: 52.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 122.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 134.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 39.71pt;"></span></span><span style="left: 42.34pt; position: var(--position);">2,579<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 49.71pt;"></span></span><span style="left: 52.34pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 134.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 45.96pt;"></span></span><span style="left: 48.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 134.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">77,045<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 146.25pt; width: 69pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 40.96pt;"></span></span><span style="left: 43.59pt; position: var(--position);">81,500<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">20,747<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 35.71pt;"></span></span><span style="left: 38.34pt; position: var(--position);">15,192<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 146.25pt; width: 60pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 31.96pt;"></span></span><span style="left: 34.59pt; position: var(--position);">45,561<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 477.75pt; position: var(--position); top: 146.25pt; width: 62.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 257.81pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 543pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 0pt; width: 401.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 188.97pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 401.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 21pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CURRENT AND NON-CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;">GROSS <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;">AMOUNT<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 21pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.32pt; position: var(--position); text-decoration: none; white-space: pre;">CONTRACTUAL <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 71.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.09pt; position: var(--position); text-decoration: none; white-space: pre;">CASH FLOWS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;">LESS THAN 1 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 1 TO 2 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;">FROM 2 TO 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 21pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">LONGER <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;">THAN 5 <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;">YEARS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Heights convertible notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">21,574<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 54pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">24,063<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,750<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">6,563<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 54pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret convertible notes <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(OCABSA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">23,370<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 66pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">30,653<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">19,943<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,460<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 66pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 86.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Kreos/Claret bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">46,401<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 86.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 43.21pt;"></span></span><span style="left: 45.84pt; position: var(--position);">58,080<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">24,016<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">25,715<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">8,348<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 86.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 98.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">PGE<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,488<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 98.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">2,586<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,293<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 98.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 110.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">13,023<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 110.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 57.21pt;"></span></span><span style="left: 59.84pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 110.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 122.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">2,363<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 122.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">2,512<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">993<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">996<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.96pt;"></span></span><span style="left: 47.59pt; position: var(--position);">516<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 122.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 134.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 134.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 47.21pt;"></span></span><span style="left: 49.84pt; position: var(--position);">4,786<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">1,166<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 38.96pt;"></span></span><span style="left: 41.59pt; position: var(--position);">3,620<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 134.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.96pt;"></span></span><span style="left: 51.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 146.25pt; width: 141.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 30.96pt;"></span></span><span style="left: 33.59pt; position: var(--position);">114,004<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 146.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 39.21pt;"></span></span><span style="left: 41.84pt; position: var(--position);">122,680<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">38,468<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">56,698<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 34.96pt;"></span></span><span style="left: 37.59pt; position: var(--position);">27,507<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 480pt; position: var(--position); top: 146.25pt; width: 63pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.96pt;"></span></span><span style="left: 55.59pt; position: var(--position);">7<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Changes In Derivative Financial Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfLeasesForLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Leases For Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfLeasesForLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Disclosure of defined benefit plans [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Disclosure of main actuarial assumptions used to measure the retirement benefit obligations</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.28pt; position: var(--position); text-decoration: none; white-space: pre;">The main actuarial assumptions used to measure the retirement benefit <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 570.06pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">obligations are as follows:<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">ACTUARIAL ASSUMPTIONS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 0pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement age<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;">65 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;">63 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;">65 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;">63 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 30.75pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;">65 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for key management / <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;">64 years<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"> for other employees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 61.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Collective agreement<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 61.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical&#160;industry<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 73.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Discount Rate (IBoxx Corporates AA)<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;">0.90%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;">3.34%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 73.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;">3.40%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Mortality rate table<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 85.5pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;">INSEE 2016-2018 <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 17.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Salary increase rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;">2.55%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;">2.55%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 97.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"> for key management / <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;">2.55%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"> for other employees<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 56.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 25.06pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Turnover rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;">Decreasing from <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;">5.80%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"> at <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;">20 years-old to <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">0.05%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"> from <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;">55 years-old<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;">Decreasing from <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;">5.80%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"> at <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;">20 years-old to <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;">0.05%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"> from <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;">55 years-old<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 139.5pt; width: 105pt;"><div><div style="line-height: 9pt; position: var(--position); top: 7.72pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.68pt; position: var(--position); white-space: pre;">Decreasing rates by age <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 18.97pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.16pt; position: var(--position); white-space: pre;">and <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.4pt; position: var(--position); text-decoration: none; white-space: pre;">zero<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 43.870000000000005pt; position: var(--position); white-space: pre;"> from age 55, <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.18pt; position: var(--position); white-space: pre;">generating an average exit <span style="display: inline-block; height: 6.24pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 41.47pt; width: 105pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.53pt; position: var(--position); white-space: pre;">rate for 2025 of <span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.97pt; position: var(--position); text-decoration: none; white-space: pre;">2.05%<span style="display: inline-block; height: 6.24pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.21000000000001pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 6.24pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195.75pt; width: 159.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employee contribution rate<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;">45%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;">45%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 375.75pt; position: var(--position); top: 195.75pt; width: 105pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;">45%<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory', window );">Disclosure of changes in projected benefit obligation</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Changes in the projected benefit obligation for the periods presented were as follows:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 313.91pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 322.71pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 321.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 153.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 168pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 25.34pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 0pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.72pt; position: var(--position); text-decoration: none; white-space: pre;">RETIREMENT BENEFIT OBLIGATIONS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">JANUARY 1, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 12pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">693<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 33pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">143<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 45pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 157.96pt;"></span></span><span style="left: 160.59pt; position: var(--position);">8<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 57pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">(235)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 69pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">610<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 90pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">109<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 102pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);">23<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 114pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 126pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">629<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 147pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 147pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">115<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 159pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 159pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);">22<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 171pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 171pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 151.3pt;"></span></span><span style="left: 153.93pt; position: var(--position);">(41)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 183pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 183pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 153.96pt;"></span></span><span style="left: 156.59pt; position: var(--position);">31<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 195pt; width: 153.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 195pt; width: 168pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 149.96pt;"></span></span><span style="left: 152.59pt; position: var(--position);">756<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of defined benefit plans. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 138<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Payables and other current liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock', window );">Disclosure of breakdown of trade and other payables</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities break down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 70.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 447pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TRADE PAYABLES AND OTHER CURRENT <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">LIABILITIES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">8,216<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">21,953<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">30,748<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Accrued invoices<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">7,250<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">25,269<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">13,049<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 70.21pt;"></span></span><span style="left: 72.83999999999999pt; position: var(--position);">9<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 67.55pt;"></span></span><span style="left: 70.17999999999999pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">26<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 200.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Trade payables and other current liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 200.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">15,475<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">47,221<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">43,824<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock', window );">Disclosure of tax and employee-related payables</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables are presented below:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 284.11pt; width: 612pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div><div style="position: var(--position); top: 295.44pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 195pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">TAX AND EMPLOYEE-RELATED PAYABLES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employee-related payables<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,348<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">3,694<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,742<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Social security and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">840<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,251<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,783<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other tax and related payments<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">112<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">127<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">184<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 195pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 195pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax and employee-related payables<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,300<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,073<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,709<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Breakdown Of Trade And Other Payables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Tax And Employee-Related Payables Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock', window );">Disclosure of breakdown of operating income</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">Operating income is composed as below:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; position: var(--position); top: 501.89pt; width: 612pt;"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 90.75pt;"></span></span><div style="font-size: 0pt; left: 38.5pt; position: var(--position); top: 0pt; width: 381pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">OPERATING INCOME<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research tax credit ("CIR")<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,476<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,493<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,651<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">29<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">81<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,140<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">78<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">47<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,657<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total operating income<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,583<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,621<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">12,449<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information Of Operating Income Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses by nature [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory', window );">Disclosure of expenses by nature</a></td>
<td class="text"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">SALES AND MARKETING<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,710<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,323<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,012<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,699<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other sales and marketing expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">709<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">932<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sales &amp; Marketing<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,431<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">5,954<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses break down as follows: <span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 558.34pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">RESEARCH AND DEVELOPMENT EXPENSES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Sub-contracting, studies and research<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">38,858<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">85,726<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">110,993<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">3,072<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">8,048<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">18,455<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">4,246<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,561<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">12,581<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Intellectual property fees<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,187<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,645<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,741<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other research and development expenses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">931<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,196<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,762<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenses&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">48,295<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">103,176<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.21pt;"></span></span><span style="left: 50.84pt; position: var(--position);">146,532<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">GENERAL AND ADMINISTRATIVE EXPENSES<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Personnel costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,403<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">13,105<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">19,434<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Consulting and professional fees&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,624<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,393<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">7,990<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other general and administrative expenses&#160;<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">3,466<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">2,893<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">5,522<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">General and administrative expenses&#160;<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">7,492<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">22,391<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">32,946<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock', window );">Disclosure of principal audit fees and services</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">Our principal audit fees and services are set forth below. For the years ended December 31, 2023 and 2024, they include fees due our <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;">joint statutory auditor Agili3f, in addition to PricewaterhouseCoopers Audit. <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 106.56pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 524.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 275.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"></td></tr><tr style="height: 34.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 14.18pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 86.09pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statutory Auditor, certification of individual and consolidated financial statements<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 49.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issuer<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">100<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">1,848<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 49.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">1,144<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 64.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other procedures required by law<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;">Issuer<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">740<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">492<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 79.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.96pt;"></span></span><span style="left: 69.58999999999999pt; position: var(--position);">89<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 275.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.96pt;"></span></span><span style="left: 65.59pt; position: var(--position);">840<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">2,340<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 94.5pt; width: 81pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">1,233<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Principal Audit Fees And Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses by nature. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesByNatureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employees (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EmployeesAbstract', window );"><strong>Employees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock', window );">Disclosure of average workforce during the periods</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s average workforce during the periods ended December 31, 2022, 2023 and 2024 was as follows:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 287.06pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 360pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">HEADCOUNTS<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">France<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">23<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">28<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">38<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">12<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">29<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 88.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">23<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">40<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 74.46pt;"></span></span><span style="left: 77.08999999999999pt; position: var(--position);">67<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Average Number Of Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EmployeesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employees [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EmployeesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial gain (loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialIncomeLossAbstract', window );"><strong>Financial Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock', window );">Disclosure of net financial income (loss)</a></td>
<td class="text"><span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The financial loss breaks down as follows:<span style="display: inline-block; height: 6.93pt;"></span></span><div style="position: var(--position); top: 112.66pt; width: 612pt;"><div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 510pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 279pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 87.96pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">FINANCIAL GAIN (LOSS)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on Kreos 1 &amp; 2 straight bond loans<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,737)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(760)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(5,800)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on convertible loan notes<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(2,641)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,935)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(5,691)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on conditional advances<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(196)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(176)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(85)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on royalty certificates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(356)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(8,942)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 78.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 54.3pt;"></span></span><span style="left: 56.93pt; position: var(--position);">(794)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest on lease liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(10)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(13)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 90.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(61)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in derivatives fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,046)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 102.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,462)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in other liabilities at fair value through profit and loss<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 114.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,367)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loss on derecognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,431)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 126.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 138.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,924)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 138.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(1,615)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 150.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange losses<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(5,573)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 150.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(51)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(83)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(73)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 162.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 58.3pt;"></span></span><span style="left: 60.93pt; position: var(--position);">(64)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial expenses<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(7,022)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(27,875)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 174.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(16,991)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Interest income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,418<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 186.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">8,246<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in derivatives fair value<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">9,366<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,006<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 198.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,413<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 210.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in other liabilities at fair value through profit and loss<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">1,446<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">3,198<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 210.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 222.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effect of unwinding the discount related to advances made to CROs<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">355<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 222.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">710<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 234.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Day-one gain on recognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">212<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 234.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">590<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 246.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Gain on derecognition of financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">192<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 246.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 258.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange gains <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 56.62pt;"></span></span><span style="left: 59.25pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 6.55pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 258.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">2,774<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial income<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">306<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.96pt;"></span></span><span style="left: 59.59pt; position: var(--position);">130<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 270.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 60.96pt;"></span></span><span style="left: 63.59pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 282.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial income<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">11,118<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">7,511<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 282.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 46.96pt;"></span></span><span style="left: 49.59pt; position: var(--position);">13,732<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 294.75pt; width: 279pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial gain (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 50.96pt;"></span></span><span style="left: 53.59pt; position: var(--position);">4,096<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(20,364)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 294.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 48.3pt;"></span></span><span style="left: 50.93pt; position: var(--position);">(3,258)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Finance Income (Cost)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock', window );">Disclosure of reconciliation of effective income tax (loss)</a></td>
<td class="text"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 214.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 39.07pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros, except percentage)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Loss before tax <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(60,740)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.14pt;"></span></span><span style="left: 67.77pt; position: var(--position);">(147,740)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.14pt;"></span></span><span style="left: 67.77pt; position: var(--position);">(176,242)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Statutory French tax rates<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);">25.00<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);">25.00<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 78.43pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt;"></span></span><span style="left: 78.43pt; position: var(--position);">25.00<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span><span style="left: 99.09pt; position: var(--position);">%<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Nominal income tax using statutory French tax rate<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);">15,185<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);">36,935<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 71.8pt;"></span></span><span style="left: 74.42999999999999pt; position: var(--position);">44,061<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 67.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax effect of:<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax rates in foreign jurisdictions<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payment<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">342<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 73.14pt;"></span></span><span style="left: 75.77pt; position: var(--position);">(2,045)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 73.14pt;"></span></span><span style="left: 75.77pt; position: var(--position);">(5,056)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 103.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">CIR<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">1,119<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">1,123<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">1,663<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 115.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs related to capital increase <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">820<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.8pt;"></span></span><span style="left: 78.42999999999999pt; position: var(--position);">3,073<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(112)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 127.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Decrease / (increase) in derivatives fair value and other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">895<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 81.8pt;"></span></span><span style="left: 84.42999999999999pt; position: var(--position);">748<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(207)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 139.5pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 4.89pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Non-recognition of deferred tax assets related to tax losses and <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.49pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">temporary differences<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(18,169)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(39,612)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.14pt;"></span></span><span style="left: 71.77pt; position: var(--position);">(40,399)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 162.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(192)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.14pt;"></span></span><span style="left: 81.77pt; position: var(--position);">(222)<span style="display: inline-block; height: 5.54pt; width: 6.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">49<span style="display: inline-block; height: 5.54pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-left: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; border-top: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 174.75pt; width: 214.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Effective income tax (loss)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 85.8pt;"></span></span><span style="left: 88.42999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 9.32pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Disclosure of deferred tax assets and liabilities by nature</a></td>
<td class="text"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 242.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.92pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">DEFERRED TAX ASSETS AND LIABILITIES BY NATURE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 12pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;">AS OF <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, 2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Retirement benefit obligation<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">152<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">157<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 33pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">189<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">135<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">591<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 57pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">198<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">351<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 57pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,678<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Tax losses carryforward<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);">77,207<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">114,946<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">152,372<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 81pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other items<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">417<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">886<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 93pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);">77,558<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">116,006<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 93pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">155,715<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Subsidies<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">50<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">24<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 105pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">12<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 117pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Leases<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">124<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 117pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">485<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 129pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other financial liabilities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,377<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">285<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,075<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Other items<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">10<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 141pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">12<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 153pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,427<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 75.71pt;"></span></span><span style="left: 78.33999999999999pt; position: var(--position);">444<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 153pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 69.71pt;"></span></span><span style="left: 72.33999999999999pt; position: var(--position);">1,584<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 165pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets, net<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 65.71pt;"></span></span><span style="left: 68.33999999999999pt; position: var(--position);">76,130<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">115,562<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 61.71pt;"></span></span><span style="left: 64.34pt; position: var(--position);">154,131<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 177pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Unrecognized deferred tax assets<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 63.05pt;"></span></span><span style="left: 65.67999999999999pt; position: var(--position);">(76,130)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.05pt;"></span></span><span style="left: 61.68pt; position: var(--position);">(115,562)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 177pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.05pt;"></span></span><span style="left: 61.68pt; position: var(--position);">(154,131)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189pt; width: 242.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total deferred taxes, net recognized in the statement of financial <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 242.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">position<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 344.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 446.25pt; position: var(--position); top: 189pt; width: 93.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 79.71pt;"></span></span><span style="left: 82.33999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (loss) per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of earnings per share</a></td>
<td class="text"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 23.63pt; position: var(--position); text-decoration: none; white-space: pre;">(amounts in thousands of euros, except share data)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">BASIC AND DILUTED LOSS PER SHARE<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 12pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of outstanding shares<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">19,092,442<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">43,066,012<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 32.96pt;"></span></span><span style="left: 35.59pt; position: var(--position);">63,046,350<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Net loss for the period<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 44.3pt;"></span></span><span style="left: 46.93pt; position: var(--position);">(60,740)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(147,740)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 40.3pt;"></span></span><span style="left: 42.93pt; position: var(--position);">(176,242)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 210.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Basic and diluted loss per share (&#8364;/share)<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(3.18)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(3.43)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.3pt;"></span></span><span style="left: 54.93pt; position: var(--position);">(2.80)<span style="display: inline-block; height: 5.41pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Disclosure of aggregate compensation of the members of the Group&#8217;s Board of Directors and CEO</a></td>
<td class="text"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">The aggregate compensation of the members of the Group&#8217;s Board of Directors and to the Chief Executive Officer includes the <span style="display: inline-block; height: 6.93pt;"></span></span><div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.11pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;">following: <span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="position: var(--position); top: 423.31pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 241.5pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"></td><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.54pt; position: var(--position); text-decoration: none; white-space: pre;">(In thousands of euros)<span style="display: inline-block; height: 5.55pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">COMPENSATION<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 12pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;">YEAR ENDED <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;">DECEMBER 31, <span style="display: inline-block; height: 5.41pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Fixed compensation owed <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">322<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">471<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">578<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Variable compensation owed <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">193<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">282<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 54.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Contributions in-kind <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 70.21pt;"></span></span><span style="left: 72.83999999999999pt; position: var(--position);">9<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">32<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 66.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">68<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">17<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Attendance fees&#8212;Board of Directors <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">103<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">375<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 90.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">495<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments <span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 59.55pt;"></span></span><span style="left: 62.18pt; position: var(--position);">(217)<span style="display: inline-block; height: 5.54pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">6,561<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 102.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">10,517<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Departure indemnities<span style="display: inline-block; height: 5.54pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">1,210<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 114.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.54pt; width: 66.21pt;"></span></span><span style="left: 68.83999999999999pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.54pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126.75pt; width: 241.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 241.5pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 5.41pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 62.21pt;"></span></span><span style="left: 64.84pt; position: var(--position);">427<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324.75pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 56.21pt;"></span></span><span style="left: 58.84pt; position: var(--position);">8,930<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.41pt; width: 52.21pt;"></span></span><span style="left: 54.84pt; position: var(--position);">11,657<span style="display: inline-block; height: 5.41pt; width: 2.66pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Group (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate information and statement of IFRS compliance [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">&#8364; 40,584<span></span>
</td>
<td class="nump">&#8364; 196,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 7,189<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 25,934<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of preparation (Details)<br> &#8364; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="2">121 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 02, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 176,242<span></span>
</td>
<td class="nump">&#8364; 147,740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 60,740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="nump">&#8364; 223,300<span></span>
</td>
<td class="nump">$ 235.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">353,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 557,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">175,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromResearchTaxCredit', window );">Proceeds from research tax credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,493<span></span>
</td>
<td class="nump">4,476<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates', window );">Net proceeds from sale of royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,931<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,221<span></span>
</td>
<td class="nump">251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">26,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 60,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,370<span></span>
</td>
<td class="nump">21,643<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">21,643<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes', window );">Current convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,574<span></span>
</td>
<td class="nump">29,605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">19,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">29,605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 19,332<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes', window );">Current convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,574<span></span>
</td>
<td class="nump">29,605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29,605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentConvertibleLoansNotes', window );">Non-current convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 20,652<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,652<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes', window );">Current convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 29,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=abvx_BanquePubliqueDInvestissementBPIMember', window );">Conditional advances BPI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities', window );">Proceeds from government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromConditionalAdvances', window );">Proceeds from conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_SaleOfStockAxis=abvx_RegisteredDirectOfferingMember', window );">Registered direct offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 223,300<span></span>
</td>
<td class="nump">&#8364; 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorRevenueTransactionsMember', window );">Major revenue transactions | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromResearchTaxCredit', window );">Proceeds from research tax credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="15"></td></tr>
<tr><td colspan="15"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Portion Of Non-Current Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Sale Of Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromSaleOfRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromResearchTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Research Tax Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromResearchTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=abvx_BanquePubliqueDInvestissementBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=abvx_BanquePubliqueDInvestissementBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_SaleOfStockAxis=abvx_RegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_SaleOfStockAxis=abvx_RegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorRevenueTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorRevenueTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2022 (Details)<br> &#8364; / shares in Units, &#8364; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">121 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 22, 2023 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 11, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 07, 2022 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 02, 2022 </div>
<div>EUR (&#8364;) </div>
<div>transaction </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 01, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Feb. 23, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Dec. 12, 2022</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 19, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>May 24, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 25, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals', window );">Cash advances and loans made to (reimbursed from) hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="num">&#8364; (3,302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="nump">&#8364; 223,300<span></span>
</td>
<td class="nump">$ 235.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 353,377<span></span>
</td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 557,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="nump">20,325,500<span></span>
</td>
<td class="nump">20,325,500<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,325,500<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates', window );">Net proceeds from sale of royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 2,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatePercentageOfFutureSales', window );">Royalty certificate, percentage of future sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificateMaximumAmount', window );">Royalty certificate, maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,111<span></span>
</td>
<td class="nump">3,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations', window );">Cash advances and loans made to CRO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">12,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentAdvancesToCROContracts', window );">Advances related to CRO contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,929<span></span>
</td>
<td class="nump">12,172<span></span>
</td>
<td class="nump">10,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member', window );">&#8364;49.2 million cross-over financing, september 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAmount', window );">Financial agreement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 49,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementNumberOfTransactions', window );">Financial agreement, number of transactions | transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 46,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuancePercentageOfCurrentShareCapital', window );">Equity issuance, percentage of current share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates', window );">Net proceeds from sale of royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatePercentageOfFutureSales', window );">Royalty certificate, percentage of future sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificateMaximumAmount', window );">Royalty certificate, maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member', window );">&#8364;49.2 million cross-over financing, september 2022 | Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PrincipalAgreementsAxis=abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember', window );">Research agreement with University Hospital Center of Nice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals', window );">Cash advances and loans made to (reimbursed from) hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (3,302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member', window );">AGA 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Compensation expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes', window );">Social taxes related to AGAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member', window );">Wittycel SAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill', window );">Impairment loss recognised in profit or loss, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Intangible assets with indefinite useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities', window );">Loan granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashPrepaymentAssetsAcquisitions', window );">Cash prepayment made in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 325<span></span>
</td>
<td class="nump">&#8364; 325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashTransferredAssetsAcquisitions', window );">Cash payment made in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutMaximumAmount', window );">Earn-out, maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LoanGrantedAssetsAcquisitions', window );">Loan granted to Prosynergia in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Advances And Loans Made To (Reimbursed From) Hospitals</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashPrepaymentAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Prepayment, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashPrepaymentAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashTransferredAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Transferred, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashTransferredAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuancePercentageOfCurrentShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Percentage Of Current Share Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuancePercentageOfCurrentShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuanceSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuanceSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense From Equity-Settled Share-Based Payment Transactions, Social Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementNumberOfTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Agreement, Number Of Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementNumberOfTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LoanGrantedAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loan Granted, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LoanGrantedAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Sale Of Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromSaleOfRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentAdvancesToCROContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Advances To CRO Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentAdvancesToCROContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Advances Made to Contract Research Organizations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PaymentsForAdvancesMadeToContractResearchOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificateMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificate, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificateMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificatePercentageOfFutureSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificate, Percentage Of Future Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificatePercentageOfFutureSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash advances and loans made to other parties (other than advances and loans made by a financial institution), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B67_d_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 122<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_122_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PrincipalAgreementsAxis=abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PrincipalAgreementsAxis=abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2023 (Details)<br> &#8364; / shares in Units, $ / shares in Units, &#8364; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
<th class="th" colspan="1">121 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 02, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 22, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 21, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 20, 2023 </div>
<div>EUR (&#8364;) </div>
<div>transaction </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>May 24, 2023 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 22, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 07, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 02, 2022 </div>
<div>EUR (&#8364;) </div>
<div>transaction </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 30, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares </div>
<div>plan </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 19, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Capital increase from issuance of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 130,000<span></span>
</td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 353,377<span></span>
</td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,325,500<span></span>
</td>
<td class="nump">20,325,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,325,500<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.50<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 28,111<span></span>
</td>
<td class="nump">&#8364; 3,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,750<span></span>
</td>
<td class="nump">27,188<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 223,300<span></span>
</td>
<td class="nump">$ 235.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">353,377<span></span>
</td>
<td class="nump">46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 557,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants', window );">Capital increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,000<span></span>
</td>
<td class="nump">212.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Payments for share issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 21,300<span></span>
</td>
<td class="nump">$ 23.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember', window );">Free Shares (AGA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfShareBasedCompensationPlansIssued', window );">Number of share-based compensation plans issued | plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,601,296<span></span>
</td>
<td class="nump">1,946,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,547,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=abvx_AmericanDepositorySharesMember', window );">ADS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,699,460<span></span>
</td>
<td class="nump">18,699,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfSharesReceivedPerADS', window );">Number of shares received per ADS (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssueOfEquityOfferingPricePerShare', window );">Issue of equity, offering price per share (in dollar/euro per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,626,040<span></span>
</td>
<td class="nump">1,626,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssueOfEquityOfferingPricePerShare', window );">Issue of equity, offering price per share (in dollar/euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10.9864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheAMember', window );">Kreos 1, convertible bond loans, tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOtherShareWarrantsRepurchased', window );">Number of other share warrants repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember', window );">Kreos 1, convertible bond loans, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOtherShareWarrantsRepurchased', window );">Number of other share warrants repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember', window );">Kreos &amp; Claret financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted', window );">Aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember', window );">Kreos &amp; Claret financing | Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfOtherShareWarrants', window );">Issuance of other share warrants</a></td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember', window );">Kreos &amp; Claret financing | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted', window );">Aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14.4303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14.4303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,964,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 30.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember', window );">Kreos &amp; Claret financing and Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness', window );">Proceeds from borrowings, net of refinancing of existing indebteness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember', window );">Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Capital increase from issuance of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 352,974<span></span>
</td>
<td class="nump">&#8364; 46,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_A130.0MillionCrossOverFinancingFebruary2023Member', window );">&#8364;130.0&#160;million cross-over financing, february 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAmount', window );">Financial agreement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Capital increase from issuance of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_A130.0MillionCrossOverFinancingFebruary2023Member', window );">&#8364;130.0&#160;million cross-over financing, february 2023 | Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member', window );">&#8364;49.2 million cross-over financing, september 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAmount', window );">Financial agreement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 49,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuancePercentageOfCurrentShareCapital', window );">Equity issuance, percentage of current share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementNumberOfTransactions', window );">Financial agreement, number of transactions | transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 46,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member', window );">&#8364;49.2 million cross-over financing, september 2022 | Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_A150.0MillionFinancingAugust2023Member', window );">&#8364;150.0&#160;million financing, august 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAmount', window );">Financial agreement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementNumberOfTransactions', window );">Financial agreement, number of transactions | transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AggregateExercisePriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Exercise Price, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AggregateExercisePriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuancePercentageOfCurrentShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Percentage Of Current Share Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuancePercentageOfCurrentShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuanceSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuanceSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementNumberOfTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Agreement, Number Of Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementNumberOfTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IssuanceOfOtherShareWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Other Share Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IssuanceOfOtherShareWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IssueOfEquityOfferingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue Of Equity, Offering Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IssueOfEquityOfferingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfOtherShareWarrantsRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Other Share Warrants Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfOtherShareWarrantsRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfShareBasedCompensationPlansIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Share-Based Compensation Plans Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfShareBasedCompensationPlansIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfSharesReceivedPerADS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Received Per ADS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfSharesReceivedPerADS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Borrowings, Net Of Refinancing Of Existing Indebteness</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuing Shares Other Than Through Exercise Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=abvx_AmericanDepositorySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=abvx_AmericanDepositorySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosCBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosCBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_A130.0MillionCrossOverFinancingFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_A130.0MillionCrossOverFinancingFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_A49.2MillionCrossOverFinancingSeptember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_A150.0MillionFinancingAugust2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_A150.0MillionFinancingAugust2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2024 (Details)<br> &#8364; / shares in Units, &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">27 Months Ended</th>
<th class="th" colspan="1">31 Months Ended</th>
<th class="th" colspan="1">73 Months Ended</th>
<th class="th" colspan="1">109 Months Ended</th>
<th class="th" colspan="1">121 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 19, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 11, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 04, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>shares </div>
<div>plan</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 19, 2024 </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 20, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>May 24, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Feb. 22, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 07, 2022 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfFreeSharesPlansIssued', window );">Number of free shares plans issued | plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Income from government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,140<span></span>
</td>
<td class="nump">&#8364; 81<span></span>
</td>
<td class="nump">&#8364; 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfADSPerOrdinaryShares', window );">Number of ADS per ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_SaleOfStockAxis=abvx_AtTheMarketATMProgramMember', window );">At-The-Market (ATM) Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedProceedsFromShareIssuance', window );">Expected proceeds from share issuance | $</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration', window );">Expected proceeds from share issuance, shelf registration | $</a></td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember', window );">RNP-VIR conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromConditionalAdvances', window );">Proceeds from conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,930<span></span>
</td>
<td class="nump">&#8364; 346<span></span>
</td>
<td class="nump">&#8364; 1,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities', window );">Proceeds from government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PercentageOfConditionalAdvancesWaived', window );">Percentage of conditional advances waived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Income from government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember', window );">CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromConditionalAdvances', window );">Proceeds from conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 29<span></span>
</td>
<td class="nump">&#8364; 1,008<span></span>
</td>
<td class="nump">&#8364; 1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PercentageOfConditionalAdvancesWaived', window );">Percentage of conditional advances waived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Income from government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember', window );">RNP-VIR conditional advance and CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Income from government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember', window );">Kreos &amp; Claret financing, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember', window );">Kreos &amp; Claret financing, tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBAndCMember', window );">Kreos &amp; Claret financing, tranche B and C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2024Member', window );">AGA-2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,946,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2024Member', window );">AGA-2024 | Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2024Member', window );">AGA-2024 | Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2024Member', window );">AGA-2024 | Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member', window );">AGA-2024-6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member', window );">BSA 2024-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpectedProceedsFromShareIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Proceeds From Share Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpectedProceedsFromShareIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpectedProceedsFromShareIssuanceShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Proceeds From Share Issuance, Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpectedProceedsFromShareIssuanceShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfADSPerOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ADS per Ordinary Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfADSPerOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfFreeSharesPlansIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Free Shares Plans Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfFreeSharesPlansIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PercentageOfConditionalAdvancesWaived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Conditional Advances Waived</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PercentageOfConditionalAdvancesWaived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_SaleOfStockAxis=abvx_AtTheMarketATMProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_SaleOfStockAxis=abvx_AtTheMarketATMProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBAndCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBAndCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - Subsequent events (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>shares </div>
<div>plan</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>plan</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfFreeSharesPlansIssued', window );">Number of free shares plans issued | plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfFreeSharesPlansIssued', window );">Number of free shares plans issued | plan</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | BSA-2025-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | BSA-2025-1 | Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | BSA-2025-1 | Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | BSA-2025-1 | Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | BSA-2025-1 | Tranche 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | AGA-2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">4,490,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | AGA-2025 | Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | AGA-2025 | Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | AGA-2025 | Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember', window );">Major share-based transactions | AGA-2025-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">123,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfFreeSharesPlansIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Free Shares Plans Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfFreeSharesPlansIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=abvx_MajorShareBasedTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20251Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20251Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20252Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20252Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting principles - Intangible assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>criteria</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias', window );">Research and development costs recognition, initial measurement, number of criterias</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life measured as period of time, intangible assets other than goodwill</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Costs Recognition, Initial Measurement, Number Of Criterias</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting principles - Disclosure of depreciation period of property, plant and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Office fixtures and fittings</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_IndustrialMaterialsAndEquipmentMember', window );">Industrial materials and equipment | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_IndustrialMaterialsAndEquipmentMember', window );">Industrial materials and equipment | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_TechnicalFacilitiesMember', window );">Technical facilities | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_TechnicalFacilitiesMember', window );">Technical facilities | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_FurnitureMember', window );">Furniture</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_IndustrialMaterialsAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_IndustrialMaterialsAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_TechnicalFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_TechnicalFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_FurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_FurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting principles - Accounting of Prosynergia acquisition (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 01, 2021</div></th>
<th class="th"><div>Dec. 12, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 49,797<span></span>
</td>
<td class="nump">&#8364; 114,004<span></span>
</td>
<td class="nump">&#8364; 77,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Prosynergia earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Gains on financial liabilities at fair value through profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutAtFairValueAssetsAcquisitions', window );">Earn-out measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutMarketCapitalizationThreshold', window );">Earn-out, market capitalization threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutPercentage', window );">Earn-out, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutMaximumAmount', window );">Earn-out, maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutAmountPayableIfConditionsAreNotMet', window );">Earn-out, amount payable if conditions are not met</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities', window );">Loan granted</a></td>
<td class="nump">&#8364; 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutAmountPayableIfConditionsAreNotMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Amount Payable If Conditions Are Not Met</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutAmountPayableIfConditionsAreNotMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutAtFairValueAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out At Fair Value, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutAtFairValueAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutMarketCapitalizationThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Market Capitalization, Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutMarketCapitalizationThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash advances and loans made to other parties (other than advances and loans made by a financial institution), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on financial liabilities at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting principles - Disclosure of allocation of acquisition cost (Details) - Prosynergia - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Nov. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashPrepaymentAssetsAcquisitions', window );">Cash prepayment made in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 325<span></span>
</td>
<td class="nump">&#8364; 325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LoanGrantedAssetsAcquisitions', window );">Loan granted to Prosynergia in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashTransferredAssetsAcquisitions', window );">Cash payment made in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AcquisitionRelatedCostsAssetsAcquisition', window );">Acquisition fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutAtFairValueAssetsAcquisitions', window );">Earn-out measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions', window );">Total acquisition cost allocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CashAndCashEquivalentsAssetsAcquisitions', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AssetsRecognisedAsOfAcquisitionDate', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LiabilitiesRecognisedAsOfAcquisitionDate', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PaymentsForAssetsAcquisitionsCosts', window );">Payments for assets acquisition costs</a></td>
<td class="nump">&#8364; 15<span></span>
</td>
<td class="nump">&#8364; 451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AcquisitionRelatedCostsAssetsAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-Related Costs, Assets Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AcquisitionRelatedCostsAssetsAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets Recognised As Of Acquisition Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashAndCashEquivalentsAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashAndCashEquivalentsAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashPrepaymentAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Prepayment, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashPrepaymentAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CashTransferredAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Transferred, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CashTransferredAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consideration Transferred, Acquisition-Date Fair Value, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutAtFairValueAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out At Fair Value, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutAtFairValueAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identifiable Assets Acquired (Liabilities Assumed), Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities Recognised As Of Acquisition Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LoanGrantedAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loan Granted, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LoanGrantedAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PaymentsForAssetsAcquisitionsCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Assets Acquisitions Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PaymentsForAssetsAcquisitionsCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Technology-Based Intangible Assets, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Details) - segment<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOperatingSegment', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">United States | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ContributionToGroupsAssetsPercentage', window );">Contribution to Group's assets, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ContributionToGroupsLiabilitiesPercentage', window );">Contribution to Group's liabilities, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ContributionToGroupsNetProfitsLossesPercentage', window );">Contribution to Group's net profits (losses), percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ContributionToGroupsAssetsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contribution To Group's Assets, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ContributionToGroupsAssetsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ContributionToGroupsLiabilitiesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contribution To Group's Liabilities, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ContributionToGroupsLiabilitiesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ContributionToGroupsNetProfitsLossesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contribution To Group's Net Profits (Losses), Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ContributionToGroupsNetProfitsLossesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfOperatingSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Operating Segment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfOperatingSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and impairment test (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems', window );"><strong>Disclosure of information for cash-generating units [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">&#8364; 18,419<span></span>
</td>
<td class="nump">&#8364; 18,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 18,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate (WACC)</a></td>
<td class="nump">11.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment loss recognised in profit or loss, intangible assets and goodwill</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,632<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_SplicosSASABX464Member', window );">Splicos SAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems', window );"><strong>Disclosure of information for cash-generating units [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">18,419<span></span>
</td>
<td class="nump">18,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member', window );">Wittycel SAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems', window );"><strong>Disclosure of information for cash-generating units [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment loss recognised in profit or loss, intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,632<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill', window );">Impairment loss recognised in profit or loss, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B67_d_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_SplicosSASABX464Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_SplicosSASABX464Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember', window );">Exclusive licensing contract with the Scripps Research Institute, University of Chicago and Brigham Young University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval', window );">Collaboration agreements, development milestone payment, IND approval</a></td>
<td class="nump">&#8364; 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember', window );">Exclusive licensing agreement with CNRS, University of Montpellier and Institut Curie</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2', window );">Collaboration agreements, development milestone payment, Phase 2</a></td>
<td class="nump">&#8364; 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member', window );">Wittycel SAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Intangible assets with indefinite useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreements, Development Milestone Payment, IND Approval</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreements, Development Milestone Payment, Phase 2</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Technology-Based Intangible Assets, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 122<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_122_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=abvx_WittycelSASABX196Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets - Disclosure of reconciliation of intangible assets (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">&#8364; 6,604<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 6,607<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">6,606<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,604<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">6,607<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">LICENCES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">SOFTWARES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">PATENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">6,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisition</a></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,564<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">6,677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES | LICENCES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES | SOFTWARES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisition</a></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">27<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES | PATENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">AMORTIZATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="num">(69)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseIntangibleAssetsOtherThanGoodwill', window );">Increase</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="num">(70)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(69)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">AMORTIZATION | LICENCES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseIntangibleAssetsOtherThanGoodwill', window );">Increase</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">AMORTIZATION | SOFTWARES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseIntangibleAssetsOtherThanGoodwill', window );">Increase</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="num">(25)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">AMORTIZATION | PATENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Reconciliation of changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseIntangibleAssetsOtherThanGoodwill', window );">Increase</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill at end of period</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase, Intangible Assets Other Than Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Disclosure of reconciliation of property, plant and equipment (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">&#8364; 878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 1,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">2,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_RightofuseAssetsMember', window );">ROU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">501<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,270<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">212<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">1,929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">501<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,270<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">BUILDINGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">501<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">148<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">2,205<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">501<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">59<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">94<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">59<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_FurnitureAndComputerEquipmentMember', window );">FURNITURE AND COMPUTER EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Acquisition</a></td>
<td class="nump">2,870<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">614<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,768<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="num">(1,229)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(649)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(597)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">4,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES | ROU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">1,262<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,561<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">682<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Acquisition</a></td>
<td class="nump">2,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,472<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="num">(975)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(649)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(593)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">2,504<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,262<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,561<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES | BUILDINGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">1,346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,618<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">593<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Acquisition</a></td>
<td class="nump">2,578<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,618<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="num">(1,110)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(622)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(593)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,618<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES | EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">436<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">402<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">103<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">436<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">GROSS VALUES | FURNITURE AND COMPUTER EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="nump">507<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Acquisition</a></td>
<td class="nump">292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">161<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="num">(119)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="nump">698<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">507<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">DEPRECIATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="num">(1,488)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(808)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(925)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets', window );">Increase</a></td>
<td class="num">(1,089)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(707)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(481)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">597<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="num">(1,363)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,488)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(808)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">DEPRECIATION | ROU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="num">(761)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(290)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(470)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets', window );">Increase</a></td>
<td class="num">(788)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(498)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(414)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="nump">975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">593<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="num">(575)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(761)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(290)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">DEPRECIATION | BUILDINGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="num">(837)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(259)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(445)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets', window );">Increase</a></td>
<td class="num">(886)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(578)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(407)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="nump">1,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">593<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="num">(613)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(837)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(259)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">DEPRECIATION | EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="num">(387)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(378)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(346)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets', window );">Increase</a></td>
<td class="num">(32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(36)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(35)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="num">(419)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(387)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(378)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">DEPRECIATION | FURNITURE AND COMPUTER EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Reconciliation of changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at beginning of period</a></td>
<td class="num">(265)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(171)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets', window );">Increase</a></td>
<td class="num">(171)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(94)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Disposal</a></td>
<td class="nump">104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Effect of the change in foreign currency exchange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Property, plant and equipment including right-of-use assets at end of period</a></td>
<td class="num">&#8364; (332)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (265)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (171)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase, Property Plant AndEquipment including right-of-use assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment including right-of-use assets other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment including right-of-use assets resulting from disposals. [Refer: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment including right-of-use assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment including right-of-use assets whose underlying assets would be presented as property, plant and equipment if they were owned. [Refer: Property, plant and equipment; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_FurnitureAndComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=abvx_FurnitureAndComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Narrative (Details) - Buildings - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">&#8364; 453<span></span>
</td>
<td class="nump">&#8364; 1,846<span></span>
</td>
<td class="nump">&#8364; 1,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesParisMember', window );">Lease facilities, Paris</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets', window );">Decrease through reassessment of lease term</a></td>
<td class="nump">&#8364; 622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease Through Reassessment Of Lease Term, Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesParisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesParisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other financial assets - Disclosure of other financial assets (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Disclosure of financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentAdvancesToCROContracts', window );">Advances related to CRO contracts</a></td>
<td class="nump">&#8364; 4,929<span></span>
</td>
<td class="nump">&#8364; 12,172<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 10,471<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermDeposits', window );">Deposits</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,238<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherNonCurrentMiscellaneousFinancialAssets', window );">Other</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Total other non-current financial assets</a></td>
<td class="nump">5,919<span></span>
</td>
<td class="nump">12,870<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">11,708<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentAdvancesToCROContracts', window );">Advances related to CRO contracts</a></td>
<td class="nump">7,418<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherCurrentInvestments', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Deposits</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Total other current financial assets</a></td>
<td class="nump">7,554<span></span>
</td>
<td class="nump">9,186<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinancialAssets', window );">Other financial assets</a></td>
<td class="nump">&#8364; 13,473<span></span>
</td>
<td class="nump">&#8364; 22,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 11,708<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentAdvancesToCROContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Advances To CRO Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentAdvancesToCROContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentAdvancesToCROContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Advances To CRO Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentAdvancesToCROContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherCurrentInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherCurrentInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherNonCurrentMiscellaneousFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Non-Current Miscellaneous Financial Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherNonCurrentMiscellaneousFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of long-term deposits held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other financial assets - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 11, 2022</div></th>
<th class="th"><div>Feb. 23, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DiscountRateAppliedToLongTermAdvances', window );">Disount rate applied to long-term advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.83%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations', window );">Cash advances and loans made to CRO</a></td>
<td class="nump">&#8364; 12,187<span></span>
</td>
<td class="nump">&#8364; 5,538<span></span>
</td>
<td class="nump">&#8364; 1,620<span></span>
</td>
<td class="nump">&#8364; 231<span></span>
</td>
<td class="nump">&#8364; 1,620<span></span>
</td>
<td class="nump">&#8364; 12,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DiscountRateAppliedToLongTermAdvances', window );">Disount rate applied to long-term advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.09%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DiscountRateAppliedToLongTermAdvances', window );">Disount rate applied to long-term advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.59%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DiscountRateAppliedToLongTermAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount Rate Applied To Long-Term Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DiscountRateAppliedToLongTermAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PaymentsForAdvancesMadeToContractResearchOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Advances Made to Contract Research Organizations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PaymentsForAdvancesMadeToContractResearchOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other receivables and other assets - Disclosure of other receivables and other assets (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentPrepaidExpenses', window );">Prepaid expenses - non current</a></td>
<td class="nump">&#8364; 948<span></span>
</td>
<td class="nump">&#8364; 2,320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Total non-current other assets</a></td>
<td class="nump">948<span></span>
</td>
<td class="nump">2,320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentResearchTaxCreditReceivables', window );">Research tax credit ("CIR")</a></td>
<td class="nump">5,774<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,595<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">VAT receivables</a></td>
<td class="nump">9,841<span></span>
</td>
<td class="nump">14,439<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,467<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">3,233<span></span>
</td>
<td class="nump">5,746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">915<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentReceivablesFromCreditNotes', window );">Credit notes</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentReceivablesAndCurrentPrepaidExpenses', window );">Total current other receivables and assets</a></td>
<td class="nump">18,896<span></span>
</td>
<td class="nump">24,845<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAssets', window );">Other receivables and other assets</a></td>
<td class="nump">&#8364; 19,843<span></span>
</td>
<td class="nump">&#8364; 27,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 10,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentReceivablesAndCurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CurrentReceivablesAndCurrentPrepaidExpenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentReceivablesAndCurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentReceivablesFromCreditNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Receivables From Credit Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentReceivablesFromCreditNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentResearchTaxCreditReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Research Tax Credit Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentResearchTaxCreditReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Prepaid Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other receivables and other assets - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">121 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems', window );"><strong>Disclosure Of Other Receivables And Other Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromResearchTaxCredit', window );">Proceeds from research tax credit</a></td>
<td class="nump">&#8364; 4,493<span></span>
</td>
<td class="nump">&#8364; 4,476<span></span>
</td>
<td class="nump">&#8364; 35,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentResearchTaxCreditReceivables', window );">Research tax credit ("CIR")</a></td>
<td class="nump">5,774<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">&#8364; 4,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPrepaidExpensesRelatedToCRO', window );">Current prepaid expenses related to CRO</a></td>
<td class="nump">1,577<span></span>
</td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">&#8364; 1,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAdvancesToSuppliers', window );">Current advances to suppliers</a></td>
<td class="nump">2,604<span></span>
</td>
<td class="nump">3,567<span></span>
</td>
<td class="nump">3,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember', window );">Kreos &amp; Claret financing, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems', window );"><strong>Disclosure Of Other Receivables And Other Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent', window );">Reclassification of prepaid expenses to carrying value of debt component</a></td>
<td class="nump">&#8364; 1,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=abvx_DeferredFinancingCostsNettingMember', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems', window );"><strong>Disclosure Of Other Receivables And Other Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,152<span></span>
</td>
<td class="nump">&#8364; 3,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentPrepaidExpensesRelatedToCRO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Prepaid Expenses Related To CRO</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentPrepaidExpensesRelatedToCRO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentResearchTaxCreditReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Research Tax Credit Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentResearchTaxCreditReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Other Receivables And Other Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromResearchTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Research Tax Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromResearchTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Prepaid Expenses to Carrying Value of Debt Component</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAdvancesToSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current advances made to suppliers before goods or services are received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAdvancesToSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=abvx_DeferredFinancingCostsNettingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=abvx_DeferredFinancingCostsNettingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents - Disclosure of composition of cash and cash equivalents (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">&#8364; 87,265<span></span>
</td>
<td class="nump">&#8364; 18,105<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">56,956<span></span>
</td>
<td class="nump">233,837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,944<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">&#8364; 144,221<span></span>
</td>
<td class="nump">&#8364; 251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 26,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 60,701<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCashAndCashEquivalentsLineItems', window );"><strong>Disclosure Of Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCashAndCashEquivalents', window );">Notice accounts</a></td>
<td class="nump">&#8364; 44,239<span></span>
</td>
<td class="nump">&#8364; 231,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Foreign exchange gain (loss) on translation of cash and cash equivalents</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="num">(5,072)<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCashAndCashEquivalentsLineItems', window );"><strong>Disclosure Of Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Foreign exchange gain (loss) on translation of cash and cash equivalents</a></td>
<td class="nump">&#8364; 2,035<span></span>
</td>
<td class="num">&#8364; (3,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfCashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Cash And Cash Equivalents [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfCashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and liabilities (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 22, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Financial assets</a></td>
<td class="nump">&#8364; 205,228<span></span>
</td>
<td class="nump">&#8364; 327,062<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 75,544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">176,754<span></span>
</td>
<td class="nump">301,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">&#8364; 162,256<span></span>
</td>
<td class="nump">125,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 58,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_DiscountedCashFlowMember', window );">Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember', window );">Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Percentage of reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_NonCurrentFinancialLiabilitiesMember', window );">Financial liabilities-non current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">&#8364; 73,497<span></span>
</td>
<td class="nump">40,622<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 9,439<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_CurrentFinancialLiabilitiesMember', window );">Financial liabilities-current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">44,935<span></span>
</td>
<td class="nump">37,348<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,555<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_TradePayablesAndOtherCurrentLiabilitiesMember', window );">Trade payables and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">43,824<span></span>
</td>
<td class="nump">47,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember', window );">LIABILITIES AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">24,803<span></span>
</td>
<td class="nump">30,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember', window );">LIABILITIES AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS | Financial liabilities-non current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">18,506<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember', window );">LIABILITIES AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS | Financial liabilities-current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">21,183<span></span>
</td>
<td class="nump">11,531<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember', window );">LIABILITIES AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS | Trade payables and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">LIABILITIES AT&#160;AMORTIZED COST</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">137,453<span></span>
</td>
<td class="nump">95,154<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,903<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">LIABILITIES AT&#160;AMORTIZED COST | Financial liabilities-non current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">69,877<span></span>
</td>
<td class="nump">42,768<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,873<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">LIABILITIES AT&#160;AMORTIZED COST | Financial liabilities-current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">23,752<span></span>
</td>
<td class="nump">5,165<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,555<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">LIABILITIES AT&#160;AMORTIZED COST | Trade payables and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">43,824<span></span>
</td>
<td class="nump">47,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember', window );">ASSETS AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember', window );">ASSETS AT AMORTIZED COST</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">176,754<span></span>
</td>
<td class="nump">301,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Financial assets</a></td>
<td class="nump">177,537<span></span>
</td>
<td class="nump">301,161<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,889<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Financial liabilities</a></td>
<td class="nump">157,828<span></span>
</td>
<td class="nump">124,266<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Financial liabilities-non current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Financial liabilities</a></td>
<td class="nump">&#8364; 69,069<span></span>
</td>
<td class="nump">39,697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Kreos 1 &amp; 2 bond loans | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Oceane | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 476<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Kreos / Claret convertible notes (OCABSA) | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Kreos &amp; Claret Financing, Tranche A,B and C | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.0750<span></span>
</td>
<td class="nump">0.0900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="nump">&#8364; 958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Conditional advances and PGE loan | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.0730<span></span>
</td>
<td class="nump">0.0900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | PGE | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="nump">&#8364; 21<span></span>
</td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | RNP-VIR conditional advance | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | CARENA conditional advance | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Ebola conditional advance | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Financial liabilities-current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Financial liabilities</a></td>
<td class="nump">44,935<span></span>
</td>
<td class="nump">37,348<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,555<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Recurring fair value measurement | Trade payables and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Financial liabilities</a></td>
<td class="nump">43,824<span></span>
</td>
<td class="nump">47,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherFinancialAssetsMember', window );">Other financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">12,690<span></span>
</td>
<td class="nump">22,394<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherFinancialAssetsMember', window );">Other financial assets | ASSETS AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherFinancialAssetsMember', window );">Other financial assets | ASSETS AT AMORTIZED COST</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">12,690<span></span>
</td>
<td class="nump">22,394<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherFinancialAssetsMember', window );">Other financial assets | Recurring fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Financial assets</a></td>
<td class="nump">13,473<span></span>
</td>
<td class="nump">22,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,708<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherReceivablesAndAssetsMember', window );">Other receivables and assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">19,843<span></span>
</td>
<td class="nump">27,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherReceivablesAndAssetsMember', window );">Other receivables and assets | ASSETS AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherReceivablesAndAssetsMember', window );">Other receivables and assets | ASSETS AT AMORTIZED COST</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">19,843<span></span>
</td>
<td class="nump">27,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherReceivablesAndAssetsMember', window );">Other receivables and assets | Recurring fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Financial assets</a></td>
<td class="nump">19,843<span></span>
</td>
<td class="nump">27,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_CashAndCashEquivalentMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">144,221<span></span>
</td>
<td class="nump">251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_CashAndCashEquivalentMember', window );">Cash and cash equivalents | ASSETS AT FAIR VALUE THROUGH PROFIT&#160;AND LOSS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_CashAndCashEquivalentMember', window );">Cash and cash equivalents | ASSETS AT AMORTIZED COST</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">144,221<span></span>
</td>
<td class="nump">251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_CashAndCashEquivalentMember', window );">Cash and cash equivalents | Recurring fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Financial assets</a></td>
<td class="nump">144,221<span></span>
</td>
<td class="nump">251,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_NonCurrentAdvancesToCROContractsMember', window );">Long-term advances made to CROs | Recurring fair value measurement | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Decrease in financial assets at fair value</a></td>
<td class="nump">&#8364; 235<span></span>
</td>
<td class="nump">&#8364; 23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_NonCurrentAdvancesToCROContractsMember', window );">Long-term advances made to CROs | Recurring fair value measurement | Bottom of range | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputAssets', window );">Significant unobservable input, assets</a></td>
<td class="nump">0.0131<span></span>
</td>
<td class="nump">0.0104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0016<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=abvx_NonCurrentAdvancesToCROContractsMember', window );">Long-term advances made to CROs | Recurring fair value measurement | Top of range | Credit spread | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputAssets', window );">Significant unobservable input, assets</a></td>
<td class="nump">0.0271<span></span>
</td>
<td class="nump">0.0218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0476<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Fair Value Measurement Of Assets And Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_DiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_DiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_NonCurrentFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_NonCurrentFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_CurrentFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_CurrentFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_TradePayablesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_TradePayablesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_Kreos12BondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_Kreos12BondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretFinancingTrancheABAndCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretFinancingTrancheABAndCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_ConditionalAdvancesAndPGELoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_ConditionalAdvancesAndPGELoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=abvx_OtherFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=abvx_OtherReceivablesAndAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=abvx_OtherReceivablesAndAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=abvx_CashAndCashEquivalentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=abvx_CashAndCashEquivalentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=abvx_NonCurrentAdvancesToCROContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=abvx_NonCurrentAdvancesToCROContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; equity - Share capital issued (Details) - EUR (&#8364;)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 19, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 24, 2023</div></th>
<th class="th"><div>May 24, 2023</div></th>
<th class="th"><div>Feb. 22, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 07, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">&#8364; 633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 629<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued (in shares)</a></td>
<td class="nump">63,347,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,928,818<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,313,185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,764,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share)</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfTreasurySharesHeld', window );">Number of treasury shares held (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding (in shares)</a></td>
<td class="nump">63,347,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,917,479<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,301,185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfTreasurySharesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Treasury Shares Held</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfTreasurySharesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; equity - Equity line instruments (Details) - BSAs<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>shares</div>
</th>
<th class="th"><div>Sep. 24, 2021</div></th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>criteria </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_EquityLineAgreementWithKeplerCheuvreuxMember', window );">Equity line agreement with Kepler Cheuvreux</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued', window );">Maximum number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">730,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderwritingAgreementMaximumPeriod', window );">Maximum period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays', window );">Number of trading days | criteria</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount', window );">Maximum discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderwritingAgreementExtendedPeriod', window );">Extended period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnderwritingAgreementExtendedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting Agreement, Extended Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnderwritingAgreementExtendedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnderwritingAgreementIssuancePriceMaximumDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting Agreement, Issuance Price, Maximum Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnderwritingAgreementIssuancePriceMaximumDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting Agreement, Issuance Price, Number Of Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnderwritingAgreementMaximumNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting Agreement, Maximum Number Of Shares Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnderwritingAgreementMaximumNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnderwritingAgreementMaximumPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting Agreement, Maximum Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnderwritingAgreementMaximumPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_EquityLineAgreementWithKeplerCheuvreuxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_EquityLineAgreementWithKeplerCheuvreuxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; equity - Disclosure of reconciliation of BSAs, equity line agreement (Details) - BSAs<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,072)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_EquityLineAgreementWithKeplerCheuvreuxMember', window );">Equity line agreement with Kepler Cheuvreux</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Number Of Other Equity Instruments To Be Issued In Share-Based Payment Arrangement If All Conditions Are Met</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_EquityLineAgreementWithKeplerCheuvreuxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_EquityLineAgreementWithKeplerCheuvreuxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; equity - Change in share capital (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">130 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 22, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 07, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 19, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of equity | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 130,000<span></span>
</td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 353,377<span></span>
</td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares)</a></td>
<td class="nump">20,325,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,325,500<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.50<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsExercised', window );">Number of warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464,309<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 28,111<span></span>
</td>
<td class="nump">&#8364; 3,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ShareIssueRelatedCostCredit', window );">Transaction costs related to capital increase | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 446<span></span>
</td>
<td class="num">(28,111)<span></span>
</td>
<td class="num">&#8364; (3,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfFreeSharesIssued', window );">Issue of free shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=abvx_AmericanDepositorySharesMember', window );">ADS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares)</a></td>
<td class="nump">18,699,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssueOfEquityOfferingPricePerShare', window );">Issue of equity, offering price per share (in dollar/euro per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares)</a></td>
<td class="nump">1,626,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssueOfEquityOfferingPricePerShare', window );">Issue of equity, offering price per share (in dollar/euro per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 10.9864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_Kreos1Member', window );">Kreos share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 18.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialAgreementAxis=abvx_OtherEquityAgreementsMember', window );">Other equity agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsExercised', window );">Number of warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">1,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">190,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 11.14<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 11.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_KreosABSAMember', window );">Kreos A BSA | Kreos share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsExercised', window );">Number of warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA | Kreos share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsExercised', window );">Number of warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember', window );">BSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241AndBSA20242Member', window );">BSA-2024-1 and BSA-2024-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ShareWarrantsSubscriptionPricePerShare', window );">Share warrants, subscription price (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuanceSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuanceSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IssueOfEquityOfferingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue Of Equity, Offering Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IssueOfEquityOfferingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfFreeSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Free Shares Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfFreeSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherShareWarrantsSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Share Warrants, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherShareWarrantsSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ShareIssueRelatedCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Issue Related Cost (Credit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ShareIssueRelatedCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ShareWarrantsSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Warrants, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ShareWarrantsSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=abvx_AmericanDepositorySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=abvx_AmericanDepositorySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_Kreos1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_Kreos1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialAgreementAxis=abvx_OtherEquityAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialAgreementAxis=abvx_OtherEquityAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_KreosABSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_KreosABSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_KreosBBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_KreosBBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241AndBSA20242Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241AndBSA20242Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Disclosure of reconciliation of BCEs (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">130 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 14, 2018</div></th>
<th class="th"><div>Mar. 15, 2018</div></th>
<th class="th"><div>Nov. 20, 2017</div></th>
<th class="th"><div>Jan. 23, 2017</div></th>
<th class="th"><div>Nov. 07, 2016</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember', window );">Total BCEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">530,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,179<span></span>
</td>
<td class="nump">330,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,962<span></span>
</td>
<td class="nump">245,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,179<span></span>
</td>
<td class="nump">330,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20161Member', window );">BCE-2016-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,796<span></span>
</td>
<td class="nump">18,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,796<span></span>
</td>
<td class="nump">18,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,796<span></span>
</td>
<td class="nump">18,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20171Member', window );">BCE-2017-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,735<span></span>
</td>
<td class="nump">41,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20172Member', window );">BCE-2017-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20174Member', window );">BCE-2017-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,373<span></span>
</td>
<td class="nump">67,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,686<span></span>
</td>
<td class="nump">33,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,373<span></span>
</td>
<td class="nump">67,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20175Member', window );">BCE-2017-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,687)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,687<span></span>
</td>
<td class="nump">33,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,687<span></span>
</td>
<td class="nump">33,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20181Member', window );">BCE-2018-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20183Member', window );">BCE 2018-3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">33,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20184Member', window );">BCE-2018-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">16,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,422<span></span>
</td>
<td class="nump">8,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20185Member', window );">BCE-2018-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Number Of Other Equity Instruments To Be Issued In Share-Based Payment Arrangement If All Conditions Are Met</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20161Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20161Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20171Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20171Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20172Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20172Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20174Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20174Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20175Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20175Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20181Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20181Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20183Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20183Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20184Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20184Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20185Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCE20185Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Narrative (Details)<br> &#8364; / shares in Units, &#8364; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">130 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 05, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 11, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 23, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 02, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 01, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 28, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 11, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 01, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Sep. 05, 2024</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember', window );">BCEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold', window );">Change of control, minimum percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Compensation expenses | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 112<span></span>
</td>
<td class="nump">&#8364; 112<span></span>
</td>
<td class="nump">&#8364; 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCEExceptBCE20142Member', window );">BCE except BCE 2014-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing', window );">Performance conditions, minimum financing | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember', window );">BSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold', window );">Change of control, minimum percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Compensation expenses | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 211<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241AndBSA20242Member', window );">BSA-2024-1 and BSA-2024-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member', window );">AGA 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod', window );">Vesting service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare', window );">M&amp;A transaction, minimum price per share | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Compensation expenses | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes', window );">Social taxes related to AGAs | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member', window );">AGA 2021 | Vesting conditions completed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member', window );">AGA 2021 | Vesting conditions not completed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member', window );">AGA-2023-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,382,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member', window );">AGA-2023-1 | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,382,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member', window );">AGA-2023-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member', window );">AGA-2023-2 | Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AndAGA20234Member', window );">AGA-2023-3 and AGA-2023-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">985,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member', window );">AGA-2023-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AGA20234AndAGA20235Member', window );">AGA-2023-3 , AGA-2023-4 and AGA-2023-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing', window );">Performance conditions, minimum financing | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,118,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition', window );">Number of instruments issued subject to non-market performance condition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member', window );">AGA-2024-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,549,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,549,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member', window );">AGA-2024-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member', window );">AGA-2024-3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244AGA20245AndAGA20246Member', window );">AGA-2024-4, AGA-2024-5 and AGA-2024-6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member', window );">AGA-2024-7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member', window );">AGA-2024-6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member', window );">AGA-2024-6 | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheOneMember', window );">Tranche 1 | BCEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheOneMember', window );">Tranche 1 | BSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheOneMember', window );">Tranche 1 | AGA-2023-1 | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheOneMember', window );">Tranche 1 | AGA-2023-2 | Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheOneMember', window );">Tranche 1 | AGA-2023-3 , AGA-2023-4 and AGA-2023-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheOneMember', window );">Tranche 1 | AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheOneMember', window );">Tranche 1 | AGA-2024-6 | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | BCEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth', window );">Vesting percentage per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0833%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | BSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth', window );">Vesting percentage per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0833%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | AGA-2023-1 | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | AGA-2023-2 | Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | AGA-2023-2 | Former Chief Executive Officer | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | AGA-2023-3 , AGA-2023-4 and AGA-2023-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheTwoMember', window );">Tranche 2 | AGA-2024-6 | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheThreeMember', window );">Tranche 3 | AGA-2023-1 | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheThreeMember', window );">Tranche 3 | AGA-2023-1 | Chief Executive Officer | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheThreeMember', window );">Tranche 3 | AGA-2023-3 , AGA-2023-4 and AGA-2023-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheThreeMember', window );">Tranche 3 | AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheFourMember', window );">Tranche 4 | AGA-2023-1 | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing', window );">Performance conditions, minimum financing | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheFourMember', window );">Tranche 4 | AGA-2023-1 | Chief Executive Officer | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheFiveMember', window );">Tranche 5 | AGA-2023-1 | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheFiveMember', window );">Tranche 5 | AGA-2023-1 | Chief Executive Officer | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TranchesAxis=abvx_TrancheSixMember', window );">Tranche 6 | AGA-2023-1 | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense From Equity-Settled Share-Based Payment Transactions, Social Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Other Equity Instruments Granted Subject To Non-Market Performance Condition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Change Of Control, Minimum Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Performance Conditions, Minimum Financing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Service Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage Per Month</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, M&amp;A Transaction, Minimum Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCEExceptBCE20142Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCEExceptBCE20142Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241AndBSA20242Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241AndBSA20242Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingServiceConditionsAxis=abvx_VestingConditionsCompletedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingServiceConditionsAxis=abvx_VestingConditionsCompletedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_VestingServiceConditionsAxis=abvx_VestingConditionsNotCompletedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_VestingServiceConditionsAxis=abvx_VestingConditionsNotCompletedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=abvx_FormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=abvx_FormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AndAGA20234Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AndAGA20234Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AGA20234AndAGA20235Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AGA20234AndAGA20235Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244AGA20245AndAGA20246Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244AGA20245AndAGA20246Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=abvx_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=abvx_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Disclosure of reconciliation of BSAs (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">130 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 04, 2024</div></th>
<th class="th"><div>Jan. 22, 2018</div></th>
<th class="th"><div>Sep. 18, 2017</div></th>
<th class="th"><div>Dec. 04, 2015</div></th>
<th class="th"><div>Mar. 11, 2014</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember', window );">Total BSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">324,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,072)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,944<span></span>
</td>
<td class="nump">223,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,124<span></span>
</td>
<td class="nump">146,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,944<span></span>
</td>
<td class="nump">223,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA201511Member', window );">BSA-2015-11</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
<td class="nump">96,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA201512Member', window );">BSA-2015-12</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20171Member', window );">BSA-2017-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20181Member', window );">BSA-2018-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20144Member', window );">BSA-2014-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20145Member', window );">BSA-2014-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member', window );">BSA 2024-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">58,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,820<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,365<span></span>
</td>
<td class="nump">58,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,365<span></span>
</td>
<td class="nump">58,365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member', window );">BSA 2024-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">19,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,455<span></span>
</td>
<td class="nump">19,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Number of instruments exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet', window );">Maximum number of shares to be issued if all conditions are met (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,455<span></span>
</td>
<td class="nump">19,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Number Of Other Equity Instruments To Be Issued In Share-Based Payment Arrangement If All Conditions Are Met</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA201511Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA201511Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA201512Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA201512Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20171Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20171Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20181Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20181Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20144Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20144Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20145Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20145Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Disclosure of assumptions used for the measurement of BSAs (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 04, 2024 </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member', window );">BSA 2024-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="nump">&#8364; 14.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">NUMBE OF BSAs ( in shares) | shares</a></td>
<td class="nump">58,365<span></span>
</td>
<td class="nump">77,820<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">BSA SUBSCRIPTION PRICE (in euro per share)</a></td>
<td class="nump">&#8364; 2.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted', window );">STRIKE PRICE PER SHARE ( in euro per share)</a></td>
<td class="nump">&#8364; 13.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">RISK&#160;FREE&#160;RATE</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">VOLATILITY</a></td>
<td class="nump">60.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member', window );">BSA 2024-1 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE BSA (in euro per share)</a></td>
<td class="nump">&#8364; 5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedMaturityOtherEquityInstrumentsGranted', window );">EXPECTED MATURITY</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member', window );">BSA 2024-1 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE BSA (in euro per share)</a></td>
<td class="nump">&#8364; 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedMaturityOtherEquityInstrumentsGranted', window );">EXPECTED MATURITY</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member', window );">BSA 2024-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="nump">&#8364; 14.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">NUMBE OF BSAs ( in shares) | shares</a></td>
<td class="nump">19,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">BSA SUBSCRIPTION PRICE (in euro per share)</a></td>
<td class="nump">&#8364; 2.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted', window );">STRIKE PRICE PER SHARE ( in euro per share)</a></td>
<td class="nump">&#8364; 13.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">RISK&#160;FREE&#160;RATE</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">VOLATILITY</a></td>
<td class="nump">60.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member', window );">BSA 2024-2 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE BSA (in euro per share)</a></td>
<td class="nump">&#8364; 5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedMaturityOtherEquityInstrumentsGranted', window );">EXPECTED MATURITY</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member', window );">BSA 2024-2 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE BSA (in euro per share)</a></td>
<td class="nump">&#8364; 6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedMaturityOtherEquityInstrumentsGranted', window );">EXPECTED MATURITY</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Instrument Fair Value, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Instrument Price, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Instrument Strike Price, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpectedMaturityOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Maturity, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpectedMaturityOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Volatility, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpectedVolatilityOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk Free Interest Rate, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underlying Share Fair Value, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20242Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Disclosure of reconciliation of AGAs (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 05, 2024</div></th>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>May 23, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Jan. 02, 2024</div></th>
<th class="th"><div>Dec. 01, 2023</div></th>
<th class="th"><div>Sep. 28, 2023</div></th>
<th class="th"><div>Jul. 11, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember', window );">Free Shares (AGA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,601,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,601,296<span></span>
</td>
<td class="nump">1,946,125<span></span>
</td>
<td class="nump">4,547,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(744,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(415,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,601,296<span></span>
</td>
<td class="nump">3,388,040<span></span>
</td>
<td class="nump">3,388,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member', window );">AGA-2023-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,382,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,382,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(212,737)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(390,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,382,796<span></span>
</td>
<td class="nump">780,040<span></span>
</td>
<td class="nump">780,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member', window );">AGA-2023-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233Member', window );">AGA-2023-3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(245,625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,500<span></span>
</td>
<td class="nump">485,875<span></span>
</td>
<td class="nump">485,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20234Member', window );">AGA-2023-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,250<span></span>
</td>
<td class="nump">213,250<span></span>
</td>
<td class="nump">213,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member', window );">AGA-2023-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,750<span></span>
</td>
<td class="nump">81,250<span></span>
</td>
<td class="nump">81,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member', window );">AGA-2024-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,549,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,549,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Number of instruments lapsed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(193,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,355,625<span></span>
</td>
<td class="nump">1,355,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member', window );">AGA-2024-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member', window );">AGA-2024-3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,500<span></span>
</td>
<td class="nump">38,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244Member', window );">AGA-2024-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000<span></span>
</td>
<td class="nump">93,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20245Member', window );">AGA-2024-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member', window );">AGA-2024-6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member', window );">AGA-2024-7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of instruments issued (in shares)</a></td>
<td class="nump">198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of instruments outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,000<span></span>
</td>
<td class="nump">198,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20234Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20234Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20245Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20245Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based payments - Disclosure of assumptions used for the measurement of AGAs (Details) - &#8364; / shares<br></strong></div></th>
<th class="th"><div>Sep. 05, 2024</div></th>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>May 23, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Jan. 02, 2024</div></th>
<th class="th"><div>Dec. 01, 2023</div></th>
<th class="th"><div>Sep. 28, 2023</div></th>
<th class="th"><div>Jul. 11, 2023</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member', window );">AGA 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 31.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">VOLATILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">RISK&#160;FREE&#160;RATE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member', window );">AGA-2023-1 | Tranches 1-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member', window );">AGA-2023-1 | Tranche 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">VOLATILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">RISK&#160;FREE&#160;RATE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member', window );">AGA-2023-1 | Tranche 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">VOLATILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">RISK&#160;FREE&#160;RATE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member', window );">AGA-2023-2 | Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member', window );">AGA-2023-2 | Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233Member', window );">AGA-2023-3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20234Member', window );">AGA-2023-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member', window );">AGA-2023-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 9.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member', window );">AGA-2024-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member', window );">AGA-2024-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 13.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member', window );">AGA-2024-3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244Member', window );">AGA-2024-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20245Member', window );">AGA-2024-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member', window );">AGA-2024-6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member', window );">AGA-2024-7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)</a></td>
<td class="nump">&#8364; 10.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted', window );">FAIR VALUE OF THE AGA (in euro per share)</a></td>
<td class="nump">10.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted', window );">AGA PRICE (in euro per share)</a></td>
<td class="nump">&#8364; 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Instrument Fair Value, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Instrument Price, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpectedVolatilityOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Volatility, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpectedVolatilityOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk Free Interest Rate, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underlying Share Fair Value, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TranchesOneToFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TranchesOneToFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20234Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20234Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20245Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20245Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Disclosure of breakdown of the compensation expenses (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Total</a></td>
<td class="num">&#8364; (20,941)<span></span>
</td>
<td class="num">&#8364; (8,605)<span></span>
</td>
<td class="num">&#8364; (1,369)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember', window );">BCEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation expense</a></td>
<td class="num">(112)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember', window );">BSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation expense</a></td>
<td class="num">(211)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember', window );">AGAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation expense</a></td>
<td class="num">(19,900)<span></span>
</td>
<td class="num">(8,067)<span></span>
</td>
<td class="num">(1,026)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes', window );">Social taxes related to AGAs</a></td>
<td class="num">&#8364; (717)<span></span>
</td>
<td class="num">&#8364; (426)<span></span>
</td>
<td class="num">&#8364; (205)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense From Equity-Settled Share-Based Payment Transactions, Social Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of financial liabilities breakdown (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">&#8364; 69,069<span></span>
</td>
<td class="nump">&#8364; 39,697<span></span>
</td>
<td class="nump">&#8364; 16,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">44,935<span></span>
</td>
<td class="nump">37,348<span></span>
</td>
<td class="nump">33,555<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">114,004<span></span>
</td>
<td class="nump">77,045<span></span>
</td>
<td class="nump">49,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BorrowingsByNameMember', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">29,056<span></span>
</td>
<td class="nump">2,563<span></span>
</td>
<td class="nump">9,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">22,195<span></span>
</td>
<td class="nump">1,655<span></span>
</td>
<td class="nump">10,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos1ClaretBondLoansMember', window );">Kreos &amp; Claret bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">26,373<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">20,028<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">379<span></span>
</td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">1,252<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
<td class="nump">3,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">1,235<span></span>
</td>
<td class="nump">1,276<span></span>
</td>
<td class="nump">1,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_ConvertibleLoansNotesMember', window );">Convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">23,370<span></span>
</td>
<td class="nump">21,643<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">21,574<span></span>
</td>
<td class="nump">29,605<span></span>
</td>
<td class="nump">19,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">23,370<span></span>
</td>
<td class="nump">21,643<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">21,574<span></span>
</td>
<td class="nump">29,605<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_DerivativesMember', window );">Derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos1Member', window );">Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Kreos &amp; Claret minimum return indemnifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingBSAMember', window );">Kreos / Claret BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OtherFinancialLiabilitiesMember', window );">Other financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">13,023<span></span>
</td>
<td class="nump">15,491<span></span>
</td>
<td class="nump">6,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,509<span></span>
</td>
<td class="nump">3,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_ConditionalAdvancesMember', window );">Conditional advances Bpifrance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,262<span></span>
</td>
<td class="nump">3,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,509<span></span>
</td>
<td class="nump">3,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">&#8364; 13,023<span></span>
</td>
<td class="nump">&#8364; 12,229<span></span>
</td>
<td class="nump">&#8364; 3,287<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BorrowingsByNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BorrowingsByNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos1ClaretBondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos1ClaretBondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_ConvertibleLoansNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_ConvertibleLoansNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_DerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_DerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OtherFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OtherFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_ConditionalAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_ConditionalAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Kreos / Claret Financing (Details)<br> &#8364; / shares in Units, &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">121 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 02, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 22, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 20, 2023 </div>
<div>EUR (&#8364;) </div>
<div>tranche </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 24, 2018 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfBondLoans', window );">Repayments of bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 11,635<span></span>
</td>
<td class="nump">&#8364; 9,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">&#8364; 162,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 125,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 58,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 162,256<span></span>
</td>
<td class="nump">&#8364; 125,191<span></span>
</td>
<td class="nump">&#8364; 58,469<span></span>
</td>
<td class="nump">&#8364; 125,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent', window );">Carrying amount of the equity component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_MarketRateMeasurementInputMember', window );">Market rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_MarketRateMeasurementInputMember', window );">Market rate | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Decrease in financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible increase in unobservable input, liabilities | &#8364; / shares</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 197<span></span>
</td>
<td class="nump">&#8364; 78<span></span>
</td>
<td class="nump">&#8364; 176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price | Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price | Kreos A &amp; B &amp; C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">&#8364; 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price | Kreos &amp; Claret minimum return indemnifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 48<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="nump">&#8364; 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility | Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility | Kreos A &amp; B &amp; C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">&#8364; 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility | Kreos &amp; Claret minimum return indemnifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility | Kreos &amp; Claret minimum return indemnifications | Black Scholes Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility | Kreos &amp; Claret minimum return indemnifications | Monte Carlo Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 64<span></span>
</td>
<td class="nump">&#8364; 12<span></span>
</td>
<td class="nump">&#8364; 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate | Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate | Kreos A &amp; B &amp; C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">&#8364; 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate | Kreos &amp; Claret minimum return indemnifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate | Kreos &amp; Claret minimum return indemnifications | Black Scholes Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate | Kreos &amp; Claret minimum return indemnifications | Monte Carlo Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember', window );">Final redemption scenario probability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember', window );">Final redemption scenario probability | Kreos &amp; Claret minimum return indemnifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember', window );">Discount rate | Kreos &amp; Claret minimum return indemnifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember', window );">7-year expiry scenario probability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember', window );">7-year expiry scenario probability | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember', window );">7-year expiry scenario probability | Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember', window );">7-year expiry scenario probability | Kreos A &amp; B &amp; C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">&#8364; 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted', window );">Expiry scenario period, other equity instruments granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosCBSAMember', window );">Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted', window );">Expiry scenario period, other equity instruments granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABCBSAMember', window );">Kreos A &amp; B &amp; C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted', window );">Expiry scenario period, other equity instruments granted</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember', window );">Kreos &amp; Claret financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfTranches', window );">Borrowings, number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacityPerTranche', window );">Borrowings, maximum borrowing capacity per tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsExercisePeriod', window );">Other share warrants, exercise period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember', window );">Kreos &amp; Claret financing | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsGranted', window );">Number of warrants granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price, other equity instruments granted (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 18.6744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted', window );">Exercise price, percentage of premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember', window );">Kreos &amp; Claret financing | Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsGranted', window );">Number of warrants granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price, other equity instruments granted (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 9.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted', window );">Exercise price, percentage of 15-day WVAP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfOtherShareWarrants', window );">Issuance of other share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately', window );">Number of instruments granted, percentage exercisable immediately</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable', window );">Number of instruments granted, remaining percentage exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos &amp; Claret financing, tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsFixedConversionPrice', window );">Borrowings, fixed conversion price | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 21.2209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsEarlyRepaymentDiscountRate', window );">Borrowings, early repayment, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeePercentage', window );">Borrowings, exit fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfTranches', window );">Borrowings, number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsEarlyRepaymentDiscountRate', window );">Borrowings, early repayment, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeePercentage', window );">Borrowings, exit fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C | European Central Bank base rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Borrowings, adjustment to interest rate basis</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C | European Central Bank base rate | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsBasisInterestRate', window );">Borrowings, interest rate basis</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C | European Central Bank base rate | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsBasisInterestRate', window );">Borrowings, interest rate basis</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember', window );">Kreos &amp; Claret financing, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsDebtToMarketCapitalizationRatio', window );">Borrowings, debt-to-market capitalization ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember', window );">Kreos &amp; Claret financing, tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsDebtToMarketCapitalizationRatio', window );">Borrowings, debt-to-market capitalization ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsPerformanceConditionsMinimumFinancing', window );">Performance conditions, minimum financing | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1BondLoansMember', window );">Kreos 1 bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfBondLoans', window );">Repayments of bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsBasisInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Basis Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsBasisInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsDebtToMarketCapitalizationRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Debt-To-Market Capitalization Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsDebtToMarketCapitalizationRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsEarlyRepaymentDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Early Repayment, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsEarlyRepaymentDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsExitFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Exit Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsExitFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsFixedConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Fixed Conversion Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsFixedConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaximumBorrowingCapacityPerTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Maximum Borrowing Capacity Per Tranche</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaximumBorrowingCapacityPerTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsPerformanceConditionsMinimumFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Performance Conditions, Minimum Financing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsPerformanceConditionsMinimumFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Carrying Amount Of The Equity Component</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExercisePriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExercisePriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price, Percentage Of 15-Day WVAP, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price, Percentage Of Premium Over 15-Day VWAP, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry Scenario Period, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IssuanceOfOtherShareWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Other Share Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IssuanceOfOtherShareWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Instruments Granted, Other Equity Instruments, Percentage Exercisable Immediately</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Instruments Granted, Other Equity Instruments, Remaining Percentage Exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherShareWarrantsExercisePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Share Warrants, Exercise Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherShareWarrantsExercisePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherShareWarrantsSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Share Warrants, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherShareWarrantsSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfBondLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Bond Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfBondLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAdjustmentToInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_MarketRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_MarketRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosCBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosCBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABCBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABCBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_BlackScholesModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_BlackScholesModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosABBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosABBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosCBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosCBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosABCBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosABCBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=abvx_EuropeanCentralBankBaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=abvx_EuropeanCentralBankBaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1BondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1BondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret minimum return indemnifications (Details) - Kreos &amp; Claret minimum return indemnifications<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding', window );">Fair value of other equity instruments</a></td>
<td class="nump">&#8364; 2,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding', window );">Fair value of other equity instruments</a></td>
<td class="nump">&#8364; 984<span></span>
</td>
<td class="nump">&#8364; 475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Final redemption scenario probability | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Final redemption scenario probability | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.95<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Minimal return | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Minimal return | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">1.30<span></span>
</td>
<td class="nump">1.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Discount rate | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Discount rate | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Probability-weighted present value of shortfall payment, final redemption | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">2,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Probability-weighted present value of shortfall payment, final redemption | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Probability-weighted present value of shortfall payment, tender offer | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Probability-weighted present value of shortfall payment, tender offer | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Final redemption, probability-weighted fair value with MRI | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Final redemption, probability-weighted fair value with MRI | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">684<span></span>
</td>
<td class="nump">2,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Final redemption, probability-weighted fair value without MRI | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Final redemption, probability-weighted fair value without MRI | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">3,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Total fair value of MRI, final redemption | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">2,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Total fair value of MRI, final redemption | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Total fair value of MRI, tender offer | Amortized cost (EIR method) | Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Total fair value of MRI, tender offer | Amortized cost (EIR method) | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Fair Value, Other Equity Instruments Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AggregateFairValueOtherEquityInstrumentsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TranchesAxis=abvx_TrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TranchesAxis=abvx_TrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_AmortizedCostEIRMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_AmortizedCostEIRMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_MinimalReturnMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_MinimalReturnMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_TenderOfferFairValueOfMRIMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_TenderOfferFairValueOfMRIMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret BSA (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 02, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Aug. 20, 2023</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>scenario </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 22, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Exercise price per share (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.67<span></span>
</td>
<td class="nump">18.67<span></span>
</td>
<td class="nump">18.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Ordinary share price (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.76<span></span>
</td>
<td class="nump">9.82<span></span>
</td>
<td class="nump">17.10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | 7-year expiry scenario probability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Volatility, expiry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.443<span></span>
</td>
<td class="nump">0.595<span></span>
</td>
<td class="nump">0.719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Volatility, tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.443<span></span>
</td>
<td class="nump">0.649<span></span>
</td>
<td class="nump">0.652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0230<span></span>
</td>
<td class="nump">0.0300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Risk-free rate, expiry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA | Option pricing model | Risk-free rate, tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Exercise price per share (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">9.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.86<span></span>
</td>
<td class="nump">9.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Ordinary share price (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">8.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.67<span></span>
</td>
<td class="nump">9.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | 7-year expiry scenario probability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Probability of Drawdown of Tranche C credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Volatility, expiry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.443<span></span>
</td>
<td class="nump">0.674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Volatility, tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.443<span></span>
</td>
<td class="nump">0.649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.0300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Risk-free rate, expiry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember', window );">Kreos C BSA | Option pricing model | Risk-free rate, tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfProbabilityWeightedScenarios', window );">Number of probability-weighted scenarios | scenario</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted', window );">Expiry scenario period, other equity instruments granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstanding', window );">Number of outstanding warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,198<span></span>
</td>
<td class="nump">214,198<span></span>
</td>
<td class="nump">214,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding', window );">Fair value of other equity instruments | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 243<span></span>
</td>
<td class="nump">&#8364; 920<span></span>
</td>
<td class="nump">&#8364; 2,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosCBSAMember', window );">Kreos C BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted', window );">Expiry scenario period, other equity instruments granted</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstanding', window );">Number of outstanding warrants (in shares) | shares</a></td>
<td class="nump">405,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,832<span></span>
</td>
<td class="nump">405,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition', window );">Number of outstanding warrants subject to non-market performance condition (in shares) | shares</a></td>
<td class="nump">202,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">202,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding', window );">Fair value of other equity instruments | &#8364;</a></td>
<td class="nump">&#8364; 1,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 923<span></span>
</td>
<td class="nump">&#8364; 1,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Fair Value, Other Equity Instruments Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AggregateFairValueOtherEquityInstrumentsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfWarrantsArrangementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Warrants Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfWarrantsArrangementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry Scenario Period, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfProbabilityWeightedScenarios">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Probability-Weighted Scenarios</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfProbabilityWeightedScenarios</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Warrants Outstanding Subject To Non-Market Performance Condition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosABBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_OptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_OptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExercisePricePerShareMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExercisePricePerShareMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExpiryScenarioProbablityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_VolatilityForSharesMeasurementInputExpiryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_VolatilityForSharesMeasurementInputExpiryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_VolatilityForSharesMeasurementInputTenderOfferMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_VolatilityForSharesMeasurementInputTenderOfferMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputExpiryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputExpiryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=abvx_KreosCBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_DrawdownProbablityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_DrawdownProbablityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosABBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosABBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosCBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosCBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Heights convertible notes (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 20, 2023 </div>
<div>EUR (&#8364;) </div>
<div>installment </div>
<div>closing </div>
<div>shares </div>
<div>tranche </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 30, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 02, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Feb. 22, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 07, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 55,841,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.50<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750,000<span></span>
</td>
<td class="nump">27,188,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_GainsArisingFromRecognitionOfFinancialLiabilities', window );">Day-one gain on recognition of financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 590,000<span></span>
</td>
<td class="nump">&#8364; 212,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible increase in unobservable input, liabilities | &#8364; / shares</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember', window );">Held to maturity / voluntary conversion scenario probability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Heights convertible notes, tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">&#8364; 35,000,000<span></span>
</td>
<td class="nump">&#8364; 35,000,000,000<span></span>
</td>
<td class="nump">&#8364; 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 35,000,000<span></span>
</td>
<td class="nump">&#8364; 35,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Heights convertible notes, tranche A | Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="nump">239,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Heights convertible notes, tranche A | Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">39,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="nump">1,069,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Heights convertible notes, tranche A | Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="num">(219,000)<span></span>
</td>
<td class="num">(366,000)<span></span>
</td>
<td class="num">(239,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Heights convertible notes, tranche A | Held to maturity / voluntary conversion scenario probability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="num">&#8364; (631,000)<span></span>
</td>
<td class="num">&#8364; (364,000)<span></span>
</td>
<td class="num">(80,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfTranches', window );">Borrowings, number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesNominalValue', window );">Convertible loan notes, nominal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfQuarterlyInstallments', window );">Borrowings, number of quarterly installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaturityDeferralPeriod', window );">Borrowings maturity, deferral period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsPercentageOfMarketPrice', window );">Borrowings, percentage of market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP', window );">Borrowings, market price, number of days with lowest daily VWAP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMarketPriceNumberOfTradingDays', window );">Borrowings, market price, number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14.4303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate', window );">Conversion option, maximum period prior to maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_GainsArisingFromRecognitionOfFinancialLiabilities', window );">Day-one gain on recognition of financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnrecognitionDayOneGainOfFinancialLiabilities', window );">Unrecognition day-one gain of financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,147,000<span></span>
</td>
<td class="nump">1,557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP', window );">Issuance price, percentage of discount to 15-day WVAP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal', window );">Early redemption amount, percentage of outstandong principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14.4303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue', window );">Settlement in shares, percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceCashCarveOut', window );">Equity issuance, cash carve-out</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 13,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Heights convertible notes, tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfConvertibleNotesIssued', window );">Number of convertible notes issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesNominalValue', window );">Convertible loan notes, nominal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsFixedConversionPrice', window );">Borrowings, fixed conversion price | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23.7674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted', window );">Exercise price, percentage of premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember', window );">Heights convertible notes, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfConvertibleNotesIssued', window );">Number of convertible notes issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesNominalValue', window );">Convertible loan notes, nominal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted', window );">Exercise price, percentage of 15-day WVAP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember', window );">Heights convertible notes, tranche B | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesPeriod', window );">Convertible loan notes, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesNumberOfSeparateClosings', window );">Convertible loan notes, number of separate closings | closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember', window );">Heights convertible notes, tranche B | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesPeriod', window );">Convertible loan notes, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 30.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsFixedConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Fixed Conversion Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsFixedConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Market Price, Number Of Days With Lowest Daily VWAP</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMarketPriceNumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Market Price, Number Of Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMarketPriceNumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaturityDeferralPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings Maturity, Deferral Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaturityDeferralPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNumberOfQuarterlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Number Of Quarterly Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNumberOfQuarterlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsPercentageOfMarketPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Percentage Of Market Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsPercentageOfMarketPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Conversion Option, Maximum Period Prior To Maturity Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Early Redemption Amount, Percentage Of Outstandong Principal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesNominalValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Nominal Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesNominalValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesNumberOfSeparateClosings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Number Of Separate Closings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesNumberOfSeparateClosings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Settlement In Shares, Percentage Of Fair Market Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuanceCashCarveOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Cash Carve-Out</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuanceCashCarveOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuanceSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuanceSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price, Percentage Of 15-Day WVAP, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price, Percentage Of Premium Over 15-Day VWAP, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_GainsArisingFromRecognitionOfFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains Arising From Recognition Of Financial Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_GainsArisingFromRecognitionOfFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IssuancePricePercentageOfDiscountTo15DayWVAP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Price, Percentage Of Discount To 15-Day WVAP</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IssuancePricePercentageOfDiscountTo15DayWVAP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfConvertibleNotesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Convertible Notes Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfConvertibleNotesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnrecognitionDayOneGainOfFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognition Day-One Gain Of Financial Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnrecognitionDayOneGainOfFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of the main data and assumptions, Heights convertible loan notes (Details) - Heights convertible notes, tranche A<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfConvertibleNotesOutstanding', window );">Number of outstanding notes (in shares) | shares</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Original principal amount | &#8364;</a></td>
<td class="nump">&#8364; 35,000<span></span>
</td>
<td class="nump">&#8364; 35,000,000<span></span>
</td>
<td class="nump">&#8364; 35,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueConvertibleNotes', window );">Fair value of convertible notes | &#8364;</a></td>
<td class="nump">&#8364; 20,017<span></span>
</td>
<td class="nump">&#8364; 27,456<span></span>
</td>
<td class="nump">&#8364; 32,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Interest rate | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Conversion price per share (in euro per share) | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">23.77<span></span>
</td>
<td class="nump">23.77<span></span>
</td>
<td class="nump">23.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Ordinary share price (in euro per share) | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">6.76<span></span>
</td>
<td class="nump">9.82<span></span>
</td>
<td class="nump">16.74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Held to maturity / voluntary conversion scenario probability | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Initial price limit (in euro per share) | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">14.43<span></span>
</td>
<td class="nump">14.43<span></span>
</td>
<td class="nump">14.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Early redemption amount (put event) | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Volatility | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Credit spread | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="nump">0.20<span></span>
</td>
<td class="nump">0.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember', window );">Risk-free rate | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.029<span></span>
</td>
<td class="nump">0.023<span></span>
</td>
<td class="nump">0.029<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AggregateFairValueConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Fair Value, Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AggregateFairValueConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfConvertibleNotesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Convertible Notes Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfConvertibleNotesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModelIFRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModelIFRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ConversionPricePerShareMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ConversionPricePerShareMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_InitialPriceLimitMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_InitialPriceLimitMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_EarlyRedemptionAmountMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_EarlyRedemptionAmountMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Kreos 1 (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 21, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 20, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>May 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 24, 2018 </div>
<div>EUR (&#8364;) </div>
<div>installment </div>
<div>tranche </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 02, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 22, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Oct. 13, 2020 </div>
<div>installment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 55,841<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464,309<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfMonthlyInstallments', window );">Borrowings, number of monthly installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="nump">&#8364; 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,750<span></span>
</td>
<td class="nump">27,188<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 566<span></span>
</td>
<td class="nump">&#8364; 9,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,786<span></span>
</td>
<td class="nump">&#8364; 2,579<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="nump">&#8364; 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible increase in unobservable input, liabilities | &#8364; / shares</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 78<span></span>
</td>
<td class="nump">&#8364; 176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate | Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12<span></span>
</td>
<td class="nump">&#8364; 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstanding', window );">Number of outstanding warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,957<span></span>
</td>
<td class="nump">110,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price, other equity instruments granted (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstanding', window );">Number of outstanding warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,766<span></span>
</td>
<td class="nump">74,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price, other equity instruments granted (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstanding', window );">Number of outstanding warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,198<span></span>
</td>
<td class="nump">214,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherShareWarrantsSubscriptionPricePerShare', window );">Other share warrants, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfSharesSubscribedPerWarrant', window );">Number of shares subscribed per warrant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaturityTerm', window );">Borrowings, maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1Member', window );">Kreos 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfTranches', window );">Borrowings, number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacityPerTranche', window );">Borrowings, maximum borrowing capacity per tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeePercentage', window );">Borrowings, exit fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNoticePeriod', window );">Borrowings, notice period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsAnnualDiscountRate', window );">Borrowings, annual discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1Member', window );">Kreos 1 | Euribor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Borrowings, adjustment to interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1Member', window );">Kreos 1 | Bottom of range | Euribor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsBasisInterestRate', window );">Borrowings, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1Member', window );">Kreos 1 | Top of range | Euribor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsBasisInterestRate', window );">Borrowings, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1NonConvertibleBondLoansMember', window );">Kreos 1, non-convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansMember', window );">Kreos 1, convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaximumBorrowingCapacity', window );">Borrowings, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeePercentage', window );">Borrowings, exit fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeeAmount', window );">Borrowings, exit fee amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheAMember', window );">Kreos 1, convertible bond loans, tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaturityDeferralPeriod', window );">Borrowings maturity, deferral period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOtherShareWarrantsRepurchased', window );">Number of other share warrants repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOtherShareWarrantsConverted', window );">Number of other share warrants converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember', window );">Kreos 1, convertible bond loans, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants', window );">Exercises of share warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaturityDeferralPeriod', window );">Borrowings maturity, deferral period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="nump">&#8364; 7,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOtherShareWarrantsRepurchased', window );">Number of other share warrants repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfOtherShareWarrantsConverted', window );">Number of other share warrants converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid', window );">Loss of extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsAnnualDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Annual Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsAnnualDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsBasisInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Basis Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsBasisInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsExitFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Exit Fee Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsExitFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsExitFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Exit Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsExitFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaturityDeferralPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings Maturity, Deferral Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaturityDeferralPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaturityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings Maturity, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaturityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaximumBorrowingCapacityPerTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Maximum Borrowing Capacity Per Tranche</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaximumBorrowingCapacityPerTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Notice Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNumberOfMonthlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Number Of Monthly Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNumberOfMonthlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExercisePriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price, Other Equity Instruments Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExercisePriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfOtherShareWarrantsConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Other Share Warrants Converted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfOtherShareWarrantsConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfOtherShareWarrantsRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Other Share Warrants Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfOtherShareWarrantsRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfSharesSubscribedPerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Subscribed Per Warrant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfSharesSubscribedPerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherShareWarrantsSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Share Warrants, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherShareWarrantsSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAdjustmentToInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) arising from the difference between the carrying amount of the financial liability extinguished and the measurement of the consideration paid (equity instruments issued) to the creditor. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 11<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_11&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosABSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosABSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosBBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosBBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosABBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosABBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=abvx_EuriborMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=abvx_EuriborMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1NonConvertibleBondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1NonConvertibleBondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos12BondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos12BondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of the main data and assumptions, Kreos BSA (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>May 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>yr </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>yr </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 24, 2018 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstanding', window );">Number of outstanding warrants (in shares) | shares</a></td>
<td class="nump">110,957<span></span>
</td>
<td class="nump">110,957<span></span>
</td>
<td class="nump">110,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding', window );">Fair value of other equity instruments | &#8364;</a></td>
<td class="nump">&#8364; 1,261<span></span>
</td>
<td class="nump">&#8364; 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA | Exercise price per share (in euro per share) | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">7.21<span></span>
</td>
<td class="nump">7.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA | Ordinary share price (in euro per share) | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">18.57<span></span>
</td>
<td class="nump">6.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA | Residual maturity | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities | yr</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA | Volatility | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA | Dividend | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosABSAMember', window );">Kreos A BSA | Risk-free rate | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfWarrantsOutstanding', window );">Number of outstanding warrants (in shares) | shares</a></td>
<td class="nump">74,766<span></span>
</td>
<td class="nump">74,766<span></span>
</td>
<td class="nump">74,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding', window );">Fair value of other equity instruments | &#8364;</a></td>
<td class="nump">&#8364; 589<span></span>
</td>
<td class="nump">&#8364; 149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA | Exercise price per share (in euro per share) | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">10.70<span></span>
</td>
<td class="nump">10.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA | Ordinary share price (in euro per share) | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">18.57<span></span>
</td>
<td class="nump">6.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA | Residual maturity | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities | yr</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA | Volatility | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA | Dividend | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_WarrantsAxis=abvx_KreosBBSAMember', window );">Kreos B BSA | Risk-free rate | Option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfWarrantsArrangementsLineItems', window );"><strong>Disclosure Of Warrants Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AggregateFairValueOtherEquityInstrumentsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Fair Value, Other Equity Instruments Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AggregateFairValueOtherEquityInstrumentsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfWarrantsArrangementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Warrants Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfWarrantsArrangementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosABSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosABSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExercisePricePerShareMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExercisePricePerShareMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_OptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_OptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ResidualMaturityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ResidualMaturityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_WarrantsAxis=abvx_KreosBBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_WarrantsAxis=abvx_KreosBBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Kreos 2 (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 21, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 13, 2020 </div>
<div>EUR (&#8364;) </div>
<div>installment </div>
<div>tranche</div>
</th>
<th class="th">
<div>Jul. 24, 2018 </div>
<div>installment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfMonthlyInstallments', window );">Borrowings, number of monthly installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="nump">&#8364; 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,750<span></span>
</td>
<td class="nump">&#8364; 27,188<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos2Member', window );">Kreos 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNumberOfTranches', window );">Borrowings, number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsAdditionalTrancheAmount', window );">Borrowings, additional tranche mount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsInterestRateForFollowingInstallments', window );">Borrowings, interest rate for following installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeePercentage', window );">Borrowings, exit fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsNoticePeriod', window );">Borrowings, notice period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments', window );">Borrowings, exit fee percentage if prepayment between 18th and 30th installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment', window );">Borrowings, exit fee percentage if prepayment after 30th installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsAnnualDiscountRate', window );">Borrowings, annual discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos2Member', window );">Kreos 2 | Euribor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments', window );">Borrowings, interest rate for first 12 installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos2TrancheAMember', window );">Kreos 2, tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeeAmount', window );">Borrowings, exit fee amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos2TrancheBMember', window );">Kreos 2, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsExitFeeAmount', window );">Borrowings, exit fee amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember', window );">Kreos 1, convertible bond loans, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="nump">&#8364; 7,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsAdditionalTrancheAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Additional Tranche Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsAdditionalTrancheAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Adjustment To Interest Rate Basis For First 12 Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsAnnualDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Annual Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsAnnualDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsExitFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Exit Fee Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsExitFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsExitFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Exit Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsExitFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Exit Fee Percentage If Prepayment After 30th Installment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Exit Fee Percentage If Prepayment Between 18th And 30th Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsInterestRateForFollowingInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Interest Rate For Following Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsInterestRateForFollowingInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Notice Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNumberOfMonthlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Number Of Monthly Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNumberOfMonthlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=abvx_EuriborMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=abvx_EuriborMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos2TrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos2TrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos2TrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos2TrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_Kreos1ConvertibleBondLoansTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - OCEANE (Details)<br> &#8364; / shares in Units, &#8364; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">121 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Feb. 22, 2023 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 07, 2022 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 30, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 02, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 20, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="nump">20,325,500<span></span>
</td>
<td class="nump">20,325,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,325,500<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="nump">&#8364; 223,300<span></span>
</td>
<td class="nump">$ 235.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 353,377<span></span>
</td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="nump">&#8364; 557,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">55,841<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750<span></span>
</td>
<td class="nump">27,188<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,786<span></span>
</td>
<td class="nump">&#8364; 2,579<span></span>
</td>
<td class="nump">&#8364; 566<span></span>
</td>
<td class="nump">&#8364; 2,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 9,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible increase in unobservable input, liabilities | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueConvertibleNotes', window );">Fair value of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane | Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane | Volatility | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane | Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane | Share price | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane | Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane | Risk-free rate | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane | Credit spread | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes', window );">Proceeds from issuing shares and convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,964,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 30.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Capital increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfSharesSubscribedPerWarrant', window );">Number of shares subscribed per warrant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceOtherLiabilities', window );">Conversion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceVolumeWeightedAveragePricePeriod', window );">Conversion price, VWAP, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 17,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid', window );">Loss of extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane | After 18 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceOtherLiabilities', window );">Conversion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 32.462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceAdjustmentPeriod', window );">Conversion price, adjustment, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane | After 18 months | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPricePercentageOfInitialPriceThreshold', window );">Conversion price, percentage of initial price, threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane | After 24 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceOtherLiabilities', window );">Conversion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 26.733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceAdjustmentPeriod', window );">Conversion price, adjustment, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane | After 24 months | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPricePercentageOfInitialPriceThreshold', window );">Conversion price, percentage of initial price, threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane | After 36 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceOtherLiabilities', window );">Conversion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25.969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPriceAdjustmentPeriod', window );">Conversion price, adjustment, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane | After 36 months | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConversionPricePercentageOfInitialPriceThreshold', window );">Conversion price, percentage of initial price, threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AggregateFairValueConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Fair Value, Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AggregateFairValueConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConversionPriceAdjustmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Price, Adjustment, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConversionPriceAdjustmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConversionPriceOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Price, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConversionPriceOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConversionPricePercentageOfInitialPriceThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Price, Percentage Of Initial Price, Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConversionPricePercentageOfInitialPriceThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConversionPriceVolumeWeightedAveragePricePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Price, Volume Weighted Average Price, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConversionPriceVolumeWeightedAveragePricePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuanceSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuanceSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfSharesSubscribedPerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Subscribed Per Warrant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfSharesSubscribedPerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuing Shares And Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) arising from the difference between the carrying amount of the financial liability extinguished and the measurement of the consideration paid (equity instruments issued) to the creditor. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 11<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_11&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModelIFRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModelIFRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RemeasurementPeriodAxis=abvx_After18MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RemeasurementPeriodAxis=abvx_After18MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RemeasurementPeriodAxis=abvx_After24MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RemeasurementPeriodAxis=abvx_After24MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RemeasurementPeriodAxis=abvx_After36MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RemeasurementPeriodAxis=abvx_After36MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Financial liabilities - Disclosure of the main data and assumptions, OCEANE convertible loan notes (Details) (Details) - Oceane<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 30, 2021 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AggregateFairValueConvertibleNotes', window );">Fair value of convertible notes | &#8364;</a></td>
<td class="nump">&#8364; 1,762<span></span>
</td>
<td class="nump">&#8364; 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Risk-free rate | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.0322<span></span>
</td>
<td class="nump">0.0305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Credit spread | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.1398<span></span>
</td>
<td class="nump">0.1475<span></span>
</td>
<td class="nump">0.1400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Ordinary share price (in euro per share) | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities | &#8364; / shares</a></td>
<td class="nump">16.74<span></span>
</td>
<td class="nump">6.18<span></span>
</td>
<td class="nump">31.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Volatility | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.37<span></span>
</td>
<td class="nump">0.4401<span></span>
</td>
<td class="nump">0.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Dividend | Monte Carlo model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AggregateFairValueConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Fair Value, Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AggregateFairValueConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModelIFRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=abvx_MonteCarloModelIFRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_CreditSpreadMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - State guaranteed loan &#8211; &#8220;PGE&#8221; (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Subsidies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,140<span></span>
</td>
<td class="nump">&#8364; 81<span></span>
</td>
<td class="nump">&#8364; 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaturityTerm', window );">Borrowings, maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, interest rate</a></td>
<td class="nump">0.58%<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaturityExtensionTerm', window );">Borrowings maturity, extension term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsMaturityDeferralPeriod', window );">Borrowings maturity, deferral period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsStateGuaranteedPremium', window );">Borrowings, state guaranteed premium</a></td>
<td class="nump">&#8364; 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Subsidies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 377<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaturityDeferralPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings Maturity, Deferral Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaturityDeferralPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaturityExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings Maturity, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaturityExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsMaturityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings Maturity, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsMaturityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsStateGuaranteedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, State Guaranteed Premium</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsStateGuaranteedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_PretGarantiParLEtatPGEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_PretGarantiParLEtatPGEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of conditional advances (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,771<span></span>
</td>
<td class="nump">&#8364; 6,783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember', window );">RNP VIR &#8211; Bpifrance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">&#8364; 2,945<span></span>
</td>
<td class="nump">4,232<span></span>
</td>
<td class="nump">4,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember', window );">CARENA &#8211; Bpifrance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">&#8364; 3,255<span></span>
</td>
<td class="nump">2,485<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember', window );">EBOLA &#8211; Bpifrance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 55<span></span>
</td>
<td class="nump">&#8364; 158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Conditional advances (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">25 Months Ended</th>
<th class="th" colspan="1">27 Months Ended</th>
<th class="th" colspan="1">31 Months Ended</th>
<th class="th" colspan="1">73 Months Ended</th>
<th class="th" colspan="1">109 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 02, 2017</div></th>
<th class="th"><div>Dec. 16, 2016</div></th>
<th class="th"><div>Dec. 16, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 6,771<span></span>
</td>
<td class="nump">&#8364; 6,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,783<span></span>
</td>
<td class="nump">&#8364; 6,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Income from government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,140<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember', window );">RNP-VIR conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromConditionalAdvances', window );">Proceeds from conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,930<span></span>
</td>
<td class="nump">&#8364; 346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentOfExcessConditionalAdvancesClaimed', window );">Excess conditional advances claimed</a></td>
<td class="nump">&#8364; 1,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PercentageOfConditionalAdvancesWaived', window );">Percentage of conditional advances waived</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="nump">&#8364; 2,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,232<span></span>
</td>
<td class="nump">4,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,171<span></span>
</td>
<td class="nump">4,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Income from government grants</a></td>
<td class="nump">1,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember', window );">CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromConditionalAdvances', window );">Proceeds from conditional advances</a></td>
<td class="nump">&#8364; 1,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 29<span></span>
</td>
<td class="nump">&#8364; 1,008<span></span>
</td>
<td class="nump">&#8364; 1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PercentageOfConditionalAdvancesWaived', window );">Percentage of conditional advances waived</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="nump">&#8364; 3,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,485<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Income from government grants</a></td>
<td class="nump">&#8364; 2,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember', window );">Ebola conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ProceedsFromConditionalAdvances', window );">Proceeds from conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 55<span></span>
</td>
<td class="nump">&#8364; 158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 158<span></span>
</td>
<td class="nump">&#8364; 158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Maximum Drawdown Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PercentageOfConditionalAdvancesWaived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Conditional Advances Waived</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PercentageOfConditionalAdvancesWaived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ProceedsFromConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ProceedsFromConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentOfExcessConditionalAdvancesClaimed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment Of Excess Conditional Advances Claimed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentOfExcessConditionalAdvancesClaimed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of variation in lease liabilities (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Disclosure of financial liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities at beginning of period</a></td>
<td class="nump">&#8364; 540<span></span>
</td>
<td class="nump">&#8364; 1,384<span></span>
</td>
<td class="nump">&#8364; 214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseInLeaseLiabilities', window );">Increase</a></td>
<td class="nump">2,221<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseInLeaseLiabilities', window );">Decrease</a></td>
<td class="num">(398)<span></span>
</td>
<td class="num">(1,194)<span></span>
</td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities at end of period</a></td>
<td class="nump">&#8364; 2,363<span></span>
</td>
<td class="nump">&#8364; 540<span></span>
</td>
<td class="nump">&#8364; 1,384<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DecreaseInLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease In Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DecreaseInLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseInLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase In Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseInLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Lease liabilities (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 02, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpenseOnLeaseLiabilities', window );">Expense on lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 730<span></span>
</td>
<td class="nump">&#8364; 548<span></span>
</td>
<td class="nump">&#8364; 424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DepreciationExpenseLease', window );">Depreciation expense, lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Expense relating to short-term leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 352<span></span>
</td>
<td class="nump">&#8364; 334<span></span>
</td>
<td class="nump">&#8364; 331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesParisMember', window );">Lease facilities, Paris</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseDurationPeriod', window );">Lease, duration period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseTacitRenewalPeriod', window );">Lease, tacit renewal period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseBreakClausePeriod', window );">Lease, break clause period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm', window );">Decrease in lease liabilities through modification of term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesBostonMember', window );">Lease facilities, Boston</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseDurationPeriod', window );">Lease, duration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesBostonMember', window );">Lease facilities, Boston | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseExtensionPeriod', window );">Lease, extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesBostonMember', window );">Lease facilities, Boston | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseExtensionPeriod', window );">Lease, extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMontpellierMember', window );">Lease facilities, Montpellier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseDurationPeriod', window );">Lease, duration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseTacitRenewalPeriod', window );">Lease, tacit renewal period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseBreakClausePeriod', window );">Lease, break clause period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMember', window );">Lease facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseLiabilityPercentageOfTotal', window );">Lease liability, percentage of total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93.00%<span></span>
</td>
<td class="nump">93.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease In Lease Liabilities Through Modification Of Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DepreciationExpenseLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation Expense, Lease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DepreciationExpenseLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfLeaseLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Lease Liabilities [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfLeaseLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense On Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense Relating To Short-Term Leases And Low Value Assets For Which Recognition Exemption Has Been Used</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LeaseBreakClausePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Break Clause Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LeaseBreakClausePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LeaseDurationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Duration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LeaseDurationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LeaseExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Extension Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LeaseExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LeaseLiabilityPercentageOfTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liability, Percentage Of Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LeaseLiabilityPercentageOfTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LeaseTacitRenewalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Tacit Renewal Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LeaseTacitRenewalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesParisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesParisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesBostonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesBostonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMontpellierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMontpellierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Prosynergia earn-out liability (Details) - EUR (&#8364;)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 21, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 02, 2023</div></th>
<th class="th"><div>Aug. 24, 2023</div></th>
<th class="th"><div>Aug. 20, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">&#8364; 49,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 114,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 77,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Prosynergia earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Prosynergia earn-out liability | Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">&#8364; 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Prosynergia earn-out liability | Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Prosynergia earn-out liability | Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember', window );">Prosynergia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems', window );"><strong>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutMarketCapitalizationThreshold', window );">Earn-out, market capitalization threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutPercentage', window );">Earn-out, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutMaximumAmount', window );">Earn-out, maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutAtFairValueAssetsAcquisitions', window );">Earn-out measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Assets Acquisitions [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutAtFairValueAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out At Fair Value, Assets Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutAtFairValueAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutMarketCapitalizationThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Market Capitalization, Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutMarketCapitalizationThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AssetsAcquisitionsAxis=abvx_ProsynergiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of main data and assumptions used for the measurement of earn-out liability (Details) - Prosynergia earn-out liability<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>yr</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>yr</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EarnOutAtFairValue', window );">Fair value of earn-out liability</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="num">&#8364; (1,446)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Option pricing model | Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.023<span></span>
</td>
<td class="num">(0.003)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Option pricing model | Market capitalization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">135,952<span></span>
</td>
<td class="nump">403,118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Option pricing model | Ordinary share price (in euro per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities | &#8364; / shares</a></td>
<td class="nump">6.18<span></span>
</td>
<td class="nump">24.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Option pricing model | Time to maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities | yr</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Option pricing model | Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0.44<span></span>
</td>
<td class="nump">0.61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember', window );">Option pricing model | Dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Significant unobservable input, liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EarnOutAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn-Out At Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EarnOutAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EarnOutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_OptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=ifrs-full_OptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_RiskFreeInterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_MarketCapitalizationMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_MarketCapitalizationMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ResidualMaturityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ResidualMaturityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ExpectedDividendMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Royalty certificates (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="2">121 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 22, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 07, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 02, 2022 </div>
<div>EUR (&#8364;) </div>
<div>transaction </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 19, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Nov. 02, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 24, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Aug. 20, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>May 24, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 353,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,325,500<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,325,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,530,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates', window );">Net proceeds from sale of royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,931<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 2,931<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 2,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatePercentageOfFutureSales', window );">Royalty certificate, percentage of future sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificateMaximumAmount', window );">Royalty certificate, maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentRoyaltyCertificates', window );">Royalty certificates</a></td>
<td class="nump">&#8364; 13,023<span></span>
</td>
<td class="nump">&#8364; 12,229<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,023<span></span>
</td>
<td class="nump">12,229<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12,229<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates', window );">Decrease in interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Increase (decrease) through amortization cost remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_InterestExpenseOnRoyaltyCertificates', window );">Interest on royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">8,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">356<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnwindingOfDiscountOnRoyalties', window );">Unwinding of discount on royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">&#8364; 162,256<span></span>
</td>
<td class="nump">&#8364; 125,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 58,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 162,256<span></span>
</td>
<td class="nump">&#8364; 125,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 58,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 125,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible increase in unobservable input, liabilities | &#8364; / shares</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Increase (decrease) through amortization cost remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (3,404)<span></span>
</td>
<td class="nump">&#8364; 6,421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 49,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherLiabilitiesNumberOfTransactions', window );">Other liabilities, number of transactions | transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 46,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease', window );">Capital increase from issuance of ordinary shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_EquityIssuanceSubscriptionPricePerShare', window );">Equity issuance, subscripion price per share (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatePercentageOfFutureSales', window );">Royalty certificate, percentage of future sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificateMaximumAmount', window );">Royalty certificate, maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatesEIR', window );">Royalty certificates, EIR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">34.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">&#8364; 7,313<span></span>
</td>
<td class="nump">&#8364; 12,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7,313<span></span>
</td>
<td class="nump">&#8364; 12,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 3,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 12,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates | POS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">0.05%<span></span>
</td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.05%<span></span>
</td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible increase in unobservable input</a></td>
<td class="nump">&#8364; 572<span></span>
</td>
<td class="nump">&#8364; 1,104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 299<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible decrease in unobservable input, liabilities</a></td>
<td class="num">(0.05%)<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.05%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.05%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible decrease in unobservable input</a></td>
<td class="num">&#8364; (572)<span></span>
</td>
<td class="num">&#8364; (1,104)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (294)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates | Peak penetration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible increase in unobservable input</a></td>
<td class="nump">&#8364; 1,735<span></span>
</td>
<td class="nump">&#8364; 1,757<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible decrease in unobservable input, liabilities</a></td>
<td class="num">(5.00%)<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible decrease in unobservable input</a></td>
<td class="num">&#8364; (2,527)<span></span>
</td>
<td class="num">&#8364; (2,311)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (347)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates | WACC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible increase in unobservable input, liabilities</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible increase in unobservable input</a></td>
<td class="num">&#8364; (314)<span></span>
</td>
<td class="num">&#8364; (577)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (191)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Percentage of reasonably possible decrease in unobservable input, liabilities</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible decrease in unobservable input</a></td>
<td class="nump">&#8364; 332<span></span>
</td>
<td class="nump">&#8364; 612<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 205<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates | Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible increase in unobservable input</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Increase (decrease) in financial liabilities at fair value due to reasonably possible decrease in unobservable input</a></td>
<td class="num">&#8364; (1,160)<span></span>
</td>
<td class="num">&#8364; (1,325)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible increase in unobservable input, liabilities | &#8364; / shares</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities', window );">Amount of reasonably possible decrease in unobservable input, liabilities | &#8364; / shares</a></td>
<td class="num">&#8364; (1)<span></span>
</td>
<td class="num">&#8364; (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1)<span></span>
</td>
<td class="num">&#8364; (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember', window );">Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 352,974<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 46,176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember', window );">Share premium | Royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 3,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="26"></td></tr>
<tr><td colspan="26"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Reasonably Possible Decrease In Unobservable Input, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DecreaseInInterestExpenseOnRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease In Interest Expense On Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DecreaseInInterestExpenseOnRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_EquityIssuanceSubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Issuance, Subscription Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_EquityIssuanceSubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Amortization Cost Remeasurement, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_InterestExpenseOnRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense On Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_InterestExpenseOnRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromSaleOfRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Sale Of Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromSaleOfRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherLiabilitiesNumberOfTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Number Of Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherLiabilitiesNumberOfTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificateMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificate, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificateMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificatePercentageOfFutureSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificate, Percentage Of Future Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificatePercentageOfFutureSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificatesEIR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificates, EIR</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificatesEIR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnwindingOfDiscountOnRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unwinding Of Discount On Royalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnwindingOfDiscountOnRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible decrease in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible decrease in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_RoyaltyCertificatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_RoyaltyCertificatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_ProbabilityOfSuccessMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_ProbabilityOfSuccessMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=abvx_PeakPenetrationMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=abvx_PeakPenetrationMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of reconciliation of liabilities arising from financing activities (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">&#8364; 74,466<span></span>
</td>
<td class="nump">&#8364; 49,231<span></span>
</td>
<td class="nump">&#8364; 51,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">47,444<span></span>
</td>
<td class="nump">58,119<span></span>
</td>
<td class="nump">2,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(13,167)<span></span>
</td>
<td class="num">(38,993)<span></span>
</td>
<td class="num">(9,806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="num">(7,696)<span></span>
</td>
<td class="num">(5,278)<span></span>
</td>
<td class="num">(4,006)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="num">(3,204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="num">(590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">15,834<span></span>
</td>
<td class="num">(1,046)<span></span>
</td>
<td class="nump">6,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,005)<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="num">(3,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">3,027<span></span>
</td>
<td class="num">(1,446)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="num">(4,070)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">2,221<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">109,218<span></span>
</td>
<td class="nump">74,466<span></span>
</td>
<td class="nump">49,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,982<span></span>
</td>
<td class="nump">21,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(11,635)<span></span>
</td>
<td class="num">(9,410)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,278)<span></span>
</td>
<td class="num">(2,456)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,957<span></span>
</td>
<td class="nump">18,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23,238)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,602)<span></span>
</td>
<td class="num">(1,496)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,069<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">21,643<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,119<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="num">(2,250)<span></span>
</td>
<td class="num">(818)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">3,977<span></span>
</td>
<td class="num">(1,046)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,005)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">23,370<span></span>
</td>
<td class="nump">21,643<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_Kreos1ClaretBondLoansMember', window );">Kreos &amp; Claret bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">47,444<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="num">(3,639)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="num">(3,204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">46,401<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">29,605<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(8,750)<span></span>
</td>
<td class="num">(2,188)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="num">(1,772)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="num">(590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">1,367<span></span>
</td>
<td class="num">(212)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">21,574<span></span>
</td>
<td class="nump">29,605<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">3,678<span></span>
</td>
<td class="nump">4,838<span></span>
</td>
<td class="nump">4,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(1,250)<span></span>
</td>
<td class="num">(1,250)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">2,488<span></span>
</td>
<td class="nump">3,678<span></span>
</td>
<td class="nump">4,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_ConditionalAdvancesMember', window );">Conditional advances Bpifrance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">6,771<span></span>
</td>
<td class="nump">6,783<span></span>
</td>
<td class="nump">6,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(2,708)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="num">(4,070)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,771<span></span>
</td>
<td class="nump">6,783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(459)<span></span>
</td>
<td class="num">(573)<span></span>
</td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">2,221<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">2,363<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_EarnOutLiabilityMember', window );">Prosynergia earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,446)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at beginning of period</a></td>
<td class="nump">12,229<span></span>
</td>
<td class="nump">3,287<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: classification of embedded derivatives as separate derivative financial instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: (gain)/loss on recognition or derecognition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: interest expense and other</a></td>
<td class="nump">4,198<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: recognition of earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: amortized cost remeasurement</a></td>
<td class="num">(3,404)<span></span>
</td>
<td class="nump">6,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes: fair value remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities', window );">Non-cash changes&#160;: subsidies</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes: additional leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Non cash changes : Effect of the change in foreign currency exhange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities at end of period</a></td>
<td class="nump">&#8364; 13,023<span></span>
</td>
<td class="nump">&#8364; 12,229<span></span>
</td>
<td class="nump">&#8364; 3,287<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease Through Interest Paid, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease Through Repayments, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Amortization Cost Remeasurement, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Classification of Embedded Derivatives as Separate Financial Instruments, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Gain (Loss) On Recognition/Derecognition, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Recognition of Earn Out Liability, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Subsidies, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Through Proceeds, Liabilities Arising From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in fair values. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_Kreos12BondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_Kreos12BondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_Kreos1ClaretBondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_Kreos1ClaretBondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_PretGarantiParLEtatPGEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_PretGarantiParLEtatPGEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_ConditionalAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_ConditionalAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_EarnOutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_EarnOutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_RoyaltyCertificatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=abvx_RoyaltyCertificatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Change in financial liabilities (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 24, 2023</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 55,841<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="nump">&#8364; 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750<span></span>
</td>
<td class="nump">27,188<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_GrossProceedsFromNonConvertibleLoansNotes', window );">Proceeds from the issuance of non-convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDebtIssueCosts', window );">Payments for debt issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDebtIssueCosts', window );">Payments for debt issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDebtIssueCosts', window );">Payments for debt issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NetProceedsFromConvertibleLoansNotes', window );">Net proceeds from the issuance of convertible bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConvertibleLoansNotes', window );">Repayments of convertible loan notes</a></td>
<td class="nump">&#8364; 25,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember', window );">Kreos &amp; Claret financing, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDebtIssueCosts', window );">Payments for debt issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember', window );">Kreos &amp; Claret financing, tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDebtIssueCosts', window );">Payments for debt issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheABMember', window );">Kreos &amp; Claret financing, tranche A-B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDebtIssueCosts', window );">Payments for debt issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_GrossProceedsFromNonConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Proceeds From Non-Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_GrossProceedsFromNonConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NetProceedsFromConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NetProceedsFromConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepurchaseOfDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase Of Derivative Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepurchaseOfDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForDebtIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForDebtIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheABMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingTrancheABMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of changes in derivative instruments (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at beginning of period</a></td>
<td class="nump">&#8364; 2,579<span></span>
</td>
<td class="nump">&#8364; 566<span></span>
</td>
<td class="nump">&#8364; 9,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfDerivativeInstruments', window );">Issuance</a></td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">3,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Increase in fair value</a></td>
<td class="nump">1,462<span></span>
</td>
<td class="nump">3,046<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives', window );">Decrease in fair value</a></td>
<td class="num">(1,413)<span></span>
</td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(9,366)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExerciseOfDerivativeInstruments', window );">Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,021)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at end of period</a></td>
<td class="nump">4,786<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABSAMember', window );">Kreos A BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">2,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfDerivativeInstruments', window );">Issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Increase in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">986<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives', window );">Decrease in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExerciseOfDerivativeInstruments', window );">Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(771)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosBBSAMember', window );">Kreos B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">1,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfDerivativeInstruments', window );">Issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Increase in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives', window );">Decrease in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,376)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExerciseOfDerivativeInstruments', window );">Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">OCEANE conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">5,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfDerivativeInstruments', window );">Issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Increase in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives', window );">Decrease in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,787)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,762)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExerciseOfDerivativeInstruments', window );">Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos/Claret BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at beginning of period</a></td>
<td class="nump">2,579<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfDerivativeInstruments', window );">Issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Increase in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives', window );">Decrease in fair value</a></td>
<td class="num">(1,413)<span></span>
</td>
<td class="num">(1,006)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExerciseOfDerivativeInstruments', window );">Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at end of period</a></td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember', window );">Kreos/Claret Minimum Return Indemnifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IssuanceOfDerivativeInstruments', window );">Issuance</a></td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Increase in fair value</a></td>
<td class="nump">1,462<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives', window );">Decrease in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepurchaseOfDerivativeInstruments', window );">Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ExerciseOfDerivativeInstruments', window );">Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities at end of period</a></td>
<td class="nump">&#8364; 3,620<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ExerciseOfDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Of Derivative Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ExerciseOfDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IssuanceOfDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Derivative Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IssuanceOfDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepurchaseOfDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase Of Derivative Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepurchaseOfDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosBBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosBBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretMinimumReturnIndemnificationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Change in derivative instruments (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 24, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 24, 2023</div></th>
<th class="th"><div>Aug. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants</a></td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="nump">&#8364; 45<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 162,256<span></span>
</td>
<td class="nump">&#8364; 58,469<span></span>
</td>
<td class="nump">&#8364; 125,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember', window );">Kreos A &amp; B BSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercises of share warrants</a></td>
<td class="nump">&#8364; 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember', window );">Oceane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosABBSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OCEANEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Disclosure of remaining contractual maturities of financial liabilities (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 6,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 6,783<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NonCurrentRoyaltyCertificates', window );">Royalty certificates</a></td>
<td class="nump">13,023<span></span>
</td>
<td class="nump">12,229<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatesUndiscountedCashFlows', window );">Royalty certificates, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">2,363<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,384<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Gross lease liabilities</a></td>
<td class="nump">2,512<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,403<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="nump">4,786<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">566<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Derivative financial liabilities, undiscounted cash flows</a></td>
<td class="nump">4,786<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">566<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">114,004<span></span>
</td>
<td class="nump">77,045<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities, undiscounted cash flows</a></td>
<td class="nump">122,680<span></span>
</td>
<td class="nump">81,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">59,053<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatesUndiscountedCashFlows', window );">Royalty certificates, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Gross lease liabilities</a></td>
<td class="nump">993<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">558<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Derivative financial liabilities, undiscounted cash flows</a></td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities, undiscounted cash flows</a></td>
<td class="nump">38,468<span></span>
</td>
<td class="nump">20,747<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatesUndiscountedCashFlows', window );">Royalty certificates, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Gross lease liabilities</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">557<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Derivative financial liabilities, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities, undiscounted cash flows</a></td>
<td class="nump">56,698<span></span>
</td>
<td class="nump">15,192<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,905<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember', window );">FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatesUndiscountedCashFlows', window );">Royalty certificates, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Gross lease liabilities</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Derivative financial liabilities, undiscounted cash flows</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">424<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities, undiscounted cash flows</a></td>
<td class="nump">27,507<span></span>
</td>
<td class="nump">45,561<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,925<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatesUndiscountedCashFlows', window );">Royalty certificates, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Gross lease liabilities</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Derivative financial liabilities, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities, undiscounted cash flows</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,982<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,098<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans | LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans | FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,065<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans | FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember', window );">Kreos 1 &amp; 2 bond loans | LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option | LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option | FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option | FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember', window );">Oceane conversion option | LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="nump">21,574<span></span>
</td>
<td class="nump">29,605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">24,063<span></span>
</td>
<td class="nump">36,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">8,750<span></span>
</td>
<td class="nump">10,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">8,750<span></span>
</td>
<td class="nump">9,997<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">6,563<span></span>
</td>
<td class="nump">16,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember', window );">Heights convertible notes | LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="nump">23,370<span></span>
</td>
<td class="nump">21,643<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">30,653<span></span>
</td>
<td class="nump">30,903<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA) | LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA) | FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">19,943<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA) | FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">8,460<span></span>
</td>
<td class="nump">26,403<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember', window );">Kreos / Claret convertible notes (OCABSA) | LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretBondLoansMember', window );">Kreos &amp; Claret bond loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotes', window );">Convertible loans notes</a></td>
<td class="nump">46,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">58,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretBondLoansMember', window );">Kreos &amp; Claret bond loans | LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">24,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretBondLoansMember', window );">Kreos &amp; Claret bond loans | FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">25,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretBondLoansMember', window );">Kreos &amp; Claret bond loans | FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">8,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretBondLoansMember', window );">Kreos &amp; Claret bond loans | LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows', window );">Convertible loans notes, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">2,488<span></span>
</td>
<td class="nump">3,678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="nump">2,586<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,173<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE | LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE | FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE | FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember', window );">PGE | LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings, undiscounted cash flows</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BanquePubliqueDInvestissementBPIMember', window );">Conditional advances BPI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvances', window );">Conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,783<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvancesUndiscountedCashFlows', window );">Conditional advances, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BanquePubliqueDInvestissementBPIMember', window );">Conditional advances BPI | LESS THAN 1 YEAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvancesUndiscountedCashFlows', window );">Conditional advances, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BanquePubliqueDInvestissementBPIMember', window );">Conditional advances BPI | FROM 1 TO 2 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvancesUndiscountedCashFlows', window );">Conditional advances, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BanquePubliqueDInvestissementBPIMember', window );">Conditional advances BPI | FROM 2 TO 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvancesUndiscountedCashFlows', window );">Conditional advances, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,626<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,626<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BanquePubliqueDInvestissementBPIMember', window );">Conditional advances BPI | LONGER THAN 5 YEARS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ConditionalAdvancesUndiscountedCashFlows', window );">Conditional advances, undiscounted cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConditionalAdvancesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conditional Advances, Undiscounted Cash Flows</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConditionalAdvancesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ConvertibleLoansNotesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Loans Notes, Undiscounted Cash Flows</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ConvertibleLoansNotesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Liabilities, Undiscounted Cash Flows</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NonCurrentRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NonCurrentRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificatesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificates, Undiscounted Cash Flows</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificatesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankBorrowingsUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph IG31A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG31A&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph B11D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B11D&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankBorrowingsUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 58<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_Kreos12BondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_OceaneConversionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_HeightsConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretFinancingTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretBondLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_KreosClaretBondLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_PretGarantiParLEtatPGEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BanquePubliqueDInvestissementBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_BanquePubliqueDInvestissementBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Breakdown of financial liabilities by maturity (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>Sep. 02, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatePercentageOfFutureSales', window );">Royalty certificate, percentage of future sales</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificateMaximumAmount', window );">Royalty certificate, maximum amount</a></td>
<td class="nump">&#8364; 172,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember', window );">Royalty certificates</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificatePercentageOfFutureSales', window );">Royalty certificate, percentage of future sales</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificateMaximumAmount', window );">Royalty certificate, maximum amount</a></td>
<td class="nump">&#8364; 172,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RoyaltyCertificateExpirationPeriod', window );">Royalty certificate, expiration period</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificateExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificate, Expiration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificateExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificateMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificate, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificateMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RoyaltyCertificatePercentageOfFutureSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Certificate, Percentage Of Future Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RoyaltyCertificatePercentageOfFutureSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RoyaltyCertificatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit obligations - Disclosure of main actuarial assumptions used to measure the retirement benefit obligations (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount Rate (IBoxx Corporates AA)</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.34%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate', window );">Turnover rate, average exit rate</a></td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ActuarialAssumptionOfEmployeeContributionRate', window );">Employee contribution rate</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover', window );">Turnover rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover', window );">Turnover rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.05%<span></span>
</td>
<td class="nump">0.05%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ManagementMember', window );">Key magement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfRetirementAge2019', window );">Retirement age</a></td>
<td class="text">65 years<span></span>
</td>
<td class="text">65 years<span></span>
</td>
<td class="text">65 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Salary increase rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=abvx_OtherEmployeesMember', window );">Other employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfRetirementAge2019', window );">Retirement age</a></td>
<td class="text">64 years<span></span>
</td>
<td class="text">63 years<span></span>
</td>
<td class="text">63 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Salary increase rate</a></td>
<td class="nump">2.55%<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ActuarialAssumptionOfEmployeeContributionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial Assumption Of Employee Contribution Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ActuarialAssumptionOfEmployeeContributionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ActuarialAssumptionOfExpectedRatesOfTurnover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial Assumption Of Expected Rates Of Turnover</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ActuarialAssumptionOfExpectedRatesOfTurnover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial Assumption Of Expected Rates Of Turnover, Average Exit Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [domain]; Defined benefit obligation, at present value; Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfRetirementAge2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The retirement age used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfRetirementAge2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=abvx_OtherEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=abvx_OtherEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit obligations - Disclosure of changes in projected benefit obligation (Details) - RETIREMENT BENEFIT OBLIGATIONS - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liability (asset) at beginning of period</a></td>
<td class="nump">&#8364; 629<span></span>
</td>
<td class="nump">&#8364; 610<span></span>
</td>
<td class="nump">&#8364; 693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Service cost</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest cost</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset', window );">Benefits paid</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Actuarial gains and losses</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="num">(235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liability (asset) at end of period</a></td>
<td class="nump">&#8364; 756<span></span>
</td>
<td class="nump">&#8364; 629<span></span>
</td>
<td class="nump">&#8364; 610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 141<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_141_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Payables and other current liabilities - Disclosure of breakdown of trade and other payables (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">&#8364; 30,748<span></span>
</td>
<td class="nump">&#8364; 21,953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 8,216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccrualsClassifiedAsCurrent', window );">Accrued invoices</a></td>
<td class="nump">13,049<span></span>
</td>
<td class="nump">25,269<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherCurrentPayablesIncludingAdjustments', window );">Other</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade payables and other current liabilities</a></td>
<td class="nump">&#8364; 43,824<span></span>
</td>
<td class="nump">&#8364; 47,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 15,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherCurrentPayablesIncludingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Payables, Including Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherCurrentPayablesIncludingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccrualsClassifiedAsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals classified as current. [Refer: Accruals]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccrualsClassifiedAsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Payables and other current liabilities - Disclosure of tax and employee-related payables (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Employee-related payables</a></td>
<td class="nump">&#8364; 2,742<span></span>
</td>
<td class="nump">&#8364; 3,694<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,348<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax', window );">Social security and other</a></td>
<td class="nump">1,783<span></span>
</td>
<td class="nump">2,251<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">840<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments', window );">Other tax and related payments</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">112<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CurrentTaxAndEmployeeBenefitLiabilities', window );">Tax and employee-related payables</a></td>
<td class="nump">&#8364; 4,709<span></span>
</td>
<td class="nump">&#8364; 6,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 2,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.601pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#8211; Classification of Liabilities as Current or Non-current, and <span style="display: inline-block; height: 5.54pt;"></span></span><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;19,332<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#8364;20,652<span style="display: inline-block; height: 5.54pt;"></span></span><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <span style="display: inline-block; height: 5.54pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<span style="display: inline-block; height: 5.54pt;"></span></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentPayablesOnOtherTaxAndRelatedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Payables On Other Tax And Related Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentPayablesOnOtherTaxAndRelatedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CurrentTaxAndEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Tax And Employee Benefit Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CurrentTaxAndEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating income - Disclosure of breakdown of operating income (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncomeFromResearchTaxCredit', window );">Research tax credit ("CIR")</a></td>
<td class="nump">&#8364; 6,651<span></span>
</td>
<td class="nump">&#8364; 4,493<span></span>
</td>
<td class="nump">&#8364; 4,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Subsidies</a></td>
<td class="nump">4,140<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other</a></td>
<td class="nump">1,657<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Total operating income</a></td>
<td class="nump">&#8364; 12,449<span></span>
</td>
<td class="nump">&#8364; 4,621<span></span>
</td>
<td class="nump">&#8364; 4,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncomeFromResearchTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income From Research Tax Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncomeFromResearchTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating income - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOperatingIncomeLineItems', window );"><strong>Disclosure Of Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncomeFromResearchTaxCredit', window );">Research tax credit ("CIR")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,651<span></span>
</td>
<td class="nump">&#8364; 4,493<span></span>
</td>
<td class="nump">&#8364; 4,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Subsidies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,140<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember', window );">RNP-VIR conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOperatingIncomeLineItems', window );"><strong>Disclosure Of Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Subsidies</a></td>
<td class="nump">&#8364; 1,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember', window );">CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOperatingIncomeLineItems', window );"><strong>Disclosure Of Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Subsidies</a></td>
<td class="nump">&#8364; 2,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CIRTaxYearAxis=abvx_A2021TaxYearMember', window );">Tax Year 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOperatingIncomeLineItems', window );"><strong>Disclosure Of Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncomeFromResearchTaxCredit', window );">Research tax credit ("CIR")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CIRTaxYearAxis=abvx_A2022TaxYearMember', window );">Tax Year 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOperatingIncomeLineItems', window );"><strong>Disclosure Of Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncomeFromResearchTaxCredit', window );">Research tax credit ("CIR")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CIRTaxYearAxis=abvx_A2023TaxYearMember', window );">Tax Year 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOperatingIncomeLineItems', window );"><strong>Disclosure Of Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncomeFromResearchTaxCredit', window );">Research tax credit ("CIR")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfOperatingIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Operating Income [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfOperatingIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncomeFromResearchTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income From Research Tax Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncomeFromResearchTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CIRTaxYearAxis=abvx_A2021TaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CIRTaxYearAxis=abvx_A2021TaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CIRTaxYearAxis=abvx_A2022TaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CIRTaxYearAxis=abvx_A2022TaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CIRTaxYearAxis=abvx_A2023TaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CIRTaxYearAxis=abvx_A2023TaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expenses - Disclosure of sales and marketing expenses (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">&#8364; 185,433<span></span>
</td>
<td class="nump">&#8364; 131,997<span></span>
</td>
<td class="nump">&#8364; 69,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_SalesAndMarketingExpenseMember', window );">Sales and marketing expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Personnel costs</a></td>
<td class="nump">2,323<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Consulting and professional fees</a></td>
<td class="nump">2,699<span></span>
</td>
<td class="nump">4,012<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other expenses</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">709<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">&#8364; 5,954<span></span>
</td>
<td class="nump">&#8364; 6,431<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_SalesAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_SalesAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expenses - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">&#8364; 5,954<span></span>
</td>
<td class="nump">&#8364; 6,431<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_ResearchAndDevelopmentExpensesMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInUlcerativeColitisExpenses', window );">Increase in Ulcerative Colitis expenses</a></td>
<td class="nump">32,030<span></span>
</td>
<td class="nump">45,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses', window );">Increase in Crohn's Disease research expenses</a></td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">2,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInTransversalActivities', window );">Increase in transversal activities</a></td>
<td class="nump">8,233<span></span>
</td>
<td class="nump">4,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_GeneralAndAdministrativeExpensesMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses', window );">Increase in employee benefits expenses</a></td>
<td class="nump">&#8364; 6,329<span></span>
</td>
<td class="nump">&#8364; 11,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Crohn's Disease Research Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInEmployeeBenefitsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Employee Benefits Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInEmployeeBenefitsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInTransversalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Transversal Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInTransversalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IncreaseDecreaseInUlcerativeColitisExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Ulcerative Colitis Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IncreaseDecreaseInUlcerativeColitisExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_ResearchAndDevelopmentExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_ResearchAndDevelopmentExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_GeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_GeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expenses - Disclosure of research and development expenses (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">&#8364; 185,433<span></span>
</td>
<td class="nump">&#8364; 131,997<span></span>
</td>
<td class="nump">&#8364; 69,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_ResearchAndDevelopmentExpensesMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_SubContractingStudiesAndResearchExpenses', window );">Sub-contracting, studies and research</a></td>
<td class="nump">110,993<span></span>
</td>
<td class="nump">85,726<span></span>
</td>
<td class="nump">38,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Personnel costs</a></td>
<td class="nump">18,455<span></span>
</td>
<td class="nump">8,048<span></span>
</td>
<td class="nump">3,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Consulting and professional fees</a></td>
<td class="nump">12,581<span></span>
</td>
<td class="nump">6,561<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_IntellectualPropertyFees', window );">Intellectual property fees</a></td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">1,645<span></span>
</td>
<td class="nump">1,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other expenses</a></td>
<td class="nump">2,762<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">&#8364; 146,532<span></span>
</td>
<td class="nump">&#8364; 103,176<span></span>
</td>
<td class="nump">&#8364; 48,295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_IntellectualPropertyFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intellectual Property Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_IntellectualPropertyFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_SubContractingStudiesAndResearchExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sub-Contracting, Studies And Research Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_SubContractingStudiesAndResearchExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_ResearchAndDevelopmentExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_ResearchAndDevelopmentExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expenses - Disclosure of general and administrative expenses (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">&#8364; 185,433<span></span>
</td>
<td class="nump">&#8364; 131,997<span></span>
</td>
<td class="nump">&#8364; 69,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_GeneralAndAdministrativeExpensesMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Personnel costs</a></td>
<td class="nump">19,434<span></span>
</td>
<td class="nump">13,105<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Consulting and professional fees</a></td>
<td class="nump">7,990<span></span>
</td>
<td class="nump">6,393<span></span>
</td>
<td class="nump">2,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other expenses</a></td>
<td class="nump">5,522<span></span>
</td>
<td class="nump">2,893<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">&#8364; 32,946<span></span>
</td>
<td class="nump">&#8364; 22,391<span></span>
</td>
<td class="nump">&#8364; 7,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_GeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=abvx_GeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expenses - Disclosure of principal audit fees and services (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses by nature [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForAuditServices', window );">Statutory Auditor, certification of individual and consolidated financial statements</a></td>
<td class="nump">&#8364; 1,144,000<span></span>
</td>
<td class="nump">&#8364; 1,848,000<span></span>
</td>
<td class="nump">&#8364; 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForOtherServices', window );">Other procedures required by law</a></td>
<td class="nump">89,000<span></span>
</td>
<td class="nump">492,000<span></span>
</td>
<td class="nump">740,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemuneration', window );">Total</a></td>
<td class="nump">&#8364; 1,233,000<span></span>
</td>
<td class="nump">&#8364; 2,340,000<span></span>
</td>
<td class="nump">&#8364; 840,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForAuditServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for auditing services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForAuditServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForOtherServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForOtherServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employees (Details) - employee<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfEmployeeWorkforceLineItems', window );"><strong>Disclosure Of Employee Workforce [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfEmployeeWorkforceLineItems', window );"><strong>Disclosure Of Employee Workforce [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfEmployeeWorkforceLineItems', window );"><strong>Disclosure Of Employee Workforce [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfEmployeeWorkforceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Employee Workforce [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfEmployeeWorkforceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of personnel employed by the entity during a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial gain (loss) - Disclosure of net financial income (loss) (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_FinancialIncomeLossAbstract', window );"><strong>Financial Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBonds', window );">Interest on Kreos 1 &amp; 2 straight bond loans</a></td>
<td class="num">&#8364; (5,800)<span></span>
</td>
<td class="num">&#8364; (760)<span></span>
</td>
<td class="num">&#8364; (3,737)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnDebtInstrumentsIssued', window );">Interest on convertible loan notes</a></td>
<td class="num">(5,691)<span></span>
</td>
<td class="num">(3,935)<span></span>
</td>
<td class="num">(2,641)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBorrowings', window );">Interest on conditional advances</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(176)<span></span>
</td>
<td class="num">(196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_InterestExpenseOnRoyaltyCertificates', window );">Interest on royalty certificates</a></td>
<td class="num">(794)<span></span>
</td>
<td class="num">(8,942)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest on lease liabilities</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Increase in derivatives fair value</a></td>
<td class="num">(1,462)<span></span>
</td>
<td class="num">(3,046)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Increase in other liabilities at fair value through profit and loss</a></td>
<td class="num">(1,367)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities', window );">Loss on derecognition of financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TransactionCosts', window );">Transaction costs</a></td>
<td class="num">(1,615)<span></span>
</td>
<td class="num">(1,924)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ForeignExchangeLoss', window );">Foreign exchange losses</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(5,573)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Other</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">(16,991)<span></span>
</td>
<td class="num">(27,875)<span></span>
</td>
<td class="num">(7,022)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="nump">8,246<span></span>
</td>
<td class="nump">2,418<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives', window );">Decrease/(increase) in derivatives fair value</a></td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
<td class="nump">9,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Decrease/(increase) in other liabilities at fair value through profit and loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,198<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs', window );">Effect of unwinding the discount related to advances made to CROs</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_GainsArisingFromRecognitionOfFinancialLiabilities', window );">Day-one gain on recognition of financial liabilities</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities', window );">Gain on derecognition of financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ForeignExchangeGain', window );">Foreign exchange gains</a></td>
<td class="nump">2,774<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncome', window );">Other financial income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">13,732<span></span>
</td>
<td class="nump">7,511<span></span>
</td>
<td class="nump">11,118<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial gain (loss)</a></td>
<td class="num">&#8364; (3,258)<span></span>
</td>
<td class="num">&#8364; (20,364)<span></span>
</td>
<td class="nump">&#8364; 4,096<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_FinancialIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_FinancialIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_GainsArisingFromDerecognitionOfFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains Arising From Derecognition Of Financial Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_GainsArisingFromDerecognitionOfFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_GainsArisingFromRecognitionOfFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains Arising From Recognition Of Financial Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_GainsArisingFromRecognitionOfFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains On Financial Liabilities At Fair Value Through Profit Or Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_InterestExpenseOnRoyaltyCertificates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense On Royalty Certificates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_InterestExpenseOnRoyaltyCertificates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LossesArisingFromDerecognitionOfFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Losses Arising From Derecognition Of Financial Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LossesArisingFromDerecognitionOfFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Losses On Financial Liabilities At Fair Value Through Profit Or Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unwinding Effect Of Discount Related To Advances Made To CROs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2024-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2024-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBonds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on bonds issued. [Refer: Interest expense; Bonds issued]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBonds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnDebtInstrumentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on debt instruments issued. [Refer: Interest expense; Debt instruments issued]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnDebtInstrumentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial gain (loss) - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFinancialGainLossLineItems', window );"><strong>Disclosure Of Financial Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Foreign exchange gain (loss) on translation of cash and cash equivalents</a></td>
<td class="nump">&#8364; 2,382<span></span>
</td>
<td class="num">&#8364; (5,072)<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfFinancialGainLossLineItems', window );"><strong>Disclosure Of Financial Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Foreign exchange gain (loss) on translation of cash and cash equivalents</a></td>
<td class="nump">2,035<span></span>
</td>
<td class="num">(3,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations', window );">Foreign currency translation differences gain (loss)</a></td>
<td class="nump">&#8364; 714<span></span>
</td>
<td class="num">&#8364; (1,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfFinancialGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Financial Gain (Loss) [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfFinancialGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Exchange Differences Gain (Losses) On Translation Of Foreign Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax - Disclosure of reconciliation of effective income tax (loss) (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss before tax</a></td>
<td class="num">&#8364; (176,242)<span></span>
</td>
<td class="num">&#8364; (147,740)<span></span>
</td>
<td class="num">&#8364; (60,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory French tax rates</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Nominal income tax using statutory French tax rate</a></td>
<td class="nump">&#8364; 44,061<span></span>
</td>
<td class="nump">&#8364; 36,935<span></span>
</td>
<td class="nump">&#8364; 15,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfForeignTaxRates', window );">Tax rates in foreign jurisdictions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TaxEffectOfShareBasedPayment', window );">Share-based payment</a></td>
<td class="num">(5,056)<span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TaxEffectOfResearchTaxCredit', window );">CIR</a></td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease', window );">Transaction costs related to capital increase</a></td>
<td class="num">(112)<span></span>
</td>
<td class="nump">3,073<span></span>
</td>
<td class="nump">820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther', window );">Decrease / (increase) in derivatives fair value and other</a></td>
<td class="num">(207)<span></span>
</td>
<td class="nump">748<span></span>
</td>
<td class="nump">895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences', window );">Non-recognition of deferred tax assets related to tax losses and temporary differences</a></td>
<td class="num">(40,399)<span></span>
</td>
<td class="num">(39,612)<span></span>
</td>
<td class="num">(18,169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other</a></td>
<td class="nump">49<span></span>
</td>
<td class="num">(222)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Effective income tax (loss)</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TaxEffectOfChangesInDerivativeFairValueAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Effect Of Changes In Derivative Fair Value And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TaxEffectOfChangesInDerivativeFairValueAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Effect Of Non-Recognition Of Deferred Tax Assets Related To Tax Losses And Temporary Differences</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TaxEffectOfResearchTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Effect Of Research Tax Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TaxEffectOfResearchTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TaxEffectOfShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Effect Of Share-Based Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TaxEffectOfShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Effect Of Transaction Costs Related To Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income tax - Disclosure of deferred tax assets and liabilities by nature (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">&#8364; 155,715<span></span>
</td>
<td class="nump">&#8364; 116,006<span></span>
</td>
<td class="nump">&#8364; 77,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax assets, net</a></td>
<td class="nump">154,131<span></span>
</td>
<td class="nump">115,562<span></span>
</td>
<td class="nump">76,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_UnrecognizedDeferredTaxAssets', window );">Unrecognized deferred tax assets</a></td>
<td class="num">(154,131)<span></span>
</td>
<td class="num">(115,562)<span></span>
</td>
<td class="num">(76,130)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DeferredTaxAssetsRecognisedInFinancialPosition', window );">Total deferred taxes, net recognized in the statement of financial position</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember', window );">Retirement benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_SubsidiesRelatedTemporaryDifferencesMember', window );">Subsidies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_LeasesRelatedTemporaryDifferencesMember', window );">Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember', window );">Other financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">1,075<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">1,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Tax losses carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">152,372<span></span>
</td>
<td class="nump">114,946<span></span>
</td>
<td class="nump">77,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember', window );">Other items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">&#8364; 12<span></span>
</td>
<td class="nump">&#8364; 10<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DeferredTaxAssetsRecognisedInFinancialPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Recognised In Financial Position</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DeferredTaxAssetsRecognisedInFinancialPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_UnrecognizedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Deferred Tax Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_UnrecognizedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_SubsidiesRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_SubsidiesRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_LeasesRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_LeasesRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income tax - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unused tax losses for which no deferred tax asset recognised</a></td>
<td class="nump">&#8364; 609,390<span></span>
</td>
<td class="nump">&#8364; 459,752<span></span>
</td>
<td class="nump">&#8364; 308,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_AbivaxLLCMember', window );">Abivax LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unused tax losses for which no deferred tax asset recognised</a></td>
<td class="nump">&#8364; 112<span></span>
</td>
<td class="nump">&#8364; 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_AbivaxLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=abvx_AbivaxLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (loss) per share - Schedule of earnings per share (Details) - EUR (&#8364;)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of outstanding shares, basic loss per share (in shares)</a></td>
<td class="nump">63,046,350<span></span>
</td>
<td class="nump">43,066,012<span></span>
</td>
<td class="nump">19,092,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of outstanding shares, diluted loss per share (in shares)</a></td>
<td class="nump">63,046,350<span></span>
</td>
<td class="nump">43,066,012<span></span>
</td>
<td class="nump">19,092,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">&#8364; (176,242)<span></span>
</td>
<td class="num">&#8364; (147,740)<span></span>
</td>
<td class="num">&#8364; (60,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share (in euro per share)</a></td>
<td class="num">&#8364; (2.80)<span></span>
</td>
<td class="num">&#8364; (3.43)<span></span>
</td>
<td class="num">&#8364; (3.18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share (in euro per share)</a></td>
<td class="num">&#8364; (2.80)<span></span>
</td>
<td class="num">&#8364; (3.43)<span></span>
</td>
<td class="num">&#8364; (3.18)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (loss) per share - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented', window );">Number of instruments that are antidilutive in period presented (in shares)</a></td>
<td class="nump">29,570,132<span></span>
</td>
<td class="nump">28,754,280<span></span>
</td>
<td class="nump">1,707,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_MaximumNumberOfSharesToBeIssued', window );">Maximum number of shares to be issued (in shares)</a></td>
<td class="nump">6,760,392<span></span>
</td>
<td class="nump">6,510,658<span></span>
</td>
<td class="nump">1,707,037<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_MaximumNumberOfSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Number Of Shares To Be Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_MaximumNumberOfSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of (units of) instruments that are antidilutive in the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties - Disclosure of aggregate compensation of the members of the Group&#8217;s Board of Directors and CEO (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_KeyManagementPersonnelCompensationFixedCompensation', window );">Fixed compensation owed</a></td>
<td class="nump">&#8364; 578<span></span>
</td>
<td class="nump">&#8364; 471<span></span>
</td>
<td class="nump">&#8364; 322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_KeyManagementPersonnelCompensationVariableCompensation', window );">Variable compensation owed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_KeyManagementPersonnelCompensationInKindContributions', window );">Contributions in-kind</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Employer contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_KeyManagementPersonnelCompensationAttendanceFees', window );">Attendance fees&#8212;Board of Directors</a></td>
<td class="nump">495<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments</a></td>
<td class="nump">10,517<span></span>
</td>
<td class="nump">6,561<span></span>
</td>
<td class="num">(217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits', window );">Departure indemnities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">&#8364; 11,657<span></span>
</td>
<td class="nump">&#8364; 8,930<span></span>
</td>
<td class="nump">&#8364; 427<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_KeyManagementPersonnelCompensationAttendanceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Key Management Personnel Compensation, Attendance Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_KeyManagementPersonnelCompensationAttendanceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_KeyManagementPersonnelCompensationFixedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Key Management Personnel Compensation, Fixed Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_KeyManagementPersonnelCompensationFixedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_KeyManagementPersonnelCompensationInKindContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Key Management Personnel Compensation, In-Kind Contributions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_KeyManagementPersonnelCompensationInKindContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_KeyManagementPersonnelCompensationVariableCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Key Management Personnel Compensation, Variable Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_KeyManagementPersonnelCompensationVariableCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R137.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties - Narrative (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits', window );">Termination benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 1,210<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember', window );">Board of Directors and Chief Executive Officer | Key management personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan', window );">Net defined benefit liability</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=abvx_AdvisorToTheChiefExecutiveOfficerMember', window );">Advisor to the Chief Executive Officer | Key management personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Total compensation</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits', window );">Termination benefits</a></td>
<td class="nump">&#8364; 1,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=abvx_AdvisorToTheChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=abvx_AdvisorToTheChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R138.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off-balance sheet commitments given (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 16, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 16, 2013 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 11, 2006 </div>
<div>USD ($) </div>
<div>academic_institution</div>
</th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 02, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Apr. 15, 2009</div></th>
<th class="th">
<div>Dec. 04, 2008 </div>
<div>license</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConditionalAdvances', window );">Repayments of conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,708<span></span>
</td>
<td class="nump">&#8364; 110<span></span>
</td>
<td class="nump">&#8364; 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalCommitments', window );">Capital commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 194,731<span></span>
</td>
<td class="nump">234,908<span></span>
</td>
<td class="nump">&#8364; 201,777<span></span>
</td>
<td class="nump">&#8364; 194,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMontpellierMember', window );">Lease facilities, Montpellier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_LeaseDurationPeriod', window );">Lease, duration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember', window );">CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest', window );">Maximum drawdown capacity including interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight', window );">Annual percentage of proceeds from sale of intellectual property right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod', window );">Annual revenue from sale of products developed, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped', window );">Percentage of annual revenue from sale of products developed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_RepaymentsOfConditionalAdvances', window );">Repayments of conditional advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember', window );">RNP-VIR conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest', window );">Maximum drawdown capacity including interest</a></td>
<td class="nump">&#8364; 6,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight', window );">Annual percentage of proceeds from sale of intellectual property right</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod', window );">Annual revenue from sale of products developed, period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped', window );">Percentage of annual revenue from sale of products developed</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="nump">&#8364; 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember', window );">Ebola conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember', window );">Ebola conditional advance, BPI Languedoc-Roussillon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIFranceMember', window );">Ebola conditional advance, BPI France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity', window );">Maximum drawdown capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold', window );">Pre-tax revenue threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | RNP-VIR conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold', window );">Pre-tax revenue threshold</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped', window );">Annual revenue from sale of products developed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesRepaymentPeriod', window );">Repayment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | RNP-VIR conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped', window );">Annual revenue from sale of products developed</a></td>
<td class="nump">&#8364; 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_OtherFinancialLiabilitiesRepaymentPeriod', window );">Repayment period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember', window );">The Scripps Research Institute, University of Chicago and Brigham Young University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Proportion of ownership interests held by non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember', window );">Exclusive licensing agreement with CNRS, University of Montpellier and Institut Curie</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfExclusiveLicenses', window );">Number of exclusive licenses | license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PrincipalAgreementsAxis=abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember', window );">Research and collaboration agreement with CNRS, University of Montpellier and Institut Curie</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_AgreementPeriod', window );">Agreement, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember', window );">Exclusive licensing contract with the Scripps Research Institute, University of Chicago and Brigham Young University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off-Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling', window );">Potential development milestone payment, IND filing | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3', window );">Potential development milestone payment, phase 3 | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval', window );">Potential development milestone payment, IND approval | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfAcademicInstitutions', window );">Number of academic institutions | academic_institution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_AgreementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_AgreementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreements, Potential Development Milestone Payment, IND Approval</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreements, Potential Development Milestone Payment, IND Filing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreements, Potential Development Milestone Payment, Phase 3</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Off-Balance Sheet Commitments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_LeaseDurationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Duration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_LeaseDurationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfAcademicInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Academic Institutions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfAcademicInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfExclusiveLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Exclusive Licenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfExclusiveLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Annual Percentage Of Proceeds From Sale Of Intellectual Property Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Annual Revenue From Sale Of Products Developed, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Maximum Drawdown Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Maximum Drawdown Capacity Including Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Payable, Annual Revenue From Sale Of Products Developed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed, Pre-Tax Revenue Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_OtherFinancialLiabilitiesRepaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Liabilities, Repayment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_OtherFinancialLiabilitiesRepaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_RepaymentsOfConditionalAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Conditional Advances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_RepaymentsOfConditionalAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of future capital expenditures that the entity is committed to make.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMontpellierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=abvx_LeaseFacilitiesMontpellierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_EbolaConditionalAdvanceBPIFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PrincipalAgreementsAxis=abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PrincipalAgreementsAxis=abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_PrincipalAgreementsAxis=abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R139.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off-balance sheet commitments received and contingent assets (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>project</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCommitmentsReceivedLineItems', window );"><strong>Disclosure Of Commitments Received [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfProjectsTerminated', window );">Number of projects terminated | project</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember', window );">Kreos &amp; Claret financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCommitmentsReceivedLineItems', window );"><strong>Disclosure Of Commitments Received [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Undrawn borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember', window );">Heights convertible notes, tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCommitmentsReceivedLineItems', window );"><strong>Disclosure Of Commitments Received [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Undrawn borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember', window );">RNP-VIR conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCommitmentsReceivedLineItems', window );"><strong>Disclosure Of Commitments Received [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Undrawn borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember', window );">CARENA conditional advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_DisclosureOfCommitmentsReceivedLineItems', window );"><strong>Disclosure Of Commitments Received [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Undrawn borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_DisclosureOfCommitmentsReceivedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Commitments Received [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_DisclosureOfCommitmentsReceivedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfProjectsTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Projects Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfProjectsTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndrawnBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndrawnBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_HeightsConvertibleNotesTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_RNPVIRConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=abvx_CARENAConditionalAdvanceBPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R140.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Management and assessment of financial risks (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;) </div>
<div>financial_institution</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Aug. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expense</a></td>
<td class="nump">&#8364; 185,433,000<span></span>
</td>
<td class="nump">&#8364; 131,997,000<span></span>
</td>
<td class="nump">&#8364; 69,419,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C | European Central Bank base rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Borrowings, adjustment to interest rate basis</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_InterestRateCollarRange', window );">Interest rate collar range</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C | European Central Bank base rate | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsBasisInterestRate', window );">Borrowings, interest rate basis</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember', window );">Kreos &amp; Claret financing, tranche B and C | European Central Bank base rate | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BorrowingsBasisInterestRate', window );">Borrowings, interest rate basis</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss', window );">Reasonably possible change in risk variable, impact on foreign exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember', window );">Credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_NumberOfFinancialInstitutionsToMaintainCash', window );">Number of financial institutions to maintain cash | financial_institution</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit', window );">Balances with banks in excess of legally insured limit</a></td>
<td class="nump">&#8364; 143,881,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expense</a></td>
<td class="nump">&#8364; 10,547,000<span></span>
</td>
<td class="nump">10,112,000<span></span>
</td>
<td class="nump">&#8364; 1,390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars | Currency risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent', window );">Reasonably possible change in risk variable, percent</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss', window );">Reasonably possible change in risk variable, impact on foreign exchange</a></td>
<td class="nump">&#8364; 291,000<span></span>
</td>
<td class="nump">&#8364; 386,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balances With Banks In Excess Of Legally Insured Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_BorrowingsBasisInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Basis Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_BorrowingsBasisInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_InterestRateCollarRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Collar Range</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_InterestRateCollarRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_NumberOfFinancialInstitutionsToMaintainCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Financial Institutions To Maintain Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_NumberOfFinancialInstitutionsToMaintainCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Foreign Exchange Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAdjustmentToInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=abvx_EuropeanCentralBankBaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=abvx_EuropeanCentralBankBaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>187
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  .(>%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  .(>%IHY7U[]@   "L"   1
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MBOIR4W.QNDGG;7;]X7<6MDZ;K?DWQI7@7/#K;\8GP:Z%7_^B^P102P,$%
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M-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04    "  #B'A:/',_9^$&  "W(@
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MVN_=V.O"IGLTAE&EK]BM,K;^_;2P#1?0.=C]G5+F:+@#VA:>_@502P,$%
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M;5P\I"_?Y8Z06?J;IW%>_4M>=EBC1^;;O$C7.V,8P3I*ZK_AS]U$'!A0T6+
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MYBSBN1'H^TLAU,N)>4"]ESSY#U!+ P04    "  #B'A:]3RL&<H#   <#
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MS6KO06'0UET7U+(!I3E0F@NE>5 :@])\*"V TL)#*F6$"MF0FET[,6R]$^/
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MF_+C6H9+F2D _+Y*H?/J+ZJ"YCVZL_\#4$L#!!0    (  .(>%J03$LIK08
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M^/+DY-SA(32:>*BK&+.KZU@M]EF?*@E",#!@DTMB\/AT?)9LB^!!YV0GXED
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M(0\Z'K 9VF9%*$K,K+O:QGEG-&8X(Y_E^7YHPY5O*67>XA?Y0 N?L;994W?
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MB6LHR&@86#=N4U5-HVD?$BD$M-N<3 ^X"C$(6LN$>$/54=8U30;#.%(B6SI
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M2(@;695Z;> D"&=$Q''-C\",9!$6S(QNM7V!^K2+$8*I/Z#J]R#P,'?9B"6
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MG2R+_26&/X!9Z;P?Y!HL J;!$R)A9L <ZQ 8$_0!$P(;P>\TR&.#I@0^$RN
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MY4*K/!/73<HYA!OP 4R0*2.D>RO75I8291R^NS /H >>*B3:8!P.:S3IA2<
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M6=1KS2." MGSMAU0L\J7@5E.$UZ'N6@!*)7*1M%*O8E X? D"F@(6]Q3DRJ
M0HJ3,S6OHK%Q[KBCP#6.7<M@W[7 /AWV!?7'F@]RX?D+<L]G9:I6F^?!_;C$
MMXOJCO6+]J.G)^V=MPT>%<5RX'#5A'"PB7LX$/Z1XVJE6K90O/1#WO@-1 JV
M5%1+#+6%V"[L&93&:H<Y8]OBC #54JF AO5)M1>Q[%9[?/77*V1C3$*DT6+1
M62M@.-9/L5!RFI4P(P>T?.NB86L3%&+Y(^VWF.@?WN4>'XH]!A[B>>CV"]U@
MK$!-O;9U#(/R\5$$SL'C$#. YJ2!A=$TG(/9-8^6$JHT!7P8^2(,IBN=][!M
M;[Q/=SC[>WQ@R?GRP4E+*CZY?!+5LF(WD[A KY3WU,/AC^>HA=#=E\'[QS-T
M=!YW'.>HA9(WV)P@)K\P<9NV;X9RZ<YP 'Z79G^U8D^B<L*LW1802;KMC83,
MK>$4G8N@"-MY@Q2[W_WVBB;SSV 3K1$5&$O5"VD=LGTA0^H2#LS,;M-W^)CN
MS?W^\O7LE]=B#I[FB=DB_6JR+:#O/?"(S>'KT%$\G0J&< $^,,J5B2):,-R9
M@ZY@/S(?E$)5>R4=U%B*MP/>C@[3L\Z2>V:/5 Z7$UK5/5.J5J68@58'N8GG
M5U3.:](JNPX_V>MZC!N#!:8"N') ^VTW$CY5>I 9@$*G(T^5(9H46G3C(04(
M74"$KXM%+M=K"9':-JX -DE 7!_O[E$U.?*/W,N&9]E%6GA;96.L:D>O%' V
MMT;V84&XO]"8AR8R.&1.?M]QW[F-0^ HKICN*AUU'CVA=&W(LN-=#OB3X/P/
M0>UA#.*:['N:&^MT%$'J%?5TY^*FGN<@RO>+!3>VNNLM[L;)6RX]77/*O:,8
M-XZ+<8T3.)03V"$"SO:=-K5M)7"THVS#E)GG4!8G=[MRN@ IQZ.3Y,1U#NQ%
M2VW )_?77F 2:GI^GDRF@SV7XKO]3$EH?K:&0:G$'G;*L^&3M_RD!VFS'V]#
M!)$(NN+2B@[(L/@"?O!DQ:XW2[IKES$RHG*"EVYT[PS!5N2&VUM-IJ-I,IAT
M[M0'._^L03'AR#/ 1A^&/0%.2=OT1"%24PF(B0PX^:;4=W@J;W+)A79'<7(
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M@0_ [PL#ALC]@0N$U\C_\-]02P,$%     @  XAX6F]OV,8;*0  "H<  !D
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MH)T/(]5!8$KB-3;<$\;I%>;DCVM,869;9 B?A&0X=HN#KK7@*?15VQS2$E0
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M%!JJ;NTI$6X/\=K<"<.D3&T72*\GK-A@M6@3P(0PCV(:F[X=E;+Q61N:)?7
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M ,V2/W![#0Y+K]44X.'/Z4&3@"X6+@@1I/*XVG\9E2#$%^K&5< V83GP89'
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M-IM3JNG)%>((9QUXB=$II .'+;$6)":_;8TKWR$57B0Y0=<"P^3[X#A3;'?
MV"]62<472]$KF$D:E _C;TY$MMZ?:BE,:NEXKB0,3X;#&2"1+G]X]O+Y\CS!
ML(_%EDY<C50;%2N;ZF6 G80E7)@R/E['$FFHYF:OX/  5'B6EAJ5*G8#RD=I
MDX-$V&F'5R32>*#.&Z<0!7!]I<=PHW$H/TJ)X.!W&'$X2#[T06D D4L3U5=!
MSU2J=5%V,WW32*%/W0(++LO(*1:=7 Z'B\55(3N?EQD4_.?.BB">=G V&GJ&
MWS *8PW[QYW_6WDYG)MUR"C5;?4S"H:S%T7X98(+6C-MG _@\0IS3PKG\7(K
MF"54;$3:<H6[L!YFR(LABNKJ:7C3GPP4V@;!52N^(^E57"Z?0C>H6"1,%K*[
M9\=CW"Y5^M78D<P(P#UWH0.[EV.A<T*JW=Q%1::#H[+=@,G"&I..ZA[_I%<Y
MPR>6U!J!IEK:XR0,=[ IV(!J^D6L[U=ZHH)%!+^-SV\JVN2SAN(F@H]=$&9\
M$C&$5S75U4>>_"5)R^33B-K#H_%!PTZKE&36\961<@><QVDJC7Z.O(<'[B9Y
M4*,L_(EI3:X:4)J3N@C><A?&/2Z\%D%3J-AKK?>@$)\<-==Q\W&69'"1Q> .
M!3'=LS@&XJTM/EQ3V K+B6J*1H5YAF/.']YBY6L"]U0 >&[UPGL99I7+4R6\
M4T*D!WT5ZHGK&R8,!I$T,_IA;@)BEHU*UT\(@G&U^3&/#H^$29EW=::U^#:+
M8K=W%#1B2:X&Y27L? S=!DED820W-YR,+\F=B"$4V]IC)\,J]JL+YQ*A0+FA
M8"DIO6OO&[Z75FZ^B=3[1,&91=RU%.X::MC"]4ZYW)TK-<3XYZ:O,X&7=9"Z
ME^6<'2:*+KA2CDP\,BKP_!E;,S(X+I8H=1:"0C]R'AFKM8V2R!RH.,P]'] S
M]92,9S(UC[DQD_8^-;13@S'C966@5/GBP9''K@7H<6+!^H]E+P(+80U@@@S.
M'/BG?/0,W"F!]#AE1L+$F!!)V.MT+KY+9 R^99&G1LG$(2CE^T&=.>%]326A
M-,_"Y:L)!H_CD6N8.#5$#!;XF8N7D<J"O\KT'H^QI]0!97^LT=/@2S/<@_A*
M"=&(\8T24XD!B!>O@CO9B*A )A<PQK\I!767MELS# !ZK:1TTPQB5;@1_;D1
M*54%?P>U ;\KM"N>+(6Y))Z*]45-%1\'>AQJHKIT<I8R.#_DG"H!.GFT893L
M7^S"\R@T;#C:$U(P(,Q4;1IXA:NT\_&X>%'&G/14YGE:,?(XNT/N[B"F0V:5
M*P\"S0W*=69J873X7< GQ@[_'$B#()V/KV.I$&!O#Y-%!AFP'M\U,2T'0@#7
MGPN;@E.4PP?!49@BVP&:FNT6<+!LHSF/X1ZYP^# 5Y-ZRV*F2GIX9"QP7E&Z
MA_HB$/#I]'4?Q/P+EUH?U&H+VEGX$_!<(4AS2AFB]0D+K>Z@D&>/E5M.QD$+
M5H]70.9<:K8U0TGE2(<B/2B=<.57-8(\PUM.4JPTO86A? F(L@@.1&,@Y$>-
M@[ B".XKCB3:#!=%_7'%T="B"*[NE: !::_5*CE5&0R-+W#[NJ4B>Q-U('$7
M$RT@D=RK-RC<]?DI=>RC%SG=Y0G@_/CFO'<3A)GZ;;"9%0K(N08Y Q03&QKD
M6LU[2CA'=&3P*\<@'0HJYR38_^SD*LNU5@80YI[HBO%IN54DR/^$F1J^CZ=W
MEXUQ0S%ON\M@W04^*9D]7739XX.SG9HL7@(TGJN>[^$[/?/@1!U6*@7;Z\$:
MI;Z>RXKNQU;>\_;4\V5X\ '31MI&K@]*H_L!WB.O7X$Y4,I=XBNL>.?SN3"A
MU[C+.GFGO0-SE0)Y%RO^)#[>VMSS/;T7Y^?_07^T=E?LXR26<#1\J@+WVR()
MKI<.WI$C)]+^+H6]37=.D3,6O >F.B?@$<1.5\2X>W:!N[A684EAS+ZMQ>GC
MTO5TXB4NSR(G@O@(F*2]^,J2(CWY[)$VJ.$R2N+P0_2M\4PF-=. +!1'[5S&
MS/!B*\3%FY+RPO/9]L)5\6EIJ-2$SD0OO5I9ZEQ'S+",QY1:9@@Y=QRV7TSP
MQ412:=@<A7"96S E#N,ZO%88+M'ZC)1"+L>7$.34Y @/@/ID>SW4AWR$J&DC
M80-_T0*"#STZ_IG<+NH_*7R?LRDD3N\R@$81^4N>I1Z[7X@F'5Q4V<AMJ%O2
MF-Z209+Z:Z)"ZR>Z!GU.8TGDGB[42^BV*%<-*P KPRHM*9]Y#1=YX<YX#$P3
MO25*\7^4Q7Q)VD*DJQY*HV*(B$O?ZT%!D[^0^[(& !<QRVAN0^MG"K?W13D#
M8RCCPIN3=V#[$XL2YFFQ7%KNKLT(0!^?U#)<(5_9CPK5#N_TLG.+(P'T5V?=
MFU=GA87_9/"_MKF'_Q(0\PZ6Z\TKVD_7IBS1F(,>7A]=' 6_8DC@]='5Q8NK
MU=$9?.E??_-JGV[-SRD>N,!@W@8^/5_^^/R(=Y'^T35[;!(K671-1?_$^RM-
MBR_ \TT#*D/^P [NF_8K#>_-_P%02P,$%     @  XAX6OEJ88>' P  !@@
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M(OQ:<XZ-;%';=N/@YH$626)@AKEB.M@@&V.%32VOP9U$8VT$XJ/SX48$;*V
MR1 &&GN,Q?!%I7)=WH>'$VQQ8P;^4:LT@82)$!CV3,2QBR0GL+=O3MM=_YW?
MP7TJ-80I),QY8GF\1$%XS=899@/-L(C8UV2#$AE/WL,*)8)QTDQ_\$?KK%MW
MT=ZS**7L0$J!(AX16#&A\Q5T;C";!M-K%83"),I@!O.L9D@P_'@'2T[H4D3D
M'Y>Q!S).>1]X-61UB'^,@6J7W4BAKRV::QXHC:T(8:H)E5SM,,_ J4&?0L.)
MX1PFRG+H5NM8R;R4>+A$;*DTRPY0]/9,28>3V;SF3H($E2(HFZB/HD3[W R1
M$G]UP9JO*!@A(C.]HZW)!H]L9)*5S>_Z+CR,[Y99W(26P;=4:$[DD,4Z(^0F
MD3:%C9:W6IF=Y'HM6(E4M];QSAYXG02K>I9#OYII(]F[P+Z2RF()++!8:2O^
MY6$-C,!0&;8/*2-/K*FY1)&%D-A'5"Z,(M<*TG=:H>R5ZFXQ7Y"D&J7%31VN
M<RB'M.= DEA+<DSI.MS[Q+'@A_1DP,GSKEBDKD<MH**0$U:*24R*.QJ<KI8[
M1Q2G\75.S.K0I]($"NE\2SGB9>&1=4 29>3"*6C<GT.[6Z-TFH+4EJ-CDR[_
MP7.'DL1(A)).H!^C/]HS^-MV/NE54LLU%Z+0*)Y<,T1'[IYT4M:1I<3AR8;"
M<]EW(EFJ>_X+[4>9X/(+FO/5C8EJQ8JD5$$G@PS7!<M35&45KL?#T60XFL-\
M^F'QN3_#T6U_,9HLYK"8+OK7\'$VG<_A4__Z#I<PR],/\%M_<M>??8&]E],.
M>#ZT6DWHEX3?[E!(7LM[!YG4\1<%F$&\'PU'-X/1[(%JRVL2RGYKM]=^A+:'
M.O9_&+;]4MAV:708RL^@>B6HWL]GMW\SG2W&?_87X^GD2';WQ$Y:O>KCA[$,
M\$,:]5[,^M5'X_&#?D[\3O5)TMSDL8*XQ1.O58+L=@\Y;9=V>,?PVGN\,L7N
MV2&\LL?6,3Q_CU<*ZZ37K/Y\22:C!0RFT]__5_.GA>.S8Z+QH-=!1162:?:.
MIJ?WM%VZS6/MXO^(VSWTF=@H?=?'^/IQMQ?ZG,#\9)_XQ6QQ0>IG]X*'[=GM
MZH;AVTL:_!Y9H6FSWNM40&<WENS!JL3=$I;*XIW##3=XR>.:-N#Z2N&K+7\@
M!\6U\>H_4$L#!!0    (  .(>%KRX?VU+08  *H0   9    >&PO=V]R:W-H
M965T<R]S:&5E=#$V+GAM;+U8^V_:2!#^5T94JD#BP+M^DI<$"6WH-< 1:'4Z
MW0\.+,$Z8]/==6C^^YM9&V-:R+4YJ5*PO:]O7M_,[N9BF\I_U$H(#5_7<:(N
M:RNM-V?MMIJOQ#I4K70C$AQ9IG(=:FS*Q[;:2!$NS*)UW.:6Y;778934KBY,
MWUA>7:29CJ-$C"6H;+T.Y7-/Q.GVLL9JNXY)]+C2U-&^NMB$C^)>Z-EF++'5
M+E$6T5HD*DH3D&)Y6>NRLYY#\\V$3Y'8JLHWD"4/:?H/-0:+RYI%"HE8S#4A
MA/AZ$M<BC@D(U?A28-9*D;2P^KU#?V=L1UL>0B6NT_ASM-"KRUI0@X58AEFL
M)^GV5A3VN(0W3V-EGK#-YSHH<9XIG:Z+Q=A>1TG^#K\6?J@L"*P3"WBQ@!N]
M<T%&RYM0AU<7,MV"I-F(1A_&5+,:E8L2"LJ]EC@:X3I]-9887ZF?F[")PT1#
MF"Q ?,FB#3I>7[0UBJ")[7D!U\OA^ DXQN$N3?1*03]9B,4A0!MU*Q7D.P5[
M_$7$&S%O@<V:P"WNO(!GEP;;!L]^C<'P5_B@M$2J_'W,]AS9.8Y,Z7.F-N%<
M7-8P/Y203Z)V]?8-\ZSS%_1V2KV=E]!_/E#_ PZF*P'+-,:,C9)'T.%#+!08
MHW!PO@J31VQ'"7:]A!(E\SA;& 3$DY0?D"XA4X)>H5)"*ZBG$MZ^"3BWSB>C
MF?EBYPT<I3D8?+%^$')' &Z>MI%#?#B#>KA.LT0;;?0JS10.F:4BDZEJ0&\V
M^'@S&+Z_A_X?L\'XKC^<PKO99#B8SB9]Z YOX'IT-YY-^Y/*A.EHVOT(HW?P
M^79P?0NH%[R?C.[OX5/WXZQ_#]U[&OS0'<ZZDS^A4 W<C@V.Q8';+O9QVP(O
MX-"=HS]49$H0:WHL +L#C#%L^%Z 3\?G<!.I3:K"&.H(TH Z_5B#6GZCZ,ME
MWO2O^W<]5';GD +3L3VP'0]XT[$L[',]=B#9=K'7LH%AO\<<T]X+]3A',1QE
MD?\9/\<NI],HGL<E(U:3)+K,!M?R4;+M>62W=V@S;[I^4.+R#OJG&?@6/CGS
M*SJP)F-610'&2 '$X_3N^&X#^LLEUG(*+O$IIR'%';<F++X)EDLI13)_!O&U
M&)2A1J(Z)2I*1)?AWW&;'-(-O4DV>1WT:M/B';+ <GX9T6[ZXTG_>M"=#D;#
M$T2K.XY+)'$\\I#MD'\X]3@^>G"0S'%WQARK.Q:QQS9S QH.B%,.PP6EWXFT
M&$I\^^;[%,WJW*4XV#X!,9^  HN^>>= IFLFV*19AQ3SC0Y.)ZC(+,G@5S_Q
M[Q33ZH%M+ GHR3W7$,,)2)+OL:KX("#)-B^59$TK(,7]H*H!D8WM68'A1:(Q
M%Y!F/\.R*LDH7W> >Q+G>7R*;76/V28BQK6YUIA&U.<2X7\5YX;]*?1&H]]?
MKF_,P<S %+<8V)8+:.$+1<EV.\@G3#BJA6Z'NCAF_:D(NPC*.-8OK$L!U@MJ
MG\Y1CN([6,0\*GB>*3L=3-1)=8<IMA<I8@P/Z!0>LBBFS4@UX4FLHCEM:;2/
M+#.91#J3HF6VO00/PG2(A*<PSLQ&)4_"+@YP(8]6WHL4L#WGG.J74\8.FKM^
MQ[7WO?0KYP=84_<C/[0+HC9J(\SQ-GYN5:LO+G_"=43D9Q%*$'0H^QX/Z/0>
M/Q<;MOA^NS965XW6QE-;6.$]X$L62BVD0G1\X7B4X RD[(<,,?/JH82 88J!
M8&XK:#3)L"V>Q',#E]$<CQN1UKD7T:K!='^,:)5I6[$&3QU1NO@QO=6WBM-5
M!G&JNK_":_;KO=9+\5R?%)9_[[<ABC>22$J+!)OJIHX*%&L<R^B5E$7KO[4@
M0$14U57C4$8*;JL1C4U5Q<]UD[R&L2E(3FL*RN+A84_8;P)]RJU%^(X[UGEE
M6,FSN0T'K"2UZ$ZR0;Y%*.64U^_"9S.WNY%1_'U>'7"6Q+'?##EP+Q!;W%(*
M)WX3VMR!AUZ!1I72KR)1P> CUAJ!3=AB@5L5_C69F(C<I-:QJTB[<G]$W$=S
M2U8PITCG5\FRM[R(=_/[YWYZ?HN_"^5CE) >2UQJM7RWEMNS:^AT8VZC#ZG&
MNZWY) .$I DXODS13T6#!)3_GKCZ%U!+ P04    "  #B'A:[%1ZWY4&   5
M$   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6R]6%MSV[P1_2L[^B9I
M,L-((G6/+S.^I5_:)O'8;OO0Z0-$@B(F)*  H!7WU_<L>)&<V&F^//3!$8G+
MV;.[9Y= CG?&?G:%E)Z^5J5V)X/"^^W;T<BEA:R$&YJMU)C)C:V$QZO=C-S6
M2I&%354Y2L;C^:@22@].C\/8M3T]-K4OE9;7EEQ=5<(^G,O2[$X&\: ;N%&;
MPO/ Z/1X*S;R5OJ_;Z\MWD8]2J8JJ9TRFJS,3P9G\=OS*:\/"_ZAY,X=/!-[
MLC;F,[^\STX&8R8D2YEZ1A#XN9<7LBP9"#2^M)B#WB1O/'SNT-\%W^'+6CAY
M8<I_JLP7)X/E@#*9B[KT-V;WNVS]F3%>:DH7_J5=LW::#"BMG3=5NQD,*J6;
M7_&UC</!AN7XF0U)NR$)O!M#@>6E\.+TV)H=65X--'X(KH;=(*<T)^766\PJ
M[/.GGWPA+>5*"YTJ49)P3GIW//+ YA6CM,4Y;W"29W#BA#X8[0M'5SJ3V6.
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MGHN"P!9R&OCHOT0*Y"+3%Y1829E+@ <R8$X3=>\G7(10_V;7^E)S35Z8R59
MF<"42A%-GB[DGA%>/8-DL&XLW0F(P]D4KOF[#>4')FRUDMEF)5A9:%59N$X%
M3%+>N%A'LEA9A3R0]L@VG1N2P2I0)^727@$8)!0H?Z4!SY(G.:QJ -U!RZW4
MWW+5/ZP2)92C)%Y"4!87? WI?2N?:>A>\TQ3Z:[#&9)/=O7FR184%$WR)):F
MP.1$^4_64-)EI*B:#O:%EB_H'SH<N2!M1]-H!>[E:23D9 P^.%Q:NJ_B
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MCI"Y (]%79);VFO4P0ABL=D_@ O\Q%-#2O ( G\?F 3N!!Q'?H'2L (K<W8
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MKP.M C*P>Z:++/5$TV+C@3&&M_+C$-JH]Y(?K11M-I(H:P!8X0C*$J_K'P(
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M@[T_,GCP1P97H,WLC\S61MO@6J WY[N<(C7A/YYX?3#2:8VZDI@3;M11H@I
M9$2UJ*4.9#D?!,VYBMWIRDV[XQ-IN7P3BF2-Z"9BSS)'5<Y693+>B-JYEJ0!
M!I 8T4=<QGZ8]2ESAP7,++&47=:NB1*M'67V5L >Q(<B@JUE\U*.MX9"C:*
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MO](M@6_ S&U->Z5/D36=XJA199]53DEZ,2S*XH&,I\<CC^Z2B=_2EV3JFH<
M$5W:B#2DNGJN=Y=7,]]9%J5$TA/BRB7,JVY5#::4;%55Y4AX3951A-.UZE:E
MAU)+(L]62R37T"*Z":R*DQ6OY%1H(SPDK$=7!M+I5*6<3;]!/@-KM_9H4$;B
M6524\SE B:K&GD>HL^<KNM4!?RT,R3(L2]RSHWJ,LE"A3*[K_@,V=.EJGDZ
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MG)S/\>=DYC)M#+.< YJB^6PFDB2*%S/Q[OKEY5L8MX@6L_/.NFSWZ@ S&\@
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M4N[P/0);R=_VLFZ44,,#MV6^!C^%Q@/FOYCMD^L"6%U)%Y7Q"/:Z$!%*QM]
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M7[LILLM5LS<<IATWQXM):ZTF9%J!YB:!1+YH:UO8B7&4=%8%]9BC49"G5RM
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M<B9>L:$JOLZ!P'DTG\>B5:ZDC!7)?273QH8*0 G7PT;"?-GE*26?LL+4ADV
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M')>KC$2*L@OM V85K7A>@JXT"7@3P<>O7.@Q8<(BW#C>2U=>/$BQ!<):'Z^
M!)\"IM*V?.EJO9++L)3KP*!0^&7*?BZ=I$"DZ*LI%P"I#L+D;*1=@W.E/0I5
MYH:?82(<KQ(4#>88?45%,8<3Q"LE]/+U![VRMCI^'J(VT1R :DLER\XU.H+
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MRW/+A@&IG+3N4M1@Z+<:UVUQ]J#IIJ>L7;HX7&\ [C!X1P4]VW<<Z-O.P(?
M'CBG_U'2RU@;U$&J.]CW2,K?D]03KU96<<J*-;8=1'(J:+PQZ8%&EK=YTW'
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MA2("W)]*=%/]00*:/RF._P-02P,$%     @  XAX6N;&LUC.!@  /!   !D
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M>-;>")^&M_?JSTQN.*5V@6LR=<=)- #9WE7;#RUJ>S]<"4VW3?NZI>L]2C.
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M'\V=^=^*]</]+^X^2JB](FJ]P*.'DV?'.YY\QS>-J?F78ZEI4 SRRQ6?:-
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M\I0%4 4HO*F/0#T#+O"OPX9]N]_D/)@M9-P&WZ$78@/LQ+4=)TJVLI=9W!H
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MJ/91[Y,YC4:_)\?U.=4%=F+$!Z5O:H,HCTL.3QU27SU<I)RM(C6HN<;A\41
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MW>48 P"X!; +$9Z2H]I;01YRFCQ7A ?![60Z[1)R@E?.BPCT)"S BW-%T,/
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M@@UBQY(L(;O;^Y;HVBK?YIN85M.I>R.?7#G! MK@4\\C<+?HT5CUR%S>RCJ
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M2>W$X.,)%V>2C4>"#J8\LH0EB^,BGU+:P]26DA1XK#(X"DSTIMQANL, GGF
M9+R3U#[VK/D0&H;ZV[,'"G"+$;3+O^S1GKZAZC99NM-I'SXH5N;E:BY(?E5
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MZ1]=O<,A,1NGJ[?TSUN7P\[Q!7B^KD%XE3]P@KNZ^43+^_'_ E!+ P04
M"  #B'A:2?![6EP$  #M"@  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6R55MMNVS@0_96!"A0)D%J6?,FEM@$[<;$&MALC]>X^+/:!ED8648I42"I.
M_GZ'E"P[C>-V_1#Q,G/FS(V9T5;I[R9'M/!<"&G&06YM>1.&)LFQ8*:C2I1T
MDRE=,$M;O0E-J9&E7JD08=SM#L."<1E,1OYLJ2<C55G!)2XUF*HHF'Z9H5#;
M<1 %NX,'OLFM.P@GHY)M\!O:/\NEIEW8HJ2\0&FXDJ Q&P?3Z&8V</)>X"^.
M6W.P!N?)6JGO;K-(QT'7$4*!B74(C#Y/>(M".""B\=A@!JU)IWBXWJ%_\;Z3
M+VMF\%:)OWEJ\W%P%4"*&:N$?5#;W[#QQQ-,E##^+VQKV>%E $EEK"H:96)0
M<%E_V7,3AP.%J^X["G&C$'O>M2'/\HY9-AEIM07MI G-+;RK7IO(<>F2\LUJ
MNN6D9R?3)%&5M%QNH-1<)KP4:.!LQ=;T/1^%EFPXR3!I\&8U7OP.7A3#5R5M
M;F N4TQ? X1$KF48[QC.XI.(=YATH!==0-R-^R?P>JW'/8_7^[G'R[W'_TS7
MQFJJD7^/^5PC]H\CNKZY,25+<!Q08QC43QA,/GZ(AMW/)_CV6[[]4^B3.VX2
MH4RE$51&!4<F$LY\29>HN4K=<:FI3;5]N8!2,&F!R13PL>(E]8\]YM%)F\<]
M6IZR 8SXM>0PA<JX"-L<P<75]<8G9P4*M+GC_(3:WZ*QO&@T,*L$")YY3]TE
M,P9M!U:T;*J3B;W<$^6-E:7@I.S,,P.9$O3,F!NXFR\?YK>+Z6IQ_P<LYP^+
M^SN855RDQ,K ?9;Q!"'CSY;B:KPK&;?67_;@!9FF)HC.8=[ZMY I=:/F1,#1
M=0OS0P@&8!5$W49]A4DN>4+R&4NXX):3H=<B7RHMN6/@@1)5E!4A[Q%O=D3?
ML[%8'5SUWJ"V<LZ5DSX?R8*+;J(TB9:*1,FLR\B2:6X@I^?_L6*:V-9 ,T4O
ME:2T.1N&7FO#TXI<W^.>Z(1!VPF#_]$)C#*=U'W@=@G%P7"_38C,L9H_C>Z*
M[#6FK\ ?<(&\/ZRSLVGA7A,#7)*\J@Q%PSAEK+0RYU!?[X!=H?K;*96S@/I1
MB^&6F9P*'$OVXC-9L!0=(%U&T&E^T(L'\+MB$C::V@]]2J@GS8M$O>&L58@N
M^MUN@_D6,&X!:]3XXIIPIP=N9HAUQ73>_T%_.(0YT_(3_:.GGF8N*^2<I6+G
M&IZ8J'#/G!CUA[!2EBKB34#WH6FDAQ>#84R%9M'%]02)H\1(.[ZNO?=-Y1:N
M1XC243SHQSMF[K'Y58/.SF74: K.UKL._[GFV?5YHR=IZ/I%JTU4ZD:&;<Z3
M'#Y^N.H-^Y_[@Z@M/=BB>X>Y65?:4$AW->&N&O%HL)=N2J)3Y]]ET,>+-35-
M!;:S$>^5.L=:.3P800JJ1S]HN0>$@.III#UM9[EI/<+LQ>M!\"NC<I8&!&:D
MVNU<4M_J>KBJ-U:5?J!9*TOCD5^Z!PFU$Z#[3"F[VS@#[80[^0]02P,$%
M  @  XAX6L;N27%$ P  L@@  !D   !X;"]W;W)K<VAE971S+W-H965T-# N
M>&ULI9;=CMHZ$(!?991*%4C5)G%"PFX!*;!L2[L+*\BVZCGJA0D&K"8VM9W2
M\_;'3DB:;0FMU)O$8\]\\V,[D\&1BR]R3XB"[UG*Y-#:*W6XL6V9[$F&Y14_
M$*97MEQD6&E1[&QY$ 1O"J,LM9'C!':&*;-&@V+N48P&/%<I9>11@,RS#(O_
MQB3EQZ'E6M7$DN[VRDS8H\$![\B*J*?#H]"275,V-"-,4LY D.W0BMR;L6_T
M"X4/E!QE8PPFDS7G7XPPVPPMQP1$4I(H0\#Z]8U,2)H:D [CZXEIU2Z-87-<
MT>^*W'4N:RS)A*<?Z4;MAU;?@@W9XCQ52WY\2T[Y] POX:DLGG L=7N.!4DN
M%<].QCJ"C++RC;^?ZM PZ+<9H),!*N(N'151WF*%1P/!CR",MJ:909%J8:V#
MH\QLRDH)O4JUG1K-F,)L1]<I 2PE41(Z,=:2[ YLI?E&RTY.K'')0BTL%\$#
M9VHO8<HV9/,<8.O ZNA0%=T8723>DN0*//<5( ?Y%WA>G:U7\+P_SI:K/1&@
M]IC!CO/-D:8I_(O74@E]7CZ?JT'IP3_OP=RA&WG "1E:^I)((KX1:_3RA1LX
MKR_$[]?Q^Y?HHULJDY3+7!#@6WTG$LX2FE)<'' ]0W_.[UP"EUUT<,9SIBM#
MF2X+SR5F&VG8)!=<=N%^-IG.)],5K!9W\<=HJ4>/43R=QRN(%W%T#V^6B]4*
M/D3W3WHI6L'B#MY%\Z=H^0G*C430[P'RP74=B)*O.96TB-_KP<L7?>2BUQ"\
MZJ%K\PS\$^)V.ID^C*?+ZC0@<)%C*)5J$'K/:!6J[7T>Z_TIUFN,SJ/\$A4V
M4"'\=76CA\4RGOT3Q;/%O*6Z56 =-^P^%V8LT1]N27[,^MUGXUEVP%3H;Z[2
M8J_[2]&*R;8-*18[R&T@@^"<4Z^A@=IX7L5KAAA<G^,U/;IM/+_B-=+JA$[W
M[[=D/HUAO%B\_^V9[]>.K]L.#8*PIT]4?62<L+4\X:_7)7#:KHO_,S<X]S6R
M&WTD(V)7=$L)B:E/V5+JV;HA1V4?^J%>=O,'+':424C)5ILZ5V'/ E%VR%)0
M_%!TI357NL<5P[W^J2#"*.CU+>>J$HR#^C=E]#]02P,$%     @  XAX6D4P
MEAG(!   CPL  !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&ULO59MC]HX
M$/XKHU2J0$(E=M[W!0D6MJ77!8Z75J?3?<@& U%#3&W3[?[[FW$@RTH+TMV'
M2I#88_N99\;/.+YYDNJ[W@AAX->V*/6MLS%F=]5NZVPCMJG^('>BQ)&55-O4
M8%>MVWJG1+JTB[9%F[MNV-ZF>>ET;JQMHCHW<F^*O!03!7J_W:;JN2<*^73K
M,.=HF.;KC2%#NW.S2]=B)LQB-U'8:]<HRWPK2IW+$I18W3I==M7S:;Z=\#47
M3_JD#13)HY3?J3-<WCHN$1*%R PAI/CZ*>Y$41 0TOAQP'1JE[3PM'U$O[>Q
M8RR/J19WLOB6+\WFUHD=6(I5NB_,5#Y]$H=X L++9*'M$YZJN2%W(-MK([>'
MQ<A@FY?5._UUR,/)@M@]LX ?%G#+NW)D6?93DW9NE'P"1;,1C1HV5+L:R>4E
M;<K,*!S-<9WI3!3NKS+/+=@5:6D@+9<@?NSS'2;>0&.>/A9"-V_:!GW1BG9V
MP.U5N/P,+N/P($NST3 HEV+Y&J"-)&NF_,BTQR\B]D7V 3S6 NYR_P*>5T?N
M63SO?T7^=_JHC4+-_/-6[!6R_S8RU=&5WJ69N'6P4+10/X73>?^.A>[U!=Y^
MS=N_A-[IYSHKI-XK 7*%=9'),LN+/+4B1\ON4EQO!7/9W7PC8"4++-Z\7(.Q
M>@ ;%F)GF[1<8S\O+[O%"5FQ7UH$Q%-4*L1UKVT0J=;":&A(!>_?Q9R[U]/Q
MPK;8=1-':0YNO]@^"G64 +=/S_HA15Q!(]W*?6DL&[.1>XU#=JG8*ZF;T%L,
MO_2'HX\S&/RY&$X>!J,YW"^FH^%\,1U =]2'N_'#9#$?3$\FS,?S[A<8W\.W
M3\.[3X"\X.-T/)O!U^Z7Q6 &W1D-?NZ.%MWI7W"@!D'B@>]RX%Z -NZY$,8<
MNAGF0^=VHU@K9#%X"3#&L!.%,3[]B -N[T[JM( &@C2A07_6I%[4/-@JG_W!
MW>"AAV2/"3E@^EX(GA\";_FNB[8@9*\\>P%:70\8VD/FV_Z+TY!S=,/1%^6?
M\6LT^4GS\'S;,V*UR&/ / C<"#U[84AQAZ]CYJT@BFM<GF!^6G'DXI.SZ(0#
M:S'FGA!@C @@'J=W$@5-&*Q6>*S3YI*>*AG2ON-7"L_A$D].I429/8/X=1A4
MJ4&A^C4J>L24X>_MF'SBAMFDF,($L]IR>4(1N/YO$UI_,)D.[H;=^7 \.B.T
MAN\')!(_I QY/N6'D\6/,(/#,L,/-=98PW=)/9Z=&]-P3)KR&2ZH\TZBQ:W$
M=V3;YV36X 'M@Q<1$(L(*':IS9-7/@,[P2-F"1&++ <_B4]\UF*(3IOX.Z>T
M1NS92&)Z\C"PPO!C\A2%[-1]')-GC]<D6<N-B7@4GS(@L;$75>#VHM!8 "BS
M_Z*R4Y%1O1X!7T1<U?$YM35"YMD=L:FM6&,9D2T@P?\NS8T&<^B-QW]</M^8
MCY6!)>XR\-P ,,(+AY(7)*@G+#@Z"X.$3!RK_MP.!PC*.)Y?>"[%>%Y0_WR-
M<G2?X"$6TH$7VF,GX<E;G]GVR25I*]3:7@4U9)36ZKY46^O;9K>Z9+U,KZZJ
M#ZE:YZ6&0JQPJ?LA"ISJFW;L&+FS5ZY':? "9YL;O#$+11-P?"6E.7;(07T'
M[_P+4$L#!!0    (  .(>%I%G8A? @,  -T&   9    >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;(U5;6_:2!#^*R-7JEK)%]MK R8%)"!$C=0T4<BU'ZK[
ML-@#7L7>Y7;7H??O;]8&A[L"Z@?;.[,SSSS/OHQ'.Z5?3(%HX6=52C/V"FNW
MUT%@L@(K;J[4%B7-K)6NN"53;P*SU<CS)JDJ Q:&_:#B0GJ34>-[U).1JFTI
M)#YJ,'55<?W/#$NU&WN1=W \B4UAG2.8C+9\@TNT?VX?-5E!AY*+"J412H+&
M]=B;1M>SQ,4W =\$[LS1&)R2E5(OSKC+QU[H"&&)F74(G#ZO.,>R=$!$X^\]
MIM>5=(G'XP/Z;:.=M*RXP;DJOXO<%F,O]2#'-:]+^Z1VGW&OI^?P,E6:Y@V[
M-C9A'F2UL:K:)Q.#2LCVRW_NU^$H(0W/)+!] FMXMX4:EC?<\LE(JQUH%TUH
M;M!(;;*)G)!N4Y96TZR@/#MYL 5J6 O)929X"=P8M 8^//-5B>;C*+!4Q(4&
MV1YPU@*R,X 1@WLE;6%@(7/,_PL0$+N.(CM0G+&+B#>874$<^<!"EES BSO)
M<8,7G\,3)BN5J36"6O\J_0=?&:OIM/QU2GP+G9R&=C?HVFQYAF./KHA!_8K>
MY/V[J!]^ND \Z8@GE]#_1UR=W+E3G"^CGCD!*[KB+Y"K'=T< VM5TO4UU_"!
M5ZJ6-"\DV$+5ALO<.#I8:V4^PG0)#[=PLY@O[F>+I\.VL3/^^(P_@8?GSV3>
MWGV=?IW?3;]0W'+QO(1I_DHTT5 _*+G%'*R"^=,#9'3DW)X9B$(_&400,3\:
M,$C\(1O"#6Z5$6[29W$*O4$":3^&5OG[=RF+V"?*2.CIP[.RM KMZDHE_\AJ
MK5':7U<HBOQ!F+I*Z2"$GC^,AK_![U#N\!WX293NJ0CYBL92RSN*&_IA+^RL
M-R5QOWF.V9YE^H85I7VJV.LE<&;;]Z(8H[(]JD"+&9\ZNL%1RZE0;YK&:D@G
M'8ZV^W3>KG=/VY;U%MXV_GNN-T(:*'%-J>'5H.>!;IMI:UBU;1K82EEJA\VP
MH/\/:A= \VNE[,%P!;H_VN1?4$L#!!0    (  .(>%ID/#._%P,  /(&   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;(U5;6_B.!#^*Z.L=&JE;/-F
M O0 B;=J*VVW%7"]#Z?[8)*!1$UBUG9*]]_O. DYV@/4+XGG[9EG//9XL!?R
M126(&M[RK%!#*]%Z=^LX*DHPY^I&[+ @RT;(G&L2Y=91.XD\KH+RS/%=-W1R
MGA;6:%#IGN1H($J=I04^25!EGG/Y:X*9V \MSSHH%NDVT4;AC 8[OL4EZK]V
M3Y(DIT6)TQP+E8H")&Z&UMB[G3#C7SD\I[A71VLPE:R%>#'"?3RT7$,(,XRT
M0>#T>\4I9ID!(AH_&TRK36D"C]<']+NJ=JIES15.1?9W&NMD:/4LB''#RTPO
MQ/X;-O5T#%XD,E5]85_[LKX%4:FTR)M@8I"G1?WG;\T^' 7TW#,!?A/@5[SK
M1!7+&==\-)!B#])X$YI95*56T40N+4Q3EEJ2-:4X/7K4"4K:W0C35[[.4 $O
M8A"5EBN%6L'5JC)<#QQ-"4V8$S7@DQK</P/N^? @"ITHF!<QQN\!'&+:TO4/
M="?^1<091C<0>#;XKL\NX 5M^4&%%YS!6TD>XU')QQOQ#U\K+>G8_'NJ\AJ7
MG<8U5^E6[7B$0XONBD+YBM;HCR]>Z/YY@35K6;-+Z*-9JJ),J%(BB,T)YA];
M>(K_Y0R?.!9KF@$O$(L]72T%&Y'1_5:W<,5S419D3PO0B2@5!2I#$TLIU#6,
ME_!X![/Y=/XPF2\.O?3/Z(,S>@:/JV\D+DA__SR>?)\O8?QCUFC'R^5\M80G
MB3N>QH!O-,(4U? 5"AH$42DE%AH\VPVZX-N![T*?]6 E-,^,Q]>#Q[MZ/[HO
MJ*U<1@EH_@:1Q#C5<&5-[Q?6-3"[T^_0-W1=Z-C=+H/G\>K==@8V"[O@,9L%
M?>C;/>;]GV[?ZYAH%I*W'P0PK9,40I/1[S (76AYO^?\L7--#7W"\<!GE*\#
M7L_N]4/X1*L]U_;#'OA=VPL9>(9N<.H8.T=S*$>YK::M@L@<B'HDM=IVH(_K
M.?:?>_T:/'"Y30L%&6XHU+WI=BR0]82M!2UVU51;"TTSLEHF]"BA- YDWPC:
MID8P"=IG;O0;4$L#!!0    (  .(>%IP0!X&FP(  .H%   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0T+GAM;)54;6^;,!#^*R<F3:T4%3"09EF"E+>JE=:N
M:]KNP[0/#ER"58.I;4KW[V=#PK(IB;0O^.Y\]_AY;.Y&M9 O*D/4\)[S0HV=
M3.MRZ+HJR3"GZD*46)B=M9 YU<:5&U>5$FG:%.7<)9[7=W/*"B<>-;%[&8]$
MI3DK\%Z"JO*<RE]3Y*(>.[ZS"SRP3:9MP(U')=W@$O53>2^-YW8H*<NQ4$P4
M('$]=B;^<!K:_";AF6&M]FRP2E9"O%CG)AT[GB6$'!-M$:A9WG"&G%L@0^-U
MB^ET1]K"?7N'?M5H-UI65.%,\.\LU=G8&3B0XII67#^(^AJW>B*+EPBNFB_4
M;6X4.9!42HM\6VP8Y*QH5_J^O8>]@H%WI(!L"TC#NSVH83FGFL8C*6J0-MN@
M6:.1VE0;<JRPC[+4TNPR4Z?C&549T"*%Q!KX6K$WRK'0"LX>Z8JC.A^YVIQC
ML]UDBSEM,<D13)_ K2ATIF!1I)C^#> :@AU+LF,Y)2<1YYA<0.#W@'@D/($7
M=*J#!B_X;]4_Z$II:?Z5GX=TMZCA853;/T-5T@3'CFD0A?(-G?CC![_O?3[!
M.>PXAZ?0XSE3"1>JD@AB#8G(2Z%8\V=;]YB@0RI.GW/\;E:FZU\@%;5I)@5K
MP4U'JR&<T5Q4=I\5H#-1*5.L+"FLI%#G,%G"URN8+V:+V^GB8?>,Y$@\.!(/
M83997L/D;MX:BV]/-\^3+XN[QR7,_F7:!W_0\[T(!I<]TH_:!-+O?0I#($'0
M&P27$!DWZL-QN38_\H!$OJDCX(=ACQ#_T$NZ>_V7H]PT4T:9-S+7TK9B%^T&
MV:3MWS_I[12\I7+#"@4<UZ;4N[@T<T.VDZ5UM"B;;EX);69#8V9F&*.T"69_
M+83>.?: ;KS'OP%02P,$%     @  XAX6OU* O=X"0  M3H  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#4N>&UL[1MK;]LX\J\07J!(<(IMO>7F 2B.TQJ7
MV('M=H$[W ?:IF.ADN@5J;BY7[]#ZF%9D91NLCW<8O7%-"ERWC.<T4 7>QI]
M8UM"./H>^"&[[&PYWWWL]=AJ2P+,NG1'0GBRH5& .4RCQQ[;102OY:' [VG]
MOM4+L!=VKB[DVD-T=4%C[GLA>8@0BX, 1\_7Q*?[RX[:R19FWN.6BX7>U<4.
M/Y(YX5]V#Q',>CF4M1>0D'DT1!'97'9<]>.U*?;+#5\]LF>%_TAPLJ3TFYB,
MUY>=OB"(^&3%!00,PQ,9$M\7@(",WU*8G1RE.%C\GT&_E;P#+TO,R)#ZOWIK
MOKWL.!VT)AL<^WQ&]Y])RH\D<$5])G_1/MEK \95S#@-TL,P#[PP&?'W5 Z%
M TZ_YH"6'M DW0DB2>4-YOCJ(J)[%(G= $W\D:S*TT"<%PJES'D$3STXQZ]N
MO1"'*P_["#-&.$,X7"/?PTO/][A'&#I9X*5/V.E%CP,Z<:BW2D%?)Z"U&M"J
MANYIR+<,C<(U61\#Z &=.;%:1NRUU@CQAJRZ2%<5I/4UHP&>GC.O2WAZ'?/8
MB]!7[,<$W1/,XHB N7'T;W?)> 3V\I\JIA.01C5(X4,?V0ZOR&4'G(21Z(ET
MKC[\HEK]\P:"C9Q@HPGZU8W'5CX5A"*Z02L<1<]>^(AP0.,PU=U&\/0D>8(M
MFY)ZJQAJ1KG8$K2A/CBOP,2%,2"VI7N&.#QY PG)EGRQ8&L*\L*5'Z\EHBT!
M(#YY(CZ#98FL '?KD0A'J^US%RWP=PF2!#N?/A-R%A$?<[)&._PL31=A$%=(
MP[-*I/*LV $8("!0^$>^"RH PB:B@<3,$T!+$<, XY8\RR-2PZ' !11.*"=(
MM;M:%[ES-+U%-Z/AZ/YZ-,LL5D,F.LGD)%FB,0/L3$B)Q!%EI\B]GWZ9+-!L
M-)Q^FHS_-;I!XPE:?!ZA^<)=C.Y'\ P@WXXG[F0X=N_0PW0^7HRG$W3KCF?H
MJWOW9038YZ/%O(?NQN[U^ X>C^;(711W+#[/IE\^?48/L^GM>('<R0VZF\[G
MZ4FQ&>B8+23^X72^*(,J/9T*T;W4\XEVBE15L?N.&#1;11]^<315.R]/D_,1
M61'O*=68T,D!RD#1=#7]S0X=SX:8;>6IE?A#?HL!DD^$H$_44Z19RL#L9T-V
MIC1=4 ZTO^#"L!7'&8C!,+5\<VEZ6V59Z4-A>:LXBD1DV=%(WD4GAI+:BPDR
MLA3-$.P9^@"9EI5#=13'UAMAOX"K%^#JNF*:9C9D0+,Q75Y$>$T*K@(BI%(=
M&>BCNT ':DW%L,UL*$--E\NR+ *Q3% ^^(*C&-8QOZ:M#/IZC??H?T/OT32E
M#SJ"01\8![L]GK[J/9JMJ):1#3F4X^DK#F2JRL#0\C$'4IK7^)#>5P&9*D>S
M?W"Y\OQ=;J0/%&M@(Z.O6!!J50<@'TS+T!3;<M[A2[:B&TXV0/PR"\''!.;>
MX$D00S1-S8:R)Z7+39ZD:H:B@?^H&E P$.)5^KI]B)"P:AHU[F3\[9Q)U2$T
MZ2 L,).#R96FKSJ3.E <0\^&',KQM-F95,.0JLW&'$AI7N-,JFV#]=DP6HIM
M'CRX/'^7,UD#I0_1V0:9@4_IX%('&<$SQ[;?[DO YD WLT&#T. <1*?IP(3V
M!F?2%0>,.AU>.%.RW.A,</LX&OBVI2F::2'P+:=?T+ N;GQ=*G!QG(O*3+Q.
MX1Z#&I&3"$HW2!-%_0B<A.A.)+9(+8()"A6(!$6!4[:CPBLYE6DHE,W?H$[/
MT8JUQ"JZTC@7+S/RR@P\106&S<4VT-%_B4#(>$(O$+$6.)< 'IP!,QK*O)\P
M[D$AG*3U.>6*2)C)CD.9$$F2?!H^G@F>$5X_ 6:0;B#4"1"'LRFD^?LM94<B
M;)22WB0E.)E153BXB;FHD80VSC:^*%;64#D)>21,IX*,X!20$S,AKQ4(Q.,H
M?;<!S\)'L2QK -5"RYV@W[#E/RP#)92C)%B"468)OH+4OI'NU%2G?J<N:5?A
M#DDWVVK]9@,*BCI\ I8B@8F-XI^HH83*2%8U'?&%EL_H'RI<N8!M3V-_#>IE
ML<_%9@PZ.#Z:JZ^@    /J%;QKEF]/.+ RGYJEY<%+_Y [/X1-@VD:]D?"CB
MA O76"\4FQ%/S*G:<QNL>8__N#D#,4:5C_\S(I2AZ[F+W \XV)U?*V@Z'+F3
M$: *GT@D7U/1G8AWP!U]QCY_1BL"Y&R\56)HR3LBEA[@GB BI/)1 KV'ACX4
MEERB$7*Z]T(OB ,T(V#0(1J':Q*$"4# (\/+^[TEH&M19:<W71SL$MC@D=CS
MB\6MV:V02Q*7#SY?K:3_!P^7[Q!0_BZCP.M'&><U"V[--(:MR9*#G@*(OS*.
MYP:@2N5K:"D",QAXR;]@GRI+H/HHT>#.?Z[[5A!<\N2">T)VG'MGM_N*/ 3Y
MJ?'7R(%Y@0>FG-Q<H(]*8_H?R2&EM,1"94P3\?T@AA^QBH.@<^>=#EWAOR<<
M[I 5/'9/I:#EBZ1D">*(7!K60!"O'T6HD-(%W\)A2<0HM;6!)66 D:3%C1]C
MB'J'BV&0B*CI$K+-ABWYU?,"\DM@979?P(**P_>!VX@<Y'#Z<VP^%V198<=*
M+]Y!N1\ H2]O-5,ON$?!:P:FTV0O$.B!$8@P(O?*+M/,%AX^C:1JWQ1$?DRW
M>K-N,W+==ZB %]\/'^)H8\923%A>:# 3R[&N#IHP:_(+?5"I(2BH\N7CG.,5
M4C,B]2HB9Y.'LZ]0Q%8HN#JPZ&HE=:KY,Z@;NK/1Q/T#Q-F5Q!67_SSB1DOJ
MXQ^GK49N#:DDE)AC" V[G9^F25F0=2&G6 <R#L"U-';G4( ])*_P\WV'JG8.
MBR39+8M ]5P$%<;R[$MLORLV$A@:IM4IN/\$2NRL6DWL=%(HNHOG]A[?HB%]
M(H"90YP7I%85Z"D7Q7NW+CKD,:8!3FTR6AM2]@0RKHBL4BG 92Y(SP)&56$^
M+,"6/BT1G#:2+5$=1>83!C>&3!JTTVY#%\W,NVCFS^JB%;BK:J4UXVU;:6TK
MK6VEM:VTMI76MM+:5EK;2OO+.E/;2FM;:6TKK6VEM:VTMI76MM+:5EK;2FM;
M:6TKK6VEM:VTMI76MM+:5EK;2OO+MM)ZA4\) Q(]R@\F!6>0#B9?%>:K^3>9
M;O(IXF%[\D'G/8Z@[&/()QLXVN_:9@=%R4>2R833G?PP<4DYIX'\NX4022*Q
M 9YO*!":3@2"_$O5J]\!4$L#!!0    (  .(>%KPT@5HJ@8  &@5   9
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M>M'\G^$TO7]_Y!Z1:3#SU_-T%#U^#K(.V4AO$LT3>22/65GSB$S621HMLLK
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M'&A79N[55<,P>*X@EH7Q 5^0UX!*2S1UO1$(;Z: \AI) 7Q9QV!!Z-Y:EHN
M@N>P0NBR"F;8'E5U\^TF4!.@%^(:N\G10JN,'H[U2F^"KV)O7OT9- X28%F%
MR@]"X/$5>@RIL&#9\66"M"AO[UP?ZKM+-O"]=O49!@O,0S1Y959Z9?:L65F<
MET?4#\Y*?GVELF\( SF4T8+(/<M$>Y@8;[ZRE2T ',*,_CW]PSRZ6GC/?3JV
M>A<C*L7GZ^4T>_LCF*KWZ<,E)D3!!B]A"?95-M&I]4R]F]$(W#'I#L_(\')X
MG%_KTZ]/H\MK\-P7ES=0I'<Y'(^ZO?$-%.IUKS^3C^>7_[PFYWTH,O[<'1)*
MOO:[(_)Q='D!_\>7A,D;U^H.PSMV=N?\<O@)V)+5\GN'A37M['(^#P1P#%"P
M9Y@ @FU(Q>T=[<WFH;,9(T[EE Z$G^+(W(U9'IQ)5O-'MD$=G#]B7GX$5^"6
M,U:U\\WYBJE+.9J-Y\B]I<I1E]4;/D]R:&#;G=A6LUVX68(36R[Q.M#!TIDU
M?&\%?]7P5?U(S '?IK#QVS9<?O,$5!U&&U-MD!(K15+GA_\?JVC]BD0^VR P
MF\</JMA@C# LJ U"3C_FP[*!O1H^!I1-9W#3P%>+9&*?'X44>%6%U2P'-USU
MD1=O4Y$/46&'ODR%LWF4E^LP3LK8@*<L$Q020I^S3WM5A*X>ZQIKTN/LXRIN
MYA5,P[$<S*^IQXAE&W8E]ZZ+H']-1<Z2-G"UD*?)R:GL*.1'K9ZMQBHE!#7&
MQ2ZEP.B=+21N"5-/L/IU+Y5,VN"W75/R105A -PI2$]^4:=J""K95)Y;9P+-
MNJRRT9?KLDINH74*Q@^M>AXX6F#7J=-E";"RHP)>):"OPOPF32Z^#P3(0\ 0
M<1Q7B 4"#-G%W82VZ1"G"<65W].CC1^\>P&*PT_UO C)-3/R$\G]-WN7GTCN
M)Y+[+U?1GTCN)Y+[B>1^(KF_")([J7P6>A'$=_+CUZ@4H#KJ"]'%W>(#VUWU
M6>FRN/HZ]X4?WT''R#R8056SX]A')%8?O%87:;22'YF^C=(T6LB_]X$/( \+
MP/-9!'J376 #Q6?'/_PO4$L#!!0    (  .(>%I;R+$>5 0  *X+   9
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MKO00J+>9GKHH#$#[MYRKDV$N:.=X\ =02P,$%     @  XAX6@KWR0WK!
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ME26)^V-!.Q6U"R#_2BF[,UR!=DLGOP%02P,$%     @  XAX6FY'6N]T!
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M];L7YP[(=AJUBA:UG0!+H6F>6#&G 8[2.)!])83>*2;!_I<P^@-02P,$%
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MS&*+%3.80<.4X:CARS/;5:@O9KXA=.OCIP>D58<4_0=2&,&=%*;4D(@,LX\
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MJE6X>'\U/A/R]/'I]8<R>_YT-CBK#J_*,INO'SXE\7V2KQ:H?O^09>7+#ZL
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M%(OIMH>^6-Q*%WUDIGBPB].+U%14TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4
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MIDG3 C(YJP5D<'.E2.+KCJOR87/>]6GS3:6G*%W1)1[JTNA"-175-%334<U
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M'EJ2C6H*JJFHIJ': -5T5#-0S40U"]5L5'-0S95?UC/W7]0S>^@Z?50;HEJ
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M>*->#ER$LQ;#V3'P[*P'B.<MQ/.?P[.XVU$GSRY: !?_GV=WLHZ2+.KBP!7
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M*HH&^OL5Y^KYI.B@V>"^^!=02P,$%     @  XAX6KE@DV![!   BQ<  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C<N>&ULM9A=C]HX%(;_BI5*52OMD ]"
MF)D"$A!6.U*[BZ8?>[':"T]BP&IBI[:!SK]?V\D$$H([D;PW8"<^[[$?.\<^
MGAPI^\YW" GP,\\(GSH[(8I[U^7)#N60#VB!B'RSH2R'0E;9UN4%0S#51GGF
M!IX7N3G$Q)E-]+,UFTWH7F28H#4#?)_GD#TO4$:/4\=W7AX\XNU.J ?N;%+
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M"&Z/#ZO[X";3UMK$SMENN_S[&R=IFD :RBG:^]+&]LPS,X\]DXE'&R%_J"6
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M6B39XQ)H!-((X/I<($G%P!@HKV_'_P)02P,$%     @  XAX6MA#ROK)!
M91X  !D   !X;"]W;W)K<VAE971S+W-H965T-S N>&ULQ9EK;Z,X%(;_BL5(
MHQFI6RZY]#))I#: MA^FJIKMC$:K_>"2DV -8-8V2?OOUP9*0H8RC716_=*"
MX_>Q\7OP,?9DR\5/&0,H\I0FF9Q:L5+YI6W+*(:4RE.>0Z9_67&14J5OQ=J6
MN0"Z+$5I8GN.,[93RC)K-BG+[L1LP@N5L SN!)%%FE+Q? T)WTXMUWHIN&?K
M6)D">S;)Z1H6H![R.Z'O[(:R9"EDDO&,"%A-K2OW,G1'1E#6^,9@*_>NB7F4
M1\Y_FIN;Y=1R3(\@@4@9!-7_-C"')#$DW8]_:ZC5M&F$^]<O]+!\>/TPCU3"
MG"??V5+%4^O<(DM8T2)1]WS[)]0/5'8PXHDL_Y)M7=>Q2%1(Q=-:K'N0LJSZ
M3Y_J@=@3:$ZWP*L%WJ%@_(I@4 L&AX+A*X)A+1B^53"J!:.W"L:U8%R.?358
MY4C[5-'91/ M$::VIIF+TJY2K0>892:R%DKH7YG6J=E-IFBV9H\)$"HE*$G^
M(+=4"&H,)Y]\4)0E\K,N#1[NR:>/'\X'X^&7SZ2^("PC?\6\D#1;RHFM=(\,
MUX[JUJ^KUKU76G?)5YZI6)(@6\*R0S__C=[K =AZ*)KQ\%[&X]KK)2X@/R4#
MYX1XCGO1U:%^N0^1EKM&[@T[Y/[;Y8,.>?!VN=<A#_OE5[DX)4ZGO#66@R:V
M!B5O^ KO3G#YG(%8,]H5&KUB,Z->RIQ&,+7TE"E!;,":??S@CITO7;9@PGQ,
M6( )"Y%@+3N'C9W#DCYX+;J8C!(N"P&$K_3L;68&6.H9H,IO99YXU,E+EQS.
M*7\;%F$*4OE/5R@,,4,!$^9CP@),6(@$:X7"J F%4?^;315DJG/"[Q4>:R4F
MS,>$!9BPL(*-2YA9"FYFXY&GL\^FPZ)Q8]&XUZ+@*4H*:9)XPB*S$LS6)-*Y
M4NBUG%YCJ)BH&,@B$BS/);G7G:0BBLE-)A53A8(3\I!IM9!,/9OW?1ZSB*XY
MT8F>7 N]7J,I^<$+3=W5ZXJ'WEX>&P^8,!\3%F#"0B18*V[.FK@Y>Z]9_@PS
M%#!A/B8LP(2%2+!6*)PWH7#>.X7HK[5$>RUJU]<"(#73_HD.BXW^)LW-G?XH
M24!_IFCG<_IL2D[(S:U/:)X+OJ%)5R"<_S+?#4?-;%?9V]NS8^W%A 68L! )
MUK+WHK'WXN@,T9A<I8CY[?WB,!&8#ZX<DH2!*)/!2\8@\T(PZ+*[MQO'OO>8
M,!\3%F#"0B18*S!<9[<IX+Q7$JA;1HH&5)J/2@M0:2$6K1T1>]M$[O^3"^YB
M*H%T[49<UTVV\H!SD ?ZNW6TP9BT )468M':!GL[@[U>@[\SI9XC2,CB:M%I
M5J_\Z/<6D^:CT@)46HA%:]NZVX)S!^\VDZ-NX*'2?%1:@$H+L6CMB-CMXKF]
M.T,=._[E4H]E2UBQ3-M-"@FK(M&KPE7G<JZ??[3OJ-MUJ+2@INTGJ(/\%&(U
MV#9SMP_G]F_$W:0Y9<)DVDZG4#?CW%^WJ0Y&P_]]E:"CRN''7XC5[VI0[;W3
ML13$NCS'E"3B1::J@Z&FM#HKG;N707FD>%!^Y5Y>E2>']@Y3'<!^I6+-,DD2
M6&FD<WJF'T!49YK5C>)Y>0;WR)7B:7D9 UV",!7T[RO.U<N-:: Y69[]!U!+
M P04    "  #B'A:*S$G+!<)  #42   &0   'AL+W=O<FMS:&5E=',O<VAE
M970W,2YX;6S%7/%OXC84_E<L3CK=2>U!["2TO1:) ]Q5NFNKMK=).^V' &Z)
M%F*6A+))^^/GA!3'B>.$[0U^:4GXWF>_9_OYBW%\N>'1[_&"L03]N0S"^*JS
M2)+51;<;SQ9LZ<6?^(J%XIMG'BV]1%Q&+]UX%3%OGADM@R[N]=SNTO/#SN R
MNW<?#2[Y.@G\D-U'*%XOEU[TUQ<6\,U5Q^J\W7CP7Q9)>J,[N%QY+^R1)=]7
M]Y&XZNY8YOZ2A;'/0Q2QYZO.T+JX=DEJD"%^]MDF+GQ&J2M3SG]/+V[F5YU>
M6B,6L%F24GCBWRL;L2!(F40]_LA).[LR4\/BYS=VFCDOG)EZ,1OQX!=_GBRN
M.F<=-&?/WCI('OCF)Y8[Y*1\,Q[$V5^TR;&]#IJMXX0O<V-1@Z4?;O][?^:!
M*!A8;HT!S@UPV8#4&)#<@)0-[!H#.S>PVY;@Y 9.VQ+<W,!M6T(_-^AGC;6-
M;M8T8R_Q!I<1WZ H10NV]$/6OIFU:!$_3+OB8Q*);WUAEPQNPL0+7_QIP) 7
MQRR)T2D:^_$LX/$Z8H@_B_XVX^',#WPOZSOBCE^Q^3!FB><'\4=A/?G^@#Z\
M?W=&7/OS1Y1_$#;H:<'7L1?.X\MN(FJ>EM^=Y;7\LJTEKJFEA=$W'B:+&$W"
M.9NK!%WA\LYO_.;W%VQD'+/9)T2L$X1[V-94:-S>G&C,:7MS;/"&[%J19'RD
MAN^ATD:SA6@B%J=QKS873Q8L0HF H!?.YQL_"- /;QHGD<@,O^F:9UN\K2\^
M39<7\<J;L:N.R(<QBUY99_#^G>7V/NM""TE&@<B4L-N[L-LF=LW@T4762]"4
MO?AAZ(<O:=.L6.3SN2[*V]+<K+1T#GD=N&Y/],[7 FADKM(/2]=^8RUS7V6>
M_!MF6F4^)SM>):K.+JH.3%19.#?'<UN.HWKMJEZ/M:!2T"?F&M>$1LM<"OKU
MGLQ*1-U=1%TCR]>;T>1V-'G4Q<AHN>_(AB2C0&1*Q/J[B/6/FU#[D&&')*-
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M4#;9J"TVV9Q"KSO1CB8QXT)A8YO;9*.VV.2 KE@E8/,JX=^9Q-I&2,+#5Y:
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MQN]$Q1!^_P$:A</.9V7FK+AOOAA4]Y_W:?E2_-75]JM$D?OKLT3*7R@^.,/
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M)DPUD.?7E(KG@NJ@W;U;_ =02P,$%     @  XAX6G*FP?FI!   J0\  !D
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M,H<%W:3JB>\^044HU/H2GLKB/]E5LHY%DHU4/*O Z$'&\O*7OE:!: #<X C
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MW4"Q 7PRX\9<PS'78;?KP+M(XK;K+6"7(2&K!86YE0$;!>/T.1;>4NDL;47
M!2VJ,,Z/26"3,P&A%U6"[8#Y#W*F + 2&DAP?MFUO]U6;Y6#7-JVV>2/.56G
M7[-:=>:IWQ_;#G9O_3;I3Y..]8G?O^NT[]4=OOO3;?5Y\ >52U8HPF&!(7B7
M/=Q)LFJYJXD6I>WX9D)C_VB'*_Q* 6D,\/E"8,+UQ#AHOGM&_P%02P,$%
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MK%:OXF8G>X>TZ5OHV"W:GTKQ3\WJ7Y^8NB0E:#T BL:A: *%IC(D:P)TT*(
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MK@, \IK90F^N=!/L:QD0:E%H+-HM75^!+!4$A]U!4.:XT17_.@(G0+-;O<F
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M2UI;(N)ZP_@/L0*0Z%<81.*FL9(ROK0LX:\@)*+)8HC4DR7C(9'JEC];(N9
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M;#V3(O1F6T6@M!1*8U :A]($E+9 T53A9$7@N^\@L?6A50.4ED)I#$KC4)J
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M]Q/4NP(N"?8-.!++24R0F"0Q16*:Q R)%216DI@E,4=B_ALV;83$<)AU(NZ
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MBY36CMVZB#1*%Y&><\^Z--T[3-%&$JH)5).HIE!-HYH9[>B;C,ZRT_-.Y:1
MARU1S:*:0S6/:A6J!52+E-;.R;J4-$J7DNJC^<$?@W>?Y[./ _';[/+K:O[+
M;%!]_#B_G.VZ4<+;--L[(]%*$JH)5).HIE!-HYI!M0+52E2SJ.90S:-:A6H!
MU2*EM8.T[BZ-CF$EHQ%:<T*U'-4$JDE44ZBF4<V@6H%J):I95'.HYE&M0K6
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M_ZQYT33=.S?1[A&J"523J*903:.:V6JM>=')HWN8%NB@):I95'.HYE&M0K6
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M%S&NDZN-RM3Z\3%,F8[9(":YG.4$RTF64RRG6<ZP7,%R)<M9EG,LYUFN8KG
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MMV8W+-FDQSV_)8PE47JYQFB%B6C ?[]+$O9\(SHHCA@/_P=02P,$%     @
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MI^?-+.N]")UB?A6E4H>?Q&H2$R0F24R1F"8Q0V(6PKQ ]+JN ^L^@[.C[8.
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M' OJU!C536&YV?OO#-_SX.QER%&Q']5-8;G9Z3;8S_WC["=Q* >FU9(.KXF
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MTMO<Z6I5K-O?SJ+U+E3S42U M1#5(E2+42W9:;5WHY/3YOOTQQN=GC7?J+=
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M.:I92JM';+^,6'<3$)C+Z+YFIWM?C@Y3M/.':@&JA:@6H5J,:@FJI:B6H9I
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M18=>]J??=<?LGB0LE[)<QG*"Y23+*9;3+&=8+F<YBW&-I)Y4DMI=8CRRGWB
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M+F*YF.62/5>[#E*_][+?/YDTK\*!CIRQG& YR7**Y33+&9;+6<YB7".6*WW
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M[+SG!.$_?O[+.-[:XV,OHR2_6:;Y)HNE]*[<%:[^#,:WY2"/!PO;G>[K\DA
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MBL.[N&BG#=5D5%-0344U#=7T6NOLXDZZN[AHK0W5+%2S4<U!-1?5/%3S42U
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M.Y&;OM[LY2]?-T/+?*@FHYJ":BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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M7I0[T461KK8W[^/H-LZJ!<I_OTO3XNF':H"O:?;G=K/?_Q]02P,$%     @
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MH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&EM2.[:=4;';D)5_^3(WK>-4!<\.3
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ME0 )2AFFZ..'D>>ZM_K?<VX?XE ?J9)/ 4A,4O%9:<-OC^B3NM#S^[>?476
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MYR3)#I<(1HC* G%_3@A_/9$[-.6>G_</4$L#!!0    (  .(>%JWP^B;JPH
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M?>#N#F@SP+F_##?_"N^[MK6*,'\-(W^U"XY'L/+6V_^=[[L3<1(0._D!TBY
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MWT/?1[L<H)J*:AJJ#5%MA&HZJHWS+J/L]\$$[=) M2FJF:AFH=H,U6Q*2Z>
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M"_.'*^K-:9RMD+Z^8(QOGV0;V-V&>_H_4$L#!!0    (  .(>%HED;Z5-P@
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M<,'9C&=%0/[^/$WEPY/BNRJVWQ,S^0]02P,$%     @  XAX6DNKM6-?!
MZ18  !H   !X;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;+5876^;2!3]*R,J
M58G4& :PXZ2VI2;9:/=AU2AINP^K?1C#M3W*P+ S@UVO^N,[ X0/!] ZQ2\V
MF'O/G7ON 1]FMN/B66X %/H>L5C.K8U2R;5MRV #$9$CGD"LKZRXB(C2IV)M
MRT0 ";.DB-FNXTSLB-#86LRRWQ[$8L93Q6@,#P+)-(J(V-\ X[NYA:V7'Q[I
M>J/,#_9BEI U/('ZFCP(?6:7*"&-():4QTC :FY]PM>W;I:017RCL).U8V1:
M67+^;$[^".>68U8$# )E((C^VL(M,&:0]#K^+4"MLJ9)K!^_H-]GS>MFED3"
M+6=_T5!MYM;40B&L2,K4(]_]#D5#8X,7<":S3[0K8AT+!:E4/"J2]0HB&N??
MY'M!1"W!FW0DN$6"^W\3O"+!RQK-5Y:U=4<46<P$WR%AHC6:.<BXR;)U-S0V
M8WQ20E^E.D\M[FE,XH 2AA@E2\JHHB#1!;JC,F!<I@(07R&C!Q1J?$3B$!&I
MAYZ8*4B42@B15A-2&T 1$).AIZQ,%A 17VCIE-![='8'BE FSW6)!\'E/@:Q
MIJ0M]/V[J3?Q/R)=^<N&IU)7EC-;Z9[-RNV@Z.\F[\_MZ.\.@A'R\ ?D.JZ+
M?OOZB,X*X/.R@HWDA@C=]EZT%+CM+_ I$2/DO+& K:=5CLPM1^9F%;VNEAJC
M6;4.\&^3A*B"2/[31EI>P6^O8!X=US(A <PM_6R0(+9@+=Z_PQ/G8QM! X$U
MR/!*,KP^],4]H0)M"4NA77%MS>>(DPS1/.:V"V=F;^L=O8ZXP+X_*:,:2_7+
MI?J]2_V<W3(H$32@\1I%/ 2&?J!'*I\O5@( ":*@;;V]L,<.:R"P!@/CDH'Q
MR94['I*,@< :9$Q*,B:]<GBBZYBN:$#TPS*-^=+@DR73O<=)JC[426GC(0?'
M5W45CQS7.U!R2]B%CG.\=BU?EHN_?(N6_R3B65N/@"14$4;_(R:J;?6]Z,=.
M<2"P!A'3DHCIR24]'9*,@< :9%R59%R=4M(Y^+@F5>R-K\;N@:1?A_F.A_&T
M7='8J9R0\Q9-?Q:AGJK8Y__AV65 9]J50"HX2D#D%\Y;O4EOQ6-'.Q1:DY^:
M4\0GEWI18BA"!D)K$E+Y,-SK;(Z1N];1H1ELI2<OB*<U<4]&-6D7?;>$N?X(
MCSMN@<I,X7XWU7$+?-$O;DAQ_1J@4M%AJOJ1CY[L0&A-'BJGAOW32WU0VS84
M6I.0RKCA7BMTI-1;WZ-NBA(-U3HC=WPH[O'KOX$.75=6"_=[K0Y=?^-,.Y2N
MUX1^S*,'.!!:DX'*K^'+TRMZ4-<V%%J3D,JWX5XG]*M>I4 _$+/O'XJY-6S2
M)>C*:.%^I]4AZ#NZI2'$8>N*>Q&/GMY :,T=D,JKN<[I]T &-6=#H34)J<R9
MV^MU?E7.!7K]H7NX)](;DJ_:KNU#FDU@_3JXIK%$#%8ZQQE=ZF21[ZOF)XHG
MV=;DDBO%H^QP R0$80+T]17GZN7$[':6N]N+GU!+ P04    "  #B'A:;-!O
MR6P9  #CF@$ &@   'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&ULU=W[<YO&
MVL#Q?X5QY^TD,VXLT,5VFF8F=9#*I81RAS/G!R+CF*DNKH22YIW^\2^ZV!B$
M,/+Y-J=OYO3$EG<_N\LZ^PBT#[SY,E_\OKQ-DDSX<SJ9+7\ZN<VRN]=G9\OQ
M;3*-EZ_F=\DL_\G-?#&-L_S;Q:>SY=TBB:\WE::3,ZG3&9Q-XW1V\O;-YC5S
M\?;-?)5-TEEB+H3E:CJ-%U]_3B;S+S^=B"?W+UCII]ML_<+9VS=W\:?$3C+W
MSESDWYT]*-?I-)DMT_E,6"0W/YV\$U]'@_-UA4T)+TV^+!]]+:R'\G$^_WW]
MC7+]TTEGW:-DDHRS-1'G?WU.KI+)9"WE_?ACAYX\M+FN^/CK>WVX&7P^F(_Q
M,KF:3_ST.KO]Z>3B1+A.;N+5)+/F7WY)=@/JK[WQ?++<_+_P95>V<R*,5\ML
M/MU5SGLP36?;O^,_=P?B485N]T %:5=!:ENANZO0K500#U7H[2KTJBU(!RKT
M=Q7ZE0J]0X,>["H,VH[A?%?AO.T8+G85+MIVZ7)7X;)2H7]HT&+G?N8Z;4<A
M/DQV=;8/=DN\GVZQ.M\'AR[>3[A8G?'#K=Q/N5B=\\.MW$^Z6)WUP\._GW:Q
M.N^'6[F?>+$Z\U+_4)7[J1>K<W^XROWDB]79/UA%NI]]J3K[AZO<S[Y4G?W#
M51[^L5=G_W"5^]F7JK,O]0Y5N9]]J3K[AUNYGWVI.ON'J]S/OK29_;/M$KE9
M7]_'6?SVS6+^15BLR^?>^HO-(KVIGR^KZ6P=3^QLD?\TS>ME;X?I+)Z-TW@B
M3-+X8SI)LS19"C\(UOQK/,F^"N-DD:4WZ3C.\I=?O$^R.)TL7PK??W?1'?1^
M%,Z$Y6V\R'^4S@1WEF;+TX<?Y:\XM_/5,IY=+]^<97E?URV>C7?]TK;]D@[T
M2Y2$7^>S['8IR+/KY+H&,)\"Q ;A+#],#\=*NC]6/TN-Y/MD_$KHBJ>"U)%Z
M@NQ:PHO=8/</2$V'K]KKW>-UN5G_,,Y>"5)OI^]-WT%VV,P.DX\Y*[7J].%&
M1NV/C'3\D5&:=3NY>R5TSEOIAQM1VS0BU3:2+>+9,MZ^O6K?H/:W_J[JW._J
MX48,;MH/-V+^K?_JK&;=F']^)8B7NUEHX=G-GKJ:Y?_<Q/:>T^S]&B]R[Z*]
MY[88;T<ZL,K4>%ZS]V[UJ6'5JO'\-EZGO1<\=?R^'M6]\(GNW>73T;G_C6_A
M1>U_N<4GO%)$[#Z\>^AN&N@>:B!=CB?SY6J1"/.;_#1N_>X@N<Y#__9$=W/"
M^#$_BQ4^SA<YG<X^+85_K1$AS9+I\M\U0_IYVV*OOL7UZ?7KY5T\3GXZR<^?
ME\GB<W+R]OOOQ$'GQ[J02V(RB0U);$1B"HFI)*:1F$YB!HF9)&:1F$UB#HFY
M).:1F$]B 8F%)!9!6"D,]1["4*])?ZLLEZM-!$K^6*79U[JHT@@<&U5(3":Q
MX18;;+#UI>3/;\5N)__SYNSSXWA!MJGLM]D;2%VQW*1*-JF1F+[?_VZ_VST_
M+P_ :#5,D^R916(VB3DDYI*81V(^B04D%I)8!&&EM;O_L';W&]?NJ_@NS>))
M?LXP7B3Q,A%N%O.ID.8K>CP;;Q;U^>(ZG<6+K_>G^B_2V>[+E\)?A\^-?FYL
M]]@EG\3D+=9_M)1(G:[4[U?7Z6%=P>V?RH).=D_9;[7?KXDB*MFH1F+Z_@AZ
MM0?8:#E4D^R=16(VB3DDYI*81V(^B04D%I)8!&&E97WPL*P/&I=U,UX(G^-)
M_K;\+EEL%^G-PIVL%O/BI?4"WN(RU\_;MLX?_3/MO.I4WGI=M2DDMRDT;%-H
MU*:0TJ:0VG@DCUU'V[2HMREDM"EDMBEDM2EDDT?!(3&7Q#P2\TDL:#-+(=EB
M!&&E!>K\88$Z;UR@Y,VE@H<WFJ?"<O5Q.5ZD=^N+UG>+=,RL7(V=./9-*(G)
M)#8\W_O=&;SJ5Q9,LD%EO\&+5]W^Y>,_E566;%XC,9W$#!(S2<PB,9O$'!)S
M2<PC,9_$ A(+22R"L%)4N7B(*A>-4<5(LCQXS,=)<KW<7LE8QI/-58Q%S8:J
MNH#1Z!\;,$A,)K$AB8U(3"$Q]6+OHK%T6;UFK.T7JEQ^T)\L8;1IR*PK5+W4
M89'CMTG,(3&7Q#P2\TDL(+&0Q"((*RW3EP_+]&7C,EVSN_5T_=Y^G,RR^--F
MO;Y99>MM+>OENW:=;FS@V'6:Q&02&Y+8B,04$E.WV&7YW%>JK--DBSJ)&21F
MDIA%8C:).23FDIA'8CZ)!206DE@$8:5H(G8>PLDZ3>G8>#*-_TRGJZD03^>K
M65870YK58X,(JLFH-D2U$:HIJ*;NM-(6G'-I[Q-%#6U51S4#U4Q4LU#-1C4'
MU5Q4\U#-1[4 U4)4BRBM'%D>I>>)C9'%WGS^D&XV."Z221Y8KH7Q?%D?3AJI
MH\,)J<FH-D2U$:HIJ*:BFH9J^DXK;4^Z$,7JY\@UQ;K2176'#=HU"]5L5'-0
MS44U#]5\5 M0+42UB-+*44(JHH1T[/E'[46K'5/9'RYU*SMIZHI)DE3Y1/7]
M$YWZEUB7WR4WUSHZ$I#:J&;@^5)5V0G^R[/&K: ]55%-VVG]YM\+O:[8_N_%
MK\\Z/D8-OG_L/SS+-MMU_+=GX18Z%3:J.:CFHIJ':CZJ!:@6HEI$:>584Z3\
MBHVI7.NDXNU&_726_R]+\C8R(?GS+IDMD]J8@R;THIJ,:D-4&Z&:@FHJJFFH
MIJ.:L=-*D6,O.P!MTD(U&]4<5'-1S4,U']4"5 M1+:*T<CPI<G?7MT5KB"?*
M?>+7B^M=9'DI9+>+^>K3[?JCD_R$YG^W=Y)87_82%LDT+[):_W7@,Y7&UHX.
M-Z0FH]H0U4:HIJ":BFK:3GN\I/_0[75ZU9,=LE$#U4Q4LU#-1C4'U5Q4\U#-
M1[4 U4)4BRBM''"*A&.Q.>-8N3]I6=\1M^V%,S29&-5D5!NBV@C5%%1344T3
M]U.)SR_W8LI^H8O+GE3]P&2_5+<_J)YSH"G)J&:CFH-J+JIYJ.:C6H!J(:I%
ME%8. 45RLMB<G>S.OJ2SZW3V:7/;NG0Y7N_0*N)!>B (D,F/5Z@FH]H0U4:H
MIJ":BFK:3BO=>$*\O*A& ;)- ]5,5+-0S48U!]5<5/-0S4>U -5"5(LHK1Q6
MBI1RL3FGO/9FZJ="G DW<;J['T9M8#G?_[Q]($G5]WQ7=>6DOGA9O<E%<S>/
M#@:D-JH90_^B-ZA\%*N@C:JHIK6<+KWE=!GM#HG9DK/0P=JHYJ":BVH>JOFH
M%J!:B&H1I947W2+C6FQ.N=[ND-W<L:-V;443JE%-1K4AJHU034$U%=4T5--1
MS4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B2BO'F2)E7-SF$'[+9QV(:!8YJLFH
M-D2U$:HIJ*:BFH9J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6D1IY0?3%0GH
M4G,"^KOI]A.,&V&]@VH^BS].O@IW\^4R_3A)BGMKIS-A-9M_7+<?;W]PM\I.
M2X_^:W=;0ZDFR[ERL>KI(G+SH(X-,:@V>KK["MJ@BFK:T]W7GRYB/%W$?+J(
MA8[,?KI!Y^DB[M-%O*>+^$\7"=#!AT\W&#46*2\O11:RU)R%W#:_K)DY]OTL
MJLFH-D2U$:HIJ*:BFH9J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6D1IY8 C
M%0%'^N876R0R"^\*U614&Z+:"-445%-134,U'=4,5#-1S4(U&]4<5'-1S4,U
M']4"5 M1+:*T<G J,J"EY@QH.&.MN;6CXQ*:((UJ0U0;H9J":BJJ:3OM\2E]
M7<9:3;%!3]J[IH,^JQC5+%2S4<U!-1?5/%3S42U M1#5(DHK!Y(B]3G_$KFL
MUL@<'2%(34:U(:J-4$U!-175-%334<U -1/5+%2S4<U!-1?5/%3S42U M1#5
M(DHK!YPB]5GJ?_O+:FAJ-*K)J#9$M1&J*:BFHIJ&:CJJ&:AFHIJ%:C:J.:CF
MHIJ':CZJ!:@6HEI$:>7@5"1E2\U)V<9\'8#B2<,#,YJ%HV,-FH&-:D-4&Z&:
M@FKJ3GM\U:IW*0ZJ#U]"&]51S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B2BL'
MD2(%6VI.P?Z0W2:+<OKU;#7]F+^6G_!DBWBVC,?K,+/>Z/KHV]I@@SZ[&]5D
M5!NBV@C5%%13=UKID1750(,^VQO5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42VB
MM'*@*=+.I>:T<V7S2*8\J"1_K-+L:VT 05//44U&M2&JC5!-0355VG^&=F\@
M[3W2&VU41S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BRBM'$2*G'*I^3GD5_%=
MFL63(D'O9C&?;I[V%\_&F^@R7URGLWCQ=9>+)[Q(9[LO7^9G, T)>FAF.:K)
MJ#9$M1&J*:BF[K3')R_]?K>S_VQ9M%D=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4
M"U$MHK12].D62>/=YJ1Q,][=DU"X2Q;;6+*)+\EJ,2]>>MDR);RYL6,C#JK)
MJ#9$M1&J*:BF[K3S1Q&G\ZI3/=E!V]11S4 U$]4L5+-1S4$U%]4\5/-1+4"U
M$-4B2BN'F^(F MWFFPC(FPME#V<WI\)R]7$Y7J1WZVUGF_LW,G$(O0<!JLFH
M-D2U$:HIJ*;NM,=QZ.)5MW_Y^$\U**$W&D U ]5,5+-0S48U!]5<5/-0S4>U
M -5"5(LHK1R4I"(H'?WD]--US!DGLRS^M+D$=[/*UANFE_'D0,!![RN :C*J
M#5%MA&H*JJD[[;)\XE/=*H"VJ:.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD64
M5HXQQ?T"NLWW"ZB-,=/XSW2ZFC9L=FY6CXXKZ'T!4&V(:B-44U!-[>ZGZ(OG
MTOXG.&BK.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6D1IY<A2W$ @__+(R+(\
M%63%JHTGC=;1\:17\PZY6[DEB8RV.42U$:HIJ*:BFH9J>JN9-] VS59M6FB;
M-JHYJ.:BFH=J/JH%J!:B6D1IY=6_R.;O-C_(_+F/&]RQC]^$GG?%;N7^[36E
M1*E[V:^N\&B*/:J-:H;0[7;.*[=Q1]M444UK-55ZNZDR6AT.LQUFH>.T4<U!
M-1?5/%3S42U M1#5(DHKK[5%<GJW.3F][IVV\)=@?K!K5U@T3QW59%0;HMH(
MU1144U%-0S4=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$MHK1RV"G2V;O;+,9O
M><.N+IK7CFHRJ@U1;81J"JJIJ*:AFHYJ!JJ9J&:AFHUJ#JJYJ.:AFH]J :J%
MJ!916CDX%2GPW>84>+.T3>H_?/!@;:3:MB]VRMMP.IU^]5I5RX)R\XB.CB]H
MVGO;02AHLRJJ:6T'H;<M:+0M:+8M:*$CME'-0347U3Q4\U$M0+40U2)**R_3
M19)YMSG)O.YQ)?EZ?%/WZ4'YPP/A.O\OFS]C::]=S2_W+BSWSZ7J2KY?2!2K
M3[J0FT=\]#*.9I#7C$"J9B<H:),JJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:
M@&HAJD645@HKO2)[O/=$]OB3[_[OP\TSW_T_T?Z+_+U=_W]>UEV3>G9-N;GF
ML8$%U4;/'I6"]D-%->W9H]*?7=-X=DWSV34M]*C9J.:@FHMJ'JKYJ!:@6HAJ
M$:65HT.1[-UK3O;^>TXZFB-*;1 1]]Z-_[!_UE%7JN:THWG,1T<'-'V[;@C2
M964$"MJFBFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1I94CBU1$EJ,S
MMC<[L9+X=^$NF279(CYT1_=F^=A/OE%-1K4AJHU034$U%=4T5--1S4 U$]4L
M5+-1S4$U%]4\5/-1+4"U$-4B2BO'H"*CN]?]YMNR>FBZ-ZK)J#9$M1&J*:BF
MHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEI$:>7@5"2%YU_^5[=E[=JO
MW!RINB>K52FY>2Q'1Q92&[4:@8*VJ:*:UFH$>JM21JM29JM2%CI*&]4<5'-1
MS4,U']4"5 M1+:*T\HI<)&KWFA.U_RD[L'HUJ;WGW;V%NZY4_[RZ<*-YWZ@V
MJAF!)(G5=1M-^T8U#=5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42UB-+*<:5(
M2N\U)Z7__5NPFMM_T7_5Z1S8@O7<FG)SS:,#"YJ?_NQ1*6@_5%33GCTJ_=DU
MC6?7-)]=TT*/FHUJ#JJYJ.:AFH]J :J%J!916CDZ%+GCO>9'H?]CMF"=U^Q,
MZDOGU=..NF)=4:R>=Z 9XJ@VJAM"MU>]WQ3:IHIJ&JKIJ&:@FHEJ%JK9J.:@
MFHMJ'JKYJ!:@6HAJ$:650TN1^=UKSOP^L ?+?W=U51L!T >AHYJ,:D-4&Z&:
M@FHJJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD645HX[12I[[_+;[[M"
MGY2.:C*J#5%MA&H*JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%E%:
M*3CUBX3X_G^:$/\?[KO:M5_96U.Y0';5JI3</)9C(PNJC5J-0$';5%%-:S4"
MO54IHU4ILU4I"QVEC6H.JKFHYJ&:CVH!JH6H%E%:>44NDM#[_XTD]./W7?5K
M<K.[8J^Z<->FJE?W734/^>B%&\U!KQN!>+FW<*,YZ*BFH9J.:@:JF:AFH9J-
M:@ZJN:CFH9J/:@&JA:@645HYL$A%8&G.0?_;-UX]T?X+\>#&JV?7E)MK'AU9
MT ST9X]*0?NAHIKV[%'ISZYI/+NF^>R:%GK4;%1S4,U%-0_5?%0+4"U$M8C2
MRM&AR [O-S_O^Y^R\:J__[#I;K=ZZZN:0@-1JIYTH/G?J#:J&8"TEZ2'-JFB
MFH9J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6D1IY:A2I'7G7SYCSY5]&R\2
MX6Z1CFN?]=J,'OOI-JK)J#9$M1&J*:BFHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ'
M:CZJ!:@6HEI$:>7P4^2P]_O??.M5GTS&O$(U&=6&J#9"-0755%334$U'-0/5
M3%2S4,U&-0?57%3S4,U'M0#50E2+**T<G(I$^'YSTN\_YH/^;3?[CZY%B?D@
MJY?<:DIUI>J=L9J'?'0 0O/@44U!-175-%334<U -1/5+%2S4<U!-1?5/%3S
M42U M1#5(DHK!Z BU[[__R/7OE^3@5X7@>J*U80@--<>U4:HIJ":BFH:JNFH
M9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1I95#4)&3WV_.R7\WG:]F&9!Z(OPE
M?/_=17?0^U$X$Y;KCY?JMZA=[,60O524)XO(S8,Z.L2@Z?>HIJ":BFK:TQ.E
M/UW$0/MD/MV@A39HHYJ#:BZJ>:CFHUJ :B&J19167N&+[/=^\X/<FU?X(W8<
MMUWA]Y]D_L/>$O]T&;EY6$>O\6@6.ZHIJ*:BFM9BIO0690RT5V:+%BVT11O5
M'%1S4<U#-1_5 E0+42VBM-(R/RCRR ?->>3W.[J2:;J:UJW+S?6/_=@<U614
M&Z+:"-445%-134,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+:*T<J0I\N,'
MXC??TS4@\SRO4$U&M2&JC5!-0345U314TU'-0#43U2Q4LU'-0347U3Q4\U$M
M0+40U2)**P<GJ0A.S?G$RG*YVL2EY(]5FGVMC37H\]Q134:U(:J-4$U!-175
M-%33=UHIH;8O79Y7[N1CU)3K#<3S0>6>76CG+%2S4<U!-1?5/%3S42U M1#5
M(DHKAX<BR7[0G&1?NDHF_"74I4?6Q@ST,>NH)J/:$-5&J*:@FHIJ&JKIJ&:@
MFHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:65 U"1CY]_^<TOGO70X$1J,JH-46V$
M:@JJJ:BFH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@645HY.!79^H/F)\YO
MSX[2S26T13+)3X:NA?%\69LSTDP='730+'Q4&Z+:"-445%-134,U'=6,G5:Z
M)B===*J7VM#L>E2S4<U!-1?5/%3S42U M1#5(DHK!Y-U=GWYE2+=<="<[O@O
M\=^"*"CY&<[=W61]K6U]MI.?!66WB?!NFLRN\_^RY3JM47EGYR7-=;=FV4.Y
MX4->I)V_F&Q+?__=A22*/PI7DWBYW%["VQ77'R=/+H6KU6*1K#="+P1C/OMA
MO/WV5(AGUX]?*%7[DF:WPM7\<Y(WG"U/-SV=/2I[-U\\'L2'*_F=(>>G;K/K
M39/YR^^3<3+]F"R$KG@J2!U)RAO<;,C.S^S6(]WMJ!8O3[M=*4?FJV7>H6VO
MGFCMER3]=)L?@?%\]GE]^7*]:WLVSY)#37?KFY8ZIX/^XZ:_)(MU^!_O#FC^
M'F!]&-+9IM'[OCS>%_[BZE$/)O-XMNW&RT.'8#.X=8?R5I9WR3A+/R>3K\*+
M99+D,Y$E@O3R5=VOX-GR-DFR]W$6OWTS31:?DJMD,EF//Q_33R?B^C/"AY=S
M^B:/&M+K7Z63L[W7WPT&KZ/\5WG_)U?2Z_=U-:[$U^_%FM<U\?6'NM='XNM?
M:E^77O]2YQO2ZP_U/3W/>WI>\Q-3>OU;70U3?/U;7<OOQ-?O-N7/BF/W]LU=
M_"GY-5Y\2F=+89+<Y,>Q\^H\7S@6Z]^M^V^R^5U^?$_R7^PLFT\W7]XF\76R
M6!?(?WXSSV=M]\VZ@2_SQ>^;N7K[?U!+ P04    "  #B'A:C9-,LU\3  !Z
MP   &@   'AL+W=O<FMS:&5E=',O<VAE970Q,3$N>&ULS5UK;^0VEOTK@@<(
M$F =BWJKXS;07<P\L#,[C61GY\-@/\AEV1925?)(<G=Z?_U*Y2KS=74O6:;<
M_I+8[J.KRTM*.CRB>"Z_M-UO_7U=#\'OV\VN?W]V/PP/[RXN^O5]O:WZ']N'
M>C?^RVW;;:MA_+6[N^@?NKJZV1^TW5Q$89A=;*MF=W9UN?_;I^[JLGT<-LVN
M_M0%_>-V6W5?/]:;]LO[,W9V_,,OS=W],/WAXNKRH;JK?ZV'?SQ\ZL;?+IZC
MW#3;>M<W[2[HZMOW9Q_8.\[R?#IB#_F?IO[22S\'4UNNV_:WZ9>_W+P_"Z>4
MZDV]'J88U?B_S_6JWFRF4&,B_SY$/7L^Z72@_/,Q^A_WK1];<UWU]:K=_+.Y
M&>[?GQ5GP4U]6SUNAE_:+W^N#RU*IWCK=M/O_QM\.6##LV#]V _M]G#PF,&V
MV3W]O_K]4 GI );-'! =#HCT Y*9 ^+# ;'M <GA@&1?F:>F[.O JZ&ZNNS:
M+T$WH<=HTP_[8NZ/'IO?[*:._W7HQG]MQN.&JS\VNVJW;JI-L&FJZV;3#$W=
M!^<!;_KUINT?NSIH;\<>7K<C:H3L.VO\BXRNNJ9O=G?!;==N@]NG@..O^RY]
M0GS/ZZ%J-OT/8^2?__%+\/UW?RCB+/GIA^#P0]#L@O^^;Q_[:G?37UX,8\NF
M_"[6AU9\?&I%--,*%@5_:W?#?1_\O+NI;]0 %V-)GNL2'>OR,4(C\GK]8Q"S
M_PBB,$J A%;VA\? X=S^\ AI3?S<R_$^7CP7SVMO_FL*'S1#O>W_%^JKIUP2
M.)?I3O:N?ZC6]?NS\5;5U]WG^NSJNS^P+/P)JK//8-Q3,*4/DN<^2+#H5W]U
MJG$U!-?U7;/;37\?>^BA[IKV!JKVTUFS_5FGV_SGJSQ)LNSRXK-<1A.5E%',
M5!0W42G+TO@9I30\?6YXBC;\4]>NZQJ^K)^.3.6TQNP3+7D3E1:,E5KR)BHJ
MI18JN6?/N6=H[K_4#]77\3DW@-EGQAG/6<RR7$L?@,5%6<9:_@"L+,(,;D#^
MW( <;<!?=D,]CN4A>*@:</CDYEGSK-2'#X!*H[S06@"@DG"N!<5S"PJT!?_5
M[L[757\?K.^KW5W=OPO6FZKOF]MF_7S_JK?7]<UXXQ^?^%WSN9JHQ'@)]4$_
M=E]7#;7T]^/E-C[QFET_=(^SO5L W1:%^MA$DW>]/WD*IM2Y?*YSZ5CG[^]&
MXOC#Q?C@Z(,]S5NW=[OFJ>;=5%+Q!ZA^)3!FRE K'YJ3:_D\!5/*QT+!I$+'
M C;'BZ_^?23J?1V,["9HA_NZ RE.:!2,I46L#S@ =L["1+MB.0#+RF+F5LXD
MNL@<&ZD,B_%2K+K=^3C#>.847\&VHF=QY0B':%I)PE0OB0EC23)S>V*1*$GD
M6))JVW9#\W_C_6C=CKW?U=NZFLC7=*L!JQ$!MYK$N-7@>;A>++ZBJ543C)2A
M9 NHVFW5=,'G:O-86U0L-KLR-AZ\ "H.HUP?%B;J'!D7@N\QG/#I+7PJWKMQ
MCGW=-S<CR0,;ED#/T%R_;>*G=AX*GJ*IA1+\D.$$<2Q4H%U -S?[&\HT+1T'
MPDRI ,(714RO%(#*(WT(F""6Y',C0)!'AK-'O6'!N^#GV]MZ/4PWRO$Q</C[
M-/F];;NZN1OACUU7[]9?QT?&T[]-] 5NOLD7F7$!H/DY#Q-/T=1J"B;+<"KK
M/(&JIZ<M-G5B)F%E81FQ0B^CB0/F6!R J9,LM>&" #.< ?]G5[=]P(+OJNW#
M3T$47+=CPS9MM8/'A4]&NO(:C?N*IA92,%Q6OB$9A/GDMBNOT;BO:*JV)JAR
MA%/EI;20R"2]^I,3@+"H+/0G @"+&&,A?"U'@C]'.'_&Q!#\4+A3 E";]!2(
M1R9CGJN H,L13I=Q204_V*4& *=F+(OU20&$*Y/9CA;\-L+Y+2F\X,>[M!3@
MKY$ISH"P))TA.9&@N9$;S7TU?0;/RZ6 7LFTKVAJ=P@R'9%DVJ^,@Y_/I<PG
M!$+*["F:6F9![2.2VK]([,'#NU354R >F?.).(^+F=N#8.T1SMH]"4;X65S)
MU"G1X**9E'_NR2'H?N0J>+OJ2?@)7 :75_;O*YI:5\'^(U>!VT5QPH.[U-34
MQ9FN[W /9U-?% MJ'KNIV%:J54SS;ORTSB]R/453BR18?$RJX*<H5GA4AS'D
M*Q#W$$@MH9@&Q*1JOIPVAI_;I=!>)7=?T=222XM \"F)?P$M-N<4QG5/0C@
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MHJD5DVP5WM*FLZ775:5>HW%?T31_!MF@X=ML.WL\KS+?S_0=.%<0+"F,_1U
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M5'.<-1,C2W>$)-+@@>2&6_P" &47X/-<2O,ZL:=2]TT1_P%02P,$%     @
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M%[@V4.\WC,F7C0[03M31?U!+ P04    "  #B'A:.R>@\1 $  !C#   &@
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M-0)< ]3])6-R.]$;M-\WX3]02P,$%     @  XAX6IVF<N]W!   WA\  !H
M  !X;"]W;W)K<VAE971S+W-H965T,3(R+GAM;+69:V_;-A2&_PJA D4"K)$I
MR[*=V@82B\,RK&G@M!V&81\8B;:%2J)'TG;V[T==HHNCL%%Q\B66*+X/J?<P
MQSSF[,C%=[EE3*'')$[EW-HJM;NT;1EL64+E!=^Q5#]9<Y%0I6_%QI8[P6B8
MBY+8=@8#STYHE%J+6=YV)Q8SOE=QE+([@>0^2:CX[YK%_#BWL/74L(HV6Y4U
MV(O9CF[8/5-?=W="W]D5)8P2ELJ(ITBP]=RZPI?$&62"O,>WB!UEXQIEK_+
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M5W2U3]=1O&ZK@357NK9HFX6N%XDP /U]R[EZ[I@)A@IT]0]02P,$%     @
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MNYCKZ(JNE^XFBM=M=[GA2O>J[;#0WQ\@C(%^GW.N[B=F@^&+9OT;4$L#!!0
M   (  .(>%H:S8B-'0,  * (   :    >&PO=V]R:W-H965T<R]S:&5E=#$R
M-RYX;6RM5M%NFS 4_16+254K;84 95F;(+5-I^UA6M6NV\.T!P<NP:JQF6V2
M]N]W;0A+!XGZL)?$-O<<SKFV[V6VD>I1EP"&/%5<Z+E7&E.?^[[.2JBH/I4U
M"'Q22%51@U.U\G6M@.8.5'$_#(+$KR@37CIS:[<JG<G&<";@5A'=5!55SU?
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M?8\Y56T_;"=&UJY#+*7!?N.&)7Y"@+(!^+R0TFPG]@7]1TGZ!U!+ P04
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M0!3$0=RJ3A#'+>+X;,245SLF9'Y?, .$*BX92'6(.3ZABB;8H@)4P2086UB
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M$)1-2&ACN+(^C,[EX,'&/U,N7WGX"K&'=$VK%3-W6\]Z!$"WLNL&*!K'=ND
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MTI.8759ZN 9A#/3WDG/UM#$7].-Z^@M02P,$%     @  XAX6C@!U$QM!
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MJ"3P\H5_>2+9KG@%OF12LK0XW!*\(CP'J/MKQN3K2?Y6O?[9Q>(_4$L#!!0
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MC"UL PKD'*SP^*@7.%?;9#XD670@LK42>%T)O%WLX=.&O-@229VQ."-<F$X
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M9_ORXX>9BZ>W JT8X8F>BBA7668*1XH$K>__0I\BD(1FXK-:[_[[(_JDC+S
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MZ5Q/52QY5=%6'<E*4^-MF%05HVFFZBL N :H^2UC\M31"S3?%>'_4$L#!!0
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M?^!='Q/6)BRR!&L)VZN%[771)_>;? &2B'0_C131(#$BJ49-_^N87-,2W"_
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M4QEX=L3 \P3"+ S92+N$MUOU8-P$ _.',,8IEH@%3V 6 A7@F9J11*;2UNI
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M(1#UK$W[,RS/#9I+O?+%LI@N:3RNNV(VJ9J6:BBO]0< NY:KZF.V8!AM,UO
MAOG!%& 8C<+\_$_KZ:/KT39,6]]HZ:.8/HK1*)-E7'TQ/V9,I#[FE4:1[P<!
M%M'QV*A@C,4M".#'S(9I P3F!SP]+=9XMO$*V5\'6$[W50BV4KP2L97BL0:+
M.6Z B")SMC$_@,"R@-4.^#?[@9HR8WP?LHIIP]Y@W!)%F 5JT5RC08!$)X"O
M.3_86^+[462V@,VLP/<Q"[R-N 53 !HPB^]7Y^#.>>2LSREG\Z^WT5]02P,$
M%     @  XAX6I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M5.\$T#NIW@F@=U*]$T#OY#XL >B=5.\$T#NIW@F@=U*]$T#OI'HG@-Y)]4X
MO9/JG0!Z9]4[ _3.JG<&Z)U5[PS0.ZO>&:!W=A]V _3.JG<&Z)U5[PS0.ZO>
M&:!W5KTS0.^L>F> WD7U+@"]B^I= 'H7U;L ]"ZJ=P'H753O M"[N']6 O0N
MJG<!Z%U4[P+0NZC>!:!W4;T+0.^J>E> WE7UK@"]J^I= 7I7U;L"]*ZJ=P7H
M757O"M"[NIM- 'I7U;L"]*ZJ=P7H757O"M"[J=X-H'=3O1M [Z9Z-X#>3?5N
M +V;ZMT >C?5NP'T;JIW ^C=W,V" +V;ZMT >C?5NP'T[JIW!^C=5>\.T+NK
MWAV@=U>].T#OKGIW@-Y=]>X O;OJW0%Z=]6[ _3N[F9O@-Y=]>X O8?J/0!Z
M#]5[ /0>JO< Z#U4[P'0>ZC> Z#W4+T'0.^A>@^ WD/U'@"]A^H] 'H/%^L
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M\?"/VY^N<5^WPTO_9"GJ;GX"4$L! A0#%     @  XAX6D;'34B5    S0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M"  #B'A::.5]>_8    K @  $0              @ '#    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    "  #B'A:F5R<(Q &  "<)P  $P
M    @ 'H 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  .(>%H\
M<S]GX08  +<B   8              " @2D(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    "  #B'A:G[5@-$0"  #.!0  &
M    @(% #P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
M XAX6D(3?;R,"@  Y#$  !@              ("!NA$  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    (  .(>%KQ>P[Z<P0  .01   8
M          " @7P<  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    "  #B'A:JCXR'F0%  !7%@  &               @($E(0  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @  XAX6O4\K!G* P  ' P
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M965T,3 N>&UL4$L! A0#%     @  XAX6D,OO,-%'@  4EX  !D
M     ("!8&$  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  .(>%KRX?VU+08  *H0   9              "
M@96[  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @  XAX
M6NQ4>M^5!@  %1   !D              ("!^<$  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    "  #B'A:MIO_XO %  "0#P  &0
M        @('%R   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   (  .(>%H8S(Z3$ 0  $X)   9              " @>S.  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @  XAX6EO/=T,#"0  81\
M !D              ("!,],  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    "  #B'A:/F(N$<D*  "A(   &0              @(%MW
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  .(>%I;JY">
M6!4  "5/   9              " @6WG  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @  XAX6K=N;1OV)   !HD  !D
M ("!_/P  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  #
MB'A:KV,"2,<$  !8#   &0              @($I(@$ >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (  .(>%HL@;6#< 0  -8*   9
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M970R.2YX;6Q02P$"% ,4    "  #B'A:YL:S6,X&   \$   &0
M    @(%40P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M  .(>%K,N@5>7P0  ,<)   9              " @5E* 0!X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @  XAX6G]']A62!0  U T  !D
M             ("![TX! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    "  #B'A:@KU_(/(2  !6.   &0              @(&X5 $ >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (  .(>%K[=Q=<3@0
M )4*   9              " @>%G 0!X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @  XAX6C? J(IZ"0  :1@  !D              ("!
M9FP! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  #B'A:
M/*4S.!$"  #=!   &0              @($7=@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    (  .(>%KF:KLVM@H  . U   9
M      " @5]X 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @  XAX6@]GK:(*0   FN$  !D              ("!3(,! 'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    "  #B'A:2?![6EP$  #M"@
M&0              @(&-PP$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    (  .(>%K&[DEQ1 ,  +((   9              " @2#( 0!X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @  XAX6D4PEAG(
M!   CPL  !D              ("!F\L! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    "  #B'A:19V(7P(#  #=!@  &0
M@(&:T $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (  .(
M>%ID/#._%P,  /(&   9              " @=/3 0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @  XAX6G! '@:; @  Z@4  !D
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M=#0X+GAM;%!+ 0(4 Q0    (  .(>%I;R+$>5 0  *X+   9
M  " @4L- @!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
M XAX6C<9@;-N P  9@@  !D              ("!UA$" 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    "  #B'A:U T/DK0"  #3!0  &0
M            @(%[%0( >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    (  .(>%H*]\D-ZP0  /(+   9              " @688 @!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @  XAX6MLMC7R0 @
ML04  !D              ("!B!T" 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    "  #B'A:;D=:[W0$  !""@  &0              @(%/
M( ( >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (  .(>%KW
MI4DVYP0  #T+   9              " @?HD @!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @  XAX6N)W!CKD @  '@8  !D
M     ("!&"H" 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
M"  #B'A:USC\<3T#   N!P  &0              @($S+0( >&PO=V]R:W-H
M965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (  .(>%KP7>WHJP,  *T*   9
M              " @:<P @!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L!
M A0#%     @  XAX6I@V1LW&"@  $G4  !D              ("!B30" 'AL
M+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    "  #B'A:SSOTI+D4
M   .5P$ &0              @(&&/P( >&PO=V]R:W-H965T<R]S:&5E=#8P
M+GAM;%!+ 0(4 Q0    (  .(>%H-]*YZIR   +E_ @ 9              "
M@794 @!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @  XAX
M6J&#&!\.&P  PR4" !D              ("!5'4" 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    "  #B'A:?S+#M$8&  #T.   &0
M        @(&9D ( >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   (  .(>%K,#R0UO@(  %P'   9              " @1:7 @!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @  XAX6DC8!A/Q P  XQ@
M !D              ("!"YH" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    "  #B'A:-[47B[4%  #L+@  &0              @($SG@(
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (  .(>%JY8)-@
M>P0  (L7   9              " @1^D @!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @  XAX6E$M9M+X @  !@H  !D
M ("!T:@" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    "  #
MB'A:"W[=:_ $  #*%0  &0              @($ K ( >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (  .(>%K80\KZR00  &4>   9
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M970W-"YX;6Q02P$"% ,4    "  #B'A:74N8G3($  #)&P  &0
M    @(&?U ( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (
M  .(>%IRIL'YJ00  *D/   9              " @0C9 @!X;"]W;W)K<VAE
M971S+W-H965T-S8N>&UL4$L! A0#%     @  XAX6I'\,!E4!   J!0  !D
M             ("!Z-T" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"
M% ,4    "  #B'A:F&T>%OP#   ##0  &0              @(%SX@( >&PO
M=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    (  .(>%JZ.J\C-0,
M *0+   9              " @:;F @!X;"]W;W)K<VAE971S+W-H965T-SDN
M>&UL4$L! A0#%     @  XAX6M#92.8G$P  *N   !D              ("!
M$NH" 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    "  #B'A:
M@#I0MT4%  #F&0  &0              @(%P_0( >&PO=V]R:W-H965T<R]S
M:&5E=#@Q+GAM;%!+ 0(4 Q0    (  .(>%KCC(W4.00  " 8   9
M      " @>P" P!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%
M  @  XAX6OJ^WK==!   D1D  !D              ("!7 <# 'AL+W=O<FMS
M:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    "  #B'A:O?$3Q.P,   SM@
M&0              @('P"P, >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+
M 0(4 Q0    (  .(>%H,><5L*@\  #W?   9              " @1,9 P!X
M;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @  XAX6C#CA?*J
M)P  T6T# !D              ("!="@# 'AL+W=O<FMS:&5E=',O<VAE970X
M-BYX;6Q02P$"% ,4    "  #B'A:]I$PP'\.  "9X@  &0
M@(%54 , >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    (  .(
M>%KV;='&'@8  &XL   9              " @0M? P!X;"]W;W)K<VAE971S
M+W-H965T.#@N>&UL4$L! A0#%     @  XAX6@1 1\&M#P  71@! !D
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M 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4    "  #B'A:HJ]
M<U4K   ME0, &0              @($JD0, >&PO=V]R:W-H965T<R]S:&5E
M=#DS+GAM;%!+ 0(4 Q0    (  .(>%K2<I-%7 @  )A3   9
M  " @;:\ P!X;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @
M XAX6A<RZ-.$"P  ,88  !D              ("!2<4# 'AL+W=O<FMS:&5E
M=',O<VAE970Y-2YX;6Q02P$"% ,4    "  #B'A:F+'3<C48  ! F0$ &0
M            @($$T0, >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4
M Q0    (  .(>%I\Q]$R\@4  &8I   9              " @7#I P!X;"]W
M;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @  XAX6A#UFNZ?&@
M1^8! !D              ("!F>\# 'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6Q02P$"% ,4    "  #B'A:WSX7/ML&  !//   &0              @(%O
M"@0 >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    (  .(>%IS
M?WM&8 <  ,%*   :              " @8$1! !X;"]W;W)K<VAE971S+W-H
M965T,3 P+GAM;%!+ 0(4 Q0    (  .(>%IOR TY_1<  *NH 0 :
M      " @1D9! !X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0
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M965T,3 U+GAM;%!+ 0(4 Q0    (  .(>%JF+.MA^0(  "P)   :
M      " @2))! !X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0
M   (  .(>%J\3Z=7V@<  ));   :              " @5-,! !X;"]W;W)K
M<VAE971S+W-H965T,3 W+GAM;%!+ 0(4 Q0    (  .(>%HED;Z5-P@  #-F
M   :              " @654! !X;"]W;W)K<VAE971S+W-H965T,3 X+GAM
M;%!+ 0(4 Q0    (  .(>%I+J[5C7P0  .D6   :              " @=1<
M! !X;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;%!+ 0(4 Q0    (  .(>%IL
MT&_);!D  ..: 0 :              " @6MA! !X;"]W;W)K<VAE971S+W-H
M965T,3$P+GAM;%!+ 0(4 Q0    (  .(>%J-DTRS7Q,  'K    :
M      " @0][! !X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0
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M965T,3$U+GAM;%!+ 0(4 Q0    (  .(>%H>I6Y-M@(  %\(   :
M      " @2VU! !X;"]W;W)K<VAE971S+W-H965T,3$V+GAM;%!+ 0(4 Q0
M   (  .(>%I=;:E28@0  +P8   :              " @1NX! !X;"]W;W)K
M<VAE971S+W-H965T,3$W+GAM;%!+ 0(4 Q0    (  .(>%I,.0->BP,  %T+
M   :              " @;6\! !X;"]W;W)K<VAE971S+W-H965T,3$X+GAM
M;%!+ 0(4 Q0    (  .(>%H[)Z#Q$ 0  &,,   :              " @7C
M! !X;"]W;W)K<VAE971S+W-H965T,3$Y+GAM;%!+ 0(4 Q0    (  .(>%IC
MB^&*%P0  'T,   :              " @<#$! !X;"]W;W)K<VAE971S+W-H
M965T,3(P+GAM;%!+ 0(4 Q0    (  .(>%K"LD42^0(  .L(   :
M      " @0_)! !X;"]W;W)K<VAE971S+W-H965T,3(Q+GAM;%!+ 0(4 Q0
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M965T,3(U+GAM;%!+ 0(4 Q0    (  .(>%I1L75&?0,  -T,   :
M      " @:O<! !X;"]W;W)K<VAE971S+W-H965T,3(V+GAM;%!+ 0(4 Q0
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M965T,3,P+GAM;%!+ 0(4 Q0    (  .(>%HX =1,;00  #(/   :
M      " @4_P! !X;"]W;W)K<VAE971S+W-H965T,3,Q+GAM;%!+ 0(4 Q0
M   (  .(>%H*>J4]. 4  ((A   :              " @?3T! !X;"]W;W)K
M<VAE971S+W-H965T,3,R+GAM;%!+ 0(4 Q0    (  .(>%JY'J17S@(  ",*
M   :              " @63Z! !X;"]W;W)K<VAE971S+W-H965T,3,S+GAM
M;%!+ 0(4 Q0    (  .(>%K*'[M?3P,  +(*   :              " @6K]
M! !X;"]W;W)K<VAE971S+W-H965T,3,T+GAM;%!+ 0(4 Q0    (  .(>%H_
M)[KUR@(  +\'   :              " @?$ !0!X;"]W;W)K<VAE971S+W-H
M965T,3,U+GAM;%!+ 0(4 Q0    (  .(>%H/6L IP@,  &,,   :
M      " @?,#!0!X;"]W;W)K<VAE971S+W-H965T,3,V+GAM;%!+ 0(4 Q0
M   (  .(>%JPF?_XN0,  )T2   :              " @>T'!0!X;"]W;W)K
M<VAE971S+W-H965T,3,W+GAM;%!+ 0(4 Q0    (  .(>%KE7^U$) \  /;C
M   :              " @=X+!0!X;"]W;W)K<VAE971S+W-H965T,3,X+GAM
M;%!+ 0(4 Q0    (  .(>%I=QJ(V! 0  $86   :              " @3H;
M!0!X;"]W;W)K<VAE971S+W-H965T,3,Y+GAM;%!+ 0(4 Q0    (  .(>%K8
M#M]M,08  +8M   :              " @78?!0!X;"]W;W)K<VAE971S+W-H
M965T,30P+GAM;%!+ 0(4 Q0    (  .(>%KU."&1I0,  (<;   -
M      "  =\E!0!X;"]S='EL97,N>&UL4$L! A0#%     @  XAX6I>*NQS
M    $P(   L              ( !KRD% %]R96QS+RYR96QS4$L! A0#%
M  @  XAX6D33$U_8"   UEL   \              ( !F"H% 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    (  .(>%K%Y(,CQ@,   ]2   :
M  "  9TS!0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M  .(>%KW,#*&V0(  %-.   3              "  9LW!0!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@    "4 )0 ["@  *4Z!0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1353</ContextCount>
  <ElementCount>608</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>288</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>20</UnitCount>
  <MyReports>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Coverpage</Role>
      <ShortName>Cover page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Auditor information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Auditorinformation</Role>
      <ShortName>Auditor information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONSOLIDATED STATEMENTS OF INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - The Group</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/TheGroup</Role>
      <ShortName>The Group</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Basis of preparation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Basisofpreparation</Role>
      <ShortName>Basis of preparation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents</Role>
      <ShortName>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Accounting principles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Accountingprinciples</Role>
      <ShortName>Accounting principles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Segmentinformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Goodwill and impairment test</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Goodwillandimpairmenttest</Role>
      <ShortName>Goodwill and impairment test</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Intangibleassets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Propertyplantandequipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Other financial assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Otherfinancialassets</Role>
      <ShortName>Other financial assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Other receivables and other assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Otherreceivablesandotherassets</Role>
      <ShortName>Other receivables and other assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Cashandcashequivalents</Role>
      <ShortName>Cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Financial assets and liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Financialassetsandliabilities</Role>
      <ShortName>Financial assets and liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Shareholders??? equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Shareholdersequity</Role>
      <ShortName>Shareholders??? equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Share-based payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Sharebasedpayments</Role>
      <ShortName>Share-based payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Financial liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Financialliabilities</Role>
      <ShortName>Financial liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Retirement benefit obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Retirementbenefitobligations</Role>
      <ShortName>Retirement benefit obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Payables and other current liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Payablesandothercurrentliabilities</Role>
      <ShortName>Payables and other current liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Operating income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Operatingincome</Role>
      <ShortName>Operating income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9952175 - Disclosure - Operating expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Operatingexpenses</Role>
      <ShortName>Operating expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9952176 - Disclosure - Employees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Employees</Role>
      <ShortName>Employees</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9952177 - Disclosure - Financial gain (loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Financialgainloss</Role>
      <ShortName>Financial gain (loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9952178 - Disclosure - Income tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Incometax</Role>
      <ShortName>Income tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9952179 - Disclosure - Income (loss) per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Incomelosspershare</Role>
      <ShortName>Income (loss) per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9952180 - Disclosure - Related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Relatedparties</Role>
      <ShortName>Related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9952181 - Disclosure - Off-balance sheet commitments given</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Offbalancesheetcommitmentsgiven</Role>
      <ShortName>Off-balance sheet commitments given</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9952182 - Disclosure - Off-balance sheet commitments received and contingent assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Offbalancesheetcommitmentsreceivedandcontingentassets</Role>
      <ShortName>Off-balance sheet commitments received and contingent assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9952183 - Disclosure - Management and assessment of financial risks</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/Managementandassessmentoffinancialrisks</Role>
      <ShortName>Management and assessment of financial risks</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Accounting principles (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/AccountingprinciplesPolicies</Role>
      <ShortName>Accounting principles (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Accountingprinciples</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Accounting principles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/AccountingprinciplesTables</Role>
      <ShortName>Accounting principles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Accountingprinciples</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IntangibleassetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Intangibleassets</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/PropertyplantandequipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Propertyplantandequipment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Other financial assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OtherfinancialassetsTables</Role>
      <ShortName>Other financial assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Otherfinancialassets</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Other receivables and other assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OtherreceivablesandotherassetsTables</Role>
      <ShortName>Other receivables and other assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Otherreceivablesandotherassets</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CashandcashequivalentsTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Cashandcashequivalents</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Financial assets and liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialassetsandliabilitiesTables</Role>
      <ShortName>Financial assets and liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Financialassetsandliabilities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Shareholders??? equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/ShareholdersequityTables</Role>
      <ShortName>Shareholders??? equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Shareholdersequity</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Share-based payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsTables</Role>
      <ShortName>Share-based payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Sharebasedpayments</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Financial liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesTables</Role>
      <ShortName>Financial liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Financialliabilities</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Retirement benefit obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/RetirementbenefitobligationsTables</Role>
      <ShortName>Retirement benefit obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Retirementbenefitobligations</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Payables and other current liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/PayablesandothercurrentliabilitiesTables</Role>
      <ShortName>Payables and other current liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Payablesandothercurrentliabilities</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Operating income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingincomeTables</Role>
      <ShortName>Operating income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Operatingincome</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Operating expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingexpensesTables</Role>
      <ShortName>Operating expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Operatingexpenses</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Employees (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/EmployeesTables</Role>
      <ShortName>Employees (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Employees</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Financial gain (loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialgainlossTables</Role>
      <ShortName>Financial gain (loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Financialgainloss</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Income tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IncometaxTables</Role>
      <ShortName>Income tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Incometax</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Income (loss) per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IncomelosspershareTables</Role>
      <ShortName>Income (loss) per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Incometax</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Related parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/RelatedpartiesTables</Role>
      <ShortName>Related parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Relatedparties</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - The Group (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/TheGroupDetails</Role>
      <ShortName>The Group (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/TheGroup</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Basis of preparation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/BasisofpreparationDetails</Role>
      <ShortName>Basis of preparation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Basisofpreparation</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2022 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details</Role>
      <ShortName>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2022 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2023 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details</Role>
      <ShortName>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2023 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2024 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details</Role>
      <ShortName>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2024 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - Subsequent events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails</Role>
      <ShortName>Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - Subsequent events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Accounting principles - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails</Role>
      <ShortName>Accounting principles - Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Accounting principles - Disclosure of depreciation period of property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails</Role>
      <ShortName>Accounting principles - Disclosure of depreciation period of property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Accounting principles - Accounting of Prosynergia acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails</Role>
      <ShortName>Accounting principles - Accounting of Prosynergia acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Accounting principles - Disclosure of allocation of acquisition cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails</Role>
      <ShortName>Accounting principles - Disclosure of allocation of acquisition cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Segment information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SegmentinformationDetails</Role>
      <ShortName>Segment information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Segmentinformation</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Goodwill and impairment test (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/GoodwillandimpairmenttestDetails</Role>
      <ShortName>Goodwill and impairment test (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Goodwillandimpairmenttest</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Intangible assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IntangibleassetsNarrativeDetails</Role>
      <ShortName>Intangible assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Intangible assets - Disclosure of reconciliation of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails</Role>
      <ShortName>Intangible assets - Disclosure of reconciliation of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Property, plant and equipment - Disclosure of reconciliation of property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails</Role>
      <ShortName>Property, plant and equipment - Disclosure of reconciliation of property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Property, plant and equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails</Role>
      <ShortName>Property, plant and equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Other financial assets - Disclosure of other financial assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails</Role>
      <ShortName>Other financial assets - Disclosure of other financial assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Other financial assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails</Role>
      <ShortName>Other financial assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Other receivables and other assets - Disclosure of other receivables and other assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails</Role>
      <ShortName>Other receivables and other assets - Disclosure of other receivables and other assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Other receivables and other assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails</Role>
      <ShortName>Other receivables and other assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Cash and cash equivalents - Disclosure of composition of cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails</Role>
      <ShortName>Cash and cash equivalents - Disclosure of composition of cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Cash and cash equivalents - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails</Role>
      <ShortName>Cash and cash equivalents - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Financial assets and liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialassetsandliabilitiesDetails</Role>
      <ShortName>Financial assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/FinancialassetsandliabilitiesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Shareholders??? equity - Share capital issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails</Role>
      <ShortName>Shareholders??? equity - Share capital issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Shareholders??? equity - Equity line instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails</Role>
      <ShortName>Shareholders??? equity - Equity line instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Shareholders??? equity - Disclosure of reconciliation of BSAs, equity line agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails</Role>
      <ShortName>Shareholders??? equity - Disclosure of reconciliation of BSAs, equity line agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Shareholders??? equity - Change in share capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails</Role>
      <ShortName>Shareholders??? equity - Change in share capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Share-based payments - Disclosure of reconciliation of BCEs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails</Role>
      <ShortName>Share-based payments - Disclosure of reconciliation of BCEs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Share-based payments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails</Role>
      <ShortName>Share-based payments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Share-based payments - Disclosure of reconciliation of BSAs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails</Role>
      <ShortName>Share-based payments - Disclosure of reconciliation of BSAs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Share-based payments - Disclosure of assumptions used for the measurement of BSAs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails</Role>
      <ShortName>Share-based payments - Disclosure of assumptions used for the measurement of BSAs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Share-based payments - Disclosure of reconciliation of AGAs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails</Role>
      <ShortName>Share-based payments - Disclosure of reconciliation of AGAs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - Share-based payments - Disclosure of assumptions used for the measurement of AGAs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails</Role>
      <ShortName>Share-based payments - Disclosure of assumptions used for the measurement of AGAs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - Share-based payments - Disclosure of breakdown of the compensation expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails</Role>
      <ShortName>Share-based payments - Disclosure of breakdown of the compensation expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - Financial liabilities - Disclosure of financial liabilities breakdown (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails</Role>
      <ShortName>Financial liabilities - Disclosure of financial liabilities breakdown (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - Financial liabilities - Kreos / Claret Financing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails</Role>
      <ShortName>Financial liabilities - Kreos / Claret Financing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret minimum return indemnifications (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails</Role>
      <ShortName>Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret minimum return indemnifications (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret BSA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails</Role>
      <ShortName>Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret BSA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - Financial liabilities - Heights convertible notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails</Role>
      <ShortName>Financial liabilities - Heights convertible notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Heights convertible loan notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails</Role>
      <ShortName>Financial liabilities - Disclosure of the main data and assumptions, Heights convertible loan notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - Financial liabilities - Kreos 1 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesKreos1Details</Role>
      <ShortName>Financial liabilities - Kreos 1 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos BSA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails</Role>
      <ShortName>Financial liabilities - Disclosure of the main data and assumptions, Kreos BSA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - Financial liabilities - Kreos 2 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesKreos2Details</Role>
      <ShortName>Financial liabilities - Kreos 2 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9955574 - Disclosure - Financial liabilities - OCEANE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails</Role>
      <ShortName>Financial liabilities - OCEANE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9955575 - Disclosure - Financial liabilities - Financial liabilities - Disclosure of the main data and assumptions, OCEANE convertible loan notes (Details) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails</Role>
      <ShortName>Financial liabilities - Financial liabilities - Disclosure of the main data and assumptions, OCEANE convertible loan notes (Details) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9955576 - Disclosure - Financial liabilities - State guaranteed loan ??? ???PGE??? (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails</Role>
      <ShortName>Financial liabilities - State guaranteed loan ??? ???PGE??? (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9955577 - Disclosure - Financial liabilities - Disclosure of conditional advances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails</Role>
      <ShortName>Financial liabilities - Disclosure of conditional advances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9955578 - Disclosure - Financial liabilities - Conditional advances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails</Role>
      <ShortName>Financial liabilities - Conditional advances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9955579 - Disclosure - Financial liabilities - Disclosure of variation in lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails</Role>
      <ShortName>Financial liabilities - Disclosure of variation in lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9955580 - Disclosure - Financial liabilities - Lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails</Role>
      <ShortName>Financial liabilities - Lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9955581 - Disclosure - Financial liabilities - Prosynergia earn-out liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails</Role>
      <ShortName>Financial liabilities - Prosynergia earn-out liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9955582 - Disclosure - Financial liabilities - Disclosure of main data and assumptions used for the measurement of earn-out liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails</Role>
      <ShortName>Financial liabilities - Disclosure of main data and assumptions used for the measurement of earn-out liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9955583 - Disclosure - Financial liabilities - Royalty certificates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails</Role>
      <ShortName>Financial liabilities - Royalty certificates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9955584 - Disclosure - Financial liabilities - Disclosure of reconciliation of liabilities arising from financing activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails</Role>
      <ShortName>Financial liabilities - Disclosure of reconciliation of liabilities arising from financing activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9955585 - Disclosure - Financial liabilities - Change in financial liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails</Role>
      <ShortName>Financial liabilities - Change in financial liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9955586 - Disclosure - Financial liabilities - Disclosure of changes in derivative instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails</Role>
      <ShortName>Financial liabilities - Disclosure of changes in derivative instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>9955587 - Disclosure - Financial liabilities - Change in derivative instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails</Role>
      <ShortName>Financial liabilities - Change in derivative instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>9955588 - Disclosure - Financial liabilities - Disclosure of remaining contractual maturities of financial liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails</Role>
      <ShortName>Financial liabilities - Disclosure of remaining contractual maturities of financial liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>9955589 - Disclosure - Financial liabilities - Breakdown of financial liabilities by maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails</Role>
      <ShortName>Financial liabilities - Breakdown of financial liabilities by maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>9955590 - Disclosure - Retirement benefit obligations - Disclosure of main actuarial assumptions used to measure the retirement benefit obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails</Role>
      <ShortName>Retirement benefit obligations - Disclosure of main actuarial assumptions used to measure the retirement benefit obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>9955591 - Disclosure - Retirement benefit obligations - Disclosure of changes in projected benefit obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails</Role>
      <ShortName>Retirement benefit obligations - Disclosure of changes in projected benefit obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>9955592 - Disclosure - Payables and other current liabilities - Disclosure of breakdown of trade and other payables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails</Role>
      <ShortName>Payables and other current liabilities - Disclosure of breakdown of trade and other payables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>9955593 - Disclosure - Payables and other current liabilities - Disclosure of tax and employee-related payables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails</Role>
      <ShortName>Payables and other current liabilities - Disclosure of tax and employee-related payables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>9955594 - Disclosure - Operating income - Disclosure of breakdown of operating income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails</Role>
      <ShortName>Operating income - Disclosure of breakdown of operating income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>9955595 - Disclosure - Operating income - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingincomeNarrativeDetails</Role>
      <ShortName>Operating income - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>9955596 - Disclosure - Operating expenses - Disclosure of sales and marketing expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails</Role>
      <ShortName>Operating expenses - Disclosure of sales and marketing expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>9955597 - Disclosure - Operating expenses - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingexpensesNarrativeDetails</Role>
      <ShortName>Operating expenses - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>9955598 - Disclosure - Operating expenses - Disclosure of research and development expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails</Role>
      <ShortName>Operating expenses - Disclosure of research and development expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>9955599 - Disclosure - Operating expenses - Disclosure of general and administrative expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails</Role>
      <ShortName>Operating expenses - Disclosure of general and administrative expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>9955600 - Disclosure - Operating expenses - Disclosure of principal audit fees and services (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails</Role>
      <ShortName>Operating expenses - Disclosure of principal audit fees and services (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>9955601 - Disclosure - Employees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/EmployeesDetails</Role>
      <ShortName>Employees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/EmployeesTables</ParentRole>
      <Position>128</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>9955602 - Disclosure - Financial gain (loss) - Disclosure of net financial income (loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails</Role>
      <ShortName>Financial gain (loss) - Disclosure of net financial income (loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/FinancialgainlossTables</ParentRole>
      <Position>129</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>9955603 - Disclosure - Financial gain (loss) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/FinancialgainlossNarrativeDetails</Role>
      <ShortName>Financial gain (loss) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/FinancialgainlossTables</ParentRole>
      <Position>130</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>9955604 - Disclosure - Income tax - Disclosure of reconciliation of effective income tax (loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails</Role>
      <ShortName>Income tax - Disclosure of reconciliation of effective income tax (loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>131</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>9955605 - Disclosure - Income tax - Disclosure of deferred tax assets and liabilities by nature (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails</Role>
      <ShortName>Income tax - Disclosure of deferred tax assets and liabilities by nature (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>132</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>9955606 - Disclosure - Income tax - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IncometaxNarrativeDetails</Role>
      <ShortName>Income tax - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>133</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>9955607 - Disclosure - Income (loss) per share - Schedule of earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails</Role>
      <ShortName>Income (loss) per share - Schedule of earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/IncometaxTables</ParentRole>
      <Position>134</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>9955608 - Disclosure - Income (loss) per share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/IncomelosspershareNarrativeDetails</Role>
      <ShortName>Income (loss) per share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/IncometaxTables</ParentRole>
      <Position>135</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>9955609 - Disclosure - Related parties - Disclosure of aggregate compensation of the members of the Group???s Board of Directors and CEO (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails</Role>
      <ShortName>Related parties - Disclosure of aggregate compensation of the members of the Group???s Board of Directors and CEO (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>136</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R137.htm</HtmlFileName>
      <LongName>9955610 - Disclosure - Related parties - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/RelatedpartiesNarrativeDetails</Role>
      <ShortName>Related parties - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>137</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R138.htm</HtmlFileName>
      <LongName>9955611 - Disclosure - Off-balance sheet commitments given (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails</Role>
      <ShortName>Off-balance sheet commitments given (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Offbalancesheetcommitmentsgiven</ParentRole>
      <Position>138</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R139.htm</HtmlFileName>
      <LongName>9955612 - Disclosure - Off-balance sheet commitments received and contingent assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails</Role>
      <ShortName>Off-balance sheet commitments received and contingent assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Offbalancesheetcommitmentsreceivedandcontingentassets</ParentRole>
      <Position>139</Position>
    </Report>
    <Report instance="abvx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R140.htm</HtmlFileName>
      <LongName>9955613 - Disclosure - Management and assessment of financial risks (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails</Role>
      <ShortName>Management and assessment of financial risks (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.abivax.com/role/Managementandassessmentoffinancialrisks</ParentRole>
      <Position>140</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="abvx-20241231.htm">abvx-20241231.htm</File>
    <File>abvx-20241231.xsd</File>
    <File>abvx-20241231_cal.xml</File>
    <File>abvx-20241231_def.xml</File>
    <File>abvx-20241231_lab.xml</File>
    <File>abvx-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>abvx-20241231_g1.jpg</File>
    <File>abvx-20241231_g10.jpg</File>
    <File>abvx-20241231_g11.jpg</File>
    <File>abvx-20241231_g12.jpg</File>
    <File>abvx-20241231_g13.jpg</File>
    <File>abvx-20241231_g14.jpg</File>
    <File>abvx-20241231_g15.jpg</File>
    <File>abvx-20241231_g16.jpg</File>
    <File>abvx-20241231_g17.jpg</File>
    <File>abvx-20241231_g18.jpg</File>
    <File>abvx-20241231_g19.jpg</File>
    <File>abvx-20241231_g2.jpg</File>
    <File>abvx-20241231_g20.jpg</File>
    <File>abvx-20241231_g21.jpg</File>
    <File>abvx-20241231_g22.jpg</File>
    <File>abvx-20241231_g23.jpg</File>
    <File>abvx-20241231_g24.jpg</File>
    <File>abvx-20241231_g3.jpg</File>
    <File>abvx-20241231_g4.jpg</File>
    <File>abvx-20241231_g5.jpg</File>
    <File>abvx-20241231_g6.jpg</File>
    <File>abvx-20241231_g7.jpg</File>
    <File>abvx-20241231_g8.jpg</File>
    <File>abvx-20241231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
    <BaseTaxonomy items="2098">https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>194
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "abvx-20241231.htm": {
   "nsprefix": "abvx",
   "nsuri": "http://www.abivax.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "abvx-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "abvx-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2024-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd",
      "https://xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "abvx-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "abvx-20241231_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/dim_full_ifrs_2024-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "abvx-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abvx-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 324,
   "keyCustom": 284,
   "axisStandard": 39,
   "axisCustom": 9,
   "memberStandard": 55,
   "memberCustom": 190,
   "hidden": {
    "total": 25,
    "http://www.abivax.com/20241231": 20,
    "http://xbrl.sec.gov/dei/2024": 5
   },
   "contextCount": 1353,
   "entityCount": 1,
   "segmentCount": 288,
   "elementCount": 1174,
   "unitCount": 20,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 2098,
    "http://xbrl.sec.gov/dei/2024": 46,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://www.abivax.com/role/Coverpage",
     "longName": "0000001 - Document - Cover page",
     "shortName": "Cover page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.abivax.com/role/Auditorinformation",
     "longName": "0000002 - Document - Auditor information",
     "shortName": "Auditor information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
     "longName": "9952151 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION",
     "shortName": "CONSOLIDATED STATEMENTS OF FINANCIAL POSITION",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:Goodwill",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:OtherNoncurrentNonfinancialAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical",
     "longName": "9952152 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "abvx:NonCurrentConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "abvx:NonCurrentConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
     "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF INCOME (LOSS)",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME (LOSS)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:OtherIncome",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:RevenueAndOperatingIncome",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
     "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "ifrs-full:Equity",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.abivax.com/role/TheGroup",
     "longName": "9952157 - Disclosure - The Group",
     "shortName": "The Group",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.abivax.com/role/Basisofpreparation",
     "longName": "9952158 - Disclosure - Basis of preparation",
     "shortName": "Basis of preparation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents",
     "longName": "9952159 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events",
     "shortName": "Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.abivax.com/role/Accountingprinciples",
     "longName": "9952160 - Disclosure - Accounting principles",
     "shortName": "Accounting principles",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.abivax.com/role/Segmentinformation",
     "longName": "9952161 - Disclosure - Segment information",
     "shortName": "Segment information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.abivax.com/role/Goodwillandimpairmenttest",
     "longName": "9952162 - Disclosure - Goodwill and impairment test",
     "shortName": "Goodwill and impairment test",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.abivax.com/role/Intangibleassets",
     "longName": "9952163 - Disclosure - Intangible assets",
     "shortName": "Intangible assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.abivax.com/role/Propertyplantandequipment",
     "longName": "9952164 - Disclosure - Property, plant and equipment",
     "shortName": "Property, plant and equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.abivax.com/role/Otherfinancialassets",
     "longName": "9952165 - Disclosure - Other financial assets",
     "shortName": "Other financial assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.abivax.com/role/Otherreceivablesandotherassets",
     "longName": "9952166 - Disclosure - Other receivables and other assets",
     "shortName": "Other receivables and other assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.abivax.com/role/Cashandcashequivalents",
     "longName": "9952167 - Disclosure - Cash and cash equivalents",
     "shortName": "Cash and cash equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.abivax.com/role/Financialassetsandliabilities",
     "longName": "9952168 - Disclosure - Financial assets and liabilities",
     "shortName": "Financial assets and liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.abivax.com/role/Shareholdersequity",
     "longName": "9952169 - Disclosure - Shareholders\u2019 equity",
     "shortName": "Shareholders\u2019 equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.abivax.com/role/Sharebasedpayments",
     "longName": "9952170 - Disclosure - Share-based payments",
     "shortName": "Share-based payments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.abivax.com/role/Financialliabilities",
     "longName": "9952171 - Disclosure - Financial liabilities",
     "shortName": "Financial liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.abivax.com/role/Retirementbenefitobligations",
     "longName": "9952172 - Disclosure - Retirement benefit obligations",
     "shortName": "Retirement benefit obligations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.abivax.com/role/Payablesandothercurrentliabilities",
     "longName": "9952173 - Disclosure - Payables and other current liabilities",
     "shortName": "Payables and other current liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.abivax.com/role/Operatingincome",
     "longName": "9952174 - Disclosure - Operating income",
     "shortName": "Operating income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.abivax.com/role/Operatingexpenses",
     "longName": "9952175 - Disclosure - Operating expenses",
     "shortName": "Operating expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.abivax.com/role/Employees",
     "longName": "9952176 - Disclosure - Employees",
     "shortName": "Employees",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.abivax.com/role/Financialgainloss",
     "longName": "9952177 - Disclosure - Financial gain (loss)",
     "shortName": "Financial gain (loss)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.abivax.com/role/Incometax",
     "longName": "9952178 - Disclosure - Income tax",
     "shortName": "Income tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.abivax.com/role/Incomelosspershare",
     "longName": "9952179 - Disclosure - Income (loss) per share",
     "shortName": "Income (loss) per share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.abivax.com/role/Relatedparties",
     "longName": "9952180 - Disclosure - Related parties",
     "shortName": "Related parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.abivax.com/role/Offbalancesheetcommitmentsgiven",
     "longName": "9952181 - Disclosure - Off-balance sheet commitments given",
     "shortName": "Off-balance sheet commitments given",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.abivax.com/role/Offbalancesheetcommitmentsreceivedandcontingentassets",
     "longName": "9952182 - Disclosure - Off-balance sheet commitments received and contingent assets",
     "shortName": "Off-balance sheet commitments received and contingent assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.abivax.com/role/Managementandassessmentoffinancialrisks",
     "longName": "9952183 - Disclosure - Management and assessment of financial risks",
     "shortName": "Management and assessment of financial risks",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.abivax.com/role/AccountingprinciplesPolicies",
     "longName": "9955511 - Disclosure - Accounting principles (Policies)",
     "shortName": "Accounting principles (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.abivax.com/role/AccountingprinciplesTables",
     "longName": "9955512 - Disclosure - Accounting principles (Tables)",
     "shortName": "Accounting principles (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.abivax.com/role/IntangibleassetsTables",
     "longName": "9955513 - Disclosure - Intangible assets (Tables)",
     "shortName": "Intangible assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.abivax.com/role/PropertyplantandequipmentTables",
     "longName": "9955514 - Disclosure - Property, plant and equipment (Tables)",
     "shortName": "Property, plant and equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.abivax.com/role/OtherfinancialassetsTables",
     "longName": "9955515 - Disclosure - Other financial assets (Tables)",
     "shortName": "Other financial assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.abivax.com/role/OtherreceivablesandotherassetsTables",
     "longName": "9955516 - Disclosure - Other receivables and other assets (Tables)",
     "shortName": "Other receivables and other assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.abivax.com/role/CashandcashequivalentsTables",
     "longName": "9955517 - Disclosure - Cash and cash equivalents (Tables)",
     "shortName": "Cash and cash equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.abivax.com/role/FinancialassetsandliabilitiesTables",
     "longName": "9955518 - Disclosure - Financial assets and liabilities (Tables)",
     "shortName": "Financial assets and liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.abivax.com/role/ShareholdersequityTables",
     "longName": "9955519 - Disclosure - Shareholders\u2019 equity (Tables)",
     "shortName": "Shareholders\u2019 equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R47": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsTables",
     "longName": "9955520 - Disclosure - Share-based payments (Tables)",
     "shortName": "Share-based payments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesTables",
     "longName": "9955521 - Disclosure - Financial liabilities (Tables)",
     "shortName": "Financial liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.abivax.com/role/RetirementbenefitobligationsTables",
     "longName": "9955522 - Disclosure - Retirement benefit obligations (Tables)",
     "shortName": "Retirement benefit obligations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.abivax.com/role/PayablesandothercurrentliabilitiesTables",
     "longName": "9955523 - Disclosure - Payables and other current liabilities (Tables)",
     "shortName": "Payables and other current liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.abivax.com/role/OperatingincomeTables",
     "longName": "9955524 - Disclosure - Operating income (Tables)",
     "shortName": "Operating income (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.abivax.com/role/OperatingexpensesTables",
     "longName": "9955525 - Disclosure - Operating expenses (Tables)",
     "shortName": "Operating expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.abivax.com/role/EmployeesTables",
     "longName": "9955526 - Disclosure - Employees (Tables)",
     "shortName": "Employees (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfAverageNumberOfEmployeesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfAverageNumberOfEmployeesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.abivax.com/role/FinancialgainlossTables",
     "longName": "9955527 - Disclosure - Financial gain (loss) (Tables)",
     "shortName": "Financial gain (loss) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.abivax.com/role/IncometaxTables",
     "longName": "9955528 - Disclosure - Income tax (Tables)",
     "shortName": "Income tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.abivax.com/role/IncomelosspershareTables",
     "longName": "9955529 - Disclosure - Income (loss) per share (Tables)",
     "shortName": "Income (loss) per share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.abivax.com/role/RelatedpartiesTables",
     "longName": "9955530 - Disclosure - Related parties (Tables)",
     "shortName": "Related parties (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.abivax.com/role/TheGroupDetails",
     "longName": "9955531 - Disclosure - The Group (Details)",
     "shortName": "The Group (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:Equity",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R59": {
     "role": "http://www.abivax.com/role/BasisofpreparationDetails",
     "longName": "9955532 - Disclosure - Basis of preparation (Details)",
     "shortName": "Basis of preparation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-58",
      "name": "abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
     "longName": "9955533 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2022 (Details)",
     "shortName": "Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2022 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-72",
      "name": "abvx:NetProceedsFromSaleOfRoyaltyCertificates",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
     "longName": "9955534 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2023 (Details)",
     "shortName": "Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2023 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-443",
      "name": "ifrs-full:IssueOfEquity",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-95",
      "name": "abvx:ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
     "longName": "9955535 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2024 (Details)",
     "shortName": "Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - For the year ended 2024 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-100",
      "name": "abvx:NumberOfFreeSharesPlansIssued",
      "unitRef": "plan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-115",
      "name": "abvx:NumberOfADSPerOrdinaryShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails",
     "longName": "9955536 - Disclosure - Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - Subsequent events (Details)",
     "shortName": "Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events - Subsequent events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-100",
      "name": "abvx:NumberOfFreeSharesPlansIssued",
      "unitRef": "plan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-122",
      "name": "abvx:NumberOfFreeSharesPlansIssued",
      "unitRef": "plan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails",
     "longName": "9955537 - Disclosure - Accounting principles - Intangible assets (Details)",
     "shortName": "Accounting principles - Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias",
      "unitRef": "criteria",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias",
      "unitRef": "criteria",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
     "longName": "9955538 - Disclosure - Accounting principles - Disclosure of depreciation period of property, plant and equipment (Details)",
     "shortName": "Accounting principles - Disclosure of depreciation period of property, plant and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-129",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-129",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
     "longName": "9955539 - Disclosure - Accounting principles - Accounting of Prosynergia acquisition (Details)",
     "shortName": "Accounting principles - Accounting of Prosynergia acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
     "longName": "9955540 - Disclosure - Accounting principles - Disclosure of allocation of acquisition cost (Details)",
     "shortName": "Accounting principles - Disclosure of allocation of acquisition cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-63",
      "name": "abvx:CashPrepaymentAssetsAcquisitions",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-63",
      "name": "abvx:AcquisitionRelatedCostsAssetsAcquisition",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.abivax.com/role/SegmentinformationDetails",
     "longName": "9955541 - Disclosure - Segment information (Details)",
     "shortName": "Segment information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-145",
      "name": "abvx:ContributionToGroupsAssetsPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "abvx:ContributionToGroupsLiabilitiesPercentage",
       "abvx:ContributionToGroupsNetProfitsLossesPercentage",
       "abvx:ContributionToGroupsAssetsPercentage",
       "abvx:ContributionToGroupsNetProfitsLossesPercentage",
       "abvx:ContributionToGroupsLiabilitiesPercentage",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-145",
      "name": "abvx:ContributionToGroupsAssetsPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "abvx:ContributionToGroupsLiabilitiesPercentage",
       "abvx:ContributionToGroupsNetProfitsLossesPercentage",
       "abvx:ContributionToGroupsAssetsPercentage",
       "abvx:ContributionToGroupsNetProfitsLossesPercentage",
       "abvx:ContributionToGroupsLiabilitiesPercentage",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.abivax.com/role/GoodwillandimpairmenttestDetails",
     "longName": "9955542 - Disclosure - Goodwill and impairment test (Details)",
     "shortName": "Goodwill and impairment test (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:Goodwill",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
     "longName": "9955543 - Disclosure - Intangible assets - Narrative (Details)",
     "shortName": "Intangible assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-63",
      "name": "abvx:TechnologyBasedIntangibleAssetsAssetsAcquisitions",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-149",
      "name": "abvx:CollaborationAgreementsDevelopmentMilestonePaymentINDApproval",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails",
     "longName": "9955544 - Disclosure - Intangible assets - Disclosure of reconciliation of intangible assets (Details)",
     "shortName": "Intangible assets - Disclosure of reconciliation of intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails",
     "longName": "9955545 - Disclosure - Property, plant and equipment - Disclosure of reconciliation of property, plant and equipment (Details)",
     "shortName": "Property, plant and equipment - Disclosure of reconciliation of property, plant and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails",
     "longName": "9955546 - Disclosure - Property, plant and equipment - Narrative (Details)",
     "shortName": "Property, plant and equipment - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-301",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-301",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails",
     "longName": "9955547 - Disclosure - Other financial assets - Disclosure of other financial assets (Details)",
     "shortName": "Other financial assets - Disclosure of other financial assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "abvx:NonCurrentAdvancesToCROContracts",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:LongtermDeposits",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails",
     "longName": "9955548 - Disclosure - Other financial assets - Narrative (Details)",
     "shortName": "Other financial assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-310",
      "name": "abvx:DiscountRateAppliedToLongTermAdvances",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-310",
      "name": "abvx:DiscountRateAppliedToLongTermAdvances",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails",
     "longName": "9955549 - Disclosure - Other receivables and other assets - Disclosure of other receivables and other assets (Details)",
     "shortName": "Other receivables and other assets - Disclosure of other receivables and other assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "abvx:NonCurrentPrepaidExpenses",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "abvx:NonCurrentPrepaidExpenses",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails",
     "longName": "9955550 - Disclosure - Other receivables and other assets - Narrative (Details)",
     "shortName": "Other receivables and other assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:ProceedsFromResearchTaxCredit",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "abvx:CurrentPrepaidExpensesRelatedToCRO",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails",
     "longName": "9955551 - Disclosure - Cash and cash equivalents - Disclosure of composition of cash and cash equivalents (Details)",
     "shortName": "Cash and cash equivalents - Disclosure of composition of cash and cash equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:CashEquivalents",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:CashEquivalents",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails",
     "longName": "9955552 - Disclosure - Cash and cash equivalents - Narrative (Details)",
     "shortName": "Cash and cash equivalents - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
     "longName": "9955553 - Disclosure - Financial assets and liabilities (Details)",
     "shortName": "Financial assets and liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:Assets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:FinancialAssetsAtFairValue",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails",
     "longName": "9955554 - Disclosure - Shareholders\u2019 equity - Share capital issued (Details)",
     "shortName": "Shareholders\u2019 equity - Share capital issued (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:IssuedCapital",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "abvx:NumberOfTreasurySharesHeld",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails",
     "longName": "9955555 - Disclosure - Shareholders\u2019 equity - Equity line instruments (Details)",
     "shortName": "Shareholders\u2019 equity - Equity line instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-533",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-435",
      "name": "abvx:UnderwritingAgreementMaximumNumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
     "longName": "9955556 - Disclosure - Shareholders\u2019 equity - Disclosure of reconciliation of BSAs, equity line agreement (Details)",
     "shortName": "Shareholders\u2019 equity - Disclosure of reconciliation of BSAs, equity line agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-532",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-438",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
     "longName": "9955557 - Disclosure - Shareholders\u2019 equity - Change in share capital (Details)",
     "shortName": "Shareholders\u2019 equity - Change in share capital (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-443",
      "name": "ifrs-full:IssueOfEquity",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "abvx:NumberOfWarrantsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
     "longName": "9955558 - Disclosure - Share-based payments - Disclosure of reconciliation of BCEs (Details)",
     "shortName": "Share-based payments - Disclosure of reconciliation of BCEs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-493",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-493",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
     "longName": "9955559 - Disclosure - Share-based payments - Narrative (Details)",
     "shortName": "Share-based payments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-494",
      "name": "abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-494",
      "name": "abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
     "longName": "9955560 - Disclosure - Share-based payments - Disclosure of reconciliation of BSAs (Details)",
     "shortName": "Share-based payments - Disclosure of reconciliation of BSAs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-532",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-500",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
     "longName": "9955561 - Disclosure - Share-based payments - Disclosure of assumptions used for the measurement of BSAs (Details)",
     "shortName": "Share-based payments - Disclosure of assumptions used for the measurement of BSAs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-523",
      "name": "abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-523",
      "name": "abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
     "longName": "9955562 - Disclosure - Share-based payments - Disclosure of reconciliation of AGAs (Details)",
     "shortName": "Share-based payments - Disclosure of reconciliation of AGAs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-583",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-584",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
     "longName": "9955563 - Disclosure - Share-based payments - Disclosure of assumptions used for the measurement of AGAs (Details)",
     "shortName": "Share-based payments - Disclosure of assumptions used for the measurement of AGAs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-586",
      "name": "abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-586",
      "name": "abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
     "longName": "9955564 - Disclosure - Share-based payments - Disclosure of breakdown of the compensation expenses (Details)",
     "shortName": "Share-based payments - Disclosure of breakdown of the compensation expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
     "longName": "9955565 - Disclosure - Financial liabilities - Disclosure of financial liabilities breakdown (Details)",
     "shortName": "Financial liabilities - Disclosure of financial liabilities breakdown (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:NoncurrentFinancialLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:NoncurrentFinancialLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
     "longName": "9955566 - Disclosure - Financial liabilities - Kreos / Claret Financing (Details)",
     "shortName": "Financial liabilities - Kreos / Claret Financing (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-52",
      "name": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-688",
      "name": "abvx:ConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
     "longName": "9955567 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret minimum return indemnifications (Details)",
     "shortName": "Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret minimum return indemnifications (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-711",
      "name": "abvx:AggregateFairValueOtherEquityInstrumentsOutstanding",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-711",
      "name": "abvx:AggregateFairValueOtherEquityInstrumentsOutstanding",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
     "longName": "9955568 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret BSA (Details)",
     "shortName": "Financial liabilities - Disclosure of the main data and assumptions, Kreos / Claret BSA (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-778",
      "name": "ifrs-full:SignificantUnobservableInputLiabilities",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-778",
      "name": "ifrs-full:SignificantUnobservableInputLiabilities",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
     "longName": "9955569 - Disclosure - Financial liabilities - Heights convertible notes (Details)",
     "shortName": "Financial liabilities - Heights convertible notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:NetProceedsFromConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-901",
      "name": "ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
     "longName": "9955570 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Heights convertible loan notes (Details)",
     "shortName": "Financial liabilities - Disclosure of the main data and assumptions, Heights convertible loan notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-870",
      "name": "abvx:NumberOfConvertibleNotesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-870",
      "name": "abvx:NumberOfConvertibleNotesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
     "longName": "9955571 - Disclosure - Financial liabilities - Kreos 1 (Details)",
     "shortName": "Financial liabilities - Kreos 1 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:NetProceedsFromConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-930",
      "name": "abvx:ExercisePriceOtherEquityInstrumentsGranted",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
     "longName": "9955572 - Disclosure - Financial liabilities - Disclosure of the main data and assumptions, Kreos BSA (Details)",
     "shortName": "Financial liabilities - Disclosure of the main data and assumptions, Kreos BSA (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-937",
      "name": "abvx:NumberOfWarrantsOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-937",
      "name": "abvx:AggregateFairValueOtherEquityInstrumentsOutstanding",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
     "longName": "9955573 - Disclosure - Financial liabilities - Kreos 2 (Details)",
     "shortName": "Financial liabilities - Kreos 2 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-975",
      "name": "abvx:BorrowingsNumberOfMonthlyInstallments",
      "unitRef": "installment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-971",
      "name": "ifrs-full:NotionalAmount",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
     "longName": "9955574 - Disclosure - Financial liabilities - OCEANE (Details)",
     "shortName": "Financial liabilities - OCEANE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-95",
      "name": "abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1002",
      "name": "ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
     "longName": "9955575 - Disclosure - Financial liabilities - Financial liabilities - Disclosure of the main data and assumptions, OCEANE convertible loan notes (Details) (Details)",
     "shortName": "Financial liabilities - Financial liabilities - Disclosure of the main data and assumptions, OCEANE convertible loan notes (Details) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c-998",
      "name": "abvx:AggregateFairValueConvertibleNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-997",
      "name": "ifrs-full:SignificantUnobservableInputLiabilities",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails",
     "longName": "9955576 - Disclosure - Financial liabilities - State guaranteed loan \u2013 \u201cPGE\u201d (Details)",
     "shortName": "Financial liabilities - State guaranteed loan \u2013 \u201cPGE\u201d (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1006",
      "name": "abvx:BorrowingsMaturityTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
     "longName": "9955577 - Disclosure - Financial liabilities - Disclosure of conditional advances (Details)",
     "shortName": "Financial liabilities - Disclosure of conditional advances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "abvx:ConditionalAdvances",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R105": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
     "longName": "9955578 - Disclosure - Financial liabilities - Conditional advances (Details)",
     "shortName": "Financial liabilities - Conditional advances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "abvx:ConditionalAdvances",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-111",
      "name": "abvx:RepaymentOfExcessConditionalAdvancesClaimed",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails",
     "longName": "9955579 - Disclosure - Financial liabilities - Disclosure of variation in lease liabilities (Details)",
     "shortName": "Financial liabilities - Disclosure of variation in lease liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "ifrs-full:LeaseLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:IncreaseInLeaseLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
     "longName": "9955580 - Disclosure - Financial liabilities - Lease liabilities (Details)",
     "shortName": "Financial liabilities - Lease liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:ExpenseOnLeaseLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:ExpenseOnLeaseLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
     "longName": "9955581 - Disclosure - Financial liabilities - Prosynergia earn-out liability (Details)",
     "shortName": "Financial liabilities - Prosynergia earn-out liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1064",
      "name": "ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
     "longName": "9955582 - Disclosure - Financial liabilities - Disclosure of main data and assumptions used for the measurement of earn-out liability (Details)",
     "shortName": "Financial liabilities - Disclosure of main data and assumptions used for the measurement of earn-out liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "abvx:EarnOutAtFairValue",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-138",
      "name": "abvx:EarnOutAtFairValue",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
     "longName": "9955583 - Disclosure - Financial liabilities - Royalty certificates (Details)",
     "shortName": "Financial liabilities - Royalty certificates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c-443",
      "name": "ifrs-full:IssueOfEquity",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "abvx:DecreaseInInterestExpenseOnRoyaltyCertificates",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
     "longName": "9955584 - Disclosure - Financial liabilities - Disclosure of reconciliation of liabilities arising from financing activities (Details)",
     "shortName": "Financial liabilities - Disclosure of reconciliation of liabilities arising from financing activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
     "longName": "9955585 - Disclosure - Financial liabilities - Change in financial liabilities (Details)",
     "shortName": "Financial liabilities - Change in financial liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:NetProceedsFromConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:GrossProceedsFromNonConvertibleLoansNotes",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
     "longName": "9955586 - Disclosure - Financial liabilities - Disclosure of changes in derivative instruments (Details)",
     "shortName": "Financial liabilities - Disclosure of changes in derivative instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "ifrs-full:DerivativeFinancialLiabilities",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:IssuanceOfDerivativeInstruments",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
     "longName": "9955587 - Disclosure - Financial liabilities - Change in derivative instruments (Details)",
     "shortName": "Financial liabilities - Change in derivative instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c-970",
      "name": "ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-998",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValue",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
     "longName": "9955588 - Disclosure - Financial liabilities - Disclosure of remaining contractual maturities of financial liabilities (Details)",
     "shortName": "Financial liabilities - Disclosure of remaining contractual maturities of financial liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "abvx:ConditionalAdvances",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "abvx:RoyaltyCertificatesUndiscountedCashFlows",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
     "longName": "9955589 - Disclosure - Financial liabilities - Breakdown of financial liabilities by maturity (Details)",
     "shortName": "Financial liabilities - Breakdown of financial liabilities by maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c-1069",
      "name": "abvx:RoyaltyCertificatePercentageOfFutureSales",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1067",
      "name": "abvx:RoyaltyCertificateExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails",
     "longName": "9955590 - Disclosure - Retirement benefit obligations - Disclosure of main actuarial assumptions used to measure the retirement benefit obligations (Details)",
     "shortName": "Retirement benefit obligations - Disclosure of main actuarial assumptions used to measure the retirement benefit obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails",
     "longName": "9955591 - Disclosure - Retirement benefit obligations - Disclosure of changes in projected benefit obligation (Details)",
     "shortName": "Retirement benefit obligations - Disclosure of changes in projected benefit obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c-1280",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1276",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails",
     "longName": "9955592 - Disclosure - Payables and other current liabilities - Disclosure of breakdown of trade and other payables (Details)",
     "shortName": "Payables and other current liabilities - Disclosure of breakdown of trade and other payables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails",
     "longName": "9955593 - Disclosure - Payables and other current liabilities - Disclosure of tax and employee-related payables (Details)",
     "shortName": "Payables and other current liabilities - Disclosure of tax and employee-related payables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:ShorttermEmployeeBenefitsAccruals",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:ShorttermEmployeeBenefitsAccruals",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R121": {
     "role": "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails",
     "longName": "9955594 - Disclosure - Operating income - Disclosure of breakdown of operating income (Details)",
     "shortName": "Operating income - Disclosure of breakdown of operating income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:IncomeFromResearchTaxCredit",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:MiscellaneousOtherOperatingIncome",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.abivax.com/role/OperatingincomeNarrativeDetails",
     "longName": "9955595 - Disclosure - Operating income - Narrative (Details)",
     "shortName": "Operating income - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:IncomeFromResearchTaxCredit",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1286",
      "name": "abvx:IncomeFromResearchTaxCredit",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails",
     "longName": "9955596 - Disclosure - Operating expenses - Disclosure of sales and marketing expenses (Details)",
     "shortName": "Operating expenses - Disclosure of sales and marketing expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:OperatingExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1289",
      "name": "ifrs-full:EmployeeBenefitsExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R124": {
     "role": "http://www.abivax.com/role/OperatingexpensesNarrativeDetails",
     "longName": "9955597 - Disclosure - Operating expenses - Narrative (Details)",
     "shortName": "Operating expenses - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:SalesAndMarketingExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1292",
      "name": "abvx:IncreaseDecreaseInUlcerativeColitisExpenses",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R125": {
     "role": "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
     "longName": "9955598 - Disclosure - Operating expenses - Disclosure of research and development expenses (Details)",
     "shortName": "Operating expenses - Disclosure of research and development expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "125",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:OperatingExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1292",
      "name": "abvx:SubContractingStudiesAndResearchExpenses",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R126": {
     "role": "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
     "longName": "9955599 - Disclosure - Operating expenses - Disclosure of general and administrative expenses (Details)",
     "shortName": "Operating expenses - Disclosure of general and administrative expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "126",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:OperatingExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1295",
      "name": "ifrs-full:EmployeeBenefitsExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R127": {
     "role": "http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails",
     "longName": "9955600 - Disclosure - Operating expenses - Disclosure of principal audit fees and services (Details)",
     "shortName": "Operating expenses - Disclosure of principal audit fees and services (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "127",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AuditorsRemunerationForAuditServices",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AuditorsRemunerationForAuditServices",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R128": {
     "role": "http://www.abivax.com/role/EmployeesDetails",
     "longName": "9955601 - Disclosure - Employees (Details)",
     "shortName": "Employees (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "128",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AverageNumberOfEmployees",
      "unitRef": "employee",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AverageNumberOfEmployees",
      "unitRef": "employee",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R129": {
     "role": "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails",
     "longName": "9955602 - Disclosure - Financial gain (loss) - Disclosure of net financial income (loss) (Details)",
     "shortName": "Financial gain (loss) - Disclosure of net financial income (loss) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "129",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:InterestExpenseOnBonds",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:InterestExpenseOnBonds",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R130": {
     "role": "http://www.abivax.com/role/FinancialgainlossNarrativeDetails",
     "longName": "9955603 - Disclosure - Financial gain (loss) - Narrative (Details)",
     "shortName": "Financial gain (loss) - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "130",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-314",
      "name": "abvx:ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R131": {
     "role": "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails",
     "longName": "9955604 - Disclosure - Income tax - Disclosure of reconciliation of effective income tax (loss) (Details)",
     "shortName": "Income tax - Disclosure of reconciliation of effective income tax (loss) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "131",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AccountingProfit",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "abvx:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AccountingProfit",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "abvx:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R132": {
     "role": "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails",
     "longName": "9955605 - Disclosure - Income tax - Disclosure of deferred tax assets and liabilities by nature (Details)",
     "shortName": "Income tax - Disclosure of deferred tax assets and liabilities by nature (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "132",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:DeferredTaxAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:DeferredTaxAssets",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R133": {
     "role": "http://www.abivax.com/role/IncometaxNarrativeDetails",
     "longName": "9955606 - Disclosure - Income tax - Narrative (Details)",
     "shortName": "Income tax - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "133",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R134": {
     "role": "http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails",
     "longName": "9955607 - Disclosure - Income (loss) per share - Schedule of earnings per share (Details)",
     "shortName": "Income (loss) per share - Schedule of earnings per share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "134",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "ifrs-full:AdjustedWeightedAverageShares",
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R135": {
     "role": "http://www.abivax.com/role/IncomelosspershareNarrativeDetails",
     "longName": "9955608 - Disclosure - Income (loss) per share - Narrative (Details)",
     "shortName": "Income (loss) per share - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "135",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R136": {
     "role": "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails",
     "longName": "9955609 - Disclosure - Related parties - Disclosure of aggregate compensation of the members of the Group\u2019s Board of Directors and CEO (Details)",
     "shortName": "Related parties - Disclosure of aggregate compensation of the members of the Group\u2019s Board of Directors and CEO (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "136",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:KeyManagementPersonnelCompensationFixedCompensation",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "abvx:KeyManagementPersonnelCompensationFixedCompensation",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R137": {
     "role": "http://www.abivax.com/role/RelatedpartiesNarrativeDetails",
     "longName": "9955610 - Disclosure - Related parties - Narrative (Details)",
     "shortName": "Related parties - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "137",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1324",
      "name": "ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R138": {
     "role": "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
     "longName": "9955611 - Disclosure - Off-balance sheet commitments given (Details)",
     "shortName": "Off-balance sheet commitments given (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "138",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "abvx:RepaymentsOfConditionalAdvances",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ifrs-full:CapitalCommitments",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    },
    "R139": {
     "role": "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
     "longName": "9955612 - Disclosure - Off-balance sheet commitments received and contingent assets (Details)",
     "shortName": "Off-balance sheet commitments received and contingent assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "139",
     "firstAnchor": {
      "contextRef": "c-1343",
      "name": "abvx:NumberOfProjectsTerminated",
      "unitRef": "project",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1343",
      "name": "abvx:NumberOfProjectsTerminated",
      "unitRef": "project",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R140": {
     "role": "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
     "longName": "9955613 - Disclosure - Management and assessment of financial risks (Details)",
     "shortName": "Management and assessment of financial risks (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "140",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:OperatingExpense",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1346",
      "name": "abvx:InterestRateCollarRange",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "abvx-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "abvx_A130.0MillionCrossOverFinancingFebruary2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "A130.0MillionCrossOverFinancingFebruary2023Member",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u20ac130.0\u00a0million cross-over financing, february 2023",
        "label": "\u20ac130.0\u00a0Million Cross-Over Financing, February 2023 [Member]",
        "documentation": "\u20ac130.0\u00a0Million Cross-Over Financing, February 2023"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_A150.0MillionFinancingAugust2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "A150.0MillionFinancingAugust2023Member",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u20ac150.0\u00a0million financing, august 2023",
        "label": "\u20ac150.0\u00a0Million Financing, August 2023 [Member]",
        "documentation": "\u20ac150.0\u00a0Million Financing, August 2023"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_A2021TaxYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "A2021TaxYearMember",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Year 2021",
        "label": "2021, Tax Year [Member]",
        "documentation": "Tax Year 2021"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_A2022TaxYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "A2022TaxYearMember",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Year 2022",
        "label": "2022, Tax Year [Member]",
        "documentation": "Tax Year 2022"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_A2023TaxYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "A2023TaxYearMember",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Year 2023",
        "label": "2023, Tax Year [Member]",
        "documentation": "Tax Year 2023"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_A49.2MillionCrossOverFinancingSeptember2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "A49.2MillionCrossOverFinancingSeptember2022Member",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u20ac49.2 million cross-over financing, september 2022",
        "label": "\u20ac49.2\u00a0Million Cross-Over Financing, September 2022 [Member]",
        "documentation": "\u20ac49.2\u00a0Million Cross-Over Financing, September 2022"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA2021Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA 2021",
        "label": "AGA 2021 [Member]",
        "documentation": "AGA 2021"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20231Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20231Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2023-1",
        "label": "AGA-2023-1 [Member]",
        "documentation": "AGA-2023-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20232Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20232Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2023-2",
        "label": "AGA-2023-2 [Member]",
        "documentation": "AGA-2023-2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20233AGA20234AndAGA20235Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20233AGA20234AndAGA20235Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2023-3 , AGA-2023-4 and AGA-2023-5",
        "label": "AGA-2023-3 , AGA-2023-4 And AGA-2023-5 [Member]",
        "documentation": "AGA-2023-3 , AGA-2023-4 And AGA-2023-5"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20233AndAGA20234Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20233AndAGA20234Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2023-3 and AGA-2023-4",
        "label": "AGA-2023-3 And AGA-2023-4 [Member]",
        "documentation": "AGA-2023-3 And AGA-2023-4"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20233Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20233Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2023-3",
        "label": "AGA-2023-3 [Member]",
        "documentation": "AGA-2023-3"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20234Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20234Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2023-4",
        "label": "AGA-2023-4 [Member]",
        "documentation": "AGA-2023-4"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20235Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20235Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2023-5",
        "label": "AGA-2023-5 [Member]",
        "documentation": "AGA-2023-5"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7",
        "label": "AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7 [Member]",
        "documentation": "AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20241Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20241Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-1",
        "label": "AGA-2024-1 [Member]",
        "documentation": "AGA-2024-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20242Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20242Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-2",
        "label": "AGA-2024-2 [Member]",
        "documentation": "AGA-2024-2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20243Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20243Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-3",
        "label": "AGA-2024-3 [Member]",
        "documentation": "AGA-2024-3"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20244AGA20245AndAGA20246Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20244AGA20245AndAGA20246Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-4, AGA-2024-5 and AGA-2024-6",
        "label": "AGA-2024-4, AGA-2024-5 and AGA-2024-6 [Member]",
        "documentation": "AGA-2024-4, AGA-2024-5 and AGA-2024-6"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20244Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20244Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-4",
        "label": "AGA-2024-4 [Member]",
        "documentation": "AGA-2024-4"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20245Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20245Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-5",
        "label": "AGA-2024-5 [Member]",
        "documentation": "AGA-2024-5"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20246Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20246Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-6",
        "label": "AGA-2024-6 [Member]",
        "documentation": "AGA-2024-6"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20247Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20247Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024-7",
        "label": "AGA-2024-7 [Member]",
        "documentation": "AGA-2024-7"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA2024Member",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2024",
        "label": "AGA-2024 [Member]",
        "documentation": "AGA-2024"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA20252Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA20252Member",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2025-2",
        "label": "AGA-2025-2 [Member]",
        "documentation": "AGA-2025-2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AGA2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AGA2025Member",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AGA-2025",
        "label": "AGA-2025 [Member]",
        "documentation": "AGA-2025"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AbivaxLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AbivaxLLCMember",
     "presentation": [
      "http://www.abivax.com/role/IncometaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Abivax LLC",
        "label": "Abivax LLC [Member]",
        "documentation": "Abivax LLC"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AccountingPrinciplesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AccountingPrinciplesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Principles [Abstract]",
        "label": "Accounting Principles [Abstract]",
        "documentation": "Accounting Principles [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccountingProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccountingProfit",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss before tax",
        "label": "Accounting profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41"
     ]
    },
    "ifrs-full_AccrualsClassifiedAsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccrualsClassifiedAsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued invoices",
        "label": "Accruals classified as current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accruals classified as current. [Refer: Accruals]"
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AMORTIZATION",
        "label": "Accumulated depreciation, amortisation and impairment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r50",
      "r95",
      "r105",
      "r108"
     ]
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DEPRECIATION",
        "label": "Accumulated depreciation and amortisation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r399",
      "r405",
      "r408",
      "r409"
     ]
    },
    "abvx_AcquisitionRelatedCostsAssetsAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AcquisitionRelatedCostsAssetsAcquisition",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition fees",
        "label": "Acquisition-Related Costs, Assets Acquisition",
        "documentation": "Acquisition-Related Costs, Assets Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRates",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount Rate (IBoxx Corporates AA)",
        "label": "Actuarial assumption of discount rates"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "abvx_ActuarialAssumptionOfEmployeeContributionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ActuarialAssumptionOfEmployeeContributionRate",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee contribution rate",
        "label": "Actuarial Assumption Of Employee Contribution Rate",
        "documentation": "Actuarial Assumption Of Employee Contribution Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salary increase rate",
        "label": "Actuarial assumption of expected rates of salary increases"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [domain]; Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "abvx_ActuarialAssumptionOfExpectedRatesOfTurnover": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ActuarialAssumptionOfExpectedRatesOfTurnover",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Turnover rate",
        "label": "Actuarial Assumption Of Expected Rates Of Turnover",
        "documentation": "Actuarial Assumption Of Expected Rates Of Turnover"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Turnover rate, average exit rate",
        "label": "Actuarial Assumption Of Expected Rates Of Turnover, Average Exit Rate",
        "documentation": "Actuarial Assumption Of Expected Rates Of Turnover, Average Exit Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionOfRetirementAge2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfRetirementAge2019",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement age",
        "label": "Actuarial assumption of retirement age"
       }
      },
      "en": {
       "role": {
        "documentation": "The retirement age used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition",
        "label": "Additions other than through business combinations, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition",
        "label": "Additions other than through business combinations, property, plant and equipment including right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment including right-of-use assets other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average number of outstanding shares used for computing diluted loss per share (in shares)",
        "terseLabel": "Weighted average number of outstanding shares, diluted loss per share (in shares)",
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease / (increase) in other receivables and other assets",
        "label": "Adjustments for decrease (increase) in trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elimination of amortization of intangibles and depreciation of property, plant and equipment",
        "label": "Adjustments for depreciation and amortisation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "ifrs-full_AdjustmentsForFairValueGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForFairValueGainsLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in derivatives and liabilities fair value",
        "label": "Adjustments for fair value losses (gains)"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "abvx_AdjustmentsForForgivenessOfCovid19ConditionalAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdjustmentsForForgivenessOfCovid19ConditionalAdvances",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgiveness of conditional advances",
        "label": "Adjustments For Forgiveness Of Covid 19 Conditional Advances",
        "documentation": "Adjustments For Forgiveness Of Covid 19 Conditional Advances"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elimination of Impairment loss of goodwill",
        "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "abvx_AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase / (decrease) in deferred income and other liabilities",
        "label": "Adjustments For Increase (Decrease) In Deferred Income And Other Liabilities",
        "documentation": "Adjustments For Increase (Decrease) In Deferred Income And Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elimination of retirement benefit obligations",
        "label": "Adjustments for increase (decrease) in employee benefit liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "abvx_AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase / (decrease) in tax and social security liabilities",
        "label": "Adjustments For Increase (Decrease) In Tax And Social Security Liabilities",
        "documentation": "Adjustments For Increase (Decrease) In Tax And Social Security Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase / (decrease) in trade payables",
        "label": "Adjustments for increase (decrease) in trade accounts payable"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "abvx_AdjustmentsForNetGainOnSaleOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdjustmentsForNetGainOnSaleOfTreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net gain on sale of treasury shares",
        "label": "Adjustments For Net Gain On Sale Of Treasury Shares",
        "documentation": "Adjustments For Net Gain On Sale Of Treasury Shares"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AdjustmentsForOtherFinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdjustmentsForOtherFinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expenses and other financial expenses",
        "label": "Adjustments For Other Finance Costs",
        "documentation": "Adjustments For Other Finance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AdjustmentsForOtherFinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdjustmentsForOtherFinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Financial income",
        "label": "Adjustments For Other Finance Income",
        "documentation": "Adjustments For Other Finance Income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for:",
        "label": "Adjustments to reconcile profit (loss) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elimination of share-based compensation expenses",
        "label": "Adjustments for share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "abvx_AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of unwinding the discount related to advances",
        "label": "Adjustments For Unwinding Of Discount Related To Conditional Advances",
        "documentation": "Adjustments For Unwinding Of Discount Related To Conditional Advances"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AdvisorToTheChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AdvisorToTheChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advisor to the Chief Executive Officer",
        "label": "Advisor To The Chief Executive Officer [Member]",
        "documentation": "Advisor To The Chief Executive Officer"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_After18MonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "After18MonthsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After 18 months",
        "label": "After 18 Months [Member]",
        "documentation": "After 18 Months"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_After24MonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "After24MonthsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After 24 months",
        "label": "After 24 Months [Member]",
        "documentation": "After 24 Months"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_After36MonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "After36MonthsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After 36 months",
        "label": "After 36 Months [Member]",
        "documentation": "After 36 Months"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AggregateExercisePriceOtherEquityInstrumentsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AggregateExercisePriceOtherEquityInstrumentsGranted",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate exercise price",
        "label": "Aggregate Exercise Price, Other Equity Instruments Granted",
        "documentation": "Aggregate Exercise Price, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AggregateFairValueConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AggregateFairValueConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of convertible notes",
        "label": "Aggregate Fair Value, Convertible Notes",
        "documentation": "Aggregate Fair Value, Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AggregateFairValueOtherEquityInstrumentsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AggregateFairValueOtherEquityInstrumentsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of other equity instruments",
        "label": "Aggregate Fair Value, Other Equity Instruments Outstanding",
        "documentation": "Aggregate Fair Value, Other Equity Instruments Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r301",
      "r311",
      "r344"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r293",
      "r304",
      "r314",
      "r347"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "abvx_AgreementPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AgreementPeriod",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement, period",
        "label": "Agreement, Period",
        "documentation": "Agreement, Period"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails",
      "http://www.abivax.com/role/FinancialgainlossNarrativeDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Currencies [Domain]",
        "label": "All Currencies [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r339",
      "r348",
      "r352",
      "r360"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AmericanDepositorySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AmericanDepositorySharesMember",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ADS",
        "label": "American Depository Shares [Member]",
        "documentation": "American Depository Shares"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AmericanDepositorySharesNASDAQGlobalMarketMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AmericanDepositorySharesNASDAQGlobalMarketMember",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "American Depositary Shares, each representing one ordinary share, nominal value \u20ac0.01 per share",
        "label": "American Depository Shares, NASDAQ Global Market [Member]",
        "documentation": "American Depository Shares, NASDAQ Global Select Market [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AmortizedCostEIRMethodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AmortizedCostEIRMethodMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized cost (EIR method)",
        "label": "Amortized Cost (EIR Method) [Member]",
        "documentation": "Amortized Cost (EIR Method)"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amount of reasonably possible decrease in unobservable input, liabilities",
        "label": "Amount Of Reasonably Possible Decrease In Unobservable Input, Liabilities",
        "documentation": "Amount Of Reasonably Possible Decrease In Unobservable Input, Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of reasonably possible increase in unobservable input, liabilities",
        "label": "Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities",
        "documentation": "Amount Of Reasonably Possible Increase In Unobservable Input, Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory French tax rates",
        "label": "Applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "terseLabel": "Financial assets",
        "label": "Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r144",
      "r145",
      "r147",
      "r206",
      "r208"
     ]
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AssetsAcquisitionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AssetsAcquisitionsAxis",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets Acquisitions [Axis]",
        "label": "Assets Acquisitions [Axis]",
        "documentation": "Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AssetsAcquisitionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AssetsAcquisitionsDomain",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets Acquisitions [Domain]",
        "label": "Assets Acquisitions [Domain]",
        "documentation": "Assets Acquisitions [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets Recognised As Of Acquisition Date",
        "documentation": "Assets Recognised As Of Acquisition Date"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_AtTheMarketATMProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AtTheMarketATMProgramMember",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market (ATM) Program",
        "label": "At-The-Market (ATM) Program [Member]",
        "documentation": "At-The-Market (ATM) Program"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attribution of expenses by nature to their function [axis]",
        "label": "Attribution of expenses by nature to their function [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r387"
     ]
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionDomain",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attribution of expenses by nature to their function [domain]",
        "label": "Attribution of expenses by nature to their function [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r387"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.abivax.com/role/Auditorinformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r297"
     ]
    },
    "abvx_AuditorInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "AuditorInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Information [Abstract]",
        "documentation": "Auditor Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.abivax.com/role/Auditorinformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r297"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.abivax.com/role/Auditorinformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r297"
     ]
    },
    "ifrs-full_AuditorsRemuneration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemuneration",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Auditor's remuneration"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_AuditorsRemunerationForAuditServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemunerationForAuditServices",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails": {
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory Auditor, certification of individual and consolidated financial statements",
        "label": "Auditor's remuneration for audit services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for auditing services."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_AuditorsRemunerationForOtherServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemunerationForOtherServices",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails": {
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofprincipalauditfeesandservicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other procedures required by law",
        "label": "Auditor's remuneration for other services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_AverageNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AverageNumberOfEmployees",
     "presentation": [
      "http://www.abivax.com/role/EmployeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average number of employees",
        "label": "Average number of employees"
       }
      },
      "en": {
       "role": {
        "documentation": "The average number of personnel employed by the entity during a period."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r355"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "abvx_BCE20161Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20161Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2016-1",
        "label": "BCE-2016-1 [Member]",
        "documentation": "BCE-2016-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20171Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20171Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2017-1",
        "label": "BCE-2017-1 [Member]",
        "documentation": "BCE-2017-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20172Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20172Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2017-2",
        "label": "BCE-2017-2 [Member]",
        "documentation": "BCE-2017-2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20174Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20174Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2017-4",
        "label": "BCE-2017-4 [Member]",
        "documentation": "BCE-2017-4"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20175Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20175Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2017-5",
        "label": "BCE-2017-5 [Member]",
        "documentation": "BCE-2017-5"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20181Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20181Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2018-1",
        "label": "BCE-2018-1 [Member]",
        "documentation": "BCE-2018-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20183Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20183Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE 2018-3",
        "label": "BCE-2018-3 [Member]",
        "documentation": "BCE-2018-3"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20184Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20184Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2018-4",
        "label": "BCE-2018-4 [Member]",
        "documentation": "BCE-2018-4"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCE20185Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCE20185Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE-2018-5",
        "label": "BCE-2018-5 [Member]",
        "documentation": "BCE-2018-5"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BCEExceptBCE20142Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BCEExceptBCE20142Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BCE except BCE 2014-2",
        "label": "BCE Except BCE 2014-2 [Member]",
        "documentation": "BCE Except BCE 2014-2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20144Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20144Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2014-4",
        "label": "BSA-2014-4 [Member]",
        "documentation": "BSA-2014-4"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20145Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20145Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2014-5",
        "label": "BSA-2014-5 [Member]",
        "documentation": "BSA-2014-5"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA201511Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA201511Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2015-11",
        "label": "BSA-2015-11 [Member]",
        "documentation": "BSA-2015-11"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA201512Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA201512Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2015-12",
        "label": "BSA-2015-12 [Member]",
        "documentation": "BSA-2015-12"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20171Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20171Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2017-1",
        "label": "BSA-2017-1 [Member]",
        "documentation": "BSA-2017-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20181Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20181Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2018-1",
        "label": "BSA-2018-1 [Member]",
        "documentation": "BSA-2018-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20241AndBSA20242Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20241AndBSA20242Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2024-1 and BSA-2024-2",
        "label": "BSA-2024-1 And BSA-2024-2 [Member]",
        "documentation": "BSA-2024-1 And BSA-2024-2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20241Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20241Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA 2024-1",
        "label": "BSA-2024-1 [Member]",
        "documentation": "BSA-2024-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20242Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20242Member",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA 2024-2",
        "label": "BSA-2024-2 [Member]",
        "documentation": "BSA-2024-2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BSA20251Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BSA20251Member",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BSA-2025-1",
        "label": "BSA-2025-1 [Member]",
        "documentation": "BSA-2025-1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BalancesWithBanksInExcessOfLegallyInsuredLimit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BalancesWithBanksInExcessOfLegallyInsuredLimit",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balances with banks in excess of legally insured limit",
        "label": "Balances With Banks In Excess Of Legally Insured Limit",
        "documentation": "Balances With Banks In Excess Of Legally Insured Limit"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BankBorrowingsUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BankBorrowingsUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "abvx_FinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, undiscounted cash flows",
        "label": "Bank borrowings, undiscounted cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r262",
      "r265"
     ]
    },
    "abvx_BanquePubliqueDInvestissementBPIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BanquePubliqueDInvestissementBPIMember",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conditional advances BPI",
        "label": "Banque Publique d\u2019Investissement (BPI) [Member]",
        "documentation": "Banque Publique d\u2019Investissement (BPI)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic loss per share (in euro per share)",
        "label": "Basic earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "abvx_BlackScholesModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BlackScholesModelMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Black Scholes Model",
        "label": "Black Scholes Model [Member]",
        "documentation": "Black Scholes Model"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BoardOfDirectorsAndChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BoardOfDirectorsAndChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Board of Directors and Chief Executive Officer",
        "label": "Board Of Directors And Chief Executive Officer [Member]",
        "documentation": "Board Of Directors And Chief Executive Officer"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Borrowings",
        "terseLabel": "Borrowings",
        "label": "Borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "abvx_BorrowingsAdditionalTrancheAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsAdditionalTrancheAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, additional tranche mount",
        "label": "Borrowings, Additional Tranche Amount",
        "documentation": "Borrowings, Additional Tranche Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsAdjustmentToInterestRateBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsAdjustmentToInterestRateBasis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, adjustment to interest rate basis",
        "label": "Borrowings, adjustment to interest rate basis"
       }
      },
      "en": {
       "role": {
        "documentation": "The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "abvx_BorrowingsAdjustmentToInterestRateBasisForFirst12Installments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsAdjustmentToInterestRateBasisForFirst12Installments",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, interest rate for first 12 installments",
        "label": "Borrowings, Adjustment To Interest Rate Basis For First 12 Installments",
        "documentation": "Borrowings, Adjustment To Interest Rate Basis For First 12 Installments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsAnnualDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsAnnualDiscountRate",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, annual discount rate",
        "label": "Borrowings, Annual Discount Rate",
        "documentation": "Borrowings, Annual Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsBasisInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsBasisInterestRate",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, interest rate basis",
        "label": "Borrowings, Basis Interest Rate",
        "documentation": "Borrowings, Basis Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings by name [axis]",
        "label": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "ifrs-full_BorrowingsByNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsByNameDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings by name [domain]",
        "label": "Borrowings by name [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "abvx_BorrowingsByNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsByNameMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Borrowings By Name [Member]",
        "documentation": "Borrowings by name"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsDebtToMarketCapitalizationRatio": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsDebtToMarketCapitalizationRatio",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, debt-to-market capitalization ratio",
        "label": "Borrowings, Debt-To-Market Capitalization Ratio",
        "documentation": "Borrowings, Debt-To-Market Capitalization Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsEarlyRepaymentDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsEarlyRepaymentDiscountRate",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, early repayment, discount rate",
        "label": "Borrowings, Early Repayment, Discount Rate",
        "documentation": "Borrowings, Early Repayment, Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsExitFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsExitFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, exit fee amount",
        "label": "Borrowings, Exit Fee Amount",
        "documentation": "Borrowings, Exit Fee Amount"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsExitFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsExitFeePercentage",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, exit fee percentage",
        "label": "Borrowings, Exit Fee Percentage",
        "documentation": "Borrowings, Exit Fee Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, exit fee percentage if prepayment after 30th installment",
        "label": "Borrowings, Exit Fee Percentage If Prepayment After 30th Installment",
        "documentation": "Borrowings, Exit Fee Percentage If Prepayment After 30th Installment"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, exit fee percentage if prepayment between 18th and 30th installments",
        "label": "Borrowings, Exit Fee Percentage If Prepayment Between 18th And 30th Installments",
        "documentation": "Borrowings, Exit Fee Percentage If Prepayment Between 18th And 30th Installments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsFixedConversionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsFixedConversionPrice",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, fixed conversion price",
        "label": "Borrowings, Fixed Conversion Price",
        "documentation": "Borrowings, Fixed Conversion Price"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsInterestRate",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, interest rate",
        "label": "Borrowings, interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "abvx_BorrowingsInterestRateForFollowingInstallments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsInterestRateForFollowingInstallments",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, interest rate for following installments",
        "label": "Borrowings, Interest Rate For Following Installments",
        "documentation": "Borrowings, Interest Rate For Following Installments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, market price, number of days with lowest daily VWAP",
        "label": "Borrowings, Market Price, Number Of Days With Lowest Daily VWAP",
        "documentation": "Borrowings, Market Price, Number Of Days With Lowest Daily VWAP"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsMarketPriceNumberOfTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsMarketPriceNumberOfTradingDays",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, market price, number of trading days",
        "label": "Borrowings, Market Price, Number Of Trading Days",
        "documentation": "Borrowings, Market Price, Number Of Trading Days"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsMaturityDeferralPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsMaturityDeferralPeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings maturity, deferral period",
        "label": "Borrowings Maturity, Deferral Period",
        "documentation": "Borrowings Maturity, Deferral Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsMaturityExtensionTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsMaturityExtensionTerm",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings maturity, extension term",
        "label": "Borrowings Maturity, Extension Term",
        "documentation": "Borrowings Maturity, Extension Term"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsMaturityTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsMaturityTerm",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, maturity term",
        "label": "Borrowings Maturity, Term",
        "documentation": "Borrowings Maturity, Term"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, maximum borrowing capacity",
        "label": "Borrowings, Maximum Borrowing Capacity",
        "documentation": "Borrowings, Maximum Borrowing Capacity"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsMaximumBorrowingCapacityPerTranche": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsMaximumBorrowingCapacityPerTranche",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, maximum borrowing capacity per tranche",
        "label": "Borrowings, Maximum Borrowing Capacity Per Tranche",
        "documentation": "Borrowings, Maximum Borrowing Capacity Per Tranche"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsNoticePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsNoticePeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, notice period",
        "label": "Borrowings, Notice Period",
        "documentation": "Borrowings, Notice Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsNumberOfMonthlyInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsNumberOfMonthlyInstallments",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, number of monthly installments",
        "label": "Borrowings, Number Of Monthly Installments",
        "documentation": "Borrowings, Number Of Monthly Installments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsNumberOfQuarterlyInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsNumberOfQuarterlyInstallments",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, number of quarterly installments",
        "label": "Borrowings, Number Of Quarterly Installments",
        "documentation": "Borrowings, Number Of Quarterly Installments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsNumberOfTranches": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsNumberOfTranches",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, number of tranches",
        "label": "Borrowings, Number Of Tranches",
        "documentation": "Borrowings, Number Of Tranches"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsPercentageOfMarketPrice": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsPercentageOfMarketPrice",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, percentage of market price",
        "label": "Borrowings, Percentage Of Market Price",
        "documentation": "Borrowings, Percentage Of Market Price"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsPerformanceConditionsMinimumFinancing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsPerformanceConditionsMinimumFinancing",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance conditions, minimum financing",
        "label": "Borrowings, Performance Conditions, Minimum Financing",
        "documentation": "Borrowings, Performance Conditions, Minimum Financing"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_BorrowingsStateGuaranteedPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "BorrowingsStateGuaranteedPremium",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings, state guaranteed premium",
        "label": "Borrowings, State Guaranteed Premium",
        "documentation": "Borrowings, State Guaranteed Premium"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bottom of range",
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r150",
      "r164",
      "r172",
      "r249",
      "r251",
      "r420"
     ]
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BUILDINGS",
        "verboseLabel": "Buildings",
        "label": "Buildings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r274",
      "r297"
     ]
    },
    "abvx_CARENAConditionalAdvanceBPIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CARENAConditionalAdvanceBPIMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CARENA conditional advance",
        "verboseLabel": "CARENA \u2013 Bpifrance",
        "label": "CARENA Conditional Advance, BPI [Member]",
        "documentation": "CARENA Conditional Advance, BPI"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CIRTaxYearAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CIRTaxYearAxis",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CIR Tax Year [Axis]",
        "label": "CIR Tax Year [Axis]",
        "documentation": "CIR Tax Year"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CIRTaxYearDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CIRTaxYearDomain",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CIR Tax Year [Domain]",
        "label": "CIR Tax Year [Domain]",
        "documentation": "CIR Tax Year [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CapitalCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CapitalCommitments",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital commitments",
        "label": "Capital commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of future capital expenditures that the entity is committed to make."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]",
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r95",
      "r98",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r178",
      "r187",
      "r188"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount [member]",
        "label": "Carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r98",
      "r104",
      "r106",
      "r107",
      "r178",
      "r187",
      "r188"
     ]
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan granted",
        "label": "Cash advances and loans made to other parties, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash advances and loans made to other parties (other than advances and loans made by a financial institution), classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "abvx_CashAdvancesAndLoansMadeToReimbursedFromHospitals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CashAdvancesAndLoansMadeToReimbursedFromHospitals",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment / (disbursement) of the advance made to the Nice CHU",
        "terseLabel": "Cash advances and loans made to (reimbursed from) hospitals",
        "label": "Cash Advances And Loans Made To (Reimbursed From) Hospitals",
        "documentation": "Cash Advances And Loans Made To (Reimbursed From) Hospitals"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CashAndCashEquivalentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CashAndCashEquivalentMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash And Cash Equivalent [Member]",
        "documentation": "Cash And Cash Equivalent"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the year",
        "periodEndLabel": "Cash and cash equivalents at the end of the year",
        "totalLabel": "Cash and cash equivalents",
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r119",
      "r138"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CashAndCashEquivalentsAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CashAndCashEquivalentsAssetsAcquisitions",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_AssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash And Cash Equivalents, Assets Acquisitions",
        "documentation": "Cash And Cash Equivalents, Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsDisclosureofcompositionofcashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash flows provided by (used in) financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r121"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows provided by (used in) financing activities",
        "label": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash flows provided by (used in) investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r121"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows provided by (used in) investing activities",
        "label": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash flows used in operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r109",
      "r121"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows used in operating activities",
        "label": "Cash flows from (used in) operating activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash flows used in operating activities before change in working capital requirements",
        "label": "Cash flows from (used in) operations before changes in working capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r413"
     ]
    },
    "abvx_CashPaymentsForDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CashPaymentsForDeposits",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Increase in Deposits",
        "label": "Cash Payments For Deposits",
        "documentation": "Cash Payments For Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CashPrepaymentAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CashPrepaymentAssetsAcquisitions",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash prepayment made in 2021",
        "label": "Cash Prepayment, Assets Acquisitions",
        "documentation": "Cash Prepayment, Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CashTransferredAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CashTransferredAssetsAcquisitions",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment made in 2022",
        "label": "Cash Transferred, Assets Acquisitions",
        "documentation": "Cash Transferred, Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial assets [axis]",
        "label": "Categories of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ifrs-full_CategoriesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialAssetsDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial assets [domain]",
        "label": "Categories of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial liabilities [axis]",
        "label": "Categories of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial liabilities [domain]",
        "label": "Categories of financial liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of related parties [axis]",
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of related parties [domain]",
        "label": "Categories of related parties [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ifrs-full_ChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ChangesInEquityAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in equity [abstract]",
        "label": "Changes in equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer",
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of assets [axis]",
        "label": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r84",
      "r149",
      "r157"
     ]
    },
    "ifrs-full_ClassesOfAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfAssetsDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of assets [domain]",
        "label": "Classes of assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r149",
      "r157"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical",
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of financial liabilities [axis]",
        "label": "Classes of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r195",
      "r213",
      "r214"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesDomain",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical",
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of financial liabilities [domain]",
        "label": "Classes of financial liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r194",
      "r195",
      "r213",
      "r214"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails",
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of intangible assets other than goodwill [axis]",
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails",
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of intangible assets other than goodwill [domain]",
        "label": "Classes of intangible assets other than goodwill [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ifrs-full_ClassesOfLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of liabilities [axis]",
        "label": "Classes of liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_ClassesOfLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of liabilities [domain]",
        "label": "Classes of liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of property, plant and equipment [axis]",
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of property, plant and equipment [domain]",
        "label": "Classes of property, plant and equipment [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of share capital [axis]",
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalDomain",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of share capital [domain]",
        "label": "Classes of share capital [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "abvx_CollaborationAgreementsDevelopmentMilestonePaymentINDApproval": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CollaborationAgreementsDevelopmentMilestonePaymentINDApproval",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration agreements, development milestone payment, IND approval",
        "label": "Collaboration Agreements, Development Milestone Payment, IND Approval",
        "documentation": "Collaboration Agreements, Development Milestone Payment, IND Approval"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CollaborationAgreementsDevelopmentMilestonePaymentPhase2": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CollaborationAgreementsDevelopmentMilestonePaymentPhase2",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration agreements, development milestone payment, Phase 2",
        "label": "Collaboration Agreements, Development Milestone Payment, Phase 2",
        "documentation": "Collaboration Agreements, Development Milestone Payment, Phase 2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential development milestone payment, IND approval",
        "label": "Collaboration Agreements, Potential Development Milestone Payment, IND Approval",
        "documentation": "Collaboration Agreements, Potential Development Milestone Payment, IND Approval"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential development milestone payment, IND filing",
        "label": "Collaboration Agreements, Potential Development Milestone Payment, IND Filing",
        "documentation": "Collaboration Agreements, Potential Development Milestone Payment, IND Filing"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential development milestone payment, phase 3",
        "label": "Collaboration Agreements, Potential Development Milestone Payment, Phase 3",
        "documentation": "Collaboration Agreements, Potential Development Milestone Payment, Phase 3"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of equity [axis]",
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of equity [domain]",
        "label": "Components of equity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income (loss) for the period",
        "label": "Comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r33",
      "r127",
      "r129",
      "r136",
      "r242"
     ]
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "IT equipment",
        "label": "Computer equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "ifrs-full_ComputerSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComputerSoftwareMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOFTWARES",
        "label": "Computer software [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "abvx_ConditionalAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConditionalAdvances",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conditional advances",
        "label": "Conditional Advances",
        "documentation": "Conditional Advances"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConditionalAdvancesAndPGELoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConditionalAdvancesAndPGELoanMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conditional advances and PGE loan",
        "label": "Conditional Advances And PGE Loan [Member]",
        "documentation": "Conditional Advances And PGE Loan"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConditionalAdvancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConditionalAdvancesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conditional advances Bpifrance",
        "label": "Conditional Advances [Member]",
        "documentation": "Conditional Advances"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConditionalAdvancesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConditionalAdvancesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "abvx_FinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conditional advances, undiscounted cash flows",
        "label": "Conditional Advances, Undiscounted Cash Flows",
        "documentation": "Conditional Advances, Undiscounted Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total acquisition cost allocated",
        "label": "Consideration Transferred, Acquisition-Date Fair Value, Assets Acquisitions",
        "documentation": "Consideration Transferred, Acquisition-Date Fair Value, Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Name",
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ContributionToGroupsAssetsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ContributionToGroupsAssetsPercentage",
     "presentation": [
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution to Group's assets, percentage",
        "label": "Contribution To Group's Assets, Percentage",
        "documentation": "Contribution To Group's Assets, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ContributionToGroupsLiabilitiesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ContributionToGroupsLiabilitiesPercentage",
     "presentation": [
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution to Group's liabilities, percentage",
        "label": "Contribution To Group's Liabilities, Percentage",
        "documentation": "Contribution To Group's Liabilities, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ContributionToGroupsNetProfitsLossesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ContributionToGroupsNetProfitsLossesPercentage",
     "presentation": [
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution to Group's net profits (losses), percentage",
        "label": "Contribution To Group's Net Profits (Losses), Percentage",
        "documentation": "Contribution To Group's Net Profits (Losses), Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConversionPriceAdjustmentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConversionPriceAdjustmentPeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price, adjustment, period",
        "label": "Conversion Price, Adjustment, Period",
        "documentation": "Conversion Price, Adjustment, Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConversionPriceOtherLiabilities": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConversionPriceOtherLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price per share (in euro per share)",
        "label": "Conversion Price, Other Liabilities",
        "documentation": "Conversion Price, Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConversionPricePerShareMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConversionPricePerShareMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price per share (in euro per share)",
        "label": "Conversion Price Per Share, Measurement Input [Member]",
        "documentation": "Conversion Price Per Share, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConversionPricePercentageOfInitialPriceThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConversionPricePercentageOfInitialPriceThreshold",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price, percentage of initial price, threshold",
        "label": "Conversion Price, Percentage Of Initial Price, Threshold",
        "documentation": "Conversion Price, Percentage Of Initial Price, Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConversionPriceVolumeWeightedAveragePricePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConversionPriceVolumeWeightedAveragePricePeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price, VWAP, period",
        "label": "Conversion Price, Volume Weighted Average Price, Period",
        "documentation": "Conversion Price, Volume Weighted Average Price, Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotes",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loans notes",
        "label": "Convertible Loans Notes",
        "documentation": "Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesCarryingAmountOfTheEquityComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesCarryingAmountOfTheEquityComponent",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount of the equity component",
        "label": "Convertible Loans Notes, Carrying Amount Of The Equity Component",
        "documentation": "Convertible Loans Notes, Carrying Amount Of The Equity Component"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion option, maximum period prior to maturity date",
        "label": "Convertible Loans Notes, Conversion Option, Maximum Period Prior To Maturity Date",
        "documentation": "Convertible Loans Notes, Conversion Option, Maximum Period Prior To Maturity Date"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Early redemption amount, percentage of outstandong principal",
        "label": "Convertible Loans Notes, Early Redemption Amount, Percentage Of Outstandong Principal",
        "documentation": "Convertible Loans Notes, Early Redemption Amount, Percentage Of Outstandong Principal"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loan notes",
        "label": "Convertible Loans Notes [Member]",
        "documentation": "Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesNominalValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesNominalValue",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loan notes, nominal value",
        "label": "Convertible Loans Notes, Nominal Value",
        "documentation": "Convertible Loans Notes, Nominal Value"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesNumberOfSeparateClosings": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesNumberOfSeparateClosings",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loan notes, number of separate closings",
        "label": "Convertible Loans Notes, Number Of Separate Closings",
        "documentation": "Convertible Loans Notes, Number Of Separate Closings"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesPeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loan notes, period",
        "label": "Convertible Loans Notes, Period",
        "documentation": "Convertible Loans Notes, Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement in shares, percentage of fair market value",
        "label": "Convertible Loans Notes, Settlement In Shares, Percentage Of Fair Market Value",
        "documentation": "Convertible Loans Notes, Settlement In Shares, Percentage Of Fair Market Value"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ConvertibleLoansNotesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ConvertibleLoansNotesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "abvx_FinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loans notes, undiscounted cash flows",
        "label": "Convertible Loans Notes, Undiscounted Cash Flows",
        "documentation": "Convertible Loans Notes, Undiscounted Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PATENTS",
        "label": "Copyrights, patents and other industrial property rights, service and operating rights [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CorporateInformationAndStatementOfIFRSComplianceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate information and statement of IFRS compliance [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CreditRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CreditRiskMember",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit risk",
        "label": "Credit risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r257"
     ]
    },
    "ifrs-full_CreditSpreadMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CreditSpreadMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit spread",
        "label": "Credit spread, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the credit spread used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails",
      "http://www.abivax.com/role/FinancialgainlossNarrativeDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency [Axis]",
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrencyRiskMember",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency risk",
        "label": "Currency risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r202"
     ]
    },
    "abvx_CurrentAdvancesToCROContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentAdvancesToCROContracts",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherCurrentFinancialAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advances related to CRO contracts",
        "label": "Current Advances To CRO Contracts",
        "documentation": "Current Advances To CRO Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAdvancesToSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAdvancesToSuppliers",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current advances to suppliers",
        "label": "Current advances to suppliers"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current advances made to suppliers before goods or services are received."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r132",
      "r242"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentDeferredIncomeOtherThanCurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income",
        "label": "Current deferred income other than current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current deferred income other than current contract liabilities. [Refer: Deferred income other than contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r394"
     ]
    },
    "ifrs-full_CurrentDerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentDerivativeFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "label": "Current derivative financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current financial liabilities",
        "label": "Current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "abvx_CurrentFinancialLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentFinancialLiabilitiesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities-current portion",
        "label": "Current Financial Liabilities [Member]",
        "documentation": "Current Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r134",
      "r242"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CurrentPayablesOnOtherTaxAndRelatedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentPayablesOnOtherTaxAndRelatedPayments",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails": {
       "parentTag": "abvx_CurrentTaxAndEmployeeBenefitLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other tax and related payments",
        "label": "Current Payables On Other Tax And Related Payments",
        "documentation": "Current Payables On Other Tax And Related Payments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails": {
       "parentTag": "abvx_CurrentTaxAndEmployeeBenefitLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Social security and other",
        "label": "Current payables on social security and taxes other than income tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]"
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "abvx_CurrentPortionOfNonCurrentConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentPortionOfNonCurrentConvertibleLoansNotes",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loan notes",
        "verboseLabel": "Current convertible loans notes",
        "label": "Current Portion Of Non-Current Convertible Loans Notes",
        "documentation": "Current Portion Of Non-Current Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": "abvx_CurrentReceivablesAndCurrentPrepaidExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Current prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "abvx_CurrentPrepaidExpensesRelatedToCRO": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentPrepaidExpensesRelatedToCRO",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current prepaid expenses related to CRO",
        "label": "Current Prepaid Expenses Related To CRO",
        "documentation": "Current Prepaid Expenses Related To CRO"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CurrentReceivablesAndCurrentPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentReceivablesAndCurrentPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": "ifrs-full_OtherAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables and assets",
        "totalLabel": "Total current other receivables and assets",
        "label": "CurrentReceivablesAndCurrentPrepaidExpenses",
        "documentation": "CurrentReceivablesAndCurrentPrepaidExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CurrentReceivablesFromCreditNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentReceivablesFromCreditNotes",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": "abvx_CurrentReceivablesAndCurrentPrepaidExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit notes",
        "label": "Current Receivables From Credit Notes",
        "documentation": "Current Receivables From Credit Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_CurrentResearchTaxCreditReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentResearchTaxCreditReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": "abvx_CurrentReceivablesAndCurrentPrepaidExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research tax credit (\"CIR\")",
        "label": "Current Research Tax Credit Receivables",
        "documentation": "Current Research Tax Credit Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service cost",
        "label": "Increase in net defined benefit liability (asset) resulting from current service cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "abvx_CurrentTaxAndEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "CurrentTaxAndEmployeeBenefitLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax and employee-related payables",
        "totalLabel": "Tax and employee-related payables",
        "label": "Current Tax And Employee Benefit Liabilities",
        "documentation": "Current Tax And Employee Benefit Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentValueAddedTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": "abvx_CurrentReceivablesAndCurrentPrepaidExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VAT receivables",
        "label": "Current value added tax receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r282",
      "r371"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r282",
      "r371"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r284",
      "r373"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r284",
      "r373"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r286",
      "r375"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r284",
      "r373"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r366"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r278",
      "r367"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r278",
      "r367"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r365"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r365"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r365"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r279",
      "r368"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r281",
      "r370"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r281",
      "r370"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r282",
      "r371"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r285",
      "r374"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r372"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r280",
      "r369"
     ]
    },
    "abvx_DecreaseInInterestExpenseOnRoyaltyCertificates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DecreaseInInterestExpenseOnRoyaltyCertificates",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in interest expense",
        "label": "Decrease In Interest Expense On Royalty Certificates",
        "documentation": "Decrease In Interest Expense On Royalty Certificates"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DecreaseInLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DecreaseInLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease",
        "label": "Decrease In Lease Liabilities",
        "documentation": "Decrease In Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DecreaseInLeaseLiabilitiesThroughModificationOfTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DecreaseInLeaseLiabilitiesThroughModificationOfTerm",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in lease liabilities through modification of term",
        "label": "Decrease In Lease Liabilities Through Modification Of Term",
        "documentation": "Decrease In Lease Liabilities Through Modification Of Term"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest paid",
        "label": "Decrease Through Interest Paid, Liabilities Arising From Financing Activities",
        "documentation": "Decrease Through Interest Paid, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease through reassessment of lease term",
        "label": "Decrease Through Reassessment Of Lease Term, Right-Of-Use Assets",
        "documentation": "Decrease Through Reassessment Of Lease Term, Right-Of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments",
        "label": "Decrease Through Repayments, Liabilities Arising From Financing Activities",
        "documentation": "Decrease Through Repayments, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DeferredFinancingCostsNettingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DeferredFinancingCostsNettingMember",
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred financing costs",
        "label": "Deferred Financing Costs, Netting [Member]",
        "documentation": "Deferred Financing Costs, Netting"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails": {
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r19",
      "r43"
     ]
    },
    "abvx_DeferredTaxAssetsRecognisedInFinancialPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DeferredTaxAssetsRecognisedInFinancialPosition",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred taxes, net recognized in the statement of financial position",
        "label": "Deferred Tax Assets Recognised In Financial Position",
        "documentation": "Deferred Tax Assets Recognised In Financial Position"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails": {
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r19",
      "r43"
     ]
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilityAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails": {
       "parentTag": "abvx_DeferredTaxAssetsRecognisedInFinancialPosition",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Deferred tax assets, net",
        "label": "Deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "abvx_DepreciationExpenseLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DepreciationExpenseLease",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense, lease",
        "label": "Depreciation Expense, Lease",
        "documentation": "Depreciation Expense, Lease"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DerivativeFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial liabilities",
        "periodStartLabel": "Derivative financial liabilities at beginning of period",
        "periodEndLabel": "Derivative financial liabilities at end of period",
        "label": "Derivative financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DerivativeFinancialLiabilitiesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "abvx_FinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial liabilities, undiscounted cash flows",
        "label": "Derivative financial liabilities, undiscounted cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "ifrs-full_DerivativesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DerivativesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "label": "Derivatives [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r244",
      "r250",
      "r259",
      "r266"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBorrowingsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conditional advances and PGE",
        "label": "Description of accounting policy for borrowings [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred taxes",
        "label": "Description of accounting policy for deferred income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for deferred income tax. [Refer: Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee benefits",
        "label": "Description of accounting policy for employee benefits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at amortized cost",
        "label": "Description of accounting policy for financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities",
        "label": "Description of accounting policy for financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Translation of transactions denominated in foreign currency",
        "label": "Description of accounting policy for foreign currency translation [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "abvx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Going concern",
        "label": "Description Of Accounting Policy For Going Concern [Policy Text Block]",
        "documentation": "Description Of Accounting Policy For Going Concern"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGoodwillExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Description of accounting policy for goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research tax credit and subsidies",
        "label": "Description of accounting policy for government grants [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of goodwill, intangible assets, property and plant and equipment",
        "label": "Description of accounting policy for impairment of non-financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current taxes",
        "label": "Description of accounting policy for income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "label": "Description of accounting policy for issued capital [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Description of accounting policy for leases [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Description of accounting policy for property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions",
        "label": "Description of accounting policy for provisions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Description of accounting policy for share-based payment transactions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate (WACC)",
        "label": "Discount rate applied to cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted loss per share (in euro per share)",
        "label": "Diluted earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "abvx_DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of judgments and estimates",
        "label": "Disclosure Of Accounting Policy For Accounting Judgements And Estimates Explanatory [Policy Text Block]",
        "documentation": "Disclosure Of Accounting Policy For Accounting Judgements And Estimates Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting of Prosynergia acquisition",
        "label": "Disclosure Of Accounting Policy For Assets Acquisitions [Policy Text Block]",
        "documentation": "Disclosure Of Accounting Policy For Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New, revised or amended Standards and Interpretations",
        "label": "Disclosure Of Accounting Policy For New, Revised Or Amended Standards And Interpretations [Policy Text Block]",
        "documentation": "Disclosure Of Accounting Policy For New, Revised Or Amended Standards And Interpretations"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, 2023",
        "label": "Disclosure Of Accounting Policy For New Standards, Amendments And Interpretations Issued By IASB But Not Yet Mandatory [Policy Text Block]",
        "documentation": "Disclosure Of Accounting Policy For New Standards, Amendments And For Financial Years"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of attribution of expenses by nature to their function [line items]",
        "label": "Disclosure of attribution of expenses by nature to their function [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of attribution of expenses by nature to their function [table]",
        "label": "Disclosure of attribution of expenses by nature to their function [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r387"
     ]
    },
    "abvx_DisclosureOfAverageNumberOfEmployeesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfAverageNumberOfEmployeesTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/EmployeesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of average workforce during the periods",
        "label": "Disclosure Of Average Number Of Employees [Table Text Block]",
        "documentation": "Disclosure Of Average Number Of Employees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Basisofpreparation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of preparation",
        "label": "Disclosure of basis of preparation of financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBorrowingsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of conditional advances",
        "label": "Disclosure of borrowings [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "abvx_DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of breakdown of trade and other payables",
        "label": "Disclosure Of Breakdown Of Trade And Other Payables [Table Text Block]",
        "documentation": "Disclosure Of Breakdown Of Trade And Other Payables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Cashandcashequivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Disclosure of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "abvx_DisclosureOfCashAndCashEquivalentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfCashAndCashEquivalentsLineItems",
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Cash And Cash Equivalents [Line Items]",
        "label": "Disclosure Of Cash And Cash Equivalents [Line Items]",
        "documentation": "Disclosure Of Cash And Cash Equivalents [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfCashAndCashEquivalentsTable",
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Cash And Cash Equivalents [Table]",
        "label": "Disclosure Of Cash And Cash Equivalents [Table]",
        "documentation": "Disclosure Of Cash And Cash Equivalents [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of changes in derivative instruments",
        "label": "Disclosure Of Changes In Derivative Financial Instruments [Table Text Block]",
        "documentation": "Disclosure Of Changes In Derivative Financial Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of classes of share capital [line items]",
        "label": "Disclosure of classes of share capital [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of classes of share capital [table]",
        "label": "Disclosure of classes of share capital [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCommitmentsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Offbalancesheetcommitmentsgiven"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Off-balance sheet commitments given",
        "label": "Disclosure of commitments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "abvx_DisclosureOfCommitmentsReceivedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfCommitmentsReceivedLineItems",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Commitments Received [Line Items]",
        "label": "Disclosure Of Commitments Received [Line Items]",
        "documentation": "Disclosure Of Commitments Received [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfCommitmentsReceivedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfCommitmentsReceivedTable",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Commitments Received [Table]",
        "label": "Disclosure Of Commitments Received [Table]",
        "documentation": "Disclosure Of Commitments Received [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of composition of cash and cash equivalents",
        "label": "Disclosure Of Composition Of Cash And Cash Equivalents [Table Text Block]",
        "documentation": "Disclosure Of Composition Of Cash And Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfConditionsForConditionalLoansNotesDrawdownTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of conditions for conditional loans notes drawdown",
        "label": "Disclosure Of Conditions For Conditional Loans Notes Drawdown [Table Text Block]",
        "documentation": "Disclosure Of Conditions For Conditional Loans Notes Drawdown"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCreditRiskExposureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureLineItems",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of credit risk exposure [line items]",
        "label": "Disclosure of credit risk exposure [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCreditRiskExposureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureTable",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of credit risk exposure [table]",
        "label": "Disclosure of credit risk exposure [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the credit risk exposure."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of defined benefit plans [abstract]",
        "label": "Disclosure of defined benefit plans [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of main actuarial assumptions used to measure the retirement benefit obligations",
        "label": "Disclosure of defined benefit plans [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansLineItems",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of defined benefit plans [line items]",
        "label": "Disclosure of defined benefit plans [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of defined benefit plans [table]",
        "label": "Disclosure of defined benefit plans [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of allocation of acquisition cost",
        "label": "Disclosure Of Detailed Information About Assets Acquisitions Explanatory [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Assets Acquisitions Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutAssetsAcquisitionsLineItems",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Detailed Information About Assets Acquisitions [Line Items]",
        "label": "Disclosure Of Detailed Information About Assets Acquisitions [Line Items]",
        "documentation": "Disclosure Of Detailed Information About Assets Acquisitions [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutAssetsAcquisitionsTable",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Detailed Information About Assets Acquisitions [Table]",
        "label": "Disclosure Of Detailed Information About Assets Acquisitions [Table]",
        "documentation": "Disclosure Of Detailed Information About Assets Acquisitions [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about borrowings [line items]",
        "label": "Disclosure of detailed information about borrowings [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about borrowings [table]",
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "abvx_DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of net financial income (loss)",
        "label": "Disclosure Of Detailed Information About Finance Income (Cost) [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Finance Income (Cost)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of intangible assets",
        "label": "Disclosure of detailed information about intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "abvx_DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of other receivables and other assets",
        "label": "Disclosure Of Detailed Information About Other Receivables And Other Assets [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Other Receivables And Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of depreciation period of property, plant and equipment",
        "label": "Disclosure of detailed information about property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "abvx_DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of breakdown of operating income",
        "label": "Disclosure Of Detailed Information Of Operating Income Explanatory [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information Of Operating Income Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Incomelosspershare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income (loss) per share",
        "label": "Disclosure of earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Retirementbenefitobligations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement benefit obligations",
        "label": "Disclosure of employee benefits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "abvx_DisclosureOfEmployeeWorkforceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfEmployeeWorkforceLineItems",
     "presentation": [
      "http://www.abivax.com/role/EmployeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Employee Workforce [Line Items]",
        "label": "Disclosure Of Employee Workforce [Line Items]",
        "documentation": "Disclosure Of Employee Workforce [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfEmployeeWorkforceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfEmployeeWorkforceTable",
     "presentation": [
      "http://www.abivax.com/role/EmployeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Employee Workforce [Table]",
        "label": "Disclosure Of Employee Workforce [Table]",
        "documentation": "Disclosure Of Employee Workforce [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Segmentinformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment information",
        "label": "Disclosure of entity's operating segments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of expenses by nature",
        "label": "Disclosure of expenses by nature [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]",
        "label": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]",
        "documentation": "Disclosure Of Fair Value Measurement Of Assets And Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]",
        "label": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]",
        "documentation": "Disclosure Of Fair Value Measurement Of Assets And Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of carrying amounts and fair value of financial assets",
        "label": "Disclosure of fair value measurement of assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of carrying amounts and fair value of financial liabilities",
        "label": "Disclosure of fair value measurement of liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of liabilities."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Financialassetsandliabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets and liabilities",
        "label": "Disclosure of fair value of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Financialgainloss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial gain (loss)",
        "label": "Disclosure of finance income (cost) [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of other financial assets",
        "label": "Disclosure of financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsLineItems",
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of financial assets [line items]",
        "label": "Disclosure of financial assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsTable",
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of financial assets [table]",
        "label": "Disclosure of financial assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "abvx_DisclosureOfFinancialGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfFinancialGainLossLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Financial Gain (Loss) [Line Items]",
        "label": "Disclosure Of Financial Gain (Loss) [Line Items]",
        "documentation": "Disclosure Of Financial Gain (Loss) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfFinancialGainLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfFinancialGainLossTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Financial Gain (Loss) [Table]",
        "label": "Disclosure Of Financial Gain (Loss) [Table]",
        "documentation": "Disclosure Of Financial Gain (Loss) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Financialliabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities",
        "label": "Disclosure of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about financial instruments [line items]",
        "label": "Disclosure of detailed information about financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about financial instruments [table]",
        "verboseLabel": "Disclosure of detailed information about financial instruments [table]",
        "label": "Disclosure of detailed information about financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r189",
      "r196"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of financial liabilities [abstract]",
        "label": "Disclosure of financial liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of financial liabilities breakdown",
        "label": "Disclosure of financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of financial liabilities [line items]",
        "label": "Disclosure of financial liabilities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of financial liabilities [table]",
        "label": "Disclosure of financial liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Managementandassessmentoffinancialrisks"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management and assessment of financial risks",
        "label": "Disclosure of financial risk management [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/TheGroup"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Group",
        "label": "Disclosure of general information about financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ifrs-full_DisclosureOfGeographicalAreasLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasLineItems",
     "presentation": [
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of geographical areas [line items]",
        "label": "Disclosure of geographical areas [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeographicalAreasTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasTable",
     "presentation": [
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of geographical areas [table]",
        "label": "Disclosure of geographical areas [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to geographical areas."
       }
      }
     },
     "auth_ref": [
      "r211"
     ]
    },
    "ifrs-full_DisclosureOfGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfGoodwillExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Goodwillandimpairmenttest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and impairment test",
        "label": "Disclosure of goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "abvx_DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of the Ukraine/Russia Hostilities on the Group",
        "label": "Disclosure Of Impact Of The Ukraine/Russia Hostilities On The Group [Policy Text Block]",
        "documentation": "Disclosure Of Impact Of The Ukraine/Russia Hostilities On The Group"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Incometax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax",
        "label": "Disclosure of income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "abvx_DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of main data and assumptions used for the measurement of convertible loan notes",
        "label": "Disclosure Of Indirect Measurement Of Convertible Loans Instruments [Table Text Block]",
        "documentation": ""
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables",
      "http://www.abivax.com/role/SharebasedpaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of main data and assumptions used for the measurement of other equity instruments",
        "label": "Disclosure of indirect measurement of fair value of goods or services received, other equity instruments granted during period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options)."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "abvx_DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfIndirectMeasurementOfRoyaltyCertificatesTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of sensitivity analysis of key assumptions",
        "label": "Disclosure Of Indirect Measurement Of Royalty Certificates [Table Text Block]",
        "documentation": "Disclosure Of Indirect Measurement Of Royalty Certificates"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutEmployeesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Employees"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees",
        "label": "Disclosure of information about employees [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about employees."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of information for cash-generating units [line items]",
        "label": "Disclosure of information for cash-generating units [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of information for cash-generating units [table]",
        "label": "Disclosure of information for cash-generating units [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to cash-generating units."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Intangibleassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Disclosure of intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails",
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about intangible assets [line items]",
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails",
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about intangible assets [table]",
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "abvx_DisclosureOfLeaseLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfLeaseLiabilitiesLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Lease Liabilities [Line Items]",
        "label": "Disclosure Of Lease Liabilities [Line Items]",
        "documentation": "Disclosure Of Lease Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfLeaseLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfLeaseLiabilitiesTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Lease Liabilities [Table]",
        "label": "Disclosure Of Lease Liabilities [Table]",
        "documentation": "Disclosure Of Lease Liabilities [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfLeasesForLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfLeasesForLesseeTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of variation in lease liabilities",
        "label": "Disclosure Of Leases For Lessee [Table Text Block]",
        "documentation": "Disclosure Of Leases For Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Accountingprinciples"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting principles",
        "label": "Disclosure of material accounting policy information [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure of material accounting policy information applied by the entity."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of maturity analysis for derivative financial liabilities [line items]",
        "label": "Disclosure of maturity analysis for derivative financial liabilities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of maturity analysis for derivative financial liabilities [table]",
        "label": "Disclosure of maturity analysis for derivative financial liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis for derivative financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of changes in projected benefit obligation",
        "label": "Disclosure of net defined benefit liability (asset) [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of non-adjusting events after reporting period [line items]",
        "verboseLabel": "Disclosure of non-adjusting events after reporting period [line items]",
        "label": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of non-adjusting events after reporting period [table]",
        "verboseLabel": "Disclosure of non-adjusting events after reporting period [table]",
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsTables",
      "http://www.abivax.com/role/ShareholdersequityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of other equity instruments",
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "abvx_DisclosureOfOffBalanceSheetCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfOffBalanceSheetCommitmentsLineItems",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Off-Balance Sheet Commitments [Line Items]",
        "label": "Disclosure Of Off-Balance Sheet Commitments [Line Items]",
        "documentation": "Disclosure Of Off-Balance Sheet Commitments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfOffBalanceSheetCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfOffBalanceSheetCommitmentsTable",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Off-Balance Sheet Commitments [Table]",
        "label": "Disclosure Of Off-Balance Sheet Commitments [Table]",
        "documentation": "Disclosure Of Off-Balance Sheet Commitments [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfOperatingIncomeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfOperatingIncomeLineItems",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Operating Income [Line Items]",
        "label": "Disclosure Of Operating Income [Line Items]",
        "documentation": "Disclosure Of Operating Income [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfOperatingIncomeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfOperatingIncomeTable",
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Operating Income [Table]",
        "label": "Disclosure Of Operating Income [Table]",
        "documentation": "Disclosure Of Operating Income [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Otherfinancialassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "label": "Disclosure of other assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other assets. [Refer: Other assets]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingExpenseExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Operatingexpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses",
        "label": "Disclosure of other operating expense [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other operating expense. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Operatingincome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating income",
        "label": "Disclosure of other operating income [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Offbalancesheetcommitmentsreceivedandcontingentassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Off-balance sheet commitments received and contingent assets",
        "label": "Disclosure of other provisions, contingent liabilities and contingent assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for other provisions, contingent liabilities and contingent assets."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "abvx_DisclosureOfOtherReceivablesAndOtherAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfOtherReceivablesAndOtherAssetsLineItems",
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Other Receivables And Other Assets [Line Items]",
        "label": "Disclosure Of Other Receivables And Other Assets [Line Items]",
        "documentation": "Disclosure Of Other Receivables And Other Assets [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfOtherReceivablesAndOtherAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfOtherReceivablesAndOtherAssetsTable",
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Other Receivables And Other Assets [Table]",
        "label": "Disclosure Of Other Receivables And Other Assets [Table]",
        "documentation": "Disclosure Of Other Receivables And Other Assets [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of principal audit fees and services",
        "label": "Disclosure Of Principal Audit Fees And Services [Table Text Block]",
        "documentation": "Disclosure Of Principal Audit Fees And Services"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Propertyplantandequipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Disclosure of property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [line items]",
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [table]",
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of quantitative information about right-of-use assets [line items]",
        "label": "Disclosure of quantitative information about right-of-use assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of quantitative information about right-of-use assets [table]",
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "abvx_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/IncometaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of effective income tax (loss)",
        "label": "Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate [Table Text Block]",
        "documentation": "Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of property, plant and equipment",
        "label": "Disclosure of reconciliation of changes in property, plant and equipment, including right-of-use assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in property, plant and equipment, including right-of-use assets."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of liabilities arising from financing activities",
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of liabilities arising from financing activities [line items]",
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of liabilities arising from financing activities [table]",
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Relatedparties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related parties",
        "label": "Disclosure of related party [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Shareholdersequity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders\u2019 equity",
        "label": "Disclosure of share capital, reserves and other equity interest [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Sharebasedpayments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Disclosure of share-based payment arrangements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "abvx_DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequentevents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events",
        "label": "Disclosure Of Significant Events For The Period Reported And Events After Reporting Period [Text Block]",
        "documentation": "Disclosure Of Significant Events For The Period Reported And Events After Reporting Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of main data and assumptions used for the measurement of earn-out liability",
        "label": "Disclosure of significant unobservable inputs used in fair value measurement of liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of liabilities."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "abvx_DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock",
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of tax and employee-related payables",
        "label": "Disclosure Of Tax And Employee-Related Payables Explanatory [Table Text Block]",
        "documentation": "Disclosure Of Tax And Employee-Related Payables Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "presentation": [
      "http://www.abivax.com/role/IncometaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of deferred tax assets and liabilities by nature",
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails",
      "http://www.abivax.com/role/IncometaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]",
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails",
      "http://www.abivax.com/role/IncometaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]",
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [line items]",
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [table]",
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Payablesandothercurrentliabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and other current liabilities",
        "label": "Disclosure of trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/Otherreceivablesandotherassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables and other assets",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of aggregate compensation of the members of the Group\u2019s Board of Directors and CEO",
        "label": "Disclosure of transactions between related parties [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of transactions between related parties [line items]",
        "label": "Disclosure of transactions between related parties [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of transactions between related parties [table]",
        "label": "Disclosure of transactions between related parties [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "abvx_DisclosureOfWarrantsArrangementsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfWarrantsArrangementsLineItems",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Warrants Arrangements [Line Items]",
        "label": "Disclosure Of Warrants Arrangements [Line Items]",
        "documentation": "Disclosure Of Warrants Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DisclosureOfWarrantsArrangementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DisclosureOfWarrantsArrangementsTable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Warrants Arrangements [Table]",
        "label": "Disclosure Of Warrants Arrangements [Table]",
        "documentation": "Disclosure Of Warrants Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DiscountRateAppliedToLongTermAdvances": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DiscountRateAppliedToLongTermAdvances",
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disount rate applied to long-term advances",
        "label": "Discount Rate Applied To Long-Term Advances",
        "documentation": "Discount Rate Applied To Long-Term Advances"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DiscountRateMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DiscountRateMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Discount rate, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a discount rate used as a measurement input used in valuation techniques based on a present value calculation."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "ifrs-full_DiscountedCashFlowMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DiscountedCashFlowMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discounted cash flow",
        "label": "Discounted cash flow [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a specific valuation technique consistent with the income approach that involves analysing future cash flow amounts through the application of present value techniques and inputs (for example, weighted average cost of capital, long-term revenue growth rate, long-term pre-tax operating margin, discount for lack of marketability, control premium). [Refer: Income approach [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r245",
      "r251"
     ]
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Disposal",
        "label": "Disposals, property, plant and equipment including right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment including right-of-use assets resulting from disposals. [Refer: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Accounting Standard",
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r297"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r297",
      "r340"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Registration Statement",
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Shell Company Report",
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "abvx_DrawdownProbablityMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "DrawdownProbablityMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability of Drawdown of Tranche C credit facility",
        "label": "Drawdown Probablity, Measurement Input [Member]",
        "documentation": "Drawdown Probablity, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "abvx_EarlyRedemptionAmountMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarlyRedemptionAmountMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Early redemption amount (put event)",
        "label": "Early Redemption Amount, Measurement Input [Member]",
        "documentation": "Early Redemption Amount, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EarnOutAmountPayableIfConditionsAreNotMet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarnOutAmountPayableIfConditionsAreNotMet",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earn-out, amount payable if conditions are not met",
        "label": "Earn-Out, Amount Payable If Conditions Are Not Met",
        "documentation": "Earn-Out, Amount Payable If Conditions Are Not Met"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EarnOutAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarnOutAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of earn-out liability",
        "label": "Earn-Out At Fair Value",
        "documentation": "Earn-Out At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EarnOutAtFairValueAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarnOutAtFairValueAssetsAcquisitions",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earn-out measured at fair value",
        "label": "Earn-Out At Fair Value, Assets Acquisitions",
        "documentation": "Earn-Out At Fair Value, Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EarnOutLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarnOutLiabilityMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prosynergia earn-out liability",
        "label": "Earn-Out Liability [Member]",
        "documentation": "Earn-Out Liability"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EarnOutMarketCapitalizationThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarnOutMarketCapitalizationThreshold",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earn-out, market capitalization threshold",
        "label": "Earn-Out, Market Capitalization, Threshold",
        "documentation": "Earn-Out, Market Capitalization, Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EarnOutMaximumAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarnOutMaximumAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earn-out, maximum amount",
        "label": "Earn-Out, Maximum Amount",
        "documentation": "Earn-Out, Maximum Amount"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EarnOutPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EarnOutPercentage",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earn-out, percentage",
        "label": "Earn-Out, Percentage",
        "documentation": "Earn-Out, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share (\u20ac/share)",
        "label": "Earnings per share [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://www.abivax.com/role/IncomelosspershareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of earnings per share",
        "label": "Earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "abvx_EbolaConditionalAdvanceBPIFranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EbolaConditionalAdvanceBPIFranceMember",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ebola conditional advance, BPI France",
        "label": "Ebola Conditional Advance, BPI France [Member]",
        "documentation": "Ebola Conditional Advance, BPI France"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EbolaConditionalAdvanceBPILanguedocRoussillonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EbolaConditionalAdvanceBPILanguedocRoussillonMember",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ebola conditional advance, BPI Languedoc-Roussillon",
        "label": "Ebola Conditional Advance, BPI Languedoc-Roussillon [Member]",
        "documentation": "Ebola Conditional Advance, BPI Languedoc-Roussillon"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EbolaConditionalAdvanceBPIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EbolaConditionalAdvanceBPIMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ebola conditional advance",
        "verboseLabel": "EBOLA \u2013 Bpifrance",
        "label": "Ebola Conditional Advance, BPI [Member]",
        "documentation": "Ebola Conditional Advance, BPI"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails",
      "http://www.abivax.com/role/FinancialgainlossNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of movements in exchange rates on cash held",
        "verboseLabel": "Foreign exchange gain (loss) on translation of cash and cash equivalents",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113"
     ]
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EmployeeBenefitsExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personnel costs",
        "label": "Employee benefits expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r37",
      "r216"
     ]
    },
    "abvx_EmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EmployeeMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee",
        "label": "Employee [Member]",
        "documentation": "Employee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EmployeesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EmployeesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees [Abstract]",
        "documentation": "Employees [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/TheGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity",
        "periodStartLabel": "Equity at beginning of period",
        "periodEndLabel": "Equity at end of period",
        "terseLabel": "Equity",
        "label": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r26",
      "r126",
      "r128",
      "r144",
      "r145",
      "r147"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders\u2019 equity",
        "label": "Equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY",
        "label": "Equity and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAndLiabilitiesAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY",
        "label": "Equity and liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EquityInstrumentFairValueOtherEquityInstrumentsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EquityInstrumentFairValueOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "FAIR VALUE OF THE BSA (in euro per share)",
        "terseLabel": "FAIR VALUE OF THE AGA (in euro per share)",
        "label": "Equity Instrument Fair Value, Other Equity Instruments Granted",
        "documentation": "Equity Instrument Fair Value, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EquityInstrumentPriceOtherEquityInstrumentsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EquityInstrumentPriceOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "BSA SUBSCRIPTION PRICE (in euro per share)",
        "terseLabel": "AGA PRICE (in euro per share)",
        "label": "Equity Instrument Price, Other Equity Instruments Granted",
        "documentation": "Equity Instrument Price, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EquityInstrumentStrikePriceOtherEquityInstrumentsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EquityInstrumentStrikePriceOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STRIKE PRICE PER SHARE ( in euro per share)",
        "label": "Equity Instrument Strike Price, Other Equity Instruments Granted",
        "documentation": "Equity Instrument Strike Price, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EquityIssuanceCashCarveOut": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EquityIssuanceCashCarveOut",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity issuance, cash carve-out",
        "label": "Equity Issuance, Cash Carve-Out",
        "documentation": "Equity Issuance, Cash Carve-Out"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EquityIssuancePercentageOfCurrentShareCapital": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EquityIssuancePercentageOfCurrentShareCapital",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity issuance, percentage of current share capital",
        "label": "Equity Issuance, Percentage Of Current Share Capital",
        "documentation": "Equity Issuance, Percentage Of Current Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EquityIssuanceSubscriptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EquityIssuanceSubscriptionPricePerShare",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity issuance, subscripion price per share (in euro per share)",
        "label": "Equity Issuance, Subscription Price Per Share",
        "documentation": "Equity Issuance, Subscription Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EquityLineAgreementWithKeplerCheuvreuxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EquityLineAgreementWithKeplerCheuvreuxMember",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity line agreement with Kepler Cheuvreux",
        "label": "Equity Line Agreement With Kepler Cheuvreux [Member]",
        "documentation": "Equity Line Agreement With Kepler Cheuvreux"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r301",
      "r311",
      "r344"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r287",
      "r298",
      "r308",
      "r341"
     ]
    },
    "abvx_EuriborMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EuriborMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Euribor",
        "label": "Euribor [Member]",
        "documentation": "Euribor"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_EuropeanCentralBankBaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "EuropeanCentralBankBaseRateMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "European Central Bank base rate",
        "label": "European Central Bank Base Rate [Member]",
        "documentation": "European Central Bank Base Rate"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exclusive licensing agreement with CNRS, University of Montpellier and Institut Curie",
        "label": "Exclusive Licensing Agreement With CNRS, University Of Montpellier And Institut Curie [Member]",
        "documentation": "Exclusive Licensing Agreement With CNRS, University Of Montpellier And Institut Curie"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exclusive licensing contract with the Scripps Research Institute, University of Chicago and Brigham Young University",
        "label": "Exclusive Licensing Contract With The Scripps Research Institute, University Of Chicago And Brigham Young University [Member]",
        "documentation": "Exclusive Licensing Contract With The Scripps Research Institute, University Of Chicago And Brigham Young University"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "abvx_ExerciseOfDerivativeInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExerciseOfDerivativeInstruments",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Exercises",
        "label": "Exercise Of Derivative Instruments",
        "documentation": "Exercise Of Derivative Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExercisePriceOtherEquityInstrumentsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExercisePriceOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, other equity instruments granted (in euro per share)",
        "label": "Exercise Price, Other Equity Instruments Granted",
        "documentation": "Exercise Price, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExercisePricePerShareMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExercisePricePerShareMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per share (in euro per share)",
        "label": "Exercise Price Per Share, Measurement Input [Member]",
        "documentation": "Exercise Price Per Share, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, percentage of 15-day WVAP",
        "label": "Exercise Price, Percentage Of 15-Day WVAP, Other Equity Instruments Granted",
        "documentation": "Exercise Price, Percentage Of 15-Day WVAP, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, percentage of premium",
        "label": "Exercise Price, Percentage Of Premium Over 15-Day VWAP, Other Equity Instruments Granted",
        "documentation": "Exercise Price, Percentage Of Premium Over 15-Day VWAP, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpectedDividendMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpectedDividendMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend",
        "label": "Expected Dividend, Measurement Input [Member]",
        "documentation": "Expected Dividend, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpectedMaturityOtherEquityInstrumentsGranted": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpectedMaturityOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EXPECTED MATURITY",
        "label": "Expected Maturity, Other Equity Instruments Granted",
        "documentation": "Expected Maturity, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpectedProceedsFromShareIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpectedProceedsFromShareIssuance",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected proceeds from share issuance",
        "label": "Expected Proceeds From Share Issuance",
        "documentation": "Expected Proceeds From Share Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpectedProceedsFromShareIssuanceShelfRegistration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpectedProceedsFromShareIssuanceShelfRegistration",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected proceeds from share issuance, shelf registration",
        "label": "Expected Proceeds From Share Issuance, Shelf Registration",
        "documentation": "Expected Proceeds From Share Issuance, Shelf Registration"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpectedVolatilityOtherEquityInstrumentsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpectedVolatilityOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VOLATILITY",
        "label": "Expected Volatility, Other Equity Instruments Granted",
        "documentation": "Expected Volatility, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseByNatureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseByNatureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses by nature [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails": {
       "parentTag": "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Social taxes related to AGAs",
        "terseLabel": "Social taxes related to AGAs",
        "label": "Expense From Equity-Settled Share-Based Payment Transactions, Social Taxes",
        "documentation": "Expense From Equity-Settled Share-Based Payment Transactions, Social Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails": {
       "parentTag": "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Compensation expenses",
        "verboseLabel": "Share-based compensation expense",
        "label": "Expense from equity-settled share-based payment transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Expense from share-based payment transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "abvx_ExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense on lease liabilities",
        "label": "Expense On Lease Liabilities",
        "documentation": "Expense On Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense relating to short-term leases",
        "label": "Expense Relating To Short-Term Leases And Low Value Assets For Which Recognition Exemption Has Been Used",
        "documentation": "Expense Relating To Short-Term Leases And Low Value Assets For Which Recognition Exemption Has Been Used"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpiryScenarioPeriodOtherEquityInstrumentsGranted": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpiryScenarioPeriodOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiry scenario period, other equity instruments granted",
        "label": "Expiry Scenario Period, Other Equity Instruments Granted",
        "documentation": "Expiry Scenario Period, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ExpiryScenarioProbablityMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ExpiryScenarioProbablityMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "7-year expiry scenario probability",
        "label": "Expiry Scenario Probablity, Measurement Input [Member]",
        "documentation": "Expiry Scenario Probablity, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of breakdown of the compensation expenses",
        "label": "Explanation of effect of share-based payments on entity's profit or loss [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "country_FR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "FR",
     "presentation": [
      "http://www.abivax.com/role/EmployeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "France",
        "label": "FRANCE"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FairValueMeasurementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FairValueMeasurementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement [Abstract]",
        "documentation": "Fair Value Measurement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinalRedemptionFairValueOfMRIMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinalRedemptionFairValueOfMRIMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fair value of MRI, final redemption",
        "label": "Final Redemption, Fair Value Of MRI , Measurement Input [Member]",
        "documentation": "Final Redemption, Fair Value Of MRI , Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Final redemption, probability-weighted fair value with MRI",
        "label": "Final Redemption, Probability-Weighted Fair Value With MRI , Measurement Input [Member]",
        "documentation": "Final Redemption, Probability-Weighted Fair Value With MRI , Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Final redemption, probability-weighted fair value without MRI",
        "label": "Final Redemption, Probability-Weighted Fair Value Without MRI , Measurement Input [Member]",
        "documentation": "Final Redemption, Probability-Weighted Fair Value Without MRI , Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability-weighted present value of shortfall payment, final redemption",
        "label": "Final Redemption, Probability-Weighted Present Value Of Shortfall Payment, Measurement Input [Member]",
        "documentation": "Final Redemption,Probability-Weighted Present Value Of Shortfall Payment, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinalRedemptionScenarioProbabilityMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinalRedemptionScenarioProbabilityMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Final redemption scenario probability",
        "label": "Final Redemption Scenario Probability, Measurement Input [Member]",
        "documentation": "Final Redemption Scenario Probability, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Financial expenses",
        "negatedTotalLabel": "Financial expenses",
        "label": "Finance costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial income",
        "totalLabel": "Financial income",
        "label": "Finance income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Financial gain (loss)",
        "label": "Finance income (cost)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "abvx_FinancialAgreementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinancialAgreementAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial agreement, amount",
        "label": "Financial Agreement, Amount",
        "documentation": "Financial Agreement, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinancialAgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinancialAgreementAxis",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Agreement [Axis]",
        "label": "Financial Agreement [Axis]",
        "documentation": "Financial Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinancialAgreementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinancialAgreementDomain",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Agreement [Domain]",
        "label": "Financial Agreement [Domain]",
        "documentation": "Financial Agreement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinancialAgreementNumberOfTransactions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinancialAgreementNumberOfTransactions",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial agreement, number of transactions",
        "label": "Financial Agreement, Number Of Transactions",
        "documentation": "Financial Agreement, Number Of Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsAtAmortisedCostCategoryMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS AT AMORTIZED COST",
        "label": "Financial assets at amortised cost, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets at amortised cost category. [Refer: Financial assets at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets, at fair value",
        "label": "Financial assets, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS AT FAIR VALUE THROUGH PROFIT\u00a0AND LOSS",
        "label": "Financial assets at fair value through profit or loss, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets at fair value through profit or loss category. [Refer: Financial assets at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialEffectOfChangesInAccountingPolicyMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) due to changes in accounting policy",
        "label": "Increase (decrease) due to changes in accounting policy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial effect of changes in accounting policy."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123"
     ]
    },
    "abvx_FinancialIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinancialIncomeLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Income (Loss) [Abstract]",
        "documentation": "Financial Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total financial liabilities",
        "totalLabel": "Total financial liabilities",
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtAmortisedCostCategoryMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AT\u00a0AMORTIZED COST",
        "label": "Financial liabilities at amortised cost, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities at amortised cost category. [Refer: Financial liabilities at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities, at fair value",
        "label": "Financial liabilities, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AT FAIR VALUE THROUGH PROFIT\u00a0AND LOSS",
        "label": "Financial liabilities at fair value through profit or loss, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities at fair value through profit or loss category. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "abvx_FinancialLiabilitiesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinancialLiabilitiesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Financial liabilities, undiscounted cash flows",
        "label": "Financial Liabilities, Undiscounted Cash Flows",
        "documentation": "Financial Liabilities, Undiscounted Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FinancialRiskManagementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FinancialRiskManagementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management [Abstract]",
        "documentation": "Financial Risk Management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FixturesAndFittingsMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office fixtures and fittings",
        "label": "Fixtures and fittings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "abvx_ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation differences gain (loss)",
        "label": "Foreign Exchange Differences Gain (Losses) On Translation Of Foreign Operations",
        "documentation": "Foreign Exchange Differences Gain (Losses) On Translation Of Foreign Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ForeignExchangeGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ForeignExchangeGain",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange gains",
        "label": "Foreign exchange gain"
       }
      },
      "en": {
       "role": {
        "documentation": "The gross gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r61"
     ]
    },
    "ifrs-full_ForeignExchangeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ForeignExchangeLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign exchange losses",
        "label": "Foreign exchange loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The gross loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r61"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r348"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r348"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r348"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r348"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r348"
     ]
    },
    "abvx_FormerChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FormerChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Former Chief Executive Officer",
        "label": "Former Chief Executive Officer [Member]",
        "documentation": "Former Chief Executive Officer"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FoundersShareSubscriptionWarrantsBCEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FoundersShareSubscriptionWarrantsBCEMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total BCEs",
        "verboseLabel": "BCEs",
        "label": "Founders\u2019 Share Subscription Warrants (BCE) [Member]",
        "documentation": "Founders\u2019 Share Subscription Warrants (BCE)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "abvx_FreeSharesAGAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FreeSharesAGAMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Free Shares (AGA)",
        "verboseLabel": "AGAs",
        "label": "Free Shares (AGA) [Member]",
        "documentation": "Free Shares (AGA)"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FurnitureAndComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FurnitureAndComputerEquipmentMember",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FURNITURE AND COMPUTER EQUIPMENT",
        "label": "Furniture And Computer Equipment [Member]",
        "documentation": "Furniture And Computer Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_FurnitureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "FurnitureMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture",
        "label": "Furniture [Member]",
        "documentation": "Furniture"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss of extinguishment",
        "label": "Gain (loss) arising from difference between carrying amount of financial liability extinguished and consideration paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The gain (loss) arising from the difference between the carrying amount of the financial liability extinguished and the measurement of the consideration paid (equity instruments issued) to the creditor. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Actuarial gains and losses",
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "abvx_GainsArisingFromDerecognitionOfFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "GainsArisingFromDerecognitionOfFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on derecognition of financial liabilities",
        "label": "Gains Arising From Derecognition Of Financial Liabilities",
        "documentation": "Gains Arising From Derecognition Of Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_GainsArisingFromRecognitionOfFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "GainsArisingFromRecognitionOfFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Day-one gain on recognition of financial liabilities",
        "label": "Gains Arising From Recognition Of Financial Liabilities",
        "documentation": "Gains Arising From Recognition Of Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gains on financial liabilities at fair value through profit or loss",
        "label": "Gains (losses) on financial liabilities at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) on financial liabilities at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "ifrs-full_GainsOnChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GainsOnChangeInFairValueOfDerivatives",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease in fair value",
        "terseLabel": "Decrease/(increase) in derivatives fair value",
        "label": "Gains on change in fair value of derivatives"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "abvx_GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease/(increase) in other liabilities at fair value through profit and loss",
        "label": "Gains On Financial Liabilities At Fair Value Through Profit Or Loss",
        "documentation": "Gains On Financial Liabilities At Fair Value Through Profit Or Loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "General and administrative",
        "label": "General and administrative expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "abvx_GeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "GeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative expense",
        "label": "General And Administrative Expenses [Member]",
        "documentation": "General And Administrative Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://www.abivax.com/role/EmployeesDetails",
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical areas [axis]",
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r226",
      "r252",
      "r256"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://www.abivax.com/role/EmployeesDetails",
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical areas [domain]",
        "label": "Geographical areas [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r226",
      "r252",
      "r256"
     ]
    },
    "ifrs-full_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r85",
      "r90",
      "r178"
     ]
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GROSS VALUES",
        "label": "Gross carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r95",
      "r105",
      "r108",
      "r178",
      "r188",
      "r190",
      "r258"
     ]
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "abvx_FinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross lease liabilities",
        "label": "Gross lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r261"
     ]
    },
    "abvx_GrossProceedsFromNonConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "GrossProceedsFromNonConvertibleLoansNotes",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the issuance of non-convertible bond loans",
        "label": "Gross Proceeds From Non-Convertible Loans Notes",
        "documentation": "Gross Proceeds From Non-Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_HeightsConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "HeightsConvertibleNotesMember",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Heights convertible notes",
        "label": "Heights Convertible Notes [Member]",
        "documentation": "Heights Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_HeightsConvertibleNotesTrancheAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "HeightsConvertibleNotesTrancheAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Heights convertible notes, tranche A",
        "label": "Heights Convertible Notes, Tranche A [Member]",
        "documentation": "Heights Convertible Notes, Tranche A"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_HeightsConvertibleNotesTrancheBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "HeightsConvertibleNotesTrancheBMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Heights convertible notes, tranche B",
        "label": "Heights Convertible Notes, Tranche B [Member]",
        "documentation": "Heights Convertible Notes, Tranche B"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "HistoricalVolatilityForSharesMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility",
        "label": "Historical volatility for shares, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the historical volatility for shares used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r297"
     ]
    },
    "abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total net assets",
        "label": "Identifiable Assets Acquired (Liabilities Assumed), Assets Acquisitions",
        "documentation": "Identifiable Assets Acquired (Liabilities Assumed), Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment loss recognised in profit or loss, goodwill",
        "label": "Impairment loss recognised in profit or loss, goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Goodwill impairment loss",
        "terseLabel": "Impairment loss recognised in profit or loss, intangible assets and goodwill",
        "label": "Impairment loss recognised in profit or loss, intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails",
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment",
        "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "abvx_IncomeFromResearchTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncomeFromResearchTaxCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails",
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research tax credit (\"CIR\")",
        "label": "Income From Research Tax Credit",
        "documentation": "Income From Research Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax",
        "totalLabel": "Effective income tax (loss)",
        "label": "Tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r35",
      "r39",
      "r40",
      "r41",
      "r73",
      "r142",
      "r205"
     ]
    },
    "ifrs-full_IncomeTaxesPaidRefundAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes paid (refund) [abstract]",
        "label": "Income taxes paid (refund) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreaseDecreaseFromFreeSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseFromFreeSharesIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of free shares",
        "label": "Increase (Decrease) From Free Shares Issued",
        "documentation": "Increase (Decrease) From Free Shares Issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (decrease) in cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "abvx_IncreaseDecreaseInCrohnsDiseaseResearchExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseInCrohnsDiseaseResearchExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in Crohn's Disease research expenses",
        "label": "Increase (Decrease) In Crohn's Disease Research Expenses",
        "documentation": "Increase (Decrease) In Crohn's Disease Research Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreaseDecreaseInEmployeeBenefitsExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseInEmployeeBenefitsExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in employee benefits expenses",
        "label": "Increase (Decrease) In Employee Benefits Expenses",
        "documentation": "Increase (Decrease) In Employee Benefits Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in financial liabilities at fair value due to reasonably possible decrease in unobservable input",
        "label": "Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible decrease in an unobservable input."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease in financial assets at fair value",
        "terseLabel": "Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets",
        "label": "Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of assets due to a reasonably possible increase in an unobservable input."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease in financial liabilities at fair value",
        "terseLabel": "Increase (decrease) in financial liabilities at fair value due to reasonably possible increase in unobservable input",
        "label": "Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible increase in an unobservable input."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "abvx_IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital increase from issuance of ordinary shares (in shares)",
        "label": "Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase",
        "documentation": "Increase (Decrease) In Number Of Ordinary Shares Issued Through Capital Increase"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercises of share warrants (in shares)",
        "label": "Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants",
        "documentation": "Increase (Decrease) In Number Of Shares Issued Through Exercise Of Share Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreaseDecreaseInTransversalActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseInTransversalActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in transversal activities",
        "label": "Increase (Decrease) In Transversal Activities",
        "documentation": "Increase (Decrease) In Transversal Activities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreaseDecreaseInUlcerativeColitisExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseInUlcerativeColitisExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in Ulcerative Colitis expenses",
        "label": "Increase (Decrease) In Ulcerative Colitis Expenses",
        "documentation": "Increase (Decrease) In Ulcerative Colitis Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInWorkingCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Changes in working capital requirements",
        "label": "Increase (decrease) in working capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in working capital."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "abvx_IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (decrease) through amortization cost remeasurement",
        "terseLabel": "Non-cash changes: amortized cost remeasurement",
        "label": "Increase (Decrease) Through Amortization Cost Remeasurement, Liabilities Arising From Financing Activities",
        "documentation": "Increase (Decrease) Through Amortization Cost Remeasurement, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughAppropriationOfRetainedEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Appropriation of prior period net loss",
        "label": "Increase (decrease) through appropriation of retained earnings, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the appropriation of retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash changes: fair value remeasurement",
        "label": "Increase (decrease) through changes in fair values, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in fair values. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "abvx_IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash changes: classification of embedded derivatives as separate derivative financial instruments",
        "label": "Increase (Decrease) Through Classification of Embedded Derivatives as Separate Financial Instruments, Liabilities Arising From Financing Activities",
        "documentation": "Increase (Decrease) Through Classification of Embedded Derivatives as Separate Financial Instruments, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non cash changes : Effect of the change in foreign currency exhange rates",
        "label": "Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercises of share warrants",
        "label": "Increase (decrease) through exercise of warrants, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of warrants."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "abvx_IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash changes: (gain)/loss on recognition or derecognition",
        "label": "Increase (Decrease) Through Gain (Loss) On Recognition/Derecognition, Liabilities Arising From Financing Activities",
        "documentation": "Increase (Decrease) Through Gain (Loss) On Recognition/Derecognition, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreaseDecreaseThroughIssuanceOfWarrantsEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseThroughIssuanceOfWarrantsEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share warrants",
        "label": "Increase (Decrease) Through Issuance of Warrants, Equity",
        "documentation": "Increase (Decrease) Through Issuance of Warrants, Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of the change in foreign currency exchange rates",
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment including right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment including right-of-use assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash changes: interest expense and other",
        "label": "Increase (decrease) through other changes, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "abvx_IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash changes: recognition of earn-out liability",
        "label": "Increase (Decrease) Through Recognition of Earn Out Liability, Liabilities Arising From Financing Activities",
        "documentation": "Increase (Decrease) Through Recognition of Earn Out Liability, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares based compensation expense",
        "label": "Increase (decrease) through share-based payment transactions, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "abvx_IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash changes\u00a0: subsidies",
        "label": "Increase (Decrease) Through Subsidies, Liabilities Arising From Financing Activities",
        "documentation": "Increase (Decrease) Through Subsidies, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTreasuryShareTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction on treasury shares",
        "label": "Increase (decrease) through treasury share transactions, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "abvx_IncreaseInLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseInLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase",
        "label": "Increase In Lease Liabilities",
        "documentation": "Increase In Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreaseIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase",
        "label": "Increase, Intangible Assets Other Than Goodwill",
        "documentation": "Increase, Intangible Assets Other Than Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase",
        "label": "Increase, Property Plant AndEquipment including right-of-use assets",
        "documentation": "Increase, Property Plant AndEquipment including right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non cash changes: additional leases",
        "label": "Increase through new leases, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r236",
      "r240"
     ]
    },
    "abvx_IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds",
        "label": "Increase Through Proceeds, Liabilities Arising From Financing Activities",
        "documentation": "Increase Through Proceeds, Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash-generating units [axis]",
        "label": "Cash-generating units [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesDomain",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash-generating units [domain]",
        "label": "Cash-generating units [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Cash-generating units' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r92"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r339",
      "r348",
      "r352",
      "r360"
     ]
    },
    "abvx_IndustrialMaterialsAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IndustrialMaterialsAndEquipmentMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Industrial materials and equipment",
        "label": "Industrial Materials And Equipment [Member]",
        "documentation": "Industrial Materials And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_InitialPriceLimitMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "InitialPriceLimitMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial price limit (in euro per share)",
        "label": "Initial Price Limit, Measurement Input [Member]",
        "documentation": "Initial Price Limit, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r275",
      "r364"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r275",
      "r364"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r275",
      "r364"
     ]
    },
    "ifrs-full_IntangibleAssetsAndGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "periodStartLabel": "Intangible assets other than goodwill at beginning of period",
        "periodEndLabel": "Intangible assets other than goodwill at end of period",
        "label": "Intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r98"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLife",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets with indefinite useful life",
        "label": "Intangible assets with indefinite useful life"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r91",
      "r100"
     ]
    },
    "abvx_IntellectualPropertyFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IntellectualPropertyFees",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property fees",
        "label": "Intellectual Property Fees",
        "documentation": "Intellectual Property Fees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest cost",
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_InterestExpenseOnBonds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnBonds",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest on Kreos 1 &amp; 2 straight bond loans",
        "label": "Interest expense on bonds"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on bonds issued. [Refer: Interest expense; Bonds issued]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_InterestExpenseOnBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest on conditional advances",
        "label": "Interest expense on borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_InterestExpenseOnDebtInstrumentsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnDebtInstrumentsIssued",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest on convertible loan notes",
        "label": "Interest expense on debt instruments issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on debt instruments issued. [Refer: Interest expense; Debt instruments issued]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails",
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense on lease liabilities",
        "negatedTerseLabel": "Interest on lease liabilities",
        "label": "Interest expense on lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "abvx_InterestExpenseOnRoyaltyCertificates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "InterestExpenseOnRoyaltyCertificates",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on royalty certificates",
        "negatedTerseLabel": "Interest on royalty certificates",
        "label": "Interest Expense On Royalty Certificates",
        "documentation": "Interest Expense On Royalty Certificates"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest paid",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "abvx_InterestRateCollarRange": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "InterestRateCollarRange",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate collar range",
        "label": "Interest Rate Collar Range",
        "documentation": "Interest Rate Collar Range"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestRateMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestRateMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Interest rate, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an interest rate used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestReceivedClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest received",
        "label": "Interest received, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "abvx_IssuanceOfDerivativeInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IssuanceOfDerivativeInstruments",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance",
        "label": "Issuance Of Derivative Instruments",
        "documentation": "Issuance Of Derivative Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IssuanceOfOtherShareWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IssuanceOfOtherShareWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of other share warrants",
        "label": "Issuance Of Other Share Warrants",
        "documentation": "Issuance Of Other Share Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_IssuancePricePercentageOfDiscountTo15DayWVAP": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IssuancePricePercentageOfDiscountTo15DayWVAP",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance price, percentage of discount to 15-day WVAP",
        "label": "Issuance Price, Percentage Of Discount To 15-Day WVAP",
        "documentation": "Issuance Price, Percentage Of Discount To 15-Day WVAP"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssueOfConvertibleInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssueOfConvertibleInstruments",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of convertible notes",
        "label": "Issue of convertible instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The change in equity resulting from the issuing of convertible instruments."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital increase from issuance of ordinary shares",
        "verboseLabel": "Issue of equity",
        "label": "Issue of equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "abvx_IssueOfEquityOfferingPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "IssueOfEquityOfferingPricePerShare",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of equity, offering price per share (in dollar/euro per share)",
        "label": "Issue Of Equity, Offering Price Per Share",
        "documentation": "Issue Of Equity, Offering Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "label": "Issued capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHARE CAPITAL",
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Key management personnel compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "abvx_KeyManagementPersonnelCompensationAttendanceFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KeyManagementPersonnelCompensationAttendanceFees",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attendance fees\u2014Board of Directors",
        "label": "Key Management Personnel Compensation, Attendance Fees",
        "documentation": "Key Management Personnel Compensation, Attendance Fees"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KeyManagementPersonnelCompensationFixedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KeyManagementPersonnelCompensationFixedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed compensation owed",
        "label": "Key Management Personnel Compensation, Fixed Compensation",
        "documentation": "Key Management Personnel Compensation, Fixed Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KeyManagementPersonnelCompensationInKindContributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KeyManagementPersonnelCompensationInKindContributions",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions in-kind",
        "label": "Key Management Personnel Compensation, In-Kind Contributions",
        "documentation": "Key Management Personnel Compensation, In-Kind Contributions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contributions",
        "label": "Key management personnel compensation, post-employment benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Key management personnel compensation, share-based payment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total compensation",
        "label": "Key management personnel compensation, short-term employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationTerminationBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails",
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Departure indemnities",
        "terseLabel": "Termination benefits",
        "label": "Key management personnel compensation, termination benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "abvx_KeyManagementPersonnelCompensationVariableCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KeyManagementPersonnelCompensationVariableCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesDisclosureofaggregatecompensationofthemembersoftheGroupsBoardofDirectorsandCEODetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable compensation owed",
        "label": "Key Management Personnel Compensation, Variable Compensation",
        "documentation": "Key Management Personnel Compensation, Variable Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Key management personnel",
        "label": "Key management personnel of entity or parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "abvx_Kreos12BondLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos12BondLoansMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 1 &amp; 2 bond loans",
        "label": "Kreos 1 &amp; 2 Bond Loans [Member]",
        "documentation": "Kreos 1 &amp; 2 Bond Loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos1BondLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos1BondLoansMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 1 bond loans",
        "label": "Kreos 1 Bond Loans [Member]",
        "documentation": "Kreos 1 Bond Loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos1ClaretBondLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos1ClaretBondLoansMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret bond loans",
        "label": "Kreos 1 &amp; Claret Bond Loans [Member]",
        "documentation": "Kreos 1 &amp; Claret Bond Loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos1ConvertibleBondLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos1ConvertibleBondLoansMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 1, convertible bond loans",
        "label": "Kreos 1, Convertible Bond Loans [Member]",
        "documentation": "Kreos 1, Convertible Bond Loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos1ConvertibleBondLoansTrancheAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos1ConvertibleBondLoansTrancheAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 1, convertible bond loans, tranche A",
        "label": "Kreos 1, Convertible Bond Loans, Tranche A [Member]",
        "documentation": "Kreos 1, Convertible Bond Loans, Tranche A"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos1ConvertibleBondLoansTrancheBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos1ConvertibleBondLoansTrancheBMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 1, convertible bond loans, tranche B",
        "label": "Kreos 1, Convertible Bond Loans, Tranche B [Member]",
        "documentation": "Kreos 1, Convertible Bond Loans, Tranche B"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos1Member",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Kreos share warrants",
        "terseLabel": "Kreos A &amp; B BSA",
        "verboseLabel": "Kreos 1",
        "label": "Kreos 1 [Member]",
        "documentation": "Kreos 1"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos1NonConvertibleBondLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos1NonConvertibleBondLoansMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 1, non-convertible bond loans",
        "label": "Kreos 1, Non-Convertible Bond Loans [Member]",
        "documentation": "Kreos 1, Non-Convertible Bond Loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos2Member",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 2",
        "label": "Kreos 2 [Member]",
        "documentation": "Kreos 2"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos2TrancheAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos2TrancheAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 2, tranche A",
        "label": "Kreos 2, Tranche A [Member]",
        "documentation": "Kreos 2, Tranche A"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_Kreos2TrancheBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "Kreos2TrancheBMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos 2, tranche B",
        "label": "Kreos 2, Tranche B [Member]",
        "documentation": "Kreos 2, Tranche B"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosABBSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosABBSAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos A &amp; B BSA",
        "label": "Kreos A &amp; B BSA [Member]",
        "documentation": "Kreos A &amp; B BSA"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosABCBSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosABCBSAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos A &amp; B &amp; C BSA",
        "label": "Kreos A &amp; B &amp; C BSA [Member]",
        "documentation": "Kreos A &amp; B &amp; C BSA"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosABSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosABSAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos A BSA",
        "label": "Kreos A BSA [Member]",
        "documentation": "Kreos A BSA"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosBBSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosBBSAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos B BSA",
        "label": "Kreos B BSA [Member]",
        "documentation": "Kreos B BSA"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosCBSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosCBSAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos C BSA",
        "label": "Kreos C BSA [Member]",
        "documentation": "Kreos C BSA"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretBondLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretBondLoansMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret bond loans",
        "label": "Kreos &amp; Claret bond loans [Member]",
        "documentation": "Kreos &amp; Claret bond loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingAndHeightsConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingAndHeightsConvertibleNotesMember",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret financing and Heights convertible notes",
        "label": "Kreos &amp; Claret Financing And Heights Convertible Notes [Member]",
        "documentation": "Kreos &amp; Claret Financing And Heights Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingBSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingBSAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos / Claret BSA",
        "label": "Kreos &amp; Claret Financing, BSA [Member]",
        "documentation": "Kreos &amp; Claret Financing, BSA"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret financing",
        "label": "Kreos &amp; Claret Financing [Member]",
        "documentation": "Kreos &amp; Claret Financing"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret financing, tranche B and C",
        "label": "Kreos &amp; Claret Financing, Senior Secured Non-Convertible Loans [Member]",
        "documentation": "Kreos &amp; Claret Financing, Senior Secured Non-Convertible Loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingTrancheABAndCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingTrancheABAndCMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret Financing, Tranche A,B and C",
        "label": "Kreos &amp; Claret Financing, Tranche A,B and C [Member]",
        "documentation": "Kreos &amp; Claret Financing, Tranche A,B and C"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingTrancheABMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingTrancheABMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret financing, tranche A-B",
        "label": "Kreos &amp; Claret Financing, Tranche A-B [Member]",
        "documentation": "Kreos &amp; Claret Financing, Tranche A-B"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingTrancheAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingTrancheAMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos / Claret convertible notes (OCABSA)",
        "verboseLabel": "Kreos &amp; Claret financing, tranche A",
        "netLabel": "Kreos/Claret BSA",
        "label": "Kreos &amp; Claret Financing, Tranche A [Member]",
        "documentation": "Kreos &amp; Claret Financing, Tranche A"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingTrancheBAndCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingTrancheBAndCMember",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret financing, tranche B and C",
        "label": "Kreos &amp; Claret Financing, Tranche B and C [Member]",
        "documentation": "Kreos &amp; Claret Financing, Tranche B and C"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingTrancheBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingTrancheBMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret financing, tranche B",
        "label": "Kreos &amp; Claret Financing, Tranche B [Member]",
        "documentation": "Kreos &amp; Claret Financing, Tranche B"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretFinancingTrancheCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretFinancingTrancheCMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret financing, tranche C",
        "label": "Kreos &amp; Claret Financing, Tranche C [Member]",
        "documentation": "Kreos &amp; Claret Financing, Tranche C"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_KreosClaretMinimumReturnIndemnificationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "KreosClaretMinimumReturnIndemnificationsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kreos &amp; Claret minimum return indemnifications",
        "verboseLabel": "Kreos/Claret Minimum Return Indemnifications",
        "label": "Kreos &amp; Claret Minimum Return Indemnifications [Member]",
        "documentation": "Kreos &amp; Claret Minimum Return Indemnifications"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LONGER THAN 5 YEARS",
        "label": "Later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r170",
      "r260",
      "r263",
      "r265"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FROM 1 TO 2 YEARS",
        "label": "Later than one year and not later than two years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r170",
      "r260",
      "r265",
      "r387"
     ]
    },
    "ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanTwoYearsAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FROM 2 TO 5 YEARS",
        "label": "Later than two years and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than two years and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "abvx_LeaseBreakClausePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseBreakClausePeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, break clause period",
        "label": "Lease, Break Clause Period",
        "documentation": "Lease, Break Clause Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeaseDurationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseDurationPeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, duration period",
        "label": "Lease, Duration Period",
        "documentation": "Lease, Duration Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeaseExtensionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseExtensionPeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, extension period",
        "label": "Lease, Extension Period",
        "documentation": "Lease, Extension Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeaseFacilitiesBostonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseFacilitiesBostonMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease facilities, Boston",
        "label": "Lease Facilities, Boston [Member]",
        "documentation": "Lease Facilities, Boston"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeaseFacilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseFacilitiesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease facilities",
        "label": "Lease Facilities [Member]",
        "documentation": "Lease Facilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeaseFacilitiesMontpellierMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseFacilitiesMontpellierMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease facilities, Montpellier",
        "label": "Lease Facilities, Montpellier [Member]",
        "documentation": "Lease Facilities, Montpellier"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeaseFacilitiesParisMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseFacilitiesParisMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease facilities, Paris",
        "label": "Lease Facilities, Paris [Member]",
        "documentation": "Lease Facilities, Paris"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofvariationinleaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Lease liabilities at beginning of period",
        "periodEndLabel": "Lease liabilities at end of period",
        "terseLabel": "Lease liabilities",
        "label": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Lease liabilities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r237",
      "r241"
     ]
    },
    "abvx_LeaseLiabilityPercentageOfTotal": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseLiabilityPercentageOfTotal",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability, percentage of total",
        "label": "Lease Liability, Percentage Of Total",
        "documentation": "Lease Liability, Percentage Of Total"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeaseTacitRenewalPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeaseTacitRenewalPeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, tacit renewal period",
        "label": "Lease, Tacit Renewal Period",
        "documentation": "Lease, Tacit Renewal Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_LeasesRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LeasesRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Leases Related Temporary Differences [Member]",
        "documentation": "Leases Related Temporary Differences"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities",
        "label": "Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r144",
      "r145",
      "r147",
      "r206",
      "r209"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Liabilities arising from financing activities at beginning of period",
        "periodEndLabel": "Liabilities arising from financing activities at end of period",
        "label": "Liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities arising from financing activities [axis]",
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities arising from financing activities [domain]",
        "label": "Liabilities arising from financing activities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "abvx_LiabilitiesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LiabilitiesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Total liabilities",
        "label": "Liabilities Recognised As Of Acquisition Date",
        "documentation": "Liabilities Recognised As Of Acquisition Date"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Net defined benefit liability (asset) at beginning of period",
        "periodEndLabel": "Net defined benefit liability (asset) at end of period",
        "label": "Net defined benefit liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_LicencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LicencesMember",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LICENCES",
        "label": "Licences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "abvx_LoanGrantedAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LoanGrantedAssetsAcquisitions",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan granted to Prosynergia in 2021",
        "label": "Loan Granted, Assets Acquisitions",
        "documentation": "Loan Granted, Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LongtermDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentFinancialAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits",
        "label": "Long-term deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of long-term deposits held by the entity."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "abvx_LossesArisingFromDerecognitionOfFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LossesArisingFromDerecognitionOfFinancialLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on derecognition of financial liabilities",
        "label": "Losses Arising From Derecognition Of Financial Liabilities",
        "documentation": "Losses Arising From Derecognition Of Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LossesOnChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LossesOnChangeInFairValueOfDerivatives",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase in fair value",
        "negatedTerseLabel": "Increase in derivatives fair value",
        "label": "Losses on change in fair value of derivatives"
       }
      },
      "en": {
       "role": {
        "documentation": "The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "abvx_LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Increase in other liabilities at fair value through profit and loss",
        "label": "Losses On Financial Liabilities At Fair Value Through Profit Or Loss",
        "documentation": "Losses On Financial Liabilities At Fair Value Through Profit Or Loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MachineryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MachineryMember",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUIPMENT",
        "label": "Machinery [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "abvx_MajorRevenueTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MajorRevenueTransactionsMember",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major revenue transactions",
        "label": "Major Revenue Transactions [Member]",
        "documentation": "Major Revenue Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_MajorShareBasedTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MajorShareBasedTransactionsMember",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major share-based transactions",
        "label": "Major Share-Based Transactions [Member]",
        "documentation": "Major Share-Based Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ManagementMember",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Key magement",
        "label": "Management [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_MarketCapitalizationMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MarketCapitalizationMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market capitalization",
        "label": "Market Capitalization, Measurement Input [Member]",
        "documentation": "Market Capitalization, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_MarketRateMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MarketRateMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market rate",
        "label": "Market Rate, Measurement Input [Member]",
        "documentation": "Market Rate, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityAnalysisForDerivativeFinancialLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of remaining contractual maturities of derivative financial liabilities",
        "label": "Disclosure of maturity analysis for derivative financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityAnalysisForNonderivativeFinancialLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of remaining contractual maturities of non-derivative financial liabilities",
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity [axis]",
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r151",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r170",
      "r182",
      "r193",
      "r227",
      "r260"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity [domain]",
        "label": "Maturity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r151",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r170",
      "r182",
      "r227",
      "r260",
      "r264"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of shares to be issued if all conditions are met (in shares)",
        "label": "Maximum Number Of Other Equity Instruments To Be Issued In Share-Based Payment Arrangement If All Conditions Are Met",
        "documentation": "Maximum Number Of Other Equity Instruments To Be Issued In Share-Based Payment Arrangement If All Conditions Are Met"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_MaximumNumberOfSharesToBeIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MaximumNumberOfSharesToBeIssued",
     "presentation": [
      "http://www.abivax.com/role/IncomelosspershareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of shares to be issued (in shares)",
        "label": "Maximum Number Of Shares To Be Issued",
        "documentation": "Maximum Number Of Shares To Be Issued"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "ifrs-full_MeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MeasurementAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement [axis]",
        "label": "Measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r107",
      "r144"
     ]
    },
    "ifrs-full_MeasurementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MeasurementDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement [domain]",
        "label": "Measurement [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r107",
      "r144"
     ]
    },
    "abvx_MinimalReturnMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MinimalReturnMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimal return",
        "label": "Minimal Return, Measurement Input [Member]",
        "documentation": "Minimal Return, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MiscellaneousOtherOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expenses",
        "label": "Miscellaneous other operating expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_MiscellaneousOtherOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MiscellaneousOtherOperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Miscellaneous other operating income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "abvx_MonteCarloModel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MonteCarloModel1Member",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monte Carlo Model",
        "label": "Monte Carlo Model1 [Member]",
        "documentation": "Monte Carlo Model"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_MonteCarloModelIFRSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "MonteCarloModelIFRSMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monte Carlo model",
        "label": "Monte Carlo Model IFRS [Member]",
        "documentation": "Monte Carlo Model IFRS"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NetDefinedBenefitLiabilityAssetAxis",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net defined benefit liability (asset) [axis]",
        "label": "Net defined benefit liability (asset) [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NetDefinedBenefitLiabilityAssetDomain",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net defined benefit liability (asset) [domain]",
        "label": "Net defined benefit liability (asset) [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NetProceedsFromConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NetProceedsFromConvertibleLoansNotes",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from the issuance of convertible bond loans",
        "label": "Net Proceeds From Convertible Loans Notes",
        "documentation": "Net Proceeds From Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NetProceedsFromNonConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NetProceedsFromNonConvertibleLoansNotes",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from the issuance of non-convertible bond loans",
        "label": "Net Proceeds From Non-Convertible Loans Notes",
        "documentation": "Net Proceeds From Non-Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NetProceedsFromSaleOfRoyaltyCertificates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NetProceedsFromSaleOfRoyaltyCertificates",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from sale of royalty certificates",
        "label": "Net Proceeds From Sale Of Royalty Certificates",
        "documentation": "Net Proceeds From Sale Of Royalty Certificates"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No Trading Symbol Flag",
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NonCurrentAdvancesToCROContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NonCurrentAdvancesToCROContracts",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentFinancialAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advances related to CRO contracts",
        "label": "Non-Current Advances To CRO Contracts",
        "documentation": "Non-Current Advances To CRO Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NonCurrentAdvancesToCROContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NonCurrentAdvancesToCROContractsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term advances made to CROs",
        "label": "Non-Current Advances To CRO Contracts [Member]",
        "documentation": "Non-Current Advances To CRO Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NonCurrentConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NonCurrentConvertibleLoansNotes",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible loan notes",
        "negatedLabel": "Non-current convertible loans notes",
        "verboseLabel": "Non-current convertible loans notes",
        "label": "Non-Current Convertible Loans Notes",
        "documentation": "Non-Current Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NonCurrentFinancialLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NonCurrentFinancialLiabilitiesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities-non current portion",
        "label": "Non-Current Financial Liabilities [Member]",
        "documentation": "Non-Current Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NonCurrentPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NonCurrentPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses - non current",
        "label": "Non-Current Prepaid Expenses",
        "documentation": "Non-Current Prepaid Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NonCurrentRoyaltyCertificates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NonCurrentRoyaltyCertificates",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty certificates",
        "label": "Non-Current Royalty Certificates",
        "documentation": "Non-Current Royalty Certificates"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r305",
      "r315",
      "r339",
      "r348"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-adjusting events after reporting period [axis]",
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-adjusting events after reporting period [domain]",
        "label": "Non-adjusting events after reporting period [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r133",
      "r242"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current assets",
        "label": "Non-current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentDerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentDerivativeFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "label": "Non-current derivative financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current financial liabilities",
        "label": "Non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "label": "Non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r23",
      "r135",
      "r242"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current liabilities",
        "label": "Non-current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentPortionOfOtherNoncurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Non-current portion of other non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current other borrowings. [Refer: Other borrowings]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement benefit obligations",
        "label": "Non-current provisions for employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LESS THAN 1 YEAR",
        "label": "Not later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r159",
      "r160",
      "r170",
      "r260",
      "r265"
     ]
    },
    "ifrs-full_NotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotionalAmount",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional amount",
        "verboseLabel": "Original principal amount",
        "label": "Notional amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "abvx_NumberOfADSPerOrdinaryShares": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfADSPerOrdinaryShares",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of ADS per ordinary shares (in shares)",
        "label": "Number of ADS per Ordinary Shares",
        "documentation": "Number of ADS per Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfAcademicInstitutions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfAcademicInstitutions",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of academic institutions",
        "label": "Number Of Academic Institutions",
        "documentation": "Number Of Academic Institutions"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfConvertibleNotesIssued": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfConvertibleNotesIssued",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of convertible notes issued (in shares)",
        "label": "Number Of Convertible Notes Issued",
        "documentation": "Number Of Convertible Notes Issued"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfConvertibleNotesOutstanding": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfConvertibleNotesOutstanding",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of outstanding notes (in shares)",
        "label": "Number Of Convertible Notes Outstanding",
        "documentation": "Number Of Convertible Notes Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfExclusiveLicenses": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfExclusiveLicenses",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of exclusive licenses",
        "label": "Number Of Exclusive Licenses",
        "documentation": "Number Of Exclusive Licenses"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfFinancialInstitutionsToMaintainCash": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfFinancialInstitutionsToMaintainCash",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of financial institutions to maintain cash",
        "label": "Number Of Financial Institutions To Maintain Cash",
        "documentation": "Number Of Financial Institutions To Maintain Cash"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfFreeSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfFreeSharesIssued",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of free shares (in shares)",
        "label": "Number Of Free Shares Issued",
        "documentation": "Number Of Free Shares Issued"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfFreeSharesPlansIssued": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfFreeSharesPlansIssued",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of free shares plans issued",
        "label": "Number Of Free Shares Plans Issued",
        "documentation": "Number Of Free Shares Plans Issued"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments granted, percentage exercisable immediately",
        "label": "Number Of Instruments Granted, Other Equity Instruments, Percentage Exercisable Immediately",
        "documentation": "Number Of Instruments Granted, Other Equity Instruments, Percentage Exercisable Immediately"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments granted, remaining percentage exercisable",
        "label": "Number Of Instruments Granted, Other Equity Instruments, Remaining Percentage Exercisable",
        "documentation": "Number Of Instruments Granted, Other Equity Instruments, Remaining Percentage Exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments issued (in shares)",
        "verboseLabel": "NUMBE OF BSAs ( in shares)",
        "label": "Number of other equity instruments granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r418"
     ]
    },
    "ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented",
     "presentation": [
      "http://www.abivax.com/role/IncomelosspershareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments that are antidilutive in period presented (in shares)",
        "label": "Number of instruments that are antidilutive in period presented"
       }
      },
      "en": {
       "role": {
        "documentation": "Number of (units of) instruments that are antidilutive in the period presented."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "abvx_NumberOfOperatingSegment": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfOperatingSegment",
     "presentation": [
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segment",
        "documentation": "Number of Operating Segment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments exercisable (in shares)",
        "label": "Number of other equity instruments exercisable in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Number of instruments exercised (in shares)",
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments lapsed (in shares)",
        "negatedTerseLabel": "Number of instruments lapsed (in shares)",
        "label": "Number of other equity instruments expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments issued subject to non-market performance condition (in shares)",
        "label": "Number Of Other Equity Instruments Granted Subject To Non-Market Performance Condition",
        "documentation": "Number Of Other Equity Instruments Granted Subject To Non-Market Performance Condition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of instruments outstanding, beginning balance (in shares)",
        "periodEndLabel": "Number of instruments outstanding, ending balance (in shares)",
        "label": "Number of other equity instruments outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "abvx_NumberOfOtherShareWarrantsConverted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfOtherShareWarrantsConverted",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of other share warrants converted (in shares)",
        "label": "Number Of Other Share Warrants Converted",
        "documentation": "Number Of Other Share Warrants Converted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfOtherShareWarrantsRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfOtherShareWarrantsRepurchased",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of other share warrants repurchased (in shares)",
        "label": "Number Of Other Share Warrants Repurchased",
        "documentation": "Number Of Other Share Warrants Repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfProbabilityWeightedScenarios": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfProbabilityWeightedScenarios",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of probability-weighted scenarios",
        "label": "Number Of Probability-Weighted Scenarios",
        "documentation": "Number Of Probability-Weighted Scenarios"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfProjectsTerminated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfProjectsTerminated",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of projects terminated",
        "label": "Number Of Projects Terminated",
        "documentation": "Number Of Projects Terminated"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfShareBasedCompensationPlansIssued": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfShareBasedCompensationPlansIssued",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share-based compensation plans issued",
        "label": "Number Of Share-Based Compensation Plans Issued",
        "documentation": "Number Of Share-Based Compensation Plans Issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of shares issued at beginning of period (in shares)",
        "periodEndLabel": "Number of shares issued at end of period (in shares)",
        "terseLabel": "Number of shares issued (in shares)",
        "label": "Number of shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares outstanding (in shares)",
        "label": "Number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "abvx_NumberOfSharesReceivedPerADS": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfSharesReceivedPerADS",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares received per ADS (in shares)",
        "label": "Number Of Shares Received Per ADS",
        "documentation": "Number Of Shares Received Per ADS"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfSharesSubscribedPerWarrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfSharesSubscribedPerWarrant",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares subscribed per warrant (in shares)",
        "label": "Number Of Shares Subscribed Per Warrant",
        "documentation": "Number Of Shares Subscribed Per Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfTreasurySharesHeld": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfTreasurySharesHeld",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of treasury shares held (in shares)",
        "label": "Number Of Treasury Shares Held",
        "documentation": "Number Of Treasury Shares Held"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfWarrantsExercised",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants exercised (in shares)",
        "label": "Number Of Warrants Exercised",
        "documentation": "Number Of Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfWarrantsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfWarrantsGranted",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants granted (in shares)",
        "label": "Number Of Warrants Granted",
        "documentation": "Number Of Warrants Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfWarrantsOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfWarrantsOutstanding",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of outstanding warrants (in shares)",
        "label": "Number Of Warrants Outstanding",
        "documentation": "Number Of Warrants Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of outstanding warrants subject to non-market performance condition (in shares)",
        "label": "Number Of Warrants Outstanding Subject To Non-Market Performance Condition",
        "documentation": "Number Of Warrants Outstanding Subject To Non-Market Performance Condition"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OCEANEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OCEANEMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Oceane",
        "label": "OCEANE [Member]",
        "documentation": "OCEANE"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OceaneConversionOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OceaneConversionOptionMember",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Oceane conversion option",
        "verboseLabel": "OCEANE conversion option",
        "label": "Oceane Conversion Option [Member]",
        "documentation": "Oceane Conversion Option"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OffBalanceSheetCommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OffBalanceSheetCommitmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Off-Balance Sheet Commitments [Abstract]",
        "documentation": "Off-Balance Sheet Commitments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office equipment",
        "label": "Office equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "ifrs-full_OperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total operating expenses",
        "totalLabel": "Operating expenses",
        "terseLabel": "Operating expense",
        "label": "Operating expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "ifrs-full_OptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OptionPricingModelMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option pricing model",
        "label": "Option pricing model [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a specific valuation technique consistent with the income approach that involves analysing future amounts with option pricing models, such as the Black-Scholes-Merton formula or a binominal model (ie a lattice model), that incorporate present value techniques and reflect both the time value and intrinsic value of an option. [Refer: Income approach [member]]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r251"
     ]
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "label": "Ordinary shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "abvx_OrdinarySharesNASDAQGlobalMarketMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OrdinarySharesNASDAQGlobalMarketMember",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, nominal value \u20ac0.01 per share",
        "label": "Ordinary Shares, NASDAQ Global Market [Member]",
        "documentation": "Ordinary Shares, NASDAQ Global Market [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherAdjustmentsForNoncashItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherAdjustmentsForNoncashItems",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other adjustments for non-cash items"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "ifrs-full_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other receivables and other assets",
        "label": "Other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_OtherCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notice accounts",
        "label": "Other cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss)",
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r32",
      "r36",
      "r137"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation differences",
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r36"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial gains and losses on retirement benefit obligations",
        "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [domain]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r36",
      "r401"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Items that are or may be reclassified subsequently to profit or loss",
        "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r221",
      "r222"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Items that will not be reclassified to profit or loss",
        "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r221",
      "r222"
     ]
    },
    "ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Other current borrowings and current portion of other non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current other borrowings and the current portion of non-current other borrowings. [Refer: Other borrowings]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_OtherCurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherCurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherFinancialAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "totalLabel": "Total other current financial assets",
        "label": "Other current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "ifrs-full_OtherCurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherCurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial liabilities",
        "label": "Other current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r139"
     ]
    },
    "abvx_OtherCurrentInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherCurrentInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherCurrentFinancialAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other investments",
        "label": "Other Current Investments",
        "documentation": "Other Current Investments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherCurrentPayablesIncludingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherCurrentPayablesIncludingAdjustments",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Current Payables, Including Adjustments",
        "documentation": "Other Current Payables, Including Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherEmployeesMember",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other employees",
        "label": "Other Employees [Member]",
        "documentation": "Other Employees"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherEquityAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherEquityAgreementsMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other equity agreement",
        "label": "Other Equity Agreements [Member]",
        "documentation": "Other Equity Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherFinanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherFinanceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Other finance cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_OtherFinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherFinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial income",
        "label": "Other finance income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_OtherFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other financial assets",
        "label": "Other financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "abvx_OtherFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialAssetsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "label": "Other Financial Assets [Member]",
        "documentation": "Other Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual percentage of proceeds from sale of intellectual property right",
        "label": "Other Financial Liabilities, Annual Percentage Of Proceeds From Sale Of Intellectual Property Right",
        "documentation": "Other Financial Liabilities, Annual Percentage Of Proceeds From Sale Of Intellectual Property Right"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual revenue from sale of products developed, period",
        "label": "Other Financial Liabilities, Annual Revenue From Sale Of Products Developed, Period",
        "documentation": "Other Financial Liabilities, Annual Revenue From Sale Of Products Developed, Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesMaximumDrawdownCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum drawdown capacity",
        "label": "Other Financial Liabilities, Maximum Drawdown Capacity",
        "documentation": "Other Financial Liabilities, Maximum Drawdown Capacity"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum drawdown capacity including interest",
        "label": "Other Financial Liabilities, Maximum Drawdown Capacity Including Interest",
        "documentation": "Other Financial Liabilities, Maximum Drawdown Capacity Including Interest"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial liabilities",
        "label": "Other Financial Liabilities [Member]",
        "documentation": "Other Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual revenue from sale of products developed",
        "label": "Other Financial Liabilities, Payable, Annual Revenue From Sale Of Products Developed",
        "documentation": "Other Financial Liabilities, Payable, Annual Revenue From Sale Of Products Developed"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of annual revenue from sale of products developed",
        "label": "Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed",
        "documentation": "Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-tax revenue threshold",
        "label": "Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed, Pre-Tax Revenue Threshold",
        "documentation": "Other Financial Liabilities, Percentage Of Annual Revenue From Sale Of Products Developed, Pre-Tax Revenue Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial liabilities",
        "label": "Other Financial Liabilities Related Temporary Differences [Member]",
        "documentation": "Other Financial Liabilities Related Temporary Differences"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherFinancialLiabilitiesRepaymentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherFinancialLiabilitiesRepaymentPeriod",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment period",
        "label": "Other Financial Liabilities, Repayment Period",
        "documentation": "Other Financial Liabilities, Repayment Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_RevenueAndOperatingIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating income",
        "totalLabel": "Total operating income",
        "label": "Other income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r216",
      "r217"
     ]
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other inflows (outflows) of cash, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other intangible assets",
        "label": "Other intangible assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "abvx_OtherLiabilitiesNumberOfTransactions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherLiabilitiesNumberOfTransactions",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities, number of transactions",
        "label": "Other Liabilities, Number Of Transactions",
        "documentation": "Other Liabilities, Number Of Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherLongtermProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherLongtermProvisions",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions",
        "label": "Other non-current provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "abvx_OtherNonCurrentMiscellaneousFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherNonCurrentMiscellaneousFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentFinancialAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Non-Current Miscellaneous Financial Assets",
        "documentation": "Other Non-Current Miscellaneous Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails": {
       "parentTag": "ifrs-full_OtherAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsDisclosureofotherreceivablesandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current other assets",
        "label": "Other non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_OtherNoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherFinancialAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "totalLabel": "Total other non-current financial assets",
        "label": "Other non-current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "ifrs-full_OtherNoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial liabilities",
        "label": "Other non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r140"
     ]
    },
    "ifrs-full_OtherNoncurrentNonfinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentNonfinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other non-current non-financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "abvx_OtherReceivablesAndAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherReceivablesAndAssetsMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables and assets",
        "label": "Other Receivables And Assets [Member]",
        "documentation": "Other Receivables And Assets"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherShareWarrantsExercisePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherShareWarrantsExercisePeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other share warrants, exercise period",
        "label": "Other Share Warrants, Exercise Period",
        "documentation": "Other Share Warrants, Exercise Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_OtherShareWarrantsSubscriptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "OtherShareWarrantsSubscriptionPricePerShare",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other share warrants, subscripion price per share (in euro per share)",
        "label": "Other Share Warrants, Subscription Price Per Share",
        "documentation": "Other Share Warrants, Subscription Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherShorttermProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherShorttermProvisions",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions",
        "label": "Other current provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ifrs-full_OtherTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherTemporaryDifferencesMember",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other items",
        "label": "Other temporary differences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences that the entity does not separately disclose in the same statement or note. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r292",
      "r303",
      "r313",
      "r346"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r306",
      "r316",
      "r349"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r306",
      "r316",
      "r349"
     ]
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/ShareholdersequitySharecapitalissuedDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Par value per share (in euro per share)",
        "label": "Par value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "abvx_PaymentsForAdvancesMadeToContractResearchOrganizations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PaymentsForAdvancesMadeToContractResearchOrganizations",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Advances made to CROs",
        "terseLabel": "Cash advances and loans made to CRO",
        "label": "Payments For Advances Made to Contract Research Organizations",
        "documentation": "Payments For Advances Made to Contract Research Organizations"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_PaymentsForAssetsAcquisitionsCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PaymentsForAssetsAcquisitionsCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for assets acquisition costs",
        "label": "Payments For Assets Acquisitions Costs",
        "documentation": "Payments For Assets Acquisitions Costs"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments for the acquisition of Prosynergia, incl. related costs, net of cash acquired",
        "label": "Payments For Assets Acquisitions, Including Related Costs, Net Of Cash Acquired",
        "documentation": "Payments For Assets Acquisitions, Including Related Costs, Net Of Cash Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsForDebtIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsForDebtIssueCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for debt issue costs",
        "label": "Payments for debt issue costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for debt issue costs."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "abvx_PaymentsForProceedsFromShareIssueRelatedCostsCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PaymentsForProceedsFromShareIssueRelatedCostsCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transaction costs related to capital increase",
        "label": "Payments For (Proceeds From) Share Issue Related Costs (Credit)",
        "documentation": "Payments For (Proceeds From) Share Issue Related Costs (Credit)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsForShareIssueCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for share issue costs",
        "label": "Payments for share issue costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsFromPlanNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefits paid",
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments of the lease liabilities",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "abvx_PeakPenetrationMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PeakPenetrationMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peak penetration",
        "label": "Peak Penetration, Measurement Input [Member]",
        "documentation": "Peak Penetration, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "abvx_PercentageOfConditionalAdvancesWaived": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PercentageOfConditionalAdvancesWaived",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of conditional advances waived",
        "label": "Percentage Of Conditional Advances Waived",
        "documentation": "Percentage Of Conditional Advances Waived"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedNetLabel": "Percentage of reasonably possible decrease in unobservable input, liabilities",
        "label": "Percentage of reasonably possible decrease in unobservable input, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of a reasonably possible decrease in an unobservable input used in fair value measurement of liabilities."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of reasonably possible increase in unobservable input, assets",
        "label": "Percentage of reasonably possible increase in unobservable input, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of reasonably possible increase in unobservable input, liabilities",
        "label": "Percentage of reasonably possible increase in unobservable input, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of liabilities."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "ifrs-full_PresentValueOfDefinedBenefitObligationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PresentValueOfDefinedBenefitObligationMember",
     "presentation": [
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofchangesinprojectedbenefitobligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RETIREMENT BENEFIT OBLIGATIONS",
        "label": "Present value of defined benefit obligation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the present value of a defined benefit obligation. The present value of a defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "abvx_PretGarantiParLEtatPGEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PretGarantiParLEtatPGEMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PGE",
        "label": "Pr\u00eat Garanti Par l'Etat (PGE) [Member]",
        "documentation": "Pr\u00eat Garanti Par l'Etat (PGE)"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_PrincipalAgreementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PrincipalAgreementsAxis",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal Agreements [Axis]",
        "label": "Principal Agreements [Axis]",
        "documentation": "Principal Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_PrincipalAgreementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "PrincipalAgreementsDomain",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal Agreements [Domain]",
        "label": "Principal Agreements [Domain]",
        "documentation": "Principal Agreements [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ProbabilityOfSuccessMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProbabilityOfSuccessMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "POS",
        "label": "Probability Of Success, Measurement Input [Member]",
        "documentation": "Probability Of Success, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from borrowings",
        "label": "Proceeds from borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "abvx_ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from borrowings, net of refinancing of existing indebteness",
        "label": "Proceeds From Borrowings, Net Of Refinancing Of Existing Indebteness",
        "documentation": "Proceeds From Borrowings, Net Of Refinancing Of Existing Indebteness"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ProceedsFromConditionalAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProceedsFromConditionalAdvances",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from conditional advances",
        "label": "Proceeds From Conditional Advances",
        "documentation": "Proceeds From Conditional Advances"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from government grants",
        "label": "Proceeds from government grants, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital increases",
        "label": "Proceeds from issuing shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r233"
     ]
    },
    "abvx_ProceedsFromIssuingSharesAndConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProceedsFromIssuingSharesAndConvertibleLoansNotes",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuing shares and convertible loan notes",
        "label": "Proceeds From Issuing Shares And Convertible Loans Notes",
        "documentation": "Proceeds From Issuing Shares And Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital increases",
        "label": "Proceeds From Issuing Shares Other Than Through Exercise Of Warrants",
        "documentation": "Proceeds From Issuing Shares Other Than Through Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ProceedsFromReimbursementsOfDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProceedsFromReimbursementsOfDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in Deposits",
        "label": "Proceeds From Reimbursements Of Deposits",
        "documentation": "Proceeds From Reimbursements Of Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ProceedsFromResearchTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProceedsFromResearchTaxCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from research tax credit",
        "label": "Proceeds From Research Tax Credit",
        "documentation": "Proceeds From Research Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromSaleOrIssueOfTreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from sale of treasury shares",
        "label": "Proceeds from sale or issue of treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfessionalFeesExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofgeneralandadministrativeexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting and professional fees",
        "label": "Professional fees expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 12.0
      },
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss for the period",
        "terseLabel": "Net loss for the period",
        "negatedLabel": "Net loss",
        "label": "Profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r31",
      "r110",
      "r127",
      "r129",
      "r206",
      "r207",
      "r242",
      "r254"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss before tax",
        "label": "Profit (loss) before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r179",
      "r216",
      "r217",
      "r267",
      "r268"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Profit (loss) from operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r228",
      "r396"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentIncludingRightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "periodStartLabel": "Property, plant and equipment including right-of-use assets at beginning of period",
        "periodEndLabel": "Property, plant and equipment including right-of-use assets at end of period",
        "label": "Property, plant and equipment including right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment including right-of-use assets whose underlying assets would be presented as property, plant and equipment if they were owned. [Refer: Property, plant and equipment; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r153",
      "r390",
      "r400"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment including right-of-use assets [axis]",
        "label": "Property, plant and equipment including right-of-use assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment including right-of-use assets [domain]",
        "label": "Property, plant and equipment including right-of-use assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of asset representing property, plant and equipment including right-of-use assets whose underlying assets would be presented as property, plant and equipment if they were owned. [Refer: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of ownership interest in subsidiary",
        "label": "Proportion of ownership interest in subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r76",
      "r131"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of ownership interests held by non-controlling interests",
        "label": "Proportion of ownership interests held by non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "abvx_ProsynergiaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ProsynergiaMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prosynergia",
        "label": "Prosynergia [Member]",
        "documentation": "Prosynergia"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisitions of intangible assets",
        "label": "Purchase of intangible assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisitions of property, plant and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "abvx_RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RNP-VIR conditional advance and CARENA conditional advance",
        "label": "RNP-VIR Conditional Advance, BPI And CARENA Conditional Advance, BPI [Member]",
        "documentation": "RNP-VIR Conditional Advance, BPI And CARENA Conditional Advance, BPI"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RNPVIRConditionalAdvanceBPIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RNPVIRConditionalAdvanceBPIMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofconditionaladvancesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails",
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RNP-VIR conditional advance",
        "verboseLabel": "RNP VIR \u2013 Bpifrance",
        "label": "RNP-VIR Conditional Advance, BPI [Member]",
        "documentation": "RNP-VIR Conditional Advance, BPI"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails",
      "http://www.abivax.com/role/SegmentinformationDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [axis]",
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r150",
      "r164",
      "r172",
      "r249",
      "r251",
      "r420"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails",
      "http://www.abivax.com/role/SegmentinformationDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [domain]",
        "label": "Range [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r150",
      "r164",
      "r172",
      "r249",
      "r251",
      "r420"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OtherreceivablesandotherassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of prepaid expenses to carrying value of debt component",
        "label": "Reclassification of Prepaid Expenses to Carrying Value of Debt Component",
        "documentation": "Reclassification of Prepaid Expenses to Carrying Value of Debt Component"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RecognisedLiabilitiesDefinedBenefitPlan",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net defined benefit liability",
        "label": "Net defined benefit liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract",
     "presentation": [
      "http://www.abivax.com/role/IntangibleassetsDisclosureofreconciliationofintangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of changes in intangible assets other than goodwill [abstract]",
        "label": "Reconciliation of changes in intangible assets other than goodwill [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of changes in property, plant and equipment [abstract]",
        "label": "Reconciliation of changes in property, plant and equipment [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReconciliationOfNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of number of shares outstanding [abstract]",
        "label": "Reconciliation of number of shares outstanding [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r287",
      "r298",
      "r308",
      "r341"
     ]
    },
    "ifrs-full_RecurringFairValueMeasurementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RecurringFairValueMeasurementMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recurring fair value measurement",
        "label": "Recurring fair value measurement [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for fair value measurements which other IFRSs require or permit in the statement of financial position at the end of each reporting period. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "abvx_RegisteredDirectOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RegisteredDirectOfferingMember",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registered direct offering",
        "label": "Registered Direct Offering [Member]",
        "documentation": "Registered Direct Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party transactions [abstract]",
        "label": "Related party transactions [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RemeasurementPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RemeasurementPeriodAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement Period [Axis]",
        "label": "Remeasurement Period [Axis]",
        "documentation": "Remeasurement Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RemeasurementPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RemeasurementPeriodDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement Period [Domain]",
        "label": "Remeasurement Period [Domain]",
        "documentation": "Remeasurement Period [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RepaymentOfExcessConditionalAdvancesClaimed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RepaymentOfExcessConditionalAdvancesClaimed",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excess conditional advances claimed",
        "label": "Repayment Of Excess Conditional Advances Claimed",
        "documentation": "Repayment Of Excess Conditional Advances Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RepaymentsOfBondLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RepaymentsOfBondLoans",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of non-convertible bond loans",
        "terseLabel": "Repayments of bond loans",
        "label": "Repayments Of Bond Loans",
        "documentation": "Repayments Of Bond Loans"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RepaymentsOfConditionalAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RepaymentsOfConditionalAdvances",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of conditional advances",
        "terseLabel": "Repayments of conditional advances",
        "label": "Repayments Of Conditional Advances",
        "documentation": "Repayments Of Conditional Advances"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RepaymentsOfConvertibleLoansNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RepaymentsOfConvertibleLoansNotes",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of convertible bond loans",
        "terseLabel": "Repayments of convertible loan notes",
        "label": "Repayments Of Convertible Loans Notes",
        "documentation": "Repayments Of Convertible Loans Notes"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RepaymentsOfPGE": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RepaymentsOfPGE",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of PGE",
        "label": "Repayments Of PGE",
        "documentation": "Repayments Of PGE"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RepurchaseOfDerivativeInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RepurchaseOfDerivativeInstruments",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesChangeinfinancialliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofchangesinderivativeinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchases",
        "negatedLabel": "Repurchases",
        "label": "Repurchase Of Derivative Instruments",
        "documentation": "Repurchase Of Derivative Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ResearchAgreementWithUniversityHospitalCenterOfNiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ResearchAgreementWithUniversityHospitalCenterOfNiceMember",
     "presentation": [
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research agreement with University Hospital Center of Nice",
        "label": "Research Agreement With University Hospital Center Of Nice [Member]",
        "documentation": "Research Agreement With University Hospital Center Of Nice"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ResearchAndCollaborationAgreementWithCNRSAndUniversityOfMontpellierMember",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and collaboration agreement with CNRS and University of Montpellier",
        "label": "Research And Collaboration Agreement With CNRS And University Of Montpellier [Member]",
        "documentation": "Research And Collaboration Agreement With CNRS And University Of Montpellier"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and collaboration agreement with CNRS, University of Montpellier and Institut Curie",
        "label": "Research And Collaboration Agreement With CNRS, University Of Montpellier And Institut Curie [Member]",
        "documentation": "Research And Collaboration Agreement With CNRS, University Of Montpellier And Institut Curie"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ResearchAndDevelopmentContractWithLicenseOptionWithCNRSUniversityOfMontpellierAndTheradiagMember",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development contract with license option with CNRS, University of Montpellier and Theradiag",
        "label": "Research And Development Contract With License Option With CNRS, University Of Montpellier And Theradiag [Member]",
        "documentation": "Research And Development Contract With License Option With CNRS, University Of Montpellier And Theradiag"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development costs recognition, initial measurement, number of criterias",
        "label": "Research And Development Costs Recognition, Initial Measurement, Number Of Criterias",
        "documentation": "Research And Development Costs Recognition, Initial Measurement, Number Of Criterias"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and development",
        "label": "Research and development expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "abvx_ResearchAndDevelopmentExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ResearchAndDevelopmentExpensesMember",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails",
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Research And Development Expenses [Member]",
        "documentation": "Research And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Translation reserves",
        "label": "Reserve of exchange differences on translation"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TRANSLATION RESERVE",
        "label": "Reserve of exchange differences on translation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r62",
      "r218"
     ]
    },
    "abvx_ResidualMaturityMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ResidualMaturityMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Residual maturity",
        "verboseLabel": "Time to maturity",
        "label": "Residual Maturity, Measurement Input [Member]",
        "documentation": "Residual Maturity, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RestatedMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currently stated [member]",
        "label": "Currently stated [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the information currently stated in the financial statements. It also represents the standard value for the 'Retrospective application and retrospective restatement' and 'Departure from requirement of IFRS' axes if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r122",
      "r123",
      "r124",
      "r163",
      "r389"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r288",
      "r299",
      "r309",
      "r342"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r289",
      "r300",
      "r310",
      "r343"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r296",
      "r307",
      "r317",
      "r350"
     ]
    },
    "ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarningsExcludingProfitLossForReportingPeriod",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained earnings, excluding profit (loss) for reporting period"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity\u2019s cumulative undistributed earnings or deficit excluding the profit or loss for the reporting period. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarningsExcludingProfitLossForReportingPeriodMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RETAINED EARNINGS",
        "label": "Retained earnings, excluding profit (loss) for reporting period [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit, excluding profit or loss for the reporting period. [Refer: Retained earnings [member]]"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "ifrs-full_RetainedEarningsProfitLossForReportingPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarningsProfitLossForReportingPeriod",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss for the period",
        "label": "Retained earnings, profit (loss) for reporting period"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity\u2019s undistributed profit or loss for the reporting period. [Refer: Retained earnings; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarningsProfitLossForReportingPeriodMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET LOSS FOR THE YEAR",
        "label": "Retained earnings, profit (loss) for reporting period [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing the entity\u2019s undistributed profit or loss for the reporting period. [Refer: Retained earnings [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "abvx_RetirementBenefitObligationsRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RetirementBenefitObligationsRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement benefit obligation",
        "label": "Retirement Benefit Obligations Related Temporary Differences [Member]",
        "documentation": "Retirement Benefit Obligations Related Temporary Differences"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetrospectiveApplicationAndRetrospectiveRestatementAxis",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retrospective application and retrospective restatement [axis]",
        "label": "Retrospective application and retrospective restatement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r122",
      "r123",
      "r124"
     ]
    },
    "ifrs-full_RevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueAndOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueAndOperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating income",
        "label": "Revenue and other operating income"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount of the entity's revenue and other operating income. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "ifrs-full_RevenueFromGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueFromGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesConditionaladvancesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesStateguaranteedloanPGEDetails",
      "http://www.abivax.com/role/OperatingincomeDisclosureofbreakdownofoperatingincomeDetails",
      "http://www.abivax.com/role/OperatingincomeNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income from government grants",
        "terseLabel": "Subsidies",
        "label": "Income from government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]"
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "ifrs-full_RevenueFromInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueFromInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from interest."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r204",
      "r210",
      "r387"
     ]
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r156"
     ]
    },
    "ifrs-full_RightofuseAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RightofuseAssetsMember",
     "presentation": [
      "http://www.abivax.com/role/PropertyplantandequipmentDisclosureofreconciliationofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ROU",
        "label": "Right-of-use assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "abvx_RiskFreeInterestRateMeasurementInputExpiryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RiskFreeInterestRateMeasurementInputExpiryMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate, expiry",
        "label": "Risk-Free Interest Rate, Measurement Input, Expiry [Member]",
        "documentation": "Risk-Free Interest Rate, Measurement Input, Expiry"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RiskFreeInterestRateMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RiskFreeInterestRateMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Risk-Free Interest Rate, Measurement Input [Member]",
        "documentation": "Risk-Free Interest Rate, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RiskFreeInterestRateMeasurementInputTenderOfferMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RiskFreeInterestRateMeasurementInputTenderOfferMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate, tender offer",
        "label": "Risk-Free Interest Rate, Measurement Input, Tender Offer [Member]",
        "documentation": "Risk-Free Interest Rate, Measurement Input, Tender Offer"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RiskFreeInterestRateOtherEquityInstrumentsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RiskFreeInterestRateOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RISK\u00a0FREE\u00a0RATE",
        "label": "Risk Free Interest Rate, Other Equity Instruments Granted",
        "documentation": "Risk Free Interest Rate, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RoyaltyCertificateExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RoyaltyCertificateExpirationPeriod",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty certificate, expiration period",
        "label": "Royalty Certificate, Expiration Period",
        "documentation": "Royalty Certificate, Expiration Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RoyaltyCertificateMaximumAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RoyaltyCertificateMaximumAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty certificate, maximum amount",
        "label": "Royalty Certificate, Maximum Amount",
        "documentation": "Royalty Certificate, Maximum Amount"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RoyaltyCertificatePercentageOfFutureSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RoyaltyCertificatePercentageOfFutureSales",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty certificate, percentage of future sales",
        "label": "Royalty Certificate, Percentage Of Future Sales",
        "documentation": "Royalty Certificate, Percentage Of Future Sales"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RoyaltyCertificatesEIR": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RoyaltyCertificatesEIR",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty certificates, EIR",
        "label": "Royalty Certificates, EIR",
        "documentation": "Royalty Certificates, EIR"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RoyaltyCertificatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RoyaltyCertificatesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesBreakdownoffinancialliabilitiesbymaturityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiesbreakdownDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofreconciliationofliabilitiesarisingfromfinancingactivitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty certificates",
        "label": "Royalty Certificates [Member]",
        "documentation": "Royalty Certificates"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_RoyaltyCertificatesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "RoyaltyCertificatesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails": {
       "parentTag": "abvx_FinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofremainingcontractualmaturitiesoffinancialliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty certificates, undiscounted cash flows",
        "label": "Royalty Certificates, Undiscounted Cash Flows",
        "documentation": "Royalty Certificates, Undiscounted Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "abvx_SaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SaleOfStockAxis",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale Of Stock [Axis]",
        "label": "Sale Of Stock [Axis]",
        "documentation": "Sale Of Stock"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_SaleOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SaleOfStockDomain",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale Of Stock [Domain]",
        "label": "Sale Of Stock [Domain]",
        "documentation": "Sale Of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SalesAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/OperatingexpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Sales and marketing",
        "terseLabel": "Sales and marketing",
        "label": "Sales and marketing expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "abvx_SalesAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SalesAndMarketingExpenseMember",
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofsalesandmarketingexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing expenses",
        "label": "Sales And Marketing Expense [Member]",
        "documentation": "Sales And Marketing Expense"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Domain]",
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reasonably possible change in risk variable, impact on foreign exchange",
        "label": "Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Foreign Exchange Gain (Loss)",
        "documentation": "Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Foreign Exchange Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reasonably possible change in risk variable, percent",
        "label": "Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percent",
        "documentation": "Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ShareBasedPaymentArrangementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ShareBasedPaymentArrangementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangements [Abstract]",
        "label": "Share-Based Payment Arrangements [Abstract]",
        "documentation": "Share-Based Payment Arrangements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShareIssueRelatedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share issue related cost",
        "verboseLabel": "Share issue related cost",
        "label": "Share issue related cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "abvx_ShareIssueRelatedCostCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ShareIssueRelatedCostCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transaction costs related to capital increase",
        "label": "Share Issue Related Cost (Credit)",
        "documentation": "Share Issue Related Cost (Credit)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Premiums related to share capital",
        "label": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PREMIUMS RELATED TO SHARE CAPITAL",
        "verboseLabel": "Share premium",
        "label": "Share premium [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "abvx_SharePriceMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SharePriceMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share price",
        "terseLabel": "Ordinary share price (in euro per share)",
        "label": "Share Price, Measurement Input [Member]",
        "documentation": "Share Price, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ShareSubscriptionWarrantsBSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ShareSubscriptionWarrantsBSAMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "BSAs",
        "terseLabel": "Total BSAs",
        "label": "Share Subscription Warrants (BSA) [Member]",
        "documentation": "Share Subscription Warrants (BSA)"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_ShareWarrantsSubscriptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "ShareWarrantsSubscriptionPricePerShare",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share warrants, subscription price (in euro per share)",
        "label": "Share Warrants, Subscription Price Per Share",
        "documentation": "Share Warrants, Subscription Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails": {
       "parentTag": "ifrs-full_OtherCurrentFinancialAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OtherfinancialassetsDisclosureofotherfinancialassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits",
        "label": "Short-term deposits, not classified as cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails": {
       "parentTag": "abvx_CurrentTaxAndEmployeeBenefitLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureoftaxandemployeerelatedpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee-related payables",
        "label": "Short-term employee benefits accruals"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/IncometaxNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries [axis]",
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r77",
      "r143"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesDomain",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesAccountingofProsynergiaacquisitionDetails",
      "http://www.abivax.com/role/IncometaxNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries [domain]",
        "label": "Subsidiaries [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r77",
      "r143"
     ]
    },
    "ifrs-full_SignificantUnobservableInputAssets": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantUnobservableInputAssets",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant unobservable input, assets",
        "label": "Significant unobservable input, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The value of significant unobservable input used in the measurement of the fair value of assets."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ifrs-full_SignificantUnobservableInputLiabilities": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantUnobservableInputLiabilities",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant unobservable input, liabilities",
        "label": "Significant unobservable input, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The value of significant unobservable input used in the measurement of the fair value of liabilities."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "abvx_SplicosSASABX464Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SplicosSASABX464Member",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Splicos SAS",
        "label": "Splicos SAS - ABX464 [Member]",
        "documentation": "Splicos SAS - ABX464"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of changes in equity [line items]",
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of changes in equity [table]",
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfIFRSCompliance": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfIFRSCompliance",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of compliance",
        "label": "Statement of IFRS compliance [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "An explicit and unreserved statement of compliance with all the requirements of IFRSs."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.abivax.com/role/BasisofpreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Axis]",
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r291",
      "r302",
      "r312",
      "r345"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_SubContractingStudiesAndResearchExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SubContractingStudiesAndResearchExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/OperatingexpensesDisclosureofresearchanddevelopmentexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sub-contracting, studies and research",
        "label": "Sub-Contracting, Studies And Research Expenses",
        "documentation": "Sub-Contracting, Studies And Research Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_SubsidiesRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "SubsidiesRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidies",
        "label": "Subsidies Related Temporary Differences [Member]",
        "documentation": "Subsidies Related Temporary Differences"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "abvx_TaxEffectOfChangesInDerivativeFairValueAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TaxEffectOfChangesInDerivativeFairValueAndOther",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease / (increase) in derivatives fair value and other",
        "label": "Tax Effect Of Changes In Derivative Fair Value And Other",
        "documentation": "Tax Effect Of Changes In Derivative Fair Value And Other"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxEffectOfForeignTaxRates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxEffectOfForeignTaxRates",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax rates in foreign jurisdictions",
        "label": "Tax effect of foreign tax rates"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "abvx_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-recognition of deferred tax assets related to tax losses and temporary differences",
        "label": "Tax Effect Of Non-Recognition Of Deferred Tax Assets Related To Tax Losses And Temporary Differences",
        "documentation": "Tax Effect Of Non-Recognition Of Deferred Tax Assets Related To Tax Losses And Temporary Differences"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TaxEffectOfResearchTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TaxEffectOfResearchTaxCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CIR",
        "label": "Tax Effect Of Research Tax Credit",
        "documentation": "Tax Effect Of Research Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TaxEffectOfShareBasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TaxEffectOfShareBasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment",
        "label": "Tax Effect Of Share-Based Payment",
        "documentation": "Tax Effect Of Share-Based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TaxEffectOfTransactionCostsRelatedToCapitalIncrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TaxEffectOfTransactionCostsRelatedToCapitalIncrease",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs related to capital increase",
        "label": "Tax Effect Of Transaction Costs Related To Capital Increase",
        "documentation": "Tax Effect Of Transaction Costs Related To Capital Increase"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofreconciliationofeffectiveincometaxlossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nominal income tax using statutory French tax rate",
        "label": "Tax expense (income) at applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "abvx_TechnicalFacilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TechnicalFacilitiesMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technical facilities",
        "label": "Technical Facilities [Member]",
        "documentation": "Technical Facilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TechnologyBasedIntangibleAssetsAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TechnologyBasedIntangibleAssetsAssetsAcquisitions",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails": {
       "parentTag": "abvx_AssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofallocationofacquisitioncostDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents",
        "label": "Technology-Based Intangible Assets, Assets Acquisitions",
        "documentation": "Technology-Based Intangible Assets, Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [axis]",
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [domain]",
        "label": "Temporary difference, unused tax losses and unused tax credits [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "abvx_TenderOfferFairValueOfMRIMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TenderOfferFairValueOfMRIMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fair value of MRI, tender offer",
        "label": "Tender Offer, Fair Value Of MRI , Measurement Input [Member]",
        "documentation": "Tender Offer, Fair Value Of MRI , Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability-weighted present value of shortfall payment, tender offer",
        "label": "Tender Offer, Probability-Weighted Present Value Of Shortfall Payment, Measurement Input [Member]",
        "documentation": "Tender Offer, Probability-Weighted Present Value Of Shortfall Payment, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Scripps Research Institute, University of Chicago and Brigham Young University",
        "label": "The Scripps Research Institute, University Of Chicago And Brigham Young University [Member]",
        "documentation": "The Scripps Research Institute, University Of Chicago And Brigham Young University"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Axis]",
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.abivax.com/role/RelatedpartiesNarrativeDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Domain]",
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails",
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails",
      "http://www.abivax.com/role/OtherfinancialassetsNarrativeDetails",
      "http://www.abivax.com/role/RetirementbenefitobligationsDisclosureofmainactuarialassumptionsusedtomeasuretheretirementbenefitobligationsDetails",
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Top of range",
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r150",
      "r164",
      "r172",
      "r249",
      "r251",
      "r420"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables and other current liabilities",
        "totalLabel": "Trade payables and other current liabilities",
        "label": "Trade and other current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current payables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/PayablesandothercurrentliabilitiesDisclosureofbreakdownoftradeandotherpayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade payables",
        "label": "Current trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r394"
     ]
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TradePayablesAndOtherCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TradePayablesAndOtherCurrentLiabilitiesMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables and other current liabilities",
        "label": "Trade Payables And Other Current Liabilities [Member]",
        "documentation": "Trade Payables And Other Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.abivax.com/role/Coverpage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheBMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche B",
        "label": "Tranche B [Member]",
        "documentation": "Tranche B"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheCMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche C",
        "label": "Tranche C [Member]",
        "documentation": "Tranche C"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheFiveMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 5",
        "label": "Tranche Five [Member]",
        "documentation": "Tranche Five"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheFourMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 4",
        "label": "Tranche Four [Member]",
        "documentation": "Tranche Four"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheOneMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 1",
        "label": "Tranche One [Member]",
        "documentation": "Tranche One"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheSixMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 6",
        "label": "Tranche Six [Member]",
        "documentation": "Tranche Six"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheThreeMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 3",
        "label": "Tranche Three [Member]",
        "documentation": "Tranche Three"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TrancheTwoMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 2",
        "label": "Tranche Two [Member]",
        "documentation": "Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TranchesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TranchesAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranches [Axis]",
        "label": "Tranches [Axis]",
        "documentation": "Tranches"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TranchesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TranchesDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranches [Domain]",
        "label": "Tranches [Domain]",
        "documentation": "Tranches [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TranchesOneToFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TranchesOneToFourMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranches 1-4",
        "label": "Tranches One To Four [Member]",
        "documentation": "Tranches One To Four"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_TransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "TransactionCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Transaction costs",
        "label": "Transaction Costs",
        "documentation": "Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "ifrs-full_TypesOfContractsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfContractsAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of contracts [axis]",
        "label": "Types of contracts [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r255"
     ]
    },
    "ifrs-full_TypesOfContractsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfContractsDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesLeaseliabilitiesDetails",
      "http://www.abivax.com/role/OffbalancesheetcommitmentsgivenDetails",
      "http://www.abivax.com/role/PropertyplantandequipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of contracts [domain]",
        "label": "Types of contracts [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r255"
     ]
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfInterestRatesAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of interest rates [axis]",
        "label": "Types of interest rates [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "ifrs-full_TypesOfInterestRatesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfInterestRatesDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreos2Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of interest rates [domain]",
        "label": "Types of interest rates [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of risks [axis]",
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r169",
      "r181",
      "r185",
      "r186",
      "r215"
     ]
    },
    "ifrs-full_TypesOfRisksDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfRisksDomain",
     "presentation": [
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of risks [domain]",
        "label": "Types of risks [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r169",
      "r181",
      "r185",
      "r186",
      "r215"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of share-based payment arrangements [axis]",
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofbreakdownofthecompensationexpensesDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBCEsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofreconciliationofBSAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/ShareholdersequityChangeinsharecapitalDetails",
      "http://www.abivax.com/role/ShareholdersequityDisclosureofreconciliationofBSAsequitylineagreementDetails",
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of share-based payment arrangements [domain]",
        "label": "Types of share-based payment arrangements [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.abivax.com/role/EmployeesDetails",
      "http://www.abivax.com/role/SegmentinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "USD",
     "presentation": [
      "http://www.abivax.com/role/CashandcashequivalentsNarrativeDetails",
      "http://www.abivax.com/role/FinancialgainlossNarrativeDetails",
      "http://www.abivax.com/role/ManagementandassessmentoffinancialrisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States of America, Dollars",
        "label": "United States of America, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnderlyingShareFairValueOtherEquityInstrumentsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnderlyingShareFairValueOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofAGAsDetails",
      "http://www.abivax.com/role/SharebasedpaymentsDisclosureofassumptionsusedforthemeasurementofBSAsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE OF THE UNDERLYING SHARE (in euro per share)",
        "label": "Underlying Share Fair Value, Other Equity Instruments Granted",
        "documentation": "Underlying Share Fair Value, Other Equity Instruments Granted"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnderwritingAgreementExtendedPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnderwritingAgreementExtendedPeriod",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extended period",
        "label": "Underwriting Agreement, Extended Period",
        "documentation": "Underwriting Agreement, Extended Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnderwritingAgreementIssuancePriceMaximumDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnderwritingAgreementIssuancePriceMaximumDiscount",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum discount",
        "label": "Underwriting Agreement, Issuance Price, Maximum Discount",
        "documentation": "Underwriting Agreement, Issuance Price, Maximum Discount"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnderwritingAgreementIssuancePriceNumberOfTradingDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnderwritingAgreementIssuancePriceNumberOfTradingDays",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading days",
        "label": "Underwriting Agreement, Issuance Price, Number Of Trading Days",
        "documentation": "Underwriting Agreement, Issuance Price, Number Of Trading Days"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnderwritingAgreementMaximumNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnderwritingAgreementMaximumNumberOfSharesIssued",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of shares issued (in shares)",
        "label": "Underwriting Agreement, Maximum Number Of Shares Issued",
        "documentation": "Underwriting Agreement, Maximum Number Of Shares Issued"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnderwritingAgreementMaximumPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnderwritingAgreementMaximumPeriod",
     "presentation": [
      "http://www.abivax.com/role/ShareholdersequityEquitylineinstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum period",
        "label": "Underwriting Agreement, Maximum Period",
        "documentation": "Underwriting Agreement, Maximum Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UndrawnBorrowingFacilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UndrawnBorrowingFacilities",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/OffbalancesheetcommitmentsreceivedandcontingentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undrawn borrowing facilities",
        "label": "Undrawn borrowing facilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]"
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "ifrs-full_UnobservableInputsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnobservableInputsAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unobservable inputs [axis]",
        "label": "Unobservable inputs [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r417"
     ]
    },
    "ifrs-full_UnobservableInputsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnobservableInputsDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails",
      "http://www.abivax.com/role/FinancialliabilitiesProsynergiaearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unobservable inputs [domain]",
        "label": "Unobservable inputs [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r417"
     ]
    },
    "abvx_UnrecognitionDayOneGainOfFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnrecognitionDayOneGainOfFinancialLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognition day-one gain of financial liabilities",
        "label": "Unrecognition Day-One Gain Of Financial Liabilities",
        "documentation": "Unrecognition Day-One Gain Of Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnrecognizedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnrecognizedDeferredTaxAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails": {
       "parentTag": "abvx_DeferredTaxAssetsRecognisedInFinancialPosition",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrecognized deferred tax assets",
        "label": "Unrecognized Deferred Tax Assets",
        "documentation": "Unrecognized Deferred Tax Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "presentation": [
      "http://www.abivax.com/role/IncometaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused tax losses for which no deferred tax asset recognised",
        "label": "Unused tax losses for which no deferred tax asset recognised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnusedTaxLossesMember",
     "presentation": [
      "http://www.abivax.com/role/IncometaxDisclosureofdeferredtaxassetsandliabilitiesbynatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax losses carryforward",
        "label": "Unused tax losses [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "abvx_UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs",
     "crdr": "credit",
     "calculation": {
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.abivax.com/role/FinancialgainlossDisclosureofnetfinancialincomelossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of unwinding the discount related to advances made to CROs",
        "label": "Unwinding Effect Of Discount Related To Advances Made To CROs",
        "documentation": "Unwinding Effect Of Discount Related To Advances Made To CROs"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_UnwindingOfDiscountOnRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "UnwindingOfDiscountOnRoyalties",
     "crdr": "debit",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unwinding of discount on royalties",
        "label": "Unwinding Of Discount On Royalties",
        "documentation": "Unwinding Of Discount On Royalties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life measured as period of time, intangible assets other than goodwill",
        "label": "Useful life measured as period of time, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://www.abivax.com/role/AccountingprinciplesDisclosureofdepreciationperiodofpropertyplantandequipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life measured as period of time, property, plant and equipment",
        "label": "Useful life measured as period of time, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ValuationTechniquesUsedInFairValueMeasurementAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation techniques used in fair value measurement [axis]",
        "label": "Valuation techniques used in fair value measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ValuationTechniquesUsedInFairValueMeasurementDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialassetsandliabilitiesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofmaindataandassumptionsusedforthemeasurementofearnoutliabilityDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretminimumreturnindemnificationsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesFinancialliabilitiesDisclosureofthemaindataandassumptionsOCEANEconvertibleloannotesDetailsDetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/FinancialliabilitiesOCEANEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation techniques used in fair value measurement [domain]",
        "label": "Valuation techniques used in fair value measurement [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for valuation techniques used by the entity to measure fair value. It also represents the standard value for the 'Valuation techniques used in fair value measurement' axis if no other member is used. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "abvx_VestingConditionsCompletedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingConditionsCompletedMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting conditions completed",
        "label": "Vesting Conditions Completed [Member]",
        "documentation": "Vesting Conditions Completed"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingConditionsNotCompletedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingConditionsNotCompletedMember",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting conditions not completed",
        "label": "Vesting Conditions Not Completed [Member]",
        "documentation": "Vesting Conditions Not Completed"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change of control, minimum percentage",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Change Of Control, Minimum Threshold",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Change Of Control, Minimum Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing",
     "crdr": "credit",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance conditions, minimum financing",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Performance Conditions, Minimum Financing",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Performance Conditions, Minimum Financing"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementServicePeriod",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service period",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Service Period",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Service Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementVestingPercentage",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage per month",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage Per Month",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage Per Month"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementVestingPeriod",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2024Details",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsSubsequenteventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Period",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "M&amp;A transaction, minimum price per share",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, M&amp;A Transaction, Minimum Price Per Share",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, M&amp;A Transaction, Minimum Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting service period",
        "label": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, Period",
        "documentation": "Vesting Requirements For Share-Based Payment Arrangement, Vesting Service Condition, Period"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingServiceConditionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingServiceConditionsAxis",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Service Conditions [Axis]",
        "label": "Vesting Service Conditions [Axis]",
        "documentation": "Vesting Service Conditions"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VestingServiceConditionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VestingServiceConditionsDomain",
     "presentation": [
      "http://www.abivax.com/role/SharebasedpaymentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Service Conditions [Domain]",
        "label": "Vesting Service Conditions [Domain]",
        "documentation": "Vesting Service Conditions [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VolatilityForSharesMeasurementInputExpiryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VolatilityForSharesMeasurementInputExpiryMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility, expiry",
        "label": "Volatility For Shares Measurement Input, Expiry [Member]",
        "documentation": "Volatility For Shares Measurement Input, Expiry"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VolatilityForSharesMeasurementInputTenderOfferMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VolatilityForSharesMeasurementInputTenderOfferMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility, tender offer",
        "label": "Volatility For Shares Measurement Input, Tender Offer [Member]",
        "documentation": "Volatility For Shares Measurement Input, Tender Offer"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_VoluntaryConversionScenarioProbabilityMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "VoluntaryConversionScenarioProbabilityMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsHeightsconvertibleloannotesDetails",
      "http://www.abivax.com/role/FinancialliabilitiesHeightsconvertiblenotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Held to maturity / voluntary conversion scenario probability",
        "label": "Voluntary Conversion Scenario Probability, Measurement Input [Member]",
        "documentation": "Voluntary Conversion Scenario Probability, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "abvx_WarrantsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "WarrantsAxis",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants [Axis]",
        "label": "Warrants [Axis]",
        "documentation": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "abvx_WarrantsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "WarrantsDomain",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesDisclosureofthemaindataandassumptionsKreosClaretBSADetails",
      "http://www.abivax.com/role/FinancialliabilitiesKreos1Details",
      "http://www.abivax.com/role/FinancialliabilitiesKreosClaretFinancingDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants [Domain]",
        "label": "Warrants [Domain]",
        "documentation": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageCostOfCapitalMeasurementInputMember",
     "presentation": [
      "http://www.abivax.com/role/FinancialliabilitiesRoyaltycertificatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WACC",
        "label": "Weighted average cost of capital, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the weighted average cost of capital used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r251"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://www.abivax.com/role/CONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.abivax.com/role/IncomelosspershareScheduleofearningspershareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average number of outstanding shares used for computing basic loss per share (in shares)",
        "terseLabel": "Weighted average number of outstanding shares, basic loss per share (in shares)",
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "abvx_WittycelSASABX196Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.abivax.com/20241231",
     "localname": "WittycelSASABX196Member",
     "presentation": [
      "http://www.abivax.com/role/GoodwillandimpairmenttestDetails",
      "http://www.abivax.com/role/IntangibleassetsNarrativeDetails",
      "http://www.abivax.com/role/SignificanteventsfortheyearsendedDecember3120222023and2024andsubsequenteventsFortheyearended2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Wittycel SAS",
        "label": "Wittycel SAS - ABX196 [Member]",
        "documentation": "Wittycel SAS - ABX196"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_m&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2024-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2024-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_140_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "141",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_141_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "141",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_141_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "141",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_141_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI",
   "URIDate": "2024-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2024-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2024-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS37_g84-92_TI",
   "URIDate": "2024-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2024-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_f_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "29",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_29_c_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "49",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_49_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRIC",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&num=19&code=ifrs-tx-2024-en-r&anchor=para_11&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_c&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_h_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "58",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "8",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "8",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "8",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "8",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "8",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2024-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2024-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2024-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2024-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2024-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2025-01-01",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "A19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_A19_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2024-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2024-03-27"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2024-03-27"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B11_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B11_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B36_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B36_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE60",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_IE60&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "96",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11D&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG40B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r388": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r389": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_20_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r390": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r391": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r392": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r393": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r394": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r395": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r396": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r397": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r398": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r399": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r400": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r401": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r402": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "144",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r403": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r404": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r405": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r406": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r407": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r408": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r409": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r410": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r411": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r412": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r413": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r414": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r415": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r416": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_h_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r417": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r418": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r419": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r420": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>195
<FILENAME>0001956827-25-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001956827-25-000010-xbrl.zip
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MJ\&YR.,BAS#A_I\&GSVK"ZU/RXNT_P)02P,$%     @ !(AX6@=)8.O02@
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M4KK@AQBTBBB>X#N#9A;QC7^#,2=E%Q+0T'XRG<.&B5L1R27!R'%K8*4_D6T
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M \]HR:DF3U3O=VR251AA[/71<R_ (4N$3J7S2>G.&2>JM7NGSZZ^S/-*)L:
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MQEI.X$PQ'^F9L(#,(9 ?@PJ+:B>3M3/6&RF0 >92J;1CYQ6X?*#5='GYM)-
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MT-_)(&040<IR,(DJ"N_$M@K<:SM>$G8-XG@E5,M,%T5BJIT1<NFTRFC)+GY
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MB6,D6"!)KQ3WW'Q>$&C1H=]5-H&7X *P 2TEY\+1:_6ZS-=O5TSVE\!,PXS
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M10VP9<8([H>MJ[Y ?U[TN[0(.=]![ZCV.3RWG7]\A<_'9J_L+HQI%[@5!VU
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M*^=:"W?V$K91\B!NT*-O?B0G$VX!NJX*P<*[Y+R1$,A-)N<N->Z$E"^%0'K
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MX$1WBE:^@??R&X<@MY+_'N N% R=PS D^?301Q'9,]9=7M-]8ZROJ;E&Z7M
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M$MHH3MOXEO#ILI]+I4L"!6YS#"F,[9RTVQ2P)DP&SO.<+#@#, B7SB:CGYN
MMCN+Q:(0B$M$)]FQGANRA<>2X6)=V_XZ=I"\S$(TX97:RC#G$\4!K67A!!SZ
M(ID[H.C:TI:'%WF4EN0[J19!N9@0JE/.Q\0:X@=JYRHL# 5.(18("B 9G4T&
MGW"G"UZ:1"IA9HZ6#%3S79:YNLY":N,YO=K->4]0^<>"HATWORU:?N!(=57P
MU/?ZZ'-:!5?M A>$+94$[1(;CC4+!LT"KP[,V@5!NZ .T=IE 1N+207$VB$2
M)NV!"FVP*%6$QDF.!MB9?_[AU+_NW;6=4)=]6D6@19YC_6670L_DC&M?W)).
M2 @!<I:5J1%%*IRC0-TZEY*FKJ_0NL0J) 6I:I^)UBHT^;RJ0R4KEP2*=.%&
MYR@GQD'VB1<^>@PYJ 6'D7]=1-R]CMV>+GM'V'I,4QGM@0OZ6^DB.$:L5^U2
M.FM&'+2#HQ'Z"$7;6E-KQUDL9$4J9T [CHROT;8L:Z+M%%P9',W2/UE )+,"
M@YZND]8X\^CFH<<^-$X]U7. (=L,#<Z0TT'7G>L1* 7Q?#2"<K,/(7E#'\1,
M! 6JND 3Q775SN$WNQMSEU9%4=_53H4>/BZM@6BH)159:)-4S2> /H]%A/HS
M<;[)9<%S@0#2N ?UO'"[=4EXKT8C[9X)'*&:E4-X=2R@,(";A*";"/WAM']S
MEQ#\T8_B'DT3:>?7BLRK!QNW.E/06X>F!5O.:'C-:Y:AL266<A3P$7K,#L7:
M*8%]05=V^*E L@D!#8+8#;_3@!,I&KM)5+T?BGQ/_OZ)DAFD1QO&O2TOD>MK
MQ)#-TZ1L4A;:ZD@BETZU3<%L5'M!![=\[*4P,L/+ZW:.[:OLW_9NN\AW10*C
MKMP,/7]0O&(V<ZOZ^?G;;?Y=2U-^KQOT20^?:O:H0KN:15KLM5_IFT))AJ=,
M_I9 JD.X1119\32DO-"43U RJXY9?!Z2,#D!XG<C<:T-EC>)4&;F46+T[/+Z
MO!J+CG(VCD4ZU3"Q<9Z,D)X)N2YI0HF2"5"2HW*^HLJ(4*&C;9UAZ(D]1W84
ME%AJAD7$ 65D:.RQDIK2(F/$#.01=-9[KPS!U#",A2NO(N&IP&7D+$==X7GP
M[+9WCL?CF75Y$7#[*L0=;CE&J[76&MY_[A_FH<'WM<_!Q=JF,TM-Y+L6DZC$
MXH>>:U2]IAXVN]G7)\F#8KMP;]CNMGM]LX;L@B/9O0'9(0"1Z^SX[*P_V(GM
ML)*XQV9,W/&"<KA)E7<-\7B%!PY!AUX*;F6>+H7B+JQQK2E'18GBQI2J9 &;
M 5?K%_-_3+=/$24S[8D-JS)A#,"A$^YATZN_$RJC/:+7_O4RO5+>8!V[DC40
MW"CDB>O700W2H(QZ9[753USA =.W[Y#]P3PO'O*4YY%]K?2$>'1V[M_:5K>'
M&3^91 &RT67-BR\'].J9_4#@S!ZKEX"4*NNL3VR,RG1![G902E785X&<10G/
MQS9EBM,R2J9+*NJXM(1H%=);/AYJJ:JD'$?]4&JG2JQ5R8S5;AFH,6BKOQ4K
M:PP@L(T"RN#1#E9ZM3>$K(\D1Y0C)&UNN1(V.9_G86Q]#%:6^OJ)W(,BO'AO
M"&_0':P<G@=?E_!^+-',@V SW_W(<Y?E#XYLMSO;;41"\TY<(;6EH:'" ->(
M"6R\)5==+>LMNA"3I*79W&7E4MIFH#8_$[7 [!B\$ GDLV?SP4.>3C'P.WFW
MU_Q><+K^7Y^<CL[U'3O7U>NGA^)N[8U4>"MWB]*_>+Z@MYQ;W>U(ELK:SMQ1
M^MK4-U"_W.AZET8WV_QRW6AP=,S'8\A[8<J]I;Q=2.?D8;0WE.?[W<OE(P9=
MYMB1\QX+)=+MC-=NLI;OVDW6LEV[R9'KCEQWY+K#X+KQWG#=FK=S]JK:?Q;>
M[1:Y[=)H:]JE;O2EO,N1\XZ<=^2\/>&\9,\Y;]?P[LAY1\X[<MZA9?_V\X:R
M)<9_8KN8E%3_%.SM>-+^A,,99T(WTA&2_%ED94:_AVE.DC;0[]D[._9J?>/>
M#OW8ALAK\P61%^S.]FW>]_=&%^Z_1ES8_U;Q.U!+ P04    "  $B'A:&P-7
M3"\(   G)P  '@   &%B:79A>"TR,'AF>&5X-#$W<W5M;6%R>6]F+FAT;>U:
M;7/;N!'^WE^!QG.)/2,I>K5DR><9GYO,M-.[WC1I[V,'(E<B+B3! J!DW:_O
MLP ID?%+DDY]=NKX@X<O"V!W\>RSBZ7.$Y>E%^<)R?CB#^=_[';%GW149I0[
M$1F2CF)16I6OQ2\QV0^BVZVDKG2Q,VJ=.#'L#R?B%VT^J(T,[YUR*5W4\YR_
M#O?GK_TBYTL=[R[.8[41*O[^A5JM)H,Q1>.X/^J/Y>CL;-2/XO'9:!93/!T-
M^_\:O,!0B(<QUNU2^OY%IO)N0KS^?#HLW&*K8I?,!_W^=R]:<HZN75>F:IW/
MO;9XN]*PK7H=Z52;^5'?_RWX37<E,Y7NYJ_>JXRL^(FVXN\ZD_FKCI6Y[5HR
M:A4$K?J-L"(6#[<\XUPY+!:%)]N@WQ@SIRJG6M^@Y)OK1"V5$^/>8'K^FN5K
M*V_8VK A@C_)/((1TUN->%=FF30[H5?BAZLWXN<4L[>-N=V,7TOKU&I7V0%(
MF(LO'_8 YM^[8Y=62"?>TM*4;/-PUO'0[X@<HMY^FTA#8BN-D5"O8&^(+>&1
M+IUU,H\11R^/)K.%EQ[V!Z?=0:>^GK:NAXWK<>-ZLK^>->1GW5'C>BRPU.%V
MTON_W9*WNLQC,B^/9L/!=&';&V#%<6W!TPCYI08>8A)6ES8RJG!*YWQ?2./\
MBPB6#$>C!5BW-"*NS$+(&RJ,LO3 YMRK_$E':,.@LAT!C9C1A12)3N%_X;2@
M:S(1=!0N.83 "D/XWN]2NN,TLB'+.<7OE \HF1_&PLH(_S%CV,F8P':@>@Q8
M@F7@E*66)F:^B96AR&EC/=@Q3TK2.D'_+F7*^O"R*ZF, $%]("<V,BV)!V(]
M;1")',-A%>P"2\=P.PNL6?6>^ 2V,@F%\G0GEB24M650<6WTUB4BTEDA<P4#
M,R+'9D=DG%0YMEC!)"5[XIW*(_(VJ5PY!:V+<@D@0845)# &XF^Q6$0=+T8(
M.*2,5+D=&^@7A8?OU5+A2;G\%9[B(7LE-*B(T8>]A!9IR<0$'\"+O%#EL4@6
M'MJ_R0!4#7-R#1=?1P1KL>3H=+P83/H_]L3[!#2'W8:J6^ "*N1:I#I?4ZTW
MX/*92G_5=/6%"?0R!KJ5=<;[^#'CNR=^+HTM.6JQ3S&EM/8ZV1 /Y&.,T2'S
MG$.L!C8"QF]?8 +;N2M*]Z%L?;#AL2H4B 0C./#L/O)\/'_$"'AW/V8Z?M*\
MS)8 W">EV4*$[=XP+,C#6<% )X< X<D\E7QB^688>093.J[&@H,J<V05O=6"
M>,%LR(-LE%!<IO2<L/^/0U((V:#WF/A_>30X[2_ 8\)25(*EF;V!DVVBHL1O
MZJ%FJPD?K/B3WI 'W;3C7S;+N8;87V0>BL:1%YLV*[W;9AOV;\B-&W+#?E.T
M)3;YK.EF+>U^E 8V#B9>:-:L*EM".S$8WQ 9WRG2+D+O$!/'3J\)[C4AA#G
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M_F&(7%J=EN[FD#N5:/T//U1[[7\@]Q]02P,$%     @ !(AX6O)A#7 G"P
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MU,U7B7P"-E_EJDI(8SS&-,3#4+T$30&#4C,0>09B5K>8Q<BG(F$QA2I7JV0
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M;+1M S[?)$VP63'Z)06#UV[KT;T#KL<=&)Q.B5/7[EN=ME..4\+9(]P4X&,
MB1PU&%Q%4%P =X98 ,%G8V"%>#;@U21/97AE7VM\P;-(S+4=W@)YNV?U.FO%
M!O+."@6GYY%$HIDZAQCJE#W)V:4NO*%+R6LT"53X1V5N;V@KD%@]#N;$-Z)6
MF4G(097JEP]_ !8Y(20&$;G>VV)8VN%?44BJ7M;YP4M9($ ++(A1I.,]<U8
MHYX0YP2+D\<4?C @NC@!71CC4" 0^"PL$1+?R,FIY:3=ZEIV=U C.5%W?N8L
M38 @>QX80T ?$BOR',)X62A!2H? 1Q4+AXX ,\<QU9,S,/H.B3)0_X &(^C!
M4 D8C:$Z3 AE73U"@)9>J3*>)7 "!# BNI6_ Y=78^Z.HZMJ&\MT!A*'D4B(
M1V%(M]U$S:4S#^6J<!M_ N')XY]Y1&C5:JD*&#DZN1R=FO0N1\1SLP.06F _
MJ&)!3!FF0,N0E<6^)5'AI<P>S217$"_E(#Y$Z$F.+/ ]EQY+V2HP9$!^9C%
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M;*"O>'A@K=X\KRUY'<NR\DGN]0$BOU11!LQ1106L8I3#TBZM@]_2U&EVPQ\
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M_';?DXHZJR8=JSC,=^L%[$P3TW96_=VS&>VJ4?">AXP9AZ4L7(<)\BPV=(A
MFST%MSH)G*@G[K7&X_%:@0FIH71+?4TLR>WPZH'BH1OX,& $IS[#/JEZC77
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M_BB9P[>R/ :"&$E<=Y,Y35EV&T)H.,);V8WB]+0Z3!.=-KCTJ V?(&8'#:-
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MF.&I2=IAP?&..T1A@V(^13(F!K:R0@(&/L DCB(#J]]N9=&*!QG$B+M"<2!
MS$]3LQRNWBL8H)OY2#]#^!BAYLZ@%T$/$:<*&^CRNA*,2!QVN71H=#?*FF:2
M-#9_6)7%,#..:*$XL*BY#(,D "=H$(3HFQ>$[1=KX&JL,>E_E,Y8""+^L;,4
M:,3!I-[C@>O&<#RNKNXBG]=GC-67;3X%A\@),'\@>4%HFP8;0QO$PL87*K/
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MWE*_@67;#3\/WO4_2_X/4$L#!!0    (  2(>%K:R9+/?P<  *<E   >
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M^6+'9U6GRVQY_DA%Z/*\.1R51])3K^IA=R+UMC)1HY/A\0E. _MXL2\UI11
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M_2!#)7$B6@&%JNA7S^]=%/N[H7+2S_AK=J;8N,;@XE^YM!:VPWE:]$#8O2*
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MGVI9>D<86AL0I7!2I)2YT*I!GD01'; )8)FH5)/+,UN(/9!E.U'&)V^O^IJ
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MX?U.0S=T#\#]MS7F90" 3PFDC26>.S8*,*F9A082RBV2V!R A45*1Z+AQ#Q
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MNH\(9L6C"_7?'X6R\EY]^->!-SX:G?WP_<GYV^.3<WSTZ(BY'>D+#_Q;O"G
M(TNYC\FD/T=,:^AA^#<0:6"0OMR(T"KK!-MI:%+I8&W7AVY@N7#^Y4D@#%;9
M_?I>Q+U[C?BX&O%BKQ%W0;=UV'K8ZK9?L=4EZ(2)I2F-X@R1_/=K6;!%DZ27
MN&U?WV_;_CB)@R7\9YXMPI__/U!+ P04    "  $B'A:Y;[.G8#]"@#D++@
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M@,.K,16LY/6YLS]"MZ,@5Y.(Y V11]&K0E-D#8)#9,*-U4!@6E8Q(/%J3:%
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M?.\(F<B2!G,N),C\TO':+1ZX'[DQK5(,6#SP4.#VCC"5 &2>!\KJ$HF:3=1
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MF$V8BC@4RF+RJ]X.WY0W$8=4J5!257D3<<B0FM2D,6\"CAZ!**FJO DXTN'
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M!'&XK^X7*BB]:M--@CF[)$FY,?0P08E#BE4GJ(H(24,<3JLF)6F(?#3 D5T
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M3&:9NEB 242(83+3N0=,F<$.DYE* 3!Y),/DLBY-*^_2-)8NC4/FYWC#Y*9
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M^07']PF:C@./R"7!:-XLPHMG498\G5[<BF<A 3,QS4FC,2L'F%5I3AJ-62K
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MXTV'L<M(=E2\ 8Z".!E@;Y9@_SJ.5@!R%:.(HUT$!CB.X9B!L<.#"718N&Z
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M0E4MDP 95+AOFAU[FSQ?8WWI*;*MY3&RK?DYLF #;U.W807>]:59VFYIEB5
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M:*\%D_/#?*$$%[JB=_8PN3J[^.VMC;B[M=EZ7V@;]WBCM]RS,LW10+^<ZW^
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M3EY;A\!\ULMST]>&0',WN@G!*E'8J2O=.;*,YD48*#.:YC.:[<&!JF@RH]F
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MEZW9J.(S\_]V#LVK__?T_M_A(^/J_^TNY9D]GEPE0O7V_R)_9MHF\V91R)S
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MNJB2DLH@6!)FS=9K4G>Z8.=,!N"IJ&>I3Z: FP !?5'"C>>+S<B 6ZLL'P:
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M$$<Z@(I2TH$1EJV@>XL$>,N]U$A8U/*LRS^01%X#.UTHGW$G-Y9HQB1WX1\
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MM-$AK81NR\_59OF=Q'?A:!U$-7;-<U3L4O/'F9_$"SF!M:[RHL+$L9A27W9
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M\T2@*Q'=W97K):P(?2;D+%,3A_X$I^97 *#%#WDGZ3_IF(L2+"C2=&HS)@=
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MTIZ&ZWO10-(*R-,D5LMEGE6+Y?YA2)J2S%+<AX(KIQF@+,HJC(FW%5P=*=U
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MS&4_M"0+;[K#U&Q+TVX=I^VFP)IG#DF0)/]CFQ R,ZI"+ =BA!P;OU$+DS;
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MCO1"<K#2WVUWA%!%RL=:1.D!!]P/#K*.EI8^OJ:C"P-#[V!^.=[94(IGF %
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MB;QA]= (TME0(:T;$EI[,\L;]IS'"%O)3ZB5>Q%_E=75;Y<.5DN04NLAN+J
MZN/WZ*@C?*0,;U7*8HJHH2Q9OI*^M4YL.:Y>::1^Q5D:;:D,.6N1HYJ40 5&
MQ*B Z,#'X9W;(D%"F1U!0O:@\49M !UL%NFP.17=O EGH2B8M-IT[V,A;Z>/
M*FIK K^JRO7:HX--(4D9>B'GT.X^23=-_5[V@PJ\MANV:Y&Y1H"7P 8L!1=Y
M(U*G#9S#32#ME0D4Y,5,F5EUA.Z3 #Q>D>Z$<+E:D6SVSL#1GN@O9) IDK<D
M=@2V$OR@8JGB#.7F=MS70Y5.;;#TM,+R-#/^"*JDI1*EY)V^D5;_]!I;Z;&<
M+'M(B@VXN:M]^5QM,1TLI7&;2 4.1$P!(%)MX6/6)FM].'8[+A,RR>NE<CY8
M:N.V\+P@Q-W6/1;$K?LY=#/BUY4,8B)A*!I%HIQ5YZ%+?@A\WL05Q]0I 'Q:
M_$2!^C'W>3+VYJ?:)][$.]V-WMDIYU0G_M(ZL,2 99NL?9%E(9UNPH"I"%V4
M+EBPO:G4+Y#Q7D.-?"K=Z6.@-(<*94- K8_0M&=;9[S;3S!+&; \AZ.CV2D^
M2[!"H((SU)A.X'XKTHC,YQ'[9[S*1)+RYJ?_:<Z]D?(+Y9N-8HEI:DJ0RB!<
M%X_!<S0#M,\-%!EK5I2M''.C]43:/T@M@.X<U>0QAB.%RWM '1N_BZ&[=E%?
M-7)HY -Z[G 1K7<E!MGMXXU\>I:F%4O$\#G5EG#$,D*XQ Q>'!GD]=&3P9*E
M"TD:$N=!M<*^JH >"*D10-]I),\;+L(<)R"E5FT#<#\>^E/='G-JCF?]C1Z!
M&6JX55 ETL!*6[TU6MLBR0HAOHV90V3/OH<BU#F9.D\ORWTZW.6._*P7/58W
M=WKTOY Q]=!:M6A\NI'2O7_A@P7Y\Y]FMN>\,>VQ9\#M2&+94*O/83T;[MJ^
M%Y@[UF$]A0MMO8(4'QJFZFW7#%>'\,? 52^6KX7X,27EM,%T/EQ,JS3NQC&P
MR=HY<O@@F4)MW"N$;,G7K,P"GB38'XU15A"G<*E&F7-6BJ6![3L!6]>AEDY-
M/-/)<#&MJ28HGA%%?6:D_&X$WX5D0)L1W&-V*S*JR)N[:5+EK3*S8BDQ7DK9
M589M0'Z<UI/E_:%Y%4^]BJ<^Q;8[3CS5.?G"OXJG/DEKU6J-%J1X1<PO114L
M1XI_&@\]Q4 -=G%!W&LK%M:-'"E?9&5#NL&ZEI3E)?@UQ3)>D[M+;]3E+!QL
MC5&T$0<QDH*3]E3.^3^Y["[N''.+G*THL):NJ,2T<68 T1V7)PU0?T[X-LD)
M"?_[B+GG0\48*8>V"F,20Q6N7':NR;*\\6S:V^WZF!K_624;TI$A2X3[(VP-
MM'$JM1>P:(3>FKB7<HNHU8X"1-HN=7,RU+7N<YZ"+Q@EPKW_(1]O(#OV!6D
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M/DEA9SY42%%#$<"C5C,<#$;I$KC/F6352Q+,("%%5#W:3;UEE.8ESNMR"??
MG?Q+S<^!_:+PBY*JU@R+XN\8B-$;]0F'-9-A[#4<_DJS^W&!<_NU)1991#4%
M+L94JRB*@YA4Q%FQ1/1AH]:SC74^228YMN=Q3L7D?%5@;&&IDH2LK*/<O3/X
MM255\BKIENAML:=76+R9R'M4DE*C 8SAZC ^IH\7[SR9X#A =K=:\*.A3SG4
M(R@X.@7#CC;8#G9>JMN.N;]9D,EV075$[O8*!@F+5\))$J:<RC7WVW-M<!WL
MT-1])^:*?1/$C46PY&&%=(O2VZT';'X\?+'3)&%DFLD;#W9Z:F_._V$4-UV^
M%77,CAX@::8-K(.=GVI3WNP(<W[;OU-AR\%QN>"YP5F>;-J$'2*RH9AW_YK0
M!M'!CDT]?M?1^%.V@G-72NWB+LRJ,LFR;V/C(Q'I(#,Y;'3\J!8KBT%!L3Z@
M#G9FBK5%Y.M&8&P$+7=DY.4$JN@[DQL56R3V[U41O<*>QDW;<J)2?1Q@;[#S
M,7L\U,9J"CYRU&[ /"'@"YL/I="0 [O",BU. MQ29G\_JOIDD+PS-E2<D_;J
MTR."4P-^_"U1@[8&5:NZ0U\T'>($,S:A-5M\9RQ9%QXL[XQM%.?$='>L29R
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M,'EK2@Q%JA>5?!J9=#"6K("_\[3Q9' HHBBP@^INR:E61PWARD(BT4D<2:H
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M#WX#.#?OD)>*OMG7?40EA'>W@TT=VNZR&P*H?)&<\X>#\2W\5!@*:/O)83X
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MY5H8[B*$7S\GRKFC%;WN)!Z"YKGEJ$R[8KZE39F302MY3'.SQ5"QK9GQ  !
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MB_'JB\Y_[^ZN9A_*?S^^E"#GG-X*FU;I=3;['[3CD.?[D9.-?B@>%-*^8 B
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M-XV"\:'#_3<BFO.!,+D6E=GW&M'\SOD"+KY4AJ@^K:ZQ:.@ZX&Q17#8E5@,
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MN<,3SJK*C>Z6=XBKKWL.I=W8,R''[RQ.X:&LWHV87>^!R_4L<'*R!/.1=;G
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M34&"D;00BAJ\L6'*N0SF4S%"G\_^,FCK&I56Z8895=H).]KVA\^/F-UWZR2
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M"#_G2RRLP^QZ("LXH7J1J'ME<D\>N-1KPV,2Y"]TS=_GQQ[]M&-8O[#BPF"
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MQ8![-UQPN9#@K(E5K3?\3ZQWC6]>HR$7)'".&8[M#&&HW0YBO?>HX%PEOZ)
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M&&D*)Z#$>J"$*!BX4P?UV] J]T'2&T#9N619PWB3 1-F?3 .\G>DSRDK3<-
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MQ%M[;.IP"MSDCFA5D_E0,8Y;QJQ"<JHN>K28Q]>II@WK,/5,"J>H *VJJGP
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MT$JG56,83@A>3$LB#^_U)Z3LGZ(T=E:"\($B&C11KI)O&1H:ZW1;O"V^$+W
M%U+=SD;XUV ,5!D(9[0?;F";)'.MM=IV8AHYPX.+P6ZT\73UWL]\0ES#<2J
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M\\LQ\./KVZN;]_^Y?_LO9+2<+%Y_PI/WCV<\N[J=GT+BQ&\TN;FZGE^W__O
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M*%6X_B6U<3&\'5S;HV36^.:U#:$(+A3_A7:D_<II-W#ME$KA%>VX$^T"*,A
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M*T>\!S;J^J 'TTHMHW6P37*VG F)07*P1,;!F$;@40T.+U-OVE42.*O$X17
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ML KH83UY>EE %JX$83<*T0.JKG9.WW9885#\'JHCG=S:F'>/;W>PH8BCGX/
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MQJ5OFI703)I+Q3DWBF19Q[JF&F<D8DG=P:*>CD >J<L=I4(H-;.RLD7+TBQ
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MO#5@+;:J\0*\XPFT]@YU7\P=A'@G7DH;WXFW"F]:L!VL[\T'S:UYS&7WVF=
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MX(7E14>?K.RFO1VK>?;.<M.>P$92IIGA>E5@E3$%05$49J%(%_WFE19POOC
M$,)!.0./B&\4J]MFN2D^%4\7&_J$NK$#%-GPM(O:>_=5W *Q*Q/,-Y$NBKH
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M\VKS)@OJ\G:47:)YGV*PXCI*T&_L+A"-]$!ZKPK2/CNT?CX9G#6?Y(?%1.?
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MP11@JS;<;QVS*&_,S0>-=V&#LXU%_L0E&=O>=CP4:CTM.M% &"*FC\=5MZ)
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M8[QKDO&>$>]A(\B6;2WW[:*MX BP*.?M)VQRGH]S,KT;)H9U.]MD=<UIS=)
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MS %G47=80.7=&H^EG"WDZ6(N:^[B A/'Y#,M$R;NKT+@D-;,C;L]E@;""J=
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M+^!R2\2II% Y'M\DS7'NCJ46PM9+,Y!'TQZ")F,GLZ&"2G0&2!E,@N&-=P1
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M.]AJR"D!*9P\=_2Z-@AN),],REHO#:&D4]T-PMRS09@89"=#1?:!,+?IE1W
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M0];:=>\#LQ!I?O#]1U\/UPDF]?L3$XQ397:T&6:R+?,<VN0B@:@RS?>^,MZ
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M$VS0D9L'XP5(FWTZA,?ONRZTCG9@L40@^=53YA<$=C9<8"FYY)$X3"_@HT_
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M9V#7F1AZ^>EB+@F[2XU!?U*.P?+?'&QONNFLX'A!TSTYPVWDQA$$K8U.EZ(
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M-^M)HS).E=F5E,EC5/F)B1&WYR2E=#.9#A/1KKXOC42NL5%,V4)>5^ ^M5?
M@(_? -CK=>DV"KF+3&1M<@IMD]E2DAOLM]!V=L"*+[,6Y_O_S]Z[-K=M9&NC
M?P65/=DEUZ$8WBE-WME5BNW,ZYE<?,9.I<ZG74V@278,HAE<)#&__JQ+=Z-!
M4I*M :4.1E,UL2V1$(4':_6Z/H]3>K-;NOM)W)YTF(%X6:4I:JS30% X,\[#
M25"0MFB"7(0Q?*2T)=C8#1&6#]H1&#9<K!FY(L_*JT3HF*D0)U8"J11QQ$OG
M^^6\8'"==A57>\HAKPF%BB;SXZU0MUQDRJ(NS#Q^&JHL3BL:SZO1KH_/7_H?
MPNE5#6==170IX88WUW4QF0CHUH=5X6SUW&.-BT-'IK=;ZC<TO&(B-U@"6PCJ
M1)B>(7I20U$"84]>1C<4_%AI1>DDUH.!L[/5S1H/^*. !&*I\UA2R-G #.?"
MN9H9JSRN-D7)H\O4,80LG1KZ=XBJ8@;/8Q@\.AD,K*-!5V%%H*R3!,_8CS[R
M08>*0I ?KB1;GX.;RK04PE#Y%@=G*G@K7.P<\4'!13^;Y <&X(879Y)RCG!
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M!LM15[&T%6GB;/",T2J%F'HF4L/$AC60E#!S?:MPUXZ\:\8DV:(JUSI7?U@
M&_8L;)P:SJ[D-*RUYM:)SO>47'P3].O:+I% 4'<-R_W \P7,4#^<6 _N7RFH
M&==I9[>::THR6CU?+E5,LQ[4,LXERGT4!\Z85;FV.G?M90R81H-O"[!3^$5P
MG)*^,OP6P5\J],HQ3CGOZII=$5)E9]K9]>:FJ<V.F9J);]DQLYD>F:)4N5/G
M,F1F(I5. <AC=PD'U,YN.'O* VLL$)#^P">(FK(,9]$)';E1Y^;?2Y42._T^
MJ@A<"@Z=UM^SZ&V5PP^\+:/W..H59DXS[RJD)DJJBS[(6:\32%78T[+-X89>
M1O5S)U!1-*M! @6#;%Y*T1.79+<TT5XTRD3!H'K1553K---63SU1IAKKWRN1
METCBZ< &<X2D<V/<]N#\_T4HK=3XT1==G/_3"\J"@3:LVE*+T#:#U8:,"+4]
M>,/'3G*PQ:$)NI*@7XB%="<VQ$#HE$W]EDN[?+50 )UUMJKDAJY8Z/!&&FN]
MJW883J S>T)AP]!:6JY;TF,V74ER+S$392TUZ7G8XM%:;V@E-BMSI_\A:9**
M*7\"ZHC,GE#9\"DA):+/'"4( $K>:*:NLUTRH!(>S]-%!<"N("$5%,I0YOF3
M*!+QNRO/'[T4DH\D(D\*;'_)+]8B.*6N1#<QK2V)]!^68+&).?5R79I5$EP.
M\#CKW=%FIR)E]IO>&=?+TPBH4UNEEA*6Z8 LW,% ^H2:AD\)Z3%SLJ4#ML'H
M[ZE>0![RH\@_R2]>L3LA(F'-HK;:S+SG/*0\OB9D.H:1.S*]]MF=_C28T.8R
M*#A/;&(>T8M!D,MQA@*43\?C#T#1C(:\Z(>BGE#PG ^ZBJ>-*X_&)(U@$XZV
MBEA"OB28Z?$Q:$-9>1M+DA,-:,]N'M9V<ZMJW%&JL=5!<^84DU)0HYQI)K4W
MM>>D(J$+$_N45)Y-KB&6%2O: J*U J<*RXK.]):D78')%Y6/%Y6/YS"_QZE\
MS%Y4/H)!L-7N!C8C/!7L(B)]I+M"&6QU</3R?2XSW"E_[*D:RN'86<6/A\(6
M,^EC>.KA1\")D,I^]-I$,@\C^WV.7[.[L2H<3"^[BBGV(/QB:8\J.P^5Y1XL
MQ^$8I1ORHT4A8]VA #H,:ZNR]48D )D92H%F/<T24+*IX<>@/M1B=T[?,0U+
M &PC?M.Y83G$5]1#0F#GV#O)$KF%&#8H38K.;E::C@>8HIF[0^BR<Q\$;XJK
MB#82-W[<T$XN-Q42$)H6Y(9*!Y(;*?C](,'L[$IE<]YN?TX Z^9FMAGG!(IX
M+9,**7F,ZFN!NK!\0A*_QQW/ -:(6&XFG/;E\ E[7<^U?Y(6NC%"Z8U!%I)J
M>N4:8YU&V8_A=,XWL[5>5@>EBJ#*2.;9.NI@('W"5M<3BXO@2)5'W.I-H_]>
MZ;S:],Q^+)@CE7CXJSZ;%K7&J/\%/^2\7"ODY.&:D:Y*BI=P$,3(/0<#Z1.V
MNIYXG:B$FP@)"5+P%J4C(C"Q*9%'^,%0HQ@O++[&2IGKE5TLL_TTNIYK<1T4
MIO.N8BJ0M%44972F7O%\W&CPM;4R(ZSFL]J!L4F[ $@\LB38M:?%MJ>W;IR
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M&&R[R[IGZ7_ RL:>E3& ^S9,LY,)'[\T& MF.V@:+=@]_#!:#8(S%[O?B5R
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MYT((J\0J1KK/-\&%?+^LG$C #MZ);%'AX-K92A1OX-Z@E[41KC4X[C775M>
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MQYF:*.9VP9Q$L\!@;3E'WQ>>P*W+&EZDDE4%VR/\*4F&FV+%7*82]0PI(X"
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M%=K[C\F&UD<JJ;N_K!F5<+DXIS@YV6.]6RA-Z4_.X15=USP(P6 Z["JFUL@
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MM,%3(K-YZ:\)>+59;*K4<>N1C0(;M&+^Z;,G'+[4L=D$@^ZPJ^A:OJ"MP'J
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M<D<RSIUID& ?>RTP((9WU0S8DO@/<!H%+O#)%##8CA-;+LS@DX4#:W<+3/O
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M5W$O+LJ*1+04#K\C 1G<H"I=8AH2#)ZSCN-9Z$15&\?D]^;#!\<8O]',1I%
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M8$<D-7F['#GMPL'THJN8YK2B@C99%3A(8<:<,GE#N<L:LQ5/!Z,F/K)Z?!4
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M%4K+_.M\2/O=Q)Z!$!0H^Y6KDJO=.K6QIIT&4?56L,J6J0!73')MP<#9V8W
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MGY78^+0P%>^4UP( <LAM:9/7"Z.06I#8IV)-,)/YZ@@O2[Q'P2#:V74]!$E
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M5KXD2<B=HQO%NWAKDV.<=A72>C!RE6I$X<8G*8GC\ZR"MSE+A'*+7S?PV]!
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M\3Z-Q$+ F]^S;>I<PL>QIR'N#SN,ZIF<I,7=YEJ2,B]2\)2*?3;?XCH?(JI
MKL6QDM4S5H,LXW2&NPB(!;K6ZI9@\&D^3R$M0Y9#CFB>]RIJJ#6XNAW&U8!
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MQ8W8_7G01D/?$M".[SH\BUS'IH];G'&C1,:->;@TV;",K7F1B;FCW$N98RT
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M>L#V#IZ/Z%[Q'>!Z]9MW*D)PWOKVA3^CH660MA[^ $0R%SF(V\!1W1)W-#F
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M >^]*2C[P4C?Q_8*^-E-FLF0CV9L,[&N^\6 7E[P33]"JK2:QJ<RL9S&A\=
MPJF'N(N5R(XTN=D&N.[0*G3;#.W!YA9B4:RJN?@;1W ;NF!-$;C?7E6-NB.-
M5=^"XMTX\H?IW&V@^!USY+V#RYKW6RQW9GVWT%_QAD9_I2HI__)9GS1]L+O)
MX7[+Q!V,7+/A(@.#V[HM;7@9WP^:/_O)'4W;/<8](0?R*E@Z-I1:%J3ATFOH
MX#?W3]"XU5>QAK?&* 129DINYYB;7UI!.+ -X1:=D+(SMKO)!8^8)F*U/I("
M[(:NS\#YU'A:*A(VKI,A^C5>P%ZTPPZC35$;X2NH<[=56L[OV38]N&D5['J(
MVV#<@?-FCTQ/\.;@!;"T6(6'DIUCQ)?V0CWJ,-155(\-O@W/P 6O>62*=I#[
M;I;Z$>^?2S!VW^U1TG"DP/!VXL[H!F2>.$1Q[Q"B./B,$'/;N:1)DL,S?MY@
M8@Y,M1.RW*WA-QH$1PNJGUM,?6?&R.VW=7S#;;UUN-(?WF%4[31?>9JO/'SQ
M%LSV-%]Y7U=[)WL-I^' G1[)U=K&3G?_%#L=#OS)(3CW/XSK!K=_FHL?_V\P
M"OIX'+]3<>B%CH@^EL6F1 YS_B?CG?O2REMXHD9#__MYHO[<-&C+3Y25TWMM
M/%&N^_T\47]N'+3E)\JZ>;X6DHN1-SG>T]3=Y.)!VOW3(][I)R\\*WGWL;NO
MXM!S1GYS][C(G$#-*R+5I3#D+G/S?:%/RM!@;2,;5Z?XMB':ZA[6X,6YN1DL
MPD248PD%64I9&CMGN4QAT\Q1:\DBYWT:B87 OV")\A*+DN<#YX.DHA^BH%L#
M9M!A,",PO'G!=]O(56=([AI?8!PD6P:R_7QSA^C$M#LQ[;Y+IMUDV!VFW8E8
MM]M7]9U7NC?Z67'HD\CYE2]+,$+<M?B)%:MKME5^]"@\N8?HPUHEEMYJ6/D?
M[C"($L"Y?:F6S;S[/_]^=]%SF+.,TQE M<%1=DC**"YA\P+3>CC%YGB"+5FB
MU&1[:E$FCDH:_7#?OC734ZO@;+.=+6WJ +<-_L,SQ5M((7&&PQ'_SF1MYK=7
M/?B$,9R6^ S@]&,9%W*:15XLJRV4+5&X L=F;('3'785SWJ0Z.UK,,@W[^&/
M5Z_?D-/\]/[UA3W;7UQ_:!,&QZ!\B:L43LQ]KZ:,3LT,TPCX=6J,C*OOGUW\
M^/G-J\]]E]!3__#.JXER:Y ,K$*RW9FPG/]>(OM7WOY]*7.XWU<<<J$E7"LQ
M]ZTA3R1*<RDA(EG?")PD^ZDY0'\D"V)SR)3@:MR>0HH;=A53.-H^I!F<4!=K
M^&QSUG-^0>CJ?[XILW3#I<WE@D& .1<+,<<AS:LTOD*4W9XW'-YZ0MH#YJBK
M8)H5?TS?<7>R ]?A^<!Y@XL)E+Q&%>;$L3/CCMYIP*-><S\%@@XHS?DL[:N:
M6HPO*FF2PQH\QUW%$S#@&PY_4-,F<N8<\P=4QM(C5HCFE8AXVB\8KBFL*)=<
M!9ZTT303:P:1I^X@XAL/J*%9@^>DJW@VQ P0F0/%:(?E<$KF!K-RXIQ5P9 ,
M=_:%@H- -BO, ]D:/*==Q5.&/&<%Q;6A1W#EJ":8HYA%NEZC[4;.;$L8O;4I
MW_!<JTJ=K<O8';(LKF9.<XQ&=*^(XA-1;'O.C*'58<*QRC@V^3*VY@7/\K_#
M'4G3V%ED%/W.M[B#<EY85)#Q/*O0;-'$(!CAY#'1[QD#!0I+@>J0%-I4<&F7
M*.<-(+99PF]*4Z=_\"QUSN1'I9Y@HH)3]2R<HUNV!E*_JY!*\SJ3&4)E?^>T
MX[?2Q,_(3G?L3F%Z]K>_3CQO^/+R[27]S7TICT5EE-4CTWSUKS_6KZ9NH?R!
MUN!M5^^I1;RUU6[K*2"15\Z8CD=FA+8,TDCG#->(PJLH#Y&S0"S9UE&K2'#\
M1 H1L1E2,(KZX;%G3ZP7=A54<J@HQ5R!2[Q%L3,:5,^'81HJ+8Z*LI1QS#.!
M3%I6'[T0(SG+4D04P.*09[.J8 VNHZ[B>J!N(W*G>4XZ$5_ /5.6>RC2 D<[
M&88OG5 FH6?@>\^K+[J-L]SP"M:@V]G5I%A[Q<C'=\[F:;(09*: 8M/[ZJ-X
MMVRPH)C)5'(UTTW<D&AO4<'K[(I2;8R0=$) 5 _8*HG5PED2ATJ)LJ&GQ=LG
M>0,_7CK_@)??8(_&K.Z%KD78T[7T.KND-.?( C!-+U>2B-Q,@12E$=58>ON+
M-WIZ,0+\M'ECYT'DK 0$UG&Z%/,6=Z__.33]XVTNM23\!136Y3S-,7JMD:O2
MDW^^>?].YR>UO06!3F?W6FWP"W_C.;$&5[OJ3,?!M6&)!\T.##3%J= T!T^<
MBJB_P!QX_[R$MY=YP<BA6T?[\3M;93+N/]KA;K')V$1RL<"C5-DF4KQ0\;1?
MH'X=_#2>Y!5C0;;7)"N(0J=J[."^RV:.BFEGRTQX^ZD*9.K3PF^%)&9\*XOI
M*Y)9KK;12')Y#X.>,BE$3)Z7"OG9'" UUKZ;&M7PP^<KS)N<=#XO,WMH"WYG
M:TJ0NN3%P)K[/+)*&+#U9HI!;5RQK&CL!8HX3LN0252[?W;)7?<@5%H#Z=@J
M2%MM0JO"SI$6,CU DM&?G"096Y=D]*=WE&0<#J:/*GGD&9)'TGL<%C0:!3N"
M1O!)I4+'_99>W7%IR;CYTY[<Y%OUXF]()X\23I5/T@E:M=O*)*(*$=;OLW29
ML;6>&O\M$=BDN2RH(4<!3B9K]1_G15IM0G&EWH4W<#ZGFSY5F&QQY>'$-FC;
MK/[A<A5JQB!8!RG2^U1J;+]]W<B!2SA\9YB2)&F9S.4 9BW%_'L)Q[ULJ0.X
MH3W%OW#:84SE9C-E18< /L2[OAU262[:P73T*)2DNT Z&AX3TN<6!AQ7Z&'T
MF,;SN'.2%W5ZOSLJ^:I2>*!\Q%@L8,N<Y"CP+'-K;:\0T-47G)>K\D5W;QBH
M6@B6%) 4SCA/3'V.5)%DY4EE[H!$UZE$'&PYJD:A;9@>8_NC61'[NW,FSJ7+
M8Q7"*XZ5@VRU+59KY^S_?)9JOE<L/M?M#*S&42D-]TI(86< V_6&^-ZX6&V=
MJS0NX5T\RU_: ^^HP_">B7T@=TH[@'R4E<L^_B$Q911KYA)0HF65V4:/?F&C
M1! [;U%F\,VL0>62.]GMP7974[=+V,*;<FI'F* U#5G5[0@FQ#>_R4A'AVT4
M'I_]Y\<:<"<=!A>U9[*-/&@CW-DH9J7\UYH7;);&(E_++M?7><;KW/"@S2YY
M@J5:8F'7T14E)BC*H^S8&ERG'<95LV;-1=@'S^";C].#EHJ/PIFXNMG9VX+N
M>-AA=*4)*@D0F;C_S.#7PO'YJHUIF%SU-&Q6##[2//T"-[00\WQ_.7K3KU-%
M0+39J#QI9)TTLI["^AZFD>6>-+*L0;#5D':#*CNJO'#H^ LF!XX_27?..(KV
MY*H_DO,;:Q,RA;&GO]%99G->;G"Y)$T>4!4<(,6BD3[^*F B?L7C=+/6<_+X
MN[W&?/1BLXG56O&*:/GA]44U!P:':L7L>BNONDXS;D^?H[,<9R.1N,G.D!8B
MGP ',#.P(L$U0"1)>#1P_K/"X!>,G&J&\,,%#HPA\1TN &E,7MICJFYG6<X&
MGA6.J(F'H>:O%W(4#)O+R%+N56C5-5V=<NPOCH,+U O"L![QZP52[FR2YG4[
M2W*^QBSS&L[/.3A>ML02 !Q_Z:(/_S='X=U-(7VS]M4-T2?TL^[X)<*.<3JB
M"><P5IRPD  '+NG(B&01L_5:JN-9 VEGN<Z87@I9[)OQ+7:$W_WXVAYABB>7
MVIJE<72,Q>B-[/O5ZWO>\/'X:#=\=) G]GBMX"/=<+C%U3)Z:^ZU7;%ZJ\U=
MN-\X*>S,5UF:X%",Z=8KIR/'Q.?(PU\LN!*Z_>F=(W5QB>>R3DL4KL*)_Q)\
M%,[V;S<8$.!4,KW)'H:]V]D 74X^Q&IB,&9Y@00BV:63#$((N\NU<X:S+P+C
M/OHWSJY!>IV6RY54](QX9E"0V!JNR@J^Q(<"K@-'#PZNHGZN31J>7F?C],HJ
M"4@YKJ+D-Q& 67K-(7 '6U/%DYBSB%*Q2(#I99AA4]"NLFH]<$B#-A"OSXLR
MDP-."Y$79<SL7=9KF0)6F\,QNI\^P#A#NTPID^(//%3H<-S><#B$OZ4;&8]+
MF<]>4PQ4=8.4P*YB O\+L([2=3L1XU/=[6#B#B;3]LX^K"[27$6\/5+QJ)5'
MOK-)#=9X\X(VR^.SFDE1_N:^>7<0R@=ZC9.!*07AIF+J3V.G4AX>.!]U&;A>
M]M2\7#A]<22AH5:@[NQ<)P*KL=9<YTBP99+FFMGY;2GB5Z\']^?CVN; _- =
MC-J[J;*(2B4Z+?)#?]6WE15$S&)+BVKCW55,0_T.TM+"9@3-'V,83@OH6)3&
M/)^3S\*#>0L>"[^*K2OU6'^JEF=5:=,&%XY Z$;6P6:H]HP1^X:)Q"(\.RN6
M!G:492O.>LX"7KHL980L?ZP30^RMD'N70'*D2%<R$D]G$%7+X9V>60:'^)S%
M>4HS'W!>X1S(#"D/6BG3&DP[*Y1V!3:$MUM!AQWD6'SAL5BE*<DRK]B5E!_(
MEAR2W76:(Y4]*CF=6;OHDFFJ+#D6"P[G&S&ZF!&E.*TR=DX::3?$%XTH;S)\
MH1#^D6,Q(U?0-9)@PS2QLF48)?S4C/6180L1"[I<^-4!W5PO!])-Z3?OWN>Z
M*VV11[:K7-EFOD#%#;'>,%6"S+_@4<BWTC7_5XHI204\E(JMC1S>?\5B A=#
M3+11!(]JGXTGQPM>4*,+7#56N:S!M+,5RSI1\\8O=A:)]JB.S')G!1\"_^N'
M+U0?1K_$GA:8[SU>"^PQ.S)OOHJ<(A2PHXS1C@HT-OB7R)Q?!)RGRBO:TJ[Q
M_<=KC3UVN^82[G?,,@Q&N,8%#(86[JZER52'VIIM:1@/LV?<N0N.<UU"8EAN
M,+& 7Q%?G9=SLBSV!X-()@7?F5@F=158A6:+AK7FQ2H%Y+[B@<1P;S7F![F3
MKY \A=0-E50T1>@.I1VWE4YDGR;=2$-%1IXU\(9=A9=%5XP&^0ORF]M*Y/&*
M4VL5RP,JR9]G8@8O_/SA;9_%FQ6#EZ[$3!0IJIJ!G0J*19<9!B;PKUD:T2;*
M=[_T7>\'S[<'S$<D)3QV ZX&!&X[W//Z*^0N?[[XE_&E.O)4)Z9VLX<AKH T
M+@HV*G^0->".NP\N]1]$@B,[C#0?E_),S;BJQ5&EQD'U(URGQV1?5>D,8@V6
MC+Z M^F2@3Z-%:E.+F?3)I]57[8&Y$E7088_J1.N-A1(HD1RQ1.9\N.D%<9(
MA3999<)-NY;]J3F6$5@BI J[FN>[9ED"3T>N@;<&T<."8AU %,[3C-,*BDSD
M7ZCL%L'9FN/** J M=,5R8*K8NP<C^0,G2M D*):;VI3#AFX5NUT;EE&1.M9
MU;+F<E^0LD<$3N<T19UK@L7%4C4$;D(X?+&WPF#W<ND"OF,/I)Y5D+:ZPD#:
MGUQ:BJ5O&LG*"!' )W?*!'(<)^$\DB!38XP3LP7S$@0R*C,Z:560W#.829 =
MP<55:]BBN8' [RJBU8&(8K&QH$2%LE3 [XSE!D<C267=] I%!1OG)@%-,H52
M":W,>5.44)ZK4IGPO%<] -:@&W0573 \"%EQ#V)5+B)MEZH_N4KE?,^""9RZ
MG FY;:**@I5@?E1M1,"A3+!4XSOUE6TJ,@1A5S&5?$WQ!_I+9 V"1ZVP:):-
M'-I=8&CB_X<[,S!RCM7!_=F?BC@JB+!337<IV0I[NEURW+J+V-8G8932R!66
M:1T<W^K3)L2>Z7FW9@51@#5'?)TF>9$IOM6.VAIY7?E/9 G#BWK5A[8'VG%G
MH07_R*Y2//FV$M9ZULXX._=*B+*"2[ZU<ML[%05PQHOJ;+8GLPF'W9Q7^EAF
MSGN6?8$X]R/-4I8)"9H<:U2L#99I:!>AN/7%!S7/="V126MDR'8 G&NVV_G_
M'S<<J(4B,T4UAKCU.LWBZ!J%(R#@X<0X1E%T>=(>B=C3"L:=91*;@LD0;<Y7
M@-QDX-X-.7\X<-Y)"'>9X?_C#@?CYE4@.I;OG>,$%(VYV0MX9WFU>WKV \=H
M@]-W7RE+)XV"*JK%Z$CF+G4!_^;JO>$D+!X&"3M+M]TP3%=*@!6,$6(8JM[*
MP(>7)(^&+#TMXU,O\%+U=Y)%5!FNSE)R(OPQ56%*]SL[%L5'DVZRAXP!>CAU
M7QN2/Y_4Q@I[PR2[.B=M:WJ_Y;.LQ#64\C"\-G</T+@WBC:E#?C>?7CM+*@V
M1%59=+VX^AM.UM=\SM>0?N#%? JNK/6@HT?,1!ZY?!MSELG "!S@G&/^A^+M
M,1QXZVJ0!!%;P/=0NI%@7^M5X @XH"P%?-2&,'2KC,999/N&^M]1FO/C[*!M
M!6"WJP!G+"$Q'R6Z--L171HXF(TV5P2A*58Z>J):_U,G,0BZZ\G=F,)HT;$(
M!X]M3G%&7E=QKE*<Y@Z8%8L7U0*8DPCL203V?M74;HC >B<16&L0?/*5I7M'
MX*&=I:]>V[,S\WBC6=[3'EE/N#)S>G -Z9Y!W_[+MKDNTS?696Z6@#NJO<LG
M%D+L;RW0G(SE$C&GZ4J.L#W3'P;-']4=W;Y/53OM5;J>B40J)WU6;31- /UL
M\B!PW&]WPYCDO, ULH1#5)W>>S_F$:><O.&3@W?$T^ USS=";<PPA:(!*+BJ
M2,O<Z(Y"G"=7C#5(2 BHI*;A "A*H7E#O2H>J\#)4M<!K:D"^KYMH+8YO4LU
M(\AA\TKJ"NRSJMEJTB"/RQSB;5.1#H7.^O)\KUXN*[LBQX&F->0G*"A#.Y'@
MAU7+ JW!->@PKG.FEA35Y0,<6M-QV2X]5TI(XSYBVA)(+3R2D@9PYGR6]EF$
M^69ESE3\=^9<(-7,*3=6D>O##N/J#U\,G'>:3589'@TDUF>JIJ:HBK!(-R7.
MD*HAX0/C3O  Y'(W)-&5HFK\S1I01QT&]>SRXX=WKPB<WU[U+W][]>K-Y>4Y
MS=E'0@KPSV17'4]-!IZ:X[D+%S6? 66- ^?-FF=4DB0Y<;!4Q46,2HNV3_GC
M#@-Z4Q2D57<IF2;!?L21$:,;DNM$Y&L:'98K!-%WHRX*;U#1-DQ*^J+\@D6[
MXOQ)A_&LXR%)=:"R")7T90!4VQCIODF&YW+KG/W[S4\7Y_"N!'7"_H#GH&((
M$DL"V;_8"H]C'ALT;:S;;O)'*9#<<5RMP]B>N>?2,]YX@"[+G,=?RC6;.6<[
M<\;G$"!!UK-,8[&6+SAPNL+'.?..)'#YD)KSL,-H&EBQF%X$2>>9K[8QUCC1
M-R&=D9)%/(FT%+?K]7?:;JA A5L@&=@E6"CX7(B^:$.'#*JMP=7M,*Z5WS1\
M*9+D;S)<"):0;Q8=2GG.FAS#8/SB7&6N\J+6 &I=-:G-(U70XK%UFJ0:L_H
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M((4#^KIDF*&1:KN%9&G@?&Q^07<"#U8=K(%SU%4X55W'@>@FCL@]0OP$9YY
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M0I+"JT$;^%D$ZM8A<.38<K6_NP+9%EC'PZ["J@23\C);,!IA=N8BFQ.1&).
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MK_[<]Q1X(;BD4TC\9T/BT7#0XA.H:M\-EP+/G!J!IJ8[O*".DG4 !6]PR6W
M7T)[/,6HJYY"@Y,3C^6FW,1<:G#O>%F=X2Y5W:Q!=-Q51*OT)N@Y/[Z_!.R2
MM)QKIDNJG;]2S98GLEP.6,MCZU&_';*%5AD!'#_.BU3UK'Q[>E;!I*NH2DJD
M!),HM!6_#"SPWSS.Q4846T+H]OQ5 NW]X&.$7;^YB;8]/*=@VE54L=M4)@#7
M-=N26:'^(;X')TMV;.S?X&ZW7YT?19K/!8=G(#>>AHSG90S!.A7-!?Q%0;QK
MP19ICX3#KJ+Z[\__=SCT)/%SX/PSO483[#F+,J,A$W.K.JX82$F$E@[3!#QQ
M$DG.&R5;?$EK%[,B@3<BPTTRZ!WU(^ KUL#I=A5.?2SNN$=K2A*A;Q5SL-62
MQ$&-=#FK56PW4H/9F/^J];;)J^)/EO3=@BWEBPWC@U^[A$B)V7/0A7:IP[9H
M0Q_>2>%E.+WD8&W5MDOA5P&7ALOJF?,+2XH57 G)H)=;^#LOT/9>]7_!:79/
M%YW2[!QANR:]YGQ?6<0>0,.N FJLSZ28X\=,Y$4:.^^W'+YT^7LI9K-Z'V9:
M;+\4I7,6\7*>L:NJ34NO<%\V"N_$L/I-\CWV8QY-Y;0&X5%7$880PYF&$WLX
MUI9M@F_UG'LK8\-UFO&>\_D7]\+<3TM<MB7+$MI22W)G'-)UM9X@!8^7<]Q/
MNW02?HTG(XE,R.H[6]9*6M8 :0N%IGUY ;%8<(Q !'5&JH@1O!ON$!TX[WDV
M_]+_!,AQP+N4&,G<OO]K"F<;9 $2[DK*%]Z[%B@?XG"6062C,SLM\6L+JB.[
M> ,MHCJ#@-.9B31.(1O+^_SK!CXBEU48@*_^3@)AC>=/7P)^>GI%RD82I-5*
M0'@HU -R4VIA#ZAVB?:TZG,_EAG)NO!"NMDUV\I$ ]*".9?!B!SL1..K2-^O
MTK72*I2:/:CH2@F)(2;:%'.V!LS.BO7(*C8*,J.V3B3 -\('Q]/4R=A&1%@*
M7<%O65;:3/.TC,&WQK@C!MUP01I-RP3GR] )ZP<#2Z8 &=5=,(D<('T(U\-;
M VIGM7I0PV53:(50U/78!9B&"2.^X>!B4=K.24H:I(&7+R!5)"FN2J'G[\Z9
M.)<[NS9I06=T[%2XYK2-QAY4.ZO6P[^*G ;DD6,20RB;T&X?&L$&4T4@((+%
M&8Z7 )A&3*W3*K&$G3EP_BHU]7K,-Q=82%!*,++6H^<XZ$+FE:Q!N;/J/96X
M<H(#V<I\<T;;M"J-!!D;P?V'J&=6RH8CVS#:104/PDOZ]IFX,I#+YW ($_TH
MJ4]9K<=V6LS[6(>M#GQ0"1T.S4;H(WFQ"*!%8>S4JMF:UDOD<)C-Q09U7*G)
M?ZWF[&D#'NELYURM;R*)0G2_58"#!V>.E0.]T$+)W$MGC NO)>=C;5?<,QY:
M!6G;:YNT4A9NDT\HO^0XI0JH\5JEKDT#.ZT@/*T@?**9^UL^]Z$5A.'1'_S3
M"L*;$9RE<70$Q_<36F-"O @U>2WN/3@_'A_KP)E8==ZT&D*\JL2-(;K.U*9<
MV8G;D4%&:B"$ZUOJRN?E#/=>(0NEUC[.YQF\%J)S11^5<09B:DOD8%<LV&;@
M4(?>%,6M 2HGX@ ;M7_@]T,B4A\W/BR)8]2("&G-(*9BDB<8\R761Y+(#.YY
M<B6R-)$KS&W!T_6L8AZUOH3%Y(LA@X6B=)Q<BZ]X7NT(D!07C%1R3@Q@RJU-
MM@M<L>XS8(&EM]MWL(?(Z_I68=J^D<JY42R&)"76*LN,"B+@+=<\FPM<I5OO
MZX ?5/1K:<F\S*XXY'>8(5ADAG9Q75HU0USZ*/?G8+-=UHMW3L!*G$XN:>"2
MD"8'7=8;:M*7,WBKJCM3Q9IGM!T@39#K*:A;: V:G>6U8$ 2"VHKT+%83>[S
M! Q+%A$U;S"ABP%>9Q .O<WP35(U\N+#Y?MS7,BQK+\OB4OR^V_>7YP[%K7^
MW*=.&8X&YX)'=/YI!'Y+!';6+POL$%6"K^=VUB5=NY@P[5*:F(C!GM WDLEM
MI;E)'YI5^9WLN\\:OG0A]UPIJ:Z\!-^:T') L"B\2)2Q:Z8]LC5@>ITEP#1B
M%IE;X"(,ZI7++ZE#C^35((5<P"?931V)NTOV5R/+Q1_XB.S!:@VD=LEHM+G>
M2&O<*1:AKN_WJ/V:TLR)D-W6(BTPOS"L<*'&!AO!:V-AN9F*5KP::U"U2U*C
MS:4IRHI,'?JF[5;2>A=YI:R'ZY %+8[3.BD8V9 S?D^[KN/*SNNW&^^7=03)
M:5-U VN@[NS><C!@)*D!Q*20#6=J6A;4'H+<@^$J9)P,I&U%]L0[EBVA:CE'
M!$,KERNI:%B[0B.](U<H.<+2[S+DH2583Z4U5,0C[.T6?&0SEH[16IK4&D0[
M2V%!YN:J7!-KD,M:JAG'-M+\'$(=F3DR8J01?K2W"M&EE ,K>7G!-[E:/T[7
MXIBJS.1">6L0[2QQI2;SPJ_R_J(>-E(GV'[^2$4>2<6/<80>^;PHAY2?ME:=
M]$AW/YY:12*9AW6I/68SO"5X%%#576[V+<I(2+TLU..@VCO^?0ZW+ZIK4S_A
M?M!?Z@NTJ&=Z6B9TZ]PWRF4)@$('O3_]\DG'O/8,(/JN)>W,D_W7]K^KI *F
M3:$$'?X17\N0L.#FJB)T"WR!)97Y5I>V5+A'4R2<S5L:X6OQX?,L>?B.X@ P
M<A>1&KJ,5 Y\LY]^I4'?=QRO*L?1<]@"&95-^5@,'.WQ*+;L,CH2J)J/HFM4
MTO20'5&LQ#RG'BSNBN 6.?G0DC+&=^_DQ4(I*6G%)5H80B^XXL2QV+"L[MS3
MWI%<5TTI[;C0U>\#3R(Y%R++6N?I1Y8\@<<1E$XUO=TX=1_%_.]T[\<36:<Z
MQMU_VI1<3O;<YSX/!Z/IT=SL>'J\&WURM/=SM DR:G1T=(._U'%RHQ&%8R]J
MA S=J>1WF-$T..8?<.5[6V74%A_ B34/X)&V+RPAFI9K/?'@K'%K+'#=I>A0
M>/V^@;&.L>N6U$_O+<S.@V%H"Z GCW)7C\+S@LUBD:]D<;\>4(7G;BV7QLFA
M4]F*J4*VMM086WS\7&L>OZ/XDWKAL\@.>XW7YG3Q?F+^VO 9&*];XS=\UQ;@
M3GYCX22<1\B*D*4!:LPJ%Z+8$4FQRW,CSO;[BT:?L*5&?(N/63"VY3$[0D?^
M=<E5KIW?U)&7!%&SX4ZU($-88*X$#-B.^HA5RCY!:!F.[?*UFR,16L('2=K8
MHJ5:+)[-.(=6$&F[1!D]V6'_J@M\20H@8XFES$OJYL(GX$FDA%_T&,V6L\PB
M@G P><P#7!1PD^>/,^SYYC<;ASS#X6.>NP?O]_%TK(VF]*7J/]_S.0^.=M]=
MRQQ8NQ(=$!!@URB.D6SR7FY[UQ,*)E>@I@6@:!4WN0,<SJ.RVKZELQ?U:> J
M9=7)L,5WA9YEF+9H2Y@ADEZ%!D-MU]@;E];UCFI]-5+CT>M)94_,('NFEK5^
M N L4XASJX8<0K^[H!9IS&G&RSDKTJ]B+F4]:[/$YJT<8I"&-N,K=B72;+=;
M7\>(8/3PZBS5!#/%]:%AI2MQE9[;$VF$H66EQ];GJ&_@9U4^-S='D Z.OY/.
M&#;S($+\D";]O6LPBWB<X<@R0-LDO\L1(UDTWN73K#B+(0%'RDPM5X @55J!
M*'8U7_$U80>OTPJ^-.9"0[ISO@NQ-;#:TZ-J'=8S=7RF_8;_/:_LBUC8L\J4
MI4;O7MWOET]TI.:<B%/P%7@1Q%VO1::6#7K#8?"#._S!&DQM:_NTF>>]<L[*
M)*8J"DXR7(N<*RDQ ?AA%46-J<B9,]Q;FATJL^M=$7RP'/2<C$4B[>^$6^C6
MRRRGI10656?":7?AE3A G@+Q*]9@( ^!ZT"L1.O,:D3_?_;>=;F-(]D6?I6.
M_<5W0HJ :()7:1QQ(FA=;.T]FM&1[#V_&]T%H$:-;K@OI.BG/[DRJZJK 5"6
MO)MTGC;GQU@B 8C$0E;E9>5:,[S$WH4Y2UA;?3=-0FHT"\%.L)4ENJ_AU-<C
MDW!Q/%UHZ5:%,+IL Z+')G_:TI'JE.^A,V.=;<LN)9(]A__^GEZ+BEF[9>57
MZ=OE!OO=T-LVG(S57>$$B]2@.I\NJEE-7ZIMRB=DFOS:I5S&-K=-:S:)-WBM
MZA75*K]Y^0O?!_=%+.Y?_J?EH#T4VKSQU,AG0 VN)]/%%5EKGM8Y=O&7!5<Q
M!-0_(QP9JM<$746);_*R>N;$WAQ5\54T!+F'H=4HHNAJAJ+W4**^/U"3LO<=
MOL^ T(OV1MENX=KU ^]<./@;=QUE)54(JT''2)G+Z\6%,G1']GEE*G#;2LVZ
MLR,\4.YKW5;(AB"RD/MMXDDS(\Z*BU86[O>\8X+AJ!ID+Z>++'VI,/O2>GWR
M&CH5E B)M(8K7EF$^ZZPG86BJ*C*U3.ZL3>#?^11]_E1]_G;!LG3T'V^>-1]
M5H/@F),7D2/U?KQRA%;PE7#M'W:(04_0SUXRJCUM6:U,R5^;L;2&6&EWQNW8
MB7C8S@).?(UJN2"?3Q;7+^4I6M[]^?SAM&8?EO$1-E)_#NG%3[*&K(7W,9^P
MOR!FCEY(= NCQ^:.2LV+D.P(RD9N=$/R8EM7A?17;D.>J2:8)NLQ.)@Y[78[
MG89,T(N-]"V%8MJW9]*\VK8B%H1OO"V=!QH_[V55LH$L/._TW$_SR7H,_I36
M:'.[!IE?"WC[\J>!N-V/+]\KNJXN5*WGC\O8#B/:LCK"F';^W<GQ=Z]?(AC:
M(85C]QQMH+W&!^?:86IVNRS+.MT8*M0^J9H.SB]5X3GFB7G753?#Z$=,(#M6
M5=L@U^<QD&]ONN&3MZD8RF5\Z1I5%*BZ'&-&!/;GBL** I&M<;>I:UPN3'MC
MC.#0UO23^]=N_%VWPWR-^-_GIQ<4Z?,S!/HNM)HNPLEZQQP@7 P%$(4*MS4I
MC_D'7!IW2,^2F[1/;PBUJVUM"[JO9@F@1<)J]8P;3B;K']CGGDEJ-TPE7G8U
M6Y3W5Z.(T-4FW>"]D\MU$'<[1ZZ; ,]@9E%7XM=K]5RB)UI4T,:?ZW9;4POK
M= :3XVUAE[?PAS0U1:6YEG$M2!E,OP%,>5<[0H6WY8K.Y!35Q>V!*U1;?.J2
M%KN?^%R8#&,^UY-<%%SU_6=:=BFEJZ=S')PG)T?)&Q8=Y5R(D*R->88U-0'4
M2GC2;UGE,Q[V[MZ?:A#5I2LV)F\UF,P3/"S%7:XJG[J*.+>O7/B*="?KX5;"
M7340M@]J0T<Y=A?58'HV54RC3IS;[7#4?[_M<2A[;2Q@W G@\]Z,;YT2K LD
MR8M:ZE5;CJ4:,8H\^U31W.6( T!9\>B; K;U1O)T%\*]1N+9N@Z>9$4%R*V\
M9CS,CP+$<+*A-W-K\@>I1+\*5MZ7?50/:^]7/>Q$5R-GU,;<+V7N!JJ[V46?
MS;A&]Y;.R*KF>:Q0GB1:HK&K,$^_6&YH.A0GV\:AKV/[R4L?['1G@G1:Y@N(
MX0KR^[1ND[?^-LRKIK'T["=-AG57=D($^_\I]NJRM*ZQ[(%NGQI8)]O*&0AB
MP&&$_^8WCJ4\Y.T,W&W]_;<3OKC+7/RF"?L#F[T@UH+EZ61[.<-3\=JFDHQ2
MM8\CLVFJS#*P(:EY_4N2IVVZ0,SZ<=;+G]]^[/6GD0K5MI%JTO7>=X)6#["3
M;>OXY?X\^3=5BFUQZ\UC'(B#PW@H8RGWY8VE!V,5,CI;G_#'@(_UY7[#70^J
MDVWM4)6?F;K$>I00?*G:K^G4Q,I45P_@D,ERVE,&./ R$%.E[C"B1\YQ#MW"
M4'BV0H3M/T%J<)UL@\=2^KLU]'\^4MF,(893S]CQ].+AZ&Q_DHQ#5G21$>5=
M$>9]NE9IS3L7PX15I",W??L<B6INC!,54$2I.KU4!>B8]- ].'$##B^M<*1&
MBRW[5UM_\(K%7I.N:A-Z/8K&&J?/IPIF!*04^&7'"!&JA=VPJ1IF4<R(8S^;
MSRGT^>BEA#,@NHQ6^@QIZW;'[5927\?OV&D:J$'UQ511O:FZ(J>7346?.Q!4
M:Y,9>^U&4H2KB*):L!?=FA.#"+$5_M%ZY+9>A%<X798>;"B%!4-+7!*U@'IV
M/%50![?D\.AL$8VU67:NYQ,Q[@[$'P*S;6( U8!WHFJG8ERGV<05]M*6<:4]
M)2\93ZB&141_+(<"PB5"J#_DCV^CUAX+8=FFZ82BS(FN>YX:;$]587M/@1DG
M-<SE:.AY3C7'#25]L\ZQ8W/#)F7T_===76T-O1W2*5(4EEJ,K.ZI. F(+/<G
M'(,% M?F<8ABP[L.YM&ON[Q._]NN;,$#R]#/0S:+-D]N"#T]D.IRAAJS^8H&
MC6SC0["S:1D!ZX,MS?%NB<Z8-Y3XPG#,53>U*>BPE5P)/[B,4^BMZKC+HZB=
M<W8Y56#Q$V$K"P!WI?GLWGA/JJ-T-I.KT)VSMKPF].W*M^KVR+)'R=M>DU<<
M11;5'Q%8OD<A\:F"V=^2P_J1FSR>)KE<2@>U:_GGX6\N3&F6MNUW#D+%Z8T!
M;CDE=F(XNE*@%U.%TVX072A,^$0LI3,$^]NZ@(-VO;'E0 ;;T0>@L'S+@BEZ
MLIWSN:J]N5&SG;=E L6, \2/:'+LLQI,(!/$*65%H*[.0LSE73T4-1_<H#-L
M[%^59:>HUW.N:V5YQ-#[* *Y'Z0=_N3JXX>G27">WKT#V0VE:_IL=HB<HB#4
M15$=-0C?( DI;F>^G.C)C!&E'))#.WGI&BSDHJF$BQIMFM,1BZV0<H4^D.<5
MJ$%RLO34B$O\Y/4O3[$O=?'=Q>4+?RJ&>OX]W8(V#49%[MLOJZ[,;(&_\LZ5
M\")/+GGQZF+F^P.4K+;. (\>J0957?O,(Z+*1D0H$B@'136Q,X]TD&"MBE=A
ME^Z!.%RIY!> !;DEAEF;ZIH5&?%(5LK!HV8[BWEJ4-5%AAT1U7X_X\7Y=V<7
MV$Y_\B,=ED#Z%7![WX?9AZC^[RT'/_1D+&'U&&A \$V*7;VJEN'(N_36!?(Y
M!_)S91M:YY,EQD8;6K@IA_>CWZG+<>%F].*_49'"XN27WR<U?C+>=U[)=(RB
M=T.16QLOW")V8S+X&L0[T.T:/:J-YY,ER J7A\]<MZU^NS7[YV]T-L<DNUP,
MB'=3*B^-+.YSX8R6[\ZP7*(%V(O)LF4W>'U0=TH#Y+"#A>27P+MEZ+CAZIS!
M7<>6WO8#Y_:5MP-F&KRO<UF5R9A/[#$N4VTUF$Z6*"MM<M?=0_8C5Z;?M:H6
M4$F%D41=;:12W1F[.,:"GH+TX@'5E!Y6;^Z#X2:0'5JC?72-(9R0;\NF$XNM
M?RX*UTS8?9P6;;J+"U5CYK&[=UZ*)^[=-6N,J,!VW920&7 *FO_>HQ^S[PYF
MDO3%/-VD*Y.D?JF@X;T""M9?.Q$RTU-K7DQ70542RD.<N=HT!DX=L\3Y\+AU
M9IXZNT&)PS"O#+,,G%B\'*J\)93BKZYGZ_ZRY(Z[&F@G*Z+*MDDN-T6):.IK
M4R+2;-D'I%OHDI >TDA64IP6_20K#0'/<FG7D(.A5_-'\Z.X^*.X^#=.(R<A
M+G[Y*"ZN!L%1"0*.#HE9?V:O;9$4UMOW^K*]_XJ[U^X^;_U]RD=N/P/%DQ"N
M*/HK562!R=Z,D2B+8X$<ZLR P^$)[+&H<IIOZ(%L'$J'\"S):KMA4@]])KZC
MN[$VVZX-VWF&_K]E7RLML$Y7M_Q=6G\RO#]YM07&W]YH>10L_P-O^[]Z=B.R
MR$U @8[$ _J05!:L<+26PA1__4NL>IU$FEB+KN6BPJ\!*1+WF*Y<^8Y"Y_-3
M#*IPVT6SYLL3Z%8=GWWW^A=%3N1S76/^44/LG^5@0L_2J">GL^&0_V6U\9XE
M;A&#8H[^.5QFLEI7&[GW FNJJVOT1G<DK11A.MDA_U4!4KZCE'J<=LSD61,7
M<,DQ295V:]N.STD_ E[0O[7Q1%5$;;>%JIA[XDR66.%;K@;1R0[X(T4<P69H
M3<V:NFF;K.JTY-L1G-/B%CJ.:*X1W&B_P3F3@Q6N\[,(5UXJ6"XA^0AREKM7
M%3'%IRM;[O8Y3+E.RPS(-=UV6]Q&Z0UTKUBX;##Q!]\J]VVTR- XR4U#1<,"
MJP.+"B4$93F$JIZFZ'3URCGH.&Y8>9%3U<1\YE7':Y3QHHC[,.7:UT!Q,G\4
M870_RKV*,.H:A-_7T&ZO'$OHK,IM+GNC*3;*(%3#"TD;4V>6RG?H#8LQG@S-
M1: X>7=UE/Q<N:^I.;DF+__-MK^^N\'KHGM()AVK;O:%-9XC1NW(&\U0I ](
M7HF"@K=KUZ31-UWU[[SR0L&),,L(G'13H6_"DSLT559-8&'W!#'VN=E?)20$
M,:/#QME-Q=PTGKV_NVK^I@=-+7O<7P_3X(>3#\'\^/G1Y9=_7=QOST].+K[I
M@G/OO'][YF='S\\/(7'@)SJY/#H^/^[_]SNYA?OQCK]_205'[0YY^J1X30A\
MBKA0Z0WG#K49XNWS+'JEH!>:+)CQ.LK';\1/H:[5<P%OO+F_G!?5EJ[JOM7#
MJ+6M,7RZOPO'Q_O8MH==/I-?8@W0G]Z]#YYV?JODW94NQ9T371OG(^/Y[LJW
M\SJGIDTW1A]A]!=*!:QX0A3%G@BHGF;>B1:UJ[_\X?_SG><U5+>KS;8K&G8^
M1",*_<6031R8YWCW[84%#WI=5D6U&JF5,=YG[U27*-?(1X3'8H;6DEV):'=5
M;]?TV^TC-NNQ ^?)EW3<)DZEVTC% 9QG,VA8>'$@+<?(Z0/.KQ\>2K_@WHOC
M83OS[:N/,Q1X&60L2T.I6&ZDL<AP$1K,:L,'P*8+@VH> Y^NK>QFTY72/KZV
MM:+5@].3*<-(;RR6O5#2Y=? C>E"=;J]/72$/O%G*##U#YSAZ*5_)Z.C6@2^
M^>G,/.*$0 ^4IU.&TI0K>DMXT=(#]E3RWSNO4)F^8:1*4?B[AZT:&,^F#&-_
MI3%['0N:()?<0H4+:@9#=S4GC$#P#2"4P=X65+Y2#"YZ7I@:&,^G#*,<@Z:C
M<W$6^T_@VD3VR0P^6Y;5M5L2JKF909<H4S*AQA9TF[I%0<]<F[1HUQJ=H$\O
ME+",_O(%D^N&_,/3.G=:9:X^AYA4;\Q0F&M3!(6_(/#FSAE>)O4TG"!%YBIW
M;<73I9+/X;V<*+Y-\C.$VX"FM%-X$G9(:SK^$/#,;!$^ (.[@J^9O.);9HG.
MC)ICY?F4X8RT-NEGS=WT*ZNV879R,&T[BGJB.]<];SK)=AO$RS65PB^FC&1T
MEJ('6O*JQ"&'(B'?4!A&.5P\FJ!_[3#D6G \.YXRCC\/&]:F!(.MD25AN^D*
MRLH-9%5QB*9N\[>,#UF"WIL-0CNEZ@A,7JGH[275(*E+NG'LKL;A0&*Y10N7
M(\Z^O:>CD%EYZA2$J^[,@U0*QNM:VAA[KG38*HX)(8P=.TT?)?\,OG#-KGT.
M4Q="P]FENDY"4%%%?*9K6V/LBKA"(PG=0[$77U*5BU-TX-;AY[D?W@5+1]?#
MV@O(<,?28Y.\3I>PX=7#\#I[0!F4/R'GV;,70[^7OK>ERH1Q^+AY_W(&VE>:
M?8+V0F'296%:9PO(>"5%NC %=/T\%1UE#;>LE*V8GIU/&4SA<>V>L]=5<=TW
M&:-+]%-9W90^CE_N]@3<\P,QXUWDS:J)L'>FI6EU/_'IJ)>LW%]6"<&0U*EM
M.#;IY.3='8M%1F$^81F'_F4<L"PJY1P$:MM\XI6/N 4YB[M':N"<=.]',AW/
M= N-8<>H=8R:KPS@Y(D],D<S_W7<GEXE0 V8D^[\4"PJ6D<]T]:;N1CMC?Z7
M,(U#G(@L>&W2_'9OEH:8ZC?"N8FS2U'S6XI1LT<+B.>Z-"_'!-%UKFMZ[*KT
M8\^TW,]9!JVT3=?"5,$]BR=L43^--TTT20UKXYB,!U^4-^[V0_WZJ<PDQ(C(
M<OKQ[FHGRZ1+:B;K(*[$T%3IG>ORZQL3O?TRS[&V]Q>TZ/SLMKS6@P33?+8-
MGZ3R-"?MW3M1:RSRSL^4T;/'P_$EXJ>M5H9/36<;;=R"%@4?BO5>*\I7Y5+3
M#^MW-+-991%+>+Z*T .AMCI]/ B_O4Y#G''-E\O9BQJ0#]LGS=-D.+3R%84:
M''7I:8Q\(>*\%$C@]\5CA;[]U<\GW/%(\.RL.-%MJ*=^.'^AZO8;=2/YU:Z2
M?E]$=R&L7A- +GQ"2!WH5C^QAL(..<R,\MEEY3?7A&:I!<V+8U5HCBFZ=H7Q
M^R?.'*.TQLT0G%GB=WR0\FOY[_C\)IR_$9DO(V#I%TWQV%\[2.^##2TV8_0E
MF(RK 78^56"1I)@ER*W9;3QJ/\QZ%K[-9[OI-JQLPVHXX?[K?<)%)Q,[YV&Q
M5)IP:@#5Y0 _(J G\^,D3V^;F0B>Y")Z26\L_5[5MN'RG;YC/'D]DP4&3G%^
M>O<^$9N,K:GAK,#AGF6FP Z*R5E:C-Z"'ETU>.JJ(D>UN, $@DV"6FQZS<\%
MW^0)R&J]CF*$\5. +-SHZW $>SWWM%[Q'#'IR@W]@4M1^AB4QCG)(XM2@ZHN
MX>@142WL)\B"M17;E"SI4/TW6*4[7'5'97>\-U/8E84LF,C\E1TW@\"J^;PE
M%!&?.=C(U398 +IX58/G^53QI""C?!3**W[)"P?J>ZHOF6OQ+@BY^<GN^P]O
MW[T.._=-MC8;X^?XK%R<\Q0*U["%&4-CZ2U):U_6L/2[;]FJ@5>7)\JX!AJ\
MEN=Y4+8WT/CEZ*/KS[G/0')#Z!=I5Q*F^2#]@6M?3?B*[R8?MDXNL%>=T]1'
MF*XA"L'A3/D:UOE#7S683D=G:"S^-[@_]R]/9%;<G VE3N\%J ;0R8J]\UV9
M2CO5'XMB"I_;M*A6G9&^+5H+:6E9GI%A1LQ1X&[$GBA2>J2#%@N>&_KUW'9(
M_,%0@ZBN_M&8-VH!NQ4<DLT6N6FW=3!$528,:DRQ%1]-<5<(\JI WYKZ*'F'
MU)E>(^,53C;$]ET)AZBI77!K0?5RLGTDURD2[RC.@;PTKDRJH^]*^ HQLG)+
MU)'4W3"N_1V+AR]K-A<;$\Y'JZ)'JZ(_(_+^F%71\T>K(C4(CBDE:9NL:\31
MABZ_'2=3*4WDQA1Z3YRO^-K$%.P2CV1U@ZR7-:Q!2<V-5P!B 8M,^@=:+L3)
MYJUT. (&T]5RZ84V+!42^);ER:5<A:[@E%M3.@;),LUP,Z2.=^<+#M:0@Q!&
M[AQ:-)65TTU975I)F61<8&9!E)'% HZ2*WI-BD44EUW16L2UW=(;"4MJ]/+J
MEIL"T=@D+9J*:Y>JD2T[UR)2@^E\LAGKJK.Y[*LZQ4U>42T.M%I[%6:XAIF5
M%;V!CHK)0:9K&V[M4HBRF 27-PA3J7#T0#K=F6<_P/9BV"RA? 7A; O'EC99
M=2G31@SW<J7I2E]G'Y9^MHWGZB&3S$]54?!&)9.@BD?HA<T+"-VSE;18+ H3
MRTU*OD+46&8HX@,!0.G?36[IGM4#IBX^Y<B4 Z:SEN:&;6[2LNS0F%$42;K6
MVT:-I*O=H(EVHUQLI8O&F[,W'<@A:*GU!4>>MBGW1\45 ES6.I?T!2^G*]N<
MZUIM&].*JBJ*ZD9HXFS=S94=#_ WAOZI)_:IV*\<IIS':0@N.$B1HC5*>4W)
MA/3<IJN2$DXZ)Y>$>(&O.<JL)A<C7=MN8];[9M'7=DYJ=$:H>EC1*.V*I2TX
M03G(Z."']X]O#C'U;.\^L4@;&_3*TNO4%GP^JX%:U[+=F%!3?,W<2UTSR-<]
MR 2)IXNL75G8JV_<6*I%((H$H*+"4+RH^5C(N7*LS=J4#1."JJ9]1@=U.,^U
MX'NB2R!I9'RY2GP2<"U[^OK.?GC$J&UV>+2AIV W"'/>%Y(P%7ORV%^0JA7^
MO53=QB>ZE)/&[.31B8H;%5NS_796D6:?OI1&Z4EYE5DPC9KR0@(GK NPG=9^
M"IQFGAO =:,?&%.26]B5V%;/=LP^9>X%THZN5;R3,U50CAAD@*@P//LG&(<3
M$$=B=LSE(#%'OU33=KEU9I B3U84;O4.I^\ZI8=G=&VNZ"#%T_BTMES5F%J3
M(?F)+O/K48$ME[;>?-TV"=3*,N/0EA%'@+@V/@6BY->VCE; ;3O.D./ 5P.K
MKGV]4=>&%%UP6HR)[J,[>M5P[Y/G1%$#5+RD!NL>MLZZC6CD<]UXP*@"O5&W
M4IFX$U?/Y:;,XV?$8(F(;534&QQ=6/%8]"<:/<N4A^L!,?#!<RU@K>C@K%$R
MFI*55-G8PHG,77-YX%X%Y")%*^C*;']&1!?YRJ ,-X"4HG#6HYIU-1</#0M\
MH&SHMR6AZ%&8?&7N@I"K#(I9SEX42<4ILP :$=(>MT%"R;O,!J-!=,09CINJ
M*W)$<E>:=HV<U>T,2.V1%6BS!O'<06F2-HGT@-3@J<L':%3S9?J9KJ4=?N!:
ME&6MH/K!MGD0K#:^.<MV7 <V T+AT;?M\LJ(,XT:5'79 HV(ZKHJ?-GG4AD.
MR890*LP*<\>^4>IW0#A_<FNNT6SK*/FINC$\A>Y*]&0/!.Q,#Z2Z+(+&7<?:
M;8$CEMC"8:<'SO-^S$^ >4'7:AV!B'YK$#VCL];MYNUGS6H@O9@JI(.ZQ+ON
M1)/IW"Q9W^S:@*_*TPW;?'KF-P86:>$[/G=..V49EO-@X1NH4^X\O9PJO)+G
M@%R5U^D-+T]">& ?2#^3Q-)[494K"L1E>DW_P*)09.5QJHO#.K)L3[.UK>GO
MP= TQ^6VJ-IP7.)F)7SZMNHAUP>T)>C?Q7D,YZSREH5#-'55SR;+7?7QECRY
MKHJN;-/:PNZJ[MV?Z>]/(XW7P$$7,5?VU6/8N=2A\*1;UZ1^72X6^%$#YF19
MJ\Z/LA$M$!DWLB)(F!4'96LW M9S7IX]8'5AVY02PX="Y96?[+\+\L>OH;O3
MV&L,Y+\1@+-[ T"7M..H%];;GA",:5^HU^_4I]YE.T5=;FZ\/AD#M3_KLWUV
M<GKTXO>V!K]AL?[('*E].[[BDW9V>G$T'^_MF%$5X:UW@D^TGBC715L><PN'
M[KC:]6K8GC'A?Y$I^QS#7-^;Z.1E>94RP<*R*^+;FZI_O$MPXF=T6SH8XHQ7
MS>TY60JS%!+B4;6'H%O.".,._@S8C)%=V,HK(H5&4"/I*\9> ]%1$W@BFE9:
ME;ETC-G*V5E,!JZ\5&S+?L7 VP>ZALW>J2H5![!E,&5=QW\"Z"_1!T"DE=3@
M.EF2LB192=[5HKK;+T_%9W$H(5G-OO*&@W> G-(3;-VT<;*FT*/]?++,Y)_[
M8O]KSMYAY#'6"\/RD]5F8^K,.LG8@&'2T75*1P$%LWP^U$ Z628RCT%,D6ZQ
M*Q["4<(,:MMWG;A1W-&G0FCJ .X9[T7>_2%Q'C-J@-7EYSHF0>ASOZZ5!AUF
MG+\0%O !9I<S?T;WN.]DRW36HOGNGS/;Z>C*8I\J0]!S7>ZN8Z[#NIO/,;_H
MA,4N,AH6Z/.AHR'JDZ9KZ0#NB5Z-DPL=H!T1AB(ZV18ZI(Y?8O4P@\YUF;S>
M%Z8S9B6O3<&!NW#9$]1Z6)$N7@GQ4S",Q["-4-L&&104SH(GD'P:6%Q"#9"7
M#[>K_K#MW?>\987,Y]4?5W^\MW[/^80IS5%7%\H<?##B,#Q S&)K,U%"]XN/
M35?(\IQ?# !)AQX<.7H&9+5$T<5DF<W;:@MM'#X+W=%66.9K\-&6)GV8O2VO
M#9USLG&5O"_H=P^2V6_?!\'L=%5#%#36?@Q<Z/[%7@;E)3483Y;?'%!Z]?*?
M0_-YP@UL.]Y(%=\F*A^=/]K&I$T'SW,*YJT7MY)FKR?JT1>\1',:16W$>%?4
MJKV8+-GY,*VJ7Q41AH\T QJ0ZEJ'/GT>N$043B64!JGPK"$G(85HOV )J"T&
M<;HDEB?+=VY8S*IF^^M G'/QZ/Z.V'4='+$#AI9RO\OL S0W&RI(6/9,G("<
MHY#H-P=+)TU<NXO)$IYC8_,<>=!1\J:K@=_L0,!YLFQ_LA[LWTN/YR:UU[VN
M%H<V]^G5@#IERG/C-Y-E<P"K!3 :J&4E@6I\1-_"9&GGB)41]W7@-T/OZW)I
M1%&;-Q80H9R8K6V1UZ:<Z8K4R9*>W=Z(,/+<$D%TI>Y@&-2:JBSKT,<K1126
M@SSI<VSH^=1[JX+Z5DXN)LMVKHTCZ^WT>>)&GF_U0-0P:NY A4MTO/ YZ _E
MGM,7=M\EXY)>K=2U:I!]/E5DD2JYP=9&S-AY5],95;1=?AN:#VQ'*TV)OND0
MKF;6J)"*F'OW'*ZE6:4B *616GNAJ]LTIGM,,S17:^SGA!+:=MVXI@)7H%*7
M8!.,D&G=OF=F:FZWX^[E^0SOXCZQ2Z:Z\ZF=R&WK)9V9_@[6(2\2IL4WT\?N
MT79DJ@!7O6XLKYU \+7>@CSMU%_X3(YZBM"6;6\J&7WVN/J259Y[8"3:;RR-
MV9U_M!]YM!_Y,R+PC]F/O'BT'YGB*.Q=6G;+-&L=_8ORG5>4M-9VT>&)SS@*
M*=/Y$&O1:AF4/5<EL#2NMEV5T.4$<VY?(H2<A?MN,[?/%8$W@V!!0(ZAM.P&
MPVF)] 5V[D5Z5DVUB @,*V+1OE %[)CBSK:TS5K,UV7*2>5_Y6L/U!:L]=1T
MBW\CMZ1ON2SEVNS(08,MC:7-0.^AY*;_.,#[3A.@\^.I(AIBKG(;"/N#;.FN
M!T2'>D&1P0@RHX897;V][&QH=: &S_E4\8S,)"B OG.[E_T2=(17O _M2HAW
MTCWXR-T#/4R>N:ZIR+@B>;T)M_1E')O*UO[2H]AS"A1/A52RB&].:>- )[;.
M>_+"C^_>#PY<15A.=ACR,P]#7("AXYVL<"26PS3'&_2X[AS_+<=P4[RWRZI-
M%\5M&("A\3.X.6-Y7S683G86@D,Q#/\#K^/7+F5A\^:V:<VFD5NQ;.M*EKE<
MYHOG^D?R;E]K6!'8X\ZWZU$RK&#40#K9,0B?JG+K^=/4J3.S03K%'DY0SW5E
M5VYDJ #G.D4GBJI;0MA$2T6_>[VJ076R(Y!#"8P;6*+=W30=+]Q[;YH48C]0
M4_<A[233,CJO\4 QL&0Z\]M^77>6U!65GJ6>*?1\NM./ (]4(#U5%JFM"S08
MD(I@0EOUQV[:QF1."[4?ZQ8]]>1!)[HD8<85:XJ+2CYD@U6H.UX32HS8DM)F
M[2"_F25]%KRJJGS8%-K6.+VA$>V)G3^^>M_S.M5@>Z(*VWO-<>-$]0">R:"H
M.9!+I7X2B5)GF%BI:@&=G$X5TS0GO# I[FN1P7$ZR&(C"D C%$TP17BS.@[4
M;"T>?+F0+M&B996,9EN5N:;2Y437;&M4P8/4;AI(PV2$DRLO1:"+<%S2B2P,
M <YK7)^H:WH2@*/N]:G0+$%<]]["E#4W55G"._JCK%X+ET\-M.=3A?:+<Y.^
MO-EIW*9NX])3/+ZA?E'&DCZYF"JRH]<OWC*#C@)0??A0E\O8$7_48/J (^H'
M7I!OT-*SS9I/3JE,3--OB3FI(-"\HL3JB'XMJ35W*R&72W^I'%*4"K]091@]
M:IGS!G,R+_S\K;/J3>C[QR/4OEB"J/] ?48+HJ?'JA =-1&^3MGZ)'99B[L*
MP^2WWAG# -5P%1\>RV".DZ=USF=Q8=)&#X_V=#Y56)&U4KH3_"\A,A*H[5Z=
M%K''Q$D]1^>I+G&1<8_.U!8<5L.ND-B\5[ML$:AUTWE(OPU?@_VN5]/1U>A(
ML'40<N^W.-5 .5E-D4$I\EU<B7SG;L0=U9&,JI."_E-CW5KLV]-\ UX1%C7Y
MXC3T=2DX77 J!E:7@O&XWI>NF'#YS&X"L\\%V]%I5W22/I^L$@Q<TZ]\0:^2
MY7KV@/L;]_+FL_$.?O'#".P9]<8H_+\L4GUR?'ET<3G:1U7/!U*7QN+HGN*]
M8AY7DZ'](&6G&X6B&[CWR8W&+KG!BB@:P&GR?]#^7\*"_#VW?-6<ZV>3%57\
MP).2)NS^[9\R?@#Z?]Z__^\@0'2SKL13:OAL%K\8=*'"1X%RK>!0E>JI1L]T
MU3YCRIMPC,DTAAG3QHAGJA,DH:L<=@]WDK%90/XVH>L%2VHK_S27KC4B;P-H
M]6 YV>*GURP)(Q*$8U!](]0V6PQ54 @Y^7XN6;EQB]^GZ@C2G#\&]+#4=7E=
M5;QO6Z4&TLF6/;PQWRT\AYX $SUAB!WLG<'=EN7$!=^>D_+^XR\?F@=EI7P5
M9I?G]X79GPN9:$)_R[M\?'3QXMY"0Y<MQJC9Y14L3>D'?7=U-92W3)E8@'9X
MNA*=M&VLD?CA7:^12(EE5MN%)P3M/L^EH.K&DQ,VQF":\ZT8UFX[5NBB=YF.
M-SX+32LW5]?V,FPLT,4:_*P(;4N[H5\EX$E76M-4F>7-V]#7[9,9-9A.UA3#
MI8N2#-[!Z4!3G2>-3"X HX *QX@NPC+M74'):,&1B=R%,A=6\8X2'_XW&CV!
M.EU3##XJ:P-@D9KTHH@U7K]]-I1LCW-30)VA(&Q:'FYN4TI',Q &9H"U-JS\
MDYF@BKBI2DL?&&87J0%65]MFS!D*)/67F'CQ#3C(/CF7G 5'=R@O@6+0^X<-
M=1$;/S)Q*RV^N.</B!XH)]NW&<:@BR:G]JUG'G)^_O_X/.3++?DK%-2M;9"W
M3*49/[\\/SI[?MS_;[S/K)K&_+FNG</[,@Y@DD/T$77KH)NJ=6?^@;:?;?:4
M-8KTIO%M/[=7[%Y"S3$SY6W#?9!FK(5:^R8>%SYKDQ;M.@-7#(U=P_=Z"C8^
MW?&%27/_ 1!C%2% ['XXNG*9:C+(F>S.86\7UV^:20WEG%[!H"\SNT5_/J+M
MNFHIQJW_A!AOB<1*]'65YL4MY.99'C75T].=KM$'NAM(AMF1MZKJ9VWU#/\=
M"IYF:7F=-A)TLD-QF_!C*+BE-R4S47&#D-/6*UIS3VLKKZ,&S\F:>K#LZ2U^
MO,*K5#?=9GOW]2E>5V$"*OQ!F(929LCD)D6Y^86N/<-Q^\<4B(-#LAXF/ND!
M+P_N,\<<4=LV;H6)</RX>?_R*'E)'P"IGO&Q4(/D9%<+<: .@*N6RV=%NC!%
M]&7+N\%KN["L._N62C:3[V>_PE$ILZJKTY7K(:>NM^'6$=4 .MV%PK",LKA-
MG$J\F]#0K<DE!YV2+@(Q"C"?T]7*R.MRCMJN.R2U !-J_I"H"@GN4?**#UK<
MNVJPG.P*H=R&IMY-1^,L)=X^<I5E'ZNQY>Y5 ;Q7ZY  #WCYX!:I 72R^X/?
MVBO8S76X639,=^08SDV;VD*>(%)EDAFI@?3Y5"&-!30@Q9_"JBQ:_966 /V:
MN5TNC;,TAP$O79-E6_.:?4KG[-K4CXKNCXKN?TE%]Q?'CXKN:A <5S[*;$W)
MG=&JW%=UF\6)31!XCT@.O[,ZZ!4V%5UTD[WG?F]'<Y^:\ILW"SN0V 0EFP/?
M:XS]3514M8#Z8JJ@5ELN_"@\Z?UFQ2_.8UCL":918;73"5#SQB>0:DS6:_O'
M#F1+BRT$M-U]G"IJR,UU+<:/OBZ44A7'AZ4<CU0GU%WAU(-<U4>G933M\.6A
M%W5_31E<M;$9964F#9S/UZ^OHK44C#_4 'JB"M"12W_;M&$9X>1RWQ)N6W3T
MNU3U37H[2_YN3;:&04-KG%S;VXPNU%*13N;\ 9MN#[N[^Q*%!WJ>>-\_&+M9
M='7SAURF[XV1,;]0Y9-P7XR,;8UT0KHK]0 (K_!-[P#:G]?PV?M",>Y>0=7Z
MU?Q2%89C"KLXBSOV$&:BLUM[M+%:I5)/BQ-=X_:1TPH, X9:=BC$?+[HICSE
MR@QX$LG 9-C62>D'04*C@1):5\>;RFK G.RLW<G[-COGHE"6Q/) L,(9:F9>
M#CAW&SQP%2VH''##@MI<6_J=>=2[\X*27W)YH ;5DXFCRJ.>5WXJD#Q_\=W\
M^/R[UZ]? J&3N2S6O3*9!/+\Q?/GP3+!R1C*?H^B4U578W/44_5CM=DU.,"
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M^OKLMD^O.*_Z9+-/T/D=\'2:A,YE/2V"B\F.*%A,Q>]8B/LRQ>0R+DN'@(M
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M17$9N!*$D).>S^NK6:0WP"O1]-@@1]$S;^F17(G4AM(;..IP):L%S\FFKL)
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M]RUO]_'1Q8M["]*+D_M[H[]N"^X>[:QZAL7'B$;Q]A^OOOF^.KLW "Z?/R
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M3W6I_XR(ZJ*NLC7[.K[I:ARX8)'T]B^N$1%XT"Q4#P5K-K1JZ>$H:<R><O;
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MUA=WV2S7*9ZF<+A?-..&4="F,.'(]J)$:G"=3Q57\8\E]+P ,4R&GCG)S((
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M=B.>^$*.8MM>=W[\5W_Q'-FUO1GK?W=L](&_[XB/#G/YH^)#<S,!S5:LKB:
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M(@YH"EG)?W Q+)7\RQN$UKFQQ3 [-+88LJN*.-XF7AV_:0U+.7'Z=7QUC+M
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MK>+<<N0^ A\)HENZ-Z4>B0NI5N_.GQE\\G/B[;I!\6TY<D_'\8*8$RXJF%
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M9O"[ST:L$U'!P>ZY+_1MZR6*.L[;[EL&C9L3AX>^VV_[O!CPGG+ (^". />
M@8\?4F^WKER4LXRS+-Y Y+/-)#_.<9/.O@8^*U)\8(AX \6:?OSBES9#@D$(
M>[.9></$]L)P3X00]K_/0!#".>6A&Y)\( R\@>0]81 "2!9?& 8=)J)I"_W4
MRM*IB49WJ/G05/!$FO?MQ,61YA'(Q9##1G1MX1HG9A8G)Q>=@>E#J\$9/MNW
M&B+ 9SRD@W]1=GM(<TI1MNL.P/Y''#BM;?[_R?C9,U'+>"2O(VP]BYT0F'5G
ML>LTKL1^2U+'4.MOR_6WW[+EN,=>V^#D)M/T7>*M6<Y!R<"@6[R[8%Y*VXSY
M(]S],4ZD[.[DY=R#%?CVNG'=E15^PW$?=YN/]A;QG+H71K1CTBQ=MGJPR$**
M\TZE\=(#3<;-2098**.M/KX[)WWS%T>WC&M=DUT)OG\(KQ[SZ9B*+6L]YJ\O
M)))R88MA%+FC"*;(^Z2IO'BS)0FHK"P>M02J&%?P&]U22J"FR<84)%"U'5GI
M,Q9_-0$SKRDNSTW"+YCY/C6QPAR3KNNRVR/C"UHZ@EOT$DI2BGOJ1WT(KM7>
M W2R&E$5V9J"&C%,1;;[>8+)J-G"L"S9:M.?W=G"L+D495WL-!Q#=GMT@\K2
M[W>!R!Z=>UC-/T:/KE;%#^ ];Y-@0Q+XJI*?4_3QFKHZB*3M_J*KT:MO] +Y
M1?2E^K;D<1MV0Y6M/NNO2HLU>NVM.P[/I>B&,V[MC=%X;^7]DO(81+'W&7>N
M&!/0XPF%WRF-X& Q EOE82BQV". B-W+4%7CX\L\"'TISMD#"+C]_1NRV5[?
M@-"N213\FW&S]+ZBFP\4(+X7YU'&(#GZKSS('J4E>TI8RZRKU@0HBE@+C=*"
M(DQD/N#+O#NX 9)D0  0JI!D]/1]T*(I&<U299.?PPR.2YIOMW&2,9ZG7^&V
M<+AX)00,Q8H>&6#X0$%0R$Y3^?"5UB04F+DUT3)"K<S=G7)'A\$SS1.SR3F%
MY2!I&GL!01%X"+([*0;30HIA\O D^*XDO J#%)_?YLLP\"J*<YPLP9NJIBH;
M0E&U/<_7G:QS^N_-X(*=TG_=CVG."LXYB>Y9P5/X2N1DH6[I@ED#CC9^SB&^
M)*^V;$Y!7+$MK#6%V/UP)I)9-,Z46>PS@T288\( IS6S>)*FGU+"41TBX6C(
M[C=_42WE>@*:QS#,]JSC20[HN.%LPU)Y)B-5UQTWGMTE&WE"O_*X><-Q>Z5F
MQ4[,ZK8Y-N]Y3LR>(3&KJO*)'0N"G8IAO?',K*OSS,PZNC%N4Z;V2LTN1LT#
MAJ:UWG1W%DAHM89VE<0;%F$&:9J3R.,3:@YCWQQ[;/:M.T7 <D7P+<M$,WD@
MB9^BP4,8.%ZM @\L79&*WFS#^)'2="'!#9$UW= HD[P[$JTIYL!))L6>ER>(
M-/EY@C1&\H*E#&*_0)(C@6GLNM.E\2[76E4?[*H,>.1NCV<1A:6UH8J6^^.<
MT14G=WLQS\4"E<T/E!"F=LHPSLJZ04: (\[%NG^/8_\!7&?I$S!@D##[\E.<
MGJQ)CD[$X7+ZEFB.P*N:@Q'03I]KB65*_4FF? $V0/(#'[Y&)B5(5#3KC]*Z
M(ITP@F([!\M)+TVJ7IC$3A!"$ 1QRVE,1945H8Z;9SG-_]"2UT%0B%2B&V,V
MCY@MM/F!LJH^C08J#6)=DQ\,MM.*!W(\B>RJ;CJR.6=7VR'_#I-Z3\E__,Z)
M;WA861,D7RRUS]$=?59Z@XAQY4&B(*$AB[+*9,'N/1E-,PBJ(C_WZB@LH>F6
M>BSZ1CUP\_W_5EU+'+)JYG3)ZI'T[JHH<&1A<!X%61$+%^ D A]IL(Z"5> 1
M(!]<F"8(:E10%Y ?:79'MR2+/1J&>0BJRR.)%T1PZU*64)(5W (^=.J1+>4#
M 7,AK6Y/E[1%MP9)BBI5KY3&!+%->(P@T+F 3XW6V=WC C&P^T<6YB1!^N<C
M$*,DM$_O:1AO&0FW"9 89/Y]7A2S$(1'ED%4=(EP2OMQ(:SA3I>P"$G%.0C3
M!UFZ2:4T]^X6^+J08CP*NC4-?,I*'$$PXVU%&XH411D'TH)6AL#&H_!2>&!+
MD@PT0'H7;)%%5G#M&NT,*7N_,(2U1 NM^&8?V+'#N>#PPSW1@^<*N\A APWQ
M*7LM7#=@ #72+:'TW]7#>T*[3LB&N=FE:0T$(J@]8:<)2;$S@$#")V8R\FBR
M*!OKPD)#L^;)AL=44[Z.H/B4_?"@GJ6<E7I'$=CF/@B.M/NU3@U\BD 14ND]
MHJ\?N"S/& 1ULC31;-X\K'$>UOCJ;JUGV[(BFC7R=RP6?>#45G,Q%,DV99-_
M@36:V.E46.N&K/=B&F".9O</81PD;!+!,J8PLO% 0$=>&:H:JJSRJV:OY%.S
M96,R\JFZKNR:W5=(3+?A2E=EG9\_.M66;=TT9;?'N,])=589JB,[_%*TI6(Q
M3-F:C%XQ;$UN7<TUR18JQY%-?CDSW1IUV;FI6++3HPU!]'F.EG C6(9M&QJY
MPM9,A6>$7REL?4*.H*[HO=K[$)W&87(DP?15Y.^!V=7 E4&L_S"";6ECJ[WK
M-3-Z,GRK:J;L]%FK#'S;8530F(]&P_(=?I5R[)@PS,-ZPG44\,PB7P["LV3N
M"($BFY,1+T,S9+=U66)W'L("%1*6<_K W_B3,KA)7'M@ZZ5ZF: ]J)0<_\$$
M2^+]N4ZP[.&J6J6W8C_EK9W+.&"-'[\ZSY9;#*([^-H9Z[DY<B9"L;4KVM3;
M>83D/$)RJ*3DJ2,DYUSEF\R%=,I5GC@V<D0I3%N9\+#H.;/9+LV6(3N3$6;5
M-4Y+;+ZU 9.:=:9\YZA;H'13:<]WOM$!DP9$5_S3H)8V)?C$LMO3H&]IP*2C
M\\R.NF//CJKMV=&W,E^R;ZJ8<Z*X^=^&@WUU]<\\S8(57+7\XUK:?;/O)+),
MXS#/@#!'H*^/[ >>PC9\>$#=?I7@Y8$O_>46?JZQ"RBC<#+W01HL@S#(X&-(
MGL5P8&%,LHKF>^2X20(2+J0O0 +IRQ,2*+O[M5UFYC<D60<1(\Y7=O'=7]=2
M?$\3^*B'[Z2[P/=I!$0@O@_N,KO2[C99HVAP3P]B!.D![NSJ(2$01BS!MOUY
MA0_@$3<;%AB9NX4BFE)0J/'V\@,-%NV_>_6,#5<V-)%B'<UUY!YI+%55!N?]
M$PC73K:#S^ ?Q0I%U;DJX^Q5&2;$?5,8Z#$79#!Y=HQ1R7.O>?I38->!ZS#F
MXH/.&X4GL<*I4]W!I0L,>JBS8EG):-392T4#DZT94'C.AKI(S<#%C$"7>HNC
M,3QENPD*?Z3<SX=S+B#$!=<W7JU2FDG+1V8!(-2F.',;)/W(F"/^$\L%X4L<
M9F[Q@\XZ\^5!$A,I4+DN.#IOR$J7'OJU+"-Y2<$*0D^.KF1G6I:.09$#K<="
MEC/!9-%(J;>2DAN]SCFJXF,0D<@#S3:6416J)50,-L^IF.=4O+HD[,7:KU4M
MH1.I_>K0BWERH*G+HRX<U%U%UGHTJ.X6)(VKNDNU37GTT/B!8(X<_P$'1]:Y
M T":,J&23-75VB<0/]>K1!J*/"A<K9%S#"8).58[5WVLLCH9AM$-N[W.^:6:
MOI<62^B,K82)CQQ+%LHQ[Z/1,?!<5".E@WL:/@XT+I&'#=441QX+O.!:K>4$
M P ,=9@U#)8IR-EBVP/'70N=3_?%B&W2)ZZ9X ?P,WR=3WPQ!51>,^WVPSO6
M,_%\.+PA<.N/DI^ RHX0F&<#R'%90)VP!5=KMTO7%,9J:JRT;-0VLT)Q6:%'
M6$QS+Y'Y59  #;($Z'7'O-V41@'HY)1Z.<:I7AS=TR0+EB&5EG'DI\5*AP>2
MP%MPXUZ6$7BG7RT*^*^$QJGTK3C4T]7Q1[&W(4E K$H<.%I+[\ND"O#F=77B
MY8M^O;WY_LL->TZ]_K!@1 %BQI%?5D0$B5_1.SU"\(+()36%H:*AC=]S/2!4
M@YI^0AXB"83R9U:#I3F-K73_F4=4TDJ;O>_X?JAK7$H:-H55&-*9NCSZ$H8H
MSG:[4/[!+IL>BN.[ZO';!A5^P3>^ S&L)WTXTC/:&(UG$C^2,'N4/'P_KF3)
ML/).&%)BO]_825FOM%-W=4^[PL:2Q"L2)'"U,*?59N!GB5O((.C3E'B,E.4F
MV@TN'&9[H>/=)XJS]4BS1R^4)?'8DK"4EN=^O!"D]#Z7CT45:^EY[B"^DD".
MK#TGG6QY.Y">[0X6%V]P[/%[.VP+$04G9)7$&Z86_Y"_R'"\ 1*U6MR,8H>K
MG%'$@$2_D-0G_V*/KN($ODL$@46QQ$I: _6;X84FVS69QQRF&0[744OO01["
MW!=ZNA+BV>-R!$_;)E-;BAV'PNNO<(T;*UGSLLH@)13M4[V9BXF('X?@6\*G
M1?$&MW9A_(;O1*E@?^!R,'@;99$;MW38()36%7=D?F-W2C_!XCZ(N^Q8US6Q
MG#ZN./4DJGSX@LN3'?S$%Q'F7S8L',)[PK <3L"O+KL"6R1#,$W(T2*]$/4<
MQ1=KY.GEN+B.J]SGXBIQJ6U.E]K/0TUD)XE*1W3$A]N[9[UW\/ZN0(C(8FY-
ME_"[4D2FKFM:[V"/HDPN JI>'31.(N5_O?WQYI<?RQS!,PV63:T@+I'MZ1*Y
MF05@P/7B."R"I-ZSOJ9LU7S0  ,:<6F34YZ)2\4EN3-=DJ//?D5QN?<K48$/
M7=#4 D85E]#N= G]/':M[:4SGL>N>Z&KPM+:4*9+ZP+21EL-+^^=G@)A/:*\
MBVKGYG4;;IS Y%:G2^X&47<T4W=N./?V^;-B5+8EZQPWBXC+H;I@.?(9+KT8
M7#KJ.;;<X=*G&&'IPS100H+U37G(@@DR:BXS3$/F-Q-DUW<SA5$]IJ++)L<5
M0>(: T,P8\#177G9)VUZD^^K%$ QCQ!?W'PSZH7TCF"@F00XI04<6/:B+5PC
M]C^4OJJX1#:G2^1=J=Q>O]\^_8!6"1P<87-H T3^LR8W9'=)G*_O,/!<!1G.
MHV888\45<(7?DCA]C&BR#H@$UC2ZBO.LON#CAX$*(+G0?G05D=UI#P]Y=\5(
MT>, 4#,M\')2S][GGF>33#M<65R*V].E>(TD62_2"Q5V,Q$P3.U*#]J89P6#
MCDX &HPVY>2?W\G7T_$98[ #5SNTMXXZV*4$=&")L;W4Z&TTVKV+#F64DC+
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MH<]YR_"\9?@R3:@]MPQK@_/^V;8,]Z#CA&&=WUEH5]77L"6.X#T6;B2J2+"
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M/[^V&.\UH. ^8Q=4HQ@M)YYI8!;K--O0<4Z5;.EGL@T]MQ^57Y!K]4$5"!7
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M]S9N-S1JI81KK9IF)"OF'\ ;*'LVP919D,(C.-\6)!=)1](T3\IV$I*A\GV
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M+POI'[__]-]7Z@=&I@W-"(A[D&ZD]_&2PN<_?EA(7W[[Z=/MK_!2^#SO3GH
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M\=^B@&^J>G2 WN3J@-B"66&*?U3-$LFF<*W\^?WTH'&HS9Z]5@N"WR^;_#:
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M=:.KTK&4GJ-<.^91YCJ=.=T]?_ (/GA\26#+G.<L#)<$IO!<O&)_SBG@\Z2
MIY#^-;11=]YK_?*_AEX ^2.]ZYZS)0Q#5D7(]5\NWPDG8*BGI'_/.8A8I!PH
M*$G)C_-E2"^:!#UT&>8DJ  H-^<DZ%BR/H.*1,<LZ!-YF+.@(LC#@#,)QI+U
M&5(Z3DB*/A&0.2EZ:?$8,BFJ&L9"TT9003.D>)R0%3T4CSE;,V=K1I2M$4OL
MNB=)9[&;5C&"H4^\&&%T:5''G9.B4TR*"H)#[;$7Y^D%SC, ER#,92FRPV]$
MZUMBKXZ8SCYO\1U?X#P#%HG"6Z:LS[S%O<I@ I_\.G][3Z1X3C!PCGGQ@@B3
MH;5G]P02)N9B?ILM8_\1?Q/@F6.O?5UT9&KJ09,$.Z*AZ@^"#'C8>R'_:/,C
MT*];BJ^)UM*-EP7W< 'XUH-4?C1OF7W_/H0PW',2HH.XN!;'UM>/<=*C\J9]
MT] Y#T35VF/?$X[DD9($BY*H+_U /;I9TD32U86D*9HQYF/23*VLON!R3(NB
MH"M/X9R"2(IKJ28[J7X@ITJV6$=F*&99IL/)-#FZ95RKIB&K$MQ ""\?]?%8
M1FN:_"2. G;QXLV6),!36<R%=88Q"J9H1H&C?2ZYU+6GP:2J9I;>+Y?3@8^:
M@,4T;5E3NN<K^5A/?<Q'ICFJS--XPEW4V^=.'GXEUM%@E8/-$PUA^L>$VRQB
MN0DH(=UU9(N?BEY(H(3&?!Z&:L@&/Z5LNESV@U[L-'1-MODIEQ/K<<_I-]FF
M8'[3'$Q?+)@>MSLP!]-B!--3"5,,""G?9BSMB&83^,?2IBZ[4V#2.986)98^
ML;!>K".;8^DSQ]*&+FMS+#W'TEW.PU'F6+H12XOK.%G*X1S%"3E.DPBE%5U6
MYKQTJS>@V;+%TQT8]6& ^N)X&.VH0H!S6+(D6.:LD@E#Q<J7\J7/WY#-]OH'
M*=WBD!9Q-:'JE!9P@IK03X)[&DG+1Z8/MTF\3FB:PGNJH3E_W$J_W:'KJTL>
M'!Y6)$I 4/@OX42TBWEZ0%?7&F3H!1X<G%46L!=61UF<H[:4;G\HCG#!SA"?
M6N5A*#$5+*X8:*YL354,@@W\*T-"[=132-<EEX-8K JI@ =6%&X)'XV!< F\
M?I60-$MR+\L3*GEQBK.GTC3V@/APE8<@NVOJ1GA2\G,27HE+:$,Y*)"?$*'#
M($6J;/-E&'@%A!D]CEF+X>1+36]H,7YG5<Q5NR/1&BUY)#W$R9_(PQ[98D7O
M,(G T\O/+4N5E<'X]=((+]]R<]ZJPC8&//HY2!Q1D#CN?"OO(%'\R*B/M#O6
M=*6]?R"T&#/GZXHF*VVC/X_Y!CMFO:/$]^(\RI"'TWR[C9-R].I7N*GF$0K#
MR*XS-D8^0H+X'M0*A(UQLB91\&_&X ND2YC[3-E($7T('R6D$_J\*0G+R&5#
MDC\I4T@^W9(DV] H6[1'/OS(]TPGV]75/_,T"U9PU?*/:VEW"M])9)G&89Z!
M "^)]^<Z :;SKZK6PH_L!YYB?9?HN7VM9DK?PL\U./M1!C=Z=1^DP3((@PP^
MAN19#(0)8Y)5NF&/[#=%F/X%2"U]>;IL<7>_=C&5!DYV'42,";ZRB^_^NI:0
M8/!1#]])=X'OTP@(3GPD%;O2[C83&@(Q[^D!>Z+_[5\]) 0X> F4^O,*'^@_
M',+6E&UV\/:JA9,9PW>OE3/#E0U-)#'30/![+/=4U1/G"?7@_1,(UTZV@\]X
M]3 =H8C81U?R FTF!Q\8NLMSCL5SD($HEM\Q1L7)IZ1B"DQ&7/Q8+183BW+V
M<VGVQ4JSQUU=QKLT>]R'8?,\C';49$/@8![!0UZ%U$-+'.<)A#F9%,9I.O;J
M/%,U9)V?4BJK\RQ%M@6V"JI05H&C19Y +:2J*.T%V:_?C"':3>L\I1 =8NRM
MV2;!AB1P X6"P]ITU%T)3<%0>L4.(Y_>TS#>(APCT16\!**2]V,^2]T"GZ(U
MB7=RO;$CZY.I-S8T5=9;)^)U/J(/1; *;)6'K)[A ,D6)1!3M:GJ?91JA,!7
M,;#FGDB_1ZPU("'H@'BU2L%K*;,-- PV0;17*T0V<(D2U"W*4C((JH-E!>'Z
M%#[-V]47"4-7?:IT!4$"CS1[9,>/B^8*HL+Q([UNOO_?JFL5>;\UC2K7-8^"
M[,,"XJ [$GF@]I>/>^TDX.;Z<*/W#.XM"!L&A('3IX\M&Y"HQE2)NB)! N\/
M<];:4TU0 J]GS[XL$/ZC.YIE"?&IM"6/A,GC[IV:;.R]L8 <:UD_(#W(- 75
MG&&BC$:I2 0WITKP':UL6=FCE5S\2QP:.-;9:'#. 8V?(E!UHQG0J,VHI=#N
M\SR=\3*H)7-T5DF\@0.HY'E"TR1TUY05?E%9/9KQP+$8\Q$9$(:[_&)[J0)*
M2HC7S\6I%])45QY]"CR+B\HV\EC$+46<^?<DSK?_7RI95QOXN#L@6++!X!(O
MU7!L75F1FCYM*?F%_YI*$(I2B&#*QU$WE!I"& KJBCRNU.\1"NYM-P<BI'=Q
MDETQBA5*>,.>VE'-D;4IS 717$5V.6XD%C89HIFZ?#ZGOXN[:7!V-\?,ABKB
M G,M?7N/L2D;@]723]/;=""(X3X6RIG(Z#+=XKD-YYB?":X1$3=%KEFF6%9A
M@&G@._=RS*RJ:AWRY2>PZLZK0]5'CCOI50MYP[''JG*\-@FE,([6A8MX^_E7
M>.(>\Q#B ,V:;4^6M\D&FV+05(%^J1  V9+JI,*Q=."1F.K8=339J*XCKCNK
M*ZI8Q)W1T[GF4QST=-(NK:$8LL9_MXUVD+0;]1&9CJQPG<F[[]F*8N-U53 S
MP+/M(M[ ^[ .>26]#SX4O(F>%C8;)B#/Z<[GPI*__<[A%"_IW4EWY)X%(4N*
M5A_;!-'LETVTK(* _5F\AT_%.!?":M,E[%'G33N8<UJ(''AM[X.*]D@G9(J0
M[E5S>?_*@^);X$._)7'Z&-%D'1 T &@>:S<^H2B^(O5,Z?ITR7R0#6G2:9L$
M'MVK[7$/B'_,?P=.:+("?/ 5B'2>)$C1\DKZ0?EJI2+$H;@Q78HGM*(YRU7]
M$4&,E<!U'J5_Q"GKH4.:_X*TQZIM(''%'+>__O>G'ZY4%\5WG9#-@3(?J/6N
M#_FL<Z81SED[]#&(0%#&4CND.X(!=W/\.U</B1/_,OV[JB5Z%_R.^:ATV^0Y
M/G[T.( ..D?E7DBE3:2RP3 56>%70[4HX\E1'XFC%M^(4Q<FPT+&?""FXLH6
MQ_RG,%ZJ*YAWQ!46BM)B4@S$#GY"'OSX(4I9KU "Y@Z\IN\A4L12NC*[TXPS
MS4JS?2A @?(=MYW>(5 K&&YDFRJ!T?%-:12 #YQB> ^4QE ?Z [19(9M>A "
M17Y:.#GXZO]*:)Q*WTJW(4EH)M61S(*-+T V"=)EGB"6B!1/T1T"?BE'$PDT
M!=)0ITO6,J>>/B]JN_PM:P1#S&B]3NB:9/3#<42H!AR:E9FJOG-@I/?P.#_#
MS87&VG1I7%='.34!<@C9BF#V'^S3<;?A3I"C."M[,VLFL _>"B^O*RXJO+_0
MWG6/7\T$PM!8GRZ-FUU^MOB%$H8I&-XZ T47 XK&7?M[7J!H1D>.FC8=-+L^
M#7C$' (>V8O.A#''EF V@*,YQ@AGF\0>I55$1*HE(E)"@I06 U=_S!.XPM=,
M^HTDP9ZWK.D[AD;?O!IQ_312VKW)DNV]+.L'<0HG#'NZM#ZD;"-VPE'S-17A
M\3VVZ$A5G):T0SL8+^' G3_D+W*Y<8OGG/)7DMF9+IG+"<@0YE)6VE",KBG*
M&(%LOY#4)_\JI@''$=8_8,9]RT;=4 D( DX/&XGT$M6%0CW<Z=*2Q; /2<"(
MY\6;3<#&A>V)7:.9Z,-B7W++\HB;?)U#G(LN; UY5L^M@@2>*I',^AVBT-84
MK4Z=(VV?@QWK>K,*\6@ DEX<XG35X)Z&C\>[#^PF>E7BE_LXES"TG7#Q*5O^
MD6=I!K1D)&6D2H&L)"OK",''Q0:W'<#UD4GB?]U*-^N$TF+Q!S[^A2*&M?=$
MS2+"T'+"]::_WOYX\\N/1=*@'4@^0L]?:I1RGYS%X_MXMC $G7!EZ<YVF@<]
M"T#>W_[^X[,IACT']P!"#OQGW]8(^3^<I12Q$X%-93@"7SJ-(/1F1G.&E 4'
MM^;>NQE2'@^D?-CZ,N8C&JCJ;@<K"^-?31A3WLW3W_E AG7 I4]0Q@/PN9[&
MVQ%];,#0)0HB#*DG#"GO4P_M?I"F.>N8*I&D)'XD8?8H>5BSL0H\DA7KQXZ7
M\'3IX]K5Z1Q,=!:&X!,&E_?1I).#W2=!DSBM698BVH0WGFZY.,<\X=HF<0[9
MN/CLGH':#'\&^X$MG=(MQ@J?<>YF0OM4[W5L-NQS^&<="G;.'L_;N)B<D,/Y
M_[H,@S5[0Z'5?XIQ$;,P-!#-!'-5YK]CWBX.P_B!><6XZD("YXC-L<CN=F7/
MN$P7OP5SF,DRSC-I4\F/UZ!EW*0E<ZHKG*)PL!"L$$:U33C;B\VH/!VB>9?[
MO,O](L!@WUWNUN"\/^]ROYC%8N4KQ<C,*AU>]ND4%FQ)06@EDM GZ]YW$YM8
M_AQ?0M&R>92]D14X@<$+!9JLY0A%2XXV:AF4%0TLP@=JI%OJ@0F1L.0A#=81
M WF QCC9-%U(-7JWD%;!5RSL3:1-$ 6;? ,^2W(?X/RM8L 63MTK7[6H7\-I
M,CD/FKI3I2F\-6"25 Q6VB8Q&F_P!A<UD$.V\.C7 -U'*<.5B.O=8*;"<=QA
M0;6XRM+'/,M16N]9A.;%>>A+'@%""T-459DJ54OGO@;K0,C\ (M":[ 6R(#C
M+9&H0*L;$.!*,=.O'MUFY=2SK RQ048CN@J>U]O"T%2=*DVWN)0X0L,(;GE:
M1-YX\B!\0>HA[>AY(-766RHVR0Y&!VUL)2:.K&N=SKGU4/6CVW*.%ZDP=BWO
M7I=;%[54;J^T\W1EVZP_X&__?XDU%)]3A( 8&89DF\*G57]=2X>'P=Y77U95
ME+_B);-E[#_"KZ2Z8EV/PY[% O403^D_WJGOI"1^J/^NCJH1UU67MHWR&W_;
M\PJN\MH+Z*]Y-ZXRT:K/_S9+CAU/1?/V#]B/HAE_DQ"<M.\84UQ+K)/:(V'U
M*'! QZ_>Z\I'0K&:8"<Q9DVDEL"KM3J%C3LIEU@\O793OBL 1&$_!P!&=\WE
MG(R>Z[+&KQ;I9@_>ZS4"S90-M5O<_6WFGY.5<!O'Z9RD#\5&ND \9)0(T<Q#
M+3RDF^W0U1,>VNGL ?BH>7$A>$G5987?RK?S,]-EC&I?%'(OE-EY-T,P6N/B
M0C":)EO\ILV=[K$+JZ.ZNTQ[S/.6?":NK/,331GR?%)EK;#<T]E+VF>>-^$F
M<66;G^.$CI1M+A9Z]K62FC%;21X\^_X3(KMQ#M^N:!^G>1*G'\;'P:\RFWO<
M-)O-GKRD2MCX- G6Z6PS]SEGMIEOF&<Z(PG[MNM-00E<>>?W."/A!7 #HSY3
MP9PBO5DGV=DIZC@BO!Q\WN(5G;7JC"<SE3-72"CY=)DU*V0%::_4BGSBR:W-
MBB7K;>F$H5H;.-RVTO^VW;9)_4+?=@&YGGS;MJSTJ,3D?MN5A5D:^+_>%J9?
M-S\> K^V:_G9GV&*5X6-DO;,2]<HJ:MU4<VSA4DG,E5W3MG[LEUMU,';NK%1
M=5"F)9M&FRR6NTM<66U1B._^IEL+77%?\87  3W.YH)P>^? ;I_9NP1V_3A]
MN,AN2FSNR/;1>3U/OXFEMF:^W_W-=A>*W6<4RUC8O',LNA\R=(U%N[*ZIC]S
M]<NQ>Q&-"L;L=C.TLM7"]^O [+;>NHX*NVS,A>Z<R.U[WZ@?MX\N?#9+_IPC
MZ)Y94YS>(E[@;,A6GU#*UF2G;3"1P &D6D[J.O6N]9&'S5:?FT:5Y#9^QGP
M:L\3,$;,[#W1$KQK0S"Z7Q(XP?,X!V[RED&40R=CQE%$"# MM[O/K7;PN5VW
MS^ZHL427G4&4)\P^XRB797.].XYB=<!1U(6I3ADM[ RC/ D=9R1% "3%Z8ZD
M.%V0% W8?<91.@RCDV<8I;?;_+ENOT_K_GM!PJR>2(HC0D+ZO%473H?!WP+?
M=3\8!6[:;NL3$_JF>T$G<-?.6P<.X Q<[00@A2>(\,;P@P/C.L,'(L150+W.
M\('5P='\YB^.IFHG-2^.+++J#"$<\ON,(%R6T]5B.$6WY+3;7HEA]AD!.18N
M[XP?'(9,,WP@ GS@="ZN<]4.Q74G\_I;! _L<@#50.A!Q3)310]^7:VNEB1D
M"UG2.TI%[&3H"2.H6@6RCC.^[%F1H6KJR'/S?:)JO&O+%2PW?^86%CB",4-G
MBJSTY?>3P 2QCZ"?IH,CF M3#@YDV,J4B\)(Y6#-99QE\097+&35BH4]7_RL
M0-.A(S8C32+$WZ;:O>''Z!"3:+JQ<!5'P!C\?#+1&8MZ(A(S&'59,,KJ#D8Y
M'< H<6'7\PE#9\CJ2: ^8U8"8%:\FX=ZV8?A<"M35-C*?0Y5>ED4ND%6SG.
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M8T58OR]V!N/,*JQ9B03RLZ0=1\P,Z^J>,&/"*@KX;!JR,4V8O7;%>"]OO4W
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M[U^9S]^G@?/B1WT*I+/K"*A'WKJS*6K- "^NV7IL%\:"(VU&M4\D]F?TJ)X
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MW+3<RY";8T<HAGVFW$P7?@QBTX[/3&Q.Q$)!B4TE-MN)3>2RF"Z)#](QWB]
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M"X'R_/5F.1!S3<)\.,:Z+@AK4C9J@Q;<"0VOO"R.44Y/L:A3%,TH5GZLT^C
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MQ]Z[-C=N9%NB?P71GNY;[J!0>(,LQ9V(<MGN[C/'[9XCWYB8^7(#)%,27"!
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MO*\W[(GN93>NH>TS@,7'\R^TG/FKESJ$H1;%MM$3V;Z.0IOL>2[FM:G24PM
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M*-$JR[T<\,O[_I5>-"%A!P<KBQ>UYOEQ*5GF> >>+8*5T[:=YA)4M]W\6-.
M#3N21:CCY&?S9#%%-S_JP(_"CXZC*D%W%ZHM%3MVFY(NIB2FY%Z*P)PY\WUJ
MR+W1^TP-S92LSW?UZV2):Q=YUUYI)GB/Z:%*Q,I>*T>M]:F@5Q'5C*<ILB-;
MLJ2$*,C4A52<W<&D[TS.]A8^+$)2+WX@*;5O ]O*$Q@;NJ;.1Q 8S^&%X86+
ML7!M=C#PX!:-/KWP)\[3I[]2$D]L&%;>ATB627Z]C9H.GE@BMC9-U1@!6R_
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MF0O)K-0@M#UAD,]\AHD8YFO=MVYHF3:8&(0>).=X1S##'O38+"S5+F?>ZO8
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M[F1SE?YLY7['3B&R9^D$CK()O/92ZD=)3*+[=I.QFU]L.!D=7;6DHL]ND]'
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M$R$9W5 [<$R1;?XE/QO.=FJG13=' !D?WU1BU7JQPA,@^8]=2!2;+^U-<5M
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MBFRU51>F/K.AR'8XZ#FMYKE09&M)*5!D0WNX'F@'BFSU*SDHLJ$=+KA'//=
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MZS4)J0U+L>#A-F,2>*G_1"JQMO),[^SF.?8H+)<Q\;[>L">ZTZIK:*\B^"(
M=^:O7CJ:.WJC;[ 6JE6>FOLU@X"ID_V"MG-G,5<[9-ETLY48M*,NS&9SIGO,
M_;[9*M_1:J'GGK085GE8Y8T_ (-.+U:$UXK0?B2K[-RT#I'>Z:X 44$#D=X1
M%-! I!?Y"Z'>43>-F0N1WL/2>D)=.B'2VYY2JOA 7=X9=7F@G7TKEPFUZ81(
M;T?NJ8($W /N$< ]5=WY47,/1'I;DDX5'2 =D(X TJD*SH^:="#/VY)TJN@
MZ8!T!)!.57!^U*0#<=Y6E%/%!B@'E"-BA[4J-#]JSH$VK\#-JRIRP$A@)!&,
M5%6A'S4C0997&!]5<0,^ A\)J4&;4OX9BKSM"GB0?0;G], Y58GY,7,.Q'B;
M\TT5%^";,_CF:K6%$A?<5R7FQTP\T.,]BXNJ4!E] 3,4)=-+ZO%6#D9!C1?0
ME$7LM )-:/$"GA+#4Z02[] 7UG-K,LHF4"KL(>BMX&?T,2^$"F5@K84S&=:"
M3B$$F49T(!Z*$DT]:X7CX%DEV2*3URT:QGPZ&DO0*81;A%N<G%M\Q7'PBZ>
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MF2+.Q%8.EJ;-M&O4T4E*/I/2Q8$08#<&ZE<>9V(,Q!K?Z(; YE<#9Z!)B>1
M#E JF9R)48]N(/@YRJ--2BP'JH!R*>),C'P0]U30-2E='*@#RB1^ ^J9-O5,
M2@('(H&#$<B9&"\Y-I9C97!-224'2H'B2*E?%9V)D=(<.:(C<$U)00=R@3))
MYDR,>!8@GB-P.1-*3D,SL#GI5'$!TCF#=-R%=9UB1'D/$.ANKXEIR>NE&X@(
MMEB6O:DM*+!\?1"D5<64\./ELO4"@D16>DEQP<J),#&C)N:HC@5QP?% LX-Z
M6P6:KE3B@@U/GP">4X'G'.*"^\FAS?N3Z9*\.4 3L<$6<3 T")O#["KK>;G6
M[] @[)_<J)_MD=R:K/$O1F:CU2"4;)S'*K8DV3!#5Z*QV)+6IP;AQ$[N0WRB
M;'S;Z%&K4#+"&:M6H63##/<)]RF5^ZQR'/SG>9UO3,N&B%,%!/.I.-$QRAI*
M-L0CE364;)3A/YOZSSF<IRCG:6CFS$&=UI%_T]T)UVDU$$1LCB[H)+Y&D^AM
M*.GJ#*"3V*J*:13FFZ!.XEA,!YU$Z"368!TZB4TGDVXZT$F$3B)T$J=6UP>=
M1.@DMDE:]Z:3:$ G<=]39Z)<!)W$D>DD2K^&A #BJ0P!!! %\(^L HB7W_6"
MRJ$@2#'5FT>^$PV-PPH0H'$H F CJ"V!QJ$\%2C0.!RRWX;&H3 $&<9URCPE
M76! X+!V80J!0RP:T.L> H=GD@\$#KLQ$ 0.P4 0.(3 (00.03UCHAX('#8H
M58# (<@'Y-,#^4#@L#[R@< AJ ?4([ZD;EHI9P@<0N 0O#0 7H+"8?==>2@<
M@I7 2GVP$B0.:Q=JD#@$\X!YA#,/- YKF0<:AV"=898CRGM^ !*'XM9E;TH<
M3HRRH'#8WK=-5J>K@\+AT6DPZ!L"F+((R!T!$^J& *>TX(2VX6%J0-M05  ,
M;</F,,,Z_@RD00(1$HB00'RU_I!JG*'A! T*F=)2D$"$!"(D$"&!"/<)]PGW
M"0E$[$1+YD2A?]C!ATI"Z[)Y3^@?PGG*Y#RA?XB5Y_"4#V7O/&IH^;:'$&#]
MB\3W[!O9'H$7K@=&^M?;0Q1J! +]2>A/-@N'H3\Y9/-!?W*PIH/^)/0G:[ .
M_<FFDTDW7>A/0G\2^I-3J[V$_B3T)]LLLWO3GVRI_P;]R?%Q$?0GH3\)_<FK
M\P_T)T7P#_0G3\$)YTW.@-0OWHMBF%"?? 4#J$^*@-<(*GN@/HFM8*A/"MG^
MA?JD* 29<ZA/ELP/]<G:92G4)[%D0(-+J$^>23Y0G^S&0%"?! -!?1+JDU"?
M!/6,B7J@/MF@4 'JDR ?D$\/Y /UR?K(!^J3H!Y0C_B"NFFEG*$^"?5)\-(
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M@=F@7 $:F" ?(6D?^TKGJ64E'VA@UD<^T, $]2#N$5]6-ZV4,S0PH8$)7AH
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MGH2<).0DVRRS>Y.3;"5G##G),7(1Y"0A)PDYR:OS#^0D1? /Y"1/P0D=(,Z
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MLHD0_]J#;MYG@EMR&H/ZEV &JX()# ;YKTL(&/:9#I>L8S7TOR!@@@;L$VS
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M2L>[)7:B4)'LX$,EH779O"=4).$\97*>4)'$RA,JDE"1'&$='%0DH2)YC3U
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MV?+7;&=ZIOP2JR6QR1FU*OU0PH.87>O]L+YZ2KP>*C^EZ]O5^TTEZ)3LH,-
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M'*$',4\GOZ6[HP!-\YCG"#2(>1#SB&E@7R[21\QS"B__L0N)\I]D:GM21\A
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M-<7.I#/E[;>H2V56D5J[9;7203>#U5S5UA:E/V%CE.?^<^@WR(S0".V76"W
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M'I"=J#J-2GGF'2FPVH&?\XCXTRR>LQ -?^E<'E"=OH+*.T?8I&>?(IE@)FK
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M$H=@_O$2H'%(1;Y9I+'QX4D<9U&,<]Y2RGI\LME*+(MESQ**PP.R*ID=T4F
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M@J7Q;$1[=;-(B_"HKP@S\1PH<*B"(9E6M3)E*=1@:QT4N.D10?]^(VC)G',
MU2.\&?=N'#R2K\K#W4!>='6MK_ .;W6=6Z+C. _I(Y(Z_D3R-(5O'0V4H:UI
M(VQ7"@!G/MN#SUN9LTZ+%5&OSSM'!Q 3% B[R&4D>"?G8IO; _+>]6(@GZ]
MSNB:J^&JYM:6O&?ZQ'9.OMNVJ-NA8[)PZ-T75EMQ;<L>E=?^S_^/'Q?B([C[
M<LN(IQ<I?%#QTUME?1W8^ZJZ4DW[#B^9C6-_"?\DQ15+EXP]B[12(2[0?WRC
M?Z,D\5/Y<[%*-9]$7-JP+=5@-:O?-[R"X\IT@>^S9-L"F4-5%.;N^@3CFVT[
M06QO$@930!_WQ%L%7#TV"JAX%+9 <T^MOG4J+%J9-FSJJC/<<?F7.S+J/7:&
MZIBM:9-?X%S'@[L6TF,\4+*TVEF&#,N_.7VHQ?JGXQ7ZX?[S]YG_DL):HG.4
MQ)::IQ6!7=LPM8M?1EQUC<\L:DE>6<Z4;YEX(HN4ZM(MNJFZ[0TD_56D,F5)
M=AC2+?>(1[-;I",\LMG[G"49DBWV2-7;V]H_U"HM9%GQ]3/_XBNNN[PCK25M
M@O4LO3CN35!$U]-^9:O8JM[>8?^YS,A?#_SK@2_3<K?J@_+SGF]Q<1[)LO#2
M'?Z&I8[:<ST;'/LOY^I??*VOQ_Z.8W^DJ<-+G_N&ZIK[-TM1^\+9 =9J5[IH
M"!Q?WGQ&?G;9,4"WM#T^LG_QU)<LJV])O_K#-H,"G[%=ZG^UM_@;^G-'SD.W
MN:Y;2WI86],JY3=BM_%,)D6OHMC[DS4OFDJQ31'!/4\ZI3 <^YE-L;];X2O\
M^QFWZ\MMF\.#^NM[I]TCWSS(/'Q9?;>6Y6]Q\OS%LD(G;J"#TL]-K]PY;>H,
MU;XKT[4"XC;5Z>_W/RKW29RF6!A^H[^1A#3#4AVKB788JON69AL[AB0WK:NZ
MV^2F7=7:%Y>3^*XUU6EVTWO]8ZEO6F]XU^ZH_J?+*Z UW.Q[4_TO<=>%#32V
M\'\O; /!&K07B%?;^-,](^HD*WS-YKB$$=Y5H]L9:+8SL$=.+[;,P>G95[-C
M3IN>LF^C??.?(]5NLG7*"F6WJ*_=1WQKF?N_S'>M<]9><B\?G'.X;N:6-C-L
MQB9=G9W=S)T++KBZ$(EK=*')8?\^R@+&6@O?DPU\'^,4IWPR":ER3Q9!1L(;
M0Y:8@\%[>(XN5;>'^^L%)';$&D8==!N4CU5S1?=E 25>@F8A"%P!5P9?]&4]
M<+SMC@<>FH06=7ND[IM]T/O( U^$(X2^Y3!$+WS&P\,,Z]9'?PWM]N,,UL 9
MZ@-=&_9BSQP<9W@]6^;<OME0-9OLG<[Z9C(&&JZ[N:W=K!NJ-CIE.YL=V\Z=
M"S6,ZNR*USC#<>T-\22(HOB1U&H9S(['%4:N:LG@;[QLAGO4>>>RB4\] K>J
MPX4K#5UJO&L9:C@NZ5'C&DB2R^^%HW2X<[URWO;7L&S?L[8'AF,-AF83<U*^
M#7.P9_U*]LOY4YZF?G6K+^M67[=R.SZUIHY."A%=?>HS^]0Z0-3[5JLS^M4?
MH\<\O;%D\:2U9IZTZ:BV7IM@+H73\;(.)BY!M]WJ)@XFW+4C0PCED@XFKH%Q
MS.9_X<KQU^Z&;AQ1_;7'SE%,;IOVP'9>F2OZBO;,"]CPI_FC7;/A9?1'K_NY
MQ?8(_:0T;]?"*]US20WKVJ_>_,1_1^E"^3TAWI>R@-R6Q3UMV+0^,E2KP[Y9
MP_KQ$6AEZU6W,L,*2-'*_,))7W-_\W+??7)<@_88)J_^]E'^]MKYVU]3LWUW
MVQP,77/@-K(PY=LSA[O;KV;+G-L[L4],F'7-.Y'2V;[NYM9VLWGMWI;:US;=
M:_MV&^W;9(*#:]EXV:<@FRG_HE$"&^K&D<7U;MJ[;6FOT??6+5W5.MRRWK!?
M&^[:M'L3<FC4Q Q+8+_VC#A?A,LU,;]2OWO]+.ZOW7D.Q]O1]8$]U'JQ:0YW
MO%_/GCF_K])H\W365Y'2\[YNY_:VL^:^INV\P_5VY'2[[5U>\?.[_+!-KNL'
MN-QMC2AH<.[O7:(SSB?0^#@8^8[\(^S$E<USL(9LL'?./-WBNG4:;)WK:(M5
M61CU/'AYMC%![X*$>EF<I J)?.77R23P7N&TH-4-=)T5=)T5],H5ZO 5C%X[
M8T+H$TD\Q:?*CR0)?!K>#&7)_S2=%S3J]!29AND?5U-',B0!7C3[X\)B]69T
M3J-DIXOIKR[?=:,J6[AKR^@+[HV2?K@"LE5:7S+_A^LA">72*TT%KEMA_8V#
MGX'7>#0::,-7-CU)BAW3%U?V?_9C[QR>=KMNGFYLGNZ%$]SK[.&38K1^0!/E
MAS".,)C@RA),:#B1MO/M?(WFL5KPOJMS45\/?6\R\J49=GIQX!_A7[B7GT_8
ME_/>&0[,H=6+#72XMW'=/YVP%Z5T-JY[IQ-[IW.^AJ%=1Y&>LID^D'$0*_<D
M(Z$?2&)S-\Q:VHXZ7*%TE(%/H^$2-&S<LX>JV^&!HPT3M[:[/W,A\5TW\ZMM
M5XX<_26]2ARYJATC\1<B<>V%L7>XH[EQ)E^MO5,J[%Q#-SI88G>*JWG=0=<=
M=*+'>=U"G=I"W7,\]>M@RN8I+O(8^,K_/R/15!(CO*G/B1V7O9FAT<@/<52C
MT_F]9HZVHYHRY/1>-JL)=VT-98NP7-0!=?;S)%UJ<$@O[+TCG$[]TM/;KL:>
M?/OG<(_SNGVNV^<4=_.Z?SJS?[KG:YK7>8VG;*G/ 4T2JMS'>9+1( SIS4B6
MHLJ&B3Y74^T.,U4V[="$]\G6LO6R?B=K6NOR73=MU;/W'3!]=S5Q#=K3B%<'
M\W@'<_T0OAIYU_K9HUS,ZP;J1A&DE/[E=?-T8_-TS[FTKI,73^_6>_!FZ&,F
M-[HFBVMY=;)>JY.E-V0"DL+)>MF4)MZU#%G,EW>H9:@3O[1#?4R+[M6Y/J=S
M;5U^^EI?K%O3'@R'9B\VT.&^]77_=,([DM*UONZ=3NR=[GG6]G7.XBF;Z:-/
ME)](%N=S2:SMID7"VJLO$M9?99&P_BJ+A/5KD?#&@LCE7+YF1W/]3+Y:>S*7
MZLGH:EYWT'4'G>AQ7K=0E[90]QS/8;-)@U>O$^[B81D^!E3Y,?G;MX9IOIW&
M04(EL<@;9G0=1]4[7"S<T/N"N^XV*U"C+"[<M6WV)7O?*+>)*_#:<YNX!C*Z
MG+VP\XYP-E?.X:N1)[.1)Z.G>=T^U^USBIMYW3^=V3_=\S'=X;4G]80M]8\\
MHLK/E-[H^AM9+.ZF^<UAIYM1F_.OFO4TURO,;[J=9AMNFM]TU5&GXPJ-O&J\
M:U>V[7YI[F$97>Q7Z&6O6R+7N9E'S,T<N,YKJQ6^[A<Y"SRE]*&OFT7.S=(Y
MA]G4]&N?;?.]]'L2+Y6/TXB&_QW<Z(8L3;;-G$>0\U%O>FR;9>E&ZKYYD'WW
M(' )I)N)^>J\AW6U?#W?K\[#=;MTSAR4T7>X[A4Y]TKW7 ?=OC82GK"9[N,D
MB"*B_'>>*#_$44JCV]]G\*73&]V4Q9%HF'O334L=RA"+?]F25MVTU4X[34V\
M1MUT5+W3=]THS8BW;79XBS>LY,7;MF0@9+JDC\P6X5)3/7MAKA[A":];&5=[
M]?"=9>@#X]7YPC)LF+Z4&+XZY_BZ>;JQ>;KG+9O:U55NNI/^&41DKOP41U/E
M)J'P&#C+60"_/<03\*'C1Z)\)DD6T21]<Z-;LGC/#=U(0W-?8>DJWK5K]R7]
MV,BY,K21JLF0@'S9VE5VV_7$<[?+=YL$S-@2R"#REW2K^2(<L0].<+%[8=<>
MX46O6!]7%_KPG6.#!VT-AN:H%SOF<"_ZE6R8PS?"RI<[<)]]\Y^N:NH-=DZQ
M-KJKVOM4-O\NEKG_RWS7RAZ692L?[M1?]W(K>UG7U-'PE,UL=FPS=R_(8!4&
MP37.T"@EC]\Y),I#3".?)N/EC6YW/)@P<E2]TVG*)H[T").4DH42+NE9C0Y@
M'WJIHMY>V-%'>%[K*KF_]L>UE+<-QTN&_7+-0$FU=P[W=*Z;IQN;IWN>A>U>
M^P2;[Z6[,%3\(*%>%B>I0B)?B2>3P*/X"_RG3),X7R@WNOFW;W5'>[N )^(H
M[;CKH8_<CH\Q;%0A.<(\9I?ONED][*MWLF %7BQ]]1H=J;43Z.I''9/$&@VU
M@>Z^MB36=<LTWC(CU=+;";%??+L<[CY=]TOC_:(;JG;6#<-<IN^S<>PO\5\R
M#NFVU]8PV@>(K>EKQ;ZZ4:*];1?B2\7*[5TX_(!ZVM'&:7/US<3NH/B4<9SX
M-+D%B0C)(H7/*GYZJZRO(GM?E5/3M.^8N\C79=.EU YS)A?$]X-HRD1MXQM_
MO]MA-?@*'O09XB;'<9;%<S0T\:U*&H>!OQ8M>"FO]EF =DG[WL:?+0YM_>(M
M2'LC:E#5;,\@Y6[J,=)N\9+(\TG["D9[[Y3)OSY2MXI_"P@=YR^?EKEW]Y'6
M'!G+LE7;JJ?M+=4\,&^/>;<C&(2^^<_?BF+N5!G3B$X"+R"A$C]A)?<L6"CQ
M!'9OFBK9##Y*_TX]RF$4]_%\TO^T'60,7\L.^E^G["!3=;<BT<(.NE/\.,>3
M]#%F'0$)?@,E2!629<2;41^04BC\I"1T&J093> A.(B"B"1+)9V1A"HW]*M'
MX2C*$DK2O'CX#>XZ=JD9#7VX4_B=*A&94]R6^'.*/[/7SN(0CC;9=J=I2[([
M*VSWVN$'[^-)G #&<&F2 G)/L;*D)$E;TA M++YE2K+X9U<--_I1@>HUY3!2
MM>=*LRZX5T_DPOL=-$003?"R^"*N0$";3.(XB^*,HF89DQ354:00Y0&550Z*
M3#=_5"9!"(\_!=F,*9J']_?XHKM%$H2*/AHHAF98RGBI_'[_HW*?Q&D:@UVL
M_/CYH_)QH/S\\[UR\PT^)8LLV+HDLG"X(MI6'59;:.7C-V\&:\O_(8]\MO[J
M9U4 4#T)KV=YG_L9C93_RMO14Q=:/],QVZPG D%)X1RE7I[ F^%KXYG,SMR-
M'?Y15:3:U[(X$.<X8%>W.VHK5$53,-,3L-$7O-\23:$-B,0>+]X"'CY5X&;)
M% VT.9V/M[T//T0N=!U9C/OSHOMQ78\QN%%7O4M4A)$;R<*^QL<1$_:9CQ2^
MS!.\A9U4X,DMJ)>AP<U@KP1ZIS#+ O6PSY8R&B)@.41>L #!'><IK _XU,3W
M$_P7))'Y1ULE<GUOK&P,D.^A9BL_P2TH#YDZ4#Z3,%;NPBP>*/=WRL@R-7T@
M#<:N+ ;Y.3#^(X*'?$"!9%0B)V@DB^%W?B?H./+O YV@%@(D]W&4!FG&Y/PF
M>*,8 T,W!Z9IKD5!*BW]X?[S;\KO23Z9P+E]3Q9!!FKCXT?E!@?.&=K;S:?8
M$_I;L(AO@N -#P[K _A[X&K6SL^1+%HRZK,Q!YA^5/[X\$'YR.@RF$,Z+!%=
M?8+C-UP!M405O$]-TY[;.QN?H]O/?I!N5Y\DB=YRM#Z;?C?!8X'F4!\X^]#\
M$"<9C@6T2A17'Z[MD\<WRD@?C(;/ZI;JK:+:<>6RLNP O<\680V "KM2Q.WA
M0#]6Q(T=(@[/K'Q&^2&:.;">^1!9MH'19Z-Q*Y+63B2M520+*%UK,'+W2'QA
M,A0;S]ZN2R0\"4Q9+-CSG 1?!8BV-="-HV1>R+&S<[LXM>U2?(SN#,S1;HMP
M9:](LP/Z;!<B8%X2!RE\0X\JAE8SU@H@MKRF#FVA!TSG68U>7.T=?:1AO%C0
M.8VRC<^2!72KSP;@"@0K4()_J(^&^RW\'X+X$_5_I]ZL1+!ZJ+@B"Q7A1='K
M=.QGKRH+[G:OS;ZZ>@6P:)QL""!_N(!0W1('&&SXD1N/Z/9@S7=8^]V4YX!W
M^FSA;1CC&U"YF^"M@V5OOL09*,^<#@/ISO!AGZVX%74^J.GF =/ :P*/N1R6
MC*,KQW(AWSN"?$(AL MF\91F,YJP+,_:R]]'&4OYR&?(#_MLQ@592L.)XL'G
M)7&(M2,D4TQ'=>WOE)NB6HVE\3R.YYLB6Q? WEGB1GB7J-R.^SP+P@!VD_@M
MSD.:94O82[74;<QFUI#$YUOL4_'>'V@"I[M_^W.<!ZDTT+M]-N9^B__*,>6S
M/\N'FV!=3C&'9RM)3A6?*B%1?B#YG Z4H:UI+N;SDB"%TR!!U2Y-5LD9R6*D
MG3^K=-PDJ&MIW;[2NG??W^THKOM QTF.G@G:/X9FV*@4*W[Q>@K\X>?/LLC"
M4+/$*)J+"\-)M75XBB0T))C$IH5NP@<%%0(W/  M+Y[#C2W1OM"';U-X$TB?
MWU+*^T)K9KBN.FQOGE ]XUO2U^[TO%]BB^]HV;F]_7>>9L$$KBI^>*M4]_QW
MA8S3.,PSN,LQ\;X@1T;DWQ8M_A_8'WB*=97]7=$77XM>LGOX\Y890["5;A^#
M-!B#29/!QY \BP&*,"99L8 K.-\E 0D'R@-@JSQL4B-4]SL<L0[ .4FF0<3:
M+[^RBU<_O55P*>&CGOZNS +?IQ' 6^NRJVZ3[7NPP]9D6'F".[M]2@B(^3BA
MY,LM/M"\V6UH:(OU[D;Q@9;C;CS5H,/5&HG98&?01<TX7$;NWD[Q;;VL]IE(
MQYIW*3X/V]IGG'JFG O#RQO+A7>[1>E5(:]M&A$,BIISM:(VB\DCRL/=@[+Y
M <73.SUH22P)5U-'73,DCFE878-E/5"A*N]%$>1=E,6P>@#<(@!W-O@R4.ZI
MGP2>\BD&-9P/E&H<S4ZO^!]Q2A<SN);/[!>&^C^(AZZ:-("/U%%_)1U<A#Q!
M,E_>#%A#*6/.PR--,Y:! H-R'F0995U]VT0?H9N3I3)&'YG.>4?AC#R*B(I?
MKXRN75<2E)&-RNTMRD(G,U.K"G(]:]P>&BG95!6LWOE6UWFH:XR!,?CJOBQ(
MZ]J0M]GV$^J?2)ZF\!TC'IT:21J<TG5'E4/>SA^<.F[0VF5*GELL,KZ0&.$P
M=4,[;3R6,[!->V [1Q& 218ET1WGN'4X7  V@B.<JS-<E@?)Q^@Q3Y7/^3@$
M._#]7SD[$(I63V%<BM>\KTS*K>]2[OS'((V3E'?JRJ*W#%O$H"ZNN,[I^!48
ME2!4B4IA2Z0%:N\'R,T:@!I9[WE$2X]X'MLTTW YV#0/*S(3V$/Q$Z>.6-]D
MLB /^J7'+O^:!+_G]M^/ !"8=F,T'KC7E[#JEBC##"9>$GY[4._5NTJ^M[SD
MF=U3$W.QC<H66%F MTS5D<-6.0?PPN-K25@WM]&V'?.)%58P_^\!MXXL2-N&
MZO37-7A&0&N(5+)*>%]Z*8^U7O8MEZC)]K8/V+6_9('>T=7^'NM'"C$C=-H&
MXEZ=4(C[CXRH_6'S6) %[J$F.-=[B3=;_@U!9@03:09K+'BX=ISGE2[8(],U
M-2Z[>&-96W^-M[;DNP;H :+^)TTS"KA+=82[KFKUUU@KE*E8^@T1AR-:!.NQ
M^J,2<*80-J29:^F&EI\L@(^&JM5?F^T9T>7H'2"G#UG@S5CNY<Z?!U&09OBQ
M] N)LCA.2C&^J=4IEV]9V6&20&YHL,2]17Q._ATG0;9<8<P$018PU82X *XE
MUXUMK>*:LD"MVZK97SOM .']E(!-/2=(M_IGD&5Q[GU9->A6,[9CS*NS%&TA
MP;4-P_)UI3(@$L%L6&*<3B]A;DLX5_$[8/.LIG!E =LT5:._)MI&HAP9>,MH
M)PK=1NB39<QM3?F9?@5@,Z0P?:113@>*J64SY4,(Q_2 W?U_Q0F(_R__A0,-
M#&-GCEX6I"U#-?I[4M<!WAH0V^=<K]CF]=,<E7ZA[7%S_ M$FBXQE0_H6]9
M^:WL1)$%:IS<T%ND<?W_]BTHKK<@DS_?&HZCP[_Y5SAZXSR9[JV5P1VRJKP!
MU/N0Y#XV^L/+TV5(2 38.@,0;==0/KV#4Q]IV'TR'\CD;QF.QD=4]!/I7UC!
M:0A"^"+T@/I! W(,9Z3J<DC7^:ME[*.J9=Q5N_&,U3(G\)3O;*;Z)7[DUKMH
MIK*.FE8H[EVR.AS+=,2A?USMS5'2MNO6+W;/[OY[;M:9U.55V=NLM>7>S<'0
M-0>N?E0)UAEO7&\RY=76&A2?=1EJ6]^CV)N$/%O1A2U8/*[1YUSA6N'&.TH7
MRN\) <?CAP".-6\6Q6$\78+C@N8HF]X MF_F5YG=VEOPV8K7R&.F+IQS8SHC
MX035V01>@&4^@EL#C*RU=TMCYR(GLQPVUUF8,-8;M6HP%!PG/WYFI9?<NPE)
MEFUK\"HY+=Z1Q\!7_IG$8!@]S6+63A*F\6I)%P]6\BM* K2I:7W.&.[OX*@A
M7V_A,#1-^3&A-'H"GU4$I)2C&C[/6!AMJTV.9=,>-A[(PO;*K:Z.3'>T7ER]
M/FPSS1<TV8I&XA^S@*;J:+I$I[SIP/W72\N'K6W3(LA9[KB!<O^[HCFNJ0T4
M.5G[36TD2^;Y_%ZY<R58:7=VV<$$*VR V;]HE, **S]1$F8S#QFJBE-:%FG0
MW<XEY;<@6G:I?_Q8C"A[U9PKIF7QB<SM1S9N"D9<8^!JVL!X9@1&L?UEV>O&
ML,]5"5N43"D6[W]<Z^;ZUT_WG^'1;:--AN9P8+OZ7E2?^[Q*#&7!WG3Z7*JP
M NO':F0-)REF',5##-'9NU'%=]['MQ^K'O^?XA"K'PHT<>YF_6-67EQU!;+G
M9$'=LOM<LU"K^]T*T:=R&]1G%6Z9<5ALF_),K(8:UEZP KAD0-M6GTL6:D S
M3;Z.<TV3'P3U^Q]5-N7NASB:*O^,9PSW7X)YD,Z4AQF9,1I=O(H@_^#Q'VD*
M5'!":W]UN0#I$P.E@/=07H_B<%YA]5!^2)8$]@XO1#',Q-]5G*2[TE :FT.C
MSQ4++Q$<V<B'-4#!U5]/#</P&BUIZ!.2-UWVEG4P$[7A6;@W+,<<.(;6Y<49
MZN=:G.W."&%;JHRG&:X@+&:NS/@-V'H#RW:424+I2IDU6J8L+!=$BJ,I/EEN
M7DA:-3O25*V_C@KB)_$9-P+=+8?S</XSSNT JQ4>)^9P1UQQGWK(%]A4X6P?
M\Q2D:4[&X!GEBYAW;-"O-/&"E+;,IG6.?6II0UGVZ5G\G@6^@,?EGTB2@,<B
M-#MZH\%\3OT C.5P66#&@(R3E5_WZ'^Y%9&EV[( ?'Y%-.J((H+[7E,C1^HA
M<\O X.?U4"$)LNLCPY1ENYZE3^CUZB%3EP78\^LA73M%$=DOHXC YQGNFCN^
M0Q&UM+W.N<M>D=FMZQW89?S(L@:NT_3$.DEGRKY?K5Z;W]T^L>Q79#GKQE67
M=%V7.+TVG;NM2X:OR?H]:03CB^H20Q\8+Z=,9%<@0VF,YW,HD/ZXTJXT1N,+
M*).31F:\D#*Q!MKQ,R,9=Y=/4R\)QA0'(56] J9"QO 2]=FY6;)KDY$TYO,Y
MM(F86M:C25DM8&YKO39!&\S.>D;(K4+(I453?TU&:Q?.&<P=#2U]8%L[6BD.
M2R"-G,'(V$R%=SJ1;>N]-EY?+I']?C*A'@Y7%IOI$TF\6?&\)6^YDVU(8Q6?
M8P,\$&R(0=ZYJH?FX;>?%1#<8!K!T3))XCFS"TO>5SZ2*TXD+@6V36F,Q!<X
M8H[C,[O&6"4\9:Q>&[@O%A:YT&H9.IP1^YC(CJ@UOH!:U;6#]NDY<P'\*QR_
M4=O;IW?K>_,8(!QUM%>1ON3*Z,Y(!>OU',7P7&0[O3@CZWR+ P<=(\K'(G\1
M5/L2Q4\A]:=TH#S!\99FP1S.+'Z,Z28X7L; QHYG_NHXS](,SKMC1Q3N6N4]
M#+&'B?Y0-M$?[F6V;3P#Y2:(O#!GZ[]AK' +!1E9V/";=P_I&\"T*+4<+Y5)
M4,39^&@-IE0X4T?Q;FE =7L,ZEK;(C:E$B_+2:A$>1%8+1 *4F6:4)*Q !QA
M(('UR5]7QT^\?B BI[A)8#&JL0CR(#OJ,;+Q$V/N>)K%Z>8<"Z3*!Z%4RNKG
M &\WH313(C*G**'C)/Z"%T 08V3CAH^:PQKS;0)[H=H@LN#IG#,$?FD\-_4D
MXW7T8_CZ49P5@E9**P=>X"WR' 7469+#L0L@<V +.J6C:*\/!K*Z>S).XS#/
M"AH_QQ11HV^4P/^/;P+BCJRQ;IEC9^)9MF$0S7)-T]; #O$<PZ;_5]>-;UK:
M*>89 U8'[I0Q %5:Z'N_]>')L2-1' Y74&3O97"89.(ZMN=/X#]K9.A$<QQS
M-+$]?>111R,7M%/K2Z?O)7D^?.U^$_QBR'NT1#+.*$7VW#A*3UK3<WJ;CG/&
M1-'EO<T'4&NTTTZ4[JI.>UWZRC](A'XWI_;2>6*@T^OC6NK0.9.3"6XD2^C3
M:$JFU*_\DC",G]!QR6HBSBD@T;4L@_<#C(]Z.<O(Q!.P7H\ES3FKM7/.NL9+
M6SMH==8LGGG,"(S@MNSOM@4 1*E&"F E0<D,"5@'B4( N!"CWP G?)(WPVV1
MT FZ,3&;X1<?7=-S5ES='N-:,'@B@U5P+%'.65=]))=%V.*:WV$^B-.-U93<
MNT+),5%Y7^JY7YOIN>=,GOK?-91N;_\-;D@P@:N*']XJU2W6W84Q\;Y,DSB/
M_%LO#N/D[\JW']@?> H\(0H/Z(NOR)$6^,JW]_#G+>/'ASN^?0S28 P*((./
M(7D6PYJ',<F*]5I!]"X)<&#< Z"H/&R@J%7W.QPQ>.8DF081P_<KNWCUTUM6
MJ00?]?1W91;X/HT 3>*CMF)7JFZ3B02L_-K.4Y[@SFZ?$@*;<YQ0\N46'\ E
MKF]TME<.VN!#0^,(U=XN/M!RW(VG&HB0-5*M<U%+-=);QLC=:XIND1?=;L6B
M>G;O'P'<?MC6/N-4'(<O!R*RS ;>RZC!0N%MUW?*?3Q?4# &\2HMZK[3H.!Q
M 5GDJ57/[D_*HH_"$$ CC,X78;QD1;9DFE!Q8%7Q1Z^.$*D=:@.E2D70OW*<
MVBV+6:%K4B'8HC@]@\:F(\50W.)+!6MCECUX%Z]H*0@Q53B(J2+(43]F="X/
MM'I?H774'U;5(:+W \O?9*D@IL7DWLK0A81."9NNO2JGQ72;/=;F>4+/35 U
MST7;=EDGH QMLFD)]=BF\AG,9N]8E7F^,T^WI7)^VS[T4#K")=>1'Q(:>3,E
M)$\U\2&+11(_DI")SD9\:L.!_ACQG[T\) F>A/(H2$<J(-N,3GF8@".1Q^NZ
M%;;^(55^5@W#OC5=IN12^I=:J#\!-"C5.=9; KCWL4\'.^*/!<VW(&Q/CRO\
M/BNDP[Y"6HOYKI2ES'C!=RT"J6O?%;"*L&."WZVD[!;S9]@>P'^+WXN!?4S&
MY4'4[2NB-1AWHXCBMH+B0#@;O,*E+I[[;55Y0!WU%50F5%C5/B_G.X4TFF:S
M ?,FRV%&:3[^-\@SB_ CS3ZZ_<6Y.EXR($47:34H)Z&+.,EX'RCK,,Q(EH-*
M %$&WY(9KSA1<XZU$[(@;5PZ9GTVI &!"']<(*Y$X>#@9+8TAY.T)IF#:BB.
MP!$N/0GX7%0FL2#C*SH=-A ^3J(("]W*TY92U /RI"0,XUSC$BYO"(/5BL%P
MCE^1IB5^O$#Y(X65>[M@A1@UL.'3F;/"BH)3FN&0OT2832#>'O5SK'="YU2F
M&E+C;'/*+BVF@8_58^#$$XYE0A\#^C1 :R>%YY(J@%#Y-8G"1=0K0P0[\08'
MYP.\?I$G\.UHVH1_X:RX6GW%5<A9'(7+P;,"&6"/_23 -DB2*C>Z4,)H\081
MK&[@YQQSO$>.(+P:?"?T@NI(R^/E&&>;,W]I5.MQ6B:'+/<(BS\+%BL5_0(^
M.@;0F6D++Y[F!!L+.:-&_<DW+.Q0UE84CH\T<#I]A7,M&(0F\(#W60!<3T$8
M8M$OCPX%"\)B\_ $<W">L'.4G[HB3*^P@*[X.0"<X2#-V!MNC)I0EZD9>? =
M]A5?U)H!?&F2K*C</$*?MA8\Y*(W(6&8%D0#S('QX@43UKLR/J6( -7.N)0T
MH+I]!14C?YM6#1M8S0_=VGFK\/,6F8Y ]/BD8^:$!DPCHR<,CV=PZ[!1,!S)
M>^JF012QOJQ)Z0!)@^NHK[B&),W M$D]D*(E!9%](M@#529!!^5/12?-EO+2
M0;U/BK7P;"M_9.%$^+Q4INX;4^LKLK4@8:W"E%62+"MR!87?F& DNTG?%.('
MSBB=QOAN,:I\4+QW$B1S=)5 #0A'J3B>Y4'U;#,;+XTJZWI:5I8K K(+,=2W
MO#P%=#+:24@]5TYA36J#/)D1!4\6YW;QU<03TL J5VRI15@YF"Q(*,[+&?BE
ME08EJ$/7E2SZ/Z7-JRI_, ,+=T)Q(N\.4,@#:6]C3"SB/J9*/4"?IT5X%Z"A
MCS@.=S,U#B?EBN&,.V%,*3:X\:@5#UJLAS>D0;2WT:65\/V\FH;-D(:7I/C+
M]NHB ?F.:)3HY6"Y'18%+N*1TF#:V]C2X1%?5?FM*A:C24:":"T26&&(G<MP
M'3B,T==A8:<%C7R9X@]F;^-+]"L<H1D\ \=ER;L:3 O?LN:F\I-V+2X<!E^0
M<JR@U24*\KE@BP48S? Q+)O'6/-(R&IITAD2$$@#:Y_#2J!B\S#CY6,L]."1
M%.N1\$>!.M><91@1]3-<MNJB3!>4&5!%9G:R*VF.JD :4'L;5H)%]<(XK<H7
M%OD8;%=%5$(P,F16G@1 "SX(QL+$(_W525L)+?%!YE/\A3!>4A1OGZ(+G% P
MDG^5**ID]C:J5#L%D>XCI?0+C^DM@BBHZJN9L-4XST'FOH]KM.C5J;E%0 /V
M*B2*3*5*W%B]C2CY<3[.D(,\YZ4H?^4D7$F(/WNTUHJ;F+X&$RL7AM6?6#4#
MS[-MX,O6VFSU-IC$Q+0L22N<#J:&100)H_;[\VW%X;H"]XS $8P</V4J+T.9
M5H*L^*@S%2U52[-&W6/9K"OQ8-X>NR7>'OZYDG1GM$C:<]\6:8^GD8FE^Y2X
M$\TRG!'QB6M.-&_HFHZK&5H/27L^"M%AR9#WS';E-N=]G$=@OLC2UV+)53M_
M0#G?EL7^)6['0;O47>NZJ>XCY3ZFGF:Q !L;V;,[O2@X;7/?6;CE[EMLVKM2
M1%PI(CI%$=$*L[,<%!$[K3QF'Q]NY+DM&7DOR#_QC*%RVDR*/=H4K!9L97>;
MF'WERG"=?<!0BKW6UMH]'/<]6-KQD&]A6?N^Q8>R,/AC%9%JPWZK#&3+'WD.
M<0TZLAR+3C3B&=YDY!-;IY8['FVR6A[N%+$8U,'B8N@MB<NE0U]G<HGNVG*)
M;-/7M?%DX@TUR_)&9#S1-,<9CZW19#1RC%$/72(<*H.&#BFYO2LNE5]9>='9
M)*V5]D5#(B^_Q2!1M>@5)M*LN5QV6:O-9IBI\.HB436@I#7AP  X)]'VBQ9!
M&OEE<>X=;Q?\K6Q$_(#C#0SM]L, +Y/P8:'RY"]U6RI$V^Q-(E.J?+C5Y2&-
MN71HYTP*ZV<ZA1W_&?LJ*1M[)XVVNK31<T9M]0&'";*2?DSDPK^L058P^ ?1
M8QP^\B0\?$80YRE6@@=S?KB'#+!%!9@('6#=5%R^, E25L&1GTE9U9>S*:^Y
MT=O<7T%?O!"E4JFJ_-GMZ*&E#K6S,'ASBD#,?'EYDL IC;4(HB=&E"YL[GAL
M#1^4;!U5FAP7O2HUY'P1\F[_WF9*=Q>%B7H3A?)JDZ(XK" "[+*,&".3?Z.6
MI@#P^LF0IJ(C/O-B/"="N-24UQ!X)!(+')4+*XNY)!FQ19ML"&5=(]:G4X_D
MG"'(IQ,:I53P@F59R,N=O3C%GEQ83<!'J*E:-71"4Y  C]9)4">$CQ66!DNK
MGWR)[Y"Y -T_R=@1C4M'Q\_+CLA4%B\VAK>$<$:S?JL%"029&DEGBB^P28LS
M8FV\&1A45/%C9C@(';@LNPH .'G:L Q7*C3;[/"( ;3E,Y@)HN9:0V4U-1*0
MHFPD]23/\H0R/"L+$&NE(E;;EE#6.X#E4;(1PXSZ"BQY)$$HP$$X"[8/#I5"
M21)Q,SP6+@X5Y,\+=HC5+3K6!$]2)8PQ<L9K3\D\SK'W1Z*^.JVO4-8GZ.1E
MR^,_$QJGG._C>^4>57!6I NB*8M%%$X9P%O5F0IUC=IZ3KYPG5L(/2.E.%NX
MH5%7<U\QQ3@W'G,3C"+]\Q[AX!B*5@^0T$?&L%^!$^!\2)\A5YRYO'05_#(1
M5X*K<K*VDN7TU_N['Q[N)))2HZ^(,O)U7.H@37,N:X K*W#DPBE&73T+%SP"
M-E46H-X&T:7UJ_W$[B#%( KN"'D@-?L*Z83Q/X!?CD5MS-5;@8FY@NPB=4N6
M1&7M-UA6K'?R.,-*&ESE2C6VB^N:Z2IF8&\Q6 ^UHW"O8!2A#&C6.VRE@;2W
MN49FMQ:QF;KU.E"F 9RDG%T6L\@\SO-(PWB!(BT/CZQYZ>SD.>?#5JU0G!@
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M_N/N&DE/XF2!TDI]!0N-82>,D9%H0I$B[,4/J.%Q!]2HK0-JV,\#ZL2ZM>J
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M#K,S,X:F&":.U@=CW%D]T\0@ 8KX!FDQRU55[N1A2#+D:AYK6@A=L F4YH-
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M.$_Y;SZE<RQME*?WW>E^^1)6'8&_P*@PN3&#"XSCKD'K/I/UQ]A=HBS"O*@
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MG%^.I >4SZL$*1K'CQ)E"24;UWL=D-C"^2:T1Z=7Q+*;-315$X- -8+52:,
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M\C%UO('K]C336HQ<B5$5XD 112JY6 JXI7!-4%!1,H5?"R\OZ3O;3"FZF%S
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M/ ,L>Z$R=&5V=PI<7KH0@Q9UR',>],>SDQW_H7>Z!_VB]94/]0C%EZ9_4)"
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M>-OH#?Q"C!VR\LX&T^FT[UJ*Z<^0I&4K7 -8X%-7G7JU(:5D=$F @*IUOWS
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M6TON.1AE%>5F["R*Z[[S-BFR7JN^DHK[A,_4[7!B*Z9&3<*6T,H=^_U9=_7
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MI0#0O4?PH9JD7(N..J-!"T^RTCN1![<D>Y>#Y4(V6L]=(]R I@!\KYKNES&
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MN;_4_:IW1^'+;^@#_XTOK]=':[-$*3E*/C;($HXB(K9"/>Z9YQ.D"E++Q$0
M9MCF()=@UZ@9ES#)NLJ =PD_JR@4E0TFJHN%D!J?JA9DFBT;:)^1 ^/9)1]I
M?>$NCJH@H65 8[(2+U&B9\NS=8XK1G*^?1?$\"3T6@.6D_+;FJA(]E_4<"<?
M2.U5\Q"01*)BPT+DN5X*,PH)9+ETBVZ;;]_Y4.7XT9Z^1N';8K%>$OY!+@20
ME7D\K\C+UXL.<SX;@V-KU3S:R2:N*$#<T])X<''I:(-A0?]5SHJ9\*$FA"$4
M88+)J7([ME;"PX13E17PP5_%UW_\@SNFN"A48_%+;*+("U:Q:LB7[!<XJ[D5
MY&*E@<!EAAP.O:X;WQ<]LXN>V4N8Y-%Z9K.+GAD;$+M-1)L8Y9%\1"WY:;'D
M%0Z%I2DZXEH5-%Y!'(51+Y+=T!KV9B@E2?_X]$^L#7V,T@*?7HC+BU2X6X'R
M! *$E.XK+'S'FZT13 -CHZJ*GU+5G%S<5DF #%&2'%QS#%&I7+T&=5GC!7)^
M:YZ@FE",V4JM:RW+L H\Y2PS444'M-YU4V8W:LVK9@*7XU?T2J6/$4M9H8;%
M7XN7EPT7E!HJ8)7WN]:R"QM0-%=8JMC6="*Q#B IA%AS*6NG9+M-G;49\WC"
MEDG6^@%I240:,2K4N=82#;>'THE*D3B\#NX^LI)S="<0N?N#YI\NRV#.*D[C
MU>%<*JP$'CW/[X_=SIX*7+QIJ>0$6Y>W(>3A[+B=G?;ZTJ]!$06_\=& Y"5K
MUJ'9_R7)YG"#_J(D5! >33#DCIPH>*C'O:BL6SMD1=-I>'D$.4'MCWJI4(&X
M\2W8N')K-<VHA8*5=4PC>TZ0H*3*[;(]2:VFJV\A $][]9ATHP*Y>3-_#U1&
MT;2U:F9&$98*K!A2X;P1QLJ:NC'.D3Q,=D.CN[C(\D)-(5%HEI5*,SVX"^(D
M:'1?$=>-R)P-H-9JF>G<AY'QS,:<GG77LY?!QJSD5U'L.OF-CM'F&-?&#'NC
M;&-.CG !TQNP K-S:FG*#[$O6=1L>8L@SC6!3(L64<8G<CZ$2 \6,IIICW"I
M.3%XCR#"/A+.H8 G)?8+/F&+Y]J**X4M&X:5-H:52(&&NCQ.U):;1V ;N=89
M,#"FP\(&5,]64%OFV#;!K2'*JWD%L*88<K9F0]1K4Z&7M27G.WD!^"YW<585
M#94\G]E:;V@KJD&S]_Y(_*AOT6O%?+G[ZGWTKJWG#!H[5J5&-N#ZMH(K:[9:
M':EVJ!GREVB)W:)A/-629').6NK#;>XQ:(%MI=T@Y\+,<5XVJ(YL117,E("E
MQ1-) [44Z4;73:-N%.HW]>.(RS]], 3--_8W4X:Q\-A65 F%KN[-I[TZ&T G
MM@+Z]+WY>!-U(SAN4]@F2%U#-?>&#X58-CD1UGI36W%M82%(6UZNON\"1H9#
MBOK4I+2IE>QIQNBK$O8(PI"LFUKBIDPH&UAY%98ZG877G7 YP*5Z)<1&(U?*
MJ+).1K9!_HZ0[@*?3SV0F3I9M_-'Q)H(MU\S@I+),*9VCD6[4TFO VP7%7A-
MN1?Z67ZIG)1VO=E(7YLH,EIOG_W7SQ^<GQ/]4K5[Q@9C:W7*-J>)@F;BK)DJ
M^LXM:\+F:.:P19P7M$-6KWTVM!EL(+56HNS[R[LFHR+F-(_>K.DVUXE1VJ\9
MC(R17C;06JM6IC(7J:F :K[2J6[<KWWYT8]I48H@ZFU8+EVUVGR5>\<05ZZ
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MC;G[^4!Z:UQ^#-:H!ZP4L20(M(RLW:)I:XVE2&[)#"?/I(TQ&P\=/CVAQ>0
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MKE/):WS9BRVC&G/WH6^XD$8UUE347/ST@>9^%DWQ5W1];ZE?9O DD/<SPQR
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MQ$/Z^X5Z(67I0_.X/JE.E7-U:<U0^0V_V_4"; @#OOU=D:VZ-]60M>I(UG]
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MQ6L:XR7--!CCP1@?*]MOIG[=P1+W6.98->,,+M1K:FUW4-G[5]G8W(V5*.W
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M/K-G#A/K>H-:(R,^0TNH-6@:OFW,>W:(%HAA9LV3C?D'KR,03 16M8>F"6*
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M"JER976JHXG//8#_B\)+\TZD31C:V4=/.X_&Z0/.AV<#MYB0%7Q'"\\X36B
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MF.+&,+/NLKD#%)4!*A8GX689IRK3%6U8RJ1J&CYJQC8,V="4]F>7S37I49\
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MYA+#-$S7-JU ,7Q*?2<T5'>]P.S46"R4R7.-72S>+:5M< Q0#.=@IT^8.$#
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M7%'W/LWR7>&EP0S_)5Y,5[WV97Q@F=T9@A:KY!*(!VRM-P[X:[5@H/J'43T
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MW1$0&^]'>Y<1M$Q/:Z];\DKJ>7S: $E0P@Y%: !0MOK7WRJ %$F % M$@94
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MFPIS:$.W3)Z7_-B< </T"+BAHZKO'[W%J3&/U1M8LJ78XD.>[@(%,RF"0(%
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M1F]@52:K<%;D.9AK1 1$!%;ZN@(BF$W>M-(*1&"FKQ$1$!%8.>P*B&#1:3<
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M(J0:ZX,S-?F_*9C#E#GQSWLDS@L7-%4+=LY_Z[_XBZ4_7$QOUJ!SXK%J\F$
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M9^82"DZ)(]1$C5 #S2.\34X[45%QE=[ <F5#+8Y.*TD+',"MEHFM8)"$F35
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M@0PINIU-_F$B5;FF.UH]C(E)]_"8LJL; H#CT"0SM5J)A9"5NM;V.&ON]17
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M.1A20M/?!1&>@GX>1  (^O!!A+><7PI$C%- 9!;\\*<7?_A1N <_'&4C/G#
MCZYUF .!$_82A%TTX5E_D$<3 /4'\-&$A"2LXH6N]%W5W?ISA%TJJ61H)K.2
M<5JDXJB]@:/)MEUUJR0&*N=$%O8*A1P?4AL9@J!R#%2LOL(8HM"4R*H15*RZ
M047K#2Q%M@T$E0:!2HE:BQU0X5=HD0,5X846\$'%4-CI59TOO5H $4[8H?<&
MMJPZK@#H.-1G;[[Q>,TKU()8';:-9OO0#B\47BB\4'BA\$+AA<(+=>PSMZD,
M5%.VHULL \4RT.9=^O\>7O\^O/VGE!6!ZEA/=ICJ> \B!1> [B)1-\I$.E(
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M.>?W]0%R,_N\.CUNL\/C/KP,R4_HNWKSX>H4V1<4T>;6QF1+K4"($F0*@@1
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M@?MO6#W?ER  .&N>@R0ASHI'*L5C^-NG.(V]XTP<VMFQ-9QYT]R>:ZSVN1W
MV^E4&XICGO$FA&4>KC>E&!22*_F$*@,Z#N,8!U1P*PH\,*>D6P 5/]:<LLR-
M@IM3-MQ:CA38N3=E[Y4=:;)'RWQ^'O,]_ICO49M[C6VZ>P5X3L;%E:/U7.U4
M%]7^%%IDAXS069&<%4E;D3@'TB/FQ97A]'S[O&M%9CVR=7[GK$8D5"-'S"Z[
M!U(C%J@16^_YUH^FDL^@(XL"[5K[!1TY9W5:61T*STF<SSGB I<E-CRG<SJ3
MSI&IAB8!J,P2HY_])PG\IY\@#+-// S[2;3(#@F=LR*13Y'\!(&8(U$@=M8D
M(E(Z9T5R5B0M16(?2)&X$*Q85L\P)*@P=:I1QUM:EWT>$/II!X1^^@TRSS7-
M2I 06!;7<]/LL9MF?_(1(5OS3FY$Z*QS=DT?G-6.=&KGYQP2\D]]2.BL>W9,
M.)Q5CVRJYR<?$P*?Z^AC0K_D@R28X[\$I'?=M2VQ:+&@SNS [G+B^%Y;3-AM
MEGA(_C2<K:G6L[RHOV2S<"T9KNH]15+@EE&2Y'&24\Y-\:6![,<?^IRP=%*>
MSW[]Y9?'QT?U^R"-U"0=_V)HFOE+"D__4EU[C,/GI^@YSYWB#E2Z2Y-L'M-T
M'!+EOO_Y#^55DBH7K4<OA'2]M,[]:.>F^YIJ:*V?9URR=<<E9NOU4[KB\O+?
M19:'([AK^<L;I?E4ORID  Y!D0,UU[@9']A/Y4.@__"]\A^NX><-5^5P0@]A
M%@["*,SA;4B1)V]P_1+)*T99H$H_#4G44^Z!$LK]"B6TYONZW,F=$N ;^*2Z
M!N^.-V]^>Z,DX)_@IJ=?E4D8!#0& I @".,QNU/S-5,: >L^T"65ISS"-[M\
M3 FHQ $8E6^7^,#+LZ^NH:N653LSU1TJ4%/'6WEJ077K6[V)Y:I[T][\$^S:
M1>?[JO:<\[>&^S]<^KOPOZ/ZZYWZI_A_!^)IF^AF6^532^^Q<.TZD>(\H:DV
M\ZZ8A0B)YUL#W3('SFAHV89!-,LS35O3?6OH&#;]/\,S+]9]D=T9I7KG(S)*
M.S>ON[9JB,O.]]_>_-G_7[ RRJ?;+^_OE2^WRI??WRL?;C[U/UW?]/]0[K_T
MO[S_^/[3EWME-S9SW<ULM@W%?6-7BCOK*/ZTF[<="U0?11(6,!UAY/^$/I>N
M"B$M=_H_%5/XCL/5^&0Y$'D79L,HR8J4WHY^H^#7D.@FYC$'?.;^("GR<J,&
MB>YSDO/5 ^^_PT>+29ZD\R;TT'DX%,8%#?IY^1B^)X4P90;OFJ>%(-_P!>1R
M/-5R_=:/,.I]F5#E-W V9F)$<X& NXBJKGF[RJJ_+UFM/\N*L,+7*[F$G6O#
M/9?K^<?8%\>$.8G"X4$%'$2\)5RXK2.O>0>+L&&>*8,B@^/.,F',U#[MBMJ;
MB6"L)8)Y(9Y#S.-;]$773R"]&WO^"BF,"/B&]N8ZF<)7F[._]#>OE3!3",0@
MP_"?_S!,\TW._P%.2.+Y%(+P&-YIAF]& P5"&9HR=HG(8X:C%Q]2T,H4F>@=
M'=+I )ZV>HJAZ29P&3!22L=AEM.4XJ#&*(1+Q3FHHGG!.KYIWQLO )7A:!D1
M2:ZXE[JNO$V*B,(M ^5W4F09?/RX7)+@VIKF*W<D#;->26%500-3\@[R3$ ?
M:)3,$%$%%V&#:2WR<)C!'W#_"4F9]F#(*TG F$UWW^RJ3@Y)?-OJ+O'!1RK
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M>72IH02,#@-,1B$I6^,0.GH,]*.\&6]-6,=K'@F6 M#F(N&2 D=0N5_&,'_
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M*;6U>SL#]QU383601RM)UFW9,S17U<6-&^Y5*=N[A%Z_(>YJC&3^#4B;"P_
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MS7CE.-W%(=]PBV(8LV6,=,Y&<MB,!KS; M93"0:W-,ASB)D*T5MO-X)Y;FX
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MY4=V\56GHUNJ9Z^ES7&=!;:B3VM^Q'7FK&X5-70%PY#W#&&9^:'7$Q*/>0_
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MIJWIOC5T#)O^G^%[%WO2Q?5G.:(N'B11T +N$5=82G(*;OF.U&5X=RO4?=D
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M6TBKTJPNKZI[KLGE53AJ5%7P>JGIA=2-+K75.O5N,=,Q55UXQFA3+L Y?"[
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M\\LO9V66"X#IWM/$>^BS%/($D:GE1EA2JQW?&_MY8?Q5^AF$^7@Z,2LP#?Q
MCBE:J\M08T&$JBU91I1 1H>B#=*;!+Y12/D!3\&(?FP PLXREJ]0Y!SN183+
M5$?+>>@0(JE6([!(PFJ..@+?".\N\D'UEIYH,8\C:\?6]W@_J?CF/H1-^X+;
MDTO6!4T[N/HV1HQFO]@SU0:LK*'=YWZUK;6FQF5>1343A2F%K='XE%;UM',W
M[_/"G\51OI"H,/A%U\45".KJ#YIU,RXOKK_]<?'*^"RJFG ._^'GH?^7<=6$
MPRL\?V--A_JZQ4])+04<2=@N8B;@S (1&$7+54P<AA78C\O[6RUO6;V^%-A
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M-'U#'D#AP W9PK25*,;GN[L1Q,%+(\S7Y4T)1MMV!X8]M!U9F@UWI'FX_*L
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M%FLWN$_TB\WJ";U]!L_CB"D]X=/H62$ ,.IJ@,[;('ERM/=D=QULL D=YSJ
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MORTREB_2.'R<F1O59LZY>./L3!KAKL?1P>Q :LG4\\QAC[CO2XHM*-0(6(9
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M=4_>_Z,?3Z. N-*W\X\9CMSAM-<XK4&=A-@I^H1\HJ]1^$^?O&F\MZW5'8P
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M$:[+]HAA $(PI[O@(*O*V[?Y(E65E\;3,ZTJMTT6UKRU#C@1\O"<D82:+)5
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MPS^%Y*>%]ZF4*TTUK7U77GA&48GPKV;NH$7[EZ_SZLB#+"8["2JM/8W47T
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M@,E^1+ ]PZWX]'WF@_5P2@I*#MV<QLZQ>9>VAF)>2,F+(0G5ZJ^B,/ZEY@;
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M>$, ;F4]M=B858#\:_(0SE[QOS@BVON[Z'/B$PJ6*R_]H 5E*,@>":R5+>T
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M?&9Z*&7"4Z-C.U^\V2Q8/A*0*!&"5!"VYPEK8W7L W3Y[EU\]S4T_WJ0AX>
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M19]]*LBT!?=\9[)SG+A@5"X &A,YKM]1XPY&$ ZU#NP>$6&.E0B3%*0&<M%
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M32:@+FMF?[2!/Z8EE&I=U.SQ54'W>O^>)6EX!Y^3_W*BS9=@T5AM:(SRA?W
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M\/YH&7+@&P\_CF;Q!"[ZL( R$-]A<W7VA\9>599C)9=D &9<<6=&F:;381<
MYLS!>H1U"K2!GX#5!6,"3_E/0>S?TS$'\9]!*C$NF2W&I4PLV<> 9#*/F!49
MH^R03C2>T:\"_A,]%TV;ZPNCX=96@K>)R.Z?;_I)X%6"6QKZ(CREBWP??:?R
MFM,K?"JKS_Y+LHY=X#+1R05),-WH+=F=T_0Y:I6GA!U7Q\B8_PBD6:394FLC
M6&OZV#!@?])C;]G1V2[<1$(GN4PRDZ+!XF5GW1I^EM,BIBX.;][<+!D+8LM6
M(24W2F[>/^>B>-T(=#32ZTYP(&[0UV.&OS9::+05MSAKKFM78OS.:@RTU6(#
MO9"V,EE)!RWTY]'@,L&4&F;ZT#P)1C,9U,,:C=@'9N=LP,-M.A81&R0MG/#X
M5OQ@;T>;\WS]2P00C&+>P@""CFX026RD.DRU>C9]S="-7BF.:7;>;.2G@<34
M1=-N,3"!1;@:IA$@4]9.:FD,SQR*,G@2.4^[-O>2.#JJC?!B$N>-H&&=]+(T
M&?:U5'G^\S&,@]'%E*59623^W7^A3_7IB=][)J_R:5>O<TJ,]J5=L>WIMD!N
MS"*W]]--/]'&_B,]+%D+>FT-?K.A<E6B%ZX7O3+,*K/VKDXPU]IO75?/>)MM
MLNN,Z&SK]Z>C_Y.G<OI9=NT\/Y7+PJ'D'6A8GQOM&1LX!IZQ86[T9L5CNXY7
M<,6PO6)-+.1F58]./E8O97-3\T_)ID_2H91L%WW4BM].M%4ILO>]7A89QE_I
M)=-!-'J!?^+BBH64#?;LB%Z0BO=_.O!MX^CY]?="Q@LC)8M+TUX2[(Y_W?$*
MCK7G!6RD[_=^<[_W6WB_]^^_ /,O\&L:;Y(O*CZ"YQ,6E3D'%W\<WH,"4[4^
MT6"+I2%8Q.)1T&+.>U=7/M8KOZ&7%JI:+W<=@5KLF'6<RY'YK=&U6YVGC,>B
M>]X;5U\TSD53ABRQNW-3!G<'K\/114X**^MV6+KU#I-LZ;_IZ)#*\RJITAKD
M6 (5".XBG]N\=O':]&>1BXI(/HE7##'WQ[=/Y]?:U9=R*L0ZOVSW7,NO/I%\
M];$K\LP.C=LD67A3\H5W]>U!)G^JZ<?MS6W_\O/%Y5=QRU\G='J>OA-R%@Z^
M".!<4:#YI:70'T]D8X-O_7]=?/OQ39*MB^1>>51X9 (-EB0KO^HK2+;RKDB=
MO_J2^9HW?^]?G]]((H!5=T$R 2!79 7K]BJ3P*=S259_U6>0;?7M+,,J9O4O
M;FY^G']NA;N [:VPL-%9,,4Y"VO(:4JE.DYVW$JDR<KVKK2!EF0"H+1N<7M7
MXCA+LG5W12K^^;_.K\\N;EJ"F@1;NP59116C"MR<7UL2]3%;ZNJOXJ5D"X\,
MG3C"?7V)<5.^]1>H^;_UO[<&-;?WUU0I?9725RE]E=)7*?T%W#2M7:NA(L-T
MN8,5,+H"R?N2)_7E6OKV)T@DSU A.Q]<*>90D-1)?;E6'ALZ.J:DOERKCQS=
M;5!2_RW6:$[0EHR:9SOZ3LP\KG*"K2/TQL4KT"S$I5G+Q+RM:U0A+<_0;4]*
M1Y2?EK>B/;PA_"[*4VTHHW3GT+RD%=7AI"7MHCF5UJB/2'&P#!7J57N%G*J,
M57%EI33RH@UGJEF9*:4XN^;:5NT47ZIM)SM59=C5<LUI5M#E>+L%79P)7&P>
M+NA2IZ%J"+M6]$=HY71%?62H("GM$1EXK2B/V/,@2[HC 3FX):HC1>BU:K6X
M0B].O<F83 <(O7:B:@CDE'^YNM9N_WZN_7'>O];.+S\?%^='&:XFHH\LH=BJ
MY1+*>EBV7/57P!JL.V\$8]AX;<<C63SFH0KC,81RGJ@*R!KF%_$'9*L*1)SE
MSE-O*=!6_C:]N*43[XV++Z[RCOKBE':(L&Z+:PO<O]&NOFC_Z%_^Z%__L=0%
MLHP*F;K#-RNK_.HC+,'R+V]7VQ$YHZ?\AC5UUY)RPW(&,JN[560@LPSUFP*9
M0[*63'%<R<_G9^=SSA[989.^A?,'6YSE7>39NB7N_$:I'ISO6SRQWL;!57!U
M/O#VK-0Q^A:< ?,J5)D&GV.Q$UHM7+P6P$*>3L2UR\T\B];!%@)8=VUOX:?]
M&%:'8JZX7)[(DRLJ E\7.5H^TB(V!B]"EBTA^ $52F@0Q9J!W]-II<%(F]$A
M$ZQ3_N)D8EFVMB&=)) I4A2O4PLD,3$X+UZ47!33R=K$O[<H55D0 =\:Y5,6
MRGYK5[<6AW\9VUQ7B9? R"9NE5\!=W$!MLX_DWH%T(Y+X#5:[L:.JK_5DY3[
M6YN[?&M/-Z3;\$4A8&#2_QVT$$#70YR;JW/\M**$6:*/]:J?*[0$OAHXR5<#
MQY;N"A^^QC__R-US_M'5? */X!E('A(S TG>/<+=L'AUBXADJ*WN$.DH:K1_
MJ/#IYOMO$#:^,!^%^OX6N8T^!72 ZNN4L$^;=\C%77\\/HNFV7C)I!\'WX(=
MM@UN^;;A;=RYMFD$DF/6-HUL[!CLZ:C&3>/M/54O&[ UNHI_#Y*TW'R]N_!G
M,.K]-XBCC?N#T&RCBQ$^:>?^X&_1N+I#1/9H7-TA$K2J6S$K8.?$);D^U+!%
MJA@\Z9EO6X]?VK$].'OQ'7E80LPZPQ+3J"<LV6(ZK):;CA+]UI1W)=_FJ"4D
MV;)E[%JV#*OV_IK/(_V532M=>=7RI/AJ)I7;Q&OOI'+0BB0<P6U-[[.Q\;2^
M^C6.9H^@K[/Q""X53\*IGP9:%&O)+'D,\G'EBT78^4CSP8LVF+W0JPW\X9_L
MA:R("V\.I\,X\)/LD\2,.Z]&WF:+Y0VRI+BB!7EH!@^'PR"?00_B_V?P. YB
M[>PAF#W%P>RG]NPGH F329C2&GP:@0X,DF$<#@(FQ0S<M/"._35\Q1CM.8@#
M;1*DW;D.R"MQJ\42+^@3(+HUX6ZF5+SNYER*T=U=;^"/_>F0RCL(TEPALI?
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MZ5CD"$61A'+9%@N[0IT#D7I>"Z6<X#9N"6)X8L]8"&:4R[9>ID5T(D5BU!+
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MBL9Y"D3D 9&ZR7D"0*0Z<I[84P.J*TW5Y#P%+ I87H&EIED"[T.*U_B#!*V
M%'YBGH(4!2G"(&5'8MX62&G\$8)V0 HW*4]!BH*4K9!2"REO"]!@B8"F-7WS
M,"**D-=60EX[Z.9\A+QE/5:$O+W[YBEMKK5OWK)"*S?MJ/DU50^4XZAK>41D
MBW1UV$H\(4\!A@*, C#DG>#BF0I':L"1$H0\A2/2X$CMA+RJ&_9N2?E8C2/D
MM0,L^ EY"BSD 8NZD\G\8'&@OGF>+5'*^'CAI 0U3\&)@A-Q<%(9-<\3>U)
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MN5T#EEN=4Z=E6(YL4S>Q,?\1I^]+P-YEOS*GDT*\AGXUW?1!>PRH7SJ%WR*
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M&FK&@9\D ?Q_1/.B :@"*!?<<$E__[""=Y%NM%7PU/!*G(NV#=)>6WN1)7(
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M"DTC@6]^#)*5FF]D.^20\CBX%SD707>!>/(JHY2F;T;!8P#_ 4_S4T1KB9.
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MP]3 \13YMO )IDK$20T\(WP<4P.NDKX32E_#U,#92I\XJ8$6TO?"U(#7D]2
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M"542[;@.51K'495?+G^NR?DE6D9WJSL:]UQ_K)H0)QD1\^H(IV"$=[D27F
MM(Q3^E:G!4 "<@S;WH > F5&51Y\K3ZS)C)-W3\88#EW3'+EPR1D<R6\5DK'
M6Z+0^RT4&'FZR2^?OU<:F&>S*PCF_CSBBP4!^'L*?P4W:PX?X0J+>_4L_N=>
MT]%"^N'H<7,>)[C?Z_.P@:_Y^>VM^?J964M'XVM_,'9MR=C:=73'XD;&MX43
MEH=70"EF$?7NBZ!EX?4S;Y]%96A4DQA#\SB9AQ&-;1)G7ES;U$:Z*:MMNL=_
M7L;9_C#*AD.O"TPXXCW)2C@0I;02XD\U$NB(YD]:D&J3.+L%B8+WCNZ"Y(\P
M(T86C3LO-](";^+I=)4D(7D42$N('N^+JTU"N$"X2?NW M/>L^2-J)$86J#E
MI*V0<R?@S2*I)'::!U.9&\IB;_%\'B8LM#8%32D/Z7U'WE@""YA__O3C6L.$
MCLMI!""="HS"-OA$TJ9HB4&S"!_"!96>Z6T$OQ,;L[",=F04=.L,[-1I!K($
MQ%NL9NO@-C&#M7D0)?")%JLR$CY/PM+$6D?/XTDPB191]L3D5ESRE\52$I*_
M*5H2LF]3FW@A=T&1GL_J\I7/9<XF3_0]XM+=,N15P)-P&<ZC:10DD=C8ZYCR
MNBX?5DF1^;^GM14:V#H@&1_"*:N2*:1O2%]#_<Y'L'@T$*.*\YE&Q/Q=QK6F
MSV/0QW2R[5KRJMPM[_,GJ1T L%PM\BJI /YZ"),T6!2XFH2+@#Q)"!D":2EE
MPU_D][#_I5&^;O,+Z31(PVQ'YQRW&IP;F0.0J)LE_%:$Z:)YDH[FJ\7BW4=V
MYI^2^(XUKZ1AEBW"&8W632K1NDJJ)?V\_._;:'K[USB>I=^2/"V3_@ ACQ["
MV8=H]C7._B_S?3_%"3P>WRSI%[],+U.X0;I1<O4.E.QH%M/C(!^YC/V9Z]"?
M249Y#0WL[$3__O(GY!@7V6V\ AK.^LPW%K9Y=J^7ANFV[ 73:4(J,.:<(N#'
MP4O/EM=&36.P4Q9:%OR"S]MSM/-MGO'K8X =Z]G;QKGK"LZ]WX-SUY1./PF9
MVB,6&HRQL9NMD >OD&WIV#36/_RRK+F;%1 S EY.3,B 2LJV(8D$MO0==-(*
MPFZ;$Z@)" 0QA>U+<"R)<T9O@K?:]U62KDBY->T\>!\'R8P"8TKC&3F)$),;
M<UBIZ 3G*YY2<SR ]P(;5<(>?08HTS=XEL7L54HL-+2;(M\8M/GYZZ==Z_LK
M/>=O\TK'^($^\B9:J%+M9)+!*D/3PT/7W[6=^TQ<R^1*7!:+ ,GYDNC:ER"9
M NFTOP9)- L70Z)\Q%4S-I8WLE""%!B&&+D7J79U&X5S[>.O<+K*P-O4OLWG
MX'PF0T*[1^*5UB=669Q^IPT+'KZ_!UA\ ^1G[0X$'$?H[3MQZ>V*ED;E&^S
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M_?#Q0RLO[XBP@%S=$?GX39Y%2!\^7GW\\O[C#VK>"D( [.9UL((2 *QIAY\
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MOJ/VD<KK*TQ>[I>I+*)9,\4[+9B O*XR8(,:%/A$?PH1)^+]JQ#O*_BY8(P
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M(?!=FB6K.V![U7++Q0G>YE'5L-+5.-8NZXKM5[?<UJ@4?S"V'0&F(?8O!R,
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M@C_@TY*X#CEM(@Q@-D9Q O^;TD"1N& /GJ58\1V.\%9-NK%,'HW+/09)0I*
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M-G4ZU(I&T:+[DU77%M9;+NQKZ6:!)185@.M,2':/EM6R>KYA$8?*9S-N<XO
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M"F%.@3#2!*>MZNA<91O7\=&'**5S=FDCJ&A:Z\R"T!OLJF(_YQK[<8X9^_%
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MG+;+R#8;+#BI6O6PJ:]H)1O!04I(>N*04'9T[H8EJ_S O[&<F&W*B3.9F7#
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MN".ORRIZOJ<)TV7;VIU_4K=,^BYR%M345=D9JD-&Z3'=#YF01 ]\M6V-?&7
M. )7 *_S!5X5I8@95))%I#EGN=N41-9$W0WEZZ&?,>!%D[2).4Q(7]PMJ*9;
M4D=5Y7 ?Z(,,"AO?V +#[?HI-I4ZR4SAC=AS47,\3OXH#81,KKOSQ(4[&\E"
M\7Q+@TNV&W']F*R#P(%/D"P-8KQ(22IMF;^ 1:M8)0_A>[)GE]X[WM^R>W@8
M"MR ")$;>>(VDYB.)E9%*D?*!P3@2"K[?H6]6YQMQF9#'K+)#Y3N)$]Z&[E!
MPLJXENX#:^AFYOJ<SE2%ISP\IQ83_9_L(8E25@<6W]'DK+N*:65%Z5+\B)_]
MZ_]\3RPR/TA=5JQ78HV+"U*FYB_A/MDOE]+V%-]+[CP.5VD"YS9W%W_< H0'
MWL4B7(71>^F7+_3GDGQS, R CO<_)7BY[TF_?(2?2Q94! H^^'&V1QRNF";A
M)3,%<Y+LL WU$*;2#0GSWI1812GTCS*[:^U&MWY F>@GO?CVMTLI!(F#6SV^
ME^Y\S\,!, S9;TY<<Z7(/!%>40[88V^)+"Z[>(Q<$(!YA-T_+L@#Y- +1\C8
ML98064B5=9V1K7"%[)ZZ:9>>.JHP3W:$DE3DF++QDG:L$,LO%X;)723V!: !
M]91#A#/T[*GB/?9D+P]O&XYUH6HLW@[/8>\JV3ZNL\MS!V]+M/D=/%>JO*1E
M66Z/F:ULQ=.;S>!Y_'.!=YI-,ISWMY->P#LA18J;*8S_&^$PEMY)'U=NA).M
MI2#P=C9;M$D>/)>SD6QNXOJD<\2= ]YW,_>OELNH*J(-(>!(B.OB5L-F#HR&
M7G+F*HR/)?W9,Q[:+JK698XIV>>_H!^ 4>F3<R$K(K5I(;R2+73.JSA),*;@
MAV_J>:L.4DQ:'.-S:TCANM&N-C7Z<ZQ'(0+2.CG6(SH,'/1,@\$F=AU?+RL+
M%NKU&6B%N@1G,D/&5%70@3Z#!-P[((4W< 8!$.17R%";/Z;2SMK=J@#D]<?/
M5]\^\Y3/=E8EJ];+,311B-V!NIL#A<FJ]B?IT7VB11(XN0B7R^VZJ%*4C@7A
MW 4=ETZY@Q2"T<P5*Y FP_8B.)<,5>!/_!,8@A8!@AHE@""IAFS(1S#/:?=L
MZ^8)PW!^XJ[\Q:DXY*J*?B2FNL9NG$8T/]Z0,/KI"&/:@XV/?@WR_2A%5_D*
MZ.&QP": \=>K&TF5O@-"DX*__'69A(+G?0,/8O;JO/D,/.@X]I>%R_[#=VF8
MD+C?X-A]3 'Q6?;Y6QA<B"N4MC)0RB\8!5A5"J%!]L .I2@N?P37&VB=Q-,7
MPC%T,'9&><PGX=%942="LFKQ#&7DQ[O<R,UJ5R0:UOF=5@P<51:J%(*C('S"
M"TR+-C6U47!#-)9UD*QHA?FP'$N2>WTLNFRT<RPD=D/1$W[1>WU&*EG>R0_M
MWL08,\,;";RJ!:G:H L>6$ 1M#2M1/!HPGN:I44VS:51=1U@:4I7WHJWK>IA
MQ@"-RU^0"\ ;..G\=JB-!!N[Q=.4>VG'#B$S,]^!1$39>1XM9HC\!YH;CUDU
M1-Y7G(V'F/M+8 B7O&<9A>NL<?(NC!-6# H>-_/.&:>)2WJQ:ODX$GZ.V>H1
MVF!"*S.)3;EZR@9%DCK<*G*3XDL_F\_""O9H97I AAS%P .LQ_P^C!*VW):V
M,?A)[JRS]I7'NW E\K93W1JLQ;HM/"*4I -"&<'S0LS[*%SZ%-)78;P=K?CE
M]Q_?_Y$781.78SL09OXD??WRVXWDR-+70EG3AN)P'_KN;6-#PZTFIR6^88O5
MEL07[/,J1.)O%RG$ +K #S0>FLEY#1'/YY05Q@:Q\O]LL%GQR@([J\AT!FO8
ML053^Q&$)Q+VWFIX/]A# (&-<+$Z+'B&O&GG(,Y[(9X-G#WB/4G>2MHT6]/A
M^<LEF7*;6V);P092+S#F[7X*DJ72;87G4.W:F2HO)BJ18\I(P+,U%)TE1\6O
M![#-YPH"_N:"1705^601WQ>0C]_@X]X&]!M<+S=YBD)<NW&!@*9,9FBJ&0[_
M^H ^,8P%PMA! 8G,4Q!;6ONKO>QM"$+%+A+_-T05[MN0A=QO'FHJ>#8DD?_@
M>QC>2-T3E[Z+Y1,3O+@+_#^IQ^,61B&& ?B^9*H0&+0N4Y4AF+O1 W60A6<B
M,HAY9**#3,2F;619R(4;14^%FLA'TKI*!S.S^!6=C,@Z$JGE1/A(FN/DD0S9
M>(81<Q^H6%-"YWLP]TAX'B)SKT<>.LA#K$7U"9 "2[=@-F2[.B,,!@&)AE/#
MX3]9Y];&SP+THGNE MK/%[GDVUP0ZF1=!Z07B7$-CM9E+.N!_M)JU!Z=,=M<
MQ6SXX#93+.UD_Z:%N GU' J[%7.@VEG>DW6)[F)6XOZ1;1//ZMW8K"?1>>?E
M02%GS#EI4 "5'>0AT;N6_(63YHY-13;XY8Z/<@[-9YS#?^8$(-?YY#Y=!YCX
MB[P<0Y4XAJINO>08]IC"")FRR4]TF!W5Y_/035GA5T9R%,=;W7$\FLS4J6$,
MF>,U%?'<^S/-MY7Z#WCU)&XP7K,$F^;'N2)F-W_U?$C^#9O@P29%X&T6?8G)
M6'U<W(JQ"=S3:EE7^I7(*MGSLPJE=>CAE<#]PYJM#C97!D2-?5+U0&CX&))$
MR3S+EV4W)YM,%CAP(S^,WP/)WQ8+G$CR+)L!^>Z3']-A&028\W?D&];)FQ[@
MR2 A@_>+M3C-1ER=>&,T&FPYU&;Q14XI/LM0F;;[!AY]Y"_V%+*ZHX"!6Q:K
MD&#"]?)KX/F@CI-?MS&F<M=BH>3B!PE5_H K?R"?JJ!V*P9+P(/DSAB4]#W<
M&RZ!.Z2@JBJRR2^=Q-;4@)]$8[E$UMPX3M?WV]*'O8&L7&1MA\@OS/O(CK^*
M*FAWF,A+TJBK1G7ZH%KJ*77JBDT^WB2_MD%G5>?32!(:&<_]6#KLA_BP*_<^
MAAOEOUU*^^=)W[>YIJHH?R&73.:A]P3_1?D5\_-6Z+-DA-:*'/1_3^#<HO!Q
M\WM^3H4)/OFE=4U&9,+,Y-V15]!>\V85V9W>7G6$N?V[)*HBK6IE+ZESCR(3
M9V#@KOQ;8%S"SI<2145P.?)'@7N/'\E4Y/HM&Y7'\.RHSQ>M?CKV.@.ZBHL7
M02B/=2GTY^A8EUT+C.?ARMMXJ++)KV;BL(U\L1D+HB"M"?P:+(U<8YS3N\1K
MC:]J246&B?,P2<(UF8.6Y'/0=JC*@:=)_R]Z<=)DB;$W -4&8Q<N+@1C Q[9
M_$R,JQOI^HMT]<^__?/F!QEM,_(Q#SY&EB4W9^.-IFF#C0L7%X*-;9X;/QD7
M?_K\\?.O'S[_MLE-C7S\2C[6'$>V1D;NFI'U%AF9ATE;D=M<+#!>+OEQ8KT6
M[>Q#MV7Q[DR9%,+BW<O*\+1YOVW6^!2G$%&KMQD[&L^,*3D"5WDS6SW(/7S3
M#(T9 XI@&I>D@+-YO"L%(IC'^T$XC6<0[F!2DFTP*N<E[6)>\NNW+SMQ4295
M.^%/.J_M>BMCFXRC4@A]ZI.99I2WQHV2>'I)K&W<EP21LUVT*X@BV$5[@JCH
MG0JBTX8@&J,@BB*(];V341([E41+:4,2S9-+X@%?":FO<)1VBD!/Y2AINMR>
MGY1[(6?B)UU'_JT?N*OBAJAL%S?M&6>E8(UGFSW/FJ\BD(ID=$X4RJH+WXJF
MHU\E^L?J:-YX4]\OW0<=KFZIE;5("^R6*J=Q2RMK9>WJ6EE_&<479,K^>]"X
M<!5WQ3:;-Z^(M8@RGL*9"F\9#T+J:ON@^T+'U?#=%SKQ#%_G-'9OI<PY;<B<
M69 Y>Y2Y4\I<?7=S%+JNA&[7TVQ#T3E="-V0DG2&T:+O>68YNJ_Y&F)X9:/Q
M1X,/09[>O=GGZ[/)NAW9,9PGZTS9UI\_@@D7:#WZWH?T3T#CEF45I!95$"IK
MH!M@.+H7(DC^&6QGLWP-[M-DIRLQTSX7:*M^=&4R,UO1/!7'0U:0O7@\?^$"
M.R/ZO,[-VP>?L\EOO Y\%*L[\*EW[Z;@@]H$'_6$X*.J(_AT"S[U_=T1?4;T
MH>BCM8D^Z S1IR7'OY.DLX4R.!D]_]=[_A^W/?9T-!^98R_1\@O1P@"#B/W6
M#P.4N/QLX@"MI#EK3 ;ZCJ,;POAE=:1S5D>%ZB-=F\R0)EOE$4"C_'69[RR)
MW]G8HFWD7EXE?4:+TJ>/TB=DYG,4/V'$SVQ1_(P.Q&](.5"GS;D<9^4'74>>
M'Y"A8]3W8;Z0:#I@$-' ^AZ0T^9LCM']J:\!K!8U@#F9J:9LZ<(;8(,0OMKN
MC]/F' ;AC2];&-&S6Q0]:S(C(X!&R1,K"3:*GABBY[0H>O9D!DJOG2Q4PYY#
MJV_I'Y)R;'$ZBZKLU44/W/'Y-9_PZPE8^CF(J%>#B2LEUN8]D5#TWC:-YQ L
MI+]3['=(08;T!D!9PF04^5MI\[ E3".ML==(*QYE-"0;_"CSYN\_?GU7->A]
M[*WEBT [:E[:<P+)JK7E*GQ\+]WYGH>#8P"*JWV:UPF+:Y^",<!QS6\U0(D"
M2F ("4X-I,LVO^5!!;VPAT^"4 0ILB(X12Q;MODM,!OUPBGUPC9$,2J&43&,
MBF%4#&>N&(2O%-C_1%(AC'8$AFMZFX$U1;;J%!3T-8[V=[RBBX<W&[/>56\R
M$P0R ,2U(9-CLUFNL*E.-!MR$(FM!M'-$KZ<34W'*UO;48>M[;7NW;"_RU;:
M[.]R)C/+&'O;SP6 ZH_1+N'/V2377]E?JG787UKKWDWQI\W1&H9R2OP1I<'T
M?/&GP?3P$8!& &( U.9X#4,]1P :4H>[:JCC;#M>D8"O((L^&ZN^P-+*7_N)
M:(& GB>3&@<"]MG[;.( PO5VV+PGK12J7 TTF:FZK&O"5Y@/0O[J^\'[XG<V
M5JAHO;5VBX,E#&V4OA-*7P,O<!0_4<2OQ<D2AMZ!^ F?L&[B YGV..:+FYA\
M=J/5DQ1A#Z_OJ8#DJZ7:J"X:@X/'.$4E?C\;K^B5P4&[P^!@K7LW#0[RGKBR
M$QPT0"^A=I9.C.E1 1&HOEM8 J"S,4Q?!4!@^'>%/_5NW11^>(_[V($?\Z3P
M(TIRXGSAIX%?/.+/B#\$?WC//-G!'^LL\6=0R5'[D.,^1@4:1@5^#U?P$A%+
MHP<1$V[@_-N'G//1\S^GNFC>,X=V5)\]F1FCXW\VZ%/?\;</&<:CU7U&-8E.
MFTT9AG-*\!'%[#Y?\&G@]H_H,Z(/H$^;+1FF<H[H,Z1J *1H;?:FGYG?_S'"
MGI](,?SE>J*Y_H,(>]=W_<N</7K_Y^G].VTV!9GJ9#:F_<\'@&I[_V7\&4WP
M,S7!V]RZ:Z)3XH\H)OCYXD_] , (0", 90#$NQUF!X#(HM6Q*[K'B7\$5N48
M N 4 OC-C_^X6$882]&X]V'WIO,P\G!T,0^3)%S#L=\G4ARN?&^/Z*>-$NSS
M_A@DJ!<DJ..(MJ4#:MV[J8[<Z5G3..M(L@Y9=L8HP0A1S>,(^P@U6O'UK/@Z
MEF);5GRM>S=%*+--A"(;H^5VFFH%-N-'A.(2:1@A:H0H"E%6FQ!EGM2($@6B
M#NV75'M7:J!9;0X>0+(E6IAA'JZ\5H(,7UP_@O>O4BR%2^GO]'9Q-@P_\4&@
MX*T)?)-FW*FKA\,/KR*-"I;%V=#FC1](R5V8PJ?S8D*>;))*PSD0SQ%C .F0
M/3,&CE_RPI1P[H;\V4N8< L1*RH!&-=@D74P$-6QD+S*R'E9MIJ:.%0R\F-R
M@'B5DE+^)(XMVV#3;G^.MGYP6C9]S)WNRHN-[>/.'WZ^O[J]C?"MFV "W+\3
MW/ZXQ>IO!*HG</! @ 2,I9_)>S"O+KR0'CJYX,8<T@K6D#69:6AJZNHK#:*=
MXS1ETSR';*PX\%,_#E1"'ZY>EG70@QO1YZ"XV%9M]+&=5M''.3'ZV."+65/=
M,$?TZ3/Z-(CQC/ SPL\A^+&4$\./0XK>IHIJ=0\_-#[S+IF'WA/YGX2S*E\+
MGY.<FA^D+ON@SS]>D*:+BW^G<>(OX7MDOUQ*6V*]E]PYH$.: %=68,X7^I,#
M"HC6_<\<3#["SR4C);#]@Q_[;)T;7#%-0I"&5>@F.</OB-I5Y+NKJ70#XB7=
ME,1+V9ZPY=")I&LWNO4#$G6$NY.+;W^K7*CH>IX?W-(K;;]FA,E0A0>\I9=*
M+_X(W^SB,7(!1>81=O^X( \<'Z:RD,K6L.Y>(;NG;MJEIW;03JUU$]V2';O(
M>O2K[('!D>C&/D'3&AAPI(R7%$%5).K"L)J(G"D[6KW QG'44PX1SM"SI_;N
M08&N*( YR!B.=:'J#.K@.>Q=)=O'C=U[%$^?\N01+&$INWF.2I9X*1MU(FYA
M&RZYA,M>^'I^< <?F9S#%0VF7:6W ($2TJ<24I VE=(8D$)*[C!\P366W#A.
MV236& XRN9/@XGZP %R(::RT2D,>R;(BT@6]7#[:!FW^JW&BZ*595-]QM "M
MY-[BZ^5O0+PP ,7Z]#V,8Y_FBQA%OP:-LTA@JLS*(9._#)PO="2_:(;S9PNR
MJ#>;@S0=NN39IJR]Z$CQ/^(LN7!8 )^;T^[L1 V^?ONR:[?32=8<Q*\PO=U2
MJZ1OV*RA*VIF[)U8^F)"=+:>:>CBIQN:K/!;?M":XG.4EX;!M*?XT!DJ/MWJ
M2/:BG38 L$*]@4N@H1LL&"6\!+XT$*4]"=3.4 (-4Y=5JP,)Y'BLI8 $#W_?
M5F5K]/</$_ ^"N=,GIZ(X^XN[GS\D/OZ=WCEP3%*:S=)(_**&$36C?Q0>@Q3
M>"K"<;I*X&J2*RWNW. 62[0L!S]3++7<%E7-GX1G'P?)SL@^A]D'.. >+TB\
M>,65F (>+[B>+^?PNG$]R]H756>*MNHW5["?<*YH-WFC7^'O-,)KT,Z?4OPC
M;*2=K^(8)\U3319IW=+*5<=__44UE<N\T&_8#*8:BNQTH,.'[K6JAM')N1XG
MN5K?))=L9)HJYGG++D*6;+Z0[1]E]XASU5 GYYK)[D4SV=7W93?V;P/X37PA
M-D?UB\AFUPY"*V<0M=)4758Z2)@>)\5&;Z78FLSL\I"R<Q)BS5(RA_VTG":+
M'LA054/6QDC&2X4O(,F8Q+,!LL;2ERK*=$&:QG4O^DNC(-M+/MAGF'S0#+T3
MT#VGPA?'EHT.C--7%;[H^LD+7YPS+'P!XUKMP+@^J\(7TY#5#@H<FFL^HRO-
M9Y]CQ:=N=R1[[1:^M..!(',LO>=;8V-V)NR5!:8#%_:NK-RQ1.-Y7"$MLR.N
MC#4:?:O1L'J6Z;5):;-]UN%E5>^FE&#H_E57I2_'">Z!&43B"JXVF6D&.FO)
M12IX\&.!1@N%+THGYWI<:K<TOZ<OJ5U;!Q$VRV. SDJ$;22K8X%&*VZ)HK*I
MN7V08K4T!J<W4FP0*=;/6HHU4Y/UL4*C(HYA@B8=XQA-*S3TL4*C?Q4:EOG2
MLN#V0M?F&8:NQPJ-L4*CHD+#,K535VC8UEBA,59HG&^%AF6^M"6V/<UWCK6)
M8X5& P_$4L<:<:X5&FIG4U!L4@E9[@49N+0;SEBB(2*PV&@L_1I+-(0HT1CT
MX3J6K'5@!#<+W_=M-HFC3&;GG3Q7]7$RR9#*B<X##%7#E#O0Y<W L&_C7AQU
M,COW01'*6$K43HE6CTJ)U-[.>G$0F#/JF8NP-982M39&1Y6-X@ZL#E3P<1+=
MV[DOCC:9F5HYM'].$JT90RDK*J\J*T3CME]NNXZ,+0Y$%HO=,[;P7=O1YZJN
MS<WE0C<0<A7=UC1#41U]82(#_Y^.]$E+X;[-9RF%^YY; F4<6 )E[E&#&U?Y
MB;OR%WM<55Q8SC$22!;P260$CRS=)%&Z2  C/(";>2(M_< -%B183(N5_C?"
M82S%Z3Q>1/X<7N0'TO^DJR<P.U6;;#E'JGI)_T?*)7NQ2O^"1YLQH655,N&!
M37G/D<X\0#IKPI^WC#H+O'H:+[[.24WW;JGVE&8!_@;0<R^!0L$198<DE%SI
M=_@;>$CZ1PC?^NHVPE3E3.$9X"^7?$[I0QAXL?0UCE.\?06U0%RIL!LR>YVP
MR0-DUAGAWE.*[U.G  $?W7N"4-+OTIM__N];Z1^))T^E-V&T(_N9Y+^=DHLO
M[D@BZL'W@$W A)" :X!7>"O\TQ95&;+)+T"6V87-S,(#;9JT0NI#&$7A(V!W
M_*O[TU^GZ\T#0#UWX2=/S8TYDRU=55X<Y-=CNNJFF<DT%[H2';E1H[+ 4$:*
M488*9=_3*$Y=P## '**V0%VM:<4V^</-$2Z>9O!&'Z%Y\8VM0T&KSVRMJ8ZL
M\0LK' 57!YI36X,K4L]I#ARN-$>1^=60$;2")R^*51US:H/1Z)"PX.74F2#:
M4_ Z2M1*W:0MBYH]F>D#ES150;+"+P= 1*TD9E.B=$#;^,3V]DC]U-;+@M?W
M^?@TQ>1: ')(',#%#!9WI7Z"/6-YOY]@*Q/?:+GD]?('N\YNR!,.8T'D@2R8
MCW%0U47@.)-9\AB6^PCZ3#NDRAH_7T?*:$1-L%Z?BP7*EQ]/=^ #?L?1CUQ@
M&F$^ K G9;P#!WU=5V6#(^=C=W$G2S^(#Y++P"..-H OK(5%T'NPL<V=,#8Q
M=']UZ1_.5"I6OPKLO6O(KK$,L*?D(=)2=DBHV!0?IM'G +X.Z&8_<*,GUF.V
M\?.9%>62,#.85?#EI644KLE3?D3E#^21-</ :\@;@,"+"%,(YJ2GVJ&]7J<Y
MOZ>T9]2Y"U<>CF)9^AI(UXLD)#WV2$%*'K")\)^IWV<U@Q1;-C5NIT:2,<E&
M:N*,@]W5JO!H49;@T2?6"_*FSZ>H:XZL<ZS2:F*'H=+DEX(=]@TGWZ-P@;$7
M?P',*62X2(XL)AG8FJ452L'^4B<S1,RO2A.LUW2TN-*1QFXS*U>Z$CN2I1EU
M^AQ["N;-!$H]N4"AH0H4SWQ649@^O.4F39U%]0Q+YJ=X#W(X,T7+3+[3<*3L
M\'BYDB\/3=&!&3'-SWL_[L"LO;W[_!-'"S_&V9/_<B,@4=UZO:(,:).9;NI3
M32E7X?::S+8C\PO4Y)Y%P77O\^$@TY1-HU 7RR_@(;+/;&G#+=[Y["[N\A"3
M-,=N1#)X_09J9,CV"6R1 ^,2T$M[V[:QUBOOWVF<D(J"'^%76AH7)[^Y"?[@
MQG[51 1 77TR*T\O_TNOR06^&,>.&>#>('57),A#SY-.+IE*]ZLTEK2+-7R.
M.^ES&OGS,)J2B7JKU"-EJZZT7(5@L+A)KWE?<Y!LG,!*.<3[U7.!]E(,E+V+
M_%[-ZL;@6%U7N")35@:[<._[SK:Z8<OH!"G?0VQ;O7#L.+8U)[.R1=QOMK54
MGDO%IY1OUZ#Y2 %#A.]=W^M[S8)!)K>= '?]($[<U8J8#&4N-IO5+?Q*=.'J
MZ>OVDA7##H&AK<G,*(][[C6U+*[4$MASL?7A9OO6C'^E@DS$@"U+ &C0BAY>
MXHBD-PC /-&^A"R]%X1K/P +D4V>ZGMS ;(Y5G5FN ,( 9]N40(8ZV#-"!L*
M]HF>N;OZ#N\.O7(]E)=&E&@%<"'C'#=S:;+[SB3ZJKC7=+$46>,(,2282IAW
MZ4>@-W-__4W61K/)6>2M-+V/MAK(R<I(3L'8-G_&=B8S<X!\;9@FUXR;N*K3
M,8=;+)&C"?!N"$!Q"$X^Y'!"ZRE<SZ-WFM+:M+V8(?[I)](2#Z!2TU2Y3M5H
M.FS5J>.*?H;3_H+Q=O!JI2NJ*H-S135+EW6.72R929B$I$G5B]Q'+WP$3J<S
MXZ4WOHP%3DOHRJ$)!0- J!9[63+A88L!&A<SJRH(U: KF1U=-CAJ^'MPQS)=
M\78J@2]&)L5(Z7W(Q@.O7+!G*UPYZ<U6I41X[?K!YKVD439=K6A?3+8.!W00
MO!W</<R6YKR5Q15;L&P'FTVLW3^[K;.]<VE9H121CS;=*;N=I]DP@2"$CQJ3
MU_4\-ZF#N\ZQ/^8%M\8Y% $,$W^!GW%F//>I@'AH,M.4DB\#K^FU)Z,;?/..
M]W":$3Q/CI:P/RTXGO**+[4#160D[E"AZ)X&_B2@R7T:+>Z(HF#1O]VF91(H
MJ>BNQ#\7JS1FL\PS?<.Z<>ZW\<1''Y30'$OX3Y)P!D*_\=_2>P K! O_'AX4
ME_0&&JY[F]GO89J .1&0_'Y6 /#&!PH-QE5%BB+;W(._]5U5BZ.KJ@W.545D
M81;'AL"2JRH5?54"8\#=&0#%Z3KOX]C6P>2X%6=CEMCB#G$1RM2&Z][>N0\D
M<H:)4^.3%AQ:FPN Q4QAZN]XX#CE1 <S.O\]PBO\0$WL+ !'NL\(#[ Q 'T6
M&<UQN.X_:P70KFA]V:?LT _6@:CZ9%;.FO<:T705\=P.22,#I%IO+7*0S3:&
MZZW_V''*>PT==.8*/][T_%Z'\%2P/2R.70S@U5*P)%$X$IW)YM2!(;(('W!
M&D@$EF%#L<>EY,_-?_Y*!PP%F*E)&G$KIOB*T;I\_,2@YW CS99MCM5\=>G0
MM"E,4YZK^,OK_/(6K^NM.]RXVTLU)C-55::.89W9WF-$]HEJRO:GBSVLR:8G
MF6U#?LQ(6AJE"Z_X<+-7!31H\NB6):,^B*IZ,E$U)S-+GUJF>6:2:BA@]'3
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M+MGK$?T+'FW&AI95R88'FH6?(1X0J9IX*O\61F2@X:JBZRVU58UBCL(4S]_
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MPW!X'L9Q)74,[DIJCB80EY14V*2*([%/,WQDH*O"^0VX&C8P$.^;XUF<P 7
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MY,I6CM*5B]E2.F%]5\N0&,NR58"%I70#3R !B'3,+X$TG#EVT.8QQTXX<9+
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M1^2I\7H:)QYY#8I4PN8W')!-0I!0ZDR>$7EOF2/UY,6:-YO1/#>1#YU^2K]
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M'IA<O1?$,:G\NA'*UU0FC1M@3#IV&I415J+V%\OF.466UJ.GQ/OW@KDV?:9
MFWC+)?5#8]8USOQ0*E-ZDA2;26A- 3A*4ES>U+N!R.@+Q$'? FIQ$R(ODE$[
MAP\M80[_A9N^;WYP/UU',6-#T>M.DR3+O5O/^E(VMYKB0_X/BQ,UITUED[F[
MB#9L3_V5OPB2;*X Q6 F+XK2R_")2"*-08B13=;1AO+N/7G1/&T%IZU(P?R9
M=8IGK=W_]MGW0O*3$67+A_>^-E]'^8BF#/3]U=P7&69DKJ_E:Q=3-R;;O6BD
M_?WY).BA=X,!Q^(Y7^DL9Q6<W"+QS7_T5VN?-GS_2OVC%07-7ZG7VIPF:E(Z
MM2WU#@ALZAP#$('GV4-'-!>3L^$AOQYDC<,IC8SVL+(.Z$V8D!J*.+,4%:MB
MZ? _EL$AGV MB&G1X9X\E[@@C'E:)!T5/15>D7DK@B=>F+33<V;>0T \0R:S
MW+6(N1*TS^),($!@I1EGPFJ+,[%Y+XTX$_:!AGM')LZ$K6OO\[H55:+Y(TWA
M-FR1/DB,F'HFFF$?S]!L@>>VZ?DS2I* 4VN&/1_,N1 CG -R<AL1(T[6+Y@B
MX4,\U:-]$647Y4,0SY8A'7KQ9;%-L'W\2<Z91 5A]%SP0,K<'?I%^E2?^"L/
MY+E)M/;WE#*?>P 16$!C;V[!<,"M2C=9'%2YYGS7=M&1AN1'TP)M(XUV='@R
MO-\]T/?>,IA&P9&#!.<<)+9UQ*_Q\@V/,]COM3AV/S,]Y7\-3=B8+MZ2A/BI
M>AI1-++;!V6T;T1/'J@#4Q O'6BUY!@JU#V!?!Y%_FSDH,W[9F\TH;-\\E=)
M![30N2U+[R$FKY5_]E;;/PWV>]NDG&'\A3XRF8;S9_*?*']B?EH&^^Z</I >
MTU]'!$$)\&X^S\^J,'4E?S3"V3O^Y<PG.."2WT9#?^E?DJA*(KF2G7YX4?>R
M2T7N\RW1-ZJ%;S4V!(,$[_E7B=*=/_JFJ*Q;T6?*>FC@S4F*"[MG.D0''EYE
MO-.4\=G&V]D'-!HG!+,3''_=Y&=Q7N4+T%@\FN9*F/'VUU$8OVZ"=68ZEZ?&
MQ)Q?DGEK*E7K)J@G\WCR <Q AFZ;0L)&-H:K#=R 4#_X]"Z XV1D"G6+7UKX
M_9?/'VY^W'SY?/V;=OWA']>?WW_\W@PJV+).?E"1^233,$G">SH[+LEGQVU/
MF8.6;:3:3-4<P$W-LN[EO0>+H6&.[O#K8+O^KGWYU,C7/JY4%QT[@+HI[+G3
MC1K\>CL_?'S_\?=W'[^QH%V0X]\'5Z&.'T&.&]]HEJ17(&W/RS@*T5Q1&@)'
MH;1":;'.7:&T5"B-%$I?B-+(@ JE%4J+=>X*I:5":=PB2E^<,:^8@3^;^?ZB
M-*.^Y:P8AFF^KK6$.A8M+[;77L<S,_;M\U?M'S??-@,MWST$"\:Y:YA)QWS3
M8X=5+3/X*33WGC;;UT6NUAZ)!'M<R!2G57?OU^HI7GY(II6. *_!HC#=DU6I
M([SAZC9B<(3S5F@[N<ZZ3IIW#ENC"1X#^[+-HWMGENV@/L[7X'N%6XP&SL&-
MGG(Y"CH4=&R@X\#:1'[085/H@ @JZ! 6.NHG&!1TB 0=5GWHL AT.&[M$:&-
M8>3 :LEZ,+((?OKSJW_[45B)($[*<P7P;?\8TD8LNV ?'<>R)FXSEMV[S;+'
MLN^OOWW\?"U^*,M;T^J'J_OJI@S'"_8Y#^Q7Y>=SNJ,)'&.SO#EX&#[G1=?T
M7)^3-S;4CT<5-BALV&!#:2<:9VRP#(8-3GDUA<*&SK"A?L"IL$$D;! HX+3:
M"S@M('G V4OQE.B."CAY!9P?WWWY;0#QYEX>LX->J?H1Z;X^*LO2JV6!]2W+
M:5I?8VMB-[4F%58#CB:@8MCR,-Q*$<H<0C6\*W@0"A[$<3P=#E"!1A-SJ 'H
M"T&*^B&J0@J%%)5(<6P2^:4A*I8\1.VE)FH[K?;WBA:?MD9Z_Q'2(7ZS"V>Q
M\:>^'U:S/;M"CD*;AVLZRF<CBHYZ<>H'L/O:RL_N"&5T4BT5S.2DU!<!*B87
MI4'KE$O,T<0:VPZZT,SL'-A+*9>(@RKUXUZ%*@I5KAJGPYJBBL50Y6(^@4*5
M7E&E?HRL4$405!$E/+ZHS>-$;&SSBHTYP N+C7_)YGC^PJ9\5O[LL;GD!34\
M>VRX":Q=,GF[8^-K3&?D.&[VV^>O5Y54TJ:3XX\41'G+ \$NY='M^-\_5O-L
M14,NF7RCVYA]]5=BV![81B"?&)B FJXDI-N!_.#1U\BWR+^&O(:$SNCG.!SA
MK-4R<'>UC+F#L%_HZJ5/P8K<D<!;_A9XTV!)WI<?_^[]#.[7]Q\B[VD>/JW>
M>^1]!,ES/0?/*F"P0QP\O1PTIH.AB1"6Y%^#%K&%=<COQM"ALE7Y,GH3%NN(
M;<J:^X_^,GS0[OWDCJX]$79%B8DEQC:Z XMB&#GP&=U$\TQ' *_(^[X/E_YL
MO?3IE/[T1Y+(]Y)\H<QC$!&Y!JN%3V_".J8/\+V8BOB.P.%MNH$]DW'^2_1+
M;,6?\?;W<+Y>I@/IR3>^?;X66/ZFQ/*?!N&MO_+C(&:"(=X&.?>$PJ.N71]:
MYK U>G?>/#=T?);;]7:DT-$QO^G:Y]FX8W,/OD;AS/?G,5V=QB5GX5(BLU%!
M9)9G?QIR,8GYN EU3*\#^?KL;M"JCI&MHYXW!<)C/'W>JFX;HPD8VZ8EL:J;
M!M(QQ[W6V7[3%-B)-R>N=;8DML[?_8<D-;[0 #:?%>%]'0LP+!WRT]#S8.<8
MKY\[[(#1!&&900>0J-'AEQB@.'.]OEW'27I$1.<=C==R]K[.B*[4YK@H[#RU
M/\90YJ[VM'%\[")#8L5' .N8GV-)%?\SB;YSI'=U[0?;XOK@/1=BY]C7%FNZ
MI2>(M9C\)HF]V/9R<6VS+;%M9OD-+_$U<OW2H" IRBQF2P[)[5@2!VKZK+W[
M>B/P_F631DJR2NIFI?U]O?+9ZLEB\H*:EFUMQ;N-_&R#LA_=!RLJ6K:6.0K_
MZ<\2;;[VTV_.[E:TFJPMO&"YCGR]\(S9TB.',J_8P2RLY"VCTTI:MY(/%T.V
M,ACW':<?G<3Y+8>Z+XN//XFG$%=X#^_3"]'<B4#4B8"XW%&CR> _ &!PC=;)
MST1^_$#/?W5+48JF\C>&B'@/E<48BG_Q>AH'\X#\ZQ7-\V\-V3:_NPH3<JRS
M-7F)%-G$Q3+@R(MENS+^]I_>_</;#YK_\\%?Q7[\FDES:\.>/%I['O(=@03^
M^&U". A[!(R(UWT"^>!NQ.1',W*QO%O_RZ("\_Z;'OU\@VI7L !K>#2QRH'1
M7P8M)POJ-C\SE=<)(__>"U94U3=X1;XSY(.BRY7MGA,!;8\CLDTZCLC%93:H
M/,$_QJYN\\OHI, ]FT5KEFDGP8<?)_%8>QKR&9G8T2$_9>=6<VO'[4"&O&X'
MT<;U,DF+0%[F+CX/634!L'6'GVI2USB\]X=NG("%]'Y;_ [%FL$BBJ\6Z^62
M!)R/_FKMTT3UKS3 6='PYM?((S%.<T-ET0#3L65N?X#0U0%'0\4VQ=-$&8DR
M;FEZ[%7L^]KGD'P&G-=\LIN](:9I\2QET?1]N$[BQ$O#->\^7*\25E6GJOS,
M\L0!2PR+'5'+W/N8ICCFZX@E38@88I_F2;0[;[F@>$[SQ;JXHK$D3MQ^SX$%
MFCK4M??A_7V0I-FL->O&?_?UIC*IQ;/&4F:Q%#DN!7%>7?US'2?!@KQ.]LE;
M;?N'O]&\:1PNUPGY4RMX<)_81TYRHP2WGSG![3WY>)O:27+HCT$<L,9V\C+>
M.@F)+):AE^2GN"/IZRCPEF/M.Y&N]KTD76-[ G:Z"O/>BVZ#%9/[3_;P[6=O
M63*1O-33&^TNF,_]%9&Q-Z>PQIZT_3,CGW;T/OI[&JD]D;_LZBGRB-).(]_[
M\XI^X8*Q%A#H.*.V%)Z0O2:VG-*WSKA=V-9=1Z3+!5URW4^1$RMNTJ<KJ]%B
M\1-7HOH"-)"><4AP)LZ^M?<:+'57O(:9#P=,U[Z";NI'DN_Y\^MD\W5DC+@#
MKDVB/*LSE>B6<G9HXX.XC#/'ZE(:?1'.,KFPO#XU?R^$<$:LOLLO]W]>JO38
M*))V"&?%\-0>3=#8P5(W4;E0-S@6#HC2YYPRCUX3XG#XZR28:7^[^4>!O"2L
M0^]*C&@/47@;>??D3TONM.MW_Q^V<"U^D23<(D.W^Z[\')N!PKT%U*%5(.#8
M,J,7<4 <?A=$%FX1='6K;ZKXL9&VW%7=I7ED8,ILJ+%K<BQ<#X=:1!DKTEKD
MC=F%!D!#9Q;A;.YKCZ!S;#HN;]!Q&*'1,,K3^>4!'6 ;/&>X4J#98=/AX3.+
M+$<W3HXK:U?MD=&EV@/B5KH2ZSR"0+?X =F.E<T8$,#JAX52R]Y"IT5[VZ^Y
M396TR<D3^'.[<W6(WV[+ZNI4<>GR@N$^EZXIJRM/E.O:]4JC5;&L'KE]O4#@
MT48 22SVARA\#.9$3I38,/5B\EF8=K!D+5O;-!,=@4.>MS.]**!12NQ[$=$!
MZBH49QEEZ2QQFP. !>05;'=\OEO:7$8>XNW<[:R91USAVR@;YB:A\ ?>9XDM
MW>F9T]?E# R'#0,P+*DC50!UER.9CS@.7E;2W6(;J^]FA.(B%N7\KRU#SXO)
M$Z*-GY/!W5@Z?IB)@<[O)C7FAZ$V^&$.DH\?9IHNUT0.)P/0CN5UL+QNURXK
MKZ+Y<O <",?FV2]_7D+M&..>BT7&M+,$5NQKE,<B0Y,XP!S'\QQBZ+'\0($@
M->0SPP#IB%\V><L5RZ+M09^-8^I0/!/67STXS],*%\2T0Q9S&*L9FN5I)/)@
MIFEAW>)X_X4N[+N6O F28Q2](2LHH(,4.2IH0XK>L,EB$)I=!B;=DA<^OOOR
MVZ"X"Q!+G)W?DA<*N7AR4;[,9D0M5@$-(F^I@?]G2'QIC5ZQ2GK#IGCMD4.C
M"WB'[C49N'=2 ^IR[+ICD4C3E;HQTD*ZR3$N>#7LPW!UK@T3Y^AWI[4-RM$Q
M9-9O$]JZRS,GP&V&5SMFV938+._1;( ]^/Y'@)#N]DRK05U.5G><T41J>TH3
M\!P32QG>[&N^^SH?KUX<T+S7!T9_CM9)-XTF[0Z6*"!9U=B(=#6P@5)X2C4B
M\!P73P%&4VLQPR:$GH$=A$SRQO',@J;_OQBYHY:@<O->2E!YA*Q/FX4KR?J@
M4XA-MQIS!]@TR6+JCJ[]1C?AD6/=T(*;J0[C"HYV;R.3^!PX'O"]F6,@!^.9
M[QF^/<?8]:WY8K:8FF5U.S#!Y)B0P $A0?X3%1!T=>.0%I&#_KR^)T*>[:/N
M#LA^".+9,HS7D?]EP<X]_A1&O_EQ[/L_:!O%#_*+[^@)%W"T/#2"?I$^V">H
M^T >G41K_\#F;8C  IZ_>;MO/X B'_GU@/T<;1LA+[&GK:S'-?83:I^2.VWJ
MT]DO7-!O1ZS'E3&3R %H/*!/&!Y I6K%9:*H>\+Y\)+\V<@ NKEY^N3_LF78
M^8MD&^N)SBR]AYB\5/[96VW_[-CO;9X*#.,O])'9BNTDRI^X:0MGWYW3!])#
M_>N(:&T4/FT^SX^J,*$GW_@-K'1K_>B7,Y] NQOR![!-X.6WEQ_XZ><7Y9 I
ML+<,;LG94XF\U1[]**%]F?E7B0#.GQE4%-SV'#+)'9H4=+*"S(*&5->K'EZ%
M'@;[.!L]G#,RK72R';^\TZLT3QZGTP!3GY.Y6<0_#N/736#"3 <:U1@UQ';/
M=Z=2&R$VTJO-[>"A5JCZP5VHU$FGR=8!O^:*WSY>?_^H_79S_>[FMYL?_]-,
M?]A6\KKZ<P"Q(*B+6!7#VV8DP%N4AJNU#&8 MHAF=H]@=E+S(,].PNOOVI=/
MC:*ZXPIWT<$#J/=I1KH]^;]??_[C^MO_:-G EQ;O_$67.G/BIF&2A/<,DK5Y
MN*9>WN[Y=VIQ=BX_5Y-C,W=6/*/3H(F[^$[KZNW>K]73OTV 0<16J8_E=T++
M(\@M?)Q\6TTRD0<*>]M^*!8;%R:5524876,T@0"7,HP7'! Y?ZOROIYCJNL'
M%Q6W>L$^.C;5Z!"H#S[PJ-.&R]-FO/JOU]K-:A:Q9$7#*.-(9P<?BY'K5F8Q
M<@]> '.!#@02W/5/!'N1?U$PBY'.ILDMAE'?8B =G0C<&UJ)8],Z\LMULRJ;
MBH:%*A=0UA^VR[NO+S@X<2Q)+T$?-I4EX61)KE[3FB!3=M$,R8'0@P!&/A.^
M)SN"#\0&RH[T94=P.ORICAVQ=,MN$GF\XF94\GM6950J[ :D'55E9EK3K'+U
M->T\.=A+Q&$>2N"IY*!*#@[AY#]\?/_Q]W<?OVWF08N6'MP+]HZE!XOQ8/\V
M? <:5.JP[]1ACX'@@=T&Q[*%34- ML =.9(F$WL) 6VG1=/^LD) D9.)>S&@
M0,G$'0540:  0: HY:=C4TN.)18K# >=3U(Q3E^*S&$O$:$K;?.;RAR>C$KZ
MCSK<UGKDE-$X"PY-IW[FT-"M$Z)HFBT\9BF.90N;QA\FV\OBEN./@283^^DT
M-%2KH<HF#OGD][.)2+1L8H-F0[&RB;O8H-*)?:<3!0D%#^P9;-B(:(TF9L7R
M4RERA[T$@0"J3L27D#P4MQ-Q5P-5(-A_(-AK*V)'G8@VF]P)RY,[I<@G]A,4
M(M6*^ (2BL*V(N[JGS(D A@287H1^;4B.G1X87EMS4"SA_W$'%CU(JKLX9!/
M?C][B$7+'@ZV%W$7&U3VL._L88^AH-E^,Z)+HT!D(4$2BK]DTYU^8;.?*G_V
MV(3 @OZ=/7J-CG;%LLXZ+<W?T^C6*C;2?YFO 65#QMG,>/MM3&3LS?^U]J+$
MC]ADHZ]>%,3I-/)W89P0#0X7BV#F:SY;_\/6 (7T!S^'C_E*>8C27_B=_(T/
M_G(9D*\*.^O61$ZJOS+*/Y557!+6]4,4+ MK8U?D3V&2WI7__J_][CVS7V(3
M<\F7//*.8_)7:^0-T=&AY$N/_ETP(U\=T]V+?](5$<LP$7CQLXE=W9%5_%1,
M1-)4BKRGX9X*K3HZ+-OE.2?WQ%\8K.[(NZ8'$VNOV)13NDFFXG"$4G +'!@M
M*H&"TQF>Z=1.NMJ\;,W((Q[H4_Q#=NU3MI8CT4SMV]HG_I>V]+1WWOK>'VNV
M:1A.AHO^:LZ 4+M>WZ[CA/&Q=.V:(:>XLK>QO.N=MG(G_[X/Z.I?(D;["@#B
MJ:R7/GGT7/N;MXYC\F>L4FFZF33CA&H"D^??U\OG3)HW?%:9]W:V! P-?B'_
MG3?H$>K(19E?S^4TB*_#XS2.CG,VD+F3J&7>^X=U^MZ^DM\(YSL1'SFJV9OY
M.GH*HWGLKS9A'C2,'J\X-J#N\%L>F]Q%_K!W9A)H<?CM#KEZ]CTNWMS^#.K>
MS@<C'?';7D$WT[&?&1.CE]S1I5G>+$A(Q$M,M;<4V%@[$B<BP@>6_:+6VGMX
MB,*? 0$QGUC>(=]L@!R=WSSI,VS##ZK9WU+%;F0? ,'5IU"C4!(?!8*A2<2V
M>&["2?,<)*H@OQT'+(?V3),<T\CW_F3?H%*B*=1!ZS%";CJ O#=%?D</]/V2
M..M^(SV&!%E6/M-CF=08V4BW.*KQU">GF69[21Q+PM:J=4 0CK4'D3.UEF'(
MFZG]W5MYM]GJS]Q58>CC1_?!*MT'DAK16'ORB3!7(?5IO#A<>5-B1V=^E'@D
MG)VO?8I05-14YC,OIG'NW'_TE^$#V^]$)+])E(SI6YG="2QS@.1-S\["]7).
M\U?SPK97(KR(R&I&DU9>DM_97&K!BKP,40VJ%GP6<?5UCM A81&_[0DW*^V[
M_Y#LEZ#2,Z6KK,E]"1:!OUEC32L7Q!LEYQJP'1ZT@$$OF;A7 =KR)G*)UOL_
M_6@6Q#Z31Q8O4"3+ -#?];?"5;J1#AGC;"O=>P*-_K_61(S+Y]WUR5X<TS+5
M/),[31O2IS)\C>B[F[/ERN)*'AORIG'G63=BND;'SRK3\[UE7,_TV@X9[H#;
M]T;@ Z.N3K2$_K@CE^CV[O=P3M!SQM[9E\4/<GN:]IY  XTF%H02;^V$)M9-
M?IE/AD\>K6%%?OQ UZ:N;K72=:%OA%HQ$CII%.B232DL)O+5TB55/'=V\@8W
M$\F;]DKK@]M*%;E$"^*\$R]\4[.B2<I,EDQ@TW6P9)*F3LM. T:8-6#D!N\F
MT>[(SW12F+ Y%29PGX4);.HF/X]S^(4)*V<OJ,)$Y?DX5N9P\RY,4&!?A0)C
M,B6GR(K)>78E#3'2#=AII$ \HU";DF\O: C"ME^3OS8/N=G[NKHG[_&.9FC(
MGT[N/\V8$?33Q16E"W0DJRAO*MM.OZ^G<3 /O.AY8S^]S 9OPD=JC*F0J7G>
MZ6N-N[6K#B>[:O9I5P'078YV]2D<M%6%7$M0\EE5;.N88Y"T7^Y?%7)'PJ*R
M;<"L;U5"5&8&=C=;Q^K^*XTNTJ:_3*QI:C=IX#KDRPZ!FSE*_/N/*=A?!3^O
M[H+YW%^]83!OL7HGQY;CW@X.8=W@B (AG[IE;\=!01%V58''1MGK^$@9''%3
MM\.6M(\$.J9^BI'?0![$IUQMR^U;VDT:=N2%C_E>Y8.1:HI%"W[FK,RJ*W+N
M"L;NZNJ?ZS@)%N1ULD_>:MM#>*-YTSA<KA/R9U<00CZQCYQP2\FV/W.R[7OR
M\3953"*$QR#OKB%/7"<AD<TR])+\1'<D?QV18&RL?2?2UKZ7I&UL3\!VV86Z
M]Z+;8,7TX"=[^/:SMQH)'B+R4D]OM!1EB;RIC5K=LB=M_TQ6E @>_3U[K=$;
M<?44><2DLYZ@*_J%\^<$V!#H.!N44'A"]IJ83: ='28%U_,]"-2XCDBN!W2M
MT^U'%;?JTY75:(CEB2M1?0$:2,\X)#@39]_:>PV&T\5KF $K,%W["L&TAD.^
MY\^OD^W7T:@%=U1>;Y0 [)J<XG('?RU=^SID^P0PRCC87,Z('$JQ_ZC@IN\F
MRV+-N[#S2-B(S &Z+>L5V$V*Y3U?]]YSVGL4)">:CF;KB-6L6-.1L!(D?JT.
M9!7A39FS_3Z\)W_7B1RGQS*<12)^FN;<9CFW">[VTYT8<$IW.GVF.Z&MV_QH
M=G'P<\B6""-71_PB)?G2G::KN_PL]7ZZDP)!@5LC+C@#4]XR5!&-2QV+*2@3
MH\J^2_ZDG);6#]R>R[1P^PP03:3;_!H5!HZXT#(YLL[2@K9,B M=K$..Y!G:
M.#[+"_WCK"EOEU-:9#>V6.5H!YE),"QM\'\&0)[+J00&0Q;Y<N$VT"$VMA_\
MG!E=>^?1M#=K;,S3#_\GUOPX8?3@\0[E)36D<M0-$;!THS/J,*^P"P!)51R9
M1,?Y=;!H 9T\M(J#.0O,*W)EU(B0'R+J':74S#6]!^+:"&3+FQW+V^7OB9C6
MD5_D2.YQ4 3.?5F&O+FO@VQEVO+'KM(V*;8L#;S,1%DQW9#^YF[O'[FJY"5C
MFE'C<QO[.GT30-WFWD]09AJMUE0D9;(1AD6R$2R;GYQA]$SLSXR<-S'^7Q8_
MPJ1 ';J"!<L#1Q/7+E&'_C)H&2&0+@O@(Z/QL!4663P/H[G"(LX*BXC"EJ<L
M#UMA3:PCCEX2Q5]Q+:HM<=]\\^N!.5\/+.'U(+>#7UDH]UL2>H;[CB@=$1(_
M^#/:DK04V2UUD;QQ0SI;W?_YX*]BYCJFO/4DW%1@8Y813*OMWKX,T^D#9?9N
M$+.9!+<K\D?.R<TD,:1V\^G;=^+CIX-?!GU'#(?G4,ZSB/!':/ ?4V%^N7C=
M'@3F:()A>>>Z/&1WT[+%<U];03%H8-V5%<7.N4+'EHMQO$)L]7%Y\9@\5\CE
M/RYBR,<! -8-?DF+<S2[&\6V1Q,;E7=ZRZ/8P(:ZQ;'I9=AG8>J WUD071OT
M:3B6;G,LSM,0B96CL@4-I[/$.Y$3)?\_IVYUP>FF7ONKX+7 '@FPY$WW\W;J
M/]"<_BQ@+YN!.(/PYKCM$)\>R.S3\W5(AIV1=EV>9\';S>:GU"Y1ZHKUOO(H
M-3 ='0B8MN[/(;%Y.F><W6QNB@T-XF4[,BLV1);.+UP:M$Y#Y.C\O$HO'O19
M8)MG&*T5;^0VW4U1\%7 R4GNS6NUD<[/,G!T7+<K?V\8NRM.^*4?(!A-@,S9
M!TK0XDA)&K8;BQ'D>1@<_=A6=1P2'2_7ER72<3J@1#FUA<*BR9,0S\^I;57+
MZ41M(+&6FUS+(P)OH8;49,F:T,L5?^,\CK6\Y_J"U*VXLL3N2VQZB>_"*+EB
M>S5VYQ"DL<(R?"*ONUQG;2Z4^T YL=DXD6 U6ZZS!<M4+^A/9CN/*COQ!;[)
MEB%OLT"Z3(#79,V^#L1V=+L=0EM+_4C?V/2QU>V/\#N]9'3[!KN'\?5J_EOX
M] ]ZK:[9K?H41O]-V\V^I<6L-(GFWS-ZZM^\^)WOK_Z(_7ES3P./)@C)[&I0
MBA."[O:#GW,][  28-C6P;34>R3 =3'I=9&Y4@@-8N8X)AF''G]":.B(7S=D
M.[U+ EP,BUP,4^H=4,2[</DQNWE$2JW.C2VXS]L_>#L5-O6)79BVJZ2*$'B.
MBZ< HZFUF&$30L_ #D*F 5P\LZ#I_R_&<-26?YZ_EY)_?FP6)SHPB[/;=4;3
M<#EOP:O_'":^!DS=U;6O41@_K_SH-O THG"KJW"=;*.N9GK$VKQ&NQ>2B1]/
M+1OAQ=P$,PN[TZEG0=<W;<-SIM/%',\J)\M432L^)C%\0&(F_^FI"-@U-ICE
M0Y$A @MH9)(=7@A(M^70(']#K([O:!#_L(YF=VS0U>Q?ZR!]+OV)HD)E0;[F
M9>O4ES[3,8WJ6!(%M[?9JK-T_.0CFSBYG:Q%3"($]EN!DWC$2WXY>G#O17_Z
MB3;S'H+$6P;_SFX@W:2K^3]G?ARW,:.ES\,##N!)\#O#Q;-V2,I7UJZ/1Z[2
MEW7R.Y/+^QVQ_+@C_L =,1[U_#6KX*_9Q%\S#A6+R;$OR;]D$C)$4+<XUM5>
M^6DJD\YG33;C7ZASEBZC3M</:W/R$_'K,64)!C%UT7-TW0<_AK8B8R &+P<#
MR77][,5S[U\:F[1[3\R<'Z4#X@I6,(G(N\]N]T,44'\^U,@UG=WE_CM*E]!E
MV=5,\AOWBV"J_Z\UW?G./^W:IR"P:V9;K?O@M.]B*:R"TBV5O9+##IW1I)P1
MY4YA[U-$E*[+LP2;J;:XZ%5K%[$DZ)7O(I[YVM1/GGQ_56EQJAV]-O)UO=I]
MXMQA?AVDPW#NW!?FW"'BW#G\DM;DS:VG__1GK"!*S+_W,[A?WQ?,N$QGAVVH
M@U[)N7L7Q*R^($P&UTP$C2\$,D83K+^@"V%"@^>N4IZ99MZ6W7Y1.3H2,SR$
M=+4:6UR=1Q(/WC.;;OGDQ?FT2Q:6+KP@RIISPGS/2%99T%X50QD:IKY.N[?H
MG&NN0->.V)T7E)*['%-1%:9>)Y^(?A2*@]=;C6C>LXHH^V",L=5Q#;#7S*$!
M>2X[36?0[[?,%>_I+(P3<1LD,31?SJ4\.+R6[4DK .]>UF?;ZDC1.EC%P>TJ
M6 0S;Y7HVO> 1FUT6V@1TFDCY;:.,GW.DDSBZ@%Z038Y3_5E8XIWI$L>$JQN
MR>V]H_:8K7Q=T][:1S^*_;G 7A6V7E"VEZ9HC]?'::KV@%^UCFE2W]/>+;W9
MGU??9R1@)W_UMLWY/IS[2SZ2/KH+H$Q+^1#$LV5(W_.7Q?<MR/RQ"J=$!H_>
M=.G?K![624P;?FY6&U_@]^VX]"^+ HOEXT_RIE=>$D;/!:M?7F9*OTC?CT]\
MA ?RCI)H[0ND.!AAW>(7&E'EN6=;,KW$XS?Y=F\%P[&VB.R\^6. _8)RIEX<
MK^\+JU#39:?+9?A$=T:W@M,GS]\YY$U5"YJ=8-V#R=<:Y\_&!M:AN7G\Y/\F
M%!_R5TGW?-/UWTOO(2:OE7_V5ML_#?9[F\<"P_@+?60R#>?/Y#]1_L3\M SV
MW3E](#VFOXX(<$3AT^;S_*P*R[NS1T,S?\>_G/D$F\]O_Y)$57\9,G0[.]#3
MSR^*,5-;;TDP^PT3Z%N-. P)0>]E_E4BOSU%:+C.NGR*F=P/K2 _63I/V6Y9
M*K'BZ56@D=(TS@8-IW%S'=0M?HT>53Y#$Z3(B*TUUI;_DLSK:%%V3:=ADH3W
MY/(])%H<+H,Y.^B=D[M(R392;:1I=FM:9DNK86F,N9.W>PD*1OOM>E6PC 'Q
M0O2+.JUY-SH_];I( @#JYLL00;;V+NW_%^3T7P[ EM)W+<+K 3\1U'82I][L
MS]LH7*_F5_GISV:^OUCP0]YZM9?,LVW'A[1TB$5S(?=:2GAJX+<@_E-;1+ZO
MD1_UFZF?B?E:]\/ZE1G^%)M[=ROW%9"?Y=]3OMZ!+_]B@V[)XGO-FP%.KDW>
M^[TS->_,EW[5?&N16:QN(J+!1+/^.KHJ)T&/)3YW)O14]($B-)H8>GG8U.MV
MSLJR3[9DCIIUH1Y$B&$#1?WP0 %%,Z# :>ZR#Z"H]=*-<<+:PPFN\(!'$U@!
M#V<<T,;9T2UK6&#1AE.[8!\=.[785$XM-Z?V]\K6\E>LH27M F*)AZROB8L]
MY6G,>"M@?<]V7POE-UA94=;2$;^:;+,Q3=@^->"QMI5HVC)'=\D9: Q >9JY
M['>BOA.G[D0/=\+I[4Y8=,"O.78KALFT>">D2<Y9*CG'SX_Y$LV#E1<]Y[,P
MHF#F:Z]$=5MXZUM]MV5?Z5X*1-/-T-U ]%<_^DYUL *JW4J^\_DQKE$ 8YN$
MN%@'IO#N"6_=K^^>O%C==_K7?=-H4?>=T<32N_7,I<FFV"J;PL\+H>^4,I&)
M&[V.&DYK&V)H6-_OV%>S%X.]7+?P'L3>YPK$W9E&>O/Y4\N181&0W:JQ+&Q^
MINPWHKXW\E)O!')U?D-Z&UT(V-N%P :M3\.R<Y[.E!V8G])+ML15V1)^?LH_
M0CJ%FO+E4L:W:*C<7WYD7\WD1^7+^A"L_OH0:KUTTSX$LWHF'9\^! PJEX6]
MJ#8$(?"@OI>F\."%XP%N$P_@:(++*TI>%!Y(DT@CNJ(\5&X>ZH?@,9C[S680
M=9DO$([ 65(_9:F.6JK3VGJ6H<H/B=8;>[5;)B^[54QU+(*?_OSJWWX45F8Y
M$!N !@%\R].FN3J"'?F9'=_N^FZHNMWJ=A=OM]7#[<8"W6YITIH MIS73"O_
M(GF-K5&$/]49Y<>IM9WWN(:3/*W<%I'CTN;AFH[\V8A++,YG2:7YV2JL5SVW
M9TT6S% QS=P,BP*Z53-_@O%%!-#*YF2SU+"_1_\\,.2V<2\R-@^-M#WG7F_&
M>!W(ILA_VQMXINJV"W/;NW)+J^XZ.L!#J'7#*SS/XN6V>'F>.Z=U@>?Y2S8E
M[Q<V0Z_R9X]M:2VHWMDS'RV3W+L=L))XYF/%=*UQ-L^5[;\DFJ9MYT*2$TGN
MZ'3\8#6+Z')EV1:!(,/.%NAR.=W_:AY_.B?BS^W>KB^+;T0$X8I<E.>OV<[1
MFTPN-ZOF)1-;^HU?"%H\U[QHCYMFC[%<M\!R>8X'SN+ PY?A>'^[>Z"YC-F_
M=!D.AZM0S,=4[KZ32L".J?/+#NPPPV3;G8:I-\#O+C2W"-8I?D=[%J&RV5@J
MBX )TMD<;T*T,\E,>PK72T[#T/>#/BZ>K@5?CJ<;^?%ZF="%,GO^ZX%T9F&_
MP?19*DB#EJF[EK']P+Q-?;-<E@5.$>US$/O@YV!6M:GAP]K_$39"P'3E4^.<
MF&D08"Q3\^7=\82 JYO\N 62><L0\SR<\ZX0'-H5HIO2T(NZ0P[2 3^DU5HX
MGDX]+\/0#7Y^M52(@@VHF[WN:R:(<F!YHKB( @FBV"\(4+!I\<Q5CC7B(3_X
MY-0>_>6SN L6+=O1X4L)6BY?L!C$FO?P$(4_R;U)B&"E DID(;W?X.50<6X+
MDY^"E;>:!=[R1-;1I).6Y<XZVCREI6M_=%ZF:@?07./E %K3_*=KG:()M9;^
M-+'TZ4\Z<9J?;*6MA[F.;AINX4.(TIAKF5U7QDQ3]LH8 )AKE"YS:0S8+L\1
M/,U-PZE>_?9,@R6]:0 4]#CF9RHK8Y?59,CO> SDQ/7M; .^'-]NZ<<QD1SY
MNV2Z""1H 2>;:EO.Q>&AY>+LIL.V=WV9(?R)3N,_T1K:GUC9_W'Z"_*F7 $$
M/)N!=(Z&J]P676R:+IBUJZM_KN,D6)#7R3YYJVW?_QO-F\;A<IV0=UQ!IOC$
M/G*F!&5)_,Q9$N_)Q]M4Z<GY/09$*9G1)D]<)R$YUF7H)?EA[ CM.@J\Y5C[
M3@2E?2\)RMB>@)VNI+WWHMM@Q43XDSU\^]E;+7ST(_)23V^TNV ^]U=$5(6]
MY=L_,_)IK/KH[UEFXIA$\ZNGR"/&>TKNTY]7] OGLQ!MHC$8;W@;^1-R$I'E
ME+YUAI>!;=UU3CD9G7:8N-;IDG@5S_#*PARO1/4%:+@EOE)P)LZ^M?<:.S];
M=:?2T4>F#F@.(87:P'-</ 483:W%#)L0>@9V$#(-X.*9!4W_?S$E8;7CH.9O
MI:0Z>W"2&05@NO85,E/C1K[GSZ^3[=>M3E6NR';EZ,5^#DEX LBQ&#IYH\_>
MDL0=,TKNHJ3OA/P%S124F8O1KB5C4G>AN[ ,(F+;LK"/D>=9P%U SS< @#/;
M*2OU 80_)BGK@*3L$7=-HG0U7*E*?:$01Z7XLB*6Z2%)JW"P6(3[E1C(!W+(
M]P]+/_'GFJ<MTH+/ZK8-<DRG*$X'Z?8=^IQ<3$7N*WF,MTSSG8V=7,L83; [
M!E;7O4B=W@1LZ0X_OW5,Q10'Q'D<OI)C.O^%'R?HH'8G$7G3Z1=/:?E^)O\+
MP9FHD)+\S-*A7Q8_MH_<#>[(V<RH[E/7-?9759E\"XPFR5/8>BZ_4U'"G+C)
M)V59$%G\II<<XTF]9(870]UIS?#"L\J*/(T&4=9&8Y2= ^SCOM22([IX-&/N
M1X_$S\CVBNYDS3V-A.MQG&?%&R*S:.<&K3IS45IV/TZV]]S$\=K_LOCXKW60
M/#?W/NB<4FL,43G/=K[W(9H@22RK(XXUU>2.^-RW=\S]#LCQ$V^[<8>/:&>$
M$=)1!^M,6#TZ/J7HQH[_44Y+YQY(OAN0]2?$["K,?Z32>9_B4_Z[C1<[6&@T
M,<<F,L:&<5E;G'"BMKF*6EN1]YF*->M[XW(16LDV =/2$1(I1\#1.*_">W(9
MEMN.W"$K*74J^1U-#=M[> # ;G!4U>;AI36R[2,JX 33/3'&9<U+P@F)>$@<
M6S0>_"CK5_(2@B+Q>AK/HB#MJ$T[F :NU'2Z"T?D;4.KTZ%.S)F\R5R;[P4Y
M?*5B.*KGYFA"CKT\K6W0<H.N[G"TF!M%?]NX)X^7N:P7V=/I!'9;YE)%]@(Y
M#[0J1-UG"K%15=4I<^TJ0#F-]AD5(APV/)N&[O ;QG%>P.\>&;;WV4^^1N',
M]^?QIRB\_T[ ]\LBJQ&^+PBK>1K &DW@V)4Z"X"!I;O\+HRN_2#A?^55N0T>
MR7?H>^!U(]H)AAQ4HS=TH'B6D+.(M+MP.?>CF(HAE51 WKW_KS6)D@:.5="P
M=,BO-MI\*E3UQGL&4V5$*C;"?UHGZ\BGV%7=VV[1??>7];8+)RS E:B0-Z@O
MV$EJ*S\A[Y8<)_UZ./47WK^#^W"NO7H*H^6<W.V4^4%,@N8M:<)^3F5"BTJO
M-2_6%L22L,>)"U2NI5NFI$ U"^_OR>T(O&7P[[1_AD@Q7L_NR/?#^7J6I(9F
M6U+9 EER1^+D>^]9F_K:@Q?,R:TE:,=D66F7@IA6;1YHDT@SRD*GTH; T VA
M^G@X2OLLG] VCOB$9;#]W?L9W*_OS^U'H<,G;5B9]9;'&038R92LAT;J;J\3
MPMF$05&N$\>VN&^TB9K@6:%3@MR>.,E+T/1;S?P\T7I*@./RI$B?AS\GY^.Q
M=" KOV42>4^$T!QZW-$$C:'#$WA$DR<T+=W@UU3 /#N:,8_H3\^)O@<K&N P
M"GP<T,(T\;N#B Y>B?++$J8NPGXGA[ D1HC-;*>!A!"6]\_PY.+P/G_;D/?\
M#TXX6H3+9?A$TYJ>-KOS5K>^QA9,D1L5)VR8$?W%+ ;;^-M>?$>91D]QVIU=
M]+_9H@O[+35-Y(O_IC>/H*3VY#5MZ>]2] [4@:RBIW1&QFIL'!")9E5<K$-<
M&*C;:8UQWV$X0#--,]CAZOTZBHA-XI&V)H$1<QBZGKK7;8W=(.%"8?8+OZ1?
M<=%*& 6WK'ODX\TW@F++V3IU%LC%H-^>9W"7M[NE28DM+&X@,9VHD/HA'M6#
MM#E47(!SD6 =05Q]B\S32V49D%M*Y)-H_L\'?Q6W,E>\VZOA<FP_.2LT.@)U
MVV[%F^S</Z;'_F7%!?OH &.N.1K1Q NAHT-^.1K&S&;WX8&\OW!. B,:+Y4\
M/W$GCR)@RIO*N5EE6\"(#%"1VD@O4>R3_Q$ 2^(=YYL),PJG^7B>8_YX*?S-
M?V+(5\0T<%89X2*# A[Q"4>+C^AWSB _'/EQ%P@<L-$58Z=C=4D&/F7^9^0O
MEOZ,W6URL>_(BQ(X+^("+?_[WBQE;(33?Z9#IN,<0N;^H[\,'^AL&Y9/*Y?D
MB'A7<2$CD'I5M*0ML"8@IT;H+I4FQ#3J(._3N_4WPKRE9I\2XOTQK78_^<LE
M_6\:IV35;VI7OM[1. 5.M9 X:5=+;^HOR:.HR\Q^64OHD!CZ_#_>C],'+*EW
MQP*=U'")JPG8K1'C2*()U'W0-=JS[/]K391@^3RF(OK[>N4SUX(IQ<;I*SL;
MCP$5ZI"= H20SC$#U 0A11YSC2Q#-V7UG@MM/U0^1WSFPPZR-Z,E)&+>EL\L
MO1/G"9ZXF.&)]U(\XLK;!O)&2YO4-;N2F1]SNM@0'TSY#7R*!L)(=SN@KU:W
M0UJ[RVI.=4/&Y, K6Q]M.)H@W/Y<WVZ5'NJ0(_GZ=&YZ3'^/./O+--CG- ZV
M'8QRH+R5U<UDB.DS;P6NF RY8!_=NJT.T"%HI>QVXJ\-5B3$#>@A:57'(]$)
M(]WN^83/:YDZL ^Q<IY!-K'@.C75[(W3_JEO11M?&+]T'074AE,&T*=\U-LU
MS6@$Z;SXIH4$-)I88PS+W!]M4T5H1\>Z;?AT=7Z5T]SCJFRSWHR+3XND>;'M
MB24-LBXMRJ;+JG/[5;DX;S,1UVJY6-ZFD.\)$2*]<2R:)5<UO/>U5[^%<?Q:
MW,H0'2(G;17[?;@JY'+HS4C"=/+47CG[%?$XENMY'M^L5T^4ZY*.""32FM&.
MX-?%.E#E]4T[AV->C</MR!M8&5-50GF?8W /="AGYK:-\CL>39RQBV6>V@D,
MR),DP1AH]&(^^UYTH/J.!,98Y,I[YVZ&K*<H+V]P.8K53G4 %ZL#,I7$@>GH
MIZ> -$A(#K]P0KDVF%]#6</"22&%3UM4O#]9:!"RM#RE?@H=$F 3Z(:LX/@0
MA;?$@8BIN++8+%S=AM2SG)&S(A[$,BT/Q^--Y64G+[\1.G$D[OSY>KEA9/LS
M+T[BU&6H6;D15P=HIE=6'3A1+Y/*,EA Q["0=.-G)33:/#5L$P%TBV,>Z60'
M/8]"G[B(01=RRXH8,I5774=WW7;2\#U56DWY*JT V.E@@=XJK7SY/KUA /%E
M+7YAP,!)-LC".NB996.C_?1>'-RNR&<BE]4LRDW$1AEDY$D08F3HD)_%K%E5
M&_*)F9;#<PBAP*Z=@W5+5M?NHK+N, N,KBEO\KMV@?%4Z7"O .DO%OYL$[15
MEB/'YT_/[53^)IU<+JO\S_%)CM0;_\@%_67Q(1-S7G,\RY&P1Q,\!JXCL2/!
MN=+XFG<1O[=S,?'I/<:]*7H[A75G-+%=F;UF") ..'9$URBK8W$]"Y-N#^S.
MLM!)9\&L*\ORR0NB;!]/0P'@[@1@V5G54T+33CWUQ58(1P+,<3'?M<V=QP3N
MM/MP[C/6:#I5/"!X28MYA3S"6!:+@^DHJ5[GW5K6@=[I[;C)+#_C+8OIFX1>
M-K:'J;G-88,GD2'S'"F3SI'B.(-<Y*EUINUD&5P)(6UW6J&DO ]@$&WEEW6N
M3?9(1P"E6YFD)M8 C#GR(=HDT^R5_+JP!XXQF@ X1J[9.2=&$/6 P,QV>G=,
M9Z-F9?AL(PC=;+5."Y _WLZQ&/(9T?DT/0\JM7#GR )&$WN, )+8T\0&UODZ
MFA7Z+W!&PS* ;LCJ?=8/J.FZF2F;D!2FA2^ZI^B!3IU?)=O?WFRSR7M)YOZ#
MOYK'])>\.%[?LTV#L7;OS=F\4J'[V8B@=2BKY%,*!%L#&?FW7C2/\U&*>R,8
MX_5LYL?LUM(6YCA9S^FVHE=LX:;Q]NN7[^PS\/;U>*\].N^)GZ[GMWZRO\XJ
M^_T'W_M38!6 2-YL&KF9?I+^5"Y"YH9L&#+_)];^^_K]>UV[(;=W/F>O,-Z@
M ]$3-GJ/WN<[[Y'<9]^G/_?/=9Q75=-)?N2AS]H\6"S\R*>SUZ9^\D1_5.S+
MC["\20<FW:S5.,[0>T[>)=T?PD;H%:;N%<6\HQV;W[_WHC_]84_<1]C6$;\B
M3K:#)0/ (1\,)MX/X.?^";P6Q<(D1I;UPO]@Y+6LFS=8U?7Y-C.VCQ4CJ6=(
M1VLN"<A3"%GECEWQ!<7&>M.6U\7/+3G;4)_M^-Z;G2YP\.5 >25S<%?17KVR
M&#BE>]LI<3&[6P.GHB".Y_E?C=<>VSL9HYO/G\HIH^*NXV_DQ,.5-UT^?PWC
M.)@N_;Q)_6;UQRJ<T@UL'OOJP[K8B[[EK.!"[@B.)N6$]*!EB:VL29A/JN@A
M#+*V6A)DC@>MYA@8&9FV+TTW.];T CO+056:/FAR%H:N#G@N,UEH+!%2",FU
M5U/:K#P3>M^2Y2)Y4V0QN0X>\8]>#[XXXQ(O"A66CO'3W#.0R.H1B?!H4AZ,
M.&@D ARC<Y;MTY["]7*>\=93UOKNOLS*2+$04$[I;MKX(=W*L1PV79(.0G'Y
MV>VLJGGXTE3S)>U3=<U]KN3-:E/3_'W;U?AA[?\(S[]/36NCYF@"75?BRJ@)
M+!WP:^<?MH=K0L#S,/+ZOZB.CVU@>0M#3?')&20^602?*L8DRX-/KLFS]WOP
M3C  7+?K90AUU?"NN"=F'PA^:6SB0+LR7QI@6[K)KU59SX;!_7$JI;NME@P]
MHVMCW>5W@(?O5VM)W>V%:Y[4=:1+ZCI(5SG=RM@0DW?4IYY?FM)MJN?%1(HK
M7TK70KK)=_I-.:7[%$8QSR6C5 )4+X+5VDNA)OOZ?LQS=47;LH(%>9WLD[?:
M]B][HWG3.%RN$_*W5% 6/K$/\BTZ%H5\ 3S\U,B/!W/M/]Z3C[>I:I*3?0R(
M8K'.0?+$=1*^I;,UO20_IAUQ7M,1JV/M.YV7^[TD0F-[ G8Z8>?>BVZ#%1/N
M3_;P[6=O64&;CO%\H]T%\[F_(D*D#6NK6_:D[9_)1GX$C_Y>V*81N<ROGB*/
M1'93<B?^O*)?H(=>.,)43>I%AR08QAGGM_"$[#4Q&SFY]_!SQBWJKB-2! I=
MZ_1X@RI:]95E<KP2U1>@@?2,0X(S<?:MO==@8P^+US##26"Z]A6R4^@FW_/G
MU\GVZ\ZHA:Q$!F&BJ 3/G<#4-Y:G) , T&U^T?D9[L.E=9@+W ?7D*\. QT=
M<1PEK$HQ)?_,Y<EX/S-]4RK%M).^J7NW&J9O7$!K,C)/XS$1X-EHPR=";:4"
MX1#[(:NM/_-RENH0P[J<;%VPS$-+7)OKM-3ANX"VCK@7))H6[TH%B4'<%40,
MF5'.0,ES5^AJ"IYU"&'M&*#\<ED-646+_Z"5$CA9SHG+Z=#!%XKMT%GGI6/T
MQW9PL72%,<5V$);MX(#^>HQ=4[[2F&([I*X*,'4DJZNR2:T/&WML6[?X90G/
M@![8(_18TJ757:[=6&E6??!Y ^SP7&Q;)V] 5/8[Y8]7Z#LZH.]LIOPU&Z/,
M0<V-@I;;55H^:(%:7$>L#?LHB%?-SZ;=>8,^#-OEF3#=C']09<4BB<?AJ'"B
MTU8 M.3M$&F8^79.C@L5L0/?=8CU U+O(:33PCD25X8=SP"#*XOGO"*18P[R
MJKCDJMBFS!558..TT51=E=1=XG@8YS4A.-:0"5[(,$83TY;YRD ,=(Y.Q^"S
M"= R=-LIS ;A[@TW-39#''> #$",#8(RMR0@9/ <\:^_(%*D"4W=)7YM_L'O
M%)LW?E]<!CZ?'XD,Z8;>F0CKD./ZQVT96-PD K+E;3T=?/'=='E.LCX#7BZM
MO9_/*T&&?),&[6XHJ9*QJZ %=(=?H]H9M^#2,O EMT"^*7?0=G03M1*DR%$3
MIKYYQ[D/_C7AACIO%%3>E*TFC##2;8Z=#\7Q[W7K?^)ZH-C175D]T)=0=06.
MI1O<JQI-4[6E N"0^&+(L*2O!$(3ZJXJ;^2'8?,\C#/O3*D2.*P[8X\F$ &9
M!]@AB'6'GS4:]IU!T.5Y&&<6-$HEP4%<%6<T(6Z5S#?%Q;K!<63'T&-(#)!N
M]CUAHUS]&Y:!<:4O V+'T#$_=I? S&0;R$OWN8X'K8,VSZV4E1O)%3&Y.\Z4
MTQLQ&0%#MHJT(B8?\7#Z)B:[O;$#2=0K77%4$9,S3\6!\M(Z%#&9"_2X74__
M*$(/E*XBK8C)@A.3W4-]2&T1DQ% LA6A.1.3SZE!UZV&"L^\=)&\39/_-60E
MQX!GN-0LV^G"(7(= !WF9<M<&N"[.FVL;4S9@,\$D.#9X3>NM.%%08.\*+0M
M;6PCF<L!-$NN>C0*V^-Z[]%P.^IK:NO26*,),3$27QF(')Y="2QNE,'"0,O1
M7=!*EW?#&S3$>0<(T,%88W)))+XZBH,J!P?UTHK?!1Q4(-V.SA?(084&EI<!
M,/@Z:^\<U$O+K!>P[X!\JU$5!W60'-2+*WX7W (HWX8_Q4$=$@?UW/+?^1Q4
M"&0K_RD.ZC$/%%CR[BU2'-2N<K6E N"@Z X0REX)A)@KZW+8<1UG/NZ95Z94
M"AS6E:&K"\<FE'G&)L$%GC,VY:B?(T20A%^S\J4UP4'<%3R:("2S>4$NT$W%
M02TT8P&>]9TS+<RPAQQ 4_XZH+@D5'KF5*&"U=I+,P"%P'/[9KUI'"[7B9]'
MDS;6+6HQ4S$&GN/B*<!H:BUFV(30,["#D&D %\\L:/K_BTTP:BNRS=]+*;+=
M^],RC0.F:U\A)[U'Y'O^_#K9?MWM-"*>ALMY"_'PYS#Q-6#J!)VT]YL\Q2)8
M>:M9X"W)*6^N:S--8NF5T>YU8@K@3ZV9[1H>LJ86GOG0L?WY8FI HA?0F6)0
MUKZ2WJ7*<4QF;K7,L#'BKU1T^?LAI2+G_GE]3V0^V\?B,N)^".+9,J3(2M-W
MY,=GY.#9G_9E44#-ZRB@E?U/47C_*173ZO::IBW8=S_^)&)9>4D8/1=PTRH=
M!_TB?1,^0=D'\C:2:.WWF.'AF%U-M3@^J,9CS?\Y6Z[GM#MB3M[]HT=3/N3'
M8W(&U*:1GTBS>7Y,_N7/M:F_#)\T3ZZ-U]AR=<AUXS5D]'*D#7HSF0F!#OFY
M:<1II93[-URL\ Z>'$?!_'I7W7HX.F"YJ_$-&>Z!=' UD+)3SYM&ZP"H47BV
MZ9BZ;6X>/_F_"74<\U>9AA&YL5>S<+GT'F+R6OEG;[7],V6_MWDL,(R_T$<F
MTW#^3/X3Y4_,S]Q@WYW3!]+#_NN(G%T4/FT^S\_*FU/<H#^?/YJR7]@;_N7,
M!V"B<!<] %WTZK#'E[[PY(;[AZN75B_](E[ZER2J@EMB9'.4/_W\HFW);*^W
M#&Z)/:%6YJWV2$MZ,V^9?Y48E3WKE%JC6MY\T1AMH#VS1<4G%N.$DUX4,Z,Z
M<JJ?770-R%&$T1OM/])&ULQ3:>[Z./N>3Y"0PYD=]7PLGH.'7J5]"'%:]$ZS
M,HW[+DW=-&M5O9M+ T#=%5L<R,I2%5SDX:^C,'[-\?1W_C^9MW:/:R&0>K)Z
MLGJR>K)ZLGJRO$\^X$MCG.4/A/.E<R^_%7_:U4W8GP-WLD0#,<]Y?)]N/E]_
M?G]S_5M##PZ#MOQG5P<B'S_2,3_G^;>;ZW<WO]W\N/GX77NU+1X((@KHZ+;(
MHC!Y3L[:%FSB8L7F-3]9G!'89&GI:9@DX3VY&P^)%H?+8,X.>^?T+L+<7+"-
M<7>383Z!N[6R]<#<'1U=>'@+ZF8W!U[=XC?*Y?]%?AAK0/M/[_[AK08;77FL
MV[CYE:\E [@W<4LT&6 =\6L'G(:KN;8,R7OC=_I"92\Z@@^ ZIF3??" W)##
MW1WEBBM8);VIK)L67?FH[)>9[ZU\I:X7J:MS4A[5ZEHOQJB'LWLP"]OTK)KK
MK,/?U*6&3A S!\!NXX%HYT_>'\=A1^^77N0GPIQ]":S%.GNL6_R:EV;ABL$2
M;341Y/SA7E.A:.</D,Y/]5<A96,*<O+(V@MP!#MYG@?_ZLO[ZW??K[5&\;/R
M5?9]%4AS,.>%YOR\ZY*Q+.MLAYX)Q]92$3V3&J%,AX!@\ M=,B^$!=V"'';9
M%/9XV,3N<9R?K-(:EV.O?79:M%/L[3&S8?(C5_R-O8 POIK0*26L\X/E040H
M IT]A6E^I\_B$P73E\ T @*XR"*C!=%8AU__[==?/RI]O4A?+>56G(@Z$#]U
M?4_"#?9;WE(4\R8T6-@Z/Y?.FS]ZJYDX^3>Q_0I3/TUJK'WT[[[>*)2^!*6Q
M(8!7L=\0(Y2^0JZ-<'[39;%=-L&(=.YVVF/&*4MTW@P.!1<EN#"54W>B>8[C
M$,2O41@_K_SH-O!$P0RAG3I'!_R*)KX7K:["M3#]!$)[=5Q3I#E:/RNLO@BK
M7>7:G5!:CIM(OITQE/RE^G;D[^:7UR^,(U=X<0E>F%@ WTYD]P)P[1/X$2;>
MLD6-/3@XY*$FTW'JS?Z\C<+U:GZ5'_ELYON+!3^5JT6"W)DWR94!";,5%H+R
MOB#/Y>/7W[4OGT1AW &HHQ=S\G^__OS'];?_T0";[@?[)=H=OM-[5H;\_=H\
M7--R>6IFLN^G\NN;H&<=(&]=KIJV?H#XU[-B-IC^7GRG=?5Y[]?JZ>5F."#2
M8:6>EM\)"0B<$TYWX_GUUJGY];5GOS:?IVV/)A", 2@/U+[@/&$V[[ET[=N[
M_2UZKV)#3DU2GU7EE7)'F_:\78F@QJV\&Q508^GF"1)M8ZBQ>X0:9S0!SM@!
MEH*:@4)-/4*F=8 [PQ]M1'&Z108<2DRIZ=L@<#*AV!APG)8 9Q'\].=7__:C
ML!)K7+8?!0+X5H'-,,&F/J-*N3:"((U=V[5!!G_7QNT%:9"AD&;H2%.;/Z20
M1B$- (;1#]( A30#1YKZ%!B%-&(@#:B/-+ %I ']I6L0'$WPV,;E#:4*;(8!
M-K7Y2PIL%-@0L($]@@T:3:RQ;:LJU$#!ICX-1X&-&& #ZQ>B(/="%# 01["I
MP!-,R]I8H<E T:0V2T>AB2!HTF]&!O>3D3%51F;H2%.;8Z*01B$-01JS'Z2Q
M%-(,'&GJLU,4THB!-+VVZO69C+%'$Q.,+1/UCS4'2$#Y_OFS4&'!/CHF 3D'
MZ"*7WVND0US][-[N]NX>6ZYDE*]12$!]WH@J::;D[E99*+E2%4U)R<YT3C/9
MT3JN-!.8;4L1B&>2?U$PFV(6;R?Q7NLR3:#+FVD"C -,$V_Z^//-S6H6T>D^
M/^Z(9M_>Y1>M'7_6X>7/[IYN=_[L14;D7'^V4Y"I22S9A1ANWNH^OO3MK@X$
M7/H,C0]P2[H'%V[-WPI<6@.7>E22/7#A2IW?PQ=QO&:A(:9/-@DP#K!).H<8
MS*WK6T%,6Q!3GT"B7!AQ\*5?%^8 AZ1[?.'6ZZWPI35\J4T;4?BB\(7A"SC
M'.D>7Z#"%]'QI3Y91.&+PI<47P[P1;K'%Z3P17A\J<T/4?BB\"7%EP-="=WC
M"U;X(CJ^U*>$*'Q1^)+BRP%62/?XPJVS6^%+:_A2FR2B\$7A2XHO!W@BW>,+
MMWYNA2^MX4MM:HC"%V'PI5\*/3C #FD!7VKT<6,ZVWGL(J @1E"(J<\)41"C
M((:-.10*8!QA *8-GD@ORV)<MW 6BB=R_CHS_\%[OO=7B7!,$=YJ59L,LJ-:
MB@PB@"7!NFG6LR3$Z)Q:#3J:O.+(!OG@[QB3[75JT9RXHXD[QA6K2%YSN<."
M7>5+2<T=\SQVT4-YH"\VB7:4Y\$;-HZGT<S!MV'+@2#UR!Q["*+('+WCB+AD
MCHYQ9/#MUE+@2'W&AG)&Q $1<1D;'8/(X'NJY0"1VK0,!2(*1$[3,CH&D<$W
M3DL!(O6Y%PI$%(B<YEYT#"*#[XZ6 T1J$RP4B(@#(J:.:A;W[>QX.99DCA(L
M>(!(!5B8HXFK2BZ=(D-]:H1"!G&0 =1&!M0",ARC1K2$#-9H@@Q304.GT%";
MU:"@01QH$)?5T''D8:O(0P00J4U=4""B0.0T=:%C$!G\<& I0*0^.4&!B# @
M FJG+P#_]$67990:_:0FZR=U#*N/"$::Q17$-!3T2S$2SF8DW)"[$OEQHCUX
MP5PT4@)OU:I-2MA5+\5*$,"$#(>5D%^IK^1&M6='+(/2W+#9BQT9'G.V8U["
M'H H[_.E>I^-B D=(0<83< 8NPHYND6.>GR$?>10A(2^\6,XA 0.^'$\"68-
MOIM8"BBI3TE0?HA .#(83D+[.#+XAF(Y<*0V*T'AB,*1YK2$]G%D\#W%4N!(
M?6*"PA&!<*3?IN(&S(0S<:0"+\S1Q,0J[]$I.-0F'"AP$ @<Q%WIT+F3H<8B
MBX C]>D)"D<4CC3G)[2/(X-O0Y8#1VIS&12.*!QI3F9H'T<&WXDL!X[4IC,H
M'%$XTIS/T#Z.N I'!,"1^HP&A2/BX,A0* W=M)39QFB"QX90I :8]>P(05NJ
M1VJ Q6O(E=1 ;L,+(C5\#E=7,R^^TV9WWNK6CZF^930'?A2'B^0!X(MBF?@_
M'_Q5[&O>:JZ%R9T?B<8TZ6W]Q>Z=Y\HTL76LF"9G6'9;AS7;/8&K.[S;/0\0
M38)%%%\MULOE9J'2GJ'_0J_5^Q3O6C3T8#1!8QLY XT8I.! U^6@P"JOGC^N
MJ'!!\/5L!SDHHH *I%0V"Y6C!P4JW8%*37H*/$ A:0%7Q'&)1886,>DI74#+
M\?2F/?@><REPI0%71?DKXH"*D%P5 4!E\ WG<H!*?>** A4%*D>)*P* BJE
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MSR]2:",.VO3;A M/DHO:2]\0I)O@L8,<!3@#!9S:)",%. IP,L YR3!J$7#
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MH0%50L&#@H=:5(F6X &/)J9=7IZBX*%->*C/<E#P(!0\B,MRZ#@%.O@>9#F
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MBL*54]W\ N *4K@B *XT( $H7%&X<HH$( "N#+[C5PY<J4\>4+BB<.44>4
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MD /(45!OH$!0N/%)O^W "G]Y 6!%(:Q(O5W=6UR@RNVJU^F1+O)<($LCAFD
M650BB\E-%F2+)HO26/&,3@]97==4(&K3I@D9&*$J:PS.>T"&.J4%YS09PW^)
MZ 'YGX"=077J.\YL(D8<O% =,6-_35/5:CN4GXC1GXMPMLB75(COUU?SB#H/
M#XFM\VA%S2UGG<>VAH1ZVS.^TSMF%H:HP\Q_O^=!OV@E ,-7]+$+&)B"(1\S
MC9N"(0$S)F!& <SPEW^ *:,68QHW_T("8Z"/M!*,X2X$ <8 8PHK011C#'20
M5H$Q_"4AP!A@S$E#,20P!GI'*\$8[N(18 PPYJ1Q&!(8 UVC56 ,?YT), 88
M<](@# F,:7SJ>#L8PUV1 HP!QIPT D,"8SQ@C J,X2Y/ <8HQ1AD\;:D9Y4L
M@EO2Y]2GE.A*7P5LBK/+;<-@;0R)L9M<#G.0E9AZ 80!P@@8>B$++T@B7EHS
M#@,3K&.8AU%1K4HVA$&58HDS&X8Q]L.8_OYD%FA*UTTT8R;&HA;Q9GI-E_4_
MV:H>,1K#-K#8DHE6U!7SEDQLDQJJBL_WSNGHV1BGG6/NZR;;:'P:<SO8PEDM
ML<L6F)$AG3!*5DNH0YC&)S&W@C E"B7 @%$*+TH62JB#E\;G+[<#+_PU$H 7
ME?#2T&D9XO#"<X5MLZ$9I@T=K!LQ- ,(HQ1AU*R04,> :7SB<COPPE\< 7@!
MO)P\6J,VO#0^9[D5>"E1%P%X ;R</("C-KPT/EVY'7CA+XD O !>3I[241=>
MD %X40$O_-40@!? R\G3.FK#"P*\*("7$J40@!>5\"(U>"2=+1R1(X25B1Q5
M40HA9VJ';4(I1$6E$/_X&[*-SRH-[SBG4HAD-DC"$>6,P/57H.(RYZ![W I_
M^[ 3-/__2G3^ZMG2Q4MEM4^]"LR9\8H]W16=\6J5[^/PL#Q9U;@1C4^B;T5%
M-6^!S@Y2P(<XURN*HV::5 R3QN?+MP,FG!4YNS"!BASI2%&R(D<B4AJ?(]\*
MI)0HP0$312F>*%F"(Y$GT,];"9[PU]P 3X GI\PEJ9@GC4^!;P5/2E38 $^
M)Z?,(*F8)XW/>6\'3_A+:H G*O%$:H?+G)*:$DTN3P4+3TZ'U^F1KN$8T"]7
MT<DB0!.5:*)F!8T\ZP0W/J>]'3SA+YD!G@!/3IDB4C%/&I_$W@Z>\-?( $^
M)T4U,A)Y@H$G"O"D1%$,\$0EGC1U/D@-5R?8E'AULK< YCVI2HEB.+X:&)=4
M6@/CHOQG2S_XU=3 :)OC0-2I?CFG??!'H^R7_ E].L52HEH1C*(30!;XIEO\
M+5NV(^9]8,(6#N9]'%5.L(UBD=:7"]/9FN3-E9CW<<*I+>'*-3[QMQTDX:PE
MV"6)T%J"+9BH8TPHS1,E:PED\:3QB;^MX$F)0@(P3I2"B9*%!+)@TOBLWW;
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MO[E]>+S_\_O5[>-#J[0_/%GLD_<%W1&O*JQA\A=?%66%6M(Y"V3T'[2[:U5
MC;!NGL6J_Y_^[9_]^W]IBZ1:J; ^<)87OM9\;V1'YK?/NE!?R]'W/%JR[*D\
MY(]8\YS^@W5?"U?:U<V"3,Q.R=F@CE%4,I=3&[ V^Z]\W9S+)H\31X'9?LV;
M!UH32?BS)8 F0)-UFNQIK5 =3;QY,_;=?D9 $U5HPIV^ C !F*S#I+ OFF"8
M4%NH9W4][ %,E(4)?SK+-DVJ0@EPI/ ,V ;W('/;%#S(G'+$%,F1<?@K&%W\
M3Q!'N0A!6>L2C/!G@(BZ$.%.+ *31#&46/PFB56!25(X,%D@2C"@1'V4<&:W
M $<4XXA4UZ9VQ\;L]+RN9^Y.C:D=)'MBILM.!$<=^8V15G7%3!VKNIBIIU3X
M;JN#A\@ WH?__5&[F0[C@ UC"Z?:V ]C;3ZYJY1@6J3J6)YH&>,+UFT+F=C$
MR$TY4T%O++^HF.:PUE/])%N@A5.HOT5)$B1WTWG#JIOI-3U3_\F.U/H,LG*6
M*!%EB6XL9(V6Z$FG]UA+5#0R^*-R@ W QA8V]HPIK!0;%F!# 6QPA]^ &D"-
M+6H4CE6O@!HV4$,!:O#'V;:Q41DS !@<<BXYU%8XYJD"8#@ #!6 P1U3 SM#
M/6Q(MC,*YW94@ T7L*$ -CCC9\ ,8,8&,PK+%BH@AJ<0,:J(HTFI/70=B*.=
M'D>[^,AF3#0@CK:5GK'L/T*70AM%,]8B7E)=W+8<@H:1KV&(J1NY?9)SDC2L
MPN[:])B(CK7][H?3DCJ&(UW#-5B)'#;,'353MLET_G&N[E3+S/2J R7\(3C
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MK/#P_QY'2<)% $0)X%A @";4@X$1H" '9!H!^T-;QZ  =WK$@/1K]6N\@ /
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M(Q$U_%%(L&64 HY,6Z:@Z62%S"&='C:Z#CDU>Q^8(X\YO"%)  X AZ]G987
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MP-A)D:QJ?ARPGTVHNJ-?'@1L6DQU@WGVB6*V'V5$$7&)HDM*J[1+?Q(.XO#
MEB*Y6UI*3[GOEQ %%D3A4GK6?'1//:-4T.8<;^6GJ<QG#;=@F F,4CENE,I"
M "J8H_+^Y#JN$7F&J%CS4<XP1*5- TF:^.1F#U$12(SM=I>U(J/F9*#^_Y?-
M3+GZ_L>WNW]=75W<7WWK/UY]?9^H<B;C.^9;#,V%:Q$Z:"XL:^6AN;#\YL(P
MN^/D1"C'A5E+P.LS6'G@M7Q>P_".T]/)$,Q: ERW?^4!U_)Q#;,[.(1BN_^P
MR,NSS7)8^7=G%7:!N1*1LM#" 1Z<MVG0!5N)#/+F]"Y]>([B- WBE^7!^Q),
M@W&8)LOF8^73R*U.#W5-%3I?-[;50^5U;]S7/0 4 $JIZK<*@&)W>F;7]DXM
M2P&@*' ? 3P!GI0J<:N )P[U:KL.P?)YTII.,MN]C<'[/<K[?8B&H3_1DF X
MKZI[K_=1S?L5+62<[BVTT%9/>]C\!=)V[5U?MFJB[Z;S$_:P.&#]Z>C1_T6_
MSL[8X[,_O9D.HY> ?BU7<;B=GDM@,H?,R1S<CBN@0CU4*.VXGH"*L@:HQPQ0
M;)W:T@5(4H?'"B !D)3R6.L#B6.PJW;'56"";6OBN-N-C<&3/<J3S:1;2Q?%
MO6O!W*R[KVKN;/V=MCD=7FBSK9[R4=#AS5H2[.B=N8;)FA.LFA+L[:[ML)ZF
M2(%+T<8&693*TP=R #DX_%\AY,"4'-@!<JA,#FY_%\ !X."=YG$J.$P*#E>!
MO([6Q&&WFP>+;/JAE.M:7?F^R-YIYSG @].WA4;7LG7,9J-K]=*4UW7,9I.]
M11+0MU7WT_*7IX1%84SCU'@N--:7.\*#VR,&W@!O^)UA\;RQ.CV[:SBG!FN
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M?R'W7_NY%L8:>!X&3X#Y$;;2[IZQ4E#7(QU$X;.KJ4U+E+NJJ8,1FCA_>K/
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M-FO0&P6+BL$<#A8L@86N508+@SI8[-QXN0TL2O! [PU,8[,_A:-!2VA0,6S
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MPJ#4R-;)P'1%5LYIIL@^BP=_Y.@?QPN.%X>$_RC@A<'Q@@&\J!S2XXC!$>.
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M57Z@6MBKR1CJ-)5#W8E#7?6  H<Z#G5;PPHTD4[9$^F: 3JU-U!$JT*._@A
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M@YW#W![:Z'N>)"%I<B2%5UXTQO5^[^F2FM>%NHT6<KHR>!:WRGISLBB#!-#
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MMU25^F"B?N>$\.%G5<<K_=!15^>?#AD9L57VX."^H'X>:U;UW;3(]@;,O]R
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M3EYC!;AZ3MJUW#E=GS/NLRT#]@-NRRWS]>U@/;U,D. ?0Y>O15/+N 4)O8U
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ME_@M/3B":AY$[T9X?1W;Y!_V)-IVUG9<-"=W$.KU#XB\D3N+7F.3C5!Z,_N
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M\#U\X6M0#@5" 1-7-$K<JI00PLF.^HXC:?D/T[(U&FS66Z:O^#&!\I^G1?(
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MRM%F)QVU&K)4H5:** %K56&0LG2,RL@3BFR44 ;2"K\YC^D895[)3&KEC)6
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MB*OU59PZ!3ZN4F%NOR^V[DEK-,;AT*OB=9]Z>WA<969SG/O9(8V\9)/_2 -
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M33\ !W7):7+E9E?SVY:=OAS1KKD27&9S48F_)'OE:M7OC*ZNXNB>1?^DT9T
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MN>;BQGNF;N+_B]L(<IDT8+X>#$4!DC61/1A6JR%=)JE>Q?>7##A4 6-XHZE
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M/!C$42?*L\N;[:&F*=8H2:&>R& ZBB<BR&&G21L,*#3Y &[3 SB $6]AMX;
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MEH.8T[2LYR[46H^AU 8;6=;T1)<-\\IEVJ0N AV"%*.3,7N'5K9[=C7+5I?
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MOS3,9U(R!'DM3$[.QP'K%0_>SR-;TO_ 2'TR%+01?U<=FNU5VURQBY;5%VU
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MAZM:KW0TJRVACLKQ8EVM].WC9R#??R(]5SZ00C+!DHU3AZ!#@<@$=R;KS$N
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MXH[QO>W/ZR]UJ;_^X?\#4$L#!!0    (  2(>%K<Y,<S;$P! "0\#P 5
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M208M)/>."$B,2$^!.!,UD88&F;51R>FGC*VM1JY)_#HS]@[K'2B:#B7?^\I
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MJ1!1NYD:?J)H%)XQ27)S4BJS(9YY151D5F;GN.L8,;\_YHMGMZ,8U[#:K6X
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MY7U1,:THQ]I!@0?;;$F54'<UZG(R!D%9B9NWR82F%!AGC G9+M%Z'[J8;5/
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MMP%__?3W4*L.%2PGFY2V!&BY#B^#(SZ;0( YFDW2QMSMM_AH?P_U0OI[;$+
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M@3(?><OTQ7N/?MF,;2FB7FZM;UQ-1&H*.0=+-"W!)B,B\<EEDHREP'#KYF;
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ME2E%90[N:XJN42#O?G#A1",H5E). I<EY] '$B131,I@J7/&>1CN0NLZA*]
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M[X-*)1V3]:F26M+I,_,DP^*0<IK%5&>2M=Q??QW)3(H[(R(1$<DDK:Q(BDO
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MN01SL^GMB*3>?SZ'&^"RWZWNQ$A/$H)\1R!@IA=[<Q9IT(/2]4@HY5A;B<O
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M^^T0PB3W!O,Q>NR!Q+A);-=CG;)CJM0+1(ZT649DX*PL4'C(Q:0H>9XA&_<
M0A.GXD<? "9)/$/IA4X<P?!Z!ENCCSSS&8*4OL20:.[3G<T<4N+9<-@>S3+K
MH_-Q@@-OGL1+%[)518'$VH6/R0 TIP(ID2DM.=E%.&$I_@.X)YK[^&TOA!IR
M9F-/W[BS^HB;5V1=#]W>EXVQ_1E7O]T*+6 J<R=J(595KZ2*4>!UX4#?4MDB
MX[<.T>_Q5H:-_WQH,Q5(]VY(#>_ -C%4])APFA9ALQ:?K5M<?W5Z[MXW7_VE
M'^72Z^U.@IOL0J1=BQ&=HO:JNM0"8G:TK8F"JMA0<IZNQ$\7B=M>7=T8Y<)+
MS"8I5HH$KTP E42!:)0'J[U#9:4,?IZBJW=).\\%5!,^/7S'M#<TAW.-]+%&
M<VP\")V%\R8ED"4Y4#9%DC]&T H="]8[;:8KPW8IUF$<Y^P/^&VC:9#BQ\G=
MVD3T7#@/7829_'3FBH!SG<D,A.MNV/?0]>@$0)&RRCY"$)Z!TJ: PU*JTZ>E
MIO]=GB[.:73@'SUK&0/W/BH>YUQE>7:V_.U]V0BU:](G<F9(HO"2>?79#+A4
M$O @K,K)!ZFFRUBZ0\!9 C"'@G;[5&5/C8]RLO)Y^?VZ1%IZ2S3W@%%5_XJ@
M\9[\=JF8%2:CP DM[IO2/6T"[*7KUK>VU;2IE4 _AC-\]?W[R0+SY^4_EJ=?
MJ]?]*O\>:ESOEQB]=_44)V_L&YMKVT[-P49IF"J9>7;C_/V^(Y$NP\U] M+4
M;1A)RZW/RCZ$OZH7L7Z[7.WD^25D_+S<W6Y_Q#72<-_>K[Z&T\7_=Y$5]D4*
M1I(9 :;4QEQ.D&X\,9E9HST*9YT5G8@Q;/SC8\H$.$QV'+;"A/1M<I#6X30O
MZ[<:'XQU'Z'-$=G &>UY6':YA.QHMY'EXP]9=EV9;[(PHC L>@X1*RNT<^ D
M;3&>)ZN-=3GD;BT,!PR^]Z[4;;P+_UL7CBF2!1X8CZ!$E!"+3( Y!(%1<&^[
MY6SV''CL8ZU)D+^U4XVE^<,YZAJM78/"3!.7=1U&,N60D5%H-8)/G)M2$D,Q
M7=3UL700&I^8TW40ZD.0Z=JZ=)'JI8/0['SHUM]E")@34HVC(@DXR61(.D,?
M@F(&I&,J>2%RP.D"=YY#!Z$Q&-8#P^8'%EBJ'9ZWKM?IU]?+-=G?>'9&7V_E
M$]DPK90!5@)9/]Z2-\2=![3)%=H3I.X<P?'H8 ?3Q*47*,L1-3K* >5/R]5J
M^4<-1OOIKU_#;Q?G\%EA;8X5(3-7H!(=/",ONTB5% O11C;=!<5=$CX#2VEO
M8$:)-[\IU?;@MHM<D]LY=\LZEZ6S/YZ/4F0/,$:Z [M3/@Q%,N0!:&&5-7A6
M0/!> ^VE$7-)TNCIVJ1,29)';97I.-('@]:6QK^O<+E^?1)6>':Y-7Y>T>=O
M^--V6[21MD)%^V#MLP JZ ">HX9LDF,A8.(=SYT>'VL..Z,%*,OQ--K\#F2U
M3(AY_994L3MF_QS^?$VVT>*,7LVH<RH"1!&!["O'( 270%ECN7?5#LJ=L'YP
MF.E@GOYLL9U^6R/_^IP,X-.S6T)=T<:7Q&DU8\% <,(0,T4$ER,'YZQ,/@I1
MW*.7%ET'.V86M-9UZV5_*]^'%9)SG=_\^9VV15Q_Q(TS_GGY^N/[+V23I!"9
M !FPEM3R'GPI&61D40:%7(O8APH/C/4,F-!*TR,[$E]\4(ZF&"#7" TEM 'O
M. *7UA@CA0PVS& /'BE#]H9@E*J?6\KNKN8_+S^=;\(Y5NLOH7#A10I ^Q36
M-8L15=&3Y8+%&H\^\.GJ7]POY]'3I1%$#<MP;A1!\ZZ)-8NR2-L:CC?6/5KP
MML=Z_QE.SDE=/V,\JRV]EJ<TG2_%8A%D!H%)C)'13?MBB"8 ,\*25>4,8K<]
M9T]!CI0_DV-T;S'+AE$XK\/Z6SC-B3[56H:_AY,:6M0B^J;CD_>.NADR@];1
M-E6&VEV//KWY(<,/NBEEM5>%@Z^M%95" XY+,E9%3LR58DOL'V7SR*#-HFON
M'N?B8-@6&POG# JFZH<E5_-;Z#V2)=GH7(HWJRX,GM@\T30MD;TWBJ:5AN>.
MGEFOSK9[:_IK<^#'M!+680;#I:H]*P5X4WO06C+1!<\\Z/B P5/".FZPHP=O
M;)V_X<G9NOYKPZ ->VZ..?M]2C,PEPV4VM#S35L9OKPZ.=G*L\!=%8DN,G6X
M-5EC^K>OR]__MAOK O3=OWZ _I LT]Z*[(?.<B353@6[DU)J1>8Q"TS7IM("
M0@@)2O::8RI9N?0DX;[G?F-\M/MH= R4__GIYR]*9.:$-1"Y)!](64O;&;>0
M(R)RQW))#R7V]$:5QIS.96BG_9MP]E7=*$$0&V_G[BWHB_+6<E:%R]F#RBS6
MTA@<<N$QJ% 45],E;#T@Z(S^XQCF7GMP1F'.FT)&R=G[LFO:4!.1MCTDWI_>
M(W1F)BH9$$*NO2!S3!"EMH Q!R>+U+),=_\]8 )'R[2QP9PB0>CM]6(SY..?
M+.AW+BJ?[G$PT>FY>Q]+])>^]:'$V[!8;<Z@?L%0OW-1+VE;!? T_^.'.#]8
M9Z1()M:,U6!5_:"!N!8 ,V-*6B7XS;(>'?SY 8(T.[SH/O:%A\:R0<$260 2
MZ;4SF2P PP+0OJVMDY%QWS$N=+@0DQ]RC,V4>P\^QD1G[L.0>PLO7E3@5+7J
MF=" AF50-A;PFB4@&Y-68<N=CGZZJZ#Y"R-/2XUN%9%[0#1AH=LN8KU41-X+
MS*X5D0<@,65%9.L*2BZA<'H9E$3R1;5E8!W30<C@S)2)AH=>$7D$?O0!H'6(
MTL;5O%%[8!L_630O6'@ *PJME#HHB"DAS3=8P0IW@G5KM7#_& =4WK@/!LOV
M"FP=AGC'!?<UV9PS3',K@7,90"'Y;Y'92.@E'A 9\S%T!_?^@8X%X4:J;!YA
M>)>+OI4K*4MCNP*&$*.E"CE$E6G65F#6GAQWVS&T\/Y!C@#>5BIL&#.XD>O7
MY>FM^*/7']]?MHC9BN@S&E$+R'E!7I7*PH*7H8#D+D=%MBYZTPGE;N,= > C
M*':4 ,$K#LW&] C.6\%M L8Y>=*2.8BQ*! I<\^Y")E/5TKUAG#/S W<!YI1
M8HNO"+1[/3J(-+G[=TO,N5R_O0!\B Y[:'\4E^^V:(*$,8RH+I4CYLNHP==;
MS" +E]$KJ>(LR\BLKM[8?.BC]'&*\6*]?UZ<?KUKH=RE_8LH8]0&C">G106=
M:4?-"(YLWY*5H3UUNK#S#@+/88OL">WM"KZ-<1FG8U\XPZ_+U:+:8#=<W<W;
M8K4E8\Q;T,*;6B^"D6R:'*(4?9!"&_U@^%[K0BP/"OO,+)66T(V3!G._@-L7
MK(N(,U24>D3L^<I+-02\#YWV0&NDDE&/B2J358PD 5MO)16KS<T4"1U=8$:J
M).S-W,OC(U2'8E+S\JD/2*/PZ.:DSRX7\&V?J0^K95F<O5_]8U,T:S.?OW;G
M1UQ%DZV%9*0 Q1G)K5D$9&@RS_QV48<1&;;'1.:I3-64&K>H-Q6NHUADMX3?
MEG/#7"MNW9 6E;#%1 \A:9(VD*".DYZ<U,Z*G'4(T[5WZB/YLZ!=*^2FVT2O
MF*@7SK(.13I/'I#V52&U+&#)#+RTSCJ=&%-ZWGWTAL0O/L!^(#9,:.XNY>YD
MK8.<A^$-W)+]H%R"O?#O3;$]P)ME7=M%[B3.BLX62I%DW'KZ*M@@0",KT>98
MM)LP^FY&D@US$V;A6!_,QG48KDZ_CW7)7 B*UZ)WV=>B ZI ],G5C(^HC<Q1
M\.GR;_:=S<'8<'LRY7Y#;@J8QW4BKLW@(7NT!%$B,M)8L$@O,&DL&LW &)&+
MJWW&\G1-TGN+_\RHV K(<4-1;^X1Q6-*TABP&!(H%6NG(\TAB<!]\#S*/-WU
MY'U2/C<'H@58]U:I:4VC[2O51;;YXM\/QSEH@FTGRNP!S&1KT&X]+C9X%Q/M
MS8&!<H[6QZP$.)=]B G1.'NTI.D>&#\99_K@T3K&]D>\X%W[['9##4I+IX.K
MLM$&[E"#$[2U1JOI)TP+I[H%VW89;=8@S#W!N3L2LY%F6T?1;ZI,<_'3DK;4
M93C=B:19\<:%#,Y'FK 1EN;J'.24LC4<K8VR$]AW/W_B;//V*-PJU+V?"IOG
MO+Q^\^K7-[LP7TPZ!QFAUH>EB3$'(64&);(<C1<H0[>VHU>?>E0(#E97ZXCX
M!VJ^O]K5?'?%6L0:M(VJUOLF\101C+$B0E&.S.!N>>F/CW54&#=6;<-(H4?%
M^ZDF;^QZ"P43/$N*[(]-*HXP)*WC8$-U@)1%EKLE0W0<\-EP8*B26Y>^?4W;
MR$;#X627O$&2??C[F[JW[.2S.1F3)2"SEN1#"2%H#V1\8JQ554/'1M(=!CLJ
M K16;D./?]OT <_^'HB19XL/8?6/-V?AC(3;794'G@1R#5*$6(-D/9 2/ B7
MK>=98BK="G(\-,K$<#<'9#F&-EN;9Q]__?"?[S[>GOM/']YMI9..<<8S@K4E
M@\HZ0<BT D6O4661'),="U@_-M0Q =Y6KZV-N]>O/K[Y]=5#TD7KA3%)@&61
M#) H&3F<V4(2V4NN3&&BX[K^V%#'A'I;O;8V[-[$Y4EX2#B1I!6U<*8JY"(J
MJQCM8T) \;$8:R22X)U ?VRD8\*\J5:;FW"/&C#21HN&/$LM#&T^3!3P49$5
MXY&'J)(0ON.+_EP.TMKJM/6&3DY$Q@_AKVN=%K8BWY94IVQK<3!B?=&@Z)]$
M^,1 ZJA*%#9YT:T&?J]ACX4)X^EZE+SEC[74Y.;J0.MHK"L&BC&U$V"QM4)R
M@<!T3,(ED<1T][Z78CVSB]YA<-QFAFG$C.W;T$68R:]RKP@XU]WM0+CNAGT/
M78^3L7Q%J(0Y*14]\*3)7A%<@*]MNZ3*#%F268?I(LQ'!_[1^]<Q<.^CXI%:
M)Y^=+7][7S9"[8XA<G0IAP#:.*QE\UDU?@UD0]*4A"+@E%W9;PDXA]4P&+0[
MNN'MI_%1@A(_+[]?ETAG,E"-H1T-5: Y,@LA>@N9<T6V4/8Z39>E>5.ZITV
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MDZY=3ZS).-<'OQE:XGCK8[29G#M5PR*]R>"X+Q -X]I&+<G)Z^2T/_F6.+V
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MLSSIR<C]'&*H>_%I> QU'USG#F/M(NM+#/7P>-9>7-@GGG4(D+.33YGDLBO
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M8IZ\9>DR1*:R#T7;&#LVN'EFW5 '4VL"H%J;;P.:&D8?=;$\0<EDM2@E-,3
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M0\%>2FYX9_1 KI]R6'R:7K4\DE,^6>#YY/\MM?&A?CV3R',6R4+&6*LJ1(%
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M.M/W]CMMO)-YKD=C?I]G'[_@;",EF]<,F8Z@@JM5CJ2#X.FL#-9&'^L%FGB
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MT2-E<)GK.I'*4 16A/'= MVCX:O?&22CV:$U"^VO5=MXOL3W7R=?)XL-,N:
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M(YA53( OG+9742QXH1/DH%**%IW+OI/97RC?Y<X &$C'@X1 V^?ZR=KC@[%
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MH"4K-F-DHVV5G<5N.WEPW5)7S9[T_HML8@&K:O9/R@+H:O<2#UAR8'2BCI=
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M=[30(*F(AU*MZO<ZR#5Z.FR]K(?*>.UOSZT0V<,88X+%)\_)5<4EYU@=3A,
M@TAU=)Q(*I"0;KP8<4R0;,T^C8>1/C9HG4-Z/\N+7Y:>[N0]SO[ZEEQ?\G6O
M,QT2F2O!.DBE"J:9@?J4$(OQP5(\HEFW--)3JQPBQFMAB.D06FP=SM\^Z&^X
MN)Q-%C\^Y=G7,Z.LEB4SH/\<83D@>.T\,!&<9=%9J;L->5K_^8<.VX=V4ENI
M=I#LX 92_*0*B_7^T&#E'JTEEJCJR):,!/1<C$CCM=*^_,$%^\4V#6S4^B!X
M#.>W-;<Q7Z;;"==%B2RX4R"5(5PK3;BVGK[-Q7*I'!K?C9U\RT+'#H+FRFY8
M>K9!MI]RR;,9GE\S8%O-I#;< X54=33+,@'J*+(BD$9![I!DW2J5MZUTHE#8
M0]VM2\)NA5OF1'^YR8F2P_-U<OGU+/S_['U;<U/)LN8ORCEUOSP"3?<AIKLA
M@#X[YLE1ERS0;".Q)9ENYM=/EGS%EN2UI%I+LLP^<=RV 556YE=5>4_OK1$\
M@?2FWEB"D6[#+-AD<DF.=NZ[%<8]MM(SPT(#=@^2'_8>O^'T FM;F]]FWW ^
MK1ZPWRJ5BS,?N0W%)!#:U/H-;L"%%,$1:4+YE..(KN@MA)XZE-I+:^.0I($#
M3'>;V:39-*^6".<A?ZN3"5MW >JXVB AIUUV>O#84V">1U=G&N?:,[/4PAH1
M')DZADFNHC&WT[./+()RX-A3HJ,F?)V5:36]Z<+6R#&9B\*)(@6+R8?Q^B.>
M9.RI#S;;Q)[ZR/1X8D^/MWF04@FC2@2!-8/*VU4[ $E/D,^*:\]3'*^2]8GT
M^!D$,SMT_.DCNX,U9.E"Y,^./X.)?:?.++O([&  <Z1!6\14FWG72>8F5Y<L
M6=#"*Y5U*<6,%^-ZRAU_AL=5'U$U+];_\]W_O'G_ZE;[?G&I?;]\]^:Z(E05
MLS+$:A20;";!@0PE!M:F)(O@BDO>R=OQZ%+'VANHEWQF@S&W=9CLU8OWK_]\
ML8TZ'Y%Q$B-(2WM6WGDRQ$L S*E.O]""Z6ZAT$>7.CG1MV5NZU/_.L[.PS;B
MT$>?M0R@><T<XBY#B%* %Z%@P$B78K?YO(^M='*";\K:UF&.AW0MSEA( 0MF
M8+%6=DA3:*>6C,:8=(Q>&>^[A<77?/A3\CKN8CPW8>K&>WU@1^.KP9V+6U88
MQ*'8=4>'=R)*27"H-?11)%#H$&)1!KAE2@N>G<,1QPX^)2>BRBEF:1-IXXSN
M9>0*@D<+.F-@Q#U5['B=#$_3B=@#FVV<B'UD^I2<B*N6HB8Y($;6R<>$(B=7
M;W[1S%K!U(C91R?F1.R%F1V<B'UD=S ?3Q<B?SH1!Q/[3LZ>761V."<BUX59
MHL[I6#."G8.08H"8HM8Z&\7*B'WYGK 3<7A<]1'5^$[$Y#(7AE0)QC4I%5;6
MZFY=NYX6JZNK2\:.C3Z?K!.QCWSZ.1'[,'=\)Z(HBGM!T.>N=LR/A5A0=  A
M=2Y%T&/M.OH7GJP3<5?1MV7NZ$Y$)Z2W(G.H5@.HH#EX$3D$$V0DPT(9WBU/
M\LDZ$7<5?%/6MG8BOEU^QOFZ7?\1_IE\N?CRRSS\G6=_3U^%KR%-EM_/#&)Q
M/%@PQ=4&@C9#S+$.[RM999USXMTB2'U7?E+NQQW,[N'%T?JY>#>?)<2\J-F9
MZ_RF*B(K/A<(A.FJ)Q7PMG#0](AE94,N]_-N-A;?;5WH62"C);.;JXSX-7RO
MCIBWY?4_1,QB#8%TQ9(2GL\2$RPG-%#$*F'(!' )%3' JRB("\2?;LIC]T6?
M!4"&$D+K%^?NL/LU)/XK3+X1A9I7K4<Y<*JZA#)WM=&]!Y88DUS8S/BC48SN
MRST+@+1G?.MBG77WFB-#VW@?P* F>@RFFN5O009GN,TA)BFZ61S/].'8EZFC
M5^'4L=#)I#H[I8ZO3D:!,W1#L1BRS=X4-F);HQ.IPMDO#M1*6H>JPOD=PP+O
MUJJTC8QO^OA!PN*=]K)G3'QU;]R%VFK1M1T$,?(D@DJ 47H2/ZF=+CJRCT4(
MJ42NBNUF#G9:;J_79=L*EW$H8V(,=4 &3TI7!XR%P*T '0OGI& [3-T& SRZ
MU-"1XX$D^,/#TI:?QQ,+_DA_<[%2D9;SD*Y&>Z$GC;GF>'%CB$NV) C!2>#%
MV6+K53=BO=,Z"L>.^ X!@0</S]ZB&"38=I^J*P=A%[I&#^"NI_50,=O]Y?DH
M1/80QIA@8;&0LAT2R")J5V]ER0(G!0J=-2&RK)D=KZ)C3) \&G\=#R-]9-#:
M9;:Z+7\-Z>JR?!?FD\7UB+; L*B$D+ ^PTY6W3I(VG5RDKL<;5"=M)#-:QS"
M=&DAA%E[#K9VBM\CZ^5LL9Q-KP-\0DBC<P(M4!$UC$',K$!AS"=K?.2Q6PG&
MED5.4+0[\W#@0UL'+'Q%,LYP?@T\;IRK;8Y4J,TN#(_@M$)@20;%0I&QXV2Q
MQU8Z02GOQ\W67NK[Q%V-A,]*F]5UXB*1)4A%7LWB8*B2S<QKK[HY(]=^_"D*
MM3_?!AG*]3Y,/UWV/TTF)2EJD9[2OA:L9XAH-13GA%#11>O&,^1NR#I)ZVTW
MI@\RB'1%RO5 G0[$C&ZGW2'P4,;9CN):+_8]>#V(&7:7*,S%EA(46+1U_!$:
M\+'.:E?<1!=R=F;$ ,/0@G_4X!I"[GU8W%#>B_GR[ _BVI>++]>CKD3"0(H$
M,.<=$9(RA!(%Q.15EL*2H<"WR+J$15PQF#YY)>;_PO/EHOZT>M17LGRPZ"'>
M\9V9/VO!N89&U(J0RV2G*T*45<I$X<![VI-RMO8CUA842TP%8YCFV_+6.XOP
M[J)/5H0[<VX06^F7B_DJ+GG5"%21ZBAR<'2_J$I/EA!24K5W4+".^XRV6P[I
MF@\?3V)CQ%;VY=X@7HV/->7P/4[Q[YO6KESK8D(R(+,A.X'1=1&%M, +2]XP
MC(@])/IP@1.4ZIY<'.2<OIQC^/>K\W"QP"N2?$C"96$AVR1 :8>U@-Z D=P:
MYI5ZT&Q]FV ??/X)RG4_'K;V7_R":5ZI>C-]8-E]GL\N/GW^8Y97DQPKU]^6
M5<]N&XU7B6R\6+,XE"L$0\T]W3*V/CXE1-?-\;S#XJ<%B*&YWSKQ;D7E30/W
MZ[;=ADQ\&SQHOTHM)PQ[%AU82P)W+@;+>EP!]S[]M.2]-_\:)MG=$G2]Q^]W
M,S\_SI;A_"Q7!RKG'*1B6,'F( 12\X-5F(,7T?(>CNK-"YV@F!MQ=6,NW*X%
M7/]\)?3AVP<WSAE'Z;(R%DA'E+1)&2 6'L#2IJ57VF+'5.J-2YR6E-MP\J%\
MS9X/^M<YILGJQ;BB<$7?&:<'HH3, 574EP$QSW4&*QWR3'LOMEMWKTTKG)9T
MF_#QH7#M_B[*ZT$ZF_$G,' MR$X04AD@V[Z0G4#XBY'V'K1@"<>KX'^4W)/!
MS5 B>H@BU^()>(_GA.[IIX^S#Y]G\V55+E=D+EY,\^^SOU?3NE\L%KA<_#J;
M_^OS)'U^CVGVZ5(XK__!+U_K-_\=%B\1IW\M,)\5Z1BWVH-;]<]+FE13+QR@
MX,H9@X+,USXO2',*3P9JQR/'A^#TH^3JOYO/%M^G./\T"1CFT]G%\OH/OS=.
MV^^PTB 9_'UWV#J9?U/=R"667J3_7$P6JXW>P;)C.C(A$S#OR#A5R,$5>A6X
M,XX9SD,PW6:G[4E(LP* [FM?];G7Z TKFFSR%*LOQT*(G(PY.C>)3K)&UDV)
MWH.(T8L&AD;*QG*"(:5SZ$*#U68?;F05@'72>5U\((M1<U"%U\Y" H'N9E(>
M M9 4">4K?_\@V>9#"K765O^MG:T/R3INK%(!Z+6YZ-T%OXA$DN:R6&[7/=@
MXF@2+E)X9U@$GFRH<5@$%[PF+&N7N+5H.G9-&E>R&S)'QA5L']ZU%N@=3>TJ
MHLZR]";7$+H+KL[7IOUQ^@Z+-L&)J,I]"WQS2Y,?/WID$Z8-OV?-F-4P8-VG
ME9^**NB<:VJ++D2B(DM=DVV4JH.>>ZGRL?1$?#;O]U#B&R2OM$OCL"Y$_FSL
M.IC8=VK N8O,#M;8M=8Z<2\8O;+5Y$+%Z?GEIHZWR#$H9X*4IP^L!HU=A\=5
M'U$U;_$8YM.W%\N;^.75*\VST3GX!%EG#4IR6UN#*"C%<Q9YX,IT=.ZN_?QC
M;>?82Q*SMFP<1-GY:SJ+"YQ_JP_OF^G7BZO*6<Y8DC68Q3$A*!\\!.\Y%&.9
MU4)*+<:K=UE/XS-3:QH(:I :J8=T71V5+I2-KL!LHO906DL+J7: RAXB&40_
MV4BAPQ"S#0%XE*$.36*UEJ3.=&!:HQ46HSY1L#RJB8R+E3Z2& 0C_SU9T%^9
MI'#^/[,:TJROYJ^S^8?/85XK1$.]A*M'?47UM>] IF1%2( \6U!": @Y$U?H
MQE6><1OD>/#980.'4'O:(. !L(867^M:A15A[XA@W$!<SLIDAJ2;>4'$:5G
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MD@UPYG,LG.6BNCE&]Z?E.<-P9$FV]KO>(_^Z./Y=F.3N&_!.,\Z$!\9\G>9
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M"TGH,EXC]S9[:NL6[4W'I8\E,BM,D 4,J3)DM!3B:Y :="K,"1\5_?II\/6
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M%V1MX8=PCF0]>XXH9*H-U",HS3.X9!GPR,E$EYAC[);LT'G)0WLSAM:N!Q3
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MS7&Y\9?=T%@,UY$NS,(JV"6).DI+UHW7CC%,C)?Q*J8>I_<YPJNQ% ?)HGE
M47UZN2\<1$%ZC:5FX#4*""R)9(J53(V'JY\HVE-"&ZL\APQ=-"T?V_BA[4,0
M@Y:0M014,$FRJHDS7P=&1>4@V(R01&'%!)WD_6*<(W2,'TV8H0AN(GI' +2!
M[!I>&Y)'!K8$X;P+S.;Q.LP\FS!#'PRW#C/TD?@3#C-8@<E%8X%QQ4%YXZ&:
M01!C"=%XI]2(K66?2YBA%[;V#S/TD?&Q>'*[T/PSS-#.I=L+(RU<NKL(^%C
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M6())76C^&>EL%U7JA9$64:5=!'PLX*0WJ 1=8VY81S75_BBAA Q2,&ZYBJ3
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M>8/C)7Z/39JV8;01.;,/'GU;-;]=U!+(,'^!M=O;[#G,_WP.2ZSB;;9.S 5
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M[FJG(N-SMG=,&Q@.E#_DW5]AH^'^/OSFYM1]GUE>%U^4<9'OVE%]<H:@3UZ
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M<P,@@'>6M16,5^(^E E68=0 MGU8/'B7OU)^MYQ?T-P$O2!(V+.K_^@ Q&J
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MZ5#XT#IXT55BNXLR]_I9YI49WV>!1-+YZMUE/@$9)7"F:#(TCEG<D+;P0U2
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M#:&D7I </I0%D5))T[O!3RF):D#_,:07,)BO6H:6;SZG!AH^2Z*XGQ*A16I
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MTCS=E);J&1HU\IJF4^G,(L97F>H[8"]:O+WT=6#Y)"X[1$!7HOODC&"7A<K
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MK0QL87HOJ=K'X8N8D/;WF/ E_^-TS:MUO)V*73_^$1@T<AB:6CYG6;L-A6K
M5.,=.$E3B1W^#!%PM<U[0K "W]>K@3L6"&5(VM_C37%K0 IT&.R'0\C/>]7
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M"4/@M]:MXL%W6(R:FT*$B<C.:'1C=BJGE0J0;!+8K;0HMIZ3K01.,&^F -G
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M<-!T2P<]FW&)@LJ*VPIRH$V(;+1E-<]G9JN':^^-]KEWN.3XTOP24\<$[9Y
MSL>]/-:OQO0U-O,8L],3+&E_W>"T;MZ0J:FLZ=H#%+.N5+ARX P!FA(D(@X
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MTV'.ZHS217KN=5<]X;-)F_>,5M+D<OS,@DW.CI_.$P-3(SS#$5J?XJ[6-7V
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MZ;J>A)0 ;906(0>J-['SD60%6_]_]&#H_\Z#UT=%!TK?91VD+ZBF/<H-M1A
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MN/1OQ@+^#5+B;>WV18LMD8IT_())3_?R<41MR G"5:LD%_&W3U6U/#&VB9+
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M34$P!#X6])7,.8Z\N$05TI-8Z??6PKC]=FEQ'E]X-7K<,@\)#XR5D;5N9(T
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M"EX-^]CRS?;]1!RI6J[/!9<%0"9^5W$4F(6,=[,6!8J*YEZ._2M9SLJ-F+7
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MD:ZJ/JTU(D\O&7(TBNK<52?V+<M_,05^99<<TLIV<4D>TX]4$G"I*!0-I^
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M1D*C?:3G,BU* 3=6\PL#&31%KRX:HJ@;@].N02Y4Z*,7BV8$9@\3XC]=;6E
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M\W1,^'"XQ7']\ZCNK&CZ\T!Y7AY%/&Q1LBX4O $3-K EU':'5TUC6\S%YXK
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MZ;1.; 9O@"'HB/^.UD+K:+F(G3>PIGUP%&L17$^I!D"! Q<8]^=?9\#JFZF
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M;(&BK%3+/9;=(GVVSQSV<@>*&D@B_E*3)?5V*?2RM5^3ZFJ!01KZ2.C!#@T
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M=T8BIPB+[Q',HF@6IY/3=7'8QJMJIL4*7^[E&Z>/KJ[#3]AZDQY.-4W)"V)
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M?,[%Q-6X(*<MAAPT@(M2LU$%TR.&1I;AV"%XK>BK:TK]($,P*]C4+X&6LQI
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M;Z]PA#^)PUCP27.C&;^'(OP+/!';H0$L"3E%&)'%/YQ;]@]>V>@H@>EH,^I
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MR7!*-Z%U+TYC/K^5![N5O[6?9 ]E7"JSW%,X'+X)7/8*ND=/'^N<(G71;#B
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M CDE*=I-6[EMP,0R33?]^,K!&\%P9*CT6!=Q 8485S"', =D(8\P>N*!99U
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M0T1@$1'+)]TN>31I>HJ?Y2C%-1L<*#:./P/;,L=Q4YQ6>(W;*+\YV@-LZ1'
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M?[.6?:WH"K@O:32IR)^QSL+(:*^27M^H,]1LKRO3& --^!S6>BC"JE/IH&]
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M\ZB>WI!R?2MAKZ3-%NTHK[HU A^.J)>KZ <?'>P$NX=5;+4S*_/C,:77#O4
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MA5T$I0E G<Q_N_26G"R!9S'7308Z7+,?**F,DD]AC4ERKXT' UA-70P"6A[
MQ#$TDXLYC]DV0M;WU'U'XZP<6Q8=R&76(GJ\_)..;3,JP9XJ\4BU\ZKLHL,;
M.(F..[WS'0#RJ^6=^4!K0[%2*+G<2MA1DZ::9FY 4P-.5;UK>K9I#2V7*8?,
MW0L,2Y,7O;6'8(8/Z[.\?Z//E\X9G<4*@VHZ9#ZSY5K8RD&&MU!D-AIX^231
MIX[H3\_N3#^"B8L<S1Y?0/HV462.FOG#??A])1.;B(-( ^S=+,Y<05B_?&!J
M"WV-9F(S08:'V%MSX)D+.-RA([<))L1N4OYK-#1!WW[]=SX[SH]T'];_\#,*
M[E3O[G.U3"2L@?LW--77ITTZTS"[]%'G9WB*7"8ZG['2?!19LLLC%C3Y<$_,
MM;_.++ :>9AN<(OZTQ[0$&/PH&;M?<I4_L_%%*/VDLI3FL+X+,+D#)<%/3+%
M\\%[/7XK9=^?"K$R;8!PYLF_1[1/_N2#N/63__0#^Y?"_?\^QNC+F8OJ*B5+
M"S/%M)/EADU:6&]:E4>C.%,+FT4V14(HA-&MV1GU!K.(_G"0$PFDZ=R;$F36
MKZ&_+9TZ'3WWS.A\$KH8.ETO_#\N_/@A4ZK))7P"M+ D@+R]:"W_PLFLT#!<
M\VI$4@C$]*&Y7%--1H15?P^7U#2=UE26M3+V][P),'G%LNP#5@,J6T#NIZ@D
M^#\;>J:%O=P)\ 1O3NH\$@[^[_%(^"5O.EEX@U::B!M9=OGA)(79,B *)68-
MHU4H8 A' I><>J:?&WB.<NA$B3RSU.;LSN<[>O-9UX02L)%[AR%=[RLU3K=N
MM!;-H1PV56XAA+^Y21*[C55+;)X+$IHC)H.M'O7<:E\_%>S0ISY>.N5X% B=
MD"O0$1C<L*V%W=FQ*R$+AST5B.9Z9F A\X)JI<$%7XEGG:9,"R/*7,NERY\E
MH@*455NE)P[H3:OB>IH8\[SQI.7 S305CZ1,8D<J?=&9;=ZF\TS61\G5ZJTO
M/.,>IM[SDJ.R[^85<PE())8]S#Q0F:KW++ Z#1OWI=T4N<[S(<J^DKL0Q1O%
M->G"0B4&+=5Z'4.S?<3FT@G0X[;L;#?[*-P[ EB'1PA)W<LF")]+36\T5_-:
MD]8G9FQV[X\_]HV 866;7-T)=DOQ+'M_B?@&M7LY5^GM(T5<K\#[E5=1%1:I
M2_N"/,^N.B!50URVJ4.<RM?"I@<[3R IGY?:T#481<Q9S4/$& CQM.V3*.?F
MY2V-:^LV,"U?X-[VN_AA'[9;BN_X6L-I;3R2AH/408P3CJQ/[?AN?DKZLJ)J
MU*2!]_Z/^[!AS<@;066\ 7T^O0P>S_RV\&'H.66I,TN)F]43>4K:$0.L\=1T
M^'4J+WL3IE&AMC3:I;8'BA>0@1;!Y=0]21A%$2[7< PG9T;[7U:O'K"<2W5[
M5IF:BCM#-][2E&;V./<X_GJ/R(^O(&GR98<LHO:Z1/3>W83($%S*_:;%S]RC
MU*85:%L$]BMS,2$CZ._O7!OQ3L$:"[Y>]?  O?QS+]=NJJ7 @<^KUTQ*K>"M
MB^@,@IEW2%QYX(23';'/CBBV/-?^B&*+KQ#8L!7^FLG1B*J,S:'?E1_Z =RI
MA9$7\DZT0P:$FMVJA2U19Y='JWT>)-IT!,)\UR5B7=;%F/1965(94I=Z,!0+
MYIZ;C0OW0Y[A^0.JKE=I1:6)24T[7HO3$URM>HNW'R$=87&LK/TJ7Z?OP:)W
M,]&[60R-6+E6O+2PX7Y. _=0]7P5ZUJ/92>)_\M3F<CR/])+A6]6'HW&HPHG
M7%?WG<5@#LXY*V>L"W,.GDHM#(L8(H0O!)#BH4<K,1]S_4*9MA/<,N%JW"P-
MHE^WI_:_86$Z YK&,@28<HJ71OPW!X$0HFK8Q%S]DBUWCU%6_)P 09'+8.B)
MKK"=SUU8F^87H<4*[9'TGWPK_UDV:_0^,C3C&TLUC(6BE[H-2B/5NN$4N+.0
MM17AL_(A-(\Z?J#%_.)1  OI^9,%YG_*<0RQ""&V^#N_A1:U#>-W2I!%2?LX
M@Y?G#$FD:P9>I>1OKN1[X/+R2+@NSB;U+M8'P(M<H5BMC]+"I/:#/:C4<):,
MU;36#=P@N,AZ=TBB %?J-AS,1PA]E*O [ZOU@-?E BWL6A4SPY6.7A ,+_\<
M,N*X)^@YT\04+6PIA#[4/G#) _52+>R ?SI+XH?3PMH&T>YP5+5:+%ZB\WUV
M?&VS^&G3/BWL+Q0 -,M6'B?H?)\M6@5*<YWO,Z:Z,+MR$$Q07/H1:"%)-FE6
M!.M\G_T@N[;>\X\J>PY,:6'.JB=O?J]BT>_;,/6N:"I."[NK>7W^#QKVH5Y#
MN$FW,5C&CE9! GCI?4/B[88 #DM%38UYWROK07V]2\ [;XD87'D?TC0":HS;
M:_3BIVIGJ#%E %1%1.G\<RU,-HM..FL*=4SZ$]:<J3(!ZI@CD+9V0,M]B8UF
M!4'G_7P"H?:)HQ[]M7CB%J+:7/>BX 51*%#KNT$J]?SA?ON!'L]!"RVL^Z?4
MU^?1DC+\*J@)Z'1 XJ?WOF]^)V 0Y0X_!2%QA*GB$KGPG1,ZW1+L*)ZH3_8K
M$ V[9S6VZJ!ZX(O"C)9CM\?86R%(=._#0LBF'INWTMG?=Q]F;3AZ[$^=E=^[
M/O=SWOM!PXX49IA?_---AG][]1;T6QC0!UF0D?[KG_I4_^&=6^'@[[,D,GU!
M+<RW7V9KHSB4G@8!!9770L1_9:+\B5_1?T2KR@'(W$^2Y>+Q[) =$'8OE:FS
M'T849J@O:NS,'Q1!+3K/:?S+I%D^_Z^IX_=6.YD/RD\)IM^'=85!M%DS_Y5^
M! 4]= &H>Q]B1W14(10<F%]AY:^7/7\K_@$R@_;K9?BOQ8\L#?RWN'^+^U\F
M[A=[0\.IK'%R0%P.]\K+98HA 9LW(-/E5AT:6UVH(?BL00M[ "@X7VV>^[/3
ML+,]@?"7=/A<-[A8I-HX"N:]%TYVCP#.O +Z='&'TZCLQ;,Z;9>EZM_79)[3
MPKYY']]8$X.8(.OJ^P>"?TNX-4#\[>K#RONG]M 763]?_"*B$JWT$+\7X*G>
MGD#6U7^OR#R#H]LB1_:+%D"+8]*OE<&>%]( H8Y:/7@?CYDU_%ZWBWO*_DS.
MZG(+?W =H_N]VD>UL(_Y;W_1;LD_J>!]V"KV[TZ%,C]KBACR*WI_8WXA9*.$
M:YG@'.(N7)*.!I+A/Q>'F^I#EO/C.(7BOOH=)-=)I7H!QGYPS1VKA;48I6K>
M 4Z(7^^!G3F* GZ]+UOI5LUJUGO[U6>WD0+UYX."X719$?C)E%CLMO!BV3^0
M^7[M'W3[[=($W7@U*\?!+P)P^NB\G;\[=-ZX"*I0W(@0+ND'FO4TBA.V=PL;
M;91?S</%T&VI/?]1!/8VHBH3_&2?I^H%U VQ0,MR"&XEPU4S%_=R+0JA2O6.
M0CHK^'#)I4G$<#JHNK<V/N,=ZS?!GNJMR=D*R!(SWRWYQU7\WR] D.W_34ZY
M0@M;&^=<YA>" 9H9XS=9RGR8;-&B!C+H 15:&&$0!!U_,:GLLRHY2R&%"M2N
M=<J8!H1(#$) T\)86;^:Z+H 4%.M4>- LXM?3OYS";#1LJH.4#^\3J-"JY0"
M'5"BV)/%7%T<K Y.++E1R( K_?*[%2) / KH\$+% ,#":&& (01H[OT+"LBJ
M;P"SN[C X*P6]NZQ!1\J/@474'\M/OBYU/8UXIJ+_[W]D6'6!;4=L;6.>1;F
M(FZG1B"G]'>:M]RQUC?'[R#_[7CN*?N#;0L&&0H]92@<,LW=V.U:V(<0YLK2
MI:>[/$I>$!4#K[T!::/&5Q6R!$(9A80$#2D38AS1DD6+5PCA7W7F>Q\U6[T"
M!SIZJO?HW0#>UD-KQ24K+:Q]0@N+_A9X.^>F<MRDA;D.">?\&X#6K<JW8$HD
M7/FI0!V3_8=Z-367(.D]>M.OT&K5V?2>8.'O-/E]G?+VY2#P-:+N'" 3%<#=
M4])_IP0TK-/V2[O5\EZ$Q)2EY,-YG\$7-)^ [&=0O?6)J?HS<,F/KGNUL *N
M)_@1-!L,B\#-RSL0,MY!+>S)'2UL-!;X=RO^I[9B?G[YM*^BZ1?:%]@@5H8B
MWK=A*\#KA!24 T,=PF5T2:7Z*_L\RY>"3&#'=,Y&+<Q_/(8_6ZUXEI@T$'*E
M^M)=I[@-):7CR4/!R]>Y;=I\(INAA<$4$%9FV;HJ_PSU_OOX\V/7KHC_<FCO
M1R6_"M$._1]02P,$%     @ !(AX6E1E/B#:0@  8$X  !4   !A8G9X+3(P
M,C0Q,C,Q7V<Q,"YJ<&?DNP=84^NV-CHITKMTI$A7FO3>1$!$JM)[[[U+"8(4
MJ0(* @I*%6D"H?<N73J&WD5: A@"">1FK;7W.6OM?<[YSW_VO<_][W/GDYEG
MSLPQOS'>]QW?F.,+ ;V 7@,H'JEIJ %86%@X'3@= (!>QT(X^_M[RP@)>?H)
MVMA[V3H(VGEY" 7;> L)"]X3 N04@[UM[-P<_-EL'9Q</.5YCEL[>=A<[.5Y
MC,2U[FEYJS@XNSQ\YNOPY)GV4[MG;G;2]CR*"J1$<L$RP1[>'@[^-FS!'NZ>
M?C+!\NR_CRZ#.?[M8R%V!3E?>T<9_0=J?[/ G,FS_RV6H* @P2!102]?)R%A
M:6EIH7LB0B(B A@+ ;\03W^;8 %//XZ_#?# P<_.U\7;W\7+D^VW<QM;KP!_
M>?:  !=[&4<;1W%;>WMQ 5L;47L!86%[&P$;>U%A 7M147M)<6$I$4=A6_:_
MN;>W^S?OW@&^[K_[MK<3<G!W\'#P]/?#L"'\6\SV=C*^+D[._GY_>%=V]__7
MPG=W^>U^&7<;3R=Y]F !>P='FP!W?\Q%H3^N_NT XP?#*B$AH9S0GR(0^@<"
M_O8)AE/,T;\I\)L<_Z:B@R=&NB",1NAU@%TUV,41 +2T@+L  !  6%%O 6S,
M$1;PMPV]"*@ .-C8O[TP&R[F=8/@Q@U<W!M$^/AX!"1$)"3$1,3$I&14%*1D
ME&3$Q!2T%)0WJ6EH:$C(Z>AIJ>FIJ&FH?QL$"P=S#^X-PALW"*E)B4FI_[<W
M=!= 20#D8UOB8+$#V)18.)18Z#Z %1/K#:S?M[^'C(6-B1$/GX"0B!AC4$\!
M8&/AX&#CXOP6->9J..8Z@$MY@^JVL#+>33T;?'8?:I'G:1\)..[7=-/H3T(Y
M16U]HPB):.GH&1BYN'EX[]P5$Y>0E)*647F@JJ;^4./1DZ<&AD;&)J9V&*F<
MG%U<_?P# H."0YY%OXB)C8M_F9">\?I-9M;;[)R"PJ+BDM)/99]KZ\#U#8U-
MS2T]O7W] X-?AX:GIF=FY^87OD/6-S:WMG=V?^S]A)V<GOV"GR,N+G_#A07@
M8/U]^P]Q46)P8>/BXN#B_X8+"SOH-P-*W!NWA?&HE/7P;7QNLHL\)Z"^G_:Q
MIIN00U0?2F/K.TE$RRFVS@7[#=KOR/Y[P*+^1\C^#=B_XX( )#A8&/%P* %%
MX.I)00(O\"_N.&NIB[F;DBD*K"C[NNDPZ8UD3;4O'BR$D)4IVWCSD7L"J>:\
MJ/+=5(3+<0(:.%-T R&HW&85UPI63RS=%0]N>*&!PM+JS/V%8OHF 7*%HGS1
MF5_D?S9V1@.Q>8AJ-* ";T0#S[G;.A+FT^7C=\(G=/_ARE]]M" XH*G=';P(
M![MJ1.:<2",+>];CUAE!.16RMPV&Y21D#JJO6*5??]UU/?'F$XX ]A0XZZ'Y
M<-HR,6&KO?/&NE4-%_F)G)J?(HL/NCF>;$<EO,B\6YCG%^G7+@OI#UT>M[MF
M#-WHO"*'K%[CYBBNEW;PH8%O5Y5H8$VC7('W*G\'JII2<,T&4\@JL1@, 3G8
MN$^.H@&OT/NXQ1:Z+TB,[QX/Z)B3N35/H@'[D#,A1N<&%MZ9#YG#ZT>50G8O
M'5XL+G$ES1,8)%R?W+-C:\$9IERR;Q>KMCZ?D/\O8:MV.J719LHI2R:"?X0Q
MNM_NL/!>U/:U?W\X)\0I>'5MK^^4Y&&^6Q]RG"K'$ X][[\LC0O@3M!<5O"Z
ML]5H.]G4=7?X(?Z-AQQL+"'89;SR5'1M*8/_.=)JH8+R=/F8463>1S1 *@^S
MNHX[Q"B*K<4*G5ZE00,_(N;0 )1S/FM2G3,47_0H_&K].&%%J/F;V% QC :5
M/N1VLU6LE/,U;H81&EAW0M1=1Y^OGI_-$Z^#+FC!^9=G<6A B:;4,JJ4.(SW
MU]R@#AH@5NS//V/M0 .=):D(DVM^-/#AZOSJ2CQM?9D/&60Y#=[D21<\XH@<
MNEH>Q0.9'OEW$B% ?5GS]TQ-+!9(%74;&M.*FU;A\47O'OB=)*>.!V]6%SLI
M.I!N(DAV0?\>PN1?/-4KKAN.@(+'2JUZ?:P9U^3*F3+C^XQ\#P>,47M) 1.N
MM:MD'OQB;DU5@H8>%K\(W#_8FYC06.#$0CYK<.D\]HF2F3G5/400JQ!?TX(2
M%7\HAJ,!$(:C.I0)&E!&'B,OW?0B:#KAM<9#Y2I ^O1AF=B7A]@#Q'A"@T/@
M4I#>:D+J-06!IS_2K;XC=FK6?6[#+);LVMHM-N:A;C,S/FNE@BMSUI(\"1KX
M$R-BH)X)F-,5_G'G\5XE4VI,T+WE$(TRR*,T'1^O %XC8JP8W!1M(WZ)O-YJ
MEE]48=*03O<L@P8+SD&2M.4#T$I(U7!Y(P.^<$>X\*J899S#.?']?!1F;%K0
MMPCD]34F$?Z-JSE0DEB3F!6-ZQQM=TQ[_4R:&OW6(8G24$7"W+U2SIP$9*P_
M)@O^':Q++4H79CO0%QR%N 6:>&(^*^+U2^?LXW1,!_7C#EH/-- S!P-=D6!2
MX@\=S/HQZ2ULA096I\V+:?J'6 9?C@GN&OWUBCI*P(L.DYC]H-^X]7VM-\32
M_?\=*\M*I!QBQ!PF]%)<*D!+?^>2]U"RX#$RTN.GJ)6B$3ABI/-$W!4-_-I&
M _6T7RKI/WL4N3W2WS7-UYA4I=ED>:NG2@W\"SO613D:N$&+!M)/;=" -1_H
MBED^K-%*']2MVKG5M@!:(%I% ^HZ5@+S]>H(Y]//8>Z\!0D+HW,9_:9%'331
MO<D![VF9!F<XZD_FM]]/ZN4'2OI^*F089.;[^.U:%-'9"S'HR'8JZ_/?#U6K
M39G;&%@)[E/S\XFJ5>M*NR-(O_WZC+TIX9)]?M 2)ZY'XM)\+H>)4X$2_*[M
MF;FB6[B%T.O:BS$&VQ6U@ZA'E#.W<L8-+03U?TF%"VW2]4W06EKM,09L779\
MK)SPX5/Q*.D5&$KW[^^.K'#86"G<H?3 Q<GIQ)#-NG&PPAU9%%2^(4 %$D"U
M,W*UFFRG'O1.8 M,#7\-Q.'>.=O-.19# RD*I/-R*DXN-J7=Z\C07+<1OI%D
MM>'A88D$MZ!4ZYSA[_9JG)'TL7KOWK W!$PD*]!]@1UEA']TG;OM-./N?EQ5
M>IHGQ#ZMC91.>\O[JE!^IMN*J=.;]1;12&6SYD6>?"7*#)&U+G13A^R+]AL0
M\[M *N?S2_&VP#WLQFS&J^2-DT@2S>@Z:<[=G-/V4,L9.;V*E9^0RJ4L2/)6
MI=CYS5O@%&T-Q?5O1L41DY:\W\*4*Q&F([VGZ@%>!<[W7#+,543'D]F'^ Y-
M+"B^TM@;+(.QE;MP:+9FP8'M%0\:ZWL2>,LY,=H!2)T>-' BX*+X:X_\.I)/
MNTY." VPSV6@ <M7F+J-#=Z?,F,9#50I>+/VAC,9(DT9S7>G&]>?;5XE $9N
MU>9LJKE-2KWGSRC%<?^D;+CU4*\M^NI@7EJ5AW[$7_1CQ@9>JT#?$W'(3<:O
M'5;?-RB;,E@<SQ;K1ZSMOTAWE;I<WX71[!0S+HQPSJ?Z"Q8FK"QKB+RX2Z#;
M+K'E@4-_: ;;SZ'Z4>8,,W[5(B+M4*\CMD(XR 3?E15=Q6_7[N#^AE+]9&*F
M[L,3=WME8 .J[$4I3&W]E42XW*$NQ5=ZS[S1%(+-:X9('*0<"O6@*6INC+%M
M;F1\JFJ3)"I3SI,5P^ HK_C&:7$UN-JR'BE?02?Y2HNLF[G^+=M 1L@[#TO@
MU6ZJN?]&R[)B'VU:\%!UR7P%>TW]2;JL,R1(F6A 5\[]J6<V76JVMR9CZ3KR
MD.^P85*AD;DJO]3D_N3B$,= EE^FRY=M:FC*ULV4+G+3%#?7CXL?;IT@HOL3
M22"U5Y^4F;>RJ);#7X?8!NFF-AT.<@!EFWGO9@U@\*9&JE'!Z?.T(C51+\J7
M!H2\M/*M1BZ<44 WSURK;"K-@N;ZXF#3S.%.&VW67+I9#^OYJ9;?#O\GHN=U
MM[;6DC_8MM4VE+RN'F,BJ2ESI6.LO^H_7,KS&.O-YLP /&U]M?%QH)_/]"R8
MG"/O9( ^@XH5LB4O2R_U,T>S4?P3!0E\+Z#WJWX$^OQDG,MW$5RG/J?L0P9+
M.0*;IY\-Q-_/9$IZF_<$CA%7Q"^,T]^*ODA0D07%YQ'50,>B=+S<0DN'Q0D/
MYIB^X^3&?[MC,KUM?F=<-N7=W&M%,G!HYF1QHTO5$],TQO$E\QL.+]D%?)H;
M\E10A3ARM[#=Q@-([V\^;<OYN:/".2W[</##")4VOJ?&GAEM!TV3FV%+TTRE
M_X_UA_8"W@Y<<LL#PB_4I.^V=B3Q\8F]^5[@TD[YHRZ86&-ZH[GVI"@% M?B
M6BZ9R";(=-%7JOA:@4?7$OU3ZK.A(F&%P3H=;$59^OJ;C]MM!Y<7 A1)P*>Q
MKX%V,9PQ:T:LDE&>E9,YYT8U8+6W*DR/3[Z\?:U!\[K"(])05=H]H*+=3&-&
MS 5GJ?F4-L1CH3S=+E,$ITRA\&[P@>K]Q#WV=UG&.=?W-'7(-<H1SV8T.#5#
M2/OT->E-;E)*^=L:&*\UX;"1OWY',L_S:-3D)0_GB491Y52MB.>Z*K4!%<TA
M:^TQ*MFT\RH$=*A:35?M?)4%VG*=10/[(VC 5<#&"N$.R1I(+?I1D "=>/K;
M]/U7=A1FX*A$T%#(%S3PA:;S.B6OPZRZ[)];<D@A2BQD5D&"6D_5W3' D@ZZ
MDPM:;W<SG5GYT5VBX\*D[#Q<R3YL3QIKK<1A/<@\%IC%@@_E9%&$8AI4>'!\
MLB&SA XX_#/Y<NY7MNS@D^8%'K;+PPF:G08%]I;I,](G#U_:2;0D]G+VO\["
M8^\/? <['P\^*Y\.WM?+[<_1B3<1N%XNX4KRYE793G/!Q-#DQ,-'Y)26\<[V
M8ZEO5;)4F.C'?4L%#R8MF9B._%M!6#D_'Z[HP]0YMFAT[STB$\YKFROM58QM
MN!:!5K66*V15NSU9L(28"N2]^&S./[DD^NA"[>)I5V'CZK[Y1$R8'FW&QF:%
M96%+R]*Q,;63?\W#0B!MP#QH[ZDUC'FV,^;8G\;XNC\DQ"N<@T86]57?7HG,
M)TG[8O,+2BWOJRG+A!M288]?T;_ENMWS\G#\]65*>DT(K7 _<UU(QI;(%E,<
M_J[!U;3U>37I+/_F]"_-$>,JN[8$PCS.IL2C1Y_[\%D&&5"NR_/Q1U4HT5)G
M[9I$/J;RQ*_93X^%1'JJ",<)^EOL4G:K@H<+[E0NR/H3\194**M2Z^)#(C"=
M19J;!AJH?@@ZPS(-R/Z'OCE] 6Y7BS%_.UZJ EUY'^3W027PW&0V0O=;;:I
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MCHQ#O&ZW]T.>;7P>[$CY)X=P-' ZH_<["+XA_^,4%N+F)NAVS'$\N%W48EY
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M[MGS">&UN1OG=4VQET_Q:X^N5T;UH(3U+%;DPM.3$5??(&1I6-8G!X +';[
MK(P\U.$]H F):E[PU0<%5DO7R;V7&V[!QRQ+Y@=-*0\-GG;#DRN./AKJ\)S'
M2MSN.3&BP06!K7J;Q>CF=.(S!>0];<"GW."FY!R3U^#;>H4D/4J$^EBD"SG
MK^._#,_6<56DP.1R299;,;%1;O!EAF1C.?..J<[2^[JLI-O!?4YQ@A\$U0X,
MRCH4PA3C^G6#?=JT7"%MTXN+G,)%*;&:\7.: :?8KUEL15Z/A/W66NOB?T8#
M[CRH4U?%WX4($<\_)(3"T<#CV7KZ,$W\!;&FS-#$[-N94J,>MY,MN>VQ'9R8
ML%*]^948.(V>K),S_.B0FS0R^.:5>=WW%9I%\'6(7=A(70TK;2:)QIK@[ -9
M[Y]SB#L!F/M=@QG0[SZ'"B+%._^< +7.'TB]_HRX(H<7Q^S_P"%JPPPJ+'Z8
MWCK/E F"%T^)W%T$[V,#X]1MZ1*![-@6\;@Q3V+L(I5D)OXB'W[KU4?2SB@P
M&J#F?GZKY6FZ#O4Y*\3G1>;#(T8LYK3%W,;7A7)*N&1-6U2TX-N(7>;!A'H/
M; $VS7"OP ;#+\4+(B.WWQ0J^+I??86DBIP@/ZJ%D=A&RA?^.;04F-/+N)A#
M\$5R<S/2\:.'36/$<H?_<\DSZ0&_E%\3P><;_BLWYL5:7?P#\K7;FNK!2+.5
M(M\1L=,03>8V*0%1'BJI81LR95L"@*7XS[-FP[1Q4,-?P,IB^OCL1FPHJ<*F
M?H+XC-X61;_(@VK_SZ4'(SQO.56R1EUNLU'S6>#WKKY,A!'&?:_ ]5'QM/RY
M(8WZFOF$CYU3"QR2,,+TB&G[@H5V$3D.R$O^J]*<>B58,59<,_V<,[5Z8^<#
M\O'@6D_5G;6=GAFH^$PE^<IFV[?O[OOR$XE=Y:3(9VC@]]O^H,SH=7#TQMDS
M\H0 #P8PJ;Y=J;.1Z:(Y04_E8,;V35RV4PY;AQ'RUZROJ51N6,6MTM(-SNN:
MF1GWV#_-TVQ-E.WV<6,L&N#-D0X4RN&RSW+I00-E&?)X2O)_2944!6Z<@9'U
MX[IW#7E>UY.=4TJY$INKTA/KYK3-L'(#:&>\>#GIDYZ:7 ]1'9GH)6-76Z?>
MD6W3@:^3;$;O>V\PQ3/19T2*8!VN_D% ZA_@+6]67'^CPCR\:V90BK<8^QL*
MX4RM]C.2#_Q(1'F^;PE'BZ5D5'T=_NBH@:>VE*\.S8\?3#AKG/G8>.)NGZ<*
M?M5Q#+Y?6>]XR[M*V6%KFZ@APAT@Z_R_>9(DP.83\:/.R!L3#3N;,W=6!N9F
MS7ERY4XYA>_8DLTNL_$O2.EJDPD;"Z.,$U:[GEUW?MJK-5OY\63,*:1D<9B+
M>YV *.WK_5@JKZ1RBK:'DC>D 9P9-/"7YP6=Y54!.[0O?<^T([]DSY(K%G98
MW-@Y9TA,D^RQF3].IT7/]6B,$6O[:.5AEZYE_6W$DM,,F\V'(9:4+-/ ]Z#@
M\S1P9F-6&;$*Q0.26EY)B9_CM=8,RKI=5(!\[G^/#2VWL,;'!D^K\$(J9+Y-
MHH%Y163G7*243H(5644$7S"K+G3NHX^/ _-0@G&UP$.J12WJ1'[]$F4&(U4I
M#GQZ>;<8K\AG*TTU6AO5\:9Q\=4;<V?MMJ+P!XWU,>[%5!5Z9N4T*K?'+T0T
M-I, OE50[>WKTVL[%._UUSCDQ$4J] -YCCL:L,\EUL+1FQJ,KV+PDA,N#[8?
M@1L,%_]:7 )_\/P9 X\Y3MIZ.H$4:(^M%3\D[Y_>LV2/-I!Y7[R522BGYSE=
M4)/.'?^%C(&=A$P9]YPYXM7?!R]$LK,>*^XH]D0JN,Z"''+;_089R>,#%%E^
M,C9/>8);%S9G/*C43RM@K79X3U\Z=CL111Y)CRL\^0:YGI (1 ,$*/$UE8K'
M\$O!<H_/ NN1GF][0^$?8OPB"2_\\M[-MX#L5:YV48,(O:LT\O/\4]9U)5:I
ME8AATX#YOF6S?KY*ZKJ9:OM9SNGMZ8]-P4<K\P?;4QI!O(]MX&^'QI4]BLK6
M=Z]>_5K%__',HC163LVI28%G*D#"V",=,J&3,C^V*A<XQL$-%R3^[&$(^6C@
M8V7W'_B[-XCDFB@M_\EHE2)8$:8%8BG#J_DLD4M=LS(($AF3>JAI2U61^"7*
M)T7%L9Y?T4&>XV%RY8%X[B?W+(-OXKSLZ5R!R?Z?K!-X$^T]5]@8W$D\Y1@O
M^?Y.6^I!/*@-#;Q% T3 A03K0IS.]01,_MT*7U,*J06[L$KI E=QFY]Z8);P
MDB:VY!O.YX5/N:C8GC8-F'%\5Z! B:2N&\643,5L!9W32698F2^I.&=^FGJH
M_D!?&_MS4IWH+=^!=MG_R-=@08/B/R4*R3,^N_]_&E?D4[L870Z\@E\Z?H:(
M0].E;5LH7F;=74^0H9+D  PB[WH/DI3B!JQ^IT #(6A ^)KZ[XFBB__"$H77
MV0*M*OU0G9 I*^!M2>J(4\*A<KOY55NJ>RX:\%X3O9LI0N;;G;M3E3JX2C0_
M&/H $E5D^$V%^7U[?V<^5<MX^M?I.SX[%8G4/C3#[Y-YEY&]J4__>8;)92+7
MKW;>KUGA_Z 5858]"[T2W\Z&L=C&/G6R+H("^,3I2H#?DS!EA%OXYDA<(XB"
MR0)OVV/N6#M4_$UW@M4]^;;6N/3#GCH*%/L;@EZ?7SK_SL"_484S?)8?.S]W
M+54/PRNO?F_L EON+1UPG[N3+ON2\KOC:^'3^P2SNC>4(XF]K.GMU:%B0DEB
M($J-BHKYN>G<\B'3Z?.ZQQ8+;ZU 1T_+^1\WA4^J4ME[#,$[_R-7+ D+_PQ2
M^$=EZG_?>'^B@R.,QXOIIXB5B6M9D86%BR0CS?Z08Z."Q[M^3=P1P2&L)_4I
MVQ<I6Y["^XK_D7KXY%$>ARB+HGT?<YED68U<C93EV,,ASE<*&WV['%]Q5GVJ
M5*P0C.)H@,K8+7W_KM#'&4NXDYM67W6^.XS?2NHDFP/\L!'UG6H\,/KV8#VF
MSOYC_6")@#"O(S[D3+Q6K!M(FHO5ZE5P>:>PY"2/;_DFMRSL#G@6?,RTN&2E
MM1N<MRVH-<Q&[FP71;].^"Z*\B,5$,P_-LC=KOD?)>U)*VOL_.2//.Z$8\M3
M\7S*)?Y&R)OBLN?ZPM2ZU,_E!H3S[\KA"?;)9NW&E(0I(C3Q(^6T*G\&SJ>U
MMU\;\AE[/."B&TM7XO0>'%O@/-F\,+)W+I\P_07Z?TBI_\0X'C;_8C#IC/R+
MP+2Q>;^?5[B;/\>I7-E:-G=RPI:GQ63D2-H;3GLGCK>*! XMT)*:@I7]V">5
MXK-SA0$W/B3G'*DE]?,KU;D;O["^RWR!%42E/%']SR6<A3V"Z"?KHMO&\PT^
M+X26PBS_X2>%K);ID=#@PU$^KYTC''?>KHNBXR7MIP>?_!6_GZSV^KBT.,0V
M\D)G;KID91G>-,/+V=CID=(GQ.V.5%5T;.#_2/98Y88R>_OTOUY[*DE9K_S0
M0.N5ZR#\@>(*:!04H^5AQUQ.>[\O+?7M-WQ9F.R&6A8TOWM>@6O.MC6GA_"P
M$B)+'_8]>S=/BH,HF^%BVRK,J?K1R8].MU4R5[7+85(FJREQJ6F#*,G9 VJE
MK 8*<-VBL(;VSE,+-' 'HHYU;D_^%)&Z]IYI __%[E3 !6><IEFBVP5GBAZE
M84.>[ NN5"R5OF;XF'<JE'P=7E-A\2!K6NL3\;*.<>8*TY9@:ID9^&:-K@A%
MX?N\N#QGG)XP$Z0GHE%C7NC0?P$E*O=J[YG\3G[1DLOY86BEN26$'PTX1?:-
MUS3;&JA$SSA)<7=$(2IA-2A6Z'X?I#36W1VEM5%)U7]4=2;UBU[%!6GKPG"D
M=C6<0+W%NS2(I2Y-S7GU]II%JQ"1V"M:V;=7M0<) ,/D%TXW4GINDU9 7V&I
M/[ZSHAA/7AQPODJ.XBD+]NN#V$]"CF; %V)C;D_B59FWOGX[=,PST#L]\/CN
MF3TNK#0A!-L=3+T5;*4%):NS*T)$[&K#<&5,215,BF5BBX/\?W+'3E*OXPH+
MOVX]HL>7&M">Z#V&L.C$K[(&H %\ESE,(>GA*]T3"'"IH.4ZWDW9_?IV<%SN
MC?</,I$Q)HK 38D H>_YO:;G"6W"&[E>%(CTGO/[4Q^GP+O3XL*W-%V;I+I4
MWJ\)[N#O &21AH,Q(,?C. 5\Q$LT0%@=U\97\B-G=2%G1(*VII?>T'>,>U8/
MV?N^N&X8ID2?B0;JXZ+%R1E=KVFG#^L]-)]^<?MA:V;,80/R<6RM\EACL;9C
M7Z]I-C NO.'8_V2ZT^T8WPTBF/'YQS.=^%\C G;Z,MJ9<--G.Y?;'CE!QK/+
MVA0<'*(V*N4DZ\;)9J#O<3V0H)?B5TY:,P'+W![6*P^AQJL7/F9C_HI3//$>
M7P,OXI>,;SOR4K^;YRB['KB4R))\X8ZB^_R3A?:;_WOO?2H(9.5>:" 2MV&Q
M4L,0,CJ:LO[2\/80JS NCN4J?!#*M?M]*VK:(GT:2:9#L6))#+!/5W)D;C!H
M#9C=W1.HJ'FMV]<@<;25((#T"I-/[>V$^*I\[O6Y^DCV_BI79%']7KHS8_#;
MK]/Q!J9B88ZZ07?,/2_</GT#.:QB(4(U.Z8_UK8TUW1"3X-=CYC*,T$*LR5Y
M(0RYQR'57*.CXP3;33@TV79(082:#L'2#\,5#AC-*&EPK:;?55'ZNWZ&%THP
MZGLBO#QW81FM.XJ28E@^(%<=@J'-,9P>88CK1/E/>.9O/T.[Y4AP%!1BMAF"
MFYQ<ZI/,_"2YSTB^)&(>0EH:N]DZRQ\@;WEQ4[^CPP)'RU&35&'NTNV)GPCX
M10P>+;(X.T&:"!_'H-.>%2L?H7J;O +D&.SBWI^9Q05+7Q*ONTA38-946VSV
MNO-* ;!6I\Y:K:5[?G3  8[=MYRV<Q9RKV;LU;M7?U4\.Y/UQ'1<Z:)01(M;
MXM":/G(I!V@E/]1:)\YG5%U'\/_*WLPP;)S$JV,NR,4*\'%OI-W?\5I2*4RB
M*,4_MJ;0#'-"/MA# ^1AX=4_, LDNL &X1^PQ<6]!@^NZ26K"3GA*LWUY\ZO
M 8 COSTM.1@S?T'XW<'3W:2S33)7^?%S]"788BT-C9K!!FI22>J,R9V5.ANI
MD1UTL*#$71@7&E@$@4OR'S5YW?4N:]5YO]NPR2SY=;%=#9^:(&H"_ARZ/=\#
MH@J^-M/2']&"[EOV?S8V7_R\8C;B.EJGIBNMWU4V0!^=-N9'%;$005@W#Q[C
MT*N9%TML[?78240:;R()FK,_UHM69S>%%*N0?DPHOQ,>.>_@ Y7L-5+ @>6_
M8#W,_\["W]+1.N-S[U1NI$% 8F!P6$1;2JKB"@3W@Y;&RX6Z;.QF/:V=*=!\
M>,11TWI2T&[F* "\Q6HZY%>&C#0Q5S;Y*(V+#K(VD+TO0$G#G!+"%-=9*=T,
MGZFV37W_2?6='GRHU.\ML'5'B@?+/"..R$0O 0](:]Y0A"0J0\\3*L.$@@KW
M32T;0>X3C@%,SE.T^0?)?EM?J(ZE#.Z.?[8C(3H>X\ROM8KFG$0I%V!ZAGCM
MZ'(S"].2U*M/F ;BB]G+%U.YP; 8;B5ZVN7&5_<(;^1#AQ3(,_I9%\\9,]N#
M/HE#K+XZM:O=M"!6K %/(-LRG5]^'?^F<9>..U(T0!$B:C)U38:BA:7"&5TE
M.R1;IP6._9$$V<L1TP[\!P+=/J=>R4J""\#[P2;VJVHY(:ZSG!>U.@[KR'"\
M8_W6^J8O/I]4_&Y<FH@WZVYYG5HY=I$9EY&FM&?6(!407H8(T%HU 7&EZ4!O
M]XGI1)&%B<6%D;"&%TXW<=;B*465!J[U.WO*5][K5VD=K-P9$OEBC&^V@A@M
MQK-\Q/OW&4I/C^9.-&.]<4)VUFF5UI(HNP9N "(ZD-Y>/2V\O&MFV'U$II8.
MDA/AOL"SN/D.4C_E:27J./A2@^Q6M7E:=,*ET6'JFD"0)70\K52UW&)E_YNJ
MSRW;%:F5)?F^S'[[Y"T3AG1C>R-*_ER)[2_WM+WB.^U#S<:\>F5BLS<L'&61
M'@&_WEM9MG8*?+:@M!.H8)?&]F"29",&"W[KBF[:U=^'RT)I9E/C_"^XYG(?
M3885LN1S7:0S;&G&-IU:/<LT831T#(H?L))RCP2 P5SX-VA^C'NI J?+3FL*
M&C#4H-,$=]77U;:Y!>;I<3:S4> /-;^-O?N6GKGZA:(+.5'P_D9@\5HRLU!5
M #%^NG0UC>T]_ >&-L]OOU$FD6A5^[1T:&<,:3R(6[/0WY!]G6\R77VC'S5E
M8;P:HC^<E:7HDD?KT4RX<U(<V'(:RR#>[(:41I@N;M17IVXUS7J)Y][ASAEF
M&NF48%+/Y""^L*]^2V=CS2%H9]'W.3H!]]F;__*/L4:Y$9/S$'@&5'/ -#].
MO/J 645[JJHZ8NX5H</B+3*D'6=DDK'0N(JU9Q=NK"ZY1D&33N**5 L4%&>G
M)4*\5\^'?%&KF4LJ$:YR@#6;:#Y$S7M@8,#DS$&"I'Y%GW::$@<+[<_9C0X3
MJM (+=<H=5[!G13?1]:$S=$]6=+DA"T_NIV.A[1CK2-10W+8<"MS/UP PC-4
MJ76Q_FFGV<J3G?(* "5%4$^+55.X/?-/Y_MY^2[PO**A9WPY#=?22&M:DQU;
M!\JYT-T-L#2JAAW"Z@;S;D^'A5:$)X1^:I-?[R2#N-6.E/Y,=+GMU-*LD:!F
M^\JBI;@6B_B-S@J%]NY]UK5..D0!:Q*C1<P!Y,W/G\^JFKU"^"S-QDIRG3E?
M+89G4XYP/*#E+1HN(SNJ=6C( 2X9$W@_8/_3OJX@YGH.48]F0Y)NM?A9_KQT
M?"^_Q4EX.VH#3N]P5V?9-ETD]IJJ"UY%M3G0,AX-#=K@,-N_J>7W\:=D RUC
M_4A%77&+F$VQHTW<O9"4UK>LOS@BM#6 <U>^7?IZ </-C9B)W@LYO0KE]=SP
M^VLE18U%%K$6,G,^KI[DH_?!)V-#X]1WAK'KX]9!J99<,)X$!4+53\QVVO4=
M$E]^.OAKIN'5^/@4FFO;4\6WU5#[$FC3=,#>O+W;VQ09;O GQO%?1<P)2*)X
MERW%O];D(+6B]?G0@ (YR#,+LY*R[YG"P[S7!RL4KI,S!),/6E$%['/# E(R
M*H/A!/4>3QY-WQB[=,'15J<RY7W^?I/NQFU'):2^'-:K,2O'GSD6><TE%GN0
MY I)2/B2UHW^RA[\%.,%&GL'.0IEMNA]0XYDVV0]O%F]2'G@@U-/$!7*^:0$
M]F@OC]V+DB>:NS;ZJ8RAT%@I_"Q44[7.NDT"J^BDX6A)M%'.Z&,8]V3 UP[F
MZV_G][XCTJ]^:;9F@T-0&D5M1CD)(/ON6QY;;0_M1P2[B.P/>TF_T_QRH,:"
M-23R#!!K'BJ<,*52&W]WR<EZP;\V:3,UR[\%SH-\%Q<9VCJ"Q!0M@Y]3/CGW
MZ;_39@$+U,$)'OO0@HA58*^@8PG/AQ,Q<P\KEZF]"D\>51K6JN$D&/T\U/XN
MZD9XI2H0]C(D!!;7LPI6S8H[K->A<LVCKV^?3A_>.9DMC=;]XIQH)7>B[K+U
M4B5+=T),-;"_GOYF'I,Z;'Z0],DCF'N-UJ8'-W&RR/@1]ZR866)VI2 (++%T
MG\CD@?() 8G YFMVU%!;&<?Q(UZ<==+0P546'FC^"ZW*SD2QUQ+/T@=#X-)5
MI<TS5'N&LR5/IU$3MPLX"W2HF;(4[',C>7ZD1E4^RZ=3$.Y:-^RS<O']^FIW
M6$OY[$?R-QT$0:/=T7>Y'/BSTI(?<!E%2$>O$VDII-2M#/6:>&=X8>DPI<);
M6B$J4E!/E9K@?_+?PW?;?R4WE-GY.(1ZT6R_[_.@GCO]$+RM1N_P1Q)TCQD7
M1/(-ED)ZP^6W K\-AGB_O#5/3$_UL*S5MB[@=I $UE[3Y9S!1"1*-.0J#9Y*
MMB>*!NQB&+VR[6Z&OQ!<+KA5?02K]VFDA\CS!?XG$31]:: ;.#_X=O5EX+8D
M$_Y;.]Q7N2V'0SS,(J[]U%C1 6NL)%8*[\X5;DUY,FF]*:EU<;>U<^.0^+_V
MK6+3?F6QGYTQ0I6OPW1LE!=F1EU]MS%UT<MO57L_'+WZ=^^:3-L#C_^F-.3E
M-:^TU8[";OOJE9G3JJ[-+TQ>$>58FUS09KEV7;*0N]8\KDT;%)I?9/7.;R[A
MM3MWZ])UY\NY:W,3IEWC4-S2*Z21HG!22D,BI&A5I#M[QGFO&XL:+)?]2'WP
MT\9:KN&>R(7;3GWQMB:;ESOE3O.K*Q2[NW"GS6.;67>F^VZ9^^:>=T1*MOEG
MW9F+60[\EC17E]>\\6ZG[,QVIZRSJ(=X_+\) %!+ P04    "  $B'A:T_;.
M2FTC  !<+@  %0   &%B=G@M,C R-#$R,S%?9S$Q+FIP9^UX=5Q46]OVIEM
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M%<$F?D[HI'\RH=]R9C8%#A!R9CXEW/:G@6JK(A+@\FEOY_I,S7BMZV+7>:S
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M03>G.G;YI)>V0IDSW&?U9=W[TL%>N\WZ/)?LJ;DM4:\1_:):3[/;3FQN:U\
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M('?B":3QC'8<;L.*%7I?<OXWA!,KAX1W9139J\NJ:V*)7.RNW27,B"*[35Z
M%43#Q+D"SW!9G!-</KSSVI1JWZ:B1SKG#6$!9N]0E<]QP-AC)8"VZPL!\PO\
MW?__LO^]X\27=T<LJQMJ_&3&=DMF>UR([N3<-(^HC# ->[]Z1EBZK$8R?9+9
M2>23&WNS]EW( 4$&LQ)%^2T/2W;R49,(DT)^J6N&L'\')/,+C#H>M=UBVI4I
MXRWM\3/<!)R]W!Q0B5EEI$7]P]'[K:[HC_[J),^7BW-8MZLK:D:$I<54:RKB
M\JI#AH=OQ1+0ZNI^XL30*2QC=[U+/CMA^3<IW_!B(O85GI::UHI_"<G:_";F
M8F0XLQD_-%,\DE6X+%MXB,N9T1 3\^::H9:#WW_<[<V&](U_5^!W665IJAY/
M_ T37%[*ZK]!@)KZ-U!+ P04    "  $B'A:G[5=>)MA  !;=0  %0   &%B
M=G@M,C R-#$R,S%?9S$R+FIP9^R[!5"<S;8N_.(D.,$U.,'=81((%@($)VAP
M=QL(,$C0( $22""!$-S=97"7X!;<(<A @,%F+OGV/OM\W[YGWSKG/W^=^NO6
MW[Q=U3W=O>19ZUV]UM2 G$6N (3/%)05 !04%+16M%8 0*ZBP&T]/5TE>'F=
M/7C,+%W,K7@L7)QXP6:NO/P\?+R % CL:F;A8.7YT-S*QLY9FNVH"<KVT,Y2
MFDU/6)5/U57.RM9.R<_=2LM/3=O"S\%"W)(-)(-W7PHL 79R=;+R-'L(=G)T
M]I  2S/^05WB;OS[8UY&&2EW2VL)S:<*?]]Q-Y-F_+LL/CX^/#Z"/"[N-KS\
MXN+BO'P"O ("W'<[N#U\G3W-P-S.'DQ_)_#4RL/"W<[5T\[%^>'ON9FYBY>G
M-*.7EYVEA+69M;"YI:4PM[F9H"4W/[^E&;>9I2 _MZ6@H*6H,+^8@#6_.>/?
MV5M:_(.[JY>[XQ^\+2UXK1RMG*R</3WNT.#_+;.EA82[G8VMI\??N#]Q]/SO
MB>]H]_N\A*.9LXTT(YC;TLK:S,O1\VZ1]V^K?Q_<\;E#]=Z]>U*\?Y* ]Y\
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MVN\Q"6H>DYJ[C]TG8Q9:98']5NT/S?YSBH7\/]+L'XK]NU[S "X:RIWQT(@
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M*X<$VL"0CGBXP@T]$GC<0H $4%:1P/WV\?=U"4>]4ID$X6_T^B&?MI% E=S
M%6;%UJ+PV/6SU=1]U0QZMN>S05D(K-%5$R\D@,$2M76;SCTM9.-R,&@11@G:
MVRK+$9K])4TGJH(Q\5-CY*73&[=PF6Q<Z](_@5"FB*6W5\.@.;-I,V"QQV6E
M/,RCPW3\5KW&\EVOAYUH L^4+QGQB4)3,%?H0[(VIJ0X]>F<N@H5=1X/W!F!
MP@A"Z2I?J[J5K,^AL5GB=/7K)8$__T0\ZUIW$ &Y*[".]I! ;,#3^M!4)-!D
MCP26D, !A*E+GSJ@K!-Q#QYZ7-BS&<@.ETKS?8R8JQKM@VPWZAW*ZR"F*I%
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MM3G//Z;8FLRH*@MW7H<Z[+?HO6B9Y#XL*3TJ==8>EABIS=^,?/SU366=3AN
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M)'@/*D/&$NM9U,V?,,5U3:F3@!6?P7(_<PF_=:F9Q[0^N:@,;12-V4:'X,:
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M8*!=NB"0I8%O61+X[S8WGYCH<#[?0>9,"SDRN '0?S6L_M<-_>\HI/U@==C
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M6PZ5D(LAQM)+ %Q5+[T8U"%O)4]6L5E#?DE<U61WAKZ4!+'D!&-ZYGWC1RO
MH?R,ZO;.\B8;3P6H[%D_F)*2UJBR(6YF/#<2'(]^PLC\9_<#"EJ1T=.W,)2)
M$B50];F)'+!Z757BVLC<I\6'IA$E'Z_3U%U3K5]RG[9+J9<^S[T:TH<F /%*
MJK/KQU G=X0!I*[=R\HT.+4FVX13_;QM?$[E]:^X]Z2I%^;\V?H\;CG$"A6?
MRZTD,FC0]LG<57R8:_K9"]ABC X!>.P*/SLGO'8#<4PZ QNE!N\S62 W^ @
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M\3/_BP?,_TC [W>><OHT^A.!GW#\B:*I[1-T;D\80=8 E.+NEF8 @)P<@ X
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M7EW?W/Z,"PH  _7']3_&A?D4%S0L+ PLPL^XH*#=?B[ A(5[S@*/):*$8.B
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M<275I-KF,Y6RZ:0<4WM,3R^3\"LE8DM3:#S?%J? D) DH/RV=:T!1EX^7!A
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M)F,MD2+50LJL(V W4N20A@'ASN-$5#OZ%K_@SUY4"5?&O+[U^6H9S=UF_E9
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M#36Q]8BTXB-6VM0#A5HP%7'H%-HT0[!A+:R_FS%"*;.E0N-=ZVI,DD_R"@0
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M=?3"VTE&;^T*74F&PH*>HD:=#^%4#&4KK>?0!00,*L0I$HX#GWV$NI;AFR9
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M4"@:;&"8#DY?_M'5ROAM1-KJIMI)QKQ4F@R.5$*8K]=]Q),;L"9/XI$/:WM
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MS%ZMI2U=\K68T>W\<$$6BPRL5C!C]66F!]:NZ[13GP.[-2P7JA.;&);$&6L
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M@UAF>>4G@%&RY*\9#I$2O(!ML$;)<J?YG0*,PA%=VH%&>H(&G\W3^.;L*"&
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M1AF0V=C1?^.I0->#B'IM/@(BP9GU[$O[<RROV:R]UJK#F5:RS=VDJ"X0/[W
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M07(='3AJMQD9O1O!=N)M[TNE=[A7$BUXP4XL*[S%NS/EC+OGIJV!M%6APQX
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M0V]^PMQ.^?8=WTK7/$ JCV6$GG0]T#GF:FCPRP^"=T$;%IRX3>V-U6<<E0[
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MB]/UFY-9]!W:1\*%,+0+I9U1O)WCR$(\4%-"K#_C_/+$U+K%.UKW6>/LTC,
M6(E"Q!.I]AH11&MQ]_+Y([+L?DMK1YPXHYC=\^-57D[:K;HH,<1/\MWLL/4:
M"O@P52(V#<LO^86)W:_18?2^#SKF>5QK!6_C4/T8CQ"0YQC$<NS[>)QTOC,
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M(/@/"OC[D5N=WO;^M, ?YOC3BE9.MZ;SOK71S3* 50%J9PT J*L#>   P%T
M5M!'P)W;'A;@[^UF%O ,@'WGSA_?VX9S^\6]BXN+@X-+B(^/=Y>8D)B8B)"(
MB(24_!X)Z7U2(J)[5/?N/Z"@I*0D)J.FH:*@(:>@I/CC(EC8MV-P< EP<0DH
M2(A(*/Y_MYL6P/V[=U:PWV-CL0+NW,?"OH]UTP$ WLJ*B_6W]N\B8]VYE1$/
M_RX!(=$M0^4]P!TL;.P[.-A_2'U[UO_V/ #G/BXYBY <W@,M,WQ65XK'@?%?
M[K+)E[92:H\@V(7-W8(("*FH:6CI.!YR<G'SB(">B(J)2SQ[KJ"HI*RBJO-*
M5P^L_]K XM94-K9V]NX>GE[>4!_?X'<AH6'A$9$)B1^2DE,^IJ9EYWS-_9;W
M/?]'67E%955U36U=6WM'9U=W3V_?Z-CX[XG)J>F9Y975M?6-S:WM'>31\<GI
MV3GJXO(/7%@ ;*Q_;W^)Z_XMKCLX.-@X^'_@PKKC_0?#?1Q<%B$\<CDM?#/7
M!ZR/ ^]2R,=_*6TE8!/61E":NXT04K&++',@_X#V-V3_/6!!_U/(_@3V'[AF
M ,386+?&P[X/D 5<ZV1'<@'^&97T-\^P850WPYMWMYO?EXRKHNNOLV77BJ%1
MF*9/%X0G"""]F"N<4&HBDJO$XR@HDNOSG;^BM[8E]M=9 7=ZD8H7!X?L$/\G
M\X'>+<Q!/)P@W '656I1RSB*UGTU4\?*YI8!/(1MM9H=_Y:,5GRV^'RZ[^5D
M1L PL'SATY>M]HY,^@RKGV\LH>. ^T_W%VN*H2L4&6FE!=FCPQ=YD51-7U'/
M$'%R2.HV:3"XOCS2L,9PS4M;<]YB=X=WPV] QO:@^([<P\[XMRP:8NR^>L/?
MO\WLV7")%9QSC1XO?,@G"7[OSV/YLR8Q*4A>^L,-(,1>C@1?9#-D>7GD_0V@
MXF[NE52]^[J,M%?Z2QR_?'OKTG2!8YQ ?Z]T.$^8D]BF"$#;GP=>.N<POZ92
M/6G7??0-U!!?O!'3<LKS%+V%]0$K$N;2*WH_1_P&8*62FS!C*SOQ?$MV1IOK
MSF-A)57>8I3.LM"J,]#V\GG@.VH='"^B=&(F>\-U]:9@E:H$<;)&N9)RF4=0
MR/)D6^,3?E9_UAEU164BO@%Z&[$N]\Q:UB:IM 7%U%\N35T6U83^4.S(OB1=
M+:-1CSG&R.F5Y"R.AO=+*O0LL@O:/,_+:MY;O7D?6TL(;ZM^S)PCLLT&17E:
MRNX3OV2)3V$5Y=VM6'E+KVBO5Y[^<)7XWP!2#?I0\Q)'X[M\O0&H L(8M^U^
M%89![M /1].QO!Q3)//"/OV,MYH^8NH  Z&4EO0Q-*W%NQ/O 4342>\36_ G
M%PKLO&3OH-7]&$-B.FMK4]YI$0 G:IK*2BPSPY1^^AH?P,P4_&SVJ1&*P%!1
MY/SVL<@E;*>PJ (@^F:)K*O!1-+.IJLGXP8PKPWY]B!Z\O%4EY:KEZ6QG;T*
MWT9P2NASX#XW<#0MOB'L;O3F]7MU6^5.D0R>7\FB0M\?+CR5. I#\S P?=QX
M2U^5G*<F&:;=C_/.-T1V6;,TV.N+,T7D4SN*>^V,Z@#=KPSNIB]A3U&:7^R
MN'RG!7[*HZ?+UH]QU^(/C:I#65 !BR1.!E?.9PL!+SI4MOPV)RE_%3PLCB__
M-E8NQ2GR,?]K3.9K8N5?@;&$^5(VD;KE-?%N/Y65RK(0Q8GDN+F?NT9*B>_*
MO'LS7CHS]*CO&5N<KK;2%M<='NX!^BZ7K1[X#(X.E.(N5XDE"@@,8A]SO@$L
M<Q%M[L-Y/:R:WZTV%_/^@BDQEN]ZLVEJG\TVO?SAKVD_H+'?44W/_BO6WW96
MNRC]2(B(^%V<@NRR>@)UQ,^M'G\:NN'X=UH5HY.3664IK5FDT*ME=%UH@15)
MQ\KZF$=4XEL-?(.^(@55J5]U+IZ,\4>,E/N+%>?M1+)A 0]U\MI^3L])WOV-
MAP\X*7%'45^)0_W B!?@M,8/.G,O"E@KHA*#R!JM^)ZSX3Y>5=1.$;18WGD*
M&87;:A)-0V570O-RMY%\3T9P>2(?B0_XS'D)]Y^SQ&,BE8M6.;B.!;XYBE6%
MQQD8N+<A&20> \\^1)*+OE^^GWX#*",H8'>DW#+%AW%2ATO9.=I\-Q0*C QB
MUXE5]^7L)@.@_%H6R45V=8/$1%:%R$-THM^<%1J_RNVQS:^JC<L43M,RZ45&
M#K66PZT5EM\0QWXO<PC/GU/&:RQI621 TRXMAE1=+H:?H$KRXO4QEX\U::3#
M3[\G>=+DZ]>,.E;<>J*_Z-)N7(AO;E.S0(XS2?E%S-DK??UH1S%&Z";EL77V
M]YF8GFK:J ''C\#V^EB9CP4A&MX0VCZ&7%_% KR^9;!KT O??=GEE\=C#!,=
M)/B5C#P>Y9D*<S][VL>YV2[ X[($ ?>V?,];]W7 C>4QAV9\E/,:BA19&[P\
M213D#C5R UE\6MI&WV,W=!DIPX&!($9[:PHM!<!?$JH)]4UGY6KEK:SY5G8D
MZGBK[9]%X6:!&X!MW 5O)NL-H.0;1KY9B_?H\"S\!I!0NR)X>>F\QCO6 G-8
M[D1S'1MP93>.]1%R9;_]*\(V]8")RBTO3ON?\LHF[*@I6%LM;8(0C?X95T*H
M=G5D=_MN'*ZI$9]V^ 17?.W\"3#&U3QQ7?/+[S!(:A9PE[K<R/Y<E'3/2ECX
M@'U3?,A@N@$55FQJJ[6M,Z]\9E^#E1KK/G5L4E^$Z<'PR_ E2/K+V'E<<,YO
MABQQ.R.*VU=EVYIQ8?PH"]S<SD*2%;R8)$XV8D/:&P!=B:-Z17+VF9M*E3>\
M[ 8PC=^:H7OHYCAR_H@1JB=6>!O1X50-O*N:]XQ1=AZ&\/(#KC+I'\YS^D'>
MCF??,5A9J)^^FU>+5VS@R(!?[1B!L1O )/SZXR0U:^+WP4P(%TLSE11U-E1R
M%5O)DR%K.N'7KY$.%R@S0+I@=J^)UXX.=NF5\@4J?>"8:D$B4D7$^?*QMV.A
M("/471T)WN?XMGWY@W>ZQY*O9"Q(R+BZ0Q/U0HICI9]?L-7W.<*.WH+$'8O>
M!UO*3R>]]H/Y%:&0JV-.^'6A%'ZN:!@?:!<B9"7)XA5SC_FP%0"VR-F2H1[#
M$!O8&U2^L^F;9:UP_6[>8GG'=0P$/OL>>0/ 4/H'-ELG;)O)0*J-UDY_8 2&
MT,*.5=(Z-P Y2H):>=Y?U5:<6Q T S(E!"/^>J>.;6L"<9<-VW>6592=E%1B
M\AU:$B5JLR(;FQ8:+R8[736FW((]U"<'2-MI-C.]H 4-G8-O /(%BT1HL-T7
MS$A:9^5:%+&.RN-#IU0Q0(!UA7<>]_=]"VD.FBIGM"JJ>1F( PW&W+L![$&\
MJQ5>I6DYA%3%CS]9:/#]?1B[0#],OX3C&YIH0:$BT661V/\2Q1ZK(3$)1):?
MN2#)(IH>RA28.?)=&EV):N2LZ[:R8[(;Z5>KWDL)7XE.3PD[7;$^SZWS,'=_
MO<";F+1C5["Q8<"PV985Y@MNNP&$YJ_P#@A5JFLXSEH<O<O!L81]]9LH3OJV
MG57!&7(J:5A"5A7G<V<??,45+$X[^/2\.+B=Z6$34K/53RV.Q*FF_ATE-[5.
MY=/N;:/FD,,FC@RJ&\#+WR0380QL; &D>Y'JO=6\.Y+L"55AG9DLHX-1Q:93
MJU$^:4)9UFR7X!I,CPRH=!CMB9?J:E\V!&?MIHBA,0\KEF.+S2CH0(-]^#?#
M*PFLX8^?"1\XZ]2L33I>/4F\ 1!]:@>>GC3W3.9IN6M[BW$WO2X O@B8 -X_
M&>!\]7/8B<\B>6,54CA F  PBT_WNYR4(XD+D1)%5+6;C)],&>^?J]:S&)4"
M7*!KX"C,#/Q(MX+L<JWYDF[2'VD7B1FJ,R$5;@!>K4,&ULZ94W2J/RTDVI"<
M#5"?):(2LPVFMK?-\N3H"1IJDEF5F8/?XT&+K[H6J6'4"&>]X':MK>&YC[]?
M)$B7B;<R'%>74*YDE9E&\4O)(DGO"K+K9W\4'9R7 /!67G^&VV110#]UWP!F
M#/C?59^![V8UQ4!I:8=V#56%=,4?G@A'.3&,S$VBEA']3Y'-[6)H_\^M9PZ=
MFS0?<!D2NX9E<SUN ,0PT>4I#%'5EQ]3SS?FHP.307.JT4OI-@PZ4A[#:,[K
M=',$)H=974_M93;5<@0.4AUQDFFSM^MU+2H,'%"W\!'CV+"SS(6S@9>&(J7X
MD4.:$R)Z(TM!]!Y$C8XCP 1\(\]"4Q+T<P0\#.W/&;PO$F[U5EB);<@I=C80
M.SC.=_T&\*8,7H56Z4;D8=[Q#IXX7X@-*&&:+6\ PR&FY4;',2?R&^?F_;*5
M*8$.4D*K9)53BJRQJ\X]-0#+!Z,-#Q<Q,K>1%@H>@U>EW@ B&E/0^+>W7TDJ
M\PT@+KQY@7(^S'%,/3U)]X=(W/!0*(:Q%"G:4N-0LFD(\9ZCG3Z+?<H("4<X
M[\TO,0([J";C44$$3$]Z] _E9),AWQ!YH8<PG2N9W)AWCGP'##PE.DDT)5B(
MQ;U:Y)TAO2#-,J/I?8>+>E]P!K#29VHO1=-K4_/*TMC>U*&L4DAHQ"(6]-HK
MTP7 <,U]FQ ]E^/P4:1L9LO;I^I6.1?3^^_ZTY&!D2>",S^.-2M1[I]MP4>%
M:6^3YRWU=N,^D-NK:1(U!P4\T#>%2BJ+^KZ+)Y^\Y^(F0?=]P(^#ZMW*=8Y=
MFINM@7,76<AEQL:7S\5)KG>27_(G4XEINX]]4_#)VBM''"K5E?T^58J4K$?I
M5CUC)A6#$>=3[LN2VB =-]OV7=&O-_TK$Q1#K'<>6+B:2J!Q$-61[!+%^<L9
MUOH"]U,S!SG6NXX#LWP_5O=RS;E5KNSYQN8C[_"J10W(=C"1D=D<XZ8-:>HR
M6\1Z30XM8*'@7V]C4"7'MT_$"+N1GTFK']_/E?:4%,@P0A>[3-@GZ)\AE4*=
MR+N).1I30_'P7;-\C_V!VHC#MW"[J"F/8PJJ%#UDUQ<HDQDGVV[:#S=7[<B%
MCD$>HZ(,S2@IJZ]HT._/B.NX=VEGHP_6542G].1]ED)G36RN5&$<8R>Z(VAP
MWM.)$6.5N[:ET53,\7'=HXW@E<KN#BXI([#\V$'QGHV;GC+RK20X!3-"C6$O
M'_6($34:9T^O&.X_\\&?9P^^U,X-L*WHRX>(C(RC=6\ B:YCR!N S+ZN#!/*
M6R-KB?2+.\=703$I90OM19?S3@-4T0W@X7K>;>XJUXT+O0$<.5VF7+7? )Z*
M%(^+' A6'CUJMI(EWJ;K"BZ&VQDH2,D_F?L5J4^"J=DU#"!!E2^+H((YWYF-
M."Y,"2M:)DP3N0#P)?UWA<_ SJ@<M-H-P(C^!O"LA!Y!C4[9EMVMAX.*C'S6
M)<M\:E\Y>,&!,N3;NT@_S8JQU:.BDC0.*Q/ G/ 8LL0$*6)@VL)(IC;&!Q/S
MA$18M"L[/I]J94N,W&B2W+UO"Z>6$G<5[Y K.A?:PAL9\.7L:K3H]-:K,\E9
MNK*KI%=Y7RY"T[*V4N;VX<,#7ZH<BK6)S8\P)Y1[+NIP>09:H#%F^J)9'B=>
MQ%SH[6.-.7"WI5=)*89[APDT',"8>EK?NY^=M7[$?LXH:X#:J/\YN>YM _)S
MYP7J!O1(4,;F?X;P>SI2K&MK$X?3(,(8?^2U,.)UOT1U%LJY.E*4<ANQ=7TE
M^WC6Z1C0)7LDL&MZ.NA\C?4C;V_W!L!18'A9@GD'27,\?@6*',576]6,""!%
MZ:SFC>U[0/,@J<W^&X8Y;SL" [NQTWJO?TH1Y'0N,[)UU'F6&6IZ[3!:O"R(
M^7R"70):@U?<ET74< !/SF\ Y?Q^U?NO;P#LS]J!AR68* ,*'ROUO)K9#>T7
MJ,RFK>NXVY5<.09OQUN\.U%D*.OSPR9JT-GD7OFMX3=7'MP 3&4O"8J0\/;2
M9,:K7\Z=0T19T4PXB&]YY!<QH=96NX.^DP4H0WWC!QT+3(BV]WE7O+]X,5N4
MO9A>B0XF=@2QA"7JP]3#)YG3H(CEN =D]P/&XW\\T1YMLP6<=(E=\P[9U;=7
M#G9:V0GD):+U$2K(S7U)UV]/8!%,H _!P17!"XTZ71B)V\AUQ1CZ+NV%: H)
MDX$*LXHO T."Q+&1<X24IO-R\TR?5^V;>#5V5?T3FCEW,-PN+A##@IP,YZN,
M(YWNS9]]\2XYW.7Q;7U:EQAMO5=H498860^2@B_)DL#L4::"T2)J6C8B6*GQ
MKY@OE*2P=B!L9\XH2 [4N?7<1'#2L;.KI4PQ^DL86PW;.-CJ\W;P4M@>TB=O
MM^0,,IN4I"<N)OGQ#JX.BM>?K&,HZ#(T&,(LZMI56E;"*<8)+-(4J:735(OM
M3Q6M60R3I9421.)W.^8]2:',:>ONA[Y1/JX,IV7V XM>R3]C'.J:IQ*GD #U
MXNI;>D@7""XYM\A2V,J2YS;\/KDH=(B?^CI*2D_L>H$T! +QT:;\9)@FY6L2
M;:T84]<3HFHR'ZHF\:J4I0Q(>W64!6D[\=,?;0T)X'1P$;1@12\U!RU0,?&P
M-%;-YEEX]--8P! -)FEEL;*;:'GHG.4V"257!W#&H;K]):^[,?(Y22IRI<=B
MM?J:TY&3JLB\,+3WC\9WN!RU-A$FE!=RT>E8L;*$QW'3D\L<<5$PJ\(=@W1U
M_J3T!!4&N[F"^&A?B]MRJQ2(3C2EOHT<SVX V3,_ GHQW-7&%AV^3]]S#/M$
M^J[5FQ=K:'GRK[%G7PAX)B](C'G"Z5267\-8+<:J/X9T3U&X!@[N-V$J5[+(
M,7=:<V%O2L?X=$.S/"Q2VQ_$-T0'FG2*9#W80%YW1NN!O2Z]T^1-;@"DP_AB
MQ=B=3*#FX0!ANV%(]8 [RU&*1[K%>R&4EGJ?X/S>@\I*R=O\F?D(D;5W \B=
MVJJZ?$&M_8C+!.(17W/*[@<&?]ZYE*E%..LVCBP_4N*1[/L(<.)R#XQ-V@16
M*K4Q^G5/3M"5A/&M_6:-CQ+](,;  '9>,L691]$O.>7:^!:FD-%+LA%32I)1
M1FFM137E%CM9UP$!)O#NM1O Z4ASQC.=_]0W69'ZF1W)'<Z5'0GX1^)&^B-?
MY'6>=P(".D<4*)&;(R$46D]Q_XH"C#$CP".PE,+MS:J.#@G(!J\O[M^_C2?N
M'::G)XL]X+RWJ.GV*)361H66@E_>AW]6_CU<]!T>J>S?O[/OY.!D69VD\4RQ
M@^Z+ AW(6J9:.G;H+!<9DAM>15[PMMZ[G-S7 K3)Q(/\5K1*/U$S7KR6OLE"
M&X&]K>^AYYI'4_]5)_UKX?3TEBQE90GIEO#VDS+S"8MD^O ]I:-"9Q)4W57;
M9?XXWR>'JVH;=N^ATT(#[J/NG[6989J%L&>_3V-\I4U49B1[!G5'PJ72,^&$
M>TXW #M-2N/M[($,L/T^>:AD#:.[B:8BMX2KWY?\7I-?!Z"AJ)GS\ 89D4_;
M QTL7H=>''6GWP]E^"#>F0S&5"K"UC4LWDSME)T6C%SGW[Y0EI'Z,"H%8ECM
MF[!J,AU!9U)SHNP>H%$T?V1_]R+Y2.7NA0.5_RCMLG^>EQRV^';:\<.\;MYG
MS![FQ7G,P<'//V?LCU-4CE^E="P2PVQ8.ZT^0R,7'%G>DHB<+ZE4Q)6,WA:,
M=J;D,RCXTD;6LDI)3L/X"T+:G/<J?8GI6087UD,K61%\CAWW=@38L&ENO<%@
MLU+=_%"_1MAX<+3'AR,6$BGFX\[)F2W!:-4WKI'8<@.@!!UBE6*&:N&\&&CY
MO:9-ROJ5PQG\CMNZ<B!]S#_M(0TK%6M#7^2>Q\JBL$$Z^DBUK9R6ICSCEX:*
M=$!ESO*\[V:[1&=5KK77G&'5NK@T1"1- Z+F87XLX4P+O=)!=N7C8K*O-D.\
M\GNE6S%)?GJHHB((';&!0D=J15P(?9QKW+:1%25#Z91X*JAH;4*8?5AY1#F/
MY<,2QG,GC6R??V6>3--0-VOHZ2,Z,/M)"?L /_D[J[J:\5S&U%%H>_=E=\PA
M25>N)WO#FJ)^$E.+7DQS9XS39'M1#OO'"J<<UY-BGDAQ-LM"AL'SVM\HZA7%
M(L0E)-6C]XG(*DDO(RE$ DAE^FR%%I3D?%+MSB(NK3)@/J*99+*RX3_XJ<M$
M9ASMRJ/RO>DH0YSS<Z>[9&19_#C#B(+(!]T$RMG?F8G+BW&9#Q%=:<E/W,UQ
MQ+%=*7,X]T$K%RE VVXGALD$$&.GS=[G4]LF'X%OFQ$PJP+HC\-]NI"U\F:M
MVEYL_&BPV;)L'(8#D9D@LL7Q8#9D!J=0W2>7>??5,E61&;>*Y-S)1XPL](>P
MZZ=OEA\?<1DMW;G+3*:ZB19&LAD@,K^=)U,+WO?J9RTE]!F\6VPJ\D!MNM/N
MS4:*^^3AK9,T4YJ^;@!T$Y@%LSL\"_!</]I-&;//FB%S9S,^F&/G\_8<,OB2
MR4V7;D:S%[K.[31D-'([*([*3@+FU60^AV-$P&%N4*-) =W50WI]%?0D2DE^
MZO;CES*-.$VQ7[5(8SZ/:U2=O'NBGB2_SDIF90'*2YK.1]@VJD)@=7$F11-5
M6F27"4Q4"GUAH-)+'_<%.%'3D";4*:.\_X> /Q'-'=<6;5[>3\ZTS25#9FX
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M= \7:;XB>7H[359?,34,62SA5Z:)2U6'/D^\*OP*[*?DM?/^<>LJ+::'-)^
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M!;Q:&_G/(RZ%T\1S=D'PC]+1DD#Q&T [-<KBZN<-8/%AW'^,F!Q)'QD OBY
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MQR%*.!M[L=W;)I\0U>TDRUEDX?-2>1\CB.'S9Y])!_^+/6R<8N J5:WW\@T
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MRWE!6#+("K#M&=(=JHG%;Q;3&P_"8*1V&M,*M/^H!I7M+3(]CMPB,U1S#MQ
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M!-X5U'[31Y,L?NHX'4]_-0GPJ<LA?@*_F^>!GY%9(<ZBB<\0AE;AM:(4Z-'
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M?R$#]U-1@ >BUK@Q4KN^P-U]QL[FD/HQ'*-G/!$92'PH7OEG@P/^&2CX__)
M067'J::Z77FS3K"O/;%SH&LX.H^%E]=M"H-(+JVE?VN/GAG5S<O;Z#]O>RNP
M_8C_-)K&+W9+*[0LQ!Y8AP];GMPO,?'X>2>:DRD5>;*RA-C5"PRYAG4^CK\<
M,7.TKG)H09LG4$6)>+D3=)Y X36-%O)S<^2\:G(X2ON4#\OB>^=DD+)FGJ5G
M1[TE6X_UCH"MH9RAMDG.E+)_PJ9CH*K :XS4X^7"NU8FJ1<%[_3.6@$H0(]=
MX-RJ+)^Q<Y]LO2W&!L%A$ G'$X4F,AV"ZVG9''Z"V LDP&6L;5Q<11CUR M=
MT:?:QD=IO/'.5^$ER:%2!+T)UA!#][B9@Q[:M4"%14LG(ANV/K=I-]XY?^3]
MG;%JKV"G5D]!#!?" 7L)O0 *(')4]%Q15UZ >$ESCB394 S-)ICN#9<=>P)G
M<%L-8G<:MI4UU^2]( 05.%T38;J4<XSJ8RGD@=(%?R^&+7QX.BPM-JP0ZMC#
M59@+H3;-K-A-=Y#D(OA3!*4+JZ1;G?*U2S5U!WC%D@!OER479JQU/PS>2 P(
M5GQ^V9?&KKK33=R1:1YS=:A04#VL*6=;N#0[A?)W Q !9K\ \.7O0T#^UGRJ
M"2*9E3?;-: V-R ;ARS>.Y$ 0/@T>!**QX/P=(63?^S'_^2Z_R=&%1ZQN>@9
M4N>=]-1!(-CNF2D8>-A2#]9S"!N;/G<(*S8TK.6K=/!(^.TW/,'^+V(66U9-
M4:4!@5,X98NCVX%IE95%0VFMCW64J9)<+2]E+@Z5&CMK(*#P:Q<NT-4TJ_B5
M=H)NP831$80C2+;@MO2K0O=.M)3Y ]I:FJ8L?+],WSO9H9QE>ZP%W$(071NN
M*^(LH]L$=^#G2L)CRR8_.+NGC)R]85,OJ5RJ(#(4R2^?ZS=@R?6Z5U+B1DF?
MI'*\3,G[FTMO:%\<9/3VJ$<].9E\2"Z6W+A)ND%K^P8]'K\SQA^)+)B.)\K[
M)7-NDP!,F^(;/EEN409TXC'AF<@PK-&D3S+K'1M7UU=MK]YPK0D##BV_/RGX
M)F.OK^7<#S-(_[/^H7_0Z?\/Z*1Z>3<=>=BS0Q=S,^%*"&O7)WM#ZT<OUIA\
M[KWW[$].25SLK1FX5=/GP/7ZRB2SVFRF,S2EQZ:_0@II=^>6XZKRM>0.UK$E
M>P@19H]:;24!'I]ZT$(X8G83_8C>[JY$*BT/Y605B'5!/WU.WL,Y<SO,A;UT
M,D"!XZYSOMU<+B#;G>U!_C2'$)W,.ON\-O#)*CB"R\ZT_)4;V&M9@JK2XO5]
MBEFJ#%_Z'84%CHHD3OKLT18O[S1)"W^*#BM+@WS=<3Z3A23V0/W>FO+G*U^J
MPEUHO@A%,BEQ;\'O*_GY6XU7.[_"I2H?_""7.):]8%.DHB%7.OJY)^=;8-3P
M;"\OX20!^O?=0)D[JS')GBTHK?*?T\X:"/2,4['3[T:XUVI<"AC%L);5G(G%
M/9@[:]?C!UKD4!H(*)"4;%I- !\??.N@% R8M_T/IH7\;/.@B55"0 W92J$:
M9#W&]MD8B-XF:EB2+15!MO^4X)4_'+O[?YF.DX?(,5,,<")$^TI]<L \ 29!
MU*_%^^?##K"T2GTQ[<EII@V'W]A;-$-0:^OH&&$-O)1T'K[>!A=3)K^+V02B
M$:(?=/TS!K6DB\)-WR$V["W6<;8VIB6"Z(68/K9&=LTD.]P!N(GOP]DP$N"7
MFB3(-4$*?#AB0-L<1%S:UZ-WUT1]KV_1)YW:#?(@ 93#0(/Q\/7F@6*<# G@
M#%^-TIUN(F\>6&,E%NU0=_!\NU3$UPO;#7X\E#P.;25?-RL.M=V<M@@L,L>,
M_6O?I7IOO8]*I><QL603/; )%(;@9E"Q]*QV7:Q^K"_O]>5SL'W-N(C:/?V=
M5OV>#$@P/0?0G\SO8#:!V\YMLS^$BF:8TQ0H>QNWCY4)>M:Q]UBCQR,;$D,_
M\$\ZMRNP4GSA& *%UHCD+[!'8HT<HB>UAF5B]@4(46%GD,&[R3!0MJ=UW:)P
M!NW@2B8T84QQN!F\%IXXI7=EQ3WDLD\USWTGR[G73+5!"(0?;6G!A&>";F_M
M43^\3HT[W[I>$'_4]MZT*P91NC8)5@I+W"T[XX.S'Y>#Q]TV,"I)KYR=86N)
M"GW)#&<5:(>[:[F?"^P_F,/%(*V> A3&6*P\P+"\V_;@8!;0.< 2?>)2Y EQ
MZ_':D;:F@.E@ES8&!F8:AT7_-HM>5=9Y[O 4AQ ]IJD8AO-&P&*V?AL\3,D^
M5YUR7Q@-#8"5PO;_L_2NP%*Q<Q8##%A9D@@.RCAK]-ES^M"NW<0B:A#>Y&JA
M)]!A%7CO^LZ[S[/]R,1C#89I7&+1Q<QZR?(&T+/P>D;/=:+/('SLG19!>B "
M,EL;N$M@VX! Z^%*LE]\(U[,(=(@$P$U7B2 RA)D=3R-R&G7E+P^6D\D'E!%
M!1#=>!'%ZR_9-JQ_/9OUQTH'T&/M_K%;JJZIR% 2(( ;,TO8+B(!4 \CL-<1
M_/ .'^ .]AB>R(/K=$$VM;L9=R6CZRV5R;:^!=I&&Y  #."I#MSJ=1( 3@W:
M:Q.3\2"N'1F_^X3,+%RJ2  O^,M+D**."""A8J_:Y%WO+:E/35N.&*DZU$%]
MGSS=N^ABSD/2(O[F"I]O\[L=Y6Q=2G_9M0EF?5J&;GSU5WVDN=_Q^M$>7H,C
M</MUDTVSH%"^J&P#33:UWY($G7!7-;[M/Z.OHK^F4+]%7KN+5#GY[UBCG:A/
M7HW>)R6X3[WEM@*;?YYM@N,3N0\%J@.7*F0_5G-\>.;0[G.MDX:F&#/\SIL_
M_:X4V"WXBYG->>ND9X4=6OT2X ^LU:^?ZE'M#K"M0\+\6#U=)SH>N2>.W%[.
M0E4]TSEHHZ&J?=@**1N\2 +<#%&Y,#91IX*)_V#W_/R-NRO#4>'(P4S:8JQ_
M0P+\<2E.REW\@:/#BQ*PZR@;]MT$E,L27!B3D_%QL<\Y'(O@W"V<K2(.H)<8
MUIK2F\.VXD(C53&-\ /KP""7.T1&3/SC0A@8QA##8_14XYCX0X[#][W7[A2!
MW UO]ME+KB[WR^CO?FDS3:?LOA'W[UWD'&YG*P'[<A)*20)8OTO1$+4+>Y<>
M 9*4?6@WQYV6<\?4KZ!D.2[*/'8'>6.6E0*'<\.CPC+-(MA&^#1=DX\&T,T>
M-AZ EXR$)UJ-8ZUZ[A*;.*'5+P;(L9;N@C\)H)8(W=D2/]=TOJS':FWY6C@=
M"5#-/7Z)LG'!].L$SU^@Y0A7"O7_*IV-[.Y2V]__K[7$SP%,1:EO><8WL(]R
M=5NCJB2^-&0@#6+>IC#:BL_R0(?6]>S/T526O@DY_[RH!%S-1 N;P@]TFE[(
M8BK)'(::O7CG]* SJ5*.PB7X/48K.%]9)+W#U]<I2HLYKEYZWPZ%N?X[$B",
M/9G]:%_8L]V^%Y-';Z2S1+WHI,TVT&:RN4.1-7]6*T."%?!\YN6WYV/$Z*QK
MPW'?=2>.[#H]5S5RKG#19K\Z)?<6BS+N+DR\^/2)6<%E8LL>=#%";U4$RC7=
M3>34(0&<#.%ULAGPCD>@[;>(Z[?WB[O$?X39[<;L(2%WQ%(B"C?>MV5,$%0R
M)F#520#8 <@$5S=JM@ZX,VX$OX/XPF0U!?UZ5"_\Y@@98VD0KU'?CR '#;IV
MLFQ7/0@?HXQ89B.\^GW=^@1!4W+=[_;JAF+/NB%P:'\BEO4_JCMF1WB5Z GV
MC?_-,3]7/D,"^)OZ-J@J%'L$Q:HKBJ 1V;EAY8'7K8]%\YBD.7?%.MGN>@T&
MCXZ:]Q^M)O-[\[KOUF/#NG!:5HUK:"O._:6DC[I(W,W3U;4GZ!#T/7Y4+>A6
MNPCFECSZTM)=W"-*V8[S1/ &6,/5D6U:BJ'Y]9DIAM 3P#* 'WQQ[&"ALA>&
M;[5&E\KBSE:W=$#_V;>-ZOMXMP20*6@2H-&.'D+Y/OO3?))%J4_L]2N@.L!B
MP@:4+!5X140T2R!;S4:5!/%T3;NMFST%_6-$KT<\7ELI0$[LNRD>/=<)9'*N
M)=9FTT)U#73BS&= Q(S@OAFD'Y1FCJB(B0NC]=^ "AP[&NR5$59!_8[G ?[:
MP$CWG!*LG_[FEE-90E@J<YJ#:BQ-_(0*2#.RY7KF\)#B0M=AFF<<^1)76KL5
MC%-#C4(-N[3_#A_^;1&3?RY@7DW-G^]TC/*<6(U\_S;MH8_AOFP/P"H ";:K
MF_1W!O,^G\U7>CC.':=H>*M5VGWS4@(@^G\9\7\ITC46DXM FCMK"TJ/\MAJ
M-(Y_=!*/[E05\#2;HMD],7JSVB+CN15L W1N65ESXB7DO:E;G%)LJ<>];@8Y
M%P9_2]])H#^[DFJ@$TS0(>%D1EEPB^W)$N=MU_D$ $9_2.-L=3?[\+FR'FX@
MPU#)?F$ZF5+_]E5$F:\$&KG0/O6V2N%UI ZSF0#:=3@#]K[ !LY> YUX,#ZB
M?S9<>Y S VG3X@)TD;$L/OEXLB/0C[YK8Q7XJ6!I?CI_8LP!(.CAX"1[63)S
MH#'B\47LVKNLFF>[2<,GO&P;6!IE+"UVN.?1\][QH<L2 W</+E!<9DFB#,;+
M7WQ(=I*Z]3,M(<^/O#,G =AIO3$DP*>FB96R\5JK]R6VY77[:I#,=1K6XJ4,
M1'=!E94_?>^BA8O<7YX8+%PX1B'D%'PUO(\WQH09=AH]+=_85A9RJXJ61J#I
M'ERL>%+[0MFKT4]#%G2S"<*:GH/LAEH&4#Z".?IH5GTRT[D>.X\8;"9,[OB<
MXC7G[6RJY>SIJVE,66+UAX/S<NW8327>)."_2*12'9U68&LA\-KKU#!>&TK$
MQ3Q[&C!2'9;&.R"#29S(+,&P&'9/EB,3.LZ'#2]3G@2<B/0\' S8T ,U)O"C
M9$(N]([7Q!0.#L:\=QAXKQ07/4J);4N;3^+JO5TIS-O!?0U80\42CFWS?647
M8W](Y1X#\3(%^-]^*.B_5QAO4^6\=TD^J SQF=0[2>]S*K9"_;#L2:=S'H#>
M43ET>]:DN)O>J:OQVD[2EH?W0S)<MN,34'5C0/7=5^XB3P@M6VW*GUE/>RE[
M4ZGQNI@.8HTG/0)+=YD7)J:B;U0(>#U_M]$$7AGHX2Q=? X)NG&;\  \H;25
MD^(9\AXO-\JV_^BBHI30-?^DQMI;,(/;7*6!,>U]U'G:_=.\Y:S1LJM&V?R4
M>>F+?H>1J/[K?2-"4[ZE2T^>J6AO(%((AYA>,@72]1SULM_RWVFA+\(GK!MA
M'TQX$B#95Z&?WF>./3VRA%/!<G5XSR/IYSW8N?FFHW.T)8\RJV6EG.>E6-9Y
M,-?W'ZR5\[.\#L3ZD !'$&0Y/-!) G1J>K#5$U3(M0\$P1?GX',"U3^'BL1*
MIOU<>Q^-RL0%UYH &^_S:0J[=L=]BP7I*30XT>I[[SL*1:]JN -V-96" 0X0
M,38C+0 P)2T[PQ1@^F=Q9%;9Y]689TB]![N2V^3H?/.P(#-@URXU+24%F*0L
MA5YMA##<ZMULNV1H<6%4X6H<W=40=Q& ]6AE1#"(M48*(SBQN6-AJD=3GDNI
M-KV?BJ6Y47PQ)U7W29(BAXOT.]I:IVT(%0SHD?/R-!1H6CMU<DJ45G%S48W?
M%VW=> G+,:%7._8D&CIJCKN8=Y,O:X7X+!=5RK%,2\9*A/]R>VB^(YCZ.L^U
M@X\\P,L)"/]2>U>]0'UD<?AD-S.WPC,GNOFKW%EDM*:S,]#D6PER=(KR??L6
MHP92\.OP;@IPJ]6VK<H/\YJD+V_?BG$I7$FC'46BPOP;0Y4.19E+)J-/O<7?
MZC8?PGKWBT9.*] *TJJ6C>0^NI@K#7B;0OM70ULNT[NSF,M1:I[(;CF_CKN\
M66\3"I^P6;!+4FT-! 6E,'V^_?(OSO[+FCFN.(UJO?:,ODQ<#.W=N$ACGQSH
M-LRU+_*J.JM_VO%KA_!&R45FOFD=:X+K6\OK)\,&-]HN,"K=/S&#;H]WEHG3
MI?>(W+P=I /)@ :P5H1J<8L);!AQ4F:DOP=(_#\SK.>7W,K/!OLSE/U+  U<
M"S;9H!)^:>(GU6^LT97DL9-?)SN\ZJS&JXQBG2G"/G&K?M28J#JX/#U<K[C8
M,6&9E8!&@3[-VT\DTE?[#&;5=&?85?:YQMV@I0K>U*=>9/:,>+?%$0V+^:S^
MIJ27):F4(BW;MNC3D+Y8<R$FQSY8782_;VTV&"GDF;L^)?]X><75)N.S]N@Y
M@,%S^!!_V<+)9+J:J[0AD-)TS(V66S,..U)QWM8*'=UO.B),[VZ#.)%\;0Q'
MIT);:I\R,.D!?#[J"]ID=ZU+Q<=V%$(:D7;8Q(D(MCRR+N+.S#V>4JY_HEO!
MX0"-XKM]UIT#I7;0@P+HMK[:T+B9L])Y#LU\>3/0$,@A1(WSU%2FY9GYB0\V
MJIZ#826BM(>YK_D"T3P-"1%!,.X86]V=YJW<<N!'F8'16LE*Q&.EN&3XA G+
MA8H=<,V!XERJ)$!A?^3WSV@8X+J"SMSJU3Y[>C8AKC)QW@1F4!0JWVQO'H6[
M2&O_;P9T4!IV:0(T9[5F<#X#'QOOS2:W9A0>.T\"H$L35,9$/LE&U%6; LZ9
M_AOB5&DA2SQ7GD4"6.80VCR,ZN:3UXS*(/A-_9D[5%5_(_[]]>>4!.5*R?+[
MYY[L^W]W2M;/Y6=.5?E;J45^J$;VIZ>6RN59-M:FK D!=RA]IWK]W!E'TCDZ
M<1Z'CG?-GC*Y:=RZE22'#<&P-'H3O$%!^:6^)S[8B0Q=EWCQPDF] /((5<J>
MX0 V<V0;U?*[NW(>9!MT6H0KZSI(4SY@XXV@6+\TJ^ ^MKRX_L[!NLAWW.^Y
M0\6D ,;/S8B=H]R5SP6N/BWA!;Z /_8<S<'X-/D=[X6IYWBZ&@;TG.LJ? 1D
MC7*0I*,]/-LC%^#K.)3S>3[.(_Z0OO,^%UT.?(73?FB&*^2 \AV8UX0"6)@$
M,.%L( %6I6@W$?S8((Q@H^IAS')'8(T@G#WI[DV9]A[-&OX3,AT9 %]&US23
M46VAI'Y1<P::6RU-&=9MXR\I)T^O9IA6)Z6GS-10UF\%]UIAK9Q]W _;6YY:
MSZ)]2^5YRL.J!PQ]!V=3=IP8XYQC5Q7K%4!6]&>NO3JD66*]+]IK@W63:KZ:
M[V3/N< /90]/W<$OJS^X)+<'6CELZ\9-'1'XV8"9\I+.)>L*#7=>?5@KMZHY
MI=*F8F''I'$0F =.,[\=N1 Y-*K]7'ODPDW[E''7@83CM*\?<M[D[1Y01&\M
MK.R\PYMOS\H;GN:^(--NEY;^KVD,X&U"K#V$6 O"&[O^\.<BK>O?^'H%[2$2
M +S7]YF\44C&-ESN++&&!,BXM_%O0Z$Q?2:\Y4HO";#8!WE>N/ ;SP!X7/YO
M?Z5+1XU>$SQB95[\=A.<Y+Y\Z@1US>-@RJL:#!@UY@73LO*8_7$S!MP^"<5V
MKGQ?:ES/>)R=$K.;185PQXZ%4?>6=Y=ZWTM2;IX^>QAR0S;)>Z#,DZW"$Z(M
M-+W[TBN%\8=9R7RW=$TJ#6(2 &6_(@%Y9V_6'A*4_@TD. IP!OW&OVI6WRG5
MQH:_F=2LK JG='A-502J$R\F 1XEGB,!4AZC=K>.45UX@WB2D#JO"NR[I=A2
M'BE)XS5HITMDMA<G/F3?FXV1FQ"7\6JA/),^9-$CK"IL\K[J92P?FL, TQ1P
M%CDJW"L743Y=*IT[/KZAR#:/GWW[%#WF;UW453I7EM>2<95O%J=[Z$5,^.8B
MM\K6@U<F3=;6'O:LAW;[K@",IB;U?KE("C#>WH_),\6\$5IWTDEXY>;5_>(K
MXM'HB"<2!.HT@GK7IIRGE*0[VUKDD2-%*3=!.8@2$F!"J!LU=\21!/ -_E(6
MP>@I;];+O#:CJW'B1?2!^_HY4P4 IV0JF+H5>G5B.;;\]9JZQ.8Z3O"ZXJ@+
M1,-\W] (JGXLC"B(ZI-O<H2[(H4/:!\&0#)\V7P=)\+4)>+,0BS*E[BEN=3V
M,5 9P333/+7>T\CZ@O->N]T2 \ZJ@?@0CU;+0(^W$YXZM7P!'N)Y8:^XUO"X
MI*>[FK[@'O )]* J7V$<O[K5O?/+16$I.5R$Q85CD FNBFX2H*3;3N:N,;6J
MN=OB9OXJ<(X?B&[[T'%+(O?<YY4;;T#G/*@^D@"VR_P\D,"3#^F=A)1BBV\$
MZT 46L!C9-E5\QH3'UAZK_:N2E5>TYI_6?F#Y (WI:51?@QC=D5M57G<X=8)
M7::4:>YJ1\2=K2XA&U^'0V<!HRJB%*XZ/0.ZQ<&?3*H:JS6XJZ\FHV-LH!L'
MR00$^1[TPV^ 3==?[!M@]"4!CIKIDP (+6)L=S+S]WTN)VROD'^PW66L;7"=
M[&IJ?DOV^5=_A\$TP-N,(9NSN^(5A8)$VS?DJB'S%K7_UC?9?H [NZI"#C)Z
M1A?DD&-'+EQ6C:_OORNOP('>[JP4U".HH8+1$\Z5-RI/8G4/M+@*&?N9?<Q/
M?TQ$"^('7G5?I&T?E<!*33("ZUQ-/WG&3?JX7Q%W8*5H:1?O)W+.;5?)/[I[
M'5GMDP,K:\0\?.%6^%H[VFAH@<^7[I6!%9G9TJH=H[C7V<IYK2<[95_&W_D&
M8^5FEH$:__4)R/YYT]':246I_*E*]RH .^]NEX4VUGFB T^C@;OB^&.^LB*%
MR8[(A@J$SW%Q?-$BB,.9R!KGA%1KE>TQJF<0)F4ER P'\(LN"7!@MAZUP1"X
M5A@7=U\Q&6NLRD>.$#<A_Z>\:P^':GO_VZ4DE=PO0U-QDGLN(6*D1!S)_6Y.
M(7<I'/<9%$[C&J'<(U&8B4R*8=PE%4-2(F:DT)G,')<&8^:W52?U/>?\3IWS
M^WV?YWN^?ZSGV7OM];[K7>M]]_I\UMKKV2L#2D%':#$!W7M(F:FRPBWNGY09
MZHC1@DL7P"*!<Q=9'B);:BDS*VP[Z65,(!;$HZ7U^HLV)OI  (R"WO]1 8SH
M0 MF1%] 6/6;Z8IUTF4+/EJ3]4FKD[S\JD@E_;T('A1Q# %%4AE6A"/*>B4C
M,;NG;<?,RSF%9,XT%F<#KS^J!)^[&%-TSA=/<X6['^=7-RHYA-K73'9HD(&4
MWZD@O_"\:CMNEF8[=HQ]SOKP69(WE-?A<H6;G4N7B/F&L8$\N&T-0>[%JU\"
M8[Z;?M2L#S@7W<5STV8-J*I) AG#IV1^L0CI&11!)T<)HHSL_] _)-BK\H*E
M64;&\\'/,>S/%YV)@3V+,D,%*V&ELWM'OD"QPBW3W[R2]O?27_Q*_8$NOE:M
M 4U6)+D,CWI*&51EW</A+":Z!_VTRV7'"A(4(@Y>&6XN4UIVJR"OAUS?>+J@
MKW*X&<W-ZS@,\2B)46,"!B=]<GGFT.$M^4+4]>E436.J[R9-N52UL10F(,]M
MD1B6#<R=X@UI-: DU?54P-N/<P5Z'F7!J--0M5"!_2HA#"$J_Y%2 R[5%-$T
MSHU'-8-9&SC:7W#VXSR]4KV4SDLX1T5YW<X92S#=1(.;]:O>:>$D!ED!W)>N
MLRWV<EQ =)[&.7-XC'17=V^7"R=6.5=1H4VW7^SOG;A9#QE;[MA_(?>,; Q-
M:@S&$Z%#T9]O:.-!>F1>N**[:&[LZCK>=Y4JF$?E<J!@G[?SJPW5G%%,YP_8
M6M%P]"BL1(TCG0ZKJNU#:#H>RCQ%O,2[@618ZOO"DSTQ!0VS7V9M=*.,MA9
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M@:.+O\0S:*O_+Y"H^Z D@IM2*;.;39W!,Z+.B #Y5B/'Z@\4-KS-80(ZQYC
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MD<;<2)11G5?^F;S=2V,S<VEW!V-E=P450W=+0T$C1I 8-H8(6 AL;6=M[&1
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M&@YN#A8N1A96EE^((*"BH6&@8Q!@8A*P4)!0L/QO)W@K@(?V( S5"1&!%GB
MAX"(AP#O!*CO-P)DA%_3/UE$A >(2,@HJ&CH&)CW"%4/@0<(B(@/D!"1D9'N
M]VT$K_OK !(>\J/'G.(H^$H&J+3V!%R^T1EH="_*V@C?CAS1<[]W\$/'("(F
M(25C>,+(Q,S"P\O'+R H]/*5A*24M(RLLHJJFKJ&II:AD;&)J9FYA:.3LXLK
MV,W=_V- 8%!P2&A,[.>X^(0O7Q,SL[)S<O/R"PK+*RJKJFMJZ^K;.SJ[NGMZ
M^_I'Q\8G)J>F9V975M?6-WYN;FWO0(]/3L_.+V"75[_(A0 @(OQ3^KMRX=W+
M]0 )"1$)]1>Y$!ZX_H* AX3\F!/ED;@2JH$]/BV7+QK!B^B,LC9T.NZW1X3O
M'48PB.AY5AB@OXCVJV3_,<'\_E.2_4VP?Y9K%L!"1+@?/$0\  1<288RI3_X
M$_Z$_R3@?C;+##W'%6#*# 7^,? 9*QE''F @S"N">:C\\!Z^A9A9-X_FK"*/
MQPCLH?<HM17WR^058ON%,N4B2!"\^2V@:A[UW,GR)< !:Y]3N:D?JB>''=27
M3+/ZMU5P8(1#7UP=A7%-:.OFL02!.N<W]>$6_);U+(NT\P$X\"K'"UE?[$8!
M#L1$%/K,<=P^BAL+A U:>C(RWB.[]1(H20#_$% [CULNQ;-T>7\H/T8?CS(T
M0SJ!Z,6/E]9>;EML4SDWP\:Q#&:G%0#/OPN5E6EX(BS:?ZHDP8E,H/3\=V )
M5K^38B.^:UF^ES1,DQ>RHG])4:E_!0?\X8 D&[-5=XW8E\Q0UEY1Q,VED*5C
MI2K%:V,XD/FV3FA7C-&G3W("M)]P%R*[OCN1=T3GYX./P919_"DSE GXAT-E
MI2WN3BI-+=C)@[\.W+W9AD'@TD>/  <F>18,7XR?8N;43.Q3S4J2)]@C/3NG
MHQFM;PHRM?SZ-S5XZ>HS34U,](1N.;W9N=>I?<KC/\R+_VY [>=1DO! 3?Z7
M ZH\P\6>83-F./"HP'J!,]4,<;HR O<5S'5%99)WB\A+O'T]#JNMMS<"8?DA
M=^P2TFF>6<NCRBA""]:LG43I '9R(SW'I_F;W]X];P-%\0Q'($0%6I%X+54[
M>)WS@2#@_9SBBZE/L[.21JFF>-W^L"_)"#J?_ JHS&V<9!5PXRC3@F] QBMP
M((3,24NGK*KX D^ZK-@WG!&,K"C88Y^F;[$(6X #ST#78#@PZ]PIGF'A3ASJ
M5%OE(<BF>Y#%W(#$1V&*9&=9\ULL?1NA^;0*.KH>XD6.NJ.F;&^Z40C;4R(G
M3CE,O\$Y<N!F?XXQSV(3U:_QQ:P*6;B[99^U?4V_V0)IFNMK)N$6V=.T,-"Q
M8N72U748') 0U1."=(<<J2W>]>[71O8S1)1=R!'JW)%7*)-%2&C:="\GI\QL
M3*7AWB@9&%VX"KWV(] =5'OE@%HR07\7Q]]QG>(^I9]RPV&,O#]3]0XZU,H4
MY;!^/##D<G&HN]DNZO%V8DS%7Z4Q?N^%(7C69'Z@P45246#9?K:\F:PU?HF@
MJI965264>415"D#_!+ D+V3G_)!EV<X*@K[<41=C:;1^/T,S3B7^LP.7A=RL
ME82Q6CBQ!;6CE'!^KGADZQC)X!.5BB0<:-;TI8YSJ5=+0X8#/5Y*!P]!,V^&
M/IS./V "!>Y-*D:(6$.V6Q[FR,GUT56713^8*S*@)Q>W[FAVVQVKXA44EA0-
MZ(\O%V#=Q6SB@NX[8[JQ;2HV483YL3H,KQR&VN['>'C1*K)UJ_312DI?<2,J
MPQ*ZU:F>3CI=!_/4OJNKL:.=^ZKULI90.=J/>X[RNZNC>2IH,JLZ365BWXDD
MD_R+.!TK_DXK!76N_;Z"<HSL^?/,)-,X2RKJ"2?T&#:]?CD3^\]L?I!3@T^6
M$[QIES2<<& JI^8N7+8"JL40NW+Z2'I7N$?D=7FI)(,TO0?%A+7IG326S]FV
M-1S(>E3NZ*AD6V<A BFEZ[:<:<:$ [T-^3Y32W>]K'\L:\&!#MJ$;B5J\L"5
MAHYUK&.)33A@H)4J.%8YC'<C"@<^^I$;^ZT8R 5GLR#NTQMK4X)!*9I'W07+
M/OBZE4(V8::VSB2+9<.&C\H0ZZ.C>Z9XOWNJ08E*R;$QM.DKOL7BE-/97K_P
M[Q$@M[./VQU+=NYB&/JL&D'N">F;7^:)0%69RC.K#&-FUT31*'E0.A'U +)S
MASUURFI;:9%H]:DCF90P;MQ+-C:JN\FC(U%T(Z]]SDR$[TA[A]CNZ:+G#*+C
M<HP=[F,PA0NA97LB48MI[N(TN/Y\2:7FRWO0(D^$?\I.UV<CIQZ],YL&^9@"
M*N9,L+(6E(!K($O3*^?QNQ+/\=?X=U!"B['[Q1C*836YLR2=T&\0W31"$G6A
MX7^EGNW)5$F$VDEDT170=/&9Y&(N.FVT_(9X%:*O"DMQ15Y8+[5D3$2NLXU^
MD): F"[B?"@_'K=0C_Z"3WW'KM[6KU&B* 0[,HX;+3GK*T8W(@[:97 ?84K!
MMOHL[XGF3ORPM= '%Y"=AY\ W;QZ#FRW2Z@Z#4K6/]1_K,&6P8F/91WPJ:QO
M8?>3O?];3ZL:E"7I6A)D+8UA2@<"./#R<D(R.SGN*J1-<RXC:K4(#I ,+W]Y
M/'E:).SUU$V;,:3-T?<8^I,J:[;.BZ[MZKS)]CR"53[&S-'WL;$$Z$6GZ5&I
M(BP$#M!G#M_=6Y%3LKJ</N+09NKI:;"MUMU G1_3I#CZ8+"JG4IX()#JBE-;
M/"%%HLN>(\#(RMW'ZX.Z.XO=,LNKRR=M,(3E&S=.[9#M"YO0I7L^P;N=R$;;
M+Q<OGL#ZH>C,\ /KJ/.N/O4V%5%=>:JVKEIGUM,:@/B+I)3@PE0DC'$Q!Z9?
MH*&X0IY"ACG^;8)R_3%LL2NH?P=WL2>O2K\R@?%9'3%OY*.3E8M0*[9$CXC[
M%8>BT4,K_?R*%5_QB'"HSG*5E+J#R$Y/SRO%7TH8R.!G5WS:N$FY.T(L!?-?
MV2K!22IL@W2OT>A6D-YKK9QDV8O?FW#PAL5\;I7A1#<OP<YZ@ROW>X/VH$ZX
MRV85A]D\Y5Y''#/=9ZC5[.<[EJ98W9K(V=O0RY%7#H4N6(:Q]RM9LQSFLQKQ
M8L*&K3+$LYI4F2[;*"KKH655D&S-A+>H/F85+F4YI+N;%.N5&>J.^ VK\"HH
MO"K)AT3.($]?WA0Y_GLF\5Q3:"!#V;AC.)5 ;AZC6<^WY+<-IIB%YF2!8:[G
MUFJC<N;VGRCL.L:I/GJQ7('Y]6.EPE3"%-S8GLQM--H4?X^M-!!?F)IMXE"=
M6\/UERG<86JQ"B2*,P9,'3C50$<T>5$^%DVY%MS;(.3,YLK'IH&]7Z;#]QF"
M48^^,VJIS6E/>W_7[SV^3@MJ9JZLL/Q:&8(DW9!D%3R(>IT1<LM"C;Y;[Q-4
M:MK<-!9PV]XMUE\:D7]YW0,')M)RW*G;Y7U4)GY./)[@,&G0:)<.-)E7B9EI
M.]WN$0\]A@-X[=5WS!,&$:IOA6>B524!A-[6HO#DI(\AYO0Y^/6PGL?QNCB2
MU\,V>_8[+E-?I_376@BG85G7W'MX.E+GTK(RFX7AL9%?&$?K, IE\NF[^-UT
M[ST'K8=_W+^=T[!\UK/,?<ZG[AW"IE\=0LY?',(<.#"G?_OH[)30[KTW=TE4
M^SVR(SFRYS54^-[=+( #5BVGLNJ_N)N=A_?N9MYM^;T3QJPK8!O>7=/NX*0D
MX9KL^T<W0JUR0<Q+7:7Z6Q5IXJHXV69ZWXY7D%:1KE2''VHG&ZL+9]/5U:6U
M,J-9M4!1 U6L&RA(C,A<;9LR89;#A 0+.&&@*R(".9E^N\D?$5%-OY$(]!)6
M&R,BC>&Z9GBW9ONZ:/FAI%2>UOH==W96EYI"6V-N.8*B==L2*$-_M#:"4:IE
MB@,[-\YF"O\C^YMGU$P[;G23=5GRLA3?=^<7E2UT"LR<[_#&Z$;NN+6GQ>UJ
M\,3IVQC4L.M>LTM*KPD(B%T6I>%1[8!"KQRW1XIK+-@&\>HN]12?[:-&MPD<
ML+*VDGDM)D 5%2O':3S<UDY<)=>03(AI:SS-X0!#T2LX4%*==O6+VO#796%B
M)KB=PBV/%A8TT@C-SR<5\N^D?7WGN;B3A3W<U;QZ/G@J6KO96K+',J;8D707
MT(J]6*./HV>Z#&*DM"R!S< !ZBO%6X?82XA3"R'OP"UQQQL?$X7)8QW%C<9\
MNS:7V \>3A2A2OGC[V/F;5@.;G$9)F[(2[?XTLPGG*8"L3X8X90@B'*I)'OS
MCGJ*-4.]2F*=FHE&(1S6@Y?1FW88U2.M Z56ZOHK#0,M>)Z/F^]&O@P+^JUR
M\"G'V.69,\[1'1<NW7L!Z[KCH-U#.&!$()MEYSGP+IR8JT:Y9]_:M*E>SD/
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MT1B2T&!5HY(..^Z^AN44:EFD\CB^[]^UQF@]:")M>V_GL>8"PI@;:W1=">-
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MOK@@\%A%&0Y$$5TE;O,V$7=/Z3$37RF4FB.'/VU6+>K?(7EG)/219GUSBK)
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MBZ9]Q+<I ECVF64HR3!XI;2-6[%.-C^R%#))2E^2RM_ABX^<$HXS37D37>F
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MO)[I:3'9N78]/FLX.9[!: )WV\$TI4<W(A5/WS<$62L)E7Y)UPP[%*P%9IO
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MU8JE.E>6"9->G?@FJ "F\4MES=;/G?='/B_9"YGB'Y!@[^?+(YE.P/SNE?$
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M:S]=56ZK8WA%UV&RQ(-NL *<3,T8=J7]'\2:WB*0KO#^^07+T:N@C^W\BZU
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M!WB"&7_?8M-REB'W/]Y: 8L/&E&SQFK6I>JJVEZO[M];Z<]0GZHLNI/=O .
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M<\T,8WCB4\#R1B7TM[+F6S1]+(:=11]%J0R],2338>R=EP;T%5.-+L7SR\E
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MHAM\/&4+=KYD^S$,(_J4R,33\.EPJ[8B:@?6(+H(H;\02NYM@R4FFU>03J2
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MP[5EI^17/J*![DT+<3>7#OFGP$$TGM&&FK?8Q-UQU9E.TOY6 YV6AQ][.3#
MM5@FHH,4[>:S^K(+/F2TBM\,^>,V^;KNC7"9ZO1]#*&^=J1OD2/N4JH1_'1T
M9R^[X4T+C#W?_\Y 3)X;UO*;KZ;[.+IA^)CRT/ISC9)X$_P.IS5YV[ KX#UE
M.MXPOP3K"%<G&QYWQF$IRRA'T3PB.I0#&DVT*8;?E[2OW_9EIHAHD#CND=F[
MY>C2?<$MC>?G"J-0Z<SG7Z ->">R;>S,4A^P_20&M\_$W6TZW.HDCPOSQ?4\
M^.<,ZR2<2 V%>( J')ISS<OUSJ_9G9? $GI*5#3P&RT*]"\C<[T"3,W8P!?9
M^UV'4Q&O$HK 5)W;2C8W*O?;(!:\T=S&%'C5.;R3?A(S5S\;+MA?>@JC0L*@
M$FIBELUW#FEMU*0,/\'V=2O7=EOO=5^/MEVC/)9*^'X%F&O;0>V_3)GW@:ND
MGJ+FC6^QT',#!))L-N'N7/.6=AG_A[WWCFMJ6]=&)T5!41"E28M*$4%Z41 (
MBC01*4IO*DJ5)KT&1.E%0$!1B@("TE0Z!$)'0 A(";T%Z4A"#1"2;^(^>REK
MN^^W=COGWGO6'_/'9"9S9LPQWO&\SUO&.R(M7P9&*AS)G#\*./CR]#S RT\N
M'[$:Y.K1+1PRY9]:MIOHX^DF_W:G!KDUSW<8M@7LY1P7@&KXM6YV_YR!;WQN
MQ?TGQ8F(409,[IWJ,M*G<\Q6D=.BF8//*FU15%/YW++YPJN0/,##]8,]G51S
MP'(QWTZ[0)TQ%W_UB-4I>;J7#TGN4I-0X,?[TAED(;%-%5=IW<,,4 6OS1-/
M":0E\WF3Q$SQU,@.$UZLG3R?=[^0(6;HRD;ME6 #(0V23MNYT,AFE>ZB]_5J
M[XL+CVX^@?.Q^Y:1^EV$D<QOPX+.K]NR&,$#FU8ZMO59C2ZJ"[.02\UDR8Z.
M%GM-Q$U)/0E$>%AGW"[K^\85Q4&>PWO,\1NU31:\JZA=\5:"1K>M0+IZQ6I-
MONZL\F1F:5%)T7$J5??4X^4QZN=(EYUZ(Z62*61[2,3_3G91-KJX,''2>\M1
ML0-W<OQ(8OQ3OU9YX#+3J<U4FA3Q7;*)JI+7=W+4/+('Y[;3!1WBG]8<^AK,
M] #O!YFHW>[+? 29\$&$@7IQ\?([M6RQE[;MG5ORM#UHTDK!8 G=DFZ#>6;=
M$.<JVMO!KTMZ-*6S/3H4+V\[E.?;UYJ>^"8.I1NR+*W@3G'A*U,OG7MW)7/G
M*FWWV!D_F=#_MCJB2@HQ$BIT(D+U?$<>R9RS3#W<-5<B;)6I'MHQ<CZ4J?UC
MPQN9S'=+34(/W3??--_X^&6I&OE6?VB@YI ][RA7Q$//5\ !_7\A%7U:]M1L
M(BH8SR40-['STLO*SEC'K<Q5X^[,PT>IKV*+?$3U9"DPB' XQX'\5Q_<[SM/
M<"]DGQ9]&:+DV@(PK"'I9XLT*!+'<(+-IUU\!&]@Z?/ZHM[%,*NI?8V9')3X
M=.]&:D0F:S)L8,%0$V=AU+D$%W_K?E/KT5%!];OB]&6:U5^ISEWR5:R%PF=U
MEZE]+AWF(6LOAI&X1PX9HNRD3\,RZZTF*3=&E3Q9Q:X_I%(JHHTMCY)%1+BR
MLW;>Q:0\X2]ZR88Z\X6C@_3%JZ\A"_[Q9[/1?266J30"< QW<19>LM=@D@<$
M 8Y>P0-XC%A8T1(L_E@-FD0)5+(FZXAQ?D:=CU6H8A_7%K&Y=:\/O /I;8+/
MWE%^37ATPTOW_M\)KYIJJ):+S:'4XB_:M4*X570?'ER*GM/AN]3 ++6P?;3C
M^::H05Z=G[G?!.H(#04FE8:K,&%RWCU'*U%&XH0CI^,A<KBA'P6[/G]1BM&)
M96.+QT5(5N3D:JY[DZJ-.\='B3E;&V[M_O</XLC#(SVV==G0..<P4Y;/B;O+
M(6*S1S1RW71RGD,HTV3+UYL\VIT1U$6"1VMS89:S[(+E?9#6>Q+='2(DS9\U
M_.H70H&UBG_#2ER^Z<'M:]6V^R-0=C@O4-2Y4XB +6S-1E?%:*Q^;(M6#+1\
M;$!%9E!Q[<\5N7\YM'VN3 U8)>A>>_WY&-Q?I<GA4#/(#(VQ5LXJ^#L3L]ZZ
M6:K4,7<3/@>R?M.!NG20H#E8'PHO:[B;J>"T:4+%ML38#*Q<Z)^S.%L\#?2M
MCR/-,\*A57H)K)GATI<G5%FV.,HE<HZ\BZ$_.7_R&7KNILD\\XT(=,%A_3E?
MAJ[;Q@;BSSO.=ZH>@H[<)TOQ!-;_$H7[AS8I;4<AIM@8=WT'02BYZ@)"R;XT
MK!_I=05LN/*\^0K[,-L[W<67VI03&YG2&:E##3\_M0#6QWVU%[5!8XH9-N4$
M#L1[3]AL"U]OZ]V,$)7\<&I5PG$D+:P3!HI*30NT*0JG*@V:3I=W05.>C!.\
MJ>5--:*_FZ"]20)"ZR&+8,0L]!UL_%X*6@G/E7P&'&0":$?[Q\ B[G4I?<C$
MYWPC,_R_/C'*3'U+=YCB(YZEMYCMYH[%S@W"_&K;BH3/&_-8.^_/:$[T14B<
MIXN'8,W85B0H>0A"3X%!0?CG+Y$"5AZ^>_6+"B[2L(&V[?R/B;(_)K9JL%:P
M9UT7_)=U/5@&<KPZ$\3TP48Z31.A_[8L'WFOC:CWR(T3S,-;ME_%ROM96$]$
M#A3P]G[+75LZ;!-2?<:DO:"9-K:MN&J,[-I!5\H>LY/H5YZOG%-IKO>LY\AP
M&_(4G P8,^*''\YY5;Z^1N\++VA0.1N\"*?)-AHUN2R^AFD^]<@V-/<RMP+9
MMQ*O;=W,P=H-PXNV#1_;IYJRIZ\/)6&$XV5:OEF2YC+W)G54NJ5?Z;#+XU#A
M9G%XQY**= H-JB><+L)RA:-TA-N9Y1TV%KDU#MUO4JZ5=C)R#7KMCW4S@@X:
M1.^(7!8Z.$78=.A $58B_5SID\8%J8UM#&YD<MA41#RIF#]Q7E-/[>L=7-N'
M)L-2MHL@?5#I$X<N1DA^(S1Z^!3Y3PTH3"L_='Q:3N\)C]QL2&P8.YC_S50C
MR3YWF="V4?:JF>-=V=13'VH^PZ:*AOAJD4?=QCWK_!Q7;&YW&5E-%;P0\*">
M/\3$5IU<1#+;H\L_'O1BHGI@DG*]_5+[38MS"=[8?$E]:@K)N5VI6RG'!(O5
MH'6B1I9O-'FBR0L.?XNY&++U0JE@96'03\J@(T@_4C7OVKG<9?ZT[AI!1^E+
M9L^/J0@GNYFQ8H=UCTZT#1GFV:O'ULN*EE==:3#1F]\\TK$0-7[ J0QR VKT
M*<HEQSKEV'D!%ZK>1P<>UW$D!<6M7#J&&*&P)*=^XW<I[^RMTKZBY^(L_*,*
M==_"RVHY+L[AM%M7O-@4811XMN*>7'L!YAF-E<GP8=7J2UJJ]]Y$U]1(>TYF
MC^$2ZQ7>JRE=QK83,K.OM'XQ&"F$7S@577XEKL[Q%2Q6CKU%0<'*H=3583CU
MM'G$/6"#W#SCG]RF]GLVJFD3E2#%L/K]LR'%?$.JZ\%AEDMW5R_D>[1&1U9/
M?JQFF6>_H&8^V-?::N4M=F\K$_X^LO>Q;YK5U"Z5[ON6.Q;B4VX/!VLVA8]^
M^-SU:%:&S(6>MYWE4U=Z<$>*ASRI[CP/R=J>&V<,]LE+%51"B&W*/-[V:A#A
M-Q*^JRW:O^?*V5^_4?]W]1U_=Y/)B4E(\"CO!ZQ$MI7-NRV'RQ[G-3,')B]I
M&_F)Z)[UUR<"F"+I.R#XP/!QH H++C"7E#BCJ:5FLT"0\SFJX+U*!*CDFR!K
MC$2@10^&"X5.6+K7$QX1@2T^$$9HM7?#@@GW<6"K(?*:IM(@@G1B@W8/@/I'
M!T(X$X4S8 <U82J"< U420V:_X]?KA0,9!=!P14F;<+4[H)$]AC7RVO94TW/
M;\^*QFEXGM#7:<WI>CNODB-HND+6"P+:BMR/95;_>!F3_^LNMZW5G"W8(_/=
M"J\;A3M/WF(H#)7DXK <>>IK5[[V#D*)QECC0H:NO]2Q]6J!B8N3'P8^C?C!
M79IO)B[@E3 CTMH%JFZY-A4AW?T\:E*')!3+ /9R"DX+/SXS.8QI$%S(S3+1
M2&(E;M!<TH/RVP6)&S29UX"1?X<WN=JV(#UG>G^QY(WE(,3*&?"&/6-!L=@Y
MKATO PK-"?7O<B>>DYY*^KMT\\%]*Q?GZF#PF^NFSR'270KTF^._<4V0"+T
M&5'[3,K*\LSVGC-O];;CZ,_I2OG-/WM_E^] _2$+62#U,/Z>!$[_\\I$F9]S
MT>/L)U2[_.=N:2IX@\ BA< _X?Z>?C1[IL)Z7ZE YSN$4^? 5@W^MFP"^</!
M^P'^(X=II@_7#_ZP_B\W-=*6,3DI(*8Z>T=K1<7^S)G(J6Q NY6';,84IR0-
M,LG#1(! JXY32/FTHSX(RJVXFT4WRX?0L8]?\!:YN(6ZS8KFP,&F(14J*N6/
MYUB4L.RP.,]O.7ESB6P5[;FF0P.*2\4&'J3?9 -D; 2:FPGT/063'S_T+666
MORA18CX1+QL0"LQF_4OEVD&1WU=#^X<\P*%H=7RD:\H&C?KN22ZO)^ZPII0M
MUB7H(GO*MLBU]96HS8S9FM56GC?5#;_19WT<"Q$0'MMQ(P*#<0O:4P@RV/0E
M(F 'DEJM*NOJLR"1]DYI6]D;0X]4]R60 __P%IO$@6-*O[0WIBRZB:@,<% 5
MO/8&-;"W-HIP?!WDQA*@3&+]/J-@Z$;H0BI!\3T?[.>,G/QY" ".E.'W%06W
M^F#878I=9],9C9[?3F_R/V>[#[*4V[\GM/3YWYV^-_^Z_=0>2Q'!J[T=MF%G
MZA';D;PJ.BSW*5*%3/9Q9',FVNBJ%#1$_7'*E4+,VY2WU_LB[/FQ91'PKJ+L
MNJR.:;9^;")HH9 A[;POY9\-@//P%V'Y"1&.=(7Z1;,9CQY1TB15)^T0Z$?U
MV\0V--I<[&S-G0\J4P4*ET@:15++**@I  ]IY[:;7F(%-K4"U!@]?3/IA.$+
M4J=+^X54;K;YT@O6+S&#3*Q+D']=63KD/B+^GO'\@&(33:MZALLM#8JX]O$1
M#P*3=>*U?O-M]$V;X,G5M*VTX4S)$?].["N485YIR))XFD2*V<'2]';JY@]6
MQ\^&[,H+U9/-JN<YKVE0G!P?HS;1PP5H]RT[[_B<MH\[+B,[4D].U?N\H"W&
M1T;-WCV&WUKM5&E@9BC?[)0N%>^C0I[YQ]%-/CX5D<4YH/X;(03EN6?J=7-7
M8=KS _L25!QE-@?-8O1)5S^X.K40-HNMK$S8>\RPC.%ORQ[+'WQWQE!?-9OF
ML<M9($9(SX5T+[^MPU::/V\>1MU=O[EA=KVJ6Y^SL%PT-T0T1YB"*B:-U6EA
MR4!KS'U3HS2TE9]]2.75QY!BCH>Q9_P\SD'.IL@3 11;!AT0?+CI]?-RL@/!
M"\NJ?W^7O'TZ\A>;KYYCN72CD\K,[X:H'+LI5MY8"A*VQI)T9=+=><'];%F(
M&7DNBE=6P=[$=7TNN;?%G>5ZPG44_/0[)4>'P8Y2\0:4I<KIO/*MEY$X_BU/
MG7P$EJ(AQKWNZ"5-C!CJV-48"]5[)\+B*=BM)1^_HM%FRHO@:_#EPU*$K;D%
MU28P'RA22*LL*PMGZS2[1&+9DX6\+XT%S:RT_T@]YY^_#!%V+R0HR=@0ZD";
M<[8I-[$/:X&/]$3M/@9-@:X(??%M-LA$<]<><F=]O\<34FN_Q?J-""RR@_I'
M1&JU=0WZ:&Q%<H0(](,J8^V>2_US6 6RD\8!)/@3<K^RR/:.^AX7EBS!J<AS
MKF_09)8R0<7:^RJR,O^$Y]FHUY1*<98'D$M>8UO+1"!2$*>Y6P""+OASV$80
M>S,5=#F]2)QV3#8)X%5T&($.9C-*!) PO".L+KM+:?^']/PEV1Y<PSRK]_5[
M:(L>BJ[ESO^T@/:BXA#)7CQIYA=2H^#D8G_?AJM]"CM4RS2\TCJAK91]UE^.
M53V8<'K8LF+C@]6!1RI6:7.3DY,6#TZ(CE\-Z)^ZMXK35@?<QQJD2CY0)TWF
M7+),)-182X@,/1(]>;'^2$H6$5@(G8'?M!A',+L/;A)X>[M)ZRDK'1T9!Y;E
MOEZ1(.A[L@8\.N!<<;0Y<&PR%S%0\;S'CN6:\M*!HA"NJEQ*N7O#3$E3$?TU
M3+)K)+.W_AW;G>JV%Z_%>0_M$Q/V$<PFX:H:]/OBQ+[\F'+$?K[P[,^ \%Y
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M=ZLPZWNL?_:_YEO@BBA_.#8D_ #Z_O&  ':E4;Q4)T6RMT97L:2X\06C[K6
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MD"GS J_(PX:I3++8Y<[U OF"TUA4B(L]L_LC>U(<_\.PN!Z[U2> SU?D?8J
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M'_^BT <0JZ"0P-Q\UIFI<3$1[Z>X>49BQT/^\.68'C+Y)IRK&3<8)>^W!*A
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MC+\CJ&4!%]Y*FVA!%]ZR)]U?9W/JFVK4K7) :WX=N(%@3,>.#2=?.G7=S>2
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MBJA'F-G66,-U#J^OP*JI193?F.)J<!)('K8H"[.<!QTV2N8>*69\-W01/YX
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MET&K,S[4:7G. L+,J>@GZL[_+HQ'R)%[LVK*Y7]]K/\:\\?Y6K.@HFUEI/I
MB"ND9SCOD'/!6D=']*VH]3AW2_C2+Z#X+BE6=!KN*("E/>)3%DRCE?M.BJ<H
M9YPE%C3#F*$(S%]:^G$Q<#D^5>V:B7O(\_@A6;81+@_1T_')1&J(7U.22THQ
M7]8>.!N;[5OMP(S^4^2R0J[<U%C/F^(U-UAR5&T-?KVOE( I"\Q-H$ U5_O,
M,#]57\Z=.HK6<YL)N1<6[&T=ZKL">^C'Q>W2.JH:<YXC=S @4_U"DM*==ZA]
M(.Y^E K]>JPY5=D$1PK@P/V1I)1,3OR]:SL24R,F@+MD5/=.X\,IL5I-;0,N
MQ#KLC:C+ZX#E3T,_P*0&6$Y)5.0S+N3"F ;6M[;7<S]B7-_U!K48?*]SUW6Q
M?>,-;:19=U24<,G KDE#)!O,9E5FRD^=>L6]K(7=R)\4BP_O7,IO8XLPD'(A
M+?RKGA@I:A.W7.&*61\I:4&)A[5"BYG<LBLA4?)N1!&PO@4,'YQT?=XN>IK&
M(GQ!D*D%G7Z7A%RF^"*[M4:CK \FM;A^GX5_90C.NWK3*=0'BE0V9^R>B44Y
M.UA>OYA%Y>531V,9!\#<+_(1! =S<]/:5K?F50X?'BY[5XO,X8+#"</$W\ZI
M[;O\F!!2/2E755L*!M.Z=?I")';?DE:'F4;?."TW(UV'(M-E'<QSHX4#U8NT
MM1%_3[K@1B%*=X*)18P_,9)IFDVC'>E%HP/1PB>FR\KM'AE!P;>ZVKTE"TOH
M.V>_2X/<3#_TTWN\SGN946(%NR*?G:)MF['_A)KG9N**O2>PO:JNMH7'%(OJ
M07B0 DCN)DL#ZZ1W,42<<!=]^PF^\N[+2(I<C7PE06\1&<U7C%&."%28X]+U
MEM()V-.88371;7W]V>0MA&C0'+.=;8%OD)Y"O=KA7FY+7UASFFNI!+VV62"(
MXY '^BI#6P0]59&D.'%0D&^SYC+,E9K(2H/,$^%T,MPCYXPA!YKKI:UE7&\)
M8]_P!_@A,>QFX<C^NV-.^4A5S=M3HU<8:::WFIF''B$1+I0OU@QG7:7G=D[H
MM+D,WW)248FTJ?('['0(.DFA16IZ?^==A.;]SHU'GV@;F'?F075$<X8:?,L]
MXK3V.+3Q89GP$KE6;B0B^I G:U2M"K+=VHV]-IFN ]C=2\-=KT)REI= +D4S
M.8%03EDU#D@7-N\;T9>_85EW&;,EY8?@I-OWB92170(/BKNK*_20 GL?*W(4
MHPW".TWN+:67UNP(YYYD?H.R0KW!P@2NI ]V!,%?8PF1%@Q??P90!1[IDIFG
M^ZS23^:T>T:$UJ;S[=S)3_Q<XRJP-/SU<HCF6\?X".><']_!O;JS:\71VZT^
MI_WZ.4B@CCB!AY-\* 'CNVU&L1VP]R9S,=PPU)Y+ 5O FSWI7*LA**J1QN1U
MH_L"]HO"O>58-)V>MO89DXFZ-9QED(%Y6[/[%IC?.XZHIC00@TZ8J2"M?BLM
MW!F!H5PS9=8 GC\E.K][+\#W-AH]#YLNE+67-<C/' 7FSG*1A9W<F1(T5[9>
M]OX)H)P\VMA0)_,NP5)_1(H! !!^O51NLC&7Z9F/P)$/5(W?R#]3N]'$18<L
MVR$/=P!@HG>+P,ORC/]?>Z#]M_RW_+?\?R?"3XO_ U!+ P04    "  $B'A:
MY<BO8(%K  !%?   %0   &%B=G@M,C R-#$R,S%?9S$V+FIP9[2Z!5A4W=<W
M?"@1$!#I[E!*4AI!:0$%"0F1+H>.H4NZ04#I1H0!Z12D2[IDZ*%[!HDAYYW[
M?OY/_9_O?7R^]_V^<YU]7?N<O<]>\5MK[;7..:A?J!7@OJJBBB* @8&!U8;5
M!@"H50RDC9N;DP0_OX,KGZF%HYDEG[DCB!]LZL0OP/>8'Y"2!3N9FMM;NC&9
M65K;.DAS'K6T<S+96DASZHFH/U9W>F9I8ZOL[6*I[:WQVMS;WES<@E-6AA!?
M"BP!!CF!+-U,F<"@]PZN$F!IEK]7ET#W_[K-SR(CY6)A):'U7/$?,]!7TBS_
MX,73TY//4XC/T<6:7T!<7)S_L2"_H" O>@:OJY>#FRF8U\&5]1\+/+=T-7>Q
M=7*S=71@^NO:U,S1W4V:Q=W=UD+"RM1*Q,S"0H37S%3(@E= P,*4U]1"2(#7
M0DC(XHF(@)B@E8 9RS_(6YC_&W4G=Y?W?].V,.>W?&\)LG1P<T5K0^ OGBW,
M)5QLK6W<7/^%NMQ[M_\[]M_;_O6\Q'M3!VMI%C"OA:65J?M[-_0@_[^,_J.#
MIH/6*AX>GA3_?^" _Y\4\(\[:)VB>_^&P%]P_!N*E@YHZ#S1&*%6 18%L*T5
M *BK X\  +@+8 1_ C#1/0S@'P=J'G@&8&%B_G6B#VSTB7,7!P<;&P<?%_?.
MW7OX]^X1X!,0$!(]N$](1$)$0'"?XCX)*1DY.?D]8DHJ"C*J!V3D9'\M@H&%
M?@8;!P\'!X^,D("0[/_U@?H!D-S%D,+4Q\)@ 3!),+!(,%#= ".:5QR,OX]_
M91D#$\WC'=R[>/@$Z EU]P%,#"PL3&RLO[A&C_JAQP%L$IP'S )R=TA?F>*R
M.),)!B7FW665K^H@UQJ'LPF9N03CX5-04E'3L'-P<CU\)"PB^D1,7.+9<P5%
M)6455>W7.KIZ^F\,S-%06=O8VKFZN7MX@KV\0SZ$AH5'1$8E)7],24W[]#D]
MOZ"PJ+CD2^G7ZIK:NOJ&QJ;FSJ[NGMZ^_H'!B<FIZ9G97W/05=C:^L;FUO;.
M+N+X]\GIV3GRXO(ON3  +(Q_/?X?Y2)!RX6)C8V%C?N77!B8GG]-(,'&81:X
M\T#N%:ZI,RF+8-!=,OG$O*H./%8A+3BYF<LX/@6;\"H[XB_1_I;L?R98\/^1
M9/\FV+_+!07N86&@P<,B 62!5:[\J"NL+<PHKMQ_;]RN/Z"@[)HU$^*=RY#W
MWYJG>%<:WZ^1U$:5N\X'VSZQ=#[*2SSS"FW,&0Q@R\I7+W'P$]I[86'Y4C6!
M-H\5XB>^5AG%>#\760=;QK9)?R%1'^)(=_88:;S_S) WGW-PE=(6UX'NOG?B
M_J.EY-4C?'#7#Q2 )24-DU17A8$,:/<,O<H=4LGKASMNUC!C6[> >X%W5$8Q
MF[[7J(@VH #NC"O)^F09W?RV..0;.&>7Q*3!'#BX[^7B%[L&"3>:PO2B[Q_?
MLX "Y^6?J4@>,C[!4,*2HBG*O7X(%TU9729Z:W]V65_B_A4<MR8W;^V1P/*U
M_[ZJ2XP*]<B8HNN4>?H9XGODF=;"Q674^:+Y"@H(N678?LLY?;I]ZN>RM-SS
M .G22TOP(12F(W_KFA1#C0BD!!Y((W=%-.?Z.F5H$)QQFTU>%2>Q1)N]@Q,C
M>WHAFDN_#95XXMF.8PMH1Z:Q.$OL3/3#3X]1@,#50T;>UTF&0_B]$\\1Y2$N
M0@\QPK^<5DS"&,-\)5=,HB@E0+$HX)K-G[HA^R%V?=JKFB$"'.OXGR^^.*>J
M_R!)S/2H+)(1M+FE0C1T5])UP7!FXCZO9#$0?"D_<-0QYT%T>CP/%:"I/M">
MS<F 9I9QU17'W^)>1 D?^7G(".5_1P%J2%?X\:P*W#^O3'^O@6#-3QY&+R$I
M66NR/^^>^3PC\MGF0"IV'&Y#14KEC^4[8(T9$ICPU&ETDY0Y9Q@Y&J+%>V#C
MZF]<?:QL![A)SHEQFHYD#(-*PU/(U:3W^XJ^[E"\2G=D+#RM RH;XNLH\Z&Y
MW#OM@WM$[4X%O\.#YZUZ5EH>CP@SE->2$\3W>D?WQR'\X;?WKS7;'4F,P"\5
M1#_)UD% _I-LXHF]V%[4BUG?P8OI])8#P^0WLDBGUS>'NKY+@SH13,&2-*J7
M+3"E<%,DQ ^>?_ZS#5&1YH6S^'VDSOR>1WKH[^<]GXW9H8E?S3$^1W2XSE)W
M3=_B7\N$ZR.]?)R_B(;GVV]>2G;'Z\8=WUT/H<5<? 3"^!0X'$QY6JJS9NE>
M>2U[03CA1YQA.PAAQ='AZ<O%XFA+"YAK4)R680);C?/RU<9B7L[L[FYN+NL%
M7RXY XOU2RN/5A(4?7NH!EC%1.K@E3_:*.'+?9IAS27A_) DPZ,#JB-A\&FT
MGSKD#:_E+YB^=UG(@I,<W1D#BVCSP8W_TR^#9]8#/=0Z^J7XBT1BPM!+PPY9
M0C<4$,% BZ0OW),(R[UT*&)H&[[G$&AXH:%/=6L44QT\QRE=]0:*VR%[U_?%
MY#6>S^K1@3H1H>&;')76N,L-/KK"5]2^/<QDW.1: L$8K)-H.S=$ >@SP>>A
MVVT]"A#:^NK1.]]B.Y_IT$>^;T(M0P^6[6JCJI^^EO;#@>SN\IN*)MXT@4J5
M$=@\:4#7H M^=>9*RK6'# -8<+EG&>^:Q#S S]OM1JU/OM->>5%71#?(9>]X
M789(*$FZ]$IGZ*=FC>>&%%%V54NII:+EVT(B'!_K>!D:I" C@&S0AN_30(I0
M0)A(ST11TN4.NUJWE>42&<L^4R469UQA<I_?%>NP/6>7(\7.DRN%U)92P^V)
M5'J9<>RJ"NGSE-(4B]S-U![%#)>-]Q=Z0P'\_KUSDQYBQ7IS;<+P:.@UUH0_
M=5C<S.4("E"N;TEL(C%>'&!+PMJE_*GZ6Y;4EQ6NL-'>3<C9-;Y'(;$<G/PS
M]>H5VHW@\=5/7W(=C[CH8:^[%]$]MVR^;8E[;2"%\2I'\G7]'0U<.Q?#(;9(
MFN<'K#?3.FP-8YZ5D%;9E1P\7Q&$=7<\GFWJ96'Z;<I*69?G5R,-B*/KIAQM
MVZ]@S$]\&1IKUT_/.-5^F/5U^3\:.W)DU)IRS$?J$>79RT)):,8Q!]K$X)G.
ML3$N>ILC^PA^DJ()FH+QFC5;YB322)*$DRY,"6WNW4^W]/.^QB;AYQ(C5:5#
MQ4.%N]#I;D]/9Z^@!ULR!C\',5-Y""2WD/'T5:!;'#"K/D(QQ=F^]&"BO9J_
MSEA;8;+.QT\1AO5>D80S?H/EZ:ZBHK\>HYI^Q"GGK[;P$4-]+K,2VQ4Z9[6-
MIIA&12XQWCCNQ=M'P_D+_B/9V#E/JULG:W?<?38-#>>ZCVC?86('Z;D@.GY(
MK65:M2P'I=K#-.?27L(C%9("2.QH0NORL\\%#(JZ3<J%51MXO" S/TJ7C!JV
M?5/'F[^8Q9"=F(D)#U[)KLF&0^K:<<"D'11G#9YGS;(1+&-0:1[FQHRAZF</
MU=>Y0#^OJWYT<#3ZV:\L=^VQP_W+!(UV+M_F5<J$?S&<WWNY[.7UHC#;A6/:
MTJSHHP/@61K'PFN<-QBM,9 C_,I$R::]AB([O23<]TF%\:(!.$1_EC]/A975
M9A)"TM"<Q^BO:/(Q^[%KB)%G="OIRHW]JOMRK!0KZ*LM0?%N=+'1G%UR^9)+
M,X4*>7#%S.VQB_A>G\2C<8?^< T5XVQU1T?>J6 Q,Z]"J=!8-<9^;6K5*NQW
M<7>ER[:)YU! +T4;"=(3QGA $&O>*7I^#N]BC*DM$Y#H8\ESK%'I>/_NL//8
M=;Y=8<TQK I9!J,H@\E2+AON24CGA)K/KC7#KSE&C-\R>?1.<!\>+[9'Q, I
M 8\TPU1U8:T2</'GXPWR0W1D<%T)H+1K+FYRM(;Q2G9>:@1#>V8RG+1'TW5
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MK4B<E6'N3@\G.^]678.-I<#F']-\=4/Z"482E,HX!?Z( EG/G[C)%Z^^^F+
MK2)7Q2!UA :T]![J&.[N4X?N+?I3"X*.ALXVRZT"B<>10DD^'E\ON_'.M&0<
M+"QZ-[@3$Q.GO"<>I;W[2B @!KB+G(;W:(9=OBV"QW?YBTS=@WZ$6@>C/<"/
M;]!2A=6*_S995$[FY=(=,A?7?BR1+<;J_9RY9A00[6[+3N,'B0\_-% W)OV9
MH\GSDN=;,='6Z%"<F-5%N+.N5DB2(>&DG2I_Z1K!O7AF!45KZL&@Y#[.*$L_
M)00I3"$M\)9M>XFM>0)T_:K$GH&R5M^Q*$YLJZW?9J,Q32"9+B;V$;EVR+'%
MM_[*SZ?VZ$U?ZQBN0(<)LTX;C!*))77FQ'B- UCG D0_=#]N;E::L9/3\[W.
MC^+6?IP?Q07\I]9N%+"*#9^](8#JW6(HH(#N<11PES.L??OM1#L<G_^6HS7G
M .>Z)._TR77?NCOYY=H_#<<CY:1$4(#\60H*"'P5@! .L.'?("YMWY1E_5(Y
MR_A?1COQ5BLO*6LKKS&C44!DP95< )>?.CHQOJ!7\&]$ ?\T?'M?DS!@['M1
MP J9R;4Z(Y3@XMFNXT5\_^[;S#A"_\9_7NU_,WTX8Q3Z!$:( L*+QK=F/Z^F
M+^\G+=QD,[NSB?6E3H8N*:TE+\S@Y/3P/]@Y6+4*>?E:AIH/JG?(*B/GN30W
M>'WAX/]^=I?_FBF;!@7D^:BB@!]<[<ATV?^LMQE[:G40YBU$=E-6^,0$BMM[
MB9/U_7MV"7#%N]!0/S%LBEUM.,!ZE#9D)?]2DC3A,9'RMCW-%BP^DN_@!,G6
M]HPPK(BC\GVT(Q6>RSYU3NBZ!?%'Q(')EW9X,-C^-O2 &P4 ^2@ 9H,"/I!V
MF9SPVYH@<2A1 *G2[$.(%];NY*WY"G&X+ /HY$KV04/$:>7]7[O-PRA@OJAE
M_ #$&:7(9'$A&,B:+,[RG.E8[$+!$MER%C-S2AS)\!!!%/Q@5'V6@80OXXMA
MCSM=]#V[1*&",C[$-[JX#]GJ_I%_@$5IIG1Q**&R;&1F4Y:K51,&TNXU.-VL
M*U^2OBWQN-IL3 #T5S!^_%U)/P8P&TXU8QAX9D3X'Y@L[JKQSD9 UFJG<O81
MQ!+".CI&.)TK+,>-4GH[YW]2=_O;\&.2TS<! A<I*\MQ# )PAIATW>32WM17
MRI/S?:[V9)O09],POL(\F:7"F?<!9%(OTOV*$J>@^KSN)@>-/ZL*VN>)A+@%
M:#]ENK'%V]TH_1>]_C,#)L8E/L?$NY/SGZX;I]HXP?&Z-0ARR/3E &X$W\S5
M*Q,6@:T7Y6\,F?W?JJPZ/>H+;.,#%ZQF512 <DV>@1R_4$$WQ2',C6_PK:T?
M<)O3QJO>R/Z1I$P+@6&RG)^N9[O 18G[E1SX[+P[7;=)M-G@2DV%I5:G/I0Y
MELY,X3@%\WY72.((;FYA,MH_8Z&_E1NC7X>-[?!SZ_?8FF,+/&4'E(/(,3^^
MN_,Z6/)TLUWM#SZ?-OL0!8Q6W;P-&/&W,KYV0Z3T5A78O=Q]95N]W:OX+5RC
M-FSI+@$**&=A>UGBZ1N2G<*VS-!JRQDI;.S JTB@!J&V-);A-N0R#UX>UJHF
MC^#X^<T\24XVH7("!?PI(NQ]1 %;O_P, G[ZO]L.H)+26_UU+9KN7_B-/UQW
MQVT,!'-D,]H:&7E]N)A\7A/WZZNW=7<ER7:S3%JQ_JZCK6VQ29;&V/,H!NY@
MS+3%F&Q<>><#DU*3/SF1YMZW6[2>T31-D&NPV<@VYKGYN3U*)UHQ#OO0^MK:
M**CHY[:3\JJO8:XW:[M^ZGICMV@#Z$I_FU:R<[Z'4_RY--9L1@@;M+&(@\_(
MKB*%<9R)MBGE_QG 3R_+C_S-CP?78!3?/0OWTBT:\LKKRCJ^F"BMY_ZVOJ<O
MZIRR$8^%F8S.>.[7'1'L".ZD6Y[/O5__'O+2@H2548;T4Z8 -95T3<A2NW;[
M?P]LSFQ> Y.?K@E:MWO+5+Z&,(OIV9?3Z8X']HV.%7.FL=2;D?*]/[X&MSS%
M(@CJ,4+H]3G2((?D,I2G12Q3)];S6FQ 9F&&WW-<1]Q>3IACE1ZDWPC^4<B<
M"NU;N9N_ +4?NGH./@.QGYS/L(*+JD"B7@8C6,)G&ZKODXPS,O"5L3-CMBI%
MDMK1J--WD_(5MEG0<%ZS)C;,P6!=V%XFGA5X%VWGW_US_A#WC8K;?J -:,3_
MG6T Y;5A_L#J;/6T>HL-B1I.V"_S3B5FCN>F#5OW5%9_ZUDC=];$?=6+[!-W
M(ZT]BQ3'YI[9VI.)PGOGEH+)7WX0]>H77QLS/QGZ)PK_;$^7&[+KQ&6:%_%#
M1S2^^@C^^-IY=4G]UC!CF1'K=.C,T@07:^@G0/[#JZ ^3:/LPG3K<!EN<$ZG
M!XUQ:DJI7^KRBRG:UW6O[KW76BGNG'ND@@.&NDB7G9+^]U1M;SPH&CB"_[:>
MWPR,L=E"#<W!,&G+)+"(K7MM@AR#PD)@)./A\5TVD"P?L6I# ,+U%6+K5VT
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MB%L2G/+%@D^@@#<3Q6KVORIX6=X4!HZ06#3&B<KH;T3HB6%]]PB8-PBXONU
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MB^*JG(S!;/L+52_T8HR]RZ=+:%;D4ML>5M:UKV0''.,B&FX\T2N-659RBJ
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MM:4 L;5>\ 75[</L_7.##!!2X%8LZ) D%0#JHFTLJ#7T$[KY$,RWG!5^)MG
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MG>2K?)KEPAP<25)#CJ1\A(V?\)KJJ5/)@#ERTBU*3M Y=\!4*]%%3_5&Q9/
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M*_C+"@3_30%_/L'H%'/WEP5^FN,O*UH[8$SG@;$1>A%@5_8$/P, 34V !P"
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M+OSJ*M6=Z+325@(.$>U]:@OG84(:3M'%&P<_1?M#LO],L(#_+<G^$NQ?<L$
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MAJ"H_CDFZV/4 ?Q$V:\-#3R;0@.#F:QG.]"VJ.UIT/EQ( I9#'^$3$/.=Z,
M7ZW+[N5QZDLB9)(-&I!_!YVO1 .$H/+G:&!]A.SRM'E1]?3-&905CO7_SU7J
M)HMHUPZ?\&I<2LDFU1MJ>UJUR# ;"'^B" S -T+Z_/[FO\3)0GYNCOTI B@7
M#7@B.B=!MGLA*9RC@JY(U0XB%[#WM?87P6U3&AG8= X4 <)D#UT,- \L.^T+
M-/*8#2,0=8ZG2@,KW0-%+2EFXLN[X3;T9\7CT%_E_E7.H/  6.K)&=7^B'<_
MHF&H">1YV6[T(#4'/'<]AL@83VC:H3IH3G+0X*R,YA:J1Y*.Z05/<["?!'R^
M%4;X Z;2R)^=RH(&;LA^F5V8/T/D6/.S./LM,JL7CS7_W8SRM63G9TC?UA,P
M5.H<O-@<,2>VGQ)-\S$;8D]=0,8Q?3XQ-'"C'C0OI/;#2-A9':;*F5*10@V?
M77;$W=#>@,DW\E=F]([BQ7"OV:X\#?:<&BL3ZNG1EHXUSTW]&Y?P=2?S@D[.
ML.HE'*7&I]#"%Y>CKFP(9F]((R9.@U7C]-0R/J9[?%N+2#;,X.*ZH;82.U$G
MAW_Z>D*68W]2:^A8)G3'[8N;X0G1VZFE,,]5TORH>(5YR:?)W[]N0XY_][U?
M/"VVZX[Q**IIL4 V?A3$?1,>M^2=1%0OY9;T)GCO$4-%O].:V'<ZRKVNA?;O
M2\7PP67!<#^V#2<P[+1LL@K,_:&C1/EJC(+X&^>PK&DFZS+(B=+?392_53(?
M>W$9>E%0M0;B%@6%LG#LS\6"L\%UL<8&,#MP02MYF/B4>QBU=8_V P '=^<T
M>_" L4-?VG?U?6*L6.%:#K)4UD\'*C</:OPV$YGSJKO2K^1O-\W)C[V>G\8S
MA J=UV>@1AC6$A99*3H<GL5V2G?EDZ8)?!ZZLU_'YTW/(ES_P.]Q1,T"2V7[
M9BI5@VZAZI)H\\2-.A9V6U:=(PJ"FMM5/VJG#X/DL!<L(S_I;T[^[:ZZUW5'
M8)-U<D8B./;29C7G39,D?+FMB5GSFL;D6N5HAKZ!?F_$BC]HCD*MUTP6#92T
ME1Q#F2$PLC<GR:3MVO'3&A/81%MNA'>G"7A[Z)E?MM(S,84A;?YN^^5='$,Q
M^@SZ0T3+#(3=05'@8O1G@ZT8Q>P";26&<R'1DBXTX,OQ/C>:ZH*7,/\I9O-Y
MF>Z^\8#DB^HS\.=/@?=6.GQ"3&Y;M9J(*U7SQPX:(0W^;K:,+8RN4S'>"<KK
M.Q_L9998L@D]]O;%)F(V@Q@<TV>E:A[&44TWO!$F=XHGF1'BH&<F@<SZN!]T
MKH>(%H(KFP70@(:AWM=V"*Z3XEJNX;V.+]?XZ%9V>A!X?AE_;\3OH',/I&_;
M14'S)T3RJ-]USS>JHZ*-\GW:WMZ:(@]18^41EO<[7?QE6YQBAUZHLXQK=:;P
MC<LZ%<]"C/HW7')-R9]]O*X62 [@VW&;+)#.3&YY_*WQ0,7*,H=0\Q>^NK"9
M[M7F8)2TYW*;](-4S/9;K*P<G8*-BI?T<#)&&NI.$>%QY:WCCY0)^'%ZAAVU
M+K>-FA<DDM= LBHAGDWJ]-5"^M.UBK([N&1V2/._!<^3[V:HP8O+P,VRZ4^(
MQ"$?WV*XN>)$A;V@=LSH_8E'ELW5.MHW=;]=4;OA=W"9:2,[_')YC]R.A6+4
M1] I5_UF8';_)$V\M\[53(N.DB<2+*9U*<*0DX2_VWRIDQG-7"=G^./F1ZSQ
M?ISPZ65'6MOE^^-B4P[\$MV<24\C;]VT12UKL'._)%QX4BOK[S7:H'30W87B
M*0T8?3S)LG0U)W)EISI,/-[@H'356L&: X>Q9\,\U_R_AC)JD,D;Q"4&59!&
MYM_\M.U2J62UBHPA$V>P#)/6(I,;$VF,[2PW/LIO126L.$S=MWKAS..(@S ^
ML&E/@KR%DFUV]<*6E#\NQES-T1+R4LMG+]%GG:.3);N'U/T[?>:<_(#-)$+-
M[EP4%/NY'))ICQ551MQ9N[A8TLCO^\@ SHFKEHWLYNLXXTPL_-N@3&T.(SK'
M1%#LB]2SJ.X\WE/:O]7G/T+M_[ICU [9+@JTC[,)G0.Q?"G^;OYWX094 :J'
MHX$6LC^"J5=Z\U/H;Z']5[\=0NTMHP% /@>Y?+ 9A@SZVTU[J739'(4 _G^X
M2BFH)?1<4HL4.BE3C+P9$X9DBNR"T9(Q-Z@M9_  ML4@"N-IK<0)&>[1TT>K
MC3T_TL/6Q FYT_W_48H$EVFCN. V^^NZ!S<J"R1BIRH(2V:D[LI;'72I/QT"
MSA'<.!7I#1I*\*-<4Q//E(E30=)99JZ[L08,V6]RU5]:)*ECW_IH.5/PPIB0
M $:*551WN?SF=07UZ.*$F.?.G@#_]?KWBK@CG=AJ5R:BVRS$./>MIKNS (]C
M?;%,SR)-RVZ&W2CB1TDD A/CL!5*P[6D?HO *NRK@PC2&D>XF0?.HD/&TM,L
M58$O=05U<L%)3#E('B>GE:Y:N<$Y^98A_.)'9E(2.R3V]@M07,^8)1@1KZ_-
M0P:_3 %K'CYZ/2V9:ADC=JG-J[D5>Q$,D84+]<UT_$&1'Q<WBC]7C60VQS^^
MT:\IW&'M%D&7K2ZCCX],QQ?%VJK03_6QAZ<Z[2>TN2<.5'U$%AUNDD\EZ5HP
MQYW9..#S=^/,Y4[YN SOBA4^6DFD0XA!TF%V&[E%ZS:&LT,"+03?=(A)G9W"
MA_"SA\TLO_@\+VVHJDQJ'S&:?3D9D?G!3:RV(DYP2O=S4,;M^(?M+_E:L%Y-
MRCH:(8SVDU>#HSP3&RQ(#&:(5&PS3><4+*6>Z%!=I2XS!RS\90AYX_8=._9(
MX!?@Q6&Q*[6)=!,N3!.'+0/7K/CR.'4%WN 3U[*<K**$D9\Q#DJ\.2=B*YI,
MZLO13DO1*3QKIXDWVV*ECQS9YM$:B&S\@C/WI8A!*X+E6M4$WW%^TGEA\:[1
MU5.YS"[)K(]*RE0QKX4R2CA6^1/71;5@V-T=ARI\;!I":(! ^ >N'<6W8%W>
MZV0L[%VG0M5?OQ/B]^N\NXI?],CD0>I!:BLL.^VEC7T!?CQ,:I7/?M5@U0 Z
M29?)6V6:?$I3X#T(XVV%I&W"@H*.86^_;T3D9=5-#5+4O'Z"PR@-M#OI<EH)
M/-A^LH S^J58HA2.7+Q5T7AS;7=W:<)[6K*8,^BY R=-WO9#>@/5UZ:+_C8P
M4F%)J6)5?-D3*J#BD3) ]5^5QQP?.<'4="(JTR9DBY+XK-'X!SE#6,I4#_]1
M7I)U-(<GIK[V8U=<?,L*5]FA.([.K5P/.;E9'IXJE7$X%O2\&E@>E8]S:44#
M]$D=$TWXM765E<,)'31GHSUX_66TV/.LLO>O/;U#NEUK'O<^_$B!)4OY!8RU
M:_ */+KXVH-QQ'IEI?<(9W4\!1]!\LA=4QVU#&:=:,/$LTY^C7:,3ET%:4PV
MWODV/Q1GUY#;IA&LD,86F>1A/:+"VGBO_QZ^O!P&!RVY1RQFC09-)%T/<M/4
M\,-[:R)RHX8CI[_OFQ<VR3-X_FEH5+O\[0.MX"O)S+O58!=+ZPR#;O$IP;6:
MUZ"!% JJ=T1>%#-AP&D8;]00PA@*"F]>9,(D/>4Q%W+L_'<\"XVT-_<XKN,X
MXPDA:O#=EQ1[7X4M^H /FG6'4!QV*/IR*,'& ?CT] B9TY%8;DC?,,Y%\-K^
M>S?HD0++N/(+#U9Z6;'/W21%S?G&1A#L;[ U8V^#M8\WCD)TQ3MNVFBO Y^Y
MQ@C=UKOV\+Y#RGZ<,;2&G3)6EGX0RVR3?/:$,+^GW,+A:RLGSJ L$^"AHW_=
MY@#2EC#'#253S'LS-F'(?WI.&9)HV[7!;GCO_/FF% ]==&#WE1)[E(RG=X=6
MNL0;L:N.A<65DL]9(/F0#[H-'='^H>$&-LCAA7=7KG(R86-M5.A3Y"#L]AUR
MW;P=[0L(&$;H=^D'&O*92MM1E>G.2=8$\WW\]X<Q:1*O.20-7/C%&'(MMR&!
MYK E>.P)O6ZF,O'G3Y2UK4O^,GF\ 17PC86D@9MHX)'ITXSJTL.&E901SVSD
M1H<RNQ7I)1IX8RN5:PT?7H"[RMCK;$9.G-':6S+= HN8) 6MIA]BOWSEOQ+0
M@$WFI,#<2;V6<@U>A[H%!R]!:93 - ,"IHKVRWKVY5E-2^'.PA* R$;B6L.U
M@S/=L9,]PBEXX(-A^QU9U1R-+\8S8*^W]T_#WH6&U*@HEJ]R6E$*"PT WD'4
MJ])[.]<7F4%MB1.E.7TNN9K9L*SO91#UG3G/V:JN33.A#WU.#=AXMH8(V^&F
MT8*9^3G8E.T$#8U'DV6W](Q@:@UP4&&9"_ 4&:1\=GI'II)>HP>?6OA^["DF
M)683!H.,9N?)?5IZZE;1'#/\?*Y(QPH[0XKNFXK3'L@62ER4MF@@>N3T1:G(
M7-/BF3'X/:S!S@-?B65GNJIH! N(ER4$3GAXH_<G.QV)/>OU4-]&BE=K:JRC
ME]PK$B5M#*8A'[*L"-CP RL2M[X Z6'<?UM^!JY7#O(W$%+C/E(0-Y+DSF6%
M'K$V6N7#]4@SA965FR"&'>[/9(2Q"Z2UA::0:EA*VF?PF7X=R<1;8A;64;.)
M:^MD)['6WYOFVA$?W<Q?L;!1;,5[J=3G3&^@.$?YCG?,=]RC.$O/R:]JM"AA
M'=WT='CS:;(&X^VZCOOU'4V,PPZJP967WORZE4X^)#.:?!(T/92MU TU[4Y,
M3C$Z)_B38D&02\E9$W *S:B8.;G:A+3]ZERQE^O(Z<B MPAE!"/.>X,S<:F>
M0;LS'FZ<5M7MWJ'-1T8DVC)H@$AYB<[MI'2L?>9^/[M5,O-WQ.7W?)<?+I\F
M@M9;3._(\7887?F8;]RZF(_4GM8K+8\1Y[?8$M80A42*"VDKT,&T:HOMTOUE
MZSM2L5WK=_1&'X^P:/ N%\.V](M=7$1[!.-XU;Z&].L2\#E5 /)Q?<7;\U]^
M2,R))[2A.*3EFBK>%8;SK@E^;^NWCB?_VE+@8*0@3J[@ K\<H,):]&+=/L\%
M3U(,"&0]^7 @EAI"['[0JZM'9\C 9OHQE'/=2?90C;[35NE2QK@Z% %YZ91;
M#C8:SQJOC$CD$B=QS]AYT%C6_SG<G5._#*/*1_N!"R=G_F+ZS6.[HI?Y(<?P
MXZ^<Y;1X,+$GG9_Z./!ZB ZY"6\[3139-N.Z&B!<EE(IMKP<$@I-[!*B38W$
MQA-[;GPQ&']!_VJ=-X5WY,=G,LJ#G!8T0 ZO[HJUB]DZ'?TND&/S!:;JMEX^
M77"#2"&$M4_7(G,/9A ;N/48AJ"<L!@KO9EO 7.5%T$#K_-F^![<A"TY"M-*
M=;FP+T0II62P#"@#GK2O,6E94C-)\Y3YP]*:DK+*INK1=>L:R*<9CL\"#(\9
M=O39MLV3<EL+(5'^"1[2#Z(M8 57^1#,3HMOW$*21]09N!*O^/V /9 ^,AM4
M!GR02ZQ3>QTIURN'F4\T&?H,RD;31[ORK9G[:6GFC,G+[FZPGW^\[Q/S@I'S
MA9/9I2.CDB.5/<?]KVGWH\9#F+5J<[D_8X?]UX5X1Q %JHRZN#!'4E#;3K@G
MH %66#?25Q 5$E9A^\^=@]/3Q.9S:U(,#83>]LQ736H_Q!NY$G^:B R<Y;I8
M>U<79-VZ0C8X47H,G6HR9F0E-9R%W))KC&@JI8:U$H1"1\=U"HAB*![CX\SO
M%SMAW(P2ZB_/-8')1=OU#JXD'MC"9.M8$B?$BXED17B4^6(IN]<.'V/I1W1+
M%;WI9B5 :"XA7V"(;)NR70I1_.ZWG8IS?O6:JDNIQZMW6H)@JXHW7G'(>E^,
M8WRM;GZ[C_9MQD'<6F6Q>;*E6>W+Z(*BS+ )406\O!YRR=@^&*G68I@AR(8,
MKL9Y$'$6LF?O<#+@/-(FX_L QEYN.&/<DF>M)QLQPMZ$Q41\S6Q9&7BI6=S:
M-^!BG(@&.L_V-Z&0(?[CMYVE8'N8(7L-V&>H5]%TRL3?:\6UP#CJE5'7FV4B
MI%8[V6*/Z-9;&<C=R@/F3Y.#Y*]O]S9_('VP'*/^@W>&.QL_W+-YH3O4QWJ)
MA*CCVI:7=7#^X@\V:1/Q>)OM.;]5D8I7H?;AM'9?0-SK4D5.?M2>^5UUW1W\
M/$NVHE$D=DW7@]?6=VB<7QZI4K9=%JY\U:9_)Z"V#.XVT1_6T<;I\)&YE)OY
M829F/-%85C><-BX@9HN;OC!3$.-P76CM7 GL<A34PT0Q /[Y@:?H>! '(35D
M_.A5YGY59L+1O=(2PY9KV'DRU]8BM=**3=(_L& MFD^E'[67-+Y/C CJ3,X*
M.DE)?:&W,/-LD1Y'$DP,KC0(+/5S:& 8&P?9A(H-"*J/[KK9+@6,MK'N1ZCM
M=WC0NU!<PTJM_X#:6%DO]#:E\C^ DONP'41%R@H_1R@MR=V>-9R9F@4/?3>2
MU=OBQ%W->M*FM(83%1<\8_WR"Y\?+D1:^$==5Q(TR]@S]<&X@QMS(=6AT;WR
MMNNN%H?T] %8;P8=DK>F,3M9=#^UK1Z)OY@:BA#SR)V>G8=0;E(FU:0)=16Z
MU"=_E&QU^)C/0@:7R8(+M@R#ZS2S4S/A49?77<_=MA@YU1,=N6\E2<[,2\X'
MO)2##&'&2[F.3*SLRV?V=6-V[MP3,R>+8%X/-[DWP-/+>>WK8;T(#=L*,587
M/M.69]0":>$RWJ1 );]9+XG&PZI17*AUF"*AEFW_%,<+^XAZ)G)5HS,&;IS.
M8ZC_655AAJF)Z<:!N;%GF)S#BE'!;F0H44=I<-S4QZ;GNY+'W52E"(H)UUF[
M4;V2\>>:X\UAQ96+S!T/'K8[!S'(DWI\X<+/ADQAUD<']]Z7T-TWCXHU8DB.
M2TE)M16!@7EE;WVAEU^,IWG727]__<PRAG?JQS\3M_]N*3+JZQS57 ZM"/VL
MMGVSVJ:D!G<-?-TW@<?WMIE<1BYL_?-GTNRP RTJA,&8'[/GQ:Z]I=[;1_L5
M\?KEG22-%996^Q5/[3.LG[EP$T_W)^FOF=:T8PW ]9?.PA&JBQ\:[B8&!8U'
M)N3-9I?4>8:^NU--_F%9L]TE$!^&374.4R+UY%=@51TV$R.+:M!<LB=2>]L^
MB,S*AVU.K)L?9E"<DR>EK2G1G#P\\+\1-6"R<J<[=T8N_G\JD4A%,QPU =K:
M@![?U<TPA)DCH!#6D^/F"W:>X;]%R/\K"O%HKJF&DQ-SX[NXZU"^^ONT7+:R
MQ*Q&YE5VH&/2*#2 K8H&KJG$8;"7(17I"]T1+60 OET^RT #"C_0P#XG]$#4
MM_P1&OCL"H53@N")PQA9FJ:^H($A:1""@!6AR?I\#/J#F16%&X6Z66'[F7CO
MMY%5I\58+_ Q=Z\X, A>B'%$F9W$*"0.9OR6:#30,7%?FMC]+'Y2/>T.5]4S
M6Z;9:ZLTVIE?.,*#.2([)K64 6=W/^K2T09EMV(CN/Z#Z@D'1</B#"M#$R8;
M_FK9'9.+!9LL+600[=0<UN*6[JL]^;F#@A9>DY<!6J+^#57[C%PU5^J,N'$2
MAUVY&Z3XMQ-MWNP\SVQ\/_AB^ %6= ]G[.%%.9-KW[69B9S_Q4*'3P=44:^&
MT<""&AI8@JB$_?>TI)4]QWAI+I9QN\0CXMVGA?PX6:1>H9Y[(!I@$48#D^.#
MJ"@O8/C?6"..C 8:B-JQ1#5A8N-=92.QY"PTT'U:B@;,,0WI[!A3<:>'_5$B
MZ6.6Z%;#=R.5B7/HOG*P9^89"2)>%8"VYD!(7%W87_VX\\HWX_7*Z-8:JL,4
MQZWB=%!WQZ#3B8Y(7'[HWB$:B #,TC'+=@ W'Y-CTO+F/I0H]-<*EE=8!K(V
M&R/8G4D4&A"$#_]6&\+;Y(DZ74M" XI$YI>(YF757RL*1(40FA36$4<QWG.?
M)!F#1+ YV(**^!-6C[R_LQ9VKF=4)P4<JA+U,*SMTN@H,U*2OZ+F==D]DT4U
MSB#=7<,/W,R;),Z;TX^-=0/U1]/5LHZL(I<I^6KP;=FDCRT8-]-K=LS;]#W,
MB3CV@S\NOY6[Z8IL&=/FQ]!/F2? ?3H*EJ]G;[Y110=X L-1RU'!V67[X9L.
MX4U<M9?\R<7O9<>>=#)G,I;D%8G'$*R$VXBB 7R?9\,-3G(5#&Z%^RG>P:]5
M>=AX&5IBSP?>2&J6M37/D; 'I-?4-N%OT+IXNI\@S)DC,[+4[>A=&TN,1,6W
MUR277]?3U;A\.UWG8CI(6]8*+O&,N=@]NG^@FQ+H=*/M7*5_FZ)]58UQ5WI-
M2;3)?;E5Z.Y5&1<%YL& )G9PBFS#Y.(H8W^4>L,EHV:CVOMMW#I_9]H;[Z]-
M@CG"]1\;G"9(D[R>%#'6S)GN<VY=\TRF^MJ"AQ>RJ0"X;.@U5XO.7UPU0@/S
MJVB  6A4?H2:&87^N Y! ] $A.UO%>P3:M5+%TV,\P85(U'F!QF_5CX3C>F(
MG[TSN^7],B-9L=5VYC;^:%CB_PAQ 4O+/?%3XKM'F;<^'9_3EZ.!2%2EG'8S
MQG\+)5!-9*BP&'^!864JX-$_"E9R%K2[*P?CR>:7FKPJY17%<#@FO]_:0@/@
M+-L_CSNH6^"Q';3N9D*C O;KR04[1;%:=241=.>YDO1)@$MIORP:( QMM,5I
M2F]@7+(TFO6QWT>(P_R*63(<;U3VU]5-SZH3$ Z4]=(H"W6O)2"W:G6)QF+/
M7LIQM9IQ'SQ/I:#MVK<SNM8;7_?I[ 'E)J!'_[Z=D .Q&;:03:JD$CXO@??J
MA..V,E\'SZL8+46%Z_YL*PS[).)]Y@<5\ES[<LBLB5#OW);):J^*H*S9#SM5
MQC6P*P,QYU+Z-R(*5E[5-8ZJEL<^&'E>>/.]%A\YIQ9/T=!V'I;D3HRT-O8J
MU2,%O%^+C2WH8%D0Z6N"!GZ<%3)\&X(N=YE?7-2B@>$]!0;1?SLCL@%##Y %
MT,D13.^0?(SV?@TN?PU*56%^CF, G6R 7ES-K]101@/OQ-X@O;LQQ@VK_ZL7
M?:*)VJ3T1RMMO_$9Z*AH/NHN]&@ NA>M\V\FP?7[LT$UFA5Q9'ZYHO/^X?^7
MGEUY'G;-O)P0.ZKLVPM)E"3D7CG&NZ(#^E"--AA\6OP%*_\H!:Q,,[+RU&/I
M8<9;D+=)+^T7:T=WK&H2\6VGG[\BOW:8XE?#O/4.+N269Z=9.+<)\;"S$C^X
M\6FBNJ0KQ<1:(JU.U\( ;[;BB3UNC#HGSJ@=)H(B?,'-)_O08YTX]UQS#%!/
M8)#/'!\-**LKT-K^,G=[>5U]V)&.04'#\:76_)$N=#717<QQ9Q(-').@@:];
M_T,T=D,#2!SHH?3P*<86%U?0P(K;/P+47Z^H3A=C7($1(_#$'S&X&C/_D 0:
MX"AD=<#LP<^.*%6C/V+2+!03LN81D16^=6@ ]:KYG/D?H>Q_/87><X<)5-?<
M!E7Z ,-7ZCI_!4E0LD'!'BFFK1D3EB8+S"^ SR0,?P!"GE=7(>3SAD1=,B)]
MKJL7OS9%FV"*X=:SYZ2>0 HW]NJCX45O;W4:9>ZN)0_@@MXD$![ ^]'\;0J+
MXW9TM=XUNV!%B(.K<:L(GS5.O>JJP]TK!BAW+#^'2F\S>-1G3XAIU8@88^V3
M^D\J2D1@,ZHY0TLRGMR[?(\"@MD^/<375'8QHX6'IL'[MI?OU<8L#%#%XMF:
M$O((Y_+1D=3R":5D<+I*;MC^MP-M@^621"=1LF"71A8XA7UDT3BS*AC/_L&(
M8/F#! $N$=7K1TS">=VO>WIKVE)L<3#4-PS(2L=HAZ$=U;B,,8>RZ=_$Y&\C
MS<O+C]% <3$R.R[#X,+WI+)Q+CMF1ID1F;];[P\=SS)#C9>A@=0^Z.4%)HK2
M?,EKAE69'YT[8@!<'X/FOS7F"R]WN(LWL94/6[TO1,X(:U'NR-Q+H\<]QEUY
M)_/:!7&S  W834$'5YN12/.#HL<&0X_UQOGW0-5\:1#?.XP_#)0_/K;8%@H^
M$JJ,SGJ,H01]>G*V6"G<\&0T<+4Z=-LUMP&4JPGV<"))M--8+;BY]+"3XV$_
M/6J]7Z%MQ:9)RE3C- 357CJ1,^[#D;N1<R^9/YMRUECZ(P/^I\^NT0DO(O![
MM?@Y(5V;WR=D26'5'4A0Y_Q^0D?)]_1.QZP>1ZK2CAPD6(7_L#X\8,$!YU4G
MQ+:)N6H?#02+V4L/FKZVHSV32,AY%/>H=T V<G-:XLGV3-X5+[;/A$T<\-9L
MN$>KUUZH=;5[V>BZM\:30S[H\X\*>#JI=;A)0[%#7=UT7=[V\J=R&EI5]4%Q
M2S6AUBHJQ%D&V%<YOK1NF;DL@H(9!%\W:$&_*!5TNF3/3!%=SQZL#!X4P&57
MY?-IO0Q0X+G][$.,QV1:499%&+5#X;A""[9R"](6>Y9:_U*O#P7E1P-[FQ@6
MQ?JK?;#'J:DD;L_DWNZ->=7*W8(&>/Z5*XC\&TA]2T6I$ E>G*2B :7@BM^=
ME*S[7L1"*GFH([2<0]JM!3)3<BEYF"1L_?+<ZV"0>C6U')7JF[.9V-9)FIKY
M_?WK&=L#<(*XMLJTL55OC RQ^I%U7;(_$[78ECQ_Y,L&WH*LPG"CK#[#^Z4&
M@ZBBQ7[[D.FI2*Q3L38?BE(-\<F@JNB73RV,OM_HRJ+N\!#^RMX1<O=09ELI
MH"$(^\Z5%P8E<BK_!G+ZOV'@>__ZOSY94#V\XOX;IOWN\0H$T=UB)+/(JI12
ML?$.O3Z^M\3/;*ZRJ$CJT&]V[.,_-M'J>.NK?:AF,VHO>+-AY+['J08^@=-M
M"Y:;4H!#B.Q+63]$ZF+>/$T#*8JO;M\] V)Y8_8TH<C09'V Y[K_O4+>'3ZJ
M=_F3>*7OI#_YNU-ZEBL%0^"9$Z['"5JF9R&3:@Q3OE;TY_BUG4:5$WR.5<B4
MT[EE5U[G)IV\J=#R*L7 LP>DC&FMQ<#^8!NSV>72L]J;Q5FS4^ $2CMM.5@#
M.W=_=<F,<6.NMNG'<,69^U?U3+B!'6F6:_OF(06."_N(.M%23WVC,H/BF^X@
M<%65P2ZEY/VTKHF'\5.FF2*FWQ2Q;'%F1!NU!TU&"_>.+S_L\161JY-T\-=R
M/AX*G-&MZ]J'!C_==PQ^+FH,7JL-^ ;BOU'#5DO/]8G,QX^Z_!<&X>F!4D8*
MHAHM,)Z$9SOA\<9S'_41#9B50G]@^XO^#$"\O)W2@@C.%,:QX\+][M,^,-NL
M$Y B5*MVGL&);_;2)#Q2Q*ARG87]P"'?LM!TNM6MC'N>L,F(R6F75TUQ8 JK
M7V)[G3.>QAT-P!CNXCG>J'M6/=R&?.LSK%[5<?ZQNCLNLH# ^?N.J5[Q BOE
MUISPD!ADQUNC=E2T2IB9OV)*7#1K^JSW+D*-X[I.R8L<%ZS8+G,$%\,\ I,Z
MK'#^_$B]*#F!!M;/T,!U+KA>LWZ"T_=:Q_W(+8T#W?C\C,UHVWBGF7JM[(W]
M#T^]7WRU".$ASZ'[D-P2,2E\NQ6[4;@A%74MPA$%A1Y20H/<4'@3Q6))WE4-
M2=^$RH+.[RRS71!^?/1>][O!)D87+8I_>>9OYXZ0?XL$HH#^:Q_P>*6IQ!)I
M,EYD)EOBTMS\I?S\)9@OSN9HOE_XKDZH4D"8Q,$[A97$,Z_]P7#:1.OJR'!:
M"=KXHUDC\(\+'PEUNHEWINHAC^X_Z,SH*_W>JQ:MR,;<^FK'Z/FDA+1O0W5\
M6^_&D&C5DB);1&GO+F##4ODL[!;6O_$UG5_)7,5?-#HN&];./Y$]2.PP;[?9
M2X &].*\M\7GC_9HD?L\1;\3B<!_-G!?DE0C+CO1@ ]A2MC_K8_[*3BE$1H,
M/+>JG.^$DS7%Y1B.0+^VDB&]>M! VE\\'V,%5S1P>-L0.HD)3A=,8AF&HYC
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M4@N.&L%D&,W'=RO_S#"4W=Q(XAIB9S29R%4D9&-*=!]MJO_@,3J<AS&VL'#
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M:V@I;=]R+CV2C*M(X.,DJ9'W:=C%Q4FI77O%Q/565C__.^+IJ&BC2,>2U;F
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MO%\_&CADFFC>F@(=\UR0-C#I6!(6">G=E>LHIA]!T<#+CNX?<$HOVP[-;KG
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M\IK!G<.^JJDZ99=!^ZH,6X^]HS>O57(2V72=&!4F2@B0 XL[H+8Q,Y;A"J.
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M:WNQDU*]D?,7W*WAS&HHAE$!<0E#U)E2XX]$U1$N<")4-=3#]$E?BQDCO/5
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MZ;*F6>[!<PT_X,QBMS^]PYA$AY?%*OSBJ ZQ8^0$:9 S4B=/\X,4T](YY.A
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M<M?<=A]W]]SIMVK=#A2)Y=T)7MXLHJ2/@\9&<^L1N(CB%_QT*2'W4W251%]
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MJ@B7W?!"Z),;J%R-*0\>OU2ZFYP*NA6:-V15>.FWL]6CZ[:5!-J<UM *4RD
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M5^H!(&C'EC%ILG4=>A_Z &2$),K..*&C;UBA-C#+^R#.NKZWYQ!^\?.G/FK
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MH)-I=(6[*6S=VT-C;/EW@E_K]#77B5B94W^5KSB.J:-KB(2];Y]\ 'Z0N3P
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MJUH)(?&W*B'-X/*Q4->._*U$%&J%'M[7F(V)/368I[UW@ZPOW[T3K56\/7X
M>EJOIU(D 4O(^_2KS0<@$G*6_UC>G0P\ .0/P*XZ& \F][_9B""VR[G20-:D
MLFVF(B-Z?_JMB9HP49F2\$[SDN!XR?3"@)<I43WQAZ_CF%SN966K!ORN12L4
MX:PBH,NR3A'2YM%3F_U0CR3UN\T8K0X%&SSRM^&9S^FQI)L<'=Y[?42SBNF
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M%CT^ZP>M L^) GXSN73L1D+G<"$&3P*B \;*QO1T 'E0]H+! V#665'5;#=
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MOMX@47VU2VSM;1H;1D?KTD60ACM%':0,)4_\HB_]I6B ;*D C!NJ9*L7OWR
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MGORCUCJ1]46$[24GRNZL<Z=4UI=J5KQI1GH$CZ9%7Z\)9F).A!:DS9O0=S>
M3_WZQ!*53CC%N5Y=,SFM5R](6GN40P3QQ+795#2[YR!W)'@X0[I&=Q<E#9<D
MM5';I6KM$JG!F:Y1X"RST/,5U%*IWC=SR.P*1#BA4R$U5.G7EM); 1+TI9-Q
MOAT6)?&L)0/C'4-G=H:NE'</W],JW T0_.[D194Q<+FZ'>*\ [X>]W7I4G(6
M;)P-.US.4HJ]6.R,?07HK/,4&!ZITC>S%6UG,J<"P)(@U#A<V>[L657UU MP
MI,AY8^[;:BG!,^5NJ) P($,4!A=F?G<\%N#M+(MRAW,0P-60^H;"%D=?603
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M%UQNH(+;BXFOA;[BL9YOTDT%PQ6J^S\DS@Q(73J+>C=6-%IW0)W;(Z(B#:;
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MD0Q12\JY75D!#VD_@%X<3?(\#&6A(&YV8??V+=QY)1"N>(BAN3;R?0]2I;O
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ME<9F.+X==]2A'=2296_.D;"HG?@PT2K]CI_"B%E0.];FJ#"K(U/"H<V,+DR
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MW]B8"BO-[S&NO>WP5$6QZM??*]-?S?T/4$L#!!0    (  2(>%IWP< ?=/
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M%W3G@V+<#XJ2VP9NV6J,XC]OWC?GI4!3:AR]2O&[P4#OW_)Y+I#PI3\^-LH
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M"](T#^> =KC(Q=]:*<S&.28.L!-U5Z@0*=.V:/-$M.STW_P4?[0^TNB:JX
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M\ 4RKW-R%HL$+ZLP<HUB@&5L8[%V@P1!NSM:,3>M10#O0@\[#,".:PNM,,
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M;LGF#2>?.7I&69_J\F*EDG7^-8VN#U_8\'+)'W2/UL<=ZQV1Z[=5K"97&#\
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MD=<J]A+-NM[/FG_P/LB%N=4@[BBO@/2R/?-Q0L-7M@#SIRXM.^%KH!E%EYW
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M+F?&@:J4NG<FW59SVZ3?DYD@<=5E>#%N><QE,-K=?!W_'I;2?1W"M?C/L?=
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MG]3K9 G=U%ASG&V4$[GCI^,<7H;ROE]2C!!G-:L8=_OLTRMR;HM;G=N(V,4
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MJ@5C1PKU*.Z.5%(E/FB3L2VHP[CE@S2M'+ZU\;<-T^W&14W-OE@<38X*]AA
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MV\D* 5"LA.,Y-<:#;Q,A#AA[L.EJH'38R%=[\A8-Q^A@JW#XLP.<O\<,!A:
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M4WJ1EH^,IZ)E6M/7.=[#[)13.8IQ-:E?W4XRE[JB>)\[,)2=7KV#E<B?"..
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MP%=+[H5-R"=SQY'<D<1M:PK@JQUZ*(K<&B"#UM,4DH0(6!A^L?]1[ ?JO5Z
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MJFWR[!Z,N]]8\NV;FN9CT13K7YR%30=WP+MD$$CV'=XKA4 $1 2O8-D)8/J
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MT+[*%,R3\W</5H['.N3<"5_7>V 3]L/;"C_P/;D8%/UOX #^ASQIV>D9Y^5
M6GVULV00=HP,2C+*C?]E1G7ZL8/<[JF N;&!].-.YAYQA:S!B>]V\V&^XWR2
M"P&J*:Y<Z*]GPM2N)(7/J^CC B?IINN%[$I<BGUZ+Y>*O?YT?BMDTT9DJJ5A
M433N,X8]!M[F0-5X-]KRN%M>ZZQ%F"5E7_:/CA3-*T/QX7!JM(]DKSJ%G)!J
M<?3?M W^M^9VYE6F5?::5$EA77W%P^?HOB"\#GQ%S;<9)R'%]H2 ;;/]2=A;
M>+;G4QUORN"^6AZ;G5+(T/['-_I]74>&5\Y18(W!J&ST;C)C_S/OOK3O8TO[
M8=Y0@SJ_\!T/TM.*2OZ*)M.%2U%*=2;V 83[^ZJQ%]2HOR]7+ZR*W.$7WFE_
MRQ^)4-E@+'OS>*/-]JSVY\]E%ORV- V@/B3WB2ALJFJ/;9#GO3>-@]?W)QI>
MY=*>-+0L$QYC2>HYKPRH8^7XP?@#%X2886@EC''9D";Y8\$XO"G(\<TYS<=R
M%Y99/<[I,1_8U;3K[)>-=_XGEO%_RC%!,!R'!6._P?CV$ =& 5]U@$P<R7D;
MX!&N0089MVPBXK'(/18QVOT]V(*97 1!:^]HAAR#7M]??!HM_^N)O%?9BS'W
M@1%Y,$S3&# '_D]3P/M/7DL__VH$#VSLQ ^7UMA8^DHE,NV?LN$5C7JF,F2\
MK78"9W:?_:R/@*JHN&M[!ZO=!Y>6!5/O?;F6';R5 V*=T!M,N[2OEVW=8P6'
M#]UW]BN5]#Y43SM/.Z<MUB%\IF58-L\V('C^)FO@;8>6)5,!MO6D-F0P&<1O
MBZ.U+-DB@T1BWWPQ7/$Q&^7;LV QWZV-?@L%&\?W+."OJE001\#OB%1.H:Y2
MGB9A(OS/3-J9I<UMI92KD\V"!WDV"V\6?'S13*V$L#<<[+,)78+QL\B>*Q[+
M6'ZD(JV*V3"H;+;V#PP4$U#Z-F;0,"\/MCC_PL3[M3!MT$O27FZE]*:1IT@_
MAW]P>?1+A0J&) -N+F05+FQX<Z^(6FNC("MM^,V;\OY&U1,7.R?@4DH;S5GY
M=Q8,&YD$NRY^$:O*4MKRO%JYI5\[=.K$N?YQ/I$L_^*2OMTWC])<HR%OV/N3
M#"8BUCV,E8T\R2#*V'Y1FU7!I0=5?GD2]70]M3%Y8!^QN#+ZUSV.UTZ7=>SI
MCLUTD4%'[6(XV]WB<B<;$;L)\56<S2DYUA'$0KOML?LO*>ZG#![6=81+6<WS
M8V\HVUY;6U"_KG&[^?ESO?/\FNOU;/#0(K5+EU-#/H7,!@]\[K%7>+,V(QG]
MVERE5_7=>$,8OY&"#?C3LN*#.(ZC(YZ 'LR:G6.0 =T!#Q?Z/WQBS_W*3M"0
M4X3ZAO?TQX&+QZ9&N)D>76KTWH:=-^E#SB:-P0;O:*+/PJ88>\6)$\(O]OM+
M]R9RJ5+QW_*$3EB[HNJA,]KRK"8+A_O5%_4VQ[Y:7QH1O7,%/NJAN_!F>-7Y
MQ$6K>;>'U'%%F<MYMAXY2R3.TCC]*^<W AW 3D1>7B6E1;6[CX>LRL0'5>SM
MWD?<:I4I_'_MG7=8%,NVZ$=%V63)45! R:!$R2J21:)#!B4' <E#D!&5-.0L
M("#@D(<\9!C).<,,&<E(SG$8WK##.9Y][[OOOGO?>^=^]^T_ZOOZZ^JN7]7J
MKJY:M5:MUB\9E2'Y8"07ZGW@3<WD9ZMLDTBWZ@GY[I%Q)'5"F2*B^/TY0D!)
M]#125[2*1R( =;IN.79LJ5Y;H1M)2>FO[=%JC:2CV+-E[ES$MUO$I(R4V*65
MV%(.6U;7?)[ODCW+.]4\H.*:Y[I59=B4ZFG0T[5%+6>ZIB<P9L,L#D*XWVFV
M(59,-R:VN:]_TD=SFS!6LQT6Z.- 7YGTD'8L)5E<JWQ7AJI*/&^RZTX[J/W$
M47=/2DMS<D&>8E:UFM/A'OM]:"\N]+YZ-6X&MN^IPR2T'A"G0S@?_5O+W+^Y
M_AWE%4O^->;]3\8\;2V="<5JW;$H%M+I3OY'^5O7VZRIW[MD[W=\31EXV:RA
M]$6 J"WJNM7J>^%!WH_K0.QE3=F42=\K-YBWG\<DOH8)I3<$?O7)%V$LNU)U
MZ:AH)#N?_)S=AU6H/B?72%>'X(7#OHG/H:2 48U!U[%*YLY"XD9S48?MW<*Q
M\;&(. E3T1^:EMVIA0OB*Q> @NP%":ZY/!BYS B<J\K>P04T24#+!I#(NB4M
M@<S>Z4&FF6?_./6+**JGLI.XQ\9-^\;K=$<%[.\N/5:=&<V8<7-PT[@''I@S
M=>W<TQ0FK;!](PW?2#A-$J+(4_6>]'48Q1NYI0XVA(W343HJ_L?)),MFAR<&
M$1OH<@&@MM%3]2T+FB^E+A04AU96.F577LMA6/H:/O<Q7EC,+$[/.-41S/*4
MF? -#=G#P[F\OFV4ELZ^K\-;2P&=QE>1;/(//K\38;]UO*5344\V@I;,!GDV
MCJ_2\OH,#\J+R4WKD>F@IR='RC\GGR)0Z,!2]:'T<^GN5?"L:5UY?*Y43J8@
M]:DM>]1UUAR<=\2>\_>@ ]YO>9:2WWKEC,H3U>5+O4D<Z\H@M&382X2@&L3:
MQ@YL:WJ>7\FS>6H^)[/(^9YXDM$F+':[<T$%S)LG]/GJZFC#H@Y7;I2<2$3S
MGCHL-6O>88]/15*%B&".8CP,9FV;_2//FO+X'O*IB;)SZY;2)E<?6F ;<P%0
M'(%9(A);8.N^I&^3:20"BDV>BWEJ?WE1H_^$<BM;79;R[M]\7'[3B. VOR]
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M0//:DY !.:RGJ2V06TB^K,<A0J(G0J)NY-O,0Y$4D)WQYH "4#9VZ3D2_^:
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MS> W 5B.@\W!CS3('!4$A%08?179^IA)J>5#@Q1=>>V9%AU/HO)G_YN%N,-
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M 0[FY@?XR#O471$9#9FP#Z8QSO9BQW)I6>L]J-2'12'#64*W:2FC#X;5L?2
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MS9^,4;D&62N)Y&)!J"AI*NH"]V+J3'W?X++>(+V#ZTU;(T,BSV.8UA<1(G4
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M*+H]IN[\K0@D_Y?[/P_ J+7$%QDGY)!;$OU6>\84*I?,9/A<],^]MM1XON$
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M21_323])TPBGJJ"">[R!B'Y3EU&#M\USY*4^Z*%\E'2E@L536R6+=!.*;PG
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M@.>'5(,!Y&V#6-L<OIX@G&85O.6N0;-6R3O:'H-'EADS'Z5Y'JJ""OW">>L
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M=T:_7)W=K10P%ET;!?*YZ:4BCHDTCS@V5%3L6V1HEVQ9Y)CMD$03K9OM)&E
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M,ND+L\18-4 IQ(>AWF 8W\HYI\RCD)SJ$W1U*5K[+8)MTKG5UR5K[ [,&&M
MU(S'6C\_KG*QA266B> &T"SAX4W<_/E37)J+DK7 #E>::GNM4X:F,X5N6FB
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M&D.[(KU4>8*"YN=32+$WQ+ I<X1W;8M3 :,WV$&7\0Y& !3J2?5R8.Z8H>(
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M(QG58YC4ZW$)!Y%!_<L_53EF:$7"Y#H),EH^*&E/@4:"TW 6?:/5N4MD5&=
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M''WS1LUS%#@?='FWP%X7,E/_$@O-:F,.%G@E#AA2_N> (?_/@'_ -[_&ZFE
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M/OWXKES5R< PPY)6=(S\^$#(P/WI"=?]6;/2LK7R&.5ULXP)2Y6_=RYF#&E
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M?<II=X+IH3TUOF#5[-##D+ Q3+87;NJ#B@'$,)A>U.0:,<=?Z)'F&"X@;(W
M[T>1-L1&V!#.,%0[*S797G3+N<%C%"A^O<E.6S6E3!.%<=LRI'!O( VZ@ZFH
M^;CZ!S.HJSW#='G>5@*+IYU6U[Q:LL],'1 5=28N27U:.-UWG79JWQA.IIH5
M]447G&BW=V\=K^=J"K#5I 26=B<_0?O%CSACB:Q83[TE?>S4P^7HCJFIA[5V
M![;.-Y^F9<"[Y'@TE:[B^JMJ))8$,!Q,U<$V+VIL6:V[+!K['_91N9Y5Z,SV
M?7;PA9XK&5[, !W,!$K*S0&WM"/\74]C YC?#!].L[UK*4LL'/0. (\H$59
M-3<OZ389=?)8=1SA835RVPQ8A9TUEDRVDM;^1#,4WUE*=@^]$' L\@I1GF72
MQ,UF(GEER.6O!R.F(*4?KR@IT;8CMJM/K(-+TF,9S=K==R].#>8Y7BO/EZ4_
MVU?G1<_TU^(/8$8BN0Q-G@(4A(K<I9ZCM!3;C%&^P7"XX:5*:TK8H&3X5!D_
M+CLD@P:Y>DS/*(93(J0W)R:T&/)3U,'8T&<S"XDEGGEAEVM5/Y#L.EE'*LDX
M?O/9B[ZO_QA,72*]]Q3"9T,A/:$HT>RVZ4ZK:"ZUTCN4&\( ?;5S/#".*8KO
MAV]Q##(6O8F2G(R-\L#<7OM4:0YQ[Z VVAN,#&$E,J)I^ YRY$*W(F9.25X(
M;>'O5,>-67[&C77P8><M--/JG^2UV))"DV)XIWNM7"=,E*3X<*< +CY"- =&
M(NX1"[>B/_6X@Q65U(!#N?>-@NN"N72MDR/H@%7YTSUS-EU7.QOV.%5524UQ
M7VG2'#%EL3O-[D\V:QU 6H]E)&5P9I8E(U65]2CSB9WSOL2H2%5;'8:3T&8O
M(XWI8$-50C"IX7!HJ?HDV]%A5XE-<>/O6111\_'-Z/D@93ZFX  /M%NY?8#1
M:R-LYZI-28)*U ^%:_)F1)7A0&C*1/YUFM@*DRO/Q@=P49Y:0P\A0D;\M6:C
MT-: ^66-O_FGQT,QVEMKVBI$W''MPK@7<B22?,_P'-'NF:8Z+NXL(&R_8].]
M%7=&ZE0E1)O?0&Y 1FQV?Q8^<W50!PO-S9] FC.#E6#C@L\A/ZV%-(0\)MX\
M';B;'<G]<3#:-+FVOC9L /?&2&P[L+*]Z).RM,7=D@>/G+=X_?9OZ^J)4&A]
MG@MI@'M2/4T:$;'L&XRD9"N_@H[2I*MR!53"R'[F0(W1,8LW.//KE&L)]LW;
M,#1?8+//M(O: @,#WBT(J&HCK@XFC9Y7? 2O=@>M55M5/ZX-DK($G"6I'*)
MDBB,#M8*T=RU+ %?HZ>%D/-5%UT',[BTHVQJPB7*]9*!VI*?C&(+X4D("18%
M4;&#.EB22M*M33.&,.S_.S1^N?/> N',=XM4A Z6G*2 XLS9M FN.%:C@XW]
M#C1_KS;7P1YG"_34NSC0<#HN45]$[7UG*O10F+JH\TF0,)Q%0;WV.G 6,+N
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MW^",DC7N;>8,5GR8]I&(ABD[G/PCAT&[$1TL 0WW+5&_FOV XSG'ER&K,.F
MP$O!;\>>#Y?9 [=J@GNBW6TG8E01PW&9ISI*2SLZ*'N@A"&IB:>J-Z>\JD?<
MPQ]%Y=BS4VZ0MCC#D\O+S1<U/[]UN.,XGK.>0O. QC,'1=D#\JG#OX._GRLY
MY/:[TCM-Y=,._Q+_#>Y[1:.DZA5R WY]+$(0G4PN%:'XJZ=>^">6;BCM:^MS
ML4ZO"_+F@/&- 8Y')2SA9(OX+NDSH2) 0%I_7%!@Z)]AU&(8D-:.K_Q;D'?X
M 54O?MX9#?*\O7GU=3E'#M.2"UO4?8^9>1*,>C.4MYA')&"2S0>I\2WK=+W-
MW%;;? WE^9MU5:[&/#KW@[H/K:253]MT*XS!%LWJOTEW+K6*D_</6!O%66(<
MCZ%+E7G$(:_\JRS#<EY9197%A#=F;DZ) LIZM3\?*_ 8=PI^S+RO"%6MBA4+
M?5)P-J4N0OB7BN@&%R./)^%Y<R7[#.@5%OY=][:-H5G5D3H85G_<GMYD)#(>
M.XE<S_7N73)WKPF[01*MMPBIK0[?%XS,II%M!]&4><UX1.U R:'K+:30O;<>
M,Z<54JF!@#2;+]W%$A"2M7JQ)UII\69;=3!N7DGJK!/[68#K/I3QW 1F"3W^
MFL*80.9'E(JHWI+VV2J)N!F@KR)B,(("Q(\2S!W<(=LZS*.(3//^K?0]7M[<
M'?E$3%<=7C88PJWQ0F7-9-Z->^"N(31VX)$]R(>(KPXH$E678L&5>OXV8%+@
M)@F^"O5%/\?E#FYOB29)$'9EGMWII8*2]0B'BQ?SJ-W3'XO]2;PCO\=]FG:P
MO.#NX.14M]H<TDUM+JSJ&O;C#'"2??*BCU8;!ZALS$MF*Z1D8;%Z<VR3-N&T
MW=Q"#<5%9$;6=D9TZ6 X=<WRUX==;+JTE1=*M#,I)1Z]QCT[D$U <@[\*]SF
MRP**K>N!Y.$JQSYXH>]VNA6\C7%FU:%XGS<7GMOW99\AC 1M33OX?&-NV<7V
MYQ>[T([ACD=,S3)?,[*)*@KR<_45S6^8Z@"_B86F\RX6I+V1VNXZ-$5/9<)O
M <4^'VV'!T]1'K8#1L&H0=;"#V=]G7 .G\U7CHW2[U*XJ(\0<_MUXTJ57+CZ
M$!0;P+N=H&0/0FL"GA9K#?V'71DLR/LBB&J36F"2I'5 >FKK($J;@R H?U7V
M0;8$6OF+JS'J+U<JAY77OX7?L?=HXKF\#'_D#Q%T/K_\D77GC"PITQN1[=_)
MI<M1:ANYY;\UYHZY_8*NKD*J)NIFKD5:@):TDM7H&&#":@P-%QJTFJ\6'.,W
MOU],/U3M<.?*[:YKR75I1XVB3.BY=$6^V#1Q>GY $20,4=7[ _S7?Y9!VP+<
MBM'!%EH!<=X-Y&H*6WN1JEGP[1&F+>XW/O/[WBZQFXOV9R<C!0HE%"?'5]=G
M@#<7 V)BO.9U,/HW]P3H(?_K;^!B Q10$X!H(:0B-FCW!4YAV5H]B3:_;(K^
M]Q'_Z9RM'73_(A[-]KZKT8V$_!B^V(3-%DGN\;6Q4%]>^:-=#+OE;!V,B5K3
M<-R[!B@[>_<H$YAP('T+S]#!MIB;+ZWJ;8 +"E:?Z]\<_)9:_-Y%'Z*]U5T3
M.,A1/BD/$O#O.>W%V;^C+IZ4:'.%.PUEF&K7DIEWE!93XU+J'R /LM;*2RF2
MK" Z[.BC598 3;D0=RTT7=DE?:[[TF43I$]*XP<=K-.B.UE[($!]0L$0?CY@
MP](/WYOQ$YU&/]R^O@'@>?$N=:CW2Z\T6N?H8&#/B@<L;P%7F7N!_= \O(D"
M,ZA!,[9623U+- @*\\PPN2#8U@XET#\(;\4*3ZV%#O;0 1@]":B]UDJPK9W\
M^:^"(2O>^?,Z0(B5Y*.G7H!<!V(\DE(!-#Y (4+]A^](X;_@/Q\^4*S?5M[#
M,DOP1>]=>=MZ=#[47[G3-L4Q"NYI,-G>H%F!QIM&R$3PD9ZK3Y J#9:Q4D K
ML'?Q].Q>+R]J;J=T8&$-LV^CQ4\6OOZ:0IXWZ/!G4?,O L. ;25LOZVJKVLP
M1BX(B3*SK:)2!^.;K%0KNGMOH 7W@^3K[#'-IV@[[XI[RV\]1C/Q,T"<O\)?
M4]I M/8-/.QS;>)>9^B'&OU%$6FVXLDT!X5TMGVTJ69@^%K9=0M>Q;"KH69<
M.TWQQ@QYMP+C8^<A,V:NU-W31.!\B9ZXR@G5W>Z\F7>+W>GH8O7& >TN(#B.
MQ#&\/PWG. '+C>1-2GP@?SE43@?TXPGJ(XT$M7H:*9]':.U^@)3)Q0H=C)3A
MIM6Z0)21?6!OZG6<AW'-A#Q1E!P5WRXZ%E>N7@VD8)=-NO_^CLL%KFI*)L(N
MYU[)\#L&-I'I,=,"@S&[%GWW]#'2)A-+C?,<0E&ZQ%<$,Q!*13]"7*R#"<.0
M0X'=6KR-GFH*4.0)BQY\V!)T\!DR[Q(W>FU5FL).6G12$51F"Y;&.GGHQS['
M[*M-N9COFV= Z PH*V/X7L'DYD<!\63(NX";:A_I&KU-+,F'$ZA]; /[IP^B
MW^2K3H7;V4*Z=2ZF*I)##E#A.V3 @O3Y/V(UCZ#='LG^]]Y)HKL$[AFPL<L2
M&P?,'X\R%F)$VP7@G<"-O=5WF+MLL["/_<W+"?CZ#[W';E*):B<_)<D,)<^K
MTF[$]Q<>4D0)PZ./_:SREB8]R:%\>I$_W1<7T=DQ$@J%%=]2#J358Z"I(_]]
MZN$LE>F0#M;=]D@'2[34P3;[MA\1B(.6L%]=5_-G'@:0'*?]*'-U@,U<$?8:
MD& :F2><#H$"7O,4DUM:DPC7P=95A.I@",,4S2*H=G?0;@]LAN9BJ5+"5XH.
MA.SPS?&\]!LXO'=B.F=P$*6Z0QG-*"X\Q36D2FW^/)L:!)UM3]2H(=C,& 2;
M^#=C:.BH:_IDFTZ[+/^X>5QG:>41JM;!5QA;]?FSCAMQQ=\<LQO%W^>@[Y$@
M&>LD:8=KYAFHJ:ZC,1RJJF8"U,,9<B+(1]BEQ^%$B-1Y7\]V77A=M4"5"24!
M$ZG2^("X1YA93<2(K2^8TIGA;8M4C7N!HUX+%'PQOB?0L(JMW:+(B!05U<W/
M?K@//XR-NXY6^@(<'M(N-E^&>">:RZ6$]#],5P3YKMQ[W^6G\3\@C-^&T[>_
M2*TJ&7:=M]%?+,)WT"#,L#3\Q[12B[3;?V[_=ZMLAGR=FP-8J6[CV(&90@Q!
M:RRU:UUOU5Z9;FJ.];@XJ%]UZF),.V,\."1$23]"[U)[39$DK*V(_W"9H']X
MT#. OU(%T^:-?^J1^+[)4E!O0I$<9]S:G1[?W09LXJ+B>8T9Q?U;TT,RWY_J
M:1\G6P&;[:2G!UK8$,I!+?ZC"4@&M?2!@NQ9'6QR[$<(KU>*QT<\DUIX?/\@
M_/S9PX3?=OF, 7>7Y?<:] 7\KX;]W[\/RS,LY;X*VFR9QXU1WK>RBL0TRF,T
M$Q1+F/:='_N7Q;7'=M] ?#TSF!-ETY6.RL-R]E>'*/-9P<'<!=S 1Z3DGT=O
M#33_AP?^&>)F59UI-YA4UIS:_XON+8I4J8&?HD3HN]2%C\Z3.5\<^#F@HME0
M\WX 8"SX6"&A4YK-?/_9A<_^!32BG0YV/#]E_3P0F@PA_QFU&"'(,0,F_QVI
MH#&875QI @H)8"\T?93'$L-,&RK_9"&IH(R3U.\M.=7;O1?MA11&J+I'[_VK
M]Z5*,"]-$7K#<3FTLCX-WPG()7\DP" M:N.5BUK0[ND^--&;87]8_K/O5)Z?
MB.['^)';/GZ*[.G3]G^CR-<G4F.U/EGKSFX&9#902IW:*<*[L6=<U/K4?SW8
M XGGIM#,-.TWYY N^%? ESA3:=58Q3O'X*<%R%,$UUJ&ZF#M_76O*9NH74:F
M@(&<_(ZY]B.IJEWD+MSN^,EE"?M'A:^P\?N1<.O$\WTM=H8/T&;7JN^65>'
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M"A8BZP:$),R>@E%ATQ&9AQ*RX?)\LT?V2<PA)633IVT)DU9>WE-VR[2(Y0(
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MRX<_*O_*)+3>9ERA8R0]KH2\64V?\8L?^")9'WY?PP(.",+=@"TXV:B!5%U
M!.-WX>_JD'?=P2[,_ZYQA;^O8;H;U+7?MN[W-2S97OC_O?0^ R7QORR^GG4S
MW:(49@-S]>GCJT]/CPLY3GR5JS(CL5 2UEL%_QR=<+)W$:]:I9E!3L[^;)M_
MJX2T=F[2S;G"=$@[AK94(.TO.OSFUYKH'46'6][3_[,T/EA*/*CX'R7X'Q/Z
M+Y/>LJ$D&,C@@YP4*G(5IOD?$#V^'WU\W1G1HR#V=-MMJ'FPY!)R[E4)*SF#
MD". WW=K EQ :G\5L^ZIXQ,T_"46*IJ0_7Q'1^C8<Y^:4ZCOPPK*<$N;=3N&
M&U+CN$?K[V)&U4;^XD$WV>'JE?]'R]S_3SC6#WNL3K^C_/U$.PDO$JZ*>^G-
M?,?%6(,(PH^IR!H9M(<"Y0?),JMX%]EVDN+[]V#7R)M@"^-7X(X>G4S1:<K?
M4V1]5P^@X@#A1=+#-"/=OXY=_N:8I%\0:S7@M@C.3C=C#;LQ!Y&&7*)GWYXJ
M^Q6+6U6?]'3[+MVPB>53;AY%2?!),KLB=+;+:QXU5*.<VUPG_S"46ZL)V5<6
MH%"W3L+Q#X$*=4*AZ@Q5J/*,!-"W<%2*8,2?.Q*<5=?!P8]Q? @>/[_EL"(C
M]Y[X[%2/S6VK?CLXO?G)IVV4GV"78,LGK4&P5+2*CN$H](E6[&X@Z=%FGP;&
MESTRIR)"2/,L/D&[3XL@- 6&"#^2M1(/O1Z8FYK;Z!E05\MYW[D[3(^ VEA3
M)U C'YEK<:KYM;!3+]35T<E+\S^ON]RTSYVOZEY8IE W/C$.O^\W-^S;7MZJ
MJ83$Y3$$$/^'S^$;92@@=ORNUT+79K2T0:';%[#K-LMQ #E;#)<&:YE[1'^]
M5HT%#(Z9)6&U/CZ#HVE-;%C23(2!U,):LU]FE>5H.H R\;9W,Z'Z3(!HL/8D
M-S##3^LR;0^A'F(SV(2C$62_!L\\ %4B /<QZ"[<QT?VK8BZ=*L,HX\8.Z[S
MOCDF,O'A^(GT,TF4'_ ;I:TWK.^0I$W+:4J(ZLK@)^)*R>5>A@4PSR].0UFF
MDX^.OV 3)47TK?:E-+-)3AMU*9$'+,&E4U4/^PQC@@_/?R?Q]MY7VOE?S>3_
MNQ__C[XT'#=4K%^=0G!%!,:.,>A*9 WE$6F2!QAZR/*Z&I40Z4W<QY9)QNTG
M))F7FM/HM]UV:EGW_^@3HT<7]H \&;L-\RU07(8&W7?\IA&SP>@3JC<&(M[=
M9O=89 1X\I-B2BBLNDGNO+G'FYQ)F(["!NTAB02N/$6SFFDD5.#GNM?Z<!3&
M\R\%R?H*0R13I+:I<^[I?96?!%CH1R6D B=3._;25@/P7]+$)=,O%)%?/[W?
M>HQ^D+21&B+J7/*8F3XT*ZUCP'.99TE\E[?X47R:8@_FS" S5)A6;<!JUMF;
M06B,-P+%D^IWW;0_W)H;A)^ 2[R&F ,>W*A/1 ZR'<071XL;[UYY :MBWC!1
M0L;NBTP6O@H3M\3(22ZA5D_"<5L^:EJ!1C$NS^^6US)#]XSAA[I>CJ@!"*,P
MG;W ZSW/>K9]X:%^[K/Y/&9=7<=)GUC90K:4*O&X96-2!$PWY--2+.L"Z3W1
M"$=CB@E'X>VP5Q HRV<>5$)&\Y60SSIX54M-^VQ.D-HH)T2GG?";0K9V,(V=
M+06S'W-P@KNM<H42$ABR9L8(M4-FIH1<PV"[L*JBI9N+T<^>E=/4<S^B-CI&
ME_C)/[(/$R:->XY9+WE<EO6GC*XFN!ML=-D*,$^)WM^T0.V46=?U/]H6.JAC
MV8U]B4)W9M1=\H*B1N!YU93. 09:_MC&==R) NQO31X7=5TE*PS";'>*VH=#
M_75J^QX\2]I%;[D]WE$P,5S'%/<K!.'8OFIHE1(B<!3%*R&@0<]T%G]TL1!Q
M?<*NMWA'-^5>;MU;'G5N[USW<KE<6*=[9MTP="?C$-IIU/!:!,9K'.D5E:&J
MX8GA[2\*SKK*T2PAF9LC+>=;93;S_+LYG073BFU *O_X%G'_EV+U&GZ7H4LB
M+SIGP/XB;-2R'W,68#U0=,(K@W^BXFYI>@[2G5'(8A^#G,\.<KMLGU4K(0>3
MP#<MU9>_9TI]94*I%R8<6!0;21#B#ML]\OS!1IT-]%[9T**S4[-ZQ?#;DHJ*
MC@&.NW-[.YD6,7%?I<[V2\SI;H8.QFS0)C&J-RQ^2_9C1]))=IR7YMA:?(=\
M8-(-R5K"(NF#K]GO93ND_,^SM]R4#/@?&-1G/J/U4;[L7J ^1^[=E>,-HU:T
M47T0B6_9IUX''<*]U&<=O,@3E1Z<QPWF1!-%SL*4?(VKN$OP3X=#U2]JD6,&
MI1ZN1"C]^?,L?$>K/&<#2=&>!N$"_=((])I12B;AY=DA-+X%:[65W#2B+8HI
MD$B?Z%ZH\7;)<\/""R($((F.V(4H ]9)[="QDI3N181 Y?O!JB,+=5<1B8\!
MO OB6$'<KMBU@<,L)01#Q3#%6F X;X$.(20/Q,P6/ 38"TL;41'GT.'LVN-T
MA?_3H.X2)82T[)47:SKQEMR(#/0KZ5_PF!F4GD>?D-Q_$WV,N&6C0->SQU!]
MI?IZ2?,$]VW;/'(85LOQF03U-J6][Q/!PC_XIA\'$[B,(<^]A%>BFCH3OJO/
M=NZOXGXZ-]4S"V7N2-4Z5"'MEAH#A>?%M!F>:+!)<V(A/[/R:8AZ;&SLY<3E
M(G1.7H'V]#L4.UNQ?HE/_$*F!A#&#]OJRYP9=14]*$O]WL7-V"/ACP+=<:8G
M91F=4.FQI[! )F#(2Y+YB.!\8H:IK0'F^ZHZ1L_,HE5O>#0P7F$?Z#&7"].]
MW"H[%ANE. "1J_XQD/GS0=$%!%(+P$R2Y:+"!F8WGSC;$Y7ZJ-;YP(C$"8'(
MV^46ZSPA".+0)I8)0LOXB7,,!JVW]'UM;?ZQA)" 4/W\H+=/2$MWRC\<OJ_2
MP03V.\P015VC^)=WS<=@C61]FS5C9*AG=?*NA=!'*5WNO$QK3(71OL L+"J'
M.0I[ %\KLRM!UXT*KUIR+\,,O?HMM#9R/H@S"*H^+7-F\H5.^#ITR>2\8D.<
M]&O/D'B;*PY2&_06P 57>K3"M"9!";$94T)^JCR@A,18!074GAQ@.I#)8U6T
MS"^V74BVW)#54N?F\>;,NFS% /234B4D5.6JK8'([L5WC-H4@69@$W&N00++
M5U="8F/;>3.5'EV\<IH@&A$@U08RI:W)"-PVC!XM^]3 S/MP7\=W)!/:B!*2
M>QLYAXVHL.]?4L.>Q;)AE1WGL%P==='C[%*GA^B <;W<"B"S85C@=8E&C,I0
MS"/=X2LA': F$9^M2UY=7;U9%BL]A3E'I_5&\W1<#,B1./2(K[OWQ3J+A-C$
M_J#E'-SS9X.N9C*U[7QO$J\1!)(:V&U>-M7B&[:[43-405U'J$V7+"4?U/W1
M,HULP$,2(G*Y4;53G>?89^,0_+BMF$/+O>W3_%F&-E-J5!.@A##4:TGP-%C5
M!#$IN_%G["NVA?>F&-P/?I889''<1A0-1:#%<CES@OLJ)3:&8JU&AK7(I/A6
ME%_0X#E1,_=I?<K9:R[#=\YC.A6ON:6[?";=W=TI!=$NH+=MW*;_#C1E6A-T
M=TA,!"N2 EQIS-"_88>5?-2[;:Z$9 YXS*B(>IMYE="9QO%C9K=JPW4T>J+D
MI^;=,WLF9[6::+V,+BVGFH=Q.\K<X01AHE#H!EVC&()NMS4(^7$$LU&>'T'%
M0[[V9C>>Z:.RCFON=[?:?_/"!5J80*%^88D A*SYV'6-N-MFC_0;]!9.B\[&
M/B6$:I$:B/9<#K_MT\&,/Z)6X[X+#FPT2AQ0&]?1 V,0'K-?5#IB0F6F^",#
M&A5?/A>U?ZB6N'8F/.5^R[F$\!QPR3\H_[@IT4/:#^))T2GU.BFTU8[9,_ZF
MC-!R95<4.L@KH#P;\7F2%]:=LQ1K-L+Q F]S 6EC_)8'4A]LWXA%;84/?FLH
M]A#C6<7SGW%/,A&LZE\H4N=RC]@EW$@89$5S7#(.!!?)UO7:&B,N3[&WI#QU
MT;_[^.X33T%?4$W&7>^U25X,9#=-C%1"PIY@].4U-OO%\#'U[-&7HY2;.BH#
MT1>,0M\W>VL,?5DS-QY*#$_7Q6U"#CS#170-O6^%:CP (L==4C8&QH[#4FH;
M$>KQMD\X/_39AA!1,%/!@%@PS)JKQ+ <12X2$4T<VY0.389NIV\NQ>P#,N+F
MO(>F?G ,Q+QT6<ECP.ENU;(ZGUF2^9EU U7_#=)/_W<\#/^(>'(2_W 4VV\G
M;JRIA28:^@C[/?F$@U#MY5'FN]=8J!(R?$().6UMN9!C!Q][50+_5#UM7VG&
M'Z)IICDLA'*=6$5L@K-9BNT^S"1UWC;,.GXZ!2BJ<J)L'6*_U:Z+&7;4^KZT
MH^-!GA?H>[%3 DKOT7UKQNO7C<<*HB,IH<^FH96/4XM#S?WLM+G#V .50<GJ
M%R8=J<%(CL>5BXRFU41&X[RWK:.&F=AMLG@0<#F,D?=$U4-;;/7]3GQ7X_,\
M2'H>&L;,QKX=RH?ECIGE2&B=\ NN7T/W*OJ)E>LR9'9B1 -TM^T6GJ>7S%DT
M# LH<.[/2WK\-'0>*R@ ?%1/,AMK?(1&!_JVR=SEY3([%4DB\477%X#](@,N
MN(MJWL9EJTCH!3'S1C.:^]9,X#A$"4J<(OA$)&R(]5=A/+O>BE7M?SA0^J!.
M"QEQR6VY<!C[D4LEQ+;'"%#US^-@+8F&DGIY$6/'M&(3$XCC,Y,'8M55$VL&
MO9(E[ST"_5@H)#7O@M?N Y4G>6! T5AB?KWOO@J!R7<&&A7:XTK(AD;I/B6D
M(5()^<)0 I/ V2"GQ#,KD7/TSA'XR')L!$?1'POB?OA5:E<RO#*VL6L#^G:7
MU-J_)^J)@&*RJ9PUX3B/J2L,<@=C%C5!;<<G<_@,&S^I&\9&S+O9^ZUH70K6
M!&T_.^=5Y?6PG]]3M@!XRG[NFA1X6<EYA$G46)C+VT%)M+BK$::..0WDB*T2
M#\$T 87BV-.%Q*VYU;WC&8\"_7A-/+H2@DB"Y^7E,RC_>!S]B% +?<P12.*;
MP!N]%XLY"\>]V4Y&T_"##^<?9,74"MU!OUQ+(^NL%\5DBY8:O!V2J[1<GH7$
M.U?%N%LQ IS>-6H*[$8Z.GAF,:A3'T+^8^+'.+CJ@-'KQKN:\9]]\-\,.!3:
M%O'ECL6V^@CDJ9'V.%V_>VZ,CX]<N(R/UDAN7=CL,AI5^03D5(Q= $E" F"C
M2-T&6S5YKLWQH@_QOOYV];5 -<NV*(_1/6]NY54 Y)%F7*ZO=-VB.XB$)_LP
MB?R;-M"QH1M,9#<2I3Y[#'.JO>#2M^V<PO,13%-!/:D&%,*RBN0FL'T<!\4.
M$3_!Q#[XH(2$BVA)G2_[A8S^3;C X<O,NF OK5CI@?[%B1V?\)G4]S.]%Z3G
M,;OJ1<A.GB2F</<TKHA7(?1)>-*?XT4 <G*X/D.D%KJ16%?2(8K!(_CR@%%F
M"B8Z(2@]PN8<<BP]P;/L6@8C_.=7(T&3"K,<'-=;ZI\&$0&R->(UX^MF>&/$
M]9CSV=]URUS'G+2FU]EJS?NS>X[DY$(74ZX<FEUFUL.M,;MZ< @EY*H2LBG<
M5C44MEFF_]3@E]O>H0SKYX.%/H<OANZZWA8.2S3@#F-(G,M4[$_=7T-!O_(2
MQ@SNN@G[1&.L";KUFDML*9!'$41?RE6M_37!Q]K6-WS$?W*YVFI@%UGE+6\4
MEX'=(?.4/Z02=WR$#N7'IMO K4B%SI(G05*W2N?++(.WW#Q;KW,32#+<T_5K
M'0WI"5_9E3=4N J"^(5QE<H.3XY>][2_VH"!3YSITHZ#CFM;6>6$\/1Y*QYQ
MEB8"_"@OF1E*2!5-L$W4.Z;2C%H/"G^CS%*D"#6=B4HX?OKXJ959?K[U\@1^
MZ>+Q-ZVS=3X3RTMFW'_=RM[_KQ^?QO[!+*E$VA]^,NU.41A_C\!MOI<-4ODI
M,% = 7!*2*2*_/#P8(_;/.IWGTS/NRF,TXI%>T(>IKUZ\T_E87Q4: 'Y]W&#
MX]<;_V&3#$+NK_V/^,N_?YR" -.29W*R)6PH9;SXZF=O;(M&.SU.YT3[69Z<
M]PCG&8O N&O7Q966,LW\2IEG5A/:63>9;?XXLD>D>+"EN'#J8-S DKLP)Q"V
MLG'3UO9ATJ>/F=:XT3(E9.ZLS1HEY(>GS(5H-'SFNA2.P%5:IS*Z(M^'W5O7
MIW_NR<=3/!OD$K;[<V'=7I!>S%;(R#)C!JW_^&,=<WQ39 +6^_8M/*?6J$#D
MD%&%NNFOU4L_P9=_J^WBT'=AGCQ+YAUHQRVH[]R3PPC\X?R@H[\C^[\:Y?P7
M(ZS]H.=RHIL'E"G:[NUAT!T2,E176A1= 4B.N:\^P^7)W*S>&*-TUFBRZ^_F
MHC6PJ84RS[SSP*YEOU$7-F^,UZBR_BT0W*AC7MMC<0QJ/B.)Y#2PH'FZ)WGF
M]IU+>?DT)81?S[#%==LSE) 7Q^ *:_^U=HFH9\6RX@R!OJP5_+4Q 8-10AYF
M)()Q/(:Y.O2%0N&)"ZX4IFC+H!*2,7C5]=S,?MR^A%/$C@2AS)K6VK6R;Y '
MK$/\93!* BPK(7::4B4$(L !7+3:CH0-\':=GN)Y'?"WS0+QO"+-<DGQ"?O/
M(V&_>QV=!L)<2M73?_9E')X5R1X(#N ."IFB$1X4]J$0CAO5IOQI&$N+,_Y>
MO@,AE*U9S=X6/7K>]5_ZYE"/?_Y5W'IEYD!"B<Q3K+C.W[P%9GVVORQW1)L7
M QL+U9+GN 6A).XI]C?4AAU6"YSB_4V!Q7]4X+024FW] GJ#N 47S-R$)O#[
M;^!!J:W?'A+KW>CO;,CQWCD;D%==&8>0?L E><B)N0P0I!<6?K3]JAME<Z)(
M"8D(^6K$GIV<7V&!C$35+:65EI:2:3&\ J&[Q;C]H[C";2RVO2^]]=D_T2LG
MI/;8=L1#6:*H+$4TLNT*WPS:BHKE/SUKGZ^?Z<RXN)Q1DQ? G9Q50NZ%4U-
ML'%<A$T75ZBDP-=CCD4G1C_R<;B0H/]K]HCOE'5[W>- O\XE[.S;?FQ@[F.8
M!\',V(E0A6?O_;][;&FUQV  %_H7*?DK(7\6$T5/'-L(5Y?!YF!\0U$UE4^I
MPCU5#/1.5LW#N/-JL><5:H#+.$[;NYZ73->F &D#5NS>CT=]!T/(BH6P_NXV
MA[&)5*+EB?Z_]G;]:F^[**P=_JH^3&!=Z.HL@68S&[/2T-HEB?9D=B*2',=:
M)PF7S-!L Q+[YSB3PQS"!'F:<IT!JZ#VET5@-H^=-*G"+W_1:8K_D10X-RN?
M1\IY[>T\:Q$5%NRP?%&GY\''W^H0V$7)2W^OH7%(8@-J]Y2M)FKK$&#>I&$+
M]62[]]_OF438N4D[WQ\0@!'RT[+3^$"P2+/0<\NK&O&/9?:EB-BHA&R7??W\
M'J]11VO QNYX[6S^<8,6I^H,'-NSO[J;A%9I&H&*=^A ^VV.D4+S%QL/-!9Q
MW[9I=]SJI+H%! YS"B:\?7_!Y>I*<E3@O[&LOZGSKTVC7!$7-Q;PA@8E* !G
MD"$Z<5H<02D-)<3CTQ;AJD 08FBAFGW+K6!">@#$9AQ<_ZQBWJ/1^W1V'"5L
MX"@RJ<Z7Y^^L3:5O7'J451!&D2_T9QQ^0Q)>SME_'L\^SOJ-K43A?JO ]=9C
MT*N*3Q5MI&"^B@;ZW!F )M:8$0U/;]2IM+H;^$//7EHN605D 9WS1AARW>59
MCO]F<3=6S1\>4DMKJ.ZODCI_NTOKC&CV&5DOW[>= \;?N>Y+\ *AN9DX44"R
MZ-\ELVA?U=FC77\U%9QH2R]H*MW_YE>$H%_!B6OG<<!9^#;<,V8UCO^)V$%B
MG?U>"0G%71Q.+&!QZF+S:!%<9K/O4@K&L S=/I?@M\:^SY)5@/:>#(GB>)EJ
M'O80GFPOX;C%)DY]>%<H*S<'.R#TG^ETHWK@W+B?=>/^L6-=7Z"O#3:6EDR3
M7(HZJF^1EWQ>!W+F<?7^Q2(SR3=BZQ9ABJV5&$F/?TS\//V"A&QZ>,'+5,,W
MZ[NZ!]><634YA9RY9:)Y(CO/067G_*F#!PX]W8/[C;-T^(WWG38;;6U,,#$;
M<Z<\D)T!D.-W_<@+J64>=F\6AC3.T+(Q_GY-6=4#GFY>#)0DE\YT$F&9Y(_6
M\?<*'H9Y)Q."]7[D^K.]VO2^:M-%9GC;^95T\ Z0$J>(P2>63^2#[KOMMV+^
MK3W[NXY1DFT/BDS(]8.IF/UEZ!CV1/4W5N3'G6$52DAMSX'9DNV DR]5Q*7=
M+.Z._L(&%FWNXS/5X_VJ.OMD'<V^$LGNG*.Q%)V(&3"2&#N"8@_Z9\2NI83<
ML&Z"BM)![NTL3WF*:S@FP5?@PA,S72KB>/-=KSFT6.FQ$MX-[$YTZ]AG5]KX
M^ V(>_IIW.H.]ND"R\%<GB NC!.:<!3&V@K6Z?7[*/8[6U,=I,-*T/#S1.>!
M*$ZG[ID4>6"1H.Z$,4YHA/F_VOORJ*;.M=^<#J=:J[1.5%!R%!5ED,IXE"&U
M'$% BA-CA-0B01)#BL@D(?M4!12**2*D@AH5$"&$%!DB)"0*0H1 &0.2&$)"
M@S($$I!DAR0[7_C.6F>=V]Y[/+W?<+ON^O[8^2?K>?<[/._O^?V>_>YG\XZE
MD%N:7EU<1/?KO$JFS-:4F5&="\NP.UA3M 4;7%[00Y43XD;D<D0<>.N4NDKM
MWP.SG@I*S>(X=Z>*+.XY89U<B@IN%<[[FA,J.ZLJNV@-=>Y'%>7M[)4#]SA*
MT\ON!^Z^\!-^S>0[-=+&DZ"INNS*P>6A?:+URZK\U:[]5=BYB!1V)#H=:3/W
MM\VMCPIZV246T6O<$Q3<,<9,SOW7 OMG@:LQB/5L*\S&/#$J]ONI1[$J,TRM
MKD:3I^L2IVF%#;-ZP:,A9TMOB[FM1PM\TTNZ.6]SW&:EZ5-Z!F(+^WV0(H6W
MK+8_JHAKEJP8>H54T/1"D?>0O+'HT$0>(YU?P)$7[^%KL!/IKI*>'&<<XC#[
M1P6[/CVJ\J1S66YW \4I+^(PY\*?1T+4N?.,3HZH;$4O>62E7RFQ;QKXI>/\
M/?Z+=>_6+<?_<<@6!*1 EOJS U)@#=;"O/%Q1"^7&MJ!Z;=7%YP.$@6SK!2M
M[9Z>F;&LO1*[M&?QR(:.TO[S(]6%+@88EA<L1&KW(TS_W7.#_Q7/7?]8P:[!
M2DUF-KTI?EW?LP_'J3W-B&Y<*)[ERN2B1D:Z8+(*^J/NT."#P:WUQJ[EW#RO
M<<]Y/M87MXEV6L@\2['O%"+!BOFC4&A.T;W7;V=,WU55=?+JR7,V(67$;L_5
M_9Y;=1<4KIF+6A3CC*"P8K-K\&B4SX2/7M39N5RDNZ)@_R<DUUW>9<9EK'G[
MMJAV4Q4JXO(4"^/#UPBN=\/U6=X#B;Y;ZQL6S +W(&9GT6@\N"'ASCHP9!P!
M1_)<,PE;Z2G9*X1GKR_3!3\:-.!-.VYV?M\^C?]$13>OZT+YVPEF*CI+@I2;
M2+US[H-9ODT#LT"=W?CC@46;I,R@X#QB<"X;SXR<UGY%6#UDS\&0KIBA6CDP
M<<090?*+^%A)^H;<^NII\Z13#9^J*OZ]>S&\+QQELC686ZR77+>W;L]UJ3'Q
M#T8#8U+Q.^IEK-S-O8$6(U'1FK PY&Q](AGUQ^4/&:0O3M/? 8N$7J$Z%7][
MW^S&D2A(;8Q!8A456.8I@74/+X3\PT!C__<#/8]Z9'_9";Y6MT-_;\XYW320
MCW?B?.C\$\5CL2[!/\:J #%GB4:)C$[O8( EL;%]U;2SBUCS'"U"ONK3.,OK
MTH&?SD!]9HQN"YF&?$['K+3T^ZYLU[QN1\()&4@Z]R\0C!C][5-ZBJ<'=G3W
M@,\3^(S]#&*-"#L:H]MY(;?G]L]UV)_EFJ39!4^UD6G*4U#7[%D[E)<^+Q1+
M0IY$'&\UR_Q!C!NLW^(:QAE2">0XWG:<Q8OAI*$%Q$C5_4F_D^R>>1OU+<XG
MR6]E&JRH@XIK3*D_SB\=;HS<AYR>FTVI_&W"=B(/A<SY6EI#<D" Z:@F1?EH
M#C>7!4YXJ-_>Y(?9D;]-,@6^. 8=414@?E"+?_%GWZ]DCL)ZEVH]YX;'O]P7
MCPQ[F<DON.;_,1:]<Y]TRE_C)3@!18G?RA&>/"SY;1U?:OY;5ZZ)I>1VNCD!
M,VB+9V'I ?23+]I[A1U.>[DRJHN<PPRJWI9M<Z9]K_IKWS<^?T]X0&])>' >
MC:Y0-N0H5[6&)U\A(!YZ5;Q>NAR9V,QGRL("H8NM[SDPK)]4T%]ELJ_HOP>P
M<KP*K70=F767'W^R=+DR<<MNY*M<]IS@3R+U:=2L?@A5P,D@\]J_TI<WPZ],
MMDKWI8_ &>=#7,=(YF?$'[-<RU.R6I<N[[]#>MCZ"BE"LH-N&&"O;3_SLB%T
M/JFHOLX^O]CR.SCY]/_HM-6O$B/L_'^2+0'O'5P?,G)GQ3][3S/D)>>1_5.$
M62RJEI,-61(\C1[&(&Y-R2OMK0O.GOT4\8B&D$G'S_=7:G(9&+F&C&&(T/3,
MAU76 P6AYTK"S\GREN#*&!46S"]?_L (P5R"):U)#1=G+.9T8T/KM(G,]*)N
MHM#2E]DE$-OFS%,=">(DCKO-"W=_[0'7*QRT40M;0D_G33_GHP>-XIXXPI1;
M1 5J.58\#3"LEW>KL=QI=Z?H3WFWK/T<P,!>RHCI."=?:P/R3@S6/5Q$K2-8
M9OJ33#"FNYDSD^F;:^[/XHMET>1DD7XD"#)[IB=)!MY01DCC)L]N^[33QBCK
MQ)B\2<>4GY";[&?/WD-_>[,@2C\Q:8:.X.F02! [0<H M@"2,-UN\-X8OP]1
MAY"X,&H;M'@!B_.C_G8I;C1R:,$UE3(:P<0,/T$(7!;&:)0KY]WT[W#;(S]4
MKL=:T"1R/^]K^Y+T(]NB#;!@L1P';8"F'BWXK[8';HPZ6\XNP+_ B->SS9]J
M]^M\%#%7V.X1A,CFP6W7Y@YD'>M=7!%3Q_K.D5![F#;/Z-#YL1#JHAJ6N42\
M!03&0BXZPS=#O0Z$+0I"7X=5EM/M_>97][S**$X[W">0HR/ZXUX:V1UDINR!
M$[X&8ZB@S?$^]TV*8&Z+J2#':V+:M$C>3HU_A[NMHP&^-RA*Q,"ZJL/(^M%R
M?WT5RY%&<%,D9T#;=;MKE6]&UV;-"+Z\V]0E2-B.V/GBYU ^JTVS#C("75J"
MZKA,':4!6DV*K!X1AVRP#PGQ^IN)#Q</*K=,E)6]EKMP5.@&7 !QP-RN]2_B
M*74<6J@F$\62ZBCHP]7:@RE:R'0X6V=R2KJ*9MFBVLC[2H"[G+LY&>M<=^S0
M@+VN#KW@HA,GAL@@ZWD#[#MX_25"J)+1BO@$OF+D-4*1T8HWFUQ*YRXY\3[B
M;:O"RB!94K6(XR*0$#T(7QE@&2-*<J1R3K7_M5B0?\!*A3V97A8U/W;-@]E0
M+1^-G&/J3E3T%HQWK[4^ 38&-N!U\97$_G!Z%NN PG)\\YW5RLCB,B^,YZ:I
M<\Y5YB7!HI_IRT_1)?/"65T7)Q'87V_G,NT[N*<*?^JZ8'X(??',]@C:YFQA
M&!)Z'Q68DJQJ4< OL@X:8"NS,MGOO"ZR>K9"$GTI*"O\,=1S$4WBQ5K^**PG
MJD5&^ODML(' K9H:#E?1TBM1W:KBZ8[2QL>4.+&#-\XHP[4!R%.3G79YQX[F
MJ<CM)(N42ZID_0WB^Z_A)LXVE(_:I-TN =@0OE.'>S&S./.0.?[6<K%&(\]M
MJJ$K^E/RN>'#[8@7[[MCI4(C($>-B3=R8TO C&*<D+H"J8\91:-<YX"!]_&L
M>MF=/^BKWDS#+ZL0:SRWZ]P&H)TI"?YYI?U%.&]_<]Z?NAOST+EA#0LZ-R**
M/"L77E4*5<5 SIT-O:Q-$N-()R&88N-5RY,CK\T(N2Z3Q><T_8<[F<43> GD
M(FIZE+LI 4F6$[S9_5;UQ!>H3UAAIC.36G<-<=?0-NBE0C:L>B#Z @_^0"@4
M3T/XT?0)K9"]$/(34+M%EGE;>Y#@^'@P:L'.4KDADXAC(G^*H!F)+V[YARK^
MU-,3:'D!)BHX+5POJ-.H,RV_O-XJ!\XNL$<>'US S0\;67*0.MEUE&X5'!T=
MC:OB)!8VQ0[(RI]'[TY[R>V%,X8H"5':\!3P9>MV8F(;J\_QH[E<VKC J'(#
MM'\ K7R58GF Q-PC]M2=_F&YZ73L_EGDU:T91<Y&,M P@I#?QH\2!9%P,%="
M<^".?]!BYRCUKBW_2X,2VX>Y'AMRSIN3>/I,T,W:!=?1( U;'C]JK:]VYM&O
ML#]2PB_I$"7@NL,*["&!Q=5RKZ85NIY%*(U L_15(V=U'#F!GV6'BIYI]%>G
M-EY;:%U.?K8;M;2@L'T66#O]2;@H)=MMD[O# %#B<W8XC=CSLP%&%3%D1H*G
M#7ICVI)N<EAAI5N?,WZP.C?F/9=@R+QH$<<'DB=\M]SHW].G\SR=.S_\+5P8
M]21X]+-\K@NB5O4M5KF!\643#[O.N4GDVJTBU6@P3 9!R(@SP# L[9A:?JJ*
ML _D2GNN-*F*1FWY.M]R45B$361Z/O9P'^,'FHS1R8[D1W"2:@LV^:;5R'KI
ML9_J2\0&V-<(@267L]D .T/#?JYLY\17IR0\$P1)(U[7NDSO(N,[?VQ51T44
MDV7&Q<?QKVK7@-S(>OT=X,SSN\.);BEU^-6I2V?C(Y]3HRP/)G5O1[C."L]1
MX\(U"ZIH4&Z ??1*&2YL!UX BN_U=X:P0$UZ[8R6U29D=LT+#; #5$XM(%]/
M?"<2O&/>LQH)<EJ).P:0AP??I!63:J^6&&#H@\'<SBY.,EA9>92HM@5N_# (
MII*,"'XQ!2P.4>*YXDU3X:,5Z553#BD.FM/,P3UFL>98H;6N>R'( !NQD7Y)
M5Y!4#N"TM-ED9KHJ##79@=W1F9JSSG?[-YIB@,5&RPRPV& 60T*7^]XE[ #;
MJD'.\E&R>_WG [P.Y'OEM/9BYN&ULT;((PRO]>ZV),YIJ6KJ]PH4%P_^!8@Q
MP*Z@/N+4> [=L6NJ;80&M8%D%:JVZQ%N7@4M)),9<WO$JHK.6^4JX(;EL;VZ
MP'OLE;K#2@0W< 2IRNYGI56C4NYOV=DB#JW)/_I#A^TZ=*IG,+Z)>3='IJ5F
M"M74FTJUKL1'0M%?(\.75HM239\:8"1 40%M(1Q1,%2?\@&)ZT#)CUJ40$>I
MD:_5"0D-"X@AO8BGQI: KMICH2FFDDBJ0MS.?K<6S!WC4>?DYFF[ZU?:3M07
MQPV=F0A"HYA&_%@@B)WW';^!<HI271)X'U63CAA@M\(-L)?C!EAM,$.>H71M
M VI_RE,P).36;O1"RQWS.D4;NWS':*[]R [.X[S2L.VIEEIC5)%#.PL8P.I4
M<AL@M(9?A;_["HPJ)[CUZ[:6^%1P4T_I\^,;W,X$I>26&*<TU=*WN2B QP1$
MD'7$*A6GMYZ4"5DH@#941E'RL\<ZMP^%D_O)JE)!],N-TXRSN.V8+MYRM6"3
M3BHS>;3JMC5E?8DJ9X+4VI4DKONI&=$V]Z)\3/V,M"Z#J:2K:$.DG17UP?[4
MQ%A()6Z&[B/ C7-SP1_HUDO\('[X V^1(.*.6,5)CHS2'B#V"4C<V//^*\[[
MPU>"B,\S[O6[>Y098!4-P<+&FYRKQ?A1 6=6/X$_QD?$!9BT*5+20I7DI\VK
MVB@?OW';4%>O=%Y\D_->,7$F/ZQ2GC^A::A-EPN3^.VW_0B/9-#7.W;Q1!X)
MJGHPKY2P0\]BFX*,R$=8O=5AA?Y6?JL9U8'J(=!DTW1^W4SHW9,A7)Q)._O/
M8++RW3:Q">38H?27W'Y#3:.]3D[P5='V(.I2^S(9Q<F%E3QUR3P4I&5BNZ#=
MQ.'O":'@W%V=]Q 1'GLAXP&E;$]^ZEU,?GKEJK:NXE*1C%XH9K_DV."B4<V'
MAQ$8RII8Q"K=T3%.)GP5C6CA)?UV\_[V>SMK/:GNO7OF1-P):PV02@;9P7BI
MIC#*N_0$:O>7I=%=J28M$7X]WF#%6+/7D>M_KM-&8#K3KN[ 5=94=78M?RJ>
MCC/NT-Q8TR6\/%XJS'D6?>G(Q<Z);B$HT=K&SZ+ ]>?HNC^RT?3R*@/L;+=-
M&_1>/V&?\I(DB:+TB]BV=W7ACX);18E3K3J;[7U41V"<R<E)('3S@QTR#O&S
M]Y+L[6VOE:@^%I40=NM+W ^D?7#[;JMDG]V#;%2AS<VB?:HVI@&VQ0C+!7VA
M.J32JL4$M()?K(>O%%63J1C/;:R!-:4ULXV,C*)4\PZ\!MTMJYR%YO2+D59*
M0%5%YJ),HL#TL9X/)BFK6>^^LNMNSW]P:, WS4$N&#C<2;,2H230!JTPN'FA
M!=A@R]ZP7$=1MS*^"O0/5+(O58"%\T8 \1G,V77=_>5SVOI*1/*V.M_Z!H82
M8+$*+.VO'05+<9M\)%=_\AE?C1KWT:TKYYJ57[-_I=Q(EZ#6AE?G43&V_2<K
MGP]U]FER%UQY3I0TK7B&=H'!I:(^TNU5T%OM82.$]";0]4$L!&>PKG%]^^S+
M\H]>]\8-'SL9[D"-B\:3M6W%8"'["-BA/>$U+L[<CV\EO9^RK4?"_;9JUE/H
M<CLV?<<,XSBPRM?1NA9XPKD:,J$)KJL3"S@'E%:MG#4IQZ7EK:L05SB*W!8[
MI]L!SJEUU,>X&[A/GO=14[/O 2-:J@[E;'_JN-0D=MT@VUYG#&G/C,@$K\UX
ME4D(@U]S#RR?<MEH!C4UG1Q:G=(G0J8Z.)TSPG(3P#0NS@$:0H!0/03S)1QA
ML-TJ7^66=K)$ORJTOH'D5XO?(YB,GB\Z\ UG?J2X"]^L!K)PA#ZI2>[HEGQI
M\D7W  D^*QQUZ0U]E0CYDEL:%NGK1,[=S'.=J]X>T=7-B)-S[+5!%"72.+6V
M/213 VPM4&-$,>+(PP. GJRB.^(+:ZK%CA@#K ?1W%!_#1ZZX'//X6$:0AZD
M,,K_);*\6>EX6&F5(P$3[VN2U-,/@>B A[;#QY#"0WV:;W2=7?V^.^=4@,#H
MO-\25RE\+G$P<Y?C01NI+?#QGQ[S"ZI+20<?#[ [>>J0L^*TY&XUP(STT7KI
MEEGPHC+GF84;U D]@X:T")T_Q%>1K'B,:_#%XI"D.?MD(Q ^!Q%*L\#+E'6Z
MO>.?5H4<QVU<<N,\<KH3<HNJ)B=W,_1R6GC[+3W)7NT[0:IS(PD=H2]+I#'Z
MS.W&B(<=@BS &&X1?$8OL0ML1UCL )W'-I7>9'F4A[5^,YSLU^_H:T7&-OB:
MGB]F.+KP\9*(^JOC@0+2&/V9_7H,>_MRA5PX [O_1K<SGZNS<JW17'=5XD+Y
M(= []3GW(/Z=S7S/]2#R*6(MM'%$]P6I9?3K,TL7IQ9BKWNM GC[W.OQ>XE!
M*(DF",B9,$Y0FG5\EOW/(<SNW0D6;5J,#S9-:C]2'IX3@EHG$L<&3T&6V."&
M_..YI[\MN5G CA9-..+PS.;*<KE$>YS@KT#)[:N6SQ3L;%2TD^]VQ#CMG3R[
M57NB/[S5TC?! /-@JT2TQJ1*7;W4 -O,P;2#?6F*48G[UBA)F0)3]XT@]"10
MX@N_:>ZS.5ZN%U2V4W5!KT==]"QWN/)XFQ52^>I)KLDS]<9'-K'7.RKK' ^8
MT3_KWM;:,.4A+,9:TXTKEVVDR3[D(G=A@74>V=661%#&M *KP6GHPY6*_.-\
MVZJ[C7R6G07GX62 R9+V^7@Q#RU2LZ>, X<\V)A73D#N'5,%2?Z'="G]8R+?
M54#+%@<LO^M:IF"7J^!6$\&,($U)!&<T"(*KJ#_3/R7R(5=EB/P/L<KXZ$N!
MPW4:2ZBG(7<5$BFT?J2GX$>CH]$B_=Q>MCRIB2,_H,A_YKGML=*S0NL62R;N
M:OK^9<\W!-]O&HZ]!-;G8FIPFN*):,AZHT6Y0"Y;*I!ONV RHXZ_%WD&:#C(
MS6#52*XZ(35.])TNN9Z=[7,= EH]69U&#*9?H8X038E]' 7MO'U.. 9$C\H(
M0+GOJ8;^\9GO8YDL<=$N58,,Y2J+X*F)BRG\I+[+]W9O[B<[?9V.,L#>FS7
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M &[D 0 5    86)V>"TR,#(T,3(S,5]G,C$N:G!G[+L)5%/9MBX<RZX4%3M
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MV@H_\?@9\84ZUJ;$?!#QH_:A,KUSS#B6D&,D,H\8;#N1'=GIH\-'LHKY;8G
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M*1Z1(;*(=VNG5FO)'%\06.AM)!64$L1_J+@> Q,2\@.%L_']<H7]U>#**7C
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M*ZU+?=&6!^$F*L[L$@<"4"P-9 844)MZ-(.LZ;U@0B/K-QT!YC%JIJM7!N7
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M,P$6B!3]N#8%-);NA](I,8"X5;&CGTH;L36F-C1GHW1TOJ7-^/_TM+[&W96
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MF[QK'['Z+_7/^F!.[R5'AF$YJL&(H3+%9G'99 K@*]KUJ2[\O77VD.?LL*?
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M/ ^+-:L;*UR%7+YD@2V$OU2"UMM"5>$AZQN6>.B3GOW1OLNU]116-2J'+PB
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M+539.,+.'.^9/AS2<?RW-SM2=ZF(:V@ 5S%/BN=(X9@0 "<R%[L"C8$\\&X
MT6K]&QKK7%K7^RDN;M0 ?[5R^L)H7>4TQ!+D)#V"^5G^#'L@U/\;43H5W*0+
M_PK1RY[3WG;![&G#8];K1W6/:RS\@\#1@632_ I7O*T/J_NA =Q4^"=L?]&W
M@S(WP^S-.&'EDFT,TJS(*)/=*3TTRYU?GTN;PI=7DR6(CWO^: JL+[<\904
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M+1B XF_G>D+;._+']6SSO6@?=AJ.W][0Y],Y*>J7,!T*^F8&K8TLHTS62SQ
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MU[PE$=V3?%EI%YOK6%B2]G-JK<V (\N'>F;/8I1%V_5I1Y.5&BJ'%FYCU];
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M#91?@C$JZ@4&6.$4R@V&B5,Z<L/?\_40'LH0E3NAV5K+S'@9@A(_KR*QFAN
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M?\?Z_->Q?=%_'=N7)29'_L$'-8OYW>,$8R?BI*TDZ!_8:>.((ZFN>4Z38+(
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M"5#W":I@LYF _ZB1+KCO -KC7C??>FQ(S"77\P?G"#/5VIUHB4\%JW_=F(;
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M<>RB;5X/KYW(3=JE.A[<.1.;G9[7RW\^4Y.?H;QD:O\060_L2@7#2A74DAC
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M8KI!!YUE,6[8=1++=]&_)!KO,)J:#04.BWP?Z$BDC]AX C,(T:H^J?&1R86
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M\0Q_)DOHG8:Z*L&6/'8XMW7%&>C#4DTL:J=U9JA:TO.!:/M+-P<F?V^=QQB
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M$=R4ME,>Q[B&@&%<>&3!9$%8?[JA>618+-["^0ADI1 =6=;JJ$X'"S2Q(YN
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M995Y@7*$2VN1D'RO%LQK'6.>KB3@0?EX(^+N[2H.^TU_R=/&N]5D?@0AGOD
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MU;=#QJJQ:JAUU^J1$WE.&=SR JN06VOQ"63%%N]M L*ICEKK)9*A$DW&X"9
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MR;OXJ%0M?X<MB>.BMXB#F>?F':=D $VGPA>7QLJWZI%#5GQ &\C\I]+%CPM
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MS[A-;9FS6IK:8_.+XV/AK\?_2>N)_XK_BO^*_XK_BO]OL7US[+\!4$L#!!0
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MG9RM&_<(C8_0A]M4+@&4K^^K;K[<>*F\67ZGF*UJ]HB93[:]0]*HP,O-TKQ
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M.C=!]RIYA@6CQO5R<(-1H23S %/\G?B;DJ-&"&V'V_JJ\2U+8"M;J4:E3AQ
M:E<LD-1[O$5< J]]$DA3WY41,I0RSN\!WT2#4.TM0AMU$QF.=8VS)*Z3 N*R
M%B\_L'TQUWFPN,Z>VVC9O4!X5$:+'H3/EUF[F;#5A!@1UNMF.^Y]>_;K]/5-
MHG<RSQ!:6%[,K7&,$XJS!7NCO/9;V."3VBC;3[ML$PJO/K.^PR/F(?6.Z3=_
M(I1'K)&Y5OO LJ]A#@$;HKR'2HMW0\T<AXY)<\(*#7ZA80J!G@'T0/50<EA@
M3$-ENF=@$)M$\0()6L48'SNA1Q@\G=I5Y&!]M0@B.D$>3J/WHI7QI/6-,*:.
MPB&2GMD]%54HH]GN)UF.+ N?XM3_Y'9[-8KRR-36JTE?(>#M(ZWE:,VP=2S]
M]$^W<W7K"J4E411D3&S_IUNA?NJP<+*E1KX""X-S/F>4E"M[D#A/H+W T+'@
M7(7>C+:/OM')&.77C<PPS*+)O\30AMV!#3A@IV(-5CAW7GS4#6L'3]3*\*CX
M:IS>,&(HJLD\$=U MB6@N)Q*Q]3]B7*\T 5%SL#9[<R&%M+;F?ZRCG]^_E2B
M2@?[,5P,FUQ9.&,JKCOOA5WUI8PL0'W-#.-[_+<D3,E^4=B\\K'YPN\RNJS0
M3H7::<7!*=MRY&_WVP+DDH''GJ=E[N@"Y F6WB&(1>X<=FQOJ7BI+4__>>VR
M_>K14:E'%^PJ&"Z 3']W:(PH^P9[W<WJ!YOR.+V,A0?FENW=UPNVC2*9AP*"
MYONQ"FQZSG'Q"9OLBJANN'T(LA'*[?6%ZW@2XO)--\G"(B;1FK('7G$Q2VDS
MC\[([4;A'X<-2PL5JW)YB[A//8OOW9-B?Q+XJQS/9:.I:@M$WT2+ ]I& A6C
MSS7/A7=H/E<<P\3]'B[O"4CZC,/"F@F*F[AG=6VH;&BLZOH_S; =DC1\''C(
M>6.%^MF-"+,CA%J'_/!Z0K7W<5-';_A)K582N\S2 K#13(F517.,/J$DJ.I
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MG2;DZ1A;VA:+SH"QUT]_^&2 L^.C;7TPN1^1'E1TK*K'=$PEQ[Q _B9]Q:.
M4!)XLM/"!Z]%]3N5);S&6@EI;YG=!.*K[?:; YN)H*++T<%)P?7%2L);L4KB
M9];?S<^%U%-_L=)@GE9[3RBT@T_%C4-A1^.P6.W,LIT:NI*C,7=V@;$=$;*\
MOC.#&]%"+B=*>ZV@5Z+E\'1_,#(*(X6B#(+5^ U?E,*;)H]EFK2N1->NL2UX
MC+F5<(<&-C?[5%X01_+R^50/IX&7E=_LSQS[H'US9NJYJS/N8CVUIYK-2JH4
MI4WYTSQ/'R'T&$ DTKIYVY(".?!HP,#3?K?MX;[213/%8&J 9,#/P(C *&(9
MOE\6:+;<+1"9*PX@W!*'.-MYB#"_<R*>8ZU@:W7V;+\N[X4I?PM?F"JY>]0O
M>6Z,DCMYSW^X1F%KZ1BD?L^92&!!X*$$(Q%M @>)E&Q9U@0.$$5'#L?9;-=
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M^.U6&Y.="'6Y]M4_Q;6^)GN=%OQ8&0SA]BE="&4O.7_D-QH'E:E IBX$"#2
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M^3$P@*K&)/1&%)_44ED7!0W<^*V M)*'DX-GDXZMU-.ZISX37!3EU'[V+#S
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M9[W&1GQ \1/\LZ-$\':MS47Y.=^0&\O;[Z[VZ] $IYQ+6!&0QLR&5<)_'CY
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M):#5;: @L0!WBEZ%)RO[>-1N"2L_5"M+G=U)53VS#GG\8>5^%LC*=,(3GBY
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M+U:%;0Y7-WLA@Z2;SLEJG^T=<0%JV*UW.26CHTU'Z0]NA+UXZ]YID!!,!LZ
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M[.>%W1B!LQA0\ N"-7(3XYC*WZAK@ZI+$)92^$"K'G?ZYHUK/NP,[ZB$ 7J
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M^5.;$FTIWE 7N7.*KO<FMK]5R8LQ)!6EB8@*V*S+ UKBVVYZ_I3=16Q9(%S
M50,=+BANDONP2QHI/E</$\[7<#+K+!6O]A)M;*RCL1F5'WP'[XWIJVL%1R Y
M\<'%XM%?S='NNPB]%YTO4G*/^VU0"T]H>DD]Q.\DBP70I3G'])58P=I1\2R[
MIEW7;?=KU2\[V0,^QW]YNZO@QS9,.L9QA*MQKLHIH:-ECX-XZ _,-]-E@Z(E
M)B/5(Q52LZW#F'\5A*>34#B'S@$V4O(?[,&;'9C;-QA8WV*?41K]\S;TOL$I
MTK&ME4JU"A>\!,AD]2^\JB/RS5#GV\88BG$'_&+@K>UMO0\__9"TB0;!-KB
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M5.Z-'BD% $WVV9"+9MOCFTM4@/ !'D7I<).D O2NE3D3],0$ XW=&JOJ4%1
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ME447D!HM""5*WI5MF(%+5(!=F]-+>X$N\?8%#OA[P 4/\14:EXI_W;?J1@K
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MYG]L=XY%T M!\$DM+/MK[ (Q+8UC*@SZ?6[IBH['U4<_ZFZ:7V*[=!7H_[&
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M23P+\?K:A+0D[\\!Z? X"<:Y>N:I I#+^^]%;C]W,Z_A(W3XET/5? @%K3;
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M!YSATPPUPZ=%,*>VW$;B8WV2 U/[V_WS3<ZHV&ZNZLE5,!47U$C1'T7'WT5
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M&R;B=H^'(6N-<X]2BZ<"T(&GXC;"(;HR#*/LRO%KT?+]UK<"7VY)SGM*[/7
M;W3;"7G>"=ORG*R"V5MK=@GQMERUA,1TIQI;&N"0#]TO=%<F0>>MRO5G$^'H
M7=LP0\.#(MQ>IIP=B8XRI'%3C,)N?:?V1'WN)]T4$!!T1ZPSX5V&;\S!6L+C
M<=<7&4R!W.#+:29=26MO$AINA^%/)CG1\$HDEA[/U]VBBA_<B<P/P+*Y,U(!
M[<\_0[PEKT9;!OC6?0*C%XIYIE'Q"OWL_?CH%<H=)_5KIPAFD1W*]W,I"^*+
M45LI*R'4T3,4Y2;)AZBX)=WX #_>W' 9?]L8 Z.E3"Y>V@;+]6=F2@JAYD.[
M"M<](C(>1#OW=5RT/[,L-6$5F\7X\RRH\G$SG@[C'@95PI\QC/5)DYGKJWP=
MQ/'])Y:I^LN"KP47%6 3#^A>]=H,D;49PW=T9D2$MC! 3M?EJ!A)JJ0  GO2
M4@FW1:;)F8RJ@JO?&8<_\;A'QQ]]1(<^7X^;ZA9B)5]%&P8;6YM#K1JG),,+
M[')GK"R^I3KLO?7FYCG[^K-]J@=W<E:M$0'>*6"L,4)F_S9'_'H9Q'22GCLN
MG#2Q;;0$2YS :-GV:;[ :=,/\WQFX3^!8\D.Z'XA!DBR$7%%,3HWHYT!J]DQ
MLFYA(;7^\FSW,./]!Q<'-UCZ0Q=:WB/"#WY3V(@8]%I[.LSQ1-P@H<O?/4IR
MVSM.L]W?LZ*Z=I0#.#.ZGB0?F\;]I&A5+/[.\%CJJ0ITOX+'XV6)B1CG%XI_
M-HFY0$Y+[3%H&]ZN"83#4N^T+F;3R=$L-8 26NZ0'Q,UT8:Q00+XZM30EX[7
M<[SRB7*_<5;WU$JS*J[&HWU.=C(H^KMA&J(!@NH91$M,9,MUJ#P.&7,E9@N_
M:0$^W?G)64?:NA/I=Q:=11QG6B2(P>KLOYR#9'$['4!!R/9A)V_5E%$';JKC
MT%C+792<'\'"IR$2PM8C3>HT^(Q! (TAS'OW3N 4(;($$8;8*#F/\'1VSS6_
MU242LK%QE^;#F>+[L>%7RFD_#P*<@D9LI":@M#BQGNQK/[>ULLL+G0ZY%-+.
MRR?WI3Q) 7^[F"7H<4\PMVXQ9(&5F/;-*9L)_ZH>'V,\*;'S3;*:KY1G7T"!
MNV#OI:GL46([/\#RRQ6\):RZ+_7DCZ ;Y\["B3K;P[2CMPT@:5L(1-#0L2GY
M"@R70/P$0G-V9[J[NLY:CXL-]K?F/KND)_Z V=>#BR%>]IT&7PL]OJ@3F"!T
M25UXVAG)>97HYX7ZY(_1J\%5*8L6S'4O7#LS;[CF\.NAGG"_@Q4SW]ADDSGI
M 403E1#W354,H[+YZ<SJ]HR29/7@_9\=!?.Z71^[:WENQ"LD/>\+YO%30IQJ
M4F<X+Y2+F%C@4ON]H^1T^Q2F)K7E=CF^]')&R.^_^'9!M5K][:,V[:V*][;W
MC,<FY1<O0XTFR&*HA#-:N+ZI+G7A1MS)QX4KDTU/GJJ=7T!A9F_?#K9 A9:P
M\]L%]P_+T6"#I,!>QKC :9SW=B9SI2?;233AQ,+%GE';X5:$]'O1C_9G[H=H
MB$R%K%-DB(FX(L)''%<P61_CU'+E=[9<Q;C(O$+RN93N3/EO-FXKNX#SBB@-
M:-9:ME+Y$I)N'?F="FBC G@AC9TM5YLF)2H%L-UIA6W+ZY-/+__Z_FO6S?V&
M2E^QGBO_314/E["3+'49*!#?TXG!#',1=S1;B'"T[MBC4:B:XQU]P1@GRYO.
M[*P1*3_.Z_RV#&L=TE#O1V0CG>$\D#$#8@HNH%V0%6_5PIK091%VT'RP?UEA
MZBDX^ERB3&7>ES4UV<GF&$UB%&J'#=+1N< Y5LWJA8"X;"%G:H(>Q1#<J[3M
M(U8=+LY^8-]-CB?*[_5@_99.A'N0_$C'.#K06.Y$E<N\Z3/]3*6VF]=BGK]@
M5AL7:@]6E@X!LJK:L?0@^:#2>*%H,!GFG+N>>OS1?]]$9F;8723^V<R<!+!Q
M,>&/%S=;U]?1%#YB 3[CD. X29$'=KV]O:[(E23$O,'+E/"K*)XO-59S58?W
M(0, <+4RB0XZ54AFP)U$;*V3M(F5*/5,9X+T!6)\FZHA:KS-_?H#]>?SM7\$
MO6J;V:!7,47*[\(Z^(2":Q<K"5_=T:5OCJ?0;Q4;WM>8* ?E0:?TW]:R\8&D
M1GAR)3_!=X=;'BO)T1Q.12.=I1G(2J"+M;$8) Y;AG00Z'L]9J&R/CGZ'31G
M<%>H$?J]>^F\2O2^.[;7O4GUN";6=NJ:BT_VU)97GN@D1\JS9)4@6QEFST&(
M)+Q3*)I !="3Z5 D>'@EI*,G8R@VZ?44;TF/2\%T+>"D%/=FF?^/Q#>Z:N+Z
M2T*M/"VT@V@0QV;0E9H0@X?L:@NA*)*7PV=G5) /1/*'72-@A=@KML)!DXD#
MH84Z3RP)47C3<-5 K\)92QW4IH'-K.8HQB3!T-DQ44%NV3V%\'ENFB%Y]TNW
MX4@U/N(]T#DA; I48QKE_07J4JA7L!'$/5;5K_(96^&2XW535EHH8!4T8#J]
M_S_3B6@>_I>01Z[()K67Z&;F/=T)R<F-]NT[_.6UGALLMLP7U"+/%\10-!5!
M!SLLE#!1ZU.E7A&#%FJ7NZQ $$/3A>7P@>=?F57S/1-@?8=^HLSHM<__?)$(
M>JJSVX];[,F]-ZZ31P=JW5EMMH@&[,*)H,6#Q^I78$L)5$#-GW7!2)2O/9TL
M9%8J@-!W\/H&;1\,!8--W"6^.X6'0,JT#EEZY[A(Z!(0IT,%S(I/?/G,\L]B
MSQ F?^974[@.3XP3(H6(PE0 ]B.LG4(%%'OB::F L["3BK_1DHQ'HU^83*%J
MX[/=VC%ZEQ#HKJ%;<<-A9# ^7BNBZX/8>U7A.I7?-;5G+!OG^,,RGJ.,<V:4
MM@)8MSX^.:N0^N&710<8S';/_>(%3+1LF!8M@.87C8V6XM8[7'3@+/E*+$\M
M)REP\D[6_I[G9'-\-  =) 3EP?FV]\?\($OG40&O]"'1R;4SA9G^7T58%E3L
MOJY;5_]'( @=/3ZB-0Z3P'#;XC/X\4!Z:80!&?H#[GG\#B0VR)BZI_HT3^>6
MK*G.V=N);6=]Y ^M/8)4B2JY$+1.PXN9H,*.S!(/]2 9183V"4LS )JI%7!N
M:FL8D=]I^=K?=<3'^5%B[3(G\M,]*H!Q @W[STON8-6,Z ,X\16"G0KXNQMK
M>0C\?]U8?V:Y,UY=JFFVV[((\PY<82H_*7R5_&*?1XSVW9/IA3GG*:.Y&4/)
MTD['FW)21E.U9]^(CR-1&4V&?[E=__L7HX7872X?CH&TBA>U A39K HZHH1.
M5NG$\+F;G1G-!]]2:WD+L%U5<<VH5-0T3\/VE2SV'9N$OSPFX1](IUDS6;@Y
M^6VKI<>]9+'-.38P6R7-#+]>Q?_<&OBL>51*E<17OU74O7A[0?M/QVE@F#^,
M?,<TB@KXNTOXOR?^)UVZU:9RV,HNR ID->S_GK,NZ94S1^@'3?;$4%,82@Y_
M?MV2Y/MT7OJX@_#C-MDNVP_=3$OA*>FD O[.'6(C]G=.!-I^2;>U\CH];&'2
MPELE\VNVWY#WE9]_,K09/RB%SRC'S5.&&PE?9PR0!IWH9O%_Y7E5I/6J1I)+
MO\^L6E.)'#@^-O\23-;:/4'5F[D>/8+X+1V8/V]P1K)#_,A5A-9YIF_ZEH;1
M;-'#];\R_(]?:V:XD[<0[JTV6%;@!_;TA"L[.;[UN_W&]](;O[6,880Y%1#^
M&@_\.Q_-7X0*V'W=T##YN<'%N3_PC1P!/.ATW?U&5FA2>O<;.K>)=?@_L//7
M1VH(NA2ZS&3'($DJ1HW?%P];^E5T&C>K8B?\$&5N;H/C4VS];P;K!K;UDU2V
M55>;]?\%@0W)L[!M'%<WM 46+RRT%EU3B8E(O'< R/B-: (["W6H2#,ZCSQ*
M5NNPVF#7C2X1=EQYWB:2T/BC9TZP^I2GO]\D>7]]'\!/GG,3^"^P9:#E/_P/
MXJHMH@S,="9]:9GX]B)&-=-C%]X;1GE+LYSA\\FK!'3/T9'!RFJ@33CNO#X[
MZ 54!1<-$6Y/S7BE.71'9+N95WN3R$SW\V+I$BQ<63H8(^G ;NC?P>*GSACQ
MR\=H"\@_9:UQSF\A&>^(BH\(]/KL3!'!+:36>/2H:)V;;Y*A$=;->1;"\5U6
M884_V!0(,<TU[:<"!+:P36+HN-=K[50 "YG!4SX[S1%6 B*&M_;RB#5FW!CP
MO'[[6=2GQ2L?GK%Y5-'L9/,0XU"+O*^/LS_EO)YL:&IX^\3 4_)CB=Q#T=MG
M^<8_6!X:IFS<%?OR1?VO1<_)="#V4]2%]PTG&^83=;3KRO552B#0JR]%JYN^
M#Z[1B'/9FJ5&)7-S[PY;A5KW= X?<;F>VH_RIY)?[UX(5C+\SPA_BZ:B_Q5@
M]OE,BQ$Q$-]AT@1*@%^6$FV>:%)#D0K'Y +IRV;X7J26KVH;A3_W8Q"^/*,[
MI/R"I:0$+1TJR#0IW7*&\O/TV-J2&)R**CU%L-S@C >Q?=>CSNI(W ]>L+RD
M1WL^6$5 D; PR6>( T;*(\(4CZ5#5(U]!=XK[[W&]3WUD<B_<.;\C8NRC%T,
MMU(!..:>2.#29R$&54F\L#$NJ.2DUO%ZII]DW&2QJ^9TCX1]!*G,X8IR2F_L
MWO#\:KVA /0<?J&2)$7FQ\5EAZU!(CJ.)\(6"AP)=5R]T7?7F&<'WO&=FPH3
MR<(OM!1,JG*B=B[]WG56+@LM?.W_+%F^X]>">8\$D[B2SYO8 GVN5[:>27IJ
M!@#(5"S2Q>#\&DH%$M.JKQA9'0AZ$LC04?/J?-P.PD/=DP^P\-2M_S+#3V;%
M,U#+)7@W"^=O>+EO%Q7 #@GM3#NNC92;MR&T+QHU-269ANN$3-[H=.VY=39I
M^XD,C=IYEP7*5<J/( [\6B14[9NYB_H5G'SW.R>"OZL-2T.,8?RT0%:]QC51
M!O<7/HF);9PKH$I@JW0TZ%P0/W'C>,A<DNSH^<7@)"W7Y3ADWME4)D$TK".?
M66%.K^;!@E7@1-^[0<"IT5>Q&%M5UV2-ZL3KQ%)DVC"71V:?\NK$NOURMBC:
MYN^;'*E93>2@>_M*6(5F2P.=B3;ME"=*<V'9%M2FTDS<V8Y N-B3+P+<OY8[
MEAE<P?,]BYO=6^Y'F[-5R @8&^4NU WG&--R#2(UUFJA\_[;*JA2J[@KX'J!
M:M_SFC^B=C'<9TOX,<&6GN)K-TFWR:;J-#%+QK]-@+A0Z4@JH(JO!SCC^9U$
M=]S!78T&*?KR=,\O2L^?8 $!#X"7Y($,E%\U_F<;"E8.PZ'>J(F6\HKL5Y"M
M;>Q$O]]#O0NE'*X#[#3I[Y2$Q7[['P7T-)CAA;!3N(;V'_I:*#B+]6M3&]#@
MBDB(KAUC '16#=<Q)7_ !.#\^UC#@]>[\&#@GE&"._'1@?1)D89@*4@&:IML
M3 1ABJ8.X'''J1'G#O)_.-BYHWY+.^I./EF5B:)EBJDW'83R?V P'3M +W(W
M2;N@%_GOY<YL'FO%EY;]YO(W6/CT]?P=_5=;%[)GN4^VW.C;>H6S%5:#99&.
M0*Y?D,5N7NP.^;K--7QJN8NC0%7%ZX9KSA\L.JTJ"L?C:%78'C]^S$$HJ_R[
M8CC%BTQOD>P6Y$>-=?A/E/ &_,_/-?'##YR720]D!X[JTY>U:&IEGX3>G9O;
M,PGZCS2-1BK (^%$]/6?-0AR@R_NP2/A5=+!05P#A)F=R"L&]_Q_682J8J93
M:&:I@#-=?BS8*)*^-50Y"BJ$"H +=W+)1DE+&Y\KO?:R'9'W?0W8KL3_0:?5
MRU!T?%AN5*ZB5U\UOBL]:N-THP2%)N(J>T;-LIYEO2#H^ZXM(V6 ]PI/H>H[
MJ%)47UD:6B_B,&F4,:@RVI&L*H1:/*'YLQ5F<,TB.1$$ES.=AA7S@)P#EX)"
M81UM?Z:8_.0Z/2:(#.!3+CC^<8KS:$\+>* CCI5N8OGI3H0 .Y#'9_YL?$D#
M1AY=2_CK!%+=*>_$J(^DOT.[ST<19,'M4();3M5HJZ4[13?OKQ.(X8P;IRCZ
M3<LHJ?7D/!40$4I6H0(^2__9:??RJ9R2;OQOYL3W5J.!$_R(JA8<\!X2M40%
M,%,!OQG0,/*Y&BI@.1KXCU/DH]R$?_/P;Q[^S<._>?@W#__FX?_O/'B?HH%0
MJ/(KP&_*=:,-,!A/!>1M_J0(4<;A3!1A&RV[(I=^QZ\/?0JR"WAJ?=5"DG=E
MU=]%$1#]%N+9M>=7]N*^UFL=-E,!=%0 @&5&.82$!;ZL(PFE$(8EF^! =1NR
M0&/YT)U83)9I%[)\&*L&4RAW7A*ZO"@_QP70RE^<4["/OS<Z_^MDQ2W:\ K*
M[RR89&/0Q7WU(G'I>R_=G&,&N>A.OXL#).)^;7$@[S9=HE#8XB7R2S<\I ,-
MG)98'?Y4"#%]%#US.S]P4=E3//$(9K'1P@T5PB';F=0)4QT^;V8SUQ],><U9
MJ8X:7CE[WK;S75LW!PW61K\$,HM>>T?6*D9&D@UQ'5I5=:SRN9NF>Y:=SYB^
MV3YMBQB,FVW<1S?3+<&CJEDN7V^$?87T=-C<J'/.97!'Z2>H#W7=?\&T$C6W
M?/G*/F:RZ;,R\"^]FKW[_EKY(I_N$^6OX7>(><2,(L5@!QUQ$CU31$G2![VO
MGH^8SJJNO:?%86HTP&%D4TH2)PIK$1-)&A#%CJ!K%921$6^&M/C5J4%(4]>E
M1IIZ'K,W>3D"-Q4=/$NM$V[F-L,(-3C!,%P/(0(?$0Z5MSO)S/FEYU8SV?(V
M:8L)S%X[*'R'OU)V.;MZ$U9#M[6',J2!^"Y!@\[^5.\HA=1,:C4*@5,-JQ\_
M'3ZUG:VO/CLJ#,K4&1P&V/I-9CN\:88F)#HA @U_ 3%5&1\GQ9?HR40[<^OX
MG%?"'>S!(GLUEX\>/V/3X:$55E?$L)S?A+&0]0(_0V(,X+J3$O#^[%&41Z_G
MA\ +5T*X[2_=.QMJH*?V1X;+6SLCD#:E&UCQ#5[E&W<=;FJ9"3OG##M=CMZ.
M<OK"?1JRK;0"K3(_)#B6;O*S75A55PX:I$@1P?AH3,<EB,VJR*1TF65'C4*E
MY'*M0L@KL\@+V],S="SA&+%F*8>@)RL^]1@YTQI("4&:.+:$9)YSR:@-WKDV
M!AX;3-4/R Q(TQ(PZ^&(76+.QR[99Z>@O?6*OF>X>.0V<RVQM 6:8M:ZF,3;
M+5[N/K5;6[1AW9V9^2IH7S1W!B P_=$S:ZH%UG:_!0!A6=+J";Z*TXZ=>;KQ
M9(&OUN5'&>/J'8"VNMUWH<"6;3K@PVS[_%Q3\5I9_ 'G+[(D40<]'*<NG'8/
MYY;:T%(J4&E=7=\0OGCXL.];6X&W<<AFJ]+:W5:Y10:H*-X]+NB:T)G?,W)I
MV;?,BVK!P,'XVQ7WN?MXID.8&OF2?F'B<XM_9][Y<$JQ[DDVY2HD%*U0L&0@
MW6'\6OW&F'D286@24J!OFP>_[>#%MH1/H@("5C:[@&C$UAI>:"FEN70X3E7<
M.\_"&IC&^3-5/%(?H\*8J'*KG.<*&WU;CZ9^.MAS.MM=Z\^*Y<AI(?1:ESNS
M%@)BUY:F./.@\\C4V&IVYEO=TD=VW;#P@& =NM'O7$M""50 RFF6K QCLK(D
M#BW!Q1[5)]U]%"RL5V_OPYHR$ZOIUM9-,\C?7_>FI0<^8C.,1OY:PW"%J"I^
M<3E>#%FM&'7E%MD[:9B\3^\1^EJB "ZAP7?OAZK)1Z'OB![+. %O.6*@CV2&
M[ V=IFKSFD3XP770'> 6=KB:'[_-7[$%D>=4PZ9T9_JI%<RQS<S/]HX8G.TU
MPGC?=7!0#;EP)72,\YS1W_I&_\OU'ZX+V[_]OQ5.\=^-I>J=,!EB)OHP0M7E
MZV)FICOSKV'F]/RCN[INJW=3U^&^ PM/S"9\R/5>R8WQA/^1HA>)%^HX\;6:
M=)-V;1$E%G401K'3A>LU,\9MS!RT5<-V$A$BEU6R=GNXN6EK<X.5A"X0Q<UP
M"P6B0SD8*H 54GPYLEOB("!0X6YBS,T]FIJJL$/ A95H5 )/FX WQQ.Z<S@$
MZA&(60S_N, 3=E*)%F+;J-CPC\]_N5M+!3!>*MX&?^6X9Z1M>!\R'[WC]!^,
M* EQ0<3-\-<+!(;@?WN)"6>DMNM^3*""[J=0V3WZ^JKTPTL:J!"4#L\/^28E
MW*E&^7F0&3"[&!5T$W^NRK)VO2&EYN,'@Y0K;C)F75?:KH9/\7\9TKZ'_?WY
M3/2-_QP7C6"]KS8IS:A3DS._I/J_.H-\_KFP_T^,Y29SW'![MNK$M;K)_5^(
M'3#6H1K8_%;2_;:RJEMQQYM+EGR5X3S<PO*34_WJZCB3M"5DE&(ND!-J,7D0
MJ&D8XBRA*NLQQ39K^6V*CS&)E?*MLB$W^YXY\^-M@-H4:J<#Q )52C9*T EH
MC)G-H6^ &R%3=Y=R;YH]J8H=8-5>*OGI90Q]].=Y,GQZGAA2LL";D2?P+5?;
M>CSGG 4LP7;\E:736@L>#5>&_!RPBQ?.XKR_RP;@OLU<7[;X=ZFK&OR^G?WO
MEF Q@LSX6"K@>K(G1P8GN2?_C&;+9?48I)+8N^B#OD$\5\0W5=.<!6?>@H9Y
M,^MNNU2%;;5[6_?:Z,H!4VGF6G@6%"\#7P [GK;]9US-=J6$15PQ<V0K_H;
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MSH;;/H8 Q2D3R%V/;#DJ /&%"MA_Y%UCE&':;6OWL$!+9'U/1?Q-'\%S\;.
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M_N*P<T_T]:4?HQ-Z\0/XCZDN?%:"3X?E %YSDJ28;-@M*D"W<LRQ@0-3^.E
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MC?Z]/P=<#H*\0)=T3U["!1&1=EJ*X2;<*+)05QO%YKWLGW-QB.HC2\=^08>
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MW]S"7#<7%@<9=9>HD#B/]$IPXZZV!07?]?)W9X 45<@?%)\6-*D3()9#LE3
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MJ"$Q8FNV=-;UX,\ ZSG.1R$1L=K]^MKKP>^I@' J@%/9UI<8:$.R(EY[,K1
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MLV/[\EF4L<F.!GJ49;0#%>WLM'.,]<.(OJ2Q4:6,<"_7>?C+U885D@(J9 >
MLQM5LQOF7G-Z8@;?PA@;*@%,]%+];[YV*9]>L%& U>&,8+&B8"Y8'+8B*XBP
M\1B=='U\&Y6**A_INZLR&.9XG-;5Q[^9VB* 9UNA*2;(0(C 2,IUEPQHM!P8
MN'[Y=6Y+T=KNJJ*LWT-3:TT3YTM'WZY4<+Q37U$X?Q7Y#TTKRL!3\^J1\\_&
M:]SH?S+#1%OEDX3\9.:[1491H95WEN7M%EM"I^WN@^]YREAQ1,,%\58\78KH
MQ@4? J:BBK%Y>MHJ,$50]Y*/52CXO40K>G$%\XX_6R, 0K8!'A=2 4<J6O_M
MW0.0"NR328H5\6INT>/I.9Q_BFH[ 4SSEF1B;SE6_6F6SJAA9)\MP:,\3ZIO
M<7NWE[;;:F9+13.0^=GJ?S4#DW88[+AS),(^O[\C20FSGLZW(8V?='#<RT!'
M%0I''O:4OF[B>-D]^7CGU:*=0-'&=#X,\G-+?T"'>/JC8W^&W01W62T-I\9]
M#OHV^;496I)86^6+VKC;@;+1*_PQVGI_F(BYA0SX2>MW#T_H +Q!1+EMNL'%
MB2;B=XO_TOR@7K4=L3O_=E,1:&NI%1',-@D+[>S4:8*<EZ_[,.5H[S*!Y'\3
MD _<'CB9/":X:F$S:PHGX3+$FO*^_9H??>T,UR.=4ZW5E^ZV%BLH'T.=[7!!
M=V'^K0FYI%+(H&ROK,GH*[/WEKH)>466[D+O?B9-^ 5\!4HA%RC%DNV7FR12
M6JV%_LSMD,XKPTD;61\8WAQVR=VK(13,@1CG716!T=>)%WZ$;3:8;F%N9.8'
M*(7T>X]P*: >I71A[B41DP\"?.F=JW]HMMZ_L-14>D-S@5A?+'#U:O#7/932
M6!,0BV0D!1K4-Q%EN=%Y%F[AW(]6%XYE<^GX\U[Z=.K(TK@,+,PPM^1KE<,2
M&7F>C0'NU8J[#U_+?/M)0$2!-I/L6]&XD!ZYHZR$ W(Y';YEW^84C$\%B_3C
MRH#9YT&==2^)>\$WHQ[]&%%VML-NW'P@QZ.$O*U_5V%J6:1[@/_+T=I9C"*_
MSIN#]78<IF.&XW2PB9P2OA=CN6X9,T@#GIT_9G \[Q!RWV(^XMXNZ0458#I(
MUO"HH (<5[8\NVBU_@)X/4OY<_5R/T" U\@G*\(3Q(AQ#1:8P!+VR_$TKU T
M'Q?IL@68W\ZO=7?X9$ .A-L0-*0*,$E[4^Y3^0M0E47;BY,/$A/&#M8E")@.
M78%BAOT?I_EK3?383X8HT]6,S 2.J;RHI^\?530:ZM+.8&DX]P5P(?<A_+"K
M.S\SPIGZ9/W3TJ6.:B<\3Z>@B;-(P3]L$W"62J1>%5$R[F:T-D8OE_[Y9-<'
MXQC!P06:/>]G:"E8BNZH+6$[*F_F%,W(/K&YY=?LIWDGK@O%G*C%.][<&HBL
M.W.=\53NM'H+OWICP^2%SC8 XB>8B'W 2P5$!'.CXIJ$BTAI.U9(?=W 7-YY
MI_"_!"_]7@IS!"O\[!*BR81YQ*+95!/R5S&)*26W&AU+>OYZT'TYXG?"H>8P
MQ)*Y_Z[6XZ%!WT#.X'.P%$CRP:SDTB@SOL;YV>.-AOEW'[M!HMZ)7<.%HW =
M#T>"5NMK,Q=VO.FWT;Z?;V^:9(@I;Y89%7'=">!<?#-()X\@(#H57ZF^:F!L
M0^4W"O51 ?!LX;W23&;"7,)7E^,4TE3FV%Y'K,:(-/U,54*+)U"0QPN,64QT
M2<PB>G=RNU,!PM8-05W"6SP.Y+HP9.OW/CO3IHD:$=3^9<SZ[@N&Y%II3P"?
M2@@H O &N<7F<FC#5-T(@TKKV+(Z_5"0>0Q :1!]F^/$M\6JF^E<%>WS_$PN
M@:MF<^59W!:8RJ+H0[[ROK6V(TZ;#/NB0,XIZD%L!YFUKX5V)WN2F92GZ %J
M@GY ]751NS95'D)ZN+*9(TY7DF.J-\^\=9@^H,#(SS+[:2. CG>E(-#N!\"$
M8#5*X23YXW;8/SR#O;,^3>_/N-YP2YQ_)YV33OI:O*_AVE/XHP9GN,P"BD_(
MF?VOEVK*246&HL /UY ^'BV5:T^&FLSR8--M%)G!;0_Q/84:W8-1\9M--^X?
MO50R:Z#=93C>%G)D2R?J6H]D$U"19)&"N;;B+RK^,Y;FM:N_/_R\$GBZ?'K[
MG"22'Q2F1]1#%SO%IC4TG5NA'_E-D?S-!G[JVB<Z@7!2B@CU8'!^M!RHQ-O=
M=5A;1 4,.33%_I=K)H-840PQ0J^Z;S#U]'BJ\5U"U9+!Q7QV:B,>/5OR)D/]
MT!&OBY0:HI"4\F[>Z^( OM"2Q+Q,P-_?*OPBJ#;RRF+'?%J#INOD-L>Q 5T$
MW(9 !<3M([AA<5HC/@G6RY*L9J9K?@U+-3\M5"0&^FZ1M.5#*Z!";$\M/+EX
M7EO5M61=!)YWF9.M')$-\ %>H2=-Z%9ZA]^T-<XT'4VIX3M^DRJ._)0IC*,"
MHL@VI:21=G/53WDNAU*PG)XNW9H)\8IS4VM^P<[RK6I-;%[?!4J2IT-^3<=N
MH1E(=V&")L3\Q(^YO5]A!C:=#59QGZ^+7BG;[<S[4K0S,EK\"C[SER+D_TD_
M -'JZBR#ALCQ<2X)=P??Q-NV#W<$*UM+BA:3M0%73D?_*=OFZ.8)Z^2D"[A&
MOJV^1BAA:_PTW_C=.>716*WHTT>QX8&XQMN-&E49)4W)*H@SJA_JA4[!?I%Y
M2OI(A+11 8PH7Y;SW$&X+E%W 9!8XP#+1SJ%9S/WUUU_-SLC)W?:FZN""KZ4
MZ15/D=);,>&AE^1<Y:12WQ<_3];4Z5S@#"W[&:$<]M:BF6#8IV[<=%K2I'[A
MY/&K+7&QG)$TM0@FGO^-O?<,:[KI^D7_"(I(B2A%I 0I%KH(THF(-!$1E5ZB
M E(B302"! (BO0D(""JA"M(B4J(0"!"*@$@3D!H2FC1)J %"<KC?O:_K/,_]
M/M=Y]CE[G_UA7^^'X0O_S*PU:\VL]9N9M=8S__$ES9&W*+O$(>*8['P#Y;0Y
MN>.EE_+R8IE3?61+EV!]C.2+WN_>H07.GW(\?W\IS_\^D/KX[MR0Q-/7EHM%
M'0Q@3+%CFW\((4T>)ZZ]4,J4B40)TW.5ES[!WHQ.:1Z[SI:&_7#>8$*-V6TU
M?P8701<:0,+D0Z'<")4BW7SY. >2\?C%%SF*<??$NBOA$S?*A!(52YZGW-QN
ML %7;4#DBM$CD0?YC;W[GB9DA\&6NIN+9^-E]CX4]'/[^OH>H+;3GNJ,+<^5
MZ$7:47X>!7Y2S2FFQIB##UA;,KLA63N\ "YH\BG%XY/.?G=,=,*L(NC+G=U6
MC_'D:M_$(]MHS)N#K#\A1F;0(D)E2$8>U=3HH&!S88!43_[SML+!MC93*BK1
MUFK8;]WP2>11?D_0G<!R9"1$6 ;IFC2*;&]4H_2&*0E2IKOKXTJ%I2Y^"VOL
M.6)W0SNXS;2G,GHZGO9%TJVN;D7>93[$W R:C^2CBX/&C.EL"Q7PM58;K@P7
MM)O-R\LV-?$W)%@<=/@<)ZQ?GYF3TO=&BFK9WAIP/$BCGX2#;I ?YY.[\6/9
MN4^JEG;HZD,.S37\; )I>6.%!1)?Y]YR)X1*,X<&065U1W=1R3\M%S/B9>C"
M2]!:KV8P#Q5L0>ZA%WWL">"K!T76G)%SM$Z9>#/K'+\@VZB#+>Y-O]+C'#("
MK7:H+$6X-QR@-CTT;@]L>CQ=NSWHYV&?(PM?>_;PL>NX?Y_F5U[%;Z:<+U25
MAO3'/O-+UJ'>F2]"F+3YX4C20L*%?H313(,*<>ZE_UU[N?*2X]]-Q>HN1GNE
MG_L2Y;A3M2ZBI;U-G=F_YT:H1+6:GJ!=(7>$5;>131I>JJBGY"7[2#S5^+C^
M]80=BXR-R?AHM$;(E@^T<B$1*TZYL$VDF$9C>8FC6/E\*/QI $P@EJ-GP7;M
ME1BB,E)50T=S=N'=T56PM#]8K*$" 2*9R!%T*7RE1390@Q*;T<EN+]Y-U5'O
MZ#D+O69Q#D"<96L)=K5QZ>#M*LV9M0T:C\EFH<)@)/F3/6538\VD QNZJJS2
M7>?7\>*M[?H2D0\2WK&P $^#=;<KR!55'T/P&/6BUJ#WK*U3D/X_1/!XEGJN
MN:Q_\BL!,P4$YD07#T?B.V;3,>L".>-2%!CQX""= 1#OT]C)K*U>5"-<#80H
M;0C>5UD1,1U%?./XM:$Y3(CWV"_-;ASZ0>]#L2*ND /L!LH.G02P$379*_#)
MH'%@0?0+VT]/CH]W9YFEJ,TF%08K[T.1G7$T)@90P0?9NP9#'S1H2R[CCD/<
M<!$.TN2AA-K"BE&W@,MC8_9XB<JN08%S8W>O6CC&< %:/B.%MUQDM9U5RT,,
MY@]X]\$DZ-@]*)5W'S).Q9-6*Y)8$_Q.(JMH*GD%R8_U[0KD'(RX+,L2M<U_
M])V9">A&5FZA6JGTHX2B%@9PQ"U$>$B^(O,#-:,"VE:3!CVF.@VWCBT^ZIM^
M;;QW2I7SOH=#R[.MFMX(Z1&Z=DC/\[65M2*J'E8/Z>;S$3:\85?S/MO:PUP
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M!:=':#RVYH.:D!,VKGL9D<Y#HI_C'\HB.KD=E!<B"((*0L 90$&ZD'IAW]B
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MX6\/_LT:UF^OO(.'\KIMG)GKDY\,:W_PL@N7Y63N1;U&,V$ U_^4,X!0109
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M5CZS'M[L\E)[0K-PTQ&]1.OW/Q580G\]?'?JRL3(*GIEC@&<WR'CZ&T>\@S
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M+=U^20V:3H#@,74+,><&RQ%ZCW?V[J<TJ^S9256>NL]RP>=TVTO5Q_(1+"\
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MRHC2&_7$;_7$EK*PV*YF-^P+_FC:4WWB*RY%+E!(?BQU;1K:;LI,8Z=:DG
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MI&$) 407&J6IU&"K!FOL'^^UN#'C8:70AK$QX/+G\X@O#E09-R3Q'A5,?TD
M,8#I"A!=+(EZG\[* ')5#J$J53J< 43G,/_M7/;^P.9;8:X6:>&K7033SW':
M]C5EQCQN*48MQ8!32DC!4!WP?Y<\_G_?_OE55(GEWQY- 3-E(1<7;:+:/.X1
M:=X.G"ZW!Z:'/KQ/#OGQ*-T@P=S6G[1[W5#JV/'9$4<HV(K&1@U"ATQJ*YH8
MMXP%#\I'E=7\'M93VX=-=L_;<850SCU]_JP4PA["174A&:Q>HF L*;(%8_6_
ML\4_9]RJR2(.3PTC*UO:_?1$ XL><79HRAU3?,JTU<:[2\RGLK<=0B3+6&VI
MI;&HL&J0 '24FGUH8FOKA[&F?BZ^>1UL[!S^Y [!X[7Q5\DZOBFP 82/8@=Y
MF<@:VG@.[F)VB-ZXEKI\^1+RW>>EV0D24C5M/[_WYX?6JWGC96;C-ZZ!K>&E
MK193W.1V=,54P6?K17]?A^^?0ITNG>5_D/.*K>6=4U*YSC22WYK* )H=P!1]
ME!#Y%^QY<&.AE_! 25=RS]EO82TIS !>]*_':G@")^**5P5-Y:!($X2&JV&U
M<G]?[BA>I'/7_\RX:W*>6";RQ$#FB:7((YFP^[2"5<UP2ZP9>:WE/S0C"S.V
M%K$99R]M/J(IG3NU%)#^E>#K_>'8U,*%>:[U$!E7YC]+TB1"'*X*$X%@I_A.
MKT9%+0Q7)Y-*]\LOM&:DCU4O^Y5?JZ4'[-VJQUSABY^+Y!(.[3A3\V%Q>5^+
M=I>ZEDN#8((AAE5DH1")3_T6!BG'T4-R/$KNK:M39@%,/_M81WDL%_C#&MEH
MURF6+016ZC(^6Y#<_I[4'?VDQH\:Y3O#7H1[GYEBI-?R)O8D U#RX):T5%WP
MTAXER4=H"U,Q^S!XU2V*.78O.\&+R*D^5YWO31FW,]J.&;)QNJO9D_O6U9/I
MD<^[!\R_DV+!W$J$ESC05N\9V,E).[<LK:]?LZ4E+#-?GU0(R]31W!&K$];>
M4I9FAWT)EPG@EBD1>LH,Z ?OHD,U3:8G%3>V5:C[Q'&JH,4@EIET<'<$C_3T
MSS+1OCAP+,&\LW-,3I)9*ZNQDWJ!/-B"Y*"!7#R(PGR#>E4_Q6.W_:I8GPQ4
M&W)$I78"(?>9VN'+I-Z$-6UM6\05,H^(<"),BPVA4P*%A[DDVUS]LFYQ//V\
M/;KYT>H7 !_N, ,5M$+PD[7+&<#1$Y1S6/)D6G,4GF_J7'P=*N..RE<5<12N
M"7V12O'+H8ZT0$]I^DWC7F:+_G0:1,M+@$^CL?JU5=:3>I>ZQV^L[T;R/*QT
MC >]9HK/ O:W]^TH1W&)U3U2XWB(.WFRK:#*GAJ^2BD:?7SWJN[V4Y5&LM$$
MUS&U"H/M0&IA"<V&G%W_<6E[VW^$3^3<SV=OACN%S?(P[]KC=:\(MS*EOG/)
M$9;^_D=9(\%Q&T5E0S[;_^-)$_S8>X4IX7O_^!7P]Y&7U)AXY.>0JJO^>J"V
M1:>46]-B":8?M2(-<T#]ZM(+Z 2;"!Q-.6-EP4GNT;[56X>T<GR2@OZS$:;8
MK;&;R=F9Q[Z"1O'3#" 2X4;1(!'BE<>M_4QL;U#CBG4+8BJ$]!Y\^W33*88)
MT*@.O2(T*Y:8R<*\?%-ZP[<9R4GSW=>'6[:%R*":ZX[A2+!RVSN8J-8Q5&Q%
MN=>FFV-R^D5BK&I7RZ?0EQ<A"LU:L/'&2PA^"B:A&AJI+4KAB_E LZWMWV3R
MJH!;[EN7D[!8I_BWRP%-B=;:%DQ.3>?H=J=?,6V5\RY JWIC-.5):^$B?$.:
M_,X!'^"/C?T3?[3O9G[ K,_"I\[+?#>R-(!B#82$'C7P_=O48Y?^*;,U=ISN
MB:+/]AXTHHW^(1- ((8V"3GH1.T'7Q,I_^_V]YA+-,(DGVI@HAY97VKUNY9I
M^(I?L5T!]S''"/L?USJUC@7FMSJ<[Z>)%W9^A-75),85Z7>A XLG"K%21DU'
M)T+9-+E@)"CUH@$>RMWST&?&'MIVS\[UI'OZU><7HD3/1 +](7MN<,$".8F.
MNSQ);\$7-\%CBNWC'>":HB8&P K[A \B9HKC<.GM2\KP"YGG_.\LP3T?F86C
ML/#96>;%59##(,*D<'SIN78^K&01 U2KI%\IZ_O&))KF)R&B(R22,PR-"!&'
MFW9X/<T^2]%.(/'7GG"QE[X3^[M54,,X\(G_ JO <CCT?:/JB!Q=&''UX -"
MDC@Y]C@,%/MD-:<V]-4K/>\-MN1C(>;.+Y3$]XMXEZ% ^2,J<O\&W/0&!8)'
M<\!][881RO._;8I>+GR)<SJ1HH$/.GVU\X,43JE09R(\_=LOINVA_VZQ1>Z1
MU^C&F#;"_DODHK0EZ_YU.-1TN%'&=41;@NI( L6$",<9N,[$&>NE2$N'7SG5
M?/8^QY]<G=[)$U]^W-;H_><"@%^A27A\*N):_T/JZ[T4FK:'5L(G#"RM2CTI
M,W+?*/S=;A"B@0%<U'9Y#@P=H)Z!CKO617Z>$J":5B!4T@WS3_>4CAF<F 1L
M3]1?2)4,U)PI=Z?]\]L@UFW_LU+4U#:CZ:L_WQ+K\.ZR(5.>9[F1F2%]LAP,
M0"6CJG.2ID%?HUCL_*=W02#6@T^-G'8T*ZHG1MT$-Z9\P#FV-"9IA^WGCGD$
M?7KDDW 7TQ1.^;CH=/S9@WSTNT:-D/;GH#;VQ2T<:,* B#YYJVVA-:C<\\V6
MBUF7FI;U\_6;*;[0/.\1[GM-NDMO&L[U;S<N[B(=PG8']8+:*_>Y:58#?[*D
M/?AZ+>-/L6P_?RD51=@I2]@S!U$=O>(AFQ>1<[=[&4"2Y6)ES_JB=-D-"%F2
M_@!>P[L*(;<3SB!_WV$ 7>]1#$ DGWYF? 9T< *\>^_059T9@HZ-(@]8=!G
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M/K)Y WZL^A,ITH,.VM;FSZSVKN2V8_JM:R26)+97_#I\ISQ97H1J[,7BU*[
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M50%_6&-DR&L<;2SYWC'YI2#,N9WOB8P;!N&,G&T^L+A55C_L8\&K=Z2E;WU
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M3-5X'*O46!/7^-WUZ*ZZR[F\2>V^IKD<QN7QNFONZF[-O"U-8^N:8#2*GN1
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M7&ZC+I^<L38/ZLX\L7S,U/<89.[LY[$ WN3XY1N)RY7WQU"<T!?]G=D@"XN
MIK*]O.3LGF>^]I,OZU*X'#SGWX>"ANK@L8+L<I"HKRO7G<:(WE*C90Z'#Y7/
M54AP3;:-->RV4!1'8;X$[[;]%Y^*[KEWLU^_^A/'RZO(K1JDV[^HSFTM1O+W
M#R(PF@TVR'S6O7*^M"8!LIAP-^Q[[9;NF@LM>I9ZO('O%0J9K_K)F[50;,]7
MQ#N^4$C0=MMZD26*>3PF^,+:E6KSUU^5)(:D2JU%$6=#%<+!\L_53Y]KF5\J
M(&NJ&;:>S)MNX>JYU;-B)6S]^:VUID^/5EL$\G3Z:V6I%OW ]#"K@M5"N$?N
M#V)?_4AY;KETP:V6I$4S-4&\7R4V<[5$ME'-HC@:/H:D$U[F>HH&O+/I-URF
M@H564%=&46*.^Q2>9%RURS6I;=1>A=FTA3\3C8;UQ^SKPV$M@0MX_X3-JS91
MZ,FZ-:9]OP.?I;E-H>C=RN3'.$EQC=VSVC=S0,))S76)8=@CSGOCOU:E4K;6
M1"[_8.B*:'[";Z DT"DL]Q.F3I(N/(%8/BC.@05*3ZQLYW;G["2C[0_7[,9R
M*\[8TL^1_9BC\ ,5I1M9!K,6+L]0*5BL+'-/#;2#Q@P>C0-L$^5ANCFD2!PN
M,JY@JMWSX*%63B_WT;0SU>R70+;DEO7DU6;:_CK#R#U];V,E^X3XX;G")P-G
MVL04E<L3:E2\$UUNHQ$@F":&UP=A/"Q2^7+*\;623NTO45UJ M)UR$-J#\0&
M,ZP<S-,<<XAF?);06GX#;53U'G\G*G5-TWN6[RL*/]>"X.C$FN95Q#[_[N0!
MI;.]P,?QJ%\ZC,2VK2Z@FKOZR*6N/2V+]F"],(U#L8_Q[(V@*$AK?1(?E)6[
MX02TT(V';S"EFD])O)8E?Q>;^;%0_\13FYI:B& V1[.@0Q%SU+H=L6O)=/#V
M)VB<8T6-TP0RJ6S,ZN#W3.6 _73PVQR08CU)#SO%+Q^X^LOLX230H;5[]A5G
MX22OB-<(DVV&7S(^J3V#F.D!M\T+(*:6KBP<WI.L<>!G# 7S[ E&^*?.PK0(
MO[Q[10IZ)2[\1-1+7J:HSP>:J&+X+5H]H>ZMRML"I%2]>E.":-;[W2L/^++9
MZ:([!P9H.8M@5PCR<5[Y[?!\1N.F6CU31D->FN1$0-D4M^923S!IM1)O%638
M1HI="D1.=7.E+=VT<+W7%]+!J:A(6\B]K.)) T*[6=QVX>66E>9RR9A9,#FE
MGQ&^D\Q"U5:Z8"GOU76SI/@FC^%$TR/_IUOCS6FV*899@F(AEV"J>.MWWOC]
MA^/;9&4O+&]EW=G)28TK!7U-$B(!\&VV@:/)90]0Y+8*Q,8M,'<:"M:/NT@4
MEBW_/O 5D_Y\^>4PRL6CC1@,]HA*J^:AR=U9M0YXX)"/^/5VRJO;5<+5X;V[
MRC4<OY)A+(H_L_U@.5PVU<N>-F:A#.SJA'!.8_AT51W<OC1_G\9W/!PFC$6>
M)L69#,I._'J9IQS ^=!@J]KYHTKQK_Y[+!K"JY:CR^&_CK0QJOG1OU9@F>N2
M86X%(1NW%Q*0H0:@'UG7U&Q7K:-R5E_4X+5C?D%X;R\XUMDQ\N=U-+^UHV7F
M;KYZ@SW4.\5KT_+$B_T6#IOWB)_UCLYX&)>=V2,D6&@.$ [^2QC@@1[18_S3
MB(IXP.>NJ:;RY:.Y;VHZ@OL#\#Z4&S('_(SWIO!PY>$WL.^5K^C\F=MLQ\"'
M6("X]J?HHIH8O*O>X1BP*1$_!@SD]T;'_WKIF,-2^B^"05(C*$G2,!K"BQ);
MD2$'#U(XG-0$49',:L/&0[]6]5N56*=XGL;[O>%>1)%6YS8O_S;H)^J'86F3
M4$IZ. 2+A78^*65IHH+9\3?K="N'(.S5*SWT[8" 1]6>7$+Q V>2P@0KC=H1
MS3/:[8)GW47'2Z^0-:6C*J8VSZ,#4$(>K]%C^(0BJV_SMLX858W27?VC+PV<
M7O-)G-"XAQ7C*G+2$<;RHSZJ'H;R!_%J[BHO%]V%]_->7YI)>FM7L-3 BT:4
MS[5#^&&T RJB6 ^0N?-!?HCOZT/FAHS77A:DI'N:=H_-SK7=P@#W(=^5/8.)
M7B7SD D$9)C"3=8Y#V> "6-X-Y]SE;@VR!0Z5]<A)B\D5-=-6TJ-C3[UM(56
M<3QAM.4&!-KF^R>;6BG7ALEFDBO!HGCB!TRC5&5FB;C5\-CDEH7F+8JK7D/D
M:2:FKXM1MAF=>(?-RGDXCPN*ZZL^9[NY)B)&]/RD=7F1TU-)QLSXS6LB'Z:\
MHXXF)ADBN?IN(GGQD%9(=# -OJD]<&J&81\SU]:.?_:!N3ILJT%++EIS^-;&
MT-2F> _D3<RTWC.#+Z#N1QB'4#4Q\C.2%5ZOC3.;LVR(?"X',NFRC2W8D_6K
MCY6^]DG2+8& FN"FO_#ZV]9I%CK:>F@Q<0 O'0'3*UHM^4Q*-1J6=7E=,4K6
MS5M]%B2M_P9A8Y;'_.KQWF3)>XR_P.7^A":7?GJH0H<^)MK'D WZT<A-7LIX
M!G8SOV2E+O3>65MT"#Z\]LJI3=H43] K"(R?U#;?Q$C6)%E@^NF=@H7PX_%R
MDG'%'N<MG<N:94E;=[^$0GEOZ'3%C5*UW.2EK/P"A0N>@FG@YXCA28]21J:A
M3SN;_:SYPTR</OX8/UMQ(2J]IFY!RU#8@ZO_+C!7>U2F0B_8)L@"'1IC=GD<
MAU9XUF8PZ'HEO.[U.%55Q2VI0_]+G80G"T_>Q_]>;@-/3EK=QM)VJ-JV*TQ&
MOIDW9#8W,W3)6WOA;#%KVC4O\JHN8M;N!OGM,YN4:UZ]7FJ@H_?!EZ#BF/XV
MMZ?C;??GH.4M*#'4"&];ZMI];6*]1=(5UM2HZ\7,[Q8(*9XZDV9(2B^8(_B:
M%<QQA*R!F0+3KPE()-VK&W;3^LB,9B&2>NL;')2K0O)Z"J2[%)="U,+Q39M6
MF*1S%J1H:T<!"3RJ,'>5=1WYD11W[WRZO_&#2"E9!LOBTL?(*S>)W5Q^X*KE
ML&T8AR^V ]\97R(KLF-;7E\S9/3H8;;Q9:%*CVLQ(L8FS%T/OI([XW]#V@PG
MTBW+OQ)&R7 Z67B4OX+ ^<:A+U*VA-,';S87IP>^I8BXI(4J)MU3VCJ=E,DM
M-[L&IH$9*6P$8B"GF\(J(&==,F#R2R=>J*[WN]!K81FEVUZGBX0S1;W$CFJF
M66[?IRTF"Y!6/Y =K-REE W&9*4L-+.$1F2#@OLWJM,61RI<N[A#F*AMWY/S
MA;P06LA,L!TBLNDLC/8+]!ODG"D$^JAE^/=UQ^QS(W*+8SS-5_4"'B+I.7\\
MEIY5Y"VOD D2_]\7@0/K##J\WD9@(T:2D,70\5;B>#;;N$^]I)7TP^0/ 1_?
M"-U)QBQTLQ5"&M3[E&,/GL<"I+"')SOA,C2*Z#]".;\VZ5:R"S4T33R9G.HA
M:TT^GID,>MH)4^'?R6K\7R&.OU^[6^6MX.<VFI"=)V 4^[[.H=5-'$/\4+S2
M^VG57$5-*/,AJD;TH[^3>(JW>UF:1O6B<<_[5X T\>B$KAHFH<Z030BG2)+J
M-0-B!.W0)@RH;+"T DS2;2J_\FM3\_PU=_<T>;%%6_O94S1]@TEUU)[[V2!"
M?ZLJ)]%BP&[@@IK,X)Z^V[AN36.TZ)B#6;C+#4XC:=Y-)JBQL&>SW &_649Z
MI$^0R\-A7^;;NF6HIF&K3V5UM56ZHI7/ )D[/^AOJ7-?UO*4H%Y8(G$2!#MY
M/#K 7*2P%I1 &-KZVB&3,8II%&F^1'VFZ$R;I<9%MS>A'[29 /O?59$].!(C
MT8F46@KUQVI'N;M>I?"2)(T']=,2,%9Z:/C4-?-9;N,'(N[O=K"BEO(:MDNI
MNT]1T[DA:J)'"/ S*8\VE/R0G*HAAB9N/GVP8I75S:KAMA?<NV"F0IKSW6D7
MSZ<1!E@S.ZUFUTO],QLH;C(+X7/$(8?>/.\V\THY-*^].UUSW&[7S9VCU%S]
MLUZ UKAD17%QPA=.$5OAM5@)ZD7I"0N,-!I,#=,:]?#PD9R+@H,X#7;<&@1]
ML=>_W+KZKDVVZE!W)WWQJ3_K1&HQ]4Z0Q?_YZ_+_V>MSJAWQ]OY)A]M'J6HJ
MT*8'!$043-?W,[3HN[[;C4/=RDA3RZE/Q9?34NS:J"_B;WAZ#\3_/@;0'J3+
MAJT(+I@J02O, 7,,<+4'%#GY&U]K(!J'R@78V#U$6Z;0F#H [_WD]F?8J78,
MR:S[%'WC3DKK..* =7QLY(&ZH%)P.V<Z#WPC(F?&W+QR;P3TY3M'T7ON+%_)
M;P6@0B%0!TJ/,-[AP49^1 K$[(\&"ZTVN459#MO7DGP_0N_J6-R9". 12MOL
M6_$[_Y@;N'[A\?NE)L.5'%!6@W+^5.]A +1G2P\ZNP0Z[;3*_B.DPJ8T;YJ=
MV#>(L#2))&N1:HN@C"<'>C7?R<1<(*5N97C30]!Z:$]R+,'$T'0,*^/@<9F]
M[=I.GOTB?=>9B*!]:T;PQA[.D 7:WU[7'Q)\"=XJ98L-Q!7.F3H+"$8]LJN5
M*.AG+[G(P:41\:3G>G/G:>IFBC@T\-X@^<RAK$LP-P&5)]T&86"LESP&N!WE
MB_V(WU2_M3-_O],MI,DJ$NU_::<-M^V&-#[*^-5$#PW#;E7C5!FQ_M$H\37X
MSYB\:6>%M.N=3Y,#*$^%TA1M35Y?"Z82D>0C(IU(,OB/!B1)_$%;:YW;3%].
MVO:5W=G9<TO3AE<21+Z=!1C3;".H@2?>(\1?5+N@#5I<+XO'2XH@"4YL$XPG
MRYU!FZ.21 Q2S9)]A7AWKO<M"F=K$!4/7ISL_^]P9VF:-?A9L -"<(5'EMFW
M:-9)AM'%A]OITX,&K:9-^9F/T[&_+:P)H#9$G#7]GX"NB!=G2O+1F:H.>G5I
M<WI#YF,X];-?7?)K7VFI5%K>>&78IR/L;WZX%0O\YFP^!MA4Y ZOD6U(O7DP
MC<;TMJI9H7':Z%\NAW$! OQ:ESY ;BB^8U\<'"DT;'A^/;O2>[[O30[)@NA+
M6$Y0NT1R9A\@ZV/=]-J'5C+ZWI=WL6+M+: _0/4W4#];D99='PN1Q04YH!BR
MT?S1(\S62\R)3_KLU$ O&%-9',@?K$]S^QF*>V#L4O:40:SIUR=)O3OQW\2F
MNSJ7 *G _(WB$N>,_;8$K< 9@V/ <LAVW)=.EM_BD5\*=O>>673UFT\V=>I:
M\_RU]L ^TN[$(=TN)U7.SX7!JT =688=J5D\8Y3O=ZHKQY;*_:L34B8F=7CL
M'RV61R:$OJ?=2?(]U="WJU\#F3#L4,*NIO,8)& ]8LM<7DAEH?79I.+K(KY&
M1W>=H6;W8WS9QN05>T1WTH !/-I:@,1X:$%^-$81_N'#KXP^"'X- R.MVH2G
M*JZI/\3^U&$/]Y#UF$K.!N5Y6Y\GC"ZW)47"*T#M4H+Z]<,53>SK@0W"#BK,
MIZNK;VBEK3Y/OL9TNORKURMZ.L/&H!)+?[1@1)TANGZ;H?^+I34=3+E8N\1B
MTJ*KF&G_7#%=P_SC-".I&D#[!]4R5PX+N/4;"4+4(X'FC\31_G,3D\:9IXT5
MS*,C%B+<K01T[5_E9L7N;/_.3.C[>-,&(@4U5GT._@EO.09 5V";DM8D!%8R
M2VQ(-R<(_]/0_TKJ] T^_B8'8T5%43O:QN"P$]]P'N:&!Z$%0_U09TCY7TBX
M>P3Y-_C]^Q$";0;XH=4AS<_3[%4U1J\L=6MO<?SV.^''-W^[*&/%6W8)'XD-
MI&B?!.U#\78E<)1/@FU;QK3VQ5D"?[Q=<M9@3<_7A;/>H>K(6HD<4+R:/,P>
MS U^BN#J+C"5C\,Q\SX:^M5_UC$%E-U'D%-6;W[1<0P$\+X/BT]A?N&04$8P
M)%;B/2(?TU=X $X[T,P'?*\5=I<8)?H_7OP]E-2*"BM5;H$S5B"I28@.-:&*
MFH:&49A1(/\F>?^;Y)L=W+EV)NB#Z$$M=K[DU%X@P&&3&^<1:IZW@:(G=3^1
M<AOBJ"T;D;/@-J9G#.6:G-&B-^/D>L)0;4#W17K"O[,3D][,[&!!"D-"?I+D
MQ]$*GB3OQX1KOG5!?'52F7JU_HN)9'?JT)KF]J#;F@#LS2$'S!FO5EL,T\;O
M1<6XEE:6V':^V"JQL>?EWS^?).3S#GJ8IP&.>"Y8#MDX!AP(_JW' &M'+7:;
MT]Q104!Q3*J4K/#9^9*+C5^HT;0(HV"&OP/3Z9"S0*?Y84HL4/AIU?C%^72'
MSZO$P8F?9JUI1"*^="16]GY!K#( 4*\:K_SWWI[5(./5F$9\UYEEK/"_J=$4
M@?>SIL4^63KHKX(.#Y(*J./'7?XAEK!>G0_>-A?+HX!6EB'J,F>7 %,!GV9@
MZ?*EBO;VBB(.I)#. 8)5A%>P+ F,@0C,B"[EY[N.X 3K1UP7'*]R\JOY"BMN
MUBN6^E.X*7)8Z6@UU5"UP<[2LQ]7=TX Z0/K1\<  RVE"(P&D07@Q#HP1OT8
M&-4FO3P&POHIXW^>P048DB4$#PJ.@;-@?, Q,/DGE3#U,6 DB*6E@,"'5L"+
M2HY%,#X'OO:1?%*X9?D8</E(80<=/89'"Y)4CH%-'ZJU$9/7QT#K2:U%2823
MPK2(H](DTGWPW@.*$'Q^]QBH'* M-D' [I+*7# <E,XAMD./#@7;[]^&W%#^
M3-J@JVI8EGS%/K5/]H(3Q-DGQNN=V4J-X7N1. M1PW$ZR5*\89LT,TPU5G.@
MHJ!$-/W([3N;R-#^[T]/3>-WXW&3(9*P2WAA&!@?[Z>@(.@ZZFX?.*.U30FT
M['J^20XA/K"F#OP ,ZXCB3O@ESS"O\Y.395\N6'5C94TO(I5=&<UIKFAI/3!
MDJUC:V\OB)VJC7R3H!!7V7TUAR >,MY2-4;(GWCGZRA]NE'C?MG+<H %53G]
M7R05(><;&&#^&)/JZN81M\S^*O&$'S0,;"MM>Z=0=VNJT\8"+F3(1SK^_-@Q
M'VE,>_K<S_$9(S1I%W,U!M=Q>&=MS#R:BS-MWMU#'?<1-)YX E54.39,YLK5
MJOG09FMU,()#) *F__N,Q[)1$R:CP?"/MI3A$27]7[2E4A]8E_^1J<+"?U.&
MX-N_FOY5IHKM&.@GIAX#\+Q_T:E:>I%66> B8#*UO85L^% %KO@QY"H0)C+O
M>9E7>2I!:4TY4W>QLB9^42RB1XDXGZCY(ITL8Q)S#"P?ZAX#34/'P+_*6OVU
MZ?>WL6Y/9P]<5BHM5I#/L'JO:[R$CX&&Y@6*K!4TU015F3*&>]Q84Y5<W7!C
M6EE8P0K-%AJT/G@,_*VFP;_U/T1E;:I=:30K_>?F7B!)ZGI2>>?S=0%5^;#8
MXORU]#K-3H2MO^IKTM221==@E>H-T%>DX1\M+0*8? PX@?</(/\J?_?7[@.[
MDED.]QM0>NMQZ^^V[X=6L][KO?CJ.=W3Y]><M\EBV4(SDG#W-8N3Z3(-GA"#
MQ'OWJYCD_-&&0U#@%8C#(^G_K!&&/@9VCSX= W.K<-(,$&!?,DU4H%>M&++H
MBY(4N6>4OJ)]M[QP?3*[LOQ0^T%]T\1^\*BR;O5JS7N3O']>FQ\B2#X=[A;@
M/N50_>990MG@ZU#0DF0)83GQP[B*N=S1F>V*S,(<S1I[N%1XB)NRF86H#H.R
MSZJ5^/_ :F6:D<(>#V_EUU:.(*5*K\HLZS-M)8D9&&!9#%5VS?;6P?A>:_$_
M F7BE'^)S/E7@;)_G%1U 7T3$_,13GVWFQZE6MF]M26G>Q?97CU_I-BGOCG9
M*//W\0C^FQJI>WUZ Q\-^I\X8F<%/U[*_H2#XWZ07W(&4FZOMW>B+@-KYFY6
MS9W5_5P[J//]>.$_G[&.#U@KB'&UJ72EQ=1/]@5M+\\=";4<-BN._80289*#
M/29!Z5**0XU+UBVG<T9VKN2B&I'D_0#%P["Q.LB_.29_:RX'));;Z/ _,*KN
M J39WR?+Q&=N(MTXQ>;H0_%$"Z>W*U(8CFMQI.Z6+;FZ;C'BMN'ZP6DKWS.&
M)_%DR4 O#AF;@]GB6M0XRX=P-B+)";LZX,3;WP7S;3;.F)QXO2#>9L]KPY@;
M5HKH=&_8T+5?_38;DH4YIV*7Y4""3AEN"V/EYNN&5_0K,_Z(W\A0UC^)F@:&
M:IJ<^/!WG^#]B&@P/G,$3FH'_NU[H[__Y"FTOGT,)3J\(7NDUF:9LKCG)F\X
MYVCR-4=G^TGR1!:&(>=RF4CR4(@JSS\HJ--)?W&KU..-DYR"EFYL"3L^J\ZB
M[KSB2F=GKW+CE8X07J.@(DN@K>W #965]W-JM2[H6X"GN?F=,DW6),SC^Z>2
MGES^D^S0,BD!6>H&T\-3)*Z*1DJ6N)OFZTP7]83IHSR_T,[R)O/2QA=EYYA8
MF?>Q,$C7-6''5Z@TV8W5__^4".7?Q]C_1HXK_\J=U?F.JI,J>/OYK4E*O$<4
MX6]E20]JONU\XI5:\+L3=.C']^UKLRNAJS04!2XC@9V^4*9G99FQ<$YS5_Q1
M8@DE"CFMF198JQN"J:WFP@K6W?"\69(4A>(9IT@$#\QQ@BM5X-AB*=K6@Z-W
MPQ56T@\#H?Z57ZYB;]%+G9ND36VUGWZE9P<$/="$T<S*DV((^6C(.3F](##V
M-6&U;F\K*1=Q9EV^+B@B9:JJ??=IP./>"XH.N]0LGI+#*MX$FH-Q#+B-43K6
M?#]!10Y7<G=6LP[?'_*QK[#84NM4V0^J=^R@]^%VI[MNXMBI]@2J2\Q(WII-
MHY7<J-[\GQ;=OM[R0[.6.GE97ZG$ ;80^H(&&:RJ<H< [U#EYD7<Y@N#0B>.
MO:R.#D-Y[OLJ;I4A-F^>>*H+J[R$L)$$+4<H(F3AH]P&X4(7 =4P'?P(8T >
M@JU7*KN6Z;EI0\?L8GGCQRM14>(P=YF6XO$,U?V6.9*X#TH2OQ_;8" 7-\>P
MXE_6[5]B>/EGE9"HE(;'] 76&V_NG?J@K2Y!O=DCB=N.R:8F(-N28N88*[+$
ML?OQ(G!>JVDG\\W>O1Z#)A$UK[0AFD?\Q5F)'Y^T1EJSS'JLH*Z,4TZ1-4C#
MF$7"^6H</YLZWAE:KA^'-BD)]&;J2=V.OCLG(_SV98N*#]=2B-JWW"95V/4O
M,)>Q!@Z,!R\4KDLJ+";U[5W9TZY!C;DV8011D<:Z(O%F 3DB6F)/PB_7_-9M
MZ5/-1T\*-!%DB'4$Z7!$9[8X?CO"347:ID W?T4IS+RBG#M?W5CCQ^WWU>FA
MA_?9(EJ  ]X.E.P@BI]D\H@@'NT!+O]E)<^F.CK^>B? D8Y[,J1L31'(&*NL
MBST8XWW+"Y.YV)40>N.3'9^@,TFFL_ +J9XH1YK["(UKYYE%@D-4] M6C<U3
M(2K><U.M9;).T,<O%=M;NMSI-56+UYM"*51AF&,@U$TJ9ZQRT\E]2#E5K*E(
M#RYBU_'1SNV"Z%G;"#Z[#& 9%D3X;CJH)F5*5L$GA<$QTN,LK^4:-?)&;;_&
M#@WT+A0^[)JUBPB#(:0!_C:Y]3U"953K=S<]"@,']M:L,.&.@$FD5.4'8I S
M=/]FXS&0Y->R-)6T!_:>K($G0<Y_R:DD;$?#.''P>*7]:-G XIB+H[)Z 8:1
M/JNVSS4KBHJ^5NA\M%6.$C_SS5M=T ,"[=]04QI6D3F**+$,JANR:-J,OK+O
M-'9()_"XW&$QN?R-)=_\&*@%$D>- T7)!9D<2A^*'X+-48-D1$7 %*7_4M*/
MOM&.#0=WQ=74L0;L>J?Y6.&A-HPCVEG!>-*O$J.O1=G5C_2W<+*?<._I%? K
M>]@;JJ5E6 *]3E KQX GHDP:!O8L-@4V*5+3ZOOG.4&,%8:%9U?,=)1-/;5O
M*<I2'5!K0J/:M\\YUT$V+^!!]\I/,(7/C,&RI<6ZHH-=Y(IVODR'J+KGH2D-
M[\N6!1,VO&";^3& 1L0@V'R/7#IG+U'Z\/U)TJZRC2SC#Z$EISHN)J?9+_?&
MQW"<=EA4+WF9U@4<I,62"4,J;@1#G-]+K#27TR2\75>N$+EM.["$[RMS<OAH
M1O?)+E*\TDD[*_3CCQN7I%*3S ^1F'9*8]$)!YB9BW6-S,2:_5H/.&&X)N<L
MWX[T?'02YMWW$0M14I+$(:(H9PC:'6Y@'$U>(<R4D!9W%(>3\C<<M!F6,ZX*
M;;?)>L=SZ\90SC2[5N?3W"<2ZT;IN#?5"4T.R'">_ 05"YR4 MI:J/+M,?"4
M=.H\3W;U%>WO5YETK-C=IOW83_Q+<SL0%%&R;AS,-^BQYZ;E4>Y$/+]C9=E;
M49W.>LG!%=!M/CU_RN7MN-KEDX&U_H0%?G)Z,1[W*S-3SV5=&0SZ*;M?[=GW
MZ+OCO%O)OAV+1@L#5W*'Y *">CT#@4:$PRM,PGVE;#N_.@GPO/20+<<&Y)6/
M7TC4XWP[-5WE7V'_"K^PG= !E?-X.+"-.G="UY3<51Y@ML]#BU1M[^.S8_SY
MQGEFT&&&3X5$W:@\?OF@O]0_HG9\\">F/3B6M(_K3"+;8)&3\MO-YO9)"=LJ
M-W,=/2&]#O/Z6OQ*:X$Q62$I%E')O-^-[I^ZL%B>K?C%@Q5:CFT*A=LBXQ2L
MA=1$!Z1_!79-M65DEP7R.G?TYH>\E!VX.;VF5^@:VN/I2+U9USP("_AP<H35
MA/%+B"!B@D-;B7M&7O7K=:)?MK3\A9H"X^EPP=?O_5NP*%^">!1,'R^,'6]5
M_HFZ2/K8?KN=Y_O*Y&):?>#2Q#1G=?*8Z1- M-;X7D02-1>MHL@B&412=A+<
MA!!*O;!)G-<']J3.0P<K#T/3G^EQO"H9F#G<>^A7A+I5P*"8 T(Z(I-4&.'%
M4&WL4;P@)TR7 +I#,/Z [&5YXRV08]$Z6:1</5%BFT"5>,/VLKQ.T6)Z5'?S
M(<L_R3Q3.OJ7.#VCR?^E9&#_JX;]$UHA;-+F<0CZ?@Q\+C[8=(DE[),3(,Q-
M&V!I2@9RO;*T:.Z,]$E?-X> W%C)UZ?^ =S];[4:9$+3CA;LI']/&(^!([&4
M>G,L2OX8Z.8F[!^%G*#P7QEWUUOA#8^. 59R\Z9C;NP"\)<'\O_?L5-OC@%R
MD%/3'A[^Z_$;O\(3C-@YEGD,0&B/ 4U=$T?J[V2'0_"JP%529CYIAQF.MN8A
MG&G,<!I&14!?:0>Y?OM=S+XV6(6IR7Y<_ 2G>KUIOC]BTN1E@Q%.*K@UL-L#
M9A3(L;=FJ53AU>!UY>Y%*@W&2HW?<7RI_<X;CCD@KC&P?2,KKCUCMBD'6MTA
M0)-IA=@T+T%$^FI65S6\CY?]D<2[D1QE'%^H^F+71,7F4 [JWVX\RRI?-QZC
M(E<,-9_9])GQT!Z)1IE:&=GIBKRQ8XV<I)^E[[_)C;3(#5%!8I8W%C&(*!><
MM-BA^3BD?1"=@:Y;W)[\5#/!=L<B>&#"WJ^KCY;J5LB9)V:4+@I_-0F,),O4
M$"!QE6!&YZ\M;GP*XP2= Y_KNHT7J]0,.+Q#_&E$)+CG36H'U?G\XU&<3M:*
M!(<P%0VXZH))-D=#VD&/LK]1HJY(1.[%^X]33I4).UE[=:_>!X7SL,'NCL-<
M;M;4-XU50"N4ZR5#$QS'5K;FO)]M9&VPF(8JFWAI E"'*+A=%F-KDWW9<(,+
MK@ FZ7(M#<20X)F@)@=JN$.GH9 &PG-[:M/*K1@+,E:4@+%5)813-[=YS48J
M:F3?V3A RK]<U]G*,W&?1]=V7]$"YDUL-8& K.J-?8QI@S@!U.:=.;4IW6G^
M9K:PJ-/K\I:9NW "WQTCK=%3<I+O7P5TER B($SC&)/(8Z#,EB =K6+(\.VW
MB<#%>KV8#PD/'CR]%1TBQ+CZ/D57;N)D!C01K:H\WW'G/Q#$E..&2V=7""LI
MZD/B$^&7I-]R79V9VNWPM^6O'W^W+EAF&%YI!48K*4&+.S+\(WQKKXHCVN25
MFI,,$YV^6=^YS>W.MTWW8W"+6D*;XQ<_.U5S)QYR.ZD#Q4Q0K&TZA$?X%%;$
M<36@=[*YS\L]>^7:[2EL>59] 1_XI'JC;7XJ*0)U$7]F8L2C0M_[4<WH<HK3
MJ/N%VC0OM94L#K\-3P8\E$OYF_?ZZ_NT,20'XJ,!6<%H:T["">2);;#"(ME(
M/@9IZ;-"(T/S%<^;\6\G[CA_4$]^Z\J@QU?F:A*(W\5$OL'W03AT\_H#E*&I
MEC6$,\N3,Q;VZ.\\WSHK3>A.ZX4\?['C@CS9<%HXXOV!DKV2I[MML]<(^6&R
M1]:KVQX5ABQKV-D.L[DCN]C/\HYQOFH6XNYON8BJXGK5@[+%4DH#2I,3K6D$
M>OZLT(L1EN6LIO,LNMW%/O=I.Q$,</M(0D)G>W&CMRFA,W3<G("JNGK%Y_O8
MM^K1#6M8QR9?<M6"O<,I'6+:HP3TT\;,=G@Y9X3<H2!M^R?K=6OZ>OR;<C/'
M@ZA(CS.-Z/,;1<AS5Q-+OYSS;M3M,WBNB[3ZWWU*!" $26+0 .4BJ?1[^_UU
MGOUP%3,79U>M6DSF:%5-VL^J[8OJ*ZL7W1=H'H5UR4%,C][+"IZ%72!PMLV8
M6!'$"FV1/>(C<A:;=PSAPF'G3BM_N,,5*<=0P YX4MU$FN:&*&[SDZ\.H2ZX
M6)\=E;NT?0'1>I S^F5L=/2A;KB'@$A/B@F+ =6C5S<W314$ 1\$R9(3?$[V
M&#@+C;LS*HWJ/2K,7ZTNY$_,)_I.@2:%KZ>Y%7?V?$]NF7]_$,1.A>.!;S3F
MB<=4!$$L",@$F U-$JPN#?&)%&9LMBFU9:)F66,Z.O.J;*IQBF/CUW^#L^;^
MH[RCB?/K?Y ^N+SY'W(!\-^TL9F*S8X-K^QW^0_4!5E@&D>5OEG@C@S?M,)Y
M1]=*$./:KIXL]<,K(EX>7JXF:B:&<VG,?7Y)EN/#<Z?4Q)P1G#!ZP1A??GI9
MKM)GOA41[DP=IN-)UU+B0DRO\;]P:(2:;!H=RLS"U$DE&"N7VQ%OY+J'#4?S
M$IY?D/@4TW_TS1ARKR.LV&3T!4N, Z;Q?*?N\ >+0%X)UEFZ]-S<$( <$93F
M]NA*&C4+OF*H4+2T9&>BO@1B9CU[2WI0DX/P\9^ET_MWL]_BQ)JC'!43_.[]
M,1BG6$1^[X?U2<MD"V>1+I'KWWFUQ8/J1V-P X7;$ N3F."Q.3H(MKIU*O)K
ME0(/)5%_,[:C-H &''AV;_JC$,N76,F9[LLVA;C"(_=++?4N@[_@XB2JA,,;
ME &4)(E0[-P;],'IX%E,_IT/6R4_(F:?@2\S=PKZ7%=#2)<$,5O[XJDQKG"Z
M8,Y5I7.:/&'2D[[TG*0MOE/D?<96ZI70QO.UY4IO7[RM;1 )<,JWWUG?G?Z3
M./[*?Q@B^I\P!I[,@.>F/0^U=99%&RH<A +<94+HU[27#2AC892 &?B\2!-9
M_\0M78*[:!P#*EM->%8(12QITQ&\G#5..:5WPLA&)R5.I1,K!'?[UH\!*M%C
M .OX?PO_W\+_IC"U6A^DPMGD1M'=LM_7)9PNVG4S7U"<IBT@K]_Z#T79D3O^
ME>79CIL+]2FR#A;0NU&O7[XJ,BU:^,4;S;>C;0YDQ.ZTDQ;]Q>/R\*UD!8+-
M^,4R?=U-V*9DG%_R1Y,9XF9#W;4.[\Y[)ODMPOI,[@19IAZN]@MG7B4/S"<G
M;^CLY]#_"VGZ(DA/&M8GY!.[A^]]R3#.DW^CK).ID2V5J]_8=7JSNT-'$7=Z
M^S\_RO*F7")TO)L_[#TU=)1WJ%4=7.>;<2>S^NX#Q)(JP!#O_?M9'0,@44J+
M 7<@0&2[ZM'% 5Q#V*$\QB99.O>QDZT/B)VP^8Q&G'M2EW;QYJGZM1/.5KBJ
M,.PL?TFU ^&=U_-CS<U]4BQ9_2F5F()O&\!E4Q[)W=(%</Y7BO>UP0*GK]!B
M?&!7EZH#KJCD=;LZ<5&_?3E;/5H5X+ZBJ\J.$P="W ?_O<*MK.$$92R&9)(_
MYYP1%>Z[J7WG6X(=XO'P;!>Z_NU5>=WG*:STU.&=JBZ?\$W1'GN_:ES^4SO?
M_0T'U*T](D'41/0V$8)$2Y2H,4AT@^@EB!(,0?3!&"V(SF@)"1$B0O3>R^@B
MRH@RZB!JAAEB3!CCYOV^==?Z_H#W?N]=][X_/+\]/YRSUSY[[V>??<X!O7LG
MUWU6FM;BQA27[[X6OXY&DYS>S^W>SW])T?)_S.C@D2^#@H'6@(QN.6!A0FR7
M\@P!PN7L(L+GZO+7CF^.;\=Q#'/_Y[-M!ZCP0*YW'Y#!Q@.MI".4YWLD**6;
M1_?Z)W344SE"EUDZ.DJ*8@C 76]!N5Z5# <2P]8E&:$>)GJ#G3.+=_6\N>H?
M%!9KIW]V1+JWI["^Y$X+<?R_A@>'*5M_:OBX,RNM)J74<2BCSJ&[3KO:[&LC
MS/TDCEK0)XVN_O]-_Q:@U2H>2#X()=' P/\I5"]T(?'28<G8U"/^Y"%>GQ8#
MZ=1/_O_RV;C_":#8,.\Z#$1_/G]-*#BU][/3*M\9*QD\TX8V::/6"_K19GO)
M<D;7XIIKJ ;X!;K[7![,?=-YRLSB*L]Z[+Y-H"OO+!/SC"V=H#/OO%:5[T!O
MJ6G/W4CEHN27A B=LMQNA>?XA?JX.GA"?,)NYNY:\IN&QE^*8>*G%)L#.&^L
M4J@"[Q/]P(G=*O=P5(7%.\N<N/[DS8P@P2Y<BGL3^TG(<:XU)YLKT"%9,-W&
M.0J2MREA(=C)Q/L9K9(CW"/)9K7@IBBZ=WJ>FA7$.]R!9RSG67-I01SB!-5R
MF+C:[6PB^F#K%!Y[78PD$*[KE:1$Y6])AATN\1\3_7VG 4GF!W(*?^99V+;R
MW;.J>@TI+1>'?3Q7NYAL%G7N+BK70(Q$ZQ,6?@Q?1?1T/@N)'KNG8NE]:3N0
MS-U>$ZW34!UUM,X2*)W(D4T5^KSY6;J7_K6$6GD ,%/)B;,"ZX1Q?=75V.6F
M)XL[3PJ!IWY:6-K)OM_+C.[%_":XYB_SQR28W^M_>XU*B?JAQXX]T6*9C3Q=
M8'P!>.6A19YL;D[9]QBOUMC2D7%^\]-U ;&K@^[;<%ZK L7^CA><WO"4&"[^
M<=VQ*[!)W6OBCFKM.SCNRFW5%SCM#TR9ORT#F!+X[N5+WH"&(\GW$E ]:/#8
MIZ[$!HBXL8AK=,"/Q;OB)8MC=['!M5_;KKGFYO3D*@.O*P?AO)C8%JV)W]EP
MC:7C,KU6%0?I$K<L<S7R92"=1LFMC_^\?Y245F&OYU' 0+J]YB&N,FZ):TPL
MMX;L_)Q?6('@QGAK5QEJRN_0W"N[=[\W5?>')QW84W?AB6+ EVEQ1[>;;?<D
M\U@\DX=2D\K>EZ<Q,E)_NJD":L)59I5)1OKO=0A-G>E-=MYQS^4MMD@7Z^66
ME0/S-B]?/1S,[I(4V+!7LSO[ZY()%P MHGU0B=O7\C4@LR%[W.\.;/W5?1WU
M/@(=\,V?GH&17U6=0**]*<H5=0"3*[:=,_2?G4*/.]WHOXUDMG91;Y9BUI'0
MU!'.G>R<^(TUWAW8/3%L:&NI21N%R.#*.]K23.M?:)JF:0_U])10CUM+O/]*
MXB/VK$*.&>BT)Y05OD*^8"C/<\KT0DK<S(KK($$V:G'RB'LOYU>^WQ/E[E$4
M3T4R72,*&TW+C#-!:\5=G^:.ZQ,C,1T:.4_:(,A&;X$>]IO5:=+!E64 ?C4C
MCQVLDQH*IN;-PE7RWN.+&LL7'YZ@-+$R!/^(/#TC!Y_:KJBD =$/\Q#8=\-C
MAH]]\D7#\++.[6GL;Z)32_H[Q*^IF$4]9AW!HWP(Q5%5E+\-,):/'V=06 K)
MY\,[6W]OD<U_BZ=$AB1*% 6BXEXL:T5)J#G<=#FR-06H1WV8 ?6(BQKB [:0
M54S0LIF5)SB4%3&!, CN5+M=,?,AM[ZLO^B9N58*M>^'Z":_ZWOV3R KC##A
M(F*49PBR]U0\NT5I6+#U?6<!?9"4-,(VUZ@MWE%',-]OS(]/D:BBK.%: CG5
M(@DT6K,6C8IN<PW&8J;]=VX'BF^).:PY9[*G[3-%;SXPS<A]!ELI@H:K3[<+
M8+!L4_98$,,P/G9M1DI8HFXA+/^GNC?UEGJ7I#%GF%IY 8N_!Y!IGF2#:TSW
M/D\MM(%&(Z47YG9^/4N8WX+J5S!7*M?J1A^NYVLRA GC3C",\:O>]%80Q )Z
M=]9H9;A\.$BVV.WCGU&O7(X(40!%PJVJNV\XA<5"1%>HMKDR<Q"VVR&>TSE5
M]$V&LL5>KM"6F'?I1RS=:,.E08X/3.^ &/9H$,8?IC,Q&%O_8Z(")NX1P(AH
MW!47:/96 /<BDZ,\2P&9#*ML/7]2@NWC_/9 S U5@)W3S>A"XG<.&)UK@,-G
M8KDQM&(SLTWPA$)E7#[[&;/L[8B[C.&IL@1V E7.>6% ^'D>A+#7;+Z\MC=D
M_\ M1\DI<,!*<[-;V3?,0]2$Z('A]="JF9)EHMW..36+Z/^4//.>/LT&G[I4
M=,=T/07P@>D-2?3C G'<F,A;O'?"!A>9G#GHN]?_<]3'Q_MAO=X;QZ!\^6^[
M>69RK'-K]^ .9@V2=-NGL6EH0?3#K('48IA#G$%=3?YE!+>'%2Q>,$K&X55\
MKODWIY];'(.LQ]VX?40=I(Y!XANX1$#+27@>%?"Q]M7SU^L;5U2-V3D!M%_"
M5NT9W'/AA0[!&.S=?:11\YGMSZ^$)\H6TK"NCG1=S,J&X=M:^)/M.Q1U]#K>
MS!K,8CX?8TS5(CZ\!/#&J!1%T6 =4CB<+!V2U05]2LW,* $ 1<!=W7]*K_Y0
M$HTB@U<&PH\/V,FI*65P5 BXLL,3-VO0]>JIY1)T:H!SU;M-S).AV]EAR?*Y
MMO(U;66NXS$;K>K9WSOUY\8#"\;5[RC$*Q;UQ(P!:A19D=1I3"J9[EP/8RMG
M2DX'T+_1!DWFFVNW,X;?JM'=<H954L@[# U_8,IN,*1=V .R=-[>L;!CPKW?
M3\><<5OZ+W@ZF7D^]$^D:F0\0FOQ%H_R.4OHES=D?DS%E-9C@O&WCGIRS<OY
MXM<9S,=["*?) Y_6!K+J_6/UHI+#>#,;=V[W;<H?6BW?I*1H]G*$Y^"%D1<
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MD-G.1)AW!4P!5Q OL\  ,L=U)I=90G:9O\^<&,:Z562*&-44_:UF -V4$5?
MP:O8^U@'-K;L5O#Q^\QL1:]"#\C5'(/D3(F;BS&F#%\.UR%S%)?I32BWP)*]
M<!K<5C]H_O"@=_BY=_ 7M6 9K-LZO!!(<.[W$AJ4DG<-7WY@<Y(D/=-B?Q7J
MK8V;[0'&+LO4H=92^X&X7/74<DEV,-VNGYH@G_?R=1G](:>S]HPDA,<"C.GL
MX><X9<@G:(Y),XZ4T^JH[?BW8@Q"QA?GO=U(+H+L:V<;RC8J1U#4J*5_5^#X
MW8_SBF@%-V;+/)2!9*,2WXCU%\/UC>.DKK+>CWFVT;@JG9%?3W$(3(1Q%QOB
M1M?9$[@FF)CGB,=3@Q;FH@'.5["EYWT1^XGG3@BCI(SO+^_7X:.F24 \>Y\H
M"&##Q("4C,1Z"Z7J"0&J"(18O7>E2LZ6G,,Y5V*7%M/MC?56SZE"Z?8X9<"*
M>J)[J0U+"[+%+DKQ3:+!M1+WQEM,]Q44C$+-NGZ%4I3SFEHN,!AUBX,/,CM]
M7MUWX"-YS3=G-,D/__55YS@U/@8\.*8R^1-4JV>&*S7F^(9/"=35M+F#_*-1
M6RT*,SBWGL0QMZI_T-)72>&5E;QJ3[M-9L$5_,)4[+1Z=G16?=5C32F"7>.L
M\MRLSFPWN;_Y^(J)>Z/Z*Z,V5=;?%X"X3EZB2>^]960AU$ESTJ'3*,=GYQ1F
M)-X;T7WUDL@BP&6OH#W,'0TU?)0RJ]MHRVUH$W8[ZS?1?.9>]HLR,WT!CJ08
M08;F;D$3RF&0LS?C#IH)>?YR'M*8?0/TND'^N8<;L]0H[W0\%Z(HK?PP<NZE
MZ**'M,Y?;_NP[,Z>ZY+A]-EV5RIXMHDM>Y@EQ]CO:&B$(G#C<%XY%U7\K_Y=
M^W\N6(U/L=C %[1!KDI=M( F#><+@ ?X?)J42IP\KY [,3D$K:MR39L;$NI7
ME@R'+@#)0#0J/  D0):AJ/@W^=_D?Y/_EY'-;+C'&ZCH 3X[.^:E_^J)F/_6
M^+KD1+8D@Z;JR^4L+P#9H-3?'^AW_W_=A_X7 $@_P,DZ6UJQO<$\4-E!,^;W
M(UR_96[9A(_[\TR$[+]R_.R_.T3_TP$J[H[-@'ZFKI^+4"K^XXJUG9NPB!>J
MPH#F3RRF_<'&)YK3 JT-IFVH?;ZKIIRFUWAI;EX?M#[)_3-+.+L 9+C/7 #V
M#E$7 "UQ@$]7317V1AB>#E/9@?&^[FYQ@]BD49>]N;R_:P[9Q[[5L9 PT!.X
M=O7[RZ'@C9GQ7S?6QRSZ@)=(&A70NCZYUCRKO2#N8P;'X\U[W=F-^VK!'%BU
M;*]F3J%VO;5!Y)(>)A6Y\JJ+6UD F",#YT6)'3<[<6B9UZ?(!@VZFOR4(P&.
M-XN(HI]W0PI(-[;6ZKG4ATX*%J2T1]F".)Z(V7DC1ZRDL;F D\05HDA<;R@X
MN/XW>;&UT6+^_ M#PGD>YUFW=/S]"P!@O"'D<Y]]ZC(KT0\W,#M8U_&] ;-7
M$O\L1]LTO9C9U0.P'\WCEY&.8CT2CH*+P&[6G<=[^2N-8OEE[7^5O_:2B7]P
M7FMS"'2.E'=12DB_B=%4X*BD-$8=@T'DJY//SXMK!4V(D2ZU5M+]+8$]E!/-
M::F5H1/4D^Q G-%X#-OIHC4\X M_6.$QS:_,A3[M#>"RM_RV;CFC_-!F9V9=
M>[117=0NVBP?#9VQ_/0H*\ AK?OTFL?: =H;:6V><49'O",N<P:]TA[RM"8S
MZ5*5H$+ZT?FF("(T8RS$H I3D-1Z 4""8CUQ=?VMH%BL$^Z\M!-L?-M/](WC
MG,6#0QS5_GI5"&"_4PX^N<Q&I S #,' WE^T<]>_I8TYT6JGO?[F@ 9_+V9:
M_O+G$1\3KW3DZLJ" .8"D*3,O6;(<@'H0VE._+XC$!M:8;QT8SS]J(:?9M\V
M9:6MA_-RA.BF-WI=%9]<D=K#*[UF7NZT)GE-IW3W3D" 8R0_0BAWXFZ$0"K1
M@&D$Q/6[@'B'[6T0L#><EDX^5YQQUHS.A[<5E@[?R1:H?P:@PBDR^BQ'*'7%
M=36Y(H&O\^\V3/"'66BVM66J>4I4O$A'2F?$& T+8 5Q<DZ(*P$KU[L@W@PP
M)7P2_ 98M(]/%"^M+@'4Q<WD>VTE2$EQQO[D55A%4%T=T(#EX"F19 YBO!-&
MU#:4D#%U+/D^O%;<OX!*@Y 8*$_'::.YPB[H *1\2,TZ3W(A^@"30!!QW3U,
M5Q\&4Y"PXIQD#Y$S6K(J[KD5KY;B&6,I13.><Q2=M 58I=Q>B0FOUWH%E]P^
M[=]_?9)FZ[::=RY!IF!8ZJ10+M%6+F?D.+SG8V<0OEH43D>%:"IPP N_0\G8
M.YSQJ+PT*H,AS[!Y!FO48^^^K',(QY[GDL+6O(E67<S*[&OG[.IM>-;*##_9
MK7B9/!J!YO19%^/@CV;,L<N,VDLMP>/R/\.?A;\.9R!Q8X!<-M"N)U,R'9J;
M9F+H#V9GX))O'---*]S1SZETAE8GJ-'AC&0IJ,E:>*1]?ZM$2<'<1)R<L:VC
M4+U(VSO=JW^T[4+6+_.LM;N<D&GY<?DH.\^'H":)BBQ"N/LCQRZ7 3B.?DT_
MO%L::R]+NCD5D&Q#<#HO_(S[+<T@M+8V^;4H6?M\T4\FYR:3A^];OJR=SJO$
M0ES4..%VR\2!9/VK'^&UE?S-4X(+A&'OH3#$9<R;_;N/HV,X-APC5/*(B?BS
MWBY&. >:2 AJF6E_Z#\IQKQ#BY")TL<^XYUP2O'U571L;UPGTW+B/J[8)!I^
M;Q"4K%<IY$7D0>-YHL_&MGBOFCD,<O+,?C_-+BB#7 !P!HF2V-OIMPKZZ&01
MP_GBHXTT?#%]K\+\ECLD"7FXF:QB<B^95@^LLDSAS9<C]EP 4#[,Z R[  3'
M"^9O'*D"=4EF1/SJ!2"Z\WH=GJT#/NX:EEJCX1)EY778UA4H1<%Q<R.-2DLY
M@;A"2#RO^4H6MB;>(?/ND6_AEOKD#DN*W(1"%6RY1^=L1M+*JYA(6CPX:1/R
MI+WKU$&7BZ=KGQ%W*K7-SLPMK*W> .!,29?#Z=T'.]#K.ZQ ["2>\N_!2PY(
MC4LG&AI-'2<;++M(+T%>(,0"-P8$DI="-WCNG#4KTQ]2' <-K*#]>H 4SO5-
M>-;^']\_^^>_"/'*8QX%Y2#DTKZ5E:>ICM*OKLO+U^ ,"6DX^\%2K\'8RLI;
M7?5&1SNMK]1%7SWJAET:&<V7^OK2YYVSZT97LKWG5+C77EOY"J<:[ERH-O)W
M1Z@1RK$CEO5,2N+!B'JIE!@2#@59'X2[%M 0 ]<)V3^4-9SPL;.#RR)Z"A;&
M32C8@Q?8S:178#(,O,$CE^W;LJA5"0;X-X)P3PQC0R+JM66J6![^&!MJU-.H
MB?DTO!#;_2;JZ@O U1?1@_KGCXMKH]1,4N(:8#H7@,N#*$^M.)A/:5@^J#&O
M#:HRV;1UV"OM25T]/-[%%]6Y^(%IW!!M@4GM.YA?[VY4$;@ Q.RMC5\+*S=.
M-3R30WM5-.XG6,GMG^EM\9G?3UW;&U297+6/A=\A,CF ^KK82+9XN>3?O"!=
MQ/ZZ^MOGGI@B:M%-6ZELNWG*W;MQ))9RLK9=S 7 21!XJA=@5XA?((,M^NT)
MXDWD!!:*;U!VPA8Q''^C/Q^(VTS]#(TY%G<@U5N)K=%Y+;R!_XXWH&(/M'A)
MJQD\Q$JR.H.31'&?$X0G86,V%H>"]_7"2]#%V2/(Z%@(ZQO*]"QC1GE!OZ<7
M@%\!'_]NG-ZO[$&BE\#,,<VQ.$+]OF!=Q,[U\=+>2'L%\GBM=7AO(?Y!7BC^
MLPXQ&"(X5?+I@[L*=T-[[J94@ERY]F.$ZX?'E[^81$CG L[.S(G8U?= C"],
M/<=*!R9Y2U0C@%9:YJO!)%>)=-?-Y,^7K_DE<6%@TF?/H=)/\2ZIF',M33SH
MU7[#^ZYY%#%.GVUBZ4#)J(C:\1$/H(\B8Z83-MUNANF*N #45B9Z?GPOO+;_
M_JL'JC,O:$W\ZFI=DP/?K/<M1YV[/=W/3&'8;;\Q6'#<X#62%1%T ;BZDN@/
M#G^"..5\AO*79[V%6H-4#"GU1F'.7$&[Q+_Q*0Q?3IC+00+K7?(^V0R7V4"E
MD3G,:A56"SW7\@D_N<P\X[[]^7@!,%6][?O(V;_*#B^,'<;M]2JN[80T=#9!
M!""-I[E@@N7R ZM"':<DS[1&DC;%NMM-TMQF^R A:E;F@(&\O$+7(&Y]NJ*/
M^C#Y4=IV::1&@T-J.<+J3025]L;I3'A.";2<3*OF%-#(H-L+5A$=A= P)E\
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M;@BL?Z+*4]!7%:/"1NPI5"N"MNF19U#/6FR:,6>/J[%99A,/MN=U_MC&2J?
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MCVN_@CG.@W/@?N=B8^MJ$$]GX&A:.\T]WT<71Y(B@7'"-T)S:*EGPXO+T'/
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MAMLPZ-COS !GNT%.(1RP[K@;D'P$XP?]&^.L^,>:*!/W[^^RQEV4TBPDG="
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M95]XJ!6&<S3$G+JP8L5QB0R^"UEF6;'I'9ZWX>]<W\MN];!B('N3HU=)W1)
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MB0@+WPI:.I3_]#UM-:A(?__-/<]U(OJY',C]Y;"C6[QRYF [<B[6-<%FM_!
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MH\E)X>ND)X0#","LYVYX3!% 2V#D7^^.K;]SS$RO:_GKA9';%.J;LP0XG$Q
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M\EC&<?I:4_)#WNPT(3&G->LPTA>-._2Z[,3PV4U&K8V;?)%_CA1J[+1^'JU
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M41[7 * L0O,[_^T( PF ?.*UU\+@JS 2/:4&-4WT%#@:79*JJ'%\LIB6O_W
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MH#[9(<]R5?B\PYX@ZS5(^>U;(V'_0=EB:SCNEJD "V3\K)<[F*)A&\\@IDI
M@,Z&STBD1AE=('-6GCBRF=IB=F&].(,R.9Q+9P@K^3WG8*.-!O^\!"K-JK#9
M8C7/'(B_Q=P6<U[B4XWCM.[ENAM+_L?'8K"CH9HJ9[)#/VYK#YF*L?4($,]8
M?P+I7DI_[+BO;UF0(D"R9B>":KI-C>64Q-#%NT@+'YDHJ9+!&Q[R<'K"&:A7
M:QM7NAWF?"A.!'^" /K8H<2W_NN_;*%/FN >P!,S(Z75>D<DG_X \D2:ZP,H
MIF61/<)+P=5](\JV9(NO7F&U][.^Q'#OR$.2>QQV,G1B 0X<-]3#="&+H_*W
MAJOR/@783%:CDX4=25W/YT_"5NFAXB2R]/5$%4<779IARI8Z[W44<^CLX]QB
M5EGOG%-T^BN-J8YP44J/5Y.-+PMTI 5A\6<;Q\5T6&0S.+WJ7\](4$YVU459
M+7G)JN^TTWW6>'G>IEQA;&L,"5B <-OW4"-S=8P%!""W#^HXPGV0[6OA[/P.
MQ>6'-<6YPP>'[GP %82.'E&)E&5KBUU4J7%>1L\AX4L7PH.1F_J6$=D'6"5\
MHEE:>8V68&VV.>1X[A;-+KIRT?=T&&W39L\^VB.^['^_T^@?;;]*@%!C3<-B
M%TFJT&HC^PQ[ST](IHT=. 4C4F(^T+O D4;/MT<M=<Y.AP_"!LR:C%P,FBIQ
ME=Z'7# =AYH[6V/*CLPJX%__/*I:9=DG>-<UT9C6(4M]T8 O9$R=BO[B:%8)
M1]XV5RQ@>9SC9[+7Q)&AB1@'!DFRRS)TSJYXL?801;<O;U<07H(:T!61X$'_
M=(&-[OAG1/ZK:.O]E+ADV-F "_?O6BU07S *3Y;""'E@R@#@ZD#9R6^4&\</
MC,N.;H:L##_F)>%0@>W<\Z^=16Z9RV%UA7W9,$EKUNG"N./+U])Z/B8MJ5>/
M]/'TS]7\/F;L[S"?(X#G&#\'NY)"N2BB%64STT.NE'^WZ\\$>N4G/XU_H(:%
M31ML@EF;_J6OQQ/':I2[ !?)JIE6"7=;1WW^!SV#32[#9\HV5WSE(_3W45/5
M L7NTP&2>EW-]4[(/W-+)(_$_)QVE_#<_):T TJ*3J.' S2,%U>FS=9I3E_V
M-#G"&;U$A<R+EH^\>H(.0H-.&.IB?F3?9R)L/7@Q5-/TREXYR<",8'&A?G<1
M ?A03!"ZROP_[+UW5%3-MB^Z$!4E*D$RJ("@)$F2:1 1$1&0T&10<HY-AB9(
M3@("BB0%!"0IJ<E-;A EY]SD3#>QA:;[MON>\^[^OGON/GN?.]YX[XSQ_0&C
MUZJU5OW6K+FJYJSZS5F#>T>S"@Y5A3)GX2]:Q;^@I/8[2,>A$5GWXG_N?GC\
MH?=9<O4 C"V:<@E#.J53I+#_706D(5G/ZZ6-4H^L<A3?.4U]S_F@G3%@<]I]
M^":U\I)*GK=(!]-.5./0X20W[&+P+8A\!Z1K403SXOBPSN=72L,L4822[2:.
M>;2*P=%R='MJU&FD2CI3Q>S^<WE)K0-*RGM[(3(R,FJ+Q?:,[L>0'S &B5_T
MA5@58G3!O0'M6=7UH+7ULB1G2B/O4)-1./+ZL-?$9+?\HPS6HNZ+] XUGLG!
M6=64!0L)U]=/;>$C'G6W:AAFS@9KUD8N/,':Z=Y.&7)3:4X#$U^.WBC!L7H7
M:'P+WQ]6/;B9>3$1/G6;^6UL:,AD 171EB?36)I]J1X#1W.]WF,NY>[NV1.5
M+A+1YLJ'QVO@(WFW0W A!O84M1=>GA_-?F'6Q* KVN#0Q(C3#E'CP^(Z5P>E
M@KUV%+U;!NF^,W+TX V?+ND>==C17&ZYUOAP=!]#]8OLJEC69M.U@KX6MQ$P
M=(F*8CV0"<T6X_(5= Q9IW*UY*UYI0$&W9>N%R_7"$R)6NJG* B7T>0O_0HR
M?_]H;%*RC6WR^&;"YWM%KXI&5U;.5*KW9RB=HGG*<OY9C7R E5[<,6T7Y[WS
MP6U.U^UXB'H0/N)Y&LMT,D_J_;F_,UVBJ>I\)MJSGYBE2FUCE\I\_H#N0-;3
ME Q2)%K.;-A:^XL>#]0FNK?*:B^-RP3>:8SMO40ZDOFDW,=^DV1 5%/)WZ7M
M7PHG+2\T$LMZ#W%G(!]HV^=Q>AUVI[:? @L>A,2]L3-%\];+!!Y5TK!;[V"6
M-NU]O7VK;ZY=\@C:7<_3I?SX)ER7\2)+R%W[?YN:*YF_;I<]T<P,'WE,9MC2
M%W3(GY!VU*G]:H6+KH$X"A.!YJK2SWXR$/UA !3@XG,-#U20>.),3;+$O/P@
M4)?A>2-55Q%($IA/?=$V68VKHU^TST2%H;*232_K\WM32%B;5KMB*J])B8(2
M+=CL7\Y,20=#/O$'"909=GH)*UA$/M$;C4ILH'I+36*P"?_:*+X(O;0Y51;V
M63U/[?.-E_6>*58:XF:[,BR^'A++X_Q&SVR?#CV?LA\VW<IA@RCY.L4@C>]1
MA1]/C:Z%[XJ5/ES4JKEBF:)7MDC49DU,EK'4Y%*/'=.R>VU[*KV^P;3M!\Y<
M,5O(2-*[($WNIZE*PU3I&NTK;?H\6QH'6&D:G*J'04K=N@R;[G26O0SK<-(9
MN89@,<O(RLTIWL=*HBU$E&C6AU+?(3V[8T'4S&28Q:K4V[&FO.GJHT0_!@U\
MQR,@SE1&RI>_61SW\_SP,6MM#E.Y7#6.'(^>N_*92;2!ZZ: A;S/QAM#7LP2
MK=1AT@LW73^[H%6;8H.L]UZYF\(3=D(^XO??L(I?[I+G>/-D74FG5.L%V/!W
M@%O+OY)K\=[<AR_SZR?V[I^->QV%LYN8S>4Z/#@F1I_>%<TK:3F!$URD:\F=
M/ YB=$\@$N,@03*I^#S*#B_VR+WXQ6;P4/7=PSB#:8VJ5Y6&W:PNKAD0]H<2
M((/3^#&DP#:R+F97C:D;_E"8=^G@&8O+$>W'2L;E[/]:H-\]^+Y P28>T)!*
MY_G4^.:?^G*CAW$R2#Q09H_]8O"_?A=>,/A_*PE2]!Y.9O5OU%Y"A?_/;T*%
M^^6DWMD=<FRHL>PB[[C/HX?2M>T?!M/2NY,3YKPL3C9!MTP2(0&RS:4O;>E>
M#[=#5GU@/(][ XH3&\Z76LHXGJ(I"=[M5UO=9J(QIC%:H2^]MVO  ^A^ V 2
MM9J7GA;7J,!?.E%7^6!,_:KR3$9)'0=,8FW#V-B5G:IJ@F\/\B$&2FEJ [*S
M>=?IADS\!M\%)(BY.6;,Z:;_2>HV)<G2Z^<.AS[AGIQ)14MUI,JX$/MNW@T0
M,\&SIX:2&>DA8#N\48Z]GHF^5!W4(*9?S3:6-;5)9)%3DN:OXF/O:\=?N=U<
MS%W*B#S/UL/51UK2:IIT_]/T[I"K DX<(1<%^<JN7X,0S!-P:4L]N,WX2E.K
M:O]U$Z4WH9\2U"U(X+H<TPEWOS;7#@LBFRI<63LHFL7O,=L>M5X$J^(!,L4N
M]D-"+]RC!\5$+W0.%NL7=LTTZ>Q 6]>)JZ3GF7KR-^OC0SGA5DFZ2<=/7OO%
M)"8]#G0XP(H-VFOU%OI35#:,Y_DX-Z*/;:U!TMAEB$QVLLQ)EWU$-3JPR;QX
M9M,S/3;1>):E;[.X1G&W=OK42XRR>E'-M.-%U^G/@YEW7=>NT8'7OP#]38^^
M#F<^^3ZH(KH+&W3$ R0P>2G0Z^Q]4"L>,.+$Z4QZ7]CTP;HNT:>"/6E8G"2[
M6%NP09T^=Q)+3-<-0N8VM'[1D^8K;NLN'"&#Z9R?HZU@>7-SQALGS=HG/PR0
MV#S'Y23?:_++6>^*.LW6#+1<:XH$ZV8HE]K$:8S]N=!:,]_W*T5C56M4N(BX
M#_+0V5,$MUD/HWXFZ#7I7W70F+'V<Z+!%UH-1W>Z>)K<'A7=N;VE6EF_O[U[
ML-:Y4C2?&)]GX;IN7X4:C_0HIB)3LK5?/%=6JNNSBK97<&>0/7XIG'-T-M?H
M5?(%N?:TH/HI[FBG>,/1(7NYY</B^%1X!%)]APIS=B::%0B%U_#/E]EF7_IA
M.G7Z%0^D)5109#5X^<^7375CPA;]*#PV=*6>51I-;WQEP(U*W/K\BI:F']0B
M*:LB]GXAX5H".:9LZO1%8)\[7==EJ.>L^H(+E-3UXPM]OP)[68]?,Y3M"\.T
M$1U\!>1?NQ18$_;NSI&FJN!H,(7]'$^>O(_RY$Z^H7*ZEK[,B69%1!S-ZGFK
M:Y"9^]QJC[S,*/R$ =+=M2BM0T9%;5=OE0SYK#?KH^L5%+6X/[#7W;H<&R]+
MH?.,<_.[N^Y)ANDL7%XZDUT#5>7+E62,6>O032ZYP@D+\7GX:&)%^TIWR\98
M\6::D+'=U L,34=]3?67DC)-P14^CE]4O*NWRUS3#[[XT_3:NR1//T&K,E]6
M?MQ^E[6U%)?W-N/M!]_U'>>L#_XM1_-$IICT@RZ#TH3HY=I4VIJ7[K0+/C:3
M@#D[ST6GC5:6 R.NFLQ2FTZL5DY+;T&K:(RSYU.Y =6;7,_5%6>T!+%^BP'J
MZG[,LP;*L$3/^A*;L(B/]X@XT*M?;)IYQ[!2\>ER'[D:W5BJ_'3&Y1KTKE$U
M69.+Z;FK\&Q9.CI:PI\W)ZR26*(?7-EME,ZQ!P]&BL74/NQG^.5%D9-<==@*
MPAQ3"';N84Y0:^\30-MQJX$JY^Y&]G;#WC$=NI687$VOU]V?;(U8.'U^A7R)
ME^@'(,5S(#2GR1VT=MH#BP\2&HI.3U.^QZL@')*@Y-I#[7UT=Y7.LZQ7RGH(
MXZ02W>8_%=+]^T]W//26#]8YE\\L2?"5>_"D'LTIL5[UIBE)(S]G6ODB<U6'
MT.7X<8X](>0[/Z+$(^ZA.J&4W,>O\\X";_I1T&J:7KS_*9J'^$<C!#4/1H.B
MYC6_UGV+OQ%UC6](PB%X.R^PN@_:EHJFQ^(VH"?'ZKC;36W1AQNK[Z)=-&)T
M3>2]H=B[SM>A_;N$L0MJ@0<6>?! &/^BX*_S(3RPMYV-5?H;F;V9M_XLZ#<A
M_,7<;3R0/2N(P_7@@0Y-/$!JV&%Z<):/!^8G09CHWVSS\4XO4Y??I.T_%H&0
MJMXQ.*@'_.R,&P]<_QL?'%.VM?LW$OL?BI3_!.EO!'E3NMF EG\&+2W4?K&A
MO/8W[?Z/1>RH_$8E/ "J-ST_3\8#D7_CF/N#(2=$OWGQ?RS+Q='"(N%K)X0>
M&%X!1=/])MV71^\V+\B _EA"^[\)%U2--AZ?^1N/_^]+$OXDNK^1UO^G6(O+
M0Z?.\S/&A4UL\V_%Y9E5]"0!/8@>H\#D3W8&*^.3AQ\DG2SVOKHT+Q^RQP4H
MB0K-&/:0]]9+TN:6N;YY?*6PQ.-,37C4L>K,IO2C211U&%VUS&:)V:_1^><M
M;FQ$**MR9*&7G<&/^%C04AM'/1=(EQ4ZBQ@9=U:B6]8ME1IVSUJ@U51Z162$
MZ(C,<H[PK4!D1 [&DUA"N \OU_M&;T[Q3DN6.FG(B' HW\[:?'REU*9_<B3V
M3+3EU^/H4;1@Q&ZC6%E_@0GQ/DOG'8D4JL?L:Z&)^CJGY):,G4^EA0@CH?:_
MS%Y'A#6*0Q8SW63E!EXSS//E63P.+4($YA!MVM>@LZ,\X%3> 5A6I&8M>?Y*
MEWL_6L#OV[JZPO!&VWH@UVBC..>0#<S4RC:(FOTN^TV/LY:E4MM9[&.TSM';
MXS2#\O<7T54ON"<7F5/"KW0;Q5/X'!7J%NFK3+8ZE(TUS<7CY$T"%!%33A%Y
M=.F;S%<O!$1T7_%R>5 TV=/-$;[5SVJON,3G6;RH2A]+Y'V<,T-T=$OE9 M#
M9-25L@2]OI[Z</C9*&?TC+6#0S0R\$,P JE/#QN72MF&I1TTGM \6$OL4P&M
MP>QNA:>7?1%- D^7GN&!]B;YPX0+:ESP-BA-+W&5F\!Y2<'%P&TWBJ=.=]0G
M5TB?;AHH,MY*X%U+A&W$"YD$6"[R:ST?$JAJD"X7Z-N3\S<QR/S%L/E8F2W\
M+2991XZ5Z7H]'HBR<6RCXI?:G3WYUE N:R]IMG8OWL#?SI0SZ/!<Y5.:"@;"
M]6ONLYZ7",ORSC.+4VO&PG)X#0@9:+AST)A97,DXO>P#%4<VR/HM334N.E\W
MM=,]A8170CCK(3'W\EQO\WXB)ZY:2@[N<C=)<5YBI63^($D5+\98XMCV[5M6
MK_"3]ASA+^3Q&2QKK/;QG]GRZ3XUC:3^W-T;=#[Q#6['$CZ>I+@O>*")'1=C
ML%)LV,GT'1/:<3*5YUIEZWI'T[!0XT+LV0)I3[D]%3WI_5B82J \044=_N4]
M<DPU,&[T,%19"GE.1/QW6C/EA]>(34@6U,EZ%A.HE6ANG;&0<];[NU:Q-QS)
M@D2FFN.)B8F#344RQV)<\V &7_\OEE_*I/[-\-?,5",8C4_^*:-1R18/L+G@
M@7&QWU-U_^M FXC_[RYC-(B(;I3-F_U@##8>YBL#R%_6-<:+ X<2KRAL#(T-
MYZ80[M8R7M>>?LQ-Y28OHWIX92$:!8IE)V\T7LR.%-XTH$P^+GX,B[N8;1LE
M29P8[@)]>@PBWH#Y@H(.C:4U8WH:JBOC[^;.,-L3=7=SLK<%B1>_1]?D+Y*I
MJI*!2 U\TNK#AEK&G:\F\4J<5I61%#B@C<6LO",ZI+S"#O6KU5Y![\SQ45[6
MGSC489TXA3Y+!Y:X1OS!"W#:=<^IXR;Z2-$=J[5MB^HDPU[G6XPO&B0L^XT.
MBT6@;:Z+SM1VWVRGDKU-58=7KAEVG[K]Y-HRY\(#/ET_#J?'<E&[,<68\H[4
M.2&T![\EW9?L[;B;68[MY(R6>.#S:\^=H^(L/G3FLD$."A'J.';6H77'^,.Y
M6@C[+]N[77(Q\PEF\L(..([Y#3E2M.QX%$?(V@O4;$^U[4UFCOI7\G'?L))\
MPM*!*90%A=X'K>G\\&BQ':=YK4IP[*;!JXD2J'7<Q 5SR*]W12]/OJ3%R]S,
MHL&P%RK25IC.G)?Q[CS<P)UWA&O/X8%S9P5C^B[F0M.%W?+;3UB=.*)>3O>_
M,]#NDG679YV2ZF&JO_:]_6;\8H6,PN)/JK:QYL"F(D6;*[^NQUM 3S0L$Q;N
M':>13=O><'FFDL1SG25;(X?IP!4U;XCJC]K%*B+K#L\]%U<5.91*NYYM]+FR
M+$F -"X!GG,,:-HYKIJL]?7Q*<N*VAL[_EF&?;5G2*G"PWZ#@J7L&VK(#\P\
MH@W:36-BJL'V+QUVP@1\*]EWRQE/XS.5YLFW#%*_.4N,53''W=B<;1-UZZ[@
M?,^J.1Y.U^.OPFN^M =LT5LHFSL&R#96BI/&W>-YEA7D7Y!M!U2Z?O)7J?YF
M?P:EGYR;Z_JLOCTV?-WLS=$$"^O2 ,VI#A43!MYAN\!.8;K1[!4AI@;6#NE;
ME-Q)??Q:JIO!T;7[>X@4BWF!V :8_KJ!0:^[^^U.<AZ+Q(F%>\%)Z@/@9']Y
M-&M!-)9N8<=:+=Y[QTE&S7XEYO44@LV&FU&V-8?";X=JT3/1ENLH(HZ_>M*,
MX(B;U0[=#E*+]PQ7S,@*S8?(4:"5X#%8#LO2Z8(D@6N_$FEPI2-O>K-?4<F]
M$_OF!;D4ES'NE53R '4K29]EX3:A5J0)U\=-F"_)]IZKNS,SPJ?,I)<RD_[Q
M':][M8<+(I1-/,36;7C@6G6FXN+%%YOTI'.,XP("I1XI^P,.-I[(&*)D^.I"
M<O_3S6:.K?3XT'Q;&EMQ=NND);V:FK?;NK/,R76!9JX9$);Q3$S$4W0*O%T6
M]"RT-<K"7WK%1,$_O<JM7D:1[^Q"B,JO>*)-O\5Z=M8M%^\$@H'R&A*C?N25
M_C.V 5JO(IVV2:F,E&?+U\/=1%M%(.U-028C'ZLN^D<BA$%GA<((%-TW$P,Y
MYJU 1K3L?*2_N%QVV8Q1MX5-=6U/IF0?1X8UR2:00SG=SG;[0T?-\"PKT]FS
M&O"%V?+D7I]Q=G]N';;W6P8P6,TI)/8D;9COQACZ/5=*WP4>1LXQTW!(J:H>
M+,/>@*(K!N*$9)*TT*=^%E^XU4ZZW,PU:T=OL)N6IYJSQ900,4+6@ >VIU_>
MK35#6)#P 49EJVO9J4%4$8%B8UB=);5 V><B]@6(BS03!J)V3!+S7/KQPJH\
M%"'>_731S5SC8GO4]I\%HPR@X7RE$.Z*RNK:JIK$_"L ']F;#IJC(IE;BYYU
MF-'RKZCC:B?!G*H8BYHOGT?NL:=K,*]H3<2.JR+[R;$RZ,L1$)]/ZV-@W;3D
M)]RIW@S=1D*SR=Q]C0?3C$NT0/\U>X.3,*Q0KJV0G:L]V^W1W<X\J=>IO=04
M/PQ_"!5UT=V_+[4D5WW1("U:AGUQAZF]XW3$8/=#J;1A/F)B:$[5/DBX^/5"
ML<<1MF[!7T3ZD?]USLJJ*<>$R#T'_CON&5W?+\K3C%A+G+YJF(_:=))16I#6
M^T!3T\2"5'Z1&%MW:EX^%B1+_:_'>/0^'.)$LZ6*43AWU8]FY>Q+U%95P6]L
M.+5&3E:RO&IZT ANCT%-+:E0+18M9.L)PZ=6TVVIWITE_"#-H.-@Z 1\K<,]
M]$2A5;^8</DE/@TBQV>MH)38\QFBV+5L(ZJG<V7@5B&,% @&;:,VD]S'C2XW
MP$YJK+VP9/D0[7\RAH.*P5]ZV%];[;OX1#6+^<Z5.FH_J9/3H],ENO$AD8LO
M?CPL9.3, CZEZ ^FR8I;D828^G.BU4KR'7-@34:H@;[B4[FI8H(+ >]B/[R"
M!WH*H9CZHTS5Q;00C_>QX*S;50>T"Y'B:J'KGL3:(*0G5@X/? S% YQE(,RL
MG^9/H1J,X#YTE22=8(67HR/.+X#V[=AQ @D8'=Q]PD"NC%-3Q .=X_G0MAU,
M !Y0),&I&$'1]7]^$O@X2QH74%Z'!]ZQV?\)#0@)QK3C@ME_B1$\#7J3%#Q
M!D.>G).S_^)RQ0-=ZP3W8QIUA@NGPB;5XH$E#ZCM$GQMZBS[5_ J'%6,?8D'
MY!.PZ01;(B871P>-!:U?QP/)&G@ #=DP134$LD,'6@E6$I@=ZY2 ,893P=?-
M"!7S)N#$E?\"]1>HOT#]!>HO4'^!^@O4_[]!N?GSH?V^4N1_H=*MBR'>MSO\
MT[WJ$4N@(.XWM[W#B$#S->])5C5(3:>\]WX=-Z_AS,PP[@L#T1:U:/[O3[ZX
M'QNZN<S]F E4/"C7"KE2ZCA$9C/$DZM1&%E+2F)VK_E]B6W]:/F41\R9_;I?
M4^.7!3\6#[E1M\:,QW>J?4R*?P&:2G3?_VL[#?_;K!PH2D;PL_?G]NVI#'W+
MGF@+Y*(<XI2-MZ?:-#3]*._U1K+AYG4HU<\5^")SPEA3UU<Q.*NW>7L%0W6F
MT]"4YACK61Z[ME'V4 .J=D:)RC.KN&;!&X&]AP<8H ,<>.#.Q]]I2 F-9+I$
M=7H1NCP"PAK[:F(F41@6:)L"0?)>_[OD3=+^N^G#7Z#^ O47J+] _07J+U!_
M@?KO#2H7Z15+A6T3P@/.]W^C@'W",HTZ68+'=E]51&"2[AQP@@8"W.S+V9GE
MV&F"%XDPDWV@XZ?KA^KT&+\.?YOTSOREI3L\*VQF;/E4/TB0^MH_T(WUB+1E
M/*#!MU[/EHW<D>2KJKTH),CG6YFM*_O31E/)NR(Y>36Y@1B!!_[1XA/'/UJW
M.B*87-WUV<7G\NOEY8Z'LW*KI\?J]Z;&[J1;3ST?T5!EH50'#LM$</3*0=!U
M68)$W0DO1]>PE/"+N_DV'OAJW(^+ML,,-4YT"G/=22B&(SV\27"A\[^X07];
MNQ=( /# @!\>X%S[O7:_PG2O*9T[,QL,;5M'49V3P/>?0W^OAANS$1&0G>!4
M^G\OAG\7U=P><*_<W/OC>4U":^2V@ [9"(TEB0<PT;\>1\NF4WH&&/^Y /0'
M%*8\@\J5"GW]_SDXGF,;R<DCKS\5_*85#"ZPGU)!ES/P %;)/U>)[2>)M%S9
MG\ZSH^IEB/& PAXV.?LWH^"M3>YDSIKUZ/P?S^?^29;[<;1^HBS;IPU_EC&R
MG,F&3?!,'<L!PP,.9P+]TB?"RC!/S_,CQK[AX:%FT7*/\P^@54L\ #,]+WVJ
MH6)DIU8Y^Q_NK582=]7F3YQ)WC1T05")O^MY]OG'0CM=T\E]T:\?KJ:*-"Z1
MJVAU(RZ:,XJ-:,JSF'Q S9^):]<TX8'7_9WC@8]"U&]O:<_3O@-!TIQOGM"I
MX*[I_=Y"@RFS(-I?T]RU\)E5[1E;SK?+KU005P>LB64O^5+0$O7;-%/"ACP^
MS$J=Z(Q"IOT&=#5+C -RPC@N*1,#\:.)!5B>03YGOKQ4/ "&5PTO4T]NG,"R
M+)L:J.IU[E.Q5JAY$;P.(SX\<*F1".+.>;#.G)_2VQ!0X9KT7 6Y5?\I2$A&
M9&&'K'5LN!79R_ZMTP6Y8BJY/"/? I)FT9FU5AK&*N;]_&Q_HPAB*]'>A0<^
M7G2[<L0RNLE#' *Z<EAD9B@]Z]4!3G^5&/<@X-&[^U)W@<LW?:UJ9-07U'@[
MF2[%)_#!#" UV3+NTZR28W?B$O6U+V@O +-U"^#?<6]G6/9AI^//U8OJM/8W
M6D(<G8\>HL5'+I$<E45HHJS>%YFN:W5;A?.3J@L/#5$74RX +]J= HU<0W@#
MHP%EI41&5D5><CJ.FPE/EQP#Z=?'LIBJ!W(;1RA2LO+J8XGR'P[62EZA[*]+
M>BZU[U/61VBYL.P%6)! F456 +%'19V7<\US894>&5DO;8W+W.'^K!^]I::\
M923-CR7*6&2*UV0^1#*0K)E'3Q,:'5&!&LU,B*X&75/D7-U[$<^S^OCE2F'L
M2\]8"W:C9#UZ.&F5?<Q9;PR_LM[01[C;2:IOP%[*I7:V_#22<O_KQDVT1,$^
M"YF73]JN(M,JKF\D\EQ#T-#91$J2EXX\\.GWSUB[\\4&1%6U0Z-O;."HJ#UZ
M=&7Q?KOK%V.?GQ?8/MX'&(^Z?$_'=?[!+K[_ISWCJE=3:T[Q0/1'J;2(0SQ
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M0U#.1LF/,!\_.S@H^>,!\Q3WDU 4'(/2PH!O"+RVTW+;##I=C.8ISP0^1?,
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M8<04G_:MO3Q-AMK:HBACX91=<7KC30 )COYG:>/PG&W@E>$=L;OC5%YK%WY
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M/H@R%4IHIS@.XV94<WZ*( P@+2.S<S44[2+7*+WA^ 8M4E4_+FD-A_;WRG!
M%TZ55Z)(W(H4 .?A9S"4CHEMB8>,=G6;@@=+31ROR?@=91E-69E@ ,3)663V
M^[@M[H.(&(E23SN6P$>KGKF0=.J&QZE45'2*2I+3+/"$?>_%#Q<WIQ6B N=Z
M\6DSB_8B,4!,48F?])@D#5G?5&VY*9H8]N85W@F^:C:'6\<2&=41+AVO!V4.
MX47$D7T(FAVA7EDR:%[\A+7@,X08Y.ND+UQC':.(]>3L&Y$F[K,]29T541^N
MY?/:VZ;6&\P*H/=!7(X"#O%%)VS'/V"R]XR0XRK?$&V9RTK6S!,'JYYDIIK:
M+*\M!C+6S![U8FT/X0J-Z,3(+<\<:T08W6B>G+>8.E$1DLA4?.N$G^[:#4)W
M$GTD*CXP@OSS!,;A*]DDP[F^$=-JX]DO)TYPS>KJWMS KC%/_73\&Q>@W& N
MBV?TW=B)!PJ4TU5H7*I8+VQ"\M*S@>%Q,0,X=Q/I:X,!HES3[^)"Z*G:)BNT
MH3,FK2^9'HDR*\3XIVVN(5("]_W8[]IL:@8J/Q@;8V>S,H"E##HY")] E:2/
ML<9]9/27+5T./?SN8C]W"NF?5#K0/[#SE%A#-0P7KAKZFFT9/1KU4=W$ ":+
M7(LSI^?-6BEV>ZM%#/,R22#-/Y>_\"Y-Z:<R&'-#9AV$>M_4R*1L5T>\9S3!
M@O.>3',8/2GXY8&A<2RWGA3_PKSZS3&2A64E9+P!F=F?1W4E&T<2H9]4@Z>K
MP5NJLK0]9%MI;H6EBS;VH"+K9W6A#OR"S_-H5P\<G&&[KVJ0[X+4$(^U%W<2
M?^+'=($<96D5R*K-\]X,@@CJT[K)#P1LE>-]>JFVFW%C>Q,.NMRU+_:\S-Y_
M:RFA8LB9'68;IQ3$BE5PL5_6G;<S_3J1U]141Y6 167<07OT^GW-K93GU"%Y
M7G7"^[.FK/SKPR.^[-C4$=ME@IXN8(I?2DQE57VJ2AS')C63K2^[X#9&#QL5
M)E9B]C4R;?OO]^)J#QLACW,(Q2.FQEMDG'V]G0EBZK9!V=(Z6Y^&-T>N]68Q
M-,D%TC[.DW"!-\0\2Z5HW#&"PT+&S"?4T^T .5M[6YK]PM%0L=4J89?:+L@.
M_8KO@>&OX9_S*G07?E_\Q<0Y"Z^7;D6L8AJ<R54*9CME5&(RY;#D$H.=QT:Q
M[A:OAM!/\9#B6U%UAY[>9I#!?7XE4JQ(!1<1([IQV-YZ&I??E&4T_F,;"F[9
M+6FOK0<AA[-=U+9U*9[V(&=6RM1//C,WDX"@Q,0+3=QL+?TQ&PHORW#Z5?TZ
M_>9/TU9W@^E_\O*-0^N$6!M2OH\-5RJ&+,_1.$7P^Z_2QF1B "(O8,6J(GE'
M:**%R-X#/*TKDP"ATWF =5&Y:S#YIP\=2S\R"WR=0&'F*J;],O"N%T_PR5$I
MM$:'V;>$^,@T>O7R%QI\Y77D-04?'-=#1HQ^1#"=OY=ZXHA"R-+G_B]M>FN#
M%H&?!A71<.EH'G+?"'FTICQ'GU$2_PJ\;.4A@P[$ .><(AB V)"X2R>AY2WT
M^*UKC0[+[R27WS' OV2Y?-/^&\KM[_ZLL?,I]OP4O8&KK^!D#*^1O-Y$Y<"H
MI/1_P54C#PVZ]K=YKIWM:C""U/<E,0:07ISKV+6J4/U#&;AS! Z^NH4!#K7M
MT8RQ)>]D-F<O/]'9DOWX0PE2CYX( ^2THY\-_D:@.WFNA+H$.V.7?V[D^4/1
M'QLN71R& ;+M]_],KY0F^1B.8%<_">LBUMK_4(3B(L+% "/&&(#%XC<8W<47
M)K1O>V/ U*A!RA_+KG?NW"4,<(&/ =;*%E$*#*^ZP</U9[SB4,Z$?RC[@_3^
M0[".>J'=!W?:4EWJTK[?K^%FG+5GEZC+<*Z/ 47!%WLY=Z7B/"*(ZCI%+Y_*
M/L[;$1?91DX='^ZI*8NQPT:WSPR(K#Y7"QH3;QL]K#^JB?RUV3'P0-3EHGA-
M.].AGS]H/:$:^!S!(<O^N?ID-[EZQ&[C20AQ7+X;6^RN+"TX0E*%Y:1K9J9/
M>Y*0LA)5([-L,/A_@D]--K=%(:*=A9?@C>=S&?QQ+];D_;J_)*&7A;^H#6=;
M JA<O_/L$)2,;X=0'"3F>)6 Q00<BD&FA9[H:0A\UQ._4?)FQ#P&.-=X"?47
MN\.97P]O+9C;@,[JA8#BTON9GU9>'1-R)*<OGU=^:;S_+'D$2L*:%"(?_\OK
M.(<@@O-Z*+HV\/$J:RYS?6V9WL]5)3W8Q(ZM)'OOH4*N"[,3$OW<GB12WIZL
M?&$W"#B[Z)@NTZB8V%J,:9*\EJ.:\\#=8$BR4%MN&$H1VD\O@GC5G1^]-N6,
M<NW5$,0*4K!]@_0U&^O-+38JB&ZN8WH<?.VH8FF"J!\WJ3Y%OQNVY]^/,-M:
M7):E^OB?##3X36[2) CF$)?QRC7N\FY^OC6&_414.P<,U#L*%2,;@9D_")2@
M/MD50X^;WL0 1U-"X)\6_I+-JZ?9KJ[+AM(["^0)G/H)%N94O^[ ->J4C!UU
M%VXA1_.VLJBJ1D^\:;I!RJ@J02Q#7;-#N0>Q4TT'47Z/V^'MP3F&[&7.B\],
M^+^%_$I7$<6-RL+=-%)=KOP@S830SB0L2M#3TYM;']V,VW=,X">3NW(T5@B.
M?K24T+U-L[6/^\4C<64XZ 1\<U?;#9I8/CB4+:FEP%+C7UWS'AB:<Y6N/9+R
M5JR$,QHR=8DG%SI7YM5FYM?3/W<K)*K"-W6T$XAIJ*2HE&[A18#W#FW!1LI#
M)@IDV^)L'8LDNU"ZK%)+WP)FBOC'5675RI0W) *HJ%"@U)KZAZS#PJ70F-H2
M$+W.:5V!I^]:(-/E*QAWAV.&'1L=[KIA;SM<M=N/=H3[Q'MWGEO5^^G"+L$W
M"B;1)<J.@UTC9WGKX#0A+A^MRE\SD:I<SB_JZK!O4-JM/<6^&G%\$]7SJ9I$
M18PYJY:KH.QL.@ZJIS@V+!E)JE6I8R$*^*J4$Y%XV&O"*\H$YPU-52L?L9@I
MS5<[]-T\'AYGS H48$Q3]4RP8K8JB YBRKO7W[%V3^F)=BV7Y:LI,Z7)$\[F
MLZA[T:X2SUYYW>U>*=:2I4C1G]11$7^QXQZD;E?W;AF5.'30F.&Z6:@7 =%J
M'=M7Z$WU=+04I229[1^MD^+'$]*+ !J+=BZ2*SD&2FTH=,;8.UM_#C[$_E4E
M)!4;+C3(_6MV.VTHUQ*+^5/Y?I;09B40\"9I##G=T90=P%->[NH)8TW8$&"D
MT;$ L&/<.4:_=$WTU$RZTN ?^9J"76W=9@:[!?B5G:<W<"7/"GO*=[[:1!=W
M%2\H^:TE-ZN&D-1YK1]E^=4J1MQ4=7266O^90N&L(GE89<V2-""0.)'@R?KY
M-[;EO(S%\'DJ&#:- 4 ZP=--?H/91_P88+82/56<W?G*76KL\[5E%2L*WDW#
M !S)?WNS*<SR&W^KB&=O=<)E-YTSZER'3U CIEGW'OC)RU%9>GT3:P1%%YI4
MFF2\!J2?1V!K:UT1N1[-%+7&6:.T.9=SVM='YSB8GGT;F=A%?9J^PD.XVDVA
M4LB=73QK:("WU@1U8GE#XS]S(@4P:*A\]A>5PGTR?1)+?^U%Z:\T4[I4@6QL
MWPMN;=[GMQ.SIIN.ROI$WS9W!-7I6B361W'!:QP@=[.O'65WK@E- _$:.VH=
M5OY^Y?./E0\N'2>\8*18&V=-EI&2WB76]SPBY4.[+A0SW5*JBUM54[GS-9HB
MJX,-$C..]*5)1T[H!"#TO!,\MJA2PV<;N+6)7ME\VOR42[11# 8ZQ@J IRT&
M"*K=KC$.JT/H[J?H-1"];7,Q'3+,L3SP:96)) ._A"^&";9:RB.40FT96]NJ
MQRG4VL;S,YY:1(:<TZ)R@R[@H)&M'$*9+FTTYX3D:]<*9)I _LS5)WT]*\3\
M>0?=C+5!9;_^5X@I["5*%MXZ'%XC =XK-@U]-6[/U%[EJ32PT>M$UAH#3G(5
MU,1-0&:-KU!$I3^-6.VZ9^U6)_Z10H3S*I>T\I'V>LI-P)_$07T50JN-\J.=
M'H<L\$[LO7FOF&=J3Y_M=<EL+'0OZ./:$JTKP[/]K1PB1@1YY*H,S=:CG%TC
MHO'R2IH!%:'-E@@%V7QRCU%%N#H1+:&:G8T7;IB/V&H*0B3X?=[4N[::&"BZ
M5S4X1-&JXS9'LV,&P3UP)7V0 N!0=RHM@J#/KL0 =I+4I")3:J#";83XSQ&Q
M%P25'#$:3/Y>7L2) [\\O'N)D3@:=]X@.57'"D%L->G:(O'?ANZ06=S)<SN[
M>=@-J/N6_BK*(1(;W_-Q7#[ ]3!Q2:>TT^L=W[M(CA8<S7LFVV&6$H=W/$2H
MU"KW&<FC.25I6K2;-A4$6FY6+><ZWJBJ3V5.\-W<B)^1-LH@+"PL\+*]5@9J
M?I^G\)10G2YM(X::2;_^+S1<^K ?I";\;JF,,L*OB#MV8[LO<(+MB_6LA!U
M]:6^1?FF,)';E KN!_X Y9XH'<<5*=9W4!-#F* Q@TBDSR-3PI+ZY%(0N%!R
M%[]N_+ O9LZ,D-=7"FD1OSP/UD6\/HN4U+(DS':\RIJB]DNG[7Q)DMA0W7"N
M2N((H92>W"+5Q.6"3RNUPZ^WR$PFU<FE2ZGUEO??>EKUK;F[G?*#OM/=?8.
M!$.B))G<\_&#; 73C6[W@MT9X_K]4BFE>YONL&,/O9N6YM"'1E*A& H-YTOV
MT.-J*B3DHI<;3$?>2Z9;G&QZ2.=RJ ]MI/QXGJ&.CJV<?06Y&#FS)4]C7<H#
M0)1AK-4I E@"+W,C0S' TRX,P(T/1K.F=$-QPUI>YFUYK2>UB+.%NZ2FK7!*
MA'>/'AW6O-_]/@>L>:W&U"Y<SW_3TCD?%81ZN'..ZK($'1W/.Y!WM+RA"JML
M=!=9M-_[I0R+IEG[&TA7ETSQ :W1/2'A<1A338SWP-.D_@<=5&^5J7Y U-5<
MKG6:;.7@UMR<2I[- L$E2TAI+CGYUR;;0&5=D]R'7C?$O9S'Q:B:6J>[->YO
MDVQ5(2T692_U*.U<J6I),[7PNMX_/?^FZ)AA>D(?>SU70R-]6,JM@[ZS=7KI
M[X*69VC[$@PA^,K"13>KL_(#/7"RRPQ0*@BW%.F(+/):^ 1%F$G6A:\:]QLF
M.QJ;'%S1/I2W*WVJ J Y<AQIBRWW;>R]'/FI0YE*5B%V\9F4QE1#*[BSC<V>
MQF#7CW:LA>%1DBF^:TE!U]R-$ESXNDXAC2-$[UB<'3L9?H!BPP#04#3)(E(1
M_7T] VSAB;9#\YTA(<9C-:@GR[8T/=KQ^AZ!/3PFP:AN)0O#\BC+=::J<AMV
M['ZA["!Q?(_9+ML"#S>>O=>7.J<5; _ I?3J<KZ0S>%Y%&C2-/I=M&F4R;U;
M6ENWQ", #LYVY%$ZNK'^=]C;OU_FW$I;P(_RA$.X%](G:/U<*4Y=4U#GLQA@
ML0 #W*E6 )3NMI"?'SZ,X9IW8Z="E3QC_T?4UJH*DPE;H?.#O;W5YHB5*<HW
M/AB :Z1WC'8IZI[/L-98;6%)PG[[*QS+V!S+JIH,@K U<^E9_VO[&Q1<J33!
MS>-Z5UI?-9MPD2S>\=-&O:A4+#_A28?AKWE=M76C#KB*OUL;$8.FLDR $']0
M# 9(N]%*JO7GS%I#F>M:UB1$KKQ%T!]J?VK)TJ1DL4U16^=>@F[.#1Q^#L3Q
ME1VT\@!EXX/ )S_:C[$-,DFQ%G3U*04-Q6U)\/D-Y9H:$F\EQGA*GU\X]J@4
M+2B8KH(D(@/);]OZ5#W<(ESQ0AMG>E[/^ E#I-X3;V]WL#M=^9>->-;EL[4U
M C/PQ>ZS(;<)'RYK^G1;2T^IQMO,%,]HK-;LL)EVSZ?Q%0#W^W,"'O4J-9[E
M:R#?&7($Z:O^J\467ZD2N?R?68*^K[,>6GRH5C;P*;0;P]MS-J CQ9K5M1&&
MEJ5-?G1BUO#X^=9"E.AP]0(;F1:"1]/51C'!-!'!?/8VWR'D9A9?EG1CA70$
M4/NE_ZM-74*?K/*&XCMOH&/Z9<DCX[!DLV/;#WYY%SI4>N)99:ZJW@IICS7L
MLO15FZ7?PN)C=Q?\Q7G.2XPWT1Z3JN5ZX^K3M2Q-8\MM/-)/5&)39I.$!D9E
MZ>Y.A]5<1HJ91,K6!J_)ES(F]9.(QR;DU\)K$JXB#M2;8S98WXZ)X*^[;Z9M
M%.40UNO&#'=+<_"R'#O@+>,Q,SFXW<P@5*K<?C$+'<SU +V*U8G'A6+I,B[0
M< 6*$!4_0)/U7E>B%B"\2,0S#[G8_AHTO1^[!>98+WUVI'.I'FM=J$"42-;V
M)@:V8.IUO%J\NE!M]:](H'^"RF4(.Z;I&;^]9G#3W/S%(S-6+?NC8]<0 WP0
MI!A?!LW6<#JR=^;2?L8 X3F$:?^&W$"HU V^>QQ[?P=6M#BWJ"3 F*MK)MO
M\)KMI*P2^6*![G=^\I=H-.0W)'ONJ*%C[\I#,LK!&:S-;'A!B\3O_.B%5U>Q
M_Y8?/12\>?8* [17_88NWW)YC0&LWK5G!OR9_VI=Y4:@W7"SP)V_5Q#T3O;9
MJ<R_IDC_0Q.43D,XSW_1>_Y.)M_5?G19 E[\]:]P[ZH>[FBPJ\;E)</O9/*A
M"@Q0RLK-MYZ;J$?VA!A@>+\8 X!-_SU#_/+B^=6DS,$>&*7@14<*_G^JG1M>
ML=]A-\95FQHB#E[P$/ PAB1+DI#&9R<TM-]%\4Z[PA(-E*[2K>;.Z^^X\V(
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M3!XCNP]G5=F3Z.]C "X26<!\V A'X 0B40:"6@1=/M67KI+4'IU#.IK$K%A
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M)Y#=6[.5<^<,ZIM<;#75E)E/D0P;>.)(TA>Z@\>84SWBXBMM]>7K6)FM>8@
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MYC?PI0R0I8/]V:Q1_RQBG>L_F7KJOX/H55:(SBFOM62W&2P^5,YP#]S7 \8
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MQEE7/AYV& K,(ND##IM!>Y02Y%NRH8>KJ%?:3YYG#N'?#U;RZ%HMG@4UNSU
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M+K9=R>1BD#C2:L^6C&IJB3*H->4Y9,6F4=[5J=O\L>MG16>C *=K^_!#[_G
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M0/&+!F>-\"4;,8;JZ91>>;5%GL"P(5TS:$@8SQ+4:M.P-GPJ-4V)[H>R#GY
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MM3IXUG8-&$ V*7CI5D*U.08P>K?C*$QO7(XT.'D)#5+$ (+NRPQATW.IQQA
M^VUU18#BA3KX:H4*=<SQ%_7_>ZC_5S?I_FO]XR^*WXB:@0#KMVOWW#6']PCS
MRUZX#I0RK3!M4?#%!6EE4QRO-X1R632='*RYK7HMW.",[L!:4[JM*#/[_";V
M)/:355TGR/H2AMU15_OX&(")<7%$]W-WG[T6^1#N>X<RS(C)7@@18WP"GO]-
MFH>]PT&Z.,LI!<T/1(KHZ$6;ACWZ^R.PYFK;<RB40-(G?(;\'2NU@6(G!8]O
ML.>#B52Q_&W\5/!KI"H&D#.LCP'<B<"Z5EU4.IP=#1;61M*2H,6M2A69H&1H
M%=32L=Q)Y7Y'M.SI50EX>0P,_RE;C6;%&LDF-MV*D,< !KBF'7)OGEL/,;6@
M[S(:_@T5Y0OKWIPKY+3LL8,L8B.@G!SLH'[%<@GNPOW9\2^H<*!_(5(P -F,
M0C01]H'I*PV_)QS< [.&'"&8_8W_A@[3')@,O'6*312[OF( :ZF[M;JH;WSK
M"8L8 !X)Y[^@DWO#MZJ-1#OE((28D)YM1C&RM6S(I)N.Y; -Z[^E\_%?2L2X
M9%SYXFU'LJP?\H%4Z=_02?@;B9R;<:#'TD^4#__X<OV78/\2[%^"_?]>L(48
M@//?G*D[C7Z\S=21#;R(DX&G/ZR0OE[;L[2.;']F#AM,RV:-Y&&U#?.ANJY!
M'TM50I+.*DJ:2"@1M!#3AN0]K3B>\]NWWXU'9L[>W*"] RU$6!;+\5IG0@.2
MJYO?/:<QL7O@>3>_D@6AN[JSW"9#/6T2=AK\<6A&A,$6#;I<:PO8\*<ND_HQ
M3<]V<BJ'C09>_]N3]OY:_^N:O-4<JLK74ZVO[?/Z)F!LAGCG_B0(EXH;K:H/
M&I,N^^4#A\NQS)<#X.(]*X\UDIPUD-%Z<,68[;RSSR[%T:KT@C0U3SFX%8O_
M*Z7^JSY$DSR!']0X6 DU3#NW*WTL[UZKC?%'RZ&?M*U.K+AQ?VV*M7D39Z<3
M?'<8U-'W5=21O>DA">I6FVUWF7D75)!_2.0!&?@@ V(EN=0]D;ED<*><7->*
MX^\OM=*W>A'[1MD0 P"MAC(H*EZT@*^.J% 7'#>6'<C+#^@;<AP>"BKH 18V
MMUI?SN8>^&)A,XSO9E\'K]; &O@';(:#EUXEU,UC#1C4<50E1S:N&URQA [L
MPP""8V0@6-@LO8J%S7T ];^HZP:7_ _J22;/?B8J%PD!:O\!L.J_MG2;FI)5
M8RFW'*P[V M_E&  =M%-*5XY1K:*A<-NK>>^W&")[%#F&XH.Y"G6;<<QO?KC
MJ<$(>/'VU[LR?7]D3!@ ?$UYMAPKI!RTE%, QRV2JC\2+%DD:/R""WRUA0$D
MT&;' "+VC;#2&\4 &(6"8Y;0_MC8UE_X_?]6TFH\NN)O:UUVRYR<.' NTK4F
MJ'EE9W!2;9#/*XPL<GCZ6N+;':P[9_+_7^\#9/RA8[TQX1I5BP&,L53J5O+"
M_9#II!B =7W.-9[/KO 15ETCE9$<_[9#:QR-\8,$^(5;!<OL DW;QZE/F1-S
M;;,%Q"M&&JT_8  GS!VHH &4D_WQ#S$45S<&\$ XCFS)H 8N5<#U%I;4GBL6
M9%^H$5+7=MS0EU&?6[SD$+ ^["%<34.F+/X:VF6JRN#/DE/NU4P2'N18@O"=
M");M?4QP;^VW.]W<1\ZM@K%&)%?;,5-H[G&0E[9T9U-[(YWEE(VN5Q;AB?^6
MK-K/IXM"MW/A=-WA,-5,8YVDCK2Y=W)^@41-TA+QJ1]6+97Z+WO-V'[+\#=/
MLC3&B\9,4#]YZIT_<H]3CF9GL$)_Q2BZT G-,ITW=?"HA7+OA'600?Z-N)C4
MPSY+1%HT52^86)FVY'$>9TDN (=_^7[0</\^R8MV>$A$P1ZN>L<4&<%PRX7$
M,X"M.$]<;MB>KB-,XGBF-,"%V\<A[],MW^IJ>USVVZ'X"6JG"=2S\B5!KM75
M+99C&B_)^"[?"2BOZ02IC'G/:S,Z4OI2)IDI^- #'\M]P_D=J=IY%$._4<28
M:;_60;A+F[%S$5 K8%'C8@CMY#\C5")9!FH;SG@?$(\>F-4M^/Y(J17,:0T&
MT.=TMZ:OSL05($+V%'*4JV/&,W\O/+)LJ2?GU))$#F3732!54WJ.BG=\H?GY
MF[G%E'>@$U#-;V&N<=G/>FW#LI^>2KOB*Q: 3GLD^E;-'*_+/+4?=;/D]IM<
M$W7:3;?I]U[+?"@R-W5*+W7S\):+-*5^-S3 ?0=?)L\X#E0_LPKIO>8^=:#,
MP$E6?'J[+*8W=&W3I1%P>EY>&:M3/A!SIF+]R"[!9N!;D-Z6[TO? SA?MUK%
M$G3.X&79+[>G@*RUQ/:!DXK(<P*#B9'OIQPU#ZXVK3QJZ!I"#(<1F5T9SK![
M4T('+-H-]2F_R)37^\E;"KF2Q5E/!+PNX_P7LI\)!%$E:)P*^MK?D.)6?I0)
M0O%'EGAZ+)!8C_N@1'N-W'QR%^C>DR*KT?I?%T,]3G&RO_]H9[=:=$3?;FK\
MT90!?9WVC/7=\UB!'JEXH'I7,]\%_EMG;E/?GU5'F:B+C8[''@@CV;[**_8&
MZ_,9/A2AOM_Z%#'7B^.!A+H#RB7]&KA&-%$G&Z6EDGL/7KS[W8,]RYSP(.'5
M+P\-&C-[ R 7;TF(!]=N+*H/7#JWB 'TN,/N:+ICO[@Z/F*HY3;Z\0W;QQ(-
M'52SW:SH@Q!#"V+Y':N(94O<W@"F^8Z5)],=M4%'?(,8@&JR-1]=0_ Q?U:E
MMMH(@>%72L@ FMJA(@\]$V<TWJW>+JI'O06X);#D?3:JUO(=E*L$?Y!R0XN6
M3&'BS30U(;$LPQEH\]?N<:'2FI%R*V/0FY"L:X -T9<V>=KUJT@Q#<R4@URA
M1"QK;8NI;T,,F\A*^@MQY.40U_9UPJ*YN./G.=0.,DR-)L+!:F)/;)*HC7QQ
MIR+Q$OH;B>Q[3V%!)N-4RC/LP0++79^6O[QU2V?>D!^HPC.4O;4SD\V.B*NP
M!(ZQS?>.[)'W>$9TT!?OA?43*90Y4IJ)]B_R$@FPA=.PAUL_E=DE6PB5]!Z1
MWA$7J< OM@*U*$R>)^RW+,HSMY)^OB_Q#.=YVI"S"STN[-NDE-=*VRNDJ2.T
M3&^!OSN7Y<G:-@& 9,7*:Q4E,V^(6+1_'3S<VOU@36Q!9(LIGA\QM439*EO@
MD-;\YELNM,_&8XL:[OI-%"! A]O(4MFFGU47''INJ6Y0-<$]/%/H0U'&O!84
M%YLCOQL<:>?8+G4\4@ZJKY>HU1:DYY00"DSXNG!'>Z+UJ,^S(SJ$!1&H,4T0
M'+<<]IG\@-#"]96T8">2RWPU/5)(4[9;'5QHTF7KX<;Y6.CN0Q [M=ANX%8E
MN9>TV?:=HUY'FYCNP050]E9/Y\_99-A3^E\#"C_BL\\K_58M67JN7;-\7%Z$
M>=&6"=1J];\"K"^3"2;ZGU?RP0_VKQ-ZK DLK?C]\_ #&<N>K\G&<T+Z<JXH
MD/P8@$4".O1C5KEOZ%$!(F+%//#4GK<&\$ED,O(5-A5LO[,T4]/. NI%>,DK
M3KHF2S_?NT/8;T&.?H)/%QA?-Q(D?UP?EX\4J\WN[J9FCUYE]"PBOHF2S"P-
M.-4!98NYMN-O7Z8\3_"B[:/5^$E0<G*7: HWK(]8;QIG!D'7=R&1$VFPL$LB
MO1'7D1DTDO!Q/6N+_ECR3<.9-JEC"$M]<C#MW@'_BQN&UGH->GNF9Q21RPPL
M6N"H"_M]'2XKZ,<F;[ER#M9806)M_)D&;VWBG1#Z^F0B6LC^N-K-8E!_4):M
M++^P1ULBK;>NHLF_.1#'#>Z&MF&ZP&(JNTJCXQQD= 8?*F(9 Q@'6NG_JX<L
M0:.7G%:5Y[AFV+!(_O?B\ON0]"=XAK&XW%$$V;!S39<4R7S47G;9_]/>>X8U
M^37[PD$0+$!$07I14)0B4J4'12DB57HH(DUZ[R44*5(%!*1+D]Y) J'W)M(#
MTB%T""34T)+#?Y]]]KGVL]]G[_/E/<]YW_-\F$]SW7.O->N>6?-;,_>LV7&X
MP58$\%,U2%P?8!E'>[&O>KZBOO+FKU)%_"GUV1.BS-?&!WV@O3CY?V6^W_A!
MZD4%&;K"N,UO6/Z5J9H30/]O#_T;5SKB_RZ10[QE,[^@$@HK/SVM4R, <)(!
M2>Z'KB:GFHFJ[PB ]T]VJBMIG/_AB;>_1P*V+:A!$.OZ^_'[QMBUK-B#HHU_
M2WE52&)/(H6C0?K*H(Z:4P<'VTG:UW(5/28'Q%%$F: FH\^[5;D2E5KJ\9V+
M1-M&4OFJRW[&NDCA.: "O 7>X@$S=5W\*"VM?E!TWB"_9)1DK/),HTBHC.7<
M\.RB]? 29 !KQ'3JC\?<G9WQVO]Z\T]@,MV6XTO6$$M(>SL&MB%_W.B5MHM'
MXU9BTU9/O5B[8L0V!YV:J1OK:C'&$;X2A16);J8V$N%]?8!<4GJF#TRL.!KM
MQJ G>)(_U7+9F>L^3&X._*'^=0"=5ZVC6DSF?F;Q<(ORS%8W%D[LCCY?)$\M
M-/%A()WPQ4\1BS?L#V1ZLLG8I7RTFS.*'RU$\?$N3TH/1]K'/\LX5LY4>' #
M\H)5Q,.2%>VCPUJFR@R/\F5T<N.2O34MIZ]'QQ4CD="E0I(,NN>KRZ-R:C[*
M?U,VO2J&M^[RB:>W_Z >>,Y[LT7 L*6L2;;(@1EG[L9:Q:S/)^$_A)@1Q.-%
M\&)=Q.H$0,3&% %@OWXBT5*-[QF+;5I#8;N<C%@G+KAM,,O(&6.%-4_[ 25K
M_C7Z%^EB!D$R&D3H 'DI[K<+)KAIR?P_K%.D$T]TB#^TMFT>%B7=O^.B*&S.
MBRXK@V5A?%OG0%2-3]AU\$@#?C;@XW?8F%Q[>:."A6'DS_QE7DZ%RH@3M>8(
M":^J5?'5BU:YEVKU'*9U%7R8T)(<L.^+23N^57C,E@P!T)# N-8/2)-_'SJD
MDN&Y_?[/]@O]QX%+-D]+:[%.+U)X7GBGF^4C:!>#VXQZQ#;A&$2*+_7LQ\R8
M:6@Q=/<JWG\N486*)K6[?Z)1W:R(JC'H;= #<X8L1BW&DSI%#&(<8MB0KCY%
M1S9U'^L#4_5T3%Y'2"YY2;+^2EV]X$'S1?AJX3,1"<)1]?4QSX-,6WNU4/NE
M*\E#.(%C9 W[ ,5ZFM,M49ZJ=4#B=M1R[5DT=8:4F],D=++@U)5XO#:6=D,?
M/0:V\@Y2?L[86!WU.=:NU1)3* RAW_ V[X3=LW;J\KV#5LX/JF(R#Y@&W3,(
M3;&Q@RP;WO+R-:&Y'']2YN#@4!#PRO01?:ZHD> )PJ7KS=+ Y0O%1JRK-'L2
M77E>W,F7*H291#7MI!@393U-<-NH,M3#K':["9'OMD]<C/,J7=ANIGWA78KW
M)0 ^N2Y4Z020DE(3S9?@]KI;,+$S3:'?R\_RXKP"/WOIWCM?9R=K)EO? [8;
MG]Z=P3=GG?):>^[2);=Y=PXPW#0+U)I],MOZ I")Z[L8M'PR&B/5K3YZ#%=N
M+6*-_#GFS[J)^)V399VZF*.POJ+%H_IK1G,1(/$4W27OMSSW%LS+8"<R/\)P
MHG9_E,BUNHA^D;M0E%P\_@5P]Z3$Z'[5.:0#_9#?S<5ZDZ$W?D81&DAR]%N6
M>#B4Q,>UY.9BPXW:*?2'NOHON<WGGAF2E?/N_.FV?Z*< NJ6$SP]5=ZJ3RA>
M3@<.1Z$90X&.%-1$(8!XOR%O[E__PZM<>]J"O *BD^9E;P?2+LU;+MWUQ__C
M>=*MOP&%J_//"(#X9=#V\1@!(!/3)-=T88PIO ** /4W-.M_]Z]7'6%4"^4<
M+K>#M\!J7Y:I6]-OK.IVX"$)/G%T0@+-J3(AV8*6DD8>#/P>JGU5;?M;,"HX
M:M%?,Q512>/+EZ^:XVG4H=SP:=[&$R8AIZCA[&U&?*8--8.T<RX-G0&L(+CK
MK+@KR[V1%0;:(,HG !:I(4M*FF1B& *@33PY1)CW+4H]$_FZX=8=F1V%-L[T
MPJ/<;NF;XXVRRY?<6M69$VPU-SCT#(.9J^^+$BEL[AFR7CST9R( ?I F$P !
M5X)#6#%?<"[X  9C/)$\GKK>M9)IOF@QX^W)LEM!^'+FN%Z[*4\4>HTYEXS8
M'J1O3(?CU, "(P_+M/M]-(-^L<69NY.[]^HN7F<O:'*%_#M1_WX*_6026/8V
M_=@H4 VDYC$T<B?3G@"HE7CF8=O]O.#\9T*/-$DSEK+*O/13,G;:>)HKYS0O
MY%2W^JN,*%O"- *$>WTA=K4J%'P$ ""7 +@%6KJ'6;\$"+5<7(N]>.)4QT1:
M@AGK$J]%3D?CZVV\BKI1#]_E*>1^I;V]O<-MTWV%H2Z4*ZQTCEWT7R=%2$XD
MR?5)U'13KV.[7%O^_J U5HC!PDOBQF%EPJ"H&CW=ZL&"F3FI 3LQM6(/FC/[
M!S83PJI$.!?-,;-:<<.RK)38A6EP#U-D$) "/L/Z-O@-SFFI[#Y9E!5V03 ]
MA2_.W&1'X#F(Z'7.RC"SELN\Z/"S1J4EO=J9FP]BK)CIA'Z]POR1(@+EZQ,
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M*.0<>-*KP.Q41XZGZ?"<5(5/2 M]$O&H^O(A?N)%]D:K9 '9_L\M;\.D..S
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MFSG)"(!7Y2T[IP/Z&AI&/[P':59:,%#AEM.C,0)@[VI<6%=(^SB2 %B?5"4
M6AP(@*Z1R[3P_?/6HV+N/LB2M0WD8+N  %B $P#+&P1 2%$9 3!4GD4 ^"\0
M )&YYR^H5D\"MS5UX@F OY5# -Q^#R8 L@Q!^,L6 H!6_MB>?6"/&%E8\>@_
M"L+?_WGU"FD$Y/(<@G\6NS,KGSQ/5J9NI/0?I%SP*CO@_:[0T/DQ 7!AR/JG
M+I:O$:B?TYC\-S)P^JD+%V>;!, )F@# (4 U3BS&GBS0-UY\?ROB;S5BL2S9
MC)&RCM@W_EL9?Z,0_&"GE]^B]\0_M?I/K?Y3J_]@K98"J3W+QSJ2[)+T' PA
M;@#)]8DFLH-R:EQ)M_?)KM"VEV;+Q>D,$^H2E>[GS.W0 ;G)MU>N?=Y5(Z0
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M' P0+FY.=FY6=@[V;XM04)'G4-/0T=#0L3/2,[+_KQ]2+<"RG^(C50(5Q2&
MDH6"BH6"U A  8""AN(?#_#S0T%)QG$?[7ZZ _3D :7, "4%%14E-=4WK,EO
M \CO 6H6&M:#QT_M8S.Z2GOH-KML4&S&_L,:174<QITX8;EK=^[1'>#DXN;A
M%1$5$Y<X(J^@J'1"647SM):VSAG=LR:F%RZ:F5^RL+E^P];.WL'1S=W#T\O;
MQS?X?LB#T+!P5%S\HX3$I,?)*9E9S[*?Y[S(S7M=7%+ZIJS\;45]0V/3^^8/
M+1^[NGMZ^_H'O@Q.3&*GOD[/S,[-XU?7UC<VM\#MG6]T40!4%+\\/Z2+A4P7
M)34U%37M-[HH*+V^#6"AICEX?!_K*2/:J[?9#LD&[6?7B,THJJ,[+&>,X[AV
MI_, I[#\A C^&VG_H.SW$7;O/Z+LOPC[;[H& 08J"O+A4;$ <&#/)!,E#OP-
MOP^>R9<\ GR[7!3T+O9>[70?RM]]OKHD=<UGVI^ME$/O>.WFOBH:I"LZ>#DC
MZ4)OLN7#3QFCS#HO]D:<SH8XCM5'>"Z]@&K[&J5L]Q/YL!.T>]0;,03F41*
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M(C\GZ.(D]ERJ<T;/^YQ#KZ+A#Y42V03DFOQ[@_1VS(*C/]I$Y[=?/-_W6L_
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M/=JYME>WGM._IGQ*B]WD3R\(_!-0)8+9)$"XOPF]25=)QEL&$9-B1KA7 %]
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M*$S(7QO7FG1/'GU@Z&.%;0Q3EL!&4U/C4YY4[,>\H%I@NAJ]VB065XW><P3
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M<O;<WY" KK 7LZ9>L$3KGGG'S1RS-/<?->G\J5<0F$:RXHH2)7^Y@UBM 4C
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M3!'I?4>@R_GDXW";S^=A2RF]Q(=Y.@X<^KU!D3G! \_Q)FPK G=OX4*Q 7]
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MDY-_@<N.7\&S)JD_N^?G;R #!>G+_P-02P,$%     @ !(AX6NJL$)C%:
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M\ \(!/]) /]HP<@4\_2?&OBMCO_4HI431G7>&!VA80!V91\[:P! 4Q/  P
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M%C^\:E-9^R+:CP KICH.@0,Y%B\<;1CF!MJV.>]8^/1)ZW X/1/NE,*E!.O
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MG&,MC!E+7@L"PT$G\C[^:, M%S0 H0OI.D9ZH@%*,^'M<!M2-(!:M:KTNO(
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M:I&\JM5*NJI\M7T81#KZ/!D[T6F*#0$*2OOE)U]1ZRH9$EO2J3!U)I'UYNB
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M8_)RYU\<PL!>"827-U/^1XU>Y=X<&M $E '^W3&<Z0&3PN7\DVPQZ?+?QGI
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MV[3R1!3$> (J?EL!IIQ;)#!C Q@G=W!.>U]STBX?ST*6B5!4:  %Y+L:&M#
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M']?4!8,6B-]_(SY1_>FPW.,\^H$T%CO4'3D)(O7PK5F.8Z6LR+.T;#'"QW0
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M#"N0YJ]XP,(+N_E]A#\>$#!,@-)9. ;BJ+-RH_EC!!!5VSL<X<T9?U?W'U=
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MRF.4I-6(8MT(+M&OMI:7LENOC#:;6T&CE.[NYR7U4#R0FX;;2U!C2&%N#20
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M 44CZ_15AS!;%V2Z.F8=Q=P20589NX;.'I74\/.VN]&P V5^]?+R/,A-=<E
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MU-XH>D5?Y*VOOB:.]F:7&[46 =JYJK1OZ%Y0E)A\:JXHD)X?=%U9>]CN9H[
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M6<*7:%0MY&HP7%;]6[WE0*7G%U%W"G=,)ZF%?8ECZ;=5D\VB]M9%5G@+EC
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M]!SRO$O:K7_O]Y?]JF4/IUZ:,P]:2EQPD=A7Q[DQ)>L\'P?,-VA6W00,5SC
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ME*)-A&"Y0QP)V"8@]M:DBPP="B.]H2C5U!)#E6_]5DHV2 VHBFM^LCN-O$^
M$E(PY9H\":J%/_,WH#JVAMF/G.#24A&'05^U+7GI!9.?]OPU)5PM\7PV!YI.
M%+%![_W0';E \:');9P+(50MA;>PNJ:L#XT(-_1"WLS/KX12&#>R?X=_/&G<
M\NKJ=9=W;F"<R=.W@WA4DR@HL["^*&9*#&:=<SX#5E-/2K.- )B]8V<@\S\K
M:/5%Z=LW$)("1)U-WP .MCD+ YX()I\)P:WZ7I27NE#??SP8F=<G59UV^Z^1
M>(>)L D8>CS"8& 30"QPK%/3]6YA.3NUY"EY^O:>]YX^9M.)/F4&2E8O&SW[
MZ/R(!-:+[!S2.<FNE2]-['49@[L.M_H:*+D':9MBE9C-^X7D5JZ&Y(LV*++B
M,%.6G;7PDYJYWMOK6_*N7_7-%BTR7!)'J@T^!)\KXL LJOM7O:OG\5>E0V\:
M]@@8SWZ "IBK/-H>2HS3J#.?0$EZ:3?>U[5V'5^&DJ\Y5G)SE7!+3;;GKFDT
M*>R<%1"AU&8%RE\T0#J[>2WB2]_>\!8B?#35X/BHJ@F'_9'!6ZS)%[,6=2"R
M#J"QLX3<ADXD0K[?Z&KSS\.R ^]K.74D[<5LIG[$-*H2/CKL9#3T]=28T?M7
M 61ES(72B3C2TN"#"*E)*G5G!BOP85^PF9EE<)QJ>OI#O[MP0)EYYV!*'J1=
M06)PFG6 6#+$V#-K RIX-GYV]]ZFUU899*DLS:Q9 <&BJ9-YJH)#P,S>R-\9
M#<K]?7U]XYRSVN\IQ#[X?B))\A5,J[$"?%.L.7WT-&X2&=[J=I-D4\S1\IT^
MY"WZ'D_WKOQV,=A<Y9GYN.O!4Z[Z,A.1^R(,*&#%XA _,A>T#'4YTNUM#;7-
M6;WUX/*E;>^^Y*?D)@K+IM\#7 G*E_#"7=\$)*,W 1.0CB+<H;_K44?_35ZX
M?U&V_?<UM!J*_B2SDGQ_S=[?6\:O6 =VVPF8H%<0\I=(>J?^H^88\C.%U;%-
M0.?,)J ,1:E)CD=)^!H="0$MFU53Y3Z .^%QTE_= 4P$]A(2798(><U^2=4,
M+HY%>,Y_>LTAR0TV+XXHFW RIU0^KB"!#LL=.N4Z2RT5IC&<+/1.017QIQ;E
ME\LU.8)+CR,TEC(T)<5K(TR)B2_DL[@5V_1CA>BC>4/EETJU(EOM_)N_ UG*
M8DP7E;D(*[Y?I.E'_\@5594L.3)#RDBX=>>U=)5W4251"Z>D_TZ]/1@L]HIH
MM9Q<ZC4(I(D)K]FSCD;[,6]("&>7= 8%MD8-RSHZM^P0*>]1VRWAS,X7<]O%
M21UL4Y EZW;N3_%9%0VLB76_5+8_2OF.T,3$^H!&>#L)\B!H0]&45.T^H.MH
M:L_N+9L6W!W<N';YL_+1X@F/'%J#-(.G2N8IWF[84]^G*R'FXL#X" =5[6,'
ME)"VBUP_$$$763P:.= ;$M.TGM[O*FER=QV_?N^E?-?8E[=)IT(HQQY7[-H?
MD"FGNM@7)1_*4C.$M!Z0D6_[ ]^JN]H)ASM_LSEX<T14)V:/W]"^FQ6N>@O&
M96TUEO+;OB+0,F6UR(-<'=")(4_L'3W;KL/--W#JX[9/V ]AL/^%Y%<&4'QW
M.$DV*N@K';"&\\"':8:0K/R=ZBA:QX]G_#/8DL*N>,*2DT!:=9#)C#FV+WNC
MPO-):-TF@(2LKV\%N#PO1ODX*8 7.%QL?S+4"\K,-:RM6X",(:S6PRYMGU5+
MH6CLF^B,(2]@$ A_<W9KD3\]@-]P#@N_M'U$+9D]D#?Z;11%&L]>62GD#56*
M* 1#?G0UEKI=XD8]D-W^M(>+_6Z(XPV_H6(,DAJ#ZD\R&+^$7OYT%(TOG.$/
M[ 8OA"')*ROL?-%*.\5_4MAN GR<Q,&+B"WBF6W,_9;<Z[VLZ64>8XW-UL%0
M[<.#0W\1Y(OVVRGCG8Z]R\S#!*[3R/S8*L&*UD7?("\RF<927C\^OI4D]Q4D
MV\;3$B(^?%I[+Q=TFI>N(WGP\8)O=WL 2"N-)]^X"Y#Q?TI]M@/R90DU>/)[
M*_12EZS?^;V9T,EN;0F;[XUJ]V<I)1=J'U^]<Z7X_>EV1!B@YIPM;^@-;6W,
M+'(NS(,\PD<W0B')F'_:"=6#X&O!GS''-P1&L6&-6\K 0+T M3^&TM?&3G.Q
M5.K6HJ'?YCXI;FF $G7\XY5&@CK'*-AU:]X^OO B?]J--"9S0?6G,LF\,"Z2
M/)<,=8(0?%@8@^0U.-GHL<"]^!=!"2:83X&;@)O<\/!X"$$#0B\GCAE5KZS^
M,A+8HYLFO05QX3+>,7':#S-/)!*KMX2:6PS,7PQI7/<>Z>7JMA\ 49IVAH[1
MC*^IQG)W_6>/00CJ;>9/?_(<&_7:I0?Q6.P6W02L-C9%03:'_P-02P,$%
M  @ !(AX6O+L]RF"D@  DJ8  !0   !A8G9X+3(P,C0Q,C,Q7V<U+FIP9[2Y
M!5A47=\OO.GN[@ZEI)5&I$0$D>ZN8>@&24$ZI:5$VJ&'#FD0$&GI;HE!@:%F
M/KR?YWW/<Y_S7?=USA?[FG5=>^V]UOKG^O]^:P_R!W(-('ZNI*H$H*"@H'6B
M=0( <AT%;N_IZ2HA(.#LP6]A[6)IPV_E A;PM7 5$.1_) !(R?JZ6EB!;#R9
M+6WL')REN4[:NKB8':REN?1$U1^INRK8V#NH^+O;O/9_J6WE#[)Z8LTE*T.
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MKKP&N(M8^081Z8)"F:'#M?,[MMAX92UO_8G =5([RWI*VX>/R"^E4.Y3LGI
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M3#^7" 0+*(^HMJ-NBJN1,B-%F??4Y$>W9\(0-9NEMCDVX5*<E\@./'&#LRG
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M,R+TF-U\W<Z4@Y7]$W[&G7DK%5L'Z@;'$'1<U35N ) PMVR(*;_((G7=2S2
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MA+%>!/@\$7<?M?<G;17D9I_CYF5IN:+(JF3Z8EOB>SO &\"=0RS^X>>F]]"
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M9&\PE^YY:DG5Z_7!6"<IMTVPG>%4X$FMJ;WA"]@5C!Q<=?E9B*B6 :=[Z(#
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MY1G<!)9?I*?O6=AC2 9EC#<QOD9WS#]PMZ5\AX+[,^]+S,G9F:;X-^<O@C3
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M-)4UWFC?D/;T*5PO%7VE34N-,-6=':UR>O#04=FJS+\XBO,XVF5:(2V4;?-
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M'"XL=%7.+#ZF)Z:JGEVPP\S8ZZA??VL3-=X>=4-^>C=&[(45=*E%[15OJLL
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MTG_S7/?)PNI]+I'-!.>_5:MH%(\4XVHX!0:Y87\8FSZ:KWJFY^.*-<4R, )
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M+EI9S3N+JS6@\)RD_=7,BC](/]! >KE3[8?WA-S/#1X!55&:CX"I7S9CK8\
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MHH+S.6(/8\MP'*%M04@A)BT=:=^P5STHYV5YAQVQ$MHD:9/M$)4!XQ)S52W
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M%#:2[G;LAV6O@H5QHKGL5=N)XVO#8=8ST)JB,V6L=G+\9[VHYPW('33.>O5
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M(&C\*MU N]V"_3$(=UW;@2-[.AXN[?"LMV>#2/.L@*88HGSJI(5T E !S)?
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MY.BQAT((WW6D,;I!XO "-/#-1DR1E=^ST/S4QZ-Y09;LSR>LJ6OAU-67A\G
M@;Q>KN8H]WI"FRF*_"7>E?R"D#?TT*>O9KH_9HQO^:Y#D\+=%*5(#C6A)#VO
MS$S\SU5B>=OZ0R?UKUQ#;>NBZK@*(V87C$,)1EO>,JYRXB5)7OJ%4I.=V-PT
M3TK["@QV%O;S*9,6YIC"W-29X]O(6U<+,%A+?]9#RKL,F<#DXZ?JV'.45Q2*
M0Z:OA,S^K!6US;-5>](%/]ZU$'W,?U/16RFWH<@H2#:J;&DEUHMQ7(!">D!]
MQ%R/_F\A<//1=(BN_$T<!+WGD<-=UL)=_CQU=EC60DJRLG!HU37WG9SKQ:J;
M;Q-GRU^].$I-@+:4E[[W36#MGQV3J!I<6^&%H?3RDWJ$*N0_4]+^($A^H.5C
M7._SVC2L9[__[U+BFR33!5,5^/Q$:H[%E:2F)JB"!Q[I(=:4JUJF'E??U,^4
MP^&Q^J"_U!;TM.\F,TJH^L&]@+S4J!3@V3NN4['WT<TFL\=X"+"GSIRY"[E$
MJWZ/PF[Q;?I3)]>.'A'@J\X0*+5K44J,ZQC]5;!)RT*RX,!;-,;%D)U?T*4D
M1N1\#YT?1SNQ#,J]*G]3_&GP=EVET&U4DX3O@-SS.;\I,4*LG'*H6['-T9-O
M-#[T.W'2/K02*-<A6=!M9[6_K4PZ!X&_>Q?C63D%[^\P9YHBA,T:C 71-VQE
M2G0T\DMGF!B[\7Z6KZ/9>\A]B0SH'NS"95?P33E] NG#I@NI,-7+(ZUQRA[S
MU5CW5KT9*28XZ:,Y>L@H8G\NRJ,Y!C($J4QB;71H3%.\';QAEL(G_<6C66<@
M%GT-RRX7IQ>H6PA/+1IV)?8,'JVJ_" E?U9B%L;B"J&%C*&'[6F2Q,H/UJ1:
M!S(S>Y,EX0;.D!&[OY533(##MM 8B<^$M)TJ=RS")W%<=*J"03LTW?V#1F$H
MKPQ^!NFC*FR-;FBC64:M!-Q[[9]OW5%F!2XZSY=204T+<'%$)5>KV-DQF!<?
M&+0AO2QSXW<^$SX2R0!0VT%4?C^WWA8FIZHCH;8P1=HI;H&J1,AH']8^5_9\
M.AS2HVJ1//5LG\Z:$%,A>'O(L&Q,9UN&MU&OZ%&*[I:4M.9']QA2L]N"-)I#
M17HKX<!@9G"\6E@P*Z@=YP+5>I7+AR9*^L8$F1Z.WWHYOWI]: M3X=#_%WAC
MI<=368E%HIUZ?@UJ%-5,[U(2:#[0H+Y2E'FF!I4V@X4T!N5S3FA8Q"L O+Q:
M-J&_<0.M3N=L2'T-CU#^IV#)+&P.Z7Z09X6_"];**L;7@N:R$#I=IJ7DID;W
M%U"J8%L?^ECT2J!OL>T$G*VC-BAI8_D=5XS.2,4J)'9CG(8?[4SL0XSJQX-I
M[+Y6;1Z<H**N*Q;VW6QYV1WKS)D>+6L5=(:1S@F3FU@ WF8\I5"C)\:A,G>D
M*D*1D_VJP8/B-]W;Z0"GA./,/J_IB(</08[^*F(K+UVQP5_#?,0DG;YV1]I=
M]()Z;X\9->N7M@.K#X@+2_J8[>*R&#L98,0?,[JR'ISC7:'IZ5:J5),JF2*.
M^+-=^A S!\#[K)@NE2[ZD_/OXIN7OKYAPZ->68C'@>QF/1)'7\62@9W#PGM]
MQ,_1O_S%QU**@H(533S4WDB7!K?U;#^X(7OJOO:24T4"X:(L[^ZQI8\$5MY_
MK>1$W*/HTZ),!J@*R !GYU/&O^EXS!5GI9B=MG-91_B0(Q6.N6 .T_-?3#*B
M3@&'YM"Z^6$HU8<"=&]LYS6BW&7'#8H_RC5[(;<S-.78MG@H%JL9DX&/5-$B
M["'7*,QMSC/NKXN0.BA*+[[AW9LV 0&\HP$AQ!TM,A#XAWH-!>Z=#02)P&*B
M0??#YPDKJNJD0$I[UDK+8GQH'T$QMS]%?;N]8(^1 DR>2,A:*(@%^'\)_S,)
M9W$P>6,PC[)%8K?.%6  !%C]:Q5>4GRZ^64_DSZ=QJRLB<;Q?R^;_RTE!&R(
M8^GV7YBS7B@![/X$*+_G)8_]!U!+ P04    "  $B'A:O!3B>92!  !)D
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M_;M[CN*CGS/2-$^*>#_,;[6S0@9 <-!-V$''R3/]]:20^NO'*" !L@JYPEF
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MI<S3D?(:;)SUO4'^W_&87"6(Q1BA@UUWN 4M3X"P-IZ" ZV$ 15]'>U^I*]
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M,,%[S1D!=D[)+(/59;V#5#XLOX59;)X/G\E(5+2<NX6'CR1HHN7J+87W%VJ
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M8Z@_=5-GQ(6>2$$*&;QIOFJ/I_BTK;);Z 1G-Z'U9^NZV-QK7Q9H!<]0=)'
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M,KDO/S3#ZDW[Z@A7(B%*2V>'IH=EC.C79C_X;JW*A8L$$]<;]6Z5&_4?IT^
M,0$61PCF!&N3G+U FEE=Z-[6@XX)T%26TBYS*!%G6-]N]7LO];FN,N23?.@
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MB:,<-@K>*2\7U67[<$IC-1(HF4>WM7JK%JC01X5Y4PC2)2AU*22(W"R)V6[
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M\]%\N A\K9Z<H3Z9TA>F.8!4LA&*DQ6;V_'O9FRI%R3Z$GBX.>+[ V3I,VK
MA65+>^SS[#/K"":\MV.MO0F.)A@?=+ 36(>6PY3*>B..Q#"@\7"AJH.[[/QK
MA>*ZGUYTDI</&=+9.G@I'B\Q"12#,9O( 0C]?BC_9C81#*IG./N]3X(",7V%
MYMQHPR$IG0+]Y;HKE+78=GMR'V:D?U>$V,5^CB5_GSK$.51!:138DB3.$ZMB
M;P(\#FESX4CUD"H;OTYC/(@>=M);MD!K\!/X=[:A2EVQ,\XEAT7W<3+CI"/4
MWDBU-ENJ*4B.WL.(!2:=R.8M":83X2TW3_F41&[ZE;T<K:M=;5TSX<]AW!K[
MP5%Q&E=!7(#X )UU,$*30K,$-JX''W:0[<'9_^1:_C%)Y^4)W@/TU9IX>9-+
M-BLTIUOK$0GZL)#SY;K0<&<<6S//F8)(,M0\@JXOF544H1N0,F#;6+7\7_U>
M_O=TV?UNJ::D7'*KQ!)Q\@\BBHBUHBKTLU5IG;7/3YA4R-&,+T"?6AZFX"U%
MXTXGET9% ^QG7!KAVU#8'+%5P3I[=*/K.0%?20[WUGR<IF7X0](2WI&'N.A?
M=)W3D*8 [N8M;$D$;Q8I5)K!$1LR[GMTR4CVQD1IQMDA9I?:*=Y:$#'B$AM/
M7<MKFCSJ]FZ>B9E51>S6B%7Y/)/U=B1O3W(T4W^8;X&\HH55)Y$8W^9,K3;,
M198IVJ%(WR@=_Z.JS!X**Z-E(I5-VJTG=PKB5;5[P@1&D5Q!D% *3TA\'(F*
MK# :^%4QE"89??H/-$\JND8E[]TM>Q3J"II28//=I02-JG,AC+*W@[:M.5%A
MCI_LU&%G&C1=[)F4E)Z% CDFXJ,W9TQ&HV43KL@,?R3]79EKPV.M=7VCA9^I
MIY-RY[73H)E6$3'&,O+:+-&9',B.*.U]\PG9KHFGE'PU.K^Z>J$V?[H>=E62
M;F>?G-N WZ=)C"JP>J,5@U:3B_=BUIT[1$5[6=D\WV;A7*!+=KLQ88/?52\=
M=^,;UWOIO.4OL2U.&*SV7V0"_-F\0$:*W+*SE54<3/=,J*(ZQ/(]E1@)+V]0
M1<9DQ] W[+OI.W2/4]_/FJJKSYYHJ+Q4J2G!) :_I/)PD,G;*P3/<ARO&F+)
MTKMK:EAM:]#QK'1]=F--/),@L?KQK[5*_O_X/"W]7U!+ P04    "  $B'A:
M8F@3^O%T   ]@@  %    &%B=G@M,C R-#$R,S%?9S<N:G!GU+IU6!Q=MC=:
M6)!@(6BP)&B"!7</%B 0"&[!I9'@3N/N! A.D. 0@GMP"Q"L<0CN'J"!IOOK
MS)F9,^]\Y[SGSMQ[_KCUU'Z>VK5MV5[KMW858A;Q$R!\):L@"Z"@H*"UH[4#
M &(5!6KEXO)>B(/#WIG=V,S!Q)S=U,&.P\/X/0<G^PL.0$3<X[VQ*<C<Y;&)
MN:6UO2C3<4L'TV-K,U$F+5[E%\KOI<VMK.6]G,S5O5Z_-?4"F0J:,8F+X>&(
M> AYV+VW,W<Q?NQA9VOO+.0A^O0OLPLAGW^_YG@J)N)D9B&D]E+VKSV0-=&G
M?Z7%W=V=W9V;W<')DH-34%"0XP47!Q<7&[('F[.GO8NQ!YN],]U?)WAI[FSJ
M9/W>Q=K!_O'ONK&)@ZN+Z%-75VLS(0MC"UX3,S->-A-C;C,V3DXS8S9C,VY.
M-C-N;C-^7DX!+@M.DZ=_7=[,].^KOW=ULOW+VF:F'.:VYG;F]B[.2&EP_J;9
MS%3(R=K2RL7Y/U:7M'7Y?T>^K?7O\4*VQO:6HD\]V,S,+8Q=;5V0C1S_T?K7
M!^0Z2*EB8V.+</P#!1S_)("_OD'*%/GT=PW\5L??M6ANCU2=.U)'B%7@J8R'
MM04 *"L#SP$ P )0 C\"J,@G%."O%V(!D ;04%%_W\@+'7EC8&%@H*-CX&!B
MWL/"Q<'%O8]S_SX>/A$A'OX#_/OW"4D)'SPD)B$AP24@(R<E)B<B)B'^/0D*
M&G(,.@8V!@8V,=Y]/.)_^4)\ QY@ ?NH.F@H3P'4!RAH#U 0/0 MDE8,E+]<
M?R,9!15)XSU,+&R<^\@.=80 *@H:&BHZVF^JD:V^R'8 _0$&T1-.R7L/WQAC
M/G4DY@I(^(1%)U7=2:(V?D+/;>(4B(U#2D9.\8B!D8GYV7,>7CY^ 4$AZ9<R
MLG+R"J_4WVIH:FGKZ)HB565I96WC[.+JYN[AZ144'!(:%AX1F9CT(3DE]6-:
M>EY^0>'GHN*2TJ\UM77U#8U-S5W=/;U]_0.#0Q.34].0F=FY^=6U]8W-K>V=
MW;W3L_-?%Y=7T.N;WWRA &@H?[O^2[X>(/E"14='0\?\S1<*JOOO#@_0,9YP
MWB.2?(-I[/CP*5< %K%4PJ?J3FPZ;K43$A.G<1Q2>IY5AM/?K/V%L_]GC 7^
M6YS]G;'_Y&L>P$5#02H/[0$@#JRUSSDB -$-!- ^0FO;B "RS\ K%I_RVK]=
M3SC4ZX/'/,6/:^06V,6W6W.NYHJM<K'_FP'^C+?F_;"K)/@M[Y0'4Z=71RQ\
MY9)RY^<M13W!9025Y6A3[)*COQ=/J<H74162@1F-GT;A_-EHM^ YMMS&6^,Z
MCFW[:Y^HCY5DY*+SCPFJ>8G:VI;Z*8W4F=3JVB==RRHXCQXI1GF'UILD4I</
M]7HP49FY5YXM_%PN77X>U#V3_6R"YU#66Z#*Y-PR6SO+@&* 2)JR:J!4D?.)
MQ 8G!6]8)>Q5RLV^6H[<)!M,R%4FF9>D+E$AY(=S4@YOAH/F;>.^/ (@XL5&
M3XIB?AN#)R+&J+K2$F=E\'/[^"L+QV>*QF*?0^M/BBDW:9!VVBD.'_'*_1=[
MV S9"3R$P[?]>$SI^G2/Z8J.1IV#!M8^!WV#LS=/VCFL3=0]8SU*3L=.IK0-
MT%A,0  HL5*B4GS<0>H>W'W#JTMD>A/V+BR^;MUJ+Q1YU =9S7$9AKYP?LWT
M.]D6FYX$=]W,,-3^J&#E6?"VKFTZ5&(D2VOM\?\2RBAUJVU<GRA)CS+)EM"T
M\I(GWTYG$ %T$:RM%RJ7X+&HW:*_J.A>M+7+XY-8;<_ <C!_G(UO<Q4)?P2M
MZE+?0P!6@6MKPTJ-WIY5A\/D"IHX.@J=+$T?+,D'T2KLE_Q^Z$YOI57J*)K:
M/%1-69-7XF U,M4QEG_$@[/NA)4OHV&[[B"('ND0WBZZ9\CPX^*.;U^AVGRZ
MDK[1PBU%)B!K>E@VMO=-Z.(]50$F09&IY<(+Z5JVIK'=#@*82J7UC2LDR<&]
MY.XK4\9P@P(W47D?:_7C9QAA&O3.04&].B<JW5F6?5KIAS5&",!,+(HP\=!^
MK3%AZKJ,M).*LR4%MYO.@5QP5]'R5%U] D;GD.L;NJC'4/KM:^.[@[Q3^V[7
M_A6##A6O#!EHMWLA-*YWOKS9O&T&1E]Y[ ID6[TTKT1' '1]>^NXP/YDI,.\
MSJSA5G#S6.<QR:X6@1UZD$:S@:PO_^ 73^HH&5QGX;-\F^ /EFY83QI0(GO$
M4$X3NTN^N]AIF$Y2))Y&OQ9)+&L*N'F&ZS@NSQ0+*FN^^\1K(+5V?N@EF\-;
M>)!T]WF&*X!>34_27MWO[OJ^ Z7#H,D<DV"O.)RLOJ&,ISP=+_I*,V'49?>I
M3L1DGK?\8<$W@C!4\J0T[D!LP=%G3%JEU)\6MWB/P]H93SI"["Z6= 5_0>W9
MVX>IVSI=/^2P*K2@O\-]L"(V;=._RA'+D9\B_=E0MY_Z0\/MD8+$>%_I=\Q;
M;9=K%?$7HR@C'''M; 8>MTJ)$-_GHYW;4_@EKJ(U\KK>H=&RAZ$FQ(0H\P
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M0"P:@:NR)DNI)9S3*;!7'","@/O]1%J_,P+H'>>'A52([W_H&'E^"*B=.2"
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M*U#<%9A3J_3J\3=?4)>?P(EL+BL/'HO"R64J0V;HZ)%>1EF*AR97I2Y6=_Q
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M"X;: ]4(Y4&:K6MA)K$Y9<\U,Q(N]N/:>0#'<R4,'8H3/@*JX7:/ $FJH$>
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M==7+S-;+S :GLYLFZ%IMI/F3>"[D8[CQ@=7B+RB2H87,,XCQS/F/@$"-=X^
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MFFW$K_-B]\EGMST];RP?5.I3/:KY3_@4@0TLII?)D:E )[J3H6$*ISXG7C&
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M'@$AP6\D< BP-8A(J$A(J 28Z)@$_],7M W 18%#A#= @*,!X''A$'#AH%T
M)8Q7)+B_77]G&0X>QN,39!14-'38A&H< !X. 0$>$>$WU[!1/]@X@(B+A$?-
M*?$$7]D(F<:)@.M][%<4VI?E[80JXR=TW,;.@:AH3XF(24CIGS,P,KW@X>7C
M%Q 4DGPE)2TC*_=:54U=0U-+6\<$9BH+2RMK%U<W=P]/+^^@#\$A'T/#PN/B
M/R<D)B5_2<G.R<W++_CVO;"BLJJZIK:NOJ&CLZN[I[>O?V!B<FIZ9G9N?F%]
M8W-K>V?WY][^Z=GYQ>75->3F]K=<<  "W-^O?RH7+DPN>$1$!$3DWW+!P7O\
MGH"+B$3-^01/0AG9R F?ANL]"L'+V*_E[:BTW"HGA,;.XVA/Z7C6Z4]_B_8W
MR?['! O\+TGVIV#_*M<"@($ !S,> BX  AY4L\,9@?\=D&OR'C(QJ5NP 4H'
MV,:EQV5[T91$A=W*DLI$W#9"71N3J6>;U$R3M+6JFE_:,06&1N+RQ+B*#9'9
M.NS@DV8A;:%@$234]28G,5,JVQ'8$6X9"$&JRSP]-AQ/KE(+9+XM=#L4+,DY
M$$:>Z[VNQ=?++:Z@M8V4_H3<":^+@2PJ<K:YR=\5Y:+@D_ CKH.^=DJ=)D@Z
M@Z'!K;(F!<-<AO.'E;D!<0@GQZ^H$E5;O;[;(,L<RS*,R4?6>_$9WL%E/DIL
MW;W=.WU;VI1CQ3JSFM!^Q\95/#@V#<951T;.YYR!I5X)D.U3FD&%NFF&\429
M-*OSTL\\NA_C$..ZY%](>V2Y<]N+/VM'DNW$(P"9=WZA?',($R%E(>'XJKNZ
MT$I5-/+'%\JWYR:H^%>17^VV,M]R'ALPG=3VB@E];*,0F'835I#1F2XV)N+3
M\$@L(R-Y(Y7Q+)O7>*#-/@H![A-NJLCK".O-YAB_!<8%YJ[6=0?/.NL&UBI2
M5Z'TZLZN5JL(J>8 P^,F2].SVO([4 (./CZUVSM_%63>=)/3LMZ%[=*T1(-G
M(2-GNI:84TDI^N/1Z$$67CRGAVRYP8D+C.W+[4DD# 0/J41<HG>_U9)>XL_@
M*S<%JEE_&BMM&KU_2AO_.MVT.LR6-2^:>$D 8YBN@M$8%2.J?5UR<=.B"T55
M+\R7EYQ!2;9+P</(N9?"EJGYBZYMAK%(-)<Q>F4BK9/FP9Q+SD^[[*CL>D,L
M2)'Z]+WPNL_UF'UD0QINOS<Y?:4V7D#<:6/BONQ"7NCU+P.[4W2-T_R$8L])
M\S+/!E,9N<2Y!>T&+\>F6G0>92$9IM7@T,H$ 2CP#C=,N?''34/&;I5RE6:X
M=2N^B,NZ(?P]?T/]^,*UQE2)D= 238=<Z5/]6'LU*=-7SMIG)!5\]]_F;)V3
M#)\^TGJZO&UQ^"'G8?ZSY8T'J=JD7YI?RR-_<D4#$1Q-C7[C1WSISH#%U<K?
M_J+[6S$,$*]3X6XQNM.'GJ@22\/Y*]#\GFN<I!E7:"YGVU"</+5>^H0 ( TW
MYV^L'G"9DECOP20<5J5)>\K<E61 -'&Q&"&"G*D<,E_K<E9S  5>_/HUTL(/
M[D-^!05^#-<^#JMPCXT=J3.4,DW-08'ILC'5;_];-NYOR*]5Z@(+N?$V^-/>
MC"%\RPX' H7)+(_IF^0]$X],97/3WZ(^PRF78IT*T.]#SM^YY!4E> LG!0,]
M4!=E5,L3B+J7E<W&*.["SR0BIR_OHM<$V;+68JN5O(^8S\L>T8*A .UJ(.B
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MPQ\UB99*%-EXX @O/CO1U8WK!)L;B^]-P:V27Y59EA&1O'#^[FW*]1ET1MH
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MZT./VL">W]2K#5D1Y;OM5;-B!56NCE:=;4H/P+)DPQ?GV0]/EAWK!=K.1N0
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M#P6#LJDC"8E[;]Z'QV6E]H=)M O\Y \9_7AE%:0TS7+,(B+E@C*A8W6AE1_
MI:U J]OX])6IG DKXH>O;\'^=]I:3RB*UO4QFWC7[T1YCQ0V=;\_<=?/.^NZ
MZ.\UU &F7FE-*Q.\^-:F3@QXJW[[HQ>._J,NGDH@IW2$ DVKM[A9J+]?P^P\
MTL!BXDG(OO$JA9$XVO4[+?A"4&C&>Z65$>$)3SZFKR>L<4KD/P98%SF'&K6]
M!)# 'R-]FQO<"UL)'=8K3A1N1W%3R((YA0*!Q< AP4TZIK<"@UR1I<ZLD.?=
M)2+H!3HWGX8Z%M%F#AO$7 *PE! $]KW=1"T1W'L?14J@P*^4WX<,A>X53_/S
MBCTS'F</N3K-K+@ER%&Z-;<%6,3WY9!+_-#SEU!9313B<GK"B^FBXM/<Z=Y=
M'!JX;8X&@4YBK2?V=<R6W"L5/10PV@Y8E]\_XUXR3H[!O#.% N<K2G<'XU?]
M4&"W*?-ZONPUS*_ ,["M2ET !59AK587;*-C0 $8(V.2L)\MF5 @+)]VV'\>
M='\=_WC'XU<!OCEF>+BRF6A=S[QLO46Q@@+7D_^24$"_P!<XL/OC@M\I!>'_
MBXLHWYP<)NQDYO+<I@]I)@V0F&B[-%Z/DL YM:$%U^+/1JH9G@19VSA@#/N_
M[*<X+*3SP/Q,YOZ-X5&'W<% R,+7%VGV_4M>9AS58.&M&Z]12E98DXO&W^4+
M[EJ9#%X ^3 @$/<N[P6 7@"=M2?/-B6_5-/0>2IOXC[UY1:1Q !&.!FWO"F6
M77@I,5;W'!?[^;+JXK0VG$EJ"I+S/H>(<+0)]DIVN_TZX>ZRJ;4OLVS4M-[0
M%J (VMY[XQ#0<-<3NI >06-AG12/(.IT=BI.<@;AI8[>,7^<40\:40^>0V7C
MX\+<.[NXB9;&$MB:\<L,>;5"4_\C\7&W+WP'W7%@SFE'8%]4? F[A3G?,-"?
M06OZ2;4MH3=[.ANRP]$D-81L@]DM6:90*^LS +'8Q2 &8^N]'P9<KOVQ.5BD
MW.K&#18/7YP-$;S.EX-/0/IXDATG2%7#)"*Q'CQ1;):!_BN1"3OMJ4:[&5[H
M>33*R"45A30Q^<RF+\*L%J-05!@:!]>$H]#FT=3J24Z3M%$<;>$\P2?&=_HC
M+R](%L<L"B8G D0:#W\?B?0"'5?*+/X^_W@&7C5O9GXD@0*ZL!P7 G-E/]"_
ME)*/L#PA@0EZO 4_/@\0F?T_Z_[9.J['IY!1Y0E?91-3>_J,GC/U]VNQ$8#6
M&L?H2RP0VBU?4V<;Z$EO2+76)>OK?>&B4*\01HFYDH<-)56(9@$WDLJ0(]#/
MDSP BZU]UK\>F]=A(26OJ#K3C&O9VD-5JCZ;HRM0(9>).I<!N55Y<J:*">,4
M"D10(I7Z:A?5E.<,H^F_SM+3'7G]D>H=5YI;&P+R1-/=;YZ[5\\[8,4%/)*?
MI)2':H]Z 2'A6%'E]C'$ @H0@4?1#>]1"&#[%M+XZ E+6VOB9=\L2\1:-?L$
MOYQ=WW/#2+3N!I<](J*!UC/O]:& ""OXA$ISBD?Y\K9%8F@TJ?4OC]53L0/%
M!">.1.Z>AT_8VIU3-\[-7?25Y3/F7>Z7N09]R>2K;8<"H:P$3JEIO:2?I?A[
MT5 1WQ\FJ$*P7S<7W/-"(@IT]5_&.- L44>EZ)9T(;0*[#ZF".Z*E(MZE7UE
M_'Z[+9,C?X1ELG,'^@#"J;IC8CDLU2"30T"NU5V2GB<6-$B#F4-YW_")KU^)
M; R8:Z7!E%G/X)A6U"GE5B4<;/#=9]ZO?<BW^6\A>^/X9AU6]+Z'C_F+)@@O
M,0D-#8NVR(=N?/Y!>;"&_)$-Y@M/6R$XS/NDC+</AE0[%H.K?WG,^#LWG'K<
MG\#*P+;WAF_'96;W;Y"Y12AAEFQC?=FK5S/%._\N&ET;L<@!_=B*F#PR[1W&
MYJPH\PIC=OV+F70+K]"NIE/SF&SK%*P8OV^2=M]_/9>]N-/&'G4>[S']Q'[W
M#9VT9'.5!!OA9_EJ*HF#AMP,GMIA."!)R671/A=DS__N; "+.[868^R&TVQS
MX%N/[&;XZ"E64)YG]@P*+_R6!&,&B5WI5FTB$WS%D1RMF9NP]N>UR!"J$]EB
M1&<AA]Y1- -)].5!MWR2TI*#'*N2!:T,JZ^U"?##3R%]W5/R=7P3SA(O^-7)
M0 OR[9-6MU+;2]<ZICK!H<W,'C8OY'!!YO,4PXV9'@N?0\35/KAD8-J".U)/
M^!=8=_593>)6+9*V5X:R[+0(3%$Y/*MK1USB\>+CAY^N(HO@6C@X$ BY=]H&
M"CR_\]VQ?.LESN)\DSH&A_$.B0I (<9H"]!N@B01=EI%K"_S.>#[-2H\SD:5
MF,DFE"@N1^:_A/-8/OO>=J.X8\ UBGG_-JB+@G&&1YMGK^JFZI3;KBX6<2A6
M;CN)PV((Y9Z+*T1#11 QF-\M\^,CR6P)2TF9742GA>V,4^@Q?6BJ.QHI$>-:
M/QFB7L[6LQRJR8M,!$^75U-'[ =KG'IOXF7.#5Z?=E74>6DPS@]T/9O6_F#D
MK(8_]A8)W3 \D;0WZ*A))F=1]"@5HSC#]US*CJ(;:"K5K\1C%\3ZVB-VQ&%#
M]@;RD+U<G9N4XOX]7]=0^M!R8J&J4H[. <.YRRB4NZ@X/MN$/,$_ -ZC5(S4
M4^.75-+KN!5E"]8ECQ%\Y70ZJTG[7BY4A&UW:O+-%]C6<:OKH\%VEW132 5?
M/"-+XX:]6/*T;.D#+*BXB<?*R>O?ZCKM!#!:M9+[DA55_ZB:*GW.CR\!OZG0
M0*9C@O.AQ>1AH7^WNSH3;;%.A-PC80<6R1#O.9T*K?C=58=S.XUXJT9M+,2F
MZOEV$(!/:8GJ=RRTR+3 )P2\Z9^K?_^(#_[U"U"5%!0057V\)?C[1W]9J"\$
M_OY?T;]\)2CODGPFB)0<,S2&6/7WKU7_;T'!?%$<*SNEI"%='(E ^7\/>*UV
M:YSR>(<$,7R$ E5T4:22O,UQV<6C#:SOMP3GSV[JEJ)(D&H)J3&]Z9U!>-4E
M-E(3!UC!B/$K>BLHQ%+VE1R&+Z3[-%P-FPJYM##P5PG@VO9:&"'5-F;9,BYY
M"P;#]-UYS8O][_K:$=U;K3XE)$<MYC8PGQ4:8]6_*$O*MC8D6D^<>+R=+N63
M,,$8ZW<(0)<0;,P<U):^TM0J)UX[(2(+*^F9%F/5?<A>ORC29J-'[,6 TQ%8
M-FW [3Y_(R:-;JNCU!PFY'1F:YU2T!4ABMSA8%.@8VC-+^#WSDCU8,@=E[1T
M RW %.G]:%]!,^#<<!W1PKJT+/<T,[M06P8=E'J%0%X!FN_I8M[E>'O6XESZ
M&K'3!%EXQI\1DNI6)$EF6?-VKG2VSHJ5F,.AZE6<^,?1F\"N,X%48KM61Q-D
M"A"Q[__5SI5&-95DX0>1I05$=H@H$130L(AL0@,16039%8BL$9%%0&.C-(N!
M@&B L"/B" TT0:3#(FMDD576!B$B:P -)#0H-I'(%C'+Q#XS<WIP>D[WF3YS
MYL?\J!]5KZK>][ZZ==^]K^Z['I$J!/:SV.7JZ:\F0$C9N(;(>7WKI=6I-$5'
M<?VZQW-YEPSU3)09Q?SXO"I1H7RM:V:*W7=U+M)E#J-FD7H]L\PN8:WZ"U<!
M @4FCK*QBZ&-6KY42\TE]))HZOLG=*UL.C$25;E^W]3/:=[O,.A7&;M"6KBE
MEVG4)&?JMWYB 9[UIGFR)Z=ME1ID:(R=\3+D (&X$/XQ?TA7TIZ8<]J\HBZ@
M[WQ84;]]ZE<:>:WF#,\)JFYH$T(2$9WG:#X,NR&Z' B*&@[+L@264L8'?F)"
MHS?+W\(-NB-9%F'_49S='X[+6XR*8\0%4P<S_20;#'=-IVBDK(3XII']<JU:
MJC, D^E9WO#;;/GX=+QFCY"7?]AHY:.F40Q>[<Y2+CETNB8/2>( $?H9%8UN
ML3S,-CV,$@EZBXZ+>&3GUEX;0ENLSPH6'%^A4=,'G)O$9ZU<\D.K%&B,0;]O
M&H(E3LK;3B?TL)3)WJUZ)CZ@%6DKMCF><"7[V .I0:@?CW,"9.!EP,+1R]M[
MGM+UX6G03S>A[=4#&M(&*MB987^;)G&0FMWQ1[WQ2^IB?&G/]LQB\:*8&(V\
M>S+P2(+6$/JZU).BN_IYA^N,;]N?D<U'/8W-FBM3ZS33)"/\5A]&W?;>7V/G
M\NTR#PQ5LC6WP &D[2/ZKI^49"L0JSPC[(>8=B%7=/-?5HS49_9_FR2K)"$K
ME!5G#U!//,;^=JHEWK:B2%9AP.%.C%NW[^&#P!/C.,66XIX8S2<3A$,%8U:9
M%::"V<#UK)L2[[S;O1%TA8Y*P?NNH[X#T>\2]][8"#M04$S_?K>W!/W.D^1H
MM893IRW3+X@!]J&BH<;0\0I:#"E8_K5S!G)?2U.LL,GW$M@U8H()W]&:H.GL
M"-\UCPYJ:7'UQKI":I3+[]2(?V;QYBN+2.@NE#!RJBHI3:QJT9Y_I<CV.BYX
M(Q,\ZSDH-J-6:[4\Y?71L4P I-Q08CV.]#@DT#:"@*&?R51P@!$+>CJ;OXL#
M]'[^+*;IQ@%PR50%I@A7:Z9P/637]#6VL*Y)'*XMYHO+7)]9T+N. UC(],(8
M^T0Y@%SQ\@@;W8DI?:$#)Y)7[[R#K3NA?+G&6377J\R%S0M-H-_@&'T< .3#
M :@ZT>XP(N/8V#8_]N,G]M[6 #96,P6]JJ? UC[-/!A%9$DB9+F6; B,Z9]>
M?OHC!^ '%Y[\7;A'-KAML+FN<V_ T*7WC%,;A=NJ;5I<\VT*S1A2V(G+I%)A
MB2D;% VR0 V65H"?$,*+SS,O3E:%W31BE3HT3*A?:DS8!6K3DOZI$Q+Z]<2]
M0DR8B*6$;FDW6=K+O-;(TBI,<+]9<798?T)9;6WF%%X@\_1X,?,=S0>_;G$8
MQ0&^8*EL.P'S?CU/[CVR327B\<#P*^&[GIY!>O0^<%S6\UYYP-A.@4M[51.F
M=$0'/@16TV)D?1VIDY[,AHR+4_1SI&O'5_S%<<?@?E"Q?E>_76D\%T3=VWWG
M*\V<ZS T(@69K+'B[TAWX"\"%>/?N-P^H33K])D0PT]_"8H6LT M;DN-A8^0
M8#V:DNH+J37J,V<;Q+6OJ,>VN5I/"T7S!Y'_!?F3LW^<3-:7XK%CE;DT<8!X
M$8?O ZL*VW=*QQ?+O%V/+ESEDBHBM;:U$^).6/\EL>US:Z8CN]3UJ-VYZ.0-
MY%[3TH--+2\)O=CS-(CW)<%E[$BCHY62$H17"V%V>6LDR%5O\IJX3V.JWRG+
M/1- ^HL)W<#FR]9?/^+#<GV'CC\CF/H?0=5+A1@.\,Z(^QB^]N4<H$03808G
MPO; )B.&T$FH<V67HOSG$UF"L-3P>?97S'C\E).%5)&/Q=\2T/V].!&ZH88=
M?J;:O(-R/HUQ8W%OS\*34.8,?8H=FE)_0/T%PI*0HRHFO;QY^C*/U:+C(]B1
MQ$6G),4<19Z0\BW;KW1%242[ML9QY<8)%<.VHO)6IG# O;-" :VW*!19RAY
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M@#+DL9E$O_R"B8BX-%(YYF7MZY^\VTL*<CM[KD[YY, M[==M\QV>P#%57%N
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MV?E/7&@ !MJ_;/]=7"0H7.B8F!B8.#]QH:%[_AQ @HEUAQ^;5%8#Q]3E%I/
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M],:IU5+;-5WEJ,.Z5Z=$FD$8?[-7ZJRRI;U+W;JG:[1 =_5?OXA&5X$>(Y!
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M7XLE$D!;?/RFQR%_:XK)9R:[=LP=G*)G9= 04VDHQ]R]7.G 2^OH;^A;N]&
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M'(8#]E&^!Q5GC7?(-@H#]5.SZ0\W*H(GA;("OZNF!<@T.NO;F=\;O4XF^7L
M/M<<,.(G,7""^)Y8GW5&^BX4?\4I\+O0WVC._:Z0.MPS.5??HW]+OOUO0<HN
M@8<O4T24SP]3FO@0^5$ 4RDE1(G@.$8!]Y+ ^(+)?OM3'_&1;T +TUE,?8M[
M% >(Z)\H1E#/SDIK46=@K=_O'T_D(S'2T>*2R#!=W6Z'F/6FW760XWKTW@,Y
M\-I\%T".8]ZY^='SF.L"8)V:J<M!6G<I4@2_**KZ@M3B3JTSNJ^)B,!C$?-@
M3/7=-!IC'?6/88ID(KD0$25&<0%NXB>V+.>?/[^[_0S.;\'YQZN;V\O_\^XM
MN+CZ?&OK$%LQ:NJL3L63G8E:HP"D31%,ZE42)<$!4TC.E#O98IDDH9(+#9-[
M=E:@9O:Z7 C;]XB<6G&U2%<E5^+*Y^:DM>K&210&3 0$P82''D0!T]L",H$A
M"[T$IR(.D9'3TB]F8@NS$MG=?K4U+ >),34@0]6U,Q0O-)W$%O1I-/F8/RA\
MYK'=1\#^&.Y]>K#WL)W8L7Y/LO+O9/DD%B@A*/23& :<J[4&)1CJR$+(:1PC
MQ%.LUCV.#L-AB1./X/>'\I&>Z6E0*@3@BX;@["\<X=#:11C.C*M7X$#*$">@
M7]'YYOTC.%YKJN^GI6=V/_'BX/S.+[<^FD/0VWN2KW9'WA8/)%/+U-0/ K76
M@-)/$$1<\8\)19!'B% _#%,?$\=TSX80)C8C6QF.LS6@E4_=QAS4]SK$8WU<
MQQM8[OF@3:DW-393$FIG?<;G<DC^:$LZYDLG;0KLM;)+6Q+7DVS:MB57L_:+
M*.Y*\GB?,;4N*@6INB$4XU2FE'$81J'R>2(<0R(E@8FR720*/!PFPLYZ'9$T
M=1C%EE1 M%AG,W2,*E-K,P(!=D;%17<'LW%"K\FMPS'Y,QN!$S3LC_53+[@.
MZ6T'J,RJ++][K^!V_M%V3%;W_<HH"DD@A5K>$ I12'3TJ0RA&O,!YA%1JQS+
MNA26"*:.,]TJND!:.$!WX*HNPT[HH[-UL&7=U&I,R*6=-1F91@=#XTC%Y ;(
M%M?,ALF1MGV#Y=J0JR'[-7^J!+\EWW0B!5&]+\K?E+&\_U2\%6W%.?5/C7>T
MN32]2$40IH'GPR#B#*(D]F"*.((RQ"1D'(G0]@:; XJ)#5J+"*AOMTE!HD:;
MCH#YJE&!O-#Y !I<S0/-$@*4:VBV9LVE#TQ-V\3,VIFW24AU,'(#2)G<T+E@
MF]G8#:!OW^ -:<PE"?[G<V6YL-\=BN#(8QZ**8Q\FD)EQ"0DD8@@CWPL_"CV
MDLB\AN]NVQ,;*"4,:FG0)K;EA?;]1F2@3G:F8:..2SS+"[ULTM<[Z^>8M?YT
MMUDFJ3^H0']N^MU79DQ)?Q#K;B;ZPX^X9W;Z(O(GH7VH7W2FRUSWV"]-,M2%
M%S'B)S&#J9\2B&(60NK[RJOAGD@\&:2$D(5ZAQ8V^9R.RK/YMK:E&G]:W07\
M9KUPMQ;>WOZS/D+N(RYE*,0($4BE)R **((D30047#'*0K7$M?7_1J+-+5-_
ME7&'7)Y]!)DZ9R.I;6=IW3X3IW16)[6;(875<0RSIZTZ2<>A5%6G7W+P@I1/
MM4JNM\I5KWYUH;RMK%ZP* T12A#T QWLFX8)U#O14,:)E\9QR./(*';OI*2I
MS\XN;RQ<B%Y*#!REL12U&\PZ++85JQ.GKXM Z%^WHL=BP,*E&HL)]T!A-T;L
M_"X3+7N]L-X&YO/)3/38\=",7G"P2?]5BD+?<"Y%_3'+LX>GAQM1/Y6YOO+P
MT-Z2T!_"*IPM#<(D#+'RV23A.J\XA32,4TBI%WH,^9$01H=G#K(GMEL-&/ G
M\O#X5]!B @\M*% VJ$#V I;%(+=DF7-*$?.Y\HRUCRRIXCOR$_4?S-/0(PCS
MQ,Q'GIAG)X^Y@?-SQW$'"+2(P$M(TW%L,+E,QYO=='/@TSQ!F\MJWO8;-9^:
MIN/1;;*RYW.DV<N-B-[YS++)^68X-UUWYCS')ESV)R_>Z?V/J/NV8S\)":<Q
MC'V/0H1BIB8XY96GG"9Q0ACR.#??G]QI>^K]R8MW[4979+./MZN]R?ZDLTZ6
M^Y-K=9SV)W?ULMF?=-;/<7_R=+=9[D\>5*!_?W+WE1GW)P]BW=V?//R(\Q46
MJ6R'T G3'G5?==]'&/)$N5T(DH2'RNO"&-+4$S#BR$]2+Q)>9%EOXZ"<B2U
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M4&8V(N;D[)L0BW<='.9WI,ROE.=-ONET,6UU]X4( HP]BG0Z%UU''460I)&
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MN<S;FW*LN1O>W9!;A*G/$AQ&4'"=4M>/?)ARA&&(49*BA ;4,]J[&81B\@/
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MBG)3J/QP3/Q"<HFE6C-#GZ:><K;2%.IZ(S -4A\%@C&&8]N#$!<@\YR/:&1
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MO+1KI>K3^>>WY__SEV5!R?(C*?\0JXC3) W\R*,,QJE/(%+S"Z24!U!(QJ5
M./!CHYT8)^E3+UTZ.*##0\IGT (Z X*P>U"*KKAVD\0E%YKG+">KG88SH);L
M3>1JNQ_[IW_%88S^ZOW9\W4.D_8A&T_;MG-,5C,34FZYB'G!=K'%=HL&M'!
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M&#.4(F%G=[9:G]BJO-_;A'$H=+--AJF]<%31SAI\,-#)89 ?P#[Y$-Z6.?,
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M$S:2T;-0NM?ZF;0SGQFTT&K''MJ\YQP^%8;=M^FI)9[0=TO\",<0Q4) '+,
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MJ3V'8\78-^52.T" =8@&5R(_1K*!@9N,.DMWY&A%\G4IQA48<#$U;8.+N8]
MW]B%W1UH'*/,^PDF'$J^'VOQM<N_G]#4H!3\J18&Y@$YD"=K\ZO_]XG?M>4[
M=#QB56</"L%V]JSVG5OQK7ZC([ 6S!>84(ZT_8XA"I5CB44@($M$[ =(8I80
MIXPAH\*<V-;_6C6Q;/]0J-J4#3IZ3:Q@.:; &+>?3'S<[X%]2Q=Y)XW&!B%H
M$0 %>_NW&^!-PN8U=+"%'?S>O:OA@S?]889S]J!CNI-7Z\DQ$J.,TJ,3Y$R9
MA%3C["KC2G^=/"R3,'@T8\LTTIP#Y1173V6I)%Z7Q9=,W_*J%*)W#X_+XEF(
M+G2F6B34\R+.&62^]"!":0H)C23T?)9&:9J*(+3</#64//%T>2/JK&R3ZZ\"
MP JZS.X:2V&]Q6K*ING6ZP0<V4UJ"@#L$(#'-80FRZWH0*QX&W6[UE+QZ0/D
M#/','2)G1].!(#G+!@:<NBJ#UOV(5J6B_4@$"4^A8#J'5)!RG88&PYA+&@>$
M4)WJW_8 =D_,;&>QC:>]_BMR.,+<I\CBE':0XLX'MN<[.@\YO]U7WN$H=Q )
M0T]U7Y Q\B'O4=6,SGOWWY[_Z/>H!@=/@8\_[50Q[$$0[7_I_FTS_G:1ZJ$?
M2,QY"'T_B2 2:02QLC[0#P*<!EXD8VQ^L?RHF,F]F"VYJ[S1=AE\3]!D8(A&
M4=[.$$VOMU7EJ1'T=RT>Y<*#;?6G$^J=*.!T[.TY:S"=T.!%&:533SO8(>5O
M7;3^UL']U@4*4(0BRB%&R@:AA!-(]!T^P0D*_,B7$3>O0G]"V*L<.ED,RE-<
M,8&"F,<)E,03$(4\AH0G 111PKTHC'TNUL$$,[&U&TQ@Q]?V4NME3:AJ=/+B
M));<EQ+ZGJ(,Q0S#%.$(QE$H>,!]C(EG471ZQ$_-J;KTO.093(8C$F*_8N\D
M@R-';R,R83$]CLB(VR0YA!F[J=)0U=X)\U0;\TV;AMKL3)ZF[SCGME7SL$Z2
M>Y7O3--7\L2MOT7(0QEB(6"2^ PB'.H[+SZ%./42C!-E_N+$*6^U*Z)Y@M3.
M6?U$RHPLP9W"V1X*NN6W=F;>=,]S4B*'!;_]F'79<GX"F?)GC"X/JW:?ELWY
MD!Y6#?W@1TW]3[JF8;GCN*M_:O.,L.+AL13W.NO:%Z%3*Q4/(R01&(_CZ5/_
MN@*<.S/P0"(/) X>VJ*=2:W*>O&1?,L>GAY6N[*22X2Y#\.4$(@\C"$ERF#&
M*6;*$A%"0Z.[RWLM3[S>Z&29V;-]M?O-TR!E[*Q-)^;T5JKQN#\*_L PEJ2B
M#7SU4IL^1"SK2O]MDT-DO[U91MU1-5:#Z/@#8Z0H.YHA[98HWV;AA=0G@0AA
M2*5R+!!&D.H$O6J=18/(2V7$+'.)F N?>&3M9LGBHB;94LUY62Z+\J$M44YH
M\=2<$#8HS\!CDR"P"3U:9PC\O=98K1..6/2!J8LQ#;.63L4\I Y,/F;&SJQ9
MQDY >L5T8F9D]><-,VQC:/TU[67>"":R+[K9=6:R-K-C.Y@B*D(6!P0RC"1$
M<2AT"4,$4RZ0GZ@U%$O,3V<MA<]GT'3%J\;EW@+4G..UOVTQ@=]O+4R7$]L&
M6TH3<NALNKX7^ESKKXU+XRCUUX;3.:#^FCD?YO77#-I\I?IKYMH>K[]FT<98
M%YA^S;E"H",&!=?W-M\OBZ_50L;*(J,00\Z"!"(N/(@C+*%$J;+@"0]\812A
M9REWYE.D:G5WZ6D+3)N82FHX0R_@'.;6P#I/PYB=83YZU68;1YN]Z?UT9 V]
MJC28M)'O*=F2-\(=I5X*["\H'6[NE6\G]>IX^FI2_^NN"_Z_997JJXR1Y=^+
MI?I^]/;:^Z)LLOE6'S?;<9?YX].J6ASB5'IIRJ 4!$$D/1]BIC/*""YHRA)&
MB=&9_2 4$YOA#0[;Y;L+HZ;K^(EYLC.^&S#@RQI-$RG=Y!57AF1WJU]!FJ1N
MWP!2)E_'NV";>4$_@+[]E?V0QEQ-V)NBKHN'*WFC"XEV RI*4C]09@HF)%%K
M^1 KWY WJ6\2GW*/2HZ-:JGW2IG8!+42]699J67:VJ%#M)C:F8'*VMF1%WI.
M8B-Z%)K<!AR2/?,8[U%_?PSW/3R@!M8FX<7ZDG5C%70V4,%O[\OBZ>[^W3=1
MLJQ:U1/XC93JFZBK!4ZE\)@B6"*/J_%,,$QC%D)&8I\'C"3,3ZVK80U!-/'8
M7TFM-F4ZOG:2]:%\-\/^Y%#6:5 W&"P+YR;7SM:LT('_G[MW;6XC1]*%_PHB
M-F)/=X0P4Q=4%7#VDR3;O3[C;NNU/3.QX0\*7&7N4J2&I&SKW[] 77B1R"(2
M52CU.1,3;EEF(3,?$%F9B;S\TO'WJ^MKL]>9H682-5RBEDW4\;G]!.I8G7H'
M D9L3;43PX9MQ=^1L-%;8Z#G-81K$*'IQW&-@<O1P5RC+!Q\_ZW7<C5[<-_@
MHX7+)V^K]N=$98DI\DKGN"AY@4G%2RP2G>&*B,2H(BVK$N@?C\%6Y#?63=^M
M+?@*?(QM\+X<GQA<X-W3CCMG"_!=^X6'IBF#<[C/79E'&MHU(G#Q;]3'8';J
MN_81 3YR"S_FZ@&.0=OH^KKU346JRZ(P$J>:N69&1%J777&<J8)4I2Z$,/XC
M1 [7CJSZNB[IUP!C\)GP'H9UN$@PA;.5)J2V^9E8 &LU7+PPN_/\IL'LQ>/\
M]UI^SQZ9SH8[SNN!-7;B(V/=Z#;EA;=:4$*MM815DB7VS%LCB>9I@@M1D)+G
M>46D?P.S'D(3W]EV5[8/-?&AEXXM5J%7LG $1KJ#O1E3^J%WK' 41KY4/8/&
M"'>HAR+"+TW;YU_YEO10BO/7HL\^/T;B\R?MN)_-9[RQC?9Z\UZN9JX?Y#LK
MR'9@QZ7<S+[7_]JD9ADE5"Y3@DLC*DQ2-Z0Y4Q0+Q810*DE%/B Q>AAST^49
MNG#^ :ON-_,=LX@WW#950MOA1=;!Z1@>(W]ZX%9ZNY"OLD% 1W+2O1F8ACT.
MB).F:0]D^173N,<!NS_->R0: ?;GU7*U6OYP37SM^V(F=6M0L#21A*@"2ZF)
MT](2,YJ46/!4:RY+DI32V_0\3B/Z_7!'],(9G)8LW. \ 8Z'K3E<9.@M\4[:
MAB+<P#PA+<"V'"YUF%D)EQYF4/;+U6M+GGAT.C.RG_<#"_+,1T-G3Z9[ENG5
M<J%JZ[0-@62,:29HB=,LM=8@YZZJA"0X3Z@BA9:Y$%Z9*%[4(FN<9EA@>G'0
M<40LZ])Z[ML\U \V#PTT)A@P7;3%8=_;<]1;ER]TMF0?(-#!DB,!,V2JY$F
MQIPEZ2'G^4&2?8M,/$720YZ7(R1]'H*7R=<)0)<_9^M;E5.J2I5CS:H$D\18
M)28YMWZM56$D%\1(XULBOUTULK+Z[+ZSZTV=G[J7>8B^.MJ>1_,0A7Z=%"P;
M3/<$B@6JG7\AQH"Z^=U:D]7,OV!_OU[^Y3\&O/7_L9P_6IVX>FK.G>LB_%GJ
MA76;ES>KI6C;5)Q(]LYS-YO#E#@Q[C"E]B>:<%=';_V.O.)%01-OBV ()Y$/
MX'_JN4*;);KGF\>52PW_J\L3;[AM+0C'+EJW_+I;[(YAP)MST%YXF!E3(0Q3
M UNNT(XMU/&%]AB[.- 2[YLL?+A],@AE@.TR%=IA=LT0U$<R>L8 J-<@&D1@
M.F-I#!P.#*E1%@R]?KBQ7[AOW.6SO;<\+.Z<(==4U%[/^7H],S.M+M?O+6/K
MS4%X[%95(B^D3+&US!0F.C58)/:G4DF2)@G1HLB#^KL%L^1U#$=H\/:OQ]EZ
M5D^M<.'KV99)5#<B _=Y"]\"WUN"N(@&O48ZEHXB:/W\+5_V5_8#+6=[%P%C
M7@ ,QB=ZO#^<PXG#^X.A?!G-'[[D&'>S?RP77/WW8TWB[?=Z;I#9N(8$#\M5
MG;U61_2:VSN9%HR*3.$BUY7U6G.%A1&%]5J%J&2NN.; (K! 3B:]=5TL%WC+
M&-(U9X@[UM"JXZV]*!CCAA6R(5H26>05Q9IRC8DH2\SLG[BH*F9](6,8)7X]
MF"?=DJ &S?_7;(KOVVL"H&'OKG@(#[R\#D!GTIMJ"'^O>"T= &/_'73(@J'O
MK,O-9C43C\UE]]N?#WJQUNNKIS]<+$1_67[YIF>K=X\+Z3[03MY@12D3*A-L
MA**8$/O.HH8+3"O)JSQ-75H1['4%9R+RFVJ/(7=F=<L2$D]H43/EXD4;QQ8R
M+5_HJX),-QFT [ZJ,"ZN,"T8!=( !1B.273=%\#:Q&HO'+R7&F_ 6L'1"_Y4
MC_!\MUR]T6)35^I=+]>;]6TFI:ZJRIG@TEI\22DQI81@EI=5GE5$9LJKIZ('
MK<BJJZ-;UULI2QG-'&DD'6UPK.$D8-ZQA#%@ ,8*@A (B0.<DRV^GW^2@ZG]
M^'-0'/'3SSX2>LQK/U^O#Y/WW,4HS[B2N3&8,C=;AV6%BT'FV!C.A6(I,Q1X
MRD^1BGS(6[+/TV&_<O\K8P^X?,_X&"# CGB8_ %'_)QHT4_X208F/N#G@'AY
MOL\^,4:8K6[I^=&ZR[QVEAHK8K^XNDH8%25EF%=IZC)"*LR8*JP&, FEPK[C
MBP%%#N?(1U8#6\I;<WI(,.8LEB$1F#$1&A)V:<:W+)\#%J_F/ "#28,K9YEZ
MQ8B*+V#]813O54(545,%H-_74X!N4VTT(UF&\[1(K'&1YI@EI,0RKPJ224(J
MXI4N<V+]R*JDK6C@\W-#C;RPR!2E6DN!2VV_AZ02B76GK/ZM4IDHZVG),K6&
MUG+#Y_&QV%)Y)2Q\M6:PA#"UV)*),+OJJ #1==HAU8F5UE&17VJEXQ\+F9:]
M?.+SS=.U2Z$U,[LE>OWV_:=;S4I6B8KB5*<%)@5/,2M8BHLB(:G0B9%9X3\J
M^RB-R.JG)8KD'M4+9.E"9D4?!Z?__(TD,NP,=M)>CR\M9"SV8*D#9V*#I0?.
MP^Z5JW\8]O%')YR$W<O[X1CL_H^&U@A9MVVE-]L"QS8SLLK2JC!$8*TRZT;Q
M,K<.52$P+:HRX4*(E/M7(9ZF$UG+-.4>_\[O'_X#-?1W1</0&ICC.'DHFW&D
MARF<(X)O:0=7 1U' %K_,QB)(94_QQ$9L^RG5[SS!3_''Y^XU*=7AI=%/OT?
M#ZF,_GQ9P]-^PWC!C<YHB:LDIVZ>"L4T90IS)BJBRR3GU-_:.5P[LOZQQ%!M
MR*:08N!#Z3TT3+A,,*UBZ>!&G! =\DPN2'%SL'R!1<U;.<>J8CXJ0'_U\N$C
M$U8M'^7UL%KY^$="6NWQGV^-T7+ST5Q_<P50Z_>+-WHU^VXW[+M^QV>K?_#Y
MH^YF.=T2DG%#$H.-D-;Q276"65FF.!>*L#3)<IG[FR5 XI%UQ7:V]5^?3;=6
M6Y;6R%BFT'?'5=U*LPYR0KK@ >'VT#T1080I)\L(:CAQK9=;7ES'YATWR+&#
M:GYVL]PBP@?I,A@/QL VA&/#">Q:&(9'?UM#X)H3]CT,D_:P,6+@&J'!\'J5
MS]^6JXU5=O<WJ^7WF2M-6M]J3:N\* N<EQ7#)#,)%HD0V!1&"2VH*3.OD0CG
M2<7.K-D2@@:$3V+C&QL>0V*8^FSF6LK'U<H5!CZ<%ST@8'Q.JNBQXY,,3!Q&
M/@?$RXCRV2?@712^S#;SNFA&S;[/U".?USD@M*0ZU51B4I4Y)J:RSA;A EM3
MJS2<Z2J77CWB3U*(?&AKFK5Q=+-LJO# C16. ]-_=$<1%VCP@"4%]5KHE69
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MDB+#S&H#G)**\)PIEOI-7AJ7K=AW1<L%MK[\-]2$R];__F]IF?S'_T;KCE'
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M<K9YNF6<B3(Q*2X3SJQW2R6FJ1 X3Q/%TDI4B?32\D'4(ZOPEBI2+5DD6[H
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MVW(;0HJR)"7%PDBK4$N:8:Z*$N<%RURXUN3"2Z$>6SRR0JRIH2MDZ0&,SN<
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M4<RT&V) $YS;MQM7I<D)S[I[78\HX?/U ZYK@?;\CB"2CB(@=/,"#(](6I"
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M-*9N@!NDS!: I8>*BX003.%UW6DZ+M#'13NVPIUO5W7;Y=3<Q 4,4IH<![C
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MB\>U=0OX3^<IZ:ZS+B&&T8PIG)9,8F)?^IC*K,+<S5HAFLM4<5A4XRB=R,K
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M+,E+(A+_.-DI*K&S !P19^ 82[>S<H:9,R]P A@Q0Z0/-5T<S>[=W% =0^@
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M5W?I3.TO;ZSQRV?J;=N.^C9-TR2Q;C'.E4Q==I#$G.0$*_L[HRM5,F.\[0X
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M!6HXB@@?P &/"&.8?SXZG# 7/A"/7@\?NN9T 8! :0_B Z%KA/HS?UBY>D:
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MD]_T55MJ5]G_I<9PK*JRQ$1P@GE*#$YU4:8R%;)(_#.UO$A&ULPM#P=AQCK
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M>J4=#N(BLFX^8 OQ+5\72.TX0_<=:UWSK M4<X<R2!^5T'WPT.%3H O3YH?
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M21DI1,&\BJ'AI&.'$/?(!8Z%\@:Q7RG&A088> 2@$E#_ A4P>K6+-T,3U[9
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MYV4J3%9'C""-3((_DPB2*#>WGS@K\J(H(HP]F@*<HQ<ZJKM7V_S0L0#8YG>
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M+L62"!7S6""8YE)!%&$$:<0EE%B*"$L:)9%5D8XCW= ID3TC&W^U*_WH<EY
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M-; 6:BH(7&Z:JT=*>XU=P4G+!=AG [1\@.MP2+DT\@R!F&<GSXF0<VSEZ0K
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M_SAL9'M@+=1:$+C<E-P^4H8)>+N&'1O@D _P)1A2#@HP"&)^ZG JY-RTI#,
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M&51*D_J8L-5%^2BM,A9;36]OQ6";_Q98NQ#3OG%G1\<ST&IY!MJ7T2H*M*9
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M'$?$@"]'VVE'BXV)>WDN;NEQ6RTH;K3-;DSVTG9/+-5K32\9'7]R/L[IU?R
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MS.WHN*,)D$5YB*<&CW2TV1;-]+D%=X5B\OVYM6(S;]Y=@7N]LW<>R<M-X?:
MN=/+O:Y$OI!)G.-8O9T<\QQB)E.8IQS#C",>2:3^*3*JDFDI=];;0"XV9+FJ
M0R/5['MHIQTMGC8')^\[#<&WC=;1.@?>#/$0A3R,6*H+TJC%A><9)(0QB,(
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M1%L+#P\7K9]VO:Q\5Y1E\>=R?5>]>_Y"'D3=/B!@618E,8&"Z+I>. PAP2R
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M >9C*Q,[#EC+Z $']GI_>7-+?OQ3D+*N\Q>&:4@B15 !PVI;D2=8;29T3>6
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MT;,WBO;=$=JE^_/;=7HVZ>H\?L+_0RSO[C=54SUNHZ.!OQ2;7=!I3&64!*F
M+.&ZZ0"2,(\)@DG&*(DXSY+4?/KWBIJ8#%K9NE?S5CA8:^D6<Z@?*@.J\ :
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ML):E :QN-2U-!G8EU9<5G2[7NZ.$S^K/3TV9X0]/XK9P;K<;9SBD-")0ADD
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M'9F3,Y%A%I@?"'9'GNVJ^=P\F^.U^09DX6J4'4=XLL?A@MG6KI_J>OEU;L7
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M:D4,2H*\Z7LUX/"?\VW9+0>M1J!K!%!6-,P':SM :PCH6'(&MD^VQNQ3],_
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M239B];P((DH0Q2&D(D,0QRB#>1XB*!,4LEB$@E)AS:*^M)N-<CM1 ."NT?C
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MS!\>R;+4TC\55=6VWZ@$OUQ?EX4N5%CJO]?=._Y<JI]CG"4$\Q@F(D&Z3'X
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MB+6US6(<21FC1$:YL:%U@N#9XN[) LL"_JD 6)@1-UH-3+!WLNQLL8(#MGC
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MW8F.DF;/NJ0?5**LKU:D$NOMM4[!_ZLYX*NORN*[J-9+9=>_E&HCW^W9 FU
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MX>+PG-?0OT<S@&%NE^4\'4=\$H.'1D__G:/V[DN<B31$"',8(CW[$T4M#O,
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M(X5J]TYASB,!98!%1#B6.#0J<&$AT[.EN=TIG&4;B'&>KV&CXXD%EW/C0E<
M;H4W/QL767.(8C!6UGL@PGDD,\<2&%-S& Y@_JB#FW'YI M\_[_:;ZG7US=W
MOXKU8\G[)JL\3!/,(L@3P=5ND(<0ISF"4F:!S G#222,O8TA29Y-P4:TVOK5
M:_"3D@Z>&O$_6ZS'@U09."%3$6!G!;:Z7VUT;R7_[.*4#))@X9M,18:;BS)
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M'&8,,I*G$%%*81Y'%":2!R+,<1IBRRJ*TP";U2BO>YB ;W!>@)<&%U#3IZG
MK"LU%WSWMZS%.X5Q'O$&70ST/.]EC)'V_$I&&NOQ_,UJL$? ?4>C/9[D8<,]
MP?BNQONW6JC_?E[*ONHAO]2E498E5["63^*F6*NIH6L>MFD039[$_2,I?BE+
M_M=2C1"G*(B"-(0"2PR1Y"G,(_55H"EA011%:6!V^3@A)L\FN\6G7#*Y*7;*
M :GU]8;"V-@,A?("+#<X^RK&;:7#M8(*'CJLMK9Z_ LS-=.SO@8["SW/&W P
MS9-QYMTJCT<ZLT&>C-I#6SS=T*XYZ%<K4HGUIAG*O8Z/>!0?^A0QEJ)8RA"R
M+!00X32 -"$13%.!24H%RF1BEY ^*,^S^6Q3E_]!GI[_!5H<VXY>%V#=0@$?
M;).XARDTN**:EA@[@W:$DT];3NY[3IPSW(?)L4UWGXRD,;GO9\F:,B'>2./S
MV?'#P\R<*F^DTV'>O-EC]A<>EYRK=U[?JR>[_L(!QRQ,<PRSF#7) !DD..(P
M1R&2><BB !F5OSLZNF<CU\D#6B#XXZ--[^7C9)R_ 1FEHIVYLM/.ZBKDI!9.
MUR&'H\UV)7)2D=UKD=,?<O D?BO^6A9<S<E;J7>7.AKOMK@K7\E*'_8MJ$S3
M/$@99)'(H7(H,,2IX!!'C$5<9]UPHQL/ UF^-V"]<.WI\TX\* M0]0 LUL<S
MK!DX#M-Q8;D+VM!P*T$O63?$NIN>!@L783HZW-R#$;38>09FB@YZ!6>&F,\C
M,--ESQLP?&14.9VW.Z_.844R0!3G"0RS.(6(I3FDDD<PQQ%*:$K3G-/%=U'1
MTK*4SG%Y-M_97:G&7]FVBLS!:85319T3E)F>^DQ$@YTE.Z$_^./IS';'M7[.
ML(+S5,XY@>$]:N8,TW&B6LZ9AUSG_9W0-7B463G6CZ?[,D=AP#(24XCC4+LR
M.(84I10&64QHA")&F='.P$JJ9Z=F@^!$+RU;8V#"HZE1F)@=.^-PCA@O5L)"
M8^_6P@3+S%;#@IY#ZV'SL,,VZ$-95:5R31YJM;OJJD!WIQ273]I+681IA+FN
M3!-%$D&4!A)BDA$8TIBC-"$44?.$@[/B/-N-K?P+0#8(-N>H#02+?<!Y]@QV
M1)-R8F<M=NG8"M^<"EY.SX?%UFA27MQV1^/XL=L@&:L[N$<Z/\I\VR1CC?9V
M2N9/.9B[?N]U1];B\OEYM13\OOQ<%@_WHGKJJM_7"QH$,D_UZH*9\IBD3&$>
M1 QRE..<);GDF5'^I+E(_W%3S;Z^4AAT32T-0J?EKQ0,J,9[ZIN)V!R"F'%I
M8  G9\C."&Y./;1\T $ ]R70$*#&T'>SF)X="W,X.4MN)G$*MNP,HY7B@\;1
M;*3Y#*259GM&TNY)Y\3RIEN\#JK2?9YNGX4N?E4\7++U\GL3$[M0[F"829G#
M-,JD3@R0D'*!8$9RA"*:(H:3Q;I<DY7IWO*L3"M3N9%L?KK22VQ"%:TSS,\R
M9KJ+G)0'.X/8B@8_:0)^;MLIEAM6R ; I'GIIMKZ3U0_BV3NS'53:HZDLAL_
MZN!*?2F+J[;^<WN,_7HEJO52+M7+5E]SQGF4!VD"*:-JUXA#"FF>(B@%22,>
M"9(%YFTA!D7Y/FEJ)0*V(]+"#1AFR< YFDQW.QN@Q,).+N@IN/)!@84'-!D5
M;IZ/,R5V[HZ1EH-NSO (\[DW1IKLN35F3S@8J_\6M;9\=^)_7I;MT9E.^&GJ
M>WP@M>!=8O*E[O#<]M.Y>M0_W<JKLE@KC7]=%LNGEZ=[17S]6*ZX6D!0F@H:
M0\%YJO:(*( XR7*825U@)TJ%VD$:&[C)X7DVBJUT'5# 6OD7X*E%H*.*NU:A
M%B9B^M=C8%G?E70[:]Q!!;M8@0+;=GV'#=R^&@/8 7P!NC=U*\%5_Z8ZV&"#
M^UU?E(7]?]<7YK9FO-.+LUMQO/$ZN$I-+W6^E<T;8WNKH3\IK@<"5RL=:U W
MW9Z5H5^_?E7?]O5EP:\5Q*8&]N6/9;T0$64(20Q#W;4)A2C4):H)Q'F:TP %
M:<PL6S>9"?:]ZK4@]++WW,&X ,\:2)//*'HHX ^BP%@GEAJ2:WJ ,#UE=FO6
M5&PYG";8J>[]2,$0SLSG"G8D'1XN6#[O:G+:V'FA>[?4BP#1C.&0P)3P "(2
M8YCGROT.TH2GN<A8+-FB$ ]JN\#O;>S+KA2C*9&W4^) EO'TV)08V%1,MK47
M>\R()"(RS#!,0UVI7;(48AI$:CN21"&3)%2$;9BQ.8\=RXS]">S$S)C:2VM%
MW6KBME*:ME^3GJ >@^_=LNT)G=E^'5/XT$H=_92S^T/JQT^K\J_F./4WY8'=
M%#?%]]9+VQZJ7M)Z71&V7C 4Y3&E 8SC,(0HS5-(HB2%689$+ 3C.,TLW2 K
M +[=(04&2(U&+_#?EUQM9>@K^*FIZK L?E;_WT$SN328AG)CY\@;D99.TI;#
MYIYEF#SE*G6(IG67G,CP[S;9P9K;?7(B[8@;Y3:.RQEHN2+KIDICOXNLWQ9B
MO/[QO*Q>NWA7DM$@C#""$0VE<BE$!'$B<TB(E)QE B-L'OAG*=RSZ=JBN=!.
MAA)K<P9FR:/)4:0_=BP/&C= MJ=4]6%YUPO0PG%)L;:ES^: T!^-CL=_=G1.
M=9[G1L/P:9WEF#.>Q;EINW_2YCB&<Q4X(455M26+N@ISKTU>R()+2GF2,HA3
MGD"49!R24&UX$\J84'L[SECJM(\[*7*>35TOOBGWU28L78!"6"=JG&;.U/4;
M1X1;A.&N\GUQ2N4I-SQ,T-_70CG_!<Q.(IB[)MDY*HZ4&3O[B-V$KZOUXE=2
MD(?=-"**LBQD0:0]*EV?)LEA'JG](8X3DD5$A#P,3-RJ8X-[=IO^+5[!4R?0
M;.(>96!XIH[5RVYJ;B6=]V6,Y^.0"D<FH"0U;910S[6E&<1J7>M_;>LS'!UR
MEADUI$P_A08_,^%IRZ:0RDY )<D#2:7,($VIVJ:$G$ :13D4+! BHEF$:607
M@FHFV&JNV2^89T]7-F6@ICU=.4;QB%.5D<1-=9IB1=8T1R@#FK_'T<DQ..]_
M9#) DM%1R=#SKG;GB]*G#4)K4[4WAXL125#*8P)SD040T2B$E$081DB$:8CR
M-$DMK[5/B?*\CNM(QDZN8_&$DQR9FHHI-+<S#H=*>SI./:>:]]E_$L#,\_T<
M$8<S_.P3(S)9CM]1WQ1L]:+KLMSIQC6E5"M&*WJ1)Q$+,A' ) _4;.>Q\C P
MCB#+)8ISBABCW+*)HC4(SW;@ZU!<AD/JBRW% 6,Q07D.6:SCA'*N* Z"#'(:
M\RSG(8YYO&C+U'Y;DVK]]R#Z+:!IZ%9N2H<-5!H<+"54\'I31=: BH=E472%
MO%H0,[RCF+.,,A'!B*2QF@8Y5\N?T.YU+L(8<93AL'M'UP7_.[VA'LY<[T<4
M?-8W8[K4^N7:;A$>0?'$Z6:.E,R1?V8+;?Z$-$?RCF:HN8[E< /Z=9.;T(3(
M]M4%^GS9W\GRN^"+.$M1(&@$,[7(0V7?!*1)G,,(1Z',(RY(:'[O:232]S*_
MP=!E;&P*6?19_^"O!H?%+9X9E097GY,39&F0MMRTH?8;;GH$X'<_W%C<:T[.
MD=MMYGBN[.XQK=0>O+TT&VF^.TLKS?9N*NV>=*R0TK=:^2C69+G2YRRRK)Z:
M+\LE+5_ZS1E3QKIN -2?EX6X68NG>B$"E&64)U#2.()(I ',,X1@$I$@I#F)
M<&+4X60*,)[MZD[K(UT\M<,'=@""!B%H(8)=C. /C1(T,&VB)\:^'@.+/"/I
MEM>H_S_DV[+ RTR\NY=^\<N_?6&8"0@[6S)FC(QYB\E,P,9!F9DIQG18AZY_
MJ U K5:SSTNUX-7ZB/^A$LW]XN_+]>/5E[MOOQ7JSY42^GHK?RV+];-8K9:B
M4MN(FZ)>+]<OZZN7:BGZ<,8 BY %.>0B(!#Q--*E:@A,8QQG,D[S.#9JF>@%
MG>>5:@,7K'J\@/2 P5\*,="0+\ 6M-XJ[,!N=NH]<- @M["BD[],@V7L/5^1
MW;JV?3L;J&"#%?Q^].W<[K^=RX.WXQ*:.?EKLEC]WO-UN2V'7E[;1$NC+S8'
MU\K)A<ZW>/KB:V\U]2;$]5;,N@?R0G*<D(@(&.6$=5?@<21A@$*!(HGBD%BF
M-%ECF&]3IU; 2N@^,WIF-X5."%N_D%7?BGS99C>?:T%N>Q5@_U9,;P*\<NV\
MEQO3VUW\6 .J9O&?D][@._/D_7; 'MG,EP/.U!W>#;@/-:H.^J_DARZ:L?G%
M%7DF3,'X*JJN#/$BD0%+&$L@3R+=Q3?4M9^P;JM"<2;3E(K,*!#(6K)GV[=;
M[OJI!0-H_SO .CCZAK.OF.Y4&]R 80/_WA=O=G9LE[(.!]C\#O1(@(+25PWW
M19E39?5IJ1M?9'TDA:X5U\UI,"R^;C#@>]1A-]?S1$EVBP%<G5)]!:R,?A]0
M*!,B\D 2*.) >9R13"!NZG[(*%,CL#C)C6JQGQ+@V:0VR62Z]I)Z]!__@:,P
M^U<3\+ VS#@]R8NIS^>NK>4A1B/'4TCE<26\>UMOQ,[L2AU7^M!/.O$YYX([
M9266#X7:K#;%Q'YIFLNF."0,I9!PQB'*B(28DP#R0&(1I1@S;CD)CTCQ/!,[
MB4!T(L&#DFE?6N8(.Z93<:3.=O/QJ+J3%IPYK8W_NC-'9,]=?N:T^D>JT Q\
MV&&STBPJWUYHS:KEL_:U?B>Z!N"Z_O#MLL\RS)(488&AP%+G$5,!\S!B,$,\
M90SQ.$@,FSX:2K3Y)CNU?522;*I.&W DPC!%(I50(!(JJQ9)F'-!8<9Y*A"F
M81*;]_B=EB$'^]8D98/I63+8BDVKNYV=:V2#7>&@EPY^4O)_=KD(,:#%8KLU
M+3UNFZRS-$VTIS+7=7 G93#,?/LG<YWV=DT6C[FW_URKI43P:U+I0^JZN6'0
M4;,[G1_*ZDX\EY6N)_2U"4WO[\-SSG*,8Q@$D<Z;Q0@2QC&D) PRE.%4Y);9
M;"/0>+:-=]?WES=?KC^"Z\N[+S=??OEFWQ_4G6A3]W F^NS,:P\*B Z5+IC4
M1^D_[S>**2M0]>BZ- A/[49'$S5#&U)WC+.W)QU-Y[&VI>,'M;.*7"P77\K[
MBF@IWUZ?:+GZM"(/BR",F;Z>A'D6"(A0'$&<D@2&@:0(!4F6!,3$SIT8W[/E
M^E*"3B1H90(MU,Q\G6)DV"!-H*>=B;%4T=A@G%'DB FH!?O/A_+[/]63;1T.
M]<.V!,>I\6:9KF>4Z2?@N8^Y.AKWXDG-5%*]?EQ**2JAL/Y6Z.H*NE1.J>M
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M<RM3O5OF"&*J?@HR&B&:)UQP\\5L)!C?:U@?@O)/\!/?!*&H;;1NJ]84>6F
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M5JN^V"=)$I$@C"#-.88H2Y1U#7D(4Q32B&2(9Q&S*XNZ.[QG\]B5!&TDNM9
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M$]D^8WT';=_Y4>:S?<8:[=D^\Z?<0XJ.%7=89(P2)%(,DUB9/L2)@)C'#+)
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MF&=A "5/=)M;$?$D<3K^- 0PZU%HNP?; =6<7;6_O>Q,RN?1/<%,J;<\)/5
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MXI#$"20H$1#%DL$\8P%,E;&-.,E0PLP;5UH(]CSQE6SPH(2#L@"U$M\4 .P
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MSXVJIMN)]1[IU4/0BZOL0>Q>Q#DV'#/BU-0/F9HI.ULT 4E.D5SF.L\0OV4
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M!Y#+"$.4H!CF 6901FF442XHSHP,EIDXWR=:'0"P"7@&W]9JU]?\KH$#MGC
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MIGA^6?<M G@F,DX3R!C-(4(409JG$:2<I+&(HL PAV44"M\+DX8%J@TN4'?
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MFY2DHJ E1CRWRBX:J$?PE[A=N,Q>+=UJY?KN^F%L^Y('1\[1LSH"VAE@6Y4
MJ3<5(Q=W@&RU&I,\!L$2G&7\M)N8C@9!^)JWA@WG2W"_DX=GX[W>"G:_J/[]
M+.K?:EW3[R.I5OJ/XK.*CYZ;QL4?EH^D4AXW084D90++%.GKRK& 99(QR&D6
M):@H!";"C=X\M A,;EN-P'JK$GC6Y3ZJ!9!**_!=JP4>=WJ!;]QHYMPVV&<.
M;.DO,+)NY!<$5 _R&P!*<.KST6UBXAL WVO:&S+8H/RXMH#_-G6]S0IC&1$)
M*0I81D)WEN,,ZNLXL."ES/.DB%%NU8K82EI@$FOVBW?%IP?DS!U!BU 6$T93
M&)=1 3%ERM.-\A126>"(8L8+%'ED%XZ EGNVX:U^I,TN9&UGC9#8V5+X2(BX
M4?65'PR^&8K]YDV3L7A$A[?(8.R'XTA&XXF'O J]-KOC[4'SC6C+W]6=:SZS
M554KE]1T?SH0IDG""8LRHB_:Z-+_G, B3W(8,Q1%183R5.:N1P[#U9KF!&*G
MF%-QTL&86YPV3 2A9SW8-AEFD]VRT^ZL>^D/M JVC=^V ?/L=, <!':GTK!3
MPN];(3;X-+A6CAT+M!,%9 >+F;*.[%B8O"@G.]JPWDVBGWFEO@SUC7A\7HA5
M\U(E9<+2.*%J(=&7-1G-84%R"O.(RXPB1#%VO,QR2,P4?J9SF^9#<-AZD$.-
M=./O5MK_T:<[.WFCMDSNL2=\.^1#PJ=N==P#P($VQGV?'BE+L!.D7RZ>GM>W
M8L%UWJ(4JTVU5<F0P"R%><$%Q"H^A,K_2V%:)H@C@5):V-^-\5(A=+:@T@F:
M!L8KDZVU-O+!4BLP,-OM-+H6/E]PS-QHPL!U*,NMHQ,P2IV!1BU@]/*YPN.'
MZ< LPE&Q]<\D],$X8"*A-2K.R82G1W[;A$)KRT\F%=J/Y,;N7%3SB\6Z6O^<
M<:Z$U>?JQZO5[?+/Q9RD18%TL<8HB1.(12PAD06"J,S*"$DD"V;59*E'1F!^
M;J2"5NP9T((5+$"+MN.2/GSZ"7@DJ]T8ULM@ZS?<PJ0#OE@MV/^]6W[_JWK:
M>&'Z!_-^FW>[;\Q)7EX+HS9OI\U'/9RKWY</BN-5B*7;=C2W/4ZO5)%@95X0
M"6F.E6\EB8"42@Y)5'!,8HECAWO'/AJ$/HW=JN3M5GGA:N%5A4;+\81UJXU)
M+FUOBP7PJ+S@='"H0L/JYT]YP3N2,S4$D5Y?RFO@Z5RI(7;O>5*#!O+=QOJB
M+&S.9:Z7JZ8]DSFLV?U^E^LS1V6<EC$C,$DCG=-+N"+T5.]!4!'EZH]<E&YG
MSR[B W/X>^\$02<,;??$0B'CQM>Z1-3FD/6IT<-<=C>GKXO.'RW2*STVTGQ
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M;.R]6W,;29(N^#Z_HK;W=;TK[I>QF7-,HJ1JGJ,2=23U])E]@<7%0\(V"'
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M8D<I#AU(;LA^?]%_9T+\:50\@+0RU["'040G(:484F**-JT]0\G;$PY3./#
M(-A)FN, PKOI\O0X3X2S+C*L50U-+<9<:Y:10ULW.,-M,"Z+_1)V;DTW3'7
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M=WH;!2";7([WB_E7&O3TFK>),9'D(C+XVAM;I2#(JM,B]L%ER01:(?N[-WJ
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M'43I(Z G3D)DD?G^PM^'J!SZ9/BP0-M7+:, 6&W8@>2<WEPZ'\//YI7]I)"
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M,@IP':]6YYB/PMF4?,.+&K8AE<*C1Y"Y]MM6)8"KYKZ0BQH<"HIX^GO1MH7
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M$71 !#R6*/0<=8P"2IN.L<VQ=5-Q99.BCM<L7?=RU+XX[BIKM9>CUI'\5LT
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M/V.%V)A>)Q\M2$C-(]9WB^75%Z2919BO/BS6N'JS#'_DQ1_S.PD63A3)16;
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M791&S>@P6Z]J;0$Y['26H?A8K)2ZY(23PNHT[(GC8*<31#L(<NR;^^2W$\(
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MQ<@\<*UBHBM=D$\\F!/YX!;;0>^5O"+T*:ZQ==<VQZ".4-\]_6Z>?-\NYLV
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MPM7VFB@*3:H3DKU3S1AU#H&G6*M .-GBPF+&P:#Y\]Y>#O"Z8.$>] X0S"2
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MX2!2Q@XP]HO,IU][CBOG29@%7^AOKNAN6LP;YFVR#)0RWF'-PZ*[!I2T#*)
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MZ$4AI&=AP<M00'*7HR+_#KWIA)!NZRW=1'MDL$S Y";<VMOA9W7-@O-6<)N
M<:Z(0<Q!C$6!2)E[SD7(?+Z$WWN;:^0"<=[@Z1@!M8:P_2$4M&G#B -2.6*(
MC!I\?<(,LG 9O9(J+H*Q-@*FHP3^%'P&<+\) )'W1IIW=?'QH8-WZ(\EHHQ1
M&S">W'T5=":]GA$<>7XE*T.:?;XRO X;;@AD0V#Q_3SHD674!/!>A4O\N-ZL
MJA=Q+\#<G4RK+;D3WH(6WM2F;(QHT11*I.B#%-KH)Y/6QD[V?'*SC12TSWSQ
M.*( 6T?D_AC+9!5#\CUML!H4\YH"%R(NNL",5$G8^ST2EL%D&[9V5(#T@=\
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MJ*P3A$R:,GJ-*HODF.PXKN"YI19T>B<%R[@\7AHQKUZ\>_W'BZ>HB=8+8Y(
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M/#HOG<ER-B_BQR^DZP.P*0KI^HA[::?@ ^T]?<+K:ACRYJW29#Z2\!0*:Q/
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M+*__PG15VU6]*854_*%F-]0Z@10C".<**.6)C&P%.,],"84[[\< U1-;: A
M8XI\/3[_E_:7?EYO/N/F*6JR3:2O10*+=7J.-!:BB@RL<,$J:X)2W>Z9GUUJ
M&5]I+M1,P.ZEP?.:G+[UUYO&$#99(SGSD!B/9/7IIQ J)5I(:1W6-]E.2+G[
MW66N>&:%Q1&,7-@.O:N.W[61-O5^,@;02B,H4RSX*!20^DN*61]*?JI\M:O5
MN5EPZ8S[Y;SD83QO 2@W68 V<.\]<)WK6ZM#"%RIVGW )QE1<^'&@LK2#LE
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M.W._=?K_Y+M/AIUC\MW["'+IZ*A>.NQHVI+;=4C5]C;FDA04&\F'5RI#1)^
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MSDJ)W*U Y(E%%NQ=,@T:CF=E$U[+;QCH6]_4Y8$Y*)EWH@#CN=:,%E*7S&7
M7+QV/A=[OWAM0D?EX3TNV")E1$2-*HFEE<Q;.A&_A)KMLGH;-K^])G&\_>60
M."6E+3$8"2S4$KL8#7AD#K35V>>HC=3=>N4\M<J"W53&5C.C,7-I5+Q:7_R)
MF\L518T[5?G'^O(&W;7M"$]8$^E8?85)&8+6#!C95AMLU%ET:Y;UQ")+OY1-
MZIZ.Q=RE0;(SJM<V=<^FBX_[;C.'!"G2?3))&PGNLO(("?/%6LBUBU3D4FOL
M5E#]_%H+^JZC"?0[EV4\[BX-EC>O7K_XXZ *E;'%!DR0O$GUP' ((F>REQR#
MD(89WJVGYNVO+NBN3@* P1Q;6M3_B:N/GRZWMYARFQ\4;3F],X/)4@3F;(#:
MT02T2ME((YU(W?)0GUQF04]S$C",Q],F0IB?<+/ZD\3QYPT)6BK:I94@8ZH]
MY&."F$FA!5H_8$R%>747%E.^5=W?WM*)!E/Y(V-)9&F5<QW?'QK1Z\RD= J$
MT 54$AZB=Q)XX5$9ALA]MZCE]E>7OC ]4C[?7X8,8-;24GZ3,%S@M0[<$N??
M[(HU#M<XF*PN1(@5A2RD)(_(%9VA&!-L2D(8'KOY%$^LLG1<,B(*1F/FTJBX
MY2C_OKI8?;[Z_ XOKS87OUYD_'RQ*JNT$]"!858IZSDB,*=K%A.S$"FB!^-"
MH/_*D7?L"MMOW:4MR-CZ8QJ&-X2EFZ#K6Q&8B]*4VLO%%V=!:<<@>)^!1]*A
MR&TJIIOK^N0RB_=@F@0I1[)S:6#LVN\\Y'P=Z@.)'ZQ.4"BE-FQ,)H,/BES+
M(@IJAE[F;D6^SRRT-#@FO1@;D\E+ ^8F#3B<O\A_$D7?@C5=8K6NP%.=N$%>
M%KA$44BVCJ&)(LJ4NMZ?/KS$@E=AHXIP/3H_ET;%N_77<'[Y]56-X7=V\H8*
M:T5T: 58@W70=F&UE1Q"UMXK&S X['8E]N@2"]Z/38:*<?C9QI5(KX2^WVZJ
M!T+QV@OE 3DG]PI1@S.)N&A0"6=1VOMUW<TD^?[68O'M/,F4<TB["5C_L;Y(
M5YLJAH?./P4'P0<; QA>AQ$$(\#KG(!S)UB6G$)--AMZG][KXC= <T#F.Z".
M*+]&.B"\>H(<X;E3.5M(/JO:7\Z"1T&QJJ+-1$8DB?GJLI_8Z&DIS+&P.);D
M&@'B@W1XO\LP\11K4]RDK*EFQ1A(3KM2@G1>SY=N/AAZ,]5<S@>]HV5U.@61
M#UW:C%S[^-02$Y4Y=J9J_HI&M-QF'SB%*J2P%"\10BD.&$;CHBQ%Q66:Z;17
MT:A#5@PE!Q-K5!=DAAAT!)%<<'2,<UFH^/-'JVCL@\EQ*AK[B+:)R.9^\NAU
M;9.GL)!Y#2*: *JP""YY\D7(3$1I363WWYXG!.A#.VP)@9- XSLP'BVG)M&V
MOVOW$E,)FJ(N*^K09E[/J2\0T7'&.-/"E\7PUD9!XO'R?Q92 X2Q]$WT0_[0
M(5&=3INFD D,V_4C"1Z\\&0%DDXY.A^2[U%D]N :K6%BB "?>^@<P,T607$O
MY]B7H#RK92V,$3E6B-H-.H'+)ALA"W.I6^O9IC.ZQY)GSX3N/LQ=OC';0P2]
MQXO5>O,>$QGX_,?ZXGXR[$T>;- JUBY"B:F:=59;"0E7T]>=-HE.H1RN8KKM
M8<'GL+G0-8$P&M90+_?DA"@-]S69A%<6>B\A1G(9C2\N!IM93MTJYY]?JS$-
M-86\.VJP(<QO&$NO#I6 )AKT/ &=RWI5R#0$(I!8E94NF;P"W2VMY_FU&M-'
M"V)I"/.;P!*_7UK.$^<R6X2$01(%9,]#M@F2R=Q:XHTL/7)-[W]^Z4>@29SH
MHWC81*2^;T9_>WC?==\;X9QQ6A,G+"E(I;.JB4J.0E BKV!DRL[7X.JQ72X-
MJOGOAT:15[/(.^1DQD*1!3I(F1,M*F=PH21@B8Y7<<0I,5^6T./[7/I>8!PL
M=(+8 ,$L;>1>7VW67S!<O")>;L+YRW#QS]JVN9)S,-E21ZW)Z4NI)OSR2.Z
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M4*A)!T@8#:X.K_:AH!#S.<"]M[_T3<'\<=JT$CX]$!\RVS"B,H6!LU'6&^
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M:2OM>WB,J?V "=%SE+BG1LWO>4NV0LPY;7XAL5X+4O^ZPN5F%ZD^<ZA+<KZ
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M3Z/J;A:VT5TG]!=<K/^)YQ?7V85>7^1/JX.$\F*SR>0L\Q@P\63).*SRX+X
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MN:.H9N&(/]"50OO:9)<)R(K\/R4\ ==C 4''F_/&"^;L:*;O$7UDAD'/<!9
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M -_A?9+18''<2' NU_1MGLFP)1-7:*V%52G8$=.0A^FF/AN^DCZ\U&$U_/Q
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M5HM4^Q<X 4Y[#26:XB+C!FU;LE+;>%,3C/1_R T@YUD<=8?SW\8L39%2TYY
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MPOR83TD>W.C44;$18-B7F*:N2+V/16\6Z?PBSQ>?S_)_7ZPW6P=TEDIEC([
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M9RQH%K,WFC,92B>X-%>\,I LNQ:S',+8)NSIQTHGE*S3046"7#R"<C*"EZE
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M^B'""O_K/_X?4$L! A0#%     @ !(AX6B.-IH!.!0  3RL  !X
M     ( !     &$T86)I=F%X9GDR-%]C;VYS96YT9F]R9C-V+FAT;5!+ 0(4
M Q0    (  2(>%H'26#KT$H  "9? @ >              "  8H%  !A8FEV
M87@M,C!X9GAE>#$Q8GEL87=S-F9E8BYH=&U02P$"% ,4    "  $B'A:-G&2
M&5Z   "=;@, '@              @ &64   86)I=F%X+3(P>&9X97@R,61E
M<V-R:7!T:6\N:'1M4$L! A0#%     @ !(AX6G5IDO,""0  M$(  !X
M         ( !,-$  &%B:79A>"TR,'AF>&5X-#$V<W5M;6%R>6]F+FAT;5!+
M 0(4 Q0    (  2(>%H; U=,+P@  "<G   >              "  6[:  !A
M8FEV87@M,C!X9GAE>#0Q-W-U;6UA<GEO9BYH=&U02P$"% ,4    "  $B'A:
M\F$-<"<+  #BD@  '@              @ '9X@  86)I=F%X+3(P>&9X97@T
M,3AS=6UM87)Y;V8N:'1M4$L! A0#%     @ !(AX6EW7K 98&P  X[L  !X
M             ( !/.X  &%B:79A>"TR,'AF>&5X.3<Q:6YC96YT:79E+FAT
M;5!+ 0(4 Q0    (  2(>%J^PAX'AP<  )TL   >              "  = )
M 0!A8FEV87@M,C!X9GAE>&AI8FET,3(Q8V5O,RYH=&U02P$"% ,4    "  $
MB'A:VLF2SW\'  "G)0  '@              @ &3$0$ 86)I=F%X+3(P>&9X
M97AH:6)I=#$R,F-F;S,N:'1M4$L! A0#%     @ !(AX6@XQ!X""!   [A
M !X              ( !3AD! &%B:79A>"TR,'AF>&5X:&EB:70Q,S%C96\S
M+FAT;5!+ 0(4 Q0    (  2(>%K@6<W:E 0  "\1   >              "
M 0P> 0!A8FEV87@M,C!X9GAE>&AI8FET,3,R8V9O,RYH=&U02P$"% ,4
M"  $B'A:."KX8$T^  "+(0( '@              @ '<(@$ 86)I=F%X+6-O
M9&5O9FUA<FME=&-O;F1U8W0N:'1M4$L! A0#%     @ !(AX6N6^SIV _0H
MY"RX !$              ( !96$! &%B=G@M,C R-#$R,S$N:'1M4$L! A0#
M%     @ !(AX6J(S^#6].0  6 ,# !$              ( !%%\, &%B=G@M
M,C R-#$R,S$N>'-D4$L! A0#%     @ !(AX6JRU&D;E,@  L/H! !4
M         ( ! )D, &%B=G@M,C R-#$R,S%?8V%L+GAM;%!+ 0(4 Q0    (
M  2(>%K<Y,<S;$P! "0\#P 5              "  1C,# !A8G9X+3(P,C0Q
M,C,Q7V1E9BYX;6Q02P$"% ,4    "  $B'A:>PEQ<F=Q 0#;TP$ %
M        @ &W& X 86)V>"TR,#(T,3(S,5]G,2YJ<&=02P$"% ,4    "  $
MB'A:5&4^(-I"  !@3@  %0              @ %0B@\ 86)V>"TR,#(T,3(S
M,5]G,3 N:G!G4$L! A0#%     @ !(AX6M/VSDIM(P  7"X  !4
M     ( !7<T/ &%B=G@M,C R-#$R,S%?9S$Q+FIP9U!+ 0(4 Q0    (  2(
M>%J?M5UXFV$  %MU   5              "  ?WP#P!A8G9X+3(P,C0Q,C,Q
M7V<Q,BYJ<&=02P$"% ,4    "  $B'A:AZRB.U9_   9C@  %0
M    @ '+4A  86)V>"TR,#(T,3(S,5]G,3,N:G!G4$L! A0#%     @ !(AX
M6LN546:CE   ,M   !4              ( !5-(0 &%B=G@M,C R-#$R,S%?
M9S$T+FIP9U!+ 0(4 Q0    (  2(>%H;#-II93T! />U 0 5
M  "  2IG$0!A8G9X+3(P,C0Q,C,Q7V<Q-2YJ<&=02P$"% ,4    "  $B'A:
MY<BO8(%K  !%?   %0              @ '"I!( 86)V>"TR,#(T,3(S,5]G
M,38N:G!G4$L! A0#%     @ !(AX6A[6ODH;8@  /G4  !4
M ( !=A 3 &%B=G@M,C R-#$R,S%?9S$W+FIP9U!+ 0(4 Q0    (  2(>%H2
MIQC"(D4  -Q4   5              "  <1R$P!A8G9X+3(P,C0Q,C,Q7V<Q
M."YJ<&=02P$"% ,4    "  $B'A:I;US5@YJ  "]?   %0
M@ $9N!, 86)V>"TR,#(T,3(S,5]G,3DN:G!G4$L! A0#%     @ !(AX6G?!
MP!]T\   H&X! !0              ( !6B(4 &%B=G@M,C R-#$R,S%?9S(N
M:G!G4$L! A0#%     @ !(AX6ILX:O^48P$ ^N4! !4              ( !
M !,5 &%B=G@M,C R-#$R,S%?9S(P+FIP9U!+ 0(4 Q0    (  2(>%I^MKV]
MO$L! &[D 0 5              "  <=V%@!A8G9X+3(P,C0Q,C,Q7V<R,2YJ
M<&=02P$"% ,4    "  $B'A:WO:Z!(3O 0#=@@( %0              @ &V
MPA< 86)V>"TR,#(T,3(S,5]G,C(N:G!G4$L! A0#%     @ !(AX6GDIP\8K
MA $ ?D0" !4              ( !;;(9 &%B=G@M,C R-#$R,S%?9S(S+FIP
M9U!+ 0(4 Q0    (  2(>%K7Q1'N RT  ,)1   5              "  <LV
M&P!A8G9X+3(P,C0Q,C,Q7V<R-"YJ<&=02P$"% ,4    "  $B'A:ZJP0F,5H
M  !)>P  %               @ $!9!L 86)V>"TR,#(T,3(S,5]G,RYJ<&=0
M2P$"% ,4    "  $B'A:-3]4-7M,  #&5P  %               @ 'XS!L
M86)V>"TR,#(T,3(S,5]G-"YJ<&=02P$"% ,4    "  $B'A:\NSW*8*2  "2
MI@  %               @ &E&1P 86)V>"TR,#(T,3(S,5]G-2YJ<&=02P$"
M% ,4    "  $B'A:O!3B>92!  !)D   %               @ %9K!P 86)V
M>"TR,#(T,3(S,5]G-BYJ<&=02P$"% ,4    "  $B'A:8F@3^O%T   ]@@
M%               @ $?+AT 86)V>"TR,#(T,3(S,5]G-RYJ<&=02P$"% ,4
M    "  $B'A:QX3;R5=,  !=7@  %               @ %"HQT 86)V>"TR
M,#(T,3(S,5]G."YJ<&=02P$"% ,4    "  $B'A:C(]C>D9,   180  %
M            @ '+[QT 86)V>"TR,#(T,3(S,5]G.2YJ<&=02P$"% ,4
M"  $B'A:QUH6N>S_ 0!Z%A0 %0              @ %#/!X 86)V>"TR,#(T
M,3(S,5]L86(N>&UL4$L! A0#%     @ !(AX6NO_[0J1H@$ N$D3 !4
M         ( !8CP@ &%B=G@M,C R-#$R,S%?<')E+GAM;%!+!08     *@ J
+ %D+   FWR$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>abvx-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:abvx="http://www.abivax.com/20241231"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:currency="http://xbrl.sec.gov/currency/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="abvx-20241231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">abvx:AmericanDepositorySharesNASDAQGlobalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">abvx:OrdinarySharesNASDAQGlobalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:FinancialEffectOfChangesInAccountingPolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:FinancialEffectOfChangesInAccountingPolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2013-12-04</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:SaleOfStockAxis">abvx:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:SaleOfStockAxis">abvx:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-12-04</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorRevenueTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">abvx:ProsynergiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-12</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-25</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abvx:ProsynergiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-01</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAgreementWithUniversityHospitalCenterOfNiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAgreementWithUniversityHospitalCenterOfNiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAgreementWithUniversityHospitalCenterOfNiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-02</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2022-10-11</startDate>
            <endDate>2022-10-11</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A130.0MillionCrossOverFinancingFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-22</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A130.0MillionCrossOverFinancingFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-22</startDate>
            <endDate>2023-02-22</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A49.2MillionCrossOverFinancingSeptember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-22</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A130.0MillionCrossOverFinancingFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-22</startDate>
            <endDate>2023-02-22</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A150.0MillionFinancingAugust2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:A150.0MillionFinancingAugust2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-22</startDate>
            <endDate>2023-08-22</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingAndHeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2023-10-24</startDate>
            <endDate>2023-10-24</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">abvx:AmericanDepositorySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-24</startDate>
            <endDate>2023-10-24</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-24</startDate>
            <endDate>2023-10-24</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">abvx:AmericanDepositorySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-24</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-24</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-11</startDate>
            <endDate>2024-07-11</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-12-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIAndCARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2024-11-19</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:SaleOfStockAxis">abvx:AtTheMarketATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-19</startDate>
            <endDate>2024-11-19</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20251Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">abvx:MajorShareBasedTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20252Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:IndustrialMaterialsAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:IndustrialMaterialsAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:TechnicalFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:TechnicalFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:AssetsAcquisitionsAxis">abvx:ProsynergiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:SplicosSASABX464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:SplicosSASABX464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:SplicosSASABX464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">abvx:WittycelSASABX196Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">abvx:FurnitureAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2024-01-22</startDate>
            <endDate>2024-02-23</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">abvx:DeferredFinancingCostsNettingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:OtherReceivablesAndAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:TradePayablesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">abvx:NonCurrentAdvancesToCROContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-22</startDate>
            <endDate>2023-08-22</endDate>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretFinancingTrancheABAndCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:ConditionalAdvancesAndPGELoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:ConditionalAdvancesAndPGELoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:ConditionalAdvancesAndPGELoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-24</startDate>
            <endDate>2021-09-24</endDate>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-01</endDate>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:EquityLineAgreementWithKeplerCheuvreuxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2022-09-07</startDate>
            <endDate>2022-09-07</endDate>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2022-09-07</instant>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2023-02-22</startDate>
            <endDate>2023-02-22</endDate>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2023-02-22</instant>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2023-10-24</instant>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241AndBSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241AndBSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:FinancialAgreementAxis">abvx:OtherEquityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-07</startDate>
            <endDate>2016-11-07</endDate>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20161Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-23</startDate>
            <endDate>2017-01-23</endDate>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-20</startDate>
            <endDate>2017-11-20</endDate>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20172Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-20</startDate>
            <endDate>2017-11-20</endDate>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20174Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-20</startDate>
            <endDate>2017-11-20</endDate>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20175Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-15</startDate>
            <endDate>2018-03-15</endDate>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-14</startDate>
            <endDate>2018-05-14</endDate>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20183Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-14</startDate>
            <endDate>2018-05-14</endDate>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20184Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-14</startDate>
            <endDate>2018-05-14</endDate>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCE20185Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-11</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BCEExceptBCE20142Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-04</startDate>
            <endDate>2015-12-04</endDate>
        </period>
    </context>
    <context id="c-500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201511Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-04</startDate>
            <endDate>2015-12-04</endDate>
        </period>
    </context>
    <context id="c-504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA201512Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-18</startDate>
            <endDate>2017-09-18</endDate>
        </period>
    </context>
    <context id="c-508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20171Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-22</startDate>
            <endDate>2018-01-22</endDate>
        </period>
    </context>
    <context id="c-512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-11</startDate>
            <endDate>2014-03-11</endDate>
        </period>
    </context>
    <context id="c-516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20144Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-11</startDate>
            <endDate>2014-03-11</endDate>
        </period>
    </context>
    <context id="c-520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20145Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-04</startDate>
            <endDate>2024-04-04</endDate>
        </period>
    </context>
    <context id="c-524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-04</startDate>
            <endDate>2024-04-04</endDate>
        </period>
    </context>
    <context id="c-528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-11</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-04</startDate>
            <endDate>2024-04-04</endDate>
        </period>
    </context>
    <context id="c-539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-04</startDate>
            <endDate>2024-04-04</endDate>
        </period>
    </context>
    <context id="c-540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-04</startDate>
            <endDate>2024-04-04</endDate>
        </period>
    </context>
    <context id="c-541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:BSA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-04</startDate>
            <endDate>2024-04-04</endDate>
        </period>
    </context>
    <context id="c-542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-28</startDate>
            <endDate>2023-09-28</endDate>
        </period>
    </context>
    <context id="c-551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-28</startDate>
            <endDate>2023-09-28</endDate>
        </period>
    </context>
    <context id="c-555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20234Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="c-559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-02</startDate>
            <endDate>2024-01-02</endDate>
        </period>
    </context>
    <context id="c-563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20242Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20243Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-05-23</endDate>
        </period>
    </context>
    <context id="c-569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20243Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20243Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-11</startDate>
            <endDate>2024-07-11</endDate>
        </period>
    </context>
    <context id="c-572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20245Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-11</startDate>
            <endDate>2024-07-11</endDate>
        </period>
    </context>
    <context id="c-575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20245Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20245Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20247Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="c-580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20247Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20247Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-584">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TranchesOneToFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:VestingServiceConditionsAxis">abvx:VestingConditionsCompletedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:VestingServiceConditionsAxis">abvx:VestingConditionsNotCompletedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AndAGA20234Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-28</startDate>
            <endDate>2023-09-28</endDate>
        </period>
    </context>
    <context id="c-606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-28</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="c-607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-28</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="c-608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-28</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="c-609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20233AGA20234AndAGA20235Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-28</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="c-610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20244AGA20245AndAGA20246Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-11</startDate>
            <endDate>2024-07-11</endDate>
        </period>
    </context>
    <context id="c-611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="c-612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="c-613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="c-614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-02</startDate>
            <endDate>2024-01-02</endDate>
        </period>
    </context>
    <context id="c-615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-02</startDate>
            <endDate>2024-01-02</endDate>
        </period>
    </context>
    <context id="c-616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20246Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-02</startDate>
            <endDate>2024-01-02</endDate>
        </period>
    </context>
    <context id="c-617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FoundersShareSubscriptionWarrantsBCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:FreeSharesAGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:ShareSubscriptionWarrantsBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20231Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">abvx:AGA20232Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="c-628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BorrowingsByNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BorrowingsByNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BorrowingsByNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConvertibleLoansNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConvertibleLoansNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConvertibleLoansNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-664">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="c-679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-22</startDate>
            <endDate>2023-08-22</endDate>
        </period>
    </context>
    <context id="c-688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MinimalReturnMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferProbabilityWeightedPresentValueOfShortfallPaymentMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionProbabilityWeightedFairValueWithoutMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:TenderOfferFairValueOfMRIMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:AmortizedCostEIRMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:TranchesAxis">abvx:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-732">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-737">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-738">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-739">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-740">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-745">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="c-747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-748">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="c-752">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-753">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-754">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-755">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="c-758">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="c-759">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="c-760">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="c-761">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="c-762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-764">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-766">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-768">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-769">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:FinalRedemptionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-771">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-772">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-775">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-777">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-778">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-779">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-780">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-784">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-788">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-790">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-792">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-793">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-798">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-800">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:DrawdownProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:DrawdownProbablityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-814">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VolatilityForSharesMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputExpiryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputTenderOfferMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-832">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-835">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="c-838">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="c-839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="c-840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="c-841">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="c-842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="c-843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-845">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-846">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-853">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-854">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-855">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABCBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpiryScenarioProbablityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-861">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-863">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-865">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-20</instant>
        </period>
    </context>
    <context id="c-866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-867">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-873">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ConversionPricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ConversionPricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ConversionPricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-878">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-879">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-880">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:InitialPriceLimitMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-884">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:InitialPriceLimitMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:InitialPriceLimitMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-886">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:EarlyRedemptionAmountMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-887">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:EarlyRedemptionAmountMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-888">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:EarlyRedemptionAmountMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-890">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-891">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-892">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-893">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-895">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-897">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-898">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-899">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-900">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-907">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:VoluntaryConversionScenarioProbabilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-20</startDate>
            <endDate>2023-08-20</endDate>
        </period>
    </context>
    <context id="c-917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1NonConvertibleBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-24</startDate>
            <endDate>2018-07-24</endDate>
        </period>
    </context>
    <context id="c-928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-24</startDate>
            <endDate>2018-07-24</endDate>
        </period>
    </context>
    <context id="c-929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-932">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-24</instant>
        </period>
    </context>
    <context id="c-933">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-24</startDate>
            <endDate>2018-07-24</endDate>
        </period>
    </context>
    <context id="c-934">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos1ConvertibleBondLoansTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-21</startDate>
            <endDate>2023-08-21</endDate>
        </period>
    </context>
    <context id="c-935">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-936">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-938">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-939">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-940">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-941">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-942">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-943">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-944">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-946">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-947">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-948">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-950">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExercisePricePerShareMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-951">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-952">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-954">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-955">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-956">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-957">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:WarrantsAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-958">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-959">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-960">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-962">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-963">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-964">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-966">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-967">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-969">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-970">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-971">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-13</instant>
        </period>
    </context>
    <context id="c-972">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2TrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-13</instant>
        </period>
    </context>
    <context id="c-973">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2TrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-13</instant>
        </period>
    </context>
    <context id="c-974">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuriborMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-13</instant>
        </period>
    </context>
    <context id="c-975">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2020-10-13</instant>
        </period>
    </context>
    <context id="c-976">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:Kreos2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-977">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-30</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="c-978">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After18MonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-980">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After24MonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-981">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After36MonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-982">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After18MonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-983">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After24MonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abvx:RemeasurementPeriodAxis">abvx:After36MonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-985">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-986">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-987">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="c-988">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-989">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-990">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-991">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:CreditSpreadMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-992">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-993">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-994">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-995">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-996">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-997">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">abvx:MonteCarloModelIFRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="c-999">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-1003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-1004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="c-1005">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1006">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c-1007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c-1008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c-1009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c-1010">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-1011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1017">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-16</instant>
        </period>
    </context>
    <context id="c-1021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-16</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="c-1023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="c-1024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="c-1025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-1026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-16</instant>
        </period>
    </context>
    <context id="c-1027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-12-16</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-12-01</startDate>
            <endDate>2013-12-31</endDate>
        </period>
    </context>
    <context id="c-1029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-09-01</startDate>
            <endDate>2014-09-30</endDate>
        </period>
    </context>
    <context id="c-1030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="c-1031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-1032">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-1033">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-1034">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-1035">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="c-1036">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-1037">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesParisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-02</startDate>
            <endDate>2024-05-02</endDate>
        </period>
    </context>
    <context id="c-1038">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesBostonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c-1039">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesBostonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c-1040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesBostonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c-1041">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMontpellierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-1042">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1043">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1044">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1045">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1047">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketCapitalizationMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1048">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:MarketCapitalizationMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1049">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1050">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1051">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1052">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ResidualMaturityMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1053">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1055">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1056">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ExpectedDividendMeasurementInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">ifrs-full:OptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1057">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1058">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1059">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1060">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-1061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-1062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-1063">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-1064">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1065">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:RiskFreeInterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1066">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1067">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-02</instant>
        </period>
    </context>
    <context id="c-1068">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="c-1069">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="c-1070">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <instant>2022-09-02</instant>
        </period>
    </context>
    <context id="c-1071">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1072">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1074">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1075">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1076">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1077">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1078">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1081">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1082">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1083">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1084">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1085">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1086">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1087">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1088">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1089">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1090">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1091">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1092">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:ProbabilityOfSuccessMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:PeakPenetrationMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1094">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1095">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">abvx:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1096">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1097">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1098">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1099">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:Kreos1ClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:ConditionalAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:EarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">abvx:RoyaltyCertificatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:OCEANEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingTrancheABMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretMinimumReturnIndemnificationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosBBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosABBSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-1196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:Kreos12BondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:OceaneConversionOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:BanquePubliqueDInvestissementBPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:HeightsConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretFinancingTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:KreosClaretBondLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:PretGarantiParLEtatPGEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:OtherEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2021TaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2022TaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2023TaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:CIRTaxYearAxis">abvx:A2021TaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:SalesAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:SalesAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:SalesAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">abvx:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:RetirementBenefitObligationsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:RetirementBenefitObligationsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:RetirementBenefitObligationsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:LeasesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:LeasesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:LeasesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:OtherFinancialLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:SubsidiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:SubsidiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">abvx:SubsidiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">abvx:AbivaxLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">abvx:AbivaxLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">abvx:AdvisorToTheChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-18</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-12-04</instant>
        </period>
    </context>
    <context id="c-1327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ResearchAndCollaborationAgreementWithCNRSUniversityOfMontpellierAndInstitutCurieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-04-15</instant>
        </period>
    </context>
    <context id="c-1328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="abvx:PrincipalAgreementsAxis">abvx:ExclusiveLicensingContractWithTheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-11-11</startDate>
            <endDate>2006-11-11</endDate>
        </period>
    </context>
    <context id="c-1329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvx:TheScrippsResearchInstituteUniversityOfChicagoAndBrighamYoungUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-12-16</startDate>
            <endDate>2013-12-16</endDate>
        </period>
    </context>
    <context id="c-1331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-12-16</startDate>
            <endDate>2013-12-16</endDate>
        </period>
    </context>
    <context id="c-1332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-16</instant>
        </period>
    </context>
    <context id="c-1333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-12-16</startDate>
            <endDate>2013-12-16</endDate>
        </period>
    </context>
    <context id="c-1334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:CARENAConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-16</startDate>
            <endDate>2016-12-16</endDate>
        </period>
    </context>
    <context id="c-1336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-16</startDate>
            <endDate>2016-12-16</endDate>
        </period>
    </context>
    <context id="c-1337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-16</instant>
        </period>
    </context>
    <context id="c-1338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:RNPVIRConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-16</startDate>
            <endDate>2016-12-16</endDate>
        </period>
    </context>
    <context id="c-1339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-02</instant>
        </period>
    </context>
    <context id="c-1340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPILanguedocRoussillonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-02</instant>
        </period>
    </context>
    <context id="c-1341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">abvx:EbolaConditionalAdvanceBPIFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-02</instant>
        </period>
    </context>
    <context id="c-1342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">abvx:LeaseFacilitiesMontpellierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-1344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:HeightsConvertibleNotesTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">abvx:KreosClaretFinancingSeniorSecuredNonConvertibleLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">abvx:EuropeanCentralBankBaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-1351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-1353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956827</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="transaction">
        <measure>abvx:transaction</measure>
    </unit>
    <unit id="plan">
        <measure>abvx:plan</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="criteria">
        <measure>abvx:criteria</measure>
    </unit>
    <unit id="segment">
        <measure>abvx:segment</measure>
    </unit>
    <unit id="tranche">
        <measure>abvx:tranche</measure>
    </unit>
    <unit id="scenario">
        <measure>abvx:scenario</measure>
    </unit>
    <unit id="closing">
        <measure>abvx:closing</measure>
    </unit>
    <unit id="installment">
        <measure>abvx:installment</measure>
    </unit>
    <unit id="y">
        <measure>utr:Y</measure>
    </unit>
    <unit id="employee">
        <measure>abvx:employee</measure>
    </unit>
    <unit id="license">
        <measure>abvx:license</measure>
    </unit>
    <unit id="academic_institution">
        <measure>abvx:academic_institution</measure>
    </unit>
    <unit id="project">
        <measure>abvx:project</measure>
    </unit>
    <unit id="financial_institution">
        <measure>abvx:financial_institution</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-39">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-40">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-41">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-42">0001956827</dei:EntityCentralIndexKey>
    <dei:NoTradingSymbolFlag contextRef="c-4" id="f-43">true</dei:NoTradingSymbolFlag>
    <abvx:NumberOfOperatingSegment
      contextRef="c-1"
      decimals="INF"
      id="f-714"
      unitRef="segment">1</abvx:NumberOfOperatingSegment>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-496" id="f-1585">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth
      contextRef="c-497"
      decimals="6"
      id="f-1586"
      unitRef="number">0.020833</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-622" id="f-1587">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth
      contextRef="c-623"
      decimals="6"
      id="f-1588"
      unitRef="number">0.020833</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-596" id="f-1589">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementServicePeriod contextRef="c-597" id="f-1590">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementServicePeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-624" id="f-1591">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-625" id="f-1592">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-626" id="f-1593">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-601" id="f-1594">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-603" id="f-1595">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-627" id="f-1596">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:ConvertibleLoansNotesPeriod contextRef="c-916" id="f-1994">P1Y</abvx:ConvertibleLoansNotesPeriod>
    <abvx:ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate contextRef="c-86" id="f-1995">P5D</abvx:ConvertibleLoansNotesConversionOptionMaximumPeriodPriorToMaturityDate>
    <abvx:ConversionPriceVolumeWeightedAveragePricePeriod contextRef="c-978" id="f-2097">P30D</abvx:ConversionPriceVolumeWeightedAveragePricePeriod>
    <abvx:LeaseExtensionPeriod contextRef="c-1039" id="f-2206">P1Y</abvx:LeaseExtensionPeriod>
    <abvx:OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod contextRef="c-1330" id="f-3291">P5Y</abvx:OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod>
    <abvx:OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod contextRef="c-1335" id="f-3299">P5Y</abvx:OtherFinancialLiabilitiesAnnualRevenueFromSaleOfProductsDevelopedPeriod>
    <abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss contextRef="c-1353" decimals="0" id="f-3331" unitRef="eur">0</abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss>
    <dei:DocumentType contextRef="c-1" id="f-1">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c-1" id="f-2">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-3">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-5">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-6">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c-1" id="f-7">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-8">001-41842</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-9">Abivax SA</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-10">I0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-11">7-11 boulevard Haussmann</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">75009</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-13">Paris</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c-1" id="f-14">FR</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c-2" id="f-15">Marc de Garidel</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-16">7-11 boulevard Haussmann</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-17">75009</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-18">Paris</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c-2" id="f-19">FR</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="c-2" id="f-20">+33</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-2" id="f-21">1 53 83 09 63</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-3" id="f-22">American Depositary Shares, each representing one ordinary share, nominal value &#x20ac;0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-23">ABVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-24">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-4" id="f-25">Ordinary shares, nominal value &#x20ac;0.01 per share</dei:Security12bTitle>
    <dei:SecurityExchangeName contextRef="c-4" id="f-26">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-5" decimals="0" id="f-27" unitRef="shares">63347837</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-28">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-29">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-32">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-33">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-34">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-35">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-36">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="c-1" id="f-37">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c-1" id="f-38">false</dei:EntityShellCompany>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-44">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-45">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;We have implemented and maintain various information security processes designed to identify, assess and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;manage material risks from cybersecurity threats to our critical information systems, third party hosted services, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;communications systems, hardware and software, and our critical data (including intellectual property, confidential &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;information that is proprietary, strategic or competitive in nature, and data related to our clinical trials and products) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(collectively, &#x201c;Information Systems and Data&#x201d;).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our Chief Financial Officer as well as our external Data Protection Officer (&#x201c;DPO&#x201d;) and Information &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Technology Director (&#x201c;IT Director&#x201d;), and other independent service providers help identify, assess and manage the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;our cybersecurity threats and risks. Individuals in these roles identify and assess risks from cybersecurity threats by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;monitoring and evaluating our threat environment using various methods including, for example, maintaining &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;manual and automated tools, conducting scans of our threat environment, and conducting vulnerability assessments.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Depending on the environment, we implement and maintain various technical, physical, and organizational &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;threats to our Information Systems and Data. These measures, processes, standards, and policies include, for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;example: incident response plans and policies, personnel training, phishing test campaigns, penetration testing, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;system backups, cybersecurity insurance, network security controls, segmentation for certain systems and data &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;access controls and physical security controls.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our assessment and management of material risks from cybersecurity threats are integrated into our overall &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risk management processes.&#160; For example, our external DPO and IT Director work with management in an effort to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;impact to our business.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;We use independent service provider&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; to assist us from time to time to identify, assess, and manage material &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 538pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risks from cybersecurity threats, including for example: professional service firms, including legal counsel, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;penetration testing firms, dark web monitoring services, cybersecurity consultants, and cybersecurity software &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;providers.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Further, we use independent service providers to perform a variety of functions throughout our business, such &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as hosting companies and contract research organizations. We undertake efforts designed to manage cybersecurity &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risks associated with our use of these providers.&#160; For certain vendors, these efforts include security questionnaires, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reviews of vendors&#x2019; written security programs, reviews of security assessments, audits, and vulnerability scans &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 620pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;related to the vendors. Depending on the nature of the services provided, the sensitivity of the Information Systems &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 630pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and Data at issue, and the identity of the provider, our vendor management process may involve different levels of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assessment designed to help identify cybersecurity risks associated with a provider and impose contractual &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obligations related to cybersecurity on the provider.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-46">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Depending on the environment, we implement and maintain various technical, physical, and organizational &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;threats to our Information Systems and Data. These measures, processes, standards, and policies include, for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;example: incident response plans and policies, personnel training, phishing test campaigns, penetration testing, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;system backups, cybersecurity insurance, network security controls, segmentation for certain systems and data &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;access controls and physical security controls.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our assessment and management of material risks from cybersecurity threats are integrated into our overall &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risk management processes.&#160; For example, our external DPO and IT Director work with management in an effort to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;impact to our business.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-47">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-48">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-49">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-50">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-52">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our Board addresses our cybersecurity risk management as part of its general oversight function. The Board is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from cybersecurity threats.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Our&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Committee of Executives (&#x201c;COMEX&#x201d;)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, in addition to those identified below, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;provides input to the Board on cybersecurity threats. Our Committee of Executives consists of all our company's &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;officers along with our heads of manufacturing and quality.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-51">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our Board addresses our cybersecurity risk management as part of its general oversight function. The Board is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from cybersecurity threats.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Our&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Committee of Executives (&#x201c;COMEX&#x201d;)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, in addition to those identified below, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;provides input to the Board on cybersecurity threats. Our Committee of Executives consists of all our company's &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;officers along with our heads of manufacturing and quality.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;management team members, including our&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Chief Financial Officer (&#x201c;CFO&#x201d;)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; who oversees our external &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IT Director &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and DPO&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our CFO has prior significant experience in strategic business operations&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our CFO as well as our external IT Director and DPO are responsible for helping to integrate cybersecurity &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risk considerations into our overall risk management strategy, and communicating key priorities to relevant &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;personnel. Our CFO is responsible for approving cybersecurity-related budgets, approving cybersecurity processes, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and reviewing security assessments and other security-related reports.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;members of management depending on circumstances, including our CFO. Our CFO works with our incident &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which they are notified.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; In addition, our incident response process includes reporting to the Board for certain &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;cybersecurity incidents.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Board receives periodic communications from the CFO and others (such as the IT Director and DPO)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;concerning our significant cybersecurity threats, risk and the processes we have implemented in an effort to address &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;them.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-54">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;management team members, including our&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Chief Financial Officer (&#x201c;CFO&#x201d;)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; who oversees our external &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IT Director &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and DPO&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our CFO has prior significant experience in strategic business operations&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our CFO as well as our external IT Director and DPO are responsible for helping to integrate cybersecurity &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risk considerations into our overall risk management strategy, and communicating key priorities to relevant &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;personnel. Our CFO is responsible for approving cybersecurity-related budgets, approving cybersecurity processes, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and reviewing security assessments and other security-related reports.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-53">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;management team members, including our&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Chief Financial Officer (&#x201c;CFO&#x201d;)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; who oversees our external &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IT Director &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 208pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and DPO&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our CFO has prior significant experience in strategic business operations&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our CFO as well as our external IT Director and DPO are responsible for helping to integrate cybersecurity &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risk considerations into our overall risk management strategy, and communicating key priorities to relevant &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;personnel. Our CFO is responsible for approving cybersecurity-related budgets, approving cybersecurity processes, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and reviewing security assessments and other security-related reports.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;members of management depending on circumstances, including our CFO. Our CFO works with our incident &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which they are notified.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; In addition, our incident response process includes reporting to the Board for certain &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;cybersecurity incidents.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-55">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-56">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our CFO has prior significant experience in strategic business operations&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-58">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;members of management depending on circumstances, including our CFO. Our CFO works with our incident &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which they are notified.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; In addition, our incident response process includes reporting to the Board for certain &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;cybersecurity incidents.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-57">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our cybersecurity incident response procedures are designed to escalate certain cybersecurity incidents to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;members of management depending on circumstances, including our CFO. Our CFO works with our incident &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;responders (such as the external IT Director and DPO) to help us mitigate and remediate cybersecurity incidents of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which they are notified.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; In addition, our incident response process includes reporting to the Board for certain &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;cybersecurity incidents.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Board receives periodic communications from the CFO and others (such as the IT Director and DPO)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;concerning our significant cybersecurity threats, risk and the processes we have implemented in an effort to address &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;them.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-59">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-60">1347</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-61">PricewaterhouseCoopers Audit</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-62">Neuilly-sur-Seine, France</dei:AuditorLocation>
    <ifrs-full:Goodwill contextRef="c-6" decimals="-3" id="f-63" unitRef="eur">18419000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c-7" decimals="-3" id="f-64" unitRef="eur">18419000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c-5" decimals="-3" id="f-65" unitRef="eur">18419000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-6" decimals="-3" id="f-66" unitRef="eur">6607000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-7" decimals="-3" id="f-67" unitRef="eur">6604000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-5" decimals="-3" id="f-68" unitRef="eur">6606000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-6" decimals="-3" id="f-69" unitRef="eur">1592000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-7" decimals="-3" id="f-70" unitRef="eur">878000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-5" decimals="-3" id="f-71" unitRef="eur">2666000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c-6" decimals="-3" id="f-72" unitRef="eur">11708000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c-7" decimals="-3" id="f-73" unitRef="eur">12870000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c-5" decimals="-3" id="f-74" unitRef="eur">5919000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="c-6" decimals="-3" id="f-75" unitRef="eur">1037000</ifrs-full:OtherNoncurrentNonfinancialAssets>
    <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="c-7" decimals="-3" id="f-76" unitRef="eur">2320000</ifrs-full:OtherNoncurrentNonfinancialAssets>
    <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="c-5" decimals="-3" id="f-77" unitRef="eur">948000</ifrs-full:OtherNoncurrentNonfinancialAssets>
    <ifrs-full:NoncurrentAssets contextRef="c-6" decimals="-3" id="f-78" unitRef="eur">39363000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c-7" decimals="-3" id="f-79" unitRef="eur">41090000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c-5" decimals="-3" id="f-80" unitRef="eur">34558000</ifrs-full:NoncurrentAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c-6" decimals="-3" id="f-81" unitRef="eur">0</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c-7" decimals="-3" id="f-82" unitRef="eur">9186000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c-5" decimals="-3" id="f-83" unitRef="eur">7554000</ifrs-full:OtherCurrentFinancialAssets>
    <abvx:CurrentReceivablesAndCurrentPrepaidExpenses contextRef="c-6" decimals="-3" id="f-84" unitRef="eur">9231000</abvx:CurrentReceivablesAndCurrentPrepaidExpenses>
    <abvx:CurrentReceivablesAndCurrentPrepaidExpenses contextRef="c-7" decimals="-3" id="f-85" unitRef="eur">24845000</abvx:CurrentReceivablesAndCurrentPrepaidExpenses>
    <abvx:CurrentReceivablesAndCurrentPrepaidExpenses contextRef="c-5" decimals="-3" id="f-86" unitRef="eur">18896000</abvx:CurrentReceivablesAndCurrentPrepaidExpenses>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-87" unitRef="eur">26950000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-7" decimals="-3" id="f-88" unitRef="eur">251942000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-5" decimals="-3" id="f-89" unitRef="eur">144221000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets contextRef="c-6" decimals="-3" id="f-90" unitRef="eur">36181000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c-7" decimals="-3" id="f-91" unitRef="eur">285972000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c-5" decimals="-3" id="f-92" unitRef="eur">170671000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets contextRef="c-6" decimals="-3" id="f-93" unitRef="eur">75544000</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c-7" decimals="-3" id="f-94" unitRef="eur">327062000</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c-5" decimals="-3" id="f-95" unitRef="eur">205228000</ifrs-full:Assets>
    <ifrs-full:IssuedCapital contextRef="c-6" decimals="-3" id="f-96" unitRef="eur">223000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="c-7" decimals="-3" id="f-97" unitRef="eur">629000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="c-5" decimals="-3" id="f-98" unitRef="eur">633000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium contextRef="c-6" decimals="-3" id="f-99" unitRef="eur">150476000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c-7" decimals="-3" id="f-100" unitRef="eur">478218000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c-5" decimals="-3" id="f-101" unitRef="eur">478905000</ifrs-full:SharePremium>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-6" decimals="-3" id="f-102" unitRef="eur">0</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-7" decimals="-3" id="f-103" unitRef="eur">112000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-5" decimals="-3" id="f-104" unitRef="eur">-75000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod contextRef="c-6" decimals="-3" id="f-105" unitRef="eur">-82770000</ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod>
    <ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod contextRef="c-7" decimals="-3" id="f-106" unitRef="eur">-135209000</ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod>
    <ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod contextRef="c-5" decimals="-3" id="f-107" unitRef="eur">-262637000</ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriod>
    <ifrs-full:RetainedEarningsProfitLossForReportingPeriod contextRef="c-6" decimals="-3" id="f-108" unitRef="eur">-60740000</ifrs-full:RetainedEarningsProfitLossForReportingPeriod>
    <ifrs-full:RetainedEarningsProfitLossForReportingPeriod contextRef="c-7" decimals="-3" id="f-109" unitRef="eur">-147740000</ifrs-full:RetainedEarningsProfitLossForReportingPeriod>
    <ifrs-full:RetainedEarningsProfitLossForReportingPeriod contextRef="c-5" decimals="-3" id="f-110" unitRef="eur">-176242000</ifrs-full:RetainedEarningsProfitLossForReportingPeriod>
    <ifrs-full:Equity contextRef="c-6" decimals="-3" id="f-111" unitRef="eur">7189000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-7" decimals="-3" id="f-112" unitRef="eur">196010000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-5" decimals="-3" id="f-113" unitRef="eur">40584000</ifrs-full:Equity>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits contextRef="c-6" decimals="-3" id="f-114" unitRef="eur">610000</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits contextRef="c-7" decimals="-3" id="f-115" unitRef="eur">629000</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits contextRef="c-5" decimals="-3" id="f-116" unitRef="eur">756000</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:OtherLongtermProvisions contextRef="c-6" decimals="-3" id="f-117" unitRef="eur">40000</ifrs-full:OtherLongtermProvisions>
    <ifrs-full:OtherLongtermProvisions contextRef="c-7" decimals="-3" id="f-118" unitRef="eur">30000</ifrs-full:OtherLongtermProvisions>
    <ifrs-full:OtherLongtermProvisions contextRef="c-5" decimals="-3" id="f-119" unitRef="eur">819000</ifrs-full:OtherLongtermProvisions>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings contextRef="c-6" decimals="-3" id="f-120" unitRef="eur">9127000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings contextRef="c-7" decimals="-3" id="f-121" unitRef="eur">2563000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings contextRef="c-5" decimals="-3" id="f-122" unitRef="eur">29056000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <abvx:NonCurrentConvertibleLoansNotes contextRef="c-6" decimals="-3" id="f-123" unitRef="eur">0</abvx:NonCurrentConvertibleLoansNotes>
    <abvx:NonCurrentConvertibleLoansNotes contextRef="c-7" decimals="-3" id="f-124" unitRef="eur">21643000</abvx:NonCurrentConvertibleLoansNotes>
    <abvx:NonCurrentConvertibleLoansNotes contextRef="c-5" decimals="-3" id="f-125" unitRef="eur">23370000</abvx:NonCurrentConvertibleLoansNotes>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="c-6" decimals="-3" id="f-126" unitRef="eur">566000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="c-7" decimals="-3" id="f-127" unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="c-5" decimals="-3" id="f-128" unitRef="eur">3620000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <abvx:NonCurrentRoyaltyCertificates contextRef="c-6" decimals="-3" id="f-129" unitRef="eur">3287000</abvx:NonCurrentRoyaltyCertificates>
    <abvx:NonCurrentRoyaltyCertificates contextRef="c-7" decimals="-3" id="f-130" unitRef="eur">12229000</abvx:NonCurrentRoyaltyCertificates>
    <abvx:NonCurrentRoyaltyCertificates contextRef="c-5" decimals="-3" id="f-131" unitRef="eur">13023000</abvx:NonCurrentRoyaltyCertificates>
    <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="c-6" decimals="-3" id="f-132" unitRef="eur">3262000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="c-7" decimals="-3" id="f-133" unitRef="eur">3262000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="c-5" decimals="-3" id="f-134" unitRef="eur">0</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c-6" decimals="-3" id="f-135" unitRef="eur">16891000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c-7" decimals="-3" id="f-136" unitRef="eur">40356000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c-5" decimals="-3" id="f-137" unitRef="eur">70645000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings contextRef="c-6" decimals="-3" id="f-138" unitRef="eur">10077000</ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings contextRef="c-7" decimals="-3" id="f-139" unitRef="eur">1655000</ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings contextRef="c-5" decimals="-3" id="f-140" unitRef="eur">22195000</ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings>
    <abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes contextRef="c-6" decimals="-3" id="f-141" unitRef="eur">19957000</abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes>
    <abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes contextRef="c-7" decimals="-3" id="f-142" unitRef="eur">29605000</abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes>
    <abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes contextRef="c-5" decimals="-3" id="f-143" unitRef="eur">21574000</abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes>
    <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="c-6" decimals="-3" id="f-144" unitRef="eur">0</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="c-7" decimals="-3" id="f-145" unitRef="eur">2579000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="c-5" decimals="-3" id="f-146" unitRef="eur">1166000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:OtherCurrentFinancialLiabilities contextRef="c-6" decimals="-3" id="f-147" unitRef="eur">3521000</ifrs-full:OtherCurrentFinancialLiabilities>
    <ifrs-full:OtherCurrentFinancialLiabilities contextRef="c-7" decimals="-3" id="f-148" unitRef="eur">3509000</ifrs-full:OtherCurrentFinancialLiabilities>
    <ifrs-full:OtherCurrentFinancialLiabilities contextRef="c-5" decimals="-3" id="f-149" unitRef="eur">0</ifrs-full:OtherCurrentFinancialLiabilities>
    <ifrs-full:OtherShorttermProvisions contextRef="c-6" decimals="-3" id="f-150" unitRef="eur">0</ifrs-full:OtherShorttermProvisions>
    <ifrs-full:OtherShorttermProvisions contextRef="c-7" decimals="-3" id="f-151" unitRef="eur">0</ifrs-full:OtherShorttermProvisions>
    <ifrs-full:OtherShorttermProvisions contextRef="c-5" decimals="-3" id="f-152" unitRef="eur">532000</ifrs-full:OtherShorttermProvisions>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c-6" decimals="-3" id="f-153" unitRef="eur">15475000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c-7" decimals="-3" id="f-154" unitRef="eur">47221000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c-5" decimals="-3" id="f-155" unitRef="eur">43824000</ifrs-full:TradeAndOtherCurrentPayables>
    <abvx:CurrentTaxAndEmployeeBenefitLiabilities contextRef="c-6" decimals="-3" id="f-156" unitRef="eur">2300000</abvx:CurrentTaxAndEmployeeBenefitLiabilities>
    <abvx:CurrentTaxAndEmployeeBenefitLiabilities contextRef="c-7" decimals="-3" id="f-157" unitRef="eur">6073000</abvx:CurrentTaxAndEmployeeBenefitLiabilities>
    <abvx:CurrentTaxAndEmployeeBenefitLiabilities contextRef="c-5" decimals="-3" id="f-158" unitRef="eur">4709000</abvx:CurrentTaxAndEmployeeBenefitLiabilities>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities contextRef="c-6" decimals="-3" id="f-159" unitRef="eur">133000</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities contextRef="c-7" decimals="-3" id="f-160" unitRef="eur">52000</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities contextRef="c-5" decimals="-3" id="f-161" unitRef="eur">0</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c-6" decimals="-3" id="f-162" unitRef="eur">51464000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c-7" decimals="-3" id="f-163" unitRef="eur">90695000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c-5" decimals="-3" id="f-164" unitRef="eur">93999000</ifrs-full:CurrentLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c-6" decimals="-3" id="f-165" unitRef="eur">75544000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c-7" decimals="-3" id="f-166" unitRef="eur">327062000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c-5" decimals="-3" id="f-167" unitRef="eur">205228000</ifrs-full:EquityAndLiabilities>
    <abvx:NonCurrentConvertibleLoansNotes contextRef="c-8" decimals="-3" id="f-168" unitRef="eur">-19332000</abvx:NonCurrentConvertibleLoansNotes>
    <abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes contextRef="c-8" decimals="-3" id="f-169" unitRef="eur">19332000</abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes>
    <abvx:NonCurrentConvertibleLoansNotes contextRef="c-9" decimals="-3" id="f-170" unitRef="eur">-20652000</abvx:NonCurrentConvertibleLoansNotes>
    <abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes contextRef="c-9" decimals="-3" id="f-171" unitRef="eur">20652000</abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes>
    <ifrs-full:OtherIncome contextRef="c-10" decimals="-3" id="f-172" unitRef="eur">4583000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c-11" decimals="-3" id="f-173" unitRef="eur">4621000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c-1" decimals="-3" id="f-174" unitRef="eur">12449000</ifrs-full:OtherIncome>
    <ifrs-full:RevenueAndOperatingIncome contextRef="c-10" decimals="-3" id="f-175" unitRef="eur">4583000</ifrs-full:RevenueAndOperatingIncome>
    <ifrs-full:RevenueAndOperatingIncome contextRef="c-11" decimals="-3" id="f-176" unitRef="eur">4621000</ifrs-full:RevenueAndOperatingIncome>
    <ifrs-full:RevenueAndOperatingIncome contextRef="c-1" decimals="-3" id="f-177" unitRef="eur">12449000</ifrs-full:RevenueAndOperatingIncome>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-10" decimals="-3" id="f-178" unitRef="eur">0</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-11" decimals="-3" id="f-179" unitRef="eur">6431000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-1" decimals="-3" id="f-180" unitRef="eur">5954000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c-10" decimals="-3" id="f-181" unitRef="eur">48295000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c-11" decimals="-3" id="f-182" unitRef="eur">103176000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-183" unitRef="eur">146532000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c-10" decimals="-3" id="f-184" unitRef="eur">7492000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c-11" decimals="-3" id="f-185" unitRef="eur">22390000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-186" unitRef="eur">32946000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="c-10" decimals="-3" id="f-187" unitRef="eur">13632000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="c-11" decimals="-3" id="f-188" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="c-1" decimals="-3" id="f-189" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:OperatingExpense contextRef="c-10" decimals="-3" id="f-190" unitRef="eur">69419000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-11" decimals="-3" id="f-191" unitRef="eur">131997000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1" decimals="-3" id="f-192" unitRef="eur">185433000</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c-10" decimals="-3" id="f-193" unitRef="eur">-64836000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c-11" decimals="-3" id="f-194" unitRef="eur">-127376000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c-1" decimals="-3" id="f-195" unitRef="eur">-172984000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceCosts contextRef="c-10" decimals="-3" id="f-196" unitRef="eur">7022000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c-11" decimals="-3" id="f-197" unitRef="eur">27875000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c-1" decimals="-3" id="f-198" unitRef="eur">16991000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome contextRef="c-10" decimals="-3" id="f-199" unitRef="eur">11118000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="c-11" decimals="-3" id="f-200" unitRef="eur">7511000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="c-1" decimals="-3" id="f-201" unitRef="eur">13732000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncomeCost contextRef="c-10" decimals="-3" id="f-202" unitRef="eur">4096000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c-11" decimals="-3" id="f-203" unitRef="eur">-20364000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c-1" decimals="-3" id="f-204" unitRef="eur">-3258000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-10" decimals="-3" id="f-205" unitRef="eur">-60740000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-11" decimals="-3" id="f-206" unitRef="eur">-147740000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-1" decimals="-3" id="f-207" unitRef="eur">-176242000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-10" decimals="-3" id="f-208" unitRef="eur">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-11" decimals="-3" id="f-209" unitRef="eur">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-1" decimals="-3" id="f-210" unitRef="eur">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="c-10" decimals="-3" id="f-211" unitRef="eur">-60740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-11" decimals="-3" id="f-212" unitRef="eur">-147740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-213" unitRef="eur">-176242000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-10" decimals="0" id="f-214" unitRef="shares">19092442</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c-10" decimals="0" id="f-215" unitRef="shares">19092442</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c-11" decimals="0" id="f-216" unitRef="shares">43066012</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-11" decimals="0" id="f-217" unitRef="shares">43066012</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c-1" decimals="0" id="f-218" unitRef="shares">63046350</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-1" decimals="0" id="f-219" unitRef="shares">63046350</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-10"
      decimals="2"
      id="f-220"
      unitRef="eurPerShare">-3.18</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-10"
      decimals="2"
      id="f-221"
      unitRef="eurPerShare">-3.18</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-11"
      decimals="2"
      id="f-222"
      unitRef="eurPerShare">-3.43</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-11"
      decimals="2"
      id="f-223"
      unitRef="eurPerShare">-3.43</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-224"
      unitRef="eurPerShare">-2.80</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-225"
      unitRef="eurPerShare">-2.80</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:ProfitLoss contextRef="c-10" decimals="-3" id="f-226" unitRef="eur">-60740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-11" decimals="-3" id="f-227" unitRef="eur">-147740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-228" unitRef="eur">-176242000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="c-10" decimals="-3" id="f-229" unitRef="eur">235000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="c-11" decimals="-3" id="f-230" unitRef="eur">112000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="c-1" decimals="-3" id="f-231" unitRef="eur">-31000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-10" decimals="-3" id="f-232" unitRef="eur">235000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-11" decimals="-3" id="f-233" unitRef="eur">112000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-234" unitRef="eur">-31000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c-10" decimals="-3" id="f-235" unitRef="eur">0</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c-11" decimals="-3" id="f-236" unitRef="eur">112000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c-1" decimals="-3" id="f-237" unitRef="eur">-187000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c-10" decimals="-3" id="f-238" unitRef="eur">0</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c-11" decimals="-3" id="f-239" unitRef="eur">112000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c-1" decimals="-3" id="f-240" unitRef="eur">-187000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-10" decimals="-3" id="f-241" unitRef="eur">235000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-11" decimals="-3" id="f-242" unitRef="eur">225000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-1" decimals="-3" id="f-243" unitRef="eur">-219000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-10" decimals="-3" id="f-244" unitRef="eur">-60506000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-11" decimals="-3" id="f-245" unitRef="eur">-147516000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-1" decimals="-3" id="f-246" unitRef="eur">-176461000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:NumberOfSharesIssued contextRef="c-12" decimals="0" id="f-247" unitRef="shares">16764051</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-13" decimals="-3" id="f-248" unitRef="eur">168000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-14" decimals="-3" id="f-249" unitRef="eur">107578000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-15" decimals="-3" id="f-250" unitRef="eur">0</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-16" decimals="-3" id="f-251" unitRef="eur">-39361000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-17" decimals="-3" id="f-252" unitRef="eur">-42452000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-12" decimals="-3" id="f-253" unitRef="eur">25934000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c-18" decimals="-3" id="f-254" unitRef="eur">-60740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-10" decimals="-3" id="f-255" unitRef="eur">-60740000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-19" decimals="-3" id="f-256" unitRef="eur">235000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-10" decimals="-3" id="f-257" unitRef="eur">235000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-19" decimals="-3" id="f-258" unitRef="eur">235000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-18" decimals="-3" id="f-259" unitRef="eur">-60740000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-10" decimals="-3" id="f-260" unitRef="eur">-60506000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-19" decimals="-3" id="f-261" unitRef="eur">-42452000</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-18" decimals="-3" id="f-262" unitRef="eur">42452000</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-10" decimals="-3" id="f-263" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-10" decimals="0" id="f-264" unitRef="shares">5530000</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:IssueOfEquity contextRef="c-20" decimals="-3" id="f-265" unitRef="eur">55000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c-21" decimals="-3" id="f-266" unitRef="eur">46176000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c-10" decimals="-3" id="f-267" unitRef="eur">46231000</ifrs-full:IssueOfEquity>
    <abvx:ShareIssueRelatedCostCredit contextRef="c-21" decimals="-3" id="f-268" unitRef="eur">3280000</abvx:ShareIssueRelatedCostCredit>
    <abvx:ShareIssueRelatedCostCredit contextRef="c-10" decimals="-3" id="f-269" unitRef="eur">3280000</abvx:ShareIssueRelatedCostCredit>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-10" decimals="0" id="f-270" unitRef="shares">19134</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-21" decimals="-3" id="f-271" unitRef="eur">2000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-10" decimals="-3" id="f-272" unitRef="eur">3000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-19" decimals="-3" id="f-273" unitRef="eur">-1164000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-10" decimals="-3" id="f-274" unitRef="eur">-1164000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions contextRef="c-19" decimals="-3" id="f-275" unitRef="eur">-28000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions contextRef="c-10" decimals="-3" id="f-276" unitRef="eur">-28000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:NumberOfSharesIssued contextRef="c-6" decimals="0" id="f-277" unitRef="shares">22313185</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-22" decimals="-3" id="f-278" unitRef="eur">223000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-23" decimals="-3" id="f-279" unitRef="eur">150476000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-24" decimals="-3" id="f-280" unitRef="eur">0</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-25" decimals="-3" id="f-281" unitRef="eur">-82770000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-26" decimals="-3" id="f-282" unitRef="eur">-60740000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-6" decimals="-3" id="f-283" unitRef="eur">7189000</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesIssued contextRef="c-6" decimals="0" id="f-284" unitRef="shares">22313185</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-22" decimals="-3" id="f-285" unitRef="eur">223000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-23" decimals="-3" id="f-286" unitRef="eur">150476000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-24" decimals="-3" id="f-287" unitRef="eur">0</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-25" decimals="-3" id="f-288" unitRef="eur">-82770000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-26" decimals="-3" id="f-289" unitRef="eur">-60740000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-6" decimals="-3" id="f-290" unitRef="eur">7189000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c-27" decimals="-3" id="f-291" unitRef="eur">-147740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-11" decimals="-3" id="f-292" unitRef="eur">-147740000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-28" decimals="-3" id="f-293" unitRef="eur">112000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-29" decimals="-3" id="f-294" unitRef="eur">112000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-11" decimals="-3" id="f-295" unitRef="eur">225000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-28" decimals="-3" id="f-296" unitRef="eur">112000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-29" decimals="-3" id="f-297" unitRef="eur">112000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-27" decimals="-3" id="f-298" unitRef="eur">-147740000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-11" decimals="-3" id="f-299" unitRef="eur">-147516000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-29" decimals="-3" id="f-300" unitRef="eur">-60740000</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-27" decimals="-3" id="f-301" unitRef="eur">60740000</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-11" decimals="-3" id="f-302" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-11" decimals="0" id="f-303" unitRef="shares">40325500</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:IssueOfEquity contextRef="c-30" decimals="-3" id="f-304" unitRef="eur">403000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c-31" decimals="-3" id="f-305" unitRef="eur">352974000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c-11" decimals="-3" id="f-306" unitRef="eur">353377000</ifrs-full:IssueOfEquity>
    <abvx:ShareIssueRelatedCostCredit contextRef="c-31" decimals="-3" id="f-307" unitRef="eur">28111000</abvx:ShareIssueRelatedCostCredit>
    <abvx:ShareIssueRelatedCostCredit contextRef="c-11" decimals="-3" id="f-308" unitRef="eur">28111000</abvx:ShareIssueRelatedCostCredit>
    <ifrs-full:IssueOfConvertibleInstruments contextRef="c-31" decimals="-3" id="f-309" unitRef="eur">1030000</ifrs-full:IssueOfConvertibleInstruments>
    <ifrs-full:IssueOfConvertibleInstruments contextRef="c-11" decimals="-3" id="f-310" unitRef="eur">1030000</ifrs-full:IssueOfConvertibleInstruments>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-32" decimals="0" id="f-311" unitRef="shares">99583</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-33" decimals="-3" id="f-312" unitRef="eur">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-34" decimals="-3" id="f-313" unitRef="eur">1849000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-32" decimals="-3" id="f-314" unitRef="eur">1850000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-35" decimals="0" id="f-315" unitRef="shares">190550</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-36" decimals="-3" id="f-316" unitRef="eur">2000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-35" decimals="-3" id="f-317" unitRef="eur">2000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-29" decimals="-3" id="f-318" unitRef="eur">8179000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-11" decimals="-3" id="f-319" unitRef="eur">8179000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions contextRef="c-29" decimals="-3" id="f-320" unitRef="eur">10000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions contextRef="c-11" decimals="-3" id="f-321" unitRef="eur">10000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:NumberOfSharesIssued contextRef="c-7" decimals="0" id="f-322" unitRef="shares">62928818</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-37" decimals="-3" id="f-323" unitRef="eur">629000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-38" decimals="-3" id="f-324" unitRef="eur">478218000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-39" decimals="-3" id="f-325" unitRef="eur">112000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-40" decimals="-3" id="f-326" unitRef="eur">-135209000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-41" decimals="-3" id="f-327" unitRef="eur">-147740000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-7" decimals="-3" id="f-328" unitRef="eur">196010000</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesIssued contextRef="c-7" decimals="0" id="f-329" unitRef="shares">62928818</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-37" decimals="-3" id="f-330" unitRef="eur">629000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-38" decimals="-3" id="f-331" unitRef="eur">478218000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-39" decimals="-3" id="f-332" unitRef="eur">112000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-40" decimals="-3" id="f-333" unitRef="eur">-135209000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-41" decimals="-3" id="f-334" unitRef="eur">-147740000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-7" decimals="-3" id="f-335" unitRef="eur">196010000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c-42" decimals="-3" id="f-336" unitRef="eur">-176242000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-337" unitRef="eur">-176242000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-43" decimals="-3" id="f-338" unitRef="eur">-187000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-44" decimals="-3" id="f-339" unitRef="eur">-31000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-1" decimals="-3" id="f-340" unitRef="eur">-219000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-43" decimals="-3" id="f-341" unitRef="eur">-187000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-44" decimals="-3" id="f-342" unitRef="eur">-31000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-42" decimals="-3" id="f-343" unitRef="eur">-176242000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-1" decimals="-3" id="f-344" unitRef="eur">-176461000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-44" decimals="-3" id="f-345" unitRef="eur">-147740000</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-42" decimals="-3" id="f-346" unitRef="eur">147740000</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings contextRef="c-1" decimals="-3" id="f-347" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings>
    <abvx:ShareIssueRelatedCostCredit contextRef="c-45" decimals="-3" id="f-348" unitRef="eur">-446000</abvx:ShareIssueRelatedCostCredit>
    <abvx:ShareIssueRelatedCostCredit contextRef="c-1" decimals="-3" id="f-349" unitRef="eur">-446000</abvx:ShareIssueRelatedCostCredit>
    <abvx:IncreaseDecreaseThroughIssuanceOfWarrantsEquity contextRef="c-45" decimals="-3" id="f-350" unitRef="eur">200000</abvx:IncreaseDecreaseThroughIssuanceOfWarrantsEquity>
    <abvx:IncreaseDecreaseThroughIssuanceOfWarrantsEquity contextRef="c-1" decimals="-3" id="f-351" unitRef="eur">200000</abvx:IncreaseDecreaseThroughIssuanceOfWarrantsEquity>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-1" decimals="0" id="f-352" unitRef="shares">4000</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-45" decimals="-3" id="f-353" unitRef="eur">45000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-1" decimals="-3" id="f-354" unitRef="eur">45000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <abvx:NumberOfFreeSharesIssued contextRef="c-1" decimals="0" id="f-355" unitRef="shares">415019</abvx:NumberOfFreeSharesIssued>
    <abvx:IncreaseDecreaseFromFreeSharesIssued contextRef="c-46" decimals="-3" id="f-356" unitRef="eur">4000</abvx:IncreaseDecreaseFromFreeSharesIssued>
    <abvx:IncreaseDecreaseFromFreeSharesIssued contextRef="c-45" decimals="-3" id="f-357" unitRef="eur">-4000</abvx:IncreaseDecreaseFromFreeSharesIssued>
    <abvx:IncreaseDecreaseFromFreeSharesIssued contextRef="c-1" decimals="-3" id="f-358" unitRef="eur">1000</abvx:IncreaseDecreaseFromFreeSharesIssued>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-44" decimals="-3" id="f-359" unitRef="eur">20224000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-1" decimals="-3" id="f-360" unitRef="eur">20224000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions contextRef="c-44" decimals="-3" id="f-361" unitRef="eur">120000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions contextRef="c-1" decimals="-3" id="f-362" unitRef="eur">120000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:NumberOfSharesIssued contextRef="c-5" decimals="0" id="f-363" unitRef="shares">63347837</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-47" decimals="-3" id="f-364" unitRef="eur">633000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-48" decimals="-3" id="f-365" unitRef="eur">478905000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-49" decimals="-3" id="f-366" unitRef="eur">-75000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-50" decimals="-3" id="f-367" unitRef="eur">-262637000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-51" decimals="-3" id="f-368" unitRef="eur">-176242000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-5" decimals="-3" id="f-369" unitRef="eur">40584000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c-10" decimals="-3" id="f-370" unitRef="eur">-60740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-11" decimals="-3" id="f-371" unitRef="eur">-147740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-372" unitRef="eur">-176242000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c-10" decimals="-3" id="f-373" unitRef="eur">485000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c-11" decimals="-3" id="f-374" unitRef="eur">707000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c-1" decimals="-3" id="f-375" unitRef="eur">1100000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="c-10" decimals="-3" id="f-376" unitRef="eur">13632000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="c-11" decimals="-3" id="f-377" unitRef="eur">0</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="c-1" decimals="-3" id="f-378" unitRef="eur">0</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c-10" decimals="-3" id="f-379" unitRef="eur">143000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c-11" decimals="-3" id="f-380" unitRef="eur">109000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c-1" decimals="-3" id="f-381" unitRef="eur">74000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c-10" decimals="-3" id="f-382" unitRef="eur">-1164000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c-11" decimals="-3" id="f-383" unitRef="eur">8179000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c-1" decimals="-3" id="f-384" unitRef="eur">20224000</ifrs-full:AdjustmentsForSharebasedPayments>
    <abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares contextRef="c-10" decimals="-3" id="f-385" unitRef="eur">-108000</abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares>
    <abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares contextRef="c-11" decimals="-3" id="f-386" unitRef="eur">-34000</abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares>
    <abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares contextRef="c-1" decimals="-3" id="f-387" unitRef="eur">-16000</abvx:AdjustmentsForNetGainOnSaleOfTreasuryShares>
    <abvx:AdjustmentsForOtherFinanceCosts contextRef="c-10" decimals="-3" id="f-388" unitRef="eur">7028000</abvx:AdjustmentsForOtherFinanceCosts>
    <abvx:AdjustmentsForOtherFinanceCosts contextRef="c-11" decimals="-3" id="f-389" unitRef="eur">24827000</abvx:AdjustmentsForOtherFinanceCosts>
    <abvx:AdjustmentsForOtherFinanceCosts contextRef="c-1" decimals="-3" id="f-390" unitRef="eur">14203000</abvx:AdjustmentsForOtherFinanceCosts>
    <abvx:AdjustmentsForOtherFinanceIncome contextRef="c-10" decimals="-3" id="f-391" unitRef="eur">288000</abvx:AdjustmentsForOtherFinanceIncome>
    <abvx:AdjustmentsForOtherFinanceIncome contextRef="c-11" decimals="-3" id="f-392" unitRef="eur">2953000</abvx:AdjustmentsForOtherFinanceIncome>
    <abvx:AdjustmentsForOtherFinanceIncome contextRef="c-1" decimals="-3" id="f-393" unitRef="eur">11609000</abvx:AdjustmentsForOtherFinanceIncome>
    <abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances contextRef="c-10" decimals="-3" id="f-394" unitRef="eur">-2000</abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances>
    <abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances contextRef="c-11" decimals="-3" id="f-395" unitRef="eur">-355000</abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances>
    <abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances contextRef="c-1" decimals="-3" id="f-396" unitRef="eur">-710000</abvx:AdjustmentsForUnwindingOfDiscountRelatedToConditionalAdvances>
    <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="c-10" decimals="-3" id="f-397" unitRef="eur">-10817000</ifrs-full:AdjustmentsForFairValueGainsLosses>
    <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="c-11" decimals="-3" id="f-398" unitRef="eur">-1158000</ifrs-full:AdjustmentsForFairValueGainsLosses>
    <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="c-1" decimals="-3" id="f-399" unitRef="eur">1416000</ifrs-full:AdjustmentsForFairValueGainsLosses>
    <abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances contextRef="c-10" decimals="-3" id="f-400" unitRef="eur">0</abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances>
    <abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances contextRef="c-11" decimals="-3" id="f-401" unitRef="eur">0</abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances>
    <abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances contextRef="c-1" decimals="-3" id="f-402" unitRef="eur">-4140000</abvx:AdjustmentsForForgivenessOfCovid19ConditionalAdvances>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="c-10" decimals="-3" id="f-403" unitRef="eur">-100000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="c-11" decimals="-3" id="f-404" unitRef="eur">22000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="c-1" decimals="-3" id="f-405" unitRef="eur">204000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital contextRef="c-10" decimals="-3" id="f-406" unitRef="eur">-51933000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital contextRef="c-11" decimals="-3" id="f-407" unitRef="eur">-118395000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital contextRef="c-1" decimals="-3" id="f-408" unitRef="eur">-155495000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="c-10" decimals="-3" id="f-409" unitRef="eur">312000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="c-11" decimals="-3" id="f-410" unitRef="eur">-14231000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="c-1" decimals="-3" id="f-411" unitRef="eur">4591000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c-10" decimals="-3" id="f-412" unitRef="eur">-2388000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c-11" decimals="-3" id="f-413" unitRef="eur">31757000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c-1" decimals="-3" id="f-414" unitRef="eur">-3444000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities contextRef="c-10" decimals="-3" id="f-415" unitRef="eur">100000</abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities>
    <abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities contextRef="c-11" decimals="-3" id="f-416" unitRef="eur">3821000</abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities>
    <abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities contextRef="c-1" decimals="-3" id="f-417" unitRef="eur">-1487000</abvx:AdjustmentsForIncreaseDecreaseInTaxAndSocialSecurityLiabilities>
    <abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities contextRef="c-10" decimals="-3" id="f-418" unitRef="eur">-26000</abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities>
    <abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities contextRef="c-11" decimals="-3" id="f-419" unitRef="eur">-81000</abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities>
    <abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities contextRef="c-1" decimals="-3" id="f-420" unitRef="eur">1763000</abvx:AdjustmentsForIncreaseDecreaseInDeferredIncomeAndOtherLiabilities>
    <ifrs-full:IncreaseDecreaseInWorkingCapital contextRef="c-10" decimals="-3" id="f-421" unitRef="eur">2002000</ifrs-full:IncreaseDecreaseInWorkingCapital>
    <ifrs-full:IncreaseDecreaseInWorkingCapital contextRef="c-11" decimals="-3" id="f-422" unitRef="eur">-21265000</ifrs-full:IncreaseDecreaseInWorkingCapital>
    <ifrs-full:IncreaseDecreaseInWorkingCapital contextRef="c-1" decimals="-3" id="f-423" unitRef="eur">-1423000</ifrs-full:IncreaseDecreaseInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-10" decimals="-3" id="f-424" unitRef="eur">-53936000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-11" decimals="-3" id="f-425" unitRef="eur">-97130000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-426" unitRef="eur">-154072000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c-10" decimals="-3" id="f-427" unitRef="eur">35000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c-11" decimals="-3" id="f-428" unitRef="eur">0</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c-1" decimals="-3" id="f-429" unitRef="eur">3000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c-10" decimals="-3" id="f-430" unitRef="eur">288000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c-11" decimals="-3" id="f-431" unitRef="eur">265000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c-1" decimals="-3" id="f-432" unitRef="eur">640000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals contextRef="c-10" decimals="-3" id="f-433" unitRef="eur">-3302000</abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals>
    <abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals contextRef="c-11" decimals="-3" id="f-434" unitRef="eur">0</abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals>
    <abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals contextRef="c-1" decimals="-3" id="f-435" unitRef="eur">0</abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals>
    <abvx:PaymentsForAdvancesMadeToContractResearchOrganizations contextRef="c-10" decimals="-3" id="f-436" unitRef="eur">12187000</abvx:PaymentsForAdvancesMadeToContractResearchOrganizations>
    <abvx:PaymentsForAdvancesMadeToContractResearchOrganizations contextRef="c-11" decimals="-3" id="f-437" unitRef="eur">1620000</abvx:PaymentsForAdvancesMadeToContractResearchOrganizations>
    <abvx:PaymentsForAdvancesMadeToContractResearchOrganizations contextRef="c-1" decimals="-3" id="f-438" unitRef="eur">231000</abvx:PaymentsForAdvancesMadeToContractResearchOrganizations>
    <abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired contextRef="c-10" decimals="-3" id="f-439" unitRef="eur">2913000</abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired>
    <abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired contextRef="c-11" decimals="-3" id="f-440" unitRef="eur">0</abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired>
    <abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired contextRef="c-1" decimals="-3" id="f-441" unitRef="eur">0</abvx:PaymentsForAssetsAcquisitionsIncludingRelatedCostsNetOfCashAcquired>
    <abvx:CashPaymentsForDeposits contextRef="c-10" decimals="-3" id="f-442" unitRef="eur">142000</abvx:CashPaymentsForDeposits>
    <abvx:CashPaymentsForDeposits contextRef="c-11" decimals="-3" id="f-443" unitRef="eur">9351000</abvx:CashPaymentsForDeposits>
    <abvx:CashPaymentsForDeposits contextRef="c-1" decimals="-3" id="f-444" unitRef="eur">591000</abvx:CashPaymentsForDeposits>
    <abvx:ProceedsFromReimbursementsOfDeposits contextRef="c-10" decimals="-3" id="f-445" unitRef="eur">218000</abvx:ProceedsFromReimbursementsOfDeposits>
    <abvx:ProceedsFromReimbursementsOfDeposits contextRef="c-11" decimals="-3" id="f-446" unitRef="eur">741000</abvx:ProceedsFromReimbursementsOfDeposits>
    <abvx:ProceedsFromReimbursementsOfDeposits contextRef="c-1" decimals="-3" id="f-447" unitRef="eur">9050000</abvx:ProceedsFromReimbursementsOfDeposits>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c-10" decimals="-3" id="f-448" unitRef="eur">19000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c-11" decimals="-3" id="f-449" unitRef="eur">2400000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c-1" decimals="-3" id="f-450" unitRef="eur">8178000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-10" decimals="-3" id="f-451" unitRef="eur">-12026000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-11" decimals="-3" id="f-452" unitRef="eur">-8095000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-453" unitRef="eur">15762000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-10" decimals="-3" id="f-454" unitRef="eur">46231000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-11" decimals="-3" id="f-455" unitRef="eur">353377000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-1" decimals="-3" id="f-456" unitRef="eur">0</ifrs-full:ProceedsFromIssuingShares>
    <abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit contextRef="c-10" decimals="-3" id="f-457" unitRef="eur">3280000</abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit>
    <abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit contextRef="c-11" decimals="-3" id="f-458" unitRef="eur">28111000</abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit>
    <abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit contextRef="c-1" decimals="-3" id="f-459" unitRef="eur">-446000</abvx:PaymentsForProceedsFromShareIssueRelatedCostsCredit>
    <abvx:NetProceedsFromNonConvertibleLoansNotes contextRef="c-10" decimals="-3" id="f-460" unitRef="eur">0</abvx:NetProceedsFromNonConvertibleLoansNotes>
    <abvx:NetProceedsFromNonConvertibleLoansNotes contextRef="c-11" decimals="-3" id="f-461" unitRef="eur">0</abvx:NetProceedsFromNonConvertibleLoansNotes>
    <abvx:NetProceedsFromNonConvertibleLoansNotes contextRef="c-1" decimals="-3" id="f-462" unitRef="eur">47944000</abvx:NetProceedsFromNonConvertibleLoansNotes>
    <abvx:RepaymentsOfBondLoans contextRef="c-10" decimals="-3" id="f-463" unitRef="eur">9410000</abvx:RepaymentsOfBondLoans>
    <abvx:RepaymentsOfBondLoans contextRef="c-11" decimals="-3" id="f-464" unitRef="eur">11635000</abvx:RepaymentsOfBondLoans>
    <abvx:RepaymentsOfBondLoans contextRef="c-1" decimals="-3" id="f-465" unitRef="eur">0</abvx:RepaymentsOfBondLoans>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-10" decimals="-3" id="f-466" unitRef="eur">0</abvx:NetProceedsFromConvertibleLoansNotes>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-11" decimals="-3" id="f-467" unitRef="eur">55841000</abvx:NetProceedsFromConvertibleLoansNotes>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-1" decimals="-3" id="f-468" unitRef="eur">0</abvx:NetProceedsFromConvertibleLoansNotes>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-10" decimals="-3" id="f-469" unitRef="eur">0</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-11" decimals="-3" id="f-470" unitRef="eur">27188000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-1" decimals="-3" id="f-471" unitRef="eur">8750000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:RepaymentsOfPGE contextRef="c-10" decimals="-3" id="f-472" unitRef="eur">0</abvx:RepaymentsOfPGE>
    <abvx:RepaymentsOfPGE contextRef="c-11" decimals="-3" id="f-473" unitRef="eur">1250000</abvx:RepaymentsOfPGE>
    <abvx:RepaymentsOfPGE contextRef="c-1" decimals="-3" id="f-474" unitRef="eur">1250000</abvx:RepaymentsOfPGE>
    <abvx:RepaymentsOfConditionalAdvances contextRef="c-10" decimals="-3" id="f-475" unitRef="eur">90000</abvx:RepaymentsOfConditionalAdvances>
    <abvx:RepaymentsOfConditionalAdvances contextRef="c-11" decimals="-3" id="f-476" unitRef="eur">110000</abvx:RepaymentsOfConditionalAdvances>
    <abvx:RepaymentsOfConditionalAdvances contextRef="c-1" decimals="-3" id="f-477" unitRef="eur">2708000</abvx:RepaymentsOfConditionalAdvances>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c-10" decimals="-3" id="f-478" unitRef="eur">301000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c-11" decimals="-3" id="f-479" unitRef="eur">529000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c-1" decimals="-3" id="f-480" unitRef="eur">458000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <abvx:NetProceedsFromSaleOfRoyaltyCertificates contextRef="c-10" decimals="-3" id="f-481" unitRef="eur">2931000</abvx:NetProceedsFromSaleOfRoyaltyCertificates>
    <abvx:NetProceedsFromSaleOfRoyaltyCertificates contextRef="c-11" decimals="-3" id="f-482" unitRef="eur">0</abvx:NetProceedsFromSaleOfRoyaltyCertificates>
    <abvx:NetProceedsFromSaleOfRoyaltyCertificates contextRef="c-1" decimals="-3" id="f-483" unitRef="eur">0</abvx:NetProceedsFromSaleOfRoyaltyCertificates>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares contextRef="c-10" decimals="-3" id="f-484" unitRef="eur">143000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares contextRef="c-11" decimals="-3" id="f-485" unitRef="eur">10000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares contextRef="c-1" decimals="-3" id="f-486" unitRef="eur">434000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c-10" decimals="-3" id="f-487" unitRef="eur">4015000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c-11" decimals="-3" id="f-488" unitRef="eur">5279000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c-1" decimals="-3" id="f-489" unitRef="eur">7696000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="c-10" decimals="-3" id="f-490" unitRef="eur">3000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="c-11" decimals="-3" id="f-491" unitRef="eur">163000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="c-1" decimals="-3" id="f-492" unitRef="eur">245000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-10" decimals="-3" id="f-493" unitRef="eur">32211000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-11" decimals="-3" id="f-494" unitRef="eur">335290000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-495" unitRef="eur">28207000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-10" decimals="-3" id="f-496" unitRef="eur">0</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-11" decimals="-3" id="f-497" unitRef="eur">-5072000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-1" decimals="-3" id="f-498" unitRef="eur">2382000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c-10" decimals="-3" id="f-499" unitRef="eur">-33751000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c-11" decimals="-3" id="f-500" unitRef="eur">224992000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c-1" decimals="-3" id="f-501" unitRef="eur">-107720000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-12" decimals="-3" id="f-502" unitRef="eur">60701000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-503" unitRef="eur">26950000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-7" decimals="-3" id="f-504" unitRef="eur">251942000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-505" unitRef="eur">26950000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-7" decimals="-3" id="f-506" unitRef="eur">251942000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-5" decimals="-3" id="f-507" unitRef="eur">144221000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c-10" decimals="-3" id="f-508" unitRef="eur">-33751000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c-11" decimals="-3" id="f-509" unitRef="eur">224992000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c-1" decimals="-3" id="f-510" unitRef="eur">-107720000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory contextRef="c-1" id="f-511">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 1.1. Information on the Group and its business &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ABIVAX SA (the &#x201c;Company&#x201d;) is a soci&#xe9;t&#xe9; anonyme incorporated under the laws of France on December 4, 2013. Its registered office &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;is located at 7-11 Boulevard Haussmann&#x2014;75009 Paris, France. The Company is developing therapeutics that harness the body&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These consolidated financial statements as of and for the year ended December 31, 2024 comprise the Company and ABIVAX LLC &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 189.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(the &#x201c;Subsidiary&#x201d;), the United States subsidiary of ABIVAX SA, created on March 20, 2023 under the laws of the State of Delaware &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(together referred to as the &#x201c;Group&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201d;).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group has incurred losses since its inception and had shareholders&#x2019; equity of&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;40,584&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;thousand as&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of December 31, 2024. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group anticipates incurring additional losses until such time, if ever, that it can generate significant revenue from its drug candidates &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which are currently under development. Substantial additional financing will be needed by the Group to fund its operations and to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercially develop its drug candidates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group's future operations are highly dependent on a combination of factors, including: (i)&#160;the success of its research and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;development activities; (ii)&#160;regulatory approval and market acceptance of its proposed future products; (iii)&#160;the timely and successful &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;completion of additional financing and (iv)&#160;the development of competitive therapies by other biotechnology and pharmaceutical &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;companies. As a result, the Group is, and expects to continue to be, in the short to mid-term, financed through the issuance of new &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;equity or debt instruments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group is focusing its efforts on the following points: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 360.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Continuation of the Phase 3 clinical trial program (ABTECT) for obefazimod in moderately to severely active ulcerative &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;colitis (&#x201c;UC&#x201d;) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 387.04pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Initiating the Phase 2b clinical trial (ENHANCE-CD) of obefazimod in Crohn&#x2019;s disease (&#x201c;CD&#x201d;). &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 400.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Evaluating oral or injectable combination therapy candidates with obefazimod in UC.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 413.92pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Selecting a follow-on candidate for obefazimod. &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 1.2. Date of authorization of issuance &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The consolidated financial statements and related notes (the &#x201c;financial statements&#x201d;) have been prepared under the responsibility of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;management of the Group and were approved and authorized for issuance by the Group&#x2019;s board of directors on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;March 20, 2025&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;.</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:Equity contextRef="c-5" decimals="-3" id="f-512" unitRef="eur">40584000</ifrs-full:Equity>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="c-1" id="f-513">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Basis of preparation &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 533.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Except for share data and per share amounts, the financial statements are presented in thousands of euros. Amounts are rounded up or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;down the nearest whole number for the calculation of certain financial data and other information contained in these accounts. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accordingly, the total amounts presented in certain tables may not be the exact sum of the preceding figures. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statement of compliance &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The consolidated financial statements of the Group as of and for the years ended December 31, 2022, 2023 and 2024 have been &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepared in accordance with both International Financial Reporting Standards (&#x201c;IFRS&#x201d;) as issued by the International Accounting &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Standard Board (&#x201c;IASB&#x201d;) and IFRS as adopted by the European Union (&#x201c;EU&#x201d;) regulation n&#xb0;1606/2002 of July 19, 2002. The term &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;IFRS&#x201d; refers collectively to International Accounting Standards (&#x201c;IAS&#x201d;) and IFRS as well as the interpretations issued by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Standing Interpretations Committee (&#x201c;SIC&#x201d;) and the International Financial Reporting Interpretations Standards Committee (&#x201c;IFRS &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IC&#x201d;), whose application is mandatory for the year ended December 31, 2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Preparation of the financial statements &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 209.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The consolidated financial statements of the Group were prepared on a historical cost basis, with the exception of certain asset and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liability categories and in accordance with the provisions set out in IFRS such as employee benefits measured using the projected unit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 232.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit method, the Heights notes (classified under "Convertible loan notes") measured at fair value and derivative financial instruments &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 243.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measured at fair value. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Going concern &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group has incurre&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;d substantial operating losses since inception and expects to continue to incur significant operating losses for the &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;foreseeab&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;le future and may never become profitable. For the year ended December 31, 2024, the Group had a net loss &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;176,242 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Since inception, the Group has financed its operations through the issuance of ordinary shares wi&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;th gross aggregate proceeds of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;557.2&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, of which &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;130&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of gross proceeds were from offerings of its ordinary shares on Euronext Paris in February 2023 &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;223.3&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of gross proceeds were from its &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;offering of ordinary shares in the form of American Depository Shares ("ADS") on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 378.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Nasdaq Global Market as well as ordinary shares in Europe (including France) and countries outside of the United States in a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;private placement in October 2023&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, ba&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nk borrowings and structured loans&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; for &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;175.0&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reimbursements of Research Tax Credits &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Cr&#xe9;dit d&#x2019;Imp&#xf4;t Recherche (&#x201c;CIR&#x201d;)) in an aggregate amo&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;unt of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;35.6&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, subsidies received from Banque Publique &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;d&#x2019;Investissement (&#x201c;Bpifrance&#x201d;) (including &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;17.1&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of subsidies and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;1.8&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of conditional advances) and royalty certificates &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;in an amount of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;2.9&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Based on (a) the Group&#x2019;s existing cash and cash equivalents &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;144.2 million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December 31, 2024 and (b) the expected &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reimbursement of the CIR from 2024 in the second half of 2025 amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.7&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, the Group expects, as of the date of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issuance of these financial statements, to be able to fund its forecasted cash flow requirements into the fourth quarter of 2025. This &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;takes into account management's assumptions of higher R&amp;amp;D expenditure in 2024 and into 2025 driven by the progression of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Phase 3 clinical trials of obefazimod in UC and the initiation of the Phase 2b clinical trials for CD. Under these assumptions and based &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on the Group's current clinical and operational plans, the Group would have sufficient funds to finance its operations in the fourth &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;quarter of 2025, i.e. through the announcement of its top-line data from the Phase 3 ABTECT-1 and ABTECT-2 induction trials for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;UC in the third quarter of 2025.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The elements referred to above, as well as (c) the Group's expectation to generate operating losses and negative operating cash flows &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the future, and (d) the need for additional fundi&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ng to support its planned operations, result in a material uncertainty that may cast &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;significant doubt (or raise substantial doubt as contemplated by Public Company Accounting Oversight Board standards) regarding its &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ability to continue as a going concern for a period of one year after the date that these consolidated financial statements ar&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.8299999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;e issued.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;T&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;he&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group continues to monitor its spending of 2025 expenses, ensuring strict adherence to the approved budget, which may include &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;projected savings through the gating of non essential spend and to pursue additional cash resources through public or private equity or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;debt financing&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s, regional out licensing agreements and/or royalty financing&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The Group has concluded that substantial doubt exists &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;about the Group&#x2019;s ability to continue as a going concern for a period of at least 12 months from the date of issuance of these &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;consolidated financial statements.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary if the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group is unable to continue as a going concern.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impact of the Ukraine/Russia Hostilities on the Group &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In February 2022, Russia invaded Ukraine. The conflict has already had major implications for the global economy and the rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;inflation, particularly in relation to the supply of energy, raw materials and food products. It has also caused intense volatility on the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial markets, something that is still ongoing at the reporting date and has pushed down stock market prices around the world. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Given these developments, the Group has decided not to include Russia and Belarus in its global Phase 3 program for obefazimod in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;UC. However, the global scale of this conflict cannot be predicted at this stage. The Group, therefore, cannot rule out an adverse &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;impact of this conflict on its business, including in terms of access to raw materials, logistics, the performance of clinical studies and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in relation to any future financing the Group may seek. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 193.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The long-term safety and efficacy extension of the&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #ff0000; font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 237.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Phase 2b maintenance trial of obefazimod in moderately to severely active UC is &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group&#x2019;s only clinical trial with patients currently enrolled in Ukraine.&#160; The Phase 2b 12-month assessment was carried out in all &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Ukrainian patients before the war broke out and these patients are therefore included in the one-year maintenance results that were &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reported on April 6, 2022. Ukrainian patients who completed the two-year Phase 2b maintenance trial have been transitioned to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.28pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;long-term safety and efficacy trial that is still on-going. T&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;he Group also has a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;few&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Ukrainian sites active in the western part of Ukraine &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the ABTECT Phase 3 clinical trials.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; None of these sites are located in the Crimea Region of Ukraine, the so-called Donetsk &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;People&#x2019;s Republic, or the so-called Luhansk People&#x2019;s Republic. We continue to monitor developments in the region, but any &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instability as a result of the war may have material adverse impacts on these clinical sites, which could negatively impact our Phase 3 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;clinical trials.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Together with its CROs, the Group is making considerable efforts to ensure the follow-up of patients who are unable to come to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;study centers. Monitoring takes place through a remote monitoring system that was established and used successfully during the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COVID-19 pandemic.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;New, revised or amended Standards and Interpretations &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group applied the following amendments to IFRS that are effective as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December&#160;31, 2024&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 403.58pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-current, and &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.02pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-current Liabilities with Covenants; &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 91.05pt; position: var(--position);"&gt;Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures &#x2013; Supplier Finance &lt;span style="display: inline-block; height: 6.93pt; width: 5.91pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 441.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Agreements; and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group assessed the impacts resulting from the application of these issued accounting pronouncements and concluded that impacts &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are not material, with the exception of the amendments to IAS 1, issued in 2020 and 2022, which aim at clarifying the requirements on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;determining whether a liability is current or non-current, and require new disclosures for non-current liabilities that are subject to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;future covenants. In accordance with these amendments, an entity shall classify a liability as current when it does not have the right at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These amendments can impact liabilities with covenants which breach can render the related liabilities repayable within 12 months. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;However, the Group has no such liabilities.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Under the amendments, a settlement of a liability includes transferring an entity's own equity instruments to the counterparty. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Therefore, if a liability has any conversion options that involve a transfer of the entity's own equity instruments, then these generally &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;affect its classification as current or non-current. As an exception, if these conversion options are recognized as equity under IAS 32, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;then they do not affect the current or non-current classification of the liability.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As disclosed in Notes 15.1, 15.2 and 15.5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the Group has co&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;nvertible notes (respectively the Kreos / Claret OCABSA, the Heights &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.26pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;convertible notes (as of December 31, 2023 and 2024) and the OCEANE bonds (as of December 31, 2022), as defined below) that are &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;convertible into a potentially variable number of ordinary shares of the Group at any time at the option of the noteholders. Despite the &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;fact that the Group has the unconditional right to defer the settlement of such convertible notes into cash beyond twelve months, in &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.36pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;application of these amendments, the Group will no longer be considered to have an unconditional right to defer the settlements of the &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Heights convertible notes and the OCEANE bonds due to their conversion options that are embedded derivatives not recognized as &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 699.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;equity components. Consequently, the amendments led to the reclassification of these convertible notes as current liabilities on a &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;retrospective basis:&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x2022;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of December 31, 2022, the carrying value of the OCEANE bonds &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;19,957&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, of which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,332 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; were &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;classified within non-current financial liabilities in the Grou&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;p&#x2019;s annual financial statements for the year ended December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022. In application of these amendments, all of the carrying value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;19,957&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; is now presented within current &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;financial liabilities.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 145.46pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x2022;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of December 31, 2023, the carrying value of the Heights convertible notes was &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;29,605&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, of which &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;20,652 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; were classified within non-current financial liabilities in the Group&#x2019;s annual financial statements for the year ended &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.86pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;December 31, 2023. In application of these amendments, all of the carrying value of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;29,605&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; is now presented &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;within current financial liabilities.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;The classification of the Kreos / Claret OCABSA will not be impacted since they are compound instruments with conversion option &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 209.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;and attached OCABSA warrants recognized as an equity component.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group did not elect for early application of the following new standards, amendments and interpretations, which were issued but &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;not mandatory as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December&#160;31, 2024&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates &#x2013; Lack of Exchangeability whose application &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;is for annual reporting periods beginning on or after January 1, 2025;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 103.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#x2013; Amendments to the &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Classification and Measurement of Financial Instruments, whose application is for annual reporting periods beginning on &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.44pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or after January 1, 2026 (not yet approved by the EU); &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 143.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#x2013; Contracts Referencing &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 157.32pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Nature-dependent Electricity, whose application is for annual reporting periods beginning on or after January 1, 2026 &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(not yet approved by the EU); &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 184.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS 18 Presentation and Disclosure in Financial Statements, whose application is for annual reporting periods &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 197.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;beginning on or after January 1, 2027 (not yet approved by the EU); &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 211.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.89pt;"&gt;IFRS 19 Subsidiaries without Public Accountability: Disclosures, whose application is for annual reporting periods&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.89pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 222.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 288.94pt;"&gt;beginning on or after January 1, 2027 (not yet approved by the UE), and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 233.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.99pt;"&gt;Annual Improvements Volume 11, whose application is for annual reporting periods beginning on or after January 1,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.99pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 244.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 141.84pt;"&gt;2026 (not yet approved by the UE).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.58pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These texts have not been early adopted. The expected impacts are not considered significant, except for IFRS 18, for which the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;has not completed its assessment to date.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:StatementOfIFRSCompliance contextRef="c-1" id="f-514">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statement of compliance &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The consolidated financial statements of the Group as of and for the years ended December 31, 2022, 2023 and 2024 have been &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepared in accordance with both International Financial Reporting Standards (&#x201c;IFRS&#x201d;) as issued by the International Accounting &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Standard Board (&#x201c;IASB&#x201d;) and IFRS as adopted by the European Union (&#x201c;EU&#x201d;) regulation n&#xb0;1606/2002 of July 19, 2002. The term &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;IFRS&#x201d; refers collectively to International Accounting Standards (&#x201c;IAS&#x201d;) and IFRS as well as the interpretations issued by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Standing Interpretations Committee (&#x201c;SIC&#x201d;) and the International Financial Reporting Interpretations Standards Committee (&#x201c;IFRS &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;IC&#x201d;), whose application is mandatory for the year ended December 31, 2024.</ifrs-full:StatementOfIFRSCompliance>
    <abvx:DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock contextRef="c-1" id="f-515">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Going concern &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group has incurre&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;d substantial operating losses since inception and expects to continue to incur significant operating losses for the &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;foreseeab&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;le future and may never become profitable. For the year ended December 31, 2024, the Group had a net loss &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;176,242 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Since inception, the Group has financed its operations through the issuance of ordinary shares wi&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;th gross aggregate proceeds of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;557.2&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, of which &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;130&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of gross proceeds were from offerings of its ordinary shares on Euronext Paris in February 2023 &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;223.3&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of gross proceeds were from its &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;offering of ordinary shares in the form of American Depository Shares ("ADS") on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 378.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Nasdaq Global Market as well as ordinary shares in Europe (including France) and countries outside of the United States in a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;private placement in October 2023&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, ba&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nk borrowings and structured loans&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; for &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;175.0&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reimbursements of Research Tax Credits &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Cr&#xe9;dit d&#x2019;Imp&#xf4;t Recherche (&#x201c;CIR&#x201d;)) in an aggregate amo&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;unt of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;35.6&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, subsidies received from Banque Publique &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;d&#x2019;Investissement (&#x201c;Bpifrance&#x201d;) (including &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;17.1&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of subsidies and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;1.8&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of conditional advances) and royalty certificates &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;in an amount of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;2.9&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Based on (a) the Group&#x2019;s existing cash and cash equivalents &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;144.2 million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December 31, 2024 and (b) the expected &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reimbursement of the CIR from 2024 in the second half of 2025 amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.7&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, the Group expects, as of the date of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issuance of these financial statements, to be able to fund its forecasted cash flow requirements into the fourth quarter of 2025. This &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;takes into account management's assumptions of higher R&amp;amp;D expenditure in 2024 and into 2025 driven by the progression of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Phase 3 clinical trials of obefazimod in UC and the initiation of the Phase 2b clinical trials for CD. Under these assumptions and based &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on the Group's current clinical and operational plans, the Group would have sufficient funds to finance its operations in the fourth &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;quarter of 2025, i.e. through the announcement of its top-line data from the Phase 3 ABTECT-1 and ABTECT-2 induction trials for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;UC in the third quarter of 2025.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The elements referred to above, as well as (c) the Group's expectation to generate operating losses and negative operating cash flows &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the future, and (d) the need for additional fundi&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ng to support its planned operations, result in a material uncertainty that may cast &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;significant doubt (or raise substantial doubt as contemplated by Public Company Accounting Oversight Board standards) regarding its &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ability to continue as a going concern for a period of one year after the date that these consolidated financial statements ar&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.8299999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;e issued.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;T&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;he&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group continues to monitor its spending of 2025 expenses, ensuring strict adherence to the approved budget, which may include &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;projected savings through the gating of non essential spend and to pursue additional cash resources through public or private equity or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;debt financing&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s, regional out licensing agreements and/or royalty financing&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The Group has concluded that substantial doubt exists &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;about the Group&#x2019;s ability to continue as a going concern for a period of at least 12 months from the date of issuance of these &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;consolidated financial statements.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary if the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group is unable to continue as a going concern.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abvx:DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-516" unitRef="eur">-176242000</ifrs-full:ProfitLoss>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-52" decimals="-5" id="f-517" unitRef="eur">557200000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-53" decimals="-6" id="f-518" unitRef="eur">130000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-54" decimals="-5" id="f-519" unitRef="eur">223300000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-52" decimals="-5" id="f-520" unitRef="eur">175000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <abvx:ProceedsFromResearchTaxCredit contextRef="c-52" decimals="-5" id="f-521" unitRef="eur">35600000</abvx:ProceedsFromResearchTaxCredit>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities contextRef="c-55" decimals="-5" id="f-522" unitRef="eur">17100000</ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-55" decimals="-5" id="f-523" unitRef="eur">1800000</abvx:ProceedsFromConditionalAdvances>
    <abvx:NetProceedsFromSaleOfRoyaltyCertificates contextRef="c-52" decimals="-5" id="f-524" unitRef="eur">2900000</abvx:NetProceedsFromSaleOfRoyaltyCertificates>
    <ifrs-full:CashAndCashEquivalents contextRef="c-5" decimals="-5" id="f-525" unitRef="eur">144200000</ifrs-full:CashAndCashEquivalents>
    <abvx:ProceedsFromResearchTaxCredit contextRef="c-56" decimals="-5" id="f-526" unitRef="eur">5700000</abvx:ProceedsFromResearchTaxCredit>
    <abvx:DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock contextRef="c-1" id="f-527">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impact of the Ukraine/Russia Hostilities on the Group &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In February 2022, Russia invaded Ukraine. The conflict has already had major implications for the global economy and the rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;inflation, particularly in relation to the supply of energy, raw materials and food products. It has also caused intense volatility on the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial markets, something that is still ongoing at the reporting date and has pushed down stock market prices around the world. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Given these developments, the Group has decided not to include Russia and Belarus in its global Phase 3 program for obefazimod in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;UC. However, the global scale of this conflict cannot be predicted at this stage. The Group, therefore, cannot rule out an adverse &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;impact of this conflict on its business, including in terms of access to raw materials, logistics, the performance of clinical studies and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in relation to any future financing the Group may seek. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 193.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The long-term safety and efficacy extension of the&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #ff0000; font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 237.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Phase 2b maintenance trial of obefazimod in moderately to severely active UC is &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group&#x2019;s only clinical trial with patients currently enrolled in Ukraine.&#160; The Phase 2b 12-month assessment was carried out in all &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Ukrainian patients before the war broke out and these patients are therefore included in the one-year maintenance results that were &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reported on April 6, 2022. Ukrainian patients who completed the two-year Phase 2b maintenance trial have been transitioned to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.28pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;long-term safety and efficacy trial that is still on-going. T&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;he Group also has a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;few&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Ukrainian sites active in the western part of Ukraine &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the ABTECT Phase 3 clinical trials.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; None of these sites are located in the Crimea Region of Ukraine, the so-called Donetsk &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;People&#x2019;s Republic, or the so-called Luhansk People&#x2019;s Republic. We continue to monitor developments in the region, but any &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instability as a result of the war may have material adverse impacts on these clinical sites, which could negatively impact our Phase 3 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;clinical trials.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Together with its CROs, the Group is making considerable efforts to ensure the follow-up of patients who are unable to come to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;study centers. Monitoring takes place through a remote monitoring system that was established and used successfully during the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COVID-19 pandemic.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</abvx:DisclosureOfImpactOfTheUkraineRussiaHostilitiesOnTheGroupPolicyTextBlock>
    <abvx:DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock contextRef="c-1" id="f-528">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;New, revised or amended Standards and Interpretations &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group applied the following amendments to IFRS that are effective as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December&#160;31, 2024&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 403.58pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-current, and &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.02pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-current Liabilities with Covenants; &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 91.05pt; position: var(--position);"&gt;Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures &#x2013; Supplier Finance &lt;span style="display: inline-block; height: 6.93pt; width: 5.91pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 441.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Agreements; and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group assessed the impacts resulting from the application of these issued accounting pronouncements and concluded that impacts &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are not material, with the exception of the amendments to IAS 1, issued in 2020 and 2022, which aim at clarifying the requirements on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;determining whether a liability is current or non-current, and require new disclosures for non-current liabilities that are subject to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;future covenants. In accordance with these amendments, an entity shall classify a liability as current when it does not have the right at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These amendments can impact liabilities with covenants which breach can render the related liabilities repayable within 12 months. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;However, the Group has no such liabilities.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Under the amendments, a settlement of a liability includes transferring an entity's own equity instruments to the counterparty. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Therefore, if a liability has any conversion options that involve a transfer of the entity's own equity instruments, then these generally &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;affect its classification as current or non-current. As an exception, if these conversion options are recognized as equity under IAS 32, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;then they do not affect the current or non-current classification of the liability.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As disclosed in Notes 15.1, 15.2 and 15.5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the Group has co&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;nvertible notes (respectively the Kreos / Claret OCABSA, the Heights &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.26pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;convertible notes (as of December 31, 2023 and 2024) and the OCEANE bonds (as of December 31, 2022), as defined below) that are &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;convertible into a potentially variable number of ordinary shares of the Group at any time at the option of the noteholders. Despite the &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;fact that the Group has the unconditional right to defer the settlement of such convertible notes into cash beyond twelve months, in &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.36pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;application of these amendments, the Group will no longer be considered to have an unconditional right to defer the settlements of the &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Heights convertible notes and the OCEANE bonds due to their conversion options that are embedded derivatives not recognized as &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 699.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;equity components. Consequently, the amendments led to the reclassification of these convertible notes as current liabilities on a &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;retrospective basis:&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x2022;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of December 31, 2022, the carrying value of the OCEANE bonds &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;19,957&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, of which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,332 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; were &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;classified within non-current financial liabilities in the Grou&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;p&#x2019;s annual financial statements for the year ended December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022. In application of these amendments, all of the carrying value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;19,957&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; is now presented within current &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;financial liabilities.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 145.46pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x2022;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of December 31, 2023, the carrying value of the Heights convertible notes was &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;29,605&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, of which &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;20,652 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; were classified within non-current financial liabilities in the Group&#x2019;s annual financial statements for the year ended &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.86pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;December 31, 2023. In application of these amendments, all of the carrying value of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;29,605&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; is now presented &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;within current financial liabilities.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;The classification of the Kreos / Claret OCABSA will not be impacted since they are compound instruments with conversion option &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;and attached OCABSA warrants recognized as an equity component.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</abvx:DisclosureOfAccountingPolicyForNewRevisedOrAmendedStandardsAndInterpretationsPolicyTextBlock>
    <abvx:ConvertibleLoansNotes contextRef="c-57" decimals="-3" id="f-529" unitRef="eur">19957000</abvx:ConvertibleLoansNotes>
    <abvx:NonCurrentConvertibleLoansNotes contextRef="c-57" decimals="-3" id="f-530" unitRef="eur">19332000</abvx:NonCurrentConvertibleLoansNotes>
    <abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes contextRef="c-58" decimals="-3" id="f-531" unitRef="eur">19957000</abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotes contextRef="c-59" decimals="-3" id="f-532" unitRef="eur">29605000</abvx:ConvertibleLoansNotes>
    <abvx:NonCurrentConvertibleLoansNotes contextRef="c-59" decimals="-3" id="f-533" unitRef="eur">20652000</abvx:NonCurrentConvertibleLoansNotes>
    <abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes contextRef="c-60" decimals="-3" id="f-534" unitRef="eur">29605000</abvx:CurrentPortionOfNonCurrentConvertibleLoansNotes>
    <abvx:DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock contextRef="c-1" id="f-535">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;New standards, amendments and interpretations issued by IASB but not yet mandatory for financial years starting from January 1, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group did not elect for early application of the following new standards, amendments and interpretations, which were issued but &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;not mandatory as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December&#160;31, 2024&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates &#x2013; Lack of Exchangeability whose application &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;is for annual reporting periods beginning on or after January 1, 2025;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 103.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#x2013; Amendments to the &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Classification and Measurement of Financial Instruments, whose application is for annual reporting periods beginning on &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.44pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or after January 1, 2026 (not yet approved by the EU); &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 143.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures &#x2013; Contracts Referencing &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 157.32pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Nature-dependent Electricity, whose application is for annual reporting periods beginning on or after January 1, 2026 &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(not yet approved by the EU); &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 184.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS 18 Presentation and Disclosure in Financial Statements, whose application is for annual reporting periods &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 197.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;beginning on or after January 1, 2027 (not yet approved by the EU); &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 211.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.89pt;"&gt;IFRS 19 Subsidiaries without Public Accountability: Disclosures, whose application is for annual reporting periods&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.89pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 222.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 288.94pt;"&gt;beginning on or after January 1, 2027 (not yet approved by the UE), and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 233.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.5pt;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 485.99pt;"&gt;Annual Improvements Volume 11, whose application is for annual reporting periods beginning on or after January 1,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.99pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 244.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: var(--position); text-decoration: none; white-space: pre; width: 141.84pt;"&gt;2026 (not yet approved by the UE).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.58pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These texts have not been early adopted. The expected impacts are not considered significant, except for IFRS 18, for which the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;has not completed its assessment to date.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</abvx:DisclosureOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedByIASBButNotYetMandatoryPolicyTextBlock>
    <abvx:DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock contextRef="c-1" id="f-536">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 140.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Significant events for the years ended December 31, 2022, 2023 and 2024 and subsequent events &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 3.1. For the year ended December 31, 2022 &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition of Prosynergia SARL &#x2013; April 2022 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 365.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On April 1, 2022, the Company acquired &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;100%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the share capital of Prosynergia SARL (or &#x201c;Prosynergia&#x201d;), a Luxembourg biotech &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;company, in order to strengthen its portfolio. The terms of the share purchase acquisition (or the &#x201c;Prosynergia SPA&#x201d;) entered on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 385.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;November 15, 2021 included an early payment of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;325&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; made on November 25, 2021 (see Note 10), an additional payment of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 395.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,925&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; made on April 1, 2022, and possible earn-out payments for a maximum additional amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 544.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; based &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on the potential evolution of the Company&#x2019;s market capitalization, a listing of the Company&#x2019;s shares on Nasdaq or a M&amp;amp;A transaction &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;incurred before March 31, 2023. In addition, the Company granted a loan of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,400&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; to Prosynergia on December 1, 2021, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which term was at least on December 31, 2025 or at an earlier date in the event of a breach in the Prosynergia SPA (see Note 10, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;Other receivables and assets&#x201d;). Such prepayment was repayable in cash only in the event the transaction is not completed. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 457.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement or out-licensed agreement, it does not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;April 1, 2022, without recognition of goodwill. Also, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,400&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; loan granted to Prosynergia in December 2021 was included &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the acquisition cost to be allocated, as it is considered a prepayment for the acquisition of the group of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. Refer to Note 25.6 for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;information related to the claim initiated by the former owner of Prosynergia on December 12, 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Merger with Prosynergia &#x2013; December 2022 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 551.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On December&#160;12, 2022, the Company completed the merger with Prosynergia under the French legal procedure called &#x201c;Transmission &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 561.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Universelle de Patrimoine&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 140.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201d;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (universal transfer of assets and liabilities). All of Prosynergia&#x2019;s assets and liabilities were transferred to &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Company and Prosynergia was dissolved. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 593.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment of ABX196 cash-generating unit &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In the first half of 2022, management took into account significant external changes in the hepatocellular carcinoma (HC) treatment &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;landscape. These changes are expected to require a new, lengthy, heavy and risky internal development process (use of a combination &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of compounds). In this context, entering into a licensing partnership to fund the completion of the clinical development of ABX196 is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the option being considered. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;However, due to the lack of progress made in the negotiation of a development partnership, the Company made the decision to freeze &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the development program for ABX196 in the treatment of hepatocellular cancer. This decision led to the full impairment of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 683.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ABX196 goodwill, i.e. an impairment loss of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13,586&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; related to Wittycell&#x2019;s goodwill and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;45&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; related to licenses. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.98pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December&#160;31, 2022, the value in use and the fair value less costs to sell of the ABX196 cash-generating unit (&#x201c;CGU&#x201d;) are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 549.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nil&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Forfeiture of AGA plans &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs granted in September 2021 were subject to vesting conditions including the completion of a M&amp;amp;A transaction on or prior to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;July 31, 2022. As the non-market performance vesting conditions were not satisfied, the Company recognized a reversal of related &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;compensation expense of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,026&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and accrual for social taxes of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;205&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the financial statements for the period &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ended December&#160;31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayment of the advance made to Nice CHU &#x2013; August 2022 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; advance made to Nice CHU was reimbursed in August 2022 for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,302&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The remaining &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;698&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; was settled by way of compensation with a payable due to the Nice CHU related to the recharge of third-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;party services expenses that had been invoiced to the Nice CHU as part of the miR-AGE project (see Note 10, &#x201c;Other receivables and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets&#x201d;). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Change in governance &#x2013; August 2022 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August&#160;16, 2022, the Company announced a transition in the chairmanship of its Board of Directors. Philippe Pouletty, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 244.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Company&#x2019;s founder and Chairman of the Board of Directors since the Company was created in 2013, informed the Board of Directors &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 254.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of his decision to resign as Chairman with immediate effect. However, after many years of successfully leading the Board of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Directors, Mr.&#160;Pouletty continued to support the Company&#x2019;s development as a member of the Board of Directors. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pending the appointment of a new, permanent independent Chair, Ms.&#160;Corinna zur Bonsen-Thomas, an independent member of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Board of Directors of the Company, carried out the role of interim Chair.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Company completed &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 137.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;49.2&#160;million&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 191.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; cross-over financing with top-tier US and European investors &#x2013; September 2022 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On September 2, 2022, the Company announced oversubscribed financing of around &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;49.2&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, led by TCGX with the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;participation of Venrock Healthcare Capital Partners, Deep Track Capital, Sofinnova Partners, Invus and Truffle Capital, top-tier &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;investors specializing in the biotechnology sector. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The financing consists of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; transactions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;a reserved capital increase of a gross amount of approximately &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;46.2&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.34999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; through the issuance of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5,530,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; new &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;shares with a nominal value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.41000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share, representing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of its current share capital, at a subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8.36&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;an issue of royalty certificates with a subscription price amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2.9&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.72999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The royalty certificates give right to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their holders to royalties equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.66000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the future net sales of obefazimod. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(worldwide and for all indications) as from the commercialization of such product. The amount of royalties that may be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;paid under the royalty certificates is capped at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;172&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The proceeds of the financing were primarily used to fund the advancement of Phase 3 clinical trials for obefazimod in ulcerative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;colitis. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Related transaction costs amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3.3&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and were deducted from the share premiums. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates are recorded as financial liabilities at amortized cost (see Note 15.10). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Company announces first U.S. patient enrollment in global Phase 3 program with obefazimod in UC&#160;&#x2013;&#160;October 2022 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On October&#160;11, 2022, the Company announced that the first patient was enrolled in the United States into its global Phase 3 clinical &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;program with product candidate obefazimod for the treatment of moderately to severely active UC. IQVIA, a global premier contract &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;research organization, is responsible for coordinating the Company&#x2019;s Phase 3 clinical trial for obefazimod in UC. As of December&#160;31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022, the undiscounted amount of the advance payments made by the Company in relation to the IQVIA agreement is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12,187&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. They were recorded at inception at their fair value (discounted amount) and subsequently measured at amortized &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;cost calculated using the effective interest rate method. As of December&#160;31, 2022, their carrying amount is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10,471&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;repayment dates of these advances are scheduled between April 2025&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and July 2026 (see Note 9).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 3.2. For the year ended December 31, 2023 &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Company announces successful oversubscribed &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 246.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;130.0&#160;million&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 304.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; cross-over financing at market price with top-tier U.S. and &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;European Biotech investors &#x2013; February 2023 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On February&#160;22, 2023, the Company announced the successful pricing of an oversubscribed &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;130.0&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; financing with high-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;quality U.S. and European biotech specialist investors, led by TCGX, with participation from existing investors Invus, Deep Track &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Capital, Sofinnova Partners, and Venrock Healthcare Capital Partners, as well as from new investors Great Point Partners, LLC, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deerfield Management Company, Commodore Capital, Samsara BioCapital, Boxer Capital and others, by way of a reserved capital &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;130&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; through the issuance of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;20,000,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; newly-issued ordinary shares with a nominal value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 517.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;representing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;89.6%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of its current share capital, at a subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.50&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Related transaction costs amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.7&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and were deducted from the share premiums. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Change in governance and management &#x2013; February-August 2023 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On April&#160;5, 2023, the Company announced the appointment of Marc de Garidel as Chief Executive Officer (&#x201c;CEO&#x201d;) and Interim &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Board Chair, effective May&#160;5, 2023. Corinna zur Bonsen-Thomas stepped down as acting Chair, a position she held since August &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022, and remains a Board Member. Prof. Hartmut J. Ehrlich, M.D., retired from the CEO position, which he held since the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Company&#x2019;s founding in 2013,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and will stay on as a strategic advisor until the transition is complete. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 548.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On February 17, 2023, and April 18, 2023, the Company respectively announced the appointments of Dr. Sheldon Sloan, M.D., M. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Bioethics as new Chief Medical Officer and Michael Ferguson as new Chief Commercial Officer. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 582.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On July 11, 2023, the Group announced the appointments of June Lee, M.D. and Troy Ignelzi as new independent members of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group&#x2019;s Board of Directors, replacing Joy Amundson and Jean-Jacques Bertrand. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 23, 2023, the Group announced the appointment of Patrick Malloy as new Senior Vice President Investor Relations.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 638.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Creation of Abivax LLC &#x2013; March 2023 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On March&#160;20, 2023, Abivax LLC (or the "Subsidiary&#x201d;), was incorporated as a&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 347.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;limited liability company&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 450.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;under the laws of Delaware. &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of the issuance of the financial statements, the Company has full ownership over the Subsidiary. The Subsidiary hosts the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;operations in the United States. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cashless exercise of the Kreos A&amp;amp;B BSA &#x2013; May 2023 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On May 24, 2023, Kreos Capital V UK Ltd (or &#x201c;Kreos&#x201d;) opted for the cashless exercise option of the share warrants they held (as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;defined in Note 15.3), implemented through the repurchase by the Group of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43,070&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; tranche A share warrants (&#x201c;Kreos A BSA&#x201d;) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43,070&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; tranche B share warrants (&#x201c;Kreos B BSA&#x201d;) and the issuance of respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67,887&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 417pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31,696&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares, as a result of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the exercise by Kreos of the outstanding Kreos A &amp;amp; B BSA. The accounting treatment of the operation is set forth in Note 15.3.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Free shares compensation plans&#160; &#x2013; July-December 2023 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In July, September and December 2023, the Group issued &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.40999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;five&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; free shares compensation plans (&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 417.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;attributions gratuites d&#x2019;actions&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, or &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;AGAs&#x201d;) to certain of its officers and employees, representing a maximum of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,601,296&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; shares in the aggregate. The detailed terms &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and conditions and the accounting treatment of these plans are presented in Note 14.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group secures financing up to &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 177.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;150&#160;million&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 228.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 252.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 266.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; structured debt financing transactions &#x2013; August 2023 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 20, 2023, the Group concurrently signed &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.41999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; structured debt financing transactions for a total amount of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;150&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;consisting of (i) up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;75&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from Kreos Capital and Claret European Growth Capital (the &#x201c;Kreos / Claret Financing&#x201d;) together &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with the issuance of warrants (&#x201c;the Kreos / Claret BSA&#x201d;) exercisable to receive ordinary shares of the Company, for an aggregate &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;exercise price of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and (ii) up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;75&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from a fund advised by Heights Capital Management, Inc. (the &#x201c;Heights &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financing&#x201d; and together with the Kreos / Claret Financing, the &#x201c;Transaction&#x201d;). The detailed structure and characteristics of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Transaction are set forth&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; in Notes 15.1 and 15.2.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The first tranches of the Kreos / Claret Financing and the Heights Financing, for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;35&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively, were &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 327.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;drawn on August 22, 2023, and August 24, 2023, respectively. In addition, the Group concurrently granted to Kreos and Claret, for no &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;additional consideration, warrants exercisable to receive ordinary shares of the Company for an aggregate exercise price of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As part of the Transaction, the Group is also repaying in full a total outstanding amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;33&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; under (i) the pre-existing debt &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreements with Kreos for a total amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and (ii) the pre-existing OCEANE bonds for a total amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;way of set-off with the Heights Financing, thereby fully repaying such pre-existing indebtedness. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The net proceeds of the drawdown of the first tranche of the Kreos / Claret Financing and of the Heights Financing which, net of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;refinancing of the existing indebtedness, amount to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;27&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the aggregate, are expected to be allocated mainly to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;development of obefazimod for the treatment of adults with moderately to severely active UC and other potential chronic &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;inflammatory indications, as well for working capital and general corporate purposes of the Group. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On November 2, 2023, the Group granted additional warrants to Kreos and Claret, for an aggregate exercise price of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.5899999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in order to secure the future drawdown of the third tranche of the Kreos / Claret debt financing. The detailed characteristics of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issuance is set forth in Note 15.1.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 518.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group announces closing of its Initial Public Offering on the Nasdaq Global Market &#x2013; October 2023&#160;  &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On October 24, 2023, the Group announced the closing of its previously announced initial public offering on the Nasdaq Global &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Market by way of a capital increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;20,325,500&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; new ordinary shares, consisting of a public offering of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18,699,460&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the form of American Depositary Shares (&#x201c;ADSs&#x201d;), each representing the right to receive &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary share, in the United States &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(the &#x201c;U.S. Offering&#x201d;), and a concurrent offering of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,626,040&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares in certain jurisdictions outside of the United States to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 586.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certain investors (the &#x201c;European Private Placement&#x201d;, and together with the U.S. offering, the &#x201c;Global Offering&#x201d;). The offering price &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 598.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was set at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$11.60&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ADS in the U.S. Offering and a corresponding offering price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.9864&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ordinary share in the European &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Private Placement. All of the ADSs and ordinary shares in the Global Offering were offered by the Group. The ADSs began trading on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Nasdaq Global Market on October 20, 2023. The aggregate gross proceeds were approximately &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$235.8&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, equivalent to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 632.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;approximately &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;223.3&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; based on the exchange rate then in effect, before deduction of underwriting commissions and expenses &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 644.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;payable by the Group.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The net proceeds of the Global Offering were&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;$212.2&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; (&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;202.0&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;), after deducting &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;$23.6&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; (&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;21.3&#160;million&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 528.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;) i&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;n &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;transaction costs. These costs were deducted from the share premiums.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 3.3. For the year ended December 31, 2024 &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Changes in governance &#x2013; February-December 2024 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On February 7, 2024, the Group announced the appointment of Ana Sharma as Vice President, Global Head of Quality. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On April 2, 2024, the Group announced the appointment of Camilla Soenderby as Independent Board Member and also a member of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Appointments and Compensation Committee. Ms. Soenderby replaces Sant&#xe9; Holdings S.R.L., represented by Mr. Paolo Rampulla, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;who will continue to contribute to the work of the Board of Directors as an observer alongside Mr. Maurizio PetitBon from Kreos &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 202.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Capital/Blackrock.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In July&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.489999999999995pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; 2024, the Group announced the appointment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of Sylvie Gr&#xe9;goire as Independent Board Member, Chairman of the Board and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;also a member of the Audit Committee. Ms. Gr&#xe9;goire replaces Ms. Brosgart as Director, Mr. de Garidel as Chairman, and Mr. Hong as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;member of the Audit Committee. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On November 13, 2024, the Group announced the appointment of Mark Stenhouse as Board Observer &amp;amp; Advisor to the Group.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On December 23, 2024, the Group announced the resignation of Dr. Philippe Pouletty, representative of Truffle Capital, as director of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group, effective on December 31, 2024&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 311.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based compensation plans&lt;span style="display: inline-block; height: 8.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 168.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 174.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2013; February-September 2024 &lt;span style="display: inline-block; height: 8.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In February, March, May, July and September 2024, the Group issued &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;seven&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; free-share compensation plans to certain of its officers &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and employees, representing a maximum of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,946,125&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; shares in the aggregate, the vesting of which is subject to the following service &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 359.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;condition: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the AGAs vest at the end of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 397.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 517.6700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 369.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the allocation date and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date (with the exception of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;20,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; 2024-6 AGAs, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;whose vesting conditions are set forth in Note 14).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 399.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In March 2024, the Group granted its independent Board members the right to subscribe up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;77,820&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share warrants (BSA) in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 409.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;aggregate, the vesting of which (if subscribed) is subject to a service condition of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, by tranches of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, vested on each &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;anniversary date. All the BSAs have been subscribed.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 443.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Drawdown of Tranches B and C of the Kreos / Claret Financing &#x2013; March-June 2024 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 469.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On March 28, 2024 and June 21, 2024, the Group drew down &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; related to tranche B and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; related to tranche C of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 480.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;senior secured non-convertible bonds from the Kreos / Claret Financing.&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 325.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These second and third tranches each consist of &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25,000,000&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;senior secured non-convertible bonds with a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1.00&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, that will not be listed on any market.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The detailed characteristics of these bond loans and their accounting treatments are set forth in Note 15.1.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 530pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Bpifrance RNP-VIR and Carena conditional advances &#x2013; June 2024&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In June 2024, the Group and Bpifrance renegotiated the RNP-VIR and CARENA conditional advances:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 580pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Between September 2017 and November 2019, the Group had received repayable conditional advances amounting &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 593.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,032&#160;thousands&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and subsidies amounting to &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,123&#160;thousand&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in relation to the RNP-VIR project, which aimed at &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;discovering new molecules for the treatment of viral infectious diseases through the development of the &#x201c;Modulation of RNA &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;biogenesis&#x201d; platform. In June 2024, the Group and Bpifrance agreed to terminate the project &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;due to technical failure, and &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;B&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;pifrance agreed to waive &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the remaining advance&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s. &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;See Note 15.7 "Conditional Advances".&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 662.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Between December 2013 and June 2016, the Group had received repayable conditional advances amounting &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,187&#160;thousands&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in relation to the CARENA project, which aimed at developing an anti-HIV-AIDS therapeutic program &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with the compound ABX464 up to the Phase 2b study. In June 2024, the Group and Bpifrance agreed to terminate the project &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;due to technical failure, and Bpifrance agreed to waive &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.66999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the remaining conditional advance. See Note 15.7 &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 84.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;"Conditional Advances".&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 109.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group fully reimbursed the remaining conditional advances for both programs during the last quarter of 2024. The subsidy &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 121.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;income recognized over the period, corresponding to the amounts waived by Bpifrance and related interests, amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,123&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the aggregate (see Note 18).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 167.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Establishment of an At-the-Market ("ATM") Program on Nasdaq - November 2024&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On November 19, 2024, the Group announced the implementation of an At-The-Market program (&#x201c;ATM Program&#x201d;) allowing the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in the form of ADSs, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;each ADS representing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary share, nominal value &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share, of the Group, with aggregate gross sales proceeds of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$150,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (subject to French regulatory limits and within the limits of the investors&#x2019; requests expressed in the context of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 236.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;program), from time to time, pursuant to the terms of an equity distribution agreement with Piper Sandler &amp;amp; Co. (&#x201c;Piper Sandler&#x201d;), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;acting as sales agent. The timing of any issuances in the form of ADSs will depend on a variety of factors. The ATM Program will be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;effective until terminated in accordance with the equity distribution agreement or if ADSs representing the maximum gross sales &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;proceeds have been sold thereunder. To the extent that ADSs are sold pursuant to the ATM Program, the Group currently intends to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;use the net proceeds (after deduction of fees and expenses), if any, of sales of ADSs issued under the ATM Program primarily to fund &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the research and development of the Group's product candidates, for working capital and general corporate purposes, at its discretion.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A shelf registration statement on Form F-3, including a base prospectus relating to the Group's securities and an equity distribution &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement prospectus relating to the ATM Program, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was filed with the&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; SEC and went into effect during 2024&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The base prospectus &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;provides for the potential sale of ADSs of the Group with aggregate gross sales proceeds of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$350,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (including the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 351.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$150,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; covered by the equity distribution agreement prospectus) to grant additional flexibility to the Group in connection &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with its financing strategy. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in one or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;more prospectus supplements to the base prospectus. A&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s of the date of issuance of these &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; statements, the Group has not &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 385.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;utilized the ATM Program&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.26999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 3.4. Subsequent events&#160; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 457.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based compensation plans&lt;span style="display: inline-block; height: 8.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: italic; font-weight: normal; left: 168.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 174.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2013; January-February 2025&lt;span style="display: inline-block; height: 8.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In January 2025, the Group granted its independent Board members, as well as one of its Board Observers and Advisor, the right to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subscribe up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;125,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share warrants (BSA) in the aggregate, the vesting of which (if subscribed) is subject to a service condition of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, by tranches of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, vested on January, 1 of each year.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In February 2025,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the Group issued &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; free-share compensation plans to certain of its officers and employees, representing a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;maximum of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4,490,727&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; shares in the aggregate, the vesting of which is subject to the following service condition: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the AGAs &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;vest at the end of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.3399999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 563.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the end of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date (with the exception of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;123,102&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; 2025-2 AGAs, which vest at the end of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abvx:DisclosureOfSignificantEventsForThePeriodReportedAndEventsAfterReportingPeriodTextBlock>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c-61" decimals="2" id="f-537" unitRef="number">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <abvx:CashPrepaymentAssetsAcquisitions contextRef="c-62" decimals="-3" id="f-538" unitRef="eur">325000</abvx:CashPrepaymentAssetsAcquisitions>
    <abvx:CashTransferredAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-539" unitRef="eur">2925000</abvx:CashTransferredAssetsAcquisitions>
    <abvx:EarnOutMaximumAmount contextRef="c-63" decimals="-3" id="f-540" unitRef="eur">4000000</abvx:EarnOutMaximumAmount>
    <ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="c-64" decimals="-3" id="f-541" unitRef="eur">1400000</ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
    <abvx:LoanGrantedAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-542" unitRef="eur">1400000</abvx:LoanGrantedAssetsAcquisitions>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill contextRef="c-65" decimals="-3" id="f-543" unitRef="eur">13586000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-65" decimals="-3" id="f-544" unitRef="eur">45000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife contextRef="c-66" decimals="-3" id="f-545" unitRef="eur">0</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-67" decimals="-3" id="f-546" unitRef="eur">-1026000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes contextRef="c-67" decimals="-3" id="f-547" unitRef="eur">-205000</abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes>
    <abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals contextRef="c-68" decimals="-3" id="f-548" unitRef="eur">4000000</abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals>
    <abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals contextRef="c-69" decimals="-3" id="f-549" unitRef="eur">-3302000</abvx:CashAdvancesAndLoansMadeToReimbursedFromHospitals>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-70" decimals="-3" id="f-550" unitRef="eur">698000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <abvx:FinancialAgreementAmount contextRef="c-71" decimals="-5" id="f-551" unitRef="eur">49200000</abvx:FinancialAgreementAmount>
    <abvx:FinancialAgreementAmount contextRef="c-71" decimals="-5" id="f-552" unitRef="eur">49200000</abvx:FinancialAgreementAmount>
    <abvx:FinancialAgreementNumberOfTransactions
      contextRef="c-72"
      decimals="INF"
      id="f-553"
      unitRef="transaction">2</abvx:FinancialAgreementNumberOfTransactions>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-72" decimals="-5" id="f-554" unitRef="eur">46200000</ifrs-full:ProceedsFromIssuingShares>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-72" decimals="0" id="f-555" unitRef="shares">5530000</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:ParValuePerShare
      contextRef="c-71"
      decimals="2"
      id="f-556"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:EquityIssuancePercentageOfCurrentShareCapital contextRef="c-71" decimals="2" id="f-557" unitRef="number">0.33</abvx:EquityIssuancePercentageOfCurrentShareCapital>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-71"
      decimals="2"
      id="f-558"
      unitRef="eurPerShare">8.36</abvx:EquityIssuanceSubscriptionPricePerShare>
    <abvx:NetProceedsFromSaleOfRoyaltyCertificates contextRef="c-72" decimals="-5" id="f-559" unitRef="eur">2900000</abvx:NetProceedsFromSaleOfRoyaltyCertificates>
    <abvx:RoyaltyCertificatePercentageOfFutureSales contextRef="c-72" decimals="2" id="f-560" unitRef="number">0.02</abvx:RoyaltyCertificatePercentageOfFutureSales>
    <abvx:RoyaltyCertificateMaximumAmount contextRef="c-71" decimals="-6" id="f-561" unitRef="eur">172000000</abvx:RoyaltyCertificateMaximumAmount>
    <ifrs-full:ShareIssueRelatedCost contextRef="c-73" decimals="-5" id="f-562" unitRef="eur">3300000</ifrs-full:ShareIssueRelatedCost>
    <abvx:PaymentsForAdvancesMadeToContractResearchOrganizations contextRef="c-74" decimals="-3" id="f-563" unitRef="eur">12187000</abvx:PaymentsForAdvancesMadeToContractResearchOrganizations>
    <abvx:NonCurrentAdvancesToCROContracts contextRef="c-6" decimals="-3" id="f-564" unitRef="eur">10471000</abvx:NonCurrentAdvancesToCROContracts>
    <abvx:FinancialAgreementAmount contextRef="c-75" decimals="-3" id="f-565" unitRef="eur">130000000</abvx:FinancialAgreementAmount>
    <abvx:FinancialAgreementAmount contextRef="c-75" decimals="-5" id="f-566" unitRef="eur">130000000</abvx:FinancialAgreementAmount>
    <ifrs-full:IssueOfEquity contextRef="c-76" decimals="-6" id="f-567" unitRef="eur">130000000</ifrs-full:IssueOfEquity>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-76" decimals="0" id="f-568" unitRef="shares">20000000</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:ParValuePerShare
      contextRef="c-75"
      decimals="2"
      id="f-569"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:EquityIssuancePercentageOfCurrentShareCapital contextRef="c-77" decimals="3" id="f-570" unitRef="number">0.896</abvx:EquityIssuancePercentageOfCurrentShareCapital>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-75"
      decimals="2"
      id="f-571"
      unitRef="eurPerShare">6.50</abvx:EquityIssuanceSubscriptionPricePerShare>
    <ifrs-full:ShareIssueRelatedCost contextRef="c-78" decimals="-5" id="f-572" unitRef="eur">6700000</ifrs-full:ShareIssueRelatedCost>
    <abvx:NumberOfOtherShareWarrantsRepurchased contextRef="c-79" decimals="0" id="f-573" unitRef="shares">43070</abvx:NumberOfOtherShareWarrantsRepurchased>
    <abvx:NumberOfOtherShareWarrantsRepurchased contextRef="c-80" decimals="0" id="f-574" unitRef="shares">43070</abvx:NumberOfOtherShareWarrantsRepurchased>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-79" decimals="0" id="f-575" unitRef="shares">67887</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-80" decimals="0" id="f-576" unitRef="shares">31696</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <abvx:NumberOfShareBasedCompensationPlansIssued contextRef="c-81" decimals="INF" id="f-577" unitRef="plan">5</abvx:NumberOfShareBasedCompensationPlansIssued>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-81"
      decimals="INF"
      id="f-578"
      unitRef="shares">2601296</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:FinancialAgreementAmount contextRef="c-82" decimals="-6" id="f-579" unitRef="eur">150000000</abvx:FinancialAgreementAmount>
    <abvx:FinancialAgreementNumberOfTransactions
      contextRef="c-83"
      decimals="INF"
      id="f-580"
      unitRef="transaction">2</abvx:FinancialAgreementNumberOfTransactions>
    <abvx:FinancialAgreementNumberOfTransactions
      contextRef="c-83"
      decimals="INF"
      id="f-581"
      unitRef="transaction">2</abvx:FinancialAgreementNumberOfTransactions>
    <abvx:FinancialAgreementAmount contextRef="c-82" decimals="-6" id="f-582" unitRef="eur">150000000</abvx:FinancialAgreementAmount>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-84" decimals="-6" id="f-583" unitRef="eur">75000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <abvx:AggregateExercisePriceOtherEquityInstrumentsGranted contextRef="c-85" decimals="-6" id="f-584" unitRef="eur">8000000</abvx:AggregateExercisePriceOtherEquityInstrumentsGranted>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-86" decimals="-6" id="f-585" unitRef="eur">75000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-87" decimals="-6" id="f-586" unitRef="eur">25000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-88" decimals="-6" id="f-587" unitRef="eur">35000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <abvx:AggregateExercisePriceOtherEquityInstrumentsGranted contextRef="c-89" decimals="-6" id="f-588" unitRef="eur">4000000</abvx:AggregateExercisePriceOtherEquityInstrumentsGranted>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-90" decimals="-6" id="f-589" unitRef="eur">33000000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-91" decimals="-6" id="f-590" unitRef="eur">8000000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-92" decimals="-6" id="f-591" unitRef="eur">25000000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness contextRef="c-93" decimals="-6" id="f-592" unitRef="eur">27000000</abvx:ProceedsFromBorrowingsNetOfRefinancingOfExistingIndebteness>
    <abvx:IssuanceOfOtherShareWarrants contextRef="c-94" decimals="-6" id="f-593" unitRef="eur">4000000</abvx:IssuanceOfOtherShareWarrants>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-95" decimals="0" id="f-594" unitRef="shares">20325500</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-96" decimals="0" id="f-595" unitRef="shares">18699460</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <abvx:NumberOfSharesReceivedPerADS
      contextRef="c-96"
      decimals="INF"
      id="f-596"
      unitRef="shares">1</abvx:NumberOfSharesReceivedPerADS>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-97" decimals="0" id="f-597" unitRef="shares">1626040</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <abvx:IssueOfEquityOfferingPricePerShare
      contextRef="c-98"
      decimals="2"
      id="f-598"
      unitRef="usdPerShare">11.60</abvx:IssueOfEquityOfferingPricePerShare>
    <abvx:IssueOfEquityOfferingPricePerShare
      contextRef="c-99"
      decimals="4"
      id="f-599"
      unitRef="eurPerShare">10.9864</abvx:IssueOfEquityOfferingPricePerShare>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-95" decimals="-5" id="f-600" unitRef="usd">235800000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-95" decimals="-5" id="f-601" unitRef="eur">223300000</ifrs-full:ProceedsFromIssuingShares>
    <abvx:ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants contextRef="c-95" decimals="-5" id="f-602" unitRef="usd">212200000</abvx:ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants>
    <abvx:ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants contextRef="c-95" decimals="-5" id="f-603" unitRef="eur">202000000</abvx:ProceedsFromIssuingSharesOtherThanThroughExerciseOfWarrants>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c-95" decimals="-5" id="f-604" unitRef="usd">23600000</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c-95" decimals="-5" id="f-605" unitRef="eur">21300000</ifrs-full:PaymentsForShareIssueCosts>
    <abvx:NumberOfFreeSharesPlansIssued contextRef="c-100" decimals="INF" id="f-606" unitRef="plan">7</abvx:NumberOfFreeSharesPlansIssued>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-101"
      decimals="INF"
      id="f-607"
      unitRef="shares">1946125</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-102" decimals="2" id="f-608" unitRef="number">0.50</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-102" id="f-609">P2Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-103" decimals="2" id="f-610" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-103" id="f-611">P3Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-104" decimals="2" id="f-612" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-104" id="f-613">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-105"
      decimals="INF"
      id="f-614"
      unitRef="shares">20000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-106"
      decimals="INF"
      id="f-615"
      unitRef="shares">77820</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-106" id="f-616">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-106" decimals="2" id="f-617" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-107" decimals="-6" id="f-618" unitRef="eur">25000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-108" decimals="-6" id="f-619" unitRef="eur">25000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-109" decimals="-3" id="f-620" unitRef="eur">25000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <ifrs-full:ParValuePerShare
      contextRef="c-109"
      decimals="2"
      id="f-621"
      unitRef="eurPerShare">1.00</ifrs-full:ParValuePerShare>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-110" decimals="-3" id="f-622" unitRef="eur">4032000</abvx:ProceedsFromConditionalAdvances>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities contextRef="c-110" decimals="-3" id="f-623" unitRef="eur">1123000</ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities>
    <abvx:PercentageOfConditionalAdvancesWaived contextRef="c-111" decimals="2" id="f-624" unitRef="number">0.60</abvx:PercentageOfConditionalAdvancesWaived>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-112" decimals="-3" id="f-625" unitRef="eur">2187000</abvx:ProceedsFromConditionalAdvances>
    <abvx:PercentageOfConditionalAdvancesWaived contextRef="c-113" decimals="2" id="f-626" unitRef="number">0.60</abvx:PercentageOfConditionalAdvancesWaived>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-114" decimals="-3" id="f-627" unitRef="eur">4123000</ifrs-full:RevenueFromGovernmentGrants>
    <abvx:NumberOfADSPerOrdinaryShares
      contextRef="c-115"
      decimals="INF"
      id="f-628"
      unitRef="shares">1</abvx:NumberOfADSPerOrdinaryShares>
    <ifrs-full:ParValuePerShare
      contextRef="c-115"
      decimals="2"
      id="f-629"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:ExpectedProceedsFromShareIssuance contextRef="c-116" decimals="-3" id="f-630" unitRef="usd">150000000</abvx:ExpectedProceedsFromShareIssuance>
    <abvx:ExpectedProceedsFromShareIssuanceShelfRegistration contextRef="c-116" decimals="-3" id="f-631" unitRef="usd">350000000</abvx:ExpectedProceedsFromShareIssuanceShelfRegistration>
    <abvx:ExpectedProceedsFromShareIssuance contextRef="c-116" decimals="-3" id="f-632" unitRef="usd">150000000</abvx:ExpectedProceedsFromShareIssuance>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-117"
      decimals="INF"
      id="f-633"
      unitRef="shares">125000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-117" id="f-634">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-118" decimals="2" id="f-635" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-119" decimals="2" id="f-636" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-120" decimals="2" id="f-637" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-121" decimals="2" id="f-638" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:NumberOfFreeSharesPlansIssued contextRef="c-122" decimals="INF" id="f-639" unitRef="plan">4</abvx:NumberOfFreeSharesPlansIssued>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-123"
      decimals="INF"
      id="f-640"
      unitRef="shares">4490727</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-124" decimals="2" id="f-641" unitRef="number">0.50</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-124" id="f-642">P2Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-125" decimals="2" id="f-643" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-125" id="f-644">P3Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage contextRef="c-126" decimals="2" id="f-645" unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-126" id="f-646">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-127"
      decimals="INF"
      id="f-647"
      unitRef="shares">123102</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-127" id="f-648">P2Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory contextRef="c-1" id="f-649">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting principles &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.1. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Following initial recognition, goodwill is stated at cost less any accumulated impairment losses (see Note 4.4). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In respect of business combinations prior to January 1, 2020, in accordance with IFRS 1 exemption, goodwill is included on the basis &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of its deemed cost, which represents the amount recorded under the prior basis of accounting, French GAAP, (&#x201c;Previous GAAP&#x201d;). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.2. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible assets &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 38&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, intangible assets acquired are recognized as assets on the statements of financial position at &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their acquisition cost. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Licenses &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Payments for separately acquired research and development are capitalized within &#x201c;Other intangible assets&#x201d; provided that they meet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the definition of an intangible asset: a resource that is (i)&#160;controlled by the Group, (ii) expected to provide future economic benefits for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group and (iii)&#160;identifiable (i.e., it is either separable or arises from contractual or legal rights). In accordance with paragraph 25 of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IAS 38&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, the recognition criterion relating to the likelihood of future economic benefits generated by the intangible &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;asset, is presumed to be achieved for research and development activities when they are acquired separately. In this context, amounts &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;paid to third parties in the form of initial payments or milestone payments relating to pharmaceutical specialties that have not yet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obtained a marketing authorization are recognized as intangible assets. These rights will be amortized on a straight-line basis, after &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obtaining the marketing authorization, over their useful life. Unamortized rights (before marketing authorization) are subject to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;impairment tests in accordance with the method defined in Note 4.4. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development costs &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 38 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, research costs are expensed in the period during which they are incurred. Development costs &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are only recognized as intangible assets if the following criteria are met: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;it is technically feasible to complete the development of the project; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;it is the Group&#x2019;s intention to complete the project and to utilize it; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;it has capacity to utilize the intangible asset; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;there is proof of the probability of future economic benefits associated with the asset &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;there is availability of the technical, financial and other resources for completing the project; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;there is a reliable evaluation of the development expenses. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The initial measurement of the asset is the sum of expenses incurred starting on the date on which the development project meets the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;above criteria. Because of the risks and uncertainties related to regulatory authorizations and to the research and development process, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group believes that the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;six&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; criteria stipulated by IAS 38 have not been fulfilled to date and the application of this principle has &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;resulted in all development costs being expensed as incurred in all periods presented. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other intangible assets &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other intangible assets mainly consist of acquired software. Costs related to the acquisition of software licenses are recognized as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets based on the costs incurred to acquire and set up the related software. Other intangible assets are amortized using the straight-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 492.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;line method over a period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.3. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, plant and equipment &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 16 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, Plant and Equipment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, property, plant and equipment are recognized at their acquisition cost (purchase &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price and directly attributable costs) or at their production cost by the Group, as applicable. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, plant and equipment are depreciated using the straight-line method over the estimated useful life of the asset. The principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;useful lives applied are as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 15.75pt; width: 173.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 173.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DEPRECIATION PERIOD&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Buildings&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 30pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 30pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 44.25pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Office fixtures and fittings&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 44.25pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.21pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;"&gt;(1)&lt;span style="display: inline-block; height: 4.5045pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 44.25pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 58.5pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Equipment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 58.5pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 72.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Industrial materials and equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 72.75pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 72.75pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Technical facilities&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 87pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 87pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 101.25pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Furniture and computer equipment:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 101.25pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 101.25pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 115.5pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Office equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 115.5pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 115.5pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IT equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 129.75pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;  &#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 129.75pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Furniture&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 144pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.08pt; position: var(--position); white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 144pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 35.95pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 6.93pt; width: 12.84pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.45pt; position: var(--position);"&gt;Office fixtures and fittings estimated useful lives correspond to the Paris headquarters and Boston offices residual estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;lease terms. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The useful lives of property, plant and equipment as well as any residual values are reviewed at each year-end and, in the event of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;significant change, the depreciation schedule is revised prospectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.4. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment of goodwill, intangible assets, property and plant and equipment &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill and intangible assets not yet available for use are not amortized and are tested for impairment annually. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In addition, the Group assesses at the end of each reporting period whether there is an indication that intangible assets and property, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 393.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;plant and equipment may be impaired. Pursuant to IAS 36&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 278.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment of Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, criteria for assessing indication of loss in value may &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;notably include performance levels lower than forecast, a significant change in market data or the regulatory environment, or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obsolescence or physical damage of the asset not included in the amortization/depreciation schedule. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the purpose of impairment testing, goodwill and intangible assets not yet available for use are allocated to each of the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGUs expected to benefit from synergies arising from the business combination or from the use of the intangible assets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;An impairment loss is recognized when the carrying amount of a CGU, including the goodwill, exceeds the recoverable amount of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGU. The recoverable amount of a CGU is the higher of the CGU&#x2019;s fair value less cost to sell and value-in-use. The total impairment &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;loss of a CGU is allocated first to reduce the carrying amount of goodwill allocated to the CGU and then to the other assets of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGU pro-rata on the basis of the carrying amount of each asset in the CGU. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;An impairment loss on goodwill is not reversed in a subsequent period. Impairment losses on intangible assets and property, plant and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;equipment shall be reversed subsequently if the impairment loss no longer exists or has decreased. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.5. Financial assets &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 573.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial assets at amortized cost &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (advances, loans and deposits granted to third parties and other short-term investments) and other receivables are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;non-derivative financial assets with fixed or determinable payments that are not listed on an active market. They are initially &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized at fair value plus transaction costs that are directly attributable to the acquisition or issue of the financial asset. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS 9 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial Instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;requires an entity to recognize a loss allowance for expected credit losses on a financial asset at &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amortized cost at each statement of financial position date. The amount of the loss allowance for expected credit losses equal to: (i)&#160;the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12&#x2014;month expected credit losses or (ii)&#160;the full lifetime expected credit losses. The latter applies if credit risk has increased &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;significantly since initial recognition of the financial instrument. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group classifies investments as cash equivalents in the statements of financial position and statements of cash flows when they &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;meet the conditions of IAS 7&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 161.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statement of Cash Flows, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;i.e., when they are: &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;held in order to face short-term cash commitments; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;short term and highly liquid assets at acquisition date, readily convertible into known amount of cash and not exposed to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;any material risk of change in value. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.6. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share capital &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary shares are classified in shareholders&#x2019; equity. Costs associated with the issuance of new shares are directly accounted for in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;shareholders&#x2019; equity in diminution of issuance premium. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group&#x2019;s own shares bought in the context of a brokering/liquidity agreement entered with an independent broker are presented as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a reduction of shareholders&#x2019; equity until their cancellation, their reissuance or their disposal. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.7. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based payments &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Since its inception, the Group has established several plans for compensation settled in equity instruments in the form of founders&#x2019; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share subscription warrants (&#x201c;bons de souscription de parts de cr&#xe9;ateur d&#x2019;entreprise&#x201d; or &#x201c;BCE&#x201d;), share subscription warrants (&#x201c;Bons de &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;souscription d&#x2019;actions,&#x201d; or &#x201c;BSA&#x201d;) and free shares (&#x201c;Attributions gratuites d&#x2019;actions,&#x201d; or &#x201c;AGA&#x201d;), granted to its employees, corporate &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;officers and scientific consultants. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IFRS 2&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;these awards are measured at their fair value on the date of grant. The values of the equity &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments are determined using the option pricing model (in particular, a Black and Scholes model for the BCE and BSA plans and a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Monte-Carlo simulation for the AGA plans which include market performance vesting conditions) based on the value of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;underlying equity instrument at grant date, the volatility observed in a sample of comparable listed companies and the estimated life of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the related equity instruments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group recognizes the fair value of these awards as a share-based compensation expense over the period in which the related &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;services are received, i.e. over the vesting period, with a corresponding increase in shareholders&#x2019; equity. Share-based compensation is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized by installments in consistency with their graded vesting schedule, when applicable. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the related service and non-market performance conditions at the vesting date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For share-based payment awards with market vesting conditions and non-vesting conditions, the grant-date fair value of the share-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcome. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The measurement of the fair value of BSA, BCE and AGA incorporates the market-based vesting conditions and non-vesting &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conditions as described in Note 4.16 &#x201c;Use of judgments and estimates&#x201d;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.8. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;"&gt;Note 4.8.1. Financial liabilities at amortized cost&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IFRS 9 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial Instruments, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the borrowings, the debt component of the Kreos / Claret OCABSA (classified as &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible loan notes &#x2013; see &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Compound instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Compound instruments below) and Other financial liabilities (conditional &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;advances and royalty certificates) other than financial derivative liabilities are measured at amortized cost. They are initially &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized at fair value and subsequently measured at amortized cost calculated using the effective interest rate (&#x201c;EIR&#x201d;) method. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;transaction costs that are directly attributable to the issue of the financial liability reduce that financial liability. These expenses are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;then amortized over the lifetime of the liability, on the basis of the EIR. The EIR is the rate that exactly discounts estimated future &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;cash payments through the expected life of the financial liability to the amortized cost of a financial liability. Financial liabilities that &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are due within one year are presented as current financial liabilities in the statements of financial position.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 522.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates meet the definition of financial liabilities. The Group concluded that they do not include embedded derivatives &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;related to the variability of royalties that are based on future net sales. In addition, the Group concluded that the prepayment options &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;were separate derivative instruments as their redemption price did not reimburse holders for an amount up to the approximate present &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value of lost interest for the remaining term of the host contracts. However, their value at inception and subsequent dates is nil and has &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;no impact on the financial statements. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates are initially measured at fair value (refer to note 15.10 for valuation model applied). They are subsequently &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measured at amortized cost calculated using the EIR method. The EIR is calculated based on future cash flows, which are estimated on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the basis of development and commercialization plans and budgets approved by the Board of Directors of the Group, and probability-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;weighted to reflect the probability of success of clinical studies and any other uncertainty affecting them. If there is a change in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;timing or amount of estimated cash flows, then the gross carrying amount of the amortized cost of the financial liability is adjusted in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the period of change to reflect the revised actual and estimated cash flows, with a corresponding income or expense being recognized &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in profit or loss. The revised gross carrying amount of the amortized cost of the financial liability is calculated by discounting the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;future revised estimated cash flows at the original EIR. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances and State guaranteed loan &#x2013; &#x201c;PGE&#x201d; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment for conditional advances and the State-guaranteed loan (Pr&#xea;t garanti par l'Etat, or "PGE") is set forth in Note 4.9. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment for lease liabilities is set forth in Note 4.12.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;"&gt;Note 4.8.2. Financial liabilities measured at fair value through profit or loss &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA attached to Kreos 1 bonds, the conversion option of OCEANE, certain prepayment options of bonds, the Kreos / Claret warrants &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and the Kreos / Claret Minimum Return Indemnifications ("MRI") are derivatives instruments. Derivatives are recognized initially at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value at the date the derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The resulting gain or loss from change in the fair value is recognized in profit or loss immediately, as financial expenses or income. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Hybrid instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE bonds &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and Heights convertible notes (whose characteristics are described in Note 15.2 and Note 15.5)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; are hybrid &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments. A &#x201c;hybrid contract&#x201d; is a contract that includes both a non-derivative host contract and one or more embedded derivatives. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Embedded derivatives are required to be separated from the host contract (bifurcated) if: the economic characteristics and risks of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;embedded derivative are not closely related to those of the host, a separate instrument with the same terms as the embedded derivative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;would meet the definition of a derivative, and the hybrid contract is not measured at fair value through profit or loss. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Separable embedded derivatives are required to be measured at fair value at each reporting date, with changes in fair value recognized &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 460.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in profit or loss. The initial bifurcation of a separable embedded derivative does not result in any gain or loss being recognized. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Because the embedded derivative component is measured at fair value on initial recognition, the carrying amount of the host contract &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on initial recognition is the difference between the carrying amount of the hybrid instrument and the fair value of the embedded &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivative. If the fair values of the hybrid instrument and host contract are more reliably measurable than that of the derivative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;component - e.g. because of the availability of quoted market prices - then it may be acceptable to use those values to determine the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value of the derivative on initial recognition indirectly - i.e. as a residual amount. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Heights convertible notes issued on August 24, 2023 included embedded derivatives as detailed in Note 15. The Group concluded &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;that these features were embedded derivatives that would modify the cash flows required under the contract and require to be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bifurcated from their host contract. The Group being unable to reliably value each embedded derivative at issuance date and on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subsequent reporting dates, it measured the whole hybrid instrument at fair value through profit or loss (&#x201c;FVTPL&#x201d;) as permitted by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS 9. Instruments measured at FVTPL under these conditions are measured at their fair value on issuance and on subsequent &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reporting dates, with changes in fair value recognized in profit or loss.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Compound instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret OCABSA are compound instruments (whose characteristics are describ&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ed in Note 15.1). &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A &#x201c;compound contract&#x201d; is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a contract that includes both a debt component and an equity component.&#160; The debt component (excluding the conversion option and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the attached OCABSA warrants) is initially recognized at fair value and subsequently measured at amortized cost calculated using the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EIR method. The equity component corresponding to the conversion option and the attached OCABSA warrants is recorded in equity, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the difference between the whole instrument&#x2019;s fair value (its nominal value) and the standalone fair value of the debt component.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value measurement &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;When measuring the fair value of an asset or a liability, the Company uses market observable data as far as possible. Fair values are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;level 1: fair value calculated using quoted prices in an active market for identical assets and liabilities; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;level 2: fair value calculated using valuation techniques based on observable market data such as prices for assets and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liabilities or similar parameters quoted in an active market; &#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;level 3: fair value calculated using valuation techniques based in whole or in part on unobservable inputs such as prices &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in an inactive market or a valuation based on multiples of unlisted securities. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;See Note 12 Financial assets and liabilities, Note 15 Financial liabilities. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.9. Research tax credit, subsidies and conditional advances &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group benefits from the provisions of Article 244 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 255.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;quater &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;B of the French General Tax Code relating to the French research tax &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit (&#x201c;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 68.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cr&#xe9;dit d&#x2019;Imp&#xf4;t Recherche&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201d; or &#x201c;CIR&#x201d;). The CIR is granted to companies in order to encourage them to conduct technical and &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scientific research. Companies that prove that they have expenditures which meet the required criteria (research expenditures located &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in France or, since January 1, 2005, within the European Union or in another state that is a party to the Agreement on the European &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Economic Area and has concluded a tax treaty with France that contains an administrative assistance clause) receive a tax credit that &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;can be used for the payment of the corporate tax due for the fiscal year in which the expenditures were made and the next three fiscal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;years, or as applicable, companies may receive cash reimbursement for any excess portion at the three-year period following the fiscal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;year of the expenditures. Only those companies meeting the EU definition of a small or medium-sized entity (&#x201c;SME&#x201d;) are eligible for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;payment in cash of their research tax credit (to the extent not used to offset corporate tax payables) in the year following the request &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for reimbursement. The expenditures taken into account for the calculation of the CIR involve only research expenses. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The CIR is presented under &#x201c;Other operating income&#x201d; in the statements of income (loss) as it is accounted for as a government grant &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as defined in IAS 20 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 128.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting for Government Grants and Disclosure of Government Assistanc&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;e, and as &#x201c;Other receivables and &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets&#x201d; in the statement of financial position until its payment is received. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies are non-repayable grants received by the Group and recognized in the financial statements when there exists reasonable &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assurance that the Group will comply with the conditions attached to the subsidies and the subsidies will be received. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies that are upfront payments are presented as deferred income and recognized through &#x201c;Other operating income&#x201d; for the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amount of the expenses incurred as part of the research program to which the subsidy relates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A subsidy that is to be received either as compensation for expenses or for losses already incurred, or for immediate financial support &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the Group without associated future costs, is recognized in the Statements of income (loss) as &#x201c;Other operating income&#x201d; when there &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;exists reasonable assurance that the subsidies will be received. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances and PGE &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group receives conditional advances to finance at below market interest rate research and development projects. Due to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;innovative nature of its drug candidate development programs, the Group has benefited from certain sources of financial assistance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from Bpifrance. Bpifrance provides financial assistance and support to emerging French enterprises to facilitate the development and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercialization of innovative technologies. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Funds received from Bpifrance in the form of conditional advances are recognized as financial liabilities, as the Group has a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;contractual obligation to reimburse Bpifrance for such conditional advances in cash based on a repayment schedule. Each award of an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;advance is made to help fund a specific development milestone. More tails on conditional advances are provided in Note 15.7. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 626.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Receipts or reimbursements of conditional advances are reflected as financing transactions in the statements of cash flows. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The difference between the present value of the advance at market rate (i.e., present value of contractual cash flows including principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and interests, discounted using a market rate as effective interest rate in accordance with IFRS 9) and the amount received as cash &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from the Bpifrance constitutes a subsidy within the meaning of IAS 20. Considering that these advances do not finance fixed assets, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;these subsidies are presented as &#x201c;Deferred income&#x201d; in the statement of financial position and recognized in the statement of net income &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(loss) as &#x201c;Other operating income&#x201c; on a systematic basis over the periods in which the Group recognizes as expenses the related costs &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for which the grants are intended to compensate. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The incremental interest expense resulting from the difference between (a)&#160;the market interest rate and the (b)&#160;below-market rate is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;spread over the contractual period until the last repayment and recognized in the statement of income (loss) accordingly, using the EIR &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;method. In the event of a change in estimate of contractual cash flows due under the conditional advances, the Group recalculates the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;book value of the debt resulting from the discounting of the anticipated new future cash flows at the initial EIR. The adjustment is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized in the statements of income (loss) for the period during which the modification is recognized. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In the statements of financial position, these conditional advances are recorded in &#x201c;Other financial liabilities&#x201d; as current or non-current &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;portion depending on their maturity. In the event Bpifrance waived the repayment of the advance, the corresponding liability is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derecognized and treated as a subsidy in the statements of income (loss). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The benefit resulting from the low interest of PGE loans is also recognized as a subsidy corresponding to the difference between the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;present value of the PGE at market rate and the amount received as cash. The accounting treatment is therefore similar to the above-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;mentioned accounting treatment for conditional advances. PGE are recorded in &#x201c;Borrowings&#x201d; as current or non-current portion &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;depending on their maturity. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.10. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee benefits &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group&#x2019;s employees in France benefit from retirement benefits provided under French law, which consist in the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;compensation paid by the Group to employees upon their retirement (a defined benefit plan); and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;payments of retirement pensions by the social security agencies, which are financed by the contributions made by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group and employees. As they meet the definition of a defined contribution plan, the liabilities are presented as Tax and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;employee-related payables in the statement of financial position. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In accordance with IAS 19 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 153.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee Benefits&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, the liability with respect to defined benefit plans is estimated by using the projected &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit unit method. According to this method, the cost of the retirement benefit is recognized in the statements of income (loss). The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;retirement benefit commitments are valued at the current value of the estimated future payments, discounted using the market rate for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;high quality corporate bonds with a term and currency that correspond to that estimated for the payment of the benefits. The Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;applied the decision of the IFRS IC, published on May&#160;24, 2021, that concluded that, in the case that no rights were acquired in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;event of departure before retirement age and that the rights were capped after a certain number of years of seniority (&#x201c;30 years&#x201d;), the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commitment would only be recognized for the last 30 years of the employee&#x2019;s career within the Group. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The difference between the amount of the provision at the beginning of a period and at the close of that period is recognized through &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;operating expenses for the portion representing the costs of services rendered and financial expenses for the net interest costs, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;through other comprehensive income (loss) for the portion representing the actuarial gains and losses due to changes in assumptions &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and experience adjustments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.11. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Provisions &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Provisions correspond to commitments resulting from litigation and various risks to which the Group may face in the context of its &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;operations. In accordance with IAS 37 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 199.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Provisions, Contingent Liabilities and&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 354.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Contingent Assets, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a provision is recorded when the &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group has an obligation to a third party resulting from a past event that will likely result in an outflow of resources to the third party, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and for which future cash outflows may be estimated reliably. The amount recorded as a provision is an estimate of the expenditure &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;required to settle the obligation, discounted where necessary at year &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;end.&#160; Contingent liabilities are not recognized, but are disclosed in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the notes to the financial statements unless the possibility of an outflow of economic resources is remote&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.12. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;standalone price. The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases (value of the underlying asset below &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 221.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.0 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;). For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;straight-line basis over the term of the lease. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to the end of the lease term. The lease terms used by the Group reflect the non-cancellable terms of each contract, plus any extension &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or termination options that the Group is reasonably certain to exercise or not exercise for all of the leases periods covered by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;extension options. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group incremental borrowing rate for the asset subject to the lease in the respective markets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;portion of the lease payments attributable to the repayment of lease liabilities and the portion attributable to payment of interests are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized in cash flows used in financing activities. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;incentives received and any initial direct costs incurred by the Group, and expected costs for obligations to dismantle and remove &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;right-of-use assets when they are no longer used. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the right-of-use asset or the end of the lease term. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recoverable using cash flow projections. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.13. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Translation of transactions denominated in foreign currency &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 21 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Effects of Changes in Foreign Exchange Rates&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, transactions performed by the Group in currencies other than &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 515.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their functional currency, which is the Euro, are translated at the prevailing exchange rate on the transaction date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 537.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade receivables and payables and liabilities denominated in a currency other than the functional currency are translated at the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;period-end exchange rate. Unrealized gains and losses arising on translation are recognized in net financial income / (loss). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.14. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Current and deferred tax &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax assets and liabilities for the current and prior periods are measured at the amount expected to be recovered from or paid to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;French tax authorities, using tax rates and tax laws enacted or substantively enacted at the end of the reporting period in accordance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with IAS 12 &#x2013; Income Tax. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The income tax charge for the period comprises current tax due and the deferred tax charge. The tax expense is recognized in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;statement of income (loss) unless it relates to items recorded in other comprehensive income (loss) or directly in equity, in which case &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the tax is also recorded in other comprehensive income (loss) or directly in equity. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Current taxes &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The current tax expense is calculated based on taxable profit for the period, using tax rates enacted or substantively enacted at the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;statement of financial position date. Considering the level of tax loss of the Group, no current tax expense is recognized. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred taxes &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred taxes are recognized when there are temporary differences between the carrying amount of assets and liabilities in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group&#x2019;s financial statements and the corresponding tax basis used to calculate taxable profit. Deferred taxes are not recognized if they &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 267.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;arise from the initial recognition of an asset or liability in a transaction other than a business combination which, at the time of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;transaction, does not affect either the accounting or the taxable profit (tax loss). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group applies the Amendments to IAS 12 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 232.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred Tax related to Assets and Liabilities arising from a Single Transaction&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issued on May 7, 2021, and presents the deferred tax assets and liabilities arising from such transactions separately within Note 22 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 559.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;- &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Income tax, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;rather than on a net basis. The Amendments have no impact on the Statements of financial position and the Statement of &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;comprehensive income (loss) for the periods presented.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets are recognized for all deductible temporary differences, unused tax losses and unused tax credits to the extent that &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;it is probable that the temporary difference will reverse in the foreseeable future and that taxable profit will be available against which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the deductible temporary difference, unused tax losses or unused tax credits can be utilized. See Note 4.16. Use of judgments and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;estimates and Note 22. Income tax. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.15. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting of Prosynergia acquisition &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;From April 1, 2022 up until the merger completed on December&#160;12, 2022, the Company owned a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;100%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ownership interest of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prosynergia and as such, controlled Prosynergia. The Company had power over Prosynergia, was exposed or had rights to variable &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 455.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;returns from its involvement with the entity and had the ability to affect those returns through its power over the entity. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The financial statements of Prosynergia were therefore included in the consolidated financial statements of the Company from the date &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;control was obtained, i.e. April 1, 2022. Prosynergia was merged into the Company in December&#160;12, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement or out-licensed agreement, it did not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;April 1, 2022, without recognition of goodwill. For this purpose, the following approach was applied: first measurement of any &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;identifiable asset or liability initially measured at an amount other than cost in accordance with the applicable standards, deduction &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from the cost of the group of assets of the amounts allocated to these assets and liabilities, and then allocation of the residual cost of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;acquisition to the remaining identifiable assets and liabilities based on their relative fair values at the date of acquisition. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Also, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,400&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; loan granted to Prosynergia in December 2021 was included in the acquisition cost to be allocated, since, in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;substance, it was considered as a prepayment for the acquisition of the group of assets, which is repayable in cash in the event of non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;completion of the transaction. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The potential earn-out payment to be paid in the first half of 2023 was measured at fair value on April 1, 2022, for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,446&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and included in the acquisition cost. This earn out could be triggered in the event the Group&#x2019;s market capitalization &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 133.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was in excess of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (valued at certain specified record dates), a listing of the Group&#x2019;s shares on Nasdaq or a merger and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 143.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;acquisition transaction prior to March 31, 2023. The amount of the earn-out was equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the difference between the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 153.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market capitalization and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, subject to a maximum amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4.0&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. It was payable in the first half of 2023 if &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conditions were met. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;No&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; amount was payable in the event the Group&#x2019;s market capitalization was lower than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The related &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial liability was subsequently remeasured to its fair value as of December&#160;31, 2022 estimated to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nil&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (see Note 15.9). The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;remeasurement resulted in a financial income of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,446&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; over the year ended December&#160;31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As a consequence of the earn-out condition not being met on March 31, 2023, the related financial liability was derecognized.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The allocation of the acquisition cost is as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 237.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 28.8pt; position: var(--position); top: 0pt; width: 266.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 33.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 23.16pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Amounts in thousands of euros)&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 15.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amount&#160;allocated&#160;as&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 13.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 23.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of&#160;April&#160;1,&#160;2022&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 23.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 49.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash prepayment made in 2021&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.17000000000002pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.54pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.58pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;........&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 49.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;325&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Loan granted to Prosynergia in 2021&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.9pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.48pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 63.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,400&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash payment made in 2022&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.03pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.05pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.............&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 78pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,925&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 92.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition fees (1)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.07pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.11pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;...........................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 92.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;466&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 106.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Earn-out measured at fair value&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.56pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.14000000000001pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.43pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.51pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;........&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 106.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,446&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total acquisition cost allocated&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 134.47pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 134.54999999999998pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.60999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 134.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;......&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 120.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,562&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 135pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 149.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Patents&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.48pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;...............................................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 149.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,529&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 163.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.78pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 108.94pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.22999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.38pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 163.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;42&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 177.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 177.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 192pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.32pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.06pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.35pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.39pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;......................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 192pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,571&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 206.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 206.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 220.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.72pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.00999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 67.08999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 220.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 52.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(9)&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 234.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 249pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total net assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.14pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.3pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.44999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 249pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,562&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 517.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 35.95pt; position: var(--position);"&gt; (1)&lt;span style="display: inline-block; height: 6.93pt; width: 10.34pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.45pt; position: var(--position);"&gt;Of which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;451&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; were disbursed in 2021 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in 2022. Acquired cash amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;42&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The acquisition cost was mainly allocated to Prosynergia&#x2019;s patents US 10,464,903 (filed on March 20, 2017 and granted on November &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5, 2019), EP3 429 998 (filed on March 20, 2017 and granted on September 1, 2021) and continuation US 10,745,357 (filed on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;November 1, 2019 and granted on August&#160;18, 2020). All patents will expire in 2037. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These patents cover alternative synthesis process for obefazimod and a family of close chemical analogues. They also cover &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;alternative forms of obefazimod (salts thereof and crystalline forms of said salts), the pharmaceutical composition comprising them, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 601.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;that could be of interest to the Company for future development. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 4.16. &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Use of judgments and estimates &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In order to prepare financial statements in accordance with IFRS, estimates, judgments and assumptions were made by the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;management which could affect the reported amounts of assets, liabilities, contingent liabilities, income and expenses. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These estimates are based on the assumption of going concern and are prepared in accordance with information available at the date &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the financial statements were prepared. They are reviewed on an ongoing basis using past experience and various other factors &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;considered to be reasonable as the basis to measure the carrying amount of assets and liabilities. Estimates may be revised due to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;changes in the underlying circumstances or subsequent to new information. Actual results may differ significantly from these &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;estimates in line with assumptions or different conditions. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;This note provides an overview of the areas that involved a higher degree of judgement or complexity, and of items which are more &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;likely to be materially adjusted due to changes in estimates and assumptions. Detailed information about each of these estimates and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;judgements is included in other notes together with information about the basis of calculation for each affected line item in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial statements. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Recognition and measurement of impairment of CGUs. The main assumptions used for the impairment test include &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(a)&#160;the amount of cash flows that are set on the basis of the development and commercialization plans and budgets &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;approved by Board of Directors, (b)&#160;assumptions related to the achievement of the clinical trials and the launch of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercialization, (c)&#160;the discount rate, (d) assumptions on risk related to the development and (e)&#160;for the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercialization, selling price and volume of sales. The sensitivity analysis in respect of the recoverable amount of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGUs is presented in Note 6. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Measurement of share-based payments granted to employees, corporate officers and scientific consultants, such as BCE, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA and AGA, which is based on actuarial models; these models require the use by the Group of certain calculation &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 237.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions such as the estimated vesting, the occurrence dates of a change of control or a M&amp;amp;A transaction dates, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;percentage of success (&#x201c;POS&#x201d;) of obefazimod,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the expected volatility and maturity of the underlying equity instrument &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(see Note 4.7 and Note 14), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Fair value measurement at inception and after of derivative financial instruments resulting from (i)&#160;the warrants issued &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;concomitantly with the issuance of the straight and convertible bonds to Kreos on July 24, 2018 (or &#x201c;Kreos 1&#x201d;), (ii) the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepayment option attached to the straight and convertible bonds issued to Kreos on October 2, 2020 (or &#x201c;Kreos 2&#x201d;), and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(iii)&#160;the prepayment option attached to the issuance of bond convertible into new or existing shares in July 30, 2021 (or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;OCEANE&#x201d;) (see Notes 15), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(iv) the Kreos / Claret BSA issued on August 21, 2023 and November 2, 2023, related to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranches A-B and tranche C, respectively, and (v) the Kreos / Claret Minimum Return Indemnifications related to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranches B and C, issued in March 2024 and June 2024, respectively.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Fair value measurement of financial liabilities at inception (see Note 15), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and after (for the Heights convertible notes &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issued on August 24, 2023) measured at fair value at each reporting period, with fair value changed recognized in profit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or loss, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Amortized cost measurement of royalty certificates, based on the following assumptions: (a)&#160;future cash flows, estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on the basis of development and commercialization plans and budgets approved by the Board of Directors and (b)&#160;the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;effective interest rate. The sensitivity analysis in respect of the measurement of royalty certificates is presented in Note &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Fair value measurement of the call option resulting from the equity line contracts entered into on September 30, 2019 (or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;Equity lines&#x201d;) (see Note 13.2), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Estimation of CIR, based on internal and external expenses, which meet the required criteria, incurred by the Group each &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;year (see Note 4.9), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Recognition of deferred tax assets: availability of future taxable profit against which deductible temporary differences &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and tax losses carried forward can be utilized and whether sufficient evidence exists (see Note 22). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Recognition of deferred tax assets: tax deductibility of future royalty payments related to the royalty certificates issued in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 541.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;September 2022 (see Notes 15 and 22).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Determination of the terms of the leases, including whether the Group is reasonably certain to exercise extension and/or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;termination options (see Note 15.8).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main critical judgements made by the Group&#x2019;s management impact the following items: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment of specific conditions of share-based compensation plans (see Notes 4.7 and 14).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 653.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.67pt;"&gt;&#x2022;&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 173.62pt;"&gt;Accounting treatment of the 2018 &amp;amp; 2020 &lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.67pt; position: var(--position); text-decoration: none; white-space: pre; width: 31.87pt;"&gt;Kreos 1&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.54pt; position: var(--position); text-decoration: none; white-space: pre; width: 279.42pt;"&gt; &amp;amp; 2 bonds, the 2021 OCEANE bonds, and the August 2023 Kreos /&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.96pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"&gt; &lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 664.61pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 215.9pt;"&gt;Claret and Heights Financings (see Notes 4.8 and 15).&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory contextRef="c-1" id="f-650">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Following initial recognition, goodwill is stated at cost less any accumulated impairment losses (see Note 4.4). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 663.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In respect of business combinations prior to January 1, 2020, in accordance with IFRS 1 exemption, goodwill is included on the basis &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;of its deemed cost, which represents the amount recorded under the prior basis of accounting, French GAAP, (&#x201c;Previous GAAP&#x201d;).</ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="c-1" id="f-651">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible assets &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 38&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, intangible assets acquired are recognized as assets on the statements of financial position at &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their acquisition cost. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 124.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Licenses &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Payments for separately acquired research and development are capitalized within &#x201c;Other intangible assets&#x201d; provided that they meet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the definition of an intangible asset: a resource that is (i)&#160;controlled by the Group, (ii) expected to provide future economic benefits for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group and (iii)&#160;identifiable (i.e., it is either separable or arises from contractual or legal rights). In accordance with paragraph 25 of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IAS 38&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, the recognition criterion relating to the likelihood of future economic benefits generated by the intangible &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;asset, is presumed to be achieved for research and development activities when they are acquired separately. In this context, amounts &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;paid to third parties in the form of initial payments or milestone payments relating to pharmaceutical specialties that have not yet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obtained a marketing authorization are recognized as intangible assets. These rights will be amortized on a straight-line basis, after &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obtaining the marketing authorization, over their useful life. Unamortized rights (before marketing authorization) are subject to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;impairment tests in accordance with the method defined in Note 4.4. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development costs &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 38 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, research costs are expensed in the period during which they are incurred. Development costs &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are only recognized as intangible assets if the following criteria are met: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;it is technically feasible to complete the development of the project; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;it is the Group&#x2019;s intention to complete the project and to utilize it; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;it has capacity to utilize the intangible asset; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;there is proof of the probability of future economic benefits associated with the asset &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;there is availability of the technical, financial and other resources for completing the project; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;there is a reliable evaluation of the development expenses. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The initial measurement of the asset is the sum of expenses incurred starting on the date on which the development project meets the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;above criteria. Because of the risks and uncertainties related to regulatory authorizations and to the research and development process, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group believes that the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;six&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; criteria stipulated by IAS 38 have not been fulfilled to date and the application of this principle has &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;resulted in all development costs being expensed as incurred in all periods presented. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other intangible assets &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other intangible assets mainly consist of acquired software. Costs related to the acquisition of software licenses are recognized as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets based on the costs incurred to acquire and set up the related software. Other intangible assets are amortized using the straight-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;line method over a period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;.</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <abvx:ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias
      contextRef="c-1"
      decimals="INF"
      id="f-652"
      unitRef="criteria">6</abvx:ResearchAndDevelopmentCostsRecognitionInitialMeasurementNumberOfCriterias>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c-128" id="f-653">P1Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="c-1" id="f-654">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, plant and equipment &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 16 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, Plant and Equipment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, property, plant and equipment are recognized at their acquisition cost (purchase &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price and directly attributable costs) or at their production cost by the Group, as applicable. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, plant and equipment are depreciated using the straight-line method over the estimated useful life of the asset. The principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;useful lives applied are as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 15.75pt; width: 173.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 173.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DEPRECIATION PERIOD&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Buildings&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 30pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 30pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 44.25pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Office fixtures and fittings&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 44.25pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.21pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;"&gt;(1)&lt;span style="display: inline-block; height: 4.5045pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 44.25pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 58.5pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Equipment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 58.5pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 72.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Industrial materials and equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 72.75pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 72.75pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Technical facilities&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 87pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 87pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 101.25pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Furniture and computer equipment:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 101.25pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 101.25pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 115.5pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Office equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 115.5pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 115.5pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IT equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 129.75pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;  &#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 129.75pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Furniture&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 144pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.08pt; position: var(--position); white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 144pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 35.95pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 6.93pt; width: 12.84pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.45pt; position: var(--position);"&gt;Office fixtures and fittings estimated useful lives correspond to the Paris headquarters and Boston offices residual estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;lease terms. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The useful lives of property, plant and equipment as well as any residual values are reviewed at each year-end and, in the event of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;significant change, the depreciation schedule is revised prospectively.</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="c-1" id="f-655">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, plant and equipment are depreciated using the straight-line method over the estimated useful life of the asset. The principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;useful lives applied are as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 15.75pt; width: 173.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 173.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DEPRECIATION PERIOD&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Buildings&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 30pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 30pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 44.25pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Office fixtures and fittings&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 44.25pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 3.67pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.21pt; position: var(--position); text-decoration: none; top: -2.4254999999999995pt; vertical-align: super; white-space: pre;"&gt;(1)&lt;span style="display: inline-block; height: 4.5045pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 44.25pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 58.5pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Equipment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 58.5pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 72.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Industrial materials and equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 72.75pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 72.75pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Technical facilities&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 87pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 87pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 101.25pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Furniture and computer equipment:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 101.25pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 101.25pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 115.5pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Office equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 115.5pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.95pt; position: var(--position); white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 115.5pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129.75pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IT equipment&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 129.75pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;  &#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 129.75pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144pt; width: 150.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 150.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Furniture&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 150.75pt; position: var(--position); top: 144pt; width: 95.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 2.63pt; width: 95.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.08pt; position: var(--position); white-space: pre;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 246pt; position: var(--position); top: 144pt; width: 78pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 78pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 35.95pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 6.93pt; width: 12.84pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.45pt; position: var(--position);"&gt;Office fixtures and fittings estimated useful lives correspond to the Paris headquarters and Boston offices residual estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;lease terms.</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-129" id="f-656">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-130" id="f-657">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-131" id="f-658">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-132" id="f-659">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-133" id="f-660">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-134" id="f-661">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-135" id="f-662">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-136" id="f-663">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-137" id="f-664">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory contextRef="c-1" id="f-665">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment of goodwill, intangible assets, property and plant and equipment &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill and intangible assets not yet available for use are not amortized and are tested for impairment annually. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 383.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In addition, the Group assesses at the end of each reporting period whether there is an indication that intangible assets and property, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 393.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;plant and equipment may be impaired. Pursuant to IAS 36&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 278.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment of Assets&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, criteria for assessing indication of loss in value may &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;notably include performance levels lower than forecast, a significant change in market data or the regulatory environment, or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obsolescence or physical damage of the asset not included in the amortization/depreciation schedule. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the purpose of impairment testing, goodwill and intangible assets not yet available for use are allocated to each of the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGUs expected to benefit from synergies arising from the business combination or from the use of the intangible assets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;An impairment loss is recognized when the carrying amount of a CGU, including the goodwill, exceeds the recoverable amount of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGU. The recoverable amount of a CGU is the higher of the CGU&#x2019;s fair value less cost to sell and value-in-use. The total impairment &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;loss of a CGU is allocated first to reduce the carrying amount of goodwill allocated to the CGU and then to the other assets of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGU pro-rata on the basis of the carrying amount of each asset in the CGU. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;An impairment loss on goodwill is not reversed in a subsequent period. Impairment losses on intangible assets and property, plant and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;equipment shall be reversed subsequently if the impairment loss no longer exists or has decreased.</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory contextRef="c-1" id="f-666">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial assets at amortized cost &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (advances, loans and deposits granted to third parties and other short-term investments) and other receivables are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;non-derivative financial assets with fixed or determinable payments that are not listed on an active market. They are initially &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized at fair value plus transaction costs that are directly attributable to the acquisition or issue of the financial asset. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS 9 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 74.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial Instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;requires an entity to recognize a loss allowance for expected credit losses on a financial asset at &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amortized cost at each statement of financial position date. The amount of the loss allowance for expected credit losses equal to: (i)&#160;the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12&#x2014;month expected credit losses or (ii)&#160;the full lifetime expected credit losses. The latter applies if credit risk has increased &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;significantly since initial recognition of the financial instrument.</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="c-1" id="f-667">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group classifies investments as cash equivalents in the statements of financial position and statements of cash flows when they &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;meet the conditions of IAS 7&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 161.17000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statement of Cash Flows, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;i.e., when they are: &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;held in order to face short-term cash commitments; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;short term and highly liquid assets at acquisition date, readily convertible into known amount of cash and not exposed to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;any material risk of change in value.</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory contextRef="c-1" id="f-668">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share capital &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary shares are classified in shareholders&#x2019; equity. Costs associated with the issuance of new shares are directly accounted for in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;shareholders&#x2019; equity in diminution of issuance premium. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group&#x2019;s own shares bought in the context of a brokering/liquidity agreement entered with an independent broker are presented as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;a reduction of shareholders&#x2019; equity until their cancellation, their reissuance or their disposal.</ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="c-1" id="f-669">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based payments &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Since its inception, the Group has established several plans for compensation settled in equity instruments in the form of founders&#x2019; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share subscription warrants (&#x201c;bons de souscription de parts de cr&#xe9;ateur d&#x2019;entreprise&#x201d; or &#x201c;BCE&#x201d;), share subscription warrants (&#x201c;Bons de &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;souscription d&#x2019;actions,&#x201d; or &#x201c;BSA&#x201d;) and free shares (&#x201c;Attributions gratuites d&#x2019;actions,&#x201d; or &#x201c;AGA&#x201d;), granted to its employees, corporate &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;officers and scientific consultants. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IFRS 2&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;these awards are measured at their fair value on the date of grant. The values of the equity &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments are determined using the option pricing model (in particular, a Black and Scholes model for the BCE and BSA plans and a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Monte-Carlo simulation for the AGA plans which include market performance vesting conditions) based on the value of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;underlying equity instrument at grant date, the volatility observed in a sample of comparable listed companies and the estimated life of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the related equity instruments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group recognizes the fair value of these awards as a share-based compensation expense over the period in which the related &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 220.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;services are received, i.e. over the vesting period, with a corresponding increase in shareholders&#x2019; equity. Share-based compensation is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized by installments in consistency with their graded vesting schedule, when applicable. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the related service and non-market performance conditions at the vesting date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For share-based payment awards with market vesting conditions and non-vesting conditions, the grant-date fair value of the share-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcome. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The measurement of the fair value of BSA, BCE and AGA incorporates the market-based vesting conditions and non-vesting &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;conditions as described in Note 4.16 &#x201c;Use of judgments and estimates&#x201d;.</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory contextRef="c-1" id="f-670">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;"&gt;Note 4.8.1. Financial liabilities at amortized cost&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IFRS 9 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial Instruments, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the borrowings, the debt component of the Kreos / Claret OCABSA (classified as &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible loan notes &#x2013; see &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Compound instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Compound instruments below) and Other financial liabilities (conditional &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;advances and royalty certificates) other than financial derivative liabilities are measured at amortized cost. They are initially &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized at fair value and subsequently measured at amortized cost calculated using the effective interest rate (&#x201c;EIR&#x201d;) method. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;transaction costs that are directly attributable to the issue of the financial liability reduce that financial liability. These expenses are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 454.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;then amortized over the lifetime of the liability, on the basis of the EIR. The EIR is the rate that exactly discounts estimated future &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;cash payments through the expected life of the financial liability to the amortized cost of a financial liability. Financial liabilities that &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are due within one year are presented as current financial liabilities in the statements of financial position.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 506.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 522.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates meet the definition of financial liabilities. The Group concluded that they do not include embedded derivatives &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;related to the variability of royalties that are based on future net sales. In addition, the Group concluded that the prepayment options &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;were separate derivative instruments as their redemption price did not reimburse holders for an amount up to the approximate present &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value of lost interest for the remaining term of the host contracts. However, their value at inception and subsequent dates is nil and has &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;no impact on the financial statements. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates are initially measured at fair value (refer to note 15.10 for valuation model applied). They are subsequently &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measured at amortized cost calculated using the EIR method. The EIR is calculated based on future cash flows, which are estimated on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the basis of development and commercialization plans and budgets approved by the Board of Directors of the Group, and probability-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;weighted to reflect the probability of success of clinical studies and any other uncertainty affecting them. If there is a change in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;timing or amount of estimated cash flows, then the gross carrying amount of the amortized cost of the financial liability is adjusted in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the period of change to reflect the revised actual and estimated cash flows, with a corresponding income or expense being recognized &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in profit or loss. The revised gross carrying amount of the amortized cost of the financial liability is calculated by discounting the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 150.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;future revised estimated cash flows at the original EIR. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances and State guaranteed loan &#x2013; &#x201c;PGE&#x201d; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment for conditional advances and the State-guaranteed loan (Pr&#xea;t garanti par l'Etat, or "PGE") is set forth in Note 4.9. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment for lease liabilities is set forth in Note 4.12.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;"&gt;Note 4.8.2. Financial liabilities measured at fair value through profit or loss &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 127.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA attached to Kreos 1 bonds, the conversion option of OCEANE, certain prepayment options of bonds, the Kreos / Claret warrants &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and the Kreos / Claret Minimum Return Indemnifications ("MRI") are derivatives instruments. Derivatives are recognized initially at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value at the date the derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The resulting gain or loss from change in the fair value is recognized in profit or loss immediately, as financial expenses or income. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Hybrid instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE bonds &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and Heights convertible notes (whose characteristics are described in Note 15.2 and Note 15.5)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; are hybrid &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments. A &#x201c;hybrid contract&#x201d; is a contract that includes both a non-derivative host contract and one or more embedded derivatives. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Embedded derivatives are required to be separated from the host contract (bifurcated) if: the economic characteristics and risks of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;embedded derivative are not closely related to those of the host, a separate instrument with the same terms as the embedded derivative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;would meet the definition of a derivative, and the hybrid contract is not measured at fair value through profit or loss. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 450.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Separable embedded derivatives are required to be measured at fair value at each reporting date, with changes in fair value recognized &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 460.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in profit or loss. The initial bifurcation of a separable embedded derivative does not result in any gain or loss being recognized. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Because the embedded derivative component is measured at fair value on initial recognition, the carrying amount of the host contract &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on initial recognition is the difference between the carrying amount of the hybrid instrument and the fair value of the embedded &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivative. If the fair values of the hybrid instrument and host contract are more reliably measurable than that of the derivative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 500.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;component - e.g. because of the availability of quoted market prices - then it may be acceptable to use those values to determine the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value of the derivative on initial recognition indirectly - i.e. as a residual amount. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Heights convertible notes issued on August 24, 2023 included embedded derivatives as detailed in Note 15. The Group concluded &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;that these features were embedded derivatives that would modify the cash flows required under the contract and require to be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bifurcated from their host contract. The Group being unable to reliably value each embedded derivative at issuance date and on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subsequent reporting dates, it measured the whole hybrid instrument at fair value through profit or loss (&#x201c;FVTPL&#x201d;) as permitted by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS 9. Instruments measured at FVTPL under these conditions are measured at their fair value on issuance and on subsequent &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reporting dates, with changes in fair value recognized in profit or loss.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Compound instruments &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret OCABSA are compound instruments (whose characteristics are describ&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ed in Note 15.1). &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A &#x201c;compound contract&#x201d; is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a contract that includes both a debt component and an equity component.&#160; The debt component (excluding the conversion option and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the attached OCABSA warrants) is initially recognized at fair value and subsequently measured at amortized cost calculated using the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EIR method. The equity component corresponding to the conversion option and the attached OCABSA warrants is recorded in equity, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the difference between the whole instrument&#x2019;s fair value (its nominal value) and the standalone fair value of the debt component.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value measurement &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;When measuring the fair value of an asset or a liability, the Company uses market observable data as far as possible. Fair values are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;level 1: fair value calculated using quoted prices in an active market for identical assets and liabilities; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;level 2: fair value calculated using valuation techniques based on observable market data such as prices for assets and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liabilities or similar parameters quoted in an active market; &#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;level 3: fair value calculated using valuation techniques based in whole or in part on unobservable inputs such as prices &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in an inactive market or a valuation based on multiples of unlisted securities. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;See Note 12 Financial assets and liabilities, Note 15 Financial liabilities.</ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants contextRef="c-1" id="f-671">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group benefits from the provisions of Article 244 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 255.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;quater &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;B of the French General Tax Code relating to the French research tax &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit (&#x201c;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 68.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cr&#xe9;dit d&#x2019;Imp&#xf4;t Recherche&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201d; or &#x201c;CIR&#x201d;). The CIR is granted to companies in order to encourage them to conduct technical and &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scientific research. Companies that prove that they have expenditures which meet the required criteria (research expenditures located &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in France or, since January 1, 2005, within the European Union or in another state that is a party to the Agreement on the European &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Economic Area and has concluded a tax treaty with France that contains an administrative assistance clause) receive a tax credit that &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;can be used for the payment of the corporate tax due for the fiscal year in which the expenditures were made and the next three fiscal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;years, or as applicable, companies may receive cash reimbursement for any excess portion at the three-year period following the fiscal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;year of the expenditures. Only those companies meeting the EU definition of a small or medium-sized entity (&#x201c;SME&#x201d;) are eligible for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;payment in cash of their research tax credit (to the extent not used to offset corporate tax payables) in the year following the request &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for reimbursement. The expenditures taken into account for the calculation of the CIR involve only research expenses. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The CIR is presented under &#x201c;Other operating income&#x201d; in the statements of income (loss) as it is accounted for as a government grant &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as defined in IAS 20 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 128.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting for Government Grants and Disclosure of Government Assistanc&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;e, and as &#x201c;Other receivables and &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets&#x201d; in the statement of financial position until its payment is received. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies are non-repayable grants received by the Group and recognized in the financial statements when there exists reasonable &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 426.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assurance that the Group will comply with the conditions attached to the subsidies and the subsidies will be received. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies that are upfront payments are presented as deferred income and recognized through &#x201c;Other operating income&#x201d; for the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amount of the expenses incurred as part of the research program to which the subsidy relates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A subsidy that is to be received either as compensation for expenses or for losses already incurred, or for immediate financial support &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the Group without associated future costs, is recognized in the Statements of income (loss) as &#x201c;Other operating income&#x201d; when there &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;exists reasonable assurance that the subsidies will be received.</ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
    <ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory contextRef="c-1" id="f-672">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances and PGE &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 544.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group receives conditional advances to finance at below market interest rate research and development projects. Due to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;innovative nature of its drug candidate development programs, the Group has benefited from certain sources of financial assistance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from Bpifrance. Bpifrance provides financial assistance and support to emerging French enterprises to facilitate the development and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercialization of innovative technologies. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Funds received from Bpifrance in the form of conditional advances are recognized as financial liabilities, as the Group has a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;contractual obligation to reimburse Bpifrance for such conditional advances in cash based on a repayment schedule. Each award of an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 616.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;advance is made to help fund a specific development milestone. More tails on conditional advances are provided in Note 15.7. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 626.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Receipts or reimbursements of conditional advances are reflected as financing transactions in the statements of cash flows. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The difference between the present value of the advance at market rate (i.e., present value of contractual cash flows including principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and interests, discounted using a market rate as effective interest rate in accordance with IFRS 9) and the amount received as cash &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from the Bpifrance constitutes a subsidy within the meaning of IAS 20. Considering that these advances do not finance fixed assets, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;these subsidies are presented as &#x201c;Deferred income&#x201d; in the statement of financial position and recognized in the statement of net income &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(loss) as &#x201c;Other operating income&#x201c; on a systematic basis over the periods in which the Group recognizes as expenses the related costs &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for which the grants are intended to compensate. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The incremental interest expense resulting from the difference between (a)&#160;the market interest rate and the (b)&#160;below-market rate is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;spread over the contractual period until the last repayment and recognized in the statement of income (loss) accordingly, using the EIR &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;method. In the event of a change in estimate of contractual cash flows due under the conditional advances, the Group recalculates the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;book value of the debt resulting from the discounting of the anticipated new future cash flows at the initial EIR. The adjustment is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized in the statements of income (loss) for the period during which the modification is recognized. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In the statements of financial position, these conditional advances are recorded in &#x201c;Other financial liabilities&#x201d; as current or non-current &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;portion depending on their maturity. In the event Bpifrance waived the repayment of the advance, the corresponding liability is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derecognized and treated as a subsidy in the statements of income (loss). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The benefit resulting from the low interest of PGE loans is also recognized as a subsidy corresponding to the difference between the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;present value of the PGE at market rate and the amount received as cash. The accounting treatment is therefore similar to the above-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;mentioned accounting treatment for conditional advances. PGE are recorded in &#x201c;Borrowings&#x201d; as current or non-current portion &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;depending on their maturity.</ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="c-1" id="f-673">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee benefits &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group&#x2019;s employees in France benefit from retirement benefits provided under French law, which consist in the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;compensation paid by the Group to employees upon their retirement (a defined benefit plan); and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;payments of retirement pensions by the social security agencies, which are financed by the contributions made by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group and employees. As they meet the definition of a defined contribution plan, the liabilities are presented as Tax and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;employee-related payables in the statement of financial position. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In accordance with IAS 19 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 153.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee Benefits&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, the liability with respect to defined benefit plans is estimated by using the projected &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit unit method. According to this method, the cost of the retirement benefit is recognized in the statements of income (loss). The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 342.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;retirement benefit commitments are valued at the current value of the estimated future payments, discounted using the market rate for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;high quality corporate bonds with a term and currency that correspond to that estimated for the payment of the benefits. The Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;applied the decision of the IFRS IC, published on May&#160;24, 2021, that concluded that, in the case that no rights were acquired in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;event of departure before retirement age and that the rights were capped after a certain number of years of seniority (&#x201c;30 years&#x201d;), the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commitment would only be recognized for the last 30 years of the employee&#x2019;s career within the Group. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 404.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The difference between the amount of the provision at the beginning of a period and at the close of that period is recognized through &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;operating expenses for the portion representing the costs of services rendered and financial expenses for the net interest costs, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;through other comprehensive income (loss) for the portion representing the actuarial gains and losses due to changes in assumptions &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;and experience adjustments.</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="c-1" id="f-674">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Provisions &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 87.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Provisions correspond to commitments resulting from litigation and various risks to which the Group may face in the context of its &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;operations. In accordance with IAS 37 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 199.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Provisions, Contingent Liabilities and&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 354.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Contingent Assets, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a provision is recorded when the &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group has an obligation to a third party resulting from a past event that will likely result in an outflow of resources to the third party, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and for which future cash outflows may be estimated reliably. The amount recorded as a provision is an estimate of the expenditure &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;required to settle the obligation, discounted where necessary at year &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;end.&#160; Contingent liabilities are not recognized, but are disclosed in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the notes to the financial statements unless the possibility of an outflow of economic resources is remote&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="c-1" id="f-675">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 201.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;standalone price. The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases (value of the underlying asset below &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 221.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.0 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;). For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 231.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;straight-line basis over the term of the lease. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to the end of the lease term. The lease terms used by the Group reflect the non-cancellable terms of each contract, plus any extension &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or termination options that the Group is reasonably certain to exercise or not exercise for all of the leases periods covered by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;extension options. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group incremental borrowing rate for the asset subject to the lease in the respective markets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;portion of the lease payments attributable to the repayment of lease liabilities and the portion attributable to payment of interests are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized in cash flows used in financing activities. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;incentives received and any initial direct costs incurred by the Group, and expected costs for obligations to dismantle and remove &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;right-of-use assets when they are no longer used. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the right-of-use asset or the end of the lease term. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;recoverable using cash flow projections.</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="c-1" id="f-676">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Translation of transactions denominated in foreign currency &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to IAS 21 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 122.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Effects of Changes in Foreign Exchange Rates&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, transactions performed by the Group in currencies other than &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 515.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their functional currency, which is the Euro, are translated at the prevailing exchange rate on the transaction date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 537.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade receivables and payables and liabilities denominated in a currency other than the functional currency are translated at the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;period-end exchange rate. Unrealized gains and losses arising on translation are recognized in net financial income / (loss).</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="c-1" id="f-677">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax assets and liabilities for the current and prior periods are measured at the amount expected to be recovered from or paid to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 97.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;French tax authorities, using tax rates and tax laws enacted or substantively enacted at the end of the reporting period in accordance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 107.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with IAS 12 &#x2013; Income Tax. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The income tax charge for the period comprises current tax due and the deferred tax charge. The tax expense is recognized in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;statement of income (loss) unless it relates to items recorded in other comprehensive income (loss) or directly in equity, in which case &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the tax is also recorded in other comprehensive income (loss) or directly in equity. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Current taxes &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The current tax expense is calculated based on taxable profit for the period, using tax rates enacted or substantively enacted at the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;statement of financial position date. Considering the level of tax loss of the Group, no current tax expense is recognized.</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory contextRef="c-1" id="f-678">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred taxes &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred taxes are recognized when there are temporary differences between the carrying amount of assets and liabilities in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group&#x2019;s financial statements and the corresponding tax basis used to calculate taxable profit. Deferred taxes are not recognized if they &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 267.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;arise from the initial recognition of an asset or liability in a transaction other than a business combination which, at the time of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;transaction, does not affect either the accounting or the taxable profit (tax loss). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 287.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group applies the Amendments to IAS 12 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 232.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred Tax related to Assets and Liabilities arising from a Single Transaction&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issued on May 7, 2021, and presents the deferred tax assets and liabilities arising from such transactions separately within Note 22 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 559.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;- &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Income tax, &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;rather than on a net basis. The Amendments have no impact on the Statements of financial position and the Statement of &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;comprehensive income (loss) for the periods presented.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets are recognized for all deductible temporary differences, unused tax losses and unused tax credits to the extent that &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;it is probable that the temporary difference will reverse in the foreseeable future and that taxable profit will be available against which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the deductible temporary difference, unused tax losses or unused tax credits can be utilized. See Note 4.16. Use of judgments and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;estimates and Note 22. Income tax.</ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory>
    <abvx:DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock contextRef="c-1" id="f-679">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting of Prosynergia acquisition &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;From April 1, 2022 up until the merger completed on December&#160;12, 2022, the Company owned a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;100%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ownership interest of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prosynergia and as such, controlled Prosynergia. The Company had power over Prosynergia, was exposed or had rights to variable &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 455.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;returns from its involvement with the entity and had the ability to affect those returns through its power over the entity. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The financial statements of Prosynergia were therefore included in the consolidated financial statements of the Company from the date &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;control was obtained, i.e. April 1, 2022. Prosynergia was merged into the Company in December&#160;12, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Considering that Prosynergia only owned patent rights but did not enter into any employee contract, research agreement, collaboration &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement or out-licensed agreement, it did not meet the definition of a business under IFRS 3. Consequently, the acquisition cost of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;this group of assets was allocated between the identifiable assets and liabilities acquired, pro rata to their respective fair values as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;April 1, 2022, without recognition of goodwill. For this purpose, the following approach was applied: first measurement of any &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;identifiable asset or liability initially measured at an amount other than cost in accordance with the applicable standards, deduction &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from the cost of the group of assets of the amounts allocated to these assets and liabilities, and then allocation of the residual cost of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;acquisition to the remaining identifiable assets and liabilities based on their relative fair values at the date of acquisition. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Also, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,400&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.67000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; loan granted to Prosynergia in December 2021 was included in the acquisition cost to be allocated, since, in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;substance, it was considered as a prepayment for the acquisition of the group of assets, which is repayable in cash in the event of non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;completion of the transaction. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 113.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The potential earn-out payment to be paid in the first half of 2023 was measured at fair value on April 1, 2022, for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,446&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and included in the acquisition cost. This earn out could be triggered in the event the Group&#x2019;s market capitalization &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 133.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was in excess of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (valued at certain specified record dates), a listing of the Group&#x2019;s shares on Nasdaq or a merger and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 143.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;acquisition transaction prior to March 31, 2023. The amount of the earn-out was equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the difference between the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 153.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market capitalization and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, subject to a maximum amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4.0&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. It was payable in the first half of 2023 if &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conditions were met. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;No&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; amount was payable in the event the Group&#x2019;s market capitalization was lower than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The related &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial liability was subsequently remeasured to its fair value as of December&#160;31, 2022 estimated to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nil&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (see Note 15.9). The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;remeasurement resulted in a financial income of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,446&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; over the year ended December&#160;31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As a consequence of the earn-out condition not being met on March 31, 2023, the related financial liability was derecognized.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The allocation of the acquisition cost is as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 237.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 28.8pt; position: var(--position); top: 0pt; width: 266.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 33.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 23.16pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Amounts in thousands of euros)&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 15.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amount&#160;allocated&#160;as&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 13.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 23.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of&#160;April&#160;1,&#160;2022&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 23.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 49.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash prepayment made in 2021&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.17000000000002pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.54pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.58pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;........&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 49.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;325&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Loan granted to Prosynergia in 2021&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.9pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.48pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 63.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,400&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash payment made in 2022&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.03pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.05pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.............&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 78pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,925&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 92.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition fees (1)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.07pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.11pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;...........................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 92.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;466&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 106.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Earn-out measured at fair value&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.56pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.14000000000001pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.43pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.51pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;........&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 106.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,446&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total acquisition cost allocated&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 134.47pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 134.54999999999998pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.60999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 134.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;......&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 120.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,562&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 135pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 149.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Patents&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.48pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;...............................................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 149.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,529&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 163.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.78pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 108.94pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.22999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.38pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 163.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;42&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 177.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 177.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 192pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.32pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.06pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.35pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.39pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;......................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 192pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,571&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 206.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 206.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 220.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.72pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.00999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 67.08999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 220.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 52.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(9)&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 234.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 249pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total net assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.14pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.3pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.44999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 249pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,562&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 517.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 35.95pt; position: var(--position);"&gt; (1)&lt;span style="display: inline-block; height: 6.93pt; width: 10.34pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.45pt; position: var(--position);"&gt;Of which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;451&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; were disbursed in 2021 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in 2022. Acquired cash amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;42&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The acquisition cost was mainly allocated to Prosynergia&#x2019;s patents US 10,464,903 (filed on March 20, 2017 and granted on November &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5, 2019), EP3 429 998 (filed on March 20, 2017 and granted on September 1, 2021) and continuation US 10,745,357 (filed on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;November 1, 2019 and granted on August&#160;18, 2020). All patents will expire in 2037. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These patents cover alternative synthesis process for obefazimod and a family of close chemical analogues. They also cover &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;alternative forms of obefazimod (salts thereof and crystalline forms of said salts), the pharmaceutical composition comprising them, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;that could be of interest to the Company for future development.</abvx:DisclosureOfAccountingPolicyForAssetsAcquisitionsPolicyTextBlock>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c-61" decimals="2" id="f-680" unitRef="number">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="c-64" decimals="-3" id="f-681" unitRef="eur">1400000</ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
    <abvx:EarnOutAtFairValueAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-682" unitRef="eur">1446000</abvx:EarnOutAtFairValueAssetsAcquisitions>
    <abvx:EarnOutMarketCapitalizationThreshold contextRef="c-63" decimals="-6" id="f-683" unitRef="eur">300000000</abvx:EarnOutMarketCapitalizationThreshold>
    <abvx:EarnOutPercentage contextRef="c-63" decimals="2" id="f-684" unitRef="number">0.01</abvx:EarnOutPercentage>
    <abvx:EarnOutMarketCapitalizationThreshold contextRef="c-63" decimals="-6" id="f-685" unitRef="eur">300000000</abvx:EarnOutMarketCapitalizationThreshold>
    <abvx:EarnOutMaximumAmount contextRef="c-63" decimals="-5" id="f-686" unitRef="eur">4000000</abvx:EarnOutMaximumAmount>
    <abvx:EarnOutAmountPayableIfConditionsAreNotMet contextRef="c-63" decimals="-5" id="f-687" unitRef="eur">0</abvx:EarnOutAmountPayableIfConditionsAreNotMet>
    <abvx:EarnOutMarketCapitalizationThreshold contextRef="c-63" decimals="-6" id="f-688" unitRef="eur">300000000</abvx:EarnOutMarketCapitalizationThreshold>
    <ifrs-full:FinancialLiabilities contextRef="c-138" decimals="-3" id="f-689" unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c-139" decimals="-3" id="f-690" unitRef="eur">1446000</ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <abvx:DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock contextRef="c-1" id="f-691">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The allocation of the acquisition cost is as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 237.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 28.8pt; position: var(--position); top: 0pt; width: 266.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 33.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 23.16pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Amounts in thousands of euros)&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 15.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 13.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amount&#160;allocated&#160;as&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 13.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 23.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of&#160;April&#160;1,&#160;2022&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 23.17pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 49.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash prepayment made in 2021&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.17000000000002pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.46pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.54pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.58pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;........&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 49.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;325&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Loan granted to Prosynergia in 2021&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.9pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.48pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 63.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,400&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash payment made in 2022&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.03pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.05pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.............&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 78pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,925&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 92.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition fees (1)&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.07pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.11pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;...........................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 92.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;466&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 106.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Earn-out measured at fair value&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.56pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 129.14000000000001pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.43pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.51pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;........&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 106.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,446&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total acquisition cost allocated&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 134.47pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 134.54999999999998pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.60999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 134.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;......&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 120.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,562&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 135pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 149.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Patents&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.48pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;...............................................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 149.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,529&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 163.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.78pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 108.94pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.22999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.38pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;................&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 163.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;42&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 177.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 177.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 192pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 52.32pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 53.480000000000004pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.06pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.35pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.39pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 54.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;......................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 192pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,571&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 206.25pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 206.25pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 220.5pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.72pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.00999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 67.08999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 220.5pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 52.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(9)&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234.75pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 152.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 234.75pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.67pt; width: 114pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 14.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 249pt; width: 152.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 152.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total net assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 68.14pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.3pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.44999999999999pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 69.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;................................&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 249pt; width: 114pt;"&gt;&lt;div&gt;&lt;div style="line-height: 10pt; position: var(--position); top: 3.83pt; width: 114pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 46.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,562&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 35.95pt; position: var(--position);"&gt; (1)&lt;span style="display: inline-block; height: 6.93pt; width: 10.34pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.45pt; position: var(--position);"&gt;Of which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;451&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; were disbursed in 2021 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in 2022. Acquired cash amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.84999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;42&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</abvx:DisclosureOfDetailedInformationAboutAssetsAcquisitionsExplanatoryTableTextBlock>
    <abvx:CashPrepaymentAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-692" unitRef="eur">325000</abvx:CashPrepaymentAssetsAcquisitions>
    <abvx:LoanGrantedAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-693" unitRef="eur">1400000</abvx:LoanGrantedAssetsAcquisitions>
    <abvx:CashTransferredAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-694" unitRef="eur">2925000</abvx:CashTransferredAssetsAcquisitions>
    <abvx:AcquisitionRelatedCostsAssetsAcquisition contextRef="c-63" decimals="-3" id="f-695" unitRef="eur">466000</abvx:AcquisitionRelatedCostsAssetsAcquisition>
    <abvx:EarnOutAtFairValueAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-696" unitRef="eur">1446000</abvx:EarnOutAtFairValueAssetsAcquisitions>
    <abvx:ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-697" unitRef="eur">6562000</abvx:ConsiderationTransferredAcquisitionDateFairValueAssetsAcquisitions>
    <abvx:TechnologyBasedIntangibleAssetsAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-698" unitRef="eur">6529000</abvx:TechnologyBasedIntangibleAssetsAssetsAcquisitions>
    <abvx:CashAndCashEquivalentsAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-699" unitRef="eur">42000</abvx:CashAndCashEquivalentsAssetsAcquisitions>
    <abvx:AssetsRecognisedAsOfAcquisitionDate contextRef="c-63" decimals="-3" id="f-700" unitRef="eur">6571000</abvx:AssetsRecognisedAsOfAcquisitionDate>
    <abvx:LiabilitiesRecognisedAsOfAcquisitionDate contextRef="c-63" decimals="-3" id="f-701" unitRef="eur">9000</abvx:LiabilitiesRecognisedAsOfAcquisitionDate>
    <abvx:IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-702" unitRef="eur">6562000</abvx:IdentifiableAssetsAcquiredLiabilitiesAssumedAssetsAcquisitions>
    <abvx:PaymentsForAssetsAcquisitionsCosts contextRef="c-140" decimals="-3" id="f-703" unitRef="eur">451000</abvx:PaymentsForAssetsAcquisitionsCosts>
    <abvx:PaymentsForAssetsAcquisitionsCosts contextRef="c-141" decimals="-3" id="f-704" unitRef="eur">15000</abvx:PaymentsForAssetsAcquisitionsCosts>
    <abvx:CashAndCashEquivalentsAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-705" unitRef="eur">42000</abvx:CashAndCashEquivalentsAssetsAcquisitions>
    <abvx:DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock contextRef="c-1" id="f-706">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 80.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Use of judgments and estimates &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In order to prepare financial statements in accordance with IFRS, estimates, judgments and assumptions were made by the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 655.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;management which could affect the reported amounts of assets, liabilities, contingent liabilities, income and expenses. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These estimates are based on the assumption of going concern and are prepared in accordance with information available at the date &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the financial statements were prepared. They are reviewed on an ongoing basis using past experience and various other factors &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;considered to be reasonable as the basis to measure the carrying amount of assets and liabilities. Estimates may be revised due to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;changes in the underlying circumstances or subsequent to new information. Actual results may differ significantly from these &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;estimates in line with assumptions or different conditions. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;This note provides an overview of the areas that involved a higher degree of judgement or complexity, and of items which are more &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;likely to be materially adjusted due to changes in estimates and assumptions. Detailed information about each of these estimates and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;judgements is included in other notes together with information about the basis of calculation for each affected line item in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial statements. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Recognition and measurement of impairment of CGUs. The main assumptions used for the impairment test include &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(a)&#160;the amount of cash flows that are set on the basis of the development and commercialization plans and budgets &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;approved by Board of Directors, (b)&#160;assumptions related to the achievement of the clinical trials and the launch of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercialization, (c)&#160;the discount rate, (d) assumptions on risk related to the development and (e)&#160;for the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercialization, selling price and volume of sales. The sensitivity analysis in respect of the recoverable amount of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CGUs is presented in Note 6. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Measurement of share-based payments granted to employees, corporate officers and scientific consultants, such as BCE, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA and AGA, which is based on actuarial models; these models require the use by the Group of certain calculation &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 237.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions such as the estimated vesting, the occurrence dates of a change of control or a M&amp;amp;A transaction dates, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;percentage of success (&#x201c;POS&#x201d;) of obefazimod,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the expected volatility and maturity of the underlying equity instrument &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(see Note 4.7 and Note 14), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Fair value measurement at inception and after of derivative financial instruments resulting from (i)&#160;the warrants issued &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;concomitantly with the issuance of the straight and convertible bonds to Kreos on July 24, 2018 (or &#x201c;Kreos 1&#x201d;), (ii) the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepayment option attached to the straight and convertible bonds issued to Kreos on October 2, 2020 (or &#x201c;Kreos 2&#x201d;), and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(iii)&#160;the prepayment option attached to the issuance of bond convertible into new or existing shares in July 30, 2021 (or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;OCEANE&#x201d;) (see Notes 15), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(iv) the Kreos / Claret BSA issued on August 21, 2023 and November 2, 2023, related to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 335.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranches A-B and tranche C, respectively, and (v) the Kreos / Claret Minimum Return Indemnifications related to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranches B and C, issued in March 2024 and June 2024, respectively.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Fair value measurement of financial liabilities at inception (see Note 15), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and after (for the Heights convertible notes &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issued on August 24, 2023) measured at fair value at each reporting period, with fair value changed recognized in profit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or loss, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Amortized cost measurement of royalty certificates, based on the following assumptions: (a)&#160;future cash flows, estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 415.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on the basis of development and commercialization plans and budgets approved by the Board of Directors and (b)&#160;the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;effective interest rate. The sensitivity analysis in respect of the measurement of royalty certificates is presented in Note &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Fair value measurement of the call option resulting from the equity line contracts entered into on September 30, 2019 (or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;Equity lines&#x201d;) (see Note 13.2), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 477.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Estimation of CIR, based on internal and external expenses, which meet the required criteria, incurred by the Group each &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;year (see Note 4.9), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Recognition of deferred tax assets: availability of future taxable profit against which deductible temporary differences &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and tax losses carried forward can be utilized and whether sufficient evidence exists (see Note 22). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Recognition of deferred tax assets: tax deductibility of future royalty payments related to the royalty certificates issued in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 541.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;September 2022 (see Notes 15 and 22).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 559.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Determination of the terms of the leases, including whether the Group is reasonably certain to exercise extension and/or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;termination options (see Note 15.8).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main critical judgements made by the Group&#x2019;s management impact the following items: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment of specific conditions of share-based compensation plans (see Notes 4.7 and 14).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 653.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 72.69999999999999pt; position: var(--position); text-decoration: none; white-space: pre; width: 3.67pt;"&gt;&#x2022;&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 173.62pt;"&gt;Accounting treatment of the 2018 &amp;amp; 2020 &lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.67pt; position: var(--position); text-decoration: none; white-space: pre; width: 31.87pt;"&gt;Kreos 1&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.54pt; position: var(--position); text-decoration: none; white-space: pre; width: 279.42pt;"&gt; &amp;amp; 2 bonds, the 2021 OCEANE bonds, and the August 2023 Kreos /&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.96pt; position: var(--position); text-decoration: none; white-space: pre; width: 2.5pt;"&gt; &lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 664.61pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre; width: 215.9pt;"&gt;Claret and Heights Financings (see Notes 4.8 and 15).&lt;span style="display: inline-block; height: 7.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abvx:DisclosureOfAccountingPolicyForAccountingJudgementsAndEstimatesExplanatoryPolicyTextBlock>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="c-1" id="f-707">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Segment information &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The assessment of the Group&#x2019;s performance and the decisions about resources to be allocated are made by the chief operating decision &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;maker, based on the management reporting system of the Group. The Group identified the Chief Executive Officer of the Group as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;chief operating decision maker&#x201d;. The chief operating decision maker reviews on an aggregated basis the incurred expenses for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;allocating and evaluating performance of the Group. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group operates in a single operating segment: R&amp;amp;D of pharmaceutical products in order to market them in the future. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Substantially all operations, assets, liabilities, and losses of the Group are located in France. As of December 31, 2023 and 2024, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;U.S. Subsidiary&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (created in 2023&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) has contributions to the Group&#x2019;s assets, liabilities and net losses&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; that were less than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <abvx:ContributionToGroupsLiabilitiesPercentage contextRef="c-142" decimals="2" id="f-708" unitRef="number">0.10</abvx:ContributionToGroupsLiabilitiesPercentage>
    <abvx:ContributionToGroupsNetProfitsLossesPercentage contextRef="c-143" decimals="2" id="f-709" unitRef="number">0.10</abvx:ContributionToGroupsNetProfitsLossesPercentage>
    <abvx:ContributionToGroupsAssetsPercentage contextRef="c-142" decimals="2" id="f-710" unitRef="number">0.10</abvx:ContributionToGroupsAssetsPercentage>
    <abvx:ContributionToGroupsNetProfitsLossesPercentage contextRef="c-144" decimals="2" id="f-711" unitRef="number">0.10</abvx:ContributionToGroupsNetProfitsLossesPercentage>
    <abvx:ContributionToGroupsLiabilitiesPercentage contextRef="c-145" decimals="2" id="f-712" unitRef="number">0.10</abvx:ContributionToGroupsLiabilitiesPercentage>
    <abvx:ContributionToGroupsAssetsPercentage contextRef="c-145" decimals="2" id="f-713" unitRef="number">0.10</abvx:ContributionToGroupsAssetsPercentage>
    <ifrs-full:DisclosureOfGoodwillExplanatory contextRef="c-1" id="f-715">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill and impairment test &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill relates to the acquisition of Splicos SAS and Wittycel SAS that occurred in 2014 (i.e., prior the transition date to IFRS), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which were merged into the Group in the same year. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill from Splicos SAS and Wittycel SAS acquisition corresponds to the &#x201c;Modulation of RNA biogenesis / splicing&#x201d; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;technological platform and the &#x201c;iNKT agonists&#x201d; technological platform, respectively, from which derived the lead drug candidates of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group: ABX464 and ABX196, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS 3 was not applied to acquisitions of subsidiaries deemed to be a business within the meaning of IFRS, carried out before the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 312.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IFRS transition date, i.e., January&#160;1 2020. Due to the application of this exemption, the previous accounting for business combinations &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in accordance with French GAAP remains unchanged (no identified Intellectual Property, Research&#160;&amp;amp; Development (&#x201c;IPR&amp;amp;D&#x201d;) assets &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are recognized in the statement of financial position). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The carrying amount of the goodwill resulting from the Splicos SAS acquisition was &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18,419&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December&#160;31, 2022, 2023 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and 2024.&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In accordance with IAS 36, goodwill is allocated to CGUs at a level corresponding to the lead drug candidates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Thus, goodwill from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Splicos SAS is allocated to the ABX464 CGU.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Goodwill impairment tests are undertaken annually or more frequently if events or changes in circumstances indicate a potential &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 430.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;impairment, in accordance with IAS 36. The carrying amount of goodwill is compared to the recoverable amount, which is the higher &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value in use and the fair value less costs to disposal. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2024, the Group has not identified any indication of impairment loss related to goodwill, intangible or tangible &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, 2023 and 2024 the recoverable amount used for the impairment test of each CGU was the value in use. This &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value in use was based on a net present value calculation, using the following assumptions as of December 31, 2022, 2023 and 2024: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Cash flows are set on the basis of the development and commercialization plans and budgets approved by Board of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Directors; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A discount rate (or &#x201c;WACC&#x201d;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.57999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;) of&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11.5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;as o&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;f December 31, 2024;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;A risk of development is taken into consideration by applying probabilities of success (or &#x201c;POS&#x201d;) of reaching future &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;phases of development to cash flows related to the commercialization phase. Those average probabilities of success of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;R&amp;amp;D projects are based on public sources (INFORMA databases).;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;For the commercialization phase, selling price and sales volume are estimated on the basis of the potential market and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 615.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the observed performances of comparable drugs currently on the market. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 637.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;During the year ended December 31, 2022, management took into account significant external changes in the hepatocellular &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 647.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;carcinoma (HC) treatment landscape. These changes were expected to require a new, lengthy, heavy and risky internal development &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;process (use of a combination of compounds). For this purpose, entering into a licensing partnership to fund the completion of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;clinical development of ABX196 was being considered. As of December&#160;31, 2022, due to the lack of progress made in the negotiation &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 677.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of a development partnership, the Group made the decision to freeze the development program for ABX196 in the treatment of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;hepatocellular cancer. In this context, the impairment test carried out as of December&#160;31, 2022 resulted in the full impairment of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;goodwill resulting from the acquisition of Wittycell SAS and other assets included in the ABX196 CGU, i.e. an impairment loss of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13,632&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December&#160;31, 2022 (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13,586&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; related to goodwill and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;45&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; related to other assets &#x2013; see Note &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 102.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The impairment tests resulted in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;no&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; impairment charges as of December 31, 2023, and 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: underline; white-space: pre;"&gt;Sensitivity testing as of December&#160;31, 2022, 2023 and 2024:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Regarding ABX464, as the product is currently under development, a clinical trial failure or a failure to obtain a marketing approval &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 167.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;could result in an impairment. The results of the impairment test indicate a headroom level that is high enough so that any reasonably &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;possible change in any of the key assumptions (except clinical failure) would not lead to any impairment.</ifrs-full:DisclosureOfGoodwillExplanatory>
    <ifrs-full:Goodwill contextRef="c-146" decimals="-3" id="f-716" unitRef="eur">18419000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c-147" decimals="-3" id="f-717" unitRef="eur">18419000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c-148" decimals="-3" id="f-718" unitRef="eur">18419000</ifrs-full:Goodwill>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections contextRef="c-5" decimals="3" id="f-719" unitRef="number">0.115</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="c-65" decimals="-3" id="f-720" unitRef="eur">13632000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill contextRef="c-65" decimals="-3" id="f-721" unitRef="eur">13586000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-65" decimals="-3" id="f-722" unitRef="eur">45000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="c-1" decimals="-3" id="f-723" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="c-11" decimals="-3" id="f-724" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="c-1" id="f-725">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible assets &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 235.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intangible assets are mainly comprised of the intellectual property underlying: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 66.55pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.93pt; width: 4.45pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 262.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(i)&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 75.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &#160;  &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The exclusive license agreement with the Scripps Research Institute, University of Chicago and Brigham Young &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;University for which the Group paid a milestone of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;45 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in September 2019 as a result of an IND filling of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 288.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ABX196. The value in use and the fair value less costs to disposal of the ABX196 CGU being &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nil&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 299.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022, a&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.97999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;45&#160;thousand&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; impairment loss was recorded during the year ended December 31, 2022 (see Note 6).&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 522.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 66.55pt; position: var(--position);"&gt;(ii)&lt;span style="display: inline-block; height: 6.93pt; width: 12.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05pt; position: var(--position);"&gt;The collaboration and license agreement with the CNRS, Montpellier 2 university and the Curie for which the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;paid a milestone of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;40&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in September 2019 as a result of the entry in phase 2 of ABX464. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 345.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 66.55pt; position: var(--position);"&gt;(iii)&lt;span style="display: inline-block; height: 6.93pt; width: 9.53pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05pt; position: var(--position);"&gt;Patents acquired through the acquisition of Prosynergia of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6,529&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (cf. Note 4). The patents are not yet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amortized, similarly to licenses, and are included in the ABX464 CGU for impairment test purposes.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Licenses and patents recognized as Intangible assets are not amortized since they are not operating in a manner intended by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;management. As a consequence, and in accordance with IAS 36, those assets were subject to an annual impairment test as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 91.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2022, 2023 and 2024, which did &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;not&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; result in any impairment loss being recognized except for the above-mentioned &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 101.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;45&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; impairment loss recorded during the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;year ended December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 133.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 461.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LICENCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SOFTWARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PATENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;85&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;110&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;35&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,564&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,673&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 11.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 96.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,673&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.760000000000005pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.760000000000005pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,677&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 315.19pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LICENCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SOFTWARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PATENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZATION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(17)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(17)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(4)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(4)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(21)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(66)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(24)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(69)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 153.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(25)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(70)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 521.54pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LICENCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SOFTWARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PATENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NET BOOK VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;85&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.84pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;93&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.84pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,607&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 84.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,604&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 105.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.84pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,606&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <abvx:CollaborationAgreementsDevelopmentMilestonePaymentINDApproval contextRef="c-149" decimals="-3" id="f-726" unitRef="eur">45000</abvx:CollaborationAgreementsDevelopmentMilestonePaymentINDApproval>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife contextRef="c-66" decimals="-3" id="f-727" unitRef="eur">0</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-65" decimals="-3" id="f-728" unitRef="eur">45000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <abvx:CollaborationAgreementsDevelopmentMilestonePaymentPhase2 contextRef="c-150" decimals="-3" id="f-729" unitRef="eur">40000</abvx:CollaborationAgreementsDevelopmentMilestonePaymentPhase2>
    <abvx:TechnologyBasedIntangibleAssetsAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-730" unitRef="eur">6529000</abvx:TechnologyBasedIntangibleAssetsAssetsAcquisitions>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-151" decimals="-3" id="f-731" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-152" decimals="-3" id="f-732" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-65" decimals="-3" id="f-733" unitRef="eur">45000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="c-1" id="f-734">&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 461.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LICENCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SOFTWARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PATENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;85&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 42.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;110&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;35&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 63.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,564&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 75.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,673&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 11.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 96.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 96.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.56pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 108pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,673&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.760000000000005pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 129pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.760000000000005pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.760000000000005pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261.75pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.760000000000005pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 141pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.13pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.760000000000005pt; position: var(--position);"&gt;6,677&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 315.19pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LICENCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SOFTWARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PATENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZATION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(17)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(17)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(4)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(4)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 75.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(21)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 87.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(66)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 108.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(24)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 120.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(69)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 141.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.18pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 153.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(45)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(25)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 153.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.18pt; position: var(--position);"&gt;(70)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 521.54pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 464.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LICENCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SOFTWARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PATENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NET BOOK VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;85&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.84pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;93&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 63.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.84pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 63.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,607&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 84.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 84.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,604&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 105.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 194.25pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 262.5pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.84pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 330.75pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,529&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 105.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;6,606&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-153" decimals="-3" id="f-735" unitRef="eur">85000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-154" decimals="-3" id="f-736" unitRef="eur">24000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-155" id="f-737" unitRef="eur" xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-156" decimals="-3" id="f-738" unitRef="eur">110000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-157" decimals="-3" id="f-739" unitRef="eur">35000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-158" decimals="-3" id="f-740" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-159" decimals="-3" id="f-741" unitRef="eur">6529000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-160" decimals="-3" id="f-742" unitRef="eur">6564000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-161" decimals="-3" id="f-743" unitRef="eur">120000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-162" decimals="-3" id="f-744" unitRef="eur">24000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-163" decimals="-3" id="f-745" unitRef="eur">6529000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-164" decimals="-3" id="f-746" unitRef="eur">6673000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-165" decimals="-3" id="f-747" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-166" decimals="-3" id="f-748" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-167" decimals="-3" id="f-749" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-168" decimals="-3" id="f-750" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-169" decimals="-3" id="f-751" unitRef="eur">120000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-170" decimals="-3" id="f-752" unitRef="eur">24000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-171" decimals="-3" id="f-753" unitRef="eur">6529000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-172" decimals="-3" id="f-754" unitRef="eur">6673000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-173" decimals="-3" id="f-755" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-174" decimals="-3" id="f-756" unitRef="eur">3000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-175" decimals="-3" id="f-757" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c-176" decimals="-3" id="f-758" unitRef="eur">3000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-177" decimals="-3" id="f-759" unitRef="eur">120000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-178" decimals="-3" id="f-760" unitRef="eur">27000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-179" decimals="-3" id="f-761" unitRef="eur">6529000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-180" decimals="-3" id="f-762" unitRef="eur">6677000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-181" decimals="-3" id="f-763" unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-182" decimals="-3" id="f-764" unitRef="eur">-17000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-183" decimals="-3" id="f-765" unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-184" decimals="-3" id="f-766" unitRef="eur">-17000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-185" decimals="-3" id="f-767" unitRef="eur">0</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-186" decimals="-3" id="f-768" unitRef="eur">-4000</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-187" decimals="-3" id="f-769" unitRef="eur">0</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-188" decimals="-3" id="f-770" unitRef="eur">-4000</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-185" decimals="-3" id="f-771" unitRef="eur">-45000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-186" decimals="-3" id="f-772" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-187" decimals="-3" id="f-773" unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="c-188" decimals="-3" id="f-774" unitRef="eur">-45000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-189" decimals="-3" id="f-775" unitRef="eur">-45000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-190" decimals="-3" id="f-776" unitRef="eur">-21000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-191" decimals="-3" id="f-777" unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-192" decimals="-3" id="f-778" unitRef="eur">-66000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-193" decimals="-3" id="f-779" unitRef="eur">0</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-194" decimals="-3" id="f-780" unitRef="eur">-3000</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-195" decimals="-3" id="f-781" unitRef="eur">0</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-196" decimals="-3" id="f-782" unitRef="eur">-2000</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-197" decimals="-3" id="f-783" unitRef="eur">-45000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-198" decimals="-3" id="f-784" unitRef="eur">-24000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-199" decimals="-3" id="f-785" unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-200" decimals="-3" id="f-786" unitRef="eur">-69000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-201" decimals="-3" id="f-787" unitRef="eur">0</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-202" decimals="-3" id="f-788" unitRef="eur">-1000</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-203" decimals="-3" id="f-789" unitRef="eur">0</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <abvx:IncreaseIntangibleAssetsOtherThanGoodwill contextRef="c-204" decimals="-3" id="f-790" unitRef="eur">-1000</abvx:IncreaseIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-205" decimals="-3" id="f-791" unitRef="eur">-45000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-206" decimals="-3" id="f-792" unitRef="eur">-25000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-207" decimals="-3" id="f-793" unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-208" decimals="-3" id="f-794" unitRef="eur">-70000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-209" decimals="-3" id="f-795" unitRef="eur">85000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-210" decimals="-3" id="f-796" unitRef="eur">8000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-211" decimals="-3" id="f-797" unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-12" decimals="-3" id="f-798" unitRef="eur">93000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-212" decimals="-3" id="f-799" unitRef="eur">75000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-213" decimals="-3" id="f-800" unitRef="eur">3000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-214" decimals="-3" id="f-801" unitRef="eur">6529000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-6" decimals="-3" id="f-802" unitRef="eur">6607000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-215" decimals="-3" id="f-803" unitRef="eur">75000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-216" decimals="-3" id="f-804" unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-217" decimals="-3" id="f-805" unitRef="eur">6529000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-7" decimals="-3" id="f-806" unitRef="eur">6604000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-218" decimals="-3" id="f-807" unitRef="eur">75000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-219" decimals="-3" id="f-808" unitRef="eur">3000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-220" decimals="-3" id="f-809" unitRef="eur">6529000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-5" decimals="-3" id="f-810" unitRef="eur">6606000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="c-1" id="f-811">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Property, plant and equipment&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables present changes in property, plant and equipment including the right of use of assets (or &#x201c;ROU&#x201d;) as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2022, 2023 and 2024:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 105.19pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 525.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 55.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BUILDINGS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FURNITURE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPUTER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF WHICH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ROU&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;593&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;402&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;235&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,230&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;682&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,618&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;39&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;111&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,768&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,472&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(593)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.6pt; position: var(--position);"&gt;(3)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.6pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(597)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(593)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,618&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;436&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;346&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,400&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,561&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;350&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;103&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;161&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;614&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;350&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(622)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.6pt; position: var(--position);"&gt;(27)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(649)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(649)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,346&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;513&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;507&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,366&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,262&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 180pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,578&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;292&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,870&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,217&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 192pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.6pt; position: var(--position);"&gt;(1,110)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(119)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.6pt; position: var(--position);"&gt;(1,229)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(975)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 204pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effect of the change in foreign currency exchange rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.260000000000005pt; position: var(--position);"&gt;4&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;22&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;22&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 216pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,818&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;513&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;698&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;4,029&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,504&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 361.82pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 528.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 49.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BUILDINGS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FURNITURE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPUTER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF WHICH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ROU&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DEPRECIATION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 65.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(445)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(346)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(134)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(925)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(470)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(407)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(35)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(38)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(481)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(414)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;593&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;1&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;597&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;593&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(259)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(378)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(171)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(808)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(290)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 131.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(578)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(36)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(94)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(707)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(498)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 143.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 155.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(837)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(387)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(265)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.93pt; position: var(--position);"&gt;(1,488)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(761)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 176.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(886)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(32)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(171)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.93pt; position: var(--position);"&gt;(1,089)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(788)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 188.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,111&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;104&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,215&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;975&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 200.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effect of the change in foreign currency exhange rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.93pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.93pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.99pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.93pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 213pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(613)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(419)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(332)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.93pt; position: var(--position);"&gt;(1,363)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(575)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 538.5pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.55pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BUILDINGS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FURNITURE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPUTER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF WHICH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ROU&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NET BOOK VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;148&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;56&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;101&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;305&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;212&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 74.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,359&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;59&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;175&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,592&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,270&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 95.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;501&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;126&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;878&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;501&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 116.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,205&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;94&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;366&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,666&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,929&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Right of use assets relate to buildings, vehicles and furniture. The net book value of right of use assets related to buildings amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,224&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;453&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,846 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December 31, 2022, 2023 and 2024 respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 262.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisitions over the year ended December 31, 2022 mainly include the right of use asset related to the new headquarters entered into &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 274.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in July 2022 (see Note 15.8), as well as office fittings and IT equipment. Disposals over the period mainly include the right of use &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 286.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assets related to the former headquarters. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisitions over the year ended December 31, 2023 mainly include the right of use asset related to the new Boston offices entered &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 322.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;into in November 2023. Decreases mainly include the remeasurement of the right of use asset related to the reassessment of the Paris &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 334.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Headquarters lease term, for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;622&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (see Note 15.8).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisitions over the period ended December 31, 2024 mainly include the right of use assets related to the new Paris headquarters and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Montpellier offices entered into in May and April 2024 respectively, as well as the 1-year renewal of the Boston offices lease (see &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15.8&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposals mainly include the right of use asset related to the former Paris headquarters lease, which ended in June &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 513.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory contextRef="c-1" id="f-812">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables present changes in property, plant and equipment including the right of use of assets (or &#x201c;ROU&#x201d;) as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2022, 2023 and 2024:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 105.19pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 525.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 55.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BUILDINGS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FURNITURE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPUTER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 0pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF WHICH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ROU&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;593&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;402&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;235&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,230&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 69pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;682&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,618&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;39&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;111&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,768&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 90pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,472&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(593)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.6pt; position: var(--position);"&gt;(3)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.6pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(597)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 102pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(593)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,618&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;436&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;346&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,400&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 114pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,561&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;350&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;103&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;161&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;614&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 135pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;350&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(622)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.6pt; position: var(--position);"&gt;(27)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(649)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 147pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(649)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,346&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;513&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;507&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,366&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 159pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;1,262&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 180pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Acquisition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,578&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;292&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,870&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 180pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,217&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 192pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.6pt; position: var(--position);"&gt;(1,110)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(119)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.6pt; position: var(--position);"&gt;(1,229)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 192pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.97pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.6pt; position: var(--position);"&gt;(975)&lt;span style="display: inline-block; height: 5.54pt; width: 0.33pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 204pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effect of the change in foreign currency exchange rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.260000000000005pt; position: var(--position);"&gt;4&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;22&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 204pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.260000000000005pt; position: var(--position);"&gt;22&lt;span style="display: inline-block; height: 5.54pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 216pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,818&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 276.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;513&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 339.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.260000000000005pt; position: var(--position);"&gt;698&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 402.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;4,029&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 216pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.63pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.260000000000005pt; position: var(--position);"&gt;2,504&lt;span style="display: inline-block; height: 5.41pt; width: 2.99pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 361.82pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 528.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 49.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BUILDINGS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FURNITURE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPUTER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 0pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF WHICH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ROU&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DEPRECIATION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 65.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(445)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(346)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(134)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(925)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 65.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(470)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(407)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(35)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(38)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(481)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(414)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;593&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;1&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;597&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;593&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(259)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(378)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(171)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(808)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(290)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 131.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(578)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(36)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(94)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(707)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 131.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(498)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 143.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 143.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;27&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 155.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(837)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(387)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(265)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.93pt; position: var(--position);"&gt;(1,488)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 155.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(761)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 176.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(886)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.93pt; position: var(--position);"&gt;(32)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(171)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.93pt; position: var(--position);"&gt;(1,089)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 176.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(788)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 188.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 201.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Disposal&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,111&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;104&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,215&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 188.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;975&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 200.25pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effect of the change in foreign currency exhange rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.93pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.93pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 200.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.99pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.93pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 213pt; width: 201.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 201.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 201.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(613)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(419)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 333.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(332)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.93pt; position: var(--position);"&gt;(1,363)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465.75pt; position: var(--position); top: 213pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.93pt; position: var(--position);"&gt;(575)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 538.5pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.55pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BUILDINGS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.82pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FURNITURE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.42pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPUTER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EQUIPMENT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF WHICH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ROU&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NET BOOK VALUES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;148&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;56&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;101&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;305&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;212&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 74.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,359&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;59&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;175&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,592&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 74.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,270&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 95.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;501&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;126&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;878&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 95.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;501&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 116.25pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,205&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;94&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 336.75pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;366&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,666&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 473.25pt; position: var(--position); top: 116.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,929&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsExplanatory>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-221" decimals="-3" id="f-813" unitRef="eur">593000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-222" decimals="-3" id="f-814" unitRef="eur">402000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-223" decimals="-3" id="f-815" unitRef="eur">235000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-156" decimals="-3" id="f-816" unitRef="eur">1230000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-224" decimals="-3" id="f-817" unitRef="eur">682000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-225" decimals="-3" id="f-818" unitRef="eur">1618000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-226" decimals="-3" id="f-819" unitRef="eur">39000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-227" decimals="-3" id="f-820" unitRef="eur">111000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-160" decimals="-3" id="f-821" unitRef="eur">1768000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-228" decimals="-3" id="f-822" unitRef="eur">1472000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-225" decimals="-3" id="f-823" unitRef="eur">593000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-226" decimals="-3" id="f-824" unitRef="eur">3000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-227" decimals="-3" id="f-825" unitRef="eur">1000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-160" decimals="-3" id="f-826" unitRef="eur">597000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-228" decimals="-3" id="f-827" unitRef="eur">593000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-229" decimals="-3" id="f-828" unitRef="eur">1618000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-230" decimals="-3" id="f-829" unitRef="eur">436000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-231" decimals="-3" id="f-830" unitRef="eur">346000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-164" decimals="-3" id="f-831" unitRef="eur">2400000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-232" decimals="-3" id="f-832" unitRef="eur">1561000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-233" decimals="-3" id="f-833" unitRef="eur">350000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-234" decimals="-3" id="f-834" unitRef="eur">103000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-235" decimals="-3" id="f-835" unitRef="eur">161000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-168" decimals="-3" id="f-836" unitRef="eur">614000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-236" decimals="-3" id="f-837" unitRef="eur">350000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-233" decimals="-3" id="f-838" unitRef="eur">622000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-234" decimals="-3" id="f-839" unitRef="eur">27000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-235" decimals="-3" id="f-840" unitRef="eur">0</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-168" decimals="-3" id="f-841" unitRef="eur">649000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-236" decimals="-3" id="f-842" unitRef="eur">649000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-237" decimals="-3" id="f-843" unitRef="eur">1346000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-238" decimals="-3" id="f-844" unitRef="eur">513000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-239" decimals="-3" id="f-845" unitRef="eur">507000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-172" decimals="-3" id="f-846" unitRef="eur">2366000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-240" decimals="-3" id="f-847" unitRef="eur">1262000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-241" decimals="-3" id="f-848" unitRef="eur">2578000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-242" decimals="-3" id="f-849" unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-243" decimals="-3" id="f-850" unitRef="eur">292000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-176" decimals="-3" id="f-851" unitRef="eur">2870000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-244" decimals="-3" id="f-852" unitRef="eur">2217000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-241" decimals="-3" id="f-853" unitRef="eur">1110000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-242" decimals="-3" id="f-854" unitRef="eur">0</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-243" decimals="-3" id="f-855" unitRef="eur">119000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-176" decimals="-3" id="f-856" unitRef="eur">1229000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-244" decimals="-3" id="f-857" unitRef="eur">975000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-241" decimals="-3" id="f-858" unitRef="eur">4000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-242" decimals="-3" id="f-859" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-243" decimals="-3" id="f-860" unitRef="eur">17000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-176" decimals="-3" id="f-861" unitRef="eur">22000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-244" decimals="-3" id="f-862" unitRef="eur">22000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-245" decimals="-3" id="f-863" unitRef="eur">2818000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-246" decimals="-3" id="f-864" unitRef="eur">513000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-247" decimals="-3" id="f-865" unitRef="eur">698000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-180" decimals="-3" id="f-866" unitRef="eur">4029000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-248" decimals="-3" id="f-867" unitRef="eur">2504000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-249" decimals="-3" id="f-868" unitRef="eur">-445000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-250" decimals="-3" id="f-869" unitRef="eur">-346000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-251" decimals="-3" id="f-870" unitRef="eur">-134000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-252" decimals="-3" id="f-871" unitRef="eur">-925000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-253" decimals="-3" id="f-872" unitRef="eur">-470000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-254" decimals="-3" id="f-873" unitRef="eur">-407000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-255" decimals="-3" id="f-874" unitRef="eur">-35000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-256" decimals="-3" id="f-875" unitRef="eur">-38000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-257" decimals="-3" id="f-876" unitRef="eur">-481000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-258" decimals="-3" id="f-877" unitRef="eur">-414000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-254" decimals="-3" id="f-878" unitRef="eur">-593000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-255" decimals="-3" id="f-879" unitRef="eur">-3000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-256" decimals="-3" id="f-880" unitRef="eur">-1000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-257" decimals="-3" id="f-881" unitRef="eur">-597000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-258" decimals="-3" id="f-882" unitRef="eur">-593000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-259" decimals="-3" id="f-883" unitRef="eur">-259000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-260" decimals="-3" id="f-884" unitRef="eur">-378000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-261" decimals="-3" id="f-885" unitRef="eur">-171000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-262" decimals="-3" id="f-886" unitRef="eur">-808000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-263" decimals="-3" id="f-887" unitRef="eur">-290000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-264" decimals="-3" id="f-888" unitRef="eur">-578000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-265" decimals="-3" id="f-889" unitRef="eur">-36000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-266" decimals="-3" id="f-890" unitRef="eur">-94000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-267" decimals="-3" id="f-891" unitRef="eur">-707000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-268" decimals="-3" id="f-892" unitRef="eur">-498000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-264" decimals="-3" id="f-893" unitRef="eur">0</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-265" decimals="-3" id="f-894" unitRef="eur">-27000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-266" decimals="-3" id="f-895" unitRef="eur">0</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-267" decimals="-3" id="f-896" unitRef="eur">-27000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-268" decimals="-3" id="f-897" unitRef="eur">-27000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-269" decimals="-3" id="f-898" unitRef="eur">-837000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-270" decimals="-3" id="f-899" unitRef="eur">-387000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-271" decimals="-3" id="f-900" unitRef="eur">-265000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-272" decimals="-3" id="f-901" unitRef="eur">-1488000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-273" decimals="-3" id="f-902" unitRef="eur">-761000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-274" decimals="-3" id="f-903" unitRef="eur">-886000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-275" decimals="-3" id="f-904" unitRef="eur">-32000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-276" decimals="-3" id="f-905" unitRef="eur">-171000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-277" decimals="-3" id="f-906" unitRef="eur">-1089000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets contextRef="c-278" decimals="-3" id="f-907" unitRef="eur">-788000</abvx:IncreasePropertyPlantAndEquipmentIncludingRightOfUseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-274" decimals="-3" id="f-908" unitRef="eur">-1111000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-275" decimals="-3" id="f-909" unitRef="eur">0</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-276" decimals="-3" id="f-910" unitRef="eur">-104000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-277" decimals="-3" id="f-911" unitRef="eur">-1215000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-278" decimals="-3" id="f-912" unitRef="eur">-975000</ifrs-full:DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-274" decimals="-3" id="f-913" unitRef="eur">-1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-275" decimals="-3" id="f-914" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-276" decimals="-3" id="f-915" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-277" decimals="-3" id="f-916" unitRef="eur">-1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-278" decimals="-3" id="f-917" unitRef="eur">-1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-279" decimals="-3" id="f-918" unitRef="eur">-613000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-280" decimals="-3" id="f-919" unitRef="eur">-419000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-281" decimals="-3" id="f-920" unitRef="eur">-332000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-282" decimals="-3" id="f-921" unitRef="eur">-1363000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-283" decimals="-3" id="f-922" unitRef="eur">-575000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-284" decimals="-3" id="f-923" unitRef="eur">148000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-285" decimals="-3" id="f-924" unitRef="eur">56000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-286" decimals="-3" id="f-925" unitRef="eur">101000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-12" decimals="-3" id="f-926" unitRef="eur">305000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-287" decimals="-3" id="f-927" unitRef="eur">212000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-288" decimals="-3" id="f-928" unitRef="eur">1359000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-289" decimals="-3" id="f-929" unitRef="eur">59000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-290" decimals="-3" id="f-930" unitRef="eur">175000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-6" decimals="-3" id="f-931" unitRef="eur">1592000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-291" decimals="-3" id="f-932" unitRef="eur">1270000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-292" decimals="-3" id="f-933" unitRef="eur">501000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-293" decimals="-3" id="f-934" unitRef="eur">126000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-294" decimals="-3" id="f-935" unitRef="eur">250000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-7" decimals="-3" id="f-936" unitRef="eur">878000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-295" decimals="-3" id="f-937" unitRef="eur">501000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-296" decimals="-3" id="f-938" unitRef="eur">2205000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-297" decimals="-3" id="f-939" unitRef="eur">94000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-298" decimals="-3" id="f-940" unitRef="eur">366000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-5" decimals="-3" id="f-941" unitRef="eur">2666000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets contextRef="c-299" decimals="-3" id="f-942" unitRef="eur">1929000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c-300" decimals="-3" id="f-943" unitRef="eur">1224000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c-301" decimals="-3" id="f-944" unitRef="eur">453000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c-302" decimals="-3" id="f-945" unitRef="eur">1846000</ifrs-full:RightofuseAssets>
    <abvx:DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets contextRef="c-303" decimals="-3" id="f-946" unitRef="eur">622000</abvx:DecreaseThroughReassessmentOfLeaseTermRightOfUseAssets>
    <ifrs-full:DisclosureOfOtherAssetsExplanatory contextRef="c-1" id="f-947">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 68.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 497.01pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 508.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 525.11pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 445.5pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 243.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 70.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OTHER FINANCIAL ASSETS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Advances related to CRO contracts&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;10,471&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,172&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;4,929&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deposits&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,238&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;574&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;863&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;124&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;126&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total other non-current financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;11,708&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,870&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;5,919&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Advances related to CRO contracts&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 3pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -1.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;7,418&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other investments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,050&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 3pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -5.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &#160; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deposits&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;136&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;136&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total other current financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,186&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;7,554&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 138.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;11,708&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 138.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;22,055&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 138.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;13,473&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Advances related to CRO contracts &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 89.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These advances granted in 2022 for clinical studies are to be recovered at the end of the studies after final reconciliation with pass-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;through costs, which are being invoiced and paid as studies are carried out. These long-term advances were measured at fair value on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;initial recognition, using discount rates ranging from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.19%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.16%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and are subsequently measured at amortized cost. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 135.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;During the first half of 2023, additional advances related to CRO contracts amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,620&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; were made (undiscounted &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amount). These long-term advances were measured at fair value on initial recognition, using discount rates ranging from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.09%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.59%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and are subsequently measured at amortized cost. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 177.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At inception, a prepaid expenses asset was recognized for the difference between the advances&#x2019; nominal value and fair value, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;spread over the term of the advances, at the rate of recognition of the related R&amp;amp;D expenses (see Note 10).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In March 2024, a change order was signed with the CRO, extending the scope (addition of maintenance studies) and end date of one of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the studies to 2029, thus postponing the recovery date of the corresponding advance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5,538&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from June 2026 to June 2029. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group considered that this asset modification met the criteria for derecognition, and recognized a new financial asset at fair value &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on that date, using a discount rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.83%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. Since the Group considers that these advances are made in exchange for a discount on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;future services to be received from the CROs, a prepaid expense asset was also recognized for the difference between the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derecognized asset carrying value and new asset fair value, and spread over the term of the advance in a similar manner.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The credit risk related to these advances is deemed insignificant due to the CROs' credit ratings.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other investments&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other investments consist of 6-month term deposits that do not qualify for a classification under cash and cas&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;h equivalents. Term &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 356.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;deposits held by the Group as of December 31, 2024 qualify for a classification under cash equivalents.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deposits&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deposits include the deposits paid under the Kreos 1 &amp;amp; 2 bond loans (reimbursed in August 2023), the liquidity agreement, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Paris &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 410.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and Boston offices lease contracts, the ATM Program, as well as other security &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;deposits&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherAssetsExplanatory>
    <ifrs-full:DisclosureOfFinancialAssetsExplanatory contextRef="c-1" id="f-948">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 508.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 525.11pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 445.5pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 243.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 70.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OTHER FINANCIAL ASSETS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Advances related to CRO contracts&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;10,471&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,172&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;4,929&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deposits&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,238&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;574&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;863&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;124&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;126&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total other non-current financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;11,708&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,870&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;5,919&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Advances related to CRO contracts&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 3pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -1.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;7,418&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other investments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,050&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 12pt; left: 377.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 3pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 3pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -5.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &#160; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deposits&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;136&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;136&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total other current financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,186&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;7,554&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138.75pt; width: 243.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243.75pt; position: var(--position); top: 138.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;11,708&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 312pt; position: var(--position); top: 138.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;22,055&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 380.25pt; position: var(--position); top: 138.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;13,473&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinancialAssetsExplanatory>
    <abvx:NonCurrentAdvancesToCROContracts contextRef="c-6" decimals="-3" id="f-949" unitRef="eur">10471000</abvx:NonCurrentAdvancesToCROContracts>
    <abvx:NonCurrentAdvancesToCROContracts contextRef="c-7" decimals="-3" id="f-950" unitRef="eur">12172000</abvx:NonCurrentAdvancesToCROContracts>
    <abvx:NonCurrentAdvancesToCROContracts contextRef="c-5" decimals="-3" id="f-951" unitRef="eur">4929000</abvx:NonCurrentAdvancesToCROContracts>
    <ifrs-full:LongtermDeposits contextRef="c-6" decimals="-3" id="f-952" unitRef="eur">1238000</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits contextRef="c-7" decimals="-3" id="f-953" unitRef="eur">574000</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits contextRef="c-5" decimals="-3" id="f-954" unitRef="eur">863000</ifrs-full:LongtermDeposits>
    <abvx:OtherNonCurrentMiscellaneousFinancialAssets contextRef="c-6" decimals="-3" id="f-955" unitRef="eur">0</abvx:OtherNonCurrentMiscellaneousFinancialAssets>
    <abvx:OtherNonCurrentMiscellaneousFinancialAssets contextRef="c-7" decimals="-3" id="f-956" unitRef="eur">124000</abvx:OtherNonCurrentMiscellaneousFinancialAssets>
    <abvx:OtherNonCurrentMiscellaneousFinancialAssets contextRef="c-5" decimals="-3" id="f-957" unitRef="eur">126000</abvx:OtherNonCurrentMiscellaneousFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c-6" decimals="-3" id="f-958" unitRef="eur">11708000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c-7" decimals="-3" id="f-959" unitRef="eur">12870000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c-5" decimals="-3" id="f-960" unitRef="eur">5919000</ifrs-full:OtherNoncurrentFinancialAssets>
    <abvx:CurrentAdvancesToCROContracts contextRef="c-6" decimals="-3" id="f-961" unitRef="eur">0</abvx:CurrentAdvancesToCROContracts>
    <abvx:CurrentAdvancesToCROContracts contextRef="c-7" decimals="-3" id="f-962" unitRef="eur">0</abvx:CurrentAdvancesToCROContracts>
    <abvx:CurrentAdvancesToCROContracts contextRef="c-5" decimals="-3" id="f-963" unitRef="eur">7418000</abvx:CurrentAdvancesToCROContracts>
    <abvx:OtherCurrentInvestments contextRef="c-6" decimals="-3" id="f-964" unitRef="eur">0</abvx:OtherCurrentInvestments>
    <abvx:OtherCurrentInvestments contextRef="c-7" decimals="-3" id="f-965" unitRef="eur">9050000</abvx:OtherCurrentInvestments>
    <abvx:OtherCurrentInvestments contextRef="c-5" decimals="-3" id="f-966" unitRef="eur">0</abvx:OtherCurrentInvestments>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents contextRef="c-6" id="f-967" unitRef="eur" xsi:nil="true"/>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents contextRef="c-7" decimals="-3" id="f-968" unitRef="eur">136000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents contextRef="c-5" decimals="-3" id="f-969" unitRef="eur">136000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c-6" decimals="-3" id="f-970" unitRef="eur">0</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c-7" decimals="-3" id="f-971" unitRef="eur">9186000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c-5" decimals="-3" id="f-972" unitRef="eur">7554000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherFinancialAssets contextRef="c-6" decimals="-3" id="f-973" unitRef="eur">11708000</ifrs-full:OtherFinancialAssets>
    <ifrs-full:OtherFinancialAssets contextRef="c-7" decimals="-3" id="f-974" unitRef="eur">22055000</ifrs-full:OtherFinancialAssets>
    <ifrs-full:OtherFinancialAssets contextRef="c-5" decimals="-3" id="f-975" unitRef="eur">13473000</ifrs-full:OtherFinancialAssets>
    <abvx:DiscountRateAppliedToLongTermAdvances contextRef="c-304" decimals="4" id="f-976" unitRef="number">0.0019</abvx:DiscountRateAppliedToLongTermAdvances>
    <abvx:DiscountRateAppliedToLongTermAdvances contextRef="c-305" decimals="4" id="f-977" unitRef="number">0.0716</abvx:DiscountRateAppliedToLongTermAdvances>
    <abvx:PaymentsForAdvancesMadeToContractResearchOrganizations contextRef="c-306" decimals="-3" id="f-978" unitRef="eur">1620000</abvx:PaymentsForAdvancesMadeToContractResearchOrganizations>
    <abvx:DiscountRateAppliedToLongTermAdvances contextRef="c-307" decimals="4" id="f-979" unitRef="number">0.0709</abvx:DiscountRateAppliedToLongTermAdvances>
    <abvx:DiscountRateAppliedToLongTermAdvances contextRef="c-308" decimals="4" id="f-980" unitRef="number">0.0759</abvx:DiscountRateAppliedToLongTermAdvances>
    <abvx:PaymentsForAdvancesMadeToContractResearchOrganizations contextRef="c-309" decimals="-3" id="f-981" unitRef="eur">5538000</abvx:PaymentsForAdvancesMadeToContractResearchOrganizations>
    <abvx:DiscountRateAppliedToLongTermAdvances contextRef="c-310" decimals="4" id="f-982" unitRef="number">0.0683</abvx:DiscountRateAppliedToLongTermAdvances>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="c-1" id="f-983">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and other assets&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 469.26pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and other assets break down as follows:&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 273.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 481.14pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 435pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 233.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 65.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OTHER RECEIVABLES AND OTHER ASSETS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses - non current&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,037&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,320&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;948&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total non-current other assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,037&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,320&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;948&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit ("CIR")&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;4,595&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;4,600&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;5,774&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VAT receivables&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;3,467&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;14,439&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,841&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;915&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;5,746&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;3,233&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Credit notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;254&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;60&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;48&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total current other receivables and assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,231&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;24,845&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;18,896&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and other assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;10,268&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;27,164&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.89pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit (&#x201c;CIR&#x201d;) &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.89pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The CIR is recognized as Other Operating Income (see note 4.9) in the year to which the eligible research expense relates. The Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.89pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;received the&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; payments of the CIR for 2022 and 2023 tax years in the amount of respective&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ly&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,476&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,493&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.89pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively 2023 and 2024 and expects to receive the CIR for the 2024 tax year &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;o&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;f &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5,774 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; 2025. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VAT Receivables &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Value-added tax (&#x201c;VAT&#x201d;) receivables relate primarily to the deductible VAT and VAT refunds claimed.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Their increase as of December 31, 2023 compared to December 31, 2022 is due to the increase in trade payables and accrued invoices &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;over the period (see Note 17.1).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 71.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses as of December&#160;31, 2022 include prepaid expenses related to CRO contracts for amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,714&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (see &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 103.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 9).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 125.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses as of December 31, 2023 include prepaid expenses related to CRO contracts for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,347&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (see &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 9) and deferred transactions costs related to tranches B and C of the Kreos / Claret financings for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,152&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 147.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(most of which represents the issuance date fair value of the tranche A-B and C Kreos / Claret BSA, representing origination fees for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 159.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the future drawdowns of the tranches B and C of the Kreos / Claret Financing, See Note&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; 15.1) and other expenses from various &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.36pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;suppliers amounting to &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;3,567&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses as of December 31, 2024 include prepaid expenses related to CRO contracts for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,577&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (see &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 9) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 68.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;and other expenses from various suppliers amounting to &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;2,604&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The decrease in prepaid expenses over the year ended December 31, 2024 mainly corresponds to the reclassification of the deferred &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;transaction costs of tranche B of the Kreos / Claret Financing, from prepaid expenses to a reduction of the initial carrying value of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;debt component, in accordance with the effective interest rate method, for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,546&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and to the amortization of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the deferred transaction costs related to tranche C (already fully amortized on the date of drawdown).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <abvx:DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock contextRef="c-1" id="f-984">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and other assets break down as follows:&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 273.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 481.14pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 435pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 233.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 65.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OTHER RECEIVABLES AND OTHER ASSETS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses - non current&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,037&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,320&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 42.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;948&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total non-current other assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;1,037&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;2,320&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 54.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;948&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit ("CIR")&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;4,595&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;4,600&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 66.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;5,774&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VAT receivables&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;3,467&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;14,439&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 78.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,841&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prepaid expenses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;915&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;5,746&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 90.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;3,233&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Credit notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;254&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;60&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 102.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;48&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total current other receivables and assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;9,231&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;24,845&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 114.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;18,896&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 233.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 233.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and other assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 233.25pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;10,268&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 301.5pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;27,164&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 369.75pt; position: var(--position); top: 126.75pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfDetailedInformationAboutOtherReceivablesAndOtherAssetsTableTextBlock>
    <abvx:NonCurrentPrepaidExpenses contextRef="c-6" decimals="-3" id="f-985" unitRef="eur">1037000</abvx:NonCurrentPrepaidExpenses>
    <abvx:NonCurrentPrepaidExpenses contextRef="c-7" decimals="-3" id="f-986" unitRef="eur">2320000</abvx:NonCurrentPrepaidExpenses>
    <abvx:NonCurrentPrepaidExpenses contextRef="c-5" decimals="-3" id="f-987" unitRef="eur">948000</abvx:NonCurrentPrepaidExpenses>
    <ifrs-full:OtherNoncurrentAssets contextRef="c-6" decimals="-3" id="f-988" unitRef="eur">1037000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c-7" decimals="-3" id="f-989" unitRef="eur">2320000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c-5" decimals="-3" id="f-990" unitRef="eur">948000</ifrs-full:OtherNoncurrentAssets>
    <abvx:CurrentResearchTaxCreditReceivables contextRef="c-6" decimals="-3" id="f-991" unitRef="eur">4595000</abvx:CurrentResearchTaxCreditReceivables>
    <abvx:CurrentResearchTaxCreditReceivables contextRef="c-7" decimals="-3" id="f-992" unitRef="eur">4600000</abvx:CurrentResearchTaxCreditReceivables>
    <abvx:CurrentResearchTaxCreditReceivables contextRef="c-5" decimals="-3" id="f-993" unitRef="eur">5774000</abvx:CurrentResearchTaxCreditReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables contextRef="c-6" decimals="-3" id="f-994" unitRef="eur">3467000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables contextRef="c-7" decimals="-3" id="f-995" unitRef="eur">14439000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables contextRef="c-5" decimals="-3" id="f-996" unitRef="eur">9841000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentPrepaidExpenses contextRef="c-6" decimals="-3" id="f-997" unitRef="eur">915000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses contextRef="c-7" decimals="-3" id="f-998" unitRef="eur">5746000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses contextRef="c-5" decimals="-3" id="f-999" unitRef="eur">3233000</ifrs-full:CurrentPrepaidExpenses>
    <abvx:CurrentReceivablesFromCreditNotes contextRef="c-6" decimals="-3" id="f-1000" unitRef="eur">254000</abvx:CurrentReceivablesFromCreditNotes>
    <abvx:CurrentReceivablesFromCreditNotes contextRef="c-7" decimals="-3" id="f-1001" unitRef="eur">60000</abvx:CurrentReceivablesFromCreditNotes>
    <abvx:CurrentReceivablesFromCreditNotes contextRef="c-5" decimals="-3" id="f-1002" unitRef="eur">48000</abvx:CurrentReceivablesFromCreditNotes>
    <abvx:CurrentReceivablesAndCurrentPrepaidExpenses contextRef="c-6" decimals="-3" id="f-1003" unitRef="eur">9231000</abvx:CurrentReceivablesAndCurrentPrepaidExpenses>
    <abvx:CurrentReceivablesAndCurrentPrepaidExpenses contextRef="c-7" decimals="-3" id="f-1004" unitRef="eur">24845000</abvx:CurrentReceivablesAndCurrentPrepaidExpenses>
    <abvx:CurrentReceivablesAndCurrentPrepaidExpenses contextRef="c-5" decimals="-3" id="f-1005" unitRef="eur">18896000</abvx:CurrentReceivablesAndCurrentPrepaidExpenses>
    <ifrs-full:OtherAssets contextRef="c-6" decimals="-3" id="f-1006" unitRef="eur">10268000</ifrs-full:OtherAssets>
    <ifrs-full:OtherAssets contextRef="c-7" decimals="-3" id="f-1007" unitRef="eur">27164000</ifrs-full:OtherAssets>
    <ifrs-full:OtherAssets contextRef="c-5" decimals="-3" id="f-1008" unitRef="eur">19843000</ifrs-full:OtherAssets>
    <abvx:ProceedsFromResearchTaxCredit contextRef="c-11" decimals="-3" id="f-1009" unitRef="eur">4476000</abvx:ProceedsFromResearchTaxCredit>
    <abvx:ProceedsFromResearchTaxCredit contextRef="c-1" decimals="-3" id="f-1010" unitRef="eur">4493000</abvx:ProceedsFromResearchTaxCredit>
    <abvx:CurrentResearchTaxCreditReceivables contextRef="c-5" decimals="-3" id="f-1011" unitRef="eur">5774000</abvx:CurrentResearchTaxCreditReceivables>
    <abvx:CurrentPrepaidExpensesRelatedToCRO contextRef="c-6" decimals="-3" id="f-1012" unitRef="eur">1714000</abvx:CurrentPrepaidExpensesRelatedToCRO>
    <abvx:CurrentPrepaidExpensesRelatedToCRO contextRef="c-7" decimals="-3" id="f-1013" unitRef="eur">1347000</abvx:CurrentPrepaidExpensesRelatedToCRO>
    <ifrs-full:Borrowings contextRef="c-311" decimals="-3" id="f-1014" unitRef="eur">-3152000</ifrs-full:Borrowings>
    <ifrs-full:CurrentAdvancesToSuppliers contextRef="c-7" decimals="-3" id="f-1015" unitRef="eur">3567000</ifrs-full:CurrentAdvancesToSuppliers>
    <abvx:CurrentPrepaidExpensesRelatedToCRO contextRef="c-5" decimals="-3" id="f-1016" unitRef="eur">1577000</abvx:CurrentPrepaidExpensesRelatedToCRO>
    <ifrs-full:CurrentAdvancesToSuppliers contextRef="c-5" decimals="-3" id="f-1017" unitRef="eur">2604000</ifrs-full:CurrentAdvancesToSuppliers>
    <abvx:ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent contextRef="c-312" decimals="-3" id="f-1018" unitRef="eur">1546000</abvx:ReclassificationOfPrepaidExpensesToCarryingValueOfDebtComponent>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory contextRef="c-1" id="f-1019">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.96pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 352.86pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 41pt; position: var(--position); top: 0pt; width: 474pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 243pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 69.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH AND CASH EQUIVALENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash equivalents&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18,105&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;87,265&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,944&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;233,837&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;56,956&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;144,221&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 447.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash equivalents mainly include term deposits with short-term maturities. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 459.41pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2023 and 2024, in addition to the Group&#x2019;s bank accounts, cash includes notice accounts amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;231,562 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 470.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;44,239&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand respectively. These funds are available on demand within 24 hours and without penalty.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increase in cash and cash equivalents over the year ended December 31, 2023 is mainly explained by the proceeds from (i) the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.41pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret and Heights Financings from August 2023 and (ii) the Group&#x2019;s Global Offering conducted in October 2023 (see Note &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.91pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;3.3&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;)&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2023 and 2024, the impact of the revaluation of cash and cash equivalents held in U.S. dollars into the Group's &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;presentation currency is a net financial expense of&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,196&#160;thousand&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and a net financial income of&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,035&#160;thousand&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively.&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <abvx:DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-1020">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 352.86pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 41pt; position: var(--position); top: 0pt; width: 474pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 243pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 243pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 69.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 243pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH AND CASH EQUIVALENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash equivalents&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18,105&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;87,265&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 243pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,944&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;233,837&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;56,956&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 243pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 243pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 243pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 321pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;144,221&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfCompositionOfCashAndCashEquivalentsTableTextBlock>
    <ifrs-full:CashEquivalents contextRef="c-6" decimals="-3" id="f-1021" unitRef="eur">6000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents contextRef="c-7" decimals="-3" id="f-1022" unitRef="eur">18105000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents contextRef="c-5" decimals="-3" id="f-1023" unitRef="eur">87265000</ifrs-full:CashEquivalents>
    <ifrs-full:Cash contextRef="c-6" decimals="-3" id="f-1024" unitRef="eur">26944000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="c-7" decimals="-3" id="f-1025" unitRef="eur">233837000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="c-5" decimals="-3" id="f-1026" unitRef="eur">56956000</ifrs-full:Cash>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-1027" unitRef="eur">26950000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-7" decimals="-3" id="f-1028" unitRef="eur">251942000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-5" decimals="-3" id="f-1029" unitRef="eur">144221000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents contextRef="c-7" decimals="-3" id="f-1030" unitRef="eur">231562000</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents contextRef="c-5" decimals="-3" id="f-1031" unitRef="eur">44239000</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-313" decimals="-3" id="f-1032" unitRef="eur">-3196000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-314" decimals="-3" id="f-1033" unitRef="eur">2035000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory contextRef="c-1" id="f-1034">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial assets and liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 605.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following table shows the carrying amounts and fair value of financial assets and financial liabilities, including their &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;levels in the fair value hierarchy.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax and employee-related payables are non-financial liabilities and are therefore excluded from the tables below. They are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;presented in Note 17.2.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,708&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,271&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,271&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,889&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,452&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,452&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;16,241&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,439&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8,873&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65,272&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;58,469&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;57,903&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 273.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,055&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,394&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,394&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,161&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,500&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,500&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;39,697&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;40,622&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18,506&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;42,768&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;37,348&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;37,348&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,531&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5,165&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;124,266&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;125,191&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;30,037&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;95,154&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 476.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 40.12pt; position: var(--position); top: 0pt; width: 531.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 342pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 342pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 159.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 342pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 132.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;13,473&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,690&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,690&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;177,537&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;176,754&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;176,754&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;69,069&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;73,497&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;69,877&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;21,183&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;23,752&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;157,828&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;162,256&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;24,803&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;137,453&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(1)&#160; &#160;  The fair value of cash and cash equivalents is determined based on Level 1 fair value measurement and corresponds to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market value of the assets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(2)&#160; &#160;  The carrying amount of financial assets measured at amortized cost is deemed to be a reasonable estimate of fair value, except &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the long-term advances made to CROs, whose fair value is determined based on Level 3 fair value measurement and is estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;based on future cash-flows discounted at market rates, using credit spreads ranging from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;16&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;476&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;104&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;218&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2023 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;131&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;271&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2024. As of December 31, 2022, 2023, and 2024, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the advances fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;240&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;235&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(3)&#160; &#160;  The carrying amount of short-term financial liabilities measured at amortized cost was deemed to be a reasonable estimate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(4)&#160; &#160;  The fair value of Kreos BSA A&amp;amp;B, OCEANE conversion option, royalty certificates, Heights convertible notes, Kreos / Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 199.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA and Minimum Return Indemnifications is based on Level 3 fair value measurement and is estimated based on models and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions detailed in Note 15. The fair value of other long-term financial liabilities is determined based on Level 3 fair value &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measurement and is estimated based on future cash-flows discounted at market rates, using the f&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ollowing assumptions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt components of Kreos 1&amp;amp;2 bonds, a credit spread of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the Kreos 1&amp;amp;2 bonds fair &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value by&#160; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;68&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt component of OCEANE bonds, a credit spread similar to that detailed in Note 15. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31,&#160; 2022, an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the OCEANE debt &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;component fair value by&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;476&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt components of the Kreos / Claret OCABSA (tranche A) and the tranches B and C of the Kreos / Claret straight &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bond loans, a credit spr&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ead of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;960&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp a&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s of August 22, 2023, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;900&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2023 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;750&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of August 22, 2023, December 31, 2023 (tranche A) and December 31, 2024 (all three tranches), an increase in the credit &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;spread by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+100&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp would result in a decrease in the Kreos / Claret debt components fair value by respectively &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;624&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;,&#160; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;538&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;958&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 427.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x2022;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;For&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the conditional advances and the PGE loan, a credit spread of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;900&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp as of December &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;31, 2023 and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;730&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp as of December 31, 2024. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;An increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, 2023 and 2024, a decrease in the PGE loan fair value by, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;55&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;39&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;21&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the RNP-VIR conditional advance fair value by&#160;  &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;31&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the CARENA conditional advance fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;37&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;37&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the Ebola conditional advance fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(5) In application of the Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;current, and Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;non-current portion of the Heights convertible notes as of December 31, 2023 were reclassified within the current liabilities &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory contextRef="c-1" id="f-1036">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following table shows the carrying amounts and fair value of financial assets and financial liabilities, including their &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;levels in the fair value hierarchy.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax and employee-related payables are non-financial liabilities and are therefore excluded from the tables below. They are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;presented in Note 17.2.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,708&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,271&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,271&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,889&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,452&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,452&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;16,241&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,439&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8,873&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65,272&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;58,469&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;57,903&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 273.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,055&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,394&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,394&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,161&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,500&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,500&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;39,697&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;40,622&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18,506&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;42,768&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;37,348&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;37,348&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,531&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5,165&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;124,266&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;125,191&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;30,037&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;95,154&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 476.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 40.12pt; position: var(--position); top: 0pt; width: 531.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 342pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 342pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 159.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 342pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 132.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;13,473&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,690&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,690&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;177,537&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;176,754&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;176,754&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;69,069&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;73,497&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;69,877&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;21,183&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;23,752&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;157,828&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;162,256&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;24,803&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;137,453&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(1)&#160; &#160;  The fair value of cash and cash equivalents is determined based on Level 1 fair value measurement and corresponds to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market value of the assets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(2)&#160; &#160;  The carrying amount of financial assets measured at amortized cost is deemed to be a reasonable estimate of fair value, except &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the long-term advances made to CROs, whose fair value is determined based on Level 3 fair value measurement and is estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;based on future cash-flows discounted at market rates, using credit spreads ranging from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;16&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;476&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;104&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;218&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2023 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;131&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;271&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2024. As of December 31, 2022, 2023, and 2024, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the advances fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;240&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;235&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(3)&#160; &#160;  The carrying amount of short-term financial liabilities measured at amortized cost was deemed to be a reasonable estimate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(4)&#160; &#160;  The fair value of Kreos BSA A&amp;amp;B, OCEANE conversion option, royalty certificates, Heights convertible notes, Kreos / Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 199.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA and Minimum Return Indemnifications is based on Level 3 fair value measurement and is estimated based on models and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions detailed in Note 15. The fair value of other long-term financial liabilities is determined based on Level 3 fair value &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measurement and is estimated based on future cash-flows discounted at market rates, using the f&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ollowing assumptions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt components of Kreos 1&amp;amp;2 bonds, a credit spread of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the Kreos 1&amp;amp;2 bonds fair &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value by&#160; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;68&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt component of OCEANE bonds, a credit spread similar to that detailed in Note 15. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31,&#160; 2022, an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the OCEANE debt &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;component fair value by&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;476&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt components of the Kreos / Claret OCABSA (tranche A) and the tranches B and C of the Kreos / Claret straight &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bond loans, a credit spr&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ead of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;960&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp a&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s of August 22, 2023, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;900&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2023 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;750&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of August 22, 2023, December 31, 2023 (tranche A) and December 31, 2024 (all three tranches), an increase in the credit &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;spread by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+100&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp would result in a decrease in the Kreos / Claret debt components fair value by respectively &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;624&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;,&#160; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;538&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;958&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 427.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x2022;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;For&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the conditional advances and the PGE loan, a credit spread of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;900&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp as of December &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;31, 2023 and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;730&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp as of December 31, 2024. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;An increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, 2023 and 2024, a decrease in the PGE loan fair value by, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;55&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;39&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;21&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the RNP-VIR conditional advance fair value by&#160;  &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;31&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the CARENA conditional advance fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;37&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;37&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the Ebola conditional advance fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(5) In application of the Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;current, and Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;non-current portion of the Heights convertible notes as of December 31, 2023 were reclassified within the current liabilities &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory>
    <ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory contextRef="c-1" id="f-1035">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following table shows the carrying amounts and fair value of financial assets and financial liabilities, including their &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;levels in the fair value hierarchy.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax and employee-related payables are non-financial liabilities and are therefore excluded from the tables below. They are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;presented in Note 17.2.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,708&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,271&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,271&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,231&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;26,950&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,889&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,452&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,452&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;16,241&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9,439&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8,873&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;33,555&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65,272&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;58,469&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;57,903&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 273.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 39pt; position: var(--position); top: 0pt; width: 534pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 344.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 344.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 120.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 221.57pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,055&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,394&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,394&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;27,164&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;251,942&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,161&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,500&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;301,500&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 60.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;39,697&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;40,622&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18,506&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;42,768&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;37,348&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;37,348&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,531&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5,165&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;47,221&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;124,266&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 36.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;125,191&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;30,037&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 54.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 46.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;95,154&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 476.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 40.12pt; position: var(--position); top: 0pt; width: 531.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 0pt; width: 342pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 342pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 159.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 342pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 132.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 43.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RECOGNIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;IN THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;STATEMENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POSITION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS/ &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT FAIR &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.57pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THROUGH &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PROFIT&#160;AND &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LOSS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 21pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ASSETS AT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.17pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AT&#160;AMORTIZED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COST&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;13,473&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,690&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;12,690&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 90pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other receivables and assets (2)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 102pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;19,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 102pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Cash and cash equivalents (1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 114pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;144,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 114pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;177,537&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;176,754&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 126pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;176,754&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 126pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;non-current portion (4, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;69,069&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;73,497&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 138pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 138pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;69,877&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&#x2014;current portion (3, Note 15)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;21,183&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 150pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 150pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;23,752&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities (3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 162pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 162pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 189.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 189.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 189.75pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;157,828&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 33.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.84pt; position: var(--position);"&gt;162,256&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 326.25pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 37.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.84pt; position: var(--position);"&gt;24,803&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 394.5pt; position: var(--position); top: 174pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 462.75pt; position: var(--position); top: 174pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;137,453&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(1)&#160; &#160;  The fair value of cash and cash equivalents is determined based on Level 1 fair value measurement and corresponds to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market value of the assets. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(2)&#160; &#160;  The carrying amount of financial assets measured at amortized cost is deemed to be a reasonable estimate of fair value, except &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the long-term advances made to CROs, whose fair value is determined based on Level 3 fair value measurement and is estimated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;based on future cash-flows discounted at market rates, using credit spreads ranging from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;16&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;476&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;104&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;218&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.27000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2023 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;131&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;271&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2024. As of December 31, 2022, 2023, and 2024, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 116.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the advances fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;240&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;235&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(3)&#160; &#160;  The carrying amount of short-term financial liabilities measured at amortized cost was deemed to be a reasonable estimate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 163.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 187.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(4)&#160; &#160;  The fair value of Kreos BSA A&amp;amp;B, OCEANE conversion option, royalty certificates, Heights convertible notes, Kreos / Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 199.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA and Minimum Return Indemnifications is based on Level 3 fair value measurement and is estimated based on models and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions detailed in Note 15. The fair value of other long-term financial liabilities is determined based on Level 3 fair value &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measurement and is estimated based on future cash-flows discounted at market rates, using the f&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ollowing assumptions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt components of Kreos 1&amp;amp;2 bonds, a credit spread of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 259.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the Kreos 1&amp;amp;2 bonds fair &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 271.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value by&#160; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;68&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt component of OCEANE bonds, a credit spread similar to that detailed in Note 15. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31,&#160; 2022, an increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the OCEANE debt &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;component fair value by&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;476&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the debt components of the Kreos / Claret OCABSA (tranche A) and the tranches B and C of the Kreos / Claret straight &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 355.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bond loans, a credit spr&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ead of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;960&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp a&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s of August 22, 2023, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;900&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2023 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;750&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 367.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; of August 22, 2023, December 31, 2023 (tranche A) and December 31, 2024 (all three tranches), an increase in the credit &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 391.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;spread by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+100&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp would result in a decrease in the Kreos / Claret debt components fair value by respectively &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;624&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;,&#160; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 403.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;538&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;958&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 427.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x2022;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;For&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the conditional advances and the PGE loan, a credit spread of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp as of December 31, 2022,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;900&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp as of December &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;31, 2023 and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;730&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; bp as of December 31, 2024. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;An increase in the credit spread by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, 2023 and 2024, a decrease in the PGE loan fair value by, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;55&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;39&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;21&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.01999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the RNP-VIR conditional advance fair value by&#160;  &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;31&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 511.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the CARENA conditional advance fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;37&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;37&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022 and 2023, a decrease in the Ebola conditional advance fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(5) In application of the Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;current, and Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;non-current portion of the Heights convertible notes as of December 31, 2023 were reclassified within the current liabilities &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:Assets contextRef="c-315" decimals="-3" id="f-1037" unitRef="eur">11708000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-316" decimals="-3" id="f-1038" unitRef="eur">11271000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-317" decimals="-3" id="f-1039" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-318" decimals="-3" id="f-1040" unitRef="eur">11271000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-319" decimals="-3" id="f-1041" unitRef="eur">9231000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-320" decimals="-3" id="f-1042" unitRef="eur">9231000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-321" decimals="-3" id="f-1043" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-322" decimals="-3" id="f-1044" unitRef="eur">9231000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-323" decimals="-3" id="f-1045" unitRef="eur">26950000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-324" decimals="-3" id="f-1046" unitRef="eur">26950000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-325" decimals="-3" id="f-1047" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-326" decimals="-3" id="f-1048" unitRef="eur">26950000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-327" decimals="-3" id="f-1049" unitRef="eur">47889000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-6" decimals="-3" id="f-1050" unitRef="eur">47452000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-328" decimals="-3" id="f-1051" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-329" decimals="-3" id="f-1052" unitRef="eur">47452000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Liabilities contextRef="c-330" decimals="-3" id="f-1053" unitRef="eur">16241000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-331" decimals="-3" id="f-1054" unitRef="eur">9439000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-332" decimals="-3" id="f-1055" unitRef="eur">566000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-333" decimals="-3" id="f-1056" unitRef="eur">8873000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-334" decimals="-3" id="f-1057" unitRef="eur">33555000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-335" decimals="-3" id="f-1058" unitRef="eur">33555000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-336" decimals="-3" id="f-1059" unitRef="eur">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-337" decimals="-3" id="f-1060" unitRef="eur">33555000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-338" decimals="-3" id="f-1061" unitRef="eur">15475000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-339" decimals="-3" id="f-1062" unitRef="eur">15475000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-340" decimals="-3" id="f-1063" unitRef="eur">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-341" decimals="-3" id="f-1064" unitRef="eur">15475000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-327" decimals="-3" id="f-1065" unitRef="eur">65272000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-6" decimals="-3" id="f-1066" unitRef="eur">58469000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-342" decimals="-3" id="f-1067" unitRef="eur">566000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-343" decimals="-3" id="f-1068" unitRef="eur">57903000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Assets contextRef="c-344" decimals="-3" id="f-1069" unitRef="eur">22055000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-345" decimals="-3" id="f-1070" unitRef="eur">22394000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-346" decimals="-3" id="f-1071" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-347" decimals="-3" id="f-1072" unitRef="eur">22394000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-348" decimals="-3" id="f-1073" unitRef="eur">27164000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-349" decimals="-3" id="f-1074" unitRef="eur">27164000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-350" decimals="-3" id="f-1075" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-351" decimals="-3" id="f-1076" unitRef="eur">27164000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-352" decimals="-3" id="f-1077" unitRef="eur">251942000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-353" decimals="-3" id="f-1078" unitRef="eur">251942000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-354" decimals="-3" id="f-1079" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-355" decimals="-3" id="f-1080" unitRef="eur">251942000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-356" decimals="-3" id="f-1081" unitRef="eur">301161000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-7" decimals="-3" id="f-1082" unitRef="eur">301500000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-357" decimals="-3" id="f-1083" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-358" decimals="-3" id="f-1084" unitRef="eur">301500000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Liabilities contextRef="c-359" decimals="-3" id="f-1085" unitRef="eur">39697000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-360" decimals="-3" id="f-1086" unitRef="eur">40622000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-361" decimals="-3" id="f-1087" unitRef="eur">18506000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-362" decimals="-3" id="f-1088" unitRef="eur">42768000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-363" decimals="-3" id="f-1089" unitRef="eur">37348000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-364" decimals="-3" id="f-1090" unitRef="eur">37348000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-365" decimals="-3" id="f-1091" unitRef="eur">11531000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-366" decimals="-3" id="f-1092" unitRef="eur">5165000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-367" decimals="-3" id="f-1093" unitRef="eur">47221000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-368" decimals="-3" id="f-1094" unitRef="eur">47221000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-369" decimals="-3" id="f-1095" unitRef="eur">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-370" decimals="-3" id="f-1096" unitRef="eur">47221000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-356" decimals="-3" id="f-1097" unitRef="eur">124266000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-7" decimals="-3" id="f-1098" unitRef="eur">125191000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-371" decimals="-3" id="f-1099" unitRef="eur">30037000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-372" decimals="-3" id="f-1100" unitRef="eur">95154000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Assets contextRef="c-373" decimals="-3" id="f-1101" unitRef="eur">13473000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-374" decimals="-3" id="f-1102" unitRef="eur">12690000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-375" decimals="-3" id="f-1103" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-376" decimals="-3" id="f-1104" unitRef="eur">12690000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-377" decimals="-3" id="f-1105" unitRef="eur">19843000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-378" decimals="-3" id="f-1106" unitRef="eur">19843000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-379" decimals="-3" id="f-1107" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-380" decimals="-3" id="f-1108" unitRef="eur">19843000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-381" decimals="-3" id="f-1109" unitRef="eur">144221000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-382" decimals="-3" id="f-1110" unitRef="eur">144221000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-383" decimals="-3" id="f-1111" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-384" decimals="-3" id="f-1112" unitRef="eur">144221000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Assets contextRef="c-385" decimals="-3" id="f-1113" unitRef="eur">177537000</ifrs-full:Assets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-5" decimals="-3" id="f-1114" unitRef="eur">176754000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-386" decimals="-3" id="f-1115" unitRef="eur">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-387" decimals="-3" id="f-1116" unitRef="eur">176754000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:Liabilities contextRef="c-388" decimals="-3" id="f-1117" unitRef="eur">69069000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-389" decimals="-3" id="f-1118" unitRef="eur">73497000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-390" decimals="-3" id="f-1119" unitRef="eur">3620000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-391" decimals="-3" id="f-1120" unitRef="eur">69877000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-392" decimals="-3" id="f-1121" unitRef="eur">44935000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-393" decimals="-3" id="f-1122" unitRef="eur">44935000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-394" decimals="-3" id="f-1123" unitRef="eur">21183000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-395" decimals="-3" id="f-1124" unitRef="eur">23752000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-396" decimals="-3" id="f-1125" unitRef="eur">43824000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-397" decimals="-3" id="f-1126" unitRef="eur">43824000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-398" decimals="-3" id="f-1127" unitRef="eur">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-399" decimals="-3" id="f-1128" unitRef="eur">43824000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:Liabilities contextRef="c-385" decimals="-3" id="f-1129" unitRef="eur">157828000</ifrs-full:Liabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-5" decimals="-3" id="f-1130" unitRef="eur">162256000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-400" decimals="-3" id="f-1131" unitRef="eur">24803000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-401" decimals="-3" id="f-1132" unitRef="eur">137453000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="c-402"
      decimals="4"
      id="f-1133"
      unitRef="number">0.0016</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="c-403"
      decimals="4"
      id="f-1134"
      unitRef="number">0.0476</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="c-404"
      decimals="4"
      id="f-1135"
      unitRef="number">0.0104</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="c-405"
      decimals="4"
      id="f-1136"
      unitRef="number">0.0218</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="c-406"
      decimals="4"
      id="f-1137"
      unitRef="number">0.0131</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="c-407"
      decimals="4"
      id="f-1138"
      unitRef="number">0.0271</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets
      contextRef="c-408"
      decimals="4"
      id="f-1139"
      unitRef="number">0.0100</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-409" decimals="-3" id="f-1140" unitRef="eur">-240000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-410" decimals="-3" id="f-1141" unitRef="eur">-23000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-411" decimals="-3" id="f-1142" unitRef="eur">-235000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-412"
      decimals="4"
      id="f-1143"
      unitRef="number">0.1475</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-413"
      decimals="4"
      id="f-1144"
      unitRef="number">0.0100</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-414" decimals="-3" id="f-1145" unitRef="eur">-68000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-413"
      decimals="4"
      id="f-1146"
      unitRef="number">0.0100</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-415" decimals="-3" id="f-1147" unitRef="eur">-476000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-416"
      decimals="4"
      id="f-1148"
      unitRef="number">0.0960</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-417"
      decimals="4"
      id="f-1149"
      unitRef="number">0.0900</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-418"
      decimals="4"
      id="f-1150"
      unitRef="number">0.0750</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-419"
      decimals="4"
      id="f-1151"
      unitRef="number">0.0100</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-420" decimals="-3" id="f-1152" unitRef="eur">-624000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-421" decimals="-3" id="f-1153" unitRef="eur">-538000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-422" decimals="-3" id="f-1154" unitRef="eur">-958000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-423"
      decimals="4"
      id="f-1155"
      unitRef="number">0.1475</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-424"
      decimals="4"
      id="f-1156"
      unitRef="number">0.0900</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-425"
      decimals="4"
      id="f-1157"
      unitRef="number">0.0730</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-408"
      decimals="4"
      id="f-1158"
      unitRef="number">0.0100</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-426" decimals="-3" id="f-1159" unitRef="eur">-55000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-427" decimals="-3" id="f-1160" unitRef="eur">-39000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-428" decimals="-3" id="f-1161" unitRef="eur">-21000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-429" decimals="-3" id="f-1162" unitRef="eur">-31000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-430" decimals="-3" id="f-1163" unitRef="eur">-15000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-431" decimals="-3" id="f-1164" unitRef="eur">-37000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-432" decimals="-3" id="f-1165" unitRef="eur">-37000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-433" decimals="-3" id="f-1166" unitRef="eur">-1000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-434" decimals="-3" id="f-1167" unitRef="eur">-1000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="c-1" id="f-1168">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Shareholders&#x2019; equity&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 13.1. Share capital issued&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i7bb188ecefa74b61b159fe36701c7a84"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 694.76pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group manages its capital to ensure that the Group will be able to continue as a going concern while maximizing the return to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 706.76pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;shareholders through the optimization of the debt and equity balance.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, the Group&#x2019;s share capital amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;223&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; divided into &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,313,185&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares issued with a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 93.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, fully paid up, after taking into account the various capital increases that took place since the inception (see &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 13.3). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2023, the Group&#x2019;s share capital amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;629&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; divided into &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;62,928,818&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares issued with &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 141.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, fully paid up, after taking into account the various capital increases that took place since the inception (see &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 154.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 13.2). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2024, the Group&#x2019;s share capital amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;633&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; divided in&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;63,347,837&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ordinary shares issued with &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 179.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, fully paid up, after taking into account the various capital increases that took place since the inception (see &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 13.3). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 211.76pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share capital does not include founders&#x2019; share subscription warrants (&#x201c;bons de souscription de parts de cr&#xe9;ateur d&#x2019;entreprise&#x201d; or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 223.76pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;BCE&#x201d;), share subscription warrants (&#x201c;Bons de souscription d&#x2019;actions,&#x201d; or &#x201c;BSA&#x201d;) and free shares (&#x201c;Attributions gratuites &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 235.76pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;d&#x2019;actions,&#x201d; or &#x201c;AGA&#x201d;) that have been granted to certain investors or natural persons, both employees and non-employees of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.76pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group, but not yet exercised.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 277.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Treasury shares&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 299.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group held &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;11,339&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;none&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of its own shares as of December 31, 2022, 2023 and 2024, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 321.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The number of outstanding ordinary shares (excluding treasury shares held by the Group) was &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,301,185&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;62,917,479&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 528.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;63,347,837&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 573.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as of December 31, 2022, 2023 and 2024, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 57.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;13.2. Equity line instruments &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Equity line agreement with Kepler Cheuvreux &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 418.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group entered into an equity line agreement with Kepler Cheuvreux in September 2019. In accordance with the terms of this &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement, Kepler Cheuvreux, acting as financial intermediary and guarantor of the transaction, committed to subscribe for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;730,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 438.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;shares, at its own initiative, following a schedule lasting no longer than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, at an issuance price based on an average market &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 448.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price weighted according to the volumes traded over the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.21000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; trading days preceding each issue, less a maximum discount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.0%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 555.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. On &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;September 24, 2021, the Group extended the agreement for an additional period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the unsubscribed shares at that date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 468.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On October&#160;1, 2022, the agreement ended and the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;300,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; outstanding BSAs lapsed. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 478.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 490.76pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 518.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 61.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 51.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.99pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 15.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANDING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 15.75pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;SHARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO&#160;BE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 15.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&#160;OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 325.5pt; position: var(--position); top: 15.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LAPSED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 15.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANDING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 15.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&#160;OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SHARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO&#160;BE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 67.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 67.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 67.5pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 67.5pt; width: 117pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 117pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 67.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 67.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 79.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 79.5pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 79.5pt; width: 117pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 117pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FOR THE YEAR ENDED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 79.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 79.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 91.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 91.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 5.39pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF JANUARY&#160;1, 2022&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 12.39pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 4.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 91.5pt; width: 117pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 117pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER&#160;31, 2022&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 117pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 91.5pt; width: 140.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 140.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER&#160;31, 2022&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.86999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 140.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 111.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 123.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs granted under the Equity line &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.63pt; width: 123.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 47.93pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.510000000000005pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.800000000000004pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 48.95pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.010000000000005pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;....................................&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 111.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;300,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 111.75pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;300,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 111.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 325.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(300,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 111.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 111.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 639.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Considering that the Group could terminate or suspend the Equity line agreement by buying back the BSAs or increasing the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 649.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;minimum exercise price and that Kepler Cheuvreux was committed to subscribe the shares if the conditions were met, the BSAs &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;granted to Kepler Cheuvreux under the Equity line agreements were off-balance sheet commitments rather than derivative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 13.3. Change in share capital&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i6ad075e1c272438ea7f278d53e09ca0f"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increases in the share capital for the year ended December 31, 2022 relate to: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 98.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The completion of a capital increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;46,231&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; on September 7, 2022 by issuing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5,530,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares with a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share and a subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8.36&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The exercises of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;522&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share warrants for the year ended December 31, 2022 (see Note 14), resulting in a capital increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; by issuing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,134&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares with a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share and an average subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.14&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;per share; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 166.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Incremental costs directly attributable to the issue of new shares were classified as a deduction of shareholders&#x2019; equity and amounted &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 178.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.269999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,280&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the period ended December 31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increases in the share capital for the year ended December 31, 2023 relate to: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The completion of a capital increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;130,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; on February 22, 2023 by issuing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;20,000,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; new ordinary shares &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share and a subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.50&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The cash-less exercise of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67,887&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Kreos A BSA and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31,696&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.09000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Kreos B BSA on&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; May 24, 20&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;23, resulting in a capital increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 257.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,850&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; by issuing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;99,583&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares with a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share and an average subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 268.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.57&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share, which includes the impact of the derecognition of the BSA derivative financial liability; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The completion of the Group&#x2019;s Global Offering on the Nasdaq Global Market on October 24, 2023, by way of a capital &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;20,325,500&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.04000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; new ordinary shares, consisting of the U.S. Offering of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18,699,460&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares in the form of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ADSs, and the European Private Placement of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,626,040&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares, with a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share and an offering &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price set at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$11.60&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ADS in the U.S. Offering and a corresponding offering price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.9864&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ordinary share in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;European Private Placement. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The exercise of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,906&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; other share warrants, by issuing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;190,550&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares with a par value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share and an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;average subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share (see Note 14). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Incremental costs directly attributable to the issue of new shares, including underwriting commissions and offering expenses related to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Global Offering, were classified as a deduction of shareholders&#x2019; equity and amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;28,111&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the period ended &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 398.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2023. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increases in the share capital&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the year ended December 31, 2024 relate to&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 432.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the issue and subscription by members of the Board of Directors of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;77,820&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share warrants, with a subscription price of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.6700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2.57&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.1700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;each (see Note 14);&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 459.04pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a credit note received for transaction fees related to the Global Offering, amounting &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;446 thousand&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and classified in the &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share premiums; and&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 485.92pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the exercise of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4,000&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; other share warrants, by issuing &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4,000&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares with a par value of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share and an &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;average subscription price of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;11.14&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share (see Note 14).&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the issue of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.00999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;415,019&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; vested free shares, as part of the AGA plans issued by the Group to certain of its officers and employees. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Distribution of dividends &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group did not distribute any dividends for any of the periods presented, does not have any present plan to pay any cash dividends &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 580pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on its equity securities in the foreseeable future and currently intends to retain all available funds and any future earnings to operate &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;and expand our business.</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:IssuedCapital contextRef="c-6" decimals="-3" id="f-1169" unitRef="eur">223000</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued contextRef="c-6" decimals="0" id="f-1170" unitRef="shares">22313185</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="c-6"
      decimals="2"
      id="f-1171"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:IssuedCapital contextRef="c-7" decimals="-3" id="f-1172" unitRef="eur">629000</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued contextRef="c-7" decimals="0" id="f-1173" unitRef="shares">62928818</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="c-7"
      decimals="2"
      id="f-1174"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:IssuedCapital contextRef="c-5" decimals="-3" id="f-1175" unitRef="eur">633000</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued contextRef="c-5" decimals="0" id="f-1176" unitRef="shares">63347837</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="c-5"
      decimals="2"
      id="f-1177"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:NumberOfTreasurySharesHeld contextRef="c-6" decimals="0" id="f-1178" unitRef="shares">12000</abvx:NumberOfTreasurySharesHeld>
    <abvx:NumberOfTreasurySharesHeld contextRef="c-7" decimals="0" id="f-1179" unitRef="shares">11339</abvx:NumberOfTreasurySharesHeld>
    <abvx:NumberOfTreasurySharesHeld contextRef="c-5" decimals="0" id="f-1180" unitRef="shares">0</abvx:NumberOfTreasurySharesHeld>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c-6" decimals="0" id="f-1181" unitRef="shares">22301185</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c-7" decimals="0" id="f-1182" unitRef="shares">62917479</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c-5" decimals="0" id="f-1183" unitRef="shares">63347837</ifrs-full:NumberOfSharesOutstanding>
    <abvx:UnderwritingAgreementMaximumNumberOfSharesIssued
      contextRef="c-435"
      decimals="INF"
      id="f-1184"
      unitRef="shares">730000</abvx:UnderwritingAgreementMaximumNumberOfSharesIssued>
    <abvx:UnderwritingAgreementMaximumPeriod contextRef="c-435" id="f-1185">P24M</abvx:UnderwritingAgreementMaximumPeriod>
    <abvx:UnderwritingAgreementIssuancePriceNumberOfTradingDays
      contextRef="c-435"
      decimals="INF"
      id="f-1186"
      unitRef="criteria">2</abvx:UnderwritingAgreementIssuancePriceNumberOfTradingDays>
    <abvx:UnderwritingAgreementIssuancePriceMaximumDiscount
      contextRef="c-435"
      decimals="3"
      id="f-1187"
      unitRef="number">0.070</abvx:UnderwritingAgreementIssuancePriceMaximumDiscount>
    <abvx:UnderwritingAgreementExtendedPeriod contextRef="c-436" id="f-1188">P12M</abvx:UnderwritingAgreementExtendedPeriod>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-437"
      decimals="INF"
      id="f-1189"
      unitRef="shares">300000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory contextRef="c-1" id="f-1190">&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 518.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 61.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 51.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 15.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.99pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 15.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANDING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 15.75pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;SHARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO&#160;BE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 15.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&#160;OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 325.5pt; position: var(--position); top: 15.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF&#160;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LAPSED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 15.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANDING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 15.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER&#160;OF&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SHARES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO&#160;BE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.12pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 67.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 67.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 67.5pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 67.5pt; width: 117pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 117pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 67.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 67.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 1pt; position: var(--position); top: 6.11pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 79.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 79.5pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 79.5pt; width: 117pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 117pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FOR THE YEAR ENDED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 79.5pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 79.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 91.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 91.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 5.39pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF JANUARY&#160;1, 2022&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 12.39pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 4.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 91.5pt; width: 117pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 117pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER&#160;31, 2022&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 117pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 91.5pt; width: 140.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 140.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER&#160;31, 2022&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.86999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 140.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 111.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 123.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs granted under the Equity line &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.63pt; width: 123.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 47.93pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.510000000000005pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.800000000000004pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 48.95pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.99pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.010000000000005pt; position: var(--position); white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #b4b4b4; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 49.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;....................................&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 123.75pt; position: var(--position); top: 111.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;300,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 199.5pt; position: var(--position); top: 111.75pt; width: 61.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 61.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;300,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 261pt; position: var(--position); top: 111.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 325.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(300,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 111.75pt; width: 75.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 75.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 34.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 111.75pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.49pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables summarize the data relating to BCEs as well as the assumptions used for the measurement thereof in accordance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with IFRS 2 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 94.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;: &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 273.86pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 527.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 98.25pt;"&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GRANT&#160;D&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 0pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 61.5pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCEs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 37.5pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 85.5pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF ISSUED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF LAPSED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;D BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCEs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCEs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BLE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF SHARES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO BE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED IF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ALL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 65.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONDITIO&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 74.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NS ARE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 84.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MET&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 98.25pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 98.25pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2016-11-07&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 129pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2016-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;84,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;22,495&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(3,699)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;18,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;18,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;18,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-01-23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 141pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;41,735&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 153pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-11-20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 153pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;150,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 165pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-11-20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 165pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,373&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,373&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;33,686&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,373&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 177pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-11-20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 177pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;64,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 20.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 22.93pt; position: var(--position);"&gt;(26,687)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(4,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;33,687&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;33,687&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 189pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-03-15&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 189pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2018-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;22,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 201pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-05-14&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 201pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE 2018-3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;33,687&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;16,844&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 20.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 22.93pt; position: var(--position);"&gt;(16,844)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 213pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-05-14&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 213pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2018-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;8,422&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 225pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-05-14&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 225pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2018-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;22,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.25pt; position: var(--position);"&gt;6,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(4,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;2,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;2,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;2,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 237pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;530,652&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;385,409&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 20.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 22.93pt; position: var(--position);"&gt;(51,230)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(4,000)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;330,179&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;245,962&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;330,179&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables summarize the data relating to BSAs as well as the assumptions used for the measurement thereof in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.15pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;accordance with IFRS 2&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 209.78pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 52.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GRANT&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 52.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 0pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.87pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BSAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.87pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 70.87pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF ISSUED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF LAPSED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;D&#160; BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BSAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BSAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BLE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 69pt; left: 489pt; overflow: hidden; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: -6.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF SHARES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO BE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED IF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ALL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONDITIO&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NS ARE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 69.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MET&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 69pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 69pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2015-12-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 99.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2015-11&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 111.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2015-12-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2015-12&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;82,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-09-18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 123.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2017-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-01-22&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 135.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2018-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;49,200&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2014-03-11&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 147.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2014-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;1,315&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;842&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 30.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.93pt; position: var(--position);"&gt;(842)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2014-03-11&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 159.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2014-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;787&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;230&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 30.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.93pt; position: var(--position);"&gt;(230)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 171.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-04-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 171.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2024-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 183.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-04-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 183.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2024-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 195.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;324,446&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;147,196&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(1,072)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;223,944&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;146,124&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;223,944&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables summarize the data relating to AGAs as well as the assumptions used for the measurement thereof in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.41pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;accordance with IFRS 2&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 241.51pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 537pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 47.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 38.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GRANT&#160;DATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 28.65pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 47.85pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.45pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANGIN&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.05pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;G AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 52.65pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 62.25pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LAPSED AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VESTED AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.22pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANDIN&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 35.02pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;G &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 35.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 47.25pt; width: 199.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 199.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.33pt; position: var(--position); white-space: pre;"&gt;FOR THE YEAR ENDED DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 47.25pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 16.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,382,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,382,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(212,737)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(390,019)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;780,040&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;100,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;100,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 36.43pt; position: var(--position);"&gt;(25,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;75,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;09/28/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;731,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;731,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(245,625)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;485,875&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;09/28/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;254,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;254,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 36.43pt; position: var(--position);"&gt;(41,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;213,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12/01/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;132,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;132,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 36.43pt; position: var(--position);"&gt;(51,500)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;81,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;02/01/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,549,125&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,549,125&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(193,500)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,355,625&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;03/28/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;22,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;22,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;22,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;05/23/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;38,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;38,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;38,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;93,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;93,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;93,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;25,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;25,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;25,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;20,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;20,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;20,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;09/05/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-7&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;198,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;198,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;198,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;4,547,421&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;2,601,296&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,946,125&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(744,362)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(415,019)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;3,388,040&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-438"
      decimals="INF"
      id="f-1191"
      unitRef="shares">300000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-438"
      decimals="INF"
      id="f-1192"
      unitRef="shares">300000</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-439"
      decimals="INF"
      id="f-1193"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-439"
      decimals="INF"
      id="f-1194"
      unitRef="shares">300000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-440"
      decimals="INF"
      id="f-1195"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-440"
      decimals="INF"
      id="f-1196"
      unitRef="shares">0</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:IssueOfEquity contextRef="c-441" decimals="-3" id="f-1197" unitRef="eur">46231000</ifrs-full:IssueOfEquity>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease
      contextRef="c-441"
      decimals="0"
      id="f-1198"
      unitRef="shares">5530000</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:ParValuePerShare
      contextRef="c-442"
      decimals="2"
      id="f-1199"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-442"
      decimals="2"
      id="f-1200"
      unitRef="eurPerShare">8.36</abvx:EquityIssuanceSubscriptionPricePerShare>
    <abvx:NumberOfWarrantsExercised contextRef="c-10" decimals="0" id="f-1201" unitRef="shares">522</abvx:NumberOfWarrantsExercised>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-10" decimals="-3" id="f-1202" unitRef="eur">3000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-10" decimals="0" id="f-1203" unitRef="shares">19134</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:ParValuePerShare
      contextRef="c-6"
      decimals="2"
      id="f-1204"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:OtherShareWarrantsSubscriptionPricePerShare
      contextRef="c-6"
      decimals="2"
      id="f-1205"
      unitRef="eurPerShare">0.14</abvx:OtherShareWarrantsSubscriptionPricePerShare>
    <ifrs-full:ShareIssueRelatedCost contextRef="c-10" decimals="-3" id="f-1206" unitRef="eur">3280000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IssueOfEquity contextRef="c-443" decimals="-3" id="f-1207" unitRef="eur">130000000</ifrs-full:IssueOfEquity>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease
      contextRef="c-443"
      decimals="0"
      id="f-1208"
      unitRef="shares">20000000</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:ParValuePerShare
      contextRef="c-444"
      decimals="2"
      id="f-1209"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-444"
      decimals="2"
      id="f-1210"
      unitRef="eurPerShare">6.50</abvx:EquityIssuanceSubscriptionPricePerShare>
    <abvx:NumberOfWarrantsExercised
      contextRef="c-445"
      decimals="0"
      id="f-1211"
      unitRef="shares">67887</abvx:NumberOfWarrantsExercised>
    <abvx:NumberOfWarrantsExercised
      contextRef="c-446"
      decimals="0"
      id="f-1212"
      unitRef="shares">31696</abvx:NumberOfWarrantsExercised>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-447" decimals="-3" id="f-1213" unitRef="eur">1850000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants
      contextRef="c-447"
      decimals="0"
      id="f-1214"
      unitRef="shares">99583</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:ParValuePerShare
      contextRef="c-448"
      decimals="2"
      id="f-1215"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:OtherShareWarrantsSubscriptionPricePerShare
      contextRef="c-449"
      decimals="2"
      id="f-1216"
      unitRef="eurPerShare">18.57</abvx:OtherShareWarrantsSubscriptionPricePerShare>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-95" decimals="0" id="f-1217" unitRef="shares">20325500</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-96" decimals="0" id="f-1218" unitRef="shares">18699460</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease contextRef="c-97" decimals="0" id="f-1219" unitRef="shares">1626040</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:ParValuePerShare
      contextRef="c-450"
      decimals="2"
      id="f-1220"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:IssueOfEquityOfferingPricePerShare
      contextRef="c-98"
      decimals="2"
      id="f-1221"
      unitRef="usdPerShare">11.60</abvx:IssueOfEquityOfferingPricePerShare>
    <abvx:IssueOfEquityOfferingPricePerShare
      contextRef="c-99"
      decimals="4"
      id="f-1222"
      unitRef="eurPerShare">10.9864</abvx:IssueOfEquityOfferingPricePerShare>
    <abvx:NumberOfWarrantsExercised contextRef="c-35" decimals="0" id="f-1223" unitRef="shares">1906</abvx:NumberOfWarrantsExercised>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-35" decimals="0" id="f-1224" unitRef="shares">190550</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:ParValuePerShare
      contextRef="c-7"
      decimals="2"
      id="f-1225"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:OtherShareWarrantsSubscriptionPricePerShare
      contextRef="c-451"
      decimals="2"
      id="f-1226"
      unitRef="eurPerShare">0.01</abvx:OtherShareWarrantsSubscriptionPricePerShare>
    <ifrs-full:ShareIssueRelatedCost contextRef="c-11" decimals="-3" id="f-1227" unitRef="eur">28111000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-452"
      decimals="0"
      id="f-1228"
      unitRef="shares">77820</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:ShareWarrantsSubscriptionPricePerShare
      contextRef="c-453"
      decimals="2"
      id="f-1229"
      unitRef="eurPerShare">2.57</abvx:ShareWarrantsSubscriptionPricePerShare>
    <abvx:ShareIssueRelatedCostCredit contextRef="c-1" decimals="-3" id="f-1230" unitRef="eur">-446000</abvx:ShareIssueRelatedCostCredit>
    <abvx:NumberOfWarrantsExercised
      contextRef="c-454"
      decimals="0"
      id="f-1231"
      unitRef="shares">4000</abvx:NumberOfWarrantsExercised>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants
      contextRef="c-454"
      decimals="0"
      id="f-1232"
      unitRef="shares">4000</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:ParValuePerShare
      contextRef="c-5"
      decimals="2"
      id="f-1233"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:OtherShareWarrantsSubscriptionPricePerShare
      contextRef="c-455"
      decimals="2"
      id="f-1234"
      unitRef="eurPerShare">11.14</abvx:OtherShareWarrantsSubscriptionPricePerShare>
    <abvx:NumberOfFreeSharesIssued contextRef="c-1" decimals="0" id="f-1235" unitRef="shares">415019</abvx:NumberOfFreeSharesIssued>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="c-1" id="f-1236">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based payments&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.1pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group has granted BCEs, BSAs and free shares (&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 250.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;attributions gratuities d&#x2019;actions&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, or &#x201c;AGAs&#x201d;). These plans qualify as &#x201c;equity &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.3pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;settled&#x201d; under IFRS 2. The Group does not have any obligation to purchase these instruments in the event of departure or if a specific &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.5pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;event does not occur. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 688.7pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Valuation methods of BCEs, BSAs and AGAs &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The fair value of share-based awards was determined at grant date using the Black Scholes model for the BCEs and BSAs and the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Monte-Carlo simulation for AGAs plans with market performance conditions.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The assumptions used to estimate the fair value of the instruments are presented below and include: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Expected maturity of the options;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Expected volatility based on the historical market share price available; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Expected dividends based on management best estimate; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free interest rate based on French OAT rates measured at grant dates; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share price, including offered in case of change of control (only for the market conditions applicable to the free-share plans &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2021 and AGA 2023-1) is based on Monte-Carlo simulations and taking into account a change of control premium &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;based on the management best estimate. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCEs &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables summarize the data relating to BCEs as well as the assumptions used for the measurement thereof in accordance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with IFRS 2 &#x2013; &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 94.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;: &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 273.86pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 527.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 98.25pt;"&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GRANT&#160;D&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 0pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 61.5pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCEs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 37.5pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 47.1pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 56.7pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 66.3pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 75.9pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 85.5pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF ISSUED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF LAPSED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;D BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCEs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCEs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BLE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF SHARES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO BE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.12pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED IF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 55.72pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ALL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 65.32pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONDITIO&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 74.92pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NS ARE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 84.52pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MET&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 98.25pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 98.25pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2016-11-07&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 129pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2016-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;84,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;22,495&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(3,699)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;18,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;18,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 129pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;18,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-01-23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 141pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;41,735&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 141pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 153pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-11-20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 153pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;150,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 153pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;112,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 165pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-11-20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 165pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,373&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,373&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;33,686&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 165pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;67,373&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 177pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-11-20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 177pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2017-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;67,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;64,374&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 20.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 22.93pt; position: var(--position);"&gt;(26,687)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(4,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;33,687&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 177pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;33,687&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 189pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-03-15&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 189pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2018-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;22,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 189pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;11,980&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 201pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-05-14&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 201pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE 2018-3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;33,687&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;16,844&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 20.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 22.93pt; position: var(--position);"&gt;(16,844)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 201pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 213pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-05-14&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 213pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2018-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;8,422&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 213pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,843&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 225pt; width: 45pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 45pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-05-14&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 225pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCE-2018-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 28.25pt; position: var(--position);"&gt;22,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.25pt; position: var(--position);"&gt;6,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(4,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;2,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;2,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 225pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;2,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 48pt; position: var(--position); top: 237pt; width: 47.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 47.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total BCEs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 98.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;530,652&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 152.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 21.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.25pt; position: var(--position);"&gt;385,409&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 206.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 39.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 260.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 20.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 22.93pt; position: var(--position);"&gt;(51,230)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(4,000)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 368.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;330,179&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 422.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;245,962&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 476.25pt; position: var(--position); top: 237pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;330,179&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The BCEs include a service condition under which the beneficiary must still be an employee, a corporate officer or a scientific &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;consultant of the Group at the time of vesting. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 596.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The exercise rights for most of the BCEs are vested annually and have the following vesting terms: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the award vests on the first anniversary of the date of grant for all currently issued BCEs; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 630.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the remaining &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;75%&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the award, the BCEs vest 1/48th per month over &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four years&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from the anniversary date of the grant. &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.04pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Most of the BCEs plans (all BCEs plans except BCE 2014-2 fully vested as of January 1, 2020) include or partially include non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.24pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market performance conditions (obtaining financing of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, positive results on clinic studies, signature of informed consent &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.44pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in a clinical phase, signing a license agreement, FDA authorization). The level of achievement of the non-market performance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conditions are taken into account in determining the number of BCEs allocated initially and reassessed at each closing date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In the event of a change of control or a M&amp;amp;A transaction, all the BCEs will become immediately exercisable. A change of control is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;defined as a new investor/company holding directly or indirectly more than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the share capital or voting rights. As such the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;probable vesting date of each plan corresponds to the weighted average of probable change of control dates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.5pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.15pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables summarize the data relating to BSAs as well as the assumptions used for the measurement thereof in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.15pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;accordance with IFRS 2&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 209.78pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 52.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 69pt;"&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 52.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GRANT&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 52.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 0pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 46.87pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BSAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.87pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.47pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BCAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 42.07pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 51.67pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 61.27pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 70.87pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF ISSUED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF LAPSED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;D&#160; BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BSAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTAND&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF BSAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 36.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EXERCISA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 45.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BLE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 69pt; left: 489pt; overflow: hidden; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: -6.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MAXIMUM &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OF SHARES &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TO BE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.5pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED IF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.1pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ALL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 50.7pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONDITIO&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 60.3pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NS ARE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 69.9pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MET&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 69pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 53.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 69pt; width: 159pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 67.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 159pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 41.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2015-12-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 99.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2015-11&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 99.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;96,924&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 111.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2015-12-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 111.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2015-12&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;82,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 111.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2017-09-18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 123.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2017-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 123.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2018-01-22&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 135.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2018-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;49,200&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 135.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;16,400&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2014-03-11&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 147.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2014-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.59pt; position: var(--position);"&gt;1,315&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;842&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 30.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.93pt; position: var(--position);"&gt;(842)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 147.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2014-03-11&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 159.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2014-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;787&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;230&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 30.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.93pt; position: var(--position);"&gt;(230)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 159.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 171.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-04-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 171.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2024-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 171.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 183.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-04-04&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 183.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSA-2024-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 219pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 183.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.59pt; position: var(--position);"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 55.5pt; position: var(--position); top: 195.75pt; width: 52.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 52.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 111pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;324,446&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 165pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;147,196&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 24.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.93pt; position: var(--position);"&gt;(1,072)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 327pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 36.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 381pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;223,944&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;146,124&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 489pt; position: var(--position); top: 195.75pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 51pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 18.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.59pt; position: var(--position);"&gt;223,944&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.83pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs issued prior to January 1, 2024&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.43pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These BSAs include a service condition under which the beneficiary must still be an employee, a corporate officer or a scientific &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.63pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;consultant of the Group at the time of vesting. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.03pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The exercise rights for most of these BSAs are vested annually and have the following vesting terms: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 507.23pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the award vests on the first anniversary of the date of grant for all currently issued BSAs; and &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 520.67pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the remaining &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;75%&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the award, the BSAs vest 1/48th per month over &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four years&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from the anniversary date of the grant. &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 547.41pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;All of these BSAs plans include or partially include non-market performance conditions (positive results on clinic studies, signature of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.61pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;informed consent in a clinical phase, signing a license agreement, FDA authorization). The level of achievement of the non-market &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;performance conditions are taken into account in determining the number of BSAs allocated initially and reassessed at each closing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 581.01pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.41pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In the event of a change of control or a M&amp;amp;A transaction, all these BSAs will become immediately exercisable. A change of control is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.61pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;defined as a new investor/company holding directly or indirectly more than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the share capital or voting rights. As such the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;probable vesting date of each plan corresponds to the weighted average of probable change of control dates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.21pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs granted in March 2024&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.21pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In March 2024, the Group granted its independent Board members the right to subscribe up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;77,820&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share warrants (BSA) in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 684.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;aggregate, the vesting of which&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;is subject to a service condition of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, by tranches of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, vested on each anniversary &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 696.21pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;date. Additionally, the BSAs are subject to a vesting acceleration condition in case of a tender offer on the securities issued by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 707.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group and resulting in a change of control of the Group. All of the granted BSAs were subscribed by the beneficiaries in April 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The fair value of the BSAs was determined at grant date using the Black Scholes model, with the following assumptions:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.84pt; position: var(--position); white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 54pt; position: var(--position); top: 0pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.62pt; position: var(--position); white-space: pre;"&gt;FAIR VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.38pt; position: var(--position); white-space: pre;"&gt;OF THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.07pt; position: var(--position); white-space: pre;"&gt;UNDERLYING &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.61pt; position: var(--position); white-space: pre;"&gt;SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 117.75pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.5pt; position: var(--position); white-space: pre;"&gt;FAIR VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.49pt; position: var(--position); white-space: pre;"&gt;OF THE BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 179.25pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.94pt; position: var(--position); white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.92pt; position: var(--position); white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 240.75pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.27pt; position: var(--position); white-space: pre;"&gt;SUBSCRIPTI&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.82pt; position: var(--position); white-space: pre;"&gt;ON PRICE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.15pt; position: var(--position); white-space: pre;"&gt;STRIKE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.83pt; position: var(--position); white-space: pre;"&gt;PRICE PER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.48pt; position: var(--position); white-space: pre;"&gt;SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 0pt; width: 53.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.2pt; position: var(--position); white-space: pre;"&gt;RISK FREE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 53.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.52pt; position: var(--position); white-space: pre;"&gt;RATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 420pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.49pt; position: var(--position); white-space: pre;"&gt;EXPECTED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.05pt; position: var(--position); white-space: pre;"&gt;MATURITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 481.5pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.71pt; position: var(--position); white-space: pre;"&gt;VOLATILITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;BSA 2024-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 54pt; position: var(--position); top: 41.25pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.06&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 117.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.7&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;"&gt;]&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 179.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 240.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.10&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 41.25pt; width: 53.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4.30%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 420pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.4&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.9&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"&gt; years]&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 481.5pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60.41%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;BSA 2024-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 54pt; position: var(--position); top: 53.25pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.06&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 117.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.8&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;"&gt;]&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 179.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 240.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.10&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 53.25pt; width: 53.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4.30%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 420pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.5&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.0&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"&gt; years]&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 481.5pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60.41%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164.91pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.41pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following tables summarize the data relating to AGAs as well as the assumptions used for the measurement thereof in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.41pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;accordance with IFRS 2&#x2014;&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 149.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based Payment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;:&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 241.51pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 537pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 64.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 47.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 38.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GRANT&#160;DATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 28.65pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TOTAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 38.25pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 47.85pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs ISSUED&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.45pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANGIN&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 43.05pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;G AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 52.65pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 62.25pt; width: 64.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ISSUED AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LAPSED AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VESTED AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 0pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.22pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.82pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.42pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OUTSTANDIN&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 35.02pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;G &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 35.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="5" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 47.25pt; width: 199.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 199.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.33pt; position: var(--position); white-space: pre;"&gt;FOR THE YEAR ENDED DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 47.25pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 21.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 16.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 26.62pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,382,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,382,796&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(212,737)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(390,019)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 82.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;780,040&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;100,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;100,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 36.43pt; position: var(--position);"&gt;(25,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 94.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;75,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;09/28/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;731,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;731,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(245,625)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 106.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;485,875&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;09/28/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;254,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;254,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 36.43pt; position: var(--position);"&gt;(41,000)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 118.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;213,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12/01/23&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2023-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;132,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;132,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 33.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 36.43pt; position: var(--position);"&gt;(51,500)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 130.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;81,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;02/01/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,549,125&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,549,125&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(193,500)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 142.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,355,625&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;03/28/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;22,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;22,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 154.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;22,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;05/23/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;38,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;38,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 166.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;38,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-4&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;93,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;93,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 178.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;93,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;25,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;25,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 190.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;25,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;07/11/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;20,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;20,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 202.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.09pt; position: var(--position);"&gt;20,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;09/05/24&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-7&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;198,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;198,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.09pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 214.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.09pt; position: var(--position);"&gt;198,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 67.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total AGAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 135pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;4,547,421&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 202.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;2,601,296&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 270pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;1,946,125&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 337.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(744,362)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 405pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 29.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 32.43pt; position: var(--position);"&gt;(415,019)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 472.5pt; position: var(--position); top: 226.5pt; width: 64.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 64.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 26.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.09pt; position: var(--position);"&gt;3,388,040&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 72pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 0pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.22pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&#160;OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;UNDERLYING &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.02pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THE AGA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA PRICE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MATURITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VOLATILITY &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RISK&#160;FREE&#160;RATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2021 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 41.25pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;31.60&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022-07-31&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;49.0%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-1.00%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-1 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranches 1-4)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 53.25pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-1 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 5)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 75pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3.62&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-12-31&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.2%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.20%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-1 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 6)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 96.75pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.74&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-07-11&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.2%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.20%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-2 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 1)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 118.5pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-2 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 2)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 140.25pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.59&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-3&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 162pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-4&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 174pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-5&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 186pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.16&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.16&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2024-1&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 198pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.26&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.26&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2024-2&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 210pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.40&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.40&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-3&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 222pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.76&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.76&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-4&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 234pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-5&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 246pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-6&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 258pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-7&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 270pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.80&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.80&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs granted in September 2021&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs granted in September 2021 are subject to a vesting service condition of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; following the grant date. The number of shares &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;that will be finally vested under this plan will depend on the following conditions: if a M&amp;amp;A transaction is completed on or prior to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 428.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;July 31, 2022 and the price per ordinary share of the Group retained in the framework of the M&amp;amp;A transaction is at least equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 553.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 573.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;per share (or lower than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share) then &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;100%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;75%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) of the shares initially granted will be vested. The AGAs are forfeited if a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;M&amp;amp;A transaction is not completed on or prior to July 31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These conditions qualify as both a non-market performance condition (occurrence or not of a M&amp;amp;A transaction before July 31, 2022) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and a market condition (number of shares depending on the share price offered in case of a M&amp;amp;A transaction before July 31, 2022) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 496.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;under IFRS 2 principles. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 518.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The level of achievement of the market condition is directly included in the unit fair value of the free shares and the probability of a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;M&amp;amp;A transaction before July 31, 2022 is included in the estimation of the number of shares that will be finally vested by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;beneficiaries. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;During the period ended December 31, 2022, the AGAs were all forfeited since no M&amp;amp;A transaction was completed on or prior to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;July 31, 2022. This resulted in a reversal of the related compensation expense of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,026&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and the reversal of the accrual for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;social taxes of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;205&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; that was recorded as of December 31, 2021. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs granted in July 2023&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(a) Pursuant to a Board decision on July 11, 2023, the Group allocated a total number of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,382,796&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs to Mr. Marc de Garidel, as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 652.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group&#x2019;s Chief Executive Officer, to which performance conditions and service conditions apply (AGA plan 2023-1):&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 674.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;212,738&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-1 (tranche 1): the acquisition period shall end on the first anniversary of the allocation date; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 686.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;638,214&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-1 (tranche 2): the AGAs 2023-1 shall progressively be definitively acquired on a monthly basis over &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 697.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.78999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; starting after the first anniversary of the allocation date;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;212,738&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-1 (tranche 3): the acquisition period shall end on the latest date between (i) the first anniversary of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the allocation date, and (ii) the date on which a specific performance condition related to regulatory approval is fulfilled; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;106,369&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-1 (tranche 4): the acquisition period shall end on the latest date between (i) the first anniversary of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the allocation date, and (ii) the date on which the Group successfully completes a public offering raising at least &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.4200000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$100&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in gross proceeds (the condition was met on October 24, 2023); &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;106,369&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-1 (tranche 5): the acquisition period shall end on the latest date between (i) the first anniversary of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the allocation date, and (ii) the date on which a specific performance condition related to the Group&#x2019;s market capitalization is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fulfilled; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;106,368&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-1 (tranche 6): the acquisition period shall end on the first anniversary of the allocation date subject &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to the completion, prior to such date, of a tender offer on the securities issued by the Group, at a predetermined minimum &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price, and resulting in a change of control of the Group; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Additionally, AGAs related to tranches 1 to 5 are subject to a vesting acceleration condition in case of a tender offer on the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;securities issued by the Group and resulting in a change of control of the Group.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group qualified those conditions under IFRS 2 principles as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 263.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditions related to tranches 1 and 2 qualify as service conditions under IFRS 2 principles.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 277pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditions related to tranches 3 and 4 qualify as service and non-market performance conditions. Their levels of achievement &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 290.44pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are reflected in the number of instruments that are expected to vest and were estimated by management based on observable &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 303.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;industry-specific data.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 317.32pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditions related to tranches 5 and 6 qualify as service and market performance conditions. The levels of achievement of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market conditions are reflected in the unit fair value of the free shares and were estimated by management using the valuation &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 344.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;methods and assumptions set out above. The valuation of tranche 6 also incorporates management&#x2019;s estimate of the &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 357.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;probability of a M&amp;amp;A transaction prior to the limit date.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 371.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The vesting acceleration condition in case of a tender offer on the securities issued by the Group and resulting in a change of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;control of the Group qualifies as a non-market performance condition.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 411.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(b) Pursuant to a Board decision on July 11, 2023, the Group allocated a total number of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;100,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs to Mr. Hartmut Ehrlich, as the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 422.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group&#x2019;s former Chief Executive Officer, to which the following conditions apply (AGA plan 2023-2):&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 445.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25,000&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-2 (tranche 1): the acquisition period shall end on the first anniversary of the allocation date, and is &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;not subject to a future service condition; &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 472.24pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;75,000&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2023-2 (tranche 2): the acquisition period shall end on the latest date between (i) the first anniversary of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the allocation date, and (ii) the date on which a specific condition, related to positive results on clinical studies, is fulfilled. &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.12pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The acquisition is not subject to a future service condition. Additionally, the tranche is subject to a vesting acceleration &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;condition in case of a tender offer on the securities issued by the Group and resulting in a change of control of the Group.&#160; &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 526pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;This tranche qualifies as a non-vesting condition. Its level of achievement is reflected in the unit fair value of the free shares, &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.44pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and was estimated by management based on observable industry-specific data.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.32pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs granted in September and December 2023&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.72pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On September 28, 2023 and December 1, 2023, certain of the Group&#x2019;s officers and employees were allocated respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;985,750&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.92pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs (AGA plans 2023-3 and 2023-4) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;132,750&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs (AGA plan 2023-5) in the aggregate, the vesting of which is subject to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.12pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certain conditions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 633.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subject to remaining employed with the Group, each such officer or employee&#x2019;s AGAs will be vested as follows: (i) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 646.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the end of a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date, (ii) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.59000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date and &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 660.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(iii) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date (service condition). &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 685.04pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Of the &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,118,500&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs, &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;254,250&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs are subject to an additional non-market performance condition of the successful &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 698.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;completion of a public offering raising at least &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$200&#160;million&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in gross proceeds. This condition was met on October 24, 2023.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Additionally, all the 2023-3, 2023-4 and 2023-5 AGAs are subject to a vesting acceleration condition in case of a tender offer on the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;securities issued by the Group and resulting in a change of control of the Group.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 108pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs granted in February, March, May, July and September 2024&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 130.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On February 1, 2024, March 28, 2024, May 23, 2024, July 11, 2024 and September 5, 2024 certain of the Group&#x2019;s officers and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 141.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;employees were allocated respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,549,125&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs (AGA plans 2024-1), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;22,500&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs (AGA plan 2024-2), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;38,500&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs (AGA &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;plans 2024-3), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;138,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs (AGA plans 2024-4, 5 and 6) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;198,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs (AGA plans 2024-7), in the aggregate, the vesting of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 164pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which is subject to certain conditions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 189pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subject to remaining employed with the Group, each such officer or employee&#x2019;s AGAs (with the exception of AGAs 2024-6) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 202.44pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;will be vested as follows: (i) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two years&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date, (ii) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 551.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 215.88pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;period from the allocation date and (iii) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;25%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at the end of a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four years&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; period from the allocation date (service condition).&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;20,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs 2024-6 granted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;an employee &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are composed of (i) a first tranche of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs not subject to any &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;presence of performance condition&#160; and (ii) a second tranche of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; AGAs subject to a non-vesting condition, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;achievement of which was deemed certain on grant date.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 290.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Additionally, all the 2024-1 to 2024-7 AGA plans are subject to a vesting acceleration condition in case of a tender offer on &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the securities issued by the Group and resulting in a change of control of the G&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;roup.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Social taxes related to AGAs&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA plans granted to the Group's officers and employees are subject to employer's taxes, measured in accordance with the same &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 376.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;principles as the AGA plans. These taxes are classified as provisions before they are due.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 400.96pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre; width: 439.91pt;"&gt;Breakdown of the compensation expenses accounted for the period ended December 31, 2022, 2023 and 2024&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 424.31pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.88pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCEs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 41.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(138)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 41.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 41.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(211)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 65.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 65.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(1,026)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 65.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(8,067)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 65.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(19,900)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 77.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Social taxes related to AGAs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 77.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(205)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 77.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(426)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 77.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(717)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(1,369)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(8,605)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(20,941)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-456"
      decimals="INF"
      id="f-1237"
      unitRef="shares">84000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-457"
      decimals="INF"
      id="f-1238"
      unitRef="shares">22495</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-458"
      decimals="INF"
      id="f-1239"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-458"
      decimals="INF"
      id="f-1240"
      unitRef="shares">3699</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-458"
      decimals="INF"
      id="f-1241"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-459"
      decimals="INF"
      id="f-1242"
      unitRef="shares">18796</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-459"
      decimals="INF"
      id="f-1243"
      unitRef="shares">18796</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-459"
      decimals="INF"
      id="f-1244"
      unitRef="shares">18796</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-460"
      decimals="INF"
      id="f-1245"
      unitRef="shares">67374</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-461"
      decimals="INF"
      id="f-1246"
      unitRef="shares">67000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-462"
      decimals="INF"
      id="f-1247"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-462"
      decimals="INF"
      id="f-1248"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-462"
      decimals="INF"
      id="f-1249"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-463"
      decimals="INF"
      id="f-1250"
      unitRef="shares">67000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-463"
      decimals="INF"
      id="f-1251"
      unitRef="shares">41735</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-463"
      decimals="INF"
      id="f-1252"
      unitRef="shares">67000</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-464"
      decimals="INF"
      id="f-1253"
      unitRef="shares">150000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-465"
      decimals="INF"
      id="f-1254"
      unitRef="shares">112500</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-466"
      decimals="INF"
      id="f-1255"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-466"
      decimals="INF"
      id="f-1256"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-466"
      decimals="INF"
      id="f-1257"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-467"
      decimals="INF"
      id="f-1258"
      unitRef="shares">112500</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-467"
      decimals="INF"
      id="f-1259"
      unitRef="shares">112500</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-467"
      decimals="INF"
      id="f-1260"
      unitRef="shares">112500</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-468"
      decimals="INF"
      id="f-1261"
      unitRef="shares">67374</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-469"
      decimals="INF"
      id="f-1262"
      unitRef="shares">67373</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-470"
      decimals="INF"
      id="f-1263"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-470"
      decimals="INF"
      id="f-1264"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-470"
      decimals="INF"
      id="f-1265"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-471"
      decimals="INF"
      id="f-1266"
      unitRef="shares">67373</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-471"
      decimals="INF"
      id="f-1267"
      unitRef="shares">33686</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-471"
      decimals="INF"
      id="f-1268"
      unitRef="shares">67373</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-472"
      decimals="INF"
      id="f-1269"
      unitRef="shares">67374</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-473"
      decimals="INF"
      id="f-1270"
      unitRef="shares">64374</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-474"
      decimals="INF"
      id="f-1271"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-474"
      decimals="INF"
      id="f-1272"
      unitRef="shares">26687</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-474"
      decimals="INF"
      id="f-1273"
      unitRef="shares">4000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-475"
      decimals="INF"
      id="f-1274"
      unitRef="shares">33687</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-475"
      decimals="INF"
      id="f-1275"
      unitRef="shares">16843</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-475"
      decimals="INF"
      id="f-1276"
      unitRef="shares">33687</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-476"
      decimals="INF"
      id="f-1277"
      unitRef="shares">22000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-477"
      decimals="INF"
      id="f-1278"
      unitRef="shares">11980</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-478"
      decimals="INF"
      id="f-1279"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-478"
      decimals="INF"
      id="f-1280"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-478"
      decimals="INF"
      id="f-1281"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-479"
      decimals="INF"
      id="f-1282"
      unitRef="shares">11980</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-479"
      decimals="INF"
      id="f-1283"
      unitRef="shares">11980</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-479"
      decimals="INF"
      id="f-1284"
      unitRef="shares">11980</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-480"
      decimals="INF"
      id="f-1285"
      unitRef="shares">33687</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-481"
      decimals="INF"
      id="f-1286"
      unitRef="shares">16844</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-482"
      decimals="INF"
      id="f-1287"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-482"
      decimals="INF"
      id="f-1288"
      unitRef="shares">16844</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-482"
      decimals="INF"
      id="f-1289"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-483"
      decimals="INF"
      id="f-1290"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-483"
      decimals="INF"
      id="f-1291"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-483"
      decimals="INF"
      id="f-1292"
      unitRef="shares">0</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-484"
      decimals="INF"
      id="f-1293"
      unitRef="shares">16843</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-485"
      decimals="INF"
      id="f-1294"
      unitRef="shares">16843</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-486"
      decimals="INF"
      id="f-1295"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-486"
      decimals="INF"
      id="f-1296"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-486"
      decimals="INF"
      id="f-1297"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-487"
      decimals="INF"
      id="f-1298"
      unitRef="shares">16843</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-487"
      decimals="INF"
      id="f-1299"
      unitRef="shares">8422</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-487"
      decimals="INF"
      id="f-1300"
      unitRef="shares">16843</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-488"
      decimals="INF"
      id="f-1301"
      unitRef="shares">22000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-489"
      decimals="INF"
      id="f-1302"
      unitRef="shares">6000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-490"
      decimals="INF"
      id="f-1303"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-490"
      decimals="INF"
      id="f-1304"
      unitRef="shares">4000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-490"
      decimals="INF"
      id="f-1305"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-491"
      decimals="INF"
      id="f-1306"
      unitRef="shares">2000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-491"
      decimals="INF"
      id="f-1307"
      unitRef="shares">2000</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-491"
      decimals="INF"
      id="f-1308"
      unitRef="shares">2000</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-492"
      decimals="INF"
      id="f-1309"
      unitRef="shares">530652</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-493"
      decimals="INF"
      id="f-1310"
      unitRef="shares">385409</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-494"
      decimals="INF"
      id="f-1311"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-494"
      decimals="INF"
      id="f-1312"
      unitRef="shares">51230</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-494"
      decimals="INF"
      id="f-1313"
      unitRef="shares">4000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-495"
      decimals="INF"
      id="f-1314"
      unitRef="shares">330179</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-495"
      decimals="INF"
      id="f-1315"
      unitRef="shares">245962</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-495"
      decimals="INF"
      id="f-1316"
      unitRef="shares">330179</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-496"
      decimals="2"
      id="f-1317"
      unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-497"
      decimals="2"
      id="f-1318"
      unitRef="number">0.75</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-497" id="f-1319">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing contextRef="c-498" decimals="-6" id="f-1320" unitRef="eur">100000000</abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold
      contextRef="c-494"
      decimals="2"
      id="f-1321"
      unitRef="number">0.50</abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-499"
      decimals="INF"
      id="f-1322"
      unitRef="shares">96924</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-500"
      decimals="INF"
      id="f-1323"
      unitRef="shares">96924</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-501"
      decimals="INF"
      id="f-1324"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-501"
      decimals="INF"
      id="f-1325"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-501"
      decimals="INF"
      id="f-1326"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-502"
      decimals="INF"
      id="f-1327"
      unitRef="shares">96924</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-502"
      decimals="INF"
      id="f-1328"
      unitRef="shares">96924</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-502"
      decimals="INF"
      id="f-1329"
      unitRef="shares">96924</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-503"
      decimals="INF"
      id="f-1330"
      unitRef="shares">82000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-504"
      decimals="INF"
      id="f-1331"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-505"
      decimals="INF"
      id="f-1332"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-505"
      decimals="INF"
      id="f-1333"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-505"
      decimals="INF"
      id="f-1334"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-506"
      decimals="INF"
      id="f-1335"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-506"
      decimals="INF"
      id="f-1336"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-506"
      decimals="INF"
      id="f-1337"
      unitRef="shares">16400</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-507"
      decimals="INF"
      id="f-1338"
      unitRef="shares">16400</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-508"
      decimals="INF"
      id="f-1339"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-509"
      decimals="INF"
      id="f-1340"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-509"
      decimals="INF"
      id="f-1341"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-509"
      decimals="INF"
      id="f-1342"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-510"
      decimals="INF"
      id="f-1343"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-510"
      decimals="INF"
      id="f-1344"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-510"
      decimals="INF"
      id="f-1345"
      unitRef="shares">16400</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-511"
      decimals="INF"
      id="f-1346"
      unitRef="shares">49200</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-512"
      decimals="INF"
      id="f-1347"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-513"
      decimals="INF"
      id="f-1348"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-513"
      decimals="INF"
      id="f-1349"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-513"
      decimals="INF"
      id="f-1350"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-514"
      decimals="INF"
      id="f-1351"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-514"
      decimals="INF"
      id="f-1352"
      unitRef="shares">16400</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-514"
      decimals="INF"
      id="f-1353"
      unitRef="shares">16400</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-515"
      decimals="INF"
      id="f-1354"
      unitRef="shares">1315</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-516"
      decimals="INF"
      id="f-1355"
      unitRef="shares">842</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-517"
      decimals="INF"
      id="f-1356"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-517"
      decimals="INF"
      id="f-1357"
      unitRef="shares">842</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-517"
      decimals="INF"
      id="f-1358"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-518"
      decimals="INF"
      id="f-1359"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-518"
      decimals="INF"
      id="f-1360"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-518"
      decimals="INF"
      id="f-1361"
      unitRef="shares">0</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-519"
      decimals="INF"
      id="f-1362"
      unitRef="shares">787</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-520"
      decimals="INF"
      id="f-1363"
      unitRef="shares">230</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-521"
      decimals="INF"
      id="f-1364"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-521"
      decimals="INF"
      id="f-1365"
      unitRef="shares">230</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-521"
      decimals="INF"
      id="f-1366"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-522"
      decimals="INF"
      id="f-1367"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-522"
      decimals="INF"
      id="f-1368"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-522"
      decimals="INF"
      id="f-1369"
      unitRef="shares">0</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-523"
      decimals="INF"
      id="f-1370"
      unitRef="shares">58365</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-524"
      decimals="INF"
      id="f-1371"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-525"
      decimals="INF"
      id="f-1372"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-525"
      decimals="INF"
      id="f-1373"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-525"
      decimals="INF"
      id="f-1374"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-526"
      decimals="INF"
      id="f-1375"
      unitRef="shares">58365</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-526"
      decimals="INF"
      id="f-1376"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-526"
      decimals="INF"
      id="f-1377"
      unitRef="shares">58365</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-527"
      decimals="INF"
      id="f-1378"
      unitRef="shares">19455</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-528"
      decimals="INF"
      id="f-1379"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-529"
      decimals="INF"
      id="f-1380"
      unitRef="shares">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-529"
      decimals="INF"
      id="f-1381"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-529"
      decimals="INF"
      id="f-1382"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-530"
      decimals="INF"
      id="f-1383"
      unitRef="shares">19455</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-530"
      decimals="INF"
      id="f-1384"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-530"
      decimals="INF"
      id="f-1385"
      unitRef="shares">19455</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-531"
      decimals="INF"
      id="f-1386"
      unitRef="shares">324446</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-532"
      decimals="INF"
      id="f-1387"
      unitRef="shares">147196</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-533"
      id="f-1388"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-533"
      decimals="INF"
      id="f-1389"
      unitRef="shares">1072</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-533"
      decimals="INF"
      id="f-1390"
      unitRef="shares">0</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-534"
      decimals="INF"
      id="f-1391"
      unitRef="shares">223944</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c-534"
      decimals="INF"
      id="f-1392"
      unitRef="shares">146124</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet
      contextRef="c-534"
      decimals="INF"
      id="f-1393"
      unitRef="shares">223944</abvx:MaximumNumberOfOtherEquityInstrumentsToBeIssuedInShareBasedPaymentArrangementIfAllConditionsAreMet>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-535"
      decimals="2"
      id="f-1394"
      unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-536"
      decimals="2"
      id="f-1395"
      unitRef="number">0.75</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-536" id="f-1396">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold
      contextRef="c-537"
      decimals="2"
      id="f-1397"
      unitRef="number">0.50</abvx:VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-452"
      decimals="0"
      id="f-1398"
      unitRef="shares">77820</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-452" id="f-1399">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-452"
      decimals="2"
      id="f-1400"
      unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory contextRef="c-1" id="f-1401">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The fair value of the BSAs was determined at grant date using the Black Scholes model, with the following assumptions:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.84pt; position: var(--position); white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 54pt; position: var(--position); top: 0pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.62pt; position: var(--position); white-space: pre;"&gt;FAIR VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.38pt; position: var(--position); white-space: pre;"&gt;OF THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.07pt; position: var(--position); white-space: pre;"&gt;UNDERLYING &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 60.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.61pt; position: var(--position); white-space: pre;"&gt;SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 117.75pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.5pt; position: var(--position); white-space: pre;"&gt;FAIR VALUE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.49pt; position: var(--position); white-space: pre;"&gt;OF THE BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 179.25pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.94pt; position: var(--position); white-space: pre;"&gt;NUMBER OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.92pt; position: var(--position); white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 240.75pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.27pt; position: var(--position); white-space: pre;"&gt;SUBSCRIPTI&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.82pt; position: var(--position); white-space: pre;"&gt;ON PRICE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.15pt; position: var(--position); white-space: pre;"&gt;STRIKE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.83pt; position: var(--position); white-space: pre;"&gt;PRICE PER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.48pt; position: var(--position); white-space: pre;"&gt;SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 0pt; width: 53.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.2pt; position: var(--position); white-space: pre;"&gt;RISK FREE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 53.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.52pt; position: var(--position); white-space: pre;"&gt;RATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 420pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.49pt; position: var(--position); white-space: pre;"&gt;EXPECTED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.05pt; position: var(--position); white-space: pre;"&gt;MATURITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 481.5pt; position: var(--position); top: 0pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.71pt; position: var(--position); white-space: pre;"&gt;VOLATILITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;BSA 2024-1&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 54pt; position: var(--position); top: 41.25pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.06&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 117.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.7&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.5&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;"&gt;]&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 179.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;58,365&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 240.75pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.10&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 41.25pt; width: 53.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4.30%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 420pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.4&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.9&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"&gt; years]&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 481.5pt; position: var(--position); top: 41.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60.41%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 51pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 51pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;BSA 2024-2&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 54pt; position: var(--position); top: 53.25pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.06&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 117.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.26pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5.8&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.92pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 30.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.58pt; position: var(--position); white-space: pre;"&gt;]&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 179.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,455&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 240.75pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 21.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.10&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 53.25pt; width: 53.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 53.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4.30%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 420pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.15pt; position: var(--position); white-space: pre;"&gt;[&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8100000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.5&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.810000000000002pt; position: var(--position); white-space: pre;"&gt;-&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.0&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 30.47pt; position: var(--position); white-space: pre;"&gt; years]&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 481.5pt; position: var(--position); top: 53.25pt; width: 58.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 58.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 17.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60.41%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 72pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 0pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.22pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE&#160;OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 27.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;UNDERLYING &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.02pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.82pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FAIR&#160;VALUE OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.42pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THE AGA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA PRICE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;MATURITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;VOLATILITY &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RISK&#160;FREE&#160;RATE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2021 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 41.25pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;31.60&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022-07-31&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;49.0%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 41.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-1.00%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-1 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranches 1-4)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 53.25pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 53.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-1 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 5)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 75pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3.62&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-12-31&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.2%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.20%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-1 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 6)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 96.75pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.74&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024-07-11&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.2%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 96.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.20%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-2 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 1)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 118.5pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 118.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 1.73pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-2 &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 12.98pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche 2)&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 140.25pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15.98&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.59&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 140.25pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-3&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 162pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 162pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-4&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 174pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.92&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 174pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2023-5&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 186pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.16&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.16&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 186pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2024-1&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 198pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.26&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.26&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 198pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA 2024-2&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 210pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.40&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.40&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 210pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-3&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 222pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.76&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.76&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 222pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-4&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 234pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 234pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-5&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 246pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 246pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-6&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 258pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.54&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 258pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGA-2024-7&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 78pt; position: var(--position); top: 270pt; width: 72pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 72pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.80&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.80&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 231pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.00&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 309pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 387pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 270pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.48pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;T&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;he fair value of the Minimum Return Indemnifications was&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; measured using the following assumptions:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 236.2pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Tranche B Minimum Return Indemnification (issued in March &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;2024)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF MARCH 28, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Final redemption scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 21pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 21pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Minimal return&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 33pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.40&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 33pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.40&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Discount rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 45pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;13&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 45pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Probability-weighted present value of shortfall payment (in &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 57pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,959&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;68&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 57pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,635&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;136&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Probability-weighted fair value of tranche A-B warrants with MRI &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 78.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,066&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 78.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;104&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Probability-weighted fair value of tranche A-B warrants without &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 99.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,410&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 99.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;241&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Total fair value of MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 120.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,615&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;68&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 120.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,499&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;136&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 142.5pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Fair value of Tranche B MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 142.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 115.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 118.17999999999999pt; position: var(--position);"&gt;1,683&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 142.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 115.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 118.17999999999999pt; position: var(--position);"&gt;2,636&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 409.5pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Tranche C Minimum Return Indemnification (issued in June &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;2024)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF JUNE 21, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Final redemption scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 21.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 21.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Minimal return&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 33.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 33.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Discount rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 45.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;15&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 45.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(a) Probability-weighted present value of shortfall payment (in &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 57.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;741&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 57.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,160&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(b) Probability-weighted fair value of tranche C warrants with MRI &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 79.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,948&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 79.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;684&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 101.25pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(c) Probability-weighted fair value of tranche C warrants without &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 101.25pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3,250&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 101.25pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;903&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Total fair value of MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 123pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 123pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;941&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Fair value of Tranche C MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 144.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 121.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 124.17999999999999pt; position: var(--position);"&gt;475&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 144.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 121.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 124.17999999999999pt; position: var(--position);"&gt;984&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;main data and assumptions are the following:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 311.06pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 497.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 120pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret Tranche A-B BSA - &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;August 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF AUGUST 22, 2023 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 37.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche A-B)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 0pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 24pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;214,198&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 24pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 91.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;214,198&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 24pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;214,198&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 39.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 39.75pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 95.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 39.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 55.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;17.10&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 55.5pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.82&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 55.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.76&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 71.25pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise date&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19/08/2030 (expiry) 18/02/2027 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 79.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 71.25pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19/08/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 71.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19/08/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 92.25pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7-year expiry scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 92.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 92.25pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 92.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;71.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry) &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65.2%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 108pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 120pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;59.5%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 89.61999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 120pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.54pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 108pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 129pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 129pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 129pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;3.00&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 144.75pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 98.59pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 98.59pt; position: var(--position);"&gt;2.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 17.25pt; left: 378pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0.52pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 10.6pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos/Claret &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tranche A-B BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 162pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 97.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.83999999999999pt; position: var(--position);"&gt;2,092&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 162pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 97.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 100.58999999999999pt; position: var(--position);"&gt;920&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 162pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 97.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.83999999999999pt; position: var(--position);"&gt;243&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 522pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 137.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret Tranche C BSA - &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;November 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF NOVEMBER 2, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 24pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 39.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of which, number of conditional BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;202,915&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;202,916&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 118.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 55.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.86&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.86&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.86&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 71.25pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8.89&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.82&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise date&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 87pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); white-space: pre;"&gt;01/11/2030 (expiry) &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 87pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;01/11/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 87pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;01/11/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7-year expiry scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Probability of Drawdown of Tranche C &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit facility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 123.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 123.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 123.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Drawn on June 21, 2024&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.4%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 165.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 165.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 165.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 165.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 181.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 181.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;3.00&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 181.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;2.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 181.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 3.89pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 13.97pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 61.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 205.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos/Claret &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tranche C BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 205.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.09pt; width: 94.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 97.58999999999999pt; position: var(--position);"&gt;1,493&lt;span style="display: inline-block; height: 6.09pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 205.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.09pt; width: 94.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 97.58999999999999pt; position: var(--position);"&gt;1,659&lt;span style="display: inline-block; height: 6.09pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 205.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.09pt; width: 101.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 104.33999999999999pt; position: var(--position);"&gt;923&lt;span style="display: inline-block; height: 6.09pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos A BSA and Kreos B BSA are measured at fair value using a Black-Scholes valuation model. The main data and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions are the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 419.36pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos A BSA - June 1, 2018&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of and for the year &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ended December 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of May 24, 2023 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(exercise date)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding Kreos A BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;110,957&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;110,957&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7.21&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7.21&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Residual maturity&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.6 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.0 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;44.01&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2.98&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos A BSA (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.34pt; position: var(--position);"&gt;275&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;1,261&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 563.11pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos B BSA - June 1, 2019&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of and for the year &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ended December 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of May 24, 2023 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(exercise date)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding Kreos B BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;74,766&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;74,766&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.70&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.70&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Residual maturity&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.4 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.0 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;44.01&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2.96&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos B BSA (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.34pt; position: var(--position);"&gt;149&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;589&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-523"
      decimals="2"
      id="f-1402"
      unitRef="eurPerShare">14.06</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-538"
      decimals="1"
      id="f-1403"
      unitRef="eurPerShare">5.7</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-539"
      decimals="1"
      id="f-1404"
      unitRef="eurPerShare">6.5</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-523"
      decimals="INF"
      id="f-1405"
      unitRef="shares">58365</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-523"
      decimals="2"
      id="f-1406"
      unitRef="eurPerShare">2.57</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentStrikePriceOtherEquityInstrumentsGranted
      contextRef="c-523"
      decimals="2"
      id="f-1407"
      unitRef="eurPerShare">13.10</abvx:EquityInstrumentStrikePriceOtherEquityInstrumentsGranted>
    <abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="c-523"
      decimals="4"
      id="f-1408"
      unitRef="number">0.0430</abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <abvx:ExpectedMaturityOtherEquityInstrumentsGranted contextRef="c-538" id="f-1409">P5Y4M24D</abvx:ExpectedMaturityOtherEquityInstrumentsGranted>
    <abvx:ExpectedMaturityOtherEquityInstrumentsGranted contextRef="c-539" id="f-1410">P6Y10M24D</abvx:ExpectedMaturityOtherEquityInstrumentsGranted>
    <abvx:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="c-523"
      decimals="4"
      id="f-1411"
      unitRef="number">0.6041</abvx:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-527"
      decimals="2"
      id="f-1412"
      unitRef="eurPerShare">14.06</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-540"
      decimals="1"
      id="f-1413"
      unitRef="eurPerShare">5.8</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-541"
      decimals="1"
      id="f-1414"
      unitRef="eurPerShare">6.6</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-527"
      decimals="INF"
      id="f-1415"
      unitRef="shares">19455</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-527"
      decimals="2"
      id="f-1416"
      unitRef="eurPerShare">2.57</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentStrikePriceOtherEquityInstrumentsGranted
      contextRef="c-527"
      decimals="2"
      id="f-1417"
      unitRef="eurPerShare">13.10</abvx:EquityInstrumentStrikePriceOtherEquityInstrumentsGranted>
    <abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="c-527"
      decimals="4"
      id="f-1418"
      unitRef="number">0.0430</abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <abvx:ExpectedMaturityOtherEquityInstrumentsGranted contextRef="c-540" id="f-1419">P5Y6M</abvx:ExpectedMaturityOtherEquityInstrumentsGranted>
    <abvx:ExpectedMaturityOtherEquityInstrumentsGranted contextRef="c-541" id="f-1420">P7Y</abvx:ExpectedMaturityOtherEquityInstrumentsGranted>
    <abvx:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="c-527"
      decimals="4"
      id="f-1421"
      unitRef="number">0.6041</abvx:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-542"
      decimals="INF"
      id="f-1422"
      unitRef="shares">1382796</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-543"
      decimals="INF"
      id="f-1423"
      unitRef="shares">1382796</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-544"
      decimals="INF"
      id="f-1424"
      unitRef="shares">212737</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-544"
      decimals="INF"
      id="f-1425"
      unitRef="shares">390019</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-545"
      decimals="INF"
      id="f-1426"
      unitRef="shares">780040</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-546"
      decimals="INF"
      id="f-1427"
      unitRef="shares">100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-547"
      decimals="INF"
      id="f-1428"
      unitRef="shares">100000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-548"
      decimals="INF"
      id="f-1429"
      unitRef="shares">25000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-549"
      decimals="INF"
      id="f-1430"
      unitRef="shares">75000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-550"
      decimals="INF"
      id="f-1431"
      unitRef="shares">731500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-551"
      decimals="INF"
      id="f-1432"
      unitRef="shares">731500</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-552"
      decimals="INF"
      id="f-1433"
      unitRef="shares">245625</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-553"
      decimals="INF"
      id="f-1434"
      unitRef="shares">485875</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-554"
      decimals="INF"
      id="f-1435"
      unitRef="shares">254250</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-555"
      decimals="INF"
      id="f-1436"
      unitRef="shares">254250</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-556"
      decimals="INF"
      id="f-1437"
      unitRef="shares">41000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-557"
      decimals="INF"
      id="f-1438"
      unitRef="shares">213250</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-558"
      decimals="INF"
      id="f-1439"
      unitRef="shares">132750</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-559"
      decimals="INF"
      id="f-1440"
      unitRef="shares">132750</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-560"
      decimals="INF"
      id="f-1441"
      unitRef="shares">51500</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-561"
      decimals="INF"
      id="f-1442"
      unitRef="shares">81250</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-562"
      decimals="INF"
      id="f-1443"
      unitRef="shares">1549125</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-563"
      decimals="INF"
      id="f-1444"
      unitRef="shares">1549125</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-563"
      decimals="INF"
      id="f-1445"
      unitRef="shares">193500</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-564"
      decimals="INF"
      id="f-1446"
      unitRef="shares">1355625</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-565"
      decimals="INF"
      id="f-1447"
      unitRef="shares">22500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-566"
      decimals="INF"
      id="f-1448"
      unitRef="shares">22500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-567"
      decimals="INF"
      id="f-1449"
      unitRef="shares">22500</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-568"
      decimals="INF"
      id="f-1450"
      unitRef="shares">38500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-569"
      decimals="INF"
      id="f-1451"
      unitRef="shares">38500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-570"
      decimals="INF"
      id="f-1452"
      unitRef="shares">38500</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-571"
      decimals="INF"
      id="f-1453"
      unitRef="shares">93000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-572"
      decimals="INF"
      id="f-1454"
      unitRef="shares">93000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-573"
      decimals="INF"
      id="f-1455"
      unitRef="shares">93000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-574"
      decimals="INF"
      id="f-1456"
      unitRef="shares">25000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-575"
      decimals="INF"
      id="f-1457"
      unitRef="shares">25000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-576"
      decimals="INF"
      id="f-1458"
      unitRef="shares">25000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-105"
      decimals="INF"
      id="f-1459"
      unitRef="shares">20000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-577"
      decimals="INF"
      id="f-1460"
      unitRef="shares">20000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-578"
      decimals="INF"
      id="f-1461"
      unitRef="shares">20000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-579"
      decimals="INF"
      id="f-1462"
      unitRef="shares">198000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-580"
      decimals="INF"
      id="f-1463"
      unitRef="shares">198000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-581"
      decimals="INF"
      id="f-1464"
      unitRef="shares">198000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-582"
      decimals="INF"
      id="f-1465"
      unitRef="shares">4547421</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-583"
      decimals="INF"
      id="f-1466"
      unitRef="shares">2601296</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-584"
      decimals="INF"
      id="f-1467"
      unitRef="shares">1946125</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="c-584"
      decimals="INF"
      id="f-1468"
      unitRef="shares">744362</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-584"
      decimals="INF"
      id="f-1469"
      unitRef="shares">415019</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-585"
      decimals="INF"
      id="f-1470"
      unitRef="shares">3388040</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-586"
      decimals="2"
      id="f-1471"
      unitRef="eurPerShare">31.60</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-586"
      decimals="2"
      id="f-1472"
      unitRef="eurPerShare">23.92</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-586"
      decimals="2"
      id="f-1473"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="c-586"
      decimals="3"
      id="f-1474"
      unitRef="number">0.490</abvx:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="c-586"
      decimals="4"
      id="f-1475"
      unitRef="number">-0.0100</abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-587"
      decimals="2"
      id="f-1476"
      unitRef="eurPerShare">15.98</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-587"
      decimals="2"
      id="f-1477"
      unitRef="eurPerShare">15.98</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-587"
      decimals="2"
      id="f-1478"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-588"
      decimals="2"
      id="f-1479"
      unitRef="eurPerShare">15.98</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-588"
      decimals="2"
      id="f-1480"
      unitRef="eurPerShare">3.62</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-588"
      decimals="2"
      id="f-1481"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="c-588"
      decimals="3"
      id="f-1482"
      unitRef="number">0.672</abvx:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="c-588"
      decimals="4"
      id="f-1483"
      unitRef="number">0.0320</abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-589"
      decimals="2"
      id="f-1484"
      unitRef="eurPerShare">15.98</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-589"
      decimals="2"
      id="f-1485"
      unitRef="eurPerShare">0.74</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-589"
      decimals="2"
      id="f-1486"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="c-589"
      decimals="3"
      id="f-1487"
      unitRef="number">0.672</abvx:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="c-589"
      decimals="4"
      id="f-1488"
      unitRef="number">0.0320</abvx:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-590"
      decimals="2"
      id="f-1489"
      unitRef="eurPerShare">15.98</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-590"
      decimals="2"
      id="f-1490"
      unitRef="eurPerShare">15.98</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-590"
      decimals="2"
      id="f-1491"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-591"
      decimals="2"
      id="f-1492"
      unitRef="eurPerShare">15.98</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-591"
      decimals="2"
      id="f-1493"
      unitRef="eurPerShare">9.59</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-591"
      decimals="2"
      id="f-1494"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-550"
      decimals="2"
      id="f-1495"
      unitRef="eurPerShare">14.92</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-550"
      decimals="2"
      id="f-1496"
      unitRef="eurPerShare">14.92</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-550"
      decimals="2"
      id="f-1497"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-554"
      decimals="2"
      id="f-1498"
      unitRef="eurPerShare">14.92</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-554"
      decimals="2"
      id="f-1499"
      unitRef="eurPerShare">14.92</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-554"
      decimals="2"
      id="f-1500"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-558"
      decimals="2"
      id="f-1501"
      unitRef="eurPerShare">9.16</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-558"
      decimals="2"
      id="f-1502"
      unitRef="eurPerShare">9.16</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-558"
      decimals="2"
      id="f-1503"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-562"
      decimals="2"
      id="f-1504"
      unitRef="eurPerShare">12.26</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-562"
      decimals="2"
      id="f-1505"
      unitRef="eurPerShare">12.26</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-562"
      decimals="2"
      id="f-1506"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-565"
      decimals="2"
      id="f-1507"
      unitRef="eurPerShare">13.40</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-565"
      decimals="2"
      id="f-1508"
      unitRef="eurPerShare">13.40</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-565"
      decimals="2"
      id="f-1509"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-568"
      decimals="2"
      id="f-1510"
      unitRef="eurPerShare">12.76</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-568"
      decimals="2"
      id="f-1511"
      unitRef="eurPerShare">12.76</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-568"
      decimals="2"
      id="f-1512"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-571"
      decimals="2"
      id="f-1513"
      unitRef="eurPerShare">12.54</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-571"
      decimals="2"
      id="f-1514"
      unitRef="eurPerShare">12.54</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-571"
      decimals="2"
      id="f-1515"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-574"
      decimals="2"
      id="f-1516"
      unitRef="eurPerShare">12.54</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-574"
      decimals="2"
      id="f-1517"
      unitRef="eurPerShare">12.54</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-574"
      decimals="2"
      id="f-1518"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-105"
      decimals="2"
      id="f-1519"
      unitRef="eurPerShare">12.54</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-105"
      decimals="2"
      id="f-1520"
      unitRef="eurPerShare">12.54</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-105"
      decimals="2"
      id="f-1521"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted
      contextRef="c-579"
      decimals="2"
      id="f-1522"
      unitRef="eurPerShare">10.80</abvx:UnderlyingShareFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted
      contextRef="c-579"
      decimals="2"
      id="f-1523"
      unitRef="eurPerShare">10.80</abvx:EquityInstrumentFairValueOtherEquityInstrumentsGranted>
    <abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted
      contextRef="c-579"
      decimals="2"
      id="f-1524"
      unitRef="eurPerShare">0.00</abvx:EquityInstrumentPriceOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod contextRef="c-592" id="f-1525">P1Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare
      contextRef="c-592"
      decimals="0"
      id="f-1526"
      unitRef="eurPerShare">100</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare
      contextRef="c-592"
      decimals="0"
      id="f-1527"
      unitRef="eurPerShare">100</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingServiceConditionMATransactionMinimumPricePerShare>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-593"
      decimals="2"
      id="f-1528"
      unitRef="number">1</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-594"
      decimals="2"
      id="f-1529"
      unitRef="number">0.75</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-67" decimals="-3" id="f-1530" unitRef="eur">-1026000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes contextRef="c-67" decimals="-3" id="f-1531" unitRef="eur">-205000</abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-595"
      decimals="INF"
      id="f-1532"
      unitRef="shares">1382796</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-596"
      decimals="INF"
      id="f-1533"
      unitRef="shares">212738</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-597"
      decimals="INF"
      id="f-1534"
      unitRef="shares">638214</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-597" id="f-1535">P3Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-598"
      decimals="INF"
      id="f-1536"
      unitRef="shares">212738</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-599"
      decimals="INF"
      id="f-1537"
      unitRef="shares">106369</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing contextRef="c-599" decimals="-6" id="f-1538" unitRef="usd">100000000</abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-600"
      decimals="INF"
      id="f-1539"
      unitRef="shares">106369</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-601"
      decimals="INF"
      id="f-1540"
      unitRef="shares">106368</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-602"
      decimals="INF"
      id="f-1541"
      unitRef="shares">100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-603"
      decimals="INF"
      id="f-1542"
      unitRef="shares">25000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-604"
      decimals="INF"
      id="f-1543"
      unitRef="shares">75000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-605"
      decimals="INF"
      id="f-1544"
      unitRef="shares">985750</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-558"
      decimals="INF"
      id="f-1545"
      unitRef="shares">132750</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-606"
      decimals="2"
      id="f-1546"
      unitRef="number">0.50</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-606" id="f-1547">P2Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-607"
      decimals="2"
      id="f-1548"
      unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-607" id="f-1549">P3Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-608"
      decimals="2"
      id="f-1550"
      unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-608" id="f-1551">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-609"
      decimals="INF"
      id="f-1552"
      unitRef="shares">1118500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition
      contextRef="c-609"
      decimals="INF"
      id="f-1553"
      unitRef="shares">254250</abvx:NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing contextRef="c-609" decimals="-6" id="f-1554" unitRef="usd">200000000</abvx:VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-562"
      decimals="INF"
      id="f-1555"
      unitRef="shares">1549125</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-565"
      decimals="INF"
      id="f-1556"
      unitRef="shares">22500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-568"
      decimals="INF"
      id="f-1557"
      unitRef="shares">38500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-610"
      decimals="INF"
      id="f-1558"
      unitRef="shares">138000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-579"
      decimals="INF"
      id="f-1559"
      unitRef="shares">198000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-611"
      decimals="2"
      id="f-1560"
      unitRef="number">0.50</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-611" id="f-1561">P2Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-612"
      decimals="2"
      id="f-1562"
      unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-612" id="f-1563">P3Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
      contextRef="c-613"
      decimals="2"
      id="f-1564"
      unitRef="number">0.25</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPercentage>
    <abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod contextRef="c-613" id="f-1565">P4Y</abvx:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-614"
      decimals="INF"
      id="f-1566"
      unitRef="shares">20000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-615"
      decimals="INF"
      id="f-1567"
      unitRef="shares">10000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-616"
      decimals="INF"
      id="f-1568"
      unitRef="shares">10000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss contextRef="c-1" id="f-1569">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre; width: 439.91pt;"&gt;Breakdown of the compensation expenses accounted for the period ended December 31, 2022, 2023 and 2024&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 424.31pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 324pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 41.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.88pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TYPE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 32.48pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 0pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.02pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.62pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 27.22pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 41.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BCEs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 41.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(138)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 41.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 41.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 53.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BSAs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 53.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(211)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 65.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AGAs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 65.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(1,026)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 65.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(8,067)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 65.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(19,900)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 77.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Social taxes related to AGAs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 77.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(205)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 77.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.18pt; position: var(--position);"&gt;(426)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 77.25pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.31pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(717)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 122.25pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(1,369)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 190.5pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 38.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.18pt; position: var(--position);"&gt;(8,605)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 258.75pt; position: var(--position); top: 90pt; width: 65.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 65.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(20,941)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-617" decimals="-3" id="f-1570" unitRef="eur">-138000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-618" decimals="-3" id="f-1571" unitRef="eur">-112000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-494" decimals="-3" id="f-1572" unitRef="eur">-112000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-619" decimals="-3" id="f-1573" unitRef="eur">0</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-537" decimals="-3" id="f-1574" unitRef="eur">0</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-533" decimals="-3" id="f-1575" unitRef="eur">-211000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-620" decimals="-3" id="f-1576" unitRef="eur">-1026000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-621" decimals="-3" id="f-1577" unitRef="eur">-8067000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-584" decimals="-3" id="f-1578" unitRef="eur">-19900000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes contextRef="c-620" decimals="-3" id="f-1579" unitRef="eur">-205000</abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes>
    <abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes contextRef="c-621" decimals="-3" id="f-1580" unitRef="eur">-426000</abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes>
    <abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes contextRef="c-584" decimals="-3" id="f-1581" unitRef="eur">-717000</abvx:ExpenseFromEquitySettledShareBasedPaymentTransactionsSocialTaxes>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-10" decimals="-3" id="f-1582" unitRef="eur">-1369000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-11" decimals="-3" id="f-1583" unitRef="eur">-8605000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-1" decimals="-3" id="f-1584" unitRef="eur">-20941000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="c-1" id="f-1597">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.36pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 101.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 110.46pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 422.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 191.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 44.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;4,730&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; Claret bond loans &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;26,373&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;839&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;160&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,431&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,558&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,402&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,252&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Borrowings&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;9,127&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,563&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;29,056&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret convertible notes (OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Convertible loan notes&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos A &amp;amp; B BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;424&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Oceane conversion option&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; Claret minimum return indemnifications &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;566&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,262&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,262&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,287&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12,229&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 198.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;6,549&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;15,491&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 210.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total non-current financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;16,241&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;39,697&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;69,069&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 6.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 229.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 229.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;8,252&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 229.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 229.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 241.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; Claret bond loans &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 241.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 241.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 241.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;20,028&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 253.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 253.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;545&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 253.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;379&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 253.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;932&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 265.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 265.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,280&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 265.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,276&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 265.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,235&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 277.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Borrowings&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 277.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;10,077&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 277.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,655&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 277.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;22,195&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 289.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 289.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;19,957&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 289.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 289.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 301.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 301.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 301.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 301.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 313.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Convertible loan notes&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 313.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;19,957&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 313.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 313.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 325.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 325.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,521&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 325.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,509&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 325.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 337.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 337.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,521&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 337.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,509&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 337.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 349.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 349.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 349.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 361.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 361.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 361.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 361.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 373.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total current financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 373.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;33,555&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 373.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;37,348&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 373.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 385.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 385.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;49,797&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 385.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;77,045&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 385.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.59pt; position: var(--position);"&gt;114,004&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 524.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 3.601pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In application of the &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-current, and Non-current Liabilities &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 535.35pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the non-current portion of the Heights convertible notes as of December &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 545.99pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31, 2023 were reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.1. Structured debt financing with &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 209.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; Claret subscribed in August 2023 &#x2013; &#x201c;Kreos / Claret Financing&#x201d;&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.67pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 20, 2023, the Group entered into a structured debt financing agreement with Kreos and Claret&#160; (the Kreos / Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 636.87pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financing), for up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;75,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.27pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret Financing consists of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; tranches of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each in aggregate principal amount:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.67pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The first tranche (&#x201c;tranche A&#x201d;) in aggregate principal amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; takes the form of senior secured &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 692.87pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible bonds with warrants attached (the &#x201c;Kreos / Claret OCABSA&#x201d;) and was drawn on August 22, 2023. The Kreos / &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Claret OCABSA are convertible into ordinary shares at any time from their issuance at the request of their holders at a fixed &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;21.2209&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, subject to standard adjustments, including anti-dilution and dividend protections. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on the Kreos / Claret OCABSA accrues at a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.28999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9.00%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; annual fixed interest rate, payable in quarterly installments. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret OCBSA&#x2019;s maturity date is March 31, 2027, it being specified that the scheduled date of final repayment is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;January 1, 2027.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group is allowed to prepay the amounts due under the Kreos / Claret OCABSA at any time. In such case, the Group will &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;be required to pay a sum equal to (i) the principal outstanding at the time of the prepayment (plus accrued interests), plus (ii) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;an aggregate of all remaining interest payments that would have been paid throughout the remainder of the term of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranche, discounted to present value by applying a discount rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, plus (iii) an end-of-loan exit fee equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8.0%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amounts drawn thereunder. In case of prepayment, the holders of the Kreos / Claret OCABSA will have the option to request &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a conversion of their Kreos / Claret OCABSA instead of a cash repayment, in which case, the end-of-loan exit fee is not &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;payable by the Group.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The warrants included in the Kreos / Claret OCABSA will only become exercisable in case of prepayment in cash of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret convertible bonds by the Group. Upon exercise of the warrants, their holders will be able to subscribe to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;same number of ordinary shares (and at the same price conditions) as they would have been able to subscribe had they &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 273.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;converted the Kreos / Claret OCABSA which have been prepaid in cash. Any warrants not exercised on or prior to January 1, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2027 will become automatically null and void. For the avoidance of doubt, if the Group does not prepay any Kreos / Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCABSA in cash prior to their scheduled repayment dates, none of the warrants will be exercisable.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The second tranche (&#x201c;tranche B&#x201d;) in aggregate principal amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; takes the form of senior secured non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 330.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible bonds and was drawn on March 28, 2024. The drawdown of the second tranche was subject to a maximum &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Debt-To-Market Capitalization Ratio at the time of drawdown. The &#x201c;Debt-To-Market Capitalization Ratio&#x201d; is calculated on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;any relevant date, by dividing (i) the indebtedness of the Group (including amounts due under the Kreos / Claret Financing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 363.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;but excluding amounts due under the Heights Financing), by (ii) the market capitalization of the Group calculated by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;multiplying the number of outstanding ordinary shares by the closing price of the ordinary shares on such relevant date. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The third tranche (&#x201c;tranche C&#x201d;) in aggregate principal amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; takes the form of senior secured non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible bonds and was drawn on June 21, 2024. The drawdown of the third tranche was subject to a maximum &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Debt-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 419.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;To-Market Capitalization Ratio at the time of drawdown (excluding the Heights Financing) and was conditional on the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;raising a minimum of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$125,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; in gross proceeds through a listing on Nasdaq before June 30, 2024. This condition &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.26pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;was met on October 24, 2023 (see Note 3.3).&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 464.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A variable interest rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; + European Central Bank Base Rate (MRO) (with a floor at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and a cap at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.3199999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) applies to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 475.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the second and third tranche. These &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; tranches will be repaid monthly through March 31, 2027, after a deferred repayment &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 487.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the principal until February 1, 2025.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group is allowed to prepay the amounts due under the second and third tranches of the Kreos / Claret Financing at any &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;time. In such case, The Group will be required to pay a sum equal to (i) the principal outstanding at the time of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepayment (plus accrued interests), plus (ii) an aggregate of all remaining interest payments that would have been paid &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;throughout the remainder of the term of the applicable tranche, discounted to present value by applying a discount rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.9300000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 572.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;plus (iii) an end-of-loan exit fee equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.0%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the amounts drawn under the applicable tranche.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret Financing also provides for a Minimal Return Indemnification ("MRI") to the benefit of the bondholders. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 587.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Minimum Cash Return amount is defined as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 599.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(i) with respect to tranche A and tranche B, 1.4 times the amount of the cumulated principal drawn under the relevant &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 543.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.5pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instrument, and; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.7pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(ii) with respect to tranche C, 1.3 times the amount of the cumulated principal drawn under the relevant instrument.&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.7pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In the event the amount of the cash generated by the tranche A (the Kreos / Claret OCABSA), tranche B or tranche C bond loans, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.9pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;including principal and interest payments, transaction fees, and the end-of-loan exit fees, (the &#x201c;Actual Return&#x201d; calculated as at the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 671.1pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;earlier of (i) March 31, 2027, or (ii) the date of any prepayment or acceleration of the tranche B and C bond loans or more generally &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.3pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;such earlier date as the same shall become repayable ("the Redemption Date")), is lower than the Minimum Cash Return, the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.5pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;shall indemnify the bondholders for the difference between the Minimum Cash Return and the Actual Return (the &#x201c;Minimal Return &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.7pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Indemnification"). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;If at the time of the Minimum Return Indemnification payment, the warrants related to both the OCABSA Bonds and the Tranche B &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amortized bonds (the &#x201c;Kreos / Claret A-B warrants&#x201d;) or the Kreos / Claret Tranche C warrants are still outstanding, the exercise price &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for such warrants shall be adjusted up by the amount of the Minimum Return Indemnification divided by the number of warrants &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;outstanding. For any Kreos / Claret A-B or C warrants that were exercised prior to the last Redemption Date, any capital gains made &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from the exercise of such warrants will be added to the Minimum Cash Return amount.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 140.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Unless the repayment of the Tranche A and B bond loans results from a change of control (in which case the calculation of the Actual &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Return shall only include (i) interest accrued prior to conversion of any Tranche A OCABSA, (ii) transaction and end-of-loan exit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fees, and (iii) the net capital gain derived from the sale of shares underlying the Tranche A OCABSA within the framework of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;change of control transaction), neither the principal subscribed under Tranche A nor the Actual Return generated by Tranche A shall &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 185.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;be included in the calculation of the Minimum Return Indemnification (i.e. the Minimum Cash Return and the Actual Return shall &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;only be calculated, and the Minimum Return Indemnification shall only apply to Tranche B and Tranche C).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 219.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary exceptions) which include, among other &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;things, restrictions on the incurrence of indebtedness, cross-default, the distribution of dividends and the grant of security interests. As &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;security for the Kreos / Claret Financing, the lenders benefit from the grant of first-ranking collateral on The Group&#x2019;s principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tangible and intangible assets, including pledges over The Group&#x2019;s business (&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 344.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fonds de commerce&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) as a going concern and intellectual &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;property rights in The Group's lead drug candidate, as well as pledges over The Group&#x2019;s bank accounts and receivables. Such &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;securities apply to all tranches of the Kreos / Claret Financing.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In addition to the Kreos / Claret OCABSA, the Group has issued warrants (the &#x201c;tranche A-B BSA&#x201d;) for a global subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1.00&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, giving Kreos and Claret the right to subscribe to up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;214,198&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; new ordinary shares at an exercise price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.6744&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 320.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(corresponding to a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.54000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; premium over the 15-day VWAP prior to the date on which their issuance was decided). On November 2, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 331.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023, a second tranche of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Kreos / Claret warrants (the &#x201c;tranche C BSA&#x201d;) was issued. The exercise price of the additional &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;warrants is equal to approximately &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.86&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (corresponding to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;110%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the 15-day VWAP prior to the date on which their issuance was &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;decided). The number of warrants issued corresponds to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,000,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; divided by the aforementioned exercise price (i.e. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 366.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;warrants). Of these additional warrants, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; are exercisable immediately and the remaining &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (&#x201c;the conditional warrants&#x201d;) shall &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;only be exercisable if the third tranche of the Kreos / Claret Financing is drawn by the Group.&#160; The Kreos / Claret warrants can be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 389.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;exercised over a period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from their issuance date or up until the date of the successful closing of a tender offer for the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 400.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ordinary shares, whichever is earlier. At the time of exercise of the Kreos / Claret warrants, the holders of the warrants are eligible to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;sell part of their warrants to the Group in accordance with a put option agreement to allow for a cashless exercise. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 22, 2023, the Group repaid in full the pre-existing debt agreements with Kreos for a total amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7,661&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;accounting treatment of this transaction is explained in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Note 15.3.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 502.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret OCABSA&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 525.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret OCABSA are issued at market conditions: the net issuance proceeds reflect the fair value of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 536.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments at inception. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The OCABSA are compound instruments, split between (i) a debt component (then measured at amortized cost) and (ii) an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 569.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;equity component corresponding to the conversion option and the attached OCABSA warrants. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 592.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As the adjustment provisions of the OCABSA conversion ratio are aimed at preserving the rights of the bondholders and are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;anti-dilutive in nature rather than a down-round protection, the Group determined that the conversion option of the OCABSA &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;is considered to result in the delivery of a fixed number of shares, and is therefore an equity instrument (the equity component &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 625.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the bonds).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 648.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The OCABSA warrants were attached to each bond issued in the Tranche A closing and are not transferrable until after a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 659.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepayment. The OCABSA warrants become exercisable (i) upon the Group electing to prepay the bonds and (ii) in the event &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the absence of the conversion notice from the bondholders for the full amount of the prepayment. As such, the warrants are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 681.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;not freely transferable until the prepayment is made. Thus, the OCABSA warrants are considered as an embedded component &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the bonds rather than a separate stand-alone financial instrument. In all scenarios under which the exercisability conditions &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are satisfied, and whereby the bondholder&#x2019;s option to elect to convert the bonds was considered, the number of total ordinary &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;shares issuable upon warrant exercise as a result of prepayment and/or conversion option exercise remains fixed. Thus, the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;warrants represent an equity-classified component of the bonds.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The issuer prepayment option was deemed closely related to the host debt instrument and therefore does not meet the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;definition of a derivative instrument to be bifurcated.&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 138.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret B and C tranches&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The initial right granted to the Group to issue the amortized bonds under tranches B and C, upon meeting certain conditions, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;did not meet the definition of a liability and was considered an off-balance sheet loan commitment received from the issuer as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of December 31, 2023.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The interest rate collars related to tranches B and C were determined to be closely related to the host debt instruments and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;therefore do not meet the definition of a derivative instrument to be bifurcated.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The prepayment options related to tranches B and C were not determined to be closely related to the host debt instruments &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 253.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and therefore meet the definition of derivative instruments to be bifurcated. The Group determined that their fair value is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 264.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;insignificant at issuance and as of December 31, 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Minimum Return Indemnifications are embedded derivative instruments, which are not deemed closely related to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;host debt instruments and therefore meet the definition of derivative instruments to be bifurcated. They are classified as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 311.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivative financial liabilities and measured at fair value through profit or loss.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret second and third tranches are therefore hybrid instruments, split between (i) debt host contracts accounted &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for at amortized cost and (ii) bifurcated embedded derivatives accounted for at fair value through profit and loss, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 359.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;corresponding to the Minimal Return Indemnifications and the prepayment options (the fair value of the prepayment options &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;being deemed insignificant at issuance and as of December 31, 2024).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 395.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret BSA&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 417.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As the A-B and C warrants (the Kreos / Claret BSA) are contractually transferable separately from the bonds and are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;redeemable in a variable number of ordinary shares of the Group, they are classified as standalone derivative financial &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liabilities.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As the A-B and C warrants (the Kreos / Claret BSA) represent compensation for the realized and future bond issuances of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively tranches A-B and C and are an integral part of generating such bond issuances, the Group determined that they &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are in nature origination fees. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.7pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As the A-B warrants are associated with both the OCABSA issued under tranche A and the amortized bonds issued under &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.9pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;tranche B, the Group allocated the initial fair value of the A-B warrants based on the pro-rata value of the proceeds to be &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.1pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;received under each tranche. At inception, the respective initial fair values of the A-B warrants allocated to tranche A and B &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.3pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;were deferred and subsequently accounted for as an adjustment to the EIR of the related debt components upon their &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.5pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;drawdown (on August 20, 2023 and March 28, 2024 for tranches A and B respectively). &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsequent changes in the fair value &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.7pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;will be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.96000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized through profit or loss. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.3pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On November 2, 2023 (issuance date of the Kreos / Claret tranche C BSA), a derivative financial liability was recognized for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610.5pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their initial fair value with a counterparty in prepaid expenses. On that date, the Group, based on management&#x2019;s latest &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.7pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;projections, did not consider the drawdown of the tranche C bonds to be probable. Therefore, the amount of prepaid expenses &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 632.9pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;allocated to the tranche C BSA &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; has been amortized on a straight-line basis until the drawdown of the tranche C bonds.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Measurement of the debt and equity components of the OCABSA&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At inception, the fair value of the debt component of the OCABSA amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 353.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23,995&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, using a market rate assumption of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12.6%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&#160; The equity component amounts to the difference between the whole instrument&#x2019;s fair value at inception (its nominal value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) and the standalone fair value of the debt component. Therefore, the equity component amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,005&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 571.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;It is not subsequently remeasured.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On the same date, using the same assumptions and an increase in market rate by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp would result in a decrease in the fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the debt component and an increase in the value of the equity compone&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;nt by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;624&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 151.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Measurement of the Kreos / Claret second and third tranches hybrid instruments&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 176.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At inception, the net cash proceeds are the tranches' initial fair values. The fair values of the Minimal Return Indemnifications were &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 188.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;deducted from the initial carrying values of the debt components of each tranche, which were subsequently measured at amortized cost &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;using the EIR method.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 212.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;T&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;he fair value of the Minimum Return Indemnifications was&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; measured using the following assumptions:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 236.2pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Tranche B Minimum Return Indemnification (issued in March &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;2024)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF MARCH 28, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Final redemption scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 21pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 21pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Minimal return&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 33pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.40&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 33pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.40&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Discount rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 45pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;13&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 45pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Probability-weighted present value of shortfall payment (in &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 57pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,959&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;68&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 57pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,635&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;136&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Probability-weighted fair value of tranche A-B warrants with MRI &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 78.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,066&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 78.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;104&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Probability-weighted fair value of tranche A-B warrants without &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 99.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,410&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 99.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;241&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Total fair value of MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 120.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,615&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;68&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 120.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,499&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;136&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 142.5pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Fair value of Tranche B MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 142.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 115.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 118.17999999999999pt; position: var(--position);"&gt;1,683&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 142.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 115.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 118.17999999999999pt; position: var(--position);"&gt;2,636&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 409.5pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 521.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 222.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Tranche C Minimum Return Indemnification (issued in June &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;2024)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF JUNE 21, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 0pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 22.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Final redemption scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 21.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 21.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Minimal return&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 33.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 33.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 125.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.62pt; position: var(--position); white-space: pre;"&gt;x&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Discount rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 45.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 128.18pt; position: var(--position);"&gt;15&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 45.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 132.18pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 138.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(a) Probability-weighted present value of shortfall payment (in &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 57.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;741&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 57.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,160&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(b) Probability-weighted fair value of tranche C warrants with MRI &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 79.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,948&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 79.5pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;684&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 101.25pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;(c) Probability-weighted fair value of tranche C warrants without &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 101.25pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 63.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3,250&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 101.25pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;903&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 81.45pt; position: var(--position); white-space: pre;"&gt; (Final redemption)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Total fair value of MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 123pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 92.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ccecff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 123pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.63pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;941&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 47.41pt; position: var(--position); white-space: pre;"&gt; (Final redemption, i.e. a+b-c)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.31pt; width: 146.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.13pt; position: var(--position); white-space: pre;"&gt; (Tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 222.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 222.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); white-space: pre;"&gt;Fair value of Tranche C MRI (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 225.75pt; position: var(--position); top: 144.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 121.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 124.17999999999999pt; position: var(--position);"&gt;475&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375pt; position: var(--position); top: 144.75pt; width: 146.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 146.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 121.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 124.17999999999999pt; position: var(--position);"&gt;984&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 585.05pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the purpose of measuring the fair value of the MRI (shortfall payment), the fair value of the tranche A-B and C BSA was &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 597.05pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measured with a Black Scholes model under the Final redemption scenario and with a Monte Carlo model under the Tender offer &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 609.05pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scenario. As of March 28, 2024, the following assumptions were used: a share price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.40&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, a volatility of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60.3%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (Black Scholes) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 621.05pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;61.9%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (Monte Carlo), and a risk-free rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.6%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (Black Scholes) or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.8%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (Monte Carlo).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 633.05pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of June 21, 2024, the following assumptions were used: a share price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12.94&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, a volatility of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60.1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (Black Scholes) or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;59.9%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.05pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Monte Carlo), and a risk-free rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.0%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (Black Scholes) or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (Monte Carlo).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.05pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The assumptions used for the valuations as of December 31, 2024 are set f&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;orth below.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of March 28, 2024, using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price, +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk-free rate, +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;probability of achieving the Final redemption scenario and +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; discount rate would result in changes of the MRI B value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-30&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-3&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;35&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-53&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of June 21, 2024, using the same assumption with an increase of +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price, +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 457.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk-free rate, +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; i&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 540.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;n the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;probability of achieving the Final redemption scenario and +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;discount rate would result in changes of the MRI C fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 144.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-16&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;46&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-13&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2024, using the same assumption with an increase of +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price, +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;risk-free rate, +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 542.1800000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 560.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the probability of achieving the Final redemption scenario and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; +&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; discount rate would result in changes of the MRI B and C fair &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-3&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-3&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-82&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Measurement of the Kreos / Claret tranche A-B-C BSA &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret tranche A-B and tranche C BSA are measured at fair value using a Black-Scholes valuation model. The model &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;considers &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.22999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; probability-weighted scenarios, i.e. (i) the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; expiry of the BSA and (ii) an earlier exercise upon a tender offer. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 558.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;main data and assumptions are the following:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 311.06pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 497.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 120pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret Tranche A-B BSA - &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;August 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF AUGUST 22, 2023 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 37.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Tranche A-B)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 0pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 24pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;214,198&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 24pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 91.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;214,198&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 24pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 90.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;214,198&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 39.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 39.75pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 95.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 39.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 55.5pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 100.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;17.10&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 55.5pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.82&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 55.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.76&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 71.25pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise date&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19/08/2030 (expiry) 18/02/2027 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 79.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 71.25pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19/08/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 71.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19/08/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 92.25pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7-year expiry scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 92.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 92.25pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 92.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;71.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry) &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65.2%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 108pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 120pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;59.5%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 89.61999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 120pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.54pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 108pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 68.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 51.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 129pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 129pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 104.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 129pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;3.00&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 144.75pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 98.59pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 98.59pt; position: var(--position);"&gt;2.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 17.25pt; left: 378pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0.52pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 88.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 10.6pt; width: 119.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 55.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 71.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162pt; width: 123.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos/Claret &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 123.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tranche A-B BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 126.75pt; position: var(--position); top: 162pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 97.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.83999999999999pt; position: var(--position);"&gt;2,092&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 255pt; position: var(--position); top: 162pt; width: 120pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 120pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 97.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 100.58999999999999pt; position: var(--position);"&gt;920&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 378pt; position: var(--position); top: 162pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 97.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.83999999999999pt; position: var(--position);"&gt;243&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 522pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 137.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.2pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret Tranche C BSA - &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.8pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;November 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF NOVEMBER 2, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 0pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 24pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 24pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;405,832&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 39.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of which, number of conditional BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;202,915&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 96.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;202,916&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 39.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.8pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 118.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 55.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.86&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.86&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 55.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.99pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.86&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 71.25pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8.89&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.82&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 71.25pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.67&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise date&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 87pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); white-space: pre;"&gt;01/11/2030 (expiry) &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 87pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;01/11/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 87pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;01/11/2030 (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.44pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18/02/2027 (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 108pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7-year expiry scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 108pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;95&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Probability of Drawdown of Tranche C &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit facility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 123.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 123.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 123.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Drawn on June 21, 2024&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67.4%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 144.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.4pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 12.48pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44.3%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 165.75pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 165.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 165.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 165.75pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.81pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 109.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 181.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 137.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 181.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;3.00&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 181.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.93pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;2.30&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 117.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 181.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 3.89pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.86999999999999pt; position: var(--position); white-space: pre;"&gt; (expiry)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 13.97pt; width: 125.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 61.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.9%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.79pt; position: var(--position); white-space: pre;"&gt; (tender offer)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 205.5pt; width: 137.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos/Claret &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 137.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tranche C BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 140.25pt; position: var(--position); top: 205.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.09pt; width: 94.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 97.58999999999999pt; position: var(--position);"&gt;1,493&lt;span style="display: inline-block; height: 6.09pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 268.5pt; position: var(--position); top: 205.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.09pt; width: 94.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 97.58999999999999pt; position: var(--position);"&gt;1,659&lt;span style="display: inline-block; height: 6.09pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 396.75pt; position: var(--position); top: 205.5pt; width: 125.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.05pt; width: 125.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.09pt; width: 101.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 104.33999999999999pt; position: var(--position);"&gt;923&lt;span style="display: inline-block; height: 6.09pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of August 20, 2023 (date of issuance of the tranche A-B BSA), using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share price, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk-free rate or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the probability of achieving the&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; expiry scenario would result in an increase of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranche A-B BSA fair value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;48&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;197&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;64&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;64&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of November 2, 2023 (date of issuance of the tranche C BSA), using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share price, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk-free rate or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the probability of achieving the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; expiry scenario would result in an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranche A-B BSA fair value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;28&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;232&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;42&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;36&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2023, using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share price, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk-free rate and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 432.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the probability of achieving the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; expiry scenario would result in an increase of Kreos / Claret A-B and C BSA fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;96&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;401&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;95&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;76&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 468.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2024, using the same assumption with an increase of&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ri&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;sk-free rate and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 480.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 62.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the probability of achieving the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; expiry scenario would result in an increase of Kreos / Claret A-B and C BSA fair &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 492.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;37&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;350&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;61&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;75 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.2.&#160; Heights convertible notes&#160; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 20, 2023, the Group entered into a convertible notes subscription agreement with Heights, which provided for up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;75,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in financing, consisting of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; tranches: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 602.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The first tranche (&#x201c;tranche A&#x201d;) of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;35,000&#160;thousand&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in aggregate principal amount was drawn on August 24, 2023 and is &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 615.5pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;composed of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;350&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; amortizing senior convertible notes with a nominal value of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100,000&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 421.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each and a fixed conversion price of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 628.94pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.7674&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (corresponding to a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.20999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;40%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; premium over the 15-day VWAP prior to the date on which their issuance is decided, and &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.38pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subject to standard adjustments, including anti-dilution and dividend protections).&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 667.02pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The second tranche (&#x201c;tranche B&#x201d;) of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;40,000&#160;thousand&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in aggregate principal amount is composed of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;400&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; amortizing senior &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible notes with a nominal value of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100,000&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each, and a conversion price (if any) that is be equal to &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;130%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the 15-&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.9pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;day VWAP immediately preceding the date on which their issuance is decided.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;It may be drawn during the period from the date immediately following the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-month&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; anniversary of the issuance of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;first tranche to the first-year anniversary of the issuance of the first tranche (i.e. August 24, 2024), in up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.3199999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; separate &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;closings to provide the Group with additional flexibility to request a partial drawdown.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On the limit date for the drawdown of the second tranche of the Heights Financing (i.e. August 4, 2024), the Group had not &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;drawn down this tranche and has therefore forgone its right to do so in the future.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on the Heights convertible notes accrues at a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.00%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; annual fixed interest rate payable in quarterly installments in cash or, at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the option of the Group, in ordinary shares.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Heights convertible notes will be repaid through &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;sixteen&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; quarterly installment payments, beginning &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; after their &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issuance date (corresponding, for the first tranche, to a final repayment date on August 24, 2027). Installments are payable in cash or, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;at the option of the Group, in ordinary shares.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Any interest or installment payments in shares will be made on the basis of a share price equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;90%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the Market Price of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ordinary shares at the time of payment, where &#x201c;Market Price&#x201d; refers to the arithmetic average of the daily volume weighted average &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price (&#x201c;VWAP&#x201d;) for the ordinary shares on the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) days with the lowest daily VWAPs out of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;five&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) trading days immediately &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;preceding the applicable date, but in no event greater than the VWAP of the ordinary shares on the applicable date. The Market Price &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;may not be higher than the applicable conversion price. Issuances of ordinary shares may not be made at a price lower than a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 555.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 283.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;discount to the 15-day VWAP at the time of the decision to issue the Heights convertible notes (i.e., &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.4303&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ordinary share.).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 305.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Heights convertible notes include the following conversion and settlement options:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 316.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conversion at the option of the noteholders: the notes are convertible into the Group&#x2019;s ordinary shares at the option of the &lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;noteholders at any time during the period beginning on the tranche A notes closing until the fifth business day prior to the &lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 339.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;maturity date. The ordinary shares issued would be equal to the product of (i) the conversion ratio in effect on the exercise &lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 350.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;date, (ii) a fraction, the numerator of which is the outstanding principal amount per note and the denominator of which is the &lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 361.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;initial principal amount of &lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100,000&lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per note, and (iii) the number of notes for which the conversion right has been exercised.&lt;span style="display: inline-block; height: 7.28pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Settlement in shares at the option of the Group: the Group has the option to settle any interest or principal due with its own &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ordinary shares (with respect to all but not some of the notes outstanding), subject to a price limit. The ordinary shares &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issuable will be the lower of the conversion ratio or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;90%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the fair market value of the Group&#x2019;s ordinary shares. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 431.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Settlement in shares at the option of the noteholders (&#x201c;SSO Investor Price Limit Option&#x201d;): the noteholders may require a &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 444.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;principal payment to be settled in shares in the event the share settlement price on any principal payment date is below the &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 458.24pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price limit in effect (initially &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.4303&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, subject to adjustments as described in the key terms below) and the Cash Carve-Out &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.68pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(i.e. &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13.125&#160;million&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &#x2013; the amount of cash permitted to be paid to Heights for principal payments) has been utilized such that &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.12pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;it does not allow payment in full of the principal payment. The majority noteholder may agree to waive the cash payment &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(which would otherwise be deferred until the original maturity date) and require the Group to exercise the share settlement &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;option for the principal payment required. A number of the ordinary shares issuable is based on the price limit in effect.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 536.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayment of the notes upon an Event of Default (as defined below): the noteholder may notify the Group of their decision &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 550.08pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to cause the notes to become payable at a price equal to the Early Redemption Amount (as defined below) upon an Event of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 563.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Default. The Early Redemption Amount means an amount equal to the greater of (a) &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;120%&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the outstanding principal of the &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 576.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;note and (b) the market price of a number of shares issuable per note had the conversion right been exercised. Events of &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Default include the following: default in any payment due on the notes, failure to deliver shares upon exercise of conversion &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 603.84pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;right or share settlement option, default of the Group on any obligation under the agreement, and other events.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 628.48pt; width: 612pt;"&gt;&lt;span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayment or purchase of the notes upon change of control, a delisting, or free float event (each, a &#x201c;Put Event&#x201d;): Upon a Put &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 641.92pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Event, the noteholder has an option to require the Group to redeem or, at the Group&#x2019;s option, to purchase all of the notes at &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 655.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the total aggregate amount equal to the outstanding principal and interest accrued through the date of a Put Event.&lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 526.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.73pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Heights Financing is a senior, unsecured financing. The terms and conditions of the Heights convertible notes include a standard &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;negative pledge providing that any security granted in favor of other borrowed debt or debt instruments should also be granted in favor &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the Heights convertible notes on an equal basis (with the exception of the securities issued pursuant to the Kreos / Claret Financing, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as detailed above).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 24,&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; 2023, the Group repaid in full an outstanding amount of&lt;/span&gt;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 320.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;25,102&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, corresponding to the outstanding OCEANE &lt;/span&gt;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 117.6pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;bonds, by way of set-off with the Heights Financing. The accounting treatment for this transaction is explained in Note 15.5.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment and measurement&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In application of the Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 180pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;current, and Non-current Liabilities with Covenants, the Heights convertible notes are classified &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as current financial liabilities as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 191.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.53999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023 and 2024 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(see Note 2).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group concluded that, except for the repayment or purchase option of the notes upon a Put Event, the above-mentioned &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 224.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion and settlement options represented embedded derivatives that required to be bifurcated from their host contract. The Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 236pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;being unable to reliably value each embedded derivative at issuance date and on subsequent reporting dates, it measured the whole &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 247.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instrument at fair value through profit or loss (&#x201c;FVTPL&#x201d;) as permitted by IFRS 9. Instruments measured at FVTPL under these &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conditions are measured at their fair value on issuance and on subsequent reporting dates, and the amount of change in the fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 269.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the financial liability is presented in profit or loss.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 292pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At inception, the Heights convertible notes were measured at fair value, which differs from the issuance procee&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ds by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;2,359&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 303.2pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Since the fair value measurement of the instrument is evidenced by a valuation technique that does not only use data from observable &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 314.4pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;markets, the carrying amount was adjusted to defer the difference between the fair value measurement and the transaction price, and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 325.6pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;the day one gain is therefore recognized in financial income on a straight-line basis over the term of the instrument. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 336.8pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of December 31, 2023 and 2024, the amounts by which the carrying value of the notes is adjusted to take into account the &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;unrecognized day one gain are &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,147&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,557&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The fair value of the Heights convertible notes (including the embedded features) has been measured with a Monte Carlo model, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 381.6pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;considering two probability-weighted scenarios: (i) a Put Event or Default/Dissolution scenario and (ii) a voluntary conversion at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;maturity scenario. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main data and assumptions are the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 415.2pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 519pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 143.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 128.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes - August 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 0pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF AUGUST 24, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 17.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 17.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 113.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;350&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 17.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;350&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 17.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;350&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 34.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Original principal amount (in thousands of &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 34.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 34.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 34.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 55.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 55.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 116.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 116.84pt; position: var(--position);"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 55.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 55.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 72.75pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conversion price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 72.75pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.77&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 72.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.77&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 72.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.77&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 90pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;16.74&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 90pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.82&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 90pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.76&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 27pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 107.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.43pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Maturity date&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 107.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.63pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2025 (put event) 24/08/2027 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.23pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(HTM/voluntary conversion)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 27pt; left: 277.5pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2025 (put event)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2027 (HTM/voluntary &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 27pt; left: 399.75pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2025 (put event)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2027 (HTM/voluntary &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 0.76pt; width: 143.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Held to maturity / voluntary conversion &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.36pt; width: 143.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 134.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 134.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 134.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 151.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Initial price limit&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 151.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 151.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 151.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 168.75pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Early redemption amount (put event)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 168.75pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 108.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 108.84pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 168.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 168.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 186pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 186pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 186pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 203.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Credit spread&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 203.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 203.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 203.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;25&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 220.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 220.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 110.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 110.84pt; position: var(--position);"&gt;2.9&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 220.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;2.3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 220.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;2.9&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 237.75pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of Heights convertible notes &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 237.75pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 96.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 98.83999999999999pt; position: var(--position);"&gt;32,641&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 237.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 87.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 89.83999999999999pt; position: var(--position);"&gt;27,456&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 237.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 87.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 89.83999999999999pt; position: var(--position);"&gt;20,017&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of August 24, 2023, using the same assumptions with an increase of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; volatility, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+1&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; share price, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; risk-free rate and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 545.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;respectively &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+239&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+1,069&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;-239&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;-80&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of December 31, 2023, using the same assumptions with an increase of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; volatility, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+1&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; share price, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; risk-free rate and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;respectively &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+18&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+352&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;-366&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;-364&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;As of December 31, 2024, using the same assumptions with an increase of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; volatility, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+1&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; share price, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+1%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; risk-free rate and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;+10%&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; probability of achieving the held to maturity scenario would result in a change in the Heights convertible notes fair value by &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;respectively &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;2&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;+&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;39&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;-219&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;-631&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 353.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.3. Structured debt financing with Kreos subscribed in July 2018 &#x2013; &#x201c;Kreos 1&#x201d; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 250.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On July 24, 2018, the Group entered into a Venture Loan Agreement, a Straight Bonds Issue Agreement and a Convertible Bonds &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Issue Agreement with Kreos Capital V (UK) Ltd., (or &#x201c;Kreos&#x201d;), which provided for up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;20,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in financing. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 284.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to the terms of the agreements, Kreos agreed to subscribe for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;16,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in non-convertible bonds and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in convertible bonds, to be issued by the Group in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; tranches of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; each. The tranches were issued &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in July 2018 and May 2019, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The convertible bonds were convertible into new ordinary shares of the Group at any time from their issuance and at the discretion of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their holders. In October 2020, Kreos requi&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;red the conversion of all the convertible bonds they held (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,000,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for Tranche A and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 351.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2,000,000&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for Tranche B) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;464,309&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; shares were issued&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.65999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Each tranche bears an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; annual interest rate, plus 3-month Euribor, including a floor at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and a cap at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and must be repaid in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 565.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;54&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 575.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;monthly installments, after a deferred repayment of the nominal value to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the first tranche (&#x201c;Tranche A&#x201d;) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 566.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the second tranche (&#x201c;Tranche B&#x201d;). In addition, each tranche bears exit fees of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the total drawdown amount (i.e. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 407.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;900&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per tranche), payable upon the last monthly installment (exit fees remain payable in full in case of early redemption).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 429.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to the terms of the agreements, the Group has the right, at any time but with no less than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;30 days&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; prior notice to Kreos, to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 440.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepay or purchase the non-convertible and convertible bonds, exclusively in full. The prepayment will be equal to (i) the principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amount outstanding, plus (ii) exit fees of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the total draw down amount and (iii) the sum of all interest repayments which would &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;have been paid throughout the remainder of the term of the relevant tranche discounted by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 412.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per annum. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 485.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The agreements &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;did&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; not contain any financial covenants. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 508.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;In connection with each tranche, the Group issued &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;110,957&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.33000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; tranche A share warrants (or &#x201c;Kreos A BSA&#x201d;) and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;74,766&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; tranche B share &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;warrants (or &#x201c;Kreos B BSA&#x201d;), each, for a global subscription price of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;1&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;. Each Kreos A BSA and Kreos B BSA gives rights to &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 544.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;one&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;new ordinary share at an exercise price of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;7.21&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; less a discount and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;10.70&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; less a discount, respectively. Both Kreos A BSA and Kreos &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;B BSA are freely transferrable among financial institutions and are exercisable over a &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;10&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;-year&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; period from the issue date. In addition, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;the Group granted to the holders of the Kreos A BSA and the Kreos B BSA the option to sell to the Group, upon each exercise of all or &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.66pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;parts of the Kreos A BSA, at the put price defined in the agreement, a proportion of the number of the warrants, for the sole purpose of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;implementing a cash less exercise of the Kreos A BSA and Kreos B BSA. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The variation in the Kreos 1 &amp;amp; 2 bond loans during the periods ended December 31, 2021 and 2022 is primarily related to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 611.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;reimbursements of capital and interests. As of December 31, 2022, the A tranche of the Kreos 1 bond loan has come to maturity and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was repaid in full. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August, 21, 2023, the B tranche of the Kreos 1 bond loan as well as the A &amp;amp; B tranches of the Kreos 2 bond loan were repaid in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;full, for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7,661&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, using the proceeds from the new Kreos / Claret Fin&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ancing (see Note 3.3). &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 679.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group granted to the holders of the Kreos A BSA and the Kreos B BSA the option to sell to the Group, upon each exercise of all &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or parts of the Kreos A BSA, at the put price defined in the agreement, a proportion of the number of the warrants, for the sole purpose &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of implementing a cashless exercise of the Kreos A BSA and Kreos B BSA. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On May 24, 2023, the holders opted for the cashless exercise option of the share warrants they held, implemented through the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;repurchase by the Group of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43,070&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Kreos A BSA and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;43,070&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Kreos B BSA and the issuance by the Group of respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.0799999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67,887&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31,696&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary shares, as the result of the cashless exercise by Kreos of the outstanding &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;67,887&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Kreos A &amp;amp; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31,696&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; B BSA. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 127.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos 1 financing package is issued at market conditions: the net issuance proceeds reflect the fair value of the instruments at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;inception.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The straight bond tranches are split between i) a debt component (then measured at amortized cost), and ii) a premium corresponding &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to the initial fair value of attached BSA (then remeasured at fair value through profit and loss).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The BSA attached to all tranches (both straight and convertible) do not meet the &#x201c;fixed for fixed&#x201d; criteria (non cash settlement option &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which may result in exchanging a variable number of shares, for a variable price), and are accounted for as standalone derivative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 239.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 261.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The issuer prepayment options meet the definition of a separate derivative. However, their value at inception and subsequent dates is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nil&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as per Schoenbucher model, and has no impact on the financial statements.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 295.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As the differences identified between the terms of the Kreos 1 &amp;amp; 2 bond loans and the new Kreos / Claret Financing were considered &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 306.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;substantial, the repayment transaction on August 21, 2023 was accounted for as a debt extinguishment. The repayment of the Kreos 1 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&amp;amp; 2 bond loans led to the recognition of a loss on extinguishment amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;170&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, primarily due to (i) the payment of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;future interests as per the terms of the prepayment option and (ii) unamortized exit and issuance fees, reducing the carrying value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 340.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the liabilities.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Measurement of Kreos A BSA &amp;amp; Kreos B BSA &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos A BSA and Kreos B BSA are measured at fair value using a Black-Scholes valuation model. The main data and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions are the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 419.36pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos A BSA - June 1, 2018&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of and for the year &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ended December 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of May 24, 2023 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(exercise date)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding Kreos A BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;110,957&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;110,957&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7.21&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7.21&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Residual maturity&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.6 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.0 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;44.01&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2.98&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos A BSA (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.34pt; position: var(--position);"&gt;275&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;1,261&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 563.11pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43.1pt; position: var(--position); top: 0pt; width: 369.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 194.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos B BSA - June 1, 2019&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of and for the year &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ended December 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of May 24, 2023 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(exercise date)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding Kreos B BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;74,766&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 30.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;74,766&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exercise price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.70&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 42.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10.70&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 54.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;18.57&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Residual maturity&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.4 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 66.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.0 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;44.01&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 78.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 90.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2.96&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 102.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 70.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;N/A&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 194.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 194.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued Kreos B BSA (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 197.25pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.34pt; position: var(--position);"&gt;149&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 114.75pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;589&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 94.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2021, using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share price and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk-free rate would &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 105.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;result in an increase of Kreos A &amp;amp; B BSA fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;16&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;176&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;69&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;share price and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk-free rate would &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;result in an increase of Kreos A &amp;amp; B BSA fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.71000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;78&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On May 24, 2023, the holders opted for the cashless exercise option of the share warrants they held. At this date, the fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;exercised warrants of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,850&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; was reclassified from derivative financial liabilities to equity. As of this date, due to the put &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;option being exercised by the holders, the fair value of the BSAs is deemed equal to their intrinsic value, which is equal to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 195.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;difference between the share price on May 24, 2023 and their exercise price.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.4 Structured debt financing with Kreos subscribed in October 2020 &#x2013; &#x201c;Kreos 2&#x201d; &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 252.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On October 13, 2020, the Group obtained a straight bond loan of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from Kreos corresponding to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; tranches of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 263.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (&#x201c;Tranche A&#x201d;) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (&#x201c;Tranche B&#x201d;), with an option for an additional &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.8199999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tranches A and B were paid in October and November 2020, respectively, with the following conditions. Each tranche bears an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 550.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;8%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 563.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;annual interest rate, plus 3-month Euribor, for the first &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; monthly installments, after which the annual interest rate is increased to a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fixed rate of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;9.75%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the following &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;36&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; monthly installments. Each tranche is to be repaid in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;36&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; monthly installments starting from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 319.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;October 2021 and November 2021, for the tranche A and B, respectively. The agreements do not contain any financial covenants. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In addition, each tranche bears exit fees of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the total drawdown amount (i.e. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;400&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;200&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for Tranche A &amp;amp; B, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 352.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively), payable upon the last monthly installment (exit fees remain payable, in full or partially, in case of early redemption). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 375.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pursuant to the terms of the agreements, the Group has the right, at any time but with no less than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;30 days&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; prior notice to Kreos, to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 386.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prepay or purchase the non-convertible exclusively in whole. The prepayment will be equal to (i) the principal amount outstanding, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 397.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;plus (ii) exit fees of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the outstanding amount in the event of prepayment occurring between the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;th and the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;30&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;th installment or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 408.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;exit fees of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.21000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the outstanding amount in the event of prepayment occurring after the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;30&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;th installment and (iii) the sum of all &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;interest repayments which would have been paid throughout the remainder of the term of the relevant tranche discounted by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 547.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 431.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;annum. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 453.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August, 21, 2023, the B tranche of the Kreos 1 bond loan as well as the A &amp;amp; B tranches of the Kreos 2 bond loan were repaid in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 464.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;full, for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7,661&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, using the proce&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;eds from the new Kreos / Claret Financing (see Note 3.2). The accounting &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;treatment of the extinguishment of these liabilities is set forth in Note 15.3.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 498.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 520.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos 2 straight bonds were initially measured at fair value, which corresponds to the net cash proceeds, and subsequently &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measured at amortized cost. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 554.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In addition, the prepayment option is a separate derivative instrument as the redemption price does not reimburse Kreos for an amount &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 566.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;up to the approximate present value of lost interest for the remaining term of the host contract. However, its fair value at inception and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 577.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subsequent dates is nil as per Schoenbucher model, and has no impact on the financial statements.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.5. OCEANE &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 619.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group received a gross proceed of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;85,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; on July 30, 2021 through (i)&#160;the issuance of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,964,031&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; shares with a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 629.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subscription price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;30.55&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share (see Note 13.3 (changes in share capital)) for gross amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;60,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and (ii)&#160;the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 639.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issuance of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in OCEANE, maturing on July 30, 2026. The proceeds of the transaction mainly serve to finance the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 649.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;progress of ABX464 clinical trials in chronic inflammatory diseases. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 671.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The OCEANE bears a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; interest rate per year, payable semi-annually January 30, and July, 31 from January 31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The OCEANE shall be convertible into new ordinary shares and/or exchanged for existing ordinary shares of the group at any time &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 703.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from their issuance and at the discretion of their holders. The conversion ratio is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; ordinary share of the Group per OCEANE, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;representing a conversion price set to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;38.19&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ordinary share. This conversion price is updated (decrease only) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 533.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 70.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;36 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; after OCEANE issuance date to match the volume weighted average price of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="-sec-ix-hidden:f-2097"&gt;thirty&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; trading days that precedes &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the update subjected to the following floor threshold. The floor threshold for the 18-month update matches &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;85%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 483.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; initial conversion &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;32.462&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.28999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ordinary share). The floor threshold for the 24-month update matches &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;70%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; initial conversion price (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;26.733&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 543.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ordinary share). The floor threshold for the 36-month update matches &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;68%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; initial conversion price (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25.969&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per ordinary share). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE terms and conditions anticipate a conversion ratio adjustment in order to preserve the rights of OCEANE holders with the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;following achievements made by the group: issuance of new shares with the preemptive subscription right, attribution of free shares or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;securities for the benefit of all the shareholders, number of share multiplication, shares consolidation, increase of the nominal value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;incorporation of reserves, profits or bonuses, distribution of dividends, premiums or reserves, mergers, scission, repurchase of shares &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 172.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;above market value, capital reduction, creation of preferred shares. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 24, 2023, the outstanding OCEANE including accrued interests were repaid in full, for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,102&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 557.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 217.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;using the proceeds from the new Heights Financings (see Note 3.2). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accounting treatment and measurement &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 268.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In application of the Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;current, and Non-current Liabilities with Covenants, the OCEANE bonds are classified &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as current financial liabilities&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 291.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31, 2022 (see Note 2).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 308.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As the conversion ratio is adjusted &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;18 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 287.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;36 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; after the issuance date of the OCEANE bond with the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;weighted average price of the shares and is subject to a floor and a cap, the conversion does not result in the delivery of a fixed &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 328.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;number of shares. Consequently, the OCEANE bond is recorded as an hybrid instrument which includes i) a debt host contract &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;accounted for at amortized cost, and ii) a conversion option which is a embedded derivative accounted for at fair value through profit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 348.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and loss. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 370.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At inception, the net cash proceeds reflect the OCEANE initial fair value. The fair value of the bifurcated option at inception has been &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measured with a Monte Carlo model using a Longstaff Schwartz algorithm, with a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;53%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price volatility, a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,400&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp credit spread &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumption and a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;31.50&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 413.06pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 389.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF AUGUST 24, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 21pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;3.05&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 21pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;3.22&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Credit spread&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 33pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,398&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 45pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;16.74&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Expected term&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;July 21, 2026&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 57pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; July 21, 2026 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 69pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;44.01&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 69pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;37&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 81pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 81pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 81pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 93pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued OCEANE (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 93pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.34pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 93pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;1,762&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of July 30, 2021, the issuance price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; has been split between i) a financial liability for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;17,839&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 541.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and ii) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a financial derivative for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7,161&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 589.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, the fair value of conversion option amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;142&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, based on the same valuation model, a credit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;spread assumption of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp, a share price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.18&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and a price volatility of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;44%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. As of December 31, 2022, using the same &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 610.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions, an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.52pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk free rate would result in an increase of the OCEANE &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 620.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion option fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.70999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;17&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;97&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;15&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of August 24, 2023, the date at which the OCEANE were repaid, the fair value of conversion option amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,762&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 651.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;based on the same valuation model, a credit spread assumption of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,398&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp, a share price of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;16.74&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and a price volatility of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;37%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 551.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. As &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of August 24, 2023, using the same assumptions, an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk free rate would result in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 673.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;an increase of the OCEANE conversion option fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;80&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;364&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;121&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As the differences identified between the terms of the OCEANE and the new Heights convertible notes were considered substantial, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the transaction was accounted for as a debt extinguishment. The repayment of the OCEANE led to the recognition of a loss on &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;extinguishment amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,069&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.6. State guaranteed loan &#x2013; &#x201c;PGE&#x201d;&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i72e4f64c56664c4db7a276f1130c3e77"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In June 2020, the Group subscribed to a PGE from Soci&#xe9;t&#xe9; G&#xe9;n&#xe9;rale with an initial maturity of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12 months&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.25%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;five&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 538.5699999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;extension option. In March 2021, the Group exercised the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;five&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; extension option with a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; deferral of the principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 168.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;repayment, with the following conditions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Rate: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.58%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per annum excluding insurance and state guaranteed premium, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 200.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;State guaranteed premium of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.23000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;138&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; to be paid by installments over the contract period starting in June 2021, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Reimbursement by yearly installments from June 2021 to June 2026. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The benefit resulting from the low interest nature of the award as a subsidy was recognized as other income during the period ended &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December&#160;31, 2020 for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;377&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 280.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The variation in the PGE loan over the periods ended December 31, 2022, 2023 and 2024 is primarily related to the reimbursement of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 291.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;capital and interests. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.7. Conditional advances&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="iba53c4e4c3cf4d75aecc5662b6c4ae1d"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 341.76pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances as of December 31, 2022, 2023 and 2024 are as follows&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 347.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;:&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 352.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 382.77pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 383.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONDITIONAL ADVANCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 12pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 12pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 12pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RNP VIR &#x2013; Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;4,171&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 42.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;4,232&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 42.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CARENA &#x2013; Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;2,454&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 54.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;2,485&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 54.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EBOLA &#x2013; Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;158&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 66.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;55&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 66.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total conditional advances&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;6,783&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 78.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 78.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 516.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RNP-VIR &#x2013; Bpifrance &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Under the RNP-VIR contract, the Group was eligible to receive up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.3&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in conditional advances to further develop methods &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the discovery of new molecules for the treatment of viral infectious diseases through the development of the &#x201c;Modulation of RNA &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;biogenesis&#x201d; platform. As of December 31, 2022, the Group had received &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,032&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, of which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,756&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 503.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; was received in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 562.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;September 2017, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;346&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in August&#160;2018 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,930&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in November 2019. The repayment of these funds is spread from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 572.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the date on which the repayments are called by BPI. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Bpifrance claimed the reimbursement &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,241 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; corresponding to overpayments of conditional advances and subsidies (for which the Group had not incurred the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 618.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;corresponding R&amp;amp;D expenses) and agreed to waive &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the remaining advances of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,945&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and accrued interests, w&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;hich &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 630.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;resulted in a subsidy&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; income of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,872&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the aggregate (see Note 18). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The outstanding amount was fully repaid by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group during the second half of 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.52pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;See Note 25.2. Commitments under BPI conditional advances. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CARENA &#x2013; Bpifrance &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Under the CARENA agreement, the Group was eligible to receive up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,840&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; to develop a therapeutic HIV treatment &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;program with ABX464. As of December 31, 2022, the Group received &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,187&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, of which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,150&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; was received in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 2013, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,008&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in September 2014 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;29&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; received in June 2016. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 128.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 129.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The repayment of the advance is spread from the date on which the repayments are called by Bpifrance. An additional repayment is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;provided for based on the income the Group generates through this research and development program.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Bpifrance granted an additional amount &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,068&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; payable to the Group to reimburse additional expenses incurred as part of the project, and agreed to waive &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 541.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;60%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the remaining conditional advance of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,255&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and accrued interests, which resulted in&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; a subsidy income&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,251&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the aggregate (see Note 18).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; The outstanding amount was fully repaid by the Group during the second half of 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 225.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EBOLA &#x2013; Bpifrance &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 241.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Under the Bpifrance and Occitanie region joint aid agreement, the Group received a total of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;390&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2017 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;90&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December 31, 2019). The reimbursement is spread from 2019 to June 2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.8. Lease liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="id18a1eac803844cea0e7d449e6dfcfb5"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The variations in lease liabilities are set forth below:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 342.76pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 301.5pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 216.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 56.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LEASE LIABILITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 12pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;214&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;1,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 64.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 66.67999999999999pt; position: var(--position);"&gt;(305)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;1,384&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 78pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;350&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 90pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.68pt; position: var(--position);"&gt;(1,194)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 102pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 123pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 135pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 64.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 66.67999999999999pt; position: var(--position);"&gt;(398)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 147pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2,363&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 527.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities mainly relate the Group&#x2019;s headquarters in Paris, the Boston office entered into in November 2023, the Montpellier &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 538.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;offices entered into in April 2024, the new Paris headquarters entered into in May 2024 and to a lesser extent to vehicles, parking lots &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and printer&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;s (Note 8).&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 561.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The lease for the Group&#x2019;s corporate headquarters in Paris, France at 5 Rue de la Baume, 75008 Paris ended in August 2022. A new &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 574.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;lease for premises at 7-11 Boulevard Haussmann, 75009 Paris started in July 2022. It &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;had&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; duration, with a tacit renewal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 587.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;option for approximately &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and the possibility to break the contract &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; before the end. As of December 31, 2022, per &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Management, renewal and termination options were not reasonably certain due to the forecasted development of the Group, which &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;could lead the Group to relocate at the end of the initial term. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In September 2023, the Group was notified by the lessor of its intention &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 627.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to exercise its option to terminate the contract on June 30, 2024. Consequently, the Group reassessed the lease term and recorded a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;decrease in the related lease liability by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;622&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and a corresponding decrease in the right of use asset for the same amount. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;A new lease for different premises within the same building was entered into on May 2, 2024. It has a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; duration, and no &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 666.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;renewal option. The Group also benefits from an initial eight-month rent-free period.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 691.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In November 2023, the Subsidiary entered a lease contract for its new Boston offices. It has a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; duration, with an option to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;renew the contract for an additional period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="-sec-ix-hidden:f-2206"&gt;one&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; or &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. In December 2024, the Group exercised its option to extend the lease &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;up until December 2026. P&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;er Management, additional renewal options are not reasonably certain due to the forecasted development of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Subsidiary, which may lead it to relocate at the end of the current term.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In April 2024, the Company entered a lease contract for a new Montpellier office. It has an initial &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;six&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; duration, with the option for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Company to terminate the lease at any time with a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;six&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-month&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.27pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; notice period, and a tacit renewal option for an additional period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;six years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. Based on Management's estimate, the initial lease period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;six years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; is considered reasonably certain and is therefore used &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for the measurement of the lease liability.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 160.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, 2023 and 2024, the lease liabilities of the Paris headquarters and Boston offices represented &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;97%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 536.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;93%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;93%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the total lease liability, respectively.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease expenses related to contracts for which a lease liability and right of use asset is recognized under IFRS 16 were &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;424&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 567.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;548&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;730&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the years ended December 31, 2022, 2023 and 2024, respectively. They were recognized for (i) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;414&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;498&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;788&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; Depreciation expenses and (ii) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;13&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;61&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 227.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest expenses, for the years ended December 31, 2022, 2023 and 2024, respectively.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 249.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease expenses related to short-term lease contracts and low value assets that are not included in the valuation of the lease liability &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 260.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amount to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.74000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;331&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;334&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;352&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the years ended December 31, 2022, 2023 and 2024, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.9. Prosynergia earn-out liability&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i4b6734fd51c649bba629e570a8bbfd4c"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The terms of the share purchase acquisition of Prosynergia include a possible earn out triggered in the event the Company&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 329.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;market capitalization is in excess of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (evaluated at certain specified record dates), a listing of the Company&#x2019;s shares &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 341.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;on Nasdaq or a merger and acquisition transaction prior to March 31, 2023. The amount of the earn-out is equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 353.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;difference between the Company&#x2019;s market capitalization and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;300&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, subject to a maximum amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4.0&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;This potential earn-out payment was measured at fair value on April 1, 2022 (acquisition date), for an amount of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 389.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,446&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and included in the acquisition cost.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 425.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, the fair value of the earn-out liability was insignificant. Since its payment was not triggered by March &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 437.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31, 2023, the liability was extinguished and thus reversed. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 461.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Prosynergia earn-out liability is measured at fair value using a Black-Scholes valuation model. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main data and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions are the following:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 485.46pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 404.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 254.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prosynergia earn-out&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of April 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of and for the &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;period ended &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 30.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 52.27pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.27pt; position: var(--position);"&gt;(0.3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 30.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;2.3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Market capitalization (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 45.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;403,118&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 45.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;135,952&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 60.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price (&#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 60.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24.15&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 60.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Time to maturity&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 75.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1 year&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 39.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.25 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;61&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;44&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 105.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 105.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 105.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.37pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of the earn-out liability (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 120.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.27pt; position: var(--position);"&gt;(1,446)&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 120.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650.71pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of April 1, 2022, using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.73pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk free rate would &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 662.71pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;result in an increase of the earn-out liability fair value by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 265.96000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;12&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;132&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;17&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 678.21pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, the fair value of the earn-out liability is approximately &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. Using the same assumption with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.21pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; volatility, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; risk free rate would result in an increase of the earn-out liability fair value by an amount &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.21pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;less than &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.10. Royalty certificates &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i929f6094c7664e43aa619f2ae0112c78"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 120.49pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On September 2, 2022, the Group completed a financing of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;49,162&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, consisting of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; transactions: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 142.89pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;a reserved capital increase of a gross amount of &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;46,231&#160;thousand&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; through the issuance of &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5,530,000&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; new shares with a &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 156.33pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nominal value of &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;0.01&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share at a subscription price of &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8.36&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; per share; and &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 169.77pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;an issue of royalty certificates with a subscription price amounting to &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,931&#160;thousand&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The royalty certificates give right to &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 183.21pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;their holders to royalties equal to &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2%&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the future net sales of obefazimod (worldwide and for all indications) as from the &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 196.65pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;commercialization of such product. The amount of royalties that may be paid under the royalty certificates is capped at &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.09pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;172,000&#160;thousand&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.73pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Related transaction costs amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,280&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and are recorded in equity, since entirely related to the reserved capital &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 245.93pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;increase. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 270.93pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, following a change in the estimate of future royalty cash flows, the certificates&#x2019; amortized cost was &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.13pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;remeasured at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,287&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, using the original EIR calculated at the date of issuance. The change in estimate resulted in a decrease &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.33pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in the related interest expense by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; over the period ended December 31, 2022.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.73pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In April 2023, the Group reassessed its estimate of the probability of future royalty cash flows related to the royalty c&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ertificates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 549pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;This &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 326.93pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;change reflected the higher probability to reach the objectives of the development and commercialization plans following the recent &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 338.13pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;changes in management and governance, as well as results from its Phase 2b open-label maintenance trial in UC, as released in April &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 349.33pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023. Subsequently, in June 2023 and December 2023, the Group revised &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the development and commercialization plans of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 360.53pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obefazimod and reassessed its estimate of future royalty cash flows accordingly. These changes in estimates resulted in a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 371.73pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;remeasurement of the certificates&#x2019; amortized costs, using the original EIR of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;34%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; calculated at the date of issuance, which led to an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.93pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;increase by&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.21000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.71000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;6,421 thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the royalty certificates liability. The expense was recorded within the interest expenses in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.13pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statements of Income (Loss).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 405.33pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consequently, the total interest expense (including the unwinding of discount) related to royalty certificates amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 416.83pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8,942&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the year ended December 31, 2023.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 439.83pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;I&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;n December 2024, the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;revised &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the development and commercialization plans of obefazimod to take into account the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 451.03pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;progression in the ongoing clinical trials, reassessment of the commercial schedule and forecasts&#160; and reassessed its estimate of future &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.23pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;royalty cash flows accordingly.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.42000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; This&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; change in estimate resulted in a remeasurement of the certificates&#x2019; amortized costs, using the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.43pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;original EIR of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.99000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;34%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; calculated at the date of issuance, which led to a decrease &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;by &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,404&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the royalty certificates liability.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 484.63pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The expense was recorded within the interest expenses in the Statements of Income (Loss).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.83pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consequently, the total interest expense related to royalty certificates (including the effect of the unwinding of discount, amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 507.33pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,198&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;794&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for the year ended December 31, 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 542.83pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.47pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The fair value of the royalty certificates, calculated using the same model as their initial measurement, amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,307&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 560.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.67pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of December 31&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, 2022 and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;12,395 thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; as &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of December 31, 2023 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;7,313&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December 31, 2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 601.07pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The fair value of the royalty certificates is based on the net present value of royalties, which depends on assumptions made by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.27pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group with regards to the probability of success of its studies (&#x201c;POS&#x201d;), the commercialization budget of obefazimod (&#x201c;peak &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.47pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;penetration&#x201d;) and the Group's WACC. In addition, royalty projections have been adjusted to reflect any difference between the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 634.67pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group&#x2019;s value derived from management projections and the Group&#x2019;s market &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;capitalization&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645.87pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The decrease in fair value of the royalty certificates over the year ended December 31, 2024 is mainly driven by the decrease in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 657.07pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group's share price over the period.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 682.07pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2022, using the same assumptions with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; points of POS, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of peak penetration (best case &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 693.27pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scenario) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; WACC would result in a change in the royalty certificates fair value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+299&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 704.47pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+221&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-191&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&#160; Using the same assumptions with a decrease of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; points of POS, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of peak penetration (worst &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;case scenario) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; WACC would result in a change in the royalty certificates fair value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-294&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-347&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+205&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023, using the same assumptions with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; points of POS, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of peak penetration (best case &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scenario), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; WACC and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;sha&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;re price would result in a change in the royalty certificates fair value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 518.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1104&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1757&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-577&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.78999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1325&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. Using the same assumptions with a decrease of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; points of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 137.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POS, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of peak penetration (worst case scenario) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; WACC and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price would result in a change in the royalty &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certificates fair value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-1104&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-2311&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+612&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-1325&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of December 31, 2024, using the same assumptions with an increase of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; points of POS, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of peak penetration (best case &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scenario), &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; WACC and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;+1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price would result in a change in the royalty certificates fair value by respectively &#x20ac;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 193.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;572&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,735&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-314&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.91999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,160&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. Using the same assumptions with a decrease of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.9100000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-5&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; points of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 204.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;POS, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of peak penetration (worst case scenario) and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;-1%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; WACC and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-1&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price would result in a change in the royalty &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 216.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certificates fair value by respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-572&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-2,527&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &#x20ac;+&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;332&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;-1,160&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.11. Change in financial liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="ieb6c790a36b64ce287edfb0289428b41"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 297.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Changes in financial liabilities, excluding derivative instruments, are presented below as of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022, 2023 a&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nd 2024:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 309.16pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Amounts in thousands of &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;euros) &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 44.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9.52pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES (excluding &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 28.72pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivatives instruments)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 21.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bond loans&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Oceane&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 21.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 2.76pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Claret &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;notes &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 36.36pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA )&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Claret bond &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;loans&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;notes&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;advances &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BPI&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 12.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liabilities&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prosynergia &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;earn-out &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liability&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certificates&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 66pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 15.84pt; position: var(--position);"&gt;21,110&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;18,816&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 66pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;4,742&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,770&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;214&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;51,653&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Proceeds&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 87pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 87pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,931&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,931&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 99pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.18pt; position: var(--position);"&gt;(9,410)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 99pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(90)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(305)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(9,806)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 111pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 111pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.18pt; position: var(--position);"&gt;(2,456)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,496)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 111pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(54)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(4,006)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: interest &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;expense and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 123pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 19.84pt; position: var(--position);"&gt;3,738&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,636&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 123pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;150&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;102&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;356&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,983&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognition of earn-out &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liability &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 144pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 144pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,446&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,446&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: fair &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 174.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,446)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,446)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 195.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;additional leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 195.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 216.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 216.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 15.84pt; position: var(--position);"&gt;12,982&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;19,957&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 216.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;4,838&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,783&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,384&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,287&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;49,231&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 237.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Proceeds&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 237.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;23,119&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;58,119&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 249.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 249.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 10.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.18pt; position: var(--position);"&gt;(11,635)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 11.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.93pt; position: var(--position);"&gt;(23,238)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 249.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(2,188)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(110)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(573)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 11.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.93pt; position: var(--position);"&gt;(38,993)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 261.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 261.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.18pt; position: var(--position);"&gt;(2,278)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,602)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 261.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.68pt; position: var(--position);"&gt;(818)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(525)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(43)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(12)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(5,278)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 273.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: interest &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;expense and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 273.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 16.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 18.68pt; position: var(--position);"&gt;(1,046)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,046)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 294.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognition of earn-out &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liability &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 294.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 16.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 18.68pt; position: var(--position);"&gt;(1,005)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,005)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 325.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: fair &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 325.5pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.84pt; position: var(--position);"&gt;170&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,069&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 325.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(212)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,027&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 346.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;additional leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 346.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;272&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;272&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 367.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 367.5pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 367.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,678&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;12,229&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;74,466&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Amounts in thousands of &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES (excluding &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivatives instruments)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 52.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 52.5pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 52.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,678&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;12,229&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;74,466&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 73.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Proceeds&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 73.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;47,444&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;47,444&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 85.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayments &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 85.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(8,750)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(2,708)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(459)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 11.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.93pt; position: var(--position);"&gt;(13,167)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 97.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 97.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 16.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 18.68pt; position: var(--position);"&gt;(2,250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,639)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,772)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(18)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(17)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(7,696)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 50.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 109.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.09pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.69pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;classification of embedded &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.29pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivatives as separate &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.89pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivative financial &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 109.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,204)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,204)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: (gain)/&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;loss on recognition or &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derecognition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 159.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(590)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(590)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 190.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: interest &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;expense and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 190.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.34pt; position: var(--position);"&gt;3,977&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;5,800&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,714&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;77&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;61&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;4,198&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;15,834&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 211.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amortized cost &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 211.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,404)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,404)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 242.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: other &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 242.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,367&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,367&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 263.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes&#160;: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subsidies &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 263.25pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 263.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(4,070)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(4,070)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 284.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.81pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;additional leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 284.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 32.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 306pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes : Effect &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the change in foreign &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;currency exhange rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 306pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 338.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 338.25pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 338.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;46,401&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,488&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,363&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 9.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 12.59pt; position: var(--position);"&gt;109,218&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;For&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; the year ended December 31, 2023, proceeds from the issuance of the Kreos / Claret OCABSA are presented net of transaction &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;costs, amounting to &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;1,881&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;. Net proceeds from convertible loan notes of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 365.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;55,841&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.49pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; disclosed in the Consolidated Statements of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.16pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;Cash Flows also include transaction fees of (i) &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;750&#160;thousands&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; related to the Kreos / Claret B and C tranches and recorded in prepaid &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 490.36pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;expenses (see Note 10) and (ii) &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;1,528&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; related to the Heights convertible notes.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 512.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;For the year ended December 31, 2023, repayments of the OCEANE are presented net of the repurchase of the conversion option, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;value&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.629999999999995pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;d at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,762&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; on the date of repayment, which is presented in Note 15.12. The aggregate repayment amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 557.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the year ended December 31,2024, proceeds from the issuance of the Kreos / Claret tranches B and C bond loans are presented net &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 568.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of transaction costs and deposits (corresponding to the prepayments of half of the last debt installments on issuance date) included in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 579.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the debt discount using the EIR method, and amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 271.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,475&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,081 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; respectively. Net proceeds from non-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible bond loans of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;48,544&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand disclosed in the Unaudited Condensed Consolidated Statements of Cash Flows do not &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 602.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;include transaction fees of&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (i) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;500&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; related to the Kreos / Claret tranche A-B warrants classified as prepaid expenses as of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2023.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.12. Change in derivative instruments&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i7c8dd868c7e14b8cb97f5969c9da56f9"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 690.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Changes in derivative instruments, are presented below as of December 31, 2022, 2023 and 2024 :&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 44pt; position: var(--position); top: 0pt; width: 534.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 96pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 7.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.1pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 37.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos A BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos B BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 19.57pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 29.17pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion option&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Minimum Return &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.97pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Indemnifications&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 24.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DERIVATIVE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.6pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSTRUMENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,478&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,525&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;5,929&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;9,932&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 75.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(2,203)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,376)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(5,787)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 87.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(9,366)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;275&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;149&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 99.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;566&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Issuance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 120.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,585&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;3,585&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 132.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;986&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;440&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 132.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;3,046&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 144.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,006)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,006)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 156.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Repurchases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(489)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(339)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,762)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 156.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(2,591)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 168.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Exercises&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(771)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 168.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,021)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 180.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 180.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 201.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 201.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 222.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Issuance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,158&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,158&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,462&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,462&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 246.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,413)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,413)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 258.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 355.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 379.75pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Details related to these instruments' accounting treatments and terms and conditions are set forth in Notes 15.1 to 15.5.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.15pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On May 24, 2023, t&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;he holders&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; opted for the cashless exercise option of the Kreos A&amp;amp;B BSAs they held. At this date, the fair value of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 413.35pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;exercised warrants &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,850&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; (see line items "Repurchases" and "Exercises") &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;was reclassified from derivative financial &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.55pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liabilities to equity. As of this date, due to the put option being exercised by the holders, the fair value of the Kreos A&amp;amp;B BSAs is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.75pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;deemed equal to their intrinsic value, which is equal to the difference between the share price on May 24, 2023 and their exercise &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 446.95pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;price. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 469.35pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of August 24, 2023, the date at which the OCEANE were reimbursed, their conversion option had a fair value of &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,762&#160;thousand&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 15.13. Breakdown of financial liabilities by maturity&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i25f84399b4e1453298aac16ba73c09ba"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.97pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following are the remaining contractual maturities of financial liabilities as of December 31, 2022, 2023 and 2024. The amounts &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.17pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are gross and undiscounted, and include contractual interest payments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 561.67pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 147pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 0pt; width: 393pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 393pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 184.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 393pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 21pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 21pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12,982&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 54pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;14,098&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;9,034&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 54pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;5,065&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 54pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Oceane&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,957&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 66pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;31,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 66pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 66pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.84pt; position: var(--position);"&gt;28,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4,838&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 78pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;5,173&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 78pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 78pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.84pt; position: var(--position);"&gt;2,586&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances BPI&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,783&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 90pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;6,813&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;3,697&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 90pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,490&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 90pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.84pt; position: var(--position);"&gt;1,626&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3,287&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 102pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 102pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 102pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,384&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 114pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;1,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;558&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 114pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.34pt; position: var(--position);"&gt;557&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 114pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;289&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 126pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;566&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 126pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 126pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;424&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;49,797&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 138pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;59,053&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;16,223&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 138pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;9,905&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 138pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.84pt; position: var(--position);"&gt;32,925&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 0pt; width: 397.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 397.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 187.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 397.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 160.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 21pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 21pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 54pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;36,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;10,522&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;9,997&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 54pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;16,231&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 54pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret convertible notes &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 66pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;30,903&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 66pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;26,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 66pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;3,678&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 86.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;3,880&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 86.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 86.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances BPI&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 98.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;6,813&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;3,697&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,490&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 98.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.59pt; position: var(--position);"&gt;1,626&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 98.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;12,229&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 110.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 110.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 110.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 122.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 122.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;575&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;406&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;162&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 122.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 122.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 134.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 134.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 134.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 134.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 146.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;77,045&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 146.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;81,500&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;20,747&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;15,192&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 146.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;45,561&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 146.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 257.81pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 543pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 0pt; width: 401.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 401.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 188.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 401.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 71.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 71.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 54pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;24,063&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;6,563&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret convertible notes &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 66pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;30,653&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;19,943&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,460&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;46,401&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 86.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;58,080&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;24,016&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;25,715&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,348&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,488&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 98.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;2,586&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 110.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 57.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 122.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,363&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 122.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;2,512&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;993&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;996&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;516&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 134.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 134.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 146.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 30.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.59pt; position: var(--position);"&gt;114,004&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 146.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 39.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.84pt; position: var(--position);"&gt;122,680&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;38,468&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;56,698&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;27,507&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 421.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The contractual cash flows above do not include potential future royalty payments related to the royalty certificates, amounting to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 556.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 570.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 445.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the future net sales of obefazimod (worldwide and for all indications). The amount of royalties that may be paid under the royalty &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certificates is capped at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;172.0&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in the aggregate. Royalty payments are expected to take place before the expiry date of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 467.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certificates, which is &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; after their issuance date (September 2, 2037), and would be included in the "&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;f&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ro&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;m 2 to 5 year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.5699999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 531.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;" and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;"longer than 5 years" maturity categories according to management's projections.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory contextRef="c-1" id="f-1598">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial liabilities break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 101.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 110.46pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 422.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 191.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 44.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 44.2pt; position: var(--position); text-decoration: none; top: -1.8935pt; vertical-align: super; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 3.5165pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;4,730&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; Claret bond loans &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;26,373&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;839&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;160&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,431&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,558&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,402&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,252&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Borrowings&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;9,127&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,563&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;29,056&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret convertible notes (OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Convertible loan notes&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos A &amp;amp; B BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;424&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Oceane conversion option&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; Claret minimum return indemnifications &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;566&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,262&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,262&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,287&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12,229&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 198.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;6,549&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;15,491&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 210.75pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total non-current financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;16,241&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;39,697&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;69,069&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 6.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 229.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 229.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;8,252&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 229.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 229.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 241.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; Claret bond loans &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 241.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 241.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 241.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;20,028&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 253.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 253.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;545&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 253.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;379&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 253.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;932&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 265.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 265.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,280&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 265.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,276&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 265.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,235&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 277.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Borrowings&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 277.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;10,077&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 277.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,655&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 277.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;22,195&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 289.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 289.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;19,957&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 289.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 289.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 301.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 301.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 301.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 301.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 313.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Convertible loan notes&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 313.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;19,957&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 313.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 313.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 325.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 325.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,521&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 325.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,509&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 325.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 337.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 337.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,521&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 337.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,509&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 337.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 349.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 191.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos / Claret BSA&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 349.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 349.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 361.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 361.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 361.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 361.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 373.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total current financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 373.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;33,555&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 373.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;37,348&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 373.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;44,935&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 385.5pt; width: 191.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 191.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 191.25pt; position: var(--position); top: 385.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;49,797&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 269.25pt; position: var(--position); top: 385.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;77,045&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 347.25pt; position: var(--position); top: 385.5pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 42.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.59pt; position: var(--position);"&gt;114,004&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 524.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;"&gt;1&lt;span style="display: inline-block; height: 3.601pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In application of the &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-current, and Non-current Liabilities &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 535.35pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022 and the non-current portion of the Heights convertible notes as of December &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 545.99pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31, 2023 were reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-628" decimals="-3" id="f-1599" unitRef="eur">4730000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-629" decimals="-3" id="f-1600" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-630" decimals="-3" id="f-1601" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-631" decimals="-3" id="f-1602" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-632" decimals="-3" id="f-1603" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-633" decimals="-3" id="f-1604" unitRef="eur">26373000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-634" decimals="-3" id="f-1605" unitRef="eur">839000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-635" decimals="-3" id="f-1606" unitRef="eur">160000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-636" decimals="-3" id="f-1607" unitRef="eur">1431000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-637" decimals="-3" id="f-1608" unitRef="eur">3558000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-638" decimals="-3" id="f-1609" unitRef="eur">2402000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-639" decimals="-3" id="f-1610" unitRef="eur">1252000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-640" decimals="-3" id="f-1611" unitRef="eur">9127000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-641" decimals="-3" id="f-1612" unitRef="eur">2563000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-642" decimals="-3" id="f-1613" unitRef="eur">29056000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-643" decimals="-3" id="f-1614" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-644" decimals="-3" id="f-1615" unitRef="eur">21643000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-645" decimals="-3" id="f-1616" unitRef="eur">23370000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-646" decimals="-3" id="f-1617" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-647" decimals="-3" id="f-1618" unitRef="eur">21643000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-648" decimals="-3" id="f-1619" unitRef="eur">23370000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-649" decimals="-3" id="f-1620" unitRef="eur">424000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-650" decimals="-3" id="f-1621" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-651" decimals="-3" id="f-1622" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-57" decimals="-3" id="f-1623" unitRef="eur">142000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-652" decimals="-3" id="f-1624" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-58" decimals="-3" id="f-1625" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-653" decimals="-3" id="f-1626" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-654" decimals="-3" id="f-1627" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-655" decimals="-3" id="f-1628" unitRef="eur">3620000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-656" decimals="-3" id="f-1629" unitRef="eur">566000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-657" decimals="-3" id="f-1630" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-658" decimals="-3" id="f-1631" unitRef="eur">3620000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-659" decimals="-3" id="f-1632" unitRef="eur">3262000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-660" decimals="-3" id="f-1633" unitRef="eur">3262000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-661" decimals="-3" id="f-1634" unitRef="eur">0</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-662" decimals="-3" id="f-1635" unitRef="eur">3287000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-663" decimals="-3" id="f-1636" unitRef="eur">12229000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-664" decimals="-3" id="f-1637" unitRef="eur">13023000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-665" decimals="-3" id="f-1638" unitRef="eur">6549000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-666" decimals="-3" id="f-1639" unitRef="eur">15491000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-667" decimals="-3" id="f-1640" unitRef="eur">13023000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-6" decimals="-3" id="f-1641" unitRef="eur">16241000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-7" decimals="-3" id="f-1642" unitRef="eur">39697000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c-5" decimals="-3" id="f-1643" unitRef="eur">69069000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-628" decimals="-3" id="f-1644" unitRef="eur">8252000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-629" decimals="-3" id="f-1645" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-630" decimals="-3" id="f-1646" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-631" decimals="-3" id="f-1647" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-632" decimals="-3" id="f-1648" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-633" decimals="-3" id="f-1649" unitRef="eur">20028000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-634" decimals="-3" id="f-1650" unitRef="eur">545000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-635" decimals="-3" id="f-1651" unitRef="eur">379000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-636" decimals="-3" id="f-1652" unitRef="eur">932000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-637" decimals="-3" id="f-1653" unitRef="eur">1280000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-638" decimals="-3" id="f-1654" unitRef="eur">1276000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-639" decimals="-3" id="f-1655" unitRef="eur">1235000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-640" decimals="-3" id="f-1656" unitRef="eur">10077000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-641" decimals="-3" id="f-1657" unitRef="eur">1655000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-642" decimals="-3" id="f-1658" unitRef="eur">22195000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-668" decimals="-3" id="f-1659" unitRef="eur">19957000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-669" decimals="-3" id="f-1660" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-670" decimals="-3" id="f-1661" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-671" decimals="-3" id="f-1662" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-59" decimals="-3" id="f-1663" unitRef="eur">29605000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-60" decimals="-3" id="f-1664" unitRef="eur">21574000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-646" decimals="-3" id="f-1665" unitRef="eur">19957000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-647" decimals="-3" id="f-1666" unitRef="eur">29605000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-648" decimals="-3" id="f-1667" unitRef="eur">21574000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-659" decimals="-3" id="f-1668" unitRef="eur">3521000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-660" decimals="-3" id="f-1669" unitRef="eur">3509000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-661" decimals="-3" id="f-1670" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-665" decimals="-3" id="f-1671" unitRef="eur">3521000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-666" decimals="-3" id="f-1672" unitRef="eur">3509000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-667" decimals="-3" id="f-1673" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-672" id="f-1674" unitRef="eur" xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-673" decimals="-3" id="f-1675" unitRef="eur">2579000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-674" decimals="-3" id="f-1676" unitRef="eur">1166000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-656" decimals="-3" id="f-1677" unitRef="eur">0</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-657" decimals="-3" id="f-1678" unitRef="eur">2579000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-658" decimals="-3" id="f-1679" unitRef="eur">1166000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-6" decimals="-3" id="f-1680" unitRef="eur">33555000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-7" decimals="-3" id="f-1681" unitRef="eur">37348000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c-5" decimals="-3" id="f-1682" unitRef="eur">44935000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-6" decimals="-3" id="f-1683" unitRef="eur">49797000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-7" decimals="-3" id="f-1684" unitRef="eur">77045000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-5" decimals="-3" id="f-1685" unitRef="eur">114004000</ifrs-full:FinancialLiabilities>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-84" decimals="-3" id="f-1686" unitRef="eur">75000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <abvx:BorrowingsNumberOfTranches
      contextRef="c-84"
      decimals="INF"
      id="f-1687"
      unitRef="tranche">3</abvx:BorrowingsNumberOfTranches>
    <abvx:BorrowingsMaximumBorrowingCapacityPerTranche contextRef="c-84" decimals="-3" id="f-1688" unitRef="eur">25000000</abvx:BorrowingsMaximumBorrowingCapacityPerTranche>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-87" decimals="-3" id="f-1689" unitRef="eur">25000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <abvx:BorrowingsFixedConversionPrice
      contextRef="c-675"
      decimals="4"
      id="f-1690"
      unitRef="eurPerShare">21.2209</abvx:BorrowingsFixedConversionPrice>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-675"
      decimals="4"
      id="f-1691"
      unitRef="number">0.0900</ifrs-full:BorrowingsInterestRate>
    <abvx:BorrowingsEarlyRepaymentDiscountRate
      contextRef="c-675"
      decimals="2"
      id="f-1692"
      unitRef="number">0.04</abvx:BorrowingsEarlyRepaymentDiscountRate>
    <abvx:BorrowingsExitFeePercentage
      contextRef="c-675"
      decimals="3"
      id="f-1693"
      unitRef="number">0.080</abvx:BorrowingsExitFeePercentage>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-107" decimals="-3" id="f-1694" unitRef="eur">25000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <abvx:BorrowingsDebtToMarketCapitalizationRatio
      contextRef="c-676"
      decimals="2"
      id="f-1695"
      unitRef="number">0.10</abvx:BorrowingsDebtToMarketCapitalizationRatio>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-677" decimals="-3" id="f-1696" unitRef="eur">25000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <abvx:BorrowingsDebtToMarketCapitalizationRatio
      contextRef="c-677"
      decimals="2"
      id="f-1697"
      unitRef="number">0.10</abvx:BorrowingsDebtToMarketCapitalizationRatio>
    <abvx:BorrowingsPerformanceConditionsMinimumFinancing contextRef="c-678" decimals="-3" id="f-1698" unitRef="usd">125000000</abvx:BorrowingsPerformanceConditionsMinimumFinancing>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-679"
      decimals="3"
      id="f-1699"
      unitRef="number">0.075</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <abvx:BorrowingsBasisInterestRate
      contextRef="c-680"
      decimals="3"
      id="f-1700"
      unitRef="number">0.025</abvx:BorrowingsBasisInterestRate>
    <abvx:BorrowingsBasisInterestRate
      contextRef="c-681"
      decimals="2"
      id="f-1701"
      unitRef="number">0.04</abvx:BorrowingsBasisInterestRate>
    <abvx:BorrowingsNumberOfTranches
      contextRef="c-682"
      decimals="INF"
      id="f-1702"
      unitRef="tranche">2</abvx:BorrowingsNumberOfTranches>
    <abvx:BorrowingsEarlyRepaymentDiscountRate
      contextRef="c-682"
      decimals="2"
      id="f-1703"
      unitRef="number">0.04</abvx:BorrowingsEarlyRepaymentDiscountRate>
    <abvx:BorrowingsExitFeePercentage
      contextRef="c-682"
      decimals="3"
      id="f-1704"
      unitRef="number">0.060</abvx:BorrowingsExitFeePercentage>
    <abvx:OtherShareWarrantsSubscriptionPricePerShare
      contextRef="c-683"
      decimals="2"
      id="f-1705"
      unitRef="eurPerShare">1.00</abvx:OtherShareWarrantsSubscriptionPricePerShare>
    <abvx:NumberOfWarrantsGranted
      contextRef="c-684"
      decimals="INF"
      id="f-1706"
      unitRef="shares">214198</abvx:NumberOfWarrantsGranted>
    <abvx:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="c-683"
      decimals="4"
      id="f-1707"
      unitRef="eurPerShare">18.6744</abvx:ExercisePriceOtherEquityInstrumentsGranted>
    <abvx:ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted
      contextRef="c-683"
      decimals="2"
      id="f-1708"
      unitRef="number">0.10</abvx:ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted>
    <abvx:NumberOfWarrantsGranted
      contextRef="c-94"
      decimals="INF"
      id="f-1709"
      unitRef="shares">405832</abvx:NumberOfWarrantsGranted>
    <abvx:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="c-685"
      decimals="2"
      id="f-1710"
      unitRef="eurPerShare">9.86</abvx:ExercisePriceOtherEquityInstrumentsGranted>
    <abvx:ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted
      contextRef="c-685"
      decimals="2"
      id="f-1711"
      unitRef="number">1.10</abvx:ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted>
    <abvx:IssuanceOfOtherShareWarrants contextRef="c-94" decimals="-6" id="f-1712" unitRef="eur">4000000</abvx:IssuanceOfOtherShareWarrants>
    <abvx:NumberOfWarrantsGranted
      contextRef="c-94"
      decimals="INF"
      id="f-1713"
      unitRef="shares">405832</abvx:NumberOfWarrantsGranted>
    <abvx:NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately contextRef="c-94" decimals="2" id="f-1714" unitRef="number">0.50</abvx:NumberOfInstrumentsGrantedOtherEquityInstrumentsPercentageExercisableImmediately>
    <abvx:NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable contextRef="c-94" decimals="2" id="f-1715" unitRef="number">0.50</abvx:NumberOfInstrumentsGrantedOtherEquityInstrumentsRemainingPercentageExercisable>
    <abvx:OtherShareWarrantsExercisePeriod contextRef="c-686" id="f-1716">P7Y</abvx:OtherShareWarrantsExercisePeriod>
    <abvx:RepaymentsOfBondLoans contextRef="c-687" decimals="-3" id="f-1717" unitRef="eur">7661000</abvx:RepaymentsOfBondLoans>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-688" decimals="-3" id="f-1718" unitRef="eur">23995000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-689"
      decimals="3"
      id="f-1719"
      unitRef="number">0.126</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:ConvertibleLoansNotes contextRef="c-688" decimals="-3" id="f-1720" unitRef="eur">25000000</abvx:ConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotesCarryingAmountOfTheEquityComponent contextRef="c-688" decimals="-3" id="f-1721" unitRef="eur">1005000</abvx:ConvertibleLoansNotesCarryingAmountOfTheEquityComponent>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-690"
      decimals="4"
      id="f-1722"
      unitRef="number">0.0100</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-691" decimals="-3" id="f-1723" unitRef="eur">-624000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-692"
      decimals="2"
      id="f-1724"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-693"
      decimals="2"
      id="f-1725"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-694"
      decimals="2"
      id="f-1726"
      unitRef="number">1.40</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-695"
      decimals="2"
      id="f-1727"
      unitRef="number">1.40</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-696"
      decimals="2"
      id="f-1728"
      unitRef="number">0.13</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-697"
      decimals="2"
      id="f-1729"
      unitRef="number">0.08</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-698" decimals="-3" id="f-1730" unitRef="eur">1959000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-699" decimals="-3" id="f-1731" unitRef="eur">68000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-700" decimals="-3" id="f-1732" unitRef="eur">2635000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-701" decimals="-3" id="f-1733" unitRef="eur">136000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-702" decimals="-3" id="f-1734" unitRef="eur">1066000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-703" decimals="-3" id="f-1735" unitRef="eur">104000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-704" decimals="-3" id="f-1736" unitRef="eur">1410000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-705" decimals="-3" id="f-1737" unitRef="eur">241000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-706" decimals="-3" id="f-1738" unitRef="eur">1615000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-707" decimals="-3" id="f-1739" unitRef="eur">68000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-708" decimals="-3" id="f-1740" unitRef="eur">2499000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-709" decimals="-3" id="f-1741" unitRef="eur">136000</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-710" decimals="-3" id="f-1742" unitRef="eur">1683000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-711" decimals="-3" id="f-1743" unitRef="eur">2636000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-712"
      decimals="2"
      id="f-1744"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-713"
      decimals="2"
      id="f-1745"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-714"
      decimals="2"
      id="f-1746"
      unitRef="number">1.30</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-715"
      decimals="2"
      id="f-1747"
      unitRef="number">1.30</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-716"
      decimals="2"
      id="f-1748"
      unitRef="number">0.15</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-717"
      decimals="2"
      id="f-1749"
      unitRef="number">0.08</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-718" decimals="-3" id="f-1750" unitRef="eur">741000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-719" decimals="-3" id="f-1751" unitRef="eur">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-720" decimals="-3" id="f-1752" unitRef="eur">1160000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-721" decimals="-3" id="f-1753" unitRef="eur">43000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-722" decimals="-3" id="f-1754" unitRef="eur">2948000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-723" decimals="-3" id="f-1755" unitRef="eur">684000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-724" decimals="-3" id="f-1756" unitRef="eur">3250000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-725" decimals="-3" id="f-1757" unitRef="eur">903000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-726" decimals="-3" id="f-1758" unitRef="eur">475000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-727" decimals="-3" id="f-1759" unitRef="eur">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-728" decimals="-3" id="f-1760" unitRef="eur">941000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-729" decimals="-3" id="f-1761" unitRef="eur">43000</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-730" decimals="-3" id="f-1762" unitRef="eur">475000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-731" decimals="-3" id="f-1763" unitRef="eur">984000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-732"
      decimals="2"
      id="f-1764"
      unitRef="eurPerShare">13.40</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-733"
      decimals="3"
      id="f-1765"
      unitRef="number">0.603</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-734"
      decimals="3"
      id="f-1766"
      unitRef="number">0.619</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-735"
      decimals="3"
      id="f-1767"
      unitRef="number">0.026</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-736"
      decimals="3"
      id="f-1768"
      unitRef="number">0.028</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-737"
      decimals="2"
      id="f-1769"
      unitRef="eurPerShare">12.94</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-738"
      decimals="3"
      id="f-1770"
      unitRef="number">0.601</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-739"
      decimals="3"
      id="f-1771"
      unitRef="number">0.599</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-740"
      decimals="3"
      id="f-1772"
      unitRef="number">0.030</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-741"
      decimals="3"
      id="f-1773"
      unitRef="number">0.031</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-742"
      decimals="2"
      id="f-1774"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-743"
      decimals="INF"
      id="f-1775"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-744"
      decimals="2"
      id="f-1776"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-745"
      decimals="2"
      id="f-1777"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-746"
      decimals="2"
      id="f-1778"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-747" decimals="-3" id="f-1779" unitRef="eur">4000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-748" decimals="-3" id="f-1780" unitRef="eur">-30000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-749" decimals="-3" id="f-1781" unitRef="eur">-3000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-750" decimals="-3" id="f-1782" unitRef="eur">35000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-751" decimals="-3" id="f-1783" unitRef="eur">-53000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-752"
      decimals="2"
      id="f-1784"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-753"
      decimals="INF"
      id="f-1785"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-754"
      decimals="2"
      id="f-1786"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-755"
      decimals="2"
      id="f-1787"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-756"
      decimals="2"
      id="f-1788"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-757" decimals="-3" id="f-1789" unitRef="eur">4000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-758" decimals="-3" id="f-1790" unitRef="eur">-16000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-759" decimals="-3" id="f-1791" unitRef="eur">8000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-760" decimals="-3" id="f-1792" unitRef="eur">46000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-761" decimals="-3" id="f-1793" unitRef="eur">-13000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-762"
      decimals="2"
      id="f-1794"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-763"
      decimals="INF"
      id="f-1795"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-764"
      decimals="2"
      id="f-1796"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-765"
      decimals="2"
      id="f-1797"
      unitRef="number">0.10</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-766"
      decimals="2"
      id="f-1798"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-767" decimals="-3" id="f-1799" unitRef="eur">-1000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-768" decimals="-3" id="f-1800" unitRef="eur">-3000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-769" decimals="-3" id="f-1801" unitRef="eur">-3000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-770" decimals="-3" id="f-1802" unitRef="eur">3000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-771" decimals="-3" id="f-1803" unitRef="eur">-82000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <abvx:NumberOfProbabilityWeightedScenarios
      contextRef="c-772"
      decimals="INF"
      id="f-1804"
      unitRef="scenario">2</abvx:NumberOfProbabilityWeightedScenarios>
    <abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted contextRef="c-772" id="f-1805">P7Y</abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-773"
      decimals="INF"
      id="f-1806"
      unitRef="shares">214198</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-774"
      decimals="INF"
      id="f-1807"
      unitRef="shares">214198</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-775"
      decimals="INF"
      id="f-1808"
      unitRef="shares">214198</abvx:NumberOfWarrantsOutstanding>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-776"
      decimals="2"
      id="f-1809"
      unitRef="eurPerShare">18.67</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-777"
      decimals="2"
      id="f-1810"
      unitRef="eurPerShare">18.67</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-778"
      decimals="2"
      id="f-1811"
      unitRef="eurPerShare">18.67</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-779"
      decimals="2"
      id="f-1812"
      unitRef="eurPerShare">17.10</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-780"
      decimals="2"
      id="f-1813"
      unitRef="eurPerShare">9.82</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-781"
      decimals="2"
      id="f-1814"
      unitRef="eurPerShare">6.76</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-782"
      decimals="2"
      id="f-1815"
      unitRef="number">0.50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-783"
      decimals="2"
      id="f-1816"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-784"
      decimals="2"
      id="f-1817"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-785"
      decimals="3"
      id="f-1818"
      unitRef="number">0.719</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-786"
      decimals="3"
      id="f-1819"
      unitRef="number">0.652</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-787"
      decimals="3"
      id="f-1820"
      unitRef="number">0.595</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-788"
      decimals="3"
      id="f-1821"
      unitRef="number">0.649</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-789"
      decimals="3"
      id="f-1822"
      unitRef="number">0.443</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-790"
      decimals="3"
      id="f-1823"
      unitRef="number">0.443</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-791"
      decimals="2"
      id="f-1824"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-792"
      decimals="2"
      id="f-1825"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-793"
      decimals="2"
      id="f-1826"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-794"
      decimals="4"
      id="f-1827"
      unitRef="number">0.0300</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-795"
      decimals="4"
      id="f-1828"
      unitRef="number">0.0230</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-796"
      decimals="3"
      id="f-1829"
      unitRef="number">0.029</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-797"
      decimals="3"
      id="f-1830"
      unitRef="number">0.029</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-773" decimals="-3" id="f-1831" unitRef="eur">2092000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-774" decimals="-3" id="f-1832" unitRef="eur">920000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-775" decimals="-3" id="f-1833" unitRef="eur">243000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-798"
      decimals="INF"
      id="f-1834"
      unitRef="shares">405832</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-799"
      decimals="INF"
      id="f-1835"
      unitRef="shares">405832</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-800"
      decimals="INF"
      id="f-1836"
      unitRef="shares">405832</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition
      contextRef="c-798"
      decimals="INF"
      id="f-1837"
      unitRef="shares">202915</abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition>
    <abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition
      contextRef="c-799"
      decimals="INF"
      id="f-1838"
      unitRef="shares">202916</abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition>
    <abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition
      contextRef="c-800"
      decimals="INF"
      id="f-1839"
      unitRef="shares">0</abvx:NumberOfWarrantsOutstandingSubjectToNonMarketPerformanceCondition>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-801"
      decimals="2"
      id="f-1840"
      unitRef="eurPerShare">9.86</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-802"
      decimals="2"
      id="f-1841"
      unitRef="eurPerShare">9.86</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-803"
      decimals="2"
      id="f-1842"
      unitRef="eurPerShare">9.86</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-804"
      decimals="2"
      id="f-1843"
      unitRef="eurPerShare">8.89</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-805"
      decimals="2"
      id="f-1844"
      unitRef="eurPerShare">9.82</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-806"
      decimals="2"
      id="f-1845"
      unitRef="eurPerShare">6.67</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-807"
      decimals="2"
      id="f-1846"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-808"
      decimals="2"
      id="f-1847"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-809"
      decimals="2"
      id="f-1848"
      unitRef="number">0.95</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-810"
      decimals="2"
      id="f-1849"
      unitRef="number">0.30</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-811"
      decimals="2"
      id="f-1850"
      unitRef="number">0.30</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-812"
      decimals="3"
      id="f-1851"
      unitRef="number">0.673</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-813"
      decimals="3"
      id="f-1852"
      unitRef="number">0.643</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-814"
      decimals="3"
      id="f-1853"
      unitRef="number">0.674</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-815"
      decimals="3"
      id="f-1854"
      unitRef="number">0.649</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-816"
      decimals="3"
      id="f-1855"
      unitRef="number">0.443</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-817"
      decimals="3"
      id="f-1856"
      unitRef="number">0.443</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-818"
      decimals="2"
      id="f-1857"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-819"
      decimals="2"
      id="f-1858"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-820"
      decimals="2"
      id="f-1859"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-821"
      decimals="4"
      id="f-1860"
      unitRef="number">0.0300</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-822"
      decimals="4"
      id="f-1861"
      unitRef="number">0.0230</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-823"
      decimals="3"
      id="f-1862"
      unitRef="number">0.029</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-824"
      decimals="3"
      id="f-1863"
      unitRef="number">0.029</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-798" decimals="-3" id="f-1864" unitRef="eur">1493000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-799" decimals="-3" id="f-1865" unitRef="eur">1659000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-800" decimals="-3" id="f-1866" unitRef="eur">923000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-825"
      decimals="2"
      id="f-1867"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-826"
      decimals="INF"
      id="f-1868"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-827"
      decimals="2"
      id="f-1869"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-828"
      decimals="2"
      id="f-1870"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted contextRef="c-829" id="f-1871">P7Y</abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-830" decimals="-3" id="f-1872" unitRef="eur">48000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-831" decimals="-3" id="f-1873" unitRef="eur">197000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-832" decimals="-3" id="f-1874" unitRef="eur">64000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-833" decimals="-3" id="f-1875" unitRef="eur">64000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-834"
      decimals="2"
      id="f-1876"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-835"
      decimals="INF"
      id="f-1877"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-836"
      decimals="2"
      id="f-1878"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-837"
      decimals="2"
      id="f-1879"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted contextRef="c-838" id="f-1880">P7Y</abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-839" decimals="-3" id="f-1881" unitRef="eur">28000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-840" decimals="-3" id="f-1882" unitRef="eur">232000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-841" decimals="-3" id="f-1883" unitRef="eur">42000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-842" decimals="-3" id="f-1884" unitRef="eur">36000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-843"
      decimals="2"
      id="f-1885"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-844"
      decimals="INF"
      id="f-1886"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-845"
      decimals="2"
      id="f-1887"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-846"
      decimals="2"
      id="f-1888"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted contextRef="c-847" id="f-1889">P7Y</abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-848" decimals="-3" id="f-1890" unitRef="eur">96000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-849" decimals="-3" id="f-1891" unitRef="eur">401000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-850" decimals="-3" id="f-1892" unitRef="eur">95000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-851" decimals="-3" id="f-1893" unitRef="eur">76000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-762"
      decimals="2"
      id="f-1894"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-763"
      decimals="INF"
      id="f-1895"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-764"
      decimals="2"
      id="f-1896"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-852"
      decimals="2"
      id="f-1897"
      unitRef="number">0.10</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted contextRef="c-853" id="f-1898">P7Y</abvx:ExpiryScenarioPeriodOtherEquityInstrumentsGranted>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-854" decimals="-3" id="f-1899" unitRef="eur">37000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-855" decimals="-3" id="f-1900" unitRef="eur">350000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-856" decimals="-3" id="f-1901" unitRef="eur">61000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-857" decimals="-3" id="f-1902" unitRef="eur">75000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-86" decimals="-3" id="f-1903" unitRef="eur">75000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <abvx:BorrowingsNumberOfTranches
      contextRef="c-86"
      decimals="INF"
      id="f-1904"
      unitRef="tranche">2</abvx:BorrowingsNumberOfTranches>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-858" decimals="-3" id="f-1905" unitRef="eur">35000000</abvx:NetProceedsFromConvertibleLoansNotes>
    <abvx:NumberOfConvertibleNotesIssued
      contextRef="c-859"
      decimals="INF"
      id="f-1906"
      unitRef="shares">350</abvx:NumberOfConvertibleNotesIssued>
    <abvx:ConvertibleLoansNotesNominalValue contextRef="c-859" decimals="INF" id="f-1907" unitRef="eur">100000</abvx:ConvertibleLoansNotesNominalValue>
    <abvx:BorrowingsFixedConversionPrice
      contextRef="c-859"
      decimals="4"
      id="f-1908"
      unitRef="eurPerShare">23.7674</abvx:BorrowingsFixedConversionPrice>
    <abvx:ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted
      contextRef="c-859"
      decimals="2"
      id="f-1909"
      unitRef="number">0.40</abvx:ExercisePricePercentageOfPremiumOver15DayVWAPOtherEquityInstrumentsGranted>
    <ifrs-full:NotionalAmount contextRef="c-860" decimals="-3" id="f-1910" unitRef="eur">40000000</ifrs-full:NotionalAmount>
    <abvx:NumberOfConvertibleNotesIssued
      contextRef="c-860"
      decimals="INF"
      id="f-1911"
      unitRef="shares">400</abvx:NumberOfConvertibleNotesIssued>
    <abvx:ConvertibleLoansNotesNominalValue contextRef="c-860" decimals="INF" id="f-1912" unitRef="eur">100000</abvx:ConvertibleLoansNotesNominalValue>
    <abvx:ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted
      contextRef="c-860"
      decimals="2"
      id="f-1913"
      unitRef="number">1.30</abvx:ExercisePricePercentageOf15DayWVAPOtherEquityInstrumentsGranted>
    <abvx:ConvertibleLoansNotesPeriod contextRef="c-861" id="f-1914">P3M</abvx:ConvertibleLoansNotesPeriod>
    <abvx:ConvertibleLoansNotesNumberOfSeparateClosings
      contextRef="c-861"
      decimals="INF"
      id="f-1915"
      unitRef="closing">2</abvx:ConvertibleLoansNotesNumberOfSeparateClosings>
    <ifrs-full:BorrowingsInterestRate contextRef="c-86" decimals="4" id="f-1916" unitRef="number">0.0600</ifrs-full:BorrowingsInterestRate>
    <abvx:BorrowingsNumberOfQuarterlyInstallments
      contextRef="c-86"
      decimals="INF"
      id="f-1917"
      unitRef="installment">16</abvx:BorrowingsNumberOfQuarterlyInstallments>
    <abvx:BorrowingsMaturityDeferralPeriod contextRef="c-862" id="f-1918">P3M</abvx:BorrowingsMaturityDeferralPeriod>
    <abvx:BorrowingsPercentageOfMarketPrice
      contextRef="c-86"
      decimals="INF"
      id="f-1919"
      unitRef="number">0.90</abvx:BorrowingsPercentageOfMarketPrice>
    <abvx:BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP contextRef="c-862" id="f-1920">P2D</abvx:BorrowingsMarketPriceNumberOfDaysWithLowestDailyVWAP>
    <abvx:BorrowingsMarketPriceNumberOfTradingDays contextRef="c-862" id="f-1921">P5D</abvx:BorrowingsMarketPriceNumberOfTradingDays>
    <abvx:IssuancePricePercentageOfDiscountTo15DayWVAP
      contextRef="c-863"
      decimals="2"
      id="f-1922"
      unitRef="number">0.15</abvx:IssuancePricePercentageOfDiscountTo15DayWVAP>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-86"
      decimals="4"
      id="f-1923"
      unitRef="eurPerShare">14.4303</abvx:EquityIssuanceSubscriptionPricePerShare>
    <abvx:ConvertibleLoansNotesNominalValue contextRef="c-86" decimals="INF" id="f-1924" unitRef="eur">100000</abvx:ConvertibleLoansNotesNominalValue>
    <abvx:ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue
      contextRef="c-864"
      decimals="2"
      id="f-1925"
      unitRef="number">0.90</abvx:ConvertibleLoansNotesSettlementInSharesPercentageOfFairMarketValue>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-864"
      decimals="4"
      id="f-1926"
      unitRef="eurPerShare">14.4303</abvx:EquityIssuanceSubscriptionPricePerShare>
    <abvx:EquityIssuanceCashCarveOut contextRef="c-864" decimals="-3" id="f-1927" unitRef="eur">13125000</abvx:EquityIssuanceCashCarveOut>
    <abvx:ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal
      contextRef="c-865"
      decimals="2"
      id="f-1928"
      unitRef="number">1.20</abvx:ConvertibleLoansNotesEarlyRedemptionAmountPercentageOfOutstandongPrincipal>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-92" decimals="-3" id="f-1929" unitRef="eur">25102000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:GainsArisingFromRecognitionOfFinancialLiabilities contextRef="c-862" decimals="-3" id="f-1930" unitRef="eur">2359000</abvx:GainsArisingFromRecognitionOfFinancialLiabilities>
    <abvx:UnrecognitionDayOneGainOfFinancialLiabilities contextRef="c-866" decimals="-3" id="f-1931" unitRef="eur">2147000</abvx:UnrecognitionDayOneGainOfFinancialLiabilities>
    <abvx:UnrecognitionDayOneGainOfFinancialLiabilities contextRef="c-867" decimals="-3" id="f-1932" unitRef="eur">1557000</abvx:UnrecognitionDayOneGainOfFinancialLiabilities>
    <abvx:DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock contextRef="c-1" id="f-1933">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main data and assumptions are the following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 415.2pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 519pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 143.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 128.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 119.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes - August 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 0pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 19.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF AUGUST 24, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 0pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.62pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 17.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Number of outstanding notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 17.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 113.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;350&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 17.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;350&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 17.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;350&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 34.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Original principal amount (in thousands of &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 34.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 34.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 34.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 55.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 55.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 116.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 116.84pt; position: var(--position);"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 55.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 55.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 107.84pt; position: var(--position);"&gt;6&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 72.75pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conversion price per share&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 72.75pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.77&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 72.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.77&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 72.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;23.77&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 90pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;16.74&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 90pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;9.82&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 90pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 98.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.76&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 27pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 107.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.43pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Maturity date&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 107.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.63pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2025 (put event) 24/08/2027 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 15.23pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(HTM/voluntary conversion)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 27pt; left: 277.5pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2025 (put event)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2027 (HTM/voluntary &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 27pt; left: 399.75pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 0.84pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2025 (put event)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.44pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24/08/2027 (HTM/voluntary &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 20.04pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 0.76pt; width: 143.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Held to maturity / voluntary conversion &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 10.36pt; width: 143.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scenario probability&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 134.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 134.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 134.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;75&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 151.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Initial price limit&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 151.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 151.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 151.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;14.43&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 168.75pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Early redemption amount (put event)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 168.75pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 108.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 108.84pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 168.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 168.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.84pt; position: var(--position);"&gt;120&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 186pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 186pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 186pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 203.25pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Credit spread&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 203.25pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 112.84pt; position: var(--position);"&gt;20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 203.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;20&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 203.25pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 103.84pt; position: var(--position);"&gt;25&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 220.5pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk-free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 220.5pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 110.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 110.84pt; position: var(--position);"&gt;2.9&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 120.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 220.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;2.3&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 220.5pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.56pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 101.84pt; position: var(--position);"&gt;2.9&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 111.84pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 237.75pt; width: 143.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of Heights convertible notes &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 143.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 146.25pt; position: var(--position); top: 237.75pt; width: 128.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 128.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 96.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 98.83999999999999pt; position: var(--position);"&gt;32,641&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 277.5pt; position: var(--position); top: 237.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 87.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 89.83999999999999pt; position: var(--position);"&gt;27,456&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 399.75pt; position: var(--position); top: 237.75pt; width: 119.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 119.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 87.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 89.83999999999999pt; position: var(--position);"&gt;20,017&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At inception, the net cash proceeds reflect the OCEANE initial fair value. The fair value of the bifurcated option at inception has been &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 380.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;measured with a Monte Carlo model using a Longstaff Schwartz algorithm, with a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;53%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price volatility, a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.71pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,400&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp credit spread &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumption and a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;31.50&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; share price. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 413.06pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 389.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF AUGUST 24, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 34.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 21pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;3.05&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 21pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;3.22&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Credit spread&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,475&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 33pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,398&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 64.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 45pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;16.74&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Expected term&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;July 21, 2026&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 57pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 36.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; July 21, 2026 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 69pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;44.01&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 69pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.34pt; position: var(--position);"&gt;37&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.34pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 81pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 81pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 81pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 93pt; width: 213.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 213.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of issued OCEANE (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 93pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.34pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 304.5pt; position: var(--position); top: 93pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.34pt; position: var(--position);"&gt;1,762&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfIndirectMeasurementOfConvertibleLoansInstrumentsTableTextBlock>
    <abvx:NumberOfConvertibleNotesOutstanding
      contextRef="c-868"
      decimals="INF"
      id="f-1934"
      unitRef="shares">350</abvx:NumberOfConvertibleNotesOutstanding>
    <abvx:NumberOfConvertibleNotesOutstanding
      contextRef="c-869"
      decimals="INF"
      id="f-1935"
      unitRef="shares">350</abvx:NumberOfConvertibleNotesOutstanding>
    <abvx:NumberOfConvertibleNotesOutstanding
      contextRef="c-870"
      decimals="INF"
      id="f-1936"
      unitRef="shares">350</abvx:NumberOfConvertibleNotesOutstanding>
    <ifrs-full:NotionalAmount contextRef="c-868" decimals="-3" id="f-1937" unitRef="eur">35000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount contextRef="c-869" decimals="-3" id="f-1938" unitRef="eur">35000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount contextRef="c-870" decimals="-3" id="f-1939" unitRef="eur">35000000</ifrs-full:NotionalAmount>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-871"
      decimals="2"
      id="f-1940"
      unitRef="number">0.06</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-872"
      decimals="2"
      id="f-1941"
      unitRef="number">0.06</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-873"
      decimals="2"
      id="f-1942"
      unitRef="number">0.06</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-874"
      decimals="2"
      id="f-1943"
      unitRef="eurPerShare">23.77</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-875"
      decimals="2"
      id="f-1944"
      unitRef="eurPerShare">23.77</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-876"
      decimals="2"
      id="f-1945"
      unitRef="eurPerShare">23.77</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-877"
      decimals="2"
      id="f-1946"
      unitRef="eurPerShare">16.74</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-878"
      decimals="2"
      id="f-1947"
      unitRef="eurPerShare">9.82</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-879"
      decimals="2"
      id="f-1948"
      unitRef="eurPerShare">6.76</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-880"
      decimals="2"
      id="f-1949"
      unitRef="number">0.75</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-881"
      decimals="2"
      id="f-1950"
      unitRef="number">0.75</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-882"
      decimals="2"
      id="f-1951"
      unitRef="number">0.75</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-883"
      decimals="2"
      id="f-1952"
      unitRef="eurPerShare">14.43</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-884"
      decimals="2"
      id="f-1953"
      unitRef="eurPerShare">14.43</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-885"
      decimals="2"
      id="f-1954"
      unitRef="eurPerShare">14.43</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-886"
      decimals="2"
      id="f-1955"
      unitRef="number">1.20</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-887"
      decimals="2"
      id="f-1956"
      unitRef="number">1.20</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-888"
      decimals="2"
      id="f-1957"
      unitRef="number">1.20</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-889"
      decimals="2"
      id="f-1958"
      unitRef="number">0.50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-890"
      decimals="2"
      id="f-1959"
      unitRef="number">0.50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-891"
      decimals="2"
      id="f-1960"
      unitRef="number">0.50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-892"
      decimals="2"
      id="f-1961"
      unitRef="number">0.20</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-893"
      decimals="2"
      id="f-1962"
      unitRef="number">0.20</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-894"
      decimals="2"
      id="f-1963"
      unitRef="number">0.25</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-895"
      decimals="3"
      id="f-1964"
      unitRef="number">0.029</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-896"
      decimals="3"
      id="f-1965"
      unitRef="number">0.023</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-897"
      decimals="3"
      id="f-1966"
      unitRef="number">0.029</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueConvertibleNotes contextRef="c-868" decimals="-3" id="f-1967" unitRef="eur">32641000</abvx:AggregateFairValueConvertibleNotes>
    <abvx:AggregateFairValueConvertibleNotes contextRef="c-869" decimals="-3" id="f-1968" unitRef="eur">27456000</abvx:AggregateFairValueConvertibleNotes>
    <abvx:AggregateFairValueConvertibleNotes contextRef="c-870" decimals="-3" id="f-1969" unitRef="eur">20017000</abvx:AggregateFairValueConvertibleNotes>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-898"
      decimals="2"
      id="f-1970"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-899"
      decimals="INF"
      id="f-1971"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-900"
      decimals="2"
      id="f-1972"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-901"
      decimals="2"
      id="f-1973"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-902" decimals="-3" id="f-1974" unitRef="eur">239000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-903" decimals="-3" id="f-1975" unitRef="eur">1069000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-904" decimals="-3" id="f-1976" unitRef="eur">-239000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-905" decimals="-3" id="f-1977" unitRef="eur">-80000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-843"
      decimals="2"
      id="f-1978"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-844"
      decimals="INF"
      id="f-1979"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-845"
      decimals="2"
      id="f-1980"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-906"
      decimals="2"
      id="f-1981"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-907" decimals="-3" id="f-1982" unitRef="eur">18000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-908" decimals="-3" id="f-1983" unitRef="eur">352000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-909" decimals="-3" id="f-1984" unitRef="eur">-366000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-910" decimals="-3" id="f-1985" unitRef="eur">-364000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-762"
      decimals="2"
      id="f-1986"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-763"
      decimals="INF"
      id="f-1987"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-764"
      decimals="2"
      id="f-1988"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-911"
      decimals="2"
      id="f-1989"
      unitRef="number">0.10</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-912" decimals="-3" id="f-1990" unitRef="eur">2000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-913" decimals="-3" id="f-1991" unitRef="eur">39000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-914" decimals="-3" id="f-1992" unitRef="eur">-219000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-915" decimals="-3" id="f-1993" unitRef="eur">-631000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-917" decimals="-3" id="f-1996" unitRef="eur">20000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-918" decimals="-3" id="f-1997" unitRef="eur">16000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <abvx:BorrowingsMaximumBorrowingCapacity contextRef="c-919" decimals="-3" id="f-1998" unitRef="eur">4000000</abvx:BorrowingsMaximumBorrowingCapacity>
    <abvx:BorrowingsNumberOfTranches
      contextRef="c-917"
      decimals="INF"
      id="f-1999"
      unitRef="tranche">2</abvx:BorrowingsNumberOfTranches>
    <abvx:BorrowingsMaximumBorrowingCapacityPerTranche contextRef="c-917" decimals="-3" id="f-2000" unitRef="eur">10000000</abvx:BorrowingsMaximumBorrowingCapacityPerTranche>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-920" decimals="-3" id="f-2001" unitRef="eur">2000000</abvx:NetProceedsFromConvertibleLoansNotes>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-921" decimals="-3" id="f-2002" unitRef="eur">2000000</abvx:NetProceedsFromConvertibleLoansNotes>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants
      contextRef="c-922"
      decimals="0"
      id="f-2003"
      unitRef="shares">464309</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-923"
      decimals="2"
      id="f-2004"
      unitRef="number">0.08</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <abvx:BorrowingsBasisInterestRate
      contextRef="c-924"
      decimals="2"
      id="f-2005"
      unitRef="number">0.08</abvx:BorrowingsBasisInterestRate>
    <abvx:BorrowingsBasisInterestRate
      contextRef="c-925"
      decimals="2"
      id="f-2006"
      unitRef="number">0.09</abvx:BorrowingsBasisInterestRate>
    <abvx:BorrowingsNumberOfMonthlyInstallments
      contextRef="c-926"
      decimals="INF"
      id="f-2007"
      unitRef="installment">54</abvx:BorrowingsNumberOfMonthlyInstallments>
    <abvx:BorrowingsMaturityDeferralPeriod contextRef="c-927" id="f-2008">P12M</abvx:BorrowingsMaturityDeferralPeriod>
    <abvx:BorrowingsMaturityDeferralPeriod contextRef="c-928" id="f-2009">P6M</abvx:BorrowingsMaturityDeferralPeriod>
    <abvx:BorrowingsExitFeePercentage
      contextRef="c-919"
      decimals="2"
      id="f-2010"
      unitRef="number">0.09</abvx:BorrowingsExitFeePercentage>
    <abvx:BorrowingsExitFeeAmount contextRef="c-919" decimals="-3" id="f-2011" unitRef="eur">900000</abvx:BorrowingsExitFeeAmount>
    <abvx:BorrowingsNoticePeriod contextRef="c-929" id="f-2012">P30D</abvx:BorrowingsNoticePeriod>
    <abvx:BorrowingsExitFeePercentage
      contextRef="c-917"
      decimals="2"
      id="f-2013"
      unitRef="number">0.09</abvx:BorrowingsExitFeePercentage>
    <abvx:BorrowingsAnnualDiscountRate
      contextRef="c-917"
      decimals="2"
      id="f-2014"
      unitRef="number">0.04</abvx:BorrowingsAnnualDiscountRate>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-930"
      decimals="INF"
      id="f-2015"
      unitRef="shares">110957</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-931"
      decimals="INF"
      id="f-2016"
      unitRef="shares">74766</abvx:NumberOfWarrantsOutstanding>
    <abvx:OtherShareWarrantsSubscriptionPricePerShare
      contextRef="c-932"
      decimals="INF"
      id="f-2017"
      unitRef="eurPerShare">1</abvx:OtherShareWarrantsSubscriptionPricePerShare>
    <abvx:NumberOfSharesSubscribedPerWarrant
      contextRef="c-933"
      decimals="INF"
      id="f-2018"
      unitRef="shares">1</abvx:NumberOfSharesSubscribedPerWarrant>
    <abvx:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="c-930"
      decimals="2"
      id="f-2019"
      unitRef="eurPerShare">7.21</abvx:ExercisePriceOtherEquityInstrumentsGranted>
    <abvx:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="c-931"
      decimals="2"
      id="f-2020"
      unitRef="eurPerShare">10.70</abvx:ExercisePriceOtherEquityInstrumentsGranted>
    <abvx:BorrowingsMaturityTerm contextRef="c-933" id="f-2021">P10Y</abvx:BorrowingsMaturityTerm>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-934" decimals="-3" id="f-2022" unitRef="eur">7661000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:NumberOfOtherShareWarrantsRepurchased contextRef="c-79" decimals="0" id="f-2023" unitRef="shares">43070</abvx:NumberOfOtherShareWarrantsRepurchased>
    <abvx:NumberOfOtherShareWarrantsRepurchased contextRef="c-80" decimals="0" id="f-2024" unitRef="shares">43070</abvx:NumberOfOtherShareWarrantsRepurchased>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-79" decimals="0" id="f-2025" unitRef="shares">67887</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants contextRef="c-80" decimals="0" id="f-2026" unitRef="shares">31696</abvx:IncreaseDecreaseInNumberOfSharesIssuedThroughExerciseOfShareWarrants>
    <abvx:NumberOfOtherShareWarrantsConverted contextRef="c-79" decimals="0" id="f-2027" unitRef="shares">67887</abvx:NumberOfOtherShareWarrantsConverted>
    <abvx:NumberOfOtherShareWarrantsConverted contextRef="c-80" decimals="0" id="f-2028" unitRef="shares">31696</abvx:NumberOfOtherShareWarrantsConverted>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-919" decimals="-3" id="f-2029" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid contextRef="c-935" decimals="-3" id="f-2030" unitRef="eur">-170000</ifrs-full:GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-936"
      decimals="INF"
      id="f-2031"
      unitRef="shares">110957</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-937"
      decimals="INF"
      id="f-2032"
      unitRef="shares">110957</abvx:NumberOfWarrantsOutstanding>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-938"
      decimals="2"
      id="f-2033"
      unitRef="eurPerShare">7.21</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-939"
      decimals="2"
      id="f-2034"
      unitRef="eurPerShare">7.21</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-940"
      decimals="2"
      id="f-2035"
      unitRef="eurPerShare">6.18</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-941"
      decimals="2"
      id="f-2036"
      unitRef="eurPerShare">18.57</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-942" decimals="INF" id="f-2037" unitRef="y">5.6</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-943" decimals="INF" id="f-2038" unitRef="y">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-944"
      decimals="4"
      id="f-2039"
      unitRef="number">0.4401</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-945"
      decimals="2"
      id="f-2040"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-946"
      decimals="4"
      id="f-2041"
      unitRef="number">0.0298</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-936" decimals="-3" id="f-2042" unitRef="eur">275000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-937" decimals="-3" id="f-2043" unitRef="eur">1261000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-947"
      decimals="INF"
      id="f-2044"
      unitRef="shares">74766</abvx:NumberOfWarrantsOutstanding>
    <abvx:NumberOfWarrantsOutstanding
      contextRef="c-948"
      decimals="INF"
      id="f-2045"
      unitRef="shares">74766</abvx:NumberOfWarrantsOutstanding>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-949"
      decimals="2"
      id="f-2046"
      unitRef="eurPerShare">10.70</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-950"
      decimals="2"
      id="f-2047"
      unitRef="eurPerShare">10.70</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-951"
      decimals="2"
      id="f-2048"
      unitRef="eurPerShare">6.18</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-952"
      decimals="2"
      id="f-2049"
      unitRef="eurPerShare">18.57</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-953" decimals="INF" id="f-2050" unitRef="y">6.4</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-954" decimals="INF" id="f-2051" unitRef="y">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-955"
      decimals="4"
      id="f-2052"
      unitRef="number">0.4401</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-956"
      decimals="2"
      id="f-2053"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-957"
      decimals="4"
      id="f-2054"
      unitRef="number">0.0296</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-947" decimals="-3" id="f-2055" unitRef="eur">149000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <abvx:AggregateFairValueOtherEquityInstrumentsOutstanding contextRef="c-948" decimals="-3" id="f-2056" unitRef="eur">589000</abvx:AggregateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-958"
      decimals="2"
      id="f-2057"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-959"
      decimals="INF"
      id="f-2058"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-960"
      decimals="2"
      id="f-2059"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-961" decimals="-3" id="f-2060" unitRef="eur">16000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-962" decimals="-3" id="f-2061" unitRef="eur">176000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-963" decimals="-3" id="f-2062" unitRef="eur">69000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-964"
      decimals="2"
      id="f-2063"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-965"
      decimals="INF"
      id="f-2064"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-966"
      decimals="2"
      id="f-2065"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-967" decimals="-3" id="f-2066" unitRef="eur">6000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-968" decimals="-3" id="f-2067" unitRef="eur">78000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-969" decimals="-3" id="f-2068" unitRef="eur">12000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-970" decimals="-3" id="f-2069" unitRef="eur">1850000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:NotionalAmount contextRef="c-971" decimals="-3" id="f-2070" unitRef="eur">15000000</ifrs-full:NotionalAmount>
    <abvx:BorrowingsNumberOfTranches
      contextRef="c-971"
      decimals="INF"
      id="f-2071"
      unitRef="tranche">2</abvx:BorrowingsNumberOfTranches>
    <ifrs-full:NotionalAmount contextRef="c-972" decimals="-3" id="f-2072" unitRef="eur">10000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount contextRef="c-973" decimals="-3" id="f-2073" unitRef="eur">5000000</ifrs-full:NotionalAmount>
    <abvx:BorrowingsAdditionalTrancheAmount contextRef="c-971" decimals="-3" id="f-2074" unitRef="eur">5000000</abvx:BorrowingsAdditionalTrancheAmount>
    <abvx:BorrowingsAdjustmentToInterestRateBasisForFirst12Installments
      contextRef="c-974"
      decimals="2"
      id="f-2075"
      unitRef="number">0.08</abvx:BorrowingsAdjustmentToInterestRateBasisForFirst12Installments>
    <abvx:BorrowingsInterestRateForFollowingInstallments
      contextRef="c-971"
      decimals="4"
      id="f-2076"
      unitRef="number">0.0975</abvx:BorrowingsInterestRateForFollowingInstallments>
    <abvx:BorrowingsNumberOfMonthlyInstallments
      contextRef="c-975"
      decimals="INF"
      id="f-2077"
      unitRef="installment">36</abvx:BorrowingsNumberOfMonthlyInstallments>
    <abvx:BorrowingsExitFeePercentage
      contextRef="c-971"
      decimals="2"
      id="f-2078"
      unitRef="number">0.04</abvx:BorrowingsExitFeePercentage>
    <abvx:BorrowingsExitFeeAmount contextRef="c-972" decimals="-3" id="f-2079" unitRef="eur">400000</abvx:BorrowingsExitFeeAmount>
    <abvx:BorrowingsExitFeeAmount contextRef="c-973" decimals="-3" id="f-2080" unitRef="eur">200000</abvx:BorrowingsExitFeeAmount>
    <abvx:BorrowingsNoticePeriod contextRef="c-976" id="f-2081">P30D</abvx:BorrowingsNoticePeriod>
    <abvx:BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments
      contextRef="c-971"
      decimals="2"
      id="f-2082"
      unitRef="number">0.02</abvx:BorrowingsExitFeePercentageIfPrepaymentBetween18thAnd30thInstallments>
    <abvx:BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment
      contextRef="c-971"
      decimals="2"
      id="f-2083"
      unitRef="number">0.04</abvx:BorrowingsExitFeePercentageIfPrepaymentAfter30thInstallment>
    <abvx:BorrowingsAnnualDiscountRate
      contextRef="c-971"
      decimals="2"
      id="f-2084"
      unitRef="number">0.04</abvx:BorrowingsAnnualDiscountRate>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-934" decimals="-3" id="f-2085" unitRef="eur">7661000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:ProceedsFromIssuingSharesAndConvertibleLoansNotes contextRef="c-977" decimals="-3" id="f-2086" unitRef="eur">85000000</abvx:ProceedsFromIssuingSharesAndConvertibleLoansNotes>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease
      contextRef="c-977"
      decimals="0"
      id="f-2087"
      unitRef="shares">1964031</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-978"
      decimals="2"
      id="f-2088"
      unitRef="eurPerShare">30.55</abvx:EquityIssuanceSubscriptionPricePerShare>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-977" decimals="-3" id="f-2089" unitRef="eur">60000000</ifrs-full:ProceedsFromIssuingShares>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-977" decimals="-3" id="f-2090" unitRef="eur">25000000</abvx:NetProceedsFromConvertibleLoansNotes>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-978"
      decimals="2"
      id="f-2091"
      unitRef="number">0.06</ifrs-full:BorrowingsInterestRate>
    <abvx:NumberOfSharesSubscribedPerWarrant
      contextRef="c-977"
      decimals="INF"
      id="f-2092"
      unitRef="shares">1</abvx:NumberOfSharesSubscribedPerWarrant>
    <abvx:ConversionPriceOtherLiabilities
      contextRef="c-978"
      decimals="2"
      id="f-2093"
      unitRef="eurPerShare">38.19</abvx:ConversionPriceOtherLiabilities>
    <abvx:ConversionPriceAdjustmentPeriod contextRef="c-979" id="f-2094">P18M</abvx:ConversionPriceAdjustmentPeriod>
    <abvx:ConversionPriceAdjustmentPeriod contextRef="c-980" id="f-2095">P24M</abvx:ConversionPriceAdjustmentPeriod>
    <abvx:ConversionPriceAdjustmentPeriod contextRef="c-981" id="f-2096">P36M</abvx:ConversionPriceAdjustmentPeriod>
    <abvx:ConversionPricePercentageOfInitialPriceThreshold
      contextRef="c-982"
      decimals="2"
      id="f-2098"
      unitRef="number">0.85</abvx:ConversionPricePercentageOfInitialPriceThreshold>
    <abvx:ConversionPriceOtherLiabilities
      contextRef="c-979"
      decimals="3"
      id="f-2099"
      unitRef="eurPerShare">32.462</abvx:ConversionPriceOtherLiabilities>
    <abvx:ConversionPricePercentageOfInitialPriceThreshold
      contextRef="c-983"
      decimals="2"
      id="f-2100"
      unitRef="number">0.70</abvx:ConversionPricePercentageOfInitialPriceThreshold>
    <abvx:ConversionPriceOtherLiabilities
      contextRef="c-980"
      decimals="3"
      id="f-2101"
      unitRef="eurPerShare">26.733</abvx:ConversionPriceOtherLiabilities>
    <abvx:ConversionPricePercentageOfInitialPriceThreshold
      contextRef="c-984"
      decimals="2"
      id="f-2102"
      unitRef="number">0.68</abvx:ConversionPricePercentageOfInitialPriceThreshold>
    <abvx:ConversionPriceOtherLiabilities
      contextRef="c-981"
      decimals="3"
      id="f-2103"
      unitRef="eurPerShare">25.969</abvx:ConversionPriceOtherLiabilities>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-92" decimals="-3" id="f-2104" unitRef="eur">25102000</abvx:RepaymentsOfConvertibleLoansNotes>
    <abvx:ConversionPriceAdjustmentPeriod contextRef="c-979" id="f-2105">P18M</abvx:ConversionPriceAdjustmentPeriod>
    <abvx:ConversionPriceAdjustmentPeriod contextRef="c-980" id="f-2106">P24M</abvx:ConversionPriceAdjustmentPeriod>
    <abvx:ConversionPriceAdjustmentPeriod contextRef="c-981" id="f-2107">P36M</abvx:ConversionPriceAdjustmentPeriod>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-985"
      decimals="2"
      id="f-2108"
      unitRef="number">0.53</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-986"
      decimals="4"
      id="f-2109"
      unitRef="number">0.1400</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-987"
      decimals="2"
      id="f-2110"
      unitRef="eurPerShare">31.50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-988"
      decimals="4"
      id="f-2111"
      unitRef="number">0.0305</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-989"
      decimals="4"
      id="f-2112"
      unitRef="number">0.0322</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-990"
      decimals="4"
      id="f-2113"
      unitRef="number">0.1475</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-991"
      decimals="4"
      id="f-2114"
      unitRef="number">0.1398</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-992"
      decimals="2"
      id="f-2115"
      unitRef="eurPerShare">6.18</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-993"
      decimals="2"
      id="f-2116"
      unitRef="eurPerShare">16.74</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-994"
      decimals="4"
      id="f-2117"
      unitRef="number">0.4401</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-995"
      decimals="2"
      id="f-2118"
      unitRef="number">0.37</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-996"
      decimals="2"
      id="f-2119"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-997"
      decimals="2"
      id="f-2120"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:AggregateFairValueConvertibleNotes contextRef="c-668" decimals="-3" id="f-2121" unitRef="eur">142000</abvx:AggregateFairValueConvertibleNotes>
    <abvx:AggregateFairValueConvertibleNotes contextRef="c-998" decimals="-3" id="f-2122" unitRef="eur">1762000</abvx:AggregateFairValueConvertibleNotes>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-977" decimals="-3" id="f-2123" unitRef="eur">25000000</abvx:NetProceedsFromConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotes contextRef="c-978" decimals="-3" id="f-2124" unitRef="eur">17839000</abvx:ConvertibleLoansNotes>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-978" decimals="-3" id="f-2125" unitRef="eur">7161000</ifrs-full:DerivativeFinancialLiabilities>
    <abvx:AggregateFairValueConvertibleNotes contextRef="c-668" decimals="-3" id="f-2126" unitRef="eur">142000</abvx:AggregateFairValueConvertibleNotes>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-990"
      decimals="4"
      id="f-2127"
      unitRef="number">0.1475</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-992"
      decimals="2"
      id="f-2128"
      unitRef="eurPerShare">6.18</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-994"
      decimals="2"
      id="f-2129"
      unitRef="number">0.44</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-964"
      decimals="2"
      id="f-2130"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-965"
      decimals="INF"
      id="f-2131"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-966"
      decimals="2"
      id="f-2132"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-999" decimals="-3" id="f-2133" unitRef="eur">17000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1000" decimals="-3" id="f-2134" unitRef="eur">97000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1001" decimals="-3" id="f-2135" unitRef="eur">15000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <abvx:AggregateFairValueConvertibleNotes contextRef="c-998" decimals="-3" id="f-2136" unitRef="eur">1762000</abvx:AggregateFairValueConvertibleNotes>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-991"
      decimals="4"
      id="f-2137"
      unitRef="number">0.1398</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-993"
      decimals="2"
      id="f-2138"
      unitRef="eurPerShare">16.74</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-995"
      decimals="2"
      id="f-2139"
      unitRef="number">0.37</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-898"
      decimals="2"
      id="f-2140"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-899"
      decimals="INF"
      id="f-2141"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-900"
      decimals="2"
      id="f-2142"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1002" decimals="-3" id="f-2143" unitRef="eur">80000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1003" decimals="-3" id="f-2144" unitRef="eur">364000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1004" decimals="-3" id="f-2145" unitRef="eur">121000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid contextRef="c-1005" decimals="-3" id="f-2146" unitRef="eur">-3069000</ifrs-full:GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid>
    <abvx:BorrowingsMaturityTerm contextRef="c-1006" id="f-2147">P12M</abvx:BorrowingsMaturityTerm>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-1007"
      decimals="4"
      id="f-2148"
      unitRef="number">0.0025</ifrs-full:BorrowingsInterestRate>
    <abvx:BorrowingsMaturityExtensionTerm contextRef="c-1006" id="f-2149">P5Y</abvx:BorrowingsMaturityExtensionTerm>
    <abvx:BorrowingsMaturityExtensionTerm contextRef="c-1008" id="f-2150">P5Y</abvx:BorrowingsMaturityExtensionTerm>
    <abvx:BorrowingsMaturityDeferralPeriod contextRef="c-1008" id="f-2151">P1Y</abvx:BorrowingsMaturityDeferralPeriod>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-1009"
      decimals="4"
      id="f-2152"
      unitRef="number">0.0058</ifrs-full:BorrowingsInterestRate>
    <abvx:BorrowingsStateGuaranteedPremium contextRef="c-1009" decimals="-3" id="f-2153" unitRef="eur">138000</abvx:BorrowingsStateGuaranteedPremium>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-1010" decimals="-3" id="f-2154" unitRef="eur">377000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="c-1" id="f-2155">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances as of December 31, 2022, 2023 and 2024 are as follows&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 347.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;:&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 352.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 382.77pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 383.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONDITIONAL ADVANCES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 12pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 12pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 12pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RNP VIR &#x2013; Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;4,171&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 42.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;4,232&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 42.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CARENA &#x2013; Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;2,454&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 54.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;2,485&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 54.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;EBOLA &#x2013; Bpifrance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;158&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 66.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;55&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 66.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total conditional advances&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;6,783&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 218.25pt; position: var(--position); top: 78.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 302.25pt; position: var(--position); top: 78.75pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBorrowingsExplanatory>
    <abvx:ConditionalAdvances contextRef="c-1011" decimals="-3" id="f-2156" unitRef="eur">4171000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1012" decimals="-3" id="f-2157" unitRef="eur">4232000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1013" decimals="-3" id="f-2158" unitRef="eur">0</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1014" decimals="-3" id="f-2159" unitRef="eur">2454000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1015" decimals="-3" id="f-2160" unitRef="eur">2485000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1016" decimals="-3" id="f-2161" unitRef="eur">0</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1017" decimals="-3" id="f-2162" unitRef="eur">158000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1018" decimals="-3" id="f-2163" unitRef="eur">55000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-1019" decimals="-3" id="f-2164" unitRef="eur">0</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-6" decimals="-3" id="f-2165" unitRef="eur">6783000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-7" decimals="-3" id="f-2166" unitRef="eur">6771000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvances contextRef="c-5" decimals="-3" id="f-2167" unitRef="eur">0</abvx:ConditionalAdvances>
    <abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity contextRef="c-1020" decimals="-5" id="f-2168" unitRef="eur">6300000</abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1021" decimals="-3" id="f-2169" unitRef="eur">4032000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1022" decimals="-3" id="f-2170" unitRef="eur">1756000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1023" decimals="-3" id="f-2171" unitRef="eur">346000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1024" decimals="-3" id="f-2172" unitRef="eur">1930000</abvx:ProceedsFromConditionalAdvances>
    <abvx:RepaymentOfExcessConditionalAdvancesClaimed contextRef="c-111" decimals="-3" id="f-2173" unitRef="eur">1241000</abvx:RepaymentOfExcessConditionalAdvancesClaimed>
    <abvx:PercentageOfConditionalAdvancesWaived
      contextRef="c-111"
      decimals="2"
      id="f-2174"
      unitRef="number">0.60</abvx:PercentageOfConditionalAdvancesWaived>
    <abvx:ConditionalAdvances contextRef="c-1025" decimals="-3" id="f-2175" unitRef="eur">2945000</abvx:ConditionalAdvances>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-111" decimals="-3" id="f-2176" unitRef="eur">1872000</ifrs-full:RevenueFromGovernmentGrants>
    <abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity contextRef="c-1026" decimals="-3" id="f-2177" unitRef="eur">3840000</abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1027" decimals="-3" id="f-2178" unitRef="eur">2187000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1028" decimals="-3" id="f-2179" unitRef="eur">1150000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1029" decimals="-3" id="f-2180" unitRef="eur">1008000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1030" decimals="-3" id="f-2181" unitRef="eur">29000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-113" decimals="-3" id="f-2182" unitRef="eur">1068000</abvx:ProceedsFromConditionalAdvances>
    <abvx:PercentageOfConditionalAdvancesWaived
      contextRef="c-113"
      decimals="2"
      id="f-2183"
      unitRef="number">0.60</abvx:PercentageOfConditionalAdvancesWaived>
    <abvx:ConditionalAdvances contextRef="c-1031" decimals="-3" id="f-2184" unitRef="eur">3255000</abvx:ConditionalAdvances>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-113" decimals="-3" id="f-2185" unitRef="eur">2251000</ifrs-full:RevenueFromGovernmentGrants>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1032" decimals="-3" id="f-2186" unitRef="eur">390000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1033" decimals="-3" id="f-2187" unitRef="eur">300000</abvx:ProceedsFromConditionalAdvances>
    <abvx:ProceedsFromConditionalAdvances contextRef="c-1034" decimals="-3" id="f-2188" unitRef="eur">90000</abvx:ProceedsFromConditionalAdvances>
    <abvx:DisclosureOfLeasesForLesseeTableTextBlock contextRef="c-1" id="f-2189">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The variations in lease liabilities are set forth below:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 342.76pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 301.5pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 216.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 56.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 0pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LEASE LIABILITY&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 12pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;214&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 33pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;1,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 45pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 64.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 66.67999999999999pt; position: var(--position);"&gt;(305)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 57pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;1,384&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 78pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;350&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 90pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.68pt; position: var(--position);"&gt;(1,194)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 102pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.33999999999999pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 123pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 135pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 135pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 64.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 66.67999999999999pt; position: var(--position);"&gt;(398)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147pt; width: 216.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 216.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 216.75pt; position: var(--position); top: 147pt; width: 84.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 84.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.34pt; position: var(--position);"&gt;2,363&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfLeasesForLesseeTableTextBlock>
    <ifrs-full:LeaseLiabilities contextRef="c-12" decimals="-3" id="f-2190" unitRef="eur">214000</ifrs-full:LeaseLiabilities>
    <abvx:IncreaseInLeaseLiabilities contextRef="c-10" decimals="-3" id="f-2191" unitRef="eur">1476000</abvx:IncreaseInLeaseLiabilities>
    <abvx:DecreaseInLeaseLiabilities contextRef="c-10" decimals="-3" id="f-2192" unitRef="eur">305000</abvx:DecreaseInLeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c-6" decimals="-3" id="f-2193" unitRef="eur">1384000</ifrs-full:LeaseLiabilities>
    <abvx:IncreaseInLeaseLiabilities contextRef="c-11" decimals="-3" id="f-2194" unitRef="eur">350000</abvx:IncreaseInLeaseLiabilities>
    <abvx:DecreaseInLeaseLiabilities contextRef="c-11" decimals="-3" id="f-2195" unitRef="eur">1194000</abvx:DecreaseInLeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c-7" decimals="-3" id="f-2196" unitRef="eur">540000</ifrs-full:LeaseLiabilities>
    <abvx:IncreaseInLeaseLiabilities contextRef="c-1" decimals="-3" id="f-2197" unitRef="eur">2221000</abvx:IncreaseInLeaseLiabilities>
    <abvx:DecreaseInLeaseLiabilities contextRef="c-1" decimals="-3" id="f-2198" unitRef="eur">398000</abvx:DecreaseInLeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c-5" decimals="-3" id="f-2199" unitRef="eur">2363000</ifrs-full:LeaseLiabilities>
    <abvx:LeaseDurationPeriod contextRef="c-1035" id="f-2200">P3Y</abvx:LeaseDurationPeriod>
    <abvx:LeaseTacitRenewalPeriod contextRef="c-1035" id="f-2201">P2Y</abvx:LeaseTacitRenewalPeriod>
    <abvx:LeaseBreakClausePeriod contextRef="c-1035" id="f-2202">P1Y</abvx:LeaseBreakClausePeriod>
    <abvx:DecreaseInLeaseLiabilitiesThroughModificationOfTerm contextRef="c-1036" decimals="-3" id="f-2203" unitRef="eur">622000</abvx:DecreaseInLeaseLiabilitiesThroughModificationOfTerm>
    <abvx:LeaseDurationPeriod contextRef="c-1037" id="f-2204">P3Y</abvx:LeaseDurationPeriod>
    <abvx:LeaseDurationPeriod contextRef="c-1038" id="f-2205">P2Y</abvx:LeaseDurationPeriod>
    <abvx:LeaseExtensionPeriod contextRef="c-1040" id="f-2207">P2Y</abvx:LeaseExtensionPeriod>
    <abvx:LeaseDurationPeriod contextRef="c-1041" id="f-2208">P6Y</abvx:LeaseDurationPeriod>
    <abvx:LeaseBreakClausePeriod contextRef="c-1041" id="f-2209">P6M</abvx:LeaseBreakClausePeriod>
    <abvx:LeaseTacitRenewalPeriod contextRef="c-1041" id="f-2210">P6Y</abvx:LeaseTacitRenewalPeriod>
    <abvx:LeaseDurationPeriod contextRef="c-1041" id="f-2211">P6Y</abvx:LeaseDurationPeriod>
    <abvx:LeaseLiabilityPercentageOfTotal
      contextRef="c-1042"
      decimals="2"
      id="f-2212"
      unitRef="number">0.97</abvx:LeaseLiabilityPercentageOfTotal>
    <abvx:LeaseLiabilityPercentageOfTotal
      contextRef="c-1043"
      decimals="2"
      id="f-2213"
      unitRef="number">0.93</abvx:LeaseLiabilityPercentageOfTotal>
    <abvx:LeaseLiabilityPercentageOfTotal
      contextRef="c-1044"
      decimals="2"
      id="f-2214"
      unitRef="number">0.93</abvx:LeaseLiabilityPercentageOfTotal>
    <abvx:ExpenseOnLeaseLiabilities contextRef="c-10" decimals="-3" id="f-2215" unitRef="eur">424000</abvx:ExpenseOnLeaseLiabilities>
    <abvx:ExpenseOnLeaseLiabilities contextRef="c-11" decimals="-3" id="f-2216" unitRef="eur">548000</abvx:ExpenseOnLeaseLiabilities>
    <abvx:ExpenseOnLeaseLiabilities contextRef="c-1" decimals="-3" id="f-2217" unitRef="eur">730000</abvx:ExpenseOnLeaseLiabilities>
    <abvx:DepreciationExpenseLease contextRef="c-10" decimals="-3" id="f-2218" unitRef="eur">414000</abvx:DepreciationExpenseLease>
    <abvx:DepreciationExpenseLease contextRef="c-11" decimals="-3" id="f-2219" unitRef="eur">498000</abvx:DepreciationExpenseLease>
    <abvx:DepreciationExpenseLease contextRef="c-1" decimals="-3" id="f-2220" unitRef="eur">788000</abvx:DepreciationExpenseLease>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-10" decimals="-3" id="f-2221" unitRef="eur">10000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-11" decimals="-3" id="f-2222" unitRef="eur">13000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-1" decimals="-3" id="f-2223" unitRef="eur">61000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="c-10" decimals="-3" id="f-2224" unitRef="eur">331000</abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="c-11" decimals="-3" id="f-2225" unitRef="eur">334000</abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="c-1" decimals="-3" id="f-2226" unitRef="eur">352000</abvx:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <abvx:EarnOutMarketCapitalizationThreshold contextRef="c-63" decimals="-6" id="f-2227" unitRef="eur">300000000</abvx:EarnOutMarketCapitalizationThreshold>
    <abvx:EarnOutPercentage contextRef="c-63" decimals="2" id="f-2228" unitRef="number">0.01</abvx:EarnOutPercentage>
    <abvx:EarnOutMarketCapitalizationThreshold contextRef="c-63" decimals="-6" id="f-2229" unitRef="eur">300000000</abvx:EarnOutMarketCapitalizationThreshold>
    <abvx:EarnOutMaximumAmount contextRef="c-63" decimals="-5" id="f-2230" unitRef="eur">4000000</abvx:EarnOutMaximumAmount>
    <abvx:EarnOutAtFairValueAssetsAcquisitions contextRef="c-63" decimals="-3" id="f-2231" unitRef="eur">1446000</abvx:EarnOutAtFairValueAssetsAcquisitions>
    <ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory contextRef="c-1" id="f-2232">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main data and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.46pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;assumptions are the following:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 485.46pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 404.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 254.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prosynergia earn-out&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of April 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of and for the &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;period ended &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Risk free rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 30.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 52.27pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.27pt; position: var(--position);"&gt;(0.3)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 30.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;2.3&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Market capitalization (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 45.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;403,118&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 45.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;135,952&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 60.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Ordinary share price (&#x20ac;)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 60.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 54.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;24.15&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 60.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6.18&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Time to maturity&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 75.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1 year&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 75.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 39.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.25 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Volatility&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;61&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;44&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.59pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 105.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Dividend&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 105.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 105.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.24pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 254.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 6.37pt; width: 254.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fair value of the earn-out liability (in thousands of &#x20ac;)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 254.25pt; position: var(--position); top: 120.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 41.64pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 44.27pt; position: var(--position);"&gt;(1,446)&lt;span style="display: inline-block; height: 5.41pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 329.25pt; position: var(--position); top: 120.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1045"
      decimals="3"
      id="f-2233"
      unitRef="number">-0.003</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1046"
      decimals="3"
      id="f-2234"
      unitRef="number">0.023</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-1047" decimals="-3" id="f-2235" unitRef="eur">403118000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-1048" decimals="-3" id="f-2236" unitRef="eur">135952000</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1049"
      decimals="2"
      id="f-2237"
      unitRef="eurPerShare">24.15</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1050"
      decimals="2"
      id="f-2238"
      unitRef="eurPerShare">6.18</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-1051" decimals="INF" id="f-2239" unitRef="y">1</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities contextRef="c-1052" decimals="INF" id="f-2240" unitRef="y">0.25</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1053"
      decimals="2"
      id="f-2241"
      unitRef="number">0.61</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1054"
      decimals="2"
      id="f-2242"
      unitRef="number">0.44</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1055"
      decimals="2"
      id="f-2243"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-1056"
      decimals="2"
      id="f-2244"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <abvx:EarnOutAtFairValue contextRef="c-1057" decimals="-3" id="f-2245" unitRef="eur">-1446000</abvx:EarnOutAtFairValue>
    <abvx:EarnOutAtFairValue contextRef="c-138" decimals="-3" id="f-2246" unitRef="eur">0</abvx:EarnOutAtFairValue>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1058"
      decimals="2"
      id="f-2247"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1059"
      decimals="INF"
      id="f-2248"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1060"
      decimals="2"
      id="f-2249"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1061" decimals="-3" id="f-2250" unitRef="eur">12000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1062" decimals="-3" id="f-2251" unitRef="eur">132000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1063" decimals="-3" id="f-2252" unitRef="eur">17000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:FinancialLiabilities contextRef="c-138" decimals="-3" id="f-2253" unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-964"
      decimals="2"
      id="f-2254"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-965"
      decimals="INF"
      id="f-2255"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-966"
      decimals="2"
      id="f-2256"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1064" decimals="-3" id="f-2257" unitRef="eur">1000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1065" decimals="-3" id="f-2258" unitRef="eur">1000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c-1066" decimals="-3" id="f-2259" unitRef="eur">1000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:NotionalAmount contextRef="c-1067" decimals="-3" id="f-2260" unitRef="eur">49162000</ifrs-full:NotionalAmount>
    <abvx:OtherLiabilitiesNumberOfTransactions
      contextRef="c-1067"
      decimals="INF"
      id="f-2261"
      unitRef="transaction">2</abvx:OtherLiabilitiesNumberOfTransactions>
    <ifrs-full:IssueOfEquity contextRef="c-1068" decimals="-3" id="f-2262" unitRef="eur">46231000</ifrs-full:IssueOfEquity>
    <abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease
      contextRef="c-1068"
      decimals="0"
      id="f-2263"
      unitRef="shares">5530000</abvx:IncreaseDecreaseInNumberOfOrdinarySharesIssuedThroughCapitalIncrease>
    <ifrs-full:ParValuePerShare
      contextRef="c-1067"
      decimals="2"
      id="f-2264"
      unitRef="eurPerShare">0.01</ifrs-full:ParValuePerShare>
    <abvx:EquityIssuanceSubscriptionPricePerShare
      contextRef="c-1067"
      decimals="2"
      id="f-2265"
      unitRef="eurPerShare">8.36</abvx:EquityIssuanceSubscriptionPricePerShare>
    <abvx:NetProceedsFromSaleOfRoyaltyCertificates contextRef="c-1069" decimals="-3" id="f-2266" unitRef="eur">2931000</abvx:NetProceedsFromSaleOfRoyaltyCertificates>
    <abvx:RoyaltyCertificatePercentageOfFutureSales
      contextRef="c-1069"
      decimals="2"
      id="f-2267"
      unitRef="number">0.02</abvx:RoyaltyCertificatePercentageOfFutureSales>
    <abvx:RoyaltyCertificateMaximumAmount contextRef="c-1070" decimals="-3" id="f-2268" unitRef="eur">172000000</abvx:RoyaltyCertificateMaximumAmount>
    <ifrs-full:ShareIssueRelatedCost contextRef="c-1071" decimals="-3" id="f-2269" unitRef="eur">3280000</ifrs-full:ShareIssueRelatedCost>
    <abvx:NonCurrentRoyaltyCertificates contextRef="c-6" decimals="-3" id="f-2270" unitRef="eur">3287000</abvx:NonCurrentRoyaltyCertificates>
    <abvx:DecreaseInInterestExpenseOnRoyaltyCertificates contextRef="c-10" decimals="-3" id="f-2271" unitRef="eur">100000</abvx:DecreaseInInterestExpenseOnRoyaltyCertificates>
    <abvx:RoyaltyCertificatesEIR
      contextRef="c-663"
      decimals="2"
      id="f-2272"
      unitRef="number">0.34</abvx:RoyaltyCertificatesEIR>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2273" unitRef="eur">6421000</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:InterestExpenseOnRoyaltyCertificates contextRef="c-11" decimals="-3" id="f-2274" unitRef="eur">8942000</abvx:InterestExpenseOnRoyaltyCertificates>
    <abvx:RoyaltyCertificatesEIR
      contextRef="c-663"
      decimals="2"
      id="f-2275"
      unitRef="number">0.34</abvx:RoyaltyCertificatesEIR>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2276" unitRef="eur">-3404000</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:UnwindingOfDiscountOnRoyalties contextRef="c-1" decimals="-3" id="f-2277" unitRef="eur">4198000</abvx:UnwindingOfDiscountOnRoyalties>
    <abvx:InterestExpenseOnRoyaltyCertificates contextRef="c-1" decimals="-3" id="f-2278" unitRef="eur">794000</abvx:InterestExpenseOnRoyaltyCertificates>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-662" decimals="-3" id="f-2279" unitRef="eur">3307000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-663" decimals="-3" id="f-2280" unitRef="eur">12395000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-664" decimals="-3" id="f-2281" unitRef="eur">7313000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1074"
      decimals="INF"
      id="f-2282"
      unitRef="number">0.0005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1075"
      decimals="INF"
      id="f-2283"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1076"
      decimals="INF"
      id="f-2284"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1077" decimals="-3" id="f-2285" unitRef="eur">299000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1078" decimals="-3" id="f-2286" unitRef="eur">221000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1079" decimals="-3" id="f-2287" unitRef="eur">-191000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1074"
      decimals="INF"
      id="f-2288"
      unitRef="number">0.0005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1075"
      decimals="INF"
      id="f-2289"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1076"
      decimals="INF"
      id="f-2290"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1077" decimals="-3" id="f-2291" unitRef="eur">-294000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1078" decimals="-3" id="f-2292" unitRef="eur">-347000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1079" decimals="-3" id="f-2293" unitRef="eur">205000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1080"
      decimals="INF"
      id="f-2294"
      unitRef="number">0.0005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1081"
      decimals="INF"
      id="f-2295"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1082"
      decimals="INF"
      id="f-2296"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1083"
      decimals="INF"
      id="f-2297"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1084" decimals="-3" id="f-2298" unitRef="eur">1104000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1085" decimals="-3" id="f-2299" unitRef="eur">1757000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1086" decimals="-3" id="f-2300" unitRef="eur">-577000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1087" decimals="-3" id="f-2301" unitRef="eur">1325000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1080"
      decimals="INF"
      id="f-2302"
      unitRef="number">0.0005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1081"
      decimals="INF"
      id="f-2303"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1082"
      decimals="INF"
      id="f-2304"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1083"
      decimals="INF"
      id="f-2305"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1084" decimals="-3" id="f-2306" unitRef="eur">-1104000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1085" decimals="-3" id="f-2307" unitRef="eur">-2311000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1086" decimals="-3" id="f-2308" unitRef="eur">612000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1087" decimals="-3" id="f-2309" unitRef="eur">-1325000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1088"
      decimals="INF"
      id="f-2310"
      unitRef="number">0.0005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1089"
      decimals="INF"
      id="f-2311"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1090"
      decimals="INF"
      id="f-2312"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="c-1091"
      decimals="INF"
      id="f-2313"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1092" decimals="-3" id="f-2314" unitRef="eur">572000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1093" decimals="-3" id="f-2315" unitRef="eur">1735000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1094" decimals="-3" id="f-2316" unitRef="eur">-314000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities contextRef="c-1095" decimals="-3" id="f-2317" unitRef="eur">1160000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1088"
      decimals="INF"
      id="f-2318"
      unitRef="number">0.0005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1089"
      decimals="INF"
      id="f-2319"
      unitRef="number">0.05</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1090"
      decimals="INF"
      id="f-2320"
      unitRef="number">0.01</ifrs-full:PercentageOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <abvx:AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities
      contextRef="c-1091"
      decimals="INF"
      id="f-2321"
      unitRef="eurPerShare">1</abvx:AmountOfReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1092" decimals="-3" id="f-2322" unitRef="eur">-572000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1093" decimals="-3" id="f-2323" unitRef="eur">-2527000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1094" decimals="-3" id="f-2324" unitRef="eur">332000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities contextRef="c-1095" decimals="-3" id="f-2325" unitRef="eur">-1160000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities>
    <ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory contextRef="c-1" id="f-2326">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Changes in financial liabilities, excluding derivative instruments, are presented below as of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022, 2023 a&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;nd 2024:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 309.16pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Amounts in thousands of &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;euros) &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 44.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 9.52pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 19.12pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES (excluding &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 28.72pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivatives instruments)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 21.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bond loans&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Oceane&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 21.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 2.76pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Claret &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;notes &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 36.36pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA )&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos &amp;amp; &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Claret bond &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;loans&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;convertible &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;notes&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 3.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;advances &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 15.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BPI&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 12.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 7.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liabilities&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 11.16pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prosynergia &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 8.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;earn-out &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 27.96pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liability&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 15.36pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 9.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty &lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 23.76pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;certificates&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 21.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 7pt; position: var(--position); top: 19.56pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 13.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 4.74pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 66pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 15.84pt; position: var(--position);"&gt;21,110&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;18,816&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 66pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;4,742&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,770&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;214&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 66pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;51,653&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Proceeds&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 87pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 87pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,931&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 87pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,931&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 99pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.18pt; position: var(--position);"&gt;(9,410)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 99pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(90)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(305)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 99pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(9,806)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 111pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 111pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.18pt; position: var(--position);"&gt;(2,456)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,496)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 111pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(54)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 111pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(4,006)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 123pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: interest &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;expense and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 123pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 19.84pt; position: var(--position);"&gt;3,738&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,636&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 123pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;150&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;102&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;356&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 123pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,983&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognition of earn-out &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liability &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 144pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 144pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,446&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 144pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,446&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: fair &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 174.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,446)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 174.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,446)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 195.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;additional leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 195.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 195.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 216.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 216.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 15.84pt; position: var(--position);"&gt;12,982&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;19,957&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 216.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;4,838&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,783&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,384&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,287&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 216.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;49,231&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 237.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Proceeds&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 237.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;23,119&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;35,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 237.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;58,119&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 249.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 249.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 10.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.18pt; position: var(--position);"&gt;(11,635)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 11.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.93pt; position: var(--position);"&gt;(23,238)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 249.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(2,188)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(110)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(573)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 249.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 11.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.93pt; position: var(--position);"&gt;(38,993)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 261.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 261.75pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 14.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.18pt; position: var(--position);"&gt;(2,278)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,602)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 261.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 22.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 24.68pt; position: var(--position);"&gt;(818)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(525)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(43)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(12)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 261.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(5,278)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 273.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: interest &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;expense and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 273.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 16.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 18.68pt; position: var(--position);"&gt;(1,046)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 273.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,046)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 294.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognition of earn-out &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;liability &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 294.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 16.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 18.68pt; position: var(--position);"&gt;(1,005)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 294.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,005)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 325.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: fair &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;value remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 325.5pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 25.84pt; position: var(--position);"&gt;170&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,069&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 325.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(212)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 325.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,027&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 346.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;additional leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 346.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;272&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 346.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;272&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 367.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 367.5pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 367.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,678&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;12,229&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 367.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;74,466&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 17pt; position: var(--position); top: 0pt; width: 585.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.38pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 6.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Amounts in thousands of &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.98pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 36.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.23pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES (excluding &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivatives instruments)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 52.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 52.5pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 52.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;3,678&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 23.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 26.59pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;12,229&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 52.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;74,466&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 73.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Proceeds&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 73.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;47,444&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 73.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;47,444&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 85.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Repayments &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 85.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(8,750)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(2,708)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(459)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 85.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 11.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 13.93pt; position: var(--position);"&gt;(13,167)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 97.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 97.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 16.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 18.68pt; position: var(--position);"&gt;(2,250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,639)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(1,772)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(18)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 25.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 27.93pt; position: var(--position);"&gt;(17)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 97.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(7,696)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 50.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 109.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.09pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.69pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;classification of embedded &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.29pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivatives as separate &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 31.89pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derivative financial &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 41.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 109.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,204)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 109.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,204)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159.75pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: (gain)/&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;loss on recognition or &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;derecognition&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 159.75pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(590)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 159.75pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 21.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 23.93pt; position: var(--position);"&gt;(590)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 190.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: interest &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;expense and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 190.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 18.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 21.34pt; position: var(--position);"&gt;3,977&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;5,800&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,714&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;77&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;61&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;4,198&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 190.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;15,834&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 211.5pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.79pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.39pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amortized cost &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.99pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 211.5pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,404)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 211.5pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(3,404)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 242.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes: other &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value remeasurement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 242.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,367&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 242.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;1,367&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 263.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.64pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-cash changes&#160;: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;subsidies &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 263.25pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 263.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(4,070)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 263.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.43pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 15.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.93pt; position: var(--position);"&gt;(4,070)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 284.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes: &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.81pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;additional leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 284.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 284.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.81pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,221&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 32.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 306pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non cash changes : Effect &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the change in foreign &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.49pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;currency exhange rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 306pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 28.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 31.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 306pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.06pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 338.25pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.12pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 13.12pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 93.75pt; position: var(--position); top: 338.25pt; width: 41.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 41.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 29.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 138pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 183pt; position: var(--position); top: 338.25pt; width: 42.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 14.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 17.34pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 228.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;46,401&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 273.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 318.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,488&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 363.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 17.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 20.59pt; position: var(--position);"&gt;2,363&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 453.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 27.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 30.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 498.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 13.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 16.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 543.75pt; position: var(--position); top: 338.25pt; width: 42pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.87pt; width: 42pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 9.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 12.59pt; position: var(--position);"&gt;109,218&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1096" decimals="-3" id="f-2327" unitRef="eur">21110000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1097" decimals="-3" id="f-2328" unitRef="eur">18816000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1098" decimals="-3" id="f-2329" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1099" decimals="-3" id="f-2330" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1100" decimals="-3" id="f-2331" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1101" decimals="-3" id="f-2332" unitRef="eur">4742000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1102" decimals="-3" id="f-2333" unitRef="eur">6770000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1103" decimals="-3" id="f-2334" unitRef="eur">214000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1104" decimals="-3" id="f-2335" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1105" decimals="-3" id="f-2336" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-12" decimals="-3" id="f-2337" unitRef="eur">51653000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1106" decimals="-3" id="f-2338" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1107" decimals="-3" id="f-2339" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1108" decimals="-3" id="f-2340" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1109" decimals="-3" id="f-2341" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1110" decimals="-3" id="f-2342" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1111" decimals="-3" id="f-2343" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1112" decimals="-3" id="f-2344" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1113" decimals="-3" id="f-2345" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1114" decimals="-3" id="f-2346" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1115" decimals="-3" id="f-2347" unitRef="eur">2931000</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-10" decimals="-3" id="f-2348" unitRef="eur">2931000</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1106" decimals="-3" id="f-2349" unitRef="eur">9410000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1107" decimals="-3" id="f-2350" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1108" decimals="-3" id="f-2351" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1109" decimals="-3" id="f-2352" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1110" decimals="-3" id="f-2353" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1111" decimals="-3" id="f-2354" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1112" decimals="-3" id="f-2355" unitRef="eur">90000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1113" decimals="-3" id="f-2356" unitRef="eur">305000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1114" decimals="-3" id="f-2357" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1115" decimals="-3" id="f-2358" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-10" decimals="-3" id="f-2359" unitRef="eur">9806000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1106" decimals="-3" id="f-2360" unitRef="eur">2456000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1107" decimals="-3" id="f-2361" unitRef="eur">1496000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1108" decimals="-3" id="f-2362" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1109" decimals="-3" id="f-2363" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1110" decimals="-3" id="f-2364" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1111" decimals="-3" id="f-2365" unitRef="eur">54000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1112" decimals="-3" id="f-2366" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1113" decimals="-3" id="f-2367" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1114" decimals="-3" id="f-2368" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1115" decimals="-3" id="f-2369" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-10" decimals="-3" id="f-2370" unitRef="eur">4006000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1106" decimals="-3" id="f-2371" unitRef="eur">3738000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1107" decimals="-3" id="f-2372" unitRef="eur">2636000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1108" decimals="-3" id="f-2373" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1109" decimals="-3" id="f-2374" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1110" decimals="-3" id="f-2375" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1111" decimals="-3" id="f-2376" unitRef="eur">150000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1112" decimals="-3" id="f-2377" unitRef="eur">102000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1113" decimals="-3" id="f-2378" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1114" decimals="-3" id="f-2379" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1115" decimals="-3" id="f-2380" unitRef="eur">356000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-10" decimals="-3" id="f-2381" unitRef="eur">6983000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1106" decimals="-3" id="f-2382" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1107" decimals="-3" id="f-2383" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1108" decimals="-3" id="f-2384" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1109" decimals="-3" id="f-2385" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1110" decimals="-3" id="f-2386" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1111" decimals="-3" id="f-2387" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1112" decimals="-3" id="f-2388" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1113" decimals="-3" id="f-2389" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1114" decimals="-3" id="f-2390" unitRef="eur">1446000</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1115" decimals="-3" id="f-2391" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-10" decimals="-3" id="f-2392" unitRef="eur">1446000</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1106"
      id="f-2393"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1107" decimals="-3" id="f-2394" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1108" decimals="-3" id="f-2395" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1109" decimals="-3" id="f-2396" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1110" decimals="-3" id="f-2397" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1111" decimals="-3" id="f-2398" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1112" decimals="-3" id="f-2399" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1113" decimals="-3" id="f-2400" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1114" decimals="-3" id="f-2401" unitRef="eur">-1446000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1115" decimals="-3" id="f-2402" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-10" decimals="-3" id="f-2403" unitRef="eur">-1446000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1106"
      id="f-2404"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1107" decimals="-3" id="f-2405" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1108" decimals="-3" id="f-2406" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1109" decimals="-3" id="f-2407" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1110" decimals="-3" id="f-2408" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1111" decimals="-3" id="f-2409" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1112" decimals="-3" id="f-2410" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1113" decimals="-3" id="f-2411" unitRef="eur">1476000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1114" decimals="-3" id="f-2412" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1115" decimals="-3" id="f-2413" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-10" decimals="-3" id="f-2414" unitRef="eur">1476000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1116" decimals="-3" id="f-2415" unitRef="eur">12982000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1117" decimals="-3" id="f-2416" unitRef="eur">19957000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1118" decimals="-3" id="f-2417" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1119" decimals="-3" id="f-2418" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1120" decimals="-3" id="f-2419" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1121" decimals="-3" id="f-2420" unitRef="eur">4838000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1122" decimals="-3" id="f-2421" unitRef="eur">6783000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1123" decimals="-3" id="f-2422" unitRef="eur">1384000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1124" decimals="-3" id="f-2423" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1125" decimals="-3" id="f-2424" unitRef="eur">3287000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-6" decimals="-3" id="f-2425" unitRef="eur">49231000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities
      contextRef="c-1126"
      id="f-2426"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1127" decimals="-3" id="f-2427" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1128" decimals="-3" id="f-2428" unitRef="eur">23119000</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1129" decimals="-3" id="f-2429" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1130" decimals="-3" id="f-2430" unitRef="eur">35000000</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1131" decimals="-3" id="f-2431" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1132" decimals="-3" id="f-2432" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1133" decimals="-3" id="f-2433" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1134" decimals="-3" id="f-2434" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2435" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-11" decimals="-3" id="f-2436" unitRef="eur">58119000</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1126" decimals="-3" id="f-2437" unitRef="eur">11635000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1127" decimals="-3" id="f-2438" unitRef="eur">23238000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1128" decimals="-3" id="f-2439" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1129" decimals="-3" id="f-2440" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1130" decimals="-3" id="f-2441" unitRef="eur">2188000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1131" decimals="-3" id="f-2442" unitRef="eur">1250000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1132" decimals="-3" id="f-2443" unitRef="eur">110000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1133" decimals="-3" id="f-2444" unitRef="eur">573000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1134" decimals="-3" id="f-2445" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2446" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-11" decimals="-3" id="f-2447" unitRef="eur">38993000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1126" decimals="-3" id="f-2448" unitRef="eur">2278000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1127" decimals="-3" id="f-2449" unitRef="eur">1602000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1128" decimals="-3" id="f-2450" unitRef="eur">818000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1129" decimals="-3" id="f-2451" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1130" decimals="-3" id="f-2452" unitRef="eur">525000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1131" decimals="-3" id="f-2453" unitRef="eur">43000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1132" decimals="-3" id="f-2454" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1133" decimals="-3" id="f-2455" unitRef="eur">12000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1134" decimals="-3" id="f-2456" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2457" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-11" decimals="-3" id="f-2458" unitRef="eur">5278000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1126"
      id="f-2459"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1127" decimals="-3" id="f-2460" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1128" decimals="-3" id="f-2461" unitRef="eur">-1046000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1129" decimals="-3" id="f-2462" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1130" decimals="-3" id="f-2463" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1131" decimals="-3" id="f-2464" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1132" decimals="-3" id="f-2465" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1133" decimals="-3" id="f-2466" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1134" decimals="-3" id="f-2467" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2468" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-11" decimals="-3" id="f-2469" unitRef="eur">-1046000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities
      contextRef="c-1126"
      id="f-2470"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1127" decimals="-3" id="f-2471" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1128" decimals="-3" id="f-2472" unitRef="eur">-1005000</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1129" decimals="-3" id="f-2473" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1130" decimals="-3" id="f-2474" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1131" decimals="-3" id="f-2475" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1132" decimals="-3" id="f-2476" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1133" decimals="-3" id="f-2477" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1134" decimals="-3" id="f-2478" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2479" unitRef="eur">0</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities contextRef="c-11" decimals="-3" id="f-2480" unitRef="eur">-1005000</abvx:IncreaseDecreaseThroughRecognitionOfEarnOutLiabilityLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1126" decimals="-3" id="f-2481" unitRef="eur">170000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1127" decimals="-3" id="f-2482" unitRef="eur">3069000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1128" decimals="-3" id="f-2483" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1129" decimals="-3" id="f-2484" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1130" decimals="-3" id="f-2485" unitRef="eur">-212000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1131" decimals="-3" id="f-2486" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1132" decimals="-3" id="f-2487" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1133" decimals="-3" id="f-2488" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1134" decimals="-3" id="f-2489" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2490" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-11" decimals="-3" id="f-2491" unitRef="eur">3027000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1126"
      id="f-2492"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1127" decimals="-3" id="f-2493" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1128" decimals="-3" id="f-2494" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1129" decimals="-3" id="f-2495" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1130" decimals="-3" id="f-2496" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1131" decimals="-3" id="f-2497" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1132" decimals="-3" id="f-2498" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1133" decimals="-3" id="f-2499" unitRef="eur">272000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1134" decimals="-3" id="f-2500" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1072" decimals="-3" id="f-2501" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-11" decimals="-3" id="f-2502" unitRef="eur">272000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1135" decimals="-3" id="f-2503" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1136" decimals="-3" id="f-2504" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1137" decimals="-3" id="f-2505" unitRef="eur">21643000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1138" decimals="-3" id="f-2506" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1139" decimals="-3" id="f-2507" unitRef="eur">29605000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1140" decimals="-3" id="f-2508" unitRef="eur">3678000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1141" decimals="-3" id="f-2509" unitRef="eur">6771000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1142" decimals="-3" id="f-2510" unitRef="eur">540000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1143" decimals="-3" id="f-2511" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1144" decimals="-3" id="f-2512" unitRef="eur">12229000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-7" decimals="-3" id="f-2513" unitRef="eur">74466000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1135" decimals="-3" id="f-2514" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1136" decimals="-3" id="f-2515" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1137" decimals="-3" id="f-2516" unitRef="eur">21643000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1138" decimals="-3" id="f-2517" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1139" decimals="-3" id="f-2518" unitRef="eur">29605000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1140" decimals="-3" id="f-2519" unitRef="eur">3678000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1141" decimals="-3" id="f-2520" unitRef="eur">6771000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1142" decimals="-3" id="f-2521" unitRef="eur">540000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1143" decimals="-3" id="f-2522" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1144" decimals="-3" id="f-2523" unitRef="eur">12229000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-7" decimals="-3" id="f-2524" unitRef="eur">74466000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2525"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2526" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2527" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2528" unitRef="eur">47444000</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2529" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2530" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2531" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2532" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2533" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2534" unitRef="eur">0</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2535" unitRef="eur">47444000</abvx:IncreaseThroughProceedsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2536"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2537" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2538" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2539" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2540" unitRef="eur">8750000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2541" unitRef="eur">1250000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2542" unitRef="eur">2708000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2543" unitRef="eur">459000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2544" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2545" unitRef="eur">0</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2546" unitRef="eur">13167000</abvx:DecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2547"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2548" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2549" unitRef="eur">2250000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2550" unitRef="eur">3639000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2551" unitRef="eur">1772000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2552" unitRef="eur">18000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2553" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2554" unitRef="eur">17000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2555" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2556" unitRef="eur">0</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2557" unitRef="eur">7696000</abvx:DecreaseThroughInterestPaidLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2558"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2559" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2560" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2561" unitRef="eur">-3204000</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2562" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2563" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2564" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2565" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2566" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2567" unitRef="eur">0</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2568" unitRef="eur">-3204000</abvx:IncreaseDecreaseThroughClassificationOfEmbeddedDerivativesAsSeparateFinancialInstrumentsLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2569"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2570" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2571" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2572" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2573" unitRef="eur">-590000</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2574" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2575" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2576" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2577" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2578" unitRef="eur">0</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2579" unitRef="eur">-590000</abvx:IncreaseDecreaseThroughGainLossOnRecognitionDerecognitionLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2580"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2581" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2582" unitRef="eur">3977000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2583" unitRef="eur">5800000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2584" unitRef="eur">1714000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2585" unitRef="eur">77000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2586" unitRef="eur">7000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2587" unitRef="eur">61000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2588" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2589" unitRef="eur">4198000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2590" unitRef="eur">15834000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2591"
      unitRef="eur"
      xsi:nil="true"/>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2592" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2593" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2594" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2595" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2596" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2597" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2598" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2599" unitRef="eur">0</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2600" unitRef="eur">-3404000</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2601" unitRef="eur">-3404000</abvx:IncreaseDecreaseThroughAmortizationCostRemeasurementLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2602"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2603" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2604" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2605" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2606" unitRef="eur">1367000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2607" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2608" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2609" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2610" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2611" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2612" unitRef="eur">1367000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1145" decimals="-3" id="f-2613" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2614" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2615" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2616" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2617" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2618" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2619" unitRef="eur">-4070000</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2620" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2621" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2622" unitRef="eur">0</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2623" unitRef="eur">-4070000</abvx:IncreaseDecreaseThroughSubsidiesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2624"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2625" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2626" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2627" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2628" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2629" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2630" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2631" unitRef="eur">2221000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2632" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2633" unitRef="eur">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2634" unitRef="eur">2221000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="c-1145"
      id="f-2635"
      unitRef="eur"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1146" decimals="-3" id="f-2636" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1147" decimals="-3" id="f-2637" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1148" decimals="-3" id="f-2638" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1149" decimals="-3" id="f-2639" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1150" decimals="-3" id="f-2640" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1151" decimals="-3" id="f-2641" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1152" decimals="-3" id="f-2642" unitRef="eur">17000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1153" decimals="-3" id="f-2643" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1073" decimals="-3" id="f-2644" unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c-1" decimals="-3" id="f-2645" unitRef="eur">17000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1154" decimals="-3" id="f-2646" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1155" decimals="-3" id="f-2647" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1156" decimals="-3" id="f-2648" unitRef="eur">23370000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1157" decimals="-3" id="f-2649" unitRef="eur">46401000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1158" decimals="-3" id="f-2650" unitRef="eur">21574000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1159" decimals="-3" id="f-2651" unitRef="eur">2488000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1160" decimals="-3" id="f-2652" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1161" decimals="-3" id="f-2653" unitRef="eur">2363000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1162" decimals="-3" id="f-2654" unitRef="eur">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-1163" decimals="-3" id="f-2655" unitRef="eur">13023000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c-5" decimals="-3" id="f-2656" unitRef="eur">109218000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:PaymentsForDebtIssueCosts contextRef="c-1164" decimals="-3" id="f-2657" unitRef="eur">1881000</ifrs-full:PaymentsForDebtIssueCosts>
    <abvx:NetProceedsFromConvertibleLoansNotes contextRef="c-11" decimals="-3" id="f-2658" unitRef="eur">55841000</abvx:NetProceedsFromConvertibleLoansNotes>
    <ifrs-full:PaymentsForDebtIssueCosts contextRef="c-1165" decimals="-3" id="f-2659" unitRef="eur">750000</ifrs-full:PaymentsForDebtIssueCosts>
    <ifrs-full:PaymentsForDebtIssueCosts contextRef="c-867" decimals="-3" id="f-2660" unitRef="eur">1528000</ifrs-full:PaymentsForDebtIssueCosts>
    <abvx:RepurchaseOfDerivativeInstruments contextRef="c-1166" decimals="-3" id="f-2661" unitRef="eur">1762000</abvx:RepurchaseOfDerivativeInstruments>
    <abvx:RepaymentsOfConvertibleLoansNotes contextRef="c-1167" decimals="-3" id="f-2662" unitRef="eur">25000000</abvx:RepaymentsOfConvertibleLoansNotes>
    <ifrs-full:PaymentsForDebtIssueCosts contextRef="c-312" decimals="-3" id="f-2663" unitRef="eur">1475000</ifrs-full:PaymentsForDebtIssueCosts>
    <ifrs-full:PaymentsForDebtIssueCosts contextRef="c-1168" decimals="-3" id="f-2664" unitRef="eur">1081000</ifrs-full:PaymentsForDebtIssueCosts>
    <abvx:GrossProceedsFromNonConvertibleLoansNotes contextRef="c-1" decimals="-3" id="f-2665" unitRef="eur">48544000</abvx:GrossProceedsFromNonConvertibleLoansNotes>
    <ifrs-full:PaymentsForDebtIssueCosts contextRef="c-1169" decimals="-3" id="f-2666" unitRef="eur">500000</ifrs-full:PaymentsForDebtIssueCosts>
    <abvx:DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock contextRef="c-1" id="f-2667">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Changes in derivative instruments, are presented below as of December 31, 2022, 2023 and 2024 :&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 44pt; position: var(--position); top: 0pt; width: 534.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 96pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 24.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.5pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 7.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of &lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.1pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 37.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos A BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos B BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 19.57pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCEANE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 29.17pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion option&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 0pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret BSA&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Minimum Return &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 33.97pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Indemnifications&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 0pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.77pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 24.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.4pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DERIVATIVE &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.6pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSTRUMENTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,478&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,525&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;5,929&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 54.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;9,932&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 75.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 75.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 75.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 87.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(2,203)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,376)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(5,787)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 87.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 87.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(9,366)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 99.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;275&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;149&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 99.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 99.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;566&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 120.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Issuance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 120.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,585&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 120.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;3,585&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 132.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;986&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 51.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.34pt; position: var(--position);"&gt;440&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 132.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 132.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;3,046&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 144.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 144.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,006)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 144.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,006)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 156.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Repurchases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(489)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(339)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,762)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 156.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 156.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(2,591)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 168.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Exercises&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(771)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.68pt; position: var(--position);"&gt;(250)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 168.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 168.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,021)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 180.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 180.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 180.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 201.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 201.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 201.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 222.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Issuance&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,158&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 222.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;2,158&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(+) Increase in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,462&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 234.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;1,462&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 246.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(-) Decrease in fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,413)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 246.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.68pt; position: var(--position);"&gt;(1,413)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 258.75pt; width: 96pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 96pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 96pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 168.75pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 55.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 314.25pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 392.25pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 465pt; position: var(--position); top: 258.75pt; width: 69.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 69.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfChangesInDerivativeFinancialInstrumentsTableTextBlock>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1170" decimals="-3" id="f-2668" unitRef="eur">2478000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1171" decimals="-3" id="f-2669" unitRef="eur">1525000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1172" decimals="-3" id="f-2670" unitRef="eur">5929000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1173" decimals="-3" id="f-2671" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1174" decimals="-3" id="f-2672" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-12" decimals="-3" id="f-2673" unitRef="eur">9932000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1175" decimals="-3" id="f-2674" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1176" decimals="-3" id="f-2675" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1177" decimals="-3" id="f-2676" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1178" decimals="-3" id="f-2677" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1179" decimals="-3" id="f-2678" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-10" decimals="-3" id="f-2679" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1175" decimals="-3" id="f-2680" unitRef="eur">2203000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1176" decimals="-3" id="f-2681" unitRef="eur">1376000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1177" decimals="-3" id="f-2682" unitRef="eur">5787000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1178" decimals="-3" id="f-2683" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1179" decimals="-3" id="f-2684" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-10" decimals="-3" id="f-2685" unitRef="eur">9366000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1180" decimals="-3" id="f-2686" unitRef="eur">275000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1181" decimals="-3" id="f-2687" unitRef="eur">149000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-57" decimals="-3" id="f-2688" unitRef="eur">142000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-643" decimals="-3" id="f-2689" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-653" decimals="-3" id="f-2690" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-6" decimals="-3" id="f-2691" unitRef="eur">566000</ifrs-full:DerivativeFinancialLiabilities>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1182" decimals="-3" id="f-2692" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1183" decimals="-3" id="f-2693" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1166" decimals="-3" id="f-2694" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1184" decimals="-3" id="f-2695" unitRef="eur">3585000</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1185" decimals="-3" id="f-2696" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-11" decimals="-3" id="f-2697" unitRef="eur">3585000</abvx:IssuanceOfDerivativeInstruments>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1182" decimals="-3" id="f-2698" unitRef="eur">986000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1183" decimals="-3" id="f-2699" unitRef="eur">440000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1166" decimals="-3" id="f-2700" unitRef="eur">1620000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1184" decimals="-3" id="f-2701" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1185" decimals="-3" id="f-2702" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-11" decimals="-3" id="f-2703" unitRef="eur">3046000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1182" decimals="-3" id="f-2704" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1183" decimals="-3" id="f-2705" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1166" decimals="-3" id="f-2706" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1184" decimals="-3" id="f-2707" unitRef="eur">1006000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1185" decimals="-3" id="f-2708" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-11" decimals="-3" id="f-2709" unitRef="eur">1006000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <abvx:RepurchaseOfDerivativeInstruments contextRef="c-1182" decimals="-3" id="f-2710" unitRef="eur">489000</abvx:RepurchaseOfDerivativeInstruments>
    <abvx:RepurchaseOfDerivativeInstruments contextRef="c-1183" decimals="-3" id="f-2711" unitRef="eur">339000</abvx:RepurchaseOfDerivativeInstruments>
    <abvx:RepurchaseOfDerivativeInstruments contextRef="c-1166" decimals="-3" id="f-2712" unitRef="eur">1762000</abvx:RepurchaseOfDerivativeInstruments>
    <abvx:RepurchaseOfDerivativeInstruments contextRef="c-1184" decimals="-3" id="f-2713" unitRef="eur">0</abvx:RepurchaseOfDerivativeInstruments>
    <abvx:RepurchaseOfDerivativeInstruments contextRef="c-1185" decimals="-3" id="f-2714" unitRef="eur">0</abvx:RepurchaseOfDerivativeInstruments>
    <abvx:RepurchaseOfDerivativeInstruments contextRef="c-11" decimals="-3" id="f-2715" unitRef="eur">2591000</abvx:RepurchaseOfDerivativeInstruments>
    <abvx:ExerciseOfDerivativeInstruments contextRef="c-1182" decimals="-3" id="f-2716" unitRef="eur">771000</abvx:ExerciseOfDerivativeInstruments>
    <abvx:ExerciseOfDerivativeInstruments contextRef="c-1183" decimals="-3" id="f-2717" unitRef="eur">250000</abvx:ExerciseOfDerivativeInstruments>
    <abvx:ExerciseOfDerivativeInstruments contextRef="c-1166" decimals="-3" id="f-2718" unitRef="eur">0</abvx:ExerciseOfDerivativeInstruments>
    <abvx:ExerciseOfDerivativeInstruments contextRef="c-1184" decimals="-3" id="f-2719" unitRef="eur">0</abvx:ExerciseOfDerivativeInstruments>
    <abvx:ExerciseOfDerivativeInstruments contextRef="c-1185" decimals="-3" id="f-2720" unitRef="eur">0</abvx:ExerciseOfDerivativeInstruments>
    <abvx:ExerciseOfDerivativeInstruments contextRef="c-11" decimals="-3" id="f-2721" unitRef="eur">1021000</abvx:ExerciseOfDerivativeInstruments>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1186" decimals="-3" id="f-2722" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1187" decimals="-3" id="f-2723" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-652" decimals="-3" id="f-2724" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-644" decimals="-3" id="f-2725" unitRef="eur">2579000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-654" decimals="-3" id="f-2726" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-7" decimals="-3" id="f-2727" unitRef="eur">2579000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1186" decimals="-3" id="f-2728" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1187" decimals="-3" id="f-2729" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-652" decimals="-3" id="f-2730" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-644" decimals="-3" id="f-2731" unitRef="eur">2579000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-654" decimals="-3" id="f-2732" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-7" decimals="-3" id="f-2733" unitRef="eur">2579000</ifrs-full:DerivativeFinancialLiabilities>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1188" decimals="-3" id="f-2734" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1189" decimals="-3" id="f-2735" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1190" decimals="-3" id="f-2736" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1191" decimals="-3" id="f-2737" unitRef="eur">0</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1192" decimals="-3" id="f-2738" unitRef="eur">2158000</abvx:IssuanceOfDerivativeInstruments>
    <abvx:IssuanceOfDerivativeInstruments contextRef="c-1" decimals="-3" id="f-2739" unitRef="eur">2158000</abvx:IssuanceOfDerivativeInstruments>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1188" decimals="-3" id="f-2740" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1189" decimals="-3" id="f-2741" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1190" decimals="-3" id="f-2742" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1191" decimals="-3" id="f-2743" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1192" decimals="-3" id="f-2744" unitRef="eur">1462000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1" decimals="-3" id="f-2745" unitRef="eur">1462000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1188" decimals="-3" id="f-2746" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1189" decimals="-3" id="f-2747" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1190" decimals="-3" id="f-2748" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1191" decimals="-3" id="f-2749" unitRef="eur">1413000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1192" decimals="-3" id="f-2750" unitRef="eur">0</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1" decimals="-3" id="f-2751" unitRef="eur">1413000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1193" decimals="-3" id="f-2752" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-1194" decimals="-3" id="f-2753" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-58" decimals="-3" id="f-2754" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-645" decimals="-3" id="f-2755" unitRef="eur">1166000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-655" decimals="-3" id="f-2756" unitRef="eur">3620000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-5" decimals="-3" id="f-2757" unitRef="eur">4786000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c-1195" decimals="-3" id="f-2758" unitRef="eur">1850000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-998" decimals="-3" id="f-2759" unitRef="eur">1762000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities contextRef="c-1" id="f-2761">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following are the remaining contractual maturities of financial liabilities as of December 31, 2022, 2023 and 2024. The amounts &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.17pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are gross and undiscounted, and include contractual interest payments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 561.67pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 147pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 0pt; width: 393pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 393pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 184.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 393pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 21pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 21pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12,982&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 54pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;14,098&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;9,034&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 54pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;5,065&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 54pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Oceane&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,957&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 66pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;31,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 66pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 66pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.84pt; position: var(--position);"&gt;28,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4,838&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 78pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;5,173&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 78pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 78pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.84pt; position: var(--position);"&gt;2,586&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances BPI&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,783&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 90pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;6,813&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;3,697&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 90pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,490&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 90pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.84pt; position: var(--position);"&gt;1,626&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3,287&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 102pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 102pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 102pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,384&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 114pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;1,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;558&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 114pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.34pt; position: var(--position);"&gt;557&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 114pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;289&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 126pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;566&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 126pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 126pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;424&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;49,797&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 138pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;59,053&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;16,223&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 138pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;9,905&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 138pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.84pt; position: var(--position);"&gt;32,925&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 0pt; width: 397.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 397.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 187.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 397.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 160.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 21pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 21pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 54pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;36,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;10,522&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;9,997&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 54pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;16,231&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 54pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret convertible notes &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 66pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;30,903&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 66pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;26,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 66pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;3,678&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 86.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;3,880&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 86.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 86.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances BPI&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 98.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;6,813&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;3,697&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,490&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 98.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.59pt; position: var(--position);"&gt;1,626&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 98.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;12,229&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 110.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 110.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 110.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 122.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 122.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;575&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;406&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;162&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 122.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 122.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 134.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 134.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 134.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 134.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 146.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;77,045&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 146.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;81,500&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;20,747&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;15,192&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 146.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;45,561&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 146.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 257.81pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 543pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 0pt; width: 401.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 401.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 188.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 401.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 71.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 71.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 54pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;24,063&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;6,563&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret convertible notes &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 66pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;30,653&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;19,943&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,460&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;46,401&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 86.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;58,080&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;24,016&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;25,715&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,348&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,488&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 98.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;2,586&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 110.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 57.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 122.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,363&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 122.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;2,512&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;993&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;996&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;516&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 134.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 134.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 146.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 30.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.59pt; position: var(--position);"&gt;114,004&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 146.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 39.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.84pt; position: var(--position);"&gt;122,680&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;38,468&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;56,698&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;27,507&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities>
    <ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities contextRef="c-1" id="f-2760">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The following are the remaining contractual maturities of financial liabilities as of December 31, 2022, 2023 and 2024. The amounts &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.17pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;are gross and undiscounted, and include contractual interest payments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 561.67pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 147pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 0pt; width: 393pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 393pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 184.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 393pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 21pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 21pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 &amp;amp; 2 bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;12,982&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 54pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;14,098&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;9,034&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 54pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;5,065&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 54pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Oceane&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;19,957&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 66pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;31,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 66pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,500&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 66pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.84pt; position: var(--position);"&gt;28,000&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4,838&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 78pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;5,173&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 78pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 78pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.84pt; position: var(--position);"&gt;2,586&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 78pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances BPI&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,783&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 90pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;6,813&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;3,697&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 90pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;1,490&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 90pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.84pt; position: var(--position);"&gt;1,626&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 90pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3,287&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 102pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 102pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 102pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 102pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,384&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 114pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;1,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;558&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 114pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 42.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.34pt; position: var(--position);"&gt;557&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 114pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;289&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 114pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;566&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 126pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;566&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;142&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 126pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 46.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 126pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 41.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.84pt; position: var(--position);"&gt;424&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 126pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138pt; width: 147pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 147pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 147pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 38.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;49,797&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 213pt; position: var(--position); top: 138pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;59,053&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 285pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;16,223&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 351pt; position: var(--position); top: 138pt; width: 60.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 36.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 39.34pt; position: var(--position);"&gt;9,905&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 138pt; width: 59.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 59.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.84pt; position: var(--position);"&gt;32,925&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477pt; position: var(--position); top: 138pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 0pt; width: 397.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 397.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 187.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 397.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 160.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 21pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 21pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.33pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 21pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 21pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.8pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.58pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;29,605&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 54pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;36,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;10,522&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 54pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;9,997&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 54pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;16,231&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 54pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret convertible notes &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;21,643&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 66pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;30,903&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 66pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 66pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;26,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 66pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;3,678&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 86.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;3,880&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 86.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 86.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Conditional advances BPI&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;6,771&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 98.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;6,813&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;3,697&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;1,490&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 98.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.59pt; position: var(--position);"&gt;1,626&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 98.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;12,229&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 110.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 57.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 110.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 110.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 122.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;540&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 122.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;575&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;406&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.34pt; position: var(--position);"&gt;162&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 122.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 122.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 134.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 134.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 39.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.34pt; position: var(--position);"&gt;2,579&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 49.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 52.34pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 134.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 45.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 48.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 134.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 146.25pt; width: 142.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 142.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 142.5pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;77,045&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 209.25pt; position: var(--position); top: 146.25pt; width: 69pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 69pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 40.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 43.59pt; position: var(--position);"&gt;81,500&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 281.25pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;20,747&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 35.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 38.34pt; position: var(--position);"&gt;15,192&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414.75pt; position: var(--position); top: 146.25pt; width: 60pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 60pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 31.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 34.59pt; position: var(--position);"&gt;45,561&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 477.75pt; position: var(--position); top: 146.25pt; width: 62.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 62.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 257.81pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 543pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="11" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 0pt; width: 401.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 401.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 188.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 401.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 162.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 21pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CURRENT AND NON-CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GROSS &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AMOUNT&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 21pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 71.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CONTRACTUAL &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 71.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CASH FLOWS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LESS THAN 1 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 1 TO 2 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FROM 2 TO 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 21pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 5.17pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LONGER &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.77pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;THAN 5 &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 24.37pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEARS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Heights convertible notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;21,574&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 54pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;24,063&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,750&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;6,563&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 54pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 20.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.26pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret convertible notes &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 11.86pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(OCABSA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;23,370&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 66pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;30,653&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;19,943&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,460&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 66pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.06pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 86.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos/Claret bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;46,401&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 86.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 43.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 45.84pt; position: var(--position);"&gt;58,080&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;24,016&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;25,715&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;8,348&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 86.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 98.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;PGE&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,488&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 98.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;2,586&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,293&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 98.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 110.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;13,023&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 110.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 57.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.84pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 110.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 122.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;2,363&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 122.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;2,512&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;993&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;996&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 47.59pt; position: var(--position);"&gt;516&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 122.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 134.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Derivative instruments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 134.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 47.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.84pt; position: var(--position);"&gt;4,786&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;1,166&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 38.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.59pt; position: var(--position);"&gt;3,620&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 134.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 51.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 146.25pt; width: 141.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 141.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total financial liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 141.75pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 30.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 33.59pt; position: var(--position);"&gt;114,004&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 207.75pt; position: var(--position); top: 146.25pt; width: 71.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 71.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 39.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 41.84pt; position: var(--position);"&gt;122,680&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 282pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;38,468&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 348pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;56,698&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 414pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 34.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 37.59pt; position: var(--position);"&gt;27,507&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 480pt; position: var(--position); top: 146.25pt; width: 63pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 63pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 55.59pt; position: var(--position);"&gt;7&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities>
    <ifrs-full:Borrowings contextRef="c-628" decimals="-3" id="f-2762" unitRef="eur">12982000</ifrs-full:Borrowings>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-628" decimals="-3" id="f-2763" unitRef="eur">14098000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1196" decimals="-3" id="f-2764" unitRef="eur">9034000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1197" decimals="-3" id="f-2765" unitRef="eur">5065000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1198" decimals="-3" id="f-2766" unitRef="eur">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1199" decimals="-3" id="f-2767" unitRef="eur">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotes contextRef="c-57" decimals="-3" id="f-2768" unitRef="eur">19957000</abvx:ConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-57" decimals="-3" id="f-2769" unitRef="eur">31000000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1200" decimals="-3" id="f-2770" unitRef="eur">1500000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1201" decimals="-3" id="f-2771" unitRef="eur">1500000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1202" decimals="-3" id="f-2772" unitRef="eur">28000000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1203" decimals="-3" id="f-2773" unitRef="eur">0</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <ifrs-full:Borrowings contextRef="c-637" decimals="-3" id="f-2774" unitRef="eur">4838000</ifrs-full:Borrowings>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-637" decimals="-3" id="f-2775" unitRef="eur">5173000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1204" decimals="-3" id="f-2776" unitRef="eur">1293000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1205" decimals="-3" id="f-2777" unitRef="eur">1293000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1206" decimals="-3" id="f-2778" unitRef="eur">2586000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1207" decimals="-3" id="f-2779" unitRef="eur">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <abvx:ConditionalAdvances contextRef="c-1208" decimals="-3" id="f-2780" unitRef="eur">6783000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1208" decimals="-3" id="f-2781" unitRef="eur">6813000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1209" decimals="-3" id="f-2782" unitRef="eur">3697000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1210" decimals="-3" id="f-2783" unitRef="eur">1490000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1211" decimals="-3" id="f-2784" unitRef="eur">1626000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1212" decimals="-3" id="f-2785" unitRef="eur">0</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:NonCurrentRoyaltyCertificates contextRef="c-6" decimals="-3" id="f-2786" unitRef="eur">3287000</abvx:NonCurrentRoyaltyCertificates>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-6" decimals="-3" id="f-2787" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1213" decimals="-3" id="f-2788" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1214" decimals="-3" id="f-2789" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1215" decimals="-3" id="f-2790" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1216" decimals="-3" id="f-2791" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <ifrs-full:LeaseLiabilities contextRef="c-6" decimals="-3" id="f-2792" unitRef="eur">1384000</ifrs-full:LeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-6" decimals="-3" id="f-2793" unitRef="eur">1403000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1213" decimals="-3" id="f-2794" unitRef="eur">558000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1214" decimals="-3" id="f-2795" unitRef="eur">557000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1215" decimals="-3" id="f-2796" unitRef="eur">289000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1216" decimals="-3" id="f-2797" unitRef="eur">0</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-6" decimals="-3" id="f-2798" unitRef="eur">566000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-6" decimals="-3" id="f-2799" unitRef="eur">566000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1213" decimals="-3" id="f-2800" unitRef="eur">142000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1214" decimals="-3" id="f-2801" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1215" decimals="-3" id="f-2802" unitRef="eur">424000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1216" decimals="-3" id="f-2803" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities contextRef="c-6" decimals="-3" id="f-2804" unitRef="eur">49797000</ifrs-full:FinancialLiabilities>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-6" decimals="-3" id="f-2805" unitRef="eur">59053000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1213" decimals="-3" id="f-2806" unitRef="eur">16223000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1214" decimals="-3" id="f-2807" unitRef="eur">9905000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1215" decimals="-3" id="f-2808" unitRef="eur">32925000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1216" decimals="-3" id="f-2809" unitRef="eur">0</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotes contextRef="c-59" decimals="-3" id="f-2810" unitRef="eur">29605000</abvx:ConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-59" decimals="-3" id="f-2811" unitRef="eur">36750000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1217" decimals="-3" id="f-2812" unitRef="eur">10522000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1218" decimals="-3" id="f-2813" unitRef="eur">9997000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1219" decimals="-3" id="f-2814" unitRef="eur">16231000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1220" decimals="-3" id="f-2815" unitRef="eur">0</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotes contextRef="c-644" decimals="-3" id="f-2816" unitRef="eur">21643000</abvx:ConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-644" decimals="-3" id="f-2817" unitRef="eur">30903000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1221" decimals="-3" id="f-2818" unitRef="eur">2250000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1222" decimals="-3" id="f-2819" unitRef="eur">2250000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1223" decimals="-3" id="f-2820" unitRef="eur">26403000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1224" decimals="-3" id="f-2821" unitRef="eur">0</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <ifrs-full:Borrowings contextRef="c-638" decimals="-3" id="f-2822" unitRef="eur">3678000</ifrs-full:Borrowings>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-638" decimals="-3" id="f-2823" unitRef="eur">3880000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1225" decimals="-3" id="f-2824" unitRef="eur">1293000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1226" decimals="-3" id="f-2825" unitRef="eur">1293000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1227" decimals="-3" id="f-2826" unitRef="eur">1293000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1228" decimals="-3" id="f-2827" unitRef="eur">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <abvx:ConditionalAdvances contextRef="c-1229" decimals="-3" id="f-2828" unitRef="eur">6771000</abvx:ConditionalAdvances>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1229" decimals="-3" id="f-2829" unitRef="eur">6813000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1230" decimals="-3" id="f-2830" unitRef="eur">3697000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1231" decimals="-3" id="f-2831" unitRef="eur">1490000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1232" decimals="-3" id="f-2832" unitRef="eur">1626000</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:ConditionalAdvancesUndiscountedCashFlows contextRef="c-1233" decimals="-3" id="f-2833" unitRef="eur">0</abvx:ConditionalAdvancesUndiscountedCashFlows>
    <abvx:NonCurrentRoyaltyCertificates contextRef="c-7" decimals="-3" id="f-2834" unitRef="eur">12229000</abvx:NonCurrentRoyaltyCertificates>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-7" decimals="-3" id="f-2835" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1234" decimals="-3" id="f-2836" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1235" decimals="-3" id="f-2837" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1236" decimals="-3" id="f-2838" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1237" decimals="-3" id="f-2839" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <ifrs-full:LeaseLiabilities contextRef="c-7" decimals="-3" id="f-2840" unitRef="eur">540000</ifrs-full:LeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-7" decimals="-3" id="f-2841" unitRef="eur">575000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1234" decimals="-3" id="f-2842" unitRef="eur">406000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1235" decimals="-3" id="f-2843" unitRef="eur">162000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1236" decimals="-3" id="f-2844" unitRef="eur">7000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1237" decimals="-3" id="f-2845" unitRef="eur">0</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-7" decimals="-3" id="f-2846" unitRef="eur">2579000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-7" decimals="-3" id="f-2847" unitRef="eur">2579000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1234" decimals="-3" id="f-2848" unitRef="eur">2579000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1235" decimals="-3" id="f-2849" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1236" decimals="-3" id="f-2850" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1237" decimals="-3" id="f-2851" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities contextRef="c-7" decimals="-3" id="f-2852" unitRef="eur">77045000</ifrs-full:FinancialLiabilities>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-7" decimals="-3" id="f-2853" unitRef="eur">81500000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1234" decimals="-3" id="f-2854" unitRef="eur">20747000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1235" decimals="-3" id="f-2855" unitRef="eur">15192000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1236" decimals="-3" id="f-2856" unitRef="eur">45561000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1237" decimals="-3" id="f-2857" unitRef="eur">0</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotes contextRef="c-60" decimals="-3" id="f-2858" unitRef="eur">21574000</abvx:ConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-60" decimals="-3" id="f-2859" unitRef="eur">24063000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1238" decimals="-3" id="f-2860" unitRef="eur">8750000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1239" decimals="-3" id="f-2861" unitRef="eur">8750000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1240" decimals="-3" id="f-2862" unitRef="eur">6563000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1241" decimals="-3" id="f-2863" unitRef="eur">0</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotes contextRef="c-645" decimals="-3" id="f-2864" unitRef="eur">23370000</abvx:ConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-645" decimals="-3" id="f-2865" unitRef="eur">30653000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1242" decimals="-3" id="f-2866" unitRef="eur">2250000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1243" decimals="-3" id="f-2867" unitRef="eur">19943000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1244" decimals="-3" id="f-2868" unitRef="eur">8460000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1245" decimals="-3" id="f-2869" unitRef="eur">0</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotes contextRef="c-1246" decimals="-3" id="f-2870" unitRef="eur">46401000</abvx:ConvertibleLoansNotes>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1246" decimals="-3" id="f-2871" unitRef="eur">58080000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1247" decimals="-3" id="f-2872" unitRef="eur">24016000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1248" decimals="-3" id="f-2873" unitRef="eur">25715000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1249" decimals="-3" id="f-2874" unitRef="eur">8348000</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <abvx:ConvertibleLoansNotesUndiscountedCashFlows contextRef="c-1250" decimals="-3" id="f-2875" unitRef="eur">0</abvx:ConvertibleLoansNotesUndiscountedCashFlows>
    <ifrs-full:Borrowings contextRef="c-639" decimals="-3" id="f-2876" unitRef="eur">2488000</ifrs-full:Borrowings>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-639" decimals="-3" id="f-2877" unitRef="eur">2586000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1251" decimals="-3" id="f-2878" unitRef="eur">1293000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1252" decimals="-3" id="f-2879" unitRef="eur">1293000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1253" decimals="-3" id="f-2880" unitRef="eur">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-1254" decimals="-3" id="f-2881" unitRef="eur">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <abvx:NonCurrentRoyaltyCertificates contextRef="c-5" decimals="-3" id="f-2882" unitRef="eur">13023000</abvx:NonCurrentRoyaltyCertificates>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-5" decimals="-3" id="f-2883" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1255" decimals="-3" id="f-2884" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1256" decimals="-3" id="f-2885" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1257" decimals="-3" id="f-2886" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatesUndiscountedCashFlows contextRef="c-1258" decimals="-3" id="f-2887" unitRef="eur">0</abvx:RoyaltyCertificatesUndiscountedCashFlows>
    <ifrs-full:LeaseLiabilities contextRef="c-5" decimals="-3" id="f-2888" unitRef="eur">2363000</ifrs-full:LeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-5" decimals="-3" id="f-2889" unitRef="eur">2512000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1255" decimals="-3" id="f-2890" unitRef="eur">993000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1256" decimals="-3" id="f-2891" unitRef="eur">996000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1257" decimals="-3" id="f-2892" unitRef="eur">516000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-1258" decimals="-3" id="f-2893" unitRef="eur">7000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities contextRef="c-5" decimals="-3" id="f-2894" unitRef="eur">4786000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-5" decimals="-3" id="f-2895" unitRef="eur">4786000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1255" decimals="-3" id="f-2896" unitRef="eur">1166000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1256" decimals="-3" id="f-2897" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1257" decimals="-3" id="f-2898" unitRef="eur">3620000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-1258" decimals="-3" id="f-2899" unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities contextRef="c-5" decimals="-3" id="f-2900" unitRef="eur">114004000</ifrs-full:FinancialLiabilities>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-5" decimals="-3" id="f-2901" unitRef="eur">122680000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1255" decimals="-3" id="f-2902" unitRef="eur">38468000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1256" decimals="-3" id="f-2903" unitRef="eur">56698000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1257" decimals="-3" id="f-2904" unitRef="eur">27507000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:FinancialLiabilitiesUndiscountedCashFlows contextRef="c-1258" decimals="-3" id="f-2905" unitRef="eur">7000</abvx:FinancialLiabilitiesUndiscountedCashFlows>
    <abvx:RoyaltyCertificatePercentageOfFutureSales
      contextRef="c-1068"
      decimals="2"
      id="f-2906"
      unitRef="number">0.02</abvx:RoyaltyCertificatePercentageOfFutureSales>
    <abvx:RoyaltyCertificateMaximumAmount contextRef="c-1067" decimals="-3" id="f-2907" unitRef="eur">172000000</abvx:RoyaltyCertificateMaximumAmount>
    <abvx:RoyaltyCertificateExpirationPeriod contextRef="c-1067" id="f-2908">P15Y</abvx:RoyaltyCertificateExpirationPeriod>
    <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory contextRef="c-1" id="f-2909">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Retirement benefit obligations&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 534.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Retirement benefit obligations include the liability for the defined benefit plan, measured based on the provisions stipulated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 546.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;under the applicable collective agreements, i.e. the French pharmaceutical industry&#x2019;s collective agreement. This commitment &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 558.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;only applies to employees subject to French law. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main actuarial assumptions used to measure the retirement benefit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 570.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obligations are as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 480.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ACTUARIAL ASSUMPTIONS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 0pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 0pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 0pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Retirement age&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 30.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;63 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 30.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;63 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 30.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 61.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Collective agreement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 61.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pharmaceutical&#160;industry&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 61.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pharmaceutical&#160;industry&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 61.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pharmaceutical&#160;industry&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 73.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Discount Rate (IBoxx Corporates AA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 73.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.90%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 73.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.34%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 73.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.40%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 85.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Mortality rate table&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 85.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSEE 2016-2018 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 85.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSEE 2016-2018 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 85.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSEE 2016-2018 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 42pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 97.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Salary increase rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 97.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.55%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 97.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.55%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 97.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.55%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 56.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 139.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.06pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Turnover rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 139.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;"&gt;Decreasing from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.80%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;"&gt;20 years-old to &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.05%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"&gt; from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;"&gt;55 years-old&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 139.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;"&gt;Decreasing from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.80%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;"&gt;20 years-old to &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.05%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"&gt; from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;"&gt;55 years-old&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 139.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.72pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.68pt; position: var(--position); white-space: pre;"&gt;Decreasing rates by age &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 18.97pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.16pt; position: var(--position); white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;zero&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 43.870000000000005pt; position: var(--position); white-space: pre;"&gt; from age 55, &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.18pt; position: var(--position); white-space: pre;"&gt;generating an average exit &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 41.47pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.53pt; position: var(--position); white-space: pre;"&gt;rate for 2025 of &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.05%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.21000000000001pt; position: var(--position); white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 195.75pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee contribution rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 195.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;45%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 195.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;45%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 195.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;45%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.61pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Changes in the projected benefit obligation for the periods presented were as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 313.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 322.71pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 321.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 153.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 168pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 25.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 0pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RETIREMENT BENEFIT OBLIGATIONS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 12pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;693&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Service cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 33pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;143&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 45pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 157.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 160.59pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Actuarial gains and losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 57pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 147.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 149.93pt; position: var(--position);"&gt;(235)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 69pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;610&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Service cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 90pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;109&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 102pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 153.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 156.59pt; position: var(--position);"&gt;23&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Actuarial gains and losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 114pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 147.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 149.93pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 126pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;629&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Service cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 147pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;115&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 159pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 153.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 156.59pt; position: var(--position);"&gt;22&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 171pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Benefits paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 171pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 151.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 153.93pt; position: var(--position);"&gt;(41)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 183pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Actuarial gains and losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 183pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 153.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 156.59pt; position: var(--position);"&gt;31&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 195pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 195pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;756&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 551.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employees in the U.S. benefit from defined contribution plans (401(k)).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory contextRef="c-1" id="f-2910">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The main actuarial assumptions used to measure the retirement benefit &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 570.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obligations are as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 42pt; position: var(--position); top: 0pt; width: 480.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ACTUARIAL ASSUMPTIONS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 0pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 0pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 0pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.31pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Retirement age&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 30.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;63 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 30.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;63 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 30.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.51pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;65 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 17.11pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 6.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;64 years&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 32.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 61.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Collective agreement&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 61.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pharmaceutical&#160;industry&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 61.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pharmaceutical&#160;industry&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 61.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 13.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Pharmaceutical&#160;industry&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 73.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Discount Rate (IBoxx Corporates AA)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 73.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.90%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 73.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.34%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 73.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.40%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 85.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Mortality rate table&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 85.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSEE 2016-2018 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 85.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSEE 2016-2018 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 85.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;INSEE 2016-2018 &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 42pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 97.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Salary increase rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 97.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.55%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 97.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.55%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 97.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 6.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.03pt; position: var(--position); white-space: pre;"&gt; for key management / &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.1pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 3.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.55%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.029999999999998pt; position: var(--position); white-space: pre;"&gt; for other employees&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 56.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 139.5pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 25.06pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Turnover rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 139.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;"&gt;Decreasing from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.80%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;"&gt;20 years-old to &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.05%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"&gt; from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;"&gt;55 years-old&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 139.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 13.35pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.3pt; position: var(--position); white-space: pre;"&gt;Decreasing from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.80%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.96pt; position: var(--position); white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 24.6pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.91pt; position: var(--position); white-space: pre;"&gt;20 years-old to &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.120000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.05%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.36pt; position: var(--position); white-space: pre;"&gt; from &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 35.85pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.14pt; position: var(--position); white-space: pre;"&gt;55 years-old&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 139.5pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 7.72pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.68pt; position: var(--position); white-space: pre;"&gt;Decreasing rates by age &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 18.97pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.16pt; position: var(--position); white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;zero&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 43.870000000000005pt; position: var(--position); white-space: pre;"&gt; from age 55, &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.18pt; position: var(--position); white-space: pre;"&gt;generating an average exit &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 41.47pt; width: 105pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.53pt; position: var(--position); white-space: pre;"&gt;rate for 2025 of &lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.05%&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.21000000000001pt; position: var(--position); white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.24pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 195.75pt; width: 159.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 159.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee contribution rate&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 159.75pt; position: var(--position); top: 195.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;45%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 267.75pt; position: var(--position); top: 195.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;45%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 375.75pt; position: var(--position); top: 195.75pt; width: 105pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 105pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;45%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <ifrs-full:ActuarialAssumptionOfRetirementAge2019 contextRef="c-1259" id="f-2911">P65Y</ifrs-full:ActuarialAssumptionOfRetirementAge2019>
    <ifrs-full:ActuarialAssumptionOfRetirementAge2019 contextRef="c-1260" id="f-2912">P63Y</ifrs-full:ActuarialAssumptionOfRetirementAge2019>
    <ifrs-full:ActuarialAssumptionOfRetirementAge2019 contextRef="c-1261" id="f-2913">P65Y</ifrs-full:ActuarialAssumptionOfRetirementAge2019>
    <ifrs-full:ActuarialAssumptionOfRetirementAge2019 contextRef="c-1262" id="f-2914">P63Y</ifrs-full:ActuarialAssumptionOfRetirementAge2019>
    <ifrs-full:ActuarialAssumptionOfRetirementAge2019 contextRef="c-1263" id="f-2915">P65Y</ifrs-full:ActuarialAssumptionOfRetirementAge2019>
    <ifrs-full:ActuarialAssumptionOfRetirementAge2019 contextRef="c-1264" id="f-2916">P64Y</ifrs-full:ActuarialAssumptionOfRetirementAge2019>
    <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="c-6" decimals="4" id="f-2917" unitRef="number">0.0090</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="c-7" decimals="4" id="f-2918" unitRef="number">0.0334</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="c-5" decimals="4" id="f-2919" unitRef="number">0.0340</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-1265"
      decimals="2"
      id="f-2920"
      unitRef="number">0.03</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-1266"
      decimals="4"
      id="f-2921"
      unitRef="number">0.0255</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-1267"
      decimals="2"
      id="f-2922"
      unitRef="number">0.03</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-1268"
      decimals="4"
      id="f-2923"
      unitRef="number">0.0255</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-1269"
      decimals="2"
      id="f-2924"
      unitRef="number">0.03</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-1270"
      decimals="4"
      id="f-2925"
      unitRef="number">0.0255</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <abvx:ActuarialAssumptionOfExpectedRatesOfTurnover
      contextRef="c-1271"
      decimals="4"
      id="f-2926"
      unitRef="number">0.0580</abvx:ActuarialAssumptionOfExpectedRatesOfTurnover>
    <abvx:ActuarialAssumptionOfExpectedRatesOfTurnover
      contextRef="c-1272"
      decimals="4"
      id="f-2927"
      unitRef="number">0.0005</abvx:ActuarialAssumptionOfExpectedRatesOfTurnover>
    <abvx:ActuarialAssumptionOfExpectedRatesOfTurnover
      contextRef="c-1273"
      decimals="4"
      id="f-2928"
      unitRef="number">0.0580</abvx:ActuarialAssumptionOfExpectedRatesOfTurnover>
    <abvx:ActuarialAssumptionOfExpectedRatesOfTurnover
      contextRef="c-1274"
      decimals="4"
      id="f-2929"
      unitRef="number">0.0005</abvx:ActuarialAssumptionOfExpectedRatesOfTurnover>
    <abvx:ActuarialAssumptionOfExpectedRatesOfTurnover
      contextRef="c-1275"
      decimals="4"
      id="f-2930"
      unitRef="number">0</abvx:ActuarialAssumptionOfExpectedRatesOfTurnover>
    <abvx:ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate contextRef="c-5" decimals="4" id="f-2931" unitRef="number">0.0205</abvx:ActuarialAssumptionOfExpectedRatesOfTurnoverAverageExitRate>
    <abvx:ActuarialAssumptionOfEmployeeContributionRate contextRef="c-10" decimals="2" id="f-2932" unitRef="number">0.45</abvx:ActuarialAssumptionOfEmployeeContributionRate>
    <abvx:ActuarialAssumptionOfEmployeeContributionRate contextRef="c-11" decimals="2" id="f-2933" unitRef="number">0.45</abvx:ActuarialAssumptionOfEmployeeContributionRate>
    <abvx:ActuarialAssumptionOfEmployeeContributionRate contextRef="c-1" decimals="2" id="f-2934" unitRef="number">0.45</abvx:ActuarialAssumptionOfEmployeeContributionRate>
    <ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory contextRef="c-1" id="f-2935">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Changes in the projected benefit obligation for the periods presented were as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 313.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 322.71pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 321.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 153.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 168pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 25.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 0pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RETIREMENT BENEFIT OBLIGATIONS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;JANUARY 1, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 12pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;693&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Service cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 33pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;143&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 45pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 157.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 160.59pt; position: var(--position);"&gt;8&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Actuarial gains and losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 57pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 147.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 149.93pt; position: var(--position);"&gt;(235)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 69pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;610&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Service cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 90pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;109&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 102pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 153.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 156.59pt; position: var(--position);"&gt;23&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Actuarial gains and losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 114pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 147.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 149.93pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 126pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;629&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 147pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Service cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 147pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;115&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 159pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest cost&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 159pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 153.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 156.59pt; position: var(--position);"&gt;22&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 171pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Benefits paid&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 171pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 151.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 153.93pt; position: var(--position);"&gt;(41)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 183pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Actuarial gains and losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 183pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 153.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 156.59pt; position: var(--position);"&gt;31&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 195pt; width: 153.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 153.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 153.75pt; position: var(--position); top: 195pt; width: 168pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.5pt; width: 168pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 149.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 152.59pt; position: var(--position);"&gt;756&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-1276" decimals="-3" id="f-2936" unitRef="eur">693000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset contextRef="c-1277" decimals="-3" id="f-2937" unitRef="eur">143000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="c-1277" decimals="-3" id="f-2938" unitRef="eur">8000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset contextRef="c-1277" decimals="-3" id="f-2939" unitRef="eur">235000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-1278" decimals="-3" id="f-2940" unitRef="eur">610000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset contextRef="c-1279" decimals="-3" id="f-2941" unitRef="eur">109000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="c-1279" decimals="-3" id="f-2942" unitRef="eur">23000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset contextRef="c-1279" decimals="-3" id="f-2943" unitRef="eur">112000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-1280" decimals="-3" id="f-2944" unitRef="eur">629000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset contextRef="c-1281" decimals="-3" id="f-2945" unitRef="eur">115000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="c-1281" decimals="-3" id="f-2946" unitRef="eur">22000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset contextRef="c-1281" decimals="-3" id="f-2947" unitRef="eur">41000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset contextRef="c-1281" decimals="-3" id="f-2948" unitRef="eur">-31000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-1282" decimals="-3" id="f-2949" unitRef="eur">756000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="c-1" id="f-2950">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 79.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Payables and other current liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 17.1. Trade payables and other current liabilities&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="idcc8371f18b54538a715889bed3a5f64"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 614.71pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 447pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TRADE PAYABLES AND OTHER CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;8,216&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;21,953&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;30,748&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accrued invoices&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;7,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;25,269&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;13,049&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 70.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.83999999999999pt; position: var(--position);"&gt;9&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 67.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 70.17999999999999pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;26&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;15,475&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;47,221&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 181.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;No discount was applied to payables and related accounts for which maturity does not exceed one year. As a result, their fair value &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 192.51pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;approximates their carrying amount. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 214.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increase in trade payable and other current liabilities over the year ended December 31, 2024 is mainly due to the increase in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 226.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;operating expenses over the period. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 17.2. Tax and employee-related payables&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i580b0f10a0a74186b2b84677d34024e5"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 272.81pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax and employee-related payables are presented below:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 284.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 295.44pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 195pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TAX AND EMPLOYEE-RELATED PAYABLES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee-related payables&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,348&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;3,694&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,742&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Social security and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;840&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,251&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,783&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other tax and related payments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;112&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;127&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;184&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax and employee-related payables&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,300&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,073&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,709&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 401.19pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increase in employee-related, social security and other payables over the year ended December 31, 2023 is mainly related to the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 412.39pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;changes in the management team and recruitment of additional experienced employees, including C-levels, over the period (see Note &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 423.59pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3.3 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 58.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Change in governance and management &#x2013; February-August 2023)&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <abvx:DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock contextRef="c-1" id="f-2951">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities break down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 447pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 48.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TRADE PAYABLES AND OTHER CURRENT &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;LIABILITIES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;8,216&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;21,953&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;30,748&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Accrued invoices&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;7,250&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;25,269&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;13,049&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 70.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.83999999999999pt; position: var(--position);"&gt;9&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 67.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 70.17999999999999pt; position: var(--position);"&gt;(1)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;26&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 200.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 200.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Trade payables and other current liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 200.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;15,475&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 283.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;47,221&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;43,824&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfBreakdownOfTradeAndOtherPayablesTableTextBlock>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c-6" decimals="-3" id="f-2952" unitRef="eur">8216000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c-7" decimals="-3" id="f-2953" unitRef="eur">21953000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c-5" decimals="-3" id="f-2954" unitRef="eur">30748000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:AccrualsClassifiedAsCurrent contextRef="c-6" decimals="-3" id="f-2955" unitRef="eur">7250000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:AccrualsClassifiedAsCurrent contextRef="c-7" decimals="-3" id="f-2956" unitRef="eur">25269000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:AccrualsClassifiedAsCurrent contextRef="c-5" decimals="-3" id="f-2957" unitRef="eur">13049000</ifrs-full:AccrualsClassifiedAsCurrent>
    <abvx:OtherCurrentPayablesIncludingAdjustments contextRef="c-6" decimals="-3" id="f-2958" unitRef="eur">9000</abvx:OtherCurrentPayablesIncludingAdjustments>
    <abvx:OtherCurrentPayablesIncludingAdjustments contextRef="c-7" decimals="-3" id="f-2959" unitRef="eur">-1000</abvx:OtherCurrentPayablesIncludingAdjustments>
    <abvx:OtherCurrentPayablesIncludingAdjustments contextRef="c-5" decimals="-3" id="f-2960" unitRef="eur">26000</abvx:OtherCurrentPayablesIncludingAdjustments>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c-6" decimals="-3" id="f-2961" unitRef="eur">15475000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c-7" decimals="-3" id="f-2962" unitRef="eur">47221000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c-5" decimals="-3" id="f-2963" unitRef="eur">43824000</ifrs-full:TradeAndOtherCurrentPayables>
    <abvx:DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock contextRef="c-1" id="f-2964">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax and employee-related payables are presented below:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 284.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 295.44pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 195pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 45.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;TAX AND EMPLOYEE-RELATED PAYABLES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.92pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.52pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employee-related payables&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,348&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;3,694&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,742&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Social security and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;840&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,251&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,783&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other tax and related payments&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;112&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;127&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;184&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 195pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 195pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax and employee-related payables&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 195pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,300&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 278.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,073&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 361.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,709&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfTaxAndEmployeeRelatedPayablesExplanatoryTableTextBlock>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals contextRef="c-6" decimals="-3" id="f-2965" unitRef="eur">1348000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals contextRef="c-7" decimals="-3" id="f-2966" unitRef="eur">3694000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals contextRef="c-5" decimals="-3" id="f-2967" unitRef="eur">2742000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax contextRef="c-6" decimals="-3" id="f-2968" unitRef="eur">840000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax contextRef="c-7" decimals="-3" id="f-2969" unitRef="eur">2251000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax contextRef="c-5" decimals="-3" id="f-2970" unitRef="eur">1783000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <abvx:CurrentPayablesOnOtherTaxAndRelatedPayments contextRef="c-6" decimals="-3" id="f-2971" unitRef="eur">112000</abvx:CurrentPayablesOnOtherTaxAndRelatedPayments>
    <abvx:CurrentPayablesOnOtherTaxAndRelatedPayments contextRef="c-7" decimals="-3" id="f-2972" unitRef="eur">127000</abvx:CurrentPayablesOnOtherTaxAndRelatedPayments>
    <abvx:CurrentPayablesOnOtherTaxAndRelatedPayments contextRef="c-5" decimals="-3" id="f-2973" unitRef="eur">184000</abvx:CurrentPayablesOnOtherTaxAndRelatedPayments>
    <abvx:CurrentTaxAndEmployeeBenefitLiabilities contextRef="c-6" decimals="-3" id="f-2974" unitRef="eur">2300000</abvx:CurrentTaxAndEmployeeBenefitLiabilities>
    <abvx:CurrentTaxAndEmployeeBenefitLiabilities contextRef="c-7" decimals="-3" id="f-2975" unitRef="eur">6073000</abvx:CurrentTaxAndEmployeeBenefitLiabilities>
    <abvx:CurrentTaxAndEmployeeBenefitLiabilities contextRef="c-5" decimals="-3" id="f-2976" unitRef="eur">4709000</abvx:CurrentTaxAndEmployeeBenefitLiabilities>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory contextRef="c-1" id="f-2977">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Operating income&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 479.89pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Operating income is composed as below:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; position: var(--position); top: 501.89pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 90.75pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 0pt; left: 38.5pt; position: var(--position); top: 0pt; width: 381pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OPERATING INCOME&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit ("CIR")&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,493&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,651&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;29&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;81&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,140&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;78&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;47&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,657&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total operating income&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,583&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,621&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;12,449&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 608.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Operating income is composed as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit (&#x201c;CIR&#x201d;) &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group carries out research and development projects. As such, it has benefited from a research tax credit for the years ended &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Decem&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ber 31, 2022, 2023 and 2024 for an amount of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;4,476&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.95pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;4,493&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;5,668&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;, respectively (see Note &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 675.86pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;4.9). During the year ended December 31, 2024, &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;the&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.14pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; Group also received an additional tax credit payment related to the 2021 tax year &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.06pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;for an amount of &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.39pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;984&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.98000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; after a claim from the Group following a clarification of "public subsidy" definition.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 709.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies primarily relate to the Bpifrance RNP-VIR and CARENA conditional advances, the repayments of which were partly &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;waived by Bpifrance in June 2024, f&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;or&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,872&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,251&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; resp&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ectively (see Notes 3.3 and 15.7).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 171.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the year ended December 31, 2024, the line item "Other" mainly includes issuance, cancellation and depositary service fees &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;collected from ADSs holders by Citibank, who is acting as the Group's exclusive depositary for its publicly listed and freely traded &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ADSs. As part of the depositary agreement between Citibank and the Group, the latter is entitled to receive a portion of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 205.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;aforementioned fees collected by Citibank.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory>
    <abvx:DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock contextRef="c-1" id="f-2978">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Operating income is composed as below:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; position: var(--position); top: 501.89pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 90.75pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 0pt; left: 38.5pt; position: var(--position); top: 0pt; width: 381pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OPERATING INCOME&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research tax credit ("CIR")&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,476&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,493&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,651&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;29&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;81&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,140&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;78&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;47&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,657&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 134.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 134.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total operating income&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 134.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,583&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 217.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,621&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 300.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;12,449&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfDetailedInformationOfOperatingIncomeExplanatoryTableTextBlock>
    <abvx:IncomeFromResearchTaxCredit contextRef="c-10" decimals="-3" id="f-2979" unitRef="eur">4476000</abvx:IncomeFromResearchTaxCredit>
    <abvx:IncomeFromResearchTaxCredit contextRef="c-11" decimals="-3" id="f-2980" unitRef="eur">4493000</abvx:IncomeFromResearchTaxCredit>
    <abvx:IncomeFromResearchTaxCredit contextRef="c-1" decimals="-3" id="f-2981" unitRef="eur">6651000</abvx:IncomeFromResearchTaxCredit>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-10" decimals="-3" id="f-2982" unitRef="eur">29000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-11" decimals="-3" id="f-2983" unitRef="eur">81000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-1" decimals="-3" id="f-2984" unitRef="eur">4140000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:MiscellaneousOtherOperatingIncome contextRef="c-10" decimals="-3" id="f-2985" unitRef="eur">78000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome contextRef="c-11" decimals="-3" id="f-2986" unitRef="eur">47000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome contextRef="c-1" decimals="-3" id="f-2987" unitRef="eur">1657000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:OtherIncome contextRef="c-10" decimals="-3" id="f-2988" unitRef="eur">4583000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c-11" decimals="-3" id="f-2989" unitRef="eur">4621000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c-1" decimals="-3" id="f-2990" unitRef="eur">12449000</ifrs-full:OtherIncome>
    <abvx:IncomeFromResearchTaxCredit contextRef="c-1283" decimals="-3" id="f-2991" unitRef="eur">4476000</abvx:IncomeFromResearchTaxCredit>
    <abvx:IncomeFromResearchTaxCredit contextRef="c-1284" decimals="-3" id="f-2992" unitRef="eur">4493000</abvx:IncomeFromResearchTaxCredit>
    <abvx:IncomeFromResearchTaxCredit contextRef="c-1285" decimals="-3" id="f-2993" unitRef="eur">5668000</abvx:IncomeFromResearchTaxCredit>
    <abvx:IncomeFromResearchTaxCredit contextRef="c-1286" decimals="-3" id="f-2994" unitRef="eur">984000</abvx:IncomeFromResearchTaxCredit>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-111" decimals="-3" id="f-2995" unitRef="eur">1872000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c-113" decimals="-3" id="f-2996" unitRef="eur">2251000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory contextRef="c-1" id="f-2997">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Operating expenses&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 19.1. Sales and marketing&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i36c21550f6ab4c06a26eca50fdd758de"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 310.89pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SALES AND MARKETING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Personnel costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,710&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,323&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consulting and professional fees &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,012&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,699&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other sales and marketing expenses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;709&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;932&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Sales &amp;amp; Marketing&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,431&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;5,954&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 432.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the years ended December 31, 2023 and 2024, sales and marketing expenses amount&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.38pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.15pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6,431&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.17pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5,954&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.1700000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 442.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively. The decrease was primarily &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;driven by the restructuring of the Group's sales and marketing department part way through &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 452.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;These expenses consist primarily of consulting costs associated with market research in preparation for the Group's potential &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 462.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;future sales and commercialization efforts in the U.S. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 472.64pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group did not incur any sales and marketing expense for the year ended December 31, 2022.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 19.2. Research and development&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;span id="i02d53339738d4dda95bdbdb57157a5b7"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 535.94pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development expenses break down as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 558.34pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RESEARCH AND DEVELOPMENT EXPENSES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Sub-contracting, studies and research&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;38,858&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;85,726&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;110,993&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Personnel costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;3,072&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;8,048&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;18,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consulting and professional fees&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,246&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,561&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;12,581&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intellectual property fees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,187&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,645&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,741&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other research and development expenses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;931&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,196&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,762&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development expenses&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;48,295&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;103,176&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;146,532&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development expenses consist primarily of the following items: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Personnel expenses, including salaries, benefits, and share-based compensation expenses, for employees engaged in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;research and development activities; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 112.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Sub-contracting, collaboration and consultant expenses that primarily include the cost of third-party contractors such as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CROs who conduct our non-clinical studies and clinical trials, and research related to proprietary platforms, as well as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;investigative sites and consultants that conduct our preclinical studies and clinical trials; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 148.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Expenses incurred under agreements with contract manufacturing organizations (&#x201c;CMOs&#x201d;), including manufacturing &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scale-up expenses and the cost of acquiring and manufacturing preclinical study and clinical trial materials; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Expenses relating to preclinical studies and clinical trials; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 190.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Expenses relating to regulatory affairs; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Allocated expenses for facility costs, including rent, utilities and maintenance; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;Expenses relating to the implementation of the quality assurance system. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 255.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increase in research and development expenses for the years ended December 31, 2023 and 2024 is primarily due to (i) the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 266.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;increase in UC expenses (of respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;45,233 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;32,030&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand), due to the progress of Phase 3 clinical trials for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 278.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;obefazimod in UC, (ii) the increase in CD expenses (of respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,734 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,620&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 422.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand), due to the planning costs &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 289.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and progression of the Phase 2b CD trial, and (iii) the increase in transversal activities related to the overall expansion of the research &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 300.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and development headcount to support the Group's organizational growth and the issuance of new equity awards to officers and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 311.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;employees in research and development (of respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;4,477 thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;8,233&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 19.3. General and administrative&lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;span id="ibf0d702474584c3fafbf3a5cbc6a8b0d"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 198.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160; &lt;span style="display: inline-block; height: 8.25pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 363.59pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GENERAL AND ADMINISTRATIVE EXPENSES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Personnel costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;13,105&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;19,434&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consulting and professional fees&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,624&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,393&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;7,990&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other general and administrative expenses&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;3,466&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,893&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;5,522&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;General and administrative expenses&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;7,492&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;22,391&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;32,946&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.34pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;General and administrative expenses consist primarily of personnel-related expenses, including salaries, benefits and share-based &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.34pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;compensation expenses, for personnel other than employees engaged in research and development activities. General and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 503.34pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;administrative expenses also include fees for professional services, mainly related to audit and legal services, consulting costs, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 513.34pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;communications and travel costs, allocated expenses for facility costs, including rent, utilities and maintenance, directors&#x2019; attendance &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 523.34pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fees, and insurance costs. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 545.34pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The increase in general and administrative expenses for the years ended December 31, 2023 and 2024 is primarily due to the increase &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 556.54pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in personnel costs of respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.68pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;11,702&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6,329&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;t&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;housand, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;resulting from the issuance of new equity awards to officers &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 567.74pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and employees, management changes that occurred over the period (see Notes 3.2 and 3.3 &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 398.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Change in governance and management&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 559.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 578.94pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and the increased G&amp;amp;A headcount to support the expansion of the overall organization, as well as increased legal and professional fees &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 590.14pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and other costs associated with operating as a dual-listed public company.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our principal audit fees and services are set forth below. For the years ended December 31, 2023 and 2024, they include fees due our &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;joint statutory auditor Agili3f, in addition to PricewaterhouseCoopers Audit. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 524.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 275.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 34.5pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.18pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 86.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 0pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 0pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 0pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 34.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statutory Auditor, certification of individual and consolidated financial statements&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 49.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Issuer&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 49.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;100&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 49.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;1,848&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 49.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;1,144&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 64.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other procedures required by law&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Issuer&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 79.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;740&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 79.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;492&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 79.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;89&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 94.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 94.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;840&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 94.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;2,340&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 94.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;1,233&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory>
    <ifrs-full:DisclosureOfExpensesByNatureExplanatory contextRef="c-1" id="f-2998">&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;SALES AND MARKETING&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Personnel costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,710&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,323&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consulting and professional fees &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,012&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,699&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other sales and marketing expenses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;709&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;932&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Sales &amp;amp; Marketing&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,431&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;5,954&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development expenses break down as follows: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 558.34pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;RESEARCH AND DEVELOPMENT EXPENSES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Sub-contracting, studies and research&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;38,858&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;85,726&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;110,993&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Personnel costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;3,072&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;8,048&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;18,455&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consulting and professional fees&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;4,246&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,561&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;12,581&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Intellectual property fees&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,187&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,645&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,741&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other research and development expenses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;931&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,196&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,762&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development expenses&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;48,295&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;103,176&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.84pt; position: var(--position);"&gt;146,532&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 471pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 60.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;GENERAL AND ADMINISTRATIVE EXPENSES&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Personnel costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,403&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;13,105&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;19,434&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Consulting and professional fees&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,624&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,393&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;7,990&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other general and administrative expenses&#160;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;3,466&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;2,893&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;5,522&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 224.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 224.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;General and administrative expenses&#160;&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 224.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;7,492&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;22,391&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 390.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;32,946&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfExpensesByNatureExplanatory>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1287" decimals="-3" id="f-2999" unitRef="eur">0</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1288" decimals="-3" id="f-3000" unitRef="eur">1710000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1289" decimals="-3" id="f-3001" unitRef="eur">2323000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1287" decimals="-3" id="f-3002" unitRef="eur">0</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1288" decimals="-3" id="f-3003" unitRef="eur">4012000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1289" decimals="-3" id="f-3004" unitRef="eur">2699000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1287" decimals="-3" id="f-3005" unitRef="eur">0</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1288" decimals="-3" id="f-3006" unitRef="eur">709000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1289" decimals="-3" id="f-3007" unitRef="eur">932000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1287" decimals="-3" id="f-3008" unitRef="eur">0</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1288" decimals="-3" id="f-3009" unitRef="eur">6431000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1289" decimals="-3" id="f-3010" unitRef="eur">5954000</ifrs-full:OperatingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-11" decimals="-3" id="f-3011" unitRef="eur">6431000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-1" decimals="-3" id="f-3012" unitRef="eur">5954000</ifrs-full:SalesAndMarketingExpense>
    <abvx:SubContractingStudiesAndResearchExpenses contextRef="c-1290" decimals="-3" id="f-3013" unitRef="eur">38858000</abvx:SubContractingStudiesAndResearchExpenses>
    <abvx:SubContractingStudiesAndResearchExpenses contextRef="c-1291" decimals="-3" id="f-3014" unitRef="eur">85726000</abvx:SubContractingStudiesAndResearchExpenses>
    <abvx:SubContractingStudiesAndResearchExpenses contextRef="c-1292" decimals="-3" id="f-3015" unitRef="eur">110993000</abvx:SubContractingStudiesAndResearchExpenses>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1290" decimals="-3" id="f-3016" unitRef="eur">3072000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1291" decimals="-3" id="f-3017" unitRef="eur">8048000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1292" decimals="-3" id="f-3018" unitRef="eur">18455000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1290" decimals="-3" id="f-3019" unitRef="eur">4246000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1291" decimals="-3" id="f-3020" unitRef="eur">6561000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1292" decimals="-3" id="f-3021" unitRef="eur">12581000</ifrs-full:ProfessionalFeesExpense>
    <abvx:IntellectualPropertyFees contextRef="c-1290" decimals="-3" id="f-3022" unitRef="eur">1187000</abvx:IntellectualPropertyFees>
    <abvx:IntellectualPropertyFees contextRef="c-1291" decimals="-3" id="f-3023" unitRef="eur">1645000</abvx:IntellectualPropertyFees>
    <abvx:IntellectualPropertyFees contextRef="c-1292" decimals="-3" id="f-3024" unitRef="eur">1741000</abvx:IntellectualPropertyFees>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1290" decimals="-3" id="f-3025" unitRef="eur">931000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1291" decimals="-3" id="f-3026" unitRef="eur">1196000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1292" decimals="-3" id="f-3027" unitRef="eur">2762000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1290" decimals="-3" id="f-3028" unitRef="eur">48295000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1291" decimals="-3" id="f-3029" unitRef="eur">103176000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1292" decimals="-3" id="f-3030" unitRef="eur">146532000</ifrs-full:OperatingExpense>
    <abvx:IncreaseDecreaseInUlcerativeColitisExpenses contextRef="c-1291" decimals="-3" id="f-3031" unitRef="eur">45233000</abvx:IncreaseDecreaseInUlcerativeColitisExpenses>
    <abvx:IncreaseDecreaseInUlcerativeColitisExpenses contextRef="c-1292" decimals="-3" id="f-3032" unitRef="eur">32030000</abvx:IncreaseDecreaseInUlcerativeColitisExpenses>
    <abvx:IncreaseDecreaseInCrohnsDiseaseResearchExpenses contextRef="c-1291" decimals="-3" id="f-3033" unitRef="eur">2734000</abvx:IncreaseDecreaseInCrohnsDiseaseResearchExpenses>
    <abvx:IncreaseDecreaseInCrohnsDiseaseResearchExpenses contextRef="c-1292" decimals="-3" id="f-3034" unitRef="eur">4620000</abvx:IncreaseDecreaseInCrohnsDiseaseResearchExpenses>
    <abvx:IncreaseDecreaseInTransversalActivities contextRef="c-1291" decimals="-3" id="f-3035" unitRef="eur">4477000</abvx:IncreaseDecreaseInTransversalActivities>
    <abvx:IncreaseDecreaseInTransversalActivities contextRef="c-1292" decimals="-3" id="f-3036" unitRef="eur">8233000</abvx:IncreaseDecreaseInTransversalActivities>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1293" decimals="-3" id="f-3037" unitRef="eur">1403000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1294" decimals="-3" id="f-3038" unitRef="eur">13105000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c-1295" decimals="-3" id="f-3039" unitRef="eur">19434000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1293" decimals="-3" id="f-3040" unitRef="eur">2624000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1294" decimals="-3" id="f-3041" unitRef="eur">6393000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c-1295" decimals="-3" id="f-3042" unitRef="eur">7990000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1293" decimals="-3" id="f-3043" unitRef="eur">3466000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1294" decimals="-3" id="f-3044" unitRef="eur">2893000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c-1295" decimals="-3" id="f-3045" unitRef="eur">5522000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1293" decimals="-3" id="f-3046" unitRef="eur">7492000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1294" decimals="-3" id="f-3047" unitRef="eur">22391000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1295" decimals="-3" id="f-3048" unitRef="eur">32946000</ifrs-full:OperatingExpense>
    <abvx:IncreaseDecreaseInEmployeeBenefitsExpenses contextRef="c-1294" decimals="-3" id="f-3049" unitRef="eur">11702000</abvx:IncreaseDecreaseInEmployeeBenefitsExpenses>
    <abvx:IncreaseDecreaseInEmployeeBenefitsExpenses contextRef="c-1295" decimals="-3" id="f-3050" unitRef="eur">6329000</abvx:IncreaseDecreaseInEmployeeBenefitsExpenses>
    <abvx:DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock contextRef="c-1" id="f-3051">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Our principal audit fees and services are set forth below. For the years ended December 31, 2023 and 2024, they include fees due our &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 82.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;joint statutory auditor Agili3f, in addition to PricewaterhouseCoopers Audit. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 524.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 275.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 34.5pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.18pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 86.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 0pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 0pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 0pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.65pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.25pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 23.85pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 34.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statutory Auditor, certification of individual and consolidated financial statements&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 49.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Issuer&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 49.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;100&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 49.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;1,848&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 49.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;1,144&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 64.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other procedures required by law&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Issuer&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 79.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;740&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 79.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;492&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 79.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.43pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 69.58999999999999pt; position: var(--position);"&gt;89&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 94.5pt; width: 275.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 275.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 275.25pt; position: var(--position); top: 94.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.59pt; position: var(--position);"&gt;840&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 359.25pt; position: var(--position); top: 94.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;2,340&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 443.25pt; position: var(--position); top: 94.5pt; width: 81pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.87pt; width: 81pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;1,233&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfPrincipalAuditFeesAndServicesTableTextBlock>
    <ifrs-full:AuditorsRemunerationForAuditServices contextRef="c-10" decimals="-3" id="f-3052" unitRef="eur">100000000</ifrs-full:AuditorsRemunerationForAuditServices>
    <ifrs-full:AuditorsRemunerationForAuditServices contextRef="c-11" decimals="-3" id="f-3053" unitRef="eur">1848000000</ifrs-full:AuditorsRemunerationForAuditServices>
    <ifrs-full:AuditorsRemunerationForAuditServices contextRef="c-1" decimals="-3" id="f-3054" unitRef="eur">1144000000</ifrs-full:AuditorsRemunerationForAuditServices>
    <ifrs-full:AuditorsRemunerationForOtherServices contextRef="c-10" decimals="-3" id="f-3055" unitRef="eur">740000000</ifrs-full:AuditorsRemunerationForOtherServices>
    <ifrs-full:AuditorsRemunerationForOtherServices contextRef="c-11" decimals="-3" id="f-3056" unitRef="eur">492000000</ifrs-full:AuditorsRemunerationForOtherServices>
    <ifrs-full:AuditorsRemunerationForOtherServices contextRef="c-1" decimals="-3" id="f-3057" unitRef="eur">89000000</ifrs-full:AuditorsRemunerationForOtherServices>
    <ifrs-full:AuditorsRemuneration contextRef="c-10" decimals="-3" id="f-3058" unitRef="eur">840000000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration contextRef="c-11" decimals="-3" id="f-3059" unitRef="eur">2340000000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration contextRef="c-1" decimals="-3" id="f-3060" unitRef="eur">1233000000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory contextRef="c-1" id="f-3061">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employees&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.31pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group&#x2019;s average workforce during the periods ended December 31, 2022, 2023 and 2024 was as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 287.06pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 360pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;HEADCOUNTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;France&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;23&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;28&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;38&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;United States&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;12&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;29&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;23&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;40&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;67&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory>
    <abvx:DisclosureOfAverageNumberOfEmployeesTableTextBlock contextRef="c-1" id="f-3062">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group&#x2019;s average workforce during the periods ended December 31, 2022, 2023 and 2024 was as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 287.06pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 360pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;HEADCOUNTS&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 0pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;France&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;23&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;28&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 30.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;38&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;United States&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;12&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 42.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;29&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 88.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;23&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 180pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;40&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 271.5pt; position: var(--position); top: 54.75pt; width: 88.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 88.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 74.46pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 77.08999999999999pt; position: var(--position);"&gt;67&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfAverageNumberOfEmployeesTableTextBlock>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-1296"
      decimals="0"
      id="f-3063"
      unitRef="employee">23</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-1297"
      decimals="0"
      id="f-3064"
      unitRef="employee">28</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-1298"
      decimals="0"
      id="f-3065"
      unitRef="employee">38</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-1299"
      decimals="0"
      id="f-3066"
      unitRef="employee">0</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-1300"
      decimals="0"
      id="f-3067"
      unitRef="employee">12</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-1301"
      decimals="0"
      id="f-3068"
      unitRef="employee">29</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-10"
      decimals="0"
      id="f-3069"
      unitRef="employee">23</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-11"
      decimals="0"
      id="f-3070"
      unitRef="employee">40</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="c-1"
      decimals="0"
      id="f-3071"
      unitRef="employee">67</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="c-1" id="f-3072">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial gain (loss)&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.06pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The financial loss breaks down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 112.66pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 510pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 279pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 87.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL GAIN (LOSS)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on Kreos 1 &amp;amp; 2 straight bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,737)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(760)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(5,800)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on convertible loan notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(2,641)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,935)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(5,691)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on conditional advances&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(196)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(176)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(85)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(356)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(8,942)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(794)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(10)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(13)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(61)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase in derivatives fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,046)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,462)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase in other liabilities at fair value through profit and loss&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,367)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Loss on derecognition of financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,431)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Transaction costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,924)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,615)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Foreign exchange losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(5,573)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(51)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(83)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(73)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(64)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial expenses&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(7,022)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(27,875)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(16,991)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest income&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,418&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;8,246&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 198.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Decrease/(increase) in derivatives fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;9,366&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,006&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,413&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 210.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Decrease/(increase) in other liabilities at fair value through profit and loss&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,446&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,198&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 222.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effect of unwinding the discount related to advances made to CROs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;355&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;710&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Day-one gain on recognition of financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;212&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;590&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 246.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Gain on derecognition of financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;192&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 258.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Foreign exchange gains &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,774&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 270.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial income&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 270.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;306&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 270.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;130&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 270.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 282.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial income&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 282.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;11,118&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 282.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;7,511&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 282.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;13,732&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 294.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial gain (loss)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 294.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;4,096&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 294.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(20,364)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 294.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,258)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 435.71pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increases and decreases in the fair value of derivatives are detailed in Notes 15.1, 15.3, 15.5 and 15.12.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 459.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increases and decreases in other liabilities at FVTPL relate to the Prosynergia earn-out liability for the year ended December 31, 2022 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(see Note 15.9) and the Heights notes for the years ended December 31, 2023 and 2024 (see Note 15.2).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 495.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interests on royalty certificates are detailed in Note 15.10.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Transaction costs for the year ended December 31, 2023 mainly relate to Heights notes, and t&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ransaction costs for the year ended &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 531.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 31, 2024 mainly relate to the amortization of the prepaid expenses related to the transaction costs of the Kreos / Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 543.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranche C bond loans (see Note 15.1).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Gains and losses on the recognition and derecognition of financial liabilities are set forth in Notes 15.2. to 15.5.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 595.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest income mainly relates to the invested proceeds from the Group's Global Offering and the Kreos / Claret and Heights &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financings.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 631.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Foreign exchange losses for the year ended December 31, 2023 mainly relate to the translation of cash and cash equivalents held in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 642.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;U.S. dollars into the Group's presentation currency as of December 31, 2023 (see Note 11), resulting in a loss of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,196&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 552.37pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 653.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,488&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; loss resulting from foreign exchange operations.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 664.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Foreign exchange gains for the year ended December 31, 2024 mainly relate to the translation of cash and cash equivalents held in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 676.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;U.S. dollars into the Group's presentation currency as of December 31, 2024 (see Note 11), resulting in a gain of&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 487.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;2,035&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 554.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 687.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;714&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; gain resulting from foreign exchange operations.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <abvx:DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock contextRef="c-1" id="f-3073">&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The financial loss breaks down as follows:&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="position: var(--position); top: 112.66pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 43pt; position: var(--position); top: 0pt; width: 510pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 279pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 87.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 22.12pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;FINANCIAL GAIN (LOSS)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on Kreos 1 &amp;amp; 2 straight bond loans&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,737)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(760)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(5,800)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on convertible loan notes&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(2,641)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,935)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(5,691)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on conditional advances&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(196)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(176)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(85)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on royalty certificates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(356)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(8,942)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 78.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 54.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 56.93pt; position: var(--position);"&gt;(794)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest on lease liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(10)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(13)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 90.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(61)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase in derivatives fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,046)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 102.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,462)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Increase in other liabilities at fair value through profit and loss&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 114.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,367)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Loss on derecognition of financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,431)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 126.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 138.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Transaction costs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,924)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 138.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(1,615)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 150.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Foreign exchange losses&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(5,573)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 150.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(51)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(83)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(73)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 162.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 58.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 60.93pt; position: var(--position);"&gt;(64)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial expenses&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(7,022)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(27,875)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 174.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(16,991)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 186.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest income&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,418&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 186.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;8,246&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 198.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Decrease/(increase) in derivatives fair value&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;9,366&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,006&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 198.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,413&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 210.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Decrease/(increase) in other liabilities at fair value through profit and loss&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;1,446&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;3,198&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 210.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 222.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effect of unwinding the discount related to advances made to CROs&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;355&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 222.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;710&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 234.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Day-one gain on recognition of financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;212&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 234.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;590&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 246.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Gain on derecognition of financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;192&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 246.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 258.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Foreign exchange gains &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 9pt; position: var(--position); top: 2.35pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.55pt; width: 56.62pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.25pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 6.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #CCECFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 258.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;2,774&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 270.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial income&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 270.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;306&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 270.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 59.59pt; position: var(--position);"&gt;130&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 270.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 60.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 63.59pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 282.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial income&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 282.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;11,118&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 282.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;7,511&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 282.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 46.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 49.59pt; position: var(--position);"&gt;13,732&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 294.75pt; width: 279pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 279pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financial gain (loss)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 279pt; position: var(--position); top: 294.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 50.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 53.59pt; position: var(--position);"&gt;4,096&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 357pt; position: var(--position); top: 294.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(20,364)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 435pt; position: var(--position); top: 294.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 48.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 50.93pt; position: var(--position);"&gt;(3,258)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfDetailedInformationAboutFinanceIncomeCostTableTextBlock>
    <ifrs-full:InterestExpenseOnBonds contextRef="c-10" decimals="-3" id="f-3074" unitRef="eur">3737000</ifrs-full:InterestExpenseOnBonds>
    <ifrs-full:InterestExpenseOnBonds contextRef="c-11" decimals="-3" id="f-3075" unitRef="eur">760000</ifrs-full:InterestExpenseOnBonds>
    <ifrs-full:InterestExpenseOnBonds contextRef="c-1" decimals="-3" id="f-3076" unitRef="eur">5800000</ifrs-full:InterestExpenseOnBonds>
    <ifrs-full:InterestExpenseOnDebtInstrumentsIssued contextRef="c-10" decimals="-3" id="f-3077" unitRef="eur">2641000</ifrs-full:InterestExpenseOnDebtInstrumentsIssued>
    <ifrs-full:InterestExpenseOnDebtInstrumentsIssued contextRef="c-11" decimals="-3" id="f-3078" unitRef="eur">3935000</ifrs-full:InterestExpenseOnDebtInstrumentsIssued>
    <ifrs-full:InterestExpenseOnDebtInstrumentsIssued contextRef="c-1" decimals="-3" id="f-3079" unitRef="eur">5691000</ifrs-full:InterestExpenseOnDebtInstrumentsIssued>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c-10" decimals="-3" id="f-3080" unitRef="eur">196000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c-11" decimals="-3" id="f-3081" unitRef="eur">176000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c-1" decimals="-3" id="f-3082" unitRef="eur">85000</ifrs-full:InterestExpenseOnBorrowings>
    <abvx:InterestExpenseOnRoyaltyCertificates contextRef="c-10" decimals="-3" id="f-3083" unitRef="eur">356000</abvx:InterestExpenseOnRoyaltyCertificates>
    <abvx:InterestExpenseOnRoyaltyCertificates contextRef="c-11" decimals="-3" id="f-3084" unitRef="eur">8942000</abvx:InterestExpenseOnRoyaltyCertificates>
    <abvx:InterestExpenseOnRoyaltyCertificates contextRef="c-1" decimals="-3" id="f-3085" unitRef="eur">794000</abvx:InterestExpenseOnRoyaltyCertificates>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-10" decimals="-3" id="f-3086" unitRef="eur">10000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-11" decimals="-3" id="f-3087" unitRef="eur">13000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-1" decimals="-3" id="f-3088" unitRef="eur">61000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-10" decimals="-3" id="f-3089" unitRef="eur">0</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-11" decimals="-3" id="f-3090" unitRef="eur">3046000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="c-1" decimals="-3" id="f-3091" unitRef="eur">1462000</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
    <abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c-10" decimals="-3" id="f-3092" unitRef="eur">0</abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c-11" decimals="-3" id="f-3093" unitRef="eur">0</abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c-1" decimals="-3" id="f-3094" unitRef="eur">1367000</abvx:LossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <abvx:LossesArisingFromDerecognitionOfFinancialLiabilities contextRef="c-10" decimals="-3" id="f-3095" unitRef="eur">0</abvx:LossesArisingFromDerecognitionOfFinancialLiabilities>
    <abvx:LossesArisingFromDerecognitionOfFinancialLiabilities contextRef="c-11" decimals="-3" id="f-3096" unitRef="eur">3431000</abvx:LossesArisingFromDerecognitionOfFinancialLiabilities>
    <abvx:LossesArisingFromDerecognitionOfFinancialLiabilities contextRef="c-1" decimals="-3" id="f-3097" unitRef="eur">0</abvx:LossesArisingFromDerecognitionOfFinancialLiabilities>
    <abvx:TransactionCosts contextRef="c-10" decimals="-3" id="f-3098" unitRef="eur">0</abvx:TransactionCosts>
    <abvx:TransactionCosts contextRef="c-11" decimals="-3" id="f-3099" unitRef="eur">1924000</abvx:TransactionCosts>
    <abvx:TransactionCosts contextRef="c-1" decimals="-3" id="f-3100" unitRef="eur">1615000</abvx:TransactionCosts>
    <ifrs-full:ForeignExchangeLoss contextRef="c-10" decimals="-3" id="f-3101" unitRef="eur">0</ifrs-full:ForeignExchangeLoss>
    <ifrs-full:ForeignExchangeLoss contextRef="c-11" decimals="-3" id="f-3102" unitRef="eur">5573000</ifrs-full:ForeignExchangeLoss>
    <ifrs-full:ForeignExchangeLoss contextRef="c-1" decimals="-3" id="f-3103" unitRef="eur">51000</ifrs-full:ForeignExchangeLoss>
    <ifrs-full:OtherFinanceCost contextRef="c-10" decimals="-3" id="f-3104" unitRef="eur">83000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost contextRef="c-11" decimals="-3" id="f-3105" unitRef="eur">73000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost contextRef="c-1" decimals="-3" id="f-3106" unitRef="eur">64000</ifrs-full:OtherFinanceCost>
    <ifrs-full:FinanceCosts contextRef="c-10" decimals="-3" id="f-3107" unitRef="eur">7022000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c-11" decimals="-3" id="f-3108" unitRef="eur">27875000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c-1" decimals="-3" id="f-3109" unitRef="eur">16991000</ifrs-full:FinanceCosts>
    <ifrs-full:RevenueFromInterest contextRef="c-10" decimals="-3" id="f-3110" unitRef="eur">0</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-11" decimals="-3" id="f-3111" unitRef="eur">2418000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-1" decimals="-3" id="f-3112" unitRef="eur">8246000</ifrs-full:RevenueFromInterest>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-10" decimals="-3" id="f-3113" unitRef="eur">9366000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-11" decimals="-3" id="f-3114" unitRef="eur">1006000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="c-1" decimals="-3" id="f-3115" unitRef="eur">1413000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c-10" decimals="-3" id="f-3116" unitRef="eur">1446000</abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c-11" decimals="-3" id="f-3117" unitRef="eur">3198000</abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c-1" decimals="-3" id="f-3118" unitRef="eur">0</abvx:GainsOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs contextRef="c-10" decimals="-3" id="f-3119" unitRef="eur">0</abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs>
    <abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs contextRef="c-11" decimals="-3" id="f-3120" unitRef="eur">355000</abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs>
    <abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs contextRef="c-1" decimals="-3" id="f-3121" unitRef="eur">710000</abvx:UnwindingEffectOfDiscountRelatedToAdvancesMadeToCROs>
    <abvx:GainsArisingFromRecognitionOfFinancialLiabilities contextRef="c-10" decimals="-3" id="f-3122" unitRef="eur">0</abvx:GainsArisingFromRecognitionOfFinancialLiabilities>
    <abvx:GainsArisingFromRecognitionOfFinancialLiabilities contextRef="c-11" decimals="-3" id="f-3123" unitRef="eur">212000</abvx:GainsArisingFromRecognitionOfFinancialLiabilities>
    <abvx:GainsArisingFromRecognitionOfFinancialLiabilities contextRef="c-1" decimals="-3" id="f-3124" unitRef="eur">590000</abvx:GainsArisingFromRecognitionOfFinancialLiabilities>
    <abvx:GainsArisingFromDerecognitionOfFinancialLiabilities contextRef="c-10" decimals="-3" id="f-3125" unitRef="eur">0</abvx:GainsArisingFromDerecognitionOfFinancialLiabilities>
    <abvx:GainsArisingFromDerecognitionOfFinancialLiabilities contextRef="c-11" decimals="-3" id="f-3126" unitRef="eur">192000</abvx:GainsArisingFromDerecognitionOfFinancialLiabilities>
    <abvx:GainsArisingFromDerecognitionOfFinancialLiabilities contextRef="c-1" decimals="-3" id="f-3127" unitRef="eur">0</abvx:GainsArisingFromDerecognitionOfFinancialLiabilities>
    <ifrs-full:ForeignExchangeGain contextRef="c-10" decimals="-3" id="f-3128" unitRef="eur">0</ifrs-full:ForeignExchangeGain>
    <ifrs-full:ForeignExchangeGain contextRef="c-11" decimals="-3" id="f-3129" unitRef="eur">0</ifrs-full:ForeignExchangeGain>
    <ifrs-full:ForeignExchangeGain contextRef="c-1" decimals="-3" id="f-3130" unitRef="eur">2774000</ifrs-full:ForeignExchangeGain>
    <ifrs-full:OtherFinanceIncome contextRef="c-10" decimals="-3" id="f-3131" unitRef="eur">306000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome contextRef="c-11" decimals="-3" id="f-3132" unitRef="eur">130000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome contextRef="c-1" decimals="-3" id="f-3133" unitRef="eur">0</ifrs-full:OtherFinanceIncome>
    <ifrs-full:FinanceIncome contextRef="c-10" decimals="-3" id="f-3134" unitRef="eur">11118000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="c-11" decimals="-3" id="f-3135" unitRef="eur">7511000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="c-1" decimals="-3" id="f-3136" unitRef="eur">13732000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncomeCost contextRef="c-10" decimals="-3" id="f-3137" unitRef="eur">4096000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c-11" decimals="-3" id="f-3138" unitRef="eur">-20364000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c-1" decimals="-3" id="f-3139" unitRef="eur">-3258000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-313" decimals="-3" id="f-3140" unitRef="eur">-3196000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <abvx:ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations contextRef="c-313" decimals="-3" id="f-3141" unitRef="eur">-1488000</abvx:ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-314" decimals="-3" id="f-3142" unitRef="eur">2035000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <abvx:ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations contextRef="c-314" decimals="-3" id="f-3143" unitRef="eur">714000</abvx:ForeignExchangeDifferencesGainLossesOnTranslationOfForeignOperations>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="c-1" id="f-3144">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Income tax&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The income tax rate applicable to the Company is the French corporate income tax rate, i.e. 25% for the years ended December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 101.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022, 2023 and 2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 123.71pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The income tax rates applicable to the Subsidiary are the federal income tax rate of 21% and the State income tax rates of 4.35% and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 135.21pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;5.36%, i.e. a total of 25.35% and 26.36% for the&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; years ended December 31, 2023 and 2024 respectively.&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 158.71pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 214.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 39.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(In thousands of euros, except percentage)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 0pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 0pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 0pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Loss before tax &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(60,740)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 30.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 65.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.77pt; position: var(--position);"&gt;(147,740)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 65.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.77pt; position: var(--position);"&gt;(176,242)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statutory French tax rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;25.00&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.09pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 42.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;25.00&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.09pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;25.00&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.09pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Nominal income tax using statutory French tax rate&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 71.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 74.42999999999999pt; position: var(--position);"&gt;15,185&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 54.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 71.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 74.42999999999999pt; position: var(--position);"&gt;36,935&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 71.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 74.42999999999999pt; position: var(--position);"&gt;44,061&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 67.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax effect of:&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax rates in foreign jurisdictions&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 79.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 91.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based payment&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;342&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 91.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 73.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 75.77pt; position: var(--position);"&gt;(2,045)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 73.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 75.77pt; position: var(--position);"&gt;(5,056)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 103.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CIR&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;1,119&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 103.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;1,123&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;1,663&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 115.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Transaction costs related to capital increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;820&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 115.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;3,073&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 127.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Decrease / (increase) in derivatives fair value and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;895&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 127.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;748&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(207)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 23.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 139.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.89pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-recognition of deferred tax assets related to tax losses and &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.49pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;temporary differences&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(18,169)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 139.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(39,612)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(40,399)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(192)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 162.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(222)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;49&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-left: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; border-top: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effective income tax (loss)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 174.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 362.46pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 242.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(In thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DEFERRED TAX ASSETS AND LIABILITIES BY NATURE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 12pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 12pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 12pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Retirement benefit obligation&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 33pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;152&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 33pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;157&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 33pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;189&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 45pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 45pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;135&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 45pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;591&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 57pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;198&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 57pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;351&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 57pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,678&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax losses carryforward&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 69pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 65.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.33999999999999pt; position: var(--position);"&gt;77,207&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 69pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;114,946&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 69pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;152,372&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 81pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other items&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 81pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 81pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;417&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 81pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;886&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 93pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 93pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 65.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.33999999999999pt; position: var(--position);"&gt;77,558&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 93pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;116,006&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 93pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;155,715&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 105pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 105pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 105pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 105pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;12&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 117pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 117pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 117pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;124&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 117pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;485&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 129pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,377&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 129pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;285&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 129pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,075&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other items&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 141pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 141pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;10&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 141pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;12&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 153pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 153pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,427&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 153pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;444&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 153pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,584&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 165pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets, net&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 165pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 65.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.33999999999999pt; position: var(--position);"&gt;76,130&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 165pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;115,562&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 165pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;154,131&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 177pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Unrecognized deferred tax assets&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 177pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 63.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.67999999999999pt; position: var(--position);"&gt;(76,130)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 177pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 59.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 61.68pt; position: var(--position);"&gt;(115,562)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 177pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 59.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 61.68pt; position: var(--position);"&gt;(154,131)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 189pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total deferred taxes, net recognized in the statement of financial &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;position&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 189pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 189pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 189pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 589.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group incurred tax losses in the reporting periods ended December 31, 2022, 2023 and 2024. As the recoverability of these tax &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 600.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;losses is not considered probable in subsequent periods due to the uncertainties inherent in the Group&#x2019;s business, the Group has not &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 612.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized deferred tax assets beyond deferred tax liabilities arising within the same taxable entity under the same taxable regime and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 623.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;with consistent timing of reversal, after considering, if applicable, limitations in the use of deductible tax losses carried forward from &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 635.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prior periods applicable under tax laws in France and in the U.S..&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The accumulated tax loss carry&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.26pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; forwards for the Company amount to &#x20ac;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.75pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;308,829&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#160;thousand,&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &#x20ac;&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.84pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;459,752&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.34pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; thousand and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 490.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;609,390&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 527.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; thousand &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;as of December 31, 2022, 2023 and 2024,&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; respectively, and do not have any expiration date. &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 694.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The accumulated tax loss carry forwards for the U.S. Subsidiary consist of federal Net Operating Loss ("NOL") carry forwards and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 706.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;amount to &#x20ac;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.74000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;38&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.32999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;112&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.35pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; as of December 31, 2023 and 2024, respectively. They do not have any expiration date.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <abvx:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock contextRef="c-1" id="f-3145">&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 214.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.98pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 39.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(In thousands of euros, except percentage)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 0pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 0pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 0pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 7.57pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 26.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 17.17pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 15.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 30.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Loss before tax &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(60,740)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 30.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 65.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.77pt; position: var(--position);"&gt;(147,740)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 30.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 65.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 67.77pt; position: var(--position);"&gt;(176,242)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Statutory French tax rates&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;25.00&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.09pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 42.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;25.00&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.09pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 42.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.43pt; position: var(--position);"&gt;25.00&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 99.09pt; position: var(--position);"&gt;%&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Nominal income tax using statutory French tax rate&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 71.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 74.42999999999999pt; position: var(--position);"&gt;15,185&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 54.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 71.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 74.42999999999999pt; position: var(--position);"&gt;36,935&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 54.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 71.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 74.42999999999999pt; position: var(--position);"&gt;44,061&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 67.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax effect of:&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 79.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax rates in foreign jurisdictions&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 79.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 79.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 91.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based payment&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;342&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 91.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 73.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 75.77pt; position: var(--position);"&gt;(2,045)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 91.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 73.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 75.77pt; position: var(--position);"&gt;(5,056)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 103.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CIR&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;1,119&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 103.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;1,123&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 103.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;1,663&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 115.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Transaction costs related to capital increase &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;820&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 115.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.42999999999999pt; position: var(--position);"&gt;3,073&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 115.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(112)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 127.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Decrease / (increase) in derivatives fair value and other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;895&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 127.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 81.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 84.42999999999999pt; position: var(--position);"&gt;748&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 127.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(207)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 23.25pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 139.5pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 4.89pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Non-recognition of deferred tax assets related to tax losses and &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 14.49pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;temporary differences&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(18,169)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 139.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(39,612)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 139.5pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 8.56pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 71.77pt; position: var(--position);"&gt;(40,399)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 162.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(192)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 162.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.14pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 81.77pt; position: var(--position);"&gt;(222)&lt;span style="display: inline-block; height: 5.54pt; width: 6.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-left: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 162.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;49&lt;span style="display: inline-block; height: 5.54pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-left: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; border-top: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 174.75pt; width: 214.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 214.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Effective income tax (loss)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 214.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324pt; position: var(--position); top: 174.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 2pt solid #FFFFFF; border-right: 2pt solid #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-left: 2pt solid #FFFFFF; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 433.5pt; position: var(--position); top: 174.75pt; width: 106.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 106.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 85.8pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 88.42999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 9.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</abvx:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock>
    <ifrs-full:AccountingProfit contextRef="c-10" decimals="-3" id="f-3146" unitRef="eur">-60740000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit contextRef="c-11" decimals="-3" id="f-3147" unitRef="eur">-147740000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit contextRef="c-1" decimals="-3" id="f-3148" unitRef="eur">-176242000</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate contextRef="c-10" decimals="4" id="f-3149" unitRef="number">0.2500</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate contextRef="c-11" decimals="4" id="f-3150" unitRef="number">0.2500</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate contextRef="c-1" decimals="4" id="f-3151" unitRef="number">0.2500</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c-10" decimals="-3" id="f-3152" unitRef="eur">15185000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c-11" decimals="-3" id="f-3153" unitRef="eur">36935000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c-1" decimals="-3" id="f-3154" unitRef="eur">44061000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c-10" decimals="-3" id="f-3155" unitRef="eur">0</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c-11" decimals="-3" id="f-3156" unitRef="eur">0</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c-1" decimals="-3" id="f-3157" unitRef="eur">0</ifrs-full:TaxEffectOfForeignTaxRates>
    <abvx:TaxEffectOfShareBasedPayment contextRef="c-10" decimals="-3" id="f-3158" unitRef="eur">342000</abvx:TaxEffectOfShareBasedPayment>
    <abvx:TaxEffectOfShareBasedPayment contextRef="c-11" decimals="-3" id="f-3159" unitRef="eur">-2045000</abvx:TaxEffectOfShareBasedPayment>
    <abvx:TaxEffectOfShareBasedPayment contextRef="c-1" decimals="-3" id="f-3160" unitRef="eur">-5056000</abvx:TaxEffectOfShareBasedPayment>
    <abvx:TaxEffectOfResearchTaxCredit contextRef="c-10" decimals="-3" id="f-3161" unitRef="eur">1119000</abvx:TaxEffectOfResearchTaxCredit>
    <abvx:TaxEffectOfResearchTaxCredit contextRef="c-11" decimals="-3" id="f-3162" unitRef="eur">1123000</abvx:TaxEffectOfResearchTaxCredit>
    <abvx:TaxEffectOfResearchTaxCredit contextRef="c-1" decimals="-3" id="f-3163" unitRef="eur">1663000</abvx:TaxEffectOfResearchTaxCredit>
    <abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease contextRef="c-10" decimals="-3" id="f-3164" unitRef="eur">820000</abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease>
    <abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease contextRef="c-11" decimals="-3" id="f-3165" unitRef="eur">3073000</abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease>
    <abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease contextRef="c-1" decimals="-3" id="f-3166" unitRef="eur">-112000</abvx:TaxEffectOfTransactionCostsRelatedToCapitalIncrease>
    <abvx:TaxEffectOfChangesInDerivativeFairValueAndOther contextRef="c-10" decimals="-3" id="f-3167" unitRef="eur">895000</abvx:TaxEffectOfChangesInDerivativeFairValueAndOther>
    <abvx:TaxEffectOfChangesInDerivativeFairValueAndOther contextRef="c-11" decimals="-3" id="f-3168" unitRef="eur">748000</abvx:TaxEffectOfChangesInDerivativeFairValueAndOther>
    <abvx:TaxEffectOfChangesInDerivativeFairValueAndOther contextRef="c-1" decimals="-3" id="f-3169" unitRef="eur">-207000</abvx:TaxEffectOfChangesInDerivativeFairValueAndOther>
    <abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences contextRef="c-10" decimals="-3" id="f-3170" unitRef="eur">18169000</abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences>
    <abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences contextRef="c-11" decimals="-3" id="f-3171" unitRef="eur">39612000</abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences>
    <abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences contextRef="c-1" decimals="-3" id="f-3172" unitRef="eur">40399000</abvx:TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c-10" decimals="-3" id="f-3173" unitRef="eur">-192000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c-11" decimals="-3" id="f-3174" unitRef="eur">-222000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c-1" decimals="-3" id="f-3175" unitRef="eur">49000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-10" decimals="-3" id="f-3176" unitRef="eur">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-11" decimals="-3" id="f-3177" unitRef="eur">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-1" decimals="-3" id="f-3178" unitRef="eur">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory contextRef="c-1" id="f-3179">&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 540pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 242.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(In thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DEFERRED TAX ASSETS AND LIABILITIES BY NATURE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 12pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 12pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 12pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 35.22pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;AS OF &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.78pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, 2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 33pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Retirement benefit obligation&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 33pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;152&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 33pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;157&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 33pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;189&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 45pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 45pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 45pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;135&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 45pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;591&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 57pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 57pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;198&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 57pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;351&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 57pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,678&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 69pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Tax losses carryforward&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 69pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 65.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.33999999999999pt; position: var(--position);"&gt;77,207&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 69pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;114,946&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 69pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;152,372&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 81pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other items&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 81pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 81pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;417&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 81pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;886&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 93pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 93pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 65.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.33999999999999pt; position: var(--position);"&gt;77,558&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 93pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;116,006&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 93pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;155,715&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 105pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Subsidies&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 105pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;50&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 105pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;24&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 105pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;12&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 117pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Leases&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 117pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 117pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;124&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 117pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;485&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 129pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other financial liabilities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 129pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,377&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 129pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;285&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 129pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,075&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 141pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other items&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 141pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 141pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;10&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 141pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;12&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 153pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax liabilities&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 153pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,427&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 153pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 75.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 78.33999999999999pt; position: var(--position);"&gt;444&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 153pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 69.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.33999999999999pt; position: var(--position);"&gt;1,584&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 165pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Deferred tax assets, net&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 165pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 65.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.33999999999999pt; position: var(--position);"&gt;76,130&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 165pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;115,562&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 165pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 61.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.34pt; position: var(--position);"&gt;154,131&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 177pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Unrecognized deferred tax assets&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 177pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 63.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 65.67999999999999pt; position: var(--position);"&gt;(76,130)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 177pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 59.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 61.68pt; position: var(--position);"&gt;(115,562)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 177pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.24pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 59.05pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 61.68pt; position: var(--position);"&gt;(154,131)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 21pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 189pt; width: 242.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.7pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total deferred taxes, net recognized in the statement of financial &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.3pt; width: 242.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;position&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 242.25pt; position: var(--position); top: 189pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 344.25pt; position: var(--position); top: 189pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 446.25pt; position: var(--position); top: 189pt; width: 93.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 93.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 79.71pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 82.33999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:DeferredTaxAssets contextRef="c-1302" decimals="-3" id="f-3180" unitRef="eur">152000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1303" decimals="-3" id="f-3181" unitRef="eur">157000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1304" decimals="-3" id="f-3182" unitRef="eur">189000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1305" decimals="-3" id="f-3183" unitRef="eur">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1306" decimals="-3" id="f-3184" unitRef="eur">135000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1307" decimals="-3" id="f-3185" unitRef="eur">591000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1308" decimals="-3" id="f-3186" unitRef="eur">198000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1309" decimals="-3" id="f-3187" unitRef="eur">351000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1310" decimals="-3" id="f-3188" unitRef="eur">1678000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1311" decimals="-3" id="f-3189" unitRef="eur">77207000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1312" decimals="-3" id="f-3190" unitRef="eur">114946000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1313" decimals="-3" id="f-3191" unitRef="eur">152372000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1314" decimals="-3" id="f-3192" unitRef="eur">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1315" decimals="-3" id="f-3193" unitRef="eur">417000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-1316" decimals="-3" id="f-3194" unitRef="eur">886000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-6" decimals="-3" id="f-3195" unitRef="eur">77558000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-7" decimals="-3" id="f-3196" unitRef="eur">116006000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-5" decimals="-3" id="f-3197" unitRef="eur">155715000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1317" decimals="-3" id="f-3198" unitRef="eur">50000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1318" decimals="-3" id="f-3199" unitRef="eur">24000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1319" decimals="-3" id="f-3200" unitRef="eur">12000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1305" decimals="-3" id="f-3201" unitRef="eur">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1306" decimals="-3" id="f-3202" unitRef="eur">124000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1307" decimals="-3" id="f-3203" unitRef="eur">485000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1308" decimals="-3" id="f-3204" unitRef="eur">1377000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1309" decimals="-3" id="f-3205" unitRef="eur">285000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1310" decimals="-3" id="f-3206" unitRef="eur">1075000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1314" decimals="-3" id="f-3207" unitRef="eur">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1315" decimals="-3" id="f-3208" unitRef="eur">10000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-1316" decimals="-3" id="f-3209" unitRef="eur">12000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-6" decimals="-3" id="f-3210" unitRef="eur">1427000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-7" decimals="-3" id="f-3211" unitRef="eur">444000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-5" decimals="-3" id="f-3212" unitRef="eur">1584000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-6" decimals="-3" id="f-3213" unitRef="eur">-76130000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-7" decimals="-3" id="f-3214" unitRef="eur">-115562000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-5" decimals="-3" id="f-3215" unitRef="eur">-154131000</ifrs-full:DeferredTaxLiabilityAsset>
    <abvx:UnrecognizedDeferredTaxAssets contextRef="c-6" decimals="-3" id="f-3216" unitRef="eur">76130000</abvx:UnrecognizedDeferredTaxAssets>
    <abvx:UnrecognizedDeferredTaxAssets contextRef="c-7" decimals="-3" id="f-3217" unitRef="eur">115562000</abvx:UnrecognizedDeferredTaxAssets>
    <abvx:UnrecognizedDeferredTaxAssets contextRef="c-5" decimals="-3" id="f-3218" unitRef="eur">154131000</abvx:UnrecognizedDeferredTaxAssets>
    <abvx:DeferredTaxAssetsRecognisedInFinancialPosition contextRef="c-6" decimals="-3" id="f-3219" unitRef="eur">0</abvx:DeferredTaxAssetsRecognisedInFinancialPosition>
    <abvx:DeferredTaxAssetsRecognisedInFinancialPosition contextRef="c-7" decimals="-3" id="f-3220" unitRef="eur">0</abvx:DeferredTaxAssetsRecognisedInFinancialPosition>
    <abvx:DeferredTaxAssetsRecognisedInFinancialPosition contextRef="c-5" decimals="-3" id="f-3221" unitRef="eur">0</abvx:DeferredTaxAssetsRecognisedInFinancialPosition>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="c-6" decimals="-3" id="f-3222" unitRef="eur">308829000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="c-7" decimals="-3" id="f-3223" unitRef="eur">459752000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="c-5" decimals="-3" id="f-3224" unitRef="eur">609390000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="c-1320" decimals="-3" id="f-3225" unitRef="eur">38000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="c-1321" decimals="-3" id="f-3226" unitRef="eur">112000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="c-1" id="f-3227">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Income (loss) per share&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 114.11pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Basic losses per share is calculated by dividing income (loss) attributable to equity holders of the Group by the weighted-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.11pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;average number of outstanding ordinary shares for the year.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 149.61pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Diluted losses per share are calculated by adjusting the weighted average number of ordinary outstanding shares to assume &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 161.61pt; width: 612pt;"&gt;&lt;span style="color: #231f20; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;conversion of all dilutive potential ordinary shares.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 185.61pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 23.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros, except share data)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BASIC AND DILUTED LOSS PER SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Weighted average number of outstanding shares&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;19,092,442&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;43,066,012&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;63,046,350&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Net loss for the period&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(60,740)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.93pt; position: var(--position);"&gt;(147,740)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.93pt; position: var(--position);"&gt;(176,242)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Basic and diluted loss per share (&#x20ac;/share)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;(3.18)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;(3.43)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;(2.80)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 293.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Potential dilutive instruments (BCEs, BSAs, AGAs, Equity lines, BSA Kreos 1, OCEANE, Kreos/Claret BSA, Kreos/Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 304.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;OCABSA and Height notes) have been excluded from the computation of diluted weighted-average shares outstanding because such &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 315.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;instruments had an antidilutive impact due to the losses reported. As of December 31, 2022, 2023 and 2024, the number of potential &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 326.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;dilutive instruments were &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.04000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,707,037&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;28,754,280&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; a&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;nd &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;29,570,132&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;respectively, giving rights to a maximum number of shares to be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;issued of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1,707,037&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;6,510,658&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;6,760,392&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.74pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;respectively.</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:EarningsPerShareExplanatory contextRef="c-1" id="f-3228">&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 441.75pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 23.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(amounts in thousands of euros, except share data)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;BASIC AND DILUTED LOSS PER SHARE&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 12pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Weighted average number of outstanding shares&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;19,092,442&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;43,066,012&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 42.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 32.96pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 35.59pt; position: var(--position);"&gt;63,046,350&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Net loss for the period&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 44.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 46.93pt; position: var(--position);"&gt;(60,740)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.93pt; position: var(--position);"&gt;(147,740)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 54.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 40.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 42.93pt; position: var(--position);"&gt;(176,242)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 210.75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 210.75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Basic and diluted loss per share (&#x20ac;/share)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 210.75pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;(3.18)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 288.75pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;(3.43)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 3pt double #000000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 366.75pt; position: var(--position); top: 66.75pt; width: 75pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.37pt; width: 75pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.3pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.93pt; position: var(--position);"&gt;(2.80)&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:WeightedAverageShares contextRef="c-10" decimals="0" id="f-3229" unitRef="shares">19092442</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-10" decimals="0" id="f-3230" unitRef="shares">19092442</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c-11" decimals="0" id="f-3231" unitRef="shares">43066012</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-11" decimals="0" id="f-3232" unitRef="shares">43066012</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-1" decimals="0" id="f-3233" unitRef="shares">63046350</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c-1" decimals="0" id="f-3234" unitRef="shares">63046350</ifrs-full:WeightedAverageShares>
    <ifrs-full:ProfitLoss contextRef="c-10" decimals="-3" id="f-3235" unitRef="eur">-60740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-11" decimals="-3" id="f-3236" unitRef="eur">-147740000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-3237" unitRef="eur">-176242000</ifrs-full:ProfitLoss>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-10"
      decimals="2"
      id="f-3238"
      unitRef="eurPerShare">-3.18</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-10"
      decimals="2"
      id="f-3239"
      unitRef="eurPerShare">-3.18</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-11"
      decimals="2"
      id="f-3240"
      unitRef="eurPerShare">-3.43</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-11"
      decimals="2"
      id="f-3241"
      unitRef="eurPerShare">-3.43</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-3242"
      unitRef="eurPerShare">-2.80</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-3243"
      unitRef="eurPerShare">-2.80</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented contextRef="c-10" decimals="0" id="f-3244" unitRef="shares">1707037</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented contextRef="c-11" decimals="0" id="f-3245" unitRef="shares">28754280</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented contextRef="c-1" decimals="0" id="f-3246" unitRef="shares">29570132</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <abvx:MaximumNumberOfSharesToBeIssued contextRef="c-6" decimals="0" id="f-3247" unitRef="shares">1707037</abvx:MaximumNumberOfSharesToBeIssued>
    <abvx:MaximumNumberOfSharesToBeIssued contextRef="c-7" decimals="0" id="f-3248" unitRef="shares">6510658</abvx:MaximumNumberOfSharesToBeIssued>
    <abvx:MaximumNumberOfSharesToBeIssued contextRef="c-5" decimals="0" id="f-3249" unitRef="shares">6760392</abvx:MaximumNumberOfSharesToBeIssued>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="c-1" id="f-3250">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Related &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 108.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;parties&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 390.91pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The aggregate compensation of the members of the Group&#x2019;s Board of Directors and to the Chief Executive Officer includes the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 423.31pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 488.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 241.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(In thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPENSATION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fixed compensation owed &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;322&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;471&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;578&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Variable compensation owed &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;193&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;282&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Contributions in-kind &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 70.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.83999999999999pt; position: var(--position);"&gt;9&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;32&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;68&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employer contributions &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Attendance fees&#x2014;Board of Directors &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;103&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;375&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;495&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based payments &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 59.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 62.18pt; position: var(--position);"&gt;(217)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,561&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;10,517&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Departure indemnities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 114.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 114.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,210&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 114.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 126.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;427&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 126.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;8,930&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 126.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;11,657&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 591.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;span id="id16aa006a71e4472b93adcaee881ab63_1564"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; the liability related to post-employment defined benefit obligations (corresponding to the legal retirement &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 602.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;benefits obligations) for members of the Group&#x2019;s Board of Directors and Chief Executive Officer amounts to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;149&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 613.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As of December 31, 2023 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.48000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; there was &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;no&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 233.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; liability related to post-employment defined benefit obligations for members of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 624.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group&#x2019;s Board of Directors and Chief Executive Officer. No other post-employment benefits are granted.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 647.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Other arrangements with our &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 155.92000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Directors&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 194.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and Executive Officers &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 658.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group entered into an intellectual property assignment agreement with CEO Hartmut Ehrlich on July 7, 2021. The purpose of this &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 669.46pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreement is to transfer to the Group all the intellectual property rights held by Hartmut Ehrlich on certain patents of which he is a co-&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.66pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;inventor. No compensation has been paid in respect of this transfer. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 691.86pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In connection with Dr. Hartmut Ehrlich&#x2019;s retirement as CEO, the Group entered into a transition protocol with Dr. Ehrlich in April &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 703.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023. Pursuant to the transition protocol, Dr. Ehrlich remained a Group employee on a part-time basis until December 31, 2023 in a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;capacity as advisor to the new Chief Executive Officer against payment of a total compensation of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;100&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand, and a departure &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;indemnity equal to&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.91pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,210&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousand was stated.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 92.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group entered into a management contract with CEO Marc de Garidel on April 18, 202&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. In 2023 and 2024, the Group also &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 104.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;granted AGA plans to its CEO (see terms and conditions in Note 14).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 115.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group entered into a management contract with Chairman of the Board Sylvie Gr&#xe9;goire in July 2024. In 2024, the Group also &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;granted AGA plan 2024-5 to its Chairman of the Board (see terms and conditions in Note 14).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="c-1" id="f-3251">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The aggregate compensation of the members of the Group&#x2019;s Board of Directors and to the Chief Executive Officer includes the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 402.11pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;following: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="position: var(--position); top: 423.31pt; width: 612pt;"&gt;&lt;div style="font-size: 0pt; left: 36pt; position: var(--position); top: 0pt; width: 488.25pt;"&gt;&lt;div&gt;&lt;table style="border-collapse: collapse; display: inline-table; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="height: 0;"&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 241.5pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 0pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3.23pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 83.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(In thousands of euros)&lt;span style="display: inline-block; height: 5.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 30.75pt;"&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 12pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;COMPENSATION&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2023&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 12pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.77pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.82pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;YEAR ENDED &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 12.37pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;DECEMBER 31, &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 21.97pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.12pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024&lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 42.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Fixed compensation owed &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;322&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;471&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 42.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;578&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 54.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Variable compensation owed &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;193&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;282&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 54.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 66.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Contributions in-kind &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 70.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 72.83999999999999pt; position: var(--position);"&gt;9&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;32&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 66.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;68&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 78.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Employer contributions &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;17&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 78.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 90.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Attendance fees&#x2014;Board of Directors &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;103&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;375&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 90.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;495&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 102.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Share-based payments &lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 59.55pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 62.18pt; position: var(--position);"&gt;(217)&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;6,561&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 102.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;10,517&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 114.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 241.5pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Departure indemnities&lt;span style="display: inline-block; height: 5.54pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 114.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 114.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;1,210&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #cceeff; border-bottom: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 114.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 2.93pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.54pt; width: 66.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 68.83999999999999pt; position: var(--position);"&gt;&#x2014;&lt;span style="display: inline-block; height: 5.54pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 12pt;"&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 0pt; position: var(--position); top: 126.75pt; width: 241.5pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 241.5pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Total &lt;span style="display: inline-block; height: 5.41pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 241.5pt; position: var(--position); top: 126.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 62.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 64.84pt; position: var(--position);"&gt;427&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 324.75pt; position: var(--position); top: 126.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 56.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 58.84pt; position: var(--position);"&gt;8,930&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;/td&gt;&lt;td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 3pt double #000000; border-top: 2pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"&gt;&lt;div style="left: 408pt; position: var(--position); top: 126.75pt; width: 80.25pt;"&gt;&lt;div&gt;&lt;div style="line-height: 8pt; position: var(--position); top: 3pt; width: 80.25pt;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 2.63pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 5.41pt; width: 52.21pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 54.84pt; position: var(--position);"&gt;11,657&lt;span style="display: inline-block; height: 5.41pt; width: 2.66pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <abvx:KeyManagementPersonnelCompensationFixedCompensation contextRef="c-10" decimals="-3" id="f-3252" unitRef="eur">322000</abvx:KeyManagementPersonnelCompensationFixedCompensation>
    <abvx:KeyManagementPersonnelCompensationFixedCompensation contextRef="c-11" decimals="-3" id="f-3253" unitRef="eur">471000</abvx:KeyManagementPersonnelCompensationFixedCompensation>
    <abvx:KeyManagementPersonnelCompensationFixedCompensation contextRef="c-1" decimals="-3" id="f-3254" unitRef="eur">578000</abvx:KeyManagementPersonnelCompensationFixedCompensation>
    <abvx:KeyManagementPersonnelCompensationVariableCompensation contextRef="c-10" decimals="-3" id="f-3255" unitRef="eur">193000</abvx:KeyManagementPersonnelCompensationVariableCompensation>
    <abvx:KeyManagementPersonnelCompensationVariableCompensation contextRef="c-11" decimals="-3" id="f-3256" unitRef="eur">282000</abvx:KeyManagementPersonnelCompensationVariableCompensation>
    <abvx:KeyManagementPersonnelCompensationVariableCompensation contextRef="c-1" decimals="-3" id="f-3257" unitRef="eur">0</abvx:KeyManagementPersonnelCompensationVariableCompensation>
    <abvx:KeyManagementPersonnelCompensationInKindContributions contextRef="c-10" decimals="-3" id="f-3258" unitRef="eur">9000</abvx:KeyManagementPersonnelCompensationInKindContributions>
    <abvx:KeyManagementPersonnelCompensationInKindContributions contextRef="c-11" decimals="-3" id="f-3259" unitRef="eur">32000</abvx:KeyManagementPersonnelCompensationInKindContributions>
    <abvx:KeyManagementPersonnelCompensationInKindContributions contextRef="c-1" decimals="-3" id="f-3260" unitRef="eur">68000</abvx:KeyManagementPersonnelCompensationInKindContributions>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c-10" decimals="-3" id="f-3261" unitRef="eur">17000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c-11" decimals="-3" id="f-3262" unitRef="eur">0</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c-1" decimals="-3" id="f-3263" unitRef="eur">0</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <abvx:KeyManagementPersonnelCompensationAttendanceFees contextRef="c-10" decimals="-3" id="f-3264" unitRef="eur">103000</abvx:KeyManagementPersonnelCompensationAttendanceFees>
    <abvx:KeyManagementPersonnelCompensationAttendanceFees contextRef="c-11" decimals="-3" id="f-3265" unitRef="eur">375000</abvx:KeyManagementPersonnelCompensationAttendanceFees>
    <abvx:KeyManagementPersonnelCompensationAttendanceFees contextRef="c-1" decimals="-3" id="f-3266" unitRef="eur">495000</abvx:KeyManagementPersonnelCompensationAttendanceFees>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c-10" decimals="-3" id="f-3267" unitRef="eur">-217000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c-11" decimals="-3" id="f-3268" unitRef="eur">6561000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c-1" decimals="-3" id="f-3269" unitRef="eur">10517000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits contextRef="c-10" decimals="-3" id="f-3270" unitRef="eur">0</ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits contextRef="c-11" decimals="-3" id="f-3271" unitRef="eur">1210000</ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits contextRef="c-1" decimals="-3" id="f-3272" unitRef="eur">0</ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c-10" decimals="-3" id="f-3273" unitRef="eur">427000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c-11" decimals="-3" id="f-3274" unitRef="eur">8930000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c-1" decimals="-3" id="f-3275" unitRef="eur">11657000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan contextRef="c-1322" decimals="-3" id="f-3276" unitRef="eur">149000</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan contextRef="c-1323" decimals="-3" id="f-3277" unitRef="eur">0</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan contextRef="c-1324" decimals="-3" id="f-3278" unitRef="eur">0</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c-1325" decimals="-3" id="f-3279" unitRef="eur">100000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits contextRef="c-1325" decimals="-3" id="f-3280" unitRef="eur">1210000</ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits>
    <ifrs-full:DisclosureOfCommitmentsExplanatory contextRef="c-1" id="f-3281">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Off-balance sheet comm&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 176.72pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;itments give&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 228.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;n&lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 25.1. Commitments under collaboration, research, service provision and licensing agreements granted by the Group &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 203.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Collaboration, research and development, and licensing agreements, and licensing options related to the &#x201c;Modulation of RNA &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 213.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;biogenesis&#x201d; platform. &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.7pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 76.2pt; position: var(--position);"&gt;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;E&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 97.71000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;xclusive licensing agreement with the CNRS, the University of Montpellier and the Institut Curie&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 245.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On December 4, 2008, the French National Centre for Scientific Research (CNRS), the University of Montpellier and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 255.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Institut Curie granted the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.45pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;four&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; exclusive licenses. These licenses cover the use of their technology and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 265.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;products by the Group in the field of human and veterinary health relating to the use of synthetic products modifying &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 275.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;mRNA splicing, for research, diagnosis, prevention and treatment of any possible indication. The licensing agreement &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;includes low single-digit royalties based on future net sales to be paid by the Group. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 301.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research collaboration contract with the CNRS, the University of Montpellier and the Institut Curie&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 502.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Concomitantly with a research collaboration framework contract relating to the creation of a cooperative laboratory, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 327.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ended in December 2021, the parties have signed a financial agreement defining the financial terms for the exploitation &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 337.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of patents. This contract was signed on 15&#160;April 2009 for a duration of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.53000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.65000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and was subsequently renewed up until &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;March 31, 2022. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 363.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 91.05000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Research and development contract with license option with the CNRS, the University of Montpellier and Theradiag&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 568.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 373.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The CNRS, the University of Montpellier, the Group and Theradiag conducted since 2013 a collaborative project &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;notably in the fields of HIV and HTLV-1 called CARENA, in connection with a funding obtained through Bpifrance. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 396.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The overall project provided for co-ownership and cross-licenses on the project's results through various instruments. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 407.81pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group met all obligations and the project was closed in December 2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 437.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Exclu&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 58.730000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;sive licensing contract with &#x201c;The Scripps Research Institute, University of Chicago and Brigham Young University&#x201d; with the &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 447.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x201c;Immune Stimulation&#x201d; platform (ABX196 product) &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 463.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On 11&#160;November 2006, The Scripps Research Institute (La Jolla, California, USA), in agreement with the University of Chicago &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 473.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(Chicago, Illinois, USA) and Brigham Young University (Provo, Utah, USA), granted the Group an exclusive license in the field of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 483.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;human and veterinary health on its technology and products relating to the use of iNKT agonists for research, diagnosis, prevention &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 493.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and treatment of all possible indications. In consideration for the licensing rights granted to it under the agreement, the Group had to: &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;pay The Scripps Research Institute milestones at different stages of clinical and regulatory development of the first &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;product (the milestones amount to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.07pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$50&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at IND filing, paid in September 2019 and capitalized, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.62pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$300&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 564.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Phase 3 and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;$500&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.88pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; at IND approval) and low single-digit royalties for vaccines, diagnostic tests and therapeutic &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;products, according to the amount of net sales, and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 296.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"&gt;&lt;span style="left: 72.7pt; position: var(--position);"&gt;&#x2022;&lt;span style="display: inline-block; height: 6.93pt; width: 14.85pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left: 91.05000000000001pt; position: var(--position);"&gt;give The Scripps Research Institute, University of Chicago and Brigham Young University an equitable interest in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 565.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group (as of the date of these financial statements, these &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;three&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; academic institutions hold &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;0.41%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.01pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the Group&#x2019;s &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 575.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;undiluted capital). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 597.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;During the year ended December 31, 2022, the Group made the decision to freeze the development program for ABX196 in the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 607.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;treatment of hepatocellular cancer (see Note 3.1 - &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 235.97pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Impairment of ABX196 cash-generating unit )&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. Subsequently, in 2024, the licensing &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 617.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;contract was terminated.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 25.2. Commitments under BPI conditional advances &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 685.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Bpifrance CARENA contract &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As part of the development of therapeutic and diagnostic solutions targeting alternative splicing and RNA interference in the fields of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 711.31pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;virology (HIV-AIDS, HTLV-1) and metabolism (obesity), SPLICOS (absorbed by the Group on 31&#160;October 2014) has entered into a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Master Support Agreement with Bpifrance as well as a conditional advance contract in the name of the &#x201c;CARENA&#x201d; Strategic &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Industrial Innovation Project dated December 16, 2013. The Group, acting as project leader for the CARENA project, was associated &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as part of a consortium contract with Theradiag, a Group specializing in in vitro diagnostics and the development of theranostic tests &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for monitoring biotherapies, as well as at the CNRS and the University of Montpellier. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The CARENA project aimed to develop the anti-HIV-AIDS therapeutic program with the compound ABX464 up to the Phase 2b &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 132.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;study, as well as a companion test set up by Theradiag simultaneously with the clinical development. Beyond the anti-HIV-AIDS &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 142.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;program, the CARENA project could extend its pharmacological investigations to another retrovirus that could be combated by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 152.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;same approach: HTLV-1. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 174.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group is committed to reimbursing the received conditional advances up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.85pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,840&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 423.94pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The Group will also have to pay an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 186.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;annuity of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the proceeds from the sale of the intellectual property rights resulting from the project, as well as the sale of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 198.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;prototypes, preproduction and models produced under the project; the sum due to Bpifrance under this provision will be deducted &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 210.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;from the repayment of the conditional advances. In addition, if the advance is repaid under the conditions outlined above, the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 222.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;will pay to Bpifrance, over a period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.66pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="-sec-ix-hidden:f-3291"&gt;five&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; consecutive years after the date on which the repayment schedule ends and provided that &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 234.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group has reached cumulative pre-tax revenue greater than or equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;50&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 381.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, an amount equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;1.20%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.03pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the annual &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 246.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;revenue generated from the sale of the products developed as part of the project. This supplementary payment amount is capped at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 258.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6,800&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The total period, including fixed payments and incentive payments, is limited to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 282.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Termination became effective in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 294.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 2024 after the Group refunded&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;234&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.69pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; corresponding to a portion of the funding received. The Group is therefore &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 305.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;released of its obligations to pay an annuities on the proceeds from the sale of the intellectual property rights resulting from the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 317.06pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;project. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 346.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Bpifrance RNP-VIR contract &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 362.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In pursuit of the CARENA project, focused on the clinical development of a drug molecule and demonstrating the validity of an &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 372.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;innovative therapeutic approach targeting viral RNPs, the Group has entered into a Master Support Agreement with Bpifrance as well &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 382.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as a beneficiary agreement with conditional advance for the &#x201c;RNP-VIR&#x201d; structuring research and development project for &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 392.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;competitiveness dated December 16, 2016. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 414.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The RNP-VIR project aimed to further the discovery of new molecules for the treatment of multiple infectious diseases by the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 424.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;development of the antiviral technology platform. The Group, acting as project leader of the RNP-VIR project, was associated in a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 434.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;consortium contract with the CNRS and the University of Montpellier. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 456.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group is committed to reimburse the received conditional advances up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;6,576&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.6pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. If applicable, the Group will also have &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 466.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;to pay an annuity of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;50%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the proceeds from the sale of the intellectual property rights resulting from the project, as well as the sale &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the prototypes, preproduction and models produced under the project. The sum due to Bpifrance under this provision will be &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 486.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;deducted from the last payment (and if needed from the previous payments). &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 1pt; position: var(--position); top: 508.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#160;&lt;span style="display: inline-block; height: 0.69pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 509.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;If the advance is repaid under the conditions outlined above, the Group will pay to Bpifrance, over a period of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.3pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="-sec-ix-hidden:f-3299"&gt;five&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; consecutive years &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 519.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;following the date on which the repayment schedule ends and provided that the Group has reached cumulative pre-tax revenue greater &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 529.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;than or equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25&#160;million&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.28pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, an amount equal to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;3%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; of the annual revenue generated from the sale of products developed as part of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 539.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;project. The supplementary payments amount is capped at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;5,500&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.08pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The total period, including fixed payments and incentive &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 549.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;payments, is limited to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;15 years&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.07999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 571.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In June 2024, the Group and Bpifrance agreed to terminate the project due to technical failure. Termination became effective in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 583.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;December 2024. The Group is therefore released of its obligations to pay an annuities on the proceeds from the sale of the intellectual &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 594.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;property rights resulting from the project. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 624.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Bpifrance Ebola &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 640.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Bpifrance and Occitanie Region joint support agreement granted on June 2, 2017 consists of conditional advances to the Group &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 650.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;for a total amount of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.4pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;390&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, based on the success of the program (respectively &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.87pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;130&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from the Languedoc &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 660.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Roussillon Midi Pyr&#xe9;n&#xe9;es Region and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.04pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;260&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.63pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; from Bpifrance). In September 2019, the Group decided to terminate this &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 670.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;program, due to the existence of a vaccine in the process of being licensed for this indication as well as changes in the macroeconomic &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 680.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;climate for public funding. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 702.26pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The reimbursement of the conditional advance was spread until June 2024. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 25.3. Pledge assets to Kreos, Claret and Heights &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 86.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As part of the KREOS 1 &amp;amp; 2 bonds, Kreos benefits from first-rate collateral on the Group&#x2019;s principal tangible and intangible assets, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 96.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;including its commercial fund, intellectual property rights in its principal drug candidates, as well as a pledge of the Group&#x2019;s bank &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 106.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;accounts and claims. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 128.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On August 21, 2023, the outstanding Kreos 1 &amp;amp; 2 bond loans were repaid in full, using the proceeds from the new Kreos / Claret &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 139.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Financing (see Note 3.3).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 162.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Kreos / Claret Financing provides for certain restrictive covenants (subject to customary exceptions) which include, among other &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 173.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;things, restrictions on the incurrence of indebtedness, cross-default, the distribution of dividends and the grant of security interests, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 561.55pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 184.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;which would cause the bonds to become repayable on demand in case of breach. As of December 31, 2024, the Group complied with &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 195.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;these restrictive covenants.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; As security for the Kreos / Claret Financing, the lenders benefit from the grant of first-ranking collateral on the Group&#x2019;s principal &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 229.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tangible and intangible assets, including pledges over the Group&#x2019;s business (&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 341.53pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fonds de commerce&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.67pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) as a going concern and intellectual &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 240.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;property rights in the Group's lead drug candidate, as well as pledges over the Group&#x2019;s bank accounts and receivables. Such securities &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 251.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;apply to all tranches of the Kreos / Claret Financing.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 285.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Heights Financing is a senior, unsecured financing. The terms and conditions of the Heights convertible notes include a standard &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 296.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;negative pledge providing that any security granted in favor of other borrowed debt or debt instruments should also be granted in favor &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 307.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the Heights convertible notes on an equal basis (with the exception of the securities issued pursuant to the Kreos / Claret Financing, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 318.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;as detailed above).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 25.4. Other commitments related to research and partnership arrangements &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 364.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In the ordinary course of business, the Group regularly uses the services of subcontractors and enters into research and partnership &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 374.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;arrangements with various contract research organizations, or CROs, and with public- sector partners or subcontractors, who conduct &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 384.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;clinical trials and studies in relation to the drug candidates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 394.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At December 31, 2022, 2023, and 2024 the Group&#x2019;s commitments amounted to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.47pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;194,731&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;,&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.56pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;201,777&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.5799999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 532.0799999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;234,908 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 406.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;. The cost of services performed by CROs is recognized as an operating expense as incurred.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 25.5. Leases &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 471.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Following the end (in December 31, 2021) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the Framework agreement with &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CNRS &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.24pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;(French National Centre for Scientific Research) &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 482.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and the University of Montpellier for research collaboration to create a cooperative laboratory, a hosting agreement was signed in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 494.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2022 with CNRS&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.86pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, so that the Group can continue its research program at the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;CNRS&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.29pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.79pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;center for the year 2023, and was subsequently &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 505.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;renewed for 2024 and 2025. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 528.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In D&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.05pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;ecember 2022, following the end of the Research collaboration contract with the CNRS, the University of Montpellier and the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 540.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Institut Curie, the Company and the Institut Curie concluded a new contract for a duration of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;one year&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 443.31pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, renewable by amendment, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 552.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;granting the Company access to some of the Institute&#x2019;s equipment and consumables. The contract was subsequently renewed for 2024 &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 564.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and 2025, under similar conditions.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 588.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The above agreements fall within the scope of the short-term lease exemption of IFRS 16, and the related rental expenses are therefore &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 599.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;recognized in operating expenses as incurred.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 622.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group's commitments in relation to other ongoing leases are set forth in Note 15.8 and 15.13.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Note 25.6. Litigation related to Prosynergia acquisition &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On December 12, 2024, the Group was notified of a claim from the seller of Prosynergia requesting the payment of an earn-out in &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 668.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;connection with the transaction. Legal proceedings are ongoing in French court. The Group has not recorded any provision in its &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;financial statements in connection with this claim &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;due to uncertainty in the outcome of this proceeding.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <abvx:NumberOfExclusiveLicenses
      contextRef="c-1326"
      decimals="INF"
      id="f-3282"
      unitRef="license">4</abvx:NumberOfExclusiveLicenses>
    <abvx:AgreementPeriod contextRef="c-1327" id="f-3283">P1Y</abvx:AgreementPeriod>
    <abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling contextRef="c-1328" decimals="-3" id="f-3284" unitRef="usd">50000</abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDFiling>
    <abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3 contextRef="c-1328" decimals="-3" id="f-3285" unitRef="usd">300000</abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentPhase3>
    <abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval contextRef="c-1328" decimals="-3" id="f-3286" unitRef="usd">500000</abvx:CollaborationAgreementsPotentialDevelopmentMilestonePaymentINDApproval>
    <abvx:NumberOfAcademicInstitutions
      contextRef="c-1328"
      decimals="INF"
      id="f-3287"
      unitRef="academic_institution">3</abvx:NumberOfAcademicInstitutions>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="c-1329"
      decimals="4"
      id="f-3288"
      unitRef="number">0.0041</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest contextRef="c-1026" decimals="-3" id="f-3289" unitRef="eur">3840000</abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest>
    <abvx:OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight
      contextRef="c-1026"
      decimals="2"
      id="f-3290"
      unitRef="number">0.50</abvx:OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight>
    <abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold contextRef="c-1331" decimals="-6" id="f-3292" unitRef="eur">50000000</abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold>
    <abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped
      contextRef="c-1026"
      decimals="4"
      id="f-3293"
      unitRef="number">0.0120</abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped>
    <abvx:OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped contextRef="c-1332" decimals="-3" id="f-3294" unitRef="eur">6800000</abvx:OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped>
    <abvx:OtherFinancialLiabilitiesRepaymentPeriod contextRef="c-1333" id="f-3295">P15Y</abvx:OtherFinancialLiabilitiesRepaymentPeriod>
    <abvx:RepaymentsOfConditionalAdvances contextRef="c-1334" decimals="-3" id="f-3296" unitRef="eur">234000</abvx:RepaymentsOfConditionalAdvances>
    <abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest contextRef="c-1020" decimals="-3" id="f-3297" unitRef="eur">6576000</abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacityIncludingInterest>
    <abvx:OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight
      contextRef="c-1020"
      decimals="2"
      id="f-3298"
      unitRef="number">0.50</abvx:OtherFinancialLiabilitiesAnnualPercentageOfProceedsFromSaleOfIntellectualPropertyRight>
    <abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold contextRef="c-1336" decimals="-6" id="f-3300" unitRef="eur">25000000</abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDevelopedPreTaxRevenueThreshold>
    <abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped
      contextRef="c-1020"
      decimals="2"
      id="f-3301"
      unitRef="number">0.03</abvx:OtherFinancialLiabilitiesPercentageOfAnnualRevenueFromSaleOfProductsDeveloped>
    <abvx:OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped contextRef="c-1337" decimals="-3" id="f-3302" unitRef="eur">5500000</abvx:OtherFinancialLiabilitiesPayableAnnualRevenueFromSaleOfProductsDeveloped>
    <abvx:OtherFinancialLiabilitiesRepaymentPeriod contextRef="c-1338" id="f-3303">P15Y</abvx:OtherFinancialLiabilitiesRepaymentPeriod>
    <abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity contextRef="c-1339" decimals="-3" id="f-3304" unitRef="eur">390000</abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity>
    <abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity contextRef="c-1340" decimals="-3" id="f-3305" unitRef="eur">130000</abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity>
    <abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity contextRef="c-1341" decimals="-3" id="f-3306" unitRef="eur">260000</abvx:OtherFinancialLiabilitiesMaximumDrawdownCapacity>
    <ifrs-full:CapitalCommitments contextRef="c-6" decimals="-3" id="f-3307" unitRef="eur">194731000</ifrs-full:CapitalCommitments>
    <ifrs-full:CapitalCommitments contextRef="c-7" decimals="-3" id="f-3308" unitRef="eur">201777000</ifrs-full:CapitalCommitments>
    <ifrs-full:CapitalCommitments contextRef="c-5" decimals="-3" id="f-3309" unitRef="eur">234908000</ifrs-full:CapitalCommitments>
    <abvx:LeaseDurationPeriod contextRef="c-1342" id="f-3310">P1Y</abvx:LeaseDurationPeriod>
    <ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory contextRef="c-1" id="f-3311">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Off-balance sheet commitments received and contingent assets &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The maximum amounts receivable by the Group after December 31, 2023 under the &#x201c;RNP-VIR&#x201d; and &#x201c;CARENA&#x201d; and innovation &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 80.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;agreements entered into with Bpifrance, subject to the provision of evidence to support the forecast expenses and the achievement of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 90.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;scientific milestones, are &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;3,255&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,853&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.11pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;, respectively. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;In June 2024, the Group and Bpifrance agreed to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 100.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;terminate the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.9pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.89pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; projects due to technical failures (see Note 15.7).&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 122.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As part of the Kreos / Claret Financing agreement, the Group has received loan commitments from Kreos and Claret for the tranches B &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 134.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and C, of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.42pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;25,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.51pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in aggregate principal amount each (subject to the conditions set forth in Note 15.1.). The B and C &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 146.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;tranches were drawn in March 2024 and June 2024, respectively.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;As part of the Heights Financing agreement, the Group has received a loan commitment from Heights for the tranche B, of up to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;40,000&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.09pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; in aggregate principal amount (subject to the conditions set forth in Note 15.2.).&#160; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.41pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;On the limit date for the drawdown &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;of the second tranche of the Heights Financing (i.e. August 4, 2024), the Group had not drawn down this tranche and has therefore &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 206.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;forgone its right to do so in the future.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 230.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group has not received any significant off-balance sheet commitment and has no significant contingent asset as of December 31, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 242.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2024.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory>
    <ifrs-full:UndrawnBorrowingFacilities contextRef="c-1012" decimals="-3" id="f-3312" unitRef="eur">3255000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities contextRef="c-1016" decimals="-3" id="f-3313" unitRef="eur">1853000</ifrs-full:UndrawnBorrowingFacilities>
    <abvx:NumberOfProjectsTerminated
      contextRef="c-1343"
      decimals="INF"
      id="f-3314"
      unitRef="project">2</abvx:NumberOfProjectsTerminated>
    <ifrs-full:UndrawnBorrowingFacilities contextRef="c-1344" decimals="-3" id="f-3315" unitRef="eur">25000000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities contextRef="c-1345" decimals="-3" id="f-3316" unitRef="eur">40000000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="c-1" id="f-3317">&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.47999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Management and assessment of financial risks &lt;span style="display: inline-block; height: 6.77pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 302.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The principal financial instruments held by the Group are cash and cash equivalents. The purpose of holding these instruments is to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 313.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;finance the ongoing business activities of the Group. It is not the Group&#x2019;s policy to invest in financial instruments for speculative &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 324.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;purposes. The Group does not use derivative financial instruments for hedging purposes. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 347.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The principal risks to which the Group is exposed to are liquidity risk, interest rate risk, foreign currency exchange risk, credit risk and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 358.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;fair value risk. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 387.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Liquidity risk &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 409.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Liquidity risk management aims to ensure that the Group disposes of sufficient liquidity and financial resources to be able to meet &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 420.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;present and future obligations. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 443.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group prepares short-term cash forecasts and annual operating cash flow forecasts as part of its budget procedures.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 465.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Prudent liquidity risk management involves maintaining sufficient liquidity, having access to financial resources through appropriate &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 476.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;credit facilities and being able to unwind market positions.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 499.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group&#x2019;s operations have consumed substantial amounts of cash since inception. Developing pharmaceutical drug candidates, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 510.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;including conducting clinical trials, is expensive, lengthy and risky, and the Group expects its research and development expenses to &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 521.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;increase substantially in connection with its ongoing activities. Accordingly, the Group will continue to require substantial additional &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 532.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;capital to continue its clinical development activities and potentially engage in commercialization activities.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 555.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group's estimate of its cash runway as of the date of approval of these financial statements is set forth in Note 2&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 500.59pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; - Going concern.&lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 584.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Interest rate risk &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 606.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group is exposed to market risks in connection with its medium and long-term borrowings subject to variable interest rates. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 631.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Due to fluctuations in market interest rates&lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 206.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and the refinancing of most of its indebtedness over the year ended December 31, 2023, the &lt;span style="display: inline-block; height: 8.32pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 645pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Group has performed a reassessment of its exposure to interest rate risk. As of December 31, 2023, following the full repayment of the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 656.2pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Kreos 1 bonds, all the Group&#x2019;s non-derivative financial liabilities accounted for at amortized cost bear fixed interest rates. Therefore, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 667.4pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;the Group has limited exposure. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 689.8pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Over the year ended December 31, 2024, the Group has drawn down the second and third tranches of the Kreos / Claret Financing, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 701pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;bearing variable interest rates (consisting of a fixed margin of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.13pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;7.5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; + European Central Bank Base Rate (MRO), with a floor at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 548.81pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;2.5%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 569.64pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 70.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;and a cap at &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.92pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;4%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.25pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;) and has therefore performed a reassessment of its exposure to interest rate risk. Due to the interest rate collar having a &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 81.76pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;range of &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;150&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.52000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; bp, the Group concluded that it still has limited exposure.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 110.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Foreign currency risk &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 126.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The Group is exposed to a risk of exchange rates fluctuations on commercial transactions performed in currencies different from the &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 136.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;functional currency of the Group entity recording the transactions. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 158.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;For the years ended December 31, 2024, 2023 and 2022, expenses in U.S. dollars totaled &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 393.48pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10,547&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.98pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousands, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.46pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;10,112&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 505.96pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousands and &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 170.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;1,390&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.5pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; thousands respective&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ly, based on the average annual exchange rate in effect as of December 31, 2024, December 31, 2023 and &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 182.96pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;December 31, 2022. A&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.76pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;s a result, an adverse &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.21pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;10%&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.54pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; change in the exchange rate for the U.S. dollar against the euro would have resulted &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 194.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;in a foreign exchange rate loss of approxi&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.65pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;mately &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&#x20ac;291&#160;thousand&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; for 2024, &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.57pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;386&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.16pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; fo&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.99pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;r 2023 and a non-material amount for 2022.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 218.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;At this stage, the Group has not adopted any other recurring mechanism of hedging to protect its activity against currency fluctuations. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 228.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;From time to time, the Group may nevertheless subscribe currency term accounts in order to cover a commitment in currency as &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 238.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;described above. The Group may consider in the future using a suitable policy to hedge exchange risks in a more significant manner if &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 248.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;needed. &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 276.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;Credit risk &lt;span style="display: inline-block; height: 6.94pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 298.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The credit risk related to the Group&#x2019;s cash and cash equivalents is not significant in light of the quality of the co-contracting financial &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 310.16pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;institutions. As of December 31, 2024, substantially all of the Group&#x2019;s cash and cash equivalents were maintained with &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 514.1pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;two&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.0899999999999pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; financial &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 321.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;institutions in France and in the United States. While the Group&#x2019;s deposit accounts are i&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.43pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;nsured up to the legal limit, the maintained &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 332.56pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;balances may, at times, exceed this insured limit. As of December 31, 2024, the Group m&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 392.83pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;aintained &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.93pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;&#x20ac;143,881&#160;thousand&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.02pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; in bank deposit &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 343.76pt; width: 612pt;"&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;accounts that are in excess of the legally insured limit in &lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.19pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;two&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.18pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt; legally insured financial institutions. Th&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.2pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;e Group has not experienced any &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 354.96pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;losses in such accounts and does not believe that it is exposed to any significant credit risk related to these instruments.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 377.36pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;The credit risk related to the Group&#x2019;s other receivables and related account is minimal. In particular, the credit risk related to advances &lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; line-height: 10pt; position: var(--position); top: 388.56pt; width: 612pt;"&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;made to C&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color: #ffffff; font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.06pt; position: var(--position); text-decoration: none; white-space: pre;"&gt;&lt;span style="background-color: inherit;"&gt;ROs (see Note 9) is&lt;/span&gt;&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: var(--position); text-decoration: none; white-space: pre;"&gt; deemed insignificant due to their credit ratings.&lt;span style="display: inline-block; height: 6.93pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-1346"
      decimals="3"
      id="f-3318"
      unitRef="number">0.075</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <abvx:BorrowingsBasisInterestRate
      contextRef="c-1347"
      decimals="3"
      id="f-3319"
      unitRef="number">0.025</abvx:BorrowingsBasisInterestRate>
    <abvx:BorrowingsBasisInterestRate
      contextRef="c-1348"
      decimals="2"
      id="f-3320"
      unitRef="number">0.04</abvx:BorrowingsBasisInterestRate>
    <abvx:InterestRateCollarRange
      contextRef="c-1346"
      decimals="4"
      id="f-3321"
      unitRef="number">0.0150</abvx:InterestRateCollarRange>
    <ifrs-full:OperatingExpense contextRef="c-314" decimals="-3" id="f-3322" unitRef="eur">10547000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-313" decimals="-3" id="f-3323" unitRef="eur">10112000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="c-1349" decimals="-3" id="f-3324" unitRef="eur">1390000</ifrs-full:OperatingExpense>
    <abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent
      contextRef="c-1350"
      decimals="2"
      id="f-3325"
      unitRef="number">0.10</abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent>
    <abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss contextRef="c-1350" decimals="-3" id="f-3326" unitRef="eur">-291000</abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss>
    <abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss contextRef="c-1351" decimals="-3" id="f-3327" unitRef="eur">-386000</abvx:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnForeignExchangeGainLoss>
    <abvx:NumberOfFinancialInstitutionsToMaintainCash
      contextRef="c-1352"
      decimals="INF"
      id="f-3328"
      unitRef="financial_institution">2</abvx:NumberOfFinancialInstitutionsToMaintainCash>
    <abvx:BalancesWithBanksInExcessOfLegallyInsuredLimit contextRef="c-1352" decimals="-3" id="f-3329" unitRef="eur">143881000</abvx:BalancesWithBanksInExcessOfLegallyInsuredLimit>
    <abvx:NumberOfFinancialInstitutionsToMaintainCash
      contextRef="c-1352"
      decimals="INF"
      id="f-3330"
      unitRef="financial_institution">2</abvx:NumberOfFinancialInstitutionsToMaintainCash>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-100"
          xlink:label="f-100"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-162"
          xlink:label="f-162"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-142"
          xlink:label="f-142"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-159"
          xlink:label="f-159"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-66" xlink:label="f-66" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-123"
          xlink:label="f-123"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-147"
          xlink:label="f-147"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-105"
          xlink:label="f-105"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-132"
          xlink:label="f-132"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-151"
          xlink:label="f-151"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-114"
          xlink:label="f-114"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-139"
          xlink:label="f-139"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-106"
          xlink:label="f-106"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-81" xlink:label="f-81" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-148"
          xlink:label="f-148"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-160"
          xlink:label="f-160"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-124"
          xlink:label="f-124"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-133"
          xlink:label="f-133"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-115"
          xlink:label="f-115"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-75" xlink:label="f-75" xlink:type="locator"/>
        <link:loc xlink:href="#f-78" xlink:label="f-78" xlink:type="locator"/>
        <link:loc xlink:href="#f-72" xlink:label="f-72" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-135"
          xlink:label="f-135"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-67" xlink:label="f-67" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-153"
          xlink:label="f-153"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-166"
          xlink:label="f-166"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-63" xlink:label="f-63" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-117"
          xlink:label="f-117"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-121"
          xlink:label="f-121"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-145"
          xlink:label="f-145"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-94" xlink:label="f-94" xlink:type="locator"/>
        <link:loc xlink:href="#f-91" xlink:label="f-91" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-120"
          xlink:label="f-120"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-127"
          xlink:label="f-127"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-87" xlink:label="f-87" xlink:type="locator"/>
        <link:loc xlink:href="#f-82" xlink:label="f-82" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-141"
          xlink:label="f-141"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-138"
          xlink:label="f-138"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-165"
          xlink:label="f-165"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-93" xlink:label="f-93" xlink:type="locator"/>
        <link:loc xlink:href="#f-69" xlink:label="f-69" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-163"
          xlink:label="f-163"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-129"
          xlink:label="f-129"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-99" xlink:label="f-99" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-118"
          xlink:label="f-118"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-136"
          xlink:label="f-136"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-108"
          xlink:label="f-108"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-111"
          xlink:label="f-111"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-126"
          xlink:label="f-126"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-154"
          xlink:label="f-154"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-90" xlink:label="f-90" xlink:type="locator"/>
        <link:loc xlink:href="#f-88" xlink:label="f-88" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-150"
          xlink:label="f-150"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-79" xlink:label="f-79" xlink:type="locator"/>
        <link:loc xlink:href="#f-97" xlink:label="f-97" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-109"
          xlink:label="f-109"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-76" xlink:label="f-76" xlink:type="locator"/>
        <link:loc xlink:href="#f-70" xlink:label="f-70" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-157"
          xlink:label="f-157"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-84" xlink:label="f-84" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-112"
          xlink:label="f-112"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-102"
          xlink:label="f-102"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-64" xlink:label="f-64" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-144"
          xlink:label="f-144"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-130"
          xlink:label="f-130"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-156"
          xlink:label="f-156"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-73" xlink:label="f-73" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-103"
          xlink:label="f-103"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-96" xlink:label="f-96" xlink:type="locator"/>
        <link:loc xlink:href="#f-85" xlink:label="f-85" xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; top: -1.9389999999999998pt; vertical-align: super; white-space: pre;">1<xhtml:span style="display: inline-block; height: 3.601pt;"/></xhtml:span><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 74.6pt; position: var(--position); text-decoration: none; white-space: pre;">In application of the <xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 141.22pt; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IAS 1 Presentation of Financial Statements &#x2013; Classification of Liabilities as Current or Non-current, and <xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span><xhtml:div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 678.9pt; width: 612pt;"><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to <xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 482.16pt; position: var(--position); text-decoration: none; white-space: pre;">&#x20ac;19,332<xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 508.16pt; position: var(--position); text-decoration: none; white-space: pre;"><xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span></xhtml:div><xhtml:div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 688.5pt; width: 612pt;"><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to <xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 427.35pt; position: var(--position); text-decoration: none; white-space: pre;">&#x20ac;20,652<xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 453.35pt; position: var(--position); text-decoration: none; white-space: pre;"> thousand, were <xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span></xhtml:div><xhtml:div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 698.1pt; width: 612pt;"><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72pt; position: var(--position); text-decoration: none; white-space: pre;">reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).<xhtml:span style="display: inline-block; height: 5.54pt;"/></xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-100"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-162"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-142"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-159"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-66"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-123"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-147"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-105"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-132"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-151"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-114"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-139"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-106"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-81"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-148"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-160"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-124"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-133"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-115"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-75"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-78"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-72"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-135"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-67"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-153"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-166"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-63"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-117"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-121"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-145"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-94"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-91"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-120"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-127"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-87"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-82"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-141"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-138"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-165"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-93"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-69"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-163"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-129"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-99"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-118"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-136"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-108"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-111"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-126"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-154"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-90"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-88"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-150"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-79"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-97"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-109"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-76"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-70"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-157"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-84"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-112"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-102"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-64"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-144"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-130"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-156"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-73"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-103"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-96"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-85"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-440"
          xlink:label="f-440"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-441"
          xlink:label="f-441"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-439"
          xlink:label="f-439"
          xlink:type="locator"/>
        <link:footnote id="fn-2" xlink:label="fn-2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: 'Times New Roman', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 86.4pt; position: var(--position); text-decoration: none; white-space: pre;">Prosynergia SARL (or "Prosynergia"<xhtml:span style="display: inline-block; height: 4.85pt;"/></xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-440"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-441"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-439"
          xlink:to="fn-2"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
